PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Aronoff, JM; Padilla, M; Fu, QJ; Landsberger, DM				Aronoff, Justin M.; Padilla, Monica; Fu, Qian-Jie; Landsberger, David M.			Contralateral Masking in Bilateral Cochlear Implant Patients: A Model of Medial Olivocochlear Function Loss	PLOS ONE			English	Article							EVOKED OTOACOUSTIC EMISSIONS; EXCITATION PATTERNS; SPEECH-PERCEPTION; USERS; SUPPRESSION; RECIPIENTS; HEARING; DISCRIMINATION; STIMULATION; HUMANS	Contralateral masking is the phenomenon where a masker presented to one ear affects the ability to detect a signal in the opposite ear. For normal hearing listeners, contralateral masking results in masking patterns that are both sharper and dramatically smaller in magnitude than ipsilateral masking. The goal of this study was to investigate whether medial olivocochlear (MOC) efferents are needed for the sharpness and relatively small magnitude of the contralateral masking function. To do this, bilateral cochlear implant patients were tested because, by directly stimulating the auditory nerve, cochlear implants circumvent the effects of the MOC efferents. The results indicated that, as with normal hearing listeners, the contralateral masking function was sharper than the ipsilateral masking function. However, although there was a reduction in the magnitude of the contralateral masking function compared to the ipsilateral masking function, it was relatively modest. This is in sharp contrast to the results of normal hearing listeners where the magnitude of the contralateral masking function is greatly reduced. These results suggest that MOC function may not play a large role in the sharpness of the contralateral masking function but may play a considerable role in the magnitude of the contralateral masking function.	[Aronoff, Justin M.] Univ Illinois, Dept Speech & Hearing Sci, Champaign, IL 61820 USA; [Aronoff, Justin M.; Padilla, Monica; Fu, Qian-Jie; Landsberger, David M.] House Res Inst, Commun & Neurosci Div, Los Angeles, CA USA; [Padilla, Monica; Landsberger, David M.] NYU, Dept Otolaryngol, New York, NY 10016 USA; [Fu, Qian-Jie] Univ Calif Los Angeles, Div Head & Neck Surg, Los Angeles, CA 90024 USA	University of Illinois System; University of Illinois Urbana-Champaign; New York University; University of California System; University of California Los Angeles	Aronoff, JM (corresponding author), Univ Illinois, Dept Speech & Hearing Sci, Champaign, IL 61820 USA.	jaronoff@illinois.edu	Aronoff, Justin/AAP-5827-2021	Aronoff, Justin/0000-0001-6623-5273	National Organization for Hearing Research (NOHR); National Institutes of Health (NIH) [T32DC009975, R01-DC12152, R01-DC001526, R01-DC004993, R03-DC010064, R03-DC013380]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC012152, R01DC001526, R01DC004993, T32DC009975, R03DC013380] Funding Source: NIH RePORTER	National Organization for Hearing Research (NOHR); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by the National Organization for Hearing Research (NOHR) http://nohrfoundation.org/ and by National Institutes of Health (NIH http://www.nidcd.nih.gov/) grants T32DC009975, R01-DC12152, R01-DC001526, R01-DC004993, R03-DC010064, and R03-DC013380. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas PJ, 2004, AUDIOL NEURO-OTOL, V9, P203, DOI 10.1159/000078390; Aronoff JM, 2011, EAR HEARING, V32, P468, DOI 10.1097/AUD.0b013e31820dd3f0; Aschendorff A, 2005, OTOL NEUROTOL, V26, P34, DOI 10.1097/00129492-200501000-00007; Busby PA, 2008, EAR HEARING, V29, P853, DOI 10.1097/AUD.0b013e318181a878; Chatterjee M, 1998, J ACOUST SOC AM, V103, P2565, DOI 10.1121/1.422777; Donaldson GS, 2005, J ACOUST SOC AM, V118, P623, DOI 10.1121/1.1937362; Erceg-Hurn DM, 2008, AM PSYCHOL, V63, P591, DOI 10.1037/0003-066X.63.7.591; FAYAD J, 1991, ANN OTO RHINOL LARYN, V100, P807, DOI 10.1177/000348949110001004; Firszt JB, 2007, OTOL NEUROTOL, V28, P629, DOI 10.1097/01.mao.0000281803.36574.bc; Francart T, 2007, J ACOUST SOC AM, V122, P2826, DOI 10.1121/1.2783130; Guinan JJ, 2006, EAR HEARING, V27, P589, DOI 10.1097/01.aud.0000240507.83072.e7; James C, 2001, AUDIOL NEURO-OTOL, V6, P87, DOI 10.1159/000046814; Landsberger DM, 2009, HEARING RES, V254, P34, DOI 10.1016/j.heares.2009.04.007; Lin P, 2013, J ACOUST SOC AM, V133, P962, DOI 10.1121/1.4773262; Luo X, 2012, J ACOUST SOC AM, V131, P1325, DOI 10.1121/1.3672708; Luo X, 2010, J ACOUST SOC AM, V128, P1215, DOI 10.1121/1.3474237; Maison S, 2001, PSYCHOPHYSIOLOGY, V38, P35, DOI 10.1017/S0048577201990109; MARSH MA, 1993, AM J OTOL, V14, P386; Mills JH, 1996, J ACOUST SOC AM, V100, P3336, DOI 10.1121/1.416974; Moore JK, 1999, AUDIOL NEURO-OTOL, V4, P311, DOI 10.1159/000013855; Poon BB, 2009, J ACOUST SOC AM, V126, P806, DOI 10.1121/1.3158821; PRASHER D, 1994, BRIT J AUDIOL, V28, P247, DOI 10.3109/03005369409086574; RUGGERO MA, 1992, J NEUROPHYSIOL, V68, P1087, DOI 10.1152/jn.1992.68.4.1087; Saoji AA, 2009, EAR HEARING, V30, P559, DOI 10.1097/AUD.0b013e3181ab2b6f; Schrott-Fischer A, 2007, ACTA OTO-LARYNGOL, V127, P13, DOI 10.1080/00016480600652123; Srinivasan AG, 2013, HEARING RES, V299, P29, DOI 10.1016/j.heares.2013.02.004; vanHoesel RJM, 1997, J ACOUST SOC AM, V102, P495, DOI 10.1121/1.419611; Vermeire K, 2013, HEARING RES, V306, P29, DOI 10.1016/j.heares.2013.09.004; Wilcox RR, 1998, BRIT J MATH STAT PSY, V51, P1, DOI 10.1111/j.2044-8317.1998.tb00659.x; ZWICKER E, 1990, ACUSTICA, V70, P189; ZWISLOCKI JJ, 1968, J ACOUST SOC AM, V43, P1267, DOI 10.1121/1.1910978; ZWISLOCKI JJ, 1972, J ACOUST SOC AM, V52, P644, DOI 10.1121/1.1913154	32	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0121591	10.1371/journal.pone.0121591	http://dx.doi.org/10.1371/journal.pone.0121591			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25798581	Green Submitted, Green Published, gold			2022-12-27	WOS:000351987300273
J	Belhabib, D; Sumaila, UR; Lam, VWY; Zeller, D; Le Billon, P; Abou Kane, E; Pauly, D				Belhabib, Dyhia; Sumaila, U. Rashid; Lam, Vicky W. Y.; Zeller, Dirk; Le Billon, Philippe; Abou Kane, Elimane; Pauly, Daniel			Euros vs. Yuan: Comparing European and Chinese Fishing Access in West Africa	PLOS ONE			English	Article							LARGE MARINE ECOSYSTEM; CLIMATE-CHANGE; FISHERIES; MANAGEMENT; RESOURCES; POLICIES; IMPACTS; ILLEGAL; GULF; FOOD	We compare the performance of European Union (EU) and Chinese fisheries access agreements with West African countries in terms of illegal and unreported fishing, economic equity, and patterns of exploitation. Bottom-up re-estimations of catch reveal that the EU (1.6 million t.year(-1)) and China (2.3 million t.year(-1)) report only 29% and 8%, respectively, of their estimated total catches (including estimated discards whenever possible) from West African countries between 2000 and 2010. EU catches are declining, while Chinese catches are increasing and are yet to reach the historic maximum level of EU catches (3 million t.year(-1) on average in the 1970s-1980s). The monetary value of EU fishing agreements, correlated in theory with reported catches, is straightforward to access, in contrast to Chinese agreements. However, once quantified, the value of Chinese agreements is readily traceable within the African economy through the different projects they directly cover, in contrast to the funds disbursed [to host governments] by the EU. Overall, China provides resources equivalent to about 4% of the ex-vessel value [value at landing] of the catch taken by Chinese distant-water fleets from West African waters, while the EU pays 8%. We address the difficulties of separating fees directly related to fishing from other economic or political motivations for Chinese fees, which could introduce a bias to the present findings as this operation is not performed for EU access fees officially related to fishing. Our study reveals that the EU and China perform similarly in terms of illegal fishing, patterns of exploitation and sustainability of resource use, while under-reporting by the EU increases and that by China decreases. The EU agreements provide, in theory, room for improving scientific research, monitoring and surveillance, suggesting a better performance than for Chinese agreements, but the end-use of the EU funds are more difficult, and sometime impossible to ascertain.	[Belhabib, Dyhia; Lam, Vicky W. Y.; Zeller, Dirk; Pauly, Daniel] Univ British Columbia, Fisheries Ctr, Sea Us, Vancouver, BC V5Z 1M9, Canada; [Sumaila, U. Rashid] Univ British Columbia, Fisheries Ctr, Fisheries Econ Res Unit, Vancouver, BC V5Z 1M9, Canada; [Le Billon, Philippe] Univ British Columbia, Dept Geog, Vancouver, BC, Canada; [Abou Kane, Elimane] Oceanog & Fisheries Mauritanian Res Inst, Nouadhibou, Mauritania	University of British Columbia; University of British Columbia; University of British Columbia	Belhabib, D (corresponding author), Univ British Columbia, Fisheries Ctr, Sea Us, 2202 Main Mall, Vancouver, BC V5Z 1M9, Canada.	d.belhabib@fisheries.ubc.ca	Pauly, Daniel Marc/AAY-2316-2021; Sumaila, U. Rashid/ABE-6475-2020; Lam, Vicky/AAX-1684-2020	Pauly, Daniel/0000-0003-3756-4793; Zeller, Dirk/0000-0001-7304-4125	MAVA Foundation; Pew Charitable Trusts; Paul G. Allen Family Foundation	MAVA Foundation; Pew Charitable Trusts; Paul G. Allen Family Foundation	This is a contribution of the Sea Around Us toward the project "Marine Conservation Research, Collaboration and Support in West Africa", funded by the MAVA Foundation. The Sea Around Us is supported by The Pew Charitable Trusts and the Paul G. Allen Family Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acheampong A, 1998, COHERENCE EU FISHERI; African Centre for Economic Transformation, 2009, LOOK E CHIN AFR ENG; Agnew DJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004570; Agnew DJ, 2010, ESTIMATION COST ILLE; AgriTrade, 2012, EU FISH COMM PROM SE; Alder J., 2004, Journal of Environment & Development, V13, P156, DOI 10.1177/1070496504266092; Allison EH, 2009, FISH FISH, V10, P173, DOI 10.1111/j.1467-2979.2008.00310.x; [Anonymous], 2002, PEOPLE DAILY; [Anonymous], REALITY LEAVES LOT I; Aristegui J, 2009, PROG OCEANOGR, V83, P33, DOI 10.1016/j.pocean.2009.07.031; Atta-Mills J, 2004, NAT RESOUR FORUM, V28, P13, DOI 10.1111/j.0165-0203.2004.00068.x; Balguerias E, 2000, ICES J MAR SCI, V57, P15, DOI 10.1006/jmsc.1999.0572; Barber Brad M., 2006, MONITORING MONITOR E; Belhabib D., 2012, MARINE FISHERIES C 1, P23; Belhabib D, 2015, FISHERIES T IN PRESS; Belhabib D, 2012, MARINE FISHERIES CAT, P91; Belhabib D, 2013, BIG FISHING SMALL FI; Belhabib D, 2015, ATTEMPT REC IN PRESS; Belhabib D., 2014, RICH FISHERIES POOR; Belhabib D, 2014, UNSEEN 1 COLLABORATI; Belhabib D, 2014, 201504 U BRIT COL FI; Belhabib D., 2012, MARINE FISHERIES CAT, P61; Belhabib D, 2015, MARINE FI 2 IN PRESS; Belhabib D, 2015, MARINE FI IN PRESS 2; Belhabib D, 2012, MARINE FISHERIES C 1, P79; Belhabib D, 2014, FISH RES, V151, P1, DOI 10.1016/j.fishres.2013.12.006; Beuret M, 2009, CHINAFRIQUE PEKIN CO; Bignouma G, 2007, CAHIERS OUTER MER, V240, P1; Blomeyer R., 2012, DIRECTORATE GEN INTE; Bonfil R., 1998, IMPACTS DISTANT WATE; Bureau of Economic and Business Affairs, 2013, 2013 INV CLIM STAT M; Carevich KE, 1998, W BRUK OC POL SEM U; CFFA, 2012, CFFA PARTICIPATION; Chen CJ, 2010, HAMB STUD MARIT AFF, V20, P1, DOI 10.1007/978-3-642-15693-9; Cherif AM, 2011, CONVENTION PLY HONDO; COFREPECHE, 2000, ET BIL SOC MIXT CONT; Diop H, 1996, MARINE RESOURCE EC, V11, P71; Escobar A, 2012, MACAU MACAO MAGAZINE; Etim L, 2015, MARINE FI IN PRESS 2; EU, 2012, PROT FIX POSS PECH C; Failler P, 2005, PRESENT FUTURE EC NU; Food and Agriculture Organisation, 2006, NEW DIR FISH, DOI [10.1111/brv.12155, DOI 10.1111/BRV.12155]; Frederic L, 2013, MAR POLICY, V38, P257, DOI 10.1016/j.marpol.2012.06.001; Frontani H.G., 2012, J SUSTAINABLE DEV AF, V14, P275; Gascuel D, 2009, IMPACT PECHE ECOSYST; Gascuel D, 2007, RECONSTRUCTION MARIN, P105; GOFFINET T, 1992, OCEAN COAST MANAGE, V17, P105, DOI 10.1016/0964-5691(92)90039-N; Gorez B, 2010, ILLEGAL FISHING GUIN; Hutchings L, 2009, PROG OCEANOGR, V83, P15, DOI 10.1016/j.pocean.2009.07.046; Iheduru OC, 1995, J DEV AREAS, V30, P63; Ilnyckyj M, 2007, LEGALITY SUSTAINABIL; Kaczynski VM, 2000, COAST MANAGE, V28, P235, DOI 10.1080/089207500408647; Kaczynski VM, 2002, MAR POLICY, V26, P75, DOI 10.1016/S0308-597X(01)00039-2; KACZYNSKI VM, 1989, MAR POLICY, V13, P2, DOI 10.1016/0308-597X(89)90037-7; Katsarova I, 2013, EU MAURITANIA FISHER; Kent G, 1997, FOOD POLICY, V22, P393, DOI 10.1016/S0306-9192(97)00030-4; Lam VWY, 2012, AFR J MAR SCI, V34, P103, DOI 10.2989/1814232X.2012.673294; Lamm A, 2011, EPOCH TIMES; Mallory GT, 2012, CHINA DISTANT WATER; Mallory TG, 2013, MAR POLICY, V38, P99, DOI 10.1016/j.marpol.2012.05.024; MCGLADE JM, 2002, GULF GUINEA LARGE MA; Ndiaye TM, 2011, CHIN J INT LAW, V10, P373, DOI 10.1093/chinesejil/jmr012; Njock JC, 2007, PILOT PROJECT COASTA; Nunoo F.K.E., 2014, WORKING PAPER SERIES; Obaidullah F, 2010, AFRICA IS FEEDING EU; Paquotte P, 2006, OPTIONS MEDITERRAN B, P43; Pauly D, 2003, LAR MAR ECOSYST, V12, P337; Pauly D, 2002, NATURE, V418, P689, DOI 10.1038/nature01017; Pauly D., 2006, MAR STUD MAST, V4, P7, DOI DOI 10.1126/SCIENCE.279.5352.860.PMID:9452385; Pauly D, 1998, EC FISH COOP B, V11, P4, DOI DOI 10.1007/S11160-014-9353-Y; Pauly D, 2012, ROLE CHINA WORLD FIS; Pauly D, 1990, MALTHUSIAN OVERFISHI, P3; Pauly D, 2002, MASS BALANCE TROPHIC; Pauly D, 2014, FISH FISH, V15, P474, DOI 10.1111/faf.12032; Pauly D, 2009, SCI MAR, V73, P215, DOI 10.3989/scimar.2009.73n2215; Plage H, 2001, ECONOMIST; Ponte S, 2007, DEV POLICY REV, V25, P113, DOI 10.1111/j.1467-7679.2007.00362.x; Porter G, 1997, ROLE TRADE POLICIES; Seto K, 2015, MARINE FI 2 IN PRESS; Standing A, 2008, CORRUPTION IND FISHE; Sumaila U. Rashid, 2010, Journal of Bioeconomics, V12, P201, DOI 10.1007/s10818-010-9091-8; Sumaila Ussif Rashid, 2006, CATCHING MORE BAIT B; Swartz W, 2013, ENVIRON RESOUR ECON, V56, P467, DOI 10.1007/s10640-012-9611-1; Swartz W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015143; Tull D.M., 2008, CHINA AFRICA EUROPEA; Ukwe CN, 2003, MAR POLLUT BULL, V47, P219, DOI 10.1016/S0025-326X(02)00473-3; UNDOC, 2011, TRANSN ORG CRIM FISH; Vidal J., 2012, GUARDIAN; Watson R, 2004, FISH FISH, V5, P168, DOI 10.1111/j.1467-2979.2004.00142.x; WorldFishCenter, 2005, FISH FOOD SEC AFR; Zeller D, 2007, FISH B-NOAA, V105, P266	91	55	56	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0118351	10.1371/journal.pone.0118351	http://dx.doi.org/10.1371/journal.pone.0118351			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CE8IA	25793775	Green Published, gold, Green Submitted			2022-12-27	WOS:000352084200019
J	Corovic, S; Markelc, B; Dolinar, M; Cemazar, M; Jarm, T				Corovic, Selma; Markelc, Bostjan; Dolinar, Mitja; Cemazar, Maja; Jarm, Tomaz			Modeling of Microvascular Permeability Changes after Electroporation	PLOS ONE			English	Article							DORSAL WINDOW CHAMBER; VASCULAR-PERMEABILITY; ELECTRIC PULSES; DRUG-DELIVERY; GENE DELIVERY; ELECTROCHEMOTHERAPY; MACROMOLECULES; TRANSPORT; MELANOMA; CANCER	Vascular endothelium selectively controls the transport of plasma contents across the blood vessel wall. The principal objective of our preliminary study was to quantify the electroporation-induced increase in permeability of blood vessel wall for macromolecules, which do not normally extravasate from blood into skin interstitium in homeostatic conditions. Our study combines mathematical modeling (by employing pharmacokinetic and finite element modeling approach) with in vivo measurements (by intravital fluorescence microscopy). Extravasation of fluorescently labeled dextran molecules of two different sizes (70 kDa and 2000 kDa) following the application of electroporation pulses was investigated in order to simulate extravasation of therapeutic macromolecules with molecular weights comparable to molecular weight of particles such as antibodies and plasmid DNA. The increase in blood vessel permeability due to electroporation and corresponding transvascular transport was quantified by calculating the apparent diffusion coefficients for skin microvessel wall (D [mu m(2)/s]) for both molecular sizes. The calculated apparent diffusion coefficients were D = 0.0086 mu m(2)/s and D = 0.0045 mu m(2)/s for 70 kDa and 2000 kDa dextran molecules, respectively. The results of our preliminary study have important implications in development of realistic mathematical models for prediction of extravasation and delivery of large therapeutic molecules to target tissues by means of electroporation.	[Corovic, Selma; Dolinar, Mitja; Jarm, Tomaz] Univ Ljubljana, Lab Biocybernet, Fac Elect Engn, SI-1000 Ljubljana, Slovenia; [Markelc, Bostjan; Cemazar, Maja] Inst Oncol Ljubljana, Dept Expt Oncol, SI-1000 Ljubljana, Slovenia; [Cemazar, Maja] Univ Primorska, Fac Hlth Sci, SI-6310 Izola, Slovenia	University of Ljubljana; Institute of Oncology - Slovenia; University of Primorska	Jarm, T (corresponding author), Univ Ljubljana, Lab Biocybernet, Fac Elect Engn, Trzaska Cesta 25, SI-1000 Ljubljana, Slovenia.	tomaz.jarm@fe.uni-lj.si	Markelc, Bostjan/AAC-2968-2022; Cemazar, Maja/K-6182-2013	Markelc, Bostjan/0000-0002-8674-702X; Cemazar, Maja/0000-0002-1418-1928	Slovenian Research Agency [Z2-4312, P3-0003, P2-0249]	Slovenian Research Agency(Slovenian Research Agency - Slovenia)	Funding: The work was financed by Slovenian Research Agency through grants Z2-4312, P3-0003 and P2-0249. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong JK, 2004, BIOPHYS J, V87, P4259, DOI 10.1529/biophysj.104.047746; Bellard E, 2012, J CONTROL RELEASE, V163, P396, DOI 10.1016/j.jconrel.2012.09.010; Blagus T, 2013, J CONTROL RELEASE, V172, P862, DOI 10.1016/j.jconrel.2013.09.030; Brown EB, 2004, MICROVASC RES, V67, P231, DOI 10.1016/j.mvr.2004.02.001; Cemazar M, 2010, CURR GENE THER, V10, P300, DOI 10.2174/156652310791823425; Chames P, 2009, BRIT J PHARMACOL, V157, P220, DOI 10.1111/j.1476-5381.2009.00190.x; Chiarella P, 2013, CURR DRUG METAB, V14, P291, DOI 10.2174/1389200211314030004; Cornelissen LH, 2008, SKIN RES TECHNOL, V14, P462, DOI 10.1111/j.1600-0846.2008.00313.x; Corovic S, 2013, BIOMED ENG ONLINE, V12, DOI 10.1186/1475-925X-12-16; Curry FRE, 2010, CARDIOVASC RES, V87, P218, DOI 10.1093/cvr/cvq115; Daud AI, 2008, J CLIN ONCOL, V26, P5896, DOI 10.1200/JCO.2007.15.6794; Dreher MR, 2006, JNCI-J NATL CANCER I, V98, P335, DOI 10.1093/jnci/djj070; Egawa G, 2013, SCI REP-UK, V3, DOI 10.1038/srep01932; Ferraro B, 2011, CLIN INFECT DIS, V53, P296, DOI 10.1093/cid/cir334; GAHM T, 1984, RES EXP MED, V184, P1, DOI 10.1007/BF01852217; Gehl J, 2002, BBA-GEN SUBJECTS, V1569, P51, DOI 10.1016/S0304-4165(01)00233-1; Golberg A, 2013, IEEE T BIO-MED ENG, V60, P707, DOI 10.1109/TBME.2013.2238672; Goldberg A, 2014, CHEM ENG COMMUN, V201, P102; Granot Y, 2008, INT J HEAT MASS TRAN, V51, P5610, DOI 10.1016/j.ijheatmasstransfer.2008.04.041; Heller LC, 2010, CURR GENE THER, V10, P312; Jarm T, 2010, EXPERT REV ANTICANC, V10, P729, DOI 10.1586/ERA.10.43; Kanthou C, 2006, MOL CANCER THER, V5, P3145, DOI 10.1158/1535-7163.MCT-06-0410; Kim D, 1993, AM J PHYSIOL, V265, P993; Kotnik T, 2012, IEEE ELECTR INSUL M, V28, P14, DOI 10.1109/MEI.2012.6268438; Larina IV, 2005, ANTICANCER RES, V25, P149; LEY K, 1986, MICROVASC RES, V31, P84, DOI 10.1016/0026-2862(86)90009-9; Lin F, 2011, VACCINE, V29, P6771, DOI 10.1016/j.vaccine.2010.12.057; Mali B, 2013, RADIOL ONCOL, V47, P32, DOI 10.2478/raon-2013-0002; Marcan M, 2014, RADIOL ONCOL, V48, P267, DOI 10.2478/raon-2014-0022; Markelc B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059557; Markelc B, 2012, J MEMBRANE BIOL, V245, P545, DOI 10.1007/s00232-012-9435-5; Marrero B, 2012, BIOMATERIALS, V33, P3036, DOI 10.1016/j.biomaterials.2011.12.049; Matthiessen LW, 2011, ACTA ONCOL, V50, P621, DOI 10.3109/0284186X.2011.573626; Mehvar R, 2000, J CONTROL RELEASE, V69, P1, DOI 10.1016/S0168-3659(00)00302-3; Michel CC, 1996, CARDIOVASC RES, V32, P644, DOI 10.1016/0008-6363(96)00064-8; Miklavcic D, 2014, BIOMED ENG ONLINE, V13, DOI 10.1186/1475-925X-13-29; Mir LM, 2006, EJC SUPPL, V4, P14, DOI 10.1016/j.ejcsup.2006.08.003; NEUMANN E, 1982, EMBO J, V1, P841, DOI 10.1002/j.1460-2075.1982.tb01257.x; Palmer GM, 2011, NAT PROTOC, V6, P1355, DOI 10.1038/nprot.2011.349; Prijic S, 2012, BIOMATERIALS, V33, P4379, DOI 10.1016/j.biomaterials.2012.02.061; Renkin EM, 1998, MICROCIRCULATION, V5, P139, DOI 10.1038/sj.mn.7300016; RENKIN EM, 1985, J APPL PHYSIOL, V58, P315, DOI 10.1152/jappl.1985.58.2.315; RIPPE B, 1994, PHYSIOL REV, V74, P163, DOI 10.1152/physrev.1994.74.1.163; Sersa G, 2008, BRIT J CANCER, V98, P388, DOI 10.1038/sj.bjc.6604168; Sersa G, 1999, ANTICANCER RES, V19, P4017; Sersa G, 1999, EUR J CANCER, V35, P672, DOI 10.1016/S0959-8049(98)00426-2; Sersa G, 2012, CANCER TREAT REV, V38, P379, DOI 10.1016/j.ctrv.2011.07.006; Spanggaard I, 2013, HUM GENE THER CL DEV, V24, P99, DOI 10.1089/humc.2012.240; Sykova E, 2008, PHYSIOL REV, V88, P1277, DOI 10.1152/physrev.00027.2007; Towhidi L, 2012, RADIOL ONCOL, V46, P119, DOI 10.2478/v10019-012-0014-2; YUAN F, 1993, MICROVASC RES, V45, P269, DOI 10.1006/mvre.1993.1024; Zeng GSL, 2012, BIOMED ENG ONLINE, V11, DOI 10.1186/1475-925X-11-70; Zupanic A, 2008, RADIOL ONCOL, V42, P93, DOI 10.2478/v10019-008-0005-5	53	6	6	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0121370	10.1371/journal.pone.0121370	http://dx.doi.org/10.1371/journal.pone.0121370			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25793292	gold, Green Published, Green Submitted			2022-12-27	WOS:000352083900129
J	Heyne, GW; Melberg, CG; Doroodchi, P; Parins, KF; Kietzman, HW; Everson, JL; Ansen-Wilson, LJ; Lipinski, RJ				Heyne, Galen W.; Melberg, Cal G.; Doroodchi, Padydeh; Parins, Kia F.; Kietzman, Henry W.; Everson, Joshua L.; Ansen-Wilson, Lydia J.; Lipinski, Robert J.			Definition of Critical Periods for Hedgehog Pathway Antagonist-Induced Holoprosencephaly, Cleft Lip, and Cleft Palate	PLOS ONE			English	Article							SONIC-HEDGEHOG; FOREBRAIN; DEFECTS; MORPHOGENESIS; EPIDEMIOLOGY; PREVALENCE; EXPRESSION; MUTATIONS; ANOMALIES; GROWTH	The Hedgehog (Hh) signaling pathway mediates multiple spatiotemporally-specific aspects of brain and face development. Genetic and chemical disruptions of the pathway are known to result in an array of structural malformations, including holoprosencephaly (HPE), clefts of the lip with or without cleft palate (CL/P), and clefts of the secondary palate only (CPO). Here, we examined patterns of dysmorphology caused by acute, stage-specific Hh signaling inhibition. Timed-pregnant wildtype C57BL/6J mice were administered a single dose of the potent pathway antagonist vismodegib at discrete time points between gestational day (GD) 7.0 and 10.0, an interval approximately corresponding to the 15th to 24th days of human gestation. The resultant pattern of facial and brain dysmorphology was dependent upon stage of exposure. Insult between GD7.0 and GD8.25 resulted in HPE, with peak incidence following exposure at GD7.5. Unilateral clefts of the lip extending into the primary palate were also observed, with peak incidence following exposure at GD8.875. Insult between GD9.0 and GD10.0 resulted in CPO and forelimb abnormalities. We have previously demonstrated that Hh antagonist-induced cleft lip results from deficiency of the medial nasal process and show here that CPO is associated with reduced growth of the maxillary-derived palatal shelves. By defining the critical periods for the induction of HPE, CL/P, and CPO with fine temporal resolution, these results provide a mechanism by which Hh pathway disruption can result in "non-syndromic" orofacial clefting, or HPE with or without co-occurring clefts. This study also establishes a novel and tractable mouse model of human craniofacial malformations using a single dose of a commercially available and pathwayspecific drug.	[Heyne, Galen W.; Melberg, Cal G.; Doroodchi, Padydeh; Parins, Kia F.; Kietzman, Henry W.; Everson, Joshua L.; Ansen-Wilson, Lydia J.; Lipinski, Robert J.] Univ Wisconsin, Sch Vet Med, Dept Comparat Biosci, Madison, WI 53706 USA; [Everson, Joshua L.; Lipinski, Robert J.] Univ Wisconsin, Sch Med & Publ Hlth, Mol & Environm Toxicol Ctr, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Lipinski, RJ (corresponding author), Univ Wisconsin, Sch Vet Med, Dept Comparat Biosci, Madison, WI 53706 USA.	rjlipinski@wisc.edu		Lipinski, Robert/0000-0002-1994-4090; Everson, Josh/0000-0002-2887-8574; Colopy, Lydia/0000-0002-8955-117X; Kietzman, Henry/0000-0001-7435-0546	National Institute of Dental and Craniofacial Research/National Institutes of Health [R00DE022101-02]; National Institute of Environmental Health Sciences/National Institutes of Health [T32ES007015-37]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R00DE022101] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007015] Funding Source: NIH RePORTER	National Institute of Dental and Craniofacial Research/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); National Institute of Environmental Health Sciences/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was funded by R00DE022101-02 grants to RJL from the National Institute of Dental and Craniofacial Research/National Institutes of Health and T32ES007015-37 to JLE from the National Institute of Environmental Health Sciences/National Institutes of Health. The content of this publication is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ando T, 2011, MECH DEVELOP, V128, P129, DOI 10.1016/j.mod.2010.11.005; Cordero D, 2004, J CLIN INVEST, V114, P485, DOI 10.1172/JCI200419596; DASILVA OG, 1993, AM J ORTHOD DENTOFAC, V104, P269; Dhar Reema Sharma, 2014, J Indian Soc Pedod Prev Dent, V32, P346, DOI 10.4103/0970-4388.140972; DIEWERT VM, 1992, CRIT REV ORAL BIOL M, V4, P111, DOI 10.1177/10454411920040010201; Dunty WC, 2002, DEV NEUROSCI-BASEL, V24, P328, DOI 10.1159/000066748; ECHELARD Y, 1993, CELL, V75, P1417, DOI 10.1016/0092-8674(93)90627-3; Franca MM, 2010, J CLIN ENDOCR METAB, V95, pE384, DOI 10.1210/jc.2010-1050; Geng X, 2008, DEV CELL, V15, P236, DOI 10.1016/j.devcel.2008.07.003; Gritli-Linde A, 2008, CURR TOP DEV BIOL, V84, P37, DOI 10.1016/S0070-2153(08)00602-9; Hu D, 2009, DEVELOPMENT, V136, P107, DOI 10.1242/dev.026583; Jeong JH, 2004, GENE DEV, V18, P937, DOI 10.1101/gad.1190304; Keaton AA, 2010, AM J MED GENET C, V154C, P170, DOI 10.1002/ajmg.c.30251; Kietzman HW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089448; KOTCH LE, 1992, TERATOLOGY, V46, P323, DOI 10.1002/tera.1420460403; Lan Y, 2009, DEVELOPMENT, V136, P1387, DOI 10.1242/dev.028167; Leoncini E, 2008, BIRTH DEFECTS RES A, V82, P585, DOI 10.1002/bdra.20479; Lidral Andrew C, 2008, Semin Orthod, V14, P103, DOI 10.1053/j.sodo.2008.02.002; Lima MC, 2009, CLEFT PALATE-CRAN J, V46, P481, DOI 10.1597/08-018.1; Lipinski RJ, 2008, TOXICOL SCI, V104, P189, DOI 10.1093/toxsci/kfn076; Lipinski RJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102603; Lipinski RJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043067; Lipinski RJ, 2010, BIRTH DEFECTS RES A, V88, P232, DOI 10.1002/bdra.20656; Marcucio RS, 2005, DEV BIOL, V284, P48, DOI 10.1016/j.ydbio.2005.04.030; Mastroiacovo P, 2011, CLEFT PALATE-CRAN J, V48, P66, DOI 10.1597/09-217; MATSUNAGA E, 1977, TERATOLOGY, V16, P261, DOI 10.1002/tera.1420160304; Milerad J, 1997, PEDIATRICS, V100, P180, DOI 10.1542/peds.100.2.180; Mo R, 1997, DEVELOPMENT, V124, P113; Moreno LM, 2009, HUM MOL GENET, V18, P4879, DOI 10.1093/hmg/ddp444; Murray JC, 2002, CLIN GENET, V61, P248, DOI 10.1034/j.1399-0004.2002.610402.x; Orioli IM, 2010, AM J MED GENET C, V154C, P13, DOI 10.1002/ajmg.c.30233; Ribeiro LA, 2005, AM J MED GENET A, V136A, P350, DOI 10.1002/ajmg.a.30627; Richieri-Costa A, 2010, AM J MED GENET C, V154C, P149, DOI 10.1002/ajmg.c.30247; RIDDLE RD, 1993, CELL, V75, P1401, DOI 10.1016/0092-8674(93)90626-2; Robarge KD, 2009, BIOORG MED CHEM LETT, V19, P5576, DOI 10.1016/j.bmcl.2009.08.049; SANDHAM A, 1986, CLEFT PALATE J, V23, P206; Sasaki Y, 2007, ARCH ORAL BIOL, V52, P260, DOI 10.1016/j.archoralbio.2006.09.012; Solomon BD, 2012, J MED GENET, V49, P473, DOI 10.1136/jmedgenet-2012-101008; van Straaten HWM, 2001, ANAT EMBRYOL, V203, P225, DOI 10.1007/s004290100169; Vieira AR, 2008, J DENT RES, V87, P119, DOI 10.1177/154405910808700202; Watkins SE, 2014, CLIN PLAST SURG, V41, P149, DOI 10.1016/j.cps.2013.12.003; Wong H, 2011, CLIN CANCER RES, V17, P4682, DOI 10.1158/1078-0432.CCR-11-0975	42	41	43	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0120517	10.1371/journal.pone.0120517	http://dx.doi.org/10.1371/journal.pone.0120517			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25793997	gold, Green Published, Green Submitted			2022-12-27	WOS:000352083900046
J	Miyamoto-Mikami, E; Sato, K; Kurihara, T; Hasegawa, N; Fujie, S; Fujita, S; Sanada, K; Hamaoka, T; Tabata, I; Iemitsu, M				Miyamoto-Mikami, Eri; Sato, Koji; Kurihara, Toshiyuki; Hasegawa, Natsuki; Fujie, Shumpei; Fujita, Satoshi; Sanada, Kiyoshi; Hamaoka, Takafumi; Tabata, Izumi; Iemitsu, Motoyuki			Endurance Training-Induced Increase in Circulating Irisin Levels Is Associated with Reduction of Abdominal Visceral Fat in Middle-Aged and Older Adults	PLOS ONE			English	Article							BODY-COMPOSITION; ADIPOSE-TISSUE; WEIGHT-LOSS; FNDC5 GENE; EXERCISE; MUSCLE; EXPRESSION; FITNESS; HUMANS; STRENGTH	To elucidate the effects of endurance training on circulating irisin levels in young and middle-aged/older adults, and to determine the association between endurance training-induced alteration of irisin and reduction in body fat. Twenty-five healthy young (age 21 +/- 1 years; 16 men, 9 women) and 28 healthy middle-aged/older adults (age 67 +/- 8 years; 12 men, 16 women) participated in the study. Each age cohort was divided into two groups: the endurance-training group (14 young, 14 middle-aged/older) and the control group. Subjects in the training groups completed an 8-week endurance-training program (cycling at 60-70% peak oxygen uptake [VO2peak] for 45 min, 3 days/week). Before and after the intervention, we evaluated serum irisin level, VO2peak, and body composition. The increase in VO2peak in the young and middle-aged/older training groups after the intervention period was significantly greater than those in the young and middle-aged/older control groups (P < 0.05). Serum irisin level was significantly increased in the middle-aged/older training group after the intervention period (P < 0.01), but not in the young training group. Furthermore, in the middle-aged/older training group, the endurance training-induced reduction in visceral adipose tissue area was negatively correlated with the change in serum irisin level (r = -0.54, P < 0.05). These results suggest a possible role for secreted irisin in the exercise-induced alteration of abdominal visceral fat in middle-aged and older adults.	[Miyamoto-Mikami, Eri; Sato, Koji; Kurihara, Toshiyuki; Hasegawa, Natsuki; Fujie, Shumpei; Fujita, Satoshi; Sanada, Kiyoshi; Hamaoka, Takafumi; Tabata, Izumi; Iemitsu, Motoyuki] Ritsumeikan Univ, Fac Sport & Hlth Sci, Kusatsu, Shiga, Japan; [Miyamoto-Mikami, Eri] Japan Soc Promot Sci, Tokyo, Japan	Ritsumeikan University; Japan Society for the Promotion of Science	Iemitsu, M (corresponding author), Ritsumeikan Univ, Fac Sport & Hlth Sci, Kusatsu, Shiga, Japan.	iemitsu@fc.ritsumei.ac.jp	MIYAMOTO-MIKAMI, ERI/AAT-3245-2020	Miyamoto-Mikami, Eri/0000-0002-4864-8581; Sanada, Kiyoshi/0000-0003-3703-4098	Ministry of Education, Culture, Sports, Science and Technology of Japan (KAKENHI) [26282199, 25560378]; Grants-in-Aid for Scientific Research [25560378] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan (KAKENHI)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (KAKENHI: #26282199 and #25560378, M. Iemitsu).	Bostrom P, 2012, NATURE, V481, P463, DOI 10.1038/nature10777; Ciolac EG, 2013, CLINICS, V68, P710, DOI 10.6061/clinics/2013(05)20; Freedland Eric S, 2004, Nutr Metab (Lond), V1, P12, DOI 10.1186/1743-7075-1-12; Gleeson M, 2011, NAT REV IMMUNOL, V11, P607, DOI 10.1038/nri3041; Hecksteden A, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-235; Huh JY, 2014, METABOLISM, V63, P918, DOI 10.1016/j.metabol.2014.04.001; Huh JY, 2012, METABOLISM, V61, P1725, DOI 10.1016/j.metabol.2012.09.002; Ibrahim MM, 2010, OBES REV, V11, P11, DOI 10.1111/j.1467-789X.2009.00623.x; Irving BA, 2008, MED SCI SPORT EXER, V40, P1863, DOI 10.1249/MSS.0b013e3181801d40; Kang CH, 2013, EXP GERONTOL, V48, P1343, DOI 10.1016/j.exger.2013.08.004; Koltai E, 2012, AM J PHYSIOL-REG I, V303, pR127, DOI 10.1152/ajpregu.00337.2011; Lecker SH, 2012, CIRC-HEART FAIL, V5, P812, DOI 10.1161/CIRCHEARTFAILURE.112.969543; Moreno-Navarrete JM, 2013, J CLIN ENDOCR METAB, V98, pE769, DOI 10.1210/jc.2012-2749; Pedersen BK, 2009, J PHYSIOL-LONDON, V587, P5559, DOI 10.1113/jphysiol.2009.179515; Pekkala S, 2013, J PHYSIOL-LONDON, V591, P5393, DOI 10.1113/jphysiol.2013.263707; Roca-Rivada A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060563; Scalzo RL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090696; Sillanpaa E, 2008, MED SCI SPORT EXER, V40, P950, DOI 10.1249/MSS.0b013e318165c854; Sillanpaa E, 2009, EUR J APPL PHYSIOL, V106, P285, DOI 10.1007/s00421-009-1013-x; So R, 2012, NUTR METAB, V9, DOI 10.1186/1743-7075-9-56; Swick AG, 2013, METABOLISM, V62, P1070, DOI 10.1016/j.metabol.2013.02.012; Tanaka H, 2001, J AM COLL CARDIOL, V37, P153, DOI 10.1016/S0735-1097(00)01054-8; Tanisawa K, 2014, METABOLISM, V63, P574, DOI 10.1016/j.metabol.2014.01.005; Timmons JA, 2012, NATURE, V488, pE9, DOI 10.1038/nature11364; Vissers D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056415	25	73	78	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0120354	10.1371/journal.pone.0120354	http://dx.doi.org/10.1371/journal.pone.0120354			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25793753	Green Published, Green Submitted, gold			2022-12-27	WOS:000352083900016
J	Park, IU; Wojtal, N; Silverberg, MJ; Bauer, HM; Hurley, LB; Manos, MM				Park, Ina U.; Wojtal, Nicole; Silverberg, Michael J.; Bauer, Heidi M.; Hurley, Leo B.; Manos, M. Michele			Cytology and Human Papillomavirus Co-Test Results Preceding Incident High-Grade Cervical Intraepithelial Neoplasia	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; LIQUID-BASED CYTOLOGY; CONVENTIONAL CYTOLOGY; CONSENSUS GUIDELINES; CANCER PRECURSORS; CLINICAL-PRACTICE; WOMEN; METAANALYSIS; MANAGEMENT; RISK	Objective High-risk HPV (hrHPV) and cytology co-testing is utilized for primary cervical cancer screening and for enhanced follow-up of women who are hrHPV-positive, cytology negative. However, data are lacking on the utility of this method to detect pre-cancer or cancer in community-based clinical practice. This study describes cytology and hrHPV results preceding high-grade cervical intraepithelial neoplasia, adenocarcinoma in situ, or cervical cancer (i.e., CIN2+) in an integrated health system employing routine co-testing among women aged 30 years and older. Methods We conducted a cross-sectional analysis of adult female members of Kaiser Permanente Northern California (KPNC) with incident CIN2+ between July 2008 and June 2009. The primary outcome was the proportions of cytologic diagnoses and hrHPV co-test results preceding a diagnosis of CIN2+. Cervical cytology and hrHPV testing results were abstracted from electronic medical records. Results Of 1283 CIN2+ cases among adult women, 880 (68.5%) were among women aged 30 years and older and 145/880 (16.5%, 95% CI 14.1-19.1) had only normal cytology during the 12 months prior to diagnosis. Furthermore, 133/880 (15.1%, 95% 12.9-17.7) were preceded by only normal cytology and persistent hrHPV infection (at least 2 positive hrHPV tests) during the 6-36 months preceding CIN2+ diagnosis. Conclusions Incident CIN2+ is frequently preceded by normal cytology and persistent hrHPV infection among women aged 30 years and older; screening strategies that employ HPV testing and cytology may improve the detection of CIN2+ compared with cytology alone.	[Park, Ina U.; Bauer, Heidi M.] Calif Dept Publ Hlth, Ctr Infect Dis, Sexually Transmitted Dis Control Branch, Div Communicable Dis Control, Richmond, CA 94804 USA; [Wojtal, Nicole] Univ Calif Berkeley, Hlth & Med Sci, Berkeley, CA 94720 USA; [Silverberg, Michael J.; Hurley, Leo B.; Manos, M. Michele] Kaiser Permanente No Calif, Div Res, Oakland, CA USA	California Department of Public Health; University of California System; University of California Berkeley; Kaiser Permanente	Park, IU (corresponding author), Calif Dept Publ Hlth, Ctr Infect Dis, Sexually Transmitted Dis Control Branch, Div Communicable Dis Control, Richmond, CA 94804 USA.	ina.park@cdph.ca.gov			Permanente Medical Group; Centers for Disease Control and Prevention (CDC), Supplement to California Emerging Infections Program (CEIP) [5-U01/C1000309-05]; NIAID [K01AI071725]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K01AI071725] Funding Source: NIH RePORTER	Permanente Medical Group; Centers for Disease Control and Prevention (CDC), Supplement to California Emerging Infections Program (CEIP); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was jointly supported by The Permanente Medical Group and the Centers for Disease Control and Prevention (CDC), Supplement to California Emerging Infections Program (CEIP) Cooperative Agreement 5-U01/C1000309-05. Dr. Silverberg's time was also supported in part by grant number K01AI071725 from the NIAID. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arbyn M, 2008, OBSTET GYNECOL, V111, P167, DOI 10.1097/01.AOG.0000296488.85807.b3; Bruni L, 2010, J INFECT DIS, V202, P1789, DOI 10.1086/657321; Bulkmans NWJ, 2007, LANCET, V370, P1764, DOI 10.1016/S0140-6736(07)61450-0; Castle PE, 2009, OBSTET GYNECOL, V113, P18, DOI 10.1097/AOG.0b013e31818f5008; Cuzick J, 2003, LANCET, V362, P1871, DOI 10.1016/S0140-6736(03)14955-0; Datta SD, 2008, ANN INTERN MED, V148, P493, DOI 10.7326/0003-4819-148-7-200804010-00004; Gordon N, 2006, KAISER PERMANENTE ME; Kaiser Permanente, FAST FACTS KAIS PERM; Katki HA, 2011, LANCET ONCOL, V12, P663, DOI 10.1016/S1470-2045(11)70145-0; Khan MJ, 2005, JNCI-J NATL CANCER I, V97, P1072, DOI 10.1093/jnci/dji187; Kinney WK, 1998, OBSTET GYNECOL, V91, P973, DOI 10.1016/S0029-7844(98)00080-5; Kitchener HC, 2009, LANCET ONCOL, V10, P672, DOI 10.1016/S1470-2045(09)70156-1; Kyrgiou M, 2006, LANCET, V367, P489, DOI 10.1016/S0140-6736(06)68181-6; Manos MM, 1999, JAMA-J AM MED ASSOC, V281, P1605, DOI 10.1001/jama.281.17.1605; Massad LS, 2013, J LOW GENIT TRACT DI, V17, pS1, DOI 10.1097/LGT.0b013e318287d329; Naucler P, 2007, NEW ENGL J MED, V357, P1589, DOI 10.1056/NEJMoa073204; Rijkaart DC, 2012, LANCET ONCOL, V13, P78, DOI 10.1016/S1470-2045(11)70296-0; Ronco G, 2007, BRIT MED J, V335, P28, DOI 10.1136/bmj.39196.740995.BE; Ronco G, 2010, LANCET ONCOL, V11, P249, DOI 10.1016/S1470-2045(09)70360-2; Saslow D, 2012, CA-CANCER J CLIN, V62, P147, DOI 10.3322/caac.21139; Sawaya GF, 2009, NEW ENGL J MED, V361, P2503, DOI 10.1056/NEJMp0911380; Siebers AG, 2009, JAMA-J AM MED ASSOC, V302, P1757, DOI 10.1001/jama.2009.1569; Solomon D, 2001, J NATL CANCER I, V93, P293, DOI 10.1093/jnci/93.4.293; Solomon D, 2002, JAMA-J AM MED ASSOC, V287, P2114, DOI 10.1001/jama.287.16.2114; Spence AR, 2007, PREV MED, V45, P93, DOI 10.1016/j.ypmed.2007.06.007; US Food and Drug Administration, 2003, DIG HYBR CAPT 2 HIGH; Whitlock EP, 2011, ANN INTERN MED, V155, P687, DOI 10.7326/0003-4819-155-10-201111150-00376; Wright TC, 2004, OBSTET GYNECOL, V103, P304, DOI 10.1097/01.AOG.0000109426.82624.f8; Wright TC, 2007, AM J OBSTET GYNECOL, V197, P340, DOI 10.1016/j.ajog.2007.07.050; Wright TC, 2007, CLIN OBSTET GYNECOL, V50, P313, DOI 10.1097/GRF.0b013e31804a8285; Zhao CQ, 2013, ARCH PATHOL LAB MED, V137, P942, DOI 10.5858/arpa.2012-0307-OA	31	3	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0118938	10.1371/journal.pone.0118938	http://dx.doi.org/10.1371/journal.pone.0118938			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25793987	gold, Green Published, Green Submitted			2022-12-27	WOS:000352084200048
J	Shao, XY; Guo, Y; Xu, XH; Zheng, YB; Wang, JW; Chen, ZH; Huang, J; Huang, P; Cai, JF; Wang, XJ				Shao, Xiying; Guo, Yong; Xu, Xiaohong; Zheng, Yabing; Wang, Jiwen; Chen, Zhanhong; Huang, Jian; Huang, Ping; Cai, Jufen; Wang, Xiaojia			The CYP19 RS4646 Polymorphism Is Related to the Prognosis of Stage I-II and Operable Stage III Breast Cancer	PLOS ONE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISM; AROMATASE GENE; ESTROGEN-LEVELS; REPEAT POLYMORPHISM; VARIANTS; EFFICACY; WOMEN; ASSOCIATION; EXPRESSION; INHIBITOR	Purpose Aromatase, encoded by the CYP19 gene, catalyzes the final step of the conversion of androgens to estrogens. Given the critical role of CYP19 in estrogen synthesis, the potential influence of CYP19 rs4646 polymorphism on breast cancer survival, deserves further study. Methods Genotyping for CYP19 rs4646 variants was performed on 406 Chinese women with stage I-II and operable stage III breast cancer. Associations were evaluated between CYP19 rs4646 genotypes and disease-free survival (DFS). Results In premenopausal patients, women who are homozygous for the minor allele (AA) have a longer DFS compared with those carrying the major allele (CC or AC) (87 months versus 48.7 months; Hazard ratio (HR) = 0.56, 95% CI = 0.318-0.985, P = 0.041). These differences were further demonstrated by a multivariate analysis (HR = 0.456, 95% CI = 0.249-0.836, P = 0.011). Conversely, the same variant (AA) was estimated to be associated with a poorer DFS in postmenopausal women (AA versus AC or CC: 13.7 months versus 56.3 months; HR = 2.758, 95% CI = 1.432-5.313, P = 0.002). Furthermore, the differences were confirmed by the COX proportional hazards model (HR = 2.983, 95% CI = 1.494-5.955, P = 0.002). Conclusions The present study indicates that CYP19 rs4646 polymorphism is related to DFS in early breast cancer and that the prognosis index of the homozygous for the minor allele (AA) may depend on menopause status. The findings are novel, if confirmed, rs4646 genotypes may provide useful information for routine management in breast cancer.	[Shao, Xiying; Zheng, Yabing; Chen, Zhanhong; Huang, Jian; Huang, Ping; Cai, Jufen; Wang, Xiaojia] Zhejiang Chinese Med Univ, Affiliated Zhejiang Canc Hosp, Dept Med Oncol, Hangzhou, Zhejiang, Peoples R China; [Guo, Yong] Zhejiang Tradit Chinese Med Univ, Affiliated Hosp 1, Dept Oncol, Hangzhou, Zhejiang, Peoples R China; [Xu, Xiaohong] Zhejiang Chinese Med Univ, Affiliated Zhejiang Canc Hosp, Clin Lab, Hangzhou, Zhejiang, Peoples R China; [Wang, Jiwen] Zhejiang Canc Hosp, Dept Oncol, Hangzhou, Zhejiang, Peoples R China	Zhejiang Cancer Hospital; Zhejiang Chinese Medical University; Zhejiang Chinese Medical University; Zhejiang Cancer Hospital; Zhejiang Chinese Medical University; Zhejiang Cancer Hospital	Wang, XJ (corresponding author), Zhejiang Chinese Med Univ, Affiliated Zhejiang Canc Hosp, Dept Med Oncol, Hangzhou, Zhejiang, Peoples R China.	wxiaojia0803@163.com			Zhejiang provincial natural science foundation (China) [Y206856, Y2101312]; Zhejiang provincial medical science and technology program (China) [2010QNA006, 2011RCA011]; Zhejiang traditional Chinese medicine science and technology program (China) [2013ZB022, 2014ZB019]; Special fund of Wu Jieping Medical Foundation (China) [320.670010007]	Zhejiang provincial natural science foundation (China)(Natural Science Foundation of Zhejiang Province); Zhejiang provincial medical science and technology program (China); Zhejiang traditional Chinese medicine science and technology program (China); Special fund of Wu Jieping Medical Foundation (China)	Funding: This work was supported by grants from Zhejiang provincial natural science foundation (Y206856, Y2101312, China), Zhejiang provincial medical science and technology program (2010QNA006, 2011RCA011, China), Zhejiang traditional Chinese medicine science and technology program (2013ZB022, 2014ZB019, China), Special fund of Wu Jieping Medical Foundation clinical research (320.670010007, China). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bond GL, 2004, CELL, V119, P591, DOI 10.1016/j.cell.2004.11.022; Bulun SE, 2005, PHARMACOL REV, V57, P359, DOI 10.1124/pr.57.3.6; Bulun SE, 2003, J STEROID BIOCHEM, V86, P219, DOI 10.1016/S0960-0760(03)00359-5; Carbonnelle E, 2011, CLIN BIOCHEM, V44, P104, DOI 10.1016/j.clinbiochem.2010.06.017; Chen XW, 2006, HUM MUTAT, V27, P427, DOI 10.1002/humu.20319; Colomer R, 2008, CLIN CANCER RES, V14, P811, DOI 10.1158/1078-0432.CCR-07-1923; de Jong PC, 2001, BREAST, V10, P91, DOI 10.1054/brst.2000.0209; Duan JB, 2003, HUM MOL GENET, V12, P205, DOI 10.1093/hmg/ddg055; Dunning AM, 2004, JNCI-J NATL CANCER I, V96, P936, DOI 10.1093/jnci/djh167; Fasching PA, 2008, BREAST CANCER RES TR, V112, P89, DOI 10.1007/s10549-007-9822-2; Ferraldeschi R, 2012, BREAST CANCER RES TR, V133, P1191, DOI 10.1007/s10549-012-2010-z; Garcia-Casado Z, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-36; Gennari L, 2004, J CLIN ENDOCR METAB, V89, P2803, DOI 10.1210/jc.2003-031342; Germain D, 2011, ENDOCRIN METAB CLIN, V40, P473, DOI 10.1016/j.ecl.2011.05.009; Haiman CA, 2000, INT J CANCER, V87, P204, DOI 10.1002/1097-0215(20000715)87:2<204::AID-IJC8>3.3.CO;2-V; Haiman CA, 2007, CANCER RES, V67, P1893, DOI 10.1158/0008-5472.CAN-06-4123; Huang CS, 2008, ONCOLOGIST, V13, P751, DOI 10.1634/theoncologist.2007-0246; Hudis CA, 2007, J CLIN ONCOL, V25, P2127, DOI 10.1200/JCO.2006.10.3523; Irahara N, 2006, INT J CANCER, V118, P1915, DOI 10.1002/ijc.21562; Jin Y, 1996, J CLIN INVEST, V98, P1745, DOI 10.1172/JCI118973; Kristensen VN, 2000, ONCOGENE, V19, P1329, DOI 10.1038/sj.onc.1203425; Kuo SH, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/562197; Liu L, 2013, INT J MOL SCI, V14, P18973, DOI 10.3390/ijms140918973; Lonning PE, 1996, BREAST CANCER RES TR, V39, P335, DOI 10.1007/BF01806162; Ma CX, 2005, CANCER RES, V65, P11071, DOI 10.1158/0008-5472.CAN-05-1218; Pedraza AM, 2012, BREAST CANCER RES TR, V134, P1199, DOI 10.1007/s10549-012-2026-4; Miki Y, 2007, CANCER RES, V67, P3945, DOI 10.1158/0008-5472.CAN-06-3105; Park IH, 2011, CANCER CHEMOTH PHARM, V68, P1263, DOI 10.1007/s00280-011-1615-y; Piersma D, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1756; Rock CL, 2008, CANCER EPIDEM BIOMAR, V17, P614, DOI 10.1158/1055-9965.EPI-07-0761; Rodriguez S, 2009, AM J EPIDEMIOL, V169, P505, DOI 10.1093/aje/kwn359; Santen RJ, 2009, ENDOCR REV, V30, P343, DOI 10.1210/er.2008-0016; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Skorupski P, 2006, AM J OBSTET GYNECOL, V194, P346, DOI 10.1016/j.ajog.2005.07.034; Tworoger SS, 2004, CANCER EPIDEM BIOMAR, V13, P94, DOI 10.1158/1055-9965.EPI-03-0026; Wang LW, 2010, CANCER RES, V70, P319, DOI 10.1158/0008-5472.CAN-09-3224; Xu WH, 2007, AM J EPIDEMIOL, V166, P1420, DOI 10.1093/aje/kwm242; ZHAO Y, 1995, MOL ENDOCRINOL, V9, P340, DOI 10.1210/me.9.3.340	38	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0121535	10.1371/journal.pone.0121535	http://dx.doi.org/10.1371/journal.pone.0121535			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25793413	Green Submitted, Green Published, gold			2022-12-27	WOS:000352083900139
J	Dent, KA; Christie, KJ; Bye, N; Basrai, HS; Turbic, A; Habgood, M; Cate, HS; Turnley, AM				Dent, Krista A.; Christie, Kimberly J.; Bye, Nicole; Basrai, Harleen S.; Turbic, Alisa; Habgood, Mark; Cate, Holly S.; Turnley, Ann M.			Oligodendrocyte Birth and Death following Traumatic Brain Injury in Adult Mice	PLOS ONE			English	Article							CONTROLLED CORTICAL IMPACT; WHITE-MATTER; PRECURSOR CELLS; AMYLOID-BETA; PROGENITORS; ASTROCYTES; EXPRESSION; AXONS; PROLIFERATION; REMYELINATION	Oligodendrocytes are responsible for producing and maintaining myelin throughout the CNS. One of the pathological features observed following traumatic brain injury (TBI) is the progressive demyelination and degeneration of axons within white matter tracts. While the effect of TBI on axonal health has been well documented, there is limited information regarding the response of oligodendrocytes within these areas. The aim of this study was to characterize the response of both mature oligodendrocytes and immature proliferative oligodendrocyte lineage cells across a 3 month timecourse following TBI. A computer-controlled cortical impact model was used to produce a focal lesion in the left motor cortex of adult mice. Immunohistochemical analyses were performed at 48 hours, 7 days, 2 weeks, 5 weeks and 3 months following injury to assess the prevalence of mature CC-1(+) oligodendrocyte cell death, immature Olig2(+) cell proliferation and longer term survival in the corpus callosum and external capsule. Decreased CC-1 immunoreactivity was observed in white matter adjacent to the site of injury from 2 days to 2 weeks post TBI, with ongoing mature oligodendrocyte apoptosis after this time. Conversely, proliferation of Olig2(+) cells was observed as early as 48 hours post TBI and significant numbers of these cells and their progeny survived and remained in the external capsule within the injured hemisphere until at least 3 months post injury. These findings demonstrate that immature oligodendrocyte lineage cells respond to TBI by replacing oligodendrocytes lost due to damage and that this process occurs for months after injury.	[Dent, Krista A.; Christie, Kimberly J.; Bye, Nicole; Basrai, Harleen S.; Turbic, Alisa; Cate, Holly S.; Turnley, Ann M.] Univ Melbourne, Dept Anat & Neurosci, Parkville, Vic 3052, Australia; [Habgood, Mark] Univ Melbourne, Dept Pharmacol & Therapeut, Parkville, Vic 3052, Australia	University of Melbourne; University of Melbourne	Turnley, AM (corresponding author), Univ Melbourne, Dept Anat & Neurosci, Parkville, Vic 3052, Australia.	turnley@unimelb.edu.au		Cate, Holly/0000-0001-6392-9640; Turbic, Alisa/0000-0002-9703-2484	National Health and Medical Research Council of Australia (NHMRC) [GNT 1045125, 628344]; Stem Cells Australia (SCA)	National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Stem Cells Australia (SCA)	This work was supported by National Health and Medical Research Council of Australia (NHMRC) (www.NHMRC.gov.au), Project grant #GNT 1045125 to AMT, Research Fellowship # 628344 to AMT, and Stem Cells Australia (SCA) (www.stemcellsaustralia.edu.au) to AMT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bradl M, 2010, ACTA NEUROPATHOL, V119, P37, DOI 10.1007/s00401-009-0601-5; Bramlett HM, 2002, ACTA NEUROPATHOL, V103, P607, DOI 10.1007/s00401-001-0510-8; Buffo A, 2005, P NATL ACAD SCI USA, V102, P18183, DOI 10.1073/pnas.0506535102; Caprariello AV, 2012, ANN NEUROL, V72, P395, DOI 10.1002/ana.23606; Carbonnel WS, 1999, ACTA NEUROPATHOL, V98, P396, DOI 10.1007/s004010051100; Chen XH, 2004, AM J PATHOL, V165, P357, DOI 10.1016/S0002-9440(10)63303-2; Connor JR, 1996, GLIA, V17, P83, DOI 10.1002/(SICI)1098-1136(199606)17:2<83::AID-GLIA1>3.0.CO;2-7; Conti AC, 1998, J NEUROSCI, V18, P5663; Dewar D, 2003, J CEREBR BLOOD F MET, V23, P263, DOI 10.1097/01.WCB.0000053472.41007.F9; Dimou L, 2008, J NEUROSCI, V28, P10434, DOI 10.1523/JNEUROSCI.2831-08.2008; Dong HX, 2003, J NEUROSCI, V23, P8682; Eghwrudjakpor P O, 2010, Niger J Med, V19, P14; Ek CJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012021; Fawcett JW, 1999, BRAIN RES BULL, V49, P377, DOI 10.1016/S0361-9230(99)00072-6; Flygt J, 2013, EUR J NEUROSCI, V38, P2153, DOI 10.1111/ejn.12179; FOKSEANG J, 1995, DEV BIOL, V171, P1, DOI 10.1006/dbio.1995.1255; Foote AK, 2005, BRAIN, V128, P528, DOI 10.1093/brain/awh417; Hampton DW, 2004, NEUROSCIENCE, V127, P813, DOI 10.1016/j.neuroscience.2004.05.028; Horiuchi M, 2006, J BIOL CHEM, V281, P20095, DOI 10.1074/jbc.M603179200; Hughes EG, 2013, NAT NEUROSCI, V16, P668, DOI 10.1038/nn.3390; Johnson S.C., 1994, NEUROPSYCHOLOGY, V8, P307, DOI [DOI 10.1037/0894-4105.8.3.301, 10.1037/0894-4105.8.3.301]; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Jurewicz A, 2005, BRAIN, V128, P2675, DOI 10.1093/brain/awh627; Kang SH, 2010, NEURON, V68, P668, DOI 10.1016/j.neuron.2010.09.009; Keirstead HS, 1997, J NEUROPATH EXP NEUR, V56, P1191, DOI 10.1097/00005072-199711000-00003; Kernie SG, 2001, J NEUROSCI RES, V66, P317, DOI 10.1002/jnr.10013; KIDD GJ, 1990, J NEUROSCI RES, V26, P409, DOI 10.1002/jnr.490260403; Lau LT, 2001, J NEUROTRAUM, V18, P351, DOI 10.1089/08977150151071035; LEVIN HS, 1990, J NEUROSURG, V73, P77, DOI 10.3171/jns.1990.73.1.0077; LEVINE JM, 1994, J NEUROSCI, V14, P4716; Levine JM, 1999, EXP NEUROL, V160, P333, DOI 10.1006/exnr.1999.7224; Lindner M, 2008, NEUROPATH APPL NEURO, V34, P105, DOI 10.1111/j.1365-2990.2007.00879.x; Loane DJ, 2010, NEUROTHERAPEUTICS, V7, P366, DOI 10.1016/j.nurt.2010.07.002; Lotocki G, 2011, NEUROSCI LETT, V499, P143, DOI 10.1016/j.neulet.2011.05.056; Mason JL, 2004, AM J PATHOL, V164, P1673, DOI 10.1016/S0002-9440(10)63726-1; Matute C, 2007, J NEUROSCI, V27, P9525, DOI 10.1523/JNEUROSCI.0579-07.2007; McDonald JW, 1998, NAT MED, V4, P291, DOI 10.1038/nm0398-291; McGavern DB, 1999, EXP NEUROL, V158, P171, DOI 10.1006/exnr.1999.7082; MCPHILEMY K, 1990, J NEUROCYTOL, V19, P494, DOI 10.1007/BF01257239; MCPHILEMY K, 1991, NEUROPATH APPL NEURO, V17, P275, DOI 10.1111/j.1365-2990.1991.tb00725.x; McTigue DM, 2001, J NEUROSCI, V21, P3392, DOI 10.1523/JNEUROSCI.21-10-03392.2001; Menn B, 2006, J NEUROSCI, V26, P7907, DOI 10.1523/JNEUROSCI.1299-06.2006; Moore N, 2011, J ONCOL, V2011, DOI 10.1155/2011/396076; Onyszchuk G, 2007, J NEUROSCI METH, V160, P187, DOI 10.1016/j.jneumeth.2006.09.007; PALMER AM, 1993, J NEUROCHEM, V61, P2015, DOI 10.1111/j.1471-4159.1993.tb07437.x; Patel JR, 2011, FEBS LETT, V585, P3730, DOI 10.1016/j.febslet.2011.04.037; Smith DH, 2003, J NEUROSURG, V98, P1072, DOI 10.3171/jns.2003.98.5.1072; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Stone JR, 2004, EXP NEUROL, V190, P59, DOI 10.1016/j.expneurol.2004.05.022; Thorburne SK, 1996, J NEUROCHEM, V67, P1014; Tyurin VA, 2000, J NEUROCHEM, V75, P2178, DOI 10.1046/j.1471-4159.2000.0752178.x; Young KM, 2013, NEURON, V77, P873, DOI 10.1016/j.neuron.2013.01.006; Zhao JW, 2009, EUR J NEUROSCI, V29, P1853, DOI 10.1111/j.1460-9568.2009.06736.x; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016	54	41	44	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0121541	10.1371/journal.pone.0121541	http://dx.doi.org/10.1371/journal.pone.0121541			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25798924	Green Published, gold			2022-12-27	WOS:000351987300265
J	Teixeira, AS; Monteiro, PT; Carrico, JA; Ramirez, M; Francisco, AP				Teixeira, Andreia Sofia; Monteiro, Pedro T.; Carrico, Joao A.; Ramirez, Mario; Francisco, Alexandre P.			Not Seeing the Forest for the Trees: Size of the Minimum Spanning Trees (MSTs) Forest and Branch Significance in MST-Based Phylogenetic Analysis	PLOS ONE			English	Article							RECOMBINATION; EVOLUTION; GENOME	Trees, including minimum spanning trees (MSTs), are commonly used in phylogenetic studies. But, for the research community, it may be unclear that the presented tree is just a hypothesis, chosen from among many possible alternatives. In this scenario, it is important to quantify our confidence in both the trees and the branches/edges included in such trees. In this paper, we address this problem for MSTs by introducing a new edge betweenness metric for undirected and weighted graphs. This spanning edge betweenness metric is defined as the fraction of equivalent MSTs where a given edge is present. The metric provides a per edge statistic that is similar to that of the bootstrap approach frequently used in phylogenetics to support the grouping of taxa. We provide methods for the exact computation of this metric based on the well known Kirchhoff's matrix tree theorem. Moreover, we implement and make available a module for the PHYLOViZ software and evaluate the proposed metric concerning both effectiveness and computational performance. Analysis of trees generated using multilocus sequence typing data (MLST) and the goeBURST algorithm revealed that the space of possible MSTs in real data sets is extremely large. Selection of the edge to be represented using bootstrap could lead to unreliable results since alternative edges are present in the same fraction of equivalent MSTs. The choice of the MST to be presented, results from criteria implemented in the algorithm that must be based in biologically plausible models.	[Teixeira, Andreia Sofia; Monteiro, Pedro T.; Carrico, Joao A.; Francisco, Alexandre P.] INESC ID Lisboa, Lisbon, Portugal; [Teixeira, Andreia Sofia; Monteiro, Pedro T.; Francisco, Alexandre P.] Univ Lisbon, Inst Super Tecn, P-1699 Lisbon, Portugal; [Teixeira, Andreia Sofia; Carrico, Joao A.; Ramirez, Mario] Univ Lisbon, Fac Med, Inst Mol Med, Inst Microbiol, P-1699 Lisbon, Portugal	INESC-ID; Universidade de Lisboa; Universidade de Lisboa; Instituto Superior Tecnico; Universidade de Lisboa	Francisco, AP (corresponding author), INESC ID Lisboa, Lisbon, Portugal.	aplf@tecnico.pt	Monteiro, Pedro T./E-5113-2010; Carriço, Joao André/A-7367-2008; Francisco, Alexandre/B-9429-2009; Ramirez, Mario/B-4993-2008; Teixeira, Andreia Sofia Monteiro/N-1702-2018	Monteiro, Pedro T./0000-0002-7934-5495; Carriço, Joao André/0000-0002-5274-2722; Francisco, Alexandre/0000-0003-4852-1641; Ramirez, Mario/0000-0002-4084-6233; Teixeira, Andreia Sofia Monteiro/0000-0002-2758-1891	FCT-Fundacao para a Ciencia e Tecnologia [NETDYN PTDC/EIA-CCO/118533/2010, DATASTORM EXCL/EEI-ESS/0257/2012, UID/CEC/50021/2013]; Fundação para a Ciência e a Tecnologia [EXCL/EEI-ESS/0257/2012, PTDC/EIA-CCO/118533/2010] Funding Source: FCT	FCT-Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and Technology); Fundação para a Ciência e a Tecnologia	AST, PTM, JAC and APF were partly supported by national funds through FCT-Fundacao para a Ciencia e Tecnologia (http://www.fct.pt/), under project/grants NETDYN PTDC/EIA-CCO/118533/2010, DATASTORM EXCL/EEI-ESS/0257/2012 and UID/CEC/50021/2013. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Borgatti S.P., 2006, SOC NETWORKS, V28, P466, DOI DOI 10.1016/J.S0CNET.2005.11.005; Broder AZ, 1997, J ALGORITHM, V24, P171, DOI 10.1006/jagm.1996.0851; Cormen TH, 2001, INTRODUCTION TO ALGO; Costa LD, 2007, ADV PHYS, V56, P167, DOI 10.1080/00018730601170527; Darwin C, 1861, ALBEMARLE STREET; Edmonds Jack, 1971, MATH PROGRAM, V1, P127, DOI [10.1007/BF01584082, DOI 10.1007/BF01584082]; Eppstein D, 1995, TECHNICAL REPORT 95; EXCOFFIER L, 1994, GENETICS, V136, P343; Feil EJ, 2004, J BACTERIOL, V186, P1518, DOI 10.1128/JB.186.5.1518-1530.2004; Felsenstein J., 2004, INFERRING PHYLOGENIE; Flannery B. P., 1992, NUMERICAL RECIPES IN; Francisco AP, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-87; Francisco AP, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-152; FREEMAN LC, 1977, SOCIOMETRY, V40, P35, DOI 10.2307/3033543; GAVRIL F, 1987, J ALGORITHM, V8, P592, DOI 10.1016/0196-6774(87)90053-8; GEORGE A, 1988, SIAM J SCI STAT COMP, V9, P849, DOI 10.1137/0909057; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Harris J, 2008, COMBINATORICS AND GR; Kasner E, 2001, MATHEMATICS AND THE; Kirchhoff G., 1847, ANN PHYS CHEM, V72, P497, DOI [DOI 10.1002/ANDP.18471481202, 10.1002/andp.18471481202]; Kohl TA, 2014, J CLIN MICROBIOL, V52, P2479, DOI 10.1128/JCM.00567-14; Kong Y, 2013, GENOME BIOL EVOL, V5, P1611, DOI 10.1093/gbe/evt116; Kruskal J.B., 1956, P AM MATH SOC, V7, P48, DOI [10.1090/S0002-9939-1956-0078686-7, DOI 10.1090/S0002-9939-1956-0078686-7, 10.2307/2033241]; LEWIN M, 1982, MATH Z, V181, P55, DOI 10.1007/BF01214981; Maiden MCJ, 2013, NAT REV MICROBIOL, V11, P728, DOI 10.1038/nrmicro3093; Maiden MCJ, 1998, P NATL ACAD SCI USA, V95, P3140, DOI 10.1073/pnas.95.6.3140; Muzzi A, 2011, INT J MED MICROBIOL, V301, P619, DOI 10.1016/j.ijmm.2011.09.008; Papadimitriou C.H., 1998, COMBINATORIAL OPTIMI, VUnabridged edition; Pearson T, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-78; Salipante SJ, 2011, J CLIN MICROBIOL, V49, P3568, DOI 10.1128/JCM.00919-11; Smith JM, 2000, BIOESSAYS, V22, P1115, DOI 10.1002/1521-1878(200012)22:12&lt;1115::AID-BIES9&gt;3.0.CO;2-R; SNEATH P. H., 1973, NUMERICAL TAXONOMY T; TUTTE WT, 1965, J RES NATL BUR STAND, VB 69, P1, DOI 10.6028/jres.069B.001; Whitney H, 1935, AM J MATH, V57, P509, DOI 10.2307/2371182; Wilson DJ, 2009, MOL BIOL EVOL, V26, P385, DOI 10.1093/molbev/msn264	35	11	11	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0119315	10.1371/journal.pone.0119315	http://dx.doi.org/10.1371/journal.pone.0119315			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25799056	Green Published, Green Submitted, gold			2022-12-27	WOS:000351987300036
J	Viegas, EO; Tembe, N; Macovela, E; Goncalves, E; Augusto, O; Ismael, N; Sitoe, N; De Schacht, C; Bhatt, N; Meggi, B; Araujo, C; Sandstrom, E; Biberfeld, G; Nilsson, C; Andersson, S; Jani, I; Osman, N				Viegas, Edna Omar; Tembe, Nelson; Macovela, Eulalia; Goncalves, Emilia; Augusto, Orvalho; Ismael, Nalia; Sitoe, Nadia; De Schacht, Caroline; Bhatt, Nilesh; Meggi, Bindiya; Araujo, Carolina; Sandstrom, Eric; Biberfeld, Gunnel; Nilsson, Charlotta; Andersson, Soren; Jani, Ilesh; Osman, Nafissa			Incidence of HIV and the Prevalence of HIV, Hepatitis B and Syphilis among Youths in Maputo, Mozambique: A Cohort Study	PLOS ONE			English	Article							SEXUALLY-TRANSMITTED INFECTIONS; BLOOD-DONORS; SOUTH-AFRICA; VIRUS; POPULATION; WOMEN; EPIDEMIOLOGY; COMMUNITY; CITY; MEN	Background Prevalence of HIV in Mozambique among individuals aged 15-49 years is 11.5%. The HIV prevalence is higher in women than in men across the country, peaking at ages 25-29 years and 35-39 years, respectively. In this study, we aimed at determining the prevalence and incidence of HIV, prevalence of Hepatitis B (HBV), and prevalence of syphilis in youths. We also characterized a cohort of youths for future participation in phase I/II HIV vaccine trials. Methods The study was conducted at a youth clinic in Maputo Central Hospital from August 2009 to October 2011. Youths of both genders aged 18-24 years (n = 1380) were screened for HIV using a sequential algorithm of two immunochromatographic assays, HBV using an enzyme linked immunosorbant test, and syphilis using a treponemal immunochromatographic strip test. The HIV seronegative participants (n = 1309) were followed-up for 12 months with quarterly study visits. The clinical and behavioral data were collected using structured questionnaires. The HIV seroconversions were confirmed by a molecular assay. Results The study population was female dominant (76.8%). All participants had a formal education, with 44.6% studying for technical or higher education degrees. The mean age at sexual debut was 16.6 years (SD: +/-1.74), with 85.6% reporting more than one sexual partner in life. The screening showed the prevalence of HIV, HBV, and syphilis at 5.1% (95% CI: 3.97-6.31), 12.2% (95% CI 10.5%-14.0%), and 0.36% (95% CI 0.15%-0.84%), respectively. The HIV incidence rate was found to be 1.14/100 person years (95% CI: 0.67-1.92). Retention rates were stable throughout the study being 85.1% at the last visit. Conclusion Incidence of HIV in this cohort of youths in Maputo was relatively low. Also, the prevalence of HIV and syphilis was lower than the national values in this age group. However, the HBV prevalence was higher than in previous reports in the country.	[Viegas, Edna Omar; Tembe, Nelson; Ismael, Nalia; Sitoe, Nadia; Bhatt, Nilesh; Meggi, Bindiya; Jani, Ilesh] Inst Nacl Saude, Maputo, Mozambique; [Viegas, Edna Omar; Tembe, Nelson; Nilsson, Charlotta] Karolinska Inst, Dept Lab Med, Huddinge, Sweden; [Viegas, Edna Omar; Tembe, Nelson; Macovela, Eulalia; Goncalves, Emilia; Augusto, Orvalho; Araujo, Carolina; Osman, Nafissa] Univ Eduardo Mondlane, Fac Med, Maputo, Mozambique; [Macovela, Eulalia; Goncalves, Emilia; Osman, Nafissa] Hosp Cent Maputo, Maputo, Mozambique; [Biberfeld, Gunnel; Nilsson, Charlotta] Publ Hlth Agcy Sweden, Solna, Sweden; [Biberfeld, Gunnel; Nilsson, Charlotta] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden; [De Schacht, Caroline] Elizabeth Glaser Pediat AIDS Fdn, Maputo, Mozambique; [Sandstrom, Eric] Karolinska Inst, Sodersjukhuset, Dept Educ & Clin Res, Stockholm, Sweden; [Andersson, Soren] Univ Orebro, Fac Med & Hlth, Dept Lab Med, SE-70182 Orebro, Sweden	Karolinska Institutet; Eduardo Mondlane University; Public Health Agency of Sweden; Karolinska Institutet; Karolinska Institutet; Sodersjukhuset Hospital; Orebro University	Viegas, EO (corresponding author), Inst Nacl Saude, Maputo, Mozambique.	ednaviegas@gmail.com	Viegas, Elisabete Maria Macedo/C-3138-2012; Augusto, Orvalho/J-8767-2019	Viegas, Elisabete Maria Macedo/0000-0002-1970-2198; Augusto, Orvalho/0000-0002-0005-3968; Jani, Ilesh/0000-0002-6880-6655	Regional HIV/AIDS Team for Africa; Embassy of Sweden, Lusaka - Sweden (Sida) [2150012801]; Embassy of Sweden, Lusaka - Norway (Sida) [2150012801]	Regional HIV/AIDS Team for Africa; Embassy of Sweden, Lusaka - Sweden (Sida); Embassy of Sweden, Lusaka - Norway (Sida)	This study was supported by funding from The Regional HIV/AIDS Team for Africa, Embassy of Sweden, Lusaka jointly funded by Sweden and Norway (Sida contribution number 2150012801). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2006, EP SURV PSYCH ILL KO, P6; Bakari M, 2000, AIDS, V14, P313, DOI 10.1097/00002030-200002180-00014; Barnighausen T, 2008, AIDS, V22, P139, DOI 10.1097/QAD.0b013e3282f2ef43; Booker CL, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-249; Braunstein SL, 2009, AIDS REV, V11, P140; Carpenter LM, 2002, J ACQ IMMUN DEF SYND, V29, P174, DOI 10.1097/00042560-200202010-00011; Chege W, 2012, J INFECT DEV COUNTR, V6, P870, DOI 10.3855/jidc.2636; Cunha L, 2007, J MED VIROL, V79, P1832, DOI 10.1002/jmv.21010; De Schacht C, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.18808; Doody MM, 2003, AM J EPIDEMIOL, V157, P643, DOI 10.1093/aje/kwg033; Dube K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084979; Esparza J, 2001, B WORLD HEALTH ORGAN, V79, P1133; Feldblum PJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097547; Ghys PD, 2006, SEX TRANSM INFECT, V82, pI52, DOI 10.1136/sti.2005.016428; Gloyd S, 2007, SEX TRANSM DIS, V34, pS31, DOI 10.1097/01.olq.0000264586.49616.72; Gonzalez R, 2012, HIV MED, V13, P581, DOI 10.1111/j.1468-1293.2012.01018.x; Gouws E, 2008, AIDS, V22, pS5, DOI 10.1097/01.aids.0000341773.86500.9d; Gudo ES, 2009, TRANSFUSION, V49, P1146, DOI 10.1111/j.1537-2995.2009.02100.x; Hallett TB, 2007, STUD FAMILY PLANN, V38, P1, DOI 10.1111/j.1728-4465.2007.00111.x; HENG BH, 1995, J EPIDEMIOL COMMUN H, V49, P309, DOI 10.1136/jech.49.3.309; Instituto Nacional de Estatistica, 2011, MULH HOM MOC IND SEL, P15; Instituto Nacional de Saude (INS) INdEsI Grupo Tecnico Multisectorial de Combate ao HIV/SIDA (GTM), 2011, VIG EP HIV SEU IMP D, P36; Instituto Nacional de Saude (INS) INdEsI ICF Macro, 2010, INQ NAC PREV RISC CO, P151; Jani IV, 2012, J CLIN MICROBIOL, V50, P1458, DOI 10.1128/JCM.00107-12; Karim QA, 2012, AIDS BEHAV, V16, P1870, DOI 10.1007/s10461-012-0209-y; KARIM SSA, 1989, AM J PUBLIC HEALTH, V79, P893, DOI 10.2105/AJPH.79.7.893; Komas NP, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-226; Kumogola Y, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-553; Lugada ES, 2004, CLIN DIAGN LAB IMMUN, V11, P29, DOI 10.1128/CDLI.11.1.29-34.2004; McKellar MS, 2013, AIDS RES HUM RETROV, V29, P121, DOI [10.1089/aid.2012.0064, 10.1089/AID.2012.0064]; Melo J, 2008, TROP MED INT HEALTH, V13, P17, DOI [10.1111/j-1365-3156.2007.01972.x, 10.1111/j.1365-3156.2007.01972.x]; Ministerio da Saude, 2008, GUIAO ESTR OP IMPL U, P24; Ministerio da Saude GTM, 2008, ROND VIG EP HIV 2007, P33; Ministerio da Saude GTM, 2013, ROND VIG EP HIV SIF, P4; Ministry of Health, 2001, INTR DPT HEP B VACC, P2; Negero Asfaw, 2011, BMC Res Notes, V4, P35, DOI 10.1186/1756-0500-4-35; Nel A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035278; Newman L, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001396; Nyirenda M, 2008, J INFECTION, V57, P72, DOI 10.1016/j.jinf.2008.05.004; Stokx J, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-141; Tapko J.B. BT, 2014, STATUS BLOOD SAFETY, P2; Tembe N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097391; Thio CL, 2009, HEPATOLOGY, V49, pS138, DOI 10.1002/hep.22883; UNAIDS, 2014, AIDSINFO EP STAT; UNAIDS, COR EP SLID; UNAIDS JUNPoHA, 2013, GLOB REP UNAIDS REP, P2; World Health O, 2009, WKLY EPIDEMIOL REC, V84, P405, DOI DOI 10.1016/J.VACCINE.2009.10.110; World Health Organization, 2012, INV CAS EL MOTH CHIL, P9; Zeh C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021040	49	19	19	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0121452	10.1371/journal.pone.0121452	http://dx.doi.org/10.1371/journal.pone.0121452			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CE6ZS	25798607	Green Published, Green Submitted, gold			2022-12-27	WOS:000351987300253
J	Anta, AF; Georgiou, C; Mosteiro, MA; Pareja, D				Anta, Antonio Fernandez; Georgiou, Chryssis; Mosteiro, Miguel A.; Pareja, Daniel			Algorithmic Mechanisms for Reliable Crowdsourcing Computation under Collusion	PLOS ONE			English	Article								We consider a computing system where a master processor assigns a task for execution to worker processors that may collude. We model the workers' decision of whether to comply (compute the task) or not (return a bogus result to save the computation cost) as a game among workers. That is, we assume that workers are rational in a game-theoretic sense. We identify analytically the parameter conditions for a unique Nash Equilibrium where the master obtains the correct result. We also evaluate experimentally mixed equilibria aiming to attain better reliability-profit trade-offs. For a wide range of parameter values that may be used in practice, our simulations show that, in fact, both master and workers are better off using a pure equilibrium where no worker cheats, even under collusion, and even for colluding behaviors that involve deviating from the game.	[Anta, Antonio Fernandez] IMDEA Networks Inst, Madrid, Spain; [Georgiou, Chryssis] Univ Cyprus, Dept Comp Sci, CY-1678 Nicosia, Cyprus; [Mosteiro, Miguel A.; Pareja, Daniel] Kean Univ, Dept Comp Sci, Union, NJ 07083 USA	University of Cyprus	Mosteiro, MA (corresponding author), Kean Univ, Dept Comp Sci, Union, NJ 07083 USA.	mmosteir@kean.edu	Anta, Antonio Fernández/B-4176-2009	Anta, Antonio Fernández/0000-0001-6501-2377; Georgiou, Chryssis/0000-0003-4360-0260	Comunidad de Madrid [S2013/ICE-2894]; Spanish Ministerio de Ciencia e Innovacion / Ministerio de Economia y Competitividad [TEC2011-29688-C02-01]; National Natural Science Foundation of China [61020106002]; University of Cyprus [UCY-ED2014-CG]; National Science Foundation [CCF 1114930]; Kean University	Comunidad de Madrid(Comunidad de Madrid); Spanish Ministerio de Ciencia e Innovacion / Ministerio de Economia y Competitividad; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); University of Cyprus; National Science Foundation(National Science Foundation (NSF)); Kean University	A. Fernandez Anta is partially supported by grants from the Comunidad de Madrid (http://www.madrid.org) (Cloud4BigData-CM, S2013/ICE-2894), the Spanish Ministerio de Ciencia e Innovacion / Ministerio de Economia y Competitividad (http://www.mineco.gob.es)(TEC2011-29688-C02-01), and the National Natural Science Foundation of China (http://www.nsfc.gov.cn) (61020106002). C. Georgiou is partially supported by research funds from the University of Cyprus (http://www.ucy.ac.cy/en/) (UCY-ED2014-CG). M. A. Mosteiro is partially supported by grants from the National Science Foundation (http://www.nsf.gov) (CCF 1114930) and from Kean University (http://www.kean.edu) (UFRI grant). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham Ittai, 2011, SIGACT News, V42, P69, DOI 10.1145/1998037.1998055; Abraham I., 2006, P 25 ANN ACM S PRINC, P53, DOI 10.1145/1146381.1146393; Anderson D.P., 2010, ACM CROSSROADS, V16, P7, DOI [10.1145/1734160.1734164, DOI 10.1145/1734160.1734164]; Anderson DP, 2004, FIFTH IEEE/ACM INTERNATIONAL WORKSHOP ON GRID COMPUTING, PROCEEDINGS, P4, DOI 10.1109/GRID.2004.14; Anta Antonio Fernandez, 2008, 2008 7th IEEE International Symposium on Network Computing and Applications (NCA), P315, DOI 10.1109/NCA.2008.41; Christoforou Evgenia, 2013, Principles of Distributed Systems. 17th International Conference, OPODIS 2013. Proceedings: LNCS 8304, P98, DOI 10.1007/978-3-319-03850-6_8; Christoforou E, 2014, IEEE T COMPUT, V63, P179, DOI 10.1109/TC.2012.186; Christoforou E, 2013, CONCURR COMP-PRACT E, V25, P2363, DOI 10.1002/cpe.3104; Ding S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097762; Ding S, 2014, KNOWL-BASED SYST, V56, P216, DOI 10.1016/j.knosys.2013.11.014; Douceur JR, 2002, LECT NOTES COMPUT SC, V2429, P251, DOI 10.1007/3-540-45748-8_24; Anta AF, 2012, PARALLEL PROCESS LET, V22, DOI 10.1142/S0129626412500028; Golle P, 2001, LECT NOTES COMPUT SC, V2020, P425; Golle P, 2001, 5 INT C FIN CRYPT FC, P289, DOI DOI 10.1007/3-540-46088-8_23; Kondo D., 2002, P INT PAR DISTR PROC, P79; Kondo D, 2007, LECT NOTES COMPUT SC, V4641, P361; Korpela E, 2001, COMPUT SCI ENG, V3, P78, DOI 10.1109/5992.895191; NASH JF, 1950, P NATL ACAD SCI USA, V36, P48, DOI 10.1073/pnas.36.1.48; Nisan N, 2007, ALGORITHMIC GAME THEORY, P1, DOI 10.1017/CBO9780511800481; Nisan N, 2001, GAME ECON BEHAV, V35, P166, DOI 10.1006/game.1999.0790; Nisan N, 2006, P 7 ACM C EL COMM EC, P18, DOI DOI 10.1145/1134707.1134710; Osborne MJ., 2003, INTRO GAME THEORY; Sarmenta LFG, 2002, FUTURE GENER COMP SY, V18, P561, DOI 10.1016/S0167-739X(01)00077-2; Shneidman J, 2003, LECT NOTES COMPUT SC, V2735, P139; Silaghi GC, 2009, J GRID COMPUT, V7, P555, DOI 10.1007/s10723-009-9124-5; Staab E, 2009, CCGRID: 2009 9TH IEEE INTERNATIONAL SYMPOSIUM ON CLUSTER COMPUTING AND THE GRID, P412, DOI 10.1109/CCGRID.2009.12; Taufer M., 2005, P 19 IEEE INT PAR DI, p119a, DOI [10.1109/IPDPS.2005.247, DOI 10.1109/IPDPS.2005.247]; Yurkewych M., 2005, P CCS 2005, P280	28	6	6	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0116520	10.1371/journal.pone.0116520	http://dx.doi.org/10.1371/journal.pone.0116520			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25793524	Green Published, gold			2022-12-27	WOS:000352084200007
J	Delahaye-Sourdeix, M; Oliver, J; Timofeeva, MN; Gaborieau, V; Johansson, M; Chabrier, A; Wozniak, MB; Brenner, DR; Vallee, MP; Anantharaman, D; Lagiou, P; Holcatova, I; Richiardi, L; Kjaerheim, K; Agudo, A; Castellsague, X; Macfarlane, TV; Barzan, L; Canova, C; Thakker, NS; Conway, DI; Znaor, A; Healy, CM; Ahrens, W; Zaridze, D; Szeszenia-Dabrowska, N; Lissowska, J; Fabianova, E; Mates, IN; Bencko, V; Foretova, L; Janout, V; Curado, MP; Koifman, S; Menezes, A; Wunsch-Filho, V; Eluf-Neto, J; Boffetta, P; Garrote, LF; Serraino, D; Lener, M; Jaworowska, E; Lubinski, J; Boccia, S; Rajkumar, T; Samant, TA; Mahimkar, MB; Matsuo, K; Franceschi, S; Byrnes, G; Brennan, P; Mckay, JD				Delahaye-Sourdeix, Manon; Oliver, Javier; Timofeeva, Maria N.; Gaborieau, Valerie; Johansson, Mattias; Chabrier, Amelie; Wozniak, Magdalena B.; Brenner, Darren R.; Vallee, Maxime P.; Anantharaman, Devasena; Lagiou, Pagona; Holcatova, Ivana; Richiardi, Lorenzo; Kjaerheim, Kristina; Agudo, Antonio; Castellsague, Xavier; Macfarlane, Tatiana V.; Barzan, Luigi; Canova, Cristina; Thakker, Nalin S.; Conway, David I.; Znaor, Ariana; Healy, Claire M.; Ahrens, Wolfgang; Zaridze, David; Szeszenia-Dabrowska, Neonilia; Lissowska, Jolanta; Fabianova, Eleonora; Mates, Ioan Nicolae; Bencko, Vladimir; Foretova, Lenka; Janout, Vladimir; Curado, Maria Paula; Koifman, Sergio; Menezes, Ana; Wuensch-Filho, Victor; Eluf-Neto, Jose; Boffetta, Paolo; Fernandez Garrote, Leticia; Serraino, Diego; Lener, Marcin; Jaworowska, Ewa; Lubinski, Jan; Boccia, Stefania; Rajkumar, Thangarajan; Samant, Tanuja A.; Mahimkar, Manoj B.; Matsuo, Keitaro; Franceschi, Silvia; Byrnes, Graham; Brennan, Paul; McKay, James D.			The 12p13.33/RAD52 Locus and Genetic Susceptibility to Squamous Cell Cancers of Upper Aerodigestive Tract	PLOS ONE			English	Article							DIFFERENTIAL EXPRESSION ANALYSIS; HOMOLOGOUS RECOMBINATION; SYNTHETICALLY LETHAL; RAD52 INACTIVATION; RISK; BRCA2; ABERRATIONS; CARCINOMA; PROTEIN; REPAIR	Genetic variants located within the 12p13.33/RAD52 locus have been associated with lung squamous cell carcinoma (LUSC). Here, within 5,947 UADT cancers and 7,789 controls from 9 different studies, we found rs10849605, a common intronic variant in RAD52, to be also associated with upper aerodigestive tract (UADT) squamous cell carcinoma cases (OR = 1.09, 95% CI: 1.04-1.15, p = 6x10(-4)). We additionally identified rs10849605 as a RAD52 cis-eQTL inUADT(p = 1x10(-3)) and LUSC (p = 9x10(-4)) tumours, with the UADT/LUSC risk allele correlated with increased RAD52 expression levels. The 12p13.33 locus, encompassing rs10849605/RAD52, was identified as a significant somatic focal copy number amplification in UADT(n = 374, q-value = 0.075) and LUSC (n = 464, q-value = 0.007) tumors and correlated with higher RAD52 tumor expression levels (p = 6x10(-48) and p = 3x10(-29) in UADT and LUSC, respectively). In combination, these results implicate increased RAD52 expression in both genetic susceptibility and tumorigenesis of UADT and LUSC tumors.	[Delahaye-Sourdeix, Manon; Oliver, Javier; Chabrier, Amelie; Vallee, Maxime P.; McKay, James D.] IARC, Genet Canc Susceptibil Grp GCS, Lyon, France; [Timofeeva, Maria N.; Gaborieau, Valerie; Johansson, Mattias; Wozniak, Magdalena B.; Brenner, Darren R.; Anantharaman, Devasena; Brennan, Paul] IARC, GEP, Lyon, France; [Timofeeva, Maria N.] Univ Edinburgh, Inst Genet & Mol Med, Colon Canc Genet Grp, Edinburgh, Midlothian, Scotland; [Timofeeva, Maria N.] MRC, Human Genet Unit, Edinburgh, Midlothian, Scotland; [Lagiou, Pagona] Univ Athens, Sch Med, Dept Hyg Epidemiol & Med Stat, GR-11527 Athens, Greece; [Holcatova, Ivana; Bencko, Vladimir] Charles Univ Prague, Fac Med 1, Inst Hyg & Epidemiol, Prague, Czech Republic; [Richiardi, Lorenzo] Univ Turin, Dept Med Sci, Canc Epidemiol Unit, Turin, Italy; [Kjaerheim, Kristina] Canc Registry Norway, Oslo, Norway; [Agudo, Antonio; Castellsague, Xavier] IDIBELL Hosp Llobregat, Catalan Inst Oncol ICO, Barcelona, Spain; [Castellsague, Xavier] CIBER Epidemiol & Salud Publ CIBERESP, Madrid, Spain; [Macfarlane, Tatiana V.] Univ Aberdeen, Sch Med & Dent, Aberdeen, Scotland; [Barzan, Luigi] Gen Hosp Pordenone, Pordenone, Italy; [Canova, Cristina] Univ Padua, Dept Environm Med & Publ Hlth, Padua, Italy; [Canova, Cristina] Imperial Coll, Natl Heart & Lung Inst, MRC HPA Ctr Environm & Hlth, Resp Epidemiol & Publ Hlth, London, England; [Thakker, Nalin S.] Univ Manchester, Sch Dent, Manchester, Lancs, England; [Conway, David I.] Univ Glasgow, Sch Dent, Glasgow, Lanark, Scotland; [Znaor, Ariana] Croatian Natl Inst Publ Hlth, Croatian Natl Canc Registry, Zagreb, Croatia; [Healy, Claire M.] Trinity Coll Dublin, Sch Dent Sci, Dublin, Ireland; [Ahrens, Wolfgang] Leibniz Inst Prevent Res & Epidemiol BIPS, Bremen, Germany; [Ahrens, Wolfgang] Univ Bremen, Fac Math & Comp Sci, D-28359 Bremen, Germany; [Zaridze, David] Russian Acad Med Sci, Canc Res Ctr, Inst Carcinogenesis, Moscow, Russia; [Szeszenia-Dabrowska, Neonilia] Inst Occupat Med, Dept Epidemiol, Lodz, Poland; [Lissowska, Jolanta] M Sklodowska Curie Mem Canc Ctr, Dept Canc Epidemiol & Prevent, Warsaw, Poland; [Lissowska, Jolanta] Inst Oncol, Warsaw, Poland; [Fabianova, Eleonora] Reg Author Publ Hlth, Banska Bystrica, Slovakia; [Mates, Ioan Nicolae] Carol Davila Univ Med & Pharm, St Mary Gen & Esophageal Surg Clin, Bucharest, Romania; [Foretova, Lenka] Masaryk Mem Canc Inst, Dept Canc Epidemiol & Genet, Brno, Czech Republic; [Foretova, Lenka] Masaryk Univ, Brno, Czech Republic; [Janout, Vladimir] Palacky Univ, CR-77147 Olomouc, Czech Republic; [Curado, Maria Paula] IPRI, Ecully, France; [Koifman, Sergio] Fiocruz MS, Natl Sch Publ Hlth, BR-21045900 Rio De Janeiro, Brazil; [Menezes, Ana] Univ Fed Pelotas, Pelotas, Brazil; [Wuensch-Filho, Victor; Eluf-Neto, Jose] Univ Sao Paulo, Sao Paulo, Brazil; [Boffetta, Paolo] Mt Sinai Sch Med, Tisch Canc Inst, New York, NY USA; [Fernandez Garrote, Leticia] Inst Oncol & Radiobiol, Havana, Cuba; [Serraino, Diego] IRCSS, Ctr Riferimento Oncol, Unit Epidemiol & Biostat, Aviano, Italy; [Lener, Marcin; Lubinski, Jan] Pomeranian Med Univ, Int Hereditary Canc Ctr, Dept Genet & Pathol, Szczecin, Poland; [Jaworowska, Ewa] Pomeranian Med Univ, Dept Otolaryngol & Laryngol Oncol, Szczecin, Poland; [Boccia, Stefania] Univ Cattolica Sacro Cuore, Fac Med, Sect Hyg, Inst Publ Hlth, Rome, Italy; [Rajkumar, Thangarajan] Canc Inst WIA, Dept Mol Oncol, Madras, Tamil Nadu, India; [Samant, Tanuja A.; Mahimkar, Manoj B.] Tata Mem Hosp, Adv Ctr Treatment Res & Educ Canc, Canc Res Inst, Navi Mumbai, India; [Matsuo, Keitaro] Kyushu Dent Univ, Div Oral Pathol, Dept Hlth Promot, Kitakyushu, Fukuoka, Japan; [Franceschi, Silvia] IARC, Infect & Canc Epidemiol Grp ICE, Lyon, France; [Byrnes, Graham] IARC, Biostat Grp BST, Lyon, France	World Health Organization; International Agency for Research on Cancer (IARC); World Health Organization; International Agency for Research on Cancer (IARC); University of Edinburgh; University of Edinburgh; Athens Medical School; National & Kapodistrian University of Athens; Charles University Prague; University of Turin; University of Oslo; Catalan Institute of Oncology; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; University of Aberdeen; University of Padua; Imperial College London; University of Manchester; University of Glasgow; Trinity College Dublin; Leibniz Institute for Prevention Research & Epidemiology (BIPS); University of Bremen; Russian Academy of Medical Sciences; Nofer Institute of Occupational Medicine; Maria Sklodowska-Curie National Research Institute of Oncology; Maria Sklodowska-Curie National Research Institute of Oncology; Regional Authority of Public Health Banska Bystrica; Carol Davila University of Medicine & Pharmacy; Masaryk Memorial Cancer Institute; Masaryk University Brno; Palacky University Olomouc; Fundacao Oswaldo Cruz; Universidade Federal de Pelotas; Universidade de Sao Paulo; Icahn School of Medicine at Mount Sinai; IRCCS Aviano (CRO); Pomeranian Medical University; Pomeranian Medical University; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Tata Memorial Centre (TMC); Advance Centre for Treatment, Research & Education in Cancer (ACTREC); Tata Memorial Hospital; Kyushu Dental University; World Health Organization; International Agency for Research on Cancer (IARC); World Health Organization; International Agency for Research on Cancer (IARC)	Mckay, JD (corresponding author), IARC, Genet Canc Susceptibil Grp GCS, Lyon, France.	gcs@iarc.fr	Lissowska, Jolanta/AAH-3252-2020; Boccia, Stefania/AFN-1666-2022; Jaworowska, Ewa/B-1211-2015; Johansson, Mattias/ABF-3365-2020; RAJKUMAR, THANGARAJAN/AAZ-5663-2020; oliver, javier/A-5338-2009; Boffetta, Paolo/AAI-7767-2021; Boccia, Stefania/AAB-9533-2022; Mates, Ioan Nicolae/E-9255-2017; Agudo, Antonio/J-1805-2016; Bencko, Vladimir/H-8598-2017; Holcatova, Ivana/C-8327-2017; Eluf-Neto, Jose/B-2522-2009; Healy, Claire M/AGL-9755-2022; Menezes, Ana MB/G-7266-2012; Szeszenia-Dabrowska, Neonila/F-7190-2010; Serraino, Diego/J-3915-2018; franceschi, silvia/M-2452-2014; Matsuo, Keitaro/H-6758-2019; Pique, Xavier Castellsagué/N-5795-2014; Janout, Vladimir/M-5133-2014; Curado, Maria Paula/M-6200-2013; Znaor, A/H-6718-2019; richiardi, lorenzo/J-3480-2018; Ahrens, Wolfgang/A-2740-2012	Lissowska, Jolanta/0000-0003-2695-5799; Boccia, Stefania/0000-0002-1864-749X; Jaworowska, Ewa/0000-0001-9050-5042; oliver, javier/0000-0002-8073-4711; Boffetta, Paolo/0000-0002-3811-2791; Boccia, Stefania/0000-0002-1864-749X; Agudo, Antonio/0000-0001-9900-5677; Bencko, Vladimir/0000-0003-1935-2228; Holcatova, Ivana/0000-0002-1366-0337; Eluf-Neto, Jose/0000-0001-7504-2115; Healy, Claire M/0000-0003-0583-6360; Menezes, Ana MB/0000-0002-2996-9427; Serraino, Diego/0000-0003-0565-8920; franceschi, silvia/0000-0003-4181-8071; Matsuo, Keitaro/0000-0003-1761-6314; Pique, Xavier Castellsagué/0000-0002-0802-3595; Curado, Maria Paula/0000-0001-8172-2483; Ioan Nicoale, Mates/0000-0001-7210-0615; Byrnes, Graham/0000-0003-3893-7539; Johansson, Mattias/0000-0002-3116-5081; Kjaerheim, Kristina/0000-0003-0691-3735; Lubinski, Jan/0000-0003-2931-3003; Macfarlane, Tatiana/0000-0002-9392-0812; Rasul, holem/0000-0003-0579-9029; richiardi, lorenzo/0000-0003-0316-9402; Vallee, Maxime/0000-0002-3616-9508; Healy, Claire M/0000-0001-7940-4611; Timofeeva, Maria/0000-0002-2503-4253; CANOVA, CRISTINA/0000-0001-7027-7935; Foretova, Lenka/0000-0003-0494-2620; Conway, David/0000-0001-7762-4063; Ahrens, Wolfgang/0000-0003-3777-570X	US National Institutes of Health [R01 CA092039 05/05S1]; National Institute of Dental and Craniofacial Research [1R03DE020116]; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R03DE020116] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	Funding for study coordination, genotyping of replication studies and statistical analysis was provided by the US National Institutes of Health (R01 CA092039 05/05S1) and the National Institute of Dental and Craniofacial Research (1R03DE020116). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Anantharaman D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088240; Baumann P, 1998, TRENDS BIOCHEM SCI, V23, P247, DOI 10.1016/S0968-0004(98)01232-8; Beroukhim R, 2007, P NATL ACAD SCI USA, V104, P20007, DOI 10.1073/pnas.0710052104; Cramer-Morales K, 2013, BLOOD, V122, P1293, DOI 10.1182/blood-2013-05-501072; Delahaye-Sourdeix M, 2015, J NATL CANC IN PRESS; Du P, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-587; Feng ZH, 2011, P NATL ACAD SCI USA, V108, P686, DOI 10.1073/pnas.1010959107; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Flicek P, 2013, NUCLEIC ACIDS RES, V41, pD48, DOI 10.1093/nar/gks1236; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Hoeijmakers JHJ, 2001, NATURE, V411, P366, DOI 10.1038/35077232; Li QY, 2013, CELL, V152, P633, DOI 10.1016/j.cell.2012.12.034; Liu J, 2011, P NATL ACAD SCI USA, V108, P441, DOI 10.1073/pnas.1016614108; Lok BH, 2013, ONCOGENE, V32, P3552, DOI 10.1038/onc.2012.391; Lok BH, 2012, CLIN CANCER RES, V18, P6400, DOI 10.1158/1078-0432.CCR-11-3150; McKay JD, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001333; Mermel CH, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-r41; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Negri E, 2009, INT J CANCER, V124, P394, DOI 10.1002/ijc.23848; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Oze I, 2010, CANCER SCI, V101, P1875, DOI 10.1111/j.1349-7006.2010.01599.x; Portela A, 2010, NAT BIOTECHNOL, V28, P1057, DOI 10.1038/nbt.1685; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pritchard JK, 2000, GENETICS, V155, P945; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Scully C, 2000, ORAL ONCOL, V36, P256, DOI 10.1016/S1368-8375(00)00007-5; Shi JX, 2012, CANCER DISCOV, V2, P131, DOI 10.1158/2159-8290.CD-11-0246; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Stewart B.W., 2003, WORLD CANC REPORT; Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678; Sung P, 2006, NAT REV MOL CELL BIO, V7, P739, DOI 10.1038/nrm2008; Symington LS, 2002, MICROBIOL MOL BIOL R, V66, P630, DOI 10.1128/MMBR.66.4.630-670.2002; Thacker J, 1999, BIOCHIMIE, V81, P77, DOI 10.1016/S0300-9084(99)80041-8; Timofeeva MN, 2012, HUM MOL GENET, V21, P4980, DOI 10.1093/hmg/dds334; Wang YF, 2014, NAT GENET, V46, P736, DOI 10.1038/ng.3002; Yan W, 2011, AM J CANCER RES, V1, P275; Yu K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002551	39	8	8	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0117639	10.1371/journal.pone.0117639	http://dx.doi.org/10.1371/journal.pone.0117639			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25793373	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000352084200015
J	Devert, A; Fabre, N; Floris, M; Canard, B; Robaglia, C; Crete, P				Devert, Anthony; Fabre, Nicolas; Floris, Maina; Canard, Bruno; Robaglia, Christophe; Crete, Patrice			Primer-Dependent and Primer-Independent Initiation of Double Stranded RNA Synthesis by Purified Arabidopsis RNA-Dependent RNA Polymerases RDR2 and RDR6	PLOS ONE			English	Article							TRANS-ACTING SIRNAS; AGROBACTERIUM-MEDIATED TRANSFORMATION; DNA METHYLATION; GENE; BIOGENESIS; REQUIRES; REVEALS; PLANTS; SGS3; AMPLIFICATION	Cellular RNA-dependent RNA polymerases (RDRs) are fundamental components of RNA silencing in plants and many other eukaryotes. In Arabidopsis thaliana genetic studies have demonstrated that RDR2 and RDR6 are involved in the synthesis of double stranded RNA (dsRNA) from single stranded RNA (ssRNA) targeted by RNA silencing. The dsRNA is subsequently cleaved by the ribonuclease DICER-like into secondary small interfering RNAs (siRNAs) that reinforce and/or maintain the silenced state of the target RNA. Models of RNA silencing propose that RDRs could use primer-independent and primer-dependent initiation to generate dsRNA from a transcript targeted by primary siRNA or microRNA (miRNA). However, the biochemical activities of RDR proteins are still partly understood. Here, we obtained active recombinant RDR2 and RDR6 in a purified form. We demonstrate that RDR2 and RDR6 have primer-independent and primer-dependent RNA polymerase activities with different efficiencies. We further show that RDR2 and RDR6 can initiate dsRNA synthesis either by elongation of 21- to 24-nucleotides RNAs hybridized to complementary RNA template or by elongation of self-primed RNA template. These findings provide new insights into our understanding of the molecular mechanisms of RNA silencing in plants.	[Devert, Anthony; Fabre, Nicolas; Floris, Maina; Robaglia, Christophe; Crete, Patrice] Aix Marseille Univ, Lab Genet & Biophys Plantes, Marseille, France; [Devert, Anthony; Fabre, Nicolas; Floris, Maina; Robaglia, Christophe; Crete, Patrice] CNRS, UMR Biol Vegetale & Microbiol Environm 7265, Marseille, France; [Devert, Anthony; Fabre, Nicolas; Floris, Maina; Robaglia, Christophe; Crete, Patrice] Commissariat Energie Atom, Dept Sci Vivant, Inst Biol Environm & Biotechnol, Marseille, France; [Canard, Bruno] Aix Marseille Univ, AFMB UMR 7257, Marseille, France; [Canard, Bruno] CNRS, AFMB UMR 7257, Marseille, France	CEA; UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Aix-Marseille Universite; CEA; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite	Crete, P (corresponding author), Aix Marseille Univ, Lab Genet & Biophys Plantes, Marseille, France.	patrice.crete@univ-amu.fr	Crété, Patrice/A-6400-2015	Canard, Bruno/0000-0003-4924-1991	Agence Nationale de la Recherche [ANR-06-BLAN-0256]; Ecole Doctorale des Sciences de la Vie et de la Sante, Aix-Marseille Universite, Ministere de l'enseignement superieur et de la recherche; Commissariat a l'Energie Atomique, Centre National de la Recherche Scientifique, Aix-Marseille Universite	Agence Nationale de la Recherche(French National Research Agency (ANR)); Ecole Doctorale des Sciences de la Vie et de la Sante, Aix-Marseille Universite, Ministere de l'enseignement superieur et de la recherche; Commissariat a l'Energie Atomique, Centre National de la Recherche Scientifique, Aix-Marseille Universite	This research was supported by a grant from Agence Nationale de la Recherche, ANR-06-BLAN-0256 (to N.F., B.C. and P.C). A.D and M.F were supported by a PhD fellowship from the Ecole Doctorale des Sciences de la Vie et de la Sante, Aix-Marseille Universite, Ministere de l'enseignement superieur et de la recherche. Funding for open access charge: Commissariat a l'Energie Atomique, Centre National de la Recherche Scientifique, Aix-Marseille Universite. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen E, 2005, CELL, V121, P207, DOI 10.1016/j.cell.2005.04.004; Bechtold N, 1998, METH MOL B, V82, P259; Bologna NG, 2014, ANNU REV PLANT BIOL, V65, P473, DOI 10.1146/annurev-arplant-050213-035728; Borsani O, 2005, CELL, V123, P1279, DOI 10.1016/j.cell.2005.11.035; Chen HM, 2010, P NATL ACAD SCI USA, V107, P15269, DOI 10.1073/pnas.1001738107; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Cuperus JT, 2010, NAT STRUCT MOL BIOL, V17, P997, DOI 10.1038/nsmb.1866; Curaba JL, 2008, J BIOL CHEM, V283, P3059, DOI 10.1074/jbc.M708983200; Daxinger L, 2009, EMBO J, V28, P48, DOI 10.1038/emboj.2008.260; Earley KW, 2006, PLANT J, V45, P616, DOI 10.1111/j.1365-313X.2005.02617.x; Ferrari E, 2008, J BIOL CHEM, V283, P33893, DOI 10.1074/jbc.M803094200; Fukunaga R, 2009, EMBO J, V28, P545, DOI 10.1038/emboj.2009.2; Haag JR, 2012, MOL CELL, V48, P811, DOI 10.1016/j.molcel.2012.09.027; Herr AJ, 2006, P NATL ACAD SCI USA, V103, P14994, DOI 10.1073/pnas.0606536103; Howell MD, 2007, PLANT CELL, V19, P926, DOI 10.1105/tpc.107.050062; Kasschau KD, 2007, PLOS BIOL, V5, P479, DOI 10.1371/journal.pbio.0050057; Kumakura N, 2009, FEBS LETT, V583, P1261, DOI 10.1016/j.febslet.2009.03.055; Laurila MRL, 2005, J GEN VIROL, V86, P521, DOI 10.1099/vir.0.80492-0; Lu C, 2006, GENOME RES, V16, P1276, DOI 10.1101/gr.5530106; Luo ZH, 2007, PLANT CELL, V19, P943, DOI 10.1105/tpc.106.045724; Makeyev EV, 2002, MOL CELL, V10, P1417, DOI 10.1016/S1097-2765(02)00780-3; Manavella PA, 2012, P NATL ACAD SCI USA, V109, P2461, DOI 10.1073/pnas.1200169109; Matzke M, 2009, CURR OPIN CELL BIOL, V21, P367, DOI 10.1016/j.ceb.2009.01.025; Moissiard G, 2007, RNA, V13, P1268, DOI 10.1261/rna.541307; Mourrain P, 2000, CELL, V101, P533, DOI 10.1016/S0092-8674(00)80863-6; Peragine A, 2004, GENE DEV, V18, P2368, DOI 10.1101/gad.1231804; Qi XP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004971; Rajeswaran R, 2012, NUCLEIC ACIDS RES, V40, P6241, DOI 10.1093/nar/gks242; Rajeswaran R, 2012, NUCLEIC ACIDS RES, V40, P594, DOI 10.1093/nar/gkr760; Sainsbury F, 2009, PLANT BIOTECHNOL J, V7, P682, DOI 10.1111/j.1467-7652.2009.00434.x; Schiebel W, 1998, PLANT CELL, V10, P2087, DOI 10.1105/tpc.10.12.2087; SCHIEBEL W, 1993, J BIOL CHEM, V268, P11858; Schwab R, 2010, P NATL ACAD SCI USA, V107, P14945, DOI 10.1073/pnas.1009416107; Simon SA, 2011, CURR OPIN PLANT BIOL, V14, P148, DOI 10.1016/j.pbi.2010.11.007; Sugiyama T, 2005, P NATL ACAD SCI USA, V102, P152, DOI 10.1073/pnas.0407641102; Tang GL, 2003, GENE DEV, V17, P49, DOI 10.1101/gad.1048103; Vaistij FE, 2002, PLANT CELL, V14, P857, DOI 10.1105/tpc.010480; Vazquez F, 2004, MOL CELL, V16, P69, DOI 10.1016/j.molcel.2004.09.028; Vazquez F, 2010, TRENDS PLANT SCI, V15, P337, DOI 10.1016/j.tplants.2010.04.001; Voinnet O, 2003, PLANT J, V33, P949, DOI 10.1046/j.1365-313X.2003.01676.x; Voinnet O, 2008, TRENDS PLANT SCI, V13, P317, DOI 10.1016/j.tplants.2008.05.004; Wang XB, 2010, P NATL ACAD SCI USA, V107, P484, DOI 10.1073/pnas.0904086107; Wassenegger M, 2006, TRENDS PLANT SCI, V11, P142, DOI 10.1016/j.tplants.2006.01.003; Willmann MR, 2011, ARABIDOPSIS BOOK, V9, P1; Xie ZX, 2004, PLOS BIOL, V2, P642, DOI 10.1371/journal.pbio.0020104; Yoshikawa M, 2005, GENE DEV, V19, P2164, DOI 10.1101/gad.1352605; Zheng Q, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001141; Zheng ZM, 2010, PLANT J, V62, P92, DOI 10.1111/j.1365-313X.2010.04130.x	48	19	21	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0120100	10.1371/journal.pone.0120100	http://dx.doi.org/10.1371/journal.pone.0120100			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25793874	Green Published, Green Submitted, gold			2022-12-27	WOS:000352084200145
J	Holme, P; Masuda, N				Holme, Petter; Masuda, Naoki			The Basic Reproduction Number as a Predictor for Epidemic Outbreaks in Temporal Networks	PLOS ONE			English	Article							REALISTIC DISTRIBUTIONS; MODELS; R-0; COMMUNICATION; PERSPECTIVES; PATTERNS	The basic reproduction number R-0-the number of individuals directly infected by an infectious person in an otherwise susceptible population-is arguably the most widely used estimator of how severe an epidemic outbreak can be. This severity can be more directly measured as the fraction of people infected once the outbreak is over, Omega. In traditional mathematical epidemiology and common formulations of static network epidemiology, there is a deterministic relationship between R-0 and Omega. However, if one considers disease spreading on a temporal contact network-where one knows when contacts happen, not only between whom-then larger R-0 does not necessarily imply larger Omega. In this paper, we numerically investigate the relationship between R-0 and Omega for a set of empirical temporal networks of human contacts. Among 31 explanatory descriptors of temporal network structure, we identify those that make R-0 an imperfect predictor of Omega. We find that descriptors related to both temporal and topological aspects affect the relationship between R-0 and Omega, but in different ways.	[Holme, Petter] Sungkyunkwan Univ, Dept Energy Sci, Suwon, South Korea; [Holme, Petter] Umea Univ, Dept Phys, Umea, Sweden; [Holme, Petter] Stockholm Univ, Dept Sociol, S-10691 Stockholm, Sweden; [Masuda, Naoki] Univ Bristol, Dept Engn Math, Bristol, Avon, England	Sungkyunkwan University (SKKU); Umea University; Stockholm University; University of Bristol	Holme, P (corresponding author), Sungkyunkwan Univ, Dept Energy Sci, Suwon, South Korea.	holme@skku.edu	Holme, Petter/A-7646-2008	Holme, Petter/0000-0003-2156-1096; Masuda, Naoki/0000-0003-1567-801X	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [2013R1A1A2011947]; Swedish Research Council; JST, CREST; JST, ERATO, Kawarabayashi Large Graph Project	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education(National Research Foundation of KoreaMinistry of Education (MOE), Republic of KoreaNational Research Council for Economics, Humanities & Social Sciences, Republic of Korea); Swedish Research Council(Swedish Research CouncilEuropean Commission); JST, CREST(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); JST, ERATO, Kawarabayashi Large Graph Project	PH was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (2013R1A1A2011947) and the Swedish Research Council. NM acknowledges support from JST, CREST, and JST, ERATO, Kawarabayashi Large Graph Project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON R M, 1991; Bansal Shweta, 2010, Journal of Biological Dynamics, V4, P478, DOI 10.1080/17513758.2010.503376; Britton T, 2008, J APPL PROBAB, V45, P743, DOI 10.1239/jap/1222441827; Colizza V, 2008, J THEOR BIOL, V251, P450, DOI 10.1016/j.jtbi.2007.11.028; Cross PC, 2007, J R SOC INTERFACE, V4, P315, DOI 10.1098/rsif.2006.0185; Diekmann O, 2000, MATH EPIDEMIOLOGY IN, DOI [10.1016/j.mbs.2008.02.005, DOI 10.1016/J.MBS.2008.02.005]; Dietz K, 1993, Stat Methods Med Res, V2, P23, DOI 10.1177/096228029300200103; Eagle N, 2006, PERS UBIQUIT COMPUT, V10, P255, DOI 10.1007/s00779-005-0046-3; Ebel H, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.035103; Eckmann JP, 2004, P NATL ACAD SCI USA, V101, P14333, DOI 10.1073/pnas.0405728101; Eguiluz VM, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.108701; Goh KI, 2008, EPL-EUROPHYS LETT, V81, DOI 10.1209/0295-5075/81/48002; Heesterbeek JAP, 2002, ACTA BIOTHEOR, V50, P189, DOI 10.1023/A:1016599411804; Heffernan JM, 2006, THEOR POPUL BIOL, V70, P135, DOI 10.1016/j.tpb.2006.03.003; Heffernan JM, 2005, J R SOC INTERFACE, V2, P281, DOI 10.1098/rsif.2005.0042; Holland Jones J, 2007, NOTES ON RO UNPUB, DOI Standford University; Holme P, 2004, SOC NETWORKS, V26, P155, DOI 10.1016/j.socnet.2004.01.007; Holme P, 2014, J LOGISTICAL ENG U, V30, P1; Holme P, 2014, SCI REP-UK, V4, DOI 10.1038/srep04999; Holme P, 2012, PHYS REP, V519, P97, DOI 10.1016/j.physrep.2012.03.001; Holme P, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003142; Isella L, 2011, J THEOR BIOL, V271, P166, DOI 10.1016/j.jtbi.2010.11.033; Karimi F, 2014, PHYSICA A, V414, P263, DOI 10.1016/j.physa.2014.07.037; Karsai M, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.025102; Keeling M, 2005, THEOR POPUL BIOL, V67, P1, DOI 10.1016/j.tpb.2004.08.002; Keeling MJ, 2000, J THEOR BIOL, V203, P51, DOI 10.1006/jtbi.1999.1064; Li Jing, 2011, Comput Math Methods Med, V2011, P527610, DOI 10.1155/2011/527610; Liu SY, 2013, PHYS REV E, V87, DOI 10.1103/PhysRevE.87.032805; Lloyd AL, 2001, THEOR POPUL BIOL, V60, P59, DOI 10.1006/tpbi.2001.1525; Lloyd AL, 2001, P ROY SOC B-BIOL SCI, V268, P985, DOI 10.1098/rspb.2001.1599; Massad E, 2010, TROP MED INT HEALTH, V15, P120, DOI 10.1111/j.1365-3156.2009.02413.x; Masuda Naoki, 2013, F1000Prime Rep, V5, P6, DOI 10.12703/P5-6; Min B, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.036102; Newman MEJ, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.026121; Newman MEJ, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.026126; Newman MEJ, 2004, PHYS REV E, V70, DOI [10.1103/PhysRevE.70.056131, 10.1103/PhysRevE.69.026113]; Pfitzner R, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.198701; Rocha LEC, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002974; Rocha LEC, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001109; Rocha LEC, 2010, P NATL ACAD SCI USA, V107, P5706, DOI 10.1073/pnas.0914080107; Serrano MA, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.056115; Stehle J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023176; Szendroi B, 2004, P ROY SOC B-BIOL SCI, V271, pS364, DOI 10.1098/rsbl.2004.0188; Taylor M, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.016103; Valdano E, 2014, ARXIV14061449V1; van den Driessche P, 2008, LECT NOTES MATH, V1945, P159; van den Driessche P, 2002, MATH BIOSCI, V180, P29, DOI 10.1016/S0025-5564(02)00108-6; Vanhems P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073970; Vazquez A, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.158702; Viswanath B., 2009, WOSN; Volz E, 2009, J R SOC INTERFACE, V6, P233, DOI 10.1098/rsif.2008.0218; Volz EM, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002042	54	38	42	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0120567	10.1371/journal.pone.0120567	http://dx.doi.org/10.1371/journal.pone.0120567			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25793764	Green Published, gold, Green Submitted			2022-12-27	WOS:000352083900053
J	Korzeniewski, SJ; Allred, E; Logan, JW; Fichorova, RN; Engelke, S; Kuban, KCK; O'Shea, TM; Paneth, N; Holm, M; Dammann, O; Leviton, A				Korzeniewski, Steven J.; Allred, Elizabeth; Logan, J. Wells; Fichorova, Raina N.; Engelke, Stephen; Kuban, Karl C. K.; O'Shea, T. Michael; Paneth, Nigel; Holm, Mari; Dammann, Olaf; Leviton, Alan		ELGAN Study Investigators	Elevated Endogenous Erythropoietin Concentrations Are Associated with Increased Risk of Brain Damage in Extremely Preterm Neonates	PLOS ONE			English	Article							INFLAMMATION-RELATED PROTEINS; GESTATIONAL-AGE; BIRTH-WEIGHT; ANGIOGENESIS; OUTCOMES; INJURY; BLOOD; NEUROPROTECTION; CYTOKINES; CHILDREN	Background We sought to determine, in very preterm infants, whether elevated perinatal erythropoietin (EPO) concentrations are associated with increased risks of indicators of brain damage, and whether this risk differs by the co-occurrence or absence of intermittent or sustained systemic inflammation (ISSI). Methods Protein concentrations were measured in blood collected from 786 infants born before the 28th week of gestation. EPO was measured on postnatal day 14, and 25 inflammation-related proteins were measured weekly during the first 2 postnatal weeks. We defined ISSI as a concentration in the top quartile of each of 25 inflammation-related proteins on two separate days a week apart. Hypererythropoietinemia (hyperEPO) was defined as the highest quartile for gestational age on postnatal day 14. Using logistic regression and multinomial logistic regression models, we compared risks of brain damage among neonates with hyperEPO only, ISSI only, and hyperEPO+ISSI, to those who had neither hyperEPO nor ISSI, adjusting for gestational age. Results Newborns with hyperEPO, regardless of ISSI, were more than twice as likely as those without to have very low (<55) Mental (OR 2.3; 95% CI 1.5-3.5) and/or Psychomotor (OR 2.4; 95% CI 1.6-3.7) Development Indices (MDI, PDI), and microcephaly at age two years (OR 2.4; 95% CI 1.5-3.8). Newborns with both hyperEPO and ISSI had significantly increased risks of ventriculomegaly, hemiparetic cerebral palsy, microcephaly, and MDI and PDI <55 (ORs ranged from 2.2-6.3), but not hypoechoic lesions or other forms of cerebral palsy, relative to newborns with neither hyperEPO nor ISSI. Conclusion hyperEPO, regardless of ISSI, is associated with elevated risks of very low MDI and PDI, and microcephaly, but not with any form of cerebral palsy. Children with both hyperEPO and ISSI are at higher risk than others of very low MDI and PDI, ventriculomegaly, hemiparetic cerebral palsy, and microcephaly.	[Korzeniewski, Steven J.] NICHD, Perinatol Res Branch, NIH, DHHS, Bethesda, MD 20892 USA; [Korzeniewski, Steven J.] NICHD, Perinatol Res Branch, NIH, Detroit, MI USA; [Korzeniewski, Steven J.] Wayne State Univ, Sch Med, Dept Obstet & Gynecol, Detroit, MI 48201 USA; [Korzeniewski, Steven J.; Paneth, Nigel] Michigan State Univ, Dept Epidemiol & Biostat, E Lansing, MI 48824 USA; [Allred, Elizabeth; Leviton, Alan] Boston Childrens Hosp, Dept Neurol, Boston, MA USA; [Allred, Elizabeth; Fichorova, Raina N.; Leviton, Alan] Harvard Univ, Sch Med, Boston, MA USA; [Logan, J. Wells] Nationwide Childrens Hosp, Dept Neonatol, Columbus, OH USA; [Fichorova, Raina N.] Brigham & Womens Hosp, Dept Obstet, Boston, MA 02115 USA; [Fichorova, Raina N.] Brigham & Womens Hosp, Dept Gynecol, Boston, MA 02115 USA; [Fichorova, Raina N.] Brigham & Womens Hosp, Dept Reprod Biol, Boston, MA 02115 USA; [Engelke, Stephen] E Carolina Univ, Brody Sch Med, Dept Pediat, Greenville, NC USA; [Kuban, Karl C. K.] Boston Med Ctr, Dept Pediat, Boston, MA USA; [Kuban, Karl C. K.] Boston Univ, Boston, MA 02215 USA; [O'Shea, T. Michael] Wake Forest Univ, Dept Pediat, Winston Salem, NC 27109 USA; [Paneth, Nigel] Michigan State Univ, Dept Pediat & Human Dev, E Lansing, MI 48824 USA; [Holm, Mari] Norwegian Univ Sci & Technol, Fac Med, Dept Lab Med Childrens & Womens Hlth, N-7034 Trondheim, Norway; [Holm, Mari; Dammann, Olaf] Tufts Univ, Sch Med, Dept Publ Hlth & Community Med, Boston, MA 02111 USA; [Dammann, Olaf] Hannover Med Sch, Neuroepidemiol Unit, Hannover, Germany	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Wayne State University; Michigan State University; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; University of North Carolina; East Carolina University; Boston Medical Center; Boston University; Wake Forest University; Michigan State University; Norwegian University of Science & Technology (NTNU); Massachusetts Department of Public Health; Tufts University; Hannover Medical School	Korzeniewski, SJ (corresponding author), NICHD, Perinatol Res Branch, NIH, DHHS, Bethesda, MD 20892 USA.	sKorzeni@med.wayne.edu	Logan, John Wells/I-5715-2019; Korzeniewski, Steven J/U-6481-2017	Korzeniewski, Steven J/0000-0002-8895-6052; Holm, Mari/0000-0003-3968-0851; Fordham, Lynn/0000-0002-0232-0484; Soul, Janet/0000-0001-6998-7753	National Institute of Neurological Disorders and Stroke [5U01NS040069-05, 2R01NS040069-06A2]; National Eye Institute [1-R01-EY021820-01]; National Institute of Child Health and Human Development [5P30HD018655-28]; Wayne State University Perinatal Initiative; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD018655] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY021820] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U01NS040069] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Wayne State University Perinatal Initiative; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported by The National Institute of Neurological Disorders and Stroke (5U01NS040069-05; 2R01NS040069-06A2), The National Eye Institute (1-R01-EY021820-01), the National Institute of Child Health and Human Development (5P30HD018655-28), and the Wayne State University Perinatal Initiative.	Agnello D, 2002, BRAIN RES, V952, P128, DOI 10.1016/S0006-8993(02)03239-0; ARNOLD CC, 1991, AM J EPIDEMIOL, V134, P604, DOI 10.1093/oxfordjournals.aje.a116133; Ashley RA, 2002, PEDIATR RES, V51, P472, DOI 10.1203/00006450-200204000-00012; Bayley N, 1993, BAYLEY SCALES INFANT; Bierer R, 2006, PEDIATRICS, V118, pE635, DOI 10.1542/peds.2005-3186; Brines M, 2008, J INTERN MED, V264, P405, DOI 10.1111/j.1365-2796.2008.02024.x; Brown MS, 2009, PEDIATRICS, V124, pE681, DOI 10.1542/peds.2008-2701; Byts N, 2009, EXPT TRANSLATIONAL S, V21, P1; CARLINI RG, 1995, KIDNEY INT, V47, P740, DOI 10.1038/ki.1995.113; CDC, 2007, CDC GROWTH CHARTS US; Chong ZZ, 2005, CURR NEUROVASC RES, V2, P387, DOI 10.2174/156720205774962683; Contaldo C, 2011, SHOCK, V35, P315, DOI 10.1097/SHK.0b013e3181fd0700; Fichorova RN, 2008, ANAL CHEM, V80, P4741, DOI 10.1021/ac702628q; Fichorova RN, 2006, INFECT IMMUN, V74, P5773, DOI 10.1128/IAI.00631-06; Fichorova RN, 2011, MBIO, V2, DOI DOI 10.1128/MBIO.00280-11; Grivennikov S, 2009, CANCER CELL, V15, P103, DOI 10.1016/j.ccr.2009.01.001; Hecht JL, 2011, PEDIATR RES, V69, P68, DOI 10.1203/PDR.0b013e3181fed334; Iwai M, 2007, STROKE, V38, P557; Iwai M, 2010, STROKE, V41, P1032, DOI 10.1161/STROKEAHA.109.570325; Kertesz N, 2004, DEV BIOL, V276, P101, DOI 10.1016/j.ydbio.2004.08.025; Kuban K, 2007, PEDIATR RADIOL, V37, P1201, DOI 10.1007/s00247-007-0605-z; Kuban KC, 2014, J CHILD NEUROL; Kuban KCK, 2005, J CHILD NEUROL, V20, P829, DOI 10.1177/08830738050200101001; Kumral A, 2007, NEONATOLOGY, V92, P269, DOI 10.1159/000105493; Lee Seung Hun, 2005, Am J Nephrol, V25, P64, DOI 10.1159/000084275; Leviton A, 1999, PEDIATR RES, V46, P566, DOI 10.1203/00006450-199911000-00013; Leviton A, 2013, PEDIATR RES, V73, P362, DOI 10.1038/pr.2012.188; Leviton A, 2011, EARLY HUM DEV, V87, P325, DOI 10.1016/j.earlhumdev.2011.01.043; Leviton A, 2011, J PEDIATR-US, V158, P897, DOI 10.1016/j.jpeds.2010.11.059; Leviton A, 2011, CYTOKINE, V53, P66, DOI 10.1016/j.cyto.2010.09.003; Liu W, 2011, EXP NEUROL, V230, P227, DOI 10.1016/j.expneurol.2011.04.021; Logan JW, 2014, CYTOKINE, V69, P22, DOI 10.1016/j.cyto.2014.04.009; Marti HH, 2000, NEWS PHYSIOL SCI, V15, P225; MASUDA S, 1994, J BIOL CHEM, V269, P19488; McElrath TF, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2010.12.010; Morishita E, 1997, NEUROSCIENCE, V76, P105, DOI 10.1016/s0306-4522(96)00306-5; NAGAO M, 1992, BIOCHEM BIOPH RES CO, V188, P888, DOI 10.1016/0006-291X(92)91139-H; Neubauer AP, 2010, ANN NEUROL, V67, P657, DOI 10.1002/ana.21977; O'Shea TM, 2009, EARLY HUM DEV, V85, P719, DOI 10.1016/j.earlhumdev.2009.08.060; O'Shea TM, 2013, BRAIN BEHAV IMMUN, V29, P104, DOI 10.1016/j.bbi.2012.12.012; O'Shea TM, 2012, J PEDIATR-US, V160, P395, DOI 10.1016/j.jpeds.2011.08.069; Ohls RK, 2014, PEDIATRICS, V133, P1023, DOI 10.1542/peds.2013-4307; Sasaki R, 2003, INTERNAL MED, V42, P142, DOI 10.2169/internalmedicine.42.142; Schultz C, 2008, CLIN EXP IMMUNOL, V154, P187, DOI 10.1111/j.1365-2249.2008.03760.x; Villa P, 2003, J EXP MED, V198, P971, DOI 10.1084/jem.20021067; Wu YW, 2012, PEDIATRICS, V130, P683, DOI 10.1542/peds.2012-0498; YUDKIN PL, 1987, EARLY HUM DEV, V15, P45, DOI 10.1016/0378-3782(87)90099-5; Zhu CL, 2009, PEDIATRICS, V124, pE218, DOI 10.1542/peds.2008-3553	48	26	27	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0115083	10.1371/journal.pone.0115083	http://dx.doi.org/10.1371/journal.pone.0115083			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25793991	Green Published, gold, Green Submitted			2022-12-27	WOS:000352084200003
J	Lee, CT; Kokolus, KM; Leigh, ND; Capitano, M; Hylander, BL; Repasky, EA				Lee, Chen-Ting; Kokolus, Kathleen M.; Leigh, Nicholas D.; Capitano, Maegan; Hylander, Bonnie L.; Repasky, Elizabeth A.			Defining Immunological Impact and Therapeutic Benefit of Mild Heating in a Murine Model of Arthritis	PLOS ONE			English	Article							COLLAGEN-INDUCED ARTHRITIS; FEBRILE-RANGE TEMPERATURE; LPS-STIMULATED MACROPHAGES; EARLY RHEUMATOID-ARTHRITIS; NECROSIS-FACTOR INHIBITORS; HYPOXIA-INDUCIBLE FACTOR; ALPHA MESSENGER-RNA; FACTOR-KAPPA-B; GENE-EXPRESSION; SYNOVIAL INFLAMMATION	Traditional treatments, including a variety of thermal therapies have been known since ancient times to provide relief from rheumatoid arthritis (RA) symptoms. However, a general absence of information on how heating affects molecular or immunological targets relevant to RA has limited heat treatment (HT) to the category of treatments known as "alternative therapies". In this study, we evaluated the effectiveness of mild HT in a collagen-induced arthritis (CIA) model which has been used in many previous studies to evaluate newer pharmacological approaches for the treatment of RA, and tested whether inflammatory immune activity was altered. We also compared the effect of HT to methotrexate, a well characterized pharmacological treatment for RA. CIA mice were treated with either a single HT for several hours or daily 30 minute HT. Disease progression and macrophage infiltration were evaluated. We found that both HT regimens significantly reduced arthritis disease severity and macrophage infiltration into inflamed joints. Surprisingly, HT was as efficient as methotrexate in controlling disease progression. At the molecular level, HT suppressed TNF-alpha while increasing production of IL-10. We also observed an induction of HSP70 and a reduction in both NF-kappa B and HIF-1 alpha in inflamed tissues. Additionally, using activated macrophages in vitro, we found that HT reduced production of pro-inflammatory cytokines, an effect which is correlated to induction of HSF-1 and HSP70 and inhibition of NF-kappa B and STAT activation. Our findings demonstrate a significant therapeutic benefit of HT in controlling arthritis progression in a clinically relevant mouse model, with an efficacy similar to methotrexate. Mechanistically, HT targets highly relevant anti-inflammatory pathways which strongly support its increased study for use in clinical trials for RA.	[Lee, Chen-Ting; Kokolus, Kathleen M.; Leigh, Nicholas D.; Capitano, Maegan; Hylander, Bonnie L.; Repasky, Elizabeth A.] Roswell Pk Canc Inst, Dept Immunol, Buffalo, NY 14263 USA	Roswell Park Cancer Institute	Repasky, EA (corresponding author), Roswell Pk Canc Inst, Dept Immunol, Buffalo, NY 14263 USA.	elizabeth.repasky@roswellpark.org	Leigh, Nicholas/AAV-6537-2021; Kokolus, Kathleen M./I-8779-2019	Kokolus, Kathleen M./0000-0002-9088-5409; Leigh, Nicholas/0000-0002-6978-6254	National Institutes of Health (NIH) [RO1 CA135368-01A1, NIH CA16056, NIH T32 CA085183]; NATIONAL CANCER INSTITUTE [P30CA016056, R01CA135368, T32CA085183] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funding was provided by National Institutes of Health (NIH) RO1 CA135368-01A1, NIH CA16056, and NIH T32 CA085183. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal A, 2003, RHEUMATOL INT, V23, P134, DOI 10.1007/s00296-002-0267-y; Asquith DL, 2009, EUR J IMMUNOL, V39, P2040, DOI 10.1002/eji.200939578; Bongartz T, 2006, JAMA-J AM MED ASSOC, V295, P2275, DOI 10.1001/jama.295.19.2275; Brand DD, 2007, NAT PROTOC, V2, P1269, DOI 10.1038/nprot.2007.173; Capitano ML, 2008, INT J HYPERTHER, V24, P141, DOI 10.1080/02656730701858289; Chamberlain LM, 2009, J BIOMED MATER RES A, V88A, P858, DOI 10.1002/jbm.a.31930; Clair EWS, 2004, ARTHRITIS RHEUM-US, V50, P3432, DOI 10.1002/art.20568; Constantin A, 1998, ARTHRITIS RHEUM, V41, P48, DOI 10.1002/1529-0131(199801)41:1<48::AID-ART7>3.0.CO;2-K; Cooper ZA, 2010, CELL STRESS CHAPERON, V15, P665, DOI 10.1007/s12192-010-0179-9; Cooper ZA, 2010, AM J PHYSIOL-CELL PH, V298, pC171, DOI 10.1152/ajpcell.00346.2009; Davignon JL, 2013, RHEUMATOLOGY, V52, P590, DOI 10.1093/rheumatology/kes304; ENSOR JE, 1994, AM J PHYSIOL, V266, pC967, DOI 10.1152/ajpcell.1994.266.4.C967; ENSOR JE, 1995, AM J PHYSIOL-CELL PH, V269, pC1140, DOI 10.1152/ajpcell.1995.269.5.C1140; Fairchild KD, 2000, J INTERF CYTOK RES, V20, P1049, DOI 10.1089/107999000750053708; Feldmann M, 2002, NAT REV IMMUNOL, V2, P364, DOI 10.1038/nri802; Gerards AH, 2003, RHEUMATOLOGY, V42, P1189, DOI 10.1093/rheumatology/keg323; Giacomelli R, 2002, CLIN EXP RHEUMATOL, V20, P365; Gomez-Reino JJ, 2003, ARTHRITIS RHEUM-US, V48, P2122, DOI 10.1002/art.11137; Hagiwara S, 2007, INFLAMM RES, V56, P297, DOI 10.1007/s00011-007-6161-z; Hollander AP, 2001, ARTHRITIS RHEUM-US, V44, P1540, DOI 10.1002/1529-0131(200107)44:7<1540::AID-ART277>3.0.CO;2-7; Kinne RW, 2000, ARTHRITIS RES, V2, P189, DOI 10.1186/ar86; Klareskog L, 2004, LANCET, V363, P675, DOI 10.1016/S0140-6736(04)15640-7; Konisti S, 2012, NAT REV RHEUMATOL, V8, P153, DOI 10.1038/nrrheum.2011.205; Kozier B., 2004, FUNDAMENTALS NURSING; Kuprash DV, 1999, J IMMUNOL, V162, P4045; Lin CF, 2008, J CELL BIOCHEM, V105, P746, DOI 10.1002/jcb.21868; Maguire O, 2011, CYTOM PART A, V79A, P461, DOI 10.1002/cyto.a.21068; Mariette X, 2011, ANN RHEUM DIS, V70, P1895, DOI 10.1136/ard.2010.149419; McHugh GA, 2007, J CLIN NURS, V16, P168, DOI 10.1111/j.1365-2702.2007.01885.x; McInnes IB, 2007, NAT REV IMMUNOL, V7, P429, DOI 10.1038/nri2094; McInnes IB, 2011, NEW ENGL J MED, V365, P2205, DOI 10.1056/NEJMra1004965; MORIMOTO RI, 1993, SCIENCE, V259, P1409, DOI 10.1126/science.8451637; Murdoch C, 2005, J IMMUNOL, V175, P6257, DOI 10.4049/jimmunol.175.10.6257; Quattrocchi E, 2001, J IMMUNOL, V166, P5970, DOI 10.4049/jimmunol.166.10.5970; Raza K, 2005, ARTHRITIS RES THER, V7, pR784, DOI 10.1186/ar1733; Rosloniec Edward F, 2001, Curr Protoc Immunol, VChapter 15, DOI [10.1002/0471142735.im1505s89, 10.1002/0471142735.im1505s20]; Schmid KL, 2001, THERMOTHERAPY FOR NE; SCHMIDT KL, 1979, Z RHEUMATOL, V38, P391; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Sen A, 2011, CANCER RES, V71, P3872, DOI 10.1158/0008-5472.CAN-10-4482; Shi YZ, 2006, SHOCK, V26, P277, DOI 10.1097/01.shk.0000223134.17877.ad; Singh IS, 2002, J BIOL CHEM, V277, P4981, DOI 10.1074/jbc.M108154200; Singh IS, 2000, J BIOL CHEM, V275, P9841, DOI 10.1074/jbc.275.13.9841; Smolen JS, 2005, ARTHRITIS RHEUM, V52, P1020, DOI 10.1002/art.20982; Steiner G, 2006, RHEUMATOID ARTHRITIS, P194; Sukenik S, 1997, ISRAEL J MED SCI, V33, P258; Tak PP, 2001, ARTHRITIS RHEUM, V44, P1897, DOI 10.1002/1529-0131(200108)44:8<1897::AID-ART328>3.0.CO;2-4; Tas SW, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1958; Taylor CT, 2008, J PHYSIOL-LONDON, V586, P4055, DOI 10.1113/jphysiol.2008.157669; TRENTHAM DE, 1982, ARTHRITIS RHEUM, V25, P911, DOI 10.1002/art.1780250801; Verhagen AP, 2003, COCHRANE DB SYST REV, pCD000518; Wessels JAM, 2008, RHEUMATOLOGY, V47, P249, DOI 10.1093/rheumatology/kem279; Whalen JD, 1999, J IMMUNOL, V162, P3625; Wijbrandts CA, 2007, ARTHRITIS RHEUM, V56, P3869, DOI 10.1002/art.22964; Woodrick RS, 2011, NAT REV RHEUMATOL, V7, P639, DOI 10.1038/nrrheum.2011.145; Ye L, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/ar4544; Yildirim N, 2010, J CLIN NURS, V19, P1113, DOI 10.1111/j.1365-2702.2009.03070.x; Zhang HL, 2012, INFLAMMATION, V35, P1558, DOI 10.1007/s10753-012-9471-4	58	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0120327	10.1371/journal.pone.0120327	http://dx.doi.org/10.1371/journal.pone.0120327			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25793532	Green Submitted, Green Published, gold			2022-12-27	WOS:000352083900014
J	Rosso, C; Pires, C; Corvol, JC; Baronnet, F; Crozier, S; Leger, A; Deltour, S; Valabregue, R; Amor-Sahli, M; Lehericy, S; Dormont, D; Samson, Y				Rosso, Charlotte; Pires, Christine; Corvol, Jean-Christophe; Baronnet, Flore; Crozier, Sophie; Leger, Anne; Deltour, Sandrine; Valabregue, Romain; Amor-Sahli, Melika; Lehericy, Stephane; Dormont, Didier; Samson, Yves			Hyperglycaemia, Insulin Therapy and Critical Penumbral Regions for Prognosis in Acute Stroke: Further Insights from the INSULINFARCT Trial	PLOS ONE			English	Article							ISCHEMIC-STROKE; POSTSTROKE HYPERGLYCEMIA; LESION VOLUME; TIME-COURSE; IN-VIVO; DIFFUSION; PATHOPHYSIOLOGY; SEGMENTATION; RECOVERY; DAMAGE	Background Recently, the concept of 'clinically relevant penumbra' was defined as an area saved by arterial recanalization and correlated with stroke outcome. This clinically relevant penumbra was located in the subcortical structures, especially the periventricular white matter. Our aims were to confirm this hypothesis, to investigate the impact of admission hyperglycemia and of insulin treatment on the severity of ischemic damages in this area and to study the respective contributions of infarct volume and ischemic damage severity of the clinically relevant penumbra on 3-month outcome. Methods We included 99 patients from the INSULINFARCT trial. Voxel-Based Analysis was carried on the Apparent Diffusion Coefficient (ADC) maps obtained at day one to localize the regions, which were more damaged in patients i) with poor clinical outcomes at three months and ii) without arterial recanalization. We determined the intersection of the detected areas, which represents the clinically relevant penumbra and investigated whether hyperglycemic status and insulin regimen affected the severity of ischemic damages in this area. We performed logistic regression to examine the contribution of infarct volume or early ADC decrease in this strategic area on 3-month outcome. Findings Lower ADC values were found in the corona radiata in patients with poor prognosis (p<0.0001) and in those without arterial recanalization (p<0.0001). The tracking analysis showed that lesions in this area interrupted many important pathways. ADC values in this area were lower in hyperglycemic than in normoglycemic patients (average decrease of 41.6 +/- 20.8 x10(-6)mm(2)/s) and unaffected by the insulin regimen (p: 0.10). ADC values in the clinically relevant penumbra, but not infarct volumes, were significant predictors of 3month outcome. Conclusion These results confirm that the deep hemispheric white matter is part of the clinically relevant penumbra and show that hyperglycaemia exacerbates the apparition of irreversible ischemic damage within 24 hours in this area. However, early intensive insulin therapy fails to protect this area from infarction.	[Rosso, Charlotte; Corvol, Jean-Christophe; Valabregue, Romain; Lehericy, Stephane; Dormont, Didier; Samson, Yves] Inst Cerveau & Moelle Epiniere, Ctr Rech, Paris, France; [Rosso, Charlotte; Corvol, Jean-Christophe; Valabregue, Romain; Lehericy, Stephane; Dormont, Didier; Samson, Yves] Univ Paris 06, INSERM, U1127, Paris, France; [Rosso, Charlotte; Corvol, Jean-Christophe; Valabregue, Romain; Lehericy, Stephane; Dormont, Didier; Samson, Yves] CNRS, UMR 7225, Paris, France; [Rosso, Charlotte; Lehericy, Stephane] Univ Paris 06, CNRS, INSERM, CONAM,U1127,UMR 7225, Paris, France; [Rosso, Charlotte; Pires, Christine; Baronnet, Flore; Crozier, Sophie; Leger, Anne; Deltour, Sandrine; Samson, Yves] Hop La Pitie Salpetriere, APHP, Urgences Cerebrovasc, Paris, France; [Valabregue, Romain; Lehericy, Stephane] Ctr Neuroimagerie Rech CENIR, Inst Cerveau & Moelle Epiniere, Paris, France; [Corvol, Jean-Christophe] Hop La Pitie Salpetriere, APHP, INSERM, Dept Malad Syst Nerveux,Ctr Invest Clin CIC9503, Paris, France; [Amor-Sahli, Melika; Lehericy, Stephane; Dormont, Didier] Hop La Pitie Salpetriere, APHP, Serv Neuroradiol, Paris, France; [Dormont, Didier; Samson, Yves] Univ Paris 06, CNRS, INSERM, COGIMAGE,U1127,UMR 7225, Paris, France	UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite	Rosso, C (corresponding author), Inst Cerveau & Moelle Epiniere, Ctr Rech, Paris, France.	charlotte.rosso@gmail.com	Corvol, Jean-Christophe/F-2124-2017; valabregue, romain/GWQ-7484-2022	Corvol, Jean-Christophe/0000-0001-7325-0199; valabregue, romain/0000-0002-1814-9570	program "Investissements d'avenir" [ANR-10-IAIHU-06]; Assistance Publique Hopitaux de Paris (AP-HP)	program "Investissements d'avenir"(French National Research Agency (ANR)); Assistance Publique Hopitaux de Paris (AP-HP)	The research leading to these results has received funding from the program "Investissements d'avenir" ANR-10-IAIHU-06. The authors thank the Centre d'Investigation Clinique (INSERM/APHP, CIC9503) for their help in conducting this study. The INSULINFARCT study was supported by the Assistance Publique Hopitaux de Paris (AP-HP). The AP-HP had no role in the design, data analysis or writing of this report.	Baird TA, 2003, STROKE, V34, P2208, DOI 10.1161/01.STR.0000085087.41330.FF; Barber PA, 2006, NEUROLOGY, V66, P1138, DOI 10.1212/01.wnl.0000216733.77417.b1; Bellolio MF, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005346.pub4; Bruno A, 2002, NEUROLOGY, V59, P669, DOI 10.1212/WNL.59.5.669; Buzsaki G., 2006, STRUCTURE DEFINES FU, P29; Capes SE, 2001, STROKE, V32, P2426, DOI 10.1161/hs1001.096194; Catani M, 2002, NEUROIMAGE, V17, P77, DOI 10.1006/nimg.2002.1136; Catani M, 2012, CORTEX, V48, P1262, DOI 10.1016/j.cortex.2012.07.001; Cuingnet R, 2011, MED IMAGE ANAL, V15, P729, DOI 10.1016/j.media.2011.05.007; Eickhoff SB, 2005, NEUROIMAGE, V25, P1325, DOI 10.1016/j.neuroimage.2004.12.034; Farr TD, 2010, J CEREBR BLOOD F MET, V30, P703, DOI 10.1038/jcbfm.2010.5; Fiebach JB, 2002, NEURORADIOLOGY, V44, P294, DOI 10.1007/s00234-001-0720-8; Fiehler J, 2001, J CEREBR BLOOD F MET, V21, P577, DOI 10.1097/00004647-200105000-00012; Furlan M, 1996, ANN NEUROL, V40, P216, DOI 10.1002/ana.410400213; Gray CS, 2007, LANCET NEUROL, V6, P397, DOI 10.1016/S1474-4422(07)70080-7; Johnston KC, 2007, STROKE, V38, P1820, DOI 10.1161/STROKEAHA.106.479154; Konrad A, 2012, J COGNITIVE NEUROSCI, V24, P888, DOI 10.1162/jocn_a_00187; Kruyt ND, 2010, NAT REV NEUROL, V6, P145, DOI 10.1038/nrneurol.2009.231; MacDougall NJJ, 2011, J CEREBR BLOOD F MET, V31, P807, DOI 10.1038/jcbfm.2010.210; Makris N, 2005, CEREB CORTEX, V15, P854, DOI 10.1093/cercor/bhh186; Martino J, 2014, CLIN ANAT, V27, P563, DOI 10.1002/ca.22321; McCormick M, 2010, ANN NEUROL, V67, P570, DOI 10.1002/ana.21983; Moustafa RR, 2008, BRIT J PHARMACOL, V153, pS44, DOI 10.1038/sj.bjp.0707530; Nelles M, 2008, AM J NEURORADIOL, V29, P1708, DOI 10.3174/ajnr.A1201; Neumann-Haefelin T, 2004, STROKE, V35, P109, DOI 10.1161/01.STR.0000106482.31425.D1; Parsons MW, 2002, ANN NEUROL, V52, P20, DOI 10.1002/ana.10241; Phan TG, 2010, NEUROIMAGE, V49, P127, DOI 10.1016/j.neuroimage.2009.07.067; Puig J, 2013, STROKE, V44, P2016, DOI 10.1161/STROKEAHA.111.000382; Ribo M, 2007, J CEREBR BLOOD F MET, V27, P1616, DOI 10.1038/sj.jcbfm.9600460; Rosso C, 2011, J NEURORADIOLOGY, V38, P105, DOI 10.1016/j.neurad.2010.05.001; Rosso C, 2011, AM J NEURORADIOL, V32, P852, DOI 10.3174/ajnr.A2407; Rosso C, 2014, CURR OPIN NEUROL, V27, P35, DOI 10.1097/WCO.0000000000000047; Rosso C, 2012, STROKE, V43, P2343, DOI 10.1161/STROKEAHA.112.657122; Rosso C, 2011, NEURORADIOLOGY, V53, P763, DOI 10.1007/s00234-011-0916-5; Schlaug G, 1997, NEUROLOGY, V49, P113, DOI 10.1212/WNL.49.1.113; Tarr D, 2013, J CEREBR BLOOD F MET, V33, P1556, DOI 10.1038/jcbfm.2013.107; Vargas P, 2013, J MAGN RESON IMAGING, V37, P836, DOI 10.1002/jmri.23870; Vogt G, 2012, STROKE, V43, P1266, DOI 10.1161/STROKEAHA.111.646570	38	38	38	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0120230	10.1371/journal.pone.0120230	http://dx.doi.org/10.1371/journal.pone.0120230			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25793765	Green Published, Green Submitted, gold			2022-12-27	WOS:000352084200163
J	Saladie, P; Caceres, I; Huguet, R; Rodriguez-Hidalgo, A; Santander, B; Olle, A; Gabucio, MJ; Martin, P; Marin, J				Saladie, Palmira; Caceres, Isabel; Huguet, Rosa; Rodriguez-Hidalgo, Antonio; Santander, Boris; Olle, Andreu; Joana Gabucio, Ma; Martin, Patricia; Marin, Juan			Experimental Butchering of a Chimpanzee Carcass for Archaeological Purposes	PLOS ONE			English	Article							GRAN DOLINA; OLDUVAI-GORGE; BONE MODIFICATIONS; EARLY PLEISTOCENE; PERCUSSION MARKS; ATAPUERCA BURGOS; MOULA-GUERCY; CUT MARKS; HOMINID; CANNIBALISM	Two archaeological assemblages from the Sierra de Atapuerca sites show evidence of anthropogenic cannibalism. These are the late Early Pleistocene level TD6-2 at Gran Dolina, and the Bronze Age level MIR4 in the Mirador Cave. Despite the chronological distance between these two assemblages, they share the common feature that the human remains exhibit a high frequency of anthropogenic modifications (cut marks, percussion pits and notches and peeling). This frequency could denote special treatment of bodies, or else be the normal result of the butchering process. In order to test these possibilities, we subjected a chimpanzee carcass to a butchering process. The processing was intensive and intended to simulate preparation for consumption. In doing this, we used several simple flakes made from quartzite and chert from quarries in the Sierra de Atapuerca. The skull, long bones, metapodials and phalanges were also fractured in order to remove the brain and bone marrow. As a result, about 40% of the remains showed some kind of human modification. The frequency, distribution and characteristics of these modifications are very similar to those documented on the remains of Homo antecessor from TD6-2. In case of the MIR4 assemblage, the results are similar except in the treatment of skulls. Our results indicate that high frequencies of anthropogenic modifications are common after an intensive butchering process intended to prepare a hominin body for consumption in different contexts (both where there was possible ritual behavior and where this was not the case and the modifications are not the result of special treatment).	[Saladie, Palmira; Caceres, Isabel; Huguet, Rosa; Rodriguez-Hidalgo, Antonio; Santander, Boris; Olle, Andreu; Joana Gabucio, Ma; Martin, Patricia; Marin, Juan] IPHES, Inst Catala Paleoecol Humana & Evolucio Social, Tarragona 43007, Spain; [Saladie, Palmira; Caceres, Isabel; Huguet, Rosa; Rodriguez-Hidalgo, Antonio; Santander, Boris; Olle, Andreu; Joana Gabucio, Ma; Martin, Patricia; Marin, Juan] Univ Rovira & Virgili, Area Prehist, E-43007 Tarragona, Spain; [Saladie, Palmira; Santander, Boris] GQP CG, Grp Quaternario & Prehist Ctr Geociencias Ul & FC, Tomar, Portugal; [Saladie, Palmira; Huguet, Rosa] Museo Ciencias Nat MNCN, Dept Paleobiol, Unit Associated Consejo Super Invest Cient CSIC, Madrid, Spain; [Rodriguez-Hidalgo, Antonio; Marin, Juan] Equipo Primeros Pobladores Extremadura, Caceres, Spain	ICREA; Universitat Rovira i Virgili; Catalan Institute of Human Paleo-Ecology & Social Evolution (IPHES); Universitat Rovira i Virgili; Consejo Superior de Investigaciones Cientificas (CSIC)	Saladie, P (corresponding author), IPHES, Carrer Marcel Li Domingo S-N,Edifici W3,Campus Se, Tarragona 43007, Spain.	psaladie@iphes.cat	Rodríguez-Hidalgo, Antonio/B-9694-2019; Saladie, Palmira/AAR-7932-2020; Marín, Juan/ABE-1453-2020; Gabucio, Maria Joana/AAH-5586-2019; Cáceres, Isabel/G-2636-2015; Marín, Juan/O-9893-2016; Martín, Patricia/AAH-4903-2019; Rodríguez, Patricia Martín/C-9568-2019; Rodríguez-Hidalgo, Antonio/H-4128-2019; Ollé, Andreu/D-6837-2013; Huguet, Rosa/H-5713-2015; Saladie, Palmira/G-4019-2015	Rodríguez-Hidalgo, Antonio/0000-0002-5449-9287; Marín, Juan/0000-0002-5698-602X; Gabucio, Maria Joana/0000-0002-5061-1825; Cáceres, Isabel/0000-0001-8487-2591; Marín, Juan/0000-0002-5698-602X; Martín, Patricia/0000-0002-8781-7966; Rodríguez, Patricia Martín/0000-0002-8781-7966; Rodríguez-Hidalgo, Antonio/0000-0002-5449-9287; Ollé, Andreu/0000-0002-8643-5536; Saladie, Palmira/0000-0002-1730-8461	Ministry of Economy and Competitiveness (MINECO) of Spain Government [CGL2012-38434-C03-03, HAR2012-32548]; Catalonian Government [SGR2014-899]; Cultural and Tourism Council of Castilla y Leon and Atapuerca Foundation; MINECO [CGL2009-12703-C03-02]; CONICYT-Advanced Human Capital Program (Becas Chile)	Ministry of Economy and Competitiveness (MINECO) of Spain Government; Catalonian Government; Cultural and Tourism Council of Castilla y Leon and Atapuerca Foundation; MINECO(Spanish Government); CONICYT-Advanced Human Capital Program (Becas Chile)	This work was supported by Ministry of Economy and Competitiveness (MINECO) of Spain Government, project no CGL2012-38434-C03-03 and project no HAR2012-32548; and by the Catalonian Government, project no SGR2014-899. Funding for the fieldwork came from Cultural and Tourism Council of Castilla y Leon and Atapuerca Foundation. ARH is beneficiary of a predoctoral research fellowship (FPI) from the MINECO (CGL2009-12703-C03-02). BS is beneficiary of a predoctoral fellowship from CONICYT-Advanced Human Capital Program (Becas Chile 2011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews P., 2003, B NATURAL HIST MUSEU, V58, P59, DOI DOI 10.1017/5096804620300010X; Arsuaga JL, 1997, J HUM EVOL, V33, P109, DOI 10.1006/jhev.1997.0132; Bello SM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017026; Bello SM, 2009, J ARCHAEOL SCI, V36, P1869, DOI 10.1016/j.jas.2009.04.014; Berger GW, 2008, J HUM EVOL, V55, P300, DOI 10.1016/j.jhevol.2008.02.012; Binford L. R., 1978, NUNAMIUT ETHNOARCHAE; BINFORD LR, 1988, CURR ANTHROPOL, V29, P123, DOI 10.1086/203618; Binford LRB., 1981, ANCIENT MEN MODERN M; BLUMENSCHINE RJ, 1988, NATURE, V333, P763, DOI 10.1038/333763a0; Blumenschine RJ, 1996, J ARCHAEOL SCI, V23, P493, DOI 10.1006/jasc.1996.0047; Boulestin B., 1999, BAR INT SERIES, V776; Boulestin B, 2009, ANTIQUITY, V83, P968, DOI 10.1017/S0003598X00099282; BUNN HT, 1986, CURR ANTHROPOL, V27, P431, DOI 10.1086/203467; Caceres I, 2007, AM J PHYS ANTHROPOL, V133, P899, DOI 10.1002/ajpa.20610; Capaldo SD, 1997, J HUM EVOL, V33, P555, DOI 10.1006/jhev.1997.0150; Carbonell E, 1999, J HUM EVOL, V37, P653, DOI 10.1006/jhev.1999.0336; Carbonell E, 2008, NATURE, V452, P465, DOI 10.1038/nature06815; Carretero JM., 2008, MUNIBE, V59, P67; deCastro JMB, 1997, SCIENCE, V276, P1392; Defleur A, 1999, SCIENCE, V286, P128, DOI 10.1126/science.286.5437.128; Dewbury AG, 2007, J ARCHAEOL SCI, V34, P354, DOI 10.1016/j.jas.2006.05.009; Diez JC, 1999, J HUM EVOL, V37, P623, DOI 10.1006/jhev.1999.0346; Dominguez-Rodrigo M, 2003, EVOL ANTHROPOL, V12, P275, DOI 10.1002/evan.10119; Dominguez-Rodrigo M, 2009, J ARCHAEOL SCI, V36, P2643, DOI 10.1016/j.jas.2009.07.017; Dominguez-Rodrigo M, 1999, PALAEOGEOGR PALAEOCL, V149, P373, DOI 10.1016/S0031-0182(98)00213-2; Dominguez-Rodrigo M, 2009, J ARCHAEOL SCI, V36, P884, DOI 10.1016/j.jas.2008.11.007; Egeland CP, 2003, PLAINS ANTHROPOL, V48, P39, DOI 10.1080/2052546.2003.11949279; Falgueres C, 1999, J HUM EVOL, V37, P343, DOI 10.1006/jhev.1999.0326; Fernandez-Jalvo Y, 1999, J HUM EVOL, V37, P591, DOI 10.1006/jhev.1999.0324; Fernandez-Jalvo Y, 2011, J HUM EVOL, V60, P117, DOI 10.1016/j.jhevol.2010.08.003; Chacon MG, 2007, BAR INT SER, V1725, P187; Huguet R., 2007, PRIMERAS OCUPACIONES; Lyman RL, 2005, J ARCHAEOL SCI, V32, P1722, DOI 10.1016/j.jas.2005.06.003; LYMAN RL, 1995, J ANTHROPOL ARCHAEOL, V14, P45, DOI 10.1006/jaar.1995.1003; Lyman RL, 2008, CAMB MAN ARCHAEOL, P1, DOI 10.1017/CBO9780511813863; LYMAN RL, 1992, AM ANTIQUITY, V57, P246, DOI 10.2307/280730; Milo RG, 1998, J ARCHAEOL SCI, V25, P99, DOI 10.1006/jasc.1997.0233; Nilssen P.J., 2000, ACTUALISTIC BUTCHERY; Olle A, 2013, QUATERN INT, V295, P138, DOI 10.1016/j.quaint.2011.11.009; Orschiedt J, 2002, SECONDARY BURIAL MAG; Padilla M, 2008, TRANSMISION CULTURAL; Pares JM, 2013, J ARCHAEOL SCI, V40, P4586, DOI 10.1016/j.jas.2013.06.013; PARES JM, 1995, SCIENCE, V269, P830, DOI 10.1126/science.7638599; Pares JM, 1999, J HUM EVOL, V37, P325, DOI 10.1006/jhev.1999.0331; Pickering TR, 2008, J ARCHAEOL SCI, V35, P310, DOI 10.1016/j.jas.2007.03.012; Pickering TR, 2013, J ARCHAEOL SCI, V40, P1295, DOI 10.1016/j.jas.2012.09.025; POTTS R, 1981, NATURE, V291, P577, DOI 10.1038/291577a0; Rosas A, 2006, P NATL ACAD SCI USA, V103, P19266, DOI 10.1073/pnas.0609662104; Saladie P, 2014, QUATERNARY SCI REV, V93, P47, DOI 10.1016/j.quascirev.2014.04.001; Saladie P, 2013, J ARCHAEOL SCI, V40, P380, DOI 10.1016/j.jas.2012.08.002; Saladie P, 2012, J HUM EVOL, V63, P682, DOI 10.1016/j.jhevol.2012.07.004; Saladie P, 2011, J HUM EVOL, V61, P425, DOI 10.1016/j.jhevol.2011.05.012; SHIPMAN P, 1983, J ANTHROPOL ARCHAEOL, V2, P57, DOI 10.1016/0278-4165(83)90008-9; Stiner MC, 2009, P NATL ACAD SCI USA, V106, P13207, DOI 10.1073/pnas.0900564106; Turner C. G., 1983, CARNIVORES HUMAN SCA, P219; Turner CG II, 1999, CANNIBALISM VIOLENCE; Valensi P, 2012, QUATERN INT, V252, P48, DOI 10.1016/j.quaint.2011.07.028; Verges JM., 2002, TRABAJOS PREHIST, V59, P107, DOI [10.3989/tp.2002.v59.i1.213, DOI 10.3989/TP.2002.V59.I1.213]; Verges JM, 2008, ACT 4 C NEOL PEN AL, P418; VILLA P, 1986, SCIENCE, V233, P431, DOI 10.1126/science.233.4762.431; Villa P., 1992, EVOLUTIONARY ANTHR, V1, P93, DOI DOI 10.1002/EVAN.1360010307; White T.D., 1992, PREHISTORIC CANNIBAL	62	7	8	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0121208	10.1371/journal.pone.0121208	http://dx.doi.org/10.1371/journal.pone.0121208			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	CE8HY	25793521	Green Submitted, Green Published, gold			2022-12-27	WOS:000352083900113
J	Stax, MJ; Mouser, EEIM; van Montfort, T; Sanders, RW; de Vries, HJC; Dekker, HL; Herrera, C; Speijer, D; Pollakis, G; Paxton, WA				Stax, Martijn J.; Mouser, Emily E. I. M.; van Montfort, Thijs; Sanders, Rogier W.; de Vries, Henry J. C.; Dekker, Henk L.; Herrera, Carolina; Speijer, Dave; Pollakis, Georgios; Paxton, William A.			Colorectal Mucus Binds DC-SIGN and Inhibits HIV-1 Trans-Infection of CD4(+) T-Lymphocytes	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; SALT-STIMULATED LIPASE; ENVELOPE GLYCOPROTEIN; DENDRITIC CELLS; TRANSMISSION; PROTEIN; LIGAND; GP120	Bodily secretions, including breast milk and semen, contain factors that modulate HIV-1 infection. Since anal intercourse caries one of the highest risks for HIV-1 transmission, our aim was to determine whether colorectal mucus (CM) also contains factors interfering with HIV-1 infection and replication. CM from a number of individuals was collected and tested for the capacity to bind DC-SIGN and inhibit HIV-1 cis- or trans-infection of CD4(+) T-lymphocytes. To this end, a DC-SIGN binding ELISA, a gp140 trimer competition ELISA and HIV-1 capture/transfer assays were utilized. Subsequently we aimed to identify the DC-SIGN binding component through biochemical characterization and mass spectrometry analysis. CM was shown to bind DC-SIGN and competes with HIV-1 gp140 trimer for binding. Pre-incubation of Raji-DC-SIGN cells or immature dendritic cells (iDCs) with CM potently inhibits DC-SIGN mediated trans-infection of CD4(+) T-lymphocytes with CCR5 and CXCR4 using HIV-1 strains, while no effect on direct infection is observed. Preliminary biochemical characterization demonstrates that the component seems to be large (>100kDa), heat and proteinase K resistant, binds in a alpha 1-3 mannose independent manner and is highly variant between individuals. Immunoprecipitation using DC-SIGN-Fc coated agarose beads followed by mass spectrometry indicated lactoferrin (fragments) and its receptor (intelectin-1) as candidates. Using ELISA we showed that lactoferrin levels within CM correlate with DC-SIGN binding capacity. In conclusion, CM can bind the C-type lectin DC-SIGN and block HIV-1 trans-infection of both CCR5 and CXCR4 using HIV-1 strains. Furthermore, our data indicate that lactoferrin is a DC-SIGN binding component of CM. These results indicate that CM has the potential to interfere with pathogen transmission and modulate immune responses at the colorectal mucosa.	[Stax, Martijn J.; Mouser, Emily E. I. M.; van Montfort, Thijs; Sanders, Rogier W.; Pollakis, Georgios; Paxton, William A.] Univ Amsterdam, Acad Med Ctr, Dept Med Microbiol, Lab Expt Virol,Ctr Infect & Immun, NL-1105 AZ Amsterdam, Netherlands; [Sanders, Rogier W.] Cornell Univ, Dept Microbiol & Immunol, Weill Med Coll, New York, NY 10021 USA; [de Vries, Henry J. C.] Univ Amsterdam, Dept Dermatol, Med Ctr, NL-1105 AZ Amsterdam, Netherlands; [Dekker, Henk L.] Univ Amsterdam, Mass Spectrometry Biomacromol, Swammerdam Inst Life Sci, NL-1105 AZ Amsterdam, Netherlands; [Herrera, Carolina] Univ London Imperial Coll Sci Technol & Med, Fac Med, Div Infect Dis, London, England; [Speijer, Dave] Univ Amsterdam, Dept Med Biochem, Med Ctr, NL-1105 AZ Amsterdam, Netherlands; [Pollakis, Georgios; Paxton, William A.] Univ Liverpool, Inst Infect & Global Hlth, Dept Clin Infect Microbiol & Immunol, Liverpool L69 3BX, Merseyside, England; [de Vries, Henry J. C.] Univ Amsterdam, STI Outpatient Clin, Cluster Infect Dis, Publ Hlth Serv Amsterdam, NL-1105 AZ Amsterdam, Netherlands; [de Vries, Henry J. C.] Univ Amsterdam, Acad Med Ctr, Ctr Infect & Immun Amsterdam, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; Cornell University; University of Amsterdam; University of Amsterdam; Imperial College London; University of Amsterdam; University of Liverpool; Public Health Service Amsterdam; University of Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Paxton, WA (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Med Microbiol, Lab Expt Virol,Ctr Infect & Immun, NL-1105 AZ Amsterdam, Netherlands.	w.a.paxton@liverpool.ac.uk	de Vries, Henry/K-5963-2012; Georgios, Pollakis/Y-2341-2019; paxton, william/R-9747-2019; Speijer, Dave/AAE-4613-2019	de Vries, Henry/0000-0001-9784-547X; Speijer, Dave/0000-0002-2340-2753; Paxton, William/0000-0002-2654-5186; Herrera, Carolina/0000-0003-3701-752X; Paxton, William/0000-0001-5200-0801; Pollakis, Georgios/0000-0002-9659-5461	Dutch AIDS fonds grant [2005024]; University of Amsterdam; European Community [41642, 305578]	Dutch AIDS fonds grant; University of Amsterdam; European Community(European Commission)	This work was partly funded through a Dutch AIDS fonds grant (2005024), a SKE grant from the University of Amsterdam (WAP), and two European Community's Seventh Framework Programme Grants [41642 (IDEA) and 305578 (PathCo)]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand Kumar BH, 2003, INDIAN J DERMATOL VE, V69, P126; Binley JM, 2000, J VIROL, V74, P627, DOI 10.1128/JVI.74.2.627-643.2000; Buisine MP, 2001, GUT, V49, P544, DOI 10.1136/gut.49.4.544; Carthagena Laetitia, 2011, Open Virol J, V5, P27, DOI 10.2174/1874357901105010027; Ceballos A, 2009, J EXP MED, V206, P2717, DOI 10.1084/jem.20091579; Downs JA, 2011, AM J TROP MED HYG, V84, P364, DOI 10.4269/ajtmh.2011.10-0585; Eggink D, 2010, VIROLOGY, V401, P236, DOI 10.1016/j.virol.2010.02.019; Geijtenbeek TBH, 2000, CELL, V100, P587, DOI 10.1016/S0092-8674(00)80694-7; Ghosh M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011366; Grivel JC, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-S1-S6; Groot F, 2005, J VIROL, V79, P3009, DOI 10.1128/JVI.79.5.3009-3015.2005; Guo Y, 2004, NAT STRUCT MOL BIOL, V11, P591, DOI 10.1038/nsmb784; Herrera C, 2009, ANTIMICROB AGENTS CH, V53, P1797, DOI 10.1128/AAC.01096-08; Hladik F, 2008, NAT REV IMMUNOL, V8, P447, DOI 10.1038/nri2302; Jendrysik MA, 2005, J INFECT DIS, V192, P630, DOI 10.1086/432071; Martellini JA, 2009, FASEB J, V23, P3609, DOI 10.1096/fj.09-131961; Munch J, 2007, CELL, V131, P1059, DOI 10.1016/j.cell.2007.10.014; Naarding MA, 2005, J CLIN INVEST, V115, P3256, DOI 10.1172/JCI25105; Naarding MA, 2006, ANTIMICROB AGENTS CH, V50, P3367, DOI 10.1128/AAC.00593-06; NILSSON J, 1990, EUR J BIOCHEM, V192, P543, DOI 10.1111/j.1432-1033.1990.tb19259.x; Pollakis G, 2001, J BIOL CHEM, V276, P13433, DOI 10.1074/jbc.M009779200; Rescigno M, 2001, NAT IMMUNOL, V2, P361, DOI 10.1038/86373; Sabatte J, 2011, J IMMUNOL, V187, P5299, DOI 10.4049/jimmunol.1101889; Saeland E, 2009, MOL IMMUNOL, V46, P2309, DOI 10.1016/j.molimm.2009.03.025; Stax MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032534; Stax MJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017316; Stax MJ, 2009, VIROLOGY, V391, P203, DOI 10.1016/j.virol.2009.06.011; van Kooyk Y, 2003, NAT REV IMMUNOL, V3, P697, DOI 10.1038/nri1182; van Montfort T, 2007, J IMMUNOL, V178, P3177, DOI 10.4049/jimmunol.178.5.3177	29	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0122020	10.1371/journal.pone.0122020	http://dx.doi.org/10.1371/journal.pone.0122020			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25793526	Green Published, gold			2022-12-27	WOS:000352083900167
J	Wojcicki, JM; Young, MB; Perham-Hester, KA; de Schweinitz, P; Gessner, BD				Wojcicki, Janet M.; Young, Margaret B.; Perham-Hester, Katherine A.; de Schweinitz, Peter; Gessner, Bradford D.			Risk Factors for Obesity at Age 3 in Alaskan Children, Including the Role of Beverage Consumption: Results from Alaska PRAMS 2005-2006 and Its Three-Year Follow-Up Survey, CUBS, 2008-2009	PLOS ONE			English	Article							INTIMATE PARTNER VIOLENCE; CHILDHOOD OBESITY; RESPIRATORY-TRACT; WEIGHT-GAIN; OVERWEIGHT; PREGNANCY; ASSOCIATION; WATER; ADOLESCENCE; PREVENTION	Background Prenatal and early life risk factors are associated with childhood obesity. Alaska Native children have one of the highest prevalences of childhood obesity of all US racial/ethnic groups. Methods Using the Pregnancy Risk Assessment Monitoring System (PRAMS) and the follow-up survey at 3 years of age (CUBS), we evaluated health, behavioral, lifestyle and nutritional variables in relation to obesity (95th percentile for body mass index (BMI)) at 3 years of age. Multivariate logistic regression modeling was conducted using Stata 12.0 to evaluate independent risk factors for obesity in non-Native and Alaska Native children. Results We found an obesity prevalence of 24.9% in all Alaskan and 42.2% in Alaska Native 3 year olds. Among Alaska Native children, obesity prevalence was highest in the Northern/Southwest part of the state (51.6%, 95% CI (42.6-60.5)). Independent predictive factors for obesity at age 3 years in Alaska non-Native children were low income (<$10,000 in the year before the child was born (OR 3.94, 95% CI 1.22-17.03) and maternal pre-pregnancy obesity (OR 2.01, 95% CI 1.01-4.01) and longer duration of breastfeeding was protective (OR 0.95, 95% CI 0.91-0.995). Among Alaska Native children, predictive factors were witnessing domestic violence/abuse as a 3 year-old (OR 2.28, 95% CI 1.17-7.60). Among obese Alaska Native children, there was an increased daily consumption of energy dense beverages in the Northern/Southwest region of the state, which may explain higher rates of obesity in this part of the state. Conclusions The high prevalence of obesity in Alaska Native children may be explained by differences in lifestyle patterns and food consumption in certain parts of the state, specifically the Northern/Southwest region, which have higher consumption of energy dense beverages.	[Wojcicki, Janet M.] Univ Calif San Francisco, Dept Pediat GI & Nutr, San Francisco, CA 94143 USA; [Young, Margaret B.; Perham-Hester, Katherine A.] Alaska Div Publ Hlth, Sect Womens Childrens & Family Hlth, Maternal & Child Hlth Epidemiol Unit, Anchorage, AK USA; [de Schweinitz, Peter] Tanana Chiefs Conf, Fairbanks, AK USA; [Gessner, Bradford D.] Agence Med Prevent, Paris, France	University of California System; University of California San Francisco; Agence de Medecine Preventive	Wojcicki, JM (corresponding author), Univ Calif San Francisco, Dept Pediat GI & Nutr, San Francisco, CA 94143 USA.	Wojcicki@gmail.com			National Institutes of Health [NIDDK 080825]; Centers for Disease Control and Prevention [5U01DP003114]; Maternal and Child Health Bureau, Health Resources and Services Administration, Alaska DHHS [B04MC26649]; NATIONAL CENTER FOR CHRONIC DISEASE PREV AND HEALTH PROMO [U01DP003114] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007762, K01DK080825] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Maternal and Child Health Bureau, Health Resources and Services Administration, Alaska DHHS; NATIONAL CENTER FOR CHRONIC DISEASE PREV AND HEALTH PROMO(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Janet Wojcicki is supported by an National Institutes of Health NIDDK 080825 award. Alaska PRAMS is supported by grant number 5U01DP003114 from the Centers for Disease Control and Prevention. Alaska PRAMS and Alaska CUBS are supported by project B04MC26649 from the Maternal and Child Health Bureau (Title V, Social Security Act), Health Resources and Services Administration, Alaska DHHS. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Alaska Department of Health and Social Services Obesity Prevention and Control Program, 2013, ALASKA OBESITY FACTS; Anderson SE, 2009, ARCH PEDIAT ADOL MED, V163, P344, DOI 10.1001/archpediatrics.2009.18; Beck LF, 2001, MMWR-MORBID MORTAL W, V51, P1; Boles M, 2012, PREVALENCE OVERWEIGH, V4; Boynton-Jarrett R, 2010, ARCH PEDIAT ADOL MED, V164, P540, DOI 10.1001/archpediatrics.2010.94; Centers for Disease Control and Prevention, 2013, MMWR-MORBID MORTAL W, P426; Cook C, 2010, J MAN MANIP THER, V18, P3, DOI 10.1179/106698110X12595770849362; Demment MM, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-417; Dennison BA, 1997, PEDIATRICS, V99, P15; Dubnov-Raz G, 2011, INT J OBESITY, V35, P1295, DOI 10.1038/ijo.2011.130; Eberling S, 2011, RESULTS 2010 2011 SU; Ehrenthal DB, 2013, OBSTET GYNECOL, V121, P115, DOI [10.1097/AOG.0b013e318278f56a, http://10.1097/AOG.0b013e318278f56a]; Feise Ronald J, 2002, BMC Med Res Methodol, V2, P8, DOI 10.1186/1471-2288-2-8; Fenaughty AM, 2009, CHILDHOOD OBESITY AL; Flores G, 2013, INT J OBESITY, V37, P31, DOI 10.1038/ijo.2012.168; Gessner BD, 2008, J PEDIATR-US, V152, P666, DOI 10.1016/j.jpeds.2007.10.049; Grummer-Strawn LM, 2004, PEDIATRICS, V113, P81; Halpern P., 2007, OBESITY AM INDIAN AL; Hennessy TW, 2008, AM J PUBLIC HEALTH, V98, P2072, DOI 10.2105/AJPH.2007.115618; Heo M, 2011, OBESITY FACTS, V4, P449, DOI 10.1159/000335279; Irigoyen M, 2008, J URBAN HEALTH, V85, P545, DOI 10.1007/s11524-008-9285-8; Jun HJ, 2012, J EPIDEMIOL COMMUN H, V66, P629, DOI 10.1136/jech.2010.110932; Kitsantas P, 2010, EARLY HUM DEV, V86, P563, DOI 10.1016/j.earlhumdev.2010.07.006; LaRowe TL, 2010, J AM DIET ASSOC, V110, P1049, DOI 10.1016/j.jada.2010.04.009; Li Y, 2014, CHILD CARE HLTH DEV; Lindberg SM, 2012, MATERN CHILD HLTH J, V16, P1879, DOI 10.1007/s10995-012-1024-9; Ludwig DS, 2010, LANCET, V376, P984, DOI 10.1016/S0140-6736(10)60751-9; McFarlane JM, 2003, PEDIATRICS, V112, pE202, DOI 10.1542/peds.112.3.e202; Ogden CL, 2012, JAMA-J AM MED ASSOC, V307, P483, DOI 10.1001/jama.2012.40; Oken E, 2008, INT J OBESITY, V32, P201, DOI 10.1038/sj.ijo.0803760; Oken E, 2008, OBSTET GYNECOL, V112, P999, DOI 10.1097/AOG.0b013e31818a5d50; Pak A. W. P., 2005, PREVENTING CHRONIC D, V2, P1; Schiff M, 2014, CHILD ABUSE NEGL; Shulman HB, 2006, PUBLIC HEALTH REP, V121, P74, DOI 10.1177/003335490612100114; Skinner AC, 2013, PUBLIC HLTH REPORTS, V128; Suglia SF, 2012, PEDIATRICS, V129, pE1173, DOI 10.1542/peds.2011-2456; Surkan PJ, 2008, J EPIDEMIOL COMMUN H, V62, DOI 10.1136/jech.2007.065664; Weden MM, 2013, AM J EPIDEMIOL, V178, P461, DOI 10.1093/aje/kws477; Wojcicki JM, 2012, AM J PUBLIC HEALTH, V102, P1630, DOI 10.2105/AJPH.2012.300719; Wojcicki JM, 2010, NEW ENGL J MED, V362, P1457, DOI 10.1056/NEJMp1001857; Young M. B., 2011, ALASKA MATERNAL CHIL	41	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0118711	10.1371/journal.pone.0118711	http://dx.doi.org/10.1371/journal.pone.0118711			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25793411	Green Submitted, gold, Green Published			2022-12-27	WOS:000352084200033
J	Xue, YJ; Wu, LN; Liu, YN; Ma, YY; Zhang, LJ; Ma, XM; Yang, Y; Chen, JF				Xue, Yijun; Wu, Lina; Liu, Yinan; Ma, Yuanyuan; Zhang, Lijian; Ma, Xuemei; Yang, Yue; Chen, Jinfeng			ENTPD5 Induces Apoptosis in Lung Cancer Cells via Regulating Caspase 3 Expression	PLOS ONE			English	Article							GROWTH-FACTOR; PROGNOSIS; METAANALYSIS; ASSOCIATION; RESISTANCE; CARCINOMA; FAMILY; TUMORS; AKT; P53	This study is to investigate the relationship between ectonucleoside triphosphate diphosphohydrolase 5 (ENTPD5) expression and lung cancer clinicopathological factors, and the impact of ENTPD5 on lung cancer cell functions. Lung cancer specimens and matched adjacent normal tissues were obtained from patients without any preoperative radiotherapy or chemotherapy. Knockdown of ETNPD5 expression led to significantly decreased lung cancer cell growth rate, markedly increased apoptosis and the ability to repair, and significantly reduced invasion. Gene chip tests showed that knockdown of ENTPD5 expression caused more Caspase expression. Quantitative real-time polymerase chain reaction showed that the Caspase 3 expression was significantly increased after the knockdown of ENTPD5. In addition, immunohistochemistry showed that the tumor growth marker, proliferating cell nuclear antigen, was significantly reduced in the knockdown model. Tumorigenicity assay and terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling assay showed that the apoptosis of lung cancer cells was increased in the knockdown model. Our results suggest that ENTPD5 affects lung cancer apoptosis via Caspase 3 pathway, and can be potentially used to monitor prognosis or to guide appropriate therapeutic regimens.	[Xue, Yijun; Ma, Xuemei] Beijing Univ Technol, Coll Life Sci & Bioengn, Beijing 100022, Peoples R China; [Wu, Lina] Peking Univ, Canc Hosp & Inst, Key Lab Carcinogenesis & Translat Res, Minist Educ,Cent Lab, Beijing 100142, Peoples R China; [Xue, Yijun; Liu, Yinan; Ma, Yuanyuan; Zhang, Lijian; Yang, Yue; Chen, Jinfeng] Peking Univ, Canc Hosp & Inst, Key Lab Carcinogenesis & Translat Res, Minist Educ,Dept Thorac Surg 2, Beijing 100142, Peoples R China	Beijing University of Technology; Peking University; Peking University	Chen, JF (corresponding author), Peking Univ, Canc Hosp & Inst, Key Lab Carcinogenesis & Translat Res, Minist Educ,Dept Thorac Surg 2, Beijing 100142, Peoples R China.	chenjinfengdoctor@163.com			Beijing Science New Star Plan [Z11111005450000]; National Natural Science Foundation of China [81101598]	Beijing Science New Star Plan; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Beijing Science New Star Plan (No. Z11111005450000) and National Natural Science Foundation of China (No. 81101598).	Alzahouri K, 2006, EUR J CANCER CARE, V15, P348, DOI 10.1111/j.1365-2354.2006.00665.x; Beckenkamp A, 2014, BIOCHEM CELL BIOL, V92, P95, DOI 10.1139/bcb-2013-0051; Blanquez MJ, 2004, INT J ONCOL, V25, P821; Blanquez MJ, 2002, MOL CARCINOGEN, V35, P186, DOI 10.1002/mc.10091; Burke L, 2005, CLIN CANCER RES, V11, P232; Curry NL, 2013, CANCER DISCOV, V3, P908, DOI 10.1158/2159-8290.CD-12-0507; Fang M, 2010, CELL, V143, P711, DOI 10.1016/j.cell.2010.10.010; Galluzzi L, 2012, ONCOGENE, V31, P2805, DOI 10.1038/onc.2011.459; Grote HJ, 2006, CANCER CYTOPATHOL, V108, P129, DOI 10.1002/cncr.21717; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hirami Y, 2004, CANCER LETT, V214, P157, DOI 10.1016/j.canlet.2004.04.028; Horeweg N, 2014, EXPERT REV RESP MED, P1; Igney FH, 2002, NAT REV CANCER, V2, P277, DOI 10.1038/nrc776; Kim SJ, 2005, LUNG CANCER, V49, P325, DOI 10.1016/j.lungcan.2005.03.036; Ludovini V, 2004, LUNG CANCER, V46, P77, DOI 10.1016/j.lungcan.2004.03.018; MacCarthy CM, 2013, INT J ONCOL, V43, P1244, DOI 10.3892/ijo.2013.2052; Meert AP, 2002, EUR RESPIR J, V20, P975, DOI 10.1183/09031936.02.00296502; Nakamura H, 2005, CANCER-AM CANCER SOC, V103, P1865, DOI 10.1002/cncr.20957; Nicholson RI, 2001, EUR J CANCER, V37, pS9, DOI 10.1016/s0959-8049(01)00231-3; Planque C, 2010, CLIN CHEM, V56, P987, DOI 10.1373/clinchem.2009.138917; Regadera J, 2006, INT J ONCOL, V28, P595; Shen Z, 2011, COLD SH Q B, V76, P217, DOI 10.1101/sqb.2011.76.010876; Villar J, 2007, CANCER RES, V67, P10859, DOI 10.1158/0008-5472.CAN-07-2041; Villar J, 2009, CANCER RES, V69, P102, DOI 10.1158/0008-5472.CAN-08-2922; Wu YC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070839; Yoshino I, 2001, Ann Thorac Cardiovasc Surg, V7, P204; Zadran S, 2012, TUMOR BIOL, V33, P2411, DOI 10.1007/s13277-012-0505-1	27	9	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0120046	10.1371/journal.pone.0120046	http://dx.doi.org/10.1371/journal.pone.0120046			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25794010	Green Published, Green Submitted, gold			2022-12-27	WOS:000352084200138
J	Adams, C; Adams, NE; Traub, RD; Whittington, MA				Adams, Christopher; Adams, Natalie E.; Traub, Roger D.; Whittington, Miles A.			Electrographic Waveform Structure Predicts Laminar Focus Location in a Model of Temporal Lobe Seizures In Vitro	PLOS ONE			English	Article							EPILEPTIFORM DISCHARGES; CA2-CA3 REGION; GUINEA-PIG; PROPAGATION; SPREAD; MOUSE; HIPPOCAMPUS; INITIATION; SLICES; CORTEX	Temporal lobe epilepsy is the most common form of partial-onset epilepsy and accounts for the majority of adult epilepsy cases in most countries. A critical role for the hippocampus (and to some extent amygdala) in the pathology of these epilepsies is clear, with selective removal of these regions almost as effective as temporal lobectomy in reducing subsequent seizure risk. However, there is debate about whether hippocampus is 'victim' or 'perpetrator': The structure is ideally placed to 'broadcast' epileptiform activity to a great many other brain regions, but removal often leaves epileptiform events still occurring in cortex, particularly in adjacent areas, and recruitment of the hippocampus into seizure-like activity has been shown to be difficult in clinically-relevant models. Using a very simple model of acute epileptiform activity with known, single primary pathology (GABAA Receptor partial blockade), we track the onset and propagation of epileptiform events in hippocampus, parahippocampal areas and neocortex. In this model the hippocampus acts as a potential seizure focus for the majority of observed events. Events with hippocampal focus were far more readily propagated throughout parahippocampal areas and into neocortex than vice versa. The electrographic signature of events of hippocampal origin was significantly different to those of primary neocortical origin - a consequence of differential laminar activation. These data confirm the critical role of the hippocampus in epileptiform activity generation in the temporal lobe and suggest the morphology of non-invasive electrical recording of neocortical interictal events may be useful in confirming this role.	[Adams, Christopher] Newcastle Univ, Inst Neurosci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Adams, Natalie E.; Whittington, Miles A.] Univ York, Hull York Med Sch, York YO10 5DD, N Yorkshire, England; [Traub, Roger D.] IBM TJ Watson Res Ctr, Dept Phys Sci, New York, NY USA; [Traub, Roger D.] Columbia Univ, Dept Neurol, New York, NY USA	Newcastle University - UK; University of Hull; University of York - UK; International Business Machines (IBM); Columbia University	Whittington, MA (corresponding author), Univ York, Hull York Med Sch, York YO10 5DD, N Yorkshire, England.	Miles.whittington@hyms.ac.uk		Whittington, Miles Adrian/0000-0002-0247-1362	Wellcome Trust; Wolfson Foundation; NSF [DMS-1042134]; IBM TJ Watson Research Center	Wellcome Trust(Wellcome TrustEuropean Commission); Wolfson Foundation; NSF(National Science Foundation (NSF)); IBM TJ Watson Research Center(International Business Machines (IBM))	This study was supported by the Wellcome Trust, The Wolfson Foundation, NSF (DMS-1042134). IBM TJ Watson Research Center provided support in the form of salaries for author RT, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of the authors are articulated in the 'author contributions' section.	Akman O, 2010, NEUROSCI LETT, V479, P74, DOI 10.1016/j.neulet.2010.05.034; Ang CW, 2006, J NEUROSCI, V26, P11850, DOI 10.1523/JNEUROSCI.2354-06.2006; AVOLI M, 1988, NEUROSCI LETT, V94, P327, DOI 10.1016/0304-3940(88)90039-0; Barbarosie M, 1997, J NEUROSCI, V17, P9308; Biagini G, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00130; Boido D, 2014, CEREB CORTEX, V24, P163, DOI 10.1093/cercor/bhs298; Bonilha L, 2012, EPILEPSIA, V53, P1, DOI 10.1111/j.1528-1167.2011.03298.x; Borbely S, 2006, BRAIN RES BULL, V69, P161, DOI 10.1016/j.brainresbull.2005.11.018; Catenoix H, 2011, CLIN NEUROPHYSIOL, V122, P2488, DOI 10.1016/j.clinph.2011.05.007; COLOM LV, 1994, J NEUROPHYSIOL, V71, P1574, DOI 10.1152/jn.1994.71.4.1574; de la Prida LM, 2002, BRAIN RES, V940, P27, DOI 10.1016/S0006-8993(02)02564-7; Dyhrfjeld-Johnsen J, 2007, J NEUROPHYSIOL, V97, P1566, DOI 10.1152/jn.00950.2006; Fang QQ, 2009, I S BIOMED IMAGING, P1142, DOI 10.1109/ISBI.2009.5193259; Federico P, 1996, J NEUROPHYSIOL, V76, P3471, DOI 10.1152/jn.1996.76.5.3471; Ferrea E, 2012, FRONT NEURAL CIRCUIT, V6, DOI 10.3389/fncir.2012.00080; FISHER RS, 1977, ELECTROEN CLIN NEURO, V42, P608, DOI 10.1016/0013-4694(77)90279-6; Fukumoto SI, 2002, PSYCHIAT CLIN NEUROS, V56, P561, DOI 10.1046/j.1440-1819.2002.01055.x; GJERSTAD L, 1981, ACTA PHYSIOL SCAND, V113, P245, DOI 10.1111/j.1748-1716.1981.tb06890.x; Gloveli T, 2005, P NATL ACAD SCI USA, V102, P13295, DOI 10.1073/pnas.0506259102; GRISSMER S, 1994, MOL PHARMACOL, V45, P1227; Holtkamp M, 2011, NEUROBIOL DIS, V43, P220, DOI 10.1016/j.nbd.2011.03.014; Kibler AB, 2011, EPILEPSIA, V52, P1590, DOI 10.1111/j.1528-1167.2011.03125.x; KNOWLES WD, 1987, NEUROSCIENCE, V21, P441, DOI 10.1016/0306-4522(87)90134-5; LAMBERT JDC, 1990, J NEUROPHYSIOL, V64, P119, DOI 10.1152/jn.1990.64.1.119; Lefort S, 2009, NEURON, V61, P301, DOI 10.1016/j.neuron.2008.12.020; Sekino Y, 1997, J NEUROPHYSIOL, V78, P1662, DOI 10.1152/jn.1997.78.3.1662; Smith SJM, 2005, J NEUROL NEUROSUR PS, V76, P2, DOI 10.1136/jnnp.2005.069245; SPENCER SS, 1990, NEUROLOGY, V40, P74, DOI 10.1212/WNL.40.1.74; SPENCER SS, 1987, EPILEPSIA, V28, P479, DOI 10.1111/j.1528-1157.1987.tb03676.x; STRINGER JL, 1990, EPILEPSY RES, V7, P197, DOI 10.1016/0920-1211(90)90015-N; TRAUB RD, 1987, NEUROSCIENCE, V21, P457, DOI 10.1016/0306-4522(87)90135-7; TRAUB RD, 1993, J PHYSIOL-LONDON, V472, P267, DOI 10.1113/jphysiol.1993.sp019946; TRAUB RD, 1994, J PHYSIOL-LONDON, V478, P379, DOI 10.1113/jphysiol.1994.sp020259; TSAI ML, 1993, ELECTROEN CLIN NEURO, V87, P25, DOI 10.1016/0013-4694(93)90171-Q; Tsau Y, 1999, J NEUROPHYSIOL, V82, P1965, DOI 10.1152/jn.1999.82.4.1965; van Groen T, 2003, HIPPOCAMPUS, V13, P133, DOI 10.1002/hipo.10037; WADMAN WJ, 1993, NEUROSCIENCE, V52, P255, DOI 10.1016/0306-4522(93)90154-8; WIESER HG, 1988, EPILEPSIA, V29, pS100, DOI 10.1111/j.1528-1157.1988.tb05793.x; Wong R K, 1986, Adv Neurol, V44, P583	39	2	2	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0121676	10.1371/journal.pone.0121676	http://dx.doi.org/10.1371/journal.pone.0121676			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25799020	Green Published, Green Submitted, gold			2022-12-27	WOS:000351987300285
J	Bekelis, K; Missios, S; Wong, K; MacKenzie, TA				Bekelis, Kimon; Missios, Symeon; Wong, Kendrew; MacKenzie, Todd A.			The Practice of Cranial Neurosurgery and the Malpractice Liability Environment in the United States	PLOS ONE			English	Article							ADVERSE EVENTS; CLAIMS; LITIGATION; CRISIS; RISK; NEGLIGENCE; PHYSICIANS; MEDICINE; ACCESS	Object The potential imbalance between malpractice liability cost and quality of care has been an issue of debate. We investigated the association of malpractice liability with unfavorable outcomes and increased hospitalization charges in cranial neurosurgery. Methods We performed a retrospective cohort study involving patients who underwent cranial neurosurgical procedures from 2005-2010, and were registered in the National Inpatient Sample (NIS) database. We used data from the National Practitioner Data Bank (NPDB) from 2005 to 2010 to create measures of volume and size of malpractice claim payments. The association of the latter with the state-level mortality, length of stay (LOS), unfavorable discharge, and hospitalization charges for cranial neurosurgery was investigated. Results During the study period, there were 189,103 patients (mean age 46.4 years, with 48.3% females) who underwent cranial neurosurgical procedures, and were registered in NIS. In a multivariable regression, higher number of claims per physician in a state was associated with increased In-transformed hospitalization charges (beta 0.18; 95% CI, 0.17 to 0.19). On the contrary, there was no association with mortality (OR 1.00; 95% CI, 0.94 to 1.06). We observed a small association with unfavorable discharge (OR 1.09; 95% CI, 1.06 to 1.13), and LOS (beta 0.01; 95% CI, 0.002 to 0.03). The size of the awarded claims demonstrated similar relationships. The average claims payment size (ln-transformed) (Pearson's rho=0.435, P=0.01) demonstrated a positive correlation with the risk-adjusted hospitalization charges but did not demonstrate a correlation with mortality, unfavorable discharge, or LOS. Conclusions In the present national study, aggressive malpractice environment was not correlated with mortality but was associated with higher hospitalization charges after cranial neurosurgery. In view of the association of malpractice with the economics of healthcare, further research on its impact is necessary.	[Bekelis, Kimon] Dartmouth Hitchcock Med Ctr, Sect Neurosurg, Lebanon, NH 03766 USA; [Missios, Symeon] Cleveland Clin Fdn, Dept Neurosurg, Cleveland, OH 44195 USA; [Wong, Kendrew; MacKenzie, Todd A.] Dartmouth Inst Hlth Policy & Clin Practice, Lebanon, NH USA; [MacKenzie, Todd A.] Geisel Sch Med Dartmouth, Hanover, NH USA	Dartmouth College; Cleveland Clinic Foundation; Dartmouth College; Dartmouth College	Bekelis, K (corresponding author), Dartmouth Hitchcock Med Ctr, Sect Neurosurg, Lebanon, NH 03766 USA.	kbekelis@gmail.com	Bekelis, Kimon/Y-3402-2019					Baicker K, 2007, HEALTH AFFAIR, V26, P841, DOI 10.1377/hlthaff.26.3.841; Bishop TF, 2011, JAMA-J AM MED ASSOC, V305, P2427, DOI 10.1001/jama.2011.813; BRENNAN TA, 1991, NEW ENGL J MED, V324, P370, DOI 10.1056/NEJM199102073240604; Brennan TA, 1996, NEW ENGL J MED, V335, P1963, DOI 10.1056/NEJM199612263352606; California Medical Association, 1977, REP MED INS FEAS STU; Chandra A, 2005, HLTH AFF MILLWOOD S, pW5; CHARLSON ME, 1987, ARCH INTERN MED, V147, P2155, DOI 10.1001/archinte.147.12.2155; Dranove D, 2005, HEALTH AFFAIR, V24, P802, DOI 10.1377/hlthaff.24.3.802; Eloy JA, 2014, J NEUROSURG, V120, P185, DOI 10.3171/2013.8.JNS13584; Emery E, 2014, WORLD NEUROSURG, V81, P218, DOI 10.1016/j.wneu.2013.01.029; General Accounting Office, 2000, MAJ IMPR NEED ENH DA; Jena AB, 2011, NEW ENGL J MED, V365, P629, DOI 10.1056/NEJMsa1012370; Kane C.K., 2010, POLICY RES PERSPECTI; LOCALIO AR, 1991, NEW ENGL J MED, V325, P245, DOI 10.1056/NEJM199107253250405; Mello MM, 2005, ANN SURG, V242, P621, DOI 10.1097/01.sla.0000182957.54783.9a; Mello MM, 2003, NEW ENGL J MED, V348, P2281, DOI 10.1056/NEJMp030064; Mukherjee S, 2014, ANN ROY COLL SURG, V96, P266, DOI 10.1308/003588414X13814021679834; Nahed BV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039237; ROMANO PS, 1993, J CLIN EPIDEMIOL, V46, P1075, DOI 10.1016/0895-4356(93)90103-8; Rovit RL, 2007, J NEUROSURG, V106, P1108, DOI 10.3171/jns.2007.106.6.1108; Seabury SA, 2013, HEALTH AFFAIR, V32, P111, DOI 10.1377/hlthaff.2012.0967; Steiner Claudia, 2002, Eff Clin Pract, V5, P143; Studdert DM, 2006, NEW ENGL J MED, V354, P2024, DOI 10.1056/NEJMsa054479; Studdert DM, 2005, JAMA-J AM MED ASSOC, V293, P2609, DOI 10.1001/jama.293.21.2609	24	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0121191	10.1371/journal.pone.0121191	http://dx.doi.org/10.1371/journal.pone.0121191			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CE6ZS	25798994	gold, Green Published, Green Submitted			2022-12-27	WOS:000351987300225
J	Chai, J; Feng, XC; Zhang, LJ; Chen, S; Cheng, Y; He, XC; Yang, YX; He, Y; Wang, HZ; Wang, RQ; Chen, WS				Chai, Jin; Feng, Xinchan; Zhang, Liangjun; Chen, Sheng; Cheng, Ying; He, Xiaochong; Yang, Yingxue; He, Yu; Wang, Huaizhi; Wang, Rongquan; Chen, Wensheng			Hepatic Expression of Detoxification Enzymes Is Decreased in Human Obstructive Cholestasis Due to Gallstone Biliary Obstruction	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; BILE-ACID; DOWN-REGULATION; RECEPTOR REGULATION; ADAPTIVE RESPONSE; NUCLEAR RECEPTORS; UP-REGULATION; LIVER-INJURY; OST-BETA; TRANSPORTER	Background & Aims Levels of bile acid metabolic enzymes and membrane transporters have been reported to change in cholestasis. These alterations (e.g. CYP7A1 repression and MRP4 induction) are thought to be adaptive responses that attenuate cholestatic liver injury. However, the molecular mechanisms of these adaptive responses in human obstructive cholestasis due to gallstone biliary obstruction remain unclear. Methods We collected liver samples from cholestatic patients with biliary obstruction due to gallstones and from control patients without liver disease (n = 22 per group). The expression levels of bile acid synthetic and detoxification enzymes, membrane transporters, and the related nuclear receptors and transcriptional factors were measured. Results The levels of bile acid synthetic enzymes, CYP7B1 and CYP8B1, and the detoxification enzyme CYP2B6 were increased in cholestatic livers by 2.4-fold, 2.8-fold, and 1.9-fold, respectively (p< 0.05). Conversely, the expression levels of liver detoxification enzymes, UGT2B4/7, SULT2A1, GSTA1-4, and GSTM1-4, were reduced by approximately 50% (p< 0.05) in human obstructive cholestasis. The levels of membrane transporters, OST beta and OCT1, were increased 10.4-fold and 1.8-fold, respectively, (p< 0.05), whereas those of OST alpha, ABCG2 and ABCG8 were all decreased by approximately 40%, (p< 0.05) in human cholestatic livers. Hepatic nuclear receptors, VDR, HNF4 alpha, RXR alpha and RAR alpha, were induced (approximately 2.0-fold, (p< 0.05) whereas FXR levels were markedly reduced to 44% of control, (p< 0.05) in human obstructive cholestasis. There was a significantly positive correlation between the reduction in FXR mRNA and UGT2B4/7, SULT2A1, GSTA1, ABCG2/8 mRNA levels in livers of obstructive cholestatic patients (p< 0.05). Conclusions The levels of hepatic detoxification enzymes were significantly decreased in human obstructive cholestasis, and these decreases were positively associated with a marked reduction of FXR levels. These findings are consistent with impaired detoxification ability in human obstructive cholestasis.	[Chai, Jin; Feng, Xinchan; Zhang, Liangjun; Cheng, Ying; Wang, Rongquan; Chen, Wensheng] Third Mil Med Univ, Southwest Hosp, Dept Gastroenterol, Chongqing, Peoples R China; [Chen, Sheng] Third Mil Med Univ, Southwest Hosp, Dept Pediat, Chongqing, Peoples R China; [He, Xiaochong] Third Mil Med Univ, Sch Nursing, Chongqing, Peoples R China; [Yang, Yingxue] Sichuan Univ, Dept Gastroenterol, West China Hosp, Chengdu 610064, Sichuan, Peoples R China; [He, Yu; Wang, Huaizhi] Third Mil Med Univ, Inst Hepatobiliary Surg, Southwest Hosp, Chongqing, Peoples R China	Army Medical University; Army Medical University; Army Medical University; Sichuan University; Army Medical University	Chen, WS (corresponding author), Third Mil Med Univ, Southwest Hosp, Dept Gastroenterol, Chongqing, Peoples R China.	wenshengchen@hotmail.com	Zhang, Liang/GWM-6088-2022	Chen, Sheng/0000-0003-3526-7808; Chai, Jin/0000-0002-8543-4566; Wang, Rongquan/0000-0001-5307-0086	National Natural Science Foundation of China [81370560, 81100280, 81470880]; Scholarship Foundation of China Scholarship Council (CSC) [201307610015]; Third Military Medical University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Scholarship Foundation of China Scholarship Council (CSC); Third Military Medical University	Funding: This study was supported by National Natural Science Foundation of China (81370560, 81100280, and 81470880), Scholarship Foundation of China Scholarship Council (CSC No. 201307610015) and Third Military Medical University (2013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleksunes LM, 2008, TOXICOL APPL PHARM, V226, P74, DOI 10.1016/j.taap.2007.08.022; Anakk S, 2011, J CLIN INVEST, V121, P86, DOI 10.1172/JCI42846; Ballatori N, 2009, FRONT BIOSCI-LANDMRK, V14, P2829, DOI 10.2741/3416; Blazquez AG, 2012, MOL PHARMACOL, V81, P273, DOI 10.1124/mol.111.075143; Bohan A, 2003, J BIOL CHEM, V278, P36688, DOI 10.1074/jbc.M304011200; Boyer JL, 2006, AM J PHYSIOL-GASTR L, V290, pG1124, DOI 10.1152/ajpgi.00539.2005; Boyer JL, 2005, GASTROENTEROLOGY, V129, P735, DOI 10.1053/j.gastro.2005.06.053; Chai J, 2012, HEPATOLOGY, V55, P1485, DOI 10.1002/hep.24801; Chai J, 2011, J GASTROINTEST SURG, V15, P996, DOI 10.1007/s11605-011-1473-2; Chatterjee B, 2005, METHOD ENZYMOL, V400, P165, DOI 10.1016/S0076-6879(05)00010-8; Chen WS, 2007, AM J PHYSIOL-GASTR L, V292, pG1221, DOI 10.1152/ajpgi.00191.2006; Denk GU, 2004, HEPATOLOGY, V39, P1382, DOI 10.1002/hep.20176; Ghonem NS, 2014, HEPATOLOGY, V59, P1030, DOI 10.1002/hep.26894; Jin HE, 2009, PHARM RES-DORDR, V26, P549, DOI 10.1007/s11095-008-9770-5; Jonker JW, 2012, J STEROID BIOCHEM, V130, P147, DOI 10.1016/j.jsbmb.2011.06.012; Kazgan N, 2014, GASTROENTEROLOGY, V146, P1006, DOI 10.1053/j.gastro.2013.12.029; Kir S, 2011, SCIENCE, V331, P1621, DOI 10.1126/science.1198363; Lorbek G, 2012, FEBS J, V279, P1516, DOI 10.1111/j.1742-4658.2011.08432.x; Mennone A, 2006, HEPATOLOGY, V43, P1013, DOI 10.1002/hep.21158; Modica S, 2012, GASTROENTEROLOGY, V142, P355, DOI 10.1053/j.gastro.2011.10.028; Nies AT, 2009, HEPATOLOGY, V50, P1227, DOI 10.1002/hep.23103; Park YJ, 2008, HEPATOLOGY, V47, P1578, DOI 10.1002/hep.22196; Plosch T, 2006, AM J PHYSIOL-GASTR L, V291, pG414, DOI 10.1152/ajpgi.00557.2005; Schaap FG, 2009, HEPATOLOGY, V49, P1228, DOI 10.1002/hep.22771; Soroka CJ, 2011, AM J PHYSIOL-GASTR L, V301, pG574, DOI 10.1152/ajpgi.00141.2011; Soroka CJ, 2010, HEPATOLOGY, V51, P181, DOI 10.1002/hep.23265; Trauner M, 2005, J CLIN GASTROENTEROL, V39, pS111, DOI 10.1097/01.mcg.0000155551.37266.26; Trauner M, 1998, NEW ENGL J MED, V339, P1217, DOI 10.1056/NEJM199810223391707; Triantis V, 2010, HEPATOLOGY, V52, P656, DOI 10.1002/hep.23708; Trottier J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022094; Wagner M, 2005, HEPATOLOGY, V42, P420, DOI 10.1002/hep.20784; Wagner Martin, 2005, Ann Hepatol, V4, P77; Wagner M, 2010, SEMIN LIVER DIS, V30, P160, DOI 10.1055/s-0030-1253225; Wagner M, 2009, J HEPATOL, V51, P565, DOI 10.1016/j.jhep.2009.05.012; Xu SH, 2010, AM J PHYSIOL-GASTR L, V299, pG126, DOI 10.1152/ajpgi.00522.2010; Zollner G, 2003, J HEPATOL, V38, P717, DOI 10.1016/S0168-8278(03)00096-5; Zollner G, 2007, LIVER INT, V27, P920, DOI 10.1111/j.1478-3231.2007.01506.x; Zollner G, 2006, MOL PHARMACEUT, V3, P231, DOI 10.1021/mp060010s	38	31	32	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0120055	10.1371/journal.pone.0120055	http://dx.doi.org/10.1371/journal.pone.0120055			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25798860	gold, Green Submitted, Green Published			2022-12-27	WOS:000351987300104
J	Hayward, MR; AbuOun, M; Woodward, MJ; Jansen, VAA				Hayward, Matthew R.; AbuOun, Manal; Woodward, Martin J.; Jansen, Vincent A. A.			Temperature and Oxygen Dependent Metabolite Utilization by Salmonella enterica Serovars Derby and Mbandaka	PLOS ONE			English	Article							IDENTIFICATION; TYPHIMURIUM; GROWTH; PERSISTENCE; BACTERIA; CATTLE; FEED	Salmonella enterica is a zoonotic pathogen of clinical and veterinary significance, with over 2500 serovars. In previous work we compared two serovars displaying host associations inferred from isolation statistics. Here, to validate genome sequence data and to expand on the role of environmental metabolite constitution in host range determination we use a phenotypic microarray approach to assess the ability of these serovars to metabolise similar to 500 substrates at 25 degrees C with oxygen (aerobic conditions) to represent the ex vivo environment and at 37 degrees C with and without oxygen (aerobic/anaerobic conditions) to represent the in vivo environment. A total of 26 substrates elicited a significant difference in the rate of metabolism of which only one, D-galactonic acid-g-lactone, could be explained by the presence (S. Mbandaka) or the absence (S. Derby) of metabolic genes. We find that S. Mbandaka respires more efficiently at ambient temperatures and under aerobic conditions on 18 substrates including: glucosominic acid, saccharic acid, trehalose, fumaric acid, maltotriose, N-acetyl-Dglucosamine, N-acetyl-beta-D-mannosamine, fucose, L-serine and dihydroxy-acetone; whereas S. Derby is more metabolically competent anaerobically at 37 degrees C for dipeptides, glutamine-glutamine, alanine-lysine, asparagine-glutamine and nitrogen sources glycine and nitrite. We conclude that the specific phenotype cannot be reliably predicted from the presence of metabolic genes directly relating to the metabolic pathways under study.	[Hayward, Matthew R.] European Mol Biol Lab, Dept Struct & Computat Biol, D-69117 Heidelberg, Germany; [Hayward, Matthew R.; AbuOun, Manal] Anim Hlth & Vet Labs Agcy, Dept Bacteriol, Addlestone KT15 3NB, Surrey, England; [Hayward, Matthew R.; Jansen, Vincent A. A.] Royal Holloway Univ London, Sch Biol Sci, Egham TW20 0EX, Surrey, England; [Woodward, Martin J.] Univ Reading, Dept Food & Nutr Sci, Reading RG6 6AP, Berks, England	European Molecular Biology Laboratory (EMBL); Veterinary Laboratories Agency; University of London; Royal Holloway University London; University of Reading	Hayward, MR (corresponding author), European Mol Biol Lab, Dept Struct & Computat Biol, Meyerhofstr 1, D-69117 Heidelberg, Germany.	hayward@embl.de		Jansen, Vincent A.A./0000-0002-6518-2090	Engineering and Physical Sciences Research Council (EPSRC); Animal Health and Veterinary Laboratories Agency (AHVLA); Biotechnology and Biological Sciences Research Council (BBSRC) partners of the ERASysBio+ initiative under the EU ERA-NET Plus scheme in FP7 [BB/I004548/1]; BBSRC [BB/I004548/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/I004548/1] Funding Source: researchfish	Engineering and Physical Sciences Research Council (EPSRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Animal Health and Veterinary Laboratories Agency (AHVLA); Biotechnology and Biological Sciences Research Council (BBSRC) partners of the ERASysBio+ initiative under the EU ERA-NET Plus scheme in FP7(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Engineering and Physical Sciences Research Council (EPSRC), www.epsrc.ac.uk, 4 year studentship awarded to MRH. Animal Health and Veterinary Laboratories Agency (AHVLA), http://www.defra.gov.uk/ahvla-en/, seedcorn internal investment fund to MRH. Biotechnology and Biological Sciences Research Council (BBSRC) partners of the ERASysBio+ initiative supported under the EU ERA-NET Plus scheme in FP7, www.bbsrc.ac.uk, BB/I004548/1 to VAAJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AbuOun M, 2009, J BIOL CHEM, V284, P29480, DOI 10.1074/jbc.M109.005868; AGUILERA A, 1988, BIOTECHNOL BIOENG, V32, P240, DOI 10.1002/bit.260320215; AHVLA, 2011, SALM LIV PROD ANN RE; Anjum MF, 2005, INFECT IMMUN, V73, P7894, DOI 10.1128/IAI.73.12.7894-7905.2005; Azelis, 2013, AZ AN NUTR; Baumler AJ, 1998, INFECT IMMUN, V66, P4579; BLASER MJ, 1982, REV INFECT DIS, V4, P1096; Buddruhs N, 2012, PACKAGE OPM; CDC PHLIS, 2009, SALM ANN SURV; Center for Disease Control and Prevention (CDC), 2011, NAT ENT DIS SURV SAL; Chang DE, 2002, MOL MICROBIOL, V45, P289, DOI 10.1046/j.1365-2958.2002.03001.x; Davies R H, 1999, Vet Rec, V145, P655; Davis MA, 2003, VET MICROBIOL, V95, P199, DOI 10.1016/S0378-1135(03)00159-7; Grimont, 2007, ANTIGENIC FORMULAE S; Hald T, 2006, FOODBORNE PATHOG DIS, V3, P422, DOI 10.1089/fpd.2006.3.422; Hayward MR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107857; Hayward MR, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-365; JONES PW, 1982, J HYG-CAMBRIDGE, V88, P255, DOI 10.1017/S002217240007011X; Joshi T, 2010, IEEE INT C BIOINFORM, P203, DOI 10.1109/BIBM.2010.5706563; Kahm M, 2012, PACKAGE GROFIT; Kingsley RA, 2003, INFECT IMMUN, V71, P629, DOI 10.1128/IAI.71.2.629-640.2003; Kraatz M, 2011, ISOLATION LACTIC ACI; Lu SW, 2003, INFECT IMMUN, V71, P6734, DOI 10.1128/IAI.71.12.6734-6741.2003; Mappley LJ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-454; Ogata H., 1999, NUCLEIC ACIDS RES, V27, P29, DOI DOI 10.1093/nar/27.1.29; Pan ZS, 2009, MICROBIOL-SGM, V155, P3200, DOI 10.1099/mic.0.029405-0; Papadopoulou C, 2009, VET REC, V165, P681; Purvis GM, 2005, VET REC, V157, P165, DOI 10.1136/vr.157.6.165; R Core Team, 2012, R LANG ENV STAT COMP; Rabsch W, 2001, MICROBES INFECT, V3, P237, DOI 10.1016/S1286-4579(01)01375-2; Rolfe MD, 2012, J BACTERIOL, V194, P686, DOI 10.1128/JB.06112-11; Sambrook J., 2002, MOL CLONING LAB MANU; Schikora A, 2012, TRENDS PLANT SCI, V17, P245, DOI 10.1016/j.tplants.2012.03.007; Schikora A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002279; Storz G, 2011, MOL CELL, V43, P880, DOI 10.1016/j.molcel.2011.08.022; van Asselt ED, 2009, POULTRY SCI, V88, P2695, DOI 10.3382/ps.2009-00074; Wierup M, 2010, ACTA VET SCAND, V52, DOI 10.1186/1751-0147-52-15; Wilkins W, 2010, CAN J VET RES, V74, P81	38	6	7	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0120450	10.1371/journal.pone.0120450	http://dx.doi.org/10.1371/journal.pone.0120450			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25798944	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000351987300145
J	Hu, SS; Hosey, KL; Derbigny, WA				Hu, Sishun; Hosey, Kristen L.; Derbigny, Wilbert A.			Analyses of the Pathways Involved in Early- and Late-Phase Induction of IFN-Beta during C. muridarum Infection of Oviduct Epithelial Cells	PLOS ONE			English	Article							NF-KAPPA-B; ALPHA/BETA-INTERFERON GENES; CHLAMYDIA-PNEUMONIAE; POSITIVE FEEDBACK; GAMMA; RECOGNITION; ACTIVATION; RNA; SECRETION; PROTEIN	We previously reported that the IFN-beta secreted by Chlamydia muridarum-infected murine oviduct epithelial cells (OE cells) was mostly dependent on the TLR3 signaling pathway. To further characterize the mechanisms of IFN-beta synthesis during Chlamydia infection of OE cells in vitro, we utilized specific inhibitory drugs to clarify the roles of IRF3 and NF-kappa B on both early-and late-phase C. muridarum infections. Our results showed that the pathways involved in the early-phase of IFN-beta production were distinct from that in the late-phase of IFN-beta production. Disruption of IRF3 activation using an inhibitor of TBK-1 at early-phase Chlamydia infection had a significant impact on the overall synthesis of IFN-beta; however, disruption of IRF3 activation at late times during infection had no effect. Interestingly, inhibition of NF-kappa B early during Chlamydia infection also had a negative effect on IFN-beta production; however, its impact was not significant. Our data show that the transcription factor IRF7 was induced late during Chlamydia infection, which is indicative of a positive feedback mechanism of IFN-beta synthesis late during infection. In contrast, IRF7 appears to play little or no role in the early synthesis of IFN-beta during Chlamydia infection. Finally, we demonstrate that antibiotics that target chlamydial DNA replication are much more effective at reducing IFN-beta synthesis during infection versus antibiotics that target chlamydial transcription. These results provide evidence that early-and late-phase IFN-beta production have distinct signaling pathways in Chlamydia-infected OE cells, and suggest that Chlamydia DNA replication might provide a link to the currently unknown chlamydial PAMP for TLR3.	[Hu, Sishun; Hosey, Kristen L.; Derbigny, Wilbert A.] Indiana Univ Sch Med, Dept Microbiol & Immunol, Indianapolis, IN 46202 USA; [Hu, Sishun] Huazhong Agr Univ, Coll Vet Med, Wuhan, Peoples R China	Indiana University System; Indiana University Bloomington; Huazhong Agricultural University	Derbigny, WA (corresponding author), Indiana Univ Sch Med, Dept Microbiol & Immunol, Indianapolis, IN 46202 USA.	wderbign@iupui.edu			National Institutes of Health [1K22AI072072-01A1, R25GM079657-04]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI104944] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM079657] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health (http://nih.gov/) grants 1K22AI072072-01A1 (WAD and KLH) and R25GM079657-04 (KLH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarskog NK, 2009, J NEUROIMMUNOL, V212, P148, DOI 10.1016/j.jneuroim.2009.04.012; Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Aubry C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033299; Barker JR, 2013, MBIO, V4, DOI 10.1128/mBio.00018-13; Bhat N, 2013, EUR J IMMUNOL; Buss C, 2010, J IMMUNOL, V184, P3072, DOI 10.4049/jimmunol.0902947; Chen S, 2008, J IMMUNOL, V181, P7186, DOI 10.4049/jimmunol.181.10.7186; Clark K, 2009, J BIOL CHEM, V284, P14136, DOI 10.1074/jbc.M109.000414; Conzelmann KK, 2005, J VIROL, V79, P5241, DOI 10.1128/JVI.79.9.5241-5248.2005; Derbigny WA, 2005, J IMMUNOL, V175, P6065, DOI 10.4049/jimmunol.175.9.6065; Derbigny WA, 2007, INFECT IMMUN, V75, P1280, DOI 10.1128/IAI.01525-06; Derbigny WA, 2012, INFECT IMMUN, V80, P254, DOI 10.1128/IAI.05549-11; Derbigny WA, 2010, J IMMUNOL, V185, P6689, DOI 10.4049/jimmunol.1001548; Devitt A, 1996, INFECT IMMUN, V64, P3951, DOI 10.1128/IAI.64.10.3951-3956.1996; Dragan AI, 2008, J MOL BIOL, V384, P335, DOI 10.1016/j.jmb.2008.09.015; Feldman RI, 2005, J BIOL CHEM, V280, P19867, DOI 10.1074/jbc.M501367200; Francois-Newton V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022200; Gautier G, 2005, J EXP MED, V201, P1435, DOI 10.1084/jem.20041964; Hacker Hans, 2006, Sci STKE, V2006, pre13, DOI 10.1126/stke.3572006re13; HARTMANN G, 1967, BIOCHIM BIOPHYS ACTA, V145, P843, DOI 10.1016/0005-2787(67)90147-5; Honda K, 2005, INT IMMUNOL, V17, P1367, DOI 10.1093/intimm/dxh318; Honda K, 2006, IMMUNITY, V25, P349, DOI 10.1016/j.immuni.2006.08.009; Honda K, 2006, NAT REV IMMUNOL, V6, P644, DOI 10.1038/nri1900; Hosey KL, 2014, ROLE STAT1 CHL UNPUB; Johnson RM, 2004, INFECT IMMUN, V72, P3951, DOI 10.1128/IAI.72.7.3951-3960.2004; Kagnoff MF, 1997, J CLIN INVEST, V100, P6, DOI 10.1172/JCI119522; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Kylaniemi MK, 2009, MICROB PATHOGENESIS, V46, P235, DOI 10.1016/j.micpath.2009.01.006; Lad SP, 2005, J IMMUNOL, V174, P7186, DOI 10.4049/jimmunol.174.11.7186; Le Bon A, 2002, CURR OPIN IMMUNOL, V14, P432, DOI 10.1016/S0952-7915(02)00354-0; Levy DE, 2002, J INTERF CYTOK RES, V22, P87, DOI 10.1089/107999002753452692; Liao JY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026463; Lin RT, 2000, MOL CELL BIOL, V20, P6342, DOI 10.1128/MCB.20.17.6342-6353.2000; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marie I, 1998, EMBO J, V17, P6660, DOI 10.1093/emboj/17.22.6660; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Nagarajan UM, 2005, J IMMUNOL, V175, P450, DOI 10.4049/jimmunol.175.1.450; NEWHALL WJ, 1986, J CLIN MICROBIOL, V23, P333, DOI 10.1128/JCM.23.2.333-338.1986; Panne D, 2008, CURR OPIN STRUC BIOL, V18, P236, DOI 10.1016/j.sbi.2007.12.002; Prantner D, 2010, J IMMUNOL, V184, P2551, DOI 10.4049/jimmunol.0903704; Rasmussen SJ, 1997, J CLIN INVEST, V99, P77, DOI 10.1172/JCI119136; Rodel J, 2001, FEMS IMMUNOL MED MIC, V32, P9; Rodel J, 1998, INFECT IMMUN, V66, P4491; Rothenfusser S, 2005, J IMMUNOL, V175, P5260, DOI 10.4049/jimmunol.175.8.5260; Rothfuchs AG, 2004, J IMMUNOL, V172, P6345, DOI 10.4049/jimmunol.172.10.6345; Rothfuchs AG, 2001, J IMMUNOL, V167, P6453, DOI 10.4049/jimmunol.167.11.6453; Rothfuchs AG, 2006, J IMMUNOL, V176, P6982, DOI 10.4049/jimmunol.176.11.6982; Royer PJ, 2013, INFECT IMMUN, V81, P4299, DOI 10.1128/IAI.00477-13; Rozen S, 2000, Methods Mol Biol, V132, P365; Sato M, 2000, IMMUNITY, V13, P539, DOI 10.1016/S1074-7613(00)00053-4; Sato M, 1998, FEBS LETT, V441, P106, DOI 10.1016/S0014-5793(98)01514-2; SCHACHTER J, 1980, ANNU REV MICROBIOL, V34, P285, DOI 10.1146/annurev.mi.34.100180.001441; Schachter J, 1980, CHLAMYDIAE MANUAL CL, P357; Schaefer TM, 2005, J IMMUNOL, V174, P992, DOI 10.4049/jimmunol.174.2.992; SEIBERT G, 1983, EUR J CLIN MICROBIOL, V2, P548, DOI 10.1007/BF02016563; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Shin HM, 2004, FEBS LETT, V571, P50, DOI 10.1016/j.febslet.2004.06.056; Su H, 1998, J EXP MED, V188, P809, DOI 10.1084/jem.188.5.809; Suchland RJ, 2009, ANTIMICROB AGENTS CH, V53, P4604, DOI 10.1128/AAC.00477-09; Suchland RJ, 2003, ANTIMICROB AGENTS CH, V47, P636, DOI 10.1128/AAC.47.2.636-642.2003; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; tenOever BR, 2004, J VIROL, V78, P10636, DOI 10.1128/JVI.78.19.10636-10649.2004; Witte CE, 2013, MBIO, V4, DOI 10.1128/mBio.00282-13; Yuhas Y, 2011, ANTIMICROB AGENTS CH, V55, P5541, DOI 10.1128/AAC.05149-11	64	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0119235	10.1371/journal.pone.0119235	http://dx.doi.org/10.1371/journal.pone.0119235			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25798928	Green Published, gold			2022-12-27	WOS:000351987300035
J	Lim, SY; Tyan, YS; Chao, YP; Nien, FY; Weng, JC				Lim, Seong Yong; Tyan, Yeu-Sheng; Chao, Yi-Ping; Nien, Fang-Yu; Weng, Jun-Cheng			New Insights into the Developing Rabbit Brain Using Diffusion Tensor Tractography and Generalized q-Sampling MRI	PLOS ONE			English	Article							WHITE-MATTER DEVELOPMENT; CEREBRAL-PALSY; MATURATION; MODEL; COEFFICIENT; CHILDHOOD; CHILDREN; INFANTS	The use of modern neuroimaging methods to characterize the complex anatomy of brain development at different stages reveals an enormous wealth of information in understanding this highly ordered process and provides clues to detect neurological and neurobehavioral disorders that have their origin in early structural and functional cerebral maturation. Non-invasive diffusion tensor magnetic resonance imaging (DTI) is able to distinguish cerebral microscopic structures, especially in the white matter regions. However, DTI is unable to resolve the complicated neural structure, i.e., the fiber crossing that is frequently observed during the maturation process. To overcome this limitation, several methods have been proposed. One such method, generalized q-sampling imaging (GQI), can be applied to a variety of datasets, including the single shell, multi-shell or grid sampling schemes that are believed to be able to resolve the complicated crossing fibers. Rabbits have been widely used for neurodevelopment research because they exhibit human-like timing of perinatal brain white matter maturation. Here, we present a longitudinal study using both DTI and GQI to demonstrate the changes in cerebral maturation of in vivo developing rabbit brains over a period of 40 weeks. Fractional anisotropy (FA) of DTI and generalized fractional anisotropy (GFA) of GQI indices demonstrated that the white matter anisotropy increased with age, with GFA exhibiting an increase in the hippocampus as well. Normalized quantitative anisotropy (NQA) of GQI also revealed an increase in the hippocampus, allowing us to observe the changes in gray matter as well. Regional and whole brain DTI tractography also demonstrated refinement in fiber pathway architecture with maturation. We concluded that DTI and GQI results were able to characterize the white matter anisotropy changes, whereas GQI provided further information about the gray matter hippocampus area. This developing rabbit brain DTI and GQI database could also be used for educational purposes and neuroscience investigations.	[Lim, Seong Yong; Tyan, Yeu-Sheng; Nien, Fang-Yu; Weng, Jun-Cheng] Chung Shan Med Univ, Sch Med Imaging & Radiol Sci, Taichung, Taiwan; [Tyan, Yeu-Sheng; Weng, Jun-Cheng] Chung Shan Med Univ Hosp, Dept Med Imaging, Taichung 40201, Taiwan; [Tyan, Yeu-Sheng] Chung Shan Med Univ, Sch Med, Taichung, Taiwan; [Chao, Yi-Ping] Chang Gung Univ, Grad Inst Med Mechatron, Dept Comp Sci & Informat Engn, Taoyuan, Taiwan	Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital; Chung Shan Medical University; Chang Gung University	Weng, JC (corresponding author), Chung Shan Med Univ, Sch Med Imaging & Radiol Sci, Taichung, Taiwan.	jcweng@csmu.edu.tw	Chao, Yi-Ping/GOP-0833-2022	Chao, Yi-Ping/0000-0002-1681-5410	Ministry of Science and Technology, Taipei, Taiwan [NSC102-2320-B-040-002, NSC101-2320-B-040-001]; Chung Shan Medical University, Taichung, Taiwan [CSMU-INT-103-08]	Ministry of Science and Technology, Taipei, Taiwan; Chung Shan Medical University, Taichung, Taiwan	This study was supported in part by the research programs NSC102-2320-B-040-002 and NSC101-2320-B-040-001, sponsored by the Ministry of Science and Technology, Taipei, Taiwan, and the intramural research program CSMU-INT-103-08 of the Chung Shan Medical University, Taichung, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander AL, 2001, MAGN RESON MED, V45, P770, DOI 10.1002/mrm.1105; BARKOVICH AJ, 1988, RADIOLOGY, V166, P173, DOI 10.1148/radiology.166.1.3336675; Basser PJ, 1996, J MAGN RESON SER B, V111, P209, DOI [10.1006/jmrb.1996.0086, 10.1016/j.jmr.2011.09.022]; Berman JI, 2005, NEUROIMAGE, V27, P862, DOI 10.1016/j.neuroimage.2005.05.018; Callaghan PT, 1993, PRINCIPLES NUCL MAGN, P438; D'Arceuil H, 2008, DEV NEUROSCI-BASEL, V30, P262, DOI 10.1159/000110503; Derrick M, 2007, STROKE, V38, P731, DOI 10.1161/01.STR.0000251445.94697.64; Drobyshevsky A, 2007, J CEREBR BLOOD F MET, V27, P270, DOI 10.1038/sj.jcbfm.9600333; Eixarch E, 2009, FETAL DIAGN THER, V26, P203, DOI 10.1159/000264063; Eixarch E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031497; Fukunaga M, 2010, P NATL ACAD SCI USA, V107, P3834, DOI 10.1073/pnas.0911177107; Glenn OA, 2003, J MAGN RESON IMAGING, V18, P641, DOI 10.1002/jmri.10420; Hermoye L, 2006, NEUROIMAGE, V29, P493, DOI 10.1016/j.neuroimage.2005.08.017; Huppi PS, 1998, PEDIATR RES, V44, P584; Jin T, 2008, NEUROIMAGE, V41, P801, DOI 10.1016/j.neuroimage.2008.03.014; Khachaturian MH, 2007, MAGN RESON MED, V57, P289, DOI 10.1002/mrm.21090; Klingberg T, 1999, NEUROREPORT, V10, P2817, DOI 10.1097/00001756-199909090-00022; Mukherjee P, 2001, RADIOLOGY, V221, P349, DOI 10.1148/radiol.2212001702; Mukherjee P, 2002, AM J NEURORADIOL, V23, P1445; Neil J, 2002, NMR BIOMED, V15, P543, DOI 10.1002/nbm.784; Neil JJ, 1998, RADIOLOGY, V209, P57, DOI 10.1148/radiology.209.1.9769812; Rutherford MA, 2005, PEDIATRICS, V116, P1001, DOI 10.1542/peds.2005-0328; Saadani-Makki F, 2008, AM J OBSTET GYNECOL, V199, DOI 10.1016/j.ajog.2008.06.090; Tuch DS, 2002, MAGNET RESON MED, V48, P577, DOI 10.1002/mrm.10268; Tuch DS, 2004, MAGN RESON MED, V52, P1358, DOI 10.1002/mrm.20279; Wedeen VJ, 2005, MAGN RESON MED, V54, P1377, DOI 10.1002/mrm.20642; Weng JC, 2007, MAGN RESON IMAGING, V25, P78, DOI 10.1016/j.mri.2006.08.018; Wiegell MR, 2000, RADIOLOGY, V217, P897, DOI 10.1148/radiology.217.3.r00nv43897; Wu YC, 2007, NEUROIMAGE, V36, P617, DOI 10.1016/j.neuroimage.2007.02.050; Yeh FC, 2010, IEEE T MED IMAGING, V29, P1626, DOI 10.1109/TMI.2010.2045126	30	9	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0119932	10.1371/journal.pone.0119932	http://dx.doi.org/10.1371/journal.pone.0119932			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25798595	Green Published, gold, Green Submitted			2022-12-27	WOS:000351987300093
J	Morino, M; Nukina, K; Sakaguchi, H; Maeda, T; Takahara, M; Shiomi, Y; Nishitani, H				Morino, Masayuki; Nukina, Kohei; Sakaguchi, Hiroki; Maeda, Takeshi; Takahara, Michiyo; Shiomi, Yasushi; Nishitani, Hideo			Mitotic UV Irradiation Induces a DNA Replication-Licensing Defect that Potentiates G1 Arrest Response	PLOS ONE			English	Article							NUCLEOTIDE EXCISION-REPAIR; S-PHASE; CDT1 PROTEOLYSIS; DAMAGE RESPONSE; RE-REPLICATION; FISSION YEAST; CELL-CYCLE; PIP BOX; PROTEINS; PCNA	Cdt1 begins to accumulate in M phase and has a key role in establishing replication licensing at the end of mitosis or in early G1 phase. Treatments that damage the DNA of cells, such as UV irradiation, induce Cdt1 degradation through PCNA-dependent CRL4-Cdt2 ubiquitin ligase. How Cdt1 degradation is linked to cell cycle progression, however, remains unclear. In G1 phase, when licensing is established, UV irradiation leads to Cdt1 degradation, but has little effect on the licensing state. In M phase, however, UV irradiation does not induce Cdt1 degradation. When mitotic UV-irradiated cells were released into G1 phase, Cdt1 was degraded before licensing was established. Thus, these cells exhibited both defective licensing and G1 cell cycle arrest. The frequency of G1 arrest increased in cells expressing extra copies of Cdt2, and thus in cells in which Cdt1 degradation was enhanced, whereas the frequency of G1 arrest was reduced in cell expressing an extra copy of Cdt1. The G1 arrest response of cells irradiated in mitosis was important for cell survival by preventing the induction of apoptosis. Based on these observations, we propose that mammalian cells have a DNA replication-licensing checkpoint response to DNA damage induced during mitosis.	[Morino, Masayuki; Nukina, Kohei; Sakaguchi, Hiroki; Maeda, Takeshi; Takahara, Michiyo; Shiomi, Yasushi; Nishitani, Hideo] Univ Hyogo, Grad Sch Life Sci, Kamigori, Hyogo, Japan	University of Hyogo	Nishitani, H (corresponding author), Univ Hyogo, Grad Sch Life Sci, Kamigori, Hyogo, Japan.	hideon@sci.u-hyogo.ac.jp		Nishitani, Hideo/0000-0001-5907-9380	JSPS KAKENHI [23131512, 25131718, 26291025, 25430171]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was financially supported by Grant-in-Aid for Scientific Research on Innovative Area (JSPS KAKENHI Grant Number 23131512 and 25131718) and by Grants-in-Aid for Basic Scientific Research (B) (JSPS KAKENHI Number 26291025) to HN, and by Grants-in-Aid for Basic Scientific Research (C) (JSPS KAKENHI Number 25430171) to YS.	Abbas T, 2011, CELL CYCLE, V10, P241, DOI 10.4161/cc.10.2.14530; Araujo SJ, 2000, GENE DEV, V14, P349; Arias EE, 2006, NAT CELL BIOL, V8, P84, DOI 10.1038/ncb1346; Arias EE, 2007, GENE DEV, V21, P497, DOI 10.1101/gad.1508907; Bell SP, 2002, ANNU REV BIOCHEM, V71, P333, DOI 10.1146/annurev.biochem.71.110601.135425; Blow JJ, 2005, NAT REV MOL CELL BIO, V6, P476, DOI 10.1038/nrm1663; Chandrasekaran S, 2011, MOL CELL BIOL, V31, P4405, DOI 10.1128/MCB.06163-11; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; Feng H, 2003, CELL CYCLE, V2, P431, DOI 10.4161/cc.2.5.527; Friedberg EC, 2006, DNA REPAIR, V5, P986, DOI 10.1016/j.dnarep.2006.05.005; Gillet LCJ, 2006, CHEM REV, V106, P253, DOI 10.1021/cr040483f; Giunta S, 2010, J CELL BIOL, V190, P197, DOI 10.1083/jcb.200911156; Harper JW, 2007, MOL CELL, V28, P739, DOI 10.1016/j.molcel.2007.11.015; Havens CG, 2012, J BIOL CHEM; Havens CG, 2011, GENE DEV, V25, P1568, DOI 10.1101/gad.2068611; Havens CG, 2009, MOL CELL, V35, P93, DOI 10.1016/j.molcel.2009.05.012; Higa LA, 2006, NAT CELL BIOL, V8, P1277, DOI 10.1038/ncb1490; Ishii T, 2010, J BIOL CHEM, V285, P41993, DOI 10.1074/jbc.M110.161661; Jascur T, 2011, J BIOL CHEM, V286, P29531, DOI 10.1074/jbc.M111.221341; Jin JP, 2006, MOL CELL, V23, P709, DOI 10.1016/j.molcel.2006.08.010; KELLY TJ, 1993, CELL, V74, P371, DOI 10.1016/0092-8674(93)90427-R; Lau E, 2009, MOL BIOL CELL, V20, P3953, DOI 10.1091/mbc.E09-01-0022; Liu PJ, 2009, CELL CYCLE, V8, P125, DOI 10.4161/cc.8.1.7528; Marini F, 2006, P NATL ACAD SCI USA, V103, P17325, DOI 10.1073/pnas.0605446103; Marti TM, 2006, P NATL ACAD SCI USA, V103, P9891, DOI 10.1073/pnas.0603779103; Masai H, 2010, ANNU REV BIOCHEM, V79, P89, DOI 10.1146/annurev.biochem.052308.103205; Michishita M, 2011, GENES CELLS, V16, P12, DOI 10.1111/j.1365-2443.2010.01464.x; Miotto B, 2011, MOL CELL, V44, P62, DOI 10.1016/j.molcel.2011.06.021; Morino M, 2014, METHODS MOL BIOL, V1170, P529, DOI 10.1007/978-1-4939-0888-2_29; Nevis KR, 2009, CELL CYCLE, V8, P1952, DOI 10.4161/cc.8.12.8811; Nishitani H, 2002, GENES CELLS, V7, P523, DOI 10.1046/j.1365-2443.2002.00544.x; Nishitani H, 2006, EMBO J, V25, P1126, DOI 10.1038/sj.emboj.7601002; Nishitani H, 2000, NATURE, V404, P625, DOI 10.1038/35007110; Nishitani H, 2001, J BIOL CHEM, V276, P44905, DOI 10.1074/jbc.M105406200; Nishitani H, 2008, J BIOL CHEM, V283, P29045, DOI 10.1074/jbc.M806045200; NURSE P, 1994, CELL, V79, P547, DOI 10.1016/0092-8674(94)90539-8; Orthwein A, 2014, SCIENCE, V344, P189, DOI 10.1126/science.1248024; Peterson SE, 2011, J CELL BIOL, V194, P705, DOI 10.1083/jcb.201103103; PIATTI S, 1995, EMBO J, V14, P3788, DOI 10.1002/j.1460-2075.1995.tb00048.x; Ralph E, 2006, EMBO REP, V7, P1134, DOI 10.1038/sj.embor.7400827; Raman M, 2011, MOL CELL, V44, P72, DOI 10.1016/j.molcel.2011.06.036; Roukos V, 2011, J CELL SCI, V124, P422, DOI 10.1242/jcs.074229; Sakaguchi H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046480; Sansam CL, 2006, GENE DEV, V20, P3117, DOI 10.1101/gad.1482106; Senga T, 2006, J BIOL CHEM, V281, P6246, DOI 10.1074/jbc.M512705200; Seo YR, 2002, ONCOGENE, V21, P731, DOI 10.1038/sj.onc.1205129; Shiomi Y, 2012, MOL CELL BIOL, V32, P2279, DOI 10.1128/MCB.06506-11; Shreeram S, 2002, ONCOGENE, V21, P6624, DOI 10.1038/sj.onc.1205910; Stathopoulou A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034621; Sugasawa K, 2001, GENE DEV, V15, P507, DOI 10.1101/gad.866301	50	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0120553	10.1371/journal.pone.0120553	http://dx.doi.org/10.1371/journal.pone.0120553			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25798850	gold, Green Published, Green Submitted			2022-12-27	WOS:000351987300154
J	Yune, HY; Chung, SP; Park, YS; Chung, HS; Lee, HS; Lee, JW; Park, JW; You, JS; Park, I; Lee, HS				Yune, Ho Young; Chung, Sung Phil; Park, Yoo Seok; Chung, Hyun Soo; Lee, Hye Sun; Lee, Jong Wook; Park, Jong Woo; You, Je Sung; Park, Incheol; Lee, Hahn Shick			Delta Neutrophil Index as a Promising Prognostic Marker in Out of Hospital Cardiac Arrest	PLOS ONE			English	Article							MORTALITY; CARDIOPULMONARY; RESUSCITATION; DIAGNOSIS	Background The post-resuscitation phase after out-of-hospital cardiac arrest (OHCA) is characterised by a systemic inflammatory response (e.g., severe sepsis), for which the immature granulocyte count is a diagnostic marker. In this study we evaluated the prognostic significance of the delta neutrophil index (DNI), which is the difference in leukocyte subfractions as assessed by an automated blood cell analyser, for early mortality after OHCA. Materials and Methods OHCA records from the emergency department cardiac arrest registry were retrospectively analysed. Patients who survived at least 24 h after return of spontaneous circulation were included in the analysis. We evaluated mortality and cerebral performance category scores at 30 days. Results A total of 83 patients with OHCA were included in the study. Our results showed that DNI >8.4% on day 1 (hazard ratio [HR], 3.227; 95% CI, 1.485-6.967; p = 0.001) and DNI >10.5% on day 2 (HR, 3.292; 95% CI, 1.662-6.519; p<0.001) were associated with increased 30-day mortality in patients with OHCA. Additionally, DNI >8.4% on day 1 (HR, 2.718; 95% CI, 1.508-4.899; p<0.001) and DNI >10.5% on day 2 (HR, 1.709; 95% CI, 1.051-2.778; p = 0.02) were associated with worse neurologic outcomes 30 days after OHCA. Conclusion A higher DNI is a promising prognostic marker for 30-day mortality and neurologic outcomes after OHCA. Our findings indicate that patients with elevated DNI values after OHCA might be closely monitored so that appropriate treatment strategies can be implemented.	[Yune, Ho Young; Chung, Sung Phil; Park, Yoo Seok; Chung, Hyun Soo; You, Je Sung; Park, Incheol; Lee, Hahn Shick] Yonsei Univ, Coll Med, Dept Emergency Med, Seoul, South Korea; [Lee, Hye Sun] Yonsei Univ, Coll Med, Dept Res Affairs, Biostat Collaborat Unit, Seoul, South Korea; [Lee, Jong Wook] Jincheon Sungmo Hosp, Dept Lab Med, Jincheon, South Korea; [Park, Jong Woo] Changwon Fatima Hosp, Dept Emergency Med, Chang Won, South Korea; [You, Je Sung] Kangwon Natl Univ, Grad Sch Med, Dept Emergency Med, Chunchon, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Kangwon National University	You, JS (corresponding author), Yonsei Univ, Coll Med, Dept Emergency Med, Seoul, South Korea.	youjsmd@yuhs.ac	; Lee, Hye Sun/J-2154-2015; Chung, Sung Phil/F-8344-2016	You, Je Sung/0000-0002-2074-6745; Park, Incheol/0000-0001-7033-766X; Lee, Hye Sun/0000-0001-6328-6948; Chung, Sung Phil/0000-0002-3074-011X; Park, Yoo Seok/0000-0003-1543-4664	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [NRF-2013R1A1A2009391]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (NRF-2013R1A1A2009391). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adrie C, 2002, CIRCULATION, V106, P562, DOI 10.1161/01.CIR.0000023891.80661.AD; Adrie Christophe, 2004, Curr Opin Crit Care, V10, P208, DOI 10.1097/01.ccx.0000126090.06275.fe; Alves JC, 2010, SHOCK, V34, P15, DOI 10.1097/SHK.0b013e3181e7e61b; Andersson U, 2011, ANNU REV IMMUNOL, V29, P139, DOI 10.1146/annurev-immunol-030409-101323; Engel H, 2013, RESUSCITATION, V84, P776, DOI 10.1016/j.resuscitation.2013.01.029; Go AS, 2014, CIRCULATION, V129, pE28, DOI 10.1161/01.cir.0000441139.02102.80; Grigoriu BD, 2007, CLIN CANCER RES, V13, P2928, DOI 10.1158/1078-0432.CCR-06-2144; Ha SO, 2015, SCAND J CLIN LAB INV, V75, P36, DOI 10.3109/00365513.2014.965736; HyunNahm C, 2008, ANN CLIN LAB SCI, V38, P241; Kim HW, 2012, SCAND J INFECT DIS, V44, P475, DOI 10.3109/00365548.2012.657232; Kim J, 2013, RESUSCITATION, V84, P48, DOI 10.1016/j.resuscitation.2012.09.003; Kim J, 2012, RESUSCITATION, V83, P1248, DOI 10.1016/j.resuscitation.2012.01.038; Lim TS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086884; Nolan JP, 2008, RESUSCITATION, V79, P350, DOI 10.1016/j.resuscitation.2008.09.017; Park BH, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-299; Pyo JY, 2013, LUPUS, V22, P1102, DOI 10.1177/0961203313499957; Roger VL, 2011, CIRCULATION, V123, pE18, DOI 10.1161/CIR.0b013e3182009701; Seok Y, 2012, SHOCK, V37, P242, DOI 10.1097/SHK.0b013e3182454acf; Vincent JL, 2014, CLIN EXP EMERG MED, V1, P3, DOI 10.15441/ceem.14.005	19	34	34	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0120677	10.1371/journal.pone.0120677	http://dx.doi.org/10.1371/journal.pone.0120677			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25798609	Green Published, Green Submitted, gold			2022-12-27	WOS:000351987300163
J	Boix, N; Teixido, E; Vila-Cejudo, M; Ortiz, P; Ibanez, E; Llobet, JM; Barenys, M				Boix, Nuria; Teixido, Elisabet; Vila-Cejudo, Marta; Ortiz, Pedro; Ibanez, Elena; Llobet, Juan M.; Barenys, Marta			Triclabendazole Sulfoxide Causes Stage-Dependent Embryolethality in Zebrafish and Mouse In Vitro	PLOS ONE			English	Article							WHOLE-EMBRYO CULTURE; DEVELOPMENTAL TOXICITY; ALBENDAZOLE SULFOXIDE; METABOLITES; DISPOSITION; FLUBENDAZOLE; FASCIOLIASIS; OXFENDAZOLE; KINETICS; FOOD	Background Fascioliasis and paragonimiasis are widespread foodborne trematode diseases, affecting millions of people in more than 75 countries. The treatment of choice for these parasitic diseases is based on triclabendazole, a benzimidazole derivative which has been suggested as a promising drug to treat pregnant women and children. However, at the moment, this drug is not approved for human use in most countries. Its potential adverse effects on embryonic development have been scarcely studied, and it has not been assigned a pregnancy category by the FDA. Thus, to help in the process of risk-benefit decision making upon triclabendazole treatment during pregnancy, a better characterization of its risks during gestation is needed. Methodology The zebrafish embryo test, a preimplantation and a postimplantation rodent whole embryo culture were used to investigate the potential embryotoxicity/teratogenicity of triclabendazole and its first metabolite triclabendazole sulfoxide. Albendazole and albendazole sulfoxide were included as positive controls. Principal Findings Triclabendazole was between 10 and 250 times less potent than albendazole in inducing dysmorphogenic effects in zebrafish or postimplantation rodent embryos, respectively. However, during the preimplantation period, both compounds, triclabendazole and triclabendazole sulfoxide, induced a dose-dependent embryolethal effect after only 24 h of exposure in rodent embryos and zebrafish (lowest observed adverse effect concentrations = 10 mu M). Conclusions/Significance In humans, after ingestion of the recommended doses of triclabendazole to treat fascioliasis and paragonimiasis (10 mg/kg), the main compound found in plasma is triclabendazole sulfoxide (maximum concentration 38.6 mu M), while triclabendazole concentrations are approximately 30 times lower (1.16 mu M). From our results it can be concluded that triclabendazole, at concentrations of the same order of magnitude as the clinically relevant ones, does not entail teratogenic potential in vitro during the organogenesis period, but its first metabolite triclabendazole sulfoxide has a high embryotoxic capacity in vitro during the preimplantation stage.	[Boix, Nuria; Teixido, Elisabet; Llobet, Juan M.; Barenys, Marta] Univ Barcelona, Fac Pharm, Pharmacol & Therapeut Chem Dept, GRET CERETOX INSA UB & Toxicol Unit, Barcelona, Spain; [Teixido, Elisabet] Univ Autonoma Barcelona, Fac Biociencies, Dept Genet Microbiol, Grp Mutagenesi, Bellaterra, Spain; [Vila-Cejudo, Marta; Ibanez, Elena] Univ Autonoma Barcelona, Fac Biociencies, Dept Biol Cellular Fisiol & Immunol, Unitat Biol Cellular, Bellaterra, Spain; [Ortiz, Pedro] Univ Nacl Cajamarca, Fac Ciencias Vet, Cajamarca, Peru; [Barenys, Marta] IUF Leibniz Res Inst Environm Med, Dusseldorf, Germany	University of Barcelona; Autonomous University of Barcelona; Autonomous University of Barcelona; Universidad Nacional de Cajamarca; Leibniz Institut fur Umweltmedizinische Forschung (IUF)	Barenys, M (corresponding author), Univ Barcelona, Fac Pharm, Pharmacol & Therapeut Chem Dept, GRET CERETOX INSA UB & Toxicol Unit, Barcelona, Spain.	marta.barenys@iuf-duesseldorf.de	Llobet, Juan M/F-7775-2016; Ibáñez, Elena/K-4320-2014; Teixido, Elisabet/P-2823-2015	Ibáñez, Elena/0000-0002-0275-6958; Teixido, Elisabet/0000-0002-0146-876X; Ortiz, Pedro/0000-0001-8846-777X; Vila Cejudo, Marta/0000-0002-3138-2668; Barenys, Marta/0000-0001-5046-9796	University of Barcelona [MCI2011D]; Generalitat de Catalunya [2014 SGR566, 2014 SGR524]; Universitat Autonoma de Barcelona	University of Barcelona; Generalitat de Catalunya(Generalitat de Catalunya); Universitat Autonoma de Barcelona	Funding: Funding for this work was provided by the University of Barcelona, with the International Cooperation and Development project MCI2011D. The Toxicology Unit of the University of Barcelona and the Cellular Biology unit of the Biosciences Faculty of the Universitat Autonoma de Barcelona were financially supported by the Generalitat de Catalunya (2014 SGR566 and 2014 SGR524, respectively). MVC received a predoctoral scholarship from the Universitat Autonoma de Barcelona. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALVAREZBUJIDOS ML, 1993, COMP BIOCHEM PHYS C, V106, P805, DOI 10.1016/0742-8413(93)90245-G; Barenys M, 2012, REPROD TOXICOL, V34, P57, DOI 10.1016/j.reprotox.2012.02.001; Biggers JD, 2000, BIOL REPROD, V63, P281, DOI 10.1095/biolreprod63.1.281; Bogan JA, 1988, P 4 C EUR ASS VET PH, P159; Capece BPS, 2003, VET J, V165, P266, DOI 10.1016/S1090-0233(02)00158-2; Carlsson G, 2011, REPROD TOXICOL, V32, P129, DOI 10.1016/j.reprotox.2011.05.015; Ceballos L, 2010, BMC VET RES, V6, DOI 10.1186/1746-6148-6-8; CHATOT CL, 1989, J REPROD FERTIL, V86, P679, DOI 10.1530/jrf.0.0860679; Cristofol C, 1997, TOXICOL APPL PHARM, V144, P56, DOI 10.1006/taap.1997.8114; de Jong E, 2011, TOXICOL APPL PHARM, V253, P103, DOI 10.1016/j.taap.2011.03.014; DELATOUR P, 1984, J VET PHARMACOL THER, V7, P139, DOI 10.1111/j.1365-2885.1984.tb00890.x; Eckardt K, 2012, REPROD TOXICOL, V34, P378, DOI 10.1016/j.reprotox.2012.05.037; El-Makawy A, 2006, REPROD NUTR DEV, V46, P139, DOI 10.1051/rnd:2006007; El-Tantawy WH, 2007, PHARM WORLD SCI, V29, P190, DOI 10.1007/s11096-006-9069-8; Fairweather I, 2009, J HELMINTHOL, V83, P139, DOI 10.1017/S0022149X09321173; Flick B, 2006, CURR PHARM DESIGN, V12, P1467, DOI 10.2174/138161206776389822; Flick B, 2009, TOXICOL APPL PHARM, V237, P154, DOI 10.1016/j.taap.2009.02.024; HENNESSY DR, 1987, J VET PHARMACOL THER, V10, P64, DOI 10.1111/j.1365-2885.1987.tb00078.x; HOPKINS DR, 1992, AM J TROP MED HYG, V46, P626, DOI 10.4269/ajtmh.1992.46.626; Hurtt ME, 2003, FOOD CHEM TOXICOL, V41, P611, DOI 10.1016/S0278-6915(02)00326-5; Imperiale F, 2011, FOOD ADDIT CONTAM A, V28, P438, DOI 10.1080/19440049.2010.551422; Keiser J, 2005, EXPERT OPIN INV DRUG, V14, P1513, DOI 10.1517/13543784.14.12.1513; KLUG S, 1985, ARCH TOXICOL, V58, P84, DOI 10.1007/BF00348314; Kohler P, 2001, INT J PARASITOL, V31, P336, DOI 10.1016/S0020-7519(01)00131-X; Lecaillon JB, 1998, BRIT J CLIN PHARMACO, V45, P601, DOI 10.1046/j.1365-2125.1998.00725.x; Longo M, 2013, REPROD TOXICOL, V36, P78, DOI 10.1016/j.reprotox.2012.12.004; MANTOVANI A, 1995, REPROD TOXICOL, V9, P265, DOI 10.1016/0890-6238(95)00008-X; Mattsson A, 2012, REPROD TOXICOL, V34, P31, DOI 10.1016/j.reprotox.2012.02.007; Mestorino N, 2008, VET RES COMMUN, V32, P21, DOI 10.1007/s11259-007-9000-3; Ministerio de Salud y Desarrollo Social. Junta revisora de productos farmaceuticos, 2004, MIN SAL DES SOC B; Nagel R., 2002, ALTEX, V19, P37; OFORIADJEI D, 2008, INT J RISK SAF MED, V20, P113, DOI DOI 10.3233/JRS-2008-0440; Organisation of Economic Co-operation and Development, 2013, GUID TEST CHEM TEST; Piersma AH, 2002, INVITTOX PROTOCOL 12; Richard-Lenoble D, 2003, Med Trop (Mars), V63, P491; Stitt AW, 1996, PARASITOL RES, V82, P333, DOI 10.1007/s004360050122; Teixido E, 2013, TOXICOL IN VITRO, V27, P469, DOI 10.1016/j.tiv.2012.07.010; Teruel MT, 2003, VET HUM TOXICOL, V45, P131; WHITTAKER SG, 1991, TOXICOL APPL PHARM, V109, P73, DOI 10.1016/0041-008X(91)90192-H; WHITTAKER SG, 1992, TOXICOL APPL PHARM, V113, P144, DOI 10.1016/0041-008X(92)90019-O; World Health Organization, 1993, TOX EV CERT VET DRUG; World Health Organization, 2006, WHO INF M US TRICL F; World Health Organization, 2011, REP WHO EXP CONS FOO; YOSHIMURA H, 1987, TOXICOLOGY, V43, P283, DOI 10.1016/0300-483X(87)90087-4; Yoshimura H, 2003, REPROD TOXICOL, V17, P377, DOI 10.1016/S0890-6238(03)00033-9	45	4	4	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0121308	10.1371/journal.pone.0121308	http://dx.doi.org/10.1371/journal.pone.0121308			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25793498	Green Published, Green Submitted, gold			2022-12-27	WOS:000352083900122
J	Burke, SD; Seaward, AVC; Ramshaw, H; Smith, GN; Virani, S; Croy, BA; Lima, PDA				Burke, Suzanne D.; Seaward, Alexandra V. C.; Ramshaw, Heather; Smith, Graeme N.; Virani, Sophia; Croy, Barbara A.; Lima, Patricia D. A.			Homing Receptor Expression Is Deviated on CD56(+) Blood Lymphocytes during Pregnancy in Type 1 Diabetic Women	PLOS ONE			English	Article							NATURAL-KILLER-CELLS; NK CELLS; IL-7; PREECLAMPSIA; CD56(BRIGHT); RECRUITMENT; UTERUS; INFLAMMATION; TROPHOBLASTS; TRAFFICKING	Type 1 Diabetes Mellitus (T1DM) is characterized by an augmented pro-inflammatory immune state. This contributes to the increased risk for gestational complications observed in T1DM mothers. In normal pregnancies, critical immunological changes occur, including the massive recruitment of lymphocytes, particularly CD56(bright) NK cells, into early decidua basalis and a 2(nd) trimester shift towards Type 2 immunity. Decidual CD56bright NK cells arise at least partly from circulating progenitors expressing adhesion molecules SELL and ITGA4 and the chemokine receptors CXCR3 and CXCR4. In vitro studies show that T1DM reduces interactions between blood CD56(+) NK cells and decidual endothelial cells by reducing SELL and ITGA4- based interactions. To address the mechanisms by which specific lymphocyte subsets may be recruited from the circulation during pregnancy and whether these mechanisms are altered in T1DM, flow cytometry was used to examine eight peripheral blood lymphocyte subsets (Type 1 (IL18R1(+)) and Type 2 (IL1RL1(+)) CD56(bright) NK, CD56(dim) NK, NKT and T cells) from control and T1DM women. Blood was collected serially over pregnancy and postpartum, and lymphocytes were compared for expression of homing receptors SELL, ITGA4, CXCR3, and CXCR4. The decline of Type 1/Type 2 immune cells in normal pregnancy was driven by an increase in Type 2 cells that did not occur in T1DM. CD56(bright) NK cells from control women had the highest expression of all four receptors with greatest expression in 2nd trimester. At this time, these receptors were expressed at very low levels by CD56(bright) NK cells from TIDM patients. Type 1/Type 2 NKT cell ratios were not influenced by either pregnancy or TIDM. Our results suggest that T1DM alters immunological balances during pregnancy with its greatest impact on CD56(bright) NK cells. This implicates CD56(bright) NK cells in diabetic pregnancy complications.	[Burke, Suzanne D.; Seaward, Alexandra V. C.; Virani, Sophia; Croy, Barbara A.; Lima, Patricia D. A.] Queens Univ, Dept Biomed & Mol Sci, Kingston, ON, Canada; [Ramshaw, Heather; Smith, Graeme N.] Queens Univ, Dept Obstet & Gynecol, Kingston, ON, Canada	Queens University - Canada; Queens University - Canada	Lima, PDA (corresponding author), Ottawa Hosp Res Inst, Ottawa, ON, Canada.	limapda@gmail.com	Smith, Graeme Neil/ABB-6863-2021	Smith, Graeme Neil/0000-0002-3128-4523; Burke, Suzanne/0000-0003-4594-4163	Canadian Institutes for Health Research [CIHR MOP 77519]; Canada Research Chairs Program; Canada Doctoral Fellowship from CIHR	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Canada Research Chairs Program(Canada Research Chairs); Canada Doctoral Fellowship from CIHR(Canadian Institutes of Health Research (CIHR))	This study was supported by the Canadian Institutes for Health Research (CIHR MOP 77519) and the Canada Research Chairs Program (BAC). SDB was supported by a Canada Doctoral Fellowship from CIHR (CIHR: http://www.cihr-irsc.gc.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson A, 2009, J IMMUNOL, V182, P6951, DOI 10.4049/jimmunol.0803340; Borzychowski AM, 2006, SEMIN FETAL NEONAT M, V11, P309, DOI 10.1016/j.siny.2006.04.001; Borzychowski AM, 2005, EUR J IMMUNOL, V35, P3054, DOI 10.1002/eji.200425929; Bulmer JN, 2005, MOL IMMUNOL, V42, P511, DOI 10.1016/j.molimm.2004.07.035; Campbell JJ, 2000, CURR OPIN IMMUNOL, V12, P336, DOI 10.1016/S0952-7915(00)00096-0; Campbell JJ, 2001, J IMMUNOL, V166, P6477, DOI 10.4049/jimmunol.166.11.6477; Carlino C, 2008, BLOOD, V111, P3108, DOI 10.1182/blood-2007-08-105965; Cella M, 2010, P NATL ACAD SCI USA, V107, P10961, DOI 10.1073/pnas.1005641107; Chan WL, 2001, J IMMUNOL, V167, P1238, DOI 10.4049/jimmunol.167.3.1238; Chantakru S, 2003, J IMMUNOL, V171, P4011, DOI 10.4049/jimmunol.171.8.4011; Chantakru S, 2002, J IMMUNOL, V168, P22, DOI 10.4049/jimmunol.168.1.22; Chazara O, 2011, J LEUKOCYTE BIOL, V90, P703, DOI 10.1189/jlb.0511227; Chen ZL, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.102293; Cimbro R, 2012, BLOOD, V120, P2610, DOI 10.1182/blood-2012-06-434779; Evers IN, 2004, BMJ-BRIT MED J, V328, P915, DOI 10.1136/bmj.38043.583160.EE; Frey M, 1998, J IMMUNOL, V161, P400; GISMONDI A, 1991, J IMMUNOL, V146, P384; Hanna J, 2003, BLOOD, V102, P1569, DOI 10.1182/blood-2003-02-0517; Hanna J, 2006, NAT MED, V12, P1065, DOI 10.1038/nm1452; Holmes VA, 2013, DIABETES CARE, V36, P3671, DOI 10.2337/dc13-0944; Keskin DB, 2007, P NATL ACAD SCI USA, V104, P3378, DOI 10.1073/pnas.0611098104; Lash GE, 2011, HUM REPROD, V26, P2289, DOI 10.1093/humrep/der198; Lehuen A, 2010, NAT REV IMMUNOL, V10, P501, DOI 10.1038/nri2787; Lima PDA, 2014, CELL MOL IMMUNOL, V11, P522, DOI 10.1038/cmi.2014.63; Male V, 2010, J IMMUNOL, V185, P3913, DOI 10.4049/jimmunol.1001637; Michaud A, 2010, J IMMUNOTHER, V33, P382, DOI 10.1097/CJI.0b013e3181cd872d; Murphy SP, 2009, BIOL REPROD, V80, P848, DOI 10.1095/biolreprod.108.073353; Oboki K, 2011, ALLERGY ASTHMA IMMUN, V3, P81, DOI 10.4168/aair.2011.3.2.81; Peralta CG, 2008, J LEUKOCYTE BIOL, V84, P1065, DOI 10.1189/jlb.0308164; Rahmati M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102286; Ranson T, 2003, BLOOD, V101, P4887, DOI 10.1182/blood-2002-11-3392; Rao RM, 2007, CIRC RES, V101, P234, DOI 10.1161/CIRCRESAHA.107.151860b; Red-Horse K, 2001, AM J PATHOL, V159, P2199, DOI 10.1016/S0002-9440(10)63071-4; Rutella S, 2005, J IMMUNOL, V175, P7085, DOI 10.4049/jimmunol.175.11.7085; Saito S, 1999, CLIN EXP IMMUNOL, V117, P550; Salker MS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052252; Schmitt N, 2003, J VIROL, V77, P5784, DOI 10.1128/JVI.77.10.5784-5793.2003; Seaward AVC, 2011, HUM REPROD, V26, P1675, DOI 10.1093/humrep/der114; Sentman CL, 2004, J IMMUNOL, V173, P6760, DOI 10.4049/jimmunol.173.11.6760; SPRINGER TA, 1994, CELL, V76, P301, DOI 10.1016/0092-8674(94)90337-9; Srikhajon K, 2014, BIOL REPROD, V91, DOI 10.1095/biolreprod.113.114975; Taylor R, 2007, BMJ-BRIT MED J, V334, P742, DOI 10.1136/bmj.39154.700417.BE; Tognarelli S, 2014, J IMMUNOL, V192, P3399, DOI 10.4049/jimmunol.1301508; Tokmadzic VS, 2002, AM J REPROD IMMUNOL, V48, P191, DOI 10.1034/j.1600-0897.2002.01132.x; Vacca P, 2011, TRENDS IMMUNOL, V32, P517, DOI 10.1016/j.it.2011.06.013; van den Heuvel MJ, 2008, AM J REPROD IMMUNOL, V59, P90, DOI 10.1111/j.1600-0897.2007.00546.x; van den Heuvel MJ, 2007, AM J REPROD IMMUNOL, V58, P447, DOI 10.1111/j.1600-0897.2007.00529.x; van den Heuvel MJ, 2005, AM J REPROD IMMUNOL, V54, P322, DOI 10.1111/j.1600-0897.2005.00336.x; Vehik K, 2013, CURR DIABETES REP, V13, P642, DOI 10.1007/s11892-013-0406-8; Venet F, 2012, J IMMUNOL, V189, P5073, DOI 10.4049/jimmunol.1202062; Vince GS, 1996, J REPROD IMMUNOL, V32, P101, DOI 10.1016/S0165-0378(96)00995-3; Wallace AE, 2013, AM J PATHOL, V183, P1853, DOI 10.1016/j.ajpath.2013.08.023; Wang JW, 2002, SCIENCE, V295, P2094, DOI 10.1126/science.1068438; Williams PJ, 2009, REPRODUCTION, V138, P177, DOI 10.1530/REP-09-0007; Wu X, 2005, J IMMUNOL, V175, P61, DOI 10.4049/jimmunol.175.1.61; Yu Y, 2009, DIABETOLOGIA, V52, P160, DOI 10.1007/s00125-008-1182-x; Zhang JH, 2009, PLACENTA, V30, P968, DOI 10.1016/j.placenta.2009.08.011; Zhang Y, 2007, IMMUNOLOGY, V121, P258, DOI 10.1111/j.1365-2567.2007.02573.x	58	12	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0119526	10.1371/journal.pone.0119526	http://dx.doi.org/10.1371/journal.pone.0119526			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25793768	gold, Green Published, Green Submitted			2022-12-27	WOS:000352084200091
J	Contreras-Ruiz, L; Masli, S				Contreras-Ruiz, Laura; Masli, Sharmila			Immunomodulatory Cross-Talk between Conjunctival Goblet Cells and Dendritic Cells	PLOS ONE			English	Article							TGF-BETA; EPITHELIAL-CELLS; CROHNS-DISEASE; MURINE MODEL; T-CELLS; THROMBOSPONDIN-1; EXPRESSION; PEPTIDE; TEAR; INFLAMMATION	Goblet cells are secretory epithelial cells of mucosal tissues that confer protection from environmental agents or pathogens via expression and secretion of soluble mucins. Loss of these cells is associated with several chronic inflammatory disorders of the mucosa. Although demonstrated to transfer antigens from the luminal surface to stromal cells in the intestinal mucosa, it is not known if goblet cells contribute to the regulation of an immune response. In this study we report that similar to intestinal and respiratory mucosal epithelia, mouse ocular surface epithelia predominantly express the TGF-beta 2 isoform. Specifically, we demonstrate the ability of goblet cells to express TGF-beta 2 and increase it in response to Toll-Like Receptor 4 mediated stimulus in cultures. Goblet cells not only express TGF-beta 2, but are also able to activate it in a thrombospondin-1 (TSP-1) dependent manner via their cell surface receptor CD36. Furthermore, goblet cell derived soluble factors that possibly include TGF-beta 2, alter dendritic cell (DC) phenotype to a tolerogenic type by downregulating DC expression of MHC class II and co-stimulatory molecules CD80, CD86 and CD40. Thus our study demonstrates goblet cells as a cellular source of active TGF-beta 2 in ocular mucosa and implicates their immunomodulatory function in maintaining mucosal immune homeostasis.	[Contreras-Ruiz, Laura; Masli, Sharmila] Boston Univ, Sch Med, Dept Ophthalmol, Boston, MA 02118 USA	Boston University	Masli, S (corresponding author), Boston Univ, Sch Med, Dept Ophthalmol, Boston, MA 02118 USA.	smasli@bu.edu			National Eye Institute Grant [EY015472]; NATIONAL EYE INSTITUTE [R01EY015472] Funding Source: NIH RePORTER	National Eye Institute Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	Funding was provided by National Eye Institute Grant EY015472 (https://www.nei.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annes JP, 2003, J CELL SCI, V116, P217, DOI 10.1242/jcs.00229; Balzar S, 2005, J ALLERGY CLIN IMMUN, V115, P110, DOI 10.1016/j.jaci.2004.09.034; Chu HW, 2004, AM J PATHOL, V165, P1097, DOI 10.1016/S0002-9440(10)63371-8; Contreras-Ruiz L, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/636812; Contreras-Ruiz L, 2014, OPHTHALMOLOGY, V121, P1389, DOI 10.1016/j.ophtha.2014.01.033; Contreras-Ruiz L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075937; Coombes JL, 2007, J EXP MED, V204, P1757, DOI 10.1084/jem.20070590; Egan RM, 2000, J IMMUNOL, V164, P4543, DOI 10.4049/jimmunol.164.9.4543; Ezzie ME, 2011, AM J RESP CELL MOL, V44, P556, DOI 10.1165/rcmb.2009-0019OC; Fukata M, 2005, AM J PHYSIOL-GASTR L, V288, pG1055, DOI 10.1152/ajpgi.00328.2004; Gandhi NB, 2013, J LEUKOCYTE BIOL, V94, P1293, DOI 10.1189/jlb.1012524; Gersemann M, 2009, DIFFERENTIATION, V77, P84, DOI 10.1016/j.diff.2008.09.008; GILBARD JP, 1990, OPHTHALMOLOGY, V97, P308; Gipson IK, 1998, ADV EXP MED BIOL, V438, P221; Benito MJ, 2013, EXP EYE RES, V107, P88, DOI 10.1016/j.exer.2012.11.017; Kasper M, 2002, CLIN EXP ALLERGY, V32, P1251, DOI 10.1046/j.1365-2745.2002.01423.x; Khandelwal P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064193; Knop N, 2000, INVEST OPHTH VIS SCI, V41, P1270; Laffont S, 2010, EUR J IMMUNOL, V40, P1877, DOI 10.1002/eji.200939957; Leonardi A, 2011, CLIN EXP ALLERGY, V41, P52, DOI 10.1111/j.1365-2222.2010.03626.x; Leonardi A, 2006, GRAEF ARCH CLIN EXP, V244, P1240, DOI 10.1007/s00417-006-0285-7; Maheshwari A, 2011, GASTROENTEROLOGY, V140, P242, DOI 10.1053/j.gastro.2010.09.043; Mantelli F, 2008, CURR OPIN ALLERGY CL, V8, P477, DOI 10.1097/ACI.0b013e32830e6b04; Nakamura T, 2001, INVEST OPHTH VIS SCI, V42, P549; Pflugfelder SC, 2008, CORNEA, V27, P64, DOI 10.1097/ICO.0b013e318158f6dc; Punekar S, 2008, PATHOBIOLOGY, V75, P9, DOI 10.1159/000113790; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Ramalingam R, 2012, J IMMUNOL, V189, P3878, DOI 10.4049/jimmunol.1201029; Reinoso R, 2012, MUCOSAL IMMUNOL, V5, P455, DOI 10.1038/mi.2012.27; Ribeiro SMF, 1999, J BIOL CHEM, V274, P13586, DOI 10.1074/jbc.274.19.13586; Schaumburg CS, 2014, INVEST OPHTHALMOL VI, V55; Siebelmann S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082355; Tesseur I, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-15; Thompson HGR, 2006, AM J PHYSIOL-LUNG C, V291, pL1277, DOI 10.1152/ajplung.00057.2006; TSENG SCG, 1984, OPHTHALMOLOGY, V91, P545; Turpie B, 2009, AM J PATHOL, V175, P1136, DOI 10.2353/ajpath.2009.081058; Wen FQ, 2002, AM J RESP CELL MOL, V26, P484, DOI 10.1165/ajrcmb.26.4.4784; Wu F, 2007, INFLAMM BOWEL DIS, V13, P807, DOI 10.1002/ibd.20110; Yamaguchi Y, 1997, STEM CELLS, V15, P144, DOI 10.1002/stem.150144; Yehualaeshet T, 1999, AM J PATHOL, V155, P841, DOI 10.1016/S0002-9440(10)65183-8	40	57	60	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0120284	10.1371/journal.pone.0120284	http://dx.doi.org/10.1371/journal.pone.0120284			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25793763	gold, Green Submitted, Green Published			2022-12-27	WOS:000352083900008
J	Gong, MC; Dong, WJ; He, TY; Shi, ZR; Huang, GY; Ren, R; Huang, SC; Qiu, SP; Yuan, RQ				Gong, Mancheng; Dong, Wenjing; He, Tingyu; Shi, Zhirong; Huang, Guiying; Ren, Rui; Huang, Sichong; Qiu, Shaopeng; Yuan, Runqiang			MTHFR 677C > T Polymorphism Increases the Male Infertility Risk: A Meta-Analysis Involving 26 Studies	PLOS ONE			English	Article							METHYLENETETRAHYDROFOLATE REDUCTASE C677T; GENETIC POLYMORPHISMS; PLASMA HOMOCYSTEINE; GSTM1 DELETION; ENZYME GENES; ZINC-SULFATE; FOLIC-ACID; FOLATE; ASSOCIATION; SPERM	Background and Objectives Methylenetetrahydrofolate reductase (MTHFR) polymorphism may be a risk factor for male infertility. However, the epidemiologic studies showed inconsistent results regarding MTHFR polymorphism and the risk of male infertility. Therefore, we performed a meta-analysis of published case-control studies to re-examine the controversy. Methods Electronic searches of PubMed, EMBASE, Google Scholar and China National Knowledge Infrastructure (CNKI) were conducted to select eligible literatures for this meta-analysis (updated to June 19, 2014). According to our inclusion criteria and the Newcastle-Ottawa Scale (NOS), only high quality studies that observed the association between MTHFR polymorphism and male infertility risk were included. Crude odds ratio (OR) with 95% confidence interval (CI) was used to assess the strength of association between the MTHFR polymorphism and male infertility risk. Results Twenty-six studies involving 5,575 cases and 5,447 controls were recruited. Overall, MTHFR 677C>T polymorphism showed significant associations with male infertility risk in both fixed effects (CT+TT vs. CC: OR = 1.34, 95% CI: 1.23-1.46) and random effects models (CT+TT vs. CC: OR = 1.39, 95% CI: 1.19-1.62). Further, when stratified by ethnicity, sperm concentration and control sources, the similar results were observed in Asians, Caucasians, Azoo or OAT subgroup and both in population-based and hospital-based controls. Nevertheless, no significant association was only observed in oligo subgroup. Conclusions Our results indicated that the MTHFR polymorphism is associated with an increased risk of male infertility. Further well-designed analytical studies are necessary to confirm our conclusions and evaluate gene-environment interactions with male infertility risk.	[Gong, Mancheng; Qiu, Shaopeng] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Urol, Guangzhou 510080, Guangdong, Peoples R China; [Gong, Mancheng; Ren, Rui; Huang, Sichong; Yuan, Runqiang] Sun Yat Sen Univ, Zhongshan Affiliated Hosp, Dept Androl, Guangzhou 510275, Guangdong, Peoples R China; [Dong, Wenjing] Sun Yat Sen Univ, Zhongshan Affiliated Hosp, Dept Oncol, Zhongshan 528403, Guangdong, Peoples R China; [He, Tingyu] Sun Yat Sen Univ, Zhongshan Affiliated Hosp, Dept Reprod Ctr, Zhongshan 528403, Guangdong, Peoples R China; [Shi, Zhirong] Second Peoples Hosp Zhuhai, Dept Pharm, Zhuhai 519020, Guangdong, Peoples R China; [Huang, Guiying] Sun Yat Sen Univ, Zhongshan Affiliated Hosp, Gen Dept 2, Zhongshan 528403, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University	Qiu, SP (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 1, Dept Urol, Guangzhou 510080, Guangdong, Peoples R China.	medicinegd@163.com; yuanrunqiang2013@163.com						[阿周存 A Zhoucun], 2010, [生殖与避孕, Reproduction and Contraception], V30, P183; Antony AC, 2001, AM J CLIN NUTR, V74, P157; Aston KI, 2010, HUM REPROD, V25, P1383, DOI 10.1093/humrep/deq081; Aston KI, 2009, J ANDROL, V30, P711, DOI 10.2164/jandrol.109.007971; Austin RC, 2004, CELL DEATH DIFFER, V11, pS56, DOI 10.1038/sj.cdd.4401451; Bashamboo A, 2010, AM J HUM GENET, V87, P505, DOI 10.1016/j.ajhg.2010.09.009; BENTIVOGLIO G, 1993, FERTIL STERIL, V60, P698; Bezold G, 2001, NEW ENGL J MED, V344, P1172, DOI 10.1056/NEJM200104123441517; Camprubi C, 2013, J ASSIST REPROD GEN, V30, P1125, DOI 10.1007/s10815-013-0013-2; Chellat D, 2012, GENET TEST MOL BIOMA, V16, P874, DOI 10.1089/gtmb.2011.0367; Chen ZT, 2001, HUM MOL GENET, V10, P433, DOI 10.1093/hmg/10.5.433; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dhillon VS, 2007, MOL HUM REPROD, V13, P213, DOI 10.1093/molehr/gal118; Dohle GR, 2002, HUM REPROD, V17, P13, DOI 10.1093/humrep/17.1.13; Donnelly JG, 2001, CRIT REV CL LAB SCI, V38, P183, DOI 10.1080/20014091084209; Dordevic V, 2010, ARCH BIOL SCI, V62, P525, DOI 10.2298/ABS1003525D; Dowsing AT, 1999, LANCET, V354, P640, DOI 10.1016/S0140-6736(98)08413-X; Ebisch IMW, 2003, FERTIL STERIL, V80, P1190, DOI 10.1016/S0015-0282(03)02157-5; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Eloualid A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034111; Ferlin A, 2007, REPROD BIOMED ONLINE, V14, P734, DOI 10.1016/S1472-6483(10)60677-3; Foresta C, 2001, ENDOCR REV, V22, P226, DOI 10.1210/er.22.2.226; Fowler Brian, 2005, Semin Vasc Med, V5, P77; FROSST P, 1995, NAT GENET, V10, P111, DOI 10.1038/ng0595-111; Gava MM, 2011, REPROD SCI, V18, P1267, DOI 10.1177/1933719111411729; Gava MM, 2011, GENET TEST MOL BIOMA, V15, P153, DOI 10.1089/gtmb.2010.0128; Goyette P, 1998, MAMM GENOME, V9, P652, DOI 10.1007/s003359900838; Gupta N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022277; [孙赫彤 Hetong SUN], 2007, [生殖与避孕, Reproduction and Contraception], V27, P443; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Huang T, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-867; Kobayashi H, 2007, HUM MOL GENET, V16, P2542, DOI 10.1093/hmg/ddm187; Kumar K, 2011, INDIAN J BIOCHEM BIO, V48, P422; Lakshmi AV, 2001, ASIA PAC J CLIN NUTR, V10, P194, DOI 10.1046/j.1440-6047.2001.00252.x; Lee HC, 2006, HUM REPROD, V21, P3162, DOI 10.1093/humrep/del280; Lee S, 2003, FERTIL STERIL, V80, pS229; Li E, 2002, NAT REV GENET, V3, P662, DOI 10.1038/nrg887; Li SS, 2014, GENET MOL RES, V13, P6367, DOI 10.4238/2014.March.24.26; Li Y, 2007, J CHROMATOGR A, V1172, P57, DOI 10.1016/j.chroma.2007.09.062; Lin PI, 2007, AM J HUM GENET, V80, P531, DOI 10.1086/512133; Liu L, 2011, J CENT S U MED SCI, V37, P1054; MacLean JA, 2005, CURR TOP DEV BIOL, V71, P131, DOI 10.1016/S0070-2153(05)71005-X; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; MANTEL N, 1959, J NATL CANCER I, V22, P719; Marth GT, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-9-r84; Mehlig K, 2013, HEART, V99, P1761, DOI 10.1136/heartjnl-2013-304460; Mfady DS, 2014, GENE, V536, P40, DOI 10.1016/j.gene.2013.12.001; Montjean D, 2011, FERTIL STERIL, V95, P635, DOI 10.1016/j.fertnstert.2010.08.054; Murphy LE, 2011, ASIAN J ANDROL, V13, P856, DOI 10.1038/aja.2011.96; Naqvi H, 2014, MOL BIOL REP, V41, P573, DOI 10.1007/s11033-013-2894-7; O'Brien KLO, 2010, FERTIL STERIL, V93, P1, DOI 10.1016/j.fertnstert.2009.10.045; Ownby RL, 2006, ARCH GEN PSYCHIAT, V63, P530, DOI 10.1001/archpsyc.63.5.530; Paracchini V, 2006, BIOMARKERS, V11, P53, DOI 10.1080/13547500500442050; Park JH, 2005, J ASSIST REPROD GEN, V22, P361, DOI 10.1007/s10815-005-6795-0; Parodi PW, 1997, MED HYPOTHESES, V49, P313, DOI 10.1016/S0306-9877(97)90197-3; Pathak Priyali, 2004, Nepal Med Coll J, V6, P13; Pei J., 2013, CHINA HLTH CARE NUTR, V2, P629; Pelucchi C, 2005, CANCER EPIDEM BIOMAR, V14, P2056, DOI 10.1158/1055-9965.EPI-05-0192; Qiu XF., 2011, J NINGXIA MED U, V33, P625; Ravel C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006540; Safarinejad MR, 2011, REPROD SCI, V18, P304, DOI 10.1177/1933719110385135; Schneider JA, 1998, AM J HUM GENET, V62, P1258, DOI 10.1086/301836; Singh K, 2005, INT J ANDROL, V28, P115, DOI 10.1111/j.1365-2605.2004.00513.x; Singh K, 2013, REPROD SCI, V20, P622, DOI 10.1177/1933719112459232; Stevenson RE, 1997, AM J HUM GENET, V60, P229; Stuppia L, 2003, J ENDOCRINOL INVEST, V26, P620, DOI 10.1007/BF03347018; Suryandari DA, 2012, MED J INDONES, V21, P23; Teng Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055332; Tetik A, 2008, EUR UROL SUPPL, V7, P92, DOI 10.1016/S1569-9056(08)60088-3; Tuttelmann F, 2007, REPROD BIOMED ONLINE, V15, P643, DOI 10.1016/s1472-6483(10)60531-7; Vani GT, 2012, ANDROLOGIA, V44, P252, DOI 10.1111/j.1439-0272.2011.01172.x; Wei BB, 2012, MOL BIOL REP, V39, P2347, DOI 10.1007/s11033-011-0985-x; Weiner AS, 2014, FERTIL STERIL, V101, P87, DOI 10.1016/j.fertnstert.2013.09.014; Wells G.A., NEWCASTLE OTTAWA SCA; Wong WY, 2002, FERTIL STERIL, V77, P491, DOI 10.1016/S0015-0282(01)03229-0; Wu W, 2012, INT J ANDROL, V35, P18, DOI 10.1111/j.1365-2605.2011.01147.x; Yang BH., 2010, J WANNAN MED U, V29, P5; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608; Zintzaras E, 2005, GENET EPIDEMIOL, V28, P123, DOI 10.1002/gepi.20048	79	41	41	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0121147	10.1371/journal.pone.0121147	http://dx.doi.org/10.1371/journal.pone.0121147			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25793386	Green Submitted, Green Published, gold			2022-12-27	WOS:000352083900103
J	Grabinski, TM; Kneynsberg, A; Manfredsson, FP; Kanaan, NM				Grabinski, Tessa M.; Kneynsberg, Andrew; Manfredsson, Fredric P.; Kanaan, Nicholas M.			A Method for Combining RNAscope In Situ Hybridization with Immunohistochemistry in Thick Free-Floating Brain Sections and Primary Neuronal Cultures	PLOS ONE			English	Article							SIGNAL AMPLIFICATION; NUCLEIC-ACID; RAT MODEL; SENSITIVITY; MOLECULES; INCREASE; TISSUES	In situ hybridization (ISH) is an extremely useful tool for localizing gene expression and changes in expression to specific cell populations in tissue samples across numerous research fields. Typically, a research group will put forth significant effort to design, generate, validate and then utilize in situ probes in thin or ultrathin paraffin embedded tissue sections. While combining ISH and IHC is an established technique, the combination of RNAscope ISH, a commercially available ISH assay with single transcript sensitivity, and IHC in thick free-floating tissue sections has not been described. Here, we provide a protocol that combines RNAscope ISH with IHC in thick free-floating tissue sections from the brain and allows simultaneous co-localization of genes and proteins in individual cells. This approach works well with a number of ISH probes (e.g. small proline-rich repeat 1a, beta III-tubulin, tau, and beta-actin) and IHC antibody stains (e.g. tyrosine hydroxylase, beta III-tubulin, NeuN, and glial fibrillary acidic protein) in rat brain sections. In addition, we provide examples of combining ISH-IHC dual staining in primary neuron cultures and double-ISH labeling in thick free-floating tissue sections from the brain. Finally, we highlight the ability of RNAscope to detect ectopic DNA in neurons transduced with viral vectors. RNAscope ISH is a commercially available technology that utilizes a branched or "tree" in situ method to obtain ultrasensitive, single transcript detection. Immunohistochemistry is a tried and true method for identifying specific protein in cell populations. The combination of a sensitive and versatile oligonucleotide detection method with an established and versatile protein assay is a significant advancement in studies using free-floating tissue sections.	[Grabinski, Tessa M.; Kneynsberg, Andrew; Manfredsson, Fredric P.; Kanaan, Nicholas M.] Michigan State Univ, Coll Human Med, Dept Translat Sci & Mol Med, Grand Rapids, MI 49503 USA	Michigan State University; Michigan State University College of Human Medicine	Kanaan, NM (corresponding author), Michigan State Univ, Coll Human Med, Dept Translat Sci & Mol Med, Grand Rapids, MI 49503 USA.	Nicholas.kanaan@hc.msu.edu	Manfredsson, Fredric/GMI-5876-2022; Kanaan, Nicholas M./J-3428-2016	Manfredsson, Fredric/0000-0001-5802-5487; Kanaan, Nicholas M./0000-0002-4362-2593; Kneynsberg, Andrew/0000-0001-7321-9415	National Institutes of Health/National Institute of Neurological Disorders and Stroke [P50 NS058830]; Saint Mary's Doran Foundation Research Fund; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS082730, P50NS058830] Funding Source: NIH RePORTER	National Institutes of Health/National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Saint Mary's Doran Foundation Research Fund; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the National Institutes of Health/National Institute of Neurological Disorders and Stroke funded Morris K. Udall Center for Excellence in Parkinson's disease research (P50 NS058830) at Michigan State University, as well as the Saint Mary's Doran Foundation Research Fund (NMK).	Andras SC, 2001, MOL BIOTECHNOL, V19, P29, DOI 10.1385/MB:19:1:029; Bonilla IE, 2002, J NEUROSCI, V22, P1303, DOI 10.1523/JNEUROSCI.22-04-01303.2002; CACCAMO D, 1989, LAB INVEST, V60, P390; GALL JG, 1969, P NATL ACAD SCI USA, V63, P378, DOI 10.1073/pnas.63.2.378; GENDELMAN HE, 1985, J VIROL METHODS, V11, P93, DOI 10.1016/0166-0934(85)90033-3; Guenin S, 2009, J EXP BOT, V60, P487, DOI 10.1093/jxb/ern305; Huebner EA, 2009, RESULTS PROBL CELL D, V48, P339, DOI 10.1007/400_2009_19; Itzkovitz S, 2011, NAT METHODS, V8, pS12, DOI [10.1038/NMETH.1573, 10.1038/nmeth.1573]; Jin L, 1997, J CLIN LAB ANAL, V11, P2, DOI 10.1002/(SICI)1098-2825(1997)11:1<2::AID-JCLA2>3.0.CO;2-F; Kaech S, 2006, NAT PROTOC, V1, P2406, DOI 10.1038/nprot.2006.356; KERSTENS HMJ, 1995, J HISTOCHEM CYTOCHEM, V43, P347, DOI 10.1177/43.4.7897179; Komminoth P, 1997, HISTOCHEM CELL BIOL, V108, P325, DOI 10.1007/s004180050173; Kwon S, 2013, BMB REP, V46, P65, DOI 10.5483/BMBRep.2013.46.2.016; Lutfalla G, 2006, METHOD ENZYMOL, V410, P386, DOI 10.1016/S0076-6879(06)10019-1; Mabruk MJEMF, 2004, EXPERT REV MOL DIAGN, V4, P653, DOI 10.1586/14737159.4.5.653; Manfredsson FP, 2007, EXP NEUROL, V207, P289, DOI 10.1016/j.expneurol.2007.06.019; Manfredsson FP, 2009, MOL THER, V17, P980, DOI 10.1038/mt.2009.45; Player AN, 2001, J HISTOCHEM CYTOCHEM, V49, P603, DOI 10.1177/002215540104900507; Qian X, 2003, DIAGN MOL PATHOL, V12, P1, DOI 10.1097/00019606-200303000-00001; Ramos-Vara JA, 2014, VET PATHOL, V51, P42, DOI 10.1177/0300985813505879; Speel EJM, 1999, J HISTOCHEM CYTOCHEM, V47, P281, DOI 10.1177/002215549904700302; Spieles-Engemann AL, 2010, NEUROBIOL DIS, V39, P105, DOI 10.1016/j.nbd.2010.03.009; Wang F, 2012, J MOL DIAGN, V14, P22, DOI 10.1016/j.jmoldx.2011.08.002	23	67	69	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0120120	10.1371/journal.pone.0120120	http://dx.doi.org/10.1371/journal.pone.0120120			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25794171	Green Published, gold, Green Submitted			2022-12-27	WOS:000352084200148
J	Otmakhov, N; Gorbacheva, EV; Regmi, S; Yasuda, R; Hudmon, A; Lisman, J				Otmakhov, Nikolai; Gorbacheva, Elena V.; Regmi, Shaurav; Yasuda, Ryohei; Hudmon, Andy; Lisman, John			Excitotoxic Insult Results in a Long-Lasting Activation of CaMKII alpha and Mitochondrial Damage in Living Hippocampal Neurons	PLOS ONE			English	Article							PROTEIN-KINASE-II; SUBUNIT 2B NR2B; CEREBRAL-ISCHEMIA; TERM POTENTIATION; DENDRITIC SPINES; SELF-ASSOCIATION; PERMEABILITY TRANSITION; SYNAPTIC STRENGTH; SLICE MODEL; CALCIUM	Over-activation of excitatory NMDA receptors and the resulting Ca2+ overload is the main cause of neuronal toxicity during stroke. CaMKII becomes misregulated during such events. Biochemical studies show either a dramatic loss of CaMKII activity or its persistent autonomous activation after stroke, with both of these processes being implicated in cell toxicity. To complement the biochemical data, we monitored CaMKII activation in living hippocampal neurons in slice cultures using high spatial/temporal resolution two-photon imaging of the CaMKII alpha FRET sensor, Camui. CaMKII activation state was estimated by measuring Camui fluorescence lifetime. Short NMDA insult resulted in Camui activation followed by a redistribution of its protein localization: an increase in spines, a decrease in dendritic shafts, and concentration into numerous clusters in the cell soma. Camui activation was either persistent (> 1-3 hours) or transient (similar to 20 min) and, in general, correlated with its protein redistribution. After longer NMDA insult, however, Camui redistribution persisted longer than its activation, suggesting distinct regulation/phases of these processes. Mutational and pharmacological analysis suggested that persistent Camui activation was due to prolonged Ca2+ elevation, with little impact of autonomous states produced by T286 autophosphorylation and/or by C280/M281 oxidation. Cell injury was monitored using expressible mitochondrial marker mito-dsRed. Shortly after Camui activation and clustering, NMDA treatment resulted in mitochondrial swelling, with persistence of the swelling temporarily linked to the persistence of Camui activation. The results suggest that in living neurons excitotoxic insult produces long-lasting Ca2+-dependent active state of CaMKII temporarily linked to cell injury. CaMKII function, however, is to be restricted due to strong clustering. The study provides the first characterization of CaMKII activation dynamics in living neurons during excitotoxic insults.	[Otmakhov, Nikolai; Gorbacheva, Elena V.; Regmi, Shaurav; Lisman, John] Brandeis Univ, Dept Biol, Waltham, MA 02254 USA; [Yasuda, Ryohei] Max Planck Florida Inst, Jupiter, FL 33458 USA; [Hudmon, Andy] Indiana Univ Sch Med, STARK Neurosci Res Inst, Indianapolis, IN 46202 USA	Brandeis University; Max Planck Society; Indiana University System; Indiana University Bloomington	Otmakhov, N (corresponding author), Brandeis Univ, Dept Biol, Waltham, MA 02254 USA.	otmakhov@brandeis.edu		Yasuda, Ryohei/0000-0001-6263-9297	Ellison Medical Foundation [AG-SS-2358-09]; Angelman Syndrome Foundation; National Institutes of Health [NS078171]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS078171] Funding Source: NIH RePORTER	Ellison Medical Foundation(Lawrence Ellison Foundation); Angelman Syndrome Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by Ellison Medical Foundation, Senior Scholar in Aging, AG-SS-2358-09 (to J.L.) (http://www.ellisonfoundation.org/); Angelman Syndrome Foundation grant (to J.L.) (http://www.angelman.org/research/); and National Institutes of Health Grant NS078171 (to A.H.) (http://health.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARONOWSKI J, 1992, J NEUROCHEM, V58, P1743, DOI 10.1111/j.1471-4159.1992.tb10049.x; Ashpole NM, 2011, MOL CELL NEUROSCI, V46, P720, DOI 10.1016/j.mcn.2011.02.003; Asrican B, 2007, J NEUROSCI, V27, P14007, DOI 10.1523/JNEUROSCI.3587-07.2007; Bayer KU, 2001, NATURE, V411, P801, DOI 10.1038/35081080; Bell JR, 2014, CLIN EXP PHARMACOL P, V41, P940, DOI 10.1111/1440-1681.12301; Bickler PE, 2004, NEUROSCIENCE, V127, P673, DOI 10.1016/j.neuroscience.2004.05.035; Brustovetsky N, 2002, J NEUROCHEM, V80, P207, DOI 10.1046/j.0022-3042.2001.00671.x; CHURN SB, 1995, J NEUROSCI, V15, P3200; CONNOR JA, 1988, SCIENCE, V240, P649, DOI 10.1126/science.2452481; Coultrap SJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037176; Coultrap SJ, 2011, ACTA PHARMACOL SIN, V32, P861, DOI 10.1038/aps.2011.68; Davies KD, 2007, BRAIN RES, V1158, P39, DOI 10.1016/j.brainres.2007.05.008; Ding JD, 2013, J COMP NEUROL, V521, P3570, DOI 10.1002/cne.23372; Dosemeci A, 2000, J NEUROSCI, V20, P3076, DOI 10.1523/JNEUROSCI.20-09-03076.2000; Dosemeci A, 2002, J NEUROCYTOL, V31, P605, DOI 10.1023/A:1025735410738; Erickson JR, 2008, CELL, V133, P462, DOI 10.1016/j.cell.2008.02.048; Erickson JR, 2011, CIRC RES, V109, P729, DOI 10.1161/CIRCRESAHA.111.247148; FONG YL, 1989, J BIOL CHEM, V264, P16759; Fujii H, 2013, CELL REP, V3, P978, DOI 10.1016/j.celrep.2013.03.033; Giese KP, 1998, SCIENCE, V279, P870, DOI 10.1126/science.279.5352.870; Greenwood SM, 2007, NEUROPHARMACOLOGY, V53, P891, DOI 10.1016/j.neuropharm.2007.10.003; Gurd JW, 2008, BRAIN RES, V1218, P158, DOI 10.1016/j.brainres.2008.04.040; Haas K, 2002, DIFFERENTIATION, V70, P148, DOI 10.1046/j.1432-0436.2002.700404.x; HAJIMOHAMMADREZA I, 1995, J NEUROSCI, V15, P4093; HANSON PI, 1994, NEURON, V12, P943, DOI 10.1016/0896-6273(94)90306-9; HANSON SK, 1994, STROKE, V25, P466, DOI 10.1161/01.STR.25.2.466; HIESTAND DM, 1992, J NEUROL SCI, V113, P31, DOI 10.1016/0022-510X(92)90261-I; Hudmon A, 2002, BIOCHEM J, V364, P593, DOI 10.1042/BJ20020228; Hudmon A, 2005, J NEUROSCI, V25, P6971, DOI 10.1523/JNEUROSCI.4698-04.2005; Hudmon A, 1996, J BIOL CHEM, V271, P8800, DOI 10.1074/jbc.271.15.8800; Hudmon A, 2001, J NEUROCHEM, V76, P1364, DOI 10.1046/j.1471-4159.2001.00119.x; Kato K, 2013, MOL BRAIN, V6, DOI 10.1186/1756-6606-6-37; KOLB SJ, 1995, J NEUROCHEM, V64, P2147; Kristensen BW, 2001, BRAIN RES, V917, P21, DOI 10.1016/S0006-8993(01)02900-6; Lee SJR, 2009, NATURE, V458, P299, DOI 10.1038/nature07842; Lemieux M, 2012, J CELL BIOL, V198, P1055, DOI 10.1083/jcb.201202058; Lisman J, 2012, NAT REV NEUROSCI, V13, P169, DOI 10.1038/nrn3192; Luo M, 2013, CIRC RES, V113, P690, DOI 10.1161/CIRCRESAHA.113.301651; Meng FJ, 2003, BRAIN RES, V967, P161, DOI 10.1016/S0006-8993(02)04267-1; Meng FJ, 2002, NEUROSCI LETT, V333, P59, DOI 10.1016/S0304-3940(02)00961-8; MOLLOY SS, 1991, P NATL ACAD SCI USA, V88, P4756, DOI 10.1073/pnas.88.11.4756; Montero M, 2007, EXP NEUROL, V204, P106, DOI 10.1016/j.expneurol.2006.09.026; Moskowitz MA, 2010, NEURON, V67, P181, DOI 10.1016/j.neuron.2010.07.002; O'Leary H, 2011, J BIOL CHEM, V286, P31272, DOI 10.1074/jbc.M111.233668; Otmakhov N, 2004, J NEUROSCI, V24, P9324, DOI 10.1523/JNEUROSCI.2350-04.2004; Otmakhov N, 2012, J NEUROSCI METH, V203, P106, DOI 10.1016/j.jneumeth.2011.09.022; Pi HJ, 2010, J NEUROSCI, V30, P8704, DOI 10.1523/JNEUROSCI.0133-10.2010; Pivovarova NB, 2010, FEBS J, V277, P3622, DOI 10.1111/j.1742-4658.2010.07754.x; Pivovarova NB, 2004, J NEUROSCI, V24, P5611, DOI 10.1523/JNEUROSCI.0531-04.2004; Rasola A, 2011, CELL CALCIUM, V50, P222, DOI 10.1016/j.ceca.2011.04.007; Rich RC, 1998, J BIOL CHEM, V273, P28424, DOI 10.1074/jbc.273.43.28424; Rintoul GL, 2003, J NEUROSCI, V23, P7881; Sanhueza M, 2011, J NEUROSCI, V31, P9170, DOI 10.1523/JNEUROSCI.1250-11.2011; Schulman Howard, 2010, Drug Discov Today Dis Mech, V7, pe117, DOI 10.1016/j.ddmec.2010.07.005; Shamloo M, 2000, NEUROSCIENCE, V96, P665, DOI 10.1016/S0306-4522(99)00586-2; Shen K, 1999, SCIENCE, V284, P162, DOI 10.1126/science.284.5411.162; Shetty PK, 2008, J BIOL CHEM, V283, P5389, DOI 10.1074/jbc.M708479200; SIMS NR, 1995, METAB BRAIN DIS, V10, P191, DOI 10.1007/BF02081026; Skelding KA, 2012, J CEREBRAL BLOOD FLO; TAFT WC, 1988, BRAIN RES, V447, P159, DOI 10.1016/0006-8993(88)90978-X; Takao K, 2005, J NEUROSCI, V25, P3107, DOI 10.1523/JNEUROSCI.0085-05.2005; Tang KX, 2004, J NEUROCHEM, V91, P429, DOI 10.1111/j.1471-4159.2004.02733.x; Tao-Cheng JH, 2001, NEUROSCIENCE, V106, P69, DOI 10.1016/S0306-4522(01)00262-7; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; Vest RS, 2007, MOL BIOL CELL, V18, P5024, DOI 10.1091/mbc.E07-02-0185; Vest RS, 2010, J BIOL CHEM, V285, P20675, DOI 10.1074/jbc.M109.088617; Vest RS, 2009, FEBS LETT, V583, P3577, DOI 10.1016/j.febslet.2009.10.028; Vinade L, 2003, J NEUROCHEM, V87, P1255, DOI 10.1046/j.1471-4159.2003.02091.x; Wang N, 2014, NEURAL PLAST, V2014, DOI 10.1155/2014/827161; WESTGATE SA, 1994, J NEUROCHEM, V63, P2217; Woodruff TM, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-11; YAMAMOTO H, 1992, J NEUROCHEM, V58, P1110, DOI 10.1111/j.1471-4159.1992.tb09369.x; Yasuda R, 2006, NAT NEUROSCI, V9, P283, DOI 10.1038/nn1635; Zalewska T, 1996, NEUROREPORT, V7, P637, DOI 10.1097/00001756-199601310-00062; Zhang YL, 1999, J NEUROSCI, V19, P3307; Zhou XJ, 2012, J NEUROCHEM, V122, P295, DOI 10.1111/j.1471-4159.2012.07787.x	76	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0120881	10.1371/journal.pone.0120881	http://dx.doi.org/10.1371/journal.pone.0120881			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25793533	Green Published, gold			2022-12-27	WOS:000352083900086
J	Rahman, S; Rehman, MT; Singh, LR; Warepam, M; Ahmad, F; Dar, TA				Rahman, Safikur; Rehman, Md Tabish; Singh, Laishram R.; Warepam, Marina; Ahmad, Faizan; Dar, Tanveer Ali			Salt Potentiates Methylamine Counteraction System to Offset the Deleterious Effects of Urea on Protein Stability and Function	PLOS ONE			English	Article							TRIMETHYLAMINE-N-OXIDE; ELASMOBRANCH FISHES; OSMOLYTE; WATER; MECHANISM; LYSOZYME; SOLUTES; STRESS; KIDNEY; CELLS	Cellular methylamines are osmolytes (low molecular weight organic compounds) believed to offset the urea's harmful effects on the stability and function of proteins in mammalian kidney and marine invertebrates. Although urea and methylamines are found at 2: 1 molar ratio in tissues, their opposing effects on protein structure and function have been questioned on several grounds including failure to counteraction or partial counteraction. Here we investigated the possible involvement of cellular salt, NaCl, in ureamethylamine counteraction on protein stability and function. We found that NaCl mediates methylamine counteracting system from no or partial counteraction to complete counteraction of urea's effect on protein stability and function. These conclusions were drawn from the systematic thermodynamic stability and functional activity measurements of lysozyme and RNaseA. Our results revealed that salts might be involved in protein interaction with charged osmolytes and hence in the ureamethylamine counteraction.	[Rahman, Safikur; Rehman, Md Tabish; Ahmad, Faizan] Jamia Millia Islamia, Ctr Interdisciplinary Res Basic Sci, New Delhi 110025, India; [Singh, Laishram R.; Warepam, Marina] Univ Delhi, Dr BR Ambedkar Ctr Biomed Res, Delhi 110007, India; [Dar, Tanveer Ali] Univ Kashmir, Clin Biochem, Srinagar 190006, Jammu & Kashmir, India	Jamia Millia Islamia; University of Delhi; University of Kashmir	Dar, TA (corresponding author), Univ Kashmir, Clin Biochem, Srinagar 190006, Jammu & Kashmir, India.	tanveerali@kashmiruniversity.ac.in	Rahman, Safikur/K-1264-2019; Dar, Tanveer/F-3738-2019; Rehman, Md Tabish/AAC-8512-2019; Ahmad, Faizan/AGH-4493-2022; REHMAN, TABISH/H-8471-2012	Rahman, Safikur/0000-0002-6282-8706; Dar, Tanveer/0000-0002-1574-9036; Rehman, Md Tabish/0000-0003-2341-900X; Ahmad, Faizan/0000-0001-7021-7502; REHMAN, TABISH/0000-0003-2341-900X	Department of Science and Technology (DST); Council of Scientific and Industrial Research (India)	Department of Science and Technology (DST)(Department of Science & Technology (India)); Council of Scientific and Industrial Research (India)(Council of Scientific & Industrial Research (CSIR) - India)	The authors thank Department of Science and Technology (DST) and Council of Scientific and Industrial Research (India) for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldwin RL, 1996, BIOPHYS J, V71, P2056, DOI 10.1016/S0006-3495(96)79404-3; Baskakov I, 1998, J BIOL CHEM, V273, P4831, DOI 10.1074/jbc.273.9.4831; Baskakov I, 1998, BIOPHYS J, V74, P2666, DOI 10.1016/S0006-3495(98)77972-X; BECK F, 1984, KIDNEY INT, V25, P397, DOI 10.1038/ki.1984.30; BIGELOW C C, 1960, C R Trav Lab Carlsberg, V31, P305; BULGER RE, 1981, J CELL BIOL, V88, P274, DOI 10.1083/jcb.88.2.274; HAMAGUCHI K, 1963, J BIOCHEM-TOKYO, V54, P111; Haque I, 2005, FEBS LETT, V579, P3891, DOI 10.1016/j.febslet.2005.06.005; HAUSSINGER D, 1992, TRENDS PHARMACOL SCI, V13, P371, DOI 10.1016/0165-6147(92)90114-L; LIN TY, 1994, BIOCHEMISTRY-US, V33, P12695, DOI 10.1021/bi00208a021; MASHINO T, 1987, ARCH BIOCHEM BIOPHYS, V258, P356, DOI 10.1016/0003-9861(87)90355-9; MAUREL P, 1976, J MOL BIOL, V102, P253, DOI 10.1016/S0022-2836(76)80052-6; Muller E, 1998, PFLUG ARCH EUR J PHY, V435, P705, DOI 10.1007/s004240050572; Neuhofer W, 2005, ANNU REV PHYSIOL, V67, P531, DOI 10.1146/annurev.physiol.67.031103.154456; NOZAKI Y, 1963, J BIOL CHEM, V238, P4074; PANG PKT, 1977, AM ZOOL, V17, P365; Perlman D.F., 1988, P253; Prosser, 1973, COMP ANIMAL PHYSL, P966; Prosser C.L., 1961, COMP ANIMAL PHYSL; Scaloni F, 2009, FASEB J, V23, P2360, DOI 10.1096/fj.08-128306; SCHELLMAN JA, 1987, ANNU REV BIOPHYS BIO, V16, P115, DOI 10.1146/annurev.bb.16.060187.000555; Schmidt-Nielsen K, 1997, ANIMAL PHYSL ADAPTAT; Singh LR, 2009, J BIOSCIENCES, V34, P321, DOI 10.1007/s12038-009-0036-0; Singh LR, 2007, BBA-PROTEINS PROTEOM, V1774, P1555, DOI 10.1016/j.bbapap.2007.09.006; Singh R, 2005, J BIOL CHEM, V280, P11035, DOI 10.1074/jbc.M410716200; Sinha A, 2000, BIOCHEM J, V345, P711, DOI 10.1042/0264-6021:3450711; Timasheff SN, 2002, P NATL ACAD SCI USA, V99, P9721, DOI 10.1073/pnas.122225399; TIMASHEFF SN, 1993, ANNU REV BIOPH BIOM, V22, P67, DOI 10.1146/annurev.bb.22.060193.000435; Von Hippel PH, 1969, STRUCTURE STABILITY, P417; Wang AJ, 1997, BIOCHEMISTRY-US, V36, P9101, DOI 10.1021/bi970247h; WOLFF SD, 1990, ANNU REV PHYSIOL, V52, P727; Yancey Paul H., 2004, Science Progress, V87, P1, DOI 10.3184/003685004783238599; YANCEY PH, 1980, J EXP ZOOL, V212, P205, DOI 10.1002/jez.1402120207; YANCEY PH, 1988, J COMP PHYSIOL B, V158, P369, DOI 10.1007/BF00695336; YANCEY PH, 1979, BIOCHEM J, V183, P317, DOI 10.1042/bj1830317; YANCEY PH, 1982, SCIENCE, V217, P1214, DOI 10.1126/science.7112124; Yancey PH, 2003, BIOLOGIST, V50, P126; Zhang YJ, 2006, CURR OPIN CHEM BIOL, V10, P658, DOI 10.1016/j.cbpa.2006.09.020; Zhang Z, 2000, AM J PHYSIOL-RENAL, V278, pF155, DOI 10.1152/ajprenal.2000.278.1.F155	39	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0119597	10.1371/journal.pone.0119597	http://dx.doi.org/10.1371/journal.pone.0119597			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25793733	Green Submitted, gold, Green Published			2022-12-27	WOS:000352084200099
J	So, SHW; Kwok, NTK				So, Suzanne Ho-Wai; Kwok, Nate Tsz-Kit			Jumping to Conclusions Style along the Continuum of Delusions: Delusion-Prone Individuals Are Not Hastier in Decision Making than Healthy Individuals	PLOS ONE			English	Article							PSYCHOTIC-LIKE EXPERIENCES; GENERAL-POPULATION; TO-CONCLUSIONS; PERSECUTORY DELUSIONS; BELIEF FLEXIBILITY; REASONING BIASES; VIRTUAL-REALITY; IDEATION; CONVICTION; INVENTORY	Literature comparing 'jumping to conclusions' (JTC) between patients and healthy controls has demonstrated the importance of the reasoning bias in the development of delusions. When groups that vary along the entire delusional continuum are included, the relationship between JTC and delusionality is less clear. This study compared JTC and delusional dimensions between 28 patients with delusions, 35 delusion-prone individuals and 32 non-delusion-prone individuals. Delusion proneness was defined by an established threshold based on the Peters et al. Delusions Inventory. Two versions of the beads task (85: 15 and 60: 40) were used to measure JTC. As hypothesized, patients manifested hastier data gathering than the two non-clinical groups on both beads tasks. However, delusion-prone individuals did not manifest a hastier decision making style than non-delusion prone individuals. Instead, non-delusion-prone participants showed more JTC bias than delusion-prone individuals on the easier beads task. There was no evidence for a dose-response relationship between JTC and delusional dimensions, with correlations between JTC and PDI scores found in the non-delusion-prone group only. The present finding confirms the link between an extreme JTC bias and the presence of clinical delusions, and argues against a linear relationship between JTC and delusionality along the symptomatic continuum.	[So, Suzanne Ho-Wai; Kwok, Nate Tsz-Kit] Chinese Univ Hong Kong, Dept Psychol, Hong Kong, Hong Kong, Peoples R China	Chinese University of Hong Kong	So, SHW (corresponding author), Chinese Univ Hong Kong, Dept Psychol, Hong Kong, Hong Kong, Peoples R China.	shwso@psy.cuhk.edu.hk		So, Suzanne/0000-0001-8918-7139				Andreasen NC, 2010, BIOL PSYCHIAT, V67, P255, DOI 10.1016/j.biopsych.2009.08.040; Balzan R, 2012, AUST J PSYCHOL, V64, P100, DOI 10.1111/j.1742-9536.2011.00032.x; Balzan RP, 2012, AUST NZ J PSYCHIAT, V46, P532, DOI 10.1177/0004867411435291; Bentall RP, 2009, ARCH GEN PSYCHIAT, V66, P236, DOI 10.1001/archgenpsychiatry.2009.1; CHAPMAN LJ, 1980, SCHIZOPHRENIA BULL, V6, P476, DOI 10.1093/schbul/6.3.476; CLARIDGE G, 1987, BRIT J PSYCHIAT, V151, P735, DOI 10.1192/bjp.151.6.735; Colbert SM, 2010, PSYCHOL PSYCHOTHER-T, V83, P45, DOI 10.1348/147608309X467320; Colbert SM, 2002, J NERV MENT DIS, V190, P27, DOI 10.1097/00005053-200201000-00007; Dudley REJ, 1997, BRIT J CLIN PSYCHOL, V36, P243, DOI 10.1111/j.2044-8260.1997.tb01410.x; Dudley R, 2011, EARLY INTERV PSYCHIA, V5, P50, DOI 10.1111/j.1751-7893.2010.00258.x; Falcone MA, 2014, SCHIZOPHR B; Fine Cordelia, 2007, Cogn Neuropsychiatry, V12, P46, DOI 10.1080/13546800600750597; Freeman D, 2008, SCHIZOPHR RES, V102, P254, DOI 10.1016/j.schres.2008.03.020; Freeman D, 2008, BRIT J PSYCHIAT, V192, P258, DOI 10.1192/bjp.bp.107.044677; Freeman Daniel, 2006, Curr Psychiatry Rep, V8, P191, DOI 10.1007/s11920-006-0023-1; Freeman D, 2014, SOC PSYCH PSYCH EPID, V49, P1179, DOI 10.1007/s00127-014-0928-7; Freeman D, 2010, J ABNORM PSYCHOL, V119, P83, DOI 10.1037/a0017514; Garety PA, 2013, BRIT J PSYCHIAT, V203, P327, DOI 10.1192/bjp.bp.113.126953; Garety PA, 2005, J ABNORM PSYCHOL, V114, P373, DOI 10.1037/0021-843X.114.3.373; Garety PA, 1999, BRIT J CLIN PSYCHOL, V38, P113, DOI 10.1348/014466599162700; GARETY PA, 1991, J NERV MENT DIS, V179, P194, DOI 10.1097/00005053-199104000-00003; Green CEL, 2008, PSYCHOL MED, V38, P101, DOI 10.1017/S0033291707001638; HUQ SF, 1988, Q J EXP PSYCHOL-A, V40, P801, DOI 10.1080/14640748808402300; Johns LC, 2001, CLIN PSYCHOL REV, V21, P1125, DOI 10.1016/S0272-7358(01)00103-9; Kao YC, 2012, SOC PSYCH PSYCH EPID, V47, P1221, DOI 10.1007/s00127-011-0428-y; Kay SR, 1987, POSITIVE AND NEGATIV; Kelleher I, 2011, PSYCHOL MED, V41, P1, DOI 10.1017/S0033291710001005; Lim MH, 2012, J NERV MENT DIS, V200, P868, DOI 10.1097/NMD.0b013e31826b6eb4; Mckay R, 2006, J NERV MENT DIS, V194, P422, DOI 10.1097/01.nmd.0000221353.44132.25; Menon M, 2013, EUR PSYCHIAT, V28, P71, DOI 10.1016/j.eurpsy.2011.03.005; Moritz S, 2014, CLIN PSYCHOL REV, V34, P358, DOI 10.1016/j.cpr.2014.04.004; Myin-Germeys I, 2003, CURR OPIN PSYCHIATR, V16, P443, DOI 10.1097/01.yco.0000079208.36371.cd; Peters E, 2004, SCHIZOPHRENIA BULL, V30, P1005, DOI 10.1093/oxfordjournals.schbul.a007116; Peters E, 1999, BRIT J CLIN PSYCHOL, V38, P83, DOI 10.1348/014466599162683; Peters ER, 1999, SCHIZOPHRENIA BULL, V25, P553, DOI 10.1093/oxfordjournals.schbul.a033401; Preti A, 2007, COMPR PSYCHIAT, V48, P62, DOI 10.1016/j.comppsych.2006.05.003; Rodier M, 2011, PSYCHIAT RES, V189, P433, DOI 10.1016/j.psychres.2011.06.018; Ross K, 2011, SCHIZOPHRENIA BULL, V37, P324, DOI 10.1093/schbul/sbn165; Sisti D, 2012, COMPR PSYCHIAT, V53, P1039, DOI 10.1016/j.comppsych.2012.02.005; So SH, 2012, J ABNORM PSYCHOL, V121, P129, DOI 10.1037/a0025297; So SHW, 2008, AUST NZ J PSYCHIAT, V42, P879, DOI 10.1080/00048670802345466; Startup H, 2008, EUR PSYCHIAT, V23, P457, DOI 10.1016/j.eurpsy.2008.04.005; Stefanis NC, 2002, PSYCHOL MED, V32, P347, DOI 10.1017/S0033291701005141; STRAUSS JS, 1969, ARCH GEN PSYCHIAT, V21, P581; Taylor HE, 2014, EARLY INTERV PSYCHIA, V8, P221, DOI 10.1111/eip.12064; Van Dael F, 2006, SCHIZOPHRENIA BULL, V32, P341, DOI 10.1093/schbul/sbj021; van Os J, 2001, ARCH GEN PSYCHIAT, V58, P663, DOI 10.1001/archpsyc.58.7.663; van Os J, 2000, SCHIZOPHR RES, V45, P11, DOI 10.1016/S0920-9964(99)00224-8; van Os J, 2009, PSYCHOL MED, V39, P179, DOI 10.1017/S0033291708003814; Verdoux H, 2002, SCHIZOPHR RES, V54, P59, DOI 10.1016/S0920-9964(01)00352-8; Waller H, 2011, J BEHAV THER EXP PSY, V42, P414, DOI 10.1016/j.jbtep.2011.03.001; Warman DM, 2008, J NERV MENT DIS, V196, P9, DOI 10.1097/NMD.0b013e3181601141; Warman DM, 2007, BEHAV RES THER, V45, P1255, DOI 10.1016/j.brat.2006.09.002; Warman DM, 2006, J NERV MENT DIS, V194, P760, DOI 10.1097/01.nmd.0000239907.83668.aa; White LO, 2009, CLIN PSYCHOL PSYCHOT, V16, P111, DOI 10.1002/cpp.607; Woods SW, 2003, J CLIN PSYCHIAT, V64, P663, DOI 10.4088/JCP.v64n0607; Ziegler M, 2008, PSYCHOL PSYCHOTHER-T, V81, P237, DOI 10.1348/147608308X297104	57	13	15	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0121347	10.1371/journal.pone.0121347	http://dx.doi.org/10.1371/journal.pone.0121347			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CE8HY	25793772	Green Submitted, gold, Green Published			2022-12-27	WOS:000352083900125
J	Tschinkel, WR				Tschinkel, Walter R.			Biomantling and Bioturbation by Colonies of the Florida Harvester Ant, Pogonomyrmex badius	PLOS ONE			English	Article							NEST ARCHITECTURE; SOIL; HYMENOPTERA; FORMICIDAE; TRANSPORT; SOCIOGENESIS; SOCIOMETRY; AUSTRALIA; ECOLOGY	In much of the world, soil-nesting ants are among the leading agents of biomantling and bioturbation, depositing excavated soil on the surface or in underground chambers. Colonies of the Florida harvester ant, Pogonomyrmex badius excavate a new nest once a year on average, depositing 0.1 to 12 L (3 L average) of soil on the surface. Repeated surveys of a population of about 400 colonies yielded the frequency of moves (approximately once per year), the distance moved (mean 4 m), and the direction moved (random). The area of the soil disc correlated well with the volume and maximum depth of the nest, as determined by excavation and mapping of chambers. The population-wide frequency distribution of disc areas thus yielded the frequency distribution of nest volumes and maximum depths. For each surveyed colony, the volume of soil excavated from six specified depth ranges and deposited on the surface was estimated. These parameters were used in a simulation to estimate the amount of soil mantled over time by the observed population of P. badius colonies. Spread evenly, P. badius mantling would create a soil layer averaging 0.43 cm thick in a millennium, with 10-15% of the soil deriving from depths greater than 1 m. Biomantling by P. badius is discussed in the context of the ant community of which it is a part, and in relation to literature reports of ant biomantling.	Florida State Univ, Dept Biol Sci, Tallahassee, FL 32306 USA	State University System of Florida; Florida State University	Tschinkel, WR (corresponding author), Florida State Univ, Dept Biol Sci, B-157, Tallahassee, FL 32306 USA.	tschinkel@bio.fsu.edu			National Science Foundation [IOS-1021632]	National Science Foundation(National Science Foundation (NSF))	This work was funded by National Science Foundation grant number IOS-1021632. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAXTER FP, 1967, SOIL SCI SOC AM PRO, V31, P425, DOI 10.2136/sssaj1967.03615995003100030036x; Borojevic K, 2011, J ARCHAEOL SCI, V38, P829, DOI 10.1016/j.jas.2010.11.005; BRIESE DT, 1982, INSECT SOC, V29, P375, DOI 10.1007/BF02228765; Cerda A, 2008, J APPL ENTOMOL, V132, P306, DOI 10.1111/j.1439-0418.2008.01267.x; Cole BJ, 1999, SCIENCE, V285, P891, DOI 10.1126/science.285.5429.891; Darwin C, 1881, FORMATION VEGETABLE, DOI DOI 10.1017/CBO9780511703850; DEBRUYN LAL, 1994, AUST J SOIL RES, V32, P555, DOI 10.1071/SR9940555; Dorn RI, 2014, GEOLOGY, V42, P771, DOI 10.1130/G35825.1; Eldridge DJ, 2012, P LINN SOC N S W, V134, pA11; ELDRIDGE DJ, 1994, AUST J SOIL RES, V32, P323, DOI 10.1071/SR9940323; Folgarait PJ, 1998, BIODIVERS CONSERV, V7, P1221, DOI 10.1023/A:1008891901953; Gabet EJ, 2003, ANNU REV EARTH PL SC, V31, P249, DOI 10.1146/annurev.earth.31.100901.141314; Gabet EJ, 2000, EARTH SURF PROC LAND, V25, P1419, DOI 10.1002/1096-9837(200012)25:13&lt;1419::AID-ESP148&gt;3.0.CO;2-1; Halfen AF, 2010, 19 WORLD C SOIL SCI; Halfen AF, 2010, PALAIOS, V25, P703, DOI 10.2110/palo.2010.p10-005r; Hembree DI, 2008, PALAEOGEOGR PALAEOCL, V270, P349, DOI 10.1016/j.palaeo.2008.07.019; Humphreys G.S., 1998, 16 WORLD C SOIL SCI; JOHNSON DL, 1990, SOIL SCI, V149, P84, DOI 10.1097/00010694-199002000-00004; Johnson DL, 2010, 19 WORLD C SOIL SCI; Johnson RA, 2000, SOCIOBIOLOGY, V36, P89; KACZOR SA, 1990, AM MIDL NAT, V123, P100, DOI 10.2307/2425763; Keeler K, 1993, SW NAT, V38, P1229; King JR, 2008, P NATL ACAD SCI USA, V105, P20339, DOI 10.1073/pnas.0809423105; McGlynn TP, 2012, ANNU REV ENTOMOL, V57, P291, DOI 10.1146/annurev-ento-120710-100708; Meysman FJR, 2006, TRENDS ECOL EVOL, V21, P688, DOI 10.1016/j.tree.2006.08.002; Moser JC, 2006, ANN ENTOMOL SOC AM, V99, P891, DOI 10.1603/0013-8746(2006)99[891:CEAMOA]2.0.CO;2; Nkem JN, 2000, PEDOBIOLOGIA, V44, P609, DOI 10.1078/S0031-4056(04)70075-X; Persson T, 2007, R06123 SWED NUCL FUE; Phillips JD, 2007, CATENA, V70, P92, DOI 10.1016/j.catena.2006.08.002; PORTER SD, 1988, J RANGE MANAGE, V41, P104, DOI 10.2307/3898942; Richards PJ, 2011, EARTH SURF PROC LAND, V36, P1240, DOI 10.1002/esp.2149; Richards PJ, 2010, EARTH SURF PROC LAND, V35, P856, DOI 10.1002/esp.2007; Richards PJ, 2009, EARTH-SCI REV, V96, P92, DOI 10.1016/j.earscirev.2009.06.004; Rink WJ, 2013, J ARCHAEOL SCI, V40, P2217, DOI 10.1016/j.jas.2012.11.006; Robins R, 2011, ENVIRON ARCHAEOL, V16, P151, DOI 10.1179/174963111X13110803261010; Rodrigues K., 2013, THESIS MCMASTER U FL; Seal JN, 2006, ANN ENTOMOL SOC AM, V99, P673, DOI 10.1603/0013-8746(2006)99[673:CPOTFA]2.0.CO;2; Smith CR, 2007, ECOL ENTOMOL, V32, P105, DOI 10.1111/j.1365-2311.2006.00845.x; Tschinkel WR, 2012, J INSECT SCI, V12, P1, DOI 10.1673/031.012.11401; Tschinkel WR, 1999, ANN ENTOMOL SOC AM, V92, P80, DOI 10.1093/aesa/92.1.80; TSCHINKEL WR, 1993, ECOL MONOGR, V63, P425, DOI 10.2307/2937154; Tschinkel WR, 2004, J INSECT SCI, V4, DOI 10.1093/jis/4.1.21; Tschinkel WR, 2005, J INSECT SCI, V5, DOI 10.1093/jis/5.1.9; Tschinkel WR, 2003, PALAEOGEOGR PALAEOCL, V192, P321, DOI 10.1016/S0031-0182(02)00690-9; Tschinkel WR, 2014, PLOSONE IN PRESS; Whitford WG, 2000, INVERTEBRATES AS WEB-MASTERS IN ECOSYSTEMS, P25, DOI 10.1079/9780851993942.0025; Wilkinson MT, 2009, EARTH-SCI REV, V97, P257, DOI 10.1016/j.earscirev.2009.09.005	47	16	16	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0120407	10.1371/journal.pone.0120407	http://dx.doi.org/10.1371/journal.pone.0120407			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25794047	gold, Green Published, Green Submitted			2022-12-27	WOS:000352083900028
J	Choi, JE; Kwon, JH; Kim, JH; Hur, W; Sung, PS; Choi, SW; Yoon, SK				Choi, Jung Eun; Kwon, Jung Hyun; Kim, Jung-Hee; Hur, Wonhee; Sung, Pil Soo; Choi, Sang Wook; Yoon, Seung Kew			Suppression of Dual Specificity Phosphatase I Expression Inhibits Hepatitis C Virus Replication	PLOS ONE			English	Article							RIBAVIRIN COMBINATION THERAPY; PLUS RIBAVIRIN; UP-REGULATION; INTERFERON; HCV; SOFOSBUVIR; LEDIPASVIR; PREDICT	It was reported that dual specificity phosphatase 1 (DUSP1) is specifically upregulated in the liver of patients with chronic hetpatitis C virus (HCV) infection who do not respond to peginterferon (PegIFN) treatment. Here, we have investigated the role of DUSP1 in HCV replication in hepatoma cells stably expressing the full HCV replicon (FK). DUSP1 was silenced in cells harboring the FK replicon using a lentiviral vector encoding a DUSP1-specific short hairpin RNA (LV-shDUSP1). We demonstrated that knock-down of DUSP1 significantly inhibited HCV RNA and protein expression. Also, DUSP1 silencing enhanced the expression of phosphorylated signal transducer and activator of transcription 1 (phosho-STAT1) and facilitated the translocation of STAT1 into the nucleus. The mRNA expression levels of myxovirus resistance protein A (MxA), 2'-5'-oligoadenylate synthetase 1 (OAS1), ISG15 ubiquitin-like modifier (ISG15), chemokine C-X-C motif ligand 10 (CXCL10), and ubiquitin-specific protease 18 (USP18) were also accelerated by silencing of DUSP1. Furthermore, combined with the IFN treatment, DUSP1 silencing synergistically decreased the levels of HCV RNA. These results suggest that suppression of DUSP1 expression enhances phosphorylation and nuclear translocation of STAT1, resulting in increasing expression of interferon-stimulated genes (ISGs), which synergizes with IFN's antiviral effect against HCV. In conclusion, DUSP1 is involved in the antiviral host defense mechanism against a HCV infection and thus DUSP1 might be a target to treat chronic HCV infection.	[Choi, Jung Eun; Kwon, Jung Hyun; Kim, Jung-Hee; Hur, Wonhee; Choi, Sang Wook; Yoon, Seung Kew] Catholic Univ Korea, Catholic Univ Liver Res Ctr, Seoul, South Korea; [Choi, Jung Eun; Kwon, Jung Hyun; Kim, Jung-Hee; Hur, Wonhee; Choi, Sang Wook; Yoon, Seung Kew] Catholic Univ Korea, WHO Collaborating Ctr Hepatitis, Seoul, South Korea; [Kwon, Jung Hyun] Catholic Univ Korea, Dept Internal Med, Incheon St Marys Hosp, Incheon, South Korea; [Sung, Pil Soo] Korea Adv Inst Sci & Technol, Grad Sch Med Sci & Engn, Lab Immunol & Infect Dis, Taejon 305701, South Korea; [Choi, Sang Wook] Catholic Univ Korea, St Paul Hosp, Dept Internal Med, Seoul, South Korea; [Yoon, Seung Kew] Catholic Univ Korea, Seoul St Marys Hosp, Dept Internal Med, Seoul, South Korea	Catholic University of Korea; Catholic University of Korea; Catholic University of Korea; Korea Advanced Institute of Science & Technology (KAIST); Catholic University of Korea; Catholic University of Korea; Seoul St. Mary's Hospital	Yoon, SK (corresponding author), Catholic Univ Korea, Catholic Univ Liver Res Ctr, Seoul, South Korea.	yoonsk@catholic.ac.kr	Sung, Pil Soo/AAD-6344-2021; Sung, Pil Soo/K-2072-2019	Sung, Pil Soo/0000-0002-5780-9607; 	Ministry of Science, ICT and Basic Science Research Program [NRF-2013M3A9C4078136, NRF-2012R1A2A1A01001941]; Future Planning through the National Research Foundation	Ministry of Science, ICT and Basic Science Research Program; Future Planning through the National Research Foundation(National Research Foundation of Korea)	This research was supported by grants of Bio-Synergy Research Project (NRF-2013M3A9C4078136) of the Ministry of Science, ICT and Basic Science Research Program (NRF-2012R1A2A1A01001941) and Future Planning through the National Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afdhal N, 2014, NEW ENGL J MED, V370, P1889, DOI 10.1056/NEJMoa1402454; Afdhal N, 2014, NEW ENGL J MED, V370, P1483, DOI 10.1056/NEJMoa1316366; Ajakaiye MA, 2011, BIOCHEM BIOPH RES CO, V409, P406, DOI 10.1016/j.bbrc.2011.05.007; Asselah T, 2008, GUT, V57, P516, DOI 10.1136/gut.2007.128611; Chen LM, 2005, GASTROENTEROLOGY, V128, P1437, DOI 10.1053/j.gastro.2005.01.059; Choi JE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091958; Choi JE, 2011, CANCER LETT, V303, P99, DOI 10.1016/j.canlet.2011.01.015; Duong FHT, 2004, GASTROENTEROLOGY, V126, P263, DOI 10.1053/j.gastro.2003.10.076; Fried MW, 2002, NEW ENGL J MED, V347, P975, DOI 10.1056/NEJMoa020047; Hadziyannis SJ, 2004, ANN INTERN MED, V140, P346, DOI 10.7326/0003-4819-140-5-200403020-00010; HEIM MH, 1995, SCIENCE, V267, P1347, DOI 10.1126/science.7871432; Janssen HLA, 2013, NEW ENGL J MED, V368, P1685, DOI 10.1056/NEJMoa1209026; Lawitz E, 2011, ANTIVIR RES, V89, P238, DOI 10.1016/j.antiviral.2011.01.003; Leelawat K, 2010, J CANCER RES CLIN, V136, P1537, DOI 10.1007/s00432-010-0811-1; Lempicki RA, 2006, J INFECT DIS, V193, P1172, DOI 10.1086/501365; Liu DX, 2002, BIOCHEM BIOPH RES CO, V299, P574, DOI 10.1016/S0006-291X(02)02694-3; Lok AS, 2014, J HEPATOL, V60, P490, DOI 10.1016/j.jhep.2013.10.019; Manns MP, 2001, LANCET, V358, P958, DOI 10.1016/S0140-6736(01)06102-5; Patterson KI, 2009, BIOCHEM J, V418, P475, DOI 10.1042/BJ20082234; Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604; Randall G, 2006, GASTROENTEROLOGY, V131, P1584, DOI 10.1053/j.gastro.2006.08.043; Sadler AJ, 2008, NAT REV IMMUNOL, V8, P559, DOI 10.1038/nri2314; Schneider MD, 2014, ANTIVIR RES, V105, P64, DOI 10.1016/j.antiviral.2014.02.011; Suppiah V, 2009, NAT GENET, V41, P1100, DOI 10.1038/ng.447; Tanaka Y, 2009, NAT GENET, V41, P1105, DOI 10.1038/ng.449; Zeisel MB, 2013, J HEPATOL, V58, P375, DOI 10.1016/j.jhep.2012.09.022; Zhang YL, 2009, J BIOL CHEM, V284, P30815, DOI 10.1074/jbc.M109.052472	27	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0119172	10.1371/journal.pone.0119172	http://dx.doi.org/10.1371/journal.pone.0119172			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25798824	Green Published, Green Submitted, gold			2022-12-27	WOS:000351987300034
J	Dalton, DL; Linden, B; Wimberger, K; Nupen, LJ; Tordiffe, ASW; Taylor, PJ; Madisha, MT; Kotze, A				Dalton, Desire L.; Linden, Birthe; Wimberger, Kirsten; Nupen, Lisa Jane; Tordiffe, Adrian S. W.; Taylor, Peter John; Madisha, M. Thabang; Kotze, Antoinette			New Insights into Samango Monkey Speciation in South Africa	PLOS ONE			English	Article							CERCOPITHECUS-MITIS; MICROSATELLITE MARKERS; PAPIO-HAMADRYAS; LINKAGE MAP; SOFTWARE; DNA; IDENTIFICATION; CONSERVATION; POLYMORPHISMS; INFERENCE	The samango monkey is South Africa's only exclusively forest dwelling primate and represents the southernmost extent of the range of arboreal guenons in Africa. The main threats to South Africa's forests and thus to the samango are linked to increasing land- use pressure and increasing demands for forest resources, resulting in deforestation, degradation and further fragmentation of irreplaceable habitats. The species belongs to the highly polytypic Cercopithecus nictitans group which is sometimes divided into two species C. mitis and C. albogularis. The number of subspecies of C. albogularis is also under debate and is based only on differences in pelage colouration and thus far no genetic research has been undertaken on South African samango monkey populations. In this study we aim to further clarify the number of samango monkey subspecies, as well as their respective distributions in South Africa by combining molecular, morphometric and pelage data. Overall, our study provides the most comprehensive view to date into the taxonomic description of samango monkeys in South Africa. Our data supports the identification of three distinct genetic entities namely; C. a. labiatus, C. a. erythrarchus and C. a. schwarzi and argues for separate conservation management of the distinct genetic entities defined by this study.	[Dalton, Desire L.; Nupen, Lisa Jane; Tordiffe, Adrian S. W.; Madisha, M. Thabang; Kotze, Antoinette] Natl Zool Gardens South Africa, Pretoria, South Africa; [Dalton, Desire L.; Kotze, Antoinette] Univ Orange Free State, Dept Genet, Bloemfontein, South Africa; [Linden, Birthe] Univ Venda, Sch Math & Nat Sci, Dept Zool, Thohoyandou, South Africa; [Linden, Birthe; Taylor, Peter John] Univ Venda, Sch Math & Nat Sci, SARChI Chair Biodivers Value & Change Vhembe Bios, Thohoyandou, South Africa; [Wimberger, Kirsten] Univ Cape Town, Dept Biol Sci, ZA-7700 Rondebosch, South Africa; [Nupen, Lisa Jane] Univ Cape Town, Dept Biol Sci, Percy FitzPatrick Inst, ZA-7700 Rondebosch, South Africa; [Tordiffe, Adrian S. W.] Univ Pretoria, Fac Vet Sci, Dept Compan Anim Clin Studies, ZA-0110 Onderstepoort, South Africa	National Research Foundation - South Africa; National Zoological Gardens of South Africa; University of the Free State; University of Venda; University of Venda; University of Cape Town; University of Cape Town; University of Pretoria	Dalton, DL (corresponding author), Natl Zool Gardens South Africa, Pretoria, South Africa.	desire@nzg.ac.za	Taylor, Peter/E-8655-2011; Taylor, Peter John/N-3172-2019; Tordiffe, Adrian/T-4517-2017	Taylor, Peter/0000-0001-9048-7366; Tordiffe, Adrian/0000-0001-5416-3153; Nupen, Lisa/0000-0003-1030-6057; Dalton, Desire Lee/0000-0001-5975-6425; Madisha, M. Thabang/0000-0002-7295-9283; Wimberger, Kirsten/0000-0002-8420-0987	National Research Foundation (NRF); Department of Science Technology (DST) through the SARChI Chair on Biodiversity Value Change in the Vhembe Biosphere; NRF; National Zoological Gardens of South Africa (NZG); University of Venda; Ezemvelo KZN Wildlife; Novartis South African Veterinary Foundation Wildlife Research Fund; Primate Conservation Inc; Mazda Wildlife Fund [BD06MZGP]	National Research Foundation (NRF); Department of Science Technology (DST) through the SARChI Chair on Biodiversity Value Change in the Vhembe Biosphere(Department of Science & Technology (India)); NRF; National Zoological Gardens of South Africa (NZG); University of Venda; Ezemvelo KZN Wildlife; Novartis South African Veterinary Foundation Wildlife Research Fund; Primate Conservation Inc; Mazda Wildlife Fund	PJT acknowledges funding from the National Research Foundation (NRF) and Department of Science Technology (DST) through the SARChI Chair on Biodiversity Value Change in the Vhembe Biosphere. DLD, AK and ASWT acknowledge NRF and the National Zoological Gardens of South Africa (NZG) for organizational core grant funding of support of research. BL thanks the University of Venda for research funding for field work. ASWT and KW would like to thank Ezemvelo KZN Wildlife for providing funding for the sample collection at those sites. KW would like to thank Novartis South African Veterinary Foundation Wildlife Research Fund (Grant 13/11/2010), and Primate Conservation Inc, for project funding, and Mazda Wildlife Fund for sponsorship of a research vehicle (Number: BD06MZGP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1847, GOTTINGERSTUDIEN, V1, P595; [Anonymous], 1986, BIOINFORMATICS; Avise John C., 2004, P1; Bayes M. K., 2000, Conservation Genetics, V1, P173, DOI 10.1023/A:1026595324974; Bouckaert R, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003537; Clifford SL, 1999, MOL ECOL, V8, P1556, DOI 10.1046/j.1365-294X.1999.07184.x; CONSTABLE JJ, 1995, NATURE, V373, P393, DOI 10.1038/373393a0; Coote T, 1996, J HERED, V87, P406, DOI 10.1093/oxfordjournals.jhered.a023026; Cotterill FPD, 2014, SYST BIOL, V63, P819, DOI 10.1093/sysbio/syu003; Dandelot P, 1974, MAMMALS AFRICA IDE 3, P1; DEMENOCAL PB, 1995, SCIENCE, V270, P53, DOI 10.1126/science.270.5233.53; DeMenocal PB, 2004, EARTH PLANET SC LETT, V220, P3, DOI 10.1016/S0012-821X(04)00003-2; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Ekernas LS, 2007, ANIM BEHAV, V73, P1009, DOI 10.1016/j.anbehav.2006.11.007; Ely JJ, 1998, INT J PRIMATOL, V19, P255, DOI 10.1023/A:1020379531874; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 1992, WINAMOVA VER 1 55 AN; Friedmann Y, 2004, RED DATA BOOK MAMMAL; Gippoliti S, 2013, HYSTRIX ITA IN PRESS; Gippoliti S, 2012, HYSTRIX, V23, P8, DOI 10.4404/hystrix-23.2-8685; Grobler JP, 2006, ECOLOGICAL ENV ANTRO, V2, P12; Groves C.P., 2005, MAMMAL SPECIES WORLD, P111; Groves C.P., 2001, PRIMATE TAXONOMY; Groves CP, 2013, MAMM BIOL, V78, P7, DOI 10.1016/j.mambio.2012.09.009; Grubb P, 2003, INT J PRIMATOL, V24, P1301, DOI 10.1023/B:IJOP.0000005994.86792.b9; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Hart JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044271; Heller R, 2013, SYST BIOL, V62, P490, DOI 10.1093/sysbio/syt004; HENZI SP, 1987, FOLIA PRIMATOL, V48, P125, DOI 10.1159/000156290; HENZI SP, 1988, INT J PRIMATOL, V9, P479, DOI 10.1007/BF02736221; Hsieh HM, 2001, FORENSIC SCI INT, V122, P7, DOI 10.1016/S0379-0738(01)00403-0; Hudson RR, 1992, MOL BIOL EVOL, V23, P254; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Kayser M, 1996, MOL ECOL, V5, P157, DOI 10.1111/j.1365-294X.1996.tb00302.x; Kingdon J, 2011, KINGDON FIELD GUIDE, V4th; Kingdon J, 2013, KINGDON FIELD GUIDE; LAWES MJ, 1990, J BIOGEOGR, V17, P669, DOI 10.2307/2845148; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Morin PA, 1997, AM J PRIMATOL, V42, P199, DOI 10.1002/(SICI)1098-2345(1997)42:3<199::AID-AJP3>3.0.CO;2-S; Morin PA, 1998, GENOMICS, V53, P12, DOI 10.1006/geno.1998.5460; MORITZ C, 1994, TRENDS ECOL EVOL, V9, P373, DOI 10.1016/0169-5347(94)90057-4; Napier PH, 1981, CATALOGUE PRIMATES 3; Palumbi S.R, 1991, SIMPLE FOOLS GUIDE P; Park SDE, 2001, EXC MICR TOOLK; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Perelygin AA, 1996, CYTOGENET CELL GENET, V75, P207, DOI 10.1159/000134484; Polzin T, 2003, OPER RES LETT, V31, P12, DOI 10.1016/S0167-6377(02)00185-2; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Pritchard JK, 2000, GENETICS, V155, P945; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Roberts A., 1951, MAMMALS S AFRICA; Rogers J, 2000, GENOMICS, V67, P237, DOI 10.1006/geno.2000.6245; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Roos C, 2011, FUTURE TRENDS PRIMAT, P9; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Ruiz-Garcia M, 2007, FOLIA PRIMATOL, V78, P73, DOI 10.1159/000097058; Skinner J.D., 2006, MAMMALS S AFRICAN SU; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Toews DPL, 2012, MOL ECOL, V21, P3907, DOI 10.1111/j.1365-294X.2012.05664.x; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; WEBER JL, 1989, AM J HUM GENET, V44, P388; WERLE E, 1994, NUCLEIC ACIDS RES, V22, P4354, DOI 10.1093/nar/22.20.4354; XIONG B, 1991, GENOME, V34, P306, DOI 10.1139/g91-050; Yan Guangmei, 2011, Nat Biotechnol, V29, P1019, DOI 10.1038/nbt.1992; Zachos FE, 2013, NATURE, V494, P35, DOI 10.1038/494035c; Zachos FE, 2013, MAMM BIOL, V78, P1, DOI 10.1016/j.mambio.2012.07.083; Zhang YW, 2001, CONSERV GENET, V2, P391, DOI 10.1023/A:1012594626095	70	15	15	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0117003	10.1371/journal.pone.0117003	http://dx.doi.org/10.1371/journal.pone.0117003			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25798604	Green Published, gold, Green Submitted			2022-12-27	WOS:000351987300003
J	Kumari, R; Nambiar, M; Shanbagh, S; Raghavan, SC				Kumari, Rupa; Nambiar, Mridula; Shanbagh, Shaika; Raghavan, Sathees C.			Detection of G-Quadruplex DNA Using Primer Extension as a Tool	PLOS ONE			English	Article							MAJOR BREAKPOINT REGION; CHROMOSOMAL TRANSLOCATIONS; THERMOCOCCUS-LITORALIS; STABILITY; POLYMERASE; FRAGILITY; SEQUENCE; CANCER	DNA sequence and structure play a key role in imparting fragility to different regions of the genome. Recent studies have shown that non-B DNA structures play a key role in causing genomic instability, apart from their physiological roles at telomeres and promoters. Structures such as G-quadruplexes, cruciforms, and triplexes have been implicated in making DNA susceptible to breakage, resulting in genomic rearrangements. Hence, techniques that aid in the easy identification of such non-B DNA motifs will prove to be very useful in determining factors responsible for genomic instability. In this study, we provide evidence for the use of primer extension as a sensitive and specific tool to detect such altered DNA structures. We have used the G-quadruplex motif, recently characterized at the BCL2 major breakpoint region as a proof of principle to demonstrate the advantages of the technique. Our results show that pause sites corresponding to the non-B DNA are specific, since they are absent when the G-quadruplex motif is mutated and their positions change in tandem with that of the primers. The efficiency of primer extension pause sites varied according to the concentration of monovalant cations tested, which support G-quadruplex formation. Overall, our results demonstrate that primer extension is a strong in vitro tool to detect non-B DNA structures such as G-quadruplex on a plasmid DNA, which can be further adapted to identify non-B DNA structures, even at the genomic level.	[Kumari, Rupa; Nambiar, Mridula; Shanbagh, Shaika; Raghavan, Sathees C.] Indian Inst Sci, Dept Biochem, Bangalore 560012, Karnataka, India	Indian Institute of Science (IISC) - Bangalore	Raghavan, SC (corresponding author), Indian Inst Sci, Dept Biochem, Bangalore 560012, Karnataka, India.	sathees@biochem.iisc.ernet.in			CSIR, India [37(1400)/10/EMR-II:2010]	CSIR, India(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by grants from CSIR, India [37(1400)/10/EMR-II:2010] to SCR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bacolla A, 2004, J BIOL CHEM, V279, P47411, DOI 10.1074/jbc.R400028200; Bergoglio V, 2013, J CELL BIOL, V201, P395, DOI 10.1083/jcb.201207066; Bochman ML, 2012, NAT REV GENET, V13, P770, DOI 10.1038/nrg3296; FRY M, 1994, P NATL ACAD SCI USA, V91, P4950, DOI 10.1073/pnas.91.11.4950; Gopalakrishnan V, 2012, FUTURE ONCOL, V8, P1121, DOI [10.2217/FON.12.107, 10.2217/fon.12.107]; Han HY, 2000, TRENDS PHARMACOL SCI, V21, P136, DOI 10.1016/S0165-6147(00)01457-7; Han YJ, 2008, MOL CELL BIOL, V28, P863, DOI 10.1128/MCB.00960-07; Hegde ML, 2006, ARCH BIOCHEM BIOPHYS, V449, P143, DOI 10.1016/j.abb.2006.02.018; Huppert JL, 2007, NUCLEIC ACIDS RES, V35, P406, DOI 10.1093/nar/gkl1057; Katapadi VK, 2012, GENOMICS, V100, P72, DOI 10.1016/j.ygeno.2012.05.008; Kejnovska I, 2001, BBA-GEN SUBJECTS, V1527, P73, DOI 10.1016/S0304-4165(01)00150-7; KONG HM, 1993, J BIOL CHEM, V268, P1965; KORSMEYER SJ, 1992, ANNU REV IMMUNOL, V10, P785, DOI 10.1146/annurev.immunol.10.1.785; Kypr J, 2009, NUCLEIC ACIDS RES, V37, P1713, DOI 10.1093/nar/gkp026; Lam EYN, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2792; LUSTIG AJ, 1992, NUCLEIC ACIDS RES, V20, P3021, DOI 10.1093/nar/20.12.3021; MATTILA P, 1991, NUCLEIC ACIDS RES, V19, P4967, DOI 10.1093/nar/19.18.4967; Nambiar M, 2013, MOL CELL BIOL, V33, P4266, DOI 10.1128/MCB.00540-13; Nambiar M, 2013, CELL MOL LIFE SCI, V70, P1381, DOI 10.1007/s00018-012-1135-x; Nambiar M, 2011, NUCLEIC ACIDS RES, V39, P5813, DOI 10.1093/nar/gkr223; Nambiar M, 2011, NUCLEIC ACIDS RES, V39, P936, DOI 10.1093/nar/gkq824; Nambiar M, 2008, BBA-REV CANCER, V1786, P139, DOI 10.1016/j.bbcan.2008.07.005; Nilsen Timothy W, 2013, Cold Spring Harb Protoc, V2013, P1182, DOI 10.1101/pdb.prot079400; Qin Y, 2008, BIOCHIMIE, V90, P1149, DOI 10.1016/j.biochi.2008.02.020; RABBITTS TH, 1994, NATURE, V372, P143, DOI 10.1038/372143a0; Raghavan SC, 2007, FRONT BIOSCI, V12, P4402, DOI 10.2741/2397; Raghavan SC, 2005, MOL CELL BIOL, V25, P5904, DOI 10.1128/MCB.25.14.5904-5919.2005; Raghavan SC, 2004, NATURE, V428, P88, DOI 10.1038/nature02355; Rich A, 2003, NAT REV GENET, V4, P566, DOI 10.1038/nrg1115; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Siddiqui-Jain A, 2002, P NATL ACAD SCI USA, V99, P11593, DOI 10.1073/pnas.182256799; SINDEN R. R., 1994, DNA STRUCTURE FUNCTI; Srivastava M, 2012, CELL, V151, P1474, DOI 10.1016/j.cell.2012.11.054; Vasudevaraju P, 2012, J PHARM BIOALLIED SC, V4, P112, DOI 10.4103/0975-7406.94811; Zhao JH, 2010, CELL MOL LIFE SCI, V67, P43, DOI 10.1007/s00018-009-0131-2	35	15	15	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0119722	10.1371/journal.pone.0119722	http://dx.doi.org/10.1371/journal.pone.0119722			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25799152	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000351987300077
J	Ross, KA; Gashugi, E; Gafasi, A; Wuest, A; Schmid, M				Ross, Kelly Ann; Gashugi, Elisee; Gafasi, Augustin; Wueest, Alfred; Schmid, Martin			Characterisation of the Subaquatic Groundwater Discharge That Maintains the Permanent Stratification within Lake Kivu; East Africa	PLOS ONE			English	Article							LATE PLEISTOCENE; WATER; HOLOCENE	Warm and cold subaquatic groundwater discharge into Lake Kivu forms the large-scale density gradients presently observed in the lake. This structure is pertinent to maintaining the stratification that locks the high volume of gases in the deepwater. Our research presents the first characterisation of these inflows. Temperature and conductivity profiling was conducted from January 2010 to March 2013 to map the locations of groundwater discharge. Water samples were obtained within the lake at the locations of the greatest temperature anomalies observed from the background lake-profile. The isotopic and chemical signatures of the groundwater were applied to assess how these inflows contribute to the overall stratification. It is inferred that Lake Kivu's deepwater has not been completely recharged by the groundwater inflows since its turnover that is speculated to have occurred within the last similar to 1000 yrs. Given a recent salinity increase in the lake constrained to within months of seismic activity measured beneath the basin, it is plausible that increased hydrothermal-groundwater inflows into the deep basin are correlated with episodic geologic events. These results invalidate the simple two-component end-member mixing regime that has been postulated up to now, and indicate the importance of monitoring this potentially explosive lake.	[Ross, Kelly Ann; Wueest, Alfred; Schmid, Martin] Eawag, Dept Surface Waters Res & Management, Swiss Fed Inst Aquat Sci & Technol, Kastanienbaum, Switzerland; [Ross, Kelly Ann] ETH, Inst Biogeochem & Pollutant Dynam, Swiss Fed Inst Technol, Zurich, Switzerland; [Gashugi, Elisee; Gafasi, Augustin] UR CST, Dept Chem, Kigali, Rwanda; [Wueest, Alfred] Ecole Polytech Fed Lausanne, Lab Phys Aquat Syst, CH-1015 Lausanne, Switzerland	Swiss Federal Institutes of Technology Domain; Swiss Federal Institute of Aquatic Science & Technology (EAWAG); Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Schmid, M (corresponding author), Eawag, Dept Surface Waters Res & Management, Swiss Fed Inst Aquat Sci & Technol, Kastanienbaum, Switzerland.	martin.schmid@eawag.ch	Wuest, Alfred/L-2607-2014; Schmid, Martin/C-3953-2009	Wuest, Alfred/0000-0001-7984-0368; Schmid, Martin/0000-0001-8699-5691	Swiss National Science Foundation; Swiss Agency for the Development and Cooperation [IZ70Z0 123923]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss Agency for the Development and Cooperation	This project was financially supported by the Swiss National Science Foundation and the Swiss Agency for the Development and Cooperation under grant IZ70Z0 123923. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaberg AA, 2013, THESIS U MINNESOTA E; Anderson EI, 2008, WATER RESOUR RES, V44, DOI 10.1029/2008WR006925; Ayenew Tenalem, 2008, Lakes & Reservoirs Research and Management, V13, P181, DOI 10.1111/j.1440-1770.2008.00368.x; Bhattarai S, 2012, MICROB ECOL, V64, P291, DOI 10.1007/s00248-012-0034-x; Borges AV, 2012, AQUAT ECOL SER, V5, P47, DOI 10.1007/978-94-007-4243-7_4; Borges AV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109500; BUTTERFIELD DA, 1990, J GEOPHYS RES-SOLID, V95, P12895, DOI 10.1029/JB095iB08p12895; CHEN CTA, 1986, LIMNOL OCEANOGR, V31, P657, DOI 10.4319/lo.1986.31.3.0657; Chiodini G, 2012, B VOLCANOL, V74, P861, DOI 10.1007/s00445-011-0573-x; d'Oreye N, 2011, GEOPHYS J INT, V184, P934, DOI 10.1111/j.1365-246X.2010.04899.x; DEGENS ET, 1973, MINER DEPOSITA, V8, P388; Degens ET, 1973, GEOL RUNDSCH, V62, P245, DOI DOI 10.1007/BF01826830; Freeze R. A., 1977, GROUNDWATER; Gafasi A, 2013, THESIS U RWANDA; HABERYAN KA, 1987, PALAEOGEOGR PALAEOCL, V61, P169, DOI 10.1016/0031-0182(87)90048-4; Holz M, 2000, PHYS CHEM CHEM PHYS, V2, P4740, DOI 10.1039/b005319h; Katsev S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109084; Lorke A, 2004, LIMNOL OCEANOGR, V49, P778, DOI 10.4319/lo.2004.49.3.0778; Morgan LA, 2003, J VOLCANOL GEOTH RES, V122, P221, DOI 10.1016/S0377-0273(02)00503-6; Muvundja FA, 2014, LIMNOLOGICA, V47, P21, DOI 10.1016/j.limno.2014.02.003; Muvundja FA, 2009, J GREAT LAKES RES, V35, P406, DOI 10.1016/j.jglr.2009.06.002; Ohsawa Shinji, 2002, Limnology, V3, P169, DOI 10.1007/s102010200020; Ojiambo SB, 2003, APPL GEOCHEM, V18, P1789, DOI 10.1016/S0883-2927(03)00104-5; Pasche N, 2011, J GEOPHYS RES-BIOGEO, V116, DOI 10.1029/2011JG001690; Pasche N, 2010, J PALEOLIMNOL, V44, P931, DOI 10.1007/s10933-010-9465-x; Pasche N, 2009, LIMNOL OCEANOGR, V54, P1863, DOI 10.4319/lo.2009.54.6.1863; Ross KA, 2015, J PALEOLIMN IN PRESS; Ross KA, 2014, GEOMORPHOLOGY, V221, P274, DOI 10.1016/j.geomorph.2014.05.010; Schmid M, 2005, GEOCHEM GEOPHY GEOSY, V6, DOI 10.1029/2004GC000892; Schmid M, 2012, AQUAT ECOL SER, V5, P13, DOI 10.1007/978-94-007-4243-7_2; Schmid M, 2012, J LIMNOL, V71, P330, DOI 10.4081/jlimnol.2012.e35; Schmid M, 2010, LIMNOL OCEANOGR, V55, P225, DOI 10.4319/lo.2010.55.1.0225; Sommer T, 2014, GEOPHYS RES LETT, V41, P5114, DOI 10.1002/2014GL060716; Stoffers P., 1978, INT ASS SEDIMENTOL S, V2, P43; Takano B, 2008, J VOLCANOL GEOTH RES, V178, P145, DOI 10.1016/j.jvolgeores.2008.06.038; Tassi F, 2009, GEOCHEM GEOPHY GEOSY, V10, DOI 10.1029/2008GC002191; Tierney JE, 2013, NATURE, V493, P389, DOI 10.1038/nature11785; Wauthier C, 2012, J GEOPHYS RES-SOL EA, V117, DOI 10.1029/2011JB008257; Wessel P, 1991, EOS T AM GEOPHYS UN, V72, P445, DOI [10.1029/90EO00319, DOI 10.1029/90EO00319, DOI 10.1029/90E000319]; WUEST A, 1996, LIMNOLOGY CLIMATOLOG, P183; Wuest A., 2009, MODELLING REINJECTIO	41	22	23	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0121217	10.1371/journal.pone.0121217	http://dx.doi.org/10.1371/journal.pone.0121217			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25799098	Green Published, Green Submitted, gold			2022-12-27	WOS:000351987300226
J	Silinski, A; Heuner, M; Schoelynck, J; Puijalon, S; Schroder, U; Fuchs, E; Troch, P; Bouma, TJ; Meire, P; Temmerman, S				Silinski, Alexandra; Heuner, Maike; Schoelynck, Jonas; Puijalon, Sara; Schroeder, Uwe; Fuchs, Elmar; Troch, Peter; Bouma, Tjeerd J.; Meire, Patrick; Temmerman, Stijn			Effects of Wind Waves versus Ship Waves on Tidal Marsh Plants: A Flume Study on Different Life Stages of Scirpus maritimus	PLOS ONE			English	Article							SALT-MARSH; RELATIVE IMPORTANCE; VEGETATION; DISTURBANCE; FEEDBACKS; STIFFNESS; SEDIMENT; SHIFTS; DRAG; FACE	Recent research indicates that many ecosystems, including intertidal marshes, follow the alternative stable states theory. This theory implies that thresholds of environmental factors can mark a limit between two opposing stable ecosystem states, e. g. vegetated marshes and bare mudflats. While elevation relative to mean sea level is considered as the overall threshold condition for colonization of mudflats by vegetation, little is known about the individual driving mechanisms, in particular the impact of waves, and more specifically of wave period. We studied the impact of different wave regimes on plants in a full scale flume experiment. Seedlings and adult shoots of the pioneer Scirpus maritimus were subjected to two wave periods at two water levels. Drag forces acting on, and sediment scouring occurring around the plants were quantified, as these are the two main mechanisms determining plant establishment and survival. Depending on life stage, two distinct survival strategies emerge: seedlings present a stress avoidance strategy by being extremely flexible, thus limiting the drag forces and thereby the risk of breaking. Adult shoots present a stress tolerance strategy by having stiffer stems, which gives them a higher resistance to breaking. These strategies work well under natural, short period wind wave conditions. For long period waves, however, caused e. g. by ships, these survival strategies have a high chance to fail as the flexibility of seedlings and stiffness of adults lead to plant tissue failure and extreme drag forces respectively. This results in both cases in strongly bent plant stems, potentially limiting their survival.	[Silinski, Alexandra; Schoelynck, Jonas; Meire, Patrick; Temmerman, Stijn] Univ Antwerp, Dept Biol, Ecosyst Management Res Grp, B-2020 Antwerp, Belgium; [Heuner, Maike; Schroeder, Uwe; Fuchs, Elmar] Fed Inst Hydrol, Koblenz, Germany; [Puijalon, Sara] Univ Lyon 1, CNRS, ENTPE, UMR 5023,LEHNA, F-69622 Villeurbanne, France; [Troch, Peter] Univ Ghent, Dept Civil Engn, B-9000 Ghent, Belgium; [Bouma, Tjeerd J.] Royal Netherlands Inst Sea Res, Yerseke, Netherlands	University of Antwerp; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Ghent University; Utrecht University; Royal Netherlands Institute for Sea Research (NIOZ)	Silinski, A (corresponding author), Univ Antwerp, Dept Biol, Ecosyst Management Res Grp, B-2020 Antwerp, Belgium.	Alexandra.Silinski@uantwerpen.be	Temmerman, Stijn/C-5521-2009; Troch, Peter/L-2463-2017; Puijalon, Sara/ABA-6520-2020	Troch, Peter/0000-0003-3274-0874; Puijalon, Sara/0000-0002-1942-7958; Bouma, Tjeerd/0000-0001-7824-7546; Schoelynck, Jonas/0000-0003-0166-280X; Temmerman, Stijn/0000-0003-3346-9115	Research Foundation Flanders (FWO) [11E0914N]; FWO Scientific Research Community on "The functioning of river ecosystems through plant-flow-soil interactions" [WO.027.11N]; Port of Antwerp; KLIWAS (Impacts of climate change on waterways and navigation-Searching for options of adaptation)	Research Foundation Flanders (FWO)(FWO); FWO Scientific Research Community on "The functioning of river ecosystems through plant-flow-soil interactions"(FWO); Port of Antwerp; KLIWAS (Impacts of climate change on waterways and navigation-Searching for options of adaptation)	This work was supported by a personal grant of Research Foundation Flanders (FWO, www.fwo.be/), grant number 11E0914N (AS); FWO Scientific Research Community on "The functioning of river ecosystems through plant-flow-soil interactions", grant number WO.027.11N (AS and MH); Port of Antwerp (www.portofantwerp.com) (AS); and KLIWAS (Impacts of climate change on waterways and navigation-Searching for options of adaptation, www.kliwas.de/KLIWAS/EN/) (MH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Augustin LN, 2009, COAST ENG, V56, P332, DOI 10.1016/j.coastaleng.2008.09.004; Bal KD, 2011, FUNCT ECOL, V25, P1197, DOI 10.1111/j.1365-2435.2011.01909.x; Balke T, 2013, BIOGEOSCIENCES, V10, P5411, DOI 10.5194/bg-10-5411-2013; Balke T, 2014, J ECOL, V102, P700, DOI 10.1111/1365-2745.12241; Balke T, 2013, J APPL ECOL, V50, P740, DOI 10.1111/1365-2664.12067; Balke T, 2011, MAR ECOL PROG SER, V440, P1, DOI 10.3354/meps09364; Barbier EB, 2008, SCIENCE, V319, P321, DOI 10.1126/science.1150349; Barbier EB, 2011, ECOL MONOGR, V81, P169, DOI 10.1890/10-1510.1; Bouma TJ, 2013, GEOMORPHOLOGY, V180, P57, DOI 10.1016/j.geomorph.2012.09.005; Bouma TJ, 2009, MAR ECOL PROG SER, V388, P293, DOI 10.3354/meps08130; Bouma TJ, 2009, OIKOS, V118, P260, DOI 10.1111/j.1600-0706.2008.16892.x; Bouma TJ, 2005, ECOLOGY, V86, P2187, DOI 10.1890/04-1588; Callaghan DP, 2010, ESTUAR COAST SHELF S, V89, P73, DOI 10.1016/j.ecss.2010.05.013; Curtiss GM, 2009, MAR GEOL, V259, P73, DOI 10.1016/j.margeo.2008.12.009; Da Lio C, 2013, PHILOS T R SOC A, V371, DOI 10.1098/rsta.2012.0367; Denny MW, 2006, AQUAT ECOL, V40, P439, DOI 10.1007/s10452-004-5409-8; Fagherazzi S, 2012, REV GEOPHYS, V50, DOI 10.1029/2011RG000359; Francalanci S, 2013, GEOMORPHOLOGY, V195, P53, DOI 10.1016/j.geomorph.2013.04.026; Friess DA, 2012, BIOL REV, V87, P346, DOI 10.1111/j.1469-185X.2011.00198.x; Hamann E, 2013, ANN BOT-LONDON, V112, P1869, DOI 10.1093/aob/mct221; Henry PY, 2013, COAST ENG, V78, P13, DOI 10.1016/j.coastaleng.2013.03.004; Houser C, 2010, J COASTAL RES, V26, P230, DOI 10.2112/08-1084.1; Kirwan ML, 2013, NATURE, V504, P53, DOI 10.1038/nature12856; Kirwan ML, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL045489; Marani M, 2010, J GEOPHYS RES-EARTH, V115, DOI 10.1029/2009JF001600; Marani M, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL030178; Mariotti G, 2010, J GEOPHYS RES-EARTH, V115, DOI 10.1029/2009JF001326; McConchie J.A., 2003, J HYDROL, V42, P163; Miler O, 2014, AQUAT SCI, V76, P465, DOI 10.1007/s00027-014-0347-6; Moller I, 2006, ESTUAR COAST SHELF S, V69, P337, DOI 10.1016/j.ecss.2006.05.003; Puijalon S, 2011, NEW PHYTOL, V191, P1141, DOI 10.1111/j.1469-8137.2011.03763.x; Pujol D, 2012, CONT SHELF RES, V49, P1, DOI 10.1016/j.csr.2012.09.004; Sand-Jensen K, 2003, FRESHWATER BIOL, V48, P271, DOI 10.1046/j.1365-2427.2003.00998.x; Temmerman S, 2013, NATURE, V504, P79, DOI 10.1038/nature12859; Temmerman S, 2012, GLOBAL PLANET CHANGE, V92-93, P267, DOI 10.1016/j.gloplacha.2012.06.001; Umeda S, 2011, J COASTAL RES, P845; van de Koppel J, 2005, AM NAT, V165, pE1; van Wesenbeeck BK, 2008, ECOSYSTEMS, V11, P1133, DOI 10.1007/s10021-008-9184-6; Wang C, 2013, J GEOPHYS RES-EARTH, V118, P229, DOI 10.1029/2012JF002474	39	50	55	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0118687	10.1371/journal.pone.0118687	http://dx.doi.org/10.1371/journal.pone.0118687			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25799017	Green Published, Green Submitted, gold			2022-12-27	WOS:000351987300015
J	van der Zwaluw, K; de Haan, A; Pluister, GN; Bootsma, HJ; de Neeling, AJ; Schouls, LM				van der Zwaluw, Kim; de Haan, Angela; Pluister, Gerlinde N.; Bootsma, Hester J.; de Neeling, Albert J.; Schouls, Leo M.			The Carbapenem Inactivation Method (CIM), a Simple and Low-Cost Alternative for the Carba NP Test to Assess Phenotypic Carbapenemase Activity in Gram-Negative Rods	PLOS ONE			English	Article							DESORPTION IONIZATION-TIME; FLIGHT MASS-SPECTROMETRY; BETA-LACTAMASE GENE; RAPID DETECTION; MULTIPLEX PCR; KLEBSIELLA-PNEUMONIAE; ENTEROBACTERIACEAE; RESISTANCE; ACINETOBACTER; PSEUDOMONAS	A new phenotypic test, called the Carbapenem Inactivation Method (CIM), was developed to detect carbapenemase activity in Gram-negative rods within eight hours. This method showed high concordance with results obtained by PCR to detect genes coding for the carbapenemases KPC, NDM, OXA-48, VIM, IMP and OXA-23. It allows reliable detection of carbapenemase activity encoded by various genes in species of Enterobacteriaceae (e.g., Klebsiella pneumoniae, Escherichia coli and Enterobacter cloacae), but also in non-fermenters Pseudomonas aeruginosa and Acinetobacter baumannii. The CIM was shown to be a cost-effective and highly robust phenotypic screening method that can reliably detect carbapenemase activity.	[van der Zwaluw, Kim; de Haan, Angela; Pluister, Gerlinde N.; Bootsma, Hester J.; de Neeling, Albert J.; Schouls, Leo M.] Natl Inst Publ Hlth & Environm RIVM, Ctr Infect Dis Res Diagnost & Screening IDS, Bilthoven, Netherlands	Netherlands National Institute for Public Health & the Environment	van der Zwaluw, K (corresponding author), Natl Inst Publ Hlth & Environm RIVM, Ctr Infect Dis Res Diagnost & Screening IDS, Bilthoven, Netherlands.	Kim.van.der.Zwaluw@rivm.nl		de Haan, Angela/0000-0003-1916-1835; de Neeling, Albert Johannes/0000-0001-8578-1990				Anthony RM, 2000, J CLIN MICROBIOL, V38, P781, DOI 10.1128/JCM.38.2.781-788.2000; Burckhardt I, 2011, J CLIN MICROBIOL, V49, P3321, DOI 10.1128/JCM.00287-11; Carattoli A, 2013, INT J MED MICROBIOL, V303, P298, DOI 10.1016/j.ijmm.2013.02.001; COLLIS CM, 1995, ANTIMICROB AGENTS CH, V39, P155, DOI 10.1128/AAC.39.1.155; Dallenne C, 2010, J ANTIMICROB CHEMOTH, V65, P490, DOI 10.1093/jac/dkp498; Dortet L, 2014, J CLIN MICROBIOL, V52, P2359, DOI 10.1128/JCM.00594-14; Dortet L, 2014, J MED MICROBIOL, V63, P772, DOI 10.1099/jmm.0.071340-0; Dortet L, 2012, J CLIN MICROBIOL, V50, P3773, DOI 10.1128/JCM.01597-12; El Salabi A, 2013, CRIT REV MICROBIOL, V39, P113, DOI 10.3109/1040841X.2012.691870; Hrabak J, 2011, J CLIN MICROBIOL, V49, P3222, DOI 10.1128/JCM.00984-11; Jacoby GA, 2004, ANTIMICROB AGENTS CH, V48, P3203, DOI 10.1128/AAC.48.8.3203-3206.2004; Karah N, 2012, DRUG RESIST UPDATE, V15, P237, DOI 10.1016/j.drup.2012.06.001; Kempf M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031676; Knox J, 2014, J CLIN MICROBIOL, V52, P4075, DOI 10.1128/JCM.02121-14; Lauretti L, 1999, ANTIMICROB AGENTS CH, V43, P1584, DOI 10.1128/AAC.43.7.1584; Livermore DM, 2012, KOREAN J INTERN MED, V27, P128, DOI 10.3904/kjim.2012.27.2.128; Livermore DM, 2001, J ANTIMICROB CHEMOTH, V47, P247, DOI 10.1093/jac/47.3.247; MASUDA G, 1976, J ANTIBIOT, V29, P662, DOI 10.7164/antibiotics.29.662; Miriagou V, 2010, ANTIMICROB AGENTS CH, V54, P4497, DOI 10.1128/AAC.00665-10; Nordmann P, 2014, MED MALADIES INFECT, V44, P51, DOI 10.1016/j.medmal.2013.11.007; Nordmann P, 2012, EMERG INFECT DIS, V18, P1503, DOI 10.3201/eid1809.120355; Papagiannitsis CC, 2012, ANTIMICROB AGENTS CH, V56, P4024, DOI 10.1128/AAC.00470-12; Poirel L, 2011, DIAGN MICR INFEC DIS, V70, P119, DOI 10.1016/j.diagmicrobio.2010.12.002; Tijet Nathalie, 2013, Antimicrob Agents Chemother, V57, P4578, DOI 10.1128/AAC.00878-13; Vardakas KZ, 2012, J ANTIMICROB CHEMOTH, V67, P2793, DOI 10.1093/jac/dks301; Woodford N, 2006, INT J ANTIMICROB AG, V27, P351, DOI 10.1016/j.ijantimicag.2006.01.004; Zhao WH, 2011, CRIT REV MICROBIOL, V37, P214, DOI 10.3109/1040841X.2011.559944	27	233	246	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0123690	10.1371/journal.pone.0123690	http://dx.doi.org/10.1371/journal.pone.0123690			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25798828	Green Submitted, gold, Green Published			2022-12-27	WOS:000351987300344
J	Zhu, YH; He, ZJ; Chen, SJ				Zhu, Yuhong; He, Zhaojian; Chen, Shi-Jie			TBI Server: A Web Server for Predicting Ion Effects in RNA Folding	PLOS ONE			English	Article							TERTIARY STRUCTURE; HELIX STABILITY; BINDING; POLYELECTROLYTE; DEPENDENCE; VALENCE; CHAIN; SIZE	Background Metal ions play a critical role in the stabilization of RNA structures. Therefore, accurate prediction of the ion effects in RNA folding can have a far-reaching impact on our understanding of RNA structure and function. Multivalent ions, especially Mg2+, are essential for RNA tertiary structure formation. These ions can possibly become strongly correlated in the close vicinity of RNA surface. Most of the currently available software packages, which have widespread success in predicting ion effects in biomolecular systems, however, do not explicitly account for the ion correlation effect. Therefore, it is important to develop a software package/web server for the prediction of ion electrostatics in RNA folding by including ion correlation effects. Results The TBI web server http://rna.physics.missouri.edu/tbi_index.html provides predictions for the total electrostatic free energy, the different free energy components, and the mean number and the most probable distributions of the bound ions. A novel feature of the TBI server is its ability to account for ion correlation and ion distribution fluctuation effects. Conclusions By accounting for the ion correlation and fluctuation effects, the TBI server is a unique online tool for computing ion-mediated electrostatic properties for given RNA structures. The results can provide important data for in-depth analysis for ion effects in RNA folding including the ion-dependence of folding stability, ion uptake in the folding process, and the interplay between the different energetic components.	[Zhu, Yuhong; He, Zhaojian; Chen, Shi-Jie] Univ Missouri, Dept Phys, Dept Biochem, Columbia, MO 65211 USA; [Zhu, Yuhong; He, Zhaojian; Chen, Shi-Jie] Univ Missouri, Inst Informat, Columbia, MO 65211 USA	University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia	Chen, SJ (corresponding author), Univ Missouri, Dept Phys, Dept Biochem, Columbia, MO 65211 USA.	chenshi@missouri.edu		Chen, Shi-Jie/0000-0002-8093-7244	National Institutes of Health [GM063732]; National Science Foundation [MCB0920411]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063732] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by National Institutes of Health grant GM063732 and National Science Foundation grant MCB0920411. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker N, 2000, J COMPUT CHEM, V21, P1343, DOI 10.1002/1096-987X(20001130)21:15<1343::AID-JCC2>3.0.CO;2-K; Bowman JC, 2012, CURR OPIN STRUC BIOL, V22, P262, DOI 10.1016/j.sbi.2012.04.006; Chen AA, 2009, METHOD ENZYMOL, V469, P411, DOI 10.1016/S0076-6879(09)69020-0; Draper DE, 2005, ANNU REV BIOPH BIOM, V34, P221, DOI 10.1146/annurev.biophys.34.040204.144511; Draper DE, 2004, RNA, V10, P335, DOI 10.1261/rna.5205404; Fiore JL, 2012, J MOL BIOL, V423, P198, DOI 10.1016/j.jmb.2012.07.006; Grilley D, 2007, BIOCHEMISTRY-US, V46, P10266, DOI 10.1021/bi062284r; Ha BY, 2003, MACROMOLECULES, V36, P9658, DOI 10.1021/ma021226k; Harris RC, 2014, J CHEM PHYS, V140, DOI 10.1063/1.4864460; He ZJ, 2014, PHYS CHEM CHEM PHYS, V16, P6367, DOI 10.1039/c3cp53655f; He ZJ, 2012, J CHEM THEORY COMPUT, V8, P2095, DOI 10.1021/ct300227a; Holland JA, 1999, RNA, V5, P257, DOI 10.1017/S1355838299981360; Hou TJ, 2011, J CHEM INF MODEL, V51, P69, DOI 10.1021/ci100275a; Kirmizialtin S, 2012, BIOPHYS J, V102, P819, DOI 10.1016/j.bpj.2012.01.013; Leipply D, 2010, BIOCHEMISTRY-US, V49, P1843, DOI 10.1021/bi902036j; Leipply D, 2009, METHOD ENZYMOL, V469, P433, DOI 10.1016/S0076-6879(09)69021-2; Li L, 2012, BMC BIOPHYS, V5, DOI 10.1186/2046-1682-5-9; Li PTX, 2009, J MOL BIOL, V386, P1343, DOI 10.1016/j.jmb.2009.01.023; Misra VK, 2003, BIOPOLYMERS, V69, P118, DOI 10.1002/bip.10353; Misra VK, 2002, J MOL BIOL, V317, P507, DOI 10.1006/jmbi.2002.5422; Moghaddam S, 2009, J MOL BIOL, V393, P753, DOI 10.1016/j.jmb.2009.08.044; Qiu XY, 2013, BIOPHYS J, V105, P984, DOI 10.1016/j.bpj.2013.07.004; Qiu XY, 2010, P NATL ACAD SCI USA, V107, P21482, DOI 10.1073/pnas.1003374107; Schroeder R, 2004, NAT REV MOL CELL BIO, V5, P908, DOI 10.1038/nrm1497; Tan ZJ, 2008, BIOPHYS J, V94, P3137, DOI 10.1529/biophysj.107.122366; Tan ZJ, 2007, BIOPHYS J, V92, P3615, DOI 10.1529/biophysj.106.100388; Tan ZJ, 2011, METAL IONS LIFE SCI, V9, P101, DOI 10.1039/978184973251200101; Tan ZJ, 2011, BIOPHYS J, V101, P176, DOI 10.1016/j.bpj.2011.05.050; Tan ZJ, 2010, BIOPHYS J, V99, P1565, DOI 10.1016/j.bpj.2010.06.029; Tan ZJ, 2006, BIOPHYS J, V90, P1175, DOI 10.1529/biophysj.105.070904; Tan ZJ, 2005, J CHEM PHYS, V122, DOI 10.1063/1.1842059; Woodson SA, 2005, CURR OPIN CHEM BIOL, V9, P104, DOI 10.1016/j.cbpa.2005.02.004; Xu XJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107504; Zhou HX, 2010, BIOPHYS J, V98, pL15, DOI 10.1016/j.bpj.2009.11.029; Zhu YH, 2014, J CHEM PHYS, V141, DOI 10.1063/1.4890656	35	18	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0119705	10.1371/journal.pone.0119705	http://dx.doi.org/10.1371/journal.pone.0119705			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25798933	Green Published, Green Submitted, gold			2022-12-27	WOS:000351987300075
J	Bernard, MA; Wang, LY; Tachado, SD				Bernard, Mark A.; Wang, Leyu; Tachado, Souvenir D.			DICER-ARGONAUTE2 Complex in Continuous Fluorogenic Assays of RNA Interference Enzymes	PLOS ONE			English	Article							DOUBLE-STRANDED-RNA; MESSENGER-RNA; NUCLEAR EXPORT; PROTEIN; DECAY; RIBONUCLEASE; ARGONAUTE2; CLEAVAGE; KINETICS; EXOSOME	Mechanistic studies of RNA processing in the RNA-Induced Silencing Complex (RISC) have been hindered by lack of methods for continuous monitoring of enzymatic activity. "Quencherless" fluorogenic substrates of RNAi enzymes enable continuous monitoring of enzymatic reactions for detailed kinetics studies. Recombinant RISC enzymes cleave the fluorogenic substrates targeting human thymidylate synthase (TYMS) and hypoxiainducible factor 1-alpha subunit (HIF1A). Using fluorogenic dsRNA DICER substrates and fluorogenic siRNA, DICER+ARGONAUTE2 mixtures exhibit synergistic enzymatic activity relative to either enzyme alone, and addition of TRBP does not enhance the apparent activity. Titration of AGO2 and DICER in enzyme assays suggests that AGO2 and DICER form a functional high-affinity complex in equimolar ratio. DICER and DICER+AGO2 exhibit Michaelis-Menten kinetics with DICER substrates. However, AGO2 cannot process the fluorogenic siRNA without DICER enzyme, suggesting that AGO2 cannot self-load siRNA into its active site. The DICER+AGO2 combination processes the fluorogenic siRNA substrate (K-m=74 nM) with substrate inhibition kinetics (K-i=105 nM), demonstrating experimentally that siRNA binds two different sites that affect Dicing and AGO2-loading reactions in RISC. This result suggests that siRNA (product of DICER) bound in the active site of DICER may undergo direct transfer (as AGO2 substrate) to the active site of AGO2 in the DICER+AGO2 complex. Competitive substrate assays indicate that DICER+AGO2 cleavage of fluorogenic siRNA is specific, since unlabeled siRNA and DICER substrates serve as competing substrates that cause a concentration-dependent decrease in fluorescent rates. Competitive substrate assays of a series of DICER substrates in vitro were correlated with cell-based assays of HIF1A mRNA knockdown (log-log slope=0.29), suggesting that improved DICER substrate designs with 10-fold greater processing by the DICER+AGO2 complex can provide a strong (similar to 2800-fold) improvement in potency for mRNA knockdown. This study laysthe foundation of a systematic biochemical approach to optimize nucleic acid-based therapeutics for Dicing and ARGONAUTE2-loading for improving efficacy.	[Bernard, Mark A.; Wang, Leyu] Pfizer Oligonucleotide Therapeut Unit, Dept Target Biol, Cambridge, MA USA; [Bernard, Mark A.] Pfizer Global Biotherapeut Technol Unit, Dept Prot Biol, Cambridge, MA USA; [Bernard, Mark A.; Tachado, Souvenir D.] Beth Israel Deaconess Med Ctr, Dept Med, Div Pulm Crit Care & Sleep Med, Boston, MA 02215 USA; [Bernard, Mark A.; Tachado, Souvenir D.] Harvard Univ, Sch Med, Boston, MA USA	Pfizer; Pfizer; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School	Bernard, MA (corresponding author), Omniome Inc, Dept Enzymol, La Jolla, CA 92037 USA.	MarkABernard@hotmail.com		Tachado, Souvenir/0000-0002-8368-6102; Bernard, Mark/0000-0001-7141-2975	Pfizer Inc.; National Institutes of Health [2R56HL092811]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R56HL092811] Funding Source: NIH RePORTER	Pfizer Inc.(Pfizer); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	MAB and LW received salary from Pfizer Inc. but are no longer affiliated with Pfizer. This work was supported by the National Institutes of Health grant 2R56HL092811 (to SDT). The National Institutes of Health had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Pfizer Oligonucleotide Therapeutics Unit had a role in funding, study design, data collection and analysis, and gave permission to publish the manuscript, but had no role in manuscript preparation. Pfizer Global Biotherapeutics Technology Unit had a role in funding and data collection, but had no role in study design, analysis, decision to publish, or preparation of the manuscript. The specific roles of the authors are listed in the authors contributions section.	Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Bohnsack MT, 2004, RNA, V10, P185, DOI 10.1261/rna.5167604; Chakravarthy S, 2010, J MOL BIOL, V404, P392, DOI 10.1016/j.jmb.2010.09.030; Chendrimada TP, 2005, NATURE, V436, P740, DOI 10.1038/nature03868; DiNitto JP, 2010, BIOTECHNIQUES, V48, P303, DOI 10.2144/000113402; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Fritz DT, 2004, CELL BIOCHEM BIOPHYS, V41, P265, DOI 10.1385/CBB:41:2:265; Kim DH, 2005, NAT BIOTECHNOL, V23, P222, DOI 10.1038/nbt1051; Kurata S, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.6.e34; Lee HY, 2012, RNA, V18, P2012, DOI 10.1261/rna.035501.112; Li F, 2012, CHEM COMMUN, V48, P12192, DOI 10.1039/c2cc36404b; Lima WF, 2009, J BIOL CHEM, V284, P26017, DOI 10.1074/jbc.M109.010835; Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513; Liu XK, 2007, ANAL BIOCHEM, V360, P154, DOI 10.1016/j.ab.2006.10.011; MacRae IJ, 2008, P NATL ACAD SCI USA, V105, P512, DOI 10.1073/pnas.0710869105; Marras SAE, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf121; MORRISON JF, 1969, BIOCHIM BIOPHYS ACTA, V185, P269, DOI 10.1016/0005-2744(69)90420-3; Parniak MA, 2003, ANAL BIOCHEM, V322, P33, DOI 10.1016/j.ab.2003.06.001; Rose SD, 2005, NUCLEIC ACIDS RES, V33, P4140, DOI 10.1093/nar/gki732; Schaeffer D, 2009, NAT STRUCT MOL BIOL, V16, P56, DOI 10.1038/nsmb.1528; Tani H, 2007, ANAL BIOCHEM, V369, P105, DOI 10.1016/j.ab.2007.06.047; Torimura M, 2001, ANAL SCI, V17, P155, DOI 10.2116/analsci.17.155; Van Dijk EL, 2007, RNA, V13, P1027, DOI 10.1261/rna.575107; Wang HW, 2009, NAT STRUCT MOL BIOL, V16, P1148, DOI 10.1038/nsmb.1673; Wang LY, 2008, PROTEIN EXPRES PURIF, V61, P204, DOI 10.1016/j.pep.2008.05.017; Wasilko D., 2006, BIOPROCESS J, V5, P29, DOI [10.12665/J53.WasilkoLee, DOI 10.12665/J53.WASILKOLEE]; Wasilko DJ, 2009, PROTEIN EXPRES PURIF, V65, P122, DOI 10.1016/j.pep.2009.01.002; Werner A, 2012, BIOL CHEM, V393, P187, DOI 10.1515/hsz-2011-0202; Yi R, 2003, GENE DEV, V17, P3011, DOI 10.1101/gad.1158803; Zamore PD, 2000, CELL, V101, P25, DOI 10.1016/S0092-8674(00)80620-0	30	2	3	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0120614	10.1371/journal.pone.0120614	http://dx.doi.org/10.1371/journal.pone.0120614			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25793518	Green Submitted, Green Published, gold			2022-12-27	WOS:000352083900059
J	Christiansen, IK; Sandve, GK; Schmitz, M; Durst, M; Hovig, E				Christiansen, Irene Kraus; Sandve, Geir Kjetil; Schmitz, Martina; Duerst, Matthias; Hovig, Eivind			Transcriptionally Active Regions Are the Preferred Targets for Chromosomal HPV Integration in Cervical Carcinogenesis	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS TYPE-16; CELLULAR FUSION TRANSCRIPTS; COMMON FRAGILE SITES; GENOMIC HYPERBROWSER; ANOGENITAL LESIONS; VIRAL INTEGRATION; CANCER; GENE; CHROMATIN; DNA	Integration of human papillomavirus (HPV) into the host genome is regarded as a determining event in cervical carcinogenesis. However, the exact mechanism for integration, and the role of integration in stimulating cancer progression, is not fully characterized. Although integration sites are reported to appear randomly distributed over all chromosomes, fragile sites, translocation break points and transcriptionally active regions have all been suggested as being preferred sites for integration. In addition, more recent studies have reported integration events occurring within or surrounding essential cancer-related genes, raising the question whether these may reflect key events in the molecular genesis of HPV induced carcinomas. In a search for possible common denominators of the integration sites, we utilized the chromosomal coordinates of 121 viral-cellular fusion transcripts, and examined for statistical overrepresentation of integration sites with various features of ENCODE chromatin information data, using the Genomic HyperBrowser. We find that integration sites coincide with DNA that is transcriptionally active in mucosal epithelium, as judged by the relationship of integration sites to DNase hypersensitivity and H3K4me3 methylation data. Finding an association between integration and transcription is highly informative with regard to the spatio-temporal characteristics of the integration process. These results suggest that integration is an early event in carcinogenesis, more than a late product of chromosomal instability. If the viral integrations were more likely to occur in destabilized regions of the DNA, a completely random distribution of the integration sites would be expected. As a by-product of integration in actively transcribing DNA, a tendency of integration in or close to genes is likely to be observed. This increases the possibility of viral signals to modulate the expression of these genes, potentially contributing to the progression towards cancer.	[Christiansen, Irene Kraus] Akershus Univ Hosp, Dept Microbiol & Infect Control, Lorenskog, Norway; [Sandve, Geir Kjetil; Hovig, Eivind] Univ Oslo, Dept Informat, N-0316 Oslo, Norway; [Schmitz, Martina; Duerst, Matthias] Jena Univ Hosp, Dept Gynaecol, Jena, Germany; [Hovig, Eivind] Oslo Univ Hosp, Inst Canc Res, Dept Tumor Biol, Oslo, Norway; [Hovig, Eivind] Oslo Univ Hosp, Inst Canc Genet & Informat, Oslo, Norway	University of Oslo; University of Oslo; Friedrich Schiller University of Jena; University of Oslo; University of Oslo	Christiansen, IK (corresponding author), Akershus Univ Hosp, Dept Microbiol & Infect Control, Lorenskog, Norway.	irene.kraus.christiansen@ahus.no	Hovig, Eivind/H-2474-2011	Hovig, Eivind/0000-0002-9103-1077; Sandve, Geir Kjetil/0000-0002-4959-1409; Christiansen, Irene Kraus/0000-0001-8850-3304	Norwegian Cancer Society [419936 71220 - PR-2006-0433]	Norwegian Cancer Society(Norwegian Cancer Society)	This work was in part supported by a grant to EH from the Norwegian Cancer Society (Grant #419936 71220 - PR-2006-0433). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akagi K, 2014, GENOME RES, V24, P185, DOI 10.1101/gr.164806.113; Bannister AJ, 2011, CELL RES, V21, P381, DOI 10.1038/cr.2011.22; Collins SI, 2009, CANCER RES, V69, P3828, DOI 10.1158/0008-5472.CAN-08-3099; DURST M, 1987, P NATL ACAD SCI USA, V84, P1070, DOI 10.1073/pnas.84.4.1070; Gallo G, 2003, J CLIN PATHOL, V56, P532, DOI 10.1136/jcp.56.7.532; Greer EL, 2012, NAT REV GENET, V13, P343, DOI 10.1038/nrg3173; Gundersen S, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-494; Hafner N, 2008, ONCOGENE, V27, P1610, DOI 10.1038/sj.onc.1210791; IARC, 2012, MONOGRAPHS ON THE EV, V100B; Kraus I, 2008, CANCER RES, V68, P2514, DOI 10.1158/0008-5472.CAN-07-2776; Kulmala SMA, 2006, J CLIN PATHOL, V59, P513, DOI 10.1136/jcp.2004.024570; Li H, 2013, J CLIN VIROL, V56, P342, DOI 10.1016/j.jcv.2012.12.014; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; Moody CA, 2010, NAT REV CANCER, V10, P550, DOI 10.1038/nrc2886; Ojesina AI, 2013, NATURE, V10; Peitsaro P, 2002, J CLIN MICROBIOL, V40, P886, DOI 10.1128/JCM.40.3.886-891.2002; Peter M, 2010, J PATHOL, V221, P320, DOI 10.1002/path.2713; Pett M, 2007, J PATHOL, V212, P356, DOI 10.1002/path.2192; Reuter S, 1998, EMBO J, V17, P215, DOI 10.1093/emboj/17.1.215; ROSL F, 1993, J GEN VIROL, V74, P791, DOI 10.1099/0022-1317-74-5-791; Sandve GK, 2013, NUCLEIC ACIDS RES, V41, pW133, DOI 10.1093/nar/gkt342; Sandve GK, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-12-r121; Schmitz M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039632; Schmitz M, 2012, INT J CANCER, V131, pE593, DOI 10.1002/ijc.27433; Tang KW, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3513; Thorland EC, 2003, ONCOGENE, V22, P1225, DOI 10.1038/sj.onc.1206170; Thorland EC, 2000, CANCER RES, V60, P5916; Thurman RE, 2012, NATURE, V489, P75, DOI 10.1038/nature11232; Tjalma WA, 2013, INT J CANCER, V132, P854, DOI 10.1002/ijc.27713; Trynka G, 2013, NAT GENET, V45, P124, DOI 10.1038/ng.2504; Van Tine B. A., 2001, V106, P381; Wentzensen N, 2002, ONCOGENE, V21, P419, DOI 10.1038/sj.onc.1205104; Wentzensen N, 2007, DIS MARKERS, V23, P315, DOI 10.1155/2007/678793; Xu B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066693; Yu TX, 2005, CANCER GENET CYTOGEN, V158, P27, DOI 10.1016/j.cancergencyto.2004.08.021; Ziegert C, 2003, ONCOGENE, V22, P3977, DOI 10.1038/sj.onc.1206629; zur Hausen H, 2002, NAT REV CANCER, V2, P342, DOI 10.1038/nrc798	37	24	25	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0119566	10.1371/journal.pone.0119566	http://dx.doi.org/10.1371/journal.pone.0119566			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25793388	gold, Green Published, Green Submitted			2022-12-27	WOS:000352084200096
J	Eterovick, PC; Bar, LFF; Souza, JB; Castro, JFM; Leite, FSF; Alford, RA				Eterovick, Paula C.; Bar, Luis F. F.; Souza, Jorge B.; Castro, Jose F. M.; Leite, Felipe S. F.; Alford, Ross A.			Testing the Relationship between Human Occupancy in the Landscape and Tadpole Developmental Stress	PLOS ONE			English	Article							GLOBAL AMPHIBIAN DECLINES; FLUCTUATING ASYMMETRY; CONSERVATION; ANURA; STABILITY; ECOLOGY; QUALITY; BRAZIL; POPULATIONS; BOKERMANN	Amphibian population declines are widespread; the main causal factors are human related and include habitat fragmentation due to agriculture, mining, fires, and urban development. Brazil is the richest country in species of amphibians, and the Brazilian regions with the greatest amphibian diversity are experiencing relatively high rates of habitat destruction, but there are presently relatively few reports of amphibian declines. It is thus important to develop research methods that will detect deterioration in population health before severe declines occur. We tested the use of measurements of fluctuating asymmetry (FA) taken on amphibian larvae to detect anthropogenic stress. We hypothesized that greater human occupancy in the landscape might result in more stressful conditions for amphibians. We conducted this study at the Espinhaco mountain range in southeastern Brazil, using as a model an endemic species (Bokermannohyla saxicola, Hylidae). We chose two tadpole denticle rows and eye-nostril distance as traits for FA measurement. We measured percent cover of human-altered habitats in the landscape around tadpole sampling points and measured FA levels in sampled tadpoles. We found FA levels to differ among localities but found no relationship between human modification of the landscape and tadpole FA levels. Levels of FA in the traits we examined may not be strongly affected by environmental conditions, or may be affected by local variables that were not captured by our landscape-scale measures. Alternatively, populations may be genetically differentiated, affecting how FA levels respond to stress and obscuring the effects of anthropogenic disturbance.	[Eterovick, Paula C.; Bar, Luis F. F.] Pontificia Univ Catolica Minas Gerais, Programa Pos Grad Zool Vertebrados, Belo Horizonte, MG, Brazil; [Souza, Jorge B.; Castro, Jose F. M.] Pontificia Univ Catolica Minas Gerais, Programa Pos Grad Geog Tratamento Informacao Espa, Belo Horizonte, MG, Brazil; [Leite, Felipe S. F.] Univ Fed Vicosa, Inst Ciencias Biol & Saude, Florestal, MG, Brazil; [Alford, Ross A.] James Cook Univ, Ctr Trop Biodivers & Climate Change, Coll Marine & Environm Sci, Townsville, Qld 4811, Australia	Pontificia Universidade Catolica de Minas Gerais; Pontificia Universidade Catolica de Minas Gerais; Universidade Federal de Vicosa; James Cook University	Eterovick, PC (corresponding author), Pontificia Univ Catolica Minas Gerais, Programa Pos Grad Zool Vertebrados, Belo Horizonte, MG, Brazil.	pceterovick@gmail.com	Leite, Felipe S. F. Sá Fortes/H-9179-2012; Eterovick, Paula Cabral/AGC-1678-2022; Souza, Jorge/ABF-2883-2020; Alford, Ross A/H-1577-2011	Leite, Felipe S. F. Sá Fortes/0000-0003-4561-5634; Eterovick, Paula Cabral/0000-0002-1316-1255; Alford, Ross A/0000-0002-3010-6768; Castro, Jose Flavio Morais/0000-0002-5387-7987	Fundo de Incentivo a Pesquisa (FIP) of the Pontificia Universidade Catolica de Minas Gerais (PUC-Minas) [FIP-2012/7485-2S]; Fundacao de Amparo a Pesquisa do Estado de Minas Gerais [CRA-765/06]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); CNPq [301077/2010-0, 555081/2010-9]	Fundo de Incentivo a Pesquisa (FIP) of the Pontificia Universidade Catolica de Minas Gerais (PUC-Minas); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	Funding was provided by Fundo de Incentivo a Pesquisa (FIP) of the Pontificia Universidade Catolica de Minas Gerais (PUC-Minas) (FIP-2012/7485-2S, http://www.pucminas.br). Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (CRA-765/06, http://www.fapemig.br/). Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, http://www.cnpq.br/). A Research Productivity grant (301077/2010-0) was provided to PCE and a Masters scholarship (555081/2010-9) was provided to LFFB by CNPq. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alford R. A., 1999, DECLINES DISAPPEARAN, P34; Alford RA, 1999, ANNU REV ECOL SYST, V30, P133, DOI 10.1146/annurev.ecolsys.30.1.133; Alford RA, 1999, TADPOLES, P240; Alford RA, 2007, NATURE, V447, pE3, DOI 10.1038/nature05940; Altig R, 1999, TADPOLES, P295; Alvarez D, 2002, FUNCT ECOL, V16, P640, DOI 10.1046/j.1365-2435.2002.00658.x; Beasley DE, 2013, ECOL INDIC, V30, P218, DOI 10.1016/j.ecolind.2013.02.024; Bebbee TJC., 1996, ECOLOGY CONSERVATION, P214; Becker CG, 2007, SCIENCE, V318, P1775, DOI 10.1126/science.1149374; BERTOLUCI J, 1995, FROGLOG, V14, P2; Boorse GC, 2003, INTEGR COMP BIOL, V43, P646, DOI 10.1093/icb/43.5.646; BOYER R, 1995, ENVIRON HEALTH PERSP, V103, P352, DOI 10.2307/3432288; CHENG P., 2009, GEOINFORMATICS, V12, P36; Collins JP, 2003, DIVERS DISTRIB, V9, P89, DOI 10.1046/j.1472-4642.2003.00012.x; Dauwe T, 2006, ENVIRON POLLUT, V140, P71, DOI 10.1016/j.envpol.2005.06.024; Delgado-Acevedo J, 2008, CONSERV BIOL, V22, P773, DOI 10.1111/j.1523-1739.2008.00930.x; Dongen SV, 2006, J EVOLUTION BIOL, V19, P1727, DOI 10.1111/j.1420-9101.2006.01175.x; Eterovick P.C., 2004, AMPHIBIANS SERRA CIP; Eterovick PC, 2006, HERPETOLOGICA, V62, P365, DOI 10.1655/0018-0831(2006)62[365:DOTWAA]2.0.CO;2; Eterovick Paula C., 2009, South American Journal of Herpetology, V4, P235, DOI 10.2994/057.004.0306; Eterovick PC, 2005, BIOTROPICA, V37, P166, DOI 10.1111/j.1744-7429.2005.00024.x; Eterovick PC, 2001, J HERPETOL, V35, P442, DOI 10.2307/1565962; Leite FSF, 2012, HERPETOLOGICA, V68, P401, DOI 10.1655/HERPETOLOGICA-D-11-00006.1; Gardner T., 2001, Animal Biodiversity and Conservation, V24, P25; Gosner K. L., 1960, Herpetologica, V16, P183; GRUBBS FE, 1969, TECHNOMETRICS, V11, P1, DOI 10.2307/1266761; Guix Juan C., 1998, Herpetological Natural History, V6, P1; Hamer AJ, 2008, BIOL CONSERV, V141, P2432, DOI 10.1016/j.biocon.2008.07.020; Hels T, 2002, ECOGRAPHY, V25, P303, DOI 10.1034/j.1600-0587.2002.250307.x; HEYER WR, 1988, BIOTROPICA, V20, P230, DOI 10.2307/2388238; Hogg ID, 2001, J APPL ECOL, V38, P1326, DOI 10.1046/j.0021-8901.2001.00682.x; Izecksohn E, 2001, ANFIBIOS MUNICIPIO R; Kark S, 2001, HEREDITY, V86, P119, DOI 10.1038/sj/hdy/6888560; Kellner JR, 2003, AM NAT, V161, P931, DOI 10.1086/375177; Kupferberg SJ, 1997, AM ZOOL, V37, P146; Leite F.S.F., 2008, MEGADIVERSIDADE, V4, P158; Leite FSF, 2008, J NAT HIST, V42, P2777, DOI 10.1080/00222930802361022; Lens L, 2002, BIOL REV, V77, P27, DOI 10.1017/S1464793101005796; Lens L, 2002, CONSERV BIOL, V16, P479, DOI 10.1046/j.1523-1739.2002.00516.x; Lips KR, 1998, CONSERV BIOL, V12, P106, DOI 10.1046/j.1523-1739.1998.96359.x; Lopez P, 2002, BEHAV ECOL SOCIOBIOL, V52, P342, DOI 10.1007/s00265-002-0514-y; Lopez-Romero F, 2012, ECOTOX ENVIRON SAFE, V84, P25, DOI 10.1016/j.ecoenv.2012.06.008; McDonald K, 1999, DECLINES DISAPPEARAN, P14; Moller AP, 1997, AM NAT, V149, P916, DOI 10.1086/286030; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Palmer, 1994, DEV INSTABILITY ITS, P335, DOI DOI 10.1007/978-94-011-0830-0_; Palmer A. Richard, 2003, P279; Palmer AR, 1996, BIOSCIENCE, V46, P518, DOI 10.2307/1312930; PALMER AR, 1986, ANNU REV ECOL SYST, V17, P391, DOI 10.1146/annurev.es.17.110186.002135; Pombal Jose P. Jr., 1995, Boletim do Museu Nacional Rio de Janeiro Zoologia, V363, P1; Pombal JP, 1999, COPEIA, P1014, DOI 10.2307/1447976; Pough FH, 2013, VERTEBRATE ZOOLOGY; Pounds JA, 2004, NATURE, V427, P107, DOI 10.1038/427107a; R Core Team, 2012, R LANG ENV STAT COMP; Rasmuson M, 2002, HEREDITAS, V136, P177, DOI 10.1034/j.1601-5223.2002.1360301.x; de Oliveira FFR, 2009, ACTA OECOL, V35, P727, DOI 10.1016/j.actao.2009.07.004; Richardson JML, 2001, BEHAV ECOL, V12, P51, DOI 10.1093/oxfordjournals.beheco.a000378; SANSEVERINO AM, 2008, OECOLOGIA BRASILIENS, V12, P382, DOI DOI 10.4257/OECO.2008.1203.03; Segalla Magno V., 2014, Herpetologia Brasileira, V3, P37; Semlitsch RD, 2003, CONSERV BIOL, V17, P1219, DOI 10.1046/j.1523-1739.2003.02177.x; Sheehan MJ, 2011, BEHAV ECOL, V22, P1166, DOI 10.1093/beheco/arr101; Siikamaki P, 1998, EVOLUTION, V52, P1285, DOI 10.1111/j.1558-5646.1998.tb02010.x; SILVANO DL, 2005, MEGADIVERSIDADE, V1, P79; Soderman F, 2007, OECOLOGIA, V151, P593, DOI 10.1007/s00442-006-0611-0; Solis R, 2010, BIOL INVASIONS, V12, P1641, DOI 10.1007/s10530-009-9577-2; *SYST SOFTW, 2007, SYST VERS 12; Tavares LHS, 1994, LIMNOLOGIA APLICADA, DOI [10.4137/EBO.S14457, DOI 10.4137/EBO.S14457]; Trokovik N, 2012, BMC EVOL BIOL, V12, P1, DOI [10.1186/1471-2148-12-1, DOI 10.1186/1471-2148-12-1]; Tyc G, 2005, ACTA ASTRONAUT, V56, P213, DOI 10.1016/j.actaastro.2004.09.029; Valkama J, 2001, J APPL ECOL, V38, P665, DOI 10.1046/j.1365-2664.2001.00628.x; Van Poucke E, 2007, POULTRY SCI, V86, P2110, DOI 10.1093/ps/86.10.2110; VANVALEN L, 1962, EVOLUTION, V16, P125; Walker SF, 2008, CURR BIOL, V18, pR853, DOI 10.1016/j.cub.2008.07.033; Wassersug RJ, 2001, COMP BIOCHEM PHYS A, V131, P183, DOI 10.1016/S1095-6433(01)00468-8; WEYGOLDT P, 1989, STUD NEOTROP FAUNA E, V24, P249, DOI 10.1080/01650528909360795; Windig JJ, 2000, J INSECT CONSERV, V4, P253, DOI 10.1023/A:1011332401156; Young BE, 2001, CONSERV BIOL, V15, P1213, DOI 10.1046/j.1523-1739.2001.00218.x; Zachos FE, 2007, HEREDITY, V98, P392, DOI 10.1038/sj.hdy.6800954	78	7	7	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0120172	10.1371/journal.pone.0120172	http://dx.doi.org/10.1371/journal.pone.0120172			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25793699	Green Published, Green Accepted, gold			2022-12-27	WOS:000352084200153
J	Toledo, ME; Vanlerberghe, V; Lambert, I; Montada, D; Baly, A; Van der Stuyft, P				Eugenia Toledo, Maria; Vanlerberghe, Veerle; Lambert, Isora; Montada, Domingo; Baly, Alberto; Van der Stuyft, Patrick			No Effect of Insecticide Treated Curtain Deployment on Aedes Infestation in a Cluster Randomized Trial in a Setting of Low Dengue Transmission in Guantanamo, Cuba	PLOS ONE			English	Article							VECTOR CONTROL; AEGYPTI CONTROL; COST; EPIDEMIC; LESSONS	Objective & Methodology The current study evaluated the effectiveness and cost-effectiveness of Insecticide Treated Curtain (ITC) deployment for reducing dengue vector infestation levels in the Cuban context with intensive routine control activities. A cluster randomized controlled trial took place in Guantanamo city, east Cuba. Twelve neighborhoods (about 500 households each) were selected among the ones with the highest Aedes infestation levels in the previous two years, and were randomly allocated to the intervention and control arms. Long lasting ITC (PermaNet) were distributed in the intervention clusters in March 2009. Routine control activities were continued in the whole study area. In both study arms, we monitored monthly pre-and post-intervention House Index (HI, number of houses with at least 1 container with Aedes immature stages/100 houses inspected), during 12 and 18 months respectively. We evaluated the effect of ITC deployment on HI by fitting a generalized linear regression model with a negative binomial link function to these data. Principal Findings At distribution, the ITC coverage (% of households using >= 1 ITC) reached 98.4%, with a median of 3 ITC distributed/household. After 18 months, the coverage remained 97.4%. The local Aedes species was susceptible to deltamethrin (mosquito mortality rate of 99.7%) and the residual deltamethrin activity in the ITC was within acceptable levels (mosquito mortality rate of 73.1%) after one year of curtain use. Over the 18 month observation period after ITC distribution, the adjusted HI rate ratio, intervention versus control clusters, was 1.15 (95% CI 0.57 to 2.34). The annualized cost per household of ITC implementation was 3.8 USD, against 16.8 USD for all routine ACP activities. Conclusion Deployment of ITC in a setting with already intensive routine Aedes control actions does not lead to reductions in Aedes infestation levels.	[Eugenia Toledo, Maria; Montada, Domingo; Baly, Alberto] Inst Trop Med Pedro Kouri, Dept Epidemiol, Havana, Cuba; [Vanlerberghe, Veerle; Van der Stuyft, Patrick] Inst Trop Med, Unit Gen Epidemiol & Dis Control, B-2000 Antwerp, Belgium; [Lambert, Isora] Prov Ctr Surveillance & Vector Control, Guantanamo, Cuba; [Van der Stuyft, Patrick] Univ Ghent, Dept Publ Hlth, B-9000 Ghent, Belgium	Institute of Tropical Medicine (ITM); Ghent University	Toledo, ME (corresponding author), Inst Trop Med Pedro Kouri, Dept Epidemiol, Havana, Cuba.	mariaeugenia@ipk.sld.cu		Vanlerberghe, Veerle/0000-0002-6531-0793	Institute of Tropical Medicine, Antwerp; Belgian Directorate-General for Development Co-operation; Cuban Ministry of Health	Institute of Tropical Medicine, Antwerp; Belgian Directorate-General for Development Co-operation; Cuban Ministry of Health	This study received funding from the framework agreement between the Institute of Tropical Medicine, Antwerp and the Belgian Directorate-General for Development Co-operation, from the Cuban Ministry of Health and from the Institute of Tropical Medicine, Antwerp. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott WS, 1925, J ECON ENTOMOL, V18, P265, DOI 10.1093/jee/18.2.265a; [Anonymous], 1998, TEST PROC INS RES MO; Baly A, 2012, TROP MED INT HEALTH, V17, P123, DOI 10.1111/j.1365-3156.2011.02881.x; Baly A, 2011, AM J TROP MED HYG, V84, P747, DOI 10.4269/ajtmh.2011.10-0532; Baly A, 2009, AM J TROP MED HYG, V81, P88, DOI 10.4269/ajtmh.2009.81.88; Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; Chao DL, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001876; Corbel V, 2012, LANCET INFECT DIS, V12, P617, DOI 10.1016/S1473-3099(12)70081-6; Eisen L, 2009, J MED ENTOMOL, V46, P1245, DOI 10.1603/033.046.0601; Guzman MG, 2006, REV PANAM SALUD PUBL, V19, P282, DOI 10.1590/S1020-49892006000400014; Tirado MGG, 2012, MEDICC REV, V14, P46, DOI 10.37757/MR2012V14.N2.11; Hayes RJ, 1999, INT J EPIDEMIOL, V28, P319, DOI 10.1093/ije/28.2.319; Hertlein MB, 2010, J AM MOSQUITO CONTR, V26, P67, DOI 10.2987/09-5936.1; Horstick O, 2010, T ROY SOC TROP MED H, V104, P379, DOI 10.1016/j.trstmh.2009.07.027; Johns Benjamin, 2003, Cost Eff Resour Alloc, V1, P1, DOI 10.1186/1478-7547-1-1; KOURI GP, 1989, B WORLD HEALTH ORGAN, V67, P375; Kroeger A, 2006, BMJ-BRIT MED J, V332, P1247, DOI 10.1136/bmj.332.7552.1247; Lenhart A, 2008, TROP MED INT HEALTH, V13, P56, DOI 10.1111/j.1365-3156.2007.01966.x; Lenhart A, 2013, AM J TROP MED HYG, V88, P254, DOI 10.4269/ajtmh.2012.12-0423; Protopopoff N, 2008, AM J TROP MED HYG, V79, P12, DOI 10.4269/ajtmh.2008.79.12; Rizzo N, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-931; Romani MET, 2007, SOC SCI MED, V64, P976, DOI 10.1016/j.socscimed.2006.10.033; Sabchareon A, 2012, LANCET, V380, P1559, DOI 10.1016/S0140-6736(12)61428-7; Sanchez L, 2005, TROP MED INT HEALTH, V10, P82, DOI 10.1111/j.1365-3156.2004.01347.x; Stoddard ST, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000481; Toledo ME, 2008, TROP MED INT HEALTH, V13, P728, DOI 10.1111/j.1365-3156.2008.02046.x; Vanlerberghe V, 2010, TROP MED INT HEALTH, V15, P1067, DOI 10.1111/j.1365-3156.2010.02582.x; Vanlerberghe V, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b1959; Vanlerberghe V, 2013, AM J TROP MED HYG, V89, P93, DOI 10.4269/ajtmh.13-0015; Vanlerberghe V, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000994; Williams CR, 2007, J MED ENTOMOL, V44, P256, DOI 10.1603/0022-2585(2007)44[256:IOABLO]2.0.CO;2; World Health Organization, 2009, WHOHTMNTDDEN2009; World Health Organization, 2006, PEST THEIR APPL CONT; World Health Organization, 1981, WHOVBC81806	34	11	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0119373	10.1371/journal.pone.0119373	http://dx.doi.org/10.1371/journal.pone.0119373			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25794192	Green Published, gold, Green Submitted			2022-12-27	WOS:000352084200076
J	Gorska-Ciebiada, M; Saryusz-Wolska, M; Borkowska, A; Ciebiada, M; Loba, J				Gorska-Ciebiada, Malgorzata; Saryusz-Wolska, Malgorzata; Borkowska, Anna; Ciebiada, Maciej; Loba, Jerzy			Serum Levels of Inflammatory Markers in Depressed Elderly Patients with Diabetes and Mild Cognitive Impairment	PLOS ONE			English	Article							C-REACTIVE PROTEIN; CORONARY-HEART-DISEASE; LATE-LIFE DEPRESSION; METABOLIC SYNDROME; SYMPTOMS; ASSOCIATION; CYTOKINES; DEMENTIA; ADULTS; RISK	Objective The aim of the study was to determine the serum levels of CRP, IL-6 and TNF-alpha in elderly diabetic patients with depressive syndrome alone or with coexisting mild cognitive impairment (MCI). Methods 276 diabetics elders were screened for depressive symptoms (using Geriatric Depression Scale: GDS-30) and MCI (using the Montreal Cognitive Assessment: MoCA score). Data of HbA1c, blood lipids and inflammatory markers levels were collected. Results In all groups of patients levels of CRP, IL-6 and TNF-alpha were significantly higher as compared to controls. The highest level of inflammatory markers was detected in group with depressive mood and coexisting MCI, however IL-6 level didn't significantly differ as compared to MCI group. We founded correlations between all inflammatory markers in group of patients with depressive mood and in group of subjects with depressive symptoms and coexisting MCI. GDS-30 score was correlated with levels of inflammatory markers in group with depressive mood, and with levels of CRP and TNF-alpha in group with depressive mood and coexisting MCI. In the group with depressive mood and coexisting MCI we founded that MoCA score was negatively correlated with CRP and TNF-alpha levels; and HbA1c level was positively correlated with all inflammatory markers. The univariate logistic regression models revealed that variables which increased the likelihood of having been diagnosed with MCI in depressed patients were: higher levels of HbA1c, CRP, IL-6 and TNF-alpha, previous CVD or stroke, increased number of co-morbidities and microvascular complications, older age, less years of formal education. The multivariable model showed that previous CVD, higher HbA1c and IL-6 levels are significant factors. Conclusions We demonstrated that the presence of depressive syndrome is associated with higher levels of inflammatory markers in elderly patients with diabetes. The presence of MCI in these depressed subjects has additive effect on levels of inflammatory mediators.	[Gorska-Ciebiada, Malgorzata; Saryusz-Wolska, Malgorzata; Borkowska, Anna; Loba, Jerzy] Med Univ Lodz, Dept Internal Med & Diabetol, Lodz, Poland; [Ciebiada, Maciej] Med Univ Lodz, Dept Gen & Oncol Pneumol, Lodz, Poland	Medical University Lodz; Medical University Lodz	Gorska-Ciebiada, M (corresponding author), Med Univ Lodz, Dept Internal Med & Diabetol, Lodz, Poland.	magoca@poczta.onet.pl	Gorska-Ciebiada, Malgorzata Maria/S-9668-2016; Ciebiada, Maciej Ireneusz/S-9324-2016	Gorska-Ciebiada, Malgorzata Maria/0000-0002-0065-4376; Ciebiada, Maciej Ireneusz/0000-0003-3391-264X; Borkowska, Anna/0000-0002-8971-9868	Medical University of Lodz [502-03/8-072-03/502-64-052]	Medical University of Lodz	This work was supported by nonprofit grant of Medical University of Lodz no 502-03/8-072-03/502-64-052. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama H, 2000, NEUROBIOL AGING, V21, P383, DOI 10.1016/S0197-4580(00)00124-X; Alagiakrishnan K, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/186106; Alexopoulos GS, 2006, BIOL PSYCHIAT, V60, P1304, DOI 10.1016/j.biopsych.2006.09.006; Banks WA, 1998, NEUROIMMUNOMODULAT, V5, P36, DOI 10.1159/000026324; Barnes DE, 2006, ARCH GEN PSYCHIAT, V63, P273, DOI 10.1001/archpsyc.63.3.273; Camus V, 2004, J AFFECT DISORDERS, V81, P1, DOI 10.1016/j.jad.2003.08.003; Danner M, 2003, PSYCHOSOM MED, V65, P347, DOI 10.1097/01.PSY.0000041542.29808.01; de Groot M, 2001, PSYCHOSOM MED, V63, P619, DOI 10.1097/00006842-200107000-00015; Dinan TG, 2009, CURR OPIN PSYCHIATR, V22, P32, DOI 10.1097/YCO.0b013e328315a561; Ding J, 2010, DIABETES, V59, P2883, DOI 10.2337/db10-0752; Dowlati Y, 2010, BIOL PSYCHIAT, V67, P446, DOI 10.1016/j.biopsych.2009.09.033; Doyle TA, 2013, J PSYCHOSOM RES, V75, P419, DOI 10.1016/j.jpsychores.2013.08.006; Elovainio M, 2005, PSYCHOSOM MED, V67, P561, DOI 10.1097/01.psy.0000170340.74035.23; Empana JP, 2005, CIRCULATION, V111, P2299, DOI 10.1161/01.CIR.0000164203.54111.AE; Faramawi MF, 2007, AM J CARDIOL, V99, P1610, DOI 10.1016/j.amjcard.2006.12.090; Ferketich AK, 2005, AM HEART J, V150, P132, DOI 10.1016/j.ahj.2004.08.029; Ford DE, 2004, ARCH INTERN MED, V164, P1010, DOI 10.1001/archinte.164.9.1010; Gimeno D, 2009, PSYCHOL MED, V39, P413, DOI 10.1017/S0033291708003723; Gorska-Ciebiada M, 2014, J DIABETES RES, V2014, DOI 10.1155/2014/179648; Hermida AP, 2012, EXPERT REV NEUROTHER, V12, P1339, DOI [10.1586/ern.12.127, 10.1586/ERN.12.127]; Hidaka S, 2012, INT J GERIATR PSYCH, V27, P271, DOI 10.1002/gps.2715; Howren MB, 2009, PSYCHOSOM MED, V71, P171, DOI 10.1097/PSY.0b013e3181907c1b; Iosif RE, 2006, J NEUROSCI, V26, P9703, DOI 10.1523/JNEUROSCI.2723-06.2006; Jellinger KA, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00017; Kahl KG, 2006, BIOL PSYCHIAT, V59, P667, DOI 10.1016/j.biopsych.2005.08.001; KATZ S, 1970, GERONTOLOGIST, V10, P20, DOI 10.1093/geront/10.1_Part_1.20; Ladwig KH, 2005, EUR HEART J, V26, P2537, DOI 10.1093/eurheartj/ehi456; LAWTON MP, 1969, GERONTOLOGIST, V9, P179, DOI 10.1093/geront/9.3_Part_1.179; Leonard BE, 2007, NEUROCHEM RES, V32, P1749, DOI 10.1007/s11064-007-9385-y; Luchsinger JA, 2007, ARCH NEUROL-CHICAGO, V64, P570, DOI 10.1001/archneur.64.4.570; Miller GE, 2005, AM J CARDIOL, V95, P317, DOI 10.1016/j.amjcard.2004.09.026; Monje ML, 2003, SCIENCE, V302, P1760, DOI 10.1126/science.1088417; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; Nouwen A, 2010, DIABETOLOGIA, V53, P2480, DOI 10.1007/s00125-010-1874-x; Panza F, 2010, AM J GERIAT PSYCHIAT, V18, P98, DOI 10.1097/JGP.0b013e3181b0fa13; Petersen RC, 2004, J INTERN MED, V256, P183, DOI 10.1111/j.1365-2796.2004.01388.x; Pizzi C, 2008, EUR HEART J, V29, P1110, DOI 10.1093/eurheartj/ehn137; Portet F, 2006, J NEUROL NEUROSUR PS, V77, P714, DOI 10.1136/jnnp.2005.085332; Quan N, 2007, BRAIN BEHAV IMMUN, V21, P727, DOI 10.1016/j.bbi.2007.05.005; Raison CL, 2006, TRENDS IMMUNOL, V27, P24, DOI 10.1016/j.it.2005.11.006; Roberts RO, 2010, ALZ DIS ASSOC DIS, V24, P11, DOI 10.1097/WAD.0b013e3181a4485c; Roberts RO, 2009, ALZHEIMERS DEMENT, V5, P398, DOI 10.1016/j.jalz.2009.01.025; Rutter MK, 2005, DIABETES, V54, P3252, DOI 10.2337/diabetes.54.11.3252; Steptoe A, 2007, BRAIN BEHAV IMMUN, V21, P901, DOI 10.1016/j.bbi.2007.03.011; Stuart MJ, 2012, NEUROSCI BIOBEHAV R, V36, P658, DOI 10.1016/j.neubiorev.2011.10.001; Tiemeier H, 2004, ARCH GEN PSYCHIAT, V61, P369, DOI 10.1001/archpsyc.61.4.369; Tousoulis D, 2013, J AM COLL CARDIOL, V62, P667, DOI 10.1016/j.jacc.2013.03.089; Trollor JN, 2010, DEMENT GERIATR COGN, V30, P569, DOI 10.1159/000322092; Umegaki H, 2011, DEMENT GER COGN D EX, V1, P1, DOI 10.1159/000323188; Whipple MO, 2009, STROKE, V40, P3166, DOI 10.1161/STROKEAHA.109.554519; Yaffe K, 2003, NEUROLOGY, V61, P76, DOI 10.1212/01.WNL.0000073620.42047.D7; YESAVAGE JA, 1983, J PSYCHIATR RES, V17, P37, DOI 10.1016/0022-3956(82)90033-4	52	44	48	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0120433	10.1371/journal.pone.0120433	http://dx.doi.org/10.1371/journal.pone.0120433			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25793613	gold, Green Published, Green Submitted			2022-12-27	WOS:000352083900033
J	Moeller, M; Thonig, A; Pohl, S; Ripoll, C; Zipprich, A				Moeller, Miriam; Thonig, Antje; Pohl, Sabine; Ripoll, Cristina; Zipprich, Alexander			Hepatic Arterial Vasodilation Is Independent of Portal Hypertension in Early Stages of Cirrhosis	PLOS ONE			English	Article							BUFFER RESPONSE; BLOOD-FLOW; CCL4-CIRRHOTIC LIVER; INTRINSIC REGULATION; NITRIC-OXIDE; HYPOXIA; VEIN; RAT; TRANSPLANTATION; HYPERPERFUSION	Introduction The compensatory increase in hepatic arterial flow with a decrease in portal venous flow is known as the hepatic arterial buffer response. In cirrhosis with elevated portal pressure, the vascular resistance of the hepatic artery is decreased. Whether this lower resistance of the hepatic artery is a consequence of portal hypertension or not remains unknown. Study Aim The aim of the study was to investigate the hepatic arterial resistance and response to vasoconstriction in cirrhosis without portal hypertension (normal portal resistance). Methods Cirrhosis was induced by CCl4-inhalation for 8 weeks (8W, normal portal resistance) and for 12-14 weeks (12W, elevated portal resistance). Bivascular liver perfusion was performed at 8W or 12W and dose response curves of methoxamine were obtained in the presence or absence of LNMMA (nitric oxide synthase blocker). Vascular resistances of the hepatic artery (HAR), portal vein (PVR) and sinusoids (SVR) were measured. Western Blot (WB) and Immunohistochemistry (IHC) were done to measure eNOS and HIF 1a expression. Results HAR in both groups of cirrhotic animals (8W and 12W) were lower compared to controls. Dose response curves to methoxamine revealed lower HAR in both cirrhotic models (8W and 12W) regardless the magnitude of portal resistance. LNMMA corrected the dose response curves in cirrhosis (8W and 12W) to control. WB and IHC show increased protein expression of eNOS and HIF1a in 8W and 12W. Conclusion Hepatic arterial resistance is decreased in cirrhosis independent of portal resistance. Vasodilation of the hepatic artery in cirrhosis seems to be influenced by hypoxia rather than increase in portal resistance. Nitric oxide is the main vasodilator.	[Moeller, Miriam; Thonig, Antje; Pohl, Sabine; Ripoll, Cristina; Zipprich, Alexander] Univ Halle Wittenberg, Dept Internal Med 1, D-06108 Halle, Germany	Martin Luther University Halle Wittenberg	Zipprich, A (corresponding author), Univ Halle Wittenberg, Dept Internal Med 1, D-06108 Halle, Germany.	alexander.zipprich@medizin.uni-halle.de	Ripoll, Cristina/AAF-6497-2019	Moller, Miriam/0000-0002-0948-9469				Cejudo-Martin P, 2002, HEPATOLOGY, V36, P1172, DOI 10.1053/jhep.2002.36371; Corpechot C, 2002, HEPATOLOGY, V35, P1010, DOI 10.1053/jhep.2002.32524; Demetris AJ, 2006, AM J SURG PATHOL, V30, P986, DOI 10.1097/00000478-200608000-00009; El-Desoky AEH, 2000, EUR SURG RES, V32, P207, DOI 10.1159/000008766; Fondevila C, 2010, LIVER TRANSPLANT, V16, P364, DOI 10.1002/lt.21989; Gracia-Sancho J, 2011, GUT, V60, P517, DOI 10.1136/gut.2010.220913; Iwakiri Y, 2008, HEPATOLOGY, V47, P1754, DOI 10.1002/hep.22203; James PE, 2002, NITRIC OXIDE-BIOL CH, V6, P18, DOI 10.1006/niox.2001.0383; Kleber G, 1999, GASTROENTEROLOGY, V116, P906, DOI 10.1016/S0016-5085(99)70074-0; LAUTT WW, 1990, GASTROENTEROLOGY, V98, P1024, DOI 10.1016/0016-5085(90)90029-Z; LAUTT WW, 1985, AM J PHYSIOL, V249, pG549, DOI 10.1152/ajpgi.1985.249.5.G549; Lautt WW, 1996, CAN J PHYSIOL PHARM, V74, P223, DOI 10.1139/cjpp-74-3-223; Lautt WW, 1985, AM J PHYSL; Marrone G, 2013, J HEPATOL, V58, P98, DOI 10.1016/j.jhep.2012.08.026; Mucke I, 2000, INT J COLORECTAL DIS, V15, P335, DOI 10.1007/s003840000247; Nagula S, 2006, J HEPATOL, V44, P111, DOI 10.1016/j.jhep.2005.07.036; Richter S, 2000, AM J PHYSIOL-GASTR L, V279, pG454, DOI 10.1152/ajpgi.2000.279.2.G454; Richter S, 2001, ANESTH ANALG, V93, P872, DOI 10.1097/00000539-200110000-00014; Richter S, 2001, J PHYSIOL-LONDON, V531, P193, DOI 10.1111/j.1469-7793.2001.0193j.x; Rosmorduc O, 1999, AM J PATHOL, V155, P1065, DOI 10.1016/S0002-9440(10)65209-1; Smyrniotis V, 2002, TRANSPL INT, V15, P355, DOI 10.1111/j.1432-2277.2002.tb00178.x; Sohail MA, 2009, HEPATOLOGY, V49, P185, DOI 10.1002/hep.22589; Zipprich A, 2003, HEPATOLOGY, V37, P385, DOI 10.1053/jhep.2003.50065; Zipprich A, 2008, J HEPATOL, V49, P739, DOI 10.1016/j.jhep.2008.06.027; Zipprich A, 2008, AM J PHYSIOL-GASTR L, V295, pG197, DOI 10.1152/ajpgi.00190.2007; Zipprich A, 2007, J CLIN GASTROENTEROL, V41, pS254, DOI 10.1097/MCG.0b013e318150d3b5; Zipprich A, 2010, LIVER INT, V30, P988, DOI 10.1111/j.1478-3231.2010.02278.x	27	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0121229	10.1371/journal.pone.0121229	http://dx.doi.org/10.1371/journal.pone.0121229			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25793622	Green Published, gold, Green Submitted			2022-12-27	WOS:000352083900114
J	Morishita, S; Takahashi, K; Araki, M; Hironaka, Y; Sunami, Y; Edahiro, Y; Tsutsui, M; Ohsaka, A; Tsuneda, S; Komatsu, N				Morishita, Soji; Takahashi, Kochi; Araki, Marito; Hironaka, Yumi; Sunami, Yoshitaka; Edahiro, Yoko; Tsutsui, Miyuki; Ohsaka, Akimichi; Tsuneda, Satoshi; Komatsu, Norio			Melting Curve Analysis after T Allele Enrichment (MelcaTle) as a Highly Sensitive and Reliable Method for Detecting the JAK2V617F Mutation	PLOS ONE			English	Article							PEPTIDE-NUCLEIC-ACID; JAK2 V617F MUTATION; REAL-TIME PCR; CHRONIC MYELOPROLIFERATIVE DISORDERS; TYROSINE KINASE JAK2; POLYCYTHEMIA-VERA; QUANTIFICATION; DIAGNOSIS; PROBE; NEOPLASMS	Detection of the JAK2V617F mutation is essential for diagnosing patients with classical myeloproliferative neoplasms (MPNs). However, detection of the low-frequency JAK2V617F mutation is a challenging task due to the necessity of discriminating between true-positive and false-positive results. Here, we have developed a highly sensitive and accurate assay for the detection of JAK2V617F and named it melting curve analysis after T allele enrichment (MelcaTle). MelcaTle comprises three steps: 1) two cycles of JAK2V617F allele enrichment by PCR amplification followed by BsaXI digestion, 2) selective amplification of the JAK2V617F allele in the presence of a bridged nucleic acid (BNA) probe, and 3) a melting curve assay using a BODIPY-FL-labeled oligonucleotide. Using this assay, we successfully detected nearly a single copy of the JAK2V617F allele, without false-positive signals, using 10 ng of genomic DNA standard. Furthermore, MelcaTle showed no positive signals in 90 assays screening healthy individuals for JAK2V617F. When applying MelcaTle to 27 patients who were initially classified as JAK2V617F-positive on the basis of allele-specific PCR analysis and were thus suspected as having MPNs, we found that two of the patients were actually JAK2V617F-negative. A more careful clinical data analysis revealed that these two patients had developed transient erythrocytosis of unknown etiology but not polycythemia vera, a subtype of MPNs. These findings indicate that the newly developed MelcaTle assay should markedly improve the diagnosis of JAK2V617F-positive MPNs.	[Morishita, Soji; Araki, Marito; Ohsaka, Akimichi] Juntendo Univ, Grad Sch Med, Dept Transfus Med & Stem Cell Regulat, Tokyo 113, Japan; [Takahashi, Kochi; Tsuneda, Satoshi] Waseda Univ, Dept Life Sci & Med Biosci, Tokyo, Japan; [Takahashi, Kochi; Hironaka, Yumi; Sunami, Yoshitaka; Edahiro, Yoko; Tsutsui, Miyuki; Komatsu, Norio] Juntendo Univ, Sch Med, Dept Hematol, Tokyo 113, Japan	Juntendo University; Waseda University; Juntendo University	Komatsu, N (corresponding author), Juntendo Univ, Sch Med, Dept Hematol, Tokyo 113, Japan.	komatsun@juntendo.ac.jp	Araki, Marito/T-4283-2019	Araki, Marito/0000-0002-3502-5000	Japan Society for the Promotion of Science (JSPS) KAKENHI grant [25860416]; Ministry of Health, Labor and Welfare [14700000340]	Japan Society for the Promotion of Science (JSPS) KAKENHI grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Ministry of Health, Labor and Welfare(Ministry of Health, Labour and Welfare, Japan)	This work was funded by Japan Society for the Promotion of Science (JSPS) (http://www.jsps.go.jp/english/e-grants/) KAKENHI grant #25860416 (SM) and by Research on Measures for Intractable Diseases, Health Labor Sciences Research Grant from The Ministry of Health, Labor and Welfare (http://www.mhlw.go.jp/english/) project #14700000340 (NK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baxter EJ, 2005, LANCET, V365, P1054, DOI 10.1016/S0140-6736(05)71142-9; Bentin T, 2003, BIOCHEMISTRY-US, V42, P13987, DOI 10.1021/bi0351918; Cankovic M, 2009, AM J CLIN PATHOL, V132, P713, DOI 10.1309/AJCPFHUQZ9AGUEKA; Huijsmans CJJ, 2011, J MOL DIAGN, V13, P558, DOI 10.1016/j.jmoldx.2011.04.002; James C, 2005, NATURE, V434, P1144, DOI 10.1038/nature03546; Jelinek J, 2005, BLOOD, V106, P3370, DOI 10.1182/blood-2005-05-1800; Jovanovic JV, 2013, LEUKEMIA, V27, P2032, DOI 10.1038/leu.2013.219; KOMATSU N, 1993, BLOOD, V82, P456; Kralovics R, 2005, NEW ENGL J MED, V352, P1779, DOI 10.1056/NEJMoa051113; Kurata S, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.6.e34; Larsen TS, 2007, BRIT J HAEMATOL, V136, P745, DOI 10.1111/j.1365-2141.2007.06497.x; Levine RL, 2005, CANCER CELL, V7, P387, DOI 10.1016/j.ccr.2005.03.023; Li J, 2011, CLIN CHEM, V57, P770, DOI 10.1373/clinchem.2010.157784; Lippert E, 2006, BLOOD, V108, P1865, DOI 10.1182/blood-2006-01-013540; Lippert E, 2014, HAEMATOLOGICA, V99, DOI 10.3324/haematol.2014.107656; Lippert E, 2009, HAEMATOL-HEMATOL J, V94, P38, DOI 10.3324/haematol.13486; Miller JC, 2007, NAT BIOTECHNOL, V25, P778, DOI 10.1038/nbt1319; Morishita S, 2011, LEUKEMIA RES, V35, P1632, DOI 10.1016/j.leukres.2011.06.016; Murugesan G, 2006, AM J CLIN PATHOL, V125, P625, DOI 10.1309/TK0XL917XK2VLRPQ; Oh JE, 2010, J MOL DIAGN, V12, P418, DOI 10.2353/jmoldx.2010.090146; Poodt J, 2006, HEMATOL ONCOL, V24, P227, DOI 10.1002/hon.800; Quentmeier H, 2006, LEUKEMIA, V20, P471, DOI 10.1038/sj.leu.2404081; Rapado I, 2008, ANN HEMATOL, V87, P741, DOI 10.1007/s00277-008-0512-x; Shepard GC, 2011, INT J LAB HEMATOL, V33, P267, DOI 10.1111/j.1751-553X.2010.01282.x; Tani H, 2009, ANAL CHEM, V81, P5678, DOI 10.1021/ac900414u; Tefferi A, 2008, LEUKEMIA, V22, P14, DOI 10.1038/sj.leu.2404955; Torigoe H, 2012, J BIOCHEM, V152, P17, DOI 10.1093/jb/mvs049; Zhao AH, 2011, J HEMATOL ONCOL, V4, DOI 10.1186/1756-8722-4-40	28	5	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0122003	10.1371/journal.pone.0122003	http://dx.doi.org/10.1371/journal.pone.0122003			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25794279	Green Submitted, Green Published, gold			2022-12-27	WOS:000352083900164
J	Urbano, J; Gonzalez, R; Lopez, J; Solana, MJ; Bellon, JM; Botran, M; Garcia, A; Fernandez, SN; Lopez-Herce, J				Urbano, Javier; Gonzalez, Rafael; Lopez, Jorge; Solana, Maria J.; Bellon, Jose M.; Botran, Marta; Garcia, Ana; Fernandez, Sarah N.; Lopez-Herce, Jesus			Comparison of Normal Saline, Hypertonic Saline Albumin and Terlipressin plus Hypertonic Saline Albumin in an Infant Animal Model of Hypovolemic Shock	PLOS ONE			English	Article							UNCONTROLLED HEMORRHAGIC-SHOCK; RANDOMIZED CONTROLLED-TRIAL; FLUID RESUSCITATION; HYPERTONIC/HYPERONCOTIC SOLUTION; CEREBRAL OXYGENATION; ARGININE-VASOPRESSIN; SEPTIC SHOCK; BLOOD-VOLUME; MAJOR TRAUMA; SWINE	Introduction In series of cases and animal models suffering hemorrhagic shock, the use of vasopressors has shown potential benefits regarding hemodynamics and tissue perfusion. Terlipressin is an analogue of vasopressin with a longer half-life that can be administered by bolus injection. We have previously observed that hypertonic albumin improves resuscitation following controlled hemorrhage in piglets. The aim of the present study was to analyze whether the treatment with the combination of terlipressin and hypertonic albumin can produce better hemodynamic and tissular perfusion parameters than normal saline or hypertonic albumin alone at early stages of hemorrhagic shock in an infant animal model. Methods Experimental, randomized animal study including 39 2-to-3-month-old piglets. Thirty minutes after controlled 30 ml/kg bleed, pigs were randomized to receive either normal saline (NS) 30 ml/kg (n = 13), 5% albumin plus 3% hypertonic saline (AHS) 15 ml/kg (n = 13) or single bolus of terlipressin 15 mu g/kg i.v. plus 5% albumin plus 3% hypertonic saline 15 ml/kg (TAHS) (n = 13) over 30 minutes. Global hemodynamic and tissular perfusion parameters were compared. Results After controlled bleed a significant decrease of blood pressure, cardiac index, central venous saturation, carotid and peripheral blood flow, brain saturation and an increase of heart rate, gastric PCO2 and lactate was observed. After treatment no significant differences in most hemodynamic (cardiac index, mean arterial pressure) and perfusion parameters (lactate, gastric PCO2, brain saturation, cutaneous blood flow) were observed between the three therapeutic groups. AHS and TAHS produced higher increase in stroke volume index and carotid blood flow than NS. Conclusions In this pediatric animal model of hypovolemic shock, albumin plus hypertonic saline with or without terlipressin achieved similar hemodynamics and perfusion parameters than twice the volume of NS. Addition of terlipressin did not produce better results than AHS.	[Urbano, Javier; Gonzalez, Rafael; Lopez, Jorge; Solana, Maria J.; Botran, Marta; Garcia, Ana; Fernandez, Sarah N.; Lopez-Herce, Jesus] Gregorio Maranon Univ Hosp, Pediat Intens Care Dept, Madrid, Spain; [Urbano, Javier; Gonzalez, Rafael; Lopez, Jorge; Solana, Maria J.; Botran, Marta; Garcia, Ana; Fernandez, Sarah N.; Lopez-Herce, Jesus] Spanish Hlth Inst Carlos III, Res Network Maternal & Child Hlth & Dev RedSAMID, Inst Invest Sanitaria Hosp Gregorio Maranon IiSGM, Madrid, Spain; [Urbano, Javier; Gonzalez, Rafael; Lopez, Jorge; Lopez-Herce, Jesus] Spanish Hlth Inst Carlos III, Hlth Res Fund, Madrid, Spain; [Bellon, Jose M.] Inst Invest Sanitaria Hosp Gregorio Maranon Madri, Prevent & Qual Control Serv, Madrid, Spain	General University Gregorio Maranon Hospital	Urbano, J (corresponding author), Gregorio Maranon Univ Hosp, Pediat Intens Care Dept, Madrid, Spain.	javierurbanovillaescusa@gmail.com	Cano, Jose Maria Bellon/G-3061-2012; Lopez-Herce, Jesus/A-1602-2019; Lopez, Jorge/AAD-4109-2022; Cortes, Rafael Gonzalez/ABB-4855-2020; Fernandez Lafever, Sarah Nicole/AAE-4978-2022; Bellon-Cano, José María/G-6120-2016	Cano, Jose Maria Bellon/0000-0002-8492-1565; Lopez-Herce, Jesus/0000-0001-6105-9178; Lopez, Jorge/0000-0002-9942-6399; Cortes, Rafael Gonzalez/0000-0002-3259-7898; Fernandez Lafever, Sarah Nicole/0000-0003-4859-5966; Bellon-Cano, José María/0000-0002-8492-1565; Urbano, Javier/0000-0002-3511-2905; SOLANA, MARIA JOSE/0000-0001-6083-2528	Francisco Ruza Research Grant of the Spanish Society of Pediatric Intensive Care Medicine (SECIP); Health Research Fund (FIS) of the Carlos III Health Institute (ISCIII), Madrid Spain [PI14/02046]	Francisco Ruza Research Grant of the Spanish Society of Pediatric Intensive Care Medicine (SECIP); Health Research Fund (FIS) of the Carlos III Health Institute (ISCIII), Madrid Spain	Funding: This study was supported by the Francisco Ruza Research Grant of the Spanish Society of Pediatric Intensive Care Medicine (SECIP), 2012, https://www.secip.com/congresos-secip/congresos-secip/xxvii-congreso-secip. This study was supported by the Research Grant PI14/02046, from the Health Research Fund (FIS), of the Carlos III Health Institute (ISCIII), Madrid Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand T, 2012, J SURG RES, V178, P321, DOI 10.1016/j.jss.2012.02.062; Balogh Z, 2003, ARCH SURG-CHICAGO, V138, P637, DOI 10.1001/archsurg.138.6.637; Barbee RW, 2010, SHOCK, V33, P113, DOI 10.1097/SHK.0b013e3181b8569d; Bayram B, 2012, AM J EMERG MED, V30, P1176, DOI 10.1016/j.ajem.2011.09.007; Bein B, 2005, EUR J ANAESTH, V22, P62, DOI 10.1017/S026502150500013X; Borrego R, 2006, PEDIATR CRIT CARE ME, V7, P267, DOI 10.1097/01.PCC.0000216419.84855.D6; Bulger EM, 2011, ANN SURG, V253, P431, DOI 10.1097/SLA.0b013e3181fcdb22; Calvete JO, 2008, REV ASSOC MED BRAS, V54, P116, DOI 10.1590/S0104-42302008000200012; Carcillo JA, 2002, CRIT CARE MED, V30, P1365, DOI 10.1097/00003246-200206000-00040; Choong K, 2009, AM J RESP CRIT CARE, V180, P632, DOI 10.1164/rccm.200902-0221OC; Cossu AP, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/421291; Cotton BA, 2006, SHOCK, V26, P115, DOI 10.1097/01.shk.0000209564.84822.f2; Devlin JJ, 2013, J EMERG MED, V45, P78, DOI 10.1016/j.jemermed.2012.12.023; DYKES EH, 1989, J PEDIATR SURG, V24, P107, DOI 10.1016/S0022-3468(89)80312-4; Johnson KB, 2006, J CARDIOTHOR VASC AN, V20, P167, DOI 10.1053/j.jvca.2005.11.015; Junger WG, 2012, SHOCK, V38, P341, DOI 10.1097/SHK.0b013e3182635aca; KAWESKI SM, 1990, J TRAUMA, V30, P1215, DOI 10.1097/00005373-199010000-00005; Kentner R, 2005, RESUSCITATION, V65, P87, DOI 10.1016/j.resuscitation.2004.10.012; Krismer AC, 2005, ANAESTHESIST, V54, P220, DOI 10.1007/s00101-004-0793-y; Lee CC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095821; Lopez-Herce J, 2006, RESUSCITATION, V68, P259, DOI 10.1016/j.resuscitation.2005.06.014; Meybohm P, 2007, PEDIATR RES, V62, P440, DOI 10.1203/PDR.0b013e3181425858; Meybohm P, 2007, J TRAUMA, V62, P640, DOI 10.1097/01.ta.0000240962.62319.c8; Meyer S, 2011, WIEN MED WOCHENSCHR, V161, P192, DOI 10.1007/s10354-010-0853-7; Ng KFJ, 2002, BRIT J ANAESTH, V88, P475, DOI 10.1093/bja/88.4.475; Rodriguez-Nunez A, 2010, ANN PHARMACOTHER, V44, P1545, DOI 10.1345/aph.1P254; Schmelzer TM, 2008, AM J EMERG MED, V26, P119, DOI 10.1016/j.ajem.2007.01.024; Skhirtladze K, 2014, BRIT J ANAESTH, V112, P255, DOI 10.1093/bja/aet348; Somasetia DH, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0466-4; Sondeen JL, 2007, SHOCK, V28, P426, DOI 10.1097/shk.0b013e31804a5791; Spahn DR, 2013, CRIT CARE, V17, DOI 10.1186/cc12685; Trzeciak S, 2008, INTENS CARE MED, V34, P2210, DOI 10.1007/s00134-008-1193-6; Urbano J, 2012, RESUSCITATION, V83, P1159, DOI 10.1016/j.resuscitation.2012.02.003; Wade CE, 1997, SURGERY, V122, P609, DOI 10.1016/S0039-6060(97)90135-5; Walley KR, 2011, AM J RESP CRIT CARE, V184, P514, DOI 10.1164/rccm.201010-1584CI; Watters JM, 2006, J TRAUMA, V61, P300, DOI 10.1097/01.ta.0000224211.36154.44; Watters JM, 2006, J TRAUMA, V61, P75, DOI 10.1097/01.ta.0000222723.54559.47; Yoo JH, 2007, J VET MED SCI, V69, P459, DOI 10.1292/jvms.69.459; Younes RN, 1997, SHOCK, V7, P79, DOI 10.1097/00024382-199702000-00001	40	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0121678	10.1371/journal.pone.0121678	http://dx.doi.org/10.1371/journal.pone.0121678			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25794276	gold, Green Published, Green Submitted			2022-12-27	WOS:000352083900146
J	Czemmel, S; Galarneau, ER; Travadon, R; McElrone, AJ; Cramer, GR; Baumgartner, K				Czemmel, Stefan; Galarneau, Erin R.; Travadon, Renaud; McElrone, Andrew J.; Cramer, Grant R.; Baumgartner, Kendra			Genes Expressed in Grapevine Leaves Reveal Latent Wood Infection by the Fungal Pathogen Neofusicoccum parvum	PLOS ONE			English	Article							CV CABERNET-SAUVIGNON; ESCA DISEASE; EUTYPA-LATA; PLANT; BOTRYOSPHAERIACEAE; TRANSCRIPTOME; TRUNK; XYLEM; INOCULATION; ENDOPHYTES	Some pathogenic species of the Botryosphaeriaceae have a latent phase, colonizing woody tissues while perennial hosts show no apparent symptoms until conditions for disease development become favorable. Detection of these pathogens is often limited to the later pathogenic phase. The latent phase is poorly characterized, despite the need for non-destructive detection tools and effective quarantine strategies, which would benefit from identification of host-based markers in leaves. Neofusicoccum parvum infects the wood of grapevines and other horticultural crops, killing the fruit-bearing shoots. We used light microscopy and high-resolution computed tomography (HRCT) to examine the spatiotemporal relationship between pathogen colonization and anatomical changes in stem sections. To identify differentially-expressed grape genes, leaves from inoculated and noninoculated plants were examined using RNA-Seq. The latent phase occurred between 0 and 1.5 months post-inoculation (MPI), during which time the pathogen did not spread significantly beyond the inoculation site nor were there differences in lesion lengths between inoculated and non-inoculated plants. The pathogenic phase occurred between 1.5 and 2 MPI, when recovery beyond the inoculation site increased and lesion lengths of inoculated plants tripled. By 2 MPI, inoculated plants also had decreased starch content in xylem fibers and rays, and increased levels of gel-occluded xylem vessels, the latter of which HRCT revealed at a higher frequency than microscopy. RNA-Seq and screening of 21 grape expression datasets identified 20 candidate genes that were transcriptionally-activated by infection during the latent phase, and confirmed that the four best candidates (galactinol synthase, abscisic acid-induced wheat plasma membrane polypeptide-19 ortholog, embryonic cell protein 63, BURP domain-containing protein) were not affected by a range of common foliar and wood pathogens or abiotic stresses. Assuming such host responses are consistent among cultivars, and do not cross react with other trunk/foliar pathogens, these grape genes may serve as host-based markers of the latent phase of N. parvum infection.	[Czemmel, Stefan; Cramer, Grant R.] Univ Nevada, Dept Biochem & Mol Biol, Reno, NV 89557 USA; [Galarneau, Erin R.; McElrone, Andrew J.; Baumgartner, Kendra] USDA ARS, Davis, CA 94710 USA; [Travadon, Renaud] Univ Calif Davis, Dept Plant Pathol, Davis, CA 95616 USA	Nevada System of Higher Education (NSHE); University of Nevada Reno; United States Department of Agriculture (USDA); University of California System; University of California Davis	Baumgartner, K (corresponding author), USDA ARS, Davis, CA 94710 USA.	kbaumgartner@ucdavis.edu	Cramer, Grant R/E-1815-2011	Travadon, Renaud/0000-0001-6062-1755; McElrone, Andrew/0000-0001-9466-4761	United States Department of Agriculture, National Institute of Food and Agriculture, Specialty Crop Research Initiative [2012-51181-19954]; ARS [ARS-0426234] Funding Source: Federal RePORTER	United States Department of Agriculture, National Institute of Food and Agriculture, Specialty Crop Research Initiative; ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This research was funded by grant 2012-51181-19954 to Baumgartner and Cramer from the United States Department of Agriculture, National Institute of Food and Agriculture, Specialty Crop Research Initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahimera N, 2003, PLANT DIS, V87, P846, DOI 10.1094/PDIS.2003.87.7.846; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Berger S, 2007, J EXP BOT, V58, P4019, DOI 10.1093/jxb/erm298; Bertsch C, 2013, PLANT PATHOL, V62, P243, DOI 10.1111/j.1365-3059.2012.02674.x; Blanco-Ulate B, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.00339-13; Bogs J, 2005, PLANT PHYSIOL, V139, P652, DOI 10.1104/pp.105.064238; Brodersen CR, 2011, NEW PHYTOL, V191, P1168, DOI 10.1111/j.1469-8137.2011.03754.x; Brunner E, 2002, NONPARAMETRIC ANAL L; Camps C, 2010, J EXP BOT, V61, P1719, DOI 10.1093/jxb/erq040; Christen D, 2007, ENVIRON EXP BOT, V60, P504, DOI 10.1016/j.envexpbot.2007.02.003; De Vos M, 2005, MOL PLANT MICROBE IN, V18, P923, DOI 10.1094/MPMI-18-0923; Downey MO, 2003, AUST J GRAPE WINE R, V9, P110, DOI 10.1111/j.1755-0238.2003.tb00261.x; Fasoli M, 2012, PLANT CELL, V24, P3489, DOI 10.1105/tpc.112.100230; Fung RWM, 2008, PLANT PHYSIOL, V146, P236, DOI 10.1104/pp.107.108712; Gambino G, 2008, PHYTOCHEM ANALYSIS, V19, P520, DOI 10.1002/pca.1078; HammondKosack KE, 1996, PLANT CELL, V8, P1773, DOI 10.1105/tpc.8.10.1773; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Letousey P, 2010, PHYTOPATHOLOGY, V100, P424, DOI 10.1094/PHYTO-100-5-0424; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lima MRM, 2010, J EXP BOT, V61, P4033, DOI 10.1093/jxb/erq214; Liu GT, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-174; Luini E, 2010, PHYSIOL MOL PLANT P, V74, P403, DOI 10.1016/j.pmpp.2010.06.007; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Magnin-Robert M, 2011, FUNCT PLANT BIOL, V38, P856, DOI 10.1071/FP11083; Martin JA, 2005, PHYTOCHEMISTRY, V66, P2458, DOI 10.1016/j.phytochem.2005.08.004; Martinelli F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038039; McElrone AJ, 2013, JOVE-J VIS EXP, DOI 10.3791/50162; MUNKVOLD GP, 1994, PHYTOPATHOLOGY, V84, P186, DOI 10.1094/Phyto-84-186; Pontin MA, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-224; Pouzoulet J, 2013, PHYTOPATHOL MEDITERR, V52, P313; Ramirez-Suero M, 2014, PROTOPLASMA, V251, P1417, DOI 10.1007/s00709-014-0643-y; Rolshausen PE, 2008, PHYTOPATHOLOGY, V98, P222, DOI 10.1094/PHYTO-98-2-0222; Rolshausen PE, 2005, PLANT DIS, V89, P734, DOI 10.1094/PD-89-0734; Rolshausen PE, 2010, AM J ENOL VITICULT, V61, P113; Rudelle J, 2005, FUNCT PLANT BIOL, V32, P537, DOI 10.1071/FP05012; Ruiz E, 2002, J PHYTOPATHOL, V150, P76, DOI 10.1046/j.1439-0434.2002.00720.x; Saikkonen K, 1998, ANNU REV ECOL SYST, V29, P319, DOI 10.1146/annurev.ecolsys.29.1.319; Shah DA, 2004, PHYTOPATHOLOGY, V94, P33, DOI 10.1094/PHYTO.2004.94.1.33; Siebert J.B., 2001, WINES VINES, V4, P50; Slippers Bernard, 2007, Fungal Biology Reviews, V21, P90, DOI 10.1016/j.fbr.2007.06.002; Spagnolo A, 2014, PHYTOPATHOLOGY, V104, P1021, DOI 10.1094/PHYTO-01-14-0007-R; Sun Q, 2006, AM J BOT, V93, P1567, DOI 10.3732/ajb.93.11.1567; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Travadon R, 2013, PLANT DIS, V97, P1529, DOI 10.1094/PDIS-05-13-0525-RE; Urbez-Torres JR, 2010, PLANT DIS, V94, P717, DOI 10.1094/PDIS-94-6-0717; Urbez-Torres JR, 2011, PHYTOPATHOL MEDITERR, V50, pS5; van der Laan MJ, 2003, J STAT PLAN INFER, V117, P275, DOI 10.1016/S0378-3758(02)00388-9; VERAESTRELLA R, 1994, PLANT PHYSIOL, V106, P97, DOI 10.1104/pp.106.1.97; Voegele RT, 2001, P NATL ACAD SCI USA, V98, P8133, DOI 10.1073/pnas.131186798; Weber EA, 2007, AM J ENOL VITICULT, V58, P61; Wilcox WW, 1964, FPL056 USDA FOR SERV; Ye J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-134	53	37	37	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0121828	10.1371/journal.pone.0121828	http://dx.doi.org/10.1371/journal.pone.0121828			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25798871	Green Published, Green Submitted, gold			2022-12-27	WOS:000351987300294
J	Dutta, N; Lashmit, P; Yuan, JX; Meier, J; Stinski, MF				Dutta, Nirmal; Lashmit, Philip; Yuan, Jinxiang; Meier, Jeffery; Stinski, Mark F.			The Human Cytomegalovirus UL133-138 Gene Locus Attenuates the Lytic Viral Cycle in Fibroblasts	PLOS ONE			English	Article							IE86 PROTEIN; EXPRESSION; PROMOTER; ACCUMULATION; REQUIREMENT; ACTIVATION; ENHANCER	The genomes of HCMV clinical strains (e.g. FIX, TR, PH, etc) contain a 15 kb region that encodes 20 putative ORFs. The region, termed ULb', is lost after serial passage of virus in human foreskin fibroblast (HFF) cell culture. Compared to clinical strains, laboratory strains replicate faster and to higher titers of infectious virus. We made recombinant viruses with 22, 14, or 7 ORFs deleted from the ULb' region using FIX and TR as model clinical strains. We also introduced a stop codon into single ORFs between UL133 and UL138 to prevent protein expression. All deletions within ULb' and all stop codon mutants within the UL133 to UL138 region increased to varying degrees, viral major immediate early RNA and protein, DNA, and cell-free infectious virus compared to the wild type viruses. The wild type viral proteins slowed down the viral replication process along with cell-free infectious virus release from human fibroblast cells.	[Dutta, Nirmal; Yuan, Jinxiang; Meier, Jeffery] Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA; [Lashmit, Philip] Univ Iowa, Ctr Biocatalysis & Bioproc, Iowa City, IA USA; [Meier, Jeffery] Iowa Vet Affairs Healthcare Syst, Iowa City, IA USA; [Stinski, Mark F.] Univ Iowa, Dept Microbiol, Iowa City, IA 52242 USA	University of Iowa; University of Iowa; US Department of Veterans Affairs; Veterans Health Administration (VHA); Iowa City VA Health Care System; University of Iowa	Stinski, MF (corresponding author), Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA.	mark-stinski@uiowa.edu		Meier, Jeffery/0000-0001-9491-1697	Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Biomedical Laboratory Research and Development [1BX001107-01 (JLM and JY)]; National Institutes of Health [AI-13562]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI013562, R01AI013562] Funding Source: NIH RePORTER	Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Biomedical Laboratory Research and Development(US Department of Veterans Affairs); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by the Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Biomedical Laboratory Research and Development 1BX001107-01 (JLM and JY) and by grant AI-13562 from the National Institutes of Health (MFS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boeckh M, 2011, J CLIN INVEST, V121, P1673, DOI 10.1172/JCI45449; Bughio F, 2013, J VIROL, V87, P3062, DOI 10.1128/JVI.02510-12; Cha TA, 1996, J VIROL, V70, P78, DOI 10.1128/JVI.70.1.78-83.1996; Compton T, 2003, J VIROL, V77, P4588, DOI 10.1128/JVI.77.8.4588-4596.2003; Du GX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081583; Du GX, 2011, J VIROL, V85, P804, DOI 10.1128/JVI.01173-10; Goodrum F, 2007, BLOOD, V110, P937, DOI 10.1182/blood-2007-01-070078; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; Grainger L, 2010, J VIROL, V84, P9472, DOI 10.1128/JVI.00855-10; Homer EG, 1999, J VIROL, V73, P8512, DOI 10.1128/JVI.73.10.8512-8518.1999; Isomura H, 2008, J VIROL, V82, P1638, DOI 10.1128/JVI.01917-07; Isomura H, 2008, J VIROL, V82, P849, DOI 10.1128/JVI.01593-07; Lee EC, 2001, GENOMICS, V73, P56, DOI 10.1006/geno.2000.6451; Liu XQ, 2010, J VIROL, V84, P8495, DOI 10.1128/JVI.00416-10; Meier JL, 2006, CYTOMEGALOVIRUSES: MOLECULAR BIOLOGY AND IMMUNOLOGY, P151; Meier JL, 2002, J VIROL, V76, P313, DOI 10.1128/JVI.76.1.313-326.2002; Mocarski E., 2007, FIELDS VIROLOGY; Montag C, 2011, J VIROL, V85, P11409, DOI 10.1128/JVI.05028-11; Murphy E, 2003, P NATL ACAD SCI USA, V100, P14976, DOI 10.1073/pnas.2136652100; Petrik DT, 2006, J VIROL, V80, P3872, DOI 10.1128/JVI.80.8.3872-3883.2006; Petrik DT, 2007, J VIROL, V81, P5807, DOI 10.1128/JVI.02437-06; Petrucelli A, 2012, J VIROL, V86, P8653, DOI 10.1128/JVI.00465-12; Petrucelli A, 2009, J VIROL, V83, P5615, DOI 10.1128/JVI.01989-08; Sanchez V, 2004, J VIROL, V78, P11219, DOI 10.1128/JVI.78.20.11219-11232.2004; STENBERG RM, 1984, J VIROL, V49, P190, DOI 10.1128/JVI.49.1.190-199.1984; Stern-Ginossar N, 2012, SCIENCE, V338, P1088, DOI 10.1126/science.1227919; Stinski MF, 2008, CURR TOP MICROBIOL, V325, P133; STINSKI MF, 1976, J VIROL, V19, P594, DOI 10.1128/JVI.19.2.594-609.1976; Umashankar M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002444; Wang WJ, 2005, J VIROL, V79, P2115, DOI 10.1128/JVI.79.4.2115-2123.2005	31	6	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0120946	10.1371/journal.pone.0120946	http://dx.doi.org/10.1371/journal.pone.0120946			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25799165	Green Submitted, Green Published, gold			2022-12-27	WOS:000351987300197
J	Guildea, C; Hitchen, Y; Duffy, R; Dias, PJ; Ledger, JM; Snow, M; Kennington, WJ				Guildea, Clodagh; Hitchen, Yvette; Duffy, Rodney; Dias, P. Joana; Ledger, Jason M.; Snow, Michael; Kennington, W. Jason			Introgression Threatens the Survival of the Critically Endangered Freshwater Crayfish Cherax tenuimanus (Decapoda: Parastacidae) in the Wild	PLOS ONE			English	Article							ERICHSON DECAPODA; HAIRY MARRON; HYBRIDIZATION; EXTINCTION; INFERENCE; SOFTWARE; LOCI	Hybridization and genetic introgression following the introduction of exotic species can pose a significant threat to the survival of geographically restricted species. A remnant population of the critically endangered freshwater crayfish Cherax tenuimanus in the upper reaches of the Margaret River in southwestern Australia is under threat following the introduction and spread of its congener Cherax cainii. Here, we examine the extent of hybridization and introgression between the two species using twelve polymorphic microsatellite loci. Our study reveals there are three times more C. cainii than C. tenuimanus at our study site in the upper reaches of the Margaret River. There is also evidence of hybridization and introgression between C. tenuimanus and C. cainii at this site, with F-1, F-2 and backcrossed individuals identified. While interbreeding was confirmed in this study, our simulations suggest that the levels of introgression are much lower than would be expected under random mating, indicating partial reproductive barriers exist. Nevertheless, it is apparent that hybridization and introgression with C. cainii pose a serious threat to C. tenuimanus and their survival in the wild will require active adaptive management and continued genetic monitoring to evaluate management effectiveness.	[Guildea, Clodagh; Dias, P. Joana; Kennington, W. Jason] Univ Western Australia, Sch Anim Biol, Ctr Evolutionary Biol, Crawley, WA 6009, Australia; [Hitchen, Yvette] Helix Mol Solut, Leederville, WA 6903, Australia; [Duffy, Rodney; Dias, P. Joana; Snow, Michael] Govt Western Australia, Western Australian Fisheries & Marine Res Labs, Dept Fisheries, North Beach, WA 6920, Australia; [Ledger, Jason M.] Univ Western Australia, Sch Anim Biol, Crawley, WA 6009, Australia	University of Western Australia; Government of Western Australia; Western Australian Fisheries & Marine Research Laboratories; University of Western Australia	Kennington, WJ (corresponding author), Univ Western Australia, Sch Anim Biol, Ctr Evolutionary Biol, Crawley, WA 6009, Australia.	jason.kennington@uwa.edu.au	Kennington, Winn J/H-5182-2014; Dias, Patrícia/HGT-6805-2022	Kennington, Winn J/0000-0001-6100-6543; 	University of Western Australia; Western Australian Department of Fisheries	University of Western Australia; Western Australian Department of Fisheries	Financial support for this project was provided by The University of Western Australia and the Western Australian Department of Fisheries. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allendorf FW., 2009, CONSERV GENET; Anderson EC, 2002, GENETICS, V160, P1217; Austin CM, 1996, AUST J ZOOL, V44, P223, DOI 10.1071/ZO9960223; Austin CM, 2002, INVERTEBR SYST, V16, P357, DOI 10.1071/IT01010; Balloux F, 2001, J HERED, V92, P301, DOI 10.1093/jhered/92.3.301; Binks RM, 2007, CONSERV GENET, V8, P1421, DOI 10.1007/s10592-007-9293-3; Bunn JJS, 2004, INVESTIGATION REPLAC; Bunn John J.S., 2008, Freshwater Crayfish, V16, P113; de Graaf M, 2009, CRUSTACEANA, V82, P1469, DOI 10.1163/156854009X463937; Ellegren H, 2000, TRENDS GENET, V16, P551, DOI 10.1016/S0168-9525(00)02139-9; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Falush D, 2003, GENETICS, V164, P1567; Goudet J, 2002, MOL ECOL, V11, P1103, DOI 10.1046/j.1365-294X.2002.01496.x; Goudet J, 2002, FSTAT PROGRAM ESTIMA, DOI DOI 10.1093/OXFORDJOURNALS.JHERED.A111627; Hardig TM, 2005, CASTANEA, V70, P246, DOI 10.2179/0008-7475(2005)070[0246:MEOHBL]2.0.CO;2; Hausdorf B, 2011, EVOLUTION, V65, P923, DOI 10.1111/j.1558-5646.2011.01231.x; Homyack JA, 2008, AM MIDL NAT, V159, P504, DOI 10.1674/0003-0031(2008)159[504:CLLCLR]2.0.CO;2; Imgrund JA, 1998, POPULATION GENETIC A; Kennington WJ, 2014, CONSERV GENET RESOUR, V6, P337, DOI 10.1007/s12686-013-0088-1; Kennington WJ, 2012, MOL ECOL, V21, P3489, DOI 10.1111/j.1365-294X.2012.05636.x; Lawrence C, 2007, IMPROVED PERFORMANCE, V17, P40; Levin DA, 2002, AM SCI, V90, P254; Mack RN, 2000, ECOL APPL, V10, P689, DOI 10.1890/1051-0761(2000)010[0689:BICEGC]2.0.CO;2; Mooney HA, 2001, P NATL ACAD SCI USA, V98, P5446, DOI 10.1073/pnas.091093398; Perry WL, 2001, CONSERV BIOL, V15, P1656, DOI 10.1046/j.1523-1739.2001.00019.x; Perry WL, 2002, SYST BIOL, V51, P255, DOI 10.1080/10635150252899761; Pritchard JK, 2000, GENETICS, V155, P945; Rhymer JM, 1996, ANNU REV ECOL SYST, V27, P83, DOI 10.1146/annurev.ecolsys.27.1.83; Smith G., 1912, P ZOOL SOC LOND, V1912, P144, DOI [10. 1111/j. 1469-7998. 1912. tb07010. x, DOI 10.1111/J.1469-7998.1912.TB07010.X]; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; WRIGHT S, 1951, ANN EUGENIC, V15, P323; Young KA, 2004, ECOLOGY, V85, P134, DOI 10.1890/02-0402; [No title captured]	34	2	2	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0121075	10.1371/journal.pone.0121075	http://dx.doi.org/10.1371/journal.pone.0121075			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25799102	gold, Green Submitted, Green Published			2022-12-27	WOS:000351987300206
J	Jeong, WK; Kim, TY; Sohn, JH; Kim, Y; Kim, J				Jeong, Woo Kyoung; Kim, Tae Yeob; Sohn, Joo Hyun; Kim, Yongsoo; Kim, Jinoo			Severe Portal Hypertension in Cirrhosis: Evaluation of Perfusion Parameters with Contrast-Enhanced Ultrasonography	PLOS ONE			English	Article							DEGUM MULTICENTER TRIAL; TRANSIT-TIME ANALYSIS; FOCAL LIVER-LESIONS; VEIN WAVE-FORM; HEPATITIS-C; HEPATOCELLULAR-CARCINOMA; HEPATOPULMONARY SYNDROME; DOPPLER SONOGRAPHY; ULTRASOUND CEUS; DAMPING INDEX	Objective To investigate the role of contrast-enhanced ultrasonography (CEUS) and Doppler ultrasonography (DUS) in the diagnosis of severe portal hypertension (PH) in patients with liver cirrhosis (LC). Methods Patients with PH scheduled to receive hepatic venous pressure gradient (HVPG) measurement were recruited for this study. Hepatic DUS and CEUS were performed successively. Several Doppler and CEUS parameters were explored for correlation with HVPG values and their association with severe PH (>= 12 mmHg of HVPG). Comparison of the parameters between the severe and non-severe PH groups and their correlation with HVPG values was evaluated. A receiver operating characteristic (ROC) curve analysis was also performed to investigate the performance in order to diagnose severe PH. Results Fifty-three consecutive patients were enrolled in this study. Among them, 43 patients did not have significant ascites. Compared with the non-severe PH group, portal venous velocity and intrahepatic transit time (ITT) were significantly reduced in the severe PH group (all p<0.05). Difference between inspiratory and expiratory hepatic venous damping indices (.HVDI), hepatic venous arrival time (HVAT) and ITT moderately correlated with HVPG (r = -0.358, -0.338, and -0.613, respectively). Areas under the curves for severe PH were 0.94 of ITT and 0.72 of HVAT, respectively (all p<0.05). ITT under 6 seconds indicated severe PH with a sensitivity of 92% and a specificity of 89%. Conclusions Hepatic CEUS may be more useful in estimating the HVPG value and determining the presence of severe PH compared to DUS, and ITT was the most accurate parameter to diagnose severe PH.	[Jeong, Woo Kyoung] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Radiol, Seoul, South Korea; [Jeong, Woo Kyoung] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Ctr Imaging Sci, Seoul, South Korea; [Kim, Tae Yeob; Sohn, Joo Hyun] Hanyang Univ, Dept Internal Med, Guri Hosp, Coll Med, Guri Si, Gyeonggi Do, South Korea; [Kim, Yongsoo] Hanyang Univ, Dept Radiol, Guri Hosp, Coll Med, Guri Si, Gyeonggi Do, South Korea; [Kim, Jinoo] Ajou Univ, Dept Radiol, Ajou Univ Hosp, Coll Med, Suwon, Gyeonggi Do, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Hanyang University; Hanyang University; Ajou University; Ajou University Hospital	Sohn, JH (corresponding author), Hanyang Univ, Dept Internal Med, Guri Hosp, Coll Med, Guri Si, Gyeonggi Do, South Korea.	sonjh@hanyang.ac.kr	Jeong, Woo Kyoung/ABE-7025-2021	Jeong, Woo Kyoung/0000-0002-0676-2116; Kim, Jinoo/0000-0001-7238-2528				Albrecht T, 1999, LANCET, V353, P1579, DOI 10.1016/S0140-6736(98)06373-9; Baik SK, 2006, RADIOLOGY, V240, P574, DOI 10.1148/radiol.2402051142; Bendtsen F, 1999, LANCET, V354, P598, DOI 10.1016/S0140-6736(05)77953-8; Berzigottil A, 2012, ULTRASCHALL MED, V33, P8, DOI 10.1055/s-0031-1299145; Blomley MJK, 2003, GUT, V52, P1188, DOI 10.1136/gut.52.8.1188; D'Amico G, 2006, GASTROENTEROLOGY, V131, P1611, DOI 10.1053/j.gastro.2006.09.013; Gines P, 2010, J HEPATOL, V53, P397, DOI 10.1016/j.jhep.2010.05.004; Kim MY, 2007, LIVER INT, V27, P1103, DOI 10.1111/j.1478-3231.2007.01526.x; Kim Moon Young, 2010, Korean J Hepatol, V16, P347, DOI 10.3350/kjhep.2010.16.4.347; Kim MY, 2012, HEPATOLOGY; Kim SY, 2011, J ULTRAS MED, V30, P455, DOI 10.7863/jum.2011.30.4.455; Lassau N, 2011, RADIOLOGY, V258, P291, DOI 10.1148/radiol.10091870; Li N, 2010, ULTRASOUND MED BIOL, V36, P1066, DOI 10.1016/j.ultrasmedbio.2010.04.012; Lim AKP, 2005, AM J ROENTGENOL, V184, P1848, DOI 10.2214/ajr.184.6.01841848; Lim AKP, 2005, GUT, V54, P128, DOI 10.1136/gut.2003.030965; Orlacchio A, 2011, ULTRASOUND MED BIOL, V37, P1, DOI 10.1016/j.ultrasmedbio.2010.10.012; Ridolfi F, 2012, WORLD J GASTROENTERO, V18, P5225, DOI 10.3748/wjg.v18.i37.5225; Rockey DC, 2001, SEMIN LIVER DIS, V21, P337, DOI 10.1055/s-2001-17551; Rodriguez-Roisin R, 2008, NEW ENGL J MED, V358, P2378, DOI 10.1056/NEJMra0707185; Schenk P, 2002, GUT, V51, P853, DOI 10.1136/gut.51.6.853; Schneider AW, 1999, J HEPATOL, V30, P876, DOI 10.1016/S0168-8278(99)80142-1; Seitz K, 2010, ULTRASCHALL MED, V31, P492, DOI 10.1055/s-0029-1245591; Staub F, 2009, EUR RADIOL, V19, P1991, DOI 10.1007/s00330-009-1313-x; Strobel D, 2008, ULTRASCHALL MED, V29, P499, DOI 10.1055/s-2008-1027806; Strobel D, 2009, ULTRASCHALL MED, V30, P376, DOI 10.1055/s-0028-1109672; Sugimoto H, 2002, J HEPATOL, V37, P578, DOI 10.1016/S0168-8278(02)00264-7; Tang A, 2011, ULTRASOUND MED BIOL, V37, P1963, DOI 10.1016/j.ultrasmedbio.2011.09.010; Taourel P, 1998, HEPATOLOGY, V28, P932, DOI 10.1002/hep.510280406; Zhang CX, 2011, J ULTRAS MED, V30, P205, DOI 10.7863/jum.2011.30.2.205; Zhang L, 2011, BMC GASTROENTEROL, V11, DOI 10.1186/1471-230X-11-84; Zhou JH, 2011, RADIOLOGY, V259, P406, DOI 10.1148/radiol.10101339	31	25	26	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0121601	10.1371/journal.pone.0121601	http://dx.doi.org/10.1371/journal.pone.0121601			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25798930	Green Published, Green Submitted, gold			2022-12-27	WOS:000351987300275
J	Kappen, JH; Medina-Gomez, C; van Hagen, PM; Stolk, L; Estrada, K; Rivadeneira, F; Uitterlinden, AG; Stanford, MR; Ben-Chetrit, E; Wallace, GR; Soylu, M; van Laar, JAM				Kappen, Jasper H.; Medina-Gomez, Carolina; van Hagen, P. Martin; Stolk, Lisette; Estrada, Karol; Rivadeneira, Fernando; Uitterlinden, Andre G.; Stanford, Miles R.; Ben-Chetrit, Eldat; Wallace, Graham R.; Soylu, Merih; van Laar, Jan A. M.			Genome-Wide Association Study in an Admixed Case Series Reveals IL12A as a New Candidate in Behcet Disease	PLOS ONE			English	Article							SUSCEPTIBILITY LOCI; IL23R-IL12RB2; POLYMORPHISM; METAANALYSIS; POPULATIONS; CHINESE; STAT4; SNPS	Introduction The etiology of Behcet's disease (BD) is unknown, but widely considered an excessive T-cell mediated inflammatory response in a genetically susceptible host. Recent genomewide association studies (GWAS) have shown limited number of novel loci-associations. The rarity and unequal distribution of the disease prevalence amongst different ethnic backgrounds have hampered the use of GWAS in cohorts of mixed ethnicity and sufficient sample size. However, novel statistical approaches have now enabled GWAS in admixed cohorts. Methods We ran a GWAS on 336 BD cases and 5,843 controls. The cases consisted of Western Europeans, Middle Eastern and Turkish individuals. Participants from the Generation R study, a multiethnic birth cohort in Rotterdam, The Netherlands were used as controls. All samples were genotyped and data was combined. Linear regression models were corrected for population stratification using Genomic Principal Components and Linear Mixed Modelling. Meta-analysis was performed on selected results previously published. Results We identified SNPs associated at genome-wide significant level mapping to the 6p21.33 (HLA) region. In addition to this known signal two potential novel associations on chromosomes 6 and 18 were identified, yet with low minor allele frequencies. Extended meta-analysis reveal a GWS association with the IL12A variant rs17810546 on chromosome 3. Discussion We demonstrate that new statistical techniques enable GWAS analyses in a limited sized cohort of mixed ethnicity. After implementation, we confirmed the central role of the HLA region in the disease and identified new regions of interest. Moreover, we validated the association of a variant in the IL2A gene by meta-analysis with previous work. These findings enhance our knowledge of genetic associations and BD, and provide further justification for pursuing collective initiatives in genetic studies given the low prevalence of this and other rare diseases.	[Kappen, Jasper H.; van Hagen, P. Martin; van Laar, Jan A. M.] Erasmus MC, Immunol Sect, Internal Med, Rotterdam, Netherlands; [Medina-Gomez, Carolina; van Hagen, P. Martin; Stolk, Lisette; Estrada, Karol; Rivadeneira, Fernando; Uitterlinden, Andre G.] Erasmus MC, Dept Internal Med, Rotterdam, Netherlands; [van Hagen, P. Martin; van Laar, Jan A. M.] Erasmus MC, Dept Immunol, Rotterdam, Netherlands; [Medina-Gomez, Carolina; Rivadeneira, Fernando] Erasmus MC, Dept Epidemiol, Rotterdam, Netherlands; [Medina-Gomez, Carolina; Rivadeneira, Fernando] Erasmus M Med Ctr C, Generat Study Grp R, Rotterdam, Netherlands; [Stanford, Miles R.] Kings Coll London, Dept Ophthalmol, London WC2R 2LS, England; [Wallace, Graham R.] Univ Birmingham, Ctr Translat Inflammat, Birmingham, W Midlands, England; [Ben-Chetrit, Eldat] Hadassah Hebrew Univ Med Ctr, Dept Med, Jerusalem, Israel; [Soylu, Merih] Cukurova Univ, Sch Med, Dept Ophthalmol, Adana, Turkey	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; University of London; King's College London; University of Birmingham; Hebrew University of Jerusalem; Cukurova University	Kappen, JH (corresponding author), Erasmus MC, Immunol Sect, Internal Med, Rotterdam, Netherlands.	j.Kappen@erasmusmc.nl	Medina-Gomez, Carolina/I-1725-2019; Rivadeneira, Fernando/O-5385-2015	Medina-Gomez, Carolina/0000-0001-7999-5538; Rivadeneira, Fernando/0000-0001-9435-9441; Wallace, Graham/0000-0003-2054-0509	Vereniging Trustfonds Erasmus Universiteit Rotterdam; De Landelijke Stichting voor Blinden en Slechtzienden; Stichting Janivo; Stichting Mitialto; Actelion	Vereniging Trustfonds Erasmus Universiteit Rotterdam; De Landelijke Stichting voor Blinden en Slechtzienden; Stichting Janivo; Stichting Mitialto; Actelion	Financial support provided by; Vereniging Trustfonds Erasmus Universiteit Rotterdam, De Landelijke Stichting voor Blinden en Slechtzienden, Stichting Janivo, Stichting Mitialto, dr N. Nobel and Actelion made this study possible. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altenburg A, 2012, OPHTHALMOLOGE, V109, P531, DOI 10.1007/s00347-012-2601-4; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Baranathan V, 2007, ANN RHEUM DIS, V66, P1531, DOI 10.1136/ard.2007.073866; Coram MA, 2013, AM J HUM GENET, V92, P904, DOI 10.1016/j.ajhg.2013.04.025; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Gul A, 2000, ANN RHEUM DIS, V59, P622, DOI 10.1136/ard.59.8.622; Gul A, 2001, CLIN EXP RHEUMATOL, V19, pS6; Hou SP, 2012, ARTHRITIS RHEUM-US, V64, P4104, DOI 10.1002/art.37708; Hu K, 2010, HUM IMMUNOL, V71, P723, DOI 10.1016/j.humimm.2010.04.007; Jaddoe VWV, 2012, EUR J EPIDEMIOL, V27, P739, DOI 10.1007/s10654-012-9735-1; Kang HM, 2010, NAT GENET, V42, P348, DOI 10.1038/ng.548; Kappen JH, 2009, RHEUMATOLOGY, V48, P1375, DOI 10.1093/rheumatology/kep292; Kirino Y, 2013, NAT GENET, V45, P202, DOI 10.1038/ng.2520; Lee YJ, 2012, ANN RHEUMATIC DIS; Lee YJ, 2013, ANN RHEUM DIS, V72, P1510, DOI 10.1136/annrheumdis-2011-200288; McCarthy MI, 2008, HUM MOL GENET, V17, pR156, DOI 10.1093/hmg/ddn289; Mizuki N, 2010, NAT GENET, V42, P703, DOI 10.1038/ng.624; Morris AP, 2011, GENET EPIDEMIOL, V35, P809, DOI 10.1002/gepi.20630; Naib OKD, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00342; Ortiz-Fernandez L, 2014, ANN RHEUMATIC DIS; Plomin R, 2014, MOL PSYCHIAT; Price AL, 2010, NAT REV GENET, V11, P459, DOI 10.1038/nrg2813; Remmers EF, 2010, NAT GENET, V42, P698, DOI 10.1038/ng.625; Sakane T, 1999, NEW ENGL J MED, V341, P1284, DOI 10.1056/NEJM199910213411707; SILMAN AJ, 1990, LANCET, V335, P1078; Thornton T, 2012, AM J HUM GENET, V91, P122, DOI 10.1016/j.ajhg.2012.05.024; Touma Z, 2010, ARCH MED RES, V41, P142, DOI 10.1016/j.arcmed.2010.02.002; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340; Xavier JM, 2012, ARTHRITIS RHEUM-US, V64, P2761, DOI 10.1002/art.34437; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Yazici H, 2007, NAT CLIN PRACT RHEUM, V3, P148, DOI 10.1038/ncprheum0436; Zaitlen N, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003520	32	53	54	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0119085	10.1371/journal.pone.0119085	http://dx.doi.org/10.1371/journal.pone.0119085			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25799145	Green Published, Green Submitted, gold			2022-12-27	WOS:000351987300027
J	Morris, S; Gurusamy, KS; Sheringham, J; Davidson, BR				Morris, Stephen; Gurusamy, Kurinchi S.; Sheringham, Jessica; Davidson, Brian R.			Cost-Effectiveness Analysis of Endoscopic Ultrasound versus Magnetic Resonance Cholangiopancreatography in Patients with Suspected Common Bile Duct Stones	PLOS ONE			English	Article							LAPAROSCOPIC CHOLECYSTECTOMY; RETROGRADE CHOLANGIOPANCREATOGRAPHY; INTRAOPERATIVE CHOLANGIOGRAPHY; DIAGNOSTIC-ACCURACY; ULTRASONOGRAPHY; MANAGEMENT; EUS; CHOLEDOCHOLITHIASIS; GALLBLADDER; ERCP	Background Patients with suspected common bile duct (CBD) stones are often diagnosed using endoscopic retrograde cholangiopancreatography (ERCP), an invasive procedure with risk of significant complications. Using endoscopic ultrasound (EUS) or Magnetic Resonance CholangioPancreatography (MRCP) first to detect CBD stones can reduce the risk of unnecessary procedures, cut complications and may save costs. Aim This study sought to compare the cost-effectiveness of initial EUS or MRCP in patients with suspected CBD stones. Methods This study is a model based cost-utility analysis estimating mean costs and quality-adjusted life years (QALYs) per patient from the perspective of the UK National Health Service (NHS) over a 1 year time horizon. A decision tree model was constructed and populated with probabilities, outcomes and cost data from published sources, including one-way and probabilistic sensitivity analyses. Results Using MRCP to select patients for ERCP was less costly than using EUS to select patients or proceeding directly to ERCP ($1299 versus $1753 and $1781, respectively), with similar QALYs accruing to each option (0.998, 0.998 and 0.997 for EUS, MRCP and direct ERCP, respectively). Initial MRCP was the most cost-effective option with the highest monetary net benefit, and this result was not sensitive to model parameters. MRCP had a 61% probability of being cost-effective at $29,000, the maximum willingness to pay for a QALY commonly used in the UK. Conclusion From the perspective of the UK NHS, MRCP was the most cost-effective test in the diagnosis of CBD stones.	[Morris, Stephen; Sheringham, Jessica] UCL, Dept Appl Hlth Res, London, England; [Gurusamy, Kurinchi S.; Davidson, Brian R.] UCL, Sch Med, Royal Free Hosp, Dept Surg, London W1N 8AA, England	University of London; University College London; University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School	Sheringham, J (corresponding author), UCL, Dept Appl Hlth Res, Gower St, London, England.	j.sheringham@ucl.ac.uk		Gurusamy, Kurinchi/0000-0002-0313-9134; Sheringham, Jessica/0000-0003-3468-129X; Morris, Stephen/0000-0002-5828-3563	National Institute for Health Research Cochrane Programme Grants Scheme [10/4001/11]	National Institute for Health Research Cochrane Programme Grants Scheme	This project was funded by the National Institute for Health Research Cochrane Programme Grants Scheme (reference number 10/4001/11). The views and opinions expressed are those of the authors and do not necessarily reflect those of the National Institute for Health Research (NIHR), National Health Services (NHS), or the Department of Health.	Alkhaffaf B, 2011, ARCH SURG-CHICAGO, V146, P329, DOI 10.1001/archsurg.2011.30; Ang TL, 2012, GASTROINTEST ENDOSC, V75, P203; Arguedas MR, 2001, AM J GASTROENTEROL, V96, P2892; Ausch C, 2005, SURG ENDOSC, V19, P574, DOI 10.1007/s00464-004-9093-5; Bodger K, 2011, GASTROINTEST ENDOSC, V74, P825, DOI 10.1016/j.gie.2011.06.007; Boraschi P, 2002, ACTA RADIOL, V43, P593, DOI 10.1034/j.1600-0455.2002.430610.x; Briggs A, 2006, DECISION MODELING HL; Buscarini E, 2003, GASTROINTEST ENDOSC, V57, P510, DOI 10.1067/mge.2003.149; Caddy G R, 2005, Ulster Med J, V74, P108; Canto MIF, 1998, GASTROINTEST ENDOSC, V47, P439, DOI 10.1016/S0016-5107(98)70242-1; Center for the Evaluation of Value and Risk in Health (CEVR), COST EFF AN REG; Choo L, 2012, GASTROINTEST ENDOSC, V75, P203; DASARI BVM, 2013, COCHRANE DB SYST REV; de Ledinghen V, 1999, GASTROINTEST ENDOSC, V49, P26, DOI 10.1016/S0016-5107(99)70441-4; Department of Health, 2012, NAT SCH REF COSTS YE; Eisen GM, 2002, GASTROINTEST ENDOSC, V55, P784, DOI 10.1016/S0016-5107(02)70404-5; Fazel A, 2002, GASTROINTEST ENDOSC, V55, pAB246; Fernandez-Esparrach G, 2007, AM J GASTROENTEROL, V102, P1632, DOI 10.1111/j.1572-0241.2007.01333.x; Gautier G, 2004, GASTROEN CLIN BIOL, V28, P129, DOI 10.1016/S0399-8320(04)94866-X; Giljaca V, 2014, COCHRANE DA IN PRESS; Guarise A, 2005, RADIOL MED, V109, P239; Gurusamy K, 2011, BRIT J SURG, V98, P908, DOI 10.1002/bjs.7460; Gurusamy KS, 2015, COCHRANE DA IN PRESS; Gurusamy K, 2012, APPL HEALTH ECON HEA, V10, P15, DOI 10.2165/11594950-000000000-00000; HAINSWORTH PJ, 1994, GUT, V35, P991, DOI 10.1136/gut.35.7.991; Howard K, 2006, INT J TECHNOL ASSESS, V22, P109, DOI 10.1017/S0266462306050902; Jendresen MB, 2002, EUR J SURG, V168, P690, DOI 10.1080/11024150201680024; Kaltenthaler E, 2004, HEALTH TECHNOL ASSES, V8, P1; Kohut M, 2002, ENDOSCOPY, V34, P299, DOI 10.1055/s-2002-23641; Liu CL, 2001, GASTROINTEST ENDOSC, V54, P325, DOI 10.1067/mge.2001.117513; Miletic D, 2006, WORLD J SURG, V30, P1705, DOI 10.1007/s00268-005-0459-1; Montariol T, 1998, SURGERY, V124, P6; National Institute for Health and Care Excellence (NICE), 2013, GUID METH TECHN APPR; Ney Marcus Vinicius Silva, 2005, Arq. Gastroenterol., V42, P239, DOI 10.1590/S0004-28032005000400009; Norton SA, 1997, BRIT J SURG, V84, P1366; OECD, 2012, STATS EXTR PURCH POW; Office for National Statistics, CENS 2012 STAT POP; Prat F, 1996, LANCET, V347, P75, DOI 10.1016/S0140-6736(96)90208-1; Spencer, 2012, EC ANAL HLTH CARE; Stinton LM, 2012, GUT LIVER, V6, P172, DOI 10.5009/gnl.2012.6.2.172; Vergel Yolanda Bravo, 2006, Int J Surg, V4, P12, DOI 10.1016/j.ijsu.2006.01.007; WEINSTEIN MC, 1990, J GEN INTERN MED, V5, P277, DOI 10.1007/BF02600391; Williams EJ, 2008, GUT, V57, P1004, DOI 10.1136/gut.2007.121657; Williams EJ, 2007, GUT, V56, P821, DOI 10.1136/gut.2006.097543; Wilson E, 2010, BRIT J SURG, V97, P210, DOI 10.1002/bjs.6872; Yang MH, 2008, SURG ENDOSC, V22, P1620, DOI 10.1007/s00464-007-9665-2	46	24	28	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0121699	10.1371/journal.pone.0121699	http://dx.doi.org/10.1371/journal.pone.0121699			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25799113	Green Published, gold, Green Submitted			2022-12-27	WOS:000351987300286
J	Thumbi, SM; Njenga, MK; Marsh, TL; Noh, S; Otiang, E; Munyua, P; Ochieng, L; Ogola, E; Yoder, J; Audi, A; Montgomery, JM; Bigogo, G; Breiman, RF; Palmer, GH; McElwain, TF				Thumbi, S. M.; Njenga, M. Kariuki; Marsh, Thomas L.; Noh, Susan; Otiang, Elkanah; Munyua, Peninah; Ochieng, Linus; Ogola, Eric; Yoder, Jonathan; Audi, Allan; Montgomery, Joel M.; Bigogo, Godfrey; Breiman, Robert F.; Palmer, Guy H.; McElwain, Terry F.			Linking Human Health and Livestock Health: A "One-Health" Platform for Integrated Analysis of Human Health, Livestock Health, and Economic Welfare in Livestock Dependent Communities	PLOS ONE			English	Article							DEMOGRAPHIC SURVEILLANCE; NUTRITION; DETERMINANTS; MALNUTRITION; INFECTIONS; MORBIDITY; IMMUNITY; DISEASES; POVERTY; GROWTH	Background For most rural households in sub-Saharan Africa, healthy livestock play a key role in averting the burden associated with zoonotic diseases, and in meeting household nutritional and socio-economic needs. However, there is limited understanding of the complex nutritional, socio-economic, and zoonotic pathways that link livestock health to human health and welfare. Here we describe a platform for integrated human health, animal health and economic welfare analysis designed to address this challenge. We provide baseline epidemiological data on disease syndromes in humans and the animals they keep, and provide examples of relationships between human health, animal health and household socio-economic status. Method We designed a study to obtain syndromic disease data in animals along with economic and behavioral information for 1500 rural households in Western Kenya already participating in a human syndromic disease surveillance study. Data collection started in February 2013, and each household is visited bi-weekly and data on four human syndromes (fever, jaundice, diarrhea and respiratory illness) and nine animal syndromes (death, respiratory, reproductive, musculoskeletal, nervous, urogenital, digestive, udder disorders, and skin disorders in cattle, sheep, goats and chickens) are collected. Additionally, data from a comprehensive socio-economic survey is collected every 3 months in each of the study households. Findings Data from the first year of study showed 93% of the households owned at least one form of livestock (55%, 19%, 41% and 88% own cattle, sheep, goats and chickens respectively). Digestive disorders, mainly diarrhea episodes, were the most common syndromes observed in cattle, goats and sheep, accounting for 56% of all livestock syndromes, followed by respiratory illnesses (18%). In humans, respiratory illnesses accounted for 54% of all illnesses reported, followed by acute febrile illnesses (40%) and diarrhea illnesses (5%). While controlling for household size, the incidence of human illness increased 1.31-fold for every 10 cases of animal illness or death observed (95% CI 1.16-1.49). Access and utilization of animal source foods such as milk and eggs were positively associated with the number of cattle and chickens owned by the household. Additionally, health care seeking was correlated with household incomes and wealth, which were in turn correlated with livestock herd size. Conclusion This study platform provides a unique longitudinal dataset that allows for the determination and quantification of linkages between human and animal health, including the impact of healthy animals on human disease averted, malnutrition, household educational attainment, and income levels.	[Thumbi, S. M.; Marsh, Thomas L.; Noh, Susan; Yoder, Jonathan; Palmer, Guy H.; McElwain, Terry F.] Washington State Univ, Paul G Allen Sch Global Anim Hlth, Pullman, WA 99164 USA; [Thumbi, S. M.; Otiang, Elkanah; Ochieng, Linus; Ogola, Eric; Audi, Allan; Bigogo, Godfrey] Kenya Govt Med Res Ctr, Ctr Global Hlth Res, Kisumu, Kenya; [Njenga, M. Kariuki; Munyua, Peninah; Montgomery, Joel M.] Ctr Dis Control & Prevent, Nairobi, Kenya; [Marsh, Thomas L.; Yoder, Jonathan] Washington State Univ, Sch Econ Sci, Pullman, WA 99164 USA; [Noh, Susan] ARS, Anim Dis Res Unit, USDA, Pullman, WA USA; [Breiman, Robert F.] Emory Univ, Atlanta, GA 30322 USA	Washington State University; Kenya Medical Research Institute; Washington State University; United States Department of Agriculture (USDA); Emory University	Thumbi, SM (corresponding author), Washington State Univ, Paul G Allen Sch Global Anim Hlth, Pullman, WA 99164 USA.	thumbi.mwangi@wsu.edu	Yoder, Jonathan K/F-4840-2011; Munyua, Peninah/AAA-5922-2021; Bigogo, Godfrey/W-3591-2019; Mwangi, Thumbi/L-2216-2019	Mwangi, Thumbi/0000-0002-5754-0556; Yoder, Jonathan/0000-0002-9049-9591; Audi, Allan/0000-0003-1683-554X	Paul G. Allen School for Global Animal Health	Paul G. Allen School for Global Animal Health	The study was funded through the Paul G. Allen School for Global Animal Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aanensen DM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006968; Adazu K, 2005, AM J TROP MED HYG, V73, P1151, DOI 10.4269/ajtmh.2005.73.1151; [Anonymous], 2014, R LANG ENV STAT COMP; Argent J, 2014, J EC BEHAV ORG; Bhaskaram P, 2002, NUTR REV, V60, pS40, DOI 10.1301/00296640260130722; Bradford GE, 1999, LIVEST PROD SCI, V59, P95, DOI 10.1016/S0301-6226(99)00019-6; Darapheak Chau, 2013, Int Arch Med, V6, P29, DOI 10.1186/1755-7682-6-29; Eshitera EE, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-234; Feikin DR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016085; Feikin DR, 2010, INT J EPIDEMIOL, V39, P450, DOI 10.1093/ije/dyp374; Grace D, 2014, ONDERSTEPOORT J VET, V81, DOI 10.4102/ojvr.v81i2.725; Hughes S, 2006, PARASITE IMMUNOL, V28, P577, DOI 10.1111/j.1365-3024.2006.00897.x; Jin MC, 2014, SOC SCI MED, V105, P16, DOI 10.1016/j.socscimed.2014.01.001; Knobel DL, 2013, AM J TROP MED HYG, V88, P513, DOI 10.4269/ajtmh.12-0169; Kotloff KL, 2013, LANCET, V382, P209, DOI 10.1016/S0140-6736(13)60844-2; Kristjanson P, 2004, 14 FAO, P23; Lannotti L, 2014, AM J PHYS ANTHR; Mableson HE, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002800; Madden M., 2012, PEW INTERNET REP, P1; Marmot M, 2008, LANCET, V372, P1661, DOI 10.1016/S0140-6736(08)61690-6; Mazet JAK, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000190; Morse SS, 2012, LANCET, V380, P1956, DOI 10.1016/S0140-6736(12)61684-5; Murphy SP, 2003, J NUTR, P3932; Narrod C, 2012, ECOHEALTH, V9, P150, DOI 10.1007/s10393-012-0747-9; Nicholson CF, 2003, 2003 AAEA ANN M MONT; Njuki J, 2013, LIVESTOCK OWNERSHIP; Odhiambo FO, 2012, INT J EPIDEMIOL, V41, P977, DOI 10.1093/ije/dys108; Okwi PO, 2007, P NATL ACAD SCI USA, V104, P16769, DOI 10.1073/pnas.0611107104; Perry B, 2009, PHILOS T R SOC B, V364, P2643, DOI 10.1098/rstb.2009.0097; Randolph TF, 2007, J ANIM SCI, V85, P2788, DOI 10.2527/jas.2007-0467; SIGMAN M, 1989, J PEDIATR-US, V115, P357, DOI 10.1016/S0022-3476(89)80832-7; Singer M, 2012, ANN ANTHROPL PRACT, V36, P328, DOI 10.1111/napa.12007; Staal S., 2009, TARGETING STRATEGIC; Thornton P.K., 2002, MAPPING POVERTY LIVE; von Wissmann B, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000941; Whaley SE, 2003, J NUTR, V133, p3965S, DOI 10.1093/jn/133.11.3965S; Zinsstag J, 2005, LANCET, V366, P2142, DOI 10.1016/S0140-6736(05)67731-8	37	49	49	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0120761	10.1371/journal.pone.0120761	http://dx.doi.org/10.1371/journal.pone.0120761			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CE6ZS	25798951	Green Published, gold, Green Submitted			2022-12-27	WOS:000351987300174
J	Andersson, ES; Tynelius, P; Nohr, EA; Sorensen, TIA; Rasmussen, F				Andersson, Elina Scheers; Tynelius, Per; Nohr, Ellen Aagaard; Sorensen, Thorkild I. A.; Rasmussen, Finn			No Association of Maternal Gestational Weight Gain with Offspring Blood Pressure and Hypertension at Age 18 Years in Male Sibling-Pairs: A Prospective Register-Based Cohort Study	PLOS ONE			English	Article							BODY-MASS INDEX; BIRTH-WEIGHT; PREGNANCY; OBESITY; FAMILY; ADIPOSITY	Background Maternal gestational weight gain (GWG) is associated with birth weight, obesity, and possibly blood pressure (BP) and hypertension in the offspring. These associations may however be confounded by genetic and/or shared environmental factors. In contrast to previous studies based on non-siblings and self-reported data, we investigated whether GWG is associated with offspring BP and hypertension, in a register-based cohort of full brothers while controlling for fixed shared effects. Methods By using Swedish nation-wide record-linkage data, we identified women with at least two male children (full brothers) born 1982-1989. Their BP was obtained from the mandatory military conscription induction tests. We adopted linear and Poisson regression models with robust variance, using generalized estimating equations to analyze associations between GWG and BP, as well as with hypertension, within and between offspring sibling-pairs. Results Complete data on the mothers' GWG and offspring BP was obtained for 9,816 brothers (4,908 brother-pairs). Adjusted regression models showed no significant associations between GWG and SBP (beta = 0.03 mmHg per 1-kg GWG difference, [95% CI -0.08, 0.14], or DBP (beta = -0.03 mmHg per 1-kg GWG difference [95% CI -0.11, 0.05]), or between GWG and offspring's risk of hypertension (relative risk = 1.0 [95% CI 0.99, 1.02], neither within nor between siblings. Conclusions In this large sibling-pair study, we did not find any significant association between GWG and offspring BP or the risk of hypertension at 18y, when taking genetic and environmental factors shared within sibling pairs into account. Further large sibling studies are required to confirm a null association between GWG and other cardiovascular risk factors.	[Andersson, Elina Scheers; Tynelius, Per; Rasmussen, Finn] Karolinska Inst, Dept Publ Hlth Sci Child & Adolescent Publ Hlth E, Stockholm, Sweden; [Nohr, Ellen Aagaard] Univ Southern Denmark, Inst Clin Res, Res Unit Obstet & Gynecol, Odense, Denmark; [Sorensen, Thorkild I. A.] Univ Copenhagen, Fac Hlth & Med Sci, Sect Metab Genet, Novo Nordisk Fdn Ctr Basic Metab Res, Copenhagen, Denmark; [Sorensen, Thorkild I. A.] Bispebjerg & Frederiksberg Hosp, Inst Prevent Med, Copenhagen, The Capital Reg, Denmark; [Sorensen, Thorkild I. A.] Univ Bristol, MRC Integrat Epidemiol Unit, Bristol, Avon, England	Karolinska Institutet; University of Southern Denmark; Novo Nordisk Foundation; University of Copenhagen; University of Copenhagen; Bispebjerg Hospital; University of Bristol	Rasmussen, F (corresponding author), Karolinska Inst, Dept Publ Hlth Sci Child & Adolescent Publ Hlth E, Stockholm, Sweden.	finn.rasmussen@ki.se		Rasmussen, Finn/0000-0001-7915-7809	Swedish Research Council for Health, Working Life and Welfare (FORTE) [2010-0671]; Karolinska Institutet Faculty Funds (KID); MRC [MC_UU_12013/1] Funding Source: UKRI	Swedish Research Council for Health, Working Life and Welfare (FORTE); Karolinska Institutet Faculty Funds (KID); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was supported by a grant from the Swedish Research Council for Health, Working Life and Welfare (FORTE) (http://www.forte.se) (Grant No 2010-0671) and the Karolinska Institutet Faculty Funds (KID) (http://ki.se). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afridi I, 2003, J HYPERTENS, V21, P1983, DOI 10.1097/01.hjh.0000084751-37215.d2; Beyerlein A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033205; Cai ZJ, 1999, WHO TECH REP SER, V887, P1; Chen L, 2008, PLOS MED, V5, DOI 10.1371/journal.pmed.0050052; Christofaro DGD, 2013, SCAND J MED SCI SPOR, V23, P317, DOI 10.1111/j.1600-0838.2011.01382.x; Clark PM, 1998, OBSTET GYNECOL, V91, P103, DOI 10.1016/S0029-7844(97)00581-4; CNATTINGIUS S, 1990, SCAND J SOC MED, V18, P143, DOI 10.1177/140349489001800209; Crozier SR, 2010, AM J CLIN NUTR, V91, P1745, DOI 10.3945/ajcn.2009.29128; Dello Russo M, 2013, INT J OBESITY, V37, P914, DOI 10.1038/ijo.2013.35; Fraser A, 2010, CIRCULATION, V121, P2557, DOI 10.1161/CIRCULATIONAHA.109.906081; Frederick IO, 2008, MATERN CHILD HLTH J, V12, P557, DOI 10.1007/s10995-007-0276-2; Gaillard R, 2014, INT J OBES LOND; Gardiner JC, 2009, STAT MED, V28, P221, DOI 10.1002/sim.3478; Hochner H, 2012, CIRCULATION, V125, P1381, DOI 10.1161/CIRCULATIONAHA.111.070060; KALLEN B, 1995, EUR J EPIDEMIOL, V11, P601, DOI 10.1007/BF01719316; Laor A, 1997, BRIT MED J, V315, P449, DOI 10.1136/bmj.315.7106.449; Ludwig DS, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001521; Ludwig DS, 2010, LANCET, V376, P984, DOI 10.1016/S0140-6736(10)60751-9; MACINTYRE S, 1991, LANCET, V338, P869, DOI 10.1016/0140-6736(91)91513-T; Mamun AA, 2009, CIRCULATION, V119, P1720, DOI 10.1161/CIRCULATIONAHA.108.813436; Mann V, 2004, STAT MED, V23, P2745, DOI 10.1002/sim.1853; National Board of Health and Welfare, 2013, PREGN DEL NEWB INF S; Oken E, 2008, OBSTET GYNECOL, V112, P999, DOI 10.1097/AOG.0b013e31818a5d50; Oken E, 2007, AM J OBSTET GYNECOL, V196, DOI 10.1016/j.ajog.2006.11.027; Reynolds RM, 2010, J CLIN ENDOCR METAB, V95, P5365, DOI 10.1210/jc.2010-0697; Schack-Nielsen L, 2010, INT J OBESITY, V34, P67, DOI 10.1038/ijo.2009.206; Sridhar SB, 2014, AM J OBSTET GYNECOL, V211, DOI 10.1016/j.ajog.2014.02.030; Stuebe AM, 2009, INT J OBESITY, V33, P743, DOI 10.1038/ijo.2009.101; Sykes B, 2000, AM J HUM GENET, V66, P1417, DOI 10.1086/302850; Wen XZ, 2011, PEDIATRICS, V127, pE713, DOI 10.1542/peds.2010-2000; Zilko CEM, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2009.12.007	31	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0121202	10.1371/journal.pone.0121202	http://dx.doi.org/10.1371/journal.pone.0121202			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25794174	Green Published, gold, Green Submitted			2022-12-27	WOS:000352083900110
J	DeFranco, E; Hall, E; Hossain, M; Chen, A; Haynes, EN; Jones, D; Ren, S; Lu, L; Muglia, L				DeFranco, Emily; Hall, Eric; Hossain, Monir; Chen, Aimin; Haynes, Erin N.; Jones, David; Ren, Sheng; Lu, Long; Muglia, Louis			Air Pollution and Stillbirth Risk: Exposure to Airborne Particulate Matter during Pregnancy Is Associated with Fetal Death	PLOS ONE			English	Article							BIRTH-WEIGHT; OUTCOMES; COUNTY	Objective To test the hypothesis that exposure to fine particulate air pollution (PM2.5) is associated with stillbirth. Study Design Geo-spatial population-based cohort study using Ohio birth records (2006-2010) and local measures of PM2.5, recorded by the EPA (2005-2010) via 57 monitoring stations across Ohio. Geographic coordinates of the mother's residence for each birth were linked to the nearest PM2.5 monitoring station and monthly exposure averages calculated. The association between stillbirth and increased PM2.5 levels was estimated, with adjustment for maternal age, race, education level, quantity of prenatal care, smoking, and season of conception. Results There were 349,188 live births and 1,848 stillbirths of non-anomalous singletons (20-42 weeks) with residence <= 10 km of a monitor station in Ohio during the study period. The mean PM2.5 level in Ohio was 13.3 mu g/m(3) [+/- 1.8 SD, IQR(Q1: 12.1, Q3: 14.4, IQR: 2.3)], higher than the current EPA standard of 12 mu g/m(3). High average PM2.5 exposure through pregnancy was not associated with a significant increase in stillbirth risk, adjOR 1.21(95% CI 0.96,1.53), nor was it increased with high exposure in the 1st or 2nd trimester. However, exposure to high levels of PM2.5 in the third trimester of pregnancy was associated with 42% increased stillbirth risk, adjOR 1.42(1.06,1.91). Conclusions Exposure to high levels of fine particulate air pollution in the third trimester of pregnancy is associated with increased stillbirth risk. Although the risk increase associated with high PM2.5 levels is modest, the potential impact on overall stillbirth rates could be robust as all pregnant women are potentially at risk.	[DeFranco, Emily; Hall, Eric; Muglia, Louis] Cincinnati Childrens Hosp Med Ctr, Perinatal Inst, Cincinnati, OH 45229 USA; [DeFranco, Emily; Muglia, Louis] Univ Cincinnati, Coll Med, Dept Obstet & Gynecol, Div Maternal Fetal Med, Cincinnati, OH 45267 USA; [Hossain, Monir; Jones, David] Cincinnati Childrens Hosp Med Ctr, Div Biostat & Epidemiol, Cincinnati, OH 45229 USA; [Chen, Aimin; Haynes, Erin N.] Univ Cincinnati, Coll Med, Dept Environm Hlth, Cincinnati, OH 45267 USA; [Ren, Sheng] Univ Cincinnati, Dept Math, Cincinnati, OH USA; [Ren, Sheng; Lu, Long] Cincinnati Childrens Hosp Med Ctr, Div Biomed Informat, Cincinnati, OH 45229 USA	Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center	DeFranco, E (corresponding author), Cincinnati Childrens Hosp Med Ctr, Perinatal Inst, Cincinnati, OH 45229 USA.	emily.defranco@uc.edu	Hossain, Md/N-5360-2015; Hall, Eric S./F-2814-2015	Hall, Eric S./0000-0002-9477-8619; Chen, Aimin/0000-0001-9713-6438; Haynes, Erin/0000-0001-9110-0477	Perinatal Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA; March of Dimes [22-FY13-543]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000077, UL1TR001425] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES006096, RC4ES019755] Funding Source: NIH RePORTER	Perinatal Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA; March of Dimes(March of Dimes); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by the Perinatal Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA, and March of Dimes Grant 22-FY13-543. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACOG, 2009, OBSTET GYNECOL, V113, P748, DOI DOI 10.1097/AOG.0B013E31819E9EE2; Bobak M, 1999, OCCUP ENVIRON MED, V56, P539, DOI 10.1136/oem.56.8.539; Cousens S, 2011, LANCET, V377, P1319, DOI 10.1016/S0140-6736(10)62310-0; Dietz PM, 2014, AM J OBSTET GYNECOL, V210, DOI 10.1016/j.ajog.2013.10.875; Faiz AS, 2013, EPIDEMIOLOGY, V24, P538, DOI 10.1097/EDE.0b013e3182949ce5; Faiz AS, 2012, AM J EPIDEMIOL, V176, P308, DOI 10.1093/aje/kws029; Fell DB, 2004, PAEDIATR PERINAT EP, V18, P408, DOI 10.1111/j.1365-3016.2004.00580.x; Glinianaia SV, 2004, EPIDEMIOLOGY, V15, P36, DOI 10.1097/01.ede.0000101023.41844.ac; Hoek G., 2013, ENV HLTH, V12, P12, DOI DOI 10.1186/1476-069X-12-43; Hwang BF, 2011, ENVIRON HEALTH PERSP, V119, P1345, DOI 10.1289/ehp.1003056; Kloog I, 2012, ENVIRON HEALTH-GLOB, V11, DOI 10.1186/1476-069X-11-40; Landgren O, 1996, ACTA PAEDIATR, V85, P1361, DOI 10.1111/j.1651-2227.1996.tb13926.x; MacDorman MF, 2006, NATL VITAL STAT REPO, V60; Mainolfi MB, 2013, J OCCUP ENVIRON MED, V55, P490, DOI 10.1097/JOM.0b013e31828df013; Padula AM, 2013, AM J EPIDEMIOL, V177, P1074, DOI 10.1093/aje/kws367; Pearce MS, 2010, ENVIRON RES, V110, P118, DOI 10.1016/j.envres.2009.10.003; Pereira LAA, 1998, ENVIRON HEALTH PERSP, V106, P325, DOI 10.2307/3434038; Reichman NE, 2007, AM J OBSTET GYNECOL, V197, DOI 10.1016/j.ajog.2007.02.026; Rich DQ, 2009, J EPIDEMIOL COMMUN H, V63, P488, DOI 10.1136/jech.2008.082792; United States Environmental Protection Agency website, STAT COUNT EM SUMM A; United States Environmental Protection Agency website. National Ambient Air Quality Standards (NAAQS), NAT AM AIR QUAL STAN; US Department of Health and Human Services Centers for Disease Control and Prevention website, 1997, STAT DEF REP REQ; Vassilev ZP, 2001, AM J IND MED, V40, P255, DOI 10.1002/ajim.1096; Vinikoor-Imler LC, 2012, PAEDIATR PERINAT EP, V26, P91, DOI 10.1111/j.1365-3016.2011.01245.x; Wilhelm M, 2012, ENVIRON HEALTH PERSP, V120, P132, DOI 10.1289/ehp.1103408; World Health Organization website, COUNTR STILLB RAT PE	26	64	68	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0120594	10.1371/journal.pone.0120594	http://dx.doi.org/10.1371/journal.pone.0120594			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25794052	Green Published, Green Submitted, gold			2022-12-27	WOS:000352083900056
J	DesRochers, TM; Kuo, IY; Kimmerling, EP; Ehrlich, BE; Kaplan, DL				DesRochers, Teresa M.; Kuo, Ivana Y.; Kimmerling, Erica P.; Ehrlich, Barbara E.; Kaplan, David L.			The Effects of Mycoplasma Contamination upon the Ability to Form Bioengineered 3D Kidney Cysts	PLOS ONE			English	Article							CULTURED-CELLS; DISEASE; INFECTION; MODELS	Mycoplasma contamination of cell cultures is a pervasive, often undiagnosed and ignored problem in many laboratories that can result in reduced cell proliferation and changes in gene expression. Unless contamination is specifically suspected, it is often undetected in two dimensional (2D) cultures and the resulting effects of mycoplasma contamination are rarely appreciated and can lead to incorrect conclusions. Three dimensional (3D) tissue cultures are increasingly utilized to explore tissue development and phenotype. However, 3D cultures are more complex than 2D cell cultures and require a more controlled cellular environment in order to generate structures necessary to mimic in vivo responses and are often maintained for longer time periods. Changes to the microenvironment are assumed to have a more extreme effect upon the success of 3D tissue cultures than 2D cell cultures, but the effects of mycoplasma have not been studied. To test this hypothesis, we grew 2D cell cultures and 3D tissues from pig kidney epithelial cells (LLC-PK1) that were contaminated withmycoplasma and the same stock of cells after mycoplasma removal. We did not observe an effect of mycoplasma contamination on proliferation in 2D monolayer cell culture. However, cyst formation in 3D tissues was altered, with effects upon the number, size and structure of cysts formed. These data serve to reinforce the necessity of testing cell stocks for mycoplasma contamination.	[DesRochers, Teresa M.; Kimmerling, Erica P.; Kaplan, David L.] Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA; [Kuo, Ivana Y.; Ehrlich, Barbara E.] Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06510 USA; [Kuo, Ivana Y.; Ehrlich, Barbara E.] Yale Univ, Sch Med, Dept Cellular & Mol Physiol, New Haven, CT 06510 USA	Tufts University; Yale University; Yale University	Ehrlich, BE (corresponding author), Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06510 USA.	Barbara.ehrlich@yale.edu; David.kaplan@tufts.edu	/AAX-8408-2021	/0000-0001-9657-9704; DesRochers, Teresa/0000-0003-3819-5491; Kuo, Ivana/0000-0002-9867-2408	NIH [P30 DK090744, R01 DK61747, R01 DK087844, P41 EB002520]; AHA [R10682]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB002520] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK057751, P30DK090744, R01DK087844, R01DK061747, P30DK034989] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AHA(American Heart Association); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by NIH grants: P30 DK090744, R01 DK61747, and R01 DK087844 (B.E.E.), AHA postdoctoral fellowship R10682 (I.Y.K.), and NIH P41 EB002520 (D.L.K.). Use of the Yale Cell Biology Confocal core (P01 DK57751 and P30 DK34989) is acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cai YQ, 2004, J BIOL CHEM, V279, P19987, DOI 10.1074/jbc.M312031200; DesRochers TM, 2014, ADV DRUG DELIVER REV, V69, P67, DOI 10.1016/j.addr.2013.12.002; DesRochers TM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059219; Drexler HG, 2002, CYTOTECHNOLOGY, V39, P75, DOI 10.1023/A:1022913015916; HAY RJ, 1989, NATURE, V339, P487, DOI 10.1038/339487a0; Hernandez FJ, 2012, NUCLEIC ACID THER, V22, P58, DOI 10.1089/nat.2011.0316; Kuo IY, 2014, P NATL ACAD SCI USA, V111, P14283, DOI 10.1073/pnas.1412323111; Moreau JE, 2007, CANCER RES, V67, P10304, DOI 10.1158/0008-5472.CAN-07-2483; Paddenberg R, 1996, EUR J CELL BIOL, V71, P105; Sammels E, 2010, J BIOL CHEM, V285, P18794, DOI 10.1074/jbc.M109.090662; Subramanian B, 2012, BIOMATERIALS, V33, P8383, DOI 10.1016/j.biomaterials.2012.08.020; Subramanian B, 2010, TISSUE ENG PT A, V16, P2821, DOI [10.1089/ten.tea.2009.0595, 10.1089/ten.TEA.2009.0595]; Torrente M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096823; Torres VE, 2007, LANCET, V369, P1287, DOI 10.1016/S0140-6736(07)60601-1; Torres VE, 2014, J AM SOC NEPHROL, V25, P18, DOI 10.1681/ASN.2013040398; Uphoff CC, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/267678; Uphoff CC, 2011, METHODS MOL BIOL, V731, P93, DOI 10.1007/978-1-61779-080-5_8; WAYNER EA, 1984, J IMMUNOL, V132, P2135; Zhao Haitian, 2008, BMC Res Notes, V1, P38, DOI 10.1186/1756-0500-1-38; Zihni C, 2014, J CELL SCI, V127, P3401, DOI 10.1242/jcs.145029	20	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0120097	10.1371/journal.pone.0120097	http://dx.doi.org/10.1371/journal.pone.0120097			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25793639	gold, Green Published, Green Submitted			2022-12-27	WOS:000352084200143
J	Fontana, A; Spadaro, S; Copetti, M; Spoto, B; Salvemini, L; Pizzini, P; Frittitta, L; Mallamaci, F; Pellegrini, F; Trischitta, V; Menzaghi, C				Fontana, Andrea; Spadaro, Sara; Copetti, Massimiliano; Spoto, Belinda; Salvemini, Lucia; Pizzini, Patrizia; Frittitta, Lucia; Mallamaci, Francesca; Pellegrini, Fabio; Trischitta, Vincenzo; Menzaghi, Claudia			Association between Resistin Levels and All-Cause and Cardiovascular Mortality: A New Study and a Systematic Review and Meta-Analysis	PLOS ONE			English	Article							TYPE-2 DIABETIC-PATIENTS; ACUTE CORONARY SYNDROME; SERUM RESISTIN; HEART-FAILURE; RISK; DISEASE; MARKER; ADIPONECTIN; REGRESSION; ASYMMETRY	Context Studies concerning the association between circulating resistin and mortality risk have reported, so far, conflicting results. Objective To investigate the association between resistin and both all-cause and cardiovascular (CV) mortality risk by 1) analyzing data from the Gargano Heart Study (GHS) prospective design (n=359 patients; 81 and 58 all-cause and CV deaths, respectively); 2) performing meta-analyses of all published studies addressing the above mentioned associations. Data Source and Study Selection MEDLINE and Web of Science search of studies reporting hazard ratios (HR) of circulating resistin for all-cause or CV mortality. Data Extraction Performed independently by two investigators, using a standardized data extraction sheet. Data Synthesis In GHS, adjusted HRs per one standard deviation (SD) increment in resistin concentration were 1.28 (95% CI: 1.07-1.54) and 1.32 (95% CI: 1.06-1.64) for all-cause and CV mortality, respectively. The meta-analyses included 7 studies (n=4016; 961 events) for all-cause mortality and 6 studies (n=4,187: 412 events) for CV mortality. Pooled HRs per one SD increment in resistin levels were 1.21 (95% CI: 1.03-1.42, Q-test p for heterogeneity<0.001) and 1.05 (95% CI: 1.01-1.10, Q-test p for heterogeneity=0.199) for all-cause and CV mortality, respectively. At meta-regression analyses, study mean age explained 9.9% of all-cause mortality studies heterogeneity. After adjusting for age, HR for all-cause mortality was 1.24 (95% CI: 1.06-1.45). Conclusions Our results provide evidence for an association between circulating resistin and mortality risk among high-risk patients as are those with diabetes and coronary artery disease.	[Fontana, Andrea; Copetti, Massimiliano; Pellegrini, Fabio] IRCCS Casa Sollievo Sofferenza, Unit Biostat, San Giovanni Rotondo, Italy; [Spadaro, Sara; Frittitta, Lucia] Univ Catania, Dept Clin & Mol Biomed, Endocrine Unit, Catania, Italy; [Spadaro, Sara] Univ Catania, Scuola Super Catania, Catania, Italy; [Spoto, Belinda; Pizzini, Patrizia; Mallamaci, Francesca] CNR IBIM, Reggio Di Calabria, Italy; [Spoto, Belinda; Pizzini, Patrizia; Mallamaci, Francesca] Nephrol Dialysis & Transplantat Unit Reggio Calab, Reggio Di Calabria, Italy; [Salvemini, Lucia; Trischitta, Vincenzo; Menzaghi, Claudia] IRCCS Casa Sollievo Sofferenza, Res Unit Diabet & Endocrine Dis, San Giovanni Rotondo, Italy; [Trischitta, Vincenzo] Univ Roma La Sapienza, Dept Expt Med, I-00185 Rome, Italy	IRCCS Casa Sollievo Della Sofferenza; University of Catania; University of Catania; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biomedicina e di Immunologia Molecolare "Alberto Monroy" (IBIM-CNR); IRCCS Casa Sollievo Della Sofferenza; Sapienza University Rome	Trischitta, V (corresponding author), IRCCS Casa Sollievo Sofferenza, Res Unit Diabet & Endocrine Dis, San Giovanni Rotondo, Italy.	vincenzo.trischitta@uniroma1.it; c.menzaghi@operapadrepio.it	Trischitta, Vincenzo/K-1487-2016; Salvemini, Lucia/K-2121-2016; Fontana, Andrea/J-8584-2016; Menzaghi, Claudia/J-7210-2016; Copetti, Massimiliano/K-3186-2016; frittitta, lucia/AAA-4733-2019; COPETTI, MASSIMILIANO/AAG-1473-2021; frittitta, Lucia/J-2334-2012	Trischitta, Vincenzo/0000-0003-1174-127X; Salvemini, Lucia/0000-0001-8776-9477; Fontana, Andrea/0000-0002-6660-5315; Menzaghi, Claudia/0000-0002-7438-8955; Copetti, Massimiliano/0000-0002-7960-5947; frittitta, lucia/0000-0002-7941-5828; COPETTI, MASSIMILIANO/0000-0002-7960-5947; 	Accordo Programma Quadro in Materia di Ricerca Scientifica nella Regione Puglia-PST; Accordo Programma Quadro in Materia di Ricerca Scientifica nella Regione PO Puglia FESR; Italian Ministry of Health [RC2014, RC2015]; European Foundation for the Study of Diabetes/Pfizer; Societa Italiana di Diabetologia-Fondazione Diabete Ricerca	Accordo Programma Quadro in Materia di Ricerca Scientifica nella Regione Puglia-PST; Accordo Programma Quadro in Materia di Ricerca Scientifica nella Regione PO Puglia FESR; Italian Ministry of Health(Ministry of Health, Italy); European Foundation for the Study of Diabetes/Pfizer; Societa Italiana di Diabetologia-Fondazione Diabete Ricerca	This study was supported by Accordo Programma Quadro in Materia di Ricerca Scientifica nella Regione Puglia-PST 2006 and PO Puglia FESR 2007-2013, Italian Ministry of Health grants RC2014 and RC2015, European Foundation for the Study of Diabetes/Pfizer grant and Societa Italiana di Diabetologia-Fondazione Diabete Ricerca (CM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Burnett MS, 2005, ATHEROSCLEROSIS, V182, P241, DOI 10.1016/j.atherosclerosis.2005.02.014; Cheng JM, 2013, EUR J HEART FAIL, V15, P1350, DOI 10.1093/eurjhf/hft106; Cho Youngjin, 2011, J Am Coll Cardiol, V57, P99, DOI 10.1016/j.jacc.2010.07.035; Coleman RL, 2007, DIABETES CARE, V30, P1292, DOI 10.2337/dc06-1358; D'Agostino RB, 2004, HDB STAT, V23; De Cosmo S, 2013, DIABETES CARE, V36, P2830, DOI 10.2337/dc12-1906; Efstathiou SP, 2007, CLIN CHIM ACTA, V378, P78, DOI 10.1016/j.cca.2006.10.023; GREENLAND S, 1987, EPIDEMIOL REV, V9, P1; Hartemink N, 2006, AM J EPIDEMIOL, V163, P1042, DOI 10.1093/aje/kwj141; Il'yasova D, 2005, CANCER CAUSE CONTROL, V16, P383, DOI 10.1007/s10552-004-5025-x; Ioannidis JPA, 2007, CAN MED ASSOC J, V176, P1091, DOI 10.1503/cmaj.060410; Langheim S, 2010, AM J PHYSIOL-HEART C, V298, pH746, DOI 10.1152/ajpheart.00617.2009; Lee SH, 2009, CORONARY ARTERY DIS, V20, P33, DOI 10.1097/MCA.0b013e328318ecb0; Lubos E, 2007, ATHEROSCLEROSIS, V193, P121, DOI 10.1016/j.atherosclerosis.2006.05.039; Menzaghi C, 2006, J CLIN ENDOCR METAB, V91, P2792, DOI 10.1210/jc.2005-2715; Menzaghi C, 2014, CARDIOVASC DIABETOL, V13, DOI 10.1186/s12933-014-0130-y; Menzaghi C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064729; On YK, 2007, CIRC J, V71, P868, DOI 10.1253/circj.71.868; Pilz S, 2007, CLIN ENDOCRINOL, V66, P380, DOI 10.1111/j.1365-2265.2007.02743.x; Pischon T, 2005, OBES RES, V13, P1764, DOI 10.1038/oby.2005.215; Reilly MP, 2005, CIRCULATION, V111, P932, DOI 10.1161/01.CIR.0000155620.10387.43; Silva AP, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/247649; Spoto B, 2013, NEPHROL DIAL TRANSPL, V28, P181, DOI 10.1093/ndt/gft365; Sterne JAC, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4002; Tsukahara T, 2009, DIABETES RES CLIN PR, V84, P179, DOI 10.1016/j.diabres.2008.10.021; van Houwelingen HC, 2002, STAT MED, V21, P589, DOI 10.1002/sim.1040; Zhang MH, 2011, J CARD FAIL, V17, P24, DOI 10.1016/j.cardfail.2010.08.007	27	53	54	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0120419	10.1371/journal.pone.0120419	http://dx.doi.org/10.1371/journal.pone.0120419			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25793385	gold, Green Submitted, Green Published			2022-12-27	WOS:000352083900031
J	Jamison, S; Lin, YF; Lin, WS				Jamison, Stephanie; Lin, Yifeng; Lin, Wensheng			Pancreatic Endoplasmic Reticulum Kinase Activation Promotes Medulloblastoma Cell Migration and Invasion through Induction of Vascular Endothelial Growth Factor A	PLOS ONE			English	Article							UNFOLDED PROTEIN RESPONSE; SMALL-MOLECULE INHIBITOR; VEGF-RECEPTOR; ER STRESS; PERK; TRANSLATION; HYPOXIA; EXPRESSION; PATHWAY; OLIGODENDROCYTES	Evidence is accumulating that activation of the pancreatic endoplasmic reticulum kinase (PERK) in response to endoplasmic reticulum (ER) stress adapts tumor cells to the tumor microenvironment and enhances tumor angiogenesis by inducing vascular endothelial growth factor A (VEGF-A). Recent studies suggest that VEGF-A can act directly on certain tumor cell types in an autocrine manner, via binding to VEGF receptor 2 (VEGFR2), to promote tumor cell migration and invasion. Although several reports show that PERK activation increases VEGF-A expression in medulloblastoma, the most common solid malignancy of childhood, the role that either PERK or VEGF-A plays in medulloblastoma remains elusive. In this study, we mimicked the moderate enhancement of PERK activity observed in tumor patients using a genetic approach and a pharmacologic approach, and found that moderate activation of PERK signaling facilitated medulloblastoma cell migration and invasion and increased the production of VEGF-A. Moreover, using the VEGFR2 inhibitor SU5416 and the VEGF-A neutralizing antibody to block VEGF-A/VEGFR2 signaling, our results suggested that tumor cell-derived VEGF-A promoted medulloblastoma cell migration and invasion through VEGFR2 signaling, and that both VEGF-A and VEGFR2 were required for the promoting effects of PERK activation on medulloblastoma cell migration and invasion. Thus, these findings suggest that moderate PERK activation promotes medulloblastoma cell migration and invasion through enhancement of VEGF-A/VEGFR2 signaling.	[Jamison, Stephanie; Lin, Yifeng; Lin, Wensheng] Univ Minnesota, Dept Neurosci, Minneapolis, MN 55455 USA; [Jamison, Stephanie; Lin, Yifeng; Lin, Wensheng] Univ Minnesota, Inst Translat Neurosci, Minneapolis, MN USA; [Jamison, Stephanie; Lin, Yifeng; Lin, Wensheng] Univ Minnesota, Mason Canc Ctr, Minneapolis, MN USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Lin, WS (corresponding author), Univ Minnesota, Dept Neurosci, Minneapolis, MN 55455 USA.	linw@umn.edu	Lin, Wensheng/J-2661-2019	Lin, Wensheng/0000-0003-4931-7642	National Institutes of Health [NS073132]; National Multiple Sclerosis Society [TA3026-A-1, RG4813-A-2, RG5239-A-3]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS073132] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Multiple Sclerosis Society(National Multiple Sclerosis Society); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	National Institutes of Health (NS073132) and National Multiple Sclerosis Society (TA3026-A-1, RG4813-A-2, and RG5239-A-3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerman D, 2014, TRENDS CELL BIOL, V24, P472, DOI 10.1016/j.tcb.2014.06.001; Akino T, 2014, CANCER RES, V74, P3716, DOI 10.1158/0008-5472.CAN-13-3116; Atkins C, 2013, CANCER RES, V73, P1993, DOI 10.1158/0008-5472.CAN-12-3109; Axten JM, 2012, J MED CHEM, V55, P7193, DOI 10.1021/jm300713s; Bi MX, 2005, EMBO J, V24, P3470, DOI 10.1038/sj.emboj.7600777; Boyce M, 2005, SCIENCE, V307, P935, DOI 10.1126/science.1101902; Carmeliet P, 2013, CELL MOL LIFE SCI, V70, P1763, DOI 10.1007/s00018-013-1283-7; Crawford JR, 2007, LANCET NEUROL, V6, P1073, DOI 10.1016/S1474-4422(07)70289-2; Davare MA, 2014, BIOCHEM BIOPH RES CO, V450, P555, DOI 10.1016/j.bbrc.2014.06.018; Fels DR, 2006, CANCER BIOL THER, V5, P723, DOI 10.4161/cbt.5.7.2967; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Harding HP, 2012, J BIOL CHEM, V287, P44338, DOI 10.1074/jbc.M112.428987; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Hashizume H, 2010, CANCER RES, V70, P2213, DOI 10.1158/0008-5472.CAN-09-1977; Hervey-Jumper SL, 2014, J NEUROSURG-PEDIATR, V14, P121, DOI 10.3171/2014.4.PEDS13244; Hetz C, 2012, NAT REV MOL CELL BIO, V13, P89, DOI 10.1038/nrm3270; Hicklin DJ, 2005, J CLIN ONCOL, V23, P1011, DOI 10.1200/JCO.2005.06.081; Huber AL, 2013, MOL CELL, V49, P1049, DOI 10.1016/j.molcel.2013.01.009; Keles GE, 1995, ONCOL RES, V7, P493; Lichtenberger BM, 2010, CELL, V140, P268, DOI 10.1016/j.cell.2009.12.046; Lin JH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004170; Lin WS, 2008, AM J PATHOL, V173, P1508, DOI 10.2353/ajpath.2008.080449; Lin WS, 2013, J NEUROSCI, V33, P5980, DOI 10.1523/JNEUROSCI.1636-12.2013; Lin WS, 2011, J NEUROSCI RES, V89, P1586, DOI 10.1002/jnr.22693; Lin WS, 2010, J NEUROSCI RES, V88, P2569, DOI 10.1002/jnr.22425; Lin WS, 2005, J CELL BIOL, V169, P603, DOI 10.1083/jcb.200502086; Lin YF, 2014, J NEUROSCI, V34, P12182, DOI 10.1523/JNEUROSCI.1373-14.2014; Lin YF, 2014, AM J PATHOL, V184, P507, DOI 10.1016/j.ajpath.2013.10.009; Lin YF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036408; Lu PD, 2004, EMBO J, V23, P169, DOI 10.1038/sj.emboj.7600030; Ma YJ, 2004, NAT REV CANCER, V4, P966, DOI 10.1038/nrc1505; Marciniak SJ, 2006, PHYSIOL REV, V86, P1133, DOI 10.1152/physrev.00015.2006; Martin-Perez R, 2014, CANCER RES, V74, P1766, DOI 10.1158/0008-5472.CAN-13-1747; Mendel DB, 2000, ANTI-CANCER DRUG DES, V15, P29; Mercurio AM, 2004, SEMIN CANCER BIOL, V14, P115, DOI 10.1016/j.semcancer.2003.09.016; Moenner M, 2007, CANCER RES, V67, P10631, DOI 10.1158/0008-5472.CAN-07-1705; Moreira IS, 2007, ANTI-CANCER AGENT ME, V7, P223; Mujcic H, 2013, CLIN CANCER RES, V19, P6126, DOI 10.1158/1078-0432.CCR-13-0526; Nagelkerke A, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3373; Northcott PA, 2012, NAT REV CANCER, V12, P818, DOI 10.1038/nrc3410; Pavitt GD, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a012278; Pereira ER, 2014, J BIOL CHEM, V289, P3352, DOI 10.1074/jbc.M113.507194; Pereira ER, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012521; Qi L, 2011, METHOD ENZYMOL, V490, P137, DOI 10.1016/B978-0-12-385114-7.00008-8; Ranganathan AC, 2008, CANCER RES, V68, P3260, DOI 10.1158/0008-5472.CAN-07-6215; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Rouschop KMA, 2010, J CLIN INVEST, V120, P127, DOI 10.1172/JCI40027; Schmidt EK, 2009, NAT METHODS, V6, P275, DOI [10.1038/NMETH.1314, 10.1038/nmeth.1314]; Slongo ML, 2007, NEURO-ONCOLOGY, V9, P384, DOI 10.1215/15228517-2007-032; Smith ER, 2008, CLIN CANCER RES, V14, P2378, DOI 10.1158/1078-0432.CCR-07-1253; Tabas I, 2011, NAT CELL BIOL, V13, P184, DOI 10.1038/ncb0311-184; Vandewynckel YP, 2013, ANTICANCER RES, V33, P4683; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038	55	26	29	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0120252	10.1371/journal.pone.0120252	http://dx.doi.org/10.1371/journal.pone.0120252			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25794107	Green Published, Green Submitted, gold			2022-12-27	WOS:000352083900002
J	Knox, PC; Wolohan, FDA				Knox, Paul C.; Wolohan, Felicity D. A.			Temporal Stability and the Effects of Training on Saccade Latency in "Express Saccade Makers"	PLOS ONE			English	Article							TEST-RETEST RELIABILITY; EYE-MOVEMENTS; REACTION-TIMES; PERFORMANCE; SCHIZOPHRENIA; GENERATION	The temporal stability of saccade latency, and the effects of training, particularly in "express saccade makers" (ESMs), has received little attention. ESMs are healthy, naive, adults, who persist in executing very many low latency "express saccades" (ES; saccades with latency of 80 ms to 130 ms), in conditions designed to suppress such responses. We investigated the stability of ES production (%ES) in 59 ESM and 54 non-ESM participants in overlap tasks. Within a single session, the intraclass correlation coefficient (ICC) for %ES in two runs of 200 trials was 0.97 (p<0.001); participants in whom >30% of saccades over the two runs were ES, were classified as ESMs. For 60 participants tested over two sessions 12 weeks apart, and 30 participants tested in three sessions over approximately six months, the ICC for % ES was uniformly high (0.95, p<0.001 and 0.97, p<0.001 respectively) and participants behaved consistently with their initial classification. Fourteen participants (7 ESMs) were then exposed to training consisting of either gap or overlap tasks. Training increased %ES in both groups. However, when tested in overlap tasks, it was not sufficient to transform Normal participants into ESMs. We conclude that the pattern of saccade behaviour exhibited by ESMs constitutes a stable and distinct oculomotor phenotype.	[Knox, Paul C.; Wolohan, Felicity D. A.] Univ Liverpool, Inst Ageing & Chron Dis, Eye & Vis Sci, Liverpool L69 3BX, Merseyside, England	University of Liverpool	Knox, PC (corresponding author), Univ Liverpool, Inst Ageing & Chron Dis, Eye & Vis Sci, Liverpool L69 3BX, Merseyside, England.	pcknox@liv.ac.uk	Knox, Paul/Q-1920-2019	Knox, Paul/0000-0002-2578-7335; Wolohan, Felicity/0000-0002-8403-1730	Leverhulme Trust [RPG-329]	Leverhulme Trust(Leverhulme Trust)	This study was funded by a project grant from the Leverhulme Trust (RPG-329). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amatya N, 2011, EXP BRAIN RES, V210, P117, DOI 10.1007/s00221-011-2609-z; Balota DA, 2011, CURR DIR PSYCHOL SCI, V20, P160, DOI 10.1177/0963721411408885; BARTKO JJ, 1991, SCHIZOPHRENIA BULL, V17, P483, DOI 10.1093/schbul/17.3.483; Bibi R, 2009, J NEUROPHYSIOL, V102, P3101, DOI 10.1152/jn.90710.2008; Biscaldi M, 1996, J NEUROPHYSIOL, V76, P199, DOI 10.1152/jn.1996.76.1.199; Blekher T, 2009, INVEST OPHTH VIS SCI, V50, P5707, DOI 10.1167/iovs.09-3538; Calkins ME, 2003, INT J PSYCHOPHYSIOL, V49, P139, DOI 10.1016/S0167-8760(03)00101-6; CARPENTER RHS, 1995, NATURE, V377, P59, DOI 10.1038/377059a0; Cavegn D, 1996, EXP BRAIN RES, V109, P101; CURRIE J, 1993, EXP BRAIN RES, V97, P343; Delinte A, 2002, NEUROSCI RES, V42, P21, DOI 10.1016/S0168-0102(01)00300-5; Dorris MC, 1997, J NEUROSCI, V17, P8566; Edelman JA, 1996, J NEUROPHYSIOL, V76, P908, DOI 10.1152/jn.1996.76.2.908; FISCHER B, 1993, EXP BRAIN RES, V92, P528; Fischer B, 1997, BRAIN RES, V754, P285, DOI 10.1016/S0006-8993(97)00094-2; FISCHER B, 1986, EXP BRAIN RES, V64, P569, DOI 10.1007/BF00340494; FISCHER B, 1984, EXP BRAIN RES, V57, P191; Gooding DC, 2004, PSYCHOL MED, V34, P921, DOI 10.1017/S003329170300165X; Harwood MR, 2008, J NEUROPHYSIOL, V99, P1743, DOI 10.1152/jn.00589.2007; IACONO WG, 1981, PSYCHOPHYSIOLOGY, V18, P49, DOI 10.1111/j.1469-8986.1981.tb01542.x; Klein C, 2005, BIOL PSYCHOL, V68, P201, DOI 10.1016/j.biopsycho.2004.06.005; Knox PC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094424; Knox PC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047688; Munoz DP, 1998, EXP BRAIN RES, V121, P391, DOI 10.1007/s002210050473; Wolohan FDA, 2014, EXP BRAIN RES, V232, P3949, DOI 10.1007/s00221-014-4076-9; Zee DS., 1999, NEUROLOGY EYE MOVEME	26	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0120437	10.1371/journal.pone.0120437	http://dx.doi.org/10.1371/journal.pone.0120437			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25793932	Green Submitted, Green Published, gold			2022-12-27	WOS:000352083900036
J	Kyle, M; Haande, S; Ostermaier, V; Rohrlack, T				Kyle, Marcia; Haande, Sigrid; Ostermaier, Veronika; Rohrlack, Thomas			The Red Queen Race between Parasitic Chytrids and Their Host, Planktothrix: A Test Using a Time Series Reconstructed from Sediment DNA	PLOS ONE			English	Article							CYANOBACTERIA; LAKE; INFECTIVITY; CHEMOTYPES; DEPTH	Parasitic chytrid fungi (phylum Chytridiomycota) are known to infect specific phytoplankton, including the filamentous cyanobacterium Planktothrix. Subspecies, or chemotypes of Planktothrix can be identified by the presence of characteristic oligopeptides. Some of these oligopeptides can be associated with important health concerns due to their potential for toxin production. However, the relationship between chytrid parasite and Planktothrix host is not clearly understood and more research is needed. To test the parasite - host relationship over time, we used a sediment core extracted from a Norwegian lake known to contain both multiple Planktothrix chemotype hosts and their parasitic chytrid. Sediment DNA of chytrids and Planktothrix was amplified and a 35-year coexistence was found. It is important to understand how these two antagonistic species can coexistence in a lake. Reconstruction of the time series showed that between 1979-1990 at least 2 strains of Planktothrix were present and parasitic pressure exerted by chytrids was low. After this period one chemotype became dominant and yet showed continued low susceptibility to chytrid parasitism. Either environmental conditions or intrinsic characteristics of Planktothrixcould have been responsible for this continued dominance. One possible explanation could be found in the shift of Planktothrix to the metalimnion, an environment that typically consists of low light and decreased temperatures. Planktothrix are capable of growth under these conditions while the chytrid parasites are constrained. Another potential explanation could be due to the differences between cellular oligopeptide variations found between Planktothrix chemotypes. These oligopeptides can function as defense systems against chytrids. Our findings suggest that chytrid driven diversity was not maintained over time, but that the combination of environmental constraints and multiple oligopeptide production to combat chytrids could have allowed one Planktothrix chemotype to have dominance despite chytrid presence.	[Kyle, Marcia; Rohrlack, Thomas] Norwegian Univ Life Sci NMBU, Environm Sci, As, Norway; [Haande, Sigrid; Ostermaier, Veronika] Norwegian Inst Water Res NIVA, Oslo, Norway	Norwegian University of Life Sciences; Norwegian Institute for Water Research (NIVA)	Kyle, M (corresponding author), Norwegian Univ Life Sci NMBU, Environm Sci, As, Norway.	marcia.kyle@nmbu.no			Norwegian Institute for Water research (NIVA); Norwegian University of Life Sciences (UMBU); Short Term Scientific Mission (STSM) of COST action [ES1105]	Norwegian Institute for Water research (NIVA); Norwegian University of Life Sciences (UMBU); Short Term Scientific Mission (STSM) of COST action	This project was funded by internal grants from both Norwegian Institute for Water research (NIVA) and Norwegian University of Life Sciences (UMBU) and a Short Term Scientific Mission (STSM) grant in the framework of COST action ES1105 for VO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boere AC, 2011, GEOBIOLOGY, V9, P377, DOI 10.1111/j.1472-4669.2011.00290.x; BRUNING K, 1991, J PLANKTON RES, V13, P103, DOI 10.1093/plankt/13.1.103; De Bruin A, 2008, J EUKARYOT MICROBIOL, V55, P69, DOI 10.1111/j.1550-7408.2008.00306.x; Dokulil MT, 2012, HYDROBIOLOGIA, V698, P29, DOI 10.1007/s10750-012-1020-5; Garneau ME, 2013, LIMNOL OCEANOGR, V58, P1892, DOI 10.4319/lo.2013.58.5.1892; Gerphagnon M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060894; Gsell AS, 2013, THESIS UTRECHT U UTR; Haande S, 2014, 66612014 NIVA; Halstvedt CB, 2007, J PLANKTON RES, V29, P471, DOI 10.1093/plankt/fbm036; Ibelings BW, 2011, FRESHWATER BIOL, V56, P754, DOI 10.1111/j.1365-2427.2010.02565.x; Kyle M, 2014, J PALEOLIMNOL, DOI [10.1007/s10933-014-9807-119, DOI 10.1007/S10933-014-9807-119]; Legnani Elena, 2005, Journal of Limnology, V64, P61; Miki T, 2011, FRESHWATER BIOL, V56, P1173, DOI 10.1111/j.1365-2427.2010.02562.x; R Core Team, 2018, R LANG ENV STAT COMP; Rasconi S, 2012, ENVIRON MICROBIOL, V14, P2151, DOI 10.1111/j.1462-2920.2011.02690.x; Rohrlack T, 2008, LIMNOL OCEANOGR, V53, P1279, DOI 10.4319/lo.2008.53.4.1279; Rohrlack T, 2013, APPL ENVIRON MICROB, V79, P2642, DOI 10.1128/AEM.03499-12; Rudi K, 2005, PREP BIOCHEM BIOTECH, V35, P301, DOI 10.1080/10826060500218131; Sime-Ngando T, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00361; Sogge H, 2013, APPL ENVIRON MICROB, V79, P508, DOI 10.1128/AEM.02417-12; Sonstebo JH, 2011, APPL ENVIRON MICROB, V77, P1344, DOI 10.1128/AEM.02153-10; Tooming-Klunderud A, 2013, APPL ENVIRON MICROB, V79, P6803, DOI 10.1128/AEM.01455-13; Van Valen L., 1973, EVOL THEORY, V1, P1, DOI DOI 10.1038/344864A0; Walsby AE, 2004, NEW PHYTOL, V162, P133, DOI 10.1111/j.1469-8137.2004.01020.x; Welker M, 2004, ARCH MICROBIOL, V182, P288, DOI 10.1007/s00203-004-0711-3	25	22	22	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0118738	10.1371/journal.pone.0118738	http://dx.doi.org/10.1371/journal.pone.0118738			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25793898	Green Published, Green Accepted, gold			2022-12-27	WOS:000352084200037
J	Liu, YC; Liu, M; Wang, X				Liu, Yuanchao; Liu, Ming; Wang, Xin			Towards Semantically Sensitive Text Clustering: A Feature Space Modeling Technology Based on Dimension Extension	PLOS ONE			English	Article							SELF-ORGANIZING MAPS; WEBSOM	The objective of text clustering is to divide document collections into clusters based on the similarity between documents. In this paper, an extension-based feature modeling approach towards semantically sensitive text clustering is proposed along with the corresponding feature space construction and similarity computation method. By combining the similarity in traditional feature space and that in extension space, the adverse effects of the complexity and diversity of natural language can be addressed and clustering semantic sensitivity can be improved correspondingly. The generated clusters can be organized using different granularities. The experimental evaluations on well-known clustering algorithms and datasets have verified the effectiveness of our approach.	[Liu, Yuanchao; Liu, Ming; Wang, Xin] Harbin Inst Technol, Sch Comp Sci & Technol, Harbin 150006, Peoples R China	Harbin Institute of Technology	Liu, YC (corresponding author), Harbin Inst Technol, Sch Comp Sci & Technol, Harbin 150006, Peoples R China.	lyc@insun.hit.edu.cn						Azcarraga AP, 2004, IEEE T KNOWL DATA EN, V16, P380; Bagga A., 1998, P 36 ANN M ASS COMP, P79, DOI [10.3115/980845.980859, DOI 10.3115/980845.980859]; Bote VPG, 2002, INFORM PROCESS MANAG, V38, P79, DOI 10.1016/S0306-4573(00)00066-2; Chim H, 2008, IEEE T KNOWL DATA EN, V20, P1217, DOI 10.1109/TKDE.2008.50; Cui XH, 2005, 2005 IEEE SWARM INTELLIGENCE SYMPOSIUM, P185; Dhillon I. S., 2003, Journal of Machine Learning Research, V3, P1265, DOI 10.1162/153244303322753661; Dong Q., 2000, HOWNET; Elahi A, 2012, J ADV COMP SCI TECHN, V2012, P2; Ercan G, 2007, INFORM PROCESS MANAG, V43, P1705, DOI 10.1016/j.ipm.2007.01.015; Gabrilovich E, 2007, 20TH INTERNATIONAL JOINT CONFERENCE ON ARTIFICIAL INTELLIGENCE, P1606; Granados A, 2012, EXPERT SYST APPL, V39, P8537, DOI 10.1016/j.eswa.2012.01.215; Griffiths T., 2002, STANDFORD U, P1; Griffiths TL, 2004, P NATL ACAD SCI USA, V101, P5228, DOI 10.1073/pnas.0307752101; Hammouda KM, 2004, IEEE T KNOWL DATA EN, V16, P1279, DOI 10.1109/TKDE.2004.58; Hartigan J. A., 1979, Applied Statistics, V28, P100, DOI 10.2307/2346830; Heinrich G, 2013, TECHNICAL REPORT; Hofmann T, 1999, P 15 ANN C UNC ART I, P34; Huang S, 2006, IEEE T KNOWL DATA EN, V18, P448, DOI 10.1109/TKDE.2006.1599384; Jiaju M, 1983, SHANGHAI DICT PUBLIC, V1983; Jing J, 2007, JISUANJI XUEBAO CHIN, V30, P1354; Kaski S, 1998, NEUROCOMPUTING, V21, P101, DOI 10.1016/S0925-2312(98)00039-3; Kohonen T., 2001, SELF ORG MAPS; Kwak M, 2013, J BIOMED INFORM, V46, P929, DOI 10.1016/j.jbi.2013.07.006; Letsche TA, 1997, INFORM SCIENCES, V100, P105, DOI 10.1016/S0020-0255(97)00044-3; Liu Y, 2006, WEB AG INF MAN WORKS, P16; Liu YB, 2007, LECT NOTES ARTIF INT, V4632, P389; Merkl D, 1998, NEUROCOMPUTING, V21, P61, DOI 10.1016/S0925-2312(98)00032-0; Metzler D, 2007, P 29 EUR C IR RES EC, P12; Nasir JA, 2013, KNOWL-BASED SYST, V54, P216, DOI 10.1016/j.knosys.2013.09.012; Pinto D, 2007, LECT NOTES COMPUT SC, V4394, P611; Rennie J, 2013, ORIGINAL 20 NEWSGROU; SALTON G, 1975, COMMUN ACM, V18, P613, DOI 10.1145/361219.361220; Shady S, 2007, IEEE INT C DATA MINI, P1043; Shan C, 2005, INT C COMP INT MOD C, V2005, P7; Song SX, 2005, LECT NOTES ARTIF INT, V3801, P713; Turney PD, 2012, J ARTIF INTELL RES, V44, P533, DOI 10.1613/jair.3640; Xiang Ji, 2006, Proceedings of the Twenty-Ninth Annual International ACM SIGIR Conference on Research and Development in Information Retrieval, P405; Yang Y, 1997, ICML, P412, DOI DOI 10.1093/BI0INF0RMATICS/BTH267	38	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0117390	10.1371/journal.pone.0117390	http://dx.doi.org/10.1371/journal.pone.0117390			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25794172	Green Published, Green Submitted, gold			2022-12-27	WOS:000352084200013
J	Muro, R; Nitta, T; Okada, T; Ideta, H; Tsubata, T; Suzuki, H				Muro, Ryunosuke; Nitta, Takeshi; Okada, Toshiyuki; Ideta, Hitoshi; Tsubata, Takeshi; Suzuki, Harumi			The Ras GTPase-Activating Protein Rasal3 Supports Survival of Naive T Cells	PLOS ONE			English	Article							POSITIVE SELECTION; PATHWAY; PROLIFERATION; MOLECULES	The Ras-mitogen-activated protein kinase (MAPK) pathway is crucial for T cell receptor (TCR) signaling in the development and function of T cells. The significance of various modulators of the Ras-MAPK pathway in T cells, however, remains to be fully understood. Ras-activating protein-like 3 (Rasal3) is an uncharacterized member of the SynGAP family that contains a conserved Ras GTPase-activating protein (GAP) domain, and is predominantly expressed in the T cell lineage. In the current study, we investigated the function and physiological roles of Rasal3. Our results showed that Rasal3 possesses RasGAP activity, but not Rap1GAP activity, and represses TCR-stimulated ERK phosphorylation in a T cell line. In systemic Rasal3-deficient mice, T cell development in the thymus including positive selection, negative selection, and beta-selection was unaffected. However, the number of naive, but not effector memory CD4 and CD8 T cell in the periphery was significantly reduced in Rasal3-deficient mice, and associated with a marked increase in apoptosis of these cells. Indeed, survival of Rasal3 deficient naive CD4 T cells in vivo by adoptive transfer was significantly impaired, whereas IL-7-dependent survival of naive CD4 T cells in vitro was unaltered. Collectively, Rasal3 is required for in vivo survival of peripheral naive T cells, contributing to the maintenance of optimal T cell numbers.	[Muro, Ryunosuke; Nitta, Takeshi; Okada, Toshiyuki; Ideta, Hitoshi; Suzuki, Harumi] Natl Ctr Global Hlth & Med, Dept Pathol & Immunol, Res Inst, Ichikawa, Chiba, Japan; [Muro, Ryunosuke; Tsubata, Takeshi] Tokyo Med & Dent Univ, Med Res Inst, Dept Immunol, Bunkyo Ku, Tokyo, Japan	National Center for Global Health & Medicine - Japan; Tokyo Medical & Dental University (TMDU)	Suzuki, H (corresponding author), Natl Ctr Global Hlth & Med, Dept Pathol & Immunol, Res Inst, Ichikawa, Chiba, Japan.	hsuzuki@ri.ncgm.go.jp	Suzuki, Harumi/L-1271-2013; Tsubata, Takeshi/AAI-7489-2021	Suzuki, Harumi/0000-0003-3616-9361; Tsubata, Takeshi/0000-0003-0760-1258	National Center for Global Health and Medicine [22303, 25-103]; Grants-in-Aid for Scientific Research [25111516] Funding Source: KAKEN	National Center for Global Health and Medicine(National Center for Global Health & Medicine - Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grant for National Center for Global Health and Medicine (22303, 25-103). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberola-Ila J, 2003, IMMUNOL REV, V191, P79, DOI 10.1034/j.1600-065X.2003.00012.x; Boyman O, 2009, EUR J IMMUNOL, V39, P2088, DOI 10.1002/eji.200939444; Crompton T, 1996, CELL, V86, P243, DOI 10.1016/S0092-8674(00)80096-3; Dorfman JR, 2000, NAT IMMUNOL, V1, P329, DOI 10.1038/79783; Grandjean I, 2003, J EXP MED, V198, P1089, DOI 10.1084/jem.20030963; Kim K, 1998, J IMMUNOL, V160, P5735; King PD, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003669; KISIELOW P, 1988, NATURE, V335, P730, DOI 10.1038/335730a0; KISIELOW P, 1988, NATURE, V333, P742, DOI 10.1038/333742a0; Kortum RL, 2013, TRENDS IMMUNOL, V34, P259, DOI 10.1016/j.it.2013.02.004; Kortum RL, 2012, MOL CELL BIOL, V32, P2748, DOI 10.1128/MCB.00317-12; Kupzig S, 2009, MOL CELL BIOL, V29, P3929, DOI 10.1128/MCB.00427-09; Lapinski PE, 2011, J IMMUNOL, V187, P151, DOI 10.4049/jimmunol.1100178; Li WQ, 2004, J BIOL CHEM, V279, P29160, DOI 10.1074/jbc.M401656200; Murali-Krishna K, 1999, SCIENCE, V286, P1377, DOI 10.1126/science.286.5443.1377; Navarro MN, 2011, NAT IMMUNOL, V12, P352, DOI 10.1038/ni.2008; Nitta Takeshi, 2013, Methods Mol Biol, V946, P85, DOI 10.1007/978-1-62703-128-8_6; Oda H, 2009, J IMMUNOL, V182, P957, DOI 10.4049/jimmunol.182.2.957; Oliver JA, 2013, MOL IMMUNOL, V55, P292, DOI 10.1016/j.molimm.2013.03.005; Patrick MS, 2009, P NATL ACAD SCI USA, V106, P16345, DOI 10.1073/pnas.0908593106; Rooke R, 1997, IMMUNITY, V7, P123, DOI 10.1016/S1074-7613(00)80515-4; Rothenberg EV, 2005, ANNU REV IMMUNOL, V23, P601, DOI 10.1146/annurev.immunol.23.021704.115737; Saitoh T, 2002, FEBS LETT, V532, P45, DOI 10.1016/S0014-5793(02)03622-0; Sharp LL, 1997, IMMUNITY, V7, P609, DOI 10.1016/S1074-7613(00)80382-9; SHINKAI Y, 1993, SCIENCE, V259, P822, DOI 10.1126/science.8430336; Sprent J, 2011, NAT IMMUNOL, V12, P478, DOI 10.1038/ni.2018; Takeda S, 1996, IMMUNITY, V5, P217, DOI 10.1016/S1074-7613(00)80317-9; Tanchot C, 1997, SCIENCE, V276, P2057, DOI 10.1126/science.276.5321.2057; Walker SA, 2004, EMBO J, V23, P1749, DOI 10.1038/sj.emboj.7600197	29	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0119898	10.1371/journal.pone.0119898	http://dx.doi.org/10.1371/journal.pone.0119898			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25793935	Green Published, gold, Green Submitted			2022-12-27	WOS:000352084200128
J	Okada, H; Schittenhelm, RB; Straessle, A; Hafen, E				Okada, Hirokazu; Schittenhelm, Ralf B.; Straessle, Anna; Hafen, Ernst			Multi-Functional Regulation of 4E-BP Gene Expression by the Ccr4-Not Complex	PLOS ONE			English	Article							MESSENGER-RNA DEADENYLATION; POLY(A) TAIL; SACCHAROMYCES-CEREVISIAE; DIFFERENTIALLY AFFECTS; CAF1 PROTEINS; TRANSCRIPTION; DROSOPHILA; TRANSLATION; DEGRADATION; INITIATION	The mechanistic target of rapamycin (mTOR) signaling pathway is highly conserved from yeast to humans. It senses various environmental cues to regulate cellular growth and homeostasis. Deregulation of the pathway has been implicated in many pathological conditions including cancer. Phosphorylation cascades through the pathway have been extensively studied but not much is known about the regulation of gene expression of the pathway components. Here, we report that the mRNA level of eukaryotic translation initiation factor (eIF) subunit 4E-binding protein (4E-BP) gene, one of the key mTOR signaling components, is regulated by the highly conserved Ccr4-Not complex. RNAi knockdown of Not1, a putative scaffold protein of this protein complex, increases the mRNA level of 4E-BP in Drosophila Kc cells. Examination of the gene expression mechanism using reporter swap constructs reveals that Not1 depletion increases reporter mRNAs with the 3'UTR of 4E-BP gene, but decreases the ones with the 4E-BP promoter region, suggesting that Ccr4-Not complex regulates both degradation and transcription of 4E-BP mRNA. These results indicate that the Ccr4-Not complex controls expression of a single gene at multiple levels and adjusts the magnitude of the total effect. Thus, our study reveals a novel regulatory mechanism of a key component of the mTOR signaling pathway at the level of gene expression.	[Okada, Hirokazu; Straessle, Anna; Hafen, Ernst] Swiss Fed Inst Technol, Inst Mol Syst Biol, CH-8093 Zurich, Switzerland; [Schittenhelm, Ralf B.] Monash Univ, Dept Biochem & Mol Biol, Sch Biomed Sci, Fac Med Nursing & Hlth Sci, Clayton, Vic 3800, Australia	Swiss Federal Institutes of Technology Domain; ETH Zurich; Monash University	Hafen, E (corresponding author), Swiss Fed Inst Technol, Inst Mol Syst Biol, Wolfgang Pauli Str 16, CH-8093 Zurich, Switzerland.	hafen@imsb.biol.ethz.ch		Okada, Hirokazu/0000-0002-1065-2470; Schittenhelm, Ralf/0000-0001-8738-1878	SystemsX.ch [SXRTX0-123851]; Swiss National Science Foundation	SystemsX.ch; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by Grant SXRTX0-123851 by SystemsX.ch and the Swiss National Science Foundation (https://www.mysnf.ch). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert TK, 2002, EMBO J, V21, P355, DOI 10.1093/emboj/21.3.355; Behm-Ansmant I, 2006, GENE DEV, V20, P1885, DOI 10.1101/gad.1424106; Bianchin C, 2005, RNA, V11, P487, DOI 10.1261/rna.7135305; Chan TF, 2000, P NATL ACAD SCI USA, V97, P13227, DOI 10.1073/pnas.240444197; Chen JJ, 2002, EMBO J, V21, P1414, DOI 10.1093/emboj/21.6.1414; Clement SL, 2011, MOL CELL BIOL, V31, P256, DOI 10.1128/MCB.00717-10; Collart MA, 2004, PROG NUCLEIC ACID RE, V77, P289, DOI 10.1016/S0079-6603(04)77008-7; COLLART MA, 1993, EMBO J, V12, P177, DOI 10.1002/j.1460-2075.1993.tb05643.x; COLLART MA, 1994, GENE DEV, V8, P525, DOI 10.1101/gad.8.5.525; Collart MA, 2012, GENE, V492, P42, DOI 10.1016/j.gene.2011.09.033; Coller J, 2005, CELL, V122, P875, DOI 10.1016/j.cell.2005.07.012; Coller JM, 2001, RNA, V7, P1717, DOI 10.1017/S135583820101994X; Costa-Mattioli M, 2013, NAT NEUROSCI, V16, P1537, DOI 10.1038/nn.3546; Daniel JA, 2007, MUTAT RES-FUND MOL M, V618, P135, DOI 10.1016/j.mrfmmm.2006.09.008; Deluen C, 2002, MOL CELL BIOL, V22, P6735, DOI 10.1128/MCB.22.19.6735-6749.2002; Eulalio A, 2009, RNA, V15, P21, DOI 10.1261/rna.1399509; Fabian MR, 2009, MOL CELL, V35, P868, DOI 10.1016/j.molcel.2009.08.004; GLOOR GB, 1993, GENETICS, V135, P81; Goldstrohm AC, 2006, NAT STRUCT MOL BIOL, V13, P533, DOI 10.1038/nsmb1100; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; Maillet L, 2002, J BIOL CHEM, V277, P2835, DOI 10.1074/jbc.M107979200; Marchese FP, 2010, J BIOL CHEM, V285, P27590, DOI 10.1074/jbc.M110.136473; Miller JE, 2012, CRIT REV BIOCHEM MOL, V47, P315, DOI 10.3109/10409238.2012.667214; Morris JZ, 2005, DEVELOPMENT, V132, P1165, DOI 10.1242/dev.01672; MUNROE D, 1990, MOL CELL BIOL, V10, P3441, DOI 10.1128/MCB.10.7.3441; Oberholzer U, 1998, GENE, V207, P61, DOI 10.1016/S0378-1119(97)00605-7; Papai G, 2011, CURR OPIN GENET DEV, V21, P219, DOI 10.1016/j.gde.2011.01.009; Puig O, 2003, GENE DEV, V17, P2006, DOI 10.1101/gad.1098703; Rendl LM, 2008, RNA, V14, P1328, DOI 10.1261/rna.955508; Sandler H, 2011, NUCLEIC ACIDS RES, V39, P4373, DOI 10.1093/nar/gkr011; Semotok JL, 2005, CURR BIOL, V15, P284, DOI 10.1016/j.cub.2005.01.048; Suganuma T, 2011, ANNU REV BIOCHEM, V80, P473, DOI 10.1146/annurev-biochem-061809-175347; Tarun SZ, 1997, P NATL ACAD SCI USA, V94, P9046, DOI 10.1073/pnas.94.17.9046; Tarun SZ, 1996, EMBO J, V15, P7168, DOI 10.1002/j.1460-2075.1996.tb01108.x; Temme C, 2004, EMBO J, V23, P2862, DOI 10.1038/sj.emboj.7600273; Temme C, 2010, RNA, V16, P1356, DOI 10.1261/rna.2145110; Tucker M, 2001, CELL, V104, P377, DOI 10.1016/S0092-8674(01)00225-2; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Yamashita A, 2005, NAT STRUCT MOL BIOL, V12, P1054, DOI 10.1038/nsmb1016; Zaessinger S, 2006, DEVELOPMENT, V133, P4573, DOI 10.1242/dev.02649	41	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0113902	10.1371/journal.pone.0113902	http://dx.doi.org/10.1371/journal.pone.0113902			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25793896	Green Published, Green Submitted, gold			2022-12-27	WOS:000352084200002
J	Przybylska, A; Fiedler, Z; Kucharczyk, H; Obrepalska-Steplowska, A				Przybylska, Arnika; Fiedler, Zaneta; Kucharczyk, Halina; Obrepalska-Steplowska, Aleksandra			Detection of the Quarantine Species Thrips palmi by Loop-Mediated Isothermal Amplification	PLOS ONE			English	Article							MOLECULAR TECHNIQUES; THYSANOPTERA; IDENTIFICATION; EFFICACY; VECTORS; TABACI; KARNY	Thrips palmi (from the order Thysanoptera) is a serious insect pest of various crops, including vegetables, fruits and ornamental plants, causing significant economic losses. Its presence constitutes a double threat; not only does T. palmi feed on the plants, it is also a vector for several plant viruses. T. palmi originated in Asia, but has spread to North and Central America, Africa, Oceania and the Caribbean in recent decades. This species has been sporadically noted in Europe and is under quarantine regulation in the European Union. For non-specialists its larval stages are indistinguishable morphologically from another widespread and serious insect pest Frankliniella occidentalis (a non-quarantine species in the European Union) as well as other frequently occurring thrips. In this study, we have developed a loop-mediated isothermal amplification protocol to amplify rDNA regions of T. palmi. The results were consistent whether isolated DNA or crushed insects were used as template, indicating that the DNA isolation step could be omitted. The described method is species-specific and sensitive and provides a rapid diagnostic tool to detect T. palmi in the field.	[Przybylska, Arnika; Obrepalska-Steplowska, Aleksandra] Natl Res Inst, Inst Plant Protect, Interdept Lab Mol Biol, Poznan, Poland; [Fiedler, Zaneta] Natl Res Inst, Inst Plant Protect, Dept Biol Control, Poznan, Poland; [Kucharczyk, Halina] Marie Curie Sklodowska Univ, Dept Zool, Lublin, Poland	Maria Curie-Sklodowska University	Obrepalska-Steplowska, A (corresponding author), Natl Res Inst, Inst Plant Protect, Interdept Lab Mol Biol, Poznan, Poland.	olaob@o2.pl	Kucharczyk, Halina/G-6636-2016; Obrepalska-Steplowska, Aleksandra/AAC-5684-2019	Kucharczyk, Halina/0000-0001-5341-1872; Obrepalska-Steplowska, Aleksandra/0000-0002-0314-8110; Przybylska, Arnika/0000-0001-9486-4501	Polish Ministry of Agriculture and Rural Development, the Long-Term Programme of IPP-NRI [2.7]	Polish Ministry of Agriculture and Rural Development, the Long-Term Programme of IPP-NRI	This work was supported by the Polish Ministry of Agriculture and Rural Development, the Long-Term Programme of IPP-NRI, Project 2.7 to AOS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BHATTI JS, 1980, SYST ENTOMOL, V5, P109, DOI 10.1111/j.1365-3113.1980.tb00404.x; BOURNIER JP, 1983, COTON FIBRES TROP, V38, P286; CABI/EPPO, 1997, QUARANTINE PESTS EUR; Fujisawa I, 1988, ANN PHYTOPATHOL SOC, V54, P932; Gombac P, 2014, J PLANT DIS PROTECT, V121, P117, DOI 10.1007/BF03356499; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Helyer NL, 1995, ANN APPL BIOL, V127, P405, DOI 10.1111/j.1744-7348.1995.tb07600.x; IWAKI M, 1984, PLANT DIS, V68, P1006, DOI 10.1094/PD-69-1006; Jeszke A, 2015, PEST MANAG SCI, V71, P243, DOI 10.1002/ps.3788; Kato K., 2000, AGR HORTICULTURE, V75, P103; Kox LFF, 2005, OEPP EPPO B, V35, P141, DOI DOI 10.1111/j.1365-2338.2005.00797.x; Kucharczyk H., 2007, FAUNA POLAND CHARACT; Mehle N, 2012, J PEST SCI, V85, P179, DOI 10.1007/s10340-012-0423-4; Mound L.A., 1998, THYSANOPTERA IDENTIF, V2nd ed., P1; Mound LA, 2005, ZOOTAXA, P1; MURAI T, 2001, P 7 INT S THYS, P19; Nakahara S, 1994, USDA TECHNICAL B, P1822; Nicholas K. B., 1997, PITTSBURGH SUPERCOMP; Notomi T, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.12.e63; Nowaczyk K, 2009, J ECON ENTOMOL, V102, P1691, DOI 10.1603/029.102.0437; Obrepalska-Steplowska A, 2008, FOOD ADDIT CONTAM A, V25, P1179, DOI 10.1080/02652030802015689; Palmer J.M., 1992, Bulletin of the British Museum (Natural History) Entomology, V61, P1; Rebijith KB, 2012, ENTOMOL NEWS, V122, P201, DOI 10.3157/021.122.0301; Riley DG, 2011, J INTEGR PEST MANAG, V2, DOI 10.1603/IPM10020; Sakimura K., 1986, Entomology Circular, Division of Plant Industry, Florida Department of Agriculture and Consumer Services; Sampson C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080787; Seal DR, 2013, FLA ENTOMOL, V96, P789, DOI 10.1653/024.096.0312; Strassen R. zur, 1989, Gesunde Pflanzen, V41, P63; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Toda S, 2002, B ENTOMOL RES, V92, P359, DOI 10.1079/BER2002177; Trdan S, 2007, J PEST SCI, V80, P217, DOI 10.1007/s10340-007-0174-9; Vierbergen G, 2002, VERSLAGEN MEDEDELING, V219, P49; Vierbergen G. (Bert), 2010, Tijdschrift voor Entomologie, V153, P99; Walsh K, 2005, J APPL ENTOMOL, V129, P272, DOI 10.1111/j.1439-0418.2005.00960.x; Winder L, 2011, METHODS ECOL EVOL, V2, P312, DOI 10.1111/j.2041-210X.2010.00079.x; Yao MC, 2012, J ECON ENTOMOL, V105, P1100, DOI 10.1603/EC11381; Yeh WB, 2014, J ECON ENTOMOL, V107, P1728, DOI 10.1603/EC14027; zur Strassen R., 2003, TIERWELT DEUTSCHLAND, V74	38	26	29	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0122033	10.1371/journal.pone.0122033	http://dx.doi.org/10.1371/journal.pone.0122033			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25793743	Green Published, Green Submitted, gold			2022-12-27	WOS:000352083900169
J	Sharma, PM; Ponnaiya, B; Taveras, M; Shuryak, I; Turner, H; Brenner, DJ				Sharma, Preety M.; Ponnaiya, Brian; Taveras, Maria; Shuryak, Igor; Turner, Helen; Brenner, David J.			High Throughput Measurement of gamma H2AX DSB Repair Kinetics in a Healthy Human Population	PLOS ONE			English	Article							DOUBLE-STRAND BREAKS; HISTONE H2AX PHOSPHORYLATION; DNA-DAMAGE RESPONSE; IONIZING-RADIATION; HOMOLOGOUS RECOMBINATION; HUMAN-LYMPHOCYTES; CANCER PATIENTS; CELL LINES; AGING MICE; IN-VIVO	The Columbia University RABiT (Rapid Automated Biodosimetry Tool) quantifies DNA damage using fingerstick volumes of blood. One RABiT protocol quantifies the total gamma-H2AX fluorescence per nucleus, a measure of DNA double strand breaks (DSB) by an immunofluorescent assay at a single time point. Using the recently extended RABiT system, that assays the gamma-H2AX repair kinetics at multiple time points, the present small scale study followed its kinetics post irradiation at 0.5 h, 2 h, 4 h, 7 h and 24 h in lymphocytes from 94 healthy adults. The lymphocytes were irradiated ex vivo with 4 Gy gamma rays using an external Cs-137 source. The effect of age, gender, race, ethnicity, alcohol use on the endogenous and post irradiation total gamma-H2AX protein yields at various time points were statistically analyzed. The endogenous gamma-H2AX levels were influenced by age, race and alcohol use within Hispanics. In response to radiation, induction of gamma-H2AX yields at 0.5 h and peak formation at 2 h were independent of age, gender, ethnicity except for race and alcohol use that delayed the peak to 4 h time point. Despite the shift in the peak observed, the gamma-H2AX yields reached close to baseline at 24 h for all groups. Age and race affected the rate of progression of the DSB repair soon after the yields reached maximum. Finally we show a positive correlation between endogenous gamma-H2AX levels with radiation induced gamma-H2AX yields (RIY) (r=0.257, P=0.02) and a negative correlation with residuals (r=-0.521, P=<0.0001). A positive correlation was also observed between RIY and DNA repair rate (r=0.634, P<0.0001). Our findings suggest age, race, ethnicity and alcohol use influence DSB gamma-H2AX repair kinetics as measured by RABiT immunofluorescent assay.	[Sharma, Preety M.; Ponnaiya, Brian; Taveras, Maria; Shuryak, Igor; Turner, Helen; Brenner, David J.] Columbia Univ, Ctr Radiol Res, New York, NY 10032 USA	Columbia University	Sharma, PM (corresponding author), Columbia Univ, Ctr Radiol Res, New York, NY 10032 USA.	pms2144@columbia.edu			National Institute of Health [R21 5R21ES019494-02, 5U19AI067773-09]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI067773] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R21ES019494] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work is supported by National Institute of Health R21 5R21ES019494-02 grant and National Institute of Health 5U19AI067773-09. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Henriquez-Hernandez LA, 2011, RADIAT ONCOL, V6, DOI 10.1186/1748-717X-6-60; Andrievski A, 2009, INT J RADIAT BIOL, V85, P369, DOI 10.1080/09553000902781147; Banath JP, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-4; Bhogal N, 2010, RADIAT RES, V173, P1, DOI 10.1667/RR1851.1; Bhogal N, 2009, INT J RADIAT BIOL, V85, P732, DOI 10.1080/09553000902785791; Bonner WM, 2008, NAT REV CANCER, V8, P957, DOI 10.1038/nrc2523; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Burnham KP, 2011, BEHAV ECOL SOCIOBIOL, V65, P23, DOI 10.1007/s00265-010-1029-6; Chen Yong, 2009, Shengwu Jiagong Guocheng, V7, P61, DOI 10.3969/j.issn.1762-3678.2009.04.013; Collins AR, 2003, CARCINOGENESIS, V24, P511, DOI 10.1093/carcin/24.3.511; Costes SV, 2010, MUTAT RES-REV MUTAT, V704, P78, DOI 10.1016/j.mrrev.2009.12.006; Dikomey E, 1998, INT J RADIAT BIOL, V73, P269, DOI 10.1080/095530098142365; Djuzenova CS, 2013, RADIAT ONCOL, V8, DOI 10.1186/1748-717X-8-98; Edelstein Arthur, 2010, Curr Protoc Mol Biol, VChapter 14, DOI 10.1002/0471142727.mb1420s92; Endt H, 2011, J GERONTOL A-BIOL, V66, P367, DOI 10.1093/gerona/glq197; Fenech M, 2005, CARCINOGENESIS, V26, P991, DOI 10.1093/carcin/bgi042; Firsanov D V, 2011, Tsitologiia, V53, P586; Garm C, 2013, AGING CELL, V12, P58, DOI 10.1111/acel.12019; Garty G, 2010, HEALTH PHYS, V98, P209, DOI 10.1097/HP.0b013e3181ab3cb6; Goodarzi AA, 2008, MOL CELL, V31, P167, DOI 10.1016/j.molcel.2008.05.017; GOODHEAD DT, 1994, INT J RADIAT BIOL, V65, P7, DOI 10.1080/09553009414550021; Hamasaki K, 2007, ENVIRON MOL MUTAGEN, V48, P38, DOI 10.1002/em.20273; Horn S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025113; Hudson D, 2011, AGING-US, V3, P609, DOI 10.18632/aging.100340; Ismail IH, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkl1169; Jeggo PA, 2011, RADIOTHER ONCOL, V101, P7, DOI 10.1016/j.radonc.2011.06.019; Kotova N, 2013, CARCINOGENESIS, V34, P325, DOI 10.1093/carcin/bgs340; Kuhne M, 2004, CANCER RES, V64, P500, DOI 10.1158/0008-5472.CAN-03-2384; Lobrich M, 2000, GENE CHROMOSOME CANC, V27, P59; Lobrich M, 2010, CELL CYCLE, V9, P662, DOI 10.4161/cc.9.4.10764; MacPhail SH, 2003, INT J RADIAT BIOL, V79, P351, DOI 10.1080/0955300032000093128; Marcon F, 2003, MUTAT RES-GEN TOX EN, V541, P1, DOI 10.1016/S1383-5718(03)00171-2; Marcon F, 2013, MUTAGENESIS, V28, P135, DOI 10.1093/mutage/ges062; Martin NT, 2011, RADIOTHER ONCOL, V101, P35, DOI 10.1016/j.radonc.2011.05.065; Martin OA, 2013, DNA REPAIR, V12, P844, DOI 10.1016/j.dnarep.2013.07.002; MAYER PJ, 1991, ANN HUM BIOL, V18, P405, DOI 10.1080/03014469100001702; Mohankumar MN, 2002, MUTAT RES-GEN TOX EN, V520, P179, DOI 10.1016/S1383-5718(02)00201-2; Olive PL, 2004, INT J RADIAT ONCOL, V58, P331, DOI 10.1016/j.ijrobp.2003.09.028; Redon CE, 2009, ADV SPACE RES, V43, P1171, DOI 10.1016/j.asr.2008.10.011; Riballo E, 2004, MOL CELL, V16, P715, DOI 10.1016/j.molcel.2004.10.029; Roch-Lefevre S, 2010, RADIAT RES, V174, P185, DOI 10.1667/RR1775.1; Rogakou EP, 1999, J CELL BIOL, V146, P905, DOI 10.1083/jcb.146.5.905; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Rothkamm K, 2003, MOL CELL BIOL, V23, P5706, DOI 10.1128/MCB.23.16.5706-5715.2003; Rothkamm K, 2009, ANN I SUPER SANITA, V45, P265; Rube CE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017487; Schurman SH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045728; Scott D, 1999, INT J RADIAT BIOL, V75, P1, DOI 10.1080/095530099140744; Sedelnikova OA, 2004, NAT CELL BIOL, V6, P168, DOI 10.1038/ncb1095; Sedelnikova OA, 2008, AGING CELL, V7, P89, DOI 10.1111/j.1474-9726.2007.00354.x; Taneja N, 2004, J BIOL CHEM, V279, P2273, DOI 10.1074/jbc.M310030200; Turner HC, THE RABIT HIGH THROU; Turner HC, 2014, RADIAT ENVIRON BIOPH, V53, P265, DOI 10.1007/s00411-014-0514-0; Turner HC, 2011, RADIAT RES, V175, P282, DOI 10.1667/RR2125.1; Valdiglesias V, 2013, MUTAT RES-REV MUTAT, V753, P24, DOI 10.1016/j.mrrev.2013.02.001; Wang CF, 2009, AGING CELL, V8, P311, DOI 10.1111/j.1474-9726.2009.00481.x	56	50	53	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0121083	10.1371/journal.pone.0121083	http://dx.doi.org/10.1371/journal.pone.0121083			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25794041	Green Published, Green Submitted, gold			2022-12-27	WOS:000352083900101
J	Osteikoetxea, X; Balogh, A; Szabo-Taylor, K; Nemeth, A; Szabo, TG; Paloczi, K; Sodar, B; Kittel, A; Gyorgy, B; Pallinger, E; Matko, J; Buzas, EI				Osteikoetxea, Xabier; Balogh, Andrea; Szabo-Taylor, Katalin; Nemeth, Andrea; Szabo, Tames Geza; Paloczi, Krisztina; Sodar, Barbara; Kittel, Agnes; Gyoergy, Bence; Pallinger, Eva; Matko, Janos; Buzas, Edit Iran			Improved Characterization of EV Preparations Based on Protein to Lipid Ratio and Lipid Properties	PLOS ONE			English	Article							EXTRACELLULAR VESICLES; MEMBRANE-VESICLES; APOPTOTIC BODIES; EMERGING ROLE; EXOSOMES; MICROVESICLES; STANDARDIZATION; MICROPARTICLES	In recent years the study of extracellular vesicles has gathered much scientific and clinical interest. As the field is expanding, it is becoming clear that better methods for characterization and quantification of extracellular vesicles as well as better standards to compare studies are warranted. The goal of the present work was to find improved parameters to characterize extracellular vesicle preparations. Here we introduce a simple 96 well plate-based total lipid assay for determination of lipid content and protein to lipid ratios of extracellular vesicle preparations from various myeloid and lymphoid cell lines as well as blood plasma. These preparations included apoptotic bodies, microvesicles/microparticles, and exosomes isolated by size-based fractionation. We also investigated lipid bilayer order of extracellular vesicle subpopulations using Di-4-ANEPPDHQ lipid probe, and lipid composition using affinity reagents to clustered cholesterol (monoclonal anti-cholesterol antibody) and ganglioside GM1 (cholera toxin subunit B). We have consistently found different protein to lipid ratios characteristic for the investigated extracellular vesicle subpopulations which were substantially altered in the case of vesicular damage or protein contamination. Spectral ratiometric imaging and flow cytometric analysis also revealed marked differences between the various vesicle populations in their lipid order and their clustered membrane cholesterol and GM1 content. Our study introduces for the first time a simple and readily available lipid assay to complement the widely used protein assays in order to better characterize extracellular vesicle preparations. Besides differentiating extracellular vesicle subpopulations, the novel parameters introduced in this work (protein to lipid ratio, lipid bilayer order, and lipid composition), may prove useful for quality control of extracellular vesicle related basic and clinical studies.	[Osteikoetxea, Xabier; Szabo-Taylor, Katalin; Nemeth, Andrea; Szabo, Tames Geza; Paloczi, Krisztina; Sodar, Barbara; Gyoergy, Bence; Pallinger, Eva; Buzas, Edit Iran] Semmelweis Univ, Dept Genet Cell & Immunobiol, H-1085 Budapest, Hungary; [Balogh, Andrea; Matko, Janos] Eotvos Lorand Univ, Dept Immunol, Budapest, Hungary; [Kittel, Agnes] Hungarian Acad Sci, Inst Expt Med, Budapest, Hungary; [Gyoergy, Bence] Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA	Semmelweis University; Eotvos Lorand University; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Institute of Experimental Medicine; Harvard University; Harvard Medical School; Howard Hughes Medical Institute	Buzas, EI (corresponding author), Semmelweis Univ, Dept Genet Cell & Immunobiol, H-1085 Budapest, Hungary.	edit.buzas@gmail.com	Osteikoetxea, Xabier/K-3067-2019; Szabo, Tamas Geza/E-9722-2011	Szabo, Tamas Geza/0000-0001-9745-6255; Osteikoetxea, Xabier/0000-0003-3628-0174; Paloczi, Krisztina/0000-0001-7065-3582	OTKA [84043]; DYNANO [FP7-PEOPLE-2011-ITN-PITN-GA-2011-289033]; BMBS COST Action [BM1202 ME HAD]	OTKA(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); DYNANO; BMBS COST Action(European Cooperation in Science and Technology (COST))	This work was supported by OTKA 84043 (http://www.otka.hu/) FP7-PEOPLE-2011-ITN-PITN-GA-2011-289033 "DYNANO"(http://www.dynano.eu/) BMBS COST Action BM1202 ME HAD (http://www.mehad-cost.eu/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aatonen MT, 2014, J EXTRACELL VESICLES, V3, DOI 10.3402/jev.v3.24692; Adami C, 2001, GLIA, V33, P131, DOI 10.1002/1098-1136(200102)33:2<131::AID-GLIA1012>3.0.CO;2-D; Al-Nedawi K, 2009, CELL CYCLE, V8, P2014, DOI 10.4161/cc.8.13.8988; Bilyy RO, 2012, J BIOL CHEM, V287, P496, DOI 10.1074/jbc.M111.273144; Biro A, 2007, J LIPID RES, V48, P19, DOI 10.1194/jlr.M600158-JLR200; Bissig C, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a016816; Booth AM, 2006, J CELL BIOL, V172, P923, DOI 10.1083/jcb.200508014; Buzas EI, 2014, NAT REV RHEUMATOL, V10, P356, DOI 10.1038/nrrheum.2014.19; Chabrol E, 1937, PRESS MED, V45, P1713; Crescitelli R, 2013, J EXTRACELL VESICLES, V2, DOI 10.3402/jev.v2i0.20677; de Gassart A, 2003, BLOOD, V102, P4336, DOI 10.1182/blood-2003-03-0871; Dean WL, 2009, THROMB HAEMOSTASIS, V102, P711, DOI 10.1160/TH09-04-243; Gyorgy B, 2014, THROMB RES, V133, P285, DOI 10.1016/j.thromres.2013.11.010; Gyorgy B, 2011, CELL MOL LIFE SCI, V68, P2667, DOI 10.1007/s00018-011-0689-3; Gyorgy B, 2011, BLOOD, V117, pE39, DOI 10.1182/blood-2010-09-307595; HOLMGREN J, 1975, P NATL ACAD SCI USA, V72, P2520, DOI 10.1073/pnas.72.7.2520; Kahlert C, 2014, J BIOL CHEM, V289, P3869, DOI 10.1074/jbc.C113.532267; Kasal A, 2010, STEROID ANALYSIS: SECOND EDITION, P27, DOI 10.1023/b135931_2; Lacroix R, 2013, J THROMB HAEMOST, V11, P1190, DOI 10.1111/jth.12207; Lacroix R, 2012, J THROMB HAEMOST, V10, P437, DOI 10.1111/j.1538-7836.2011.04610.x; Llorente A, 2013, BBA-MOL CELL BIOL L, V1831, P1302, DOI 10.1016/j.bbalip.2013.04.011; McMahon A, 2013, LIPIDS, V48, P513, DOI 10.1007/s11745-013-3755-9; Momen-Heravi F, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00354; Owen DM, 2012, NAT PROTOC, V7, P24, DOI 10.1038/nprot.2011.419; Record M, 2014, BBA-MOL CELL BIOL L, V1841, P108, DOI 10.1016/j.bbalip.2013.10.004; Szabo GT, 2014, CELL MOL LIFE SCI, V71, P4055, DOI 10.1007/s00018-014-1618-z; Tan SS, 2013, J EXTRACELL VESICLES, V2, DOI 10.3402/jev.v2i0.22614; Thery Clotilde, 2011, F1000 Biol Rep, V3, P15, DOI 10.3410/B3-15; Thery C, 2009, NAT REV IMMUNOL, V9, P581, DOI 10.1038/nri2567; Turiak L, 2011, J PROTEOMICS, V74, P2025, DOI 10.1016/j.jprot.2011.05.023; van der Pol E, 2012, PHARMACOL REV, V64, P676, DOI 10.1124/pr.112.005983; Varga Z, 2014, J EXTRACELL VESICLES, V3, DOI 10.3402/jev.v3.23298	32	114	115	4	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0121184	10.1371/journal.pone.0121184	http://dx.doi.org/10.1371/journal.pone.0121184			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25798862	Green Accepted, gold, Green Published, Green Submitted			2022-12-27	WOS:000351987300224
J	Saint-Marcoux, D; Proust, H; Dolan, L; Langdale, JA				Saint-Marcoux, Denis; Proust, Helene; Dolan, Liam; Langdale, Jane A.			Identification of Reference Genes for Real-Time Quantitative PCR Experiments in the Liverwort Marchantia polymorpha	PLOS ONE			English	Article							AGROBACTERIUM-MEDIATED TRANSFORMATION; CANDIDATE REFERENCE GENES; EXPRESSION ANALYSIS; BRASSICA-NAPUS; NORMALIZATION; VALIDATION; SELECTION; PUBLICATION; ARABIDOPSIS; INTEGRITY	Real-time quantitative polymerase chain reaction (qPCR) has become widely used as a method to compare gene transcript levels across different conditions. However, selection of suitable reference genes to normalize qPCR data is required for accurate transcript level analysis. Recently, Marchantia polymorpha has been adopted as a model for the study of liverwort development and land plant evolution. Identification of appropriate reference genes has therefore become a necessity for gene expression studies. In this study, transcript levels of eleven candidate reference genes have been analyzed across a range of biological contexts that encompass abiotic stress, hormone treatment and different developmental stages. The consistency of transcript levels was assessed using both geNorm and NormFinder algorithms, and a consensus ranking of the different candidate genes was then obtained. MpAPT and MpACT showed relatively constant transcript levels across all conditions tested whereas the transcript levels of other candidate genes were clearly influenced by experimental conditions. By analyzing transcript levels of phosphate and nitrate starvation reporter genes, we confirmed that MpAPT and MpACT are suitable reference genes in M. polymorpha and also demonstrated that normalization with an inappropriate gene can lead to erroneous analysis of qPCR data.	[Saint-Marcoux, Denis; Proust, Helene; Dolan, Liam; Langdale, Jane A.] Univ Oxford, Dept Plant Sci, Oxford, England	University of Oxford	Proust, H (corresponding author), Univ Oxford, Dept Plant Sci, Oxford, England.	helene.proust@plants.ox.ac.uk	Langdale, Jane A./AAE-8343-2019	Dolan, Liam/0000-0003-1206-7096; Saint-Marcoux, Denis/0000-0002-0830-7096; Langdale, Jane/0000-0001-7648-3924	ERC [EVO500]; Biotechnology and Biological Sciences Research Council [BB/M020517/1] Funding Source: researchfish; BBSRC [BB/M020517/1] Funding Source: UKRI	ERC(European Research Council (ERC)European Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by ERC Advanced Investigator grants to JAL (EDIP) and LD (EVO500). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Amil-Ruiz F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070603; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Borowski JM, 2014, PLANTA, V239, P1187, DOI 10.1007/s00425-014-2041-2; Bowman JL, 2007, CELL, V129, P229, DOI 10.1016/j.cell.2007.04.004; Bustin SA, 2010, METHODS, V50, P217, DOI 10.1016/j.ymeth.2009.12.006; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Czechowski T, 2005, PLANT PHYSIOL, V139, P5, DOI 10.1104/pp.105.063743; Derveaux S, 2010, METHODS, V50, P227, DOI 10.1016/j.ymeth.2009.11.001; FREDERICQ H, 1966, NATURWISSENSCHAFTEN, V53, P337, DOI 10.1007/BF00631208; Gutierrez L, 2008, PLANT BIOTECHNOL J, V6, P609, DOI 10.1111/j.1467-7652.2008.00346.x; Hong SY, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-112; Hruz T, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-156; Ishizaki K, 2008, PLANT CELL PHYSIOL, V49, P1084, DOI 10.1093/pcp/pcn085; Ishizaki K, 2013, PLANT CELL, V25, P4075, DOI 10.1105/tpc.113.117051; Ishizaki K, 2013, SCI REP-UK, V3, DOI 10.1038/srep01532; Ishizaki K, 2012, J PLANT RES, V125, P643, DOI 10.1007/s10265-012-0477-7; JOHNSON G. M. et al., 1957, Plant and Soil, V8, P337, DOI 10.1007/BF01666323; Kubota A, 2013, BIOSCI BIOTECH BIOCH, V77, P167, DOI 10.1271/bbb.120700; Le Bail A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070998; Le Bail A, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-75; Manoli A, 2012, J PLANT PHYSIOL, V169, P807, DOI 10.1016/j.jplph.2012.01.019; Moura Jullyana Cristina Magalhaes Silva, 2012, BMC Res Notes, V5, P634, DOI 10.1186/1756-0500-5-634; Orsel M, 2002, PLANT PHYSIOL, V129, P886, DOI 10.1104/pp.005280; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Qiu YL, 2006, P NATL ACAD SCI USA, V103, P15511, DOI 10.1073/pnas.0603335103; Remans T, 2014, PLANT CELL, V26, P3829, DOI 10.1105/tpc.114.130641; Ruijter JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp045; Schroeder A, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-3; Shin H, 2004, PLANT J, V39, P629, DOI 10.1111/j.1365-313X.2004.02161.x; TAREN NIINA, 1958, BRYOL OGIST, V61, P191; Tougane K, 2010, PLANT PHYSIOL, V152, P1529, DOI 10.1104/pp.110.153387; Untergasser A, 2007, NUCLEIC ACIDS RES, V35, pW71, DOI 10.1093/nar/gkm306; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wang HL, 2014, PHYSIOL PLANTARUM, V152, P529, DOI 10.1111/ppl.12206; Wang Z, 2014, MOL GENET GENOMICS, V289, P1023, DOI 10.1007/s00438-014-0853-1; Wann FB, 1925, AM J BOT, V12, P307, DOI 10.2307/2435337; Wickett NJ, 2014, P NATL ACAD SCI USA, V111, pE4859, DOI 10.1073/pnas.1323926111; Yang HL, 2014, GENE, V538, P113, DOI 10.1016/j.gene.2013.12.057	39	41	42	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0118678	10.1371/journal.pone.0118678	http://dx.doi.org/10.1371/journal.pone.0118678			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25798897	gold, Green Published, Green Submitted			2022-12-27	WOS:000351987300014
J	Schuler, W; Bunikis, I; Weber-Lehman, J; Comstedt, P; Kutschan-Bunikis, S; Stanek, G; Huber, J; Meinke, A; Bergstrom, S; Lundberg, U				Schueler, Wolfgang; Bunikis, Ignas; Weber-Lehman, Jacqueline; Comstedt, Paer; Kutschan-Bunikis, Sabrina; Stanek, Gerold; Huber, Jutta; Meinke, Andreas; Bergstrom, Sven; Lundberg, Urban			Complete Genome Sequence of Borrelia afzelii K78 and Comparative Genome Analysis	PLOS ONE			English	Article							LYME-DISEASE SPIROCHETE; BURGDORFERI SENSU-LATO; FIBRONECTIN-BINDING PROTEIN; 32-KILOBASE CIRCULAR PLASMIDS; RIBOSOMAL-RNA GENES; ANTIGENIC VARIATION; LINEAR CHROMOSOMES; TELOMERE RESOLVASE; OPEN SOFTWARE; GARINII	The main Borrelia species causing Lyme borreliosis in Europe and Asia are Borrelia afzelii, B. garinii, B. burgdorferi and B. bavariensis. This is in contrast to the United States, where infections are exclusively caused by B. burgdorferi. Until to date the genome sequences of four B. afzelii strains, of which only two include the numerous plasmids, are available. In order to further assess the genetic diversity of B. afzelii, the most common species in Europe, responsible for the large variety of clinical manifestations of Lyme borreliosis, we have determined the full genome sequence of the B. afzelii strain K78, a clinical isolate from Austria. The K78 genome contains a linear chromosome (905,949 bp) and 13 plasmids (8 linear and 5 circular) together presenting 1,309 open reading frames of which 496 are located on plasmids. With the exception of lp28-8, all linear replicons in their full length including their telomeres have been sequenced. The comparison with the genomes of the four other B. afzelii strains, ACA-1, PKo, HLJ01 and Tom3107, as well as the one of B. burgdorferi strain B31, confirmed a high degree of conservation within the linear chromosome of B. afzelii, whereas plasmid encoded genes showed a much larger diversity. Since some plasmids present in B. burgdorferi are missing in the B. afzelii genomes, the corresponding virulence factors of B. burgdorferi are found in B. afzelii on other unrelated plasmids. In addition, we have identified a species specific region in the circular plasmid, cp26, which could be used for species determination. Different non-coding RNAs have been located on the B. afzelii K78 genome, which have not previously been annotated in any of the published Borrelia genomes.	[Schueler, Wolfgang; Comstedt, Paer; Meinke, Andreas; Lundberg, Urban] Valneva Austria GmbH, Vienna, Austria; [Bunikis, Ignas; Kutschan-Bunikis, Sabrina; Bergstrom, Sven] Umea Univ, Dept Mol Biol, Umea, Sweden; [Weber-Lehman, Jacqueline; Huber, Jutta] Eurofins Genom GmbH, Ebersberg, Germany; [Stanek, Gerold] Med Univ Vienna, Inst Hyg & Appl Immunol, Vienna, Austria	Umea University; Medical University of Vienna	Lundberg, U (corresponding author), Valneva Austria GmbH, Vienna, Austria.	Urban.LUNDBERG@valneva.com			European Union [512598-BOVAC, FA794A0101]; Swedish Research Council [07922]	European Union(European Commission); Swedish Research Council(Swedish Research CouncilEuropean Commission)	This work was funded by the European Union (512598-BOVAC; grant FA794A0101) and the Swedish Research Council grant number 07922 to SB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aanensen DM, 2005, NUCLEIC ACIDS RES, V33, pW728, DOI 10.1093/nar/gki415; Apweiler R, 2012, NUCLEIC ACIDS RES, V40, pD71, DOI 10.1093/nar/gkr981; BARBOUR AG, 1984, YALE J BIOL MED, V57, P521; BARBOUR AG, 1988, J CLIN MICROBIOL, V26, P475, DOI 10.1128/JCM.26.3.475-478.1988; Barbour AG, 2010, MBIO, V1, DOI 10.1128/mBio.00153-10; Barrick JE, 2005, RNA, V11, P774, DOI 10.1261/rna.7286705; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Biskup UG, 2011, PLASMID, V66, P1, DOI 10.1016/j.plasmid.2011.02.006; Brenner EV, 2012, J BACTERIOL, V194, P5713, DOI 10.1128/JB.01360-12; Brissette CA, 2009, INFECT IMMUN, V77, P2802, DOI 10.1128/IAI.00227-09; Brisson D, 2013, APPL ENVIRON MICROB, V79, P4115, DOI 10.1128/AEM.00817-13; Bruen TC, 2006, GENETICS, V172, P2665, DOI 10.1534/genetics.105.048975; CANICA MM, 1993, SCAND J INFECT DIS, V25, P441, DOI 10.3109/00365549309008525; Casjens S, 1997, MOL MICROBIOL, V26, P581, DOI 10.1046/j.1365-2958.1997.6051963.x; Casjens S, 1997, J BACTERIOL, V179, P217, DOI 10.1128/jb.179.1.217-227.1997; Casjens S, 2000, MOL MICROBIOL, V35, P490, DOI 10.1046/j.1365-2958.2000.01698.x; Casjens SR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033280; Casjens SR, 2011, J BACTERIOL, V193, P6995, DOI 10.1128/JB.05951-11; Casjens SR, 2011, J BACTERIOL, V193, P1489, DOI 10.1128/JB.01521-10; Damman CJ, 2000, J BACTERIOL, V182, P6791, DOI 10.1128/JB.182.23.6791-6797.2000; Darling AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011147; Delcher AL, 1999, NUCLEIC ACIDS RES, V27, P4636, DOI 10.1093/nar/27.23.4636; Eggers CH, 1999, J BACTERIOL, V181, P7308, DOI 10.1128/JB.181.23.7308-7313.1999; Ellis TC, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003567; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Enright AJ, 2002, NUCLEIC ACIDS RES, V30, P1575, DOI 10.1093/nar/30.7.1575; Farlow J, 2002, J CLIN MICROBIOL, V40, P4612, DOI 10.1128/JCM.40.12.4612-4618.2002; Fischer JR, 2006, INFECT IMMUN, V74, P435, DOI 10.1128/IAI.74.1.435-441.2006; Fraser CM, 1997, NATURE, V390, P580, DOI 10.1038/37551; Gardner PP, 2009, NUCLEIC ACIDS RES, V37, pD136, DOI 10.1093/nar/gkn766; Glockner G, 2004, NUCLEIC ACIDS RES, V32, P6038, DOI 10.1093/nar/gkh953; Glockner G, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-211; Gordon D., 2003, CURR PROTOC BIOINFOR, V11, P1, DOI DOI 10.1002/0471250953.BI1102S02; Grimm D, 2003, INFECT IMMUN, V71, P3138, DOI 10.1128/IAI.71.6.3138-3145.2003; Guo BP, 1998, MOL MICROBIOL, V30, P711, DOI 10.1046/j.1365-2958.1998.01103.x; GUO BP, 1995, INFECT IMMUN, V63, P3467, DOI 10.1128/IAI.63.9.3467-3472.1995; Haft DH, 2003, NUCLEIC ACIDS RES, V31, P371, DOI 10.1093/nar/gkg128; Heikkila T, 2002, J MED MICROBIOL, V51, P641, DOI 10.1099/0022-1317-51-8-641; Hu GQ, 2009, BIOINFORMATICS, V25, P123, DOI 10.1093/bioinformatics/btn576; Huang WM, 2004, J BACTERIOL, V186, P4134, DOI 10.1128/JB.186.13.4134-4141.2004; Hughes JL, 2008, INFECT IMMUN, V76, P2498, DOI 10.1128/IAI.01583-07; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Hyde JA, 2011, MOL MICROBIOL, V82, P99, DOI 10.1111/j.1365-2958.2011.07801.x; Jewett MW, 2007, MOL MICROBIOL, V64, P1358, DOI 10.1111/j.1365-2958.2007.05746.x; Jiang BG, 2012, J BACTERIOL, V194, P7014, DOI 10.1128/JB.01863-12; Jiang BG, 2012, J BACTERIOL, V194, P6660, DOI 10.1128/JB.01844-12; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kurilshikov AM, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.01315-14; Kurtenbach K, 2006, NAT REV MICROBIOL, V4, P660, DOI 10.1038/nrmicro1475; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Labandeira-Rey M, 2001, INFECT IMMUN, V69, P1409, DOI 10.1128/IAI.69.3.1409-1419.2001; Lagal V, 2003, J CLIN MICROBIOL, V41, P5059, DOI 10.1128/JCM.41.11.5059-5065.2003; Lagesen K, 2007, NUCLEIC ACIDS RES, V35, P3100, DOI 10.1093/nar/gkm160; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Li X, 2006, INFECT IMMUN, V74, P3305, DOI 10.1128/IAI.02035-05; Lin T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047532; Lindstedt BA, 2005, ELECTROPHORESIS, V26, P2567, DOI 10.1002/elps.200500096; Ludwig A, 2008, INT J MED MICROBIOL, V298, P473, DOI 10.1016/j.ijmm.2007.07.014; Lybecker MC, 2010, MOL MICROBIOL, V78, P622, DOI 10.1111/j.1365-2958.2010.07374.x; Marchler-Bauer A, 2013, NUCLEIC ACIDS RES, V41, pD348, DOI 10.1093/nar/gks1243; Margos G, 2008, P NATL ACAD SCI USA, V105, P8730, DOI 10.1073/pnas.0800323105; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Miller JC, 2000, J BACTERIOL, V182, P6254, DOI 10.1128/JB.182.21.6254-6258.2000; Mongodin EF, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-693; Moriarty TJ, 2009, J BIOL CHEM, V284, P23293, DOI 10.1074/jbc.M109.023549; Norris SJ, 2011, APPL ENVIRON MICROB, V77, P1483, DOI 10.1128/AEM.01877-10; Ohlenbush A, 1996, J INFECT DIS, V174, P421, DOI 10.1093/infdis/174.2.421; OJAIMI C, 1994, MICROBIOL-SGM, V140, P2931, DOI 10.1099/13500872-140-11-2931; Orlov YL, 2004, NUCLEIC ACIDS RES, V32, pW628, DOI 10.1093/nar/gkh466; Paccanaro A, 2006, NUCLEIC ACIDS RES, V34, P1571, DOI 10.1093/nar/gkj515; PAVESI A, 1994, NUCLEIC ACIDS RES, V22, P1247, DOI 10.1093/nar/22.7.1247; Pei AY, 2010, APPL ENVIRON MICROB, V76, P3886, DOI 10.1128/AEM.02953-09; Pruitt KD, 2012, NUCLEIC ACIDS RES, V40, pD130, DOI 10.1093/nar/gkr1079; Purser JE, 2003, MOL MICROBIOL, V48, P753, DOI 10.1046/j.1365-2958.2003.03452.x; Purser JE, 2000, P NATL ACAD SCI USA, V97, P13865, DOI 10.1073/pnas.97.25.13865; Rauter C, 2005, APPL ENVIRON MICROB, V71, P7203, DOI 10.1128/AEM.71.11.7203-7216.2005; Revel AT, 2005, P NATL ACAD SCI USA, V102, P6972, DOI 10.1073/pnas.0502565102; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Richter D, 2006, INT J SYST EVOL MICR, V56, P873, DOI 10.1099/ijs.0.64050-0; Roberts DM, 2002, INFECT IMMUN, V70, P7033, DOI 10.1128/IAI.70.12.7033-7041.2002; Roberts WC, 1998, INFECT IMMUN, V66, P5275, DOI 10.1128/IAI.66.11.5275-5285.1998; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; Sandholm K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108013; Schutzer SE, 2012, J BACTERIOL, V194, P545, DOI 10.1128/JB.06263-11; Schutzer SE, 2011, J BACTERIOL, V193, P1018, DOI 10.1128/JB.01158-10; SCHWAN TG, 1988, INFECT IMMUN, V56, P1831, DOI 10.1128/IAI.56.8.1831-1836.1988; Seinost G, 1999, INFECT IMMUN, V67, P3518, DOI 10.1128/IAI.67.7.3518-3524.1999; Seshu J, 2006, MOL MICROBIOL, V59, P1591, DOI 10.1111/j.1365-2958.2005.05042.x; Setubal JC, 2006, MICROBIOL-SGM, V152, P113, DOI 10.1099/mic.0.28317-0; Skare JT, 1999, INFECT IMMUN, V67, P4407, DOI 10.1128/IAI.67.9.4407-4417.1999; Staden R, 1996, MOL BIOTECHNOL, V5, P233, DOI 10.1007/BF02900361; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Stanek G, 2012, LANCET, V379, P461, DOI 10.1016/S0140-6736(11)60103-7; Steere AC, 2001, NEW ENGL J MED, V345, P115, DOI 10.1056/NEJM200107123450207; Stevenson B, 2003, J MOL EVOL, V57, P309, DOI 10.1007/s00239-003-2482-x; Stevenson B, 2000, J MOL MICROB BIOTECH, V2, P411; Strle F, 2006, CLIN INFECT DIS, V43, P704, DOI 10.1086/506936; Strother KO, 2005, VECTOR-BORNE ZOONOT, V5, P237, DOI 10.1089/vbz.2005.5.237; Tatusov RL, 2000, NUCLEIC ACIDS RES, V28, P33, DOI 10.1093/nar/28.1.33; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Tourand Y, 2003, MOL MICROBIOL, V48, P901, DOI 10.1046/j.1365-2958.2003.03485.x; Tourand Y, 2009, J BIOL CHEM, V284, P7264, DOI 10.1074/jbc.M808918200; Wang DC, 2003, MOL MICROBIOL, V47, P1407, DOI 10.1046/j.1365-2958.2003.03386.x; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Wu Q, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.00010-14; Wywial E, 2009, GENE, V445, P26, DOI 10.1016/j.gene.2009.05.017; Yu NY, 2010, BIOINFORMATICS, V26, P1608, DOI 10.1093/bioinformatics/btq249; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhang HM, 2005, J BACTERIOL, V187, P7985, DOI 10.1128/JB.187.23.7985-7995.2005; Zhang JR, 1997, CELL, V89, P275, DOI 10.1016/S0092-8674(00)80206-8; Zhang LL, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002079	115	13	14	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0120548	10.1371/journal.pone.0120548	http://dx.doi.org/10.1371/journal.pone.0120548			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25798594	Green Published, Green Submitted, gold			2022-12-27	WOS:000351987300153
J	Taulemesse, F; Le Gouis, J; Gouache, D; Gibon, Y; Allard, V				Taulemesse, Francois; Le Gouis, Jacques; Gouache, David; Gibon, Yves; Allard, Vincent			Post-Flowering Nitrate Uptake in Wheat Is Controlled by N Status at Flowering, with a Putative Major Role of Root Nitrate Transporter NRT2.1	PLOS ONE			English	Article							GRAIN PROTEIN-CONCENTRATION; SPRING WHEAT; WINTER-WHEAT; BREAD WHEAT; POSTTRANSLATIONAL REGULATION; FUNCTIONAL-CHARACTERIZATION; NITROGEN REMOBILIZATION; NEGATIVE RELATIONSHIP; ARABIDOPSIS-THALIANA; GLUTAMINE-SYNTHETASE	In bread wheat (Triticum aestivum L.), the simultaneous improvement of both yield and grain protein is difficult because of the strong negative relationship between these two traits. However, some genotypes deviate positively from this relationship and this has been linked to their ability to take up nitrogen (N) during the post-flowering period, regardless of their N status at flowering. The physiological and genetic determinants of post-flowering N uptake relating to N satiety are poorly understood. This study uses semi-hydroponic culture of cv. Recital under controlled conditions to explore these controls. The first objective was to record the effects of contrasting N status at flowering on post-flowering nitrate (NO3-) uptake under nonlimiting NO3- conditions, while following the expression of key genes involved in NO3- uptake and assimilation. We found that post-flowering NO3- uptake was strongly influenced by plant N status at flowering during the first 300-400 degree-days after flowering, overlapping with a probable regulation of nitrate uptake exerted by N demand for growth. The uptake of NO3- correlated well with the expression of the gene TaNRT2.1, coding for a root NO3- transporter, which seems to play a major role in post-flowering NO3- uptake. These results provide a useful knowledge base for future investigation of genetic variability in post-flowering N uptake and may lead to concomitant gains in both grain yield and grain protein in wheat.	[Taulemesse, Francois; Le Gouis, Jacques; Allard, Vincent] INRA, UMR Genet Diversite & Ecophysiol Cereales 1095, Clermont Ferrand, France; [Taulemesse, Francois; Le Gouis, Jacques; Allard, Vincent] Blaise Pascal Univ, UMR Genet Diversite & Ecophysiol Cereales 1095, Aubiere, France; [Taulemesse, Francois; Gouache, David] Arvalis Inst Vegetal, Serv Biotechnol, Boigneville, France; [Gibon, Yves] INRA, UMR Biol Fruit & Pathol 1332, Villenave Dornon, France	INRAE; Universite Clermont Auvergne (UCA); INRAE	Allard, V (corresponding author), INRA, UMR Genet Diversite & Ecophysiol Cereales 1095, Clermont Ferrand, France.	vincent.allard@clermont.inra.fr	Allard, Vincent/B-8806-2009; Gouache, David/AAX-2128-2020	Allard, Vincent/0000-0003-1949-9158; Gibon, Yves/0000-0001-8161-1089	French "Fonds de Soutien a l'Obtention Vegetale" (FSOV); ANRT (Association Nationale de la Recherche et de la Technologie) [CIFRE 878/2011]	French "Fonds de Soutien a l'Obtention Vegetale" (FSOV); ANRT (Association Nationale de la Recherche et de la Technologie)(French National Research Agency (ANR))	Funding: This work was supported by the French "Fonds de Soutien a l'Obtention Vegetale" (FSOV) 2010F project (2011-2013). The authors are also grateful to the ANRT (Association Nationale de la Recherche et de la Technologie) which supports the PhD thesis (CIFRE 878/2011) during which the analyses were conducted. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2004, AZ QUANT PCR; BARLOW EWR, 1983, AUST J PLANT PHYSIOL, V10, P99, DOI 10.1071/PP9830099; Barneix AJ, 2007, J PLANT PHYSIOL, V164, P581, DOI 10.1016/j.jplph.2006.03.009; Bernard SM, 2008, PLANT MOL BIOL, V67, P89, DOI 10.1007/s11103-008-9303-y; Bertheloot J, 2012, EUR J AGRON, V42, P11, DOI 10.1016/j.eja.2012.03.005; Bogard M, 2010, J EXP BOT, V61, P4303, DOI 10.1093/jxb/erq238; Boisson M, 2005, THEOR APPL GENET, V110, P932, DOI 10.1007/s00122-004-1913-4; Branlard G, 2001, EUPHYTICA, V119, P59, DOI 10.1023/A:1017586220359; Carillo P, 2005, FUNCT PLANT BIOL, V32, P209, DOI 10.1071/FP04184; CASTLE SL, 1987, AUST J PLANT PHYSIOL, V14, P503, DOI 10.1071/PP9870503; CLARKSON DT, 1985, ANNU REV PLANT PHYS, V36, P77, DOI 10.1146/annurev.pp.36.060185.000453; COX MC, 1986, CROP SCI, V26, P737, DOI 10.2135/cropsci1986.0011183X002600040022x; Cross JM, 2006, PLANT PHYSIOL, V142, P1574, DOI 10.1104/pp.106.086629; Feil B., 1997, AGRONOMY, V1, P103; Filleur S, 2001, FEBS LETT, V489, P220, DOI 10.1016/S0014-5793(01)02096-8; Finnemann J, 2000, PLANT J, V24, P171, DOI 10.1046/j.1365-313x.2000.00863.x; Garnett T, 2013, NEW PHYTOL, V198, P82, DOI 10.1111/nph.12166; Glass ADM, 2009, BOTANY, V87, P659, DOI 10.1139/B09-014; Howarth JR, 2008, J EXP BOT, V59, P3675, DOI 10.1093/jxb/ern218; Huang NC, 1999, PLANT CELL, V11, P1381, DOI 10.1105/tpc.11.8.1381; IMSANDE J, 1994, PLANT PHYSIOL, V105, P3, DOI 10.1104/pp.105.1.3; JENNER CF, 1991, AUST J PLANT PHYSIOL, V18, P211, DOI 10.1071/PP9910211; Jeuffroy MH, 2002, J EXP BOT, V53, P809, DOI 10.1093/jexbot/53.370.809; JUSTES E, 1994, ANN BOT-LONDON, V74, P397, DOI 10.1006/anbo.1994.1133; Kaiser WM, 2001, J EXP BOT, V52, P1981, DOI 10.1093/jexbot/52.363.1981; Kichey T, 2007, FIELD CROP RES, V102, P22, DOI 10.1016/j.fcr.2007.01.002; KING BJ, 1993, PLANT PHYSIOL, V102, P1279, DOI 10.1104/pp.102.4.1279; KIRKMAN MA, 1979, J SCI FOOD AGR, V30, P653, DOI 10.1002/jsfa.2740300703; Krouk G, 2010, DEV CELL, V18, P927, DOI 10.1016/j.devcel.2010.05.008; LEA PJ, 1994, PLANT CELL ENVIRON, V17, P541, DOI 10.1111/j.1365-3040.1994.tb00148.x; Lemaire G., 1997, DIAGNOSIS NITROGEN S, P3, DOI [DOI 10.1007/978-3-642-60684-7, 10.1007/978-3-642-60684-7, DOI 10.1007/978-3-642-60684-7_1]; Lin CM, 2000, PLANT PHYSIOL, V122, P379, DOI 10.1104/pp.122.2.379; Liu KH, 1999, PLANT CELL, V11, P865, DOI 10.1105/tpc.11.5.865; Maathuis FJM, 2009, CURR OPIN PLANT BIOL, V12, P250, DOI 10.1016/j.pbi.2009.04.003; Martre P, 2003, PLANT PHYSIOL, V133, P1959, DOI 10.1104/pp.103.030585; Martre P, 2006, EUR J AGRON, V25, P138, DOI 10.1016/j.eja.2006.04.007; Masclaux-Daubresse C, 2010, ANN BOT-LONDON, V105, P1141, DOI 10.1093/aob/mcq028; MATTSSON M, 1992, J EXP BOT, V43, P25, DOI 10.1093/jxb/43.1.25; Meyer C, 2001, NITRATE REDUCTION SI, P37; Migocka M, 2013, PLANT SOIL, V364, P245, DOI 10.1007/s11104-012-1345-x; Miller AJ, 2007, J EXP BOT, V58, P2297, DOI 10.1093/jxb/erm066; Monaghan JM, 2001, EUPHYTICA, V122, P309, DOI 10.1023/A:1012961703208; Nazoa P, 2003, PLANT MOL BIOL, V52, P689, DOI 10.1023/A:1024899808018; Okamoto M, 2003, PLANT CELL PHYSIOL, V44, P304, DOI 10.1093/pcp/pcg036; Olesen JE, 2002, EUR J AGRON, V16, P279, DOI 10.1016/S1161-0301(01)00134-4; Orsel M, 2002, PLANT PHYSIOL, V129, P886, DOI 10.1104/pp.005280; Orsel M, 2006, PLANT PHYSIOL, V142, P1304, DOI 10.1104/pp.106.085209; OSCARSON P, 1995, PLANT SOIL, V175, P179, DOI 10.1007/BF00011353; Oscarson P, 1996, ANN BOT-LONDON, V78, P479, DOI 10.1006/anbo.1996.0145; Oscarson P, 2000, J EXP BOT, V51, P1921, DOI 10.1093/jexbot/51.352.1921; OSCARSON P, 1995, CROP SCI, V35, P1056, DOI 10.2135/cropsci1995.0011183X003500040023x; Oury FX, 2007, EUPHYTICA, V157, P45, DOI 10.1007/s10681-007-9395-5; Oury FX, 2003, J GENET BREED, P57; PALTA JA, 1994, CROP SCI, V34, P118, DOI 10.2135/cropsci1994.0011183X003400010021x; PALTA JA, 1995, AUST J AGR RES, V46, P519, DOI 10.1071/AR9950519; Paolacci AR, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-11; Plett D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015289; Quraishi UM, 2011, PLANT J, V65, P745, DOI 10.1111/j.1365-313X.2010.04461.x; R Core Team, 2012, R LANG ENV STAT COMP; Rothstein SJ, 2007, PLANT CELL, V19, P2695, DOI 10.1105/tpc.107.053074; Sadras VO, 2010, FIELD CROP RES, V118, P297, DOI 10.1016/j.fcr.2010.06.010; Shewry PR, 2007, J CEREAL SCI, V46, P239, DOI 10.1016/j.jcs.2007.06.006; SIDDIQI MY, 1990, PLANT PHYSIOL, V93, P1426, DOI 10.1104/pp.93.4.1426; SIMMONDS NW, 1995, J SCI FOOD AGR, V67, P309, DOI 10.1002/jsfa.2740670306; TALOUIZTE A, 1984, J PLANT PHYSIOL, V116, P113, DOI 10.1016/S0176-1617(84)80068-1; Tocquin Pierre, 2003, BMC Plant Biology, V3, P2, DOI 10.1186/1471-2229-3-2; Triboi E, 2003, J EXP BOT, V54, P1731, DOI 10.1093/jxb/erg183; Triboi E, 2006, EUR J AGRON, V25, P108, DOI 10.1016/j.eja.2006.04.004; Tsay YF, 2007, FEBS LETT, V581, P2290, DOI 10.1016/j.febslet.2007.04.047; VANSANFORD DA, 1987, CROP SCI, V27, P295, DOI 10.2135/cropsci1987.0011183X002700020035x; Vidmar JJ, 2000, PLANT PHYSIOL, V123, P307, DOI 10.1104/pp.123.1.307; Wang P, 2011, AGR SCI CHINA, V10, P695, DOI 10.1016/S1671-2927(11)60052-7; Wang RC, 2004, PLANT PHYSIOL, V136, P2512, DOI 10.1104/pp.104.044610; Yin LP, 2007, PLANT SCI, V172, P621, DOI 10.1016/j.plantsci.2006.11.014; Yuan LX, 2007, PLANT PHYSIOL, V143, P732, DOI 10.1104/pp.106.093237	75	57	60	1	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0120291	10.1371/journal.pone.0120291	http://dx.doi.org/10.1371/journal.pone.0120291			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25798624	Green Published, gold			2022-12-27	WOS:000351987300123
J	Chakraborty, S; Hu, SY; Wu, SH; Karmenyan, A; Chiou, A				Chakraborty, Sandeep; Hu, Shih-Yang; Wu, Shu-Han; Karmenyan, Artashes; Chiou, Arthur			The Interaction Affinity between Vascular Cell Adhesion Molecule-1 (VCAM-1) and Very Late Antigen-4 (VLA-4) Analyzed by Quantitative FRET	PLOS ONE			English	Article							TRANSENDOTHELIAL MIGRATION; PROTEIN INTERACTIONS; BINDING; INTEGRINS; EXPRESSION; PATHWAYS; DOMAIN-4; RECEPTOR; ICAM-1	Very late antigen-4 (VLA-4), a member of integrin superfamily, interacts with its major counter ligand vascular cell adhesion molecule-1 (VCAM-1) and plays an important role in leukocyte adhesion to vascular endothelium and immunological synapse formation. However, irregular expressions of these proteins may also lead to several autoimmune diseases and metastasis cancer. Thus, quantifying the interaction affinity of the VCAM-1/VLA-4 interaction is of fundamental importance in further understanding the nature of this interaction and drug discovery. In this study, we report an 'in solution' steady state organic fluorophore based quantitative fluorescence resonance energy transfer (FRET) assay to quantify this interaction in terms of the dissociation constant (K-d). We have used, in our FRET assay, the Alexa Fluor 488-VLA-4 conjugate as the donor, and Alexa Fluor 546-VCAM-1 as the acceptor. From the FRET signal analysis, K-d of this interaction was determined to be 41.82 +/- 2.36 nM. To further confirm our estimation, we have employed surface plasmon resonance (SPR) technique to obtain K-d = 39.60 +/- 1.78 nM, which is in good agreement with the result obtained by FRET. This is the first reported work which applies organic fluorophore based 'in solution' simple quantitative FRET assay to obtain the dissociation constant of the VCAM-1/VLA-4 interaction, and is also the first quantification of this interaction. Moreover, the value of K-d can serve as an indicator of abnormal protein-protein interactions; hence, this assay can potentially be further developed into a drug screening platform of VLA-4/VCAM-1 as well as other protein-ligand interactions.	[Chakraborty, Sandeep; Hu, Shih-Yang; Wu, Shu-Han; Chiou, Arthur] Natl Yang Ming Univ, Inst Biophoton, Taipei 11221, Taiwan; [Wu, Shu-Han] Acad Sinica, Res Ctr Appl Sci, Taipei 11529, Taiwan; [Karmenyan, Artashes] Natl Dong Hwa Univ, Dept Phys, Hualien 97401, Taiwan; [Karmenyan, Artashes; Chiou, Arthur] Natl Yang Ming Univ, Biophoton & Mol Imaging Res Ctr, Taipei 11221, Taiwan	National Yang Ming Chiao Tung University; Academia Sinica - Taiwan; National Dong Hwa University; National Yang Ming Chiao Tung University	Karmenyan, A (corresponding author), Natl Dong Hwa Univ, Dept Phys, Hualien 97401, Taiwan.	artashes@mail.ndhu.edu.tw; aechiou@ym.edu.tw	Karmenyan, Artashes/U-3697-2019		Ministry of Science & Technology, Taiwan, ROC [NSC99-2923-E-010-001-MY3]; Top University Project from Taiwan Ministry of Education, ROC	Ministry of Science & Technology, Taiwan, ROC; Top University Project from Taiwan Ministry of Education, ROC	Funding: SC, SH, SW, AK, and AC were jointly supported by the Ministry of Science & Technology, Taiwan, ROC (Project No. NSC99-2923-E-010-001-MY3), and the Top University Project from Taiwan Ministry of Education, ROC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azab W, 2013, J VIROL, V87, P5937, DOI 10.1128/JVI.03522-12; Azab W, 2012, VET RES, V43, DOI 10.1186/1297-9716-43-61; BERGESE SD, 1995, AM J PATHOL, V147, P166; Boozer C, 2006, CURR OPIN BIOTECH, V17, P400, DOI 10.1016/j.copbio.2006.06.012; Chakraborty S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102572; Chen HM, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2799171; Chigaev A, 2001, J BIOL CHEM, V276, P48670, DOI 10.1074/jbc.M103194200; CLARK EA, 1995, SCIENCE, V268, P233, DOI 10.1126/science.7716514; Clark K, 2000, FEBS LETT, V471, P182, DOI 10.1016/S0014-5793(00)01391-0; CYBULSKY MI, 1991, AM J PATHOL, V138, P815; de Andres Clara, 2012, PLoS One, V7, pe34103, DOI 10.1371/journal.pone.0034103; Ding ZQ, 2001, J LEUKOCYTE BIOL, V69, P458; ELICES MJ, 1990, CELL, V60, P577, DOI 10.1016/0092-8674(90)90661-W; ENGELHARDT B, 2007, PROG INFLAM RES, P117; HEMLER ME, 1990, ANNU REV IMMUNOL, V8, P365, DOI 10.1146/annurev.iy.08.040190.002053; Hieb AR, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr1045; Hulme EC, 2010, BRIT J PHARMACOL, V161, P1219, DOI 10.1111/j.1476-5381.2009.00604.x; HYDUK SJ, 2007, PROG INFLAM RES, P141; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; KILGER G, 1995, J BIOL CHEM, V270, P5979, DOI 10.1074/jbc.270.11.5979; Klemke M, 2007, J CELL PHYSIOL, V212, P368, DOI 10.1002/jcp.21029; Lakowicz J.R., 2013, PRINCIPLES FLUORESCE, DOI [DOI 10.1007/978-0-387-46312-4, 10.1007/978-0-387-46312-4]; Lichlyter DJ, 2003, BIOSENS BIOELECTRON, V19, P219, DOI 10.1016/S0956-5663(03)00215-X; Liu Yan, 2012, [Frontiers in Biology, 生物学前沿], V7, P57; Lu X, 2011, CANCER CELL, V20, P701, DOI 10.1016/j.ccr.2011.11.002; Martin SF, 2008, PROTEIN SCI, V17, P777, DOI 10.1110/ps.073369608; MASUMOTO A, 1993, J BIOL CHEM, V268, P228; Mittelbrunn M, 2004, P NATL ACAD SCI USA, V101, P11058, DOI 10.1073/pnas.0307927101; Morimoto C, 1998, CURR TOP MICROBIOL, V231, P1; NORRIS P, 1991, J INVEST DERMATOL, V96, P763, DOI 10.1111/1523-1747.ep12471720; OPPENHEIMERMARKS N, 1991, J IMMUNOL, V147, P2913; OSBORN L, 1992, J EXP MED, V176, P99, DOI 10.1084/jem.176.1.99; Perozzo R, 2004, J RECEPT SIG TRANSD, V24, P1, DOI 10.1081/RRS-120037896; POLTE T, 1991, DNA CELL BIOL, V10, P349, DOI 10.1089/dna.1991.10.349; Salza R, 2014, BIOCHEM J, V457, P137, DOI 10.1042/BJ20130295; Song Y, 2012, BIOTECHNOL BIOENG, V109, P2875, DOI 10.1002/bit.24564; Song Y, 2011, ANN BIOMED ENG, V39, P1224, DOI 10.1007/s10439-010-0225-x; Soto MS, 2013, NEURO-ONCOLOGY, P1; Sun YS, 2013, CYTOM PART A, V83, P780, DOI 10.1002/cyto.a.22321; Takeuchi E, 2002, ARTHRITIS RES, V4, DOI 10.1186/ar593; Vogel Steven S, 2006, Sci STKE, V2006, pre2; VONDERHEIDE RH, 1994, J CELL BIOL, V125, P215, DOI 10.1083/jcb.125.1.215; Waksman G., 2005, PROTEOMICS PROTEIN P; WAYNER EA, 1989, J CELL BIOL, V109, P1321, DOI 10.1083/jcb.109.3.1321; Weber C, 1998, J IMMUNOL, V161, P6825; Wu SH, 2014, BIOSENS BIOELECTRON, V56, P159, DOI 10.1016/j.bios.2014.01.008; Zwartz G, 2004, BIOPHYS J, V86, P1243, DOI 10.1016/S0006-3495(04)74198-3	47	12	14	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0121399	10.1371/journal.pone.0121399	http://dx.doi.org/10.1371/journal.pone.0121399			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25793408	Green Submitted, gold, Green Published			2022-12-27	WOS:000352083900130
J	Dupont, DM; Thuesen, CK; Botkjaer, KA; Behrens, MA; Dam, K; Sorensen, HP; Pedersen, JS; Ploug, M; Jensen, JK; Andreasen, PA				Dupont, Daniel M.; Thuesen, Cathrine K.; Botkjaer, Kenneth A.; Behrens, Manja A.; Dam, Karen; Sorensen, Hans P.; Pedersen, Jan S.; Ploug, Michael; Jensen, Jan K.; Andreasen, Peter A.			Protein-Binding RNA Aptamers Affect Molecular Interactions Distantly from Their Binding Sites	PLOS ONE			English	Article							PLASMINOGEN-ACTIVATOR INHIBITOR-1; RECEPTOR-RELATED PROTEIN; UROKINASE RECEPTOR; ALPHA(2)-MACROGLOBULIN RECEPTOR; MONOCLONAL-ANTIBODIES; STRUCTURE PREDICTION; SCATTERING; EPITOPE; ENDOCYTOSIS; COMPLEX	Nucleic acid aptamer selection is a powerful strategy for the development of regulatory agents for molecular intervention. Accordingly, aptamers have proven their diligence in the intervention with serine protease activities, which play important roles in physiology and pathophysiology. Nonetheless, there are only a few studies on the molecular basis underlying aptamer-protease interactions and the associated mechanisms of inhibition. In the present study, we use site-directed mutagenesis to delineate the binding sites of two 2 '-fluoropyrimidine RNA aptamers (upanap-12 and upanap-126) with therapeutic potential, both binding to the serine protease urokinase-type plasminogen activator (uPA). We determine the subsequent impact of aptamer binding on the well-established molecular interactions (plasmin, PAI-1, uPAR, and LRP-1A) controlling uPA activities. One of the aptamers (upanap-126) binds to the area around the C-terminal alpha-helix in pro-uPA, while the other aptamer (upanap-12) binds to both the beta-hairpin of the growth factor domain and the kringle domain of uPA. Based on the mapping studies, combined with data from small-angle X-ray scattering analysis, we construct a model for the upanap-12: pro-uPA complex. The results suggest and highlight that the size and shape of an aptamer as well as the domain organization of a multi-domain protein such as uPA, may provide the basis for extensive sterical interference with protein ligand interactions considered distant from the aptamer binding site.	[Dupont, Daniel M.; Thuesen, Cathrine K.; Botkjaer, Kenneth A.; Dam, Karen; Sorensen, Hans P.; Jensen, Jan K.; Andreasen, Peter A.] Aarhus Univ, Dept Mol Biol & Genet, Aarhus, Denmark; [Dupont, Daniel M.; Thuesen, Cathrine K.; Botkjaer, Kenneth A.; Sorensen, Hans P.; Ploug, Michael; Jensen, Jan K.; Andreasen, Peter A.] Aarhus Univ, Danish Chinese Ctr Proteases & Canc, Aarhus, Denmark; [Behrens, Manja A.; Pedersen, Jan S.] Aarhus Univ, INANO Interdisciplinary Nanosci Ctr, Aarhus, Denmark; [Behrens, Manja A.; Sorensen, Hans P.] Aarhus Univ, Dept Chem, DK-8000 Aarhus, Denmark; [Ploug, Michael] Rigshosp, Finsen Lab, DK-2100 Copenhagen, Denmark; [Ploug, Michael] Biotech Res & Innovat Ctr, Copenhagen, Denmark; [Behrens, Manja A.] Lund Univ, Dept Chem, Lund, Sweden	Aarhus University; Aarhus University; Aarhus University; Aarhus University; Rigshospitalet; University of Copenhagen; Lund University	Dupont, DM (corresponding author), Aarhus Univ, Dept Mol Biol & Genet, Aarhus, Denmark.	dmd@mbg.au.dk	Dupont, Daniel M./H-7556-2019; Pedersen, Jan Skov/A-8346-2008	Pedersen, Jan Skov/0000-0002-7768-0206; Ploug, Michael/0000-0003-2215-4265; Dupont, Daniel Miotto/0000-0003-1378-1670	Danish Cancer Society [R40-A1838, R56-A2997-12-S2]; Carlsberg Foundation [2010-01-0819]; Danish National Research Foundation [26-331-6]; Danish Research Agency [272-06-0518]; Novo Nordisk Foundation [R114-A11382]; Novo Nordisk Fonden [NNF13OC0006627] Funding Source: researchfish	Danish Cancer Society(Danish Cancer Society); Carlsberg Foundation(Carlsberg Foundation); Danish National Research Foundation(Danmarks Grundforskningsfond); Danish Research Agency; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Novo Nordisk Fonden(Novo Nordisk Foundation)	This work was supported by grants from the Danish Cancer Society [R40-A1838 to KAB, R56-A2997-12-S2]; the Carlsberg Foundation [2010-01-0819 to DMD]; the Danish National Research Foundation [26-331-6]; the Danish Research Agency [272-06-0518]; and the Novo Nordisk Foundation [R114-A11382]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreasen PA, 1997, INT J CANCER, V72, P1, DOI 10.1002/(SICI)1097-0215(19970703)72:1<1::AID-IJC1>3.0.CO;2-Z; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Barinka C, 2006, J MOL BIOL, V363, P482, DOI 10.1016/j.jmb.2006.08.063; Behrens MA, 2012, METHOD ENZYMOL, V511, P191, DOI 10.1016/B978-0-12-396546-2.00031-0; Behrens MA, 2011, J MOL BIOL, V411, P417, DOI 10.1016/j.jmb.2011.05.026; BOCK LC, 1992, NATURE, V355, P564, DOI 10.1038/355564a0; Botkjaer KA, 2012, MOL CANCER RES, V10, P1532, DOI 10.1158/1541-7786.MCR-12-0349; Carriero MV, 2011, CURR PHARM DESIGN, V17, P1944; Ding F, 2008, RNA, V14, P1164, DOI 10.1261/rna.894608; Drag M, 2010, NAT REV DRUG DISCOV, V9, P690, DOI 10.1038/nrd3053; Dupont DM, 2011, CURR MED CHEM, V18, P4139; Dupont DM, 2006, J BIOL CHEM, V281, P36071, DOI 10.1074/jbc.M606851200; Dupont DM, 2010, RNA, V16, P2360, DOI 10.1261/rna.2338210; Dupont DM, 2009, FRONT BIOSCI-LANDMRK, V14, P1337, DOI 10.2741/3312; Egelund R, 2001, EUR J BIOCHEM, V268, P673, DOI 10.1046/j.1432-1327.2001.01921.x; ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; Gardsvoll H, 2006, J BIOL CHEM, V281, P19260, DOI 10.1074/jbc.M513583200; Gardsvoll H, 2011, J BIOL CHEM, V286, P33544, DOI 10.1074/jbc.M111.220087; GLIEMANN J, 1994, ANN NY ACAD SCI, V737, P20, DOI 10.1111/j.1749-6632.1994.tb44299.x; Harbeck N, 2014, CANCER TREAT REV, V40, P434, DOI 10.1016/j.ctrv.2013.09.014; Huai Q, 2008, NAT STRUCT MOL BIOL, V15, P422, DOI 10.1038/nsmb.1404; JENSEN PH, 1990, CELL REGUL, V1, P1043, DOI 10.1091/mbc.1.13.1043; Jeter ML, 2004, FEBS LETT, V568, P10, DOI 10.1016/j.febslet.2004.04.087; Keefe AD, 2010, NAT REV DRUG DISCOV, V9, P537, DOI 10.1038/nrd3141; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; Lin L, 2010, J BIOL CHEM, V285, P10982, DOI 10.1074/jbc.M109.093492; Long SB, 2008, RNA, V14, P2504, DOI 10.1261/rna.1239308; Magdolen V, 1996, EUR J BIOCHEM, V237, P743, DOI 10.1111/j.1432-1033.1996.0743p.x; NYKJAER A, 1994, J BIOL CHEM, V269, P25668; Pedersen JS, 2004, J APPL CRYSTALLOGR, V37, P369, DOI 10.1107/S0021889804004170; PEDERSEN JS, 1994, EUR BIOPHYS J BIOPHY, V22, P379, DOI 10.1007/BF00180159; Petersen HH, 2001, EUR J BIOCHEM, V268, P4430, DOI 10.1046/j.1432-1327.2001.02365.x; Petoukhov MV, 2005, BIOPHYS J, V89, P1237, DOI 10.1529/biophysj.105.064154; Pjura PE, 2000, J MOL BIOL, V300, P235, DOI 10.1006/jmbi.2000.3851; PLOUG M, 1995, BIOCHEMISTRY-US, V34, P12524, DOI 10.1021/bi00039a006; Sharma S, 2008, BIOINFORMATICS, V24, P1951, DOI 10.1093/bioinformatics/btn328; Skeldal S, 2006, FEBS J, V273, P5143, DOI 10.1111/j.1742-4658.2006.05511.x; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; WEI Y, 1994, J BIOL CHEM, V269, P32380	42	16	16	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0119207	10.1371/journal.pone.0119207	http://dx.doi.org/10.1371/journal.pone.0119207			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25793507	Green Published, Green Submitted, gold			2022-12-27	WOS:000352084200061
J	Guo, W; Xue, JM; Shao, D; Long, ZT; Cao, FL				Guo, Wei; Xue, Jiao-Mei; Shao, Di; Long, Zhou-Ting; Cao, Feng-Lin			Effect of the Interplay between Trauma Severity and Trait Neuroticism on Posttraumatic Stress Disorder Symptoms among Adolescents Exposed to a Pipeline Explosion	PLOS ONE			English	Article							QUALITY-OF-LIFE; BORDERLINE PERSONALITY-DISORDER; RISK-FACTORS; PSYCHIATRIC COMORBIDITY; MAGNITUDE EARTHQUAKE; DEPRESSIVE REACTIONS; HURRICANE-KATRINA; CHILDHOOD TRAUMA; PTSD; CHILDREN	Background While numerous studies have explored relevant factors of posttraumatic stress disorder (PTSD) symptoms, there have been few joint investigations of trauma severity and trait neuroticism on the development of PTSD symptoms. This study aims to assess the involvement and interrelationship of trauma severity and neuroticism in the expression of PTSD symptoms among adolescents exposed to an accidental explosion. Methods Six hundred and sixty-two adolescents were recruited from a junior middle school closest to the 2013 pipeline explosion site in China and were assessed using the Explosion Exposure Questionnaire, the NEO Five Factor Inventory-Neuroticism Subscale (FFI-N), and the PTSD Checklist-Civilian (PCL-C). A battery of hierarchical multiple regression analyses and two-way ANOVAs were performed to examine the effect of trauma severity and trait neuroticism on adolescent PTSD symptoms. Results Eighty-seven adolescents (13.1%) showed PTSD symptoms after the pipeline explosion. Correlation analysis showed that all the factors of explosion exposure and trait neuroticism were positively associated with adolescent PTSD symptoms. Being male and younger was linked to lower risk for PTSD symptoms. The regression models identified explosion exposure and neuroticism as independent risk factors for PTSD symptoms, and the interactions between trait neuroticism and trauma exposure (personal casualty, degree of influence, total traumatic severity) were related to PTSD symptoms. Conclusions The results highlight the role of trauma exposure and trait neuroticism as risk factors for PTSD symptoms. Therefore, the combination of these two factors should be investigated in clinical settings due to an augmented risk for more severe PTSD symptoms.	[Guo, Wei; Xue, Jiao-Mei; Shao, Di; Long, Zhou-Ting; Cao, Feng-Lin] Shandong Univ, Sch Nursing, Jinan 250100, Shandong, Peoples R China	Shandong University	Cao, FL (corresponding author), Shandong Univ, Sch Nursing, Jinan 250100, Shandong, Peoples R China.	caofenglin2008@126.com			Natural Science Foundation of Shandong Province [ZR2013HM087]; Independent Innovation Foundation of Shandong University [IFW12113]	Natural Science Foundation of Shandong Province(Natural Science Foundation of Shandong Province); Independent Innovation Foundation of Shandong University	This work was supported by Natural Science Foundation of Shandong Province (Grant number: ZR2013HM087) and Independent Innovation Foundation of Shandong University (Grant number: IFW12113). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agorastos A, 2014, J PSYCHIATR RES, V58, P46, DOI 10.1016/j.jpsychires.2014.07.014; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Bonanno GA, 2011, ANNU REV CLIN PSYCHO, V7, P511, DOI 10.1146/annurev-clinpsy-032210-104526; Boscarino JA, 2008, J NERV MENT DIS, V196, P100, DOI 10.1097/NMD.0b013e318162a9f5; Breslau N, 2013, PSYCHOL MED, V43, P1697, DOI 10.1017/S0033291712002632; Breslau N, 2009, TRAUMA VIOLENCE ABUS, V10, P198, DOI 10.1177/1524838009334448; Brietzke E, 2012, REV BRAS PSIQUIATR, V34, P480, DOI 10.1016/j.rbp.2012.04.009; Brown TH, 2011, J TRAUMA STRESS, V24, P575, DOI 10.1002/jts.20680; Burri Andrea, 2014, BMC Res Notes, V7, P407, DOI 10.1186/1756-0500-7-407; Chen YL, 2011, INT PSYCHOGERIATR, V23, P1686, DOI 10.1017/S1041610211000986; Chou FHC, 2007, PSYCHIAT CLIN NEUROS, V61, P370, DOI 10.1111/j.1440-1819.2007.01688.x; CICCHETTI D, 1991, INTERNALIZING AND EXTERNALIZING EXPRESSIONS OF DYSFUNCTION : ROCHESTER SYMPOSIUM ON DEVELOPMENTAL PSYCHOPATHOLOGY, VOL 2, P1; Cicchetti D, 1997, DEV PERSPECTIVES TRA, P1; Costa Jr PT, 1991, LIFE SPAN DEV PSYCHO; COSTA PT, 1995, J PERS ASSESS, V64, P21, DOI 10.1207/s15327752jpa6401_2; Cox BJ, 2004, BEHAV RES THER, V42, P105, DOI 10.1016/S0005-7967(03)00105-0; Dias A, 2014, EUR J PSYCHOTRAUMATO, V5, DOI 10.3402/ejpt.v5.20198; Eksi A, 2007, INT J PSYCHIAT CLIN, V11, P190, DOI 10.1080/13651500601017548; Eksi A, 2009, EUR CHILD ADOLES PSY, V18, P384, DOI 10.1007/s00787-009-0745-9; Fan F, 2011, J TRAUMA STRESS, V24, P44, DOI 10.1002/jts.20599; Feo P, 2014, BMC PSYCHIATRY, V14, DOI 10.1186/s12888-014-0270-3; Furr JM, 2010, J CONSULT CLIN PSYCH, V78, P765, DOI 10.1037/a0021482; Galea S, 2008, J TRAUMA STRESS, V21, P357, DOI 10.1002/jts.20355; Gauthier P., 1977, ELECTROENCEPHALOGRAP, V43, P449; GOENJIAN AK, 1995, J AM ACAD CHILD PSY, V34, P1174, DOI 10.1097/00004583-199509000-00015; Goenjian AK, 2005, AM J PSYCHIAT, V162, P2302, DOI 10.1176/appi.ajp.162.12.2302; Goenjian AK, 2011, J AFFECT DISORDERS, V133, P509, DOI 10.1016/j.jad.2011.04.053; HAGGERTY RJ, 1994, STRESS RISK RESILIEN; Hapke U, 2006, EUR ARCH PSY CLIN N, V256, P299, DOI 10.1007/s00406-006-0654-6; Juang KD, 2014, CURR PAIN HEADACHE R, V18, DOI 10.1007/s11916-014-0405-8; Kelly B, 1998, GEN HOSP PSYCHIAT, V20, P345, DOI 10.1016/S0163-8343(98)00042-5; Knezevic G, 2005, PSYCHOL MED, V35, P659, DOI 10.1017/S0033291704004131; Kolaitis G, 2003, EUR CHILD ADOLES PSY, V12, P273, DOI 10.1007/s00787-003-0339-x; Kotler M, 2001, J NERV MENT DIS, V189, P162, DOI 10.1097/00005053-200103000-00004; La Greca AM, 2013, J AFFECT DISORDERS, V151, P860, DOI 10.1016/j.jad.2013.07.024; Liu RT, 2010, CLIN PSYCHOL REV, V30, P582, DOI 10.1016/j.cpr.2010.04.010; Loncar M, 2014, PSYCHIAT DANUB, V26, P231; Ma XH, 2011, PSYCHIAT RES, V189, P385, DOI [10.1016/j.psychres.2010.12.016, 10.1016/j.psychres.2011.02.016]; March J, 2014, J TRAUMA ACUTE CARE, V76, P180, DOI 10.1097/TA.0b013e3182a900bc; Martin-Blanco A, 2014, COMPR PSYCHIAT, V55, P311, DOI 10.1016/j.comppsych.2013.08.026; McDermott BM, 2005, CAN J PSYCHIAT, V50, P137, DOI 10.1177/070674370505000302; Messo IN, 2013, J HEALTH PSYCHOL, V18, P627, DOI 10.1177/1359105312451188; Michel G, 2006, PERS INDIV DIFFER, V41, P549, DOI 10.1016/j.paid.2006.01.019; North CS, 2013, SOC PSYCH PSYCH EPID, V48, P1189, DOI 10.1007/s00127-012-0639-x; ORMEL J, 1991, J PERS SOC PSYCHOL, V60, P744, DOI 10.1037/0022-3514.60.5.744; Ormel J, 2001, AM J PSYCHIAT, V158, P885, DOI 10.1176/appi.ajp.158.6.885; Parslow RA, 2006, PSYCHOL MED, V36, P387, DOI 10.1017/S0033291705006306; Peirce J. M, 2002, GENDER PTSD, P177; Perrin M, 2014, SOC PSYCH PSYCH EPID, V49, P447, DOI 10.1007/s00127-013-0762-3; Roussos A, 2005, AM J PSYCHIAT, V162, P530, DOI 10.1176/appi.ajp.162.3.530; RUTTER M, 1989, J CHILD PSYCHOL PSYC, V30, P23, DOI 10.1111/j.1469-7610.1989.tb00768.x; Sar V, 2006, J CLIN PSYCHIAT, V67, P1583, DOI 10.4088/JCP.v67n1014; Schaaf KPW, 2013, RESUSCITATION, V84, P873, DOI 10.1016/j.resuscitation.2012.11.021; Sezgin U, 2012, J AFFECT DISORDERS, V141, P432, DOI 10.1016/j.jad.2012.03.005; Shaar KH, 2013, J PUBLIC HEALTH RES, V2, P99, DOI 10.4081/jphr.2013.e17; Shaw JA, 1996, J AM ACAD CHILD PSY, V35, P359, DOI 10.1097/00004583-199603000-00018; Stallard P, 2004, EUR CHILD ADOLES PSY, V13, P172, DOI 10.1007/s00787-004-0399-6; Sun Yan-ping, 2006, Zhonghua Er Ke Za Zhi, V44, P21; Tian YL, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1073; Trickey D, 2012, CLIN PSYCHOL REV, V32, P122, DOI 10.1016/j.cpr.2011.12.001; Wang W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041665; Weathers F.W., 1993, INT SOC TRAUM STRESS; Wolff N, 2012, INT J ENV RES PUB HE, V9, P1908, DOI 10.3390/ijerph9051908; [徐唯 Xu Wei], 2003, [中国心理卫生杂志, Chinese Mental Health Journal], V17, P603; Xu Wei, 2005, CHIN J CLIN REHABILI, V9, P238; Yang X., 2007, CHINA J HLTH PSYCHOL, V15, P6, DOI [DOI 10.1097/TA.0000000000000749, 10.13342/j.cmki.cjhp.2007.01.003, DOI 10.13342/J.CMKI.CJHP.2007.01.003]; Yehuda R, 2002, NEW ENGL J MED, V346, P108, DOI 10.1056/NEJMra012941; Ying L, 2014, SUICIDE LIFE THREAT; Ying LH, 2013, EUR CHILD ADOLES PSY, V22, P567, DOI 10.1007/s00787-013-0400-3; Zaffina S, 2014, MED LAV, V105, P163; Zheng YH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029404	71	13	13	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0120493	10.1371/journal.pone.0120493	http://dx.doi.org/10.1371/journal.pone.0120493			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CE8HY	25793606	gold, Green Published			2022-12-27	WOS:000352083900042
J	Ito, S; Nozoye, T; Sasaki, E; Imai, M; Shiwa, Y; Shibata-Hatta, M; Ishige, T; Fukui, K; Ito, K; Nakanishi, H; Nishizawa, NK; Yajima, S; Asami, T				Ito, Shinsaku; Nozoye, Tomoko; Sasaki, Eriko; Imai, Misaki; Shiwa, Yuh; Shibata-Hatta, Mari; Ishige, Taichiro; Fukui, Kosuke; Ito, Ken; Nakanishi, Hiromi; Nishizawa, Naoko K.; Yajima, Shunsuke; Asami, Tadao			Strigolactone Regulates Anthocyanin Accumulation, Acid Phosphatases Production and Plant Growth under Low Phosphate Condition in Arabidopsis	PLOS ONE			English	Article							TRANSCRIPTION FACTOR; GENE-EXPRESSION; BUD OUTGROWTH; RESPONSES; INHIBITION; ETHYLENE; ARCHITECTURE; MICRORNA399; DEGRADATION; GERMINATION	Phosphate is an essential macronutrient in plant growth and development; however, the concentration of inorganic phosphate (Pi) in soil is often suboptimal for crop performance. Accordingly, plants have developed physiological strategies to adapt to low Pi availability. Here, we report that typical Pi starvation responses in Arabidopsis are partially dependent on the strigolactone (SL) signaling pathway. SL treatment induced root hair elongation, anthocyanin accumulation, activation of acid phosphatase, and reduced plant weight, which are characteristic responses to phosphate starvation. Furthermore, the expression profile of SL-response genes correlated with the expression of genes induced by Pi starvation. These results suggest a potential overlap between SL signaling and Pi starvation signaling pathways in plants.	[Ito, Shinsaku; Nozoye, Tomoko; Fukui, Kosuke; Nakanishi, Hiromi; Nishizawa, Naoko K.; Asami, Tadao] Univ Tokyo, Grad Sch Agr & Life Sci, Bunkyo Ku, Tokyo, Japan; [Ito, Shinsaku; Ito, Ken; Yajima, Shunsuke] Tokyo Univ Agr, Fac Appl Biosci, Dept Biosci, Setagaya Ku, Tokyo, Japan; [Sasaki, Eriko] Gregor Mendel Inst Mol Plant Biol, Vienna, Austria; [Imai, Misaki; Shiwa, Yuh; Shibata-Hatta, Mari; Ishige, Taichiro] Tokyo Univ Agr, Genome Res Ctr, Setagaya Ku, Tokyo, Japan; [Asami, Tadao] King Abdulaziz Univ, Dept Biochem, Jeddah 21413, Saudi Arabia	University of Tokyo; Tokyo University of Agriculture; Austrian Academy of Sciences; Vienna Biocenter (VBC); Gregor Mendel Institute of Molecular Plant Biology (GMI); Tokyo University of Agriculture; King Abdulaziz University	Asami, T (corresponding author), Univ Tokyo, Grad Sch Agr & Life Sci, Bunkyo Ku, 1-1-1 Yayoi, Tokyo, Japan.	asami@pgr1.ch.a.u-tokyo.ac.jp	; Nakanishi, Hiromi/C-6461-2015	Fukui, Kosuke/0000-0002-1955-624X; Nakanishi, Hiromi/0000-0001-5556-5058	Core Research for Evolutional Science and Technology (CREST); Kato Memorial Bioscience Foundation; MEXT-Supported Program for the Strategic Research Foundation at Private Universities [S1311017]; Grants-in-Aid for Scientific Research [23248011] Funding Source: KAKEN	Core Research for Evolutional Science and Technology (CREST)(Core Research for Evolutional Science and Technology (CREST)); Kato Memorial Bioscience Foundation; MEXT-Supported Program for the Strategic Research Foundation at Private Universities(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by grants from the Core Research for Evolutional Science and Technology (CREST) (T.A.), the Kato Memorial Bioscience Foundation (S.I.) and MEXT-Supported Program for the Strategic Research Foundation at Private Universities, 2013-2017 (S1311017). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama K, 2005, NATURE, V435, P824, DOI 10.1038/nature03608; Alder A, 2012, SCIENCE, V335, P1348, DOI 10.1126/science.1218094; Aung K, 2006, PLANT PHYSIOL, V141, P1000, DOI 10.1104/pp.106.078063; Bari R, 2006, PLANT PHYSIOL, V141, P988, DOI 10.1104/pp.106.079707; Ha CV, 2014, P NATL ACAD SCI USA, V111, P851, DOI 10.1073/pnas.1322135111; COOK CE, 1966, SCIENCE, V154, P1189, DOI 10.1126/science.154.3753.1189; Devaiah BN, 2009, MOL PLANT, V2, P43, DOI 10.1093/mp/ssn081; Dun EA, 2012, PLANT PHYSIOL, V158, P487, DOI 10.1104/pp.111.186783; Franco-Zorrilla JM, 2007, NAT GENET, V39, P1033, DOI 10.1038/ng2079; Gomez-Roldan V, 2008, NATURE, V455, P189, DOI 10.1038/nature07271; Hamiaux C, 2012, CURR BIOL, V22, P2032, DOI 10.1016/j.cub.2012.08.007; Huang TK, 2013, PLANT CELL, V25, P4044, DOI 10.1105/tpc.113.115998; Jiang CF, 2007, PLANT PHYSIOL, V145, P1460, DOI 10.1104/pp.107.103788; Jiang L, 2013, NATURE, V504, P401, DOI 10.1038/nature12870; Kapulnik Y, 2011, J EXP BOT, V62, P2915, DOI 10.1093/jxb/erq464; Kapulnik Y, 2011, PLANTA, V233, P209, DOI 10.1007/s00425-010-1310-y; Lei MG, 2011, NEW PHYTOL, V189, P1084, DOI 10.1111/j.1469-8137.2010.03555.x; Lung SC, 2008, PHYTOCHEMISTRY, V69, P365, DOI 10.1016/j.phytochem.2007.06.036; Mayzlish-Gati E, 2012, PLANT PHYSIOL, V160, P1329, DOI 10.1104/pp.112.202358; Misson J, 2005, P NATL ACAD SCI USA, V102, P11934, DOI 10.1073/pnas.0505266102; Misson J, 2004, PLANT MOL BIOL, V55, P727, DOI 10.1007/s11103-004-1965-5; Mudge SR, 2002, PLANT J, V31, P341, DOI 10.1046/j.1365-313X.2002.01356.x; Nakamura H, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3613; Nelson DC, 2011, P NATL ACAD SCI USA, V108, P8897, DOI 10.1073/pnas.1100987108; Raghothama KG, 2000, CURR OPIN PLANT BIOL, V3, P182, DOI 10.1016/S1369-5266(00)00062-5; Ribot C, 2008, PLANT PHYSIOL, V147, P696, DOI 10.1104/pp.108.119321; Richardson AE, 2001, PLANT J, V25, P641, DOI 10.1046/j.1365-313x.2001.00998.x; Rubio V, 2001, GENE DEV, V15, P2122, DOI 10.1101/gad.204401; Ruyter-Spira C, 2011, PLANT PHYSIOL, V155, P721, DOI 10.1104/pp.110.166645; Sasaki E, 2011, PLANT CELL PHYSIOL, V52, P169, DOI 10.1093/pcp/pcq185; Seto Y, 2012, PLANT CELL PHYSIOL, V53, P1843, DOI 10.1093/pcp/pcs142; Stanga JP, 2013, PLANT PHYSIOL, V163, P318, DOI 10.1104/pp.113.221259; Torres-Vera R, 2014, MOL PLANT PATHOL, V15, P211, DOI 10.1111/mpp.12074; Umehara M, 2008, NATURE, V455, P195, DOI 10.1038/nature07272; Umehara M, 2010, PLANT CELL PHYSIOL, V51, P1118, DOI 10.1093/pcp/pcq084; Wang LS, 2012, PLANT CELL PHYSIOL, V53, P1093, DOI 10.1093/pcp/pcs072; Wang Y, 2013, DEV CELL, V27, P681, DOI 10.1016/j.devcel.2013.11.010; Waters MT, 2012, PLANT PHYSIOL, V159, P1073, DOI 10.1104/pp.112.196253; Waters MT, 2012, DEVELOPMENT, V139, P1285, DOI 10.1242/dev.074567; Yoneyama K, 2007, PLANTA, V227, P125, DOI 10.1007/s00425-007-0600-5; Zhang YM, 2014, J MANUF PROCESS, V16, P1, DOI 10.1016/j.jmapro.2013.12.004; Zhou F, 2013, NATURE, V504, P406, DOI 10.1038/nature12878	42	37	41	6	80	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0119724	10.1371/journal.pone.0119724	http://dx.doi.org/10.1371/journal.pone.0119724			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25793732	Green Published, Green Submitted, gold			2022-12-27	WOS:000352084200108
J	Jiang, Y; Li, CY				Jiang, Yu; Li, Changying			Detection and Discrimination of Cotton Foreign Matter Using Push-Broom Based Hyperspectral Imaging: System Design and Capability	PLOS ONE			English	Article							TRASH	Cotton quality, a major factor determining both cotton profitability and marketability, is affected by not only the overall quantity of but also the type of the foreign matter. Although current commercial instruments can measure the overall amount of the foreign matter, no instrument can differentiate various types of foreign matter. The goal of this study was to develop a hyperspectral imaging system to discriminate major types of foreign matter in cotton lint. A push-broom based hyperspectral imaging system with a custom-built multi-thread software was developed to acquire hyperspectral images of cotton fiber with 15 types of foreign matter commonly found in the U.S. cotton lint. A total of 450 (30 replicates for each foreign matter) foreign matter samples were cut into 1 by 1 cm2 pieces and imaged on the lint surface using reflectance mode in the spectral range from 400-1000 nm. The mean spectra of the foreign matter and lint were extracted from the user-defined region-of-interests in the hyperspectral images. The principal component analysis was performed on the mean spectra to reduce the feature dimension from the original 256 bands to the top 3 principal components. The score plots of the 3 principal components were used to examine clusterization patterns for classifying the foreign matter. These patterns were further validated by statistical tests. The experimental results showed that the mean spectra of all 15 types of cotton foreign matter were different from that of the lint. Nine types of cotton foreign matter formed distinct clusters in the score plots. Additionally, all of them were significantly different from each other at the significance level of 0.05 except brown leaf and bract. The developed hyperspectral imaging system is effective to detect and classify cotton foreign matter on the lint surface and has the potential to be implemented in commercial cotton classing offices.	[Jiang, Yu; Li, Changying] Univ Georgia, Coll Engn, Athens, GA 30602 USA	University System of Georgia; University of Georgia	Li, CY (corresponding author), Univ Georgia, Coll Engn, Athens, GA 30602 USA.	cyli@uga.edu	Jiang, Yu/J-1458-2019	Jiang, Yu/0000-0003-4495-3033	Cotton Incorporated; Georgia Cotton Commission	Cotton Incorporated(Cotton R&D Corp); Georgia Cotton Commission	This research is funded by Cotton Incorporated and Georgia Cotton Commission. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen A, 2007, J COTTON SCI, V11, P68; Boundless, 2014, BOUNDL BIOL; Dogan MS, 2004, THESIS TEXAS TECH U; Fortier CA, 2011, TEXT RES J, V81, P230, DOI 10.1177/0040517510383620; Frydrych I, 2002, FIBRES TEXT EAST EUR, V10, P35; Guo JunXian, 2012, Transactions of the Chinese Society of Agricultural Engineering, V28, P126; Himmelsbach DS, 2006, J AGR FOOD CHEM, V54, P7405, DOI 10.1021/jf052949g; International Trade Centre, 2001, COTT EXP GUID; Lawrence KC, 2003, T ASAE, V46, P513, DOI 10.13031/2013.12940; Pai A, 2004, IEEE T IND APPL, V40, P77, DOI 10.1109/TIA.2003.821647; Qin JW, 2013, J FOOD ENG, V118, P157, DOI 10.1016/j.jfoodeng.2013.04.001; Raven P.H., 1992, BIOL PLANTS; USDA Agricultural Marketing Service, 2005, COTT CLASS; USDA Economic Research Service, 2013, COTT WOOL OV; Xu B, 1999, TEXT RES J, V69, P656, DOI 10.1177/004051759906900906; Xu BG, 1997, TEXT RES J, V67, P881, DOI 10.1177/004051759706701204; Yang WZ, 2011, MATH COMPUT MODEL, V54, P877, DOI 10.1016/j.mcm.2010.11.010; Yang WZ, 2009, COMPUT ELECTRON AGR, V68, P68, DOI 10.1016/j.compag.2009.04.005; Zhang Q, 2013, AGR AUTOMATION FUNDA	19	13	14	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0121969	10.1371/journal.pone.0121969	http://dx.doi.org/10.1371/journal.pone.0121969			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25793990	Green Published, Green Submitted, gold			2022-12-27	WOS:000352083900162
J	Maneenil, G; Kemp, MW; Kannan, PS; Kramer, BW; Saito, M; Newnham, JP; Jobe, AH; Kallapur, SG				Maneenil, Gunlawadee; Kemp, Matthew W.; Kannan, Paranthaman Senthamarai; Kramer, Boris W.; Saito, Masatoshi; Newnham, John P.; Jobe, Alan H.; Kallapur, Suhas G.			Oral, Nasal and Pharyngeal Exposure to Lipopolysaccharide Causes a Fetal Inflammatory Response in Sheep	PLOS ONE			English	Article							INTRAAMNIOTIC ENDOTOXIN; LUNG MATURATION; ONSET SEPSIS; RISK-FACTOR; CHORIOAMNIONITIS; BIRTH; PULMONARY	Background A fetal inflammatory response (FIR) in sheep can be induced by intraamniotic or selective exposure of the fetal lung or gut to lipopolysaccharide (LPS). The oral, nasal, and pharyngeal cavities (ONP) contain lymphoid tissue and epithelium that are in contact with the amniotic fluid. The ability of the ONP epithelium and lymphoid tissue to initiate a FIR is unknown. Objective To determine if FIR occurs after selective ONP exposure to LPS in fetal sheep. Methods Using fetal recovery surgery, we isolated ONP from the fetal lung, GI tract, and amniotic fluid by tracheal and esophageal ligation and with an occlusive glove fitted over the snout. LPS (5 mg) or saline was infused with 24 h Alzet pumps secured in the oral cavity (n = 7-8/group). Animals were delivered 1 or 6 days after initiation of the LPS or saline infusions. Results The ONP exposure to LPS had time-dependent systemic inflammatory effects with changes in WBC in cord blood, an increase in posterior mediastinal lymph node weight at 6 days, and pro-inflammatory mRNA responses in the fetal plasma, lung, and liver. Compared to controls, the expression of surfactant protein A mRNA increased 1 and 6 days after ONP exposure to LPS. Conclusion ONP exposure to LPS alone can induce a mild FIR with time-dependent inflammatory responses in remote fetal tissues not directly exposed to LPS.	[Maneenil, Gunlawadee; Kannan, Paranthaman Senthamarai; Jobe, Alan H.; Kallapur, Suhas G.] Univ Cincinnati, Sch Med, Cincinnati Childrens Hosp Med Ctr, Div Pulm Biol, Cincinnati, OH 45220 USA; [Kemp, Matthew W.; Kramer, Boris W.; Saito, Masatoshi; Newnham, John P.; Jobe, Alan H.; Kallapur, Suhas G.] Univ Western Australia, Sch Womens & Infants Hlth, Perth, WA 6009, Australia; [Kramer, Boris W.] Maastricht Univ, Med Ctr, Dept Pediat, Sch Oncol & Dev Biol, NL-6200 MD Maastricht, Netherlands; [Saito, Masatoshi] Tohoku Univ Hosp, Dept Perinatal Med, Sendai, Miyagi, Japan; [Maneenil, Gunlawadee] Prince Songkla Univ, Fac Med, Dept Pediat, Hat Yai, Thailand	Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; University of Western Australia; Maastricht University; Tohoku University; Prince of Songkla University	Kallapur, SG (corresponding author), Univ Cincinnati, Sch Med, Cincinnati Childrens Hosp Med Ctr, Div Pulm Biol, Cincinnati, OH 45220 USA.	Suhas.kallapur@cchmc.org	Kramer, Boris/AAO-3183-2021; Senthamaraikannan, Paranthaman/H-3992-2018; Maneenil, Gunlawadee/L-1343-2019; Senthamaraikannan, Paranthaman/B-6428-2011	Senthamaraikannan, Paranthaman/0000-0002-3333-3720; Maneenil, Gunlawadee/0000-0002-6332-3216; Senthamaraikannan, Paranthaman/0000-0002-3333-3720; Newnham, John/0000-0001-9983-7457	Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) [HD-57869]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD057869] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by grant HD-57869 from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) to SGK. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander JM, 1998, OBSTET GYNECOL, V91, P725, DOI 10.1016/S0029-7844(98)00056-8; Been JV, 2013, J PEDIATR-US, V162, P236, DOI 10.1016/j.jpeds.2012.07.012; Collins JJP, 2010, AM J PHYSIOL-LUNG C, V299, pL852, DOI 10.1152/ajplung.00183.2010; Gisslen T, 2014, INNATE IMMUN-LONDON, V20, P214, DOI 10.1177/1753425913488430; Goldenberg RL, 2008, LANCET, V371, P75, DOI 10.1016/S0140-6736(08)60074-4; Gomez R, 1998, AM J OBSTET GYNECOL, V179, P194, DOI 10.1016/S0002-9378(98)70272-8; Hartling L, 2012, ARCH DIS CHILD-FETAL, V97, pF8, DOI 10.1136/adc.2010.210187; Hedenstierna G, 2008, CURR OPIN CRIT CARE, V14, P31, DOI 10.1097/MCC.0b013e3282f2f4b5; Jobe AH, 2000, AM J RESP CRIT CARE, V162, P1656, DOI 10.1164/ajrccm.162.5.2003044; Kallapur SG, 2001, AM J PHYSIOL-LUNG C, V280, pL527, DOI 10.1152/ajplung.2001.280.3.L527; Kallapur SG, 2007, J IMMUNOL, V179, P8491, DOI 10.4049/jimmunol.179.12.8491; Kallapur SG, 2013, J IMMUNOL, V191, P1102, DOI 10.4049/jimmunol.1300270; Kallapur SG, 2011, AM J PHYSIOL-LUNG C, V301, pL285, DOI 10.1152/ajplung.00446.2010; Kemp MW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063355; Kemp MW, 2011, REPROD SCI, V18, P1128, DOI 10.1177/1933719111408114; Kemp MW, 2011, REPROD SCI, V18, P88, DOI 10.1177/1933719110380470; Kramer BW, 2001, AM J RESP CRIT CARE, V164, P982, DOI 10.1164/ajrccm.164.6.2103061; Kramer BW, 2010, AM J OBSTET GYNECOL, V202, DOI [10.1016/j.ajog.2009.11.012, DOI 10.1016/J.AJOG.2009.11.012]; Kuypers E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038257; Moss TJM, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2007.06.065; Moss TJM, 2002, AM J OBSTET GYNECOL, V187, P1059, DOI 10.1067/mob.2002.126296; Nijland M J, 2001, J Matern Fetal Med, V10, P251, DOI 10.1080/714904334; Novy MJ, 2009, REPROD SCI, V16, P56, DOI 10.1177/1933719108325508; Payne MS, 2014, PEDIATR RES, V75, P716, DOI 10.1038/pr.2014.35; Shimoya K, 2000, HUM REPROD, V15, P2234, DOI 10.1093/humrep/15.10.2234; Snyder CC, 2013, AM J OBSTET GYNECOL, V208, DOI 10.1016/j.ajog.2013.02.018; Stoll BJ, 2002, NEW ENGL J MED, V347, P240, DOI 10.1056/NEJMoa012657; Strunk T, 2012, PEDIATRICS, V129, pE134, DOI 10.1542/peds.2010-3493; Wolfs TGAM, 2014, AM J PHYSIOL-GASTR L, V306, pG382, DOI 10.1152/ajpgi.00260.2013; Wolfs TGAM, 2012, J MATERN-FETAL NEO M, V25, P8, DOI 10.3109/14767058.2012.664447; Wolfs TGAM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005837	31	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0119281	10.1371/journal.pone.0119281	http://dx.doi.org/10.1371/journal.pone.0119281			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25793992	Green Submitted, Green Published, gold			2022-12-27	WOS:000352084200066
J	Provencher, S; Paruchuru, P; Spezzi, A; Waterhouse, B; Gomberg-Maitland, M				Provencher, Steeve; Paruchuru, Patrap; Spezzi, Andrea; Waterhouse, Brian; Gomberg-Maitland, Mardi		pH12 Flolan Reformulation Study Gr	Quality of Life, Safety and Efficacy Profile of Thermostable Flolan in Pulmonary Arterial Hypertension	PLOS ONE			English	Article							THERAPY; PROSTACYCLIN; SURVIVAL; GUIDELINES	Background Flolan (epoprostenol sodium) is most commonly prescribed to patients with severe pulmonary arterial hypertension (PAH) owing to the requirement that the drug be delivered by continuous intravenous infusion and the reconstituted solution may only be administered up to 24 hours when it is maintained between a temperature of 2 degrees C and 8 degrees C. The aim of this single-arm, open label study was to describe the effects of the new thermostable formulation of Flolan on health-related quality of life (HRQoL) and ease of administration in subjects switching from the currently marketed Flolan to the reformulated product. Methods Following a 4-week run-in period and after 4 weeks of treatment with the reformulated product, patients completed the SF-36 HRQoL questionnaire and a study-specific questionnaire evaluating ease of administration, along with World Health Organization (WHO) functional class, six-minute walked distance (6MWD) and N-terminal-pro B-type natriuretic peptide (NT-proBNP) assessment. Results 16 participants completed the study. The SF-36 scores remained unchanged from baseline to Week 4. Conversely, there were small improvements for the majority of the study-specific questionnaire items and 14 (88%) subjects preferred the reformulated product to the currently marketed Flolan. There was no significant change in the dose of reformulated product, 6MWD, Borg dyspnoea index, WHO functional class and mean NT-proBNP levels. No significant changes in haemodynamic parameters were seen from baseline to 2 hours post transition in a subset of patients undergoing catheterization. Conclusion The reformulated product was not associated with significant improvement in HRQoL compared with the currently marketed Flolan as measured by the SF-36. However, most subjects preferred the reformulated product to the currently marketed Flolan. Moreover, the 2 formulations of Flolan had similar safety and efficacy profiles.	[Provencher, Steeve] Univ Laval, Inst Univ Cardiol & Pneumol Quebec, Ctr Rech, Pulm Hypertens Res Grp, Quebec City, PQ, Canada; [Paruchuru, Patrap; Spezzi, Andrea; Waterhouse, Brian] GlaxoSmithKline R&D, Brentford, Middx, England; [Gomberg-Maitland, Mardi] Univ Chicago, Med Ctr, Chicago, IL 60637 USA	Laval University; GlaxoSmithKline; University of Chicago; University of Chicago Medical Center	Provencher, S (corresponding author), Univ Laval, Inst Univ Cardiol & Pneumol Quebec, Ctr Rech, Pulm Hypertens Res Grp, Quebec City, PQ, Canada.	Steve.provencher@criucpq.ulaval.ca	Waterhouse, Brian/GRJ-6738-2022; Gomberg-Maitland, Mardi/N-7158-2019		Actelion; Bayer; Merck; Pfizer; Glaxo Smith Kline; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000430] Funding Source: NIH RePORTER	Actelion; Bayer(Bayer AG); Merck(Merck & Company); Pfizer(Pfizer); Glaxo Smith Kline(GlaxoSmithKline); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	SP is a research scholar of the Fonds de Recherche en Sante du Quebec and as received speaker fees from Actelion, consultant fees from Actelion, Bayer, Merck and Pfizer, and research grant from Actelion, Bayer and Glaxo Smith Kline. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barst RJ, 1996, NEW ENGL J MED, V334, P296, DOI 10.1056/NEJM199602013340504; BORG GAV, 1982, MED SCI SPORT EXER, V14, P377, DOI 10.1249/00005768-198205000-00012; Crapo RO, 2002, AM J RESP CRIT CARE, V166, P111, DOI 10.1164/rccm.166/1/111; DALONZO GE, 1991, ANN INTERN MED, V115, P343, DOI 10.7326/0003-4819-115-5-343; Galie N, 2009, EUR HEART J, V30, P2493, DOI 10.1093/eurheartj/ehp297; Gomberg-Maitland M, 2008, EUR RESPIR J, V31, P891, DOI 10.1183/09031936.00097107; Humbert M, 2004, NEW ENGL J MED, V351, P1425, DOI 10.1056/NEJMra040291; McLaughlin VV, 2002, CIRCULATION, V106, P1477, DOI 10.1161/01.CIR.0000029100.82385.58; Rich S, 1999, J AM COLL CARDIOL, V34, P1184, DOI 10.1016/S0735-1097(99)00320-4; Rubin LJ, 1997, NEW ENGL J MED, V336, P111, DOI 10.1056/NEJM199701093360207; Shafazand S, 2004, CHEST, V126, P1452, DOI 10.1378/chest.126.5.1452; Sitbon O, 2002, J AM COLL CARDIOL, V40, P780, DOI 10.1016/S0735-1097(02)02012-0; Taichman DB, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-92; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002	14	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0120657	10.1371/journal.pone.0120657	http://dx.doi.org/10.1371/journal.pone.0120657			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25793960	Green Submitted, Green Published, gold			2022-12-27	WOS:000352083900063
J	Reveles, KR; Juday, TR; Labreche, MJ; Mortensen, EM; Koeller, JM; Seekins, D; Oramasionwu, CU; Bollinger, M; Copeland, LA; Jones, X; Frei, CR				Reveles, Kelly R.; Juday, Timothy R.; Labreche, Matthew J.; Mortensen, Eric M.; Koeller, Jim M.; Seekins, Daniel; Oramasionwu, Christine U.; Bollinger, Mary; Copeland, Laurel A.; Jones, Xavier; Frei, Christopher R.			Comparative Value of Four Measures of Retention in Expert Care in Predicting Clinical Outcomes and Health Care Utilization in HIV Patients	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; VETERANS-AFFAIRS; LIFETIME COST; UNITED-STATES; ENGAGEMENT; MORTALITY; ADHERENCE; ASSOCIATION; SERVICES; VISITS	This study compared the ability of four measures of patient retention in HIV expert care to predict clinical outcomes. This retrospective study examined Veterans Health Administration (VHA) beneficiaries with HIV (ICD-9-CM codes 042 or V08) receiving expert care (defined as HIV-1 RNA viral load and CD4 cell count tests occurring within one week of each other) at VHA facilities from October 1, 2006, to September 30, 2008. Patients were >= 18 years old and continuous VHA users for at least 24 months after entry into expert care. Retention measures included: Annual Appointments (>= 2 appointments annually at least 60 days apart), Missed Appointments (missed >= 25% of appointments), Infrequent Appointments (> 6 months without an appointment), and Missed or Infrequent Appointments (missed >= 25% of appointments or > 6 months without an appointment). Multivariable nominal logistic regression models were used to determine associations between retention measures and outcomes. Overall, 8,845 patients met study criteria. At baseline, 64% of patients were virologically suppressed and 37% had a CD4 cell count > 500 cells/mm(3). At 24 months, 82% were virologically suppressed and 46% had a CD4 cell count > 500 cells/mm(3). During follow-up, 13% progressed to AIDS, 48% visited the emergency department (ED), 28% were hospitalized, and 0.3% died. All four retention measures were associated with virologic suppression and antiretroviral therapy initiation at 24 months follow-up. Annual Appointments correlated positively with CD4 cell count > 500 cells/mm(3). Missed Appointments was predictive of all primary and secondary outcomes, including CD4 cell count <= 500 cells/mm(3), progression to AIDS, ED visit, and hospitalization. Missed Appointments was the only measure to predict all primary and secondary outcomes. This finding could be useful to health care providers and public health organizations as they seek ways to optimize the health of HIV patients.	[Reveles, Kelly R.; Koeller, Jim M.; Frei, Christopher R.] Univ Texas Austin, Austin, TX 78712 USA; [Reveles, Kelly R.; Koeller, Jim M.; Frei, Christopher R.] Univ Texas Hlth Sci Ctr San Antonio, San Antonio, TX 78229 USA; [Juday, Timothy R.; Seekins, Daniel] Bristol Myers Squibb Co, Plainsboro, NJ USA; [Labreche, Matthew J.] Johns Hopkins Univ Hosp, Baltimore, MD 21287 USA; [Mortensen, Eric M.] VA North Texas Hlth Care Syst, Dallas, TX USA; [Mortensen, Eric M.] Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA; [Oramasionwu, Christine U.] Univ N Carolina, Chapel Hill, NC USA; [Bollinger, Mary; Jones, Xavier] South Texas Vet Hlth Care Syst, San Antonio, TX USA; [Copeland, Laurel A.] Cent Texas Vet Hlth Care Syst, Temple, TX USA; [Copeland, Laurel A.] Scott & White Healthcare, Ctr Appl Hlth Res, Temple, TX USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Health San Antonio; Bristol-Myers Squibb; Johns Hopkins University; Johns Hopkins Medicine; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA North Texas Health Care System; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of North Carolina; University of North Carolina Chapel Hill; US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital	Frei, CR (corresponding author), Univ Texas Austin, Austin, TX 78712 USA.	freic@uthscsa.edu	Reveles, Kelly/AAI-1575-2021; Frei, Christopher/AAI-1421-2020; Copeland, Laurel A/C-3763-2017; Mortensen, Eric/AAF-2713-2020	Frei, Christopher/0000-0002-0692-4787; Copeland, Laurel A/0000-0002-9478-0209; Mortensen, Eric/0000-0002-3880-5563	Bristol-Myers Squibb Company, Plainsboro, NJ; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001120, TL1TR001119] Funding Source: NIH RePORTER	Bristol-Myers Squibb Company, Plainsboro, NJ(Bristol-Myers Squibb); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported by Bristol-Myers Squibb Company, Plainsboro, NJ (http://www.bms.com/pages/default.aspx). The funders assisted with the study design and preparation of the manuscript. This work was partially supported with the resources of the Department of Veterans Affairs. The views are those of the authors and do not necessarily reflect the views of the Department of Veterans Affairs.	[Anonymous], 2011, GUID US ANT AG HIV 1, P1; Berg MB, 2005, AIDS CARE, V17, P902, DOI 10.1080/09540120500101658; Braithwaite RS, 2007, AIDS, V21, P1579, DOI 10.1097/QAD.0b013e3281532b31; Centers for Disease Control and Prevention, 2011, HIV SURV REP; Chalker John, 2008, J Int Assoc Physicians AIDS Care (Chic), V7, P193, DOI 10.1177/1545109708320687; Chi BH, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001111; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Gardner EM, 2011, CLIN INFECT DIS, V52, P793, DOI 10.1093/cid/ciq243; Giordano TP, 2007, CLIN INFECT DIS, V44, P1493, DOI 10.1086/516778; Giordano TP, 2003, JAIDS-J ACQ IMM DEF, V32, P399, DOI 10.1097/00126334-200304010-00009; HELLINGER FJ, 1993, JAMA-J AM MED ASSOC, V270, P474, DOI 10.1001/jama.270.4.474; Hellinger FJ, 2010, PHARMACOECONOMICS, V28, P23, DOI 10.2165/11313810-000000000-00000; Horberg MA, 2010, CLIN INFECT DIS, V51, P732, DOI 10.1086/655893; Horstmann E, 2010, CLIN INFECT DIS, V50, P752, DOI 10.1086/649933; Kazis LE, 1998, ARCH INTERN MED, V158, P626, DOI 10.1001/archinte.158.6.626; Kposowa AJ, 2013, INT J INFECT DIS, V17, pE868, DOI 10.1016/j.ijid.2013.02.018; Lau B, 2007, JAIDS-J ACQ IMM DEF, V44, P179, DOI 10.1097/01.qai.0000247229.68246.c5; Lo W, 2002, AIDS CARE, V14, pS45, DOI 10.1080/0954012022014992049984; Lucas GM, 1999, ANN INTERN MED, V131, P81, DOI 10.7326/0003-4819-131-2-199907200-00002; Martin Leslie R, 2005, Ther Clin Risk Manag, V1, P189; McGuire M, 2010, TROP MED INT HEALTH, V15, P55, DOI 10.1111/j.1365-3156.2010.02504.x; Meditz AL, 2011, J INFECT DIS, V203, P442, DOI 10.1093/infdis/jiq085; Miller CJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095061; Moore RD, 2007, CLIN INFECT DIS, V44, P441, DOI 10.1086/510746; Morgan RO, 2005, HEALTH SERV RES, V40, P1573, DOI 10.1111/j.1475-6773.2005.00448.x; Motto JA, 2001, PSYCHIATR SERV, V52, P828, DOI 10.1176/appi.ps.52.6.828; Mugavero MJ, 2013, CLIN INFECT DIS, V57, P1164, DOI 10.1093/cid/cit420; Mugavero MJ, 2012, JAIDS-J ACQ IMM DEF, V61, P574, DOI 10.1097/QAI.0b013e318273762f; Mugavero MJ, 2012, JAIDS-J ACQ IMM DEF, V59, P86, DOI 10.1097/QAI.0b013e318236f7d2; Mugavero MJ, 2010, AIDS PATIENT CARE ST, V24, P607, DOI 10.1089/apc.2010.0086; Mugavero MJ, 2009, CLIN INFECT DIS, V48, P248, DOI 10.1086/595705; Panel on opportunistic infections in HIV-infected adults and adolescents, GUID PREV TREATM OPP; Park WB, 2007, J INTERN MED, V261, P268, DOI 10.1111/j.1365-2796.2006.01762.x; Park WB, 2008, INT J STD AIDS, V19, P125, DOI 10.1258/ijsa.2007.007101; Pugh MJV, 2005, EPILEPSIA, V46, P1820, DOI 10.1111/j.1528-1167.2005.00291.x; Rich ML, 2012, JAIDS-J ACQ IMM DEF, V59, pE35, DOI 10.1097/QAI.0b013e31824476c4; Rintamaki LS, 2006, AIDS PATIENT CARE ST, V20, P359, DOI 10.1089/apc.2006.20.359; Rodriguez-Penney AT, 2013, AIDS PATIENT CARE ST, V27, P5, DOI 10.1089/apc.2012.0329; Rosen S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001056; Schackman BR, 2006, MED CARE, V44, P990, DOI 10.1097/01.mlr.0000228021.89490.2a; Schneeweiss S, 2001, AM J EPIDEMIOL, V154, P854, DOI 10.1093/aje/154.9.854; Schneider Eileen, 2008, Morbidity and Mortality Weekly Report, V57, P1; Sethi AK, 2003, CLIN INFECT DIS, V37, P1112, DOI 10.1086/378301; Shen YJ, 2003, MED CARE RES REV, V60, P253, DOI 10.1177/1077558703060002007; Yehia BR, 2012, AIDS, V26, P1131, DOI 10.1097/QAD.0b013e3283528afa	45	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0120953	10.1371/journal.pone.0120953	http://dx.doi.org/10.1371/journal.pone.0120953			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CE8HY	25794182	Green Published, gold, Green Submitted			2022-12-27	WOS:000352083900092
J	Roth, VN; Dittmar, T; Gaupp, R; Gleixner, G				Roth, Vanessa-Nina; Dittmar, Thorsten; Gaupp, Reinhard; Gleixner, Gerd			The Molecular Composition of Dissolved Organic Matter in Forest Soils as a Function of pH and Temperature	PLOS ONE			English	Article							RESOLUTION MASS-SPECTROMETRY; SIZE CLASSES; FAGUS-SYLVATICA; CARBON-CYCLE; FULVIC-ACIDS; DOM; ECOSYSTEM; SPECTRA; MARINE; RIVER	We examined the molecular composition of forest soil water during three different seasons at three different sites, using electrospray ionization Fourier transform ion cyclotron resonance mass spectrometry (ESI-FT-ICR-MS). We examined oxic soils and tested the hypothesis that pH and season correlate with the molecular composition of dissolved organic matter (DOM). We used molecular formulae and their relative intensity from ESI-FT-ICR-MS for statistical analysis. Applying unconstrained and constrained ordination methods, we observed that pH, dissolved organic carbon (DOC) concentration and season were the main factors correlating with DOM molecular composition. This result is consistent with a previous study where pH was a main driver of the molecular differences between DOM from oxic rivers and anoxic bog systems in the Yenisei River catchment. At a higher pH, the molecular formulae had a lower degree of unsaturation and oxygenation, lower molecular size and a higher abundance of nitrogen-containing compounds. These characteristics suggest a higher abundance of tannin connected to lower pH that possibly inhibited biological decomposition. Higher biological activity at a higher pH might also be related to the higher abundance of nitrogen-containing compounds. Comparing the seasons, we observed a decrease in unsaturation, molecular diversity and the number of nitrogen-containing compounds in the course of the year from March to November. Temperature possibly inhibited biological degradation during winter, which could cause the accumulation of a more diverse compound spectrum until the temperature increased again. Our findings suggest that the molecular composition of DOM in soil pore waters is dynamic and a function of ecosystem activity, pH and temperature.	[Roth, Vanessa-Nina; Gleixner, Gerd] Max Planck Inst Biogeochem, D-07745 Jena, Germany; [Dittmar, Thorsten] Carl von Ossietzky Univ Oldenburg, Inst Chem & Biol Marine Environm ICBM, Res Grp Marine Geochem ICBM, MPI Bridging Grp, D-26111 Oldenburg, Germany; [Gaupp, Reinhard] Univ Jena, Inst Geosci, Jena, Germany	Max Planck Society; Carl von Ossietzky Universitat Oldenburg; Friedrich Schiller University of Jena	Roth, VN (corresponding author), Max Planck Inst Biogeochem, D-07745 Jena, Germany.	vroth@bgc-jena.mpg.de	Dittmar, Thorsten/L-7796-2013; Gleixner, Gerd/O-4215-2019; Gleixner, Gerd/M-8519-2017	Dittmar, Thorsten/0000-0002-3462-0107; Gleixner, Gerd/0000-0002-4616-0953; Gleixner, Gerd/0000-0002-4616-0953	Deutsche Forschungsgemeinschaft [GRK 1257, SFB 1076]; Max Planck Society; foundation "Zwillenberg-Tietz Stiftung"	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Max Planck Society(Max Planck Society); foundation "Zwillenberg-Tietz Stiftung"	VNR was funded by the Deutsche Forschungsgemeinschaft (http://www.dfg.de/) as part of GRK 1257 Alteration and Element Mobility at the Microbe-Mineral Interface as well as SFB 1076 AquaDiva with support from the Max Planck Society. Since October 2014 Vanessa-Nina Roth also receives funding from the foundation "Zwillenberg-Tietz Stiftung" which is located in Germany and promotes science and research especially in the field of nature conservation. More information can be found at http://www.zwillenberg-tietz-stiftung.de/, unfortunately only in German. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamczyk B, 2011, SOIL BIOL BIOCHEM, V43, P628, DOI 10.1016/j.soilbio.2010.11.034; Amon RMW, 2004, MAR CHEM, V92, P311, DOI 10.1016/j.marchem.2004.06.034; Amon RMW, 1996, LIMNOL OCEANOGR, V41, P41, DOI 10.4319/lo.1996.41.1.0041; AZAM F, 1983, MAR ECOL PROG SER, V10, P257, DOI 10.3354/meps010257; Battin TJ, 2009, NAT GEOSCI, V2, P598, DOI 10.1038/ngeo618; Bussotti F, 1998, NEW PHYTOL, V138, P469, DOI 10.1046/j.1469-8137.1998.00121.x; Chanton JP, 2008, GLOBAL BIOGEOCHEM CY, V22, DOI 10.1029/2008GB003274; Cole JJ, 2007, ECOSYSTEMS, V10, P171, DOI 10.1007/s10021-006-9013-8; D'Andrilli J, 2010, ORG GEOCHEM, V41, P791, DOI 10.1016/j.orggeochem.2010.05.009; Dittmar T, 2008, LIMNOL OCEANOGR-METH, V6, P230, DOI 10.4319/lom.2008.6.230; Fenchel T, 2008, J EXP MAR BIOL ECOL, V366, P99, DOI 10.1016/j.jembe.2008.07.013; Flerus R, 2012, BIOGEOSCIENCES, V9, P1935, DOI 10.5194/bg-9-1935-2012; Freeman C, 2001, NATURE, V409, P149, DOI 10.1038/35051650; Gleixner G, 1999, RAPID COMMUN MASS SP, V13, P1278, DOI 10.1002/(SICI)1097-0231(19990715)13:13<1278::AID-RCM649>3.0.CO;2-N; Gleixner G, 2002, ORG GEOCHEM, V33, P357, DOI 10.1016/S0146-6380(01)00166-8; Gleixner G, 2009, ECOL STUD-ANAL SYNTH, V207, P231, DOI 10.1007/978-3-540-92706-8_11; Green NW, 2014, MAR CHEM, V161, P14, DOI 10.1016/j.marchem.2014.01.012; Hedges J.I., 2011, BIOGEOCHEMISTRY OF M, P1; Hedges JI, 1997, ORG GEOCHEM, V27, P195, DOI 10.1016/S0146-6380(97)00066-1; Hernes PJ, 2003, J GEOPHYS RES-OCEANS, V108, DOI 10.1029/2002JC001421; Hertkorn N, 2007, ANAL BIOANAL CHEM, V389, P1311, DOI 10.1007/s00216-007-1577-4; Herzsprung P, 2012, ENVIRON SCI TECHNOL, V46, P5511, DOI 10.1021/es300345c; Huguet A, 2010, ORG GEOCHEM, V41, P595, DOI 10.1016/j.orggeochem.2010.02.006; Jaffe R, 2012, GEOCHIM COSMOCHIM AC, V94, P95, DOI 10.1016/j.gca.2012.06.031; Kaiser K, 2001, BIOGEOCHEMISTRY, V55, P103, DOI 10.1023/A:1010694032121; Kaiser K, 2012, SOIL BIOL BIOCHEM, V52, P29, DOI 10.1016/j.soilbio.2012.04.002; Kim S, 2006, INT J MASS SPECTROM, V251, P260, DOI 10.1016/j.ijms.2006.02.001; Kim S, 2003, ANAL CHEM, V75, P5336, DOI 10.1021/ac034415p; Kindler R, 2011, GLOBAL CHANGE BIOL, V17, P1167, DOI 10.1111/j.1365-2486.2010.02282.x; Kisand V, 2008, AQUAT MICROB ECOL, V53, P151, DOI 10.3354/ame01240; Knicker H, 1997, EUR J SOIL SCI, V48, P431, DOI 10.1046/j.1365-2389.1997.00093.x; Knohl A, 2003, AGR FOREST METEOROL, V118, P151, DOI 10.1016/S0168-1923(03)00115-1; Koch BP, 2006, RAPID COMMUN MASS SP, V20, P926, DOI 10.1002/rcm.2386; Koch BP, 2005, GEOCHIM COSMOCHIM AC, V69, P3299, DOI 10.1016/j.gca.2005.02.027; Kraus TEC, 2003, PLANT SOIL, V256, P41, DOI 10.1023/A:1026206511084; Kujawinski EB, 2004, MAR CHEM, V92, P23, DOI 10.1016/j.marchem.2004.06.038; Landry C, 2012, ENVIRON SCI TECHNOL, V46, P1700, DOI 10.1021/es203711v; Lechtenfeld OJ, 2013, MAR CHEM, V150, P25, DOI 10.1016/j.marchem.2013.01.006; Legendre P, 2008, J PLANT ECOL, V1, P3, DOI 10.1093/jpe/rtm001; Leps J., 2003, MULTIVARIATE ANALYSI; Malik A, 2013, FEMS MICROBIOL ECOL, V86, P139, DOI 10.1111/1574-6941.12182; Malik A, 2012, ENVIRON SCI TECHNOL, V46, P10123, DOI 10.1021/es302467y; MCKNIGHT DM, 1991, LIMNOL OCEANOGR, V36, P998, DOI 10.4319/lo.1991.36.5.0998; Michalzik B, 1999, EUR J SOIL SCI, V50, P579, DOI 10.1046/j.1365-2389.1999.00267.x; Minor EC, 2012, ORG GEOCHEM, V43, P1, DOI 10.1016/j.orggeochem.2011.11.007; Moore PD, 2002, ENVIRON CONSERV, V29, P3, DOI 10.1017/S0376892902000024; Moyano FE, 2008, AGR FOREST METEOROL, V148, P135, DOI 10.1016/j.agrformet.2007.09.006; Nebbioso A, 2013, ANAL BIOANAL CHEM, V405, P109, DOI 10.1007/s00216-012-6363-2; Ohno T, 2010, ENVIRON SCI TECHNOL, V44, P8594, DOI 10.1021/es101089t; POMEROY LR, 1974, BIOSCIENCE, V24, P499, DOI 10.2307/1296885; Reemtsma T, 2009, J CHROMATOGR A, V1216, P3687, DOI 10.1016/j.chroma.2009.02.033; Riedel T, 2014, ANAL CHEM, V86, P8376, DOI 10.1021/ac501946m; Riedel T, 2012, ENVIRON SCI TECHNOL, V46, P4419, DOI 10.1021/es203901u; Roth VN, 2013, GEOCHIM COSMOCHIM AC, V123, P93, DOI 10.1016/j.gca.2013.09.002; Sachse D, 2009, ORG GEOCHEM, V40, P732, DOI 10.1016/j.orggeochem.2009.02.008; Schmidt MWI, 2011, NATURE, V478, P49, DOI 10.1038/nature10386; Schulze WX, 2005, OECOLOGIA, V142, P335, DOI 10.1007/s00442-004-1698-9; Seidel M, 2014, GEOCHIM COSMOCHIM AC, V140, P418, DOI 10.1016/j.gca.2014.05.038; Sleighter RL, 2008, MAR CHEM, V110, P140, DOI 10.1016/j.marchem.2008.04.008; Sleighter RL, 2007, J MASS SPECTROM, V42, P559, DOI 10.1002/jms.1221; Sleighter RL, 2010, ENVIRON SCI TECHNOL, V44, P7576, DOI 10.1021/es1002204; Smolander A, 2005, SOIL BIOL BIOCHEM, V37, P1309, DOI 10.1016/j.soilbio.2004.12.002; Smolander A, 2012, PLANT SOIL, V350, P1, DOI 10.1007/s11104-011-0895-7; Soule MCK, 2010, ORG GEOCHEM, V41, P725, DOI 10.1016/j.orggeochem.2010.05.017; Steinbeiss S, 2008, SOIL BIOL BIOCHEM, V40, P2634, DOI 10.1016/j.soilbio.2008.07.007; Stenson AC, 2003, ANAL CHEM, V75, P1275, DOI 10.1021/ac026106p; Strobel BW, 2001, BIOGEOCHEMISTRY, V56, P1, DOI 10.1023/A:1011934929379; Stubbins A, 2010, LIMNOL OCEANOGR, V55, P1467, DOI 10.4319/lo.2010.55.4.1467; Tefs C, 2012, FOREST ECOL MANAG, V263, P131, DOI 10.1016/j.foreco.2011.09.010; Tfaily MM, 2013, GEOCHIM COSMOCHIM AC, V112, P116, DOI 10.1016/j.gca.2013.03.002; Thoss V, 2004, PLANT SOIL, V259, P355, DOI 10.1023/B:PLSO.0000020984.17403.82; Thurman EM., 1985, DEVELOPMENTS IN BIOG, V2	72	58	62	11	160	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0119188	10.1371/journal.pone.0119188	http://dx.doi.org/10.1371/journal.pone.0119188			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25793306	Green Published, Green Submitted, gold			2022-12-27	WOS:000352084200059
J	Shivanandan, A; Unnikrishnan, J; Radenovic, A				Shivanandan, Arun; Unnikrishnan, Jayakrishnan; Radenovic, Aleksandra			Accounting for Limited Detection Efficiency and Localization Precision in Cluster Analysis in Single Molecule Localization Microscopy	PLOS ONE			English	Article							RESOLUTION	Single Molecule Localization Microscopy techniques like PhotoActivated Localization Microscopy, with their sub-diffraction limit spatial resolution, have been popularly used to characterize the spatial organization of membrane proteins, by means of quantitative cluster analysis. However, such quantitative studies remain challenged by the techniques' inherent sources of errors such as a limited detection efficiency of less than 60%, due to incomplete photo-conversion, and a limited localization precision in the range of 10 - 30nm, varying across the detected molecules, mainly depending on the number of photons collected from each. We provide analytical methods to estimate the effect of these errors in cluster analysis and to correct for them. These methods, based on the Ripley's L(r) - r or Pair Correlation Function popularly used by the community, can facilitate potentially breakthrough results in quantitative biology by providing a more accurate and precise quantification of protein spatial organization.	[Shivanandan, Arun; Radenovic, Aleksandra] Ecole Polytech Fed Lausanne, Inst Bioengn, Lab Nanoscale Biol, CH-1015 Lausanne, Switzerland; [Unnikrishnan, Jayakrishnan] Ecole Polytech Fed Lausanne, Sch Comp & Commun Sci, Audiovisual Commun Lab, CH-1015 Lausanne, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Radenovic, A (corresponding author), Ecole Polytech Fed Lausanne, Inst Bioengn, Lab Nanoscale Biol, CH-1015 Lausanne, Switzerland.	aleksandra.radenovic@epfl.ch	Radenovic, Aleksandra/AAZ-5582-2021; Radenovic, Aleksandra/C-5350-2011	Radenovic, Aleksandra/0000-0001-8194-2785; Unnikrishnan, Jayakrishnan/0000-0002-8464-4641	Swiss National Competence Center for Biomedical Imaging PhD fellowship; ERC Advanced Grant-SPARSAM [247006]; FNS [200021-125319, 200021-132206]	Swiss National Competence Center for Biomedical Imaging PhD fellowship; ERC Advanced Grant-SPARSAM; FNS(Swiss National Science Foundation (SNSF))	AS was funded by a Swiss National Competence Center for Biomedical Imaging PhD fellowship. JU was supported by the ERC Advanced Grant-SPARSAM No. 247006. AR acknowledges financial support by FNS grants No. 200021-125319 and No. 200021-132206. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annibale P., 2012, OPT NANOSCOPY, V1, P1, DOI DOI 10.1186/2192-2853-1-9; Annibale P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022678; Annibale P, 2011, NAT METHODS, V8, P527, DOI 10.1038/nmeth.1627; Baddeley A., 2008, ANAL SPATIAL POINT P, P171; Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344; Deschout H, 2014, HISTOCHEM CELL BIOL, V142, P5, DOI 10.1007/s00418-014-1217-y; Durisic N, 2014, NAT METHODS, V11, P156, DOI [10.1038/NMETH.2784, 10.1038/nmeth.2784]; Engelhardt J, 2011, NANO LETT, V11, P209, DOI 10.1021/nl103472b; Ester M., 1996, KDD-96 Proceedings. Second International Conference on Knowledge Discovery and Data Mining, P226; Hartman NC, 2011, CURR OPIN CELL BIOL, V23, P370, DOI 10.1016/j.ceb.2011.05.003; Hess ST, 2006, BIOPHYS J, V91, P4258, DOI 10.1529/biophysj.106.091116; Kiskowski MA, 2009, BIOPHYS J, V97, P1095, DOI 10.1016/j.bpj.2009.05.039; Lang T, 2010, PHYSIOLOGY, V25, P116, DOI 10.1152/physiol.00044.2009; Lee SH, 2012, P NATL ACAD SCI USA, V109, P17436, DOI 10.1073/pnas.1215175109; Lillemeier BF, 2010, NAT IMMUNOL, V11, P90, DOI 10.1038/ni.1832; Lillemeier BF, 2006, P NATL ACAD SCI USA, V103, P18992, DOI 10.1073/pnas.0609009103; Moller J., 2003, STAT INFERENCE SIMUL; Mortensen KI, 2010, NAT METHODS, V7, P377, DOI [10.1038/nmeth.1447, 10.1038/NMETH.1447]; Nan XL, 2013, P NATL ACAD SCI USA, V110, P18519, DOI 10.1073/pnas.1318188110; Pertsinidis A, 2013, P NATL ACAD SCI USA, V110, pE2812, DOI 10.1073/pnas.1310654110; Rust MJ, 2006, NAT METHODS, V3, P793, DOI 10.1038/nmeth929; Scarselli M, 2012, J BIOL CHEM, V287, P16768, DOI 10.1074/jbc.M111.329912; Sengupta P, 2011, NAT METHODS, V8, P969, DOI [10.1038/nmeth.1704, 10.1038/NMETH.1704]; Shivanandan A, 2014, FEBS LETT, V588, P3595, DOI 10.1016/j.febslet.2014.06.014; Sieber JJ, 2007, SCIENCE, V317, P1072, DOI 10.1126/science.1141727; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Stallinga S, 2010, OPT EXPRESS, V18, P24461, DOI 10.1364/OE.18.024461; Thompson RE, 2002, BIOPHYS J, V82, P2775, DOI 10.1016/S0006-3495(02)75618-X; Williamson DJ, 2011, NAT IMMUNOL, V12, P655, DOI 10.1038/ni.2049	29	10	10	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0118767	10.1371/journal.pone.0118767	http://dx.doi.org/10.1371/journal.pone.0118767			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25794150	Green Published, gold, Green Submitted			2022-12-27	WOS:000352084200039
J	Sortica, DA; Buffon, MP; Souza, BM; Nicoletto, BB; Santer, A; Assmann, TS; Crispim, D; Canani, LH				Sortica, Denise Alves; Buffon, Marjorie Piucco; Souza, Bianca Marmontel; Nicoletto, Bruna Bellicanta; Santer, Andressa; Assmann, Tais Silveira; Crispim, Daisy; Canani, Luis Henrique			Association between the ENPP1 K121Q Polymorphism and Risk of Diabetic Kidney Disease: A Systematic Review and Meta-Analysis	PLOS ONE			English	Article							MEMBRANE GLYCOPROTEIN PC-1; STAGE RENAL-DISEASE; RECEPTOR TYROSINE-KINASE; GENOME-WIDE SEARCH; ACID VARIANT K121Q; INSULIN-RESISTANCE; LINKAGE SCAN; PYROPHOSPHATASE/PHOSPHODIESTERASE-1 GENE; NONDIABETIC SUBJECTS; SKELETAL-MUSCLE	The potential association between the K121Q (A/C, rs1044498) polymorphism in the ectonucleotide pyrophosphatase/phosphodiesterase (ENPP1) gene and risk of diabetic kidney disease (DKD) has been investigated. Nevertheless, the effect of this variant on DKD risk is still under debate, and conflicting results have been reported. To this date, no meta-analysis has evaluated the association of the K121Q polymorphism with DKD. This paper describes the first meta-analysis conducted to evaluate whether the ENPP1K121Q polymorphism is associated with DKD. A literature search was conducted to identify all case-control or cross-sectional studies that evaluated associations between the ENPP1K121Q polymorphism and DKD. Pooled odds ratios (OR) and 95% confidence intervals (95% CI) were calculated for allele contrast, additive, dominant and recessive inheritance models. Seven studies were eligible for inclusion in the meta-analysis, providing data on 3571 type 1 or type 2 diabetic patients (1606 cases with DKD and 1965 diabetic controls without this complication). No significant heterogeneity was observed among the studies included in the meta-analysis when assuming different inheritance models (I-2 < 50% or P > 0.10 for the entire sample and after stratification by ethnicity). Meta-analysis results revealed significant associations between the K121Q polymorphism and risk of DKD in Asians and Europeans when assuming the different inheritance models analyzed. The most powerful association was observed for the additive model (OR = 1.74, 95% CI 1.27-2.38 for the total sample). In conclusion, the present meta-analysis detected a significant association between the ENPP1 K121Q polymorphism and increased susceptibility of DKD in European and Asian populations.	[Sortica, Denise Alves; Buffon, Marjorie Piucco; Souza, Bianca Marmontel; Nicoletto, Bruna Bellicanta; Santer, Andressa; Assmann, Tais Silveira; Crispim, Daisy; Canani, Luis Henrique] Hosp Clin Porto Alegre, Div Endocrine, Porto Alegre, RS, Brazil; [Sortica, Denise Alves; Buffon, Marjorie Piucco; Souza, Bianca Marmontel; Nicoletto, Bruna Bellicanta; Assmann, Tais Silveira; Crispim, Daisy; Canani, Luis Henrique] Univ Fed Rio Grande do Sul, Postgrad Program Med Sci Endocrinol, Porto Alegre, RS, Brazil	Universidade Federal do Rio Grande do Sul	Canani, LH (corresponding author), Hosp Clin Porto Alegre, Div Endocrine, Porto Alegre, RS, Brazil.	luishenriquecanani@gmail.com	Assmann, Tais/AAC-4026-2020; Canani, Luis H/G-9686-2012; Crispim, Daisy/R-5170-2019	Canani, Luis H/0000-0002-1813-4491; Crispim, Daisy/0000-0001-5095-9269; Assmann, Tais/0000-0001-9114-8243	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul (FAPERGS); Fundo de Incentivo a Pesquisa e Eventos (FIPE) at the Hospital de Clinicas de Porto Alegre; CNPq	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul (FAPERGS)(Fundacao de Amparo a Ciencia e Tecnologia do Estado do Rio Grande do Sul (FAPERGS)); Fundo de Incentivo a Pesquisa e Eventos (FIPE) at the Hospital de Clinicas de Porto Alegre; CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This study was supported by grants from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul (FAPERGS) and Fundo de Incentivo a Pesquisa e Eventos (FIPE) at the Hospital de Clinicas de Porto Alegre. D.C. and L.H.C. are recipients of scholarships from CNPq. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abate N, 2000, J DIABETES COMPLICAT, V14, P154, DOI 10.1016/S1056-8727(00)00067-2; Abate N, 2005, DIABETES, V54, P1207, DOI 10.2337/diabetes.54.4.1207; Amer Diabet Assoc, 2012, DIABETES CARE, V35, pS64, DOI [10.2337/dc12-S064, 10.2337/dc09-S062, 10.2337/dc11-S011]; Arar NH, 2008, NEPHROL DIAL TRANSPL, V23, P3184, DOI 10.1093/ndt/gfn215; Bacci S, 2005, DIABETES, V54, P3021, DOI 10.2337/diabetes.54.10.3021; Berhouma R, 2012, HUM BIOL, V84, P423, DOI 10.3378/027.084.0405; Bollen M, 2000, CRIT REV BIOCHEM MOL, V35, P393, DOI 10.1080/10409230091169249; Boucas AP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083451; Brondani LA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096411; BUCKLEY MF, 1990, J BIOL CHEM, V265, P17506; Canani LH, 2002, DIABETES, V51, P1188, DOI 10.2337/diabetes.51.4.1188; Carpena MP, 2010, ARQ BRAS ENDOCRINOL, V54, P253, DOI 10.1590/S0004-27302010000300002; Chen GJ, 2007, AM J KIDNEY DIS, V49, P394, DOI 10.1053/j.ajkd.2006.12.011; Chen J, 2012, ENDOCRINE, V42, P307, DOI 10.1007/s12020-012-9643-x; Craig DW, 2009, DIABETIC MED, V26, P1090, DOI 10.1111/j.1464-5491.2009.02846.x; De Cosmo S, 2000, DIABETES, V49, P521, DOI 10.2337/diabetes.49.3.521; De Cosmo S, 2013, NEPHROL DIAL TRANSPL, V28, P29, DOI 10.1093/ndt/gfs290; De Cosmo S, 2009, AM J KIDNEY DIS, V53, P273, DOI 10.1053/j.ajkd.2008.07.040; de Souza BM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054259; Freedman BI, 2007, CLIN J AM SOC NEPHRO, V2, P1306, DOI 10.2215/CJN.02560607; Freedman BI, 2005, NEPHROL DIAL TRANSPL, V20, P712, DOI 10.1093/ndt/gfh704; Frittitta L, 1996, DIABETOLOGIA, V39, P1190, DOI 10.1007/BF02658505; Frittitta L, 1998, DIABETES, V47, P1095, DOI 10.2337/diabetes.47.7.1095; Frittitta L, 1997, DIABETOLOGIA, V40, P282, DOI 10.1007/s001250050675; Goding JW, 1998, IMMUNOL REV, V161, P5, DOI 10.1111/j.1600-065X.1998.tb01567.x; Grarup N, 2006, DIABETOLOGIA, V49, P2097, DOI 10.1007/s00125-006-0353-x; Gu HF, 2000, DIABETES, V49, P1601, DOI 10.2337/diabetes.49.9.1601; Higgins JPT, 2002, INT J EPIDEMIOL, V31, P96, DOI 10.1093/ije/31.1.96; Igo RP, 2011, AM J NEPHROL, V33, P381, DOI 10.1159/000326763; Jacobsen P, 2002, NEPHROL DIAL TRANSPL, V17, P1408, DOI 10.1093/ndt/17.8.1408; Kao WHL, 2008, NAT GENET, V40, P1185, DOI 10.1038/ng.232; Keene KL, 2008, DIABETES, V57, P1057, DOI 10.2337/db07-0886; Keshavarz P, 2006, J HUM GENET, V51, P559, DOI 10.1007/s10038-006-0399-0; Krolewski AS, 2006, KIDNEY INT, V69, P129, DOI 10.1038/sj.ki.5000023; Leitao CB, 2008, BRAZ J MED BIOL RES, V41, P229, DOI 10.1590/S0100-879X2006005000202; Levin A, 2013, KIDNEY INT SUPPL, V3, P5, DOI 10.1038/kisup.2012.77; Li YY, 2012, METABOLISM, V61, P625, DOI 10.1016/j.metabol.2011.10.002; Lin CC, 2011, GENET TEST MOL BIOMA, V15, P239, DOI 10.1089/gtmb.2010.0148; MacIsaac RJ, 2014, AM J KIDNEY DIS, V63, pS39, DOI 10.1053/j.ajkd.2013.10.048; Maddux BA, 2006, AM J PHYSIOL-ENDOC M, V290, pE746, DOI 10.1152/ajpendo.00298.2005; MADDUX BA, 1995, NATURE, V373, P448, DOI 10.1038/373448a0; Maddux BA, 2000, DIABETES, V49, P13, DOI 10.2337/diabetes.49.1.13; McAteer JB, 2008, DIABETES, V57, P1125, DOI 10.2337/db07-1336; McFarlane SI, 2001, J CLIN ENDOCR METAB, V86, P713, DOI 10.1210/jc.86.2.713; Meyre D, 2005, NAT GENET, V37, P863, DOI 10.1038/ng1604; Mima A, 2013, J DIABETES RES, V2013, DOI 10.1155/2013/248563; Minelli C, 2005, INT J EPIDEMIOL, V34, P1319, DOI 10.1093/ije/dyi169; Moher D, 2009, ANN INTERN MED, V151, P264, DOI 10.7326/0003-4819-151-4-200908180-00135; Mooyaart AL, 2011, DIABETOLOGIA, V54, P544, DOI 10.1007/s00125-010-1996-1; Murea M, 2011, AM J NEPHROL, V33, P502, DOI 10.1159/000327985; Palmer ND, 2012, CURR DIABETES REP, V12, P423, DOI 10.1007/s11892-012-0279-2; Pizzuti A, 1999, DIABETES, V48, P1881, DOI 10.2337/diabetes.48.9.1881; Rogus JJ, 2008, DIABETES, V57, P2519, DOI 10.2337/db07-1086; Schelling JR, 2008, DIABETES, V57, P235, DOI 10.2337/db07-0313; Sortica DA, 2011, ARQ BRAS ENDOCRINOL, V55, P677, DOI 10.1590/S0004-27302011000900002; Stang A, 2010, EUR J EPIDEMIOL, V25, P603, DOI 10.1007/s10654-010-9491-z; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Tarnow L, 2001, NEPHROL DIAL TRANSPL, V16, P1653, DOI 10.1093/ndt/16.8.1653; Thomas MC, 2012, CURR OPIN NEPHROL HY, V21, P195, DOI 10.1097/MNH.0b013e328350313e; Wang Min, 2010, Yichuan, V32, P808, DOI 10.3724/SP.J.1005.2010.00808; Weedon MN, 2006, DIABETES, V55, P3175, DOI 10.2337/db06-0410; Whiting DR, 2011, DIABETES RES CLIN PR, V94, P311, DOI 10.1016/j.diabres.2011.10.029; Wu LSH, 2009, NEPHROL DIAL TRANSPL, V24, P3360, DOI 10.1093/ndt/gfp271; Youngren JF, 1996, DIABETES, V45, P1324, DOI 10.2337/diabetes.45.10.1324; Zhao T, 2011, J HUM GENET, V56, P12, DOI 10.1038/jhg.2010.124; Zhou HH, 2009, EUR J PHARMACOL, V616, P346, DOI 10.1016/j.ejphar.2009.06.057	66	11	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0118416	10.1371/journal.pone.0118416	http://dx.doi.org/10.1371/journal.pone.0118416			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25794151	Green Published, gold, Green Submitted			2022-12-27	WOS:000352084200022
J	Gustafson, MP; Lin, Y; Maas, ML; Van Keulen, VP; Johnston, PB; Peikert, T; Gastineau, DA; Dietz, AB				Gustafson, Michael P.; Lin, Yi; Maas, Mary L.; Van Keulen, Virginia P.; Johnston, Patrick B.; Peikert, Tobias; Gastineau, Dennis A.; Dietz, Allan B.			A Method for Identification and Analysis of Non-Overlapping Myeloid Immunophenotypes in Humans	PLOS ONE			English	Article							SUPPRESSOR-CELLS; HUMAN BASOPHILS; CD14(+)HLA-DRLO/NEG MONOCYTES; GRANULOCYTES; NEUTROPHILS; CANCER; BLOOD; EXPRESSION	The development of flow cytometric biomarkers in human studies and clinical trials has been slowed by inconsistent sample processing, use of cell surface markers, and reporting of immunophenotypes. Additionally, the function(s) of distinct cell types as biomarkers cannot be accurately defined without the proper identification of homogeneous populations. As such, we developed a method for the identification and analysis of human leukocyte populations by the use of eight 10-color flow cytometric protocols in combination with novel software analyses. This method utilizes un-manipulated biological sample preparation that allows for the direct quantitation of leukocytes and non-overlapping immunophenotypes. We specifically designed myeloid protocols that enable us to define distinct phenotypes that include mature monocytes, granulocytes, circulating dendritic cells, immature myeloid cells, and myeloid derived suppressor cells (MDSCs). We also identified CD123 as an additional distinguishing marker for the phenotypic characterization of immature LIN-CD33(+)HLA-DR-MDSCs. Our approach permits the comprehensive analysis of all peripheral blood leukocytes and yields data that is highly amenable for standardization across inter-laboratory comparisons for human studies.	[Gustafson, Michael P.; Maas, Mary L.; Gastineau, Dennis A.; Dietz, Allan B.] Mayo Clin, Dept Lab Med & Pathol, Div Transfus Med, Human Cellular Therapy Lab, Rochester, MN 55905 USA; [Lin, Yi; Johnston, Patrick B.; Gastineau, Dennis A.] Mayo Clin, Div Hematol, Dept Med, Rochester, MN USA; [Van Keulen, Virginia P.] Mayo Clin, Dept Immunol, Rochester, MN USA; [Peikert, Tobias] Mayo Clin, Pulm & Crit Care Med, Rochester, MN USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic	Dietz, AB (corresponding author), Mayo Clin, Dept Lab Med & Pathol, Div Transfus Med, Human Cellular Therapy Lab, Rochester, MN 55905 USA.	dietz.allan@mayo.edu	Gustafson, Michael P./H-4056-2011; Dietz, Allan B/H-7414-2015; Lin, Yi/K-1510-2013; Dietz, Allan/AAI-6976-2021	Gustafson, Michael P./0000-0002-5514-7072; Dietz, Allan B/0000-0003-3410-9621; Dietz, Allan/0000-0003-3410-9621; Lin, Yi/0000-0002-1556-6416	Henry J. Predolin Foundation; University of Iowa/Mayo Clinic Lymphoma Specialized Program of Research Excellence (SPORE) [CA090628]; Mayo Clinic Cancer Center; Mayo Clinic Center for Individualized Medicine; Mayo Clinic Center for Regenerative Medicine; NATIONAL CANCER INSTITUTE [K12CA090628, K23CA159391] Funding Source: NIH RePORTER	Henry J. Predolin Foundation; University of Iowa/Mayo Clinic Lymphoma Specialized Program of Research Excellence (SPORE); Mayo Clinic Cancer Center; Mayo Clinic Center for Individualized Medicine; Mayo Clinic Center for Regenerative Medicine; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work is supported by the Henry J. Predolin Foundation, University of Iowa/Mayo Clinic Lymphoma Specialized Program of Research Excellence (SPORE, number CA090628), Mayo Clinic Cancer Center, the Mayo Clinic Center for Individualized Medicine and the Mayo Clinic Center for Regenerative Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almand B, 2001, J IMMUNOL, V166, P678, DOI 10.4049/jimmunol.166.1.678; Brandau S, 2013, SEMIN CANCER BIOL, V23, P171, DOI 10.1016/j.semcancer.2013.02.007; Brandau S, 2013, SEMIN IMMUNOPATHOL, V35, P163, DOI 10.1007/s00281-012-0344-6; Buhring HJ, 1999, BLOOD, V94, P2343; Chavan R, 2014, CANCER IMMUNOL RES, V2, P241, DOI 10.1158/2326-6066.CIR-13-0094; De Palma M, 2013, CANCER CELL, V23, P277, DOI 10.1016/j.ccr.2013.02.013; Duffy A, 2013, CANCER IMMUNOL IMMUN, V62, P299, DOI 10.1007/s00262-012-1332-3; Dumitru CA, 2012, CANCER IMMUNOL IMMUN, V61, P1155, DOI 10.1007/s00262-012-1294-5; Gabrilovich DI, 2007, CANCER RES, V67, P425, DOI 10.1158/0008-5472.CAN-06-3037; Gabrilovich DI, 2012, NAT REV IMMUNOL, V12, P253, DOI 10.1038/nri3175; Gustafson MP, 2013, J IMMUNOTHER CANCER, V1, DOI 10.1186/2051-1426-1-7; Gustafson' MP, 2014, J IMMUNOTHER CANCER, V2, DOI 10.1186/2051-1426-2-18; Gustafson MP, 2012, BRIT J HAEMATOL, V156, P674, DOI 10.1111/j.1365-2141.2011.08902.x; Gustafson MP, 2010, NEURO-ONCOLOGY, V12, P631, DOI 10.1093/neuonc/noq001; Laborde RR, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00147; Lee JA, 2008, CYTOM PART A, V73A, P926, DOI 10.1002/cyto.a.20623; Lin Y, 2011, BLOOD, V117, P872, DOI 10.1182/blood-2010-05-283820; MacDonald KPA, 2002, BLOOD, V100, P4512, DOI 10.1182/blood-2001-11-0097; Meknache N, 2009, J IMMUNOL, V182, P2542, DOI 10.4049/jimmunol.0801665; Munder M, 2005, BLOOD, V105, P2549, DOI 10.1182/blood-2004-07-2521; Nakayama F, 2001, J BIOL CHEM, V276, P16100, DOI 10.1074/jbc.M007272200; Poschke I, 2012, CLIN IMMUNOL, V144, P250, DOI 10.1016/j.clim.2012.06.003; Robbins SH, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r17; Talmadge JE, 2013, NAT REV CANCER, V13, P739, DOI 10.1038/nrc3581; Toba K, 1999, CYTOMETRY, V35, P249, DOI 10.1002/(SICI)1097-0320(19990301)35:3<249::AID-CYTO8>3.3.CO;2-F; Vantourout P, 2013, NAT REV IMMUNOL, V13, P88, DOI 10.1038/nri3384; Vuk-Pavlovic S, 2010, PROSTATE, V70, P443, DOI 10.1002/pros.21078; Wagner C, 2003, SHOCK, V19, P5, DOI 10.1097/00024382-200301000-00002; Ziegler-Heitbrock L, 2010, BLOOD, V116, pE74, DOI 10.1182/blood-2010-02-258558	29	76	77	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0121546	10.1371/journal.pone.0121546	http://dx.doi.org/10.1371/journal.pone.0121546			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25799053	Green Published, Green Submitted, gold			2022-12-27	WOS:000351987300266
J	Leibold, S; Hammerschmidt, M				Leibold, Sandra; Hammerschmidt, Matthias			Long-Term Hyperphagia and Caloric Restriction Caused by Low- or High-Density Husbandry Have Differential Effects on Zebrafish Postembryonic Development, Somatic Growth, Fat Accumulation and Reproduction	PLOS ONE			English	Article							MELANOCYTE-STIMULATING HORMONE; DIET-INDUCED OBESITY; CORTICOTROPIN-RELEASING HORMONE; NON-SHIVERING THERMOGENESIS; FASTING-INDUCED SUPPRESSION; BETA-ENDORPHIN-LIKE; ENERGY DENSITY; NEUROPEPTIDE-Y; ADIPOSE-TISSUE; ANIMAL-MODELS	In recent years, the zebrafish (Danio rerio) has emerged as an alternative vertebrate model for energy homeostasis and metabolic diseases, including obesity and anorexia. It has been shown that diet-induced obesity (DIO) in zebrafish shares multiple pathophysiological features with obesity in mammals. However, a systematic and comprehensive analysis of the different pathways of energy expenditure in obese and starved fish had been missing thus far. Here, we carry out long-term ad libitum feeding (hyperphagia) and caloric restriction studies induced by low-or high-density husbandry, respectively, to investigate the impact of caloric intake on the timing of scale formation, a crucial step of postembryonic development and metamorphosis, and on somatic growth, body weight, fat storage and female reproduction. We show that all of them are positively affected by increased caloric intake, that middle-aged fish develop severe DIO, and that the body mass index (BMI) displays a strict linear correlation with whole-body triglyceride levels in adult zebrafish. Interestingly, juvenile fish are largely resistant to DIO, while BMI and triglyceride values drop in aged fish, pointing to aging-associated anorexic effects. Histological analyses further indicate that increased fat storage in white adipose tissue involves both hyperplasia and hypertrophy of adipocytes. Furthermore, in ovaries, caloric intake primarily affects the rate of oocyte growth, rather than total oocyte numbers. Finally, comparing the different pathways of energy expenditure with each other, we demonstrate that they are differentially affected by caloric restriction / high-density husbandry. In juvenile fish, scale formation is prioritized over somatic growth, while in sexually mature adults, female reproduction is prioritized over somatic growth, and somatic growth over fat storage. Our data will serve as a template for future functional studies to dissect the neuroendocrine regulators of energy homeostasis mediating differential energy allocation.	[Leibold, Sandra; Hammerschmidt, Matthias] Univ Cologne, Inst Dev Biol, D-50931 Cologne, Germany; [Leibold, Sandra; Hammerschmidt, Matthias] Univ Cologne, Cologne Excellence Cluster Cellular Stress Respon, D-50931 Cologne, Germany; [Hammerschmidt, Matthias] Univ Cologne, CMMC, D-50931 Cologne, Germany	University of Cologne; University of Cologne; University of Cologne	Hammerschmidt, M (corresponding author), Univ Cologne, Inst Dev Biol, D-50931 Cologne, Germany.	mhammers@uni-koeln.de			German Research Foundation (DFG; CECAD); European Union (Seventh Framework Programme, Integrated Project ZF-HEALTH, EC Grant) [HEATH-F4-2010-242048]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063904] Funding Source: NIH RePORTER	German Research Foundation (DFG; CECAD)(German Research Foundation (DFG)); European Union (Seventh Framework Programme, Integrated Project ZF-HEALTH, EC Grant); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Work was supported by the German Research Foundation (DFG; CECAD) and the European Union (Seventh Framework Programme, Integrated Project ZF-HEALTH, EC Grant agreement HEATH-F4-2010-242048). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS EF, 1987, ACTA ENDOCRINOL-COP, V115, P149, DOI 10.1530/acta.0.1150149; Ali S, 2014, GERONTOLOGY, V60, P294, DOI 10.1159/000356760; Almind K, 2004, DIABETES, V53, P3274, DOI 10.2337/diabetes.53.12.3274; ANGEL A, 1974, J LIPID RES, V15, P491; Arble DM, 2009, OBESITY, V17, P2100, DOI 10.1038/oby.2009.264; Balen Adam H, 2007, Hum Fertil (Camb), V10, P195, DOI 10.1080/14647270701731290; Belgardt BF, 2010, P NATL ACAD SCI USA, V107, P6028, DOI 10.1073/pnas.1001796107; Bessesen DH, 2008, J CLIN ENDOCR METAB, V93, P2027, DOI 10.1210/jc.2008-0520; Biga PR, 2006, AM J PHYSIOL-REG I, V291, pR1327, DOI 10.1152/ajpregu.00905.2005; BOISSONNEAULT GA, 1978, P SOC EXP BIOL MED, V157, P402, DOI 10.3181/00379727-157-40063; Brand M., 2002, ZEBRAFISH PRACTICAL; Bray GA, 1998, AM J CLIN NUTR, V68, P1157, DOI 10.1093/ajcn/68.6.1157; Bray George A., 1997, Human Reproduction (Oxford), V12, P26; BRAZEAU P, 1973, SCIENCE, V179, P77, DOI 10.1126/science.179.4068.77; Broberger C, 1998, P NATL ACAD SCI USA, V95, P15043, DOI 10.1073/pnas.95.25.15043; BRONSON FH, 1984, BIOL REPROD, V31, P83, DOI 10.1095/biolreprod31.1.83; Calle EE, 2003, NEW ENGL J MED, V348, P1625, DOI 10.1056/NEJMoa021423; Carroll KK, 1998, LIPIDS, V33, P1055, DOI 10.1007/s11745-998-0305-8; Casper RC, 2008, PSYCHOPHARMACOLOGY, V199, P313, DOI 10.1007/s00213-008-1102-2; Chapman IM, 2007, CLIN GERIATR MED, V23, P735, DOI 10.1016/j.cger.2007.06.001; Chu CY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036474; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; Collins S, 2004, PHYSIOL BEHAV, V81, P243, DOI 10.1016/j.physbeh.2004.02.006; Cone RD, 2005, NAT NEUROSCI, V8, P571, DOI 10.1038/nn1455; Danielsen ET, 2013, CURR TOP DEV BIOL, V105, P37, DOI 10.1016/B978-0-12-396968-2.00002-6; DeLaurier A, 2010, GENESIS, V48, P505, DOI 10.1002/dvg.20639; Desai M, 2013, CURR DIABETES REP, V13, P27, DOI 10.1007/s11892-012-0344-x; Deshpande P.A., 2013, INT J CURR RES, V5, P1565; DESPRES JP, 1989, CLIN INVEST MED, V12, P374; Farooqi IS, 2003, NEW ENGL J MED, V348, P1085, DOI 10.1056/NEJMoa022050; FEINGOLD KR, 1984, DIABETOLOGIA, V26, P234; Fekete C, 2000, NEUROSCI LETT, V289, P152, DOI 10.1016/S0304-3940(00)01256-8; Fekete C, 2002, ENDOCRINOLOGY, V143, P3846, DOI 10.1210/en.2002-220338; Fekete C, 2000, J NEUROSCI, V20, P1550; FENTON PF, 1953, J NUTR, V49, P319, DOI 10.1093/jn/49.2.319; Fernald RD, 1999, FRONT NEUROENDOCRIN, V20, P224, DOI 10.1006/frne.1999.0181; Filby AL, 2010, PHYSIOL BEHAV, V101, P576, DOI 10.1016/j.physbeh.2010.09.004; Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5; Flynn EJ, 2009, J LIPID RES, V50, P1641, DOI 10.1194/jlr.M800590-JLR200; GANTZ I, 1993, J BIOL CHEM, V268, P15174; GANTZ I, 1993, J BIOL CHEM, V268, P8246; Gardner DS, 2009, PHILOS T R SOC B, V364, P3419, DOI 10.1098/rstb.2009.0121; Girardet C, 2014, BBA-MOL BASIS DIS, V1842, P482, DOI 10.1016/j.bbadis.2013.05.004; Goolish EM, 1998, PROG FISH CULT, V60, P127, DOI 10.1577/1548-8640(1998)060&lt;0127:CVRFRO&gt;2.0.CO;2; Gorissen M, 2009, J ENDOCRINOL, V201, P329, DOI 10.1677/JOE-09-0034; Guh DP, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-88; Han JC, 2010, LANCET, V375, P1737, DOI 10.1016/S0140-6736(10)60171-7; Hariri N, 2010, NUTR RES REV, V23, P270, DOI 10.1017/S0954422410000168; Hasty AH, 2001, J BIOL CHEM, V276, P37402, DOI 10.1074/jbc.M010176200; Hasumura T, 2012, NUTR METAB, V9, DOI 10.1186/1743-7075-9-73; Heinrichs SC, 1999, NEUROPEPTIDES, V33, P350, DOI 10.1054/npep.1999.0047; Heisler LK, 2006, NEURON, V51, P239, DOI 10.1016/j.neuron.2006.06.004; HERBERG L, 1974, J LIPID RES, V15, P580; Hill JO, 2000, J NUTR, V130, p284S, DOI 10.1093/jn/130.2.284S; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; HUMMEL KP, 1966, SCIENCE, V153, P1127, DOI 10.1126/science.153.3740.1127; Huszar D, 1997, CELL, V88, P131, DOI 10.1016/S0092-8674(00)81865-6; Imrie D, 2010, DEV DYNAM, V239, P3013, DOI 10.1002/dvdy.22443; INGALLS AM, 1950, J HERED, V41, P317, DOI 10.1093/oxfordjournals.jhered.a106073; Irani BG, 2005, BIOCHEM BIOPH RES CO, V326, P638, DOI 10.1016/j.bbrc.2004.11.084; Israel D, 2010, TRENDS ENDOCRIN MET, V21, P10, DOI 10.1016/j.tem.2009.07.004; Israel DD, 2012, ENDOCRINOLOGY, V153, P2408, DOI 10.1210/en.2011-1822; Jensen TK, 2004, FERTIL STERIL, V82, P863, DOI 10.1016/j.fertnstert.2004.03.056; Jo J, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000324; Jones KS, 2008, NUTR METAB, V5, DOI 10.1186/1743-7075-5-23; Jungheim ES, 2010, ENDOCRINOLOGY, V151, P4039, DOI 10.1210/en.2010-0098; Kaplowitz PB, 2008, PEDIATRICS, V121, pS208, DOI 10.1542/peds.2007-1813F; Karanth S, 2013, DIS MODEL MECH, V6, P1365, DOI 10.1242/dmm.013425; Kim MS, 2000, J CLIN INVEST, V105, P1005, DOI 10.1172/JCI8857; Kishi S, 2003, EXP GERONTOL, V38, P777, DOI 10.1016/S0531-5565(03)00108-6; Klapper W, 1998, FEBS LETT, V434, P409, DOI 10.1016/S0014-5793(98)01020-5; KRAUSE BR, 1984, J LIPID RES, V25, P97; Lai Shih-Wei, 2001, Yale Journal of Biology and Medicine, V74, P205; Lawrence C, 2012, LAB ANIMAL, V41, P158, DOI 10.1038/laban0612-158; Lessman CA, 2009, GEN COMP ENDOCR, V161, P53, DOI 10.1016/j.ygcen.2008.11.004; Levine JA, 2002, BEST PRACT RES CL EN, V16, P679, DOI 10.1053/beem.2002.0227; LIOTTA AS, 1980, P NATL ACAD SCI-BIOL, V77, P1880, DOI 10.1073/pnas.77.4.1880; LIOTTA AS, 1984, J NEUROSCI, V4, P956; Liu HY, 2003, J NEUROSCI, V23, P7143, DOI 10.1523/JNEUROSCI.23-18-07143.2003; Lohr H, 2011, ANNU REV PHYSIOL, V73, P183, DOI 10.1146/annurev-physiol-012110-142320; Lu XY, 2003, J NEUROSCI, V23, P7863; Lucas J, 2014, J FISH BIOL, V84, P1171, DOI 10.1111/jfb.12306; MABEE TM, 1976, SURGERY, V79, P460; Martinelli CE, 2011, J CLIN ENDOCR METAB, V96, pE181, DOI 10.1210/jc.2010-1369; McMenamin SK, 2013, ENDOCRINOLOGY, V154, P1476, DOI 10.1210/en.2012-1734; McMenamin SK, 2013, CURR TOP DEV BIOL, V103, P127, DOI 10.1016/B978-0-12-385979-2.00005-8; MCMURRAY RG, 1995, INT J OBESITY, V19, P881; MCNAB BK, 1963, AM NAT, V97, P133, DOI 10.1086/282264; Meguro S, 2013, NUTR METAB, V10, DOI 10.1186/1743-7075-10-61; Michalakis K, 2013, METABOLISM, V62, P1341, DOI 10.1016/j.metabol.2013.05.019; MIETTINEN TA, 1971, CIRCULATION, V44, P842, DOI 10.1161/01.CIR.44.5.842; Mukhi S, 2007, GEN COMP ENDOCR, V150, P486, DOI 10.1016/j.ygcen.2006.11.013; NIIMI M, 1989, PEPTIDES, V10, P605, DOI 10.1016/0196-9781(89)90150-2; NISHINA PM, 1994, METABOLISM, V43, P549, DOI 10.1016/0026-0495(94)90194-5; Nishio SI, 2008, DEV DYNAM, V237, P1682, DOI 10.1002/dvdy.21559; Oka Takehiko, 2010, BMC Physiol, V10, P21, DOI 10.1186/1472-6793-10-21; Parichy DM, 2009, DEV DYNAM, V238, P2975, DOI 10.1002/dvdy.22113; Parichy DM, 2003, DEV BIOL, V256, P242, DOI 10.1016/S0012-1606(03)00015-0; Pasquali R, 2003, HUM REPROD UPDATE, V9, P359, DOI 10.1093/humupd/dmg024; Patino R, 2002, FISH PHYSIOL BIOCHEM, V26, P57, DOI 10.1023/A:1023311613987; Pavlidis M, 2013, ZEBRAFISH, V10, P524, DOI 10.1089/zeb.2012.0819; Poppitt SD, 1996, APPETITE, V26, P153, DOI 10.1006/appe.1996.0013; Power D. M., 2008, P607; Raguso CA, 2006, CLIN NUTR, V25, P573, DOI 10.1016/j.clnu.2005.10.013; Ramsay JM, 2006, AQUACULTURE, V258, P565, DOI 10.1016/j.aquaculture.2006.04.020; RIVEST S, 1989, AM J PHYSIOL, V257, pR1417, DOI 10.1152/ajpregu.1989.257.6.R1417; Roa J, 2012, ENDOCRINOLOGY, V153, P5587, DOI 10.1210/en.2012-1470; Rolls BJ, 1999, AM J CLIN NUTR, V69, P863; Rosen ED, 2006, NATURE, V444, P847, DOI 10.1038/nature05483; Sarkar S, 2002, BRAIN RES, V945, P50, DOI 10.1016/S0006-8993(02)02619-7; Schlegel A, 2007, PLOS GENET, V3, P2037, DOI 10.1371/journal.pgen.0030199; Schrauwen P, 2000, BRIT J NUTR, V84, P417, DOI 10.1017/S0007114500001720; Scully T, 2014, NATURE, V508, pS50, DOI 10.1038/508S50a; Seli E, 2014, MOL ENDOCRINOL, V28, P790, DOI 10.1210/me.2013-1413; SELMAN K, 1993, J MORPHOL, V218, P203, DOI 10.1002/jmor.1052180209; Seth A, 2013, DIS MODEL MECH, V6, P1080, DOI 10.1242/dmm.011346; SHAH M, 1988, EUR J CLIN NUTR, V42, P455; Sharma AM, 2005, ACTA DIABETOL, V42, pS3, DOI 10.1007/s00592-005-0175-1; Sire JY, 2004, INT J DEV BIOL, V48, P233, DOI 10.1387/ijdb.15272389; Sire JY, 1997, J ANAT, V190, P545, DOI 10.1046/j.1469-7580.1997.19040545.x; Smith JV, 2004, CURR OPIN CLIN NUTR, V7, P615, DOI 10.1097/00075197-200411000-00005; Soenen S, 2013, J AM MED DIR ASSOC, V14, P642, DOI 10.1016/j.jamda.2013.02.004; Song Y, 2003, ENDOCRINE, V22, P257, DOI 10.1385/ENDO:22:3:257; Song Y, 2007, FASEB J, V21, P2042, DOI 10.1096/fj.06-7503com; SPADY DK, 1983, J LIPID RES, V24, P303; Speakman J, 2007, OBES REV, V8, P55, DOI 10.1111/j.1467-789X.2007.00319.x; STEINBERG MD, 1962, J PEDIATR-US, V61, P299, DOI 10.1016/S0022-3476(62)80282-0; Stuart JA, 1999, BBA-BIOENERGETICS, V1413, P50, DOI 10.1016/S0005-2728(99)00081-X; Stubbs RJ, 2004, PHYSIOL BEHAV, V81, P755, DOI 10.1016/j.physbeh.2004.04.027; SURWIT RS, 1988, DIABETES, V37, P1163, DOI 10.2337/diabetes.37.9.1163; Tainaka T, 2011, NUTR METAB, V8, DOI 10.1186/1743-7075-8-88; TANNENBAUM GS, 1984, ENDOCRINOLOGY, V115, P1952, DOI 10.1210/endo-115-5-1952; Tao YX, 2010, METHOD ENZYMOL, V484, P267, DOI [10.1016/S0076-6879(10)84014-5, 10.1016/B978-0-12-381298-8.00014-9]; Tchkonia T, 2010, AGING CELL, V9, P667, DOI 10.1111/j.1474-9726.2010.00608.x; TRAYHURN P, 1978, PFLUG ARCH EUR J PHY, V373, P189, DOI 10.1007/BF00584859; TRAYHURN P, 1979, PFLUG ARCH EUR J PHY, V380, P227, DOI 10.1007/BF00582901; Tsai SB, 2007, AGING CELL, V6, P209, DOI 10.1111/j.1474-9726.2007.00278.x; Tseng YC, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0018180, 10.1371/journal.pone.0024057]; TULLIS A, 1991, J EXP BIOL, V161, P383; Turley ML, 1998, EUR J CLIN NUTR, V52, P728, DOI 10.1038/sj.ejcn.1600634; Ussher JR, 2010, DIABETES, V59, P2453, DOI 10.2337/db09-1293; Varga ZM, 2011, METHOD CELL BIOL, V104, P453, DOI 10.1016/B978-0-12-374814-0.00024-0; Vella KR, 2011, CELL METAB, V14, P780, DOI 10.1016/j.cmet.2011.10.009; Vijgen GHEJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017247; Visser M, 2003, J APPL PHYSIOL, V94, P2368, DOI 10.1152/japplphysiol.00124.2002; Warne JP, 2013, TRENDS ENDOCRIN MET, V24, P68, DOI 10.1016/j.tem.2012.10.005; Watanobe H, 1999, BIOCHEM BIOPH RES CO, V257, P860, DOI 10.1006/bbrc.1999.0547; WEST DB, 1992, AM J PHYSIOL, V262, pR1025, DOI 10.1152/ajpregu.1992.262.6.R1025; Wu KK, 2005, ATHEROSCLEROSIS, V181, P251, DOI 10.1016/j.atherosclerosis.2005.01.029; Yang ZY, 2013, MATERN CHILD NUTR, V9, P105, DOI 10.1111/mcn.12010; Yaswen L, 1999, NAT MED, V5, P1066, DOI 10.1038/12506; Yoshizaki G, 2002, FISH PHYSIOL BIOCHEM, V26, P3, DOI 10.1023/A:1023388317621; Zhang C, 2012, CELL METAB, V15, P256, DOI 10.1016/j.cmet.2011.12.014	153	26	27	3	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0120776	10.1371/journal.pone.0120776	http://dx.doi.org/10.1371/journal.pone.0120776			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25799180	Green Published, Green Submitted, gold			2022-12-27	WOS:000351987300176
J	Lin, JC; Peng, YJ; Wang, SY; Young, TH; Salter, DM; Lee, HS				Lin, Jung-Chun; Peng, Yi-Jen; Wang, Shih-Yu; Young, Ton-Ho; Salter, Donald M.; Lee, Herng-Sheng			Role of the Sympathetic Nervous System in Carbon Tetrachloride-Induced Hepatotoxicity and Systemic Inflammation	PLOS ONE			English	Article							INDUCED LIVER-INJURY; CHEMICAL SYMPATHECTOMY; LIPID-PEROXIDATION; HEPATIC STEATOSIS; INDUCED APOPTOSIS; IMMUNE-RESPONSES; OXIDATIVE STRESS; GENE-EXPRESSION; KUPFFER CELLS; DENERVATION	Carbon tetrachloride (CCl4) is widely used as an animal model of hepatotoxicity and the mechanisms have been arduously studied, however, the contribution of the sympathetic nervous system (SNS) in CCl4-induced acute hepatotoxicity remains controversial. It is also known that either CCl4 or SNS can affect systemic inflammatory responses. The aim of this study was to establish the effect of chemical sympathectomy with 6-hydroxydopamine (6-OHDA) in a mouse model of CCl4-induced acute hepatotoxicity and systemic inflammatory response. Mice exposed to CCl4 or vehicle were pretreated with 6-OHDA or saline. The serum levels of aminotransferases and alkaline phosphatase in the CCl4-poisoning mice with sympathetic denervation were significantly lower than those without sympathetic denervation. With sympathetic denervation, hepatocellular necrosis and fat infiltration induced by CCl4 were greatly decreased. Sympathetic denervation significantly attenuated CCl4-induced lipid peroxidation in liver and serum. Acute CCl4 intoxication showed increased expression of inflammatory cytokines/chemokines [eotaxin-2/CCL24, Fas ligand, interleukin (IL)-1 alpha, IL-6, IL-12p40p70, monocyte chemoattractant protein-1 (MCP-1/CCL2), and tumor necrosis factor-alpha (TNF-alpha)], as well as decreased expression of granulocyte colony-stimulating factor and keratinocyte-derived chemokine. The overexpressed levels of IL-1 alpha, IL-6, IL-12p40p70, MCP-1/CCL2, and TNF-alpha were attenuated by sympathetic denervation. Pretreatment with dexamethasone significantly reduced CCl4-induced hepatic injury. Collectively, this study demonstrates that the SNS plays an important role in CCl4-induced acute hepatotoxicity and systemic inflammation and the effect may be connected with chemicalor drug-induced hepatotoxicity and circulating immune response.	[Lin, Jung-Chun; Peng, Yi-Jen; Lee, Herng-Sheng] Natl Def Med Ctr, Grad Inst Med Sci, Taipei, Taiwan; [Lin, Jung-Chun] Triserv Gen Hosp, Natl Def Med Ctr, Dept Internal Med, Div Gastroenterol & Hepatol, Taipei, Taiwan; [Peng, Yi-Jen; Wang, Shih-Yu; Lee, Herng-Sheng] Triserv Gen Hosp, Natl Def Med Ctr, Dept Pathol, Taipei, Taiwan; [Wang, Shih-Yu; Lee, Herng-Sheng] Kaohsiung Vet Gen Hosp, Dept Pathol & Lab Med, Kaohsiung, Taiwan; [Young, Ton-Ho] Fu Jen Catholic Univ, Cardinal Tien Hosp, Dept Internal Med, Div Gastroenterol, Taipei 231, Taiwan; [Salter, Donald M.] Univ Edinburgh, MRC IGMM, Ctr Mol Med, Edinburgh, Midlothian, Scotland	National Defense Medical Center; National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center; Tri-Service General Hospital; Kaohsiung Veterans General Hospital; Fu Jen Catholic University; University of Edinburgh	Lee, HS (corresponding author), Natl Def Med Ctr, Grad Inst Med Sci, Taipei, Taiwan.	herngsheng131419@gmail.com	Peng, Yi-Jen/X-9124-2019	Peng, Yi-Jen/0000-0003-4630-2103	National Science Council, Taiwan [NSC100-2320-B-016-006-MY3]; Department of Medical Research of Cardinal Tien Hospital, Taiwan [CTH-103-1-2C04]; National Defense Medical Center, Tri-Service General Hospital, Taiwan [TSGH-C102-069, TSGH-C103-078, TSGH-C103-080, TSGH-C104-175]; Ministry of National Defense Medical Affairs Bureau [MAB-103-066, MAB-104-089]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); Department of Medical Research of Cardinal Tien Hospital, Taiwan; National Defense Medical Center, Tri-Service General Hospital, Taiwan; Ministry of National Defense Medical Affairs Bureau	This study was supported in part by grants from the National Science Council, Taiwan (NSC100-2320-B-016-006-MY3); Department of Medical Research of Cardinal Tien Hospital, Taiwan (CTH-103-1-2C04); National Defense Medical Center, Tri-Service General Hospital, Taiwan (TSGH-C102-069, TSGH-C103-078, TSGH-C103-080, and TSGH-C104-175); and Ministry of National Defense Medical Affairs Bureau (MAB-103-066 and MAB-104-089). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aninat C, 2008, CRIT CARE MED, V36, P848, DOI 10.1097/CCM.0B013E31816532BE; ARMBRUST T, 1995, BIOCHEM BIOPH RES CO, V207, P637, DOI 10.1006/bbrc.1995.1235; Boll M, 2001, Z NATURFORSCH C, V56, P111; Cailotto C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005650; Callahan TA, 2002, BRAIN BEHAV IMMUN, V16, P764, DOI 10.1016/S0889-1591(02)00029-6; CALVERT DN, 1960, AM J PHYSIOL, V198, P669, DOI 10.1152/ajplegacy.1960.198.3.669; Chan CC, 2014, J GASTROEN HEPATOL, V29, P603, DOI 10.1111/jgh.12366; Chida Y, 2005, GUT, V54, P994, DOI 10.1136/gut.2004.058818; Dubuisson L, 2002, HEPATOLOGY, V35, P325, DOI 10.1053/jhep.2002.31166; Duval C, 2010, DIABETES, V59, P3181, DOI 10.2337/db10-0224; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Gewiese-Rabsch J, 2010, BBA-MOL BASIS DIS, V1802, P1054, DOI 10.1016/j.bbadis.2010.07.023; Grebe KM, 2010, J IMMUNOL, V184, P540, DOI 10.4049/jimmunol.0903395; Grebe KM, 2009, P NATL ACAD SCI USA, V106, P5300, DOI 10.1073/pnas.0808851106; HAGLUND O, 1991, J NUTR, V121, P165, DOI 10.1093/jn/121.2.165; Hamasaki K, 2001, J GASTROENTEROL, V36, P111, DOI 10.1007/s005350170139; Hasko G, 1998, BIOCHEM PHARMACOL, V56, P1079, DOI 10.1016/S0006-2952(98)00153-1; Hiramoto T, 2008, GASTROENTEROLOGY, V134, P2122, DOI 10.1053/j.gastro.2008.03.005; HOLMIN T, 1984, EUR SURG RES, V16, P288, DOI 10.1159/000128421; ISHII K, 1992, J AUTONOM NERV SYST, V39, P13, DOI 10.1016/0165-1838(92)90246-D; Jaruga B, 2003, J IMMUNOL, V171, P3233, DOI 10.4049/jimmunol.171.6.3233; Jensen KJ, 2013, COMPR PHYSIOL, V3, P655, DOI 10.1002/cphy.c120018; Joers V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104850; JUDAH JD, 1959, FED PROC, V18, P1013; Kaiser JP, 2012, INT J TOXICOL, V31, P551, DOI 10.1177/1091581812466418; Kamari Y, 2011, J HEPATOL, V55, P1086, DOI 10.1016/j.jhep.2011.01.048; KAMINSKI NE, 1989, FUND APPL TOXICOL, V12, P117, DOI 10.1016/0272-0590(89)90067-5; Knockaert L, 2012, LAB INVEST, V92, P396, DOI 10.1038/labinvest.2011.193; Kremer M, 2010, HEPATOLOGY, V51, P130, DOI 10.1002/hep.23292; KRUSZEWSKA B, 1995, J IMMUNOL, V155, P4613; Kulcsar-Gergely J, 1973, Toxicology, V1, P125, DOI 10.1016/0300-483X(73)90024-3; LARSON RE, 1964, P SOC EXP BIOL MED, V116, P557; Leifeld L, 2002, HEPATOLOGY, V36, P1001, DOI 10.1053/jhep.2002.35532; Lentsch AB, 1999, HEPATOLOGY, V30, P1448, DOI 10.1002/hep.510300615; Leo NA, 1998, NEUROIMMUNOMODULAT, V5, P22, DOI 10.1159/000026323; Letteron P, 1996, J HEPATOL, V24, P200, DOI 10.1016/S0168-8278(96)80030-4; Li JJ, 2011, EUR J PHARMACOL, V671, P120, DOI 10.1016/j.ejphar.2011.09.174; LIBBY P, 1986, J CLIN INVEST, V78, P1432, DOI 10.1172/JCI112732; Liu C, 2010, LAB INVEST, V90, P1805, DOI 10.1038/labinvest.2010.123; Manibusan MK, 2007, J ENVIRON SCI HEAL C, V25, P185, DOI 10.1080/10590500701569398; Nishida K, 1998, TOXICOL LETT, V95, P141, DOI 10.1016/S0378-4274(98)00030-7; Obuchowicz Rafal, 2002, Folia Med Cracov, V43, P95; Pan XY, 2007, J BIOL CHEM, V282, P17078, DOI 10.1074/jbc.M701742200; PENCIL SD, 1984, BIOCHEM PHARMACOL, V33, P2419, DOI 10.1016/0006-2952(84)90713-5; Pessayre D, 2012, DRUG METAB REV, V44, P34, DOI 10.3109/03602532.2011.604086; POLI G, 1985, LIFE SCI, V36, P533, DOI 10.1016/0024-3205(85)90634-4; Poniachik J, 2006, CYTOKINE, V33, P252, DOI 10.1016/j.cyto.2006.02.006; Pritchard MT, 2010, J HEPATOL, V53, P655, DOI 10.1016/j.jhep.2010.04.017; Proctor WR, 2013, HEPATOLOGY, V57, P2026, DOI 10.1002/hep.26196; RECKNAGE RO, 1967, PHARMACOL REV, V19, P145; Sakurai T, 2008, CANCER CELL, V14, P156, DOI 10.1016/j.ccr.2008.06.016; Sato A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092515; Sato Y, 2003, J HEPATOL, V39, P47, DOI 10.1016/S0168-8278(03)00146-6; SMIALOWICZ RJ, 1991, FUND APPL TOXICOL, V17, P186, DOI 10.1016/0272-0590(91)90250-8; Teixeira-Clerc F, 2010, HEPATOLOGY, V52, P1046, DOI 10.1002/hep.23779; Tiegs G, 1999, J NEUROIMMUNOL, V96, P131, DOI 10.1016/S0165-5728(99)00014-4; Tseng CK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086557; Vanden Berghe Tom, 2004, Methods Mol Med, V98, P101; Wang MF, 2013, AM J PHYSIOL-REG I, V305, pR900, DOI 10.1152/ajpregu.00120.2013; Weber LWD, 2003, CRIT REV TOXICOL, V33, P105, DOI 10.1080/713611034; Wen Tao, 2006, Zhongguo Wei Zhong Bing Ji Jiu Yi Xue, V18, P417; WHEATLEY AM, 1993, J AUTON PHARMACOL, V13, P15, DOI 10.1111/j.1474-8673.1993.tb00395.x; Xia F, 2006, HEPATOL RES, V36, P259, DOI 10.1016/j.hepres.2006.08.009; Xie WD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058639; Yamaji K, 2008, TOXICOL APPL PHARM, V226, P38, DOI 10.1016/j.taap.2007.08.014; Zamara E, 2007, J HEPATOL, V46, P230, DOI 10.1016/j.jhep.2006.09.007; Zapater P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043371; Zhang H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046574; Zhu RZ, 2010, WORLD J GASTROENTERO, V16, P2771, DOI 10.3748/wjg.v16.i22.2771; Zhu RZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071612	71	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0121365	10.1371/journal.pone.0121365	http://dx.doi.org/10.1371/journal.pone.0121365			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25799095	Green Published, gold, Green Submitted			2022-12-27	WOS:000351987300246
J	Miyakawa, H; Sato, M; Colbourne, JK; Iguchi, T				Miyakawa, Hitoshi; Sato, Masanao; Colbourne, John K.; Iguchi, Taisen			Ionotropic Glutamate Receptors Mediate Inducible Defense in the Water Flea Daphnia pulex	PLOS ONE			English	Article							JUVENILE-HORMONE BIOSYNTHESIS; PREDATOR-INDUCED POLYPHENISM; EXPRESSION; INSECTS; MK-801	Phenotypic plasticity is the ability held in many organisms to produce different phenotypes with a given genome in response to environmental stimuli, such as temperature, nutrition and various biological interactions. It seems likely that environmental signals induce a variety of mechanistic responses that influence ontogenetic processes. Inducible defenses, in which prey animals alter their morphology, behavior and/or other traits to help protect against direct or latent predation threats, are among the most striking examples of phenotypic plasticity. The freshwater microcrustacean Daphnia pulex forms tooth-like defensive structures, "neckteeth," in response to chemical cues or signals, referred to as "kairomones," in this case released from phantom midge larvae, a predator of D. pulex. To identify factors involved in the reception and/or transmission of a kairomone, we used microarray analysis to identify genes up-regulated following a short period of exposure to the midge kairomone. In addition to identifying differentially expressed genes of unknown function, we also found significant up-regulation of genes encoding ionotropic glutamate receptors, which are known to be involved in neurotransmission in many animal species. Specific antagonists of these receptors strongly inhibit the formation of neckteeth in D. pulex, although agonists did not induce neckteeth by themselves, indicating that ionotropic glutamate receptors are necessary but not sufficient for early steps of neckteeth formation in D. pulex. Moreover, using co-exposure of D. pulex to antagonists and juvenile hormone (JH), which physiologically mediates neckteeth formation, we found evidence suggesting that the inhibitory effect of antagonists is not due to direct inhibition of JH synthesis/secretion. Our findings not only provide a candidate molecule required for the inducible defense response in D. pulex, but also will contribute to the understanding of complex mechanisms underlying the recognition of environmental changes, which form the basis of phenotypic plasticity.	[Miyakawa, Hitoshi; Sato, Masanao; Iguchi, Taisen] Natl Inst Basic Biol, Okazaki, Aichi 444, Japan; [Miyakawa, Hitoshi; Sato, Masanao; Iguchi, Taisen] Natl Inst Nat Sci, Okazaki Inst Integrat Biosci, Okazaki, Aichi 4448787, Japan; [Sato, Masanao; Iguchi, Taisen] SOKENDAI, Fac Life Sci, Dept Basic Biol, Okazaki, Aichi, Japan; [Colbourne, John K.] Univ Birmingham, Sch Biosci, Birmingham, W Midlands, England	National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); National Institutes of Natural Sciences (NINS) - Japan; Okazaki Institute for Integrative Bioscience (OIIB); Graduate University for Advanced Studies - Japan; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Okazaki Institute for Integrative Bioscience (OIIB); University of Birmingham	Miyakawa, H (corresponding author), Natl Inst Basic Biol, 5-1 Higashiyama, Okazaki, Aichi 444, Japan.	h-miya@nibb.ac.jp	Colbourne, John K/L-7748-2014; Iguchi, Taisen/AAL-4225-2021	Colbourne, John K/0000-0002-6966-2972; Sato, Masanao/0000-0003-3790-8218	Ministry of Education, Culture, Sports, Science and Technology of Japan [24370029]; Grants-in-Aid for Scientific Research [26840122] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Support was provided to TI by Grants-in-Aid for Scientific Research (B) (No. 24370029) from the Ministry of Education, Culture, Sports, Science and Technology of Japan (http://www.jsps.go.jp/english/e-grants/index.html). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADLER FR, 1990, TRENDS ECOL EVOL, V5, P407, DOI 10.1016/0169-5347(90)90025-9; Barry MJ, 2002, PHYSIOL BIOCHEM ZOOL, V75, P179, DOI 10.1086/339389; Beaton MJ, 1997, LIMNOL OCEANOGR, V42, P346, DOI 10.4319/lo.1997.42.2.0346; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Chiang AS, 2002, P NATL ACAD SCI USA, V99, P37, DOI 10.1073/pnas.012318899; Chiang AS, 2002, INSECT BIOCHEM MOLEC, V32, P669, DOI 10.1016/S0965-1748(01)00146-1; Colbourne JK, 2011, SCIENCE, V331, P555, DOI 10.1126/science.1197761; Dingledine R, 1999, PHARMACOL REV, V51, P7; Dudley AM, 2002, P NATL ACAD SCI USA, V99, P7554, DOI 10.1073/pnas.112683499; Geister TL, 2008, J EXP BIOL, V211, P1587, DOI 10.1242/jeb.016725; Gilbert S. F., 2009, ECOLOGICAL DEV BIOL; Gotoh H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021139; Hepp Y, 2013, J COMP NEUROL, V521, P2279, DOI 10.1002/cne.23285; Hiruta C, 2013, BMC BIOTECHNOL, V13, DOI 10.1186/1472-6750-13-96; Huang JH, 2011, DEVELOPMENT, V138, P2283, DOI 10.1242/dev.057687; Imai M, 2009, J EXP ZOOL PART A, V311A, P788, DOI 10.1002/jez.565; Kato Y, 2011, DEV GENES EVOL, V220, P337, DOI 10.1007/s00427-011-0353-9; KRUEGER DA, 1981, LIMNOL OCEANOGR, V26, P219, DOI 10.4319/lo.1981.26.2.0219; Lee HK, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-269; Miyakawa H, 2014, DAPHNIA BIOL MATH PE, P245; Miyakawa H, 2014, CURR OPIN INSECT SCI, V1, P81, DOI 10.1016/j.cois.2014.04.006; Miyakawa H, 2013, J EXP ZOOL PART A, V319, P440, DOI 10.1002/jez.1807; Miyakawa H, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-45; Naraki Y, 2013, ZOOL SCI, V30, P619, DOI 10.2108/zsj.30.619; Nijhout H.F., 1994, INSECT HORMONES; Nijhout HF, 1999, BIOSCIENCE, V49, P181, DOI 10.2307/1313508; Pener MP, 1998, J INSECT PHYSIOL, V44, P365, DOI 10.1016/S0022-1910(97)00169-8; Pigliucci Massimo, 2010, P355; R Core Team, 2021, R LANGUAGE ENV STAT; RANDLE JCR, 1992, EUR J PHARMACOL, V215, P237, DOI 10.1016/0014-2999(92)90033-Z; Sato M, 2007, PLANT J, V49, P565, DOI 10.1111/j.1365-313X.2006.02972.x; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Tollrian Ralph, 1999, P177; Weiss LC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036879; West-Eberhard Mary Jane, 2003, pi; WONG EHF, 1986, P NATL ACAD SCI USA, V83, P7104, DOI 10.1073/pnas.83.18.7104; Yanai H., 2004, STATCEL USEFUL ADD I	38	16	16	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0121324	10.1371/journal.pone.0121324	http://dx.doi.org/10.1371/journal.pone.0121324			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25799112	Green Published, gold, Green Submitted			2022-12-27	WOS:000351987300236
J	Saffarini, CM; McDonnell-Clark, EV; Amin, A; Huse, SM; Boekelheide, K				Saffarini, Camelia M.; McDonnell-Clark, Elizabeth V.; Amin, Ali; Huse, Susan M.; Boekelheide, Kim			Developmental Exposure to Estrogen Alters Differentiation and Epigenetic Programming in a Human Fetal Prostate Xenograft Model	PLOS ONE			English	Article							INCREASES SUSCEPTIBILITY; CANCER PROGRESSION; DNA METHYLATION; RECEPTOR-BETA; CARCINOGENESIS; MOUSE; ESTRADIOL; PACKAGE; STROMA; RAT	Prostate cancer is the most frequent non-cutaneous malignancy in men. There is strong evidence in rodents that neonatal estrogen exposure plays a role in the development of this disease. However, there is little information regarding the effects of estrogen in human fetal prostate tissue. This study explored early life estrogen exposure, with and without a secondary estrogen and testosterone treatment in a human fetal prostate xenograft model. Histopathological lesions, proliferation, and serum hormone levels were evaluated at 7, 30, 90, and 200-day time-points after xenografting. The expression of 40 key genes involved in prostatic glandular and stromal growth, cell-cycle progression, apoptosis, hormone receptors and tumor suppressors was evaluated using a custom PCR array. Epigenome-wide analysis of DNA methylation was performed on whole tissue, and laser capture-microdissection (LCM) isolated epithelial and stromal compartments of 200-day prostate xenografts. Combined initial plus secondary estrogenic exposures had the most severe tissue changes as revealed by the presence of hyperplastic glands at day 200. Gene expression changes corresponded with the cellular events in the KEGG prostate cancer pathway, indicating that initial plus secondary exposure to estrogen altered the PI3K-Akt signaling pathway, ultimately resulting in apoptosis inhibition and an increase in cell cycle progression. DNA methylation revealed that differentially methylated CpG sites significantly predominate in the stromal compartment as a result of estrogen-treatment, thereby providing new targets for future investigation. By using human fetal prostate tissue and eliminating the need for species extrapolation, this study provides novel insights into the gene expression and epigenetic effects related to prostate carcinogenesis following early life estrogen exposure.	[Saffarini, Camelia M.; McDonnell-Clark, Elizabeth V.; Amin, Ali; Huse, Susan M.; Boekelheide, Kim] Brown Univ, Dept Pathol & Lab Med, Providence, RI 02912 USA; [Amin, Ali] Rhode Isl Hosp, Dept Pathol & Lab Med, Providence, RI USA	Brown University; Lifespan Health Rhode Island; Rhode Island Hospital	Boekelheide, K (corresponding author), Brown Univ, Dept Pathol & Lab Med, Providence, RI 02912 USA.	kim_boekelheide@brown.edu			United States Environmental Protection Agency [RD-83459401]; National Institute of Environmental Health Sciences [5P20ES018169-02]; Training grant in Environmental Pathology [T32-ES007272]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P20ES018169, T32ES007272] Funding Source: NIH RePORTER	United States Environmental Protection Agency(United States Environmental Protection Agency); National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Training grant in Environmental Pathology; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by United States Environmental Protection Agency RD-83459401, National Institute of Environmental Health Sciences 5P20ES018169-02, and Training grant in Environmental Pathology T32-ES007272. CMS and KB are the authors who received this funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbassi-Ghanavati M, 2009, OBSTET GYNECOL, V114, P1326, DOI 10.1097/AOG.0b013e3181c2bde8; Aksglaede L, 2006, HUM REPROD UPDATE, V12, P341, DOI 10.1093/humupd/dml018; Anderson PD, 2012, J CLIN INVEST, V122, P1907, DOI 10.1172/JCI58540; Arbab I. A., 2012, EVID-BASED COMPL ALT, V2012, DOI DOI 10.1155/2012/856029; Arredouani MS, 2009, CLIN CANCER RES, V15, P5794, DOI 10.1158/1078-0432.CCR-09-0911; Aryee MJ, 2014, BIOINFORMATICS, V30, P1363, DOI 10.1093/bioinformatics/btu049; Bjerke GA, 2013, ONCOGENE; Brett A, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-3; Carruba G, 2007, J CELL BIOCHEM, V102, P899, DOI 10.1002/jcb.21529; Coffey D S, 1980, Prog Clin Biol Res, V37, P379; Crews D, 2006, ENDOCRINOLOGY, V147, pS4, DOI 10.1210/en.2005-1122; Cunha GR, 2002, DIFFERENTIATION, V70, P473, DOI 10.1046/j.1432-0436.2002.700902.x; Cunha GR, 2003, INT J CANCER, V107, P1, DOI 10.1002/ijc.11335; Damber JE, 2008, LANCET, V371, P1710, DOI 10.1016/S0140-6736(08)60729-1; De Paepe ME, 2012, EXP LUNG RES, V38, P43, DOI 10.3109/01902148.2011.641139; Dey P, 2013, J MOL ENDOCRINOL, V51, pT61, DOI 10.1530/JME-13-0150; Ekbom A, 1998, SEMIN CANCER BIOL, V8, P237, DOI 10.1006/scbi.1998.0073; Farnsworth WE, 1999, PROSTATE, V38, P60; Franco OE, 2012, ADV PHARMACOL, V65, P267, DOI 10.1016/B978-0-12-397927-8.00009-9; Gann Peter H, 2002, Rev Urol, V4 Suppl 5, pS3; Gathirua-Mwangi WG, 2013, EUR J CANC PREV; Gilmore W, 1997, J IMMUNOL, V158, P446; Halvorsen OJ, 2007, CLIN CANCER RES, V13, P892, DOI 10.1158/1078-0432.CCR-06-1207; Harmelin A, 2005, LAB ANIM-UK, V39, P215, DOI 10.1258/0023677053739756; Hayward SW, 1996, ANN NY ACAD SCI, V784, P50, DOI 10.1111/j.1749-6632.1996.tb16227.x; Ho SM, 2006, CANCER RES, V66, P5624, DOI 10.1158/0008-5472.CAN-06-0516; Huang DW, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r183; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2013, NUCL ACIDS RES; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Kim JW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048455; Kohl M, 2007, FUNCTIONS ANAL REAL; Leek JT, 2012, BIOINFORMATICS, V28, P882, DOI 10.1093/bioinformatics/bts034; Li LC, 2004, BBA-REV CANCER, V1704, P87, DOI 10.1016/j.bbcan.2004.06.001; Li LC, 2005, JNCI-J NATL CANCER I, V97, P103, DOI 10.1093/jnci/dji010; Liu Y, 2013, J APPL GENETICS; Maksimovic J, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-6-r44; McLachlan JA, 2001, APMIS, V109, P263, DOI 10.1034/j.1600-0463.2001.d01-119.x; MCNEAL JE, 1988, AM J SURG PATHOL, V12, P619, DOI 10.1097/00000478-198808000-00003; Nash AF, 2000, ENDOCR-RELAT CANCER, V7, P37, DOI 10.1677/erc.0.0070037; Nelles JL, 2011, EXPERT REV ENDOCRINO, V6, P437, DOI 10.1586/EEM.11.20; Pettersson K, 2001, ANNU REV PHYSIOL, V63, P165, DOI 10.1146/annurev.physiol.63.1.165; Pflieger-Bruss S, 2004, ANDROLOGIA, V36, P337, DOI 10.1111/j.1439-0272.2004.00641.x; Prins GS, 2008, ENDOCR-RELAT CANCER, V15, P649, DOI 10.1677/ERC-08-0043; Prins GS, 2008, BASIC CLIN PHARMACOL, V102, P134, DOI 10.1111/j.1742-7843.2007.00166.x; Prins GS, 2007, REPROD TOXICOL, V23, P374, DOI 10.1016/j.reprotox.2006.10.001; Prins GS, 2001, REPROD FERT DEVELOP, V13, P241, DOI 10.1071/RD00107; PRINS GS, 1992, ENDOCRINOLOGY, V130, P2401, DOI 10.1210/en.130.4.2401; RAO GN, 1987, FUND APPL TOXICOL, V9, P329, DOI 10.1016/0272-0590(87)90055-8; Ricke EA, 2012, CARCINOGENESIS, V33, P1391, DOI 10.1093/carcin/bgs153; Ricke WA, 2006, INT J CANCER, V118, P2123, DOI 10.1002/ijc.21614; Risbridger GP, 2005, CELL TISSUE RES, V322, P173, DOI 10.1007/s00441-005-1121-9; Saffarini CM, 2013, PROSTATE, V73, P1761, DOI 10.1002/pros.22713; Sanchez-Chapado M, 2003, PROSTATE, V54, P238, DOI 10.1002/pros.10177; Shappell SB, 2004, CANCER RES, V64, P2270, DOI 10.1158/0008-5472.CAN-03-0946; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; van der Heul-Nieuwenhuijsen L, 2009, PROSTATE, V69, P1538, DOI 10.1002/pros.20996; van der Heul-Nieuwenhuijsen L, 2009, BJU INT, V103, P1574, DOI 10.1111/j.1464-410X.2009.08351.x; van Leenders GJLH, 2003, AM J PATHOL, V162, P1529, DOI 10.1016/S0002-9440(10)64286-1; Wang D, 2012, BIOINFORMATICS, V28, P729, DOI 10.1093/bioinformatics/bts013; Wang YH, 2000, CANCER RES, V60, P6008; Wang YZ, 2005, PROSTATE, V64, P149, DOI 10.1002/pros.20225; XIA T, 1990, Pediatric Pathology, V10, P527	65	14	14	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0122290	10.1371/journal.pone.0122290	http://dx.doi.org/10.1371/journal.pone.0122290			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25799167	gold, Green Submitted, Green Published			2022-12-27	WOS:000351987300327
J	Bonvallet, PP; Schultz, MJ; Mitchell, EH; Bain, JL; Culpepper, BK; Thomas, SJ; Bellis, SL				Bonvallet, Paul P.; Schultz, Matthew J.; Mitchell, Elizabeth H.; Bain, Jennifer L.; Culpepper, Bonnie K.; Thomas, Steven J.; Bellis, Susan L.			Microporous Dermal-Mimetic Electrospun Scaffolds Pre-Seeded with Fibroblasts Promote Tissue Regeneration in Full-Thickness Skin Wounds	PLOS ONE			English	Article							IN-VITRO; ENGINEERED SKIN; GRAFT CONTRACTION; NUDE-MICE; NANOFIBERS; MECHANISM; CHITOSAN; VIVO; RECONSTRUCTION; INFILTRATION	Electrospun scaffolds serve as promising substrates for tissue repair due to their nanofibrous architecture and amenability to tailoring of chemical composition. In this study, the regenerative potential of a microporous electrospun scaffold pre-seeded with dermal fibroblasts was evaluated. Previously we reported that a 70% collagen I and 30% poly(epsilon-caprolactone) electrospun scaffold (70:30 col/PCL) containing 160 mu m diameter pores had favorable mechanical properties, supported fibroblast infiltration and subsequent cell-mediated deposition of extracellular matrix (ECM), and promotedmore rapid and effective in vivo skin regeneration when compared to scaffolds lacking micropores. In the current study we tested the hypothesis that the efficacy of the 70:30 col/PCL microporous scaffolds could be further enhanced by seeding scaffolds with dermal fibroblasts prior to implantation into skin wounds. To address this hypothesis, a Fischer 344 (F344) rat syngeneic model was employed. In vitro studies showed that dermal fibroblasts isolated from F344 rat skin were able to adhere and proliferate on 70:30 col/PCL microporous scaffolds, and the cells also filled the 160 mu m pores with native ECM proteins such as collagen I and fibronectin. Additionally, scaffolds seeded with F344 fibroblasts exhibited a low rate of contraction (similar to 14%) over a 21 day time frame. To assess regenerative potential, scaffolds with or without seeded F344 dermal fibroblasts were implanted into full thickness, critical size defects created in F344 hosts. Specifically, we compared:microporous scaffolds containing fibroblasts seeded for 4 days; scaffolds containing fibroblasts seeded for only 1 day; acellularmicroporous scaffolds; and a sham wound (no scaffold). Scaffolds containing fibroblasts seeded for 4 days had the best response of all treatment groups with respect to accelerated wound healing, a more normal-appearing dermal matrix structure, and hair follicle regeneration. Collectively these results suggest thatmicroporous electrospun scaffolds pre-seeded with fibroblasts promote greater wound-healing than acellular scaffolds.	[Bonvallet, Paul P.; Schultz, Matthew J.; Mitchell, Elizabeth H.; Bellis, Susan L.] Univ Alabama Birmingham, Dept Cell Dev & Integrat Biol, Birmingham, AL 35233 USA; [Bain, Jennifer L.] Univ Alabama Birmingham, Dept Periodontol, Birmingham, AL USA; [Culpepper, Bonnie K.; Bellis, Susan L.] Univ Alabama Birmingham, Dept Biomed Engn, Birmingham, AL USA; [Thomas, Steven J.] Univ Alabama Birmingham, Dept Surg, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Bellis, SL (corresponding author), Univ Alabama Birmingham, Dept Cell Dev & Integrat Biol, Birmingham, AL 35233 USA.	jbain@uab.edu		Mowry, Katie/0000-0002-0047-544X	National Institutes of Health [P30 AR050948, GM 008111-25, F31DE021613]; National Institutes of Health, National Center for Advancing Translational Research [TL1TR000167]; Howard Hughes Medical Institute Med into Grad Initiative [56005705]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [TL1TR000167] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR050948] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [F31DE021613] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health, National Center for Advancing Translational Research; Howard Hughes Medical Institute Med into Grad Initiative(Howard Hughes Medical Institute); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by the National Institutes of Health, P30 AR050948 (SLB), National Institutes of Health, T32 training grant GM 008111-25 (PPB), National Institutes of Health, National Center for Advancing Translational Research TL1TR000167 (PPB), Howard Hughes Medical Institute Med into Grad Initiative 56005705 (PPB) and the National Institutes of Health F31DE021613 (BKC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Augustine R, 2014, RSC ADV, V4, P51528, DOI 10.1039/c4ra07361d; Barker DA, 2013, JAMA OTOLARYNGOL, V139, P914, DOI 10.1001/jamaoto.2013.4119; Berthod F, 2001, MATRIX BIOL, V20, P463, DOI 10.1016/S0945-053X(01)00162-7; Blackstone BN, 2014, TISSUE ENG PT A, V20, P2746, DOI [10.1089/ten.tea.2013.0687, 10.1089/ten.TEA.2013.0687]; Blakeney BA, 2011, BIOMATERIALS, V32, P1583, DOI 10.1016/j.biomaterials.2010.10.056; Bonvallet PP, 2014, TISSUE ENG PT A, V20, P2434, DOI [10.1089/ten.tea.2013.0645, 10.1089/ten.TEA.2013.0645]; Brown BN, 2014, TRANSL RES, V163, P268, DOI 10.1016/j.trsl.2013.11.003; Calota D R, 2012, J Med Life, V5, P486; Cedidi C, 2007, EUR J MED RES, V12, P541; Chern PL, 2009, DERMATOL SURG, V35, P891, DOI 10.1111/j.1524-4725.2009.01153.x; Chiu T, 2005, CLIN DERMATOL, V23, P419, DOI 10.1016/j.clindermatol.2004.07.027; Croisier F, 2014, ADV HEALTHC MATER, V3, P2032, DOI 10.1002/adhm.201400380; Deepa R, 2013, J BIOMATER TISS ENG, V3, P261, DOI 10.1166/jbt.2013.1094; Duan HC, 2013, INT J NANOMED, V8, P2077, DOI 10.2147/IJN.S42384; Fang TL, 2014, ANN PLAS SURG, V73, P509, DOI 10.1097/SAP.0b013e3182840883; Gomes SR, 2015, MAT SCI ENG C-MATER, V46, P348, DOI 10.1016/j.msec.2014.10.051; Ham R G, 1980, Methods Cell Biol, V21A, P255, DOI 10.1016/S0091-679X(08)60770-0; Harrison CA, 2008, BURNS, V34, P153, DOI 10.1016/j.burns.2007.08.011; Harrison CA, 2006, TISSUE ENG, V12, P3119, DOI 10.1089/ten.2006.12.3119; Kamel RA, 2013, J AM COLL SURGEONS, V217, P533, DOI 10.1016/j.jamcollsurg.2013.03.027; Kempf M, 2011, BIOMATERIALS, V32, P4782, DOI 10.1016/j.biomaterials.2011.03.023; Kim TG, 2008, ACTA BIOMATER, V4, P1611, DOI 10.1016/j.actbio.2008.06.008; Kumbar SG, 2008, BIOMED MATER, V3, DOI 10.1088/1748-6041/3/3/034002; Kuppan P, 2011, BIOMACROMOLECULES, V12, P3156, DOI 10.1021/bm200618w; Lai HJ, 2014, ACTA BIOMATER, V10, P4156, DOI 10.1016/j.actbio.2014.05.001; Mogosanu GD, 2014, INT J PHARMACEUT, V463, P127, DOI 10.1016/j.ijpharm.2013.12.015; Nelson CE, 2014, ADV MATER, V26, P607, DOI 10.1002/adma.201303520; Ng KW, 2004, BIOMATERIALS, V25, P2807, DOI 10.1016/j.biomaterials.2003.09.058; Pezeshki-Modaress M, 2014, J BIOMED MATER RES A, V102, P3908, DOI 10.1002/jbm.a.35054; Pham QP, 2006, TISSUE ENG, V12, P1197, DOI 10.1089/ten.2006.12.1197; Phipps MC, 2012, BIOMATERIALS, V33, P524, DOI 10.1016/j.biomaterials.2011.09.080; Priya SG, 2008, TISSUE ENG PART B-RE, V14, P105, DOI 10.1089/teb.2007.0318; Ravichandran R, 2012, MACROMOL BIOSCI, V12, P286, DOI 10.1002/mabi.201100325; Reddy VJ, 2013, WOUND REPAIR REGEN, V21, P1, DOI 10.1111/j.1524-475X.2012.00861.x; Revi D, 2014, J BIOMED MATER RES A, V102, P3273, DOI 10.1002/jbm.a.35003; Richardson TP, 2001, NAT BIOTECHNOL, V19, P1029, DOI 10.1038/nbt1101-1029; Rnjak-Kovacina J, 2012, ACTA BIOMATER, V8, P3714, DOI 10.1016/j.actbio.2012.06.032; Rnjak-Kovacina J, 2011, TISSUE ENG PART B-RE, V17, P365, DOI 10.1089/ten.teb.2011.0235; Stephenson AJ, 2000, BRIT J PLAST SURG, V53, P397, DOI 10.1054/bjps.2000.3335; Suganya S, 2014, INT J BIOL MACROMOL, V68, P135, DOI 10.1016/j.ijbiomac.2014.04.031; Sundaramurthi D, 2014, POLYM REV, V54, P348, DOI 10.1080/15583724.2014.881374; Sundaramurthi D, 2013, J BIOMED NANOTECHNOL, V9, P1383, DOI 10.1166/jbn.2013.1618; Supp DM, 2005, CLIN DERMATOL, V23, P403, DOI 10.1016/j.clindermatol.2004.07.023; Vaquette C, 2011, ACTA BIOMATER, V7, P2544, DOI 10.1016/j.actbio.2011.02.036; Yannas IV, 2013, BIOMATERIALS, V34, P321, DOI 10.1016/j.biomaterials.2012.10.006; Yildirimer L, 2012, TRENDS BIOTECHNOL, V30, P638, DOI 10.1016/j.tibtech.2012.08.004; You HJ, 2014, J KOREAN MED SCI, V29, P311, DOI 10.3346/jkms.2014.29.3.311; Zeinali R, 2014, ASAIO J, V60, P106, DOI 10.1097/MAT.0000000000000025; Zhang YZ, 2005, J BIOMED MATER RES B, V72B, P156, DOI 10.1002/jbm.b.30128; ZHONG SP, 2012, TISSUE ENG PART B-RE, V18, P77, DOI DOI 10.1089/ten.teb.2011.0390	50	48	50	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0122359	10.1371/journal.pone.0122359	http://dx.doi.org/10.1371/journal.pone.0122359			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25793720	gold, Green Published, Green Submitted			2022-12-27	WOS:000352083900178
J	Chen, H; Ren, CL; Han, CX; Wang, DX; Chen, Y; Fu, DY				Chen, Hui; Ren, Chuanli; Han, Chongxu; Wang, Daxin; Chen, Yong; Fu, Deyuan			Expression and Prognostic Value of miR-486-5p in Patients with Gastric Adenocarcinoma	PLOS ONE			English	Article								MicroRNA (miR)-486-5p expression is often reduced in human cancers. However, its expression in gastric carcinoma and its relation to clinicopathological features and prognosis are unclear. Tissue microarrays were constructed from 84 patients with gastric adenocarcinoma (GC) who were undergoing radical resection. miR-486-5p expression was detected by miRNA-locked nucleic acid in situ hybridization, and its correlations with clinicopathological features and overall survival were analyzed. Bioinformatic studies predict that fibroblast growth factor 9 (FGF9) is a potential target gene of miR-486-5p. miR-486-5p was mainly located in the cytoplasm of GC cells and neighboring normal tissues. Compared with paracancerous normal tissue, miR-486-5p expression was decreased in 63.1%(53/84) of the GC samples, increased in 32.1% (27/84) and unchanged in 4.8% (4/84). FGF9 expression was decreased in 69.0% (58/84) of GC samples and increased in 31.0%(26/84) compared with normal paracancerous tissues using immunohistochemical analysis. Low or unchanged miR-486-5p expression (P = 0.002), tumor stage (P = 0.001), tumor status (P = 0.001), node status (P = 0.001), tumor size (P = 0.004), and depth of tumor invasion (P = 0.013) were significant negative prognostic predictors for overall survival in patients with GC. After stratification according to American Joint Committee on Cancer (AJCC) stage, low/unchanged miR-486-5p expression remained a significant predictor of poor survival in stage II (P = 0.024) and stage III (P = 0.003). Cox regression analysis identified the following predictors of poor prognosis: tumor status (hazard ratio [HR], 7.19; 95% confidence interval [CI], 1.75-29.6; P = 0.006), stage (HR, 2.62; 95% CI, 1.50-4.59; P = 0.001), lymph node metastasis (HR, 2.52; 95% CI, 1.27-4.99; P = 0.008), low/unchanged miR486-5p (HR, 2.47; 95% CI, 1.35-4.52; P = 0.003), high level of FGF9 (HR, 2.41; 95% CI, 1.42-4.09; P = 0.001) and tumor size (HR, 2.50; 95% CI, 1.30-4.82; P = 0.006). Low or unchanged expression of miR-486-5p compared with neighboring normal tissues was associated with a poor prognosis, while high expression was associated with a good prognosis in GC. miR-486-5p may thus be useful for evaluating prognosis and may provide a novel target treatment in patients with GC.	[Chen, Hui] Northern Jiangsu Peoples Hosp, Geriatr Med, Yangzhou, Jiangsu, Peoples R China; [Chen, Hui; Ren, Chuanli; Han, Chongxu; Wang, Daxin; Chen, Yong; Fu, Deyuan] Yangzhou Univ, Clin Med Coll, Yangzhou 225009, Jiangsu, Peoples R China; [Ren, Chuanli; Han, Chongxu; Wang, Daxin] Northern Jiangsu Peoples Hosp, Clin Med Testing Lab, Yangzhou, Jiangsu, Peoples R China; [Chen, Yong] Northern Jiangsu Peoples Hosp, Dept Oncol, Yangzhou, Jiangsu, Peoples R China; [Fu, Deyuan] Northern Jiangsu Peoples Hosp, Breast Oncol Surg, Yangzhou, Jiangsu, Peoples R China; [Ren, Chuanli] Nanjing Med Univ, Minist Educ MOE, Dept Epidemiol & Biostat, Key Lab Modern Toxicol,Sch Publ Hlth, Nanjing, Jiangsu, Peoples R China	Yangzhou University; Nanjing Medical University	Ren, CL (corresponding author), Northern Jiangsu Peoples Hosp, Clin Med Testing Lab, Yangzhou, Jiangsu, Peoples R China.	renchl@163.com			Foundation of the Social Development of Jiangsu Province [BE2012705]; Foundation of China Postdoctoral Studies [M2013541699]; Foundation of Jiangsu Province Postdoctoral Studies [1302149C]; National Nature Science Foundation of China [81172508]; Foundation for Yong Scholar in Yangzhou [YZ2014046]	Foundation of the Social Development of Jiangsu Province; Foundation of China Postdoctoral Studies; Foundation of Jiangsu Province Postdoctoral Studies; National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Foundation for Yong Scholar in Yangzhou	This study was supported by the Foundation of the Social Development of Jiangsu Province (BE2012705), the Foundation of China Postdoctoral Studies (M2013541699), the Foundation of Jiangsu Province Postdoctoral Studies (1302149C), the National Nature Science Foundation of China (81172508) and the Foundation for Yong Scholar in Yangzhou (YZ2014046).	Alexander MS, 2014, J CLIN INVEST, V124, P2651, DOI 10.1172/JCI73579; Bansal A, 2011, AM J GASTROENTEROL, V106, P1055, DOI 10.1038/ajg.2011.37; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Deng M., 2013, PLOS ONE, V8; Ferlay J, 2010, INT J CANC, V127; Goto K, 2013, MOL CLIN ONCOL, V1, P235, DOI 10.3892/mco.2012.46; Hartgrink HH, 2009, LANCET, V374; He C, 2014, INT J CLIN EXP PATHO, V7; Hu Z, 2010, J CLIN ONCOL, V28; Kim Y., 2012, ASIA PACIFIC J TOURI, V2012, P1, DOI DOI 10.1016/J.JECP.2012.03.002; Konishi H, 2012, BR J CANC, V106; Li Y, 2013, ANAL CHEM, V85; Mees ST, 2009, ANN SURG ONCOL, V16; Navon R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008003; Oh HK, 2011, CLIN CANC RES, V17; Ohgino K, 2014, LUNG CANCER, V83, DOI [10.1016/j.lungcan.2013.11.002, DOI 10.1016/J.LUNGCAN.2013.11.002]; Peng Y, 2013, P NATL ACAD SCI USA, V110, P15043, DOI 10.1073/pnas.1307107110; Ragusa M, 2010, MOL CANC THER, V9; Rask L, 2014, CELL ONCOL DORDR, V37; Shen J, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-374; Small EM, 2010, P NATL ACAD SCI US, V107; Stuelten CH, 2010, CELL CYCLE, V9, P4608, DOI 10.4161/cc.9.23.13928; Tahiri A, 2013, CARCINOGENESIS, V35; Tan X, 2011, CLIN CANC RES, V17; Teishima J, 2012, PROSTATE CANCER P D, V15, DOI [10.1038/pcan.2011.53, DOI 10.1038/PCAN.2011.53]; Turner N, 2010, NAT REV CANCER, V10, DOI [10.1038/nrc2627-c1, DOI 10.1038/NRC2627-C1]; van Kouwenhove M, 2011, NAT REV CANCER, V11, DOI [10.1038/nrc3004-c1, DOI 10.1038/NRC3004-C1]; Villarroya-Beltri C, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3980; Wang J, 2014, ONCOGENE, V33, DOI [10.1038/onc.2013.69, DOI 10.1038/ONC.2013.69]; Wu ZB, 2014, MOL CELL ENDOCRINOL, V395, DOI [10.1016/j.mce.2014.07.018, DOI 10.1016/J.MCE.2014.07.018]; Xie ZJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057502; Yu L, 2010, INT J CANC, V127; Zhang CZ, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-229; Zhang G, 2014, TUMOUR BIOL, V35; Zhu C, 2014, BR J CANC, V110	35	33	34	3	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0119384	10.1371/journal.pone.0119384	http://dx.doi.org/10.1371/journal.pone.0119384			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25793394	Green Submitted, gold, Green Published			2022-12-27	WOS:000352084200078
J	Ching, B; Woo, JM; Hiong, KC; Boo, MV; Choo, CYL; Wong, WP; Chew, SF; Ip, YK				Ching, Biyun; Woo, Jia M.; Hiong, Kum C.; Boo, Mel V.; Choo, Celine Y. L.; Wong, Wai P.; Chew, Shit F.; Ip, Yuen K.			Na plus /K plus -ATPase alpha-subunit (nka alpha) Isoforms and Their mRNA Expression Levels, Overall Nka alpha Protein Abundance, and Kinetic Properties of Nka in the Skeletal Muscle and Three Electric Organs of the Electric Eel, Electrophorus electricus	PLOS ONE			English	Article							NA,K-ATPASE ALPHA; CYTOCHEMICAL-LOCALIZATION; SODIUM-CHANNEL; ELECTROCYTE; MEMBRANE; ISOZYMES; IDENTIFICATION; NA+,K+-ATPASE; HETEROGENEITY; BINDING	This study aimed to obtain the coding cDNA sequences of Na+/K+-ATPase alpha (nka alpha) isoforms from, and to quantify their mRNA expression in, the skeletal muscle (SM), the main electric organ (EO), the Hunter's EO and the Sach's EO of the electric eel, Electrophorus electricus. Four nkaa isoforms (nka alpha 1c1, nka alpha 1c2, nka alpha 2 and nka alpha 3) were obtained from the SM and the EOs of E. electricus. Based on mRNA expression levels, the major nka alpha expressed in the SM and the three EOs of juvenile and adult E. electricus were nka alpha 1c1 and nka alpha 2, respectively. Molecular characterization of the deduced Nka alpha 1c1 and Nka alpha 2 sequences indicates that they probably have different affinities to Na+ and K+. Western blotting demonstrated that the protein abundance of Nka alpha was barely detectable in the SM, but strongly detected in the main and Hunter's EOs and weakly in the Sach's EO of juvenile and adult E. electricus. These results corroborate the fact that the main EO and Hunter's EO have high densities of Na+ channels and produce high voltage discharges while the Sach's EO produces low voltage discharges. More importantly, there were significant differences in kinetic properties of Nka among the three EOs of juvenile E. electricus. The highest and lowest V-max of Nka were detected in the main EO and the Sach's EO, respectively, with the Hunter's EO having a V-max value intermediate between the two, indicating that the metabolic costs of EO discharge could be the highest in the main EO. Furthermore, the Nka from the main EO had the lowest K-m (or highest affinity) for Na+ and K+ among the three EOs, suggesting that the Nka of the main EO was more effective than those of the other two EOs in maintaining intracellular Na+ and K+ homeostasis and in clearing extracellular K+ after EO discharge.	[Ching, Biyun; Woo, Jia M.; Hiong, Kum C.; Boo, Mel V.; Choo, Celine Y. L.; Wong, Wai P.; Ip, Yuen K.] Natl Univ Singapore, Dept Biol Sci, Singapore 117543, Singapore; [Ip, Yuen K.] Natl Univ Singapore, Trop Marine Sci Inst, Singapore 119227, Singapore; [Chew, Shit F.] Nanyang Technol Univ, Natl Inst Educ, Nat Sci & Sci Educ, Singapore 637616, Singapore	National University of Singapore; National University of Singapore; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; National Institute of Education (NIE) Singapore	Ip, YK (corresponding author), Natl Univ Singapore, Dept Biol Sci, Singapore 117543, Singapore.	dbsipyk@nus.edu.sg	Ip, Yuen Kwong/H-8041-2012; Chew, Shit Fun/I-2248-2012	Ip, Yuen Kwong/0000-0001-9124-7911; Chew, Shit Fun/0000-0003-4599-5817; Choo, Celine Yen Ling/0000-0001-9099-6988	 [R-347-000188-232]		The authors received anonymous funding from grant R-347-000188-232 to YKI. The authors are not aware of any competing interests regarding this funder. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert J. S., 2005, PHYSL FISHES, P431; APERIA A, 1994, FASEB J, V8, P436, DOI 10.1096/fasebj.8.6.8168694; BEGUIN P, 1994, J BIOL CHEM, V269, P24437; BENNETT MVL, 1989, BRAIN RES, V488, P22, DOI 10.1016/0006-8993(89)90689-6; Bennett MVL, 1971, FISH PHYSIOL, P346; Berra TM., 2001, FRESHWATER FISH DIST; Blanco G, 1998, AM J PHYSIOL-RENAL, V275, pF633, DOI 10.1152/ajprenal.1998.275.5.F633; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CLAUSEN T, 1991, PHYSIOL REV, V71, P733, DOI 10.1152/physrev.1991.71.3.733; Couceiro A, 1953, NEUROBIOLOGIA, V16, P299; ELLISMAN MH, 1982, P NATL ACAD SCI-BIOL, V79, P6707, DOI 10.1073/pnas.79.21.6707; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; FRITZ LC, 1983, J NEUROSCI, V3, P2300; Gallant JR, 2012, J EXP BIOL, V215, P2479, DOI 10.1242/jeb.063222; Gerwick L, 2007, FISH SHELLFISH IMMUN, V22, P157, DOI 10.1016/j.fsi.2006.04.003; Gotter AL, 1998, COMP BIOCHEM PHYS A, V119, P225, DOI 10.1016/S1095-6433(97)00414-5; GRUNDFEST H, 1960, BIOL BULL, V119, P284; Guynn SR, 2002, J EXP MAR BIOL ECOL, V273, P15, DOI 10.1016/S0022-0981(02)00136-3; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; He SW, 2001, AM J PHYSIOL-REG I, V281, pR917, DOI 10.1152/ajpregu.2001.281.3.R917; Horisberger JD, 2002, J PHYSIOL-LONDON, V539, P669, DOI 10.1113/jphysiol.2001.013201; HORISBERGER JD, 1991, ANNU REV PHYSIOL, V53, P565, DOI 10.1146/annurev.physiol.53.1.565; Ip YK, 2012, AM J PHYSIOL-REG I, V303, pR112, DOI 10.1152/ajpregu.00618.2011; JEWELL EA, 1991, J BIOL CHEM, V266, P16925; Jorgensen PL, 2003, ANNU REV PHYSIOL, V65, P817, DOI 10.1146/annurev.physiol.65.092101.142558; Jorgensen PL, 2001, BBA-BIOENERGETICS, V1505, P57, DOI 10.1016/S0005-2728(00)00277-2; Kaya S, 1997, ANN NY ACAD SCI, V834, P129, DOI 10.1111/j.1749-6632.1997.tb52238.x; Keynes KD, 1961, BIOELECTROGENESIS, P14; Keynes R, 1957, PHYSL FISHES, VII, P323; KEYNES RD, 1953, J PHYSIOL-LONDON, V119, P315, DOI 10.1113/jphysiol.1953.sp004849; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LINGREL JB, 1992, J BIOENERG BIOMEMBR, V24, P263; Lingrel JB, 2007, J BIOENERG BIOMEMBR, V39, P385, DOI 10.1007/s10863-007-9107-9; Lowe J, 2004, BBA-BIOMEMBRANES, V1661, P40, DOI 10.1016/j.bbamem.2003.11.020; Lucking K, 1996, AM J PHYSIOL-RENAL, V271, pF253, DOI 10.1152/ajprenal.1996.271.2.F253; MACHADO RD, 1976, CELL TISSUE RES, V174, P355, DOI 10.1007/BF00220681; MACHADO RD, 1980, CELL TISSUE RES, V213, P69, DOI 10.1007/BF00236921; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; MIDDLETON JP, 1993, J BIOL CHEM, V268, P15958; Moller P., 1995, ELECT FISHES HIST BE; Morth JP, 2007, NATURE, V450, P1043, DOI 10.1038/nature06419; NACHMANSOHN D, 1970, SCIENCE, V168, P1059, DOI 10.1126/science.168.3935.1059; NAKAMURA Y, 1965, J GEN PHYSIOL, V49, P321, DOI 10.1085/jgp.49.2.321; Nelson ME, 2011, CURR BIOL, V21, pR528, DOI 10.1016/j.cub.2011.03.045; Ogawa H, 2002, P NATL ACAD SCI USA, V99, P15977, DOI 10.1073/pnas.202622299; ORLOWSKI J, 1988, J BIOL CHEM, V263, P10436; Ortega H., 1986, SMITHS CONTR ZOOL, V437, P1, DOI DOI 10.5479/SI.00810282.437; Palmgren MG, 2011, ANNU REV BIOPHYS, V40, P243, DOI 10.1146/annurev.biophys.093008.131331; Peng L, 1997, J NEUROSCI, V17, P3488; Rajarao SJR, 2001, GENOME RES, V11, P1211, DOI 10.1101/gr.186001; Richards JG, 2003, J EXP BIOL, V206, P4475, DOI 10.1242/jeb.00701; Semple JW, 2002, MAR BIOTECHNOL, V4, P512, DOI 10.1007/s10126-002-0031-z; SHENKEL S, 1991, J GEN PHYSIOL, V97, P1013, DOI 10.1085/jgp.97.5.1013; SKOU JC, 1992, J BIOENERG BIOMEMBR, V24, P249; SOMLO C, 1977, CELL TISSUE RES, V185, P115, DOI 10.1007/BF00226673; SWEADNER KJ, 1992, CAN J PHYSIOL PHARM, V70, pS255, DOI 10.1139/y92-269; SWEADNER KJ, 1989, BIOCHIM BIOPHYS ACTA, V988, P185, DOI 10.1016/0304-4157(89)90019-1; SZABO T, 1966, ANAT REC, V155, P103, DOI 10.1002/ar.1091550112; Taguchi K, 2007, NEUROSCI LETT, V413, P42, DOI 10.1016/j.neulet.2006.11.061; Therien AG, 2000, AM J PHYSIOL-CELL PH, V279, pC541, DOI 10.1152/ajpcell.2000.279.3.C541; Valasco T, 2003, ELECTROPHORUS ELECTR; Wilson Jonathan Mark, 2007, P359; Wong ML, 2005, BIOTECHNIQUES, V39, P75, DOI 10.2144/05391RV01; Xu KY, 2005, BIOCHEM BIOPH RES CO, V338, P1669, DOI 10.1016/j.bbrc.2005.10.067; Zahler R, 1997, J GEN PHYSIOL, V110, P201, DOI 10.1085/jgp.110.2.201	65	11	11	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0118352	10.1371/journal.pone.0118352	http://dx.doi.org/10.1371/journal.pone.0118352			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25793901	Green Published, gold, Green Submitted			2022-12-27	WOS:000352084200020
J	Gilbert, F; Richard, JB; Lapie-Legouis, P; Beck, F; Vercambre, MN				Gilbert, Fabien; Richard, Jean-Baptiste; Lapie-Legouis, Pascale; Beck, Francois; Vercambre, Marie-Noel			Health Behaviors: Is There Any Distinction for Teachers? A Cross-Sectional Nationwide Study	PLOS ONE			English	Article							SHORT-SLEEP DURATION; EPIDEMIOLOGIC SURVEY; PHYSICAL-ACTIVITY; TOBACCO SMOKING; PREVENTION; POPULATION; PREVALENCE; ATTITUDES; OCCUPATION; EDUCATORS	Background Health behaviors, as important modifiable determinants of health, are consistently targeted by prevention messages. Teachers, as educators and role models, may play a key-role in bringing such messages to children and adolescents. It is not clear which areas of prevention could be improved in collaboration with teachers to promote healthy behaviors at the population level through health education in schools. Methods to evaluate teacher's health awareness, we compared their health/risk behaviors to those of non-teachers, taking into account demographic and socioeconomic factors that could confound crude differences. We used data from the 2010 Health Barometer, a cross-sectional nationally-representative French survey conducted by telephone among 27,653 persons aged 15-85. Adjusting sequentially for potential confounders, we compared six indicators of lifestyle and risky conducts (at-risk drinking, current smoking, cannabis use, gambling, corpulence, sleep duration) between teachers (n = 725) and two comparison groups: other occupations (n = 12,483) on the one hand, and other intermediate and managerial/professional occupations (n = 6,026) on the other. Results In the fully-adjusted models, teachers were less likely than other occupations to smoke, to have used cannabis in the last 12 months, to gamble regularly and to be overweight or obese. When restricting the comparison group to other occupations belonging to the same socio-professional category, differences were attenuated, but remain highly significant for tobacco, cannabis and gambling. No significant differences were observed between teachers and non-teachers regarding alcohol use and sleep duration, once important confounders had been adjusted for. Conclusions Our results suggest that teachers behave on the whole more healthily than other adults with a similar demographic and socioeconomic profile. The absence of a teacher distinction toward at-risk drinking needs to be examined in more detail.	[Gilbert, Fabien; Lapie-Legouis, Pascale; Vercambre, Marie-Noel] MGEN Fdn Publ Hlth, Paris, France; [Richard, Jean-Baptiste] Natl Inst Prevent & Hlth Educ INPES, St Denis, France; [Beck, Francois] French Monitoring Ctr Drugs & Drug Addict OFDT, St Denis, France; [Beck, Francois] Univ Paris 05, Ctr Rech Psychotropes Sante Mentale Soc CESAMES, INSERM, U611,Sorbonne Paris Cite,CNRS,UMR 8136, F-75270 Paris, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Vercambre, MN (corresponding author), MGEN Fdn Publ Hlth, Paris, France.	mvercambre@mgen.fr		Richard, Jean-Baptiste/0000-0002-4193-9159; Vercambre, Marie-Noel/0000-0002-9735-4651; Beck, Francois/0000-0002-4880-1638	MGEN Foundation for Public Health; National Institute for Prevention and Health Education (INPES)	MGEN Foundation for Public Health; National Institute for Prevention and Health Education (INPES)(Institut National de la Sante et de la Recherche Medicale (Inserm))	This work was supported by the MGEN Foundation for Public Health. The 2010 Health Barometer was funded and carried out by the National Institute for Prevention and Health Education (INPES). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARIC L, 1979, MED KLIN, V74, P1648; Barrueco M, 2000, Allergol Immunopathol (Madr), V28, P219; Beck F, 2013, REV NEUROL-FRANCE, V169, P956, DOI 10.1016/j.neurol.2013.02.011; BECK F, 2013, HLTH BAROMETER 2010; Beck F, 2013, 2010 HLTH BAROMETER; Ben Abdelaziz A., 2007, Eastern Mediterranean Health Journal, V13, P907; Bin YS, 2013, AM J EPIDEMIOL, V177, P826, DOI 10.1093/aje/kws308; BREWLEY BR, 1979, J EPIDEMIOL COMMUN H, V33, P219, DOI 10.1136/jech.33.3.219; Chan CMS, 2010, HEALTH PROMOT INT, V25, P412, DOI 10.1093/heapro/daq031; Cook-Cottone C, 2009, PSYCHOL SCHOOLS, V46, P695, DOI 10.1002/pits.20409; DEPP, 2010, STAT BENCHM REF TEAC; Drivsholm T, 2006, SCAND J PUBLIC HEALT, V34, P623, DOI 10.1080/14034940600607616; El Ghezal S., 2012, 4 C INT RES U ED SAN, P391; Franco M, 2011, AM J MED, V124, P95, DOI 10.1016/j.amjmed.2010.08.015; Gache P, 2005, ALCOHOL CLIN EXP RES, V29, P2001, DOI 10.1097/01.alc.0000187034.58955.64; GEOFFROYPEREZ B, 2006, ANAL MORTALITE CAUSE; Goldberg M, 2001, AM J EPIDEMIOL, V154, P373, DOI 10.1093/aje/154.4.373; Guillemin F, 1997, Sante Publique, V9, P35; Higgins C W, 1983, Health Educ, V14, P24; Insee, 2012, EMPL WORKF 2010 KEY; Jackson CL, 2013, AM J EPIDEMIOL, V178, P1442, DOI 10.1093/aje/kwt159; Kealey KA, 2000, HEALTH EDUC BEHAV, V27, P64, DOI 10.1177/109019810002700107; KISH L, 1949, J AM STAT ASSOC, V44, P380, DOI 10.2307/2280236; Kovess-Masfety V, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-101; Laaksonen M, 2003, J EPIDEMIOL COMMUN H, V57, P711, DOI 10.1136/jech.57.9.711; Laaksonen M, 2003, SCAND J PUBLIC HEALT, V31, P37, DOI 10.1080/14034940210/33915; Launay M, 2010, EUR J PUBLIC HEALTH, V20, P151, DOI 10.1093/eurpub/ckp149; Lemanne D, 2013, ONCOLOGY-NY, V27, P580; Luckhaupt SE, 2010, SLEEP, V33, P149, DOI 10.1093/sleep/33.2.149; Maguire KB, 2009, J ENVIRON MANAGE, V90, P3528, DOI 10.1016/j.jenvman.2009.06.005; Maziak W, 2000, East Mediterr Health J, V6, P352; McLellan L, 1999, SOC SCI MED, V49, P611, DOI 10.1016/S0277-9536(99)00136-7; McTiernan A, 2003, ONCOLOGIST, V8, P326, DOI 10.1634/theoncologist.8-4-326; Merini C, 2012, 4 C INT RES U ED SAN, P193; Mocan N, 2013, HEPAC HLTH EC PREV C, DOI [10.1007/s10198-013-0473-4, DOI 10.1007/S10198-013-0473-4]; Myers-Clack SA, 2001, J SCHOOL HEALTH, V71, P462, DOI 10.1111/j.1746-1561.2001.tb07327.x; Ohida T, 2000, J Epidemiol, V10, P16; Papart J.-P, 2003, SANTE ENSEIGNANTS ED; PARKERSON GR, 1990, MED CARE, V28, P1056, DOI 10.1097/00005650-199011000-00007; Pyle SA, 2006, PSYCHOL SCHOOLS, V43, P361, DOI 10.1002/pits.20146; Rhodes C., 2012, SANTE HOMME, V422, P41; Swift DL, 2013, CIRC J, V77, P281, DOI 10.1253/circj.CJ-13-0007; Vallet L.A., 2000, ED FORMATIONS, P56; Vamos S, 2007, HEALTH EDUC BEHAV, V34, P376, DOI 10.1177/1090198106288513; Vercambre MN, 2012, J CLIN EPIDEMIOL, V65, P1181, DOI 10.1016/j.jclinepi.2012.05.002; Virtanen M, 2007, J EPIDEMIOL COMMUN H, V61, P326, DOI 10.1136/jech.2006.052878; Weyers S, 2010, GLOB HEALTH PROMOT, V17, P25, DOI 10.1177/1757975910365232; World Health Organization, BMI CLASS GLOB DAT B	48	9	9	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0120040	10.1371/journal.pone.0120040	http://dx.doi.org/10.1371/journal.pone.0120040			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CE8IA	25793968	Green Published, Green Submitted, gold			2022-12-27	WOS:000352084200137
J	Haddeland, PJ; Junge, C; Serbezov, D; Vollestad, LA				Haddeland, Peter Jorgen; Junge, Claudia; Serbezov, Dimitar; Vollestad, Leif Asbjorn			Genetic Parentage Analysis Confirms a Polygynandrous Breeding System in the European Grayling (Thymallus thymallus)	PLOS ONE			English	Article							INDIVIDUAL REPRODUCTIVE SUCCESS; TROUT SALMO-TRUTTA; EARLY-LIFE-HISTORY; BROWN TROUT; CROSS-AMPLIFICATION; MICROSATELLITE LOCI; WATER TEMPERATURE; SEXUAL SELECTION; BODY-SIZE; POPULATION	Knowing the breeding system of a species is important in order to understand individual variation in reproductive success. Large variation in reproductive success and thus reproductive skew strongly impacts on the effective number of breeders and thus the long-term effective population size (N-e). Fishes, in particular species belonging to the salmonid family, exhibit a wide diversity of breeding systems. In general, however, breeding systems are rarely studied in detail in the wild. Here we examine the breeding system of the spring-spawning European grayling Thymallus thymallus from a small Norwegian stream using parentage assignment based on the genotyping of 19 polymorphic microsatellite loci. In total 895 individual grayling fry and 154 mature grayling (57 females and 97 males) were genotyped. A total of 466 offspring were assigned a father, a mother, or a parent pair with a confidence of 90% or higher. Successfully reproducing males had on average 11.9 +/- 13.3 (SD) offspring with on average 2.1 +/- 1.2 partners, whereas successful females had on average 9.5 +/- 12.8 offspring and 2.3 +/- 1.5 partners. Parents with more partners also produced more offspring. Thus the grayling breeding system within this small stream revealed a polygynandrous breeding system, similar to what has been observed for many other salmonid fish species. The present study thus unambiguously corroborates a polygynadrous breeding system in the European grayling. This knowledge is critical for managing populations of this species, which has suffered significant local population declines throughout its range over the last several decades.	[Haddeland, Peter Jorgen; Junge, Claudia; Serbezov, Dimitar; Vollestad, Leif Asbjorn] Univ Oslo, Dept Biosci, Ctr Ecol & Evolutionary Synth, N-0316 Oslo, Norway; [Haddeland, Peter Jorgen] Norwegian Inst Publ Hlth, Dept Genet Kinship & Ident, N-0403 Oslo, Norway; [Junge, Claudia] Univ Adelaide, Sch Biol Sci, Southern Seas Ecol Labs, Adelaide, SA 5005, Australia; [Serbezov, Dimitar] Natl Agcy Fisheries & Aquaculture, Sofia 1606, Bulgaria	University of Oslo; Norwegian Institute of Public Health (NIPH); University of Adelaide	Vollestad, LA (corresponding author), Univ Oslo, Dept Biosci, Ctr Ecol & Evolutionary Synth, POB 1066, N-0316 Oslo, Norway.	avollest@ibv.uio.no	Vøllestad, Leif Asbjørn/H-7305-2019	Vøllestad, Leif Asbjørn/0000-0002-9389-7982	Norwegian Research Council [177728]; Marie Curie EST program	Norwegian Research Council(Research Council of NorwayEuropean Commission); Marie Curie EST program(European Commission)	This study was financially supported by the Norwegian Research Council (http://www.forskningsradet.no/en/Home_page/1177315753906; project no 177728 to LAV) and the Marie Curie EST program (http://cordis.europa.eu/mariecurie-actions/est/home.html) under the 6th framework (to CJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aljanabi SM, 1997, NUCLEIC ACIDS RES, V25, P4692, DOI 10.1093/nar/25.22.4692; Andersson Malte, 1994; Avise JC, 2002, ANNU REV GENET, V36, P19, DOI 10.1146/annurev.genet.36.030602.090831; BARDONNET A, 1993, J FISH BIOL, V43, P755; Barson N, 2006, EVOLUTION, V63, P549; Bentzen P, 2001, J HERED, V92, P127, DOI 10.1093/jhered/92.2.127; Blanchfield PJ, 2003, MOL ECOL, V12, P2417, DOI 10.1046/j.1365-294X.2003.01917.x; Clutton-Brock T, 2007, SCIENCE, V318, P1882, DOI 10.1126/science.1133311; Coleman SW, 2011, BIOL J LINN SOC, V103, P735, DOI 10.1111/j.1095-8312.2011.01673.x; Crow JF, 1988, GENETICS, V10, P783; Darchambeau F, 1997, J FISH BIOL, V51, P1066, DOI 10.1111/j.1095-8649.1997.tb01545.x; Dickerson BR, 2005, ECOLOGY, V86, P347, DOI 10.1890/03-625; Diggs MD, 2008, MOL ECOL RESOUR, V8, P828, DOI 10.1111/j.1755-0998.2007.02081.x; ELLIOTT JM, 1987, ARCH HYDROBIOL, V109, P257; EMLEN ST, 1977, SCIENCE, V197, P215, DOI 10.1126/science.327542; FABRICIUS ERIC, 1955, REPT INST FRESHWATER RES DROTTNINGHOLM, V36, P75; Fleming IA, 1998, CAN J FISH AQUAT SCI, V55, P59, DOI 10.1139/cjfas-55-S1-59; Fleming IA, 2003, EVOLUTION ILLUMINATED: SALMON AND THEIR RELATIVES, P264; Fleming IA, 1996, REV FISH BIOL FISHER, V6, P379, DOI 10.1007/BF00164323; Garant D, 2001, J HERED, V92, P137, DOI 10.1093/jhered/92.2.137; Gregersen F, 2008, ECOL FRESHW FISH, V17, P110, DOI 10.1111/j.1600-0633.2007.00264.x; Gregersen F, 2006, ECOL FRESHW FISH, V15, P237, DOI 10.1111/j.1600-0633.2006.00129.x; Grimardias D, 2012, ECOL FRESHW FISH, V21, P495, DOI 10.1111/j.1600-0633.2012.00572.x; GROSS MR, 1991, ECOLOGY, V72, P1180, DOI 10.2307/1941091; Hadfield JD, 2006, MOL ECOL, V15, P3715, DOI 10.1111/j.1365-294X.2006.03050.x; Haugen TO, 2000, J EVOLUTION BIOL, V13, P897, DOI 10.1046/j.1420-9101.2000.00242.x; HUMPESCH UH, 1985, ARCH HYDROBIOL, V104, P129; Jones OR, 2010, MOL ECOL RESOUR, V10, P551, DOI 10.1111/j.1755-0998.2009.02787.x; Junge C, 2011, HEREDITY, V106, P460, DOI 10.1038/hdy.2010.160; Junge C, 2010, CONSERV GENET RESOUR, V2, P219, DOI 10.1007/s12686-009-9147-z; Junge C, 2011, THESIS U OSLO OSLO; Kalinowski ST, 2007, MOL ECOL, V16, P1099, DOI 10.1111/j.1365-294X.2007.03089.x; Kavanagh KD, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-350; Lahnsteiner F, 2012, FISH PHYSIOL BIOCHEM, V38, P455, DOI 10.1007/s10695-011-9526-8; Marshall TC, 1998, MOL ECOL, V7, P639, DOI 10.1046/j.1365-294x.1998.00374.x; Mateescu RG, 2005, J HERED, V96, P847, DOI 10.1093/jhered/esi109; Meraner A, 2013, KNOWL MANAG AQUAT EC, DOI 10.1051/kmae/2013046; Morrissey MB, 2009, MOL ECOL, V18, P4330, DOI 10.1111/j.1365-294X.2009.04318.x; Mylonas CC, 2005, AQUACULTURE, V246, P467, DOI 10.1016/j.aquaculture.2005.02.046; NORTHCOTE TG, 1995, REV FISH BIOL FISHER, V5, P141; Olsen JB, 1998, MOL ECOL, V7, P1087; Ovidio M, 2004, FOLIA ZOOL, V53, P87; Papakostas S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5071; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Poncin P, 1996, J FISH BIOL, V48, P802, DOI 10.1006/jfbi.1995.9998; SAS Institute Inc, 2010, US JMP 9; Seamons TR, 2004, CAN J FISH AQUAT SCI, V61, P193, DOI 10.1139/F03-158; Serbezov D, 2012, EVOL APPL, V5, P607, DOI 10.1111/j.1752-4571.2012.00239.x; Serbezov D, 2010, MOL ECOL, V19, P3193, DOI 10.1111/j.1365-294X.2010.04744.x; Susnik S, 2000, J ANIM SCI, V78, P488; Susnik S, 1999, MOL ECOL, V8, P1756, DOI 10.1046/j.1365-294x.1999.00723-2.x; Susnik S, 1999, ANIM GENET, V30, P478, DOI 10.1046/j.1365-2052.1999.00498-18.x; Thomassen G, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-360; Wang JL, 2004, GENETICS, V166, P1963, DOI 10.1534/genetics.166.4.1963; Wang JL, 2003, GENETICS, V163, P429; Waples RS, 2003, EVOLUTION ILLUMINATED: SALMON AND THEIR RELATIVES, P295; Wedekind C, 2013, CONSERV BIOL, V27, P229, DOI 10.1111/j.1523-1739.2012.01909.x	57	8	10	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0122032	10.1371/journal.pone.0122032	http://dx.doi.org/10.1371/journal.pone.0122032			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25793629	Green Published, gold, Green Submitted			2022-12-27	WOS:000352083900168
J	Jia, HH; Wang, C; Wang, F; Liu, SC; Li, GL; Guo, XQ				Jia, Haihong; Wang, Chen; Wang, Fang; Liu, Shuchang; Li, Guilin; Guo, Xingqi			GhWRKY68 Reduces Resistance to Salt and Drought in Transgenic Nicotiana benthamiana	PLOS ONE			English	Article							WRKY TRANSCRIPTION FACTORS; ABIOTIC STRESS RESPONSES; ABSCISIC-ACID; SUPEROXIDE-DISMUTASE; SIGNAL-TRANSDUCTION; DISEASE RESISTANCE; OXIDATIVE STRESS; OSMOTIC-STRESS; DNA-BINDING; TOLERANCE	The WRKY transcription factors modulate numerous physiological processes, including plant growth, development and responses to various environmental stresses. Currently, our understanding of the functions of the majority of the WRKY family members and their possible roles in signalling crosstalk is limited. In particular, very few WRKYs have been identified and characterised from an economically important crop, cotton. In this study, we characterised a novel group IIc WRKY gene, GhWRKY68, which is induced by different abiotic stresses and multiple defence-related signalling molecules. The beta-glucuronidase activity driven by the GhWRKY68 promoter was enhanced after exposure to drought, salt, abscisic acid (ABA) and H2O2. The overexpression of GhWRKY68 in Nicotiana benthamiana reduced resistance to drought and salt and affected several physiological indices. GhWRKY68 may mediate salt and drought responses by modulating ABA content and enhancing the transcript levels of ABA-responsive genes. GhWRKY68-overexpressing plants exhibited reduced tolerance to oxidative stress after drought and salt stress treatments, which correlated with the accumulation of reactive oxygen species (ROS), reduced enzyme activities, elevated malondialdehyde (MDA) content and altered ROS-related gene expression. These results indicate that GhWRKY68 is a transcription factor that responds to drought and salt stresses by regulating ABA signalling and modulating cellular ROS.	[Jia, Haihong; Wang, Chen; Wang, Fang; Liu, Shuchang; Li, Guilin; Guo, Xingqi] Shandong Agr Univ, Coll Life Sci, State Key Lab Crop Biol, Tai An, Shandong, Peoples R China	Shandong Agricultural University	Guo, XQ (corresponding author), Shandong Agr Univ, Coll Life Sci, State Key Lab Crop Biol, Tai An, Shandong, Peoples R China.	xqguo@sdau.edu.cn			National Natural Science Foundation of China [31171837, 31471424]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was financially supported with two fundings from the National Natural Science Foundation of China (Grant no. 31171837; 31471424). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbasi AR, 2007, PLANT PHYSIOL, V143, P1720, DOI 10.1104/pp.106.094771; Apel K, 2004, ANNU REV PLANT BIOL, V55, P373, DOI 10.1146/annurev.arplant.55.031903.141701; Barrero JM, 2006, PLANT CELL ENVIRON, V29, P2000, DOI 10.1111/j.1365-3040.2006.01576.x; Baumann K, 1999, PLANT CELL, V11, P323, DOI 10.1105/tpc.11.3.323; Ben Rejeb K, 2014, PLANT PHYSIOL BIOCH, V80, P278, DOI 10.1016/j.plaphy.2014.04.007; Besseau S, 2012, J EXP BOT, V63, P2667, DOI 10.1093/jxb/err450; Bhattacharjee S, 2005, CURR SCI INDIA, V89, P1113; Chen LG, 2012, BBA-GENE REGUL MECH, V1819, P120, DOI 10.1016/j.bbagrm.2011.09.002; Chen ZZ, 2006, MOL CELL BIOL, V26, P6902, DOI 10.1128/MCB.00433-06; Cheng Y, 2012, PLANT PHYSIOL, V159, P810, DOI 10.1104/pp.112.196816; Chi YJ, 2013, MOL PLANT, V6, P287, DOI 10.1093/mp/sst026; Christianson JA, 2010, PLANT CELL PHYSIOL, V51, P21, DOI 10.1093/pcp/pcp163; Cutler SR, 2010, ANNU REV PLANT BIOL, V61, P651, DOI 10.1146/annurev-arplant-042809-112122; Dang FF, 2013, PLANT CELL ENVIRON, V36, P757, DOI 10.1111/pce.12011; Ding ZJ, 2014, PLANT J, V79, P810, DOI 10.1111/tpj.12597; Eulgem T, 2007, CURR OPIN PLANT BIOL, V10, P366, DOI 10.1016/j.pbi.2007.04.020; Finkelstein Ruth R., 2002, Plant Cell, V14, pS15; Fujii H, 2009, NATURE, V462, P660, DOI 10.1038/nature08599; Fujita M, 2006, CURR OPIN PLANT BIOL, V9, P436, DOI 10.1016/j.pbi.2006.05.014; Fujita Y, 2005, PLANT CELL, V17, P3470, DOI 10.1105/tpc.105.035659; Gao S, 2008, PLANT SOIL ENVIRON, V54, P374, DOI 10.17221/410-PSE; Jia HH, 2014, J INSECT PHYSIOL, V60, P68, DOI 10.1016/j.jinsphys.2013.11.004; Jiang YJ, 2012, MOL PLANT, V5, P1375, DOI 10.1093/mp/sss080; Kishor PBK, 2014, PLANT CELL ENVIRON, V37, P300, DOI 10.1111/pce.12157; Krasensky J, 2012, J EXP BOT, V63, P1593, DOI 10.1093/jxb/err460; Kurepa J, 1998, PLANT J, V14, P759, DOI 10.1046/j.1365-313x.1998.00168.x; Leshem Y, 2010, J EXP BOT, V61, P2615, DOI 10.1093/jxb/erq099; Li J, 2013, NEW PHYTOL, V200, P455, DOI 10.1111/nph.12378; Li SJ, 2011, PLANTA, V233, P1237, DOI 10.1007/s00425-011-1375-2; Lichtenthaler H., 1983, BIOCHEM SOC T, V11, P591, DOI [10.1042/bst0110591, 10.1042/BST0110591, DOI 10.1042/BST0110591]; Liu QL, 2014, PLANT MOL BIOL REP, V32, P282, DOI 10.1007/s11105-013-0639-3; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luo X, 2012, J PLANT PHYSIOL, V169, P1192, DOI 10.1016/j.jplph.2012.03.019; Ma Y, 2009, SCIENCE, V324, P1064, DOI 10.1126/science.1172408; Miao Y, 2007, PLANT MOL BIOL, V65, P63, DOI 10.1007/s11103-007-9198-z; Miller G, 2010, PLANT CELL ENVIRON, V33, P453, DOI 10.1111/j.1365-3040.2009.02041.x; Niu CF, 2012, PLANT CELL ENVIRON, V35, P1156, DOI 10.1111/j.1365-3040.2012.02480.x; Olivella C, 1998, BIOL PLANTARUM, V41, P613, DOI 10.1023/A:1001860920706; Park CY, 2005, FEBS LETT, V579, P1545, DOI 10.1016/j.febslet.2005.01.057; Pei ZM, 2000, NATURE, V406, P731, DOI 10.1038/35021067; Porebski S, 1997, PLANT MOL BIOL REP, V15, P8, DOI 10.1007/BF02772108; Raghavendra AS, 2010, TRENDS PLANT SCI, V15, P395, DOI 10.1016/j.tplants.2010.04.006; Ren XZ, 2010, PLANT J, V63, P417, DOI 10.1111/j.1365-313X.2010.04248.x; Rushton DL, 2012, PLANT BIOTECHNOL J, V10, P2, DOI 10.1111/j.1467-7652.2011.00634.x; Rushton PJ, 2010, TRENDS PLANT SCI, V15, P247, DOI 10.1016/j.tplants.2010.02.006; Shan DP, 2007, NEW PHYTOL, V176, P70, DOI 10.1111/j.1469-8137.2007.02160.x; Shi J, 2011, BMC MOL BIOL, V12, DOI 10.1186/1471-2199-12-22; Shi J, 2010, PLANT MOL BIOL, V74, P1, DOI 10.1007/s11103-010-9661-0; Shinozaki K, 2007, J EXP BOT, V58, P221, DOI 10.1093/jxb/erl164; SINGH NK, 1989, PLANT PHYSIOL, V90, P1096, DOI 10.1104/pp.90.3.1096; Smith CW, 1999, COTTON ORIGIN HISTOR; Tao Z, 2011, J EXP BOT, V62, P4863, DOI 10.1093/jxb/err144; Ulker B, 2004, CURR OPIN PLANT BIOL, V7, P491, DOI 10.1016/j.pbi.2004.07.012; Urao T, 1996, PLANT J, V10, P1145, DOI 10.1046/j.1365-313X.1996.10061145.x; Wang LN, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-103; Wang YN, 2013, MOL PLANT PATHOL, V14, P131, DOI 10.1111/j.1364-3703.2012.00836.x; Wang Z, 2014, MOL PLANT PATHOL, V15, P677, DOI 10.1111/mpp.12123; Wei KF, 2012, DNA RES, V19, P153, DOI 10.1093/dnares/dsr048; Xiong LM, 2006, PLANT PHYSIOL, V142, P1065, DOI 10.1104/pp.106.084632; Yan HR, 2014, PLANT CELL PHYSIOL, V55, P2060, DOI 10.1093/pcp/pcu133; Yang YN, 2000, PLANT J, V22, P543, DOI 10.1046/j.1365-313x.2000.00760.x; Yoshida T, 2014, CURR OPIN PLANT BIOL, V21, P133, DOI 10.1016/j.pbi.2014.07.009; Yoshida T, 2015, PLANT CELL ENVIRON, V38, P35, DOI 10.1111/pce.12351; Yoshimura K, 2004, PLANT J, V37, P21, DOI 10.1046/j.1365-313X.2003.01930.x; Yu FF, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-144; Zhang L, 2012, J EXP BOT, V63, P3935, DOI 10.1093/jxb/ers086; Zhang LA, 2011, FEBS J, V278, P1367, DOI 10.1111/j.1742-4658.2011.08056.x; Zhang X, 2004, PLANT PHYSIOL, V136, P4150, DOI 10.1104/pp.104.046573; Zhang X, 2011, PLANT MOL BIOL, V75, P365, DOI 10.1007/s11103-011-9732-x; Zhao L, 2012, PHYTOCHEM ANALYSIS, V23, P647, DOI 10.1002/pca.2368; Zheng Hui-Qiong, 2006, Zhiwu Shengli yu Fenzi Shengwuxue Xuebao, V32, P189; Zheng L, 2013, PLANT MOL BIOL, V82, P303, DOI 10.1007/s11103-013-0063-y; Zhou QY, 2008, PLANT BIOTECHNOL J, V6, P486, DOI 10.1111/j.1467-7652.2008.00336.x; Zhu JK, 2002, ANNU REV PLANT BIOL, V53, P247, DOI 10.1146/annurev.arplant.53.091401.143329	74	68	86	0	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0120646	10.1371/journal.pone.0120646	http://dx.doi.org/10.1371/journal.pone.0120646			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25793865	gold, Green Published, Green Submitted			2022-12-27	WOS:000352083900062
J	Kume, S; Yamato, M; Tamura, Y; Jin, GH; Nakano, M; Miyashige, Y; Eguchi, A; Ogata, Y; Goda, N; Iwai, K; Yamano, E; Watanabe, Y; Soga, T; Kataoka, Y				Kume, Satoshi; Yamato, Masanori; Tamura, Yasuhisa; Jin, Guanghua; Nakano, Masayuki; Miyashige, Yukiharu; Eguchi, Asami; Ogata, Yoshiyuki; Goda, Nobuhito; Iwai, Kazuhiro; Yamano, Emi; Watanabe, Yasuyoshi; Soga, Tomoyoshi; Kataoka, Yosky			Potential Biomarkers of Fatigue Identified by Plasma Metabolome Analysis in Rats	PLOS ONE			English	Article							ANIMAL-MODEL; PROTEIN; LIVER; ACID	In the present study, prior to the establishment of a method for the clinical diagnosis of chronic fatigue in humans, we validated the utility of plasma metabolomic analysis in a rat model of fatigue using capillary electrophoresis-mass spectrometry (CE-MS). In order to obtain a fatigued animal group, rats were placed in a cage filled with water to a height of 2.2 cm for 5 days. A food-restricted group, in which rats were limited to 10 g/d of food (around 50% of the control group), was also assessed. The food-restricted group exhibited weight reduction similar to that of the fatigued group. CE-MS measurements were performed to evaluate the profile of food intake-dependent metabolic changes, as well as the profile in fatigue loading, resulting in the identification of 48 metabolites in plasma. Multivariate analyses using hierarchical clustering and principal component analysis revealed that the plasma metabolome in the fatigued group showed clear differences from those in the control and food-restricted groups. In the fatigued group, we found distinctive changes in metabolites related to branched-chain amino acid metabolism, urea cycle, and proline metabolism. Specifically, the fatigued group exhibited significant increases in valine, leucine, isoleucine, and 2-oxoisopentanoate, and significant decreases in citrulline and hydroxyproline compared with the control and food-restricted groups. Plasma levels of total nitric oxide were increased in the fatigued group, indicating systemic oxidative stress. Further, plasma metabolites involved in the citrate cycle, such as cis-aconitate and isocitrate, were reduced in the fatigued group. The levels of ATP were significantly decreased in the liver and skeletal muscle, indicative of a deterioration in energy metabolism in these organs. Thus, this comprehensive metabolic analysis furthered our understanding of the pathophysiology of fatigue, and identified potential diagnostic biomarkers based on fatigue pathophysiology.	[Kume, Satoshi; Yamato, Masanori; Tamura, Yasuhisa; Jin, Guanghua; Nakano, Masayuki; Miyashige, Yukiharu; Eguchi, Asami; Kataoka, Yosky] RIKEN Ctr Life Sci Technol, Div Biofunct Dynam Imaging, Cellular Funct Imaging Team, Kobe, Hyogo, Japan; [Nakano, Masayuki; Yamano, Emi; Watanabe, Yasuyoshi; Kataoka, Yosky] Osaka City Univ, Grad Sch Med, Dept Physiol, Osaka 558, Japan; [Ogata, Yoshiyuki] Osaka Prefecture Univ, Grad Sch Life & Environm Sci, Osaka, Japan; [Goda, Nobuhito] Waseda Univ, Sch Adv Sci & Engn, Dept Life Sci & Med Biosci, Tokyo, Japan; [Iwai, Kazuhiro] Kyoto Univ, Grad Sch Med, Dept Mol & Cellular Physiol, Kyoto, Japan; [Watanabe, Yasuyoshi] RIKEN Ctr Life Sci Technol, Pathophysiol & Hlth Sci Team, Kobe, Hyogo, Japan; [Soga, Tomoyoshi] Keio Univ, Inst Adv Biosci, Tsuruoka, Yamagata, Japan	RIKEN; Osaka Metropolitan University; Osaka Metropolitan University; Waseda University; Kyoto University; RIKEN; Keio University	Kataoka, Y (corresponding author), RIKEN Ctr Life Sci Technol, Div Biofunct Dynam Imaging, Cellular Funct Imaging Team, Kobe, Hyogo, Japan.	kataokay@riken.jp	IWAI, KAZUHIRO/GSN-7385-2022; Goda, Nobuhito/W-2468-2019; Yamano, Emi/AAL-6201-2020; Soga, Tomoyoshi/B-8105-2014; Kume, Satoshi/C-4160-2017	Yamano, Emi/0000-0003-3907-5360; Soga, Tomoyoshi/0000-0001-9502-2509; Iwai, Kazuhiro/0000-0001-5620-5951; Kume, Satoshi/0000-0001-7481-2843; Goda, Nobuhito/0000-0003-0295-4257	Core Research for Evolutional Science and Technology (CREST) Program of the Japan Science and Technology Agency (JST); JSPS KAKENHI [25882051]; Ministry of Education, Culture, Sports, Science and Technology of the Japanese Government [25460399]	Core Research for Evolutional Science and Technology (CREST) Program of the Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Ministry of Education, Culture, Sports, Science and Technology of the Japanese Government(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported by the Core Research for Evolutional Science and Technology (CREST) Program of the Japan Science and Technology Agency (JST), by a Grant-in-Aid for Research Activity Start-up to SK (JSPS KAKENHI Grant Number 25882051), and by a Grant-in-Aid for Scientific Research (C) from the Ministry of Education, Culture, Sports, Science and Technology of the Japanese Government to YK (JSPS KAKENHI Grant Number 25460399). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bain JR, 2009, DIABETES, V58, P2429, DOI 10.2337/db09-0580; Berlett BS, 1997, J BIOL CHEM, V272, P20313, DOI 10.1074/jbc.272.33.20313; BLOMSTRAND E, 1991, EUR J APPL PHYSIOL, V63, P83, DOI 10.1007/BF00235174; Bulau P, 2007, AM J PHYSIOL-LUNG C, V292, pL18, DOI 10.1152/ajplung.00076.2006; Chaudhuri A, 2004, LANCET, V363, P978, DOI 10.1016/S0140-6736(04)15794-2; Chen ZP, 1999, FEBS LETT, V443, P285, DOI 10.1016/S0014-5793(98)01705-0; Chida J, 2012, ANAL CHIM ACTA, V727, P8, DOI 10.1016/j.aca.2012.03.022; Edoardo Gaude FC, 2013, CURRENT METABOLOMICS, V1, P180; FUKUDA K, 1994, ANN INTERN MED, V121, P953, DOI 10.7326/0003-4819-121-12-199412150-00009; Hirayama A, 2009, CANCER RES, V69, P4918, DOI 10.1158/0008-5472.CAN-08-4806; Houtkooper RH, 2011, SCI REP-UK, V1, DOI 10.1038/srep00134; Hussein SZ, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/109636; Ishii N, 2007, SCIENCE, V316, P593, DOI 10.1126/science.1132067; Jin GH, 2009, NUTRITION, V25, P597, DOI 10.1016/j.nut.2008.11.021; Kuhlencordt PJ, 2001, CIRCULATION, V103, P3099, DOI 10.1161/01.CIR.103.25.3099; LEHMANN M, 1995, INT J SPORTS MED, V16, P155, DOI 10.1055/s-2007-972984; Lentner C., 1981, GEIGY SCI TABLES, V1; Lubec B, 1997, FREE RADICAL BIO MED, V22, P355, DOI 10.1016/S0891-5849(96)00386-3; Maekawa K, 2013, J MOL CELL CARDIOL, V59, P76, DOI 10.1016/j.yjmcc.2013.02.008; Matsui T, 2012, J PHYSIOL-LONDON, V590, P607, DOI 10.1113/jphysiol.2011.217919; Mizuno K, 2007, J NEURAL TRANSM, V114, P555, DOI 10.1007/s00702-006-0608-1; MORI M, 1981, J BIOL CHEM, V256, P4127; Ogawa T, 2005, J NEUROCHEM, V95, P1156, DOI 10.1111/j.1471-4159.2005.03436.x; Ogawa T, 2009, J NEUROCHEM, V109, P1389, DOI 10.1111/j.1471-4159.2009.06057.x; Rohn H, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-139; Sessa WC, 2004, J CELL SCI, V117, P2427, DOI 10.1242/jcs.01165; Soga T, 2000, ANAL CHEM, V72, P1236, DOI 10.1021/ac990976y; Soga T, 2006, J BIOL CHEM, V281, P16768, DOI 10.1074/jbc.M601876200; Soga T, 2011, J HEPATOL, V55, P896, DOI 10.1016/j.jhep.2011.01.031; Soga T, 2009, ANAL CHEM, V81, P6165, DOI 10.1021/ac900675k; Takeuchi K, 2013, J PROTEOME RES, V12, P1399, DOI 10.1021/pr3010452; Tanaka M, 2003, NEUROSCI LETT, V352, P159, DOI 10.1016/j.neulet.2003.08.051; Tanaka M, 2008, NUTRITION, V24, P599, DOI 10.1016/j.nut.2008.03.001; Team RC, 2014, R LANG ENV STAT COMP; Villas-Boas SG, 2005, MASS SPECTROM REV, V24, P613, DOI 10.1002/mas.20032; WALKER EA, 1993, J GEN INTERN MED, V8, P436, DOI 10.1007/BF02599621; Xia JG, 2012, NUCLEIC ACIDS RES, V40, pW127, DOI 10.1093/nar/gks374; Xia JG, 2011, NAT PROTOC, V6, P743, DOI 10.1038/nprot.2011.319; Yasui M, 2014, GLIA	39	35	36	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0120106	10.1371/journal.pone.0120106	http://dx.doi.org/10.1371/journal.pone.0120106			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25793974	Green Submitted, gold, Green Published			2022-12-27	WOS:000352084200146
J	Kunitomi, T; Hashiguchi, M; Mochizuki, M				Kunitomi, Taro; Hashiguchi, Masayuki; Mochizuki, Mayumi			Effect of Common Comparators in Indirect Comparison Analysis of the Effectiveness of Different Inhaled Corticosteroids in the Treatment of Asthma	PLOS ONE			English	Article							MODERATE PERSISTENT ASTHMA; DRY POWDER INHALER; FLUTICASONE/FORMOTEROL COMBINATION THERAPY; METERED-DOSE INHALER; MOMETASONE FUROATE; BECLOMETHASONE DIPROPIONATE; PROPIONATE POWDER; EFFICACY; SAFETY; BUDESONIDE	Purpose Indirect comparison (IC) and direct comparison (DC) of four inhaled corticosteroid (CS) treatments for asthma were conducted, and the factors that may influence the results of IC were investigated. Among those factors, we focused on the effect of common comparator selection in the treatment of asthma, where little control group bias or placebo effect is expected. Method IC and DC were conducted using the change from baseline in forced expiratory volume in 1 s (FEV1(L)) as an outcome parameter. Differences between inhaled CS were evaluated to compare the results of IC and DC. As a common comparator for IC, placebo (PLB) or mometasone (MOM) was selected. Whether the results of IC are affected by the selection of a common comparator and whether the results of IC and DC are consistent were examined. Results 23 articles were identified by a literature search. Our results showed that ICs yielded results similar to DCs in the change from baseline of FEV1(L). No statistically significant difference was observed in inconsistency analysis between ICs and DCs. It was clinically and statistically confirmed that ICs with PLB and those with MOM did not differ in terms of the results of FEV1(L) analysis in this dataset. Conclusion This study demonstrated that ICs among inhaled CS can deliver results consistent with those of DCs when using the change from baseline in FEV1(L) as an outcome parameter in asthma patients. It was also shown that using an active comparator has similar results if there is no effect of control group bias. It should be emphasized that the investigation of control group bias is a key factor in conducting relevant ICs so that an appropriate common comparator can be selected.	[Kunitomi, Taro; Hashiguchi, Masayuki; Mochizuki, Mayumi] Keio Univ, Fac Pharm, Tokyo, Japan; [Kunitomi, Taro] GlaxoSmithKline KK, Dev & Med Affairs Div, Tokyo, Japan	Keio University; GlaxoSmithKline	Kunitomi, T (corresponding author), Keio Univ, Fac Pharm, Tokyo, Japan.	taro-k@z7.keio.jp			GlaxoSmithKline K.K.	GlaxoSmithKline K.K.(GlaxoSmithKline)	The authors report no conflicts of interest. Taro Kunitomi is a full time employee of GlaxoSmithKline K.K. and works for Development and Medical Affairs division. No financial support was done by GlaxoSmithKline K.K. to this work. Taro Kunitomi has no patent and relationship to any development and marketed products related to this work. GlaxoSmithKline K.K. provided support in the form of salaries for author TK, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of the authors are articulated in the 'author contributions' section. Other authors, Mayumi Mochizuki and Masayuki Hashiguchi, are not employed by a commercial company. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.	Bensch GW, 2006, ANN ALLERG ASTHMA IM, V96, P533, DOI 10.1016/S1081-1206(10)63547-8; Bousquet J, 2000, EUR RESPIR J, V16, P808, DOI 10.1183/09031936.00.16580800; Bronsky E, 1998, ANN ALLERG ASTHMA IM, V80, P295, DOI 10.1016/S1081-1206(10)62972-9; Bucher HC, 1997, J CLIN EPIDEMIOL, V50, P683, DOI 10.1016/S0895-4356(97)00049-8; Corren J, 2003, INT J CLIN PRACT, V57, P567; Corren J, 2007, CLIN THER, V29, P823, DOI 10.1016/j.clinthera.2007.05.011; Corren J, 2013, RESP MED, V107, P180, DOI 10.1016/j.rmed.2012.10.025; Galant SP, 1999, ANN ALLERG ASTHMA IM, V82, P273, DOI 10.1016/S1081-1206(10)62608-7; Global Initiative for Asthma, POCK GUID ASTHM MAN; Harnest U, 2008, J ASTHMA, V45, P215, DOI 10.1080/02770900801890646; Israel E, 2002, J ALLERGY CLIN IMMUN, V110, P847, DOI 10.1067/mai.2002.129413; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Jansen JP, 2014, VALUE HEALTH, V17, P157, DOI 10.1016/j.jval.2014.01.004; Kemp JP, 2000, J ALLERGY CLIN IMMUN, V106, P485, DOI 10.1067/mai.2000.109431; Kunitomi T, 2014, BRIT J CLIN PHARMACO, V77, P767, DOI 10.1111/bcp.12221; Lawrence M, 1997, AM J RESP CRIT CARE, V156, P744, DOI 10.1164/ajrccm.156.3.9608058; McFadden ER, 1999, J ALLERGY CLIN IMMUN, V104, P46, DOI 10.1016/S0091-6749(99)70112-0; Nathan RA, 2001, ANN ALLERG ASTHMA IM, V86, P203, DOI 10.1016/S1081-1206(10)62692-0; Nathan RA, 2000, CHEST, V118, P296, DOI 10.1378/chest.118.2.296; Nathan RA, 1999, ANN ALLERG ASTHMA IM, V82, P521, DOI 10.1016/S1081-1206(10)63159-6; Nathan RA, 2012, BMC PULM MED, V12, DOI 10.1186/1471-2466-12-67; O'Connor B, 2001, ANN ALLERG ASTHMA IM, V86, P397, DOI 10.1016/S1081-1206(10)62485-4; Pearlman DS, 2004, J ASTHMA, V41, P797, DOI 10.1081/JAS-200038368; Pearlman DS, 1999, ANN ALLERG ASTHMA IM, V82, P257, DOI 10.1016/S1081-1206(10)62606-3; Pearlman DS, 1997, ANN ALLERG ASTHMA IM, V78, P356, DOI 10.1016/S1081-1206(10)63196-1; Pinnas JL, 2005, J ASTHMA, V42, P865, DOI 10.1080/02770900500371294; Salanti G, 2012, RES SYNTH METHODS, V3, P80, DOI 10.1002/jrsm.1037; Salanti G, 2009, J CLIN EPIDEMIOL, V62, P857, DOI 10.1016/j.jclinepi.2008.10.001; Santanello NC, 1999, EUR RESPIR J, V14, P23, DOI 10.1034/j.1399-3003.1999.14a06.x; Shapiro G, 2000, AM J RESP CRIT CARE, V161, P527, DOI 10.1164/ajrccm.161.2.9905091; Song FJ, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1147; ZuWallack R, 2000, CHEST, V118, P303, DOI 10.1378/chest.118.2.303	32	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0120836	10.1371/journal.pone.0120836	http://dx.doi.org/10.1371/journal.pone.0120836			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25793900	Green Submitted, Green Published, gold			2022-12-27	WOS:000352083900080
J	Leclere, L; Fransolet, M; Cote, F; Cambier, P; Arnould, T; Van Cutsem, P; Michiels, C				Leclere, Lionel; Fransolet, Maude; Cote, Francois; Cambier, Pierre; Arnould, Thierry; Van Cutsem, Pierre; Michiels, Carine			Heat-Modified Citrus Pectin Induces Apoptosis-Like Cell Death and Autophagy in HepG2 and A549 Cancer Cells	PLOS ONE			English	Article							POLY(ADP-RIBOSE) POLYMERASE; PROTEASOMAL DEGRADATION; CLEAVAGE; INHIBITION; CASPASE-3; BIOSYNTHESIS; METASTASIS; ACTIVATION; RESISTANCE; ETOPOSIDE	Cancer is still one of the leading causes of death worldwide, and finding new treatments remains a major challenge. Previous studies showed that modified forms of pectin, a complex polysaccharide present in the primary plant cell wall, possess anticancer properties. Nevertheless, the mechanism of action of modified pectin and the pathways involved are unclear. Here, we show that citrus pectin modified by heat treatment induced cell death in HepG2 and A549 cells. The induced cell death differs from classical apoptosis because no DNA cleavage was observed. In addition, Z-VAD-fmk, a pan-caspase inhibitor, did not influence the observed cell death in HepG2 cells but appeared to be partly protective in A549 cells, indicating that heat-modified citrus pectin might induce caspase-independent cell death. An increase in the abundance of the phosphatidylethanolamine-conjugated Light Chain 3 (LC3) protein and a decrease in p62 protein abundance were observed in both cell types when incubated in the presence of heat-modified citrus pectin. These results indicate the activation of autophagy. To our knowledge, this is the first time that autophagy has been revealed in cells incubated in the presence of a modified form of pectin. This autophagy activation appears to be protective, at least for A549 cells, because its inhibition with 3-methyladenine increased the observed modified pectin-induced cytotoxicity. This study confirms the potential of modified pectin to improve chemotherapeutic cancer treatments.	[Leclere, Lionel; Fransolet, Maude; Cote, Francois; Arnould, Thierry; Michiels, Carine] Univ Namur, Lab Biochem & Cellular Biol URBC, NARILIS, B-5000 Namur, Belgium; [Cambier, Pierre; Van Cutsem, Pierre] Univ Namur, Lab Plant Cellular Biol URBV, B-5000 Namur, Belgium	University of Namur; University of Namur	Michiels, C (corresponding author), Univ Namur, Lab Biochem & Cellular Biol URBC, NARILIS, 61 Rue Bruxelles, B-5000 Namur, Belgium.	carine.michiels@unamur.be		Van Cutsem, Pierre/0000-0001-9456-2802	FRIA fellowship (Fonds pour la formation a la Recherche dans l'Industrie et dans l'Agriculture, Brussels, Belgium)	FRIA fellowship (Fonds pour la formation a la Recherche dans l'Industrie et dans l'Agriculture, Brussels, Belgium)(Fonds de la Recherche Scientifique - FNRS)	L. Leclere was the recipient of a FRIA fellowship (Fonds pour la formation a la Recherche dans l'Industrie et dans l'Agriculture, Brussels, Belgium). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Benbrook D. M., 2012, Experimental Oncology, V34, P286; Chaitanya GV, 2010, CELL COMMUN SIGNAL, V8, DOI 10.1186/1478-811X-8-31; Chauhan D, 2005, CANCER RES, V65, P8350, DOI 10.1158/0008-5472.CAN-05-0163; CHEN JW, 1988, J BIOL CHEM, V263, P8754; Chen L, 2003, MOL PHARMACOL, V64, P334, DOI 10.1124/mol.64.2.334; Codogno P, 2005, CELL DEATH DIFFER, V12, P1509, DOI 10.1038/sj.cdd.4401751; Cosse JPJ, 2009, NEOPLASIA, V11, P976, DOI 10.1593/neo.09632; de Bruin EC, 2003, CELL DEATH DIFFER, V10, P1204, DOI 10.1038/sj.cdd.4401296; Duriez PJ, 1997, BIOCHEM CELL BIOL, V75, P337, DOI 10.1139/bcb-75-4-337; Gobeil S, 2001, CELL DEATH DIFFER, V8, P588, DOI 10.1038/sj.cdd.4400851; Hajji N, 2008, ONCOGENE, V27, P3134, DOI 10.1038/sj.onc.1210976; Han SB, 2006, CANCER LETT, V243, P264, DOI 10.1016/j.canlet.2005.11.040; Harholt J, 2010, PLANT PHYSIOL, V153, P384, DOI 10.1104/pp.110.156588; HARRIS AS, 1988, J NEUROSCI, V8, P2640; Hazra B, 2012, FRONT PHARMACOL, V2, DOI 10.3389/fphar.2011.00094; Huang Zhi-liang, 2008, Nan Fang Yi Ke Da Xue Xue Bao, V28, P1358; Jackson CL, 2007, GLYCOBIOLOGY, V17, P805, DOI 10.1093/glycob/cwm054; Janicke RU, 1998, J BIOL CHEM, V273, P15540, DOI 10.1074/jbc.273.25.15540; Johansen T, 2011, AUTOPHAGY, V7, P279, DOI 10.4161/auto.7.3.14487; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Laussmann MA, 2011, CELL DEATH DIFFER, V18, P1584, DOI 10.1038/cdd.2011.27; Leclere L, 2013, FRONT PHARMACOL, V4, DOI 10.3389/fphar.2013.00128; Liu HY, 2008, WORLD J GASTROENTERO, V14, P7386, DOI 10.3748/wjg.14.7386; Maiuri MC, 2007, NAT REV MOL CELL BIO, V8, P741, DOI 10.1038/nrm2239; McStay GP, 2008, CELL DEATH DIFFER, V15, P322, DOI 10.1038/sj.cdd.4402260; Mizushima N, 2007, AUTOPHAGY, V3, P542, DOI 10.4161/auto.4600; Mohnen D, 2008, CURR OPIN PLANT BIOL, V11, P266, DOI 10.1016/j.pbi.2008.03.006; Nangia-Makker P, 2002, JNCI-J NATL CANCER I, V94, P1854, DOI 10.1093/jnci/94.24.1854; Notte A, 2011, BIOCHEM PHARMACOL, V82, P427, DOI 10.1016/j.bcp.2011.06.015; Qiu JH, 2000, J NEUROSCI, V20, P259, DOI 10.1523/JNEUROSCI.20-01-00259.2000; Rommelaere G, 2012, INT J BIOCHEM CELL B, V44, P139, DOI 10.1016/j.biocel.2011.10.009; Seibenhener ML, 2004, MOL CELL BIOL, V24, P8055, DOI 10.1128/MCB.24.18.8055-8068.2004; Sohn D, 2005, J BIOL CHEM, V280, P5267, DOI 10.1074/jbc.M408585200; Soldani C, 2002, APOPTOSIS, V7, P321, DOI 10.1023/A:1016119328968; Suzuki Y, 2001, P NATL ACAD SCI USA, V98, P8662, DOI 10.1073/pnas.161506698; Vayssade M, 2010, PHYTOTHER RES, V24, P982, DOI 10.1002/ptr.3040; Wang KKW, 2000, TRENDS NEUROSCI, V23, P20, DOI 10.1016/S0166-2236(99)01479-4; Yamamoto A, 1998, CELL STRUCT FUNCT, V23, P33, DOI 10.1247/csf.23.33; Yan J, 2010, INTEGR CANCER THER, V9, P197, DOI 10.1177/1534735410369672; Zeng RX, 2014, CELL BIOL INT	40	36	38	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0115831	10.1371/journal.pone.0115831	http://dx.doi.org/10.1371/journal.pone.0115831			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25794149	Green Submitted, Green Published, gold			2022-12-27	WOS:000352084200004
J	Sampaio, AS; Hounie, AG; Petribu, K; Cappi, C; Morais, I; Vallada, H; do Rosario, MC; Stewart, SE; Fargeness, J; Mathews, C; Arnold, P; Hanna, GL; Richter, M; Kennedy, J; Fontenelle, L; Pereira, CAD; Pauls, DL; Miguel, EC				Sampaio, Aline Santos; Hounie, Ana Gabriela; Petribu, Katia; Cappi, Carolina; Morais, Ivanil; Vallada, Homero; do Rosario, Maria Conceicao; Stewart, S. Evelyn; Fargeness, Jesen; Mathews, Carol; Arnold, Paul; Hanna, Gregory L.; Richter, Margaret; Kennedy, James; Fontenelle, Leonardo; de Braganca Pereira, Carlos Alberto; Pauls, David L.; Miguel, Euripedes Constantino			COMT and MAO-A Polymorphisms and Obsessive-Compulsive Disorder: A Family-Based Association Study	PLOS ONE			English	Article							CATECHOL-O-METHYLTRANSFERASE; MONOAMINE-OXIDASE-A; MAJOR DEPRESSIVE DISORDER; LA-TOURETTE-SYNDROME; HIGH-ACTIVITY ALLELE; FUNCTIONAL POLYMORPHISM; BIPOLAR DISORDER; PREFERENTIAL TRANSMISSION; GENETIC ASSOCIATION; ANXIETY DISORDERS	Objective Obsessive-compulsive disorder (OCD) is a common and debilitating psychiatric illness. Although a genetic component contributes to its etiology, no single gene or mechanism has been identified to the OCD susceptibility. The catechol-O-methyltransferase (COMT) and monoamine oxidase A (MAO-A) genes have been investigated in previous OCD studies, but the results are still unclear. More recently, Taylor (2013) in a comprehensive meta-analysis of genetic association studies has identified COMT and MAO-A polymorphisms involved with OCD. In an effort to clarify the role of these two genes in OCD vulnerability, a family-based association investigation was performed as an alternative strategy to the classical case-control design. Methods Transmission disequilibrium analyses were performed after genotyping 13 single-nucleotide polymorphisms (eight in COMT and five in MAO-A) in 783 OCD trios (probands and their parents). Four different OCD phenotypes (from narrow to broad OCD definitions) and a SNP x SNP epistasis were also analyzed. Results OCD, broad and narrow phenotypes, were not associated with any of the investigated COMT and MAO-A polymorphisms. In addition, the analyses of gene-gene interaction did not show significant epistatic influences on phenotype between COMT and MAO-A. Conclusions The findings do not support an association between DSM-IV OCD and the variants of COMT or MAO-A. However, results from this study cannot exclude the contribution of these genes in the manifestation of OCD. The evaluation of broader spectrum phenotypes could help to understand the role of these and other genes in the pathophysiology of OCD and its spectrum disorders.	[Sampaio, Aline Santos; Hounie, Ana Gabriela; Cappi, Carolina; Morais, Ivanil; Vallada, Homero; Miguel, Euripedes Constantino] Univ Sao Paulo, Fac Med, Dept & Inst Psychiat, Sao Paulo, SP, Brazil; [Sampaio, Aline Santos] Univ Fed Bahia, Serv Med Univ, Salvador, BA, Brazil; [Petribu, Katia] Univ Pernambuco, Fac Ciencias Med, Recife, PE, Brazil; [do Rosario, Maria Conceicao] Univ Fed Sao Paulo, Sao Paulo, SP, Brazil; [Stewart, S. Evelyn] British Columbia Mental Hlth & Addict Res Inst, Vancouver, BC, Canada; [Stewart, S. Evelyn; Pauls, David L.] Massachusetts Gen Hosp, PNGU, Boston, MA 02114 USA; [Fargeness, Jesen] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Mathews, Carol] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA USA; [Arnold, Paul] Hosp Sick Children, Program Genet & Genome Biol, Toronto, ON M5G 1X8, Canada; [Hanna, Gregory L.] Univ Michigan, Dept Psychiat, Ann Arbor, MI 48109 USA; [Richter, Margaret] Sunnybrook Hlth Sci Ctr, Frederick W Thompson Anxiety Disorders Ctr, Toronto, ON M4N 3M5, Canada; [Kennedy, James] Univ Toronto, Ctr Addict & Mental Hlth, Toronto, ON, Canada; [Fontenelle, Leonardo] Univ Fed Rio de Janeiro, Inst Psiquiatria, IPUB, Programa Ansiedade & Depressao, Rio De Janeiro, Brazil; [de Braganca Pereira, Carlos Alberto] Univ Sao Paulo, Inst Math & Stat, Dept Stat, Sao Paulo, SP, Brazil	Universidade de Sao Paulo; Universidade Federal da Bahia; Universidade de Pernambuco (UPE); Universidade Federal de Sao Paulo (UNIFESP); Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; University of California System; University of California San Francisco; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Michigan System; University of Michigan; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada; Universidade Federal do Rio de Janeiro; Universidade de Sao Paulo	Sampaio, AS (corresponding author), Univ Sao Paulo, Fac Med, Dept & Inst Psychiat, Sao Paulo, SP, Brazil.	alinestsampaio@gmail.com	Stewart, Evelyn/K-6961-2014; Vallada, Homero/D-1333-2014; Faria, Carolina Pereira de Morais/HHT-0142-2022; do Rosario, Maria Conceição/E-5213-2012; Kennedy, James Lowery/AAZ-6947-2020; Mathews, Carol A A/M-8922-2017; Fontenelle, Leonardo/D-3321-2013; Miguel, Euripedes C/B-2871-2008; Hounie, Ana G/D-2931-2014; Cappi, Carolina/P-1811-2017; Pereira, Carlos Alberto de Braganca/O-5022-2015	Vallada, Homero/0000-0001-5123-8295; do Rosario, Maria Conceição/0000-0002-9687-0072; Kennedy, James Lowery/0000-0002-8733-3806; Mathews, Carol A A/0000-0003-2208-7058; Fontenelle, Leonardo/0000-0001-9075-8226; Hounie, Ana G/0000-0002-5026-2880; Cappi, Carolina/0000-0001-6661-3756; Petribu, Katia/0000-0002-8861-0238; Stewart, S. Evelyn/0000-0002-0994-6383; Pereira, Carlos Alberto de Braganca/0000-0001-6315-7484; Hanna, Gregory/0000-0002-0742-6990	Brazilian governmental agencies; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, National Council for Scientific and Technological Development) [573974/2008-0]; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP, Foundation for the Support of Research in the State of Sao Paulo) [2005/55628-08, 2008/57896-8]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES -Coordination for Education of Graduated People), Brazil; Fundo de Aprimoramento Academico (FUAA-Grant for Academic Improvement); Department of Psychiatry University of Sao Paulo School of Medicine; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH085321] Funding Source: NIH RePORTER	Brazilian governmental agencies; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, National Council for Scientific and Technological Development)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP, Foundation for the Support of Research in the State of Sao Paulo)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES -Coordination for Education of Graduated People), Brazil(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundo de Aprimoramento Academico (FUAA-Grant for Academic Improvement); Department of Psychiatry University of Sao Paulo School of Medicine; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This study received financial support in the form of grants provided by the following Brazilian governmental agencies to Dr. Miguel: the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, National Council for Scientific and Technological Development, Grant number: 573974/2008-0) and the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP, Foundation for the Support of Research in the State of Sao Paulo, Grant number: 2005/55628-08 and 2008/57896-8); to Dr. Sampaio: by Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES -Coordination for Education of Graduated People), Brazil, Fundo de Aprimoramento Academico (FUAA-Grant for Academic Improvement), Department of Psychiatry University of Sao Paulo School of Medicine. Genotyping expenses were paid by Obsessive-Compulsive Foundation Genetics Collaborative Study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdolmaleky HM, 2006, HUM MOL GENET, V15, P3132, DOI 10.1093/hmg/ddl253; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Seixas AAA, 2008, CNS SPECTRUMS, V13, P1039, DOI 10.1017/S1092852900017090; Avramopoulos D, 2002, MOL PSYCHIATR, V7, P706, DOI 10.1038/sj.mp.4001070; Barr CL, 1999, MOL PSYCHIATR, V4, P492, DOI 10.1038/sj.mp.4000549; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bearden CE, 2005, CHILD NEUROPSYCHOL, V11, P109, DOI 10.1080/09297040590911239; Bienvenu OJ, 2012, PSYCHOL MED, V42, P1, DOI 10.1017/S0033291711000742; Bienvenu OJ, PSYCHOL MED, P1; BRUNNER HG, 1993, SCIENCE, V262, P578, DOI 10.1126/science.8211186; BRUNNER HG, 1993, AM J HUM GENET, V52, P1032; Craddock N, 1997, BRIT J PSYCHIAT, V170, P526, DOI 10.1192/bjp.170.6.526; Dawling S, 2001, CANCER RES, V61, P6716; de Mathis MA, 2008, EUR PSYCHIAT, V23, P187, DOI 10.1016/j.eurpsy.2008.01.002; de Mathis MA, 2006, CNS SPECTRUMS, V11, P762, DOI 10.1017/S1092852900014899; First M SR, 1996, STRUCTURED CLIN INTE; GOODMAN WK, 1989, ARCH GEN PSYCHIAT, V46, P1006; Gothelf D, 2007, INT J NEUROPSYCHOPH, V10, P301, DOI 10.1017/S1461145706006699; Hosak L, 2007, EUR PSYCHIAT, V22, P276, DOI 10.1016/j.eurpsy.2007.02.002; Kaufman J, 1997, J AM ACAD CHILD PSY, V36, P980, DOI 10.1097/00004583-199707000-00021; Lachman HM, 1996, PHARMACOGENETICS, V6, P243, DOI 10.1097/00008571-199606000-00007; Lahey BB, 2011, ARCH GEN PSYCHIAT, V68, P181, DOI 10.1001/archgenpsychiatry.2010.192; LECKMAN JF, 1989, J AM ACAD CHILD PSY, V28, P566, DOI 10.1097/00004583-198907000-00015; Lee SG, 2005, HUM GENET, V116, P319, DOI 10.1007/s00439-004-1239-y; Li T, 2004, AM J MED GENET B, V129B, P120, DOI 10.1002/ajmg.b.30024; Li T, 1996, PSYCHIAT GENET, V6, P131, DOI 10.1097/00041444-199623000-00005; Manor I, 2002, MOL PSYCHIATR, V7, P626, DOI 10.1038/sj.mp.4001037; Massat I, 2005, MOL PSYCHIATR, V10, P598, DOI 10.1038/sj.mp.4001615; Micallef J, 2001, CLIN NEUROPHARMACOL, V24, P191, DOI 10.1097/00002826-200107000-00002; Michaelovsky E, 2005, AM J MED GENET B, V139B, P45, DOI 10.1002/ajmg.b.30230; Miguel EC, 2005, MOL PSYCHIATR, V10, P258, DOI 10.1038/sj.mp.4001617; Miguel EC, 2008, REV BRAS PSIQUIATR, V30, P185, DOI 10.1590/S1516-44462008000300003; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Nestadt G, 2003, BIOL PSYCHIAT, V53, P914, DOI 10.1016/S0006-3223(02)01677-3; Nestadt G, 2009, PSYCHOL MED, V39, P1491, DOI 10.1017/S0033291708004753; Nicodemus KK, 2007, HUM GENET, V120, P889, DOI 10.1007/s00439-006-0257-3; Pallanti S, 2008, CNS SPECTRUMS, V13, P6, DOI 10.1017/S1092852900026882; Palmatier MA, 2004, MOL PSYCHIATR, V9, P859, DOI 10.1038/sj.mp.4001496; Pauls David L, 2010, Dialogues Clin Neurosci, V12, P149; PAULS DL, 1991, AM J HUM GENET, V48, P154; PAULS DL, 1995, AM J PSYCHIAT, V152, P76; Purcell S, 2005, AM J HUM GENET, V76, P249, DOI 10.1086/427886; Purcell S, 2003, BIOINFORMATICS, V19, P149, DOI 10.1093/bioinformatics/19.1.149; Purcell S, 2007, AM J HUMAN GENETICS, V81; Riva A, 2002, BIOINFORMATICS, V18, P1681, DOI 10.1093/bioinformatics/18.12.1681; Rolls ET, 2008, EUR J NEUROSCI, V28, P782, DOI 10.1111/j.1460-9568.2008.06379.x; Sabeti PC, 2002, NATURE, V419, P832, DOI 10.1038/nature01140; Samochowiec J, 2004, PSYCHIAT RES, V128, P21, DOI 10.1016/j.psychres.2004.05.012; Sampaio AS, 2013, REV PSIQUIATRIA CLIN, V40; Sanders AR, 2005, MOL PSYCHIATR, V10, P353, DOI 10.1038/sj.mp.4001586; Sery O, 2006, NEUROENDOCRINOL LETT, V27, P231; Shiels MS, 2008, PREV MED, V47, P116, DOI 10.1016/j.ypmed.2008.03.013; Shifman S, 2004, AM J MED GENET B, V128B, P61, DOI 10.1002/ajmg.b.30032; Shifman S, 2002, AM J HUM GENET, V71, P1296, DOI 10.1086/344514; Stewart SE, 2013, MOL PSYCHIATR, V18, P788, DOI 10.1038/mp.2012.85; Taylor S, 2013, MOL PSYCHIATR, V18, P799, DOI 10.1038/mp.2012.76; Taylor S, 2013, MOL PSYCHIAT; Tiihonen J, 1999, MOL PSYCHIATR, V4, P286, DOI 10.1038/sj.mp.4000509; van Grootheest DS, 2005, TWIN RES HUM GENET, V8, P450, DOI 10.1375/183242705774310060; Wonodi I, 2003, AM J MED GENET B, V120B, P47, DOI 10.1002/ajmg.b.20037; Wray NR, 2008, AM J MED GENET B, V147B, P1314, DOI 10.1002/ajmg.b.30744; Yu YWY, 2005, NEUROPSYCHOPHARMACOL, V30, P1719, DOI 10.1038/sj.npp.1300785	62	12	12	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0119592	10.1371/journal.pone.0119592	http://dx.doi.org/10.1371/journal.pone.0119592			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25793616	Green Published, Green Submitted, gold			2022-12-27	WOS:000352084200098
J	Santibanez, M; Aguirre, E; Belda, S; Aragones, N; Saez, J; Rodriguez, JC; Galiana, A; Sola-Vera, J; Ruiz-Garcia, M; Paz-Zulueta, M; Sarabia-Lavin, R; Brotons, A; Lopez-Girona, E; Perez, E; Sillero, C; Royo, G				Santibanez, Miguel; Aguirre, Estefania; Belda, Sofa; Aragones, Nuria; Saez, Jesus; Rodriguez, Juan Carlos; Galiana, Antonio; Sola-Vera, Javier; Ruiz-Garcia, Montserrat; Paz-Zulueta, Maria; Sarabia-Lavin, Raquel; Brotons, Alicia; Lopez-Girona, Elena; Perez, Estefana; Sillero, Carlos; Royo, Gloria			Relationship between Tobacco, cagA and vacA i1 Virulence Factors and Bacterial Load in Patients Infected by Helicobacter pylori	PLOS ONE			English	Article							VACUOLATING CYTOTOXIN ALLELES; GASTRIC-CANCER; INTESTINAL METAPLASIA; INTERMEDIATE REGION; SMOKING; RISK; ASSOCIATION; STRAINS; ULCER; RECOMBINATION	Background and Aim Several biological and epidemiological studies support a relationship between smoking and Helicobacter pylori (H. pylori) to increase the risk of pathology. However, there have been few studies on the potential synergistic association between specific cagA and vacA virulence factors and smoking in patients infected by Helicobacter pylori. We studied the relationship between smoking and cagA, vacA i1 virulence factors and bacterial load in H. pylori infected patients. Methods Biopsies of the gastric corpus and antrum from 155 consecutive patients in whom there was clinical suspicion of infection by H. pylori were processed. In 106 patients H. pylori infection was detected. Molecular methods were used to quantify the number of microorganisms and presence of cagA and vacA i1 genes. A standardized questionnaire was used to obtain patients' clinical data and lifestyle variables, including tobacco and alcohol consumption. Adjusted Odds Ratios (ORadjusted) were estimated by unconditional logistic regression. Results cagA was significantly associated with active-smoking at endoscope: ORadjusted 4.52. Evidence of association was found for vacA i1 (ORadjusted 3.15). Bacterial load was higher in active-smokers, although these differences did not yield statistical significance (median of 262.2 versus 79.4 copies of H. pylori per cell). Conclusions The association between smoking and a higher risk of being infected by a virulent bacterial population and with higher bacterial load, support a complex interaction between H. pylori infection and environmental factors.	[Santibanez, Miguel] Univ Cantabria, Dept Salud Publ, E-39005 Santander, Spain; [Santibanez, Miguel] IDIVAL Inst Invest Marques de Valdecilla, Santander, Spain; [Aguirre, Estefania; Belda, Sofa; Galiana, Antonio; Ruiz-Garcia, Montserrat; Lopez-Girona, Elena; Royo, Gloria] Microbiol S Elche Univ Gen Hosp, Elche, Alicante, Spain; [Aragones, Nuria] CIBER Epidemiol & Publ Hlth CIBERESP, Madrid, Spain; [Aragones, Nuria] ISCIII, Natl Ctr Epidemiol, Environm & Canc Epidemiol Unit, Madrid, Spain; [Saez, Jesus; Sola-Vera, Javier; Brotons, Alicia; Perez, Estefana; Sillero, Carlos] Digest Med S Elche Univ Gen Hosp, Elche, Alicante, Spain; [Rodriguez, Juan Carlos] Microbiol S Alicante Univ Gen Hosp, Alicante, Spain; [Rodriguez, Juan Carlos; Royo, Gloria] Miguel Hernandez Univ, Elche, Spain; [Paz-Zulueta, Maria; Sarabia-Lavin, Raquel] Univ Cantabria, Dept Enfermeria, E-39005 Santander, Spain	Universidad de Cantabria; Hospital Universitario Marques de Valdecilla (HUMV); CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Instituto de Salud Carlos III; General University Hospital of Alicante; Universidad Miguel Hernandez de Elche; Universidad de Cantabria	Santibanez, M (corresponding author), Univ Cantabria, Dept Salud Publ, E-39005 Santander, Spain.	santibanezm@unican.es	Lopez-Girona, Elena/V-2790-2019; Aragones, Nuria/O-5962-2015; Santibanez, Miguel/L-3323-2017	Lopez-Girona, Elena/0000-0003-0376-6135; Aragones, Nuria/0000-0003-0983-2156; Santibanez, Miguel/0000-0003-2634-615X; Sarabia-Lavin, Raquel/0000-0003-3679-4327; Galiana, Antonio/0000-0002-1134-1914; RODRIGUEZ DIAZ, JUAN CARLOS/0000-0001-8007-5739; Brotons, Alicia/0000-0003-3017-1671	Fundacion Bienvenida Navarro-Luciano Tripodi; Generalitat Valenciana Proyectos [precompetitivos/2008/317]; Fundacion para el fomento de la Investigacion del Hospital General Universitario de Elche	Fundacion Bienvenida Navarro-Luciano Tripodi; Generalitat Valenciana Proyectos; Fundacion para el fomento de la Investigacion del Hospital General Universitario de Elche	This work was supported by the collaboration of the Fundacion Bienvenida Navarro-Luciano Tripodi (research grants 2009); the Generalitat Valenciana Proyectos precompetitivos/2008/317 and Fundacion para el fomento de la Investigacion del Hospital General Universitario de Elche 2008. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Argent RH, 2008, J MED MICROBIOL, V57, P145, DOI 10.1099/jmm.0.47465-0; ATHERTON JC, 1995, J BIOL CHEM, V270, P17771, DOI 10.1074/jbc.270.30.17771; Atherton JC, 1999, J CLIN MICROBIOL, V37, P2979, DOI 10.1128/JCM.37.9.2979-2982.1999; Belda S, 2012, CLIN MICROBIOL INFEC, V18, pE251, DOI 10.1111/j.1469-0691.2012.03884.x; Belda Sofia, 2012, Diagn Microbiol Infect Dis, V74, P248, DOI 10.1016/j.diagmicrobio.2012.07.007; Brenner H, 2002, INT J CANCER, V98, P446, DOI 10.1002/ijc.10201; Cellini L, 2006, SCAND J GASTROENTERO, V41, P280, DOI 10.1080/00365520510024223; Cellini L, 2003, LETT APPL MICROBIOL, V36, P222, DOI 10.1046/j.1472-765X.2003.01295.x; Chung C, 2010, J CLIN MICROBIOL, V48, P690, DOI 10.1128/JCM.01815-09; Cover TL, 2005, NAT REV MICROBIOL, V3, P320, DOI 10.1038/nrmicro1095; DRUMM B, 1990, NEW ENGL J MED, V322, P359, DOI 10.1056/NEJM199002083220603; Falush D, 2001, P NATL ACAD SCI USA, V98, P15056, DOI 10.1073/pnas.251396098; Gonzalez CA, 2003, INT J CANCER, V107, P629, DOI 10.1002/ijc.11426; Jang S, 2010, J CLIN MICROBIOL, V48, P559, DOI 10.1128/JCM.01501-09; Jarosz M, 2000, EUR J CANCER PREV, V9, P423, DOI 10.1097/00008469-200012000-00008; Jones KR, 2011, J CLIN MICROBIOL, V49, P101, DOI 10.1128/JCM.01782-10; Kennemann L, 2011, P NATL ACAD SCI USA, V108, P5033, DOI 10.1073/pnas.1018444108; Kersulyte D, 1999, MOL MICROBIOL, V31, P31, DOI 10.1046/j.1365-2958.1999.01140.x; Kivi M, 2005, EPIDEMIOL INFECT, V133, P645, DOI 10.1017/S0950268805003900; Lai YC, 2003, WORLD J GASTROENTERO, V9, P1537, DOI 10.3748/wjg.v9.i7.1537; Letley DP, 2003, J BIOL CHEM, V278, P26734, DOI 10.1074/jbc.M304071200; Machida-Montani Ai, 2004, Gastric Cancer, V7, P46, DOI 10.1007/s10120-004-0268-5; Oldani A, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000603; Pandey A, 2014, WORLD J GASTROENTERO, V20, P6860, DOI 10.3748/wjg.v20.i22.6860; Peleteiro B, 2007, CANCER EPIDEM BIOMAR, V16, P322, DOI 10.1158/1055-9965.EPI-06-0885; Polk DB, 2010, NAT REV CANCER, V10, P403, DOI 10.1038/nrc2857; Rhead JL, 2007, GASTROENTEROLOGY, V133, P926, DOI 10.1053/j.gastro.2007.06.056; Roesler BM, 2014, CLIN MED INSIGHTS-GA, V7, P9, DOI 10.4137/CGast.S13760; Russo A, 2001, AM J GASTROENTEROL, V96, P1402, DOI 10.1111/j.1572-0241.2001.03773.x; Saez J, 2012, J CLIN MICROBIOL, V50, P3233, DOI 10.1128/JCM.01205-12; Siman JH, 2001, SCAND J GASTROENTERO, V36, P208, DOI 10.1080/003655201750065988; SOBALA GM, 1993, J CLIN PATHOL, V46, P235, DOI 10.1136/jcp.46.3.235; Suerbaum S, 1998, P NATL ACAD SCI USA, V95, P12619, DOI 10.1073/pnas.95.21.12619; Tredaniel J, 1997, INT J CANCER, V72, P565, DOI 10.1002/(SICI)1097-0215(19970807)72:4<565::AID-IJC3>3.0.CO;2-O; van Doorn LJ, 1999, GASTROENTEROLOGY, V116, P823, DOI 10.1016/S0016-5085(99)70065-X; Vannini A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098416; Wang XQ, 2011, WORLD J GASTROENTERO, V17, P3330, DOI 10.3748/wjg.v17.i28.3330; Yamazaki S, 2005, J CLIN MICROBIOL, V43, P3906, DOI 10.1128/JCM.43.8.3906-3916.2005; Yeh JM, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001451	39	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0120444	10.1371/journal.pone.0120444	http://dx.doi.org/10.1371/journal.pone.0120444			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25794002	Green Published, Green Submitted, gold			2022-12-27	WOS:000352083900037
J	Singer, HS; Mascaro-Blanco, A; Alvarez, K; Morris-Berry, C; Kawikova, I; Ben-Pazi, H; Thompson, CB; Ali, SF; Kaplan, EL; Cunningham, MW				Singer, Harvey S.; Mascaro-Blanco, Adda; Alvarez, Kathy; Morris-Berry, Christina; Kawikova, Ivana; Ben-Pazi, Hilla; Thompson, Carol B.; Ali, Syed F.; Kaplan, Edward L.; Cunningham, Madeleine W.			Neuronal Antibody Biomarkers for Sydenham's Chorea Identify a New Group of Children with Chronic Recurrent Episodic Acute Exacerbations of Tic and Obsessive Compulsive Symptoms Following a Streptococcal Infection	PLOS ONE			English	Article							DEPENDENT PROTEIN-KINASE; TOURETTE SYNDROME; DIFFERENTIATE PANDAS; SERUM AUTOANTIBODIES; MOVEMENT; RECEPTOR; HYPOTHESIS; BEHAVIOR; TUBULIN; MIMICRY	Several autoantibodies (anti-dopamine 1 (D1R) and 2 (D2R) receptors, anti-tubulin, anti-lysoganglioside-GM1) and antibody-mediated activation of calcium calmodulin dependent protein kinase II (CaMKII) signaling activity are elevated in children with Sydenham's chorea (SC). Recognizing proposed clinical and autoimmune similarities between SC and PAN-DAS (pediatric autoimmune neuropsychiatric disorder associated with a streptococcal infection), we sought to identify serial biomarker changes in a slightly different population. Antineuronal antibodies were measured in eight children (mean 11.3 years) with chronic, dramatic, recurrent tics and obsessive-compulsive disorder (OCD) associated with a group A beta-hemolytic streptococcal (GABHS) respiratory tract infection, but differing because they lacked choreiform movements. Longitudinal serum samples in most subjects included two pre-exacerbation samples, Exac), one midst Exac (abrupt recurrence of tic/OCD; temporally association with a GABHS infection in six of eight subjects), and two post-Exac. Controls included four groups of unaffected children (n = 70; mean 10.8 years) obtained at four different institutions and published controls. Clinical exacerbations were not associated with a significant rise in antineuronal antibody titers. CaMKII activation was increased at the GABHS exacerbation point in 5/6 subjects, exceeded combined and published control's 95th percentile at least once in 7/8 subjects, and median values were elevated at each time point. Anti-tubulin and anti-D2R titers did not differ from published or combined control group's 95th percentile or median values. Differences in anti-lysoganglioside-GM1 and anti-D1R titers were dependent on the selected control. Variances in antibody titers and CaMKII activation were identified among the institutional control groups. Based on comparisons to published studies, results identify two groups of PANDAS: 1) a cohort, represented by this study, which lacks choreiform movements and elevated antibodies against D2R; 2) the originally reported group with choreiform movements and elevated anti-D2R antibodies, similar to SC. Increased antibody mediated CaMKII activation was found in both groups and requires further study as a potential biomarker.	[Singer, Harvey S.; Morris-Berry, Christina; Ali, Syed F.] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Singer, Harvey S.; Morris-Berry, Christina; Ali, Syed F.] Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA; [Mascaro-Blanco, Adda; Alvarez, Kathy; Cunningham, Madeleine W.] Univ Oklahoma, Hlth Sci Ctr, Dept Microbiol, Oklahoma City, OK USA; [Mascaro-Blanco, Adda; Alvarez, Kathy; Cunningham, Madeleine W.] Univ Oklahoma, Hlth Sci Ctr, Dept Immunol, Oklahoma City, OK USA; [Kawikova, Ivana] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT USA; [Ben-Pazi, Hilla] Shaare Zedek Med Ctr, Neuropediat Unit, Jerusalem, Israel; [Thompson, Carol B.] Johns Hopkins Bloomberg Sch Publ Hlth, Biostat Ctr, Baltimore, MD USA; [Kaplan, Edward L.] Univ Minnesota, Sch Med, Dept Pediat, Minneapolis, MN 55455 USA	Johns Hopkins University; Johns Hopkins University; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; Yale University; Hebrew University of Jerusalem; Shaare Zedek Medical Center; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Minnesota System; University of Minnesota Twin Cities	Singer, HS (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA.	hsinger@jhmi.edu	kawikova, ivana/GXG-1819-2022	Ali, Syed Faizan/0000-0002-0329-0635; benpazi, hilla/0000-0002-8039-4761	National Institutes of Health [HL35280]; Oklahoma Center for the Advancement of Science and Technology; National Center for Research Resources of the National Institutes of Health [UL1T000424]; National Center for Advancing Translational Sciences (NCATS) of the National Institutes [UL1T000424]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL035280, R37HL035280] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Oklahoma Center for the Advancement of Science and Technology; National Center for Research Resources of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Center for Advancing Translational Sciences (NCATS) of the National Institutes; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Financial support included funding from National Institutes of Health grant # HL35280 (MWC) and the Oklahoma Center for the Advancement of Science and Technology. Statistical support, in part, was from the National Center for Research Resources and the National Center for Advancing Translational Sciences (NCATS) of the National Institutes of Health, Grant # UL1T000424. Molecular Labs provided support in the form of a portion of salaries for some authors [MWC, AMB, KA], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ben-Pazi H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073516; Brilot F, 2011, NEUROLOGY, V76, P1508, DOI 10.1212/WNL.0b013e3182181090; Brimberg L, 2012, NEUROPSYCHOPHARMACOL, V37, P2076, DOI 10.1038/npp.2012.56; Cardoso F, 2011, SYDENHAMS CHOREA HDB, P221, DOI [10.1016/B978-0-444-52014-2.00014-8, DOI 10.1016/B978-0-444-52014-2.00014-8]; Church AJ, 2003, J NEUROL NEUROSUR PS, V74, P602, DOI 10.1136/jnnp.74.5.602; Cox CJ, 2013, J IMMUNOL, V191, P5524, DOI 10.4049/jimmunol.1102592; Dale RC, 2006, J NEUROIMMUNOL, V172, P187, DOI 10.1016/j.jneuroim.2005.10.014; Dale RC, 2012, BRAIN, V135, P3453, DOI 10.1093/brain/aws256; ERONDU NE, 1985, J NEUROSCI, V5, P3270; Friedman M, 1937, J AM STAT ASSOC, V32, P675, DOI 10.2307/2279372; Galvin JE, 2000, J CLIN INVEST, V106, P217, DOI 10.1172/JCI7132; Gause C, 2009, J NEUROIMMUNOL, V214, P118, DOI 10.1016/j.jneuroim.2009.06.015; Huerta PT, 2006, P NATL ACAD SCI USA, V103, P678, DOI 10.1073/pnas.0510055103; Johnson DR., 1996, LAB DIAGNOSIS GROUP; Johnson DR, 2010, CLIN INFECT DIS, V50, P481, DOI 10.1086/650167; Kaplan EL, 1998, PEDIATRICS, V101, P86, DOI 10.1542/peds.101.1.86; Kirvan CA, 2006, AUTOIMMUNITY, V39, P21, DOI 10.1080/08916930500484757; Kirvan CA, 2003, NAT MED, V9, P914, DOI 10.1038/nm892; Kirvan CA, 2007, J IMMUNOL, V178, P7412, DOI 10.4049/jimmunol.178.11.7412; Kirvan CA, 2006, J NEUROIMMUNOL, V179, P173, DOI 10.1016/j.jneuroim.2006.06.017; Klug JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045323; KRUSKAL WH, 1952, J AM STAT ASSOC, V47, P583, DOI 10.1080/01621459.1952.10483441; Kurlan R, 1998, NEUROLOGY, V50, P1530, DOI 10.1212/WNL.50.6.1530; Kurlan R, 2004, PEDIATRICS, V113, P883, DOI 10.1542/peds.113.4.883; Kurlan R, 2004, MOVEMENT DISORD, V19, P371, DOI 10.1002/mds.20107; Kurlan R, 2008, PEDIATRICS, V121, P1188, DOI 10.1542/peds.2007-2657; Leckman JF, 2011, J AM ACAD CHILD PSY, V50, P108, DOI 10.1016/j.jaac.2010.10.011; Lin HQ, 2010, BIOL PSYCHIAT, V67, P684, DOI 10.1016/j.biopsych.2009.08.020; Lotan D, 2014, BRAIN BEHAV IMMUN, V38, P249, DOI 10.1016/j.bbi.2014.02.009; Luo F, 2004, PEDIATRICS, V113, pE578, DOI 10.1542/peds.113.6.e578; Macerollo A, 2013, TREMOR OTHER HYPERK, V3; MANN HB, 1947, ANN MATH STAT, V18, P50, DOI 10.1214/aoms/1177730491; Martino D, 2009, MOVEMENT DISORD, V24, P1267, DOI 10.1002/mds.22504; Mohammad SS, 2013, NEUROPEDIATRICS, V44, P336, DOI 10.1055/s-0033-1358603; Morris CM, 2009, J NEUROL SCI, V276, P45, DOI 10.1016/j.jns.2008.08.032; Morris-Berry CM, 2013, J NEUROIMMUNOL, V264, P106, DOI 10.1016/j.jneuroim.2013.09.010; Padmanabhan S, 2008, EUR J NEUROSCI, V28, P2017, DOI 10.1111/j.1460-9568.2008.06496.x; Pavone P, 2004, PEDIATR NEUROL, V30, P107, DOI 10.1016/S0887-8994(03)00413-2; Shet A, 2002, PEDIATR INFECT DIS J, V21, P420, DOI 10.1097/00006454-200205000-00014; Singer HS, 2008, PEDIATRICS, V121, P1198, DOI 10.1542/peds.2007-2658; Singer HS, 2012, J PEDIATR-US, V160, P725, DOI 10.1016/j.jpeds.2011.11.040; Singer Harvey S, 2011, Handb Clin Neurol, V100, P641, DOI 10.1016/B978-0-444-52014-2.00046-X; Singer HS, 2005, NEUROLOGY, V65, P1701, DOI 10.1212/01.wnl.0000183223.69946.f1; Singer HS, 2003, J PSYCHOSOM RES, V55, P31, DOI 10.1016/S0022-3999(02)00582-2; Spearman C, 1907, AM J PSYCHOL, V18, P161, DOI 10.2307/1412408; Swedo S., 2012, PEDIAT THERAPEUTICS, V2, P1, DOI [DOI 10.4172/2161-0665.1000113, 10.4172/2161-0665.1000113]; Swedo SE, 1998, AM J PSYCHIAT, V155, P264; WAXHAM MN, 1993, BRAIN RES, V609, P1; Yaddanapudi K, 2010, MOL PSYCHIATR, V15, P712, DOI 10.1038/mp.2009.77; Zaccaro D, 2013, VACCINE, V31, P2756, DOI 10.1016/j.vaccine.2013.03.065	50	37	38	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0120499	10.1371/journal.pone.0120499	http://dx.doi.org/10.1371/journal.pone.0120499			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25793715	gold, Green Submitted, Green Published			2022-12-27	WOS:000352083900043
J	Ajona, D; Razquin, C; Pastor, MD; Pajares, MJ; Garcia, J; Cardenal, F; Fleischhacker, M; Lozano, MD; Zulueta, JJ; Schmidt, B; Nadal, E; Paz-Ares, L; Montuenga, LM; Pio, R				Ajona, Daniel; Razquin, Cristina; Dolores Pastor, Maria; Jose Pajares, Maria; Garcia, Javier; Cardenal, Felipe; Fleischhacker, Michael; Dolores Lozano, Maria; Zulueta, Javier J.; Schmidt, Bernd; Nadal, Ernest; Paz-Ares, Luis; Montuenga, Luis M.; Pio, Ruben			Elevated Levels of the Complement Activation Product C4d in Bronchial Fluids for the Diagnosis of Lung Cancer	PLOS ONE			English	Article							BRONCHOALVEOLAR LAVAGE; FACTOR-H; CYTOLOGICAL FLUID; TUMOR-MARKERS; BIOMARKER; BIOPSY; CELLS; GLYCOPROTEINS; BRONCHOSCOPY; METHYLATION	Molecular markers in bronchial fluids may contribute to the diagnosis of lung cancer. We previously observed a significant increase of C4d-containing complement degradation fragments in bronchoalveolar lavage (BAL) supernatants from lung cancer patients in a cohort of 50 cases and 22 controls (CUN cohort). The present study was designed to determine the diagnostic performance of these complement fragments (hereinafter jointly referred as C4d) in bronchial fluids. C4d levels were determined in BAL supernatants from two independent cohorts: the CU cohort (25 cases and 26 controls) and the HUVR cohort (60 cases and 98 controls). A series of spontaneous sputum samples from 68 patients with lung cancer and 10 controls was also used (LCCCIO cohort). Total protein content, complement C4, complement C5a, and CYFRA 21-1 were also measured in all cohorts. C4d levels were significantly increased in BAL samples from lung cancer patients. The area under the ROC curve was 0.82 (95% CI = 0.71-0.94) and 0.67 (95% CI = 0.58-0.76) for the CU and HUVR cohorts, respectively. In addition, unlike the other markers, C4d levels in BAL samples were highly consistent across the CUN, CU and HUVR cohorts. Interestingly, C4d test markedly increased the sensitivity of bronchoscopy in the two cohorts in which cytological data were available (CUN and HUVR cohorts). Finally, in the LCCCIO cohort, C4d levels were higher in sputum supernatants from patients with lung cancer (area under the ROC curve: 0.7; 95% CI = 0.56-0.83). In conclusion, C4d is consistently elevated in bronchial fluids from lung cancer patients and may be used to improve the diagnosis of the disease.	[Ajona, Daniel; Razquin, Cristina; Jose Pajares, Maria; Montuenga, Luis M.; Pio, Ruben] Ctr Appl Med Res CIMA, Program Solid Tumors & Biomarkers, Pamplona, Spain; [Dolores Pastor, Maria; Paz-Ares, Luis] Univ Seville, CSIC, Lab Oncol Mol & Nuevas Terapias, Inst Biomed Sevilla IBiS,Hosp Univ Virgen Rocio, Seville, Spain; [Jose Pajares, Maria; Montuenga, Luis M.] Univ Navarra, Sch Med, Dept Histol & Pathol, E-31080 Pamplona, Spain; [Garcia, Javier; Zulueta, Javier J.] Univ Navarra Clin, Dept Pulm Med, Pamplona, Spain; [Cardenal, Felipe; Nadal, Ernest] Catalan Inst Oncol IDIBELL, Dept Med Oncol, Barcelona, Spain; [Fleischhacker, Michael; Schmidt, Bernd] Univ Klinikum Halle, Mol Biol Lab, Saale, Germany; [Dolores Lozano, Maria] Univ Navarra Clin, Dept Pathol, Pamplona, Spain; [Pio, Ruben] Univ Navarra, Sch Sci, Dept Biochem & Genet, E-31080 Pamplona, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS); Virgen del Rocio University Hospital; University of Navarra; University of Navarra; Catalan Institute of Oncology; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); University of Navarra; University of Navarra	Ajona, D (corresponding author), Ctr Appl Med Res CIMA, Program Solid Tumors & Biomarkers, Pamplona, Spain.	dajonama@unav.es	Zulueta, Javier J/GXZ-5810-2022; Montuenga, Luis M/AAF-7783-2020; Zulueta, Javier J/H-5127-2011; Razquin, Cristina/H-2366-2017; Pio, Ruben/F-5353-2017; Paz-Ares, Luis/AAH-2750-2019; Lozano, Maria D/ABD-9613-2020; Ajona, Daniel/L-5669-2014	Montuenga, Luis M/0000-0002-8739-1387; Zulueta, Javier J/0000-0003-3182-3555; Razquin, Cristina/0000-0003-3480-2645; Pio, Ruben/0000-0002-6831-6111; Lozano, Maria D/0000-0002-6796-9380; GARCIA LOPEZ, JOSE JAVIER/0000-0002-4387-4221; Ajona, Daniel/0000-0001-5517-9165; Nadal, Ernest/0000-0002-9674-5554; Pastor, Maria Dolores/0000-0003-2736-0447	UTE project CIMA; Spanish Government (Red Tematica de Investigacion Cooperativa en Cancer) [RD12/0036/0028, RD12/0036/0040, RD12/0036/0045, RD12/0036/0062]; Fondo de Investigacion Sanitaria-Fondo Europeo de Desarrollo Regional (FEDER) [PI08/1156, CD09/00148, PI10/01652, PI10/00166, PI11/00618, PI11/02688, PI13/00806, PI14/01686]; European Community [HEALTH-F2-2010-258677-CURELUNG]	UTE project CIMA; Spanish Government (Red Tematica de Investigacion Cooperativa en Cancer); Fondo de Investigacion Sanitaria-Fondo Europeo de Desarrollo Regional (FEDER); European Community(European Commission)	This work was supported by "UTE project CIMA", the Spanish Government (Red Tematica de Investigacion Cooperativa en Cancer RD12/0036/0028, RD12/0036/0040, RD12/0036/0045, and RD12/0036/0062; and Fondo de Investigacion Sanitaria-Fondo Europeo de Desarrollo Regional (FEDER) PI08/1156, CD09/00148, PI10/01652, PI10/00166, PI11/00618, PI11/02688, PI13/00806, and PI14/01686), and the European Community's Seventh Framework Programme (HEALTH-F2-2010-258677-CURELUNG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajona D, 2004, CANCER RES, V64, P6310, DOI 10.1158/0008-5472.CAN-03-2328; Ajona D, 2007, J IMMUNOL, V178, P5991, DOI 10.4049/jimmunol.178.9.5991; Ajona D, 2013, JNCI-J NATL CANCER I, V105, P1385, DOI 10.1093/jnci/djt205; Boeri M, 2011, P NATL ACAD SCI USA, V108, P3713, DOI 10.1073/pnas.1100048108; Chapman CJ, 2013, CANCER EPIDEM BIOMAR, V22, P2161, DOI [10.1158/1055-9965.EPI-13-0621, DOI 10.1158/1055-9965.EPI-13-0621]; COOPER KM, 1981, CLIN EXP IMMUNOL, V45, P18; Coronell JAL, 2012, J PROTEOMICS, V76, P102, DOI 10.1016/j.jprot.2012.07.022; Corrales L, 2012, J IMMUNOL, V189, P4674, DOI 10.4049/jimmunol.1201654; Dietrich D, 2012, INT J ONCOL, V40, P825, DOI 10.3892/ijo.2011.1264; Edelman MJ, 2012, J THORAC ONCOL, V7, P649, DOI 10.1097/JTO.0b013e31824a8db0; Finn OJ, 2005, NEW ENGL J MED, V353, P1288, DOI 10.1056/NEJMe058157; Gal P, 2002, IMMUNOBIOLOGY, V205, P383, DOI 10.1078/0171-2985-00140; Goebell PJ, 2008, WORLD J UROL, V26, P5, DOI 10.1007/s00345-008-0240-9; Hong YJ, 2011, J THORAC ONCOL, V6, P1330, DOI 10.1097/JTO.0b013e31822462b1; Hur J, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-392; Kim H, 2004, J CLIN ONCOL, V22, P2363, DOI 10.1200/JCO.2004.10.077; Li J, 2013, INT J CANCER, V132, P1098, DOI 10.1002/ijc.27757; Li QK, 2013, J PROTEOME RES, V12, P3689, DOI 10.1021/pr400274w; Li XJ, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3007013; Maeda H, 2003, INT IMMUNOPHARMACOL, V3, P319, DOI 10.1016/S1567-5769(02)00271-0; Mazzone P, 2002, CLIN CHEST MED, V23, P137, DOI 10.1016/S0272-5231(03)00065-0; Mountain CF, 1997, CHEST, V111, P1710, DOI 10.1378/chest.111.6.1710; Okroj M, 2008, MOL IMMUNOL, V45, P169, DOI 10.1016/j.molimm.2007.04.025; Pio R, 2010, CANCER EPIDEM BIOMAR, V19, P2665, DOI 10.1158/1055-9965.EPI-10-0467; Postmus PE, 2005, CHEST, V128, P16, DOI 10.1378/chest.128.1.16; Schreiber G, 2003, CHEST, V123, p115S, DOI 10.1378/chest.123.1_suppl.115S; Sen S, 2001, LUNG CANCER, V33, P41, DOI 10.1016/S0169-5002(01)00193-3; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Siegel R, 2012, CA-CANCER J CLIN, V62, P220, DOI 10.3322/caac.21149; Topaloglu O, 2004, CLIN CANCER RES, V10, P2284, DOI 10.1158/1078-0432.CCR-1111-3; Travis W, 2004, WHO CLASSIFICATION T; Turner NC, 2012, LANCET ONCOL, V13, pE178, DOI 10.1016/S1470-2045(11)70335-7; Varsano S, 1998, CLIN EXP IMMUNOL, V113, P173; VARSANO S, 1995, AM J RESP CRIT CARE, V152, P1087, DOI 10.1164/ajrccm.152.3.7545058; Villanueva J, 2006, J CLIN INVEST, V116, P271, DOI 10.1172/JCI26022	35	19	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0119878	10.1371/journal.pone.0119878	http://dx.doi.org/10.1371/journal.pone.0119878			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25799154	Green Submitted, Green Published, gold			2022-12-27	WOS:000351987300087
J	Basnet, S; Sharma, A; Mathisen, M; Shrestha, PS; Ghimire, RK; Shrestha, DM; Valentiner-Branth, P; Sommerfelt, H; Strand, TA				Basnet, Sudha; Sharma, Arun; Mathisen, Maria; Shrestha, Prakash Sunder; Ghimire, Ram Kumar; Shrestha, Dhiraj Man; Valentiner-Branth, Palle; Sommerfelt, Halvor; Strand, Tor A.			Predictors of Duration and Treatment Failure of Severe Pneumonia in Hospitalized Young Nepalese Children	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; CHILDHOOD PNEUMONIA; PULSE OXIMETRY; RISK-FACTORS; OXYGEN; MORTALITY	Background Pneumonia in young children is still the most frequent cause of death in developing countries. We aimed to identify predictors for recovery and treatment failure in children hospitalized with severe pneumonia. Methods We enrolled 610 Nepalese children, aged 2 - 35 months from February 2006 to June 2008. Study participants were provided with standard treatment for pneumonia and followed up until discharge. Three multiple regression models representing clinical variables, clinical and radiological combined and all variables, including C-reactive protein (CRP) and viral etiology were used to assess the associations. Results The median age of study participants was 6 months with 493 (82%) infants and 367 (61%) males. The median time (IQR) till recovery was 49 (31, 87) hours and treatment failure was experienced by 209 (35%) of the children. Younger age, hypoxia on admission and radiographic pneumonia were independent predictors for both prolonged recovery and risk of treatment failure. While wasting and presence of any danger sign also predicted slower recovery, Parainfluenza type 1 isolated from the nasopharynx was associated with earlier resolution of illness. Gender, being breastfed, stunting, high fever, elevated CRP, presence of other viruses and supplementation with oral zinc did not show any significant association with these outcomes. Conclusion Age, hypoxia and consolidation on chest radiograph were significant predictors for time till recovery and treatment failure in children with severe pneumonia. While chest radiograph is not always needed, detection and treatment of hypoxia is a crucial step to guide the management of hospitalized children with pneumonia.	[Basnet, Sudha; Sharma, Arun; Shrestha, Prakash Sunder] Tribhuvan Univ, Inst Med, Dept Child Hlth, Kathmandu, Nepal; [Basnet, Sudha; Sommerfelt, Halvor; Strand, Tor A.] Univ Bergen, Ctr Int Hlth, Bergen, Norway; [Basnet, Sudha; Sommerfelt, Halvor; Strand, Tor A.] Univ Bergen, Ctr Intervent Sci Maternal & Child Hlth, Bergen, Norway; [Mathisen, Maria] Univ Hosp North Norway, Dept Microbiol & Infect Control, Tromso, Norway; [Ghimire, Ram Kumar] Tribhuvan Univ, Inst Med, Dept Radiol, Kathmandu, Nepal; [Shrestha, Dhiraj Man] Kathmandu Univ, Kathmandu Med Coll, Dept Radiol, Kathmandu, Nepal; [Shrestha, Dhiraj Man] Kathmandu Univ, Teaching Hosp, Kathmandu, Nepal; [Valentiner-Branth, Palle] Statens Serum Inst, Dept Infect Dis Epidemiol, Div Natl Hlth Surveillance & Res, DK-2300 Copenhagen, Denmark; [Sommerfelt, Halvor] Norwegian Inst Publ Hlth, Dept Int Publ Hlth, Oslo, Norway; [Strand, Tor A.] Innlandet Hosp Trust, Div Med Serv, Lillehammer, Norway	Tribhuvan University; Institute of Medicine (IoM) - Nepal; University of Bergen; University of Bergen; UiT The Arctic University of Tromso; University Hospital of North Norway; Tribhuvan University; Institute of Medicine (IoM) - Nepal; Kathmandu University; Kathmandu University; Statens Serum Institut; Norwegian Institute of Public Health (NIPH); Innlandet Hospital Trust	Basnet, S (corresponding author), Tribhuvan Univ, Inst Med, Dept Child Hlth, Kathmandu, Nepal.	sudhacbasnet@gmail.com	Strand, Tor/D-9836-2016; Sommerfelt, Halvor/ABD-3552-2020	Strand, Tor/0000-0002-4038-151X; Sommerfelt, Halvor/0000-0002-5670-9786	European Commission (EU-INCO-DC) [INCO-FP6-003740]; Meltzer Foundation in Bergen, Norway; Danish Council of Developmental Research [91128]; Research Council of Norway (RCN) [151054, 172226]; South-Eastern Norway Regional Health Authority [2012090]	European Commission (EU-INCO-DC)(European CommissionEuropean Commission Joint Research Centre); Meltzer Foundation in Bergen, Norway; Danish Council of Developmental Research; Research Council of Norway (RCN)(Research Council of Norway); South-Eastern Norway Regional Health Authority	This study was funded by grants from the European Commission (EU-INCO-DC contract number INCO-FP6-003740), the Meltzer Foundation in Bergen, Norway, the Danish Council of Developmental Research (project number: 91128), the Research Council of Norway (RCN project numbers: 151054 and 172226) and a grant from the South-Eastern Norway Regional Health Authority (grant number: 2012090) The sponsors of the study had no role in study design, data collection, data analysis, data interpretation, or writing of the report. The corresponding author had full access to all the data in the study and took the final decision to submit this report for publication.	Asghar R, 2008, BMJ-BRIT MED J, V336, P80, DOI 10.1136/bmj.39421.435949.BE; Basnet S, 2012, PEDIATRICS, V129, P701, DOI 10.1542/peds.2010-3091; Bharti B, 2008, INDIAN PEDIATR, V45, P893; Bradley JS, 2011, CLIN INFECT DIS, V53, pE25, DOI [10.1093/cid/cir531, 10.1093/cid/cir625]; Cherian T, 2005, B WORLD HEALTH ORGAN, V83, P353; Djelantik IGG, 2003, J TROP PEDIATRICS, V49, P327, DOI 10.1093/tropej/49.6.327; Duke T, 2008, LANCET, V372, P1328, DOI 10.1016/S0140-6736(08)61164-2; Fu LY, 2006, PEDIATRICS, V118, pE1822, DOI 10.1542/peds.2005-2673; Ginsburg AS, 2014, TROP MED INT HEALTH, V19, P537, DOI 10.1111/tmi.12291; Ginsburg AS, 2012, J TROP PEDIATRICS, V58, P389, DOI 10.1093/tropej/fmr103; Harris M, 2011, THORAX, V66, pII1, DOI 10.1136/thoraxjnl-2011-200598; Hosmer D.W., 2005, APPL LOGISTIC REGRES; Jackson S, 2013, CROAT MED J, V54, P110, DOI 10.3325/cmj.2013.54.110; Lupisan SP, 2007, TROP MED INT HEALTH, V12, P962, DOI 10.1111/j.1365-3156.2007.01872.x; Mathisen M, 2011, PEDIATR INFECT DIS J, V30, P1032, DOI 10.1097/INF.0b013e31822f845f; Mower WR, 1997, PEDIATRICS, V99, P681, DOI 10.1542/peds.99.5.681; Patel A, 2008, INT J TUBERC LUNG D, V12, P1320; Reed C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0027793; Rudan I, 2013, J GLOB HEALTH, V3, DOI [10.7189/jogh.03.010101, 10.7189/jogh.03.010401]; Rudan I, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001099; Sigauque B, 2009, J TROP PEDIATRICS, V55, P379, DOI 10.1093/tropej/fmp030; Walker CLF, 2013, LANCET, V381, P1405, DOI 10.1016/S0140-6736(13)60222-6; World Health Organization, 2014, INTEGRATED MANAGEMEN; World Health Organization, 2013, GUIDELINES MANAGEMEN; World Health Organization (WHO), 2005, POCK BOOK HOSP CAR C	25	12	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0122052	10.1371/journal.pone.0122052	http://dx.doi.org/10.1371/journal.pone.0122052			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25798907	Green Published, Green Submitted, gold			2022-12-27	WOS:000351987300314
J	Belinsky, KL; Nemes, CE; Schmidt, KA				Belinsky, Kara L.; Nemes, Claire E.; Schmidt, Kenneth A.			Two Novel Vocalizations Are Used by Veeries (Catharus fuscescens) during Agonistic Interactions	PLOS ONE			English	Article							PAIRING SUCCESS; VOCAL SIGNALS; SOFT SONG; CALLS; RESPONSES; PLAYBACK; ATTACK; WRENS	Avian vocalizations are common examples of the complex signals used by animals to negotiate during agonistic interactions. In this study, we used two playback experiments to identify agonistic signals in a songbird species with several acoustically complex songs and calls, the veery. In the first experiment, we compared veery singing behavior in response to simulated territorial intrusions including playback of three variations of veery song: 1) song alone as a control, 2) songs with added whisper calls, and 3) songs with introductory notes removed. In the second experiment, we used multimodal stimuli including songs, whisper calls and songs with introductory notes removed, along with a robotic veery mount. Focal males readily responded to all of the playback stimuli, approached the speaker and/or robotic mount, and vocalized. Male veeries gave more whisper calls, and sang more songs without the introductory note in response to all types of playback. However, veeries responded similarly to all types of stimuli presented, and they failed to physically attack the robotic mount. These results indicate that rival veeries use two different types of novel vocalizations: whisper calls and songs lacking the introductory note as agonistic signals, but do not allow us to discern the specific functions of these two vocalizations.	[Belinsky, Kara L.] State Univ New York New Paltz, Dept Biol, New Paltz, NY 12561 USA; [Nemes, Claire E.] Ball State Univ, Dept Biol, Muncie, IN 47306 USA; [Schmidt, Kenneth A.] Texas Tech Univ, Dept Biol Sci, Lubbock, TX 79409 USA	State University of New York (SUNY) System; SUNY New Paltz; Ball State University; Texas Tech University System; Texas Tech University	Belinsky, KL (corresponding author), State Univ New York New Paltz, Dept Biol, New Paltz, NY 12561 USA.	belinskk@newpaltz.edu			National Science Foundation CAREER grant [DEB 0746985]	National Science Foundation CAREER grant(National Science Foundation (NSF))	National Science Foundation CAREER grant DEB 0746985 to K.A.S. (http://www.nsf.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akcay C, 2012, ANIM BEHAV, V83, pE1, DOI 10.1016/j.anbehav.2011.11.029; Akcay C, 2011, ANIM BEHAV, V82, P377, DOI 10.1016/j.anbehav.2011.05.016; Anderson RC, 2012, ANIM BEHAV, V83, P1443, DOI 10.1016/j.anbehav.2012.03.016; Anderson RC, 2007, BEHAV ECOL SOCIOBIOL, V61, P1267, DOI 10.1007/s00265-007-0357-7; Baker TM, 2012, ANIM BEHAV, V84, P965, DOI 10.1016/j.anbehav.2012.07.022; Ballentine B, 2008, ANIM BEHAV, V75, P693, DOI 10.1016/j.anbehav.2007.07.025; Barnett CA, 2014, J FIELD ORNITHOL, V85, P56, DOI 10.1111/jofo.12049; Beecher MD, 2000, ANIM BEHAV, V59, P21, DOI 10.1006/anbe.1999.1276; Beecher MD, 1996, ANIM BEHAV, V51, P917, DOI 10.1006/anbe.1996.0095; Benedict L, 2012, ANIM BEHAV, V84, P1463, DOI 10.1016/j.anbehav.2012.09.017; BORROR DONALD J., 1964, OHIO J SCI, V64, P195; Bradbury Jack W., 1998, pi; CLUTTONBROCK TH, 1979, BEHAVIOUR, V69, P145, DOI 10.1163/156853979X00449; DAVIES NB, 1978, NATURE, V274, P683, DOI 10.1038/274683a0; DILGER W. C., 1956, AUK, V73, P313; Foote JR, 2008, BEHAV ECOL, V19, P1192, DOI 10.1093/beheco/arn087; Geberzahn N, 2014, BEHAV ECOL SOCIOBIOL, V68, P1, DOI 10.1007/s00265-013-1616-4; Goodale E, 2008, BEHAV ECOL, V19, P887, DOI 10.1093/beheco/arn045; Griesser M, 2008, CURR BIOL, V18, P69, DOI 10.1016/j.cub.2007.11.069; Hof D, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1553; Hof D, 2010, ANIM BEHAV, V80, P821, DOI 10.1016/j.anbehav.2010.07.017; Ishizuka Toru, 2008, Ornithological Science, V7, P157, DOI 10.2326/1347-0558-7.2.157; Kondo N, 2009, JPN PSYCHOL RES, V51, P197, DOI 10.1111/j.1468-5884.2009.00399.x; MAC NALLY RC, 1986, ETHOLOGY, V71, P125; Mennill DJ, 2004, ANIM BEHAV, V67, P441, DOI 10.1016/j.anbehav.2003.04.010; Naguib M, 2010, ANIM BEHAV, V80, pE11, DOI 10.1016/j.anbehav.2010.06.001; SAMUEL DE, 1972, BIRD BANDING, V43, P118, DOI 10.2307/4511856; Schmidt R, 2008, BEHAV ECOL, V19, P635, DOI 10.1093/beheco/arn021; Schmidt R, 2006, ANIM BEHAV, V72, P1355, DOI 10.1016/j.anbehav.2006.03.022; Searcy W.N.S, 2005, EVOLUTION ANIMAL COM; Searcy WA, 2006, BEHAV ECOL SOCIOBIOL, V60, P234, DOI 10.1007/s00265-006-0161-9; Searcy WA, 2009, ANIM BEHAV, V78, P1281, DOI 10.1016/j.anbehav.2009.08.011; Templeton CN, 2012, BEHAV ECOL SOCIOBIOL, V66, P1503, DOI 10.1007/s00265-012-1405-5; Vehrencamp SL, 2007, BEHAV ECOL, V18, P849, DOI 10.1093/beheco/arm054; WEARY DM, 1986, ETHOLOGY, V72, P199; Xia CW, 2013, ETHOLOGY, V119, P653, DOI 10.1111/eth.12104	36	9	9	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0120933	10.1371/journal.pone.0120933	http://dx.doi.org/10.1371/journal.pone.0120933			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25798825	Green Published, Green Submitted, gold			2022-12-27	WOS:000351987300194
J	Gocze, I; Koch, M; Renner, P; Zeman, F; Graf, BM; Dahlke, MH; Nerlich, M; Schlitt, HJ; Kellum, JA; Bein, T				Gocze, Ivan; Koch, Matthias; Renner, Philipp; Zeman, Florian; Graf, Bernhard M.; Dahlke, Marc H.; Nerlich, Michael; Schlitt, Hans J.; Kellum, John A.; Bein, Thomas			Urinary Biomarkers TIMP-2 and IGFBP7 Early Predict Acute Kidney Injury after Major Surgery	PLOS ONE			English	Article							MORTALITY; AKI	Objective To assess the ability of the urinary biomarkers IGFBP7 (insulin-like growth factor-binding protein 7) and TIMP-2 (tissue inhibitor of metalloproteinase 2) to early predict acute kidney injury (AKI) in high-risk surgical patients. Introduction Postoperative AKI is associated with an increase in short and long-term mortality. Using IGFBP7 and TIMP-2 for early detection of cellular kidney injury, thus allowing the early initiation of renal protection measures, may represent a new concept of evaluating renal function. Methods In this prospective study, urinary [TIMP-2]x[IGFBP7] was measured in surgical patients at high risk for AKI. A predefined cut-off value of [TIMP-2]x[IGFBP7] > 0.3 was used for assessing diagnostic accuracy. Perioperative characteristics were evaluated, and ROC analyses as well as logistic regression models of risk assessment were calculated with and without a [TIMP-2] x[IGFBP7] test. Results 107 patients were included in the study, of whom 45 (42%) developed AKI. The highest median values of biomarker were detected in septic, transplant and patients after hepatic surgery (1.24 vs 0.45 vs 0.47 ng/l(2)/1000). The area under receiving operating characteristic curve (AUC) for the risk of any AKI was 0.85, for early use of RRT 0.83 and for 28-day mortality 0.77. In a multivariable model with established perioperative risk factors, the [TIMP-2]x[IGFBP7] test was the strongest predictor of AKI and significantly improved the risk assessment (p<0.001). Conclusions Urinary [TIMP-2]x[IGFBP7] test sufficiently detect patients with risk of AKI after major noncardiac surgery. Due to its rapid responsiveness it extends the time frame for intervention to prevent development of AKI.	[Gocze, Ivan; Renner, Philipp; Dahlke, Marc H.; Schlitt, Hans J.; Bein, Thomas] Univ Med Ctr Regensburg, Dept Surg, D-93053 Regensburg, Germany; [Koch, Matthias; Nerlich, Michael] Univ Med Ctr Regensburg, Dept Trauma Surg, D-93053 Regensburg, Germany; [Zeman, Florian; Bein, Thomas] Univ Med Ctr Regensburg, Ctr Clin Studies, D-93053 Regensburg, Germany; [Graf, Bernhard M.] Univ Med Ctr Regensburg, Dept Anesthesiol, D-93053 Regensburg, Germany; [Kellum, John A.] Univ Pittsburgh, Ctr Crit Care Nephrol, Pittsburgh, PA 15621 USA; [Kellum, John A.] Univ Pittsburgh, CRISMA Clin Res Invest & Syst Modeling Acute Illn, Dept Crit Care Med, Pittsburgh, PA 15621 USA	University of Regensburg; University of Regensburg; University of Regensburg; University of Regensburg; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Gocze, I (corresponding author), Univ Med Ctr Regensburg, Dept Surg, Franz Josef Strauss Allee 11, D-93053 Regensburg, Germany.	ivan.goecze@ukr.de	Zeman, Florian/GNH-3239-2022; Kellum, John/AAP-3072-2020; Schlitt, Hans J./ABG-4368-2020; Kellum, John A/HCH-2944-2022	Kellum, John/0000-0003-1995-2653; Kellum, John A/0000-0003-1995-2653; Renner, Philipp/0000-0002-4968-9537	Astute Medical	Astute Medical	JAK has received grant support and consulting fees from Astute Medical. IG received honoraria for lectures from Astute Medical. There was no commercial sponsorship or any financial support related to this study. All other authors declare that they have no competing interests. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.	Asfar P, 2014, N ENGL J MED, V370; Bartels K, 2013, ANESTHESIOLOGY, V119, P1474, DOI 10.1097/ALN.0000000000000022; Bellomo R, 2012, CRIT CARE MED, V40, P1753, DOI 10.1097/CCM.0b013e318246b9c6; Bihorac A, 2014, AM J RESP CRIT CARE; Bihorac A, 2009, ANN SURG, V249, P851, DOI 10.1097/SLA.0b013e3181a40a0b; Boonstra J, 2004, GENE, V337, P1, DOI 10.1016/j.gene.2004.04.032; Brienza N, 2009, CRIT CARE MED, V37, P2079, DOI 10.1097/CCM.0b013e3181a00a43; Eckardt KU, 2012, KIDNEY INT SUPPL, V2, P7, DOI 10.1038/kisup.2012.8; Haase M, 2012, NAT REV NEPHROL, V8, P735, DOI 10.1038/nrneph.2012.197; Hobson C, 2014, ANN SURG; Hoste EAJ, 2008, CRIT CARE MED, V36, pS146, DOI 10.1097/CCM.0b013e318168c590; Jones RM, 1998, BRIT J SURG, V85, P1058; Kashani K, 2013, CRIT CARE, V17, DOI 10.1186/cc12503; Kim CS, 2013, PLOS ONE, V8; Macedo E, 2011, KIDNEY INT, V80, P760, DOI 10.1038/ki.2011.150; Meersch M, 2014, PLOS ONE, V9; Murray PT, 2014, KIDNEY INT, V85, P513, DOI 10.1038/ki.2013.374; Murugan R, 2011, NAT REV NEPHROL, V7, P209, DOI 10.1038/nrneph.2011.13; Price PM, 2009, KIDNEY INT, V76, P604, DOI 10.1038/ki.2009.224; Rewa O, 2014, NAT REV NEPHROL; Rodier F, 2007, NUCLEIC ACIDS RES, V35, P7475, DOI 10.1093/nar/gkm744; Seo DW, 2006, J BIOL CHEM, V281, P3711, DOI 10.1074/jbc.M509932200; Seo DW, 2003, CELL, V114, P171, DOI 10.1016/S0092-8674(03)00551-8; Spolverato G, 2014, BRIT J SURG, V101, P836, DOI 10.1002/bjs.9492; Susantitaphong P, 2013, CLIN J AM SOC NEPHRO, V8, P1482, DOI 10.2215/CJN.00710113; Wajapeyee N, 2008, CELL, V132, P363, DOI 10.1016/j.cell.2007.12.032; Walsh M, 2013, ANESTH ANALG, V117, P924, DOI 10.1213/ANE.0b013e3182a1ec84; White LE, 2013, J TRAUMA ACUTE CARE, V75, P432, DOI 10.1097/TA.0b013e31829de6cd; Yang QH, 2009, J INFECTION, V58, P459, DOI 10.1016/j.jinf.2009.04.003	29	91	99	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0120863	10.1371/journal.pone.0120863	http://dx.doi.org/10.1371/journal.pone.0120863			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25798585	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000351987300183
J	Hirst, CS; Foong, JPP; Stamp, LA; Fegan, E; Dent, S; Cooper, EC; Lomax, AE; Anderson, CR; Bornstein, JC; Young, HM; McKeown, SJ				Hirst, Caroline S.; Foong, Jaime P. P.; Stamp, Lincon A.; Fegan, Emily; Dent, Stephan; Cooper, Edward C.; Lomax, Alan E.; Anderson, Colin R.; Bornstein, Joel C.; Young, Heather M.; McKeown, Sonja J.			Ion Channel Expression in the Developing Enteric Nervous System	PLOS ONE			English	Article							NEURAL CREST CELLS; GATED POTASSIUM CHANNELS; NEURITE OUTGROWTH; MYENTERIC NEURONS; SMALL-INTESTINE; VAGUS NERVES; MIGRATION; DIFFERENTIATION; BEHAVIOR; PROLIFERATION	The enteric nervous system arises from neural crest-derived cells (ENCCs) that migrate caudally along the embryonic gut. The expression of ion channels by ENCCs in embryonic mice was investigated using a PCR-based array, RT-PCR and immunohistochemistry. Many ion channels, including chloride, calcium, potassium and sodium channels were already expressed by ENCCs at E11.5. There was an increase in the expression of numerous ion channel genes between E11.5 and E14.5, which coincides with ENCC migration and the first extension of neurites by enteric neurons. Previous studies have shown that a variety of ion channels regulates neurite extension and migration of many cell types. Pharmacological inhibition of a range of chloride or calcium channels had no effect on ENCC migration in cultured explants or neuritogenesis in vitro. The non-selective potassium channel inhibitors, TEA and 4-AP, retarded ENCC migration and neuritogenesis, but only at concentrations that also resulted in cell death. In summary, a large range of ion channels is expressed while ENCCs are colonizing the gut, but we found no evidence that ENCC migration or neuritogenesis requires chloride, calcium or potassium channel activity. Many of the ion channels are likely to be involved in the development of electrical excitability of enteric neurons.	[Hirst, Caroline S.; Foong, Jaime P. P.; Stamp, Lincon A.; Fegan, Emily; Dent, Stephan; Anderson, Colin R.; Young, Heather M.; McKeown, Sonja J.] Univ Melbourne, Dept Anat & Neurosci, Parkville, Vic 3052, Australia; [Foong, Jaime P. P.; Bornstein, Joel C.] Univ Melbourne, Dept Physiol, Parkville, Vic 3052, Australia; [Cooper, Edward C.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Lomax, Alan E.] Queens Univ, Dept Biomed & Mol Sci, Kingston, ON, Canada; [Lomax, Alan E.] Queens Univ, Dept Med, Kingston, ON K7L 3N6, Canada	University of Melbourne; University of Melbourne; Baylor College of Medicine; Queens University - Canada; Queens University - Canada	Young, HM (corresponding author), Univ Melbourne, Dept Anat & Neurosci, Parkville, Vic 3052, Australia.	h.young@unimelb.edu.au	Bornstein, Joel/I-3322-2019; Cooper, Edward/X-6659-2019; Young, Heather/A-2652-2013	Bornstein, Joel/0000-0002-7518-7717; Cooper, Edward/0000-0003-3672-8442; Young, Heather/0000-0002-0457-8710; McKeown, Sonja/0000-0002-7318-116X; Stamp, Lincon/0000-0002-8925-7894; Lomax, Alan/0000-0003-4743-9929	National Health and Medical Research Council of Australia [1047953, 1002506]; Australian Research Council [DP130101596]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD083092] Funding Source: NIH RePORTER	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	National Health and Medical Research Council of Australia Project grant #1047953 to HY and SMcK, Australian Research Council grant #DP130101596 to JB and HY and National Health and Medical Research Council of Australia Senior Research Fellowship #1002506 to HY, http://www.nhmrc.gov.au/, http://www.arc.gov.au/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson RB, 2006, GASTROENTEROLOGY, V130, P1221, DOI 10.1053/j.gastro.2006.01.002; Anderson RB, 2010, INT J DEV BIOL, V54, P63, DOI 10.1387/ijdb.082667ra; BAETGE G, 1989, DEV BIOL, V132, P189, DOI 10.1016/0012-1606(89)90217-0; BAETGE G, 1990, DEVELOPMENT, V110, P689; Barlow AJ, 2008, DEVELOPMENT, V135, P1681, DOI 10.1242/dev.017418; Bartoo AC, 2005, J COMP NEUROL, V486, P117, DOI 10.1002/cne.20541; Becchetti A, 2010, ADV EXP MED BIOL, V674, P107; Bergner AJ, 2014, J COMP NEUROL, V522, P514, DOI 10.1002/cne.23423; Burns AJ, 1998, DEVELOPMENT, V125, P4335; Chen M, 2013, MOL NEUROBIOL, V48, P794, DOI 10.1007/s12035-013-8467-x; Cooper EC, 2011, SEMIN CELL DEV BIOL, V22, P185, DOI 10.1016/j.semcdb.2010.10.001; Cuddapah VA, 2014, NAT REV NEUROSCI, V15, P455, DOI 10.1038/nrn3765; Cuddapah VA, 2013, CELL CALCIUM, V53, P187, DOI 10.1016/j.ceca.2012.11.013; Cuddapah VA, 2013, J NEUROSCI, V33, P1427, DOI 10.1523/JNEUROSCI.3980-12.2013; Cuddapah VA, 2011, AM J PHYSIOL-CELL PH, V301, pC541, DOI 10.1152/ajpcell.00102.2011; D'Alessandro G, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.279; Diochot S, 1998, J BIOL CHEM, V273, P6744, DOI 10.1074/jbc.273.12.6744; Druckenbrod NR, 2007, DEV DYNAM, V236, P84, DOI 10.1002/dvdy.20974; Druckenbrod NR, 2009, DEVELOPMENT, V136, P3195, DOI 10.1242/dev.031302; Erickson CS, 2014, NEUROGASTROENT MOTIL, V26, P874, DOI 10.1111/nmo.12343; Foong JPP, 2012, J PHYSIOL-LONDON, V590, P2375, DOI 10.1113/jphysiol.2011.225938; Gershon MD, 2010, TRENDS NEUROSCI, V33, P446, DOI 10.1016/j.tins.2010.06.002; Gisser JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074311; Gu C, 2011, PROG NEUROBIOL, V94, P115, DOI 10.1016/j.pneurobio.2011.04.009; Habela CW, 2009, J NEUROPHYSIOL, V101, P750, DOI 10.1152/jn.90840.2008; Hao MM, 2010, NEUROGASTROENT MOTIL, V22, pe127, DOI 10.1111/j.1365-2982.2009.01462.x; Hao MM, 2009, DEV NEUROBIOL, V69, P22, DOI 10.1002/dneu.20683; Hao MM, 2013, DEV BIOL, V382, P365, DOI 10.1016/j.ydbio.2012.12.006; Hao MM, 2012, J NEUROSCI, V32, P10949, DOI 10.1523/JNEUROSCI.1426-12.2012; Hao MM, 2011, J NEUROSCI, V31, P15352, DOI 10.1523/JNEUROSCI.3053-11.2011; Hao MM, 2009, J CELL MOL MED, V13, P1193, DOI 10.1111/j.1582-4934.2009.00813.x; Heanue TA, 2006, P NATL ACAD SCI USA, V103, P6919, DOI 10.1073/pnas.0602152103; Hearn CJ, 1999, DEV DYNAM, V214, P239, DOI 10.1002/(SICI)1097-0177(199903)214:3<239::AID-AJA7>3.0.CO;2-O; Hilaire C, 1996, NEUROSCIENCE, V75, P1219, DOI 10.1016/0306-4522(96)00347-8; Hotta R, 2013, J CLIN INVEST, V123, P1182, DOI 10.1172/JCI65963; Huang CY, 2012, J COMP NEUROL, V520, P3650, DOI 10.1002/cne.23119; Huang L, 2014, J BIOL CHEM, V289, P2217, DOI 10.1074/jbc.M113.515932; Hur J, 2013, NEUROSCIENCE, V253, P389, DOI 10.1016/j.neuroscience.2013.09.003; KAPUR RP, 1992, DEVELOPMENT, V116, P167; KOMURO H, 1992, SCIENCE, V257, P806, DOI 10.1126/science.1323145; Korbie DJ, 2008, NAT PROTOC, V3, P1452, DOI 10.1038/nprot.2008.133; Lake JI, 2013, AM J PHYSIOL-GASTR L, V305, pG1, DOI 10.1152/ajpgi.00452.2012; Laranjeira C, 2009, AUTON NEUROSCI-BASIC, V151, P61, DOI 10.1016/j.autneu.2009.09.001; Lui VCH, 2010, ANTICANCER RES, V30, P4515; McFarlane S, 2000, J NEUROSCI, V20, P1020, DOI 10.1523/JNEUROSCI.20-03-01020.2000; McFerrin MB, 2006, NEURON GLIA BIOL, V2, P39, DOI 10.1017/S1740925X06000044; Mire E, 2012, NAT NEUROSCI, V15, P1134, DOI 10.1038/nn.3160; MORAN D, 1991, AM J ANAT, V192, P14, DOI 10.1002/aja.1001920103; Nishiyama C, 2012, NAT NEUROSCI, V15, P1211, DOI 10.1038/nn.3184; Obermayr F, 2013, NAT REV GASTRO HEPAT, V10, P43, DOI 10.1038/nrgastro.2012.234; Pan ZM, 2006, J NEUROSCI, V26, P2599, DOI 10.1523/JNEUROSCI.4314-05.2006; Pardo LA, 2014, NAT REV CANCER, V14, P39, DOI 10.1038/nrc3635; Park KJ, 2006, AM J PHYSIOL-CELL PH, V290, pC1411, DOI 10.1152/ajpcell.00447.2005; Pollock NS, 2002, J COMP NEUROL, V452, P381, DOI 10.1002/cne.10401; Sann SB, 2008, J NEUROSCI, V28, P2366, DOI 10.1523/JNEUROSCI.3828-07.2008; Sasselli V, 2013, J CLIN INVEST, V123, P1763, DOI 10.1172/JCI66759; Sato Y, 2008, DEV BIOL, V320, P185, DOI 10.1016/j.ydbio.2008.05.524; Schmidt EM, 2011, BIOCHEM BIOPH RES CO, V415, P54, DOI 10.1016/j.bbrc.2011.10.009; Schwab A, 2008, PHYSIOLOGY, V23, P212, DOI 10.1152/physiol.00003.2008; Southard-Smith EM, 1998, NAT GENET, V18, P60, DOI 10.1038/ng0198-60; Stewart AL, 2007, DEV BIOL, V307, P92, DOI 10.1016/j.ydbio.2007.04.024; Stock C, 2013, COMPR PHYSIOL, V3, P59, DOI 10.1002/cphy.c110056; Sun JL, 2012, J PHYSIOL-LONDON, V590, P3953, DOI 10.1113/jphysiol.2012.235820; Turner KL, 2013, CEREB CORTEX; Ubels JL, 2010, EXP EYE RES, V90, P216, DOI 10.1016/j.exer.2009.10.005; Vohra BPS, 2006, DEV BIOL, V298, P259, DOI 10.1016/j.ydbio.2006.06.033; Wulff H, 2009, NAT REV DRUG DISCOV, V8, P982, DOI 10.1038/nrd2983; Xu QL, 2014, BMC BIOL, V12, DOI 10.1186/s12915-014-0050-z; YNTEMA CL, 1954, J COMP NEUROL, V101, P515, DOI 10.1002/cne.901010212; Young HM, 2014, BMC BIOL, V12, DOI 10.1186/1741-7007-12-23; Young HM, 1998, DEV BIOL, V202, P67, DOI 10.1006/dbio.1998.8987; Young HM, 2003, J COMP NEUROL, V456, P1, DOI 10.1002/cne.10448; Young HM, 2002, J NEUROSCI, V22, P6005; Yu PC, 2011, CELL MOL LIFE SCI, V68, P3815, DOI 10.1007/s00018-011-0755-x	74	10	10	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0123436	10.1371/journal.pone.0123436	http://dx.doi.org/10.1371/journal.pone.0123436			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25798587	Green Published, gold			2022-12-27	WOS:000351987300343
J	Takizawa, Y; Nakata, R; Fukuhara, K; Yamashita, H; Kubodera, H; Inoue, H				Takizawa, Yoshie; Nakata, Rieko; Fukuhara, Kiyoshi; Yamashita, Hiroshi; Kubodera, Hideo; Inoue, Hiroyasu			The 4 '-Hydroxyl Group of Resveratrol Is Functionally Important for Direct Activation of PPAR alpha	PLOS ONE			English	Article							CYCLOOXYGENASE-2 EXPRESSION; BINDING; SIRTUINS; LIGAND; J(2)	Long-term moderate consumption of red wine is associated with a reduced risk of developing lifestyle-related diseases such as cardiovascular disease and cancer. Therefore, resveratrol, a constituent of grapes and various other plants, has attracted substantial interest. This study focused on one molecular target of resveratrol, the peroxisome proliferator activated receptor alpha (PPAR alpha). Our previous study in mice showed that resveratrol-mediated protection of the brain against stroke requires activation of PPARa; however, the molecular mechanisms involved in this process remain unknown. Here, we evaluated the chemical basis of the resveratrol-mediated activation of PPARa by performing a docking mode simulation and examining the structure-activity relationships of various polyphenols. The results of experiments using the crystal structure of the PPARa ligand-binding domain and an analysis of the activation of PPARa by a resveratrol analog 4-phenylazophenol (4-PAP) in vivo indicate that the 4'-hydroxyl group of resveratrol is critical for the direct activation of PPAR alpha. Activation of PPARa by 5 mu M resveratrol was enhanced by rolipram, an inhibitor of phosphodiesterase (PDE) and forskolin, an activator of adenylate cyclase. We also found that resveratrol has a higher PDE inhibitory activity (IC50 = 19 mu M) than resveratrol analogs trans-4-hydroxystilbene and 4-PAP (IC50 = 27-28 mu M), both of which has only 4'-hydroxyl group, indicating that this 4'-hydroxyl group of resveratrol is not sufficient for the inhibition of PDE. This result is consistent with that 10 mu M resveratrol has a higher agonistic activity of PPARa than these analogs, suggesting that there is a feedforward activation loop of PPARa by resveratrol, which may be involved in the long-term effects of resveratrol in vivo.	[Takizawa, Yoshie; Nakata, Rieko; Inoue, Hiroyasu] Nara Womens Univ, Dept Food Sci & Nutr, Nara 630, Japan; [Fukuhara, Kiyoshi] Showa Univ, Sch Pharm, Tokyo, Japan; [Yamashita, Hiroshi; Kubodera, Hideo] Mitsubishi Tanabe Pharma Corp, Med Chem Res Labs, Kanagawa, Japan	Nara Womens University; Showa University; Mitsubishi Tanabe Pharma Corporation	Inoue, H (corresponding author), Nara Womens Univ, Dept Food Sci & Nutr, Nara 630, Japan.	inoue@cc.nara-wu.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan [19300250, 24300217]; Iijima Memorial Foundations for the Promotion of Food Science and Technology; Uehara Memorial Foundation of Nutrition; Japan Food Chemical Research Foundation	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Iijima Memorial Foundations for the Promotion of Food Science and Technology; Uehara Memorial Foundation of Nutrition(Uehara Memorial Foundation); Japan Food Chemical Research Foundation(Japan Food Chemical Research Foundation)	This work was supported by Grants-in-Aid for Scientific Research (Nos. 19300250 and 24300217 to H.I. and R.N.) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan; the Iijima Memorial Foundations for the Promotion of Food Science and Technology; Uehara Memorial Foundation of Nutrition; and the Japan Food Chemical Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baur JA, 2006, NAT REV DRUG DISCOV, V5, P493, DOI 10.1038/nrd2060; Calleri E, 2014, CHEMBIOCHEM, V15, P1154, DOI 10.1002/cbic.201300754; Corton JC, 2004, J BIOL CHEM, V279, P46204, DOI 10.1074/jbc.M406739200; de la Lastra CA, 2005, MOL NUTR FOOD RES, V49, P405; FORMAN BM, 1995, CELL, V83, P803, DOI 10.1016/0092-8674(95)90193-0; Hotta M, 2010, J LIPID RES, V51, P132, DOI 10.1194/jlr.M900255-JLR200; Howitz KT, 2003, NATURE, V425, P191, DOI 10.1038/nature01960; Inoue H, 2000, J BIOL CHEM, V275, P28028; Inoue H, 2003, NEUROSCI LETT, V352, P203, DOI 10.1016/j.neulet.2003.09.001; Inoue H, 2002, ARTERIOSCL THROM VAS, V22, P1415, DOI 10.1161/01.ATV.0000028816.13582.13; Jang MS, 1997, SCIENCE, V275, P218, DOI 10.1126/science.275.5297.218; Jones G, 1997, J MOL BIOL, V267, P727, DOI 10.1006/jmbi.1996.0897; Kaeberlein M, 2005, J BIOL CHEM, V280, P17038, DOI 10.1074/jbc.M500655200; Kleppisch Thomas, 2009, V191, P71, DOI 10.1007/978-3-540-68964-5_5; KLIEWER SA, 1995, CELL, V83, P813, DOI 10.1016/0092-8674(95)90194-9; Kuhn B, 2000, J MED CHEM, V43, P3786, DOI 10.1021/jm000241h; LANGCAKE P, 1976, PHYSIOL PLANT PATHOL, V9, P77, DOI 10.1016/0048-4059(76)90077-1; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; McCay CM, 1935, J NUTR, V10, P63, DOI 10.1093/jn/10.1.63; Michalik L, 2006, PHARMACOL REV, V58, P726, DOI 10.1124/pr.58.4.5; Nakata R, 2012, BIOL PHARM BULL, V35, P273, DOI 10.1248/bpb.35.273; Pacholec M, 2010, J BIOL CHEM, V285, P8340, DOI 10.1074/jbc.M109.088682; Park SJ, 2012, CELL, V148, P421, DOI 10.1016/j.cell.2012.01.017; Purushotham A, 2009, CELL METAB, V9, P327, DOI 10.1016/j.cmet.2009.02.006; Subbaramaiah K, 1998, J BIOL CHEM, V273, P21875, DOI 10.1074/jbc.273.34.21875; THAKKAR K, 1993, J MED CHEM, V36, P2950, DOI 10.1021/jm00072a015; Tsukamoto T, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-46; Xu HE, 1999, MOL CELL, V3, P397, DOI 10.1016/S1097-2765(00)80467-0; Xu HE, 2001, P NATL ACAD SCI USA, V98, P13919, DOI 10.1073/pnas.241410198; Zhao P, 2013, BBA-PROTEINS PROTEOM, V1834, P2089, DOI 10.1016/j.bbapap.2013.07.004	30	28	28	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0120865	10.1371/journal.pone.0120865	http://dx.doi.org/10.1371/journal.pone.0120865			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25798826	gold, Green Submitted, Green Published			2022-12-27	WOS:000351987300184
J	Wang, LL; Zhao, GX; Li, M; Zhang, MT; Zhang, LF; Zhang, XF; An, LZ; Xu, SJ				Wang, Lilong; Zhao, Guanxiang; Li, Meng; Zhang, Mingting; Zhang, Lifang; Zhang, Xinfang; An, Lizhe; Xu, Shijian			C:N:P Stoichiometry and Leaf Traits of Halophytes in an Arid Saline Environment, Northwest China	PLOS ONE			English	Article							PHOSPHORUS STOICHIOMETRY; BIOLOGICAL STOICHIOMETRY; NITROGEN; DESERT; SOIL; TOLERANCE; AREA; PATTERNS; GROWTH; TERRESTRIAL	Salinization is an important and increasingly prevalent issue which has broad and profound effects on plant survival and distribution pattern. To understand the patterns and potential drivers of leaf traits in saline environments, we determined the soil properties, leaf morphological traits (specific leaf area, SLA, and leaf dry matter content, LDMC), leaf chemical traits (leaf carbon, C, nitrogen, N, and phosphorus, P, stoichiometry) based on 142 observations collected from 23 sites in an arid saline environment, which is a vulnerable ecosystem in northwest China. We also explored the relationships among leaf traits, the responses of leaf traits, and plant functional groups (herb, woody, and succulent woody) to various saline environments. The arid desert halophytes were characterized by lower leaf C and SLA levels, higher N, but stable P and N: P. The leaf morphological traits were correlated significantly with the C, N, and P contents across all observations, but they differed within each functional group. Succulent woody plants had the lowest leaf C and highest leaf N levels among the three functional groups. The growth of halophytes might be more limited by N rather than P in the study area. GLM analysis demonstrated that the soil available nutrients and plant functional groups, but not salinity, were potential drivers of leaf C: N: P stoichiometry in halophytes, whereas species differences accounted for the largest contributions to leaf morphological variations. Our study provides baseline information to facilitate the management and restoration of arid saline desert ecosystem.	[Wang, Lilong; Zhao, Guanxiang; Li, Meng; Zhang, Mingting; Zhang, Lifang; Zhang, Xinfang; An, Lizhe; Xu, Shijian] Lanzhou Univ, Sch Life Sci, MOE Key Lab Cell Activ & Stress Adaptat, Lanzhou 730000, Peoples R China	Lanzhou University	Xu, SJ (corresponding author), Lanzhou Univ, Sch Life Sci, MOE Key Lab Cell Activ & Stress Adaptat, Lanzhou 730000, Peoples R China.	xushijian@lzu.edu.cn			State Key Basic Research and Development Plan [2013CB429904]; National Natural Science Foundation of China [31170371, 40871041]; Gansu Province Science and Technology Support Plan [2009GS03292]	State Key Basic Research and Development Plan; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Gansu Province Science and Technology Support Plan	This research was funded jointly by grants from the State Key Basic Research and Development Plan (2013CB429904), National Natural Science Foundation of China (31170371, 40871041), and Gansu Province Science and Technology Support Plan (2009GS03292). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058179; Bazihizina N, 2012, PLANT SOIL, V354, P1, DOI 10.1007/s11104-012-1193-8; Canadell J, 1996, Oecologia, V108, P583, DOI 10.1007/BF00329030; Chaves MM, 2009, ANN BOT-LONDON, V103, P551, DOI 10.1093/aob/mcn125; Ding H, 2001, ARID ZONE RES, V18, P6; Dodd GL, 1999, AM J BOT, V86, P1146, DOI 10.2307/2656978; Drenovsky RE, 2004, PLANT SOIL, V259, P59, DOI 10.1023/B:PLSO.0000020945.09809.3d; Eallonardo AS, 2013, J VEG SCI, V24, P365, DOI 10.1111/j.1654-1103.2012.01470.x; Elser JJ, 2010, NEW PHYTOL, V186, P593, DOI 10.1111/j.1469-8137.2010.03214.x; Elser JJ, 2000, NATURE, V408, P578, DOI 10.1038/35046058; Elser JJ, 2000, ECOL LETT, V3, P540, DOI 10.1046/j.1461-0248.2000.00185.x; Flowers TJ, 2008, NEW PHYTOL, V179, P945, DOI 10.1111/j.1469-8137.2008.02531.x; Glenn EP, 1999, CRIT REV PLANT SCI, V18, P227, DOI 10.1016/S0735-2689(99)00388-3; Han WX, 2005, NEW PHYTOL, V168, P377, DOI 10.1111/j.1469-8137.2005.01530.x; He JS, 2008, OECOLOGIA, V155, P301, DOI 10.1007/s00442-007-0912-y; He JS, 2006, OECOLOGIA, V149, P115, DOI 10.1007/s00442-006-0425-0; He JS, 2010, J PLANT RES, V123, P551, DOI 10.1007/s10265-009-0294-9; He YB, 2012, GEODERMA, V185, P12, DOI 10.1016/j.geoderma.2012.03.022; Kang HZ, 2011, FOREST ECOL MANAG, V261, P195, DOI 10.1016/j.foreco.2010.10.004; Kuo S., 1996, Methods of soil analysis. Part 3 - chemical methods., P869; Li Yu-lin, 2010, Huanjing Kexue, V31, P1716; Lu XT, 2012, OECOLOGIA, V168, P301, DOI 10.1007/s00442-011-2097-7; Mansour MMF, 2000, BIOL PLANTARUM, V43, P491, DOI 10.1023/A:1002873531707; Martinez Beltran J., 2005, International salinity forum - managing saline soils and water: science, technology and social issues. Oral Presentation Abstracts, Riverside Convention Center, Riverside, California, USA, 25-28 April 2005, P311; MCCREE KJ, 1986, AUST J PLANT PHYSIOL, V13, P33, DOI 10.1071/PP9860033; Munns R, 2008, ANNU REV PLANT BIOL, V59, P651, DOI 10.1146/annurev.arplant.59.032607.092911; MURPHY J, 1962, ANAL CHIM ACTA, V26, P31; Naz N, 2013, J BIOL RES-THESSALON, V19, P150; Osnas JLD, 2013, SCIENCE, V340, P741, DOI 10.1126/science.1231574; Penuelas J, 2012, GLOBAL CHANGE BIOL, V18, P3, DOI 10.1111/j.1365-2486.2011.02568.x; Perez-Harguindeguy N, 2013, AUST J BOT, V61, P167, DOI 10.1071/BT12225; Pessarakli M, 2012, INT J AGRONOMY, V2012, P9; Poorter H, 1999, NEW PHYTOL, V143, P163, DOI 10.1046/j.1469-8137.1999.00428.x; Rahnama A, 2010, FUNCT PLANT BIOL, V37, P255, DOI 10.1071/FP09148; Reich PB, 2004, P NATL ACAD SCI USA, V101, P11001, DOI 10.1073/pnas.0403588101; Rhoades J., 1999, SOIL USE MANAGE, V57th, DOI DOI 10.1111/sum.12554; Setia R, 2013, SCI TOTAL ENVIRON, V465, P267, DOI 10.1016/j.scitotenv.2012.08.028; Shabala S, 2012, PLANT STRESS PHYSL C; Shipley B, 2005, FUNCT ECOL, V19, P602, DOI 10.1111/j.1365-2435.2005.01008.x; SHIPLEY B, 1995, FUNCT ECOL, V9, P312, DOI 10.2307/2390579; Simoes MP, 2011, AQUAT BOT, V94, P119, DOI 10.1016/j.aquabot.2011.01.001; Song ZL, 2014, PLANT SOIL, V380, P165, DOI 10.1007/s11104-014-2084-y; Song ZL, 2011, CLEAN-SOIL AIR WATER, V39, P212, DOI 10.1002/clen.201000053; Sterner R.W., 2002, ECOLOGICAL STOICHIOM; Suter M, 2013, PERSPECT PLANT ECOL, V15, P217, DOI 10.1016/j.ppees.2013.05.001; Tilman D, 2002, NATURE, V418, P671, DOI 10.1038/nature01014; Vendramini F, 2002, NEW PHYTOL, V154, P147, DOI 10.1046/j.1469-8137.2002.00357.x; VITOUSEK PM, 1991, BIOGEOCHEMISTRY, V13, P87; Vitousek PM, 2012, ECOLOGICAL APPL, V20, P5; Wang YG, 2008, ENVIRON MONIT ASSESS, V140, P291, DOI 10.1007/s10661-007-9867-z; Wang YG, 2013, CATENA, V100, P50, DOI 10.1016/j.catena.2012.08.005; Westoby M, 2002, ANNU REV ECOL SYST, V33, P125, DOI 10.1146/annurev.ecolsys.33.010802.150452; WHITFORD WG, 1987, P S STRAT CLASS MAN; Willert D. J., 1992, LIFE STRATEGIES SUCC; Wilson PJ, 1999, NEW PHYTOL, V143, P155, DOI 10.1046/j.1469-8137.1999.00427.x; Wright IJ, 2004, NATURE, V428, P821, DOI 10.1038/nature02403; Wright IJ, 2000, FUNCT ECOL, V14, P97, DOI 10.1046/j.1365-2435.2000.00393.x; Wu TG, 2012, BIOCHEM SYST ECOL, V44, P255, DOI 10.1016/j.bse.2012.06.002; Yang CW, 2008, PHOTOSYNTHETICA, V46, P107, DOI [10.1007/s11099-008-0018-8, 10.1007/s11099-008-0047-3]; Yang YL, 2013, PLANT CELL TISS ORG, V112, P33, DOI 10.1007/s11240-012-0209-7; [殷密英 YIN Miying], 2007, [南水北调与水利科技, South-to-North Water Transfers and Water Science & Technology], V5, P72; Yuan ZY, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1346; Zhan XiaoYun, 2013, Journal of Resources and Ecology, V4, P125, DOI 10.5814/j.issn.1674-764x.2013.02.004; Zhao KF, 1999, CHINESE B BOT, V16, P201; Zhao N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095196	65	35	59	12	107	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0119935	10.1371/journal.pone.0119935	http://dx.doi.org/10.1371/journal.pone.0119935			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25798853	gold, Green Submitted, Green Published			2022-12-27	WOS:000351987300094
J	Adel, A; Abatih, E; Speybroeck, N; Soukehal, A; Bouguedour, R; Boughalem, K; Bouhbal, A; Djerbal, M; Saegerman, C; Berkvens, D				Adel, Amel; Abatih, Emmanuel; Speybroeck, Niko; Soukehal, Abdelkrim; Bouguedour, Rachid; Boughalem, Karim; Bouhbal, Abdelmalek; Djerbal, Mouloud; Saegerman, Claude; Berkvens, Dirk			Estimation of Canine Leishmania Infection Prevalence in Six Cities of the Algerian Littoral Zone Using a Bayesian Approach	PLOS ONE			English	Article							DIRECT AGGLUTINATION-TEST; VISCERAL LEISHMANIASIS; DIAGNOSTIC-TESTS; CONDITIONAL DEPENDENCE; INFANTUM INFECTION; DISEASE PREVALENCE; DOGS; FOCUS; SERODIAGNOSIS; TRANSMISSION	A large-scale study on canine Leishmania infection (CanL) was conducted in six localities along a west-east transect in the Algerian littoral zone (Tlemcen, Mostaganem, Tipaza, Boumerdes, Bejaia, Jijel) and covering two sampling periods. In total 2,184 dogs were tested with an indirect fluorescent antibody test (IFAT) and a direct agglutination test (DAT). Combined multiple-testing and several statistical methods were compared to estimate the CanL true prevalence and tests characteristics (sensitivity and specificity). The Bayesian full model showed the best fit and yielded prevalence estimates between 11% (Mostaganem, first period) and 38% (Bejaia, second period). Sensitivity of IFAT varied (in function of locality) between 86% and 88% while its specificity varied between 65% and 87%. DAT was less sensitive than IFAT but showed a higher specificity (between 80% and 95% in function of locality or/and season). A general increasing trend of the CanL prevalence was noted from west to east. A concordance between the present results and the incidence of human cases of visceral leishmaniasis was observed, where also a maximum was recorded for Bejaia. The results of the present study highlight the dangers when using IFAT as a gold standard.	[Adel, Amel] Univ Saad Dahlab, Inst Vet Sci, Blida, Algeria; [Adel, Amel; Abatih, Emmanuel; Berkvens, Dirk] Inst Trop Med, Dept Biomed Sci, B-2000 Antwerp, Belgium; [Adel, Amel; Saegerman, Claude] Univ Liege, Res Unit Epidemiol & Risk Anal Appl Vet Sci UREAR, Fundamental & Appl Res Animals & Hlth FARAH, Fac Vet Med, B-4000 Sart Tilman Par Liege, Belgium; [Speybroeck, Niko] Catholic Univ Louvain, IRSS FSP, B-1200 Brussels, Belgium; [Soukehal, Abdelkrim] Univ Hosp Beni Messous, Algiers, Algeria; [Bouguedour, Rachid] OIE Sub Reg Representat North Africa, Tunis, Tunisia; [Boughalem, Karim; Bouhbal, Abdelmalek] Minist Agr & Dev Rural, Direct Serv Vet, Algiers 16000, Algeria; [Djerbal, Mouloud] Reg Vet Lab Draa Ben Kheda, Tizi Ouzou, Algeria	Universite Saad Dahlab de Blida; Institute of Tropical Medicine (ITM); University of Liege; Universite Catholique Louvain	Berkvens, D (corresponding author), Inst Trop Med, Dept Biomed Sci, Natl Str 155, B-2000 Antwerp, Belgium.	dberkvens@itg.be		Saegerman, Claude/0000-0001-9087-7436; Speybroeck, Niko/0000-0003-3322-3502	Belgian Directorate-General for Development Co-operation	Belgian Directorate-General for Development Co-operation	This work was supported by Belgian Directorate-General for Development Co-operation: scholarship AA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRANCHES P, 1991, J PARASITOL, V77, P557, DOI 10.2307/3283159; ABRANCHES P, 1983, ANN PARASIT HUM COMP, V58, P307, DOI 10.1051/parasite/1983584307; Acedo-Sanchez C, 1998, VET PARASITOL, V75, P1, DOI 10.1016/S0304-4017(97)00196-9; Addadi K., 1976, Bulletin de la Societe de Pathologie Exotique, V69, P68; Adel A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099207; Adel A, 2010, VET PARASITOL, V172, P204, DOI 10.1016/j.vetpar.2010.05.009; ALVAR J, 1994, ANN TROP MED PARASIT, V88, P371, DOI 10.1080/00034983.1994.11812879; Alvar J, 2004, ADV PARASIT, V57, P1, DOI 10.1016/S0065-308X(04)57001-X; Ballart C, 2013, PREV VET MED, V109, P116, DOI 10.1016/j.prevetmed.2012.09.003; BELAZZOUG S, 1985, ANN SOC BELG MED TR, V65, P329; Berkvens D, 2006, EPIDEMIOLOGY, V17, P145, DOI 10.1097/01.ede.0000198422.64801.8d; Bertrand P, 2005, J CLIN EPIDEMIOL, V58, P688, DOI 10.1016/j.jclinepi.2004.10.021; Boelaert M, 1999, EPIDEMIOL INFECT, V123, P499, DOI 10.1017/S0950268899003040; Chaouch M, 2013, VET PARASITOL, V198, P78, DOI 10.1016/j.vetpar.2013.07.038; CICCHETTI DV, 1990, J CLIN EPIDEMIOL, V43, P551, DOI 10.1016/0895-4356(90)90159-M; Collins J, 2014, STAT MED, V33, P4141, DOI 10.1002/sim.6218; Dendukuri N, 2001, BIOMETRICS, V57, P158, DOI 10.1111/j.0006-341X.2001.00158.x; Dendukuri N, 2009, STAT MED, V28, P441, DOI 10.1002/sim.3470; Diouani M F, 2008, Arch Inst Pasteur Tunis, V85, P55; Dohoo I.R., 2003, VET EPIDEMIOLOGIC RE; ELHARITH A, 1989, J CLIN MICROBIOL, V27, P2252, DOI 10.1128/JCM.27.10.2252-2257.1989; Enoe C, 2000, PREV VET MED, V45, P61, DOI 10.1016/S0167-5877(00)00117-3; Ertabaklar H, 2005, ACTA TROP, V93, P239, DOI 10.1016/j.actatropica.2005.01.002; Fernandez-Bellon H, 2008, VET PARASITOL, V155, P32, DOI 10.1016/j.vetpar.2008.04.009; Gardner IA, 2000, PREV VET MED, V45, P107, DOI 10.1016/S0167-5877(00)00119-7; Gomes AHS, 2008, EXP PARASITOL, V119, P319, DOI 10.1016/j.exppara.2008.02.014; Graham P, 1998, J CLIN EPIDEMIOL, V51, P763, DOI 10.1016/S0895-4356(98)00048-1; HARRAT Z, 1992, B SOC PATHOL EXOT, V85, P296; HUI SL, 1980, BIOMETRICS, V36, P167, DOI 10.2307/2530508; Iniesta L, 2002, CLIN DIAGN LAB IMMUN, V9, P1137, DOI 10.1128/CDLI.9.5.1137-1141.2002; IZRI MA, 1990, ANN PARASIT HUM COMP, V65, P151; KILLICKKENDRICK R, 1995, T ROY SOC TROP MED H, V89, P477, DOI 10.1016/0035-9203(95)90072-1; KILLICKKENDRICK R, 1990, MED VET ENTOMOL, V4, P1, DOI 10.1111/j.1365-2915.1990.tb00255.x; Lesaffre E, 2007, VET PARASITOL, V148, P58, DOI 10.1016/j.vetpar.2007.05.010; Maia C, 2008, VET PARASITOL, V158, P274, DOI 10.1016/j.vetpar.2008.07.028; MANCIANTI F, 1988, AM J VET RES, V49, P1409; MOLINA R, 1994, T ROY SOC TROP MED H, V88, P491, DOI 10.1016/0035-9203(94)90446-4; Moreno J, 2002, TRENDS PARASITOL, V18, P399, DOI 10.1016/S1471-4922(02)02347-4; Morillas F, 1996, PARASITOL RES, V82, P569, DOI 10.1007/s004360050164; Nejjar R, 1998, PARASITE, V5, P325, DOI 10.1051/parasite/1998054325; NEOGY AB, 1992, AM J TROP MED HYG, V47, P772, DOI 10.4269/ajtmh.1992.47.772; Ntais P, 2013, AM J TROP MED HYG, V89, P906, DOI 10.4269/ajtmh.13-0070; OIE, 2014, LEISHM; Oliva G, 2006, J CLIN MICROBIOL, V44, P1318, DOI 10.1128/JCM.44.4.1318-1322.2006; Rami M, 2003, PARASITE, V10, P79, DOI 10.1051/parasite/2003101p77; Rodriguez-Cortes A, 2013, VET PARASITOL, V191, P363, DOI 10.1016/j.vetpar.2012.09.009; Rodriguez-Cortes A, 2010, AM J TROP MED HYG, V82, P251, DOI 10.4269/ajtmh.2010.09-0366; ROGAN WJ, 1978, AM J EPIDEMIOL, V107, P71, DOI 10.1093/oxfordjournals.aje.a112510; Scalone A, 2002, VET PARASITOL, V104, P275, DOI 10.1016/S0304-4017(01)00643-4; Schallig HDFH, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-100; Sousa S, 2011, ACTA TROP, V120, P82, DOI 10.1016/j.actatropica.2011.06.003; Spiegelhalter DJ, 2003, WINBUGS VERSION 1 4; Vercammen F, 1996, VET REC, V139, P264, DOI 10.1136/vr.139.11.264-a; Zaffaroni E, 1999, VET PARASITOL, V81, P11, DOI 10.1016/S0304-4017(98)00237-4; Zoghlami Z, 2014, INTERACTION CANINE H	55	9	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0117313	10.1371/journal.pone.0117313	http://dx.doi.org/10.1371/journal.pone.0117313			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25793942	Green Published, gold, Green Submitted			2022-12-27	WOS:000352084200011
J	Chapman, C; Henry, M; Bishop-Lilly, KA; Awosika, J; Briska, A; Ptashkin, RN; Wagner, T; Rajanna, C; Tsang, H; Johnson, SL; Mokashi, VP; Chain, PSG; Sozhamannan, S				Chapman, Carol; Henry, Matthew; Bishop-Lilly, Kimberly A.; Awosika, Joy; Briska, Adam; Ptashkin, Ryan N.; Wagner, Trevor; Rajanna, Chythanya; Tsang, Hsinyi; Johnson, Shannon L.; Mokashi, Vishwesh P.; Chain, Patrick S. G.; Sozhamannan, Shanmuga			Scanning the Landscape of Genome Architecture of Non-O1 and Non-O139 Vibrio cholerae by Whole Genome Mapping Reveals Extensive Population Genetic Diversity	PLOS ONE			English	Article							STRAINS; EPIDEMIC; EMERGENCE	Historically, cholera outbreaks have been linked to V. cholerae O1 serogroup strains or its derivatives of the O37 and O139 serogroups. A genomic study on the 2010 Haiti cholera outbreak strains highlighted the putative role of non O1/non-O139 V. cholerae in causing cholera and the lack of genomic sequences of such strains from around the world. Here we address these gaps by scanning a global collection of V. cholerae strains as a first step towards understanding the population genetic diversity and epidemic potential of non O1/non-O139 strains. Whole Genome Mapping (Optical Mapping) based bar coding produces a high resolution, ordered restriction map, depicting a complete view of the unique chromosomal architecture of an organism. To assess the genomic diversity of non-O1/non-O139 V. cholerae, we applied a Whole Genome Mapping strategy on a well-defined and geographically and temporally diverse strain collection, the Sakazaki serogroup type strains. Whole Genome Map data on 91 of the 206 serogroup type strains support the hypothesis that V. cholerae has an unprecedented genetic and genomic structural diversity. Interestingly, we discovered chromosomal fusions in two unusual strains that possess a single chromosome instead of the two chromosomes usually found in V. cholerae. We also found pervasive chromosomal rearrangements such as duplications and indels in many strains. The majority of Vibrio genome sequences currently in public databases are unfinished draft sequences. The Whole Genome Mapping approach presented here enables rapid screening of large strain collections to capture genomic complexities that would not have been otherwise revealed by unfinished draft genome sequencing and thus aids in assembling and finishing draft sequences of complex genomes. Furthermore, Whole Genome Mapping allows for prediction of novel V. cholerae non-O1/non-O139 strains that may have the potential to cause future cholera outbreaks.	[Chapman, Carol; Henry, Matthew; Bishop-Lilly, Kimberly A.; Awosika, Joy; Tsang, Hsinyi; Sozhamannan, Shanmuga] Henry M Jackson Fdn, Bethesda, MD USA; [Chapman, Carol; Henry, Matthew; Bishop-Lilly, Kimberly A.; Awosika, Joy; Tsang, Hsinyi; Mokashi, Vishwesh P.; Sozhamannan, Shanmuga] Naval Med Res Ctr Frederick, Ft Detrick, MD USA; [Briska, Adam; Ptashkin, Ryan N.; Wagner, Trevor] OpGen Inc, Gaithersburg, MD USA; [Rajanna, Chythanya] Univ Florida, Gainesville, FL USA; [Johnson, Shannon L.; Chain, Patrick S. G.] Los Alamos Natl Lab, Biosci Div, Genome Sci, Los Alamos, NM USA	Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc; Naval Medical Research Center (NMRC); State University System of Florida; University of Florida; United States Department of Energy (DOE); Los Alamos National Laboratory	Sozhamannan, S (corresponding author), GoldBelt Raven LLC, Frederick, MD 21701 USA.	Shanmuga.Sozhamannan.ctr@mail.mil	Johnson, Shannon Lyn/H-2799-2019; Chain, Patrick/O-4140-2019; Sozhamannan, Shanmuga/AAN-7809-2020; Sozhamannan, Shanmuga/AGF-2410-2022	Johnson, Shannon Lyn/0000-0002-3972-9208; Chain, Patrick/0000-0003-3949-3634; Sozhamannan, Shanmuga/0000-0002-6762-7874; 	Defense Threat Reduction Agency [TMTI_IB06RSQ002]	Defense Threat Reduction Agency(United States Department of DefenseDefense Threat Reduction Agency)	This work was supported under contract TMTI_IB06RSQ002 through the Defense Threat Reduction Agency to SS. Additional support was provided by OpGen, Inc for data collection, analyses and interpretation of data. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bik EM, 1996, J CLIN MICROBIOL, V34, P1453, DOI 10.1128/JCM.34.6.1453-1461.1996; Center for Disease Control and Prevention, 2011, MMWR-MORBID MORTAL W, V59, P1473; Chen Q, 2006, MICROBIOL-SGM, V152, P1041, DOI 10.1099/mic.0.28648-0; DAVIS BR, 1981, J CLIN MICROBIOL, V14, P631, DOI 10.1128/JCM.14.6.631-639.1981; Frerichs RR, 2012, P NATL ACAD SCI USA, V109, pE3208, DOI 10.1073/pnas.1211512109; Hasan NA, 2012, P NATL ACAD SCI USA, V109, pE2010, DOI 10.1073/pnas.1207359109; Henz Stefan R, 2005, Bioinformatics, V21, P2329, DOI 10.1093/bioinformatics/bth324; Li MR, 2003, APPL ENVIRON MICROB, V69, P1728, DOI 10.1128/AEM.69.3.1728-1738.2003; Li MR, 2002, INFECT IMMUN, V70, P2441, DOI 10.1128/IAI.70.5.2441-2453.2002; Mekalanos JJ, 2012, P NATL ACAD SCI USA, V109, pE3206, DOI 10.1073/pnas.1212443109; MYERS EW, 1992, B MATH BIOL, V54, P599, DOI 10.1016/S0092-8240(05)80078-3; Octavia S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065342; Pengsuk C, 2011, J MICROBIOL METH, V87, P224, DOI 10.1016/j.mimet.2011.07.022; Pevzner PA, 2001, P NATL ACAD SCI USA, V98, P9748, DOI 10.1073/pnas.171285098; Pritchard JK, 2000, GENETICS, V155, P945; RAMAMURTHY T, 1993, LANCET, V341, P703, DOI 10.1016/0140-6736(93)90480-5; Reams AB, 2012, GENETICS, V192, P397, DOI 10.1534/genetics.112.142570; Schwan WR, 2010, MICROBIOL-SGM, V156, P2124, DOI 10.1099/mic.0.033977-0; SHIMADA T, 1994, CURR MICROBIOL, V28, P175, DOI 10.1007/BF01571061; TRUCKSIS M, 1991, J BACTERIOL, V173, P5854, DOI 10.1128/jb.173.18.5854-5860.1991; Trucksis M, 1998, P NATL ACAD SCI USA, V95, P14464, DOI 10.1073/pnas.95.24.14464; Val ME, 2014, MOL MICROBIOL, V91, P665, DOI 10.1111/mmi.12483; Val ME, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002472; Wang DC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021299; WATERMAN MS, 1984, NUCLEIC ACIDS RES, V12, P237, DOI 10.1093/nar/12.1Part1.237	25	15	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0120311	10.1371/journal.pone.0120311	http://dx.doi.org/10.1371/journal.pone.0120311			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25794000	Green Published, Green Submitted, gold			2022-12-27	WOS:000352083900010
J	Gladstone, M; Oliver, C; Van den Broek, N				Gladstone, Melissa; Oliver, Clare; Van den Broek, Nynke			Survival, Morbidity, Growth and Developmental Delay for Babies Born Preterm in Low and Middle Income Countries - A Systematic Review of Outcomes Measured	PLOS ONE			English	Article							LOW-BIRTH-WEIGHT; NEONATAL INTENSIVE-CARE; RESPIRATORY-DISTRESS-SYNDROME; RANDOMIZED CONTROLLED-TRIAL; INTRA-VENTRICULAR HEMORRHAGE; MUHIMBILI MEDICAL-CENTER; KANGAROO MOTHER CARE; DAR-ES-SALAAM; RISK-FACTORS; RURAL MALAWI	Background Premature birth is the leading cause of neonatal death and second leading in children under 5. Information on outcomes of preterm babies surviving the early neonatal period is sparse although it is considered a major determinant of immediate and long-term morbidity. Methods Systematic review of studies reporting outcomes for preterm babies in low and middle income settings was conducted using electronic databases, citation tracking, expert recommendations and "grey literature". Reviewers screened titles, abstracts and articles. Data was extracted using inclusion and exclusion criteria, study site and facilities, assessment methods and outcomes of mortality, morbidity, growth and development. The Child Health Epidemiology Reference Group criteria (CHERG) were used to assess quality. Findings Of 197 eligible publications, few (10.7%) were high quality (CHERG). The majority (83.3%) report on the outcome of a sample of preterm babies at time of birth or admission. Only 16.0% studies report population-based data using standardised mortality definitions. In 50.5% of studies, gestational age assessment method was unclear. Only 15.8% followed-up infants for 2 years or more. Growth was reported using standardised definitions but recommended morbidity definitions were rarely used. The criteria for assessment of neurodevelopmental outcomes was variable with few standardised tools - Bayley II was used in approximately 33% of studies, few studies undertook sensory assessments. Conclusions To determine the relative contribution of preterm birth to the burden of disease in children and to inform the planning of healthcare interventions to address this burden, a renewed understanding of the assessment and documentation of outcomes for babies born preterm is needed. More studies assessing outcomes for preterm babies who survive the immediate newborn period are needed. More consistent use of data is vital with clear and aligned definitions of health outcomes in newborn (preterm or term) and intervention packages aimed to save lives and improve health.	[Gladstone, Melissa; Oliver, Clare] Univ Liverpool, Dept Women & Childrens Hlth, Inst Translat Med, Alder Hey NHS Fdn Trust, Liverpool L69 3BX, Merseyside, England; [Van den Broek, Nynke] Univ Liverpool, Liverpool Sch Trop Med, Ctr Maternal & Newborn Hlth, Liverpool L3 5QA, Merseyside, England	Alder Hey Children's NHS Foundation Trust; University of Liverpool; Liverpool School of Tropical Medicine; University of Liverpool	Gladstone, M (corresponding author), Univ Liverpool, Dept Women & Childrens Hlth, Inst Translat Med, Alder Hey NHS Fdn Trust, Liverpool L69 3BX, Merseyside, England.	m.j.gladstone@liv.ac.uk	Gladstone, Melissa J./L-6535-2018	Gladstone, Melissa J./0000-0002-2579-9301; van den Broek, Nynke/0000-0001-8523-2684	National Institute for Health Research [CL-2009-07-003] Funding Source: researchfish	National Institute for Health Research(National Institute for Health Research (NIHR))		Abu-Salah O, 2011, J PAK MED ASSOC, V61, P769; Adair LS, 1999, J NUTR, V129, P1140, DOI 10.1093/jn/129.6.1140; Adegoke AA, 2007, AFR HEALTH SCI, V7, P170; Ahmed ASMNU, 2008, J TROP PEDIATRICS, V54, P333, DOI 10.1093/tropej/fmn035; Al-Abdi S, 2011, AM J PERINAT, V28, P219, DOI 10.1055/s-0030-1268236; Al-Riyami Nihal, 2013, Sultan Qaboos Univ Med J, V13, P51; Amiel-Tison C., 2001, NEUROLOGICAL DEV BIR; Ayaya S O, 2001, East Afr Med J, V78, P544; Badiee Z, 2007, SAUDI MED J, V28, P1362; Ballot DE, 2012, BMC PEDIATR, V12, DOI 10.1186/1471-2431-12-11; Bancalari E, 2006, SEMIN PERINATOL, V30, P164, DOI 10.1053/j.semperi.2006.05.002; Barros FC, 2005, LANCET, V365, P847, DOI 10.1016/S0140-6736(05)71042-4; Barros FC, 2012, BMC PEDIATR, V12, DOI 10.1186/1471-2431-12-169; Barros MCM, 2011, NEONATOLOGY, V99, P133, DOI 10.1159/000313590; BARTLETT AV, 1991, PEDIATR INFECT DIS J, V10, P752, DOI 10.1097/00006454-199110000-00007; Beck S, 2010, B WORLD HEALTH ORGAN, V88, P31, DOI 10.2471/BLT.08.062554; BELL MJ, 1978, NEW ENGL J MED, V298, P281; Berry MA, 2008, J PERINATOL, V28, P297, DOI 10.1038/sj.jp.7211904; Blencowe H, 2012, LANCET, V379, P2162, DOI 10.1016/S0140-6736(12)60820-4; BOO N Y, 1992, SMJ Singapore Medical Journal, V33, P33; de Almeida MFB, 2008, J PEDIAT-BRAZIL, V84, P300, DOI 10.2223/JPED.1787; Burger M, 2011, EARLY HUM DEV, V87, P303, DOI 10.1016/j.earlhumdev.2011.01.034; Can E, 2012, PEDIATR INT, V54, P869, DOI 10.1111/j.1442-200X.2012.03713.x; Caseloads R., 2022, WORLD EC OUTLOOK; Celik IH, 2013, J MATERN-FETAL NEO M, V26, P459, DOI 10.3109/14767058.2012.735994; Cetinkaya M, 2012, EARLY HUM DEV, V88, P893, DOI 10.1016/j.earlhumdev.2012.07.004; Charpak N, 2001, PEDIATRICS, V108, P1072, DOI 10.1542/peds.108.5.1072; Chaudhari S, 1999, Indian Pediatr, V36, P669; Chaudhari S, 1996, Indian Pediatr, V33, P645; Chaudhari S, 1995, Indian Pediatr, V32, P735; Chaudhari S, 1994, Indian Pediatr, V31, P1461; Chaudhari S, 1999, INDIAN PEDIATR, V28, P873; Chaudhari Sudha, 2004, Indian Pediatr, V41, P121; Chen LC, 2013, EARLY HUM DEV, V89, P301, DOI 10.1016/j.earlhumdev.2012.10.008; Chen Y, 2008, BRIT J OPHTHALMOL, V92, P326, DOI 10.1136/bjo.2007.131813; Cheung YB, 2001, INT J EPIDEMIOL, V30, P66, DOI 10.1093/ije/30.1.66; Christian P, 2014, BMC PEDIATR, V14, DOI 10.1186/1471-2431-14-58; Cooper PA, 1997, PEDIATRICS, V99, P537, DOI 10.1542/peds.99.4.537; COSTELLO AMD, 1988, DEV MED CHILD NEUROL, V30, P711; Demirel G, 2013, ACTA PAEDIATR, V102, pE560, DOI 10.1111/apa.12416; Dilli D, 2012, INDIAN PEDIATR, V49, P711, DOI 10.1007/s13312-012-0162-x; Duman N, 2003, J Matern Fetal Neonatal Med, V13, P54, DOI 10.1080/713605758; Elizabeth KE, 2007, J TROP PEDIATRICS, V53, P374, DOI 10.1093/tropej/fmm048; Engmann C, 2012, TROP MED INT HEALTH, V17, P272, DOI 10.1111/j.1365-3156.2011.02931.x; Ertan AK, 2012, ARCH GYNECOL OBSTET, V285, P1547, DOI 10.1007/s00404-011-2191-4; Feghhi M, 2012, MIDDLE EAST AFR J OP, V19, P101, DOI 10.4103/0974-9233.92124; Porto AMF, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d1696; Fortes JB, 2013, J TROP PEDIATRICS, V59, P502, DOI 10.1093/tropej/fmt036; Fortes JB, 2010, GRAEF ARCH CLIN EXP, V248, P893, DOI 10.1007/s00417-009-1248-6; Gezer A, 2013, J OBSTET GYNAECOL, V33, P38, DOI 10.3109/01443615.2012.729620; Gilbert C, 2005, PEDIATRICS, V115, pE518, DOI 10.1542/peds.2004-1180; Gladstone M, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001121; Gladstone M, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000273; Gole GA, 2005, ARCH OPHTHALMOL-CHIC, V123, P991, DOI 10.1001/archopht.123.7.991; Gonzalez R, 2006, PEDIATRICS, V117, pE949, DOI 10.1542/peds.2005-2354; GRAY RH, 1991, INT J EPIDEMIOL, V20, P467, DOI 10.1093/ije/20.2.467; Grupo Colaborativo Neocosur, 2002, J Perinatol, V22, P2; Guven S, 2013, J MATERN-FETAL NEO M, V26, P396, DOI 10.3109/14767058.2012.733778; Harrell FE, 1998, STAT MED, V17, P909, DOI 10.1002/(SICI)1097-0258(19980430)17:8<909::AID-SIM753>3.0.CO;2-O; Ho JJ, 2007, J TROP PEDIATRICS, V53, P232, DOI 10.1093/tropej/fmm050; Ho JJ, 1999, J PAEDIATR CHILD H, V35, P175, DOI 10.1046/j.1440-1754.1999.t01-1-00340.x; Iranpour R, 2011, J ISFAHAN MED SCH, V29, P1; Joy R, 2014, ARCH DIS CHILD-FETAL, V99, pF105, DOI 10.1136/archdischild-2013-304650; Karagol BS, 2013, JPEN-PARENTER ENTER, V37, P223, DOI 10.1177/0148607112449482; Katz J, 2013, LANCET, V382, P417, DOI 10.1016/S0140-6736(13)60993-9; KERO PO, 1979, EUR J PEDIATR, V130, P271, DOI 10.1007/BF00441363; Khan K, 2014, INT J GYNECOL OBSTET, V126, P201, DOI 10.1016/j.ijgo.2014.06.003; Khan NZ, 2008, CHILD CARE HLTH DEV, V34, P657, DOI 10.1111/j.1365-2214.2008.00873.x; Khan NZ, 2006, PEDIATRICS, V118, P280, DOI 10.1542/peds.2005-2014; Korkmaz A, 2011, TURKISH J PEDIATR, V53, P261; Kuklina EV, 2004, J NUTR, V134, P3296; Kulmala T, 2000, PAEDIATR PERINAT EP, V14, P219, DOI 10.1046/j.1365-3016.2000.00270.x; Lakshmi CVS, 2013, INDIAN PEDIATR, V50, P847, DOI 10.1007/s13312-013-0235-5; Lavanya KR, 2012, INDIAN PEDIATR, V49, P717, DOI 10.1007/s13312-012-0163-9; Lawn JE, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-S1-S1; Leadford AE, 2013, PEDIATRICS, V132, pE128, DOI 10.1542/peds.2012-2030; LEVENE MI, 1983, LANCET, V1, P643; Liu J, 2008, AM J PERINAT, V25, P535, DOI 10.1055/s-0028-1083841; Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1; Ma XL, 2010, CHINESE MED J-PEKING, V123, P2776, DOI 10.3760/cma.j.issn.0366-6999.2010.20.005; Ma XL, 2009, J PERINAT MED, V37, P695, DOI 10.1515/JPM.2009.130; Mancini M C, 1999, Rev Hosp Clin Fac Med Sao Paulo, V54, P151; Manji KP, 1998, E AFR MED J, V75, P382; Marston L, 2009, PAEDIATR PERINAT EP, V23, P380, DOI 10.1111/j.1365-3016.2009.01046.x; Mazzi E, 2010, J TROP PEDIATRICS, V56, P307, DOI 10.1093/tropej/fmq005; McDonald CM, 2012, EUR J CLIN NUTR, V66, P1265, DOI 10.1038/ejcn.2012.136; Meneguel Joice Fabíola, 2003, Sao Paulo Med. J., V121, P45; Mlay GS, 2000, J TROP PEDIATRICS, V46, P303, DOI 10.1093/tropej/46.5.303; Mokhachane M, 2006, ANN TROP PAEDIATR, V26, P43, DOI 10.1179/146532806X90600; Morris SS, 1998, INT J EPIDEMIOL, V27, P242, DOI 10.1093/ije/27.2.242; Carvalho PRN, 2011, J PERINAT MED, V39, P343, DOI [10.1515/JPM.2010.141, 10.1515/jpm.2010.141]; Nkyekyer K, 2006, Ghana Med J, V40, P93; Olusanya BO, 2012, J MATERN-FETAL NEO M, V25, P346, DOI 10.3109/14767058.2011.577471; Oncel MY, 2014, ARCH DIS CHILD-FETAL, V99, pF110, DOI 10.1136/archdischild-2013-304745; Osman NB, 2001, J TROP PEDIATRICS, V47, P30, DOI 10.1093/tropej/47.1.30; Ozbek A, 2005, PEDIATR INT, V47, P532, DOI 10.1111/j.1442-200x.2005.02108.x; Pambou O, 2006, Sante, V16, P185; PAPILE LA, 1978, J PEDIATR-US, V92, P529, DOI 10.1016/S0022-3476(78)80282-0; Pieper CH, 2003, J TROP PEDIATRICS, V49, P148, DOI 10.1093/tropej/49.3.148; Poudel P, 2010, J MATERN-FETAL NEO M, V23, P441, DOI [10.1080/14767050903186285, 10.3109/14767050903186285]; Prinsen CAC, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-247; Richardosn DK, 2001, J PEDIATR-US, V138, P92, DOI 10.1067/mpd.2001.109608; ROBERTSON CMT, 1992, PEDIATRICS, V89, P365; Ruiz-Pelaez JG, 2014, BIOMEDICA, V34, P29, DOI [10.7705/biomedica.v34i1.1463, 10.1590/S0120-41572014000100006]; Rylance S, 2013, PAEDIATR INT CHILD H, V33, P91, DOI 10.1179/2046905513Y.0000000053; SAIGAL S, 1982, J PEDIATR-US, V100, P606, DOI 10.1016/S0022-3476(82)80767-1; Saigal S, 2008, LANCET, V371, P261, DOI 10.1016/S0140-6736(08)60136-1; Sallakh-Niknezhad A, 2012, IRAN J PEDIATR, V22, P171; Santos IS, 2009, BMC PEDIATR, V9, DOI 10.1186/1471-2431-9-71; Satar M, 2014, TURKISH J PEDIATR, V56, P166; Schmiegelow C, 2012, ACTA OBSTET GYN SCAN, V91, P1061, DOI 10.1111/j.1600-0412.2012.01478.x; Serce O, 2013, EARLY HUM DEV, V89, P1033, DOI 10.1016/j.earlhumdev.2013.08.013; Servili C, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-693; Seth B, 2014, J PEDIATR NEUROSCI, V9, P7, DOI 10.4103/1817-1745.131470; Sloan NL, 2008, PEDIATRICS, V121, pE1047, DOI 10.1542/peds.2007-0076; Sonkusare S, 2009, Med J Malaysia, V64, P303; Stein AD, 2013, J PEDIATR-US, V163, P1740, DOI 10.1016/j.jpeds.2013.08.012; Steinglass R, 2011, INT J EPIDEMIOL, V39, pi1; Surmeli-Onay O, 2012, TURKISH J PEDIATR, V54, P239; Tanir HM, 2003, INT J GYNECOL OBSTET, V82, P167, DOI 10.1016/S0020-7292(03)00125-5; United Nations, 2011, MILL DEV GOALS REP 2; Vaahtera M, 2000, ARCH DIS CHILD-FETAL, V82, pF200, DOI 10.1136/fn.82.3.F200; van den Broek N, 2005, HUM REPROD, V20, P3235, DOI 10.1093/humrep/dei208; van den Broek NR, 2013, BRIT J OBSTET GYNAEC, V110, P902; van den Broek NR, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000191; Verma M, 1994, Indian Pediatr, V31, P1183; Vural M, 2007, PEDIATR INT, V49, P341, DOI 10.1111/j.1442-200X.2007.02381.x; Wang HH, 2012, PEDIATRICS, V129, pE731, DOI 10.1542/peds.2011-0725; Webb AL, 2009, J TROP PEDIATRICS, V55, P83, DOI 10.1093/tropej/fmn068; Welaga P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058924; Were F N, 2006, East Afr Med J, V83, P84; Were F N, 2006, East Afr Med J, V83, P243; WHO, 2009, BURD DIS DALYS 4; Wolf MJ, 1999, EUR J PEDIATR, V158, P111, DOI 10.1007/s004310051029; Worku B, 2004, ETHIOPIAN MED J, V42, P109; World Health Organization, 2006, NEON PER MORT COUNTR; World health organization, 2013, WORLD HLTH STAT 2013; Xu BZ, 1998, SCAND J SOC MED, V26, P10; ZHANG J, 1991, INT J EPIDEMIOL, V20, P958, DOI 10.1093/ije/20.4.958; Zhang X, 2009, INT J VITAM NUTR RES, V79, P238, DOI 10.1024/0300-9831.79.4.238	140	43	47	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0120566	10.1371/journal.pone.0120566	http://dx.doi.org/10.1371/journal.pone.0120566			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25793703	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000352083900052
J	Huang, WJ; Zhou, GY; Liu, JX; Zhang, DQ; Liu, SZ; Chu, GW; Fang, X				Huang, Wenjuan; Zhou, Guoyi; Liu, Juxiu; Zhang, Deqiang; Liu, Shizhong; Chu, Guowei; Fang, Xiong			Mineral Elements of Subtropical Tree Seedlings in Response to Elevated Carbon Dioxide and Nitrogen Addition	PLOS ONE			English	Article							FOREST ECOSYSTEMS; ATMOSPHERIC CO2; CLIMATE-CHANGE; SOIL; PLANT; DEPOSITION; PHOSPHORUS; DYNAMICS; AVAILABILITY; METAANALYSIS	Mineral elements in plants have been strongly affected by increased atmospheric carbon dioxide (CO2) concentrations and nitrogen (N) deposition due to human activities. However, such understanding is largely limited to N and phosphorus in grassland. Using open-top chambers, we examined the concentrations of potassium (K), calcium (Ca), magnesium (Mg), aluminum (Al), copper (Cu) and manganese (Mn) in the leaves and roots of the seedlings of five subtropical tree species in response to elevated CO2 (ca. 700 mu mol CO2 mol(-1)) and N addition (100 kg N ha(-1) yr(-1)) from 2005 to 2009. These mineral elements in the roots responded more strongly to elevated CO2 and N addition than those in the leaves. Elevated CO2 did not consistently decrease the concentrations of plant mineral elements, with increases in K, Al, Cu and Mn in some tree species. N addition decreased K and had no influence on Cu in the five tree species. Given the shifts in plant mineral elements, Schima superba and Castanopsis hystrix were less responsive to elevated CO2 and N addition alone, respectively. Our results indicate that plant stoichiometry would be altered by increasing CO2 and N deposition, and K would likely become a limiting nutrient under increasing N deposition in subtropics.	[Huang, Wenjuan; Zhou, Guoyi; Liu, Juxiu; Zhang, Deqiang; Liu, Shizhong; Chu, Guowei; Fang, Xiong] Chinese Acad Sci, South China Bot Garden, Key Lab Vegetat Restorat & Management Degraded Ec, Guangzhou 510650, Guangdong, Peoples R China; [Fang, Xiong] Chinese Acad Sci, Grad Univ, Beijing 100049, Peoples R China	Chinese Academy of Sciences; South China Botanical Garden, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Liu, JX (corresponding author), Chinese Acad Sci, South China Bot Garden, Key Lab Vegetat Restorat & Management Degraded Ec, Xingke Rd 723, Guangzhou 510650, Guangdong, Peoples R China.	ljxiu@scbg.ac.cn	Huang, Wendy/X-1221-2018		National Natural Science Foundation of China [31370530]; Science and Technology Innovation Project of Guangdong Province Forestry [2012KJCX019-02]; South China Botanical Garden-Shanghai Institute of Plant Physiology & Ecology Joint Fund	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Innovation Project of Guangdong Province Forestry; South China Botanical Garden-Shanghai Institute of Plant Physiology & Ecology Joint Fund	This study was jointly funded by the National Natural Science Foundation of China (Grant No. 31370530), Science and Technology Innovation Project of Guangdong Province Forestry (Grant No. 2012KJCX019-02), and South China Botanical Garden-Shanghai Institute of Plant Physiology & Ecology Joint Fund.	Agren GI, 2008, ANNU REV ECOL EVOL S, V39, P153, DOI 10.1146/annurev.ecolsys.39.110707.173515; Andrews JA, 2001, GLOBAL BIOGEOCHEM CY, V15, P149, DOI 10.1029/2000GB001278; Bowman WD, 2008, NAT GEOSCI, V1, P767, DOI 10.1038/ngeo339; Buol S.W., 2003, SOIL GENESIS CLASSIF; Bytnerowicz A, 2007, ENVIRON POLLUT, V147, P438, DOI 10.1016/j.envpol.2006.08.028; Cakmak I, 2005, J PLANT NUTR SOIL SC, V168, P521, DOI 10.1002/jpln.200420485; Cernusak LA, 2013, FUNCT PLANT BIOL, V40, P531, DOI 10.1071/FP12309; Deng Q, 2010, BIOGEOSCIENCES, V7, P315, DOI 10.5194/bg-7-315-2010; Duval BD, 2012, PLANT ECOL, V213, P505, DOI 10.1007/s11258-011-9998-8; Elvir JA, 2006, FOREST ECOL MANAG, V221, P207, DOI 10.1016/j.foreco.2005.09.022; Garrish V, 2010, J EXP BOT, V61, P3735, DOI 10.1093/jxb/erq183; Han WX, 2011, ECOL LETT, V14, P788, DOI 10.1111/j.1461-0248.2011.01641.x; Hofmockel KS, 2011, GLOBAL CHANGE BIOL, V17, P3338, DOI 10.1111/j.1365-2486.2011.02465.x; Hungate BA, 2003, SCIENCE, V302, P1512, DOI 10.1126/science.1091390; Johnson DW, 2004, BIOGEOCHEMISTRY, V69, P379, DOI 10.1023/B:BIOG.0000031054.19158.7c; Johnson DW, 2003, ECOL APPL, V13, P1388, DOI 10.1890/02-5139; Likens GE, 1998, BIOGEOCHEMISTRY, V41, P89, DOI 10.1023/A:1005984620681; Liu JX, 2008, BIOGEOSCIENCES, V5, P1783, DOI 10.5194/bg-5-1783-2008; Liu JX, 2014, J GEOPHYS RES-BIOGEO, V119, P676, DOI 10.1002/2013JG002343; Liu JX, 2013, GLOBAL CHANGE BIOL, V19, P208, DOI 10.1111/gcb.12022; Liu JX, 2011, ECOSYSTEMS, V14, P683, DOI 10.1007/s10021-011-9438-6; Loladze I, 2002, TRENDS ECOL EVOL, V17, P457, DOI 10.1016/S0169-5347(02)02587-9; Lucas RW, 2011, FOREST ECOL MANAG, V262, P95, DOI 10.1016/j.foreco.2011.03.018; Marinari S, 2007, ENVIRON POLLUT, V147, P507, DOI 10.1016/j.envpol.2006.08.041; Marschner H., 1995, MINERAL NUTR HIGHER, V2nd ed.; Nadelhoffer KJ, 1999, NATURE, V398, P145, DOI 10.1038/18205; Natali SM, 2009, ECOSYSTEMS, V12, P715, DOI 10.1007/s10021-009-9251-7; Niklaus PA, 1998, OECOLOGIA, V117, P201, DOI 10.1007/s004420050649; Norby RJ, 2005, P NATL ACAD SCI USA, V102, P18052, DOI 10.1073/pnas.0509478102; Reich PB, 2006, NATURE, V440, P922, DOI 10.1038/nature04486; Reich PB, 2001, NEW PHYTOL, V150, P435, DOI 10.1046/j.1469-8137.2001.00114.x; Santiago LS, 2012, J ECOL, V100, P309, DOI 10.1111/j.1365-2745.2011.01904.x; Schreeg LA, 2014, ECOLOGY, V95, P2062, DOI 10.1890/13-1671.1; Taub DR, 2008, J INTEGR PLANT BIOL, V50, P1365, DOI 10.1111/j.1744-7909.2008.00754.x; Tripler CE, 2006, ECOL LETT, V9, P451, DOI 10.1111/j.1461-0248.2006.00891.x; Turner BL, 2013, SOIL SCI SOC AM J, V77, P1357, DOI 10.2136/sssaj2012.0128; Vitousek PM, 1997, ECOL APPL, V7, P737, DOI 10.2307/2269431; VITOUSEK PM, 1986, ANNU REV ECOL SYST, V17, P137, DOI 10.1146/annurev.es.17.110186.001033; Watmough SA, 2003, ECOSYSTEMS, V6, P675, DOI 10.1007/s10021-002-0164-y; WOODIN S, 1992, NEW PHYTOL, V122, P635; Xia JY, 2008, NEW PHYTOL, V179, P428, DOI 10.1111/j.1469-8137.2008.02488.x; Xu ZH, 2009, J SOIL SEDIMENT, V9, P83, DOI 10.1007/s11368-009-0060-6; Yan JH, 2014, GLOBAL CHANGE BIOL, V20, P2230, DOI 10.1111/gcb.12501; Zhang J.S., 2006, PLANT PHYSIOL, P88; Zhao Liang, 2011, Yingyong Shengtai Xuebao, V22, P1949	45	5	6	1	73	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0120190	10.1371/journal.pone.0120190	http://dx.doi.org/10.1371/journal.pone.0120190			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25794046	gold, Green Published, Green Submitted			2022-12-27	WOS:000352084200157
J	Lim, CC; Teo, BW; Tai, ES; Lim, SC; Chan, CM; Sethi, S; Wong, TY; Sabanayagam, C				Lim, Cynthia Ciwei; Teo, Boon Wee; Tai, E. Shyong; Lim, Su Chi; Chan, Choong Meng; Sethi, Sunil; Wong, Tien Y.; Sabanayagam, Charumathi			Elevated Serum Leptin, Adiponectin and Leptin to Adiponectin Ratio Is Associated with Chronic Kidney Disease in Asian Adults	PLOS ONE			English	Article							GLOMERULAR-FILTRATION-RATE; TYPE-2 DIABETIC-PATIENTS; LEPTIN/ADIPONECTIN RATIO; INSULIN-RESISTANCE; RENAL-FUNCTION; CARDIOVASCULAR EVENTS; INDEPENDENT PREDICTOR; PLASMA ADIPONECTIN; WEIGHT; EPIDEMIOLOGY	Background Adiponectin and leptin, two of the key cytokines secreted by adipocytes, have been shown to be associated with cardiovascular disease. However, the association of these adipocytokines with chronic kidney disease (CKD) is not clear. We examined the association of serum adiponectin, leptin levels and leptin to adiponectin ratio (LAR) with CKD in a population- based sample of Asian adults. Methods We conducted a case-control study (450 CKD cases and 920 controls matched for age, sex and ethnicity) involving Chinese and Indian adults aged 40-80 years who participated in the Singapore Epidemiology of Eye Diseases Study (2007-2011). CKD was defined as an estimated glomerular filtration rate <60 mL/min/1.73m(2) from serum creatinine. Serum adiponectin and leptin levels were measured using commercially available ELISA. Odds ratio of CKD associated with elevated adiponectin and leptin levels were estimated using logistic regression models adjusted for age, gender, ethnicity, education, smoking, body mass index, diabetes, blood pressure, total and HDL cholesterol. Results CKD cases had higher levels of leptin (mean [SD] 9.7 [11.5] vs. 16.9 [20.2] ng/mL, p<0.0001) and adiponectin (10.4 [7.4] vs. 9.2 [4.2], p = 0.001) compared to controls. In multi-variable models, compared to those in the lowest quartile, the OR (95% confidence interval) of CKD among those in the highest quartile were: 6.46 (3.84, 10.88), 1.94 (1.32-2.85) and 2.88 (1.78-4.64) for leptin, adiponectin and LAR. Similar associations were also observed when adiponectin and leptin were analyzed as continuous variables. This positive association of serum adiponectin, leptin and LAR with CKD was consistently present in subgroups of gender, ethnicity, diabetes, hypertension and overweight status (all P-interaction >0.1). Conclusions Higher levels of serum adiponectin, leptin and LAR were positively associated with CKD independent of traditional risk factors in this Asian population.	[Lim, Cynthia Ciwei; Chan, Choong Meng] Singapore Gen Hosp, Dept Renal Med, Singapore, Singapore; [Teo, Boon Wee; Tai, E. Shyong] Natl Univ Singapore, Natl Univ Hlth Syst, Dept Med, Singapore 117548, Singapore; [Lim, Su Chi] Khoo Teck Puat Hosp, Ctr Diabet, Singapore, Singapore; [Sethi, Sunil] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Pathol, Singapore 117548, Singapore; [Wong, Tien Y.] Singapore Natl Eye Ctr, Singapore, Singapore; [Wong, Tien Y.; Sabanayagam, Charumathi] Natl Univ Singapore, Ophthalmol & Visual Sci Acad Clin Program, Duke NUS Grad Med Sch, Singapore 117548, Singapore; [Wong, Tien Y.; Sabanayagam, Charumathi] Singapore Eye Res Inst, Singapore, Singapore	Singapore General Hospital; National University of Singapore; National University of Singapore; Singapore National Eye Center; National University of Singapore; National University of Singapore; Singapore National Eye Center	Sabanayagam, C (corresponding author), Natl Univ Singapore, Ophthalmol & Visual Sci Acad Clin Program, Duke NUS Grad Med Sch, Singapore 117548, Singapore.	charumathi.sabanayagam@seri.com.sg	Wong, Tien Yin/AAC-9724-2020; Sabanayagam, Charumathi/C-1294-2011	Wong, Tien Yin/0000-0002-8448-1264; Sabanayagam, Charumathi/0000-0002-4042-4719; Tai, E Shyong/0000-0003-2929-8966	Singapore Ministry of Health's National Medical Research Council (NMRC) [NMRC/TA/0008/2012, NMRC/STaR/0003/2008]	Singapore Ministry of Health's National Medical Research Council (NMRC)	This work was supported by the Singapore Ministry of Health's National Medical Research Council (NMRC) under its Talent Development Scheme NMRC/TA/0008/2012 (CS), NMRC/STaR/0003/2008 (TYW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becker B, 2005, J AM SOC NEPHROL, V16, P1091, DOI 10.1681/ASN.2004090742; Cantarin MPM, 2013, KIDNEY INT, V83, P487, DOI 10.1038/ki.2012.421; Considine RV, 1996, NEW ENGL J MED, V334, P292, DOI 10.1056/NEJM199602013340503; de Almeida AR, 2014, NUTR METAB, V11, DOI 10.1186/1743-7075-11-25; Donoso MA, 2013, HORM RES PAEDIAT, V80, P363, DOI 10.1159/000356046; Doumatey AP, 2012, INT J NEPHROL, V2012, DOI 10.1155/2012/730920; Fruehwald-Schultes B, 1999, METABOLISM, V48, P1290, DOI 10.1016/S0026-0495(99)90270-6; Galletti F, 2008, J CLIN ENDOCR METAB, V93, P3922, DOI 10.1210/jc.2008-1280; Guebre-Egziabher F, 2005, NEPHROL DIAL TRANSPL, V20, P129, DOI 10.1093/ndt/gfh568; Hall JI, 2011, ANN CLIN BIOCHEM, V48, P327, DOI 10.1258/acb.2011.010199; Haynes WG, 1997, J CLIN INVEST, V100, P270, DOI 10.1172/JCI119532; Haynes WG, 1999, HYPERTENSION, V33, P542, DOI 10.1161/01.HYP.33.1.542; Inoue M, 2005, METABOLISM, V54, P281, DOI 10.1016/j.metabol.2004.09.006; Iseki K, 2013, CLIN EXP NEPHROL, V17, P372, DOI 10.1007/s10157-012-0718-z; Kappelle PJWH, 2012, EUR J INTERN MED, V23, P755, DOI 10.1016/j.ejim.2012.06.013; Kollerits B, 2007, KIDNEY INT, V71, P1279, DOI 10.1038/sj.ki.5002191; Komaba H, 2006, AM J NEPHROL, V26, P476, DOI 10.1159/000096870; Lastra G, 2006, ADV CHRONIC KIDNEY D, V13, P365, DOI 10.1053/j.ackd.2006.07.011; Lavanya R, 2009, OPHTHAL EPIDEMIOL, V16, P325, DOI 10.3109/09286580903144738; Lee MPS, 2005, INT J OBESITY, V29, P1395, DOI 10.1038/sj.ijo.0803031; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Li PKT, 2011, NEPHROLOGY, V16, P633, DOI 10.1111/j.1440-1797.2011.01503.x; Liao YC, 2013, BIOMARKERS, V18, P44, DOI 10.3109/1354750X.2012.730550; Lim CC, 2015, EUR J PREV CARDIOL, V22, P1018, DOI 10.1177/2047487314536873; Looker HC, 2004, J CLIN ENDOCR METAB, V89, P4010, DOI 10.1210/jc.2003-031916; Matsushita K, 2010, LANCET, V375, P2073, DOI 10.1016/S0140-6736(10)60674-5; Menon V, 2004, CLIN NEPHROL, V61, P163; Mills KT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076902; Mohan V, 2005, METABOLISM, V54, P476, DOI 10.1016/j.metabol.2004.10.016; Nanayakkara PWB, 2009, CLIN NEPHROL, V72, P21; Nerpin E, 2008, DIABETES CARE, V31, P1550, DOI 10.2337/dc08-0369; Norata GD, 2010, NUTR METAB CARDIOVAS, V20, P56, DOI 10.1016/j.numecd.2009.01.011; Norata GD, 2007, STROKE, V38, P2844, DOI 10.1161/STROKEAHA.107.485540; Nordfors L, 1998, KIDNEY INT, V54, P1267, DOI 10.1046/j.1523-1755.1998.00088.x; Park JT, 2013, PERITON DIALYSIS INT, V33, P67, DOI 10.3747/pdi.2011.00066; Risch L, 2007, CLIN CHIM ACTA, V376, P108, DOI 10.1016/j.cca.2006.07.026; Saraheimo M, 2005, DIABETES CARE, V28, P1410, DOI 10.2337/diacare.28.6.1410; Sarnak MJ, 2002, KIDNEY INT, V62, P2208, DOI 10.1046/j.1523-1755.2002.00677.x; Satoh N, 2004, DIABETES CARE, V27, P2488, DOI 10.2337/diacare.27.10.2488; Schalkwijk CG, 2006, J CLIN ENDOCR METAB, V91, P129, DOI 10.1210/jc.2005-1117; Shand BI, 2003, DIABETES OBES METAB, V5, P349, DOI 10.1046/j.1463-1326.2003.00279.x; Shankar A, 2012, INT J NEPHROL, V2012, DOI 10.1155/2012/269532; Sharma K, 2008, J CLIN INVEST, V118, P1645, DOI 10.1172/JCI32691; Spranger J, 2003, LANCET, V361, P226, DOI 10.1016/S0140-6736(03)12255-6; Stepien M, 2013, MED SCI MONITOR, V19, P1063, DOI 10.12659/MSM.889390; Teo BW, 2012, AM J KIDNEY DIS, V60, P500, DOI 10.1053/j.ajkd.2012.05.008; Tsuboi A, 2013, J ATHEROSCLER THROMB, V20, P568, DOI 10.5551/jat.17426; Wannamethee SG, 2007, ATHEROSCLEROSIS, V191, P418, DOI 10.1016/j.atherosclerosis.2006.04.012; Wolf G, 1999, KIDNEY INT, V56, P860, DOI 10.1046/j.1523-1755.1999.00626.x; Yaturu S, 2007, CYTOKINE, V37, P1, DOI 10.1016/j.cyto.2007.02.003; Zoccali C, 2002, J AM SOC NEPHROL, V13, P134, DOI 10.1681/ASN.V131134	51	63	69	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0122009	10.1371/journal.pone.0122009	http://dx.doi.org/10.1371/journal.pone.0122009			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25793395	Green Published, Green Submitted, gold			2022-12-27	WOS:000352083900166
J	Sasaki, K; Hayashi, K; Lee, JB; Kurosaki, F; Hayashi, T				Sasaki, Kohei; Hayashi, Kyoko; Lee, Jung-Bum; Kurosaki, Fumiya; Hayashi, Toshimitsu			Characterization of a Novel Mutation in NS1 Protein of Influenza A Virus Induced by a Chemical Substance for the Attenuation of Pathogenicity	PLOS ONE			English	Article							PI3K/AKT SIGNALING PATHWAY; MDCK CELLS; ACTIVATION; INFECTION; EXPRESSION; APOPTOSIS; RNA	It is generally accepted that live attenuated influenza vaccine (LAIV) has the potential for use as a vaccination against flu. In this study, we demonstrated the nature of an influenza A virus (IAV) mutant induced by treating the IAV with a stable furan derivative, (1R,2R)-1-(5'-methylfur-3'-yl) propane-1,2,3-triol (MFPT), which had been isolated from Streptomyces sp. strain FV60 with the objective of it being an LAIV candidate. The resulting MFPT-resistant (MFPTr) IAVs possessed attenuated pathogenicity in vitro and in vivo when compared with that of the parent virus (H1N1 subtype, NWS strain). Sequencing analysis revealed that a novel mutation, C490U in ns gene (P164S in NS1), was detected in all MFPTr virus clones tested. Therefore, NS1 might be a main target of MFPT, and it was suggested that the P164S mutation contributed to the attenuated pathogenicity of the mutants. Although the phosphatidylinositol 3-kinase (PI3K)/Akt signaling pathway is one of the targets of NS1, the MFPTr virus suppressed the phosphorylation of Akt when compared with the wild-type (WT) virus. It was suggested that this might lead to the subsequent inhibition of the cleavage of PARP-1 and caspase-3, which is important for the progression of apoptosis. At the same time, nucleoprotein (NP) was found to be retained in the nuclei in MFPTr virus-infected cells while nuclear export of NP was detected in WT virus-infected cells. In addition, the expression levels of interferon-beta transcripts were significantly decreased in MFPTr virus-infected cells. From these results it can be shown that the mutation, NS1(P164S), might be one of the key residues to control NS1 function concerning the induction of apoptosis. In conclusion, MFPT induced favorable mutation in the ns gene for the attenuation of IAV, and therefore might provide the novel methodology for preparing LAIVs.	[Sasaki, Kohei; Lee, Jung-Bum; Kurosaki, Fumiya] Toyama Univ, Grad Sch Med & Pharmaceut Sci Res, Toyama 9300194, Japan; [Hayashi, Kyoko; Hayashi, Toshimitsu] Chubu Univ, Res Inst Life & Hlth Sci, Kasugai, Aichi 4878501, Japan	University of Toyama; Chubu University	Lee, JB (corresponding author), Toyama Univ, Grad Sch Med & Pharmaceut Sci Res, Toyama 9300194, Japan.	lee@pha.u-toyama.ac.jp		Lee, Jung-Bum/0000-0002-8732-7457	Japan Society for the Promotion of Science (JSPS) [25460206]	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	KH and JL received a Grant-in-Aid for Scientific Research (C, No. 25460206) from the Japan Society for the Promotion of Science (JSPS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boulo S, 2007, VIRUS RES, V124, P12, DOI 10.1016/j.virusres.2006.09.013; Ehrhardt C, 2009, CELL MICROBIOL, V11, P863, DOI 10.1111/j.1462-5822.2009.01309.x; Hale BG, 2008, J GEN VIROL, V89, P2359, DOI 10.1099/vir.0.2008/004606-0; Hale BG, 2010, P NATL ACAD SCI USA, V107, P1954, DOI 10.1073/pnas.0910715107; Hatakeyama S, 2005, J CLIN MICROBIOL, V43, P4139, DOI 10.1128/JCM.43.8.4139-4146.2005; Hayashi K, 2000, J ANTIMICROB CHEMOTH, V46, P181, DOI 10.1093/jac/46.2.181; Heynisch B, 2010, VACCINE, V28, P8210, DOI 10.1016/j.vaccine.2010.07.076; Hoffmann E, 2001, ARCH VIROL, V146, P2275, DOI 10.1007/s007050170002; Hurt AC, 2012, LANCET INFECT DIS, V12, P240, DOI 10.1016/S1473-3099(11)70318-8; Jackson D, 2010, VIROLOGY, V396, P94, DOI 10.1016/j.virol.2009.10.004; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Le Goffic R, 2007, J IMMUNOL, V178, P3368, DOI 10.4049/jimmunol.178.6.3368; Li CJ, 2014, TRENDS BIOTECHNOL, V32, P147, DOI 10.1016/j.tibtech.2014.01.001; Lindsay SM, 2012, J VIROL METHODS, V179, P351, DOI 10.1016/j.jviromet.2011.11.022; Lui XY, 2010, J GEN VIROL, V91, P1439, DOI 10.1099/vir.0.018465-0; McLean JE, 2009, J VIROL, V83, P8233, DOI 10.1128/JVI.02672-08; Onomoto K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043031; PALESE P., 2007, FIELDS VIROLOGY, V2, P1647, DOI DOI 10.1371/JOURNAL.PPAT.1003019; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Rehwinkel J, 2010, CELL, V140, P397, DOI 10.1016/j.cell.2010.01.020; Samson M, 2013, ANTIVIR RES, V98, P174, DOI 10.1016/j.antiviral.2013.03.014; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Seitz C, 2010, J GEN VIROL, V91, P1754, DOI 10.1099/vir.0.020370-0; Shin YK, 2007, J VIROL, V81, P12730, DOI 10.1128/JVI.01427-07; Shin YK, 2007, J GEN VIROL, V88, P13, DOI 10.1099/vir.0.82419-0; Tran AT, 2013, J VIROL, V87, P1049, DOI 10.1128/JVI.02017-12; WHO, 2009, SEQ PRIM PROT; World Health Organization, 2014, INF PREV CONTR EP PA; World Health Organization, 2013, COMPREHENSIVE CERVIC; Wurzer WJ, 2003, EMBO J, V22, P2717, DOI 10.1093/emboj/cdg279	30	3	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0121205	10.1371/journal.pone.0121205	http://dx.doi.org/10.1371/journal.pone.0121205			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25793397	gold, Green Published, Green Submitted			2022-12-27	WOS:000352083900112
J	Warfield, KL; Dye, JM; Wells, JB; Unfer, RC; Holtsberg, FW; Shulenin, S; Vu, H; Swenson, DL; Bavari, S; Aman, MJ				Warfield, Kelly L.; Dye, John M.; Wells, Jay B.; Unfer, Robert C.; Holtsberg, Frederick W.; Shulenin, Sergey; Vu, Hong; Swenson, Dana L.; Bavari, Sina; Aman, M. Javad			Homologous and Heterologous Protection of Nonhuman Primates by Ebola and Sudan Virus-Like Particles	PLOS ONE			English	Article							MARBURG VIRUSES; INSECT CELLS; GUINEA-PIGS; INFECTION; VACCINE; CHALLENGE; ANTIBODIES; IMMUNIZATION; RESPONSES; MUCOSAL	Filoviruses cause hemorrhagic fever resulting in significant morbidity and mortality in humans. Several vaccine platforms that include multiple virus-vectored approaches and virus-like particles (VLPs) have shown efficacy in nonhuman primates. Previous studies have shown protection of cynomolgus macaques against homologous infection for Ebola virus (EBOV) and Marburg virus (MARV) following a three-dose vaccine regimen of EBOV or MARV VLPs, as well as heterologous protection against Ravn Virus (RAVV) following vaccination with MARV VLPs. The objectives of the current studies were to determine the minimum number of vaccine doses required for protection (using EBOV as the test system) and then demonstrate protection against Sudan virus (SUDV) and Tai Forest virus (TAFV). Using the EBOV nonhuman primate model, we show that one or two doses of VLP vaccine can confer protection from lethal infection. VLPs containing the SUDV glycoprotein, nucleoprotein and VP40 matrix protein provide complete protection against lethal SUDV infection in macaques. Finally, we demonstrate protective efficacy mediated by EBOV, but not SUDV, VLPs against TAFV; this is the first demonstration of complete cross-filovirus protection using a single component heterologous vaccine within the Ebolavirus genus. Along with our previous results, this observation provides strong evidence that it will be possible to develop and administer a broad-spectrum VLP-based vaccine that will protect against multiple filoviruses by combining only three EBOV, SUDV and MARV components.	[Warfield, Kelly L.; Unfer, Robert C.; Holtsberg, Frederick W.; Shulenin, Sergey; Vu, Hong; Aman, M. Javad] Integrated Biotherapeut Inc, Gaithersburg, MD USA; [Dye, John M.; Wells, Jay B.; Swenson, Dana L.; Bavari, Sina] US Army Med Res Inst Infect Dis, Ft Detrick, MD USA	United States Army Medical Research Institute of Infectious Diseases; United States Department of Defense; United States Army	Warfield, KL (corresponding author), Unither Virol LLC, Silver Spring, MD 20910 USA.	kwarfield@unithervirology.com	Bavari, Sina/L-3642-2019	Bavari, Sina/0000-0001-8424-5635; Dye, John/0000-0002-0883-5016	Federal funds from the National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services [HHSN272200800055C]; Defense Threat Reduction Agency JSTO-CBD; Medical Research and Material Command; Integrated Biotherapeutics	Federal funds from the National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services; Defense Threat Reduction Agency JSTO-CBD(United States Department of DefenseDefense Threat Reduction Agency); Medical Research and Material Command(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC)); Integrated Biotherapeutics	This project has been funded in part with Federal funds from the National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services, under Contract No. HHSN272200800055C to MJA (IBT) and support from the Defense Threat Reduction Agency JSTO-CBD and the Medical Research and Material Command to JMD and SB (USAMRIID). Integrated Biotherapeutics provided support in the form of salaries for authors KLW, RCU, FWH, SS, HV, and MJA but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Allaranga Yokouide, 2010, East Afr J Public Health, V7, P30; Barrette RW, 2009, SCIENCE, V325, P204, DOI 10.1126/science.1172705; Bavari S, 2002, J EXP MED, V195, P593, DOI 10.1084/jem.20011500; Boisgerault Florence, 2002, Expert Rev Vaccines, V1, P101, DOI 10.1586/14760584.1.1.101; Buonaguro L, 2010, CURR HIV RES, V8, P299, DOI 10.2174/157016210791208659; Conner ME, 1996, J INFECT DIS, V174, pS88, DOI 10.1093/infdis/174.Supplement_1.S88; Dye JM, 2012, P NATL ACAD SCI USA, V109, P5034, DOI 10.1073/pnas.1200409109; Estes MK, 1997, ADV EXP MED BIOL, V412, P387; Falzarano D, 2011, J INFECT DIS, V204, pS1082, DOI 10.1093/infdis/jir350; Formenty P, 1999, J INFECT DIS, V179, pS48, DOI 10.1086/514285; Geisbert TW, 2011, J VIROL, V85, P4222, DOI 10.1128/JVI.02407-10; Geisbert TW, 2009, J VIROL, V83, P7296, DOI 10.1128/JVI.00561-09; Hensley LE, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000904; Herbert AS, 2013, J VIROL, V87, P4952, DOI 10.1128/JVI.03361-12; Johnson JE, 2000, CURR OPIN STRUC BIOL, V10, P229, DOI 10.1016/S0959-440X(00)00073-7; Jones SM, 2005, NAT MED, V11, P786, DOI 10.1038/nm1258; Kallstrom G, 2005, J VIROL METHODS, V127, P1, DOI 10.1016/j.jviromet.2005.02.015; Kuhn JH, 2010, ARCH VIROL, V155, P2083, DOI 10.1007/s00705-010-0814-x; MOE JB, 1981, J CLIN MICROBIOL, V13, P791, DOI 10.1128/JCM.13.4.791-793.1981; Naslund J, 2009, VIROLOGY, V385, P409, DOI 10.1016/j.virol.2008.12.012; Noad R, 2003, TRENDS MICROBIOL, V11, P438, DOI 10.1016/S0966-842X(03)00208-7; Noda T, 2002, J VIROL, V76, P4855, DOI 10.1128/JVI.76.10.4855-4865.2002; Olinger GG, 2012, P NATL ACAD SCI USA, V109, P18030, DOI 10.1073/pnas.1213709109; Pratt WD, 2010, CLIN VACCINE IMMUNOL, V17, P572, DOI 10.1128/CVI.00467-09; Qiu XG, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006605; Qiu XG, 2013, J VIROL, V87, P7754, DOI 10.1128/JVI.00173-13; Sullivan NJ, 2009, NAT REV MICROBIOL, V7, P393, DOI 10.1038/nrmicro2129; Sun YL, 2009, VIROLOGY, V383, P12, DOI 10.1016/j.virol.2008.09.020; Swenson DL, 2008, EXPERT REV VACCINES, V7, P417, DOI 10.1586/14760584.7.4.417; Swenson DL, 2005, VACCINE, V23, P3033, DOI 10.1016/j.vaccine.2004.11.070; Swenson DL, 2004, FEMS IMMUNOL MED MIC, V40, P27, DOI 10.1016/S0928-8244(03)00273-6; Tacket CO, 2003, CLIN IMMUNOL, V108, P241, DOI 10.1016/S1521-6616(03)00120-7; Towner JS, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000212; Warfield KL, 2007, J INFECT DIS, V196, pS421, DOI 10.1086/520612; Warfield KL, 2007, J INFECT DIS, V196, pS430, DOI 10.1086/520583; Warfield KL, 2014, P NATL ACAD SCI USA, V111, P8873, DOI 10.1073/pnas.1316902111; Warfield KL, 2011, J INFECT DIS, V204, pS1053, DOI 10.1093/infdis/jir346; Warfield KL, 2005, J IMMUNOL, V175, P1184, DOI 10.4049/jimmunol.175.2.1184; Warfield KL, 2004, VACCINE, V22, P3495, DOI 10.1016/j.vaccine.2004.01.063; Warfield KL, 2003, P NATL ACAD SCI USA, V100, P15889, DOI 10.1073/pnas.2237038100; Warfield KL, 2006, PLOS PATHOGENS, V2; Ye L, 2006, VIROLOGY, V351, P260, DOI 10.1016/j.virol.2006.03.021	42	45	48	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0118881	10.1371/journal.pone.0118881	http://dx.doi.org/10.1371/journal.pone.0118881			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25793502	Green Submitted, Green Published, gold			2022-12-27	WOS:000352084200043
J	Hayakawa, Y; Aoyama, T; Yokoyama, C; Okamoto, C; Komaki, H; Minatoguchi, S; Iwasa, M; Yamada, Y; Kawamura, I; Kawasaki, M; Nishigaki, K; Mikami, A; Suzuki, F; Minatoguchi, S				Hayakawa, Yuka; Aoyama, Takuma; Yokoyama, Chiharu; Okamoto, Chihiro; Komaki, Hisaaki; Minatoguchi, Shingo; Iwasa, Masamitsu; Yamada, Yoshihisa; Kawamura, Itta; Kawasaki, Masanori; Nishigaki, Kazuhiko; Mikami, Atsushi; Suzuki, Fumiaki; Minatoguchi, Shinya			High Salt Intake Damages the Heart through Activation of Cardiac (Pro) Renin Receptors Even at an Early Stage of Hypertension	PLOS ONE			English	Article							ANGIOTENSIN-II; DIABETIC-NEPHROPATHY; NONPROTEOLYTIC ACTIVATION; BLOOD-PRESSURE; MUSCLE-CELLS; PRORENIN; RATS; FIBROSIS; HYPERTROPHY; EXPRESSION	Objective It has not yet been fully elucidated whether cardiac tissue levels of prorenin, renin and (P) RR are activated in hypertension with a high salt intake. We hypothesized that a high salt intake activates the cardiac tissue renin angiotensin system and prorenin-(pro) renin receptor system, and damages the heart at an early stage of hypertension. Methods Wistar Kyoto rats (WKY) and spontaneously hypertensive rats (SHR) received regular (normal-salt diet, 0.9%) and high-salt (8.9%) chow for 6 weeks from 6 to 12 weeks of age. The systolic blood pressure, plasma renin activity (PRA) and plasma angiotensin II concentration were measured, and the protein expressions of prorenin, (pro) renin receptor, angiotensinogen, angiotensin II AT1 receptor, ERK1/2, TGF-beta, p38MAPK and HSP27 in the myocardium were investigated. The cardiac function was assessed by echocardiography, and histological analysis of the myocardium was performed. Results The high-salt diet significantly increased the systolic blood pressure, and significantly reduced the PRA and plasma angiotensin II concentration both in the WKYs and SHRs. Cardiac expressions of prorenin, renin, (P) RR, angiotensinogen, angiotensin II AT1 receptor, phosphorylated (p)-ERK1/2, p-p38MAPK, TGF-beta and p-HSP27 were significantly increased by the high salt diet both in the WKYs and SHRs. The high-salt diet significantly increased the interventricular septum thickness and cardiomyocyte size, and accelerated cardiac interstitial and perivascular fibrosis both in the WKYs and SHRs. On the other hand, dilatation of left ventricular end-diastolic dimension and impairment of left ventricular fractional shortening was shown only in salt loaded SHRs. Conclusion The high-salt diet markedly accelerated cardiac damage through the stimulation of cardiac (P)RR and angiotensin II AT1 receptor by increasing tissue prorenin, renin and angiotensinogen and the activation of ERK1/2, TGF-beta, p38MAPK and HSP27 under higher blood pressure.	[Hayakawa, Yuka; Aoyama, Takuma; Yokoyama, Chiharu; Okamoto, Chihiro; Komaki, Hisaaki; Minatoguchi, Shingo; Iwasa, Masamitsu; Yamada, Yoshihisa; Kawamura, Itta; Kawasaki, Masanori; Nishigaki, Kazuhiko; Mikami, Atsushi; Minatoguchi, Shinya] Gifu Univ, Grad Sch Med, Dept Cardiol, Gifu, Japan; [Suzuki, Fumiaki] Gifu Univ, Dept Life Sci, Gifu, Japan	Gifu University; Gifu University	Minatoguchi, S (corresponding author), Gifu Univ, Grad Sch Med, Dept Cardiol, Gifu, Japan.	minatos@gifu-u.ac.jp			Gifu University Graduate School of Medicine	Gifu University Graduate School of Medicine	The funding of this study was provided from Gifu University Graduate School of Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Coelho MS, 2006, NUTR METAB CARDIOVAS, V16, P148, DOI 10.1016/j.numecd.2005.09.001; Danilczyk U, 2004, NAT MED, V10, P1193; DENTON D, 1995, NAT MED, V1, P1009, DOI 10.1038/nm1095-1009; Dunser AH, 2005, HYPERTENSION, V46, P1069; Ferreira DN, 2010, J NUTR, V140, P1742, DOI 10.3945/jn.109.117473; Fujii K, 1999, HYPERTENS RES-CLIN E, V22, P181, DOI 10.1291/hypres.22.181; Morales MG, 2012, INT J BIOCHEM CELL B, V44, P1993, DOI 10.1016/j.biocel.2012.07.028; Gerc Vjekoslav, 2010, Med Arh, V64, P295; Gurley SB, 2007, SEMIN NEPHROL, V27, P144, DOI 10.1016/j.semnephrol.2007.01.009; Hall John E., 2011, GUYTON HALL TXB MED, P213; Hodge G, 2002, ACTA PHYSIOL SCAND, V174, P209, DOI 10.1046/j.1365-201x.2002.00937.x; Huang Y, 2007, KIDNEY INT, V72, P45, DOI 10.1038/sj.ki.5002243; Ichihara A, 2006, HYPERTENSION, V47, P894, DOI 10.1161/01.HYP.0000215838.48170.0b; Ichihara A, 2004, J CLIN INVEST, V114, P1128, DOI 10.1172/JCI200421398; Kang JJ, 2008, HYPERTENSION, V51, P1597, DOI 10.1161/HYPERTENSIONAHA.107.107268; Katayama IA, 2014, J NUTR, V144, P1571, DOI 10.3945/jn.114.192054; Li WC, 2014, HYPERTENSION, V63, P316, DOI 10.1161/HYPERTENSIONAHA.113.02041; Price DA, 1999, J AM SOC NEPHROL, V10, P2382; RIBEIRO AB, 1985, DRUGS, V30, P6, DOI 10.2165/00003495-198500301-00003; Sakoda M, 2007, HYPERTENS RES, V30, P1139, DOI 10.1291/hypres.30.1139; Saris JJ, 2006, HYPERTENSION, V48, P564, DOI 10.1161/01.HYP.0000240064.19301.1b; Schnermann J., 2008, KIDNEY PHYSL PATHOPH, P589; Schroten NF, 2012, HEART FAIL REV, V17, P191, DOI 10.1007/s10741-011-9262-2; Susic D, 2008, AM J PHYSIOL-HEART C, V295, pH1117, DOI 10.1152/ajpheart.00055.2008; Varagic J, 2006, AM J PHYSIOL-HEART C, V290, pH1503, DOI 10.1152/ajpheart.00970.2005	25	32	35	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0120453	10.1371/journal.pone.0120453	http://dx.doi.org/10.1371/journal.pone.0120453			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25799069	Green Published, Green Submitted, gold			2022-12-27	WOS:000351987300146
J	Hill, J; Kayentao, K; Achieng, F; Diarra, S; Dellicour, S; Diawara, SI; Hamel, MJ; Ouma, P; Desai, M; Doumbo, OK; ter Kuile, FO; Webster, J				Hill, Jenny; Kayentao, Kassoum; Achieng, Florence; Diarra, Samba; Dellicour, Stephanie; Diawara, Sory I.; Hamel, Mary J.; Ouma, Peter; Desai, Meghna; Doumbo, Ogobara K.; ter Kuile, Feiko O.; Webster, Jayne			Access and Use of Interventions to Prevent and Treat Malaria among Pregnant Women in Kenya and Mali: A Qualitative Study	PLOS ONE			English	Article							ANTENATAL CARE; BIRTH-WEIGHT; AFRICA; METAANALYSIS; BURDEN	Background Coverage of malaria in pregnancy interventions in sub-Saharan Africa is suboptimal. We undertook a systematic examination of the operational, socio-economic and cultural constraints to pregnant women's access to intermittent preventive treatment (IPTp), long-lasting insecticide-treated nets (LLINs) and case management in Kenya and Mali to provide empirical evidence for strategies to improve coverage. Methods Focus group discussions (FGDs) were held as part of a programme of research to explore the delivery, access and use of interventions to control malaria in pregnancy. FGDs were held with four sub-groups: non-pregnant women of child bearing age (aged 15-49 years), pregnant women or mothers of children aged <1 year, adolescent women, and men. Content analysis was used to develop themes and sub-themes from the data. Results Women and men's perceptions of the benefits of antenatal care were generally positive; motivation among women consisted of maintaining a healthy pregnancy, disease prevention in mother and foetus, checking the position of the baby in preparation for delivery, and ensuring admission to a facility in case of complications. Barriers to accessing care related to the quality of the health provider-client interaction, perceived health provider skills and malpractice, drug availability, and cost of services. Pregnant women perceived themselves and their babies at particular risk from malaria, and valued diagnosis and treatment from a health professional, but cost of treatment at health facilities drove women to use herbal \remedies or drugs bought from shops. Women lacked information on the safety, efficacy and side effects of antimalarial use in pregnancy. Conclusion Women in these settings appreciated the benefits of antenatal care and yet health services in both countries are losing women to follow-up due to factors that can be improved with greater political will. Antenatal services need to be patient-centred, free-of-charge or highly affordable and accountable to the women they serve.	[Hill, Jenny; Dellicour, Stephanie; ter Kuile, Feiko O.] Univ Liverpool, Liverpool Sch Trop Med, Dept Clin Sci, Liverpool L3 5QA, Merseyside, England; [Kayentao, Kassoum; Diarra, Samba; Diawara, Sory I.; Doumbo, Ogobara K.] Univ Sci Tech & Technol, Malaria Res & Training Ctr, Bamako, Mali; [Achieng, Florence; Ouma, Peter] Ctr Global Hlth Res, Kenya Med Res Inst, Kisumu, Kenya; [Hamel, Mary J.; Desai, Meghna] Ctr Dis Control & Prevent, Atlanta, GA USA; [Webster, Jayne] Ctr Dis Control & Prevent, Atlanta, Kenya; [Webster, Jayne] London Sch Trop Med & Hyg, Dis Control Dept, London, England	Liverpool School of Tropical Medicine; University of Liverpool; University of Science & Technology of Bamako; Kenya Medical Research Institute; Centers for Disease Control & Prevention - USA; University of London; London School of Hygiene & Tropical Medicine	Hill, J (corresponding author), Univ Liverpool, Liverpool Sch Trop Med, Dept Clin Sci, Liverpool L3 5QA, Merseyside, England.	j.hill@liv.ac.uk	Kuile, Feiko ter/ABD-6681-2020; Hill, Jenny/C-3839-2017	Kuile, Feiko ter/0000-0003-3663-5617; Hill, Jenny/0000-0003-1588-485X; Webster, Jayne/0000-0002-0498-8883	Malaria in Pregnancy (MiP) Consortium through Bill & Melinda Gates Foundation	Malaria in Pregnancy (MiP) Consortium through Bill & Melinda Gates Foundation	This work was supported by the Malaria in Pregnancy (MiP) Consortium, which is funded through a grant from the Bill & Melinda Gates Foundation to the Liverpool School of Tropical Medicine, UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2004, STRATEGIC FRAMEWORK; [Anonymous], WHO TECHN REP SER; Cellule de Planification et de Statistique Ministere de la Sante Direction Nationale de la Statistique et de I'Informatique Ministere de I'Economie dlledC Bamako Mali, 2007, ENQ DEM SANT MAL 200; Dellicour S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080551; Dellicour S, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000221; Desai M, 2007, LANCET INFECT DIS, V7, P93, DOI 10.1016/S1473-3099(07)70021-X; Diala C, 2012, BARRIERS UPTAKE MALA; Division of Malaria Control MoH Republic of Kenya, 2001, NAR MAL STRAT 2001 2; Eisele TP, 2012, LANCET INFECT DIS, V12, P942, DOI 10.1016/S1473-3099(12)70222-0; Famanta Aminata, 2011, Sante, V21, P3, DOI 10.1684/san.2011.0234; Gamble C, 2007, PLOS MED, V4, P506, DOI 10.1371/journal.pmed.0040107; Garner P, 2009, DRUGS PREVENTING MAL; Gies S, 2009, AM J TROP MED HYG, V80, P460, DOI 10.4269/ajtmh.2009.80.460; Hill J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092102; Hill J, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001488; Hill J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064913; Iliyasu Z, 2012, PATHOG GLOB HEALTH, V106, P323, DOI 10.1179/2047773212Y.0000000037; Kenya Ministry of Health and Sanitation Health MoP, 2010, NAT GUID DIAGN TREAT; [Kenya National Bureau of Statistics ICF Macro], 2003, KEN DEM HLTH SURV 20; Kenya National Bureau of Statistics, 2010, KEN DEM HLTH SURV 20; Maiga Abderrahmane Sideye, 2010, Mali Med, V25, P41; Mathole T, 2004, MIDWIFERY, V20, P122, DOI 10.1016/j.midw.2003.10.003; MENACA A, 2013, MALARIA J, V12, DOI DOI 10.1186/1475-2875-12-; Menendez C, 2007, LANCET INFECT DIS, V7, P126, DOI 10.1016/S1473-3099(07)70024-5; Pell C, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-427; Pell C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053747; Pell C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022452; Programme National de Lutte Contre le Paludisme Mlnistere de al Sante Organisation Mondiale de la Sante, 2006, POL NAT LUTT CONTR P; Simkhada B, 2008, J ADV NURS, V61, P244, DOI 10.1111/j.1365-2648.2007.04532.x; Stangeland T, 2011, J ETHNOPHARMACOL, V137, P154, DOI 10.1016/j.jep.2011.05.002; van Eijk AM, 2013, LANCET INFECT DIS, V13, P1029, DOI 10.1016/S1473-3099(13)70199-3; Walker PGT, 2014, LANCET GLOB HEALTH, V2, pE460, DOI 10.1016/S2214-109X(14)70256-6; Webster J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065437; Webster J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067520; WHO, 2006, INT MAN PREGN CHILDB; World Health Organisation, 2007, EV BUS STRAT HLTH SY; World Health Organization, 2007, INT MAN PREGN CHILDB	37	24	24	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0119848	10.1371/journal.pone.0119848	http://dx.doi.org/10.1371/journal.pone.0119848			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25798847	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000351987300084
J	Inoue, H; Liu, YY				Inoue, Hiroyasu; Liu, Yang-Yu			Revealing the Intricate Effect of Collaboration on Innovation	PLOS ONE			English	Article							CREATIVITY; NETWORKS; TEAM; MATTER	We studied the Japan and U.S. patent records of several decades to demonstrate the effect of collaboration on innovation. We found that statistically inventor teams slightly outperform solo inventors while company teams perform equally well as solo companies. By tracking the performance record of individual teams, we found that inventor teams' performance generally degrades with more repeat collaborations. Though company teams' performance displays strongly bursty behavior, long-term collaboration does not significantly help innovation. To systematically study the effect of repeat collaboration, we defined the repeat collaboration number of a team as the average number of collaborations over all the teammate pairs. We found that mild repeat collaboration improves the performance of Japanese inventor teams and U.S. company teams. Yet, excessive repeat collaboration does not significantly help innovation at both the inventor and company levels in both countries. To control for unobserved heterogeneity, we performed a detailed regression analysis and the results were consistent with our simple observations. The presented results revealed the intricate effect of collaboration on innovation, which may also be observed in other creative projects.	[Inoue, Hiroyasu] Osaka Sangyo Univ, Dept Business Adm, Osaka, Japan; [Liu, Yang-Yu] Brigham & Womens Hosp, Channing Div Network Med, Boston, MA 02115 USA; [Liu, Yang-Yu] Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Liu, YY (corresponding author), Brigham & Womens Hosp, Channing Div Network Med, 75 Francis St, Boston, MA 02115 USA.	yyl@channing.harvard.edu	Liu, Yang-Yu/G-8885-2011	Liu, Yang-Yu/0000-0003-2728-4907	 [24530506]; Grants-in-Aid for Scientific Research [24530506] Funding Source: KAKEN	; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	HI was supported by 24530506, Grants-in-aid, http://kaken.nii.ac.jp/d/p/24530506.en.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], OPEN INNOVATION; Bloom N, 2010, J ECON PERSPECT, V24, P203, DOI 10.1257/jep.24.1.203; Delmestri G, 2005, J MANAGE STUD, V42, P975, DOI 10.1111/j.1467-6486.2005.00529.x; Dyer JH, 1996, ORGAN SCI, V7, P649, DOI 10.1287/orsc.7.6.649; Fleming L, 2001, RES POLICY, V30, P1019, DOI 10.1016/S0048-7333(00)00135-9; Fleming L, 2007, ADMIN SCI QUART, V52, P443, DOI 10.2189/asqu.52.3.443; Fleming L, 2006, CALIF MANAGE REV, V48, P6, DOI 10.2307/41166358; Fowler JH, 2007, SCIENTOMETRICS, V72, P427, DOI 10.1007/s11192-007-1777-2; Grant RM, 1996, STRATEGIC MANAGE J, V17, P109, DOI 10.1002/smj.4250171110; Griliches Z., 1998, R D PRODUCTIVITY EC; Guimera R, 2005, SCIENCE, V308, P697, DOI 10.1126/science.1106340; Hall B, 2000, 8498 NAT BUR EC RES; Hicks D., 2000, SCI PUBL POLICY, V27, P310, DOI [DOI 10.3152/147154300781781805, 10.3152/147154300781781805]; Laursen K, 2006, STRATEGIC MANAGE J, V27, P131, DOI 10.1002/smj.507; Lazer D, 2009, SCIENCE, V323, P721, DOI 10.1126/science.1167742; Li GC, 2014, RES POLICY, V43, P941, DOI 10.1016/j.respol.2014.01.012; Newman MEJ, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.208701; NONAKA I, 1994, ORGAN SCI, V5, P14, DOI 10.1287/orsc.5.1.14; Perretti F, 2007, J ORGAN BEHAV, V28, P563, DOI 10.1002/job.464; Porac JF, 2004, RES POLICY, V33, P661, DOI 10.1016/j.respol.2004.01.007; Ralston DA, 2007, J INT BUS STUD, P1; Reagans R, 2004, ADMIN SCI QUART, V49, P101; Simonton DK., 1988, SCI GENIUS PSYCHOL S; Singh J, 2010, MANAGE SCI, V56, P41, DOI 10.1287/mnsc.1090.1072; Skilton PF, 2010, ACAD MANAGE REV, V35, P118, DOI 10.5465/AMR.2010.45577886; Tamada S., 2002, J SCI POLICY RES MAN, V17, P222; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; TRAJTENBERG M, 1990, RAND J ECON, V21, P172, DOI 10.2307/2555502; Uzzi B, 2005, AM J SOCIOL, V111, P447, DOI 10.1086/432782; Uzzi B, 1997, ADMIN SCI QUART, V42, P35, DOI 10.2307/2393808; Venables WN., 2002, MODERN APPL STAT S 4; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Weisberg R., 2006, CREATIVITY UNDERSTAN; Wessner C, 2008, ASSESSMENT SBIR PROG; Wuchty S, 2007, SCIENCE, V316, P1036, DOI 10.1126/science.1136099; Zaheer A, 1998, ORGAN SCI, V9, P141, DOI 10.1287/orsc.9.2.141	36	13	13	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0121973	10.1371/journal.pone.0121973	http://dx.doi.org/10.1371/journal.pone.0121973			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CE6ZS	25799138	Green Published, Green Submitted, gold			2022-12-27	WOS:000351987300306
J	Israel-Assayag, E; Beaulieu, MJ; Cormier, Y				Israel-Assayag, Evelyne; Beaulieu, Marie-Josee; Cormier, Yvon			ASM-024, a Piperazinium Compound, Promotes the In Vitro Relaxation of beta 2-Adrenoreceptor Desensitized Tracheas	PLOS ONE			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTORS; SMOOTH-MUSCLE; AIRWAY; MECHANISMS; CELLS	Inhaled beta 2-adrenoreceptor agonists are widely used in asthma and chronic obstructive pulmonary disease (COPD) for bronchoconstriction relief. beta 2-adrenoreceptor agonists relax airway smooth muscle cells via cyclic adenosine monophosphate (cAMP) mediated pathways. However, prolonged stimulation induces functional desensitization of the beta 2-adrenoreceptors (beta 2-AR), potentially leading to reduced clinical efficacy with chronic or prolonged administration. ASM-024, a small synthetic molecule in clinical stage development, has shown activity at the level of nicotinic receptors and possibly at the muscarinic level and presents anti-inflammatory and bronchodilator properties. Aerosolized ASM-024 reduces airway resistance in mice and promotes in-vitro relaxation of tracheal and bronchial preparations from animal and human tissues. ASM-024 increased in vitro relaxation response to maximally effective concentration of short-acting beta-2 agonists in dog and human bronchi. Although the precise mechanisms by which ASM-024 promotes airway smooth muscle (ASM) relaxation remain unclear, we hypothesized that ASM-024 will attenuate and/or abrogate agonist-induced contraction and remain effective despite beta 2-AR tachyphylaxis. beta 2-AR tachyphylaxis was induced with salbutamol, salmeterol and formoterol on guinea pig tracheas. The addition of ASM-024 relaxed concentration-dependently intact or beta 2-AR desensitized tracheal rings precontracted with methacholine. ASM-024 did not induce any elevation of intracellular cAMP in isolated smooth muscle cells; moreover, blockade of the cAMP pathway with an adenylate cyclase inhibitor had no significant effect on ASM-024-induced guinea pig trachea relaxation. Collectively, these findings show that ASM-024 elicits relaxation of beta 2-AR desensitized tracheal preparations and suggest that ASM-024 mediates smooth muscle relaxation through a different target and signaling pathway than beta 2-adrenergic receptor agonists. These findings suggest ASM-024 could potentially provide clinical benefit when used adjunctively with inhaled beta 2-adrenoreceptor agonists in those patients exhibiting a reduced response to their chronic use.	[Israel-Assayag, Evelyne; Beaulieu, Marie-Josee; Cormier, Yvon] IUCPQ, Quebec City, PQ, Canada; [Israel-Assayag, Evelyne; Cormier, Yvon] Asmacure Ltee, Quebec City, PQ, Canada	Laval University	Cormier, Y (corresponding author), IUCPQ, Quebec City, PQ, Canada.	yvon.cormier@med.ulaval.ca			Asmacure Ltee, 2600 boul. Laurier, Suite 880, Quebec, QC	Asmacure Ltee, 2600 boul. Laurier, Suite 880, Quebec, QC	Funding: Supported by grants from Asmacure Ltee, 2600 boul. Laurier, Suite 880, Quebec, QC. G1V 4W2. The funder provided support in the form of salaries for authors YC & EIA, but had no additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Assayag EI, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086091; Barnes PJ, 2011, J BIOL CHEM, V286, P32899, DOI 10.1074/jbc.R110.206466; Buccafusco JJ, 2009, J PHARMACOL EXP THER, V328, P364, DOI 10.1124/jpet.108.145292; Cazzola M, 2012, PHARMACOL REV, V64, P450, DOI 10.1124/pr.111.004580; Cooper PR, 2011, BRIT J PHARMACOL, V163, P521, DOI 10.1111/j.1476-5381.2011.01257.x; Dajas-Bailador FA, 2002, J NEUROCHEM, V81, P606, DOI 10.1046/j.1471-4159.2002.00846.x; Dorion G, 2005, AM J PHYSIOL-LUNG C, V288, pL1139, DOI 10.1152/ajplung.00406.2004; Duringer C, 2009, BRIT J PHARMACOL, V158, P169, DOI 10.1111/j.1476-5381.2009.00262.x; Jyang Y, 2014, CELLULAR PHYSL BIOCH, V33, P389, DOI [10.1159/000356678, DOI 10.1159/000356678]; Kotlikoff MI, 1996, ANNU REV PHYSIOL, V58, P115, DOI 10.1146/annurev.ph.58.030196.000555; Lin RJ, 2006, J PHARMACOL EXP THER, V316, P709, DOI 10.1124/jpet.105.092171; Lipworth BJ, 1997, DRUG SAFETY, V16, P295, DOI 10.2165/00002018-199716050-00002; LOHSE MJ, 1990, J BIOL CHEM, V265, P3202; Papke RL, 2014, J PHARMACOL EXP THER, V350, P665, DOI 10.1124/jpet.114.215236; Stokes C., 2013, NEUR M PLANN; Townsend Elizabeth A, 2012, J Allergy (Cairo), V2012, P321949, DOI 10.1155/2012/321949; Wessler I, 2008, BRIT J PHARMACOL, V154, P1558, DOI 10.1038/bjp.2008.185	17	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0120095	10.1371/journal.pone.0120095	http://dx.doi.org/10.1371/journal.pone.0120095			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25799096	Green Published, Green Submitted, gold			2022-12-27	WOS:000351987300106
J	Ortega-Andrade, HM; Prieto-Torres, DA; Gomez-Lora, I; Lizcano, DJ				Mauricio Ortega-Andrade, H.; Prieto-Torres, David A.; Gomez-Lora, Ignacio; Lizcano, Diego J.			Ecological and Geographical Analysis of the Distribution of the Mountain Tapir (Tapirus pinchaque) in Ecuador: Importance of Protected Areas in Future Scenarios of Global Warming	PLOS ONE			English	Article							CLIMATE-CHANGE; SPECIES DISTRIBUTIONS; CONSERVATION PRIORITIES; POPULATION-SIZE; EXTINCTION RISK; RANGE; DEFORESTATION; BIODIVERSITY; MODELS; UNCERTAINTY	In Ecuador, Tapirus pinchaque is considered to be critically endangered. Although the species has been registered in several localities, its geographic distribution remains unclear, and the effects of climate change and current land uses on this species are largely unknown. We modeled the ecological niche of T. pinchaque using MaxEnt, in order to assess its potential adaptation to present and future climate change scenarios. We evaluated the effects of habitat loss due by current land use, the ecosystem availability and importance of Ecuadorian System of Protected Areas into the models. The model of environmental suitability estimated an extent of occurrence for species of 21,729 km(2) in all of Ecuador, mainly occurring along the corridor of the eastern Ecuadorian Andes. A total of 10 Andean ecosystems encompassed similar to 98% of the area defined by the model, with herbaceous paramo, northeastern Andean montane evergreen forest and northeastern Andes upper montane evergreen forest being the most representative. When considering the effect of habitat loss, a significant reduction in model area (similar to 17%) occurred, and the effect of climate change represented a net reduction up to 37.86%. However, the synergistic effect of both climate change and habitat loss, given current land use practices, could represent a greater risk in the short-term, leading to a net reduction of 19.90 to 44.65% in T. pinchaque's potential distribution. Even under such a scenarios, several Protected Areas harbor a portion (similar to 36 to 48%) of the potential distribution defined by the models. However, the central and southern populations are highly threatened by habitat loss and climate change. Based on these results and due to the restricted home range of T. pinchaque, its preference for upland forests and paramos, and its small estimated population size in the Andes, we suggest to maintaining its current status as Critically Endangered in Ecuador.	[Mauricio Ortega-Andrade, H.; Prieto-Torres, David A.] Inst Ecol, Dept Evolut Biol, Lab Biogeog, AC, Xalapa 91070, Veracruz, Mexico; [Mauricio Ortega-Andrade, H.] Fdn EcoCiencia, Programa Conservac Especies Amenazadas Extinc Ecu, Quito, Ecuador; [Mauricio Ortega-Andrade, H.] Museo Ecuatoriano Ciencias Nat, Secc Vertebrados, Div Herpetol, Quito, Ecuador; [Prieto-Torres, David A.] Univ Zulia, Ctr Modelado Cient, Eje BioCiencias, Maracaibo 4011, Venezuela; [Gomez-Lora, Ignacio] UIMP, Consejo Super Invest Cient Espana SCIC, Areas Trop & Conservac, Biodiversidad, Madrid, Spain; [Gomez-Lora, Ignacio] Fdn EcoCiencia, Proyecto Conservac Tapir Andino Tapirus Pinchaqua, Quito, Ecuador; [Gomez-Lora, Ignacio] Univ Autonoma Madrid, Fdn Fernando Gonzalez Bernaldez, Espacios Nat Protegidos, Madrid, Spain; [Lizcano, Diego J.] Univ Laica Eloy Alfaro Manabi, Dept Cent Invest, Manta, Ecuador	Instituto de Ecologia - Mexico; Autonomous University of Madrid; Universidad Laica Eloy Alfaro De Manabi	Prieto-Torres, DA (corresponding author), Inst Ecol, Dept Evolut Biol, Lab Biogeog, AC, Carretera Antigua Coatepec 351, Xalapa 91070, Veracruz, Mexico.	dprieto@cmc.org.ve	Prieto-Torres, David A./N-1157-2017; Andrade, H. Mauricio Ortega/G-8245-2016; Lizcano, Diego J./E-6893-2011	Prieto-Torres, David A./0000-0002-0493-5941; Andrade, H. Mauricio Ortega/0000-0001-9464-3688; Lizcano, Diego J./0000-0002-9648-0576	EcoFondo-Ecuador, Programa para la Conservacion de Especies y Ecosistemas Amenazados de Extincion en Ecuador; Fundacion Ecociencia, Fundacion Zoologica del Ecuador; UICN/SSC Tapir Specialist Group-Ecuador; Idea Wild	EcoFondo-Ecuador, Programa para la Conservacion de Especies y Ecosistemas Amenazados de Extincion en Ecuador; Fundacion Ecociencia, Fundacion Zoologica del Ecuador; UICN/SSC Tapir Specialist Group-Ecuador; Idea Wild	This project received financial support by EcoFondo-Ecuador, Programa para la Conservacion de Especies y Ecosistemas Amenazados de Extincion en Ecuador sponsored by Fundacion Ecociencia, Fundacion Zoologica del Ecuador and the UICN/SSC Tapir Specialist Group-Ecuador. Additional field equipment were provided by a grant from Idea Wild.	Anderson RP, 2003, ECOL MODEL, V162, P211, DOI 10.1016/S0304-3800(02)00349-6; Bassler C, 2010, ECOL INDIC, V10, P341, DOI 10.1016/j.ecolind.2009.06.014; BARVE N, 2008, TOOL PARTIAL ROC VER; Barve N, 2011, ECOL MODEL, V222, P1810, DOI 10.1016/j.ecolmodel.2011.02.011; Becker CG, 2007, SCIENCE, V318, P1775, DOI 10.1126/science.1149374; Bedia J, 2013, GLOBAL PLANET CHANGE, V107, P1, DOI 10.1016/j.gloplacha.2013.04.005; BROMLEY R, 1981, SINGAPORE J TROP GEO, V2, P15, DOI 10.1111/j.1467-9493.1981.tb00114.x; Castellanos P Armando X., 2013, Tapir Conservation, V22, P20; Castellanos P Armando X., 2013, Tapir Conservation, V22, P9; Chen IC, 2009, P NATL ACAD SCI USA, V106, P1479, DOI 10.1073/pnas.0809320106; CITES, 2013, CONV INT TRAD END SP; CONGDON JD, 1993, CONSERV BIOL, V7, P826, DOI 10.1046/j.1523-1739.1993.740826.x; Crawley M.J., 2007, R BOOK; Cuesta-Camacho F, 2007, ANALISIS VACIOS AREA, P83; de Grammont PC, 2006, CONSERV BIOL, V20, P14, DOI 10.1111/j.1523-1739.2006.00352.x; Munoz MED, 2011, GEOINFORMATICA, V15, P111, DOI 10.1007/s10707-009-0090-7; Diaz AG, 2008, TAPIRUS PINCHAQUE IU; DODSON CH, 1991, ANN MO BOT GARD, V78, P273, DOI 10.2307/2399563; Downer CC, 2001, J ZOOL, V254, P279, DOI 10.1017/S0952836901000796; Downer CC, 2003, LYONIA, V4, P31; Downer Craig C., 1997, P10; Downer Craig C., 1996, Oryx, V30, P45; Dudley N, 2006, TECHNICAL SERIE, V24; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; ESRI, 2010, ARCMAP 10 0; Feeley KJ, 2010, GLOBAL CHANGE BIOL, V16, P3215, DOI 10.1111/j.1365-2486.2010.02197.x; Forero-Medina G, 2011, CONSERV BIOL, V25, P163, DOI 10.1111/j.1523-1739.2010.01572.x; Gibbons JW, 2000, BIOSCIENCE, V50, P653, DOI 10.1641/0006-3568(2000)050[0653:TGDORD]2.0.CO;2; Hannah L, 2007, FRONT ECOL ENVIRON, V5, P131, DOI 10.1890/1540-9295(2007)5[131:PANIAC]2.0.CO;2; Hernandez PA, 2006, ECOGRAPHY, V29, P773, DOI 10.1111/j.0906-7590.2006.04700.x; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; IPCC, 2013, CLIM CHANG 2013 PHYS, DOI [10.18203/2319-2003.ijbcp20175200, DOI 10.1017/CBO9781107415324]; Isaac NJB, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000296; IUCN, 2001, CAT CRIT LISTA ROJ U; *IUCN, 2012, PROT PLAN LAT IN HAR; IUCN, 2013, IUCN RED LIST THREAT; Kozak KH, 2008, TRENDS ECOL EVOL, V23, P141, DOI 10.1016/j.tree.2008.02.001; Laurance WF, 2004, SCIENCE, V304, P1109, DOI 10.1126/science.304.5674.1109b; Lees AC, 2006, BIOL CONSERV, V133, P198, DOI 10.1016/j.biocon.2006.06.005; Lessmann J, 2014, ECOL EVOL, V4, P2410, DOI 10.1002/ece3.1102; Lizcano DJ, 2002, J BIOGEOGR, V29, P7, DOI 10.1046/j.1365-2699.2002.00654.x; Lobo JM, 2008, GLOBAL ECOL BIOGEOGR, V17, P145, DOI 10.1111/j.1466-8238.2007.00358.x; Lobo JM, 2010, ECOGRAPHY, V33, P103, DOI 10.1111/j.1600-0587.2009.06039.x; MacLaren C, 2014, AGROFOREST SYST, V88, P369, DOI 10.1007/s10457-014-9690-9; Ministerio del Ambiente de Ecuador-MAE, 2013, SIST CLAS EC EC CONT; Moritz C, 2008, SCIENCE, V322, P261, DOI 10.1126/science.1163428; Morrone JJ, 2002, PROYECTO RED IBEROAM, V2, P267; Mota-Vargas C, 2012, J NAT CONSERV, V20, P10, DOI 10.1016/j.jnc.2011.07.002; Urbina-Cardona JN, 2008, TROP CONSERV SCI, V1, P359, DOI 10.1177/194008290800100405; Nogues-Bravo D, 2007, GLOBAL ENVIRON CHANG, V17, P420, DOI 10.1016/j.gloenvcha.2006.11.007; Olson DM, 2001, BIOSCIENCE, V51, P933, DOI 10.1641/0006-3568(2001)051[0933:TEOTWA]2.0.CO;2; Ortega-Andrade H Mauricio, 2013, PLoS One, V8, pe81837, DOI 10.1371/journal.pone.0081837; Padilla Miguel, 2010, Mammalian Species, P166, DOI 10.1644/863.1; Pauli H, 2007, GLOBAL CHANGE BIOL, V13, P147, DOI 10.1111/j.1365-2486.2006.01282.x; Pearman PB, 2008, TRENDS ECOL EVOL, V23, P149, DOI 10.1016/j.tree.2007.11.005; Pearson RG, 2003, GLOBAL ECOL BIOGEOGR, V12, P361, DOI 10.1046/j.1466-822X.2003.00042.x; Pearson RG, 2007, J BIOGEOGR, V34, P102, DOI 10.1111/j.1365-2699.2006.01594.x; Pearson RG, 2006, J BIOGEOGR, V33, P1704, DOI 10.1111/j.1365-2699.2006.01460.x; Peterson AT, 2008, ECOL MODEL, V213, P63, DOI 10.1016/j.ecolmodel.2007.11.008; Peterson AT, 2012, NAT CONSERVACAO, V10, P102, DOI 10.4322/natcon.2012.019; Peterson AT, 2001, BIOSCIENCE, V51, P363, DOI 10.1641/0006-3568(2001)051[0363:PSIUEN]2.0.CO;2; Peterson AT, 1998, IBIS, V140, P288, DOI 10.1111/j.1474-919X.1998.tb04391.x; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2009, ECOL APPL, V19, P181, DOI 10.1890/07-2153.1; R-Core-Team, 2012, R LANG ENV STAT COMP, DOI [10.1002/jcc.22917, DOI 10.1002/JCC.22917]; Raxworthy CJ, 2008, GLOBAL CHANGE BIOL, V14, P1703, DOI 10.1111/j.1365-2486.2008.01596.x; Riahi K, 2011, CLIMATIC CHANGE, V109, P33, DOI 10.1007/s10584-011-0149-y; Rodda GH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014670; Rojas-Soto OR, 2008, J FIELD ORNITHOL, V79, P245, DOI 10.1111/j.1557-9263.2008.00170.x; Romero D, 2014, J BIOGEOGR, V41, P111, DOI 10.1111/jbi.12189; Roulin X, 1829, ANN SCI NAT ZOOL, V17, P26; Royle JA, 2012, METHODS ECOL EVOL, V3, P545, DOI 10.1111/j.2041-210X.2011.00182.x; Rull V, 2006, GLOBAL CHANGE BIOL, V12, P1, DOI 10.1111/j.1365-2486.2005.001080.x; SCHAUENBERG P, 1969, Revue Suisse de Zoologie, V76, P211; SHUKLA J, 1990, SCIENCE, V247, P1322, DOI 10.1126/science.247.4948.1322; Sierra R, 2002, LANDSCAPE URBAN PLAN, V59, P95, DOI 10.1016/S0169-2046(02)00006-3; Soberon Jorge, 2005, Biodiversity Informatics, V2, P1; Stockman AK, 2006, DIVERS DISTRIB, V12, P81, DOI 10.1111/j.1366-9516.2006.00225.x; Tapia A, 2011, ESTRATEGIS NACL CONS; Thuiller W, 2005, GLOBAL ECOL BIOGEOGR, V14, P347, DOI 10.1111/j.1466-822x.2005.00162.x; Tirira D., 2011, LIBRO ROJO MAMIFEROS; van Vuuren DP, 2011, CLIMATIC CHANGE, V109, P5, DOI [10.1007/s10584-011-0148-z, DOI 10.1007/S10584-011-0148-Z]	83	23	29	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0121137	10.1371/journal.pone.0121137	http://dx.doi.org/10.1371/journal.pone.0121137			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25798851	Green Submitted, Green Published, gold			2022-12-27	WOS:000351987300214
J	Seifert, M; Catanzaro, D; Catanzaro, A; Rodwell, TC				Seifert, Marva; Catanzaro, Donald; Catanzaro, Antonino; Rodwell, Timothy C.			Genetic Mutations Associated with Isoniazid Resistance in Mycobacterium tuberculosis: A Systematic Review	PLOS ONE			English	Review							DRUG-RESISTANCE; MOLECULAR ANALYSIS; RAPID DETECTION; KATG GENE; STRAINS; COMPLEX; DIAGNOSTICS; MECHANISMS; TARGET; INHA	Background Tuberculosis (TB) incidence and mortality are declining worldwide; however, poor detection of drug-resistant disease threatens to reverse current progress toward global TB control. Multiple, rapid molecular diagnostic tests have recently been developed to detect genetic mutations in Mycobacterium tuberculosis (Mtb) genes known to confer first-line drug resistance. Their utility, though, depends on the frequency and distribution of the resistance associated mutations in the pathogen population. Mutations associated with rifampicin resistance, one of the two first-line drugs, are well understood and appear to occur in a single gene region in >95% of phenotypically resistant isolates. Mutations associated with isoniazid, the other first-line drug, are more complex and occur in multiple Mtb genes. Objectives/Methodology A systematic review of all published studies from January 2000 through August 2013 was conducted to quantify the frequency of the most common mutations associated with isoniazid resistance, to describe the frequency at which these mutations co-occur, and to identify the regional differences in the distribution of these mutations. Mutation data from 118 publications were extracted and analyzed for 11,411 Mtb isolates from 49 countries. Principal Findings/Conclusions Globally, 64% of all observed phenotypic isoniazid resistance was associated with the katG315 mutation. The second most frequently observed mutation, inhA-15, was reported among 19% of phenotypically resistant isolates. These two mutations, katG315 and inhA-15, combined with ten of the most commonly occurring mutations in the inhA promoter and the ahpC-oxyR intergenic region explain 84% of global phenotypic isoniazid resistance. Regional variation in the frequency of individual mutations may limit the sensitivity of molecular diagnostic tests. Well-designed systematic surveys and whole genome sequencing are needed to identify mutation frequencies in geographic regions where rapid molecular tests are currently being deployed, providing a context for interpretation of test results and the opportunity for improving the next generation of diagnostics.	[Seifert, Marva; Catanzaro, Donald; Catanzaro, Antonino; Rodwell, Timothy C.] Univ Calif San Diego, Sch Med, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Rodwell, TC (corresponding author), Univ Calif San Diego, Sch Med, La Jolla, CA 92093 USA.	trodwell@ucsd.edu	Catanzaro, Donald/AAA-4932-2019	Catanzaro, Donald/0000-0003-1760-0574; Seifert, Marva/0000-0002-7554-6396	Global Consortium for Drug-Resistant TB Diagnostics (GCDD) - National Institute of Allergy and Infectious Diseases (NIAID) [U01AI082229-05]; NIAID [R01A1105185, R01AI111435]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI105185, R01AI111435, U01AI082229] Funding Source: NIH RePORTER	Global Consortium for Drug-Resistant TB Diagnostics (GCDD) - National Institute of Allergy and Infectious Diseases (NIAID); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Support for this project was provided by the Global Consortium for Drug-Resistant TB Diagnostics (GCDD [see http://gcdd.ucsd.edu]), funded by National Institute of Allergy and Infectious Diseases (NIAID) grant U01AI082229-05. TCR and AC were also supported by NIAID grant#: R01A1105185 and R01AI111435. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abal AT, 2002, MICROB DRUG RESIST, V8, P99, DOI 10.1089/107662902760190644; Abate G, 2001, EUR J CLIN MICROBIOL, V20, P329, DOI 10.1007/PL00011272; Ahmad S, 2009, RESP MED, V103, P1777, DOI 10.1016/j.rmed.2009.07.010; Alcaide F, 2011, ENFERM INFEC MICR CL, V29, P34, DOI 10.1016/S0213-005X(11)70016-7; Ando H, 2010, ANTIMICROB AGENTS CH, V54, P1793, DOI 10.1128/AAC.01691-09; [Anonymous], 2010, MULTIDRUG EXTENSIVEL; Baker LV, 2005, ANTIMICROB AGENTS CH, V49, P1455, DOI 10.1128/AAC.49.4.1455-1464.2005; BANERJEE A, 1994, SCIENCE, V263, P227, DOI 10.1126/science.8284673; Campbell PJ, 2011, ANTIMICROB AGENTS CH, V55, P2032, DOI 10.1128/AAC.01550-10; Chikamatsu Kinuyo, 2011, Kekkaku, V86, P697; Cohen T, 2004, MICROB DRUG RESIST, V10, P280, DOI 10.1089/mdr.2004.10.280; Gagneux S, 2006, PLOS PATHOG, V2, P603, DOI 10.1371/journal.ppat.0020061; Georghiou SB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033275; Haas WH, 1997, ANTIMICROB AGENTS CH, V41, P1601, DOI 10.1128/AAC.41.7.1601; Hoek KGP, 2011, MOL DIAGN THER, V15, P189, DOI 10.2165/11593780-000000000-00000; Jenkins HE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022927; Laurenzo D, 2011, ACTA TROP, V119, P5, DOI 10.1016/j.actatropica.2011.04.008; Lessells RJ, 2011, J INFECT DIS, V204, pS1187, DOI 10.1093/infdis/jir412; Lin SYG, 2014, J CLIN MICROBIOL, V52, P475, DOI 10.1128/JCM.01821-13; Lin SYG, 2004, J CLIN MICROBIOL, V42, P4204, DOI 10.1128/JCM.42.9.4204-4208.2004; MIDDLEBROOK G, 1954, AM REV TUBERC PULM, V69, P471; Mitchison DA, 2005, AM J RESP CRIT CARE, V171, P699, DOI 10.1164/rccm.200411-1603OE; National Library of Medicine (2021), BAS LOC AL SEARCH TO; Neonakis IK, 2008, J MICROBIOL METH, V75, P1, DOI 10.1016/j.mimet.2008.05.023; O'Grady J, 2011, CURR OPIN PULM MED, V17, P134, DOI 10.1097/MCP.0b013e3283452346; Ramaswamy S., 1998, Tubercle and Lung Disease, V79, P3, DOI 10.1054/tuld.1998.0002; Rattan A, 1998, EMERG INFECT DIS, V4, P195, DOI 10.3201/eid0402.980207; Riska PF, 2000, INT J TUBERC LUNG D, V4, pS4; Rodwell TC, 2014, J CLIN MICROBIOL, V52, P781, DOI 10.1128/JCM.02701-13; Rossetti MLR, 2002, REV SAUDE PUBL, V36, P525, DOI 10.1590/S0034-89102002000400021; Scior T, 2003, ARCH PHARM, V335, P511, DOI 10.1002/ardp.200290005; Sougakoff W, 2011, CLIN MICROBIOL INFEC, V17, P800, DOI 10.1111/j.1469-0691.2011.03577.x; Sreevatsan S, 1997, ANTIMICROB AGENTS CH, V41, P600, DOI 10.1128/AAC.41.3.600; TELENTI A, 1993, LANCET, V341, P647, DOI 10.1016/0140-6736(93)90417-F; Tiemersma EW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017601; Urbanczik R, 2009, INT J TUBERC LUNG D, V13, P799; Vilcheze C, 2006, NAT MED, V12, P1027, DOI 10.1038/nm1466; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; World Health Organization, 2010, TREATM TUB GUIDL; World Health Organization, 2021, 10 THREATS GLOB HLTH; Zhang Y, 2009, INT J TUBERC LUNG D, V13, P1320; ZHANG Y, 1992, NATURE, V358, P591, DOI 10.1038/358591a0	42	180	190	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0119628	10.1371/journal.pone.0119628	http://dx.doi.org/10.1371/journal.pone.0119628			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25799046	Green Published, gold, Green Submitted			2022-12-27	WOS:000351987300065
J	Wang, KX; Xu, LL; Rui, YF; Huang, S; Lin, SE; Xiong, JH; Li, YH; Lee, WYW; Li, G				Wang, Kui-Xing; Xu, Liang-Liang; Rui, Yun-Feng; Huang, Shuo; Lin, Si-En; Xiong, Jiang-Hui; Li, Ying-Hui; Lee, Wayne Yuk-Wai; Li, Gang			The Effects of Secretion Factors from Umbilical Cord Derived Mesenchymal Stem Cells on Osteogenic Differentiation of Mesenchymal Stem Cells	PLOS ONE			English	Article							STROMAL CELLS; BONE REGENERATION; TISSUE; MARROW; REPAIR; MECHANISMS; OSTEOBLAST; SCAFFOLDS; PHOSPHATE; CARTILAGE	Factors synthesized by mesenchymal stem cells (MSCs) contain various growth factors, cytokines, exosomes and microRNAs, which may affect the differentiation abilities of MSCs. In the present study, we investigated the effects of secretion factors of human umbilical cord derived mesenchymal stem cells (hUCMSCs) on osteogenesis of human bone marrow derived MSCs (hBMSCs). The results showed that 20 mu g/ml hUCMSCs secretion factors could initiate osteogenic differentiation of hBMSCs without osteogenic induction medium (OIM), and the amount of calcium deposit (stained by Alizarin Red) was significantly increased after the hUCMSCs secretion factors treatment. Real time quantitative reverse transcription-polymerase chain reaction (real time qRT-PCR) demonstrated that the expression of osteogenesis-related genes including ALP, BMP2, OCN, Osterix, Col1 alpha and Runx2 were significantly up-regulated following hUCMSCs secretion factors treatment. In addition, we found that 10 mu g hUCMSCs secretion factors together with 2x10(5) hBMSCs in the HA/TCP scaffolds promoted ectopic bone formation in nude mice. Local application of 10 mu g hUCMSCs secretion factors with 50 mu l 2% hyaluronic acid hydrogel and 1x10(5) rat bone marrow derived MSCs (rBMSCs) also significantly enhanced the bone repair of rat calvarial bone critical defect model at both 4 weeks and 8 weeks. Moreover, the group that received the hUCMSCs secretion factors treatment had more cartilage and bone regeneration in the defect areas than those in the control group. Taken together, these findings suggested that hUCMSCs secretion factors can initiate osteogenesis of bone marrow MSCs and promote bone repair. Our study indicates that hUCMSCs secretion factors may be potential sources for promoting bone regeneration.	[Wang, Kui-Xing; Li, Gang] Chinese Univ Hong Kong, Fac Med, Sch Biomed Sci, Minist Educ,Key Lab Regenerat Med, Hong Kong, Hong Kong, Peoples R China; [Wang, Kui-Xing; Xu, Liang-Liang; Lee, Wayne Yuk-Wai; Li, Gang] Chinese Univ Hong Kong, Prince Wales Hosp, Li Ka Shing Inst Hlth Sci, Stem Cells & Regenerat Med Lab, Hong Kong, Hong Kong, Peoples R China; [Xu, Liang-Liang; Huang, Shuo; Lin, Si-En; Lee, Wayne Yuk-Wai; Li, Gang] Chinese Univ Hong Kong, Prince Wales Hosp, Fac Med, Dept Orthopaed & Traumatol, Hong Kong, Hong Kong, Peoples R China; [Xu, Liang-Liang; Huang, Shuo; Lin, Si-En; Lee, Wayne Yuk-Wai; Li, Gang] Chinese Univ Hong Kong, Fac Med, Lui Che Woo Inst Innovat Med, Hong Kong, Hong Kong, Peoples R China; [Rui, Yun-Feng; Li, Gang] Southeast Univ, Sch Med, Zhongda Hosp, Dept Orthopaed, Nanjing, Jiangsu, Peoples R China; [Xiong, Jiang-Hui; Li, Ying-Hui] Chinese Univ Hong Kong, Shenzhen Res Inst, CUHK ACC Space Med Ctr Hlth Maintenance Musculosk, Shenzhen, Peoples R China; [Xiong, Jiang-Hui; Li, Ying-Hui] Astronaut Res & Training Ctr China ACC, State Key Lab Space Med Fundamentat & Applicat, Beijing 100094, Peoples R China	Chinese University of Hong Kong; Chinese University of Hong Kong; Prince of Wales Hospital; Chinese University of Hong Kong; Prince of Wales Hospital; Chinese University of Hong Kong; Southeast University - China; Chinese University of Hong Kong, Shenzhen	Li, G (corresponding author), Chinese Univ Hong Kong, Fac Med, Sch Biomed Sci, Minist Educ,Key Lab Regenerat Med, Hong Kong, Hong Kong, Peoples R China.	gangli@cuhk.edu.hk	Lin, Sien/J-7773-2018; Liangliang, XU/K-9185-2019; Lee, Wayne YW/H-8298-2013; Li, Gang/J-7830-2018	Lin, Sien/0000-0002-7292-7062; Liangliang, XU/0000-0002-5249-7480; Lee, Wayne YW/0000-0002-0486-360X; Li, Gang/0000-0002-3981-2239	National Natural Science Foundation of China (NSFC) [81172177, 81371946]; Hong Kong Government Research Grant Council, General Research Fund [CUHK471110, CUHK470813]; National Basic Science and Development Programme (973 Programme) [2012CB518105]; SMART program	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Hong Kong Government Research Grant Council, General Research Fund; National Basic Science and Development Programme (973 Programme)(National Basic Research Program of China); SMART program	This work is supported by a grant from National Natural Science Foundation of China (NSFC No. 81172177, 81371946) and Hong Kong Government Research Grant Council, General Research Fund (CUHK471110 and CUHK470813) to Gang Li. This work was also supported in part by the National Basic Science and Development Programme (973 Programme, 2012CB518105) and SMART program seed funding to Gang Li, Lui Che Woo Institute of Innovation Medicine, The Chinese University of Hong Kong. This research work was made possible by resources donated by Lui Che Woo Foundation Limited. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amable PR, 2014, STEM CELL RES THER, V5, DOI 10.1186/scrt442; Ando Y, 2014, BONE, V61, P82, DOI 10.1016/j.bone.2013.12.029; Baek WY, 2009, J BONE MINER RES, V24, P1055, DOI [10.1359/JBMR.081248, 10.1359/jbmr.081248]; Baksh D, 2007, STEM CELLS, V25, P1384, DOI 10.1634/stemcells.2006-0709; Bian LM, 2013, BIOMATERIALS, V34, P413, DOI 10.1016/j.biomaterials.2012.09.052; BRUDER SP, 1994, J CELL BIOCHEM, V56, P283, DOI 10.1002/jcb.240560303; Byeon YE, 2010, CYTOTHERAPY, V12, P626, DOI 10.3109/14653249.2010.481665; Cameron JA, 2013, CURR TOP MICROBIOL, V367, P113, DOI 10.1007/82_2012_291; Can A, 2007, STEM CELLS, V25, P2886, DOI 10.1634/stemcells.2007-0417; Caplan AI, 2006, J CELL BIOCHEM, V98, P1076, DOI 10.1002/jcb.20886; Carlin R, 2006, REPROD BIOL ENDOCRIN, V4, DOI 10.1186/1477-7827-4-8; Chen DF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052948; Ducy P, 2000, SCIENCE, V289, P1501, DOI 10.1126/science.289.5484.1501; Fong CY, 2011, STEM CELL REV REP, V7, P1, DOI 10.1007/s12015-010-9166-x; Gnecchi M, 2005, NAT MED, V11, P367, DOI 10.1038/nm0405-367; Hendijani F, 2014, CELL TISSUE BANK; Hou TY, 2009, TISSUE ENG PT A, V15, P2325, DOI 10.1089/ten.tea.2008.0402; Hsieh JY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072604; Jiang YH, 2002, NATURE, V418, P41, DOI 10.1038/nature00870; Jochmann K, 2014, MATRIX BIOL, V35, P239, DOI 10.1016/j.matbio.2014.04.001; Khan SN, 2004, EXPERT OPIN BIOL TH, V4, P741; Kinnaird T, 2004, CIRCULATION, V109, P1543, DOI 10.1161/01.CIR.0000124062.31102.57; Komori T, 2003, J BONE MINER METAB, V21, P193, DOI 10.1007/s00774-002-0408-0; Krampera M, 2006, BONE, V39, P678, DOI 10.1016/j.bone.2006.04.020; Lai RC, 2011, REGEN MED, V6, P481, DOI [10.2217/RME.11.35, 10.2217/rme.11.35]; Liu DD, 2013, J CELL BIOCHEM, V114, P1105, DOI 10.1002/jcb.24451; Liu Y, 2011, NAT MED, V17, P1594, DOI 10.1038/nm.2542; Majore I, 2011, STEM CELL REV REP, V7, P17, DOI 10.1007/s12015-010-9165-y; Patel AN, 2013, CELL TRANSPLANT, V22, P513, DOI 10.3727/096368912X655064; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Spicer PP, 2012, NAT PROTOC, V7, P1918, DOI 10.1038/nprot.2012.113; Staines KA, 2013, J ENDOCRINOL, V219, pR1, DOI 10.1530/JOE-13-0276; Sze SK, 2007, MOL CELL PROTEOMICS, V6, P1680, DOI 10.1074/mcp.M600393-MCP200; Thein-Han W, 2011, TISSUE ENG PT A, V17, P2943, DOI 10.1089/ten.tea.2010.0674; Thery C, 2009, NAT REV IMMUNOL, V9, P581, DOI 10.1038/nri2567; Timmers L, 2011, STEM CELL RES, V6, P206, DOI 10.1016/j.scr.2011.01.001; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Wang HS, 2004, STEM CELLS, V22, P1330, DOI 10.1634/stemcells.2004-0013; Wang LM, 2010, TISSUE ENG PT A, V16, P1937, DOI 10.1089/ten.TEA.2009.0706; Wang LM, 2011, J TISSUE ENG REGEN M, V5, P712, DOI 10.1002/term.370; Wang LM, 2009, J TISSUE ENG REGEN M, V3, P398, DOI 10.1002/term.176; Xu LL, 2012, INT J BIOCHEM CELL B, V44, P612, DOI 10.1016/j.biocel.2011.12.018; Zhao L, 2010, BIOMATERIALS, V31, P3848, DOI 10.1016/j.biomaterials.2010.01.093	43	52	57	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0120593	10.1371/journal.pone.0120593	http://dx.doi.org/10.1371/journal.pone.0120593			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25799169	Green Published, gold, Green Submitted			2022-12-27	WOS:000351987300157
J	Yu, XD; Lin, M; Ye, F; Ouyang, H; Chen, Y; Zhou, CW; Su, ZH				Yu, Xiaoduo; Lin, Meng; Ye, Feng; Ouyang, Han; Chen, Yan; Zhou, Chunwu; Su, Zihua			Comparison of Contrast-Enhanced Isotropic 3D-GRE-T1WI Sequence versus Conventional Non-Isotropic Sequence on Preoperative Staging of Cervical Cancer	PLOS ONE			English	Article							TURBO SPIN-ECHO; 3.0 T; IMAGE QUALITY; 3D; CARCINOMA; 2D; EXPERIENCE; ACCURACY; MRI; CT	Purpose To compare contrast-enhanced isotropic 3D-GRE-T1WI sequence vs. conventional non-isotropic sequence in terms of image quality, estimated signal-to-noise ratio (eSNR), relative tumor contrast and performance of cervical cancer staging. Methods This retrospective study was approved by the institutional review board, and informed consent was waived. Seventy-one patients (47 +/- 9.4 years), with pathologically-confirmed cervical cancer underwent axial contrast-enhanced 1mm(3) isotropic 3D-GRE-T1WI sequence (herein referred to Isotropy), and 3-mm-thick non-isotropic sagittal and coronal sequences. Image quality score, eSNR and relative contrast between tumor to myometrium, gluteal muscle, and fat respectively, were compared between 3-mm-thick reconstructed images from Isotropy and directly scanned non-isotropic images by paired t-test. Difference in tumor staging obtained from Isotropy and combined Three-planes including reconstructed axial images, directly scanned sagittal and coronal sequence were compared by McNemar test. Results Both sequences showed similar image quality. Reconstructed images demonstrated higher eSNR, equal or lower relative tumor contrast compared with non-isotropic images. Compared with performing diagnosis on Three-planes, both reviewers showed higher accuracy when diagnosing vaginal invasion on Isotropy (p = 0.039 and 0.003, respectively). Conclusion Compared with non-isotropic sequence, 3.0T MR isotropic 3D-GRE-T1WI sequence exhibited better eSNR, providing more reliable clinical information for preoperative staging of cervical cancer.	[Yu, Xiaoduo; Lin, Meng; Ye, Feng; Ouyang, Han; Chen, Yan; Zhou, Chunwu] Chinese Acad Med Sci, Peking Union Med Coll, Canc Inst & Hosp, Dept Diagnost Radiol, Beijing 100730, Peoples R China; [Su, Zihua] GE Healthcare, Life Sci, Beijing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Peking Union Medical College; General Electric	Ouyang, H (corresponding author), Chinese Acad Med Sci, Peking Union Med Coll, Canc Inst & Hosp, Dept Diagnost Radiol, Beijing 100730, Peoples R China.	houybj@126.com			Life Science, GE Healthcare	Life Science, GE Healthcare	The authors received no specific funding for this work. Life Science, GE Healthcare provided support in the form of a salary for author ZS, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Akita A, 2011, EUR RADIOL, V21, P1850, DOI 10.1007/s00330-011-2122-6; Balleyguier C, 2011, EUR RADIOL, V21, P1102, DOI 10.1007/s00330-010-1998-x; Choi HJ, 2006, CANCER-AM CANCER SOC, V106, P914, DOI 10.1002/cncr.21641; Hecht EM, 2011, AM J ROENTGENOL, V197, pW346, DOI 10.2214/AJR.10.5914; Heverhagen JT, 2007, RADIOLOGY, V245, P638, DOI 10.1148/radiol.2453062151; Hori M, 2013, EUR RADIOL, V23, P2296, DOI 10.1007/s00330-013-2815-0; Hori M, 2011, RADIOLOGY, V258, P154, DOI 10.1148/radiol.10100866; Hricak H, 2007, RADIOLOGY, V245, P491, DOI 10.1148/radiol.2452061983; de la Pena MJ, 2008, GYNECOL ONCOL, V110, pS49, DOI 10.1016/j.ygyno.2008.05.030; Kim H, 2010, RADIOLOGY, V254, P485, DOI 10.1148/radiol.09090587; KIM SH, 1990, RADIOLOGY, V175, P45, DOI 10.1148/radiology.175.1.2315503; Komada Tomohiro, 2008, Magn Reson Med Sci, V7, P13, DOI 10.2463/mrms.7.13; Maffei E, 2011, INSIGHTS IMAGING, V2, P39, DOI 10.1007/s13244-010-0056-1; Meindl T, 2009, EUR RADIOL, V19, P713, DOI 10.1007/s00330-008-1175-7; Moraal B, 2010, RADIOLOGY, V255, P154, DOI 10.1148/radiol.09090814; Nicolet V, 2000, RADIOGRAPHICS, V20, P1539, DOI 10.1148/radiographics.20.6.g00nv111539; Pecorelli S, 2009, INT J GYNECOL OBSTET, V105, P103, DOI 10.1016/j.ijgo.2009.02.012; Puls R, 2007, J MAGN RESON IMAGING, V25, P1174, DOI 10.1002/jmri.20936; Ristow O, 2009, EUR RADIOL, V19, P1263, DOI 10.1007/s00330-008-1260-y; Rosenkrantz AB, 2010, AM J ROENTGENOL, V194, P634, DOI 10.2214/AJR.09.2994; Rosenkrantz AB, 2010, AM J ROENTGENOL, V194, P446, DOI 10.2214/AJR.09.3217; Sala E, 2007, AM J ROENTGENOL, V188, P1577, DOI 10.2214/AJR.06.1196; Scheidler J, 1998, RADIOLOGY, V206, P125, DOI 10.1148/radiology.206.1.9423661; Stevens KJ, 2008, RADIOLOGY, V249, P1026, DOI 10.1148/radiol.2493080227; Takeda T, 2008, ACTA RADIOL, V49, P1167, DOI 10.1080/02841850802477924; TOGASHI K, 1989, RADIOLOGY, V171, P245, DOI 10.1148/radiology.171.1.2928532; Van Hoe L, 1999, RADIOLOGY, V213, P608, DOI 10.1148/radiology.213.2.r99oc23608; Van Vierzen PBJ, 1998, CLIN RADIOL, V53, P183, DOI 10.1016/S0009-9260(98)80098-6	28	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0122053	10.1371/journal.pone.0122053	http://dx.doi.org/10.1371/journal.pone.0122053			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25799021	Green Submitted, gold, Green Published			2022-12-27	WOS:000351987300315
J	Ferrara, M; Bottasso, A; Tempesta, D; Carrieri, M; De Gennaro, L; Ponti, G				Ferrara, Michele; Bottasso, Anna; Tempesta, Daniela; Carrieri, Marika; De Gennaro, Luigi; Ponti, Giovanni			Gender Differences in Sleep Deprivation Effects on Risk and Inequality Aversion: Evidence from an Economic Experiment	PLOS ONE			English	Article							COGNITIVE REFLECTION; SOCIAL PREFERENCES; NEURAL MECHANISMS; DECISION-MAKING; ONE NIGHT; SEX; PERFORMANCE; PROPENSITY; BEHAVIOR; ABILITY	Excessive working hours-even at night-are becoming increasingly common in our modern 24/7 society. The prefrontal cortex (PFC) is particularly vulnerable to the effects of sleep loss and, consequently, the specific behaviors subserved by the functional integrity of the PFC, such as risk-taking and pro-social behavior, may be affected significantly. This paper seeks to assess the effects of one night of sleep deprivation on subjects' risk and social preferences, which are probably the most explored behavioral domains in the tradition of Experimental Economics. This novel cross-over study employs thirty-two university students (gender-balanced) participating to 2 counterbalanced laboratory sessions in which they perform standard risk and social preference elicitation protocols. One session was after one night of undisturbed sleep at home, and the other was after one night of sleep deprivation in the laboratory. Sleep deprivation causes increased sleepiness and decreased alertness in all subjects. After sleep loss males make riskier decisions compared to the rested condition, while females do the opposite. Females likewise show decreased inequity aversion after sleep deprivation. As for the relationship between cognitive ability and economic decisions, sleep deprived individuals with higher cognitive reflection show lower risk aversion and more altruistic behavior. These results show that one night of sleep deprivation alters economic behavior in a gender-sensitive way. Females' reaction to sleep deprivation, characterized by reduced risky choices and increased egoism compared to males, may be related to intrinsic psychological gender differences, such as in the way men and women weigh up probabilities in their decision-making, and/or to the different neurofunctional substrate of their decision-making.	[Ferrara, Michele; Tempesta, Daniela; Carrieri, Marika] Univ Aquila, Dept Life Hlth & Environm Sci, I-67100 Laquila, Italy; [Bottasso, Anna] Univ Genoa, Dept Econ, Genoa, Italy; [De Gennaro, Luigi] Univ Roma La Sapienza, Dept Psychol, I-00185 Rome, Italy; [Ponti, Giovanni] LUISS Guido Carli, Dept Econ & Finance, Rome, Italy; [Ponti, Giovanni] Univ Alicante, Dept Fundamentos Anal Econ, E-03080 Alicante, Spain	University of L'Aquila; University of Genoa; Sapienza University Rome; Luiss Guido Carli University; Universitat d'Alacant	Ferrara, M (corresponding author), Univ Aquila, Dept Life Hlth & Environm Sci, I-67100 Laquila, Italy.	michele.ferrara@univaq.it	De Gennaro, Luigi/L-8711-2015; Tempesta, Daniela/AAB-7539-2022; Ferrara, Michele/AAB-7574-2022; BOTTASSO, Anna/AAD-6205-2021	De Gennaro, Luigi/0000-0003-3613-6631; Tempesta, Daniela/0000-0002-6942-5336; Ferrara, Michele/0000-0003-2304-7576; Ponti, Giovanni/0000-0003-1680-3580; BOTTASSO, Anna/0000-0002-9575-2840	Spanish Ministry of Economic Competititveness [ECO2012-34928]; Italian Ministry of University and Research MIUR (PRIN) [20103S5RN3_002]; Generalitat Valenciana [Gruposo3/086]; Instituto Valenciano de Investigaciones Economicas (IVIE); Ministero della Salute [RF-2009-1528677]	Spanish Ministry of Economic Competititveness; Italian Ministry of University and Research MIUR (PRIN)(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)European Commission); Instituto Valenciano de Investigaciones Economicas (IVIE); Ministero della Salute(Ministry of Health, Italy)	The authors acknowledge financial support from the Spanish Ministry of Economic Competititveness (ECO2012-34928), Italian Ministry of University and Research MIUR (PRIN 20103S5RN3_002), Generalitat Valenciana (Research Projects Gruposo3/086), the Instituto Valenciano de Investigaciones Economicas (IVIE), and the Ministero della Salute (RF-2009-1528677). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acheson A, 2007, PHYSIOL BEHAV, V91, P579, DOI 10.1016/j.physbeh.2007.03.020; AKERSTEDT T, 1990, INT J NEUROSCI, V52, P29, DOI 10.3109/00207459008994241; Andreoni J, 2001, Q J ECON, V116, P293, DOI 10.1162/003355301556419; Banks S, 2004, SLEEP, V27, P1063, DOI 10.1093/sleep/27.6.1063; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Ben-Ner A, 2004, J ECON PSYCHOL, V25, P581, DOI 10.1016/S0167-4870(03)00065-5; Benjamin DJ, 2013, J EUR ECON ASSOC, V11, P1231, DOI 10.1111/jeea.12055; Bolla KI, 2004, CEREB CORTEX, V14, P1226, DOI 10.1093/cercor/bhh083; Branas-Garza P, 2007, J ECON PSYCHOL, V28, P477, DOI 10.1016/j.joep.2006.10.001; Branas-Garza P, 2010, GAME ECON BEHAV, V69, P249, DOI 10.1016/j.geb.2009.10.014; Brown Kruse Jamie, 2002, AMBIGUITY GENDER DIF, DOI DOI 10.3929/ETHZ-A-004339594; Campitelli G, 2010, JUDGM DECIS MAK, V5, P182; Carr L, 2003, P NATL ACAD SCI USA, V100, P5497, DOI 10.1073/pnas.0935845100; Cason TN, 1998, J MATH PSYCHOL, V42, P248, DOI 10.1006/jmps.1998.1213; Cazzell M, 2012, NEUROIMAGE, V62, P1896, DOI 10.1016/j.neuroimage.2012.05.030; Charness G, 2012, J ECON BEHAV ORGAN, V83, P50, DOI 10.1016/j.jebo.2011.06.007; Chaumet G, 2009, AVIAT SPACE ENVIR MD, V80, P73, DOI 10.3357/ASEM.2366.2009; Chen CC, 2013, J ECON BEHAV ORGAN, V90, P112, DOI 10.1016/j.jebo.2013.03.032; Cokely ET, 2009, JUDGM DECIS MAK, V4, P20; Corsi-Cabrera M, 2003, INT J PSYCHOPHYSIOL, V50, P213, DOI 10.1016/S0167-8760(03)00168-5; Curcio G, 2013, NEUROL SCI, V34, P511, DOI 10.1007/s10072-012-1085-y; Dai XJ, 2012, SLEEP MED, V13, P720, DOI 10.1016/j.sleep.2011.09.019; Decety J, 2004, NEUROIMAGE, V23, P744, DOI 10.1016/j.neuroimage.2004.05.025; Engelmann D, 2004, AM ECON REV, V94, P857, DOI 10.1257/0002828042002741; Fehr-Duda H, 2006, THEOR DECIS, V60, P283, DOI 10.1007/s11238-005-4590-0; FELDSTEIN MS, 1969, REV ECON STUD, V36, P5, DOI 10.2307/2296337; Filippin A, 01 GAEL; First M., 1997, STRUCTURED CLIN INTE; FORSYTHE R, 1994, GAME ECON BEHAV, V6, P347, DOI 10.1006/game.1994.1021; Frederick S, 2005, J ECON PERSPECT, V19, P25, DOI 10.1257/089533005775196732; Frignani N, 2012, ECON LETT, V116, P143, DOI 10.1016/j.econlet.2012.02.002; Guadagni V, 2014, J SLEEP RES, V23, P657, DOI 10.1111/jsr.12192; Han SH, 2008, BRAIN RES, V1196, P85, DOI 10.1016/j.brainres.2007.12.062; Harris CR, 2006, JUDGM DECIS MAK, V1, P48; Harrison Y, 1999, ORGAN BEHAV HUM DEC, V78, P128, DOI 10.1006/obhd.1999.2827; Harrison Y, 2000, SLEEP, V23, P1067; Heffetz O., 2011, HDB SOCIAL EC, P69, DOI DOI 10.1016/B978-0-444-53187-2.00003-6; HEY JD, 1994, ECONOMETRICA, V62, P1291, DOI 10.2307/2951750; Iacoboni M, 2005, PLOS BIOL, V3, P529, DOI 10.1371/journal.pbio.0030079; KAHNEMAN D, 1979, ECONOMETRICA, V47, P263, DOI 10.2307/1914185; Killgore WDS, 2011, J SLEEP RES, V20, P395, DOI 10.1111/j.1365-2869.2010.00893.x; Knutson B, 2005, J NEUROSCI, V25, P4806, DOI 10.1523/JNEUROSCI.0642-05.2005; Krajbich I, 2009, J NEUROSCI, V29, P2188, DOI 10.1523/JNEUROSCI.5086-08.2009; Kret ME, 2012, NEUROPSYCHOLOGIA, V50, P1211, DOI 10.1016/j.neuropsychologia.2011.12.022; Leider S, 2009, Q J ECON, V124, P1815, DOI 10.1162/qjec.2009.124.4.1815; Libedinsky C, 2011, FRONT BEHAV NEUROSCI, V5, DOI 10.3389/fnbeh.2011.00070; List JA, 2007, J POLIT ECON, V115, P482, DOI 10.1086/519249; Luo PC, 2015, BRAIN IMAGING BEHAV, V9, P312, DOI 10.1007/s11682-014-9308-x; McCabe K, 2001, P NATL ACAD SCI USA, V98, P11832, DOI 10.1073/pnas.211415698; Mckenna BS, 2007, J SLEEP RES, V16, P245, DOI 10.1111/j.1365-2869.2007.00591.x; Mellers BA, 2010, J EXP PSYCHOL GEN, V139, P743, DOI 10.1037/a0020280; Oechssler J, 2009, J ECON BEHAV ORGAN, V72, P147, DOI 10.1016/j.jebo.2009.04.018; Plott Charles R., 2008, HDB EXPT EC RESULTS, V1, P509, DOI DOI 10.1016/S1574-0722(07)00057-1; Rilling JK, 2002, NEURON, V35, P395, DOI 10.1016/S0896-6273(02)00755-9; Sack RL, 2007, SLEEP, V30, P1460, DOI 10.1093/sleep/30.11.1460; Shamay-Tsoory SG, 2011, NEUROSCIENTIST, V17, P18, DOI 10.1177/1073858410379268; Sicard B, 2001, MIL MED, V166, P871, DOI 10.1093/milmed/166.10.871; Slonim R, 2007, ECON LETT, V97, P215, DOI 10.1016/j.econlet.2007.03.018; Thomas M, 2000, J SLEEP RES, V9, P335, DOI 10.1046/j.1365-2869.2000.00225.x; Toplak ME, 2011, MEM COGNITION, V39, P1275, DOI 10.3758/s13421-011-0104-1; Tricomi E, 2010, NATURE, V463, P1089, DOI 10.1038/nature08785; Venkatraman V, 2007, SLEEP, V30, P603, DOI 10.1093/sleep/30.5.603; Venkatraman V, 2011, J NEUROSCI, V31, P3712, DOI 10.1523/JNEUROSCI.4407-10.2011; Waytz A, 2012, J NEUROSCI, V32, P7646, DOI 10.1523/JNEUROSCI.6193-11.2012; Weiland S, 2012, SOC NEUROSCI-UK, V7, P537, DOI 10.1080/17470919.2012.674056; Wooldridge JM, 2010, ECONOMETRIC ANALYSIS OF CROSS SECTION AND PANEL DATA, 2ND EDITION, P1; Wright KP, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00050; Yamasue H, 2008, CEREB CORTEX, V18, P2331, DOI 10.1093/cercor/bhm254; Zaki J, 2014, SOC COGN AFFECT NEUR, V9, P464, DOI 10.1093/scan/nst005; Zaki J, 2011, PSYCHOL SCI, V22, P894, DOI 10.1177/0956797611411057	70	29	31	2	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0120029	10.1371/journal.pone.0120029	http://dx.doi.org/10.1371/journal.pone.0120029			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CE8IA	25793869	gold, Green Published, Green Submitted			2022-12-27	WOS:000352084200136
J	Herting, MM; Gautam, P; Spielberg, JM; Dahl, RE; Sowell, ER				Herting, Megan M.; Gautam, Prapti; Spielberg, Jeffrey M.; Dahl, Ronald E.; Sowell, Elizabeth R.			A Longitudinal Study: Changes in Cortical Thickness and Surface Area during Pubertal Maturation	PLOS ONE			English	Article							HUMAN CEREBRAL-CORTEX; BRAIN-DEVELOPMENT; PREFRONTAL CORTEX; STEROID-HORMONES; SEX-DIFFERENCES; VOLUME CHANGES; GRAY-MATTER; ADOLESCENCE; TESTOSTERONE; CELLS	Sex hormones have been shown to contribute to the organization and function of the brain during puberty and adolescence. Moreover, it has been suggested that distinct hormone changes in girls versus boys may contribute to the emergence of sex differences in internalizing and externalizing behavior during adolescence. In the current longitudinal study, the influence of within-subject changes in puberty (physical and hormonal) on cortical thickness and surface area was examined across a 2-year span, while controlling for age. Greater increases in Tanner Stage predicted less superior frontal thinning and decreases in precuneus surface area in both sexes. Significant Tanner Stage and sex interactions were also seen, with less right superior temporal thinning in girls but not boys, as well as greater decreases in the right bank of the superior temporal sulcus surface area in boys compared to girls. In addition, within-subject changes in testosterone over the 2-year follow-up period were found to relate to decreases in middle superior frontal surface area in boys, but increases in surface area in girls. Lastly, larger increases in estradiol in girls predicted greater middle temporal lobe thinning. These results show that within-subject physical and hormonal markers of puberty relate to region and sex-specific changes in cortical development across adolescence.	[Herting, Megan M.; Gautam, Prapti; Sowell, Elizabeth R.] Childrens Hosp Los Angeles, Keck Sch Med USC, Dept Pediat, Los Angeles, CA 90027 USA; [Spielberg, Jeffrey M.] VA Boston Hlth Care Syst, Neuroimaging Res Vet Ctr, Boston, MA USA; [Dahl, Ronald E.] Univ Calif Berkeley, Inst Human Dev, Berkeley, CA 94720 USA	Children's Hospital Los Angeles; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System; University of California System; University of California Berkeley	Herting, MM (corresponding author), Childrens Hosp Los Angeles, Keck Sch Med USC, Dept Pediat, Los Angeles, CA 90027 USA.	mherting@chla.usc.edu; esowell@chla.usc.edu	Dahl, Ronald/AAW-8714-2021; Spielberg, Jeffrey/D-1402-2014	Spielberg, Jeffrey/0000-0001-8348-7157; dahl, ronald/0000-0002-1794-7132	National Institute of Drug Abuse Grant [R01 DA018910]; National Institute of Mental Health Grant [R01 MH087563]; National Institute of Child Development Health Grant [F32 HD078084]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH087563] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA018910] Funding Source: NIH RePORTER	National Institute of Drug Abuse Grant; National Institute of Mental Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute of Child Development Health Grant; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by the National Institute of Drug Abuse Grant R01 DA018910 awarded to Dr. Dahl. Support for this research was also provided by the National Institute of Mental Health Grant R01 MH087563 awarded to Dr. Sowell and the National Institute of Child Development Health Grant F32 HD078084 awarded to Dr. Herting. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed EI, 2008, NAT NEUROSCI, V11, P995, DOI 10.1038/nn.2178; APTER D, 1980, CLIN ENDOCRINOL, V12, P107, DOI 10.1111/j.1365-2265.1980.tb02125.x; APTER D, 1978, J CLIN ENDOCR METAB, V47, P944, DOI 10.1210/jcem-47-5-944; Bennett NC, 2010, INT J BIOCHEM CELL B, V42, P813, DOI 10.1016/j.biocel.2009.11.013; Blakemore SJ, 2010, HUM BRAIN MAPP, V31, P926, DOI 10.1002/hbm.21052; Bramen JE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033850; Bramen JE, 2011, CEREB CORTEX, V21, P636, DOI 10.1093/cercor/bhq137; Casey BJ, 2008, ANN NY ACAD SCI, V1124, P111, DOI 10.1196/annals.1440.010; Fischl B, 2004, CEREB CORTEX, V14, P11, DOI 10.1093/cercor/bhg087; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Giedd JN, 2006, MOL CELL ENDOCRINOL, V254, P154, DOI 10.1016/j.mce.2006.04.016; Gonzalez M, 2007, J COMP NEUROL, V503, P790, DOI 10.1002/cne.21419; Herman-Giddens ME, 2012, PEDIATRICS, V130, pE1058, DOI 10.1542/peds.2011-3291; Herting MM, 2014, HUM BRAIN MAPP, V35, P5633, DOI 10.1002/hbm.22575; JUNGTESTAS I, 1992, J STEROID BIOCHEM, V41, P621, DOI 10.1016/0960-0760(92)90394-X; Juraska JM, 2013, HORM BEHAV, V64, P203, DOI 10.1016/j.yhbeh.2013.05.010; Juraska JM, 2004, ANN NY ACAD SCI, V1021, P431, DOI 10.1196/annals.1308.058; KOLB B, 1991, J NEUROENDOCRINOL, V3, P95, DOI 10.1111/j.1365-2826.1991.tb00245.x; Koolschijn PCMP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083929; Kreipe RE, 1992, TXB ADOLESCENT MED, P44; Lenroot RK, 2010, BRAIN COGNITION, V72, P46, DOI 10.1016/j.bandc.2009.10.008; Marin-Husstege M, 2004, DEV NEUROSCI-BASEL, V26, P245, DOI 10.1159/000082141; MARSHALL WA, 1969, ARCH DIS CHILD, V44, P291, DOI 10.1136/adc.44.235.291; MARSHALL WA, 1970, ARCH DIS CHILD, V45, P13, DOI 10.1136/adc.45.239.13; MARSHALL WA, 1968, ANNU REV MED, V19, P283, DOI 10.1146/annurev.me.19.020168.001435; Mccarthy MM, 2008, PHYSIOL REV, V88, P91, DOI 10.1152/physrev.00010.2007; MUNOZCUETO JA, 1990, BRAIN RES, V515, P64; Neufang S, 2009, CEREB CORTEX, V19, P464, DOI 10.1093/cercor/bhn100; Nottelmann ED, 1990, ADOLESCENCE PUBERTY, P88; Nunez JL, 2003, J NEUROBIOL, V56, P293, DOI 10.1002/neu.10236; Nunez JL, 2000, DEV BRAIN RES, V125, P83, DOI 10.1016/S0165-3806(00)00126-7; Ostby Y, 2009, J NEUROSCI, V29, P11772, DOI 10.1523/JNEUROSCI.1242-09.2009; Peper JS, 2011, NEUROSCIENCE, V191, P28, DOI 10.1016/j.neuroscience.2011.02.014; Peper JS, 2008, PSYCHONEUROENDOCRINO, V33, P909, DOI 10.1016/j.psyneuen.2008.03.017; Peper JS, 2009, PSYCHONEUROENDOCRINO, V34, P332, DOI 10.1016/j.psyneuen.2008.09.012; Raznahan A, 2011, J NEUROSCI, V31, P7174, DOI 10.1523/JNEUROSCI.0054-11.2011; Raznahan A, 2010, P NATL ACAD SCI USA, V107, P16988, DOI 10.1073/pnas.1006025107; Reuter M, 2012, NEUROIMAGE, V61, P1402, DOI 10.1016/j.neuroimage.2012.02.084; Shaw P, 2008, J NEUROSCI, V28, P3586, DOI 10.1523/JNEUROSCI.5309-07.2008; Sowell ER, 2003, NAT NEUROSCI, V6, P309, DOI 10.1038/nn1008; Spielberg J. M., 2014, SOCIAL COGNITIVE AFF; Spielberg JM, 2014, DEV COGN NEUROS-NETH, V8, P86, DOI 10.1016/j.dcn.2014.01.004; STEWART J, 1994, BRAIN RES, V654, P149, DOI 10.1016/0006-8993(94)91581-4; Sun SMS, 2002, PEDIATRICS, V110, P911, DOI 10.1542/peds.110.5.911; TRELOAR AE, 1967, INT J FERTIL, V12, P77; Nguyen TV, 2013, J NEUROSCI, V33, P10840, DOI 10.1523/JNEUROSCI.5747-12.2013; Nguyen TV, 2013, CEREB CORTEX, V23, P1424, DOI 10.1093/cercor/bhs125; Winkler AM, 2012, NEUROIMAGE, V61, P1428, DOI 10.1016/j.neuroimage.2012.03.026; Worthman CM, 1997, AM J PHYS ANTHROPOL, V104, P1	50	78	79	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0119774	10.1371/journal.pone.0119774	http://dx.doi.org/10.1371/journal.pone.0119774			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25793383	Green Published, gold			2022-12-27	WOS:000352084200114
J	Lee, SC; Hsu, JS; Li, CC; Chen, KM; Liu, CT				Lee, Shih-Chieh; Hsu, Jie-Sheng; Li, Chien-Chun; Chen, Ke-Ming; Liu, Cheng-Tzu			Protective Effect of Leaf Essential Oil from Cinnamomum osmophloeum Kanehira on Endotoxin-Induced Intestinal Injury in Mice Associated with Suppressed Local Expression of Molecules in the Signaling Pathways of TLR4 and NLRP3	PLOS ONE			English	Article							NF-KAPPA-B; NEUTROPHIL INFILTRATION; DIFFERENT PROVENANCES; GARLIC OIL; SEPSIS; ACTIVATION; INTERLEUKIN-18; INFLAMMASOME; RECOGNITION; DAMAGE	Endotoxin is a potent microbial mediator implicated in sepsis. We investigated the anti-inflammatory effect of leaf essential oil from Cinnamomum osmophloeum Kanehira (CO) of the linalool chemotype on endotoxin-injected mice. Mice were administered CO or vehicle by gavage before endotoxin injection and were killed 12 h after injection. Neither growth nor the organ weight or tissue weight to body weight ratio was affected by CO treatment. CO significantly lowered peripheral levels of tumor necrosis factor-alpha, interleukin (IL)-1 beta, IL-18, interferon-gamma, and nitric oxide and inhibited the expression of toll-like receptor 4 (TLR4), myeloid differentiation primary response gene (88), myeloid differentiation factor 2, apoptosis-associated speck-like protein containing a caspase-recruitment domain (ASC), caspase-1, and Nod-like receptor family, pyrin domain containing 3 (NLRP3). CO also inhibited the activation of nuclear factor-kappa B, inhibited the activity of caspase-1 in small intestine, and ameliorated intestinal edema. Our data provide strong evidence for a protective effect of CO of the linalool chemotype in the endotoxin-induced systemic inflammatory response in close association with suppression of the TLR4 and NLRP3 signaling pathways in intestine.	[Lee, Shih-Chieh] Da Yeh Univ, Dept BioInd Technol, Dacun, Changhua, Taiwan; [Hsu, Jie-Sheng; Li, Chien-Chun; Liu, Cheng-Tzu] Chung Shan Med Univ, Sch Nutr, Taichung, Taiwan; [Chen, Ke-Ming] Chung Shan Med Univ, Dept Parasitol, Taichung, Taiwan; [Liu, Cheng-Tzu] Chung Shan Med Univ Hosp, Dept Nutr, Taichung 40201, Taiwan	Da Yeh University; Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital	Liu, CT (corresponding author), Chung Shan Med Univ, Sch Nutr, 110,Sec 1,Chien Kuo N Rd, Taichung, Taiwan.	ctl@csmu.edu.tw	Li, Chien-Chun/AAI-6536-2020		Ministry of Science and Technology, Taiwan, ROC [NSC 101-2313-B-040 -008 -MY3]	Ministry of Science and Technology, Taiwan, ROC(Ministry of Science and Technology, Taiwan)	This work was supported by a grant from the Ministry of Science and Technology, Taiwan, ROC (NSC 101-2313-B-040 -008 -MY3). The website of the funder is http://www.most.gov.tw/mp.aspx. This funding was provided to CTL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adib-Conquy M, 2007, FEBS LETT, V581, P3723, DOI 10.1016/j.febslet.2007.03.074; Angus DC, 2013, NEW ENGL J MED, V369, P840, DOI [10.1056/NEJMc1312359, 10.1056/NEJMra1208623]; Arndt PG, 2000, AM J RESP CELL MOL, V22, P708, DOI 10.1165/ajrcmb.22.6.3832; Bauernfeind FG, 2009, J IMMUNOL, V183, P787, DOI 10.4049/jimmunol.0901363; Buras JA, 2005, NAT REV DRUG DISCOV, V4, P854, DOI 10.1038/nrd1854; Chao LK, 2005, J AGR FOOD CHEM, V53, P7274, DOI 10.1021/jf051151u; Chao LK, 2008, FOOD CHEM TOXICOL, V46, P220, DOI 10.1016/j.fct.2007.07.016; Cheng SS, 2006, BIORESOURCE TECHNOL, V97, P306, DOI 10.1016/j.biortech.2005.02.030; Chiang YH, 2006, TOXICOL APPL PHARM, V213, P46, DOI 10.1016/j.taap.2005.08.008; DEITCH EA, 1991, CRIT CARE MED, V19, P785, DOI 10.1097/00003246-199106000-00010; Dinarello CA, 2003, J INFECT DIS, V187, pS370, DOI 10.1086/374751; Faggioni R, 2001, J IMMUNOL, V167, P5913, DOI 10.4049/jimmunol.167.10.5913; Ganz M, 2011, WORLD J GASTROENTERO, V17, P4772, DOI 10.3748/wjg.v17.i43.4772; Gribar SC, 2008, J LEUKOCYTE BIOL, V83, P493, DOI 10.1189/jlb.0607358; Huo MX, 2013, J SURG RES, V180, pE47, DOI 10.1016/j.jss.2012.10.050; Karin M, 1999, ONCOGENE, V18, P6867, DOI 10.1038/sj.onc.1203219; Kuo CH, 2011, J AGR FOOD CHEM, V59, P7717, DOI 10.1021/jf201185v; Lee SC, 2013, J AGR FOOD CHEM, V61, P4905, DOI 10.1021/jf401039z; Lee SH, 2012, FOOD CHEM TOXICOL, V50, P567, DOI 10.1016/j.fct.2011.11.027; Lewis DH, 2012, J VET INTERN MED, V26, P457, DOI 10.1111/j.1939-1676.2012.00905.x; Lin SSC, 2011, PHYTOTHER RES, V25, P1511, DOI 10.1002/ptr.3419; Lu YC, 2008, CYTOKINE, V42, P145, DOI 10.1016/j.cyto.2008.01.006; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Matsuda N, 2006, J PHARMACOL SCI, V101, P189, DOI 10.1254/jphs.CRJ06010X; Mittal R, 2014, TRENDS MOL MED, V20, P214, DOI 10.1016/j.molmed.2013.08.004; Murugan R, 2014, NEPHROL DIAL TRANSPL, V29, P1854, DOI 10.1093/ndt/gfu051; Oberholzer A, 2001, SHOCK, V16, P411, DOI 10.1097/00024382-200116060-00001; Opal SM, 2010, CONTRIB NEPHROL, V167, P14, DOI 10.1159/000315915; Qiao Y, 2012, FEBS LETT, V586, P1022, DOI 10.1016/j.febslet.2012.02.045; Raeburn CD, 2002, AM J PHYSIOL-HEART C, V283, pH650, DOI 10.1152/ajpheart.00043.2002; Rhee SH, 2011, J NEUROGASTROENTEROL, V17, P28, DOI 10.5056/jnm.2011.17.1.28; Schroder K, 2004, J LEUKOCYTE BIOL, V75, P163, DOI 10.1189/jlb.0603252; Schulte W, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/165974; Sutterwala FS, 2006, IMMUNITY, V24, P317, DOI 10.1016/j.immuni.2006.02.004; Tsutsui H, 2010, GASTROENT RES PRACT, V2010, DOI 10.1155/2010/641865; Tung YT, 2011, J AGR FOOD CHEM, V59, P8117, DOI 10.1021/jf2018935; Tung YT, 2010, PHARM BIOL, V48, P1130, DOI 10.3109/13880200903527728; Wittebole X, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/568396; Yamamoto M, 2004, GENES CELLS, V9, P1055, DOI 10.1111/j.1365-2443.2004.00789.x; Ye ZM, 2008, CURR OPIN IMMUNOL, V20, P3, DOI 10.1016/j.coi.2008.01.003; Zhang HJ, 2011, AM J PHYSIOL-RENAL, V301, pF171, DOI 10.1152/ajprenal.00339.2010; Zheng Y, 2011, ARTERIOSCL THROM VAS, V31, P2781, DOI 10.1161/ATVBAHA.111.224907	42	6	6	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0120700	10.1371/journal.pone.0120700	http://dx.doi.org/10.1371/journal.pone.0120700			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25794175	gold, Green Published, Green Submitted			2022-12-27	WOS:000352083900065
J	Robertson, HE; Lapraz, F; Rhodes, AC; Telford, MJ				Robertson, Helen E.; Lapraz, Francois; Rhodes, Adelaide C.; Telford, Maximilian J.			The Complete Mitochondrial Genome of the Geophilomorph Centipede Strigamia maritima	PLOS ONE			English	Article							GENE ORDER REARRANGEMENT; TRANSFER-RNAS; ARTHROPOD PHYLOGENY; EMBRYONIC-DEVELOPMENT; SEGMENT FORMATION; MYRIAPODA; SEQUENCES; EVOLUTION; CHILOPODA; INSIGHTS	Strigamia maritima (Myriapoda; Chilopoda) is a species from the soil-living order of geophilomorph centipedes. The Geophilomorpha is the most speciose order of centipedes with over a 1000 species described. They are notable for their large number of appendage bearing segments and are being used as a laboratory model to study the embryological process of segmentation within the myriapods. Using a scaffold derived from the recently published genome of Strigamia maritima that contained multiple mitochondrial protein-coding genes, here we report the complete mitochondrial genome of Strigamia, the first from any geophilomorph centipede. The mitochondrial genome of S. maritima is a circular molecule of 14,938 base pairs, within which we could identify the typical mitochondrial genome complement of 13 protein-coding genes and 2 ribosomal RNA genes. Sequences resembling 16 of the 22 transfer RNA genes typical of metazoan mitochondrial genomes could be identified, many of which have clear deviations from the standard 'cloverleaf' secondary structures of tRNA. Phylogenetic trees derived from the concatenated alignment of protein-coding genes of S. maritima and > 50 other metazoans were unable to resolve the Myriapoda as monophyletic, but did support a monophyletic group of chilopods: Strigamia was resolved as the sister group of the scolopendromorph Scolopocryptos sp. and these two (Geophilomorpha and Scolopendromorpha), along with the Lithobiomorpha, formed a monophyletic group the Pleurostigmomorpha. Gene order within the S. maritima mitochondrial genome is unique compared to any other arthropod or metazoan mitochondrial genome to which it has been compared. The highly unusual organisation of the mitochondrial genome of Strigamia maritima is in striking contrast with the conservatively evolving nuclear genome: sampling of more members of this order of centipedes will be required to see whether this unusual organization is typical of the Geophilomorpha or results from a more recent reorganisation in the lineage leading to Strigamia.	[Robertson, Helen E.; Lapraz, Francois; Telford, Maximilian J.] UCL, Dept Genet Evolut & Environm, London, England; [Rhodes, Adelaide C.] Oregon State Univ, Ctr Genome Res & Biocomp, Corvallis, OR 97331 USA	University of London; University College London; Oregon State University	Telford, MJ (corresponding author), UCL, Dept Genet Evolut & Environm, Darwin Bldg,Gower St, London, England.	m.telford@ucl.ac.uk	Lapraz, Francois/W-4948-2017	Lapraz, Francois/0000-0001-9209-2018; Rhodes, Adelaide/0000-0002-1714-1972	ERC [ERC-2012-AdG 322790-XENOTURBELLA]; Biotechnology and Biological Sciences Research Council [BBS/B/0675X]; Royal Society Wolfson Research Merit Award	ERC(European Research Council (ERC)European Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Royal Society Wolfson Research Merit Award(Royal Society of London)	Funding: H.E.R. is supported by the ERC (ERC-2012-AdG 322790-XENOTURBELLA), F.L. is supported by the Biotechnology and Biological Sciences Research Council (BBS/B/0675X), and M.J. T. is supported by a Royal Society Wolfson Research Merit Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arthur W, 2005, BIOESSAYS, V27, P653, DOI 10.1002/bies.20234; Barber Anthony D., 2009, Soil Organisms, V81, P735; Bernt M, 2013, MOL PHYLOGENET EVOL, V69, P313, DOI 10.1016/j.ympev.2012.08.023; Boore JL, 1999, NUCLEIC ACIDS RES, V27, P1767, DOI 10.1093/nar/27.8.1767; Boore JL, 1998, NATURE, V392, P667, DOI 10.1038/33577; Boore JL, 1998, CURR OPIN GENET DEV, V8, P668, DOI 10.1016/S0959-437X(98)80035-X; BOORE JL, 1995, NATURE, V376, P163, DOI 10.1038/376163a0; Brena C, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-112; Brena C, 2013, EVODEVO, V4, DOI 10.1186/2041-9139-4-22; Brena C, 2012, DEV BIOL, V363, P290, DOI 10.1016/j.ydbio.2011.11.006; Capella-Gutierrez S, 2009, BIOINFORMATICS, V25, P1972, DOI 10.1093/bioinformatics/btp348; Chipman AD, 2006, DEV BIOL, V290, P337, DOI 10.1016/j.ydbio.2005.11.029; Chipman AD, 2004, CURR BIOL, V14, P1250, DOI 10.1016/j.cub.2004.07.026; Chipman AD, 2004, EVOL DEV, V6, P78, DOI 10.1111/j.1525-142X.2004.04016.x; Chipman AD, 2008, DEV BIOL, V319, P160, DOI 10.1016/j.ydbio.2008.02.038; Chipman AD, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1002005; Dong Y, 2012, GENE, V505, P57, DOI 10.1016/j.gene.2012.05.049; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Edgecombe GD, 2004, J ZOOL SYST EVOL RES, V42, P89, DOI 10.1111/j.1439-0469.2004.00245.x; Edgecombe GD, 2007, ZOOTAXA, P327, DOI 10.11646/zootaxa.1668.1.17; Edgecombe GD, 2007, ANNU REV ENTOMOL, V52, P151, DOI 10.1146/annurev.ento.52.110405.091326; Edgecombe GD, 2010, ARTHROPOD STRUCT DEV, V39, P74, DOI 10.1016/j.asd.2009.10.002; GABRIEL W, 1993, EVOLUTION, V47, P1744, DOI 10.1111/j.1558-5646.1993.tb01266.x; Gai YH, 2006, ZOOL SCI, V23, P1101, DOI 10.2108/zsj.23.1101; Gai YH, 2008, MOL PHYLOGENET EVOL, V49, P574, DOI 10.1016/j.ympev.2008.08.010; Gai YH, 2014, MITOCHONDR DNA, V25, P192, DOI 10.3109/19401736.2013.792073; Green J, 2013, DEV BIOL, V382, P235, DOI 10.1016/j.ydbio.2013.06.017; Green JE, 2014, DEV BIOL, V392, P419, DOI 10.1016/j.ydbio.2014.06.003; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hunnekuhl VS, 2014, DEV BIOL; Juhling F, 2012, NUCLEIC ACIDS RES, V40, P2833, DOI 10.1093/nar/gkr1131; Kettle C, 2003, EVOL DEV, V5, P198, DOI 10.1046/j.1525-142X.2003.03027.x; Lartillot N, 2009, BIOINFORMATICS, V25, P2286, DOI 10.1093/bioinformatics/btp368; Laslett D, 2008, BIOINFORMATICS, V24, P172, DOI 10.1093/bioinformatics/btm573; Lavrov DV, 2000, P NATL ACAD SCI USA, V97, P13738, DOI 10.1073/pnas.250402997; Lavrov DV, 2002, MOL BIOL EVOL, V19, P163, DOI 10.1093/oxfordjournals.molbev.a004068; Lewis J. G. E., 1961, Proceedings of the Zoological Society of London, V137, P221; Loesel R, 2002, ARTHROPOD STRUCT DEV, V31, P77, DOI 10.1016/S1467-8039(02)00017-8; Macey JR, 1997, MOL BIOL EVOL, V14, P30, DOI 10.1093/oxfordjournals.molbev.a025699; Macey JR, 1997, MOL BIOL EVOL, V14, P91, DOI 10.1093/oxfordjournals.molbev.a025706; Masta SE, 2004, MOL BIOL EVOL, V21, P893, DOI 10.1093/molbev/msh096; Miyazawa H, 2014, SCI REP-UK, V4, DOI 10.1038/srep04127; MORITZ C, 1987, P NATL ACAD SCI USA, V84, P7183, DOI 10.1073/pnas.84.20.7183; Negrisolo E, 2004, J MOL EVOL, V58, P413, DOI 10.1007/s00239-003-2563-x; Negrisolo E, 2004, MOL BIOL EVOL, V21, P770, DOI 10.1093/molbev/msh078; PERNA NT, 1995, J MOL EVOL, V41, P353, DOI 10.1007/BF01215182; Pisani D, 2004, BMC BIOL, V2, DOI 10.1186/1741-7007-2-1; Podsiadlowski L, 2007, MOL PHYLOGENET EVOL, V45, P251, DOI 10.1016/j.ympev.2007.07.017; Regier JC, 2005, MOL PHYLOGENET EVOL, V34, P147, DOI 10.1016/j.ympev.2004.09.005; Regier JC, 2010, NATURE, V463, P1079, DOI 10.1038/nature08742; Regier JC, 2008, SYST BIOL, V57, P920, DOI 10.1080/10635150802570791; Rehm P, 2014, MOL PHYLOGENET EVOL, V77, P25, DOI 10.1016/j.ympev.2014.04.007; Rota-Stabelli O, 2008, MOL PHYLOGENET EVOL, V48, P103, DOI 10.1016/j.ympev.2008.03.033; Rota-Stabelli O, 2011, P ROY SOC B-BIOL SCI, V278, P298, DOI 10.1098/rspb.2010.0590; Rota-Stabelli O, 2010, GENOME BIOL EVOL, V2, P425, DOI 10.1093/gbe/evq030; Saccone C, 1999, GENE, V238, P195, DOI 10.1016/S0378-1119(99)00270-X; Schattner P, 2005, NUCLEIC ACIDS RES, V33, pW686, DOI 10.1093/nar/gki366; Shear WA, 2010, ARTHROPOD STRUCT DEV, V39, P174, DOI 10.1016/j.asd.2009.11.002; STANTON DJ, 1994, GENETICS, V137, P233; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Vedel V, 2010, EVOL DEV, V12, P347, DOI 10.1111/j.1525-142X.2010.00421.x; Woo HJ, 2007, MOL CELLS, V23, P182	62	10	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0121369	10.1371/journal.pone.0121369	http://dx.doi.org/10.1371/journal.pone.0121369			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25794168	Green Published, gold			2022-12-27	WOS:000352083900128
J	Ruiz, MJ; Hupe, JM				Ruiz, Mathieu J.; Hupe, Jean-Michel			Assessment of the Hemispheric Lateralization of Grapheme-Color Synesthesia with Stroop-Type Tests	PLOS ONE			English	Article							VENTRAL STREAM; SYNAESTHESIA; SPEECH; FORM; HALF; REPRESENTATIONS; ORGANIZATION; ACTIVATION; NUMBERS; MODELS	Grapheme-color synesthesia, the idiosyncratic, arbitrary association of colors to letters or numbers, develops in childhood once reading is mastered. Because language processing is strongly left-lateralized in most individuals, we hypothesized that grapheme-color synesthesia could be left-lateralized as well. We used synesthetic versions of the Stroop test with colored letters and numbers presented either in the right or the left visual field of thirty-four synesthetes. Interference by synesthetic colors was stronger for stimuli in the right hemifield (first experiment, color naming task). Synesthetes were also faster in the right hemifield when naming the synesthetic color of graphemes (second experiment). Overall, the lateralization effect was 7 ms (the 95% confidence interval was [1.5 12] ms), a delay compatible with an additional callosal transfer for stimuli presented in the left hemifield. Though weak, this effect suggests that the association of synesthetic colors to graphemes may be preferentially processed in the left hemisphere. We speculate that this left-lateralization could be a landmark of synesthetic grapheme-color associations, if not found for color associations learnt by non-synesthete adults.	[Ruiz, Mathieu J.] Grenoble Inst Neurosci, INSERM, U836, F-38000 Grenoble, France; [Ruiz, Mathieu J.] Univ Grenoble Alpes, F-38000 Grenoble, France; [Ruiz, Mathieu J.; Hupe, Jean-Michel] Univ Toulouse, Ctr Rech Cerveau & Cognit, F-31300 Toulouse, France; [Ruiz, Mathieu J.; Hupe, Jean-Michel] CNRS, F-31300 Toulouse, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS)	Hupe, JM (corresponding author), Univ Toulouse, Ctr Rech Cerveau & Cognit, F-31300 Toulouse, France.	jean-michel.hupe@cerco.ups-tlse.fr			Agence Nationale de la Recherche [ANR-11-BSH2-010]	Agence Nationale de la Recherche(French National Research Agency (ANR))	This work was supported by Agence Nationale de la Recherche [ANR-11-BSH2-010] to JMH. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asher JE, 2006, CORTEX, V42, P137, DOI 10.1016/S0010-9452(08)70337-X; BASHORE TR, 1982, CORTEX, V18, P245, DOI 10.1016/S0010-9452(82)80006-3; Belanger HG, 2002, BRAIN LANG, V83, P384, DOI 10.1016/S0093-934X(02)00508-4; Bor D, 2014, SCI REP-UK, V4, DOI 10.1038/srep07089; Brang D, 2009, NEUROCASE, V16, P1; Brown TL, 1998, BRAIN LANG, V63, P122, DOI 10.1006/brln.1997.1940; Chiou R, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00105; Chun CA, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00776; Colizoli O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039799; Corballis MC, 2003, BEHAV BRAIN SCI, V26, P199, DOI 10.1017/S0140525X03000062; Coulson M, 2010, FRONT PSYCHOL, V1, DOI 10.3389/fpsyg.2010.00026; Cumming G., 2013, UNDERSTANDING NEW ST; Cumming G, 2014, PSYCHOL SCI, V25, P7, DOI 10.1177/0956797613504966; Dehaene S, 1998, TRENDS NEUROSCI, V21, P355, DOI 10.1016/S0166-2236(98)01263-6; Dehaene S, 2011, TRENDS COGN SCI, V15, P254, DOI 10.1016/j.tics.2011.04.003; Dixon MJ, 2004, COGN AFFECT BEHAV NE, V4, P335, DOI 10.3758/CABN.4.3.335; Dixon MJ, 2000, NATURE, V406, P365, DOI 10.1038/35019148; Eagleman DM, 2007, J NEUROSCI METH, V159, P139, DOI 10.1016/j.jneumeth.2006.07.012; Edquist J, 2006, CORTEX, V42, P222, DOI 10.1016/S0010-9452(08)70347-2; Flournoy T, 1893, PHENOMENES SYNOPSIE; FRANZON M, 1987, CORTEX, V23, P615, DOI 10.1016/S0010-9452(87)80052-7; Hupe JM, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00103; Hupe JM, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00018; Hupe JM, 2012, CEREB CORTEX, V22, P1622, DOI 10.1093/cercor/bhr236; James KH, 2005, COGN AFFECT BEHAV NE, V5, P452, DOI 10.3758/CABN.5.4.452; Josse G, 2004, BRAIN RES REV, V44, P1, DOI 10.1016/j.brainresrev.2003.10.001; Levy J, 2008, NEUROIMAGE, V43, P581, DOI 10.1016/j.neuroimage.2008.08.008; MACLEOD CM, 1991, PSYCHOL BULL, V109, P163, DOI 10.1037/0033-2909.109.2.163; Mattingley JB, 2001, NATURE, V410, P580, DOI 10.1038/35069062; Neufeld J, 2012, NEUROPSYCHOLOGIA, V50, P85, DOI 10.1016/j.neuropsychologia.2011.11.001; Nunn JA, 2002, NAT NEUROSCI, V5, P371, DOI 10.1038/nn818; Price GR, 2011, NEUROIMAGE, V57, P1205, DOI 10.1016/j.neuroimage.2011.05.035; Price MC, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00689; Price MC, 2013, CORTEX, V49, P1165, DOI 10.1016/j.cortex.2012.10.013; Ramachandran VS, 2001, P ROY SOC B-BIOL SCI, V268, P979, DOI 10.1098/rspb.2000.1576; Rasmussen T, 1977, Ann N Y Acad Sci, V299, P355, DOI 10.1111/j.1749-6632.1977.tb41921.x; Rich AN, 2013, COGN NEUROPSYCHOL, V30, P110, DOI 10.1080/02643294.2013.805686; Rothen N, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00109; Rothen N, 2013, CONSCIOUS COGN, V22, P1047, DOI 10.1016/j.concog.2013.07.005; Rouw R, 2007, NAT NEUROSCI, V10, P792, DOI 10.1038/nn1906; SATZ P, 1979, SCIENCE, V203, P1131, DOI 10.1126/science.424744; Shum J, 2013, J NEUROSCI, V33, P6709, DOI 10.1523/JNEUROSCI.4558-12.2013; Simner J, 2006, PERCEPTION, V35, P1024, DOI 10.1068/p5469; Simner J, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00603; Simner J, 2009, BRAIN, V132, P57, DOI 10.1093/brain/awn292; Starrfelt R, 2011, NEUROPSYCHOLOGIA, V49, P2283, DOI 10.1016/j.neuropsychologia.2011.04.028; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Suarez de Mendoza F, 1890, AUDITION COLOREE ETU; Toga AW, 2003, NAT REV NEUROSCI, V4, P37, DOI 10.1038/nrn1009; Turkeltaub PE, 2008, ANN NY ACAD SCI, V1145, P13, DOI 10.1196/annals.1416.026; Vinckier F, 2007, NEURON, V55, P143, DOI 10.1016/j.neuron.2007.05.031; Ward J, 2007, CONSCIOUS COGN, V16, P913, DOI 10.1016/j.concog.2006.09.012; Witthoft N, 2006, CORTEX, V42, P175, DOI 10.1016/S0010-9452(08)70342-3; Witthoft N, 2013, PSYCHOL SCI, V24, P258, DOI 10.1177/0956797612452573	54	5	5	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0119377	10.1371/journal.pone.0119377	http://dx.doi.org/10.1371/journal.pone.0119377			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25793307	Green Submitted, gold, Green Published			2022-12-27	WOS:000352084200077
J	Simon, E; Guerrero, I				Simon, Eleanor; Guerrero, Isabel			The Transcription Factor Optomotor-Blind Antagonizes Drosophila Haltere Growth by Repressing Decapentaplegic and Hedgehog Targets	PLOS ONE			English	Article							HOX GENE ULTRABITHORAX; BITHORAX COMPLEX; WING DEVELOPMENT; DNA-BINDING; DPP; EXPRESSION; PROTEIN; BRINKER; MORPHOGENESIS; IDENTIFICATION	Drosophila, decapentaplegic, which codes for a secreted signaling molecule, is activated by the Hedgehog signaling pathway at the anteroposterior compartment border of the two dorsal primordia; the wing and the haltere imaginal discs. In the wing disc, Decapentaplegic and Hedgehog signaling targets are implicated in cell proliferation and cell survival. However, most of their known targets in the wing disc are not expressed in the haltere disc due to their repression by the Hox gene Ultrabithorax. The T-box gene optomotor-blind escapes this repression in the haltere disc, and therefore is expressed in both the haltere and wing discs. Optomotor-blind is a major player during wing development and its function has been intensely investigated in this tissue, however, its role in haltere development has not been reported so far. Here we show that Optomotor-blind function in the haltere disc differs from that in the wing disc. Unlike its role in the wing, Optomotor-blind does not prevent apoptosis in the haltere but rather limits growth by repressing several Decapentaplegic and Hedgehog targets involved both in wing proliferation and in modulating the spread of morphogens similar to Ultrabithorax function but without disturbing Ultrabithorax expression.	[Simon, Eleanor] CSIC, Ctr Biol Mol Severo Ochoa, Madrid, Spain; Univ Autonoma Madrid, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); Autonomous University of Madrid	Simon, E (corresponding author), CSIC, Ctr Biol Mol Severo Ochoa, Madrid, Spain.	esimon@cbm.csic.es; iguerrero@cbm.csic.es	Guerrero, Isabel/K-2518-2014	Guerrero, Isabel/0000-0001-6761-1218	Spanish Ministry of Economy and Commutativity [BFU2011-25987, CDS 2007-00008]; Initial Training Networks (ITN) - Marie Curie Actions (ITN) [238186]; Fundacion Ramon Areces	Spanish Ministry of Economy and Commutativity; Initial Training Networks (ITN) - Marie Curie Actions (ITN); Fundacion Ramon Areces	Funding: This work was supported by grants Biologia Fundamental (BFU2011-25987) and Consolider Program (CDS 2007-00008) from the Spanish Ministry of Economy and Commutativity (http://www.mineco.gob.es), by Initial Training Networks (ITN) - Marie Curie Actions (ITN 238186) (http://ec.europa.eu/research/mariecurieactions/about-mca/actions/itn/indexen.htm) and by an institutional grant to Centro Biologia Molecular "Severo Ochoa" from the Fundacion Ramon Areces (http://fundacionareces.es/fundacionareces). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi-Yamada T, 1999, NATURE, V400, P166, DOI 10.1038/22112; Barrio R, 1999, DEV BIOL, V215, P33, DOI 10.1006/dbio.1999.9434; Burke R, 1996, DEVELOPMENT, V122, P2261; Calleja M, 1996, SCIENCE, V274, P252, DOI 10.1126/science.274.5285.252; Campbell G, 1999, CELL, V96, P553, DOI 10.1016/S0092-8674(00)80659-5; CAPDEVILA J, 1994, EMBO J, V13, P71, DOI 10.1002/j.1460-2075.1994.tb06236.x; Crickmore MA, 2007, DEVELOPMENT, V134, P327, DOI 10.1242/dev.02737; de Navas L, 2006, MECH DEVELOP, V123, P860, DOI 10.1016/j.mod.2006.07.010; de Navas LF, 2006, DEVELOPMENT, V133, P4495, DOI 10.1242/dev.02609; de Navas LF, 2011, DEVELOPMENT, V138, P107, DOI 10.1242/dev.051409; deCelis JF, 1996, NATURE, V381, P421, DOI 10.1038/381421a0; Galant R, 2002, DEVELOPMENT, V129, P3115; GomezSkarmeta JL, 1996, CELL, V85, P95, DOI 10.1016/S0092-8674(00)81085-5; Grimm S, 1996, SCIENCE, V271, P1601, DOI 10.1126/science.271.5255.1601; HINZ U, 1994, CELL, V76, P77, DOI 10.1016/0092-8674(94)90174-0; Jazwinska A, 1999, CELL, V96, P563, DOI 10.1016/S0092-8674(00)80660-1; Kim J, 1996, NATURE, V382, P133, DOI 10.1038/382133a0; Krzemien J, 2007, NATURE, V446, P325, DOI 10.1038/nature05650; Lecuit T, 1996, NATURE, V381, P387, DOI 10.1038/381387a0; LEWIS EB, 1978, NATURE, V276, P565, DOI 10.1038/276565a0; LEWIS EB, 1963, AM ZOOL, V3, P33; Lin XH, 2004, DEVELOPMENT, V131, P6009, DOI 10.1242/dev.01522; Makhijani K, 2007, DEV BIOL, V302, P243, DOI 10.1016/j.ydbio.2006.09.029; Mann RS, 2009, CURR TOP DEV BIOL, V88, P63, DOI 10.1016/S0070-2153(09)88003-4; Martin-Blanco E, 1998, GENE DEV, V12, P557, DOI 10.1101/gad.12.4.557; Minami M, 1999, NATURE, V398, P242, DOI 10.1038/18451; NAKATO H, 1995, DEVELOPMENT, V121, P3687; Pavlopoulos A, 2011, P NATL ACAD SCI USA, V108, P2855, DOI 10.1073/pnas.1015077108; PFLUGFELDER GO, 1990, GENETICS, V126, P91; PFLUGFELDER GO, 1992, BIOCHEM BIOPH RES CO, V186, P918, DOI 10.1016/0006-291X(92)90833-7; Reim I, 2003, DEVELOPMENT, V130, P3187, DOI 10.1242/dev.00548; Rodriguez DD, 2004, DEV BIOL, V268, P481, DOI 10.1016/j.ydbio.2004.01.005; Sanchez J, 2011, BIOCHEM J, V438, P437, DOI 10.1042/BJ20110229; Sivasankaran R, 2000, EMBO J, V19, P6162, DOI 10.1093/emboj/19.22.6162; STAEHLINGHAMPTON K, 1994, CELL GROWTH DIFFER, V5, P585; Sui LY, 2012, DEVELOPMENT, V139, P2773, DOI 10.1242/dev.079384; SUN YH, 1995, GENETICS, V141, P1075; Szuperak M, 2011, DEVELOPMENT, V138, P715, DOI 10.1242/dev.059477; Umemori M, 2007, DEV BIOL, V308, P68, DOI 10.1016/j.ydbio.2007.05.007; Vervoort M, 1999, CURR BIOL, V9, P632, DOI 10.1016/S0960-9822(99)80285-1; WAGNERBERNHOLZ JT, 1991, GENE DEV, V5, P2467, DOI 10.1101/gad.5.12b.2467; Weatherbee SD, 1998, GENE DEV, V12, P1474, DOI 10.1101/gad.12.10.1474; WHITE RAH, 1984, CELL, V39, P163, DOI 10.1016/0092-8674(84)90202-2; Zecca M, 2007, DEVELOPMENT, V134, P3001, DOI 10.1242/dev.006411; Zhang XB, 2013, DEVELOPMENT, V140, P2917, DOI 10.1242/dev.094300	45	7	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0121239	10.1371/journal.pone.0121239	http://dx.doi.org/10.1371/journal.pone.0121239			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25793870	Green Published, Green Submitted, gold			2022-12-27	WOS:000352083900116
J	Wendt, A; Stephenson, R; Young, M; Webb-Girard, A; Hogue, C; Ramakrishnan, U; Martorell, R				Wendt, Amanda; Stephenson, Rob; Young, Melissa; Webb-Girard, Amy; Hogue, Carol; Ramakrishnan, Usha; Martorell, Reynaldo			Individual and Facility-Level Determinants of Iron and Folic Acid Receipt and Adequate Consumption among Pregnant Women in Rural Bihar, India	PLOS ONE			English	Article							REPRODUCTIVE HEALTH OUTCOMES; CONTEXTUAL INFLUENCES; EARLY MARRIAGE; ANEMIA; CARE; SUPPLEMENTATION; DEFICIENCY; PRADESH	Background In Bihar, India, high maternal anemia prevalence and low iron and folic acid supplement (IFA) receipt and consumption have continued over time despite universal IFA distribution and counseling during pregnancy. Purpose To examine individual and facility-level determinants of IFA receipt and consumption among pregnant women in rural Bihar, India. Methods Using District Level Household Survey (2007-08) data, multilevel modeling was conducted to examine the determinants of two outcomes: IFA receipt (any IFA receipt vs. none) and IFA consumption (>= 90 days vs. <90 days). Individual-level and facility-level factors were included. Factor analysis was utilized to construct antenatal care (ANC) quality and health sub-center (HSC) capacity variables. Results Overall, 37% of women received any IFA during their last pregnancy. Of those, 24% consumed IFA for 90 or more days. Women were more likely to receive any IFA when they received additional ANC services and counseling, and attended ANC earlier and more frequently. Significant interactions were found between ANC quality factors (odds ratio (OR): 0.37, 95% confidence interval (CI): 0.25, 0.56) and between ANC services and ANC timing and frequency (OR: 0.68, 95% CI: 0.56, 0.82). No HSC factors were significantly associated with IFA receipt. Women were more likely to consume IFA for >= 90 days if they attended at least 4 ANC check-ups and received more ANC services. IFA supply at the HSC (OR: 1.37, 95% CI: 1.04, 1.82) was also significantly associated with IFA consumption. Conclusions Our findings indicate that individual and ANC factors (timing, frequency, and quality) play a key role in facilitating IFA receipt and consumption. Although HSC capacity factors were not found to influence our outcomes, significant variation at the facility level indicates unmeasured factors that could be important to address in future interventions.	[Wendt, Amanda; Webb-Girard, Amy; Ramakrishnan, Usha; Martorell, Reynaldo] Emory Univ, Div Biol & Biomed Sci, Nutr & Hlth Sci, Atlanta, GA 30322 USA; [Wendt, Amanda] Heidelberg Univ, Inst Publ Hlth, Epidemiol & Biostat Unit, Heidelberg, Germany; [Stephenson, Rob; Young, Melissa; Webb-Girard, Amy; Ramakrishnan, Usha; Martorell, Reynaldo] Emory Univ, Hubert Dept Global Hlth, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA; [Hogue, Carol] Emory Univ, Rollins Sch Publ Hlth, Dept Epidemiol, Atlanta, GA 30322 USA	Emory University; Ruprecht Karls University Heidelberg; Emory University; Rollins School Public Health; Emory University; Rollins School Public Health	Wendt, A (corresponding author), Emory Univ, Div Biol & Biomed Sci, Nutr & Hlth Sci, Atlanta, GA 30322 USA.	awendt@alum.emory.edu	Webb Girard, Amy/J-7999-2013; Ramakrishnan, Usha/L-8921-2016; Martorell, Reynaldo/I-2539-2012	Wendt, Amanda/0000-0001-6019-1900	Bill & Melinda Gates Foundation [0000011951]; CARE-India (Cooperative for Assistance and Relief Everywhere); Integrated Family Health Initiative in Bihar, India; T-32 Reproductive, Perinatal, Pediatric Predoctoral National Institute of Health [2T32HD052460]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD052460] Funding Source: NIH RePORTER	Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); CARE-India (Cooperative for Assistance and Relief Everywhere); Integrated Family Health Initiative in Bihar, India; T-32 Reproductive, Perinatal, Pediatric Predoctoral National Institute of Health; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Funding support was provided by a Bill & Melinda Gates Foundation grant (#0000011951) through a subcontract with CARE-India (Cooperative for Assistance and Relief Everywhere) and the Integrated Family Health Initiative in Bihar, India. (www.careindia.org; RM), and T-32 Reproductive, Perinatal, Pediatric Predoctoral National Institute of Health Grant # 2T32HD052460. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGARWAL D K, 1988, Indian Pediatrics, V25, P319; Aikawa R, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-144; Allen LH, 2000, AM J CLIN NUTR, V71, p1280S, DOI 10.1093/ajcn/71.5.1280s; [Anonymous], 2001, IRON DEFICIENCY ANAE; [Anonymous], 2010, GUID ANT CAR SKILL A; [Anonymous], 2007, RAM P 7 11 1 AN NUTR, P268; Balarajan Y, 2011, LANCET, V378, P2123, DOI 10.1016/S0140-6736(10)62304-5; Barroso F, 2011, EUR J OBSTET GYN R B, V159, P99, DOI 10.1016/j.ejogrb.2011.07.041; Barua A, 2001, REPROD HEALTH MATTER, V9, P53, DOI 10.1016/S0968-8080(01)90008-4; Black RE, 2008, LANCET, V371, P243, DOI 10.1016/S0140-6736(07)61690-0; Bloom SS, 2001, DEMOGRAPHY, V38, P67, DOI 10.1353/dem.2001.0001; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Delaney KP, 2013, COLLINEARITY MACRO S; Ezzati M, 2002, LANCET, V360, P1347, DOI 10.1016/S0140-6736(02)11403-6; Gage AJ, 2007, SOC SCI MED, V65, P1666, DOI 10.1016/j.socscimed.2007.06.001; GALLOWAY R, 1994, SOC SCI MED, V39, P381, DOI 10.1016/0277-9536(94)90135-X; Galloway R, 2002, SOC SCI MED, V55, P529, DOI 10.1016/S0277-9536(01)00185-X; Godha D, 2013, J ADOLESCENT HEALTH, V52, P552, DOI 10.1016/j.jadohealth.2013.01.021; Haider BA, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f3443; Haverkate M, 2014, J EPIDEMIOL COMMUN H, V68, P116, DOI 10.1136/jech-2012-202336; Hazarika I, 2011, MATERN CHILD HLTH J, V15, P1381, DOI 10.1007/s10995-010-0687-3; International Institute for Population Sciences (IIPS), FACILITY SURVEY UNDE; International Institute for Population Sciences (IIPS), 2010, DISTR LEV HOUS FAC S, DOI [10.1371/journal.pone.0071584, DOI 10.1371/JOURNAL.PONE.0071584]; International Institute for Population Sciences (IIPS), KEY IND BIH NFHS 3; International Institute for Population Sciences (IIPS) and Macro International, 2007, NAT FAM HLTH SURV NF; International institute for Population Sciences (IIPS) Ministry of Health & Family Welfare, FAC SURV REPR CHILD; Jat TR, 2011, INT J EQUITY HEALTH, V10, DOI 10.1186/1475-9276-10-59; Kapil U, 1996, HLTH POPULATION PERS, V19, P19; Kwon HJ, 2013, ASIA PACIFIC J PUBLI; Lacerte P, 2011, ASIA-PAC J PUBLIC HE, V23, P315, DOI 10.1177/1010539511403133; Malagi Usha, 2006, Journal of Human Ecology, V20, P279; Masters SH, 2013, SOC SCI MED, V93, P147, DOI 10.1016/j.socscimed.2013.06.012; Ministry of Health and Family Welfare, 2013, GUID CONTR IR DEF AN; Ministry of Health & Family Welfare, 2005, CHILD HLTH PROGR IND; Ministry of Health & Family Welfare Government of India, 2012, IND PUBL HLTH STAND; Ministry of Health & Family Welfare Government of India, 2007, NAT RUR HLTH MISS; National Rural Health Mission Ministry of Health & Family Welfare Government of India, 2007, MONTHL VILL HLTH NUT; Nayar KR, 2007, INDIAN J MED RES, V126, P355; Holgado-Tello FP, 2010, QUAL QUANT, V44, P153, DOI 10.1007/s11135-008-9190-y; Pasricha SR, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-617; Pena-Rosas JP, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004736.pub4; Rani M, 2008, INT J QUAL HEALTH C, V20, P62, DOI 10.1093/intqhc/mzm052; Roy M. P., 2013, National Journal of Community Medicine, V4, P386; Sabarwal S, 2012, PAEDIATR PERINAT EP, V26, P77, DOI 10.1111/j.1365-3016.2011.01227.x; Santhya KG, 2011, CURR OPIN OBSTET GYN, V23, P334, DOI 10.1097/GCO.0b013e32834a93d2; Santhya KG, 2010, INT PERSPECT SEX R H, V36, P132, DOI 10.1363/ipsrh.36.132.10; Santhya KG, 2008, EARLY MARRIAGE SEXUA; Seck BC, 2008, PUBLIC HEALTH NUTR, V11, P596, DOI 10.1017/S1368980007000924; Singh Manish K, 2010, Indian J Community Med, V35, P414, DOI 10.4103/0970-0218.69272; Singh PK, 2013, HLTH POLICY PLANNING; Singh PK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031666; State Health Society National Rural Health Mission Government of Bihar, 2011, CONS REV NRHM STAT P; Stephenson R, 2006, AM J PUBLIC HEALTH, V96, P84, DOI 10.2105/AJPH.2004.057422; Stephenson R, 2002, STUD FAMILY PLANN, V33, P309, DOI 10.1111/j.1728-4465.2002.00309.x; Stoltzfus RJ., 2004, COMP QUANTIFICATION, pp. 163; Sugathan KS, 2001, PROMOTING I DELIVERI; UNICEF, 2010, COV EV SURV BIH FACT; Vijayaraghavan K, 1990, Indian J Pediatr, V57, P183, DOI 10.1007/BF02722084; Villar J., 2001, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000934; Vogel JP, 2013, REPROD HEALTH, V10, DOI 10.1186/1742-4755-10-19; Worku AG, 2013, BMC INT HEALTH HUM R, V13, DOI 10.1186/1472-698X-13-20; World Health Organization, 2008, WORLDWIDE PREVALENCE, DOI [10.1017/S1368980008002401, DOI 10.1017/S1368980008002401]; World Health Organization, 2002, WHO ANT CAR RAND TRI; Yip R, 2002, J NUTR, V132, p859S, DOI 10.1093/jn/132.4.859S	64	22	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0120404	10.1371/journal.pone.0120404	http://dx.doi.org/10.1371/journal.pone.0120404			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25793866	gold, Green Published, Green Submitted			2022-12-27	WOS:000352083900026
J	Zhang, X; Lei, DS; Zhang, L; Rames, M; Zhang, SL				Zhang, Xing; Lei, Dongsheng; Zhang, Lei; Rames, Matthew; Zhang, Shengli			A Model of Lipid-Free Apolipoprotein A-I Revealed by Iterative Molecular Dynamics Simulation	PLOS ONE			English	Article							HIGH-DENSITY-LIPOPROTEINS; RESONANCE ENERGY-TRANSFER; COMPUTATIONAL-EXPERIMENTAL-APPROACH; STRUCTURAL ORGANIZATION; APOA-I; SECONDARY STRUCTURE; FLUORESCENCE PROBE; DOMAIN-STRUCTURE; STABILITY; CONFORMATION	Apolipoprotein A-I (apo A-I), the major protein component of high-density lipoprotein, has been proven inversely correlated to cardiovascular risk in past decades. The lipid-free state of apo A-I is the initial stage which binds to lipids forming high-density lipoprotein. Molecular models of lipid-free apo A-I have been reported by methods like X-ray crystallography and chemical cross-linking/mass spectrometry (CCL/MS). Through structural analysis we found that those current models had limited consistency with other experimental results, such as those from hydrogen exchange with mass spectrometry. Through molecular dynamics simulations, we also found those models could not reach a stable equilibrium state. Therefore, by integrating various experimental results, we proposed a new structural model for lipidfree apo A-I, which contains a bundled four-helix N-terminal domain (1-192) that forms a variable hydrophobic groove and a mobile short hairpin C-terminal domain (193-243). This model exhibits an equilibrium state through molecular dynamics simulation and is consistent with most of the experimental results known from CCL/MS on lysine pairs, fluorescence resonance energy transfer and hydrogen exchange. This solution-state lipid-free apo A-I model may elucidate the possible conformational transitions of apo A-I binding with lipids in high-density lipoprotein formation.	[Zhang, Xing; Lei, Dongsheng; Zhang, Shengli] Xi An Jiao Tong Univ, Dept Appl Phys, Xian 710049, Shaanxi, Peoples R China; [Zhang, Xing; Lei, Dongsheng; Zhang, Lei; Rames, Matthew] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Mat Sci, Mol Foundry, Berkeley, CA 94720 USA	Xi'an Jiaotong University; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Zhang, SL (corresponding author), Xi An Jiao Tong Univ, Dept Appl Phys, Xian 710049, Shaanxi, Peoples R China.	zhangsl@mail.xjtu.edu.cn	Lei, Dongsheng/AAH-4177-2020; Zhang, Lei/G-6427-2012; Lei, Dongsheng/K-3485-2012	Zhang, Lei/0000-0002-4880-824X; Lei, Dongsheng/0000-0003-1640-0693	National Nature Science Foundation of China [11374237]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	The research was funded by National Nature Science Foundation of China (No. 11374237). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agree AKB, 2002, BBA-PROTEIN STRUCT M, V1594, P286, DOI 10.1016/S0167-4838(01)00317-X; Barter P, 2007, NEW ENGL J MED, V357, P1301, DOI 10.1056/NEJMoa064278; Beckstead JA, 2005, BIOCHEMISTRY-US, V44, P4591, DOI 10.1021/bi0477135; Bhat S, 2007, BIOCHEMISTRY-US, V46, P7811, DOI 10.1021/bi700384t; Borhani DW, 1997, P NATL ACAD SCI USA, V94, P12291, DOI 10.1073/pnas.94.23.12291; Borhani DW, 1999, ACTA CRYSTALLOGR D, V55, P1578, DOI 10.1107/S0907444999008914; Brouillette CG, 2005, BIOCHEMISTRY-US, V44, P16413, DOI 10.1021/bi051018v; Catte A, 2008, BIOPHYS J, V94, P3361; Catte A, 2006, BIOPHYS J, V90, P4345, DOI 10.1529/biophysj.105.071456; Caves LSD, 1998, PROTEIN SCI, V7, P649, DOI 10.1002/pro.5560070314; Chetty PS, 2009, P NATL ACAD SCI USA, V106, P19005, DOI 10.1073/pnas.0909708106; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Davidson WS, 2005, CURR OPIN LIPIDOL, V16, P295, DOI 10.1097/01.mol.0000169349.38321.ad; Davidson WS, 1999, BIOCHEMISTRY-US, V38, P14387, DOI 10.1021/bi991428h; Deng XD, 2012, STRUCTURE, V20, P767, DOI 10.1016/j.str.2012.02.020; FELLER SE, 1995, J CHEM PHYS, V103, P4613, DOI 10.1063/1.470648; Frank PG, 2000, J LIPID RES, V41, P853; Gogonea V, 2010, BIOCHEMISTRY-US, V49, P7323, DOI 10.1021/bi100588a; GREST GS, 1986, PHYS REV A, V33, P3628, DOI 10.1103/PhysRevA.33.3628; Gu FF, 2010, J BIOL CHEM, V285, P4652, DOI 10.1074/jbc.M109.069914; Gursky O, 2012, BIOCHEMISTRY; Hatters DM, 2006, TRENDS BIOCHEM SCI, V31, P445, DOI 10.1016/j.tibs.2006.06.008; Huang R, 2011, NAT STRUCT MOL BIOL, V18, P416, DOI 10.1038/nsmb.2028; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jones MK, 2010, J BIOL CHEM, V285, P41161, DOI 10.1074/jbc.M110.187799; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kale L, 1999, J COMPUT PHYS, V151, P283, DOI 10.1006/jcph.1999.6201; Koyama M, 2009, BIOCHEMISTRY-US, V48, P2529, DOI 10.1021/bi802317v; Kumar S, 1999, J MOL BIOL, V293, P1241, DOI 10.1006/jmbi.1999.3218; Lagerstedt JO, 2012, BIOCH BIOPHYSICA ACT; Li HH, 2000, J BIOL CHEM, V275, P37048, DOI 10.1074/jbc.M005336200; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Marcel YL, 2003, CURR OPIN LIPIDOL, V14, P151, DOI 10.1097/00041433-200304000-00006; Miyazaki O, 2014, J LIPID RES, V55, P214, DOI 10.1194/jlr.M041038; Okon M, 2002, FEBS LETT, V517, P139, DOI 10.1016/S0014-5793(02)02600-5; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Roberts LM, 1997, BIOCHEMISTRY-US, V36, P7615, DOI 10.1021/bi962952g; Rogers DP, 1998, BIOCHEMISTRY-US, V37, P945, DOI 10.1021/bi9713512; Rogers DP, 1997, BIOCHEMISTRY-US, V36, P288, DOI 10.1021/bi961876e; Rye KA, 2004, ARTERIOSCL THROM VAS, V24, P421, DOI 10.1161/01.ATV.0000104029.74961.f5; Saito H, 2004, PROG LIPID RES, V43, P350, DOI 10.1016/j.plipres.2004.05.002; Saito H, 2004, J BIOL CHEM, V279, P20974, DOI 10.1074/jbc.M402043200; Saito H, 2003, J BIOL CHEM, V278, P23227, DOI 10.1074/jbc.M303365200; Segrest JP, 1999, J BIOL CHEM, V274, P31755, DOI 10.1074/jbc.274.45.31755; Segrest JP, 2000, CURR OPIN LIPIDOL, V11, P105, DOI 10.1097/00041433-200004000-00002; SEGREST JP, 1992, J LIPID RES, V33, P141; Shen MY, 2006, PROTEIN SCI, V15, P2507, DOI 10.1110/ps.062416606; Shih AY, 2008, BIOPHYS J, V94, pL87, DOI 10.1529/biophysj.108.131581; Shih AY, 2007, J STRUCT BIOL, V157, P579, DOI 10.1016/j.jsb.2006.08.006; Shih AY, 2009, J R SOC INTERFACE, V6, P863, DOI 10.1098/rsif.2009.0173; Silva RAGD, 2008, ARTERIOSCL THROM VAS, V28, pE64; Silva RAGD, 2008, ANN MED, V40, P5, DOI 10.1080/07853890701687201; Silva RAGD, 2005, BIOCHEMISTRY-US, V44, P2759, DOI 10.1021/bi047717+; Tanaka M, 2006, BIOCHEMISTRY-US, V45, P10351, DOI 10.1021/bi060726t; Thomas MJ, 2008, J LIPID RES, V49, P1875, DOI 10.1194/jlr.R800010-JLR200; Tricerri MA, 2000, BIOCHEMISTRY-US, V39, P14682, DOI 10.1021/bi0014251; Tricerri MA, 2001, BIOCHEMISTRY-US, V40, P5065, DOI 10.1021/bi002815q; Vaughan AM, 2009, J LIPID RES, V50, P285, DOI 10.1194/jlr.M800366-JLR200; Wu ZP, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.209130; Wu ZP, 2009, J BIOL CHEM, V284, P36605, DOI 10.1074/jbc.M109.039537	61	5	5	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0120233	10.1371/journal.pone.0120233	http://dx.doi.org/10.1371/journal.pone.0120233			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25793886	Green Published, gold, Green Submitted			2022-12-27	WOS:000352084200164
J	Zhou, WB; Karcher, D; Fischer, A; Maximova, E; Walther, D; Bock, R				Zhou, Wenbin; Karcher, Daniel; Fischer, Axel; Maximova, Eugenia; Walther, Dirk; Bock, Ralph			Multiple RNA Processing Defects and Impaired Chloroplast Function in Plants Deficient in the Organellar Protein-Only RNase P Enzyme	PLOS ONE			English	Article							PHOTOSYSTEM-I; ARABIDOPSIS-THALIANA; MESSENGER-RNA; TOBACCO; RECONSTITUTION; IDENTIFICATION; MITOCHONDRIA; NUCLEOTIDE; EXPRESSION; NUCLEUS	Transfer RNA (tRNA) precursors undergo endoribonucleolytic processing of their 5' and 3' ends. 5' cleavage of the precursor transcript is performed by ribonuclease P (RNase P). While in most organisms RNase P is a ribonucleoprotein that harbors a catalytically active RNA component, human mitochondria and the chloroplasts (plastids) and mitochondria of seed plants possess protein-only RNase P enzymes (PRORPs). The plant organellar PRORP (PRORP1) has been characterized to some extent in vitro and by transient gene silencing, but the molecular, phenotypic and physiological consequences of its down-regulation in stable transgenic plants have not been assessed. Here we have addressed the function of the dually targeted organellar PRORP enzyme in vivo by generating stably transformed Arabidopsis plants in which expression of the PRORP1 gene was suppressed by RNA interference (RNAi). PRORP1 knock-down lines show defects in photosynthesis, while mitochondrial respiration is not appreciably affected. In both plastids and mitochondria, the effects of PRORP1 knock-down on the processing of individual tRNA species are highly variable. The drastic reduction in the levels of mature plastid tRNA-Phe(GAA) and tRNA-Arg (ACG) suggests that these two tRNA species limit plastid gene expression in the PRORP1 mutants and, hence, are causally responsible for the mutant phenotype.	[Zhou, Wenbin; Karcher, Daniel; Fischer, Axel; Maximova, Eugenia; Walther, Dirk; Bock, Ralph] Max Planck Inst Mol Pflanzenphysiol, Potsdam, Germany	Max Planck Society	Bock, R (corresponding author), Max Planck Inst Mol Pflanzenphysiol, Potsdam, Germany.	rbock@mpimp-golm.mpg.de	Bock, Ralph/B-4352-2009	Bock, Ralph/0000-0001-7502-6940; Walther, Dirk/0000-0002-5755-9265; Zhou, Wenbin/0000-0001-5911-1686; Karcher, Daniel/0000-0001-6393-7376; Fischer, Axel/0000-0001-6130-6984	Deutsche Forschungsgemeinschaft [FOR 804, BO 1482/15-2]; Max Planck Society	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Max Planck Society(Max Planck SocietyFoundation CELLEX)	This work was supported by a grant from the Deutsche Forschungsgemeinschaft (FOR 804, BO 1482/15-2) to RB and by the Max Planck Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agris PF, 2007, J MOL BIOL, V366, P1, DOI 10.1016/j.jmb.2006.11.046; Albus CA, 2010, PLANT CELL, V22, P2838, DOI 10.1105/tpc.110.073908; Alkatib S, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003076; ALTMAN S, 1995, BIO-TECHNOL, V13, P327, DOI 10.1038/nbt0495-327; BARKAN A, 1993, PLANT CELL, V5, P389, DOI 10.1105/tpc.5.4.389; Baum M, 1996, J MOL BIOL, V257, P43, DOI 10.1006/jmbi.1996.0145; Beeckman T, 2000, BIOTECH HISTOCHEM, V75, P23, DOI 10.3109/10520290009047981; BURGIN AB, 1990, EMBO J, V9, P4111, DOI 10.1002/j.1460-2075.1990.tb07633.x; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Cognat V, 2013, NUCLEIC ACIDS RES, V41, pD273, DOI 10.1093/nar/gks935; Delannoy E, 2009, PLANT CELL, V21, P2058, DOI 10.1105/tpc.109.066654; Doyle JJ, 1987, PHYTOCHEM B, V19, P11, DOI 10.1016/j.bse.2009.07.003; Duchene AM, 2009, CURR GENET, V55, P1, DOI 10.1007/s00294-008-0223-9; Fleischmann TT, 2011, PLANT CELL, V23, P3137, DOI 10.1105/tpc.111.088906; Forner J, 2007, NUCLEIC ACIDS RES, V35, P3676, DOI 10.1093/nar/gkm270; Giege P, 1999, P NATL ACAD SCI USA, V96, P15324, DOI 10.1073/pnas.96.26.15324; Gobert A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2358; Gobert A, 2010, NAT STRUCT MOL BIOL, V17, P740, DOI 10.1038/nsmb.1812; Gutmann B, 2012, GENE DEV, V26, P1022, DOI 10.1101/gad.189514.112; Hausler RE, 2009, PLANT PHYSIOL, V149, P515, DOI 10.1104/pp.108.128124; Hager M, 2002, J BIOL CHEM, V277, P14031, DOI 10.1074/jbc.M112053200; Helm M, 2006, NUCLEIC ACIDS RES, V34, P721, DOI 10.1093/nar/gkj471; Hilson P, 2004, GENOME RES, V14, P2176, DOI 10.1101/gr.2544504; Holzmann J, 2008, CELL, V135, P462, DOI 10.1016/j.cell.2008.09.013; Hricova A, 2006, PLANT PHYSIOL, V141, P942, DOI 10.1104/pp.106.080069; Karcher D, 2009, RNA, V15, P1251, DOI 10.1261/rna.1600609; Karimi M, 2002, TRENDS PLANT SCI, V7, P193, DOI 10.1016/S1360-1385(02)02251-3; KIRSEBOM LA, 1995, MOL MICROBIOL, V17, P411, DOI 10.1111/j.1365-2958.1995.mmi_17030411.x; KIRSEBOM LA, 1994, EMBO J, V13, P4870, DOI 10.1002/j.1460-2075.1994.tb06814.x; Knoop V, 2004, CURR GENET, V46, P123, DOI 10.1007/s00294-004-0522-8; Krech K, 2012, PLANT PHYSIOL, V159, P579, DOI 10.1104/pp.112.196642; Kubo T, 2007, PHYSIOL PLANTARUM, V129, P6, DOI 10.1111/j.1399-3054.2006.00768.x; Li D, 2007, BIOCHIMIE, V89, P1528, DOI 10.1016/j.biochi.2007.08.004; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; LICHTENTHALER HK, 1987, METHOD ENZYMOL, V148, P350; LIU FY, 1994, CELL, V77, P1093, DOI 10.1016/0092-8674(94)90448-0; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lohmann A, 2006, J BIOL CHEM, V281, P40461, DOI 10.1074/jbc.M609412200; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Pascual A, 1999, FEBS LETT, V442, P7, DOI 10.1016/S0014-5793(98)01621-4; Phizicky EM, 2010, FEBS LETT, V584, P265, DOI 10.1016/j.febslet.2009.11.049; Preuten T, 2010, PLANT J, V64, P948, DOI 10.1111/j.1365-313X.2010.04389.x; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Randau L, 2008, NATURE, V453, P120, DOI 10.1038/nature06833; Reardon EM, 1995, PLANT MOL BIOL REP, V13, P320, DOI 10.1007/BF02669185; Schottler MA, 2007, J BIOL CHEM, V282, P976, DOI 10.1074/jbc.M606436200; Sugita C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108962; Tiller N, 2012, PLANT J, V69, P302, DOI 10.1111/j.1365-313X.2011.04791.x; Walter M, 2010, PLANT J, V64, P851, DOI 10.1111/j.1365-313X.2010.04377.x; WANG MJ, 1988, EMBO J, V7, P1567, DOI 10.1002/j.1460-2075.1988.tb02981.x; WITTIG B, 1978, NUCLEIC ACIDS RES, V5, P1165, DOI 10.1093/nar/5.4.1165; Wycliffe P, 2005, PLANT J, V44, P1, DOI 10.1111/j.1365-313X.2005.02482.x; YUAN Y, 1994, SCIENCE, V263, P1269, DOI 10.1126/science.8122108; Zhou WB, 2013, NUCLEIC ACIDS RES, V41, P3362, DOI 10.1093/nar/gkt013	54	15	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0120533	10.1371/journal.pone.0120533	http://dx.doi.org/10.1371/journal.pone.0120533			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25793367	Green Published, Green Submitted, gold			2022-12-27	WOS:000352083900049
J	Mora, DJ; Fortunato, LR; Andrade-Silva, LE; Ferreira-Paim, K; Rocha, IH; Vasconcelos, RR; Silva-Teixeira, DN; Nascentes, GAN; Silva-Vergara, ML				Mora, Delio Jose; Fortunato, Laila Rigolin; Andrade-Silva, Leonardo Euripedes; Ferreira-Paim, Kennio; Rocha, Ivonete Helena; Vasconcelos, Rakel Rocha; Silva-Teixeira, David Nascimento; Nogueira Nascentes, Gabriel Antonio; Silva-Vergara, Mario Leon			Cytokine Profiles at Admission Can Be Related to Outcome in AIDS Patients with Cryptococcal Meningitis	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; CENTRAL-NERVOUS-SYSTEM; CEREBROSPINAL-FLUID; INTERFERON-GAMMA; INFECTED PATIENTS; IMMUNE-RESPONSE; AMPHOTERICIN-B; T-LYMPHOCYTES; NEOFORMANS; CELLS	Cryptococcal meningitis (CM) remains as common life-threatening AIDS-defining illness mainly in resource-limited settings. Previous reports suggested that baseline cytokine profiles can be associated to fungal burden and clinical outcome. This study aimed to evaluate the baseline cytokine profiles in AIDS patients with CM and its relation with the outcome at weeks 2 and 10. Thirty AIDS patients with CM diagnosed by cerebrospinal fluid (CSF) Cryptococcus neoformans positive culture, India ink stain and cryptococcal antigen test were prospectively evaluated. As controls, 56 HIV-infected patients without CM and 48 non-HIV individuals were included. Baseline CSF and sera levels of IL-2, IL-4, IL-8, IL-10, IL-12p40, IL-17A, INF-gamma and TNF-alpha were measured by ELISA. Of 30 CM patients, 24 (80%) were male, median age of 38.1. The baseline CSF high fungal burden and positive blood culture were associated with a positive CSF culture at week 2 (p = 0.043 and 0.029). Most CSF and sera cytokines presented higher levels in CM patients than control subjects (p < 0.05). CSF levels of IL-8, IL-12p40, IL-17A, TNF-alpha, INF-gamma and sera TNF-alpha were significantly higher among survivors at weeks 2 and 10 (p < 0.05). Patients with increased intracranial pression exhibited CSF IL-10 high levels and poor outcome at week 10 (p = 0.032). Otherwise, baseline CSF log10 IFN-gamma and IL-17A were negatively correlated with fungal burden (r = -0.47 and -0.50; p = 0.0175 and 0.0094, respectively). The mortality rate was 33% (10/30) at week 2 and 57% (17/30) at week 10. The severity of CM and the advanced immunodeficiency at admission were related to a poor outcome in these patients. Otherwise, the predominant Th1 cytokines profile among survivors confirms its pivotal role to infection control and would be a prognostic marker in cryptococcal meningitis.	[Mora, Delio Jose; Fortunato, Laila Rigolin; Andrade-Silva, Leonardo Euripedes; Ferreira-Paim, Kennio; Rocha, Ivonete Helena; Vasconcelos, Rakel Rocha; Silva-Teixeira, David Nascimento; Silva-Vergara, Mario Leon] Triangulo Mineiro Fed Univ, Infect Dis Unit, Dept Internal Med, Uberaba, MG, Brazil; [Nogueira Nascentes, Gabriel Antonio] Fed Inst Triangulo Mineiro, Uberaba, MG, Brazil	Universidade Federal do Triangulo Mineiro; Instituto Federal do Triangulo Mineiro (IFTM); Universidade Federal do Triangulo Mineiro	Mora, DJ (corresponding author), Triangulo Mineiro Fed Univ, Infect Dis Unit, Dept Internal Med, Uberaba, MG, Brazil.	delioj@gmail.com; marioleon.dip@mednet.com.br	Ferreira-Paim, Kennio/A-8194-2013; Mora, Delio José/G-1614-2012; andrade-silva, leonardo/AAA-4356-2020	Ferreira-Paim, Kennio/0000-0002-6035-8392; andrade-silva, leonardo/0000-0002-0485-229X	Fundacao de Amparo a Pesquisa de Minas Gerais (FAPEMIG) [BPD-00507-13]	Fundacao de Amparo a Pesquisa de Minas Gerais (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG))	Funding: This work was supported by Fundacao de Amparo a Pesquisa de Minas Gerais (FAPEMIG) - grant # BPD-00507-13. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altfeld M, 2000, J ACQ IMMUN DEF SYND, V23, P287; Anekthananon T, 2011, INT J STD AIDS, V22, P665, DOI 10.1258/ijsa.2011.010538; Antinori S, 2013, ISRN AIDS, V25; Bicanic T, 2007, CLIN INFECT DIS, V45, P76, DOI 10.1086/518607; Bicanic T, 2009, CLIN INFECT DIS, V49, P702, DOI 10.1086/604716; Boulware DR, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000384; Brizendine KD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060431; Brouwer AE, 2004, LANCET, V363, P1764, DOI 10.1016/S0140-6736(04)16301-0; Buchanan KL, 2000, INFECT IMMUN, V68, P456, DOI 10.1128/IAI.68.2.456-462.2000; Cachay ER, 2010, AIDS RES THER, V7, DOI 10.1186/1742-6405-7-29; Lindenberg ADC, 2008, REV INST MED TROP SP, V50, P75, DOI 10.1590/S0036-46652008000200002; Chaka W, 1997, J INFECT DIS, V176, P1633, DOI 10.1086/517344; Chuang YM, 2010, EPIDEMIOL INFECT, V138, P1036, DOI 10.1017/S0950268809990926; CLEMONS KV, 1994, ANTIMICROB AGENTS CH, V38, P460, DOI 10.1128/AAC.38.3.460; Clemons KV, 2001, ANTIMICROB AGENTS CH, V45, P686, DOI 10.1128/AAC.45.3.686-689.2001; Dammert P, 2008, J INFECTION, V57, P260, DOI 10.1016/j.jinf.2008.06.020; Dromer F, 2007, PLOS MED, V4, P297, DOI 10.1371/journal.pmed.0040021; EDWARDS VE, 1970, J NEUROL NEUROSUR PS, V33, P415, DOI 10.1136/jnnp.33.4.415; Ellerbroek PM, 2004, CURR MED CHEM, V11, P253, DOI 10.2174/0929867043456188; Hernandez Y, 2005, J IMMUNOL, V174, P1027, DOI 10.4049/jimmunol.174.2.1027; Jarvis JN, 2014, CLIN INFECT DIS, V58, P736, DOI 10.1093/cid/cit794; Jarvis JN, 2013, J INFECT DIS, V207, P1817, DOI 10.1093/infdis/jit099; Jarvis JN, 2012, AIDS, V26, P1105, DOI 10.1097/QAD.0b013e3283536a93; Kambugu A, 2008, CLIN INFECT DIS, V46, P1694, DOI 10.1086/587667; Kawakami K, 2004, JPN J INFECT DIS, V57, P137; Kawakami K, 1996, CLIN EXP IMMUNOL, V104, P208, DOI 10.1046/j.1365-2249.1996.14723.x; Kedzierska Katherine, 2001, Antiviral Chemistry and Chemotherapy, V12, P133; Kozakiewicz L, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003472; KWONCHUNG KJ, 1982, J CLIN MICROBIOL, V15, P535, DOI 10.1128/JCM.15.3.535-537.1982; Lawn SD, 2010, CURR OPIN HIV AIDS, V5, P18, DOI 10.1097/COH.0b013e328333850f; Lindell DM, 2005, J IMMUNOL, V174, P7920, DOI 10.4049/jimmunol.174.12.7920; Lipovsky MM, 1998, J INFECT DIS, V177, P260, DOI 10.1086/517368; Lortholary O, 2005, CLIN MICROBIOL INFEC, V11, P296, DOI 10.1111/j.1469-0691.2005.01074.x; Lortholary O, 2001, J INFECT DIS, V183, P294, DOI 10.1086/317937; Loyse A, 2010, AIDS, V24, P405, DOI 10.1097/QAD.0b013e328333c005; Lutz JE, 2000, J ANTIMICROB CHEMOTH, V46, P437, DOI 10.1093/jac/46.3.437; Mao LY, 2013, EPILEPSIA, V54, pe142, DOI 10.1111/epi.12337; Maxeiner HG, 2014, CYTOKINE, V69, P62, DOI 10.1016/j.cyto.2014.05.008; McClelland EE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063632; Meyer W, 2003, EMERG INFECT DIS, V9, P189; Mora DJ, 2012, MYCOPATHOLOGIA, V173, P321, DOI 10.1007/s11046-011-9504-9; Mosser DM, 2008, IMMUNOL REV, V226, P205, DOI 10.1111/j.1600-065X.2008.00706.x; Naranbhai V, 2014, AIDS, V28, P657, DOI 10.1097/QAD.0000000000000200; Netea MG, 2004, CLIN INFECT DIS, V39, pE83, DOI 10.1086/425121; Nussbaum JC, 2010, CLIN INFECT DIS, V50, P338, DOI 10.1086/649861; Osakwe Chukwunomso E, 2010, Roum Arch Microbiol Immunol, V69, P24; Pappas PG, 2004, J INFECT DIS, V189, P2185, DOI 10.1086/420829; Park BJ, 2009, AIDS, V23, P525, DOI 10.1097/QAD.0b013e328322ffac; Pietrella D, 2001, J INFECT DIS, V183, P51, DOI 10.1086/317648; Pyrgos V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056269; Robertson EJ, 2014, J INFECT DIS, V209, P74, DOI 10.1093/infdis/jit435; Rudner XL, 2007, INFECT IMMUN, V75, P3055, DOI 10.1128/IAI.01329-06; Siddiqui AA, 2005, J IMMUNOL, V174, P1746, DOI 10.4049/jimmunol.174.3.1746; Singh N, 2006, TRANSPL IMMUNOL, V16, P69, DOI 10.1016/j.trim.2006.03.009; Srikanth P, 2000, INT J STD AIDS, V11, P49, DOI 10.1258/0956462001914904; Stacey AR, 2009, J VIROL, V83, P3719, DOI 10.1128/JVI.01844-08; Stenzel W, 2009, AM J PATHOL, V174, P486, DOI 10.2353/ajpath.2009.080598; Uicker WC, 2005, MED MYCOL, V43, P27, DOI 10.1080/13693780410001731510; Vecchiarelli A, 2007, CRIT REV IMMUNOL, V27, P547, DOI 10.1615/CritRevImmunol.v27.i6.50; Vidal JE, 2013, BRAZ J INFECT DIS, V17, P353, DOI 10.1016/j.bjid.2012.10.020; Voelz K, 2009, INFECT IMMUN, V77, P3450, DOI 10.1128/IAI.00297-09; Wijewardana I, 2011, J INFECTION, V63, P484, DOI 10.1016/j.jinf.2011.09.002; Wirleitner B, 2003, CURR MED CHEM, V10, P1581, DOI 10.2174/0929867033457179; Wormley FL, 2007, INFECT IMMUN, V75, P1453, DOI 10.1128/IAI.00274-06; Wozniak KL, 2012, BMC IMMUNOL, V13, DOI 10.1186/1471-2172-13-65; Wozniak KL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017204; Zhang YM, 2009, AM J PATHOL, V175, P2489, DOI 10.2353/ajpath.2009.090530; Zhou Q, 2007, J IMMUNOL, V178, P5753, DOI 10.4049/jimmunol.178.9.5753	68	31	31	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0120297	10.1371/journal.pone.0120297	http://dx.doi.org/10.1371/journal.pone.0120297			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25799044	gold, Green Published, Green Submitted			2022-12-27	WOS:000351987300125
J	Nguyen, T; Ruan, Z; Oruganty, K; Kannan, N				Tuan Nguyen; Ruan, Zheng; Oruganty, Krishnadev; Kannan, Natarajan			Co-Conserved MAPK Features Couple D-Domain Docking Groove to Distal Allosteric Sites via the C-Terminal Flanking Tail	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; CRYSTAL-STRUCTURE; P38; MECHANISMS; P38-ALPHA; RECEPTOR; COMPLEX; MUTANTS; LOOP; ERK2	Mitogen activated protein kinases (MAPKs) form a closely related family of kinases that control critical pathways associated with cell growth and survival. Although MAPKs have been extensively characterized at the biochemical, cellular, and structural level, an integrated evolutionary understanding of how MAPKs differ from other closely related protein kinases is currently lacking. Here, we perform statistical sequence comparisons of MAPKs and related protein kinases to identify sequence and structural features associated with MAPK functional divergence. We show, for the first time, that virtually all MAPK-distinguishing sequence features, including an unappreciated short insert segment in the beta 4-beta 5 loop, physically couple distal functional sites in the kinase domain to the D-domain peptide docking groove via the C-terminal flanking tail (C-tail). The coupling mediated by MAPK-specific residues confers an allosteric regulatory mechanism unique to MAPKs. In particular, the regulatory alpha C-helix conformation is controlled by a MAPK-conserved salt bridge interaction between an arginine in the aC-helix and an acidic residue in the C-tail. The salt-bridge interaction is modulated in unique ways in individual sub-families to achieve regulatory specificity. Our study is consistent with a model in which the C-tail co-evolved with the D-domain docking site to allosterically control MAPK activity. Our study provides testable mechanistic hypotheses for biochemical characterization of MAPK-conserved residues and new avenues for the design of allosteric MAPK inhibitors.	[Tuan Nguyen; Oruganty, Krishnadev; Kannan, Natarajan] Univ Georgia, Dept Biochem & Mol Biol, Athens, GA 30602 USA; [Ruan, Zheng; Kannan, Natarajan] Univ Georgia, Inst Bioinformat, Athens, GA 30602 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Kannan, N (corresponding author), Univ Georgia, Dept Biochem & Mol Biol, Athens, GA 30602 USA.	kannan@bmb.uga.edu	Oruganty, KrishnaDev/N-9465-2017	Oruganty, KrishnaDev/0000-0003-0866-6862; Ruan, Zheng/0000-0002-4412-4916	National Science Foundation [MCB-1149106]; American Cancer Society [RSG-10-188-01-TBE]; Georgia Cancer Coalition	National Science Foundation(National Science Foundation (NSF)); American Cancer Society(American Cancer Society); Georgia Cancer Coalition	National Science Foundation Grant MCB-1149106 (to N.K.) http://www.nsf.gov/funding/, American Cancer Society Grant RSG-10-188-01-TBE (to N.K.) http://www.cancer.org/research/applyforaresearchgrant/, Georgia Cancer Coalition (to N.K.) http://gra.org/page/1036/gra_cancer_scientists.html.	Bakan A, 2011, BIOINFORMATICS, V27, P1575, DOI 10.1093/bioinformatics/btr168; Bellon S, 1999, STRUCTURE, V7, P1057, DOI 10.1016/S0969-2126(99)80173-7; Bhattacharyya RP, 2006, SCIENCE, V311, P822, DOI 10.1126/science.1120941; Bubici C, 2014, BRIT J PHARMACOL, V171, P24, DOI 10.1111/bph.12432; Canagarajah BJ, 1997, CELL, V90, P859, DOI 10.1016/S0092-8674(00)80351-7; Cargnello M, 2011, MICROBIOL MOL BIOL R, V75, P50, DOI 10.1128/MMBR.00031-10; Chen Z, 2001, CHEM REV, V101, P2449, DOI 10.1021/cr000241p; Cheng M, 1996, J BIOL CHEM, V271, P8951, DOI 10.1074/jbc.271.15.8951; De Nicola GF, 2013, NAT STRUCT MOL BIOL, V20, P1182, DOI 10.1038/nsmb.2668; Diskin R, 2004, J BIOL CHEM, V279, P47040, DOI 10.1074/jbc.M404595200; Diskin R, 2007, J MOL BIOL, V365, P66, DOI 10.1016/j.jmb.2006.08.043; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; Elkins JM, 2013, J MED CHEM, V56, P4413, DOI 10.1021/jm4000837; Fiser A, 2000, PROTEIN SCI, V9, P1753, DOI 10.1110/ps.9.9.1753; Glatz G, 2013, J BIOL CHEM, V288, P8596, DOI 10.1074/jbc.M113.452235; Gogl G, 2013, ACTA CRYSTALLOGR D, V69, P486, DOI 10.1107/S0907444912051062; Hu JC, 2013, CELL, V154, P1036, DOI 10.1016/j.cell.2013.07.046; Hubbard SR, 2004, NAT REV MOL CELL BIO, V5, P464, DOI 10.1038/nrm1399; Huse M, 2002, CELL, V109, P275, DOI 10.1016/S0092-8674(02)00741-9; Huse M, 1999, CELL, V96, P425, DOI 10.1016/S0092-8674(00)80555-3; Ishitani T, 2013, CELL SIGNAL, V25, P190, DOI 10.1016/j.cellsig.2012.09.017; Johnson LN, 1996, CELL, V85, P149, DOI 10.1016/S0092-8674(00)81092-2; Jura N, 2011, MOL CELL, V42, P9, DOI 10.1016/j.molcel.2011.03.004; Kannan N, 2005, J MOL BIOL, V351, P956, DOI 10.1016/j.jmb.2005.06.057; Kannan N, 2004, PROTEIN SCI, V13, P2059, DOI 10.1110/ps.04637904; Kannan N, 2007, PLOS BIOL, V5, P467, DOI 10.1371/journal.pbio.0050017; Kannan N, 2007, P NATL ACAD SCI USA, V104, P1272, DOI 10.1073/pnas.0610251104; Khokhlatchev AV, 1998, CELL, V93, P605, DOI 10.1016/S0092-8674(00)81189-7; Kumar S, 2003, NAT REV DRUG DISCOV, V2, P717, DOI 10.1038/nrd1177; Laughlin JD, 2012, STRUCTURE, V20, P2174, DOI 10.1016/j.str.2012.09.021; Lee T, 2004, MOL CELL, V14, P43, DOI 10.1016/S1097-2765(04)00161-3; Li M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026999; Ma W, 2014, STRUCTURE, V18, P1502; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Mirza A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014310; Mittelstadt PR, 2005, NEW TRICKS FOR AN OL, P1189; Neuwald AF, 2003, GENOME RES, V13, P673, DOI 10.1101/gr.862303; Neuwald AF, 2007, TRENDS BIOCHEM SCI, V32, P487, DOI 10.1016/j.tibs.2007.08.009; Neuwald AF, 2011, STAT APPL GENET MOL, V10, DOI 10.2202/1544-6115.1666; Neuwald AF, 2009, BIOINFORMATICS, V25, P1869, DOI 10.1093/bioinformatics/btp342; Niefind K, 2007, J MOL BIOL, V370, P427, DOI 10.1016/j.jmb.2007.04.068; Nolen B, 2004, MOL CELL, V15, P661, DOI 10.1016/j.molcel.2004.08.024; Oruganty K, 2012, P NATL ACAD SCI USA, P1; Oruganty K, 2012, PHILOS T R SOC B, V367, P2529, DOI 10.1098/rstb.2012.0015; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; Pronk S, 2013, BIOINFORMATICS, V29, P845, DOI 10.1093/bioinformatics/btt055; Roskoski R, 2012, PHARMACOL RES, V66, P105, DOI 10.1016/j.phrs.2012.04.005; Russo AA, 1996, NATURE, V382, P325, DOI 10.1038/382325a0; Saklatvala J, 2004, CURR OPIN PHARMACOL, V4, P372, DOI 10.1016/j.coph.2004.03.009; Salvador JM, 2005, NAT IMMUNOL, V6, P390, DOI 10.1038/ni1177; Sanz V, 2000, FEBS LETT, V474, P169, DOI 10.1016/S0014-5793(00)01598-2; Shi ZS, 2006, CURR OPIN STRUC BIOL, V16, P686, DOI 10.1016/j.sbi.2006.10.011; Takahashi R, 2013, CANCER SCI, V104, P337, DOI 10.1111/cas.12080; Talevich E, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-117; Talevich E, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-321; Tanoue T, 2000, NAT CELL BIOL, V2, P110, DOI 10.1038/35000065; Taylor SS, 2011, TRENDS BIOCHEM SCI, V36, P65, DOI 10.1016/j.tibs.2010.09.006; ter Haar E, 2007, J BIOL CHEM, V282, P9733, DOI 10.1074/jbc.M611165200; Tokunaga Y, 2014, NAT STRUCT MOL BIOL, V21, P704, DOI 10.1038/nsmb.2861; Tzarum N, 2011, J MOL BIOL, V405, P1154, DOI 10.1016/j.jmb.2010.11.023; Ubersax JA, 2007, NAT REV MOL CELL BIO, V8, P530, DOI 10.1038/nrm2203; Wan PTC, 2004, CELL, V116, P855, DOI 10.1016/S0092-8674(04)00215-6; Wang C, 2014, STRUCTURE, V20, P791; Wang ZL, 1997, P NATL ACAD SCI USA, V94, P2327, DOI 10.1073/pnas.94.6.2327; Webster RR, 2008, PLACENTA, V29, P985, DOI 10.1016/j.placenta.2008.09.003; Webster RP, 2007, PROTEOM CLIN APPL, V1, P1147, DOI 10.1002/prca.200700128; Webster RP, 2006, PROTEOMICS, V6, P4838, DOI 10.1002/pmic.200600176; Wilson KP, 1996, J BIOL CHEM, V271, P27696, DOI 10.1074/jbc.271.44.27696; Xie XL, 1998, STRUCTURE, V6, P983, DOI 10.1016/S0969-2126(98)00100-2; Yan CL, 2011, J PHYS CHEM B, V115, P1491, DOI 10.1021/jp1073522; ZERVOS AS, 1995, P NATL ACAD SCI USA, V92, P10531, DOI 10.1073/pnas.92.23.10531; ZHANG FM, 1994, NATURE, V367, P704, DOI 10.1038/367704a0; Zhang J, 2012, ACTA CRYSTALLOGR F, V68, P1434, DOI 10.1107/S1744309112042972; Zhang YY, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.203786; Zhou TJ, 2006, STRUCTURE, V14, P1011, DOI 10.1016/j.str.2006.04.006	75	10	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0119636	10.1371/journal.pone.0119636	http://dx.doi.org/10.1371/journal.pone.0119636			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25799139	Green Published, gold, Green Submitted			2022-12-27	WOS:000351987300066
J	Barcelo, F; Cerda, JJ; Gutierrez, A; Jimenez-Marco, T; Duran, MA; Novo, A; Ros, T; Sampol, A; Portugal, J				Barcelo, Francisca; Cerda, Joan J.; Gutierrez, Antonio; Jimenez-Marco, Teresa; Antonia Duran, M.; Novo, Andres; Ros, Teresa; Sampol, Antonia; Portugal, Jose			Characterization of Monoclonal Gammopathy of Undetermined Significance by Calorimetric Analysis of Blood Serum Proteome	PLOS ONE			English	Article							DIFFERENTIAL SCANNING CALORIMETRY; MULTIPLE-MYELOMA; SIGNIFICANCE MGUS; PLASMA PROTEOME; COLORECTAL-CANCER; PATHOGENESIS; PREVALENCE; PROFILES; MARKERS	Monoclonal gammopathy of undetermined significance (MGUS) is a premalignant proliferative disorder that may progress to multiple myeloma, a malignant plasma cell neoplasia. We evaluated differential scanning calorimetry (DSC) as an experimental tool for differentiating serum samples of MGUS patients from healthy individuals. DSC thermograms can be used for monitoring changes in the serum proteome associated with MGUS. MGUS patients showed great variability in serum thermogram characteristics, which depended on the IgG, IgA or IgM iso-types and/or the. or. light chains. Thermogram feature parameters distinguished patients with MGUS from healthy people. Serum samples, named as non-MGUS, were also collected from patients with subjacent immunological pathologies who were discarded of having MGUS through serum immunofixation. They were used to verify the sensitivity of DSC for discriminating MGUS from related blood dyscrasias. Only some DSC thermogram feature parameters differentiated, to a lesser extent, between MGUS and non-MGUS individuals. We contemplate DSC as a tool for early diagnosis and monitoring of MGUS.	[Barcelo, Francisca] Univ Islas Baleares, Grp Invest Clin & Translac, Inst Univ Invest Ciencias Salud, Palma De Mallorca, Spain; [Cerda, Joan J.] Univ Islas Baleares, Consejo Super Invest Cient, Inst Fis Interdisciplinar & Sistemas Complejos, Palma De Mallorca, Spain; [Gutierrez, Antonio; Antonia Duran, M.; Novo, Andres; Ros, Teresa] Hosp Univ Son Espases, Biol Clin Hematol, Palma De Mallorca, Spain; [Jimenez-Marco, Teresa] Univ Islas Baleares, Fdn Banco Sangre & Tejidos Islas Baleares, Palma De Mallorca, Spain; [Jimenez-Marco, Teresa] Univ Islas Baleares, Inst Univ Invest Ciencias Salud, Palma De Mallorca, Spain; [Sampol, Antonia] Hosp Univ Son Espases, Inst Invest Sanitaria Palma, Serv Hematol & Hemoterapia, Palma De Mallorca, Spain; [Portugal, Jose] CSIC, Inst Biol Mol Barcelona, Barcelona, Spain	Universitat de les Illes Balears; Consejo Superior de Investigaciones Cientificas (CSIC); Universitat de les Illes Balears; CSIC-UIB - Instituto de Fisica Interdisciplinar y Sistemas Complejos (IFISC); Hospital Universitari Son Espases; Fundacio Banc Sang Teixits de les Illes Balears; Universitat de les Illes Balears; Universitat de les Illes Balears; Hospital Universitari Son Espases; Institut Investigacio Sanitaria Illes Balears (IdISBa); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biologia Molecular de Barcelona (IBMB)	Barcelo, F (corresponding author), Univ Islas Baleares, Grp Invest Clin & Translac, Inst Univ Invest Ciencias Salud, Palma De Mallorca, Spain.	francisca.barcelo@uib.es	Portugal, José/K-4504-2014; Barceló, Francisca/K-5288-2014; Cerdà, Joan Josep/M-1910-2018; Cerdà, Joan Josep/H-1306-2013	Portugal, José/0000-0002-1923-9666; Barceló, Francisca/0000-0002-9158-099X; Cerdà, Joan Josep/0000-0003-1132-5989; Cerdà, Joan Josep/0000-0003-1132-5989; Jimenez-Marco, Teresa/0000-0001-9631-6541	Spanish Ministry of Science and Innovation [BFU2010-15518]	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	BFU2010-15518 from the Spanish Ministry of Science and Innovation.	Anderson KC, 2011, ANNU REV PATHOL-MECH, V6, P249, DOI 10.1146/annurev-pathol-011110-130249; Attaelmannan M, 2000, CLIN CHEM, V46, P1230; Blade J, 2008, LEUKEMIA, V22, P1651, DOI 10.1038/leu.2008.203; Engwegen JYMN, 2008, PROTEOM CLIN APPL, V2, P936, DOI 10.1002/prca.200780068; Garbett NC, 2008, BIOPHYS J, V94, P1377, DOI 10.1529/biophysj.107.119453; Garbett NC, 2007, CLIN CHEM, V53, P2012, DOI 10.1373/clinchem.2007.091165; Garbett NC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084710; Garbett NC, 2013, BBA-GEN SUBJECTS, V1830, P4675, DOI 10.1016/j.bbagen.2013.05.007; Garbett NC, 2009, EXP MOL PATHOL, V86, P186, DOI 10.1016/j.yexmp.2008.12.001; Gutierrez NC, 2007, CLIN TRANSL ONCOL, V9, P618, DOI 10.1007/s12094-007-0114-4; Korde N, 2011, BLOOD, V117, P5573, DOI 10.1182/blood-2011-01-270140; Kyle RA, 2006, NEW ENGL J MED, V354, P1362, DOI 10.1056/NEJMoa054494; Kyle RA, 2006, BRIT J HAEMATOL, V134, P573, DOI 10.1111/j.1365-2141.2006.06235.x; Landgren O, 2014, LEUKEMIA, V28, P1537, DOI [10.1038/leu.2014.34, 10.1038/1eu.2014.34]; Landgren O, 2009, BLOOD, V113, P5412, DOI 10.1182/blood-2008-12-194241; Lopez-Corral L, 2014, HAEMATOLOGICA, V99, P1365, DOI 10.3324/haematol.2013.087809; Mangiacavalli S, 2013, EUR J HAEMATOL, V91, P356, DOI 10.1111/ejh.12172; Michnik A, 2010, J THERM ANAL CALORIM, V102, P57, DOI 10.1007/s10973-009-0602-6; Michnik A, 2010, J THERM ANAL CALORIM, V101, P513, DOI 10.1007/s10973-010-0826-5; Mor G, 2005, P NATL ACAD SCI USA, V102, P7677, DOI 10.1073/pnas.0502178102; Palladino C, 2014, TRANSL MED UNISA, V8, P12; Roeker LE, 2013, LEUKEMIA, V27, P1391, DOI 10.1038/leu.2013.34; Scudla V, 2011, NEOPLASMA, V58, P499, DOI 10.4149/neo_2011_06_499; Stein W., 2012, SAGE MATH SOFTWARE V; Todinova S, 2014, ANAL CHEM, V86, P12355, DOI 10.1021/ac503677d; Todinova S, 2012, BBA-GEN SUBJECTS, V1820, P1879, DOI 10.1016/j.bbagen.2012.08.001; Todinova S, 2011, ANAL CHEM, V83, P7992, DOI 10.1021/ac202055m; Zhou M, 2004, ELECTROPHORESIS, V25, P1289, DOI 10.1002/elps.200405866	28	18	18	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0120316	10.1371/journal.pone.0120316	http://dx.doi.org/10.1371/journal.pone.0120316			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25794164	Green Submitted, Green Published, gold			2022-12-27	WOS:000352083900011
J	Chen, C; Zhao, ZG; Liao, YB; Peng, Y; Meng, QT; Chai, H; Li, Q; Luo, XL; Liu, W; Zhang, C; Chen, M; Huang, DJ				Chen, Chi; Zhao, Zhen-Gang; Liao, Yan-Biao; Peng, Yong; Meng, Qing-Tao; Chai, Hua; Li, Qiao; Luo, Xiao-Lin; Liu, Wei; Zhang, Chen; Chen, Mao; Huang, De-Jia			Impact of Renal Dysfunction on Mid-Term Outcome after Transcatheter Aortic Valve Implantation: A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							CHRONIC KIDNEY-DISEASE; HIGH-RISK PATIENTS; LONG-TERM OUTCOMES; OBSTRUCTIVE PULMONARY-DISEASE; CLINICAL-OUTCOMES; PROGNOSTIC VALUE; STENOSIS; REPLACEMENT; MORTALITY; REGURGITATION	Background There is conflicting evidence regarding the impact of preexisting renal dysfunction (RD) on mid-term outcomes after transcatheter aortic valve implantation (TAVI) in patients with symptomatic aortic stenosis (AS). Methods and results Forty-seven articles representing 32,131 patients with AS undergoing a TAVI procedure were included in this systematic review and meta-analysis. Pooled analyses were performed with both univariate and multivariate models, using a fixed or random effects method when appropriate. Compared with patients with normal renal function, mid-term mortality was significantly higher in patients with preexisting RD, as defined by the author (univariate hazard ratio [HR]: 1.69; 95% confidence interval [CI]: 1.50-1.90; multivariate HR: 1.47; 95% CI: 1.17-1.84), baseline estimated glomerular filtration rate (eGFR) (univariate HR: 1.65; 95% CI: 1.47-1.86; multivariate HR: 1.46; 95% CI: 1.24-1.71), and serum creatinine (univariate HR: 1.69; 95% CI: 1.48-1.92; multivariate HR: 1.65; 95% CI: 1.36-1.99). Advanced stage of chronic kidney disease (CKD stage 3-5) was strongly related to bleeding (univariate HR in CKD stage 3: 1.30, 95% CI: 1.13-1.49; in CKD stage 4: 1.30, 95% CI: 1.04-1.62), acute kidney injure (AKI) (univariate HR in CKD stage 3: 1.28, 95% CI: 1.03-1.59; in CKD stage 4: 2.27, 95% CI: 1.74-2.96), stroke (univariate HR in CKD stage 4: 3.37, 95% CI: 1.52-7.46), and mid-term mortality (univariate HR in CKD stage 3: 1.57, 95% CI: 1.26-1.95; in CKD stage 4: 2.77, 95% CI: 2.06-3.72; in CKD stage 5: 2.64, 95% CI: 1.91-3.65) compared with CKD stage 1+2. Patients with CKD stage 4 had a higher incidence of AKI (univariate HR: 1.70, 95% CI: 1.34-2.16) and all-cause death (univariate HR: 1.60, 95% CI: 1.28-.99) compared with those with CKD stage 3. A per unit decrease in serum creatinine was also associated with a higher mortality at mid-term follow-up (univariate HR: 1.24, 95% CI: 1.18-1.30; multivariate HR: 1.19, 95% CI: 1.08-1.30). Conclusions Preexisting RD was associated with increased mid-term mortality after TAVI. Patients with CKD stage 4 had significantly higher incidences of peri-procedural complications and a poorer prognosis, a finding that should be factored into the clinical decision-making process regarding these patients.	[Chen, Chi; Zhao, Zhen-Gang; Liao, Yan-Biao; Peng, Yong; Meng, Qing-Tao; Chai, Hua; Li, Qiao; Luo, Xiao-Lin; Liu, Wei; Zhang, Chen; Chen, Mao; Huang, De-Jia] Sichuan Univ, West China Hosp, Dept Cardiol, Chengdu 610064, Peoples R China	Sichuan University	Chen, M (corresponding author), Sichuan Univ, West China Hosp, Dept Cardiol, Chengdu 610064, Peoples R China.	hmaochen@hotmail.com		Zhao, Zhen-Gang/0000-0003-1237-1696; Nombela Franco, Luis/0000-0003-3438-8907				Aregger F, 2009, NEPHROL DIAL TRANSPL, V24, P2175, DOI 10.1093/ndt/gfp036; Barbanti M, 2014, CATHETER CARDIOVASC; Ben-Dor I, 2012, AM J CARDIOL, V110, P1008, DOI 10.1016/j.amjcard.2012.05.034; Chopard R, 2014, AM J CARDIOL, V113, P1543, DOI 10.1016/j.amjcard.2014.01.432; Codner P, 2013, AM J CARDIOL, V111, P1330, DOI 10.1016/j.amjcard.2013.01.275; Conrotto F, 2014, AM J CARDIOL, V113, P529, DOI 10.1016/j.amjcard.2013.10.025; Cronin RE, 2010, PEDIATR NEPHROL, V25, P191, DOI 10.1007/s00467-009-1204-z; D'Ascenzo F, 2013, INT J CARDIOL, V167, P1514, DOI 10.1016/j.ijcard.2012.04.161; Drews T, 2013, ANN THORAC SURG, V95, P85, DOI 10.1016/j.athoracsur.2012.08.055; Dumonteil N, 2013, AM HEART J, V165, P752, DOI 10.1016/j.ahj.2012.12.013; Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x; Dvir D, 2014, J AM COLL CARDIOL, V63, P269, DOI 10.1016/j.jacc.2013.09.024; Godino C, 2010, JACC-CARDIOVASC INTE, V3, P1110, DOI 10.1016/j.jcin.2010.09.012; Gotzmann M, 2012, AM J CARDIOL, V110, P1500, DOI 10.1016/j.amjcard.2012.07.010; Gummert JF, 2004, THORAC CARDIOV SURG, V52, P70, DOI 10.1055/s-2004-817806; Hayashida K, 2012, JACC-CARDIOVASC INTE, V5, P1247, DOI 10.1016/j.jcin.2012.09.003; Heinz A, 2014, J THORAC CARDIOV SUR, V147, P1021, DOI 10.1016/j.jtcvs.2013.11.011; Houthuizen P, 2012, CIRCULATION, V126, P720, DOI 10.1161/CIRCULATIONAHA.112.101055; Kamga M, 2013, ACTA CARDIOL, V68, P599, DOI 10.1080/AC.68.6.8000007; Katsanos S, 2013, J AM SOC ECHOCARDIOG, V26, P691, DOI 10.1016/j.echo.2013.04.003; Kodali SK, 2012, NEW ENGL J MED, V366, P1686, DOI 10.1056/NEJMoa1200384; Lange R, 2012, J AM COLL CARDIOL, V59, P280, DOI 10.1016/j.jacc.2011.10.868; Le Ven F, 2013, J AM COLL CARDIOL, V62, P782, DOI 10.1016/j.jacc.2013.05.044; Leon MB, 2011, EUR HEART J, V32, P205, DOI 10.1093/eurheartj/ehq406; Leon MB, 2010, NEW ENGL J MED, V363, P1597, DOI 10.1056/NEJMoa1008232; Levey AS, 2005, KIDNEY INT, V67, P2089, DOI 10.1111/j.1523-1755.2005.00365.x; Linke A, 2014, EUR HEART J, V35, P2672, DOI 10.1093/eurheartj/ehu162; London GM, 2000, J AM SOC NEPHROL, V11, P778, DOI 10.1681/ASN.V114778; Lucon A, 2014, CIRC-CARDIOVASC INTE, V7, P240, DOI 10.1161/CIRCINTERVENTIONS.113.000482; Madershahian N, 2012, EUR J CARDIO-THORAC, V41, P1225, DOI 10.1093/ejcts/ezr199; Makkar RR, 2012, NEW ENGL J MED, V366, P1696, DOI 10.1056/NEJMoa1202277; McCullough PA, 2008, J AM COLL CARDIOL, V51, P1419, DOI 10.1016/j.jacc.2007.12.035; Moat NE, 2011, J AM COLL CARDIOL, V58, P2130, DOI 10.1016/j.jacc.2011.08.050; Mok M, 2013, JACC-CARDIOVASC INTE, V6, P1072, DOI 10.1016/j.jcin.2013.06.008; Moretti C, 2014, J INTERV CARDIOL, V27, P293, DOI 10.1111/joic.12115; Munoz-Garcia AJ, 2013, INT J CARDIOL, V169, P359, DOI 10.1016/j.ijcard.2013.09.006; Nguyen TC, 2013, J THORAC CARDIOV SUR, V146, P1399, DOI 10.1016/j.jtcvs.2013.07.065; Nombela-Franco L, 2012, CIRCULATION, V126, P3041, DOI 10.1161/CIRCULATIONAHA.112.110981; Nuis RJ, 2012, NETH HEART J, V20, P16, DOI 10.1007/s12471-011-0224-z; Panico C, 2012, MINERVA CARDIOANGIOL, V60, P561; Rau S, 2012, NEPHRON CLIN PRACT, V120, pC86, DOI 10.1159/000335781; Rodes-Cabau J, 2012, J AM COLL CARDIOL, V60, P1864, DOI 10.1016/j.jacc.2012.08.960; Rodes-Cabau J, 2010, J AM COLL CARDIOL, V55, P1080, DOI 10.1016/j.jacc.2009.12.014; Sabate M, 2013, REV ESP CARDIOL, V66, P949, DOI 10.1016/j.rec.2013.07.003; Saia F, 2013, INT J CARDIOL, V168, P1034, DOI 10.1016/j.ijcard.2012.10.029; Seiffert M, 2013, CATHETER CARDIO INTE, V82, P640, DOI 10.1002/ccd.24751; Sinning JM, 2012, EUR HEART J, V33, P1459, DOI 10.1093/eurheartj/ehs002; Sinning JM, 2012, J AM COLL CARDIOL, V59, P1134, DOI 10.1016/j.jacc.2011.11.048; Sinning JM, 2010, JACC-CARDIOVASC INTE, V3, P1141, DOI 10.1016/j.jcin.2010.09.009; Smith CR, 2011, NEW ENGL J MED, V364, P2187, DOI 10.1056/NEJMoa1103510; SOSLAU G, 1990, AM J HEMATOL, V35, P171, DOI 10.1002/ajh.2830350306; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Tamburino C, 2012, AM J CARDIOL, V109, P1487, DOI 10.1016/j.amjcard.2012.01.364; Tamburino C, 2011, CIRCULATION, V123, P299, DOI 10.1161/CIRCULATIONAHA.110.946533; Thourani VH, 2011, ANN THORAC SURG, V91, P1798, DOI 10.1016/j.athoracsur.2011.02.015; Tzikas A, 2011, ANN THORAC SURG, V91, P685, DOI 10.1016/j.athoracsur.2010.09.037; Unbehaun A, 2014, EUR J CARDIO-THORAC; Unbehaun A, 2011, ANN THORAC SURG, V92, P1315, DOI 10.1016/j.athoracsur.2011.05.077; Urena M, 2014, CIRCULATION, V129, P1233, DOI 10.1161/CIRCULATIONAHA.113.005479; Van Belle E, 2014, CIRCULATION, V129, P1415, DOI 10.1161/CIRCULATIONAHA.113.002677; Van Linden A, 2011, EUR J CARDIO-THORAC, V39, P835, DOI 10.1016/j.ejcts.2010.11.034; Vasa-Nicotera M, 2012, JACC-CARDIOVASC INTE, V5, P858, DOI 10.1016/j.jcin.2012.04.011; Webb JG, 2009, CIRCULATION, V119, P3009, DOI 10.1161/CIRCULATIONAHA.108.837807; Wendler O, 2013, EUR J CARDIO-THORAC, V43, P505, DOI 10.1093/ejcts/ezs297; Wessely M, 2012, NEPHROL DIAL TRANSPL, V27, P3502, DOI 10.1093/ndt/gfs102; Yamamoto M, 2014, ANN THORAC SURG, V97, P29, DOI 10.1016/j.athoracsur.2013.07.100; Yamamoto M, 2013, J AM COLL CARDIOL, V62, P869, DOI 10.1016/j.jacc.2013.04.057; Yamamoto M, 2013, JACC-CARDIOVASC INTE, V6, P479, DOI 10.1016/j.jcin.2013.02.007; Zahn R, 2013, AM J CARDIOL, V112, P272, DOI 10.1016/j.amjcard.2013.03.024	69	40	39	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0119817	10.1371/journal.pone.0119817	http://dx.doi.org/10.1371/journal.pone.0119817			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25793780	gold, Green Published, Green Submitted			2022-12-27	WOS:000352084200118
J	Ferdous, J; Li, Y; Reid, N; Langridge, P; Shi, BJ; Tricker, PJ				Ferdous, Jannatul; Li, Yuan; Reid, Nicolas; Langridge, Peter; Shi, Bu-Jun; Tricker, Penny J.			Identification of Reference Genes for Quantitative Expression Analysis of MicroRNAs and mRNAs in Barley under Various Stress Conditions	PLOS ONE			English	Article							RT-PCR NORMALIZATION; REAL-TIME PCR; DROUGHT-RESPONSIVE MICRORNAS; GENOME-WIDE IDENTIFICATION; POLYMERASE-CHAIN-REACTION; SUPEROXIDE-DISMUTASE; HOUSEKEEPING GENES; OXIDATIVE STRESS; BETA-ACTIN; BIOCHEMICAL RESPONSES	For accurate and reliable gene expression analysis using quantitative real-time reverse transcription PCR (qPCR), the selection of appropriate reference genes as an internal control for normalization is crucial. We hypothesized that non-coding, small nucleolar RNAs (snoRNAs) would be stably expressed in different barley varieties and under different experimental treatments, in different tissues and at different developmental stages of plant growth and therefore might prove to be suitable reference genes for expression analysis of both microRNAs (miRNAs) and mRNAs. In this study, we examined the expression stability of ten candidate reference genes in six barley genotypes under five experimental stresses, drought, fungal infection, boron toxicity, nutrient deficiency and salinity. We compared four commonly used housekeeping genes; Actin (ACT), alpha-Tubulin (a-TUB), Glycolytic glyceraldehyde-3-phosphate dehydrogenase (GAPDH), ADP-ribosylation factor 1-like protein (ADP), four snoRNAs; (U18, U61, snoR14 and snoR23) and two microRNAs (miR168, miR159) as candidate reference genes. We found that ADP, snoR14 and snoR23 were ranked as the best of these candidates across diverse samples. For accurate and reliable gene expression analysis using quantitative real-time reverse transcription PCR (qPCR), the selection of appropriate reference genes as an internal control for normalization is crucial. We hypothesized that non-coding, small nucleolar RNAs (snoRNAs) would be stably expressed in different barley varieties and under different experimental treatments, in different tissues and at different developmental stages of plant growth and therefore might prove to be suitable reference genes for expression analysis of both microRNAs (miRNAs) and mRNAs. In this study, we examined the expression stability of ten candidate reference genes in six barley genotypes under five experimental stresses, drought, fungal infection, boron toxicity, nutrient deficiency and salinity. We compared four commonly used housekeeping genes; Actin (ACT), alpha-Tubulin (a-TUB), Glycolytic glyceraldehyde-3-phosphate dehydrogenase (GAPDH), ADP-ribosylation factor 1-like protein (ADP), four snoRNAs; (U18, U61, snoR14 and snoR23) and two microRNAs (miR168, miR159) as candidate reference genes. We found that ADP, snoR14 and snoR23 were ranked as the best of these candidates across diverse samples. Additionally, we found that miR168 was a suitable reference gene for expression analysis in barley. Finally, we validated the performance of our stable and unstable candidate reference genes for both mRNA and miRNA qPCR data normalization under different stress conditions and demonstrated the superiority of the stable candidates. Our data demonstrate the suitability of barley snoRNAs and miRNAs as potential reference genes for miRNA and mRNA qPCR data normalization under different stress treatments.	[Ferdous, Jannatul; Li, Yuan; Reid, Nicolas; Langridge, Peter; Shi, Bu-Jun; Tricker, Penny J.] Univ Adelaide, Australian Ctr Plant Funct Genom, Urrbrae, SA 5064, Australia	University of Adelaide	Shi, BJ (corresponding author), Univ Adelaide, Australian Ctr Plant Funct Genom, Urrbrae, SA 5064, Australia.	bujun.shi@adelaide.edu.au	Langridge, Peter/G-5864-2010; Tricker, Penny/A-8213-2015	Langridge, Peter/0000-0001-9494-400X; Tricker, Penny/0000-0002-1626-3556	Australian Centre for Plant Functional Genomics	Australian Centre for Plant Functional Genomics	Funded by the Australian Centre for Plant Functional Genomics.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Barrera-Figueroa BE, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-127; Benes V, 2010, METHODS, V50, P244, DOI 10.1016/j.ymeth.2010.01.026; Bottino MC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059423; Brattelid T, 2011, PHYSIOL GENOMICS, V43, P604, DOI 10.1152/physiolgenomics.00131.2010; Brosius J, 2005, TRENDS GENET, V21, P287, DOI 10.1016/j.tig.2005.02.014; BURKE JJ, 1985, PLANT PHYSIOL, V79, P415, DOI 10.1104/pp.79.2.415; Bustin SA, 2002, J MOL ENDOCRINOL, V29, DOI 10.1677/jme.0.0290023; Cervilla LM, 2007, ANN BOT-LONDON, V100, P747, DOI 10.1093/aob/mcm156; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chu YJ, 2012, NUCLEIC ACID THER, V22, P271, DOI 10.1089/nat.2012.0367; Czechowski T, 2005, PLANT PHYSIOL, V139, P5, DOI 10.1104/pp.105.063743; Davoren PA, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-76; Dheda K, 2004, BIOTECHNIQUES, V37, P112, DOI 10.2144/04371RR03; Eldem V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050298; Genc Y, 2007, PLANT CELL ENVIRON, V30, P1486, DOI 10.1111/j.1365-3040.2007.01726.x; Gimenez MJ, 2011, PLANTA, V233, P163, DOI 10.1007/s00425-010-1290-y; Glare EM, 2002, THORAX, V57, P765, DOI 10.1136/thorax.57.9.765; Guenin S, 2009, J EXP BOT, V60, P487, DOI 10.1093/jxb/ern305; Gutierrez L, 2008, PLANT BIOTECHNOL J, V6, P609, DOI 10.1111/j.1467-7652.2008.00346.x; Hackenberg M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042030; Hernandez JA, 2001, PLANT PHYSIOL, V127, P817, DOI 10.1104/pp.010188; Huang LK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093724; Huggett J, 2005, GENES IMMUN, V6, P279, DOI 10.1038/sj.gene.6364190; Jain M, 2006, BIOCHEM BIOPH RES CO, V345, P646, DOI 10.1016/j.bbrc.2006.04.140; Jones-Rhoades MW, 2006, ANNU REV PLANT BIOL, V57, P19, DOI 10.1146/annurev.arplant.57.032905.105218; Kantar M, 2011, PLANTA, V233, P471, DOI 10.1007/s00425-010-1309-4; Kantar M, 2010, FUNCT INTEGR GENOMIC, V10, P493, DOI 10.1007/s10142-010-0181-4; Kulcheski FR, 2010, ANAL BIOCHEM, V406, P185, DOI 10.1016/j.ab.2010.07.020; Lardizabal MN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036323; Lascano HR, 2001, AUST J PLANT PHYSIOL, V28, P1095, DOI 10.1071/PP01061; Lei YB, 2006, PHYSIOL PLANTARUM, V127, P182, DOI 10.1111/j.1399-3054.2006.00638.x; Li H, 2008, P NATL ACAD SCI USA, V105, P20179, DOI 10.1073/pnas.0807121105; Li QQ, 2012, BMC MOL BIOL, V13, DOI 10.1186/1471-2199-13-22; Lin YA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095445; Linsen SEV, 2009, NAT METHODS, V6, P474, DOI 10.1038/nmeth0709-474; Liu HH, 2008, RNA, V14, P836, DOI 10.1261/rna.895308; Ma SS, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003840; Matouskova P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086033; Mayer KFX, 2012, NATURE, V491, P711, DOI 10.1038/nature11543; MCKERSIE BD, 1993, PLANT PHYSIOL, V103, P1155, DOI 10.1104/pp.103.4.1155; McKersie BD, 1996, PLANT PHYSIOL, V111, P1177, DOI 10.1104/pp.111.4.1177; Meng Y, 2009, PLANT PHYSIOL, V149, P271, DOI 10.1104/pp.108.129031; MITTLER R, 1994, PLANT J, V5, P397, DOI 10.1111/j.1365-313X.1994.00397.x; Nicot N, 2005, J EXP BOT, V56, P2907, DOI 10.1093/jxb/eri285; Ohl F, 2005, J MOL MED, V83, P1014, DOI 10.1007/s00109-005-0703-z; Olbrich M, 2008, Z NATURFORSCH C, V63, P574; Paolacci AR, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-11; Peltier HJ, 2008, RNA, V14, P844, DOI 10.1261/rna.939908; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Pinheiro HA, 2004, PLANT SCI, V167, P1307, DOI 10.1016/j.plantsci.2004.06.027; Raabe CA, 2014, NUCLEIC ACIDS RES, V42, P1414, DOI 10.1093/nar/gkt1021; Radonic A, 2004, BIOCHEM BIOPH RES CO, V313, P856, DOI 10.1016/j.bbrc.2003.11.177; Rapacz M, 2012, ACTA PHYSIOL PLANT, V34, P1723, DOI 10.1007/s11738-012-0967-1; Reinhart BJ, 2002, GENE DEV, V16, P1616, DOI 10.1101/gad.1004402; Rueda-Martinez C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097449; Schmidt GW, 2010, MOL GENET GENOMICS, V283, P233, DOI 10.1007/s00438-010-0511-1; Schmittgen TD, 2000, J BIOCHEM BIOPH METH, V46, P69, DOI 10.1016/S0165-022X(00)00129-9; Schreiber AW, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-129; Selvey S, 2001, MOL CELL PROBE, V15, P307, DOI 10.1006/mcpr.2001.0376; Sharma P, 2005, PLANT GROWTH REGUL, V46, P209, DOI 10.1007/s10725-005-0002-2; Shen JQ, 2010, MOL GENET GENOMICS, V284, P477, DOI 10.1007/s00438-010-0581-0; Sunkar R, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-25; Tian XR, 2007, RUSS J PLANT PHYSL+, V54, P676, DOI 10.1134/S1021443707050160; Tong ZG, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-71; Tripathy BC, 2012, PLANT SIGNAL BEHAV, V7, P1621, DOI 10.4161/psb.22455; Turkan I, 2005, PLANT SCI, V168, P223, DOI 10.1016/j.plantsci.2004.07.032; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Varkonyi-Gasic E, 2007, PLANT METHODS, V3, DOI 10.1186/1746-4811-3-12; Wang FZ, 2005, J PLANT PHYSIOL, V162, P465, DOI 10.1016/j.jplph.2004.09.009; Wang TZ, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-367; Xie KB, 2012, PLANT PHYSIOL, V158, P1382, DOI 10.1104/pp.111.190488; Zhong H, 1999, BIOCHEM BIOPH RES CO, V259, P523, DOI 10.1006/bbrc.1999.0815; Zhou LG, 2010, J EXP BOT, V61, P4157, DOI 10.1093/jxb/erq237	74	44	46	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0118503	10.1371/journal.pone.0118503	http://dx.doi.org/10.1371/journal.pone.0118503			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25793505	Green Submitted, Green Published, gold			2022-12-27	WOS:000352084200025
J	Harper, AR; Wiechmann, AF; Moiseyev, G; Ma, JX; Summers, JA				Harper, Angelica R.; Wiechmann, Allan F.; Moiseyev, Gennadiy; Ma, Jian-Xing; Summers, Jody A.			Identification of Active Retinaldehyde Dehydrogenase Isoforms in the Postnatal Human Eye	PLOS ONE			English	Article							RETINOIC ACID SYNTHESIS; INDUCED MYOPIA; GUINEA-PIG; GROWTH; SCLERA; PURIFICATION; MAINTENANCE; VISION; SYSTEM; TISSUE	Background/Objectives Retinaldehyde dehydrogenase 2 (RALDH2) has been implicated in regulating all-trans-retinoic acid (atRA) synthesis in response to visual signals in animal models of myopia. To explore the potential role of retinaldehyde dehydrogenase (RALDH) enzymes and atRA in human postnatal ocular growth, RALDH activity, along with the distribution of RALDH1, RALDH2, and RALDH3 in the postnatal eye was determined. Methodology Retina, retinal pigment epithelium (RPE), choroid, and sclera were isolated from donor human eyes. RALDH catalytic activity was measured in tissue homogenates using an in vitro atRA synthesis assay together with HPLC quantification of synthesized atRA. Homogenates were compared by western blotting for RALDH1, RALDH2, and RALDH3 protein. Immunohistochemistry was used to determine RALDH1 and RALDH2 localization in posterior fundal layers of the human eye. Principal Findings In the postnatal human eye, RALDH catalytic activity was detected in the choroid (6.84 +/- 1.20 pmol/hr/ug), RPE (5.46 +/- 1.18 pmol/hr/ug), and retina (4.21 +/- 1.55 pmol/hr/ug), indicating the presence of active RALDH enzymes in these tissues. RALDH2 was most abundant in the choroid and RPE, in moderate abundance in the retina, and in relatively low abundance in sclera. RALDH1 was most abundant in the choroid, in moderate abundance in the sclera, and substantially reduced in the retina and RPE. RALDH3 was undetectable in human ocular fundal tissues. In the choroid, RALDH1 and RALDH2 localized to slender cells in the stroma, some of which were closely associated with blood vessels. Conclusions/Significance Results of this study demonstrated that: 1) Catalytically active RALDH is present in postnatal human retina, RPE, and choroid, 2) RALDH1 and RALDH2 isoforms are present in these ocular tissues, and 3) RALDH1 and RALDH2 are relatively abundant in the choroid and/or RPE. Taken together, these results suggest that RALDH1 and 2 may play a role in the regulation of postnatal ocular growth in humans through the synthesis of atRA.	[Harper, Angelica R.; Wiechmann, Allan F.; Summers, Jody A.] Univ Oklahoma, Hlth Sci Ctr, Dept Cell Biol, Oklahoma City, OK 73106 USA; [Moiseyev, Gennadiy; Ma, Jian-Xing] Univ Oklahoma, Hlth Sci Ctr, Dept Physiol, Oklahoma City, OK USA	University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center	Harper, AR (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Cell Biol, Oklahoma City, OK 73106 USA.	angelica-harper@ouhsc.edu			National Eye Institute [EY09391, EY012231]; NATIONAL EYE INSTITUTE [R01EY009391, R01EY012231] Funding Source: NIH RePORTER	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by the National Eye Institute EY09391 (JAS) and National Eye Institute EY012231 (JM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amory JK, 2014, FERTIL STERIL, V101, P960, DOI 10.1016/j.fertnstert.2013.12.053; Bitzer M, 2000, EXP EYE RES, V70, P97, DOI 10.1006/exer.1999.0762; Chen Y, 2013, PROG RETIN EYE RES, V33, P28, DOI 10.1016/j.preteyeres.2012.10.001; Chiang MY, 1998, NEURON, V21, P1353, DOI 10.1016/S0896-6273(00)80654-6; Collop AH, 2006, DEV BIOL, V291, P96, DOI 10.1016/j.ydbio.2005.12.018; Duester G, 2000, EUR J BIOCHEM, V267, P4315, DOI 10.1046/j.1432-1327.2000.01497.x; Duester G, 2003, CHEM-BIOL INTERACT, V143, P201, DOI 10.1016/S0009-2797(02)00204-1; Duester G, 2008, CELL, V134, P921, DOI 10.1016/j.cell.2008.09.002; Duester G, 2009, CHEM-BIOL INTERACT, V178, P178, DOI 10.1016/j.cbi.2008.09.004; EICHELE G, 1987, J CELL BIOL, V105, P1917, DOI 10.1083/jcb.105.4.1917; Farjo KM, 2011, DEVELOPMENTAL BIOLOG; Graham C, 1996, J BIOL CHEM, V271, P15623, DOI 10.1074/jbc.271.26.15623; Kane MA, 2008, ANAL CHEM, V80, P1702, DOI 10.1021/ac702030f; Kawakami Y, 2013, CELL REP, V3, P1337, DOI 10.1016/j.celrep.2013.05.010; KING G, 1993, BIOCHEM MOL BIOL INT, V31, P49; Kumar S, 2014, DEVELOPMENT, V141, P2972, DOI 10.1242/dev.112367; Lassen N, 2008, SEMIN CELL DEV BIOL, V19, P100, DOI 10.1016/j.semcdb.2007.10.004; LUFKIN T, 1993, P NATL ACAD SCI USA, V90, P7225, DOI 10.1073/pnas.90.15.7225; Ma JX, 2001, INVEST OPHTH VIS SCI, V42, P1429; Maden M, 2007, NAT REV NEUROSCI, V8, P755, DOI 10.1038/nrn2212; Mao JF, 2012, INT J OPHTHALMOL-CHI, V5, P670, DOI 10.3980/j.issn.2222-3959.2012.06.04; Marmorstein AD, 2002, INVEST OPHTH VIS SCI, V43, P2435; McCaffery P, 1996, P NATL ACAD SCI USA, V93, P12570, DOI 10.1073/pnas.93.22.12570; MCCAFFERY P, 1992, DEVELOPMENT, V115, P371; McFadden SA, 2004, VISION RES, V44, P643, DOI 10.1016/j.visres.2003.11.002; Mertz JR, 2000, EXP EYE RES, V70, P519, DOI 10.1006/exer.1999.0813; Misner DL, 2001, P NATL ACAD SCI USA, V98, P11714, DOI 10.1073/pnas.191369798; Napoli JL, 2011, BIOCH BIOPHYS ACTA; NICOTRA CMA, 1994, MOL CELL BIOCHEM, V132, P45, DOI 10.1007/BF00925674; NORTON TT, 1995, VISION RES, V35, P1271, DOI 10.1016/0042-6989(94)00243-F; RABIN J, 1981, INVEST OPHTH VIS SCI, V20, P561; Rada JA, 2000, INVEST OPHTH VIS SCI, V41, P2050; RADA JA, 1991, DEV BIOL, V147, P303, DOI 10.1016/0012-1606(91)90288-E; Saari JC, RETINOIDS BIOL CHEM, P351; Shimozono S, 2013, NATURE, V496, P363, DOI 10.1038/nature12037; Summers JA, 2013, EXP EYE RES, V114, P120, DOI 10.1016/j.exer.2013.03.008; Troilo D, 2006, INVEST OPHTH VIS SCI, V47, P1768, DOI 10.1167/iovs.05-0298; Wagner E, 2002, CEREB CORTEX, V12, P1244, DOI 10.1093/cercor/12.12.1244; White RJ, 2007, PLOS BIOL, V5, P2522, DOI 10.1371/journal.pbio.0050304; Zhang DQ, 2001, MOL VIS, V7, P247; Zhang DQ, 2000, P NATL ACAD SCI USA, V97, P14754, DOI 10.1073/pnas.010325897	41	14	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0122008	10.1371/journal.pone.0122008	http://dx.doi.org/10.1371/journal.pone.0122008			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25793304	Green Published, Green Submitted, gold			2022-12-27	WOS:000352083900165
J	Jung, SW; Thamphiwatana, S; Zhang, LF; Obonyo, M				Jung, Sung Woo; Thamphiwatana, Soracha; Zhang, Liangfang; Obonyo, Marygorret			Mechanism of Antibacterial Activity of Liposomal Linolenic Acid against Helicobacter pylori	PLOS ONE			English	Article							POLYUNSATURATED FATTY-ACIDS; PROPIONIBACTERIUM-ACNES; STAPHYLOCOCCUS-AUREUS; LAURIC ACIDS; INFECTION; MONOGLYCERIDES; MEMBRANE	Helicobacter pylori infects approximately half of the world population and is a major cause of gastritis, peptic ulcer, and gastric cancer. Moreover, this bacterium has quickly developed resistance to all major antibiotics. Recently, we developed a novel liposomal linolenic acid (LipoLLA) formulation, which showed potent bactericidal activity against several clinical isolated antibiotic-resistant strains of H. pylori including both the spiral and coccoid form. In addition, LipoLLA had superior in vivo efficacy compared to the standard triple therapy. Our data showed that LipoLLA associated with H. pylori cell membrane. Therefore, in this study, we investigated the possible antibacterial mechanism of LipoLLA against H. pylori. The antibacterial activity of LipoLLA (C18:3) was compared to that of liposomal stearic acid (LipoSA, C18: 0) and oleic acid (LipoOA, C18: 1). LipoLLA showed the most potent bactericidal effect and completely killed H. pylori within 5 min. The permeability of the outer membrane of H. pylori increased when treated with LipoOA and LipoLLA. Moreover, by detecting released adenosine triphosphate (ATP) from bacteria, we found that bacterial plasma membrane of H. pylori treated with LipoLLA exhibited significantly higher permeability than those treated with LipoOA, resulting in bacteria cell death. Furthermore, LipoLLA caused structural changes in the bacterial membrane within 5 min affecting membrane integrity and leading to leakage of cytoplasmic contents, observed by both transmission electron microscopy (TEM) and scanning electron microscopy (SEM). Our findings showing rapid bactericidal effect of LipoLLA suggest it is a very promising new, effective anti-H. pylori agent.	[Jung, Sung Woo; Obonyo, Marygorret] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Jung, Sung Woo] Korea Univ, Coll Med, Dept Internal Med, Seoul 136705, South Korea; [Thamphiwatana, Soracha; Zhang, Liangfang] Univ Calif San Diego, Dept NanoEngn, La Jolla, CA 92093 USA	University of California System; University of California San Diego; Korea University; Korea University Medicine (KU Medicine); University of California System; University of California San Diego	Zhang, LF (corresponding author), Univ Calif San Diego, Dept NanoEngn, La Jolla, CA 92093 USA.	zhang@ucsd.edu; mobonyo@ucsd.edu	Thamphiwatana, Soracha D./B-5338-2017	Thamphiwatana, Soracha D./0000-0003-3664-9488	National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health [R01DK095168]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK095168] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work is supported by the National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health (http://www.niddk.nih.gov/Pages/default.aspx) under Award Number R01DK095168. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brown JC, 2013, J APPL MICROBIOL, V114, P982, DOI 10.1111/jam.12129; Chiu HC, 2007, HELICOBACTER, V12, P74; Correia M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035072; Desbois AP, 2010, APPL MICROBIOL BIOT, V85, P1629, DOI 10.1007/s00253-009-2355-3; Duggan AE, 1997, BRIT J NUTR, V78, P515, DOI 10.1079/BJN19970171; GEIS G, 1990, J CLIN MICROBIOL, V28, P930, DOI 10.1128/JCM.28.5.930-932.1990; HAZELL SL, 1990, J CLIN MICROBIOL, V28, P1060, DOI 10.1128/JCM.28.5.1060-1061.1990; Helander IM, 2000, J APPL MICROBIOL, V88, P213, DOI 10.1046/j.1365-2672.2000.00971.x; Huang CM, 2011, BIOMATERIALS, V32, P214, DOI 10.1016/j.biomaterials.2010.08.076; KABARA JJ, 1972, ANTIMICROB AGENTS CH, V2, P23, DOI 10.1128/AAC.2.1.23; KHULUSI S, 1995, J MED MICROBIOL, V42, P276, DOI 10.1099/00222615-42-4-276; Lee A, 1997, GASTROENTEROLOGY, V112, P1386, DOI 10.1016/S0016-5085(97)70155-0; LOH B, 1984, ANTIMICROB AGENTS CH, V26, P546, DOI 10.1128/AAC.26.4.546; Malfertheiner P, 2012, GUT, V61, P646, DOI 10.1136/gutjnl-2012-302084; Megraud F, 2004, GUT, V53, P1374, DOI 10.1136/gut.2003.022111; O'Connor A, 2013, HELICOBACTER, V18, P58, DOI 10.1111/hel.12075; Obonyo M, 2007, INFECT IMMUN, V75, P2408, DOI 10.1128/IAI.01794-06; Obonyo M, 2012, MOL PHARMACEUT, V9, P2677, DOI 10.1021/mp300243w; Parsons JB, 2012, J BACTERIOL, V194, P5294, DOI 10.1128/JB.00743-12; Petschow BW, 1996, ANTIMICROB AGENTS CH, V40, P302, DOI 10.1128/AAC.40.2.302; Pornpattananangkul D, 2013, ADV HEALTHC MATER, V2, P1322, DOI 10.1002/adhm.201300002; SHEU CW, 1973, J BACTERIOL, V115, P869, DOI 10.1128/JB.115.3.869-875.1973; Suerbaum S, 2002, NEW ENGL J MED, V347, P1175, DOI 10.1056/NEJMra020542; Sun CQ, 2003, FEMS IMMUNOL MED MIC, V36, P9, DOI 10.1016/S0928-8244(03)00008-7; Thamphiwatana S, 2014, PNAS IN PRESS; Thamphiwatana S, 2013, LANGMUIR, V29, P12228, DOI 10.1021/la402695c; THOMPSON L, 1994, GUT, V35, P1557, DOI 10.1136/gut.35.11.1557; TRAUBLE H, 1973, BIOCHIM BIOPHYS ACTA, V307, P491, DOI 10.1016/0005-2736(73)90296-4; Yang DR, 2009, BIOMATERIALS, V30, P6035, DOI 10.1016/j.biomaterials.2009.07.033	29	39	40	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0116519	10.1371/journal.pone.0116519	http://dx.doi.org/10.1371/journal.pone.0116519			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25793403	Green Published, gold, Green Submitted			2022-12-27	WOS:000352084200006
J	Kobal, M; Bertoncelj, I; Pirotti, F; Dakskobler, I; Kutnar, L				Kobal, Milan; Bertoncelj, Irena; Pirotti, Francesco; Dakskobler, Igor; Kutnar, Lado			Using Lidar Data to Analyse Sinkhole Characteristics Relevant for Understory Vegetation under Forest Cover-Case Study of a High Karst Area in the Dinaric Mountains	PLOS ONE			English	Article							LASER SCANNER DATA; EBRO RIVER; MORPHOMETRIC-ANALYSIS; EVAPORITE KARST; AIRBORNE LIDAR; CLIMATE; DOLINE; TOPOGRAPHY; SUBSIDENCE; LANDSCAPE	In this article, we investigate the potential for detection and characterization of sinkholes under dense forest cover by using airborne laser scanning data. Laser pulse returns from the ground provide important data for the estimation of digital elevation model (DEM), which can be used for further processing. The main objectives of this study were to map and determine the geomorphometric characteristics of a large number of sinkholes and to investigate the correlations between geomorphology and vegetation in areas with such characteristics. The selected study area has very low anthropogenic influences and is particularly suitable for studying undisturbed karst sinkholes. The information extracted from this study regarding the shapes and depths of sinkholes show significant directionality for both orientation of sinkholes and their distribution over the area. Furthermore, significant differences in vegetation diversity and composition occur inside and outside the sinkholes, which indicates their presence has important ecological impacts.	[Kobal, Milan; Dakskobler, Igor; Kutnar, Lado] Univ Ljubljana, Dept Forestry & Renewable Forest Resources, Biotech Fac, Ljubljana, Slovenia; [Bertoncelj, Irena] Natl Inst Biol, Dept Freshwater & Terr Ecosyst Res, Ljubljana, Slovenia; [Pirotti, Francesco] Univ Padua, Interdept Res Ctr Geomat, Dept Land Environm Agr & Forestry, Padua, Italy; [Dakskobler, Igor] Slovenian Acad Sci & Arts, Jovan Hadzi Inst Biol, Res Ctr, Ljubljana, Slovenia	University of Ljubljana; National Institute of Biology - Slovenia; University of Padua; Slovenian Academy of Sciences & Arts (SASA)	Kobal, M (corresponding author), Univ Ljubljana, Dept Forestry & Renewable Forest Resources, Biotech Fac, Ljubljana, Slovenia.	milan.kobal@bf.uni-lj.si	Pirotti, Francesco/C-4906-2018	Pirotti, Francesco/0000-0002-4796-6406; Kutnar, Lado/0000-0001-9785-1263	Slovenian Research Agency; Man-For C. BD. [LIFE 09 ENV/IT/000078]	Slovenian Research Agency(Slovenian Research Agency - Slovenia); Man-For C. BD.	This work was supported by the Slovenian Research Agency (http://www.arrs.gov.si/sl/), a doctoral study grant from Milan Kobal and by a research Grant from the Man-For C. BD. (LIFE 09 ENV/IT/000078). Lidar data was acquired by the Slovenia Forestry Institute projects. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti G, 2013, IFOREST, V6, P156, DOI 10.3832/ifor0876-006; Angel JC, 2004, J CAVE KARST STUD, V66, P9; [Anonymous], 2014, HEXAGON BINNING OVER; ar J., 2001, ACTA CARSOLOGICA, V30, P239; Axelsson P., 2000, INT ARCH PHOTOGRAMM, V33, P110, DOI DOI 10.1016/J.ISPRSJPRS.2005.10.005; Bahtijarevic A, 1996, MORPHOMETRIC ANAL NO; Basso A, 2013, ENVIRON EARTH SCI, V70, P2545, DOI 10.1007/s12665-013-2297-z; Batori Z, 2014, INT J SPELEOL, V43, P15, DOI 10.5038/1827-806X.43.1.2; Batori Z, 2012, J CAVE KARST STUD, V74, P127, DOI 10.4311/2011LSC0216; Batori Z, 2011, ACTA BOT CROAT, V70, P147, DOI 10.2478/v10184-010-0018-1; Bell R, 2009, GEOPH RES ABSTR, P11; Bivand R., 2013, APPL SPATIAL DATA AN, V2nd; Braun-Blanquet J., 1964, PFLANZENSOZIOLOGIE G, V3; Bremer M, 2012, GEOMORPHOLOGY, V138, P49, DOI 10.1016/j.geomorph.2011.08.024; Burrough P., 1998, PRINCIPLES GEOGRAPHI; Castaneda C, 2009, EARTH SURF PROC LAND, V34, P1562, DOI 10.1002/esp.1848; Csardi G., 2005, INTERJ COMPLEX SYST, P1695; Dakskobler I., 2008, Zbornik Gozdarstva in Lesarstva, P3; de Carvalho OA, 2014, REMOTE SENS-BASEL, V6, P330, DOI 10.3390/rs6010330; Denizman C, 2003, J CAVE KARST STUD, V65, P29; Doctor D.H., 2013, P 13 MULTIDISCIPLINA, P449, DOI DOI 10.5038/9780979542275.1156; European Commission, 2007, EUR 27 BRUSS BE; Filin S, 2011, NAT HAZARDS, V58, P1135, DOI 10.1007/s11069-011-9718-7; Galve JP, 2009, GEOMORPHOLOGY, V108, P145, DOI 10.1016/j.geomorph.2008.12.018; Gams I, 2003, KRAS SLOVENIJI PROST; Gams I, 1974, KRAS ZGODOVINSKI NAR; Gao Y, 2005, ENVIRON GEOL, V47, P1083, DOI 10.1007/s00254-005-1241-2; Giraudoux P., 2013, PGIRMESS DATA ANAL E; Gutierrez F, 2014, EARTH-SCI REV, V138, P61, DOI 10.1016/j.earscirev.2014.08.002; Gutierrez-Santolalla F, 2005, ENVIRON GEOL, V48, P370, DOI 10.1007/s00254-005-1281-7; Habic P, 1986, ACTA CARSOLOGICA, V14, P39; Hijmans R.J., 2019, GEOGRAPHIC DATA ANAL; HILL MO, 1980, VEGETATIO, V42, P47, DOI 10.1007/BF00048870; Hofle B, 2011, Z GEOMORPHOL, V55, P1, DOI 10.1127/0372-8854/2011/0055S2-0043; Hofton MA, 2002, J GEODYN, V34, P491, DOI 10.1016/S0264-3707(02)00046-7; JENSON SK, 1988, PHOTOGRAMM ENG REM S, V54, P1593; KEMMERLY PR, 1976, GEOL SOC AM BULL, V87, P42, DOI 10.1130/0016-7606(1976)87<42:DDCITC>2.0.CO;2; Kobal M, 2015, FOREST ECOL MANAG, V337, P77, DOI 10.1016/j.foreco.2014.10.017; Kobler A, 2007, REMOTE SENS ENVIRON, V108, P9, DOI 10.1016/j.rse.2006.10.013; Kunaver J., 1983, GEOGRAFSKI ZBORNIK, V22, P197; Kutnar L, 2011, SUMAR LIST, V135, P113; Laurin GV, 2014, ISPRS J PHOTOGRAMM, V89, P49, DOI 10.1016/j.isprsjprs.2014.01.001; LAVALLE P, 1967, ANN ASSOC AM GEOGR, V57, P49, DOI 10.1111/j.1467-8306.1967.tb00590.x; Mallet C, 2009, ISPRS J PHOTOGRAMM, V64, P1, DOI 10.1016/j.isprsjprs.2008.09.007; Meng XL, 2010, REMOTE SENS-BASEL, V2, P833, DOI 10.3390/rs2030833; Nagel TA, 2015, CAN J FOREST RES, V45, P266, DOI 10.1139/cjfr-2014-0249; Nagel TA, 2014, ECOL APPL, V24, P663, DOI 10.1890/13-0632.1; Newby PRT, 2012, PHOTOGRAMM REC, V27, P360, DOI 10.1111/j.1477-9730.2012.00693.x; Obu J, 2013, GEOD VESTN, V57, P260, DOI 10.15292/geodetski-vestnik.2013.02.260-270; Ogden AE, 1988, P C ENV PROBL KARST; Oksanen J., VEGAN INTRO ORDINATI; Ozkan K, 2010, J ENVIRON BIOL, V31, P51; Passalacqua P, 2012, WATER RESOUR RES, V48, DOI 10.1029/2011WR010958; Pebesma E.J., 2005, R NEWS; Pirotti F, 2011, IFOREST, V4, P100, DOI 10.3832/ifor0562-004; Pirotti F, 2013, APPL GEOMAT, V5, P311, DOI 10.1007/s12518-013-0119-3; Pirotti F, 2013, EUR J REMOTE SENS, V46, P66, DOI 10.5721/EuJRS20134605; Pirotti F, 2010, FORESTS, V1, P194, DOI 10.3390/f1040194; Podobnikar T, 2009, ENVIRON GEOL, V58, P257, DOI 10.1007/s00254-008-1607-3; PUNCER I, 1974, Fragmenta Floristica et Geobotanica, V20, P41; R Core Team, 2018, R LANG ENV STAT COMP; Rahimi M., 2013, P 13 MULT C SINKH EN, P469; SCHUMM SA, 1956, GEOL SOC AM BULL, V67, P597, DOI 10.1130/0016-7606(1956)67[597:EODSAS]2.0.CO;2; Seale LD, 2008, ENVIRON GEOL, V54, P995, DOI 10.1007/s00254-007-0890-8; Shamos M.I., 1978, THESIS YALE U; Siegel S, 1988, NONPARAMETRIC STAT B, V2; Sofia G, 2013, EARTH SURF PROC LAND, V38, P1116, DOI 10.1002/esp.3363; Surina B, 2014, SUMAR LIST, V138, P259; Surina Bostjan, 2013, Hacquetia, V12, P11, DOI [10.2478/HACQ-2013-0002, 10.2478/hacq-2013-0002]; Sustersic F, 1994, ACTA CARSOLOGICA, V23, P123; Telbisz T, 2009, HRVAT GEORGR GLAS, V71, P5; Ticci M, GEOM 2011 C P, P7; Varhola A, 2013, J HYDROL, V487, P70, DOI 10.1016/j.jhydrol.2013.02.032; Vilhar U, 2005, EUR J FOREST RES, V124, P165, DOI 10.1007/s10342-005-0067-5; Vilhar U, 2012, EUR J FOREST RES, V131, P1381, DOI 10.1007/s10342-012-0605-x; Vilhar U, 2010, EUR J FOREST RES, V129, P729, DOI 10.1007/s10342-010-0379-y; Weishampel JF, 2011, J CAVE KARST STUD, V73, P187, DOI 10.4311/2010EX0179R1; Williams P., 1971, Z GEOMORPHOL, V15, P40; WILLIAMS PW, 1972, GEOL SOC AM BULL, V83, P761, DOI 10.1130/0016-7606(1972)83[761:MAOPKI]2.0.CO;2; Witze A, 2013, NATURE, V504, P196, DOI 10.1038/504196a	80	55	56	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0122070	10.1371/journal.pone.0122070	http://dx.doi.org/10.1371/journal.pone.0122070			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25793871	Green Published, Green Submitted, gold			2022-12-27	WOS:000352083900170
J	Lv, Q; Luo, FL; Zhao, XY; Liu, Y; Hu, GB; Sun, CD; Li, X; Chen, KS				Lv, Qiang; Luo, Fenglei; Zhao, Xiaoyong; Liu, Yu; Hu, Guibing; Sun, Chongde; Li, Xian; Chen, Kunsong			Identification of Proanthocyanidins from Litchi (Litchi chinensis Sonn.) Pulp by LC-ESI-Q-TOF-MS and Their Antioxidant Activity	PLOS ONE			English	Article							POLYMERIC PROCYANIDINS; PHENOLIC-COMPOUNDS; OLIGOMERIC PROANTHOCYANIDINS; MASS-SPECTROMETRY; GRAPE; FLAVONOIDS; APPLE; FOODS; COMPONENTS; PRODUCTS	Content of total proanthocyanidins as well as total phenolics, flavonoids, antioxidant activities were evaluated for litchi (Litchi chinensis Sonn.) pulp of 32 cultivars. One cultivar, Hemaoli, showed the highest total proanthocyanidins and total phenolics, and DPPH or ABTS radical scavenging activities. ESI-MS and NMR analysis of the Hemaoli pulp crude extracts (HPCE) showed that procyandins composed of (epi) catechin unites with degree of polymerization (DP) of 2-6 were dominant proanthocyanidins in HPCE. After the HPCE was fractionated by a Sephadex LH-20 column, 32 procyanidins were identified by LC-ESI-Q-TOF-MS in litchi pulp for the first time. Quantification of individual procyanidin in HPCE indicated that epicatechin, procyanidin B2, procyanidin C1 and A-type procyanidin trimer were the main procyanidins. The radical scavenging activities of different fractions of HPCE as well as six procyanidins standards were evaluated by both DPPH and ABTS assays. HPCE fractions showed similar antioxidant activities with those of Vc and six individual procyanidins, the IC50 of which ranged from 1.88 +/- 0.01 to 2.82 +/- 0.10 mu g/ml for DPPH assay, and from 1.52 +/- 0.17 to 2.71 +/- 0.15 mu g/ml for ABTS assay. Such results indicate that litchi cultivars rich in proanthocyanidins are good resources of dietary antioxidants and have the potential to contribute to human health.	[Lv, Qiang; Luo, Fenglei; Zhao, Xiaoyong; Sun, Chongde; Li, Xian; Chen, Kunsong] Zhejiang Univ, Lab Fruit Qual Biol, State Agr Minist, Lab Hort Plant Growth Dev & Qual Improvement, Hangzhou 310003, Zhejiang, Peoples R China; [Liu, Yu] Zhejiang Univ, Coll Life Sci, Hangzhou 310003, Zhejiang, Peoples R China; [Hu, Guibing] South China Agr Univ, Coll Hort, Guangzhou, Guangdong, Peoples R China	Zhejiang University; Zhejiang University; South China Agricultural University	Li, X (corresponding author), Zhejiang Univ, Lab Fruit Qual Biol, State Agr Minist, Lab Hort Plant Growth Dev & Qual Improvement, Zijingang Campus, Hangzhou 310003, Zhejiang, Peoples R China.	xianli@zju.edu.cn		zhao, xiaoyong/0000-0002-7606-900X; Li, Xian/0000-0002-9526-9031	National Project of Scientific and Technical Supporting Programs - Ministry of Science & Technology of China [2012BAD33B08]; Program for New Century Excellent Talents in University of Ministry of Education of China	National Project of Scientific and Technical Supporting Programs - Ministry of Science & Technology of China(Ministry of Science and Technology, China); Program for New Century Excellent Talents in University of Ministry of Education of China(Program for New Century Excellent Talents in University (NCET))	This work was supported by the National Project of Scientific and Technical Supporting Programs Funded by the Ministry of Science & Technology of China (2012BAD33B08) and the Program for New Century Excellent Talents in University of Ministry of Education of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Actis-Goretta L, 2008, J NUTR BIOCHEM, V19, P797, DOI 10.1016/j.jnutbio.2007.10.004; Amarowicz R, 2010, FOOD CHEM, V121, P705, DOI 10.1016/j.foodchem.2010.01.009; Bagchi DB, 2003, MUTAT RES-FUND MOL M, V523, P87, DOI 10.1016/S0027-5107(02)00324-X; Bak MJ, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/409321; BRAND-WILLIAMS W, 1995, FOOD SCI TECHNOL-LEB, V28, P25; Brat P, 2006, J NUTR, V136, P2368, DOI 10.1093/jn/136.9.2368; Cai YZ, 2004, LIFE SCI, V74, P2157, DOI 10.1016/j.lfs.2003.09.047; Cao GH, 1997, FREE RADICAL BIO MED, V22, P749, DOI 10.1016/S0891-5849(96)00351-6; de Freitas VAP, 1998, PHYTOCHEMISTRY, V49, P1435, DOI 10.1016/S0031-9422(98)00107-1; Deprez S, 2001, ANTIOXID REDOX SIGN, V3, P957, DOI 10.1089/152308601317203503; Es-Safi NE, 2006, J AGR FOOD CHEM, V54, P6969, DOI 10.1021/jf061090f; Flamini R, 2003, MASS SPECTROM REV, V22, P218, DOI 10.1002/mas.10052; Fu C, 2007, J AGR FOOD CHEM, V55, P7689, DOI 10.1021/jf071166n; Gabetta B, 2000, FITOTERAPIA, V71, P162, DOI 10.1016/S0367-326X(99)00161-6; Gu LW, 2004, J NUTR, V134, P613, DOI 10.1093/jn/134.3.613; Gu LW, 2003, J AGR FOOD CHEM, V51, P7513, DOI 10.1021/jf034815d; Gu LW, 2002, J AGR FOOD CHEM, V50, P4852, DOI 10.1021/jf020214v; Guyot S, 1998, J AGR FOOD CHEM, V46, P1698, DOI 10.1021/jf970832p; Hagerman AE, 1998, J AGR FOOD CHEM, V46, P1887, DOI 10.1021/jf970975b; Jerez M, 2009, RAPID COMMUN MASS SP, V23, P4013, DOI 10.1002/rcm.4342; Jia Z, 1999, FOOD CHEM, V64, P555, DOI 10.1016/S0308-8146(98)00102-2; Jiao LH, 2013, FOOD CHEM TOXICOL, V56, P398, DOI 10.1016/j.fct.2013.02.049; Le Roux E, 1998, PHYTOCHEMISTRY, V48, P1251, DOI 10.1016/S0031-9422(97)01070-4; Li SY, 2012, FOOD CHEM, V135, P31, DOI 10.1016/j.foodchem.2012.04.039; Lin LZ, 2014, J AGR FOOD CHEM, V62, P9387, DOI 10.1021/jf501011y; Lv Q, 2014, J FUNCT FOODS, V7, P621, DOI 10.1016/j.jff.2013.12.023; Muchuweti M, 2005, J SCI FOOD AGR, V85, P1647, DOI 10.1002/jsfa.2163; OhnishiKameyama M, 1997, RAPID COMMUN MASS SP, V11, P31, DOI 10.1002/(SICI)1097-0231(19970115)11:1<31::AID-RCM784>3.0.CO;2-T; Ou KQ, 2014, J FUNCT FOODS, V7, P43, DOI 10.1016/j.jff.2013.08.004; Payne MJ, 2010, J AOAC INT, V93, P89; Pesca MS, 2013, J NAT PROD, V76, P29, DOI 10.1021/np300614u; PORTER LJ, 1994, FLAVONOIDS ADV RES 1, P23; Prasad KN, 2009, FOOD CHEM, V116, P1, DOI 10.1016/j.foodchem.2009.01.079; Prior RL, 2005, PHYTOCHEMISTRY, V66, P2264, DOI 10.1016/j.phytochem.2005.03.025; Prior RL, 2001, J AGR FOOD CHEM, V49, P1270, DOI 10.1021/jf001211q; Rasmussen SE, 2005, MOL NUTR FOOD RES, V49, P159, DOI 10.1002/mnfr.200400082; Re R, 1999, FREE RADICAL BIO MED, V26, P1231, DOI 10.1016/S0891-5849(98)00315-3; Gonzalez-Centeno MR, 2012, J AGR FOOD CHEM, V60, P11850, DOI 10.1021/jf303047k; Schieber A, 2001, J CHROMATOGR A, V910, P265, DOI 10.1016/S0021-9673(00)01217-6; Xu XY, 2010, J AGR FOOD CHEM, V58, P11667, DOI 10.1021/jf1033202; Yang DJ, 2012, FOOD CHEM TOXICOL, V50, P3056, DOI 10.1016/j.fct.2012.06.011; Zhao MM, 2006, FOOD CHEM, V98, P539, DOI 10.1016/j.foodchem.2005.06.028; Zhou HC, 2011, FOOD RES INT, V44, P613, DOI 10.1016/j.foodres.2010.12.016	43	61	64	5	82	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0120480	10.1371/journal.pone.0120480	http://dx.doi.org/10.1371/journal.pone.0120480			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25793378	Green Published, gold, Green Submitted			2022-12-27	WOS:000352083900040
J	Qu, XQ; Proll, M; Neuhoff, C; Zhang, R; Cinar, MU; Hossain, MM; Tesfaye, D; Grosse-Brinkhaus, C; Salilew-Wondim, D; Tholen, E; Looft, C; Holker, M; Schellander, K; Uddin, MJ				Qu, Xueqi; Proell, Maren; Neuhoff, Christiane; Zhang, Rui; Cinar, Mehmet Ulas; Hossain, Md. Munir; Tesfaye, Dawit; Grosse-Brinkhaus, Christine; Salilew-Wondim, Dessie; Tholen, Ernst; Looft, Christian; Hoelker, Michael; Schellander, Karl; Uddin, Muhammad Jasim			Sulforaphane Epigenetically Regulates Innate Immune Responses of Porcine Monocyte-Derived Dendritic Cells Induced with Lipopolysaccharide	PLOS ONE			English	Article							TOLL-LIKE RECEPTOR; NF-KAPPA-B; NECROSIS-FACTOR-ALPHA; PROINFLAMMATORY GENE-EXPRESSION; BLOOD MONONUCLEAR-CELLS; HISTONE DEACETYLASES; TNF-ALPHA; INFLAMMATORY RESPONSES; MEDIATED ACTIVATION; CYTOKINE PRODUCTION	Histone acetylation, regulated by histone deacetylases (HDACs) is a key epigenetic mechanism controlling gene expressions. Although dendritic cells (DCs) are playing pivotal roles in host immune responses, the effect of epigenetic modulation of DCs immune responses remains unknown. Sulforaphane (SFN) as a HDAC inhibitor has anti-inflammatory properties, which is used to investigate the epigenetic regulation of LPS-induced immune gene and HDAC family gene expressions in porcine monocyte-derived dendritic cells (moDCs). SFN was found to inhibit the lipopolysaccharide LPS induced HDAC6, HDAC10 and DNA methyltransferase (DNMT3a) gene expression, whereas up-regulated the expression of DNMT1 gene. Additionally, SFN was observed to inhibit the global HDAC activity, and suppressed moDCs differentiation from immature to mature DCs through down-regulating the CD40, CD80 and CD86 expression and led further to enhanced phagocytosis of moDCs. The SFN pre-treated of moDCs directly altered the LPS-induced TLR4 and MD2 gene expression and dynamically regulated the TLR4-induced activity of transcription factor NF-kappa B and TBP. SFN showed a protective role in LPS induced cell apoptosis through suppressing the IRF6 and TGF-beta 1 production. SFN impaired the pro-inflammatory cytokine TNF-alpha and IL-1 beta secretion into the cell culture supernatants that were induced in moDCs by LPS stimulation, whereas SFN increased the cellular-resident TNF-alpha accumulation. This study demonstrates that through the epigenetic mechanism the HDAC inhibitor SFN could modulate the LPS induced innate immune responses of porcine moDCs.	[Qu, Xueqi; Proell, Maren; Neuhoff, Christiane; Zhang, Rui; Cinar, Mehmet Ulas; Hossain, Md. Munir; Tesfaye, Dawit; Grosse-Brinkhaus, Christine; Salilew-Wondim, Dessie; Tholen, Ernst; Looft, Christian; Hoelker, Michael; Schellander, Karl; Uddin, Muhammad Jasim] Univ Bonn, Inst Anim Sci, D-53115 Bonn, Germany; [Cinar, Mehmet Ulas] Erciyes Univ, Dept Anim Sci, Fac Agr, TR-38039 Kayseri, Turkey; [Hossain, Md. Munir] Bangladesh Agr Univ, Fac Anim Husb, Dept Anim Breeding & Genet, Mymensingh 2202, Bangladesh	University of Bonn; Erciyes University; Bangladesh Agricultural University (BAU)	Uddin, MJ (corresponding author), Univ Bonn, Inst Anim Sci, Endenicher Allee 15, D-53115 Bonn, Germany.	judd@itw.uni-bonn.de	Hossain, Munir/C-6692-2008; Uddin, Muhammad Jasim/N-3866-2013; Große-Brinkhaus, Christine/AAF-6712-2020; Uddin, Muhammad Jasim/P-8497-2019	Große-Brinkhaus, Christine/0000-0002-6190-4463; Uddin, Muhammad Jasim/0000-0002-6732-5534; Wondim, Dr. Dessie Salilew/0000-0002-8756-0865; Uddin, Dr. Md. Jashim/0000-0002-3243-3455; Hossain, Dr Md Munir/0000-0002-8595-7578	China Scholarship Council	China Scholarship Council(China Scholarship Council)	We thank Ludger Buschen for animal husbandry; Birgit Koch-Fabritius and Helga Brodesser for technical assistance; Elmar Endl, Andreas Dolf and Peter Wurst for flow cytometry analysis (Institutes of Molecular Medicine and Experimental Immunology, University of Bonn); Nicole Kramer for phagocytosis measurement (Life and Medical Science (LIMES) Institute, Program Unit Chemical Biology and Medicinal Chemistry, University of Bonn); Huitao Fan and Mohammad Ariful Islam for sample collection. We would like to extend acknowledgment to China Scholarship Council for supporting Xueqi Qu.	Andreakos E, 2004, BLOOD, V103, P2229, DOI 10.1182/blood-2003-04-1356; Apostolaki M, 2010, CURR DIR AUTOIMMUN, V11, P1, DOI 10.1159/000289195; Ashburner BP, 2001, MOL CELL BIOL, V21, P7065, DOI 10.1128/MCB.21.20.7065-7077.2001; Aung HT, 2006, FASEB J, V20, P1315, DOI 10.1096/fj.05-5360com; Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Baumann A, 2014, J IMMUNOL, V193, P364, DOI 10.4049/jimmunol.1303219; Berghe W.V., 2006, BIOCHEM PHARMACOL, V72, P1114, DOI DOI 10.1016/j.bcp.2006.07.012; Bierne H, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a010272; Bode KA, 2007, IMMUNOLOGY, V122, P596, DOI 10.1111/j.1365-2567.2007.02678.x; Calao M, 2008, TRENDS BIOCHEM SCI, V33, P339, DOI 10.1016/j.tibs.2008.04.015; Cao WS, 2008, J EXP MED, V205, P1491, DOI 10.1084/jem.20071728; Carrasco CP, 2001, IMMUNOLOGY, V104, P175, DOI 10.1046/j.1365-2567.2001.01299.x; Dearman RJ, 2009, IMMUNOLOGY, V126, P475, DOI 10.1111/j.1365-2567.2008.02922.x; Do DP, 2010, INT J PHARMACEUT, V386, P114, DOI 10.1016/j.ijpharm.2009.11.009; Facci MR, 2010, IMMUNOLOGY, V129, P396, DOI 10.1111/j.1365-2567.2009.03192.x; Fahey JW, 2002, P NATL ACAD SCI USA, V99, P7610, DOI 10.1073/pnas.112203099; Fan HT, 2012, EPIGENETICS-US, V7, P1379, DOI 10.4161/epi.22609; de Oliveira JMPF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092980; Halili MA, 2010, J LEUKOCYTE BIOL, V87, P1103, DOI 10.1189/jlb.0509363; Hu N, 2012, GENE DEV, V26, P2380, DOI 10.1101/gad.198747.112; Ingraham CR, 2006, NAT GENET, V38, P1335, DOI 10.1038/ng1903; Inoue A, 2012, ARTHRITIS RHEUM-US, V64, P3877, DOI 10.1002/art.34666; Jones B, 2006, EMBO J, V25, P2443, DOI 10.1038/sj.emboj.7601148; Joyee AG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083463; Kallifatidis G, 2009, GUT, V58, P949, DOI 10.1136/gut.2008.149039; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kim SY, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.95; Konwinski RR, 2004, TOXICOL LETT, V153, P343, DOI 10.1016/j.toxlet.2004.06.006; Koo JE, 2013, BIOCHEM BIOPH RES CO, V434, P600, DOI 10.1016/j.bbrc.2013.03.123; Kotian S, 2011, J BIOL CHEM, V286, P7722, DOI 10.1074/jbc.C110.194233; Kushwah R, 2009, J IMMUNOL, V183, P7104, DOI 10.4049/jimmunol.0900824; Lam HC, 2013, J CLIN INVEST, V123, P5212, DOI 10.1172/JCI69636; Li CJ, 2009, FUNCT INTEGR GENOMIC, V9, P335, DOI 10.1007/s10142-009-0116-0; Liu H, 2013, P NATL ACAD SCI USA, V110, P19065, DOI 10.1073/pnas.1318247110; Lunney JK, 2007, INT J BIOL SCI, V3, P179, DOI 10.7150/ijbs.3.179; Misaki K, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3339; Moon DO, 2009, CANCER LETT, V274, P132, DOI 10.1016/j.canlet.2008.09.013; Moore TA, 2005, CLIN INFECT DIS, V41, pS213, DOI 10.1086/430126; Moore TA, 2003, INFECT IMMUN, V71, P4891, DOI 10.1128/IAI.71.9.4891-4900.2003; Mukherjee R, 2012, CELL PHYSIOL BIOCHEM, V29, P617, DOI 10.1159/000338515; Mussa T, 2013, VET IMMUNOL IMMUNOP, V154, P25, DOI 10.1016/j.vetimm.2013.04.004; Mussa T, 2011, VIROLOGY, V420, P125, DOI 10.1016/j.virol.2011.09.001; Myzak MC, 2006, FASEB J, V20, P506, DOI 10.1096/fj.05-4785fje; Myzak MC, 2004, CANCER RES, V64, P5767, DOI 10.1158/0008-5472.CAN-04-1326; Myzak MC, 2007, EXP BIOL MED, V232, P227; Ngkelo A, 2012, J INFLAMM-LOND, V9, DOI 10.1186/1476-9255-9-1; Park JH, 2008, BIOCHEM BIOPH RES CO, V368, P318, DOI 10.1016/j.bbrc.2008.01.056; Pham NA, 2004, MOL CANCER THER, V3, P1239; Popadin K, 2013, AM J HUM GENET, V93, P1015, DOI 10.1016/j.ajhg.2013.10.022; Provenzano MJ, 2007, HEARING RES, V233, P1, DOI 10.1016/j.heares.2007.07.002; Qu XQ, 2015, INNATE IMMUN-LONDON, V21, P242, DOI 10.1177/1753425914526266; Raymond CR, 2005, VET IMMUNOL IMMUNOP, V107, P235, DOI 10.1016/j.vetimm.2005.05.008; Ren Y, 2008, J IMMUNOL, V180, P4978, DOI 10.4049/jimmunol.180.7.4978; Roger T, 2011, BLOOD, V117, P1205, DOI 10.1182/blood-2010-05-284711; Rozen S, 2000, Methods Mol Biol, V132, P365; Ruud Tom E, 2007, Surg Infect (Larchmt), V8, P495, DOI 10.1089/sur.2006.083; SAHLIN S, 1983, J IMMUNOL METHODS, V60, P115, DOI 10.1016/0022-1759(83)90340-X; Savina A, 2007, IMMUNOL REV, V219, P143, DOI 10.1111/j.1600-065X.2007.00552.x; Schwab M, 2008, IMMUNOLOGY, V125, P241, DOI 10.1111/j.1365-2567.2008.02834.x; Seki T, 2012, NAT PROTOC, V7, P718, DOI 10.1038/nprot.2012.015; Serrador JM, 2004, IMMUNITY, V20, P417, DOI 10.1016/S1074-7613(04)00078-0; Shakespear MR, 2011, TRENDS IMMUNOL, V32, P335, DOI 10.1016/j.it.2011.04.001; Silva-Campa E, 2010, VIROLOGY, V396, P264, DOI 10.1016/j.virol.2009.10.024; Uddin MJ, 2012, VET IMMUNOL IMMUNOP, V147, P211, DOI 10.1016/j.vetimm.2012.04.020; Vincent IE, 2003, J VIROL, V77, P13288, DOI 10.1128/JVI.77.24.13288-13300.2003; Wade PA, 2001, HUM MOL GENET, V10, P693, DOI 10.1093/hmg/10.7.693; Wellmer A, 2001, INFECT IMMUN, V69, P6881, DOI 10.1128/IAI.69.11.6881-6886.2001; Yamaguchi Y, 1997, STEM CELLS, V15, P144, DOI 10.1002/stem.150144; Youn HS, 2010, J IMMUNOL, V184, P411, DOI 10.4049/jimmunol.0803988; ZDS, 2003, RICHTL FUER STAT MAS; Zhang Y, 1999, BLOOD, V93, P1208, DOI 10.1182/blood.V93.4.1208.404k05_1208_1220; Zhu HQ, 2010, J BIOL CHEM, V285, P9429, DOI 10.1074/jbc.M109.071274	73	24	25	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0121574	10.1371/journal.pone.0121574	http://dx.doi.org/10.1371/journal.pone.0121574			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25793534	gold, Green Published, Green Submitted			2022-12-27	WOS:000352083900140
J	Torstensson, T; Butler, S; Lindgren, A; Peterson, M; Eriksson, M; Kristiansson, P				Torstensson, Thomas; Butler, Stephen; Lindgren, Anne; Peterson, Magnus; Eriksson, Margaretha; Kristiansson, Per			Referred Pain Patterns Provoked on Intra-Pelvic Structures among Women with and without Chronic Pelvic Pain: A Descriptive Study	PLOS ONE			English	Article							LOW-BACK-PAIN; MUSCLE PAIN; GIRDLE PAIN; PREGNANCY; RELIABILITY; HEALTH; PREVALENCE; INJECTIONS; DIAGNOSIS; SPINE	Objectives To describe referred pain patterns provoked from intra-pelvic structures in women with chronic pelvic pain (CPP) persisting after childbirth with the purpose to improve diagnostics and give implications for treatment. Materials and Methods In this descriptive and comparative study 36 parous women with CPP were recruited from a physiotherapy department waiting list and by advertisements in newspapers. A control group of 29 parous women without CPP was consecutively assessed for eligibility from a midwifery surgery. Inclusion criterion for CPP was: moderate pain in the sacral region persisting at least six months after childbirth confirmed by pelvic pain provocation tests. Exclusion criteria in groups with and without CPP were: persistent back or pelvic pain with onset prior to pregnancy, previous back surgery and positive neurological signs. Pain was provoked by palpation of 13 predetermined intra-pelvic anatomical landmarks. The referred pain distribution was expressed in pain drawings and described in pain maps and calculated referred pain areas. Results Pain provoked by palpation of the posterior intra-pelvic landmarks was mostly referred to the sacral region and pain provoked by palpation of the ischial and pubic bones was mostly referred to the groin and pubic regions, with or without pain referred down the ipsilateral leg. The average pain distribution area provoked by palpation of all 13 anatomical landmarks was 30.3 mm(2) (19.2 to 53.7) in women with CPP as compared to 3.2 mm(2) (1.0 to 5.1) in women without CPP, p< 0.0001. Conclusions Referred pain patterns provoked from intra-pelvic landmarks in women with CPP are consistent with sclerotomal sensory innervation. Magnification of referred pain patterns indicates allodynia and central sensitization. The results suggest that pain mapping can be used to evaluate and confirm the pain experience among women with CPP and contribute to diagnosis.	[Torstensson, Thomas; Butler, Stephen; Lindgren, Anne; Peterson, Magnus; Eriksson, Margaretha; Kristiansson, Per] Uppsala Univ, Dept Publ Hlth & Caring Sci, Uppsala, Sweden; [Torstensson, Thomas; Lindgren, Anne] Sundsvall Hosp, Dept Physiotherapy, Sundsvall, Sweden; [Butler, Stephen; Peterson, Magnus] Univ Uppsala Hosp, Pain Ctr, Uppsala, Sweden	Uppsala University; Uppsala University; Uppsala University Hospital	Torstensson, T (corresponding author), Uppsala Univ, Dept Publ Hlth & Caring Sci, Uppsala, Sweden.	thomas.torstensson@pubcare.uu.se			Vasternorrland County Council; Medical Faculty, Uppsala University	Vasternorrland County Council; Medical Faculty, Uppsala University	This study was supported by grants from the Vasternorrland County Council and Medical Faculty, Uppsala University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert H, 2000, EUR SPINE J, V9, P161, DOI 10.1007/s005860050228; Albert H, 2001, ACTA OBSTET GYN SCAN, V80, P505, DOI 10.1034/j.1600-0412.2001.080006505.x; Arendt-Nielsen L, 2001, CLIN J PAIN, V17, P11, DOI 10.1097/00002508-200103000-00003; Berkley KJ, 2005, PHYSIOL BEHAV, V86, P272, DOI 10.1016/j.physbeh.2005.08.013; Bonica JJ, 1990, MANAGEMENT PAIN, P133; Brown PB, 1997, SOMATOSENS MOT RES, V14, P93, DOI 10.1080/08990229771097; CARLSSON AM, 1983, PAIN, V16, P87, DOI 10.1016/0304-3959(83)90088-X; Dalpiaz O, 2008, BJU INT, V102, P1061, DOI 10.1111/j.1464-410X.2008.07771.x; Dejerine J, 1914, PARIS, V1-2, P1; FAST A, 1987, SPINE, V12, P368, DOI 10.1097/00007632-198705000-00011; Fung B K, 1993, Zhonghua Yi Xue Za Zhi (Taipei), V51, P103; GILLETTE RG, 1993, PAIN, V54, P85, DOI 10.1016/0304-3959(93)90103-V; GravenNielsen T, 1997, PAIN, V69, P111, DOI 10.1016/S0304-3959(96)03243-5; Gutke A, 2006, SPINE, V31, pE149, DOI 10.1097/01.brs.0000201259.63363.e1; Inman VT, 1944, J NERV MENT DIS, V99, P660, DOI 10.1097/00005053-194405000-00023; Ivanusic JJ, 2007, CLIN ANAT, V20, P956, DOI 10.1002/ca.20555; Kang YS, 2000, DIS COLON RECTUM, V43, P1288, DOI 10.1007/BF02237438; Kellgren JH, 1938, BRIT MED J, V1, P325, DOI 10.1136/bmj.1.4023.325; Koninckx PR, 1997, HUM REPROD, V12, P1785, DOI 10.1093/humrep/12.8.1785; Kristiansson P, 1996, SPINE, V21, P702, DOI 10.1097/00007632-199603150-00008; Langford CF, 2007, NEUROUROL URODYNAM, V26, P59, DOI 10.1002/nau.20393; Latremoliere A, 2009, J PAIN, V10, P895, DOI 10.1016/j.jpain.2009.06.012; Latthe P, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-177; Mathias SD, 1996, OBSTET GYNECOL, V87, P321, DOI 10.1016/0029-7844(95)00458-0; Merskey H., 1994, PAIN S3, V3, pS1; Merskey H, 1994, CLASSIFICATION CHRON, DOI DOI 10.1016/0304-3959(86)90113-2; Midttun A, 1986, MODERN MANUAL THERAP, P815; Mousavi SJ, 2007, SPINE, V32, pE100, DOI 10.1097/01.brs.0000254123.26649.6e; SALEN BA, 1994, J CLIN EPIDEMIOL, V47, P1423, DOI 10.1016/0895-4356(94)90086-8; SIMONS DG, 1983, POSTGRAD MED, V73, P99, DOI 10.1080/00325481.1983.11697758; Simons DG, 1983, POSTGRAD MED, V73, P73; Southerst D, 2013, J MANIP PHYSIOL THER, V36, P450, DOI 10.1016/j.jmpt.2013.05.021; Srinivasan Arun K, 2007, Curr Pain Headache Rep, V11, P359, DOI 10.1007/s11916-007-0218-0; Swanton A, 2006, BJOG-INT J OBSTET GY, V113, P792, DOI 10.1111/j.1471-0528.2006.00976.x; Takahashi Y, 2003, SPINE, V28, P871, DOI 10.1097/00007632-200305010-00007; Takahashi Y, 2010, J PAIN, V11, P652, DOI 10.1016/j.jpain.2009.10.007; Torstensson T, 2009, SPINE, V34, P2254, DOI 10.1097/BRS.0b013e3181b07eac; Tu FF, 2008, CLIN J PAIN, V24, P45, DOI 10.1097/AJP.0b013e318156db13; van der Windt DAWM, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007431.pub2; Vleeming A, 2008, EUR SPINE J, V17, P794, DOI 10.1007/s00586-008-0602-4; Warren JW, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.04.003; Zondervan K, 2000, BEST PRACT RES CL OB, V14, P403, DOI 10.1053/beog.1999.0083	42	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0119542	10.1371/journal.pone.0119542	http://dx.doi.org/10.1371/journal.pone.0119542			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25793999	Green Submitted, Green Published, gold			2022-12-27	WOS:000352084200093
J	van der Linden, MH; Seslija, L; Schneider, P; Driessen, EMC; Castro, PG; Stumpel, DJPM; van Roon, E; de Boer, J; Williams, O; Pieters, R; Stam, RW				van der Linden, Marieke H.; Seslija, Lidija; Schneider, Pauline; Driessen, Emma M. C.; Castro, Patricia Garrido; Stumpel, Dominique J. P. M.; van Roon, Eddy; de Boer, Jasper; Williams, Owen; Pieters, Rob; Stam, Ronald W.			Identification of Genes Transcriptionally Responsive to the Loss of MLL Fusions in MLL-Rearranged Acute Lymphoblastic Leukemia	PLOS ONE			English	Article							ACUTE MYELOID-LEUKEMIA; ETS-RELATED GENE; CANCER; EXPRESSION; ERG; PROLIFERATION; ACTIVATION; DIFFERENTIATION; CLASSIFICATION; RECEPTOR	Introduction MLL-rearranged acute lymphoblastic leukemia (ALL) in infants (< 1 year) is characterized by high relapse rates and a dismal prognosis. To facilitate the discovery of novel therapeutic targets, we here searched for genes directly influenced by the repression of various MLL fusions. Methods For this, we performed gene expression profiling after siRNA-mediated repression of MLL-AF4, MLL-ENL, and AF4-MLL in MLL-rearranged ALL cell line models. The obtained results were compared with various already established gene signatures including those consisting of known MLL-AF4 target genes, or those associated with primary MLL-rearranged infant ALL samples. Results Genes that were down-regulated in response to the repression of MLL-AF4 and MLL-ENL appeared characteristically expressed in primary MLL-rearranged infant ALL samples, and often represented known MLL-AF4 targets genes. Genes that were up-regulated in response to the repression of MLL-AF4 and MLL-ENL often represented genes typically silenced by promoter hypermethylation in MLL-rearranged infant ALL. Genes that were affected in response to the repression of AF4-MLL showed significant enrichment in gene expression profiles associated with AF4-MLL expressing t(4;11)+ infant ALL patient samples. Conclusion We conclude that the here identified genes readily responsive to the loss of MLL fusion expression potentially represent attractive therapeutic targets and may provide additional insights in MLL-rearranged acute leukemias.	[van der Linden, Marieke H.; Seslija, Lidija; Schneider, Pauline; Driessen, Emma M. C.; Castro, Patricia Garrido; Stumpel, Dominique J. P. M.; van Roon, Eddy; Pieters, Rob; Stam, Ronald W.] Erasmus MC Sophia Childrens Hosp, Dept Pediat Oncol Hematol, Rotterdam, Netherlands; [de Boer, Jasper; Williams, Owen] UCL, Inst Child Hlth, Mol Haematol & Canc Biol Unit, London, England; [de Boer, Jasper; Williams, Owen] Great Ormond St Hosp Sick Children, London WC1N 3JH, England; [Pieters, Rob] Princess Maxima Ctr Pediat Oncol, Utrecht, Netherlands	Erasmus University Rotterdam; Erasmus MC; University of London; University College London; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust	Stam, RW (corresponding author), Erasmus MC Sophia Childrens Hosp, Dept Pediat Oncol Hematol, Rotterdam, Netherlands.	r.stam@erasmusmc.nl	Stam, Ronald/AAE-7033-2022; de Boer, Jasper/B-5067-2013	de Boer, Jasper/0000-0002-3220-8776; williams, owen/0000-0002-1760-6880; Schneider, Pauline/0000-0003-0162-9436	KIKA (Stichting Kinderen Kankervrij) [18]; KWF Kankerbestrijding (Dutch Cancer Society); Great Ormond Street Hospital Childrens Charity [V1305] Funding Source: researchfish	KIKA (Stichting Kinderen Kankervrij); KWF Kankerbestrijding (Dutch Cancer Society); Great Ormond Street Hospital Childrens Charity	This research was funded by KIKA (Stichting Kinderen Kankervrij, project no. 18), and RWS was financially supported by KWF Kankerbestrijding (Dutch Cancer Society). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong SA, 2002, NAT GENET, V30, P41, DOI 10.1038/ng765; Ayton PM, 2003, GENE DEV, V17, P2298, DOI 10.1101/gad.1111603; Bursen A, 2010, BLOOD, V115, P3570, DOI 10.1182/blood-2009-06-229542; Cao X, 2006, ONCOGENE, V25, P3719, DOI 10.1038/sj.onc.1209408; Drexler HG, 2004, LEUKEMIA, V18, P227, DOI 10.1038/sj.leu.2403236; Duong MT, 2013, CANCER RES, V73, P5556, DOI 10.1158/0008-5472.CAN-13-0013; Gaussmann A, 2007, ONCOGENE, V26, P3352, DOI 10.1038/sj.onc.1210125; Goldberg L, 2013, BLOOD, V122, P2694, DOI 10.1182/blood-2013-01-477133; Greaves MF, 1996, LEUKEMIA, V10, P372; Guenther MG, 2008, GENE DEV, V22, P3403, DOI 10.1101/gad.1741408; Heidenreich O, 2003, BLOOD, V101, P3157, DOI 10.1182/blood-2002-05-1589; Hu XL, 2009, MOL CANCER RES, V7, P511, DOI 10.1158/1541-7786.MCR-08-0107; Iizuka M, 2013, CANCER SCI, V104, P1647, DOI 10.1111/cas.12303; Jansen MWJC, 2007, LEUKEMIA, V21, P633, DOI 10.1038/sj.leu.2404578; Jurmeister S, 2012, MOL CELL BIOL, V32, P633, DOI 10.1128/MCB.06212-11; Krivtsov AV, 2008, CANCER CELL, V14, P355, DOI 10.1016/j.ccr.2008.10.001; Kumar AR, 2011, LEUKEMIA RES, V35, P305, DOI 10.1016/j.leukres.2010.08.011; Lyu JH, 2014, J CELLULAR BIOCH; Marcucci G, 2005, J CLIN ONCOL, V23, P9234, DOI 10.1200/JCO.2005.03.6137; Marcucci G, 2007, J CLIN ONCOL, V25, P3337, DOI 10.1200/JCO.2007.10.8720; Meyer C, 2009, LEUKEMIA, V23, P1490, DOI 10.1038/leu.2009.33; MORISAKI T, 1985, AM J HEMATOL, V19, P37, DOI 10.1002/ajh.2830190106; Niu Y, 2014, APMIS ACTA PATH 0925; Pieters R, 2007, LANCET, V370, P240, DOI 10.1016/S0140-6736(07)61126-X; POCOCK CFE, 1995, BRIT J HAEMATOL, V90, P855, DOI 10.1111/j.1365-2141.1995.tb05207.x; Schafer E, 2010, BLOOD, V115, P4798, DOI 10.1182/blood-2009-09-243634; Schwable J, 2005, BLOOD, V105, P2107, DOI 10.1182/blood-2004-03-0940; Stam RW, 2010, BLOOD, V115, P2835, DOI 10.1182/blood-2009-07-233049; STONG RC, 1985, BLOOD, V65, P21, DOI 10.1182/blood.V65.1.21.21; Stumpel DJPM, 2009, BLOOD, V114, P5490, DOI 10.1182/blood-2009-06-227660; Susila A, 2010, CELL CYCLE, V9, P179, DOI 10.4161/cc.9.1.10406; Thomas M, 2005, BLOOD, V106, P3559, DOI 10.1182/blood-2005-03-1283; Thoms JAI, 2011, BLOOD, V117, P7079, DOI 10.1182/blood-2010-12-317990; van der Linden MH, 2014, CELL CYCLE, V13, P834, DOI 10.4161/cc.27757; Wilkinson AC, 2013, CELL REP, V3, P116, DOI 10.1016/j.celrep.2012.12.016; Yeoh EJ, 2002, CANCER CELL, V1, P133, DOI 10.1016/S1535-6108(02)00032-6; Ying L, 2014, FEBS J          1016; Zhang L, 2014, CANCER BIOTHER RADIO, V29, P77, DOI 10.1089/cbr.2013.1502; Zhang YM, 2014, J MANUF PROCESS, V16, P1, DOI 10.1016/j.jmapro.2013.12.004	39	4	4	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0120326	10.1371/journal.pone.0120326	http://dx.doi.org/10.1371/journal.pone.0120326			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25793396	Green Published, gold, Green Submitted			2022-12-27	WOS:000352083900013
J	Yang, FQ; Zhang, HM; Chen, SJ; Yan, Y; Zheng, JH				Yang, Feng-qiang; Zhang, Hai-ming; Chen, Shao-Jun; Yan, Yang; Zheng, Jun-hua			MiR-506 Is Down-Regulated in Clear Cell Renal Cell Carcinoma and Inhibits Cell Growth and Metastasis via Targeting FLOT1	PLOS ONE			English	Article							UP-REGULATION; CANCER; MICRORNA; PROLIFERATION; DIAGNOSTICS; EXPRESSION; SURVIVAL; STAGE	Background Some microRNAs (miRNAs) are abnormally expressed in cancer and contribute to tumorigenesis. In the present study, we investigated the role of miR-506 in clear cell renal cell carcinoma (ccRCC). Methods miR-506 expression was detected in renal cancer cell lines 786-O, ACHN, Caki-1, and Caki-2 and ccRCC specimens by quantitative real-time-PCR. We assessed the association of miR-506 expression with pathology and prognosis in ccRCC patients. We over-expressed and knocked-down miR-506 expression in two renal cancer cell lines, 786-O and ACHN, and assessed the impact on cell proliferation, migration and invasion. A luciferase reporter assay was conducted to confirm the target gene of miR-506 in renal cancer cell lines. Results miR-506 was significantly down-regulated in renal cancer cell lines and ccRCC specimens. Low miR-506 expression in ccRCC specimens was associated with an advanced clinical stage and poor prognosis. miR-506 expression was an independent prognostic marker of overall ccRCC patient survival in a multivariate analysis. Over-expression of miR-506 in renal cancer cells decreased cell growth and metastasis, In contrast, down-regulation of miR-506 expression promoted renal cancer cell growth and metastasis. FLOT1, a potential target gene of miR-506, was inversely correlated with miR-506 expression in ccRCC tissues. Consistent with the effect of miR-506, knockdown of FLOT1 by siRNA inhibited cell malignant behaviors. Rescue of FLOT1 expression partially restored the effects of miR-506. Conclusions miR-506 exerts its anti-cancer function by directly targeting FLOT1 in renal cancer, indicating a potential novel therapeutic role in renal cancer treatment.	[Yang, Feng-qiang; Zhang, Hai-ming; Chen, Shao-Jun; Yan, Yang; Zheng, Jun-hua] Tongji Univ, Dept Urol, Shanghai Peoples Hosp 10, Shanghai 200092, Peoples R China	Tongji University	Zheng, JH (corresponding author), Tongji Univ, Dept Urol, Shanghai Peoples Hosp 10, Shanghai 200092, Peoples R China.	junhuazheng07@gmail.com	Wei, Li/AAE-9938-2020; wei, li/GSD-3630-2022		National Natural Science Foundation of China [81270831]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Natural Science Foundation of China (No. 81270831) (http://npd.nsfc.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arora H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064273; Babuke T, 2007, EUR J CELL BIOL, V86, P525, DOI 10.1016/j.ejcb.2007.03.003; Banales JM, 2012, HEPATOLOGY, V56, P687, DOI 10.1002/hep.25691; Bentwich I, 2005, NAT GENET, V37, P766, DOI 10.1038/ng1590; Cho WCS, 2010, INT J BIOCHEM CELL B, V42, P1273, DOI 10.1016/j.biocel.2009.12.014; Cindolo L, 2005, CANCER-AM CANCER SOC, V104, P1362, DOI 10.1002/cncr.21331; de Planell-Saguer M, 2011, ANAL CHIM ACTA, V699, P134, DOI 10.1016/j.aca.2011.05.025; Garzon R, 2012, CURR OPIN ONCOL, V24, P655, DOI 10.1097/CCO.0b013e328358522c; Iorio MV, 2012, CARCINOGENESIS, V33, P1126, DOI 10.1093/carcin/bgs140; Jiang Z, 2008, CLIN CANCER RES, V14, P5579, DOI 10.1158/1078-0432.CCR-08-0504; Karakiewicz PI, 2007, J CLIN ONCOL, V25, P1316, DOI 10.1200/JCO.2006.06.1218; Kasinski AL, 2011, NAT REV CANCER, V11, P849, DOI 10.1038/nrc3166; Li H, 2014, TUMOR BIOL, V35, P3311, DOI 10.1007/s13277-013-1434-3; Lin CY, 2011, CLIN CANCER RES, V17, P3089, DOI 10.1158/1078-0432.CCR-10-3068; Lin YZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079299; Liu G, 2014, J PATHOL, V233, P308, DOI 10.1002/path.4348; Miyamoto H, 2010, PATHOL INT, V60, P1, DOI 10.1111/j.1440-1827.2009.02477.x; Patil S, 2010, CANCER-AM CANCER SOC, V116, P347, DOI 10.1002/cncr.24713; Riento K, 2009, J CELL SCI, V122, P912, DOI 10.1242/jcs.039024; Rufino-Palomares EE, 2014, MICRORNAS MED, P223; Wen S, 2014, ONCOGENE; Xiong P, 2013, NEOPLASMA, V60, P395, DOI 10.4149/neo_2013_051; Zeng Y, 2006, ONCOGENE, V25, P6156, DOI 10.1038/sj.onc.1209908; Zhao Y, 2011, TOXICOL LETT, V205, P320, DOI 10.1016/j.toxlet.2011.06.022	24	51	55	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0120258	10.1371/journal.pone.0120258	http://dx.doi.org/10.1371/journal.pone.0120258			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25793370	Green Published, gold			2022-12-27	WOS:000352083900004
J	Sruamsiri, R; Ross-Degnan, D; Lu, CY; Chaiyakunapruk, N; Wagner, AK				Sruamsiri, Rosarin; Ross-Degnan, Dennis; Lu, Christine Y.; Chaiyakunapruk, Nathorn; Wagner, Anita K.			Policies and Programs to Facilitate Access to Targeted Cancer Therapies in Thailand	PLOS ONE			English	Article							HEALTH TECHNOLOGY-ASSESSMENT; PATIENT ASSISTANCE PROGRAMS; DECISIONS; COVERAGE	Background Increasing access to clinically beneficial targeted cancer medicines is a challenge in every country due to their high cost. We describe the interplay of innovative policies and programs involving multiple stakeholders to facilitate access to these medicines in Thailand, as well as the utilization of selected targeted therapies over time. Methods We selected two medicines on the 2013 Thai national list of essential medicines (NLEM) [letrozole and imatinib] and three unlisted medicines for the same indications [trastuzumab, nilotinib and dasatinib]. We created timelines of access policies and programs for these products based on scientific and grey literature. Using IMS Health sales data, we described the trajectories of sales volumes of the study medicines between January 2001 and December 2012. We compared estimated average numbers of patients treated before and after the implementation of policies and programs for each product. Results Different stakeholders implemented multiple interventions to increase access to the study medicines for different patient populations. During 2007-2009, the Thai Government created a special NLEM category with different coverage requirements for payers and issued compulsory licenses; payers negotiated prices with manufacturers and engaged in pooled procurement; pharmaceutical companies expanded patient assistance programs and lowered prices in different ways. Compared to before the interventions, estimated numbers of patients treated with each medicine increased significantly afterwards: for letrozole from 645 (95% CI 366-923) to 3683 (95% CI 2,748-4,618); for imatinib from 103 (95% CI 72174) to 350 (95% CI 307-398); and for trastuzumab from 68 (95% CI 45-118) to 412 (95% CI 344-563). Conclusions Government, payers, and manufacturers implemented multi-pronged approaches to facilitate access to targeted cancer therapies for the Thai population, which differed by medicine. Routine monitoring is needed to assess clinical and economic impacts of these strategies in the health system.	[Sruamsiri, Rosarin; Chaiyakunapruk, Nathorn] Naresuan Univ, Fac Pharmaceut Sci, Ctr Pharmaceut Outcomes Res, Dept Pharm Practice, Phitsanulok, Thailand; [Sruamsiri, Rosarin; Ross-Degnan, Dennis; Lu, Christine Y.; Wagner, Anita K.] Harvard Univ, Sch Med, Dept Populat Med, Boston, MA USA; [Sruamsiri, Rosarin; Ross-Degnan, Dennis; Lu, Christine Y.; Wagner, Anita K.] Harvard Pilgrim Hlth Care Inst, Boston, MA USA; [Chaiyakunapruk, Nathorn] Monash Univ Malaysia, Sch Pharm, Subang Jaya, Malaysia; [Chaiyakunapruk, Nathorn] Univ Queensland, Sch Populat Hlth, Brisbane, Qld, Australia; [Chaiyakunapruk, Nathorn] Univ Wisconsin, Sch Pharm, Madison, WI 53706 USA	Naresuan University; Harvard University; Harvard Medical School; Harvard Pilgrim Health Care; Monash University; Monash University Sunway; University of Queensland; University of Wisconsin System; University of Wisconsin Madison	Sruamsiri, R (corresponding author), Naresuan Univ, Fac Pharmaceut Sci, Ctr Pharmaceut Outcomes Res, Dept Pharm Practice, Phitsanulok, Thailand.	r.sruamsiri@gmail.com			Thailand Research Fund (TRF) through the Royal Golden Jubilee PhD program [PHD/0127/2552]	Thailand Research Fund (TRF) through the Royal Golden Jubilee PhD program(Thailand Research Fund (TRF))	This study was supported by a grant from the Thailand Research Fund (TRF) through the Royal Golden Jubilee PhD program (Grant No. PHD/0127/2552 to RS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American College of Physicians, 2011, CAN OUR NAT CONS DIS; CanTreat Int, 2010, ANN ONCOL, V21, P680, DOI 10.1093/annonc/mdq055; Choudhry NK, 2009, HEALTH AFFAIR, V28, P827, DOI 10.1377/hlthaff.28.3.827; Damrongplasit K, 2009, HEALTH AFFAIR, V28, pW457, DOI 10.1377/hlthaff.28.3.w457; Espin J, 2011, EXP IMP EUR RIUSK SH; Farmer P, 2010, LANCET, V376, P1186, DOI 10.1016/S0140-6736(10)61152-X; Felder TM, 2011, J HEALTH CARE POOR U, V22, P24, DOI 10.1353/hpu.2011.0003; Food Drug and Administration, 2013, PHARM PROD INF; Health Insurance System Research Office, 2012, THAIL U COV SCHE ACH; IMS Health, 2012, ONC SAL CHANN; Internaltional Agency for Research on Cancer, 2008, GLOBOCAN2008 EST CAN; International Agency for Research on Cancer, 2008, WORLD CANC REPORT 20; Kanavos P, 2006, ANN ONCOL, V17, P15, DOI 10.1093/annonc.mdl983; Kanavos P, 2010, OPTIONS FINANCING OP; Keskinaslan A, 2011, ASSESSMENT PRICING R; Lassarat S, 2006, ANN ONCOL, V17, P43, DOI [10.1093/annonc.mdl987, 10.1093/annonc/mdl987]; Lichtenberg FR, 2004, 10328 NAT BUR EC RES; Lopes GD, 2013, NAT REV CLIN ONCOL, V10, P314, DOI 10.1038/nrclinonc.2013.55; Low O, 2012, IDEALS IMPLEMENTATIO; Manager Online, 2012, NHSO SWO ALLOW REIMB; Mohara A, 2012, J COMP EFFECT RES, V1, P137, DOI [10.2217/CER.12.10, 10.2217/cer.12.10]; Mohara A, 2012, VALUE HEALTH, V15, pS95, DOI 10.1016/j.jval.2011.11.016; Murray SA, 2003, BRIT MED J, V326, P368, DOI 10.1136/bmj.326.7385.368; *NAT DRUG COMM, 2004, NAT LIST ESS MED; National Comprehensive Cancer Network, 2013, NCCN CLIN PRACT GUID; National Drug Commitee, 2013, NAT LIST MED 2013; National Drug Committee, 2008, NAT LIS ESS MED 2008; National Health Security Office, 2010, CLIN PRACT GUID BREA; National Health Security Office, 2006, CLIN PRACT AD CHRON; National statistical office Thailand, 2012, Q THAI POP; Rodin J, 2012, LANCET, V380, P861, DOI 10.1016/S0140-6736(12)61340-3; Sakunphanit T, 2006, UNIVERSAL HLTH COVER; Savedoff W.D., 2012, TRANSITIONS HLTH FIN; Savedoff WD, 2012, LANCET, V380, P924, DOI 10.1016/S0140-6736(12)61083-6; Sloan FA, 2007, CANC CONTR OPP LOW M; Tangcharoensathien V, 2011, LANCET, V377, P863, DOI 10.1016/S0140-6736(10)61890-9; Teerawattananon Y, 2009, INT J TECHNOL ASSESS, V25, P241, DOI 10.1017/S0266462309090709; Thai CML Patient Group (THCML), 2010, CLIN PRACT GUID AD C; Thai PR, 2008, 5 ANNIVERSARY GIPAP; Thai working group on National Health Account, 2010, REP 1994 2008 NAT HL; Thailand Health Insurance System Research Office, 2012, THAILANDS UNIVERSAL; The Ministry of Public Health and the National Health Security Office, 2008, 10 BURN QUEST GOV US; The National Health Security Office, 2013, Q ANN REP; The National Health Security Office, 2010, VMI HELPS SAV B4BN D; The World Health Organization, 2014, DEF UN HLTH COV; Towse A, 2004, BRIT MED J, V328, P103, DOI 10.1136/bmj.328.7431.103; Towse A, 2010, PHARMACOECONOMICS, V28, P93, DOI 10.2165/11314080-000000000-00000; Turongkaravee S, 2012, EVALUATION HIGH COST; Turongkarawee S, 2011, EVALUATION HIGH COST; University M, 2010, THAIL HLTH PROF 2009; Vatanasapt V, 2002, JPN J CLIN ONCOL, V32, pS82, DOI 10.1093/jjco/hye134; WHO, 2010, WOR HEALT REP, P1; Wibulpolprasert S, 2011, GLOBALIZATION HEALTH, V7, DOI 10.1186/1744-8603-7-32; World Health Organization, 2009, INT TRAD HLTH REF GU; World Health Organization, PROM RAT US MED COR; World Trade Organization, 2001, AGGR TRAD REL ASP IN; Yamabhai I, 2009, ASSESSING IMPLICATIO; Yamabhai I, 2011, GLOBALIZATION HEALTH, V7, DOI 10.1186/1744-8603-7-28; Yoongthong W, 2012, VALUE HEALTH, V15, pS126, DOI 10.1016/j.jval.2011.11.003	59	19	20	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0119945	10.1371/journal.pone.0119945	http://dx.doi.org/10.1371/journal.pone.0119945			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CE6ZS	25798948	Green Published, gold, Green Submitted			2022-12-27	WOS:000351987300095
J	Bastos, HP; Sousa, L; Clarke, LA; Couto, FM				Bastos, Hugo P.; Sousa, Lisete; Clarke, Luka A.; Couto, Francisco M.			GRYFUN: A Web Application for GO Term Annotation Visualization and Analysis in Protein Sets	PLOS ONE			English	Article							GENE ONTOLOGY; SEMANTIC SIMILARITY; TOOL	Functional context for biological sequence is provided in the form of annotations. However, within a group of similar sequences there can be annotation heterogeneity in terms of coverage and specificity. This in turn can introduce issues regarding the interpretation of actual functional similarity and overall functional coherence of such a group. One way to mitigate such issues is through the use of visualization and statistical techniques. Therefore, in order to help interpret this annotation heterogeneity we created a web application that generates Gene Ontology annotation graphs for protein sets and their associated statistics from simple frequencies to enrichment values and Information Content based metrics. The publicly accessible website http://xldb.di.fc.ul.pt/gryfun/ currently accepts lists of UniProt accession numbers in order to create user-defined protein sets for subsequent annotation visualization and statistical assessment. GRYFUN is a freely available web application that allows GO annotation visualization of protein sets and which can be used for annotation coherence and cohesiveness analysis and annotation extension assessments within under-annotated protein sets.	[Bastos, Hugo P.; Couto, Francisco M.] Univ Lisbon, Fac Ciencias, Dept Informat, LaSIGE, Lisbon, Portugal; [Sousa, Lisete] Univ Lisbon, Fac Ciencias, Dept Estat & Invest Operac, Lisbon, Portugal; [Sousa, Lisete] Univ Lisbon, Fac Ciencias, Ctr Estat & Aplicacoes, Lisbon, Portugal; [Clarke, Luka A.] Univ Lisbon, Fac Ciencias, BioFIG Ctr Biodivers Funct & Integrat Genom, Lisbon, Portugal	Universidade de Lisboa; Universidade de Lisboa; Universidade de Lisboa; Universidade de Lisboa	Bastos, HP (corresponding author), Univ Lisbon, Fac Ciencias, Dept Informat, LaSIGE, Lisbon, Portugal.	hbastos@xldb.di.fc.ul.pt	Couto, Francisco M/A-4066-2010; Clarke, Luka A/E-5843-2012; Sousa, Lisete M R/M-1842-2015	Couto, Francisco M/0000-0003-0627-1496; Clarke, Luka A/0000-0003-3254-9121; Sousa, Lisete M R/0000-0002-2114-720X	Portuguese Fundacao para a Ciencia e Tecnologia [SFRH/BD/48035/2008, PTDC/MAT/118335/2010, PEst-OE/MAT/UI0006/2014, PEst-OE/BIA/UI4046/2011, PEst-OE/EEI/UI0408/2014]; European Commission [317871]	Portuguese Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was supported by the Portuguese Fundacao para a Ciencia e Tecnologia through the PhD Grant ref. SFRH/BD/48035/2008 to HPB and projects PTDC/MAT/118335/2010, PEst-OE/MAT/UI0006/2014 to LS, PEst-OE/BIA/UI4046/2011 (BioFIG) to LAC, and PEst-OE/EEI/UI0408/2014 (LaSIGE) to HPB and FMC, and by the European Commission (http://ec.europa.eu http://ec.europa.eu) through the BiobankCloud project under the Seventh Framework Programme (grant #317871) to FMC. Additionally we like to thank FCUL for the tuition support for HPB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexa A, 2006, BIOINFORMATICS, V22, P1600, DOI 10.1093/bioinformatics/btl140; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Barrell D, 2009, NUCLEIC ACIDS RES, V37, pD396, DOI 10.1093/nar/gkn803; Bastos Hugo P., 2013, Frontiers in Genetics, V4, P201, DOI 10.3389/fgene.2013.00201; Booton R, 2014, CHEST, V146, P193, DOI 10.1378/chest.13-2736; Breitling R, 2004, FEBS LETT, V573, P83, DOI 10.1016/j.febslet.2004.07.055; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Chatziioannou AA, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00008; Clarke LA, 2013, RESP RES, V14, DOI 10.1186/1465-9921-14-38; du Plessis L, 2011, BRIEF BIOINFORM, V12, P723, DOI 10.1093/bib/bbr002; Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48; Ellson J, 2002, LECT NOTES COMPUT SC, V2265, P483; Gansner ER, 2000, SOFTWARE PRACT EXPER, V30, P1203, DOI 10.1002/1097-024X(200009)30:11<1203::AID-SPE338>3.0.CO;2-N; Haji R, 2007, J PATHOL, V211, P340, DOI 10.1002/path.2118; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Khatri P, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002375; Lee JSM, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-189; Lombard V, 2010, BIOCHEM J, V432, P437, DOI 10.1042/BJ20101185; Martin AJM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078383; Pesquita C, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S5-S4; Pu SY, 2007, PROTEOMICS, V7, P944, DOI 10.1002/pmic.200600636; Pu SY, 2009, NUCLEIC ACIDS RES, V37, P825, DOI 10.1093/nar/gkn1005; Radivojac P, 2013, NAT METHODS, V10, P221, DOI [10.1038/NMETH.2340, 10.1038/nmeth.2340]; Rawlings ND, 2012, NUCLEIC ACIDS RES, V40, pD343, DOI [10.1093/nar/gkr987, 10.1093/nar/gkt953]; Resnik P, 1995, INT JOINT CONF ARTIF, P448; Robinson P, 2011, CHAPMAN HALL CRC MAT; Sealfon RSG, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-443; Soleti R, 2013, APOPTOSIS, V18, P1029, DOI 10.1007/s10495-013-0874-y; Valencia A, 2005, CURR OPIN STRUC BIOL, V15, P267, DOI 10.1016/j.sbi.2005.05.010	29	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0119631	10.1371/journal.pone.0119631	http://dx.doi.org/10.1371/journal.pone.0119631			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25794277	Green Submitted, Green Published, gold			2022-12-27	WOS:000352084200103
J	Benito-Calvo, A; Carvalho, S; Arroyo, A; Matsuzawa, T; de la Torre, I				Benito-Calvo, Alfonso; Carvalho, Susana; Arroyo, Adrian; Matsuzawa, Tetsuro; de la Torre, Ignacio			First GIS Analysis of Modern Stone Tools Used by Wild Chimpanzees (Pan troglodytes verus) in Bossou, Guinea, West Africa	PLOS ONE			English	Article							NUT CRACKING; APES VIEW; OLDOWAN; SITE; ARCHAEOLOGY; TECHNOLOGY; HOMINIDS; ECOLOGY; ORIGINS	Stone tool use by wild chimpanzees of West Africa offers a unique opportunity to explore the evolutionary roots of technology during human evolution. However, detailed analyses of chimpanzee stone artifacts are still lacking, thus precluding a comparison with the earliest archaeological record. This paper presents the first systematic study of stone tools used by wild chimpanzees to crack open nuts in Bossou (Guinea-Conakry), and applies pioneering analytical techniques to such artifacts. Automatic morphometric GIS classification enabled to create maps of use wear over the stone tools (anvils, hammers, and hammers/anvils), which were blind tested with GIS spatial analysis of damage patterns identified visually. Our analysis shows that chimpanzee stone tool use wear can be systematized and specific damage patterns discerned, allowing to discriminate between active and passive pounders in lithic assemblages. In summary, our results demonstrate the heuristic potential of combined suites of GIS techniques for the analysis of battered artifacts, and have enabled creating a referential framework of analysis in which wild chimpanzee battered tools can for the first time be directly compared to the early archaeological record.	[Benito-Calvo, Alfonso] CENIEH, Lab Digital Mapping & Anal 3D, Burgos, Spain; [Carvalho, Susana] George Washington Univ, Ctr Adv Study Human Paleobiol, Washington, DC USA; [Carvalho, Susana] Univ Algarve, Interdisciplinary Ctr Archaeol & Evolut Human Beh, Faro, Portugal; [Arroyo, Adrian; de la Torre, Ignacio] UCL, Inst Archaeol, London, England; [Matsuzawa, Tetsuro] Kyoto Univ, Primate Res Inst, Sect Language & Intelligence, Kyoto 6068501, Japan	Centro Nacional de Investigacion de La Evolucion Humana (CENIEH); George Washington University; Universidade do Algarve; University of London; University College London; Kyoto University	Benito-Calvo, A (corresponding author), CENIEH, Lab Digital Mapping & Anal 3D, Burgos, Spain.	alfonso.benito@cenieh.es; scarvalho@email.gwu.edu	Benito-Calvo, Alfonso/G-3897-2015; Matsuzawa, Tetsuro/ABE-9654-2021; Arroyo, Adrian/I-1522-2019	Benito-Calvo, Alfonso/0000-0002-6363-1753; Matsuzawa, Tetsuro/0000-0002-8147-2725; Arroyo, Adrian/0000-0002-5850-0847; de la Torre, Ignacio/0000-0002-1805-634X; Carvalho, Susana/0000-0003-4542-3720	Leverhulme Trust [IN-052]; MEXT [20002001, 24000001]; JSPS-U04-PWS; FCT-Portugal [SFRH/BD/36169/2007]; Wenner-Gren Foundation for Anthropological Research	Leverhulme Trust(Leverhulme Trust); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); JSPS-U04-PWS; FCT-Portugal(Portuguese Foundation for Science and Technology); Wenner-Gren Foundation for Anthropological Research	Funding: Funding by the Leverhulme Trust (IN-052) is gratefully acknowledged. The research in Guinea was supported by a MEXT grant #20002001 and #24000001, JSPS-U04-PWS to TM, FCT-Portugal (SFRH/BD/36169/2007), and a Dissertation Fieldwork Grant from the Wenner-Gren Foundation for Anthropological Research to SC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akerman K., 1975, OCCASIONAL PAPERS AN, V4; Benito-Calvo A, 2009, EARTH SURF PROC LAND, V34, P1433, DOI 10.1002/esp.1840; Biro D, 2003, ANIM COGN, V6, P213, DOI 10.1007/s10071-003-0183-x; Biro D, 2010, MIND CHIMPANZEE ECOL, P128; Boesch C, 2012, COMP CHIMPANZEE HUMA; BOESCH C, 2000, BEHAV ECOLOGY EVOLUT; Boesch C, 2009, J HUM EVOL, V56, P560, DOI 10.1016/j.jhevol.2009.04.001; Caruana MV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113856; Carvalho S, 2008, J HUM EVOL, V55, P148, DOI 10.1016/j.jhevol.2008.02.005; Carvalho S, 2012, STONE TOOLS AND FOSSIL BONES: DEBATES IN THE ARCHAEOLOGY OF HUMAN ORIGINS, P201; Carvalho S, 2012, CURR BIOL, V22, pR180, DOI 10.1016/j.cub.2012.01.052; Carvalho S, 2009, ANIM COGN, V12, pS103, DOI 10.1007/s10071-009-0271-7; De Beaune S, 1989, GALLIA PREHISTOIRE, V31, P27, DOI DOI 10.3406/GALIP.1989.2264; de Beaune SA, 1997, GALTS UTILISES PALEO; de Beaune SA, 2000, ARCHAEOLOGIE GESTE B; de Heinzelin J, 1999, SCIENCE, V284, P625; de la Torre I, 2013, J ARCHAEOL SCI, V40, P313, DOI 10.1016/j.jas.2012.08.007; de la Torre I, 2010, STONE TOOLS AND THE EVOLUTION OF HUMAN COGNITION, P45; Dikau R., 1989, 3 DIMENSIONAL APPL G, V1st, P51, DOI 10.1201/9781003069454-5; Dubreuil L, 2014, J ARCHAEOL SCI, V48, P139, DOI 10.1016/j.jas.2013.06.023; Foley R, 2009, PHILOS T R SOC B, V364, P3267, DOI 10.1098/rstb.2009.0136; Goren-Inbar N, 2002, P NATL ACAD SCI USA, V99, P2455, DOI 10.1073/pnas.032570499; Guisan A, 1999, PLANT ECOL, V143, P107, DOI 10.1023/A:1009841519580; Haslam M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072872; Haslam M, 2009, NATURE, V460, P339, DOI 10.1038/nature08188; Hengl T, 2009, DEV SOIL SCI, V33, P1; Hobson R., 2019, SPATIAL ANAL GEOMORP, P221; Iwahashi J, 2007, GEOMORPHOLOGY, V86, P409, DOI 10.1016/j.geomorph.2006.09.012; Jones P.R., 1994, OLDUVAI GORGE, P254; JOULIAN F, 1996, MODELLING EARLY HUMA, P173; KLINKENBERG B, 1992, GEOMORPHOLOGY, V5, P5, DOI 10.1016/0169-555X(92)90055-S; Koops K, 2013, ANIM BEHAV, V85, P175, DOI 10.1016/j.anbehav.2012.10.022; KORTLANDT A, 1986, J HUM EVOL, V15, P77, DOI 10.1016/S0047-2484(86)80068-9; Lovejoy CO, 2010, SCIENCE, V327, P410, DOI 10.1126/science.327.5964.410-b; Matsuzawa T, 2011, PRIMATOL MONOGR, P1, DOI 10.1007/978-4-431-53921-6; Matsuzawa Tetsuro, 1994, P351; McGrew WC, 2010, PHILOS T R SOC B, V365, P3267, DOI 10.1098/rstb.2010.0067; McGrew W.C., 1992, CHIMPANZEE MAT CULTU; Mcgrew WC, 2014, LITHIC TECHNOL, V39, P113, DOI 10.1179/0197726114Z.00000000037; McGrew WC, 2010, SCIENCE, V328, P579, DOI 10.1126/science.1187921; McPherron SP, 2010, NATURE, V466, P857, DOI 10.1038/nature09248; Mercader J, 2002, SCIENCE, V296, P1452, DOI 10.1126/science.1070268; Mercader J, 2007, P NATL ACAD SCI USA, V104, P3043, DOI 10.1073/pnas.0607909104; Miliaresis GC, 2009, CAN J REMOTE SENS, V35, P385, DOI 10.5589/m09-027; Riley S.J., 1999, INTERMOUNTAIN J SCI, V5, P23, DOI DOI 10.1016/j.geomorph.2010.11.003; Gilabert XR, 2012, J ARCHAEOL SCI, V39, P1587, DOI 10.1016/j.jas.2011.12.017; Sappington JM, 2007, J WILDLIFE MANAGE, V71, P1419, DOI 10.2193/2005-723; Schick KD, 1999, J ARCHAEOL SCI, V26, P821, DOI 10.1006/jasc.1998.0350; Smith MW, 2014, EARTH-SCI REV, V136, P202, DOI 10.1016/j.earscirev.2014.05.016; Stemp WJ, 2013, SCANNING, V35, P28, DOI 10.1002/sca.21032; Stewart FA, 2011, J HUM EVOL, V61, P388, DOI 10.1016/j.jhevol.2011.05.005; Stout D, 2002, CURR ANTHROPOL, V43, P693, DOI 10.1086/342638; SUGIYAMA Y, 1981, Primates, V22, P435, DOI 10.1007/BF02381236; Toth N, 2009, ANNU REV ANTHROPOL, V38, P289, DOI 10.1146/annurev-anthro-091908-164521; Visalberghi E, 2008, AM J PRIMATOL, V70, P884, DOI 10.1002/ajp.20578; White TD, 2009, SCIENCE, V326, P75, DOI 10.1126/science.1175802; Whiten A, 1999, NATURE, V399, P682, DOI 10.1038/21415; Wieczorek M, 2014, GEOMORPHOLOGY, V206, P133, DOI 10.1016/j.geomorph.2013.10.005; Wilson J.P., 2000, TERRAIN ANAL PRINCIP; WRIGHT KI, 1994, AM ANTIQUITY, V59, P238, DOI 10.2307/281929; WYNN T, 1989, MAN, V24, P383, DOI 10.2307/2802697; Wynn T, 2011, EVOL ANTHROPOL, V20, P181, DOI 10.1002/evan.20323; Yamakoshi G, 2001, PRIMATE ORIGINS OF HUMAN COGNITION AND BEHAVIOR, P537	63	41	42	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0121613	10.1371/journal.pone.0121613	http://dx.doi.org/10.1371/journal.pone.0121613			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25793642	gold, Green Published, Green Submitted			2022-12-27	WOS:000352083900141
J	Bosco, C; Crawley, D; Adolfsson, J; Rudman, S; Van Hemelrijck, M				Bosco, Cecilia; Crawley, Danielle; Adolfsson, Jan; Rudman, Sarah; Van Hemelrijck, Mieke			Quantifying the Evidence for the Risk of Metabolic Syndrome and Its Components following Androgen Deprivation Therapy for Prostate Cancer: A Meta-Analysis	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE; TESTOSTERONE DEFICIENCY; ERECTILE DYSFUNCTION; ARTERIAL STIFFNESS; INSULIN-RESISTANCE; BODY-COMPOSITION; MEN; OBESITY; HYPOGONADISM; ASSOCIATION	Background No meta-analysis is yet available for the risk of metabolic syndrome (MetS) following androgen deprivation therapy (ADT) for men with prostate cancer. To summarize the evidence for the link between ADT and MetS or its components quantitatively with a meta-analysis including all studies published to date. Methods PubMed and Embase were searched using predefined inclusion criteria to perform meta-analyses on the association between metabolic syndrome, hyperglycemia, diabetes, hypertension, dyslipidemia or obesity and androgen deprivation therapy in patients with prostate cancer. Random effects methods were used to estimate pooled relative risks (RRs) and 95% confidence intervals (CI). Results A total of nine studies was included. There was a positive association between ADT and risk of MetS (RR: 1.75 (95% CI: 1.27-2.41)). Diabetes was the only MetS component present in more than 3 studies, and also showed an increased risk following ADT (RR: 1.36 (95% CI: 1.17-1.58)). Conclusion This is the first quantitative summary addressing the potential risk of MetS following ADT in men with PCa. The positive RRs indicate that there is a need to further elucidate how type and duration of ADT affect these increased risks of MetS and diabetes as the number of men with PCa treated with ADT is increasing.	[Bosco, Cecilia; Crawley, Danielle; Van Hemelrijck, Mieke] Kings Coll London, Sch Med, Div Canc Studies, Canc Epidemiol Grp, London WC2R 2LS, England; [Crawley, Danielle; Rudman, Sarah] Guys St Thomas NHS Fdn Trust, Dept Oncol, London, England; [Adolfsson, Jan] Karolinska Inst, CLINTEC Dept, Stockholm, Sweden	University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust; Karolinska Institutet	Van Hemelrijck, M (corresponding author), Kings Coll London, Sch Med, Div Canc Studies, Canc Epidemiol Grp, London WC2R 2LS, England.	mieke.vanhemelrijck@kcl.ac.uk	Bosco, Cecilia/F-4950-2019	Crawley, Danielle/0000-0001-7294-5634; Adolfsson, Jan/0000-0003-2992-1869; Van Hemelrijck, Mieke/0000-0002-7317-0858	Experimental Cancer Medicine Centre at King's College London; National Institute for Health Research (NIHR) Biomedical Research Centre based at Guy's and St Thomas' NHS Foundation Trust and King's College London	Experimental Cancer Medicine Centre at King's College London; National Institute for Health Research (NIHR) Biomedical Research Centre based at Guy's and St Thomas' NHS Foundation Trust and King's College London(General Electric)	This research was supported by the Experimental Cancer Medicine Centre at King's College London and also by the National Institute for Health Research (NIHR) Biomedical Research Centre based at Guy's and St Thomas' NHS Foundation Trust and King's College London. The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alibhai SMH, 2009, J CLIN ONCOL, V27, P3452, DOI 10.1200/JCO.2008.20.0923; Allott EH, 2013, EUR UROL, V63, P800, DOI 10.1016/j.eururo.2012.11.013; Basaria S, 2006, CANCER-AM CANCER SOC, V106, P581, DOI 10.1002/cncr.21642; Bo J, 2011, ASIAN J ANDROL, P883; Braga-Basaria M, 2006, J CLIN ONCOL, V24, P3979, DOI 10.1200/JCO.2006.05.9741; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Collier A, 2012, AM J CLIN ONCOL-CANC, V35, P504, DOI 10.1097/COC.0b013e318201a406; Corona G, 2009, INT J ANDROL, V32, P587, DOI 10.1111/j.1365-2605.2008.00951.x; Corona G, 2008, AGING MALE, V11, P193, DOI 10.1080/13685530802468497; Corona G, 2011, BEST PRACT RES CL EN, V25, P337, DOI 10.1016/j.beem.2010.07.002; DiBlasio CJ, 2008, BJU INT, V102, P39, DOI 10.1111/j.1464-410X.2008.07505.x; Dockery F, 2003, CLIN SCI, V104, P195, DOI 10.1042/CS20020209; Faris JE, 2010, CURR OPIN ENDOCRINOL, V17, P240, DOI 10.1097/MED.0b013e3283391fd1; Gruca D, 2012, INT J UROL, V19, P614, DOI 10.1111/j.1442-2042.2012.03001.x; Grundy SM, 2004, J CLIN ENDOCR METAB, V89, P2595, DOI 10.1210/jc.2004-0372; Hakimian P, 2008, BJU INT; Haseen F, 2010, J CANCER SURVIV, V4, P128, DOI 10.1007/s11764-009-0114-1; Huggins C, 1941, ARCH SURG-CHICAGO, V43, P209, DOI 10.1001/archsurg.1941.01210140043004; International Diabetes Federation, 2006, IDF CONS WORLDW DEF; Jones T, 2007, PRACTICAL DIABETES I, V24, P269, DOI DOI 10.1002/PDI.1117; Keating NL, 2006, J CLIN ONCOL, V24, P4448, DOI 10.1200/JCO.2006.06.2497; Keating NL, 2010, J NATL CANCER I, V102, P39, DOI 10.1093/jnci/djp404; Lage MJ, 2007, UROLOGY, V70, P1104, DOI 10.1016/j.urology.2007.08.012; Munoz Garcia J, 2013, 55 ANN M AM SOC RAD, P356; Nobes JP, 2008, CLIN ONCOL; Petrylak PJ, 2002, PROSTATE CANC PRINCI; Valverde JR, 2011, EUR UROL SUPPL, V10, P337; Saad F, 2012, CURR DIABETES REV, V8, P131, DOI 10.2174/157339912799424573; Saylor PJ, 2013, J UROLOGY, V189, pS34, DOI 10.1016/j.juro.2012.11.017; Shahani S, 2008, J CLIN ENDOCR METAB, V93, P2042, DOI 10.1210/jc.2007-2595; Smith JC, 2001, J CLIN ENDOCR METAB, V86, P4261, DOI 10.1210/jc.86.9.4261; Smith MR, 2008, ANN ONCOL, V19, P86, DOI 10.1093/annonc/mdn458; Smith MR, 2002, J CLIN ENDOCR METAB, V87, P599, DOI 10.1210/jc.87.2.599; Sokka T, 2008, CLIN EXP RHEUMATOL, V26, pS35, DOI 10.1161/CIRCULATIONAHA.109.192644; Sprenkle PC, 2007, CURR OPIN UROL, V17, P424, DOI 10.1097/MOU.0b013e3282f0ebef; STROBE, STRENGTH REP OBS STU; Strum SB, 1997, BRIT J UROL, V79, P933, DOI 10.1046/j.1464-410X.1997.00234.x; Taylor LG, 2009, CANCER-AM CANCER SOC, V115, P2388, DOI 10.1002/cncr.24283; Terrier JE, 2013, PROG UROL, V23, P88, DOI 10.1016/j.purol.2012.09.008; Van Hemelrijck M, 2010, J CLIN ONCOL, V28, P3448, DOI 10.1200/JCO.2010.29.1567; Van Hemelrijck M, 2010, LANCET ONCOL, V11, P450, DOI 10.1016/S1470-2045(10)70038-3	41	53	55	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0117344	10.1371/journal.pone.0117344	http://dx.doi.org/10.1371/journal.pone.0117344			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25794005	gold, Green Submitted, Green Published			2022-12-27	WOS:000352084200012
J	Chen, JY; Tibroni, N; Sauter, D; Galaski, J; Miura, T; Alter, G; Mueller, B; Haller, C; Walker, BD; Kirchhoff, F; Brumme, ZL; Ueno, T; Fackler, OT				Chen, Jingyan; Tibroni, Nadine; Sauter, Daniel; Galaski, Johanna; Miura, Toshiyuki; Alter, Galit; Mueller, Birthe; Haller, Claudia; Walker, Bruce D.; Kirchhoff, Frank; Brumme, Zabrina L.; Ueno, Takamasa; Fackler, Oliver T.			Modest Attenuation of HIV-1 Vpu Alleles Derived from Elite Controller Plasma	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; NK CELL-FUNCTION; PARTICLE RELEASE; TETHERIN ANTAGONISM; BETA-TRCP; HLA-C; RESTRICTION; PROTEIN; DEGRADATION; EXPRESSION	In the absence of antiretroviral therapy, infection with human immunodeficiency virus type 1 (HIV-1) can typically not be controlled by the infected host and results in the development of acquired immunodeficiency. In rare cases, however, patients spontaneously control HIV-1 replication. Mechanisms by which such elite controllers (ECs) achieve control of HIV-1 replication include particularly efficient immune responses as well as reduced fitness of the specific virus strains. To address whether polymorphisms in the accessory HIV-1 protein Vpu are associated with EC status we functionally analyzed a panel of plasma-derived vpu alleles from 15 EC and 16 chronic progressor (CP) patients. Antagonism of the HIV particle release restriction by the intrinsic immunity factor CD317/tetherin was well conserved among EC and CP Vpu alleles, underscoring the selective advantage of this Vpu function in HIV-1 infected individuals. In contrast, interference with CD317/tetherin induced NF-kappa B activation was little conserved in both groups. EC Vpus more frequently displayed reduced ability to downregulate cell surface levels of CD4 and MHC class I (MHC-I) molecules as well as of the NK cell ligand NTB-A. Polymorphisms potentially associated with high affinity interactions of the inhibitory killer immunoglobulin-like receptor (KIR) KIR2DL2 were significantly enriched among EC Vpus but did not account for these functional differences. Together these results suggest that in a subgroup of EC patients, some Vpu functions are modestly reduced, possibly as a result of host selection.	[Chen, Jingyan; Tibroni, Nadine; Galaski, Johanna; Mueller, Birthe; Haller, Claudia; Fackler, Oliver T.] Univ Heidelberg Hosp, Integrat Virol, Dept Infect Dis, Heidelberg, Germany; [Chen, Jingyan; Tibroni, Nadine; Galaski, Johanna; Mueller, Birthe; Haller, Claudia; Fackler, Oliver T.] Heidelberg Univ, German Ctr Infect Res, Heidelberg, Germany; [Sauter, Daniel; Kirchhoff, Frank] Univ Ulm, Inst Mol Virol, Med Ctr, D-89069 Ulm, Germany; [Miura, Toshiyuki] Nagasaki Univ, Inst Trop Med, Nagasaki 852, Japan; [Alter, Galit; Walker, Bruce D.] MIT, Massachusetts Gen Hosp, Ragon Inst, Boston, MA USA; [Alter, Galit; Walker, Bruce D.] Harvard Univ, Boston, MA USA; [Walker, Bruce D.] Massachusetts Gen Hosp, Div Infect Dis, Boston, MA 02114 USA; [Walker, Bruce D.] Howard Hughes Med Inst, Chevy Chase, MD USA; [Brumme, Zabrina L.] Simon Fraser Univ, Fac Hlth Sci, Burnaby, BC V5A 1S6, Canada; [Brumme, Zabrina L.] British Columbia Ctr Excellence HIV AIDS, Vancouver, BC, Canada; [Ueno, Takamasa] Kumamoto Univ, Ctr AIDS Res, Kumamoto, Japan; [Ueno, Takamasa] Kumamoto Univ, Int Res Ctr Med Sci IRCMS, Kumamoto 860, Japan	Ruprecht Karls University Heidelberg; German Center for Infection Research; Ruprecht Karls University Heidelberg; Ulm University; Nagasaki University; Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute; Harvard University; Harvard University; Massachusetts General Hospital; Howard Hughes Medical Institute; Simon Fraser University; B.C. Centre for Excellence in HIV/AIDS; Kumamoto University; Kumamoto University	Fackler, OT (corresponding author), Univ Heidelberg Hosp, Integrat Virol, Dept Infect Dis, INF 324, Heidelberg, Germany.	oliver.fackler@med.uni-heidelberg.de	Kirchhoff, Frank/O-8367-2018; Ueno, Takamasa/AAW-9491-2020; Ueno, Takamasa/F-5788-2013	Kirchhoff, Frank/0000-0002-7052-2360; Ueno, Takamasa/0000-0003-4852-4236; Ueno, Takamasa/0000-0003-4852-4236; Brumme, Zabrina/0000-0002-8157-1037; Fackler, Oliver Till/0000-0003-2982-4209	German Center for Infection Research [8.2 TTU HIV]; German Center for Infection Research (MD student fellowship); Deutsche Forschungsgemeinschaft; Ministry of Education, Science, Sports, and Culture of Japan; Ministry of Health, Labor, and Welfare of Japan	German Center for Infection Research; German Center for Infection Research (MD student fellowship); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Ministry of Education, Science, Sports, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	This study was supported by the German Center for Infection Research (project 8.2 TTU HIV to OTF and MD student fellowship to JG), the Deutsche Forschungsgemeinschaft (grants to OTF, DS and FK) and grants-in-aid for scientific research from the Ministry of Education, Science, Sports, and Culture of Japan and the Ministry of Health, Labor, and Welfare of Japan (to TU). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addo MM, 2002, AIDS, V16, P1071, DOI 10.1097/00002030-200205030-00015; AIKEN C, 1994, CELL, V76, P853, DOI 10.1016/0092-8674(94)90360-3; Alter G, 2011, NATURE, V476, P96, DOI 10.1038/nature10237; Altfeld M, 2006, PLOS MED, V3, P1851, DOI 10.1371/journal.pmed.0030403; Alvarez RA, 2014, J VIROL, V88, P6031, DOI 10.1128/JVI.00449-14; Apps R, 2013, SCIENCE, V340, P87, DOI 10.1126/science.1232685; Arias JF, 2014, P NATL ACAD SCI USA, V111, P6425, DOI 10.1073/pnas.1321507111; Bolduan S, 2013, VIROLOGY, V440, P190, DOI 10.1016/j.virol.2013.02.021; Bour S, 2001, J BIOL CHEM, V276, P15920, DOI 10.1074/jbc.M010533200; Brumme ZL, 2011, JAIDS-J ACQ IMM DEF, V56, P100, DOI 10.1097/QAI.0b013e3181fe9450; Cerboni C, 2007, J GEN VIROL, V88, P242, DOI 10.1099/vir.0.82125-0; CRISE B, 1990, J VIROL, V64, P5585, DOI 10.1128/JVI.64.11.5585-5593.1990; DEACON NJ, 1995, SCIENCE, V270, P988, DOI 10.1126/science.270.5238.988; Dube M, 2009, J VIROL, V83, P4574, DOI 10.1128/JVI.01800-08; Estrabaud E, 2007, PLOS PATHOG, V3, P995, DOI 10.1371/journal.ppat.0030104; Fadda L, 2011, ADV EXP MED BIOL, V780, P27, DOI 10.1007/978-1-4419-5632-3_3; Fausther-Bovendo H, 2009, AIDS, V23, P1077, DOI 10.1097/QAD.0b013e32832cb26b; Fellay J, 2007, SCIENCE, V317, P944, DOI 10.1126/science.1143767; FOLKS T, 1985, P NATL ACAD SCI USA, V82, P4539, DOI 10.1073/pnas.82.13.4539; Fritz JV, 2012, VIROLOGY, V424, P33, DOI 10.1016/j.virol.2011.12.008; Galao RP, 2012, CELL HOST MICROBE, V12, P633, DOI 10.1016/j.chom.2012.10.007; Goffinet C, 2010, J VIROL, V84, P4089, DOI 10.1128/JVI.01549-09; Goffinet C, 2009, CELL HOST MICROBE, V5, P285, DOI 10.1016/j.chom.2009.01.009; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hatziioannou T, 2014, SCIENCE, V344, P1401, DOI 10.1126/science.1250761; Hersperger AR, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000917; Hotter D, 2013, J VIROL, V87, P7160, DOI 10.1128/JVI.00526-13; Jafari M, 2014, J VIROL, V88, P5062, DOI 10.1128/JVI.03472-13; Johansson SE, 2011, VIRAL IMMUNOL, V24, P359, DOI 10.1089/vim.2011.0025; Kerkau T, 1997, J EXP MED, V185, P1295, DOI 10.1084/jem.185.7.1295; KIRCHHOFF F, 1995, NEW ENGL J MED, V332, P228, DOI 10.1056/NEJM199501263320405; Kluge SF, 2014, CELL HOST MICROBE, V16, P639, DOI 10.1016/j.chom.2014.10.002; Kueck T, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002609; Lassen KG, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000377; Lobritz MA, 2011, CURR OPIN HIV AIDS, V6, P214, DOI 10.1097/COH.0b013e3283454cf5; Majumder B, 2008, J VIROL, V82, P7189, DOI 10.1128/JVI.01979-07; McNatt MW, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003299; Medina-Ramirez M, 2011, J VIROL, V85, P5804, DOI 10.1128/JVI.02482-10; Miura T, 2008, J VIROL, V82, P8422, DOI 10.1128/JVI.00535-08; Miura T, 2009, J VIROL, V83, P140, DOI 10.1128/JVI.01471-08; Mwimanzi P, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-1; Neil SJD, 2008, NATURE, V451, P425, DOI 10.1038/nature06553; Pereyra F, 2008, J INFECT DIS, V197, P563, DOI 10.1086/526786; Pham TNQ, 2014, RETROVIROLOGY, V11, DOI 10.1186/1742-4690-11-15; Pickering S, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003895; Platt EJ, 1998, J VIROL, V72, P2855, DOI 10.1128/JVI.72.4.2855-2864.1998; Rollason R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075680; Saez-Cirion A, 2007, P NATL ACAD SCI USA, V104, P6776, DOI 10.1073/pnas.0611244104; Sauter D, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-85; Sauter D, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003093; Sauter D, 2009, CELL HOST MICROBE, V6, P409, DOI 10.1016/j.chom.2009.10.004; Schmidt S, 2011, MBIO, V2, DOI 10.1128/mBio.00036-11; Schwartz O, 1996, NAT MED, V2, P338, DOI 10.1038/nm0396-338; Shah AH, 2010, CELL HOST MICROBE, V8, P397, DOI 10.1016/j.chom.2010.10.008; Tervo HM, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-9; Thomas R, 2009, NAT GENET, V41, P1290, DOI 10.1038/ng.486; Thorn M, 2007, APMIS, V115, P757, DOI 10.1111/j.1600-0463.2007.apm_595.x; Tokarev A, 2013, J VIROL, V87, P2046, DOI 10.1128/JVI.02272-12; Van Damme N, 2008, CELL HOST MICROBE, V3, P245, DOI 10.1016/j.chom.2008.03.001; Venkatesh S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003483; Vigan R, 2010, J VIROL, V84, P12958, DOI 10.1128/JVI.01699-10; Walker BD, 2007, TOP HIV MED, V15, P134; Ward J, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000613; WILLEY RL, 1992, J VIROL, V66, P7193, DOI 10.1128/JVI.66.12.7193-7200.1992; Wren LH, 2013, IMMUNOLOGY, V138, P116, DOI 10.1111/imm.12016; Zhai S, 2008, CURR HIV RES, V6, P335, DOI 10.2174/157016208785132473	66	25	25	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0120434	10.1371/journal.pone.0120434	http://dx.doi.org/10.1371/journal.pone.0120434			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25793728	gold, Green Published, Green Submitted			2022-12-27	WOS:000352083900034
J	Kuley, R; Smith, HE; Frangoulidis, D; Smits, MA; Roest, HIJ; Bossers, A				Kuley, Runa; Smith, Hilde E.; Frangoulidis, Dimitrios; Smits, Mari A.; Roest, Hendrik I. Jan; Bossers, Alex			Cell-Free Propagation of Coxiella burnetii Does Not Affect Its Relative Virulence	PLOS ONE			English	Article							REAL-TIME PCR; Q-FEVER; ETHIDIUM MONOAZIDE; PHASE-II; PROPIDIUM MONOAZIDE; DEAD CELLS; T-CELLS; LIPOPOLYSACCHARIDE; INFECTION; STRAINS	Q fever is caused by the obligate intracellular bacterium Coxiella burnetii. In vitro growth of the bacterium is usually limited to viable eukaryotic host cells imposing experimental constraints for molecular studies, such as the identification and characterisation of major virulence factors. Studies of pathogenicity may benefit from the recent development of an extracellular growth medium for C. burnetii. However, it is crucial to investigate the consistency of the virulence phenotype of strains propagated by the two fundamentally different culturing systems. In the present study, we assessed the viability of C. burnetii and the lipopolysaccaride (LPS) encoding region of the bacteria in both culture systems as indirect but key parameters to the infection potential of C. burnetii. Propidium monoazide (PMA) treatment-based real-time PCR was used for enumeration of viable C. burnetii which were validated by fluorescent infectious focus forming unit counting assays. Furthermore, RNA isolated from C. burnetiipropagated in both the culture systems was examined for LPS-related gene expression. All thus far known LPS-related genes were found to be expressed in early passages in both culturing systems indicating the presence of predominantly the phase I form of C. burnetii. Finally, we used immune-competent mice to provide direct evidence, that the relative virulence of different C. burnetii strains is essentially the same for both axenic and cell-based methods of propagation.	[Kuley, Runa; Smith, Hilde E.; Smits, Mari A.; Bossers, Alex] Wageningen UR, Cent Vet Inst, Dept Infect Biol, Lelystad, Netherlands; [Roest, Hendrik I. Jan] Wageningen UR, Cent Vet Inst, Dept Bacteriol, Lelystad, Netherlands; [Roest, Hendrik I. Jan] Wageningen UR, Cent Vet Inst, TSEs, Lelystad, Netherlands; [Kuley, Runa; Smits, Mari A.] Wageningen Univ, Host Microbe Interact, NL-6700 AP Wageningen, Netherlands; [Frangoulidis, Dimitrios] Bundeswehr Inst Microbiol, Munich, Germany	Wageningen University & Research; Wageningen University & Research; Wageningen University & Research; Wageningen University & Research; Bundeswehr Institute of Microbiology (IMB)	Bossers, A (corresponding author), Wageningen UR, Cent Vet Inst, Dept Infect Biol, Lelystad, Netherlands.	alex.bossers@wur.nl	smits, mari/J-4892-2013; Bossers, Alex/AAA-6025-2021; Bossers, Alex/F-7757-2019	smits, mari/0000-0002-3493-291X; Bossers, Alex/0000-0002-6586-717X; Bossers, Alex/0000-0002-6586-717X	Dutch Ministry of Economic Affairs [01-002-005.05]; Netherlands Organisation for Health Research and Development [205520009]	Dutch Ministry of Economic Affairs(Ministry of Economic Affairs, Netherlands); Netherlands Organisation for Health Research and Development(Netherlands Organization for Health Research and Development)	Funding: This work was supported by the Dutch Ministry of Economic Affairs [01-002-005.05] http://www.government.nl/ministries/ez and The Netherlands Organisation for Health Research and Development [205520009] http://www.zonmw.nl/en/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Yanez MA, 2011, J MICROBIOL METH, V85, P124, DOI 10.1016/j.mimet.2011.02.004; AMANO KI, 1984, J BACTERIOL, V160, P982, DOI 10.1128/JB.160.3.982-988.1984; Andoh M, 2007, INFECT IMMUN, V75, P3245, DOI 10.1128/IAI.01767-06; Angelakis E, 2010, VET MICROBIOL, V140, P297, DOI 10.1016/j.vetmic.2009.07.016; BACA OG, 1980, CAN J MICROBIOL, V26, P819, DOI 10.1139/m80-141; Beare PA, 2006, J BACTERIOL, V188, P2309, DOI 10.1128/JB.188.7.2309-2324.2006; Beare PA, 2012, APPL ENVIRON MICROB, V78, P4580, DOI 10.1128/AEM.00881-12; Beare PA, 2011, MBIO, V2, DOI 10.1128/mBio.00175-11; Beare PA, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00097; Beare PA, 2009, J BACTERIOL, V191, P1369, DOI 10.1128/JB.01580-08; Bouvery NA, 2003, VET RES, V34, P423, DOI 10.1051/vetres:2003017; Brennan RE, 2003, J CLIN MICROBIOL, V41, P1869, DOI 10.1128/JCM.41.5.1869-1874.2003; BUZONIGATEL D, 1983, ANN INST PASTEUR MIC, VA134, P91, DOI 10.1016/0769-2609(83)90107-2; Cawthorn DM, 2008, J APPL MICROBIOL, V105, P1178, DOI 10.1111/j.1365-2672.2008.03851.x; Denison AM, 2007, FEMS MICROBIOL LETT, V267, P102, DOI 10.1111/j.1574-6968.2006.00544.x; Enserink M, 2010, SCIENCE, V327, P266, DOI [10.1126/science.327.5963.266-a, 10.1126/science.327.5963.266-b]; Hoover TA, 2002, INFECT IMMUN, V70, P6726, DOI 10.1128/IAI.70.12.6726-2733.2002; Howe D, 2002, INFECT IMMUN, V70, P5140, DOI 10.1128/IAI.70.9.5140-5147.2002; Kampschreur LM, 2013, EPIDEMIOL INFECT, V141, P847, DOI 10.1017/S0950268812001203; KAZAR J, 1993, ACTA VIROL, V37, P437; Kersh GJ, 2011, VECTOR-BORNE ZOONOT, V11, P1433, DOI 10.1089/vbz.2011.0670; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Leroy Q, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015321; LUKACOVA M, 1993, FEMS MICROBIOL LETT, V113, P285, DOI 10.1111/j.1574-6968.1993.tb06528.x; Maurin M, 1999, CLIN MICROBIOL REV, V12, P518, DOI 10.1128/CMR.12.4.518; Mayer H, 1988, Adv Exp Med Biol, V228, P577; Mazokopakis Elias E., 2010, Infectious Disorders - Drug Targets, V10, P27; MOOS A, 1987, INFECT IMMUN, V55, P1144, DOI 10.1128/IAI.55.5.1144-1150.1987; Mori M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067622; Narasaki CT, 2012, ADV EXP MED BIOL, V984, P65, DOI 10.1007/978-94-007-4315-1_4; Nocker A, 2006, APPL ENVIRON MICROB, V72, P1997, DOI 10.1128/AEM.72.3.1997-2004.2006; Nocker A, 2006, J MICROBIOL METH, V67, P310, DOI 10.1016/j.mimet.2006.04.015; Nogva HK, 2003, BIOTECHNIQUES, V34, P804, DOI 10.2144/03344rr02; Omsland A, 2011, APPL ENVIRON MICROB, V77, P3720, DOI 10.1128/AEM.02826-10; Omsland A, 2009, P NATL ACAD SCI USA, V106, P4430, DOI 10.1073/pnas.0812074106; Pan Y, 2007, APPL ENVIRON MICROB, V73, P8028, DOI 10.1128/AEM.01198-07; Raoult D, 2005, LANCET INFECT DIS, V5, P219, DOI 10.1016/S1473-3099(05)70052-9; Read AJ, 2010, INFECT IMMUN, V78, P3019, DOI 10.1128/IAI.00101-10; Rodolakis A., 2010, INT Q FEV C BRED NET; Roest HIJ, 2011, EPIDEMIOL INFECT, V139, P1, DOI 10.1017/S0950268810002268; Roest HIJ, 2011, EMERG INFECT DIS, V17, P668, DOI 10.3201/eid1704.101562; Roest HJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048949; Russell-Lodrigue KE, 2009, INFECT IMMUN, V77, P5640, DOI 10.1128/IAI.00851-09; SCHRAMEK S, 1982, INFECT IMMUN, V38, P53, DOI 10.1128/IAI.38.1.53-57.1982; Seshadri R, 2003, P NATL ACAD SCI USA, V100, P5455, DOI 10.1073/pnas.0931379100; Stein A, 2005, INFECT IMMUN, V73, P2469, DOI 10.1128/IAI.73.4.2469-2477.2005; STOKER MGP, 1956, CAN J MICROBIOL, V2, P310, DOI 10.1139/m56-036; Tang F, 2013, GENOMICS, V101, P336, DOI 10.1016/j.ygeno.2013.04.005; van der Hoek W, 2010, EURO SURVEILL, P15; Wagner AO, 2008, APPL ENVIRON MICROB, V74, P2537, DOI 10.1128/AEM.02288-07; Zhang GQ, 2003, ANN NY ACAD SCI, V990, P510, DOI 10.1111/j.1749-6632.2003.tb07420.x	51	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0121661	10.1371/journal.pone.0121661	http://dx.doi.org/10.1371/journal.pone.0121661			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25793981	Green Published, gold, Green Submitted			2022-12-27	WOS:000352083900144
J	Lee, I; Kim, E; Marcotte, EM				Lee, Insuk; Kim, Eiru; Marcotte, Edward M.			Modes of Interaction between Individuals Dominate the Topologies of Real World Networks	PLOS ONE			English	Article							SEXUAL NETWORKS; GENE NETWORK; YEAST; DYNAMICS	We find that the topologies of real world networks, such as those formed within human societies, by the Internet, or among cellular proteins, are dominated by the mode of the interactions considered among the individuals. Specifically, a major dichotomy in previously studied networks arises from modeling networks in terms of pairwise versus group tasks. The former often intrinsically give rise to scale-free, disassortative, hierarchical networks, whereas the latter often give rise to single-or broad-scale, assortative, nonhierarchical networks. These dependencies explain contrasting observations among previous topological analyses of real world complex systems. We also observe this trend in systems with natural hierarchies, in which alternate representations of the same networks, but which capture different levels of the hierarchy, manifest these signature topological differences. For example, in both the Internet and cellular proteomes, networks of lower-level system components (routers within domains or proteins within biological processes) are assortative and nonhierarchical, whereas networks of upper-level system components (internet domains or biological processes) are disassortative and hierarchical. Our results demonstrate that network topologies of complex systems must be interpreted in light of their hierarchical natures and interaction types.	[Lee, Insuk; Kim, Eiru] Yonsei Univ, Dept Biotechnol, Coll Life Sci & Biotechnol, Seoul 120749, South Korea; [Marcotte, Edward M.] Univ Texas Austin, Dept Mol Biosci, Ctr Syst & Synthet Biol, Austin, TX 78712 USA; [Marcotte, Edward M.] Univ Texas Austin, Inst Cellular & Mol Biol, Austin, TX 78712 USA	Yonsei University; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Lee, I (corresponding author), Yonsei Univ, Dept Biotechnol, Coll Life Sci & Biotechnol, 50 Yonsei Ro, Seoul 120749, South Korea.	insuklee@yonsei.ac.kr; marcotte@icmb.utexas.edu		Kim, Eiru/0000-0002-1901-5670; Marcotte, Edward/0000-0001-8808-180X	National Research Foundation of Korea [2010-0017649, 2012M3A9B4028641, 2012M3A9C7050151]; National Science Foundation; National Institutes of Health; United States Army [58343-MA]; Welch Foundation [F-1515]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [DP1GM106408] Funding Source: NIH RePORTER	National Research Foundation of Korea(National Research Foundation of Korea); National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Army(United States Department of DefenseUnited States Army); Welch Foundation(The Welch Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding: This work was supported by grants from the National Research Foundation of Korea (2010-0017649, 2012M3A9B4028641, 2012M3A9C7050151) to IL, and from the National Science Foundation, National Institutes of Health, United States Army (58343-MA) and Welch Foundation (F-1515) to EMM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaral LAN, 2000, P NATL ACAD SCI USA, V97, P11149, DOI 10.1073/pnas.200327197; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Batada NN, 2006, PLOS BIOL, V4, P1720, DOI 10.1371/journal.pbio.0040317; Davis G. F., 2003, Strategic Organization, V1, P301, DOI 10.1177/14761270030013002; Domingos P, 2011, PROCEEDINGS OF THE 7, P57; Doyle JC, 2005, P NATL ACAD SCI USA, V102, P14497, DOI 10.1073/pnas.0501426102; Enright AJ, 2002, NUCLEIC ACIDS RES, V30, P1575, DOI 10.1093/nar/30.7.1575; Holme P, 2004, SOC NETWORKS, V26, P155, DOI 10.1016/j.socnet.2004.01.007; Jeong H, 2000, NATURE, V407, P651, DOI 10.1038/35036627; Lee I, 2004, SCIENCE, V306, P1555, DOI 10.1126/science.1099511; Lee I, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000988; Lee I, 2008, NAT GENET, V40, P181, DOI 10.1038/ng.2007.70; Liljeros F, 2003, MICROBES INFECT, V5, P189, DOI 10.1016/S1286-4579(02)00058-8; Ma JL, 2013, J THEOR BIOL, V325, P12, DOI 10.1016/j.jtbi.2013.01.006; Maslov S, 2004, PHYSICA A, V333, P529, DOI 10.1016/j.physa.2003.06.002; Maslov S, 2002, SCIENCE, V296, P910, DOI 10.1126/science.1065103; Mones E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033799; Newman MEJ, 2001, P NATL ACAD SCI USA, V98, P404, DOI 10.1073/pnas.021544898; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Newman MEJ, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.208701; Rahman M, 2014, KNOWL INF SYST, V38, P511, DOI 10.1007/s10115-013-0673-3; Ravasz E, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.026112; Rocha LEC, 2010, P NATL ACAD SCI USA, V107, P5706, DOI 10.1073/pnas.0914080107; Trusina A, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.178702; Vazquez A, 2002, ARXIV COND MAT 02060; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Yook SH, 2004, PROTEOMICS, V4, P928, DOI 10.1002/pmic.200300636; Yu HY, 2008, SCIENCE, V322, P104, DOI 10.1126/science.1158684	29	3	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0121248	10.1371/journal.pone.0121248	http://dx.doi.org/10.1371/journal.pone.0121248			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25793969	Green Submitted, Green Published, gold			2022-12-27	WOS:000352083900117
J	Matarazzo, SA				Matarazzo, Stacey A.			Trabecular Architecture of the Manual Elements Reflects Locomotor Patterns in Primates	PLOS ONE			English	Article							COMPUTED-TOMOGRAPHY; BONE-STRUCTURE; FEMORAL-HEAD; APPARENT DENSITY; SUBCHONDRAL BONE; KNUCKLE-WALKING; CANCELLOUS BONE; BIOMECHANICS; HAND; ADAPTATION	The morphology of trabecular bone has proven sensitive to loading patterns in the long bones and metacarpal heads of primates. It is expected that we should also see differences in the manual digits of primates that practice different methods of locomotion. Primate proximal and middle phalanges are load-bearing elements that are held in different postures and experience different mechanical strains during suspension, quadrupedalism, and knuckle walking. Micro CT scans of the middle phalanx, proximal phalanx and the metacarpal head of the third ray were used to examine the pattern of trabecular orientation in Pan, Gorilla, Pongo, Hylobates and Macaca. Several zones, i.e., the proximal ends of both phalanges and the metacarpal heads, were capable of distinguishing between knuckle-walking, quadrupedal, and suspensory primates. Orientation and shape seem to be the primary distinguishing factors but differences in bone volume, isotropy index, and degree of anisotropy were seen across included taxa. Suspensory primates show primarily proximodistal alignment in all zones, and quadrupeds more palmar-dorsal orientation in several zones. Knuckle walkers are characterized by having proximodistal alignment in the proximal ends of the phalanges and a palmar-dorsal alignment in the distal ends and metacarpal heads. These structural differences may be used to infer locmotor propensities of extinct primate taxa.	Univ Massachusetts, Dept Anthropol, Amherst, MA 01003 USA	University of Massachusetts System; University of Massachusetts Amherst	Matarazzo, SA (corresponding author), Univ Massachusetts, Dept Anthropol, Amherst, MA 01003 USA.	smataraz@anthro.umass.edu			Wenner Gren Foundation dissertation grant; LSB Foundation dissertation grant	Wenner Gren Foundation dissertation grant; LSB Foundation dissertation grant	SM attained the following grants in support of this research: the Wenner Gren Foundation dissertation grant (http://www.wennergren.org) and the LSB Foundation dissertation grant (www.leakeyfoundation.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barak MM, 2011, BONE, V49, P1141, DOI 10.1016/j.bone.2011.08.020; Bertram JEA, 2001, AM J PHYS ANTHROPOL, V115, P319, DOI 10.1002/ajpa.1088; Carlson KJ, 2006, J ANAT, V208, P659, DOI 10.1111/j.1469-7580.2006.00555.x; Chang YH, 2000, AM J PHYS ANTHROPOL, V113, P201, DOI 10.1002/1096-8644(200010)113:2<201::AID-AJPA5>3.3.CO;2-J; Chirchir H, 2010, AM J PHYS ANTHROPOL, P81; DeSilva JM, 2012, J HUM EVOL, V63, P536, DOI 10.1016/j.jhevol.2012.06.006; Fajardo RJ, 2002, AM J PHYS ANTHROPOL, V118, P1, DOI 10.1002/ajpa.10086; Fajardo RJ, 2001, AM J PHYS ANTHROPOL, V115, P327, DOI 10.1002/ajpa.1089; Fox JC, 2001, J THEOR BIOL, V212, P211, DOI 10.1006/jtbi.2001.2371; Jacobs CR, 2000, J REHABIL RES DEV, V37, P209; Jungers W. L., 1994, AM J PHYS ANTHR S, V18, P117; Jungers WL, 2001, ADV PRIMATO, P371; Jungers WL, 1997, P NATL ACAD SCI USA, V94, P11998, DOI 10.1073/pnas.94.22.11998; Keaveny TM, 2001, ANNU REV BIOMED ENG, V3, P307, DOI 10.1146/annurev.bioeng.3.1.307; Ketcham RA, 2005, J STRUCT GEOL, V27, P1217, DOI 10.1016/j.jsg.2005.02.006; Ketcham RA, 2004, J MICROSC-OXFORD, V213, P158, DOI 10.1111/j.1365-2818.2004.01277.x; Kivell TL, 2011, J ANAT, V218, P209, DOI 10.1111/j.1469-7580.2010.01314.x; Lazenby RA, 2011, AM J PHYS ANTHROPOL, V144, P215, DOI 10.1002/ajpa.21390; MacLatchy L, 2002, J HUM EVOL, V43, P89, DOI 10.1006/jhev.2002.0559; Marchi D, 2005, J HUM EVOL, V49, P743, DOI 10.1016/j.jhevol.2005.08.002; Matarazzo SA, 2011, AM J PHYS ANTHROPOL, V144, P208; Matarazzo S, 2013, AM J PHYS ANTHROPOL, V152, P44, DOI 10.1002/ajpa.22325; Mittra E, 2005, J BIOMECH, V38, P1229, DOI 10.1016/j.jbiomech.2004.06.007; Patel BA, 2007, J HUM EVOL, V52, P130, DOI 10.1016/j.jhevol.2006.08.007; Patel BA, 2010, J HUM EVOL, V58, P320, DOI 10.1016/j.jhevol.2010.01.001; Polk JD, 2008, ANAT REC, V291, P293, DOI 10.1002/ar.20653; Polk JD, 2010, INT J PRIMATOL, V31, P275, DOI 10.1007/s10764-010-9401-y; Pontzer H, 2006, J EXP BIOL, V209, P57, DOI 10.1242/jeb.01971; Richmond BG, 1998, THESIS STATE U NEW Y; Richmond BG, 2007, J HUM EVOL, V53, P678, DOI 10.1016/j.jhevol.2007.05.011; Ruff C, 2006, AM J PHYS ANTHROPOL, V129, P484, DOI 10.1002/ajpa.20371; Ryan TM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041037; Ryan TM, 2010, ANAT REC, V293, P719, DOI 10.1002/ar.21139; Ryan TM, 2005, AM J PHYS ANTHROPOL, V126, P82, DOI 10.1002/ajpa.10414; Ryan TM, 2002, J HUM EVOL, V43, P1, DOI 10.1006/jhev.2002.0552; Scherf H, 2013, J HUM EVOL, V65, P29, DOI 10.1016/j.jhevol.2013.03.008; Scherf H, 2009, AM J PHYS ANTHROPOL, V140, P39, DOI 10.1002/ajpa.21033; Schilling AM, 2014, J MORPHOL, V275, P572, DOI 10.1002/jmor.20238; Shaw CN, 2012, AM J PHYS ANTHROPOL, V147, P187, DOI 10.1002/ajpa.21635; Tsegai ZJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078781; Usherwood JR, 2003, AM J PHYS ANTHROPOL, V120, P364, DOI 10.1002/ajpa.10133; Waarsing J. H., 2005, Journal of Musculoskeletal & Neuronal Interactions, V5, P310; Zeininger A, 2011, J HUM EVOL, V60, P703, DOI 10.1016/j.jhevol.2011.01.002	43	23	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0120436	10.1371/journal.pone.0120436	http://dx.doi.org/10.1371/journal.pone.0120436			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25793781	Green Published, Green Submitted, gold			2022-12-27	WOS:000352083900035
J	Oh, K; Matsumoto, T; Yamagami, A; Ogawa, A; Yamada, K; Suzuki, R; Sawada, T; Fujioka, S; Yoshizawa, Y; Nakano, T				Oh, Keimei; Matsumoto, Tadashi; Yamagami, Ayumi; Ogawa, Atushi; Yamada, Kazuhiro; Suzuki, Ryuichiro; Sawada, Takayuki; Fujioka, Shozo; Yoshizawa, Yuko; Nakano, Takeshi			YCZ-18 Is a New Brassinosteroid Biosynthesis Inhibitor	PLOS ONE			English	Article							ARABIDOPSIS-THALIANA; CYTOCHROME-P450 MONOOXYGENASE; POTENT INHIBITORS; CELL ELONGATION; LEAF SENESCENCE; HIGH-EFFICIENCY; C-6 OXIDATION; MUTANT; PATHWAY; PROTEIN	Plant hormone brassinosteroids (BRs) are a group of polyhydroxylated steroids that play critical roles in regulating broad aspects of plant growth and development. The structural diversity of BRs is generated by the action of several groups of P450s. Brassinazole is a specific inhibitor of C-22 hydroxylase (CYP90B1) in BR biosynthesis, and the application use of brassinazole has emerged as an effective way of complementing BR-deficient mutants to elucidate the functions of BRs. In this article, we report a new triazole-type BR biosynthesis inhibitor, YCZ-18. Quantitative analysis the endogenous levels of BRs in Arabidopsis indicated that YCZ-18 significantly decreased the BR contents in plant tissues. Assessment of the binding affinity of YCZ-18 to purified recombinant CYP90D1 indicated that YCZ-18 induced a typical type II binding spectrum with a K-d value of approximately 0.79 mu M. Analysis of the mechanisms underlying the dwarf phenotype associated with YCZ-18 treatment of Arabidopsis indicated that the chemically induced dwarf phenotype was caused by a failure of cell elongation. Moreover, dissecting the effect of YCZ-18 on the induction or down regulation of genes responsive to BRs indicated that YCZ-18 regulated the expression of genes responsible for BRs deficiency in Arabidopsis. These findings indicate that YCZ-18 is a potent BR biosynthesis inhibitor and has a new target site, C23-hydroxylation in BR biosynthesis. Application of YCZ-18 will be a good starting point for further elucidation of the detailed mechanism of BR biosynthesis and its regulation.	[Oh, Keimei; Matsumoto, Tadashi; Yamada, Kazuhiro; Yoshizawa, Yuko] Akita Prefectural Univ, Fac Bioresource Sci, Dept Biotechnol, Akita, Japan; [Yamagami, Ayumi; Fujioka, Shozo; Nakano, Takeshi] RIKEN, Antibiot Lab, Wako, Saitama, Japan; [Ogawa, Atushi; Suzuki, Ryuichiro] Akita Prefectural Univ, Fac Bioresource Sci, Dept Bioprod, Akita, Japan; [Sawada, Takayuki] Akita Prefectural Univ, Fac Bioresource Sci, Biotechnol Res Ctr, Akita, Japan; [Fujioka, Shozo; Nakano, Takeshi] RIKEN Ctr Sustainable Resource Sci, Wako, Saitama, Japan; [Nakano, Takeshi] Japan Sci & Technol Agcy, CREST, Kawaguchi, Saitama, Japan	Akita Prefectural University; RIKEN; Akita Prefectural University; Akita Prefectural University; RIKEN; Japan Science & Technology Agency (JST)	Oh, K (corresponding author), Akita Prefectural Univ, Fac Bioresource Sci, Dept Biotechnol, Akita, Japan.	jmwang@akita-pu.ac.jp	Yamagami, Ayumi/C-7602-2017; Nakano, Takeshi/E-9171-2013	Nakano, Takeshi/0000-0002-3188-7770	Akita Prefectural University; CREST, Japan Science and Technology Agency	Akita Prefectural University; CREST, Japan Science and Technology Agency(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST))	This study was supported in part by funding from the Akita Prefectural University President's Research Project to KO and the CREST, Japan Science and Technology Agency to TN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asami T, 1999, TRENDS PLANT SCI, V4, P348, DOI 10.1016/S1360-1385(99)01456-9; Asami T, 2001, J BIOL CHEM, V276, P25687, DOI 10.1074/jbc.M103524200; Asami T, 2000, PLANT PHYSIOL, V123, P93, DOI 10.1104/pp.123.1.93; Azpiroz R, 1998, PLANT CELL, V10, P219, DOI 10.1105/tpc.10.2.219; Bishop GJ, 1999, P NATL ACAD SCI USA, V96, P1761, DOI 10.1073/pnas.96.4.1761; Blackwell HE, 2003, PLANT PHYSIOL, V133, P448, DOI 10.1104/pp.103.031138; CARY AJ, 1995, PLANT PHYSIOL, V107, P1075, DOI 10.1104/pp.107.4.1075; Castle J, 2005, PLANT MOL BIOL, V57, P129, DOI 10.1007/s11103-004-6851-7; Choe S, 2001, PLANT J, V26, P573, DOI 10.1046/j.1365-313x.2001.01055.x; Choe S, 1999, PLANT PHYSIOL, V119, P897, DOI 10.1104/pp.119.3.897; Choe SW, 1998, PLANT CELL, V10, P231, DOI 10.1105/tpc.10.2.231; CHORY J, 1991, PLANT CELL, V3, P445, DOI 10.1105/tpc.3.5.445; Clouse SD, 1998, ANNU REV PLANT PHYS, V49, P427, DOI 10.1146/annurev.arplant.49.1.427; Divi UK, 2009, NEW BIOTECHNOL, V26, P131, DOI 10.1016/j.nbt.2009.07.006; Fujioka S, 2003, ANNU REV PLANT BIOL, V54, P137, DOI 10.1146/annurev.arplant.54.031902.134921; Fujioka S, 2002, PLANT PHYSIOL, V130, P930, DOI 10.1104/pp.008722; Fujioka S, 1997, PLANT CELL, V9, P1951, DOI 10.1105/tpc.9.11.1951; Hartwig T, 2011, P NATL ACAD SCI USA, V108, P19814, DOI 10.1073/pnas.1108359108; Hayashi K, 2008, PROTEIN EXPRES PURIF, V62, P120, DOI 10.1016/j.pep.2008.07.007; Hong Z, 2003, PLANT CELL, V15, P2900, DOI 10.1105/tpc.014712; Kim GT, 2005, PLANT J, V41, P710, DOI 10.1111/j.1365-313X.2004.02330.x; Kim GT, 1998, GENE DEV, V12, P2381, DOI 10.1101/gad.12.15.2381; Knight ZA, 2006, CELL, V125, P733, DOI 10.1016/j.cell.2006.03.035; KREBBERS E, 1988, PLANT MOL BIOL, V11, P745, DOI 10.1007/BF00019515; Krishna P, 2003, J PLANT GROWTH REGUL, V22, P289, DOI 10.1007/s00344-003-0058-z; Kusaba M, 2013, PHOTOSYNTH RES, V117, P221, DOI 10.1007/s11120-013-9862-x; LEUTWILER LS, 1986, NUCLEIC ACIDS RES, V14, P4051, DOI 10.1093/nar/14.10.4051; Nomura T, 1997, PLANT PHYSIOL, V113, P31, DOI 10.1104/pp.113.1.31; Oh K, 2006, FEBS LETT, V580, P5791, DOI 10.1016/j.febslet.2006.09.044; Oh K, 2013, BIOORG MED CHEM LETT, V23, P6915, DOI 10.1016/j.bmcl.2013.09.056; Oh K, 2012, BIOORG MED CHEM LETT, V22, P1625, DOI 10.1016/j.bmcl.2011.12.120; Ohnishi T, 2006, PLANT CELL, V18, P3275, DOI 10.1105/tpc.106.045443; Ohnishi T, 2012, J BIOL CHEM, V287, P31551, DOI 10.1074/jbc.M112.392720; ROGERSON TD, 1977, BIOCHEM PHARMACOL, V26, P1039, DOI 10.1016/0006-2952(77)90241-6; Sakamoto T, 2006, NAT BIOTECHNOL, V24, P105, DOI 10.1038/nbt1173; Sakamoto T, 2012, AM J PLANT SCI, V3, P1699, DOI DOI 10.4236/AJPS.2012.312208; Sakurai A, 1997, BIOSCI BIOTECH BIOCH, V61, P757, DOI 10.1271/bbb.61.757; Sasse JM, 2003, J PLANT GROWTH REGUL, V22, P276, DOI 10.1007/s00344-003-0062-3; Seki M, 1998, PLANT J, V15, P707, DOI 10.1046/j.1365-313x.1998.00237.x; Seki M, 2002, SCIENCE, V296, P141, DOI 10.1126/science.1071006; Sekimata K, 2008, BIOSCI BIOTECH BIOCH, V72, P7, DOI 10.1271/bbb.70141; Shen H, 2012, MOL PLANT, V5, P750, DOI 10.1093/mp/sss029; Tanaka K, 2005, PLANT PHYSIOL, V138, P1117, DOI 10.1104/pp.104.058040; TESTA B, 1981, DRUG METAB REV, V12, P1, DOI 10.3109/03602538109011082; Tocquin Pierre, 2003, BMC Plant Biology, V3, P2, DOI 10.1186/1471-2229-3-2; Vriet C, 2012, PLANT CELL, V24, P842, DOI 10.1105/tpc.111.094912; Wang ZY, 2002, DEV CELL, V2, P505, DOI 10.1016/S1534-5807(02)00153-3; Woo HR, 2001, PLANT CELL, V13, P1779, DOI 10.1105/tpc.13.8.1779; Wu CY, 2008, PLANT CELL, V20, P2130, DOI 10.1105/tpc.107.055087; XU W, 1995, PLANT CELL, V7, P1555, DOI 10.1105/tpc.7.10.1555; Yamada K, 2013, BIOORGAN MED CHEM, V21, P2451, DOI 10.1016/j.bmc.2013.03.006; Yamada K, 2012, MOLECULES, V17, P4460, DOI 10.3390/molecules17044460; Yamagami A, 2009, BIOSCI BIOTECH BIOCH, V73, P415, DOI 10.1271/bbb.80752	53	11	12	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0120812	10.1371/journal.pone.0120812	http://dx.doi.org/10.1371/journal.pone.0120812			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25793645	Green Submitted, Green Published, gold			2022-12-27	WOS:000352083900078
J	Spencer-Smith, M; Klingberg, T				Spencer-Smith, Megan; Klingberg, Torkel			Benefits of a Working Memory Training Program for Inattention in Daily Life: A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; COGNITIVE DEFICITS; FLUID INTELLIGENCE; CHILDREN; ADOLESCENTS; ADHD; ACHIEVEMENT; MATHEMATICS; PREDICTORS; PLASTICITY	Background Many common disorders across the lifespan feature impaired working memory (WM). Reported benefits of aWM training program include improving inattention in daily life, but this has not been evaluated in a meta-analysis. This study aimed to evaluate whether one WM training method has benefits for inattention in daily life by conducting a systematic review and meta-analysis. Methods We searched Medline and PsycINFO, relevant journals and contacted authors for studies with an intervention and control group reporting post-training estimates of inattention in daily life. To reduce the influence of differentWM training methods on the findings, the review was restricted to trials evaluating the Cogmed method. A meta-analysis calculated the pooled standardised difference in means (SMD) between intervention and control groups. Results A total of 622 studies were identified and 12 studies with 13 group comparisons met inclusion criteria. The meta-analysis showed a significant training effect on inattention in daily life, SMD=-0.47, 95% CI -0.65, -0.29, p<.00001. Subgroup analyses showed this significant effect was observed in groups of children and adults as well as users with and without ADHD, and in studies using control groups that were active and non-adaptive, wait-list and passive as well as studies using specific or general measures. Seven of the studies reported follow-up assessment and a meta-analysis showed persisting training benefits for inattention in daily life, SMD=-0.33, 95% CI -0.57 -0.09, p =.006. Additional meta-analyses confirmed improvements after training on visuospatial WM, SMD=0.66, 95% CI 0.43, 0.89, p<.00001, and verbal WM tasks, SMD=0.40, 95% CI 0.18, 0.62, p = .0004. Conclusions Benefits of aWM training program generalise to improvements in everyday functioning. Initial evidence shows that the Cogmed method has significant benefits for inattention in daily life with a clinically relevant effect size.	[Spencer-Smith, Megan; Klingberg, Torkel] Karolinska Inst, Dept Neurosci, Stockholm, Sweden; [Spencer-Smith, Megan] Monash Univ, Sch Psychol Sci, Melbourne, Vic 3004, Australia	Karolinska Institutet; Monash University	Spencer-Smith, M (corresponding author), Karolinska Inst, Dept Neurosci, Stockholm, Sweden.	megan.spencer-smith@mcri.edu.au		Spencer-Smith, Megan/0000-0002-1047-0829; Klingberg, Torkel/0000-0002-3175-2171				Aarnoudse-Moens CSH, 2009, PEDIATRICS, V124, P717, DOI 10.1542/peds.2008-2816; Alloway T. P., 2012, J INTERACTIVE LEARNI, V23, P1; Beck SJ, 2010, J CLIN CHILD ADOLESC, V39, P825, DOI 10.1080/15374416.2010.517162; Bjorkdahl A, 2013, BRAIN INJURY, V27, P1658, DOI 10.3109/02699052.2013.830196; Brehmer Y, 2012, FRONT HUM NEUROSCI, V6, DOI DOI https://doi.org/10.3389/fnhum.2012.00063; Bull R, 2008, DEV NEUROPSYCHOL, V33, P205, DOI 10.1080/87565640801982312; Castellanos FX, 2002, NAT REV NEUROSCI, V3, P617, DOI 10.1038/nrn896; Chacko A, 2014, J CHILD PSYCHOL PSYC, V55, P247, DOI 10.1111/jcpp.12146; Chacko A, 2013, J CLIN CHILD ADOLESC, V42, P769, DOI 10.1080/15374416.2013.787622; *COGNIFIT LTD, 2008, COGNIFIT PERS COACH; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Dahlin KIE, 2011, READ WRIT, V24, P479, DOI 10.1007/s11145-010-9238-y; Egeland J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075660; Forbes NF, 2009, PSYCHOL MED, V39, P889, DOI 10.1017/S0033291708004558; Gathercole S. E., 2003, EDUC CHILD PSYCHOL, V20, P109, DOI DOI 10.1037/A0036633; Gathercole SE, 2004, APPL COGNITIVE PSYCH, V18, P1, DOI 10.1002/acp.934; Gathercole SE, 2008, LEARN INDIVID DIFFER, V18, P214, DOI 10.1016/j.lindif.2007.10.003; Geary DC, 2011, DEV PSYCHOL, V47, P1539, DOI 10.1037/a0025510; Gibson BS, 2011, CHILD NEUROPSYCHOL, V17, P546, DOI 10.1080/09297049.2010.551186; Gray SA, 2012, J CHILD PSYCHOL PSYC, V53, P1277, DOI 10.1111/j.1469-7610.2012.02592.x; Green CT, 2012, NEUROTHERAPEUTICS, V9, P639, DOI 10.1007/s13311-012-0124-y; Gropper R, 2013, THESIS U TORONTO; Grunewaldt KH, 2013, PEDIATRICS, V131, pE747, DOI 10.1542/peds.2012-1965; Hardy KK, 2011, J PEDIATR ONCOL NURS, V28, P27, DOI 10.1177/1043454210377178; Harrison TL, 2013, PSYCHOL SCI, V24, P2409, DOI 10.1177/0956797613492984; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.ED000049; Jaeggi SM, 2008, P NATL ACAD SCI USA, V105, P6829, DOI 10.1073/pnas.0801268105; Johansson B, 2012, SCAND J OCCUP THER, V19, P176, DOI 10.3109/11038128.2011.603352; Kirsch I, 2008, PLOS MED, V5, P260, DOI 10.1371/journal.pmed.0050045; Klingberg T, 2005, J AM ACAD CHILD PSY, V44, P177, DOI 10.1097/00004583-200502000-00010; Klingberg T, 2010, TRENDS COGN SCI, V14, P317, DOI 10.1016/j.tics.2010.05.002; Kofler MJ, 2010, J ABNORM CHILD PSYCH, V38, P149, DOI 10.1007/s10802-009-9357-6; Kronenberger WG, 2011, J SPEECH LANG HEAR R, V54, P1182, DOI 10.1044/1092-4388(2010/10-0119); Lohaugen GCC, 2011, J PEDIATR-US, V158, P555, DOI 10.1016/j.jpeds.2010.09.060; Long B, 2011, DEV NEUROPSYCHOL, V36, P971, DOI 10.1080/87565641.2011.581537; Ludqvist A, 2010, BRAIN INJURY, V24, P1173, DOI [10.3109/02699052.2010.498007, DOI 10.3109/02699052.2010.498007]; Martin N, 2002, BRIT J PSYCHIAT, V180, P260, DOI 10.1192/bjp.180.3.260; Martinussen R, 2005, J AM ACAD CHILD PSY, V44, P377, DOI 10.1097/01.chi.0000153228.72591.73; McLoughlin G, 2011, BEHAV GENET, V41, P668, DOI 10.1007/s10519-011-9473-2; Melby-Lervag M, 2013, DEV PSYCHOL, V49, P270, DOI 10.1037/a0028228; Merikangas KR, 2010, PEDIATRICS, V125, P75, DOI 10.1542/peds.2008-2598; Mezzacappa E., 2010, SCH MENTAL HLTH, V2, P202, DOI DOI 10.1007/S12310-010-9030-9; Morrison AB, 2011, PSYCHON B REV, V18, P46, DOI 10.3758/s13423-010-0034-0; Nutley SB, 2011, DEVELOPMENTAL SCI, V14, P591, DOI 10.1111/j.1467-7687.2010.01022.x; Raghubar KP, 2010, LEARN INDIVID DIFFER, V20, P110, DOI 10.1016/j.lindif.2009.10.005; Rockwood K, 2004, J NEUROL NEUROSUR PS, V75, P677, DOI 10.1136/jnnp.2003.029074; Rogers M, 2011, CHILD NEUROPSYCHOL, V17, P444, DOI 10.1080/09297049.2010.544648; Roughan L, 2011, LEARN INDIVID DIFFER, V21, P759, DOI 10.1016/j.lindif.2011.07.011; Schatz J, 2000, NEUROPSYCHOLOGY, V14, P189, DOI 10.1037//0894-4105.14.2.189; Shipstead Z, 2012, PSYCHOL BULL, V138, P628, DOI 10.1037/a0027473; Shipstead Z, 2010, PSYCHOL BELG, V50, P245, DOI 10.5334/pb-50-3-4-245; Soderqvist S, 2014, J COGNITIVE NEUROSCI, V26, P54, DOI 10.1162/jocn_a_00478; Soderqvist S, 2012, DEV PSYCHOL, V48, P836, DOI 10.1037/a0026179; The Cochrane Collaboration, 2012, REV MAN REVMAN VERS; Thorell LB, 2009, DEVELOPMENTAL SCI, V12, P106, DOI 10.1111/j.1467-7687.2008.00745.x; von Bastian CC, 2014, PSYCHOL RES-PSYCH FO, V78, P803, DOI 10.1007/s00426-013-0524-6; Westerberg H, 2004, CHILD NEUROPSYCHOL, V10, P155, DOI 10.1080/09297040490911014; What Works Clearing House, 2014, WHAT WORKS CLEARINGH	59	99	100	1	97	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0119522	10.1371/journal.pone.0119522	http://dx.doi.org/10.1371/journal.pone.0119522			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CE8IA	25793607	Green Submitted, gold, Green Published			2022-12-27	WOS:000352084200089
J	Zancajo-Blazquez, S; Gonzalez-Aguilera, D; Gonzalez-Jorge, H; Hernandez-Lopez, D				Zancajo-Blazquez, Sandra; Gonzalez-Aguilera, Diego; Gonzalez-Jorge, Higinio; Hernandez-Lopez, David			An Automatic Image-Based Modelling Method Applied to Forensic Infography	PLOS ONE			English	Article							STEREO	This paper presents a new method based on 3D reconstruction from images that demonstrates the utility and integration of close-range photogrammetry and computer vision as an efficient alternative to modelling complex objects and scenarios of forensic infography. The results obtained confirm the validity of the method compared to other existing alternatives as it guarantees the following: (i) flexibility, permitting work with any type of camera (calibrated and non-calibrated, smartphone or tablet) and image (visible, infrared, thermal, etc.); (ii) automation, allowing the reconstruction of three-dimensional scenarios in the absence of manual intervention, and (iii) high quality results, sometimes providing higher resolution than modern laser scanning systems. As a result, each ocular inspection of a crime scene with any camera performed by the scientific police can be transformed into a scaled 3d model.	[Zancajo-Blazquez, Sandra; Gonzalez-Aguilera, Diego] Univ Salamanca, Polytech Sch Avila, Dept Cartog & Land Engn, Avila 05003, Spain; [Gonzalez-Jorge, Higinio] Univ Vigo, Dept Nat Resources & Environm Engn, Vigo 36310, Spain; [Hernandez-Lopez, David] Univ Castilla La Mancha, IDR, Albacete, Spain	University of Salamanca; Universidade de Vigo; Universidad de Castilla-La Mancha	Gonzalez-Aguilera, D (corresponding author), Univ Salamanca, Polytech Sch Avila, Dept Cartog & Land Engn, Hornos Caleros 50, Avila 05003, Spain.	daguilera@usal.es	; Hernandez-Lopez, David/B-4372-2017	Gonzalez-Aguilera, Diego/0000-0002-8949-4216; Gonzalez-Jorge, Higinio/0000-0002-0195-8849; Hernandez-Lopez, David/0000-0001-9874-5243	Instituto de Ciencias de la Seguridad. Universidad de Salamanca	Instituto de Ciencias de la Seguridad. Universidad de Salamanca	The authors received specific funding for this work. In particular the "Instituto de Ciencias de la Seguridad. Universidad de Salamanca (www.usal.es/similar to cise)" supported this work with a grant of 36000 Euros. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bay H, 2008, COMPUT VIS IMAGE UND, V110, P346, DOI 10.1016/j.cviu.2007.09.014; Cavagnini G, 2009, IS T SPIE EL IM INT; D'Apuzzo N, 2008, ADV PHOTOGRAMMETRY R, P425; Deseilligny MP, 2011, INT ARCH PHOTOGRAMM, V38-5, P269; Docchio F, 2006, P 23 C NAZ ASS GRUPP, P255; ElHakim SF, 1995, P SOC PHOTO-OPT INS, V2646, P14, DOI 10.1117/12.227862; FISCHLER MA, 1981, COMMUN ACM, V24, P381, DOI 10.1145/358669.358692; Gonzalez-Aguilera D, 2009, J FORENSIC SCI, V54, P1376, DOI 10.1111/j.1556-4029.2009.01170.x; Gruen AW., 1985, S AFR J PHOTOGRAMM R, V14, P175; Hartley R, 2003, MULTIPLE VIEW GEOMET, V2; Hirschmuller H, 2008, IEEE T PATTERN ANAL, V30, P328, DOI 10.1109/TPAMl.2007.1166; James SH, 2003, FORENSIC SCI INTRO S, P16; Joglekar J, 2012, INT J EMERGING TECHN, V2, P2250; Kovacs L, 2006, J PLAST RECONSTR AES, V59, P1193, DOI 10.1016/j.bjps.2005.10.025; Kraus K., 1993, PHOTOGRAMMETRY, P389; Longuet-Higgins H., 1987, READINGS COMPUTER VI, P61, DOI DOI 10.1016/B978-0-08-051581-6.50012-X; Lowe D. G., 1999, Proceedings of the Seventh IEEE International Conference on Computer Vision, P1150, DOI 10.1109/ICCV.1999.790410; Luhmann T., 2006, CLOSE RANGE PHOTOGRA, P1; Matas J, 2004, IMAGE VISION COMPUT, V22, P761, DOI 10.1016/j.imavis.2004.02.006; Moisan L, 2004, INT J COMPUT VISION, V57, P201, DOI 10.1023/B:VISI.0000013094.38752.54; Pastra K, 2003, KNOWL-BASED SYST, V16, P313, DOI 10.1016/S0950-7051(03)00033-9; Remondino F, 2005, PROC SPIE, V5665, P216, DOI 10.1117/12.586294; Remondino F., 2006, INT ARCH PHOTOGRAMM, V36, P266, DOI DOI 10.3929/ETHZ-B-000158067; Ronnholm P, 2007, REMOTE SENSING SPATI, V36, P355; Samaan M, 2013, REMOTE SENSING SPATI, V1, P549; Sansoni G, 2009, SENSORS-BASEL, V9, P568, DOI 10.3390/s90100568; Smith SM, 1997, INT J COMPUT VISION, V23, P45, DOI 10.1023/A:1007963824710	28	19	19	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0118719	10.1371/journal.pone.0118719	http://dx.doi.org/10.1371/journal.pone.0118719			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25793628	Green Published, gold, Green Submitted			2022-12-27	WOS:000352084200035
J	Ashby-Mitchell, K; Jagger, C; Fouweather, T; Anstey, KJ				Ashby-Mitchell, Kimberly; Jagger, Carol; Fouweather, Tony; Anstey, Kaarin J.			Life Expectancy with and without Cognitive Impairment in Seven Latin American and Caribbean Countries	PLOS ONE			English	Article							MINI-MENTAL-STATE; DEMENTIA; HEALTH; POPULATION; OLDER; PREVALENCE; EDUCATION; NUTRITION; ENGLAND; CITIES	Background The rising prevalence of cognitive impairment is an increasing challenge with the ageing of our populations but little is known about the burden in low-and middle-income Latin American and Caribbean countries (LAC) that are aging more rapidly than their developed counterparts. We examined life expectancies with cognitive impairment (CILE) and free of cognitive impairment (CIFLE) in seven developing LAC countries. Methods Data from The Survey on Health, Well-being and Ageing in LAC (N = 10,597) was utilised and cognitive status was assessed by the Mini-Mental State Examination (MMSE). The Sullivan Method was applied to estimate CILE and CIFLE. Logistic regression was used to determine the effect of age, gender and education on cognitive outcome. Meta-regression models were fitted for all 7 countries together to investigate the relationship between CIFLE and education in men and women at age 60. Results The prevalence of CI increased with age in all countries except Uruguay and with a significant gender effect observed only in Mexico where men had lower odds of CI compared to women [OR = 0.464 95% CInt (0.268 - 0.806)]. Low education was associated with increased prevalence of CI in Brazil [OR = 4.848 (1.173-20.044)], Chile [OR = 3.107 (1.098-8.793), Cuba [OR = 2.295 (1.247-4.225)] and Mexico [OR = 3.838 (1.368-10.765). For males, total life expectancy (TLE) at age 60 was highest in Cuba (19.7 years) and lowest in Brazil and Uruguay (17.6 years). TLE for females at age 60 was highest for Chileans (22.8 years) and lowest for Brazilians (20.2 years). CIFLE for men was greatest in Cuba (19.0 years) and least in Brazil (16.7 years). These differences did not appear to be explained by educational level (Men: p = 0.408, women: p = 0.695). Conclusion Increasing age, female sex and low education were associated with higher CI in LAC reflecting patterns found in other countries.	[Ashby-Mitchell, Kimberly; Anstey, Kaarin J.] Australian Natl Univ, Ctr Res Ageing Hlth & Wellbeing, Canberra, ACT 0200, Australia; [Jagger, Carol; Fouweather, Tony] Newcastle Univ, Inst Ageing & Hlth, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	Australian National University; Newcastle University - UK	Ashby-Mitchell, K (corresponding author), Australian Natl Univ, Ctr Res Ageing Hlth & Wellbeing, Canberra, ACT 0200, Australia.	Kimberly.ashby-mitchell@anu.edu.au	Anstey, Kaarin/A-3852-2008	Anstey, Kaarin/0000-0002-9706-9316; Jagger, Carol/0000-0002-6377-9926	Australian Research Council Centre of Excellence in Population Ageing Research [CE110001029]; AXA Research Fund; JA:EHLEIS Project [20102301]; European Commission; DG SANCO; DREES; CNSA; NHMRC [1002560]; NHMRC Dementia Collaborative Research Centres; ESRC [ES/I017399/1] Funding Source: UKRI; Economic and Social Research Council [ES/I017399/1] Funding Source: researchfish	Australian Research Council Centre of Excellence in Population Ageing Research(Australian Research Council); AXA Research Fund(AXA Research Fund); JA:EHLEIS Project; European Commission(European CommissionEuropean Commission Joint Research Centre); DG SANCO; DREES; CNSA; NHMRC(National Health and Medical Research Council (NHMRC) of Australia); NHMRC Dementia Collaborative Research Centres(National Health and Medical Research Council (NHMRC) of Australia); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	This research was supported by the Australian Research Council Centre of Excellence in Population Ageing Research (project number CE110001029). Professor Carol Jagger is funded by the AXA Research Fund. Mr. Tony Fouweather is funded by JA:EHLEIS Project Grant Number 20102301, co-funded by 10 Member States (Belgium, Czech Republic, Denmark, France, Germany, Greece, Italy, The Netherlands, Sweden, United Kingdom), the European Commission, DG SANCO and two French institutions: DREES and CNSA. Professor Kaarin J. Anstey is funded by NHMRC Fellowship #1002560. The authors acknowledge support from the NHMRC Dementia Collaborative Research Centres. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade F, 2009, REV PANAM SALUD PUBL, V26, P9, DOI 10.1590/S1020-49892009000700002; Anstey K, 2000, GERONTOLOGY, V46, P163, DOI 10.1159/000022153; Barcelo A, 2006, J AGING HEALTH, V18, P224, DOI 10.1177/0898264305285728; Barnes DE, 2009, FUTUR NEUROL, V4, P555, DOI 10.2217/FNL.09.43; Brayne C, 2001, AGE AGEING, V30, P53, DOI 10.1093/ageing/30.1.53; Chiang CL, 1984, LIFE TABLE ITS APPL; Cloos P, 2010, AGEING SOC, V30, P79, DOI 10.1017/S0144686X09990286; Dangour AD, 2006, BRIT J NUTR, V96, pS2, DOI 10.1079/BJN20061689; Dubois MF, 2006, DEMENT GERIATR COGN, V22, P327, DOI 10.1159/000095593; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Icaza M G AC, 1999, MINIMENTAL STATE EXA; Jagger C, 2002, J WOMEN AGING, V14, P85, DOI 10.1300/J074v14n01_06; Jagger C, 1999, HLTH EXPECTANCY CALC; Jagger C, 2008, LANCET, V372, P2124, DOI 10.1016/S0140-6736(08)61594-9; Matthews FE, 2013, LANCET, V382, P1405, DOI 10.1016/S0140-6736(13)61570-6; Matthews FE, 2009, J GERONTOL A-BIOL, V64, P125, DOI 10.1093/gerona/gln003; Mejia-Arango S, 2011, J AGING HEALTH, V23, P1050, DOI 10.1177/0898264311421199; Meng XF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038268; Mirowsky J., 2003, ED SOCIAL STATUS HLT; Morris MC, 2009, EUR J NEUROL, V16, P1, DOI 10.1111/j.1468-1331.2009.02735.x; Mungas D, 1996, NEUROLOGY, V46, P700, DOI 10.1212/WNL.46.3.700; Nepal B, 2008, AUST NZ J PUBL HEAL, V32, P565, DOI 10.1111/j.1753-6405.2008.00311.x; Palaez M, 2005, ICPSR03546V1 SABE; PFEFFER RI, 1982, J GERONTOL, V37, P323, DOI 10.1093/geronj/37.3.323; RITCHIE K, 1994, AUST J PUBLIC HEALTH, V18, P149; ROBINE JM, 1991, BMJ-BRIT MED J, V302, P457, DOI 10.1136/bmj.302.6774.457; Roelands M, 1994, EUR J PUBLIC HEALTH, V4, P33; U.S. Census Bureau, 2012, INT DAT BAS; U.S. Department of Health and Human Services Centers for Disease Control and Prevention, 2011, COGN IMP CALL ACT NO; Wong R, 2006, J AGING HEALTH, V18, P157, DOI 10.1177/0898264305285655	30	12	12	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0121867	10.1371/journal.pone.0121867	http://dx.doi.org/10.1371/journal.pone.0121867			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CE6ZS	25799186	Green Published, gold, Green Submitted			2022-12-27	WOS:000351987300297
J	Chugh, RM; Chaturvedi, M; Yerneni, LK				Chugh, Rishi Man; Chaturvedi, Madhusudan; Yerneni, Lakshmana Kumar			Occurrence and Control of Sporadic Proliferation in Growth Arrested Swiss 3T3 Feeder Cells	PLOS ONE			English	Article							HUMAN EPIDERMAL-KERATINOCYTES; EPITHELIAL-CELLS; CULTURE; TRANSFORMATION; LAYER	Growth arrested Swiss mouse embryonic 3T3 cells are used as feeders to support the growth of epidermal keratinocytes and several other target cells. The 3T3 cells have been extensively subcultured owing to their popularity and wide distribution in the world and, as a consequence selective inclusion of variants is a strong possibility in them. Inadvertently selected variants expressing innate resistance to mitomycin C may continue to proliferate even after treatment with such growth arresting agents. The failure of growth arrest can lead to a serious risk of proliferative feeder contamination in target cell cultures. In this study, we passaged Swiss 3T3 cells (CCL-92, ATCC) by different seeding densities and incubation periods. We tested the resultant cultures for differences in anchorage-independent growth, resumption of proliferation after mitomycin C treatment and occurrence of proliferative feeder contaminants in an epidermal keratinocyte co-culture system. The study revealed subculture dependent differential responses. The cultures of a particular subculture procedure displayed unique cell size distribution and disintegrated completely in 6 weeks following mitomycin C treatment, but their repeated subculture resulted in feeder regrowth as late as 11 weeks after the growth arrest. In contrast, mitomycin C failed to inhibit cell proliferation in cultures of the other subculture schemes and also in a clone that was established from a transformation focus of super-confluent culture. The resultant proliferative feeder cells contaminated the keratinocyte cultures. The anchorage-independent growth appeared in late passages as compared with the expression of mitomycin C resistance in earlier passages. The feeder regrowth was prevented by identifying a safe subculture protocol that discouraged the inclusion of resistant variants. We advocate routine anchorage-independent growth assay and absolute confirmation of feeder disintegration to qualify feeder batches and caution on the use of fetal bovine serum.	[Chugh, Rishi Man; Chaturvedi, Madhusudan; Yerneni, Lakshmana Kumar] Natl Inst Pathol ICMR, Cell Biol Lab, New Delhi, India	Indian Council of Medical Research (ICMR); ICMR - National Institute of Pathology (IOP)	Yerneni, LK (corresponding author), Natl Inst Pathol ICMR, Cell Biol Lab, New Delhi, India.	yernenilk@icmr.org.in	Chugh, Rishi Man/AAC-7545-2021		Indian Council of Medical Research, New Delhi, India [2009-02800]	Indian Council of Medical Research, New Delhi, India(Indian Council of Medical Research (ICMR))	The study was supported by extra mural Research grant 2009-02800 to LKY by the Indian Council of Medical Research, (http://www.icmr.nic.in) New Delhi, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALITALO K, 1982, J CELL BIOL, V94, P497, DOI 10.1083/jcb.94.3.497; ALLENHOFFMANN BL, 1984, P NATL ACAD SCI-BIOL, V81, P7802, DOI 10.1073/pnas.81.24.7802; American Type Culture Collection (ATCC) USA, CCL92 ATCC; Atiyeh BS, 2007, BURNS, V33, P139, DOI 10.1016/j.burns.2006.06.010; BERRY RD, 1988, BRIT J CANCER, V57, P287, DOI 10.1038/bjc.1988.62; Bowen-pope DF, 1994, PNAS US, V81, P2396; Bray LJ, 2012, CYTOTHERAPY, V14, P936, DOI 10.3109/14653249.2012.684379; ChangLiu CM, 1997, CANCER LETT, V113, P77, DOI 10.1016/S0304-3835(97)04599-0; Conner D A, 2001, Curr Protoc Mol Biol, VChapter 23, DOI 10.1002/0471142727.mb2302s51; Epstein Seth P, 2005, Trans Am Ophthalmol Soc, V103, P187; Hultman CS, 1996, J TRAUMA, V41, P51, DOI 10.1097/00005373-199607000-00009; Japan Tissue Engineering Co. Ltd, 2007, REV REP; Kumar A, 2008, IN VITRO CELL DEV-AN, V44, P189, DOI 10.1007/s11626-008-9081-5; Lamb R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052494; LECHNER JF, 1981, CANCER RES, V41, P2294; Lu R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038825; Mallon BS, 2006, INT J BIOCHEM CELL B, V38, P1063, DOI 10.1016/j.biocel.2005.12.014; Navasaria HA, 1994, KERATINOCYTE METHODS, P5; OCONNOR NE, 1981, LANCET, V1, P75; PALLEN CJ, 1991, P NATL ACAD SCI USA, V88, P6996, DOI 10.1073/pnas.88.16.6996; PEEHL DM, 1981, P NATL ACAD SCI-BIOL, V78, P3053, DOI 10.1073/pnas.78.5.3053; Ponchio L, 2000, CYTOTHERAPY, V2, P281, DOI 10.1080/146532400539215; Qin J, 2010, CANC STEM CELLS, P37; RHEINWALD JG, 1975, CELL, V6, P331, DOI 10.1016/S0092-8674(75)80001-8; RUBIN H, 1989, P NATL ACAD SCI USA, V86, P1860, DOI 10.1073/pnas.86.6.1860; SORIANO JV, 1995, J CELL SCI, V108, P413; Takeuchi T, 2008, JPN J INFECT DIS, V61, P9; TODARO GJ, 1963, J CELL BIOL, V17, P299, DOI 10.1083/jcb.17.2.299; WATT FM, 1984, J CELL BIOL, V98, P16, DOI 10.1083/jcb.98.1.16; Zhou D, 2014, ARCH TOXICOL, DOI [10.1007/s00204-014-1250-56, DOI 10.1007/S00204-014-1250-56]	30	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0122056	10.1371/journal.pone.0122056	http://dx.doi.org/10.1371/journal.pone.0122056			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25799110	Green Submitted, gold, Green Published			2022-12-27	WOS:000351987300316
J	Li, C; Klco, JM; Helton, NM; George, DR; Mudd, JL; Miller, CA; Lu, C; Fulton, R; O'Laughlin, M; Fronick, C; Wilson, RK; Ley, TJ				Li, Cheng; Klco, Jeffery M.; Helton, Nichole M.; George, Daniel R.; Mudd, Jacqueline L.; Miller, Christopher A.; Lu, Charles; Fulton, Robert; O'Laughlin, Michelle; Fronick, Catrina; Wilson, Richard K.; Ley, Timothy J.			Genetic Heterogeneity of Induced Pluripotent Stem Cells: Results from 24 Clones Derived from a Single C57BL/6 Mouse	PLOS ONE			English	Article							COPY NUMBER; MUTATIONS; DIFFERENTIATION; FIBROBLASTS; IPSCS	Induced pluripotent stem cells (iPSCs) have tremendous potential as a tool for disease modeling, drug testing, and other applications. Since the generation of iPSCs "captures" the genetic history of the individual cell that was reprogrammed, iPSC clones (even those derived from the same individual) would be expected to demonstrate genetic heterogeneity. To assess the degree of genetic heterogeneity, and to determine whether some cells are more genetically "fit" for reprogramming, we performed exome sequencing on 24 mouse iPSC clones derived from skin fibroblasts obtained from two different sites of the same 8-week-old C57BL/6J male mouse. While no differences in the coding regions were detected in the two parental fibroblast pools, each clone had a unique genetic signature with a wide range of heterogeneity observed among the individual clones: a total of 383 iPSC variants were validated for the 24 clones (mean 16.0/clone, range 0-45). Since these variants were all present in the vast majority of the cells in each clone (variant allele frequencies of 40-60% for heterozygous variants), they most likely preexisted in the individual cells that were reprogrammed, rather than being acquired during reprogramming or cell passaging. We then tested whether this genetic heterogeneity had functional consequences for hematopoietic development by generating hematopoietic progenitors in vitro and enumerating colony forming units (CFUs). While there was a range of hematopoietic potentials among the 24 clones, only one clone failed to differentiate into hematopoietic cells; however, it was able to form a teratoma, proving its pluripotent nature. Further, no specific association was found between the mutational spectrum and the hematopoietic potential of each iPSC clone. These data clearly highlight the genetic heterogeneity present within individual fibroblasts that is captured by iPSC generation, and suggest that most of the changes are random, and functionally benign.	[Li, Cheng; Helton, Nichole M.; George, Daniel R.; Mudd, Jacqueline L.; Ley, Timothy J.] Washington Univ, Sch Med, Dept Med, Sect Stem Cell Biol,Div Oncol, St Louis, MO 63110 USA; [Klco, Jeffery M.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO USA; [Miller, Christopher A.; Lu, Charles; Fulton, Robert; O'Laughlin, Michelle; Fronick, Catrina; Wilson, Richard K.] Washington Univ, Sch Med, Genome Inst, St Louis, MO USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Ley, TJ (corresponding author), Washington Univ, Sch Med, Dept Med, Sect Stem Cell Biol,Div Oncol, St Louis, MO 63110 USA.	timley@wustl.edu	Wilson, Richard K./AAF-4139-2019; Miller, Christopher A./A-1060-2009; Klco, Jeffery/M-9717-2018	Wilson, Richard K./0000-0002-1992-1358; Miller, Christopher A./0000-0003-4266-6700; Klco, Jeffery/0000-0003-2961-6960	NIH [CA101937, CA162086, HL116605]; Barnes Jewish Hospital Foundation [00335-0505-02]; Burroughs Wellcome Fund; NATIONAL CANCER INSTITUTE [P01CA101937, R01CA162086, P30CA091842, R35CA197561] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL116605] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Barnes Jewish Hospital Foundation; Burroughs Wellcome Fund(Burroughs Wellcome Fund); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by grants from the NIH (CA101937 and CA162086, to TJL, and HL116605, to JMK), the Barnes Jewish Hospital Foundation (00335-0505-02, to TJL), and the Burroughs Wellcome Fund (to JMK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abyzov A, 2012, NATURE, V492, P438, DOI 10.1038/nature11629; Bock C, 2011, CELL, V144, P439, DOI 10.1016/j.cell.2010.12.032; Boulting GL, 2011, NAT BIOTECHNOL, V29, P279, DOI 10.1038/nbt.1783; Cahan P, 2013, NAT REV MOL CELL BIO, V14, P357, DOI 10.1038/nrm3584; Chang CW, 2009, STEM CELLS, V27, P1042, DOI 10.1002/stem.39; Chen K, 2009, NAT METHODS, V6, P677, DOI [10.1038/NMETH.1363, 10.1038/nmeth.1363]; Gore A, 2011, NATURE, V471, P63, DOI 10.1038/nature09805; Kajiwara M, 2012, P NATL ACAD SCI USA, V109, P12538, DOI 10.1073/pnas.1209979109; Kim K, 2010, NATURE, V467, P285, DOI 10.1038/nature09342; Kim K, 2011, NAT BIOTECHNOL, V29, P1117, DOI 10.1038/nbt.2052; Klco JM, 2014, CANCER CELL, V25, P379, DOI 10.1016/j.ccr.2014.01.031; Koboldt DC, 2012, GENOME RES, V22, P568, DOI 10.1101/gr.129684.111; Larson DE, 2012, BIOINFORMATICS, V28, P311, DOI 10.1093/bioinformatics/btr665; Laurent LC, 2011, CELL STEM CELL, V8, P106, DOI 10.1016/j.stem.2010.12.003; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liang GY, 2013, CELL STEM CELL, V13, P149, DOI 10.1016/j.stem.2013.07.001; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Mills JA, 2013, BLOOD, V122, P2047, DOI 10.1182/blood-2013-02-484444; Polo JM, 2010, NAT BIOTECHNOL, V28, P848, DOI 10.1038/nbt.1667; Saunders CT, 2012, BIOINFORMATICS, V28, P1811, DOI 10.1093/bioinformatics/bts271; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Vodyanik Maxim A, 2007, Curr Protoc Cell Biol, VChapter 23, DOI 10.1002/0471143030.cb2306s36; Yang SH, 2008, GENESIS, V46, P711, DOI 10.1002/dvg.20435; Ye K, 2009, BIOINFORMATICS, V25, P2865, DOI 10.1093/bioinformatics/btp394; Young MA, 2012, CELL STEM CELL, V10, P570, DOI 10.1016/j.stem.2012.03.002; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	27	10	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0120585	10.1371/journal.pone.0120585	http://dx.doi.org/10.1371/journal.pone.0120585			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25799070	Green Published, gold, Green Submitted			2022-12-27	WOS:000351987300156
J	McMillan, EM; Pare, MF; Baechler, BL; Graham, DA; Rush, JWE; Quadrilatero, J				McMillan, Elliott M.; Pare, Marie-France; Baechler, Brittany L.; Graham, Drew A.; Rush, James W. E.; Quadrilatero, Joe			Autophagic Signaling and Proteolytic Enzyme Activity in Cardiac and Skeletal Muscle of Spontaneously Hypertensive Rats following Chronic Aerobic Exercise	PLOS ONE			English	Article							DNA FRAGMENTATION; MOLECULAR CHARACTERIZATION; DEPENDENT DEGRADATION; OXIDATIVE STRESS; SOLEUS MUSCLE; SINGLE BOUT; BECLIN 1; APOPTOSIS; BCL-2; PHOSPHORYLATION	Hypertension is a cardiovascular disease associated with deleterious effects in skeletal and cardiac muscle. Autophagy is a degradative process essential to muscle health. Acute exercise can alter autophagic signaling. Therefore, we aimed to characterize the effects of chronic endurance exercise on autophagy in skeletal and cardiac muscle of normotensive and hypertensive rats. Male Wistar Kyoto (WKY) and spontaneously hypertensive rats (SHR) were assigned to a sedentary condition or 6 weeks of treadmill running. White gastrocnemius (WG) of hypertensive rats had higher (p<0.05) caspase-3 and proteasome activity, as well as elevated calpain activity. In addition, skeletal muscle of hypertensive animals had elevated (p<0.05) ATG7 and LC3I protein, LAMP2 mRNA, and cathepsin activity, indicative of enhanced autophagic signaling. Interestingly, chronic exercise training increased (p<0.05) Beclin-1, LC3, and p62 mRNA as well as proteasome activity, but reduced (p<0.05) Beclin-1 and ATG7 protein, as well as decreased (p<0.05) caspase-3, calpain, and cathepsin activity. Left ventricle (LV) of hypertensive rats had reduced (p<0.05) AMPKa and LC3II protein, as well as elevated (p<0.05) p-AKT, p-p70S6K, LC3I and p62 protein, which collectively suggest reduced autophagic signaling. Exercise training had little effect on autophagy-related signaling factors in LV; however, exercise training increased (p<0.05) proteasome activity but reduced (p<0.05) caspase-3 and calpain activity. Our results suggest that autophagic signaling is altered in skeletal and cardiac muscle of hypertensive animals. Regular aerobic exercise can effectively alter the proteolytic environment in both cardiac and skeletal muscle, as well as influence several autophagy-related factors in skeletal muscle of normotensive and hypertensive rats.	[McMillan, Elliott M.; Pare, Marie-France; Baechler, Brittany L.; Graham, Drew A.; Rush, James W. E.; Quadrilatero, Joe] Univ Waterloo, Dept Kinesiol, Waterloo, ON N2L 3G1, Canada	University of Waterloo	Quadrilatero, J (corresponding author), Univ Waterloo, Dept Kinesiol, Waterloo, ON N2L 3G1, Canada.	jquadril@uwaterloo.ca			Natural Sciences and Engineering Research Council of Canada (NSERC) [RGPIN 238342, RGPIN 258590]	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This research was supported by funds provided by the Natural Sciences and Engineering Research Council of Canada (NSERC) to JWER (RGPIN 238342) and JQ (RGPIN 258590). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alers S, 2012, MOL CELL BIOL, V32, P2, DOI 10.1128/MCB.06159-11; Argiles JA, 2008, INT J BIOCHEM CELL B, V40, P1674, DOI 10.1016/j.biocel.2008.02.001; ATRAKCHI A, 1994, AM J PHYSIOL, V267, pC827, DOI 10.1152/ajpcell.1994.267.3.C827; Benziane B, 2008, AM J PHYSIOL-ENDOC M, V295, pE1427, DOI 10.1152/ajpendo.90428.2008; Bhatnagar S, 2012, J CELL PHYSIOL, V227, P1042, DOI 10.1002/jcp.22821; Bloemberg D, 2014, ACTA PHYSIOL, V210, P381, DOI 10.1111/apha.12178; Breitschopf K, 2000, MOL CELL BIOL, V20, P1886, DOI 10.1128/MCB.20.5.1886-1896.2000; Brunelle JK, 2009, J CELL SCI, V122, P437, DOI 10.1242/jcs.031682; Cao DJ, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000016; Condorelli G, 1999, CIRCULATION, V99, P3071, DOI 10.1161/01.CIR.99.23.3071; Cunha TF, 2012, J APPL PHYSIOL, V112, P1839, DOI 10.1152/japplphysiol.00346.2011; De Chiara G, 2006, J BIOL CHEM, V281, P21353, DOI 10.1074/jbc.M511052200; De Palma C, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.159; Deng XM, 2004, P NATL ACAD SCI USA, V101, P153, DOI 10.1073/pnas.2533920100; Dimmeler S, 1999, J EXP MED, V189, P1815, DOI 10.1084/jem.189.11.1815; Graham DA, 2004, J APPL PHYSIOL, V96, P2088, DOI 10.1152/japplphysiol.01252.2003; GRAY SD, 1994, AM J PHYSIOL, V267, pR735, DOI 10.1152/ajpregu.1994.267.3.R735; He CC, 2012, NATURE, V481, P511, DOI 10.1038/nature10758; He CC, 2009, ANNU REV GENET, V43, P67, DOI 10.1146/annurev-genet-102808-114910; Huang STJ, 2002, FASEB J, V16, DOI 10.1096/fj.01-0852com; Hwee DT, 2014, AGING CELL, V13, P92, DOI 10.1111/acel.12150; Jamart C, 2012, J APPL PHYSIOL, V112, P1529, DOI 10.1152/japplphysiol.00952.2011; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kang R, 2011, CELL DEATH DIFFER, V18, P571, DOI 10.1038/cdd.2010.191; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; Kim R, 2005, BIOCHEM BIOPH RES CO, V333, P336, DOI 10.1016/j.bbrc.2005.04.161; Kim YA, 2013, J PHYSIOL BIOCHEM, V69, P697, DOI 10.1007/s13105-013-0246-7; Kim YA, 2012, J PHYSIOL BIOCHEM, V68, P229, DOI 10.1007/s13105-011-0135-x; Lepine S, 2011, J BIOL CHEM, V286, P44380, DOI 10.1074/jbc.M111.257519; Lira VA, 2013, FASEB J, V27, P4184, DOI 10.1096/fj.13-228486; Mammucari C, 2008, AUTOPHAGY, V4, P524, DOI 10.4161/auto.5905; Marquez RT, 2012, AM J CANCER RES, V2, P214; Masiero E, 2010, AUTOPHAGY, V6, P307, DOI 10.4161/auto.6.2.11137; McMillan EM, 2012, J APPL PHYSIOL, V113, P1048, DOI 10.1152/japplphysiol.00290.2012; McMillan EM, 2011, AM J PHYSIOL-REG I, V300, pR531, DOI 10.1152/ajpregu.00488.2010; Miyachi M, 2009, HYPERTENSION, V53, P701, DOI 10.1161/HYPERTENSIONAHA.108.127290; Mizushima N, 1998, J BIOL CHEM, V273, P33889, DOI 10.1074/jbc.273.51.33889; Muller AL, 2012, HEART FAIL REV, V17, P395, DOI 10.1007/s10741-011-9269-8; Ogura Y, 2011, BIOCHEM BIOPH RES CO, V414, P756, DOI 10.1016/j.bbrc.2011.09.152; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Plant PJ, 2009, J APPL PHYSIOL, V107, P224, DOI 10.1152/japplphysiol.90932.2008; Quadrilatero J, 2008, BIOCHEM BIOPH RES CO, V368, P168, DOI 10.1016/j.bbrc.2008.01.067; Quadrilatero J, 2006, J APPL PHYSIOL, V101, P1149, DOI 10.1152/japplphysiol.00194.2006; Quadrilatero J, 2011, APPL PHYSIOL NUTR ME, V36, P608, DOI [10.1139/h11-064, 10.1139/H11-064]; Quadrilatero J, 2010, BIOCHEM BIOPH RES CO, V391, P1437, DOI 10.1016/j.bbrc.2009.12.084; Raben N, 2008, HUM MOL GENET, V17, P3897, DOI 10.1093/hmg/ddn292; Ravikumar B, 2010, PHYSIOL REV, V90, P1383, DOI 10.1152/physrev.00030.2009; Rodriguez A, 2008, LIFE SCI, V83, P540, DOI 10.1016/j.lfs.2008.07.022; Sanchez AMJ, 2012, J CELL BIOCHEM, V113, P695, DOI 10.1002/jcb.23399; Sandri M, 2010, AM J PHYSIOL-CELL PH, V298, pC1291, DOI 10.1152/ajpcell.00531.2009; She PX, 2011, AM J PHYSIOL-ENDOC M, V301, pE49, DOI 10.1152/ajpendo.00630.2010; Smuder AJ, 2011, J APPL PHYSIOL, V111, P1190, DOI 10.1152/japplphysiol.00429.2011; Smuder AJ, 2011, J APPL PHYSIOL, V110, P935, DOI 10.1152/japplphysiol.00677.2010; Supinski GS, 2009, J APPL PHYSIOL, V107, P1389, DOI 10.1152/japplphysiol.00341.2009; Talbert EE, 2013, J APPL PHYSIOL, V114, P1482, DOI 10.1152/japplphysiol.00925.2012; Tsutsui H, 2011, AM J PHYSIOL-HEART C, V301, pH2181, DOI 10.1152/ajpheart.00554.2011; Vanhorebeek I, 2011, J CLIN ENDOCR METAB, V96, pE633, DOI 10.1210/jc.2010-2563; Wei YJ, 2008, MOL CELL, V30, P678, DOI 10.1016/j.molcel.2008.06.001; Xing SS, 2014, BIOCHEM BIOPH RES CO, V445, P375, DOI 10.1016/j.bbrc.2014.02.008; Yamamoto K, 1999, MOL CELL BIOL, V19, P8469; Yang ZF, 2006, MOL BIOL CELL, V17, P5094, DOI 10.1091/mbc.E06-06-0479; Zalckvar E, 2009, EMBO REP, V10, P285, DOI 10.1038/embor.2008.246; Zhang J, 2009, CELL DEATH DIFFER, V16, P939, DOI 10.1038/cdd.2009.16; Zhu HX, 2007, J CLIN INVEST, V117, P1782, DOI 10.1172/JCI27523	64	28	30	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0119382	10.1371/journal.pone.0119382	http://dx.doi.org/10.1371/journal.pone.0119382			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25799101	gold, Green Published, Green Submitted			2022-12-27	WOS:000351987300046
J	Yang, ZH; Fang, SR; Di, YC; Ying, WW; Tan, Y; Gu, W				Yang, Zhenhua; Fang, Surong; Di, Yicheng; Ying, Weiwei; Tan, Yan; Gu, Wei			Modulation of NF-kappa B/miR-21/PTEN Pathway Sensitizes Non-Small Cell Lung Cancer to Cisplatin	PLOS ONE			English	Article							GENE-EXPRESSION; MICRORNA-21; PTEN; TRANSCRIPTION; CHEMOTHERAPY; MUTATION; MIR-21; RNA	Background Platinum-based chemotherapy is a standard strategy for non-small cell lung cancer (NSCLC), while chemoresistance remains a major therapeutic challenge in current clinical practice. Our present study was aimed to determine whether inhibition of the NF-kappa B/miR21/PTEN pathway could increase the sensitivity of NSCLC to cisplatin. Methods The expression of miR-21 in NSCLC tissues was determined using in situ hybridization. Next, the effect of miR-21 on the sensitivity of A549 cells to cisplatin was determined in vitro. Whether miR-21 regulated PTEN expression was assessed by luciferase assay. Furthermore, whether NF-kappa B targeted its binding elements in the miR-21 gene promoter was determined by luciferase and ChIP assay. Finally, we measured the cell viability and apoptosis under cisplatin treatment when NF-kappa B was inhibited. Results An elevated level of miR-21 was observed in NSCLC lung tissues and was related to a short survival time. Exogenous miR-21 promoted cell survival when exposed to cisplatin, while miR-21 inhibition could reverse this process. The RNA and protein levels of PTEN were significantly decreased by exogenous miR-21, and the 30-untranslated region of PTEN was shown to be a target of miR-21. The expression of miR-21 was regulated by NF-kappa B binding to its element in the promoter, a finding that was verified by luciferase and ChIP assay. Hence, inhibition of NF-kappa B by RNA silencing protects cells against cisplatin via decreasing miR-21 expression. Conclusion Modulation of the NF-kappa B/miR-21/PTEN pathway in NSCLC showed that inhibition of this pathway may increase cisplatin sensitivity.	[Yang, Zhenhua; Fang, Surong; Di, Yicheng; Ying, Weiwei; Tan, Yan; Gu, Wei] Nanjing Med Univ, Nanjing Hosp 1, Dept Resp Med, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University	Gu, W (corresponding author), Nanjing Med Univ, Nanjing Hosp 1, Dept Resp Med, Nanjing, Jiangsu, Peoples R China.	njguwei@163.com			Program of Jiangsu Health Department [H201341]	Program of Jiangsu Health Department	This study was financially supported by the Program of Jiangsu Health Department (H201341). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, ISRN STROKE, DOI [DOI 10.1007/S00531-013-0931-3, DOI 10.1155/2013/858945]; Blanco R, 2014, ANN ONCOL; Cai JC, 2013, CANCER RES, V73, P5402, DOI 10.1158/0008-5472.CAN-13-0297; Collisson EA, 2014, NATURE, V511, P543, DOI 10.1038/nature13385; Gao W, 2012, CANCER BIOL THER, V13, P330, DOI 10.4161/cbt.19073; Hammerman PS, 2012, NATURE, V489, P519, DOI 10.1038/nature11404; Kim EJ, 2013, J CELL BIOCHEM, V114, P1248, DOI 10.1002/jcb.24465; Li X, 2012, ONCOGENE, V31, P4979, DOI 10.1038/onc.2011.655; Liu M, 2014, ONCOL LETT, V7, P1903, DOI 10.3892/ol.2014.2049; Liu ZL, 2013, MOL CELL BIOCHEM, V372, P35, DOI 10.1007/s11010-012-1443-3; Ma XL, 2012, ASIAN PAC J CANCER P, V13, P2329, DOI 10.7314/APJCP.2012.13.5.2329; Markou A, 2008, CLIN CHEM, V54, P1696, DOI 10.1373/clinchem.2007.101741; Meng FY, 2007, GASTROENTEROLOGY, V133, P647, DOI 10.1053/j.gastro.2007.05.022; Meng FY, 2006, GASTROENTEROLOGY, V130, P2113, DOI 10.1053/j.gastro.2006.02.057; Niu JX, 2012, J BIOL CHEM, V287, P21783, DOI 10.1074/jbc.M112.355495; Qian WF, 2011, BRAZ J MED BIOL RES, V44, P1222, DOI [10.1590/S0100-879X2011007500143, 10.1590/S0100-879X2011001200005]; Qiu ZH, 2014, EXPERT OPIN INV DRUG, V23, P347, DOI 10.1517/13543784.2014.867327; Reck M, 2014, ANN ONCOL, V25, P27, DOI 10.1093/annonc/mdu199; Seike M, 2009, P NATL ACAD SCI USA, V106, P12085, DOI 10.1073/pnas.0905234106; Shen H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103305; Stankovic T, 2014, BIOMED PHARMACOTHER, V68, P521, DOI 10.1016/j.biopha.2014.03.014; Umemura S, 2014, J THORAC ONCOL, V9, P1324, DOI 10.1097/JTO.0000000000000250; Xie B, 2011, J NEUROSCI, V31, P5032, DOI 10.1523/JNEUROSCI.5504-10.2011; Xu LF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103698; Yang CH, 2010, CANCER RES, V70, P8108, DOI 10.1158/0008-5472.CAN-10-2579; Zhang JG, 2010, CLIN CHIM ACTA, V411, P846, DOI 10.1016/j.cca.2010.02.074; Zhao N, 2014, LUNG CANCER, V86, P255, DOI 10.1016/j.lungcan.2014.08.013; Zhu WJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103373	28	68	73	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0121547	10.1371/journal.pone.0121547	http://dx.doi.org/10.1371/journal.pone.0121547			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25799148	Green Submitted, Green Published, gold			2022-12-27	WOS:000351987300267
J	Colli, A; Prati, D; Fraquelli, M; Segato, S; Vescovi, PP; Colombo, F; Balduini, C; Della Valle, S; Casazza, G				Colli, Agostino; Prati, Daniele; Fraquelli, Mirella; Segato, Sergio; Vescovi, Pier Paolo; Colombo, Fabrizio; Balduini, Carlo; Della Valle, Serena; Casazza, Giovanni			The Use of a Pocket-Sized Ultrasound Device Improves Physical Examination: Results of an In- and Outpatient Cohort Study	PLOS ONE			English	Article							OF-CARE ULTRASOUND; DIAGNOSTIC-ACCURACY; ULTRASONOGRAPHY	Background The performance of pocket mobile ultrasound devices (PUDs) is comparable with that of standard ultrasonography, whereas the accuracy of a physical examination is often poor requiring further tests to assess diagnostic hypotheses. Adding the use of PUD to physical examination could lead to an incremental benefit. Aim We assessed whether the use of PUD in the context of physical examination can reduce the prescription of additional tests when used by physicians in different clinical settings. Methods We conducted a cohort impact study in four hospital medical wards, one gastroenterological outpatient clinic, and 90 general practices in the same geographical area. The study involved 135 physicians who used PUD, after a short predefined training course, to examine 1962 consecutive patients with one of 10 diagnostic hypotheses: ascites, pleural effusion, pericardial effusion, urinary retention, urinary stones, gallstones, biliary-duct dilation, splenomegaly, abdominal mass, abdominal aortic aneurysm. According to the physicians' judgment, PUD examination could rule out or in the diagnostic hypothesis or require further testing; the concordance with the final diagnosis was assessed. The main outcome was the proportion of cases in which additional tests were required after PUD. The PUD diagnostic accuracy was assessed in patients submitted to further testing. Findings The 1962 patients included 37% in-patients, 26% gastroenterology outpatients, 37% from general practices. Further testing after PUD examination was deemed unnecessary in 63%. Only 5% of patients with negative PUD not referred for further testing were classified false negatives with respect to the final diagnosis. In patients undergoing further tests, the sensitivity was 91%, and the specificity 83%. Conclusions After a simple and short training course, a PUD examination can be used in addition to a physical examination to improve the answer to ten common clinical questions concerning in-and outpatients, and can reduce the need for further testing.	[Colli, Agostino; Della Valle, Serena] Osped A Manzoni, Dept Internal Med, Lecce, Italy; [Prati, Daniele] Osped A Manzoni, Dept Transfus Med & Hematol, Lecce, Italy; [Fraquelli, Mirella] Univ Milan, IRCCS Fdn Ca Granda, Osped Maggiore Policlin, Div Gastroenterol 2, Milan, Italy; [Segato, Sergio] Azienda Osped Univ Macchi, Gastroenterol & GI Endoscopy Unit, Varese, Italy; [Vescovi, Pier Paolo] Azienda Osped Carlo Poma, Div Internal Med, Mantua, Italy; [Colombo, Fabrizio] AO Niguarda, Div Internal Med 1, Milan, Italy; [Balduini, Carlo] Fdn IRCCS Policlin San Matteo Univ, Div Internal Med 3, Pavia, Italy; [Casazza, Giovanni] Univ Milan, Dept Biomed & Clin Sci L Sacco, Milan, Italy	IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; Ospedale Circolo & Fondazione Macchi; Hospital Carlo Poma; IRCCS Fondazione San Matteo; University of Milan; Luigi Sacco Hospital	Colli, A (corresponding author), Osped A Manzoni, Dept Internal Med, Lecce, Italy.	a.colli@ospedale.lecco.it	Casazza, Giovanni/G-3661-2012; Prati, Daniele/P-8215-2019; Della Valle, Serena/AAB-1869-2020	Casazza, Giovanni/0000-0003-3718-1784; Prati, Daniele/0000-0002-2281-7498; Della Valle, Serena/0000-0003-4286-7035	Lombardy Regional Council Italy [DGR IX/001137]	Lombardy Regional Council Italy	This study was approved and funded by Lombardy Regional Council Italy (DGR IX/001137 23.12.2010). The funding source (the Lombardy Regional Council) had no role in the study's design, conduct and reporting. The authors take fully responsibility for the design, conduct of the study, had authority over manuscript preparation and controlled the decision to submit the manuscript for publication.	[Anonymous], 2012, J AM COLL CARDIOL, V60, P242, DOI [10.1016/j.jacc.2012.02.009, DOI 10.1016/J.JACC.2012.02.009]; Barreiros AP, 2014, Z GASTROENTEROL, V52, P269, DOI 10.1055/s-0033-1350114; Biais M, 2012, CRIT CARE, V16, DOI 10.1186/cc11340; Bossuyt PM, 2006, BRIT MED J, V332, P1089, DOI 10.1136/bmj.332.7549.1089; Bossuyt PM, 2003, ANN INTERN MED, V138, P40, DOI 10.7326/0003-4819-138-1-200301070-00010; Colli A, 2014, HEPATOLOGY, V60, P408, DOI 10.1002/hep.26948; Feinstein AR, 1967, CLIN JUDGEMENT; Kobal SL, 2005, AM J CARDIOL, V96, P1002, DOI 10.1016/j.amjcard.2005.05.060; Kopelman RI, 2010, LEARNING CLIN REASON; Liebo MJ, 2011, ANN INTERN MED, V155, P33, DOI 10.7326/0003-4819-155-1-201107050-00005; MCGEE S, 2001, EVIDENCE BASED PHYS; Moons KGM, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b606; Moore CL, 2011, NEW ENGL J MED, V364, P749, DOI 10.1056/NEJMra0909487; Nelson BP, 2013, GLOB HEART, V8, P287, DOI 10.1016/j.gheart.2013.12.002; Reilly BM, 2006, ANN INTERN MED, V144, P201, DOI 10.7326/0003-4819-144-3-200602070-00009; Ruddox V, 2013, INT J CARDIOVAS IMAG, V29, P1749, DOI 10.1007/s10554-013-0278-7; Simel DL, 2009, RATIONAL CLIN EXAM E; Siso-Almirall A, 2013, MED CLIN-BARCELONA, V141, P417, DOI 10.1016/j.medcli.2013.02.038; Solomon SD, 2014, NEW ENGL J MED, V370, P1083, DOI 10.1056/NEJMp1311944; Verghese A, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b5448	20	46	46	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0122181	10.1371/journal.pone.0122181	http://dx.doi.org/10.1371/journal.pone.0122181			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25793296	gold, Green Published			2022-12-27	WOS:000352083900174
J	Estill, J; Salazar-Vizcaya, L; Blaser, N; Egger, M; Keiser, O				Estill, Janne; Salazar-Vizcaya, Luisa; Blaser, Nello; Egger, Matthias; Keiser, Olivia			The Cost-Effectiveness of Monitoring Strategies for Antiretroviral Therapy of HIV Infected Patients in Resource-Limited Settings: Software Tool	PLOS ONE			English	Article							CD4 CELL COUNT; VIRAL LOAD; SOUTHERN AFRICA; TRANSMISSION; ADHERENCE; PROGRAMS; OUTCOMES; MALAWI; COHORT; ADULTS	Background The cost-effectiveness of routine viral load (VL) monitoring of HIV-infected patients on anti-retroviral therapy (ART) depends on various factors that differ between settings and across time. Low-cost point-of-care (POC) tests for VL are in development and may make routine VL monitoring affordable in resource-limited settings. We developed a software tool to study the cost-effectiveness of switching to second-line ART with different monitoring strategies, and focused on POC-VL monitoring. Methods We used a mathematical model to simulate cohorts of patients from start of ART until death. We modeled 13 strategies (no 2nd-line, clinical, CD4 (with or without targeted VL), POC-VL, and laboratory-based VL monitoring, with different frequencies). We included a scenario with identical failure rates across strategies, and one in which routine VL monitoring reduces the risk of failure. We compared lifetime costs and averted disability-adjusted life-years (DALYs). We calculated incremental cost-effectiveness ratios (ICER). We developed an Excel tool to update the results of the model for varying unit costs and cohort characteristics, and conducted several sensitivity analyses varying the input costs. Results Introducing 2nd-line ART had an ICER of US$1651-1766/DALY averted. Compared with clinical monitoring, the ICER of CD4 monitoring was US$1896-US$5488/DALY averted and VL monitoring US$951-US$5813/DALY averted. We found no difference between POC- and laboratory-based VL monitoring, except for the highest measurement frequency (every 6 months), where laboratory-based testing was more effective. Targeted VL monitoring was on the cost-effectiveness frontier only if the difference between 1st- and 2nd-line costs remained large, and if we assumed that routine VL monitoring does not prevent failure. Conclusion Compared with the less expensive strategies, the cost-effectiveness of routine VL monitoring essentially depends on the cost of 2nd-line ART. Our Excel tool is useful for determining optimal monitoring strategies for specific settings, with specific sex-and age-distributions and unit costs.	[Estill, Janne; Salazar-Vizcaya, Luisa; Blaser, Nello; Egger, Matthias; Keiser, Olivia] Univ Bern, Inst Social & Prevent Med, Bern, Switzerland; [Egger, Matthias] Univ Cape Town, Ctr Infect Dis Epidemiol & Res, ZA-7925 Cape Town, South Africa	University of Bern; University of Cape Town	Estill, J (corresponding author), Univ Bern, Inst Social & Prevent Med, Bern, Switzerland.	janne.estill@ispm.unibe.ch	Blaser, Nello/V-1028-2019	Blaser, Nello/0000-0001-9489-1657; Keiser, Olivia/0000-0001-8191-2789; Egger, Matthias/0000-0001-7462-5132; Salazar-Vizcaya, Luisa/0000-0003-0527-0141	UNITAID; National Institutes of Health (NIH) [U01AI069924]; Swiss National Science Foundation [32333B_131629, PDFMP3_137106]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI069924] Funding Source: NIH RePORTER	UNITAID; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	UNITAID, www.unitaid.eu; National Institutes of Health (NIH), grant U01AI069924; Swiss National Science Foundation, grants 32333B_131629 and PDFMP3_137106. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Actuarial Society of South Africa, 2011, ASSA2008 MOD; Bendavid E, 2008, ARCH INTERN MED, V168, P1910, DOI 10.1001/archinternmed.2008.1; Bishai D, 2007, AIDS, V21, P1333, DOI 10.1097/QAD.0b013e328137709e; Blaser N, 2014, J STAT SOFT IN PRESS; Bonner K, 2013, JAIDS-J ACQ IMM DEF, V64, P74, DOI 10.1097/QAI.0b013e31829f05ac; Braithwaite RS, 2011, J INT AIDS SOC, V14, DOI 10.1186/1758-2652-14-38; Brinkhof MWG, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000066; Chimbwandira F, 2013, MMWR-MORBID MORTAL W, V62, P148; Egger M, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000390; Estill J, 2014, JAIDS-J ACQ IMM DEF, V65, pE179, DOI 10.1097/QAI.0000000000000075; Estill J, 2013, AIDS, V27, P1483, DOI 10.1097/QAD.0b013e328360a4e5; Estill J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057611; Estill J, 2012, AIDS, V26, P1403, DOI 10.1097/QAD.0b013e3283536988; Granich RM, 2009, LANCET, V373, P48, DOI 10.1016/S0140-6736(08)61697-9; Gupta RK, 2014, CLIN INFECT DIS, V58, P1023, DOI 10.1093/cid/cit933; Hamers RL, 2012, AIDS, V26, P1663, DOI 10.1097/QAD.0b013e3283560678; Hoffmann CJ, 2009, CLIN INFECT DIS, V49, P1928, DOI 10.1086/648444; IDF (International Diabetes Federation), 2021, CONSOLIDATED GUIDELI, V10th ed.; International Monetary Fund, 2014, WORLD ECONOMIC AND F; Jani IV, 2011, LANCET, V378, P1572, DOI 10.1016/S0140-6736(11)61052-0; Joint United Nations Programme on HIV/AIDS (UNAIDS) and Medecines Sans Frontieres (MSF), 2012, SPEED SCAL UP STRAT; Kahn JG, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d6884; Keebler D, 2014, LANCET GLOB HEALTH, V2, pE35, DOI 10.1016/S2214-109X(13)70048-2; Kimmel AD, 2010, JAIDS-J ACQ IMM DEF, V54, P258, DOI 10.1097/QAI.0b013e3181d0db97; Maggiolo F, 2007, HIV CLIN TRIALS, V8, P282, DOI 10.1310/hct0805-282; Mermin J, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d6792; Orrell C, 2007, ANTIVIR THER, V12, P83; Phillips AN, 2008, LANCET, V371, P1443, DOI 10.1016/S0140-6736(08)60624-8; Rousseau C, 2012, HIV POINT CARE VIRAL; Salazar Vizcaya L, 2014, GEMS GEN MULTISTATE; Tweya H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075761; UNITAID, 2013, HIV AIDS DIAGN TECHN; Vijayaraghavan A, 2007, JAIDS-J ACQ IMM DEF, V46, P91; Walensky RP, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000382; Walensky RP, 2010, CLIN INFECT DIS, V51, P85, DOI 10.1086/653119; Wandeler G, 2012, JAIDS-J ACQ IMM DEF, V59, pE9, DOI 10.1097/QAI.0b013e31823edb6a; World Health Organization, 2004, GLOB BURD DIS 2004 U; World Health Organization, 2001, MACR HLTH INV HLTH E; Zoufaly A, 2014, J ANTIMICRO IN PRESS	39	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0119299	10.1371/journal.pone.0119299	http://dx.doi.org/10.1371/journal.pone.0119299			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25793531	Green Published			2022-12-27	WOS:000352084200070
J	Lautenschlager, I; Frerichs, I; Dombrowsky, H; Sarau, J; Goldmann, T; Zitta, K; Albrecht, M; Weiler, N; Uhlig, S				Lautenschlaeger, Ingmar; Frerichs, Inez; Dombrowsky, Heike; Sarau, Juergen; Goldmann, Torsten; Zitta, Karina; Albrecht, Martin; Weiler, Norbert; Uhlig, Stefan			Quinidine, but Not Eicosanoid Antagonists or Dexamethasone, Protect the Gut from Platelet Activating Factor-Induced Vasoconstriction, Edema and Paralysis	PLOS ONE			English	Article							CHEEK POUCH MICROCIRCULATION; INFLAMMATORY-BOWEL-DISEASE; RAT MESENTERIC-ARTERY; NITRIC-OXIDE SYNTHASE; SMALL-INTESTINE; RECEPTOR ANTAGONIST; REPERFUSION INJURY; NECROTIZING ENTEROCOLITIS; MUCOSAL PERMEABILITY; PULMONARY-EDEMA	Intestinal circulatory disturbances, atony, edema and swelling are of great clinical relevance, but the relatedmechanisms and possible therapeutic options are poorly characterized, in part because of the difficulties to comprehensively analyze these conditions. To overcome these limitations we have developed a model of the isolated perfused rat small intestine where all of these symptoms can be studied simultaneously. Here we used this model to study the role of eicosanoids, steroids and quinidine in platelet-activating factor (PAF)-induced intestinal disorders. A vascular bolus of PAF (0.5 nmol) triggered release of thromboxane and peptidoleukotrienes into the vascular bed (peak concentration 35 nM and 0.8 nM) and reproduced all symptoms of intestinal failure: mesenteric vasoconstriction, translocation of fluid and macromolecules from the vasculature to the lumen and lymphatics, intestinal edema formation, loss of intestinal peristalsis and decreased galactose uptake. All effects of PAF were abolished by the PAF-receptor antagonist ABT491 (2.5 mu M). The COX and LOX inhibitors ASA and AA861 (500 mu M, 10 mu M) did not exhibit barrier-protective effects and the eicosanoid antagonists SQ29548 and MK571 (10 mu M, each) only moderately attenuated the loss of vascular fluid, the redistribution to the lumen and the transfer of FITC dextran to the lumen. The steroid dexamethasone (10 mu M) showed no barrier-protective properties and failed to prevent edema formation. Quinidine (100 mu M) inhibited the increase in arterial pressure, stabilized all the intestinal barriers, and reduced lymph production and the transfer of FITC dextran to the lymph. While quinidine by itself reduced peristalsis, it also obviated paralysis, preserved intestinal functions and prevented edema formation. We conclude that quinidine exerts multiple protective effects against vasoconstriction, edema formation and paralysis in the intestine. The therapeutic use of quinidine for intestinal ailments deserves further study.	[Lautenschlaeger, Ingmar; Frerichs, Inez; Zitta, Karina; Albrecht, Martin; Weiler, Norbert] Univ Med Ctr Schleswig Holstein, Dept Anesthesiol & Intens Care Med, Kiel, Germany; [Lautenschlaeger, Ingmar; Dombrowsky, Heike; Sarau, Juergen] Leibniz Ctr Med & Biosci, Res Ctr Borstel, Div Barrier Integr, Borstel, Germany; [Sarau, Juergen] Leibniz Ctr Med & Biosci, Div Mucosal Immunol & Diagnost, Res Ctr Borstel, Borstel, Germany; [Goldmann, Torsten] Leibniz Ctr Med & Biosci, Res Ctr Borstel, Div Clin & Expt Pathol, Borstel, Germany; [Uhlig, Stefan] Rhein Westfal TH Aachen, Fac Med, Inst Pharmacol & Toxicol, Aachen, Germany	University of Kiel; Schleswig Holstein University Hospital; Forschungszentrum Borstel; Forschungszentrum Borstel; Forschungszentrum Borstel; RWTH Aachen University	Lautenschlager, I (corresponding author), Univ Med Ctr Schleswig Holstein, Dept Anesthesiol & Intens Care Med, Campus Kiel, Kiel, Germany.	ingmar.lautenschlaeger@uksh.de	Goldmann, Torsten/E-5906-2010; Uhlig, Stefan/A-7290-2014; Frerichs, I./AAT-3685-2021; Albrecht, Martin/AAW-9303-2021	Goldmann, Torsten/0000-0002-1621-560X; Uhlig, Stefan/0000-0003-2332-1280; Frerichs, I./0000-0002-7712-6539; Albrecht, Martin/0000-0003-2580-768X				Adamson RH, 2003, AM J PHYSIOL-HEART C, V285, pH406, DOI 10.1152/ajpheart.00021.2003; [Anonymous], 2009, EUR RESP J; Arumugam TV, 2003, BRIT J PHARMACOL, V140, P71, DOI 10.1038/sj.bjp.0705402; BARNATAN MF, 1995, J SURG RES, V58, P38, DOI 10.1006/jsre.1995.1007; Ben-Zvi I, 2012, CLIN REV ALLERG IMMU, V42, P145, DOI 10.1007/s12016-010-8243-x; BOUGHTONSMITH NK, 1993, BRIT J PHARMACOL, V110, P1189, DOI 10.1111/j.1476-5381.1993.tb13940.x; Buchholz BM, 2010, NEUROGASTROENT MOTIL, V22, P232, DOI 10.1111/j.1365-2982.2009.01464.x; Charous BL, 1998, J ALLERGY CLIN IMMUN, V102, P198, DOI 10.1016/S0091-6749(98)70086-7; CHASIN M, 1978, BIOCHEM PHARMACOL, V27, P2065, DOI 10.1016/0006-2952(78)90070-9; CHIBA Y, 1990, N-S ARCH PHARMACOL, V341, P68; Claing A, 2002, BRIT J PHARMACOL, V135, P433, DOI 10.1038/sj.bjp.0704441; CLAING A, 1994, BRIT J PHARMACOL, V112, P1202, DOI 10.1111/j.1476-5381.1994.tb13211.x; DILLON PK, 1988, CIRC RES, V62, P732, DOI 10.1161/01.RES.62.4.732; DILLON PK, 1988, CIRC RES, V62, P722, DOI 10.1161/01.RES.62.4.722; Dombrowsky H, 2011, J NUTR, V141, P1635, DOI 10.3945/jn.111.143016; Ewer AK, 2004, GUT, V53, P207, DOI 10.1136/gut.2003.024521; Falk S, 1999, AM J RESP CRIT CARE, V160, P1734, DOI 10.1164/ajrccm.160.5.9902033; FERGUSON MK, 1988, J SURG RES, V44, P172, DOI 10.1016/0022-4804(88)90046-7; Gantner F, 1995, EUR J PHARMACOL, V294, P353, DOI 10.1016/0014-2999(95)00724-5; Goggel R, 2004, NAT MED, V10, P155, DOI 10.1038/nm977; Goggel R, 2002, AM J RESP CRIT CARE, V166, P657, DOI 10.1164/rccm.20011.0710C; GOLDENBERG MM, 1984, PROSTAGLANDINS, V28, P271, DOI 10.1016/0090-6980(84)90062-5; HSUEH W, 1986, J CLIN INVEST, V78, P108, DOI 10.1172/JCI112538; Huston M, 2006, J EMERG MED, V31, P395, DOI 10.1016/j.jemermed.2006.07.018; Inama G, 2010, J CARDIOVASC MED, V11, P143, DOI 10.2459/JCM.0b013e3283313525; INOUE H, 1993, BRIT J PHARMACOL, V110, P1614, DOI 10.1111/j.1476-5381.1993.tb14009.x; Jang CH, 2006, RHEUMATOLOGY, V45, P703, DOI 10.1093/rheumatology/kei282; Karres I, 1998, AM J PHYSIOL-REG I, V274, pR1058, DOI 10.1152/ajpregu.1998.274.4.R1058; Katsanos KH, 2012, J CROHNS COLITIS, V6, P735, DOI 10.1016/j.crohns.2012.03.005; KING JN, 1990, J VET PHARMACOL THER, V13, P333, DOI 10.1111/j.1365-2885.1990.tb00786.x; KOBAYASH.S, 1968, JPN J PHARMACOL, V18, P80, DOI 10.1254/jjp.18.80; Kosior DA, 2009, CARDIOL J, V16, P521; Kuebler WM, 2010, CELL PHYSIOL BIOCHEM, V26, P29, DOI 10.1159/000315103; Lautenschlager I, 2010, AM J PHYSIOL-GASTR L, V298, pG304, DOI 10.1152/ajpgi.00313.2009; LEVY S, 1994, J CARDIOVASC ELECTR, V5, P635, DOI 10.1111/j.1540-8167.1994.tb01304.x; Malagon I, 2005, J THORAC CARDIOV SUR, V130, P265, DOI 10.1016/j.jtcvs.2005.02.047; Million M, 1997, EUR J PHARMACOL, V334, P67, DOI 10.1016/S0014-2999(97)01142-4; MION F, 1994, GUT, V35, P490, DOI 10.1136/gut.35.4.490; Misra UK, 1997, J CELL BIOCHEM, V64, P225, DOI 10.1002/(SICI)1097-4644(199702)64:2<225::AID-JCB6>3.0.CO;2-Z; Muguruma K, 1997, ADV EXP MED BIOL, V407, P379; Nagar J, 2014, INT IMMUNOPHARMACOL, V21, P328, DOI 10.1016/j.intimp.2014.05.005; Oketani K, 2001, EUR J PHARMACOL, V427, P159, DOI 10.1016/S0014-2999(01)01234-1; PELLON MI, 1994, BRIT J PHARMACOL, V112, P1101, DOI 10.1111/j.1476-5381.1994.tb13197.x; Picado C, 2006, CURR ALLERGY ASTHM R, V6, P198, DOI 10.1007/s11882-006-0035-2; PONS L, 1989, LIFE SCI, V45, P533, DOI 10.1016/0024-3205(89)90104-5; Qu XW, 2005, CRIT CARE MED, V33, P1050, DOI 10.1097/01.CCM.0000162908.14887.36; Santos FA, 1998, J PHARM PHARMACOL, V50, P225, DOI 10.1111/j.2042-7158.1998.tb06180.x; Souza DG, 2003, BRIT J PHARMACOL, V139, P733, DOI 10.1038/sj.bjp.0705296; STAHL GL, 1987, BLOOD VESSELS, V24, P24; Szabo A, 1997, SHOCK, V8, P284, DOI 10.1097/00024382-199710000-00008; Szczeklik A, 2003, J ALLERGY CLIN IMMUN, V111, P913, DOI 10.1067/mai.2003.1487; TABUCHI Y, 1995, EUR J PHARMACOL, V273, P281, DOI 10.1016/0014-2999(94)00739-T; Tan XD, 2000, BRIT J PHARMACOL, V129, P1522, DOI 10.1038/sj.bjp.0702939; Uhlig S, 2005, PHARMACOL REP, V57, P206; Uhlig S, 1996, MOL MED, V2, P373, DOI 10.1007/BF03401635; UHLIG S, 1994, J APPL PHYSIOL, V77, P262, DOI 10.1152/jappl.1994.77.1.262; Valeski JE, 2003, MICROCIRCULATION, V10, P411, DOI 10.1038/sj.mn.7800202; VANRENTERGHEM C, 1995, J NEUROCHEM, V65, P1274; Victorino GP, 2004, J TRAUMA, V56, P379, DOI 10.1097/01.TA.0000042156.89779.6C; VINARDELL MP, 1987, COMP BIOCHEM PHYS A, V86, P617, DOI 10.1016/0300-9629(87)90611-6; Viskin S, 2013, J AM COLL CARDIOL, V61, P2383, DOI 10.1016/j.jacc.2013.02.077; WALLACE JL, 1988, DIGEST DIS SCI, V33, P225, DOI 10.1007/BF01535737; WALLACE JL, 1988, EUR J PHARMACOL, V151, P43, DOI 10.1016/0014-2999(88)90690-5; YARWOOD H, 1993, BRIT J PHARMACOL, V108, P959, DOI 10.1111/j.1476-5381.1993.tb13492.x; Yost CC, 2010, BIOCHIMIE, V92, P692, DOI 10.1016/j.biochi.2010.02.011; Zhou H, 2004, INT IMMUNOPHARMACOL, V4, P223, DOI 10.1016/j.intimp.2003.12.006	66	3	4	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0120802	10.1371/journal.pone.0120802	http://dx.doi.org/10.1371/journal.pone.0120802			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25793535	gold, Green Published, Green Submitted			2022-12-27	WOS:000352083900077
J	Lawrence, M; Pringle, J; Kerr, S; Booth, J; Govan, L; Roberts, NJ				Lawrence, Maggie; Pringle, Jan; Kerr, Susan; Booth, Joanne; Govan, Lindsay; Roberts, Nicola J.			Multimodal Secondary Prevention Behavioral Interventions for TIA and Stroke: A Systematic Review and Meta-Analysis	PLOS ONE			English	Article							TRANSIENT ISCHEMIC ATTACK; RISK-FACTOR MODIFICATION; CARDIOVASCULAR-DISEASE; BLOOD-PRESSURE; MINOR STROKE; FOLLOW-UP; MANAGEMENT; PROGRAM; CARE; HEALTH	Background Guidelines recommend implementation of multimodal interventions to help prevent recurrent TIA/stroke. We undertook a systematic review to assess the effectiveness of behavioral secondary prevention interventions. Strategy Searches were conducted in 14 databases, including MEDLINE (1980-January 2014). We included randomized controlled trials (RCTs) testing multimodal interventions against usual care/modified usual care. All review processes were conducted in accordance with Cochrane guidelines. Results Twenty-three papers reporting 20 RCTs (6,373 participants) of a range of multimodal behavioral interventions were included. Methodological quality was generally low. Meta-analyses were possible for physiological, lifestyle, psychosocial and mortality/recurrence outcomes. Note: all reported confidence intervals are 95%. Systolic blood pressure was reduced by 4.21 mmHg (mean) (-6.24 to -2.18, P = 0.01 I-2 = 58%, 1,407 participants); diastolic blood pressure by 2.03 mmHg (mean) (-3.19 to -0.87, P = 0.004, I-2 = 52%, 1,407 participants). No significant changes were found for HDL, LDL, total cholesterol, fasting blood glucose, high sensitivity-CR, BMI, weight or waist: hip ratio, although there was a significant reduction in waist circumference (-6.69 cm, -11.44 to -1.93, P = 0.006, I-2 = 0%, 96 participants). There was no significant difference in smoking continuance, or improved fruit and vegetable consumption. There was a significant difference in compliance with antithrombotic medication (OR 1.45, 1.21 to 1.75, P< 0.0001, I-2 = 0%, 2,792 participants) and with statins (OR 2.53, 2.15 to 2.97, P< 0.00001, I-2 = 0%, 2,636 participants); however, there was no significant difference in compliance with antihypertensives. There was a significant reduction in anxiety (-1.20, -1.77 to -0.63, P< 0.0001, I-2 = 85%, 143 participants). Although there was no significant difference in odds of death or recurrent TIA/stroke, there was a significant reduction in the odds of cardiac events (OR 0.38, 0.16 to 0.88, P = 0.02, I-2 = 0%, 4,053 participants). Conclusions There are benefits to be derived from multimodal secondary prevention interventions. However, the findings are complex and should be interpreted with caution. Further, high quality trials providing comprehensive detail of interventions and outcomes, are required.	[Lawrence, Maggie; Kerr, Susan; Booth, Joanne; Roberts, Nicola J.] Glasgow Caledonian Univ, Inst Appl Hlth Res, Glasgow G4 0BA, Lanark, Scotland; [Pringle, Jan] Univ Dundee, Sch Educ Social Work & Community Educ, Dundee DD1 4HN, Scotland; [Govan, Lindsay] Univ Glasgow, Hlth Econ & Hlth Technol Assessment, Inst Hlth & Wellbeing, Glasgow, Lanark, Scotland	Glasgow Caledonian University; University of Dundee; University of Glasgow	Lawrence, M (corresponding author), Glasgow Caledonian Univ, Inst Appl Hlth Res, Glasgow G4 0BA, Lanark, Scotland.	maggie.lawrence@gcu.ac.uk	Roberts, Nicola/AAJ-5784-2021; Lawrence, Maggie/E-7722-2010	Roberts, Nicola/0000-0002-7589-8113; Lawrence, Maggie/0000-0002-1685-4639; Booth, Joanne/0000-0002-7870-6391	Stroke Association; Stroke Association [TSA SRTF 2011/02]; Medical Research Council [MR/J012459/1] Funding Source: researchfish; Stroke Association [TSASRTF2011/02] Funding Source: researchfish; MRC [MR/J012459/1] Funding Source: UKRI	Stroke Association; Stroke Association; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Stroke Association; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This review was undertaken as part of the Stroke Association Senior Research Training Fellowship (2012-2015) held by Dr. Maggie Lawrence. Dr. Pringle's post was funded by the fellowship. Stroke Association: http://www.stroke.org.uk/. Project Ref No: TSA SRTF 2011/02. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adie K, 2010, AGE AGEING, V39, P598, DOI 10.1093/ageing/afq085; Allen K, 2009, J STROKE CEREBROVASC, V18, P443, DOI 10.1016/j.jstrokecerebrovasdis.2009.02.002; [Anonymous], 2008, MAN PAT STROK TIA AS; Bandura A, 2004, HEALTH EDUC BEHAV, V31, P143, DOI 10.1177/1090198104263660; Banet G A, 1997, J Vasc Nurs, V15, P29, DOI 10.1016/S1062-0303(97)90050-9; Campbell SC, 2008, ATHEROSCLEROSIS, V201, P225, DOI 10.1016/j.atherosclerosis.2008.04.046; Chanruengvanich W, 2006, THAI J NURSING RES, V10, P165; Damush TM, 2011, TRANSL BEHAV MED, V1, P561, DOI 10.1007/s13142-011-0070-y; Dixon A., 2008, MOTIVATION CONFIDENC; Eames S, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-002538; Ellis G, 2005, AGE AGEING, V34, P389, DOI 10.1093/ageing/afi075; Faulkner J, 2013, NZ MED J, V125, P68; Faulkner J, 2013, J STROKE CEREBROVASC, V22, pE388, DOI 10.1016/j.jstrokecerebrovasdis.2013.04.014; Flemming Kelly D, 2013, Hosp Pract (1995), V41, P70, DOI 10.3810/hp.2013.08.1070; Gillham S, 2010, CLIN REHABIL, V24, P822, DOI 10.1177/0269215510367970; Goldfinger JZ, 2012, CONTEMP CLIN TRIALS, V33, P1065, DOI 10.1016/j.cct.2012.06.003; Goldstein LB, 2006, STROKE, V37, P1583, DOI 10.1161/01.STR.0000223048.70103.F1; HATANO S, 1976, B WORLD HEALTH ORGAN, V54, P541; Hoffmann TC, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f3755; Hornnes N, 2011, J STROKE CEREBROVASC, V20, P16, DOI 10.1016/j.jstrokecerebrovasdis.2009.10.002; Horowitz CR, 2013, STROKE, V44; Johnston SC, 2009, LANCET NEUROL, V8, P345, DOI 10.1016/S1474-4422(09)70023-7; Joubert J, 2006, J CLIN NEUROSCI, V13, P84, DOI 10.1016/j.jocn.2005.07.003; Joubert J, 2009, J NEUROL NEUROSUR PS, V80, P279, DOI 10.1136/jnnp.2008.148122; Kernan WN, 2014, STROKE, V45, P2160, DOI 10.1161/STR.0000000000000024; Kirk H, 2014, CLIN REHABIL, V28, P339, DOI 10.1177/0269215513502211; Kono Y, 2013, CEREBROVASC DIS, V36, P88, DOI 10.1159/000352052; Lawrence M, 2014, CEREBROVASC DIS, V37, DOI [10.1159/000362854, DOI 10.1159/000362854]; Lawrence M, 2013, INT J STROKE, V8, P465, DOI 10.1111/ijs.12135; Lawrence M, 2013, DISABIL REHABIL, V35, P586, DOI 10.3109/09638288.2012.711895; Lawrence Maggie, 2011, JBI Libr Syst Rev, V9, P1782; Lawrence M, 2012, INT J STROKE, V7, P243, DOI 10.1111/j.1747-4949.2012.00771.x; Lennon O, 2013, EUR J PREV CARDIOL, P1; Maasland L, 2007, CEREBROVASC DIS, V23, P435, DOI 10.1159/000101468; Macdonald Geraldine, 2012, Cochrane Database Syst Rev, pCD001930, DOI 10.1002/14651858.CD001930.pub3; McManus JA, 2009, CLIN REHABIL, V23, P99, DOI 10.1177/0269215508095874; Mendis S., 2011, GLOB ATL CARD DIS PR; Michie S, 2011, IMPLEMENT SCI, V6, DOI 10.1186/1748-5908-6-42; Mohan KM, 2011, STROKE, V42, P1489, DOI 10.1161/STROKEAHA.110.602615; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1136/bmj.b2535, 10.1016/j.ijsu.2010.02.007]; National Cancer Institute, 2005, THEOR GLANC GUID HLT; National Institute for Health and Clinical Excellence, 2006, BRIEF INT REF SMOK C; National Institute for Health and Clinical Excellence, 2007, BEHAVIOUR CHANGE THE; Negron R., 2014, COMMUNICATION; O'Carroll R, 2011, ANN BEHAV MED, V41, P383, DOI 10.1007/s12160-010-9257-6; O'Donnell MJ, 2010, LANCET, V376, P112, DOI 10.1016/S0140-6736(10)60834-3; Ostlund U, 2014, J FAM NURS, V20, P259, DOI 10.1177/1074840714542962; Peng B, 2014, STROKE, V45, P515, DOI 10.1161/STROKEAHA.113.001424; PROCHASKA JO, 1983, J CONSULT CLIN PSYCH, V51, P390, DOI 10.1037//0022-006X.51.3.390; PROGRESS Collaborat Grp, 2001, LANCET, V358, P1556; Redfern J, 2006, STROKE, V37, P2410, DOI 10.1161/01.STR.0000237097.00342.a9; Richardson WS, 1995, ACP J CLUB, V123, pA12, DOI DOI 10.7326/ACPJC-1995-123-3-A12; Scottish Intercollegiate Guidelines Network (SIGN), SIGN 97 RISK EST PRE; Sharma M, 2008, THEORETICAL FDN HLTH; Sit JWH, 2007, J CLIN NURS, V16, P272, DOI 10.1111/j.1365-2702.2005.01522.x; Strong K, 2007, LANCET NEUROL, V6, P182, DOI 10.1016/S1474-4422(07)70031-5; The Cochrane Collaboration, 2008, REV MAN REVMAN COMP; van Nes M, 2010, J AM ACAD NURSE PRAC, V22, P654, DOI 10.1111/j.1745-7599.2010.00561.x; Visser-Meily A, 2006, DISABIL REHABIL, V28, P1557, DOI 10.1080/09638280600648215; Wolfe CDA, 2010, STROKE, V41, P2470, DOI 10.1161/STROKEAHA.110.588046; Wood DA, 2008, LANCET, V371, P1999, DOI 10.1016/S0140-6736(08)60868-5; Wright LM, 2005, NURSES AND FAMILIES; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	64	50	52	3	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0120902	10.1371/journal.pone.0120902	http://dx.doi.org/10.1371/journal.pone.0120902			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CE8HY	25793643	Green Accepted, Green Published, gold			2022-12-27	WOS:000352083900087
J	Louzada, VHP; Araujo, NAM; Verma, T; Daolio, F; Herrmann, HJ; Tomassini, M				Louzada, Vitor H. P.; Araujo, Nuno A. M.; Verma, Trivik; Daolio, Fabio; Herrmann, Hans J.; Tomassini, Marco			Critical Cooperation Range to Improve Spatial Network Robustness	PLOS ONE			English	Article							COMMUNITY STRUCTURE; AIRPORT NETWORK; INTERNET; WORLD	A robust worldwide air-transportation network (WAN) is one that minimizes the number of stranded passengers under a sequence of airport closures. Building on top of this realistic example, here we address how spatial network robustness can profit from cooperation between local actors. We swap a series of links within a certain distance, a cooperation range, while following typical constraints of spatially embedded networks. We find that the network robustness is only improved above a critical cooperation range. Such improvement can be described in the framework of a continuum transition, where the critical exponents depend on the spatial correlation of connected nodes. For the WAN we show that, except for Australia, all continental networks fall into the same universality class. Practical implications of this result are also discussed.	[Louzada, Vitor H. P.; Verma, Trivik; Herrmann, Hans J.] ETH, IfB, Computat Phys, Zurich, Switzerland; [Araujo, Nuno A. M.] Univ Lisbon, Fac Ciencias, Dept Fis, Lisbon, Portugal; [Araujo, Nuno A. M.] Univ Lisbon, Ctr Fis Teor & Computac, P-1699 Lisbon, Portugal; [Daolio, Fabio] Shinshu Univ, Fac Engn, Nagano 380, Japan; [Herrmann, Hans J.] Univ Fed Ceara, Dept Fis, Fortaleza, Ceara, Brazil; [Tomassini, Marco] Univ Lausanne, Fac Business & Econ, Lausanne, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; Universidade de Lisboa; Universidade de Lisboa; Shinshu University; Universidade Federal do Ceara; University of Lausanne	Louzada, VHP (corresponding author), ETH, IfB, Computat Phys, Zurich, Switzerland.	louzada@ethz.ch	Araujo, Nuno A M/B-6313-2008	Araujo, Nuno A M/0000-0002-1677-6060; Verma, Trivik/0000-0003-2761-5155; Daolio, Fabio/0000-0003-4240-4161	CNPq, Conselho Nacional de Desenvolvimento Cientifico e Tecnologico-Brasil; European Research Council [FP7-319968-flowCSS]; ETH Zurich Risk Center; Portuguese Foundation for Science and Technology (FCT) [IF/00255/2013]	CNPq, Conselho Nacional de Desenvolvimento Cientifico e Tecnologico-Brasil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); European Research Council(European Research Council (ERC)European Commission); ETH Zurich Risk Center; Portuguese Foundation for Science and Technology (FCT)(Portuguese Foundation for Science and Technology)	The authors would like to thank the CNPq, Conselho Nacional de Desenvolvimento Cientifico e Tecnologico-Brasil (http://cnpq.br/), the European Research Council advanced grant FP7-319968-flowCSS (http://erc.europa.eu/), and the ETH Zurich Risk Center (http://www.riskcenter.ethz.ch/) for financial support. NAMA acknowledges financial support from the Portuguese Foundation for Science and Technology (FCT) under Contract no. IF/00255/2013 (http://www.fct.pt/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert R, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.025103; [Anonymous], 2010, BBC NEWS; Araujo AD, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.046304; Bagler G, 2008, PHYSICA A, V387, P2972, DOI 10.1016/j.physa.2008.01.077; Balcan D, 2009, P NATL ACAD SCI USA, V106, P21484, DOI 10.1073/pnas.0906910106; Barrat A, 2004, P NATL ACAD SCI USA, V101, P3747, DOI 10.1073/pnas.0400087101; Calder S, 2013, INDEPENDENT; Cardillo A, 2013, SCI REP-UK, V3, DOI 10.1038/srep01344; Cardillo A, 2013, EUR PHYS J-SPEC TOP, V215, P23, DOI 10.1140/epjst/e2013-01712-8; Chi LP, 2004, INT J MOD PHYS B, V18, P2394, DOI 10.1142/S0217979204025427; Cohen R, 2001, PHYS REV LETT, V86, P3682, DOI 10.1103/PhysRevLett.86.3682; D'Agostino G, 2014, UNDERST COMPLEX SYST, pVII; Donetti L, 2006, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2006/08/P08007; Doyle JC, 2005, P NATL ACAD SCI USA, V102, P14497, DOI 10.1073/pnas.0501426102; Erlander Sven, 1990, GRAVITY MODEL TRANSP, V3; Gallos LK, 2012, P NATL ACAD SCI USA, V109, P2825, DOI 10.1073/pnas.1106612109; Gautreau A, 2009, P NATL ACAD SCI USA, V106, P8847, DOI 10.1073/pnas.0811113106; Guimera R, 2004, EUR PHYS J B, V38, P381, DOI 10.1140/epjb/e2004-00131-0; Guimera R, 2005, P NATL ACAD SCI USA, V102, P7794, DOI 10.1073/pnas.0407994102; Herrmann HJ, 2011, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2011/01/P01027; ICAO, 2012, ANN PASS TOT APPR 3; Kaluza Pablo, 2010, J R Soc Interface, V7, P1093, DOI 10.1098/rsif.2009.0495; Kim DH, 2008, J PHYS A-MATH THEOR, V41, DOI 10.1088/1751-8113/41/22/224019; Krings G, 2009, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2009/07/L07003; Li G, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.018701; Li W, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.046106; Louzada VHP, 2013, J COMPLEX NETW, V1, P150, DOI 10.1093/comnet/cnt010; Louzada VHP, 2014, PROPAGATION PHENOMEN; Matray P, 2012, COMPUT NETW, V56, P2237, DOI 10.1016/j.comnet.2012.03.005; Motter AE, 2013, NAT PHYS, V9, P191, DOI 10.1038/nphys2535; Newman MEJ, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.026126; Newman MEJ, 2004, PHYS REV E, V70, DOI [10.1103/PhysRevE.70.056131, 10.1103/PhysRevE.69.026113]; Pastor-Satorras R, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.258701; Patokallio J, 2013, OPENFLIGHTS     0701; Peixoto TP, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.118703; Pyrgiotis N, 2013, TRANSPORT RES C-EMER, V27, P60, DOI 10.1016/j.trc.2011.05.017; Schneider CM, 2011, P NATL ACAD SCI USA, V108, P3838, DOI 10.1073/pnas.1009440108; Verma T, 2014, SCI REP-UK, V4, DOI 10.1038/srep05638; Wu ZH, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.056104; Wu ZX, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.026106; Yglesias M, 2013, SLATE           1128; Zhang J, 2010, PHYSICA A, V389, P3922, DOI 10.1016/j.physa.2010.05.042; Zhou Q, 2005, IEEE T POWER SYST, V20, P782, DOI 10.1109/TPWRS.2005.846178	43	7	7	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0118635	10.1371/journal.pone.0118635	http://dx.doi.org/10.1371/journal.pone.0118635			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25793986	gold, Green Published, Green Submitted			2022-12-27	WOS:000352084200030
J	Brandon, AE; Tid-Ang, J; Wright, LE; Stuart, E; Suryana, E; Bentley, N; Turner, N; Cooney, GJ; Ruderman, NB; Kraegen, EW				Brandon, Amanda E.; Tid-Ang, Jennifer; Wright, Lauren E.; Stuart, Ella; Suryana, Eurwin; Bentley, Nicholas; Turner, Nigel; Cooney, Gregory J.; Ruderman, Neil B.; Kraegen, Edward W.			Overexpression of SIRT1 in Rat Skeletal Muscle Does Not Alter Glucose Induced Insulin Resistance	PLOS ONE			English	Article							MITOCHONDRIAL BIOGENESIS DIFFERENCES; FATTY-ACID OXIDATION; IN-VIVO EXPERIMENTS; ACTIVATED PROTEIN-KINASE; BODY ENERGY-EXPENDITURE; AS160 PHOSPHORYLATION; CALORIC RESTRICTION; ENDOTHELIAL-CELLS; METABOLISM; EXERCISE	SIRT1 is a NAD(+)-dependent deacetylase thought to regulate cellular metabolic pathways in response to alterations in nutrient flux. In the current study we investigated whether acute changes in SIRT1 expression affect markers of muscle mitochondrial content and also determined whether SIRT1 influenced muscle insulin resistance induced by acute glucose oversupply. In male Wistar rats either SIRT1 or a deacetylase inactive mutant form (H363Y) was electroprated into the tibialis cranialis (TC) muscle. The other leg was electroporated with an empty control vector. One week later, glucose was infused and hyperglycaemia was maintained at similar to 11mM. After 5 hours, 11mM glucose induced significant insulin resistance in skeletal muscle. Interestingly, overexpression of either SIRT1 or SIRT1 (H363Y) for 1 week did not change markers of mitochondrial content or function. SIRT1 or SIRT1 (H363Y) overexpression had no effect on the reduction in glucose uptake and glycogen synthesis in muscle in response to hyperglycemia. Therefore we conclude that acute increases in SIRT1 protein have little impact on mitochondrial content and that overexpressing SIRT1 does not prevent the development of insulin resistance during hyperglycaemia.	[Brandon, Amanda E.; Tid-Ang, Jennifer; Wright, Lauren E.; Stuart, Ella; Suryana, Eurwin; Turner, Nigel; Cooney, Gregory J.; Kraegen, Edward W.] St Vincents Hosp, Garvan Inst Med Res, Diabet & Metab Div, Darlinghurst, NSW 2010, Australia; [Bentley, Nicholas; Turner, Nigel; Cooney, Gregory J.; Kraegen, Edward W.] Univ New S Wales, UNSW Med, Sydney, NSW, Australia; [Ruderman, Neil B.] Boston Univ, Sch Med, Boston, MA 02118 USA	Garvan Institute of Medical Research; St Vincents Hospital Sydney; University of New South Wales Sydney; Boston University	Brandon, AE (corresponding author), St Vincents Hosp, Garvan Inst Med Res, Diabet & Metab Div, 384 Victoria St, Darlinghurst, NSW 2010, Australia.	a.brandon@garvan.org.au	Turner, Nigel/H-7176-2013	Turner, Nigel/0000-0002-0119-9328	National Health and Medical Research Council (NHMRC) of Australia's Fellowship Scheme; National Institutes of Health, USA [RO1DK067509]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK067509] Funding Source: NIH RePORTER	National Health and Medical Research Council (NHMRC) of Australia's Fellowship Scheme; National Institutes of Health, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	GJC and EWK are supported by the National Health and Medical Research Council (NHMRC) of Australia's Fellowship Scheme. NT is an Australian Research Council (ARC) Future Fellow. This study was also funded by a grant to NBR and EWK from the National Institutes of Health, USA (RO1DK067509). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai P, 2011, CELL METAB, V13, P450, DOI 10.1016/j.cmet.2011.03.013; Bai P, 2011, CELL METAB, V13, P461, DOI 10.1016/j.cmet.2011.03.004; Balestrieri ML, 2008, BBA-PROTEINS PROTEOM, V1784, P936, DOI 10.1016/j.bbapap.2008.03.004; Boily G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001759; Bordone L, 2007, AGING CELL, V6, P759, DOI 10.1111/j.1474-9726.2007.00335.x; Brandon AE, 2011, ARCH BIOCHEM BIOPHYS, V509, P133, DOI 10.1016/j.abb.2011.03.008; Bruce CR, 2007, AM J PHYSIOL-ENDOC M, V292, pE1231, DOI 10.1152/ajpendo.00561.2006; Canto C, 2012, CELL METAB, V15, P838, DOI 10.1016/j.cmet.2012.04.022; Canto C, 2009, CURR OPIN LIPIDOL, V20, P98, DOI 10.1097/MOL.0b013e328328d0a4; Cleasby ME, 2005, DIABETES, V54, P2702, DOI 10.2337/diabetes.54.9.2702; Feige JN, 2008, CELL METAB, V8, P347, DOI 10.1016/j.cmet.2008.08.017; Frojdo S, 2011, MOL CELL ENDOCRINOL, V335, P166, DOI 10.1016/j.mce.2011.01.008; Gerhart-Hines Z, 2007, EMBO J, V26, P1913, DOI 10.1038/sj.emboj.7601633; Gurd BJ, 2012, J APPL PHYSIOL, V112, P931, DOI 10.1152/japplphysiol.00078.2012; Gurd BJ, 2012, J APPL PHYSIOL, V112, P926, DOI 10.1152/japplphysiol.01262.2011; Gurd BJ, 2009, J PHYSIOL-LONDON, V587, P1817, DOI 10.1113/jphysiol.2008.168096; Higashida K, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001603; Hoy AJ, 2007, AM J PHYSIOL-ENDOC M, V293, pE1358, DOI 10.1152/ajpendo.00133.2007; Hoy AJ, 2009, AM J PHYSIOL-ENDOC M, V297, pE67, DOI 10.1152/ajpendo.90945.2008; JAMES DE, 1985, AM J PHYSIOL, V248, pE567, DOI 10.1152/ajpendo.1985.248.5.E567; Kraegen EW, 2006, AM J PHYSIOL-ENDOC M, V290, pE471, DOI 10.1152/ajpendo.00316.2005; Lan F, 2008, J BIOL CHEM, V283, P27628, DOI 10.1074/jbc.M805711200; Larsen S, 2013, J AM COLL CARDIOL, V61, P44, DOI 10.1016/j.jacc.2012.09.036; McMahon JM, 2001, GENE THER, V8, P1264, DOI 10.1038/sj.gt.3301522; Menzies KJ, 2013, J BIOL CHEM, V288, P6968, DOI 10.1074/jbc.M112.431155; Menzies KJ, 2012, J APPL PHYSIOL, V112, P929, DOI 10.1152/japplphysiol.00094.2012; Montgomery MK, 2013, J LIPID RES, V54, P3322, DOI 10.1194/jlr.M040451; Nedachi T, 2008, AM J PHYSIOL-ENDOC M, V294, pE668, DOI 10.1152/ajpendo.00640.2007; Nogueiras R, 2012, PHYSIOL REV, V92, P1479, DOI 10.1152/physrev.00022.2011; Philp A, 2011, J BIOL CHEM, V286, P30561, DOI 10.1074/jbc.M111.261685; Price NL, 2012, CELL METAB, V15, P675, DOI 10.1016/j.cmet.2012.04.003; Purushotham A, 2009, CELL METAB, V9, P327, DOI 10.1016/j.cmet.2009.02.006; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Saha AK, 2010, DIABETES, V59, P2426, DOI 10.2337/db09-1870; Schenk S, 2011, J CLIN INVEST, V121, P4281, DOI 10.1172/JCI58554; Shabalina IG, 2013, CELL REP, V5, P1196, DOI 10.1016/j.celrep.2013.10.044; Suchankova G, 2009, BIOCHEM BIOPH RES CO, V378, P836, DOI 10.1016/j.bbrc.2008.11.130; Sun C, 2007, CELL METAB, V6, P307, DOI 10.1016/j.cmet.2007.08.014; Turner N, 2007, DIABETES, V56, P2085, DOI 10.2337/db07-0093; Wang RH, 2011, J CLIN INVEST, V121, P4477, DOI 10.1172/JCI46243; Wang Y, 2013, INVEST OPHTH VIS SCI, V54, P3806, DOI 10.1167/iovs.13-12091; White AT, 2013, DIABETOLOGIA, V56, P1629, DOI 10.1007/s00125-013-2912-2; White AT, 2014, AM J PHYSIOL-ENDOC M, V307, pE764, DOI 10.1152/ajpendo.00001.2014; Wright LE, 2011, DIABETOLOGIA; Xu Y, 2012, TOXICOL APPL PHARM, V259, P395, DOI 10.1016/j.taap.2011.09.028; Yuan Q, 2011, CAN J PHYSIOL PHARM, V89, P713, DOI [10.1139/Y11-069, 10.1139/y11-069]; Zu Y, 2010, CIRC RES, V106, P1384, DOI 10.1161/CIRCRESAHA.109.215483	47	16	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0121959	10.1371/journal.pone.0121959	http://dx.doi.org/10.1371/journal.pone.0121959			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25798922	gold, Green Published, Green Submitted			2022-12-27	WOS:000351987300304
J	Gao, L; Bai, LJ; Zhang, YC; Dai, XJ; Netra, R; Min, YJ; Zhou, FQ; Niu, C; Dun, WH; Gong, HH; Zhang, M				Gao, Lei; Bai, Lijun; Zhang, Yuchen; Dai, Xi-jian; Netra, Rana; Min, Youjiang; Zhou, Fuqing; Niu, Chen; Dun, Wanghuan; Gong, Honghan; Zhang, Ming			Frequency-Dependent Changes of Local Resting Oscillations in Sleep-Deprived Brain	PLOS ONE			English	Article							WORKING-MEMORY; DEFAULT-MODE; NEURAL BASIS; DEPRIVATION; CONNECTIVITY; NETWORKS; CORTEX; ACTIVATION; MECHANISMS; ATTENTION	Sleep deprivation (SD) adversely affects brain function and is accompanied by frequency dependent changes in EEG. Recent studies have suggested that BOLD fluctuations pertain to a spatiotemporal organization with different frequencies. The present study aimed to investigate the frequency-dependent SD-related brain oscillatory activity by using the amplitude of low-frequency fluctuation (ALFF) analysis. The ALFF changes were measured across different frequencies (Slow-4: 0.027-0.073 Hz; Slow-5: 0.01-0.027 Hz; and Typical band: 0.01-0.08 Hz) in 24 h SD as compared to rested wakeful during resting-state fMRI. Sixteen volunteers underwent two fMRI sessions, once during rested wakefulness and once after 24 h of SD. SD showed prominently decreased ALFF in the right inferior parietal lobule (IPL), bilateral orbitofrontal cortex (OFC) and dorsolateral prefrontal cortex (DLPFC), while increased ALFF in the visual cortex, left sensorimotor cortex and fusiform gyrus. Across the Slow-4 and Slow-5, results differed significantly in the OFC, DLPFC, thalamus and caudate in comparison to typical frequency band; and Slow-4 showed greater differences. In addition, negative correlations of behavior performance and ALFF patterns were found mainly in the right IPL across the typical frequency band. These observations provided novel insights about the physiological responses of SD, identified how it disturbs the brain rhythms, and linked SD with frequency-dependent alterations in amplitude patterns.	[Gao, Lei; Netra, Rana; Niu, Chen; Dun, Wanghuan; Zhang, Ming] Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Med Imaging, Xian 710049, Peoples R China; [Gao, Lei; Dai, Xi-jian; Zhou, Fuqing; Gong, Honghan] Nanchang Univ, Affiliated Hosp 1, Dept Radiol, Nanchang, Jiangxi, Peoples R China; [Bai, Lijun] Xi An Jiao Tong Univ, Key Lab Biomed Informat Engn, Minist Educ, Dept Biomed Engn,Sch Life Sci & Technol, Xian 710049, Peoples R China; [Zhang, Yuchen] Xi An Jiao Tong Univ, Zonglian Expt Class, Xian 710049, Peoples R China; [Min, Youjiang] Jiangxi Univ Tradit Chinese Med, Affiliated Hosp, Acupuncture & Rehabil Dept, Nanchang, Jiangxi, Peoples R China	Xi'an Jiaotong University; Nanchang University; Xi'an Jiaotong University; Xi'an Jiaotong University; Jiangxi University of Traditional Chinese Medicine	Gong, HH (corresponding author), Nanchang Univ, Affiliated Hosp 1, Dept Radiol, Nanchang, Jiangxi, Peoples R China.	honghan_gong@sina.com; zmmri@163.com	Dai, Xi/HCG-9886-2022; Zhang, Yuchen/GYI-8858-2022; Bai, Lijun/C-5119-2015	Gao, Lei/0000-0002-0081-0172; Bai, Lijun/0000-0001-8790-5424; DAI, Xi-jian/0000-0001-5328-6522	National Natural Science Foundation of China [81371630, 81260217, 81371530]; Fundamental Research Funds for the Central Universities; Beijing Nova program [Z111101054511116]; Beijing Natural Science Foundation [4122082]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Beijing Nova program(Beijing Municipal Science & Technology Commission); Beijing Natural Science Foundation(Beijing Natural Science Foundation)	Funding: This study was supported by the National Natural Science Foundation of China (Grant No. 81371630, 81260217, and 81371530), the Fundamental Research Funds for the Central Universities, the Beijing Nova program (grant number Z111101054511116), and the Beijing Natural Science Foundation (grant number 4122082).	Abou Elseoud A, 2014, HUM BRAIN MAPP, V35, P161, DOI 10.1002/hbm.22164; Altena E, 2010, BIOL PSYCHIAT, V67, P182, DOI 10.1016/j.biopsych.2009.08.003; Anticevic A, 2012, TRENDS COGN SCI, V16, P584, DOI 10.1016/j.tics.2012.10.008; Baliki MN, 2011, J NEUROSCI, V31, P13981, DOI 10.1523/JNEUROSCI.1984-11.2011; Baria AT, 2011, J NEUROSCI, V31, P7910, DOI 10.1523/JNEUROSCI.1296-11.2011; BENINGTON JH, 1995, PROG NEUROBIOL, V45, P347, DOI 10.1016/0301-0082(94)00057-O; Biswal BB, 2010, P NATL ACAD SCI USA, V107, P4734, DOI 10.1073/pnas.0911855107; Born J, 2012, NEURON, V75, P933, DOI 10.1016/j.neuron.2012.09.007; Bosch OG, 2013, P NATL ACAD SCI USA, V110, P19597, DOI 10.1073/pnas.1317010110; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Chee MWL, 2008, CURR OPIN NEUROL, V21, P417, DOI 10.1097/WCO.0b013e3283052cf7; Chee MWL, 2007, P NATL ACAD SCI USA, V104, P9487, DOI 10.1073/pnas.0610712104; Chee MWL, 2004, J NEUROSCI, V24, P4560, DOI 10.1523/JNEUROSCI.0007-04.2004; Chuah YML, 2006, J NEUROSCI, V26, P7156, DOI 10.1523/JNEUROSCI.0906-06.2006; De Havas JA, 2012, NEUROIMAGE, V59, P1745, DOI 10.1016/j.neuroimage.2011.08.026; Disner SG, 2011, NAT REV NEUROSCI, V12, P467, DOI 10.1038/nrn3027; Drummond SPA, 2005, SLEEP, V28, P1059; Dworak M, 2010, J NEUROSCI, V30, P9007, DOI 10.1523/JNEUROSCI.1423-10.2010; Etkin A, 2011, TRENDS COGN SCI, V15, P85, DOI 10.1016/j.tics.2010.11.004; Forster KI, 2003, BEHAV RES METH INS C, V35, P116, DOI 10.3758/BF03195503; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Gevins A, 1997, CEREB CORTEX, V7, P374, DOI 10.1093/cercor/7.4.374; Gevins A, 1998, HUM FACTORS, V40, P79, DOI 10.1518/001872098779480578; Goel N, 2009, SEMIN NEUROL, V29, P320, DOI 10.1055/s-0029-1237117; Gujar N, 2011, J NEUROSCI, V31, P4466, DOI 10.1523/JNEUROSCI.3220-10.2011; Gujar N, 2010, J COGNITIVE NEUROSCI, V22, P1637, DOI 10.1162/jocn.2009.21331; Han Y, 2011, NEUROIMAGE, V55, P287, DOI 10.1016/j.neuroimage.2010.11.059; Hasler G, 2011, MOL PSYCHIATR, V16, P604, DOI 10.1038/mp.2011.23; Hoptman MJ, 2010, SCHIZOPHR RES, V117, P13, DOI 10.1016/j.schres.2009.09.030; Jiao Q, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025159; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Killgore WDS, 2012, NEUROSCI LETT, V518, P10, DOI 10.1016/j.neulet.2012.04.029; Knoblauch V, 2002, CEREB CORTEX, V12, P1092, DOI 10.1093/cercor/12.10.1092; Koenis MMG, 2013, HUM BRAIN MAPP, V34, P487, DOI 10.1002/hbm.21455; Kong DY, 2014, NEUROIMAGE, V91, P169, DOI 10.1016/j.neuroimage.2014.01.037; Lawrence NS, 2003, J COGNITIVE NEUROSCI, V15, P1028, DOI 10.1162/089892903770007416; Libedinsky C, 2011, FRONT BEHAV NEUROSCI, V5, DOI 10.3389/fnbeh.2011.00070; Lim JL, 2008, ANN NY ACAD SCI, V1129, P305, DOI 10.1196/annals.1417.002; Menon V, 2010, BRAIN STRUCT FUNCT, V214, P655, DOI 10.1007/s00429-010-0262-0; Menz MM, 2012, J NEUROSCI, V32, P6937, DOI 10.1523/JNEUROSCI.3553-11.2012; Motomura Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056578; Mullin BC, 2013, PSYCHOL MED, V43, P2215, DOI 10.1017/S0033291712002875; Olbrich E, 2013, J SLEEP RES; Piantoni G, 2013, NEUROIMAGE, V79, P213, DOI 10.1016/j.neuroimage.2013.04.103; Picchioni D, 2013, NEUROIMAGE, V80, P387, DOI 10.1016/j.neuroimage.2013.05.067; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; Raichle ME, 2011, BRAIN CONNECT, V1, P3, DOI 10.1089/brain.2011.0019; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Samann PG, 2010, MAGN RESON MATER PHY, V23, P375, DOI 10.1007/s10334-010-0213-z; Satterthwaite TD, 2013, NEUROIMAGE, V64, P240, DOI 10.1016/j.neuroimage.2012.08.052; Shao YC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078830; Smith ME, 1999, COGNITIVE BRAIN RES, V7, P389, DOI 10.1016/S0926-6410(98)00043-3; Song XP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086818; Tallon-Baudry C, 2005, CEREB CORTEX, V15, P654, DOI 10.1093/cercor/bhh167; Thomas M, 2000, J SLEEP RES, V9, P335, DOI 10.1046/j.1365-2869.2000.00225.x; Thomas Maria L., 2003, Thalamus & Related Systems, V2, P199, DOI 10.1017/S1472928803000207; Tomasi D, 2009, CEREB CORTEX, V19, P233, DOI 10.1093/cercor/bhn073; Van Dijk KRA, 2012, NEUROIMAGE, V59, P431, DOI 10.1016/j.neuroimage.2011.07.044; Venkatraman V, 2007, SLEEP, V30, P603, DOI 10.1093/sleep/30.5.603; Venkatraman V, 2011, J NEUROSCI, V31, P3712, DOI 10.1523/JNEUROSCI.4407-10.2011; Wei LQ, 2014, HUM BRAIN MAPP, V35, P331, DOI 10.1002/hbm.22176; WU JC, 1991, SLEEP, V14, P155; Yamasaki H, 2002, P NATL ACAD SCI USA, V99, P11447, DOI 10.1073/pnas.182176499; Yan CG, 2013, NEUROIMAGE, V80, P246, DOI 10.1016/j.neuroimage.2013.04.081; Yan CG, 2013, NEUROIMAGE, V76, P183, DOI 10.1016/j.neuroimage.2013.03.004; Yan CG, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00013; Yoo SS, 2007, CURR BIOL, V17, pR877, DOI 10.1016/j.cub.2007.08.007; Yu RJ, 2014, HUM BRAIN MAPP, V35, P627, DOI 10.1002/hbm.22203; Zang YF, 2004, NEUROIMAGE, V22, P394, DOI 10.1016/j.neuroimage.2003.12.030; Zang YF, 2007, BRAIN DEV-JPN, V29, P83, DOI 10.1016/j.braindev.2006.07.002; Zuo XN, 2010, NEUROIMAGE, V49, P1432, DOI 10.1016/j.neuroimage.2009.09.037	71	55	57	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0120323	10.1371/journal.pone.0120323	http://dx.doi.org/10.1371/journal.pone.0120323			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25798918	Green Published, gold, Green Submitted			2022-12-27	WOS:000351987300134
J	Gong, Z; Schwieters, CD; Tang, C				Gong, Zhou; Schwieters, Charles D.; Tang, Chun			Conjoined Use of EM and NMR in RNA Structure Refinement	PLOS ONE			English	Article							SPECTROSCOPY; DYNAMICS; RIBOSOME; ELEMENT	More than 40% of the RNA structures have been determined using nuclear magnetic resonance (NMR) technique. NMR mainly provides local structural information of protons and works most effectively on relatively small biomacromolecules. Hence structural characterization of large RNAs can be difficult for NMR alone. Electron microscopy (EM) provides global shape information of macromolecules at nanometer resolution, which should be complementary to NMR for RNA structure determination. Here we developed a new energy term in Xplor-NIH against the density map obtained by EM. We conjointly used NMR and map restraints for the structure refinement of three RNA systems-U2/U6 small-nuclear RNA, genome-packing motif (psi(CD)) 2 from Moloney murine leukemia virus, and ribosome-binding element from turnip crinkle virus. In all three systems, we showed that the incorporation of a map restraint, either experimental or generated from known PDB structure, greatly improves structural precision and accuracy. Importantly, our method does not rely on an initial model assembled from RNA duplexes, and allows full torsional freedom for each nucleotide in the torsion angle simulated annealing refinement. As increasing number of macromolecules can be characterized by both NMR and EM, the marriage between the two techniques would enable better characterization of RNA three-dimensional structures.	[Gong, Zhou; Tang, Chun] Chinese Acad Sci, CAS Key Lab Magnet Resonance Biol Syst, State Key Lab Magnet Resonance & Atom Mol Phys, Natl Magnet Resonance Ctr Wuhan,Wuhan Inst Phys &, Wuhan 430071, Hubei Province, Peoples R China; [Schwieters, Charles D.] NIH, Div Computat Biosci, Ctr Informat Technol, Bethesda, MD 20892 USA	Chinese Academy of Sciences; National Institutes of Health (NIH) - USA; NIH Center for Information Technology (CIT)	Tang, C (corresponding author), Chinese Acad Sci, CAS Key Lab Magnet Resonance Biol Syst, State Key Lab Magnet Resonance & Atom Mol Phys, Natl Magnet Resonance Ctr Wuhan,Wuhan Inst Phys &, Wuhan 430071, Hubei Province, Peoples R China.	tanglab@wipm.ac.cn	Tang, Chun/P-4060-2019	Tang, Chun/0000-0001-6477-6500	Chinese Ministry of Science and Technology [2013CB910200]; National Natural Sciences Foundation of China [31400735, 31225007, 31170728]; International Early Career Scientist program from the Howard Hughes Medical Institute; NIH CIT Intramural Research Program; CENTER FOR INFORMATION TECHNOLOGY [ZIACT000090] Funding Source: NIH RePORTER	Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); International Early Career Scientist program from the Howard Hughes Medical Institute; NIH CIT Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CENTER FOR INFORMATION TECHNOLOGY(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Center for Information Technology (CIT))	C.T. is supported by grants from the Chinese Ministry of Science and Technology (2013CB910200) and the National Natural Sciences Foundation of China (31400735, 31225007, and 31170728), and supported in part by the International Early Career Scientist program from the Howard Hughes Medical Institute. C.D.S. is supported by the NIH CIT Intramural Research Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baird NJ, 2010, J AM CHEM SOC, V132, P16352, DOI 10.1021/ja107492b; Bax A, 2005, CURR OPIN STRUC BIOL, V15, P563, DOI 10.1016/j.sbi.2005.08.006; Breaker RR, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a003566; Burke JE, 2012, RNA, V18, P673, DOI 10.1261/rna.031138.111; Cao S, 2010, RNA, V16, P538, DOI 10.1261/rna.1800210; Clore GM, 2003, J AM CHEM SOC, V125, P1518, DOI 10.1021/ja028383j; Dethoff EA, 2012, NATURE, V482, P322, DOI 10.1038/nature10885; Gagnon MG, 2014, SCIENCE, V345, P684, DOI 10.1126/science.1253525; Gajda MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078007; Grishaev A, 2008, J BIOMOL NMR, V42, P99, DOI 10.1007/s10858-008-9267-x; Hannon GJ, 2002, NATURE, V418, P244, DOI 10.1038/418244a; Hershkovitz E, 2003, NUCLEIC ACIDS RES, V31, P6249, DOI 10.1093/nar/gkg835; Liu JJ, 2014, NAT STRUCT MOL BIOL, V21, P95, DOI 10.1038/nsmb.2736; Lu K, 2010, J BIOMOL NMR, V46, P113, DOI 10.1007/s10858-009-9375-2; Mainz A, 2013, ANGEW CHEM INT EDIT, V52, P8746, DOI 10.1002/anie.201301215; Miracco EJ, 2014, CURR OPIN STRUC BIOL, V24, P115, DOI 10.1016/j.sbi.2014.01.008; Miyazaki Y, 2010, J MOL BIOL, V404, P751, DOI 10.1016/j.jmb.2010.09.009; Mustoe AM, 2014, ANNU REV BIOCHEM, V83, P441, DOI 10.1146/annurev-biochem-060713-035524; Parisien M, 2008, NATURE, V452, P51, DOI 10.1038/nature06684; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Scheres SHW, 2014, ELIFE, V3, DOI 10.7554/eLife.03665; Schwieters CD, 2006, PROG NUCL MAG RES SP, V48, P47, DOI 10.1016/j.pnmrs.2005.10.001; Schwieters CD, 2002, J BIOMOL NMR, V23, P221, DOI 10.1023/A:1019875223132; Schwieters CD, 2014, PROG NUCL MAG RES SP, V80, P1, DOI 10.1016/j.pnmrs.2014.03.001; Scott Lincoln G., 2008, V452, P29, DOI 10.1007/978-1-60327-159-2_2; Sternberg SH, 2014, NATURE, V507, P62, DOI 10.1038/nature13011; Tolbert BS, 2010, J BIOMOL NMR, V47, P205, DOI 10.1007/s10858-010-9424-x; van Ingen H, 2014, J MAGN RESON, V241, P103, DOI 10.1016/j.jmr.2013.10.021; Wang JB, 2009, J MOL BIOL, V393, P717, DOI 10.1016/j.jmb.2009.08.001; Wriggers W, 2012, ACTA CRYSTALLOGR D, V68, P344, DOI 10.1107/S0907444911049791; Zuo XB, 2010, P NATL ACAD SCI USA, V107, P1385, DOI 10.1073/pnas.0908140107	31	20	21	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0120445	10.1371/journal.pone.0120445	http://dx.doi.org/10.1371/journal.pone.0120445			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25798848	Green Published, Green Submitted, gold			2022-12-27	WOS:000351987300144
J	Kim, JS; Park, J; Lim, SY; Oh, YM; Yoo, KH; Park, YB; Sheen, SS; Kim, MJ; Carriere, KC; Jung, JY; Park, HY				Kim, Jung Soo; Park, Jinkyeong; Lim, Seong Yong; Oh, Yeon-Mok; Yoo, Kwang Ha; Park, Yong Bum; Sheen, Seung Soo; Kim, Min-Ji; Carriere, K. C.; Jung, Ji Ye; Park, Hye Yun			Comparison of Clinical Efficacy and Safety between Indacaterol and Tiotropium in COPD: Meta-Analysis of Randomized Controlled Trials	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; ONCE-DAILY INDACATEROL	Two once-daily inhaled bronchodilators, indacaterol and tiotropium, are widely used as first-line therapy in stable COPD patients. This study was performed to compare the clinical efficacy and safety between indacaterol and tiotropium in patients with moderate-to-severe COPD. MEDLINE, EMBASE, and Cochrane Central Register of Controlled Trials were searched to identify all published randomized controlled trials (RCTs). The primary outcome was trough forced expiratory volume in 1 second (FEV1) at week 12. Four RCTs were eligible for inclusion (three RCTs with moderate-to-severe COPD patients and one RCT with only severe COPD patients). Trough FEV1 at weeks 12 and 26 were not significantly different between indacaterol and tiotropium by the standardized mean difference with 0.014 (95% CI, -0.036, 0.063, I-2 = 23.5%) and with 0.037 (95% CI, -0.059 to 0.133, I-2 = 0%) along with differences in means of 0.003L and 0.014L, respectively. Indacaterol and tiotropium also showed similar St. George's Respiratory Questionnaire (SGRQ) total scores and percentages of patients with SGRQ improvement (>= 4 units) at week 26. The incidences of nasopharyngitis, serious cardiovascular events, and serious adverse events were not different between indacaterol and tiotropium, while those of cough (OR = 1.68, P < 0.001, and RR = 1.63) and COPD worsening (OR = 1.18, P = 0.003, and RR = 1.12) were higher for indacaterol than tiotropium. However, when one study with only severe COPD patients was removed from the meta-analysis, the difference in the incidence of COPD worsening between indacaterol and tiotropium became non-significant (OR = 1.13, P = 0.204, and RR = 1.09). The clinical efficacy and serious adverse events between indacaterol and tiotropium were equivocal in patients with moderate-to-severe COPD. Cough is a common complaint associated with indacaterol, and COPD worsening needs to be carefully monitored in severe COPD patients when treated with indacaterol.	[Kim, Jung Soo; Park, Hye Yun] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Pulm & Crit Care Med,Dept Med, Seoul, South Korea; [Park, Jinkyeong] Catholic Univ Korea, Coll Med, Dept Internal Med, Uijeongbu St Marys Hosp, Uijongbu, South Korea; [Lim, Seong Yong] Sungkyunkwan Univ, Sch Med, Kangbuk Samsung Hosp, Dept Med, Seoul, South Korea; [Oh, Yeon-Mok] Univ Ulsan, Dept Pulm & Crit Care Med, Clin Res Ctr Chron Obstruct Airway Dis, Asan Med Ctr,Coll Med, Seoul, South Korea; [Yoo, Kwang Ha] Konkuk Univ, Coll Med, Dept Internal Med, Seoul, South Korea; [Park, Yong Bum] Hallym Univ, Kangdong Sacred Heart Hosp, Med Ctr, Dept Pulm Allergy & Crit Care Med, Seoul, South Korea; [Sheen, Seung Soo] Ajou Univ, Sch Med, Dept Pulm & Crit Care Med, Suwon 441749, South Korea; [Kim, Min-Ji] Samsung Biomedial Res Inst, Biostat Team, Seoul, South Korea; [Carriere, K. C.] Univ Alberta, Dept Math & Stat Sci, Edmonton, AB, Canada; [Carriere, K. C.] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Biostat & Clin Epidemiol Ctr, Seoul, South Korea; [Jung, Ji Ye] Yonsei Univ, Coll Med, Dept Internal Med, Inst Chest Dis,Div Pulmonol, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Catholic University of Korea; Sungkyunkwan University (SKKU); Samsung Medical Center; University of Ulsan; Asan Medical Center; Konkuk University; Konkuk University Medical Center; Hallym University; Ajou University; University of Alberta; Sungkyunkwan University (SKKU); Samsung Medical Center; Yonsei University; Yonsei University Health System	Jung, JY (corresponding author), Yonsei Univ, Coll Med, Dept Internal Med, Inst Chest Dis,Div Pulmonol, Seoul, South Korea.	stopyes@yuhs.ac; hyeyunpark@skku.edu	park, hy/O-5934-2014; Park, Jinkyeong/GLV-1649-2022; Sheen, Seungsoo/AAB-4963-2021; Jung, Ji Ye/AAB-4993-2021; Park, Jinkyeong/AGB-3445-2022	Park, Jinkyeong/0000-0002-8833-9062; Park, Yong Bum/0000-0002-5814-6104; Kim, Jung Soo/0000-0001-6603-6768; Jung, Ji Ye/0000-0003-1589-4142				Bateman ED, 2013, EUR RESPIR J, V42, P1484, DOI 10.1183/09031936.00200212; Buhl R, 2011, EUR RESPIR J, V38, P797, DOI 10.1183/09031936.00191810; Buist AS, 2007, LANCET, V370, P741, DOI 10.1016/S0140-6736(07)61377-4; Chung VCH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070784; Dahl R, 2010, THORAX, V65, P473, DOI 10.1136/thx.2009.125435; Decramer ML, 2013, LANCET RESP MED, V1, P524, DOI 10.1016/S2213-2600(13)70158-9; Donohue JF, 2010, AM J RESP CRIT CARE, V182, P155, DOI 10.1164/rccm.200910-1500OC; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Global Initiative for Chronic Obstructive Lung Disease, GLOB STRAT DIAGN MAN; Han JN, 2013, BMC PULM MED, V13, DOI 10.1186/1471-2466-13-26; Higgins Julian P T, 2011, BMJ, V343, pd5928, DOI 10.1136/bmj.d5928; Jones PW, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-55; Jones PW, 2002, EUR RESPIR J, V19, P398, DOI 10.1183/09031936.02.00063702; Karner C, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009285.pub3; Korn S, 2011, RESP MED, V105, P719, DOI 10.1016/j.rmed.2011.02.008; Kornmann O, 2011, EUR RESPIR J, V37, P273, DOI 10.1183/09031936.00045810; Liberati Alessandro, 2009, J Clin Epidemiol, V62, pe1, DOI 10.1016/j.jclinepi.2009.06.006; Lopez AD, 2006, EUR RESPIR J, V27, P397, DOI 10.1183/09031936.06.00025805; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Macdonald Geraldine, 2012, Cochrane Database Syst Rev, pCD001930, DOI 10.1002/14651858.CD001930.pub3; Ray SM, 2012, PHARMACOTHERAPY, V32, P456, DOI 10.1002/j.1875-9114.2012.01025.x; Rodrigo GJ, 2007, PULM PHARMACOL THER, V20, P495, DOI 10.1016/j.pupt.2006.02.003; Rodrigo GJ, 2014, CHEST, V146, P309, DOI 10.1378/chest.13-2807; Rodrigo GJ, 2012, CHEST, V142, P1104, DOI 10.1378/chest.11-2252	24	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0119948	10.1371/journal.pone.0119948	http://dx.doi.org/10.1371/journal.pone.0119948			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25799171	Green Submitted, Green Published, gold			2022-12-27	WOS:000351987300097
J	Moro, MF; Silva, IA; de Araujo, FS; Lughadha, EN; Meagher, TR; Martins, FR				Moro, Marcelo Freire; Silva, Igor Aurelio; de Araujo, Francisca Soares; Lughadha, Eimear Nic; Meagher, Thomas R.; Martins, Fernando Roberto			The Role of Edaphic Environment and Climate in Structuring Phylogenetic Pattern in Seasonally Dry Tropical Plant Communities	PLOS ONE			English	Article							NICHE CONSERVATISM; SPATIAL-ANALYSIS; EVOLUTION; CAATINGA; ECOLOGY; DIVERSITY; LIFE; OVERDISPERSION; BIODIVERSITY	Seasonally dry tropical plant formations (SDTF) are likely to exhibit phylogenetic clustering owing to niche conservatism driven by a strong environmental filter (water stress), but heterogeneous edaphic environments and life histories may result in heterogeneity in degree of phylogenetic clustering. We investigated phylogenetic patterns across ecological gradients related to water availability (edaphic environment and climate) in the Caatinga, a SDTF in Brazil. Caatinga is characterized by semiarid climate and three distinct edaphic environments - sedimentary, crystalline, and inselberg - representing a decreasing gradient in soil water availability. We used two measures of phylogenetic diversity: Net Relatedness Index based on the entire phylogeny among species present in a site, reflecting long-term diversification; and Nearest Taxon Index based on the tips of the phylogeny, reflecting more recent diversification. We also evaluated woody species in contrast to herbaceous species. The main climatic variable influencing phylogenetic pattern was precipitation in the driest quarter, particularly for herbaceous species, suggesting that environmental filtering related to minimal periods of precipitation is an important driver of Caatinga biodiversity, as one might expect for a SDTF. Woody species tended to show phylogenetic clustering whereas herbaceous species tended towards phylogenetic overdispersion. We also found phylogenetic clustering in two edaphic environments (sedimentary and crystalline) in contrast to phylogenetic overdispersion in the third (inselberg). We conclude that while niche conservatism is evident in phylogenetic clustering in the Caatinga, this is not a universal pattern likely due to heterogeneity in the degree of realized environmental filtering across edaphic environments. Thus, SDTF, in spite of a strong shared environmental filter, are potentially heterogeneous in phylogenetic structuring. Our results support the need for scientifically informed conservation strategies in the Caatinga and other SDTF regions that have not previously been prioritized for conservation in order to take into account this heterogeneity.	[Moro, Marcelo Freire; Silva, Igor Aurelio; Martins, Fernando Roberto] State Univ Campinas UNICAMP, Dept Biol Vegetal, BR-13083970 Sao Paulo, Brazil; [de Araujo, Francisca Soares] Univ Fed Ceara, Dept Biol, Ctr Ciencias, BR-60455760 Fortaleza, Ceara, Brazil; [Lughadha, Eimear Nic] Royal Bot Gardens, Richmond TW9 3AB, Surrey, England; [Meagher, Thomas R.] Univ St Andrews, Sch Biol, St Andrews KY16 9TH, Fife, Scotland	Universidade Estadual de Campinas; Universidade Federal do Ceara; Royal Botanic Gardens, Kew; University of St Andrews	Moro, MF (corresponding author), State Univ Campinas UNICAMP, Dept Biol Vegetal, Bloco M, BR-13083970 Sao Paulo, Brazil.	bio_moro@yahoo.com.br	Martins, Fernando R./F-5652-2012; Araújo, Francisca Soares/H-9371-2012; Moro, Marcelo F/J-9882-2012; Nic Lughadha, Eimear/N-4560-2014; Moro, Marcelo Freire/U-7997-2019	Martins, Fernando R./0000-0002-3068-7099; Araújo, Francisca Soares/0000-0003-4661-6137; Moro, Marcelo F/0000-0003-4527-346X; Nic Lughadha, Eimear/0000-0002-8806-4345; 	Sao Paulo Research Foundation (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - Fapesp) [2013/15280-9]	Sao Paulo Research Foundation (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - Fapesp)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This study was made possible through the kind financial support of the Sao Paulo Research Foundation - http://fapesp.br/en (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - Fapesp 2013/15280-9). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ab'Saber A.N., 2003, DOMINIOS NATUREZA BR, P159, DOI DOI 10.1016/J.SCITOTENV.2014.12.090; Ab'Saber A.N., 1974, GEOMORFOLOGIA, V43, P1; ArauCjo F.S., 1998, REV BRASILEIRA BOT, V21, P105, DOI [10.1590/S0100-84041998000200001, DOI 10.1590/S0100-84041998000200001]; Araújo Francisca Soares, 2008, Rodriguésia, V59, P659, DOI 10.1590/2175-7860200859403; Araújo Francisca Soares de, 2011, Rodriguésia, V62, P341, DOI 10.1590/2175-7860201162210; Barbosa HA, 2006, J ARID ENVIRON, V67, P288, DOI 10.1016/j.jaridenv.2006.02.022; Borcard D, 2002, ECOL MODEL, V153, P51, DOI 10.1016/S0304-3800(01)00501-4; Borcard D, 2011, USE R, P1, DOI 10.1007/978-1-4419-7976-6; Castelletti C. H. M., 2003, ECOLOGIA CONSERVACAO, P719; Cavender-Bares J, 2004, AM NAT, V163, P823, DOI 10.1086/386375; Cavender-Bares J, 2009, ECOL LETT, V12, P693, DOI 10.1111/j.1461-0248.2009.01314.x; Cooper N, 2008, P ROY SOC B-BIOL SCI, V275, P2031, DOI 10.1098/rspb.2008.0420; Costa K. C., 2009, Revista Brasileira de Ciencias Agrarias (Agraria), V4, P48; Crisp MD, 2009, NATURE, V458, P754, DOI 10.1038/nature07764; da Costa RC, 2007, J ARID ENVIRON, V68, P237, DOI 10.1016/j.jaridenv.2006.06.003; de Araujo F S, 1999, Rev Bras Biol, V59, P663, DOI 10.1590/S0034-71081999000400015; de Queiroz L.P, 2009, LEGUMINOSAS CAATINGA; Diniz JAF, 2005, GLOBAL ECOL BIOGEOGR, V14, P177, DOI 10.1111/j.1466-822X.2005.00147.x; Forest F, 2007, NATURE, V445, P757, DOI 10.1038/nature05587; Franca Flavio, 2005, Hoehnea, V32, P93; Gomes Ana Paula de Souza, 2006, Acta Bot. Bras., V20, P37; Gomes Polyhanna, 2010, Braz. J. Bot., V33, P661, DOI 10.1590/S0100-84042010000400014; Gotelli NJ, 2004, PRIMER ECOLOGICAL ST, P429; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Kembel SW, 2010, BIOINFORMATICS, V26, P1463, DOI 10.1093/bioinformatics/btq166; LEGENDRE P, 1993, ECOLOGY, V74, P1659, DOI 10.2307/1939924; Legendre P, 2012, NUMERICAL ECOLOGY, P990; Losos JB, 2008, ECOL LETT, V11, P995, DOI 10.1111/j.1461-0248.2008.01229.x; MADDISON WP, 1991, EVOLUTION, V45, P1184, DOI [10.1111/j.1558-5646.1991.tb04385.x, 10.2307/2409726]; Mendes MRDA, 2010, CHECK LIST, V6, P39, DOI [10.15528/2176-4158/rcpa.v12n2p138-141, DOI 10.15528/2176-4158/RCPA.V12N2P138-141, DOI 10.15560/6.1.039]; Miles L, 2006, J BIOGEOGR, V33, P491, DOI 10.1111/j.1365-2699.2005.01424.x; Moro MF, 2014, PHYTOTAXA, V160, P1; Moro MF, 2013, THESIS STATE U CAMPI; MURPHY PG, 1986, ANNU REV ECOL SYST, V17, P67, DOI 10.1146/annurev.es.17.110186.000435; Myers N, 2001, P NATL ACAD SCI USA, V98, P5389, DOI 10.1073/pnas.091092498; Niklas K.J., 1997, EVOLUTIONARY BIOL PL; Oliveira AT, 2013, S AFR J BOT, V89, P42, DOI 10.1016/j.sajb.2013.06.010; Olson DM, 2001, BIOSCIENCE, V51, P933, DOI 10.1641/0006-3568(2001)051[0933:TEOTWA]2.0.CO;2; de Queiroz LP, 2006, SYST ASSOC SPEC VOL, P121; Pavoine S, 2011, BIOL REV, V86, P792, DOI 10.1111/j.1469-185X.2010.00171.x; Pearman PB, 2008, TRENDS ECOL EVOL, V23, P149, DOI 10.1016/j.tree.2007.11.005; Pennington RT, 2006, SYST ASSOC SPEC VOL, P1; Pennington RT, 2009, ANNU REV ECOL EVOL S, V40, P437, DOI 10.1146/annurev.ecolsys.110308.120327; Porto P. A. F., 2008, Caatinga, V21, P214; R Development Core Team, 2012, R LANG ENV STAT COMP; Rangel TF, 2010, ECOGRAPHY, V33, P46, DOI 10.1111/j.1600-0587.2009.06299.x; RAUNKIAER C., 1934; Rodal M. J. N., 2005, ANALISE VARIACOES BI, P139; Sampaio Everardo V. S. B., 1995, P35, DOI 10.1017/CBO9780511753398.003; Santos RM, 2012, ECOL EVOL, V2, P409, DOI 10.1002/ece3.91; Smith SA, 2008, SCIENCE, V322, P86, DOI 10.1126/science.1163197; Vamosi SM, 2009, MOL ECOL, V18, P572, DOI 10.1111/j.1365-294X.2008.04001.x; VANEWRIGHT RI, 1991, BIOL CONSERV, V55, P235, DOI 10.1016/0006-3207(91)90030-D; Velloso A.L., 2002, ECORREGIOES PROPOSTA; Webb CO, 2008, BIOINFORMATICS, V24, P2098, DOI 10.1093/bioinformatics/btn358; Webb CO, 2005, MOL ECOL NOTES, V5, P181, DOI 10.1111/j.1471-8286.2004.00829.x; Webb CO, 2002, ANNU REV ECOL SYST, V33, P475, DOI 10.1146/annurev.ecolsys.33.010802.150448; Webb CO, 2000, AM NAT, V156, P145, DOI 10.1086/303378; Wiens JJ, 2005, ANNU REV ECOL EVOL S, V36, P519, DOI 10.1146/annurev.ecolsys.36.102803.095431; Wikstrom N, 2001, P ROY SOC B-BIOL SCI, V268, P2211, DOI 10.1098/rspb.2001.1782	60	46	49	3	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0119166	10.1371/journal.pone.0119166	http://dx.doi.org/10.1371/journal.pone.0119166			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25798584	Green Published, gold, Green Submitted			2022-12-27	WOS:000351987300033
J	Oikawa, N; Matsubara, T; Fukuda, R; Yasumori, H; Hatsuta, H; Murayama, S; Sato, T; Suzuki, A; Yanagisawa, K				Oikawa, Naoto; Matsubara, Teruhiko; Fukuda, Ryoto; Yasumori, Hanaki; Hatsuta, Hiroyuki; Murayama, Shigeo; Sato, Toshinori; Suzuki, Akemi; Yanagisawa, Katsuhiko			Imbalance in Fatty-Acid-Chain Length of Gangliosides Triggers Alzheimer Amyloid Deposition in the Precuneus	PLOS ONE			English	Article							GM1 GANGLIOSIDE; BETA-PROTEIN; BRAIN GANGLIOSIDES; NEURITIC TERMINALS; BASE COMPOSITION; DISEASE; DEMENTIA; DENSITY; SPHINGOLIPIDS; ACCUMULATION	Amyloid deposition, a crucial event of Alzheimer's disease (AD), emerges in distinct brain regions. A key question is what triggers the assembly of the monomeric amyloid beta-protein (A beta) into fibrils in the regions. On the basis of our previous findings that gangliosides facilitate the initiation of A beta assembly at presynaptic neuritic terminals, we investigated how lipids, including gangliosides, cholesterol and sphingomyelin, extracted from synaptic plasma membranes (SPMs) isolated from autopsy brains were involved in the A beta assembly. We focused on two regions of the cerebral cortex; precuneus and calcarine cortex, one of the most vulnerable and one of the most resistant regions to amyloid deposition, respectively. Here, we show that lipids extracted from SPMs isolated from the amyloid-bearing precuneus, but neither the amyloid-free precuneus nor the calcarine cortex, markedly accelerate the A beta assembly in vitro. Through liquid chromatography-mass spectrometry of the lipids, we identified an increase in the ratio of the level of GD1b-ganglioside containing C20:0 fatty acid to that containing C18:0 as a cause of the enhanced A beta assembly in the precuneus. Our results suggest that the local glycolipid environment play a critical role in the initiation of Alzheimer amyloid deposition.	[Oikawa, Naoto; Yanagisawa, Katsuhiko] Natl Ctr Geriatr & Gerontol, Ctr Dev Adv Med Dementia, Dept Drug Discovery, Obu, Aichi, Japan; [Matsubara, Teruhiko; Fukuda, Ryoto; Yasumori, Hanaki; Sato, Toshinori] Keio Univ, Dept Biosci & Informat, Fujisawa, Kanagawa, Japan; [Hatsuta, Hiroyuki; Murayama, Shigeo] Tokyo Metropolitan Inst Gerontol, Dept Neuropathol, Tokyo, Japan; [Suzuki, Akemi] Tokai Univ, Inst Glycosci, Hiratsuka, Kanagawa 25912, Japan; [Yanagisawa, Katsuhiko] Natl Ctr Geriatr & Gerontol, Ctr Dev Adv Med Dementia, Dept Alzheimers Dis Res, Obu, Aichi, Japan	National Center for Geriatrics & Gerontology; Keio University; Tokyo Metropolitan Institute of Gerontology; Tokai University; National Center for Geriatrics & Gerontology	Yanagisawa, K (corresponding author), Natl Ctr Geriatr & Gerontol, Ctr Dev Adv Med Dementia, Dept Drug Discovery, Obu, Aichi, Japan.	katuhiko@ncgg.go.jp		Sato, Toshinori/0000-0002-4429-6101	Research Funding of the Longevity Sciences from the National Center for Geriatrics and Gerontology [25-19]; Strategic Research Program for Brain Sciences by the Ministry of Education, Sports, Science and Technology of Japan; Grants-in-Aid for Scientific Research [23241075] Funding Source: KAKEN	Research Funding of the Longevity Sciences from the National Center for Geriatrics and Gerontology; Strategic Research Program for Brain Sciences by the Ministry of Education, Sports, Science and Technology of Japan; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by the Research Funding of the Longevity Sciences (25-19) from the National Center for Geriatrics and Gerontology and the Strategic Research Program for Brain Sciences by the Ministry of Education, Sports, Science and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi T, 2010, J NEUROPATH EXP NEUR, V69, P737, DOI 10.1097/NEN.0b013e3181e5ae5c; ANDO S, 1984, J NEUROSCI RES, V12, P205, DOI 10.1002/jnr.490120208; Ariga T, 2008, J LIPID RES, V49, P1157, DOI 10.1194/jlr.R800007-JLR200; Bernardo A, 2009, NEUROBIOL AGING, V30, P1777, DOI 10.1016/j.neurobiolaging.2007.12.022; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Cavanna AE, 2006, BRAIN, V129, P564, DOI 10.1093/brain/awl004; ChooSmith LP, 1997, J BIOL CHEM, V272, P22987, DOI 10.1074/jbc.272.37.22987; Cohen SIA, 2013, P NATL ACAD SCI USA, V110, P9758, DOI 10.1073/pnas.1218402110; CRINO PB, 1989, ARCH NEUROL-CHICAGO, V46, P398, DOI 10.1001/archneur.1989.00520400054019; de Chaves EP, 2010, FEBS LETT, V584, P1748, DOI 10.1016/j.febslet.2009.12.010; Esparza TJ, 2013, ANN NEUROL, V73, P104, DOI 10.1002/ana.23748; FOLCH J, 1957, J BIOL CHEM, V226, P497; Greenshields KN, 2009, J CLIN INVEST, V119, P595, DOI 10.1172/JCI37338; Greicius MD, 2004, P NATL ACAD SCI USA, V101, P4637, DOI 10.1073/pnas.0308627101; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hayashi H, 2004, J NEUROSCI, V24, P4894, DOI 10.1523/JNEUROSCI.0861-04.2004; Hong S, 2014, NEURON, V82, P308, DOI 10.1016/j.neuron.2014.02.027; HUGHES CP, 1982, BRIT J PSYCHIAT, V140, P566, DOI 10.1192/bjp.140.6.566; Iijima K, 2009, J COLLOID INTERF SCI, V337, P369, DOI 10.1016/j.jcis.2009.05.032; Ikeda K, 2010, RAPID COMMUN MASS SP, V24, P2957, DOI 10.1002/rcm.4716; Ikonomovic MD, 2011, NEUROLOGY, V77, P39, DOI 10.1212/WNL.0b013e3182231419; Kakio A, 2001, J BIOL CHEM, V276, P24985, DOI 10.1074/jbc.M100252200; Katsel P, 2007, NEUROCHEM RES, V32, P845, DOI 10.1007/s11064-007-9297-x; Kirkwood CM, 2013, J NEUROPATH EXP NEUR, V72, P791, DOI 10.1097/NEN.0b013e31829ecc89; Koffie RM, 2009, P NATL ACAD SCI USA, V106, P4012, DOI 10.1073/pnas.0811698106; KRACUN I, 1990, J HIRNFORSCH, V31, P789; KRACUN I, 1991, International Journal of Developmental Biology, V35, P289; KRACUN I, 1984, J NEUROCHEM, V43, P979, DOI 10.1111/j.1471-4159.1984.tb12833.x; MANSSON JE, 1978, J NEUROCHEM, V30, P273, DOI 10.1111/j.1471-4159.1978.tb07064.x; MASSERINI M, 1986, BIOCHEMISTRY-US, V25, P1043, DOI 10.1021/bi00353a014; MASSERINI M, 1989, BIOCHEMISTRY-US, V28, P5029, DOI 10.1021/bi00438a019; Matsubara T, 2013, LANGMUIR, V29, P2258, DOI 10.1021/la3038999; Matsuzaki K, 2010, BBA-MOL CELL BIOL L, V1801, P868, DOI 10.1016/j.bbalip.2010.01.008; Mauri L, 2012, GLYCOBIOLOGY, V22, P352, DOI 10.1093/glycob/cwr139; Mintun MA, 2006, NEUROLOGY, V67, P446, DOI 10.1212/01.wnl.0000228230.26044.a4; MIRRA SS, 1991, NEUROLOGY, V41, P479, DOI 10.1212/WNL.41.4.479; Moyano AL, 2012, GLYCOBIOLOGY, V22, P1768, DOI 10.1093/glycob/cws117; Mucke L, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006338; Nagafuku M, 2012, P NATL ACAD SCI USA, V109, pE336, DOI 10.1073/pnas.1114965109; Naiki H, 1999, METHOD ENZYMOL, V309, P305; Oikawa N, 2014, J NEUROSCI RES, V92, P641, DOI 10.1002/jnr.23341; Oikawa N, 2012, NEUROSCI LETT, V525, P49, DOI 10.1016/j.neulet.2012.07.027; Petkova AT, 2005, SCIENCE, V307, P262, DOI 10.1126/science.1105850; ROSENBERG A, 1966, J LIPID RES, V7, P122; ROUSER G, 1972, J NEUROCHEM, V19, P2697, DOI 10.1111/j.1471-4159.1972.tb01329.x; Sorg C, 2007, P NATL ACAD SCI USA, V104, P18760, DOI 10.1073/pnas.0708803104; Sperling RA, 2010, NEUROMOL MED, V12, P27, DOI 10.1007/s12017-009-8109-7; van Echten-Deckert G, 2012, PROG LIPID RES, V51, P378, DOI 10.1016/j.plipres.2012.07.001; Walter J, 2013, MOL NEURODEGENER, V8, DOI 10.1186/1750-1326-8-34; Yamamoto N, 2007, BBA-BIOMEMBRANES, V1768, P1128, DOI 10.1016/j.bbamem.2007.01.009; Yamamoto N, 2008, BBA-BIOMEMBRANES, V1778, P2717, DOI 10.1016/j.bbamem.2008.07.028; YANAGISAWA K, 1995, NAT MED, V1, P1062, DOI 10.1038/nm1095-1062; Yanagisawa K, 2007, BBA-BIOMEMBRANES, V1768, P1943, DOI 10.1016/j.bbamem.2007.01.018; Yuyama K, 2010, NEUROSCI LETT, V481, P168, DOI 10.1016/j.neulet.2010.06.080	54	27	28	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0121356	10.1371/journal.pone.0121356	http://dx.doi.org/10.1371/journal.pone.0121356			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25798597	Green Published, Green Submitted, gold			2022-12-27	WOS:000351987300243
J	Atzema, CL; Khan, S; Lu, H; Allard, YE; Russell, SJ; Gravelle, MR; Klein-Geltink, J; Austin, PC				Atzema, Clare L.; Khan, Saba; Lu, Hong; Allard, Yvon E.; Russell, Storm J.; Gravelle, Mario R.; Klein-Geltink, Julie; Austin, Peter C.			Cardiovascular Disease Rates, Outcomes, and Quality of Care in Ontario Metis: A Population-Based Cohort Study	PLOS ONE			English	Article							ATRIAL-FIBRILLATION; RISK; INDICATORS; DISCHARGE; CANADA	Background The burden of cardiovascular disease in the Metis, Canada's fastest growing Aboriginal group, is not well studied. We determined rates of five cardiovascular diseases and associated outcomes in Ontario Metis, compared to the general Ontario population. Methods Metis persons were identified using the Metis Nation of Ontario Citizenship Registry. Metis citizens aged 20-105 were linked to Ontario health databases for the period of April 2006 to March 2011. Age-and sex-standardized prevalence and incidence of acute coronary syndromes (ACS), congestive heart failure (CHF), cerebrovascular disease (stroke), atrial fibrillation, and hypertension were compared between the Metis and the general population. Secondary outcome measures included one-year hospitalizations and mortality following the incident cardiovascular diagnosis, as well as quality-of-care measures. Results There were 12,550 eligible Metis persons and 10,144,002 in the general population. The adjusted prevalence of each disease was higher (p< 0.05) among the Metis compared to the general population: ACS 5.3% vs. 3.0%; CHF 5.1% vs. 3.9%; stroke 1.4% vs. 1.1%; atrial fibrillation 2.1% vs. 1.4%; hypertension 34.9% vs. 29.8%. Incident ACS, stroke, and atrial fibrillation were also higher (p< 0.05) among the Metis: ACS 2.4% vs. 1.5%; stroke 0.8% vs. 0.6%; atrial fibrillation 0.6% vs. 0.3%. One-year all-cause and cardiovascular-related mortality were not significantly different. Hospitalizations were higher for Metis persons with CHF (OR 1.93; 95% CI 1.34-2.78) and hypertension (OR 2.27; 95% CI 1.88-2.74). Metis with CHF made more emergency department (ED) visits in the year after diagnosis compared to non-Metis with CHF, while Metis aged (3)65 with ACS were more likely to be on beta-blockers following diagnosis. Conclusions The burden of cardiovascular disease was markedly higher in the Metis compared to the general population: prevalence rates for five cardiovascular conditions were 25% to 77% higher. Metis persons with CHF had more frequent hospitalizations and ED visits following their diagnosis.	[Atzema, Clare L.; Khan, Saba; Lu, Hong; Klein-Geltink, Julie; Austin, Peter C.] Inst Clin Evaluat Sci, Toronto, ON, Canada; [Atzema, Clare L.] Sunnybrook Hlth Sci Ctr, Toronto, ON M4N 3M5, Canada; [Atzema, Clare L.] Univ Toronto, Toronto, ON, Canada; [Allard, Yvon E.; Russell, Storm J.; Gravelle, Mario R.] Metis Nation Ontario, Ottawa, ON, Canada	University of Toronto; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto	Atzema, CL (corresponding author), Inst Clin Evaluat Sci, Toronto, ON, Canada.	clare.atzema@ices.on.ca		Austin, Peter/0000-0003-3337-233X; Atzema, Clare/0000-0002-7236-5522	Public Health Agency of Canada; Department of Emergency Services at Sunnybrook Health Sciences; Department of Medicine, University of Toronto; Sunnybrook Research Institute; Heart and Stroke Foundation of Ontario	Public Health Agency of Canada; Department of Emergency Services at Sunnybrook Health Sciences; Department of Medicine, University of Toronto(University of Toronto); Sunnybrook Research Institute(University of Toronto); Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario)	The project was funded by a grant from the Public Health Agency of Canada. Dr. Atzema was supported by the Practice Plan of the Department of Emergency Services at Sunnybrook Health Sciences, the Department of Medicine, University of Toronto, and the Sunnybrook Research Institute. Dr. Austin was supported by a Career Investigator award from the Heart and Stroke Foundation of Ontario. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand SS, 2001, LANCET, V358, P1147, DOI 10.1016/S0140-6736(01)06255-9; Anderson JL, 2013, CIRCULATION, V127, P1916, DOI 10.1161/CIR.0b013e318290826d; Atzema CL, 2013, AM HEART J, V165, P939, DOI 10.1016/j.ahj.2013.02.026; Atzema CL, 2013, ANN EMERG MED, V61, P539, DOI 10.1016/j.annemergmed.2012.12.022; Austin PC, 2002, AM HEART J, V144, P290, DOI 10.1067/mhj.2002.123839; Canadian Institute for Health Information, 2013, HOSP CAR HEART ATT 1; Chan B., 2005, SUPPLY UTILIZATION G; Chobanian AV., 2003, HYPERTENSION, V42, P1206, DOI [10.1161/01.HYP.0000107251, DOI 10.1161/01.HYP.9.2_PT_2.II36, DOI 10.1161/01.HYP.0000107251.49515.C2]; Evans M, 2012, INT J CRIT INDIG STU, V5, P54, DOI DOI 10.5204/ijcis.v5i1.94; Findlay Leanne C, 2011, Health Rep, V22, P47; First Nations Education Steering Committee, 2008, 1 NAT IN MET PUBL DI; Iezonni LI, 1997, RISK ADJUSTMENT MEAS; Iron K, 2008, LIVING DYING ONTARIO; Kumar MB, 2012, CAN J PUBLIC HEALTH, V103, P23, DOI 10.1007/BF03404064; Lee D, 2003, PROF ENG, V16, P19; Lee DS, 2010, CIRCULATION, V122, P1806, DOI 10.1161/CIRCULATIONAHA.110.940262; Lindsay P, 2002, ACAD EMERG MED, V9, P1131, DOI 10.1197/aemj.9.11.1131; Martens P., 2010, PROFILE METIS HLTH S; Public Health Agency of Canada Canadian Institute for Health Information Canadian Stroke Network Heart and Stroke Foundation of Canada Statistics Canada, 2009, TRACK HEART DIS STRO; Ralph-Campbell K, 2009, INT J CIRCUMPOL HEAL, V68, P433; Reading C. L., 2009, HLTH INEQUALITIES SO; Roshanafshar, 2013, SELECT HLTH INDICATO; Shah BR, 2011, DIABETES CARE, V34, P2555, DOI 10.2337/dc11-0945; Statistics Canada, 2011, 10 LEAD CAUS DEATH; Statistics Canada, 2006, POST COD CONV FIL PC; Statistics Canada, 2013, AB PEOPL CAN 1 NAT P; Statistics Canada, 2010, AB STAT GLANC; Tjepkema Michael, 2011, Health Rep, V22, P25; Tran CTT, 2003, CAN J CARDIOL, V19, P38; Tu Karen, 2007, Open Med, V1, pe18; WOLF PA, 1991, STROKE, V22, P983, DOI 10.1161/01.STR.22.8.983; Young TK, 2012, HEART LUNG CIRC, V21, P618, DOI 10.1016/j.hlc.2012.05.009; Young TK, 2003, BMJ-BRIT MED J, V327, P419, DOI 10.1136/bmj.327.7412.419	33	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0121779	10.1371/journal.pone.0121779	http://dx.doi.org/10.1371/journal.pone.0121779			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25793978	Green Published, gold, Green Submitted			2022-12-27	WOS:000352083900153
J	Dai, Y; Wang, XT; Tang, JX; Zhao, S; Xing, YT; Dai, JR; Jin, XL; Zhu, YC				Dai, Yang; Wang, Xiaoting; Tang, Jianxia; Zhao, Song; Xing, Yuntian; Dai, Jianrong; Jin, Xiaolin; Zhu, Yinchang			Enhancement of Protective Efficacy through Adenoviral Vectored Vaccine Priming and Protein Boosting Strategy Encoding Triosephosphate Isomerase (SjTPI) against Schistosoma japonicum in Mice	PLOS ONE			English	Article							REPUBLIC-OF-CHINA; IMMUNE-RESPONSES; C57BL/6 MICE; IGG AVIDITY; INFECTION; SYSTEM; IMMUNOGENICITY; VACCINATIONS; IMMUNIZATION; PRAZIQUANTEL	Background Schistosomiasis japonica is a zoonotic parasitic disease; developing transmission blocking veterinary vaccines are urgently needed for the prevention and control of schistosomiasis in China. Heterologous prime-boost strategy, a novel vaccination approach, is more effective in enhancing vaccine efficacy against multiple pathogens. In the present study, we established a novel heterologous prime-boost vaccination strategy, the rAdV-SjTPI. opt intramuscular priming and rSjTPI subcutaneous boosting strategy, and evaluated its protective efficacy against Schistosoma japonicum in mice. Methodology/Principal Findings Adenoviral vectored vaccine (rAdV-SjTPI. opt) and recombinant protein vaccine (rSjTPI) were prepared and used in different combinations as vaccines in a mouse model. The specific immune responses and protective efficacies were evaluated. Furthermore, the longevity of protective efficacy was also determined. Results showed that the rAdV-SjTPI. opt priming-rSjTPI boosting strategy elicited higher levels of specific IgG responses and broad-spectrum specific cellular immune responses. The protective efficacy could reach up to nearly 70% and 50% of protection could be observed at 10 weeks after the last immunization in mice. Conclusions/Significance The rAdV-SjTPI. opt intramuscular priming-rSjTPI subcutaneous boosting vaccination strategy is a novel, highly efficient, and stable approach to developing vaccines against Schistosoma japonicum infections in China.	[Dai, Yang; Wang, Xiaoting; Tang, Jianxia; Zhao, Song; Xing, Yuntian; Dai, Jianrong; Jin, Xiaolin; Zhu, Yinchang] Minist Hlth, Key Lab Parasit Dis Control & Prevent, Wuxi, Jiangsu, Peoples R China; [Dai, Yang; Wang, Xiaoting; Tang, Jianxia; Zhao, Song; Xing, Yuntian; Dai, Jianrong; Jin, Xiaolin; Zhu, Yinchang] Jiangsu Inst Parasit Dis, Jiangsu Prov Key Lab Parasite Mol Biol, Wuxi, Jiangsu, Peoples R China; [Wang, Xiaoting] Soochow Univ, Coll Med, Inst Med Biotechnol, Jiangsu Stem Cell Key Lab, Suzhou, Jiangsu, Peoples R China	Soochow University - China	Dai, Y (corresponding author), Minist Hlth, Key Lab Parasit Dis Control & Prevent, Wuxi, Jiangsu, Peoples R China.	jipddy@hotmail.com	Wang, Xiaoting/AAI-3159-2020; Ibrahim, Essam Hassan/G-1960-2018	Ibrahim, Essam Hassan/0000-0003-0130-2257	National Natural Science Foundation of China [81000748, 81000749]; Jiangsu Provincial Nature Science Foundation [BK2010152]; Jiangsu Province's Outstanding Medical Academic Leader Program [LJ2011032]; Jiangsu Province's Key Medical Center Program [201108]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Provincial Nature Science Foundation; Jiangsu Province's Outstanding Medical Academic Leader Program; Jiangsu Province's Key Medical Center Program	This work was supported by the National Natural Science Foundation of China (Nos. 81000748 and 81000749), the Jiangsu Provincial Nature Science Foundation (BK2010152), Jiangsu Province's Outstanding Medical Academic Leader Program (LJ2011032) and Jiangsu Province's Key Medical Center Program (No. 201108). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alba Raul, 2012, Methods Mol Biol, V891, P55, DOI 10.1007/978-1-61779-873-3_4; [Anonymous], 2014, Wkly Epidemiol Rec, V89, P21; Betts G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050447; Bigaillon C, 2010, J VIROL METHODS, V164, P127, DOI 10.1016/j.jviromet.2009.11.028; Chen MG, 2005, ACTA TROP, V96, P168, DOI 10.1016/j.actatropica.2005.07.011; Chmielewska AM, 2014, J VIROL, V88, P5502, DOI 10.1128/JVI.03574-13; Colley DG, 2014, LANCET, V383, P2253, DOI 10.1016/S0140-6736(13)61949-2; Dai Y, 2014, VACCINE, V32, P771, DOI 10.1016/j.vaccine.2013.12.059; Dai Y, 2009, CLIN VACCINE IMMUNOL, V16, P1796, DOI 10.1128/CVI.00231-09; Deisseroth A, 2013, CANCER GENE THER, V20, P65, DOI 10.1038/cgt.2012.87; Fiorino F, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00128; Gray DJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005900; Gryseels B, 2012, INFECT DIS CLIN N AM, V26, P383, DOI 10.1016/j.idc.2012.03.004; Hewitson JP, 2005, PARASITE IMMUNOL, V27, P271, DOI 10.1111/j.1365-3024.2005.00764.x; Hong XC, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002122; Hu Y, 2007, EXP PARASITOL, V115, P379, DOI 10.1016/j.exppara.2006.09.022; Lawrence TM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067123; Li Shi-Zhu, 2013, Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi, V25, P557; Lin DD, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-103; Liu JM, 2013, VET PARASITOL, V198, P219, DOI 10.1016/j.vetpar.2013.08.020; Liu JM, 2004, PARASITE IMMUNOL, V26, P351, DOI 10.1111/j.0141-9838.2004.00720.x; Liu R, 2013, PARASITOL RES, V112, P1483, DOI 10.1007/s00436-013-3295-5; LIU SX, 1995, VACCINE, V13, P603, DOI 10.1016/0264-410X(94)00045-O; Lu S, 2009, CURR OPIN IMMUNOL, V21, P346, DOI 10.1016/j.coi.2009.05.016; Luo J, 2007, NAT PROTOC, V2, P1236, DOI 10.1038/nprot.2007.135; McWilliam HEG, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002460; Meng M, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-494; Pajuaba ACAM, 2010, CLIN VACCINE IMMUNOL, V17, P588, DOI 10.1128/CVI.00444-09; Radosevic K, 2009, EXPERT REV VACCINES, V8, P577, DOI 10.1586/ERV.09.14; Ranasinghe C, 2009, EXPERT REV VACCINES, V8, P1171, DOI 10.1586/ERV.09.86; Rentian F, 2000, CHINESE JOURNAL OF G, V19, P174; Saljoughian N, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002174; Seto EYW, 2011, AM J TROP MED HYG, V85, P74, DOI 10.4269/ajtmh.2011.10-0542; Teixeira LH, 2014, INFECT IMMUN, V82, P793, DOI 10.1128/IAI.01410-13; Tian F, 2011, PLOS ONE, V5; Trunova GV, 2011, B EXP BIOL MED+, V151, P99, DOI 10.1007/s10517-011-1268-1; Wang W, 2012, PARASITOL RES, V111, P1871, DOI 10.1007/s00436-012-3151-z; Wang YF, 2014, NORD J BOT, V32, P185, DOI 10.1111/j.1756-1051.2013.00200.x; Wen XY, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001399; Woodland DL, 2004, TRENDS IMMUNOL, V25, P98, DOI 10.1016/j.it.2003.11.009; Wu W, 2013, PARASITOL RES, V112, P909, DOI 10.1007/s00436-013-3303-9; Yang GJ, 2014, LANCET INFECT DIS, V14, P881, DOI 10.1016/S1473-3099(14)70727-3; Yu Chuanxin, 1999, Chinese Journal of Zoonoses, V15, P31; Zhu YC, 2004, VACCINE, V23, P78, DOI 10.1016/j.vaccine.2004.04.031; Zhu Yinchang, 2004, Southeast Asian Journal of Tropical Medicine and Public Health, V35, P518; Zhu YC, 2010, VACCINE, V28, P5347, DOI 10.1016/j.vaccine.2010.05.017; Zhu Yingchang, 2003, Southeast Asian Journal of Tropical Medicine and Public Health, V34, P697	47	10	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0120792	10.1371/journal.pone.0120792	http://dx.doi.org/10.1371/journal.pone.0120792			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25793406	Green Published, Green Submitted, gold			2022-12-27	WOS:000352083900076
J	Lambert, SL; Aslam, S; Stillman, E; MacPhail, M; Nelson, C; Ro, B; Sweetwood, R; Lei, YM; Woo, JC; Tang, RS				Lambert, Stacie L.; Aslam, Shahin; Stillman, Elizabeth; MacPhail, Mia; Nelson, Christine; Ro, Bodrey; Sweetwood, Rosemary; Lei, Yuk Man; Woo, Jennifer C.; Tang, Roderick S.			A Novel Respiratory Syncytial Virus (RSV) F Subunit Vaccine Adjuvanted with GLA-SE Elicits Robust Protective T(H)1-Type Humoral and Cellular Immunity In Rodent Models	PLOS ONE			English	Article							MONOPHOSPHORYL-LIPID-A; CD8(+) T-LYMPHOCYTES; RECEPTOR 4 AGONIST; FUSION PROTEIN; BALB/C MICE; PULMONARY EOSINOPHILIA; IN-VIVO; INFECTION; CELLS; RESPONSES	Background Illness associated with Respiratory Syncytial Virus (RSV) remains an unmet medical need in both full-term infants and older adults. The fusion glycoprotein (F) of RSV, which plays a key role in RSV infection and is a target of neutralizing antibodies, is an attractive vaccine target for inducing RSV-specific immunity. Methodology and Principal Findings BALB/c mice and cotton rats, two well-characterized rodent models of RSV infection, were used to evaluate the immunogenicity of intramuscularly administered RSV vaccine candidates consisting of purified soluble F (sF) protein formulated with TLR4 agonist glucopyranosyl lipid A (GLA), stable emulsion (SE), GLA-SE, or alum adjuvants. Protection from RSV challenge, serum RSV neutralizing responses, and anti-F IgG responses were induced by all of the tested adjuvanted RSV sF vaccine formulations. However, only RSV sF + GLA-SE induced robust F-specific T(H)1-biased humoral and cellular responses. In mice, these F-specific cellular responses include both CD4 and CD8 T cells, with F-specific polyfunctional CD8 T cells that traffic to the mouse lung following RSV challenge. This RSV sF + GLA- SE vaccine formulation can also induce robust RSV neutralizing titers and prime IFN gamma-producing T cell responses in Sprague Dawley rats. Conclusions/Significance These studies indicate that a protein subunit vaccine consisting of RSV sF + GLA-SE can induce robust neutralizing antibody and T cell responses to RSV, enhancing viral clearance via a T(H)1 immune-mediated mechanism. This vaccine may benefit older populations at risk for RSV disease.	[Lambert, Stacie L.; Aslam, Shahin; Stillman, Elizabeth; MacPhail, Mia; Nelson, Christine; Ro, Bodrey; Sweetwood, Rosemary; Lei, Yuk Man; Woo, Jennifer C.; Tang, Roderick S.] MedImmune, Dept Res, Mountain View, CA 94043 USA	AstraZeneca; Medimmune	Lambert, SL (corresponding author), MedImmune, Dept Res, Mountain View, CA 94043 USA.	lamberts@medimmune.com		Tang, Roderick/0000-0003-0018-4869	MedImmune	MedImmune(AstraZenecaMedimmune)	This work was fully funded by MedImmune, which employed all authors at the time this work was generated and reviewed and authorized the manuscript. The funder provided support in the form of salaries for all authors, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Anderson RC, 2010, COLLOID SURFACE B, V75, P123, DOI 10.1016/j.colsurfb.2009.08.022; Baldwin SL, 2009, VACCINE, V27, P5956, DOI 10.1016/j.vaccine.2009.07.081; Becker Y, 2006, VIRUS GENES, V33, P235, DOI 10.1007/s11262-006-0064-x; Behzad H, 2012, J INFECT DIS, V205, P466, DOI 10.1093/infdis/jir769; Bernstein DI, 2012, PEDIATR INFECT DIS J, V31, P109, DOI 10.1097/INF.0b013e31823386f1; Cherukuri A, 2013, CLIN VACCINE IMMUNOL, V20, P239, DOI 10.1128/CVI.00580-12; Cherukuri A, 2012, IMMUN AGEING, V9, DOI 10.1186/1742-4933-9-21; Coler RN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016333; Coler RN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013677; Cusi Maria Grazia, 2010, Immun Ageing, V7, P14, DOI 10.1186/1742-4933-7-14; Cyr SL, 2007, VACCINE, V25, P5378, DOI 10.1016/j.vaccine.2007.05.004; De Temmerman ML, 2011, DRUG DISCOV TODAY, V16, P569, DOI 10.1016/j.drudis.2011.04.006; Durand V, 2009, VACCINE, V27, P1912, DOI 10.1016/j.vaccine.2009.01.109; Falsey AR, 1996, VACCINE, V14, P1214, DOI 10.1016/S0264-410X(96)00030-8; Falsey AR, 1999, J MED VIROL, V59, P221, DOI 10.1002/(SICI)1096-9071(199910)59:2&lt;221::AID-JMV16&gt;3.0.CO;2-H; FINKELMAN FD, 1988, J IMMUNOL, V140, P1022; Fries L, 2013, ICAAC 2013 DEN; Garg R, 2014, J GEN VIROL, V95, P1043, DOI 10.1099/vir.0.062570-0; Garlapati S, VACCINE; GRAHAM BS, 1993, PEDIATR RES, V34, P167, DOI 10.1203/00006450-199308000-00013; HALL CB, 1991, J INFECT DIS, V163, P693, DOI 10.1093/infdis/163.4.693; Hammarlund E, 2003, NAT MED, V9, P1131, DOI 10.1038/nm917; Hancock GE, 2001, VACCINE, V19, P4874, DOI 10.1016/S0264-410X(01)00228-6; Huang K, 2010, VIRUS GENES, V40, P212, DOI 10.1007/s11262-010-0449-8; Hurwitz JL, 2011, EXPERT REV VACCINES, V10, P1415, DOI [10.1586/erv.11.120, 10.1586/ERV.11.120]; Hussell T, 1997, EUR J IMMUNOL, V27, P3341, DOI 10.1002/eji.1830271233; Johnson TR, 2008, J LEUKOCYTE BIOL, V84, P748, DOI 10.1189/jlb.0907621; Krilov LR, 2002, EXPERT OPIN BIOL TH, V2, P763, DOI 10.1517/14712598.2.7.763; Kumar R, 2008, EXPERT REV VACCINES, V7, P467, DOI 10.1586/14760584.7.4.467; Lambert SL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051618; Langley JM, 2009, VACCINE, V27, P5913, DOI 10.1016/j.vaccine.2009.07.038; Lasarte JJ, 2007, J IMMUNOL, V178, P748, DOI 10.4049/jimmunol.178.2.748; Lee FEH, 2004, ANTIVIR RES, V63, P191, DOI 10.1016/j.antiviral.2004.04.005; Lee S, 2014, J IMMUNOL, V192, P293, DOI 10.4049/jimmunol.1300453; Liu XM, 2007, KIDNEY INT, V71, P388, DOI 10.1038/sj.ki.5002030; Lumsden JM, 2011, INFECT IMMUN, V79, P3492, DOI 10.1128/IAI.05257-11; MacLeod MKL, 2011, P NATL ACAD SCI USA, V108, P7914, DOI 10.1073/pnas.1104588108; Magro M, 2012, P NATL ACAD SCI USA, V109, P3089, DOI 10.1073/pnas.1115941109; Maher CF, 2004, MICROBES INFECT, V6, P1049, DOI 10.1016/j.micinf.2004.07.001; Manicassamy S, 2009, SEMIN IMMUNOL, V21, P185, DOI 10.1016/j.smim.2009.05.005; Matthews SP, 2005, J VIROL, V79, P2050, DOI 10.1128/JVI.79.4.2050-2057.2005; Mbawuike IN, 1996, CELL IMMUNOL, V173, P64, DOI 10.1006/cimm.1996.0252; McLellan JS, 2011, J VIROL, V85, P7788, DOI 10.1128/JVI.00555-11; Mukherjee S, 2011, AM J PATHOL, V179, P248, DOI 10.1016/j.ajpath.2011.03.003; MUNOZ JL, 1991, J VIROL, V65, P4494; Neuzil KM, 1997, VACCINE, V15, P525, DOI 10.1016/S0264-410X(97)00218-1; Newcomb DC, 2013, THORAX, V68, P717, DOI 10.1136/thoraxjnl-2012-202404; Nimmerjahn F, 2007, ADV IMMUNOL, V96, P179, DOI 10.1016/S0065-2776(07)96005-8; Olson MR, 2008, EXPERT REV VACCINES, V7, P1239, DOI 10.1586/14760584.7.8.1239; Pasare C, 2005, ADV EXP MED BIOL, V560, P11; Power UF, 1997, VIROLOGY, V230, P155, DOI 10.1006/viro.1997.8465; PRINCE GA, 1985, VIRUS RES, V3, P193, DOI 10.1016/0168-1702(85)90045-0; Ramanathan S, 2008, ARCH IMMUNOL THER EX, V56, P311, DOI 10.1007/s00005-008-0033-2; Seder RA, 2008, NAT REV IMMUNOL, V8, P247, DOI 10.1038/nri2274; Srikiatkhachorn A, 1997, J EXP MED, V186, P421, DOI 10.1084/jem.186.3.421; Swanson KA, 2011, P NATL ACAD SCI USA, V108, P9619, DOI 10.1073/pnas.1106536108; Tang RS, 2004, J VIROL, V78, P11198, DOI 10.1128/JVI.78.20.11198-11207.2004; Walsh Edward E., 2012, Infectious Disorders - Drug Targets, V12, P98; Walsh EE, 2004, J INFECT DIS, V189, P233, DOI 10.1086/380907	59	46	48	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0119509	10.1371/journal.pone.0119509	http://dx.doi.org/10.1371/journal.pone.0119509			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25793508	Green Published, Green Submitted, gold			2022-12-27	WOS:000352084200088
J	Pantziaras, I; Fors, U; Ekblad, S				Pantziaras, Ioannis; Fors, Uno; Ekblad, Solvig			Innovative Training with Virtual Patients in Transcultural Psychiatry: The Impact on Resident Psychiatrists' Confidence	PLOS ONE			English	Article							PRIMARY-CARE; COMMUNICATION-SKILLS; COMPETENCE; DISORDER; PROGRAM; PTSD	Background Virtual patients are now widely accepted as efficient and safe training tools in medical education, but very little is known about their implementation in psychiatry, especially in transcultural clinical care of traumatized refugee patients. Objective This study aimed at assessing the impact of training with a virtual patient on confidence in providing clinical care for traumatized refugee patients. Methods The authors developed an educational tool based on virtual patient methodology portraying the case of "Mrs. K", a traumatized refugee woman with symptoms of PTSD and depression. A group (N=32) of resident psychiatrists tested the system and their confidence in different aspects of providing clinical care for this patient group was evaluated pre- and posttest by using a validated confidence questionnaire. Cronbach's a was calculated for all clusters. Changes between pre- and post-test were compared by using the matched-pair t-test, binomial distribution for exact significance test and a calculation of effect sizes (Cohen's d). Results A statistically significant improvement was exhibited in overall confidence (mean.: 0.34; p < 0.0001; d: 0.89) as well as in four more specific domains of clinical care, with the area of identifying and evaluating trauma-related diagnoses and disability showing the most prominent improvement (mean Delta: 0.47; p < 0.0001; d: 1.00). Conclusions This VP-system can lead to physicians' improvement of confidence in providing transcultural clinical care for traumatized refugee patients. Further research is required to investigate improvement in actual performance and cognitive outcomes with several VPs and in a long-term effect perspective.	[Pantziaras, Ioannis; Ekblad, Solvig] Karolinska Inst, Cultural Med Unit, Dept Learning Informat Management & Eth LIME, Stockholm, Sweden; [Fors, Uno] Stockholm Univ, Dept Comp & Syst Sci, S-10691 Stockholm, Sweden	Karolinska Institutet; Stockholm University	Pantziaras, I (corresponding author), Karolinska Inst, Cultural Med Unit, Dept Learning Informat Management & Eth LIME, Stockholm, Sweden.	ioannis.pantziaras@ki.se			PRIMA Barn och Vuxenpsykiatri AB; National Board of Health and Welfare	PRIMA Barn och Vuxenpsykiatri AB; National Board of Health and Welfare	All the funding of this study was by PRIMA Barn och Vuxenpsykiatri AB and the National Board of Health and Welfare (www.socialstyrelsen.se). Title of project: "Competence increase in Sodertalje" (diary number: 28629 Socialstyrelsen dnr 6.2.2-17928/2010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bender E, 2003, PSYCHIAT NEWS, V38, P6; Cohen J., 1998, STAT POWER ANAL BEHA; Coughlin S, 2012, POSTTRAUMATIC STRESS, P165; Davis DA, 2006, JAMA-J AM MED ASSOC, V296, P1094, DOI 10.1001/jama.296.9.1094; Ekblad S, 2013, TRANSCULT PSYCHIATRY, V50, P841, DOI 10.1177/1363461513511181; Ekblad S, 2013, BMC MED EDUC, V13, DOI 10.1186/1472-6920-13-110; Ellaway R, 2008, MED TEACH, V30, P170, DOI 10.1080/01421590701874074; Fernandez A, 2004, J GEN INTERN MED, V19, P167, DOI 10.1111/j.1525-1497.2004.30266.x; Fleetwood J, 2000, TEACH LEARN MED, V12, P96, DOI 10.1207/S15328015TLM1202_7; Fors UGH, 2009, MED TEACH, V31, P732, DOI 10.1080/01421590903124724; Foster AP, 2014, VET DERMATOL, V25, P1, DOI 10.1111/vde.12102; Gorrindo T, 2013, PSYCHIAT SERV, V64, P808, DOI 10.1176/appi.ps.201200461; Gorrindo T, 2011, ACAD PSYCHIATR, V35, P232, DOI 10.1176/appi.ap.35.4.232; Henderson DC, 2005, J NERV MENT DIS, V193, P551, DOI 10.1097/01.nmd.0000172869.01711.33; Hollander AC, 2013, J EPIDEMIOL COMMUN H, V67, P875, DOI 10.1136/jech-2013-202701; Kenny P, 2008, LECT NOTES COMPUT SC, V5208, P394; Kenny P, 2007, LECT NOTES ARTIF INT, V4722, P197; Lin CC, 2012, MED EDUC, V46, P1111, DOI 10.1111/medu.12020; McGee JB, 1997, STUDIES HLTH TECHNOL, V52, P732; Mollica RF, 1998, J NERV MENT DIS, V186, P543, DOI 10.1097/00005053-199809000-00005; Pantziaras I, 2014, J CONT MED ED, V2, P109; Pantziaras I, 2012, INT J MED EDUC, V3, P132, DOI 10.5116/ijme.5004.7c78; Parsons TD, 2008, STUD HEALTH TECHNOL, V132, P357; Raij AB, 2007, IEEE T VIS COMPUT GR, V13, P443, DOI 10.1109/TVCG.2007.1036; Rasmusson AM, 2010, EXP BIOL MED, V235, P1150, DOI 10.1258/ebm.2010.009334; ROBBINS JM, 1994, MED CARE, V32, P795, DOI 10.1097/00005650-199408000-00004; Saleh N., 2010, ANN BEHAV SCI MED ED, V16, P29; Santos J.R.A., 1999, J EXT, V37, P1; Shah H, 2012, ACAD PSYCHIATR, V36, P146, DOI 10.1176/appi.ap.10030049; Sledjeski EM, 2008, J BEHAV MED, V31, P341, DOI 10.1007/s10865-008-9158-3; Smith RC, 1998, ANN INTERN MED, V128, P118, DOI 10.7326/0003-4819-128-2-199801150-00008; Srinivasan M, 2006, ACAD PSYCHIATR, V30, P505, DOI 10.1176/appi.ap.30.6.505; Stevens A, 2006, AM J SURG, V191, P806, DOI 10.1016/j.amjsurg.2006.03.002; Swartout W, 2006, AI MAG, V27, P96; The Swedish Medical Association, 2006, STUD DIR CENTR PART; Triola M, 2006, J GEN INTERN MED, V21, P424, DOI 10.1111/j.1525-1497.2006.00421.x; Williams K, 2011, ACAD PSYCHIATR, V35, P328, DOI 10.1176/appi.ap.35.5.328; Yellowlees P, 2010, HARVARD REV PSYCHIAT, V18, P96, DOI 10.3109/10673221003683952	38	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0119754	10.1371/journal.pone.0119754	http://dx.doi.org/10.1371/journal.pone.0119754			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CE8IA	25794169	gold, Green Published, Green Submitted			2022-12-27	WOS:000352084200112
J	Salem, M; Paneru, B; Al-Tobasei, R; Abdouni, F; Thorgaard, GH; Rexroad, CE; Yao, JB				Salem, Mohamed; Paneru, Bam; Al-Tobasei, Rafet; Abdouni, Fatima; Thorgaard, Gary H.; Rexroad, Caird E.; Yao, Jianbo			Transcriptome Assembly, Gene Annotation and Tissue Gene Expression Atlas of the Rainbow Trout	PLOS ONE			English	Article							3 ABUNDANCE CLASSES; RNA-SEQ DATA; ONCORHYNCHUS-MYKISS; MESSENGER-RNA; GENOME DUPLICATION; ATLANTIC SALMON; INTEGRATED MAP; FISH GENOMES; SKIN MUCUS; GENERATION	Efforts to obtain a comprehensive genome sequence for rainbow trout are ongoing and will be complemented by transcriptome information that will enhance genome assembly and annotation. Previously, transcriptome reference sequences were reported using data from different sources. Although the previous work added a great wealth of sequences, a complete and well-annotated transcriptome is still needed. In addition, gene expression in different tissues was not completely addressed in the previous studies. In this study, non-normalized cDNA libraries were sequenced from 13 different tissues of a single doubled haploid rainbow trout from the same source used for the rainbow trout genome sequence. A total of similar to 1.167 billion paired-end reads were de novo assembled using the Trinity RNA-Seq assembler yielding 474,524 contigs > 500 base-pairs. Of them, 287,593 had homologies to the NCBI non-redundant protein database. The longest contig of each cluster was selected as a reference, yielding 44,990 representative contigs. A total of 4,146 contigs (9.2%), including 710 full-length sequences, did not match any mRNA sequences in the current rainbow trout genome reference. Mapping reads to the reference genome identified an additional 11,843 transcripts not annotated in the genome. A digital gene expression atlas revealed 7,678 housekeeping and 4,021 tissue-specific genes. Expression of about 16,000-32,000 genes (35-71% of the identified genes) accounted for basic and specialized functions of each tissue. White muscle and stomach had the least complex transcriptomes, with high percentages of their total mRNA contributed by a small number of genes. Brain, testis and intestine, in contrast, had complex transcriptomes, with a large numbers of genes involved in their expression patterns. This study provides comprehensive de novo transcriptome information that is suitable for functional and comparative genomics studies in rainbow trout, including annotation of the genome.	[Salem, Mohamed; Paneru, Bam; Al-Tobasei, Rafet; Abdouni, Fatima] Middle Tennessee State Univ, Dept Biol, Murfreesboro, TN 37132 USA; [Thorgaard, Gary H.] Washington State Univ, Sch Biol Sci, Pullman, WA 99164 USA; [Thorgaard, Gary H.] Washington State Univ, Ctr Reprod Biol, Pullman, WA 99164 USA; [Rexroad, Caird E.] USDA ARS, Natl Ctr Cool & Cold Water Aquaculture, Leetown, WV 25430 USA; [Yao, Jianbo] W Virginia Univ, Div Anim & Nutr Sci, Morgantown, WV 26506 USA	Middle Tennessee State University; Washington State University; Washington State University; United States Department of Agriculture (USDA); West Virginia University	Salem, M (corresponding author), Middle Tennessee State Univ, Dept Biol, Murfreesboro, TN 37132 USA.	Mohamed.salem@mtsu.edu	Salem, Mohamed/AGB-2739-2022	Salem, Mohamed/0000-0003-2142-6716; Paneru, Bam/0000-0001-6589-8446; Al-Tobasei, Rafet/0000-0002-0578-0734	United States Department of Agriculture, Agriculture and Food Research [58-1930-0-059]; United States Department of Agriculture, National Institute of Food and Agriculture [2014-67015-21602]	United States Department of Agriculture, Agriculture and Food Research; United States Department of Agriculture, National Institute of Food and Agriculture(United States Department of Agriculture (USDA))	Funding: This study was supported by a cooperative agreement grant No. 58-1930-0-059 from the United States Department of Agriculture, Agriculture and Food Research (JY); and a competitive grant No. 2014-67015-21602 from the United States Department of Agriculture, National Institute of Food and Agriculture (MS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali A, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00348; Alkan C, 2011, NAT METHODS, V8, P61, DOI 10.1038/NMETH.1527; ALLENDORF FW, 1984, TETRAPLOIDY EVOLUTIO, P1; Altschmied J, 2002, GENETICS, V161, P259; [Anonymous], 2014, MOL ECOL RESOUR; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; AXEL R, 1976, CELL, V7, P247, DOI 10.1016/0092-8674(76)90024-6; BAILEY GS, 1978, P NATL ACAD SCI USA, V75, P5575, DOI 10.1073/pnas.75.11.5575; Bamps Sophie, 2008, Briefings in Functional Genomics & Proteomics, V7, P175, DOI 10.1093/bfgp/eln013; Behenke RJ, 1992, AM FISHERIES SOC MON; Berthelot C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4657; BISHOP JO, 1974, NATURE, V250, P199, DOI 10.1038/250199a0; Butte AJ, 2001, PHYSIOL GENOMICS, V7, P95, DOI 10.1152/physiolgenomics.2001.7.2.95; Chan Esther T., 2009, Journal of Biology (London), V8, P33, DOI 10.1186/jbiol130; Chikina MD, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000417; Christensen KA, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-325; Conn PJJP, ANNUAL REVIEW OF PHA, V37, P205; Davidson WS, 2012, MOL ECOL, V21, P219, DOI 10.1111/j.1365-294X.2011.05387.x; Devisetty UK, 2014, G3-GENES GENOM GENET, V4, P2065, DOI 10.1534/g3.114.012526; Fowlkes CC, 2008, CELL, V133, P364, DOI 10.1016/j.cell.2008.01.053; Fox SE, 2014, MAR GENOM, V15, P13, DOI 10.1016/j.margen.2013.12.001; Genet C, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-314; Giaquinto PC, 2008, BIOL RES, V41, P33, DOI [10.4067/S0716-97602008000100005, /S0716-97602008000100005]; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Harris MA, 2008, NUCLEIC ACIDS RES, V36, pD440, DOI 10.1093/nar/gkm883; HASTIE ND, 1976, CELL, V9, P761, DOI 10.1016/0092-8674(76)90139-2; Henrich T, 2005, BIOINFORMATICS, V21, P3195, DOI 10.1093/bioinformatics/bti478; Hoegg S, 2004, J MOL EVOL, V59, P190, DOI 10.1007/s00239-004-2613-z; Iseli C, 1999, Proc Int Conf Intell Syst Mol Biol, P138; Ji PF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035152; Jongeneel CV, 2005, GENOME RES, V15, P1007, DOI 10.1101/gr.4041005; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Koop BF, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-545; Kudoh T, 2001, GENOME RES, V11, P1979, DOI 10.1101/gr.209601; Lamp K, 2001, CYTOGENET CELL GENET, V92, P116, DOI 10.1159/000056880; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lee AP, 2011, MOL BIOL EVOL, V28, P1205, DOI 10.1093/molbev/msq304; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Liu S, 2015, MAR BIOTECHNOL NY; Lottaz C, 2003, BIOINFORMATICS, V19, pII103, DOI 10.1093/bioinformatics/btg1067; Lu JG, 2010, MOL GENET GENOMICS, V283, P531, DOI 10.1007/s00438-010-0538-3; Marancik D, 2015, FRONT GENET, V5, DOI 10.3389/fgene.2014.00453; Martin JA, 2011, NAT REV GENET, V12, P671, DOI 10.1038/nrg3068; MCLAREN BA, 1947, FED PROC, V6, P413; Miller M, 2011, RAPID ACCURATE SEQUE; Miller M, 2013, RAINBOW TROUT GENOME; Min XJ, 2005, NUCLEIC ACIDS RES, V33, pW677, DOI 10.1093/nar/gki394; Modrek B, 2002, NAT GENET, V30, P13, DOI 10.1038/ng0102-13; Palti Y, 2004, ANIM GENET, V35, P130, DOI 10.1111/j.1365-2052.2004.01112.x; Palti Y, 2011, MAR BIOTECHNOL NY; Palti Y, 2013, SINGLE NUCL POLYM SN; Palti Y, 2011, GENERATION HIGH DENS; Palti Y, 2010, PRODUCTION DRAFT REF; Palti Y, 2014, MOL ECOL RESOUR, V14, P588, DOI 10.1111/1755-0998.12204; Palti Y, 2012, MAR BIOTECHNOL, V14, P343, DOI 10.1007/s10126-011-9418-z; Palti Y, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-180; Palti Y, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-462; Papanastasiou AD, 2007, MOL IMMUNOL, V44, P1300, DOI 10.1016/j.molimm.2006.05.014; Patel M, 2006, AQUAT TOXICOL, V80, P362, DOI 10.1016/j.aquatox.2006.09.012; Ramskold D, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000598; Ravi V, 2008, CURR OPIN GENET DEV, V18, P544, DOI 10.1016/j.gde.2008.11.001; Rexroad CE, 2003, CYTOGENET GENOME RES, V102, P347, DOI 10.1159/000075773; Robison BD, 1999, AQUACULTURE, V173, P131, DOI 10.1016/S0044-8486(98)00481-5; Ryynanen HJ, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-192; Salem M, 2008, J FISH BIOL, V72, P2187, DOI 10.1111/j.1095-8649.2008.01860.x; Salem M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036264; Salem M, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-564; Salgado LR, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-236; Sanchez CC, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-626; Sanchez CC, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-559; SCHEERER PD, 1991, J EXP ZOOL, V260, P382, DOI 10.1002/jez.1402600312; SCHEERER PD, 1986, AQUACULTURE, V57, P289, DOI 10.1016/0044-8486(86)90207-3; Shin SC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043762; Smith CT, 2005, MOL ECOL, V14, P4193, DOI 10.1111/j.1365-294X.2005.02731.x; Speare DJ, 1998, CONTEMP TOP LAB ANIM, V37, P55; Spooren WPJM, 2001, TRENDS PHARMACOL SCI, V22, P331, DOI 10.1016/S0165-6147(00)01694-1; Steinke D, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-20; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Suzuki Y, 2003, COMP BIOCHEM PHYS B, V136, P723, DOI 10.1016/S1096-4959(03)00178-7; Taylor JS, 2003, GENOME RES, V13, P382, DOI 10.1101/gr.640303; Tomancak P, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r145; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Tsutsui S, 2003, J BIOL CHEM, V278, P20882, DOI 10.1074/jbc.M301038200; Wang SL, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-1-r8; Watson J. D., 1987, MOL BIOL GENE; Welsh PG, 2008, ECOTOX ENVIRON SAFE, V69, P199, DOI 10.1016/j.ecoenv.2007.04.003; Williams DE, 2012, COMP BIOCHEM PHYS C, V155, P121, DOI 10.1016/j.cbpc.2011.05.013; Xiao SJ, 2010, BIOINFORMATICS, V26, P1273, DOI 10.1093/bioinformatics/btq109; Xing Y, 2006, NAT REV GENET, V7, P499, DOI 10.1038/nrg1896; Young WP, 1996, J HERED, V87, P77, DOI 10.1093/oxfordjournals.jhered.a022960; Yu WP, 2003, TRENDS GENET, V19, P180, DOI 10.1016/S0168-9525(03)00048-9; Zhang H, 2014, SCI REP-UK, V4, DOI 10.1038/srep06780; Zhao QY, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S14-S2	94	37	37	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0121778	10.1371/journal.pone.0121778	http://dx.doi.org/10.1371/journal.pone.0121778			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25793877	Green Published, gold, Green Submitted			2022-12-27	WOS:000352083900152
J	Tsikliras, AC; Dinouli, A; Tsiros, VZ; Tsalkou, E				Tsikliras, Athanassios C.; Dinouli, Anny; Tsiros, Vasileios-Zikos; Tsalkou, Eleni			The Mediterranean and Black Sea Fisheries at Risk from Overexploitation	PLOS ONE			English	Article							MARINE ECOSYSTEMS; GLOBAL FISHERIES; BIOMASS ACCUMULATION; FISH STOCKS; CATCH DATA; INDICATORS; STATE; SUSTAINABILITY; ABUNDANCE; DYNAMICS	The status of the Mediterranean and Black Sea fisheries was evaluated for the period 1970-2010 on a subarea basis, using various indicators including the temporal variability of total landings, the number of recorded stocks, the mean trophic level of the catch, the fishing-in-balance index and the catch-based method of stock classification. All indicators confirmed that the fisheries resources of the Mediterranean and Black Sea are at risk from overexploitation. The pattern of exploitation and the state of stocks differed among the western (W), central (C) and eastern (E) Mediterranean subareas and the Black Sea (BS), with the E Mediterranean and BS fisheries being in a worst shape. Indeed, in the E Mediterranean and the BS, total landings, mean trophic level of the catch and fishing-in-balance index were declining, the cumulative percentage of overexploited and collapsed stocks was higher, and the percentage of developing stocks was lower, compared to the W and C Mediterranean. Our results confirm the need for detailed and extensive stock assessments across species that will eventually lead to stocks recovering through conservation and management measures.	[Tsikliras, Athanassios C.; Dinouli, Anny; Tsiros, Vasileios-Zikos; Tsalkou, Eleni] Aristotle Univ Thessaloniki, Sch Biol, Dept Zool, Lab Ichthyol, GR-54006 Thessaloniki, Greece	Aristotle University of Thessaloniki	Tsikliras, AC (corresponding author), Aristotle Univ Thessaloniki, Sch Biol, Dept Zool, Lab Ichthyol, GR-54006 Thessaloniki, Greece.	atsik@bio.auth.gr	Tsikliras, Athanassios C./G-6548-2015	Tsikliras, Athanassios C./0000-0002-9074-3259				Alheit J, 2014, J MARINE SYST, V131, P21, DOI 10.1016/j.jmarsys.2013.11.002; [Anonymous], MEDITERRANEAN FISHER; Anticamara JA, 2011, FISH RES, V107, P131, DOI 10.1016/j.fishres.2010.10.016; Aquarone MC, 2008, REPORT STUDIES; Borja A, 2013, MAR POLLUT BULL, V76, P16, DOI 10.1016/j.marpolbul.2013.08.042; Carruthers TR, 2012, FISH RES, V119, P66, DOI 10.1016/j.fishres.2011.12.011; Coll M, 2008, ECOL MODEL, V217, P95, DOI 10.1016/j.ecolmodel.2008.06.013; Coll M, 2012, GLOBAL ECOL BIOGEOGR, V21, P465, DOI 10.1111/j.1466-8238.2011.00697.x; Coll M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011842; Colloca F, 2013, FISH FISH, V14, P89, DOI 10.1111/j.1467-2979.2011.00453.x; Cullis-Suzuki S, 2010, MAR POLICY, V34, P1036, DOI 10.1016/j.marpol.2010.03.002; Cury PM, 2005, ICES J MAR SCI, V62, P430, DOI 10.1016/j.icesjms.2004.12.006; Daskalov GM, 2002, MAR ECOL PROG SER, V225, P53, DOI 10.3354/meps225053; FAO, 2013, FISHSTAT J UNIV SOFT; FAO, 1997, REV STAT WORLD FISH; FAO (Food and Agriculture Organization of the United Nations), 2014, STAT WORLD FISH AQ; Fortibuoni T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015502; Froese R, 2013, MAR POLICY, V38, P548, DOI 10.1016/j.marpol.2012.07.001; Froese R, 2012, MAR BIOL, V159, P1283, DOI 10.1007/s00227-012-1909-6; Froese R, 2010, FISH FISH, V11, P194, DOI 10.1111/j.1467-2979.2009.00349.x; Froese R, 2009, MAR POLICY, V33, P180, DOI 10.1016/j.marpol.2008.03.009; GFCM, 2011, FAO FISH AQUACULT RE, V974, P1; GFCM, 2012, FAO FISH AQUACULT RE, V1001, P1; GFCM-SAC, 2012, REP WORK GROUP STOCK, P1; Harley SJ, 2001, CAN J FISH AQUAT SCI, V58, P1760, DOI 10.1139/cjfas-58-9-1760; Heileman S, 2008, UNEP LARGE MARINE EC, P203; Hilborn R, 2007, ECOSYSTEMS, V10, P1362, DOI 10.1007/s10021-007-9100-5; HUTCHINGS JA, 1994, CAN J FISH AQUAT SCI, V51, P2126, DOI 10.1139/f94-214; ICES, 2014, ICES CM 2014 ACOM, V50, P1; Kleisner K, 2014, MAR ECOL PROG SER, V512, P185, DOI 10.3354/meps10949; Kleisner K, 2013, FISH FISH, V14, P293, DOI 10.1111/j.1467-2979.2012.00469.x; Le Quesne W, 2013, DATA DEFICIENT FISHE, P7; Libralato S, 2014, MAR ECOL PROG SER, V512, P1, DOI 10.3354/meps11033; Lleonart J, 2003, SCI MAR, V67, P37, DOI 10.3989/scimar.2003.67s137; Lotze HK, 2011, ECOSYSTEMS, V14, P198, DOI 10.1007/s10021-010-9404-8; Pauly D, 1998, SCIENCE, V279, P860, DOI 10.1126/science.279.5352.860; Pauly D, 2000, ICES J MAR SCI, V57, P697, DOI 10.1006/jmsc.2000.0726; Pauly D, 2008, J BIOL RES-THESSALON, V9, P3; Pauly D, 2013, NATURE, V494, P303, DOI 10.1038/494303a; Pennino MG, 2011, ANIM BIODIV CONSERV, V34, P123; Pilling GM, 2008, ADVANCES IN FISHERIES SCIENCE: 50 YEARS ON FROM BEVERTON AND HOLT, P280, DOI 10.1002/9781444302653.ch12; Pranovi F, 2014, MAR ECOL PROG SER, V512, P201, DOI 10.3354/meps10881; Pranovi F, 2012, MAR ECOL PROG SER, V459, P185, DOI 10.3354/meps09738; Rosenberg A. A., 2014, FAO FISH AQUAC CIRC, V1086; Shannon L, 2014, MAR ECOL PROG SER, V512, P115, DOI 10.3354/meps10821; Sherman K, 2010, SUSTAINABLE DEV WORL; Shiganova TA, 1998, FISH OCEANOGR, V7, P305, DOI 10.1046/j.1365-2419.1998.00080.x; Stergiou K, 2005, STATE HELLENIC MARIN, P326; Stergiou KI, 2011, MAR ECOL PROG SER, V441, P295, DOI 10.3354/meps09377; Sumaila UR, 2007, FISH RES, V88, P1, DOI 10.1016/j.fishres.2007.08.017; Thorson JT, 2013, CAN J FISH AQUAT SCI, V70, P1829, DOI 10.1139/cjfas-2013-0280; Tsikliras A. C., 2013, Ethics in Science and Environmental Politics (ESEP), V13, P23, DOI 10.3354/esep00133; Tsikliras AC, 2013, FISHERIES MANAG ECOL, V20, P34, DOI 10.1111/j.1365-2400.2012.00863.x; Tsikliras AC, 2015, FISH AQUAC J, V5; Tsikliras AC, 2013, ACTA ADRIAT, V54, P273; Van Beveren E, 2014, MAR BIOL, V161, P1809, DOI 10.1007/s00227-014-2463-1; Vasilakopoulos P, 2014, CURR BIOL, V24, P1643, DOI 10.1016/j.cub.2014.05.070; Watson R, 2001, NATURE, V414, P534, DOI 10.1038/35107050; Watson RA, 2013, FISH FISH, V14, P493, DOI 10.1111/j.1467-2979.2012.00483.x; Worm B, 2006, SCIENCE, V314, P787, DOI 10.1126/science.1132294; Zeller D, 2007, FISH CTR RES REP, V15, P1; Zeller D., 2008, FISHERIES TRADE DEV, P55; [No title captured]	63	89	90	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0121188	10.1371/journal.pone.0121188	http://dx.doi.org/10.1371/journal.pone.0121188			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25793975	Green Published, Green Submitted, gold			2022-12-27	WOS:000352083900108
J	van der Horst-Schrivers, ANA; Sluiter, WJ; Kobold, ACM; Wolffenbuttel, BHR; Plukker, JTM; Bisschop, PH; de Klerk, JM; Al Younis, I; Lips, P; Smit, JW; Brouwers, AH; Links, TP				van der Horst-Schrivers, Anouk N. A.; Sluiter, Wim J.; Kobold, Anneke C. Muller; Wolffenbuttel, Bruce H. R.; Plukker, John T. M.; Bisschop, Peter H.; de Klerk, John M.; Al Younis, Imad; Lips, Paul; Smit, Jan W.; Brouwers, Adrienne H.; Links, Thera P.			Recombinant TSH Stimulated Remnant Ablation Therapy in Thyroid Cancer: The Success Rate Depends on the Definition of Ablation Success-An Observational Study	PLOS ONE			English	Article							LOW-DOSE RADIOIODINE; QUALITY-OF-LIFE; RADIOACTIVE IODINE; HORMONE WITHDRAWAL; HUMAN THYROTROPIN; FOLLOW-UP; I-131; CARCINOMA; RHTSH; MANAGEMENT	Introduction Patients with differentiated thyroid cancer (DTC) are treated with (near)-total thyroidectomy followed by remnant ablation. Optimal radioiodine-131 (I-131) uptake is achieved by withholding thyroid hormone (THW), pretreatment with recombinant human Thyrotropin Stimulating Hormone (rhTSH) is an alternative. Six randomized trials have been published comparing THW and rhTSH, however comparison is difficult because an uniform definition of ablation success is lacking. Using a strict definition, we performed an observational study aiming to determine the efficacy of rhTSH as preparation for remnant ablation. Patients and Methods Adult DTC patients with, tumor stage T1b to T3, Nx, N0 and N1, M0 were included in a prospective multicenter observational study with a fully sequential design, using a stopping rule. All patients received remnant ablation with I-131 using rhTSH. Ablation success was defined as no visible uptake in the original thyroid bed on a rhTSH stimulated 150 MBq I-131 whole body scan (WBS) 9 months after remnant ablation, or no visible uptake in the original thyroid bed on a post therapeutic WBS when a second high dose was necessary. Results After interim analysis of the first 8 patients, the failure rate was estimated to be 69% (90% confidence interval (CI) 20-86%) and the inclusion of new patients had to be stopped. Final analysis resulted in an ablation success in 11 out of 17 patients (65%, 95% CI 38-86%). Conclusion According to this study, the efficacy of rhTSH in the preparation of I-131 ablation therapy is inferior, when using a strict definition of ablation success. The current lack of agreement as to the definition of successful remnant ablation, makes comparison between different ablation strategies difficult. Our results point to the need for an international consensus on the definition of ablation success, not only in routine patient's care but also for scientific reasons.	[van der Horst-Schrivers, Anouk N. A.; Sluiter, Wim J.; Wolffenbuttel, Bruce H. R.; Links, Thera P.] Univ Groningen, Univ Med Ctr Groningen, Dept Endocrinol, Groningen, Netherlands; [Kobold, Anneke C. Muller] Univ Groningen, Univ Med Ctr Groningen, Dept Lab Med, Groningen, Netherlands; [Plukker, John T. M.] Univ Groningen, Univ Med Ctr Groningen, Dept Surg, Groningen, Netherlands; [Bisschop, Peter H.] Univ Amsterdam, Acad Med Ctr, Dept Endocrinol, NL-1105 AZ Amsterdam, Netherlands; [de Klerk, John M.] Meander Med Ctr Amersfoort, Dept Nucl Med, Amersfoort, Netherlands; [Al Younis, Imad] Leiden Univ, Med Ctr, Dept Nucl Med & Mol Imaging, Leiden, Netherlands; [Lips, Paul] Vrije Univ Amsterdam Med Ctr, Dept Internal Med Endocrinol, Amsterdam, Netherlands; [Smit, Jan W.] Radboud Univ Nijmegen, Med Ctr, Dept Internal Med, NL-6525 ED Nijmegen, Netherlands; [Brouwers, Adrienne H.] Univ Groningen, Univ Med Ctr Groningen, Dept Nucl Med & Mol Imaging, Groningen, Netherlands	University of Groningen; University of Groningen; University of Groningen; University of Amsterdam; Academic Medical Center Amsterdam; Meander Medisch Centrum; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Radboud University Nijmegen; University of Groningen	Links, TP (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Endocrinol, Groningen, Netherlands.	t.p.links@umcg.nl	Smit, J.W.A./H-8091-2014; Muller Kobold, Anna/HHC-2189-2022	Smit, J.W.A./0000-0003-1052-9314; Brouwers, Adrienne/0000-0003-2698-1516; Wolffenbuttel, Bruce H.R./0000-0001-9262-6921	Genzyme Corporation	Genzyme Corporation(Sanofi-AventisGenzyme Corporation)	This work was supported by the Genzyme Corporation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aronson JK, 2005, BRIT J CLIN PHARMACO, V59, P491, DOI 10.1111/j.1365-2125.2005.02435.x; Association of Comprehensive Cancer Centres (ACCC), CANCER CLINICAL PRAC; Cailleux AF, 2000, J CLIN ENDOCR METAB, V85, P175, DOI 10.1210/jc.85.1.175; Chianelli M, 2009, EUR J ENDOCRINOL, V160, P431, DOI 10.1530/EJE-08-0669; Cooper DS, 2009, THYROID, V19, P1167, DOI 10.1089/thy.2009.0110; de Klerk JMH, 2000, NUCL MED COMMUN, V21, P529, DOI 10.1097/00006231-200006000-00005; Hackshaw A, 2007, J CLIN ENDOCR METAB, V92, P28, DOI 10.1210/jc.2006-1345; Hanscheid H, 2006, J NUCL MED, V47, P648; Haugen BR, 1999, J CLIN ENDOCR METAB, V84, P3877, DOI 10.1210/jc.84.11.3877; Haymart MR, 2013, J CLIN ENDOCR METAB, V98, P2001, DOI 10.1210/jc.2012-3355; HILL AB, 1965, P ROY SOC MED, V58, P295, DOI 10.1177/003591576505800503; Jonklaas J, 2006, THYROID, V16, P1229, DOI 10.1089/thy.2006.16.1229; Lee J, 2010, THYROID, V20, P173, DOI 10.1089/thy.2009.0187; Links TP, 2012, NAT REV ENDOCRINOL, V8, P514, DOI 10.1038/nrendo.2012.113; Luster M, 2008, EUR J NUCL MED MOL I, V35, P1941, DOI 10.1007/s00259-008-0883-1; Maenpaa HO, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001885; Mallick U, 2012, CLIN ONCOL-UK, V24, P159, DOI 10.1016/j.clon.2012.01.001; Mallick U, 2012, NEW ENGL J MED, V366, P1674, DOI 10.1056/NEJMoa1109589; MAZZAFERRI EL, 1994, AM J MED, V97, P418, DOI 10.1016/0002-9343(94)90321-2; Pacini F, 2006, J CLIN ENDOCR METAB, V91, P926, DOI 10.1210/jc.2005-1651; Pacini F, 2002, J CLIN ENDOCR METAB, V87, P1499, DOI 10.1210/jc.87.4.1499; Pacini F, 2002, J CLIN ENDOCR METAB, V87, P4063, DOI 10.1210/jc.2001-011918; Pacini F, 2006, EUR J ENDOCRINOL, V154, P787, DOI 10.1530/eje.1.02158; Phan HTT, 2008, EUR J ENDOCRINOL, V158, P77, DOI 10.1530/EJE-07-0399; Sacks W, 2010, THYROID, V20, P1235, DOI 10.1089/thy.2009.0455; Sawka AM, 2004, J CLIN ENDOCR METAB, V89, P3668, DOI 10.1210/jc.2003-031167; Schlumberger M, 2007, J CLIN ENDOCR METAB, V92, P2487, DOI 10.1210/jc.2006-0723; Schlumberger M, 2012, NEW ENGL J MED, V366, P1663, DOI 10.1056/NEJMoa1108586; Schvartz C, 2012, J CLIN ENDOCR METAB, V97, P1526, DOI 10.1210/jc.2011-2512; SWEENEY DC, 1995, ENDOCRIN METAB CLIN, V24, P803, DOI 10.1016/S0889-8529(18)30022-7; Taieb D, 2009, CLIN ENDOCRINOL, V71, P115, DOI 10.1111/j.1365-2265.2008.03424.x; Van der Zee AGJ, 2008, J CLIN ONCOL, V26, P884, DOI 10.1200/JCO.2007.14.0566; Verkooijen RBT, 2008, EUR J ENDOCRINOL, V159, P301, DOI 10.1530/EJE-08-0062; Westbury C, 2000, THYROID, V10, P171, DOI 10.1089/thy.2000.10.171; Zanotti-Fregonara P, 2010, EUR J NUCL MED MOL I, V37, P2264, DOI 10.1007/s00259-010-1608-9	35	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0120184	10.1371/journal.pone.0120184	http://dx.doi.org/10.1371/journal.pone.0120184			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25793762	Green Published, gold, Green Submitted			2022-12-27	WOS:000352084200154
J	Vu, TH; Le Lamer, AC; Lalli, C; Boustie, J; Samson, M; Devehat, FL; Le Seyec, J				Vu, Thi Huyen; Le Lamer, Anne-Cecile; Lalli, Claudia; Boustie, Joel; Samson, Michel; Devehat, Franoise Lohezic-Le; Le Seyec, Jacques			Depsides: Lichen Metabolites Active against Hepatitis C Virus	PLOS ONE			English	Article							IN-VITRO; ENTRY; REPLICATION; CONSTITUENTS; DERIVATIVES; INHIBITORS	A thorough phytochemical study of Stereocaulon evolutum was conducted, for the isolation of structurally related atranorin derivatives. Indeed, pilot experiments suggested that atranorin (1), the main metabolite of this lichen, would interfere with the lifecycle of hepatitis C virus (HCV). Eight compounds, including one reported for the first time (2), were isolated and characterized. Two analogs (5, 6) were also synthesized, to enlarge the panel of atra-norin-related structures. Most of these compounds were active against HCV, with a half-maximal inhibitory concentration of about 10 to 70 mu M, with depsides more potent than monoaromatic phenols. The most effective inhibitors (1, 5 and 6) were then added at different steps of the HCV lifecycle. Interestingly, atranorin (1), bearing an aldehyde function at C-3, inhibited only viral entry, whereas the synthetic compounds 5 and 6, bearing a hydroxymethyl and a methyl function, respectively, at C-3 interfered with viral replication.	[Vu, Thi Huyen; Le Lamer, Anne-Cecile; Lalli, Claudia; Boustie, Joel; Devehat, Franoise Lohezic-Le] CNRS, ISCR, UMR 6226, Rennes, France; [Vu, Thi Huyen; Le Lamer, Anne-Cecile; Lalli, Claudia; Boustie, Joel; Samson, Michel; Devehat, Franoise Lohezic-Le; Le Seyec, Jacques] Univ Rennes 1, Rennes, France; [Le Lamer, Anne-Cecile] Univ Toulouse 3, F-31062 Toulouse, France; [Samson, Michel; Le Seyec, Jacques] INSERM, IRSET, UMR 1085, Rennes, France; [Samson, Michel; Le Seyec, Jacques] Federat Rech BioSit Rennes, Rennes, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Universite de Rennes; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Institut National de la Sante et de la Recherche Medicale (Inserm)	Devehat, FL (corresponding author), CNRS, ISCR, UMR 6226, Rennes, France.	francoise.le-devehat@univ-rennes1.fr; jacques.leseyec@univ-rennes1.fr	Le Seyec, Jacques/GLU-3933-2022; Le Seyec, Jacques/J-5680-2015; Samson, Michel/F-8356-2013	Le Seyec, Jacques/0000-0002-1118-3311; 	Biology and Health Federative Research Structure of Rennes (Biosit) [UMS CNRS 3480 / US INSERM 018]; Comite Grand-Ouest de la Ligue contre le Cancer; "Institute National de la Sante Et de la Recherche Medicale" (INSERM); Universite de Rennes 1; "Centre National de Recherche Scientifique" (CNRS); Vietnamese Government (Ministry of Education and Training) [322]	Biology and Health Federative Research Structure of Rennes (Biosit); Comite Grand-Ouest de la Ligue contre le Cancer; "Institute National de la Sante Et de la Recherche Medicale" (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Universite de Rennes 1; "Centre National de Recherche Scientifique" (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Vietnamese Government (Ministry of Education and Training)	This research was supported by the Biology and Health Federative Research Structure of Rennes (Biosit, UMS CNRS 3480 / US INSERM 018), by the Comite Grand-Ouest de la Ligue contre le Cancer, by the "Institute National de la Sante Et de la Recherche Medicale" (INSERM), by the "Universite de Rennes 1" and by the "Centre National de Recherche Scientifique" (CNRS). THV. is supported by a scholarship from the Vietnamese Government (Project 322, Ministry of Education and Training). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, NAT MED, V20, P319, DOI 10.1038/nm.3538; Atalay F, 2011, TURK J CHEM, V35, P647, DOI 10.3906/kim-1008-847; Bhat R, 2014, BIOORG MED CHEM LETT, V24, P4162, DOI 10.1016/j.bmcl.2014.07.051; Bo L, 1990, ACT BOT YUNN, V12, P447; Boustie J, 2005, PLANT GENET RESOUR, V3, P273, DOI DOI 10.1079/PGR200572; Bugni TS, 2009, FITOTERAPIA, V80, P270, DOI 10.1016/j.fitote.2009.03.003; Bush CO, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065273; Calland N, 2012, VIRUSES-BASEL, V4, P2197, DOI 10.3390/v4102197; Calland N, 2012, HEPATOLOGY, V55, P720, DOI 10.1002/hep.24803; Chen L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107767; CULBERSON CF, 1978, EXP MYCOL, V2, P245, DOI 10.1016/S0147-5975(78)80018-8; deLemos AS, 2014, TRENDS MOL MED, V20, P315, DOI 10.1016/j.molmed.2014.02.002; ELIX JA, 1987, AUST J CHEM, V40, P1581, DOI 10.1071/CH9871581; Francoise LD, 2014, ADV BOT RES, V71, P467, DOI 10.1016/B978-0-12-408062-1.00016-0; GOLLAPUDI SR, 1994, J NAT PROD, V57, P934, DOI 10.1021/np50109a009; GONZALEZ AG, 1992, Z NATURFORSCH C, V47, P503; Hattori M, 2013, CAN CHEM T, V1, P116; Huneck S, 1996, IDENTIFICATION LICHE; Ingolfsdottir K, 1996, PHYTOMEDICINE, V2, P243, DOI 10.1016/S0944-7113(96)80049-3; Jiang B, 2001, FITOTERAPIA, V72, P832, DOI 10.1016/S0367-326X(01)00287-8; Jiang Bei, 2002, Acta Botanica Yunnanica, V24, P525; Kumar S, 1999, J NAT PROD, V62, P817, DOI 10.1021/np9803777; Lai DW, 2013, PLANTA MED, V79, P1440, DOI 10.1055/s-0033-1350711; Lindenbach BD, 2005, SCIENCE, V309, P623, DOI 10.1126/science.1114016; Lupberger J, 2011, NAT MED, V17, P589, DOI 10.1038/nm.2341; MATSUMOTO T, 1982, J AM OIL CHEM SOC, V59, P521, DOI 10.1007/BF02636314; Neyts J, 2006, ANTIVIR RES, V71, P363, DOI 10.1016/j.antiviral.2006.06.006; Parrot D, 2013, PHYTOCHEMISTRY, V89, P114, DOI 10.1016/j.phytochem.2013.02.002; Paulson MS, 2009, ANTIVIR RES, V83, P135, DOI 10.1016/j.antiviral.2009.04.003; PULGARIN C, 1985, HELV CHIM ACTA, V68, P1948, DOI 10.1002/hlca.19850680720; Shibata C, 2014, VIROLOGY, V462, P42, DOI 10.1016/j.virol.2014.05.024; Siqueira RS, 2010, Z NATURFORSCH C, V65, P551; Stocker-Worgotter E, 2008, NAT PROD REP, V25, P188, DOI 10.1039/b606983p; Trotard M, 2009, FASEB J, V23, P3780, DOI 10.1096/fj.09-131920; Tscherne DM, 2006, J VIROL, V80, P1734, DOI 10.1128/JVI.80.4.1734-1741.2006; Uprichard SL, 2015, GUT, V64, P690, DOI 10.1136/gutjnl-2014-308396; Zambare VP, 2012, PHARM BIOL, V50, P778, DOI 10.3109/13880209.2011.633089; Zhong J, 2005, P NATL ACAD SCI USA, V102, P9294, DOI 10.1073/pnas.0503596102; Zhong ZJ, 2013, EUR J MED CHEM, V69, P32, DOI 10.1016/j.ejmech.2013.07.053; Zofou D, 2012, PARASITOL RES, V110, P539, DOI 10.1007/s00436-011-2519-9	40	25	25	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0120405	10.1371/journal.pone.0120405	http://dx.doi.org/10.1371/journal.pone.0120405			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25793970	gold, Green Submitted, Green Published			2022-12-27	WOS:000352083900027
J	Weiterer, S; Uhle, F; Lichtenstern, C; Siegler, BH; Bhuju, S; Jarek, M; Bartkuhn, M; Weigand, MA				Weiterer, Sebastian; Uhle, Florian; Lichtenstern, Christoph; Siegler, Benedikt H.; Bhuju, Sabin; Jarek, Michael; Bartkuhn, Marek; Weigand, Markus A.			Sepsis Induces Specific Changes in Histone Modification Patterns in Human Monocytes	PLOS ONE			English	Article							GENE-EXPRESSION; IMMUNOSUPPRESSION; EPIDEMIOLOGY; INJURY	Background Sepsis is a global burden and the primary cause of death in intensive care units worldwide. The pathophysiological changes induced by the host's systemic inflammatory response to infection are not yet fully understood. During sepsis, the immune system is confronted with a variety of factors, which are integrated within the individual cells and result in changes of their basal state of responsiveness. Epigenetic mechanisms like histone modifications are known to participate in the control of immune reactions, but so far the situation during sepsis is unknown. Methods and Findings In a pilot approach, we performed combined chromatin immunoprecipitation followed by high-throughput sequencing to assess the genome-wide distribution of the chromatin modifications histone 3 lysine 4 and 27 trimethylation and lysine 9 acetylation in monocytes isolated from healthy donors (n = 4) and patients with sepsis (n = 2). Despite different underlying causes for sepsis, a comparison over promoter regions shows a high correlation between the patients for all chromatin marks. These findings hold true also when comparing patients to healthy controls. Despite the global similarity, differential analysis reveals a set of distinct promoters with significant enrichment or depletion of histone marks. Further analysis of overrepresented GO terms show an enrichment of genes involved in immune function. To the most prominent ones belong different members of the HLA family located within the MHC cluster together with the gene coding for the major regulator of this locus-CIITA. Conclusions We are able to show for the first time that sepsis in humans induces selective and precise changes of chromatin modifications in distinct promoter regions of immunologically relevant genes, shedding light on basal regulatory mechanisms that might be contributing to the functional changes occurring in monocytes.	[Weiterer, Sebastian; Uhle, Florian; Lichtenstern, Christoph; Siegler, Benedikt H.; Weigand, Markus A.] Univ Heidelberg Hosp, Dept Anaesthesiol, Heidelberg, Germany; [Weiterer, Sebastian; Weigand, Markus A.] German Ctr Infect Res DZIF, Giessen, Germany; [Bhuju, Sabin; Jarek, Michael] Helmholtz Ctr Infect Res, Genome Analyt, Braunschweig, Germany; [Bartkuhn, Marek] Univ Giessen, Inst Genet, D-35390 Giessen, Germany	Ruprecht Karls University Heidelberg; German Center for Infection Research; Helmholtz Association; Helmholtz-Center for Infection Research; Justus Liebig University Giessen	Weiterer, S (corresponding author), Univ Heidelberg Hosp, Dept Anaesthesiol, Heidelberg, Germany.	Sebastian.Weiterer@med.uni-Heidelberg.de	Uhle, Florian/Q-6191-2019	Bartkuhn, Marek/0000-0001-6872-9082	German Centre for Infection Research (DZIF); Deutsche Forschungsgemeinschaft; Ruprecht-Karls-Universitat Heidelberg	German Centre for Infection Research (DZIF); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Ruprecht-Karls-Universitat Heidelberg	Funding: This work was supported by the German Centre for Infection Research (DZIF). The authors acknowledge the financial support of the Deutsche Forschungsgemeinschaft and Ruprecht-Karls-Universitat Heidelberg within the funding program Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Aung HT, 2006, FASEB J, V20, P1315, DOI 10.1096/fj.05-5360com; Beck S, 1999, NATURE, V401, P921, DOI 10.1038/44853; Bo LL, 2011, CRIT CARE, V15, DOI 10.1186/cc10031; Bone RC, 1997, CHEST, V112, P235, DOI 10.1378/chest.112.1.235; Cajander S, 2013, CRIT CARE, V17, DOI 10.1186/cc13046; CHANG CH, 1995, J EXP MED, V181, P765, DOI 10.1084/jem.181.2.765; Chen XF, 2012, P NATL ACAD SCI USA, V109, pE2865, DOI 10.1073/pnas.1121131109; De Santa F, 2009, EMBO J, V28, P3341, DOI 10.1038/emboj.2009.271; Engel C, 2007, INTENS CARE MED, V33, P606, DOI 10.1007/s00134-006-0517-7; Hall MW, 2011, INTENS CARE MED, V37, P525, DOI 10.1007/s00134-010-2088-x; Hotchkiss RS, 2013, LANCET INFECT DIS, V13, P260, DOI 10.1016/S1473-3099(13)70001-X; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Ishii M, 2009, BLOOD, V114, P3244, DOI 10.1182/blood-2009-04-217620; Kent WJ, 2010, BIOINFORMATICS, V26, P2204, DOI 10.1093/bioinformatics/btq351; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lyn-Kew K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011145; Majumder P, 2008, J EXP MED, V205, P785, DOI 10.1084/jem.20071843; Meisel C, 2009, AM J RESP CRIT CARE, V180, P640, DOI 10.1164/rccm.200903-0363OC; Monneret G, 2008, MOL MED, V14, P64, DOI 10.2119/2007-00102.Monneret; Moreno CS, 1999, IMMUNITY, V10, P143, DOI 10.1016/S1074-7613(00)80015-1; Natoli G, 2011, GENE DEV, V25, P101, DOI 10.1101/gad.2018811; Nicodeme E, 2010, NATURE, V468, P1119, DOI 10.1038/nature09589; Seok J, 2013, P NATL ACAD SCI USA, V110, P3507, DOI 10.1073/pnas.1222878110; Shi C, 2011, NAT REV IMMUNOL, V11, P762, DOI 10.1038/nri3070; Thompson CM, 2014, CRIT CARE MED, V42, P1397, DOI 10.1097/CCM.0000000000000218; Vincent JL, 2006, CRIT CARE MED, V34, P344, DOI 10.1097/01.CCM.0000194725.48928.3A; Weiterer S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094164; Zhang L, 2009, HEPATOL RES, V39, P931, DOI 10.1111/j.1872-034X.2009.00521.x	31	30	30	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0121748	10.1371/journal.pone.0121748	http://dx.doi.org/10.1371/journal.pone.0121748			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25793379	gold, Green Published, Green Submitted			2022-12-27	WOS:000352083900148
J	Goeser, L; Fan, TJ; Tchaptchet, S; Stasulli, N; Goldman, WE; Sartor, RB; Hansen, JJ				Goeser, Laura; Fan, Ting-Jia; Tchaptchet, Sandrine; Stasulli, Nikolas; Goldman, William E.; Sartor, R. Balfour; Hansen, Jonathan J.			Small Heat-Shock Proteins, IbpAB, Protect Non-Pathogenic Escherichia coli from Killing by Macrophage-Derived Reactive Oxygen Species	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; CROHNS-DISEASE; COMMENSAL BACTERIA; PHAGOCYTE OXIDASE; OXIDATIVE STRESS; ILEAL MUCOSA; ADHERENT; EXPRESSION; SECRETION; GENES	Many intracellular bacterial pathogens possess virulence factors that prevent detection and killing by macrophages. However, similar virulence factors in non-pathogenic bacteria are less well-characterized and may contribute to the pathogenesis of chronic inflammatory conditions such as Crohn's disease. We hypothesize that the small heat shock proteins IbpAB, which have previously been shown to reduce oxidative damage to proteins in vitro and be upregulated in luminal non-pathogenic Escherichia strain NC101 during experimental colitis in vivo, protect commensal E. coli from killing by macrophage-derived reactive oxygen species (ROS). Using real-time PCR, we measured ibpAB expression in commensal E. coli NC101 within wild-type (wt) and ROS-deficient (gp91phox(-/-)) macrophages and in NC101 treated with the ROS generator paraquat. We also quantified survival of NC101 and isogenic mutants in wt and gp91phox(-/-) macrophages using gentamicin protection assays. Similar assays were performed using a pathogenic E. coli strain O157:H7. We show that non-pathogenic E. coli NC101inside macrophages upregulate ibpAB within 2 hrs of phagocytosis in a ROS-dependent manner and that ibpAB protect E. coli from killing by macrophage-derived ROS. Moreover, we demonstrate that ROS-induced ibpAB expression is mediated by the small E. coli regulatory RNA, oxyS. IbpAB are not upregulated in pathogenic E. coli O157:H7 and do not affect its survival within macrophages. Together, these findings indicate that ibpAB may be novel virulence factors for certain non-pathogenic E. coli strains.	[Goeser, Laura; Fan, Ting-Jia; Tchaptchet, Sandrine; Sartor, R. Balfour; Hansen, Jonathan J.] Univ N Carolina, Ctr Gastrointestinal Biol & Dis, Chapel Hill, NC 27515 USA; [Goeser, Laura; Fan, Ting-Jia; Tchaptchet, Sandrine; Sartor, R. Balfour; Hansen, Jonathan J.] Univ N Carolina, Dept Med, Div Gastroenterol & Hepatol, Chapel Hill, NC USA; [Fan, Ting-Jia; Stasulli, Nikolas; Goldman, William E.; Sartor, R. Balfour; Hansen, Jonathan J.] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Hansen, JJ (corresponding author), Univ N Carolina, Ctr Gastrointestinal Biol & Dis, Chapel Hill, NC 27515 USA.	jjhansen@med.unc.edu		Stasulli, Nikolas/0000-0002-9419-2634; Goldman, William/0000-0002-1551-6718	National Institutes of Health [R01 DK53347, K08DK087896, R03 DK099419]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R03DK099419, K08DK087896, P30DK034987, R01DK053347] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010995] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Funding: This work was funded by grants from the National Institutes of Health, R01 DK53347 (R.B.S.), K08DK087896 (J.J.H.) and R03 DK099419 (J. J. H.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altuvia S, 1997, CELL, V90, P43, DOI 10.1016/S0092-8674(00)80312-8; Barnich N, 2007, J CLIN INVEST, V117, P1566, DOI 10.1172/JCI30504; Bissonnette SA, 2010, MOL MICROBIOL, V75, P1539, DOI 10.1111/j.1365-2958.2010.07070.x; Boisen N, 2008, INFECT IMMUN, V76, P3281, DOI 10.1128/IAI.01646-07; Bringer MA, 2006, CELL MICROBIOL, V8, P471, DOI 10.1111/j.1462-5822.2005.00639.x; Bringer MA, 2005, INFECT IMMUN, V73, P712, DOI 10.1128/IAI.73.2.712-721.2005; Brown DE, 2013, VET PATHOL, V50, P867, DOI 10.1177/0300985813478213; CHUANG SE, 1993, GENE, V134, P1, DOI 10.1016/0378-1119(93)90167-2; Darfeuille-Michaud A, 2004, GASTROENTEROLOGY, V127, P412, DOI 10.1053/j.gastro.2004.04.061; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Dubreuil JD, 2012, CURR ISSUES MOL BIOL, V14, P71; Etienne-Mesmin L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023594; Fang FC, 2004, NAT REV MICROBIOL, V2, P820, DOI 10.1038/nrmicro1004; Gaubig LC, 2011, MICROBIOL-SGM, V157, P66, DOI 10.1099/mic.0.043802-0; Hansen J, 2010, CURR OPIN GASTROEN, V26, P564, DOI 10.1097/MOG.0b013e32833f1195; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Keshavarzian A, 2003, GUT, V52, P720, DOI 10.1136/gut.52.5.720; KESHAVARZIAN A, 1992, GASTROENTEROLOGY, V103, P177, DOI 10.1016/0016-5085(92)91111-G; Kim SC, 2005, GASTROENTEROLOGY, V128, P891, DOI 10.1053/j.gastro.2005.02.009; Kitagawa M, 2000, FEMS MICROBIOL LETT, V184, P165, DOI 10.1111/j.1574-6968.2000.tb09009.x; Kitagawa M, 2002, EUR J BIOCHEM, V269, P2907, DOI 10.1046/j.1432-1033.2002.02958.x; Kuczynska-Wisnik D, 2002, MICROBIOL-SGM, V148, P1757, DOI 10.1099/00221287-148-6-1757; Kuczynska-Wisnik D, 2001, BIOCHEM BIOPH RES CO, V284, P57, DOI 10.1006/bbrc.2001.4926; Lee J, 2010, J APPL MICROBIOL, V108, P2088, DOI 10.1111/j.1365-2672.2009.04611.x; Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; Matuszewska E, 2008, MICROBIOL-SGM, V154, P1739, DOI 10.1099/mic.0.2007/014696-0; Patwa LG, 2011, GASTROENTEROLOGY, V141, P1842, DOI 10.1053/j.gastro.2011.06.064; Perez JFC, 2007, ARCH LATINOAM NUTR, V57, P211; Petruzziello-Pellegrini TN, 2013, VIRULENCE, V4, P556, DOI 10.4161/viru.26143; Poirier K, 2008, INFECT IMMUN, V76, P4814, DOI 10.1128/IAI.00446-08; Raymond B, 2013, TRENDS MICROBIOL, V21, P430, DOI 10.1016/j.tim.2013.06.008; Ruiz-Perez F, 2014, CELL MOL LIFE SCI, V71, P745, DOI 10.1007/s00018-013-1355-8; Shiloh MU, 1999, IMMUNITY, V10, P29, DOI 10.1016/S1074-7613(00)80004-7; Shimizu T, 2012, MOL MICROBIOL, V85, P492, DOI 10.1111/j.1365-2958.2012.08122.x; Smith AM, 2009, J EXP MED, V206, P1883, DOI 10.1084/jem.20091233; STANLEY ER, 1977, J BIOL CHEM, V252, P4305; Staudinger BJ, 2002, J CLIN INVEST, V110, P1151, DOI 10.1172/JCI200215268; Tjaden B, 2006, NUCLEIC ACIDS RES, V34, P2791, DOI 10.1093/nar/gkl356; VIDAL S, 1995, J EXP MED, V182, P655, DOI 10.1084/jem.182.3.655	39	10	11	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0120249	10.1371/journal.pone.0120249	http://dx.doi.org/10.1371/journal.pone.0120249			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25798870	Green Published, gold, Green Submitted			2022-12-27	WOS:000351987300114
J	Sidahmed, HMA; Hashim, NM; Abdulla, MA; Ali, HM; Mohan, S; Abdelwahab, SI; Taha, MME; Fai, LM; Vadivelu, J				Sidahmed, Heyam Mohamed Ali; Hashim, Najihah Mohd; Abdulla, Mahmood Ameen; Ali, Hapipah Mohd; Mohan, Syam; Abdelwahab, Siddig Ibrahim; Taha, Manal Mohamed Elhassan; Fai, Loke Mun; Vadivelu, Jamuna			Antisecretory, Gastroprotective, Antioxidant and Anti-Helicobcter Pylori Activity of Zerumbone from Zingiber Zerumbet (L.) Smith	PLOS ONE			English	Article							INDUCED GASTRIC-LESIONS; HELICOBACTER-PYLORI; LIPID-PEROXIDATION; MUCOSAL INJURY; ETHANOL; ULCER; EXTRACT; DISEASE; PLANT; CYTOPROTECTION	Background Zingiber zerumbet Smith is a perennial herb, broadly distributed in many tropical areas. In Malaysia, it's locally known among the Malay people as "lempoyang" and its rhizomes, particularly, is widely used in traditional medicine for the treatment of peptic ulcer disease beyond other gastric disorders. Aim of the study The aim of the current study is to evaluate the gastroprotective effect of zerumbone, the main bioactive compound of Zingiber zerumbet rhizome, against ethanol-induced gastric ulcer model in rats. Materials and Methods Rats were pre-treated with zerumbone and subsequently exposed to acute gastric ulcer induced by absolute ethanol administration. Following treatment, gastric juice acidity, ulcer index, mucus content, histological analysis (HE and PAS), immunohistochemical localization for HSP-70, prostaglandin E2 synthesis (PGE2), non-protein sulfhydryl gastric content (NP-SH), reduced glutathione level (GSH), and malondialdehyde level (MDA) were evaluated in ethanol-induced ulcer in vivo. Ferric reducing antioxidant power assay (FRAP) and anti-H. pylori activity were investigated in vitro. Results The results showed that the intragastric administration of zerumbone protected the gastric mucosa from the aggressive effect of ethanol-induced gastric ulcer, coincided with reduced submucosal edema and leukocyte infiltration. This observed gastroprotective effect of zerumbone was accompanied with a significant (p < 0.05) effect of the compound to restore the lowered NP-SH and GSH levels, and to reduce the elevated MDA level into the gastric homogenate. Moreover, the compound induced HSP-70 up-regulation into the gastric tissue. Furthermore, zerumbone significantly (p < 0.05) enhanced mucus production, showed intense PAS stain and maintained PG content near to the normal level. The compound exhibited antisecretory activity and an interesting minimum inhibitory concentration (MIC) against H. pylori strain. Conclusion The results of the present study revealed that zerumbone promotes ulcer protection, which might be attributed to the maintenance of mucus integrity, antioxidant activity, and HSP-70 induction. Zerumbone also exhibited antibacterial action against H. pylori.	[Sidahmed, Heyam Mohamed Ali; Hashim, Najihah Mohd] Univ Malaya, Dept Pharm, Fac Med, Kuala Lumpur, Malaysia; [Abdulla, Mahmood Ameen] Univ Malaya, Fac Med, Dept Biomed Sci, Kuala Lumpur, Malaysia; [Ali, Hapipah Mohd] Univ Malaya, Dept Chem, Fac Sci, Kuala, Lumpur, Malaysia; [Mohan, Syam; Abdelwahab, Siddig Ibrahim; Taha, Manal Mohamed Elhassan] Jazan Univ, Med Res Ctr, Jazan, Saudi Arabia; [Fai, Loke Mun; Vadivelu, Jamuna] Univ Malaya, Fac Med, Dept Med Microbiol, Kuala Lumpur, Malaysia	Universiti Malaya; Universiti Malaya; Universiti Malaya; Jazan University; Universiti Malaya	Sidahmed, HMA (corresponding author), Univ Malaya, Dept Pharm, Fac Med, Kuala Lumpur, Malaysia.	Diamondhm@hotmail.com	Abdelwahab, Siddig I/E-8929-2010; Mohan, Syam/A-1231-2011; Loke, Mun Fai/B-1060-2011; Hashim, Najihah Mohd/J-5508-2015; VADIVELU, JAMUNARANI S/B-8696-2010; TAHA, MANAL M/C-5968-2011	Abdelwahab, Siddig I/0000-0002-6145-4466; Loke, Mun Fai/0000-0002-3554-5313; Hashim, Najihah Mohd/0000-0003-1133-7998; VADIVELU, JAMUNARANI S/0000-0001-7322-3676; sidahmed, heyam/0000-0003-2466-6248; Taha, Manal/0000-0003-0166-8929	University of Malaya [PG151-2012B]; Ministry of Higher Education Malaysia under High Impact Research grant (UM-MOHE) [UM.C/625/1/HIR/MOHE/SC/09]	University of Malaya(Universiti Malaya); Ministry of Higher Education Malaysia under High Impact Research grant (UM-MOHE)	The authors would like to express their extreme thankfulness and gratefulness to University of Malaya (PG151-2012B) and the Ministry of Higher Education Malaysia under High Impact Research grant (UM-MOHE UM.C/625/1/HIR/MOHE/SC/09) for providing financial funds to perform this work. Also, the authors would like to express their utmost gratitude and appreciation to the late Prof. Datuk Dr. A. Hamid A. Hadi for his help and support throughout this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelwahab SI, 2013, J ETHNOPHARMACOL, V148, P277, DOI 10.1016/j.jep.2013.04.027; Abdelwahab SI, 2011, J ETHNOPHARMACOL, V137, P963, DOI 10.1016/j.jep.2011.07.010; Adibhatla RM, 2010, ANTIOXID REDOX SIGN, V12, P125, DOI [10.1089/ars.2009.2668, 10.1089/ARS.2009.2668]; Andreo MA, 2006, J ETHNOPHARMACOL, V107, P431, DOI 10.1016/j.jep.2006.04.001; Aruoma OI, 2010, TOXICOLOGY, V278, P6, DOI 10.1016/j.tox.2010.09.006; Atherton JC, 2006, ANNU REV PATHOL-MECH, V1, P63, DOI 10.1146/annurev.pathol.1.110304.100125; Behmer O.A., 1976, MANUAL TECNICAS HIST, V1st; Benzie IFF, 1996, ANAL BIOCHEM, V239, P70, DOI 10.1006/abio.1996.0292; Choi JI, 2010, CHEM-BIOL INTERACT, V183, P249, DOI 10.1016/j.cbi.2009.09.015; Collins TJ, 2007, BIOTECHNIQUES, V43, P25, DOI 10.2144/000112517; CROSS CE, 1984, LANCET, V1, P1328; DRAPER HH, 1990, METHOD ENZYMOL, V186, P421; Sanchez-Mendoza ME, 2010, FITOTERAPIA, V81, P66, DOI 10.1016/j.fitote.2009.07.009; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; Faridah QZ, 2011, AFR J BIOTECHNOL, V10, P9303; Palacios-Espinosa JF, 2014, J ETHNOPHARMACOL, V151, P990, DOI 10.1016/j.jep.2013.12.012; Goel R. K., 2002, Indian Journal of Pharmacology, V34, P100; Gomes RD, 2009, J ETHNOPHARMACOL, V121, P466, DOI 10.1016/j.jep.2008.11.013; Gourine N, 2010, IND CROP PROD, V31, P203, DOI 10.1016/j.indcrop.2009.10.003; Grotto D, 2009, QUIM NOVA, V32, P169, DOI 10.1590/S0100-40422009000100032; Guo JS, 2002, TOXICOL APPL PHARM, V183, P41, DOI 10.1006/taap.2002.9457; Hodges DM, 1999, PLANTA, V207, P604, DOI 10.1007/s004250050524; Ibrahim MY, 2010, AFR J BIOTECHNOL, V9, P4442; Jain KS, 2007, BIOORGAN MED CHEM, V15, P1181, DOI 10.1016/j.bmc.2006.07.068; Jainu M, 2006, CHEM-BIOL INTERACT, V161, P262, DOI 10.1016/j.cbi.2006.04.011; Jorgensen JH, 2007, CLIN INFECT DIS, V44, P280, DOI 10.1086/510431; Klopell FC, 2007, Z NATURFORSCH C, V62, P537; Konturek JW, 1998, AM J GASTROENTEROL, V93, P2385, DOI 10.1016/S0002-9270(98)00573-5; Kusters JG, 2006, CLIN MICROBIOL REV, V19, P449, DOI 10.1128/CMR.00054-05; La Casa C, 2000, J ETHNOPHARMACOL, V71, P45, DOI 10.1016/S0378-8741(99)00174-9; LAINE L, 1988, GASTROENTEROLOGY, V94, P1254, DOI 10.1016/0016-5085(88)90661-0; Laine L, 2008, GASTROENTEROLOGY, V135, P41, DOI 10.1053/j.gastro.2008.05.030; Lee JS, 2005, MUTAT RES-FUND MOL M, V579, P214, DOI 10.1016/j.mrfmmm.2005.03.027; LOGUERCIO C, 1993, GUT, V34, P161, DOI 10.1136/gut.34.2.161; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Malfertheiner P, 2009, LANCET, V374, P1449, DOI 10.1016/S0140-6736(09)60938-7; Mathew A, 1998, ANN NY ACAD SCI, V851, P99, DOI 10.1111/j.1749-6632.1998.tb08982.x; Mejia Alex, 2009, Expert Rev Clin Pharmacol, V2, P295, DOI 10.1586/ecp.09.8; Mizushima T, 2014, CURR OPIN PHARMACOL, V19, pR1, DOI 10.1016/j.coph.2014.10.006; Moraes TDM, 2008, J ETHNOPHARMACOL, V120, P161, DOI 10.1016/j.jep.2008.08.001; NASH J, 1994, DRUGS, V47, P862, DOI 10.2165/00003495-199447060-00002; Odashima M, 2002, DIGEST DIS SCI, V47, P2799, DOI 10.1023/A:1021029927386; Okabe S, 2005, BIOL PHARM BULL, V28, P1321, DOI 10.1248/bpb.28.1321; PIHAN G, 1986, GASTROENTEROLOGY, V91, P1415, DOI 10.1016/0016-5085(86)90195-2; Potrich FB, 2010, J ETHNOPHARMACOL, V130, P85, DOI 10.1016/j.jep.2010.04.014; Prakash R.O., 2011, INT J RES AYURVEDA P, V2, P1; ROBERT A, 1985, GASTROENTEROLOGY, V88, P328, DOI 10.1016/S0016-5085(85)80187-6; Rodrigues PD, 2010, J ETHNOPHARMACOL, V127, P725, DOI 10.1016/j.jep.2009.11.031; Romano M, 2008, J CLIN PATHOL, V61, P1112, DOI 10.1136/jcp.2008.060392; Santin JR, 2010, J ETHNOPHARMACOL, V130, P334, DOI 10.1016/j.jep.2010.05.014; Sasaki M, 2007, J CLIN BIOCHEM NUTR, V40, P1, DOI 10.3164/jcbn.40.1; SEDLAK J, 1968, ANAL BIOCHEM, V25, P192, DOI 10.1016/0003-2697(68)90092-4; Shakirin FH, 2010, J FOOD COMPOS ANAL, V23, P777, DOI 10.1016/j.jfca.2010.04.008; SHAY H, 1945, GASTROENTEROLOGY, V5, P43; Shine VJ, 2009, J ETHNOPHARMACOL, V125, P350, DOI 10.1016/j.jep.2009.04.039; Sidahmed HMA, 2013, PHYTOMEDICINE, V20, P834, DOI 10.1016/j.phymed.2013.03.002; Sidahmed HMA, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/450840; Sidahmed HMA, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-183; Sri Nurestri A. M., 2005, Malaysian Journal of Science, V24, P49; SZABO S, 1978, AM J PATHOL, V93, P273; SZABO S, 1985, GASTROENTEROLOGY, V88, P228, DOI 10.1016/S0016-5085(85)80176-1; Taha MME, 2012, J ETHNOPHARMACOL, V141, P273, DOI 10.1016/j.jep.2012.02.030; Tan PV, 2002, J ETHNOPHARMACOL, V82, P69, DOI 10.1016/S0378-8741(02)00142-3; Vimala S, 1999, BRIT J CANCER, V80, P110, DOI 10.1038/sj.bjc.6690329; Wahab A, 2009, J BIOMEDICINE BIOTEC, V2009; Whittle BJR, 2003, FUND CLIN PHARMACOL, V17, P301, DOI 10.1046/j.1472-8206.2003.00135.x; Wojdylo A, 2007, FOOD CHEM, V105, P940, DOI 10.1016/j.foodchem.2007.04.038; Yob N, 2011, EVIDENCE BASED COMPL, V2011	68	63	67	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0121060	10.1371/journal.pone.0121060	http://dx.doi.org/10.1371/journal.pone.0121060			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25798602	Green Published, gold, Green Submitted			2022-12-27	WOS:000351987300203
J	Wang, GX; van Driel, BJ; Liao, GX; O'Keeffe, MS; Halibozek, PJ; Flipse, J; Yigit, B; Azcutia, V; Luscinskas, FW; Wang, NH; Terhorst, C				Wang, Guoxing; van Driel, Boaz J.; Liao, Gongxian; O'Keeffe, Michael S.; Halibozek, Peter J.; Flipse, Jacky; Yigit, Burcu; Azcutia, Veronica; Luscinskas, Francis W.; Wang, Ninghai; Terhorst, Cox			Migration of Myeloid Cells during Inflammation Is Differentially Regulated by the Cell Surface Receptors Slamf1 and Slamf8	PLOS ONE			English	Article							SKIN DENDRITIC CELLS; NADPH OXIDASE; T-CELL; PROTEIN LIGAND; NOX2 ACTIVITY; CUTTING EDGE; FAMILY; ACTIVATION; EXPRESSION; RECRUITMENT	Previous studies have demonstrated that the cell surface receptor Slamf1 (CD150) is requisite for optimal NADPH-oxidase (Nox2) dependent reactive oxygen species (ROS) production by phagocytes in response to Gram-bacteria. By contrast, Slamf8 (CD353) is a negative regulator of ROS in response to Gram+ and Gram-bacteria. Employing in vivo migration after skin sensitization, induction of peritonitis, and repopulation of the small intestine demonstrates that in vivo migration of Slamf1(-/-) dendritic cells and macrophages is reduced, as compared to wt mice. By contrast, in vivo migration of Slamf8(-/-) dendritic cells, macrophages and neutrophils is accelerated. These opposing effects of Slamf1 and Slamf8 are cell-intrinsic as judged by in vitro migration in transwell chambers in response to CCL19, CCL21 or CSF-1. Importantly, inhibiting ROS production of Slamf8(-/-) macrophages by diphenyleneiodonium chloride blocks this in vitro migration. We conclude that Slamf1 and Slamf8 govern ROS-dependent innate immune responses of myeloid cells, thus modulating migration of these cells during inflammation in an opposing manner.	[Wang, Guoxing; van Driel, Boaz J.; Liao, Gongxian; O'Keeffe, Michael S.; Halibozek, Peter J.; Flipse, Jacky; Yigit, Burcu; Wang, Ninghai; Terhorst, Cox] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Med,Div Immunol, Boston, MA 02215 USA; [Azcutia, Veronica; Luscinskas, Francis W.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Pathol,Ctr Excellence Vasc Biol, Boston, MA 02115 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Terhorst, C (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Med,Div Immunol, Boston, MA 02215 USA.	cterhors@bidmc.harvard.edu	Azcutia, Veronica/AAW-2443-2020; Azcutia, Veronica/A-7704-2017	Azcutia, Veronica/0000-0003-2160-5175; Azcutia, Veronica/0000-0003-2160-5175; Flipse, Jacky/0000-0002-2195-5282; Luscinskas, Francis/0000-0001-7100-4103	National Institutes of Health [AI-015066]; Dutch Digestive Foundation [10-04S]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI015066, P01AI065687, R56AI015066] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dutch Digestive Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institutes of Health AI-015066 (nih.gov), and the Dutch Digestive Foundation #10-04S (mlds.nl) to Jacky Flipse. The funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acton SE, 2012, IMMUNITY, V37, P276, DOI 10.1016/j.immuni.2012.05.022; Anderson KE, 2008, BLOOD, V112, P5202, DOI 10.1182/blood-2008-04-149450; Azcutia V, 2013, MOL BIOL CELL, V24, P3358, DOI 10.1091/mbc.E13-01-0063; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Berger SB, 2010, NAT IMMUNOL, V11, P920, DOI 10.1038/ni.1931; Calpe S, 2008, ADV IMMUNOL, V97, P177, DOI 10.1016/S0065-2776(08)00004-7; Cannons JL, 2011, ANNU REV IMMUNOL, V29, P665, DOI 10.1146/annurev-immunol-030409-101302; Cao E, 2006, IMMUNITY, V25, P559, DOI 10.1016/j.immuni.2006.06.020; Chang SY, 2013, IMMUNITY, V38, P153, DOI 10.1016/j.immuni.2012.09.018; Chaubey S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054869; Comerford I, 2013, CYTOKINE GROWTH F R, V24, P269, DOI 10.1016/j.cytogfr.2013.03.001; Dong X, 2013, J CELL BIOCHEM, V114, P174, DOI 10.1002/jcb.24315; Hattori H, 2010, P NATL ACAD SCI USA, V107, P3546, DOI 10.1073/pnas.0914351107; Heng TSP, 2008, NAT IMMUNOL, V9, P1091, DOI 10.1038/ni1008-1091; Kim SY, 2010, IMMUNOL CELL BIOL, V88, P197, DOI 10.1038/icb.2009.87; Kingsbury GA, 2001, J IMMUNOL, V166, P5675, DOI 10.4049/jimmunol.166.9.5675; Lam GY, 2010, SEMIN IMMUNOPATHOL, V32, P415, DOI 10.1007/s00281-010-0221-0; Lelli A, 2013, GLIA, V61, P1542, DOI 10.1002/glia.22540; Li QA, 2006, MOL CELL BIOL, V26, P140, DOI 10.1128/MCB.26.1.140-154.2006; Liao GX, 2014, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00035; Liao GX, 2014, FASEB J, V28, P474, DOI 10.1096/fj.13-236505; Longman RS, 2014, J EXP MED, V211, P1571, DOI 10.1084/jem.20140678; Ma CY, 2012, J BIOL CHEM, V287, P18359, DOI 10.1074/jbc.M112.367060; Malhotra D, 2013, IMMUNOL REV, V251, P160, DOI 10.1111/imr.12023; Malhotra D, 2012, NAT IMMUNOL, V13, P499, DOI 10.1038/ni.2262; Meng TC, 2002, MOL CELL, V9, P387, DOI 10.1016/S1097-2765(02)00445-8; Niess JH, 2010, GUT MICROBES, V1, P396, DOI 10.4161/gmic.1.6.13939; Niess JH, 2005, SCIENCE, V307, P254, DOI 10.1126/science.1102901; Noubade R, 2014, NATURE, V509, P235, DOI 10.1038/nature13152; Oyoshi MK, 2010, J ALLERGY CLIN IMMUN, V126, P976, DOI 10.1016/j.jaci.2010.08.041; Pasham V, 2012, AM J PHYSIOL-CELL PH, V303, pC416, DOI 10.1152/ajpcell.00420.2011; Romero X, 2005, J IMMUNOL, V174, P7033, DOI 10.4049/jimmunol.174.11.7033; Saeki H, 1999, J IMMUNOL, V162, P2472; Schroder K, 2014, ANTIOXID REDOX SIGN, V20, P2043, DOI 10.1089/ars.2013.5633; Sobierajska K, 2014, J BIOL CHEM, V289, P5758, DOI 10.1074/jbc.M113.479477; Stoitzner P, 2010, METHODS MOL BIOL, V595, P235, DOI 10.1007/978-1-60761-421-0_16; van Driel B, 2012, GASTROENTEROLOGY, V143, P1544, DOI 10.1053/j.gastro.2012.08.042; Veillette A, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a002469; Wang GX, 2012, J IMMUNOL, V188, P5829, DOI 10.4049/jimmunol.1102620; WANG JM, 1988, J IMMUNOL, V141, P575; Wang N, 2001, IMMUNOGENETICS, V53, P382, DOI 10.1007/s002510100337; Wang NH, 2004, J EXP MED, V199, P1255, DOI 10.1084/jem.20031835; Wang Y, 2012, ANTIOXID REDOX SIGN, V16, P649, DOI 10.1089/ars.2011.4313	43	23	24	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0121968	10.1371/journal.pone.0121968	http://dx.doi.org/10.1371/journal.pone.0121968			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25799045	Green Published, Green Submitted, gold			2022-12-27	WOS:000351987300305
J	Fernandes, RK; Bachiega, TF; Rodrigues, DR; Golim, MD; Dias-Melicio, LA; Balderramas, HD; Kaneno, R; Soares, AMVC				Fernandes, Reginaldo K.; Bachiega, Tatiana F.; Rodrigues, Daniela R.; Golim, Marjorie de A.; Dias-Melicio, Luciane A.; Balderramas, Helanderson de A.; Kaneno, Ramon; Soares, Angela M. V. C.			Paracoccidioides brasiliensis Interferes on Dendritic Cells Maturation by Inhibiting PGE(2) Production	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; ANTIGEN-PRESENTING FUNCTION; REGULATORY T-CELLS; PROSTAGLANDIN E-2; IMMUNE-RESPONSES; HUMAN MONOCYTES; INTERLEUKIN-12 PRODUCTION; ADAPTIVE IMMUNITY; DOWN-REGULATION; RESISTANT MICE	Paracoccidioidomycosis (PCM) is a systemic mycosis, endemic in most Latin American countries, especially in Brazil, whose etiologic agent is the thermodimorphic fungus of the genus Paracoccidioides, comprising cryptic species of Paracoccidioides brasiliensis, S1, PS2, PS3 and Paracoccidioides lutzii. The mechanisms involved in the initial interaction of the fungus with cells of the innate immune response, as dendritic cells (DCs), deserve to be studied. Prostaglandins (PGs) are eicosanoids that play an important role in modulating functions of immune cells including DCs. Here we found that human immature DCs derived from the differentiation of monocytes cultured with GM-CSF and IL-4 release substantial concentrations of PGE2, which, however, were significantly inhibited after challenge with P. brasiliensis. In vitro blocking of pattern recognition receptors (PRRs) by monoclonal antibodies showed the involvement of mannose receptor (MR) in PGE2 inhibition by the fungus. In addition, phenotyping assays showed that after challenge with the fungus, DCs do not change their phenotype of immature cells to mature ones, as well as do not produce IL-12 p70 or adequate concentrations of TNF-alpha. Assays using exogenous PGE2 confirmed an association between PGE2 inhibition and failure of cells to phenotypically mature in response to P. brasiliensis. We conclude that a P. brasiliensis evasion mechanism exists associated to a dysregulation on DC maturation. These findings may provide novel information for the understanding of the complex interplay between the host and this fungus.	[Fernandes, Reginaldo K.; Bachiega, Tatiana F.; Rodrigues, Daniela R.; Balderramas, Helanderson de A.; Kaneno, Ramon; Soares, Angela M. V. C.] Sao Paulo State Univ, UNESP, Biosci Inst, Dept Microbiol & Immunol, Sao Paulo, Brazil; [Golim, Marjorie de A.] Sao Paulo State Univ, UNESP, Hemoctr, Flow Cytometry Lab, Sao Paulo, Brazil; [Dias-Melicio, Luciane A.] Sao Paulo State Univ, UNESP, Botucatu Med Sch, Dept Pathol, Sao Paulo, Brazil	Universidade Estadual Paulista; Universidade Estadual Paulista; Universidade Estadual Paulista	Fernandes, RK (corresponding author), Sao Paulo State Univ, UNESP, Biosci Inst, Dept Microbiol & Immunol, Sao Paulo, Brazil.	regiskeller@msn.com; acsoares@ibb.unesp.br	Dias-Melicio, Luciane A/I-5788-2014; Fernandes, Reginaldo Keller/H-3180-2017; Kaneno, Ramon/H-3088-2012	Dias-Melicio, Luciane A/0000-0001-9254-2074; Fernandes, Reginaldo Keller/0000-0001-7069-9628; Kaneno, Ramon/0000-0002-4292-3298; de Assis Golim, Marjorie/0000-0002-4824-9441	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	The work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP), http://www.fapesp.br/. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abendroth A, 2001, J VIROL, V75, P6183, DOI 10.1128/JVI.75.13.6183-6192.2001; Algood HMS, 2005, CLIN INFECT DIS, V41, pS189, DOI 10.1086/429994; Almeida SR, 2001, BRAZ J MED BIOL RES, V34, P529, DOI 10.1590/S0100-879X2001000400014; Anjos AR, 2002, MED MYCOL, V40, P377, DOI 10.1080/714031128; Aronoff DM, 2004, J IMMUNOL, V173, P559, DOI 10.4049/jimmunol.173.1.559; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; BANKHURST AD, 1982, J CLIN LAB IMMUNOL, V7, P85; Bansal K, 2010, J BIOL CHEM, V285, P36511, DOI 10.1074/jbc.M110.158055; Benard G, 2001, CYTOKINE, V13, P248, DOI 10.1006/cyto.2000.0824; Benard G, 2008, MYCOPATHOLOGIA, V165, P209, DOI 10.1007/s11046-007-9065-0; BETZ M, 1991, J IMMUNOL, V146, P108; Bordon AP, 2007, MICROBES INFECT, V9, P744, DOI 10.1016/j.micinf.2007.02.019; Bordon-Graciani AP, 2012, MED MYCOL, V50, P726, DOI 10.3109/13693786.2012.676740; BRUMMER E, 1993, CLIN MICROBIOL REV, V6, P89, DOI 10.1128/CMR.6.2.89-117.1993; Bueno SM, 2012, IMMUNOLOGY, V137, P28, DOI 10.1111/j.1365-2567.2012.03614.x; Calich Vera L. G., 1994, Ciencia e Cultura (Sao Paulo), V46, P455; Calich VLG, 1998, BRAZ J MED BIOL RES, V31, P615, DOI 10.1590/S0100-879X1998000500003; Calvi SA, 2003, MICROBES INFECT, V5, P107, DOI 10.1016/S1286-4579(02)00078-3; Cella M, 1997, CURR OPIN IMMUNOL, V9, P10, DOI 10.1016/S0952-7915(97)80153-7; Chu WM, 2013, CANCER LETT, V328, P222, DOI 10.1016/j.canlet.2012.10.014; de Almeida SR, 1998, CELL IMMUNOL, V190, P68, DOI 10.1006/cimm.1998.1388; de Castro LF, 2013, J INFECTION, V67, P470, DOI 10.1016/j.jinf.2013.07.019; Dias-Melicio LA, 2011, INFLAMM RES, V60, P167; Donini M, 2007, EUR J IMMUNOL, V37, P1194, DOI 10.1002/eji.200636532; Elgueta R, 2009, IMMUNOL REV, V229, P152, DOI 10.1111/j.1600-065X.2009.00782.x; Engelmayer J, 1999, J IMMUNOL, V163, P6762; Ferreira KS, 2007, J INFECT DIS, V196, P1108, DOI 10.1086/521369; Ferreira KS, 2004, IMMUNOL LETT, V94, P107, DOI 10.1016/j.imlet.2004.04.005; Fornazim MC, 2008, 33 C BRAZ SOC IMM, V1, P1; Calich VLG, 2008, MYCOPATHOLOGIA, V165, P223, DOI 10.1007/s11046-007-9048-1; Geijtenbeek TBH, 2009, NAT REV IMMUNOL, V9, P465, DOI 10.1038/nri2569; GOTO T, 1983, J IMMUNOL, V130, P1350; Hanekom WA, 2003, J INFECT DIS, V188, P257, DOI 10.1086/376451; Harizi H, 2005, TISSUE ANTIGENS, V65, P507, DOI 10.1111/j.1399-0039.2005.00394.x; Hart DNJ, 1997, BLOOD, V90, P3245, DOI 10.1182/blood.V90.9.3245; Hashimoto K, 2002, INFECT IMMUN, V70, P5167, DOI 10.1128/IAI.70.9.5167-5176.2002; Hedi H, 2004, CELL IMMUNOL, V228, P99, DOI 10.1016/j.cellimm.2004.04.003; Huston SM, 2013, J IMMUNOL, V191, P249, DOI 10.4049/jimmunol.1202707; Joshi PC, 2001, J IMMUNOL, V166, P885, DOI 10.4049/jimmunol.166.2.885; Kalinski P, 1998, J IMMUNOL, V161, P2804; Kalinski P, 1997, J IMMUNOL, V159, P28; Kalinski P, 2012, J IMMUNOL, V188, P21, DOI 10.4049/jimmunol.1101029; Kashino SS, 2000, J INTERF CYTOK RES, V20, P89, DOI 10.1089/107999000312766; Kolenko V, 1999, BLOOD, V93, P2308, DOI 10.1182/blood.V93.7.2308.407k16_2308_2318; KRAAN TCTMV, 1995, J EXP MED, V181, P775, DOI 10.1084/jem.181.2.775; Livonesi MC, 2008, MED MYCOL, V46, P637, DOI 10.1080/13693780801982762; Luft T, 2002, BLOOD, V100, P1362, DOI 10.1182/blood-2001-12-0360; Ma XJ, 2001, ADV IMMUNOL, V79, P55; Madan-Lala R, 2014, J IMMUNOL, V192, P4263, DOI 10.4049/jimmunol.1303185; Mamomi RL, 2005, CYTOKINE, V32, P20, DOI 10.1016/j.cyto.2005.07.006; Mamoni RL, 2002, MED MYCOL, V40, P153, DOI 10.1080/714031098; Matute DR, 2006, MOL BIOL EVOL, V23, P65, DOI 10.1093/molbev/msj008; MCEWEN JG, 1987, J MED VET MYCOL, V25, P165; O'Shea JJ, 2002, NAT IMMUNOL, V3, P506, DOI 10.1038/ni0602-506; Oliveira SJ, 2002, MICROBES INFECT, V4, P139, DOI 10.1016/S1286-4579(01)01521-0; Pina A, 2013, INFECT IMMUN, V81, P1064, DOI 10.1128/IAI.00736-12; Popi AF, 2002, CELL IMMUNOL, V218, P87, DOI 10.1016/S0008-8749(02)00576-2; Rieser C, 1997, J EXP MED, V186, P1603, DOI 10.1084/jem.186.9.1603; RINCON M, 1988, EUR J IMMUNOL, V18, P1791, DOI 10.1002/eji.1830181121; Ritter U, 2003, J LEUKOCYTE BIOL, V74, P216, DOI 10.1189/jlb.1202587; Salio M, 1999, EUR J IMMUNOL, V29, P3245, DOI 10.1002/(SICI)1521-4141(199910)29:10<3245::AID-IMMU3245>3.3.CO;2-O; San-Blas G, 1993, Arch Med Res, V24, P267; Sato PK, 2011, SCAND J IMMUNOL, V74, P609, DOI 10.1111/j.1365-3083.2011.02614.x; Scandella E, 2002, BLOOD, V100, P1354, DOI 10.1182/blood-2001-11-0017; Serezani CH, 2007, AM J RESP CELL MOL, V37, P562, DOI 10.1165/rcmb.2007-0153OC; Servet-Delprat C, 2000, J IMMUNOL, V164, P1753, DOI 10.4049/jimmunol.164.4.1753; Shikanai-Yasuda MA, 2006, REV SOC BRAS MED TRO, V39, P297, DOI 10.1590/S0037-86822006000300017; SILVA CL, 1994, MICROBIOL-SGM, V140, P1189, DOI 10.1099/13500872-140-5-1189; SMITH RJ, 1977, J PHARMACOL EXP THER, V200, P647; SNIJDEWINT FGM, 1993, J IMMUNOL, V150, P5321; Soares AMVC, 2001, IMMUNOLOGY, V102, P480, DOI 10.1046/j.1365-2567.2001.01179.x; STEINMAN RM, 1991, ANNU REV IMMUNOL, V9, P271, DOI 10.1146/annurev.iy.09.040191.001415; Tavares AH, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001459; Teixeira MM, 2009, MOL PHYLOGENET EVOL, V52, P273, DOI 10.1016/j.ympev.2009.04.005; Tercarioli GR, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-92; Trinath J, 2013, BLOOD, V122, P1419, DOI 10.1182/blood-2012-11-468264; Valera I, 2008, J IMMUNOL, V180, P5727, DOI 10.4049/jimmunol.180.8.5727; van Kooyk Y, 2008, BIOCHEM SOC T, V36, P1478, DOI 10.1042/BST0361478; Van Overtvelt L, 1999, INFECT IMMUN, V67, P4033, DOI 10.1128/IAI.67.8.4033-4040.1999; van Vliet SJ, 2008, IMMUNOL CELL BIOL, V86, P580, DOI 10.1038/icb.2008.55; van Vliet SJ, 2007, CURR OPIN IMMUNOL, V19, P435, DOI 10.1016/j.coi.2007.05.006; Vassiliou E, 2003, CELL IMMUNOL, V223, P120, DOI 10.1016/S0008-8749(03)00158-8; WALKER C, 1983, J IMMUNOL, V130, P1770; Walker W, 2004, IMMUNOLOGY, V111, P298, DOI 10.1111/j.1365-2567.2004.01810.x; Watts C, 2010, CURR OPIN IMMUNOL, V22, P124, DOI 10.1016/j.coi.2009.12.005; Wu CY, 1998, J IMMUNOL, V161, P2723; Zanoni I, 2010, J MOL MED, V88, P873, DOI 10.1007/s00109-010-0638-x; Zhou LJ, 1996, P NATL ACAD SCI USA, V93, P2588, DOI 10.1073/pnas.93.6.2588	88	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0120948	10.1371/journal.pone.0120948	http://dx.doi.org/10.1371/journal.pone.0120948			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25793979	Green Published, Green Submitted, gold			2022-12-27	WOS:000352083900090
J	Gomez-Anson, B; Roman, E; de Bobadilla, RF; Pires-Encuentra, P; Diaz-Manera, J; Nunez, F; Martinez-Horta, S; Vives-Gilabert, Y; Pagonabarraga, J; Kulisevsky, J; Cordoba, J; Guarner, C; Soriano, G				Gomez-Anson, Beatriz; Roman, Eva; Fernandez de Bobadilla, Ramon; Pires-Encuentra, Patricia; Diaz-Manera, Jordi; Nunez, Fidel; Martinez-Horta, Saul; Vives-Gilabert, Yolanda; Pagonabarraga, Javier; Kulisevsky, Jaume; Cordoba, Juan; Guarner, Carlos; Soriano, German			Alterations in Cerebral White Matter and Neuropsychology in Patients with Cirrhosis and Falls	PLOS ONE			English	Article							MINIMAL HEPATIC-ENCEPHALOPATHY; QUALITY-OF-LIFE; PARKINSONS-DISEASE; MAGNETIC-RESONANCE; RATING-SCALE; PERIPHERAL NEUROPATHY; CLINICAL-SIGNIFICANCE; OLDER-PEOPLE; BRAIN; RISK	Background & Aim Falls are frequent in patients with cirrhosis but underlying mechanisms are unknown. The aim was to determine the neuropsychological, neurological and brain alterations using magnetic resonance-diffusion tensor imaging (MR-DTI) in cirrhotic patients with falls. Patients and methods Twelve patients with cirrhosis and falls in the previous year were compared to 9 cirrhotic patients without falls. A comprehensive neuropsychological and neurological evaluation of variables that may predispose to falls included: the Mini-Mental State Examination, Psychometric Hepatic Encephalopathy Score (PHES), Parkinson's Disease-Cognitive Rating Scale, specific tests to explore various cognitive domains, Unified Parkinson's Disease Rating Scale to evaluate parkinsonism, scales for ataxia and muscular strength, and electro-neurography. High-field MR (3T) including DTI and structural sequences was performed in all patients. Results The main neuropsychological findings were impairment in PHES (p = 0.03), Parkinson's Disease-Cognitive Rating Scale (p = 0.04) and in executive (p<0.05) and visuospatial-visuoconstructive functions (p<0.05) in patients with falls compared to those without. There were no statistical differences between the two groups in the neurological evaluation or in the visual assessment of MRI. MR-DTI showed alterations in white matter integrity in patients with falls compared to those without falls (p<0.05), with local maxima in the superior longitudinal fasciculus and corticospinal tract. These alterations were independent of PHES as a covariate and correlated with executive dysfunction (p<0.05). Conclusions With the limitation of the small sample size, our results suggest that patients with cirrhosis and falls present alterations in brain white matter tracts related to executive dysfunction. These alterations are independent of PHES impairment.	[Gomez-Anson, Beatriz; Nunez, Fidel] Hosp Santa Creu & Sant Pau, Dept Radiol, Neuroradiol Unit, Barcelona, Spain; [Roman, Eva; Guarner, Carlos; Soriano, German] Hosp Santa Creu & Sant Pau, Dept Gastroenterol, Barcelona, Spain; [Fernandez de Bobadilla, Ramon; Martinez-Horta, Saul; Pagonabarraga, Javier; Kulisevsky, Jaume] Hosp Santa Creu & Sant Pau, Movement Disorders Unit, Dept Neurol, Barcelona, Spain; [Diaz-Manera, Jordi] Hosp Santa Creu & Sant Pau, Dept Neurol, Neuromuscular Disorders Unit, Barcelona, Spain; [Gomez-Anson, Beatriz; Roman, Eva; Fernandez de Bobadilla, Ramon; Martinez-Horta, Saul; Kulisevsky, Jaume; Guarner, Carlos; Soriano, German] Hosp Santa Creu & Sant Pau, Inst Recerca IIB St Pau, Barcelona, Spain; [Roman, Eva] Hosp Santa Creu & Sant Pau, Escola Univ Infermeria EUI St Pau, Barcelona, Spain; [Cordoba, Juan] Hosp Valle De Hebron, Dept Internal Med, Barcelona, Spain; [Vives-Gilabert, Yolanda] Univ Autonoma Barcelona, PIC, Bellaterra, Cerdanyola Del, Spain; [Vives-Gilabert, Yolanda] Univ Autonoma Barcelona, IFAE, Bellaterra, Cerdanyola Del, Spain; [Roman, Eva; Diaz-Manera, Jordi; Vives-Gilabert, Yolanda; Pagonabarraga, Javier; Kulisevsky, Jaume; Cordoba, Juan; Guarner, Carlos; Soriano, German] Univ Autonoma Barcelona, Bellaterra, Cerdanyola Del, Spain; [Roman, Eva; Cordoba, Juan; Guarner, Carlos; Soriano, German] CIBEREHD, Barcelona, Spain; [Diaz-Manera, Jordi] CIBERER, Valencia, Spain; [Pagonabarraga, Javier; Kulisevsky, Jaume] Ctr Invest Biomed Red Enfermedades Neurodegenerat, Madrid, Spain; [Pires-Encuentra, Patricia] CR, INNDACYT, Sant Feliu de Llobregat, Spain	Hospital of Santa Creu i Sant Pau; Hospital of Santa Creu i Sant Pau; Hospital of Santa Creu i Sant Pau; Hospital of Santa Creu i Sant Pau; Hospital of Santa Creu i Sant Pau; Hospital of Santa Creu i Sant Pau; Hospital Universitari Vall d'Hebron; Autonomous University of Barcelona; Autonomous University of Barcelona; Barcelona Institute of Science & Technology; Institute for High Energy Physics (IFAE); Autonomous University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; CIBERNED	Soriano, G (corresponding author), Hosp Santa Creu & Sant Pau, Dept Gastroenterol, Barcelona, Spain.	gsoriano@santpau.cat	martinez-horta, saul/ABA-4265-2020; Vives-Gilabert, Yolanda/ABB-7461-2021; Kulisevsky, Jaime/AEW-0433-2022; Roman, Eva/P-2377-2016	Kulisevsky, Jaime/0000-0003-4870-1431; Martinez-Horta, Saul/0000-0003-0125-7249; Fernandez-Bobadilla, Ramon/0000-0002-5045-732X; Diaz-Manera, Jordi/0000-0003-2941-7988; Guarner, Carlos/0000-0001-5957-9481; Vives-Gilabert, Yolanda/0000-0002-3744-5893; Soriano, German/0000-0002-9267-6811; Roman, Eva/0000-0001-9084-8555	Instituto de Salud Carlos III, Ministerio de Economia y Competitividad, Madrid, Spain [PI10/01028]; Instituto de Salud Carlos III, Ministerio de Economia y Competitividad, Madrid, Spain	Instituto de Salud Carlos III, Ministerio de Economia y Competitividad, Madrid, Spain; Instituto de Salud Carlos III, Ministerio de Economia y Competitividad, Madrid, Spain	JC was supported by Grant PI10/01028 from the Instituto de Salud Carlos III (www.isciii.es), Ministerio de Economia y Competitividad, Madrid, Spain. CIBEREHD and CIBERNED are supported by Instituto de Salud Carlos III, Ministerio de Economia y Competitividad, Madrid, Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander AL, 2007, NEUROTHERAPEUTICS, V4, P316, DOI 10.1016/j.nurt.2007.05.011; Alonso J, 2014, SEMIN ULTRASOUND CT, V35, P136, DOI 10.1053/j.sult.2013.09.008; Bajaj JS, 2009, HEPATOLOGY, V50, P2014, DOI 10.1002/hep.23216; Bajaj JS, 2009, HEPATOLOGY, V50, P1175, DOI 10.1002/hep.23128; Butterworth RF, 2012, NAT REV GASTRO HEPAT, V9, P197, DOI 10.1038/nrgastro.2012.22; Chavarria L, 2011, AM J NEURORADIOL, V32, P1510, DOI 10.3174/ajnr.A2533; Chen HJ, 2012, J NEUROL SCI, V321, P65, DOI 10.1016/j.jns.2012.07.056; Cohen SM, 2005, J ARTHROPLASTY, V20, P460, DOI 10.1016/j.arth.2004.05.004; Cordoba J, 2003, HEPATOLOGY, V38, P1026, DOI 10.1053/jhep.2003.50406; Cordoba J, 2003, J HEPATOL, V39, P231, DOI 10.1016/S0168-8278(03)00189-2; DeMott TK, 2007, AM J PHYS MED REHAB, V86, P125, DOI 10.1097/PHM.0b013e31802ee1d1; Dhiman RK, 2010, DIGEST DIS SCI, V55, P2381, DOI 10.1007/s10620-010-1249-7; Eggers C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046813; Fischer J.S., 2012, NEUROPSYCHOLOGICAL A, V5th; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Guevara M, 2011, J HEPATOL, V55, P564, DOI 10.1016/j.jhep.2010.12.008; Hoeft F, 2007, J NEUROSCI, V27, P11960, DOI 10.1523/JNEUROSCI.3591-07.2007; JOHN J, 1984, INT J REHABIL RES, V7, P173, DOI 10.1097/00004356-198406000-00005; Jover R, 2005, J HEPATOL, V42, P659, DOI 10.1016/j.jhep.2004.12.030; Kengne FG, 2008, QJM-INT J MED, V101, P583, DOI 10.1093/qjmed/hcn061; Martin K, 2009, DEMENT GERIATR COGN, V27, P451, DOI 10.1159/000216840; Matsusue E, 2005, AM J NEURORADIOL, V26, P347; Mellion M, 2011, MUSCLE NERVE, V43, P309, DOI 10.1002/mus.21946; Mirelman A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040297; Nagano-Saito A, 2004, NEUROIMAGE, V22, P553, DOI 10.1016/j.neuroimage.2004.01.030; Ortiz M, 2005, J HEPATOL, V42, pS45, DOI 10.1016/j.jhep.2004.11.028; Pagonabarraga J, 2008, MOVEMENT DISORD, V23, P998, DOI 10.1002/mds.22007; Peeters G, 2009, BEST PRACT RES CL RH, V23, P797, DOI 10.1016/j.berh.2009.09.004; Perez-Iglesias R, 2010, AM J PSYCHIAT, V167, P451, DOI 10.1176/appi.ajp.2009.09050716; Prosperini L, 2010, MULT SCLER J, V16, P491, DOI 10.1177/1352458509359923; Roman E, 2013, EUR J GASTROEN HEPAT, V25, P77, DOI 10.1097/MEG.0b013e3283589f49; Gomez MR, 2006, MED CLIN-BARCELONA, V127, P246, DOI 10.1157/13091264; Sasson E, 2012, BRAIN STRUCT FUNCT, V217, P503, DOI 10.1007/s00429-011-0344-7; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; Soriano G, 2012, HEPATOLOGY, V55, P1922, DOI 10.1002/hep.25554; Spahr L, 2000, GASTROENTEROLOGY, V119, P774, DOI 10.1053/gast.2000.17857; Srikanth V, 2009, STROKE, V40, P175, DOI 10.1161/STROKEAHA.108.524355; Stebbins GT, 1998, MOVEMENT DISORD, V13, P633, DOI 10.1002/mds.870130404; Trouillas P, 1997, J NEUROL SCI, V145, P205, DOI 10.1016/S0022-510X(96)00231-6; Tsai CF, 2013, J HEPATOL, V58, P706, DOI 10.1016/j.jhep.2012.12.001; Wymbs NF, 2012, NEURON, V74, P936, DOI 10.1016/j.neuron.2012.03.038; Yarnall A, 2011, MOVEMENT DISORD, V26, P2496, DOI 10.1002/mds.23932; Zhang JY, 2014, DIABETES, V63, P3596, DOI 10.2337/db14-0342; Zheng JJJ, 2012, J GERONTOL A-BIOL, V67, P1085, DOI 10.1093/gerona/gls063	46	10	10	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0118930	10.1371/journal.pone.0118930	http://dx.doi.org/10.1371/journal.pone.0118930			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25793766	Green Published, Green Submitted, gold			2022-12-27	WOS:000352084200046
J	Kim, JY; Shin, E; Kim, JW; Lee, HS; Lee, DW; Kim, SH; Lee, JO; Kim, YJ; Kim, JH; Bang, SM; Ahn, SH; Park, DJ; Lee, JS; Lee, JS; Kim, HH; Lee, KW				Kim, Ji-Yeon; Shin, Eun; Kim, Jin Won; Lee, Hye Seung; Lee, Dae-Won; Kim, Se-Hyun; Lee, Jeong-Ok; Kim, Yu Jung; Kim, Jee Hyun; Bang, Soo-Mee; Ahn, Sang-Hoon; Park, Do Joong; Lee, Jong Seok; Lee, Ju-Seog; Kim, Hyung-Ho; Lee, Keun-Wook			Impact of Intratumoral Expression Levels of Fluoropyrimidine-Metabolizing Enzymes on Treatment Outcomes of Adjuvant S-1 Therapy in Gastric Cancer	PLOS ONE			English	Article							MESSENGER-RNA LEVEL; DIHYDROPYRIMIDINE DEHYDROGENASE-ACTIVITY; THYMIDYLATE SYNTHASE; 5-FLUOROURACIL; CHEMOTHERAPY; CAPECITABINE; CHEMOSENSITIVITY; IMMUNOREACTIVITY; SENSITIVITY; DOCETAXEL	We analyzed the expression levels of fluoropyrimidine-metabolizing enzymes (thymidylate synthase [TS], dihydropyrimidine dehydrogenase [DPD], thymidine phosphorylase [TP] and orotate phosphoribosyltransferase [OPRT]) to identify potential biomarkers related to treatment outcomes in gastric cancer (GC) patients receiving adjuvant S-1 chemotherapy. In this study, 184 patients who received curative gastrectomy (D2 lymph node dissection) and adjuvant S-1 were included. Immunohistochemistry and quantitative reverse transcription polymerase chain reaction were performed to measure the protein and mRNA levels of TS, DPD, TP, and OPRT in tumor tissue. In univariate analysis, low intratumoral DPD protein expression was related to poorer 5-year disease-free survival (DFS; 78% vs. 88%; P = 0.068). Low intratumoral DPD mRNA expression (1st [lowest] quartile) was also related to poorer DFS (69% vs. 90%; P < 0.001) compared to high intratumoral DPD expression (2nd to 4th quartiles). In multivariate analyses, low intratumoral DPD protein or mRNA expression was related to worse DFS (P < 0.05), irrespective of other clinical variables. TS, TP, and OPRT expression levels were not related to treatment outcomes. Severe non-hematologic toxicities (grade >= 3) had a trend towards more frequent development in patients with low intratumoral DPD mRNA expression (29% vs. 16%; P = 0.068). In conclusion, GC patients with high intratumoral DPD expression did not have inferior outcome following adjuvant S-1 therapy compared with those with low DPD expression. Instead, low intratumoral DPD expression was related to poor DFS.	[Kim, Ji-Yeon; Kim, Jin Won; Lee, Dae-Won; Kim, Se-Hyun; Lee, Jeong-Ok; Kim, Yu Jung; Kim, Jee Hyun; Bang, Soo-Mee; Lee, Jong Seok; Lee, Keun-Wook] Seoul Natl Univ, Coll Med, Bundang Hosp, Dept Internal Med, Songnam, South Korea; [Shin, Eun; Lee, Hye Seung] Seoul Natl Univ, Coll Med, Bundang Hosp, Dept Pathol, Songnam, South Korea; [Ahn, Sang-Hoon; Park, Do Joong; Kim, Hyung-Ho] Seoul Natl Univ, Coll Med, Bundang Hosp, Dept Surg, Songnam, South Korea; [Lee, Ju-Seog] Univ Texas MD Anderson Canc Ctr, Dept Syst Biol, Houston, TX 77030 USA	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); University of Texas System; UTMD Anderson Cancer Center	Lee, KW (corresponding author), Seoul Natl Univ, Coll Med, Bundang Hosp, Dept Internal Med, Songnam, South Korea.	hmodoctor@snubh.org	Kim, Hyung-Ho/AAG-3720-2019; Kim, Hyung Ho/J-5451-2012; Lee, Hye Seung/G-6419-2011; Lee, Ju-Seog/X-1786-2018; SANG-HOON, AHN/AAV-2600-2020; LEE, Daewon/GWZ-8418-2022	Kim, Hyung-Ho/0000-0002-8916-0048; Lee, Hye Seung/0000-0002-1667-7986; Lee, Ju-Seog/0000-0002-5666-9753; SANG-HOON, AHN/0000-0001-8827-3625; 	Seoul National University Bundang Hospital [02-2014-019]; Jeil Pharmaceutical Company (Seoul, Korea)	Seoul National University Bundang Hospital; Jeil Pharmaceutical Company (Seoul, Korea)	This study was partially supported by research grants from the Seoul National University Bundang Hospital Research Fund (02-2014-019) and Jeil Pharmaceutical Company (Seoul, Korea). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bang YJ, 2012, LANCET, V379, P315, DOI 10.1016/S0140-6736(11)61873-4; BECK A, 1994, EUR J CANCER, V30A, P1517, DOI 10.1016/0959-8049(94)00216-R; Bertino EM, 2013, LUNG CANCER, V79, P27, DOI 10.1016/j.lungcan.2012.09.013; Choi IS, 2011, MED ONCOL, V28, P991, DOI 10.1007/s12032-010-9590-4; Cui YH, 2013, CANCER CHEMOTH PHARM, V71, P145, DOI 10.1007/s00280-012-1991-y; Ferlay J, 2012, GLOBOCAN 2012 ESTIMA; Fujiwara H, 2003, EUR J CANCER, V39, P2387, DOI 10.1016/S0959-8049(03)00513-6; Fujiwara H, 2002, JPN J CANCER RES, V93, P1342, DOI 10.1111/j.1349-7006.2002.tb01243.x; Fukuda H, 2006, CANCER INVEST, V24, P235, DOI 10.1080/07357900600632082; Ichikawa W, 2006, INT J CANCER, V119, P1927, DOI 10.1002/ijc.22080; Ide H, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-420; Ishikawa Y, 1999, CLIN CANCER RES, V5, P883; Ishikawa Y, 2000, JPN J CANCER RES, V91, P105, DOI 10.1111/j.1349-7006.2000.tb00866.x; Japanese Gastric Cancer Association, 1998, GASTRIC CANCER, V1, P10, DOI [DOI 10.1007/PL00011681, DOI 10.1007/S101209800016]]; Jeong JH, 2012, CANCER CHEMOTH PHARM, V70, P523, DOI 10.1007/s00280-012-1935-6; Kim J., 2014, J ELECT MAT, V2014, P1, DOI DOI 10.1167/14.7.1.[; Kim N, 2012, ANN ONCOL, V23, P2065, DOI 10.1093/annonc/mds106; Kim SJ, 2013, CANCER SCI, V104, P116, DOI 10.1111/cas.12044; Kim Yeul Hong, 2005, Cancer Res Treat, V37, P79, DOI 10.4143/crt.2005.37.2.79; Koizumi W, 2008, ANTI-CANCER DRUG, V19, P819, DOI 10.1097/CAD.0b013e3283094b5d; Kondo N, 2011, J SURG ONCOL, V104, P146, DOI 10.1002/jso.21955; Kuramochi H, 2008, CANCER CHEMOTH PHARM, V63, P85, DOI 10.1007/s00280-008-0714-x; Miyamoto S, 2000, INT J ONCOL, V17, P653; Oeda M, 2006, ONCOL REP, V16, P1165; Sasako M, 2014, GASTRIC CANC; Sasako M, 2011, J CLIN ONCOL, V29, P4387, DOI 10.1200/JCO.2011.36.5908; Shimizu T, 2005, ANTICANCER RES, V25, P2997; Shirasaka T, 1996, ANTI-CANCER DRUG, V7, P548, DOI 10.1097/00001813-199607000-00010; Takabayashi A, 2000, INT J ONCOL, V17, P889; Takiuchi Hiroya, 2007, Gastrointest Cancer Res, V1, P171; Terashima Masanori, 2003, Gastric Cancer, V6 Suppl 1, P71, DOI 10.1007/s10120-003-0221-z; Toriumi F, 2004, ANTICANCER RES, V24, P2455	32	7	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0120324	10.1371/journal.pone.0120324	http://dx.doi.org/10.1371/journal.pone.0120324			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25793299	Green Published, Green Submitted, gold			2022-12-27	WOS:000352083900012
J	Makai, S; Li, X; Hussain, J; Cui, CJ; Wang, YS; Chen, MJ; Yang, ZW; Ma, C; Guo, AY; Zhou, YH; Chang, JL; Yang, GX; He, GY				Makai, Szabolcs; Li, Xiao; Hussain, Javeed; Cui, Cuiju; Wang, Yuesheng; Chen, Mingjie; Yang, Zhaowan; Ma, Chuang; Guo, An-Yuan; Zhou, Yanhong; Chang, Junli; Yang, Guangxiao; He, Guangyuan			A Census of Nuclear Cyanobacterial Recruits in the Plant Kingdom	PLOS ONE			English	Article							GENE-TRANSFER; PROTEIN IMPORT; CHLOROPLAST DEVELOPMENT; GENOMES; EVOLUTION; MITOCHONDRIA; EUKARYOTES; ALIGNMENT; PLASTIDS; ORIGIN	The plastids and mitochondria of the eukaryotic cell are of endosymbiotic origin. These events occurred similar to 2 billion years ago and produced significant changes in the genomes of the host and the endosymbiont. Previous studies demonstrated that the invasion of land affected plastids and mitochondria differently and that the paths of mitochondrial integration differed between animals and plants. Other studies examined the reasons why a set of proteins remained encoded in the organelles and were not transferred to the nuclear genome. However, our understanding of the functional relations of the transferred genes is insufficient. In this paper, we report a high-throughput phylogenetic analysis to identify genes of cyanobacterial origin for plants of different levels of complexity: Arabidopsis thaliana, Chlamydomonas reinhardtii, Physcomitrella patens, Populus trichocarpa, Selaginella moellen-dorffii, Sorghum bicolor, Oryza sativa, and Ostreococcus tauri. Thus, a census of cyanobacterial gene recruits and a study of their function are presented to better understand the functional aspects of plastid symbiogenesis. From algae to angiosperms, the GO terms demonstrated a gradual expansion over functionally related genes in the nuclear genome, beginning with genes related to thylakoids and photosynthesis, followed by genes involved in metabolism, and finally with regulation-related genes, primarily in angiosperms. The results demonstrate that DNA is supplied to the nuclear genome on a permanent basis with no regard to function, and only what is needed is kept, which thereby expands on the GO space along the related genes.	[Makai, Szabolcs; Li, Xiao; Hussain, Javeed; Cui, Cuiju; Wang, Yuesheng; Chen, Mingjie; Chang, Junli; Yang, Guangxiao; He, Guangyuan] Huazhong Univ Sci & Technol, Genet Engn Int Cooperat Base Chinese Minist Sci &, Key Lab Mol Biophys, Chinese Minist Educ,Coll Life Sci & Technol, Wuhan 430074, Peoples R China; [Yang, Zhaowan; Ma, Chuang; Guo, An-Yuan; Zhou, Yanhong] Huazhong Univ Sci & Technol, Hubei Bioinformat & Mol Imaging Key Lab, Coll Life Sci & Technol, Wuhan 430074, Peoples R China; [Makai, Szabolcs] Hungarian Acad Sci, Bioinformat Lab, Appl Genom Dept, Agr Inst,Ctr Agr Res, H-2462 Martonvasar, Hungary	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Centre for Agricultural Research	Chang, JL (corresponding author), Huazhong Univ Sci & Technol, Genet Engn Int Cooperat Base Chinese Minist Sci &, Key Lab Mol Biophys, Chinese Minist Educ,Coll Life Sci & Technol, Wuhan 430074, Peoples R China.	cjl@hust.edu.cn; ygx@hust.edu.cn; hegy@hust.edu.cn			National Science and Technology Major Project of China [2013ZX08002004-007, 2014ZX08010004-004]; International Collaboration Project of the Chinese Ministry of Science and Technology; Innovative Foundation of Huazhong University of Science and Technology [2014QN124]	National Science and Technology Major Project of China; International Collaboration Project of the Chinese Ministry of Science and Technology; Innovative Foundation of Huazhong University of Science and Technology	This work was supported by the grants from the National Science and Technology Major Project of China (2013ZX08002004-007; 2014ZX08010004-004), the International Collaboration Project of the Chinese Ministry of Science and Technology, and the Innovative Foundation of Huazhong University of Science and Technology (2014QN124). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN JF, 1993, J THEOR BIOL, V165, P609, DOI 10.1006/jtbi.1993.1210; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Balzer M, 2005, INFOVIS 05: IEEE SYMPOSIUM ON INFORMATION VISUALIZATION, PROCEEDINGS, P49, DOI 10.1109/INFVIS.2005.1532128; Banks JA, 2011, SCIENCE, V332, P960, DOI 10.1126/science.1203810; Barbrook AC, 2006, TRENDS PLANT SCI, V11, P101, DOI 10.1016/j.tplants.2005.12.004; Bock R, 2008, BIOESSAYS, V30, P556, DOI 10.1002/bies.20761; Cavalier-Smith T, 2009, INT J BIOCHEM CELL B, V41, P307, DOI 10.1016/j.biocel.2008.10.002; Cavalier-Smith T, 2013, ANNU REV ECOL EVOL S, V44, P145, DOI 10.1146/annurev-ecolsys-110411-160320; Dacks JB, 2007, J CELL SCI, V120, P2977, DOI 10.1242/jcs.013250; Darling ACE, 2004, GENOME RES, V14, P1394, DOI 10.1101/gr.2289704; de la Cruz J, 2003, GENE, V321, P47, DOI 10.1016/S0378-1119(03)00831-X; Delcher AL, 2002, NUCLEIC ACIDS RES, V30, P2478, DOI 10.1093/nar/30.11.2478; Derelle E, 2006, P NATL ACAD SCI USA, V103, P11647, DOI 10.1073/pnas.0604795103; Deusch O, 2008, MOL BIOL EVOL, V25, P748, DOI 10.1093/molbev/msn022; Dolezal P, 2006, SCIENCE, V313, P314, DOI 10.1126/science.1127895; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Esseiva AC, 2004, J BIOL CHEM, V279, P42363, DOI 10.1074/jbc.M404519200; Gould SB, 2008, ANNU REV PLANT BIOL, V59, P491, DOI 10.1146/annurev.arplant.59.032607.092915; Green BR, 2011, PLANT J, V66, P34, DOI 10.1111/j.1365-313X.2011.04541.x; Gross J, 2009, TRENDS PLANT SCI, V14, P13, DOI 10.1016/j.tplants.2008.10.003; Hirakawa Y, 2009, P NATL ACAD SCI USA, V106, P12820, DOI 10.1073/pnas.0902578106; Jackson-Constan D, 2001, BBA-MOL CELL RES, V1541, P102, DOI 10.1016/S0167-4889(01)00148-3; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Keeling PJ, 2013, ANNU REV PLANT BIOL, V64, P583, DOI 10.1146/annurev-arplant-050312-120144; KIM MY, 1993, PLANT MOL BIOL, V22, P447, DOI 10.1007/BF00015975; Lane Nick, 2011, Genome Biol Evol, V3, P372, DOI 10.1093/gbe/evr003; Lang BF, 1999, ANNU REV GENET, V33, P351, DOI 10.1146/annurev.genet.33.1.351; Lister DL, 2003, GENE, V316, P33, DOI 10.1016/S0378-1119(03)00754-6; Martin W, 2002, P NATL ACAD SCI USA, V99, P12246, DOI 10.1073/pnas.182432999; Martin W, 1998, PLANT PHYSIOL, V118, P9, DOI 10.1104/pp.118.1.9; Oldenburg DJ, 2004, J MOL BIOL, V344, P1311, DOI 10.1016/j.jmb.2004.10.001; Palmer JD, 1997, SCIENCE, V275, P790, DOI 10.1126/science.275.5301.790; Pennisi E, 2011, SCIENCE, V332, P1372, DOI 10.1126/science.332.6036.1372; Reyes-Prieto A, 2006, CURR BIOL, V16, P2320, DOI 10.1016/j.cub.2006.09.063; Richly E, 2004, MOL BIOL EVOL, V21, P1972, DOI 10.1093/molbev/msh210; Rodermel S, 2001, TRENDS PLANT SCI, V6, P471, DOI 10.1016/S1360-1385(01)02085-4; Rosenblad MA, 2004, PLANT CELL PHYSIOL, V45, P1633, DOI 10.1093/pcp/pch185; Sanchez H, 1996, EMBO J, V15, P2138, DOI 10.1002/j.1460-2075.1996.tb00567.x; Sheiner L, 2013, BBA-MOL CELL RES, V1833, P352, DOI 10.1016/j.bbamcr.2012.05.030; Stork S, 2013, PROTOPLASMA, V250, P1013, DOI 10.1007/s00709-013-0498-7; Timmis JN, 2004, NAT REV GENET, V5, P123, DOI 10.1038/nrg1271; VONHEIJNE G, 1986, FEBS LETT, V198, P1, DOI 10.1016/0014-5793(86)81172-3; Waller RF, 2000, EMBO J, V19, P1794, DOI 10.1093/emboj/19.8.1794; Westphal S, 2001, FEBS LETT, V506, P257, DOI 10.1016/S0014-5793(01)02931-3; WOLFE KH, 1992, P NATL ACAD SCI USA, V89, P10648, DOI 10.1073/pnas.89.22.10648; Yamauchi A, 2005, GENETICS, V171, P1387, DOI 10.1534/genetics.104.036350; Yizhak K, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.11; Zhang Z, 2000, J COMPUT BIOL, V7, P203, DOI 10.1089/10665270050081478	48	0	0	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0120527	10.1371/journal.pone.0120527	http://dx.doi.org/10.1371/journal.pone.0120527			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25794152	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000352083900047
J	Martin-Guerrero, I; Gutierrez-Camino, A; Lopez-Lopez, E; Bilbao-Aldaiturriaga, N; Pombar-Gomez, M; Ardanaz, M; Garcia-Orad, A				Martin-Guerrero, Idoia; Gutierrez-Camino, Angela; Lopez-Lopez, Elixabet; Bilbao-Aldaiturriaga, Nerea; Pombar-Gomez, Maria; Ardanaz, Maite; Garcia-Orad, Africa			Genetic Variants in MiRNA Processing Genes and Pre-MiRNAs Are Associated with the Risk of Chronic Lymphocytic Leukemia	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; MICRORNA TARGET SITES; LUNG-CANCER; LINKING POLYMORPHISMS; FOLLICULAR LYMPHOMA; CELL-PROLIFERATION; POLYMIRTS DATABASE; COMMON VARIATION; COMPLEX TRAITS; BREAST-CANCER	Genome wide association studies (GWAS) have identified several low-penetrance susceptibility alleles in chronic lymphocytic leukemia (CLL). Nevertheless, these studies scarcely study regions that are implicated in non-coding molecules such as microRNAs (miRNAs). Abnormalities in miRNAs, as altered expression patterns and mutations, have been described in CLL, suggesting their implication in the development of the disease. Genetic variations in miRNAs can affect levels of miRNA expression if present in pre-miRNAs and in miRNA biogenesis genes or alter miRNA function if present in both target mRNA and miRNA sequences. Therefore, the present study aimed to evaluate whether polymorphisms in pre-miRNAs, and/or miRNA processing genes contribute to predisposition for CLL. A total of 91 SNPs in 107 CLL patients and 350 cancer-free controls were successfully analyzed using TaqMan Open Array technology. We found nine statistically significant associations with CLL risk after FDR correction, seven in miRNA processing genes (rs3805500 and rs6877842 in DROSHA, rs1057035 in DICER1, rs17676986 in SND1, rs9611280 in TNRC6B, rs784567 in TRBP and rs11866002 in CNOT1) and two in pre-miRNAs (rs11614913 in miR196a2 and rs2114358 in miR1206). These findings suggest that polymorphisms in genes involved in miRNAs biogenesis pathway as well as in pre-miRNAs contribute to the risk of CLL. Large-scale studies are needed to validate the current findings.	[Martin-Guerrero, Idoia; Gutierrez-Camino, Angela; Lopez-Lopez, Elixabet; Bilbao-Aldaiturriaga, Nerea; Pombar-Gomez, Maria; Garcia-Orad, Africa] Univ Basque Country, UPV EHU, Dept Genet Phys Anthropol & Anim Physiol, Fac Med & Odontol, Bilbao, Spain; [Ardanaz, Maite] Hosp Txagorritxu, Vitoria, Spain; [Garcia-Orad, Africa] Univ Basque Country, BioCruces Hlth Res Inst, E-48940 Leioa, Spain	University of Basque Country; University Hospital of Araba; University of Basque Country	Garcia-Orad, A (corresponding author), Univ Basque Country, UPV EHU, Dept Genet Phys Anthropol & Anim Physiol, Fac Med & Odontol, Bilbao, Spain.	africa.garciaorad@ehu.es	López-López, Elixabet/T-4607-2019; Gutierrez-Camino, Angela/AAM-2032-2020; Martin-Guerrero, Idoia/AAF-3446-2020	Gutierrez-Camino, Angela/0000-0002-8679-6868; Martin-Guerrero, Idoia/0000-0002-0098-1908; Lopez-Lopez, Elixabet/0000-0002-5309-3031; Garcia.Orad, Africa/0000-0002-5575-3080	Basque Government [IT661-13]; UPV/EHU [UFI11/35]; Saiotek [S-PE13UN079]; RTICC [RD12/0036/0060, RD12/0036/0036]; Basque Government through the grant "Programa de Formacion de Personal Investigador no doctor del Departamento de Educacion, Politica Linguistica y Cultura del Gobierno Vasco"; Basque Government through the grant "Programa Posdoctoral, de Perfeccionamiento de Personal Investigador Doctor del Departamento de Educacion, Politica Linguistica y Cultura del Gobierno Vasco"	Basque Government(Basque Government); UPV/EHU; Saiotek; RTICC(Instituto de Salud Carlos III); Basque Government through the grant "Programa de Formacion de Personal Investigador no doctor del Departamento de Educacion, Politica Linguistica y Cultura del Gobierno Vasco"(Basque Government); Basque Government through the grant "Programa Posdoctoral, de Perfeccionamiento de Personal Investigador Doctor del Departamento de Educacion, Politica Linguistica y Cultura del Gobierno Vasco"(Basque Government)	This work was supported by the Basque Government (IT661-13), UPV/EHU (UFI11/35), Saiotek (S-PE13UN079) and RTICC (RD12/0036/0060, RD12/0036/0036). AGC was supported by a predoctoral grant from the Basque Government through the grant "Programa de Formacion de Personal Investigador no doctor del Departamento de Educacion, Politica Linguistica y Cultura del Gobierno Vasco". ELL was supported by a postdoctoral grant from the Basque Government through the grant "Programa Posdoctoral, de Perfeccionamiento de Personal Investigador Doctor del Departamento de Educacion, Politica Linguistica y Cultura del Gobierno Vasco". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akkiz H, 2011, J VIRAL HEPATITIS, V18, pE399, DOI 10.1111/j.1365-2893.2010.01414.x; Bao L, 2007, NUCLEIC ACIDS RES, V35, pD51, DOI 10.1093/nar/gkl797; Beck-Engeser GB, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-4; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berndt SI, 2013, NAT GENET, V45, P868, DOI 10.1038/ng.2652; Brisbin AG, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-156; Calin GA, 2005, NEW ENGL J MED, V353, P1793, DOI 10.1056/NEJMoa050995; Calin GA, 2004, P NATL ACAD SCI USA, V101, P11755, DOI 10.1073/pnas.0404432101; Carramusa L, 2007, J CELL PHYSIOL, V213, P511, DOI 10.1002/jcp.21133; Chendrimada TP, 2005, NATURE, V436, P740, DOI 10.1038/nature03868; Christensen BC, 2010, CLIN CANCER RES, V16, P3713, DOI 10.1158/1078-0432.CCR-10-0657; Clague J, 2010, MOL CARCINOGEN, V49, P183, DOI 10.1002/mc.20588; Conde L, 2010, NAT GENET, V42, P661, DOI 10.1038/ng.626; Crowther-Swanepoel D, 2010, BRIT J HAEMATOL, V150, P473, DOI 10.1111/j.1365-2141.2010.08270.x; Crowther-Swanepoel D, 2010, HUM MOL GENET, V19, P1840, DOI 10.1093/hmg/ddq044; Crowther-Swanepoel D, 2010, NAT GENET, V42, P132, DOI 10.1038/ng.510; Di Bernardo MC, 2008, NAT GENET, V40, P1204, DOI 10.1038/ng.219; Dou TH, 2010, J CANCER RES CLIN, V136, P1853, DOI 10.1007/s00432-010-0844-5; Facchetti F., 2008, WHO CLASSIFICATION T, V4th ed; Fulci V, 2007, BLOOD, V109, P4944, DOI 10.1182/blood-2006-12-062398; George GP, 2011, MOL BIOL REP, V38, P1609, DOI 10.1007/s11033-010-0270-4; Goldin LR, 2010, CURR OPIN HEMATOL, V17, P350, DOI 10.1097/MOH.0b013e328338cd99; Goldin LR, 2009, HAEMATOL-HEMATOL J, V94, P647, DOI 10.3324/haematol.2008.003632; Gruber AR, 2008, NUCLEIC ACIDS RES, V36, pW70, DOI 10.1093/nar/gkn188; Guan YH, 2007, CLIN CANCER RES, V13, P5745, DOI 10.1158/1078-0432.CCR-06-2882; Hiard S, 2010, NUCLEIC ACIDS RES, V38, pD640, DOI 10.1093/nar/gkp926; Hoffman AE, 2009, CANCER RES, V69, P5970, DOI 10.1158/0008-5472.CAN-09-0236; Holt R, 2010, EUR J HUM GENET, V18, P1013, DOI 10.1038/ejhg.2010.69; Huppi K, 2008, MOL CANCER RES, V6, P212, DOI 10.1158/1541-7786.MCR-07-0105; Jakymiw A, 2010, GENE CHROMOSOME CANC, V49, P549, DOI 10.1002/gcc.20765; Karube Y, 2005, CANCER SCI, V96, P111, DOI 10.1111/j.1349-7006.2005.00015.x; Kim HK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047454; Kminkova J, 2014, CARCINOGENESIS; Ma HX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047544; Martin-Guerrero I, 2011, GENE CHROMOSOME CANC, V50, P887, DOI 10.1002/gcc.20912; Meister G, 2005, CURR BIOL, V15, P2149, DOI 10.1016/j.cub.2005.10.048; Merritt WM, 2008, NEW ENGL J MED, V359, P2641, DOI 10.1056/NEJMoa0803785; Mi SL, 2007, P NATL ACAD SCI USA, V104, P19971, DOI 10.1073/pnas.0709313104; Muralidhar B, 2007, J PATHOL, V212, P368, DOI 10.1002/path.2179; Peng S, 2010, DIGEST DIS SCI, V55, P2288, DOI 10.1007/s10620-009-1007-x; Pfeufer A, 2009, NAT GENET, V41, P407, DOI 10.1038/ng.362; Phua SLC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025689; Rotunno M, 2010, BRIT J CANCER, V103, P1870, DOI 10.1038/sj.bjc.6605976; Ryan BM, 2010, NAT REV CANCER, V10, P389, DOI 10.1038/nrc2867; Skibola CF, 2009, NAT GENET, V41, P873, DOI 10.1038/ng.419; Slager SL, 2012, BLOOD, V120, P843, DOI 10.1182/blood-2012-03-413591; Slager SL, 2011, BLOOD, V117, P1911, DOI 10.1182/blood-2010-09-308205; Slager SL, 2010, CANCER EPIDEM BIOMAR, V19, P1098, DOI 10.1158/1055-9965.EPI-09-1217; Sugito N, 2006, CLIN CANCER RES, V12, P7322, DOI 10.1158/1078-0432.CCR-06-0515; Tian T, 2009, CANCER EPIDEM BIOMAR, V18, P1183, DOI 10.1158/1055-9965.EPI-08-0814; Wang F, 2012, MOL BIOL REP, V39, P269, DOI 10.1007/s11033-011-0735-0; Wojcik SE, 2010, CARCINOGENESIS, V31, P208, DOI 10.1093/carcin/bgp209; Yang HS, 2008, CANCER RES, V68, P2530, DOI 10.1158/0008-5472.CAN-07-5991; Zhang XF, 2010, CARCINOGENESIS, V31, P2118, DOI 10.1093/carcin/bgq177; Ziebarth JD, 2012, NUCLEIC ACIDS RES, V40, pD216, DOI 10.1093/nar/gkr1026	55	23	25	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0118905	10.1371/journal.pone.0118905	http://dx.doi.org/10.1371/journal.pone.0118905			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25793711	Green Published, gold, Green Submitted			2022-12-27	WOS:000352084200045
J	Melillo, P; Izzo, R; Orrico, A; Scala, P; Attanasio, M; Mirra, M; De Luca, N; Pecchia, L				Melillo, Paolo; Izzo, Raffaele; Orrico, Ada; Scala, Paolo; Attanasio, Marcella; Mirra, Marco; De Luca, Nicola; Pecchia, Leandro			Automatic Prediction of Cardiovascular and Cerebrovascular Events Using Heart Rate Variability Analysis	PLOS ONE			English	Article							RECURRENCE QUANTIFICATION ANALYSIS; INTIMA-MEDIA THICKNESS; TARGET ORGAN DAMAGE; FEATURE-SELECTION; VASCULAR EVENTS; MORTALITY; ENTROPY; RISK; ASSOCIATION; FEATURES	Background There is consensus that Heart Rate Variability is associated with the risk of vascular events. However, Heart Rate Variability predictive value for vascular events is not completely clear. The aim of this study is to develop novel predictive models based on data-mining algorithms to provide an automatic risk stratification tool for hypertensive patients. Methods A database of 139 Holter recordings with clinical data of hypertensive patients followed up for at least 12 months were collected ad hoc. Subjects who experienced a vascular event (i.e., myocardial infarction, stroke, syncopal event) were considered as high-risk subjects. Several data-mining algorithms (such as support vector machine, tree-based classifier, artificial neural network) were used to develop automatic classifiers and their accuracy was tested by assessing the receiver-operator characteristics curve. Moreover, we tested the echographic parameters, which have been showed as powerful predictors of future vascular events. Results The best predictive model was based on random forest and enabled to identify high-risk hypertensive patients with sensitivity and specificity rates of 71.4% and 87.8%, respectively. The Heart Rate Variability based classifier showed higher predictive values than the conventional echographic parameters, which are considered as significant cardiovascular risk factors. Conclusions Combination of Heart Rate Variability measures, analyzed with data-mining algorithm, could be a reliable tool for identifying hypertensive patients at high risk to develop future vascular events.	[Melillo, Paolo; Orrico, Ada; Attanasio, Marcella] Univ Naples 2, Multidisciplinary Dept Med Surg & Dent Sci, Naples, Italy; [Melillo, Paolo; Orrico, Ada; Scala, Paolo; Attanasio, Marcella] Italian Minist Educ, Sci Res, SHARE Project, Rome, Italy; [Melillo, Paolo; Orrico, Ada; Scala, Paolo; Attanasio, Marcella] Univ Rome, Rome, Italy; [Izzo, Raffaele; Mirra, Marco; De Luca, Nicola] Univ Naples Federico II, Dept Translat Med Sci, Naples, Italy; [Pecchia, Leandro] Univ Warwick, Sch Engn, Coventry CV4 7AL, W Midlands, England	Universita della Campania Vanvitelli; Sapienza University Rome; University of Naples Federico II; University of Warwick	Melillo, P (corresponding author), Univ Naples 2, Multidisciplinary Dept Med Surg & Dent Sci, Naples, Italy.	paolomelillo85@gmail.com; nideluca@unina.it	Melillo, Paolo/H-4067-2011; Pecchia, Leandro/P-6344-2015; Pecchia, Leandro/AAF-7325-2019; Izzo, Raffaele/G-4892-2011	Melillo, Paolo/0000-0002-6519-0293; Pecchia, Leandro/0000-0002-7900-5415; Pecchia, Leandro/0000-0002-7900-5415; Izzo, Raffaele/0000-0002-0308-2836; DE LUCA, Nicola/0000-0002-9606-6586	NOP for Research and Competitiveness for the Convergence Regions (Calabria, Campania, Puglia and Sicilia [PON04a3_00139]	NOP for Research and Competitiveness for the Convergence Regions (Calabria, Campania, Puglia and Sicilia	The current study was supported by "the 2007-2013 NOP for Research and Competitiveness for the Convergence Regions (Calabria, Campania, Puglia and Sicilia)" with code PON04a3_00139-Project Smart Health and Artificial Intelligence for Risk Estimation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Binici Z, 2011, STROKE, V42, P3196, DOI 10.1161/STROKEAHA.110.607697; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Brennan M, 2001, IEEE T BIO-MED ENG, V48, P1342, DOI 10.1109/10.959330; Camm AJ, 1996, EUR HEART J, V17, P354; Carvajal R, 2005, COMPUT METH PROG BIO, V78, P133, DOI 10.1016/j.cmpb.2005.01.004; Clifford GD, 2005, IEEE T BIO-MED ENG, V52, P630, DOI 10.1109/TBME.2005.844028; De Luca N, 2005, J HYPERTENS, V23, P1417, DOI 10.1097/01.hjh.0000173526.65555.55; de Simone G, 2010, HYPERTENSION, V56, P99, DOI 10.1161/HYPERTENSIONAHA.110.150128; Dekker JM, 2000, CIRCULATION, V102, P1239, DOI 10.1161/01.CIR.102.11.1239; DEVEREUX RB, 1986, AM J CARDIOL, V57, P450, DOI 10.1016/0002-9149(86)90771-X; Ebrahimzadeh E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0081896; Fuster V, 1999, CIRCULATION, V99, P1132, DOI 10.1161/01.CIR.99.9.1132; Goldberger AL, 2000, CIRCULATION, V101, pE215, DOI 10.1161/01.CIR.101.23.e215; Hall MA, 1997, FEATURE SUBSET SELEC; Hillebrand S, 2013, EUROPACE, V15, P742, DOI 10.1093/europace/eus341; Isler Y, 2007, COMPUT BIOL MED, V37, P1502, DOI 10.1016/j.compbiomed.2007.01.012; Izzo R, 2013, EUR HEART J, V34, P3419, DOI 10.1093/eurheartj/eht281; Jovic A, 2011, ARTIF INTELL MED, V51, P175, DOI 10.1016/j.artmed.2010.09.005; Lake DE, 2002, AM J PHYSIOL-REG I, V283, pR789, DOI 10.1152/ajpregu.00069.2002; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; Liu H, 1995, 2012 IEEE 24 INT C T; Lorenz MW, 2007, CIRCULATION, V115, P459, DOI 10.1161/CIRCULATIONAHA.106.628875; Maldonado S, 2011, INFORM SCIENCES, V181, P115, DOI 10.1016/j.ins.2010.08.047; Melillo Paolo, 2014, Ambient Assisted Living and Daily Activities. 6th International Work-Conference, IWAAL 2014. Proceedings: LNCS 8868, P155, DOI 10.1007/978-3-319-13105-4_24; Melillo P, 2013, FOCUS NONLINEAR ANAL; Melillo P., 2013, WORLD C MED PHYS BIO, V39, P477, DOI [10.1007/978-3-642-29305-4_126, DOI 10.1007/978-3-642-29305-4_126]; Melillo P, 2013, IEEE J BIOMED HEALTH, V17, P727, DOI 10.1109/JBHI.2013.2244902; Melillo P, 2012, BMC CARDIOVASC DISOR, V12, DOI 10.1186/1471-2261-12-105; Melillo P, 2011, BIOMED ENG ONLINE, V10, DOI 10.1186/1475-925X-10-96; Melillo P, 2011, MED BIOL ENG COMPUT, V49, P67, DOI 10.1007/s11517-010-0728-5; Murray CJL, 1997, LANCET, V349, P1269, DOI 10.1016/S0140-6736(96)07493-4; Nagai K, 2013, ATHEROSCLEROSIS, V231, P365, DOI 10.1016/j.atherosclerosis.2013.09.028; Pecchia L, 2011, IEEE T BIO-MED ENG, V58, P800, DOI 10.1109/TBME.2010.2092776; Pecchia L, 2011, IEEE T INF TECHNOL B, V15, P40, DOI 10.1109/TITB.2010.2091647; PENG CK, 1995, CHAOS, V5, P82, DOI 10.1063/1.166141; Penzel T, 2003, IEEE T BIO-MED ENG, V50, P1143, DOI 10.1109/TBME.2003.817636; Ramirez-Villegas JF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017060; Ramshur J., 2010, DESIGN EVALUATION AN; Richman JS, 2000, AM J PHYSIOL-HEART C, V278, pH2039; Rothwell PM, 2005, LANCET, V366, P1773, DOI 10.1016/S0140-6736(05)67702-1; Saeys Y, 2008, LECT NOTES ARTIF INT, V5212, P313, DOI 10.1007/978-3-540-87481-2_21; Sajadieh A, 2004, EUR HEART J, V25, P363, DOI 10.1016/j.ehj.2003.12.003; Sajadieh A, 2003, AM J CARDIOL, V92, P234, DOI 10.1016/S0002-9149(03)00548-4; Schillaci G, 2000, HYPERTENSION, V35, P580, DOI 10.1161/01.HYP.35.2.580; Singh A, 2011, ENG MED BIOL SOC EMB; Song T, 2014, BMC CARDIOVASC DISOR, V14, DOI 10.1186/1471-2261-14-59; Trulla LL, 1996, PHYS LETT A, V223, P255, DOI 10.1016/S0375-9601(96)00741-4; WEBBER CL, 1994, J APPL PHYSIOL, V76, P965, DOI 10.1152/jappl.1994.76.2.965; Xiao J, 2007, TESTING STATIONARITY; Zbilut JP, 2002, MED ENG PHYS, V24, P53, DOI 10.1016/S1350-4533(01)00112-6; Zong W, 2003, COMPUTERS CARDIOLOGY	51	101	104	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0118504	10.1371/journal.pone.0118504	http://dx.doi.org/10.1371/journal.pone.0118504			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25793605	Green Published, Green Submitted, gold			2022-12-27	WOS:000352084200026
J	O'Rourke, SM; Sutthent, R; Phung, P; Mesa, KA; Frigon, NL; To, B; Horthongkham, N; Limoli, K; Wrin, T; Berman, PW				O'Rourke, Sara M.; Sutthent, Ruengpung; Pham Phung; Mesa, Kathryn A.; Frigon, Normand L.; To, Briana; Horthongkham, Navin; Limoli, Kay; Wrin, Terri; Berman, Phillip W.			Glycans Flanking the Hypervariable Connecting Peptide between the A and B Strands of the V1/V2 Domain of HIV-1 gp120 Confer Resistance to Antibodies That Neutralize CRF01_AE Viruses	PLOS ONE			English	Article							ANTIRETROVIRAL-DRUG-RESISTANCE; GLYCOSYLATION SITES; SOLUBLE CD4; V2 DOMAIN; TYPE-1; POTENT; BROAD; SENSITIVITY; VACCINE; INFECTION	Understanding the molecular determinants of sensitivity and resistance to neutralizing antibodies is critical for the development of vaccines designed to prevent HIV infection. In this study, we used a genetic approach to characterize naturally occurring polymorphisms in the HIV envelope protein that conferred neutralization sensitivity or resistance. Libraries of closely related envelope genes, derived from virus quasi-species, were constructed from individuals infected with CRF01_AE viruses. The libraries were screened with plasma containing broadly neutralizing antibodies, and neutralization sensitive and resistant variants were selected for sequence analysis. In vitro mutagenesis allowed us to identify single amino acid changes in three individuals that conferred resistance to neutralization by these antibodies. All three mutations created N-linked glycosylation sites (two at N136 and one at N149) proximal to the hypervariable connecting peptide between the C-terminus of the A strand and the N-terminus of the B strand in the four-stranded V1/V2 domain beta-sheet structure. Although N136 has previously been implicated in the binding of broadly neutralizing monoclonal antibodies, this glycosylation site appears to inhibit the binding of neutralizing antibodies in plasma from HIV-1 infected subjects. Previous studies have reported that the length of the V1/V2 domain in transmitted founder viruses is shorter and possesses fewer glycosylation sites compared to viruses isolated from chronic infections. Our results suggest that vaccine immunogens based on recombinant envelope proteins from clade CRF01_AE viruses might be improved by inclusion of envelope proteins that lack these glycosylation sites. This strategy might improve the efficacy of the vaccines used in the partially successful RV144 HIV vaccine trial, where the two CRF01_AE immunogens (derived from the A244 and TH023 isolates) both possessed glycosylation sites at N136 and N149.	[O'Rourke, Sara M.; Mesa, Kathryn A.; Frigon, Normand L.; To, Briana; Berman, Phillip W.] Univ Calif Santa Cruz, Baskin Sch Engn, Dept Biomol Engn, Santa Cruz, CA 95064 USA; [Sutthent, Ruengpung; Horthongkham, Navin] Mahidol Univ, Siriraj Hosp, Natl HIV Repository & Bioinformat Ctr Thailand, Dept Microbiol,Fac Med, Bangkok 10700, Thailand; [Pham Phung; Limoli, Kay; Wrin, Terri] Monogram Biosci, San Francisco, CA USA; [Berman, Phillip W.] Gladstone Inst Virol & Immunol, San Francisco, CA USA	University of California System; University of California Santa Cruz; Mahidol University; University of California System; University of California San Francisco; The J David Gladstone Institutes	Berman, PW (corresponding author), Univ Calif Santa Cruz, Baskin Sch Engn, Dept Biomol Engn, Santa Cruz, CA 95064 USA.	pwb@soe.ucsc.edu	Horthongkham, Navin/AAZ-7963-2021		National Institute on Drug Abuse [R01DA026801-01A1]; University of California; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA026801] Funding Source: NIH RePORTER	National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); University of California(University of California System); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by award number R01DA026801-01A1 from the National Institute on Drug Abuse and by funding from the University of California. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute on Drug Abuse or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASHKENAZI A, 1991, P NATL ACAD SCI USA, V88, P7056, DOI 10.1073/pnas.88.16.7056; Berman PW, 1999, VIROLOGY, V265, P1, DOI 10.1006/viro.1999.0031; Berman PW, 1998, AIDS RES HUM RETROV, V14, pS277; Binley J, 2009, CURR OPIN HIV AIDS, V4, P364, DOI 10.1097/COH.0b013e32832e06fe; BURTON DR, 1994, SCIENCE, V266, P1024, DOI 10.1126/science.7973652; CAPON DJ, 1989, NATURE, V337, P525, DOI 10.1038/337525a0; Chohan B, 2005, J VIROL, V79, P6528, DOI 10.1128/JVI.79.10.6528-6531.2005; Clamp M, 2004, BIOINFORMATICS, V20, P426, DOI 10.1093/bioinformatics/btg430; DAAR ES, 1990, P NATL ACAD SCI USA, V87, P6574, DOI 10.1073/pnas.87.17.6574; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Derdeyn CA, 2004, SCIENCE, V303, P2019, DOI 10.1126/science.1093137; Dhillon AK, 2007, J VIROL, V81, P6548, DOI 10.1128/JVI.02749-06; Doria-Rose NA, 2009, J VIROL, V83, P188, DOI 10.1128/JVI.01583-08; Durant J, 1999, LANCET, V353, P2195, DOI 10.1016/S0140-6736(98)12291-2; Flynn MN, 2005, J INFECT DIS, V191, P654, DOI 10.1086/428404; Gianella S, 2010, J INFECT DIS, V202, P657, DOI 10.1086/655397; GOODENOW M, 1989, J ACQ IMMUN DEF SYND, V2, P344; Hirsch MS, 2008, CLIN INFECT DIS, V47, P266, DOI 10.1086/589297; Julien JP, 2013, SCIENCE, V342, P1477, DOI 10.1126/science.1245625; Julien JP, 2013, P NATL ACAD SCI USA, V110, P4351, DOI 10.1073/pnas.1217537110; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Katoh K, 2010, BIOINFORMATICS, V26, P1899, DOI 10.1093/bioinformatics/btq224; LEONARD CK, 1990, J BIOL CHEM, V265, P10373; Li YX, 2007, NAT MED, V13, P1032, DOI 10.1038/nm1624; Little SJ, 2002, NEW ENGL J MED, V347, P385, DOI 10.1056/NEJMoa013552; Lyumkis D, 2013, SCIENCE, V342, P1484, DOI 10.1126/science.1245627; MANSKY LM, 1995, J VIROL, V69, P5087, DOI 10.1128/JVI.69.8.5087-5094.1995; McLellan JS, 2011, NATURE, V480, P336, DOI 10.1038/nature10696; Montefiori DC., 2005, CURR PROTOC IMMUNOL, VChapter 12:12.11.11-12.11.15, DOI [10.1002/0471142735.im1211s64, DOI 10.1002/0471142735.IM1211S64]; Moore PL, 2012, NAT MED, V18, P1688, DOI 10.1038/nm.2985; Morales JF, 2014, J BIOL CHEM, V289, P20526, DOI 10.1074/jbc.M114.554089; O'Rourke SM, 2012, J VIROL, V86, P12105, DOI 10.1128/JVI.01352-12; O'Rourke SM, 2010, J VIROL, V84, P11200, DOI 10.1128/JVI.00790-10; O'Rourke SM, 2009, J VIROL, V83, P7728, DOI 10.1128/JVI.00688-09; Pejchal R, 2011, SCIENCE, V334, P1097, DOI 10.1126/science.1213256; Perez-Losada M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016902; Petropoulos CJ, 2000, ANTIMICROB AGENTS CH, V44, P920, DOI 10.1128/AAC.44.4.920-928.2000; Pinter A, 2004, J VIROL, V78, P5205, DOI 10.1128/JVI.78.10.5205-5215.2004; Pitisuttithum P, 2006, J INFECT DIS, V194, P1661, DOI 10.1086/508748; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Richman DD, 2003, P NATL ACAD SCI USA, V100, P4144, DOI 10.1073/pnas.0630530100; ROBERTS JD, 1988, SCIENCE, V242, P1171, DOI 10.1126/science.2460925; Sagar M, 2006, J VIROL, V80, P9586, DOI 10.1128/JVI.00141-06; Sather DN, 2009, J VIROL, V83, P757, DOI 10.1128/JVI.02036-08; Saunders CJ, 2005, J VIROL, V79, P9069, DOI 10.1128/JVI.79.14.9069-9080.2005; Schweighardt B, 2007, JAIDS-J ACQ IMM DEF, V46, P1, DOI 10.1097/01.qai.0000286594.11191.91; Schweighardt B, 2010, JAIDS-J ACQ IMM DEF, V53, P36, DOI 10.1097/QAI.0b013e3181c4b885; Simek MD, 2009, J VIROL, V83, P7337, DOI 10.1128/JVI.00110-09; Sok D, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008104; Spearman P, 2011, J INFECT DIS, V203, P1165, DOI 10.1093/infdis/jiq175; Srivastava IK, 2003, J VIROL, V77, P2310, DOI 10.1128/JVI.77.4.2310-2320.2003; Srivastava IK, 2008, VIROLOGY, V372, P273, DOI 10.1016/j.virol.2007.10.022; Stamatatos L, 1998, J VIROL, V72, P7840, DOI 10.1128/JVI.72.10.7840-7845.1998; Stiegler G, 2001, AIDS RES HUM RETROV, V17, P1757, DOI 10.1089/08892220152741450; Toma J, 2011, J VIROL, V85, P3872, DOI 10.1128/JVI.02237-10; Tomaras GD, 2011, J VIROL, V85, P11502, DOI 10.1128/JVI.05363-11; Utachee P, 2010, J VIROL, V84, P4311, DOI 10.1128/JVI.02619-09; Utachee P, 2009, MICROBES INFECT, V11, P334, DOI 10.1016/j.micinf.2008.12.008; VARTANIAN JP, 1991, J VIROL, V65, P1779, DOI 10.1128/JVI.65.4.1779-1788.1991; Vartanian JP, 2002, J GEN VIROL, V83, P801, DOI 10.1099/0022-1317-83-4-801; Walker LM, 2011, NATURE, V477, P466, DOI 10.1038/nature10373; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470; Whitcomb JM, 2007, ANTIMICROB AGENTS CH, V51, P566, DOI 10.1128/AAC.00853-06; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; Yu B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043903; Zhang M, 2004, GLYCOBIOLOGY, V14, P1229, DOI 10.1093/glycob/cwh106; Zwick MB, 2007, CURR HIV RES, V5, P608, DOI 10.2174/157016207782418443	68	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0119608	10.1371/journal.pone.0119608	http://dx.doi.org/10.1371/journal.pone.0119608			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25793890	Green Published, gold, Green Submitted			2022-12-27	WOS:000352084200100
J	Shnayder, L; van Rijnsoever, FJ; Hekkert, MP				Shnayder, Larissa; van Rijnsoever, Frank J.; Hekkert, Marko P.			Putting Your Money Where Your Mouth Is: Why Sustainability Reporting Based on the Triple Bottom Line Can Be Misleading	PLOS ONE			English	Article							CORPORATE SOCIAL-RESPONSIBILITY; STRATEGY	In the packaged food industry, Corporate Social Responsibility (CSR) is an informal requirement for which firms account through sustainability reporting. CSR behaviors are often reported and analyzed using the Triple Bottom Line (3BL) framework, which categorizes them as affecting people, planet, or profit. 3BL is useful in determining which of these categories is most elaborated upon by the firm, but has a limited scope and many documented criticisms. This paper aims to address the aforementioned insufficiencies by augmenting the 3BL framework with two important attributes of CSR practices: (1) the presence of change in core firm behavior of the firm itself or of others in the supply chain, and (2) whether the behavior qualifies as being outside of the firm's normal business practice or is something that they might have done anyway. We qualitatively analyze CSR behaviors described in sustainability reports and interviews from major players in the packaged food industry and categorize them using these attributes as a supplement to 3BL. This enables us to separate the behaviors from their framing and analyze them more critically. Our results demonstrate how the visible CSR efforts of a firm can be misleading at first glance. Using only 3BL, we find that the CSR focus of firms in this industry is people. We then discover that the codes focusing on people (as opposed to planet or profit) require the least amount of real structural change from a firm or its supply chain partners, and thus arguably, the least amount of effort. We also find that behaviors that focus on planet require the most effort within the firm itself, but for behaviors involving supply chain partners, effort is required for behaviors in all three categories. Finally, we find that CSR behavior that is related to planet tends to go beyond normal business practice.	[Shnayder, Larissa; van Rijnsoever, Frank J.; Hekkert, Marko P.] Univ Utrecht, Innovat Studies, Copernicus Inst Sustainable Dev, NL-3584 CS Utrecht, Netherlands	Utrecht University	Shnayder, L (corresponding author), Univ Utrecht, Innovat Studies, Copernicus Inst Sustainable Dev, Heidelberglaan 2, NL-3584 CS Utrecht, Netherlands.	l.shnayder@uu.nl			Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO) Netherlands Organization for Scientific Research	Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO) Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO))	This project is funded by the Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO) - in English, The Netherlands Organization for Scientific Research, which falls under the responsibility of the Dutch Ministry of Education, Culture and Science. More information (in English or Dutch) can be found here: (http://www.nwo.nl/en). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, ECONOMIST; Arora P, 2011, CORP GOV, V19, P136, DOI 10.1111/j.1467-8683.2010.00843.x; Braungart M, 2007, J CLEAN PROD, V15, P1337, DOI 10.1016/j.jclepro.2006.08.003; Burritt RL, 2010, ACCOUNT AUDIT ACCOUN, V23, P829, DOI 10.1108/09513571011080144; Campbell JL, 2007, ACAD MANAGE REV, V32, P946, DOI 10.5465/AMR.2007.25275684; Carroll A.B., 1991, BUS HORIZONS, V34, P39, DOI [10.1016/0007-6813(91)90005-G, DOI 10.1016/0007-6813(91)90005-G]; Cyert RM, 1963, PRENCTICE HALL INT S; Dani S, 2010, INT J LOGIST-RES APP, V13, P395, DOI 10.1080/13675567.2010.518564; Elkington J., 1997, CANIBALS FORKS TRIPL; Freeman R. E., 1984, STRATEGIC MANAGEMENT; Gabel H, 1993, J ENV EC MANAGEMENT; Garriga E, 2004, J BUS ETHICS, V53, P51, DOI 10.1023/B:BUSI.0000039399.90587.34; Gavetti G, 2012, ACAD MANAG ANN, V6, P1, DOI 10.1080/19416520.2012.656841; Glaser B. G., 2009, DISCOVERY GROUNDED T; Global Reporting Initiative, 2008, SUST REP FOOD PROC S; Gray R, 2002, CHARTERED ACCOUNTANT, P1; Hannan M. T., 1989, ORG ECOLOGY; Henderson D, 2013, MONOGRAPHS SOC RES C, V78, P126; Hoejmose S, 2013, INT J OPER PROD MAN, V33, P589, DOI 10.1108/01443571311322733; Ifland JR, 2009, MED HYPOTHESES, V72, P518, DOI 10.1016/j.mehy.2008.11.035; Jamali D, 2009, J BUS ETHICS, V85, P173, DOI 10.1007/s10551-008-9755-7; Kolk A., 2006, European Management Journal, V24, P59, DOI 10.1016/j.emj.2005.12.008; Kopnina H., 2011, ENV ED; Lozano R, 2011, J CLEAN PROD, V19, P99, DOI 10.1016/j.jclepro.2010.01.004; Mitchell RK, 1997, ACAD MANAGE REV, V22, P853, DOI 10.2307/259247; Moir Lance, 2001, International Journal of Corporate Governance, V1, P16, DOI 10.1108/EUM0000000005486; Murray S., 2007, FORBES MAGAZINE; Norman W, 2003, BUSINESS ETHICS Q; Parsons T., 1965, THEORIES OF SOC; Pauli G, 2010, BLUE EC OUR PLANET; Pava ML, 2007, BUS ETHICS Q, V17, P105, DOI 10.5840/beq200717116; Pfeiffer J, 2003, EXTERNAL CONTROL ORG, DOI DOI 10.2307/2392573; Poirier P, 2006, CIRCULATION, V113, P898, DOI 10.1161/CIRCULATIONAHA.106.171016; Raar J, 2002, CORP COMMUN, V7, P169, DOI DOI 10.1108/13563280210436781; Scott Cato M., 2009, GREEN EC; Scott W, 1995, I ORG; Searcy C, 2014, BUSINESS STRATEGY EN; Silberhorn D, 2007, EUR BUS REV, V19, P352, DOI 10.1108/09555340710818950; Sridhar K, 2012, ASIAN J BUS ETHICS, V1, P89, DOI 10.1007/s13520-011-0010-4; Starik M., 1994, BUSINESS SOC, V33, P82; STURDIVANT FD, 1979, CALIF MANAGE REV, V22, P53, DOI 10.2307/41164849; Subramanian V, 2014, NANO TODAY, V9, P6, DOI 10.1016/j.nantod.2014.01.001; Tate WL, 2010, J SUPPLY CHAIN MANAG, V46, P19, DOI 10.1111/j.1745-493X.2009.03184.x; Tatham E, 2014, SUSTAINABLE URBAN SY; van Rijnsoever FJ, 2011, J EPIDEMIOL COMMUN H, V65, P737, DOI 10.1136/jech.2011.141598; Waddock SA, 1997, STRATEGIC MANAGE J, V18, P303, DOI 10.1002/(SICI)1097-0266(199704)18:4<303::AID-SMJ869>3.3.CO;2-7; William M, 2003, ENV SCI TECHNOLOGY; World Commission, 1987, REP WORLD COMM ENV D	48	29	29	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0119036	10.1371/journal.pone.0119036	http://dx.doi.org/10.1371/journal.pone.0119036			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CE8IA	25793612	gold, Green Published, Green Submitted			2022-12-27	WOS:000352084200053
J	Trojsi, F; Caiazzo, G; Corbo, D; Piccirillo, G; Cristillo, V; Femiano, C; Ferrantino, T; Cirillo, M; Monsurro, MR; Esposito, F; Tedeschi, G				Trojsi, Francesca; Caiazzo, Giuseppina; Corbo, Daniele; Piccirillo, Giovanni; Cristillo, Viviana; Femiano, Cinzia; Ferrantino, Teresa; Cirillo, Mario; Monsurro, Maria Rosaria; Esposito, Fabrizio; Tedeschi, Gioacchino			Microstructural Changes across Different Clinical Milestones of Disease in Amyotrophic Lateral Sclerosis	PLOS ONE			English	Article							HEXANUCLEOTIDE REPEAT EXPANSION; VOXEL-BASED MORPHOMETRY; MOTOR-NEURON DEGENERATION; WHITE-MATTER; WHOLE-BRAIN; COGNITIVE IMPAIRMENT; PROBABILISTIC ATLAS; SPORADIC ALS; PATHOLOGY; C9ORF72	Neurodegenerative process in amyotrophic lateral sclerosis (ALS) has been proven to involve several cortical and subcortical brain regions within and beyond motor areas. However, how ALS pathology spreads progressively during disease evolution is still unknown. In this cross-sectional study we investigated 54 ALS patients, divided into 3 subsets according to the clinical stage, and 18 age and sex-matched healthy controls, by using tract-based spatial statistics (TBSS) diffusion tensor imaging (DTI) and voxel-based morphometry (VBM) analyses. We aimed to identify white (WM) and gray matter (GM) patterns of disease distinctive of each clinical stage, corresponding to specific clinical milestones. ALS cases in stage 2A (i.e., at diagnosis) were characterized by GM and WM impairment of left motor and premotor cortices and brainstem at ponto-mesenchephalic junction. ALS patients in clinical stage 2B (with impairment of two functional regions) exhibited decreased fractional anisotropy (FA) (p<0.001, uncorrected) and increased mean (MD) and radial diffusivity (RD) (p<0.001, uncorrected) in the left cerebellar hemisphere and brainstem precerebellar nuclei, as well as in motor areas, while GM atrophy (p<0.001, uncorrected) was detected only in the left inferior frontal gyrus and right cuneus. Finally, ALS patients in stage 3 (with impairment of three functional regions) exhibited decreased FA and increased MD and RD (p<0.05, corrected) within WM underneath bilateral pre and postcentral gyri, corpus callosum midbody, long associative tracts and midbrain, while no significant clusters of GM atrophy were observed. Our findings reinforce the hypothesis that the neurodegenerative process propagates along the axonal pathways and develops beyond motor areas from early stages, involving progressively several frontotemporal regions and their afferents and efferents, while the detection of GM atrophy in earlier stages and its disappearance in later stages may be the result of reactive gliosis.	[Trojsi, Francesca; Caiazzo, Giuseppina; Piccirillo, Giovanni; Cristillo, Viviana; Femiano, Cinzia; Ferrantino, Teresa; Cirillo, Mario; Monsurro, Maria Rosaria; Tedeschi, Gioacchino] Univ Naples 2, Dept Med Surg Neurol Metab & Aging Sci, Naples, Italy; [Trojsi, Francesca; Caiazzo, Giuseppina; Cirillo, Mario; Monsurro, Maria Rosaria; Esposito, Fabrizio; Tedeschi, Gioacchino] Univ Naples 2, MRI Res Ctr SUN FISM, I-80138 Naples, Italy; [Corbo, Daniele] Univ Parma, Dept Neurosci, I-43100 Parma, Italy; [Esposito, Fabrizio] Univ Salerno, Dept Med & Surg, I-84081 Baronissi, Salerno, Italy	Universita della Campania Vanvitelli; Universita della Campania Vanvitelli; University of Parma; University of Salerno	Tedeschi, G (corresponding author), Univ Naples 2, Dept Med Surg Neurol Metab & Aging Sci, Naples, Italy.	gioacchino.tedeschi@unina2.it	Corbo, Daniele/J-7589-2018; Trojsi, Francesca/AHD-9665-2022; Esposito, Fabrizio/M-8555-2015	Corbo, Daniele/0000-0001-5078-6636; Esposito, Fabrizio/0000-0002-5099-9786; Trojsi, Francesca/0000-0002-3790-8018; CIRILLO, MARIO/0000-0001-5350-7700				Abrahams S, 2005, NEUROLOGY, V64, P1222, DOI 10.1212/01.WNL.0000156519.41681.27; Agosta F, 2007, HUM BRAIN MAPP, V28, P1430, DOI 10.1002/hbm.20364; Agosta F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042816; Al-Sarraj S, 2011, ACTA NEUROPATHOL, V122, P691, DOI 10.1007/s00401-011-0911-2; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Beaufils E, 2012, AMYOTROPH LATERAL SC, V13, P84, DOI 10.3109/17482968.2011.580848; Bede P, 2013, J NEUROL NEUROSUR PS, V84, P766, DOI 10.1136/jnnp-2012-302674; Braak H, 2013, NAT REV NEUROL, V9, P708, DOI 10.1038/nrneurol.2013.221; Brettschneider J, 2013, ANN NEUROL, V74, P20, DOI 10.1002/ana.23937; Brooks BR, 2000, AMYOTROPH LATERAL SC, V1, P293, DOI 10.1080/146608200300079536; BROWNELL B, 1970, J NEUROL NEUROSUR PS, V33, P338, DOI 10.1136/jnnp.33.3.338; Cedarbaum JM, 1999, J NEUROL SCI, V169, P13, DOI 10.1016/S0022-510X(99)00210-5; Chao YP, 2009, HUM BRAIN MAPP, V30, P3172, DOI 10.1002/hbm.20739; Chio A, 2012, EUR J NEUROL, V19, P551, DOI 10.1111/j.1468-1331.2011.03540.x; Chio A, 2012, BRAIN, V135, P784, DOI 10.1093/brain/awr366; Chio A, 2011, J NEUROL NEUROSUR PS, V82, P740, DOI 10.1136/jnnp.2010.235952; Cirillo M, 2012, AM J NEURORADIOL, V33, P1102, DOI 10.3174/ajnr.A2918; Cistaro A, 2012, EUR J NUCL MED MOL I, V39, P251, DOI 10.1007/s00259-011-1979-6; Clavaguera F, 2009, NAT CELL BIOL, V11, P909, DOI 10.1038/ncb1901; Cushman M, 2010, J CELL SCI, V123, P1191, DOI 10.1242/jcs.051672; d'Ambrosio A, 2014, AM J NEURORADIOL, V35, P304, DOI 10.3174/ajnr.A3753; Donaghy C, 2011, J NEUROL NEUROSUR PS, V82, P110, DOI 10.1136/jnnp.2010.212407; Eisen A, 2001, MUSCLE NERVE, V24, P564, DOI 10.1002/mus.1042; Eisen A, 2009, MUSCLE NERVE, V40, P297, DOI 10.1002/mus.21404; Fekete T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0085190; Filippini N, 2010, NEUROLOGY, V75, P1645, DOI 10.1212/WNL.0b013e3181fb84d1; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; Geser F, 2008, ARCH NEUROL-CHICAGO, V65, P636, DOI 10.1001/archneur.65.5.636; Geser F, 2009, ARCH NEUROL-CHICAGO, V66, P180, DOI 10.1001/archneurol.2008.558; Gordon PH, 2010, J NEUROL, V257, P1713, DOI 10.1007/s00415-010-5609-1; Grace J, 1999, ASSESSMENT, V6, P269, DOI 10.1177/107319119900600307; Grossman M, 2008, NEUROLOGY, V71, P1396, DOI 10.1212/01.wnl.0000319701.50168.8c; Hua K, 2008, NEUROIMAGE, V39, P336, DOI 10.1016/j.neuroimage.2007.07.053; Ince PG, 2011, ACTA NEUROPATHOL, V122, P657, DOI 10.1007/s00401-011-0913-0; Kassubek J, 2014, BRAIN, V137, P1733, DOI 10.1093/brain/awu090; Kassubek J, 2012, THER ADV NEUROL DISO, V5, P119, DOI 10.1177/1756285612437562; Keil C, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-141; KIERNAN JA, 1991, BRAIN, V114, P843, DOI 10.1093/brain/114.2.843; Kiernan MC, 2011, LANCET, V377, P942, DOI 10.1016/S0140-6736(10)61156-7; Kwan JY, 2013, NEUROIMAGE-CLIN, V2, P151, DOI 10.1016/j.nicl.2012.12.003; Libon DJ, 2012, NEUROPSYCHOLOGY, V26, P422, DOI 10.1037/a0028668; Lillo P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043993; Ling SC, 2013, NEURON, V79, P416, DOI 10.1016/j.neuron.2013.07.033; Luk KC, 2012, SCIENCE, V338, P949, DOI 10.1126/science.1227157; Mackenzie IRA, 2014, ACTA NEUROPATHOL, V127, P347, DOI 10.1007/s00401-013-1232-4; Mahoney CJ, 2012, BRAIN, V135, P736, DOI 10.1093/brain/awr361; Mazziotta J, 2001, J AM MED INFORM ASSN, V8, P401, DOI 10.1136/jamia.2001.0080401; Mazziotta J, 2001, PHILOS T R SOC B, V356, P1293, DOI 10.1098/rstb.2001.0915; Menke RAL, 2014, BRAIN, V137, P2546, DOI 10.1093/brain/awu162; Mezzapesa DM, 2007, AM J NEURORADIOL, V28, P255; Mioshi E, 2006, INT J GERIATR PSYCH, V21, P1078, DOI 10.1002/gps.1610; Mioshi E, 2013, NEUROLOGY, V80, P1117, DOI 10.1212/WNL.0b013e31828869da; Ozawa T, 2004, BRAIN, V127, P2657, DOI 10.1093/brain/awh303; Pettit LD, 2013, BRAIN, V136, P3290, DOI 10.1093/brain/awt243; Phukan J, 2007, LANCET NEUROL, V6, P994, DOI 10.1016/S1474-4422(07)70265-X; Prell T, 2013, CLIN NEUROL NEUROSUR, V115, P1281, DOI 10.1016/j.clineuro.2012.11.031; Ravits J, 2007, NEUROLOGY, V68, P1571, DOI 10.1212/01.wnl.0000260965.20021.47; Ravits JM, 2009, NEUROLOGY, V73, P805, DOI 10.1212/WNL.0b013e3181b6bbbd; Renton AE, 2011, NEURON, V72, P257, DOI 10.1016/j.neuron.2011.09.010; Ringholz GM, 2005, NEUROLOGY, V65, P586, DOI 10.1212/01.wnl.0000172911.39167.b6; Roche JC, 2012, BRAIN, V135, P847, DOI 10.1093/brain/awr351; Rosenbohm A, 2014, J NEUROL, V261, P283, DOI 10.1007/s00415-013-7185-7; Sarro L, 2011, AM J NEURORADIOL, V32, P1866, DOI 10.3174/ajnr.A2658; Schuster C, 2014, NEUROBIOL AGING, V35, P240, DOI 10.1016/j.neurobiolaging.2013.07.020; Senda J, 2011, AMYOTROPH LATERAL SC, V12, P59, DOI 10.3109/17482968.2010.517850; Sharma R, 2011, ARCH NEUROL-CHICAGO, V68, P857, DOI 10.1001/archneurol.2011.130; Simone IL, 2010, J NEUROL SCI, V288, P106, DOI 10.1016/j.jns.2009.09.023; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Tessitore A, 2006, BRAIN RES BULL, V69, P489, DOI 10.1016/j.brainresbull.2006.01.013; Thomas M, 2013, BRAIN, V136, P1345, DOI 10.1093/brain/awt030; Tsermentseli S, 2012, CORTEX, V48, P166, DOI 10.1016/j.cortex.2011.02.004; Tsujimoto M, 2011, J NEUROL SCI, V307, P34, DOI 10.1016/j.jns.2011.05.025; Turner MR, 2004, NEUROBIOL DIS, V15, P601, DOI 10.1016/j.nbd.2003.12.012; Verstraete E, 2012, J NEUROL NEUROSUR PS, V83, P383, DOI 10.1136/jnnp-2011-300909; Wakana S, 2007, NEUROIMAGE, V36, P630, DOI 10.1016/j.neuroimage.2007.02.049; Zhang JQ, 2014, J NEUROL, V261, P412, DOI 10.1007/s00415-013-7215-5	76	26	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0119045	10.1371/journal.pone.0119045	http://dx.doi.org/10.1371/journal.pone.0119045			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25793718	Green Submitted, Green Published, gold			2022-12-27	WOS:000352084200054
J	Corthals, A; Martin, A; Warsi, OM; Woller-Skar, M; Lancaster, W; Russell, A; Davalos, LM				Corthals, Angelique; Martin, Alynn; Warsi, Omar M.; Woller-Skar, Megan; Lancaster, Winston; Russell, Amy; Davalos, Liliana M.			From the Field to the Lab: Best Practices for Field Preservation of Bat Specimens for Molecular Analyses	PLOS ONE			English	Article							PCR-AMPLIFICATION; DNA; TISSUES; DIVERSIFICATION; STORAGE; HABITS	Studies in molecular ecology depend on field-collected samples for genetic information, and the tissue sampled and preservation conditions strongly affect the quality of the DNA obtained. DNA yields from different tissue types have seldom been compared, and the relative performance of storage media has never been directly tested, even though these media may influence DNA degradation under field conditions. We analyzed DNA yield from buccal swabs and wing punches harvested from live bats using nucleic acid quantification as well as quantitative PCR for a single-copy nuclear locus. We also compared DNA yields from wing tissue preserved in three media: ethanol, NaCl-saturated dimethyl sulfoxide (DMSO), and silica desiccant. Wing punches yielded more total DNA than did buccal swabs, and wing tissues preserved in silica beads yielded significantly more total and nuclear DNA than those preserved in DMSO or ethanol. These results show that tissue type and preservation media strongly influence the quantity of DNA obtained from non-lethal genetic samples, and based on these effects we provide recommendations for field collection of tissues for genetic analyses.	[Corthals, Angelique] CUNY John Jay Coll Criminal Justice, Dept Sci, New York, NY 10019 USA; [Corthals, Angelique] SUNY Stony Brook, Sch Med, Dept Pathol, Stony Brook, NY 11794 USA; [Martin, Alynn; Woller-Skar, Megan; Russell, Amy] Grand Valley State Univ, Dept Biol, Allendale, MI 49401 USA; [Warsi, Omar M.; Davalos, Liliana M.] SUNY Stony Brook, Dept Ecol & Evolut, Stony Brook, NY 11794 USA; [Lancaster, Winston] Calif State Univ Sacramento, Dept Biol Sci, Sacramento, CA 95819 USA; [Davalos, Liliana M.] Sch Marine & Atmospher Sci, Consortium Interdisciplinary Environm Res, Stony Brook, NY USA	City University of New York (CUNY) System; John Jay College of Criminal Justice (CUNY); State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Grand Valley State University; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; California State University System; California State University Sacramento	Corthals, A (corresponding author), CUNY John Jay Coll Criminal Justice, Dept Sci, New York, NY 10019 USA.	acorthals@jjay.cuny.edu	Russell, Amy L/B-2222-2010	Davalos, Liliana/0000-0002-4327-7697; Warsi, Omar/0000-0003-3175-1184; Corthals, Angelique/0000-0002-5610-2992	Direct For Biological Sciences [1442142, 1442314] Funding Source: National Science Foundation; Division Of Environmental Biology [1442278] Funding Source: National Science Foundation	Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))		Atmadja Djaja Surya, 1995, Kobe Journal of Medical Sciences, V41, P197; Baker RJ, 1984, COLLECTIONS FROZEN T, P35; Bates D. M., 2010, LME4 MIXED EFFECTS M; BENFORD G, 1992, P NATL ACAD SCI USA, V89, P11098, DOI 10.1073/pnas.89.22.11098; Borisenko AV, 2008, MOL ECOL RESOUR, V8, P471, DOI 10.1111/j.1471-8286.2007.01998.x; Boston ESM, 2012, ACTA CHIROPTEROL, V14, P45, DOI 10.3161/150811012X654259; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Corthals A, 2005, SYST BIOL, P54; Derveaux S, 2010, METHODS, V50, P227, DOI 10.1016/j.ymeth.2009.11.001; Dessauer HC, 1984, COLLECTIONS FROZEN T, P3; Dumont ER, 2012, P ROY SOC B-BIOL SCI, V279, P1797, DOI 10.1098/rspb.2011.2005; ENGSTROM M. D., 1999, MANAGING MODERN HERB, P315; Faure PA, 2009, J MAMMAL, V90, P1148, DOI 10.1644/08-MAMM-A-332.1; Flanders J, 2009, MOL ECOL, V18, P306, DOI 10.1111/j.1365-294X.2008.04021.x; Florian M.-L., 1990, Collection Forum, V6, P1; Frey UH, 2008, NAT PROTOC, V3, P1312, DOI 10.1038/nprot.2008.112; Gebel T, 1999, MUTAT RES-GEN TOX EN, V444, P405, DOI 10.1016/S1383-5718(99)00111-4; Gelman A, 2005, ANN STAT, V33, P1, DOI 10.1214/009053604000001048; Hajibabaei M, 2005, PHILOS T R SOC B, V360, P1959, DOI 10.1098/rstb.2005.1727; Hanner R, 2005, MOL PHYLOGENET EVOL, V34, P452, DOI 10.1016/j.ympev.2004.10.008; Henke W, 1997, NUCLEIC ACIDS RES, V25, P3957, DOI 10.1093/nar/25.19.3957; Karlsson JOM, 1996, BIOMATERIALS, V17, P243, DOI 10.1016/0142-9612(96)85562-1; Kataoka T, 2009, J CLIN BIOCHEM NUTR, V45, P219, DOI 10.3164/jcbn.09-06; Kilpatrick CW, 2002, BIOCHEM GENET, V40, P53, DOI 10.1023/A:1014541222816; Kitchen RR, 2010, METHODS, V50, P231, DOI 10.1016/j.ymeth.2010.01.025; Lemmon AR, 2012, SYST BIOL, V61, P727, DOI 10.1093/sysbio/sys049; Longmire Jonathan L., 1997, Occasional Papers the Museum Texas Tech University, V163, P1; Loureiro J, 2006, ANN BOT-LONDON, V98, P679, DOI 10.1093/aob/mcl141; Michaud CL, 2011, J FORENSIC SCI, V56, P846, DOI 10.1111/j.1556-4029.2011.01771.x; Miller-Butterworth CM, 2014, J HERED, V105, P354, DOI 10.1093/jhered/esu012; Muscarella RA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017704; Phillips CD, 2012, MOL ECOL, V21, P2617, DOI 10.1111/j.1365-294X.2012.05568.x; R Development Core Team, 2012, R LANG ENV STAT COMP; Racey PA, 2013, ZOONOSES PUBLIC HLTH, V60, P58, DOI 10.1111/j.1863-2378.2012.01533.x; Rojas D, 2011, MOL ECOL, V20, P2217, DOI 10.1111/j.1365-294X.2011.05082.x; Russell AL, 2005, MOL ECOL, V14, P2207, DOI 10.1111/j.1365-294X.2005.02552.x; Russell AL, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-88; Sahdev S, 2007, MOL CELL PROBE, V21, P303, DOI 10.1016/j.mcp.2007.03.004; SAVOLAINEN V, 2006, DNA TISSUE BANKING B; SEUTIN G, 1991, CAN J ZOOL, V69, P82, DOI 10.1139/z91-013; Sheldon F., 1997, GLOBAL GENETIC RESOU, P151; Thermo Fisher Scientific, 2008, NANODROP 1000 SPECTR, P1; Vazquez-Dominguez E, 2013, ACTA CHIROPTEROL, V15, P411, DOI 10.3161/150811013X679035; Velazco PM, 2013, MOL PHYLOGENET EVOL, V68, P683, DOI 10.1016/j.ympev.2013.04.016; WORTHINGTON WILMER J. M., 1996, BAT RES NEWS, V37, P1; Zimmermann J, 2008, FRONT ZOOL, V5, DOI 10.1186/1742-9994-5-18	46	17	17	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0118994	10.1371/journal.pone.0118994	http://dx.doi.org/10.1371/journal.pone.0118994			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25798819	Green Published, gold			2022-12-27	WOS:000351987300024
J	Hallam, GP; Webb, TL; Sheeran, P; Miles, E; Wilkinson, ID; Hunter, MD; Barker, AT; Woodruff, PWR; Totterdell, P; Lindquist, KA; Farrow, TFD				Hallam, Glyn P.; Webb, Thomas L.; Sheeran, Paschal; Miles, Eleanor; Wilkinson, Iain D.; Hunter, Michael D.; Barker, Anthony T.; Woodruff, Peter W. R.; Totterdell, Peter; Lindquist, Kristen A.; Farrow, Tom F. D.			The Neural Correlates of Emotion Regulation by Implementation Intentions	PLOS ONE			English	Article							ROSTRAL PREFRONTAL CORTEX; PROSPECTIVE MEMORY; SKIN-CONDUCTANCE; FUNCTIONAL CONNECTIVITY; GOAL ACHIEVEMENT; FRONTAL-CORTEX; AMYGDALA; METAANALYSIS; VOLUNTARY; RESPONSES	Several studies have investigated the neural basis of effortful emotion regulation (ER) but the neural basis of automatic ER has been less comprehensively explored. The present study investigated the neural basis of automatic ER supported by 'implementation intentions'. 40 healthy participants underwent fMRI while viewing emotion-eliciting images and used either a previously-taught effortful ER strategy, in the form of a goal intention (e.g., try to take a detached perspective), or a more automatic ER strategy, in the form of an implementation intention (e.g., "If I see something disgusting, then I will think these are just pixels on the screen!"), to regulate their emotional response. Whereas goal intention ER strategies were associated with activation of brain areas previously reported to be involved in effortful ER (including dorsolateral prefrontal cortex), ER strategies based on an implementation intention strategy were associated with activation of right inferior frontal gyrus and ventro-parietal cortex, which may reflect the attentional control processes automatically captured by the cue for action contained within the implementation intention. Goal intentions were also associated with less effective modulation of left amygdala, supporting the increased efficacy of ER under implementation intention instructions, which showed coupling of orbitofrontal cortex and amygdala. The findings support previous behavioural studies in suggesting that forming an implementation intention enables people to enact goal-directed responses with less effort and more efficiency.	[Hallam, Glyn P.; Hunter, Michael D.; Woodruff, Peter W. R.; Farrow, Tom F. D.] Univ Sheffield, SCANLab Sheffield Cognit & Neuroimaging Lab, Acad Clin Psychiat, Dept Neurosci,Longley Ctr,Northern Gen Hosp, Sheffield, S Yorkshire, England; [Webb, Thomas L.; Miles, Eleanor; Totterdell, Peter] Univ Sheffield, Dept Psychol, Western Bank, Sheffield S10 2TN, S Yorkshire, England; [Sheeran, Paschal; Lindquist, Kristen A.] Univ N Carolina, Dept Psychol, Chapel Hill, NC USA; [Wilkinson, Iain D.] Univ Sheffield, Royal Hallamshire Hosp, Acad Unit Radiol, Sheffield S10 2JF, S Yorkshire, England; [Barker, Anthony T.] Univ Sheffield, Royal Hallamshire Hosp, Dept Med Phys & Clin Engn, Sheffield S10 2JF, S Yorkshire, England; [Farrow, Tom F. D.] Univ Sheffield, Royal Hallamshire Hosp, Dept Neurosci, Acad Clin Neurol, Sheffield S10 2JF, S Yorkshire, England; [Hallam, Glyn P.] Univ York, Dept Psychol, York YO10 5DD, N Yorkshire, England; [Miles, Eleanor] Univ Sussex, Sch Psychol, Falmer, E Sussex, England	Northern General Hospital; University of Sheffield; University of Sheffield; University of North Carolina; University of North Carolina Chapel Hill; University of Sheffield; University of Sheffield; University of Sheffield; University of York - UK; University of Sussex	Hallam, GP (corresponding author), Univ Sheffield, SCANLab Sheffield Cognit & Neuroimaging Lab, Acad Clin Psychiat, Dept Neurosci,Longley Ctr,Northern Gen Hosp, Norwood Grange Dr, Sheffield, S Yorkshire, England.	glyn.hallam@york.ac.uk	Sheeran, Paschal/Y-3370-2019; Webb, Thomas/E-8946-2010; Lindquist, Kristen/AAA-4580-2021; Farrow, Tom/B-5003-2009	Webb, Thomas/0000-0001-9320-0068; Lindquist, Kristen/0000-0002-5368-9302; Wilkinson, Iain/0000-0003-2703-6890; Hallam, Glyn Paul/0000-0002-8956-9054; Miles, Eleanor/0000-0002-8375-4638; Totterdell, Peter/0000-0002-5335-2611; Farrow, Tom/0000-0001-5096-6370	Economic and Social Research Council (ESRC) [RES-060-25-0044]; Economic and Social Research Council [ES/F037449/1] Funding Source: researchfish; ESRC [ES/F037449/1] Funding Source: UKRI	Economic and Social Research Council (ESRC)(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	This work was supported by the Economic and Social Research Council (ESRC; grant number RES-060-25-0044). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarts H, 1999, EUR J SOC PSYCHOL, V29, P971, DOI 10.1002/(SICI)1099-0992(199912)29:8<971::AID-EJSP963>3.3.CO;2-1; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Baas D, 2004, BRAIN RES REV, V45, P96, DOI 10.1016/j.brainresrev.2004.02.004; Banks SJ, 2007, SOC COGN AFFECT NEUR, V2, P303, DOI 10.1093/scan/nsm029; Barrett LF, 2009, PHILOS T R SOC B, V364, P1325, DOI 10.1098/rstb.2008.0312; Baumeister RF, 1998, J PERS SOC PSYCHOL, V74, P1252, DOI 10.1037/0022-3514.74.5.1252; Benedek M, 2010, J NEUROSCI METH, V190, P80, DOI 10.1016/j.jneumeth.2010.04.028; Benedek M, 2010, PSYCHOPHYSIOLOGY, V47, P647, DOI 10.1111/j.1469-8986.2009.00972.x; Berkman ET, 2009, NEUROIMAGE, V47, P705, DOI 10.1016/j.neuroimage.2009.04.084; Brett M., 2002, NEUROIMAGE, V16, P497; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Buhle J. T., 2013, CEREB CORTEX, DOI [10.1093/cercor/bht154, DOI 10.1093/CERC0R/BHT154]; Burgess PW, 2003, NEUROPSYCHOLOGIA, V41, P906, DOI 10.1016/S0028-3932(02)00327-5; Burghy CA, 2012, NAT NEUROSCI, V15, P1736, DOI 10.1038/nn.3257; Cabeza R, 2012, TRENDS COGN SCI, V16, P338, DOI 10.1016/j.tics.2012.04.008; Caseras X, 2007, BIOL PSYCHIAT, V62, P464, DOI 10.1016/j.biopsych.2006.10.030; Dahm T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026351; Dale AM, 1999, HUM BRAIN MAPP, V8, P109, DOI 10.1002/(SICI)1097-0193(1999)8:2/3<109::AID-HBM7>3.0.CO;2-W; Diekhof EK, 2011, NEUROIMAGE, V58, P275, DOI 10.1016/j.neuroimage.2011.05.073; Dolcos F, 2006, NEUROREPORT, V17, P1591, DOI 10.1097/01.wnr.0000236860.24081.be; Driscoll D, 2009, INT J PSYCHOPHYSIOL, V72, P61, DOI 10.1016/j.ijpsycho.2008.03.012; Durnez J, 2014, NEUROIMAGE, V84, P45, DOI 10.1016/j.neuroimage.2013.07.072; Eippert F, 2007, HUM BRAIN MAPP, V28, P409, DOI 10.1002/hbm.20291; Eisenberg N, 2000, J PERS SOC PSYCHOL, V78, P136, DOI 10.1037//0022-3514.66.4.776; Etkin A, 2007, AM J PSYCHIAT, V164, P1476, DOI 10.1176/appi.ajp.2007.07030504; Etkin A, 2011, TRENDS COGN SCI, V15, P85, DOI 10.1016/j.tics.2010.11.004; Farrow TFD, 2013, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00349; FRITH CD, 1983, BIOL PSYCHOL, V17, P27, DOI 10.1016/0301-0511(83)90064-9; Fulwiler CE, 2012, NEUROREPORT, V23, P606, DOI 10.1097/WNR.0b013e3283551cfc; Gallo IS, 2009, J PERS SOC PSYCHOL, V96, P11, DOI 10.1037/a0013460; Genovese CR, 2002, NEUROIMAGE, V15, P870, DOI 10.1006/nimg.2001.1037; Gilbert SJ, 2007, SOC COGN AFFECT NEUR, V2, P217, DOI 10.1093/scan/nsm014; Gilbert SJ, 2006, CEREB CORTEX, V16, P1783, DOI 10.1093/cercor/bhj113; Gilbert SJ, 2009, J EXP PSYCHOL LEARN, V35, P905, DOI 10.1037/a0015535; Gilbert SJ, 2006, J EXP PSYCHOL HUMAN, V32, P45, DOI 10.1037/0096-1523.32.1.45; Gilbert SJ, 2005, EUR J NEUROSCI, V21, P1423, DOI 10.1111/j.1460-9568.2005.03981.x; Glascher J, 2003, J NEUROSCI, V23, P10274; Goldin PR, 2008, BIOL PSYCHIAT, V63, P577, DOI 10.1016/j.biopsych.2007.05.031; Golkar A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048107; Gollwitzer P M, 1998, Pers Soc Psychol Rev, V2, P124, DOI 10.1207/s15327957pspr0202_5; Gollwitzer PM, 2006, ADV EXP SOC PSYCHOL, V38, P69, DOI 10.1016/S0065-2601(06)38002-1; Gollwitzer PM, 1999, AM PSYCHOL, V54, P493, DOI 10.1037//0003-066X.54.7.493; Gross JJ, 2003, J PERS SOC PSYCHOL, V85, P348, DOI 10.1037/0022-3514.85.2.348; Gross JJ, 1998, J PERS SOC PSYCHOL, V74, P224, DOI 10.1037/0022-3514.74.1.224; GROSS JJ, 1993, J PERS SOC PSYCHOL, V64, P970, DOI 10.1037/0022-3514.64.6.970; Gross JJ, 2007, HDB EMOTION REGULATI, P3, DOI DOI 10.1080/00140130600971135; Gruber O, 2003, NEUROIMAGE, V19, P797, DOI 10.1016/S1053-8119(03)00089-2; Hampshire A, 2010, NEUROIMAGE, V50, P1313, DOI 10.1016/j.neuroimage.2009.12.109; Hasenkamp W, 2012, NEUROIMAGE, V59, P750, DOI 10.1016/j.neuroimage.2011.07.008; Henson RNA, 2000, NEUROPSYCHOLOGIA, V38, P426, DOI 10.1016/S0028-3932(99)00098-6; Hornak J, 2004, J COGNITIVE NEUROSCI, V16, P463, DOI 10.1162/089892904322926791; Johnstone T, 2007, J NEUROSCI, V27, P8877, DOI 10.1523/JNEUROSCI.2063-07.2007; Kalisch R, 2009, NEUROSCI BIOBEHAV R, V33, P1215, DOI 10.1016/j.neubiorev.2009.06.003; Koenigsberg HW, 2010, NEUROPSYCHOLOGIA, V48, P1813, DOI 10.1016/j.neuropsychologia.2010.03.002; Lang P. J., 1997, NIMH CTR STUDY EMOTI, P39; Lieberman MD, 2009, SOC COGN AFFECT NEUR, V4, P423, DOI 10.1093/scan/nsp052; Lindquist KA, 2012, TRENDS COGN SCI, V16, P533, DOI 10.1016/j.tics.2012.09.005; Lindquist KA, 2012, BEHAV BRAIN SCI, V35, P121, DOI 10.1017/S0140525X11000446; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; Markowitsch HJ, 1998, BEHAV NEUROL, V11, P233; Mazziotta J, 2001, J AM MED INFORM ASSN, V8, P401, DOI 10.1136/jamia.2001.0080401; McDaniel MA, 2008, MEM COGNITION, V36, P716, DOI 10.3758/MC.36.4.716; McDaniel MA, 2010, MEM COGNITION, V38, P221, DOI 10.3758/MC.38.2.221; McRae K, 2010, J COGNITIVE NEUROSCI, V22, P248, DOI 10.1162/jocn.2009.21243; Miezin FM, 2000, NEUROIMAGE, V11, P735, DOI 10.1006/nimg.2000.0568; Mikels JA, 2005, BEHAV RES METHODS, V37, P626, DOI 10.3758/BF03192732; Muhlberger A, 2008, EMOTION, V8, P192, DOI 10.1037/1528-3542.8.2.192; Nili U, 2010, NEURON, V66, P949, DOI 10.1016/j.neuron.2010.06.009; Ochsner KN, 2002, J COGNITIVE NEUROSCI, V14, P1215, DOI 10.1162/089892902760807212; Ochsner KN, 2005, TRENDS COGN SCI, V9, P242, DOI 10.1016/j.tics.2005.03.010; Ochsner KN, 2004, NEUROIMAGE, V23, P483, DOI 10.1016/j.neuroimage.2004.06.030; Ohira H, 2006, NEUROIMAGE, V29, P721, DOI 10.1016/j.neuroimage.2005.08.047; Olatunji BO, 2007, PSYCHOL ASSESSMENT, V19, P281, DOI 10.1037/1040-3590.19.3.281; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Parks-Stamm EJ, 2007, SOC COGNITION, V25, P248, DOI 10.1521/soco.2007.25.2.248; Phan KL, 2005, BIOL PSYCHIAT, V57, P210, DOI 10.1016/j.biopsych.2004.10.030; Phillips M, 2008, MOL PSYCHIATR, V13, P833, DOI 10.1038/mp.2008.65; Richards JM, 2000, J PERS SOC PSYCHOL, V79, P410, DOI 10.1037//0022-3514.79.3.410; Richards JM, 1999, PERS SOC PSYCHOL B, V25, P1033, DOI 10.1177/01461672992511010; Rummel J, 2012, MEMORY, V20, P803, DOI 10.1080/09658211.2012.707214; Schaefer SM, 2002, J COGNITIVE NEUROSCI, V14, P913, DOI 10.1162/089892902760191135; Serences JT, 2004, NEUROIMAGE, V21, P1690, DOI 10.1016/j.neuroimage.2003.12.021; Sergerie K, 2008, NEUROSCI BIOBEHAV R, V32, P811, DOI 10.1016/j.neubiorev.2007.12.002; Shastri A, 2001, J MAGN RESON IMAGING, V14, P187, DOI 10.1002/jmri.1171; Shenhav A, 2013, NEURON, V79, P217, DOI 10.1016/j.neuron.2013.07.007; Shenhav A, 2013, COGN AFFECT BEHAV NE, V13, P46, DOI 10.3758/s13415-012-0128-4; Spence SA, 2008, NEUROIMAGE, V40, P1411, DOI 10.1016/j.neuroimage.2008.01.035; Talairach J., 1988, COPLANAR STEREOTAXIC; Thirion B, 2007, NEUROIMAGE, V35, P105, DOI 10.1016/j.neuroimage.2006.11.054; van Reekum CM, 2011, SOC COGN AFFECT NEUR, V6, P177, DOI 10.1093/scan/nsq031; Vanderhasselt MA, 2006, EXP BRAIN RES, V169, P279, DOI 10.1007/s00221-005-0344-z; Versace A, 2010, BIOL PSYCHIAT, V67, P422, DOI 10.1016/j.biopsych.2009.11.025; Webb TL, 2008, BRIT J SOC PSYCHOL, V47, P373, DOI 10.1348/014466607X267010; Webb TL, 2007, J EXP SOC PSYCHOL, V43, P295, DOI 10.1016/j.jesp.2006.02.001; Webb TL, 2012, EUR REV SOC PSYCHOL, V23, P143, DOI 10.1080/10463283.2012.718134; Webb TL, 2012, PSYCHOL BULL, V138, P775, DOI 10.1037/a0027600; Webb TL, 2004, EUR J SOC PSYCHOL, V34, P407, DOI 10.1002/ejsp.205; Williams LM, 2000, NEUROREPORT, V11, P3011, DOI 10.1097/00001756-200009110-00037	98	41	42	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0119500	10.1371/journal.pone.0119500	http://dx.doi.org/10.1371/journal.pone.0119500			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25798822	Green Accepted, gold, Green Published			2022-12-27	WOS:000351987300054
J	Kepp, KP				Kepp, Kasper P.			Genotype-Property Patient-Phenotype Relations Suggest that Proteome Exhaustion Can Cause Amyotrophic Lateral Sclerosis	PLOS ONE			English	Article							HUMAN SUPEROXIDE-DISMUTASE; WILD-TYPE; MUTANT SOD1; STABILITY CHANGES; HEXANUCLEOTIDE REPEAT; DISEASE PROGRESSION; MOUSE MODEL; MUTATIONS; ALS; AGGREGATION	Late-onset neurodegenerative diseases remain poorly understood as search continues for the perceived pathogenic protein species. Previously, variants in Superoxide Dismutase 1 (SOD1) causing Amyotrophic Lateral Sclerosis (ALS) were found to destabilize and reduce net charge, suggesting a pathogenic aggregation mechanism. This paper reports analysis of compiled patient data and experimental and computed protein properties for variants of human SOD1, a major risk factor of ALS. Both stability and reduced net charge correlate significantly with disease, with larger significance than previously observed. Using two independent methods and two data sets, a probability < 3% (t-statistical test) is found that ALS-causing mutations share average stability with all possible 2907 SOD1 mutations. Most importantly, un-weighted patient survival times correlate strongly with the misfolded/unfolded protein copy number, expressed as an exponential function of the experimental stabilities (R-2 = 0.31, p = 0.002), and this phenotype is further aggravated by charge (R-2 = 0.51, p = 1.8 x 10-5). This finding suggests that disease relates to the copy number of misfolded proteins. Exhaustion of motor neurons due to expensive protein turnover of misfolded protein copies is consistent with the data but can further explain e. g. the expression-dependence of SOD1 pathogenicity, the lack of identification of a molecular toxic mode, elevated SOD1 mRNA levels in sporadic ALS, bioenergetic effects and increased resting energy expenditure in ALS patients, genetic risk factors affecting RNA metabolism, and recent findings that a SOD1 mutant becomes toxic when proteasome activity is recovered after washout of a proteasome inhibitor. Proteome exhaustion is also consistent with energy-producing mitochondria accumulating at the neuromuscular junctions where ALS often initiates. If true, this exhaustion mechanism implies a complete change of focus in treatment of ALS towards actively nursing the energy state and protein turnover of the motor neurons.	Tech Univ Denmark, Dept Chem, DK-2800 Lyngby, Denmark	Technical University of Denmark	Kepp, KP (corresponding author), Tech Univ Denmark, Dept Chem, DK-2800 Lyngby, Denmark.	kpj@kemi.dtu.dk	Kepp, Kasper P./AAA-4626-2021; Kepp, Kasper Planeta/G-1748-2013	Kepp, Kasper P./0000-0002-6754-7348; Kepp, Kasper Planeta/0000-0002-6754-7348				Abel O, 2012, HUM MUTAT, V33, P1345, DOI 10.1002/humu.22157; Abreu IA, 2010, BBA-PROTEINS PROTEOM, V1804, P263, DOI 10.1016/j.bbapap.2009.11.005; Bourassa MW, 2012, METALLOMICS, V4, P721, DOI 10.1039/c2mt20052j; Bouteloup C, 2009, J NEUROL, V256, P1236, DOI 10.1007/s00415-009-5100-z; Brown JA, 2012, AMYOTROPH LATERAL SC, V13, P217, DOI 10.3109/17482968.2011.643899; Browne SE, 2006, NEUROBIOL DIS, V22, P599, DOI 10.1016/j.nbd.2006.01.001; Bruijn LI, 1998, SCIENCE, V281, P1851, DOI 10.1126/science.281.5384.1851; Bystrom R, 2010, J BIOL CHEM, V285, P19544, DOI 10.1074/jbc.M109.086074; Capriotti E, 2005, NUCLEIC ACIDS RES, V33, pW306, DOI 10.1093/nar/gki375; Capriotti E, 2004, BIOINFORMATICS, V20, P63, DOI 10.1093/bioinformatics/bth928; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Conte A, 2012, J NEUROL NEUROSUR PS, V83, P1201, DOI 10.1136/jnnp-2012-302897; Cudkowicz ME, 1997, ANN NEUROL, V41, P210, DOI 10.1002/ana.410410212; Dangoumau A, 2014, NEUROBIOL AGING, V35, DOI 10.1016/j.neurobiolaging.2013.07.012; de Carvalho M, 2011, CURR OPIN NEUROL, V24, P497, DOI 10.1097/WCO.0b013e32834916a9; Dehouck Y, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-151; Dehouck Y, 2009, BIOINFORMATICS, V25, P2537, DOI 10.1093/bioinformatics/btp445; DeJesus-Hernandez M, 2011, NEURON, V72, P245, DOI 10.1016/j.neuron.2011.09.011; Deng HX, 2011, NATURE, V477, P211, DOI 10.1038/nature10353; Deng HX, 2006, P NATL ACAD SCI USA, V103, P7142, DOI 10.1073/pnas.0602046103; Dupuis L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005390; Fecto F, 2011, ARCH NEUROL-CHICAGO, V68, P1440, DOI 10.1001/archneurol.2011.250; Ferraiuolo L, 2011, NAT REV NEUROL, V7, P616, DOI 10.1038/nrneurol.2011.152; Forsberg K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011552; Fukada K, 2001, EUR J NEUROSCI, V14, P2032, DOI 10.1046/j.0953-816x.2001.01828.x; Gagliardi S, 2010, NEUROBIOL DIS, V39, P198, DOI 10.1016/j.nbd.2010.04.008; Genton L, 2011, CLIN NUTR, V30, P553, DOI 10.1016/j.clnu.2011.06.004; Hayward LJ, 2002, J BIOL CHEM, V277, P15923, DOI 10.1074/jbc.M112087200; Heise K, 2003, COMP BIOCHEM PHYS C, V134, P79, DOI 10.1016/S1532-0456(02)00212-0; Ip P, 2011, J MOL BIOL, V409, P839, DOI 10.1016/j.jmb.2011.04.027; Jaarsma D, 2000, NEUROBIOL DIS, V7, P623, DOI 10.1006/nbdi.2000.0299; Johnson JO, 2010, NEURON, V68, P857, DOI 10.1016/j.neuron.2010.11.036; Kepp KP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090504; Kepp KP, 2014, J PHYS CHEM B, V118, P1799, DOI 10.1021/jp4119138; Kepp KP, 2012, CHEM REV, V112, P5193, DOI 10.1021/cr300009x; Kiernan MC, 2011, LANCET, V377, P942, DOI 10.1016/S0140-6736(10)61156-7; Kitamura A, 2014, GENES CELLS, V19, P209, DOI 10.1111/gtc.12125; Kuzma-Kozakiewicz M, 2013, AMYOTROPH LAT SCL FR, V14, P608, DOI 10.3109/21678421.2013.812119; Kwiatkowski TJ, 2009, SCIENCE, V323, P1205, DOI 10.1126/science.1166066; Le Masson G, 2014, NEURON, V83, P975, DOI 10.1016/j.neuron.2014.07.001; Leinartaite L, 2010, J AM CHEM SOC, V132, P13495, DOI 10.1021/ja1057136; Lindberg MJ, 2005, P NATL ACAD SCI USA, V102, P9754, DOI 10.1073/pnas.0501957102; Lu T, 2004, NATURE, V429, P883, DOI 10.1038/nature02661; Magrane J, 2012, J NEUROSCI, V32, P229, DOI 10.1523/JNEUROSCI.1233-11.2012; Majounie E, 2012, LANCET NEUROL, V11, P323, DOI 10.1016/S1474-4422(12)70043-1; Mattiazzi M, 2002, J BIOL CHEM, V277, P29626, DOI 10.1074/jbc.M203065200; Milani P, 2011, NEUROL RES INT, V2011, DOI 10.1155/2011/458427; Nishida Y, 2011, MONATSH CHEM, V142, P375, DOI 10.1007/s00706-010-0444-8; Nordlund A, 2006, P NATL ACAD SCI USA, V103, P10218, DOI 10.1073/pnas.0601696103; Perry JJP, 2010, BBA-PROTEINS PROTEOM, V1804, P245, DOI 10.1016/j.bbapap.2009.11.004; Pfister T, 2013, AMYOTROPH LAT SCL FR, V14, P273, DOI 10.3109/21678421.2012.754044; Pratt AJ, 2012, DEGENER NEUROL NEURO, V2, P1, DOI 10.2147/DNND.S19803; Proctor EA, 2011, J MOL BIOL, V408, P555, DOI 10.1016/j.jmb.2011.03.004; Prudencio M, 2009, HUM MOL GENET, V18, P3217, DOI 10.1093/hmg/ddp260; Redler RL, 2012, PROG MOL BIOL TRANSL, V107, P215, DOI 10.1016/B978-0-12-385883-2.00002-3; Redler RL, 2011, BIOCHEMISTRY-US, V50, P7057, DOI 10.1021/bi200614y; Renton AE, 2014, NAT NEUROSCI, V17, P17, DOI 10.1038/nn.3584; Renton AE, 2011, NEURON, V72, P257, DOI 10.1016/j.neuron.2011.09.010; Richardson K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068256; Robberecht W, 2013, NAT REV NEUROSCI, V14, P248, DOI 10.1038/nrn3430; Roberts BR, 2014, J NEUROSCI, V34, P8021, DOI 10.1523/JNEUROSCI.4196-13.2014; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Sabatelli M, 2013, CLIN GENET, V83, P408, DOI 10.1111/cge.12117; Saccon RA, 2013, BRAIN, V136, P2342, DOI 10.1093/brain/awt097; Sato T, 2005, NEUROLOGY, V65, P1954, DOI 10.1212/01.wnl.0000188760.53922.05; Shaw BF, 2007, TRENDS BIOCHEM SCI, V32, P78, DOI 10.1016/j.tibs.2006.12.005; Shi P, 2010, BBA-MOL BASIS DIS, V1802, P45, DOI 10.1016/j.bbadis.2009.08.012; SHIBATA N, 1994, NEUROSCI LETT, V179, P149, DOI 10.1016/0304-3940(94)90956-3; Somalinga BR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035818; Somalinga BR, 2011, J BIOMOL SCREEN, V16, P974, DOI 10.1177/1087057111418505; Soon CPW, 2011, J BIOL CHEM, V286, P44035, DOI 10.1074/jbc.M111.274407; Sreedharan J, 2008, SCIENCE, V319, P1668, DOI 10.1126/science.1154584; Stathopulos PB, 2006, J BIOL CHEM, V281, P6184, DOI 10.1074/jbc.M509496200; Strange RW, 2006, J MOL BIOL, V356, P1152, DOI 10.1016/j.jmb.2005.11.081; Strong MJ, 2010, J NEUROL SCI, V288, P1, DOI 10.1016/j.jns.2009.09.029; Teilum K, 2009, P NATL ACAD SCI USA, V106, P18273, DOI 10.1073/pnas.0907387106; Tokuriki N, 2009, CURR OPIN STRUC BIOL, V19, P596, DOI 10.1016/j.sbi.2009.08.003; Tortelli R, 2013, NEUROBIOL AGING, V34, DOI 10.1016/j.neurobiolaging.2012.10.027; Valentine JS, 2005, ANNU REV BIOCHEM, V74, P563, DOI 10.1146/annurev.biochem.72.121801.161647; Vance C, 2009, SCIENCE, V323, P1208, DOI 10.1126/science.1165942; Vassall KA, 2011, P NATL ACAD SCI USA, V108, P2210, DOI 10.1073/pnas.0913021108; Wang LJ, 2009, HUM MOL GENET, V18, P1642, DOI 10.1093/hmg/ddp085; Wang Q, 2008, PLOS BIOL, V6, P1508, DOI 10.1371/journal.pbio.0060170; Wang ZJ, 2014, NEUROBIOL AGING, V35, DOI 10.1016/j.neurobiolaging.2013.08.024	84	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0118649	10.1371/journal.pone.0118649	http://dx.doi.org/10.1371/journal.pone.0118649			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25798606	Green Published, gold, Green Submitted			2022-12-27	WOS:000351987300013
J	Mweresa, CK; Otieno, B; Omusula, P; Weldegergis, BT; Verhulst, NO; Dicke, M; van Loon, JJA; Takken, W; Mukabana, WR				Mweresa, Collins K.; Otieno, Bruno; Omusula, Philemon; Weldegergis, Berhane T.; Verhulst, Niels O.; Dicke, Marcel; van Loon, Joop J. A.; Takken, Willem; Mukabana, Wolfgang R.			Understanding the Long-Lasting Attraction of Malaria Mosquitoes to Odor Baits	PLOS ONE			English	Article							SENSU-STRICTO DIPTERA; ANOPHELES-GAMBIAE; HUMAN PATHOGEN; HUMAN SWEAT; IDENTIFICATION; VOLATILES; BEHAVIOR; TRAPS/TARGETS; CULICIDAE; RESPONSES	The use of odor baits for surveillance and control of malaria mosquitoes requires robust dispensing tools. In this study, the residual activity of a synthetic mosquito attractant blend dispensed from nylon or low density polyethylene (LDPE) sachets was evaluated at weekly intervals for one year without re-impregnation. The potential role of bacteria in modulating the attraction of mosquitoes to odor-treated nylon that had been used repeatedly over the one year study period, without re-impregnation, was also investigated. Significantly higher proportions of female Anopheles gambiae sensu stricto mosquitoes were consistently attracted to treated nylon strips than the other treatments, up to one year post-treatment. Additional volatile organic compounds and various bacterial populations were found on the treated nylon strips after one year of repeated use. The most abundant bacteria were Bacillus thuringiensis and Acinetobacter baumannii. Autoclaving of treated nylon strips prior to exposure had no effect on trap collections of laboratory-reared female An. Gambiae (P = 0.17) or wild female An. Gambiae sensu lato (P = 0.26) and Mansonia spp. (P = 0.17) mosquitoes. Trap catches of wild female An. Funestus (P < 0.001) and other anophelines (P < 0.007) were higher when treated strips had been autoclaved prior to deployment as opposed to when the treated nylon strips were not autoclaved. By contrast, wild female Culex mosquitoes were more strongly attracted to non-autoclaved compared to autoclaved treated nylon strips (P < 0.042). This study demonstrates the feasibility of using odor baits for sampling and surveillance of malaria as well as other mosquito vectors over prolonged periods of time. Preliminary evidence points towards the potential role of bacteria in sustaining prolonged use of nylon material for dispensing synthetic attractant odorants for host-seeking malaria and other mosquito vectors but further investigations are required.	[Mweresa, Collins K.; Otieno, Bruno; Omusula, Philemon; Mukabana, Wolfgang R.] Int Ctr Insect Physiol & Ecol, Nairobi, Kenya; [Mweresa, Collins K.; Weldegergis, Berhane T.; Verhulst, Niels O.; Dicke, Marcel; van Loon, Joop J. A.; Takken, Willem] Univ Wageningen & Res Ctr, Entomol Lab, Eh Wageningen, Netherlands; [Mukabana, Wolfgang R.] Univ Nairobi, Sch Biol Sci, Nairobi, Kenya	International Centre of Insect Physiology & Ecology (ICIPE); Wageningen University & Research; University of Nairobi	Mweresa, CK (corresponding author), Int Ctr Insect Physiol & Ecol, POB 30772 GPO, Nairobi, Kenya.	collins.mweresa@yahoo.com	Verhulst, Niels/AAH-4288-2019; Dicke, Marcel/B-2300-2010; van Loon, Joop J.A./B-3744-2009	Dicke, Marcel/0000-0001-8565-8896; van Loon, Joop J.A./0000-0002-4260-0501; Verhulst, Niels/0000-0002-1106-9711; Weldegergis, Berhane T./0000-0001-8838-7876	Foundation of the National institutes of Health (FNIH) through the Grand Challenges in Global Health initiative (GCGH) [121]	Foundation of the National institutes of Health (FNIH) through the Grand Challenges in Global Health initiative (GCGH)	This work was supported by the Foundation of the National institutes of Health (FNIH) through the Grand Challenges in Global Health initiative (GCGH#121); URL - www.fnih.org/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agresti A., 2013, CATEGORICAL DATA ANA, V3rd ed.; Bernier UR, 2000, ANAL CHEM, V72, P747, DOI 10.1021/ac990963k; Braks MAH, 1999, PARASITOL TODAY, V15, P409, DOI 10.1016/S0169-4758(99)01514-8; Braks MAH, 1999, J CHEM ECOL, V25, P663, DOI 10.1023/A:1020970307748; CHANDLER JA, 1975, J MED ENTOMOL, V12, P504, DOI 10.1093/jmedent/12.5.504; Cook SM, 2007, ANNU REV ENTOMOL, V52, P375, DOI 10.1146/annurev.ento.52.110405.091407; Cork A, 2004, PHEROMONE MANUAL; Drancourt M, 2000, J CLIN MICROBIOL, V38, P3623, DOI 10.1128/JCM.38.10.3623-3630.2000; Drancourt M, 1997, INT J SYST BACTERIOL, V47, P160, DOI 10.1099/00207713-47-1-160; Gillies M. T., 1987, A supplement to the Anophelinae of Africa south of the Sahara (Afrotropical Region).; Greenwood Brian, 2009, Trans R Soc Trop Med Hyg, V103 Suppl 1, pS2, DOI 10.1016/j.trstmh.2008.10.027; Imbahale SS, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-130; James A G, 2004, Int J Cosmet Sci, V26, P149, DOI 10.1111/j.1467-2494.2004.00214.x; James AG, 2004, WORLD J MICROB BIOT, V20, P787, DOI 10.1007/s11274-004-5843-8; Jawara M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019676; Jawara M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008167; Kline DL, 2007, J AM MOSQUITO CONTR, V23, P241, DOI 10.2987/8756-971X(2007)23[241:STAMTT]2.0.CO;2; Kline DL, 2006, J AM MOSQUITO CONTR, V22, P490, DOI 10.2987/8756-971X(2006)22[490:TATTFA]2.0.CO;2; Kline DL, 1998, J VECTOR ECOL, V23, P171; Logan J. G., 2008, Outlooks on Pest Management, V19, P280, DOI 10.1564/19dec14; Logan JG, 2008, J CHEM ECOL, V34, P308, DOI 10.1007/s10886-008-9436-0; LOUWS FJ, 1994, APPL ENVIRON MICROB, V60, P2286, DOI 10.1128/AEM.60.7.2286-2295.1994; Meijerink J, 2000, J CHEM ECOL, V26, P1367, DOI 10.1023/A:1005475422978; Mendis K, 2009, TROP MED INT HEALTH, V14, P802, DOI 10.1111/j.1365-3156.2009.02287.x; Mihok S, 2007, MED VET ENTOMOL, V21, P70, DOI 10.1111/j.1365-2915.2007.00665.x; Mukabana WR, 2012, J CHEM ECOL, V38, P235, DOI 10.1007/s10886-012-0088-8; Mukabana WR, 2012, PARASITE VECTOR, V50, P123; Okumu F, 2010, MED ENTOMOL, V47, P8; Okumu FO, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008951; Pates HV, 2001, B ENTOMOL RES, V91, P289, DOI 10.1079/BER200198; Pickett JA, 2010, J CHEM ECOL, V36, P113, DOI 10.1007/s10886-010-9739-9; Qiu YT, 2004, MED VET ENTOMOL, V18, P429, DOI 10.1111/j.0269-283X.2004.00534.x; Raaijmakers JM, 2009, PLANT SOIL, V321, P341, DOI 10.1007/s11104-008-9568-6; Schmied WH, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-230; Schulz S, 2007, NAT PROD REP, V24, P814, DOI 10.1039/b507392h; Smallegange RC, 2005, CHEM SENSES, V30, P145, DOI 10.1093/chemse/bji010; Smallegange RC, 2012, PHYSIOL ENTOMOL, V37, P60, DOI 10.1111/j.1365-3032.2011.00827.x; Smallegange RC, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-292; Smallegange RC, 2010, ECOL CONT VECTOR-BOR, V2, P143; SMITH T, 1995, J AM MOSQUITO CONTR, V11, P377; Takken W, 1999, ANNU REV ENTOMOL, V44, P131, DOI 10.1146/annurev.ento.44.1.131; Torr SJ, 1997, B ENTOMOL RES, V87, P299, DOI 10.1017/S0007485300037251; Verhulst NO, 2011, ENTOMOL EXP APPL, V139, P170, DOI 10.1111/j.1570-7458.2011.01119.x; Verhulst NO, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-28; Verhulst NO, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015829; Verhulst NO, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-302; WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/JB.173.2.697-703.1991; Wood AP, 2010, HDB HYDROCARBON LIPI, DOI [10.1007/978-3-540-77587-4_243, DOI 10.1007/978-3-540-77587-4_243]; World Health Organization, 1975, WHO MAN PRACT ENT 2	49	11	11	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0121533	10.1371/journal.pone.0121533	http://dx.doi.org/10.1371/journal.pone.0121533			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25798818	Green Submitted, Green Published, gold			2022-12-27	WOS:000351987300264
J	Roosink, M; McFadyen, BJ; Hebert, LJ; Jackson, PL; Bouyer, LJ; Mercier, C				Roosink, Meyke; McFadyen, Bradford J.; Hebert, Luc J.; Jackson, Philip L.; Bouyer, Laurent J.; Mercier, Catherine			Assessing the Perception of Trunk Movements in Military Personnel with Chronic Non-Specific Low Back Pain Using a Virtual Mirror	PLOS ONE			English	Article							REPOSITIONING ERROR; MOTOR IMAGERY; BODY SCHEMA; REPRESENTATIONS; MODULATION; POSITION; PEOPLE; FEAR	Chronic pain, including chronic non-specific low back pain (CNSLBP), is often associated with body perception disturbances, but these have generally been assessed under static conditions. The objective of this study was to use a "virtual mirror" that scaled visual movement feedback to assess body perception during active movement in military personnel with CNSLBP (n = 15) as compared to military healthy control subjects (n = 15). Subjects performed a trunk flexion task while sitting and standing in front of a large screen displaying a full-body virtual mirror-image (avatar) in real-time. Avatar movements were scaled to appear greater, identical, or smaller than the subjects' actual movements. A total of 126 trials with 11 different scaling factors were pseudo-randomized across 6 blocks. After each trial, subjects had to decide whether the avatar's movements were "greater" or "smaller" than their own movements. Based on this two-alternative forced choice paradigm, a psychophysical curve was fitted to the data for each subject, and several metrics were derived from this curve. In addition, task adherence (kinematics) and virtual reality immersion were assessed. Groups displayed a similar ability to discriminate between different levels of movement scaling. Still, subjects with CNSLBP showed an abnormal performance and tended to overestimate their own movements (a right-shifted psychophysical curve). Subjects showed adequate task adherence, and on average virtual reality immersion was reported to be very good. In conclusion, these results extend previous work in patients with CNSLBP, and denote an important relationship between body perception, movement and pain. As such, the assessment of body perception during active movement can offer new avenues for understanding and managing body perception disturbances and abnormal movement patterns in patients with pain.	[Roosink, Meyke; McFadyen, Bradford J.; Hebert, Luc J.; Jackson, Philip L.; Bouyer, Laurent J.; Mercier, Catherine] CIRRIS, Quebec City, PQ, Canada; [McFadyen, Bradford J.; Hebert, Luc J.; Bouyer, Laurent J.; Mercier, Catherine] Univ Laval, Fac Med, Dept Rehabil, Quebec City, PQ G1K 7P4, Canada; [Hebert, Luc J.] Valcartier Garrison, Canadian Forces Hlth Serv Grp Headquarters, Directorate Med Policy Physiotherapy, Quebec City, PQ, Canada; [Hebert, Luc J.] Univ Laval, Fac Med, Dept Radiol, Quebec City, PQ G1K 7P4, Canada; [Jackson, Philip L.] Univ Laval, Sch Psychol, Quebec City, PQ, Canada	Laval University; Laval University; Laval University; Laval University	Mercier, C (corresponding author), CIRRIS, Quebec City, PQ, Canada.	Catherine.Mercier@rea.ulaval.ca	Bouyer, Laurent J/A-9255-2010; Bouyer, Laurent/L-6471-2019	Bouyer, Laurent J/0000-0003-2034-4516; Bouyer, Laurent/0000-0003-2034-4516; Mercier, Catherine/0000-0002-2037-6916; Jackson, Philip/0000-0001-8991-3217; McFadyen, Bradford/0000-0003-1992-4927; Hebert, Luc J./0000-0001-8903-5258	Surgeon General Health Research Program (Canadian Armed Forces) [2011-07-038-004-0002]; Fonds de recherche Quebec-Sante; SensoriMotor Rehabilitation Research Team as part of the Regenerative Medicine; Nanomedicine Strategic Initiative of the Canadian Institute for Health Research; Canadian Institute for Health Research	Surgeon General Health Research Program (Canadian Armed Forces); Fonds de recherche Quebec-Sante; SensoriMotor Rehabilitation Research Team as part of the Regenerative Medicine; Nanomedicine Strategic Initiative of the Canadian Institute for Health Research; Canadian Institute for Health Research(Canadian Institutes of Health Research (CIHR))	Funding: Funding provided by Surgeon General Health Research Program (Canadian Armed Forces), 2011-07-038-004-0002, http://www.forces.gc.ca, Research Grant-BM LH CM LB PJ, Fonds de recherche Quebec-Sante, http://www.frqs.gouv.qc.ca, Postdoctoral fellowship-MR, Salary Grants-CM PLJ, SensoriMotor Rehabilitation Research Team as part of the Regenerative Medicine, and the Nanomedicine Strategic Initiative of the Canadian Institute for Health Research, (http://errsm.ca/), Postdoctoral fellowship-MR and Canadian Institute for Health Research, http://www.cihr-irsc.gc.ca, Salary Grants-CM PJL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anonymous, 2008, Annales de Readaptation et de Medecine Physique, V51, P379, DOI 10.1016/j.annrmp.2008.03.006; Balague F, 2012, LANCET, V379, P482, DOI 10.1016/S0140-6736(11)60610-7; Bouffard J, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00077; Bowering KJ, 2014, CLIN J PAIN, V30, P1070, DOI 10.1097/AJP.0000000000000066; Claeys K, 2013, EUR J APPL PHYSL, V111, P115; Coslett HB, 2010, J INT NEUROPSYCH SOC, V16, P603, DOI 10.1017/S1355617710000299; de Lussanet MHE, 2013, HUM MOVEMENT SCI, V32, P938, DOI 10.1016/j.humov.2013.05.002; de Lussanet MHE, 2012, PAIN, V153, P1459, DOI 10.1016/j.pain.2012.04.002; de Vignemont F, 2010, NEUROPSYCHOLOGIA, V48, P669, DOI 10.1016/j.neuropsychologia.2009.09.022; Fairbank JCT, 2000, SPINE, V25, P2940, DOI 10.1097/00007632-200011150-00017; George SZ, 2009, PHYS THER, V89, P969, DOI 10.2522/ptj.20090032; Geva N, 2013, PAIN, V154, P2317, DOI 10.1016/j.pain.2013.06.031; Haggard P, 2013, CURR BIOL, V23, pR164, DOI 10.1016/j.cub.2013.01.047; Hebert JS, 2014, 2D01 NEW TREATMENT P, P36; Hidalgo B, 2013, J BACK MUSCULOSKELET, V26, P381, DOI 10.3233/BMR-130396; Hodges PW, 2015, CLIN J PAIN, V31, P97, DOI 10.1097/AJP.0000000000000098; Kori SH, 1990, PAIN MANAG, V3, P35; Leeuw M, 2007, J BEHAV MED, V30, P77, DOI 10.1007/s10865-006-9085-0; Legrain V, 2012, PAIN, V153, P948, DOI 10.1016/j.pain.2011.12.010; Lewis JS, 2010, PAIN, V149, P463, DOI 10.1016/j.pain.2010.02.007; Lewis JS, 2010, PRACTICAL PAIN MANAG, V10, P1; Llobera J, 2013, EXP BRAIN RES, V225, P105, DOI 10.1007/s00221-012-3352-9; Longo MR, 2010, P NATL ACAD SCI USA, V107, P11727, DOI 10.1073/pnas.1003483107; Mann L, 2010, J BODYW MOV THER, V14, P361, DOI 10.1016/j.jbmt.2009.06.007; Mehling WE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005614; Moseley GL, 2008, PAIN, V140, P239, DOI 10.1016/j.pain.2008.08.001; Moseley GL, 2012, NEUROREHAB NEURAL RE, V26, P646, DOI 10.1177/1545968311433209; O'Sullivan K, 2013, MANUAL THER, V18, P526, DOI 10.1016/j.math.2013.05.005; Peltz E, 2011, J PAIN, V12, P1095, DOI 10.1016/j.jpain.2011.05.001; Proske U, 2012, PHYSIOL REV, V92, P1651, DOI 10.1152/physrev.00048.2011; Roosink M, 2015, J NEUROENG REHABIL, V12, DOI 10.1186/1743-0003-12-2; Schack T, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00328; SIRIGU A, 1991, BRAIN, V114, P629, DOI 10.1093/brain/114.1.629; Stenneken P, 2006, NEUROREPORT, V17, P545, DOI 10.1097/01.wnr.0000209013.01470.f8; Thurm BE, 2013, PERCEPT MOTOR SKILL, V116, P544, DOI 10.2466/15.27.PMS.116.2.544-553; Trojan J, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00369; Turton AJ, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00517; Uematsu H, 2009, ANN ACAD MED SINGAP, V38, P931; VLAEYEN JWS, 1995, PAIN, V62, P363, DOI 10.1016/0304-3959(94)00279-N; Witmer BG, 1998, PRESENCE-TELEOP VIRT, V7, P225, DOI 10.1162/105474698565686; Wright WG, 2014, FRONT SYST NEUROSCI, V8, DOI 10.3389/fnsys.2014.00056	41	11	12	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0120251	10.1371/journal.pone.0120251	http://dx.doi.org/10.1371/journal.pone.0120251			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25799009	Green Published, gold			2022-12-27	WOS:000351987300115
J	Vitkov, L; Krautgartner, WD; Obermayer, A; Stoiber, W; Hannig, M; Klappacher, M; Hartl, D				Vitkov, Ljubomir; Krautgartner, Wolf-Dietrich; Obermayer, Astrid; Stoiber, Walter; Hannig, Matthias; Klappacher, Michaela; Hartl, Dominik			The Initial Inflammatory Response to Bioactive Implants Is Characterized by NETosis	PLOS ONE			English	Article							NEUTROPHIL EXTRACELLULAR TRAPS; BONE-FORMATION ADJACENT; TITANIUM IMPLANTS; PULMONARY RESPONSES; IN-VITRO; PLATELETS; ACTIVATION; SURFACES; COMPLEMENT; ADHESION	Implants trigger an inflammatory response, which is important for osseointegration. Here we studied neutrophil extracellular trap (NET) release of human neutrophils in response to sandblasted large-grit acid etched (SLA) implants using fluorescent, confocal laser scanning and scanning electron microscopy. Our studies demonstrate that human neutrophils rapidly adhered to SLA surfaces, which triggered histone citrullination and NET release. Further studies showed that albumin or acetylsalicylic acid had no significant effects on the inflammatory response to SLA surfaces. In contrast to bioinert materials, which do not osseointegrate, the bioactivity of SLA surfaces is coupled with the ability to release NETs. Further investigations are necessary for clarifying the role of NETosis for osseointegration.	[Vitkov, Ljubomir; Krautgartner, Wolf-Dietrich; Obermayer, Astrid; Stoiber, Walter; Klappacher, Michaela] Salzburg Univ, Cell Biol, Dept Zool Struct Res, A-5020 Salzburg, Austria; [Vitkov, Ljubomir; Hannig, Matthias] Univ Saarland, Clin Operat Dent Periodontol & Prevent Dent, Homburg, Germany; [Hartl, Dominik] Univ Tubingen, Childrens Hosp, Tubingen, Germany; [Hartl, Dominik] Univ Tubingen, Interdisciplinary Ctr Infect Dis, Tubingen, Germany	Salzburg University; Saarland University; Eberhard Karls University of Tubingen; TUBINGEN UNIVERSITY CHILDRENS HOSPITAL; Eberhard Karls University of Tubingen	Vitkov, L (corresponding author), Salzburg Univ, Cell Biol, Dept Zool Struct Res, A-5020 Salzburg, Austria.	lvitkov@yahoo.com; dominik.hartl@med.uni-tuebingen.de	Vitkov, Ljubomir/H-5873-2019	Vitkov, Ljubomir/0000-0002-1249-0161	Deutsche Forschungsgemeinschaft; Tuebingen University; Dental Ratio Company (Langenfeld, NRW, Germany)	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Tuebingen University; Dental Ratio Company (Langenfeld, NRW, Germany)	The authors acknowledge support by Deutsche Forschungsgemeinschaft and Open Access Publishing Fund of Tuebingen University. The authors thank the Dental Ratio Company (Langenfeld, NRW, Germany) for supply of SLA titanium test plates and financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AARONS L, 1980, J PHARM PHARMACOL, V32, P537, DOI 10.1111/j.2042-7158.1980.tb12991.x; Abrahamsson I, 2004, CLIN ORAL IMPLAN RES, V15, P381, DOI 10.1111/j.1600-0501.2004.01082.x; Ayukawa Y, 2010, J ORAL REHABIL, V37, P123, DOI 10.1111/j.1365-2842.2009.02011.x; Berglundh T, 2003, CLIN ORAL IMPLAN RES, V14, P251, DOI 10.1034/j.1600-0501.2003.00972.x; Bonner JC, 2013, ENVIRON HEALTH PERSP, V121, P676, DOI 10.1289/ehp.1205693; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; CARLSSON L, 1994, J ORTHOP RES, V12, P274, DOI 10.1002/jor.1100120218; Caudrillier A, 2012, J CLIN INVEST, V122, P2661, DOI 10.1172/JCI61303; Chow OA, 2010, CELL HOST MICROBE, V8, P445, DOI 10.1016/j.chom.2010.10.005; Ciapetti G, 1998, J BIOMED MATER RES, V41, P455, DOI 10.1002/(SICI)1097-4636(19980905)41:3<455::AID-JBM15>3.0.CO;2-H; Clark SR, 2007, NAT MED, V13, P463, DOI 10.1038/nm1565; Cochran DL, 2011, INT J ORAL MAX IMPL, V26, P1324; DAVISON C, 1971, ANN NY ACAD SCI, V179, P249, DOI 10.1111/j.1749-6632.1971.tb46905.x; DONATH K, 1992, VIRCHOWS ARCH A, V420, P131, DOI 10.1007/BF02358804; Eriksson C, 1997, COLLOID SURFACE B, V9, P67, DOI 10.1016/S0927-7765(97)00010-6; Eriksson C, 2001, BIOMATERIALS, V22, P1987, DOI 10.1016/S0142-9612(00)00382-3; Eriksson C, 1997, J BIOMED MATER RES, V37, P130, DOI 10.1002/(SICI)1097-4636(199710)37:1<130::AID-JBM16>3.0.CO;2-K; Fuchs TA, 2007, J CELL BIOL, V176, P231, DOI 10.1083/jcb.200606027; Goncalves DM, 2010, TOXICOL IN VITRO, V24, P1002, DOI 10.1016/j.tiv.2009.12.007; Gupta AK, 2005, HUM IMMUNOL, V66, P1146, DOI 10.1016/j.humimm.2005.11.003; Gupta AK, 2007, SEMIN IMMUNOPATHOL, V29, P163, DOI 10.1007/s00281-007-0073-4; Hahn S, 2006, SPRINGER SEMIN IMMUN, V27, P477, DOI 10.1007/s00281-006-0016-5; Hakkim A, 2010, P NATL ACAD SCI USA, V107, P9813, DOI 10.1073/pnas.0909927107; HEDENBORG M, 1988, INT ARCH OCC ENV HEA, V61, P1, DOI 10.1007/BF00381600; Hong J, 2013, CLIN IMPLANT DENT R, V15, P105, DOI 10.1111/j.1708-8208.2011.00362.x; JACOBSSON SA, 1994, J BONE JOINT SURG BR, V76B, P831, DOI 10.1302/0301-620X.76B5.8083279; Kahlenberg JM, 2013, J IMMUNOL, V190, P1217, DOI 10.4049/jimmunol.1202388; Kessenbrock K, 2009, NAT MED, V15, P623, DOI 10.1038/nm.1959; Le Guehennec L, 2007, DENT MATER, V23, P844, DOI 10.1016/j.dental.2006.06.025; Lethaus B, 2011, INT J ORAL MAX IMPL, V26, P887; Li B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055563; Marcos V, 2009, BLOOD, V114, P4908, DOI 10.1182/blood-2009-09-242388; Milleret V, 2011, EUR CELLS MATER, V21, P430, DOI 10.22203/eCM.v021a32; Mitchell GB, 2003, INFECT IMMUN, V71, P1643, DOI 10.1128/IAI.71.4.1643-1649.2003; Mohamed BM, 2012, NANOMEDICINE-UK, V7, P1181, DOI 10.2217/nnm.11.177; Moriyama Y, 2008, CLIN ORAL IMPLAN RES, V19, P600, DOI 10.1111/j.1600-0501.2007.01508.x; Nardi M, 2004, J CLIN INVEST, V113, P973, DOI 10.1172/JCI200420726; Nardi M, 2001, CELL, V106, P551, DOI 10.1016/S0092-8674(01)00477-9; Neeli I, 2008, J IMMUNOL, V180, P1895, DOI 10.4049/jimmunol.180.3.1895; Nimeri G, 2002, BIOMATERIALS, V23, P1785, DOI 10.1016/S0142-9612(01)00305-2; Noel A, 2013, PART FIBRE TOXICOL, V10, DOI 10.1186/1743-8977-10-48; Nygren H, 1997, J LAB CLIN MED, V129, P35, DOI 10.1016/S0022-2143(97)90159-1; Rao PJ, 2014, ORTHOP SURG, V6, P81, DOI 10.1111/os.12098; Remijsen Q, 2011, CELL DEATH DIFFER, V18, P581, DOI 10.1038/cdd.2011.1; Ribeiro FV, 2006, J PERIODONTOL, V77, P1731, DOI 10.1902/jop.2006.060119; ROTH RI, 1993, TRANSFUSION, V33, P919, DOI 10.1046/j.1537-2995.1993.331194082383.x; Sall J, 2013, J INNATE IMMUN, V5, P290, DOI 10.1159/000346587; TRANCIK T, 1989, CLIN ORTHOP RELAT R, P113; Van Dyke TE, 2015, J DENT RES, V94, P148, DOI 10.1177/0022034514557331; von Bruhl ML, 2012, J EXP MED, V209, P819, DOI 10.1084/jem.20112322; Wang YM, 2009, J CELL BIOL, V184, P205, DOI 10.1083/jcb.200806072; Wettero J, 2003, J BIOMED MATER RES A, V66A, P162, DOI 10.1002/jbm.a.10591; Wettero J, 2003, BIOMATERIALS, V24, P1559, DOI 10.1016/S0142-9612(02)00543-4; Wettero J, 2000, J BIOMED MATER RES, V51, P742, DOI 10.1002/1097-4636(20000915)51:4<742::AID-JBM24>3.0.CO;2-D; Yin H, 2011, J ARTHROPLASTY, V26, P1534, DOI 10.1016/j.arth.2010.10.008	55	18	18	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0121359	10.1371/journal.pone.0121359	http://dx.doi.org/10.1371/journal.pone.0121359			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25798949	gold, Green Submitted, Green Published			2022-12-27	WOS:000351987300245
J	Wang, Y; Xie, GQ; Huang, YH; Zhang, H; Yang, B; Mao, ZG				Wang, Yong; Xie, Guoqiang; Huang, Yuanhang; Zhang, Han; Yang, Bo; Mao, Zhiguo			Calcium Acetate or Calcium Carbonate for Hyperphosphatemia of Hemodialysis Patients: A Meta-Analysis	PLOS ONE			English	Article							PHOSPHORUS BINDERS; PHOSPHATE BINDERS; SERUM PHOSPHORUS; MORTALITY RISK; OUTCOMES; FAILURE	Background High levels of serum phosphorus both at baseline and during follow-up are associated with increased mortality in dialysis patients, and administration of phosphate binders was independently associated with improved survival among hemodialysis population. Calcium-based phosphate binders are the most commonly used phosphate binders in developing countries for their relatively low costs. Objectives To compare the efficacy and safety between calcium carbonate and calcium acetate in the treatment of hyperphosphatemia in hemodialysis patients. Methods PubMed, EMBASE, Cochrane Library, Google scholar and Chinese databases (Wanfang, Weipu, National Knowledge Infrastructure of China) were searched for relevant studies published before March 2014. Reference lists of nephrology textbooks and review articles were checked. A meta-analysis of randomized controlled trials (RCTs) and quasi-RCTs that assessed the effects and adverse events of calcium acetate and calcium carbonate in adult patients with MHD was performed using Review Manager 5.0. Results A total of ten studies (625 participants) were included in this meta-analysis. There was insufficient data in all-cause mortality and cardiovascular events for meta-analysis. Compared with calcium carbonate group, the serum phosphorus was significantly lower in calcium acetate group after4 weeks' administration (MD -0.15 mmol/L, 95% CI -0.28 to -0.01) and after 8 weeks' administration (MD -0.25 mmol/L, 95% CI -0.40 to -0.11). There was no difference in serum calcium levels or the incidence of hypercalcemia between two groups at 4 weeks and 8 weeks. No statistical difference was found in parathyroid hormone (PTH) levels or serum calcium by phosphorus (Ca x P) product. There was significantly higher risk of intolerance with calcium acetate treatment (RR 3.46, 95% CI 1.48 to 8.26). Conclusions For hyperphosphatemia treatment, calcium acetate showed better efficacy and with a higher incidence of intolerance compared with calcium carbonate. There are insufficient data to establish the comparative superiority of the two calcium-based phosphate binders on all-cause mortality and cardiovascular end-points in hemodialysis patients.	[Wang, Yong] CPLA 422 Hosp, Div Hemodialysis, Zhanjiang, Guangdong, Peoples R China; [Xie, Guoqiang; Yang, Bo; Mao, Zhiguo] Second Mil Med Univ, Changzheng Hosp, Div Nephrol, Kidney Inst CPLA, Shanghai, Peoples R China; [Huang, Yuanhang] Guangzhou Mil Reg, Div Nephrol, Gen Hosp, Guangzhou, Guangdong, Peoples R China; [Zhang, Han] Second Mil Med Univ, Eastern Hepatobiliary Surg Hosp, Dept Hepat Surg, Shanghai, Peoples R China	Naval Medical University; Naval Medical University	Mao, ZG (corresponding author), Second Mil Med Univ, Changzheng Hosp, Div Nephrol, Kidney Inst CPLA, Shanghai, Peoples R China.	maozhiguo93@126.com	Barretti, Pasqual/K-4156-2012	Barretti, Pasqual/0000-0003-4979-4836	Chinese Society of Nephrology [13030340419]; Major Fundamental Research Program of Shanghai Committee of Science and Technology [12DJ1400300]; Key Projects in the National Science & Technology Pillar Program in the Twelfth Five-year Plan Period [2011BAI10B00]	Chinese Society of Nephrology; Major Fundamental Research Program of Shanghai Committee of Science and Technology; Key Projects in the National Science & Technology Pillar Program in the Twelfth Five-year Plan Period	Zhiguo Mao is an Outstanding Young Scholar of Second Military Medical University. This work was supported by Chinese Society of Nephrology (No. 13030340419), Major Fundamental Research Program of Shanghai Committee of Science and Technology (No. 12DJ1400300) and Key Projects in the National Science & Technology Pillar Program in the Twelfth Five-year Plan Period (No. 2011BAI10B00). The funders of this research had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afifi A, 2005, INT S HOME HEMODIALY, V9, P409; ALMIRALL J, 1994, AM J NEPHROL, V14, P192, DOI 10.1159/000168713; Block GA, 1998, AM J KIDNEY DIS, V31, P607, DOI 10.1053/ajkd.1998.v31.pm9531176; CARAVACA F, 1992, NEPHRON, V60, P423, DOI 10.1159/000186802; Cubbon RM, 2014, J NEPHROL; d'Almeida Filho  E J, 2000, Sao Paulo Med J, V118, P179; EMMETT M, 1991, AM J KIDNEY DIS, V17, P544, DOI 10.1016/S0272-6386(12)80496-3; Isakova T, 2009, J AM SOC NEPHROL, V20, P388, DOI 10.1681/ASN.2008060609; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Jamal SA, 2013, LANCET, V382, P1268, DOI 10.1016/S0140-6736(13)60897-1; Janssen MJA, 1996, CLIN NEPHROL, V45, P111; Liu Q, 2013, ZHEJIANG MED J, V39, P672, DOI [10.1136/medethics-2013-101815, DOI 10.1136/MEDETHICS-2013-101815]; [陆任华 Lu Renhua], 2013, [中华肾脏病杂志, Chinese Journal of Nephrology], V29, P429; MAI ML, 1989, KIDNEY INT, V36, P690, DOI 10.1038/ki.1989.247; Navaneethan SD, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006023.pub2; PFLANZ S, 1994, NEPHROL DIAL TRANSPL, V9, P1121, DOI 10.1093/ndt/9.8.1121; RING T, 1993, NEPHROL DIAL TRANSPL, V8, P341; Saif Imran, 2007, J Ayub Med Coll Abbottabad, V19, P26; SHEIKH MS, 1989, J CLIN INVEST, V83, P66, DOI 10.1172/JCI113886; Tao YM, 2011, J PRACTICAL MED, V27, P4008; Tentori F, 2008, AM J KIDNEY DIS, V52, P519, DOI 10.1053/j.ajkd.2008.03.020; Tonelli M, 2010, NEW ENGL J MED, V362, P1312, DOI 10.1056/NEJMra0912522; Wang CF, 2012, CHINESE J PRACTICAL, V39, P96; Yusuf AA, 2014, AM J KIDNEY DIS, V64, P95, DOI 10.1053/j.ajkd.2013.11.015; Zhang M, 2013, CLIN MED CHINA, V29, P1285	25	4	4	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0121376	10.1371/journal.pone.0121376	http://dx.doi.org/10.1371/journal.pone.0121376			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25799184	Green Published, Green Submitted, gold			2022-12-27	WOS:000351987300247
J	Chen, YC; Tsai, PJ; Huang, YB; Wu, PC				Chen, Yi-Cheng; Tsai, Pi-Ju; Huang, Yaw-Bin; Wu, Pao-Chu			Optimization and Validation of High-Performance Chromatographic Condition for Simultaneous Determination of Adapalene and Benzoyl Peroxide by Response Surface Methodology	PLOS ONE			English	Article							MILD ACNE-VULGARIS; RANDOMIZED-TRIAL; TRETINOIN GEL; EFFICACY; SAFETY; TOLERABILITY; FORMULATION; HPLC; ACID	The aim of this study was to develop a simple and reliable high-performance chromatographic (HPLC) method for simultaneous analysis of adapalene and benzoyl peroxide in pharmaceutical formulation by response surface methodology (RSM). An optimized mobile phase composed of acetonitrile, tetrahydrofuran and water containing 0.1% acetic acid at a ratio of 25: 50: 25 by volume was successfully predicted by using RSM. An isocratic separation was achieved by using the condition. Furthermore, the analytical method was validated in terms of specificity, linearity, accuracy and precision in a range of 80% to 120% of the expected concentration. Finally, the method was successfully applied to the analysis of a commercial product.	[Chen, Yi-Cheng; Huang, Yaw-Bin; Wu, Pao-Chu] Kaohsiung Med Univ, Coll Pharm, Sch Pharm, Kaohsiung, Taiwan; [Tsai, Pi-Ju] I Shou Univ, Dept Business Adm, Kaohsiung, Taiwan	Kaohsiung Medical University; I Shou University	Wu, PC (corresponding author), Kaohsiung Med Univ, Coll Pharm, Sch Pharm, Kaohsiung, Taiwan.	pachwu@kmu.edu.tw		Huang, Yaw-Bin/0000-0002-6024-0108	National Science Council of Taiwan [NSC 93-2320-B-037-050]; Standard Chem & Pharm Co., LTD.	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); Standard Chem & Pharm Co., LTD.	This work was supported by grant from the National Science Council of Taiwan (NSC 93-2320-B-037-050) and Standard Chem & Pharm Co., LTD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali MS, 2008, J AOAC INT, V91, P1025; [Anonymous], 2011, US PHARM USP 34 NAT; Babaeinejad SH, 2013, J DRUGS DERMATOL, V12, P1033; Babaeinejad SH, 2013, J DRUGS DERMATOL, V12, P790; Berson Diane, 2013, J Clin Aesthet Dermatol, V6, P32; Convention TUSP, 2013, US PHARM USP 36 NAT; Cunliffe WJ, 1997, J AM ACAD DERMATOL, V36, pS126, DOI 10.1016/S0190-9622(97)70056-2; FDA Food and Drug Administration, FDA GUID IND BIOAN M; Fu Lisa W, 2011, Skin Therapy Lett, V16, P3; Ghodsi SZ, 2009, J INVEST DERMATOL, V129, P2136, DOI 10.1038/jid.2009.47; Goreshi R, 2012, J DRUGS DERMATOL, V11, P1422; ICH International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use: Q2(R1), 1994, ICH INT C HARM TECHN; Lewis GA., 1999, PHARM EXPT DESIGN; Leyden JJ, 2003, J AM ACAD DERMATOL, V49, pS200, DOI 10.1067/S0190-9622(03)01154-X; LEYDEN JJ, 1995, J AM ACAD DERMATOL, V32, pS15, DOI 10.1016/0190-9622(95)90416-6; Magin Parker, 2006, Can Fam Physician, V52, P978; Malzert-Freon A, 2010, J PHARM SCI-US, V99, P4603, DOI 10.1002/jps.22177; Martin B, 1998, BRIT J DERMATOL, V139, P8; Martins LA, 2011, J CHROMATOGR SCI, V49, P796, DOI 10.1093/chrsci/49.10.796; Mu GF, 2012, J SCI FOOD AGR, V92, P960, DOI 10.1002/jsfa.4677; Shalita A, 1996, J AM ACAD DERMATOL, V34, P482, DOI 10.1016/S0190-9622(96)90443-0; Strauss JS, 2007, J AM ACAD DERMATOL, V56, P651, DOI 10.1016/j.jaad.2006.08.048; Tan JP, 2009, WOR BANK WORK PAPER, P1; Thakur Naresh Kumar, 2012, Sci Pharm, V80, P1045, DOI 10.3797/scipharm.1206-09; Tsai PJ, 2013, THESCIENTIFICWORLDJO, V2013, DOI [10.1155/2013/856967, DOI 10.1155/2013/856967]	25	9	9	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0120171	10.1371/journal.pone.0120171	http://dx.doi.org/10.1371/journal.pone.0120171			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25793581	Green Published, Green Submitted, gold			2022-12-27	WOS:000352084200152
J	Fumel, B; Froment, P; Holzenberger, M; Livera, G; Monget, P; Fouchecourt, S				Fumel, Betty; Froment, Pascal; Holzenberger, Martin; Livera, Gabriel; Monget, Philippe; Fouchecourt, Sophie			Expression of Dominant-Negative Thyroid Hormone Receptor Alpha1 in Leydig and Sertoli Cells Demonstrates No Additional Defect Compared with Expression in Sertoli Cells Only	PLOS ONE			English	Article							NEONATAL-HYPOTHYROIDISM; SPERM PRODUCTION; ADULT TESTIS; RAT TESTIS; IN-VITRO; IGF-I; MICE; AROMATASE; STEROIDOGENESIS; INCREASE	Background In the testis, thyroid hormone (T3) regulates the number of gametes produced through its action on Sertoli cell proliferation. However, the role of T3 in the regulation of steroidogenesis is still controversial. Methods The TR alpha(AMI) knock-in allele allows the generation of transgenic mice expressing a dominant- negative TR alpha 1 (thyroid receptor alpha 1) isoform restricted to specific target cells after Cre-loxP recombination. Here, we introduced this mutant allele in both Sertoli and Leydig cells using a novel aromatase-iCre (ARO-iCre) line that expresses Cre recombinase under control of the human Cyp19(IIa)/aromatase promoter. Findings We showed that loxP recombination induced by this ARO-iCre isrestricted to male and female gonads, and is effective in Sertoli and Leydig cells, but not in germ cells. We compared this model with the previous introduction of TRaAMI specifically in Sertoli cells in order to investigate T3 regulation of steroidogenesis. We demonstrated that TR alpha(AMI)-ARO males exhibited increased testis weight, increased sperm reserve in adulthood correlated to an increased proliferative index at P3 in vivo, and a loss of T3-response in vitro. Nevertheless, TR alpha(AMI)-ARO males showed normal fertility. This phenotype is similar to TR alpha(AMI)-SC males. Importantly, plasma testosterone and luteinizing hormone levels, as well as mRNA levels of steroidogenesis enzymes StAR, Cyp11a1 and Cyp17a1 were not affected in TR alpha(AMI)-ARO. Conclusions/Significance We concluded that the presence of a mutant TR alpha(AMI) allele in both Leydig and Sertoli cells does not accentuate the phenotype in comparison with its presence in Sertoli cells only. This suggests that direct T3 regulation of steroidogenesis through TR alpha 1 is moderate in Leydig cells, and that Sertoli cells are the main target of T3 action in the testis.	[Fumel, Betty; Froment, Pascal; Monget, Philippe; Fouchecourt, Sophie] INRA, Physiol Reprod & Comportements UMR85, F-37380 Nouzilly, France; [Fumel, Betty; Froment, Pascal; Monget, Philippe; Fouchecourt, Sophie] CNRS, Physiol Reprod & Comportements UMR7247, F-37380 Nouzilly, France; [Fumel, Betty; Froment, Pascal; Monget, Philippe; Fouchecourt, Sophie] Univ Tours, F-37041 Tours, France; [Fumel, Betty; Froment, Pascal; Monget, Philippe; Fouchecourt, Sophie] IFCE, F-37380 Nouzilly, France; [Holzenberger, Martin] INSERM, F-75012 Paris, France; [Holzenberger, Martin] UPMC, Univ Paris 04, UMRS 938, Hop St Antoine, F-75012 Paris, France; [Livera, Gabriel] Univ Paris 11, Univ Paris Diderot, Sorbonne Paris Cite, Lab Dev Gonades,INSERM U967,CEA DSV iRCM SCSR LDG, F-92265 Fontenay Aux Roses, France	Centre National de la Recherche Scientifique (CNRS); Universite de Tours; INRAE; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Tours; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Universite Paris Saclay	Fouchecourt, S (corresponding author), INRA, Physiol Reprod & Comportements UMR85, F-37380 Nouzilly, France.	sophie.fouchecourt@tours.inra.fr	Holzenberger, Martin/N-9732-2018; LIVERA, Gabriel/F-5740-2019	LIVERA, Gabriel/0000-0001-8436-4730; Holzenberger, Martin/0000-0003-4869-725X; Fouchecourt, Sophie/0000-0001-6923-6220; Froment, Pascal/0000-0002-7388-9598	TimeOfLife2, Agence Nationale pour la Recherche; Region Centre, France; Institut National Recherche Agronomique; Institut National de la Sante et de la Recherche Medicale; Universite Paris Diderot, Sorbonne Paris Cite	TimeOfLife2, Agence Nationale pour la Recherche(French National Research Agency (ANR)); Region Centre, France(Region Centre-Val de Loire); Institut National Recherche Agronomique; Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); Universite Paris Diderot, Sorbonne Paris Cite	This work was supported by grant: TimeOfLife2, Agence Nationale pour la Recherche (http://www.agence-nationale-recherche.fr)-SF; Region Centre, France-BF (fellowship); Institut National Recherche Agronomique-PF, PM, SF; Institut National de la Sante et de la Recherche Medicale-MH GL; Universite Paris Diderot, Sorbonne Paris Cite-GL.	ANTONY FF, 1995, J ENDOCRINOL, V144, P293, DOI 10.1677/joe.0.1440293; Ariyaratne HBS, 2000, BIOL REPROD, V63, P1115, DOI 10.1095/biolreprod63.4.1115; Ariyaratne HBS, 2000, BIOL REPROD, V62, P680, DOI 10.1095/biolreprod62.3.680; Bridges PJ, 2008, GENESIS, V46, P499, DOI 10.1002/dvg.20428; Cadoret A, 2005, INT J CANCER, V114, P668, DOI 10.1002/ijc.20805; Chatonnet F, 2014, MOL REPROD DEV, V81, P1159, DOI 10.1002/mrd.22437; Choksi NY, 2003, BIRTH DEFECTS RES B, V68, P479, DOI 10.1002/bdrb.10045; COOKE PS, 1991, ANN NY ACAD SCI, V637, P122, DOI 10.1111/j.1749-6632.1991.tb27305.x; COOKE PS, 1991, ENDOCRINOLOGY, V129, P237, DOI 10.1210/endo-129-1-237; Donnelly P, 2000, CLIN ENDOCRINOL, V52, P197, DOI 10.1046/j.1365-2265.2000.00918.x; Fauquier T, 2011, DEV BIOL, V356, P350, DOI 10.1016/j.ydbio.2011.05.657; Fumel B, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.111.098418; Gauthier K, 2001, MOL CELL BIOL, V21, P4748, DOI 10.1128/MCB.21.14.4748-4760.2001; HARDY MP, 1993, ENDOCRINOLOGY, V132, P2417, DOI 10.1210/en.132.6.2417; Hinshelwood MM, 2000, ENDOCRINOLOGY, V141, P2050, DOI 10.1210/en.141.6.2050; Holsberger DR, 2005, CELL TISSUE RES, V322, P133, DOI 10.1007/s00441-005-1082-z; Holsberger DR, 2005, BIOL REPROD, V73, P396, DOI 10.1095/biolreprod.105.041426; Holzenberger M, 2000, ENDOCRINOLOGY, V141, P2557, DOI 10.1210/en.141.7.2557; Holzenberger M, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.21.e92; Jamin SP, 2002, NAT GENET, V32, P408, DOI 10.1038/ng1003; JANNINI EA, 1995, ENDOCR REV, V16, P443, DOI 10.1210/er.16.4.443; Jeyasuria P, 2004, MOL ENDOCRINOL, V18, P1610, DOI 10.1210/me.2003-0404; JOYCE KL, 1993, J ANDROL, V14, P448; KIRBY JD, 1992, ENDOCRINOLOGY, V131, P559, DOI 10.1210/en.131.2.559; Kumar A, 2007, ANDROLOGIA, V39, P253, DOI 10.1111/j.1439-0272.2007.00798.x; Kumar Anand, 2014, Indian J Endocrinol Metab, V18, P23, DOI 10.4103/2230-8210.126523; Leneuve P, 2001, BIOTECHNIQUES, V31, P1156, DOI 10.2144/01315rr05; Levallet J, 1998, BIOL REPROD, V58, P919, DOI 10.1095/biolreprod58.4.919; Livera G, 2006, CELL TISSUE RES, V324, P507, DOI 10.1007/s00441-006-0167-7; Manna PR, 1999, J BIOL CHEM, V274, P5909, DOI 10.1074/jbc.274.9.5909; Maran RRM, 2000, ENDOCR RES, V26, P411, DOI 10.3109/07435800009066177; Maran RRM, 2003, ARCH ANDROLOGY, V49, P375, DOI 10.1080/01485010390204968; Maran RRM, 2001, ENDOCR RES, V27, P119, DOI 10.1081/ERC-100107175; Mendis-Handagama SMLC, 2001, BIOL REPROD, V65, P660, DOI 10.1095/biolreprod65.3.660; Mendis-Handagama SMLC, 2004, HISTOL HISTOPATHOL, V19, P985, DOI 10.14670/HH-19.985; O'Hara L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084541; PALMERO S, 1995, J ENDOCRINOL, V145, P355, DOI 10.1677/joe.0.1450355; PALMERO S, 1990, MOL CELL ENDOCRINOL, V68, P61, DOI 10.1016/0303-7207(90)90170-D; PAPADOPOULOS V, 1986, J STEROID BIOCHEM, V24, P1211, DOI 10.1016/0022-4731(86)90385-7; Picou F, 2014, MOL ENDOCRINOL, V28, P429, DOI 10.1210/me.2013-1414; Quignodon L, 2007, MOL ENDOCRINOL, V21, P2350, DOI 10.1210/me.2007-0176; Shimshek DR, 2002, GENESIS, V32, P19, DOI 10.1002/gene.10023; Simpson ER, 2002, ANNU REV PHYSIOL, V64, P93, DOI 10.1146/annurev.physiol.64.081601.142703; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; TAGAMI T, 1990, ENDOCRINOLOGY, V127, P1727, DOI 10.1210/endo-127-4-1727; Tanwar PS, 2010, BIOL REPROD, V82, P422, DOI 10.1095/biolreprod.109.079335; TSAIMORRIS CH, 1985, ENDOCRINOLOGY, V116, P38, DOI 10.1210/endo-116-1-38; Valenti S, 1997, INT J ANDROL, V20, P279, DOI 10.1046/j.1365-2605.1997.00071.x; Vandormael-Pournin S, 2015, CELL DEATH DIFFER, V22, P108, DOI 10.1038/cdd.2014.122; VANHAASTER LH, 1993, ENDOCRINOLOGY, V133, P755, DOI 10.1210/en.133.2.755; Velazquez EM, 1997, ARCH ANDROLOGY, V38, P85, DOI 10.3109/01485019708988535; Wagner MS, 2008, J ENDOCRINOL, V199, P351, DOI 10.1677/JOE-08-0218; Wu XF, 2007, J CELL PHYSIOL, V213, P429, DOI 10.1002/jcp.21231; Wu XF, 2012, ENDOCRINOLOGY, V153, P4929, DOI 10.1210/en.2012-1168; Wu XF, 2010, REPRODUCTION, V140, P113, DOI 10.1530/REP-09-0349; Xu QQ, 2007, ENDOCRINE, V32, P96, DOI 10.1007/s12020-007-9015-0	56	10	12	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0119392	10.1371/journal.pone.0119392	http://dx.doi.org/10.1371/journal.pone.0119392			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25793522	Green Published, Green Submitted, gold			2022-12-27	WOS:000352084200079
J	Gentaz, E; Sprenger-Charolles, L; Theurel, A				Gentaz, Edouard; Sprenger-Charolles, Liliane; Theurel, Anne			Differences in the Predictors of Reading Comprehension in First Graders from Low Socio-Economic Status Families with Either Good or Poor Decoding Skills	PLOS ONE			English	Article							FRENCH ELEMENTARY-SCHOOL; SIMPLE VIEW; VOCABULARY KNOWLEDGE; LANGUAGE; CHILDREN; ABILITY; ACQUISITION; COMPONENTS; LEVEL	Based on the assumption that good decoding skills constitute a bootstrapping mechanism for reading comprehension, the present study investigated the relative contribution of the former skill to the latter compared to that of three other predictors of reading comprehension (listening comprehension, vocabulary and phonemic awareness) in 392 Frenchspeaking first graders from low SES families. This large sample was split into three groups according to their level of decoding skills assessed by pseudoword reading. Using a cutoff of 1 SD above or below the mean of the entire population, there were 63 good decoders, 267 average decoders and 62 poor decoders. 58% of the variance in reading comprehension was explained by our four predictors, with decoding skills proving to be the best predictor (12.1%, 7.3% for listening comprehension, 4.6% for vocabulary and 3.3% for phonemic awareness). Interaction between group versus decoding skills, listening comprehension and phonemic awareness accounted for significant additional variance (3.6%, 1.1% and 1.0%, respectively). The effects on reading comprehension of decoding skills and phonemic awareness were higher in poor and average decoders than in good decoders whereas listening comprehension accounted for more variance in good and average decoders than in poor decoders. Furthermore, the percentage of children with impaired reading comprehension skills was higher in the group of poor decoders (55%) than in the two other groups (average decoders: 7%; good decoders: 0%) and only 6 children (1.5%) had impaired reading comprehension skills with unimpaired decoding skills, listening comprehension or vocabulary. These results challenge the outcomes of studies on "poor comprehenders" by showing that, at least in first grade, poor reading comprehension is strongly linked to the level of decoding skills.	[Gentaz, Edouard; Theurel, Anne] CNRS, Lab Psychol & Neurocognit, Grenoble, France; [Gentaz, Edouard; Theurel, Anne] Univ Grenoble Alpes, Grenoble, France; [Gentaz, Edouard; Theurel, Anne] Univ Geneva, Fac Psychol & Sci Educ, Geneva, Switzerland; [Gentaz, Edouard; Theurel, Anne] CNRS, LPNC, Grenoble, France; [Sprenger-Charolles, Liliane] Aix Marseille Univ, CNRS, Lab Psychol Cognit, Marseille, France	Centre National de la Recherche Scientifique (CNRS); Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); University of Geneva; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Gentaz, E (corresponding author), CNRS, Lab Psychol & Neurocognit, Grenoble, France.	edouard.gentaz@unige.ch		Theurel, Anne/0000-0001-7372-3195				Adlof SM, 2011, WHAT RES HAS SAY REA, P186; Bara F, 2007, BRIT J DEV PSYCHOL, V25, P643, DOI 10.1348/026151007X186643; Betjemann RS, 2011, SCI STUD READ, V15, P363, DOI 10.1080/10888438.2010.493965; Billard C, 2010, REV EPIDEMIOL SANTE, V58, P101, DOI 10.1016/j.respe.2009.11.002; Byrne B, 1992, READING RES Q, V23, P441; Catts HW, 2006, J SPEECH LANG HEAR R, V49, P278, DOI 10.1044/1092-4388(2006/023); Deheane S., 2011, APPRENDRE LIRE SCI C; Deltour JJ, 1980, TEST VOCABULAIRE ACT; Dunn L. M., 1970, EXAMINERS MANUAL PEA; Ehri LC, 2001, REV EDUC RES, V71, P393, DOI 10.3102/00346543071003393; Fluss J, 2009, J DEV BEHAV PEDIATR, V30, P206, DOI 10.1097/DBP.0b013e3181a7ed6c; Gentaz E., 2013, APPROCH NEUROPSYCHOL, V123, P172; Gentaz E, 2014, LES CAHIERS PEDAGOGI, V516, P21; Gentaz E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078608; Gough P. B., 1986, REM SPEC EDUC, V7, P6, DOI [10.1177/074193258600700104, DOI 10.1177/074193258600700104]; Hackman DA, 2009, TRENDS COGN SCI, V13, P65, DOI 10.1016/j.tics.2008.11.003; Hoff E, 2006, DEV REV, V26, P55, DOI 10.1016/j.dr.2005.11.002; HOOVER WA, 1990, READ WRIT, V2, P127, DOI 10.1007/BF00401799; Hulme C, 2009, DEV DISORDERS LANGUA; Jednorog K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042486; Keenan JM, 2008, SCI STUD READ, V12, P281, DOI 10.1080/10888430802132279; Kendeou P, 2009, J EDUC PSYCHOL, V101, P765, DOI 10.1037/a0015956; Lecocq P, 1996, ECOSSE EPREUVE COMPR; Lete B, 2004, BEHAV RES METH INS C, V36, P156, DOI 10.3758/BF03195560; Megherbi H, 2006, EUR J PSYCHOL EDUC, V21, P135, DOI 10.1007/BF03173573; Melby-Lervag M, 2012, PSYCHOL BULL, V138, P322, DOI 10.1037/a0026744; Muter V, 2004, DEV PSYCHOL, V40, P665, DOI 10.1037/0012-1649.40.5.665; Nation K, 2004, J SPEECH LANG HEAR R, V47, P199, DOI 10.1044/1092-4388(2004/017); Nation K, 2010, J CHILD PSYCHOL PSYC, V51, P1031, DOI 10.1111/j.1469-7610.2010.02254.x; Neale M. D., 1988, NEALE ANAL READING A; Noble KG, 2005, J DEV BEHAV PEDIATR, V26, P370, DOI 10.1097/00004703-200510000-00006; Noble KG, 2007, DEVELOPMENTAL SCI, V10, P464, DOI 10.1111/j.1467-7687.2007.00600.x; Oakhill JV, 2012, SCI STUD READ, V16, P91, DOI 10.1080/10888438.2010.529219; Oakhill JV, 2003, LANG COGNITIVE PROC, V18, P443, DOI 10.1080/01690960344000008; Ouellette G, 2010, READ WRIT, V23, P189, DOI 10.1007/s11145-008-9159-1; Peereman R, 2007, BEHAV RES METHODS, V39, P579, DOI 10.3758/BF03193029; Peereman R, 2013, ANN PSYCHOL, V113, P3, DOI 10.4074/s0003503313001012; Perfetti C.A., 1985, READING ABILITY; Perfetti C, 2007, SCI STUD READ, V11, P357, DOI 10.1080/10888430701530730; Raven J.C., 1998, ADV PROGR MATRICES; Ricketts J, 2007, SCI STUD READ, V11, P235, DOI 10.1080/10888430701344306; Seymour PHK, 2003, BRIT J PSYCHOL, V94, P143, DOI 10.1348/000712603321661859; Share DL, 2008, PSYCHOL BULL, V134, P584, DOI 10.1037/0033-2909.134.4.584; SHARE DL, 1995, COGNITION, V55, P151, DOI 10.1016/0010-0277(94)00645-2; Spencer M, 2014, LEARN DISABIL RES PR, V29, P3, DOI 10.1111/ldrp.12024; Sprenger-Charolles L., 2005, EUR REV APPL PSYCHOL, V55, P157, DOI DOI 10.1016/J.ERAP.2004.11.002; Sprenger-Charolles L., 2013, READING ACQUISITION; Stanovich K. E., 2000, PROGR UNDERSTANDING; Tunmer W. E., 1989, PHONOLOGY READING DI, P91; Tunmer WE, 2012, J LEARN DISABIL-US, V45, P453, DOI 10.1177/0022219411432685; Tunmer WE, 2012, SCI STUD READ, V16, P122, DOI 10.1080/10888438.2010.542527; Vellutino FR, 2007, SCI STUD READ, V11, P3, DOI 10.1207/s1532799xssr1101_2; Verhoeven L, 2008, APPL COGNITIVE PSYCH, V22, P407, DOI 10.1002/acp.1414; Wiederholt L, 1992, EXAMINERS MANUAL GRA; Ziegler JC, 2005, PSYCHOL BULL, V131, P3, DOI 10.1037/0033-2909.131.1.3	55	24	28	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0119581	10.1371/journal.pone.0119581	http://dx.doi.org/10.1371/journal.pone.0119581			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CE8IA	25793519	Green Published, gold, Green Submitted			2022-12-27	WOS:000352084200097
J	Johnston, SC; Desmond-Hellmann, S; Hauser, S; Vermillion, E; Mia, N				Johnston, S. Claiborne; Desmond-Hellmann, Susan; Hauser, Stewart; Vermillion, Eric; Mia, Nilo			Predictors of Negotiated NIH Indirect Rates at US Institutions	PLOS ONE			English	Article								Background The United States (US) Department of Health and Human Services and the Office of Naval Research negotiate institutional rates for payments of overhead costs associated with administration and space usage, commonly known as indirect rates. Such payments account for a large proportion of spending by the National Institutes of Health (NIH). Little has been published about differences in rates and their predictors. Methods Negotiated indirect rates for on-campus research grants were requested from the Council on Governmental Relations for the 100 institutions with greatest NIH funding in 2010. NIH funding, cost of living (ACCRA Index for 2008), public vs. private status, negotiating governmental organization (Department of Health and Human Services or Office of Naval Research), US Census Region, and year were assessed as predictors of institutional indirect rates using generalized estimating equations with all variables included in the model. Results Overall, 72 institutions participated, with 207 reported indirect rates for the years 2006, 2008, and 2010. Indirect rates ranged from 36.3% to 78%, with an average of 54.5%. Mean rates increased from 53.6% in 2006 to 55.4% in 2010 (p< 0.001). In multivariable models, private institutions had 6.2% (95% CI 3.7%-8.7%; p< 0.001) higher indirect rates than public institutions. Rates in the Northeast were highest (Midwest 4.0% lower; West 4.9% lower; South 5.2% lower). Greater NIH funding (p = 0.025) and cost of living (p = 0.034) also predicted indirect rates while negotiating governmental organization did not (p = 0.414). Conclusions Negotiated indirect rates for governmental research grants to academic centers vary widely. Although the association between indirect rates and cost of living may be justified, the cause of variation in rates by region, public-private status, and NIH funding levels is unclear.	[Johnston, S. Claiborne; Desmond-Hellmann, Susan; Vermillion, Eric; Mia, Nilo] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Hauser, Stewart] Univ Calif Los Angeles, Los Angeles, CA USA	University of California System; University of California San Francisco; University of California System; University of California Los Angeles	Johnston, SC (corresponding author), Univ Calif San Francisco, San Francisco, CA 94143 USA.	Clay.johnston@utexas.edu						Alberts B, 2014, P NATL ACAD SCI USA, V111, P5773, DOI 10.1073/pnas.1404402111; [Anonymous], 1991, FASEB J, V17, P5; Bascatta CA, 2007, GAO 07 294R EXTRAMUR; Council for Community and Economic Research, 2012, COST LIV IND MAN; Council on Governmental Relations, 2014, MEMB; FITCH FW, 1994, FASEB J, V8, P563, DOI 10.1096/fasebj.8.9.8005382; Goldman C.A., 2000, PAYING U RES FACILIT; Levene H., 1960, CONTRIBUTIONS PROBAB, P278; National Institutes of Health, 2014, NIH RES PORT ONL REP, DOI [10.1016/j.wneu.2013.11.013, DOI 10.1016/J.WNEU.2013.11.013]; Office of Science and Technology Policy, 2000, AN FAC ADM COSTS U; US Census, 2014, GEOGR TERMS CONC CEN	11	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0121273	10.1371/journal.pone.0121273	http://dx.doi.org/10.1371/journal.pone.0121273			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25794011	Green Submitted, Green Published, gold			2022-12-27	WOS:000352083900118
J	Laudy, AE; Osinska, P; Namyslowska, A; Zajac, O; Tyski, S				Laudy, Agnieszka E.; Osinska, Paula; Namyslowska, Alicja; Zajac, Olga; Tyski, Stefan			Modification of the Susceptibility of Gram-Negative Rods Producing ES beta LS to beta-Lactams by the Efflux Phenomenon	PLOS ONE			English	Article							PSEUDOMONAS-AERUGINOSA PAO1; ANTIBIOTIC-RESISTANCE; KLEBSIELLA-PNEUMONIAE; PUMPS; ENTEROBACTERIACEAE; IDENTIFICATION; INHIBITORS; STRAINS; REGULON; OPRM	The production of beta-lactamases is the most important mechanism of Gram-negative rod resistance to beta-lactams. Resistance to ceftazidime and cefepime in clinical isolates of Enterobacteriaceae (especially ES beta L-positive E. coli and K. pneumoniae) and P. aeruginosa is life-threatening. However, all strains of the above mentioned species possess chromosomally encoded RND efflux pump systems in addition to beta-lactamase production. The main goal of this study was to assess the role of efflux pump systems in cefepime and/or ceftazidime resistant phenotypes of ES beta L-positive clinical strains of Enterobacteriaceae and P. aeruginosa. The influence of the efflux pump inhibitor PA beta N on the minimum inhibitory concentration (MIC) values of tested cephalosporins was species-dependent. Generally, a significant reduction (at least four-fold) of beta-lactam MICs was observed in the presence of PA beta N only in the case of P. aeruginosa clinical isolates as well as the ES beta L-producing transformant PAO1161 Delta ampC. The usage of this agent resulted in the restoration of susceptibility to cefepime and/or ceftazidime in the majority of the P. aeruginosa ES beta L-positive strains with low and moderate resistance to the above cephalosporins. Moreover, an outer membrane permeabilizing effect in the presence of PA beta N was identified. Strain-dependent beta-lactamase leakage upon PA beta N or beta-lactam treatment was demonstrated. The most important observation was the restoration of susceptibility of P. aeruginosa WUM226 to cefepime (MIC decrease from 32 to 4 mg/L) and ceftazidime (MIC decrease from 128 to 4 mg/L) in the presence of PA beta N, which occurred despite an almost complete lack of beta-lactamase leakage from bacterial cells. In conclusion, these data indicate that RND efflux pumps can modify the susceptibility to beta-lactams in Gram-negative rods producing ES beta Ls. However, this phenomenon occurs only in P. aeruginosa strains and was not observed among E. coli and K. pneumoniae strains, representing the Enterobacteriaceae family.	[Laudy, Agnieszka E.; Osinska, Paula; Namyslowska, Alicja; Zajac, Olga; Tyski, Stefan] Med Univ Warsaw, Dept Pharmaceut Microbiol, Warsaw, Poland; [Tyski, Stefan] Natl Med Inst, Dept Antibiot & Microbiol, Warsaw, Poland	Medical University of Warsaw; National Medicines Institute Lekow (NIL)	Laudy, AE (corresponding author), Med Univ Warsaw, Dept Pharmaceut Microbiol, Warsaw, Poland.	alaudy@wp.pl	Tyski, Stefan/W-5271-2018; Laudy, Agnieszka/M-4930-2018; Laudy, Agnieszka/AAC-1000-2022	Tyski, Stefan/0000-0003-3352-038X; Laudy, Agnieszka/0000-0002-5989-4462; Zajac, Olga/0000-0001-6137-0978	Medical University of Warsaw	Medical University of Warsaw	The authors received funding for this work from Medical University of Warsaw. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alekshun MN, 1997, ANTIMICROB AGENTS CH, V41, P2067, DOI 10.1128/AAC.41.10.2067; Bialek-Davenet S, 2011, ANTIMICROB AGENTS CH, V55, P2795, DOI 10.1128/AAC.00156-11; Cabot G, 2011, ANTIMICROB AGENTS CH, V55, P1906, DOI 10.1128/AAC.01645-10; Clinical and Laboratory Standards Institute, 2012, M7A9 CLIN LAB STAND, V11th; Clinical and Laboratory Standards Institute (CLSI), 2012, M100S22 CLIN LAB S S; Drieux L, 2008, CLIN MICROBIOL INFEC, V14, P90, DOI 10.1111/j.1469-0691.2007.01846.x; Hocquet D, 2006, ANTIMICROB AGENTS CH, V50, P1347, DOI 10.1128/AAC.50.4.1347-1351.2006; Irani VR, 1997, BIOTECHNIQUES, V22, P54, DOI 10.2144/97221bm09; Kargar M, 2014, INDIAN J PATHOL MICR, V57, P244, DOI 10.4103/0377-4929.134688; Kim YJ, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-161; Kong KF, 2005, ANTIMICROB AGENTS CH, V49, P4567, DOI 10.1128/AAC.49.11.4567-4575.2005; Lamers RP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060666; Lasocki K, 2007, J BACTERIOL, V189, P5762, DOI 10.1128/JB.00371-07; Lomovskaya O, 2001, ANTIMICROB AGENTS CH, V45, P105, DOI 10.1128/AAC.45.1.105-116.2001; Masuda N, 2000, ANTIMICROB AGENTS CH, V44, P3322, DOI 10.1128/AAC.44.12.3322-3327.2000; Matsumoto Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018547; Paterson DL, 2005, CLIN MICROBIOL REV, V18, P657, DOI 10.1128/CMR.18.4.657-686.2005; Pfeifer Y, 2010, INT J MED MICROBIOL, V300, P371, DOI 10.1016/j.ijmm.2010.04.005; Picao RC, 2009, ANTIMICROB AGENTS CH, V53, P2225, DOI 10.1128/AAC.01602-08; Pitout JDD, 2008, LANCET INFECT DIS, V8, P159, DOI 10.1016/S1473-3099(08)70041-0; Poole K, 2012, ANTIBIOTIC DISCOVERY AND DEVELOPMENT, VOLS 1 AND 2, P349, DOI 10.1007/978-1-4614-1400-1_10; Poole K, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00065; Qing Y, 2014, J MED MICROBIOL, V63, P386, DOI 10.1099/jmm.0.069427-0; Renau TE, 1999, J MED CHEM, V42, P4928, DOI 10.1021/jm9904598; Rodriguez-Martinez JM, 2009, ANTIMICROB AGENTS CH, V53, P4783, DOI 10.1128/AAC.00574-09; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Srinivasan VB, 2013, ANTIMICROB AGENTS CH, V57, P4449, DOI 10.1128/AAC.02284-12; Stover CK, 2000, NATURE, V406, P959, DOI 10.1038/35023079; Strateva T, 2009, J MED MICROBIOL, V58, P1133, DOI 10.1099/jmm.0.009142-0; Vatcheva-Dobrevska R, 2013, MICROB DRUG RESIST, V19, P355, DOI 10.1089/mdr.2013.0004; Viedma E, 2009, ANTIMICROB AGENTS CH, V53, P4930, DOI 10.1128/AAC.00900-09; Weldhagen GF, 2003, ANTIMICROB AGENTS CH, V47, P2385, DOI 10.1128/AAC.47.8.2385-2392.2003; Yasufuku T, 2011, J CLIN MICROBIOL, V49, P189, DOI 10.1128/JCM.00827-10	33	15	15	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0119997	10.1371/journal.pone.0119997	http://dx.doi.org/10.1371/journal.pone.0119997			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25793625	Green Submitted, Green Published, gold			2022-12-27	WOS:000352084200134
J	Leander, M; Bass, C; Marchetti, K; Maynard, BF; Wulff, JP; Ons, S; Nichols, R				Leander, Megan; Bass, Chloe; Marchetti, Kathryn; Maynard, Benjamin F.; Wulff, Juan Pedro; Ons, Sheila; Nichols, Ruthann			Cardiac Contractility Structure-Activity Relationship and Ligand-Receptor Interactions; the Discovery Of Unique and Novel Molecular Switches in Myosuppressin Signaling	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTORS; RHODNIUS-PROLIXUS; CHAGAS-DISEASE; ACTIVATION; NEUROPEPTIDE; RHODOPSIN; MODELS; ANTAGONIST; PEPTIDES; ACCURACY	Peptidergic signaling regulates cardiac contractility; thus, identifying molecular switches, ligand-receptor contacts, and antagonists aids in exploring the underlying mechanisms to influence health. Myosuppressin (MS), a decapeptide, diminishes cardiac contractility and gut motility. Myosuppressin binds to G protein-coupled receptor (GPCR) proteins. Two Drosophila melanogaster myosuppressin receptors (DrmMS-Rs) exist; however, no mechanism underlying MS-R activation is reported. We predicted DrmMS-Rs contained molecular switches that resembled those of Rhodopsin. Additionally, we believed DrmMS-DrmMS-R1 and DrmMS-DrmMS-R2 interactions would reflect our structure-activity relationship (SAR) data. We hypothesized agonist-and antagonist-receptor contacts would differ from one another depending on activity. Lastly, we expected our study to apply to other species; we tested this hypothesis in Rhodnius prolixus, the Chagas disease vector. Searching DrmMS-Rs for molecular switches led to the discovery of a unique ionic lock and a novel 3-6 lock, as well as transmission and tyrosine toggle switches. The DrmMS-DrmMS-R1 and DrmMS-DrmMS-R2 contacts suggested tissue-specific signaling existed, which was in line with our SAR data. We identified R. prolixus (Rhp) MS-R and discovered it, too, contained the unique myosuppressin ionic lock and novel 3-6 lock found in DrmMS-Rs as well as transmission and tyrosine toggle switches. Further, these motifs were present in red flour beetle, common water flea, honey bee, domestic silkworm, and termite MS-Rs. RhpMS and DrmMS decreased R. prolixus cardiac contractility dose dependently with EC50 values of 140 nM and 50 nM. Based on ligand-receptor contacts, we designed RhpMS analogs believed to be an active core and antagonist; testing on heart confirmed these predictions. The active core docking mimicked RhpMS, however, the antagonist did not. Together, these data were consistent with the unique ionic lock, novel 3-6 lock, transmission switch, and tyrosine toggle switch being involved in mechanisms underlying TM movement and MS-R activation, and the ability of MS agonists and antagonists to influence physiology.	[Leander, Megan; Marchetti, Kathryn; Maynard, Benjamin F.; Nichols, Ruthann] Univ Michigan, Dept Chem, Undergrad Biochem Program, Ann Arbor, MI 48109 USA; [Leander, Megan; Bass, Chloe; Marchetti, Kathryn; Maynard, Benjamin F.; Nichols, Ruthann] Univ Michigan, Sch Med, Dept Biol Chem, Ann Arbor, MI 48109 USA; [Bass, Chloe] Univ Michigan, Dept Chem, Undergrad Chem Program, Ann Arbor, MI 48109 USA; [Wulff, Juan Pedro; Ons, Sheila] Univ Nacl La Plata, Fac Ciencias Exactas, Lab Genet & Genom Func, Ctr Reg Estudios Genom, RA-1459 Buenos Aires, DF, Argentina	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; National University of La Plata	Nichols, R (corresponding author), Univ Michigan, Dept Chem, Undergrad Biochem Program, Ann Arbor, MI 48109 USA.	nicholsr@umich.edu	Ons, Sheila/ABI-2195-2020		NIH [R21HL093627]; University of Michigan Medical Innovation Center; University of Michigan Cardiovascular Center Innovative Grant; Albert Euclid Hinsdale Award; Seyhan N. Ege-WISE Award; Honors Summer Fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL093627] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Michigan Medical Innovation Center; University of Michigan Cardiovascular Center Innovative Grant; Albert Euclid Hinsdale Award; Seyhan N. Ege-WISE Award; Honors Summer Fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by a NIH grant R21HL093627, Concept to Commercialization Funding from the University of Michigan Medical Innovation Center, and a University of Michigan Cardiovascular Center Innovative Grant to Ruthann Nichols. Megan Leander received an Albert Euclid Hinsdale Award, Chloe Bass received the Seyhan N. Ege-WISE Award, Kathryn Marchetti received an Honors Summer Fellowship, and Ben Maynard received an Albert Euclid Hinsdale Award to support their research in the Nichols' lab. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; Bass C, 2014, PEPTIDES, V53, P278, DOI 10.1016/j.peptides.2013.06.009; Chien EYT, 2010, SCIENCE, V330, P1091, DOI 10.1126/science.1197410; Deupi X, 2011, CURR OPIN STRUC BIOL, V21, P541, DOI 10.1016/j.sbi.2011.06.002; Dickerson M, 2012, PEPTIDES, V36, P272, DOI 10.1016/j.peptides.2012.05.002; Egerod K, 2003, P NATL ACAD SCI USA, V100, P9808, DOI 10.1073/pnas.1632197100; Farrens DL, 1996, SCIENCE, V274, P768, DOI 10.1126/science.274.5288.768; Fritze O, 2003, P NATL ACAD SCI USA, V100, P2290, DOI 10.1073/pnas.0435715100; HOLMAN GM, 1986, COMP BIOCHEM PHYS C, V85, P329, DOI 10.1016/0742-8413(86)90202-1; Jaakola V-P, 2008, SCIENCE, V330, P1091; Kim JM, 2004, P NATL ACAD SCI USA, V101, P12508, DOI 10.1073/pnas.0404519101; Lee D, 2012, J EXP BIOL, V215, P2088, DOI 10.1242/jeb.067447; Maynard BF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075502; Moncayo A, 2009, MEM I OSWALDO CRUZ, V104, P17, DOI 10.1590/S0074-02762009000900005; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; NICHOLS R, 1992, J MOL NEUROSCI, V3, P213, DOI 10.1007/BF03380141; Nichols R, 2003, ANNU REV ENTOMOL, V48, P485, DOI 10.1146/annurev.ento.48.091801.112525; Ons S, 2011, INSECT MOL BIOL, V20, P29, DOI 10.1111/j.1365-2583.2010.01050.x; Ons S, 2009, PROTEOMICS, V9, P788, DOI 10.1002/pmic.200800499; PRICE DA, 1977, SCIENCE, V197, P670, DOI 10.1126/science.877582; ROBB S, 1994, J EXP BIOL, V197, P437; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Shimamura T, 2011, NATURE, V475, P65, DOI 10.1038/nature10236; Standfuss J, 2011, NATURE, V471, P656, DOI 10.1038/nature09795; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Trzaskowski B, 2012, CURR MED CHEM, V19, P1090, DOI 10.2174/092986712799320556; Upadhyaya J, 2010, BIOCHEM BIOPH RES CO, V398, P331, DOI 10.1016/j.bbrc.2010.06.097; Wacker D, 2010, J AM CHEM SOC, V132, P11443, DOI 10.1021/ja105108q; Wu BL, 2010, SCIENCE, V330, P1066, DOI 10.1126/science.1194396; Xu D, 2011, BIOPHYS J, V101, P2525, DOI 10.1016/j.bpj.2011.10.024	30	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0120492	10.1371/journal.pone.0120492	http://dx.doi.org/10.1371/journal.pone.0120492			40	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25793503	Green Published, gold			2022-12-27	WOS:000352083900041
J	Moenninghoff, C; Kraff, O; Maderwald, S; Umutlu, L; Theysohn, JM; Ringelstein, A; Wrede, KH; Deuschl, C; Altmeppen, J; Ladd, ME; Forsting, M; Quick, HH; Schlamann, M				Moenninghoff, Christoph; Kraff, Oliver; Maderwald, Stefan; Umutlu, Lale; Theysohn, Jens M.; Ringelstein, Adrian; Wrede, Karsten H.; Deuschl, Cornelius; Altmeppen, Jan; Ladd, Mark E.; Forsting, Michael; Quick, Harald H.; Schlamann, Marc			Diffuse Axonal Injury at Ultra-High Field MRI	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; HEAD-INJURY; CEREBRAL MICROBLEEDS; INTRACEREBRAL HEMORRHAGE; WHITE-MATTER; PROGNOSTIC VALUE; 1.5 TESLA; 7 T; LESIONS; DEMENTIA	Objective Diffuse axonal injury (DAI) is a specific type of traumatic brain injury caused by shearing forces leading to widespread tearing of axons and small vessels. Traumatic microbleeds (TMBs) are regarded as a radiological marker for DAI. This study aims to compare DAIassociated TMBs at 3 Tesla (T) and 7 T susceptibility weighted imaging (SWI) to evaluate possible diagnostic benefits of ultra-high field (UHF) MRI. Material and Methods 10 study participants (4 male, 6 female, age range 20-74 years) with known DAI were included. All MR exams were performed with a 3 T MR system (Magnetom Skyra) and a 7 T MR research system (Magnetom 7 T, Siemens AG, Healthcare Sector, Erlangen, Germany) each in combination with a 32-channel-receive coil. The average time interval between trauma and imaging was 22 months. Location and count of TMBs were independently evaluated by two neuroradiologists on 3 T and 7 T SWI images with similar and additionally increased spatial resolution at 7 T. Inter-and intraobserver reliability was assessed using the interclass correlation coefficient (ICC). Count and diameter of TMB were evaluated with Wilcoxon signed rank test. Results Susceptibility weighted imaging revealed a total of 485 TMBs (range 1-190, median 25) at 3 T, 584 TMBs (plus 20%, range 1-262, median 30.5) at 7 T with similar spatial resolution, and 684 TMBs (plus 41%, range 1-288, median 39.5) at 7 T with 10-times higher spatial resolution. Hemorrhagic DAI appeared significantly larger at 7 T compared to 3 T (p = 0.005). Inter-and intraobserver correlation regarding the counted TMB was high and almost equal 3 T and 7 T. Conclusion 7 T SWI improves the depiction of small hemorrhagic DAI compared to 3 T and may be supplementary to lower field strengths for diagnostic in inconclusive or medicolegal cases.	[Moenninghoff, Christoph; Kraff, Oliver; Maderwald, Stefan; Umutlu, Lale; Theysohn, Jens M.; Ringelstein, Adrian; Deuschl, Cornelius; Altmeppen, Jan; Forsting, Michael; Schlamann, Marc] Univ Hosp Essen, Inst Diagnost & Intervent Radiol & Neuroradiol, Essen, Germany; [Moenninghoff, Christoph; Kraff, Oliver; Maderwald, Stefan; Umutlu, Lale; Theysohn, Jens M.; Wrede, Karsten H.; Deuschl, Cornelius; Ladd, Mark E.; Forsting, Michael; Quick, Harald H.; Schlamann, Marc] Univ Duisburg Essen, Erwin L Hahn Inst Magnet Resonance Imaging, Essen, Germany; [Wrede, Karsten H.] Univ Hosp Essen, Dept Neurosurg, Essen, Germany; [Ladd, Mark E.] German Canc Res Ctr, Div Med Phys Radiol, Heidelberg, Germany; [Quick, Harald H.] Univ Hosp Essen, High Field & Hybrid MR Imaging, Essen, Germany; [Schlamann, Marc] Univ Hosp Giessen, Inst Neuroradiol, Giessen, Germany	University of Duisburg Essen; University of Duisburg Essen; University of Duisburg Essen; Helmholtz Association; German Cancer Research Center (DKFZ); University of Duisburg Essen; University Hospital of Giessen & Marburg	Moenninghoff, C (corresponding author), Univ Hosp Essen, Inst Diagnost & Intervent Radiol & Neuroradiol, Essen, Germany.	christoph.moenninghoff@uk-essen.de	Wrede, Karsten/AAZ-2154-2020; Kraff, Oliver/AAE-2238-2020; Maderwald, Stefan/B-4241-2011	Wrede, Karsten/0000-0001-7076-3503; Kraff, Oliver/0000-0002-6006-8934; Ladd, Mark/0000-0002-4128-9440				ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; Akter M, 2007, ACAD RADIOL, V14, P1011, DOI 10.1016/j.acra.2007.05.013; Allkemper T, 2004, EUR RADIOL, V14, P1000, DOI 10.1007/s00330-004-2241-4; Chang MC, 2010, NEUROREHABILITATION, V26, P339, DOI 10.3233/NRE-2010-0571; Conijn MMA, 2011, AM J NEURORADIOL, V32, P1043, DOI 10.3174/ajnr.A2450; Deistung A, 2006, Z MED PHYS, V16, P261, DOI 10.1078/0939-3889-00324; Fazekas F, 1999, AM J NEURORADIOL, V20, P637; Haacke EM, 2009, AM J NEURORADIOL, V30, P19, DOI 10.3174/ajnr.A1400; Hetherington HP, 2014, MAGN RESON MED, V71, P1358, DOI 10.1002/mrm.24814; Hilal S, 2014, ALZ DIS ASSOC DIS, V28, P106, DOI 10.1097/WAD.0000000000000015; Huisman TAGM, 2004, AM J NEURORADIOL, V25, P370; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Kasahara K, 2012, MAGN RESON IMAGING, V30, P496, DOI 10.1016/j.mri.2011.12.018; Kirov II, 2013, J NEUROTRAUM, V30, P1200, DOI 10.1089/neu.2012.2696; Luccichenti G, 2010, FUNCT NEUROL, V25, P109; Lupo JM, 2012, INT J RADIAT ONCOL, V82, pE493, DOI 10.1016/j.ijrobp.2011.05.046; Lupo Janine M, 2006, Conf Proc IEEE Eng Med Biol Soc, V2006, P747; Messori A, 2003, NEURORADIOLOGY, V45, P881, DOI 10.1007/s00234-003-1048-3; MITTL RL, 1994, AM J NEURORADIOL, V15, P1583; MONACO EA, 2013, NEUROSURGERY, V72, DOI DOI 10.1227/01.NEU; Nandigam RNK, 2009, AM J NEURORADIOL, V30, P338, DOI 10.3174/ajnr.A1355; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; Parizel PM, 1998, EUR RADIOL, V8, P960, DOI 10.1007/s003300050496; Paterakis K, 2000, J TRAUMA, V49, P1071, DOI 10.1097/00005373-200012000-00016; Polders DL, 2011, J MAGN RESON IMAGING, V33, P1456, DOI 10.1002/jmri.22554; Reichenbach JR, 1997, JMRI-J MAGN RESON IM, V7, P266, DOI 10.1002/jmri.1880070203; Reichenbach JR, 1997, RADIOLOGY, V204, P272, DOI 10.1148/radiology.204.1.9205259; Ropper AH, 2007, NEW ENGL J MED, V356, P166, DOI 10.1056/NEJMcp064645; Scheid R, 2003, AM J NEURORADIOL, V24, P1049; Scheid R, 2007, J NEUROTRAUM, V24, P1811, DOI 10.1089/neu.2007.0382; Scheid R, 2010, DTSCH ARZTEBL INT, V107, P199, DOI 10.3238/arztebl.2010.0199; Schilling S, 2013, NEUROLOGY, V81, P292, DOI 10.1212/WNL.0b013e31829bfda4; Schlamann M, 2010, ACAD RADIOL, V17, P3, DOI 10.1016/j.acra.2009.10.001; Sharp DJ, 2014, NAT REV NEUROL, V10, P156, DOI 10.1038/nrneurol.2014.15; Skandsen T, 2010, J NEUROSURG, V113, P556, DOI 10.3171/2009.9.JNS09626; Soria G, 2011, ANAT REC, V294, P1035, DOI 10.1002/ar.21383; STRICH SJ, 1956, J NEUROL NEUROSUR PS, V19, P163, DOI 10.1136/jnnp.19.3.163; Sugiyama K, 2009, J NEUROTRAUM, V26, P1879, DOI [10.1089/neu.2008.0839, 10.1089/neu.2008-0839]; Tatsumi S, 2008, AJNR Am J Neuroradiol, V29, pe13, DOI 10.3174/ajnr.A0908; Theysohn JM, 2011, J MAGN RESON IMAGING, V33, P782, DOI 10.1002/jmri.22513; Tong KA, 2004, ANN NEUROL, V56, P36, DOI 10.1002/ana.20123; Tong KA, 2003, RADIOLOGY, V227, P332, DOI 10.1148/radiol.2272020176; Vernooij MW, 2009, ARCH NEUROL-CHICAGO, V66, P714, DOI 10.1001/archneurol.2009.42; Wallesch CW, 2001, BRAIN INJURY, V15, P401, DOI 10.1080/02699050010005959; Wardlaw JM, 2000, NEURORADIOLOGY, V42, P81, DOI 10.1007/s002340050019; Wargo CJ, 2013, MAGN RESON IMAGING, V31, P810, DOI 10.1016/j.mri.2013.01.013; Weiss N, 2007, CRIT CARE, V11, DOI 10.1186/cc6107	47	34	36	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0122329	10.1371/journal.pone.0122329	http://dx.doi.org/10.1371/journal.pone.0122329			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25793614	gold, Green Published, Green Submitted			2022-12-27	WOS:000352083900177
J	Nachtigall, PG; Dias, MC; Carvalho, RF; Martins, C; Pinhal, D				Nachtigall, Pedro G.; Dias, Marcos C.; Carvalho, Robson F.; Martins, Cesar; Pinhal, Danillo			MicroRNA-499 Expression Distinctively Correlates to Target Genes sox6 and rod1 Profiles to Resolve the Skeletal Muscle Phenotype in Nile Tilapia	PLOS ONE			English	Article							INTRONIC MICRORNA; FIBER TYPES; DIFFERENTIATION; CELL; EVOLUTION; IDENTIFICATION; ROBUSTNESS; REPRESSION; ROLES; WHITE	A class of small non-coding RNAs, the microRNAs (miRNAs), has been shown to be essential for the regulation of specific cell pathways, including skeletal muscle development, maintenance and homeostasis in vertebrates. However, the relative contribution of miRNAs for determining the red and white muscle cell phenotypes is far from being fully comprehended. To better characterize the role of miRNA in skeletal muscle cell biology, we investigated muscle-specific miRNA (myomiR) signatures in Nile tilapia fish. Quantitative (RT-PCR) and spatial (FISH) expression analyses revealed a highly differential expression (forty-four-fold) of miR-499 in red skeletal muscle compared to white skeletal muscle, whereas the remaining known myomiRs were equally expressed in both muscle cell types. Detailed examination of the miR-499 targets through bioinformatics led us to the sox6 and rod1 genes, which had low expression in red muscle cells according to RT-qPCR, FISH, and protein immunofluorescence profiling experiments. Interestingly, we verified that the high expression of miR-499 perfectly correlates with a low expression of sox6 and rod1 target genes, as verified by a distinctive predominance of mRNA destabilization and protein translational decay to these genes, respectively. Through a genome-wide comparative analysis of SOX6 and ROD1 protein domains and through an in silico gene regulatory network, we also demonstrate that both proteins are essentially similar in vertebrate genomes, suggesting their gene regulatory network may also be widely conserved. Overall, our data shed light on the potential regulation of targets by miR-499 associated with the slow-twitch muscle fiber type phenotype. Additionally the results provide novel insights into the evolutionary dynamics of miRNA and target genes enrolled in a putative constrained molecular pathway in the skeletal muscle cells of vertebrates.	[Nachtigall, Pedro G.; Pinhal, Danillo] Sao Paulo State Univ UNESP, Inst Biosci, Dept Genet, BR-18618970 Sao Paulo, Brazil; [Dias, Marcos C.; Carvalho, Robson F.; Martins, Cesar] Sao Paulo State Univ UNESP, Inst Biosci, Dept Morphol, BR-18618970 Sao Paulo, Brazil; [Dias, Marcos C.] Fed Univ Mato Grosso UFMT, Hlth Sci Inst, BR-78550000 Sinop, Mato Grosso, Brazil	Universidade Estadual Paulista; Universidade Estadual Paulista; Universidade Federal de Mato Grosso; Universidade Federal de Mato Grosso do Sul	Pinhal, D (corresponding author), Sao Paulo State Univ UNESP, Inst Biosci, Dept Genet, BR-18618970 Sao Paulo, Brazil.	dlpinhal@ibb.unesp.br	Pinhal, Danillo/C-5983-2012; Carvalho, Robson Francisco/AAE-4134-2020; Carvalho, Robson Francisco/E-1161-2012; Martins, Cesar/A-2594-2008; Nachtigall, Pedro Gabriel/M-5424-2017	Pinhal, Danillo/0000-0003-1075-0182; Carvalho, Robson Francisco/0000-0002-4901-7714; Carvalho, Robson Francisco/0000-0002-4901-7714; Martins, Cesar/0000-0003-3534-974X; Nachtigall, Pedro Gabriel/0000-0002-3196-0173; Correa Dias, Marcos/0000-0003-3342-3395	Sao Paulo Research Foundation (FAPESP) [2011/06465-0, 2012/15589-7]; CAPES; FAPESP [2013/06864-7]; CNPq	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	Funding was provided by the Sao Paulo Research Foundation (FAPESP) grants to CM (2011/06465-0) and DP (2012/15589-7). PGN received master's scholarship from CAPES, and a PhD scholarship from FAPESP (2013/06864-7). MCD was supported by post-doctoral fellowships from CNPq and CAPES. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An CI, 2011, BMC DEV BIOL, V11, DOI 10.1186/1471-213X-11-59; Bartel DP, 2004, NAT REV GENET, V5, P396, DOI 10.1038/nrg1328; Bearzi C, 2009, P NATL ACAD SCI USA, V106, P15885, DOI 10.1073/pnas.0907622106; Bell ML, 2010, MOL CELL BIOL, V30, P1937, DOI 10.1128/MCB.01370-09; Berezikov E, 2011, NAT REV GENET, V12, P846, DOI 10.1038/nrg3079; Bhuiyan SS, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-142; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Chen JF, 2006, NAT GENET, V38, P228, DOI 10.1038/ng1725; Chu WY, 2013, CURR MOL MED, V13, P1397, DOI 10.2174/15665240113139990059; Cohen-Barak O, 2003, NUCLEIC ACIDS RES, V31, P5941, DOI 10.1093/nar/gkg807; DRIEDZIC WR, 1976, AM J PHYSIOL, V230, P579, DOI 10.1152/ajplegacy.1976.230.3.579; Ebert MS, 2012, CELL, V149, P515, DOI 10.1016/j.cell.2012.04.005; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Flicek P, 2014, NUCLEIC ACIDS RES, V42, pD749, DOI 10.1093/nar/gkt1196; Flynt AS, 2007, NAT GENET, V39, P259, DOI 10.1038/ng1953; Gagan J, 2012, CUR OP IN PHAR, V12, P1; Ge YJ, 2011, CELL CYCLE, V10, P441, DOI 10.4161/cc.10.3.14710; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Hagiwara N, 2007, DEV DYNAM, V236, P2062, DOI 10.1002/dvdy.21223; Hosoda T, 2011, CIRCULATION, V123, P1287, DOI 10.1161/CIRCULATIONAHA.110.982918; Ketley A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065170; Kruger J, 2006, NUCLEIC ACIDS RES, V34, pW451, DOI 10.1093/nar/gkl243; Kwon C, 2005, P NATL ACAD SCI USA, V102, P18986, DOI 10.1073/pnas.0509535102; Levine E, 2007, PLOS COMPUT BIOL, V3, P2356, DOI 10.1371/journal.pcbi.0030233; McCarthy JJ, 2011, EXERC SPORT SCI REV, V39, P150, DOI 10.1097/JES.0b013e31821c01e1; McCarthy JJ, 2008, BBA-GENE REGUL MECH, V1779, P682, DOI 10.1016/j.bbagrm.2008.03.001; Mishima Y, 2009, GENE DEV, V23, P619, DOI 10.1101/gad.1760209; Nakajima RT, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-198; Obernosterer G, 2007, NAT PROTOC, V2, P1508, DOI 10.1038/nprot.2007.153; Pase L, 2011, METHOD CELL BIOL, V104, P353, DOI 10.1016/B978-0-12-374814-0.00020-3; Pette D, 2000, MICROSC RES TECHNIQ, V50, P500, DOI 10.1002/1097-0029(20000915)50:6<500::AID-JEMT7>3.0.CO;2-7; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Quiat D, 2011, P NATL ACAD SCI USA, V108, P10196, DOI 10.1073/pnas.1107413108; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Sadvakassova G, 2009, J CELL PHYSIOL, V220, P672, DOI 10.1002/jcp.21817; Schiaffino S, 2011, PHYSIOL REV, V91, P1447, DOI 10.1152/physrev.00031.2010; Small EM, 2010, P NATL ACAD SCI USA, V107, P4218, DOI 10.1073/pnas.1000300107; Sood P, 2006, P NATL ACAD SCI USA, V103, P2746, DOI 10.1073/pnas.0511045103; Stadler M, 2012, GENOME RES, V22, P2418, DOI 10.1101/gr.136515.111; Stark A, 2005, CELL, V123, P1133, DOI 10.1016/j.cell.2005.11.023; Sweetman D, 2008, DEV BIOL, V321, P491, DOI 10.1016/j.ydbio.2008.06.019; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tani S, 2013, EVOL DEV, V15, P293, DOI 10.1111/ede.12039; van Rooij E, 2009, DEV CELL, V17, P662, DOI 10.1016/j.devcel.2009.10.013; Vogel C, 2004, CURR OPIN STRUC BIOL, V14, P208, DOI 10.1016/j.sbi.2004.03.011; von Hofsten J, 2008, EMBO REP, V9, P683, DOI 10.1038/embor.2008.73; Wang XG, 2011, DEVELOPMENT, V138, P4399, DOI 10.1242/dev.070516; Williams AH, 2009, SCIENCE, V326, P1549, DOI 10.1126/science.1181046; Yamamoto H, 1999, MOL CELL BIOL, V19, P3829	49	29	33	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0119804	10.1371/journal.pone.0119804	http://dx.doi.org/10.1371/journal.pone.0119804			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25793727	Green Submitted, Green Published, gold			2022-12-27	WOS:000352084200117
J	Nakahara, J; Takechi, K; Myouga, F; Moriyama, Y; Sato, H; Takio, S; Takano, H				Nakahara, Jin; Takechi, Katsuaki; Myouga, Fumiyoshi; Moriyama, Yasuko; Sato, Hiroshi; Takio, Susumu; Takano, Hiroyoshi			Bending of Protonema Cells in a Plastid Glycolate/Glycerate Transporter Knockout Line of Physcomitrella patens	PLOS ONE			English	Article							SUBCELLULAR-LOCALIZATION; CHLOROPLAST DIVISION; MOSS; PHOTORESPIRATION; ENVELOPE; REVEALS; PROTEIN; GENE; DEATH; ACID	Arabidopsis LrgB (synonym PLGG1) is a plastid glycolate/glycerate transporter associated with recycling of 2-phosphoglycolate generated via the oxygenase activity of ribulose-1,5-bisphosphate carboxylase/oxygenase (RuBisCO). We isolated two homologous genes (PpLrgB1 and B2) from the moss Physcomitrella patens. Phylogenetic tree analysis showed that PpLrgB1 was monophyletic with LrgB proteins of land plants, whereas PpLrgB2 was divergent from the green plant lineage. Experiments with PpLrgB-GFP fusion proteins suggested that both PpLrgB1 and B2 proteins were located in chloroplasts. We generated PpLrgB single (Delta B1 and Delta B2) and double (Delta B1/Delta B2)-knockout lines using gene targeting of P. patens. The Delta B1 plants showed decreases in growth and photosynthetic activity, and their protonema cells were bent and accumulated glycolate. However, because Delta B2 and Delta B1/Delta B2 plants showed no obvious phenotypic change relative to the wild-type or Delta B1 plants, respectively, the function of PpLrgB2 remains unclear. Arabidopsis LrgB could complement the Delta B1 phenotype, suggesting that the function of PpLrgB1 is the same as that of AtLrgB. When Delta B1 was grown under high-CO2 conditions, all novel phenotypes were suppressed. Moreover, protonema cells of wild-type plants exhibited a bending phenotype when cultured on media containing glycolate or glycerate, suggesting that accumulation of photorespiratory metabolites caused P. patens cells to bend.	[Nakahara, Jin; Takechi, Katsuaki; Moriyama, Yasuko; Takio, Susumu; Takano, Hiroyoshi] Kumamoto Univ, Grad Sch Sci & Technol, Kumamoto 8608555, Japan; [Myouga, Fumiyoshi] RIKEN, CSRS, Gene Discovery Res Grp, Yokohama, Kanagawa 2300045, Japan; [Sato, Hiroshi] Kumamoto Univ, Fac Sci, Kumamoto 8608555, Japan; [Takio, Susumu] Kumamoto Univ, Ctr Marine Environm Studies, Kumamoto 8608555, Japan; [Takano, Hiroyoshi] Kumamoto Univ, Inst Pulsed Power Sci, Kumamoto 8608555, Japan	Kumamoto University; RIKEN; Kumamoto University; Kumamoto University; Kumamoto University	Takano, H (corresponding author), Kumamoto Univ, Grad Sch Sci & Technol, Kumamoto 8608555, Japan.	takano@kumamoto-u.ac.jp	Myouga, Fumiyoshi/R-4070-2017	Myouga, Fumiyoshi/0000-0003-0957-808X; Takano, Hiroyoshi/0000-0003-4720-5057	Japan Society for the Promotion of Science (KAKENHI) [26117720, 25440158]; Grants-in-Aid for Scientific Research [25440158, 26430191] Funding Source: KAKEN	Japan Society for the Promotion of Science (KAKENHI)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Japan Society for the Promotion of Science (KAKENHI Grant Numbers 26117720 and 25440158 to H.T. and K.T.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASHTON NW, 1977, MOL GEN GENET, V154, P87, DOI 10.1007/BF00265581; Bauwe H, 2010, TRENDS PLANT SCI, V15, P330, DOI 10.1016/j.tplants.2010.03.006; Chiu WL, 1996, CURR BIOL, V6, P325, DOI 10.1016/S0960-9822(02)00483-9; Eisenhut M, 2013, PLANT BIOLOGY, V15, P676, DOI 10.1111/j.1438-8677.2012.00690.x; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Ferro M, 2002, P NATL ACAD SCI USA, V99, P11487, DOI 10.1073/pnas.172390399; Gerotto C, 2012, NEW PHYTOL, V196, P763, DOI 10.1111/j.1469-8137.2012.04345.x; Hiwatashi Y, 2008, PLANT CELL, V20, P3094, DOI 10.1105/tpc.108.061705; Homi S, 2009, PLANT CELL PHYSIOL, V50, P2047, DOI 10.1093/pcp/pcp158; HOWITZ KT, 1986, PLANT PHYSIOL, V80, P390, DOI 10.1104/pp.80.2.390; Khatoon M, 2009, J BIOL CHEM, V284, P25343, DOI 10.1074/jbc.M109.007740; Kubo M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077356; Machida M, 2006, P NATL ACAD SCI USA, V103, P6753, DOI 10.1073/pnas.0510693103; Mueller SJ, 2014, PLANT PHYSIOL, V164, P2081, DOI 10.1104/pp.114.235754; Nei M., 2000, MOL EVOLUTION PHYLOG; Nishiyama T, 2000, DNA RES, V7, P9, DOI 10.1093/dnares/7.1.9; Pick TR, 2013, P NATL ACAD SCI USA, V110, P3185, DOI 10.1073/pnas.1215142110; Rensing SA, 2008, SCIENCE, V319, P64, DOI 10.1126/science.1150646; Saavedra L, 2006, PLANT J, V45, P237, DOI 10.1111/j.1365-313X.2005.02603.x; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sakaguchi E, 2011, PLANT SCI, V180, P789, DOI 10.1016/j.plantsci.2011.02.003; Schaefer DG, 1997, PLANT J, V11, P1195, DOI 10.1046/j.1365-313X.1997.11061195.x; Schneidereit J, 2006, PLANT J, V45, P206, DOI 10.1111/j.1365-313X.2005.02594.x; Somerville CR, 2001, PLANT PHYSIOL, V125, P20, DOI 10.1104/pp.125.1.20; TAKAHASHI K, 1972, J BIOCHEM, V71, P563; TAKAMI S, 1988, PHYSIOL PLANTARUM, V73, P227, DOI 10.1111/j.1399-3054.1988.tb00590.x; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Timm S, 2013, PLANT BIOLOGY, V15, P737, DOI 10.1111/j.1438-8677.2012.00691.x; Tyra HM, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r212; Vidali L, 2012, CURR OPIN PLANT BIOL, V15, P625, DOI 10.1016/j.pbi.2012.09.008; Yamaguchi M, 2012, PLANT CELL PHYSIOL, V53, P125, DOI 10.1093/pcp/pcr180; Yang YJ, 2012, NEW PHYTOL, V193, P81, DOI 10.1111/j.1469-8137.2011.03867.x	33	5	5	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0118804	10.1371/journal.pone.0118804	http://dx.doi.org/10.1371/journal.pone.0118804			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25793376	Green Published, gold, Green Submitted			2022-12-27	WOS:000352084200042
J	Ronowicz, M; Kuklinski, P; Mapstone, GM				Ronowicz, Marta; Kuklinski, Piotr; Mapstone, Gillian M.			Trends in the Diversity, Distribution and Life History Strategy of Arctic Hydrozoa (Cnidaria)	PLOS ONE			English	Article							EUROPEAN ATHECATE HYDROIDS; MEDUSAE HYDROZOA; MARINE-ENVIRONMENT; SPECIES RICHNESS; SHELF WATERS; LAPTEV SEA; SP-NOV; EVOLUTION; BIOGEOGRAPHY; ZOOPLANKTON	This is the first attempt to compile a comprehensive and updated species list for Hydrozoa in the Arctic, encompassing both hydroid and medusa stages and including Siphonophorae. We address the hypothesis that the presence of a pelagic stage (holo-or meroplanktonic) was not necessary to successfully recolonize the Arctic by Hydrozoa after the Last Glacial Maximum. Presence-absence data of Hydrozoa in the Arctic were prepared on the basis of historical and present-day literature. The Arctic was divided into ecoregions. Species were grouped into distributional categories according to their worldwide occurrences. Each species was classified according to life history strategy. The similarity of species composition among regions was calculated with the Bray-Curtis index. Average and variation in taxonomic distinctness were used to measure diversity at the taxonomic level. A total of 268 species were recorded. Arctic-boreal species were the most common and dominated each studied region. Nineteen percent of species were restricted to the Arctic. There was a predominance of benthic species over holo-and meroplanktonic species. Arctic, Arctic-Boreal and Boreal species were mostly benthic, while widely distributed species more frequently possessed a pelagic stage. Our results support hypothesis that the presence of a pelagic stage (holo- or meroplanktonic) was not necessary to successfully recolonize the Arctic. The predominance of benthic Hydrozoa suggests that the Arctic could have been colonised after the Last Glacial Maximum by hydroids rafting on floating substrata or recolonising from glacial refugia.	[Ronowicz, Marta; Kuklinski, Piotr] Polish Acad Sci, Inst Oceanol, Marine Ecol Dept, Sopot, Poland; [Kuklinski, Piotr; Mapstone, Gillian M.] Nat Hist Museum, Dept Life Sci, London SW7 5BD, England	Polish Academy of Sciences; Institute of Oceanology of the Polish Academy of Sciences; Natural History Museum London	Ronowicz, M (corresponding author), Polish Acad Sci, Inst Oceanol, Marine Ecol Dept, Sopot, Poland.	martar@iopan.gda.pl		Ronowicz, Marta/0000-0001-8703-9132; Kuklinski, Piotr/0000-0002-1507-215X	Polish National Science Centre [2012/04/M/NZ8/00670, 2011/03/B/NZ8/02872]	Polish National Science Centre	This work was supported by the Polish National Science Centre grant nrs 2012/04/M/NZ8/00670 to MR and 2011/03/B/NZ8/02872 to PK. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antsulevich Alexander E., 1992, Scientia Marina, V56, P213; ARAI MN, 1980, CAN B FISH AQUAT SCI, P1; Berrill N.J., 1961, GROWTH DEV PATTERN; Bodil Bluhm A., 2011, Marine Biodiversity, V41, P87, DOI 10.1007/s12526-010-0078-4; BOERO F, 1984, MAR ECOL-P S Z N I, V5, P93, DOI 10.1111/j.1439-0485.1984.tb00310.x; Bonnevie K., 1899, Norwegian North Atlantic Expedition 1876-1878 Zool, Vxxvi, P1; Bouillon J., 2006, INTRO HYDROZOA; Broch H, 1925, NATURWISSENSCHAFTEN, V13, P447, DOI 10.1007/BF01558740; BROCH H, 1910, FAUNA ARCTICA, V5, P127; Brochmann C, 2003, TAXON, V52, P417, DOI 10.2307/3647444; Cairns SD, 2011, ZOOKEYS, P1, DOI 10.3897/zookeys.158.1910; CALDER DR, 1990, CAN J ZOOL, V68, P442, DOI 10.1139/z90-065; CALDER DR, 1972, J FISH RES BOARD CAN, V29, P217, DOI 10.1139/f72-040; CALDER DR, 1970, J FISH RES BOARD CAN, V27, P1501, DOI 10.1139/f70-175; Cantero ALP, 2004, POLAR BIOL, V27, P767, DOI 10.1007/s00300-004-0654-9; Cartwright P, 2010, INTEGR COMP BIOL, V50, P456, DOI 10.1093/icb/icq089; Clark SF, 1877, P ACAD NAT SCI PHILA, V1876, P209; Clarke KR., 2001, CHANGE MARINE COMMUN, V2; Cooney R. T., 1981, E BERING SEA SHELF O, V2, P947; Cornelius P.F.S., 1981, Porcupine Newsletter, V2, P47; Cornelius P.F.S., 1992, ARQUIPELAGO LIFE EAR, V10, P75; Cornelius Paul F. S., 1992, Scientia Marina, V56, P245; CORNELIUS PFS, 1990, J NAT HIST, V24, P579, DOI 10.1080/00222939000770391; Cornelius PFS, 1995, SYNOPSIS BRIT FAUNA, V50, P1; Curtis M.A., 1975, Polar Record, VNo. 111, P595; Cusson M, 2007, MAR ECOL PROG SER, V331, P291, DOI 10.3354/meps331291; Daly M, 2007, ZOOTAXA, P127, DOI 10.11646/zootaxa.1668.1.11; Darby DA, 2006, PROG OCEANOGR, V71, P129, DOI 10.1016/j.pocean.2006.09.009; DUNBAR M. J., 1942, CANADIAN JOUR RES SECT D ZOOL SCI, V20, P71; DUNTON K, 1992, TRENDS ECOL EVOL, V7, P183, DOI 10.1016/0169-5347(92)90070-R; Fisher W. K., 1938, Proceedings of the United States National Museum, V84, P493; Fraser C.M., 1944, HYDROIDS ATLANTIC CO; Gibbons MJ, 2010, J BIOGEOGR, V37, P606, DOI 10.1111/j.1365-2699.2009.02237.x; Gibbons MJ, 2010, J BIOGEOGR, V37, P441, DOI 10.1111/j.1365-2699.2009.02226.x; Golikov A.N., 1989, P257; Govindarajan AF, 2005, MAR BIOL, V146, P213, DOI 10.1007/s00227-004-1434-3; GRAINGER EH, 1965, J FISH RES BOARD CAN, V22, P543, DOI 10.1139/f65-049; Grainger EH, 1975, FISH MAR SERV RES DE, P591; Gravier-Bonnet N., 2006, P 10 INT COR REEF S, P188; Gravier-Bonnet Nicole, 1992, Scientia Marina, V56, P229; Hand C, 1961, ARCTIC I N AM TECHNI, V6, P1; Henry LA, 2004, MAR ECOL PROG SER, V266, P123, DOI 10.3354/meps266123; Hughes RN, 1989, FUNCTIONAL BIOL CLON; JACKSON JBC, 1986, B MAR SCI, V39, P588; JACKSON JBC, 1986, PHILOS T R SOC B, V313, P7, DOI 10.1098/rstb.1986.0022; Jaderholm E, 1916, BIHANG KUNGLIGA SVEN, V54, P1; JOHANNESSON K, 1988, MAR BIOL, V99, P507, DOI 10.1007/BF00392558; Jones EP, 2001, POLAR RES, V20, P139, DOI 10.1111/j.1751-8369.2001.tb00049.x; Kinne O., 1956, Zeitschrift fuer Morphologie und Oekologie der Tiere, V45, P217, DOI 10.1007/BF00430254; Kosobokova K, 2000, DEEP-SEA RES PT I, V47, P2029, DOI 10.1016/S0967-0637(00)00015-7; Kosobokova KN, 1998, POLAR BIOL, V19, P63; Kosobokova Ksenia N., 2011, Marine Biodiversity, V41, P29, DOI 10.1007/s12526-010-0057-9; Kramp P, 1942, MEDD GRONLAND, V80, P3; Kramp P. L., 1947, Danish Ingolf-Expedition, V5, P1; Kramp P. L., 1943, MEDDELELSER OM GRONLAND, V121, P1; Kramp P. L., 1959, Dana Reports, V46, P1; KRAMP PL, 1961, J MAR BIOL ASSOC UK, V40, P7, DOI 10.1017/S0025315400007347; KRAMP PL, 1932, MEDDELELSER GRONLAND, V91, P1; Leclere L, 2009, SYST BIOL, V58, P509, DOI 10.1093/sysbio/syp044; Maggs CA, 2008, ECOLOGY, V89, pS108, DOI 10.1890/08-0257.1; Mapstone G.M., 2009, SIPHONOPHORA CNIDARI; Mapstone GM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087737; MARGULIS RY, 1982, ZOOL ZH, V61, P440; Margulis RYa, 1978, 16 BIOLOGIYA, V3, P1; Marktanner-Turneretscher G., 1895, ZOOLOGISCHE JB ABTHE, V8, P391; Miglietta MP, 2006, J MAR BIOL ASSOC UK, V86, P993, DOI 10.1017/S0025315406013968; MILEIKOVSKY SA, 1971, MAR BIOL, V10, P193, DOI 10.1007/BF00352809; Mora C, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000606; Motoda S., 1974, OCEANOGRAPHY BERING, P207; Moura CJ, 2008, ZOOL SCR, V37, P93, DOI 10.1111/j.1463-6409.2007.00312.x; Naumov D. V, 1969, HYDROIDS HYDROMEDUSA; NESIS KN, 1983, BIOL MORYA-VLAD+, P3; NURNBERG D, 1995, POLAR RES, V14, P43, DOI 10.1111/j.1751-8369.1995.tb00709.x; Nutting CC, 1901, P WASHINGTON ACAD SC, V3, P157; Pagliara P, 2000, SCI MAR, V64, P173, DOI 10.3989/scimar.2000.64s1173; Palerud Rune, 2004, Norsk Polarinstitutt Skrifter, V201, P5; PETERSEN KW, 1990, ZOOL J LINN SOC-LOND, V100, P101, DOI 10.1111/j.1096-3642.1990.tb01862.x; Piepenburg D, 2005, POLAR BIOL, V28, P733, DOI 10.1007/s00300-005-0013-5; Piepenburg Dieter, 2011, Marine Biodiversity, V41, P51, DOI 10.1007/s12526-010-0059-7; Piraino S, 2008, J MAR BIOL ASSOC UK, V88, P1637, DOI 10.1017/S0025315408002166; Provan J, 2008, TRENDS ECOL EVOL, V23, P564, DOI 10.1016/j.tree.2008.06.010; PUGH PR, 1995, SCI MAR, V59, P181; Raskoff KA, 2005, POLAR BIOL, V28, P207, DOI 10.1007/s00300-004-0677-2; Raskoff KA, 2010, DEEP SEA RES 2, V57, P111; Raskoff KA, 2010, ZOOTAXA, P57; Ronowicz M, 2007, J MAR BIOL ASSOC UK, V87, P1089, DOI 10.1017/S0025315407055142; Ronowicz M, 2007, ZOOTAXA, P55; Ronowicz M, 2013, POLAR BIOL, V36, P705, DOI 10.1007/s00300-013-1297-5; Ronowicz M, 2013, MAR ECOL-EVOL PERSP, V34, P165, DOI 10.1111/maec.12034; Rudels B, 1999, DEEP-SEA RES PT II, V46, P1023, DOI 10.1016/S0967-0645(99)00015-6; RUNGGER D, 1969, PUBB STA ZOOL NAPOLI, V37, P95; SCHELTEMA RS, 1983, B MAR SCI, V33, P545; Schmid Michael K., 1993, Meddelelser om Gronland Bioscience, V37, P1; Schuchert P., 2012, SYNOPSES BRIT FAUNA, V59; Schuchert P, 2008, REV SUISSE ZOOL, V115, P221, DOI 10.5962/bhl.part.80426; Schuchert P, 2006, REV SUISSE ZOOL, V113, P325, DOI 10.5962/bhl.part.80356; Schuchert P, 2014, MOL PHYLOGENET EVOL, V76, P1, DOI 10.1016/j.ympev.2014.02.020; Schuchert P, 2010, REV SUISSE ZOOL, V117, P337; Schuchert Peter, 2001, Meddelelser om Gronland Bioscience, V53, P1; Schuchert P, 2008, REV SUISSE ZOOL, V115, P677, DOI 10.5962/bhl.part.80453; Shih C T, 1971, Bull Fish Res Bd Can, V176, P1; Shirley WD, 1960, TAXONOMIC GUIDES ARC; Sommer Christian, 1992, Scientia Marina, V56, P205; Spalding MD, 2007, BIOSCIENCE, V57, P573, DOI 10.1641/B570707; Stepanjants SD, 2006, MAR BIOL RES, V2, P388, DOI 10.1080/17451000601012402; Stepanjants S.D., 1994, Issledovaniya Fauny Morei, V48, P116; Stepanjants SD, 2008, J MAR BIOL ASSOC UK, V88, P1619, DOI 10.1017/S0025315408001380; Stepanjants S.D., 1989, P397; Stepanjants SD, 2001, ISSLEDOVANIA FAUNI M, V51, P31; Stepanjants SD, 1967, SIPHONOPHORES SEAS U; Stylasteridae Broch H., 1914, DAN INGOLF EXPED, V5, P1; Thiel M, 2005, OCEANOGR MAR BIOL, V43, P279; Thiel M. E., 1932, Romer und Schaudinn Fauna Arctica Jena, V6, P119; Thiel M, 2006, OCEANOGR MAR BIOL, V44, P323, DOI 10.1201/9781420006391.ch7; Tomczak M., 1994, REGIONAL OCEANOGRAPH; UCHIDA T, 1969, Publications of the Seto Marine Biological Laboratory, V17, P285; Van Soest R.W.M., 1973, Bijdragen tot de Dierkunde, V43, P119; Voronkov A, 2010, J MAR BIOL ASSOC UK, V90, P1337, DOI 10.1017/S0025315409991573; Warwick RM, 1995, MAR ECOL PROG SER, V129, P301, DOI 10.3354/meps129301; Watson JE, 1996, SCI MAR, V60, P75; WESLAWSKI JM, 1991, ARCTIC, V44, P115; Yashnov VA, 1948, CHECK LIST FAUNA FLO, P65; ZELICKMAN EA, 1972, MAR BIOL, V17, P256, DOI 10.1007/BF00366301	123	21	23	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0120204	10.1371/journal.pone.0120204	http://dx.doi.org/10.1371/journal.pone.0120204			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25793294	Green Published, Green Submitted, gold			2022-12-27	WOS:000352084200158
J	Sahraoui, A; Winzell, MS; Gorman, T; Smith, DM; Skrtic, S; Hoeyem, M; Abadpour, S; Johansson, L; Korsgren, O; Foss, A; Scholz, H				Sahraoui, Afaf; Winzell, Maria Soerhede; Gorman, Tracy; Smith, Dave M.; Skrtic, Stanko; Hoeyem, Merete; Abadpour, Shadab; Johansson, Lars; Korsgren, Olle; Foss, Aksel; Scholz, Hanne			The Effects of Exendin-4 Treatment on Graft Failure: An Animal Study Using a Novel Re-Vascularized Minimal Human Islet Transplant Model	PLOS ONE			English	Article							BETA-CELL REPLICATION; ALLOGRAFT DYSFUNCTION; PROTEIN-KINASE; DIABETIC-RATS; IN-VITRO; APOPTOSIS; EXENATIDE; NEOGENESIS; RECEPTOR; RECIPIENTS	Islet transplantation has become a viable clinical treatment, but is still compromised by long-term graft failure. Exendin-4, a glucagon-like peptide 1 receptor agonist, has in clinical studies been shown to improve insulin secretion in islet transplanted patients. However, little is known about the effect of exendin-4 on other metabolic parameters. We therefore aimed to determine what influence exendin-4 would have on revascularized minimal human islet grafts in a state of graft failure in terms of glucose metabolism, body weight, lipid levels and graft survival. Introducing the bilateral, subcapsular islet transplantation model, we first transplanted diabetic mice with a murine graft under the left kidney capsule sufficient to restore normoglycemia. After a convalescent period, we performed a second transplantation under the right kidney capsule with a minimal human islet graft and allowed for a second recovery. We then performed a left-sided nephrectomy, and immediately started treatment with exendin-4 with a low (20 mu g/kg/day) or high (200 mu g/kg/day) dose, or saline subcutaneously twice daily for 15 days. Blood was sampled, blood glucose and body weight monitored. The transplanted human islet grafts were collected at study end point and analyzed. We found that exendin-4 exerts its effect on failing human islet grafts in a bell-shaped dose-response curve. Both doses of exendin-4 equally and significantly reduced blood glucose. Glucagon-like peptide 1 (GLP-1), C-peptide and pro-insulin were conversely increased. In the course of the treatment, body weight and cholesterol levels were not affected. However, immunohistochemistry revealed an increase in beta cell nuclei count and reduced TUNEL staining only in the group treated with a low dose of exendin-4 compared to the high dose and control. Collectively, these results suggest that exendin-4 has a potential rescue effect on failing, revascularized human islets in terms of lowering blood glucose, maintaining beta cell numbers, and improving metabolic parameters during hyperglycemic stress.	[Sahraoui, Afaf; Hoeyem, Merete; Abadpour, Shadab; Foss, Aksel; Scholz, Hanne] Oslo Univ Hosp, Inst Surg Res, Oslo, Norway; [Sahraoui, Afaf; Hoeyem, Merete; Abadpour, Shadab; Foss, Aksel; Scholz, Hanne] Oslo Univ Hosp, Sect Transplantat Surg, Oslo, Norway; [Winzell, Maria Soerhede; Smith, Dave M.; Skrtic, Stanko] AstraZeneca R&D, Molndal, Sweden; [Gorman, Tracy] AstraZeneca, Alderley Pk, Cheshire, England; [Johansson, Lars] Univ Uppsala Hosp, Dept Radiol Oncol & Radiat Sci, Uppsala, Sweden; [Korsgren, Olle] Uppsala Univ, Sci Life Lab, Dept Immunol Genet & Pathol, Uppsala, Sweden; [Foss, Aksel] Univ Oslo, Inst Clin Med, Oslo, Norway	University of Oslo; University of Oslo; AstraZeneca; AstraZeneca; Uppsala University; Uppsala University Hospital; Uppsala University; University of Oslo	Sahraoui, A (corresponding author), Oslo Univ Hosp, Inst Surg Res, Oslo, Norway.	Afaf.Sahraoui2@rr-research.no	Scholz, Hanne/J-8150-2016; Johansson, Lars/AAF-4845-2019	Korsgren, Olle/0000-0002-8524-9547; Skrtic, Stanko/0000-0002-1950-5418; Smith, David/0000-0001-6831-280X; Scholz, Hanne/0000-0003-2755-4399	Oslo University Hospital (OUS) - AstraZeneca in a scientific collaboration (OUS project) [37813]; Novo Nordisk Fonden [NNF14OC0010935] Funding Source: researchfish	Oslo University Hospital (OUS) - AstraZeneca in a scientific collaboration (OUS project); Novo Nordisk Fonden(Novo Nordisk Foundation)	This study was funded through a research program established at Oslo University Hospital (OUS) supported by AstraZeneca in a scientific collaboration (OUS project number 37813). AS and HS received financial support from this program funding. MH has no relevant disclosures. The funder provided support in the form of salaries for authors MSW, TG, DMS, SS and LJ, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the author contributions section.	Al-Adra DP, 2014, TRANSPLANTATION; Arakawa M, 2009, BIOCHEM BIOPH RES CO, V390, P809, DOI 10.1016/j.bbrc.2009.10.054; Barton FB, 2012, DIABETES CARE, V35, P1436, DOI 10.2337/dc12-0063; Berney T, 2010, TRANSPLANTATION, V90, P238, DOI 10.1097/TP.0b013e3181e25a40; Broca C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092066; Chen JQ, 2006, BIOCHEM BIOPH RES CO, V346, P1067, DOI 10.1016/j.bbrc.2006.06.027; Drucker DJ, 2006, LANCET, V368, P1696, DOI 10.1016/S0140-6736(06)69705-5; Faradji RN, 2009, CELL TRANSPLANT, V18, P1247, DOI 10.3727/096368909X474456; Farilla L, 2003, ENDOCRINOLOGY, V144, P5149, DOI 10.1210/en.2003-0323; FEHMANN HC, 1991, ENDOCRINOLOGY, V128, P2880, DOI 10.1210/endo-128-6-2880; Froud T, 2008, TRANSPLANTATION, V86, P36, DOI 10.1097/TP.0b013e31817c4ab3; Gao W, 2012, DRUG METAB DISPOS, V40, P990, DOI 10.1124/dmd.111.042291; GOKE R, 1993, LIFE SCI, V53, P1367, DOI 10.1016/0024-3205(93)90597-V; Goto M, 2004, TRANSPLANTATION, V78, P1367, DOI 10.1097/01.TP.0000140882.53773.DC; Kanak MA, 2014, INT J ENDOCRINOL, V2014, DOI 10.1155/2014/451035; Kemp DM, 2001, ENDOCRINOLOGY, V142, P1179, DOI 10.1210/en.142.3.1179; King A, 2005, DIABETOLOGIA, V48, P2074, DOI 10.1007/s00125-005-1922-0; Kwon DY, 2009, J PHARMACOL SCI, V111, P361, DOI 10.1254/jphs.09178FP; Li L, 2005, DIABETOLOGIA, V48, P1339, DOI 10.1007/s00125-005-1787-2; Li YZ, 2003, J BIOL CHEM, V278, P471, DOI 10.1074/jbc.M209423200; Luo J, 2013, METABOLISM, V62, P90, DOI 10.1016/j.metabol.2012.07.010; Nadkarni P, 2014, PROG MOL BIOL TRANSL, V121, P23, DOI 10.1016/B978-0-12-800101-1.00002-8; Nikfar S, 2012, J PHARM PHARM SCI, V15, P1; Parkes DG, 2001, METABOLISM, V50, P583, DOI 10.1053/meta.2001.22519; Parlevliet ET, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049152; Shapiro AMJ, 2011, CURR DIABETES REP, V11, P345, DOI 10.1007/s11892-011-0217-8; Suarez-Pinzon WL, 2011, CELL TRANSPLANT, V20, P1343, DOI 10.3727/096368910X557263; Szot GL, 2007, JOVE-J VIS EXP, V7, P255, DOI DOI 10.3791/255; Tian L, 2011, TRANSPL INT, V24, P856, DOI 10.1111/j.1432-2277.2011.01275.x; Velmurugan K, 2012, ENDOCRINOLOGY, V153, P1116, DOI 10.1210/en.2011-1895; Xu G, 1999, DIABETES, V48, P2270, DOI 10.2337/diabetes.48.12.2270	31	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0121204	10.1371/journal.pone.0121204	http://dx.doi.org/10.1371/journal.pone.0121204			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25793295	Green Published, gold			2022-12-27	WOS:000352083900111
J	Sola, E; Alvarez-Presas, M; Frias-Lopez, C; Littlewood, DTJ; Rozas, J; Riutort, M				Sola, Eduard; Alvarez-Presas, Marta; Frias-Lopez, Cristina; Littlewood, D. Timothy J.; Rozas, Julio; Riutort, Marta			Evolutionary Analysis of Mitogenomes from Parasitic and Free-Living Flatworms	PLOS ONE			English	Article							COMPLETE MITOCHONDRIAL GENOME; PLANARIAN MITOCHONDRIA; MOLECULAR EVOLUTION; BACTERIAL GENOMES; COMPLETE SEQUENCE; CAUTIONARY TALE; INCREASED RATES; GENETIC-CODE; PLATYHELMINTHES; DNA	Mitochondrial genomes (mitogenomes) are useful and relatively accessible sources of molecular data to explore and understand the evolutionary history and relationships of eukaryotic organisms across diverse taxonomic levels. The availability of complete mitogenomes from Platyhelminthes is limited; of the 40 or so published most are from parasitic flatworms (Neodermata). Here, we present the mitogenomes of two free-living flatworms (Tricladida): the complete genome of the freshwater species Crenobia alpina (Planariidae) and a nearly complete genome of the land planarian Obama sp. (Geoplanidae). Moreover, we have reanotated the published mitogenome of the species Dugesia japonica (Dugesiidae). This contribution almost doubles the total number of mtDNAs published for Tricladida, a species-rich group including model organisms and economically important invasive species. We took the opportunity to conduct comparative mitogenomic analyses between available free-living and selected parasitic flatworms in order to gain insights into the putative effect of life cycle on nucleotide composition through mutation and natural selection. Unexpectedly, we did not find any molecular hallmark of a selective relaxation in mitogenomes of parasitic flatworms; on the contrary, three out of the four studied free-living triclad mitogenomes exhibit higher A+T content and selective relaxation levels. Additionally, we provide new and valuable molecular data to develop markers for future phylogenetic studies on planariids and geoplanids.	[Sola, Eduard; Alvarez-Presas, Marta; Frias-Lopez, Cristina; Rozas, Julio; Riutort, Marta] Univ Barcelona, Fac Biol, Inst Recerca Biodiversitat, Catalonia, Spain; [Sola, Eduard; Alvarez-Presas, Marta; Frias-Lopez, Cristina; Rozas, Julio; Riutort, Marta] Univ Barcelona, Fac Biol, Dept Genet, Catalonia, Spain; [Littlewood, D. Timothy J.] Nat Hist Museum, Dept Life Sci, London SW7 5BD, England	University of Barcelona; University of Barcelona; Natural History Museum London	Riutort, M (corresponding author), Univ Barcelona, Fac Biol, Inst Recerca Biodiversitat, Catalonia, Spain.	mriutort@ub.edu	Álvarez-Presas, Marta/J-8078-2012; Littlewood, Tim/B-5230-2008; Riutort, Marta/B-6441-2009; Frías-López, Cristina/AAL-9385-2020; Rozas, Julio/A-1733-2009	Álvarez-Presas, Marta/0000-0002-4825-9965; Littlewood, Tim/0000-0002-2718-4001; Riutort, Marta/0000-0002-2134-7674; Frías-López, Cristina/0000-0002-8078-9552; Rozas, Julio/0000-0002-6839-9148; Sola, Eduard/0000-0003-1848-4085	Ministerio de Economia y competitividad (Spain) [CGL 2008-00378 MR, CGL 2011-23466 MR, CGL2013-45211-C2-1-P]; Natural Environment Research Council [NER/A/S/2003/00313] Funding Source: researchfish	Ministerio de Economia y competitividad (Spain); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	Funding was received from Ministerio de Economia y competitividad (Spain): CGL 2008-00378 MR, CGL 2011-23466 MR, CGL2013-45211-C2-1-P (http://www.idi.mineco.gob.es/portal/site/MICINN/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2006, NUCLEIC ACIDS RES, V34, pW389, DOI 10.1093/nar/gkl044; Alvarez-Presas M, 2014, HEREDITY, V112, P656, DOI 10.1038/hdy.2014.3; Alvarez-Presas M, 2014, PEERJ, V2, DOI 10.7717/peerj.430; Ballard JWO, 2014, FUNCT ECOL, V28, P218, DOI 10.1111/1365-2435.12177; Ballard JWO, 2004, MOL ECOL, V13, P729, DOI 10.1046/j.1365-294X.2003.02063.x; Barr CM, 2005, NEW PHYTOL, V168, P39, DOI 10.1111/j.1469-8137.2005.01492.x; BERNARDI G, 1986, J MOL EVOL, V24, P1, DOI 10.1007/BF02099946; Bernt M, 2013, MOL PHYLOGENET EVOL, V69, P313, DOI 10.1016/j.ympev.2012.08.023; Bessho Y, 1997, MOL ECOL, V6, P129, DOI 10.1046/j.1365-294X.1997.00162.x; BESSHO Y, 1992, J MOL EVOL, V34, P331, DOI 10.1007/BF00160240; Biomatters, 2014, GENEIOUS; BOORE JL, 1995, GENETICS, V141, P305; Breton S, 2010, MAR GENOM, V3, P11, DOI 10.1016/j.margen.2010.01.001; Bromham L, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-126; Castro LR, 2002, MOL BIOL EVOL, V19, P1100, DOI 10.1093/oxfordjournals.molbev.a004168; Chen H, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0085631, 10.1371/journal.pone.0086214, 10.1371/journal.pone.0087753]; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Dowton M, 1995, J MOL EVOL, V41, P958, DOI 10.1007/BF00173176; Francino MP, 1996, SCIENCE, V272, P107, DOI 10.1126/science.272.5258.107; Gissi C, 2008, HEREDITY, V101, P301, DOI 10.1038/hdy.2008.62; Huse SM, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r143; Huyse T, 2005, TRENDS PARASITOL, V21, P469, DOI 10.1016/j.pt.2005.08.009; Huyse T, 2008, GENE, V417, P27, DOI 10.1016/j.gene.2008.03.008; Jeon HK, 2007, PARASITOL INT, V56, P243, DOI 10.1016/j.parint.2007.04.001; Kang S, 2012, MITOCHONDR DNA, V23, P176, DOI 10.3109/19401736.2012.668900; Laslett D, 2008, BIOINFORMATICS, V24, P172, DOI 10.1093/bioinformatics/btm573; Lawrie DS, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003527; Le TH, 2000, MOL BIOL EVOL, V17, P1123, DOI 10.1093/oxfordjournals.molbev.a026393; Le TH, 2002, PARASITOLOGY, V124, P97, DOI 10.1017/S0031182001008976; Le Thanh Hoa, 2004, Korean Journal of Parasitology, V42, P159, DOI 10.3347/kjp.2004.42.4.159; Marin A, 2008, J THEOR BIOL, V253, P508, DOI 10.1016/j.jtbi.2008.04.004; Nakao M, 2003, J PARASITOL, V89, P633, DOI 10.1645/0022-3395(2003)089[0633:TMGOTT]2.0.CO;2; Necsulea A, 2007, MOL BIOL EVOL, V24, P2169, DOI 10.1093/molbev/msm148; Page RDM, 1998, MOL PHYLOGENET EVOL, V9, P276, DOI 10.1006/mpev.1997.0458; PERNA NT, 1995, J MOL EVOL, V41, P353, DOI 10.1007/BF01215182; Poh YP, 2012, GENOME BIOL EVOL, V4, P1245, DOI 10.1093/gbe/evs097; Riutort M, 2012, INT J DEV BIOL, V56, P5, DOI 10.1387/ijdb.113441mr; Ruiz-Trillo I, 2004, MOL PHYLOGENET EVOL, V33, P321, DOI 10.1016/j.ympev.2004.06.002; Sakai M, 2012, ZOOL SCI, V29, P672, DOI 10.2108/zsj.29.672; Schattner P, 2005, NUCLEIC ACIDS RES, V33, pW686, DOI 10.1093/nar/gki366; Schmieder R, 2011, BIOINFORMATICS, V27, P863, DOI 10.1093/bioinformatics/btr026; Sharp PM, 2010, PHILOS T R SOC B, V365, P1203, DOI 10.1098/rstb.2009.0305; SHIELDS DC, 1988, MOL BIOL EVOL, V5, P704; Sluys R, 2013, ZOOL J LINN SOC-LOND, V169, P523, DOI 10.1111/zoj.12077; Sola E, 2013, MOL PHYLOGENET EVOL, V66, P877, DOI 10.1016/j.ympev.2012.11.010; Stock M, 2006, MOL PHYLOGENET EVOL, V41, P663, DOI 10.1016/j.ympev.2006.05.026; Telford MJ, 2000, P NATL ACAD SCI USA, V97, P11359, DOI 10.1073/pnas.97.21.11359; Tillier ERM, 2000, J MOL EVOL, V50, P249, DOI 10.1007/s002399910029; Weber M, 2013, MOL PHYLOGENET EVOL, V66, P182, DOI 10.1016/j.ympev.2012.09.017; Wei SJ, 2009, GENOME, V52, P308, DOI [10.1139/G09-008, 10.1139/g09-008]; Wey-Fabrizius AR, 2013, MOL PHYLOGENET EVOL, V69, P365, DOI 10.1016/j.ympev.2012.12.015; Woolfit M, 2003, MOL BIOL EVOL, V20, P1545, DOI 10.1093/molbev/msg167; WRIGHT F, 1990, GENE, V87, P23, DOI 10.1016/0378-1119(90)90491-9; Wyman SK, 2004, BIOINFORMATICS, V20, P3252, DOI 10.1093/bioinformatics/bth352; Yamasaki H, 2012, PARASITOL INT, V61, P260, DOI 10.1016/j.parint.2011.10.007; Zhang J, 2014, MITOCHONDR DNA, V1736, P1	56	30	32	2	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0120081	10.1371/journal.pone.0120081	http://dx.doi.org/10.1371/journal.pone.0120081			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25793530	gold, Green Submitted, Green Published			2022-12-27	WOS:000352084200142
J	Arem, H; Yu, K; Xiong, X; Moy, K; Freedman, ND; Mayne, ST; Albanes, D; Arslan, AA; Austin, M; Bamlet, WR; Beane-Freeman, L; Bracci, P; Canzian, F; Cotterchio, M; Duell, EJ; Gallinger, S; Giles, GG; Goggins, M; Goodman, PJ; Hartge, P; Hassan, M; Helzlsouer, K; Henderson, B; Holly, EA; Hoover, R; Jacobs, EJ; Kamineni, A; Klein, A; Klein, E; Kolonel, LN; Li, D; Malats, N; Mannistoo, S; McCullough, ML; Olson, SH; Orlow, I; Peters, U; Petersen, GM; Porta, M; Severi, G; Shu, XO; Visvanathan, K; White, E; Yu, H; Zeleniuch-Jacquotte, A; Zheng, W; Tobias, GS; Maeder, D; Brotzman, M; Risch, H; Sampson, JN; Stolzenberg-Solomon, RZ				Arem, Hannah; Yu, Kai; Xiong, Xiaoqin; Moy, Kristin; Freedman, Neal D.; Mayne, Susan T.; Albanes, Demetrius; Arslan, Alan A.; Austin, Melissa; Bamlet, William R.; Beane-Freeman, Laura; Bracci, Paige; Canzian, Federico; Cotterchio, Michelle; Duell, Eric J.; Gallinger, Steve; Giles, Graham G.; Goggins, Michael; Goodman, Phyllis J.; Hartge, Patricia; Hassan, Manal; Helzlsouer, Kathy; Henderson, Brian; Holly, Elizabeth A.; Hoover, Robert; Jacobs, Eric J.; Kamineni, Aruna; Klein, Alison; Klein, Eric; Kolonel, Laurence N.; Li, Donghui; Malats, Nuria; Mannisto, Satu; McCullough, Marjorie L.; Olson, Sara H.; Orlow, Irene; Peters, Ulrike; Petersen, Gloria M.; Porta, Miquel; Severi, Gianluca; Shu, Xiao-Ou; Visvanathan, Kala; White, Emily; Yu, Herbert; Zeleniuch-Jacquotte, Anne; Zheng, Wei; Tobias, Geoffrey S.; Maeder, Dennis; Brotzman, Michelle; Risch, Harvey; Sampson, Joshua N.; Stolzenberg-Solomon, Rachael Z.			Vitamin D Metabolic Pathway Genes and Pancreatic Cancer Risk	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; UNITED-STATES; MORTALITY; SUSCEPTIBILITY; COHORT; DETERMINANTS; CONSORTIUM; RADIATION; JAPAN	Evidence on the association between vitamin D status and pancreatic cancer risk is inconsistent. This inconsistency may be partially attributable to variation in vitamin D regulating genes. We selected 11 vitamin D-related genes (GC, DHCR7, CYP2R1, VDR, CYP27B1, CYP24A1, CYP27A1, RXRA, CRP2, CASR and CUBN) totaling 213 single nucleotide polymorphisms (SNPs), and examined associations with pancreatic adenocarcinoma. Our study included 3,583 pancreatic cancer cases and 7,053 controls from the genome-wide association studies of pancreatic cancer PanScans-I-III. We used the Adaptive Joint Test and the Adaptive Rank Truncated Product statistic for pathway and gene analyses, and unconditional logistic regression for SNP analyses, adjusting for age, sex, study and population stratification. We examined effect modification by circulating vitamin D concentration (<= 50, >50 nmol/L) for the most significant SNPs using a subset of cohort cases (n = 713) and controls (n = 878). The vitamin D metabolic pathway was not associated with pancreatic cancer risk (p = 0.830). Of the individual genes, none were associated with pancreatic cancer risk at a significance level of p<0.05. SNPs near the VDR (rs2239186), LRP2 (rs4668123), CYP24A1 (rs2762932), GC (rs2282679), and CUBN (rs1810205) genes were the top SNPs associated with pancreatic cancer (p-values 0.008-0.037), but none were statistically significant after adjusting for multiple comparisons. Associations between these SNPs and pancreatic cancer were not modified by circulating concentrations of vitamin D. These findings do not support an association between vitamin D-related genes and pancreatic cancer risk. Future research should explore other pathways through which vitamin D status might be associated with pancreatic cancer risk.	[Arem, Hannah; Yu, Kai; Moy, Kristin; Freedman, Neal D.; Albanes, Demetrius; Beane-Freeman, Laura; Hartge, Patricia; Hoover, Robert; Tobias, Geoffrey S.; Sampson, Joshua N.; Stolzenberg-Solomon, Rachael Z.] NCI, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA; [Xiong, Xiaoqin] Informat Management Syst Inc, Calverton, MD USA; [Mayne, Susan T.; Risch, Harvey] Yale Univ, Sch Publ Hlth, Yale Canc Ctr, New Haven, CT USA; [Arslan, Alan A.; Zeleniuch-Jacquotte, Anne] NYU, Dept Populat Hlth, New York, NY USA; [Arslan, Alan A.; Zeleniuch-Jacquotte, Anne] NYU, Dept Obstet & Gynecol, New York, NY 10016 USA; [Arslan, Alan A.; Zeleniuch-Jacquotte, Anne] NYU, Dept Environm Med, New York, NY 10016 USA; [Austin, Melissa] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Bamlet, William R.; Petersen, Gloria M.] Mayo Clin, Dept Epidemiol, Rochester, MN USA; [Bracci, Paige; Holly, Elizabeth A.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Canzian, Federico] German Canc Res Ctr, Div Canc Epidemiol, Heidelberg, Germany; [Cotterchio, Michelle] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON M5S 1A1, Canada; [Cotterchio, Michelle] Canc Care Ontario Toronto, Prevent & Canc Control, Toronto, ON, Canada; [Duell, Eric J.] Catalan Inst Oncol ICO IDIBELL, Barcelona, Spain; [Gallinger, Steve] Univ Toronto, Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; [Giles, Graham G.; Severi, Gianluca] Univ Melbourne, Sch Populat Hlth, Canc Council Victoria & Ctr MEGA Epidemiol, Canc Epidemiol Ctr, Melbourne, Vic, Australia; [Goggins, Michael] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA; [Goggins, Michael] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA; [Goggins, Michael] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Goodman, Phyllis J.; Klein, Eric; Peters, Ulrike; White, Emily] Cleveland Clin, Glickman Urol & Kidney Inst, Cleveland, OH 44106 USA; [Hassan, Manal; Li, Donghui] Univ Texas MD Anderson Canc Ctr, Dept Gastrointestinal Med Oncol, Houston, TX 77030 USA; [Helzlsouer, Kathy; Visvanathan, Kala] MD Mercy, Baltimore, MD USA; [Henderson, Brian] Univ So Calif, Sch Med, Dept Preventat Med, Los Angeles, CA USA; [Jacobs, Eric J.; McCullough, Marjorie L.] Amer Canc Soc, Epidemiol Res Program, Atlanta, GA 30329 USA; [Kamineni, Aruna] Grp Hlth Res Inst, Seattle, WA USA; [Kolonel, Laurence N.; Yu, Herbert] Univ Hawaii, Ctr Canc, Manoa, HI USA; [Malats, Nuria] Spanish Natl Canc Res Ctr, Mol Pathol Program, Madrid, Spain; [Mannisto, Satu] Natl Inst Hlth & Welf, Dept Chron Dis Prevent, Helsinki, Finland; [Olson, Sara H.; Orlow, Irene] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10021 USA; [Porta, Miquel] Hosp Mar Inst Med Res IMIM, Barcelona, Spain; [Porta, Miquel] Sch Med, Barcelona, Spain; [Shu, Xiao-Ou; Zheng, Wei] Vanderbilt Univ, Vanderbilt Epidemiol Ctr, Dept Med, Div Epidemiol, Nashville, TN 37235 USA; [Shu, Xiao-Ou; Zheng, Wei] Vanderbilt Univ, Vanderbilt Ingram Canc Ctr, Nashville, TN 37235 USA; [Maeder, Dennis] NCI, Canc Genom Res Lab, Div Canc Epidemiol & Genet, Leidos Biomed Res Inc,Frederick Natl Lab Canc Res, Frederick, MD 21701 USA; [Brotzman, Michelle] WESTAT Corp, Rockville, MD 20850 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Yale University; New York University; New York University; New York University; University of Washington; University of Washington Seattle; Mayo Clinic; University of California System; University of California San Francisco; Helmholtz Association; German Cancer Research Center (DKFZ); University of Toronto; Cancer Care Ontario; Catalan Institute of Oncology; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; Cancer Council Victoria; University of Melbourne; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Cleveland Clinic Foundation; University of Texas System; UTMD Anderson Cancer Center; Mercy Medical Center - Maryland; University of Southern California; American Cancer Society; Cancer Research Center of Hawaii; University of Hawaii System; University of Hawaii Manoa; Centro Nacional de Investigaciones Oncologicas (CNIO); Finland National Institute for Health & Welfare; Memorial Sloan Kettering Cancer Center; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Vanderbilt University; Vanderbilt University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Westat	Arem, H (corresponding author), NCI, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA.	Hannah.arem@nih.gov	zhang, weihua/GXV-1334-2022; Porta, Miquel/AAD-5371-2020; Visvanathan, Kala/AAE-4396-2021; Zheng, Wei/O-3351-2013; Freedman, Neal David/B-9741-2015; Porta, Miquel/B-5787-2008; Stolzenberg-Solomon, Rachael/Y-9280-2018; Freeman, Laura E. Beane/C-4468-2015; Tobias, Geoffrey S/M-4135-2016; Severi, Gianluca/Q-1824-2019; Gallinger, Steven/E-4575-2013; Severi, Gianluca/H-3774-2018; Malats, Nuria/H-7041-2015	Porta, Miquel/0000-0003-1684-7428; Zheng, Wei/0000-0003-1226-070X; Freedman, Neal David/0000-0003-0074-1098; Porta, Miquel/0000-0003-1684-7428; Stolzenberg-Solomon, Rachael/0000-0003-3698-7006; Freeman, Laura E. Beane/0000-0003-1294-4124; Tobias, Geoffrey S/0000-0002-2878-8253; Severi, Gianluca/0000-0001-7157-419X; Severi, Gianluca/0000-0001-7157-419X; Mannisto, Satu/0000-0002-8668-3046; Cotterchio, Michelle/0000-0003-2862-7895; Zeleniuch-Jacquotte, Anne/0000-0001-9350-1303; McCullough, Marjorie/0000-0003-3025-6341; Olson, Sara/0000-0003-0182-2754; Giles, Graham/0000-0003-4946-9099; Malats, Nuria/0000-0003-2538-3784; Bamlet, William/0000-0003-2903-1284; Canzian, Federico/0000-0002-4261-4583; Orlow, Irene/0000-0001-6234-6961; Arslan, Alan/0000-0002-7775-8085	National Cancer Institute, National Institutes of Health [HHSN261200800001E]; NATIONAL CANCER INSTITUTE [UM1CA182883, UM1CA182934, K05CA154337, ZIACP010193, UM1CA182910, P50CA102701, UG1CA189974, UM1CA173640, U10CA037429] Funding Source: NIH RePORTER	National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This project has been funded in whole or in part with federal funds from the National Cancer Institute, National Institutes of Health, under Contract No. HHSN261200800001E. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the U.S. Government. Please see the Supplemental Information section for a detailed listing of study-specific funding. Co-authors Xiaoqin Xiong (Information Management Systems, Inc.), Dennis Maeder (Leidos Biomedical Research, Inc.) and Michelle Brotzman (Westat) are employed by commercial enterprises, and received salary from these companies to support this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn J, 2010, HUM MOL GENET, V19, P2739, DOI 10.1093/hmg/ddq155; Amundadottir L, 2009, NAT GENET, V41, P986, DOI 10.1038/ng.429; Anderson LN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066768; Bao Y, 2010, BRIT J CANCER, V102, P1422, DOI 10.1038/sj.bjc.6605658; Berry D, 2011, CURR OPIN NEPHROL HY, V20, P331, DOI 10.1097/MNH.0b013e328346d6ba; Boscoe FP, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-264; Campa D, 2013, DIGEST LIVER DIS, V45, P95, DOI 10.1016/j.dld.2012.09.014; Deeb KK, 2007, NAT REV CANCER, V7, P684, DOI 10.1038/nrc2196; Grant WB, 2002, CANCER-AM CANCER SOC, V94, P1867, DOI 10.1002/cncr.10427; Grant WB, 2007, INT J CANCER, V120, P1123, DOI 10.1002/ijc.22386; Helzlsouer KJ, 2010, AM J EPIDEMIOL, V172, P4, DOI 10.1093/aje/kwq119; Jiao L, 2009, ARCH INTERN MED, V169, P764, DOI 10.1001/archinternmed.2009.46; Kanemaru M, 2013, HEPATO-GASTROENTEROL, V60, P1199, DOI 10.5754/hge11073; Kinoshita S, 2007, INT J HEALTH GEOGR, V6, DOI 10.1186/1476-072X-6-34; Lin YS, 2011, J EPIDEMIOL, V21, P2, DOI 10.2188/jea.JE20100090; Millen AE, 2008, AM J CLIN NUTR, V87, p1102S, DOI 10.1093/ajcn/87.4.1102S; Mizoue T, 2004, HEALTH PHYS, V87, P532, DOI 10.1097/01.HP.0000137179.03423.0b; Moore C, 2004, J AM DIET ASSOC, V104, P980, DOI 10.1016/j.jada.2004.03.028; Petersen GM, 2010, NAT GENET, V42, P224, DOI 10.1038/ng.522; Porta M, 2012, BIOMARKERS, V17, P557, DOI 10.3109/1354750X.2012.701331; Ross AC, 2011, J CLIN ENDOCR METAB, V96, P53, DOI 10.1210/jc.2010-2704; Stolzenberg-Solomon RZ, 2006, CANCER RES, V66, P10213, DOI 10.1158/0008-5472.CAN-06-1876; Stolzenberg-Solomon RZ, 2010, AM J EPIDEMIOL, V172, P81, DOI 10.1093/aje/kwq120; Vitamin D, 2011, VIT D DIET SUPPL FAC; Wang TJ, 2010, LANCET, V376, P180, DOI 10.1016/S0140-6736(10)60588-0; Wolpin B, 2014, NATURE GENE IN PRESS; Wolpin BM, 2011, CANC EPIDEMIOL BIOMA; Wolpin BM, 2014, NATURE GENETICS; Yu K, 2009, GENET EPIDEMIOL, V33, P700, DOI 10.1002/gepi.20422; Zinser GM, 2005, J STEROID BIOCHEM, V97, P153, DOI 10.1016/j.jsbmb.2005.06.024	30	24	24	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0117574	10.1371/journal.pone.0117574	http://dx.doi.org/10.1371/journal.pone.0117574			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25799011	Green Published, gold, Green Submitted			2022-12-27	WOS:000351987300005
J	Del-Rio, G; Rego, MA; Silveira, LF				Del-Rio, Glaucia; Rego, Marco Antonio; Silveira, Luis Fabio			A Multiscale Approach Indicates a Severe Reduction in Atlantic Forest Wetlands and Highlights that Sao Paulo Marsh Antwren Is on the Brink of Extinction	PLOS ONE			English	Article							SPECIES DISTRIBUTION MODELS; HABITAT; DISTRIBUTIONS; CONSERVATION; PREDICTION; PERFORMANCE; SELECTION; ACCURACY; NUTRIENT; HOTSPOTS	Over the last 200 years the wetlands of the Upper Tiete and Upper Paraiba do Sul basins, in the southeastern Atlantic Forest, Brazil, have been almost-completely transformed by urbanization, agriculture and mining. Endemic to these river basins, the Sao Paulo Marsh Antwren (Formicivora paludicola) survived these impacts, but remained unknown to science until its discovery in 2005. Its population status was cause for immediate concern. In order to understand the factors imperiling the species, and provide guidelines for its conservation, we investigated both the species' distribution and the distribution of areas of suitable habitat using a multiscale approach encompassing species distribution modeling, fieldwork surveys and occupancy models. Of six species distribution models methods used (Generalized Linear Models, Generalized Additive Models, Multivariate Adaptive Regression Splines, Classification Tree Analysis, Artificial Neural Networks and Random Forest), Random Forest showed the best fit and was utilized to guide field validation. After surveying 59 sites, our results indicated that Formicivora paludicola occurred in only 13 sites, having narrow habitat specificity, and restricted habitat availability. Additionally, historic maps, distribution models and satellite imagery showed that human occupation has resulted in a loss of more than 346 km2 of suitable habitat for this species since the early twentieth century, so that it now only occupies a severely fragmented area (area of occupancy) of 1.42 km2, and it should be considered Critically Endangered according to IUCN criteria. Furthermore, averaged occupancy models showed that marshes with lower cattail (Typha dominguensis) densities have higher probabilities of being occupied. Thus, these areas should be prioritized in future conservation efforts to protect the species, and to restore a portion of Atlantic Forest wetlands, in times of unprecedented regional water supply problems.	[Del-Rio, Glaucia] Univ Sao Paulo, Inst Biociencias, Dept Zool, Sao Paulo, SP, Brazil; [Del-Rio, Glaucia; Rego, Marco Antonio; Silveira, Luis Fabio] Univ Sao Paulo, Museu Zool, Secao Aves, Sao Paulo, SP, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo	Del-Rio, G (corresponding author), Louisiana State Univ, Museum Nat Sci, Baton Rouge, LA 70803 USA.	gdelri1@lsu.edu	Silveira, Luis/V-6161-2019; Silveira, Luis Fabio/F-8337-2012	Silveira, Luis/0000-0003-2576-7657; Silveira, Luis Fabio/0000-0003-2576-7657	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [2011/16251]; CNPq [313818/2009-6]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by 2011/16251 (http://www.fapesp.br/) Fundacao de Amparo a Pesquisa do Estado de Sao Paulo to GDR. CNPq 313818/2009-6 (http://www.cnpq.br/) Conselho Nacional de Desenvolvimento Cientifico e Tecnologico to LFS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Allouche O, 2006, J APPL ECOL, V43, P1223, DOI 10.1111/j.1365-2664.2006.01214.x; Amaral S, 2013, AN 15 S BRAS SENS RE, V16, P6930; [Anonymous], 2010, WETLAND ECOLOGY PRIN; Araujo MB, 2005, GLOBAL CHANGE BIOL, V11, P1504, DOI 10.1111/j.1365-2486.2005.01000.x; AUCLAIR AND, 1976, ECOLOGY, V57, P941, DOI 10.2307/1941059; Austin MP, 2002, ECOL MODEL, V157, P101, DOI 10.1016/S0304-3800(02)00205-3; Barbet-Massin M, 2012, METHODS ECOL EVOL, V3, P327, DOI 10.1111/j.2041-210X.2011.00172.x; Barthram G.T., 1986, 198485 HFRO, P29; BirdLife International, 2013, SPEC FACTSH FORM LIT; BirdLife International, 2013, SPEC FACTSH MYRM SNO; Bolenbaugh JR, 2011, J FISH WILDL MANAG, V2, P49, DOI 10.3996/012011-JFWM-001; Boscolo D, 2011, ECOGRAPHY, V34, P1018, DOI 10.1111/j.1600-0587.2011.06763.x; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Breiman L., 2003, SETTING USING UNDERS; Breiman L., 2017, CLASSIFICATION REGRE; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; Coelho V., 2012, PARAIBA RIO ESTRATEG; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Coimbra-Filho AF, 1996, LIMITES ORIGINAIS BI; Buzzetti DRC, 2013, REV BRAS ORNITOL, V21, P269; Daily G. C., 1997, Nature's services: societal dependence on natural ecosystems., P113; DAVIS SM, 1991, AQUAT BOT, V40, P203, DOI 10.1016/0304-3770(91)90059-E; Dean W., 1995, With broadax and firebrand: the destruction of the Brazilian Atlantic forest.; EDDLEMAN WR, 1988, WILSON BULL, V100, P458; Elith J, 2002, PREDICTING SPECIES OCCURRENCES: ISSUES OF ACCURACY AND SCALE, P303; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Engler R, 2004, J APPL ECOL, V41, P263, DOI 10.1111/j.0021-8901.2004.00881.x; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; Fiske IJ, 2011, J STAT SOFTW, V43, P1; Fonseca GAB, 1995, BIOL CONSERV, V34, P17; Franklin J, 1995, PROG PHYS GEOG, V19, P474, DOI 10.1177/030913339501900403; FRIEDMAN JH, 1991, ANN STAT, V19, P1, DOI 10.1214/aos/1176347963; Galindo-Leal C, 2003, STATE HOTS, P3; Garcia PCA, 2009, FAUNA AMEACADA EXTIN, P329; GOLDSMITH F B, 1986, P437; Graham CH, 2004, TRENDS ECOL EVOL, V19, P497, DOI 10.1016/j.tree.2004.07.006; GRUMBINE E, 1990, Natural Areas Journal, V10, P114; Guisan A, 2000, ECOL MODEL, V135, P147, DOI 10.1016/S0304-3800(00)00354-9; Hastie T., 1986, STAT SCI, V1, P297; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hirata RCA, 2001, REV BRASIL GEOCIENC, V31, P43, DOI DOI 10.25249/0375-7536.20013114350; IBGE-Instituto Brasileiro de Geografiae Estatistica, 2010, PESQ NAC AM DOM SINT; International Union for Conservation of Nature (IUCN), 2010, GUID US IUCN RED LIS; Iserhagem I, 2009, PACTO PELA RESTAURAC, P87; Jimenez-Valverde A, 2008, DIVERS DISTRIB, V14, P885, DOI 10.1111/j.1472-4642.2008.00496.x; Jorge J, 2006, TIETE RIO QUE CIDADE; Jorge J, 2012, HIST PERSPEC, V25, P103; Ko CY, 2009, ZOOL STUD, V48, P418; Laurance WF, 2009, BIOL CONSERV, V142, P1137, DOI 10.1016/j.biocon.2008.10.011; Ledig FT, 2010, AM J BOT, V97, P970, DOI 10.3732/ajb.0900329; Lehner B., 2008, EOS T AM GEOPHYS UN, P93, DOI [DOI 10.1029/2008EO100001, 10.1029/2008EO100001]; Li XH, 2013, INTEGR ZOOL, V8, P124, DOI 10.1111/1749-4877.12000; Liu CR, 2013, J BIOGEOGR, V40, P778, DOI 10.1111/jbi.12058; Loiselle BA, 2003, CONSERV BIOL, V17, P1591, DOI 10.1111/j.1523-1739.2003.00233.x; Lu N, 2012, BIOL CONSERV, V152, P102, DOI 10.1016/j.biocon.2012.04.004; MacKenzie D. I., 2006, OCCUPANCY ESTIMATION; MacKenzie DI, 2004, J AGR BIOL ENVIR ST, V9, P300, DOI 10.1198/108571104X3361; Marmion M, 2009, ECOL MODEL, V220, P3512, DOI 10.1016/j.ecolmodel.2008.10.019; Mazerolle MJ, 2012, AICCMODAVG MODEL SEL; McCoy J, 2001, USING ARCGISTM SPATI; McPherson JM, 2007, ECOGRAPHY, V30, P135, DOI 10.1111/j.2006.0906-7590.04823.x; METI/NASA, 2012, GLOB DIG EL MOD VERS; Mitsch W. J., 1993, WETLANDS; Mitsch WJ, 2000, ECOL ECON, V35, P25, DOI 10.1016/S0921-8009(00)00165-8; Munoz J, 2004, J VEG SCI, V15, P285, DOI 10.1111/j.1654-1103.2004.tb02263.x; Myers N, 1988, Environmentalist, V8, P187, DOI 10.1007/BF02240252; NELDER JA, 1972, J R STAT SOC SER A-G, V135, P370, DOI 10.2307/2344614; Newman S, 1998, AQUAT BOT, V60, P265, DOI 10.1016/S0304-3770(97)00089-2; North American Bird Conservation Initiative, 2009, BIRD CONS PLANS; OYAKAWA O.T., 2009, FAUNA AMEACADA EXTIN, P349; Pearce J, 2000, ECOL MODEL, V133, P225, DOI 10.1016/S0304-3800(00)00322-7; Petit LJ, 2003, CONSERV BIOL, V17, P687, DOI 10.1046/j.1523-1739.2003.00124.x; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; R Core Team, 2021, R LANGUAGE ENV STAT; Reinert BL, 2007, REV BRAS ORNITOL, V15, P493; REJMANKOVA E, 1995, BIOTROPICA, V27, P28, DOI 10.2307/2388900; Renno CD, 2008, REMOTE SENS ENVIRON, V112, P3469, DOI 10.1016/j.rse.2008.03.018; Reside AE, 2012, ECOL EVOL, V2, P705, DOI 10.1002/ece3.197; RIBIC CA, 1999, P MARSH BIRD MON WOR; Ripley B. D., 1996, PATTERN RECOGNITION; Roberts DR, 2012, ECOGRAPHY, V35, P792, DOI 10.1111/j.1600-0587.2011.07147.x; Silveira LF, 2009, FAUNA AMEACADA EXTIN; Silveira LF, 2011, BIOTA NEOTROP, V11, P2; Sutherland WJ, 2004, TECH ECOL CONSERVAT, P251; Thuiller W, 2003, GLOBAL CHANGE BIOL, V9, P1353, DOI 10.1046/j.1365-2486.2003.00666.x; Tsoar A, 2007, DIVERS DISTRIB, V13, P397, DOI 10.1111/j.1472-4642.2007.00346.x; United States Geological Survey Project, 2013, EARTH EXPL LANDSAT 8; URBAN NH, 1993, AQUAT BOT, V46, P203, DOI 10.1016/0304-3770(93)90002-E; Verry ES, 1989, FRESHWATER WETLANDS, P1177; Wagenmakers EJ, 2004, PSYCHON B REV, V11, P192, DOI 10.3758/BF03206482; Warren DL, 2010, ECOGRAPHY, V33, P607, DOI 10.1111/j.1600-0587.2009.06142.x; Wisz MS, 2008, DIVERS DISTRIB, V14, P763, DOI 10.1111/j.1472-4642.2008.00482.x; Ximenes AC, 2008, THESIS I NACL PESQUI; Kamino LHY, 2012, NAT CONSERVACAO, V10, P191, DOI 10.4322/natcon.2012.033; Zedler JB, 2005, ANNU REV ENV RESOUR, V30, P39, DOI 10.1146/annurev.energy.30.050504.144248; Zimmer K.J., 2003, P448	98	5	5	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0121315	10.1371/journal.pone.0121315	http://dx.doi.org/10.1371/journal.pone.0121315			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25798608	Green Published, gold, Green Submitted			2022-12-27	WOS:000351987300233
J	Granata, S; Masola, V; Zoratti, E; Scupoli, MT; Baruzzi, A; Messa, M; Sallustio, F; Gesualdo, L; Lupo, A; Zaza, G				Granata, Simona; Masola, Valentina; Zoratti, Elisa; Scupoli, Maria Teresa; Baruzzi, Anna; Messa, Michele; Sallustio, Fabio; Gesualdo, Loreto; Lupo, Antonio; Zaza, Gianluigi			NLRP3 Inflammasome Activation in Dialyzed Chronic Kidney Disease Patients	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; OXIDATIVE STRESS; INTERLEUKIN-1-BETA; PROTEIN; LINK; BIOCOMPATIBILITY; BIOSYNTHESIS; MALNUTRITION; MITOCHONDRIA; HEMODIALYSIS	To assess whether NLR pyrin domain-containing protein 3 (NLRP3) inflammasome, a multi-protein complex that mediates the activation of caspase-1 (CASP-1) and pro-inflammatory cytokines IL-18 and IL-1 beta, could be involved in the chronic inflammatory state observed in chronic kidney disease patients undergoing hemodialysis treatment (CKD-HD), we employed several biomolecular techniques including RT-PCR, western blot, FACS analysis, confocal microscopy and microarray. Interestingly, peripheral blood mononuclear cells from 15 CKD-HD patients showed higher mRNA levels of NLRP3, CASP-1, ASC, IL-1 beta, IL-18 and P2X7receptor compared to 15 healthy subjects. Western blotting analysis confirmed the above results. In particular, active forms of CASP-1, IL1-beta and IL-18 resulted significantly up-regulated in CKD-HD versus controls. Additionally, elevated mitochondrial ROS level, colocalization of NLRP3/ASC/ mitochondria in peripheral blood mononuclear cells from CKD-HD patients and down-regulation of CASP-1, IL1-beta and IL-18 protein levels in immune-cells of CKD-HD patients stimulated with LPS/ATP in presence of mitoTEMPO, inhibitor of mitochondrial ROS production, suggested a possible role of this organelle in the aforementioned CKD-associated inflammasome activation. Then, microarray analysis confirmed, in an independent microarray study cohort, that NLRP3 and CASP-1, along with other inflammasome-related genes, were up-regulated in 17 CKD-HD patients and they were able to clearly discriminate these patients from 5 healthy subjects. All together these data showed, for the first time, that NLRP3 inflammasome was activated in uremic patients undergoing dialysis treatment and they suggested that this unphysiological condition could be possibly induced by mitochondrial dysfunction.	[Granata, Simona; Masola, Valentina; Messa, Michele; Lupo, Antonio; Zaza, Gianluigi] Univ Hosp Verona, Dept Med, Renal Unit, Verona, Italy; [Zoratti, Elisa; Scupoli, Maria Teresa] Univ Verona, Interdept Lab Med Res LURM, I-37100 Verona, Italy; [Baruzzi, Anna] Univ Verona, Sect Gen Pathol, Dept Pathol & Diagnost, I-37100 Verona, Italy; [Sallustio, Fabio; Gesualdo, Loreto] Univ Bari, Dialysis & Transplantat Unit, Dept Emergency & Organ Transplantat Nephrol, Bari, Italy	University of Verona; Azienda Ospedaliera Universitaria Integrata Verona; University of Verona; University of Verona; Universita degli Studi di Bari Aldo Moro	Zaza, G (corresponding author), Univ Hosp Verona, Dept Med, Renal Unit, Verona, Italy.	gianluigi.zaza@univr.it	Sallustio, Fabio/AFP-7212-2022; Zaza, Gianluigi/K-3827-2018; Gesualdo, Loreto/K-7751-2016; Sallustio, Fabio/D-2326-2011; SCUPOLI, Maria/AAX-9712-2021; granata, simona/K-4148-2016	Sallustio, Fabio/0000-0002-5132-6532; Gesualdo, Loreto/0000-0002-4861-0911; Sallustio, Fabio/0000-0002-5132-6532; SCUPOLI, Maria/0000-0002-3352-7859; Masola, Valentina/0000-0003-2341-2481; granata, simona/0000-0002-3740-7598; Zaza, Gianluigi/0000-0002-6004-6196				Ajioka RS, 2006, BBA-MOL CELL RES, V1763, P723, DOI 10.1016/j.bbamcr.2006.05.005; Akahoshi T, 1995, NEPHROL DIAL TRANSPL, V10, P2244, DOI 10.1093/ndt/10.12.2244; Anders HJ, 2011, J AM SOC NEPHROL, V22, P1007, DOI 10.1681/ASN.2010080798; Anders HJ, 2004, J AM SOC NEPHROL, V15, P854, DOI 10.1097/01.ASN.0000121781.89599.16; Arnoult D, 2011, EMBO REP, V12, P901, DOI 10.1038/embor.2011.157; Babelova A, 2009, J BIOL CHEM, V284, P24035, DOI 10.1074/jbc.M109.014266; CHAN SI, 1990, BIOCHEMISTRY-US, V29, P1, DOI 10.1021/bi00453a001; Chanard J, 2003, NEPHROL DIAL TRANSPL, V18, P252, DOI 10.1093/ndt/18.2.252; CHEUNG AK, 1990, KIDNEY INT, V37, P1055, DOI 10.1038/ki.1990.85; Coresh J, 2003, AM J KIDNEY DIS, V41, P1, DOI 10.1053/ajkd.2003.50007; Di Virgilio F, 2007, TRENDS PHARMACOL SCI, V28, P465, DOI 10.1016/j.tips.2007.07.002; Dinarello CA, 1998, ANN NY ACAD SCI, V856, P1, DOI 10.1111/j.1749-6632.1998.tb08307.x; Dostert C, 2008, SCIENCE, V320, P674, DOI 10.1126/science.1156995; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Fritz JH, 2005, J ENDOTOXIN RES, V11, P390, DOI 10.1179/096805105X76850; Geddes K, 2009, NAT REV DRUG DISCOV, V8, P465, DOI 10.1038/nrd2783; Gohh R., 2013, R I MED J, V104, P14; Granata S, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-388; Grassmann A, 2005, NEPHROL DIAL TRANSPL, V20, P2587, DOI 10.1093/ndt/gfi159; Green DR, 1998, CELL, V94, P695, DOI 10.1016/S0092-8674(00)81728-6; Gyorgy H, 2006, CELL CALCIUM, V40, P553, DOI 10.1016/j.ceca.2006.08.016; Hamer RA, 2006, BMJ-BRIT MED J, V332, P563, DOI 10.1136/bmj.332.7541.563; Handelman GJ, 2001, KIDNEY INT, V59, P1960, DOI 10.1046/j.1523-1755.2001.0590051960.x; Himmelfarb J, 2002, KIDNEY INT, V62, P1524, DOI 10.1046/j.1523-1755.2002.00600.x; Ito S, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/ar4483; Kalantar-Zadeh K, 2003, AM J KIDNEY DIS, V42, P864, DOI 10.1016/j.ajkd.2003.07.016; Kato S, 2008, CLIN J AM SOC NEPHRO, V3, P1526, DOI 10.2215/CJN.00950208; Kotur-Stevuljevic J, 2012, CLIN BIOCHEM, V45, P1202, DOI 10.1016/j.clinbiochem.2012.04.021; Latz E, 2010, CURR OPIN IMMUNOL, V22, P28, DOI 10.1016/j.coi.2009.12.004; LAZARUS JM, 1994, AM J KIDNEY DIS, V24, P1019, DOI 10.1016/S0272-6386(12)81077-8; Liang D, 2007, NEPHROLOGY, V12, P53, DOI 10.1111/j.1440-1797.2006.00737.x; Libetta C, 2011, CLIN BIOCHEM, V44, P1189, DOI 10.1016/j.clinbiochem.2011.06.988; LONNEMANN G, 1987, NEW ENGL J MED, V317, P963; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Mezzano D, 2001, KIDNEY INT, V60, P1844, DOI 10.1046/j.1523-1755.2001.00998.x; Munoz-Planillo R, 2009, J IMMUNOL, V183, P3942, DOI 10.4049/jimmunol.0900729; Muruve DA, 2008, NATURE, V452, P103, DOI 10.1038/nature06664; Nakahira K, 2011, NAT IMMUNOL, V12, P222, DOI 10.1038/ni.1980; NAKANISHI I, 1994, NEPHROL DIAL TRANSPL, V9, P1435; Patel UD, 2005, AM J KIDNEY DIS, V46, P406, DOI 10.1053/j.ajkd.2005.05.027; Pertosa G, 2009, AM J KIDNEY DIS, V53, P467, DOI 10.1053/j.ajkd.2008.10.046; Razmara M, 2002, J BIOL CHEM, V277, P13952, DOI 10.1074/jbc.M107811200; Rossier MF, 2006, CELL CALCIUM, V40, P155, DOI 10.1016/j.ceca.2006.04.020; Schiffrin EL, 2007, CIRCULATION, V116, P85, DOI 10.1161/CIRCULATIONAHA.106.678342; Schreiber A, 2015, J AM SOC NEPHROL, V26, P411, DOI 10.1681/ASN.2013111177; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Shahzad K, 2015, KIDNEY INT, V87, P74, DOI 10.1038/ki.2014.271; Slee AD, 2012, NUTR METAB, V9, DOI 10.1186/1743-7075-9-36; Ting JPY, 2008, IMMUNITY, V28, P285, DOI 10.1016/j.immuni.2008.02.005; Tomo T, 2011, CONTRIB NEPHROL, V168, P89, DOI 10.1159/000321747; van der Burgh R, 2014, J BIOL CHEM, V289, P5000, DOI 10.1074/jbc.M113.536920; Veal EA, 2007, MOL CELL, V26, P1, DOI 10.1016/j.molcel.2007.03.016; Vesey DA, 2002, J LAB CLIN MED, V140, P342, DOI 10.1067/mlc.2002.128468; Vilaysane A, 2010, J AM SOC NEPHROL, V21, P1732, DOI 10.1681/ASN.2010020143; Wang MR, 2012, EXP DIABETES RES, DOI 10.1155/2012/647914; WARD RA, 1995, J AM SOC NEPHROL, V5, P1697; West AP, 2011, NAT REV IMMUNOL, V11, P389, DOI 10.1038/nri2975; Yamasaki K, 2009, J BIOL CHEM, V284, P12762, DOI 10.1074/jbc.M806084200; Zaza G, 2008, NEPHROL DIAL TRANSPL, V23, P1673, DOI 10.1093/ndt/gfm804; Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663; Zhou RB, 2010, NAT IMMUNOL, V11, P136, DOI 10.1038/ni.1831; Zhuang YB, 2014, J BIOL CHEM, V289, P25101, DOI 10.1074/jbc.M114.578260	64	59	66	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0122272	10.1371/journal.pone.0122272	http://dx.doi.org/10.1371/journal.pone.0122272			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25798846	Green Published, gold			2022-12-27	WOS:000351987300324
J	Irvin, SC; Herold, BC				Irvin, Susan C.; Herold, Betsy C.			Molecular Mechanisms Linking High Dose Medroxyprogesterone with HIV-1 Risk	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; HORMONAL CONTRACEPTION; VAGINAL EPITHELIUM; GENITAL HERPES; CELL-LINES; IN-VITRO; INFECTION; EXPRESSION; ACETATE; LYMPHOCYTES	Background Epidemiological studies suggest that medroxyprogesterone acetate (MPA) may increase the risk of HIV-1. The current studies were designed to identify potential underlying biological mechanisms. Methods Human vaginal epithelial (VK2/E6E7), peripheral blood mononuclear (PBMC), and polarized endometrial (HEC-1-A) cells were treated with a range of concentrations of MPA (0.015-150 mu g/ml) and the impact on gene expression, protein secretion, and HIV infection was evaluated. Results Treatment of VK2/E6E7 cells with high doses (>15 mu g/ml] of MPA significantly upregulated proinflammatory cytokines, which resulted in a significant increase in HIV p24 levels secreted by latently infected U1 cells following exposure to culture supernatants harvested from MPA compared to mock-treated cells. MPA also increased syndecan expression by VK2/E6E7 cells and cells treated with 15 mu g/ml of MPA bound and transferred more HIV-1 to T cells compared to mock-treated cells. Moreover, MPA treatment of epithelial cells and PBMC significantly decreased cell proliferation resulting in disruption of the epithelial barrier and decreased cytokine responses to phytohaemagglutinin, respectively. Conclusion We identified several molecular mechanisms that could contribute to an association between DMPA and HIV including proinflammatory cytokine and chemokine responses that could activate the HIV promoter and recruit immune targets, increased expression of syndecans to facilitate the transfer of virus from epithelial to immune cells and decreased cell proliferation. The latter could impede the ability to maintain an effective epithelial barrier and adversely impact immune cell function. However, these responses were observed primarily following exposure to high (15-150 mu g/ml) MPA concentrations. Clinical correlation is needed to determine whether the prolonged MPA exposure associated with contraception activates these mechanisms in vivo.	[Herold, Betsy C.] Albert Einstein Coll Med, Dept Pediat, Bronx, NY 10461 USA; Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Herold, BC (corresponding author), Albert Einstein Coll Med, Dept Pediat, Bronx, NY 10461 USA.	betsy.herold@einstein.yu.edu		Herold, Betsy/0000-0001-9974-0786	National Institutes of Health [T32A1007501, U19AI03461, R01AI065309]; Montefiore Medical Center [AI51519]; Center for AIDS Research at the Albert Einstein College of Medicine; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001073] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI103461, R01AI065309, T32AI007501] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Montefiore Medical Center; Center for AIDS Research at the Albert Einstein College of Medicine; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institutes of Health [grant numbers T32A1007501 to SCI, U19AI03461 and R01AI065309 to BCH, and the Center for AIDS Research at the Albert Einstein College of Medicine and Montefiore Medical Center AI51519]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Africander D, 2011, CONTRACEPTION, V84, P423, DOI 10.1016/j.contraception.2011.06.006; Bacsa S, 2011, J GEN VIROL, V92, P733, DOI 10.1099/vir.0.027052-0; Bahamondes L, 2000, CONTRACEPTION, V62, P23, DOI 10.1016/S0010-7824(00)00132-3; Bobardt MD, 2003, IMMUNITY, V18, P27, DOI 10.1016/S1074-7613(02)00504-6; Butler AR, 2013, AIDS, V27, P105, DOI 10.1097/QAD.0b013e32835a5a52; Chandra N, 2013, AIDS RES HUM RETROV, V29, P592, DOI 10.1089/aid.2012.0271; Day S, 2014, J ACQUIR IMMUNE DEFI; Fears CY, 2006, MATRIX BIOL, V25, P443, DOI 10.1016/j.matbio.2006.07.003; Fichorova RN, 1997, BIOL REPROD, V57, P847, DOI 10.1095/biolreprod57.4.847; FOLKS TM, 1987, SCIENCE, V238, P800, DOI 10.1126/science.3313729; Geijtenbeek TBH, 2000, CELL, V100, P587, DOI 10.1016/S0092-8674(00)80694-7; Heffron R, 2012, LANCET INFECT DIS, V12, P19, DOI 10.1016/S1473-3099(11)70247-X; Hel Z, 2010, ENDOCR REV, V31, P79, DOI 10.1210/er.2009-0018; Huijbregts RPH, 2013, ENDOCRINOLOGY, V154, P1282, DOI 10.1210/en.2012-1850; Koubovec D, 2005, MOL CELL ENDOCRINOL, V242, P23, DOI 10.1016/j.mce.2005.07.001; KURAMOTO H, 1972, AM J OBSTET GYNECOL, V114, P1012, DOI 10.1016/0002-9378(72)90861-7; Marketon JIW, 2008, CELL IMMUNOL, V252, P16, DOI 10.1016/j.cellimm.2007.09.006; Mauck CK, 1999, CONTRACEPTION, V60, P15, DOI 10.1016/S0010-7824(99)00058-X; Mesquita PMM, 2008, J VIROL, V82, P6576, DOI 10.1128/JVI.00335-08; Mesquita PMM, 2009, J INFECT DIS, V200, P599, DOI 10.1086/600867; Miller L, 2000, OBSTET GYNECOL, V96, P431, DOI 10.1016/S0029-7844(00)00906-6; Mishell DR, 1996, J REPROD MED, V41, P381; Mitchell CM ML, 2014, J INFECT DIS; Mondor I, 1998, J VIROL, V72, P3623, DOI 10.1128/JVI.72.5.3623-3634.1998; Morrison C, 2014, JAIDS-J ACQ IMM DEF, V66, P109, DOI 10.1097/QAI.0000000000000103; Morrison CS, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001778; Murphy K, 2014, AM J REPROD IMMUNOL; Nixon B, 2013, J VIROL, V87, P6257, DOI 10.1128/JVI.00012-13; Phillips SJ, 2013, AIDS, V27, P787, DOI 10.1097/QAD.0b013e32835bb672; POLI G, 1990, J EXP MED, V172, P151, DOI 10.1084/jem.172.1.151; Polis CB, 2013, LANCET INFECT DIS, V13, P797, DOI 10.1016/S1473-3099(13)70155-5; Radzio J, 2014, AIDS; Saphire ACS, 2001, J VIROL, V75, P9187, DOI 10.1128/JVI.75.19.9187-9200.2001; SCHALL TJ, 1990, NATURE, V347, P669, DOI 10.1038/347669a0; Scordi-Bello IA, 2005, ANTIMICROB AGENTS CH, V49, P3607, DOI 10.1128/AAC.49.9.3607-3615.2005; Tiwari V, 2012, GLYCOBIOLOGY, V22, P1402, DOI 10.1093/glycob/cws106; Vassiliadou N, 1999, J IMMUNOL, V162, P7510; Vishwanathan SA, 2011, JAIDS-J ACQ IMM DEF, V57, P261, DOI 10.1097/QAI.0b013e318220ebd3; Wilson SS, 2009, ANTIVIR THER, V14, P1113, DOI 10.3851/IMP1463	39	17	17	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0121135	10.1371/journal.pone.0121135	http://dx.doi.org/10.1371/journal.pone.0121135			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25798593	Green Published, Green Submitted, gold			2022-12-27	WOS:000351987300213
J	Muthusamy, H; Polat, K; Yaacob, S				Muthusamy, Hariharan; Polat, Kemal; Yaacob, Sazali			Particle Swarm Optimization Based Feature Enhancement and Feature Selection for Improved Emotion Recognition in Speech and Glottal Signals	PLOS ONE			English	Article							EXTREME LEARNING-MACHINE; CLASSIFICATION; DEPRESSION; EXCITATION	In the recent years, many research works have been published using speech related features for speech emotion recognition, however, recent studies show that there is a strong correlation between emotional states and glottal features. In this work, Mel-frequency cepstralcoefficients (MFCCs), linear predictive cepstral coefficients (LPCCs), perceptual linear predictive (PLP) features, gammatone filter outputs, timbral texture features, stationary wavelet transform based timbral texture features and relative wavelet packet energy and entropy features were extracted from the emotional speech (ES) signals and its glottal waveforms(GW). Particle swarm optimization based clustering (PSOC) and wrapper based particle swarm optimization (WPSO) were proposed to enhance the discerning ability of the features and to select the discriminating features respectively. Three different emotional speech databases were utilized to gauge the proposed method. Extreme learning machine (ELM) was employed to classify the different types of emotions. Different experiments were conducted and the results show that the proposed method significantly improves the speech emotion recognition performance compared to previous works published in the literature.	[Muthusamy, Hariharan] Univ Malaysia Perlis, Sch Mechatron Engn, Arau 02600, Perlis, Malaysia; [Polat, Kemal] Abant Izzet Baysal Univ, Dept Elect & Elect Engn, Fac Engn & Architecture, TR-14280 Bolu, Turkey; [Yaacob, Sazali] Univ Kuala Lumpur, Malaysian Spanish Inst, Kulim Hitech Pk, Kulim 09000, Kedah, Malaysia	Universiti Malaysia Perlis; Abant Izzet Baysal University; University of Kuala Lumpur	Muthusamy, H (corresponding author), Univ Malaysia Perlis, Sch Mechatron Engn, Campus Pauh Putra, Arau 02600, Perlis, Malaysia.	hari@unimap.edu.my	MUTHUSAMY, HARIHARAN/P-1937-2019; POLAT, KEMAL/R-5692-2019; Muthusamy, Hariharan/D-2528-2012; Polat, Kemal/AGZ-2143-2022	Muthusamy, Hariharan/0000-0002-8929-3473; Polat, Kemal/0000-0003-1840-9958	Fundamental Research Grant Scheme (FRGS), Ministry of Higher Education, Malaysia [9003-00297]; Journal Incentive Research Grants, UniMAP [9007-00071, 9007-00117]	Fundamental Research Grant Scheme (FRGS), Ministry of Higher Education, Malaysia(Ministry of Education, Malaysia); Journal Incentive Research Grants, UniMAP	Funding: This research is supported by a Research Grant under Fundamental Research Grant Scheme (FRGS), Ministry of Higher Education, Malaysia [Grant No: 9003-00297] and Journal Incentive Research Grants, UniMAP [Grant No: 9007-00071 and 9007-00117]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander I, 2011, EURASIP J ADV SIG PR, V2011, P1; ALKU P, 1992, SPEECH COMMUN, V11, P109, DOI 10.1016/0167-6393(92)90005-R; Banda N, NOISE ANAL AUDIO VIS; Burkhardt F., 2005, P 9 EUR C SPEECH COM, DOI 10.21437/ interspeech.2005-446; Cai JJ, 2012, ENERG CONVERS MANAGE, V53, P175, DOI 10.1016/j.enconman.2011.08.023; Chang PC, 2012, COMPUT METH PROG BIO, V107, P382, DOI 10.1016/j.cmpb.2010.12.004; Chiou B-C, 2013, FEATURE SPACE DIMENS, P1; COHEN A, 1992, COMMUN PUR APPL MATH, V45, P485, DOI 10.1002/cpa.3160450502; Cohen SC, 2006, DATA CLUSTERING PART, P1792; Cowie R, 2001, IEEE SIGNAL PROC MAG, V18, P32, DOI 10.1109/79.911197; Cummings K. E., 1992, ICASSP-92: 1992 IEEE International Conference on Acoustics, Speech and Signal Processing (Cat. No.92CH3103-9), P25, DOI 10.1109/ICASSP.1992.226129; CUMMINGS KE, 1995, J ACOUST SOC AM, V98, P88, DOI 10.1121/1.413664; Cummings KE, 1993, APPL ANAL GLOTTAL EX, P207; Ding SF, 2013, J COMPUT, V8, P2110, DOI 10.4304/jcp.8.8.2110-2117; Drugman T, 2012, COMPUT SPEECH LANG, V26, P20, DOI 10.1016/j.csl.2011.03.003; Eberhart R., 1995, P 6 INT S MICR MACH, P39; El Ayadi M, 2011, PATTERN RECOGN, V44, P572, DOI 10.1016/j.patcog.2010.09.020; Ellis D.P.W., 2009, GAMMATONE LIKE SPECT; Fewzee P, 2012, DIMENSIONALITY REDUC, P532; Gheyas IA, 2010, PATTERN RECOGN, V43, P5, DOI 10.1016/j.patcog.2009.06.009; Giannoulis P, 2012, LREC 2012 - EIGHTH INTERNATIONAL CONFERENCE ON LANGUAGE RESOURCES AND EVALUATION, P1203; Haq S., 2009, SPEAKER DEPENDENT AU; Haq S., 2008, INT C AUDITORY VISUA, P185; He L, 2013, STUDY WAVELET PACKET; Henriquez P, 2011, LECT NOTES ARTIF INT, V7015, P127, DOI 10.1007/978-3-642-25020-0_17; HERMANSKY H, 1990, J ACOUST SOC AM, V87, P1738, DOI 10.1121/1.399423; Hermansky H., 1985, ICASSP 85. Proceedings of the IEEE International Conference on Acoustics, Speech, and Signal Processing (Cat. No. 85CH2118-8), P509; Huang GB, 2006, NEUROCOMPUTING, V70, P489, DOI 10.1016/j.neucom.2005.12.126; Huang GB, 2012, IEEE T SYST MAN CY B, V42, P513, DOI 10.1109/TSMCB.2011.2168604; Huang W, 2013, LIVER TUMOR DETECTIO, P3662; Iliev AI, 2010, COMPUT SPEECH LANG, V24, P445, DOI 10.1016/j.csl.2009.02.005; Jain AK, 1999, ACM COMPUT SURV, V31, P264, DOI 10.1145/331499.331504; Jiang J, 2013, COMP FEATURE DIMENSI, P1; Kohavi R, 1997, ARTIF INTELL, V97, P273, DOI 10.1016/S0004-3702(97)00043-X; Koolagudi SG, 2012, INT J SPEECH TECHNOL, V15, P99, DOI 10.1007/s10772-011-9125-1; Kotti M, 2012, INT J SPEECH TECHNOL, V15, P131, DOI 10.1007/s10772-012-9127-7; Krothapalli S. R., 2013, EMOTION RECOGNITION, P67; Krothapalli SR, 2013, INT J SPEECH TECHNOL, V16, P181, DOI 10.1007/s10772-012-9175-z; Lampropoulos AS, 2012, EVALUATION MPEG 7 DE, P98; Lavner Y, 2009, EURASIP J AUDIO SPEE, DOI 10.1155/2009/239892; Li L, 2014, P NATL ACAD SCI; Li Y, 2013, ADAPTIVE WAVELET PAC, P359; Liu H, 1998, FEATURE EXTRACTION C; Liu H, 1998, FEATURE EXTRACTION C, DOI 10. 1007/978-1-4615-5725-8; Mirjalili S, 2013, SWARM EVOL COMPUT, V9, P1, DOI 10.1016/j.swevo.2012.09.002; Moore E, 2003, P ANN INT IEEE EMBS, V25, P2849, DOI 10.1109/IEMBS.2003.1280512; Moore E, 2008, IEEE T BIO-MED ENG, V55, P96, DOI 10.1109/TBME.2007.900562; Naylor PA, 2007, IEEE T AUDIO SPEECH, V15, P34, DOI 10.1109/TASL.2006.876878; Ozdas A, 2004, IEEE T BIO-MED ENG, V51, P1530, DOI 10.1109/TBME.2004.827544; Partterson R.D., 1987, M IOC SPEECH GROUP A; Rabiner L., 1993, FUNDAMENTALS SPEECH; Rao KS, 2013, INT J SPEECH TECHNOL, V16, P143, DOI 10.1007/s10772-012-9172-2; Rong J, 2009, INFORM PROCESS MANAG, V45, P315, DOI 10.1016/j.ipm.2008.09.003; Sedaaghi M, 2008, TECHNICAL REPORT; Shahzadi A, 2013, TURKISH J ELECT ENG, DOI [10.1038/srep08157, DOI 10.1038/SREP08157]; Slaney M., 1998, 1998010 INT RES CORP, P1; Szabo A, 2010, PROPOSAL VELOCITY ME, P1; Szabo A, 2010, BEHAV PARTICLES PART, P1; Tzanetakis G, 2002, IEEE T SPEECH AUDI P, V10, P293, DOI 10.1109/TSA.2002.800560; van der Merwe D, 2003, IEEE C EVOL COMPUTAT, P215, DOI 10.1109/CEC.2003.1299577; VEENEMAN DE, 1985, IEEE T ACOUST SPEECH, V33, P369, DOI 10.1109/TASSP.1985.1164544; Ververidis D, 2006, SPEECH COMMUN, V48, P1162, DOI 10.1016/j.specom.2006.04.003; Wan M, 2012, APPL SOFT COMPUT, V12, P2387, DOI 10.1016/j.asoc.2012.03.037; WONG DY, 1979, IEEE T ACOUST SPEECH, V27, P350, DOI 10.1109/TASSP.1979.1163260; Wu SQ, 2011, SPEECH COMMUN, V53, P768, DOI 10.1016/j.specom.2010.08.013; Xue B, 2014, APPL SOFT COMPUT, V18, P261, DOI 10.1016/j.asoc.2013.09.018; Yadav D., 2013, INT J NAT LANG COMPU, DOI [10.5121/ijnlc.2013.2503, DOI 10.5121/IJNLC.2013.2503]; Yuan B, 2012, MEASURE ORIENTED TRA, P293; Yuwono M, 2012, FAST UNSUPERVISED LE, P1; Zhang SQ, 2013, MULTIMED TOOLS APPL, V63, P615, DOI 10.1007/s11042-011-0887-x; Zhang SQ, 2010, INT CONF SIGN PROCES, P538, DOI 10.1109/ICOSP.2010.5656091	72	21	21	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0120344	10.1371/journal.pone.0120344	http://dx.doi.org/10.1371/journal.pone.0120344			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25799141	Green Submitted, Green Published, gold			2022-12-27	WOS:000351987300136
J	Shabbir, M; Syed, DN; Lall, RK; Khan, MR; Mukhtar, H				Shabbir, Maria; Syed, Deeba N.; Lall, Rahul K.; Khan, Muhammad Rashid; Mukhtar, Hasan			Potent Anti-Proliferative, Pro-Apoptotic Activity of the Maytenus Royleanus Extract against Prostate Cancer Cells: Evidence in In-Vitro and In-Vivo Models	PLOS ONE			English	Article							ANDROGEN RECEPTOR GENE; DIETARY; PROGRESSION; THERAPY; RISK; MECHANISMS; RESISTANCE; QUERCETIN; MORTALITY; CYCLINS	Prostate cancer is a leading of cause of cancer related death in men. Despite intensive investment in improving early diagnosis, it often escapes timely detection. Mortality remains high in advanced stage prostate cancer where palliative care remains the only option. Effective strategies are therefore needed to prevent the occurrence and progression of the disease. Plant-derived compounds have been an important source of several clinically useful anti-cancer agents and offer an attractive approach against prostate cancer. We previously showed that the methanol extract of Maytenus royleanus (MEM) leaves and its fractions possess significant antioxidant activity with therapeutic potential against free-radical associated damages. The present study evaluated the anti-proliferative activity of MEM in the prostate cancer model system. Analysis of MEM and its various fractions revealed the presence of triterpenoids, flavonoids and tannins, conjugated to one or more polar groups and carbohydrate moieties. Further studies against known standards established the existence of caffeic acid and quercetin 3-rhamnoside in varying concentration in different MEM fractions. Time course analysis of MEM treated prostate cancer cells indicated significant decrease in cell viability, assessed by MTT and clonogenic survival assays. This was accompanied by G2 phase arrest of cell cycle, downregulation of cyclin/cdk network and increase in cdk inhibitors. MEM treated cells exhibited cleavage of Caspase-3 and PARP, and modulation of apoptotic proteins, establishing apoptosis as the primary mechanism of cell death. Notably MEM suppressed AR/PSA signaling both in prostate cancer cell cultures and in the in vivo model. Intraperitoneal injection of MEM (1.25 and 2.5mg/animal) to athymic nude mice implanted with androgen sensitive CWR22R.1 cells showed significant inhibition in tumor growth and decreased serum PSA levels reciprocating in vitro findings. Taken together, our data suggest that MEM may be explored further for its potential therapeutic effects against prostate cancer progression in humans.	[Shabbir, Maria; Syed, Deeba N.; Lall, Rahul K.; Mukhtar, Hasan] Univ Wisconsin, Dept Dermatol, Madison, WI 53706 USA; [Lall, Rahul K.] Univ Wisconsin, Dept Food Sci, Madison, WI 53706 USA; [Shabbir, Maria; Khan, Muhammad Rashid] Quaid I Azam Univ, Dept Biochem, Islamabad, Pakistan	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Quaid I Azam University	Mukhtar, H (corresponding author), Univ Wisconsin, Dept Dermatol, Madison, WI 53706 USA.	hmukhtar@wisc.edu	Razak, Suhail/ABD-1667-2020; Shabbir, Maria/AAA-5414-2019	Shabbir, Maria/0000-0002-5685-3059; Lall, Rahulkumar/0000-0002-0042-6103	National Institute of health/National Cancer Institute [RO1CA160867]; NATIONAL CANCER INSTITUTE [R01CA160867] Funding Source: NIH RePORTER	National Institute of health/National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Support was provided by the National Institute of health/National Cancer Institute RO1CA160867. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baillon L, 2014, SEMIN CELL DEV BIOL, V32, P137, DOI 10.1016/j.semcdb.2014.04.034; Buchanan G, 2001, CANCER METAST REV, V20, P207, DOI 10.1023/A:1015531326689; Cai X, 2013, CURR MED CHEM, V20, P2572, DOI 10.2174/09298673113209990120; Chen CD, 2004, NAT MED, V10, P33, DOI 10.1038/nm972; Chen FZ, 2013, IRAN RED CRESCENT ME, V15, P279, DOI 10.5812/ircmj.6499; Ekstrom AM, 2000, INT J CANCER, V87, P133, DOI 10.1002/1097-0215(20000701)87:1&lt;133::AID-IJC20&gt;3.0.CO;2-E; Farooqi AA, 2014, CANCER CELL INT, V14, DOI 10.1186/1475-2867-14-34; Gottlieb B, 2001, HUM MUTAT, V17, P382, DOI 10.1002/humu.1113; Gregory CW, 1998, CANCER RES, V58, P5718; GUO WD, 1994, INT J EPIDEMIOL, V23, P1127, DOI 10.1093/ije/23.6.1127; Haag P, 2005, J STEROID BIOCHEM, V96, P251, DOI 10.1016/j.jsbmb.2005.04.029; Karantanos T, 2013, ONCOGENE, V32, P5501, DOI 10.1038/onc.2013.206; Kasibhatla S, 2003, MOL CANCER THER, V2, P573; Kellen E, 2006, INT J CANCER, V118, P2572, DOI 10.1002/ijc.21714; Kenfield SA, 2014, EUR UROL, V65, P887, DOI 10.1016/j.eururo.2013.08.009; Khan KH, 2014, CRIT REV ONCOL HEMAT, V90, P200, DOI 10.1016/j.critrevonc.2013.12.012; Kim J, 2008, ASIAN PAC J CANCER P, V9, P543; Lamb DJ, 2001, VITAM HORM, V62, P199, DOI 10.1016/S0083-6729(01)62005-3; Lansky EP, 2005, INVEST NEW DRUG, V23, P11, DOI 10.1023/B:DRUG.0000047101.02178.07; Liu RH, 2013, J FOOD SCI, V78, pA18, DOI 10.1111/1750-3841.12101; Madan RA, 2009, EXPERT OPIN INV DRUG, V18, P1001, DOI 10.1517/13543780902997928; Mahmoud AM, 2014, J STEROID BIOCHEM, V140, P116, DOI 10.1016/j.jsbmb.2013.12.010; Mariani S, 2014, INT J MOL SCI, V15, P1433, DOI 10.3390/ijms15011433; Mellado B, 2009, CLIN TRANSL ONCOL, V11, P5, DOI 10.1007/s12094-009-0304-3; Perestelo NR, 2010, J NAT PROD, V73, P127, DOI 10.1021/np900476a; Russo GL, 2014, CANCER TREAT RES, V159, P185, DOI 10.1007/978-3-642-38007-5_11; Sanchez I, 2005, SEMIN CELL DEV BIOL, V16, P311, DOI 10.1016/j.semcdb.2005.02.007; Santamaria D, 2006, FRONT BIOSCI-LANDMRK, V11, P1164, DOI 10.2741/1871; Schaneberg BT, 2001, J NAT PROD, V64, P624, DOI 10.1021/np010041o; Seeram NP, 2004, J AGR FOOD CHEM, V52, P2512, DOI 10.1021/jf0352778; SHABBIR M, 2013, BMC COMPLEM ALTERN M, V13, DOI DOI 10.1186/1472-6882-13-143; Sharifi N, 2009, ANTI-CANCER AGENT ME, V9, P1046, DOI 10.2174/187152009789735044; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Sola S, 2013, BBA-GEN SUBJECTS, V1830, P2160, DOI 10.1016/j.bbagen.2012.09.021; Soldani C, 2002, APOPTOSIS, V7, P321, DOI 10.1023/A:1016119328968; Solit DB, 2003, SEMIN ONCOL, V30, P709, DOI 10.1016/S0093-7754(03)00346-4; Syed DN, 2008, CANCER LETT, V265, P167, DOI 10.1016/j.canlet.2008.02.050; Syed DN, 2013, ANTI-CANCER AGENT ME, V13, P1149, DOI 10.2174/1871520611313080003; Touaibia M, 2011, MINI-REV MED CHEM, V11, P695, DOI 10.2174/138955711796268750; Tsao CK, 2014, THER ADV UROL, V6, P97, DOI 10.1177/1756287214528557; Viladomiu M, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/789764; VISAKORPI T, 1995, NAT GENET, V9, P401, DOI 10.1038/ng0495-401	42	24	24	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0119859	10.1371/journal.pone.0119859	http://dx.doi.org/10.1371/journal.pone.0119859			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25798940	gold, Green Submitted, Green Published			2022-12-27	WOS:000351987300085
J	Ahmed, MM; Dhanasekaran, AR; Block, A; Tong, SH; Costa, ACS; Stasko, M; Gardiner, KJ				Ahmed, Md Mahiuddin; Dhanasekaran, A. Ranjitha; Block, Aaron; Tong, Suhong; Costa, Alberto C. S.; Stasko, Melissa; Gardiner, Katheleen J.			Protein Dynamics Associated with Failed and Rescued Learning in the Ts65Dn Mouse Model of Down Syndrome	PLOS ONE			English	Article							NMDA RECEPTOR ANTAGONIST; COGNITIVE DEFICITS; SYNAPTIC PLASTICITY; SYNDROME PHENOTYPES; CONTROLLED-TRIAL; SYNDROME MICE; MEMANTINE; MEMORY; MODULATION; PROFILES	Down syndrome (DS) is caused by an extra copy of human chromosome 21 (Hsa21). Although it is the most common genetic cause of intellectual disability (ID), there are, as yet, no effective pharmacotherapies. The Ts65Dn mouse model of DS is trisomic for orthologs of similar to 55% of Hsa21 classical protein coding genes. These mice display many features relevant to those seen in DS, including deficits in learning and memory (L/M) tasks requiring a functional hippocampus. Recently, the N-methyl-D-aspartate (NMDA) receptor antagonist, memantine, was shown to rescue performance of the Ts65Dn in several L/M tasks. These studies, however, have not been accompanied by molecular analyses. In previous work, we described changes in protein expression induced in hippocampus and cortex in control mice after exposure to context fear conditioning (CFC), with and without memantine treatment. Here, we extend this analysis to Ts65Dn mice, measuring levels of 85 proteins/protein modifications, including components of MAP kinase and MTOR pathways, and subunits of NMDA receptors, in cortex and hippocampus of Ts65Dn mice after failed learning in CFC and after learning was rescued by memantine. We show that, compared with wild type littermate controls, (i) of the dynamic responses seen in control mice in normal learning, >40% also occur in Ts65Dn in failed learning or are compensated by baseline abnormalities, and thus are considered necessary but not sufficient for successful learning, and (ii) treatment with memantine does not in general normalize the initial protein levels but instead induces direct and indirect responses in approximately half the proteins measured and results in normalization of the endpoint protein levels. Together, these datasets provide a first view of the complexities associated with pharmacological rescue of learning in the Ts65Dn. Extending such studies to additional drugs and mouse models of DS will aid in identifying pharmacotherapies for effective clinical trials.	[Ahmed, Md Mahiuddin; Dhanasekaran, A. Ranjitha; Block, Aaron; Gardiner, Katheleen J.] Univ Colorado Denver, Dept Pediat, Linda Crn Inst Syndrome, Aurora, CO 80045 USA; [Tong, Suhong] Univ Colorado Denver, Colorado Sch Publ Hlth, Aurora, CO 80045 USA; [Costa, Alberto C. S.; Stasko, Melissa] Rainbow Babies & Childrens Hosp, Case Western Reserve Sch Med, Dept Pediat, Div Pediat Neurol, Cleveland, OH 44106 USA; [Gardiner, Katheleen J.] Univ Colorado Denver, Dept Biochem & Mol Genet, Aurora, CO 80045 USA; [Gardiner, Katheleen J.] Univ Colorado Denver, Human Med Genet & Genom Program, Aurora, CO 80045 USA; [Gardiner, Katheleen J.] Univ Colorado Denver, Neurosci Program, Aurora, CO 80045 USA	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; Colorado School of Public Health; University of Colorado System; University of Colorado Anschutz Medical Campus; Case Western Reserve University; Case Western Reserve University Hospital; University Hospitals of Cleveland; Rainbow Babies & Children's Hospital; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Gardiner, KJ (corresponding author), Univ Colorado Denver, Dept Pediat, Linda Crn Inst Syndrome, Mail Stop 8608,12700 E 19th Ave, Aurora, CO 80045 USA.	katheleen.gardiner@ucdenver.edu		Costa, Alberto/0000-0002-7855-1190	National Institute of Child Health and Human Disease [HD056235]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD056235] Funding Source: NIH RePORTER	National Institute of Child Health and Human Disease; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	HD056235 National Institute of Child Health and Human Disease https://www.nichd.nih.gov to KG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed MM, 2014, MOL CELL PROTEOMICS, V13, P919, DOI 10.1074/mcp.M113.035568; Ahmed MM, 2013, HUM MOL GENET, V22, P1709, DOI 10.1093/hmg/ddt017; Ahmed MM, 2012, J PROTEOME RES, V11, P1251, DOI 10.1021/pr2011582; Boada R, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.66; Braudeau J, 2011, J PSYCHOPHARMACOL, V25, P1030, DOI 10.1177/0269881111405366; Busciglio J, 2013, CYTOGENET GENOME RES, V141, P260, DOI 10.1159/000354306; CDC Centers for Disease Control and Prevention, 2006, MMWR-MORBID MORTAL W, V54, P6; Chang Q, 2008, NEUROBIOL LEARN MEM, V89, P167, DOI 10.1016/j.nlm.2007.05.007; Chapman RS, 2000, MENT RETARD DEV D R, V6, P84, DOI 10.1002/1098-2779(2000)6:2<84::AID-MRDD2>3.3.CO;2-G; Chen HSV, 2005, J PHARMACOL EXP THER, V314, P961, DOI 10.1124/jpet.105.085142; Contestabile A, 2013, J CLIN INVEST, V123, P348, DOI 10.1172/JCI64650; Corrales A, 2013, J PINEAL RES, V54, P346, DOI 10.1111/jpi.12037; Costa ACS, 2008, NEUROPSYCHOPHARMACOL, V33, P1624, DOI 10.1038/sj.npp.1301535; Costa ACS, 2010, BEHAV BRAIN RES, V206, P52, DOI 10.1016/j.bbr.2009.08.034; Das I, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005983; Davisson M T, 1993, Prog Clin Biol Res, V384, P117; De la Torre R, 2014, MOL NUTR FOOD RES, V58, P278, DOI 10.1002/mnfr.201300325; Duchon A, 2011, MAMM GENOME, V22, P674, DOI 10.1007/s00335-011-9356-0; Garcia-Cerro S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106572; Gardiner KJ, 2014, DRUG DES DEV THER, V9, P103, DOI 10.2147/DDDT.S51476; Gardiner KJ, 2010, TRENDS PHARMACOL SCI, V31, P66, DOI 10.1016/j.tips.2009.10.010; Hanney M, 2012, LANCET, V379, P528, DOI 10.1016/S0140-6736(11)61676-0; Irving C, 2008, EUR J HUM GENET, V16, P1336, DOI 10.1038/ejhg.2008.122; Jung MS, 2011, J BIOL CHEM, V286, P40401, DOI 10.1074/jbc.M111.253971; Kleschevnikov AM, 2012, J NEUROSCI, V32, P9217, DOI 10.1523/JNEUROSCI.1673-12.2012; Korbel JO, 2009, P NATL ACAD SCI USA, V106, P12031, DOI 10.1073/pnas.0813248106; KORENBERG JR, 1994, P NATL ACAD SCI USA, V91, P4997, DOI 10.1073/pnas.91.11.4997; Krzywinski M, 2014, NAT METHODS, V11, P355, DOI 10.1038/nmeth.2900; LIEBERMAN DN, 1994, NATURE, V369, P235, DOI 10.1038/369235a0; Lipton SA, 2007, CURR DRUG TARGETS, V8, P621, DOI 10.2174/138945007780618472; Liu DP, 2003, BIOTECHNIQUES, V35, P1170, DOI 10.2144/03356st02; Lockrow J, 2011, BEHAV BRAIN RES, V221, P610, DOI 10.1016/j.bbr.2010.03.036; Martinez-Cue C, 2013, J NEUROSCI, V33, P3953, DOI 10.1523/JNEUROSCI.1203-12.2013; Nishimura T, 2006, MOL BIOL CELL, V17, P1273, DOI 10.1091/mbc.E05-07-0700; Parsons CG, 1999, NEUROPHARMACOLOGY, V38, P735, DOI 10.1016/S0028-3908(99)00019-2; Putkey JA, 2003, J BIOL CHEM, V278, P49667, DOI 10.1074/jbc.C300372200; Radulovic J, 1999, J NEUROSCI, V19, P5016; RAHMANI Z, 1990, AM J MED GENET, P98; Rothermel BA, 2003, TRENDS CARDIOVAS MED, V13, P15, DOI 10.1016/S1050-1738(02)00188-3; Rozeske RR, 2015, GENES BRAIN BEHAV, V14, P22, DOI 10.1111/gbb.12181; Rueda N, 2012, NEURAL PLAST, V2012, DOI 10.1155/2012/584071; Rueda N, 2010, J ALZHEIMERS DIS, V21, P277, DOI 10.3233/JAD-2010-100240; Scott-McKean JJ, 2011, LEARN MEMORY, V18, P774, DOI 10.1101/lm.024182.111; Siddiqui A, 2008, GENES BRAIN BEHAV, V7, P810, DOI 10.1111/j.1601-183X.2008.00428.x; Silverman W, 2007, MENT RETARD DEV D R, V13, P228, DOI 10.1002/mrdd.20156; Snyder EM, 2005, NAT NEUROSCI, V8, P1051, DOI 10.1038/nn1503; Sturgeon X, 2012, PROG BRAIN RES, V197, P73, DOI 10.1016/B978-0-444-54299-1.00005-4; Sturgeon X, 2011, MAMM GENOME, V22, P261, DOI 10.1007/s00335-011-9321-y; Tolias KF, 2005, NEURON, V45, P525, DOI 10.1016/j.neuron.2005.01.024; Vilardell M, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-229; Yang X, 2006, GENOME RES, V16, P995, DOI 10.1101/gr.5217506	51	44	46	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0119491	10.1371/journal.pone.0119491	http://dx.doi.org/10.1371/journal.pone.0119491			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25793384	Green Published, Green Submitted, gold			2022-12-27	WOS:000352084200087
J	Chen, YF; Bramley, G; Unwin, G; Hanu-Cernat, D; Dretzke, J; Moore, D; Bayliss, S; Cummins, C; Lilford, R				Chen, Yen-Fu; Bramley, George; Unwin, Gemma; Hanu-Cernat, Dalvina; Dretzke, Janine; Moore, David; Bayliss, Sue; Cummins, Carole; Lilford, Richard			Occipital Nerve Stimulation for Chronic Migraine-A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							NEUROSTIMULATION; MULTICENTER; MANAGEMENT; EFFICACY; DISEASE	Background Chronic migraine is a debilitating headache disorder that has significant impact on quality of life. Stimulation of peripheral nerves is increasingly being used to treat chronic refractory pain including headache disorders. This systematic review examines the effectiveness and adverse effects of occipital nerve stimulation (ONS) for chronic migraine. Methods Databases, including the Cochrane Library, MEDLINE, EMBASE, CINAHL and clinical trial registers were searched to September 2014. Randomized controlled trials (RCTs), other controlled and uncontrolled observational studies and case series (n >= 10) were eligible. RCTs were assessed using the Cochrane risk of bias tool. Meta-analysis was carried out using a random-effects model. Findings are presented in summary tables and forest plots. Results Five RCTs (total n=402) and seven case series (total n=115) met the inclusion criteria. Pooled results from three multicenter RCTs show that ONS was associated with a mean reduction of 2.59 days (95% CI 0.91 to 4.27, I2=0%) of prolonged, moderate to severe headache per month at 3 months compared with a sham control. Results for other outcomes generally favour ONS over sham controls but quantitative analysis was hampered by incomplete publication and reporting of trial data. Lead migration and infections are common and often require revision surgery. Open-label follow-up of RCTs and case series suggest long-term effectiveness can be maintained in some patients but evidence is limited. Conclusions While the effectiveness of ONS compared to sham control has been shown in multiple RCTs, the average effect size is modest and may be exaggerated by bias as achieving effective blinding remains a methodological challenge. Further measures to reduce the risk of adverse events and revision surgery are needed. Systematic Review Registration this systematic review is an update and expanded work of part of a broader review registered with PROSPERO. Registration No. CRD42012002633.	[Chen, Yen-Fu; Bramley, George; Unwin, Gemma; Dretzke, Janine; Moore, David; Bayliss, Sue; Cummins, Carole; Lilford, Richard] Univ Birmingham, Sch Hlth & Populat Sci, Birmingham, W Midlands, England; [Unwin, Gemma] Univ Birmingham, Sch Psychol, Birmingham, W Midlands, England; [Hanu-Cernat, Dalvina] Univ Hosp Birmingham NHS Fdn Trust, Birmingham, W Midlands, England; [Chen, Yen-Fu; Lilford, Richard] Univ Warwick, Div Hlth Sci, Coventry CV4 7AL, W Midlands, England	University of Birmingham; University of Birmingham; University of Birmingham; University of Warwick	Bramley, G (corresponding author), Univ Birmingham, Sch Hlth & Populat Sci, Birmingham, W Midlands, England.	g.bramley@bham.ac.uk	Chen, Yen-Fu/AAD-2825-2019	Cummins, Carole/0000-0001-5464-1944; Chen, Yen-Fu/0000-0002-9446-2761; Bayliss, Susan/0000-0003-3025-9323; Moore, David/0000-0002-4163-4080; Bramley, George/0000-0002-3224-1904; Unwin, Gemma/0000-0002-5205-3150; Lilford, Richard/0000-0002-0634-984X	UK National Institute for Health Research (NIHR) Surgical Reconstruction and Microbiology Research Centre (SRMRC); NIHR Collaborations for Leadership in Applied Health Research and Care for Birmingham and Black Country (CLAHRC-BBC); NIHR Health Technology Assessment Programme; UK Engineering and Physical Sciences Research Council Multidisciplinary Assessment of Technology Centre for Healthcare (EPSRC MATCH); National Institute for Health Research [NF-SI-0611-10008] Funding Source: researchfish	UK National Institute for Health Research (NIHR) Surgical Reconstruction and Microbiology Research Centre (SRMRC); NIHR Collaborations for Leadership in Applied Health Research and Care for Birmingham and Black Country (CLAHRC-BBC); NIHR Health Technology Assessment Programme(National Institute for Health Research (NIHR)); UK Engineering and Physical Sciences Research Council Multidisciplinary Assessment of Technology Centre for Healthcare (EPSRC MATCH)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); National Institute for Health Research(National Institute for Health Research (NIHR))	The original systematic review was commissioned by the UK National institute for Health and Care Excellence (NICE) to support the development of Interventional Procedures Guidance. This manuscript presents an update and expansion of part of the original systematic review as an independent academic output (not commissioned by NICE). We acknowledge NICE's input during our preparation of the original review and notify NICE of our submission of this manuscript. The authors have full control over the contents of the manuscript and the decision to publish it. The authors also received funding as salary or project grants not directly related to this review from the UK National Institute for Health Research (NIHR) Surgical Reconstruction and Microbiology Research Centre (SRMRC), NIHR Collaborations for Leadership in Applied Health Research and Care for Birmingham and Black Country (CLAHRC-BBC), NIHR Health Technology Assessment Programme and UK Engineering and Physical Sciences Research Council Multidisciplinary Assessment of Technology Centre for Healthcare (EPSRC MATCH). The views expressed here are those of the authors and not necessarily those of the NICE, NIHR, SRMRC, the CLAHRC-BBC and the EPSRC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartsch T, 2011, PROG NEUROL SURG, V24, P16, DOI 10.1159/000323008; Bes A, 2013, CEPHALALGIA, V33, P629, DOI 10.1177/0333102413485658; Bigal ME, 2008, HEADACHE, V48, P1157, DOI 10.1111/j.1526-4610.2008.01217.x; Brewer AC, 2013, NEUROMODULATION, V16, P557, DOI 10.1111/j.1525-1403.2012.00490.x; Chen Y-F, 2012, STIMULATION PERIPHER; Dodick DW, 2014, SAFETY EFFICACY PERI; Goadsby PJ, 2013, CEPHALALGIA, V33, P214, DOI 10.1177/0333102412468680; Goadsby PJ, 2011, STUDY OCCIPITAL NERV; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P1311, DOI [10.1016/j.jclinepi.2011.03.017, 10.1016/j.jclinepi.2011.06.004]; Higgins JPT, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5928; Irimia P, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-94; Jasper JF, 2008, PAIN PHYSICIAN, V11, P187; Carod-Artal FJ, 2014, J PAIN RES, V7, P185, DOI 10.2147/JPR.S61819; Kinfe TM, 2014, CEPHALALGIA; Kiss ZHT, 2012, CAN J NEUROL SCI, V39, P807, DOI 10.1017/S0317167100015651; Lanteri-Minet M, 2013, FRENCH DATABASE OCCI; Lipton R, 2013, OCCIPITAL NERVE STIM; Lipton RB, 2009, CEPHALALGIA, V29, P30; Lipton RB, 2011, CEPHALALGIA, V31, P18, DOI 10.1177/0333102410372427; Magis D, 2012, LANCET NEUROL, V11, P708, DOI 10.1016/S1474-4422(12)70139-4; Mammis Antonios, 2012, Clin Neurosurg, V59, P114; Martelletti P, 2013, J HEADACHE PAIN, V14, DOI [10.1186/1129-2377-14-13, 10.1186/1129-2377-14-86]; Matharu MS, 2004, BRAIN, V127, P220, DOI 10.1093/brain/awh022; Mercado R, 2006, MOVEMENT DISORD, V21, P1457, DOI 10.1002/mds.20935; Moore A, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2690; Moore RA, 2013, ANAESTHESIA, V68, P400, DOI 10.1111/anae.12148; Newcombe RG, 1998, STAT MED, V17, P873, DOI 10.1002/(SICI)1097-0258(19980430)17:8<873::AID-SIM779>3.0.CO;2-I; Notaro P, 2014, PAIN PHYSICIAN, V17, pE369; Oh MY, 2004, NEUROMODULATION, V7, P103, DOI 10.1111/j.1094-7159.2004.04014.x; Olesen J, 2006, CEPHALALGIA, V26, P742, DOI 10.1111/j.1468-2982.2006.01172.x; Paemeleire K, 2010, CEPHALALGIA, V30, P662, DOI 10.1111/j.1468-2982.2009.02022.x; Paemeleire K, 2012, J HEADACHE PAIN, V13, P239, DOI 10.1007/s10194-012-0430-0; Palmisani Stefano, 2013, J Headache Pain, V14, P67, DOI 10.1186/1129-2377-14-67; Popeney CA, 2003, HEADACHE, V43, P369, DOI 10.1046/j.1526-4610.2003.03072.x; Royle P, 2011, WARWICK EVIDENCE; Saper JR, 2011, CEPHALALGIA, V31, P271, DOI 10.1177/0333102410381142; Schwedt TJ, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g1416; Serra G, 2011, ITALIAN RANDOMIZED O; Serra G, 2012, PAIN PHYSICIAN, V15, P245; Silberstein S, 2008, CEPHALALGIA, V28, P484, DOI 10.1111/j.1468-2982.2008.01555.x; Silberstein S, 2012, HEADACHE, V52, P866; Silberstein SD, 2004, CEPHALALGIA, V24, P2, DOI 10.1111/j.1468-2982.2004.00892.x; SILBERSTEIN SD, 1994, HEADACHE, V34, P1, DOI 10.1111/j.1526-4610.1994.hed3401001.x; Silberstein SD, 2012, CEPHALALGIA, V32, P1165, DOI 10.1177/0333102412462642; Slavin KV, 2011, PROG NEUROL SURG, V24, P1, DOI 10.1159/000323002; Slotty PJ, 2015, CEPHALALGIA, V35, P73, DOI 10.1177/0333102414534082; Trentman TL, 2008, HEADACHE, V48, P319, DOI 10.1111/j.1526-4610.2007.01023.x; Vos T, 2012, LANCET, V380, P2163, DOI 10.1016/S0140-6736(12)61729-2	48	37	40	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0116786	10.1371/journal.pone.0116786	http://dx.doi.org/10.1371/journal.pone.0116786			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25793740	Green Published, gold, Green Submitted			2022-12-27	WOS:000352084200009
J	Liu, JP; Kachelmeier, A; Dai, CF; Li, HZ; Steyger, PS				Liu, Jianping; Kachelmeier, Allan; Dai, Chunfu; Li, Hongzhe; Steyger, Peter S.			Uptake of Fluorescent Gentamicin by Peripheral Vestibular Cells after Systemic Administration	PLOS ONE			English	Article							30S RIBOSOMAL-SUBUNIT; COCHLEAR HAIR-CELLS; PIG INNER-EAR; INTRATYMPANIC GENTAMICIN; COMPARATIVE MORPHOLOGY; INDUCED OTOTOXICITY; MENIERES-DISEASE; OTOLITH FUNCTION; GUINEA-PIGS; AMINOGLYCOSIDES	Objective In addition to cochleotoxicity, systemic aminoglycoside pharmacotherapy causes vestibulotoxicity resulting in imbalance and visual dysfunction. The underlying trafficking routes of systemically-administered aminoglycosides from the vasculature to the vestibular sensory hair cells are largely unknown. We investigated the trafficking of systemically-administered gentamicin into the peripheral vestibular system in C56Bl/6 mice using fluorescence-tagged gentamicin (gentamicin-Texas-Red, GTTR) imaged by scanning laser confocal microscopy to determine the cellular distribution and intensity of GTTR fluorescence in the three semicircular canal cristae, utricular, and saccular maculae at 5 time points over 4 hours. Results Low intensity GTTR fluorescence was detected at 0.5 hours as both discrete puncta and diffuse cytoplasmic fluorescence. The intensity of cytoplasmic fluorescence peaked at 3 hours, while punctate fluorescence was plateaued after 3 hours. At 0.5 and 1 hour, higher levels of diffuse GTTR fluorescence were present in transitional cells compared to hair cells and supporting cells. Sensory hair cells typically exhibited only diffuse cytoplasmic fluorescence at all time-points up to 4 hours in this study. In contrast, non-sensory cells rapidly exhibited both intense fluorescent puncta and weaker, diffuse fluorescence throughout the cytosol. The numbers and size of fluorescent puncta in dark cells and transitional cells increased over time. There is no preferential GTTR uptake by the five peripheral vestibular organs' sensory cells. Control vestibular tissues exposed to Dulbecco's phosphate-buffered saline or hydrolyzed Texas Red had negligible fluorescence. Conclusions All peripheral vestibular cells rapidly take up systemically-administered GTTR, reaching peak intensity 3 hours after injection. Sensory hair cells exhibited only diffuse fluorescence, while non-sensory cells displayed both diffuse and punctate fluorescence. Transitional cells may act as a primary pathway for trafficking of systemic GTTR from the vasculature to endolymph prior to entering hair cells.	[Liu, Jianping; Kachelmeier, Allan; Li, Hongzhe; Steyger, Peter S.] Oregon Hlth & Sci Univ, Oregon Hearing Res Ctr, Portland, OR 97201 USA; [Liu, Jianping; Dai, Chunfu] Fudan Univ, Eye Ear Nose & Throat Hosp, Dept Otol & Skull Base Surg, Shanghai 200433, Peoples R China	Oregon Health & Science University; Fudan University	Steyger, PS (corresponding author), Oregon Hlth & Sci Univ, Oregon Hearing Res Ctr, Portland, OR 97201 USA.	steygerp@ohsu.edu	Steyger, Peter S./B-9147-2011	Steyger, Peter S./0000-0002-6103-5237	National Institutes of Health from the National Institute of Deafness and other Communication Disorders [R01 DC04555, DC05983]; National natural science foundation of China [30600704]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC004555, P30DC005983, R01DC012588] Funding Source: NIH RePORTER	National Institutes of Health from the National Institute of Deafness and other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); National natural science foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by National Institutes of Health grants grants R01 DC04555 (PSS), and DC05983 (P30) from the National Institute of Deafness and other Communication Disorders (http://www.nidcd.nih.gov/Pages/default.aspx), and by National natural science foundation of China (http://www.nsfc.gov.cn/) grant NSFC No. 30600704 (JL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal Y, 2013, J NEUROL, V260, P876, DOI 10.1007/s00415-012-6724-y; Alharazneh A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022347; Aran JM, 1999, ANN NY ACAD SCI, V884, P60, DOI 10.1111/j.1749-6632.1999.tb08636.x; Ariano RE, 2008, ANN PHARMACOTHER, V42, P1282, DOI 10.1345/aph.1L001; Basta D, 2005, HUM MOVEMENT SCI, V24, P268, DOI 10.1016/j.humov.2005.04.002; BEAUCHAMP D, 1991, ANTIMICROB AGENTS CH, V35, P2173, DOI 10.1128/AAC.35.11.2173; Bhattacharyya TK, 2005, AM J OTOLARYNG, V26, P91, DOI 10.1016/j.amjoto.2004.08.007; Black FO, 2004, OTOL NEUROTOL, V25, P559, DOI 10.1097/00129492-200407000-00025; BLACK FO, 1993, OTOLARYNG CLIN N AM, V26, P713; Carter AP, 2000, NATURE, V407, P340, DOI 10.1038/35030019; CAWTHORNE T, 1957, BRIT MED J, V1, P1444, DOI 10.1136/bmj.1.5033.1444; Cheng PW, 2010, NEUROTOXICOLOGY, V31, P121, DOI 10.1016/j.neuro.2009.10.009; Clarke AH, 2003, J VESTIBUL RES-EQUIL, V13, P215; Dai CF, 2008, HEARING RES, V235, P114, DOI 10.1016/j.heares.2007.10.010; DEGROOT JCMJ, 1990, HEARING RES, V50, P35, DOI 10.1016/0378-5955(90)90031-J; Desai SS, 2005, J NEUROPHYSIOL, V93, P267, DOI 10.1152/jn.00747.2003; Desai SS, 2005, J NEUROPHYSIOL, V93, P251, DOI 10.1152/jn.00746.2003; Durante-Mangoni E, 2009, INT J ANTIMICROB AG, V33, P201, DOI 10.1016/j.ijantimicag.2008.09.001; Falagas ME, 2007, INT J ANTIMICROB AG, V29, P630, DOI 10.1016/j.ijantimicag.2006.12.012; GRAYBIEL A, 1967, AEROSPACE MED, V38, P1099; Hain TC, 2013, SEMIN NEUROL, V33, P195, DOI 10.1055/s-0033-1354597; Hashino E, 1995, BRAIN RES, V704, P135, DOI 10.1016/0006-8993(95)01198-6; HAYASHIDA T, 1985, ARCH OTO-RHINO-LARYN, V242, P257, DOI 10.1007/BF00453548; HAYASHIDA T, 1989, ARCH OTO-RHINO-LARYN, V246, P161, DOI 10.1007/BF00456659; Helling K, 2007, LARYNGOSCOPE, V117, P2244, DOI 10.1097/MLG.0b013e3181453a3c; Hirvonen TP, 2005, J NEUROPHYSIOL, V93, P643, DOI 10.1152/jn.00160.2004; HUY PTB, 1986, J CLIN INVEST, V77, P1492, DOI 10.1172/JCI112463; Imamura S, 2003, JARO-J ASSOC RES OTO, V4, P176, DOI 10.1007/s10162-002-2036-8; JARAMILLO F, 1991, NEURON, V7, P409, DOI 10.1016/0896-6273(91)90293-9; Jiang MY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108941; Jones Sherri M., 2009, Seminars in Hearing, V30, P231, DOI 10.1055/s-0029-1241124; Karasawa T, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.80; Karasawa T, 2011, TOXICOL SCI, V124, P378, DOI 10.1093/toxsci/kfr196; Koo JW, 2011, AUDIOL NEURO-OTOL, V16, P347, DOI 10.1159/000322851; Li HZ, 2011, SCI REP-UK, V1, DOI 10.1038/srep00159; Li HZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019130; LINDEMAN HH, 1969, ACTA OTO-LARYNGOL, V67, P177, DOI 10.3109/00016486909125441; Lyford-Pike S, 2007, JARO-J ASSOC RES OTO, V8, P497, DOI 10.1007/s10162-007-0093-8; Marcotti W, 2005, J PHYSIOL-LONDON, V567, P505, DOI 10.1113/jphysiol.2005.085951; Mendel B, 1999, CLIN OTOLARYNGOL, V24, P286, DOI 10.1046/j.1365-2273.1999.00261.x; Myrdal SE, 2005, HEARING RES, V204, P156, DOI 10.1016/j.heares.2005.02.002; Ogle JM, 2001, SCIENCE, V292, P897, DOI 10.1126/science.1060612; PARK JC, 1982, AM J OTOLARYNG, V3, P117, DOI 10.1016/S0196-0709(82)80042-2; Selimoglu E, 2007, CURR PHARM DESIGN, V13, P119, DOI 10.2174/138161207779313731; Steyger PS, 2003, JARO-J ASSOC RES OTO, V4, P565, DOI 10.1007/s10162-003-4002-5; Vicens Q, 2003, CHEMBIOCHEM, V4, P1018, DOI 10.1002/cbic.200300684; Wang Q, 2010, HEARING RES, V268, P250, DOI 10.1016/j.heares.2010.06.008; Wang Q, 2009, JARO-J ASSOC RES OTO, V10, P205, DOI 10.1007/s10162-009-0160-4; WERSALL J, 1971, ARCH KLIN EXP OHR, V200, P1, DOI 10.1007/BF00302186; Zhai F, 2013, AUDIOL NEURO-OTOL, V18, P297, DOI 10.1159/000351805; Zhang R, 2013, HEARING RES, V298, P49, DOI 10.1016/j.heares.2013.01.010; Zhang YB, 2012, HEARING RES, V283, P169, DOI 10.1016/j.heares.2011.10.003	52	13	13	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0120612	10.1371/journal.pone.0120612	http://dx.doi.org/10.1371/journal.pone.0120612			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25793391	gold, Green Published, Green Submitted			2022-12-27	WOS:000352083900058
J	Peters, JPM; Hooft, L; Grolman, W; Stegeman, I				Peters, Jeroen P. M.; Hooft, Lotty; Grolman, Wilko; Stegeman, Inge			Assessment of the Quality of Reporting of Randomised Controlled Trials in Otorhinolaryngologic Literature - Adherence to the CONSORT Statement	PLOS ONE			English	Article							MEDICAL JOURNALS; EXPLANATION; INSTRUCTIONS; ENDORSEMENT	Background Randomised Controlled Trials (RCTs) are the preferred study design when comparing therapeutical interventions in medicine. To improve clarity, consistency and transparency of reporting RCTs, the Consolidated Standards of Reporting Trials (CONSORT) statement was developed. Objectives (1) To assess the quality of reports and abstracts of RCTs in otorhinolaryngologic literature by using CONSORT checklists, (2) to compare the quality of reports and abstracts of otorhinolaryngologic RCTs between the top 5 general medical journals and top 5 otorhinolaryngologic journals, and (3) to formulate recommendations for authors and editors of otorhinolaryngologic ('ENT') journals. Methods Based on 2012 ISI Web of Knowledge impact factors, the top 5 general medical and ENT journals were selected. On 25 June 2014, using a highly sensitive Cochrane RCT filter and ENT filter, possibly relevant articles since January 1st, 2010 were retrieved and relevant RCTs were selected. We assessed how many CONSORT items were reported adequately in reports and abstracts and compared the two journal types. Results Otorhinolaryngologic RCTs (n = 15) published in general medical journals reported a mean of 92.1% (95% confidence interval: 89.5%-94.7%) of CONSORT items adequately, whereas RCTs (n = 18) published in ENT journals reported a mean of 71.8% (66.7%-76.8%) adequately (p < 0.001). For abstracts, means of 70.0% (63.7%-76.3%) and 32.3% (26.6-38.0%) were found respectively (p < 0.001). Large differences for specific items exist between the two journal types. Conclusion The quality of reporting of RCTs in otorhinolaryngologic journals is suboptimal. RCTs published in general medical journals have a higher quality of reporting than RCTs published in ENT journals. We recommend authors to report their trial according to the CONSORT Statement and advise editors to endorse the CONSORT Statement and implement the CONSORT Statement in the editorial process to ensure more adequate reporting of RCTs and their abstracts.	[Peters, Jeroen P. M.; Grolman, Wilko; Stegeman, Inge] Univ Med Ctr Utrecht, Dept Otorhinolaryngol & Head & Neck Surg, Utrecht, Netherlands; [Peters, Jeroen P. M.; Grolman, Wilko; Stegeman, Inge] Univ Med Ctr Utrecht, Brain Ctr Rudolf Magnus, Utrecht, Netherlands; [Hooft, Lotty] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Dutch Cochrane Ctr, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center	Peters, JPM (corresponding author), Univ Med Ctr Utrecht, Dept Otorhinolaryngol & Head & Neck Surg, Utrecht, Netherlands.	ENT-research@umcutrecht.nl	Stegeman, Inge/AAP-3949-2021	Stegeman, Inge/0000-0001-5154-7178; Grolman, Wilko/0000-0002-3524-3526				Agha Riaz, 2007, Int J Surg, V5, P413, DOI 10.1016/j.ijsu.2007.06.002; Agha RA, 2013, J PLAST RECONSTR AES, V66, P447, DOI 10.1016/j.bjps.2012.11.005; Altman DG, 2005, BMJ-BRIT MED J, V330, P1056, DOI 10.1136/bmj.330.7499.1056; Balasubramanian SP, 2006, ANN SURG, V244, P663, DOI 10.1097/01.sla.0000217640.11224.05; Begg C, 1996, JAMA-J AM MED ASSOC, V276, P637, DOI 10.1001/jama.276.8.637; Boutron I, 2008, ANN INTERN MED, V148, P295, DOI 10.7326/0003-4819-148-4-200802190-00008; Chan AW, 2005, LANCET, V365, P1159, DOI 10.1016/S0140-6736(05)71879-1; Chan AW, 2004, JAMA-J AM MED ASSOC, V291, P2457, DOI 10.1001/jama.291.20.2457; Development and Management of Human Resources, 2008, DEV MANAGEMENT HUMAN, V10, P4; Hewitt C, 2005, BMJ-BRIT MED J, V330, P1057, DOI 10.1136/bmj.38413.576713.AE; Hopewell S, 2008, TRIALS, V9, DOI 10.1186/1745-6215-9-20; Hopewell S, 2008, PLOS MED, V5, P48, DOI 10.1371/journal.pmed.0050020; International Committee of Medical Journal Editors, 2004, CLIN TRAIL REG NEWS; Ioannidis JPA, 2004, ANN INTERN MED, V141, P781, DOI 10.7326/0003-4819-141-10-200411160-00009; Juni P, 2001, BMJ-BRIT MED J, V323, P42, DOI 10.1136/bmj.323.7303.42; Lai TYY, 2007, OPHTHAL EPIDEMIOL, V14, P390, DOI 10.1080/09286580701344399; Mills EJ, 2005, CONTEMP CLIN TRIALS, V26, P480, DOI 10.1016/j.cct.2005.02.008; Moher D, 2001, JAMA-J AM MED ASSOC, V285, P1992, DOI 10.1001/jama.285.15.1992; Moher D, 2001, LANCET, V357, P1191, DOI 10.1016/S0140-6736(00)04337-3; Moher David, 2010, BMJ, V340, pc869, DOI [10.1016/j.jclinepi.2010.03.004, 10.1136/bmj.c869]; National Institutes of Health National Library of Medicine, 2014, PUBMED HELP     0709; Plint AC, 2006, MED J AUSTRALIA, V185, P263, DOI 10.5694/j.1326-5377.2006.tb00557.x; Rios LP, 2008, J CLIN ENDOCR METAB, V93, P3810, DOI 10.1210/jc.2008-0817; Schulz KF, 2010, BMC MED, V8, DOI [10.1186/1741-7015-8-18, 10.1136/bmj.c332]; The editorial team Cochrane Ear Nose and Throat Disorders Group, 2012, COCHR COLL COCHR REV; Turner L, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.MR000030.pub2; van de Wetering FT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049599	27	21	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0122328	10.1371/journal.pone.0122328	http://dx.doi.org/10.1371/journal.pone.0122328			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25793517	Green Published, gold, Green Submitted			2022-12-27	WOS:000352083900176
J	Schweiger, T; Nikolowsky, C; Starlinger, P; Traxler, D; Zimmermann, M; Birner, P; Hegedus, B; Dome, B; Bergmann, M; Mildner, M; Klepetko, W; Hoetzenecker, K; Ankersmit, HJ				Schweiger, Thomas; Nikolowsky, Christoph; Starlinger, Patrick; Traxler, Denise; Zimmermann, Matthias; Birner, Peter; Hegedues, Balazs; Dome, Balazs; Bergmann, Michael; Mildner, Michael; Klepetko, Walter; Hoetzenecker, Konrad; Ankersmit, Hendrik Jan			Stromal Expression of Heat-Shock Protein 27 Is Associated with Worse Clinical Outcome in Patients with Colorectal Cancer Lung Metastases	PLOS ONE			English	Article							FIBROBLAST ACTIVATION PROTEIN; TUMOR STROMA; COLON-CANCER; PULMONARY METASTASECTOMY; PROGNOSTIC INDICATOR; HSP27 EXPRESSION; CELLS; ANGIOGENESIS; MORTALITY; MARKERS	Background Pulmonary metastases are common in patients with primary colorectal cancer (CRC). Heat-shock protein 27 (Hsp27) is upregulated in activated fibroblasts during wound healing and systemically elevated in various diseases. Cancer-associated fibroblasts (CAFs) are also thought to play a role as prognostic and predictive markers in various malignancies including CRC. Surprisingly, the expression of Hsp27 has never been assessed in CAFs. Therefore we aimed to investigate the expression level of Hsp27 in CAFs and its clinical implications in patients with CRC lung metastases. Methods FFPE tissue samples from 51 pulmonary metastases (PMs) and 33 paired primary tumors were evaluated for alpha-SMA, CD31, Hsp27 and vimentin expression by immunohistochemistry and correlated with clinicopathological variables. 25 liver metastases served as control group. Moreover, serum samples (n= 10) before and after pulmonary metastasectomy were assessed for circulating phospho-Hsp27 and total Hsp27 by ELISA. Results Stromal expression of Hsp27 was observed in all PM and showed strong correlation with alpha-SMA (P< 0.001) and vimentin (P< 0.001). Strong stromal Hsp27 was associated with higher microvessel density in primary CRC and PM. Moreover, high stromal Hsp27 and alpha SMA expression were associated with decreased recurrence-free survival after pulmonary metastasectomy (P= 0.018 and P= 0.008, respectively) and overall survival (P= 0.031 and P= 0.017, respectively). Serum levels of phospho-and total Hsp27 dropped after metastasectomy to levels comparable to healthy controls. Conclusions Herein we describe for the first time that Hsp27 is highly expressed in tumor stroma of CRC. Stromal alpha-SMA and Hsp27 expressions correlate with the clinical outcome after pulmonary metastasectomy. Moreover, serum Hsp27 might pose a future marker for metastatic disease in CRC.	[Schweiger, Thomas; Nikolowsky, Christoph; Traxler, Denise; Hegedues, Balazs; Dome, Balazs; Klepetko, Walter; Hoetzenecker, Konrad; Ankersmit, Hendrik Jan] Med Univ Vienna, Dept Thorac Surg, Vienna, Austria; [Schweiger, Thomas; Nikolowsky, Christoph; Traxler, Denise; Zimmermann, Matthias; Hoetzenecker, Konrad; Ankersmit, Hendrik Jan] Med Univ Vienna, Christian Doppler Lab Cardiac & Thorac Diag & Reg, Vienna, Austria; [Starlinger, Patrick; Bergmann, Michael] Med Univ Vienna, Dept Gen Surg, Vienna, Austria; [Birner, Peter] Med Univ Vienna, Clin Inst Pathol, Vienna, Austria; [Hegedues, Balazs] Semmelweis Univ, Dept Pathol 2, H-1085 Budapest, Hungary; [Hegedues, Balazs] Semmelweis Univ, Hungarian Acad Sci, Mol Oncol Res Grp, H-1085 Budapest, Hungary; [Birner, Peter; Hegedues, Balazs] Med Univ Vienna, Ctr Comprehens Canc, Vienna, Austria; [Dome, Balazs] Natl Koranyi Inst Pulmonol, Budapest, Hungary; [Dome, Balazs] Semmelweis Univ, Natl Inst Oncol, Dept Thorac Surg, H-1085 Budapest, Hungary; [Hegedues, Balazs; Dome, Balazs] Med Univ Vienna, Div Mol & Gender Imaging, Dept Biomed Imaging & Image Guided Therapy, Vienna, Austria; [Mildner, Michael] Med Univ Vienna, Dept Dermatol, Vienna, Austria	Medical University of Vienna; Medical University of Vienna; Medical University of Vienna; Medical University of Vienna; Semmelweis University; Hungarian Academy of Sciences; Semmelweis University; Medical University of Vienna; National Institute of Oncology Hungary; Semmelweis University; Medical University of Vienna; Medical University of Vienna	Ankersmit, HJ (corresponding author), Med Univ Vienna, Dept Thorac Surg, Vienna, Austria.	hendrik.ankersmit@meduniwien.ac.at	Hegedus, Balazs/B-6076-2008; Bergmann, Michael/GZK-7700-2022; Zimmermann, Matthias/AAE-9681-2020	Hegedus, Balazs/0000-0002-4341-4153; Ankersmit, Hendrik Jan/0000-0002-8761-3517; Starlinger, Patrick/0000-0002-4666-5337; Traxler-Weidenauer, Denise/0000-0001-8679-1525; Bergmann, Michael/0000-0001-8529-1166; Hoetzenecker, Konrad/0000-0001-6775-7460; Dome, Balazs/0000-0001-8799-8624; Schweiger, Thomas/0000-0002-0173-7536; Mildner, Michael/0000-0002-6892-925X; Zimmermann, Matthias/0000-0002-4610-7853	Christian Doppler Laboratory for Cardiac and Thoracic Diagnosis and Regeneration; Medical University of Vienna	Christian Doppler Laboratory for Cardiac and Thoracic Diagnosis and Regeneration; Medical University of Vienna	This study was supported by the Christian Doppler Laboratory for Cardiac and Thoracic Diagnosis and Regeneration and by the Medical University of Vienna. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ankersmit HJ, 2012, RESPIRATION, V83, P391, DOI 10.1159/000336557; Bosman JD, 2010, BREAST CANCER RES TR, V119, P63, DOI 10.1007/s10549-009-0330-4; Brentnall TA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030219; Driessen A, 2006, ANN SURG, V243, P334, DOI 10.1097/01.sla.0000201452.09591.f3; DVORAK HF, 1986, NEW ENGL J MED, V315, P1650; Ghosh A, 2013, EXP MOL PATHOL, V94, P103, DOI 10.1016/j.yexmp.2012.09.001; Hacker S, 2009, CLIN LAB, V55, P31; Hadaschik BA, 2008, BJU INT, V102, P610, DOI 10.1111/j.1464-410X.2008.07669.x; Hanahan D, 2012, CANCER CELL, V21, P309, DOI 10.1016/j.ccr.2012.02.022; Hedges JC, 1999, J BIOL CHEM, V274, P24211, DOI 10.1074/jbc.274.34.24211; Henry LR, 2007, CLIN CANCER RES, V13, P1736, DOI 10.1158/1078-0432.CCR-06-1746; Herrera M, 2013, CLIN CANCER RES, V19, P5914, DOI 10.1158/1078-0432.CCR-13-0694; Hirano S, 2004, CELL STRESS CHAPERON, V9, P29, DOI 10.1379/1466-1268(2004)009<0029:HRFAMA>2.0.CO;2; Hirano S, 2002, J SURG RES, V102, P77, DOI 10.1006/jsre.2001.6315; Kahlert C, 2014, BRIT J CANCER, V110, P441, DOI 10.1038/bjc.2013.745; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; La Vecchia C, 2010, ANN ONCOL, V21, P1323, DOI 10.1093/annonc/mdp530; Li HC, 2007, J CELL BIOCHEM, V101, P805, DOI 10.1002/jcb.21159; Lofdahl M, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-48; Malvezzi M, 2011, ANN ONCOL, V22, P947, DOI 10.1093/annonc/mdq774; Meyer-ter-Vehn T, 2006, INVEST OPHTH VIS SCI, V47, P1500, DOI 10.1167/iovs.05-0361; Nakagawa H, 2004, ONCOGENE, V23, P7366, DOI 10.1038/sj.onc.1208013; Ngan CY, 2007, BRIT J CANCER, V96, P986, DOI 10.1038/sj.bjc.6603651; Oncogenex Corp, 2014, APATORSEN OGX 427; Orimo A, 2001, CLIN CANCER RES, V7, P3097; Piotrowicz RS, 1998, FASEB J, V12, P1481, DOI 10.1096/fasebj.12.14.1481; Sato T, 2002, APMIS, V110, P347, DOI 10.1034/j.1600-0463.2002.100410.x; Schweiger T, 2013, EUR J CARDIOTHORAC S; Schweiger T, 2014, ANN SURG ONCOL, V21, P946, DOI 10.1245/s10434-013-3386-7; Schweiger T, 2014, EUR J CARDIO-THORAC, V45, P408, DOI 10.1093/ejcts/ezt288; Smith NR, 2013, CLIN CANCER RES, V19, P6943, DOI 10.1158/1078-0432.CCR-13-1637; Suarez E, 2013, PLAST RECONSTR SURG, V131, p158E, DOI 10.1097/PRS.0b013e3182789b2b; Thuringer D, 2013, FASEB J, V27, P4169, DOI 10.1096/fj.12-226977; Torres S, 2013, CLIN CANCER RES, V19, P6006, DOI 10.1158/1078-0432.CCR-13-1130; Tsujino T, 2007, CLIN CANCER RES, V13, P2082, DOI 10.1158/1078-0432.CCR-06-2191; Tweedle EM, 2010, GUT, V59, P1501, DOI 10.1136/gut.2009.196626; Urosevic J, 2014, NAT CELL BIOL, V16, P685, DOI 10.1038/ncb2977; Wang F, 2012, MED ONCOL, V29, P1780, DOI 10.1007/s12032-011-0037-3; WEIDNER N, 1992, JNCI-J NATL CANCER I, V84, P1875, DOI 10.1093/jnci/84.24.1875; Wettstein G, 2013, FASEB J, V27, P1549, DOI 10.1096/fj.12-220053; Wikberg ML, 2013, TUMOR BIOL, V34, P1013, DOI 10.1007/s13277-012-0638-2; Yeung TM, 2013, BRIT J CANCER, V108, P2106, DOI 10.1038/bjc.2013.209; Yoshimura T, 2011, EPIGENETICS-US, V6, P1001, DOI 10.4161/epi.6.8.16063; Yu ZJ, 2010, MOL MED REP, V3, P953, DOI 10.3892/mmr.2010.372; Zhao M, 2014, TUMOR BIOL, V35, P1051, DOI 10.1007/s13277-013-1139-7; Zimmermann M, 2012, CLIN CHIM ACTA, V413, P1115, DOI 10.1016/j.cca.2012.03.008	46	25	26	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0120724	10.1371/journal.pone.0120724	http://dx.doi.org/10.1371/journal.pone.0120724			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25793600	Green Accepted, Green Submitted, Green Published, gold			2022-12-27	WOS:000352083900069
J	Yoshita, M; Arai, H; Arai, H; Arai, T; Asada, T; Fujishiro, H; Hanyu, H; Iizuka, O; Iseki, E; Kashihara, K; Kosaka, K; Maruno, H; Mizukami, K; Mizuno, Y; Mori, E; Nakajima, K; Nakamura, H; Nakano, S; Nakashima, K; Nishio, Y; Orimo, S; Samuraki, M; Takahashi, A; Taki, J; Tokuda, T; Urakami, K; Utsumi, K; Wada, K; Washimi, Y; Yamasaki, J; Yamashina, S; Yamada, M				Yoshita, Mitsuhiro; Arai, Heii; Arai, Hiroyuki; Arai, Tetsuaki; Asada, Takashi; Fujishiro, Hiroshige; Hanyu, Haruo; Iizuka, Osamu; Iseki, Eizo; Kashihara, Kenichi; Kosaka, Kenji; Maruno, Hirotaka; Mizukami, Katsuyoshi; Mizuno, Yoshikuni; Mori, Etsuro; Nakajima, Kenichi; Nakamura, Hiroyuki; Nakano, Seigo; Nakashima, Kenji; Nishio, Yoshiyuki; Orimo, Satoshi; Samuraki, Miharu; Takahashi, Akira; Taki, Junichi; Tokuda, Takahiko; Urakami, Katsuya; Utsumi, Kumiko; Wada, Kenji; Washimi, Yukihiko; Yamasaki, Junichi; Yamashina, Shouhei; Yamada, Masahito			Diagnostic Accuracy of I-123-Meta-Iodobenzylguanidine Myocardial Scintigraphy in Dementia with Lewy Bodies: A Multicenter Study	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; DIFFERENTIAL-DIAGNOSIS; PARKINSONS-DISEASE; CLINICAL-DIAGNOSIS; SENILE DEMENTIA; BODY TYPE; FP-CIT; DLB; CARDIOMYOPATHY; CONSORTIUM	Background and Purpose Dementia with Lewy bodies (DLB) needs to be distinguished from Alzheimer's disease (AD) because of important differences in patient management and outcome. Severe cardiac sympathetic degeneration occurs in DLB, but not in AD, offering a potential system for a biological diagnostic marker. The primary aim of this study was to investigate the diagnostic accuracy, in the ante-mortem differentiation of probable DLB from probable AD, of cardiac imaging with the ligand I-123-meta-iodobenzylguanidine (MIBG) which binds to the noradrenaline reuptake site, in the first multicenter study. Methods We performed a multicenter study in which we used I-123-MIBG scans to assess 133 patients with clinical diagnoses of probable (n = 61) or possible (n = 26) DLB or probable AD (n = 46) established by a consensus panel. Three readers, unaware of the clinical diagnosis, classified the images as either normal or abnormal by visual inspection. The heart-to-mediastinum ratios of I-123-MIBG uptake were also calculated using an automated region-of-interest based system. Results Using the heart-to-mediastinum ratio calculated with the automated system, the sensitivity was 68.9% and the specificity was 89.1% to differentiate probable DLB from probable AD in both early and delayed images. By visual assessment, the sensitivity and specificity were 68.9% and 87.0%, respectively. In a subpopulation of patients with mild dementia (MMSE >= 22, n = 47), the sensitivity and specificity were 77.4% and 93.8%, respectively, with the delayed heart-to-mediastinum ratio. Conclusions Our first multicenter study confirmed the high correlation between abnormal cardiac sympathetic activity evaluated with I-123-MIBG myocardial scintigraphy and a clinical diagnosis of probable DLB. The diagnostic accuracy is sufficiently high for this technique to be clinically useful in distinguishing DLB from AD, especially in patients with mild dementia.	[Yoshita, Mitsuhiro; Samuraki, Miharu; Yamada, Masahito] Kanazawa Univ, Dept Neurol & Neurobiol Aging, Grad Sch Med Sci, Kanazawa, Ishikawa 9208640, Japan; [Yoshita, Mitsuhiro] Hokuriku Natl Hosp, Dept Neurol, Nanto, Toyama 9391893, Japan; [Arai, Heii] Juntendo Univ, Sch Med, Dept Psychiat, Bunkyo Ku, Tokyo 1138431, Japan; [Arai, Hiroyuki] Tohoku Univ, Inst Dev Aging & Canc, Sendai, Miyagi 9808575, Japan; [Arai, Tetsuaki; Asada, Takashi] Univ Tsukuba, Inst Clin Med, Dept Neuropsychiat, Tsukuba, Ibaraki 3058576, Japan; [Fujishiro, Hiroshige; Iseki, Eizo] Juntendo Univ, Sch Med, PET CT Dementia Res Ctr, Juntendo Tokyo Koto Geriatr Med Ctr,Koto Ku, Tokyo 1360075, Japan; [Hanyu, Haruo] Tokyo Med Univ, Dept Geriatr Med, Shinjuku Ku, Tokyo 1600023, Japan; [Iizuka, Osamu; Mori, Etsuro; Nishio, Yoshiyuki] Tohoku Univ, Dept Behav Neurol & Cognit Neurosci, Grad Sch Med, Sendai, Miyagi 9808575, Japan; [Kashihara, Kenichi] Okayama Kyokuto Hosp, Dept Neurol, Okayama 7038265, Japan; [Kosaka, Kenji] Med Care Court Clin, Yokohama, Kanagawa 2250014, Japan; [Maruno, Hirotaka] Toranomon Gen Hosp, Dept Radiol, Minato Ku, Tokyo 1058470, Japan; [Mizukami, Katsuyoshi] Univ Tsukuba, Grad Sch Comprehens Human Sci, Bunkyo Ku, Tokyo 1120012, Japan; [Mizuno, Yoshikuni] Kitasato Univ, Div Neurogenerat Med, Dept Neurol, Sch Med, Sagamihara, Kanagawa 2520374, Japan; [Nakajima, Kenichi; Taki, Junichi] Kanazawa Univ Hosp, Dept Nucl Med, Kanazawa, Ishikawa 9208640, Japan; [Nakamura, Hiroyuki] Kanazawa Univ, Grad Sch Med Sci, Dept Environm & Prevent Med, Kanazawa, Ishikawa 9208640, Japan; [Nakano, Seigo] Med Co LTA, Ctr Treatment Care & Res Dementia, Sumida Ku, Tokyo 1300004, Japan; [Nakashima, Kenji; Wada, Kenji] Tottori Univ, Fac Med, Div Neurol, Dept Brain & Neurosci, Yonago, Tottori 6838504, Japan; [Orimo, Satoshi] Mutual Aid Assoc Publ Sch Teachers, Dept Neurol, Kanto Cent Hosp, Tokyo 1588531, Japan; [Takahashi, Akira] Tokai Cent Hosp, Kakamigahara, Gifu 5040816, Japan; [Tokuda, Takahiko] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Mol Pathobiol Brain Dis, Kyoto 6020841, Japan; [Urakami, Katsuya] Tottori Univ, Sch Hlth Sci, Fac Med, Dept Regulat Biol, Yonago, Tottori 6838503, Japan; [Utsumi, Kumiko] Sunagawa City Med Ctr, Dept Neuropsychiat, Sunagawa, Hokkaido 0730196, Japan; [Washimi, Yukihiko] Hosp Natl Ctr Geriatr & Gerontol, Dept Cognit Disorders, Obu, Aichi 4748511, Japan; [Yamasaki, Junichi; Yamashina, Shouhei] Toho Univ, Ohmori Hosp, Div Cardiovasc Med, Dept Internal Med,Sch Med, Ota, Tokyo 1438541, Japan	Kanazawa University; Juntendo University; Tohoku University; University of Tsukuba; Juntendo University; Tokyo Medical University; Tohoku University; Toranomon Hospital; University of Tsukuba; Kitasato University; Kanazawa University; Kanazawa University; Tottori University; Kyoto Prefectural University of Medicine; Tottori University; National Center for Geriatrics & Gerontology; Toho University	Yamada, M (corresponding author), Kanazawa Univ, Dept Neurol & Neurobiol Aging, Grad Sch Med Sci, Kanazawa, Ishikawa 9208640, Japan.	m-yamada@med.kanazawa-u.ac.jp	MITSUHIRO, YOSHITA/AAE-1952-2020; Yoshita, Mitsuhiro/J-4941-2019	Yoshita, Mitsuhiro/0000-0001-5979-8385	Japan Foundation for Neuroscience and Mental Health; Grants-in-Aid for Scientific Research [24390278] Funding Source: KAKEN	Japan Foundation for Neuroscience and Mental Health(Japan Foundation for Neuroscience and Mental Health); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The study was supported by the grant of Japan Foundation for Neuroscience and Mental Health (to M. Yamada). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarsland D, 2004, J GERIATR PSYCH NEUR, V17, P164, DOI 10.1177/0891988704267463; Ceravolo R, 2004, J NEURAL TRANSM, V111, P1065, DOI 10.1007/s00702-004-0140-0; CHUI HC, 1994, ARCH NEUROL-CHICAGO, V51, P676, DOI 10.1001/archneur.1994.00540190056015; CUMMINGS JL, 1994, NEUROLOGY, V44, P2308, DOI 10.1212/WNL.44.12.2308; Ferman TJ, 2011, NEUROLOGY, V77, P875, DOI 10.1212/WNL.0b013e31822c9148; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; GLOWNIAK JV, 1989, J NUCL MED, V30, P1182; Hanyu H, 2006, EUR J NUCL MED MOL I, V33, P248, DOI 10.1007/s00259-005-1921-x; HUGHES CP, 1982, BRIT J PSYCHIAT, V140, P566, DOI 10.1192/bjp.140.6.566; Knopman DS, 2001, NEUROLOGY, V56, P1143, DOI 10.1212/WNL.56.9.1143; Lopez OL, 2002, ARCH NEUROL-CHICAGO, V59, P43, DOI 10.1001/archneur.59.1.43; MCKEITH I, 1992, BRIT MED J, V305, P673, DOI 10.1136/bmj.305.6855.673; McKeith IG, 2000, NEUROLOGY, V54, P1050, DOI 10.1212/WNL.54.5.1050; MCKEITH IG, 1994, BRIT J PSYCHIAT, V165, P324, DOI 10.1192/bjp.165.3.324; McKeith IG, 2005, NEUROLOGY, V65, P1863, DOI 10.1212/01.wnl.0000187889.17253.b1; McKeith IG, 1996, NEUROLOGY, V47, P1113, DOI 10.1212/WNL.47.5.1113; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; McKieth I, 2007, LANCET NEUROL, V6, P305; MERLET P, 1992, J NUCL MED, V33, P471; Miyamoto T, 2006, NEUROLOGY, V67, P2236, DOI 10.1212/01.wnl.0000249313.25627.2e; NAKAJIMA K, 1990, AM HEART J, V119, P1329, DOI 10.1016/S0002-8703(05)80183-8; Nakajima K, 2012, EUR J NUCL MED MOL I, V39, P113, DOI 10.1007/s00259-011-1963-1; Nakajima K, 2010, ANN NUCL MED, V24, P125, DOI 10.1007/s12149-009-0337-2; O'Brien JT, 2004, ARCH NEUROL-CHICAGO, V61, P919, DOI 10.1001/archneur.61.6.919; Papka M, 1998, J NEUROPSYCH CLIN N, V10, P267, DOI 10.1176/jnp.10.3.267; Sudmeyer M, 2011, J NUCL MED, V52, P733, DOI 10.2967/jnumed.110.086959; Treglia G, 2014, J NEUROIMAGING, V24, P149, DOI 10.1111/j.1552-6569.2012.00774.x; Waldemar G, 2007, EUR J NEUROL, V14, pE1, DOI 10.1111/j.1468-1331.2006.01605.x; White L, 2009, J ALZHEIMERS DIS, V18, P713, DOI 10.3233/JAD-2009-1178; Yoshita M, 2006, NEUROLOGY, V66, P1850, DOI 10.1212/01.wnl.0000219640.59984.a7; Yoshita M, 1998, J NEUROL SCI, V155, P60, DOI 10.1016/S0022-510X(97)00278-5	31	88	90	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0120540	10.1371/journal.pone.0120540	http://dx.doi.org/10.1371/journal.pone.0120540			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25793585	gold, Green Published, Green Submitted			2022-12-27	WOS:000352083900051
J	Bhutta, HY; Rajpal, N; White, W; Freudenberg, JM; Liu, YP; Way, J; Rajpal, D; Cooper, DC; Young, A; Tavakkoli, A; Chen, LH				Bhutta, Hina Y.; Rajpal, Neetu; White, Wendy; Freudenberg, Johannes M.; Liu, Yaping; Way, James; Rajpal, Deepak; Cooper, David C.; Young, Andrew; Tavakkoli, Ali; Chen, Lihong			Effect of Roux-en-Y Gastric Bypass Surgery on Bile Acid Metabolism in Normal and Obese Diabetic Rats	PLOS ONE			English	Article							VERTICAL SLEEVE GASTRECTOMY; BARIATRIC SURGERY; WEIGHT-LOSS; GLUCOSE-METABOLISM; LIPID-METABOLISM; GLYCEMIC CONTROL; LIVER; MICE; TRANSPORTERS; HOMEOSTASIS	In addition to classic functions of facilitating hepatobiliary secretion and intestinal absorption of lipophilic nutrients, bile acids (BA) are also endocrine factors and regulate glucose and lipid metabolism. Recent data indicate that antiobesity bariatric procedures e.g. Roux-en-Y gastric bypass surgery (RYGB), which also remit diabetes, increase plasma BAs in humans, leading to the hypothesis that BAs may play a role in diabetes resolution following surgery. To investigate the effect of RYGB on BA physiology and its relationship with glucose homeostasis, we undertook RYGB and SHAM surgery in Zucker diabetic fatty (ZDF) and normoglycemic Sprague Dawley (SD) rats and measured plasma and fecal BA levels, as well as plasma glucose, insulin, Glucagon like peptide 1 (GLP-1) and Peptide YY (PYY), 2 days before and 3, 7, 14 and 28 days after surgery. RYGB decreased body weight and increased plasma GLP-1 in both SD and ZDF rats while decreasing plasma insulin and glucose in ZDF rats starting from the first week. Compared to SHAM groups, both SD-RYGB and ZDF-RYGB groups started to have increases in plasma total BAs in the second week, which might not contribute to early post-surgery metabolic changes. While there was no significant difference in fecal BA excretion between SD-RYGB and SD-SHAM groups, the ZDF-RYGB group had a transient 4.2-fold increase (P<0.001) in 24-hour fecal BA excretion on post-operative day 3 compared to ZDF-SHAM, which paralleled a significant increase in plasma PYY. Ratios of plasma and fecal cholic acid/chenodeoxycholic acid derived BAs were decreased in RYGB groups. In addition, tissue mRNA expression analysis suggested early intestinal BA reabsorption and potentially reduced hepatic cholic acid production in RYGB groups. In summary, we present novel data on RYGB-mediated changes in BA metabolism to further understand the role of BAs in RYGB-induced metabolic effects in humans.	[Bhutta, Hina Y.; Tavakkoli, Ali] Brigham & Womens Hosp, Dept Surg, Boston, MA 02115 USA; [Bhutta, Hina Y.; Tavakkoli, Ali] Harvard Univ, Sch Med, Boston, MA USA; [Bhutta, Hina Y.] Univ London Imperial Coll Sci Technol & Med, Dept Invest Med, London, England; [Rajpal, Neetu; Liu, Yaping; Way, James; Young, Andrew; Chen, Lihong] GlaxoSmithKline Inc, Metab Drug Discovery, Res Triangle Pk, NC 27709 USA; [White, Wendy] GlaxoSmithKline Inc, Mol Discovery Res, Res Triangle Pk, NC USA; [Freudenberg, Johannes M.; Rajpal, Deepak; Cooper, David C.] GlaxoSmithKline Inc, Quantitat Sci Div, Res Triangle Pk, NC USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Imperial College London; GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline	Chen, LH (corresponding author), GlaxoSmithKline Inc, Metab Drug Discovery, Res Triangle Pk, NC 27709 USA.	atavakkoli@partners.org; lihong.a.chen@icloud.com		Freudenberg, Johannes/0000-0002-5327-4414	GlaxoSmithKline [209614]; GSK	GlaxoSmithKline(GlaxoSmithKline); GSK(GlaxoSmithKline)	Researches performed at Brigham and Women's Hospital (HYB and AT) were supported by a grant (Scientific Collaboration Agreement reference number 209614) from GlaxoSmithKline. Researches performed at GlaxoSmithKline (NR, WW, JMF, YL, JW, DR, DC, AY and LC) were supported by GSK internal research funding. Co-authors NR, WW, JMF, YL, JW, DR, DC, AY and LC are employed by GlaxoSmithKline. GlaxoSmithKline provided support in the form of salaries for authors NR, WW, JMF, YL, JW, DR, DC, AY and LC, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Ahmad NN, 2013, INT J OBESITY, V37, P1553, DOI 10.1038/ijo.2013.38; ANDERSEN E, 1988, EUR J CLIN INVEST, V18, P166, DOI 10.1111/j.1365-2362.1988.tb02408.x; [Anonymous], 2013, INT J PREV MED; Ashrafian H, 2013, J PROTEOME RES; Battle MA, 2008, GASTROENTEROLOGY, V135, P1676, DOI 10.1053/j.gastro.2008.07.074; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Beuling E, 2010, GUT, V59, P888, DOI 10.1136/gut.2009.204990; Buchwald H, 1981, World J Surg, V5, P781; Chen LH, 2012, AM J PHYSIOL-ENDOC M, V302, pE68, DOI 10.1152/ajpendo.00323.2011; Chen LH, 2010, J PHARMACOL EXP THER, V334, P164, DOI 10.1124/jpet.110.166892; Cummings BP, 2012, ENDOCRINOLOGY, V153, P3620, DOI 10.1210/en.2012-1131; Fiorucci S, 2009, TRENDS PHARMACOL SCI, V30, P570, DOI 10.1016/j.tips.2009.08.001; Gustafsson U, 2005, HEPATOLOGY, V41, P1322, DOI 10.1002/hep.20686; Haeusler RA, 2013, DIABETES, V62, P4184, DOI 10.2337/db13-0639; HASSAN AS, 1980, P SOC EXP BIOL MED, V164, P449; Ishida H, 2000, J BIOCHEM, V127, P57, DOI 10.1093/oxfordjournals.jbchem.a022584; Joyce S. A, 2014, GUT MICROBES; Kashyap SR, 2010, CLEV CLIN J MED, V77, P468, DOI 10.3949/ccjm.77a.09135; Katsuma S, 2005, BIOCHEM BIOPH RES CO, V329, P386, DOI 10.1016/j.bbrc.2005.01.139; Kim I, 2007, J LIPID RES, V48, P2664, DOI 10.1194/jlr.M700330-JLR200; Kohli R, 2013, ENDOCRINOLOGY, V154, P2341, DOI 10.1210/en.2012-2069; Kohli R, 2013, J CLIN ENDOCR METAB, V98, pE708, DOI 10.1210/jc.2012-3736; Kohli R, 2010, AM J PHYSIOL-GASTR L, V299, pG652, DOI 10.1152/ajpgi.00221.2010; Kramer W, 1999, J LIPID RES, V40, P1604; Meissner M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024564; Nakatani H, 2009, METABOLISM, V58, P1400, DOI 10.1016/j.metabol.2009.05.006; Neff KJ, 2013, CURR DIABETES REV, V9, P93, DOI 10.2174/1573399811309020001; NERVI FO, 1978, BIOCHIM BIOPHYS ACTA, V529, P212, DOI 10.1016/0005-2760(78)90064-4; Nguyen A, 2008, CELL SIGNAL, V20, P2180, DOI 10.1016/j.cellsig.2008.06.014; Patti ME, 2009, OBESITY, V17, P1671, DOI 10.1038/oby.2009.102; Peterson R.G., 1990, ILAR NEWS, V32, P16, DOI [10.1093/ilar.32.3.16, DOI 10.1093/ILAR.32.3.16, DOI 10.1093/ILAR.32.3.16)]; PLAISANCIE P, 1995, J ENDOCRINOL, V145, P521, DOI 10.1677/joe.0.1450521; Porez G, 2012, J LIPID RES, V53, P1723, DOI 10.1194/jlr.R024794; Pories WJ, 2011, SURG CLIN N AM, V91, P821, DOI 10.1016/j.suc.2011.04.008; Pournaras DJ, 2013, ENDOCRINOLOGY, V154, P2255, DOI 10.1210/en.2013-1383; Pournaras DJ, 2012, ENDOCRINOLOGY, V153, P3613, DOI 10.1210/en.2011-2145; REICHEN J, 1975, GASTROENTEROLOGY, V68, P132; Rhee NA, 2012, DIABETES OBES METAB, V14, P291, DOI 10.1111/j.1463-1326.2011.01505.x; Ryan KK, 2014, NATURE, V509, P183, DOI 10.1038/nature13135; Saeidi N, 2013, SCIENCE, V341, P406, DOI 10.1126/science.1235103; Schauer PR, 2012, NEW ENGL J MED, V366, P1567, DOI 10.1056/NEJMoa1200225; Simonen M, 2012, OBES SURG, V22, P1473, DOI 10.1007/s11695-012-0673-5; Sjostrom L, 2013, J INTERN MED, V273, P219, DOI 10.1111/joim.12012; Smushkin G, 2013, DIABETES, V62, P1094, DOI 10.2337/db12-0923; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Stearns AT, 2009, AM J PHYSIOL-GASTR L, V297, pG950, DOI 10.1152/ajpgi.00253.2009; Steinert RE, 2013, OBESITY, V21, pE660, DOI 10.1002/oby.20522; Stieger B, 2011, HANDB EXP PHARMACOL, V201, P205, DOI 10.1007/978-3-642-14541-4_5; UCHIDA K, 1979, JPN J PHARMACOL, V29, P553, DOI 10.1254/jjp.29.553; UCHIDA K, 1985, DIABETES, V34, P79, DOI 10.2337/diabetes.34.1.79; Vallim TQD, 2013, CELL METAB, V17, P657, DOI 10.1016/j.cmet.2013.03.013; Watanabe M, 2006, NATURE, V439, P484, DOI 10.1038/nature04330; Zhang EY, 2002, DRUG METAB REV, V34, P709, DOI 10.1081/DMR-120015692	53	56	58	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0122273	10.1371/journal.pone.0122273	http://dx.doi.org/10.1371/journal.pone.0122273			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25798945	Green Published, Green Submitted, gold			2022-12-27	WOS:000351987300325
J	Bradley, DT; Bourke, TW; Fairley, DJ; Borrow, R; Shields, MD; Zipfel, PF; Hughes, AE				Bradley, Declan T.; Bourke, Thomas W.; Fairley, Derek J.; Borrow, Raymond; Shields, Michael D.; Zipfel, Peter F.; Hughes, Anne E.			Susceptibility to Invasive Meningococcal Disease: Polymorphism of Complement System Genes and Neisseria meningitidis Factor H Binding Protein	PLOS ONE			English	Article							DEFICIENCIES; ASSOCIATION; HAPLOTYPE; VARIANTS; RISK; CD46	Background Neisseria meningitidis can cause severe infection in humans. Polymorphism of Complement Factor H (CFH) is associated with altered risk of invasive meningococcal disease (IMD). We aimed to find whether polymorphism of other complement genes altered risk and whether variation of N. meningitidis factor H binding protein (fHBP) affected the risk association. Methods We undertook a case-control study with 309 European cases and 5,200 1958 Birth Cohort and National Blood Service cohort controls. We used additive model logistic regression, accepting P<0.05 as significant after correction for multiple testing. The effects of fHBP subfamily on the age at infection and severity of disease was tested using the independent samples median test and Student's T test. The effect of CFH polymorphism on the N. meningitidis fHBP subfamily was investigated by logistic regression and Chi squared test. Results Rs12085435 A in C8B was associated with odds ratio (OR) of IMD (0.35 [95% CI 0.19-0.67]; P = 0.03 after correction). A CFH haplotype tagged by rs3753396 G was associated with IMD (OR 0.56 [95% CI 0.42-0.76], P = 1.6x10(-4)). There was no bacterial load (CtrA cycle threshold) difference associated with carriage of this haplotype. Host CFH haplotype and meningococcal fHBP subfamily were not associated. Individuals infected with meningococci expressing subfamily A fHBP were younger than those with subfamily B fHBP meningococci (median 1 vs 2 years; P = 0.025). Discussion The protective CFH haplotype alters odds of IMD without affecting bacterial load for affected heterozygotes. CFH haplotype did not affect the likelihood of infecting meningococci having either fHBP subfamily. The association between C8B rs12085435 and IMD requires independent replication. The CFH association is of interest because it is independent of known functional polymorphisms in CFH. As fHBP-containing vaccines are now in use, relationships between CFH polymorphism and vaccine effectiveness and side-effects may become important.	[Bradley, Declan T.] Queens Univ Belfast, Sch Med Dent & Biomed Sci, Ctr Publ Hlth, Belfast, Antrim, North Ireland; [Bradley, Declan T.] Publ Hlth Agcy, Belfast, Antrim, North Ireland; [Bourke, Thomas W.; Shields, Michael D.] Queens Univ Belfast, Ctr Infect & Immun, Sch Med Dent & Biomed Sci, Belfast, Antrim, North Ireland; [Fairley, Derek J.] Belfast Hlth & Social Care Trust, Reg Virus Lab, Belfast, Antrim, North Ireland; [Borrow, Raymond] Publ Hlth England, Vaccine Evaluat Unit, Manchester, Lancs, England; [Borrow, Raymond] Univ Manchester, Sch Translat Med, Inflammat Sci Res Grp, Manchester, Lancs, England; [Zipfel, Peter F.] Hans Knoell Inst, Leibniz Inst Nat Prod Res & Infect Biol, Dept Infect Biol, Jena, Germany; [Zipfel, Peter F.] Univ Jena, Jena, Germany; [Hughes, Anne E.] Queens Univ Belfast, Sch Med Dent & Biomed Sci, Ctr Publ Hlth, Belfast, Antrim, North Ireland	Queens University Belfast; Queens University Belfast; Public Health England; University of Manchester; Hans Knoll Institute (HKI); Friedrich Schiller University of Jena; Queens University Belfast	Bradley, DT (corresponding author), Queens Univ Belfast, Sch Med Dent & Biomed Sci, Ctr Publ Hlth, Belfast, Antrim, North Ireland.	dbradley09@qub.ac.uk	Bradley, Declan T/AFO-1353-2022; Bradley, Declan/AFN-7904-2022	Bourke, Thomas/0000-0003-4786-962X; Bradley, Declan/0000-0003-1468-1823	Northern Ireland Health and Social Care Research and Development Office [EAT/3976/08]; Medical Research Council [G1001799, MR/N01104X/1] Funding Source: researchfish; Public Health Agency [EAT/3976/08] Funding Source: researchfish; MRC [G1001799, MR/N01104X/1] Funding Source: UKRI	Northern Ireland Health and Social Care Research and Development Office; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Public Health Agency; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	DTB was supported by a doctoral fellowship from the Northern Ireland Health and Social Care Research and Development Office: EAT/3976/08 (http://www.publichealth.hscni.net/directorate-public-health/hsc-research-and-development). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beernink PT, 2009, MICROBIOL-SGM, V155, P2873, DOI 10.1099/mic.0.029876-0; Bradley DT, 2012, INT J IMMUNOGENET, V39, P328, DOI 10.1111/j.1744-313X.2012.01095.x; Bradley DT, 2011, EYE, V25, P683, DOI 10.1038/eye.2011.37; Brouwer MC, 2010, LANCET INFECT DIS, V10, P262, DOI 10.1016/S1473-3099(10)70045-1; Brouwer MC, 2009, LANCET INFECT DIS, V9, P31, DOI 10.1016/S1473-3099(08)70261-5; Costa I, 2014, MBIO, V5, DOI 10.1128/mBio.01625-14; Dale AP, 2013, EXPERT REV ANTI-INFE, V11, P187, DOI [10.1586/eri.12.161, 10.1586/ERI.12.161]; Darton T, 2009, CLIN INFECT DIS, V48, P587, DOI 10.1086/596707; Davila S, 2010, NAT GENET, V42, P772, DOI 10.1038/ng.640; Dunphy KY, 2011, INFECT IMMUN, V79, P353, DOI 10.1128/IAI.00849-10; Esposito S, 2014, HUM VACC IMMUNOTHER, V10, P2005, DOI 10.4161/hv.29218; Fletcher LD, 2004, INFECT IMMUN, V72, P2088, DOI 10.1128/IAI.72.4.2088-2100.2004; Guiver M, 2000, FEMS IMMUNOL MED MIC, V28, P173, DOI 10.1111/j.1574-695X.2000.tb01473.x; Hackett SJ, 2002, ARCH DIS CHILD, V86, P44, DOI 10.1136/adc.86.1.44; Hageman GS, 2005, P NATL ACAD SCI USA, V102, P7227, DOI 10.1073/pnas.0501536102; Haines JL, 2005, SCIENCE, V308, P419, DOI 10.1126/science.1110359; Hughes AE, 2007, PLOS MED, V4, P1993, DOI 10.1371/journal.pmed.0040355; Hughes AE, 2006, NAT GENET, V38, P1173, DOI 10.1038/ng1890; Jarva H, 2005, J IMMUNOL, V174, P6299, DOI 10.4049/jimmunol.174.10.6299; Johansson L, 2003, SCIENCE, V301, P373, DOI 10.1126/science.1086476; Joint Committee on Vaccination and Immunisation, 2014, JCVI POS STAT US BEX; Kallstrom H, 1997, MOL MICROBIOL, V25, P639, DOI 10.1046/j.1365-2958.1997.4841857.x; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Ladhani S, 2014, PREVENTING SECONDARY; Lewis LA, 2012, J IMMUNOL, V188, P5063, DOI 10.4049/jimmunol.1103748; Lewis LA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001027; Madico G, 2006, J IMMUNOL, V177, P501, DOI 10.4049/jimmunol.177.1.501; Markiewski MM, 2008, J CELL MOL MED, V12, P2245, DOI 10.1111/j.1582-4934.2008.00504.x; Masignani V, 2003, J EXP MED, V197, P789, DOI 10.1084/jem.20021911; Pajon R, 2010, VACCINE, V28, P2122, DOI 10.1016/j.vaccine.2009.12.027; Phillips C, 2007, FORENSIC SCI INT-GEN, V1, P273, DOI 10.1016/j.fsigen.2007.06.008; Piet JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047973; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ram S, 2010, CLIN MICROBIOL REV, V23, P740, DOI 10.1128/CMR.00048-09; Ramsay M, 1997, Commun Dis Rep CDR Rev, V7, pR49; Schneider MC, 2009, NATURE, V458, P890, DOI 10.1038/nature07769; Tedesco F, 2008, VACCINE, V26, pI3, DOI 10.1016/j.vaccine.2008.11.010; Wigginton JE, 2005, AM J HUM GENET, V76, P887, DOI 10.1086/429864; Zhao J, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002079; Zipfel PF, 2007, PLOS GENET, V3, P387, DOI 10.1371/journal.pgen.0030041; Zipfel PF, 2009, IMMUNOL LETT, V126, P1, DOI 10.1016/j.imlet.2009.07.005; Zipfel PF, 2009, NAT REV IMMUNOL, V9, P729, DOI 10.1038/nri2620; Zipfel PF, 2008, VACCINE, V26, pI67, DOI 10.1016/j.vaccine.2008.11.015	43	14	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0120757	10.1371/journal.pone.0120757	http://dx.doi.org/10.1371/journal.pone.0120757			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25798599	Green Published, Green Submitted, gold			2022-12-27	WOS:000351987300173
J	Sosunov, SA; Ameer, X; Niatsetskaya, ZV; Utkina-Sosunova, I; Ratner, VI; Ten, VS				Sosunov, Sergey A.; Ameer, Xavier; Niatsetskaya, Zoya V.; Utkina-Sosunova, Irina; Ratner, Veniamin I.; Ten, Vadim S.			Isoflurane Anesthesia Initiated at the Onset of Reperfusion Attenuates Oxidative and Hypoxic-Ischemic Brain Injury	PLOS ONE			English	Article							MITOCHONDRIAL COMPLEX I; OXYGEN-FREE RADICALS; CEREBRAL-BLOOD-FLOW; NEONATAL MICE; AMINO-ACIDS; NEUROPROTECTION; CYCLE; RESPIRATION; METABOLISM	This study demonstrates that in mice subjected to hypoxia-ischemia (HI) brain injury isoflurane anesthesia initiated upon reperfusion limits a release of mitochondrial oxidative radicals by inhibiting a recovery of complex-I dependent mitochondrial respiration. This significantly attenuates an oxidative stress and reduces the extent of HI brain injury. Neonatal mice were subjected to HI, and at the initiation of reperfusion were exposed to isoflurane with or without mechanical ventilation. At the end of HI and isoflurane exposure cerebral mitochondrial respiration, H2O2 emission rates were measured followed by an assessment of cerebral oxidative damage and infarct volumes. At 8 weeks after HI navigational memory and brain atrophy were assessed. In vitro, direct effect of isoflurane on mitochondrial H2O2 emission was compared to that of complex-I inhibitor, rotenone. Compared to controls, 15 minutes of isoflurane anesthesia inhibited recovery of the compex I-dependent mitochondrial respiration and decreased H2O2 production in mitochondria supported with succinate. This was associated with reduced oxidative brain injury, superior navigational memory and decreased cerebral atrophy compared to the vehicle-treated HI-mice. Extended isoflurane anesthesia was associated with sluggish recovery of cerebral blood flow (CBF) and the neuroprotection was lost. However, when isoflurane anesthesia was supported with mechanical ventilation the CBF recovery improved, the event associated with further reduction of infarct volume compared to HI-mice exposed to isoflurane without respiratory support. Thus, in neonatal mice brief isoflurane anesthesia initiated at the onset of reperfusion limits mitochondrial release of oxidative radicals and attenuates an oxidative stress. This novel mechanism contributes to neuroprotective action of isoflurane. The use of mechanical ventilation during isoflurane anesthesia counterbalances negative effect of isoflurane anesthesia on recovery of cerebral circulation which potentiates protection against reperfusion injury.	[Sosunov, Sergey A.; Ameer, Xavier; Niatsetskaya, Zoya V.; Utkina-Sosunova, Irina; Ratner, Veniamin I.; Ten, Vadim S.] Columbia Univ, Dept Pediat, Div Neonatol, New York, NY 10027 USA	Columbia University	Ten, VS (corresponding author), Columbia Univ, Dept Pediat, Div Neonatol, New York, NY 10027 USA.	vt82@columbia.edu			NIH [NS071121]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS071121] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was partially supported by NIH grant NS071121 (V.S.T). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal B, 2014, BBA-BIOENERGETICS, V1837, P354, DOI 10.1016/j.bbabio.2013.11.006; Aidakkak M, 2008, CARDIOVASC RES, V77, P406, DOI 10.1016/j.cardiores.2007.08.008; AMBROSIO G, 1993, J BIOL CHEM, V268, P18532; BENZI G, 1979, BIOCHEM PHARMACOL, V28, P2545, DOI 10.1016/0006-2952(79)90024-8; Bruins B, 2013, ANESTH ANALG, V116, P838, DOI 10.1213/ANE.0b013e3182860fe7; Burchell SR, 2013, J INVEST MED, V61, P1078, DOI 10.2310/JIM.0b013e3182a07921; Caspersen CS, 2008, DEV NEUROSCI-BASEL, V30, P319, DOI 10.1159/000121416; Chen H, 2011, TRANSL STROKE RES, V2, P382, DOI 10.1007/s12975-011-0081-5; Chouchani ET, 2014, NATURE, V515, P431, DOI 10.1038/nature13909; Elsersy H, 2006, ANESTHESIOLOGY, V105, P81, DOI 10.1097/00000542-200607000-00016; FOLBERGR.J, 1974, BRAIN RES, V80, P265, DOI 10.1016/0006-8993(74)90690-8; Harada H, 1999, ANESTH ANALG, V89, P1442, DOI 10.1097/00000539-199912000-00022; Hirata N, 2011, ANESTHESIOLOGY, V115, P531, DOI 10.1097/ALN.0b013e31822a2316; Kato K, 1994, Nagoya J Med Sci, V57, P43; Kayser EB, 2011, ANESTH ANALG, V112, P1321, DOI 10.1213/ANE.0b013e3182121d37; Li CX, 2013, NEUROSCI LETT, V541, P58, DOI 10.1016/j.neulet.2013.02.007; Loepke AW, 2006, ANESTH ANALG, V102, P75, DOI 10.1213/01.ANE.0000181102.92729.B8; Matsiukevich D, 2010, RESUSCITATION, V81, P224, DOI 10.1016/j.resuscitation.2009.11.024; McAuliffe JJ, 2009, ANESTHESIOLOGY, V111, P533, DOI 10.1097/ALN.0b013e3181b060d3; Niatsetskaya ZV, 2012, J NEUROSCI, V32, P3235, DOI 10.1523/JNEUROSCI.6303-11.2012; Niatsetskaya ZV, 2012, J CEREBR BLOOD F MET, V32, P232, DOI 10.1038/jcbfm.2011.164; Piantadosi CA, 1996, STROKE, V27, P327, DOI 10.1161/01.STR.27.2.327; PISARENKO O, 1987, BIOMED BIOCHIM ACTA, V46, pS568; Ratner V, 2013, AM J RESP CELL MOL, V49, P943, DOI 10.1165/rcmb.2012-0172OC; SIMS NR, 1991, J NEUROCHEM, V56, P1836, DOI 10.1111/j.1471-4159.1991.tb03438.x; Solberg R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009606; Starkov AA, 2003, J NEUROCHEM, V86, P1101, DOI 10.1046/j.1471-4159.2003.01908.x; Starkov AA, 2008, ANN NY ACAD SCI, V1147, P37, DOI 10.1196/annals.1427.015; Stewart S, 2009, TRANSL RES, V153, P224, DOI 10.1016/j.trsl.2009.02.003; Tahara EB, 2009, FREE RADICAL BIO MED, V46, P1283, DOI 10.1016/j.freeradbiomed.2009.02.008; Ten VS, 2012, NEUROL RES INT, V2012, DOI 10.1155/2012/542976; Ten VS, 2004, STROKE, V35, P2183, DOI 10.1161/01.STR.0000137768.25203.df; Vannucci RC, 1997, ANN NY ACAD SCI, V835, P234, DOI 10.1111/j.1749-6632.1997.tb48634.x; Xiong LZ, 2003, ANESTH ANALG, V96, P233, DOI 10.1097/00000539-200301000-00047; Zhao P, 2007, ANESTHESIOLOGY, V107, P963, DOI 10.1097/01.anes.0000291447.21046.4d; Zhou YL, 2010, STROKE, V41, P1521, DOI 10.1161/STROKEAHA.110.583757	36	22	26	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0120456	10.1371/journal.pone.0120456	http://dx.doi.org/10.1371/journal.pone.0120456			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25799166	Green Published, gold, Green Submitted			2022-12-27	WOS:000351987300147
J	Andersen, V; Vogel, LK; Kopp, TI; Saebo, M; Nonboe, AW; Hamfjord, J; Kure, EH; Vogel, U				Andersen, Vibeke; Vogel, Lotte K.; Kopp, Tine Iskov; Saebo, Mona; Nonboe, Annika W.; Hamfjord, Julian; Kure, Elin H.; Vogel, Ulla			High ABCC2 and Low ABCG2 Gene Expression Are Early Events in the Colorectal Adenoma-Carcinoma Sequence	PLOS ONE			English	Article							CANCER RESISTANCE PROTEIN; INFLAMMATORY-BOWEL-DISEASE; MESSENGER-RNA EXPRESSION; BLOOD MONONUCLEAR-CELLS; TOLL-LIKE RECEPTORS; P-GLYCOPROTEIN; INTESTINAL INFLAMMATION; DRUG-RESISTANCE; ANIMAL-MODELS; BCRP ABCG2	Development of colorectal cancer (CRC) may result from a dysfunctional interplay between diet, gut microbes and the immune system. The ABC transport proteins ABCB1 (P-glycoprotein, Multidrug resistance protein 1, MDR1), ABCC2 (MRP2) and ABCG2 (BCRP) are involved in transport of various compounds across the epithelial barrier. Low mRNA level of ABCB1 has previously been identified as an early event in colorectal carcinogenesis (Andersen et al., PLoS One. 2013 Aug 19; 8(8): e72119). ABCC2 and ABCG2 mRNA levels were assessed in intestinal tissue from 122 CRC cases, 106 adenoma cases (12 with severe dysplasia, 94 with mild-moderate dysplasia) and from 18 controls with normal endoscopy. We found significantly higher level of ABCC2 in adenomas with mild to moderate dysplasia and carcinoma tissue compared to the levels in unaffected tissue from the same individual (P = 0.037, P = 0.037, and P< 0.0001) and in carcinoma and distant unaffected tissue from CRC cases compared to the level in the healthy individuals (P = 0.0046 and P = 0.036). Furthermore, ABCG2 mRNA levels were significantly lower in adenomas and carcinomas compared to the level in unaffected tissue from the same individuals and compared to tissue from healthy individuals (P< 0.0001 for all). The level of ABCB2 in adjacent normal tissue was significantly higher than in tissue from healthy individuals (P = 0.011). In conclusion, this study found that ABCC2 and ABCG2 expression levels were altered already in mild/moderate dysplasia in carcinogenesis suggesting that these ABC transporters are involved in the early steps of carcinogenesis as previously reported for ABCB1. These results suggest that dysfunctional transport across the epithelial barrier may contribute to colorectal carcinogenesis.	[Andersen, Vibeke] Hosp Southern Jutland, Organ Ctr, Aabenraa, Denmark; [Andersen, Vibeke] Univ Southern Denmark, Inst Reg Hlth Res, Odense, Denmark; [Andersen, Vibeke] Reg Hosp Viborg, Dept Med, Viborg, Denmark; [Vogel, Lotte K.; Nonboe, Annika W.] Univ Copenhagen, Dept Cellular & Mol Med, Copenhagen, Denmark; [Kopp, Tine Iskov] Tech Univ Denmark, Natl Food Inst, Soborg, Denmark; [Saebo, Mona] Telemark Univ Coll, Fac Arts & Sci, Dept Environm & Hlth Studies, Telemark, Norway; [Hamfjord, Julian; Kure, Elin H.] Oslo Univ Hosp, Inst Canc Res, Dept Genet, Oslo, Norway; [Vogel, Ulla] Natl Res Ctr Working Environm, Copenhagen, Denmark	University of Southern Denmark; University of Copenhagen; Technical University of Denmark; University College of Southeast Norway; University of Oslo; National Research Centre for the Working Environment	Andersen, V (corresponding author), Hosp Southern Jutland, Organ Ctr, Aabenraa, Denmark.	vandersen@health.sdu.dk; elin.kure@rr-research.no	Vogel, Ulla B/I-5048-2012; Nonboe, Annika W./GQZ-2531-2022; Andersen, Vibeke/I-7932-2012; Vogel, Ulla/ABC-2212-2020	Vogel, Ulla B/0000-0001-6807-1524; Andersen, Vibeke/0000-0002-0127-2863; Vogel, Ulla/0000-0001-6807-1524; Kopp, Tine/0000-0003-3729-4420; Nonboe, Annika W./0000-0003-2948-278X; Vogel, Lotte K./0000-0001-9920-0982	Viborg Regional Hospital; Telemark Hospital; Oslo University Hospital; Norwegian Colorectal Cancer Prevention (NORCCAP); Norwegian Cancer Society; Department of Health and Social Affairs	Viborg Regional Hospital; Telemark Hospital; Oslo University Hospital; Norwegian Colorectal Cancer Prevention (NORCCAP); Norwegian Cancer Society(Norwegian Cancer Society); Department of Health and Social Affairs	Funding for this study has been obtained from Viborg Regional Hospital (http://www.hospitalsenhedmidt.dk/), and funding for establishing the KAM cohort has been obtained from Telemark Hospital, Oslo University Hospital, and the Norwegian Colorectal Cancer Prevention (NORCCAP) study (Grants from the Norwegian Cancer Society (http://www.uicc.org/membership/norwegian-cancer-society), Department of Health and Social Affairs) have supported the study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Qare AW, 2003, J TOXICOL ENV HEAL B, V6, P279, DOI 10.1080/10937400306466; Albermann N, 2005, BIOCHEM PHARMACOL, V70, P949, DOI 10.1016/j.bcp.2005.06.018; Andersen V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072119; Andersen V, 2012, SCAND J GASTROENTERO, V47, P572, DOI 10.3109/00365521.2012.668933; Andersen V, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-407; Arthur JC, 2013, GUT MICROBES, V4, P253, DOI 10.4161/gmic.24220; Aye ILMH, 2009, CHEM-BIOL INTERACT, V180, P327, DOI 10.1016/j.cbi.2009.04.012; Bornholdt J, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-65; Campa D, 2008, MUTAT RES-FUND MOL M, V645, P56, DOI 10.1016/j.mrfmmm.2008.08.001; Chen C, 2014, CURR MED CHEM, V21, P3007, DOI 10.2174/092986732126140804160443; Coleman JA, 2013, BBA-MOL CELL BIOL L, V1831, P555, DOI 10.1016/j.bbalip.2012.10.006; Collett A, 2008, INFLAMM BOWEL DIS, V14, P620, DOI 10.1002/ibd.20375; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Dietrich CG, 2011, INT J CANCER, V129, P546, DOI 10.1002/ijc.25958; Ebert B, 2005, CARCINOGENESIS, V26, P1754, DOI 10.1093/carcin/bgi139; Englund G, 2007, INFLAMM BOWEL DIS, V13, P291, DOI 10.1002/ibd.20030; Fukata M, 2008, ONCOGENE, V27, P234, DOI 10.1038/sj.onc.1210908; Fukata M, 2009, SEMIN IMMUNOL, V21, P242, DOI 10.1016/j.smim.2009.06.005; Gollapudi S, 2000, GENES IMMUN, V1, P371, DOI 10.1038/sj.gene.6363693; Goncalves P, 2011, AM J PHYSIOL-CELL PH, V301, pC984, DOI 10.1152/ajpcell.00146.2011; Gondal G, 2005, EUR J CANCER PREV, V14, P373, DOI 10.1097/00008469-200508000-00010; Hansen R, 2005, CANCER LETT, V229, P85, DOI 10.1016/j.canlet.2005.04.019; Hlavata I, 2012, MUTAGENESIS, V27, P187, DOI 10.1093/mutage/ger075; Johnson RL, 2013, CANCER METAST REV, V32, P39, DOI 10.1007/s10555-012-9404-6; Jonker JW, 2002, P NATL ACAD SCI USA, V99, P15649, DOI 10.1073/pnas.202607599; Kawase A, 2014, J PHARM SCI-US, V103, P2556, DOI 10.1002/jps.24043; Larsen UL, 2007, SCAND J CLIN LAB INV, V67, P123, DOI 10.1080/00365510600986084; Leslie EM, 2005, TOXICOL APPL PHARM, V204, P216, DOI 10.1016/j.taap.2004.10.012; Lorentzen A, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-192; Mercado-Lubo R, 2010, GUT MICROBES, V1, P301, DOI 10.4161/gmic.1.5.12925; Mosaffa F, 2012, MOL CELL BIOCHEM, V363, P385, DOI 10.1007/s11010-011-1191-9; Nones K, 2009, J APPL MICROBIOL, V107, P557, DOI 10.1111/j.1365-2672.2009.04225.x; Ostergaard M, 2009, SCAND J GASTROENTERO, V44, P65, DOI 10.1080/00365520802400826; Panwala CM, 1998, J IMMUNOL, V161, P5733; Pastorelli L, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00280; Pawlik A, 2005, J PHARM PHARMACOL, V57, P1421, DOI 10.1211/jpp.57.11.0007; Saebo M, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-208; Sarkadi B, 2006, PHYSIOL REV, V86, P1179, DOI 10.1152/physrev.00037.2005; Saxena M, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00327; Selzer-Plon J, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-201; Skjelbred CF, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-175; Skjelbred CF, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-228; Skjelbred CF, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-67; Skovbjerg H, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-136; Staley EM, 2011, J PEDIATR GASTR NUTR, V53, P666, DOI 10.1097/MPG.0b013e31822860f1; Tarling EJ, 2013, TRENDS ENDOCRIN MET, V24, P342, DOI 10.1016/j.tem.2013.01.006; Tolson AH, 2010, ADV DRUG DELIVER REV, V62, P1238, DOI 10.1016/j.addr.2010.08.006; UEG, 2014, COL CANC EUR; Uno S, 2009, BIOPHARM DRUG DISPOS, V30, P49, DOI 10.1002/bdd.639; van de Wetering K, 2012, FASEB J, V26, P4014, DOI 10.1096/fj.12-210039; Veldhoen M, 2012, NAT REV IMMUNOL, V12, P696, DOI 10.1038/nri3299; Vlaming MLH, 2014, MOL PHARMACOL, V85, P520, DOI 10.1124/mol.113.088823; Vogel LK, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-176; Vogel LK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105254; Vogel U, 2002, CARCINOGENESIS, V23, P1505, DOI 10.1093/carcin/23.9.1505; Zhang JS, 2006, INT IMMUNOL, V18, P485, DOI 10.1093/intimm/dxh389	56	28	31	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0119255	10.1371/journal.pone.0119255	http://dx.doi.org/10.1371/journal.pone.0119255			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25793771	gold, Green Submitted, Green Published			2022-12-27	WOS:000352084200064
J	Fernandez-Beaskoetxea, S; Carrascal, LM; Fernandez-Loras, A; Fisher, MC; Bosch, J				Fernandez-Beaskoetxea, Saioa; Carrascal, Luis M.; Fernandez-Loras, Andres; Fisher, Matthew C.; Bosch, Jaime			Short Term Minimum Water Temperatures Determine Levels of Infection by the Amphibian Chytrid Fungus in Alytes obstetricans Tadpoles	PLOS ONE			English	Article							BATRACHOCHYTRIUM-DENDROBATIDIS; SEASONAL DYNAMICS; MIDWIFE TOAD; CHYTRIDIOMYCOSIS; DISEASE; FROGS; TRANSMISSION; PREVALENCE; MORTALITY; TIME	Amphibians are one of the groups of wildlife most seriously threatened by emerging infectious disease. In particular, chytridiomycosis, caused by the aquatic fungus Batrachochytrium dendrobatidis, is responsible for amphibian species declines on a worldwide scale. Population-level outcomes following the introduction of the pathogen are context dependent and mediated by a large suite of abiotic and biotic variables. In particular, studies have shown that temperature has a key role in determining infection dynamics owing to the ecto-thermic nature of the amphibian host and temperature-dependency of pathogen growth rates. To assess the temperature-dependent seasonality of infectious burdens in a susceptible host species, we monitored lowland populations of larval midwife toads, Alytes obstetricians, in Central Spain throughout the year. We found that infections were highly seasonal, and inversely correlated against water temperature, with the highest burdens of infection seen during the colder months. Short-term impacts of water-temperature were found, with the minimum temperatures occurring before sampling being more highly predictive of infectious burdens than were longer-term spans of temperature. Our results will be useful for selecting the optimal time for disease surveys and, more broadly, for determining the key periods to undertake disease mitigation.	[Fernandez-Beaskoetxea, Saioa; Carrascal, Luis M.; Fernandez-Loras, Andres; Bosch, Jaime] CSIC, Museo Nacl Ciencias Nat, E-28006 Madrid, Spain; [Fisher, Matthew C.] Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, St Marys Hosp, London, England; [Bosch, Jaime] Ctr Invest Seguimiento & Evaluac, Rascafria, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Museo Nacional de Ciencias Naturales (MNCN); Imperial College London	Fisher, MC (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, St Marys Hosp, London, England.	matthew.fisher@imperial.ac.uk; bosch@mncn.cisc.es	Fisher, Matthew/B-9094-2011; Bosch, Jaime/H-3042-2011; Carrascal, Luis M./B-8381-2008; Carrascal, Luis M./Q-2190-2016	Fisher, Matthew/0000-0002-1862-6402; Bosch, Jaime/0000-0002-0099-7934; Carrascal, Luis M./0000-0003-1288-5531; Carrascal, Luis M./0000-0003-1288-5531	Fundacion General CSIC; Banco Santander; Biodiversa project RACE: Risk Assessment of Chytridiomycosis to European Amphibian Biodiversity; UK Natural Environmental Research Council NERC; Natural Environment Research Council [NE/G001944/1, NE/K014455/1] Funding Source: researchfish; NERC [NE/G001944/1, NE/K014455/1] Funding Source: UKRI	Fundacion General CSIC; Banco Santander; Biodiversa project RACE: Risk Assessment of Chytridiomycosis to European Amphibian Biodiversity; UK Natural Environmental Research Council NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	The study was funded by Fundacion General CSIC and Banco Santander. S Fernandez-Beaskoetxea was supported by Biodiversa project RACE: Risk Assessment of Chytridiomycosis to European Amphibian Biodiversity. MC Fisher was funded by the UK Natural Environmental Research Council NERC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altizer S, 2006, ECOL LETT, V9, P467, DOI 10.1111/j.1461-0248.2005.00879.x; Altizer S, 2004, J ANIM ECOL, V73, P309, DOI 10.1111/j.0021-8790.2004.00807.x; Andre SE, 2008, J WILDLIFE DIS, V44, P716, DOI 10.7589/0090-3558-44.3.716; Berger L, 2004, AUST VET J, V82, P434, DOI 10.1111/j.1751-0813.2004.tb11137.x; Bjornstad ON, 2002, ECOL MONOGR, V72, P169, DOI 10.1890/0012-9615(2002)072[0169:DOMEES]2.0.CO;2; Bosch J, 2001, BIOL CONSERV, V97, P331, DOI 10.1016/S0006-3207(00)00132-4; Bosch J, 2007, P ROY SOC B-BIOL SCI, V274, P253, DOI 10.1098/rspb.2006.3713; Boyle DG, 2004, DIS AQUAT ORGAN, V60, P141, DOI 10.3354/dao060141; Bradley GA, 2002, J WILDLIFE DIS, V38, P206, DOI 10.7589/0090-3558-38.1.206; Briggs CJ, 2010, P NATL ACAD SCI USA, V107, P9695, DOI 10.1073/pnas.0912886107; Briggs CJ, 2005, ECOLOGY, V86, P3149, DOI 10.1890/04-1428; Burnham K P, 2003, MODEL SELECT MULTIMO; Bustamante HM, 2010, INTEGR ZOOL, V5, P143, DOI 10.1111/j.1749-4877.2010.00197.x; Cattadori IM, 2005, P ROY SOC B-BIOL SCI, V272, P1163, DOI 10.1098/rspb.2004.3050; Cheng AC, 2009, FISH SHELLFISH IMMUN, V26, P768, DOI 10.1016/j.fsi.2009.03.011; Doddington BJ, 2013, ECOLOGY, V94, P1795, DOI 10.1890/12-1270.1; Drew A, 2006, DIS AQUAT ORGAN, V68, P245, DOI 10.3354/dao068245; Duncan AB, 2011, P ROY SOC B-BIOL SCI, V278, P3412, DOI 10.1098/rspb.2011.0287; Fisher MC, 2009, ANNU REV MICROBIOL, V63, P291, DOI 10.1146/annurev.micro.091208.073435; Forrest MJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028444; Geiger CC, 2011, AMPHIBIA-REPTILIA, V32, P276, DOI 10.1163/017353711X556970; Gosner K. L., 1960, Herpetologica, V16, P183; Harris RN, 2009, ISME J, V3, P818, DOI 10.1038/ismej.2009.27; Hof C, 2011, NATURE, V480, P516, DOI 10.1038/nature10650; Hosseini PR, 2004, P ROY SOC B-BIOL SCI, V271, P2569, DOI 10.1098/rspb.2004.2938; Johnson ML, 2003, DIS AQUAT ORGAN, V57, P255, DOI 10.3354/dao057255; Knapp RA, 2006, COPEIA, P188, DOI 10.1643/0045-8511(2006)6[188:TMDAAA]2.0.CO;2; Knapp RA, 2011, ECOSPHERE, V2, DOI 10.1890/ES11-00028.1; Kriger KM, 2007, J ZOOL, V271, P352, DOI 10.1111/j.1469-7998.2006.00220.x; Kriger KM, 2007, DIS AQUAT ORGAN, V73, P257, DOI 10.3354/dao073257; Kriger KM, 2006, ECOHEALTH, V3, P171, DOI 10.1007/s10393-006-0027-7; Laakkonen J, 1999, PARASITOLOGY, V118, P1, DOI 10.1017/S0031182098003497; Lofgren E, 2007, J VIROL, V81, P5429, DOI 10.1128/JVI.01680-06; Longcore JE, 1999, MYCOLOGIA, V91, P219, DOI 10.2307/3761366; Longo AV, 2010, DIS AQUAT ORGAN, V92, P253, DOI 10.3354/dao02054; Murphy PJ, 2011, DIS AQUAT ORGAN, V95, P31, DOI 10.3354/dao02336; Murray KA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061061; Olson DH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056802; Ouellet M, 2005, CONSERV BIOL, V19, P1431, DOI 10.1111/j.1523-1739.2005.00108.x; Phillott AD, 2013, CONSERV BIOL, V27, P1058, DOI 10.1111/cobi.12073; Piotrowski JS, 2004, MYCOLOGIA, V96, P9, DOI 10.2307/3761981; Rachowicz LJ, 2007, J ANIM ECOL, V76, P711, DOI 10.1111/j.1365-2656.2007.01256.x; Rachowicz LJ, 2006, ECOLOGY, V87, P1671, DOI 10.1890/0012-9658(2006)87[1671:EIDAAP]2.0.CO;2; Retallick RWR, 2004, PLOS BIOL, V2, P1965, DOI 10.1371/journal.pbio.0020351; Ribas L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008408; Rowley JJL, 2007, DIS AQUAT ORGAN, V77, P1, DOI 10.3354/dao01830; Savage AE, 2011, BIOL CONSERV, V144, P1910, DOI 10.1016/j.biocon.2011.03.018; Schmeller DS, 2014, CURR BIOL, V24, P176, DOI 10.1016/j.cub.2013.11.032; Sparrow FK, 1968, FUNGI, V3; Stuart SN, 2004, SCIENCE, V306, P1783, DOI 10.1126/science.1103538; Tamerius JD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021009; Tobler U, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034667; Voordouw Maarten J., 2010, BMC Ecology, V10, P6, DOI 10.1186/1472-6785-10-6; Voyles J, 2009, SCIENCE, V326, P582, DOI 10.1126/science.1176765; Walker SF, 2010, ECOL LETT, V13, P372, DOI 10.1111/j.1461-0248.2009.01434.x; Waller PJ, 2004, VET PARASITOL, V122, P207, DOI 10.1016/j.vetpar.2004.04.007; White LJ, 2005, EPIDEMIOL INFECT, V133, P279, DOI 10.1017/S0950268804003450; Woodhams DC, 2008, ECOLOGY, V89, P1627, DOI 10.1890/06-1842.1	58	22	23	2	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0120237	10.1371/journal.pone.0120237	http://dx.doi.org/10.1371/journal.pone.0120237			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25793985	Green Published, gold			2022-12-27	WOS:000352083900001
J	Gibbins, HL; Proctor, GB; Yakubov, GE; Wilson, S; Carpenter, GH				Gibbins, Hannah L.; Proctor, Gordon B.; Yakubov, Gleb E.; Wilson, Stephen; Carpenter, Guy H.			SIgA Binding to Mucosal Surfaces Is Mediated by Mucin-Mucin Interactions	PLOS ONE			English	Article							PROLINE-RICH PROTEIN; SALIVARY; STATHERIN; PELLICLE; IDENTIFICATION; MUC5B; TRANSGLUTAMINASE; ADSORPTION; EXPRESSION; SECRETION	The oral mucosal pellicle is a layer of absorbed salivary proteins, including secretory IgA (SIgA), bound onto the surface of oral epithelial cells and is a useful model for all mucosal surfaces. The mechanism by which SIgA concentrates on mucosal surfaces is examined here using a tissue culture model with real saliva. Salivary mucins may initiate the formation of the mucosal pellicle through interactions with membrane-bound mucins on cells. Further protein interactions with mucins may then trigger binding of other pellicle proteins. HT29 colon cell lines, which when treated with methotrexate (HT29-MTX) produce a gel-forming mucin, were used to determine the importance of these mucin-mucin interactions. Binding of SIgA to cells was then compared using whole mouth saliva, parotid (mucin-free) saliva and a source of purified SIgA. Greatest SIgA binding occurred when WMS was incubated with HT29-MTX expressing mucus. Since salivary MUC5B was only able to bind to cells which produced mucus and purified SIgA showed little binding to the same cells we conclude that most SIgA binding to mucosal cells occurs because SIgA forms complexes with salivary mucins which then bind to cells expressing membrane-bound mucins. This work highlights the importance of mucin interactions in the development of the mucosal pellicle.	[Gibbins, Hannah L.; Proctor, Gordon B.; Carpenter, Guy H.] Kings Coll London, Inst Dent, Salivary Res Unit, London WC2R 2LS, England; [Yakubov, Gleb E.] Univ Queensland, Australian Res Council Ctr Excellence Plant Cell, Sch Chem Engn, Brisbane, Qld 4072, Australia; [Wilson, Stephen] Unilever R&D Discover, Sharnbrook, Beds, England	University of London; King's College London; University of Queensland; Unilever	Carpenter, GH (corresponding author), Kings Coll London, Inst Dent, Salivary Res Unit, London WC2R 2LS, England.	guy.carpenter@kcl.ac.uk	Yakubov, Gleb E/J-8817-2012	Yakubov, Gleb E/0000-0001-5420-9422; Carpenter, Guy/0000-0003-3084-3415; Proctor, Gordon/0000-0002-5684-841X	BBSRC; Unilever [BB/F01827/1]	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Unilever(Unilever)	The funding for this work was provided by a PhD Case Studentship from the BBSRC and then subsidised also by Unilever. Grant number: BB/F01827/1. URLs: http://www.bbsrc.ac.uk/home/home.aspx and http://www.unilever.co.uk/.Supervisors of the PhD student who worked/work at Unilever helped contribute to the design of the experiment, although the original idea was not from the company itself. This work was partly funded by a commercial source, Unilever, which also employs SW and previously employed GY. However, this does not alter the authors' adherence to PLOS ONE policies on sharing data and materials. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BIESBROCK AR, 1991, INFECT IMMUN, V59, P3492, DOI 10.1128/IAI.59.10.3492-3497.1991; BRADWAY SD, 1992, BIOCHEM J, V284, P557, DOI 10.1042/bj2840557; Carpenter GH, 2000, EXP PHYSIOL, V85, P281, DOI 10.1017/S0958067000019680; Carpenter GH, 2013, ANNU REV FOOD SCI T, V4, P267, DOI 10.1146/annurev-food-030212-182700; Cone RA, 2009, ADV DRUG DELIVER REV, V61, P75, DOI 10.1016/j.addr.2008.09.008; D'Agostino EM, 2012, J AGR FOOD CHEM, V60, P3318, DOI 10.1021/jf205111k; Dickinson ME, 2006, J MATER RES, V21, P1996, DOI 10.1557/JMR.2006.0248; DOUGLAS WH, 1991, BIOCHEM BIOPH RES CO, V180, P91, DOI 10.1016/S0006-291X(05)81259-8; Everest-Dass AV, 2012, GLYCOBIOLOGY, V22, P1465, DOI 10.1093/glycob/cws112; Gendler SJ, 2001, J MAMMARY GLAND BIOL, V6, P339, DOI 10.1023/A:1011379725811; Gibbins HL, 2014, ORAL DIS, V20, P707, DOI 10.1111/odi.12194; Gibbins HL, 2014, COLLOID SURFACE B, V120, P184, DOI 10.1016/j.colsurfb.2014.05.020; Iontcheva I, 2000, J DENT RES, V79, P732; LESUFFLEUR T, 1993, J CELL SCI, V106, P771; Leteurtre E, 2004, BIOL CELL, V96, P145, DOI 10.1016/j.biolcel.2003.12.005; Lindh L, 2001, BIOFOULING, V17, P227, DOI 10.1080/08927010109378482; Lindh L, 2002, COLLOID SURFACE B, V25, P139, DOI 10.1016/S0927-7765(01)00300-9; Ma JKC, 1998, NAT MED, V4, P601, DOI 10.1038/nm0598-601; Macakova L, 2010, COLLOID SURFACE B, V77, P31, DOI 10.1016/j.colsurfb.2009.12.022; McAuley JL, 2007, J CLIN INVEST, V117, P2313, DOI 10.1172/JCI26705; Nielsen PA, 1997, CANCER RES, V57, P634; Phalipon A, 2002, IMMUNITY, V17, P107, DOI 10.1016/S1074-7613(02)00341-2; Pramanik R, 2010, EUR J ORAL SCI, V118, P245, DOI 10.1111/j.1600-0722.2010.00728.x; Proctor GB, 2005, BIOCHEM J, V389, P111, DOI 10.1042/BJ20042012; Slomiany BL, 1996, GEN PHARMACOL, V27, P761, DOI 10.1016/0306-3623(95)02050-0; SLOMIANY BL, 1993, BIOCHEM MOL BIOL INT, V31, P1091; Soares RV, 2004, ARCH ORAL BIOL, V49, P337, DOI 10.1016/j.archoralbio.2003.11.007; Wickstrom C, 1998, BIOCHEM J, V334, P685, DOI 10.1042/bj3340685; Yakubov GE, 2009, LANGMUIR, V25, P2313, DOI 10.1021/la8018666; Yao Y, 2000, J DENT RES, V79, P930, DOI 10.1177/00220345000790040801	30	31	35	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0119677	10.1371/journal.pone.0119677	http://dx.doi.org/10.1371/journal.pone.0119677			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25793390	gold, Green Submitted, Green Published			2022-12-27	WOS:000352084200105
J	Li, KW; Chiu, WS				Li, Kai Way; Chiu, Wen-Sheng			Isometric Arm Strength and Subjective Rating of Upper Limb Fatigue in Two-Handed Carrying Tasks	PLOS ONE			English	Article							MUSCLE FATIGUE; MUSCULAR FATIGUE; PHYSICAL WORK; MODEL; ENDURANCE	Sustained carrying could result in muscular fatigue of the upper limb. Ten male and ten female subjects were recruited for measurements of isometric arm strength before and during carrying a load for a period of 4 minutes. Two levels of load of carrying were tested for each of the male and female subjects. Exponential function based predictive equations for the isometric arm strength were established. The mean absolute deviations of these models in predicting the isometric arm strength were in the range of 3.24 to 17.34 N. Regression analyses between the subjective ratings of upper limb fatigue and force change index (FCI) for the carrying were also performed. The results indicated that the subjective rating of muscular fatigue may be estimated by multiplying the FCI with a constant. The FCI may, therefore, be adopted as an index to assess muscular fatigue for two-handed carrying tasks.	[Li, Kai Way] Chung Hua Univ, Dept Ind Management, Hsinchu, Taiwan; [Chiu, Wen-Sheng] Chung Hua Univ, PhD Program Technol Management, Hsinchu, Taiwan	Chung Hua University; Chung Hua University	Li, KW (corresponding author), Chung Hua Univ, Dept Ind Management, Hsinchu, Taiwan.	kai@chu.edu.tw		Li, Kai Way/0000-0003-0138-183X				[Anonymous], 1989, APPL LINEAR REGRESSI; ARMSTRONG TJ, 1993, SCAND J WORK ENV HEA, V19, P73, DOI 10.5271/sjweh.1494; AYOUB MM, 1974, AM I IND ENG T, V6, P185, DOI DOI 10.1080/05695557408974953; BIGLANDRITCHIE B, 1984, MUSCLE NERVE, V7, P691, DOI 10.1002/mus.880070902; BOOTH FW, 1991, PHYSIOL REV, V71, P541, DOI 10.1152/physrev.1991.71.2.541; BORG G, 1990, SCAND J WORK ENV HEA, V16, P55, DOI 10.5271/sjweh.1815; Chaffin D. B., 1999, OCCUPATIONAL BIOMECH; CHAFFIN DB, 1975, AM IND HYG ASSOC J, V36, P505, DOI 10.1080/0002889758507283; CHAFFIN DB, 1983, HUM FACTORS, V25, P541, DOI 10.1177/001872088302500508; Dempsey PG, 1999, ERGONOMICS, V42, P183, DOI 10.1080/001401399185883; Edwards R H, 1981, Ciba Found Symp, V82, P1; Enoka RM, 2008, J PHYSIOL-LONDON, V586, P11, DOI 10.1113/jphysiol.2007.139477; Iridiastadi H, 2006, ERGONOMICS, V49, P344, DOI 10.1080/00140130500475666; Ma L, 2013, ERGONOMICS, V56, P1889, DOI 10.1080/00140139.2013.851283; Ma LA, 2011, INT J IND ERGONOM, V41, P10, DOI 10.1016/j.ergon.2010.11.005; Ma L, 2009, INT J IND ERGONOM, V39, P211, DOI 10.1016/j.ergon.2008.04.004; Mamansari DU, 1996, APPL ERGON, V27, P53, DOI 10.1016/0003-6870(95)00055-0; ROHMERT W, 1986, ERGONOMICS, V29, P1235, DOI 10.1080/00140138608967237; Roman-Liu D, 2005, ERGONOMICS, V48, P930, DOI 10.1080/00140130500182312; Roman-Liu D, 2004, J ELECTROMYOGR KINES, V14, P671, DOI 10.1016/j.jelekin.2004.04.002; Sanders MS, 1992, HUMAN FACTORS IN ENG, P248; SNOOK SH, 1978, ERGONOMICS, V21, P963, DOI 10.1080/00140137808931804; Vollestad NK, 1997, J NEUROSCI METH, V74, P219, DOI 10.1016/S0165-0270(97)02251-6; Waters TR, 2007, J OCCUP ENVIRON MED, V49, P172, DOI 10.1097/JOM.0b013e3180322559; Wood DD, 1997, HUM FACTORS, V39, P83, DOI 10.1518/001872097778940678; Zhang ZW, 2014, INT J IND ERGONOM, V44, P292, DOI 10.1016/j.ergon.2012.08.006	26	13	16	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0119550	10.1371/journal.pone.0119550	http://dx.doi.org/10.1371/journal.pone.0119550			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25794159	gold, Green Published, Green Submitted			2022-12-27	WOS:000352084200094
J	Liu, YT; Garrett, ME; Dennis, MF; Green, KT; Ashley-Koch, AE; Hauser, MA; Beckham, JC; Kimbrel, NA				Liu, Yutao; Garrett, Melanie E.; Dennis, Michelle F.; Green, Kimberly T.; Ashley-Koch, Allison E.; Hauser, Michael A.; Beckham, Jean C.; Kimbrel, Nathan A.		VA Mid-Atlantic MIRECC Registry	An Examination of the Association between 5-HTTLPR, Combat Exposure, and PTSD Diagnosis among US Veterans	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; SEROTONIN TRANSPORTER GENE; TRAUMA EXPOSURE; ENVIRONMENT INTERACTION; LIFE EVENTS; GENOTYPE; POLYMORPHISM; DEPRESSION; MODERATION; LIABILITY	Objective To examine the association between the 5-HTTLPR polymorphism of the serotonin transporter (SLC6A4) gene, combat exposure, and posttraumatic stress disorder (PTSD) diagnosis and among two samples of combat-exposed veterans. Method The first sample included 550 non-Hispanic Black (NHB) combat-exposed veterans. The second sample included 555 non-Hispanic White (NHW) combat-exposed veterans. Participants were genotyped for the 5-HTTLPR/rs25531 variants of the SLC6A4 gene. A structured clinical interview was used to diagnose PTSD. Combat and civilian trauma exposure were assessed with validated self-report instruments. Logistic regression was used to test for main effects of 5-HTTLPR on PTSD diagnosis as well as gene x environment (GxE) interactions after adjusting for sex, ancestry proportion scores, civilian trauma exposure, and combat exposure. Results Within the NHB sample, a significant additive effect was observed for 5-HTTLPR (OR = 1.502, p = .0025), such that the odds of having a current diagnosis of PTSD increased by 1.502 for each additional S' allele. No evidence for an association between 5-HTTLPR and PTSD was observed in the NHW sample. In addition, no evidence for combat x 5-HTTLPR effects were observed in either sample. Conclusion The present study suggests that there may be an association between 5-HTTLPR genotype and PTSD diagnosis among NHB veterans; however, no evidence for the hypothesized 5-HTTLPR x combat interaction was found.	[Liu, Yutao] Georgia Regents Univ, Dept Cellular Biol & Anat, Augusta, GA USA; [Garrett, Melanie E.; Ashley-Koch, Allison E.; Hauser, Michael A.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; [Dennis, Michelle F.; Beckham, Jean C.; Kimbrel, Nathan A.] Durham Vet Affairs Med Ctr, Durham, NC 27705 USA; [Dennis, Michelle F.; Beckham, Jean C.; Kimbrel, Nathan A.; VA Mid-Atlantic MIRECC Registry] VA Midatlantic Mental Illness Res Educ & Clin Ctr, Durham, NC USA; [Dennis, Michelle F.; Green, Kimberly T.; Beckham, Jean C.; Kimbrel, Nathan A.] Duke Univ, Med Ctr, Dept Psychiat & Behav Sci, Durham, NC USA	University System of Georgia; Augusta University; Duke University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Durham VA Medical Center; Duke University	Kimbrel, NA (corresponding author), Durham Vet Affairs Med Ctr, Durham, NC 27705 USA.	Nathan.Kimbrel@va.gov	Kimbrel, Nathan/P-3109-2016	Kimbrel, Nathan/0000-0001-7218-1005; Ashley-Koch, Allison/0000-0001-5409-9155	Career Development Award [IK2 CX000525]; Research Career Scientist Award from the Clinical Science Research and Development Service of the VA Office of Research and Development; NATIONAL CANCER INSTITUTE [R01CA081595] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH062482] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K24DA016388] Funding Source: NIH RePORTER; Veterans Affairs [IK2CX000525] Funding Source: NIH RePORTER	Career Development Award; Research Career Scientist Award from the Clinical Science Research and Development Service of the VA Office of Research and Development; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Veterans Affairs(US Department of Veterans Affairs)	This research was supported by the facilities and resources of the Department of Veterans Affairs (VA) Mid-Atlantic Mental Illness Research, Education, and Clinical Center, the Research & Development and Mental Health Services of the Durham VA Medical Center, and the Clinical Science Research and Development Service of the VA Office of Research and Development, and NIMH 2R01MH062482, NCI 2R01CA81595, and NIDA 2K24DA016388. In addition, NAK was supported by a Career Development Award (IK2 CX000525) and JCB was supported by Research Career Scientist Award from the Clinical Science Research and Development Service of the VA Office of Research and Development. The views expressed in this article are those of the authors and do not necessarily reflect the position or policy of the Department of Veterans Affairs, the National Institutes of Health, or the United States government. The above funding agencies played no role in study design, data collection analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 1994, DIAGN STAT MAN MENT; BLAKE DD, 1995, J TRAUMA STRESS, V8, P75, DOI 10.1007/BF02105408; Caspi A, 2003, SCIENCE, V301, P386, DOI 10.1126/science.1083968; Cerda M, 2010, J AFFECT DISORDERS, V126, P14, DOI 10.1016/j.jad.2009.11.006; Clancy CP, 2006, J CLIN PSYCHIAT, V67, P1346, DOI 10.4088/JCP.v67n0904; Davidson JRT, 1997, PSYCHOL MED, V27, P153, DOI 10.1017/S0033291796004229; Duncan LE, 2011, AM J PSYCHIAT, V168, P1041, DOI 10.1176/appi.ajp.2011.11020191; Gibbon M., 1994, STRUCTURAL CLIN INTE, Vsecond; Grabe HJ, 2009, AM J PSYCHIAT, V166, P926, DOI 10.1176/appi.ajp.2009.08101542; Gressier F, 2013, J TRAUMA STRESS, V26, P645, DOI 10.1002/jts.21855; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Hu XZ, 2006, AM J HUM GENET, V78, P815, DOI 10.1086/503850; Keane T.M., 1989, PSYCHOL ASSESSMENT J, V1, P53, DOI [10.1037/1040-3590.1.1.53, DOI 10.1037/1040-3590.1.1.53]; Kilpatrick DG, 2007, AM J PSYCHIAT, V164, P1693, DOI 10.1176/appi.ajp.2007.06122007; Kimbrel NA, DEPRESSION AND ANXIE; Koenen KC, 2009, AM J EPIDEMIOL, V169, P704, DOI 10.1093/aje/kwn397; Kolassa IT, 2010, J CLIN PSYCHIAT, V71, P543, DOI 10.4088/JCP.08m04787blu; Kremen WS, 2012, NEUROPHARMACOLOGY, V62, P647, DOI 10.1016/j.neuropharm.2011.03.012; Kubany ES, 2000, PSYCHOL ASSESSMENT, V12, P210, DOI 10.1037//1040-3590.12.2.210; Lapierre CB, 2007, J TRAUMA STRESS, V20, P933, DOI 10.1002/jts.20278; Lesch KP, 1996, SCIENCE, V274, P1527, DOI 10.1126/science.274.5292.1527; Lotrich Francis E, 2003, Am J Pharmacogenomics, V3, P145, DOI 10.2165/00129785-200303020-00007; Lyons MJ, 2013, AM J MED GENET B, V162, P762, DOI 10.1002/ajmg.b.32154; LYONS MJ, 1993, AM J MED GENET, V48, P22, DOI 10.1002/ajmg.1320480107; Mellman TA, 2009, DEPRESS ANXIETY, V26, P993, DOI 10.1002/da.20627; Moffitt TE, 2005, ARCH GEN PSYCHIAT, V62, P473, DOI 10.1001/archpsyc.62.5.473; Navarro-Mateu F, 2013, PLOS ONE, pe6627; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; RAMAMOORTHY S, 1993, P NATL ACAD SCI USA, V90, P2542, DOI 10.1073/pnas.90.6.2542; Ravindran LN, 2010, CURR TOP BEHAV NEURO, V2, P505, DOI 10.1007/7854_2009_15; Smits KM, 2008, PSYCHIAT GENET, V18, P184, DOI 10.1097/YPG.0b013e3283050aca; Stein MB, 2002, AM J PSYCHIAT, V159, P1675, DOI 10.1176/appi.ajp.159.10.1675; Strug LJ, 2010, MOL PSYCHIATR, V15, P166, DOI 10.1038/mp.2008.79; TRUE WR, 1993, ARCH GEN PSYCHIAT, V50, P257, DOI 10.1001/archpsyc.1993.01820160019002; Wang ZW, 2011, DEPRESS ANXIETY, V28, P1067, DOI 10.1002/da.20872; Wolf EJ, 2014, PSYCHOL MED, V44, P1499, DOI 10.1017/S0033291713002286; Xie PX, 2012, AM J MED GENET B, V159B, P644, DOI 10.1002/ajmg.b.32068; Xie PX, 2009, ARCH GEN PSYCHIAT, V66, P1201, DOI 10.1001/archgenpsychiatry.2009.153	38	17	17	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0119998	10.1371/journal.pone.0119998	http://dx.doi.org/10.1371/journal.pone.0119998			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25793742	Green Published, Green Submitted, gold			2022-12-27	WOS:000352084200135
J	Vagnini, LD; Renzi, A; Oliveira-Pelegrin, GR; Canas, MDT; Petersen, CG; Mauri, AL; Oliveira, JBA; Baruffi, RLR; Cavagna, M; Franco, JG				Vagnini, Laura Diniz; Renzi, Adriana; Oliveira-Pelegrin, Gabriela Ravanelli; Tomitao Canas, Maria do Carmo; Petersen, Claudia Guilhermino; Mauri, Ana Lucia; Alcantara Oliveira, Joao Batista; Razera Baruffi, Ricardo Luiz; Cavagna, Mario; Franco Junior, Jose Goncalves			The TP73 Gene Polymorphism (rs4648551, A > G) Is Associated with Diminished Ovarian Reserve	PLOS ONE			English	Article							PREDICTION INDEX ORPI; P53; REPRODUCTION; STIMULATION; FERTILITY; TAP73	It's known that the members of the TP53 family are involved in the regulation of female reproduction. Studies in mice showed that the TP73 gene (member of this family) plays a role in the size of follicular pool, ovulation rate and maintenance of genomic stability. In the present study we analyzed data from 605 patients with <= 37 years attending their first intracytoplasmic sperm injection (ICSI). The association between the TP73 polymorphism (rs4648551, A>G) and the following parameters related to ovarian reserve, like age, antral follicular count (AFC), anti-Mullerian hormone levels (AMH) and ovarian response prediction index (ORPI) was evaluated. Our results showed an association of the AA genotype with diminished ovarian reserve (AMH <1, AFC <= 9). Women presenting the AA genotype had a 2.0-fold increased risk for having AMH <1 and AFC <= 9 (OR 2.0, 95% CI 1.23-3.31, P = 0.005). Patients presenting AA genotype had the lowest levels of AMH (P = 0.02), the lowest number of antral follicles (P = 0.01) and the lowest ORPI (P = 0.007). Analyzing the alleles, we can see an enrichment of the A allele in the group of diminished ovarian reserve (OR 1.4, 95% CI 1.02-1.83, P = 0.04). To the best of our knowledge, the present study is the first to analyze this polymorphism in humans for assessing the numbers of ovarian follicles and AMH levels and, therefore, the ovarian reserve. Our findings can contribute to the use of this polymorphism as a potential marker of diminished ovarian reserve.	[Vagnini, Laura Diniz; Renzi, Adriana; Oliveira-Pelegrin, Gabriela Ravanelli; Tomitao Canas, Maria do Carmo] Paulista Ctr Diag Res & Training, Sao Paulo, Brazil; [Petersen, Claudia Guilhermino; Mauri, Ana Lucia; Alcantara Oliveira, Joao Batista; Razera Baruffi, Ricardo Luiz; Cavagna, Mario; Franco Junior, Jose Goncalves] Ctr Human Reprod Prof Franco Jr, Sao Paulo, Brazil		Franco, JG (corresponding author), Ctr Human Reprod Prof Franco Jr, Sao Paulo, Brazil.	franco@crh.com.br	Oliveira, Joao Batista A/E-3132-2015; Renzi, Adriana/M-9287-2019; Petersen, Claudia/AAS-5581-2020; Vagnini, Laura Diniz/N-3726-2019; Luchesi, Ana/N-9378-2019; Oliveira, João/GXN-3304-2022; Franco, José Gonçalves/G-3381-2019; Petersen, Claudia/N-9391-2019	Oliveira, Joao Batista A/0000-0003-4670-6650; Renzi, Adriana/0000-0002-8052-8125; Vagnini, Laura Diniz/0000-0001-5225-0608; Luchesi, Ana/0000-0002-9064-9430; Franco, José Gonçalves/0000-0001-5082-0240; 	Merck Serono grant [GFI-2014-16]	Merck Serono grant	This research was supported by Merck Serono grant (GFI-2014-16). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altmae S, 2011, HUM REPROD UPDATE, V17, P813, DOI 10.1093/humupd/dmr034; Bhattacharya S, 2010, CLIN EVID, V2010; Boudjenah R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038700; Dotsch V, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a004887; Feng ZH, 2011, FASEB J, V25, P2245, DOI 10.1096/fj.10-180166; Hardarson T, 2001, HUM REPROD, V16, P313, DOI 10.1093/humrep/16.2.313; Hu WW, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001073; Kang HJ, 2009, P NATL ACAD SCI USA, V106, P9761, DOI 10.1073/pnas.0904280106; Kohler HP, 2006, INT J ANDROL, V29, P46, DOI 10.1111/j.1365-2605.2005.00606.x; Kosova G, 2010, P NATL ACAD SCI USA, V107, P1772, DOI 10.1073/pnas.0906196106; La Marca A, 2010, HUM REPROD UPDATE, V16, P113, DOI 10.1093/humupd/dmp036; Levine AJ, 2011, NAT REV MOL CELL BIO, V12, P259, DOI 10.1038/nrm3086; Muller M, 2005, CELL DEATH DIFFER, V12, P1564, DOI 10.1038/sj.cdd.4401774; Nardo LG, 2009, FERTIL STERIL, V92, P1586, DOI 10.1016/j.fertnstert.2008.08.127; Nelson SM, 2013, FERTIL STERIL, V99, P963, DOI 10.1016/j.fertnstert.2012.11.051; Oliveira JBA, 2013, FERTIL STERIL, V100, pS275, DOI 10.1016/j.fertnstert.2013.07.1145; Oliveira JBA, 2012, REPROD BIOL ENDOCRIN, V10, DOI 10.1186/1477-7827-10-94; Simoni M, 2014, EUR J ENDOCRINOL, V170, pR91, DOI 10.1530/EJE-13-0624; Stehmeier P, 2009, DNA REPAIR, V8, P491, DOI 10.1016/j.dnarep.2009.01.002; Steuerwald NM, 2007, REPROD BIOMED ONLINE, V14, P700, DOI 10.1016/S1472-6483(10)60671-2; Tomasini R, 2008, GENE DEV, V22, P2677, DOI 10.1101/gad.1695308; Wang JL, 2007, J BIOL CHEM, V282, P29152, DOI 10.1074/jbc.M703408200; Yang A, 2000, NATURE, V404, P99, DOI 10.1038/35003607	23	5	6	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0120048	10.1371/journal.pone.0120048	http://dx.doi.org/10.1371/journal.pone.0120048			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25794170	Green Published, Green Submitted, gold			2022-12-27	WOS:000352084200139
J	Wang, JT; Wu, UI; Lauderdale, TLY; Chen, MC; Li, SY; Hsu, LY; Chang, SC				Wang, Jann-Tay; Wu, Un-In; Lauderdale, Tsai-Ling Yang; Chen, Mei-Chen; Li, Shu-Ying; Hsu, Le-Yin; Chang, Shan-Chwen			Carbapenem-Nonsusceptible Enterobacteriaceae in Taiwan	PLOS ONE			English	Article							METALLO-BETA-LACTAMASE; SUSCEPTIBLE ESCHERICHIA-COLI; KLEBSIELLA-PNEUMONIAE; EXTENDED-SPECTRUM; 1ST IDENTIFICATION; MULTIPLEX PCR; RESISTANCE; ERTAPENEM; CLOACAE; GENES	A total of 1135 carbapenem-resistant (nonsusceptible) Enterobacteriaceae (CRE) isolates were recovered between November 2010 and July 2012 (517 from 2010-2011 and 618 from 2012) from 4 hospitals in Taiwan. Carbapenemase-producing Enterobacteriaceae (CPE) comprised 5.0% (57 isolates), including 17 KPC-2 (16 Klebsiella pneumoniae and 1 Escherichia coli), 1 NDM-1 (K. oxytoca), 37 IMP-8 (26 Enterobacter cloacae, 4 Citrobacter freundii, 4 Raoultella planticola, 1 K. pneumoniae, 1 E. coli and 1 K. oxytoca), and 2 VIM-1 (1 E. cloacae, 1 E. coli). The KPC-2-positive K. pneumoniae were highly clonal even in isolates from different hospitals, and all were ST11. IMP-8 positive E. cloacae from the same hospitals showed higher similarity in PFGE pattern than those from different hospitals. A total of 518 CRE isolates (45.6%) were positive for bla(ESBL), while 704 (62.0%) isolates were bla(AmpC)-positive, 382 (33.6% overall) of which carried both bla(ESBL) and bla(AmpC). CTX-M (414, 80.0%) was the most common bla(ESBL), while DHA (497, 70.6%) and CMY (157, 22.3%) were the most common bla(AmpC). Co-carriage of bla(ESBL) and bla(AmpC) was detected in 31 (54.4%) and 15 (26.3%) of the 57 CPE, respectively. KPC-2 was the most common carbapenemase detected in K. pneumoniae (2.8%), while IMP-8 was the most common in E. cloacae (9.7%). All KPC-2-positive CRE were resistant to all three tested carbapenems. However, fourteen of the 37 IMP-8-positive CRE were susceptible to both imipenem and meropenem in vitro. Intra-and inter-hospital spread of KPC-2-producing K. pneumoniae and IMP-8-producing E. cloacae likely occurred. Although the prevalence of CPE is still low, careful monitoring is urgently needed. Non-susceptibility to ertapenem might need to be considered as one criterion of definition for CRE in areas where IMP type carbapenemase is prevalent.	[Wang, Jann-Tay; Chang, Shan-Chwen] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan; [Wu, Un-In] Natl Taiwan Univ Hosp, Dept Med Res, Taipei, Taiwan; [Lauderdale, Tsai-Ling Yang; Chen, Mei-Chen] Natl Hlth Res Inst, Natl Inst Infect Dis & Vaccinol, Zhunan, Taiwan; [Li, Shu-Ying] Ctr Dis Control, Taipei, Taiwan; [Hsu, Le-Yin] Natl Taiwan Univ, Coll Publ Hlth, Grad Inst Epidemiol & Prevent Med, Taipei 10764, Taiwan; [Chang, Shan-Chwen] Natl Taiwan Univ, Grad Inst Clin Pharm, Coll Med, Taipei 10764, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Health Research Institutes - Taiwan; Centers For Disease Control - Taiwan; National Taiwan University; National Taiwan University	Chang, SC (corresponding author), Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan.	changsc@ntu.edu.tw	Lauderdale, Tsai-Ling/B-2660-2010	CHANG, SHAN-CHWEN/0000-0001-6505-4139; WANG, JANN-TAY/0000-0002-0924-3469; WU, UN-IN/0000-0001-8182-6071	National Science Council, Taiwan [NSC 100-2321-B-002-021]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	Funding: This study was supported by a grant from the National Science Council, Taiwan (NSC 100-2321-B-002-021). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, PERF STAND ANT SUSC; Bonomo RA, 2011, CLIN INFECT DIS, V52, P485, DOI 10.1093/cid/ciq179; Bush K, 2010, CURR OPIN MICROBIOL, V13, P558, DOI 10.1016/j.mib.2010.09.006; Canton R, 2012, CLIN MICROBIOL INFEC, V18, P413, DOI 10.1111/j.1469-0691.2012.03821.x; Carattoli A, 2005, J MICROBIOL METH, V63, P219, DOI 10.1016/j.mimet.2005.03.018; Centers for Disease Control and Prevention (CDC), 2012, GUIDANCE FOR CONTROL; Chiu SK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069428; Chung KP, 2011, J ANTIMICROB CHEMOTH, V66, P1182, DOI 10.1093/jac/dkr025; Clinical and Laboratory Standards Institute (CLSI), 2009, METH DIL ANT SUSC TE, DOI [10.1016/j.diagmicrobio.2013.01.001, DOI 10.1016/J.DIAGMICROBIO.2013.01.001]; CLSI, 2012, PERF STAND ANT SUSC; Cornaglia G., 2011, Lancet Infectious Diseases, V11, P381, DOI 10.1016/S1473-3099(11)70056-1; Diancourt L, 2005, J CLIN MICROBIOL, V43, P4178, DOI 10.1128/JCM.43.8.4178-4182.2005; Doumith M, 2009, J ANTIMICROB CHEMOTH, V63, P659, DOI 10.1093/jac/dkp029; Endimiani A, 2010, J CLIN MICROBIOL, V48, P4417, DOI 10.1128/JCM.02458-09; EUCAST, 2014, BREAKP TABL INT MICS; Hawkey PM, 2009, J ANTIMICROB CHEMOTH, V64, P3, DOI 10.1093/jac/dkp256; Hayakawa K, 2014, ANTIMICROB AGENTS CH, V58, P3441, DOI 10.1128/AAC.02652-13; Hu AY, 2012, J MED MICROBIOL, V61, P1488, DOI 10.1099/jmm.0.041129-0; Huang TW, 2013, ANTIMICROB AGENTS CH, V57, P4072, DOI 10.1128/AAC.02266-12; Kumarasamy KK, 2010, LANCET INFECT DIS, V10, P597, DOI 10.1016/S1473-3099(10)70143-2; Lee CH, 2010, ANTIMICROB AGENTS CH, V54, P5395, DOI 10.1128/AAC.00083-10; Lee CM, 2012, ANTIMICROB AGENTS CH, V56, P5016, DOI 10.1128/AAC.00878-12; Leggiadro RJ, 1997, INFECT DIS CLIN N AM, V11, P875, DOI 10.1016/S0891-5520(05)70395-0; Liao Chun-Hsing, 2006, Journal of Microbiology Immunology and Infection, V39, P59; Liu YF, 2008, J ANTIMICROB CHEMOTH, V61, P1020, DOI 10.1093/jac/dkn049; Livermore DM, 2008, J ANTIMICROB CHEMOTH, V62, pII41, DOI [10.1093/jac/dkn371, 10.1093/jac/dkn351]; Livermore DM, 2011, INT J ANTIMICROB AG, V37, P415, DOI 10.1016/j.ijantimicag.2011.01.012; Livermore DM, 2009, J ANTIMICROB CHEMOTH, V64, P29, DOI 10.1093/jac/dkp255; Ma L, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-599; Ma L, 2013, J MED MICROBIOL, V62, P101, DOI 10.1099/jmm.0.050492-0; Monstein HJ, 2007, APMIS, V115, P1400, DOI 10.1111/j.1600-0463.2007.00722.x; O'Brien TF, 2011, CLIN MICROBIOL REV, V24, P281, DOI 10.1128/CMR.00021-10; Olson DS, 2013, INFECTION, V41, P259, DOI 10.1007/s15010-012-0294-x; Paterson DL, 2006, AM J MED, V119, pS20, DOI 10.1016/j.amjmed.2006.03.013; Perez-Perez FJ, 2002, J CLIN MICROBIOL, V40, P2153, DOI 10.1128/JCM.40.6.2153-2162.2002; Pfeifer Y, 2010, INT J MED MICROBIOL, V300, P371, DOI 10.1016/j.ijmm.2010.04.005; Poirel L, 2007, FUTURE MICROBIOL, V2, P501, DOI 10.2217/17460913.2.5.501; Queenan AM, 2007, CLIN MICROBIOL REV, V20, P440, DOI 10.1128/CMR.00001-07; Sheng WH, 2013, ANTIMICROB AGENTS CH, V57, P2981, DOI 10.1128/AAC.00971-12; Szabo D, 2006, ANTIMICROB AGENTS CH, V50, P2833, DOI 10.1128/AAC.01591-05; Teo I, 2012, CASE REP MED, V2012, DOI 10.1155/2012/601641; Trevino M, 2009, EUR J CLIN MICROBIOL, V28, P1253, DOI 10.1007/s10096-009-0765-x; Tzouvelekis LS, 2012, CLIN MICROBIOL REV, V25, P682, DOI 10.1128/CMR.05035-11; Vaneechoutte M, 2011, MANUAL CLIN MICROBIO, P539; Woodford N, 2006, J ANTIMICROB CHEMOTH, V57, P154, DOI 10.1093/jac/dki412; Yan JJ, 2010, EUR J CLIN MICROBIOL, V29, P1417, DOI 10.1007/s10096-010-1020-1; Yan JJ, 2002, J ANTIMICROB CHEMOTH, V50, P503, DOI 10.1093/jac/dkf170; Yang FC, 2012, J CLIN MICROBIOL, V50, P223, DOI 10.1128/JCM.01263-11; Yang K, 2007, ANN PHARMACOTHER, V41, P1427, DOI 10.1345/aph.1K213	49	76	84	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0121668	10.1371/journal.pone.0121668	http://dx.doi.org/10.1371/journal.pone.0121668			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25794144	Green Submitted, Green Published, gold			2022-12-27	WOS:000352083900145
J	Xue, C; Ge, Y; Tang, BH; Liu, Y; Kang, P; Wang, M; Zhang, LL				Xue, Chen; Ge, Yang; Tang, Bihan; Liu, Yuan; Kang, Peng; Wang, Meng; Zhang, Lulu			A Meta-Analysis of Risk Factors for Combat-Related PTSD among Military Personnel and Veterans	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; UK ARMED-FORCES; MENTAL-HEALTH; GENDER-DIFFERENCES; VIETNAM VETERANS; SEX-DIFFERENCES; NEW-ONSET; IRAQ WAR; GULF-WAR; DEPLOYMENT	Post-traumatic stress disorder (PTSD), a complex and chronic disorder caused by exposure to a traumatic event, is a common psychological result of current military operations. It causes substantial distress and interferes with personal and social functioning. Consequently, identifying the risk factors that make military personnel and veterans more likely to experience PTSD is of academic, clinical, and social importance. Four electronic databases (PubMed, Embase, Web of Science, and PsycINFO) were used to search for observational studies (cross-sectional, retrospective, and cohort studies) about PTSD after deployment to combat areas. The literature search, study selection, and data extraction were conducted by two of the authors independently. Thirty-two articles were included in this study. Summary estimates were obtained using random-effects models. Subgroup analyses, sensitivity analyses, and publication bias tests were performed. The prevalence of combat-related PTSD ranged from 1.09% to 34.84%. A total of 18 significant predictors of PTSD among military personnel and veterans were found. Risk factors stemming from before the trauma include female gender, ethnic minority status, low education, non-officer ranks, army service, combat specialization, high numbers of deployments, longer cumulative length of deployments, more adverse life events, prior trauma exposure, and prior psychological problems. Various aspects of the trauma period also constituted risk factors. These include increased combat exposure, discharging a weapon, witnessing someone being wounded or killed, severe trauma, and deployment-related stressors. Lastly, lack of post-deployment support during the post-trauma period also increased the risk of PTSD. The current analysis provides evidence of risk factors for combat-related PTSD in military personnel and veterans. More research is needed to determine how these variables interact and how to best protect against susceptibility to PTSD.	[Xue, Chen; Ge, Yang; Tang, Bihan; Liu, Yuan; Kang, Peng; Zhang, Lulu] Second Mil Med Univ, Inst Mil Hlth Management, Shanghai, Peoples R China; [Wang, Meng] Second Mil Med Univ, Fac Hlth Serv, Shanghai, Peoples R China	Naval Medical University; Naval Medical University	Zhang, LL (corresponding author), Second Mil Med Univ, Inst Mil Hlth Management, Shanghai, Peoples R China.	zllsmmu@126.com			National Natural Science Foundation of China [91224005, 71103194]; Major Project of the "12th Five-Year Plan" of People's Liberation Army [AWS12J002]; Key Joint project of "Major diseases" of Shanghai health system [2013ZYJB0006]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major Project of the "12th Five-Year Plan" of People's Liberation Army; Key Joint project of "Major diseases" of Shanghai health system	Work on this manuscript was supported by the National Natural Science Foundation of China (LZ, grant number 91224005, and YL, grant number 71103194); the Major Project of the "12th Five-Year Plan" of People's Liberation Army (LZ, grant number AWS12J002); and Key Joint project of "Major diseases" of Shanghai health system (LZ, grant number 2013ZYJB0006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler AB, 2005, J OCCUP HEALTH PSYCH, V10, P121, DOI 10.1037/1076-8998.10.2.121; American Psychiatric Association, 1994, DIAGN STAT MAN MENT; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Barrett DH, 2002, PSYCHOSOMATICS, V43, P195, DOI 10.1176/appi.psy.43.3.195; Beckham JC, 1996, ADDICT BEHAV, V21, P93, DOI 10.1016/0306-4603(95)00038-0; Begic D, 2001, MIL MED, V166, P671, DOI 10.1093/milmed/166.8.671; Booth-Kewley S, 2010, J TRAUMA STRESS, V23, P69, DOI 10.1002/jts.20485; BREMNER JD, 1995, AM J PSYCHIAT, V152, P973; BREMNER JD, 1993, AM J PSYCHIAT, V150, P235; Breslau N, 2002, CAN J PSYCHIAT, V47, P923, DOI 10.1177/070674370204701003; Breslau N, 1997, ARCH GEN PSYCHIAT, V54, P1044; Brewin CR, 2000, J CONSULT CLIN PSYCH, V68, P748, DOI 10.1037/0022-006X.68.5.748; CARROLL EM, 1985, J ABNORM PSYCHOL, V94, P329, DOI 10.1037/0021-843X.94.3.329; Carter-Visscher R, 2010, J TRAUMA STRESS, V23, P78, DOI 10.1002/jts.20481; Celiac Disease, EV REP TECHN ASS NAD; Cohen SI, 2013, WORK, V44, P213, DOI 10.3233/WOR-2012-1417; DAVIDSON JRT, 1991, PSYCHOL MED, V21, P713, DOI 10.1017/S0033291700022352; Dohrenwend BP, 2008, J TRAUMA STRESS, V21, P133, DOI 10.1002/jts.20327; Dohrenwend BP, 2007, J TRAUMA STRESS, V20, P449, DOI 10.1002/jts.20296; Du Preez J, 2012, OCCUP MED-OXFORD, V62, P47, DOI 10.1093/occmed/kqr151; Fontana A, 1997, AM J PUBLIC HEALTH, V87, P169, DOI 10.2105/AJPH.87.2.169; Foy DW, 1996, J SCH PSYCHOL, V34; Gelpin E, 1996, J CLIN PSYCHIAT, V57, P390; Goldmann E, 2012, ANN EPIDEMIOL, V22, P71, DOI 10.1016/j.annepidem.2011.11.003; Harbertson J, 2013, TROP MED INT HEALTH, V18, P925, DOI 10.1111/tmi.12129; Hofmann M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079809; Hoge CW, 2007, AM J PSYCHIAT, V164, P150, DOI 10.1176/appi.ajp.164.1.150; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Hoge CW, 2002, AM J PSYCHIAT, V159, P1576, DOI 10.1176/appi.ajp.159.9.1576; Iversen AC, 2008, PSYCHOL MED, V38, P511, DOI 10.1017/S0033291708002778; Iversen AC, 2009, BMC PSYCHIATRY, V9, DOI 10.1186/1471-244X-9-68; Jones M, 2013, PSYCHOL MED, V43, P1703, DOI 10.1017/S0033291712002619; Jones M, 2006, OCCUP MED-OXFORD, V56, P322, DOI 10.1093/occmed/kql023; KAYLOR JA, 1987, PSYCHOL BULL, V102, P257, DOI 10.1037/0033-2909.102.2.257; KING DW, 1995, J ABNORM PSYCHOL, V104, P184, DOI 10.1037/0021-843X.104.1.184; Kline A, 2013, PSYCHIATRY, V76, P256, DOI 10.1521/psyc.2013.76.3.256; Koenen KC, 2003, J CONSULT CLIN PSYCH, V71, P980, DOI 10.1037/0022-006X.71.6.980; Koenen KC, 2002, J NERV MENT DIS, V190, P209, DOI 10.1097/00005053-200204000-00001; LeardMann CA, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-437; LeardMann CA, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b1273; Li X.Y., 1999, CHIN J CLIN PSYCHOL, V7, P125; Luxton DD, 2010, DEPRESS ANXIETY, V27, P1027, DOI 10.1002/da.20730; Macera CA, 2014, J WOMENS HEALTH, V23, P499, DOI 10.1089/jwh.2013.4302; MacGregor AJ, 2013, INJURY, V44, P1458, DOI 10.1016/j.injury.2012.10.009; MacGregor AJ, 2012, AM J PUBLIC HEALTH, V102, pS55, DOI 10.2105/AJPH.2011.300341; Maguen S, 2012, J WOMENS HEALTH, V21, P666, DOI 10.1089/jwh.2011.3113; Manning L., 2008, WOMEN MILITARY THEY; MASON JW, 1986, J NERV MENT DIS, V174, P145, DOI 10.1097/00005053-198603000-00003; Mayo JA, 2013, MIL MED, V178, P945, DOI 10.7205/MILMED-D-12-00527; MCCARREN M, 1995, J TRAUMA STRESS, V8, P111, DOI 10.1007/BF02105410; Meiser-Stedman R, 2002, CLIN CHILD FAM PSYCH, V5, P217, DOI 10.1023/A:1020982122107; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; O'Toole BI, 1998, AUST NZ J PSYCHIAT, V32, P21, DOI 10.3109/00048679809062702; O'Toole BI, 1998, AUST NZ J PSYCHIAT, V32, P32, DOI 10.3109/00048679809062703; Ozer EJ, 2003, PSYCHOL BULL, V129, P52, DOI 10.1037//0033-2909.129.1.52; Pfefferbaum B, 1997, J AM ACAD CHILD PSY, V36, P1503, DOI 10.1016/S0890-8567(09)66558-8; Phillips CJ, 2010, BMC PSYCHIATRY, V10, DOI 10.1186/1471-244X-10-52; Pine DS, 2002, BIOL PSYCHIAT, V51, P519, DOI 10.1016/S0006-3223(01)01352-X; Polusny MA, 2011, PSYCHOL MED, V41, P687, DOI 10.1017/S0033291710002047; Riviere LA, 2011, BRIT J PSYCHIAT, V198, P136, DOI 10.1192/bjp.bp.110.084863; Rona RJ, 2007, BRIT MED J, V335, P603, DOI 10.1136/bmj.39274.585752.BE; Rona RJ, 2012, J PSYCHIATR RES, V46, P1191, DOI 10.1016/j.jpsychires.2012.05.009; RUBONIS AV, 1991, PSYCHOL BULL, V109, P384, DOI 10.1037/0033-2909.109.3.384; Ryder SJ, 2000, J COMP PATHOL, V122, P131, DOI 10.1053/jcpa.1999.0349; Salmon K, 2002, CLIN PSYCHOL REV, V22, P163, DOI 10.1016/S0272-7358(01)00086-1; Sandweiss DA, 2011, ARCH GEN PSYCHIAT, V68, P496, DOI 10.1001/archgenpsychiatry.2011.44; Shalev Arieh Y., 1996, P77; Shea MT, 2013, PSYCHIAT RES, V210, P1042, DOI 10.1016/j.psychres.2013.08.039; Simon RW, 2002, AM J SOCIOL, V107, P1065, DOI 10.1086/339225; Smith TC, 2008, BMJ-BRIT MED J, V336, P366, DOI 10.1136/bmj.39430.638241.AE; Stander VA, 2014, CLIN PSYCHOL REV, V34, P87, DOI 10.1016/j.cpr.2013.12.002; Street AE, 2009, CLIN PSYCHOL REV, V29, P685, DOI 10.1016/j.cpr.2009.08.007; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Taylor S, 1998, AUSTRALASIAN EPIDEMI, V5, P14; Tolin DF, 2006, PSYCHOL BULL, V132, P959, DOI 10.1037/0033-2909.132.6.959; Trickey D, 2012, CLIN PSYCHOL REV, V32, P122, DOI 10.1016/j.cpr.2011.12.001; van Liempt S, 2013, DEPRESS ANXIETY, V30, P469, DOI 10.1002/da.22054; Vogt Dawne S, 2005, J Trauma Stress, V18, P272; WEAVER TL, 1995, CLIN PSYCHOL REV, V15, P115, DOI 10.1016/0272-7358(95)00004-9; Wells TS, 2012, J TRAUMA STRESS, V25, P17, DOI 10.1002/jts.21657; Wolfe Jessica, 1997, P192; Wong CM, 2002, PSYCHIAT CLIN N AM, V25, P369, DOI 10.1016/S0193-953X(01)00006-5; Wright BK, 2013, J TRAUMA STRESS, V26, P310, DOI 10.1002/jts.21809; Yehuda R., 1999, RISK FACTORS POSTTRA; Zhang Z, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0029651, 10.1371/journal.pone.0046449, 10.1371/journal.pone.0030551]; Zhou XB, 2013, SOC PSYCH PSYCH EPID, V48, P907, DOI 10.1007/s00127-012-0596-4; Zohar J, 2009, J CLIN PSYCHIAT, V70, P1629, DOI 10.4088/JCP.08m04378blu	87	252	255	3	73	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0120270	10.1371/journal.pone.0120270	http://dx.doi.org/10.1371/journal.pone.0120270			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CE8HY	25793582	Green Published, Green Submitted, gold			2022-12-27	WOS:000352083900006
J	Yamanobe, Y; Nagahara, N; Matsukawa, T; Ito, T; Niimori-Kita, K; Chiba, M; Yokoyama, K; Takizawa, T				Yamanobe, Yoshiharu; Nagahara, Noriyuki; Matsukawa, Takehisa; Ito, Takaaki; Niimori-Kita, Kanako; Chiba, Momoko; Yokoyama, Kazuhito; Takizawa, Toshihiro			Sex Differences in Shotgun Proteome Analyses for Chronic Oral Intake of Cadmium in Mice	PLOS ONE			English	Article							SARCOSINE OXIDASE; EPITHELIAL-CELLS; UP-REGULATION; METALLOTHIONEIN; TOXICITY; RAT; KIDNEY; PURIFICATION; ADAPTATION; MECHANISMS	Environmental diseases related to cadmium exposure primarily develop owing to industrial wastewater pollution and/or contaminated food. In regions with high cadmium exposure in Japan, cadmium accumulation occurs primarily in the kidneys of individuals who are exposed to the metal. In contrast, in the itai-itai disease outbreak that occurred in the Jinzu River basin in Toyama Prefecture in Japan, cadmium primarily accumulated in the liver. On the other hand, high concentration of cadmium caused renal tubular disorder and osteomalacia (multiple bone fracture), probably resulting from the renal tubular dysfunction and additional pathology. In this study, we aimed to establish a mouse model of chronic cadmium intake. We administered cadmium-containing drinking water (32 mg/l) to female and male mice ad libitum for 11 weeks. Metal analysis using inductively coupled plasma mass spectrometry revealed that cadmium accumulated in the kidneys (927 x 10 + 185 ng/g in females and 661 x 10 + 101 ng/g in males), liver (397 x 10 + 199 ng/g in females and 238 x 10 + 652 ng/g in males), and thyroid gland (293 + 93.7 ng/g in females and 129 + 72.7 ng/g in males) of mice. Female mice showed higher cadmium accumulation in the kidney, liver, and thyroid gland than males did (p = 0.00345, p = 0.00213, and p = 0.0331, respectively). Shotgun proteome analyses after chronic oral administration of cadmium revealed that protein levels of glutathione S-transferase Mu2, Mu4, and Mu7 decreased in the liver, and those of A1 and A2 decreased in the kidneys in both female and male mice.	[Yamanobe, Yoshiharu; Nagahara, Noriyuki; Takizawa, Toshihiro] Nippon Med Sch, Isotope Res Ctr, Bunkyo Ku, Tokyo 113, Japan; [Matsukawa, Takehisa; Chiba, Momoko; Yokoyama, Kazuhito] Juntendo Univ, Fac Med, Dept Epidemiol & Environm Hlth, Bunkyo Ku, Tokyo, Japan; [Ito, Takaaki; Niimori-Kita, Kanako] Kumamoto Univ, Grad Sch Med Sci, Dept Pathol & Expt Med, Hongo, Kumamoto, Japan	Nippon Medical School; Juntendo University; Kumamoto University	Nagahara, N (corresponding author), Nippon Med Sch, Isotope Res Ctr, Bunkyo Ku, 1-1-5 Sendagi, Tokyo 113, Japan.	noriyuki@nms.ac.jp		Yamanobe, Yoshiharu/0000-0002-2647-0073	Grants-in-Aid for Scientific Research [15K08322] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Aoshima Keiko, 2012, Nihon Eiseigaku Zasshi, V67, P455; Aoyagi T, 2003, INT J UROL, V10, P332, DOI 10.1046/j.1442-2042.2003.00627.x; ATSDR (Agency for Toxic Substances and Disease Registry), 2008, TOX PROF CADM; Baba H, 2014, J TOXICOL SCI, V39, P91, DOI 10.2131/jts.39.91; Chen DJ, 2014, BIOCHEM BIOPH RES CO, V445, P95, DOI 10.1016/j.bbrc.2014.01.146; Chen HY, 2008, BIRTH DEFECTS RES A, V82, P187, DOI 10.1002/bdra.20444; Go YM, 2013, TOXICOL SCI, V139, P59; Go YM, 2014, TOXICOL SCI, V139, P59, DOI 10.1093/toxsci/kfu018; Go YM, 2013, AM J PHYSIOL-LUNG C, V305, pL831, DOI 10.1152/ajplung.00203.2013; Gottschalg E, 2006, CHEM-BIOL INTERACT, V161, P251, DOI 10.1016/j.cbi.2006.04.003; HAYASHI S, 1983, BIOCHIM BIOPHYS ACTA, V742, P630, DOI 10.1016/0167-4838(83)90282-0; Honda A, 2010, J TOXICOL SCI, V35, P209, DOI 10.2131/jts.35.209; HORIGUCHI H, 1994, ARCH TOXICOL, V68, P632, DOI 10.1007/s002040050124; Horiguchi Hyogo, 2012, Nihon Eiseigaku Zasshi, V67, P447; Ishizaki A, 1968, Nihon Eiseigaku Zasshi, V23, P271; Johri N, 2010, BIOMETALS, V23, P783, DOI 10.1007/s10534-010-9328-y; Koizumi N, 1975, Nihon Eiseigaku Zasshi, V30, P300; Krajnc E. I., 1987, 758476004 NAT I PUBL; Kuzuhara Y, 1985, KANKYO HOKEN REP, V51, P162; Lau ATY, 2007, CANCER RES, V67, P2107, DOI 10.1158/0008-5472.CAN-06-3771; Mehus AA, 2014, MOL CELL PROTEOMICS, V13, P1020, DOI 10.1074/mcp.M113.033373; Nagahara N, 1990, J TOXICOL PATHOL, V3, P45; NOGAWA K, 1986, ENVIRON RES, V40, P251, DOI 10.1016/S0013-9351(86)80101-3; Nogawa K, 1979, Nihon Eiseigaku Zasshi, V34, P574; OGUSHI S, 1988, CHEM PHARM BULL, V36, P1445; Ohta H, 2001, BIOMED RES TRACE ELE, V12, P335; ONOSAKA S, 1985, EISEI KAGAKU, V31, P352, DOI 10.1248/jhs1956.31.352; ONOSAKA S, 1981, TOXICOLOGY, V22, P91, DOI 10.1016/0300-483X(81)90109-8; Prozialeck WC, 2012, J PHARMACOL EXP THER, V343, P2, DOI 10.1124/jpet.110.166769; REHM S, 1990, TOXICOL APPL PHARM, V104, P94, DOI 10.1016/0041-008X(90)90285-3; Round table conference, 1967, NIHON RINSHO, V25, P378; Rousselet E, 2008, PROTEOMICS, V8, P2244, DOI 10.1002/pmic.200701067; Son J, 2011, PROTEOMICS, V11, P2294, DOI 10.1002/pmic.200900690; SQUIBB KS, 1974, ENVIRON PHYSIOL BIOC, V4, P24; SUMINO K, 1975, ARCH ENVIRON HEALTH, V30, P487, DOI 10.1080/00039896.1975.10666759; SUZUKI M, 1981, J BIOCHEM-TOKYO, V89, P599, DOI 10.1093/oxfordjournals.jbchem.a133236; Takase B, 1968, Naika, V21, P885; Takeuchi J, 1968, Naika, V21, P876; The Ministry of Health and Welfare Opinion, 1968, KITANIPPON NEWS 0509; Thijssen S, 2007, TOXICOLOGY, V238, P200, DOI 10.1016/j.tox.2007.06.087; Tokumoto M, 2011, J TOXICOL SCI, V36, P127, DOI 10.2131/jts.36.127; Tripathi S, 2011, TISSUE CELL, V43, P131, DOI 10.1016/j.tice.2011.01.001; Wagner MA, 2000, BIOCHEMISTRY-US, V39, P8813, DOI 10.1021/bi000349z; Yamaguchi M, 1980, Nihon Eiseigaku Zasshi, V34, P719; Yin ZK, 2009, PROTEOMICS, V9, P4686, DOI 10.1002/pmic.200800958; Yoshida M, 1998, BIOL TRACE ELEM RES, V63, P167, DOI 10.1007/BF02778875; Zhu JY, 2006, AQUAT TOXICOL, V78, P127, DOI 10.1016/j.aquatox.2006.02.010	47	11	11	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0121819	10.1371/journal.pone.0121819	http://dx.doi.org/10.1371/journal.pone.0121819			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25793409	Green Published, Green Submitted, gold			2022-12-27	WOS:000352083900157
J	Zhu, H; Yu, JJ; Yu, RB; Ding, H; Bai, J; Chen, J; Liu, H				Zhu, Hui; Yu, Jia-Jia; Yu, Rong-Bin; Ding, Hui; Bai, Jing; Chen, Ji; Liu, Hu			Association between Childhood Strabismus and Refractive Error in Chinese Preschool Children	PLOS ONE			English	Article							POPULATION-BASED SAMPLE; PSYCHOSOCIAL-ASPECTS; AMBLYOPIA; PREVALENCE; EYE; ANISOMETROPIA; PREDICTION; INFANTS; MYOPIA; AGE	Purpose To investigate the association between concomitant esotropia or concomitant exotropia and refractive error in preschool children Methods A population-based sample of 5831 children aged 3 to 6 years was selected from all kindergartens in a representative county (Yuhuatai District, Nanjing, Jiangsu Province) of Nanjing, China. Clinical examinations including ocular alignment, ocular motility, visual acuity, optometry, stereopsis screening, slit lamp examination and fundus examination were performed by trained ophthalmologists and optometrists. Odd ratios (OR) and 95% confidence intervals (95% CI) were calculated to evaluate the association of refractive error with concomitant esotropia and concomitant exotropia. Results In multivariate logistic regression analysis, concomitant esotropia was associated independently with spherical equivalent anisometropia (OR, 3.15 for 0.50 to < 1.00 diopter (D) of anisometropia, and 7.41 for > = 1.00 D of anisometropia) and hyperopia. There was a severity-dependent association of hyperopia with the development of concomitant esotropia, with ORs increasing from 9.3 for 2.00 to < 3.00 D of hyperopia, to 180.82 for > = 5.00 D of hyperopia. Concomitant exotropia was associated with astigmatism (OR, 3.56 for 0.50 to 1.00 D of astigmatism, and 1.9 for < 0.00 D of astigmatism), myopia (OR, 40.54 for -1.00 to < 0.00 D of myopia, and 18.93 for <-1.00 D of myopia), and hyperopia (OR, 67.78 for 1.00 to < 2.00 D of hyperopia, 23.13 for 2.00 to < 3.00 D of hyperopia, 25.57 for 3.00 to < 4.00 D of hyperopia, and 8.36 for 4.00 to < 5.00 D of hyperopia). Conclusions This study highlights the close associations between refractive error and the prevalence of concomitant esotropia and concomitant exotropia, which should be considered when managing childhood refractive error.	[Zhu, Hui] Nanjing Med Univ, Clin Med Coll 1, Nanjing, Jiangsu, Peoples R China; [Yu, Jia-Jia] Wuxi 2 Peoples Hosp, Dept Ophthalmol, Wuxi, Jiangsu, Peoples R China; [Yu, Rong-Bin] Nanjing Med Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Nanjing, Jiangsu, Peoples R China; [Ding, Hui; Bai, Jing; Chen, Ji] Maternal & Child Healthcare Hosp Yuhua Dist, Nanjing, Jiangsu, Peoples R China; [Liu, Hu] Nanjing Med Univ, Affiliated Hosp 1, Jiangsu Prov Hosp, Dept Ophthalmol, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University; Nanjing Medical University	Liu, H (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Jiangsu Prov Hosp, Dept Ophthalmol, Nanjing, Jiangsu, Peoples R China.	liuhu66@163.com		Liu, Hu/0000-0002-3952-4165	Science and Technology Bureau of Yuhuatai District [201001110]	Science and Technology Bureau of Yuhuatai District	The authors received funding from the Science and Technology Bureau of Yuhuatai District. The grant numbers are 201001110 and the URL is http://www.njkj.gov.cn/. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anker S, 2003, INVEST OPHTH VIS SCI, V44, P497, DOI 10.1167/iovs.02-0070; Atkinson J, 1996, EYE, V10, P189, DOI 10.1038/eye.1996.46; Atkinson J, 2000, INVEST OPHTH VIS SCI, V41, P3726; Chia A, 2013, OPHTHAL EPIDEMIOL, V20, P138, DOI 10.3109/09286586.2013.767354; Colburn JD, 2010, J AAPOS, V14, P211, DOI 10.1016/j.jaapos.2010.02.006; Cotter SA, 2011, OPHTHALMOLOGY, V118, P2251, DOI 10.1016/j.ophtha.2011.06.032; Ekdawi NS, 2010, AM J OPHTHALMOL, V149, P503, DOI 10.1016/j.ajo.2009.10.009; Fu J, 2014, OPHTHAL EPIDEMIOL, V21, P197, DOI 10.3109/09286586.2014.904371; Holmstrom G, 2006, J PEDIAT OPHTH STRAB, V43, P346, DOI 10.3928/01913913-20061101-04; Huynh SC, 2006, BRIT J OPHTHALMOL, V90, P597, DOI 10.1136/bjo.2005.083154; INGRAM RM, 1990, BRIT J OPHTHALMOL, V74, P158, DOI 10.1136/bjo.74.3.158; INGRAM RM, 1986, BRIT J OPHTHALMOL, V70, P12, DOI 10.1136/bjo.70.1.12; Ip JM, 2008, OPHTHALMOLOGY, V115, P678, DOI 10.1016/j.ophtha.2007.04.061; Kushner BJ, 1998, ARCH OPHTHALMOL-CHIC, V116, P478, DOI 10.1001/archopht.116.4.478; Lin SB, 2014, AM J OPHTHALMOL, V157, P894, DOI 10.1016/j.ajo.2014.01.012; Menon V, 2002, J PEDIAT OPHTH STRAB, V39, P203, DOI 10.3928/0191-3913-20020701-07; Miller JM, 2009, OPTOMETRY VISION SCI, V86, P599, DOI 10.1097/OPX.0b013e3181a6a211; Nelson BA, 2008, J AAPOS, V12, P72, DOI 10.1016/j.jaapos.2007.08.006; O'Connor AR, 2002, ARCH OPHTHALMOL-CHIC, V120, P767; Ojaimi E, 2005, OPHTHAL EPIDEMIOL, V12, P59, DOI 10.1080/09286580490921296; Raab E L, 1982, Trans Am Ophthalmol Soc, V80, P657; Robaei D, 2006, OPHTHALMOLOGY, V113, P1146, DOI 10.1016/j.ophtha.2006.02.019; Robaei D, 2006, ARCH OPHTHALMOL-CHIC, V124, P878, DOI 10.1001/archopht.124.6.878; SATTERFIELD D, 1993, ARCH OPHTHALMOL-CHIC, V111, P1100, DOI 10.1001/archopht.1993.01090080096024; Von Noorden GK, 2002, BINOCULAR VISION OCU, DOI [10.3368/aoj.51.1.161, DOI 10.3368/AOJ.51.1.161]; Walsh LA, 2000, J AAPOS, V4, P154, DOI 10.1016/S1091-8531(00)70005-X; Weakley D R, 1999, Trans Am Ophthalmol Soc, V97, P987; Weakley DR, 2001, OPHTHALMOLOGY, V108, P163, DOI 10.1016/S0161-6420(00)00425-5; Xu JL, 2012, J PEDIAT OPHTH STRAB, V49, P170, DOI 10.3928/01913913-20110920-02	29	26	26	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0120720	10.1371/journal.pone.0120720	http://dx.doi.org/10.1371/journal.pone.0120720			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25793499	Green Published, Green Submitted, gold			2022-12-27	WOS:000352083900068
J	Zhu, WZ; Lin, YQ; Liao, HH; Wang, Y				Zhu, Wuzheng; Lin, Yaqiu; Liao, Honghai; Wang, Yong			Selection of Reference Genes for Gene Expression Studies Related to Intramuscular Fat Deposition in Capra hircus Skeletal Muscle	PLOS ONE			English	Article							REAL-TIME PCR; SUITABLE REFERENCE GENES; REVERSE TRANSCRIPTION-PCR; INTERNAL REFERENCE GENES; SYBR GREEN QPCR; BEEF-CATTLE; HOUSEKEEPING GENES; FEEDING SYSTEM; SOMATIC-CELLS; MEAT QUALITY	The identification of suitable reference genes is critical for obtaining reliable results from gene expression studies using quantitative real-time PCR (qPCR) because the expression of reference genes may vary considerably under different experimental conditions. In most cases, however, commonly used reference genes are employed in data normalization without proper validation, which may lead to incorrect data interpretation. Here, we aim to select a set of optimal reference genes for the accurate normalization of gene expression associated with intramuscular fat (IMF) deposition during development. In the present study, eight reference genes (PPIB, HMBS, RPLP0, B2M, YWHAZ, 18S, GAPDH and ACTB) were evaluated by three different algorithms (geNorm, NormFinder and BestKeeper) in two types of muscle tissues (longissimus dorsi muscle and biceps femoris muscle) across different developmental stages. All three algorithms gave similar results. PPIB and HMBS were identified as the most stable reference genes, while the commonly used reference genes 18S and GAPDH were the most variably expressed, with expression varying dramatically across different developmental stages. Furthermore, to reveal the crucial role of appropriate reference genes in obtaining a reliable result, analysis of PPARG expression was performed by normalization to the most and the least stable reference genes. The relative expression levels of PPARG normalized to the most stable reference genes greatly differed from those normalized to the least stable one. Therefore, evaluation of reference genes must be performed for a given experimental condition before the reference genes are used. PPIB and HMBS are the optimal reference genes for analysis of gene expression associated with IMF deposition in skeletal muscle during development.	[Zhu, Wuzheng; Lin, Yaqiu; Liao, Honghai; Wang, Yong] Southwest Univ Nationalities, Coll Life Sci & Technol, Chengdu 610041, Peoples R China	Southwest Minzu University	Wang, Y (corresponding author), Southwest Univ Nationalities, Coll Life Sci & Technol, Chengdu 610041, Peoples R China.	wangyong010101@swun.cn			"twelfth Five-Year" Key Projects of Animal and Poultry Breeding Research of Sichuan Province [2011NZ0099-36]; National High Technology Research and Development Program of China [2012BAD13B06]; Key Demonstration Project of Science and Technology Innovation Industrial Chain in Sichuan province [2011NZ0003]	"twelfth Five-Year" Key Projects of Animal and Poultry Breeding Research of Sichuan Province; National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); Key Demonstration Project of Science and Technology Innovation Industrial Chain in Sichuan province	Funding: The work was supported by the "twelfth Five-Year" Key Projects of Animal and Poultry Breeding Research of Sichuan Province (No. 2011NZ0099-36), National High Technology Research and Development Program of China (No. 2012BAD13B06), the Key Demonstration Project of Science and Technology Innovation Industrial Chain in Sichuan province (No. 2011NZ0003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Bai WL, 2014, J DAIRY SCI, V97, P902, DOI 10.3168/jds.2012-6437; Bonnet M, 2013, ANIMAL, V7, P1344, DOI 10.1017/S1751731113000475; Bruge F, 2011, J BIOTECHNOL, V156, P153, DOI 10.1016/j.jbiotec.2011.09.018; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Chaillou T, 2011, PHYSIOL GENOMICS, V43, P228, DOI 10.1152/physiolgenomics.00109.2010; Cinar Mehmet Ulas, 2013, BMC Res Notes, V6, P56, DOI 10.1186/1756-0500-6-56; Deloffre LAM, 2012, GENE, V506, P69, DOI 10.1016/j.gene.2012.06.047; Dervishi E, 2011, MEAT SCI, V89, P91, DOI 10.1016/j.meatsci.2011.04.003; Feng XT, 2010, J BIOTECHNOL, V150, P288, DOI 10.1016/j.jbiotec.2010.09.949; Gerbens F, 2001, J ANIM SCI, V79, P347; Graugnard DE, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-142; Han XJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043084; da Costa ASH, 2013, BMC VET RES, V9, DOI 10.1186/1746-6148-9-118; Hruz T, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-156; Hu Q, 2014, FISH PHYSIOL BIOCHEM, V40, P1721, DOI 10.1007/s10695-014-9962-3; Huth A, 2013, INT J LEGAL MED, V127, P335, DOI 10.1007/s00414-012-0787-2; Jarczak J, 2014, GENE, V549, P280, DOI 10.1016/j.gene.2014.07.063; Kim Insook, 2011, BMC Res Notes, V4, P440, DOI 10.1186/1756-0500-4-440; Lancaster PA, 2014, J ANIM SCI, V92, P1462, DOI 10.2527/jas.2013-6976; Leal MF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105002; Li L, 2013, GENE, V528, P195, DOI 10.1016/j.gene.2013.07.013; Mannen H, 2011, ANIM SCI J, V82, P1, DOI 10.1111/j.1740-0929.2010.00845.x; McBryan J, 2010, MEAT SCI, V86, P436, DOI 10.1016/j.meatsci.2010.05.030; Modesto P, 2013, J DAIRY SCI, V96, P7932, DOI 10.3168/jds.2012-6383; Montero-Melendez T, 2014, INFLAMMATION, V37, P1059, DOI 10.1007/s10753-014-9829-x; Najafpanah MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083041; Naoumov NV, 2014, J HEPATOL, V61, P1166, DOI 10.1016/j.jhep.2014.07.008; Nygard AB, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-67; Peletto S, 2011, INT J MOL SCI, V12, P7732, DOI 10.3390/ijms12117732; Perez R, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-79; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Rosen ED, 2006, NAT REV MOL CELL BIO, V7, P885, DOI 10.1038/nrm2066; Saremi B, 2012, J DAIRY SCI, V95, P3131, DOI 10.3168/jds.2011-4803; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Serrano M, 2011, BMC MOL BIOL, V12, DOI 10.1186/1471-2199-12-36; Stephens Alexandre S, 2011, BMC Res Notes, V4, P410, DOI 10.1186/1756-0500-4-410; Talpur FN, 2008, MEAT SCI, V80, P819, DOI 10.1016/j.meatsci.2008.03.028; Thomas KC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088653; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Varga T, 2011, BBA-MOL BASIS DIS, V1812, P1007, DOI 10.1016/j.bbadis.2011.02.014; Vossaert L, 2013, BMC MOL BIOL, V14, DOI 10.1186/1471-2199-14-21; Wang LJ, 2015, MOL BIOL REP, V42, P201, DOI 10.1007/s11033-014-3759-4; Wang YH, 2009, J ANIM SCI, V87, P119, DOI 10.2527/jas.2008-1082; Wang YH, 2005, MAMM GENOME, V16, P201, DOI 10.1007/s00335-004-2419-8; Waters SM, 2009, J ANIM SCI, V87, P244, DOI 10.2527/jas.2008-1005; Wood JD, 2008, MEAT SCI, V78, P343, DOI 10.1016/j.meatsci.2007.07.019; Yue Hua, 2010, Virologica Sinica, V25, P425, DOI 10.1007/s12250-010-3114-4; Zhang HB, 2014, ANIM SCI J, V85, P411, DOI 10.1111/asj.12161; Zhang Y, 2013, ASIAN AUSTRAL J ANIM, V26, P1665, DOI 10.5713/ajas.2013.13199; Zhao DJ, 2012, FEBS OPEN BIO, V2, P235, DOI 10.1016/j.fob.2012.08.001; Zhao JP, 2012, J ANIM SCI, V90, P4337, DOI 10.2527/jas.2012-5100; Zinzow-Kramer WM, 2014, HORM BEHAV, V66, P267, DOI 10.1016/j.yhbeh.2014.04.011	53	30	34	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0121280	10.1371/journal.pone.0121280	http://dx.doi.org/10.1371/journal.pone.0121280			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25794179	Green Published, gold, Green Submitted			2022-12-27	WOS:000352083900119
J	Carrillo, E; Pacheco, L; Balleza, D; Gomez-Lagunas, F				Carrillo, Elisa; Pacheco, Lucero; Balleza, Daniel; Gomez-Lagunas, Froylan			K+-Dependent Selectivity and External Ca2+ Block of Shab K+ Channels	PLOS ONE			English	Article							SHAKER POTASSIUM CHANNELS; ION SELECTIVITY; BINDING-SITE; CONDUCTION; NA+; PORE; PERMEABILITY; PERMEATION	Potassium channels allow the selective flux of K+ excluding the smaller, and more abundant in the extracellular solution, Na+ ions. Here we show that Shab is a typical K+ channel that excludes Na+ under bi-ionic, Nao/Ki or Nao/Rbi, conditions. However, when internal K+ is replaced by Cs+ (Nao/Csi), stable inward Na+ and outward Cs+ currents are observed. These currents show that Shab selectivity is not accounted for by protein structural elements alone, as implicit in the snug-fit model of selectivity. Additionally, here we report the block of Shab channels by external Ca2+ ions, and compare the effect that internal K+ replacement exerts on both Ca2+ and TEA block. Our observations indicate that Ca2+ blocks the channels at a site located near the external TEA binding site, and that this pore region changes conformation under conditions that allow Na+ permeation. In contrast, the latter ion conditions do not significantly affect the binding of quinidine to the pore central cavity. Based on our observations and the structural information derived from the NaK bacterial channel, we hypothesize that Ca2+ is probably coordinated by main chain carbonyls of the pore's first K+-binding site.	[Carrillo, Elisa; Pacheco, Lucero; Balleza, Daniel; Gomez-Lagunas, Froylan] Univ Nacl Autonoma Mexico, Dept Fisiol, Mexico City 04510, DF, Mexico	Universidad Nacional Autonoma de Mexico	Gomez-Lagunas, F (corresponding author), Univ Nacl Autonoma Mexico, Dept Fisiol, Mexico City 04510, DF, Mexico.	froylangl@yahoo.com	Balleza, Daniel/B-2886-2017	Balleza, Daniel/0000-0002-6848-9135; Carrillo, Elisa/0000-0002-0419-395X	DGAPA_UNAM [IN220914]; CONACYT [153504]	DGAPA_UNAM(Universidad Nacional Autonoma de Mexico); CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	Support was provided by DGAPA_UNAM grant IN220914 and CONACYT grant 153504. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam A, 2007, P NATL ACAD SCI USA, V104, P15334, DOI 10.1073/pnas.0707324104; Allen TW, 2004, J GEN PHYSIOL, V124, P679, DOI 10.1085/jgp.200409111; ALMERS W, 1980, J GEN PHYSIOL, V75, P61, DOI 10.1085/jgp.75.1.61; Ambriz-Rivas M, 2005, PFLUG ARCH EUR J PHY, V450, P255, DOI 10.1007/s00424-005-1411-9; ARMSTRONG CM, 1974, Q REV BIOPHYS, V7, P179, DOI 10.1017/S0033583500001402; Becker D, 1996, P NATL ACAD SCI USA, V93, P8123, DOI 10.1073/pnas.93.15.8123; Dang TX, 1998, J GEN PHYSIOL, V111, P185, DOI 10.1085/jgp.111.2.185; Derebe MG, 2011, P NATL ACAD SCI USA, V108, P598, DOI 10.1073/pnas.1013636108; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Gomez-Lagunas F, 2003, P NATL ACAD SCI USA, V100, P347, DOI 10.1073/pnas.0237122100; Gomez-Lagunas F, 2001, J GEN PHYSIOL, V118, P639, DOI 10.1085/jgp.118.6.639; Gomez- Lagunas F, 2010, J PHISIOL, V588, P2691, DOI DOI 10.1113/JPHYSI0L.2010.193128; Gomez-Lagunas F, 1993, BIOPHYS J, V66, pA109; GomezLagunas F, 1997, J PHYSIOL-LONDON, V499, P3, DOI 10.1113/jphysiol.1997.sp021907; HEGINBOTHAM L, 1992, NEURON, V8, P483, DOI 10.1016/0896-6273(92)90276-J; HEGINBOTHAM L, 1994, BIOPHYS J, V66, P1061, DOI 10.1016/S0006-3495(94)80887-2; HEGINBOTHAM L, 1993, BIOPHYS J, V65, P2089, DOI 10.1016/S0006-3495(93)81244-X; Hoshi T, 2013, J GEN PHYSIOL, V141, P151, DOI 10.1085/jgp.201210888; IKEDA SR, 1995, J PHYSIOL-LONDON, V486, P267, DOI 10.1113/jphysiol.1995.sp020809; Immke D, 1999, J GEN PHYSIOL, V113, P819, DOI 10.1085/jgp.113.6.819; Khodakhah K, 1997, P NATL ACAD SCI USA, V94, P13335, DOI 10.1073/pnas.94.24.13335; KORN SJ, 1995, SCIENCE, V269, P410, DOI 10.1126/science.7618108; Lagunas FG, 2007, BIOPHYS J, V93, P4197, DOI 10.1529/biophysj.106.095794; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Melishchuk A, 1998, BIOPHYS J, V75, P1828, DOI 10.1016/S0006-3495(98)77624-6; NEHER E, 1992, METHOD ENZYMOL, V207, P123; NEYTON J, 1988, J GEN PHYSIOL, V92, P569, DOI 10.1085/jgp.92.5.569; Noskov SY, 2006, BIOPHYS CHEM, V124, P279, DOI 10.1016/j.bpc.2006.05.033; Ogielska EM, 1998, J GEN PHYSIOL, V112, P243, DOI 10.1085/jgp.112.2.243; Shi N, 2006, NATURE, V440, P570, DOI 10.1038/nature04508; Spassova MA, 1998, J GEN PHYSIOL, V112, P211, DOI 10.1085/jgp.112.2.211; Starkus JG, 1997, J GEN PHYSIOL, V110, P539, DOI 10.1085/jgp.110.5.539; Voet D., 2005, BIOCHEMISTRY-US; Zhou YF, 2001, NATURE, V414, P43, DOI 10.1038/35102009; ZHU Y, 1993, J PHYSIOL-LONDON, V468, P441, DOI 10.1113/jphysiol.1993.sp019781; Zhuren W, 2000, J PHYSL, V523, P575	36	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0120431	10.1371/journal.pone.0120431	http://dx.doi.org/10.1371/journal.pone.0120431			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25798591	gold, Green Submitted, Green Published			2022-12-27	WOS:000351987300143
J	Khadjesari, Z; Newbury-Birch, D; Murray, E; Shenker, D; Marston, L; Kaner, E				Khadjesari, Zarnie; Newbury-Birch, Dorothy; Murray, Elizabeth; Shenker, Don; Marston, Louise; Kaner, Eileen			Online Health Check for Reducing Alcohol Intake among Employees: A Feasibility Study in Six Workplaces across England	PLOS ONE			English	Article							COMPUTER-DELIVERED INTERVENTIONS; CONSUMPTION; DRINKING; TRIAL; AUDIT	Background Most hazardous and harmful drinkers are of working age and do not seek help with their drinking. Occupational health services are uniquely placed to universally screen employees across the range of socioeconomic and ethnic groups. The aim was to explore the feasibility and acceptability of offering electronic screening and brief intervention for alcohol misuse in the context of a health check in six different workplace settings. Methods and Findings Employees were recruited from six workplaces across England, including three local authorities, one university, one hospital and one petro-chemical company. A total of 1,254 (8%) employees completed the health check and received personalised feedback on their alcohol intake, alongside feedback on smoking, fruit and vegetable consumption and physical activity. Most participants were female (65%) and of 'White British' ethnicity (94%), with a mean age of 43 years (SD 11). Participants were mostly in Intermediate occupations (58%), followed by Higher managerial/professional (39%) and Routine and manual occupations (2%). A quarter of participants (25%) were drinking at hazardous levels (33% male, 21% female), which decreased with age. Sixty-four percent (n=797) of participants completed online follow-up at three months. Most participants were supportive of workplaces offering employees an online health check (95%), their preferred format was online (91%) and many were confident of the confidentiality of their responses (60%). Whilst the feedback reminded most participants of things they already knew (75%), some were reportedly motivated to change their behaviour (13%). Conclusions Online health screening and personalised feedback appears feasible and acceptable, but challenges include low participation rates, potentially attracting 'worried well' employees rather than those at greatest health risk, and less acceptance of the approach among older employees and those from ethnic minority backgrounds and routine or manual occupations.	[Khadjesari, Zarnie; Murray, Elizabeth; Marston, Louise] UCL, Dept Primary Care & Populat Hlth, London, England; [Newbury-Birch, Dorothy; Kaner, Eileen] Newcastle Univ, Inst Hlth & Soc, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Shenker, Don] Alcohol Hlth Network, London, England	University of London; University College London; Newcastle University - UK	Khadjesari, Z (corresponding author), UCL, Dept Primary Care & Populat Hlth, London, England.	z.khadjesari@ucl.ac.uk	Marston, Louise/A-8535-2012; Kaner, Eileen/ABF-2444-2020	Marston, Louise/0000-0002-9973-1131; Kaner, Eileen/0000-0002-7169-9344; Murray, Elizabeth/0000-0002-8932-3695; Newbury-Birch, Dorothy/0000-0003-0065-8649; Khadjesari, Zarnie/0000-0002-2958-9555	Alcohol Research UK; Balance North East; National Institute for Health Research (NIHR) School for Primary Care Research (SPCR); Alcohol Health Network; Medical Research Council [MR/K02325X/1] Funding Source: researchfish; National Institute for Health Research [SPCR-033] Funding Source: researchfish	Alcohol Research UK; Balance North East; National Institute for Health Research (NIHR) School for Primary Care Research (SPCR)(National Institute for Health Research (NIHR)); Alcohol Health Network; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	This study was funded by Alcohol Research UK and Balance North East. Zarnie Khadjesari is funded by a 3-year National Institute for Health Research (NIHR) School for Primary Care Research (SPCR) fellowship. Alcohol Health Network provided support in the form of a salary for author DS. The aforementioned funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of each author are articulated in the 'author contributions' section.	Babor TF., 2001, AUDIT ALCOHOL USE DI; Bewick BM, 2008, PREV MED, V47, P17, DOI 10.1016/j.ypmed.2008.01.005; BLACK C, 2008, WORKING HEALTHIER TO; British Medical Association, 2012, CLIN DIR ENH SERV DE; Bush K, 1998, ARCH INTERN MED, V158, P1789, DOI 10.1001/archinte.158.16.1789; Butler CC, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1191; Carey KB, 2009, ADDICTION, V104, P1807, DOI 10.1111/j.1360-0443.2009.02691.x; Del Boca FK, 2003, ADDICTION, V98, P1, DOI 10.1046/j.1359-6357.2003.00586.x; DONOHUE B, 2004, J ALCOHOL DRUG EDUC, V48, P13, DOI DOI 10.1056/NEJM196001072620104; Doumas DM, 2008, J SUBST ABUSE TREAT, V34, P263, DOI 10.1016/j.jsat.2007.04.006; Goldstein MG, 2004, AM J PREV MED, V27, P61, DOI 10.1016/j.amepre.2004.04.023; Health and Social Care Information Centre, 2013, STAT SMOK; Health & Social Care Information Centre, 2014, STAT OB PHYS ACT DIE; Heather N, 2012, ADDICT SCI CLIN PRAC, V7, DOI 10.1186/1940-0640-7-15; Hutchings D, 2006, PRIM HEALTH CARE RES, V7, P221, DOI DOI 10.1191/1463423606PC2890A; Kaner EFS, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004148.pub4; Khadjesari Z, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112553; Khadjesari Z, 2011, ADDICTION, V106, P267, DOI 10.1111/j.1360-0443.2010.03214.x; Kypri K, 2005, PREV MED, V41, P761, DOI 10.1016/j.ypmed.2005.07.010; Kypri K, 2014, JAMA-J AM MED ASSOC, V311, P1218, DOI 10.1001/jama.2014.2138; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Linke S, 2008, ALCOHOL ALCOHOLISM, V43, P669, DOI 10.1093/alcalc/agn066; Matano RA, 2007, J SUBST ABUSE TREAT, V32, P71, DOI 10.1016/j.jsat.2006.05.020; Medical Research Council, 2008, DEV EVALUATING COMPL, DOI [10.1136/bmj.a1655, DOI 10.1136/BMJ.A1655]; Murray E, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-505; National Institute for Health and Care Excellence, 2014, BEH CHANG IND APPR; NHS Choices, 2014, YPUR NHS HLTH CHECK; NHS Future Forum, 2012, NHS FUT FOR SUMM REP, DOI [10.1111/hae.12500, DOI 10.1111/HAE.12500]; Office for National Statistics, 2010, NAT STAT SOC CLASS N; Office for National Statistics, 2012, STAT B DRINK HAB AD; Office for National Statistics, 2013, GEN LIF SURV 2011; Office for National Statistics, 2014, STAT B LAB MARK STAT; Prochaska JJ, 2011, AM J LIFESTYLE MED, V5, P208, DOI 10.1177/1559827610391883; Rao T, 2013, TRENDS ALCOHOL RELAT; Rapley T, 2006, SOC SCI MED, V63, P2418, DOI 10.1016/j.socscimed.2006.05.025; Rehm J., 2012, ALCOHOL CONSUMPTION; Riper H, 2011, J MED INTERNET RES, V13, DOI 10.2196/jmir.1691; Rooke S, 2010, ADDICTION, V105, P1381, DOI 10.1111/j.1360-0443.2010.02975.x; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; Schulz DN, 2014, J MED INTERNET RES, V16, DOI 10.2196/jmir.3094; Stewart B, 2014, WORLD CANC REP 2014; The NHS Information Centre, 2009, AD PSYCH MORB ENGL 2; Wallace P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014740; Watson H, 2009, REDUCING ALCOHOL REL; Watson J, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-117; Webb G, 2009, ADDICTION, V104, P365, DOI 10.1111/j.1360-0443.2008.02472.x; White A, 2010, J MED INTERNET RES, V12, DOI 10.2196/jmir.1479; WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1; World Health Organization, 2010, GLOB STRAT RED HARMF	50	10	10	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0121174	10.1371/journal.pone.0121174	http://dx.doi.org/10.1371/journal.pone.0121174			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CE6ZS	25798596	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000351987300223
J	Machova, I; Snasel, J; Dostal, J; Brynda, J; Fanfrlik, J; Singh, M; Tarabek, J; Vanek, O; Bednarova, L; Pichova, I				Machova, Iva; Snasel, Jan; Dostal, Jiri; Brynda, Jiri; Fanfrlik, Jindrich; Singh, Mahavir; Tarabek, Jan; Vanek, Ondrej; Bednarova, Lucie; Pichova, Iva			Structural and Functional Studies of Phosphoenolpyruvate Carboxykinase from Mycobacterium tuberculosis	PLOS ONE			English	Article							CRYSTAL-STRUCTURE; MECHANISM; DISPERSION; PURIFICATION; REVEALS; PEPCK; FERROACTIVATOR; COMPLEXES; CRUZI	Tuberculosis, the second leading infectious disease killer after HIV, remains a top public health priority. The causative agent of tuberculosis, Mycobacterium tuberculosis (Mtb), which can cause both acute and clinically latent infections, reprograms metabolism in response to the host niche. Phosphoenolpyruvate carboxykinase (Pck) is the enzyme at the center of the phosphoenolpyruvate-pyruvate-oxaloacetate node, which is involved in regulating the carbon flow distribution to catabolism, anabolism, or respiration in different states of Mtb infection. Under standard growth conditions, Mtb Pck is associated with gluconeogenesis and catalyzes the metal-dependent formation of phosphoenolpyruvate. In non-replicating Mtb, Pck can catalyze anaplerotic biosynthesis of oxaloacetate. Here, we present insights into the regulation of Mtb Pck activity by divalent cations. Through analysis of the Xray structure of Pck-GDP and Pck-GDP-Mn2+ complexes, mutational analysis of the GDP binding site, and quantum mechanical (QM)-based analysis, we explored the structural determinants of efficient Mtb Pck catalysis. We demonstrate that Mtb Pck requires presence of Mn2+ and Mg2+ cations for efficient catalysis of gluconeogenic and anaplerotic reactions. The anaplerotic reaction, which preferably functions in reducing conditions that are characteristic for slowed or stopped Mtb replication, is also effectively activated by Fe2+ in the presence of Mn2+ or Mg2+ cations. In contrast, simultaneous presence of Fe2+ and Mn2+ or Mg2+ inhibits the gluconeogenic reaction. These results suggest that inorganic ions can contribute to regulation of central carbon metabolism by influencing the activity of Pck. Furthermore, the X-ray structure determination, biochemical characterization, and QM analysis of Pck mutants confirmed the important role of the Phe triad for proper binding of the GDP-Mn2+ complex in the nucleotide binding site and efficient catalysis of the anaplerotic reaction.	[Machova, Iva; Snasel, Jan; Dostal, Jiri; Brynda, Jiri; Fanfrlik, Jindrich; Tarabek, Jan; Bednarova, Lucie; Pichova, Iva] Acad Sci Czech Republ, Inst Organ Chem & Biochem, Prague, Czech Republic; [Singh, Mahavir] LIONEX Diagnost & Therapeut, Braunschweig, Germany; [Vanek, Ondrej] Charles Univ Prague, Fac Sci, Dept Biochem, Prague, Czech Republic	Czech Academy of Sciences; Institute of Organic Chemistry & Biochemistry of the Czech Academy of Sciences; Lionex Diagnostics & Therapeutics GmbH; Charles University Prague	Pichova, I (corresponding author), Acad Sci Czech Republ, Inst Organ Chem & Biochem, Prague, Czech Republic.	iva.pichova@uochb.cas.cz	Machova, Iva/G-5578-2014; Machova, Iva/AAH-7522-2020; Tarabek, Jan/G-5319-2014; Vaněk, Ondřej/I-7022-2016; Tarabek, Jan/ABE-3843-2021; Bednarova, Lucie/E-7622-2012; Pichova, Iva/G-7917-2014; Dostal, Jiri/E-9584-2012; Brynda, Jiri/G-2760-2014	Machova, Iva/0000-0003-3231-4509; Machova, Iva/0000-0003-3231-4509; Tarabek, Jan/0000-0003-0116-3824; Vaněk, Ondřej/0000-0003-1190-8535; Tarabek, Jan/0000-0003-0116-3824; Brynda, Jiri/0000-0003-3675-6769; Fanfrlik, Jindrich/0000-0002-1257-1201	EU-PF7 SysteMtb Collaborative [241587]; RVO [61388963]; NPU from the Ministry of Education, Czech Republic [LO 1302]	EU-PF7 SysteMtb Collaborative; RVO; NPU from the Ministry of Education, Czech Republic	This work was supported by EU-PF7 SysteMtb Collaborative Project no. 241587, RVO 61388963 and NPU project No: LO 1302 from the Ministry of Education, Czech Republic.	Abramovitch RB, 2011, MOL MICROBIOL, V80, P678, DOI 10.1111/j.1365-2958.2011.07601.x; AHLRICHS R, 1989, CHEM PHYS LETT, V162, P165, DOI 10.1016/0009-2614(89)85118-8; [Anonymous], 2008, AMBER 10; BAYLY CI, 1993, J PHYS CHEM-US, V97, P10269, DOI 10.1021/j100142a004; BENTLE LA, 1977, J BIOL CHEM, V252, P1431; BENTLE LA, 1976, J BIOL CHEM, V251, P2916; Beste DJV, 2013, CHEM BIOL, V20, P1012, DOI 10.1016/j.chembiol.2013.06.012; Beste DJV, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002091; Bradbrook GM, 1998, J CHEM SOC FARADAY T, V94, P1603, DOI 10.1039/a800429c; BrUnger A. T., 1992, X PLOR VERSION 3 1 S; Carlson GM, 2009, J BIOL CHEM, V284, P27037, DOI 10.1074/jbc.R109.040568; COLOMBO G, 1981, BIOCHEMISTRY-US, V20, P2749, DOI 10.1021/bi00513a008; Dapprich S, 1999, J MOL STRUC-THEOCHEM, V461, P1, DOI 10.1016/S0166-1280(98)00475-8; de Carvalho LPS, 2010, CHEM BIOL, V17, P323, DOI 10.1016/j.chembiol.2010.03.009; Dunten P, 2002, J MOL BIOL, V316, P257, DOI 10.1006/jmbi.2001.5364; FINNEGAN PM, 1995, PLANT MOL BIOL, V27, P365, DOI 10.1007/BF00020190; FOSTER DO, 1967, BIOCHEMISTRY-US, V6, P2120, DOI 10.1021/bi00859a033; Gandhi NR, 2010, LANCET, V375, P1830, DOI 10.1016/S0140-6736(10)60410-2; Gobin J, 1996, J EXP MED, V183, P1527, DOI 10.1084/jem.183.4.1527; Grimme S, 2010, J CHEM PHYS, V132, DOI 10.1063/1.3382344; HEBDA CA, 1982, J BIOL CHEM, V257, P5515; HOLTEN DD, 1965, BIOCHEMISTRY-US, V4, P723, DOI 10.1021/bi00880a018; Holyoak T, 2006, BIOCHEMISTRY-US, V45, P8254, DOI 10.1021/bi060269g; Jabalquinto AM, 2003, J PROTEIN CHEM, V22, P515, DOI 10.1023/B:JOPC.0000005500.67125.71; Johnson TA, 2012, BIOCHEMISTRY-US, V51, P9547, DOI 10.1021/bi301278t; Jurecka P, 2007, J COMPUT CHEM, V28, P555, DOI 10.1002/jcc.20570; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; KLAMT A, 1993, J CHEM SOC PERK T 2, P799, DOI 10.1039/p29930000799; Krug M, 2012, J APPL CRYSTALLOGR, V45, P568, DOI 10.1107/S0021889812011715; LEE MH, 1981, J BIOL CHEM, V256, P2793; Lobley A, 2002, BIOINFORMATICS, V18, P211, DOI 10.1093/bioinformatics/18.1.211; Lovell S.C., 2003, PROTEINS STRUCT FUNC, V50, P437, DOI [10.1002/prot.10286, DOI 10.1002/PROT.10286]; MACDONALD MJ, 1978, J BIOL CHEM, V253, P116; MACDONALD MJ, 1978, J BIOL CHEM, V253, P2300; MACDONALD MJ, 1980, BIOCHIM BIOPHYS ACTA, V615, P223, DOI 10.1016/0005-2744(80)90025-X; MACDONALD MJ, 1978, BIOCHEM J, V176, P495, DOI 10.1042/bj1760495; Machova I, 2014, J BIOL CHEM, V289, P13066, DOI 10.1074/jbc.M113.536748; Marrero J, 2010, P NATL ACAD SCI USA, V107, P9819, DOI 10.1073/pnas.1000715107; Massova I, 1999, J AM CHEM SOC, V121, P8133, DOI 10.1021/ja990935j; Matte A, 1996, J MOL BIOL, V256, P126, DOI 10.1006/jmbi.1996.0072; Matte A, 1997, J BIOL CHEM, V272, P8105, DOI 10.1074/jbc.272.13.8105; Mukhopadhyay B, 2001, J BIOL CHEM, V276, P16137, DOI 10.1074/jbc.M008960200; Pecina A, 2013, J PHYS CHEM B, V117, P16096, DOI 10.1021/jp410216m; PUNEKAR NS, 1987, J BIOL CHEM, V262, P6714; Rezac J, 2012, J CHEM THEORY COMPUT, V8, P141, DOI 10.1021/ct200751e; Rezac J, 2009, J CHEM THEORY COMPUT, V5, P1749, DOI 10.1021/ct9000922; Schocke L, 1997, ARCH MICROBIOL, V167, P289, DOI 10.1007/s002030050446; Schuck P, 2003, ANAL BIOCHEM, V320, P104, DOI 10.1016/S0003-2697(03)00289-6; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Sherman DR, 2001, P NATL ACAD SCI USA, V98, P7534, DOI 10.1073/pnas.121172498; Shi LB, 2010, MOL MICROBIOL, V78, P1199, DOI 10.1111/j.1365-2958.2010.07399.x; Stewart J. J. P., MOPAC2009; Sudom AM, 2001, J MOL BIOL, V314, P83, DOI 10.1006/jmbi.2001.5120; Sullivan SM, 2008, P NATL ACAD SCI USA, V105, P13829, DOI 10.1073/pnas.0805364105; Sullivan SM, 2007, BIOCHEMISTRY-US, V46, P10078, DOI 10.1021/bi701038x; TORTORA P, 1985, ANAL BIOCHEM, V144, P179, DOI 10.1016/0003-2697(85)90101-0; Trapani S, 2001, J MOL BIOL, V313, P1059, DOI 10.1006/jmbi.2001.5093; URBINA JA, 1987, ARCH BIOCHEM BIOPHYS, V258, P186, DOI 10.1016/0003-9861(87)90335-3; Velayati AA, 2009, CHEST, V136, P420, DOI 10.1378/chest.08-2427; Via LE, 2008, INFECT IMMUN, V76, P2333, DOI 10.1128/IAI.01515-07; Wagner D, 2005, J IMMUNOL, V174, P1491, DOI 10.4049/jimmunol.174.3.1491; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Watanabe S, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002287	63	3	3	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0120682	10.1371/journal.pone.0120682	http://dx.doi.org/10.1371/journal.pone.0120682			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25798914	Green Submitted, gold, Green Published			2022-12-27	WOS:000351987300164
J	Martoni, F; Eickbush, DG; Scavariello, C; Luchetti, A; Mantovani, B				Martoni, Francesco; Eickbush, Danna G.; Scavariello, Claudia; Luchetti, Andrea; Mantovani, Barbara			Dead Element Replicating: Degenerate R2 Element Replication and rDNA Genomic Turnover in the Bacillus rossius Stick Insect (Insecta: Phasmida)	PLOS ONE			English	Article							NON-LTR RETROTRANSPOSONS; REVERSE-TRANSCRIPTASE; RNA; DYNAMICS; BRANCHIOPODA; INHERITANCE; EVOLUTION; BINDING; HYBRIDS; GENE	R2 is an extensively investigated non-LTR retrotransposon that specifically inserts into the 28S rRNA gene sequences of a wide range of metazoans, disrupting its functionality. During R2 integration, first strand synthesis can be incomplete so that 5' end deleted copies are occasionally inserted. While active R2 copies repopulate the locus by retrotransposing, the non-functional truncated elements should frequently be eliminated by molecular drive processes leading to the concerted evolution of the rDNA array(s). Although, multiple R2 lineages have been discovered in the genome of many animals, the rDNA of the stick insect Bacillus rossius exhibits a peculiar situation: it harbors both a canonical, functional R2 element (R2Br(fun)) as well as a full-length but degenerate element (R2Br(deg)). An intensive sequencing survey in the present study reveals that all truncated variants in stick insects are present in multiple copies suggesting they were duplicated by unequal recombination. Sequencing results also demonstrate that all R2Br(deg) copies are full-length, i.e. they have no associated 5' end deletions, and functional assays indicate they have lost the active ribozyme necessary for R2 RNA maturation. Although it cannot be completely ruled out, it seems unlikely that the degenerate elements replicate via reverse transcription, exploiting the R2Br(fun) element enzymatic machinery, but rather via genomic amplification of inserted 28S by unequal recombination. That inactive copies (both R2Br(deg) or 5'-truncated elements) are not eliminated in a short term in stick insects contrasts with findings for the Drosophila R2, suggesting a widely different management of rDNA loci and a lower efficiency of the molecular drive while achieving the concerted evolution.	[Martoni, Francesco; Scavariello, Claudia; Luchetti, Andrea; Mantovani, Barbara] Univ Bologna, Dipartimento Sci Biol Geol & Ambientali, Bologna, Italy; [Eickbush, Danna G.] Univ Rochester, Dept Biol, Rochester, NY 14627 USA	University of Bologna; University of Rochester	Luchetti, A (corresponding author), Univ Bologna, Dipartimento Sci Biol Geol & Ambientali, Bologna, Italy.	andrea.luchetti@unibo.it	Martoni, Francesco/AAB-1742-2019	Martoni, Francesco/0000-0001-8064-4460; Luchetti, Andrea/0000-0002-2986-721X	RFO - University of Bologna; Canziani; National Institutes of Health [R01GM42790]	RFO - University of Bologna; Canziani; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by RFO - University of Bologna and Canziani funding to AL and BM and National Institutes of Health Grant Number R01GM42790 to DGE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arkhipova IR, 2013, CYTOGENET GENOME RES, V140, P295, DOI 10.1159/000352069; Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Bibillo A, 2004, J BIOL CHEM, V279, P14945, DOI 10.1074/jbc.M310450200; Bibillo A, 2002, J BIOL CHEM, V277, P34836, DOI 10.1074/jbc.M204345200; Bonandin L, 2014, INSECT MOL BIOL, V23, P808, DOI 10.1111/imb.12126; Chenais B, 2012, GENE, V509, P7, DOI 10.1016/j.gene.2012.07.042; Christensen SM, 2006, P NATL ACAD SCI USA, V103, P17602, DOI 10.1073/pnas.0605476103; Doma MK, 2007, CELL, V131, P660, DOI 10.1016/j.cell.2007.10.041; DOVER G, 1982, NATURE, V299, P111, DOI 10.1038/299111a0; Eickbush DG, 2008, MOL CELL BIOL, V28, P6452, DOI 10.1128/MCB.01015-08; Eickbush DG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066441; Eickbush DG, 2012, MOBILE DNA-UK, V3, DOI 10.1186/1759-8753-3-10; Eickbush DG, 2010, MOL CELL BIOL, V30, P3142, DOI 10.1128/MCB.00300-10; Eickbush T.H., 2002, MOBILE DNA, P813; Eickbush TH, 2007, GENETICS, V175, P477, DOI 10.1534/genetics.107.071399; Huang CRL, 2012, ANNU REV GENET, V46, P651, DOI 10.1146/annurev-genet-110711-155616; Jamburuthugoda VK, 2014, NUCLEIC ACIDS RES, V42, P8405, DOI 10.1093/nar/gku514; Kojima KK, 2005, MOL BIOL EVOL, V22, P2157, DOI 10.1093/molbev/msi210; Kojima KK, 2004, MOL BIOL EVOL, V21, P207, DOI 10.1093/molbev/msg235; Kojima KK, 2013, REPBASE REPORTS, V13, P1215; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; LUAN DD, 1993, CELL, V72, P595, DOI 10.1016/0092-8674(93)90078-5; Luchetti A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057076; Luchetti A, 2012, GENOMICS, V100, P51, DOI 10.1016/j.ygeno.2012.04.005; Malik HS, 1999, MOL BIOL EVOL, V16, P793, DOI 10.1093/oxfordjournals.molbev.a026164; Malik HS, 2000, GENETICS, V154, P193; MANARESI S, 1991, CARYOLOGIA, V44, P265, DOI 10.1080/00087114.1991.10797192; Mantovani B, 2001, MOL PHYLOGENET EVOL, V19, P157, DOI 10.1006/mpev.2000.0850; Mingazzini V, 2011, HEREDITY, V106, P567, DOI 10.1038/hdy.2010.86; Moss WN, 2011, RNA BIOL, V8, P714, DOI 10.4161/rna.8.5.16033; Perez-Gonzalez CE, 2001, GENETICS, V158, P1557; Ruminski DJ, 2011, J BIOL CHEM, V286, P41286, DOI 10.1074/jbc.M111.297283; Stage DE, 2010, INSECT MOL BIOL, V19, P37, DOI 10.1111/j.1365-2583.2009.00949.x; Stage DE, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-5-r49; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; TINTI F, 1991, B ZOOL, V58, P235, DOI 10.1080/11250009109355759; Zhou J, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003179; Zhou J, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000386	38	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0121831	10.1371/journal.pone.0121831	http://dx.doi.org/10.1371/journal.pone.0121831			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25799008	Green Published, gold, Green Submitted			2022-12-27	WOS:000351987300295
J	McCarthy, A; Chiang, E; Schmidt, ML; Denef, VJ				McCarthy, Ann; Chiang, Edna; Schmidt, Marian L.; Denef, Vincent J.			RNA Preservation Agents and Nucleic Acid Extraction Method Bias Perceived Bacterial Community Composition	PLOS ONE			English	Article							TARGETED OLIGONUCLEOTIDE PROBES; SEA HYDROTHERMAL PLUME; MICROBIAL DIVERSITY; DNA EXTRACTION; WATER COLUMN; SOILS; SAMPLES; OCEAN; MICROORGANISMS; IMPACT	Bias is a pervasive problem when characterizing microbial communities. An important source is the difference in lysis efficiencies of different populations, which vary depending on the extraction protocol used. To avoid such biases impacting comparisons between gene and transcript abundances in the environment, the use of one protocol that simultaneously extracts both types of nucleic acids from microbial community samples has gained popularity. However, knowledge regarding tradeoffs to combined nucleic acid extraction protocols is limited, particularly regarding yield and biases in the observed community composition. Here, we evaluated a commercially available protocol for simultaneous extraction of DNA and RNA, which we adapted for freshwater microbial community samples that were collected on filters. DNA and RNA yields were comparable to other commonly used, but independent DNA and RNA extraction protocols. RNA protection agents benefited RNA quality, but decreased DNA yields significantly. Choice of extraction protocol influenced the perceived bacterial community composition, with strong method-dependent biases observed for specific phyla such as the Verrucomicrobia. The combined DNA/RNA extraction protocol detected significantly higher levels of Verrucomicrobia than the other protocols, and those higher numbers were confirmed by microscopic analysis. Use of RNA protection agents as well as independent sequencing runs caused a significant shift in community composition as well, albeit smaller than the shift caused by using different extraction protocols. Despite methodological biases, sample origin was the strongest determinant of community composition. However, when the abundance of specific phylogenetic groups is of interest, researchers need to be aware of the biases their methods introduce. This is particularly relevant if different methods are used for DNA and RNA extraction, in addition to using RNA protection agents only for RNA samples.	[McCarthy, Ann; Chiang, Edna; Schmidt, Marian L.; Denef, Vincent J.] Univ Michigan, Dept Ecol & Evolutionary Biol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Denef, VJ (corresponding author), Univ Michigan, Dept Ecol & Evolutionary Biol, Ann Arbor, MI 48109 USA.	vdenef@umich.edu			University of Michigan	University of Michigan(University of Michigan System)	This work was supported by funds from the University of Michigan to VJD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allers E, 2013, ISME J, V7, P256, DOI 10.1038/ismej.2012.108; AMANN RI, 1990, APPL ENVIRON MICROB, V56, P1919, DOI 10.1128/AEM.56.6.1919-1925.1990; Anantharaman K, 2013, P NATL ACAD SCI USA, V110, P330, DOI 10.1073/pnas.1215340110; [Anonymous], 2013, FRONT MICROBIOL; Arnds J, 2010, SYST APPL MICROBIOL, V33, P139, DOI 10.1016/j.syapm.2009.12.005; Bergmann GT, 2011, SOIL BIOL BIOCHEM, V43, P1450, DOI 10.1016/j.soilbio.2011.03.012; Berry D, 2011, APPL ENVIRON MICROB, V77, P7846, DOI 10.1128/AEM.05220-11; Bostrom KH, 2004, LIMNOL OCEANOGR-METH, V2, P365, DOI 10.4319/lom.2004.2.365; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Carrigg C, 2007, APPL MICROBIOL BIOT, V77, P955, DOI 10.1007/s00253-007-1219-y; Daims H, 1999, SYST APPL MICROBIOL, V22, P434, DOI 10.1016/S0723-2020(99)80053-8; Dick GJ, 2010, ENVIRON MICROBIOL, V12, P1334, DOI 10.1111/j.1462-2920.2010.02177.x; Dominianni C, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-103; Forney LJ, 2004, CURR OPIN MICROBIOL, V7, P210, DOI 10.1016/j.mib.2004.04.015; Frias-Lopez J, 2008, P NATL ACAD SCI USA, V105, P3805, DOI 10.1073/pnas.0708897105; Frostegard A, 1999, APPL ENVIRON MICROB, V65, P5409; FUHRMAN JA, 1988, APPL ENVIRON MICROB, V54, P1426, DOI 10.1128/AEM.54.6.1426-1429.1988; Halm H, 2009, ENVIRON MICROBIOL, V11, P1945, DOI 10.1111/j.1462-2920.2009.01917.x; Hugenholtz P, 1998, J BACTERIOL, V180, P4765, DOI 10.1128/JB.180.18.4765-4774.1998; Hurt RA, 2001, APPL ENVIRON MICROB, V67, P4495, DOI 10.1128/AEM.67.10.4495-4503.2001; Kozich JJ, 2013, APPL ENVIRON MICROB, V79, P5112, DOI 10.1128/AEM.01043-13; Kuczynski J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-5-210; Lee CK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044224; Lesniewski RA, 2012, ISME J, V6, P2257, DOI 10.1038/ismej.2012.63; Martin-Laurent F, 2001, APPL ENVIRON MICROB, V67, P2354, DOI 10.1128/AEM.67.5.2354-2359.2001; McMurdie PJ, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003531; Morgan JL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010209; Muller EEL, 2013, TRENDS MICROBIOL, V21, P325, DOI 10.1016/j.tim.2013.04.009; Newton RJ, 2011, MICROBIOL MOL BIOL R, V75, P14, DOI 10.1128/MMBR.00028-10; Niemi MR, 2001, J MICROBIOL METH, V45, P155; Ottesen EA, 2014, SCIENCE, V345, P207, DOI 10.1126/science.1252476; Pinto AJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043093; Poretsky R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093827; Poretsky RS, 2009, ENVIRON MICROBIOL, V11, P1358, DOI 10.1111/j.1462-2920.2008.01863.x; Rich VI, 2008, ENVIRON MICROBIOL, V10, P506, DOI 10.1111/j.1462-2920.2007.01471.x; Rissanen AJ, 2010, APPL MICROBIOL BIOT, V88, P977, DOI 10.1007/s00253-010-2838-2; Roume H, 2013, ISME J, V7, P110, DOI 10.1038/ismej.2012.72; Rubin BER, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070460; Schloss PD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027310; Shakya M, 2013, ENVIRON MICROBIOL, V15, P1882, DOI 10.1111/1462-2920.12086; Shi YM, 2009, NATURE, V459, P266, DOI 10.1038/nature08055; Tatangelo V, 2014, FEMS MICROBIOL LETT, V356, P32, DOI 10.1111/1574-6968.12475; Temperton B, 2012, CURR OPIN MICROBIOL, V15, P605, DOI 10.1016/j.mib.2012.07.001; Temperton B, 2009, ISME J, V3, P792, DOI 10.1038/ismej.2009.32; Tsementzi D, 2014, ENV MICROBIOL REP, V6, P640, DOI 10.1111/1758-2229.12180; Turnbaugh PJ, 2010, P NATL ACAD SCI USA, V107, P7503, DOI 10.1073/pnas.1002355107; Vishnivetskaya TA, 2014, FEMS MICROBIOL ECOL, V87, P217, DOI 10.1111/1574-6941.12219; WALLNER G, 1993, CYTOMETRY, V14, P136, DOI 10.1002/cyto.990140205; Wesolowska-Andersen A, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-19; Willner D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034605; Yu K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038183; Yuan SQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033865	52	42	44	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0121659	10.1371/journal.pone.0121659	http://dx.doi.org/10.1371/journal.pone.0121659			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25798612	gold, Green Published, Green Submitted			2022-12-27	WOS:000351987300283
J	Sakal, F; Chochua, S; Satzke, C; Dunne, EM; Mulholland, K; Klugman, KP; Vidal, JE				Sakal, Fuminori; Chochua, Sopio; Satzke, Catherine; Dunne, Eileen M.; Mulholland, Kim; Klugman, Keith P.; Vidal, Jorge E.			Single-Plex Quantitative Assays for the Detection and Quantification of Most Pneumococcal Serotypes	PLOS ONE			English	Article							DETERMINING CAPSULAR SEROTYPES; UPPER RESPIRATORY CARRIAGE; SEQUENTIAL MULTIPLEX PCR; STREPTOCOCCUS-PNEUMONIAE; NASOPHARYNGEAL CARRIAGE; STANDARD METHOD; CHILDREN; DISEASE; IDENTIFICATION; CULTURE	Streptococcus pneumoniae globally kills more children than any other infectious disease every year. A prerequisite for pneumococcal disease and transmission is colonization of the nasopharynx. While the introduction of pneumococcal conjugate vaccines has reduced the burden of pneumococcal disease, understanding the impact of vaccination on nasopharyngeal colonization has been hampered by the lack of sensitive quantitative methods for the detection of >90 known S. pneumoniae serotypes. In this work, we developed 27 new quantitative (q) PCR reactions and optimized 26 for a total of 53 qPCR reactions targeting pneumococcal serotypes or serogroups, including all vaccine types. Reactions proved to be target-specific with a limit of detection of 2 genome equivalents per reaction. Given the number of probes required for these assays and their unknown shelf-life, the stability of cryopreserved reagents was evaluated. Our studies demonstrate that two-year cryopreserved probes had similar limit of detection as freshly-diluted probes. Moreover, efficiency and limit of detection of 1-month cryopreserved, ready-to-use, qPCR reaction mixtures were similar to those of freshly prepared mixtures. Using these reactions, our proof-of-concept studies utilizing nasopharyngeal samples (N=30) collected from young children detected samples containing >= 2 serotypes/serogroups. Samples colonized by multiple serotypes/serogroups always had a serotype that contributes at least 50% of the pneumococcal load. In addition, a molecular approach called S6-q(PCR)(2) was developed and proven to individually detect and quantify epidemiologically-important serogroup 6 strains including 6A, 6B, 6C and 6D. This technology will be useful for epidemiological studies, diagnostic platforms and to study the pneumobiome.	[Sakal, Fuminori; Chochua, Sopio; Klugman, Keith P.; Vidal, Jorge E.] Emory Univ, Rollins Sch Publ Hlth, Hubert Dept Global Hlth, Atlanta, GA 30322 USA; [Satzke, Catherine; Dunne, Eileen M.; Mulholland, Kim] Univ Melbourne, Dept Paediat, Royal Childrens Hosp, Pneumococcal Res,Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia; [Satzke, Catherine] Univ Melbourne, Peter Doherty Inst Infect & Immun, Dept Microbiol & Immunol, Melbourne, Vic 3010, Australia; [Mulholland, Kim] London Sch Hyg & Trop Med, London WC1, England	Emory University; Rollins School Public Health; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; University of Melbourne; University of Melbourne; University of London; London School of Hygiene & Tropical Medicine	Vidal, JE (corresponding author), Emory Univ, Rollins Sch Publ Hlth, Hubert Dept Global Hlth, Atlanta, GA 30322 USA.	jvidalg@emory.edu	Satzke, Catherine/D-6501-2013; Dunne, Eileen M/M-3203-2019	Satzke, Catherine/0000-0003-3164-8849; Dunne, Eileen M/0000-0001-5542-0780	Murdoch Childrens Research Institute [26180]; Bill and Melinda Gates Foundation [52099]; Victorian Government's Operational Infrastructure Support Program	Murdoch Childrens Research Institute; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Victorian Government's Operational Infrastructure Support Program	This study was supported by a subcontract granted to JEV (#26180) by Murdoch Childrens Research Institute which received funds from the Bill and Melinda Gates Foundation (Grant 52099). Research at MCRI was also supported by the Victorian Government's Operational Infrastructure Support Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrich WC, 2012, CLIN INFECT DIS, V54, P601, DOI 10.1093/cid/cir859; Azzari C, 2012, VACCINE, V30, P2701, DOI 10.1016/j.vaccine.2011.12.008; Azzari C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009282; Carvalho MDG, 2013, PEERJ, V1, DOI 10.7717/peerj.97; Carvalho MD, 2012, J CLIN MICROBIOL, V50, P3146, DOI 10.1128/JCM.01505-12; Carvalho MD, 2010, J CLIN MICROBIOL, V48, P1611, DOI 10.1128/JCM.02243-09; Carvalho MDS, 2007, J CLIN MICROBIOL, V45, P2460, DOI 10.1128/JCM.02498-06; Chien YW, 2013, PEDIATR INFECT DIS J, V32, P72, DOI 10.1097/INF.0b013e318270d850; Dias CA, 2007, J MED MICROBIOL, V56, P1185, DOI 10.1099/jmm.0.47347-0; du Plessis M, 2008, INT J ANTIMICROB AG, V32, pS66, DOI 10.1016/j.ijantimicag.2008.06.002; Dunne EM, 2013, VACCINE, V31, P2333, DOI 10.1016/j.vaccine.2013.03.024; Ercibengoa M, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-69; Green M, 2009, TLS-TIMES LIT SUPPL, P6; HOLT LB, 1962, J GEN MICROBIOL, V27, P327, DOI 10.1099/00221287-27-2-327; Huebner RE, 2000, PEDIATR INFECT DIS J, V19, P1017, DOI 10.1097/00006454-200010000-00019; Jedrzejas MJ, 2001, MICROBIOL MOL BIOL R, V65, P187, DOI 10.1128/MMBR.65.2.187-207.2001; Jin P, 2009, J INFECT DIS, V200, P1375, DOI 10.1086/606118; Jin P, 2009, J CLIN MICROBIOL, V47, P2470, DOI 10.1128/JCM.00484-09; Klugman KP, 2008, CLIN INFECT DIS, V47, pS202, DOI 10.1086/591405; Klugman KP, 2009, ADV EXP MED BIOL, V634, P121, DOI 10.1007/978-0-387-79838-7_11; Ko KS, 2013, J CLIN MICROBIOL, V51, P3395, DOI 10.1128/JCM.01645-13; Levine OS, 2009, AM J EPIDEMIOL, V170, P1067, DOI 10.1093/aje/kwp316; Menezes APD, 2013, J CLIN MICROBIOL, V51, P2470, DOI 10.1128/JCM.00743-13; Mercado E, 2011, J CLIN MICROBIOL, V49, P2080, DOI 10.1128/JCM.00153-11; Moore CE, 2010, AM J TROP MED HYG, V83, P451, DOI 10.4269/ajtmh.2010.10-0225; O'Brien KL, 2009, LANCET, V374, P893, DOI 10.1016/S0140-6736(09)61204-6; O'Brien KL, 2003, PEDIATR INFECT DIS J, V22, P133, DOI [10.1097/00006454-200302000-00009, 10.1097/00006454-200302000-00010]; O'Brien KL, 2001, J CLIN MICROBIOL, V39, P1021, DOI 10.1128/JCM.39.3.1021-1024.2001; Oftadeh S, 2010, J CLIN MICROBIOL, V48, P3378, DOI 10.1128/JCM.00675-10; Pai R, 2006, J CLIN MICROBIOL, V44, P124, DOI 10.1128/JCM.44.1.124-131.2006; Pimenta FC, 2013, J CLIN MICROBIOL, V51, P647, DOI 10.1128/JCM.02927-12; Pimenta FC, 2009, J CLIN MICROBIOL, V47, P2353, DOI 10.1128/JCM.00704-09; Rodgers Gail L, 2011, Vaccine, V29 Suppl 3, pC43, DOI 10.1016/j.vaccine.2011.07.047; Sakai F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067147; Satzke, 2014, 9 INT S PNEUM PNEUM; Satzke C, 2013, VACCINE, V32, P165, DOI 10.1016/j.vaccine.2013.08.062; Shakl JR, 2013, TRENDS MICROBIOL, V21, P129, DOI 10.1016/j.tim.2012.11.005; Simell B, 2012, EXPERT REV VACCINES, V11, P841, DOI [10.1586/ERV.12.53, 10.1586/erv.12.53]; Staples M, 2014, DIAGN MICR INFEC DIS, V78, P307, DOI 10.1016/j.diagmicrobio.2013.11.017; Tarrago D, 2008, CLIN MICROBIOL INFEC, V14, P828, DOI 10.1111/j.1469-0691.2008.02028.x; Tettelin H, 2001, SCIENCE, V293, P498, DOI 10.1126/science.1061217; Tokarz R, 2013, J CLIN MICROBIOL, V51, P995, DOI 10.1128/JCM.02974-12; Turner P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067933; Turner P, 2011, J CLIN MICROBIOL, V49, P1784, DOI 10.1128/JCM.00157-11; van der Poll T, 2009, LANCET, V374, P1543, DOI 10.1016/S0140-6736(09)61114-4; Walker CLF, 2013, LANCET, V381, P1405, DOI 10.1016/S0140-6736(13)60222-6; WU TC, 1980, J CLIN MICROBIOL, V12, P772, DOI 10.1128/JCM.12.6.772-775.1980; Wyllie AL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102045	48	20	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0121064	10.1371/journal.pone.0121064	http://dx.doi.org/10.1371/journal.pone.0121064			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25798884	gold, Green Published			2022-12-27	WOS:000351987300204
J	Sheffield, BS; Tinker, AV; Shen, YQ; Hwang, H; Li-Chang, HH; Pleasance, E; Ch'ng, C; Lum, A; Lorette, J; McConnell, YJ; Sun, S; Jones, SJM; Gown, AM; Huntsman, DG; Schaeffer, DF; Churg, A; Yip, S; Laskin, J; Marra, MA				Sheffield, Brandon S.; Tinker, Anna V.; Shen, Yaoqing; Hwang, Harry; Li-Chang, Hector H.; Pleasance, Erin; Ch'ng, Carolyn; Lum, Amy; Lorette, Julie; McConnell, Yarrow J.; Sun, Sophie; Jones, Steven J. M.; Gown, Allen M.; Huntsman, David G.; Schaeffer, David F.; Churg, Andrew; Yip, Stephen; Laskin, Janessa; Marra, Marco A.			Personalized Oncogenomics: Clinical Experience with Malignant Peritoneal Mesothelioma Using Whole Genome Sequencing	PLOS ONE			English	Article							RECEPTOR TYROSINE KINASES; BAP1; PATHOGENESIS; MUTATIONS; DELETION	Peritoneal mesothelioma is a rare and sometimes lethal malignancy that presents a clinical challenge for both diagnosis and management. Recent studies have led to a better understanding of the molecular biology of peritoneal mesothelioma. Translation of the emerging data into better treatments and outcome is needed. From two patients with peritoneal mesothelioma, we derived whole genome sequences, RNA expression profiles, and targeted deep sequencing data. Molecular data were made available for translation into a clinical treatment plan. Treatment responses and outcomes were later examined in the context of molecular findings. Molecular studies presented here provide the first reported whole genome sequences of peritoneal mesothelioma. Mutations in known mesothelioma-related genes NF2, CDKN2A, LATS2, amongst others, were identified. Activation of MET-related signaling pathways was demonstrated in both cases. A hypermutated phenotype was observed in one case (434 vs. 18 single nucleotide variants) and was associated with a favourable outcome despite sarcomatoid histology and multifocal disease. This study represents the first report of whole genome analyses of peritoneal mesothelioma, a key step in the understanding and treatment of this disease.	[Sheffield, Brandon S.; Li-Chang, Hector H.; Lum, Amy; Lorette, Julie; Gown, Allen M.; Huntsman, David G.; Schaeffer, David F.; Churg, Andrew; Yip, Stephen] Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC V5Z 1M9, Canada; [Tinker, Anna V.; Sun, Sophie; Laskin, Janessa] British Columbia Canc Agcy, Div Med Oncol, Vancouver Ctr, Vancouver, BC V5Z 4E6, Canada; [Shen, Yaoqing; Pleasance, Erin; Ch'ng, Carolyn; Jones, Steven J. M.; Marra, Marco A.] British Columbia Canc Agcy, Canadas Michael Smith Genome Sci Ctr, Vancouver, BC V5Z 4E6, Canada; [Hwang, Harry; Gown, Allen M.] PhenoPath Labs, Seattle, WA USA; [McConnell, Yarrow J.] Univ British Columbia, Dept Surg, Surg Oncol, Vancouver, BC V6T 1W5, Canada	University of British Columbia; British Columbia Cancer Agency; British Columbia Cancer Agency; PhenoPath Laboratories; University of British Columbia	Laskin, J (corresponding author), British Columbia Canc Agcy, Div Med Oncol, Vancouver Ctr, Vancouver, BC V5Z 4E6, Canada.	jlaskin@bccancer.bc.ca; mmarra@bcgsc.ca	Jones, Steven J/C-3621-2009; Yip, Stephen/E-9994-2012; Marra, Marco A/B-5987-2008; Huntsman, David/ABE-6082-2020	Jones, Steven J/0000-0003-3394-2208; Yip, Stephen/0000-0002-8514-9861; Marra, Marco A/0000-0001-7146-7175; Ch'ng, Carolyn/0000-0003-0323-4243	Personolized Oncogenomics program; BC Cancer Agency Research Foundation; PhenoPath Laboratories	Personolized Oncogenomics program; BC Cancer Agency Research Foundation; PhenoPath Laboratories	This work was supported by the Personolized Oncogenomics program with funding from the BC Cancer Agency Research Foundation. PhenoPath Laboratories provided support in the form of salaries for authors HH & AMG. The funders did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Wahab O, 2009, BLOOD, V114, P144, DOI 10.1182/blood-2009-03-210039; Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Andrysik Z, 2013, CELL REP, V3, P1346, DOI 10.1016/j.celrep.2013.04.014; Bashashati A, 2013, J PATHOL, V231, P21, DOI 10.1002/path.4230; Bott M, 2011, NAT GENET, V43, P668, DOI 10.1038/ng.855; Brevet M, 2011, J THORAC ONCOL, V6, P864, DOI 10.1097/JTO.0b013e318215a07d; Bridda Alessio, 2007, MedGenMed, V9, P32; Bueno R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010612; Cao C, 2012, ANN ONCOL, V23, P1494, DOI 10.1093/annonc/mdr477; Forbes SA, 2014, NUCL ACIDS RES; Fourouclas N, 2008, HAEMATOL-HEMATOL J, V93, P1635, DOI 10.3324/haematol.13043; Graziani I, 2008, CANCER RES, V68, P9678, DOI 10.1158/0008-5472.CAN-08-0969; Hwang H, 2014, AM J SURG PATHOL, V38, P681, DOI 10.1097/PAS.0000000000000176; Illei PB, 2003, CANCER CYTOPATHOL, V99, P51, DOI 10.1002/cncr.10923; Jamshidi F, 2014, ONCOLOGIST, V19, P623, DOI 10.1634/theoncologist.2013-0390; Jean D, 2012, ARCH PATHOL LAB MED, V136, P277, DOI 10.5858/arpa.2011-0215-RA; Klebe S, 2009, MODERN PATHOL, V23, P470; Kruger S, 2014, ANTICANCER DRUGS; McMillan R, 2012, ANN CARDIOTHORAC SUR, V1, P462, DOI 10.3978/j.issn.2225-319X.2012.10.09; Murali R, 2013, PATHOLOGY, V45, P116, DOI 10.1097/PAT.0b013e32835d0efb; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Ou WB, 2011, NEOPLASIA, V13, P12, DOI 10.1593/neo.101156; Pfeifer GP, 2006, CURR TOP MICROBIOL, V301, P259; Price B, 2009, CRIT REV TOXICOL, V39, P576, DOI 10.1080/10408440903044928; Rascoe PA, 2012, EXPERT REV MOL MED, V14, DOI 10.1017/erm.2012.6; Roberts SA, 2012, NAT REV CANCER, V14, P786; Sheffield BS, 2015, AM J SURG PATHOL; Shi YD, 2012, CLIN CANCER RES, V18, P4646, DOI 10.1158/1078-0432.CCR-12-0599; Sohn I, 2012, GYNECOL ONCOL, V126, P103, DOI 10.1016/j.ygyno.2012.03.050; Testa JR, 2011, NAT GENET, V43, P1022, DOI 10.1038/ng.912; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Weiner SJ, 2009, J CANCER RES CLIN, V135, P15, DOI 10.1007/s00432-008-0444-9; Zhou S, 2014, BRIT J CANCER, V110, P2479, DOI 10.1038/bjc.2014.220	33	30	30	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0119689	10.1371/journal.pone.0119689	http://dx.doi.org/10.1371/journal.pone.0119689			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25798586	Green Submitted, Green Published, gold			2022-12-27	WOS:000351987300073
J	Zhang, L; Wang, XH; Zheng, XM; Liu, TZ; Zhang, WB; Zheng, H; Chen, MF				Zhang, Lin; Wang, Xing-Huan; Zheng, Xin-Min; Liu, Tong-Zu; Zhang, Wei-Bin; Zheng, Hang; Chen, Mi-Feng			Maternal Gestational Smoking, Diabetes, Alcohol Drinking, Pre-Pregnancy Obesity and the Risk of Cryptorchidism: A Systematic Review and Meta-Analysis of Observational Studies	PLOS ONE			English	Review							HORMONE-BINDING GLOBULIN; ENDOCRINE-DISRUPTING CHEMICALS; CONGENITAL-CRYPTORCHIDISM; TESTICULAR DESCENT; GENITAL MALFORMATIONS; PREGNANCY; HYPOSPADIAS; CONSUMPTION; POPULATION; MANAGEMENT	Background Maternal gestational smoking, diabetes, alcohol drinking, and pre-pregnancy obesity are thought to increase the risk of cryptorchidism in newborn males, but the evidence is inconsistent. Method We conducted a systematic review and meta-analysis of studies on the association between maternal gestational smoking, diabetes, alcohol drinking, and pre-pregnancy obesity and the risk of cryptorchidism. Articles were retrieved by searching PubMed and Science-Direct, and the meta-analysis was conducted using Stata/SE 12.0 software. Sensitivity analysis was used to evaluate the influence of confounding variables. Results We selected 32 articles, including 12 case-control, five nested case-control, and 15 cohort studies. The meta-analysis showed that maternal smoking (OR = 1.17, 95% CI: 1.11-1.23) or diabetes (OR = 1.21, 95% CI: 1.00-1.46) during pregnancy were associated with increased risk of cryptorchidism. Overall, the association between maternal alcohol drinking (OR = 0.97, 95% CI: 0.87-1.07), pre-pregnancy body mass index (OR = 1.02, 95% CI: 0.95-1.09) and risk of cryptorchidism were not statistically significant. Additional analysis showed reduced risk (OR = 0.89, 95% CI: 0.82-0.96) of cryptorchidism with moderate alcohol drinking during pregnancy. No dose-response relationship was observed for increments in body mass index in the risk of cryptorchidism. Sensitivity analysis revealed an unstable result for the association between maternal diabetes, alcohol drinking and cryptorchidism. Moderate heterogeneity was detected in studies of the effect of maternal alcohol drinking and diabetes. No publication bias was detected. Conclusion Maternal gestational smoking, but not maternal pre-pregnancy overweight or obesity, was associated with increased cryptorchidism risk in the offspring. Moderate alcohol drinking may reduce the risk of cryptorchidism while gestational diabetes may be a risk factor, but further studies are needed to verify this.	[Zhang, Lin; Wang, Xing-Huan; Zheng, Xin-Min; Liu, Tong-Zu; Zhang, Wei-Bin; Zheng, Hang] Wuhan Univ, Zhongnan Hosp, Dept Urol, Wuhan 430072, Hubei, Peoples R China; [Chen, Mi-Feng] Jingmen 2 Peoples Hosp, Dept Obstet, Jingmen, Hubei, Peoples R China	Wuhan University	Zhang, L (corresponding author), Wuhan Univ, Zhongnan Hosp, Dept Urol, Wuhan 430072, Hubei, Peoples R China.	thezhanglin@hotmail.com	Wang, Xinghuan/AAB-3192-2021	Wang, Xinghuan/0000-0003-3497-0024				Abaci A, 2013, J CLIN RES PEDIATR E, V5, P65, DOI 10.4274/Jcrpe.883; Adams SV, 2011, BIRTH DEFECTS RES A, V91, P241, DOI 10.1002/bdra.20805; Agopian AJ, 2014, AM J MED GENET A, V164, P943, DOI 10.1002/ajmg.a.36389; Akre O, 1999, EPIDEMIOLOGY, V10, P364, DOI 10.1097/00001648-199907000-00005; BEARD CM, 1984, AM J EPIDEMIOL, V120, P707, DOI 10.1093/oxfordjournals.aje.a113938; Berkowitz GS, 1996, PAEDIATR PERINAT EP, V10, P39, DOI 10.1111/j.1365-3016.1996.tb00024.x; BERKOWITZ GS, 1995, EPIDEMIOLOGY, V6, P127, DOI 10.1097/00001648-199503000-00007; BERLIN JA, 1993, EPIDEMIOLOGY, V4, P218, DOI 10.1097/00001648-199305000-00005; Biggs ML, 2002, EPIDEMIOLOGY, V13, P197, DOI 10.1097/00001648-200203000-00015; Boisen KA, 2004, LANCET, V363, P1264, DOI 10.1016/S0140-6736(04)15998-9; Brouwers MM, 2012, J PEDIATR UROL, V8, P59, DOI 10.1016/j.jpurol.2010.11.001; Carbone P, 2007, INT J ANDROL, V30, P3, DOI 10.1111/j.1365-2605.2006.00703.x; Comploj E, 2012, EUR UROL SUPPL, V11, P2, DOI 10.1016/j.eursup.2012.01.005; Cook MB, 2010, INT J EPIDEMIOL, V39, P1605, DOI 10.1093/ije/dyq120; Damgaard IN, 2007, ENVIRON HEALTH PERSP, V115, P272, DOI 10.1289/ehp.9608; Damgaard IN, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003051; DAVIES TW, 1986, INT J EPIDEMIOL, V15, P197, DOI 10.1093/ije/15.2.197; Ferlin A, 2008, JAMA-J AM MED ASSOC, V300, P2271, DOI 10.1001/jama.2008.668; Fernandez MF, 2007, ENVIRON HEALTH PERSP, V115, P8, DOI 10.1289/ehp.9351; Fowler PA, 2008, J CLIN ENDOCR METAB, V93, P619, DOI 10.1210/jc.2007-1860; Fraser A, 2013, AM J EPIDEMIOL, V178, P1414, DOI 10.1093/aje/kwt137; Gaspari L, 2011, HUM REPROD, V26, P3155, DOI 10.1093/humrep/der283; Giordano F, 2008, PAEDIATR PERINAT EP, V22, P249, DOI 10.1111/j.1365-3016.2007.00918.x; Greenland S, 2004, AM J EPIDEMIOL, V160, P301, DOI 10.1093/aje/kwh221; Hackshaw A, 2011, HUM REPROD UPDATE, V17, P589, DOI 10.1093/humupd/dmr022; Hakonsen LB, 2014, ASIAN J ANDROL, V16, P39, DOI 10.4103/1008-682X.122351; Huff DS, 2001, HORM RES, V55, P11, DOI 10.1159/000049957; Hutson JM, 2005, J PEDIATR SURG, V40, P297, DOI 10.1016/j.jpedsurg.2004.10.033; Hutson JM, 1997, ENDOCR REV, V18, P259, DOI 10.1210/er.18.2.259; Jensen MS, 2007, ACTA PAEDIATR, V96, P1681, DOI 10.1111/j.1651-2227.2007.00506.x; Jensen MS, 2007, EPIDEMIOLOGY, V18, P220, DOI 10.1097/01.ede.0000254061.90686.9f; Jones ME, 1998, PAEDIATR PERINAT EP, V12, P383; Khatwa Umakanth A., 2000, Indian Journal of Pediatrics, V67, P449, DOI 10.1007/BF02859466; Kopp HP, 2001, EXP CLIN ENDOCR DIAB, V109, P365, DOI 10.1055/s-2001-17408; Kurahashi N, 2005, MED SCI MONITOR, V11, pCR274; Larsson SC, 2011, AM J EPIDEMIOL, V174, P993, DOI 10.1093/aje/kwr226; Macdonald G, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001930.pub3; MAGEE MS, 1993, JAMA-J AM MED ASSOC, V269, P609, DOI 10.1001/jama.269.5.609; Main KM, 2008, ENVIRON HEALTH PERSP, V116, pA194, DOI 10.1289/ehp.11052R; Main KM, 2007, ENVIRON HEALTH PERSP, V115, P1519, DOI 10.1289/ehp.9924; Ritzen EM, 2007, ACTA PAEDIATR, V96, P638, DOI 10.1111/j.1651-2227.2006.00159.x; MCBRIDE ML, 1991, INT J EPIDEMIOL, V20, P964, DOI 10.1093/ije/20.4.964; McGlynn KA, 2006, INT J EPIDEMIOL, V35, P787, DOI 10.1093/ije/dyl024; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Mongraw-Chaffin ML, 2008, AM J EPIDEMIOL, V167, P257, DOI 10.1093/aje/kwm311; Mori Mitsuru, 1992, Kurume Medical Journal, V39, P53; O'Leary CM, 2009, BJOG-INT J OBSTET GY, V116, P390, DOI 10.1111/j.1471-0528.2008.02058.x; Orsini N, 2006, STATA J, V6, P40, DOI 10.1177/1536867X0600600103; Pierik FH, 2004, ENVIRON HEALTH PERSP, V112, P1570, DOI 10.1289/ehp.7243; Preiksa RT, 2005, HUM REPROD, V20, P1928, DOI 10.1093/humrep/deh887; Roach VJ, 1998, GYNECOL OBSTET INVES, V45, P174, DOI 10.1159/000009950; Rubenwolf P, 2013, AKTUEL UROL, V44, P445, DOI 10.1055/s-0033-1358664; SHIONO PH, 1986, TERATOLOGY, V34, P65, DOI 10.1002/tera.1420340109; SIMMONS D, 1995, J CLIN ENDOCR METAB, V80, P2217, DOI 10.1210/jc.80.7.2217; Strandberg-Larsen K, 2009, HUM REPROD, V24, P3211, DOI 10.1093/humrep/dep325; Thadhani R, 2003, AM J OBSTET GYNECOL, V189, P171, DOI 10.1067/mob.2003.343; Trabert B, 2014, EPIDEMIOLOGY, V25, P152, DOI 10.1097/EDE.0000000000000014; Virtanen HE, 2006, J CLIN ENDOCR METAB, V91, P4862, DOI 10.1210/jc.2006-1420; Wagner-Mahler K, 2011, INT J ANDROL, V34, pE499, DOI 10.1111/j.1365-2605.2011.01211.x; Wells GA, 2011, NEWCASTLE OTTAWA SCA; Wenzler DL, 2004, J UROLOGY, V171, P849, DOI 10.1097/01.ju.0000106100.21225.d7; Zhang J, 1998, JAMA-J AM MED ASSOC, V280, P1690, DOI 10.1001/jama.280.19.1690	62	16	17	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0119006	10.1371/journal.pone.0119006	http://dx.doi.org/10.1371/journal.pone.0119006			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25798927	Green Published, Green Submitted, gold			2022-12-27	WOS:000351987300025
J	Da, YM; Niu, KY; Wang, K; Cui, GX; Wang, WJ; Jin, B; Sun, Y; Jia, J; Qin, LH; Bai, WP				Da, Yunmeng; Niu, Kaiyu; Wang, Ke; Cui, Guangxia; Wang, Wenjuan; Jin, Biao; Sun, Yu; Jia, Jing; Qin, Lihua; Bai, Wenpei			A Comparison of the Effects of Estrogen and Cimicifuga racemosa on the Lacrimal Gland and Submandibular Gland in Ovariectomized Rats	PLOS ONE			English	Article							BLACK COHOSH EXTRACT; HORMONE REPLACEMENT THERAPY; MENOPAUSAL SYMPTOMS; RECEPTOR-BETA; CELLS; WOMEN; MODULATION; EXPRESSION; ALPHA; IDENTIFICATION	This study aims to observe the effects of estradiol and Cimicifuga racemosa on the lacrimal gland and submandibular gland of ovariectomized rats. We randomly divided 20 adult female SD rats into four groups-a sham-operated group (SHAM), ovariectomized (OVX) group, ovariectomized group treated with estradiol (OVX+ E), and ovariectomized group treated with the isopropanolic extract of Cimicifuga racemosa (OVX+ iCR). The SHAM group and OVX group used distilled water to instead the drugs. Two weeks after ovariectomy, the estradiol and iCR were administered for 4 weeks. Next, we used H&E staining and electron microscopy to observe any histological changes in the lacrimal and submandibular glands and immunohistochemical staining to observe the expressions of cleaved caspase-3 (Casp-3) and Cu-Zn SOD (superoxide dismutase). The H&E staining find that both drugs can prevent the cells of area from shrinkage in the two kinds of gland. But under the electron microscopy, estradiol and iCR have different efficacy. Estradiol is more effective at protecting mitochondria in lacrimal gland acinar cells than iCR, and iCR is more effective at suppressing endoplasmic reticulum expansion than estradiol. Both estradiol and iCR have a similar protective function on mitochondria in the submandibular gland. The protective function of the two glands may inhibit apoptosis by suppressing the expression of Casp-3. In addition, iCR increases the expression of Cu-Zn SOD in duct system of submandibular gland. The results suggest that both estradiol and iCR confer a protective effect on the lacrimal and submandibular glands of ovariectomized rats via different mechanisms.	[Da, Yunmeng; Niu, Kaiyu; Jia, Jing] Gen Hosp Chinese Peoples Armed Police Forces, Dept Stomatol, Beijing, Peoples R China; [Wang, Ke; Wang, Wenjuan; Jin, Biao; Qin, Lihua] Peking Univ, Hlth Sci Ctr, Dept Anat & Embryol, Beijing 100871, Peoples R China; [Cui, Guangxia] Civil Aviat Gen Hosp, Dept Obstet & Gynecol, Beijing, Peoples R China; [Sun, Yu; Bai, Wenpei] Peking Univ, Hosp 1, Dept Obstet & Gynecol, Beijing 100871, Peoples R China	Peking University; Peking University	Jia, J (corresponding author), Gen Hosp Chinese Peoples Armed Police Forces, Dept Stomatol, Beijing, Peoples R China.	jiajing1996@126.com; qinlihua88@163.com; bwp66@163.com			Beijing Municipal Science and Technology Commission [Z131100006813005]	Beijing Municipal Science and Technology Commission(Beijing Municipal Science & Technology Commission)	Funding: This work was supported by Beijing Municipal Science and Technology Commission, grant number Z131100006813005 to JJ (URL: http://www.bjkw.gov.cn/n8785584/index.html). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Affinito P, 2003, MENOPAUSE, V10, P482, DOI 10.1097/01.GME.0000063568.84134.35; Azzarolo AM, 2003, EXP EYE RES, V77, P347, DOI 10.1016/S0014-4835(03)00120-9; Bai WP, 2007, MATURITAS, V58, P31, DOI 10.1016/j.maturitas.2007.04.009; Baltgalvis KA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010164; BARKA T, 1980, J HISTOCHEM CYTOCHEM, V28, P836, DOI 10.1177/28.8.7003006; Bednarek-Tupikowska G, 2001, GYNECOL ENDOCRINOL, V15, P298, DOI 10.1080/713602888; Burdette JE, 2002, J AGR FOOD CHEM, V50, P7022, DOI 10.1021/jf020725h; Campos LB, 2012, FREE RADICAL BIO MED, V53, P680, DOI 10.1016/j.freeradbiomed.2012.05.043; Carpenter JS, 2005, AM J MED, V118, P1409, DOI 10.1016/j.amjmed.2005.10.020; Carroll DG, 2006, AM FAM PHYSICIAN, V73, P457; Carvalho VDC, 2011, PATHOL RES PRACT, V207, P300, DOI 10.1016/j.prp.2011.01.002; Chen Z, 2005, APOPTOSIS, V10, P499, DOI 10.1007/s10495-005-1879-y; Choi EM, 2013, J APPL TOXICOL, V33, P488, DOI 10.1002/jat.1784; Cui GX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082815; Deng L, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.9; Eliasson L, 2003, ARCH ORAL BIOL, V48, P511, DOI 10.1016/S0003-9969(03)00094-3; EVANS MP, 1995, MAYO CLIN PROC, V70, P800, DOI 10.4065/70.8.800; Fontana R, 2014, ENDOCRINOLOGY, V155, P2213, DOI 10.1210/en.2013-1731; Fu ZQ, 2014, ONCOL LETT, V7, P560, DOI 10.3892/ol.2013.1701; Gonzalez M, 2008, GEN COMP ENDOCR, V155, P857, DOI 10.1016/j.ygcen.2007.10.007; Gravena AAF, 2013, BMC WOMENS HEALTH, V13, DOI 10.1186/1472-6874-13-46; Graziottin Alessandra, 2009, Menopause Int, V15, P76, DOI 10.1258/mi.2009.009021; Hickey M, 2005, LANCET, V366, P409, DOI 10.1016/S0140-6736(05)66519-1; Hughes J, 2007, NEPHROLOGY, V12, P452, DOI 10.1111/j.1440-1797.2007.00854.x; Kang LS, 2011, AM J PHYSIOL-HEART C, V300, pH2105, DOI 10.1152/ajpheart.00349.2010; Kousteni S, 2003, J CLIN INVEST, V111, P1651, DOI 10.1172/JCI200317261; Kupferer EM, 2009, JOGNN-J OBST GYN NEO, V38, P50, DOI 10.1111/j.1552-6909.2008.00305.x; Kurabuchi S, 2009, J MED INVESTIG, V56, P290, DOI 10.2152/jmi.56.290; Kusunoki T, 2006, AURIS NASUS LARYNX, V33, P47, DOI 10.1016/j.anl.2005.07.010; LIU H, 2014, PLOS NEGLECT TROP D, V8, P5138, DOI DOI 10.1371/JOURNAL.PONE.0085272; Ma XY, 2011, J ETHNOPHARMACOL, V138, P156, DOI 10.1016/j.jep.2011.08.076; Mahady GB, 2003, NUTR REV, V61, P183, DOI 10.1301/nr.2003.may.183-186; Moon L, 2011, J ETHNOPHARMACOL, V133, P336, DOI 10.1016/j.jep.2010.10.004; Mosquera L, 2014, BRAIN RES, V1561, P11, DOI 10.1016/j.brainres.2014.03.002; Nedrow A, 2006, ARCH INTERN MED, V166, P1453, DOI 10.1001/archinte.166.14.1453; Rachon D, 2008, MATURITAS, V60, P209, DOI 10.1016/j.maturitas.2008.06.001; Rees M, 2009, BEST PRACT RES CL OB, V23, P151, DOI 10.1016/j.bpobgyn.2008.10.006; Scholz M, 2005, MED RES REV, V25, P331, DOI 10.1002/med.20025; Seamon V, 2008, EXP EYE RES, V87, P184, DOI 10.1016/j.exer.2008.05.012; Serviddio G, 2002, J CLIN ENDOCR METAB, V87, P2843, DOI 10.1210/jc.87.6.2843; Song XJ, 2014, INVEST OPHTH VIS SCI, V55, P745, DOI 10.1167/iovs.12-10457; Spelsberg H, 2004, EYE, V18, P729, DOI 10.1038/sj.eye.6701314; Strehlow K, 2003, CIRC RES, V93, P170, DOI 10.1161/01.RES.0000082334.17947.11; Su Y, 2014, BIOORG MED CHEM LETT, V24, P5688, DOI 10.1016/j.bmcl.2014.10.066; SULLIVAN DA, 1986, EXP EYE RES, V42, P131, DOI 10.1016/0014-4835(86)90037-0; THAYSEN JH, 1954, AM J PHYSIOL, V178, P155, DOI 10.1152/ajplegacy.1954.178.1.155; Tiran Denise, 2006, Br J Nurs, V15, P645; Tsinti M, 2009, EUR J ORAL SCI, V117, P498, DOI 10.1111/j.1600-0722.2009.00659.x; Valimaa H, 2004, J ENDOCRINOL, V180, P55, DOI 10.1677/joe.0.1800055; Viereck V, 2005, TRENDS ENDOCRIN MET, V16, P214, DOI 10.1016/j.tem.2005.05.002; Wickham LA, 1998, ADV EXP MED BIOL, V438, P95; Winterhoff H, 2003, MATURITAS, V44, pS51, DOI 10.1016/S0378-5122(02)00348-1; Yim MB, 1999, NEUROTOX RES, V1, P91, DOI 10.1007/BF03033273	53	17	17	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0121470	10.1371/journal.pone.0121470	http://dx.doi.org/10.1371/journal.pone.0121470			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25793872	Green Submitted, gold, Green Published			2022-12-27	WOS:000352083900134
J	Habicher, J; Haitina, T; Eriksson, I; Holmborn, K; Dierker, T; Ahlberg, PE; Ledin, J				Habicher, Judith; Haitina, Tatjana; Eriksson, Inger; Holmborn, Katarina; Dierker, Tabea; Ahlberg, Per E.; Ledin, Johan			Chondroitin/Dermatan Sulfate Modification Enzymes in Zebrafish Development	PLOS ONE			English	Article							ACETYLGALACTOSAMINE 4-SULFATE 6-O-SULFOTRANSFERASE; IN-SITU HYBRIDIZATION; MOLECULAR-CLONING; DERMATAN SULFATE; HEPARAN-SULFATE; IDURONIC ACID; EXPRESSION; BIOSYNTHESIS; 4-O-SULFOTRANSFERASE-1; MUTATIONS	Chondroitin/dermatan sulfate (CS/DS) proteoglycans consist of unbranched sulfated polysaccharide chains of repeating GalNAc-GlcA/IdoA disaccharide units, attached to serine residues on specific proteins. The CS/DS proteoglycans are abundant in the extracellular matrix where they have essential functions in tissue development and homeostasis. In this report a phylogenetic analysis of vertebrate genes coding for the enzymes that modify CS/DS is presented. We identify single orthologous genes in the zebrafish genome for the sulfotransferases chst7, chst11, chst13, chst14, chst15 and ust and the epimerase dse. In contrast, two copies were found for mammalian sulfotransferases CHST3 and CHST12 and the epimerase DSEL, named chst3a and chst3b, chst12a and chst12b, dsela and dselb, respectively. Expression of CS/DS modification enzymes is spatially and temporally regulated with a large variation between different genes. We found that CS/DS 4-O-sulfotransferases and 6-O-sulfotransferases as well as CS/DS epimerases show a strong and partly overlapping expression, whereas the expression is restricted for enzymes with ability to synthesize di-sulfated disaccharides. A structural analysis further showed that CS/DS sulfation increases during embryonic development mainly due to synthesis of 4-O-sulfated GalNAc while the proportion of 6-O-sulfated GalNAc increases in later developmental stages. Di-sulfated GalNAc synthesized by Chst15 and 2-O-sulfated GlcA/IdoA synthesized by Ust are rare, in accordance with the restricted expression of these enzymes. We also compared CS/DS composition with that of heparan sulfate (HS). Notably, CS/DS biosynthesis in early zebrafish development is more dynamic than HS biosynthesis. Furthermore, HS contains disaccharides with more than one sulfate group, which are virtually absent in CS/DS.	[Habicher, Judith; Haitina, Tatjana; Holmborn, Katarina; Ahlberg, Per E.; Ledin, Johan] Uppsala Univ, Dept Organismal Biol, Sci Life Lab, Uppsala, Sweden; [Eriksson, Inger; Dierker, Tabea] Uppsala Univ, Dept Med Biochem & Microbiol, Sci Life Lab, Uppsala, Sweden	Uppsala University; Uppsala University	Ledin, J (corresponding author), Uppsala Univ, Dept Organismal Biol, Sci Life Lab, Uppsala, Sweden.	Johan.Ledin@ebc.uu.se		Haitina, Tatjana/0000-0002-8754-5534; Ahlberg, Per/0000-0001-9054-2900; Ledin, Johan/0000-0002-7319-7735	Knut and Alice Wallenberg Foundation; Swedish Research Council VR	Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Swedish Research Council VR(Swedish Research Council)	This work was supported by grants from the Knut and Alice Wallenberg Foundation (https://www.wallenberg.com/kaw/en), and the Swedish Research Council VR (http://www.vr.se/inenglish.4.12fff4451215cbd83e4800015152.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartolini B, 2012, GLYCOBIOLOGY, V22, P1007, DOI 10.1093/glycob/cws065; Diez-Roux G, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000582; Esko J.D., 2009, ESSENTIALS GLYCOBIOL; Esko JD, 1996, CURR OPIN STRUC BIOL, V6, P663, DOI 10.1016/S0959-440X(96)80034-0; Evers MR, 2001, J BIOL CHEM, V276, P36344, DOI 10.1074/jbc.M105848200; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Filipek-Gorniok B, 2013, DEV DYNAM, V242, P964, DOI 10.1002/dvdy.23981; Flicek P, 2013, NUCLEIC ACIDS RES, V41, pD48, DOI 10.1093/nar/gks1236; Fukuta M, 1998, BBA-GENE STRUCT EXPR, V1399, P57, DOI 10.1016/S0167-4781(98)00089-X; Hayes AJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075787; Hayes AJ, 2013, DEV DYNAM, V242, P778, DOI 10.1002/dvdy.23970; Hiraoka N, 2000, J BIOL CHEM, V275, P20188, DOI 10.1074/jbc.M002443200; Hoegg S, 2004, J MOL EVOL, V59, P190, DOI 10.1007/s00239-004-2613-z; Holmborn K, 2012, J BIOL CHEM, V287, P33905, DOI 10.1074/jbc.M112.401646; Izumikawa T, 2012, BIOCHEM J, V441, P697, DOI 10.1042/BJ20111472; Izumikawa T, 2011, BIOCHEM J, V434, P321, DOI 10.1042/BJ20101456; Kang HG, 2002, J BIOL CHEM, V277, P34766, DOI 10.1074/jbc.M204907200; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kitagawa H, 2000, J BIOL CHEM, V275, P21075, DOI 10.1074/jbc.M002101200; Kluppel M, 2005, DEVELOPMENT, V132, P3989, DOI 10.1242/dev.01948; Kluppel M, 2002, MECH DEVELOP, V118, P77, DOI 10.1016/S0925-4773(02)00198-3; Kobayashi M, 1999, J BIOL CHEM, V274, P10474, DOI 10.1074/jbc.274.15.10474; Kreuger J, 2006, J CELL BIOL, V174, P323, DOI 10.1083/jcb.200604035; Kusche-Gullberg M, 2003, CURR OPIN STRUC BIOL, V13, P605, DOI 10.1016/j.sbi.2003.08.002; Ledin J, 2004, J BIOL CHEM, V279, P42732, DOI 10.1074/jbc.M405382200; Ledin J, 2006, J BIOL CHEM, V281, P35727, DOI 10.1074/jbc.M604113200; Maccarana M, 2006, J BIOL CHEM, V281, P11560, DOI 10.1074/jbc.M513373200; Maccarana M, 2009, MOL CELL BIOL, V29, P5517, DOI 10.1128/MCB.00430-09; Maeda N, 2011, NEUROCHEM RES, V36, P1228, DOI 10.1007/s11064-010-0324-y; Malfait F, 2010, HUM MUTAT, V31, P1233, DOI 10.1002/humu.21355; MALMSTROM A, 1975, J BIOL CHEM, V250, P3419; Mikami T, 2013, BBA-GEN SUBJECTS, V1830, P4719, DOI 10.1016/j.bbagen.2013.06.006; Miyata S, 2012, NAT NEUROSCI, V15, P414, DOI 10.1038/nn.3023; Mizumoto S, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/495764; Mizumoto S, 2013, J BIOL CHEM, V288, P10953, DOI 10.1074/jbc.R112.437038; Mizumoto S, 2009, BIOCHEM J, V419, P387, DOI 10.1042/BJ20081639; Muller T, 2013, HUM MOL GENET, V22, P3761, DOI 10.1093/hmg/ddt227; Nandini CD, 2006, ADV PHARMACOL, V53, P253, DOI 10.1016/S1054-3589(05)53012-6; Ohtake S, 2001, J BIOL CHEM, V276, P43894, DOI 10.1074/jbc.M104922200; Ohtake-Niimi S, 2010, J BIOL CHEM, V285, P20793, DOI 10.1074/jbc.M109.084749; Pacheco B, 2009, GLYCOBIOLOGY, V19, P1197, DOI 10.1093/glycob/cwp110; Pacheco B, 2009, J BIOL CHEM, V284, P9788, DOI 10.1074/jbc.M809339200; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Prabhakar V, 2006, ADV PHARMACOL, V53, P69, DOI 10.1016/S1054-3589(06)53005-9; Reynard LN, 2013, EXPERT REV MOL MED, V15, DOI 10.1017/erm.2013.4; Sakai K, 2007, J BIOL CHEM, V282, P4152, DOI 10.1074/jbc.M606870200; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Sugahara K, 2000, CURR OPIN STRUC BIOL, V10, P518, DOI 10.1016/S0959-440X(00)00125-1; Thelin MA, 2013, FEBS J, V280, P2431, DOI 10.1111/febs.12214; Thiele H, 2004, P NATL ACAD SCI USA, V101, P10155, DOI 10.1073/pnas.0400334101; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; Unger S, 2010, AM J MED GENET A, V152A, P2543, DOI 10.1002/ajmg.a.33641; Uyama T, 2006, J BIOL CHEM, V281, P38668, DOI 10.1074/jbc.M609320200; van der Zwaag B, 2005, GENOMICS, V86, P55, DOI 10.1016/j.ygeno.2005.03.007; Yamada S, 2009, GLYCOBIOLOGY, V19, P488, DOI 10.1093/glycob/cwp005	55	13	14	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0121957	10.1371/journal.pone.0121957	http://dx.doi.org/10.1371/journal.pone.0121957			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25793894	gold, Green Published, Green Submitted			2022-12-27	WOS:000352083900161
J	Jecz, P; Bartosik, AA; Glabski, K; Jagura-Burdzy, G				Jecz, Paulina; Bartosik, Aneta A.; Glabski, Krzysztof; Jagura-Burdzy, Grazyna			A Single parS Sequence from the Cluster of Four Sites Closest to oriC Is Necessary and Sufficient for Proper Chromosome Segregation in Pseudomonas aeruginosa	PLOS ONE			English	Article							STREPTOMYCES-COELICOLOR A3(2); DNA-REPLICATION INITIATION; PROTEIN SPO0J PARB; BACILLUS-SUBTILIS; BACTERIAL CHROMOSOME; CELL-DIVISION; PARTITIONING PROTEINS; SOJ PARA; CAULOBACTER-CRESCENTUS; PLASMID PARTITION	Among the mechanisms that control chromosome segregation in bacteria are highly-conserved partitioning systems comprising three components: ParA protein (a deviant Walker-type ATPase), ParB protein (a DNA-binding element) and multiple cis-acting palindromic centromere-like sequences, designated parS. Ten putative parS sites have been identified in the P. aeruginosa PAO1 genome, four localized in close proximity of oriC and six, diverged by more than one nucleotide from a perfect palindromic sequence, dispersed along the chromosome. Here, we constructed and analyzed P. aeruginosa mutants deprived of each single parS sequence and their different combinations. The analysis included evaluation of a set of phenotypic features, chromosome segregation, and ParB localization in the cells. It was found that ParB binds specifically to all ten parS sites, although with different affinities. The P. aeruginosa parS mutant with all ten parS sites modified (parSnull) is viable however it demonstrates the phenotype characteristic for parAnull or parBnull mutants: slightly slower growth rate, high frequency of anucleate cells, and defects in motility. The genomic position and sequence of parS determine its role in P. aeruginosa biology. It transpired that any one of the four parS sites proximal to oriC (parS1 to parS4), which are bound by ParB with the highest affinity, is necessary and sufficient for the parABS role in chromosome partitioning. When all these four sites are mutated simultaneously, the strain shows the parSnull phenotype, which indicates that none of the remaining six parS sites can substitute for these four oriC-proximal sites in this function. A single ectopic parS2 (inserted opposite oriC in the parSnull mutant) facilitates ParB organization into regularly spaced condensed foci and reverses some of the mutant phenotypes but is not sufficient for accurate chromosome segregation.	[Jecz, Paulina; Bartosik, Aneta A.; Glabski, Krzysztof; Jagura-Burdzy, Grazyna] Polish Acad Sci, Dept Microbial Biochem, Inst Biochem & Biophys, Warsaw, Poland	Polish Academy of Sciences; Institute of Biochemistry & Biophysics - Polish Academy of Sciences	Jagura-Burdzy, G (corresponding author), Polish Acad Sci, Dept Microbial Biochem, Inst Biochem & Biophys, Warsaw, Poland.	gjburdzy@ibb.waw.pl	Bartosik, Aneta/AAR-9347-2021; Jecz, Paulina/S-7566-2018; Jagura-Burdzy, Grazyna/AAU-7423-2021	Bartosik, Aneta/0000-0002-2091-3101; Jecz, Paulina/0000-0001-7612-8631; Jagura-Burdzy, Grazyna/0000-0002-0794-2565	Foundation for Polish Science; European Union-Regional Development Fund	Foundation for Polish Science(Foundation for Polish ScienceEuropean Commission); European Union-Regional Development Fund(European Commission)	PJ was supported by the International PhD Projects Programme "Studies of nucleic acids and proteins-from basic to applied research" of the Foundation for Polish Science co-financed by the European Union-Regional Development Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Autret S, 2003, MOL MICROBIOL, V47, P159, DOI 10.1046/j.1365-2958.2003.03264.x; Baek JH, 2014, MBIO, V5, DOI 10.1128/mBio.01061-14; Bartosik AA, 2009, MICROBIOL-SGM, V155, P1080, DOI 10.1099/mic.0.024661-0; Bartosik AA, 2004, J BACTERIOL, V186, P6983, DOI 10.1128/JB.186.20.6983-6998.2004; Bartosik AA, 2014, MICROBIOL-SGM, V160, P2406, DOI 10.1099/mic.0.081216-0; Bartosik AA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087276; Bowman GR, 2008, CELL, V134, P945, DOI 10.1016/j.cell.2008.07.015; Breier AM, 2007, MOL MICROBIOL, V64, P703, DOI 10.1111/j.1365-2958.2007.05690.x; Broedersz CP, 2014, P NATL ACAD SCI USA, V111, P8809, DOI 10.1073/pnas.1402529111; CHURCHWARD G, 1984, GENE, V31, P165, DOI 10.1016/0378-1119(84)90207-5; Ditkowski B, 2013, OPEN BIOL, V3, DOI 10.1098/rsob.130006; Dubarry N, 2006, J BACTERIOL, V188, P1489, DOI 10.1128/JB.188.4.1489-1496.2006; Ebersbach G, 2008, CELL, V134, P956, DOI 10.1016/j.cell.2008.07.016; El-Sayed AK, 2001, MICROBIOL-SGM, V147, P2127, DOI 10.1099/00221287-147-8-2127; Fogel MA, 2005, MOL MICROBIOL, V55, P125, DOI 10.1111/j.1365-2958.2004.04379.x; Fogel MA, 2006, GENE DEV, V20, P3269, DOI 10.1101/gad.1496506; Gerdes K, 2000, MOL MICROBIOL, V37, P455, DOI 10.1046/j.1365-2958.2000.01975.x; Gerdes K, 2010, CELL, V141, P927, DOI 10.1016/j.cell.2010.05.033; Ginda K, 2013, MOL MICROBIOL, V87, P998, DOI 10.1111/mmi.12146; Glaser P, 1997, GENE DEV, V11, P1160, DOI 10.1101/gad.11.9.1160; Graham TGW, 2014, GENE DEV, V28, P1228, DOI 10.1101/gad.242206.114; Gruber S, 2009, CELL, V137, P685, DOI 10.1016/j.cell.2009.02.035; Hayes F, 2000, MOL MICROBIOL, V37, P528, DOI 10.1046/j.1365-2958.2000.02030.x; Irani VR, 1997, BIOTECHNIQUES, V22, P54, DOI 10.2144/97221bm09; IRETON K, 1994, J BACTERIOL, V176, P5320, DOI 10.1128/JB.176.17.5320-5329.1994; JAGURA-BURDZY G, 1991, J BACTERIOL, V173, P826, DOI 10.1128/jb.173.2.826-833.1991; Jakimowicz D, 2002, MOL MICROBIOL, V45, P1365, DOI 10.1046/j.1365-2958.2002.03102.x; Jakimowicz D, 2007, MOL MICROBIOL, V65, P625, DOI 10.1111/j.1365-2958.2007.05815.x; Jakimowicz D, 2012, MOL MICROBIOL, V85, P393, DOI 10.1111/j.1365-2958.2012.08107.x; Jakimowicz P, 2005, J BIOL CHEM, V280, P8309, DOI 10.1074/jbc.M412622200; Kadoya R, 2011, J BACTERIOL, V193, P1504, DOI 10.1128/JB.01067-10; Kim HJ, 2000, J BACTERIOL, V182, P1313, DOI 10.1128/JB.182.5.1313-1320.2000; KOONIN EV, 1993, NUCLEIC ACIDS RES, V21, P2541, DOI 10.1093/nar/21.11.2541; Kusiak M, 2011, J BACTERIOL, V193, P3342, DOI 10.1128/JB.00328-11; Lasocki K, 2007, J BACTERIOL, V189, P5762, DOI 10.1128/JB.00371-07; Lee PS, 2006, MOL MICROBIOL, V60, P853, DOI 10.1111/j.1365-2958.2006.05140.x; Lee PS, 2003, J BACTERIOL, V185, P1326, DOI 10.1128/JB.185.4.1326-1337.2003; Leonard TA, 2005, PHILOS T R SOC B, V360, P523, DOI 10.1098/rstb.2004.1608; Leonard TA, 2005, EMBO J, V24, P270, DOI 10.1038/sj.emboj.7600530; Lin DCH, 1998, CELL, V92, P675, DOI 10.1016/S0092-8674(00)81135-6; Lin DCH, 1997, P NATL ACAD SCI USA, V94, P4721, DOI 10.1073/pnas.94.9.4721; Livny J, 2007, J BACTERIOL, V189, P8693, DOI 10.1128/JB.01239-07; Lobocka M, 1996, J MOL BIOL, V259, P366, DOI 10.1006/jmbi.1996.0326; Mierzejewska J, 2012, MICROBIOL-SGM, V158, P1183, DOI 10.1099/mic.0.056234-0; Mierzejewska J, 2012, PLASMID, V67, P1, DOI 10.1016/j.plasmid.2011.08.003; Minnen A, 2011, MOL MICROBIOL, V81, P676, DOI 10.1111/j.1365-2958.2011.07722.x; Mohl DA, 2001, MOL MICROBIOL, V42, P741, DOI 10.1046/j.1365-2958.2001.02643.x; Mohl DA, 1997, CELL, V88, P675, DOI 10.1016/S0092-8674(00)81910-8; MULLIS K, 1986, COLD SPRING HARB SYM, V51, P263, DOI 10.1101/SQB.1986.051.01.032; Murray H, 2008, CELL, V135, P74, DOI 10.1016/j.cell.2008.07.044; Murray H, 2006, MOL MICROBIOL, V61, P1352, DOI 10.1111/j.1365-2958.2006.05316.x; OGASAWARA N, 1992, MOL MICROBIOL, V6, P629, DOI 10.1111/j.1365-2958.1992.tb01510.x; Ptacin JL, 2014, P NATL ACAD SCI USA, V111, pE2046, DOI 10.1073/pnas.1405188111; Ptacin JL, 2010, NAT CELL BIOL, V12, P791, DOI 10.1038/ncb2083; Quisel JD, 2000, J BACTERIOL, V182, P3446, DOI 10.1128/JB.182.12.3446-3451.2000; Rashid MH, 2000, P NATL ACAD SCI USA, V97, P4885, DOI 10.1073/pnas.060030097; Real G, 2005, MOL MICROBIOL, V55, P349, DOI 10.1111/j.1365-2958.2004.04399.x; Resnekov O, 1996, GENES CELLS, V1, P529, DOI 10.1046/j.1365-2443.1996.d01-262.x; Ringgaard S, 2007, J BIOL CHEM, V282, P28216, DOI 10.1074/jbc.M703733200; Ringgaard S, 2007, J BIOL CHEM, V282, P3134, DOI 10.1074/jbc.M609092200; Rodionov O, 1999, SCIENCE, V283, P546, DOI 10.1126/science.283.5401.546; Saint-Dic D, 2006, J BACTERIOL, V188, P5626, DOI 10.1128/JB.00250-06; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Schofield WB, 2010, EMBO J, V29, P3068, DOI 10.1038/emboj.2010.207; Scholefield G, 2011, MOL MICROBIOL, V79, P1089, DOI 10.1111/j.1365-2958.2010.07507.x; Schumacher MA, 2012, CURR OPIN STRUC BIOL, V22, P72, DOI 10.1016/j.sbi.2011.11.001; Sharpe ME, 1998, MOL MICROBIOL, V28, P981, DOI 10.1046/j.1365-2958.1998.00857.x; Stover CK, 2000, NATURE, V406, P959, DOI 10.1038/35023079; Sullivan NL, 2009, CELL, V137, P697, DOI 10.1016/j.cell.2009.04.044; Thanbichler M, 2006, CELL, V126, P147, DOI 10.1016/j.cell.2006.05.038; Toro E, 2008, P NATL ACAD SCI USA, V105, P15435, DOI 10.1073/pnas.0807448105; Umbarger MA, 2011, MOL CELL, V44, P252, DOI 10.1016/j.molcel.2011.09.010; Venkova-Canova T, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003579; Viollier PH, 2004, P NATL ACAD SCI USA, V101, P9257, DOI 10.1073/pnas.0402606101; Wang XD, 2013, NAT REV GENET, V14, P191, DOI 10.1038/nrg3375; Wu LJ, 2003, MOL MICROBIOL, V49, P1463, DOI 10.1046/j.1365-2958.2003.03643.x; Wu LJ, 2002, EMBO J, V21, P4001, DOI 10.1093/emboj/cdf393; Yamaichi Y, 2000, P NATL ACAD SCI USA, V97, P14656, DOI 10.1073/pnas.97.26.14656; Yamaichi Y, 2007, J BACTERIOL, V189, P5314, DOI 10.1128/JB.00416-07; Yamaichi Y, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002189	80	11	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0120867	10.1371/journal.pone.0120867	http://dx.doi.org/10.1371/journal.pone.0120867			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25794281	Green Published, gold			2022-12-27	WOS:000352083900083
J	Jin, A; Lalonde, CE; Brussoni, M; McCormick, R; George, MA				Jin, Andrew; Lalonde, Christopher E.; Brussoni, Mariana; McCormick, Rod; George, M. Anne			Injury Hospitalizations Due to Unintentional Falls among the Aboriginal Population of British Columbia, Canada: Incidence, Changes over Time, and Ecological Analysis of Risk Markers, 1991-2010	PLOS ONE			English	Article								Background Aboriginal people in British Columbia (BC) have higher injury incidence than the general population. Our project describes variability among injury categories, time periods, and geographic, demographic and socio-economic groups. This report focuses on unintentional falls. Methods We used BC's universal health care insurance plan as a population registry, linked to hospital separation and vital statistics databases. We identified Aboriginal people by insurance premium group and birth and death record notations. We identified residents of specific Aboriginal communities by postal code. We calculated crude incidence and Standardized Relative Risk (SRR) of hospitalization for unintentional fall injury, standardized for age, gender and Health Service Delivery Area (HSDA), relative to the total population of BC. We tested hypothesized associations of geographic, socio-economic, and employment-related characteristics with community SRR of injury by linear regression. Results During 1991 through 2010, the crude rate of hospitalization for unintentional fall injury in BC was 33.6 per 10,000 person-years. The Aboriginal rate was 49.9 per 10,000 and SRR was 1.89 (95% confidence interval 1.85-1.94). Among those living on reserves SRR was 2.00 (95% CI 1.93-2.07). Northern and non-urban HSDAs had higher SRRs, within both total and Aboriginal populations. In every age and gender category, the HSDA-standardized SRR was higher among the Aboriginal than among the total population. Between 1991 and 2010, crude rates and SRRs declined substantially, but proportionally more among the Aboriginal population, so the gap between the Aboriginal and total population is narrowing, particularly among females and older adults. These community characteristics were associated with higher risk: lower income, lower educational level, worse housing conditions, and more hazardous types of employment. Conclusions Over the years, as socio-economic conditions improve, risk of hospitalization due to unintentional fall injury has declined among the Aboriginal population. Women and older adults have benefited more.	[Jin, Andrew] Epidemiol Consultant, Surrey, BC, Canada; [Lalonde, Christopher E.] Univ Victoria, Dept Psychol, Fac Social Sci, Victoria, BC, Canada; [Brussoni, Mariana; George, M. Anne] Univ British Columbia, Dept Pediat, Fac Med, Vancouver, BC V6T 1W5, Canada; [Brussoni, Mariana; George, M. Anne] Child & Family Res Inst, Vancouver, BC, Canada; [Brussoni, Mariana; George, M. Anne] Univ British Columbia, Sch Populat & Publ Hlth, Vancouver, BC V5Z 1M9, Canada; [McCormick, Rod] Thompson Rivers Univ, Fac Human Social & Educ Dev, Kamloops, BC, Canada	University of Victoria; University of British Columbia; Child & Family Research Institute; University of British Columbia	George, MA (corresponding author), Univ No British Columbia, Prince George, BC V2L 5P2, Canada.	ageorge@mail.ubc.ca	Brussoni, Mariana/U-9404-2018; Jin, Andrew/H-5725-2019	Brussoni, Mariana/0000-0002-1495-816X; Jin, Andrew/0000-0002-8708-2381; George, M. Anne/0000-0001-7129-2117; Lalonde, Christopher/0000-0002-0446-0464	Canadian Institutes of Health Research, Institute of Aboriginal Peoples Health [81043]; Child & Family Research Institute; Michael Smith Foundation; British Columbia Region, First Nations and Inuit Health, Health Canada	Canadian Institutes of Health Research, Institute of Aboriginal Peoples Health(Canadian Institutes of Health Research (CIHR)); Child & Family Research Institute; Michael Smith Foundation(Michael Smith Foundation for Health Research); British Columbia Region, First Nations and Inuit Health, Health Canada	Funding: This work was funded by the Canadian Institutes of Health Research, Institute of Aboriginal Peoples Health [grant number AHR # 81043]. Salary support for authors was provided by the Child & Family Research Institute (MAG, MB), by a Michael Smith Foundation for Health Research Scholar Award (MB), and the British Columbia Region, First Nations and Inuit Health, Health Canada (AJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BC Ministry of Health [creator], 2012, CONS FIL MSP REG PRE; BC Ministry of Health [creator], 2011, DISCH ABSTR DAT HOSP; BC Vital Statistics Agency, 2011, VIT STAT DEATHS; BC Vital Statistics Agency [creator], 2011, VIT STAT BIRTHS; Bell N, 2011, INJURY PREV, V17, P394, DOI 10.1136/ip.2010.030866; Bridges FS, 2005, PSYCHOL REP, V97, P739, DOI 10.2466/pr0.97.3.739-749; *BRIT COL VIT STAT, 2004, REG AN HLTH STAT STA; British Columbia. Provincial Health Officer, 2009, PATHW HLTH HEAL 2 RE; Brussoni M, 2014, PREV SCI; Chandler M. J., 1998, TRANSCULT PSYCHIATRY, V35, P191, DOI DOI 10.1177/136346159803500202; Cloutier E, 2001, EC BURDEN UNINTENTIO; Corporate Information Management Directorate, 2005, INF MAN BRACH BAND C; Desapriya E, 2011, INJURY PREV, V17, P4, DOI 10.1136/ip.2010.026914; Evans RG, 1994, WHY ARE SOME POEPLE; George MA, 2015, HEALTH REP, V26, P3; George MA, 2013, INT J CIRCUMPOL HEAL, V72, P441, DOI 10.3402/ijch.v72i0.21182; Jin A, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-710; Kahn HA, 1989, STAT METHODS EPIDEMI, P95; Penney C, 2012, COMMUNITY WELL BEING; Sayer P, 2009, DEMOGRAPHIC SOCIOECO; Scott V., 2004, PREVENTION FALLS INJ; *SMARTRISK, 2009, EC BURD INJ CAN; Tjepkema Michael, 2011, Health Rep, V22, P25	23	15	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0121694	10.1371/journal.pone.0121694	http://dx.doi.org/10.1371/journal.pone.0121694			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25793298	Green Published, Green Submitted, gold			2022-12-27	WOS:000352083900147
J	Jung, YH; Park, HYL; Jung, KI; Park, CK				Jung, Youn Hea; Park, Hae-Young L.; Jung, Kyoung In; Park, Chan Kee			Comparison of Prelaminar Thickness between Primary Open Angle Glaucoma and Normal Tension Glaucoma Patients	PLOS ONE			English	Article							OPTIC-NERVE HEAD; LAMINA-CRIBROSA; EXTRACELLULAR-MATRIX; DISC MORPHOLOGY; BLOOD-FLOW; DISPLACEMENT; TISSUE; DAMAGE	Main Objective The thinning of prelaminar tissue and prelamina cupping is known to occur by ischemia, as we see in anterior ischemic optic neuropathy. Since normal tension glaucoma (NTG) is thought to be more related to vascular factor than in primary open-angle glaucoma (POAG), we hypothesized that prelamina thinning may occur prominently in NTG patients. This study investigated the difference in prelaminar tissue thickness between patients with POAG and NTG and verified the factors related to prelaminar thinning. Methods Complete ophthalmic examination including standard automatic perimetry was performed in all patients. The prelaminar tissue thickness was measured in all patients by performing enhanced depth imaging with a Heidelberg Spectralis Optical Coherence Tomography. The retinal nerve fiber layer and optic nerve head parameters were obtained using the Heidelberg Retina Tomography II and Cirrus Optical Coherence Tomography. Various ocular factors and their relationships with prelaminar thickness were analyzed. Results The mean prelaminar tissue thickness was significantly thinner in patients with POAG than in those with NTG. The difference in the prelaminar thickness between patients with POAG and those with NTG was greater in the early field defect group than in the moderate and severe field groups. In multivariate analysis, the mean prelaminar thickness was related to the intraocular pressure, mean deviation, cup-disc ratio, and cup volume. Conclusions The prelaminar tissue was thinner in patients with POAG than in patients with NTG, and intraocular pressure had a strong influence on the prelaminar thickness in both POAG and NTG. This may indicate that mechanical compression is the main pathogenic factor in both POAG and NTG.	[Jung, Youn Hea; Park, Hae-Young L.; Jung, Kyoung In; Park, Chan Kee] Catholic Univ Korea, Seoul St Marys Hosp, Dept Ophthalmol & Visual Sci, Seoul, South Korea	Catholic University of Korea; Seoul St. Mary's Hospital	Park, CK (corresponding author), Catholic Univ Korea, Seoul St Marys Hosp, Dept Ophthalmol & Visual Sci, Seoul, South Korea.	ckpark@catholic.ac.kr						Agoumi Y, 2011, OPHTHALMOLOGY, V118, P52, DOI 10.1016/j.ophtha.2010.05.016; ANDERSON DR, 1969, ARCH OPHTHALMOL-CHIC, V82, P506; Barrancos C, 2014, EYE, V28, P58, DOI 10.1038/eye.2013.238; Bellezza AJ, 2003, INVEST OPHTH VIS SCI, V44, P623, DOI 10.1167/iovs.01-1282; Danesh-Meyer HV, 2010, INVEST OPHTH VIS SCI, V51, P2003, DOI 10.1167/iovs.09-3492; Flammer J, 1998, PROG RETIN EYE RES, V17, P267, DOI 10.1016/S1350-9462(97)00006-2; Flammer J, 2002, PROG RETIN EYE RES, V21, P359, DOI 10.1016/S1350-9462(02)00008-3; Hayreh SS, 2001, OPHTHALMOLOGY, V108, P1586, DOI 10.1016/S0161-6420(01)00649-2; HENKIND P, 1970, AM J OPHTHALMOL, V69, P78, DOI 10.1016/0002-9394(70)91859-3; HERNANDEZ MR, 1993, ANN MED, V25, P309, DOI 10.3109/07853899309147290; HERNANDEZ MR, 1992, INVEST OPHTH VIS SCI, V33, P2891; HERNANDEZ MR, 1990, AM J OPHTHALMOL, V109, P180, DOI 10.1016/S0002-9394(14)75984-7; HERNANDEZ MR, 1986, AM J OPHTHALMOL, V102, P139, DOI 10.1016/0002-9394(86)90134-0; Lee EJ, 2012, OPHTHALMOLOGY, V119, DOI 10.1016/j.ophtha.2012.01.034; Mozaffarieh M, 2013, CURR OPIN PHARMACOL, V13, P43, DOI 10.1016/j.coph.2012.10.001; Park HYL, 2012, OPHTHALMOLOGY, V119, P10, DOI 10.1016/j.ophtha.2011.07.033; Parrish RK, 2009, AM J OPHTHALMOL, V147, P717, DOI 10.1016/j.ajo.2008.10.007; QUIGLEY HA, 1979, OPHTHALMOLOGY, V86, P1803; QUIGLEY HA, 1981, ARCH OPHTHALMOL-CHIC, V99, P635, DOI 10.1001/archopht.1981.03930010635009; Reis ASC, 2012, INVEST OPHTH VIS SCI, V53, P5819, DOI 10.1167/iovs.12-9924; Shields MB, 2008, CURR OPIN OPHTHALMOL, V19, P85, DOI 10.1097/ICU.0b013e3282f3919b	21	47	48	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0120634	10.1371/journal.pone.0120634	http://dx.doi.org/10.1371/journal.pone.0120634			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25793734	Green Published, gold			2022-12-27	WOS:000352083900061
J	Li, Y; Chen, L; Ngoc, DM; Duan, YP; Lu, ZB; Wen, ZH; Meng, XZ				Li, Yue; Chen, Ling; Ngoc, Duong Minh; Duan, Yan-Ping; Lu, Zhi-Bo; Wen, Zhi-Hao; Meng, Xiang-Zhou			Polybrominated Diphenyl Ethers (PBDEs) in PM2.5, PM10, TSP and Gas Phase in Office Environment in Shanghai, China: Occurrence and Human Exposure	PLOS ONE			English	Article							BROMINATED FLAME RETARDANTS; INDOOR AIR-QUALITY; PARTICULATE MATTER; URBAN AREAS; PERSONAL EXPOSURE; DIURNAL-VARIATION; OUTDOOR AIR; DUST; PARTICLES; ASSOCIATIONS	To evaluate risk via inhalation exposure of polybrominated diphenyl ethers (PBDEs) in office environment, thirty-six pairs air samples including PM2.5 (particles with aerodynamic diameter less than 2.5 mu m), PM10 (particles with aerodynamic diameter less than 10 mu m), total suspended particles (TSP) with matching gas phase were collected in office environment in Shanghai, China. The average concentrations of PM2.5, PM10 and TSP were 20.4, 27.2 and 50.3 mu g/m(3), respectively. Sigma 15PBDEs mean concentrations in PM2.5, PM10, TSP and gas phase were 51.8, 110.7, 148 and 59.6 pg/m(3), respectively. Much more PBDEs distributed in fine fractions than coarse ones. PBDEs congener profiles found in PM2.5, PM10 and TSP (dominated by BDE-209) were different from that in gas phase (dominated by the tri-to penta-BDEs). Approximately 3.20 pg/kg/d PM2.5 bound PBDEs can be inhaled into the lung; 3.62 pg/kg/d PM10-PM2.5(particles with aerodynamic diameter of 2.5-10 mu m) bound PBDEs tended to be deposited in the upper part of respiratory system, and the intake of PBDEs via gas-phase was 2.74 pg/kg/d. The exposure of PBDEs was far below the minimal risk levels (MRLs), indicating lower risk from PBDEs via inhalation in the studied office in Shanghai.	[Li, Yue; Chen, Ling; Ngoc, Duong Minh; Duan, Yan-Ping; Lu, Zhi-Bo; Wen, Zhi-Hao; Meng, Xiang-Zhou] Tongji Univ, Coll Environm Sci & Engn, State Key Lab Pollut Control & Resources Reuse, Shanghai 200092, Peoples R China; [Duan, Yan-Ping] Shanghai Fisheries Res Inst, Shanghai, Peoples R China	Tongji University	Chen, L (corresponding author), Tongji Univ, Coll Environm Sci & Engn, State Key Lab Pollut Control & Resources Reuse, Shanghai 200092, Peoples R China.	duanyanping@tongji.edu.cn; chenling@tongji.edu.cn	ZHIBO, LU/HHS-4083-2022		National Key Technology R&D Program in the 12th Five-Year Plan of China: Research & Development on Suitable Key Technologies of the Village Environmental Monitoring [2012BAJ24B01]	National Key Technology R&D Program in the 12th Five-Year Plan of China: Research & Development on Suitable Key Technologies of the Village Environmental Monitoring(National Key Technology R&D Program)	This study is financed by the National Key Technology R&D Program in the 12th Five-Year Plan of China: Research & Development on Suitable Key Technologies of the Village Environmental Monitoring (2012BAJ24B01). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AfTSaD R, 2004, TOX PROF POL BIPH PO, P45; Agrell C, 2004, ATMOS ENVIRON, V38, P5139, DOI 10.1016/j.atmosenv.2004.05.024; Allen JG, 2007, ENVIRON SCI TECHNOL, V41, P4574, DOI 10.1021/es0703170; Baek SO, 1997, ATMOS ENVIRON, V31, P529, DOI 10.1016/S1352-2310(96)00215-4; Batterman S, 2010, ENVIRON INT, V36, P548, DOI 10.1016/j.envint.2010.04.008; Biphenyls P., 2004, TOXICOLOGICAL PROFIL; Branis M, 2005, ENVIRON RES, V99, P143, DOI 10.1016/j.envres.2004.12.001; Chen DH, 2011, CHEMOSPHERE, V82, P1246, DOI 10.1016/j.chemosphere.2010.12.035; Chen DH, 2009, ENVIRON POLLUT, V157, P1051, DOI 10.1016/j.envpol.2008.06.005; Chen SJ, 2010, J HAZARD MATER, V176, P979, DOI 10.1016/j.jhazmat.2009.11.138; Darnerud PO, 2001, ENVIRON HEALTH PERSP, V109, P49, DOI 10.2307/3434846; Diapouli E, 2004, C PROT REST ENV MYK; Duan YP, 2010, ENVIRON SCI POLLUT R, V17, P948, DOI 10.1007/s11356-010-0295-1; Gadkari NM, 2010, ENVIRON MONIT ASSESS, V165, P365, DOI 10.1007/s10661-009-0952-3; Gemenetzis P, 2006, ATMOS ENVIRON, V40, P3195, DOI 10.1016/j.atmosenv.2006.01.049; Gevao B, 2006, ATMOS ENVIRON, V40, P1419, DOI 10.1016/j.atmosenv.2005.10.053; Han WL, 2009, B ENVIRON CONTAM TOX, V83, P783, DOI 10.1007/s00128-009-9855-9; Hardy ML, 2002, CHEMOSPHERE, V46, P757, DOI 10.1016/S0045-6535(01)00240-5; Harley KG, 2011, AM J EPIDEMIOL, V174, P885, DOI 10.1093/aje/kwr212; Harrad S, 2006, ENVIRON SCI TECHNOL, V40, P4633, DOI 10.1021/es0609147; Hayakawa K, 2004, CHEMOSPHERE, V57, P343, DOI 10.1016/j.chemosphere.2004.06.038; He C, 2007, ENVIRON SCI TECHNOL, V41, P6039, DOI 10.1021/es063049z; Heavner DL, 1996, ENVIRON INT, V22, P159, DOI 10.1016/0160-4120(96)00003-7; Horemans B, 2010, ATMOS ENVIRON, V44, P1497, DOI 10.1016/j.atmosenv.2010.01.010; Johnson PI, 2012, ENVIRON INT, V45, P9, DOI 10.1016/j.envint.2012.04.004; Koivisto AJ, 2010, ATMOS ENVIRON, V44, P2140, DOI 10.1016/j.atmosenv.2010.02.023; La Guardia MJ, 2006, ENVIRON SCI TECHNOL, V40, P6247, DOI 10.1021/es060630m; Lee CW, 2007, ATMOS ENVIRON, V41, P6598, DOI 10.1016/j.atmosenv.2007.04.016; Liu YS, 2004, ENVIRON INT, V30, P189, DOI 10.1016/S0160-4120(03)00173-9; Luoma M, 2001, INDOOR AIR, V11, P35, DOI 10.1034/j.1600-0668.2001.011001035.x; Mandalakis M, 2008, ENVIRON POLLUT, V155, P375, DOI 10.1016/j.envpol.2007.11.016; Mandalakis M, 2009, ENVIRON POLLUT, V157, P1227, DOI 10.1016/j.envpol.2008.12.010; Naeher LP, 2000, INDOOR AIR, V10, P200; Ni HG, 2011, ENVIRON POLLUT, V159, P1957, DOI 10.1016/j.envpol.2010.12.007; Ohura T, 2005, ENVIRON SCI TECHNOL, V39, P5592, DOI 10.1021/es050571x; Ott W, 1996, J AIR WASTE MANAGE, V46, P1120, DOI 10.1080/10473289.1996.10467548; Park H-R, 2014, TOXICOL APPL PHARM; Phillips K, 1998, ENVIRON INT, V24, P405, DOI 10.1016/S0160-4120(98)00020-8; Qi H, 2014, SCI TOTAL ENV; Qu WY, 2007, ENVIRON INT, V33, P1029, DOI 10.1016/j.envint.2007.05.009; Rodriguez S, 2001, ATMOS ENVIRON, V35, P2433, DOI 10.1016/S1352-2310(00)00496-9; Shoeib M, 2004, ENVIRON SCI TECHNOL, V38, P1313, DOI 10.1021/es0305555; Sjodin A, 2001, ENVIRON SCI TECHNOL, V35, P448, DOI 10.1021/es000077n; Stapleton HM, 2008, ENVIRON SCI TECHNOL, V42, P3453, DOI 10.1021/es7028813; Staskal DF, 2008, ENVIRON SCI TECHNOL, V42, P6755, DOI 10.1021/es800613k; Toms LML, 2009, CHEMOSPHERE, V76, P173, DOI 10.1016/j.chemosphere.2009.03.057; Tung EWY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094583; Wang W, 2014, ATMOS ENVIRON, V89, P786, DOI 10.1016/j.atmosenv.2014.01.030; Watkins DJ, 2013, ENVIRON INT, V59, P124, DOI 10.1016/j.envint.2013.06.001; Watkins DJ, 2011, ENVIRON HEALTH PERSP, V119, P1247, DOI 10.1289/ehp.1003271; Wensing M, 2006, P HLTH BUILD 2006 C, V2, P4; Wilford BH, 2008, ENVIRON INT, V34, P412, DOI 10.1016/j.envint.2007.09.007; World Health Organization, 2006, WHO AIR QUAL GUID PA; Wu N, 2007, ENVIRON SCI TECHNOL, V41, P1584, DOI 10.1021/es0620282; Zhang A, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0080969, 10.1371/journal.pone.0063486, 10.1371/journal.pone.0059428, 10.1371/journal.pone.0059254, 10.1371/journal.pone.0064689]	55	27	30	6	107	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0119144	10.1371/journal.pone.0119144	http://dx.doi.org/10.1371/journal.pone.0119144			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25793925	Green Submitted, gold, Green Published			2022-12-27	WOS:000352084200056
J	Meyer, BJ; Byrne, MK; Collier, C; Parletta, N; Crawford, D; Winberg, PC; Webster, D; Chapman, K; Thomas, G; Dally, J; Batterham, M; Farquhar, I; Martin, AM; Grant, L				Meyer, Barbara J.; Byrne, Mitchell K.; Collier, Carole; Parletta, Natalie; Crawford, Donna; Winberg, Pia C.; Webster, David; Chapman, Karen; Thomas, Gayle; Dally, Jean; Batterham, Marijka; Farquhar, Ian; Martin, Anne-Marie; Grant, Luke			Baseline Omega-3 Index Correlates with Aggressive and Attention Deficit Disorder Behaviours in Adult Prisoners	PLOS ONE			English	Article							POLYUNSATURATED FATTY-ACIDS; HYPERACTIVITY DISORDER; DOCOSAHEXAENOIC ACID; FOOD SOURCES; CHILDREN; DIETARY; ANGER; RISK; ADHD; N-3	Background There is emerging evidence that the supplementation of omega-3 contributes to a decrease in aggressive behaviour in prison populations. A challenge of such research is achieving statistical power against effect sizes which may be affected by the baseline omega-3 index. There are no published data on the blood omega-3 index with studies of this kind to assess the variability of the blood omega-3 index in conjunction with aggression and attention deficit assessments. Objective To determine if the variance of the omega-3 index is correlated with aggressive and attention deficit behaviour in a prison population. Design 136 adult male prisoners were recruited from South Coast Correctional Centre (SCCC), NSW Australia. A 7 point categorisation was used to quantify levels of aggressive behaviour (4 weeks) from individual SCCC case notes, whereby higher scores correspond to increasingly aggressive behaviour. Study participants completed the Aggression Questionnaire (AQ) and the Brown's Attention Deficit Disorder Scales (BADDS), provided a blood sample for erythrocyte fatty acid analysis using gas chromatography and the omega-3 index was calculated. Results The baseline omega-3 index ranged from 2.3% to 10.3%, indicating that some participants already had substantial omega-3 intake, however a median of 4.7% indicated a lower overall omega-3 intake than the general Australian population. Assessment of aggressive and attention deficit behaviour shows that there were negative correlations between baseline omega-3 index and baseline aggression categorisation scores (r = -0.21, P = 0.016); total AQ score (r = -0.234, P = 0.011); Anger (r = -0.222 p = 0.016); Hostility AQ (r = -0.239, P = 0.009); indirect aggression (r = -0.188 p = 0.042); total BADDS (r = -0.263, p = 0.005); Activation (r = -0.224, p = 0.016); Attention (r = -0.192, p = 0.043); Effort (r = -0.253, p = 0.007); Affect (r = -0.330, p = 0.000) and Memory (r = -0.240, p = 0.010). Conclusions There is a high variability in omega-3 status of a NSW prison population, and inmates with lower omega-3 index were more aggressive and had higher ADD scores.	[Meyer, Barbara J.; Webster, David] Univ Wollongong, Sch Med, Wollongong, NSW, Australia; [Meyer, Barbara J.; Byrne, Mitchell K.] Univ Wollongong, Illawarra Heath & Med Res Inst, Wollongong, NSW, Australia; [Byrne, Mitchell K.] Univ Wollongong, Sch Psychol, Wollongong, NSW, Australia; [Collier, Carole; Crawford, Donna; Chapman, Karen; Thomas, Gayle; Dally, Jean; Farquhar, Ian] South Coast Correct Ctr, Nowra, NSW, Australia; [Parletta, Natalie] Univ S Australia, Sansom Inst Hlth Res, Sch Populat Hlth, Adelaide, SA 5001, Australia; [Winberg, Pia C.] Univ Wollongong, Venus Shell Syst & Shoalhaven Marine & Freshwater, Wollongong, NSW, Australia; [Batterham, Marijka] Univ Wollongong, Stat Consulting Serv, Wollongong, NSW 2522, Australia; [Martin, Anne-Marie; Grant, Luke] Correct Serv New South Wales, Sydney, NSW, Australia	University of Wollongong; University of Wollongong; University of Wollongong; University of South Australia; University of Wollongong; University of Wollongong	Meyer, BJ (corresponding author), Univ Wollongong, Sch Med, Wollongong, NSW, Australia.	bmeyer@uow.edu.au	Meyer, Barbara/AAC-6078-2019; Winberg, Pia/G-4008-2018; Parletta, Natalie/A-7880-2008	Meyer, Barbara/0000-0001-7962-7890; Winberg, Pia/0000-0003-2554-4955; Parletta, Natalie/0000-0003-2322-5555; Byrne, Mitchell/0000-0003-0823-2917; Batterham, Marijka/0000-0002-9520-6508	University of Wollongong Research Partnership Grant; Corrective Services NSW	University of Wollongong Research Partnership Grant; Corrective Services NSW	The work was supported by a University of Wollongong Research Partnership Grant with the Corrective Services NSW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becker G, 2007, J RES PERS, V41, P434, DOI 10.1016/j.jrp.2006.05.004; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Brown TE., 1996, BROWN ATTENTION DEFI; Brown TE, 2011, CURR MED RES OPIN, V27, P23, DOI 10.1185/03007995.2011.605441; Burgess GC, 2010, BIOL PSYCHIAT, V67, P632, DOI 10.1016/j.biopsych.2009.10.036; BUSS AH, 1992, J PERS SOC PSYCHOL, V63, P452, DOI 10.1037/0022-3514.63.3.452; Butler T., 2003, MENTAL ILLNESS NEW S; Buydens-Branchey L, 2008, PSYCHIAT RES, V157, P95, DOI 10.1016/j.psychres.2007.01.004; Fite PJ, 2014, AGGRESSIVE BEHAV, V40, P69, DOI 10.1002/ab.21498; Gao Q, 2011, J NUTR HEALTH AGING, V15, P32, DOI 10.1007/s12603-011-0010-z; Gesch CB, 2002, BRIT J PSYCHIAT, V181, P22, DOI 10.1192/bjp.181.1.22; Harris JA, 1997, BEHAV RES THER, V35, P1047, DOI 10.1016/S0005-7967(97)00064-8; HARRIS JA, 1995, BEHAV RES THER, V33, P991, DOI 10.1016/0005-7967(95)00038-Y; Harris WS, 2004, PREV MED, V39, P212, DOI 10.1016/j.ypmed.2004.02.030; Hibbeln JR, 2006, INT REV PSYCHIATR, V18, P107, DOI 10.1080/09540260600582967; Hibbeln JR, 2001, WORLD REV NUTR DIET, V88, P41; Iribarren C, 2004, EUR J CLIN NUTR, V58, P24, DOI 10.1038/sj.ejcn.1601739; Johnstone SJ, 2012, ADHD-ATTEND DEFICIT, V4, P11, DOI 10.1007/s12402-011-0069-8; Byrne M, 2015, PSYCHIAT PSYCHOL LAW, V22, P407, DOI 10.1080/13218719.2014.960027; Kavanagh L, 2010, INT J LAW PSYCHIAT, V33, P20, DOI 10.1016/j.ijlp.2009.10.004; Kidd PM, 2007, ALTERN MED REV, V12, P207; Kooij JJS, 2008, J ATTEN DISORD, V11, P445, DOI 10.1177/1087054707299367; LEPAGE G, 1986, J LIPID RES, V27, P114; Lobbestael J, 2013, J PERS DISORD, V27, P53, DOI 10.1521/pedi.2013.27.1.53; Lopez LB, 2011, J NUTR HEALTH AGING, V15, P25, DOI 10.1007/s12603-011-0009-5; McNamara RK, 2006, PROSTAG LEUKOTR ESS, V75, P329, DOI 10.1016/j.plefa.2006.07.010; McNamara RK, 2010, AM J CLIN NUTR, V91, P1060, DOI 10.3945/ajcn.2009.28549; Meyer BJ, 2011, NUTRITION, V27, P1136, DOI 10.1016/j.nut.2011.01.004; Meyer BJ, 2003, LIPIDS, V38, P391, DOI 10.1007/s11745-003-1074-0; Milte CM, 2011, J CHILD HEALTH CARE, V15, P299, DOI 10.1177/1367493511403953; Milte CM, 2009, NUTR REV, V67, P573, DOI 10.1111/j.1753-4887.2009.00229.x; Morris MC, 2003, ARCH NEUROL-CHICAGO, V60, P940, DOI 10.1001/archneur.60.7.940; Ollis TE, 1999, ANN NUTR METAB, V43, P346, DOI 10.1159/000012803; Parletta N, 2013, J NUTR BIOCHEM, V24, P725, DOI 10.1016/j.jnutbio.2013.01.002; R Development Core Team, 2008, LANG ENV STAT COMP, V3; Ramirez JM, 2006, NEUROSCI BIOBEHAV R, V30, P276, DOI 10.1016/j.neubiorev.2005.04.015; Ricciardelli R, 2013, QUAL SOCIOL REV, V9, P97; Shinkfield AJ, 2014, INT J OFFENDER THER, V58, P435, DOI 10.1177/0306624X12470525; Sinn N, 2008, PROSTAG LEUKOTR ESS, V78, P311, DOI 10.1016/j.plefa.2008.04.004; Sinn N, 2010, NUTRIENTS, V2, P128, DOI 10.3390/nu2020128; SODERBERG M, 1991, LIPIDS, V26, P421, DOI 10.1007/BF02536067; Sontrop J, 2006, PREV MED, V42, P4, DOI 10.1016/j.ypmed.2005.11.005; Steadham JA, 2013, J FORENSIC PSYCHOL P, V13, P411, DOI 10.1080/15228932.2013.847350; Stevens LJ, 1996, PHYSIOL BEHAV, V59, P915, DOI 10.1016/0031-9384(95)02207-4; Sullivan BL, 2006, LIPIDS, V41, P845, DOI 10.1007/s11745-006-5039-0; Suris A, 2004, AGGRESS VIOLENT BEH, V9, P165, DOI 10.1016/S1359-1789(03)00012-0; Swierk M, 2011, NUTRITION, V27, P641, DOI 10.1016/j.nut.2010.06.011; VIRKKUNEN ME, 1987, BIOL PSYCHIAT, V22, P1087, DOI 10.1016/0006-3223(87)90051-5; White BA, 2013, J PSYCHOPATHOL BEHAV, V35, P1, DOI 10.1007/s10862-012-9310-9; Zaalberg A, 2010, AGGRESSIVE BEHAV, V36, P117, DOI 10.1002/ab.20335	50	23	24	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0120220	10.1371/journal.pone.0120220	http://dx.doi.org/10.1371/journal.pone.0120220			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25793501	Green Published, gold, Green Accepted			2022-12-27	WOS:000352084200160
J	Richard, JE; Anderberg, RH; Goteson, A; Gribble, FM; Reimann, F; Skibicka, KP				Richard, Jennifer E.; Anderberg, Rozita H.; Goteson, Andreas; Gribble, Fiona M.; Reimann, Frank; Skibicka, Karolina P.			Activation of the GLP-1 Receptors in the Nucleus of the Solitary Tract Reduces Food Reward Behavior and Targets the Mesolimbic System	PLOS ONE			English	Article							GLUCAGON-LIKE PEPTIDE-1; VENTRAL TEGMENTAL AREA; ENERGY-BALANCE; MESSENGER-RNAS; NEURONS; ACCUMBENS; DOPAMINE; OPIOIDS; OVERCONSUMPTION; SUPPRESSION	The gut/brain peptide, glucagon like peptide 1 (GLP-1), suppresses food intake by acting on receptors located in key energy balance regulating CNS areas, the hypothalamus or the hindbrain. Moreover, GLP-1 can reduce reward derived from food and motivation to obtain food by acting on its mesolimbic receptors. Together these data suggest a neuroanatomical segregation between homeostatic and reward effects of GLP-1. Here we aim to challenge this view and hypothesize that GLP-1 can regulate food reward behavior by acting directly on the hindbrain, the nucleus of the solitary tract (NTS), GLP-1 receptors (GLP-1R). Using two models of food reward, sucrose progressive ratio operant conditioning and conditioned place preference for food in rats, we show that intra-NTS microinjections of GLP-1 or Exendin-4, a stable analogue of GLP-1, inhibit food reward behavior. When the rats were given a choice between palatable food and chow, intra-NTS Exendin-4 treatment preferentially reduced intake of palatable food but not chow. However, chow intake and body weight were reduced by the NTS GLP-1R activation if chow was offered alone. The NTS GLP-1 activation did not alter general locomotor activity and did not induce nausea, measured by PICA. We further show that GLP-1 fibers are in close apposition to the NTS noradrenergic neurons, which were previously shown to provide a monosynaptic connection between the NTS and the mesolimbic system. Central GLP-1R activation also increased NTS expression of dopamine-beta-hydroxylase, a key enzyme in noradrenaline synthesis, indicating a biological link between these two systems. Moreover, NTS GLP-1R activation altered the expression of dopamine-related genes in the ventral tegmental area. These data reveal a food reward-suppressing role of the NTS GLP-1R and indicate that the neurobiological targets underlying food reward control are not limited to the mesolimbic system, instead they are distributed throughout the CNS.	[Richard, Jennifer E.; Anderberg, Rozita H.; Goteson, Andreas; Skibicka, Karolina P.] Univ Gothenburg, Dept Physiol, Inst Neurosci & Physiol, Sahlgrenska Acad, Gothenburg, Sweden; [Gribble, Fiona M.; Reimann, Frank] Univ Cambridge, MRC Metab Dis Unit, Cambridge, England; [Gribble, Fiona M.; Reimann, Frank] Univ Cambridge, Inst Metab Sci, Cambridge, England	University of Gothenburg; University of Cambridge; University of Cambridge	Skibicka, KP (corresponding author), Univ Gothenburg, Dept Physiol, Inst Neurosci & Physiol, Sahlgrenska Acad, Gothenburg, Sweden.	Karolina.Skibicka@neuro.gu.se		Richard, Jennifer/0000-0002-8473-5455; Reimann, Frank/0000-0001-9399-6377; Goteson, Andreas/0000-0001-6118-6054; Gribble, Fiona/0000-0002-4232-2898	Novo Nordisk Foundation Excellence project grant; Swedish Research Council [2011-3054]; Wellcome Trust [WT088357/Z/09/Z, WT084210/Z/07/Z]; Medical Research Council [MC_UU_12012/3] Funding Source: researchfish; Novo Nordisk Fonden [NNF13OC0003886] Funding Source: researchfish; MRC [MC_UU_12012/3] Funding Source: UKRI	Novo Nordisk Foundation Excellence project grant; Swedish Research Council(Swedish Research CouncilEuropean Commission); Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Novo Nordisk Fonden(Novo Nordisk Foundation); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This research was funded by the Novo Nordisk Foundation Excellence project grant (to KPS), Swedish Research Council (2011-3054 to KPS). FMG and FR were funded by the Wellcome Trust (WT088357/Z/09/Z, WT084210/Z/07/Z). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adell A, 2004, NEUROSCI BIOBEHAV R, V28, P415, DOI 10.1016/j.neubiorev.2004.05.001; Alhadeff AL, 2014, AM J PHYSL REGUL INT; Alhadeff AL, 2011, ENDOCRINOLOGY; Alhadeff AL, 2012, ENDOCRINOLOGY, V153, P647, DOI 10.1210/en.2011-1443; Anderberg RH, 2014, PHYSIOL BEHAV; Barrera JG, 2009, DIABETES, V58, P2820, DOI 10.2337/db09-0281; Berthoud HR, 2011, CURR OPIN NEUROBIOL, V21, P888, DOI 10.1016/j.conb.2011.09.004; Cason AM, 2010, PHYSIOL BEHAV, V100, P419, DOI 10.1016/j.physbeh.2010.03.009; Delfs JM, 1998, BRAIN RES, V806, P127, DOI 10.1016/S0006-8993(98)00672-6; Delfs JM, 2000, NATURE, V403, P430, DOI 10.1038/35000212; Dickson SL, 2012, J NEUROSCI, V32, P4812, DOI 10.1523/JNEUROSCI.6326-11.2012; Dossat AM, 2011, J NEUROSCI, V31, P14453, DOI 10.1523/JNEUROSCI.3262-11.2011; Gaykema RPA, 2009, BRAIN RES, V1294, P61, DOI 10.1016/j.brainres.2009.07.076; GOSNELL BA, 1990, PHARMACOL BIOCHEM BE, V37, P207, DOI 10.1016/0091-3057(90)90322-9; Grill HJ, 2007, CELL METAB, V6, P423, DOI 10.1016/j.cmet.2007.11.007; Grill HJ, 2004, AM J PHYSIOL-REG I, V287, pR1190, DOI 10.1152/ajpregu.00163.2004; HAN VKM, 1986, J NEUROSCI RES, V16, P97, DOI 10.1002/jnr.490160110; Harris GC, 2005, NATURE, V437, P556, DOI 10.1038/nature04071; Hayes MR, 2012, PHYSIOL BEHAV, V106, P413, DOI 10.1016/j.physbeh.2012.02.017; Hayes MR, 2010, PHYSIOL BEHAV, V100, P503, DOI 10.1016/j.physbeh.2010.02.029; Hayes MR, 2009, ENDOCRINOLOGY, V150, P2654, DOI 10.1210/en.2008-1479; HERNANDEZ L, 1988, PHYSIOL BEHAV, V44, P599, DOI 10.1016/0031-9384(88)90324-1; HERNANDEZ L, 1988, LIFE SCI, V42, P1705, DOI 10.1016/0024-3205(88)90036-7; Hisadome K, 2010, DIABETES, V59, P1890, DOI 10.2337/db10-0128; HODOS W, 1961, SCIENCE, V134, P943, DOI 10.1126/science.134.3483.943; Kanoski SE, 2014, NEUROPSYCHOPHARMACOL, V39, P605, DOI 10.1038/npp.2013.235; Kanoski SE, 2012, NEUROPHARMACOLOGY, V62, P1916, DOI 10.1016/j.neuropharm.2011.12.022; Kay K, 2014, PSYCHOPHARMACOLOGY, V231, P419, DOI 10.1007/s00213-013-3248-9; Kotz CM, 1997, AM J PHYSIOL-REG I, V272, pR1028, DOI 10.1152/ajpregu.1997.272.4.R1028; la Fleur SE, 2007, INT J OBESITY, V31, P1286, DOI 10.1038/sj.ijo.0803570; Larsen PJ, 1997, NEUROSCIENCE, V77, P257, DOI 10.1016/S0306-4522(96)00434-4; LEVINE AS, 1995, AM J PHYSIOL-REG I, V268, pR248, DOI 10.1152/ajpregu.1995.268.1.R248; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Llewellyn-Smith IJ, 2013, NEUROSCIENCE, V229, P130, DOI 10.1016/j.neuroscience.2012.09.071; Llewellyn-Smith IJ, 2011, NEUROSCIENCE, V180, P111, DOI 10.1016/j.neuroscience.2011.02.023; Margolis EB, 2008, J NEUROSCI, V28, P8908, DOI 10.1523/JNEUROSCI.1526-08.2008; Merchenthaler I, 1999, J COMP NEUROL, V403, P261, DOI 10.1002/(SICI)1096-9861(19990111)403:2<261::AID-CNE8>3.0.CO;2-5; Mietlicld-Baase E. G., 2013, AM J PHYSL ENDOCRINO; Naleid AM, 2007, AM J PHYSIOL-REG I, V293, pR99, DOI 10.1152/ajpregu.00675.2006; Nowak A, 2008, J PHYSIOL PHARMACOL, V59, P501; Olson VG, 2006, SCIENCE, V311, P1017, DOI 10.1126/science.1119311; Olszewski PK, 2007, PHYSIOL BEHAV, V91, P506, DOI 10.1016/j.physbeh.2007.01.011; Olszewski PK, 2011, PHYSIOL BEHAV, V104, P105, DOI 10.1016/j.physbeh.2011.04.033; Peyron C, 1998, J NEUROSCI, V18, P9996; Reimann F, 2008, CELL METAB, V8, P532, DOI 10.1016/j.cmet.2008.11.002; Rinaman L, 2011, AM J PHYSIOL-REG I, V300, pR222, DOI 10.1152/ajpregu.00556.2010; RITTER RC, 1984, PHYSIOL BEHAV, V32, P923, DOI 10.1016/0031-9384(84)90279-8; RITTER RC, 1981, SCIENCE, V213, P451, DOI 10.1126/science.6264602; Saper CB, 2002, NEURON, V36, P199, DOI 10.1016/S0896-6273(02)00969-8; Schick RR, 2003, AM J PHYSIOL-REG I, V284, pR1427, DOI 10.1152/ajpregu.00479.2002; Skibicka KP, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00181; Skibicka KP, 2011, ENDOCRINOLOGY, V152, P2400, DOI 10.1210/en.2010-1309; Skibicka KP, 2009, ENDOCRINOLOGY, V150, P5351, DOI 10.1210/en.2009-0804; SOUTH EH, 1983, BRAIN RES, V288, P243, DOI 10.1016/0006-8993(83)90100-2; TangChristensen M, 1996, AM J PHYSIOL-REG I, V271, pR848, DOI 10.1152/ajpregu.1996.271.4.R848; Turton MD, 1996, NATURE, V379, P69, DOI 10.1038/379069a0; Vucetic Z, 2010, WIRES SYST BIOL MED, V2, P577, DOI 10.1002/wsbm.77; WANG ZJ, 1992, BRAIN RES, V578, P347, DOI 10.1016/0006-8993(92)90269-F; Zheng H, 2009, INT J OBESITY, V33, pS8, DOI 10.1038/ijo.2009.65; Zheng HY, 2005, J COMP NEUROL, V485, P127, DOI 10.1002/cne.20515	60	92	93	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0119034	10.1371/journal.pone.0119034	http://dx.doi.org/10.1371/journal.pone.0119034			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25793511	Green Published, gold, Green Submitted			2022-12-27	WOS:000352084200052
J	Sivasankar, S; Lavanya, R; Brindha, P; Angayarkanni, N				Sivasankar, Shanmuganathan; Lavanya, Ramu; Brindha, Pemaiah; Angayarkanni, Narayanasamy			Aqueous and Alcoholic Extracts of Triphala and Their Active Compounds Chebulagic Acid and Chebulinic Acid Prevented Epithelial to Mesenchymal Transition in Retinal Pigment Epithelial Cells, by Inhibiting SMAD-3 Phosphorylation	PLOS ONE			English	Article							PROLIFERATIVE VITREORETINOPATHY; MATRIX-METALLOPROTEINASE; DIABETIC-RETINOPATHY; RISK-FACTORS; EXPRESSION; GROWTH; RPE; ANTIOXIDANTS; FORMULATION; DETACHMENT	Epithelial to Mesenchymal Transition (EMT) of the retinal pigment epitheliumis involved in the pathogenesis of proliferative vitreoretinopathy (PVR) that often leads to retinal detachment. In this study, Triphala, an ayurvedic formulation and two of its active ingredients, namely chebulagic acid and chebulinic acid were evaluated for anti-EMT properties based on in vitro experiments in human retinal pigment epithelial cell line (ARPE-19) under TGF beta 1 induced conditions. ARPE-19 cells were treated with TGF beta 1 alone or co-treated with various concentrations of aqueous extract (AqE) (30 - 300 mu g/ml); alcoholic extract (AlE) (50 -500 mu g/ml) of triphala and the active principles chebulagic acid (CA) and chebulinic acid (CI) (CA, CI: 50 -200 mu M). The expression of EMT markers namely MMP-2, alpha SMA, vimentin and the tight junction protein ZO-1 were evaluated by qPCR, western blot and immunofluorescence. The functional implications of EMT, namelymigration and proliferation of cells were assessed by proliferation assay, scratch assay and transwell migration assay. AqE, AlE, CA and CI reduced the expression and activity of MMP-2 at an ED50 value of 100 mu g/ml, 50 mu g/ml, 100 mu M and 100 mu M, respectively. At these concentrations, a significant down-regulation of the expression of alpha SMA, vimentin and up-regulation of the expression of ZO-1 altered by TGF beta 1 were observed. These concentrations also inhibited proliferation and migration of ARPE-19 cells induced by TGF beta 1. EMT was found to be induced in ARPE-19 cells, through SMAD-3 phosphorylation and it was inhibited by AqE, AlE, CA and CI. Further studies in experimental animals are required to attribute therapeutic potential of these extracts and their active compounds, as an adjuvant therapy in the disease management of PVR.	[Sivasankar, Shanmuganathan; Angayarkanni, Narayanasamy] Vis Res Fdn, RS Mehta Jain Dept Biochem & Cell Biol, Kamalnayan Bajaj Inst Res Vis & Ophthalmol, Madras, Tamil Nadu, India; [Sivasankar, Shanmuganathan] SASTRA Univ, Sch Chem & Biotechnol, Thanjavur, India; [Lavanya, Ramu; Brindha, Pemaiah] SASTRA Univ, Ctr Adv Res Indian Syst Med, Thanjavur, India	Shanmugha Arts, Science, Technology & Research Academy (SASTRA); Shanmugha Arts, Science, Technology & Research Academy (SASTRA)	Angayarkanni, N (corresponding author), Vis Res Fdn, RS Mehta Jain Dept Biochem & Cell Biol, Kamalnayan Bajaj Inst Res Vis & Ophthalmol, Madras, Tamil Nadu, India.	drak@snmail.org	Narayanasamy, Angayarkanni/ABD-8584-2020		Council of Scientific and Industrial Research [27/0219/09/EMR-II]	Council of Scientific and Industrial Research(Council of Scientific & Industrial Research (CSIR) - India)	Funding provided by a Council of Scientific and Industrial Research grant (27/0219/09/EMR-II). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham S, 2005, J PERIODONTOL, V76, P497, DOI 10.1902/jop.2005.76.4.497; Baliga MS, 2012, CHIN J INTEGR MED, V18, P946, DOI 10.1007/s11655-012-1299-x; Bochaton-Piallat ML, 2000, INVEST OPHTH VIS SCI, V41, P2336; Bouayed J, 2010, OXID MED CELL LONGEV, V3, P228, DOI 10.4161/oxim.3.4.12858; Burke JM, 2006, INVEST OPHTH VIS SCI, V47, P3635, DOI 10.1167/iovs.06-0104; Burke JM, 2008, PROG RETIN EYE RES, V27, P579, DOI 10.1016/j.preteyeres.2008.08.002; Campochiaro PA, 1997, ARCH OPHTHALMOL-CHIC, V115, P237, DOI 10.1001/archopht.1997.01100150239014; Casaroli-Marano RP, 1999, INVEST OPHTH VIS SCI, V40, P2062; Chan CM, 2010, MOL VIS, V16, P586; CHARTERIS DG, 1995, BRIT J OPHTHALMOL, V79, P953, DOI 10.1136/bjo.79.10.953; Chen HC, 2012, LAB INVEST, V92, P676, DOI 10.1038/labinvest.2011.201; Coral K, 2008, INVEST OPHTH VIS SCI, V49, P4746, DOI 10.1167/iovs.07-1550; Cui JZ, 2007, EYE, V21, P200, DOI 10.1038/sj.eye.6702169; Duong TD, 2004, DEV DYNAM, V229, P42, DOI 10.1002/dvdy.10465; Eichler W, 2002, INVEST OPHTH VIS SCI, V43, P2767; Ermakova S, 2005, J BIOL CHEM, V280, P16882, DOI 10.1074/jbc.M414185200; Flanders KC, 2004, INT J EXP PATHOL, V85, P47, DOI 10.1111/j.0959-9673.2004.00377.x; Giebel SJ, 2005, LAB INVEST, V85, P597, DOI 10.1038/labinvest.3700251; Hinton DR, 2002, EYE, V16, P422, DOI 10.1038/sj.eye.6700190; Jinnin M, 2006, MOL PHARMACOL, V69, P597, DOI 10.1124/mol.105.017483; Kalluri R, 2003, J CLIN INVEST, V112, P1776, DOI 10.1172/JCI200320530; Kalluri R, 2009, J CLIN INVEST, V119, P1417, DOI 10.1172/JCI39675; KIM J, 2013, NATL GEOGR, V224, P8; Kon CH, 1998, INVEST OPHTH VIS SCI, V39, P1524; Krishnan G, 2012, GLIA, V60, P1629, DOI 10.1002/glia.22380; Kumar MS, 2008, J SURG RES, V144, P94, DOI 10.1016/j.jss.2007.02.049; Lee H, 2007, INVEST OPHTH VIS SCI, V48, P4291, DOI 10.1167/iovs.07-0086; Li H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023322; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043934; Moustakas A, 2007, CANCER SCI, V98, P1512, DOI 10.1111/j.1349-7006.2007.00550.x; Nagasaki H, 1998, PROG RETIN EYE RES, V17, P77, DOI 10.1016/S1350-9462(97)00007-4; Nakao A, 1997, EMBO J, V16, P5353, DOI 10.1093/emboj/16.17.5353; Pastor JC, 2002, PROG RETIN EYE RES, V21, P127, DOI 10.1016/S1350-9462(01)00023-4; Pastor JC, 1998, SURV OPHTHALMOL, V43, P3, DOI 10.1016/S0039-6257(98)00023-X; Pawar V, 2009, INDIAN J PHARM SCI, V71, P382, DOI 10.4103/0250-474X.57286; Reddy DB, 2009, BIOCHEM BIOPH RES CO, V381, P112, DOI 10.1016/j.bbrc.2009.02.022; Rothmeier AS, 2009, FASEB J, V23, P1127, DOI 10.1096/fj.08-117127; RYAN SJ, 1993, AM J OPHTHALMOL, V115, P1; Sadaka A, 2012, CLIN OPHTHALMOL, V6, P1325, DOI 10.2147/OPTH.S27896; Saika S, 2004, LAB INVEST, V84, P1245, DOI 10.1038/labinvest.3700156; Saika Shizuya, 2008, Endocrine Metabolic & Immune Disorders-Drug Targets, V8, P69, DOI 10.2174/187153008783928343; Sandhya T, 2006, CANCER LETT, V231, P206, DOI 10.1016/j.canlet.2005.01.035; Shi Y, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-294; Sumantran VN, 2007, J BIOSCIENCES, V32, P755, DOI 10.1007/s12038-007-0075-3; Sun XD, 2013, ONCOL REP, V29, P2401, DOI 10.3892/or.2013.2385; Symeonidis C, 2011, ACTA OPHTHALMOL, V89, P339, DOI 10.1111/j.1755-3768.2009.01701.x; Thornton B, 2011, BIOCHEM MOL BIOL EDU, V39, P145, DOI 10.1002/bmb.20461; Williams RJ, 2004, FREE RADICAL BIO MED, V36, P838, DOI 10.1016/j.freeradbiomed.2004.01.001; Xu J, 2009, CELL RES, V19, P156, DOI 10.1038/cr.2009.5; Zeisberg M, 2009, J CLIN INVEST, V119, P1429, DOI 10.1172/JCI36183	51	26	28	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0120512	10.1371/journal.pone.0120512	http://dx.doi.org/10.1371/journal.pone.0120512			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25793924	Green Submitted, Green Published, gold			2022-12-27	WOS:000352083900045
J	Wang, H; Qiao, YQ; Chai, BZ; Qiu, CX; Chen, XD				Wang, He; Qiao, Yunqian; Chai, Baozhong; Qiu, Chenxi; Chen, Xiangdong			Identification and Molecular Characterization of the Homogentisate Pathway Responsible for Pyomelanin Production, the Major Melanin Constituents in Aeromonas media WS	PLOS ONE			English	Article							4-HYDROXYPHENYLPYRUVATE DIOXYGENASE; PSEUDOMONAS-AERUGINOSA; PHENYLALANINE-HYDROXYLASE; TRANSPOSON MUTAGENESIS; SHEWANELLA-COLWELLIANA; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; GENUS AEROMONAS; SP-NOV; TYROSINASE	The pigmentation of many Aeromonas species has been thought to be due to the production of a L-DOPA (L-3,4-dihydroxyphenylalanine) based melanin. However, in this study we found that although L-DOPA synthesis occurs in the high-melanin-yielding Aeromonas media strain WS, it plays a minor, if any, role in pigmentation. Instead, the pigmentation of A. media strain WS is due to the production of pyomelanin through HGA (homogentisate). Gene products of phhA (encodes phenylalanine hydroxylase), tyrB and aspC (both encode aromatic amino acid aminotransferase), and hppD (encodes 4-hydroxyphenylpyruvate dioxygenase) constitute a linear pathway of converting phenylalanine to HGA and disruption of any one of these genes impairs or blocks pigmentation of A. media strain WS. This HGA biosynthesis pathway is widely distributed in Aeromonas, but HGA is only detectable in the cultures of pigmented Aeromonas species. Heterologous expression of HppD from both pigmented and non-pigmented Aeromonas species in E. coli leads to the production of pyomelanin and thus pigmentation, suggesting that most Aeromonas species have the critical enzymes to produce pyomelanin through HGA. Taken together, we have identified a widely conserved biosynthesis pathway of HGA based pyomelanin in Aeromonas that may be responsible for pigmentation of many Aeromonas species.	[Wang, He; Qiao, Yunqian; Chai, Baozhong; Qiu, Chenxi; Chen, Xiangdong] Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Peoples R China; [Chen, Xiangdong] Hubei Prov Cooperat Innovat Ctr Ind Fermentat, Wuhan, Peoples R China	Wuhan University	Chen, XD (corresponding author), Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Peoples R China.	xdchen@whu.edu.cn		Qiu, Chenxi/0000-0002-0314-5307	National Basic Research Program of China (973 Program) [2011CB808800]; National Natural Science Foundation of China [31070077]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Basic Research Program of China (973 Program) (No. 2011CB808800) and National Natural Science Foundation of China (No. 31070077). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott SL, 2003, J CLIN MICROBIOL, V41, P2348, DOI 10.1128/JCM.41.6.2348-2357.2003; AURSTAD K, 1972, ACTA VET SCAND, V13, P251; BELL AA, 1986, ANNU REV PHYTOPATHOL, V24, P411, DOI 10.1146/annurev.py.24.090186.002211; Borowski T, 2005, J AM CHEM SOC, V127, P17303, DOI 10.1021/ja054433j; Chai BZ, 2012, J BACTERIOL, V194, P6693, DOI 10.1128/JB.01807-12; Chatfield CH, 2007, INFECT IMMUN, V75, P4062, DOI 10.1128/IAI.00489-07; COON SL, 1994, APPL ENVIRON MICROB, V60, P3006, DOI 10.1128/AEM.60.8.3006-3010.1994; DELORENZO V, 1990, J BACTERIOL, V172, P6568, DOI 10.1128/jb.172.11.6568-6572.1990; Dennis JJ, 1998, APPL ENVIRON MICROB, V64, P2710; DENOYA CD, 1994, J BACTERIOL, V176, P5312, DOI 10.1128/JB.176.17.5312-5319.1994; ESTEVE C, 1995, INT J SYST BACTERIOL, V45, P462, DOI 10.1099/00207713-45-3-462; Flydal MI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046209; Gibson LF, 1998, FEMS MICROBIOL LETT, V169, P261, DOI 10.1016/S0378-1097(98)00495-9; GOODWIN PH, 1994, CAN J MICROBIOL, V40, P28, DOI 10.1139/m94-005; Green MR, 2012, MOL CLONING LAB MANU, V1; GRIFFIN PJ, 1953, J BACTERIOL, V65, P652, DOI 10.1128/JB.65.6.652-659.1953; Gu W, 1998, MICROBIOL-SGM, V144, P3127, DOI 10.1099/00221287-144-11-3127; Hernandez-Romero D, 2005, APPL ENVIRON MICROB, V71, P6808, DOI 10.1128/AEM.71.11.6808-6815.2005; Hunter RC, 2010, J BACTERIOL, V192, P5962, DOI 10.1128/JB.01021-10; IGBINOSA IH, 2012, SCI WORLD J; Keith KE, 2007, J BACTERIOL, V189, P9057, DOI 10.1128/JB.00436-07; Kong KH, 2000, BIOTECHNOL APPL BIOC, V31, P113, DOI 10.1042/BA19990096; KOTOB SI, 1995, APPL ENVIRON MICROB, V61, P1620, DOI 10.1128/AEM.61.4.1620-1622.1995; KOVACH ME, 1995, GENE, V166, P175, DOI 10.1016/0378-1119(95)00584-1; Krol ES, 1998, CHEM RES TOXICOL, V11, P1434, DOI 10.1021/tx980114c; LEU WM, 1992, J BIOL CHEM, V267, P20108; LIU YG, 1995, PLANT J, V8, P457, DOI 10.1046/j.1365-313X.1995.08030457.x; Lopez-Serrano D, 2002, PIGM CELL RES, V15, P104; MARTINEZMURCIA AJ, 1992, FEMS MICROBIOL LETT, V91, P199; MCINTOSH D, 1991, J GEN MICROBIOL, V137, P1341, DOI 10.1099/00221287-137-6-1341; Milcamps A, 1999, MICROBIOL-UK, V145, P935, DOI 10.1099/13500872-145-4-935; Milton DL, 1996, J BACTERIOL, V178, P1310, DOI 10.1128/jb.178.5.1310-1319.1996; Moran GR, 2005, ARCH BIOCHEM BIOPHYS, V433, P117, DOI 10.1016/j.abb.2004.08.015; Nosanchuk JD, 2003, CELL MICROBIOL, V5, P203, DOI 10.1046/j.1462-5814.2003.00268.x; Nosanchuk JD, 2006, ANTIMICROB AGENTS CH, V50, P3519, DOI 10.1128/AAC.00545-06; Pinero S, 2007, J MOL MICROB BIOTECH, V13, P35, DOI 10.1159/000103595; Rholl DA, 2008, APPL ENVIRON MICROB, V74, P7529, DOI 10.1128/AEM.01973-08; Riley PA, 1997, INT J BIOCHEM CELL B, V29, P1235, DOI 10.1016/S1357-2725(97)00013-7; Rodriguez JM, 2000, HUM MOL GENET, V9, P2341, DOI 10.1093/oxfordjournals.hmg.a018927; Rozanowska M, 1999, FREE RADICAL BIO MED, V26, P518, DOI 10.1016/S0891-5849(98)00234-2; Ruan L, 2005, ANTON LEEUW INT J G, V87, P283, DOI 10.1007/s10482-004-4775-5; RUETSCHI U, 1992, EUR J BIOCHEM, V205, P459, DOI 10.1111/j.1432-1033.1992.tb16800.x; RUNDGREN M, 1977, J BIOL CHEM, V252, P5094; RUNDGREN M, 1982, BIOCHIM BIOPHYS ACTA, V704, P59, DOI 10.1016/0167-4838(82)90132-7; SARNA T, 1976, SCIENCE, V192, P1132, DOI 10.1126/science.179142; Schmaler-Ripcke J, 2009, APPL ENVIRON MICROB, V75, P493, DOI 10.1128/AEM.02077-08; Serre L, 1999, STRUCTURE, V7, P977, DOI 10.1016/S0969-2126(99)80124-5; SHIEH HS, 1974, INT J BIOCHEM, V5, P643, DOI 10.1016/0020-711X(74)90028-7; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; Song J, 1999, J BACTERIOL, V181, P2789, DOI 10.1128/JB.181.9.2789-2796.1999; Swan G, 1974, PROGR CHEM ORGANIC N, P521; Titus GP, 2000, NAT STRUCT BIOL, V7, P542; Turick CE, 2009, FEMS MICROBIOL ECOL, V68, P223, DOI 10.1111/j.1574-6941.2009.00670.x; Wakamatsu K, 2002, PIGM CELL RES, V15, P174, DOI 10.1034/j.1600-0749.2002.02017.x; Walton FJ, 2005, MOL MICROBIOL, V57, P1381, DOI 10.1111/j.1365-2958.2005.04779.x; Wan X, 2007, J APPL MICROBIOL, V103, P2533, DOI 10.1111/j.1365-2672.2007.03502.x; Wan X, 2009, APPL MICROBIOL BIOT, V82, P261, DOI 10.1007/s00253-008-1742-5; Wang YL, 2005, J BASIC MICROB, V45, P83, DOI 10.1002/jobm.200410446; WHITE LP, 1958, NATURE, V182, P1427, DOI 10.1038/1821427a0; YABUUCHI E, 1972, International Journal of Systematic Bacteriology, V22, P53; ZHAO GS, 1994, P NATL ACAD SCI USA, V91, P1366, DOI 10.1073/pnas.91.4.1366	61	29	29	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0120923	10.1371/journal.pone.0120923	http://dx.doi.org/10.1371/journal.pone.0120923			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25793756	Green Submitted, gold, Green Published			2022-12-27	WOS:000352083900088
J	Wang, JC; Sindhu, H; Chen, C; Kundra, A; Kafeel, MI; Wong, C; Lichter, S				Wang, Jen C.; Sindhu, Hemant; Chen, Chi; Kundra, Ajay; Kafeel, Muhammad I.; Wong, Ching; Lichter, Stephen			Immune Derangements in Patients with Myelofibrosis: The Role of Treg, Th17, and sIL2R alpha	PLOS ONE			English	Article							REGULATORY T-CELLS; CHRONIC LYMPHOCYTIC-LEUKEMIA; PREDICTS REDUCED SURVIVAL; ACUTE MYELOID-LEUKEMIA; NON-HODGKIN-LYMPHOMA; PERIPHERAL-BLOOD; SOLUBLE INTERLEUKIN-2-RECEPTOR; AUTOIMMUNE INFLAMMATION; INCREASED POPULATIONS; MULTIPLE-SCLEROSIS	Myelofibrosis (MF), including primary myelofibrosis, post-essential thrombocythemia MF, and post-polycythemia vera MF, has been reported to be associated with autoimmune phenomena. IMiDs have been reported to be effective in some patients with MF, presumably for their immune-modulator effects. We therefore sought to elucidate the immune derangements in patients with MF. We found no differences in T regulatory cells (Treg) and T helper 17 (Th17) cells in MF patients and normal healthy controls. However, we found significantly elevated soluble interleukin 2 alpha (sIL2R alpha) in MF patients compared to those with other myeloproliferative neoplasm diseases and normal healthy controls. Our studies with MF patients further revealed that Treg cells were the predominant cells producing sIL2R alpha. sIL2R alpha and IL2 complex induced the formation of Treg cells but not the formation of Th1 or Th17 cells. sIL2R alpha induced CD8(+) T cell proliferation in the presence of Treg cells. Monocytes or neutrophils had no effect on the production of sIL2R alpha by Treg cells. Furthermore, we found plasma sIL2R alpha levels were correlated to the auto-immune serology in MPN patients and ruxolitinib significantly inhibits the sIL2R alpha production by the Treg cells in MF patients which may explain the effects of ruxolitinib on the relief of constitutional symptoms. All these findings suggest that sIL2R alpha likely plays a significant role in autoimmune phenomena seen in patients with MF. Further studies of immune derangement may elucidate the mechanism of IMiD, and exploration of immune modulators may prove to be important for treating myelofibrosis.	[Wang, Jen C.; Sindhu, Hemant; Chen, Chi; Kundra, Ajay; Kafeel, Muhammad I.; Wong, Ching; Lichter, Stephen] Brookdale Univ Hosp, Div Hematol Oncol, Med Ctr, Brooklyn, NY 11212 USA		Wang, JC (corresponding author), Brookdale Univ Hosp, Div Hematol Oncol, Med Ctr, Brooklyn, NY 11212 USA.	jcwang5@aol.com			ECRIP Program, NY Department of Health; Brookdale University Research Fund	ECRIP Program, NY Department of Health; Brookdale University Research Fund	This work is supported by the grants from the ECRIP Program, NY Department of Health and the Brookdale University Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADACHI K, 1989, LANCET, V1, P559; Alvaro T, 2005, CLIN CANCER RES, V11, P1467, DOI 10.1158/1078-0432.CCR-04-1869; Barcellini W, 2013, LEUKEMIA RES, V37, P1509, DOI 10.1016/j.leukres.2013.09.001; Belkaid Y, 2005, NAT IMMUNOL, V6, P353, DOI 10.1038/ni1181; BERNHARDT B, 1976, AM J MED SCI, V272, P229, DOI 10.1097/00000441-197609000-00016; Beyer M, 2005, BLOOD, V106, P2018, DOI 10.1182/blood-2005-02-0642; Bien E, 2008, BIOMARKERS, V13, P1, DOI 10.1080/13547500701674063; Brahmer JR, 2012, NEW ENGL J MED, V366, P2455, DOI 10.1056/NEJMoa1200694; Cua DJ, 2003, NATURE, V421, P744, DOI 10.1038/nature01355; Curiel TJ, 2004, NAT MED, V10, P942, DOI 10.1038/nm1093; Fabre-Guillevin E, 2006, LEUKEMIA LYMPHOMA, V47, P603, DOI 10.1080/10428190500361029; Gambineri E, 2003, CURR OPIN RHEUMATOL, V15, P430, DOI 10.1097/00002281-200307000-00010; GORDON BR, 1981, BLOOD, V58, P904; Harrison C, 2012, NEW ENGL J MED, V366, P787, DOI 10.1056/NEJMoa1110556; HASSELBALCH H, 1990, AM J HEMATOL, V34, P291, DOI 10.1002/ajh.2830340411; Heine A, 2013, BLOOD, V122, P1192, DOI 10.1182/blood-2013-03-484642; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Ichihara F, 2003, CLIN CANCER RES, V9, P4404; Javia LR, 2003, J IMMUNOTHER, V26, P85, DOI 10.1097/00002371-200301000-00009; Kesselring R, 2011, CELL IMMUNOL, V269, P74, DOI 10.1016/j.cellimm.2011.03.026; KHUMBANONDA M, 1969, AM J MED SCI, V258, P89, DOI 10.1097/00000441-196908000-00004; Kiladjian JJ, 2008, BLOOD, V112, P3065, DOI 10.1182/blood-2008-03-143537; Kordasti SY, 2007, BLOOD, V110, P847, DOI 10.1182/blood-2007-01-067546; Kundra A, 2013, BLOOD S; LEWIS CM, 1978, BRIT J HAEMATOL, V39, P233, DOI 10.1111/j.1365-2141.1978.tb01093.x; Lewis CM, 1997, LANCET, V115, P1151; Lindqvist CA, 2010, IMMUNOLOGY, V131, P371, DOI 10.1111/j.1365-2567.2010.03308.x; Maier LM, 2009, J IMMUNOL, V182, P1541, DOI 10.4049/jimmunol.182.3.1541; Marshall NA, 2004, BLOOD, V103, P1755, DOI 10.1182/blood-2003-07-2594; Mesa RA, 2003, BLOOD, V101, P2534, DOI 10.1182/blood-2002-09-2928; Mesa RA, 2010, AM J HEMATOL, V85, P129, DOI 10.1002/ajh.21598; Miyahara Y, 2008, P NATL ACAD SCI USA, V105, P15505, DOI 10.1073/pnas.0710686105; Motta M, 2005, LEUKEMIA, V19, P1788, DOI 10.1038/sj.leu.2403907; Murphy CA, 2003, J EXP MED, V198, P1951, DOI 10.1084/jem.20030896; Nelson BH, 1998, ADV IMMUNOL, V70, P1, DOI 10.1016/S0065-2776(08)60386-7; Ormandy LA, 2005, CANCER RES, V65, P2457, DOI 10.1158/0008-5472.CAN-04-3232; Prabhala RH, 2006, BLOOD, V107, P301, DOI 10.1182/blood-2005-08-3101; Quintas-Cardama A, 2009, J CLIN ONCOL, V27, P5418, DOI 10.1200/JCO.2009.23.6075; Riley CH, 2011, BLOOD, V118, P2170, DOI 10.1182/blood-2011-03-340992; Sasada T, 2003, CANCER-AM CANCER SOC, V98, P1089, DOI 10.1002/cncr.11618; Schaefer C, 2005, BRIT J CANCER, V92, P913, DOI 10.1038/sj.bjc.6602407; Shakil SA, 2010, ASH ANN M; Tefferi A, 2006, BLOOD, V108, P1158, DOI 10.1182/blood-2006-02-004572; Tefferi A, 2011, J CLIN ONCOL, V29, P1356, DOI 10.1200/JCO.2010.32.9490; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Verstovsek S, 2012, NEW ENGL J MED, V366, P799, DOI 10.1056/NEJMoa1110557; Waldmann H, 2004, SEMIN IMMUNOL, V16, P119, DOI 10.1016/j.smim.2003.12.007; WANG JC, 1994, BRIT J HAEMATOL, V86, P380, DOI 10.1111/j.1365-2141.1994.tb04744.x; Wang XB, 2005, EUR J HAEMATOL, V75, P468, DOI 10.1111/j.1600-0609.2005.00537.x; Woo EY, 2001, CANCER RES, V61, P4766; Wu C, 2009, CLIN EXP IMMUNOL, V158, P199, DOI 10.1111/j.1365-2249.2009.04011.x; Yang ZZ, 2011, BLOOD, V118, P2809, DOI 10.1182/blood-2011-03-340885; Yang ZZ, 2006, BLOOD, V107, P3639, DOI 10.1182/blood-2005-08-3376; Yao ZB, 1995, IMMUNITY, V3, P811, DOI 10.1016/1074-7613(95)90070-5; Zhang B, 2008, BIOCHEM BIOPH RES CO, V374, P533, DOI 10.1016/j.bbrc.2008.07.060	55	20	20	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0116723	10.1371/journal.pone.0116723	http://dx.doi.org/10.1371/journal.pone.0116723			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25793623	Green Published, gold, Green Submitted			2022-12-27	WOS:000352084200008
J	Wang, WQ				Wang, Wen-Qin			Transponder-Aided Joint Calibration and Synchronization Compensation for Distributed Radar Systems	PLOS ONE			English	Article							SYNTHETIC-APERTURE RADAR; PHASE SYNCHRONIZATION; MOTION COMPENSATION; MULTISTATIC SAR; FREQUENCY	High-precision radiometric calibration and synchronization compensation must be provided for distributed radar system due to separate transmitters and receivers. This paper proposes a transponder-aided joint radiometric calibration, motion compensation and synchronization for distributed radar remote sensing. As the transponder signal can be separated from the normal radar returns, it is used to calibrate the distributed radar for radiometry. Meanwhile, the distributed radar motion compensation and synchronization compensation algorithms are presented by utilizing the transponder signals. This method requires no hardware modifications to both the normal radar transmitter and receiver and no change to the operating pulse repetition frequency (PRF). The distributed radar radiometric calibration and synchronization compensation require only one transponder, but the motion compensation requires six transponders because there are six independent variables in the distributed radar geometry. Furthermore, a maximum likelihood method is used to estimate the transponder signal parameters. The proposed methods are verified by simulation results.	Univ Elect Sci & Technol China, Sch Commun & Informat Engn, Chengdu 610054, Peoples R China	University of Electronic Science & Technology of China	Wang, WQ (corresponding author), Univ Elect Sci & Technol China, Sch Commun & Informat Engn, Chengdu 610054, Peoples R China.	wqwang@uestc.edu.cn			National Natural Science Foundation of China [41101317]; Program for New Century Excellent Talents in University [NCET-12-0095]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET))	The work described in this study was supported by the National Natural Science Foundation of China under grant 41101317 and the Program for New Century Excellent Talents in University under grant NCET-12-0095. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AUTERMAN JL, 1984, MICROWAVES RF, V23, P48; BAMLER R, 1992, IEEE T GEOSCI REMOTE, V30, P706, DOI 10.1109/36.158864; Bar-Shalom O, 2013, IEEE T SIGNAL PROCES, V61, P1239, DOI 10.1109/TSP.2012.2237169; Breit H, 2011, INT GEOSCI REMOTE SE, P2424, DOI 10.1109/IGARSS.2011.6049700; Chen J, 2011, IEEE T GEOSCI REMOTE, V49, P2712, DOI 10.1109/TGRS.2011.2109065; Chen L, 2013, REMOTE SENS-BASEL, V5, P6958, DOI 10.3390/rs5126958; Cherniakov M, 2007, BISTATIC RDAR PRINCI; Curlander J.C., 1991, SYNTHETIC APERTURE R; D'Aria D, 2010, IEEE T GEOSCI REMOTE, V48, P2076, DOI 10.1109/TGRS.2009.2033672; Doring BJ, 2013, REMOTE SENS-BASEL, V5, P6667, DOI 10.3390/rs5126667; Espeter T, 2011, IEEE GEOSCI REMOTE S, V8, P765, DOI 10.1109/LGRS.2011.2108635; Fornaro G, 2005, IEEE T AERO ELEC SYS, V41, P1338, DOI 10.1109/TAES.2005.1561879; FREEMAN A, 1992, IEEE T GEOSCI REMOTE, V30, P1107, DOI 10.1109/36.193786; Fu H, 2007, IEEE T SIGNAL PROCES, V55, P834, DOI 10.1109/TSP.2006.888055; Keller F, 2013, REMOTE SENS-BASEL, V5, P5805, DOI 10.3390/rs5115805; Krieger G, 2006, IEE P-RADAR SON NAV, V153, P184, DOI 10.1049/ip-rsn:20045111; Krieger G, 2006, IEEE GEOSCI REMOTE S, V3, P424, DOI 10.1109/LGRS.2006.874164; McKilliam RG, 2010, IEEE T SIGNAL PROCES, V58, P2953, DOI 10.1109/TSP.2010.2045786; Morelande MR, 2009, IEEE T SIGNAL PROCES, V57, P4209, DOI 10.1109/TSP.2009.2025801; Patel P, 2013, INT J ADV REMOTE SEN, V1, P1; Patel P, 2006, PROC SPIE, V6410, DOI 10.1117/12.693930; Rodriguez-Cassola M, 2012, IEEE GEOSCI REMOTE S, V9, P33, DOI 10.1109/LGRS.2011.2158984; SIMON MK, 1994, IEEE T COMMUN, V42, P430, DOI 10.1109/TCOMM.1994.577070; Srivastava HS, 2009, IEEE T GEOSCI REMOTE, V47, P2528, DOI 10.1109/TGRS.2009.2018448; Srivastava HS, 2006, INT J GEOINFORMATICS; Srivastava HS, 2009, CURRENT SCI, V97; STEIGLITZ K, 1982, IEEE T ACOUST SPEECH, V30, P984, DOI 10.1109/TASSP.1982.1163975; Touzi R, 2013, IEEE T GEOSCI REMOTE, V51, P487, DOI 10.1109/TGRS.2012.2201946; TRIBOLET JM, 1977, IEEE T ACOUST SPEECH, V25, P170, DOI 10.1109/TASSP.1977.1162923; WAITE WP, 1984, IEEE T GEOSCI REMOTE, V22, P394, DOI 10.1109/TGRS.1984.350643; Wang WQ, 2008, IET RADAR SONAR NAV, V2, P1, DOI 10.1049/iet-rsn:20060097; Wang WQ, 2009, IET SIGNAL PROCESS, V3, P17, DOI 10.1049/iet-spr:20070209; Wang W.-Q., 2013, MULTIANTENNA SYNTHET; Wang WQ, 2009, IEEE T AERO ELEC SYS, V45, P1040, DOI 10.1109/TAES.2009.5259181; Wang WQ, 2007, IEEE GEOSCI REMOTE S, V4, P80, DOI 10.1109/LGRS.2006.886036; Wang WQ, 2006, FLUCT NOISE LETT, V6, pL297, DOI 10.1142/S0219477506003434; Weib M., 2002, Proceedings 4th European Conference on Synthetic Aperture Radar. EUSAR 2002, P493; Weiss M, 2002, INT GEOSCI REMOTE SE, P3649, DOI 10.1109/IGARSS.2002.1027279; Weiss M, 2004, P EUSAR, P395; Willis NJ, 1991, BISTATIC RADAR; Yang Y, 2011, IEEE T SIGNAL PROCES, V59, P5538, DOI 10.1109/TSP.2011.2162509; Younis M, 2006, IEEE GEOSCI REMOTE S, V3, P429, DOI 10.1109/LGRS.2006.874163; Zhang H, 2013, IEEE GEOSCI REMOTE S, V10, P898, DOI 10.1109/LGRS.2012.2226864	43	0	1	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0119174	10.1371/journal.pone.0119174	http://dx.doi.org/10.1371/journal.pone.0119174			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25794158	Green Published, gold, Green Submitted			2022-12-27	WOS:000352084200058
J	Zhou, WP; Zhang, H; Zhao, YX; Liu, GQ; Zhang, JY				Zhou, Wen-ping; Zhang, Hui; Zhao, Yu-xia; Liu, Gang-qiong; Zhang, Jin-ying			RNA Interference of Myocyte Enhancer Factor 2A Accelerates Atherosclerosis in Apolipoprotein E-Deficient Mice	PLOS ONE			English	Article							CORONARY-ARTERY-DISEASE; TRANSCRIPTION FACTOR MEF2A; CAG REPEAT POLYMORPHISM; MATRIX METALLOPROTEINASE-8; MYOCARDIAL-INFARCTION; GENE; ASSOCIATION; MUTATIONS; INFLAMMATION	Objective Myocyte enhancer factor-2A (MEF 2A) has been shown to be involved in atherosclerotic lesion development, but its role in preexisting lesions is still unclear. In the present study we aim to assess the role of MEF 2A in the progression of pre-existing atherosclerosis. Methods Eighty apolipoprotein E-deficient mice (APOE KO) were randomly allocated to control, scramble and MEF 2A RNA interference (RNAi) groups, and constrictive collars were used to induce plaque formation. Six weeks after surgery, lentiviral shRNA construct was used to silence the expression of MEF 2A. Carotid plaques were harvested for analysis 4 weeks after viral vector transduction. Inflammatory gene expression in the plasma and carotid plaques was determined by using ELISAs and real-time RT-PCR. Results The expression level of MEF 2A was significantly reduced in plasma and plaque in the RNAi group, compared to the control and NC groups, whereas the expression level of pro-inflammatory cytokines was markedly increased. Silencing MEF 2A using lentiviral shRNA significantly reduced the plaque collagen content and fibrous cap thickness, as well as increased plaque area. However, silencing MEF 2A had no obvious effect on plaque lipid content. Conclusions Lentivirus-mediated MEF 2A shRNA accelerates inflammation and atherosclerosis in APOE KO mice, but has no effect on lipoprotein levels in plasma.	[Zhou, Wen-ping; Zhang, Hui; Liu, Gang-qiong; Zhang, Jin-ying] Zhengzhou Univ, Affiliated Hosp 1, Dept Cardiol, Zhengzhou 450052, Henan, Peoples R China; [Zhao, Yu-xia] Zhengzhou Univ, Affiliated Hosp 1, Dept Med Equipment, Zhengzhou 450052, Henan, Peoples R China	Zhengzhou University; Zhengzhou University	Zhang, JY (corresponding author), Zhengzhou Univ, Affiliated Hosp 1, Dept Cardiol, Zhengzhou 450052, Henan, Peoples R China.	jyzhang@zzu.edu.cn			Key Scientific and Technological Project of Henan Province [112102310174]; Scientific Fund for Distinguished Young Scholars in Henan Province [094100510017]; Research Team Project of the First Affiliated Hospital of Zhengzhou University; Science and Technology Fund for Innovation Leading Talents of Health in Henan province [3027]	Key Scientific and Technological Project of Henan Province; Scientific Fund for Distinguished Young Scholars in Henan Province; Research Team Project of the First Affiliated Hospital of Zhengzhou University; Science and Technology Fund for Innovation Leading Talents of Health in Henan province	This work was supported by grants from the Key Scientific and Technological Project of Henan Province (No. 112102310174), the Scientific Fund for Distinguished Young Scholars in Henan Province (No. 094100510017), the Research Team Project of the First Affiliated Hospital of Zhengzhou University, and the Science and Technology Fund for Innovation Leading Talents of Health in Henan province (No. 3027). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler D, 2005, J CLIN INVEST, V115, P831, DOI 10.1172/JCI200524715; Bhagavatula MRK, 2004, HUM MOL GENET, V13, P3181, DOI 10.1093/hmg/ddh329; Black BL, 1998, ANNU REV CELL DEV BI, V14, P167, DOI 10.1146/annurev.cellbio.14.1.167; Brasier AR, 2002, ARTERIOSCL THROM VAS, V22, P1257, DOI 10.1161/01.ATV.0000021412.56621.A2; Dai DP, 2010, EUR J CLIN INVEST, V40, P669, DOI 10.1111/j.1365-2362.2010.02307.x; Elhawari S, 2010, ATHEROSCLEROSIS, V209, P152, DOI 10.1016/j.atherosclerosis.2009.09.005; Fang CC, 2013, CARDIOVASC RES, V99, P146, DOI 10.1093/cvr/cvt060; Follenzi Antonia, 2002, Methods Mol Med, V69, P259; Gonzalez P, 2006, J MED GENET, V43, P167, DOI 10.1136/jmg.2005.035071; Guella I, 2009, CIRC-CARDIOVASC GENE, V2, P165, DOI 10.1161/CIRCGENETICS.108.819326; Han YL, 2007, CLIN CHEM LAB MED, V45, P987, DOI 10.1515/CCLM.2007.159; Horan PG, 2006, BMC MED GENET, V7, DOI 10.1186/1471-2350-7-65; Hsu LA, 2010, CLIN APPL THROMB-HEM, V16, P301, DOI 10.1177/1076029608330476; Kajimoto K, 2005, CIRC J, V69, P1192, DOI 10.1253/circj.69.1192; Laxton RC, 2009, CIRC RES, V105, P921, DOI 10.1161/CIRCRESAHA.109.200279; Lenglet S, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/659282; Libby P, 2000, J INTERN MED, V247, P349, DOI 10.1046/j.1365-2796.2000.00654.x; Lieb W, 2008, CIRCULATION, V117, P185, DOI 10.1161/CIRCULATIONAHA.107.728485; Liu Y, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0031406, 10.1371/journal.pone.0048083]; Makinen PI, 2006, J GENE MED, V8, P433, DOI 10.1002/jgm.860; Manrique C, 2009, MED CLIN N AM, V93, P569, DOI 10.1016/j.mcna.2009.02.014; McKinsey TA, 2002, TRENDS BIOCHEM SCI, V27, P40, DOI 10.1016/S0968-0004(01)02031-X; Morris KV, 2006, GENE THER, V13, P553, DOI 10.1038/sj.gt.3302688; Qi LH, 2009, HUM GENE THER, V20, P739, DOI 10.1089/hum.2008.203; Rahatloo KI, 2013, IRAN J BASIC MED SCI, V16, P950; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; von der Thusen JH, 2001, CIRCULATION, V103, P1164, DOI 10.1161/01.CIR.103.8.1164; Wang LJ, 2003, SCIENCE, V302, P1578, DOI 10.1126/science.1088477; Weng L, 2005, J CLIN INVEST, V115, P1016, DOI 10.1172/JCI24186; Yanai H, 2008, NUTR J, V17, P7; Zhang H, 2013, CLIN INVEST MED, V36, pE32; Zhang H, 2013, INT J MOL MED, V31, P651, DOI 10.3892/ijmm.2013.1248; Zhang H, 2012, BIOCHEM BIOPH RES CO, V427, P557, DOI 10.1016/j.bbrc.2012.09.096; Zhao W, 2012, CELL BIOCHEM FUNCT, V30, P108, DOI 10.1002/cbf.1823	34	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0121823	10.1371/journal.pone.0121823	http://dx.doi.org/10.1371/journal.pone.0121823			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25793529	Green Published, gold, Green Submitted			2022-12-27	WOS:000352083900158
J	Ahn, J; Hogan, N				Ahn, Jooeun; Hogan, Neville			Improved Assessment of Orbital Stability of Rhythmic Motion with Noise	PLOS ONE			English	Article							WALKING; ROBOTS; SERIES	Mathematical techniques have provided tools to quantify the stability of rhythmic movements of humans and machines as well as mathematical models. One archetypal example is the use of Floquet multipliers: assuming periodic motion to be a limit-cycle of a nonlinear oscillator, local stability has been assessed by evaluating the rate of convergence to the limit-cycle. However, the accuracy of the assessment in experiments is questionable: Floquet multipliers provide a measure of orbital stability for deterministic systems, but various components of biological systems and machines involve inevitable noise. In this study, we show that the conventional estimate of orbital stability, which depends on regression, has bias in the presence of noise. We quantify the bias, and devise a new method to estimate orbital stability more accurately. Compared with previous methods, our method substantially reduces the bias, providing acceptable estimates of orbital stability with an order-of-magnitude fewer cycles.	[Ahn, Jooeun] Univ Victoria, Dept Mech Engn, Victoria, BC V8W 2Y2, Canada; [Hogan, Neville] MIT, Dept Mech Engn, Cambridge, MA 02139 USA; [Hogan, Neville] MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA	University of Victoria; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Ahn, J (corresponding author), Univ Victoria, Dept Mech Engn, Victoria, BC V8W 2Y2, Canada.	jooeun@uvic.ca		Ahn, Jooeun/0000-0002-7964-5148	Eric P. and Evelyn E. Newman Fund; Gloria Blake Endowment Fund	Eric P. and Evelyn E. Newman Fund; Gloria Blake Endowment Fund	Support was provided by the Eric P. and Evelyn E. Newman Fund, and the Gloria Blake Endowment Fund to JA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn J., 2011, FEASIBILITY NOVEL GA; Ahn J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073239; Broersen PMT, 2009, IEEE T INSTRUM MEAS, V58, P1354, DOI 10.1109/TIM.2008.2009400; Burg J. P., 1967, 37 ANN INT M SOC EXP; Coleman M. J, 1998, STABILITY STUDY 3 DI; Coleman MJ, 1997, DYNAM STABIL SYST, V12, P139, DOI 10.1080/02681119708806242; Collins S, 2005, SCIENCE, V307, P1082, DOI 10.1126/science.1107799; deHoon MJL, 1996, ANN NUCL ENERGY, V23, P1219, DOI 10.1016/0306-4549(95)00126-3; Dingwell JB, 2007, J BIOMECH ENG-T ASME, V129, P586, DOI 10.1115/1.2746383; Floquet G., 1883, ANN SCI ECOLE NORM S, V12, P47, DOI DOI 10.24033/ASENS.220; Garcia M, 1998, J BIOMECH ENG-T ASME, V120, P281, DOI 10.1115/1.2798313; Goswami A, 1997, AUTON ROBOT, V4, P273, DOI 10.1023/A:1008844026298; Hamacher D, 2011, J R SOC INTERFACE, V8, P1682, DOI 10.1098/rsif.2011.0416; HAUSDORFF JM, 1995, J APPL PHYSIOL, V78, P349, DOI 10.1152/jappl.1995.78.1.349; Hurmuzlu Y, 2004, AUTOMATICA, V40, P1647, DOI 10.1016/j.automatica.2004.01.031; HURMUZLU Y, 1994, J BIOMECH ENG-T ASME, V116, P30, DOI 10.1115/1.2895701; Hyun DJ, 2014, INT J ROBOT RES, V33, P1417, DOI 10.1177/0278364914532150; Kalman RE., 1960, J BASIC ENG, V82, P35, DOI [10.1115/1.3662552, DOI 10.1115/1.3662552]; Klausmeier CA, 2008, THEOR ECOL-NETH, V1, P153, DOI 10.1007/s12080-008-0016-2; Kuo AD, 1999, INT J ROBOT RES, V18, P917, DOI 10.1177/02783649922066655; McAndrew PM, 2011, J BIOMECH, V44, P644, DOI 10.1016/j.jbiomech.2010.11.007; MCGEER T, 1993, J THEOR BIOL, V163, P277, DOI 10.1006/jtbi.1993.1121; MIURA H, 1984, INT J ROBOT RES, V3, P60, DOI 10.1177/027836498400300206; Morimoto J, 2009, AUTON ROBOT, V27, P131, DOI 10.1007/s10514-009-9133-z; Oh J-H, 2006, INT ROB SYST 2006 IE; Peshkin M, 2005, REH ROB 2005 ICORR 2; Playter R, 2006, BIG DOG; Saranli U, 2001, INT J ROBOT RES, V20, P616, DOI 10.1177/02783640122067570; SKINNER JE, 1990, BIO-TECHNOL, V8, P1018, DOI 10.1038/nbt1190-1018; Stocker AA, 2006, NAT NEUROSCI, V9, P578, DOI 10.1038/nn1669; van Schooten KS, 2011, GAIT POSTURE, V33, P656, DOI 10.1016/j.gaitpost.2011.02.017; Walker G, 1931, P R SOC LOND A-CONTA, V131, P518, DOI 10.1098/rspa.1931.0069; Yule GU, 1927, PHILOS T R SOC LOND, V226, P267, DOI 10.1098/rsta.1927.0007	33	11	11	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0119596	10.1371/journal.pone.0119596	http://dx.doi.org/10.1371/journal.pone.0119596			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25798610	Green Published, Green Submitted, gold			2022-12-27	WOS:000351987300063
J	Fayon, M; Andrieux, A; Bara, I; Rebola, M; Labbe, A; Marthan, R; Berger, P				Fayon, Michael; Andrieux, Annick; Bara, Imane; Rebola, Muriel; Labbe, Andre; Marthan, Roger; Berger, Patrick			An Age-Wise Comparison of Human Airway Smooth Muscle Proliferative Capacity	PLOS ONE			English	Article							CHILDREN BORN; LUNG; EXPRESSION; ASTHMA; RECEPTOR; FETAL; SIZE	We compared the proliferation of neonatal and adult airway smooth muscle cells (ASMC) with no/moderate lung disease, in glucose-(energy production by glycolysis) or glucose-free medium (ATP production from mitochondrial oxidative phosphorylations only), in response to 10% fetal calf serum (FCS) and PDGF-AA. In the presence of glucose, cell counts were significantly greater in neonatal vs. adult ASMC. Similarly, neonatal ASMC DNA synthesis in 10% FCS and PDGF-AA, and [Ca2+]i responses in the presence of histamine were significantly enhanced vs. adults. In glucose-free medium, cell proliferation was preserved in neonatal cells, unlike in adult cells, with concomitant increased porin (an indicator of mitochondrial activity) protein expression. Compared to adults, stimulated neonatal human ASMC are in a rapid and robust proliferative phase and have the capacity to respond disproportionately under abnormal environmental conditions, through increased mitochondrial biogenesis and altered calcium homeostasis.	[Fayon, Michael; Andrieux, Annick; Bara, Imane; Rebola, Muriel; Marthan, Roger; Berger, Patrick] Univ Bordeaux, Ctr Rech Cardiothorac Bordeaux, U1045, F-33000 Bordeaux, France; [Fayon, Michael; Andrieux, Annick; Rebola, Muriel] CHU Bordeaux, Hop Pellegrin Enfants, Pneumol Pediat, Ctr Invest Clin CIC 1401, F-33076 Bordeaux, France; [Labbe, Andre] CHU Clermont Ferrand, Pediat Pulmonol & Intens Care Unit, F-63000 Clermont Ferrand, France	UDICE-French Research Universities; Universite de Bordeaux; CHU Bordeaux; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Clermont Ferrand	Fayon, M (corresponding author), Univ Bordeaux, Ctr Rech Cardiothorac Bordeaux, U1045, F-33000 Bordeaux, France.	michael.fayon@chu-bordeaux.fr	Fayon, Michael/HDN-7887-2022; Berger, Patrick/D-8779-2012	Fayon, Michael/0000-0002-1238-2128; Berger, Patrick/0000-0003-4702-0343; Marthan, Roger/0000-0001-5412-5712				Bara I, 2012, AM J RESP CRIT CARE, V185, P715, DOI 10.1164/rccm.201105-0915OC; Baraldi E, 2007, NEW ENGL J MED, V357, P1946, DOI 10.1056/NEJMra067279; Choukroun ML, 2013, RESP MED, V107, P1966, DOI 10.1016/j.rmed.2013.06.020; El-Shazly A, 2006, J IMMUNOL, V176, P1860, DOI 10.4049/jimmunol.176.3.1860; Fawke J, 2010, AM J RESP CRIT CARE, V182, P237, DOI 10.1164/rccm.200912-1806OC; FAYON M, 1994, AM J PHYSIOL, V267, pL180, DOI 10.1152/ajplung.1994.267.2.L180; Fayon M, 2006, AM J PHYSIOL-LUNG C, V291, pL244, DOI 10.1152/ajplung.00474.2005; Girodet PO, 2015, AM J RESP CRIT CARE, V191, P876, DOI 10.1164/rccm.201410-1874OC; HALL IP, 1988, BRIT J PHARMACOL, V95, P1204, DOI 10.1111/j.1476-5381.1988.tb11757.x; Halvorsen T, 2005, PEDIAT ALLERG IMM-UK, V16, P487, DOI 10.1111/j.1399-3038.2005.00314.x; Hartman WR, 2012, AM J PHYSIOL-LUNG C, V303, pL711, DOI 10.1152/ajplung.00037.2012; Hirota JA, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-120; Hirst SJ, 1996, AM J PHYSIOL-LUNG C, V270, pL415, DOI 10.1152/ajplung.1996.270.3.L415; HISLOP AA, 1989, AM REV RESPIR DIS, V140, P1717, DOI 10.1164/ajrccm/140.6.1717; Holgate Stephen T., 2003, Journal of Allergy and Clinical Immunology, V111, pS18, DOI 10.1067/mai.2003.25; Holgate ST, 2010, CLIN SCI, V118, P439, DOI 10.1042/CS20090474; Hulsmann A R, 1997, Monaldi Arch Chest Dis, V52, P272; Jeffery P, 2001, PEDIATR PULM, P3; Johnson PRA, 2001, AM J RESP CRIT CARE, V164, P474, DOI 10.1164/ajrccm.164.3.2010109; Mahn K, 2010, THORAX, V65, P547, DOI 10.1136/thx.2009.129296; MCCRAY PB, 1993, AM J RESP CELL MOL, V8, P573, DOI 10.1165/ajrcmb/8.5.573; Mochizuki H, 2006, J ASTHMA, V43, P25, DOI 10.1080/02770900500446948; Naureckas ET, 1999, AM J RESP CRIT CARE, V160, P2062, DOI 10.1164/ajrccm.160.6.9903131; NORTHWAY WH, 1990, NEW ENGL J MED, V323, P1793, DOI 10.1056/NEJM199012273232603; Regamey N, 2008, AM J RESP CRIT CARE, V177, P837, DOI 10.1164/rccm.200707-977OC; Regamey N, 2007, CHEST, V131, P1710, DOI 10.1378/chest.06-2666; Rossignol R, 2004, CANCER RES, V64, P985, DOI 10.1158/0008-5472.CAN-03-1101; Roth M, 2004, NEW ENGL J MED, V351, P560, DOI 10.1056/NEJMoa021660; Shimotake TK, 2004, PEDIATR RES, V56, P907, DOI 10.1203/01.PDR.0000145274.47221.10; Sweeney M, 2002, J APPL PHYSIOL, V92, P1594, DOI 10.1152/japplphysiol.00722.2001; Sweet David G, 2002, Paediatr Respir Rev, V3, P140, DOI 10.1016/S1526-0550(02)00010-0; Trian T, 2006, AM J RESP CELL MOL, V34, P49, DOI 10.1165/rcmb.2005-0187OC; Trian T, 2007, J EXP MED, V204, P3173, DOI 10.1084/jem.20070956; Tulic MK, 2003, CHEST, V123, p348S, DOI 10.1378/chest.123.3_suppl.348S	34	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0122446	10.1371/journal.pone.0122446	http://dx.doi.org/10.1371/journal.pone.0122446			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25798916	Green Published, Green Submitted, gold			2022-12-27	WOS:000351987300334
J	Hettinga, KA; Reina, FM; Boeren, S; Zhang, LN; Koppelman, GH; Postma, DS; Vervoort, JJM; Wijga, AH				Hettinga, Kasper A.; Reina, Fabiola M.; Boeren, Sjef; Zhang, Lina; Koppelman, Gerard H.; Postma, Dirkje S.; Vervoort, Jacques J. M.; Wijga, Alet H.			Difference in the Breast Milk Proteome between Allergic and Non-Allergic Mothers	PLOS ONE			English	Article							BIRTH COHORT; FED INFANTS; ASTHMA; DISEASE; APOLIPOPROTEINS; QUANTIFICATION; PREVENTION; CHILDHOOD; SYMPTOMS; PROTEINS	Background Breastfeeding has been linked to a reduction in the prevalence of allergy and asthma. However, studies on this relationship vary in outcome, which may partly be related to differences in breast milk composition. In particular breast milk composition may differ between allergic and non-allergic mothers. Important components that may be involved are breast milk proteins, as these are known to regulate immune development in the newborn. The objective of this study was therefore to explore differences in the proteins of breast milk from 20 allergic and non-allergic mothers. The results from this comparison may then be used to generate hypotheses on proteins associated with allergy in their offspring. Methods Milk samples from allergic and non-allergic mothers were obtained from the PIAMA project, a prospective birth cohort study on incidence, risk factors, and prevention of asthma and inhalant allergy. Non-targeted proteomics technology, based on liquid chromatography and mass spectrometry, was used to compare breast milk from allergic and non-allergic mothers. Results Nineteen proteins, out of a total of 364 proteins identified in both groups, differed significantly in concentration between the breast milk of allergic and non-allergic mothers. Protease inhibitors and apolipoproteins were present in much higher concentrations in breast milk of allergic than non-allergic mothers. These proteins have been suggested to be linked to allergy and asthma. Conclusions The non-targeted milk proteomic analysis employed has provided new targets for future studies on the relation between breast milk composition and allergy.	[Hettinga, Kasper A.; Reina, Fabiola M.; Zhang, Lina] Wageningen Univ, Dairy Sci & Technol, Food Qual & Design Grp, NL-6700 AP Wageningen, Netherlands; [Boeren, Sjef; Vervoort, Jacques J. M.] Wageningen Univ, Biochem Lab, NL-6700 AP Wageningen, Netherlands; [Koppelman, Gerard H.] Univ Groningen, Univ Med Ctr Groningen, Dept Pediat Pulmonol & Pediat Allergol, Beatrix Childrens Hosp,GRIAC Res Inst, Groningen, Netherlands; [Postma, Dirkje S.] Univ Groningen, Univ Med Ctr Groningen, Dept Pulmonol, GRIAC Res Inst, Groningen, Netherlands; [Wijga, Alet H.] Natl Inst Publ Hlth & Environm, Ctr Nutr Prevent & Hlth Serv, NL-3720 BA Bilthoven, Netherlands	Wageningen University & Research; Wageningen University & Research; University of Groningen; University of Groningen; Netherlands National Institute for Public Health & the Environment	Hettinga, KA (corresponding author), Wageningen Univ, Dairy Sci & Technol, Food Qual & Design Grp, NL-6700 AP Wageningen, Netherlands.	kasper.hettinga@wur.nl	Koppelman, Gerard/AAG-9187-2020	Koppelman, Gerard/0000-0001-8567-3252	Netherlands Organization for Health Research and Development; Netherlands Organization for Scientific Research; Netherlands Lung Fund; Netherlands Ministry of Spatial Planning, Housing, and the Environment; Netherlands Ministry of Health, Welfare, and Sport	Netherlands Organization for Health Research and Development(Netherlands Organization for Health Research and Development); Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Netherlands Lung Fund; Netherlands Ministry of Spatial Planning, Housing, and the Environment; Netherlands Ministry of Health, Welfare, and Sport	The PIAMA study is supported by The Netherlands Organization for Health Research and Development, The Netherlands Organization for Scientific Research, The Netherlands Lung Fund, The Netherlands Ministry of Spatial Planning, Housing, and the Environment, and The Netherlands Ministry of Health, Welfare, and Sport. No additional funding was received for the proteomics study described in this paper. The funders of the PIAMA study had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belderbos ME, 2012, PEDIAT ALLERG IMM-UK, V23, P65, DOI 10.1111/j.1399-3038.2011.01230.x; Bjorksten B, 2011, ALLERGOL IMMUNOPATH, V39, P318, DOI 10.1016/j.aller.2011.02.005; Cork MJ, 2009, J INVEST DERMATOL, V129, P1892, DOI 10.1038/jid.2009.133; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; DAVIDSON LA, 1990, ACTA PAEDIATR SCAND, V79, P137, DOI 10.1111/j.1651-2227.1990.tb11429.x; Gregory LG, 2011, TRENDS IMMUNOL, V32, P402, DOI 10.1016/j.it.2011.06.006; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hubner NC, 2010, J CELL BIOL, V189, P739, DOI 10.1083/jcb.200911091; Jacquet A, 2011, INT ARCH ALLERGY IMM, V155, P95, DOI 10.1159/000320375; Jarvinen KM, 2001, CLIN EXP ALLERGY, V31, P978, DOI 10.1046/j.1365-2222.2001.01151.x; Lonnerdal B, 2003, AM J CLIN NUTR, V77, p1537S; Loss G, 2011, J ALLERGY CLIN IMMUN, V128, P766, DOI 10.1016/j.jaci.2011.07.048; Lu J, 2011, J PROTEOMICS, V75, P34, DOI 10.1016/j.jprot.2011.07.031; Matheson MC, 2012, CLIN EXP ALLERGY, V42, P827, DOI 10.1111/j.1365-2222.2011.03925.x; Nagel G, 2009, INT ARCH ALLERGY IMM, V149, P259, DOI 10.1159/000199722; Newburg DS, 2007, PEDIATR RES, V61, P2, DOI 10.1203/01.pdr.0000250274.68571.18; Oberle D, 2001, THORAX, V56, P896; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Smith PK, 2006, ALLERGY, V61, P1441, DOI 10.1111/j.1398-9995.2006.01233.x; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; van Odijk J, 2003, ALLERGY, V58, P833, DOI 10.1034/j.1398-9995.2003.00264.x; Verhasselt V, 2010, MUCOSAL IMMUNOL, V3, P326, DOI 10.1038/mi.2010.25; Walker A, 2010, J PEDIATR-US, V156, pS3, DOI 10.1016/j.jpeds.2009.11.021; Wijga AH, 2006, J ALLERGY CLIN IMMUN, V117, P440, DOI 10.1016/j.jaci.2005.10.022; Wijga AH, 2013, INT J EPIDEMIOL, V11, P11; Wright AL, 1999, J ALLERGY CLIN IMMUN, V104, P589, DOI 10.1016/S0091-6749(99)70328-3; Yao XL, 2011, CHEST, V140, P1048, DOI 10.1378/chest.11-0158; Zhang L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116710	28	33	33	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0122234	10.1371/journal.pone.0122234	http://dx.doi.org/10.1371/journal.pone.0122234			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25798592	gold, Green Submitted, Green Published			2022-12-27	WOS:000351987300323
J	Zhang, Q; Yu, L; Qin, DD; Huang, R; Jiang, XC; Zou, CD; Tang, QC; Chen, YG; Wang, GY; Wang, XS; Gao, X				Zhang, Qian; Yu, Lei; Qin, Dandan; Huang, Rui; Jiang, Xiaochen; Zou, Chendan; Tang, Qingchao; Chen, Yinggang; Wang, Guiyu; Wang, Xishan; Gao, Xu			Role of microRNA-30c Targeting ADAM19 in Colorectal Cancer	PLOS ONE			English	Article							CELL LUNG-CANCER; POTENTIAL TUMOR-SUPPRESSOR; BREAST-CANCER; HEPATOCELLULAR-CARCINOMA; MESENCHYMAL TRANSITION; PROGNOSTIC VALUE; EXPRESSION; METASTASIS; INVASION; PROLIFERATION	MicroRNAs (miRNAs) are deregulated in a number of cancers including colorectal cancer. MiR-30c belongs to miR-30 family, and is involved in a variety of malignant diseases. In this study, we detected the expression of miR-30c in colon cancer cell lines and clinical colon cancer specimens. MiR-30c was shown to be dramatically down-regulated both in cell lines and cancer tissues. Additionally, miR-30c could inhibit cancer cell growth, migration and invasion in vitro. Consistently, stable over-expression of miR-30c inhibited the growth and lung metastasis of colon cancer cell xenografts in vivo. Furthermore, bioinformatics algorithm and luciferase reporter assay indicated ADAM19 as a direct target of miR-30c. Of interest, further experiments demonstrated that inhibition of ADAM19 by miR-30c partially mediated the anti-tumor effect of miR-30c. Overall, our study provides the new insight that miR-30c inhibited colon cancer cells via targeting ADAM19. Thus, miR-30c might serve as a promising therapeutic strategy for colon cancer treatment.	[Zhang, Qian; Yu, Lei; Huang, Rui; Tang, Qingchao; Chen, Yinggang; Wang, Guiyu; Wang, Xishan] Harbin Med Univ, Affiliated Hosp 2, Dept Colorectal Surg, Harbin 150086, Heilongjiang, Peoples R China; [Zhang, Qian; Yu, Lei; Huang, Rui; Tang, Qingchao; Chen, Yinggang; Wang, Guiyu; Wang, Xishan] Harbin Med Univ, Colorectal Canc Inst, Harbin 150086, Heilongjiang, Peoples R China; [Qin, Dandan] Harbin Med Univ, Affiliated Hosp 2, Dept Nephrol, Harbin 150086, Heilongjiang, Peoples R China; [Jiang, Xiaochen; Zou, Chendan; Gao, Xu] Harbin Med Univ, Dept Biochem & Mol Biol, Harbin 150086, Heilongjiang, Peoples R China	Harbin Medical University; Harbin Medical University; Harbin Medical University; Harbin Medical University	Wang, GY (corresponding author), Harbin Med Univ, Affiliated Hosp 2, Dept Colorectal Surg, Harbin 150086, Heilongjiang, Peoples R China.	guiywang@163.com; wxshan1208@126.com; Gaoxu_671227@yahoo.com.cn	gao, xu/U-4765-2019					Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Budhu A, 2008, HEPATOLOGY, V47, P897, DOI 10.1002/hep.22160; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Calin GA, 2004, P NATL ACAD SCI USA, V101, P11755, DOI 10.1073/pnas.0404432101; Chan SH, 2014, ONCOGENE, V33, P4496, DOI 10.1038/onc.2014.10; Chang TC, 2008, NAT GENET, V40, P43, DOI 10.1038/ng.2007.30; Cheng CW, 2012, BREAST CANCER RES TR, V134, P1081, DOI 10.1007/s10549-012-2034-4; Dobson JR, 2014, CANCER CELL INT, V14, DOI 10.1186/s12935-014-0073-0; Fernandez S, 2014, ONCOGENE; Fuster O, 2013, LEUKEMIA RES, V37, P1690, DOI 10.1016/j.leukres.2013.09.015; Gaziel-Sovran A, 2011, CANCER CELL, V20, P104, DOI 10.1016/j.ccr.2011.05.027; Hu ZB, 2010, J CLIN ONCOL, V28, P1721, DOI 10.1200/JCO.2009.24.9342; Huang JW, 2013, CANCER SCI, V104, P1609, DOI 10.1111/cas.12291; Ichikawa T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031422; Jurmeister S, 2012, MOL CELL BIOL, V32, P633, DOI 10.1128/MCB.06212-11; Kong X, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0090810, DOI 10.1371/JOURNAL.PONE.0090810]; Kumarswamy R, 2012, INT J CANCER, V130, P2044, DOI 10.1002/ijc.26218; Leung YK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098037; Li N, 2012, CANCER RES, V72, P154, DOI 10.1158/0008-5472.CAN-11-2484; Li Q, 2013, CANCER LETT, V335, P168, DOI 10.1016/j.canlet.2013.02.029; Li S, 2012, BREAST CANCER RES TR, V136, P77, DOI 10.1007/s10549-012-2166-6; Li XH, 2010, GUT, V59, P579, DOI 10.1136/gut.2008.175497; Ling XH, 2014, MOL BIOL REP, V41, P2779, DOI 10.1007/s11033-014-3132-7; Liu N, 2012, LANCET ONCOL, V13, DOI 10.1016/S1470-2045(12)70102-X; Michael MZ, 2003, MOL CANCER RES, V1, P882; Mochizuki S, 2007, CANCER SCI, V98, P621, DOI 10.1111/j.1349-7006.2007.00434.x; Quintavalle C, 2013, ONCOGENE, V32, P4001, DOI 10.1038/onc.2012.410; Ramdas V, 2013, AM J PATHOL, V183, P1885, DOI 10.1016/j.ajpath.2013.08.027; Rodriguez-Gonzalez FG, 2011, BREAST CANCER RES TR, V127, P43, DOI 10.1007/s10549-010-0940-x; Roemer A, 2004, ONCOL REP, V11, P529; Seals DF, 2003, GENE DEV, V17, P7, DOI 10.1101/gad.1039703; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Visone R, 2007, ONCOGENE, V26, P7590, DOI 10.1038/sj.onc.1210564; Wang HX, 2005, MOL HUM REPROD, V11, P429, DOI 10.1093/molehr/gah183; Wang YH, 2014, BIOCHEM BIOPH RES CO, V444, P199, DOI 10.1016/j.bbrc.2014.01.028; Wildeboer D, 2006, J NEUROPATH EXP NEUR, V65, P516, DOI 10.1097/01.jnen.0000229240.51490.d3; Wu FT, 2009, CLIN CANCER RES, V15, P1550, DOI 10.1158/1078-0432.CCR-08-0820; Yamakuchi M, 2008, P NATL ACAD SCI USA, V105, P13421, DOI 10.1073/pnas.0801613105; Yamakuchi M, 2010, P NATL ACAD SCI USA, V107, P6334, DOI 10.1073/pnas.0911082107; Yao J, 2010, HEPATOLOGY, V51, P846, DOI 10.1002/hep.23443; Zhong K, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-703; Zhou HM, 2004, MOL CELL BIOL, V24, P96, DOI 10.1128/MCB.24.1.96-104.2004	42	40	45	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0120698	10.1371/journal.pone.0120698	http://dx.doi.org/10.1371/journal.pone.0120698			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25799050	Green Submitted, Green Published, gold			2022-12-27	WOS:000351987300165
J	Zaballos, MA; Cantero, W; Azpiazu, N				Angel Zaballos, Miguel; Cantero, Walter; Azpiazu, Natalia			The TALE Transcription Factor Homothorax Functions to Assemble Heterochromatin during Drosophila Embryogenesis	PLOS ONE			English	Article							PROXIMODISTAL AXIS; DNA-SEQUENCES; EXTRADENTICLE; CHROMATIN; METHYLATION; GENES; LEG; LOCALIZATION; PURIFICATION; CHROMOSOME	We have previously identified Homothorax (Hth) as an important factor for the correct assembly of the pericentromeric heterochromatin during the first fast syncytial divisions of the Drosophila embryo. Here we have extended our studies to later stages of embryonic development. We were able to show that hth mutants exhibit a drastic overall reduction in the tri-methylation of H3 in Lys9, with no reduction of the previous di-methylation. One phenotypic outcome of such a reduction is a genome instability visualized by the many DNA breaks observed in the mutant nuclei. Moreover, loss of Hth leads to the opening of closed heterochromatic regions, including the rDNA genomic region. Our data show that the satellite repeats get transcribed in wild type embryos and that this transcription depends on the presence of Hth, which binds to them as well as to the rDNA region. This work indicates that there is an important role of transcription of non-coding RNAs for constitutive heterochromatin assembly in the Drosophila embryo, and suggests that Hth plays an important role in this process.	[Angel Zaballos, Miguel; Cantero, Walter; Azpiazu, Natalia] UAM, CSIC, Ctr Biol Mol Severo Ochoa, Madrid, Spain	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM)	Azpiazu, N (corresponding author), UAM, CSIC, Ctr Biol Mol Severo Ochoa, C Nicolas Cabrera,1 Univ Autonoma Madrid, Madrid, Spain.	nazpiazu@cbm.csic.es	Zaballos, Miguel A/E-7877-2016	Zaballos, Miguel A/0000-0001-8940-6477	Ministerio de Ciencia e Innovacion Fundacion Ramon Areces [BFU2009-12152]	Ministerio de Ciencia e Innovacion Fundacion Ramon Areces	Funding from BFU2009-12152 Ministerio de Ciencia e Innovacion Fundacion Ramon Areces. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abad JP, 2000, MOL GEN GENET, V264, P371, DOI 10.1007/s004380000331; ABAD JP, 1992, P NATL ACAD SCI USA, V89, P4663, DOI 10.1073/pnas.89.10.4663; Abu-Shaar M, 1998, DEVELOPMENT, V125, P3821; Agudo M, 1999, NUCLEIC ACIDS RES, V27, P3318, DOI 10.1093/nar/27.16.3318; Aldaz S, 2005, DEVELOPMENT, V132, P439, DOI 10.1242/dev.01585; Azpiazu N, 2000, DEVELOPMENT, V127, P2685; Azpiazu N, 2002, MECH DEVELOP, V119, P55, DOI 10.1016/S0925-4773(02)00295-2; Berthelsen J, 1998, EMBO J, V17, P1423, DOI 10.1093/emboj/17.5.1423; Buhler M, 2006, CELL, V125, P873, DOI 10.1016/j.cell.2006.04.025; Bulut-Karslioglu A, 2012, NAT STRUCT MOL BIOL, V19, P1023, DOI 10.1038/nsmb.2382; Burglin TR, 1997, NUCLEIC ACIDS RES, V25, P4173, DOI 10.1093/nar/25.21.4173; Campos-Ortega J.A., 2013, EMBRYONIC DEV DROSOP; Casanova M, 2013, CELL REP, V4, P1156, DOI 10.1016/j.celrep.2013.08.015; Casares F, 1998, NATURE, V392, P723, DOI 10.1038/33706; Casares F, 2000, DEVELOPMENT, V127, P1499; Chan SK, 1996, EMBO J, V15, P2476, DOI 10.1002/j.1460-2075.1996.tb00605.x; Corsetti E, 2013, DEV BIOL, V384, P72, DOI 10.1016/j.ydbio.2013.09.018; Dernburg AF, 1996, CELL, V86, P135, DOI 10.1016/S0092-8674(00)80084-7; Dong PDS, 2002, DEVELOPMENT, V129, P1967; Gonzalez-Crespo S, 1998, NATURE, V394, P196, DOI 10.1038/28197; Grewal SIS, 2007, NAT REV GENET, V8, P35, DOI 10.1038/nrg2008; Guetg C, 2012, MOL CELL, V45, P790, DOI 10.1016/j.molcel.2012.01.024; Guetg C, 2010, EMBO J, V29, P2135, DOI 10.1038/emboj.2010.17; Knoepfler PS, 1997, P NATL ACAD SCI USA, V94, P14553, DOI 10.1073/pnas.94.26.14553; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kurant E, 1998, DEVELOPMENT, V125, P1037; Lamb JC, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-5-214; LOHE AR, 1993, GENETICS, V134, P1149; Loyola A, 2007, TRENDS BIOCHEM SCI, V32, P425, DOI 10.1016/j.tibs.2007.08.004; Lu J, 2007, J CELL BIOL, V179, P411, DOI 10.1083/jcb.200706176; Madigan JP, 2002, NUCLEIC ACIDS RES, V30, P3698, DOI 10.1093/nar/gkf496; Maison C, 2002, NAT GENET, V30, P329, DOI 10.1038/ng843; Mayer C, 2006, MOL CELL, V22, P351, DOI 10.1016/j.molcel.2006.03.028; McKeown PC, 2009, CHROMOSOMA, V118, P11, DOI 10.1007/s00412-008-0184-2; Muchardt C, 2002, EMBO REP, V3, P975, DOI 10.1093/embo-reports/kvf194; Negre N, 2006, METHOD ENZYMOL, V410, P316, DOI 10.1016/S0076-6879(06)10015-4; Pai CY, 1998, GENE DEV, V12, P435, DOI 10.1101/gad.12.3.435; Paredes S, 2009, P NATL ACAD SCI USA, V106, P17829, DOI 10.1073/pnas.0906811106; PEIFER M, 1990, GENE DEV, V4, P1209, DOI 10.1101/gad.4.7.1209; Peng HW, 2009, GENE DEV, V23, P2307, DOI 10.1101/gad.1820009; Peng JC, 2007, NAT CELL BIOL, V9, P25, DOI 10.1038/ncb1514; Peng JC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000435; Probst AV, 2010, DEV CELL, V19, P625, DOI 10.1016/j.devcel.2010.09.002; Rauskolb C, 1993, CELL, V91, P171; Rieckhof GE, 1997, CELL, V91, P171, DOI 10.1016/S0092-8674(00)80400-6; Rodriguez-Collazo P, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp273; Rudolph T, 2007, MOL CELL, V26, P103, DOI 10.1016/j.molcel.2007.02.025; Ryoo HD, 1999, GENE DEV, V13, P1704, DOI 10.1101/gad.13.13.1704; Ryoo HD, 1999, DEVELOPMENT, V126, P5137; Salvany L, 2012, MOL CELL BIOL, V32, P2407, DOI 10.1128/MCB.06311-11; Salvany L, 2009, CELL CYCLE, V8, P2748, DOI 10.4161/cc.8.17.9388; Santoro R, 2010, EMBO REP, V11, P52, DOI 10.1038/embor.2009.254; Shechter D, 2007, NAT PROTOC, V2, P1445, DOI 10.1038/nprot.2007.202; Sugiyama T, 2007, CELL, V128, P491, DOI 10.1016/j.cell.2006.12.035; Sun XP, 1997, CELL, V91, P1007, DOI 10.1016/S0092-8674(00)80491-2; Tessarz P, 2014, NATURE, V505, P564, DOI 10.1038/nature12819; TOLLERVEY D, 1993, CELL, V72, P443, DOI 10.1016/0092-8674(93)90120-F; Usakin L, 2007, GENETICS, V176, P1343, DOI 10.1534/genetics.107.071720; Verdel A, 2004, SCIENCE, V303, P672, DOI 10.1126/science.1093686; Wu J, 1999, DEVELOPMENT, V126, P109; Zhang YP, 2008, DEV CELL, V14, P481, DOI 10.1016/j.devcel.2008.01.018	61	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0120662	10.1371/journal.pone.0120662	http://dx.doi.org/10.1371/journal.pone.0120662			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25794008	Green Published, gold			2022-12-27	WOS:000352083900064
J	Bose, ME; He, J; Shrivastava, S; Nelson, MI; Bera, J; Halpin, RA; Town, CD; Lorenzi, HA; Noyola, DE; Falcone, V; Gerna, G; De Beenhouwer, H; Videla, C; Kok, T; Venter, M; Williams, JV; Henrickson, KJ				Bose, Michael E.; He, Jie; Shrivastava, Susmita; Nelson, Martha I.; Bera, Jayati; Halpin, Rebecca A.; Town, Christopher D.; Lorenzi, Hernan A.; Noyola, Daniel E.; Falcone, Valeria; Gerna, Giuseppe; De Beenhouwer, Hans; Videla, Cristina; Kok, Tuckweng; Venter, Marietjie; Williams, John V.; Henrickson, Kelly J.			Sequencing and Analysis of Globally Obtained Human Respiratory Syncytial Virus A and B Genomes	PLOS ONE			English	Article							G-PROTEIN GENE; GROUP-A; MOLECULAR EPIDEMIOLOGY; HUMAN METAPNEUMOVIRUS; CIRCULATION PATTERNS; GLYCOPROTEIN-G; SUBGROUP-B; VARIABILITY; STRAINS; DIVERSITY	Background Human respiratory syncytial virus (RSV) is the leading cause of respiratory tract infections in children globally, with nearly all children experiencing at least one infection by the age of two. Partial sequencing of the attachment glycoprotein gene is conducted routinely for genotyping, but relatively few whole genome sequences are available for RSV. The goal of our study was to sequence the genomes of RSV strains collected from multiple countries to further understand the global diversity of RSV at a whole-genome level. Methods We collected RSV samples and isolates from Mexico, Argentina, Belgium, Italy, Germany, Australia, South Africa, and the USA from the years 1998-2010. Both Sanger and next-generation sequencing with the Illumina and 454 platforms were used to sequence the whole genomes of RSV A and B. Phylogenetic analyses were performed using the Bayesian and maximum likelihood methods of phylogenetic inference. Results We sequenced the genomes of 34 RSVA and 23 RSVB viruses. Phylogenetic analysis showed that the RSVA genome evolves at an estimated rate of 6.72 x 10(-4) substitutions/site/year (95% HPD 5.61 x 10(-4) to 7.6 x 10(-4)) and for RSVB the evolutionary rate was 7.69 x 10(-4) substitutions/site/year (95% HPD 6.81 x 10(-4) to 8.62 x 10(-4)). We found multiple clades co-circulating globally for both RSV A and B. The predominant clades were GA2 and GA5 for RSVA and BA for RSVB. Conclusions Our analyses showed that RSV circulates on a global scale with the same predominant clades of viruses being found in countries around the world. However, the distribution of clades can change rapidly as new strains emerge. We did not observe a strong spatial structure in our trees, with the same three main clades of RSV co-circulating globally, suggesting that the evolution of RSV is not strongly regionalized.	[Bose, Michael E.; He, Jie; Henrickson, Kelly J.] Med Coll Wisconsin, Midwest Resp Virus Program, Milwaukee, WI 53226 USA; [Shrivastava, Susmita; Bera, Jayati; Halpin, Rebecca A.; Town, Christopher D.; Lorenzi, Hernan A.] J Craig Venter Inst, Rockville, MD USA; [Nelson, Martha I.] NIH, Fogarty Int Ctr, Bethesda, MD 20892 USA; [Noyola, Daniel E.] Univ Autonoma San Luis Potosi, Fac Med, Dept Microbiol, San Luis Potosi, Mexico; [Falcone, Valeria] Univ Med Ctr Freiburg, Dept Virol, Inst Med Microbiol & Hyg, Freiburg, Germany; [Gerna, Giuseppe] Fdn IRCCS Policlin San Matteo, Lab Sperimentali Ric, Pavia, Italy; [De Beenhouwer, Hans] OLV Hosp Aalst, Dept Microbiol, Aalst, Belgium; [Videla, Cristina] Ctr Educ Med & Invest Clin Univ Hosp, Clin Virol Lab, Buenos Aires, DF, Argentina; [Kok, Tuckweng] Univ Adelaide, Sch Mol & Biomed Sci, Adelaide, SA, Australia; [Venter, Marietjie] Univ Pretoria, Dept Med Virol, Zoonoses Res Unit, ZA-0001 Pretoria, South Africa; [Williams, John V.] Vanderbilt Univ, Sch Med, Dept Pediat, Nashville, TN 37212 USA; [Williams, John V.] Vanderbilt Univ, Sch Med, Dept Pathol, Nashville, TN 37212 USA; [Williams, John V.] Vanderbilt Univ, Sch Med, Dept Microbiol, Nashville, TN 37212 USA; [Williams, John V.] Vanderbilt Univ, Sch Med, Dept Immunol, Nashville, TN 37212 USA	Medical College of Wisconsin; J. Craig Venter Institute; National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC); Universidad Autonoma de San Luis Potosi; University of Freiburg; IRCCS Fondazione San Matteo; Centro de Educacion Medica e Investigaciones Clinicas (CEMIC); University of Adelaide; University of Pretoria; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Henrickson, KJ (corresponding author), Med Coll Wisconsin, Midwest Resp Virus Program, Milwaukee, WI 53226 USA.	khenrick@mcw.edu	Venter, Marietjie/P-9604-2016; Williams, John/ABE-3227-2020; Williams, John/F-6962-2010; Noyola, Daniel/AAL-9773-2020	Venter, Marietjie/0000-0003-2696-824X; Williams, John/0000-0001-8377-5175; Williams, John/0000-0001-8377-5175; Lorenzi, Hernan/0000-0003-0910-7894; Noyola, Daniel/0000-0002-4840-6742; Gerna, Giuseppe/0000-0001-5956-2786; Kok, Tuck-Weng/0000-0003-1924-1261	National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services [HHSN272200900007C, 5U01AI070428, 5U01AI077988]; Multinational Influenza Seasonal Mortality Study (MISMS); Department of Health and Human Services; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI077988] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Multinational Influenza Seasonal Mortality Study (MISMS); Department of Health and Human Services; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This project has been funded in whole or part with federal funds from the National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services (www.niaid.nih.gov) under contract number HHSN272200900007C and grant numbers 5U01AI070428 and 5U01AI077988. This work was supported in part by the Multinational Influenza Seasonal Mortality Study (MISMS), led by the Fogarty International Center, National Institutes of Health, with funding from the Department of Health and Human Services (www.fic.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agenbach E, 2005, VIRUS GENES, V30, P267, DOI 10.1007/s11262-004-5633-2; Almajhdi FN, 2014, ARCH VIROL, V159, P73, DOI 10.1007/s00705-013-1792-6; Arnott A, 2011, J CLIN MICROBIOL, V49, P3504, DOI 10.1128/JCM.01131-11; Bonroy C, 2007, CLIN MICROBIOL INFEC, V13, P504, DOI 10.1111/j.1469-0691.2007.01682.x; Botosso VF, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000254; CANE PA, 1991, J GEN VIROL, V72, P2091, DOI 10.1099/0022-1317-72-9-2091; Cane PA, 1997, J MED VIROL, V51, P297, DOI 10.1002/(SICI)1096-9071(199704)51:4<297::AID-JMV7>3.0.CO;2-0; Choi EH, 2000, J INFECT DIS, V181, P1547, DOI 10.1086/315468; Delport W, 2010, BIOINFORMATICS, V26, P2455, DOI 10.1093/bioinformatics/btq429; Deng J, 1999, CHINESE J PEDIAT, V37, P287; Djikeng A, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-5; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Eshaghi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032807; Faghihloo E, 2011, ACTA VIROL, V55, P81, DOI 10.4149/av_2011_01_81; Faghihloo E, 2014, INFECT GENET EVOL, V22, P130, DOI 10.1016/j.meegid.2014.01.009; Faghihloo E, 2011, IRAN J PEDIATR, V21, P58; Falsey AR, 2005, NEW ENGL J MED, V352, P1749, DOI 10.1056/NEJMoa043951; Gan SW, 2012, J BIOL CHEM, V287, P24671, DOI 10.1074/jbc.M111.332791; Gaunt ER, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017427; Gerna G, 2008, J CLIN VIROL, V41, P49, DOI 10.1016/j.jcv.2007.10.018; GLEZEN WP, 1986, AM J DIS CHILD, V140, P543, DOI 10.1001/archpedi.1986.02140200053026; Katoh Kazutaka, 2013, Mol Biol Evol, V30, P772, DOI 10.1093/molbev/mst010; Khor CS, 2013, INFECT GENET EVOL, V14, P357, DOI 10.1016/j.meegid.2012.12.017; KOK T, 1994, J VIROL METHODS, V50, P87, DOI 10.1016/0166-0934(94)90166-X; Kryazhimskiy S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000304; Kuo L, 1997, J VIROL, V71, P4944, DOI 10.1128/JVI.71.7.4944-4953.1997; Li K, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-261; Martin DP, 2010, BIOINFORMATICS, V26, P2462, DOI 10.1093/bioinformatics/btq467; MUFSON MA, 1985, J GEN VIROL, V66, P2111, DOI 10.1099/0022-1317-66-10-2111; Murrell B, 2013, MOL BIOL EVOL, V30, P1196, DOI 10.1093/molbev/mst030; NORRBY E, 1987, P NATL ACAD SCI USA, V84, P6572, DOI 10.1073/pnas.84.18.6572; Parveen S, 2006, J CLIN MICROBIOL, V44, P3055, DOI 10.1128/JCM.00187-06; Peret TCT, 1998, J GEN VIROL, V79, P2221, DOI 10.1099/0022-1317-79-9-2221; Pond SLK, 2005, MOL BIOL EVOL, V22, P1208, DOI 10.1093/molbev/msi105; Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079; Rebuffo-Scheer C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025468; Reiche J, 2009, J CLIN MICROBIOL, V47, P1800, DOI 10.1128/JCM.02286-08; SCHEPETIUK SK, 1993, J VIROL METHODS, V42, P241, DOI 10.1016/0166-0934(93)90036-Q; SORVILLO FJ, 1984, J INFECTION, V9, P252, DOI 10.1016/S0163-4453(84)90530-9; Sutherland KA, 2001, VIROLOGY, V288, P295, DOI 10.1006/viro.2001.1105; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tan L, 2013, J VIROL, V87, P8213, DOI 10.1128/JVI.03278-12; Tan L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051439; Treangen Todd J, 2011, Curr Protoc Bioinformatics, VChapter 11, DOI 10.1002/0471250953.bi1108s33; Trento A, 2003, J GEN VIROL, V84, P3115, DOI 10.1099/vir.0.19357-0; Tsukagoshi H, 2013, MICROBIOL IMMUNOL, V57, P655, DOI 10.1111/1348-0421.12075; van Niekerk S, 2011, J VIROL, V85, P8789, DOI 10.1128/JVI.02623-10; Wang SL, 2012, NUCLEIC ACIDS RES, V40, pW186, DOI 10.1093/nar/gks528; Whitehead SS, 1998, VIROLOGY, V247, P232, DOI 10.1006/viro.1998.9248; Williams JV, 2004, NEW ENGL J MED, V350, P443, DOI 10.1056/NEJMoa025472; Woelk CH, 2001, J MOL EVOL, V52, P182, DOI 10.1007/s002390010147; Zhang ZY, 2010, J CLIN MICROBIOL, V48, P1201, DOI 10.1128/JCM.02258-09; Zlateva KT, 2005, J VIROL, V79, P9157, DOI 10.1128/JVI.79.14.9157-9167.2005; Zlateva KT, 2004, J VIROL, V78, P4675, DOI 10.1128/JVI.78.9.4675-4683.2004	54	44	47	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0120098	10.1371/journal.pone.0120098	http://dx.doi.org/10.1371/journal.pone.0120098			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25793751	Green Published, Green Submitted, gold			2022-12-27	WOS:000352084200144
J	Brignell, JL; Perry, MD; Nelson, CP; Willets, JM; Challiss, RAJ; Davies, NW				Brignell, Jennifer L.; Perry, Matthew D.; Nelson, Carl P.; Willets, Jonathon M.; Challiss, R. A. John; Davies, Noel W.			Steady-State Modulation of Voltage-Gated K+ Channels in Rat Arterial Smooth Muscle by Cyclic AMP-Dependent Protein Kinase and Protein Phosphatase 2B	PLOS ONE			English	Article							MEDIATED SIGNAL-TRANSDUCTION; GENE-RELATED PEPTIDE; POTASSIUM CHANNELS; ANCHORING PROTEIN; ATP CHANNELS; PHYSIOLOGICAL ROLES; CELLS; ACTIVATION; CURRENTS; EXPRESSION	Voltage-gated potassium channels (K-v) are important regulators of membrane potential in vascular smooth muscle cells, which is integral to controlling intracellular Ca2+ concentration and regulating vascular tone. Previous work indicates that K-v channels can be modulated by receptor-driven alterations of cyclic AMP-dependent protein kinase (PKA) activity. Here, we demonstrate that K-v channel activity is maintained by tonic activity of PKA. Whole-cell recording was used to assess the effect of manipulating PKA signalling on K-v and ATPdependent K+ channels of rat mesenteric artery smooth muscle cells. Application of PKA inhibitors, KT5720 or H89, caused a significant inhibition of K-v currents. Tonic PKA-mediated activation of K-v appears maximal as application of isoprenaline (a beta-adrenoceptor agonist) or dibutyryl-cAMP failed to enhance K-v currents. We also show that this modulation of K-v by PKA can be reversed by protein phosphatase 2B/calcineurin (PP2B). PKA-dependent inhibition of K-v by KT5720 can be abrogated by pre-treatment with the PP2B inhibitor cyclosporin A, or inclusion of a PP2B auto-inhibitory peptide in the pipette solution. Finally, we demonstrate that tonic PKA-mediated modulation of K-v requires intact caveolae. Pre-treatment of the cells with methyl-beta-cyclodextrin to deplete cellular cholesterol, or adding caveolin-scaffolding domain peptide to the pipette solution to disrupt caveolae-dependent signalling each attenuated PKA-mediated modulation of the K-v current. These findings highlight a novel, caveolae-dependent, tonic modulatory role of PKA on K-v channels providing new insight into mechanisms and the potential for pharmacological manipulation of vascular tone.	[Brignell, Jennifer L.; Perry, Matthew D.; Nelson, Carl P.; Willets, Jonathon M.; Challiss, R. A. John; Davies, Noel W.] Univ Leicester, Dept Cell Physiol & Pharmacol, Leicester LE1 9HN, Leics, England; [Willets, Jonathon M.] Leicester Royal Infirm, Dept Canc Studies & Mol Med, Leicester, Leics, England	University of Leicester; University of Leicester	Davies, NW (corresponding author), Univ Leicester, Dept Cell Physiol & Pharmacol, Leicester LE1 9HN, Leics, England.	nwd@le.ac.uk	Challiss, R.A. John/A-9412-2008; Nelson, Carl/H-6782-2014	Nelson, Carl/0000-0003-1034-140X; Challiss, John/0000-0001-5506-2848	British Heart Foundation [RG06/008/22062]; British Heart Foundation [RG/06/008/22062] Funding Source: researchfish	British Heart Foundation(British Heart Foundation); British Heart Foundation(British Heart Foundation)	Funding: This study was funded by a British Heart Foundation grant (RG06/008/22062) to JMW, RAJC and NWD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adebiyi A, 2011, J BIOL CHEM, V286, P4341, DOI 10.1074/jbc.M110.179747; AIELLO EA, 1995, AM J PHYSIOL-HEART C, V268, pH926, DOI 10.1152/ajpheart.1995.268.2.H926; Aiello EA, 1998, AM J PHYSIOL-HEART C, V275, pH448, DOI 10.1152/ajpheart.1998.275.2.H448; Alto NM, 2004, CELL BIOCHEM BIOPHYS, P201; Barman SA, 2003, AM J PHYSIOL-LUNG C, V284, pL1004, DOI 10.1152/ajplung.00295.2002; Brainard AM, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-131; CARR DW, 1992, J BIOL CHEM, V267, P13376; Cheong A, 2002, J VASC RES, V39, P122, DOI 10.1159/000057761; ClementChomienne O, 1996, J PHYSIOL-LONDON, V495, P689, DOI 10.1113/jphysiol.1996.sp021626; COGHLAN VM, 1995, SCIENCE, V267, P108, DOI 10.1126/science.7528941; Cogolludo A, 2006, CIRC RES, V98, P931, DOI 10.1161/01.RES.0000216858.04599.e1; Colledge M, 1999, TRENDS CELL BIOL, V9, P216, DOI 10.1016/S0962-8924(99)01558-5; Couet J, 1997, J BIOL CHEM, V272, P6525, DOI 10.1074/jbc.272.10.6525; Cox RH, 2005, CELL BIOCHEM BIOPHYS, V42, P167, DOI 10.1385/CBB:42:2:167; DART C, 1993, J PHYSIOL-LONDON, V471, P767, DOI 10.1113/jphysiol.1993.sp019927; Dart C, 2010, J PHYSIOL-LONDON, V588, P3169, DOI 10.1113/jphysiol.2010.191585; Davies LM, 2010, J PHYSIOL-LONDON, V588, P3254, DOI 10.1113/jphysiol.2010.194779; DOBROWSKY RT, 1993, ADV LIPID RES, V25, P91; Gold MG, 2011, P NATL ACAD SCI USA, V108, P6426, DOI 10.1073/pnas.1014400108; Greenwood IA, 2009, BRIT J PHARMACOL, V156, P1196, DOI 10.1111/j.1476-5381.2009.00131.x; Hayabuchi Y, 2001, J PHYSIOL-LONDON, V536, P421, DOI 10.1111/j.1469-7793.2001.0421c.xd; Hayabuchi Y, 2001, J PHYSIOL-LONDON, V530, P193, DOI 10.1111/j.1469-7793.2001.0193l.x; Hayabuchi Y, 2001, AM J PHYSIOL-HEART C, V281, pH2480, DOI 10.1152/ajpheart.2001.281.6.H2480; Ko Eun A., 2008, Journal of Smooth Muscle Research, V44, P65, DOI 10.1540/jsmr.44.65; Ko EA, 2010, PROG BIOPHYS MOL BIO, V103, P95, DOI 10.1016/j.pbiomolbio.2009.10.001; Kyle B, 2011, AM J PHYSIOL-CELL PH, V301, pC1186, DOI 10.1152/ajpcell.00455.2010; Li HW, 2003, AM J PHYSIOL-HEART C, V285, pH1213, DOI 10.1152/ajpheart.00226.2003; Luykenaar KD, 2007, AM J PHYSIOL-HEART C, V292, pH2654, DOI 10.1152/ajpheart.01255.2006; Martens JR, 2004, TRENDS PHARMACOL SCI, V25, P16, DOI 10.1016/j.tips.2003.11.007; Mason HS, 2002, MOL PHARMACOL, V61, P285, DOI 10.1124/mol.61.2.285; McEwen DP, 2008, MOL PHARMACOL, V73, P678, DOI 10.1124/mol.107.042093; MIYOSHI H, 1995, BASIC RES CARDIOL, V90, P332, DOI 10.1007/BF00797911; Moore CL, 2014, CIRC RES, V114, P1258, DOI 10.1161/CIRCRESAHA.114.303167; Moral-Sanz J, 2011, AM J PHYSIOL-CELL PH, V301, pC186, DOI 10.1152/ajpcell.00243.2010; Moreno-Dominguez A, 2009, J PHYSIOL-LONDON, V587, P625, DOI 10.1113/jphysiol.2008.165217; Navedo MF, 2006, J GEN PHYSIOL, V127, P611, DOI 10.1085/jgp.200609519; Nelson CP, 2011, CARDIOVASC RES, V91, P694, DOI 10.1093/cvr/cvr137; Nelson CP, 2008, AM J PHYSIOL-CELL PH, V295, pC1590, DOI 10.1152/ajpcell.00365.2008; NELSON MT, 1995, AM J PHYSIOL-CELL PH, V268, pC799, DOI 10.1152/ajpcell.1995.268.4.C799; Orie NN, 2009, BRIT J PHARMACOL, V157, P554, DOI 10.1111/j.1476-5381.2009.00221.x; Park KS, 2006, SCIENCE, V313, P976, DOI 10.1126/science.1124254; Plane F, 2005, CIRC RES, V96, P216, DOI 10.1161/01.RES.0000154070.06421.25; Purves GI, 2009, J PHYSIOL-LONDON, V587, P3639, DOI 10.1113/jphysiol.2009.173534; Quayle JM, 1997, PHYSIOL REV, V77, P1165, DOI 10.1152/physrev.1997.77.4.1165; Rainbow RD, 2006, J PHYSIOL-LONDON, V575, P833, DOI 10.1113/jphysiol.2006.114009; Rainbow RD, 2011, BRIT J PHARMACOL, V163, P845, DOI 10.1111/j.1476-5381.2011.01268.x; Rainbow RD, 2009, CARDIOVASC RES, V83, P493, DOI 10.1093/cvr/cvp143; Razani B, 2002, PHARMACOL REV, V54, P431, DOI 10.1124/pr.54.3.431; Razani B, 1999, J BIOL CHEM, V274, P26353, DOI 10.1074/jbc.274.37.26353; Sampson LJ, 2004, CIRC RES, V95, P1012, DOI 10.1161/01.RES.0000148634.47095.ab; Santana LF, 2002, J PHYSIOL-LONDON, V544, P57, DOI 10.1113/jphysiol.2002.020552; Scott JD, 2013, ANNU REV PHARMACOL, V53, P187, DOI 10.1146/annurev-pharmtox-011112-140204; Skroblin P, 2010, INT REV CEL MOL BIO, V283, P235, DOI 10.1016/S1937-6448(10)83005-9; Stott JB, 2014, DRUG DISCOV TODAY, V19, P413, DOI 10.1016/j.drudis.2013.12.003; Turner JD, 2009, CELL CALCIUM, V46, P242, DOI 10.1016/j.ceca.2009.07.006; Wellman GC, 1998, J PHYSIOL-LONDON, V507, P117, DOI 10.1111/j.1469-7793.1998.117bu.x; Wilson AJ, 2000, CIRC RES, V87, P1019, DOI 10.1161/01.RES.87.11.1019; Yang Y, 2007, BIOCHIM BIOPHYS ACTA, V1778, P88	58	7	9	0	91	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0121285	10.1371/journal.pone.0121285	http://dx.doi.org/10.1371/journal.pone.0121285			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25793374	Green Published, Green Submitted, gold			2022-12-27	WOS:000352083900121
J	Chen, CH; Hsu, CL; Huang, SH; Chen, SY; Hung, YL; Chen, HR; Wu, YC; Su, LJ; Lee, HC				Chen, Chih-Hao; Hsu, Chueh-Lin; Huang, Shih-Hao; Chen, Shih-Yuan; Hung, Yi-Lin; Chen, Hsiao-Rong; Wu, Yu-Chung; Su, Li-Jen; Lee, H. C.			Method Designed to Respect Molecular Heterogeneity Can Profoundly Correct Present Data Interpretations for Genome-Wide Expression Analysis	PLOS ONE			English	Article							GENE-EXPRESSION; SUBSTANTIA-NIGRA; BIPOLAR DISORDER; MICROARRAY ANALYSIS; SCHIZOPHRENIA; DYSREGULATION; UBIQUITIN; CORTEX; PATHOGENESIS; CONSISTENCY	Although genome-wide expression analysis has become a routine tool for gaining insight into molecular mechanisms, extraction of information remains a major challenge. It has been unclear why standard statistical methods, such as the t-test and ANOVA, often lead to low levels of reproducibility, how likely applying fold-change cutoffs to enhance reproducibility is to miss key signals, and how adversely using such methods has affected data interpretations. We broadly examined expression data to investigate the reproducibility problem and discovered that molecular heterogeneity, a biological property of genetically different samples, has been improperly handled by the statistical methods. Here we give a mathematical description of the discovery and report the development of a statistical method, named HTA, for better handling molecular heterogeneity. We broadly demonstrate the improved sensitivity and specificity of HTA over the conventional methods and show that using fold-change cutoffs has lost much information. We illustrate the especial usefulness of HTA for heterogeneous diseases, by applying it to existing data sets of schizophrenia, bipolar disorder and Parkinson's disease, and show it can abundantly and reproducibly uncover disease signatures not previously detectable. Based on 156 biological data sets, we estimate that the methodological issue has affected over 96% of expression studies and that HTA can profoundly correct 86% of the affected data interpretations. The methodological advancement can better facilitate systems understandings of biological processes, render biological inferences that are more reliable than they have hitherto been and engender translational medical applications, such as identifying diagnostic biomarkers and drug prediction, which are more robust.	[Chen, Chih-Hao; Hsu, Chueh-Lin; Huang, Shih-Hao; Chen, Shih-Yuan; Su, Li-Jen; Lee, H. C.] Natl Cent Univ, Inst Syst Biol & Bioinformat, Chungli 32001, Taiwan; [Chen, Chih-Hao] Cathay Gen Hosp, Cathay Med Res Inst, Taipei 10630, Taiwan; [Hung, Yi-Lin] Natl Tsing Hua Univ, Inst Bioinformat & Struct Biol, Hsinchu 30013, Taiwan; [Chen, Hsiao-Rong] Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA; [Wu, Yu-Chung] Taipei Vet Gen Hosp, Dept Surg, Div Thorac Surg, Taipei 11217, Taiwan; [Wu, Yu-Chung] Natl Yang Ming Univ, Sch Med, Taipei 11221, Taiwan; [Lee, H. C.] Natl Ctr Theoret Sci, Hsinchu 30043, Taiwan; [Lee, H. C.] Natl Cent Univ, Dept Phys, Chungli 32001, Taiwan; [Lee, H. C.] Natl Cent Univ, Ctr Dynam Biomarkers & Translat Med, Chungli 32001, Taiwan	National Central University; Cathay General Hospital; National Tsing Hua University; Boston University; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; National Central University; National Central University	Chen, CH (corresponding author), Natl Cent Univ, Inst Syst Biol & Bioinformat, Chungli 32001, Taiwan.	chih_hao_chen@yahoo.com; sulijen@gmail.com; hclee12345@gmail.com			Ministry of Science and Technology (ROC) [98-2627-M-008-004, 99-2911-I-008-100, 100-2911-I-008-001, 101-2320-B-008-001-MY3]; Cathay General Hospital-NCU Collaboration Grants [99CGH-NCU-A3, 101-CGH-NCU-B4]; Landseed Hospital-NCU Collaboration Grant [NCU-LSH-101-A-008]	Ministry of Science and Technology (ROC); Cathay General Hospital-NCU Collaboration Grants; Landseed Hospital-NCU Collaboration Grant	This work is partly supported by Grants 98-2627-M-008-004, 99-2911-I-008-100, 100-2911-I-008-001 and 101-2320-B-008-001-MY3 from the Ministry of Science and Technology (ROC), the Cathay General Hospital-NCU Collaboration Grants 99CGH-NCU-A3 and 101-CGH-NCU-B4, and Landseed Hospital-NCU Collaboration Grant NCU-LSH-101-A-008. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen NC, 2008, NAT GENET, V40, P827, DOI 10.1038/ng.171; Altar CA, 2005, BIOL PSYCHIAT, V58, P85, DOI 10.1016/j.biopsych.2005.03.031; Arion D, 2007, BIOL PSYCHIAT, V62, P711, DOI 10.1016/j.biopsych.2006.12.021; Aston C, 2004, J NEUROSCI RES, V77, P858, DOI 10.1002/jnr.20208; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blandini F, 2013, J NEUROIMMUNE PHARM, V8, P189, DOI 10.1007/s11481-013-9435-y; Chang SH, 2013, BIOL PSYCHIAT, V74, P727, DOI 10.1016/j.biopsych.2013.04.016; Chen CH, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr137; Dracheva S, 2006, NEUROBIOL DIS, V21, P531, DOI 10.1016/j.nbd.2005.08.012; Fortunel NO, 2003, SCIENCE, V302, P393; Frantz S, 2005, NAT REV DRUG DISCOV, V4, P362, DOI 10.1038/nrd1746; Grunblatt E, 2004, J NEURAL TRANSM, V111, P1543, DOI 10.1007/s00702-004-0212-1; Guo L, 2006, NAT BIOTECHNOL, V24, P1162, DOI 10.1038/nbt1238; Hakak Y, 2001, P NATL ACAD SCI USA, V98, P4746, DOI 10.1073/pnas.081071198; Hauser MA, 2005, ARCH NEUROL-CHICAGO, V62, P917, DOI 10.1001/archneur.62.6.917; Ivanova NB, 2002, SCIENCE, V298, P601, DOI 10.1126/science.1073823; Iwamoto K, 2005, HUM MOL GENET, V14, P241, DOI 10.1093/hmg/ddi022; Kobayashi S, 2010, MOL ENDOCRINOL, V24, P2292, DOI 10.1210/me.2010-0289; Lewandowski NM, 2010, P NATL ACAD SCI USA, V107, P16970, DOI 10.1073/pnas.1011751107; Lill CM, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002548; Middleton FA, 2002, J NEUROSCI, V22, P2718, DOI 10.1523/JNEUROSCI.22-07-02718.2002; Miklos GLG, 2004, NAT BIOTECHNOL, V22, P615, DOI 10.1038/nbt965; Miller RM, 2006, NEUROBIOL DIS, V21, P305, DOI 10.1016/j.nbd.2005.07.010; Miller RM, 2004, J NEUROSCI, V24, P7445, DOI 10.1523/JNEUROSCI.4204-03.2004; Mirnics K, 2000, NEURON, V28, P53, DOI 10.1016/S0896-6273(00)00085-4; Moran LB, 2006, NEUROGENETICS, V7, P1, DOI 10.1007/s10048-005-0020-2; Nakatani N, 2006, HUM MOL GENET, V15, P1949, DOI 10.1093/hmg/ddl118; Ramalho-Santos M, 2002, SCIENCE, V298, P597, DOI 10.1126/science.1072530; Ryan MM, 2006, MOL PSYCHIATR, V11, P965, DOI 10.1038/sj.mp.4001875; SCHENA M, 1995, SCIENCE, V270, P467, DOI 10.1126/science.270.5235.467; Seifuddin F, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-213; Shendure J, 2008, NAT METHODS, V5, P585, DOI 10.1038/nmeth0708-585; Shi LM, 2006, NAT BIOTECHNOL, V24, P1151, DOI 10.1038/nbt1239; Shi LM, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-S2-S12; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tan PK, 2003, NUCLEIC ACIDS RES, V31, P5676, DOI 10.1093/nar/gkg763	37	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0121154	10.1371/journal.pone.0121154	http://dx.doi.org/10.1371/journal.pone.0121154			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25793610	Green Published, Green Submitted, gold			2022-12-27	WOS:000352083900105
J	Chen, LZ; Li, ZZ; Li, YY; Xue, J; Chen, P; Yan, SP; Jiang, CX; Hu, YY; Qiao, X				Chen, Lizhang; Li, Zhanzhan; Li, Yanyan; Xue, Jing; Chen, Peng; Yan, Shipeng; Jiang, Caixiao; Hu, Yingyun; Qiao, Xing			Red Cell Distribution Width and Inappropriateness of Left Ventricular Mass in Patients with Untreated Essential Hypertension	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; ENDOTHELIAL DYSFUNCTION; OXIDATIVE STRESS; ORGAN DAMAGE; RISK-FACTORS; INFLAMMATION; HYPERTROPHY; MARKER; MICROALBUMINURIA; QUANTITATION	Background Left ventricular hypertrophy (LVH) was suggested to be an important risk factor for hypertensive vascular complications. Previous studies had also shown that red cell distribution width (RDW) was associated with morbidity and mortality of cardiovascular disease. However, few have yet investigated possible association between RDW and LVH. The aim of the present study was to evaluate the relationship between LVH and RDW levels in hypertensive patients. Methods Physical examination, laboratory tests and echocardiography were conducted in 330 untreated newly diagnosed hypertensive patients attending the cardiology consultation unit at the Anzhen Hospital of Beijing. The multivariate logistic regression model was used to verify the independent association between RDW and LVH. Results 174 patients without LVH and 156 patients with LVH were rolled in the study. The patients with LVH had higher mean SBP, albumin to creatinine ratio, total cholesterol, RDW and fasting glucose compared with non-LVH group. The mean HDL-cholesterol level was significantly lower in patients with LVH than patients without LVH. The multiple logistic regression model suggested that patients with a higher RDW level were more likely to be LVH (OR=2.187, 95%CI: 1.447-3.307, P<0.001). Other predictive factors for LVH were mean SBP, serum creatinine, glucose level. The receiver operating characteristics (ROC) curves indicated area under the curve was 0.688(95%CI: 0.635-0.737, P<0.001) with a cut-off value of 12.9, the RDW predicted LVH status among hypertensive patients with a sensitivity of 72.4% and a specificity of 60.3%. Conclusions The higher RDW level was observed in the LVH group compared with the non-LVH group. RDW might be associated with LVH in hypertensive patients. These data highlight the role of RDW as a predictor of organ damage in essential hypertensive patients.	[Chen, Lizhang; Li, Zhanzhan; Xue, Jing; Yan, Shipeng; Jiang, Caixiao] Cent South Univ, Sch Publ Hlth, Dept Epidemiol & Hlth Stat, Changsha, Hunan, Peoples R China; [Li, Yanyan] Henan Prov Hosp Tradit Chinese Med, Dept Emergency, Zhengzhou, Henan Province, Peoples R China; [Chen, Peng] Cent South Univ, Xiangya Med Sch, Changsha, Hunan, Peoples R China; [Hu, Yingyun] Hunan Prov Tumor Hosp, Changsha, Hunan, Peoples R China; [Qiao, Xing] Xinjiang Med Univ, Teaching Hosp 1, Dept Plast Surg, Urumqi, Xinjiang Uygur, Peoples R China	Central South University; Central South University; Xinjiang Medical University	Qiao, X (corresponding author), Xinjiang Med Univ, Teaching Hosp 1, Dept Plast Surg, Urumqi, Xinjiang Uygur, Peoples R China.	xingqiaoxj@126.com			Graduate Innovation Project of Hunan Province [CX2014B097]; fundamental research funds for the central universities of central south university [2014zzts069]; Hunan Province Science and Technology Project [2014SK2013]	Graduate Innovation Project of Hunan Province; fundamental research funds for the central universities of central south university; Hunan Province Science and Technology Project	This work was supported by Graduate Innovation Project of Hunan Province (CX2014B097), the fundamental research funds for the central universities of central south university (2014zzts069), and the Hunan Province Science and Technology Project (2014SK2013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ancey C, 2003, CARDIOVASC RES, V59, P78, DOI 10.1016/S0008-6363(03)00346-8; Assadi FK, 2002, PEDIATR NEPHROL, V17, P107, DOI 10.1007/s00467-001-0762-5; BERSE B, 1992, MOL BIOL CELL, V3, P211, DOI 10.1091/mbc.3.2.211; Cave A, 2005, PHILOS T R SOC B, V360, P2327, DOI 10.1098/rstb.2005.1772; Chobanian AV., 2003, HYPERTENSION, V42, P1206, DOI [10.1161/01.HYP.0000107251, DOI 10.1161/01.HYP.9.2_PT_2.II36, DOI 10.1161/01.HYP.0000107251.49515.C2]; Demirkol S, 2013, CARDIOL J, V20, P209, DOI 10.5603/CJ.2013.0037; DEVEREUX RB, 1986, AM J CARDIOL, V57, P450, DOI 10.1016/0002-9149(86)90771-X; Felker GM, 2007, J AM COLL CARDIOL, V50, P40, DOI 10.1016/j.jacc.2007.02.067; Fornal M, 2014, CLIN HEMORHEOL MICRO, V56, P325, DOI 10.3233/CH-131745; Furumoto T, 2002, HYPERTENS RES, V25, P475, DOI 10.1291/hypres.25.475; Grandi AM, 2001, AM J HYPERTENS, V14, P644, DOI 10.1016/S0895-7061(01)01305-X; Inanc T, 2010, BLOOD PRESSURE, V19, P81, DOI 10.3109/08037050903516284; Kilicaslan B, 2014, HYPERTENS RES, V37, P560, DOI 10.1038/hr.2014.39; Kohler JJ, 2009, LAB INVEST, V89, P782, DOI 10.1038/labinvest.2009.39; Lappe JM, 2011, CLIN CHIM ACTA, V412, P2094, DOI 10.1016/j.cca.2011.07.018; Leoncini G, 2004, J HUM HYPERTENS, V18, P511, DOI 10.1038/sj.jhh.1001689; LEVINE B, 1990, NEW ENGL J MED, V323, P236, DOI 10.1056/NEJM199007263230405; Li ZC, 2013, EUR REV MED PHARMACO, V17, P3318; Luo JD, 2002, ACTA PHARMACOL SIN, V23, P124; Macdougall IAC, 2002, NEPHROL DIAL TRANSPL, V17, P48, DOI 10.1093/ndt/17.suppl_1.48; Mancia G, 2013, J HYPERTENS, V31, P1925, DOI 10.1097/HJH.0b013e328364ca4c; Mosterd A, 1999, NEW ENGL J MED, V340, P1221, DOI 10.1056/NEJM199904223401601; Ozcan F, 2013, BLOOD PRESSURE, V22, P80, DOI 10.3109/08037051.2012.707336; Sabri A, 2003, ANTIOXID REDOX SIGN, V5, P731, DOI 10.1089/152308603770380034; Sahin DY, 2013, BLOOD PRESSURE, V22, P329, DOI 10.3109/08037051.2013.778006; SAHN DJ, 1978, CIRCULATION, V58, P1072, DOI 10.1161/01.CIR.58.6.1072; Schiller N B, 1989, J Am Soc Echocardiogr, V2, P358; Semba RD, 2010, CLIN NUTR, V29, P600, DOI 10.1016/j.clnu.2010.03.001; Subramaniam A, 2003, BIOCHIM BIOPHYS ACTA, V1835, P46; Suematsu N, 2003, CIRCULATION, V107, P1418, DOI 10.1161/01.CIR.0000055318.09997.1F; Takimoto E, 2005, J CLIN INVEST, V115, P1221, DOI 10.1172/JCI200521968; Tanindi A, 2012, BLOOD PRESSURE, V21, P177, DOI 10.3109/08037051.2012.645335; Uysal OK, 2012, CARDIOL J, V19, P597, DOI 10.5603/CJ.2012.0111; Vasdev S, 2011, INT J ANGIOL, V20, P189, DOI 10.1055/s-0031-1288941; Wang SX, 2012, CHINESE MED J-PEKING, V125, P21, DOI 10.3760/cma.j.issn.0366-6999.2012.01.005; Zalawadiya SK, 2010, AM J CARDIOL, V106, P988, DOI 10.1016/j.amjcard.2010.06.006; Zhang YH, 2010, J HYPERTENS, V28, P35, DOI 10.1097/HJH.0b013e3283324650	37	9	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0120300	10.1371/journal.pone.0120300	http://dx.doi.org/10.1371/journal.pone.0120300			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25793884	gold, Green Submitted, Green Published			2022-12-27	WOS:000352083900009
J	Fox, GA; Cooper, AM; Hayes, WK				Fox, Gerad A.; Cooper, Allen M.; Hayes, William K.			The Dilemma of Choosing a Reference Character for Measuring Sexual Size Dimorphism, Sexual Body Component Dimorphism, and Character Scaling: Cryptic Dimorphism and Allometry in the Scorpion Hadrurus arizonensis	PLOS ONE			English	Article							PARUROCTONUS-MESAENSIS SCORPIONIDA; MESOBUTHUS-GIBBOSUS SCORPIONES; HAIRY DESERT SCORPION; PREY-CAPTURE; STATIC ALLOMETRY; FEEDING-BEHAVIOR; LIFE-HISTORY; EVOLUTION; EUSCORPIUS; SELECTION	Sexual differences in morphology, ranging from subtle to extravagant, occur commonly in many animal species. These differences can encompass overall body size (sexual size dimorphism, SSD) or the size and/or shape of specific body parts (sexual body component dimorphism, SBCD). Interacting forces of natural and sexual selection shape much of the expression of dimorphism we see, though non-adaptive processes may be involved. Differential scaling of individual features can result when selection favors either exaggerated (positive allometry) or reduced (negative allometry) size during growth. Studies of sexual dimorphism and character scaling rely on multivariate models that ideally use an unbiased reference character as an overall measure of body size. We explored several candidate reference characters in a cryptically dimorphic taxon, Hadrurus arizonensis. In this scorpion, essentially every body component among the 16 we examined could be interpreted as dimorphic, but identification of SSD and SBCD depended on which character was used as the reference (prosoma length, prosoma area, total length, principal component 1, or metasoma segment 1 width). Of these characters, discriminant function analysis suggested that metasoma segment 1 width was the most appropriate. The pattern of dimorphism in H. arizonensis mirrored that seen in other more obviously dimorphic scorpions, with static allometry trending towards isometry in most characters. Our findings are consistent with the conclusions of others that fecundity selection likely favors a larger prosoma in female scorpions, whereas sexual selection may favor other body parts being larger in males, especially the metasoma, pectines, and possibly the chela. For this scorpion and probably most other organisms, the choice of reference character profoundly affects interpretations of SSD, SBCD, and allometry. Thus, researchers need to broaden their consideration of anappropriate reference and exercise caution in interpreting findings. We highly recommend use of discriminant function analysis to identify the least-biased reference character.	[Fox, Gerad A.; Cooper, Allen M.; Hayes, William K.] Loma Linda Univ, Sch Med, Dept Earth & Biol Sci, Loma Linda, CA 92354 USA	Loma Linda University	Fox, GA (corresponding author), Loma Linda Univ, Sch Med, Dept Earth & Biol Sci, Loma Linda, CA 92354 USA.	gfox411@gmail.com	Hayes, William/L-1284-2013	Hayes, William/0000-0002-0903-0519	Department of Earth and Biological Sciences at Loma Linda University	Department of Earth and Biological Sciences at Loma Linda University	The authors are grateful toward the Department of Earth and Biological Sciences at Loma Linda University for laboratory space and funding of this project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abushama F. T., 1968, Revue de Zoologie et de Botanique Africaines, V77, P37; Aisenberg A, 2010, J NAT HIST, V44, P1189, DOI 10.1080/00222931003632716; ALEXANDER ANNE J., 1957, PROC ZOOL SOC LONDON, V128, P529; ALLRED D M, 1973, Great Basin Naturalist, V33, P251; Andersson Malte, 1994; Benton T, 2001, SCORPION BIOLOGY AND RESEARCH, P278; BENTON TG, 1992, ANIM BEHAV, V43, P125, DOI 10.1016/S0003-3472(05)80078-8; BENTON TG, 1991, J ARACHNOL, V19, P105; Bidau Claudio J., 2013, Journal of Insect Biodiversity, V1, P1; Bonduriansky R, 2003, EVOLUTION, V57, P2450, DOI 10.1111/j.0014-3820.2003.tb01490.x; Bonduriansky R, 2007, EVOLUTION, V61, P838, DOI 10.1111/j.1558-5646.2007.00081.x; BOOKSTEIN FL, 1989, SYST ZOOL, V38, P173, DOI 10.2307/2992387; Booncham U, 2007, NU SCI J, V4, P42; Brana F, 1996, OIKOS, V75, P511, DOI 10.2307/3545893; Brown CA, 2004, J ARACHNOL, V32, P193, DOI 10.1636/M02-56; Brown Christopher A., 2001, P307; BUB K, 1979, J ARACHNOL, V7, P243; Carlson BE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097648; Carrera PC, 2009, ZOOLOGY, V112, P332, DOI 10.1016/j.zool.2009.01.002; CASPER GS, 1985, J ARACHNOL, V13, P277; Cohen J.E., 1988, STAT POWER ANAL BEHA; Colgoni A, 2006, ENTOMOL SCI, V9, P171, DOI 10.1111/j.1479-8298.2006.00164.x; Cothran RD, 2010, EVOLUTION, V64, P2535, DOI 10.1111/j.1558-5646.2010.00998.x; Cox RM, 2003, EVOLUTION, V57, P1653, DOI 10.1554/02-227; Cox RM, 2010, EVOLUTION, V64, P798, DOI 10.1111/j.1558-5646.2009.00851.x; Cuervo JJ, 2009, J EVOLUTION BIOL, V22, P1503, DOI 10.1111/j.1420-9101.2009.01758.x; Darwin C., 1871, P423; Darwin C, 1859, ORIGIN SPECIES MEANS, DOI [10.1007/s12064-009-0058-z, DOI 10.1007/S12064-009-0058-Z]; Eberhard W. G., 1996, FEMALE CONTROL SEXUA; Eberhard WG, 1998, EVOLUTION, V52, P415, DOI 10.1111/j.1558-5646.1998.tb01642.x; Eberhard WG, 2002, CAN ENTOMOL, V134, P667, DOI 10.4039/Ent134667-5; Edmunds MC, 2010, J ARACHNOL, V38, P123, DOI 10.1636/Hi09-38.1; Emlen DJ, 2000, ANNU REV ENTOMOL, V45, P661, DOI 10.1146/annurev.ento.45.1.661; FAIRBAIRN DJ, 1990, AM NAT, V136, P61, DOI 10.1086/285082; Falster D., SMATR STANDARDISED M; Fet Victor, 2013, Revista Iberica de Aracnologia, V23, P3; Fet Victor, 2013, Euscorpius, V165, P1; Field A., 2009, DISCOVERING STAT USI, V3, DOI DOI 10.1080/1057610X.2016.1157408; Foelix RF, 1996, BIOL SPIDERS; FORMANOWICZ DR, 1993, OECOLOGIA, V94, P368, DOI 10.1007/BF00317111; FRANCKE O F, 1981, Southwestern Naturalist, V25, P517, DOI 10.2307/3670851; FRANCKE OF, 1982, J ARACHNOL, V10, P223; FRANCKE OF, 1984, J ARACHNOL, V12, P1; Gaffin DD, 1997, J COMP PHYSIOL A, V181, P291, DOI 10.1007/s003590050115; GAFFIN DD, 1992, ETHOLOGY, V91, P59; Gosnell JS, 2009, HERPETOLOGICA, V65, P70, DOI 10.1655/07-057R2.1; Graham MR, 2012, J ARACHNOL, V40, P281, DOI 10.1636/Ha11-78.1; Graham MR, 2010, J ARACHNOL, V38, P285, DOI 10.1636/Ha09-90.1; Green AJ, 2000, J AVIAN BIOL, V31, P345, DOI 10.1034/j.1600-048X.2000.310310.x; GREEN AJ, 1992, ANIM BEHAV, V43, P170, DOI 10.1016/S0003-3472(05)80086-7; HAGSTRUM DW, 1971, ANN ENTOMOL SOC AM, V64, P757, DOI 10.1093/aesa/64.4.757; Hayek LAC, 2005, AN ACAD BRAS CIENC, V77, P45, DOI 10.1590/S0001-37652005000100005; HEATWOLE H, 1967, Caribbean Journal of Science, V7, P15; Hidalgo JR, 2012, RES J COSTA RICAN DI, V4, P157; JACKSON DA, 1991, OECOLOGIA, V86, P147, DOI 10.1007/BF00317404; Jiao G, 2009, EUSCORPIUS, V84, P1, DOI [10.18590/euscorpius.2009.vol2009.iss84.1, DOI 10.18590/EUSCORPIUS.2009.VOL2009.ISS84.1]; Jiao Guo-Bin, 2009, Euscorpius, V80, P1; Kaltsas D, 2008, J NAT HIST, V42, P513, DOI 10.1080/00222930701835498; Kaltsas D, 2010, J NAT HIST, V44, P1445, DOI 10.1080/00222931003632732; Kladt N, 2007, J COMP PHYSIOL A, V193, P1033, DOI 10.1007/s00359-007-0254-6; Koch L.E., 1977, Records W Aust Mus, V5, P83; Kovarik Frantisek, 2013, Euscorpius, V178, P1; Kovarik Frantisek, 2013, Euscorpius, V168, P1; Kovarik Frantisek, 2012, Euscorpius, V150, P1; Stathi Iasmi, 2010, Euscorpius, V101, P1; Kovarik Frantisek, 2007, Euscorpius, V54, P1; Kratochvil L, 2003, CAN J ZOOL, V81, P1112, DOI 10.1139/Z03-078; Lourenco WR, 2010, ZOOKEYS, P13, DOI 10.3897/zookeys.37.369; Lourenco WR, 1996, J BIOGEOGR, V23, P681, DOI 10.1111/j.1365-2699.1996.tb00028.x; LOVICH JE, 1992, GROWTH DEVELOP AGING, V56, P269; MCMAHON TA, 1975, AM NAT, V109, P547, DOI 10.1086/283026; Melville JM, 2003, J INSECT BEHAV, V16, P97, DOI 10.1023/A:1022853413104; Melville JM, 2000, THESIS OREGON STATE; Mertler C.A., 2021, ADV MULTIVARIATE STA; Miller AL, 2011, J ETHOL, V29, P251, DOI 10.1007/s10164-010-0250-0; Mineo MF, 2006, ACTA ETHOL, V9, P79, DOI 10.1007/s10211-006-0021-7; Nakagawa S, 2004, BEHAV ECOL, V15, P1044, DOI 10.1093/beheco/arh107; Nisani Z, 2011, ANIM BEHAV, V81, P627, DOI 10.1016/j.anbehav.2010.12.010; Okada K, 2009, ANIM BEHAV, V77, P1057, DOI 10.1016/j.anbehav.2009.01.008; Outeda-Jorge S, 2009, ZOOLOGIA-CURITIBA, V26, P43, DOI 10.1590/S1984-46702009000100008; Outomuro D, 2014, ECOL ENTOMOL, V39, P399, DOI 10.1111/een.12098; Packard GC, 1999, COMP BIOCHEM PHYS A, V122, P37, DOI 10.1016/S1095-6433(98)10170-8; Painting CJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082467; Pelabon C, 2014, ANN NY ACAD SCI, V1320, P58, DOI 10.1111/nyas.12470; Pelabon C, 2013, AM NAT, V181, P195, DOI 10.1086/668820; Peretti Alfredo V., 2001, P331; Peretti Alfredo Vicente, 1997, Revue Arachnologique, V12, P31; PETRIE M, 1992, ANIM BEHAV, V43, P173, DOI 10.1016/S0003-3472(05)80087-9; Polis G.A., 1990, P161; POLIS GA, 1985, OECOLOGIA, V67, P273, DOI 10.1007/BF00384298; POLIS GA, 1979, J ARACHNOL, V7, P33; POLIS GA, 1979, J ZOOL, V187, P517; PRENTER J, 1995, BIOL J LINN SOC, V55, P345, DOI 10.1111/j.1095-8312.1995.tb01070.x; QUINLAN TG, 1995, J AUST ENTOMOL SOC, V34, P277; Quiroga M., 2004, J. Venom. Anim. Toxins incl. Trop. Dis, V10, P10, DOI 10.1590/S1678-91992004000100003; Ravosa MJ, 2000, AM J PHYS ANTHROPOL, V112, P493, DOI 10.1002/1096-8644(200008)112:4<493::AID-AJPA6>3.0.CO;2-P; Sanchez-Quiros C, 2012, J ARACHNOL, V40, P338, DOI 10.1636/B12-14.1; Santos AJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063616; Sarhan Moustafa M.H., 2013, Serket, V13, P201; Scharf I, 2013, BIOL J LINN SOC, V110, P665, DOI 10.1111/bij.12147; Schulte-Hostedde AI, 2011, J EVOLUTION BIOL, V24, P1154, DOI 10.1111/j.1420-9101.2011.02256.x; Shingleton AW, 2013, BIOESSAYS, V35, P100, DOI 10.1002/bies.201200139; Simmons L. W., 2001, MG BEH ECOL; Smith RJ, 2009, AM J PHYS ANTHROPOL, V140, P476, DOI 10.1002/ajpa.21090; Smith RJ, 1999, J HUM EVOL, V36, P423, DOI 10.1006/jhev.1998.0281; Soleglad Michael E., 2004, Revista Iberica de Aracnologia, V10, P81; STAHNKE H L, 1969, Entomological News, V80, P57; Stahnke H. L., 1945, American Museum Novitates, VNo. 1298, P1; STAHNKE H L, 1971, Entomological News, V82, P121; STAHNKE H L, 1970, Entomological News, V81, P297; STAHNKE HL, 1972, BIOSCIENCE, V22, P604, DOI 10.2307/1296207; Steinmetz Steffany B., 2004, Euscorpius, V12-17, P1; Stillwell RC, 2007, OECOLOGIA, V153, P273, DOI 10.1007/s00442-007-0724-0; Suter RB, 2011, J ARACHNOL, V39, P174, DOI 10.1636/B10-10.1; Tabachnick BG., 2013, USING MULTIVARIATE S, V6th; Tallarovic S., 2000, THESIS OREGON STATE; Tallarovic SK, 2000, J INSECT BEHAV, V13, P827, DOI 10.1023/A:1007858400402; Taylor MS, 2012, J ARACHNOL, V40, P240, DOI 10.1636/Hi11-75.1; Teruel Rolando, 2013, Euscorpius, V177, P1; Teruel Rolando, 2008, Euscorpius, V68, P1; Tomkins JL, 1996, J EVOLUTION BIOL, V9, P753, DOI 10.1046/j.1420-9101.1996.9060753.x; Toscano-Gadea CA, 2010, J ARACHNOL, V38, P360, DOI 10.1636/Hi09-31.1; TOURTLOTTE G I, 1974, Great Basin Naturalist, V34, P167; Tropea Gioele, 2013, Euscorpius, V169, P1; van der Meijden A, 2010, J ZOOL, V280, P319, DOI 10.1111/j.1469-7998.2009.00628.x; van der Meijden A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078955; van der Meijden A, 2012, J ANAT, V220, P423, DOI 10.1111/j.1469-7580.2012.01485.x; Voje KL, 2013, EVOLUTION, V67, P453, DOI 10.1111/j.1558-5646.2012.01777.x; VONBERTALANFFY L, 1952, EVOLUTION, V6, P387, DOI 10.1111/j.1558-5646.1952.tb01438.x; Walker SE, 2008, CAN J ZOOL, V86, P253, DOI 10.1139/Z08-001; Warton DI, 2006, BIOL REV, V81, P259, DOI 10.1017/S1464793106007007; Williams S. C., 1970, Occ. Pap. Calif. Acad. Sci., VNo. 87, P1; Williams SC, 1966, P CALIF ACAD SCI, V34, P419; Zelditch ML, 2004, GEOMETRIC MORPHOMETR	134	15	19	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0120392	10.1371/journal.pone.0120392	http://dx.doi.org/10.1371/journal.pone.0120392			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25793523	gold, Green Published, Green Submitted			2022-12-27	WOS:000352083900023
J	Fung, KYC; Tabor, B; Buckley, MJ; Priebe, IK; Purins, L; Pompeia, C; Brierley, GV; Lockett, T; Gibbs, P; Tie, J; McMurrick, P; Moore, J; Ruszkiewicz, A; Nice, E; Adams, TE; Burgess, A; Cosgrove, LJ				Fung, Kim Y. C.; Tabor, Bruce; Buckley, Michael J.; Priebe, Ilka K.; Purins, Leanne; Pompeia, Celine; Brierley, Gemma V.; Lockett, Trevor; Gibbs, Peter; Tie, Jeanne; McMurrick, Paul; Moore, James; Ruszkiewicz, Andrew; Nice, Edouard; Adams, Timothy E.; Burgess, Antony; Cosgrove, Leah J.			Blood-Based Protein Biomarker Panel for the Detection of Colorectal Cancer	PLOS ONE			English	Article							M2 PYRUVATE-KINASE; BINDING PROTEIN-2; ADENOMAS; DNA; TESTS; PERFORMANCE; PLASMA; MARKER; GROWTH; SPECIFICITY	Background The majority of colorectal cancer (CRC) cases are preventable by early detection and removal of precancerous polyps. Even though CRC is the second most common internal cancer in Australia, only 30 per cent of the population considered to have risk factors participate in stool-based test screening programs. Evidence indicates a robust, blood-based, diagnostic assay would increase screening compliance. A number of potential diagnostic blood-based protein biomarkers for CRC have been reported, but all lack sensitivity or specificity for use as a stand-alone diagnostic. The aim of this study was to identify and validate a panel of protein-based biomarkers in independent cohorts that could be translated to a reliable, non-invasive blood-based screening test. Principal Findings In two independent cohorts (n = 145 and n = 197), we evaluated seven single biomarkers in serum of CRC patients and age/gender matched controls that showed a significant difference between controls and CRC, but individually lack the sensitivity for diagnostic application. Using logistic regression strategies, we identified a panel of three biomarkers that discriminated between controls and CRC with 73% sensitivity at 95% specificity, when applied to either of the two cohorts. This panel comprised of Insulin like growth factor binding protein 2 (IGFBP2), Dickkopf-3 (DKK3), and Pyruvate kinase M2(PKM2). Conclusions Due to the heterogeneous nature of CRC, a single biomarker is unlikely to have sufficient sensitivity or specificity for use as a stand-alone diagnostic screening test and a panel of markers may be more effective. We have identified a 3 biomarker panel that has higher sensitivity and specificity for early stage (Stage I and -II) disease than the faecal occult blood test, raising the possibility for its use as a non-invasive blood diagnostic or screening test.	[Fung, Kim Y. C.; Tabor, Bruce; Buckley, Michael J.; Priebe, Ilka K.; Purins, Leanne; Pompeia, Celine; Brierley, Gemma V.; Lockett, Trevor; Cosgrove, Leah J.] CSIRO Preventat Hlth Natl Res Flagship, Adelaide, SA, Australia; [Gibbs, Peter; Tie, Jeanne] Royal Melbourne Hosp, Melbourne, Vic, Australia; [McMurrick, Paul] Cabrini Hosp, Melbourne, Vic, Australia; [Moore, James] Royal Adelaide Hosp, Adelaide, SA 5000, Australia; [Ruszkiewicz, Andrew] SA Pathol, Adelaide, SA, Australia; [Nice, Edouard] Monash Univ, Melbourne, Vic 3004, Australia; [Adams, Timothy E.] CSIRO Mat Sci & Engn, Parkville, Vic, Australia; [Burgess, Antony] Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Parkville, Vic 3050, Australia; [Burgess, Antony] Univ Melbourne, Royal Melbourne Hosp, Dept Surg, Melbourne, Vic 3010, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO); Royal Melbourne Hospital; Cabrini Health; Royal Adelaide Hospital; SA Pathology; Monash University; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Royal Melbourne Hospital; Walter & Eliza Hall Institute; Royal Melbourne Hospital; University of Melbourne	Cosgrove, LJ (corresponding author), CSIRO Preventat Hlth Natl Res Flagship, Adelaide, SA, Australia.	leah.cosgrove@csiro.au	Lockett, Trevor J/H-8970-2013; Tabor, Bruce/C-8902-2009; Cosgrove, Leah J/A-7764-2010; Fung, Kim YC/H-3522-2013; Adams, Timothy E/I-6231-2012; Pompeia, Celine/D-1593-2012; Brierley, Gemma/AAI-7234-2020	Lockett, Trevor J/0000-0002-8063-071X; Tabor, Bruce/0000-0002-2028-8318; Cosgrove, Leah J/0000-0002-8340-4291; Fung, Kim YC/0000-0002-7205-4206; Adams, Timothy E/0000-0003-3436-0066; Pompeia, Celine/0000-0002-7595-8702; Brierley, Gemma/0000-0002-4600-9970; Tie, Jeanne/0000-0001-9244-2057; Gibbs, Peter/0000-0003-1423-4484; Priebe, Ilka/0000-0001-8718-3003	CSIRO Preventative Health National Research Flagship; National Health and Medical Research Council [1017078]	CSIRO Preventative Health National Research Flagship(Commonwealth Scientific & Industrial Research Organisation (CSIRO)); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This work was funded by the CSIRO Preventative Health National Research Flagship and the National Health and Medical Research Council (grant number 1017078) (https://www.nhmrc.gov.au/) to LJC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlquist DA, 2012, GASTROENTEROLOGY, V142, P248, DOI 10.1053/j.gastro.2011.10.031; Allison JE, 2007, JNCI-J NATL CANCER I, V99, P1462, DOI 10.1093/jnci/djm150; Allison JE, 2012, GASTROENTEROLOGY, V142, P422, DOI 10.1053/j.gastro.2012.01.015; Australian Institute of Health and Welfare, 2012, CANC SER; Brierley GV, 2013, CANCER BIOMARK, V13, P67, DOI 10.3233/CBM-130345; Bunger S, 2011, J BIOMOL SCREEN, V16, P1018, DOI 10.1177/1087057111414894; Burt RW, 2013, J NATL COMPR CANC NE, V11, P1538, DOI 10.6004/jnccn.2013.0180; de Wit M, 2014, J PROTEOMICS, V99, P26, DOI 10.1016/j.jprot.2014.01.001; Demir AS, 2013, TURK J GASTROENTEROL, V24, P36, DOI 10.4318/tjg.2013.0607; deVos T, 2009, CLIN CHEM, V55, P1337, DOI 10.1373/clinchem.2008.115808; Diehl D, 2009, INT J CANCER, V124, P2220, DOI 10.1002/ijc.24193; Duffy MJ, 2011, INT J CANCER, V128, P3, DOI 10.1002/ijc.25654; Edge S, 2010, AJCC CANC STAGING HD; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Fung KYC, 2013, CANCER BIOMARK, V13, P75, DOI 10.3233/CBM-130335; Fung KYC, 2014, J MOL BIOMARK DIAGN; Grutzmann R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003759; Hardt PD, 2003, ANTICANCER RES, V23, P851; Hardt PD, 2008, EXPERT REV MOL DIAGN, V8, P579, DOI 10.1586/14737159.8.5.579; Haug U, 2008, BRIT J CANCER, V99, P133, DOI 10.1038/sj.bjc.6604427; He Jin, 2011, Adv Surg, V45, P31; Hol L, 2010, BRIT J CANCER, V102, P972, DOI 10.1038/sj.bjc.6605566; Imperiale TF, 2014, NEW ENGL J MED, V370, P1287, DOI 10.1056/NEJMoa1311194; Jenab M, 2007, INT J CANCER, V121, P368, DOI 10.1002/ijc.22697; Kanaan Z, 2013, ANN SURG, V258, P400, DOI 10.1097/SLA.0b013e3182a15bcc; Koss K, 2008, COLORECTAL DIS, V10, P244, DOI 10.1111/j.1463-1318.2007.01334.x; Kuipers EJ, 2013, NAT REV CLIN ONCOL, V10, P130, DOI 10.1038/nrclinonc.2013.12; Li R, 2012, INT J CANCER, V131, P1837, DOI 10.1002/ijc.27442; Liou JM, 2010, J CLIN ENDOCR METAB, V95, P1717, DOI 10.1210/jc.2009-2668; Maehata T, 2008, WORLD J GASTROENTERO, V14, P2702, DOI 10.3748/wjg.14.2702; Marshall KW, 2010, INT J CANCER, V126, P1177, DOI 10.1002/ijc.24910; Moawad FJ, 2010, AM J ROENTGENOL, V195, P1118, DOI 10.2214/AJR.10.4921; Moran A, 2010, WORLD J GASTRO ONCOL, V2, P151, DOI 10.4251/wjgo.v2.i3.151; Morikawa T, 2005, GASTROENTEROLOGY, V129, P422, DOI 10.1053/j.gastro.2005.05.056; Mulder SA, 2007, EUR J GASTROEN HEPAT, V19, P878, DOI 10.1097/MEG.0b013e3282cfa49c; Osborne J. M., 2012, Open Journal of Preventive Medicine, V2, P326; Parra-Blanco A, 2010, J GASTROENTEROL, V45, P703, DOI 10.1007/s00535-010-0214-8; Power DG, 2010, HEMATOL ONCOL CLIN N, V24, P837, DOI 10.1016/j.hoc.2010.06.006; Renehan AG, 2000, BRIT J CANCER, V83, P1344, DOI 10.1054/bjoc.2000.1462; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; Sato H, 2007, CARCINOGENESIS, V28, P2459, DOI 10.1093/carcin/bgm178; Schroy PC, 2005, AM J PREV MED, V28, P208, DOI 10.1016/j.amepre.2004.10.008; Shastri YM, 2006, INT J CANCER, V119, P2651, DOI 10.1002/ijc.22243; Sunderic M, 2014, EXP MOL PATHOL, V96, P48, DOI 10.1016/j.yexmp.2013.11.006; Toth K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046000; van Dam L, 2010, BEST PRACT RES CL GA, V24, P479, DOI 10.1016/j.bpg.2010.03.009; Vart G, 2012, PREV MED, V55, P87, DOI 10.1016/j.ypmed.2012.05.006; Warren JD, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-133; Wong CKW, 2012, INT J COLORECTAL DIS, V27, P1657, DOI 10.1007/s00384-012-1518-3; World Cancer Research Fund and American Institute for Cancer Research, 2007, FOOD NUTR PHYS ACT P; Zhang PJ, 2013, FUTURE ONCOL, V9, P1017, DOI [10.2217/FON.13.71, 10.2217/fon.13.71]; Zitt M, 2008, DIS MARKERS, V24, P101, DOI 10.1155/2008/160907	53	55	59	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0120425	10.1371/journal.pone.0120425	http://dx.doi.org/10.1371/journal.pone.0120425			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25793510	gold, Green Published, Green Submitted			2022-12-27	WOS:000352083900032
J	Trissal, MC; DeMoya, RA; Schmidt, AP; Link, DC				Trissal, Maria C.; DeMoya, Ricardo A.; Schmidt, Amy P.; Link, Daniel C.			MicroRNA-223 Regulates Granulopoiesis but Is Not Required for HSC Maintenance in Mice	PLOS ONE			English	Article							ACUTE MYELOID-LEUKEMIA; HEMATOPOIETIC STEM; SELF-RENEWAL; EXPRESSION; HIERARCHY	MIR233 is genetically or epigenetically silenced in a subset of acute myeloid leukemia (AML). MIR223 is normally expressed throughout myeloid differentiation and highly expressed in hematopoietic stem cells (HSCs). However, the contribution of MIR223 loss to leukemic transformation and HSC function is largely unknown. Herein, we characterize HSC function and myeloid differentiation in Mir223 deficient mice. We show that Mir223 loss results in a modest expansion of myeloid progenitors, but is not sufficient to induce a myeloproliferative disorder. Loss of Mir223 had no discernible effect on HSC quiescence, long-term repopulating activity, or self-renewal capacity. These results suggest that MIR223 loss is likely not an initiating event in AML but may cooperate with other AML associated oncogenes to induce leukemogenesis.	[Trissal, Maria C.; DeMoya, Ricardo A.; Schmidt, Amy P.; Link, Daniel C.] Washington Univ, Sch Med, Dept Med, Div Oncol, St Louis, MO 63110 USA	Washington University (WUSTL)	Link, DC (corresponding author), Washington Univ, Sch Med, Dept Med, Div Oncol, St Louis, MO 63110 USA.	dlink@dom.wustl.edu			Translational Research Program Award from the Leukemia & Lymphoma Society; National Institute of Health [PO1-CA101937, T32-HL7088-37]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007088] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM059244] Funding Source: NIH RePORTER	Translational Research Program Award from the Leukemia & Lymphoma Society; National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a Translational Research Program Award from the Leukemia & Lymphoma Society (DCL) and by the National Institute of Health grants PO1-CA101937 (DCL) and T32-HL7088-37 (MCT).	Bailey E, 2013, P NATL ACAD SCI USA, V110, P21113, DOI 10.1073/pnas.1310559110; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Chu SHH, 2012, CELL STEM CELL, V11, P346, DOI 10.1016/j.stem.2012.05.027; Eppert K, 2011, NAT MED, V17, P1086, DOI 10.1038/nm.2415; Fazi F, 2007, CANCER CELL, V12, P457, DOI 10.1016/j.ccr.2007.09.020; Hope KJ, 2004, NAT IMMUNOL, V5, P738, DOI 10.1038/ni1080; Johnnidis JB, 2008, NATURE, V451, P1125, DOI 10.1038/nature06607; Kent DG, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001576; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Ley TJ, 2013, NEW ENGL J MED, V368, P2059, DOI 10.1056/NEJMoa1301689; Petriv OI, 2010, P NATL ACAD SCI USA, V107, P15443, DOI 10.1073/pnas.1009320107; Ramsingh G, 2013, BLOOD, V122, pE44, DOI 10.1182/blood-2013-03-488007; Richards MK, 2003, BLOOD, V102, P3562, DOI 10.1182/blood-2003-02-0593; Schuettpelz LG, 2014, LEUKEMIA, V28, P1851, DOI 10.1038/leu.2014.68; Schuettpelz LG, 2012, BLOOD, V120, P2981, DOI 10.1182/blood-2012-02-409839; Wilson A, 2008, CELL, V135, P1118, DOI 10.1016/j.cell.2008.10.048; Zhou KS, 2012, LEUKEMIA LYMPHOMA, V53, P1155, DOI 10.3109/10428194.2011.642303	17	9	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0119304	10.1371/journal.pone.0119304	http://dx.doi.org/10.1371/journal.pone.0119304			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25793640	Green Submitted, gold, Green Published			2022-12-27	WOS:000352084200071
J	Zhou, JY; Yu, XM; Wang, J; Li, T; Jin, T; Lei, DP; Pan, XL				Zhou, Jieyu; Yu, Xuemin; Wang, Juan; Li, Tao; Jin, Tong; Lei, Dapeng; Pan, Xinliang			Aberrant Expression of PHLPP1 and PHLPP2 Correlates with Poor Prognosis in Patients with Hypopharyngeal Squamous Cell Carcinoma	PLOS ONE			English	Article							TUMOR-SUPPRESSOR; SIGNALING PATHWAY; AKT; PHOSPHATASE; PROTEIN; CANCER; DEPHOSPHORYLATES; METASTASIS; ACTIVATION; GROWTH	The PHLPP (pleckstrin homology [PH] domain leucine rich repeat protein phosphatase) family, which represents a family of novel Ser/Thr protein phosphatases, is composed of 2 members: PHLPP1 and PHLPP2. PHLPPs partake in diverse cellular activities to exhibit their antitumor and metastasis suppressor functions. It is necessary to investigate the expression patterns of PHLPP1 and PHLPP2 in hypopharyngeal squamous cell carcinomas (HSCCs) and clarify their clinical significance. A total of 138 patients with primary HSCC who underwent curative surgical treatment as an initial treatment were enrolled in this study. A total of 138 HSCC specimens and 64 adjacent noncancerousmucosal epithelial tissues were collected. The expression levels of PHLPP1 and PHLPP2 were examined by quantitative reverse transcription polymerase chain reaction and immunohistochemistry assays. Correlations between clinicopathological parameters of the patients were further evaluated. PHLPP1 and PHLPP2mRNA transcript levels were significantly lower in tumor samples than in paired adjacent nontumor mucosae (P< 0.0001, both). Positive correlations were observed between the mRNA levels of PHLPP1 and PHLPP2 in HSCC tissues (correlation coefficient r = 0.678, P< 0.001) and in adjacent nontumormucosae (r = 0.460, P< 0.001). The majority of the non-cancerous tissues showed high expression levels of PHLPP1 (87.5%, 56/64) and PHLPP2 (85.9%, 55/64). However, the expressions of PHLPP1 and PHLPP2 were significantly decreased in 83.3%(115/138) and 82.6%(114/138) of tumor tissues, respectively (P< 0.0001, both). The expressions of both PHLPP isoforms were significantly related to the tumor clinical stage, differentiation, and cervical lymph node metastasis (P< 0.05, all). It was PHLPP1 but not PHLPP2 that was significantly related to the tumor T stage. Low PHLPP1 and PHLPP2 expressions were associated with poor overall survival (OS) in HSCC patients (P = 0.004, P = 0.008, respectively). Multivariate analysis revealed that PHLPP1 was an independent prognostic factor for OS. This study indicates that, in HSCC, aberrant expressions of PHLPP1 and PHLPP2 are common events, and loss of PHLPPs might identify patients with poor prognostic outcomes.	[Zhou, Jieyu; Yu, Xuemin; Wang, Juan; Li, Tao; Jin, Tong; Lei, Dapeng; Pan, Xinliang] Shandong Univ, Qilu Hosp, Dept Otorhinolaryngol, Jinan 250100, Shandong, Peoples R China	Shandong University	Pan, XL (corresponding author), Shandong Univ, Qilu Hosp, Dept Otorhinolaryngol, Jinan 250100, Shandong, Peoples R China.	panxinl915@126.com			Shandong Provincial Natural Science Foundation, China [ZR2013HM107]	Shandong Provincial Natural Science Foundation, China(Natural Science Foundation of Shandong Province)	This work was supported by Shandong Provincial Natural Science Foundation, China (No. #ZR2013HM107). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altomare DA, 2005, ONCOGENE, V24, P7455, DOI 10.1038/sj.onc.1209085; Beaulieu JM, 2005, CELL, V122, P261, DOI 10.1016/j.cell.2005.05.012; Brognard J, 2008, TRENDS ENDOCRIN MET, V19, P223, DOI 10.1016/j.tem.2008.04.001; Brognard J, 2007, MOL CELL, V25, P917, DOI 10.1016/j.molcel.2007.02.017; Carnero A, 2008, CURR CANCER DRUG TAR, V8, P187, DOI 10.2174/156800908784293659; Chen MH, 2011, CANCER CELL, V20, P173, DOI 10.1016/j.ccr.2011.07.013; Courtney KD, 2010, J CLIN ONCOL, V28, P1075, DOI 10.1200/JCO.2009.25.3641; Gao T, 2008, J BIOL CHEM, V283, P6300, DOI 10.1074/jbc.M707319200; Gao TY, 2005, MOL CELL, V18, P13, DOI 10.1016/j.molcel.2005.03.008; Gupta T, 2009, ACTA ONCOL, V48, P541, DOI 10.1080/02841860802488839; Hall SF, 2008, LARYNGOSCOPE, V118, P1362, DOI 10.1097/MLG.0b013e318173dc4a; Harvey JM, 1999, J CLIN ONCOL, V17, P1474, DOI 10.1200/JCO.1999.17.5.1474; Jang SW, 2007, J BIOL CHEM, V282, P30836, DOI 10.1074/jbc.M704542200; Karnoub AE, 2007, NATURE, V449, P557, DOI 10.1038/nature06188; Lei DP, 2010, CARCINOGENESIS, V31, P222, DOI 10.1093/carcin/bgp279; Li X, 2013, ONCOGENE, V32, P471, DOI 10.1038/onc.2012.66; Liao WT, 2013, CLIN CANCER RES, V19, P4662, DOI 10.1158/1078-0432.CCR-13-0244; Liu J, 2009, ONCOGENE, V28, P994, DOI 10.1038/onc.2008.450; Liu JY, 2011, MOL CELL BIOL, V31, P4917, DOI 10.1128/MCB.05799-11; Liu J, 2011, ASIAN PAC J CANCER P, V12, P2653; Liu PX, 2009, NAT REV DRUG DISCOV, V8, P627, DOI 10.1038/nrd2926; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; O'Neill AK, 2013, FEBS J, V280, P572, DOI 10.1111/j.1742-4658.2012.08537.x; Ooms LM, 2009, BIOCHEM J, V419, P29, DOI 10.1042/BJ20081673; Patael-Karasik Y, 2000, CANCER GENET CYTOGEN, V121, P26, DOI 10.1016/S0165-4608(00)00224-7; Pattje WJ, 2010, BRIT J CANCER, V102, P1778, DOI 10.1038/sj.bjc.6605707; Qiao M, 2008, CELL CYCLE, V7, P2991, DOI 10.4161/cc.7.19.6784; Qiao M, 2010, MOL CELL, V38, P512, DOI 10.1016/j.molcel.2010.03.017; Rakha EA, 2006, GENE CHROMOSOME CANC, V45, P527, DOI 10.1002/gcc.20318; Talantov D, 2005, CLIN CANCER RES, V11, P7234, DOI 10.1158/1078-0432.CCR-05-0683; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Vara JAF, 2004, CANCER TREAT REV, V30, P193, DOI 10.1016/j.ctrv.2003.07.007; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Wang JR, 2013, NONLINEAR ANAL-HYBRI, V8, P1, DOI 10.1016/j.nahs.2012.08.003; Wang ZX, 2013, J SURG ONCOL, V108, P427, DOI 10.1002/jso.23419; Wycliffe Nathaniel D, 2007, Top Magn Reson Imaging, V18, P243, DOI 10.1097/RMR.0b013e3181570c3f; Yu XM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066975; Zhao XN, 2011, ASIAN PAC J CANCER P, V12, P397	38	11	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0119405	10.1371/journal.pone.0119405	http://dx.doi.org/10.1371/journal.pone.0119405			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25793736	Green Published, gold, Green Submitted			2022-12-27	WOS:000352084200081
J	Jenkins, MH; Brinckerhoff, CE; Mullins, DW				Jenkins, Molly H.; Brinckerhoff, Constance E.; Mullins, David W.			CXCR3 Signaling in BRAF(WT) Melanoma Increases IL-8 Expression and Tumorigenicity	PLOS ONE			English	Article							CHEMOKINE RECEPTOR CXCR3; CELL-LINES; METASTATIC MELANOMA; TUMOR-GROWTH; STROMAL FIBROBLASTS; CUTANEOUS MELANOMA; ANTITUMOR-ACTIVITY; LYMPH-NODES; PROGRESSION; INTERLEUKIN-8	Patients with early stage, radial growth phase (RGP) melanoma have a 97% survival rate; however, when the melanoma progresses to the invasive vertical growth phase (VGP), survival rates decrease to 15%. The targets of many clinical trials are the known genetic and molecular mechanisms involved in melanoma progression, with the most common oncogenic mutation being the BRAF(V600E). However, less than half of melanomas harbor this mutation, and consequently, do not respond to the current BRAF targeted treatments. It is therefore critical to elucidate alternative mechanisms regulating melanoma progression. Increased expression of the chemokine receptor, CXCR3, on melanoma cells is correlated with increased metastasis and poor patient outcomes, suggesting a role for CXCR3 in the RGP to VGP transition. We found that endogenous CXCR3 can be induced in two RGP cell lines, BOWES (BRAF(WT)) and WM35 (BRAF(V600E)), with in vitro environmental stress and nutrient deprivation. Signaling via induced endogenous CXCR3 is linked with IL-8 expression in BOWES cells. Ectopic overexpression of CXCR3 in BOWES cells leads to increased ligand-mediated phERK, cellular migration, and IL-8 expression in vitro, and to increased tumorigenesis and lymph node metastasis in vivo. Our results demonstrate that, in BRAF(WT) melanomas, CXCR3 signaling mediates significant increases in IL-8 expression, suggesting that CXCR3 expression and signaling may represent a transformative event that drives the progression of BRAF(WT) melanomas. Implications: Expression of CXCR3 on BRAF(WT) melanoma cells may be a mediator of melanoma progression.	[Jenkins, Molly H.; Brinckerhoff, Constance E.] Geisel Sch Med Dartmouth, Dept Med, Lebanon, NH USA; [Jenkins, Molly H.; Mullins, David W.] Geisel Sch Med Dartmouth, Dept Microbiol & Immunol, Lebanon, NH USA; [Brinckerhoff, Constance E.] Geisel Sch Med Dartmouth, Dept Biochem, Lebanon, NH USA; [Jenkins, Molly H.; Brinckerhoff, Constance E.; Mullins, David W.] Geisel Sch Med Dartmouth, Norris Cotton Canc Ctr, Lebanon, NH USA	Dartmouth College; Dartmouth College; Dartmouth College; Dartmouth College; Norris Cotton Cancer Center	Mullins, DW (corresponding author), Geisel Sch Med Dartmouth, Dept Microbiol & Immunol, Lebanon, NH USA.	david.w.mullins@dartmouth.edu	Mullins, David/J-1085-2019	Mullins, David/0000-0002-2644-350X	National Institutes of Health [CA009658, AI007363, R01 CA134799]; Hitchcock Foundation Pilot Studies Award; NATIONAL CANCER INSTITUTE [T32CA009658, P30CA023108, R01CA134799] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007363] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hitchcock Foundation Pilot Studies Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was funded by: National Institutes of Health T32 - Cancer Center Training Grant CA009658 (MHJ/CEB); National Institutes of Health T32 - Immunology Training Grant AI007363 (MHJ/DWM); National Institutes of Health R01 CA134799 (DWM); and Hitchcock Foundation Pilot Studies Award (DWM and CEB).	American Cancer Society, 2014, CANC FACTS FIG 2014; Apte RN, 2006, CANCER METAST REV, V25, P387, DOI 10.1007/s10555-006-9004-4; Balch CM, 2004, CA-CANCER J CLIN, V54, P131, DOI 10.3322/canjclin.54.3.131; Bar-Eli M, 1999, PATHOBIOLOGY, V67, P12, DOI 10.1159/000028045; Blackburn JS, 2009, ONCOGENE, V28, P4237, DOI 10.1038/onc.2009.272; Blackburn JS, 2007, CANCER RES, V67, P10849, DOI 10.1158/0008-5472.CAN-07-1791; Bromley SK, 2008, NAT IMMUNOL, V9, P970, DOI 10.1038/ni.f.213; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; CLARK WH, 1984, HUM PATHOL, V15, P1147, DOI 10.1016/S0046-8177(84)80310-X; Colvin RA, 2006, MOL CELL BIOL, V26, P5838, DOI 10.1128/MCB.00556-06; Croteau W, 2013, J CELL PHYSIOL, V228, P773, DOI 10.1002/jcp.24225; Fedorenko I V, 2014, BR J CANC; Frederick DT, 2013, CLIN CANCER RES, V19, P1225, DOI 10.1158/1078-0432.CCR-12-1630; Fulton AM, 2009, CURR ONCOL REP, V11, P125, DOI 10.1007/s11912-009-0019-1; Gogas HJ, 2007, CANCER-AM CANCER SOC, V109, P455, DOI 10.1002/cncr.22427; Goldberg-Bittman L, 2004, IMMUNOL LETT, V92, P171, DOI 10.1016/j.imlet.2003.10.020; Groom JR, 2011, EXP CELL RES, V317, P620, DOI 10.1016/j.yexcr.2010.12.017; Hofmann UB, 1999, BRIT J CANCER, V81, P774, DOI 10.1038/sj.bjc.6690763; Huntington JT, 2004, J BIOL CHEM, V279, P33168, DOI 10.1074/jbc.M405102200; Hussein MR, 2005, J CLIN PATHOL, V58, P389, DOI 10.1136/jcp.2004.021519; Iida J, 2004, J INVEST DERMATOL, V122, P167, DOI 10.1046/j.0022-202X.2003.22114.x; Johnson M, 2007, BIOORG MED CHEM LETT, V17, P3339, DOI 10.1016/j.bmcl.2007.03.106; Joseph EW, 2010, P NATL ACAD SCI USA, V107, P14903, DOI 10.1073/pnas.1008990107; Kawada K, 2007, ONCOGENE, V26, P4679, DOI 10.1038/sj.onc.1210267; Kawada K, 2004, CANCER RES, V64, P4010, DOI 10.1158/0008-5472.CAN-03-1757; Khalili JS, 2012, CLIN CANCER RES, V18, P5329, DOI 10.1158/1078-0432.CCR-12-1632; Koya RC, 2012, CANCER RES, V72, P3928, DOI 10.1158/0008-5472.CAN-11-2837; Lazar-Molnar E, 2000, CYTOKINE, V12, P547, DOI 10.1006/cyto.1999.0614; Lee JH, 2011, BRIT J DERMATOL, V164, P776, DOI 10.1111/j.1365-2133.2010.10185.x; Lee JT, 2007, J CELL BIOCHEM, V101, P862, DOI 10.1002/jcb.21204; Leslie MC, 2005, J CELL BIOCHEM, V94, P25, DOI 10.1002/jcb.20296; Long GV, 2011, J CLIN ONCOL, V29, P1239, DOI 10.1200/JCO.2010.32.4327; Luca M, 1997, AM J PATHOL, V151, P1105; Meier Friedegund, 1998, Frontiers in Bioscience, V3, pD1005; Menzies AM, 2012, CLIN CANCER RES, V18, P3242, DOI 10.1158/1078-0432.CCR-12-0052; Monteagudo C, 2007, J CLIN PATHOL, V60, P596, DOI 10.1136/jcp.2005.032144; Rubinstein JC, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-67; Ryu B, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000594; Smalley KSM, 2005, EXPERT REV ANTICANC, V5, P1069, DOI 10.1586/14737140.5.6.1069; SUZUKI H, 1994, J BIOL CHEM, V269, P18263; Tsai J, 2008, P NATL ACAD SCI USA, V105, P3041, DOI 10.1073/pnas.0711741105; Vultur A, 2011, CLIN CANCER RES, V17, P1658, DOI 10.1158/1078-0432.CCR-10-0174; Walser TC, 2006, CANCER RES, V66, P7701, DOI 10.1158/0008-5472.CAN-06-0709; WANG JM, 1990, BIOCHEM BIOPH RES CO, V169, P165, DOI 10.1016/0006-291X(90)91449-3; Whipple CA, 2014, BRIT J CANCER, V111, P1625, DOI 10.1038/bjc.2014.452; Whipple CA, 2014, BR J CANC C IN PRESS, P1625; Wyatt CA, 2005, CANCER RES, V65, P11101, DOI 10.1158/0008-5472.CAN-05-2446; Yang H, 2010, CANCER RES, V70, P5518, DOI 10.1158/0008-5472.CAN-10-0646	48	18	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0121140	10.1371/journal.pone.0121140	http://dx.doi.org/10.1371/journal.pone.0121140			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25798946	Green Published, Green Submitted, gold			2022-12-27	WOS:000351987300215
J	Lalwani, P; de Souza, GKBB; de Lima, DSN; Passos, LFS; Boechat, AL; Lima, ES				Lalwani, Pritesh; Bonfim Bacelar de Souza, Giselle Katiane; Nunes de Lima, Domingos Savio; Souza Passos, Luiz Fernando; Boechat, Antonio Luiz; Lima, Emerson Silva			Serum Thiols as a Biomarker of Disease Activity in Lupus Nephritis	PLOS ONE			English	Article							OXIDATIVE STRESS; RHEUMATOID-ARTHRITIS; LIPID-PEROXIDATION; ANTIOXIDANT STATUS; ERYTHEMATOSUS; REDOX; ACID; CLASSIFICATION; AUTOIMMUNITY; GLUTATHIONE	Lupus Nephritis (LN) develops in more than half of the Systemic Lupus Erythematous (SLE) patients. However, lack of reliable, specific biomarkers for LN hampers clinical management of patients and impedes development of new therapeutics. The goal of this study was to investigate whether oxidative stress biomarkers in patients with SLE is predictive of renal pathology. Serum biochemical and oxidative stress markers were measured in patients with inactive lupus, active lupus with and without nephritis and compared to healthy control group. To assess the predictive performance of biomarkers, Receiver Operating Characteristic (ROC) curves were constructed and cut-offs were used to identify SLE patients with nephritis. We observed an increased oxidative stress response in all SLE patients compared to healthy controls. Among the several biomarkers tested, serum thiols had a significant inverse association with SLE Disease Activity Index (SLEDAI). Interestingly, thiols were able too aptly differentiate between SLE patients with and without renal pathology, and serum thiol levels were not affected by immunosuppressive drug therapy. The decreased thiols in SLE correlated significantly with serum creatinine and serum C3 levels. Further retrospective evaluation using serum creatinine or C3 levels in combination with thiol's cutoff values from ROC analysis, we could positively predict chronicity of renal pathology in SLE patients. In summary, serum thiols emerge as an inexpensive and reliable indicator of LN, which may not only help in early identification of renal pathology but also aid in the therapeutic management of the disease, in developing countries with resource poor settings.	[Lalwani, Pritesh; Bonfim Bacelar de Souza, Giselle Katiane; Lima, Emerson Silva] Univ Fed Amazonas, PPGCF, Manaus, Amazonas, Brazil; [Lalwani, Pritesh] Ctr Pesquisa Leonidas & Maria Deane CPqL & MD FIO, Manaus, Amazonas, Brazil; [Bonfim Bacelar de Souza, Giselle Katiane; Lima, Emerson Silva] Univ Fed Amazonas, Fac Ciencias Farmaceut, Manaus, Amazonas, Brazil; [Nunes de Lima, Domingos Savio] Univ Estado Amazonas, Escola Super Ciencias Saude, Manaus, Amazonas, Brazil; [Souza Passos, Luiz Fernando] Univ Fed Amazonas, Fac Med, Manaus, Amazonas, Brazil; [Boechat, Antonio Luiz] Univ Fed Amazonas, Inst Ciencias Biol, Manaus, Amazonas, Brazil	Universidade Federal de Amazonas; Universidade Federal de Amazonas; Universidade do Estado do Amazonas; Universidade Federal de Amazonas; Universidade Federal de Amazonas	Lalwani, P (corresponding author), Univ Fed Amazonas, PPGCF, Manaus, Amazonas, Brazil.	priteshlalwani@amazonia.fiocruz.br	Boechat, A.L./H-8484-2019; Lalwani, Pritesh/I-2257-2016; Boechat, Antonio Luiz/E-6464-2010; Lima, Emerson S/L-4553-2016	Boechat, A.L./0000-0001-5597-7343; Boechat, Antonio Luiz/0000-0001-5597-7343; Lima, Emerson S/0000-0002-9367-2812; Lalwani, Pritesh/0000-0003-2996-0446	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Fundacao de Amparo a Pesquisa do Estado do Amazeonas (FAPEAM)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado do Amazeonas (FAPEAM)	This work was supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) and Fundacao de Amparo a Pesquisa do Estado do Amazeonas (FAPEAM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham P, 2011, J MED TOXICOL, V7, P118, DOI 10.1007/s13181-010-0103-9; Araujo CF, 2008, MEM I OSWALDO CRUZ, V103, P517, DOI 10.1590/S0074-02762008000600001; Ben Mansour R, 2008, SCAND J RHEUMATOL, V37, P103, DOI 10.1080/03009740701772465; Bomback AS, 2010, J AM SOC NEPHROL, V21, P2028, DOI 10.1681/ASN.2010050472; BOMBARDIER C, 1992, ARTHRITIS RHEUM, V35, P630, DOI 10.1002/art.1780350606; Contreras G, 2002, CLIN NEPHROL, V57, P95; Cordova EJ, 2010, LUPUS, V19, P1237, DOI 10.1177/0961203310367917; Fabbri C, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-315; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Gambhir JK, 1997, CLIN BIOCHEM, V30, P351, DOI 10.1016/S0009-9120(96)00007-0; Giannouli S, 2006, ANN RHEUM DIS, V65, P144, DOI 10.1136/ard.2005.041673; Gwinner W, 2000, NEPHROL DIAL TRANSPL, V15, P1127, DOI 10.1093/ndt/15.8.1127; Herrera J, 2006, J AM SOC NEPHROL, V17, pS218, DOI 10.1681/ASN.2006080918; Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928; Huh KH, 2009, PEDIATR NEPHROL, V24, P737, DOI 10.1007/s00467-008-1075-8; Jones DP, 2008, AM J PHYSIOL-CELL PH, V295, pC849, DOI 10.1152/ajpcell.00283.2008; Manson JJ, 2006, ORPHANET J RARE DIS, V1, DOI 10.1186/1750-1172-1-6; Morgan PE, 2009, FREE RADICAL RES, V43, P117, DOI 10.1080/10715760802623896; Moriarty-Craige SE, 2004, ANNU REV NUTR, V24, P481, DOI 10.1146/annurev.nutr.24.012003.132208; Moroni G, 2010, LUPUS, V19, P65, DOI 10.1177/0961203309346906; Moroni G, 2009, ANN RHEUM DIS, V68, P234, DOI 10.1136/ard.2008.094508; Nathan C, 2013, NAT REV IMMUNOL, V13, P349, DOI 10.1038/nri3423; Oates JC, 2008, ARTHRITIS RHEUM, V58, P263, DOI 10.1002/art.23153; Park J, 2004, AM J TRANSPLANT, V4, P1982, DOI 10.1111/j.1600-6143.2004.00610.x; Perez YG, 2012, REV BRAS REUMATOL, V52, P656, DOI 10.1590/S0482-50042012000400016; Perl A, 2013, NAT REV RHEUMATOL, P1; Pons-Estel GJ, 2010, SEMIN ARTHRITIS RHEU, V39, P257, DOI 10.1016/j.semarthrit.2008.10.007; Raftery MJ, 2014, J EXP MED, V211, P1484, DOI 10.1084/jem.20131092; Rovin BH, 2009, CLIN J AM SOC NEPHRO, V4, P1858, DOI 10.2215/CJN.03530509; Sfriso P, 2010, J LEUKOCYTE BIOL, V87, P385, DOI 10.1189/jlb.0709517; Shah D, 2014, J BIOMED SCI, V21, DOI 10.1186/1423-0127-21-23; Shah D, 2013, AUTOIMMUN REV, V12, P741, DOI 10.1016/j.autrev.2012.12.007; Shah D, 2013, IMMUNOBIOLOGY, V218, P620, DOI 10.1016/j.imbio.2012.07.030; Shah D, 2011, IMMUNOBIOLOGY, V216, P1010, DOI 10.1016/j.imbio.2011.04.001; Sprangers B, 2012, NAT REV NEPHROL, V8, P709, DOI 10.1038/nrneph.2012.220; Sulkowska M, 1998, EXP TOXICOL PATHOL, V50, P209; Suzuki M, 2009, PEDIATR RES, V65, P530, DOI 10.1203/PDR.0b013e31819e4305; Turell L, 2013, FREE RADICAL BIO MED, V65, P244, DOI 10.1016/j.freeradbiomed.2013.05.050; Turgay M., 2007, APLAR J RHEUMATOL, V10, P101, DOI [DOI 10.1111/11479-8077.2007.00268.X, 10.1111/j.1479-8077.2007.00268.x, DOI 10.1111/J.1479-8077.2007.00268.X]; Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001; Vilar MJP, 2002, LUPUS, V11, P528, DOI 10.1191/0961203302lu244xx; von Herrath MG, 2003, NAT REV MICROBIOL, V1, P151, DOI 10.1038/nrmicro754; Weening JJ, 2004, J AM SOC NEPHROL, V15, P241, DOI 10.1097/01.ASN.0000108969.21691.5D; Yardim-Akaydin S, 2004, FREE RADICAL RES, V38, P623, DOI 10.1080/10715760410001694044; Yip J, 2010, J RHEUMATOL, V37, P1667, DOI 10.3899/jrheum.091028; Zhang JS, 2006, CHEM-BIOL INTERACT, V162, P24, DOI 10.1016/j.cbi.2006.04.008; Zhang Q, 2010, CLIN EXP DERMATOL, V35, P287, DOI 10.1111/j.1365-2230.2009.03437.x	47	13	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0119947	10.1371/journal.pone.0119947	http://dx.doi.org/10.1371/journal.pone.0119947			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25799079	Green Published, gold, Green Submitted			2022-12-27	WOS:000351987300096
J	Li, LL; Wang, QQ; Zhang, Y; Niu, YZ; Yao, XJ; Liu, HX				Li, Lanlan; Wang, Qianqian; Zhang, Yan; Niu, Yuzhen; Yao, Xiaojun; Liu, Huanxiang			The Molecular Mechanism of Bisphenol A (BPA) as an Endocrine Disruptor by Interacting with Nuclear Receptors: Insights from Molecular Dynamics (MD) Simulations	PLOS ONE			English	Article							RESP METHODOLOGY; ACCURATE DOCKING; FREE-ENERGIES; BINDING; MODEL; GLIDE; INTEGRATION; RESISTANCE; CHEMICALS; WELL	Bisphenol A (BPA) can interact with nuclear receptors and affect the normal function of nuclear receptors in very low doses, which causes BPA to be one of the most controversial endocrine disruptors. However, the detailed molecular mechanism about how BPA interferes the normal function of nuclear receptors is still undiscovered. Herein, molecular dynamics simulations were performed to explore the detailed interaction mechanism between BPA with three typical nuclear receptors, including hER alpha, hERR gamma and hPPAR gamma. The simulation results and calculated binding free energies indicate that BPA can bind to these three nuclear receptors. The binding affinities of BPA were slightly lower than that of E2 to these three receptors. The simulation results proved that the binding process was mainly driven by direct hydrogen bond and hydrophobic interactions. In addition, structural analysis suggested that BPA could interact with these nuclear receptors by mimicking the action of natural hormone and keeping the nuclear receptors in active conformations. The present work provided the structural evidence to recognize BPA as an endocrine disruptor and would be important guidance for seeking safer substitutions of BPA.	[Li, Lanlan; Wang, Qianqian; Zhang, Yan; Liu, Huanxiang] Lanzhou Univ, Sch Pharm, Lanzhou 730000, Peoples R China; [Niu, Yuzhen; Yao, Xiaojun] Lanzhou Univ, State Key Lab Appl Organ Chem, Lanzhou 730000, Peoples R China; [Niu, Yuzhen; Yao, Xiaojun] Lanzhou Univ, Dept Chem, Lanzhou 730000, Peoples R China; [Liu, Huanxiang] Lanzhou Univ, Key Lab Preclin Study New Drugs Gansu Prov, Lanzhou 730000, Peoples R China; [Yao, Xiaojun] Macau Univ Sci & Technol, Macau Inst Appl Res Med & Hlth, State Key Lab Qual Res Chinese Med, Taipa, Macau, Peoples R China	Lanzhou University; Lanzhou University; Lanzhou University; Lanzhou University; Macau University of Science & Technology	Liu, HX (corresponding author), Lanzhou Univ, Sch Pharm, Lanzhou 730000, Peoples R China.	hxliu@lzu.edu.cn		Wang, Qianqian/0000-0003-2574-0120; Liu, Huanxiang/0000-0002-9284-3667	Natural Science Foundation of Gansu Province, China [1208RJYA034]	Natural Science Foundation of Gansu Province, China	Funding: Funding was provided by the Natural Science Foundation of Gansu Province, China (Grant No: 1208RJYA034). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAYLY CI, 1993, J PHYS CHEM-US, V97, P10269, DOI 10.1021/j100142a004; Bonefeld-Jorgensen EC, 2007, ENVIRON HEALTH PERSP, V115, P69, DOI 10.1289/ehp.9368; Bourguet W, 2000, TRENDS PHARMACOL SCI, V21, P381, DOI 10.1016/S0165-6147(00)01548-0; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; CIEPLAK P, 1995, J COMPUT CHEM, V16, P1357, DOI 10.1002/jcc.540161106; Colborn T, 2011, ENV HLTH PERSPECT, V101, P378; Delfosse V, 2012, P NATL ACAD SCI USA, V109, P14930, DOI 10.1073/pnas.1203574109; Deserno M, 1998, J CHEM PHYS, V109, P7678, DOI 10.1063/1.477414; Diamanti-Kandarakis E, 2009, ENDOCR REV, V30, P293, DOI 10.1210/er.2009-0002; Fox T, 1998, J PHYS CHEM B, V102, P8070, DOI 10.1021/jp9717655; Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430; Friesner RA, 2006, J MED CHEM, V49, P6177, DOI 10.1021/jm051256o; Frisch M. J., 2009, GAUSSIAN 09 SOFTWARE; Gaido KW, 1997, TOXICOL APPL PHARM, V143, P205, DOI 10.1006/taap.1996.8069; Gao Y, 2012, J HAZARD MATER, V199, P111, DOI 10.1016/j.jhazmat.2011.10.066; Gouda H, 2003, BIOPOLYMERS, V68, P16, DOI 10.1002/bip.10270; Gould JC, 1998, MOL CELL ENDOCRINOL, V142, P203, DOI 10.1016/S0303-7207(98)00084-7; Halgren TA, 2004, J MED CHEM, V47, P1750, DOI 10.1021/jm030644s; Hou TJ, 2007, J MED CHEM, V50, P1177, DOI 10.1021/jm0609162; Hou TJ, 2009, PROTEINS, V74, P837, DOI 10.1002/prot.22192; Hunt PA, 2012, P NATL ACAD SCI USA, V109, P17525, DOI 10.1073/pnas.1207854109; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kollman PA, 2000, ACCOUNTS CHEM RES, V33, P889, DOI 10.1021/ar000033j; Kumar R, 1999, STEROIDS, V64, P310, DOI 10.1016/S0039-128X(99)00014-8; le Maire A, 2010, CELL MOL LIFE SCI, V67, P1219, DOI 10.1007/s00018-009-0249-2; Li QA, 2010, J HAZARD MATER, V180, P703, DOI 10.1016/j.jhazmat.2010.04.094; Massova I, 2000, PERSPECT DRUG DISCOV, V18, P113, DOI 10.1023/A:1008763014207; Matsushima A, 2007, J BIOCHEM, V142, P517, DOI 10.1093/jb/mvm158; McKenna NJ, 1999, ENDOCR REV, V20, P321, DOI 10.1210/er.20.3.321; Moriyama K, 2002, J CLIN ENDOCR METAB, V87, P5185, DOI 10.1210/jc.2002-020209; Okada H, 2008, ENVIRON HEALTH PERSP, V116, P32, DOI 10.1289/ehp.10587; Onufriev A, 2000, J PHYS CHEM B, V104, P3712, DOI 10.1021/jp994072s; Osz J, 2012, P NATL ACAD SCI USA, V109, pE588, DOI 10.1073/pnas.1118192109; Overington JP, 2006, NAT REV DRUG DISCOV, V5, P993, DOI 10.1038/nrd2199; Riu A, 2011, ENVIRON HEALTH PERSP, V119, P1227, DOI 10.1289/ehp.1003328; Rubin BS, 2011, J STEROID BIOCHEM, V127, P27, DOI 10.1016/j.jsbmb.2011.05.002; Rubin BS, 2009, MOL CELL ENDOCRINOL, V304, P55, DOI 10.1016/j.mce.2009.02.023; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Saiyood S, 2010, J HAZARD MATER, V178, P777, DOI 10.1016/j.jhazmat.2010.02.008; SITKOFF D, 1994, J PHYS CHEM-US, V98, P1978, DOI 10.1021/j100058a043; Sohoni P, 1998, J ENDOCRINOL, V158, P327, DOI 10.1677/joe.0.1580327; Sonoda J, 2008, FEBS LETT, V582, P2, DOI 10.1016/j.febslet.2007.11.016; Sui YP, 2012, ENVIRON HEALTH PERSP, V120, P399, DOI 10.1289/ehp.1104426; Tabb MM, 2006, MOL ENDOCRINOL, V20, P475, DOI 10.1210/me.2004-0513; Takayanagi S, 2006, TOXICOL LETT, V167, P95, DOI 10.1016/j.toxlet.2006.08.012; Tsai WT, 2009, J HAZARD MATER, V168, P269, DOI 10.1016/j.jhazmat.2009.02.034; Uppenberg J, 1998, J BIOL CHEM, V273, P31108, DOI 10.1074/jbc.273.47.31108; Vandenberg LN, 2007, ENDOCRINOLOGY, V148, P116, DOI 10.1210/en.2006-0561; Wang JM, 2000, J COMPUT CHEM, V21, P1049, DOI 10.1002/1096-987X(200009)21:12<1049::AID-JCC3>3.0.CO;2-F; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Warnmark A, 2002, J BIOL CHEM, V277, P21862, DOI 10.1074/jbc.M200764200; Xue WW, 2014, J CHEM INF MODEL, V54, P621, DOI 10.1021/ci400060j; Xue WW, 2012, ANTIVIR RES, V93, P126, DOI 10.1016/j.antiviral.2011.11.007; Zalko D, 2011, CHEMOSPHERE, V82, P424, DOI 10.1016/j.chemosphere.2010.09.058; Zoeller RT, 2005, ENDOCRINOLOGY, V146, P607, DOI 10.1210/en.2004-1018	55	68	69	5	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0120330	10.1371/journal.pone.0120330	http://dx.doi.org/10.1371/journal.pone.0120330			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25799048	Green Published, gold, Green Submitted			2022-12-27	WOS:000351987300135
J	Lu, AT; Yu, YP; Niu, JX; Zhang, JX				Lu, Aitao; Yu, Yanping; Niu, Jiaxin; Zhang, John X.			The Effect of Sign Language Structure on Complex Word Reading in Chinese Deaf Adolescents	PLOS ONE			English	Article							MORPHOLOGICAL AWARENESS; CHILDREN; RECOGNITION; BILINGUALS; KNOWLEDGE; HEARING; CONTEXT	The present study was carried out to investigate whether sign language structure plays a role in the processing of complex words (i.e., derivational and compound words), in particular, the delay of complex word reading in deaf adolescents. Chinese deaf adolescents were found to respond faster to derivational words than to compound words for one-sign-structure words, but showed comparable performance for two-sign-structure words. For both derivational and compound words, response latencies to one-sign-structure words were shorter than to two-sign-structure words. These results provide strong evidence that the structure of sign language affects written word processing in Chinese. Additionally, differences between derivational and compound words in the one-sign-structure condition indicate that Chinese deaf adolescents acquire print morphological awareness. The results also showed that delayed word reading was found in derivational words with two signs (DW-2), compound words with one sign (CW-1), and compound words with two signs (CW-2), but not in derivational words with one sign (DW-1), with the delay being maximum in DW-2, medium in CW-2, and minimum in CW-1, suggesting that the structure of sign language has an impact on the delayed processing of Chinese written words in deaf adolescents. These results provide insight into the mechanisms about how sign language structure affects written word processing and its delayed processing relative to their hearing peers of the same age.	[Lu, Aitao; Yu, Yanping; Niu, Jiaxin] S China Normal Univ, Ctr Studies Psychol Applicat, Guangzhou, Guangdong, Peoples R China; [Lu, Aitao; Yu, Yanping; Niu, Jiaxin] S China Normal Univ, Sch Psychol, Guangzhou, Guangdong, Peoples R China; [Lu, Aitao; Yu, Yanping; Niu, Jiaxin] Guangdong Key Lab Mental Hlth & Cognit Sci, Guangzhou, Guangdong, Peoples R China; [Lu, Aitao; Yu, Yanping; Niu, Jiaxin] Guangdong Ctr Mental Assistance & Contingency Tec, Guangzhou, Guangdong, Peoples R China; [Zhang, John X.] Fudan Univ, Dept Psychol, Shanghai 200433, Peoples R China	South China Normal University; South China Normal University; Fudan University	Lu, AT (corresponding author), S China Normal Univ, Ctr Studies Psychol Applicat, Guangzhou, Guangdong, Peoples R China.	atlupsy@gmail.com	Yu, Yan/GYV-4514-2022		National Natural Science Foundation of China [31200762]; National Training Fund for Basic Research [J1030729, J1210024]; Foundation for Outstanding Young Teachers in Higher Education of Guangdong, China [HS2015001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Training Fund for Basic Research; Foundation for Outstanding Young Teachers in Higher Education of Guangdong, China	This work was supported by the National Natural Science Foundation of China (No. 31200762), the National Training Fund for Basic Research (J1030729 and J1210024), and the Foundation for Outstanding Young Teachers in Higher Education of Guangdong, China (HS2015001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander KL, 1997, SOCIOL EDUC, V70, P87, DOI 10.2307/2673158; Andrew KN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089994; Aronoff M., 1994, MORPHOLOGY ITSELF; Beard R., 1995, LEXEME MORPHEME BASE; Cai Q, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010729; Casey S, 2009, LANG COGNITIVE PROC, V24, P290, DOI 10.1080/01690960801916188; Costa A, 2000, J EXP PSYCHOL LEARN, V26, P1283, DOI 10.1037//0278-7393.26.5.1283; Dijkstra T, 2002, BILING-LANG COGN, V5, P175, DOI 10.1017/S1366728902003012; Dong XF, 2005, CHINESE LANGUAGE LEA, V6, P13; Duyck W, 2007, J EXP PSYCHOL LEARN, V33, P663, DOI 10.1037/0278-7393.33.4.663; Emmorey K, 2008, BILING-LANG COGN, V11, P43, DOI 10.1017/S1366728907003203; Friesen DC, 2012, READ WRIT, V25, P375, DOI 10.1007/s11145-010-9275-6; Gaustad Martha Gonter, 2004, J Deaf Stud Deaf Educ, V9, P269; Gaustad MG, 2002, AM ANN DEAF, V147, P5, DOI 10.1353/aad.2012.0264; Hayes H, 2011, SCI STUD READ, V15, P522, DOI 10.1080/10888438.2010.528480; Hoosain R, 1991, PSYCHOLINGUISTIC IMP; Jin Y, 1988, COMMUNICATION PSYCHO, V1, P16; Kerkhofs R, 2006, BRAIN RES, V1068, P170, DOI 10.1016/j.brainres.2005.10.087; Kuo LJ, 2006, EDUC PSYCHOL-US, V41, P161, DOI 10.1207/s15326985ep4103_3; Liu PP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055440; Lu J., 2008, P 6 SIGHAN WORKSH CH, P53; Moats LC, 1999, TEACHING IS ROCKET S; Morford JP, 2011, COGNITION, V118, P286, DOI 10.1016/j.cognition.2010.11.006; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Pittman AL, 2005, EAR HEARING, V26, P619, DOI 10.1097/01.aud.0000189921.34322.68; Schwartz AI, 2008, BILING-LANG COGN, V11, P95, DOI 10.1017/S1366728907003239; Shen D, 2008, COGNITIVE CULTURAL I, P255; Shook A, 2012, COGNITION, V124, P314, DOI 10.1016/j.cognition.2012.05.014; Sterne A, 2000, J CHILD PSYCHOL PSYC, V41, P609, DOI 10.1111/1469-7610.00648; Sun FC, 1999, READING CHINESE SCRIPT, P189; Sunderman G, 2006, STUD SECOND LANG ACQ, V28, P387, DOI 10.1017/S0272263106060177; Taft M., 1995, MORPHOLOGICAL ASPECT, P293; Transler C, 1999, J Deaf Stud Deaf Educ, V4, P124, DOI 10.1093/deafed/4.2.124; Traxler C B, 2000, J Deaf Stud Deaf Educ, V5, P337; van Hell JG, 2002, PSYCHON B REV, V9, P780, DOI 10.3758/BF03196335; van Hoogmoed AH, 2013, RES DEV DISABIL, V34, P1083, DOI 10.1016/j.ridd.2012.12.010; Wang M, 2006, J EDUC PSYCHOL, V98, P542, DOI 10.1037/0022-0663.98.3.542; Wauters LN, 2006, READ WRIT, V19, P49, DOI 10.1007/s11145-004-5894-0; Zhou XL, 1995, LANG COGNITIVE PROC, V10, P545, DOI 10.1080/01690969508407114	39	5	5	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0120943	10.1371/journal.pone.0120943	http://dx.doi.org/10.1371/journal.pone.0120943			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CE6ZS	25799066	gold, Green Published, Green Submitted			2022-12-27	WOS:000351987300196
J	Lu, JY; Jiao, TT; Li, YM; Liu, Y; Wang, YN; Wang, YT; Zheng, MH; Lu, XF				Lu, Jiaoyang; Jiao, Taotao; Li, Yanmei; Liu, Ying; Wang, Yanan; Wang, Yatian; Zheng, Minhua; Lu, Xuefeng			Heading toward the Right Direction-Solution Package for Endoscopic Submucosal Tunneling Resection in the Stomach	PLOS ONE			English	Article							GASTRIC SUBEPITHELIAL TUMORS; MUSCULARIS PROPRIA; DISSECTION	Background The emerging submucosal tunneling and endoscopic resection (STER) technique provides definitive histological diagnosis as well as a therapeutic method for the gastric submucosal tumors (SMTs). We aim to present our experience and discuss key technical issues of STER. Methods 45 patients with gastric SMTs arising from MP received STER. First, a mucosal incision was made 3cm proximal to the tumour, a submucosal tunnel was subsequently built from the incision to the tumor. The tumor was gradually exposed and dissected from surrounding tissue and retrieved from the tunnel. The initial mucosal incision was closed by metal clips. For SMTs in the gastric fundus near cardia, the submucosal tunnel was built from lower esophagus, through the angle of His, to the tumor for resection. Results STER was successfully performed in 43 patients; the other two were converted to surgery. Mean operating time was 79.3min (range 45-150min). Mean tumor size was 1.4cm (range 0.5-5cm). Of the total 47 resected SMTs, 36 were GISTs, 10 were leiomyomas and 1 was schwannoma. Complete resection was achieved in all patients. Intra-procedural peumoperitoneum occurred in 3 cases because of iatrogenic perforation, no special treatment was given. 7 patients presented with mild abdominal pain/distention and fever were given antibotics. No severe post-operative complication happened. No tumor recurrence occurred in the median 11 month follow-up period. Conclusion Based on short-term follow-up observation, STER is a feasible, safe and minimally invasive method for the diagnosis and treatment of small (<3cm) SMTs in gastric body, antrum and proximal cardia.	[Lu, Jiaoyang; Li, Yanmei; Liu, Ying; Wang, Yanan; Wang, Yatian; Lu, Xuefeng] Shandong Univ, Sch Med, Dept Gastroenterol, Qilu Hosp, Jinan 250100, Shandong, Peoples R China; [Jiao, Taotao] Shandong Prov Hosp, Dept Stat, Jinan, Shandong, Peoples R China; [Lu, Jiaoyang; Zheng, Minhua] Shanghai Jiao Tong Univ, Sch Med, Dept Gen Surg, Ruijin Hosp, Shanghai 200030, Peoples R China	Shandong University; Shandong First Medical University & Shandong Academy of Medical Sciences; Shanghai Jiao Tong University	Zheng, MH (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Dept Gen Surg, Ruijin Hosp, Shanghai 200030, Peoples R China.	zheng_minhua@yeah.net; lu0801shanyi@163.com						Blay JY, 2012, ANN ONCOL, V23, P49, DOI 10.1093/annonc/mds252; Chu YY, 2012, BMC GASTROENTEROL, V12, DOI 10.1186/1471-230X-12-124; Chun SY, 2013, SURG ENDOSC, V27, P3271, DOI 10.1007/s00464-013-2904-9; Gong W, 2012, ENDOSCOPY, V44, P231, DOI 10.1055/s-0031-1291720; Hoda KM, 2009, GASTROINTEST ENDOSC, V69, P1218, DOI 10.1016/j.gie.2008.09.045; Huang ZG, 2012, WORLD J GASTRO ENDOS, V4, P565, DOI 10.4253/wjge.v4.i12.565; Joensuu H, 2008, HUM PATHOL, V39, P1411, DOI 10.1016/j.humpath.2008.06.025; Joensuu H, 2013, LANCET, V382, P973, DOI 10.1016/S0140-6736(13)60106-3; Karaca C, 2010, GASTROINTEST ENDOSC, V71, P722, DOI 10.1016/j.gie.2009.10.019; Lee CH, 2012, J AM COLL SURGEONS, V215, P831, DOI 10.1016/j.jamcollsurg.2012.07.009; Lee IL, 2006, ENDOSCOPY, V38, P1024, DOI 10.1055/s-2006-944814; Liu BR, 2013, SURG ENDOSC, V27, P4354, DOI 10.1007/s00464-013-3023-3; Lu J, 2014, ENDOSCOPY; Lu JY, 2014, SURG ENDOSC, V28, P3401, DOI 10.1007/s00464-014-3610-y; Matthews BD, 2002, SURG ENDOSC, V16, P803, DOI 10.1007/s00464-001-8319-z; Park YS, 2004, GASTROINTEST ENDOSC, V59, P409, DOI 10.1016/S0016-5107(03)02717-2; Sepe PS, 2009, GASTROINTEST ENDOSC, V70, P254, DOI 10.1016/j.gie.2008.11.038; Sepe PS, 2009, NAT REV GASTRO HEPAT, V6, P363, DOI 10.1038/nrgastro.2009.43; Shi Q, 2011, GASTROINTEST ENDOSC, V74, P1194, DOI 10.1016/j.gie.2011.07.039; Xu MD, 2012, GASTROINTEST ENDOSC, V75, P195, DOI 10.1016/j.gie.2011.08.018	20	14	15	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0119870	10.1371/journal.pone.0119870	http://dx.doi.org/10.1371/journal.pone.0119870			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25799065	Green Published, gold, Green Submitted			2022-12-27	WOS:000351987300086
J	Almeida, TCA; Larentis, AL; Ferraz, HC				Abreu Almeida, Teresa Cristina; Larentis, Ariane Leites; Ferraz, Helen Conceicao			Evaluation of the Stability of Concentrated Emulsions for Lemon Beverages Using Sequential Experimental Designs	PLOS ONE			English	Article							WATER EMULSIONS; RHEOLOGY; GROWTH; GUM	The study of the stability of concentrated oil-in-water emulsions is imperative to provide a scientific approach for an important problem in the beverage industry, contributing to abolish the empiricism still present nowadays. The use of these emulsions would directly imply a reduction of transportation costs between production and the sales points, where dilution takes place. The goal of this research was to evaluate the influence of the main components of a lemon emulsion on its stability, aiming to maximize the concentration of oil in the beverage and to correlate its physicochemical characteristics to product stability, allowing an increase of shelf life of the final product. For this purpose, analyses of surface and interface tension, electrokinetic potential, particle size and rheological properties of the emulsions were conducted. A 24-1 fractional factorial design was performed with the following variables: lemon oil/water ratio (30% to 50%), starch and Arabic gum concentrations (0% to 30%) and dioctyl sodium sulfosuccinate (0 mg/L to 100 mg/L), including an evaluation of the responses at the central conditions of each variable. Sequentially, a full design was prepared to evaluate the two most influential variables obtained in the first plan, in which concentration of starch and gum ranged from 0% to 20%, while concentration of lemon oil/water ratio was fixed at 50%, without dioctyl sodium sulfosuccinate. Concentrated emulsions with stability superior to 15 days were obtained with either starch or Arabic gum and 50% lemon oil. The most stable formulations presented viscosity over 100 cP and ratio between the surface tension of the emulsion and the mucilage of over 1. These two answers were selected, since they better represent the behavior of emulsions in terms of stability and could be used as tools for an initial selection of the most promising formulations.	[Abreu Almeida, Teresa Cristina; Ferraz, Helen Conceicao] Univ Fed Rio de Janeiro, COPPE, Chem Engn Program, BR-21941972 Rio De Janeiro, RJ, Brazil; [Larentis, Ariane Leites] Fiocruz MS, ENSP, CESTEH, BR-21041210 Rio De Janeiro, RJ, Brazil	Universidade Federal do Rio de Janeiro; Fundacao Oswaldo Cruz	Larentis, AL (corresponding author), Fiocruz MS, ENSP, CESTEH, BR-21041210 Rio De Janeiro, RJ, Brazil.	arianelarentis@fiocruz.br; helen@peq.coppe.ufrj.br	Ferraz, Helen/AAF-1060-2019	FERRAZ, HELEN/0000-0002-6058-5296	Capes (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior/Coordination for the Improvement of Higher Education Personnel); CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico/National Counsel of Technological and Scientific Development) from Brazil	Capes (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior/Coordination for the Improvement of Higher Education Personnel); CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico/National Counsel of Technological and Scientific Development) from Brazil	No specific funding was received for this work. Scholarships and laboratory material was supported by Capes (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior/Coordination for the Improvement of Higher Education Personnel) and CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico/National Counsel of Technological and Scientific Development) from Brazil; ENSP/Fiocruz supported language revision. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acedo-Carrillo JI, 2006, CARBOHYD POLYM, V65, P327, DOI 10.1016/j.carbpol.2006.01.016; Byrd S. J., 2006, SAIB OLDEST NEW INGR; Cottrell T., 2004, Emulsifiers in food technology, P162, DOI 10.1002/9780470995747.ch7; Dickinson E., 1992, INTRO FOOD COLLOIDS; Einsfeldt K, 2011, VACCINE, V29, P7136, DOI 10.1016/j.vaccine.2011.05.073; Friberg SE., 2004, FOOD EMULSIONS; Iemma AF, 2014, EXPT DESIGN PROCESS; Marini G, 2014, BMC BIOTECHNOL, V14, DOI 10.1186/1472-6750-14-1; McClements D.J., 1999, FOOD EMULSIONS PRINC, P267; McClements DJ, 2007, CRIT REV FOOD SCI, V47, P611, DOI 10.1080/10408390701289292; Mirhosseini H, 2008, COLLOID SURFACE A, V315, P47, DOI 10.1016/j.colsurfa.2007.07.007; Mirhosseini H, 2007, J AGR FOOD CHEM, V55, P7659, DOI 10.1021/jf071061k; Myers D, 1999, SURFACES INTERFACES; Niraula B, 2004, COLLOID SURFACE A, V251, P117, DOI 10.1016/j.colsurfa.2004.08.071; Tadros T, 2004, ADV COLLOID INTERFAC, V108, P227, DOI 10.1016/j.cis.2003.10.025; Tadros T.F., 2009, EMULSION SCI TECHNOL; Tesch S, 2002, J FOOD ENG, V54, P167, DOI 10.1016/S0260-8774(01)00206-0; Walstra P., 2003, PHYS CHEM FOODS	18	16	17	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0118690	10.1371/journal.pone.0118690	http://dx.doi.org/10.1371/journal.pone.0118690			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25793301	Green Published, gold, Green Submitted			2022-12-27	WOS:000352084200032
J	Andermo, S; Sundberg, T; Forsberg, C; Falkenberg, T				Andermo, Susanne; Sundberg, Tobias; Forsberg, Christina; Falkenberg, Torkel			Capitalizing on Synergies-A Discourse Analysis of the Process of Collaboration Among Providers of Integrative Health Care	PLOS ONE			English	Article							INTERPROFESSIONAL COLLABORATION; BIOMEDICAL PRACTITIONERS; ALTERNATIVE MEDICINE; NECK PAIN; COMPLEMENTARY; SETTINGS; PATTERNS; BACK; CAM	Background Integrative health care (IHC) combines therapies and providers from complementary and conventional health care. Previous studies on IHC have shown power relations between providers but few studies have explored how the interaction develops over time. The objective of this study was to explore the development of IHC collaboration and interaction among participating providers during a series of consensus case conferences for managing patients with back and neck pain. Methods This qualitative study was conducted within a pragmatic randomized controlled clinical trial in primary care. Patients' treatment plans were developed based on IHC provider consensus conferences (n = 26) of which 15 (5 of the first, 5 in the middle, and 5 of the last in the clinical trial) were selected for analysis. Findings were derived by means of discourse analysis, focusing on the participants' use of subject positions during the conferences. Findings The IHC team in this study gradually formed a group identity, moving their subject positions from individual treating subjects to members of a team and were able to make consensus-based decisions about patients' individual treatment plans. In the discourse, the IHC team identified collaborative shortcomings and problematized the provision of IHC. They were able to capitalize on the synergies in their collaboration and developed a shared vision of IHC provision. Conclusions The process of IHC collaboration involved the gradual formation of an IHC team identity, which facilitated interdisciplinary, non-hierarchical consensus-based decision-making in the team. The discourse further suggests that a reform of some legal and organizational health sector barriers might be needed to realize sustainable implementation of IHC services in Sweden.	[Andermo, Susanne; Sundberg, Tobias; Forsberg, Christina; Falkenberg, Torkel] Karolinska Inst, Dept Neurobiol Care Sci & Soc, Div Nursing, S-14183 Huddinge, Sweden; [Sundberg, Tobias; Falkenberg, Torkel] IC Integrat Care Sci Ctr, S-15391 Jarna, Sweden	Karolinska Institutet	Andermo, S (corresponding author), Karolinska Inst, Dept Neurobiol Care Sci & Soc, Div Nursing, S-14183 Huddinge, Sweden.	Susanne.Andermo@ki.se	Andermo, Susanne/ABE-2729-2020	Andermo, Susanne/0000-0002-8006-1991; Falkenberg, Torkel/0000-0002-8150-9380	Ekhaga (Sweden); Svensk forening for vetenskaplig homeopati (Sweden); Mahle (Germany) charitable non-profit foundation; Vidar (Sweden) charitable non-profit foundation; Jochnick (the Netherlands) charitable non-profit foundation; Gyllenberg (Finland) charitable non-profit foundation; Vidar (Sweden); Mahle (Germany); Jochnick (the Netherlands); Gyllenberg (Finland)	Ekhaga (Sweden); Svensk forening for vetenskaplig homeopati (Sweden); Mahle (Germany) charitable non-profit foundation; Vidar (Sweden) charitable non-profit foundation; Jochnick (the Netherlands) charitable non-profit foundation; Gyllenberg (Finland) charitable non-profit foundation; Vidar (Sweden); Mahle (Germany); Jochnick (the Netherlands); Gyllenberg (Finland)	The research project was partly funded by Ekhaga (Sweden) and Svensk forening for vetenskaplig homeopati (Sweden). Susanne Andermo received institutional grants from Ekhaga (Sweden). Tobias Sundberg received Insamlingsstiftelsen for forskning om manuella terapier (Sweden), and Institutional grants to I C-The Integrative Care Science Centre from the Mahle (Germany), Ekhaga (Sweden), Vidar (Sweden), Jochnick (the Netherlands) and Gyllenberg (Finland) charitable non-profit foundations during the conduct of the study. Torkel Falkenberg received institutional grants from Ekhaga (Sweden), Vidar (Sweden), Mahle (Germany), Jochnick (the Netherlands), and Gyllenberg (Finland), Charitable Non Profit Foundations during the conduct of the study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson R, 1999, J ALTERN COMPLEM MED, V5, P165, DOI 10.1089/acm.1999.5.165; Andersson S, 2012, ALTERN THER HEALTH M, V18, P25; Barr H., 1998, J INTERPROF CARE, V12, P181, DOI [https://doi.org/10.3109/13561829809014104, DOI 10.3109/13561829809014104, 10.3109/13561829809014104]; Belanger E, 2008, J INTERPROF CARE, V22, P587, DOI 10.1080/13561820802380035; Boon H, 2004, BMC HEALTH SERV RES, V4, DOI 10.1186/1472-6963-4-15; D'Amour Danielle, 2005, J Interprof Care, V19 Suppl 1, P116, DOI 10.1080/13561820500082529; Frenkel MA, 2003, FAM PRACT, V20, P324, DOI 10.1093/fampra/cmg315; Gaboury I, 2012, BMC COMPLEM ALTERN M, V12, DOI 10.1186/1472-6882-12-131; Gaboury I, 2011, J INTERPROF CARE, V25, P124, DOI 10.3109/13561820.2010.523654; Gaboury I, 2009, SOC SCI MED, V69, P707, DOI 10.1016/j.socscimed.2009.05.048; Glynos J, 2012, LANGUAGE, IDEOLOGY, AND THE HUMAN: NEW INTERVENTIONS, P173; Goldblatt E, 2013, EXPLORE-NY, V9, P285, DOI 10.1016/j.explore.2013.06.006; Gray B, 2014, J ALTERN COMPLEM MED, V20, P342, DOI 10.1089/acm.2013.0167; Helman CG, 1994, CULTURE HLTH ILLNESS; Hollenberg D, 2006, SOC SCI MED, V62, P731, DOI 10.1016/j.socscimed.2005.06.030; Hollenberg D, 2011, J INTERPROF CARE, V25, P182, DOI 10.3109/13561820.2011.552133; Howarth D, 2004, DISCOURSE THEORY IN EUROPEAN POLITICS: IDENTITY, POLICY AND GOVERNANCE, P316; Jorgensen Marianne, 2002, DISCOURSE ANAL THEOR; Kaboru Berthollet Bwira, 2006, Hum Resour Health, V4, P16, DOI 10.1186/1478-4491-4-16; Laclau Ernesto, 1990, NEW REFLECTIONS REVO; Lam TP, 2013, COMPLEMENT THER MED, V21, P300, DOI 10.1016/j.ctim.2013.04.003; Lindenbaum S., 1993, KNOWLEDGE POWER PRAC; Mickan Sharon M, 2005, Aust Health Rev, V29, P211; Potter J, 1987, DISCOURSE SOCIAL PSY; Shuval JT, 2002, SOC SCI MED, V55, P1745, DOI 10.1016/S0277-9536(01)00305-7; Soklaridis S, 2009, J INTERPROF CARE, V23, P655, DOI 10.3109/13561820902886287; Sundberg T, 2007, BMC HEALTH SERV RES, V7, DOI 10.1186/1472-6963-7-107; Sundberg T, 2014, EUR J INTEGR MED, V6, P12, DOI 10.1016/j.eujim.2013.09.005; Sundberg T, 2009, BMC COMPLEM ALTERN M, V9, DOI 10.1186/1472-6882-9-33; The National Board of Health and Welfare, REGISTRET OVER LEGIT; West K, 2011, CRIT POLICY STUD, V5, P414, DOI 10.1080/19460171.2011.628033; WHO, 2008, BEIJ DECL; Wiesener S, 2012, FORSCH KOMPLEMENTMED, V19, P29, DOI 10.1159/000343125; Wodak R, 2009, METHODS CRITICAL DIS; World Health Organization, 2010, FRAM ACT INT ED COLL; Yates S., 2001, DISCOURSE DATA GUIDE; Zizek S, 1990, DISCOURSE ANAL, DOI 10.12968/jowc.2014.23.11.552; Zollman C, 1999, BRIT MED J, V319, P693, DOI 10.1136/bmj.319.7211.693	38	5	5	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0122125	10.1371/journal.pone.0122125	http://dx.doi.org/10.1371/journal.pone.0122125			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CE8HY	25793967	Green Submitted, Green Published, gold			2022-12-27	WOS:000352083900171
J	Barekatain, B; Raahemifar, K; Quintana, AA; Cabrera, AT				Barekatain, Behrang; Raahemifar, Kaamran; Ariza Quintana, Alfonso; Trivino Cabrera, Alicia			Promoting Wired Links in Wireless Mesh Networks: An Efficient Engineering Solution	PLOS ONE			English	Article							ROUTING PROTOCOLS; INTERFERENCE	Wireless Mesh Networks (WMNs) cannot completely guarantee good performance of traffic sources such as video streaming. To improve the network performance, this study proposes an efficient engineering solution named Wireless-to-Ethernet-Mesh-Portal-Passageway (WEMPP) that allows effective use of wired communication in WMNs. WEMPP permits transmitting data through wired and stable paths even when the destination is in the same network as the source (Intra-traffic). Tested with four popular routing protocols (Optimized Link State Routing or OLSR as a proactive protocol, Dynamic MANET On-demand or DYMO as a reactive protocol, DYMO with spanning tree ability and HWMP), WEMPP considerably decreases the end-to-end delay, jitter, contentions and interferences on nodes, even when the network size or density varies. WEMPP is also cost-effective and increases the network throughput. Moreover, in contrast to solutions proposed by previous studies, WEMPP is easily implemented by modifying the firmware of the actual Ethernet hardware without altering the routing protocols and/or the functionality of the IP/MAC/Upper layers. In fact, there is no need for modifying the functionalities of other mesh components in order to work with WEMPPs. The results of this study show that WEMPP significantly increases the performance of all routing protocols, thus leading to better video quality on nodes.	[Barekatain, Behrang; Raahemifar, Kaamran] Ryerson Univ, Dept Elect & Comp Engn, Toronto, ON, Canada; [Ariza Quintana, Alfonso] Univ Malaga, Dept Tecnol Elect, ETSI, Telecomunicac, E-29071 Malaga, Spain; [Trivino Cabrera, Alicia] Univ Malaga, Escuela Ingn, Dept Ingn Elect, E-29071 Malaga, Spain	Toronto Metropolitan University; Universidad de Malaga; Universidad de Malaga	Barekatain, B (corresponding author), Ryerson Univ, Dept Elect & Comp Engn, Toronto, ON, Canada.	Behrang_Barekatain@yahoo.com	Triviño, Alicia/J-2720-2013; Barekatain, Behrang/J-2799-2013	Triviño, Alicia/0000-0002-7516-2878; Barekatain, Behrang/0000-0001-5344-6282	Natural Sciences and Engineering Research Council of Canada [129619]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This research was supported by funding through Natural Sciences and Engineering Research Council of Canada to Kaamran Raahemifar. Grant approved under the Application Number: 129619. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alotaibi E, 2011, ROUTING TOPOLOGY CON; Aluvalu R, 2011, INT J RES COMPUT SCI, V2, P11; Amir Y, 2007, I S WORLD WIREL MOBI, P139; [Anonymous], 2001, 8021W IEEE; [Anonymous], 1997, 802112012 IEEE, P1, DOI DOI 10.1109/IEEESTD.2012.6178212; [Anonymous], 2013, INT J COMMUN NETW SY, DOI [10.4236/ijcns.2013.65024, DOI 10.4236/IJCNS.2013.65024]; Ariza-Quintana A, 2011, LECT NOTES COMPUT SC, V6649, P374, DOI 10.1007/978-3-642-21560-5_31; Arizona ASU, 2009, VID TRAC RES GROUP M; AURENHAMMER F, 1991, COMPUT SURV, V23, P345, DOI 10.1145/116873.116880; Barekatain B, 2011, NETWORK CODING EFFIC, P1; Barekatain B., 2013, IURNALTEKNOLOGI, V62, P85, DOI 10.11113/jt.v62.1495; Barekatain B, 2013, EURASIP J WIREL COMM, DOI 10.1186/1687-1499-2013-168; Barekatain B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069844; Borges VCM, 2011, AD HOC NETW, V9, P652, DOI 10.1016/j.adhoc.2010.08.017; CatoAkyildiz LF, 2009, WIRELESS MESH NETWOR; CCS, 2012, PATHADHOC TOOL; Chakchouk N, 2011, IEEE T VEH TECHNOL, V60, P555, DOI 10.1109/TVT.2010.2102057; Chakeres I., 2010, DYNAMIC MANET ON DEM; Cheng X., 2008, P 18 INT WORKSH NETW, P57; Ekram H, 2008, WIRELESS MESH NETWOR; Fu WH, 2013, IEEE T MOBILE COMPUT, V12, P136, DOI 10.1109/TMC.2011.247; Garnepudi P, 2013, PROACTIVE REACTIVE H, P1; Hekmat R, 2004, WIREL NETW, V10, P389, DOI 10.1023/B:WINE.0000028543.41559.ed; Hiertz GR, 2010, IEEE WIREL COMMUN, V17, P104, DOI 10.1109/MWC.2010.5416357; Jacquet P, 2001, IEEE INMIC 2001: IEEE INTERNATIONAL MULTI TOPIC CONFERENCE 2001, PROCEEDINGS, P62, DOI 10.1109/INMIC.2001.995315; Javadi F, 2012, WIREL COMMUN MOB COM, V12, P782, DOI 10.1002/wcm.1013; Kulla E, 2012, COMPUT MATH APPL, V63, P339, DOI 10.1016/j.camwa.2011.07.035; Milic B., 2009, INT C SIM TOOLS TECH; OMNET++, 2010, OBJ MOD NETW TESTB C; Pande S, 2014, LAYER 2 WIRED WIRELE, P1; Shakil SR, 2013, 2013 2ND INTERNATIONAL CONFERENCE ON ADVANCES IN ELECTRICAL ENGINEERING (ICAEE 2013), P374, DOI 10.1109/ICAEE.2013.6750366; Simaremare H, 2012, 2012 INTERNATIONAL CONFERENCE ON ADVANCED COMPUTER SCIENCE AND INFORMATION SYSTEMS, P47; Trivino-Cabrera A, 2008, TELECOMMUN SYST, V38, P3, DOI 10.1007/s11235-008-9094-0; TU WQ, 2008, NETW PROT 2008 ICNP, P43; Wei CY, 2012, ADV INTEL SOFT COMPU, V133, P1165; Zavala A.A., 2007, ANTENNA PROPAGATION	36	1	1	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0119679	10.1371/journal.pone.0119679	http://dx.doi.org/10.1371/journal.pone.0119679			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25793516	Green Published, gold, Green Submitted			2022-12-27	WOS:000352084200106
J	Bibiloni, MD; Salas, R; Novelo, HI; Villarreal, JZ; Sureda, A; Tur, JA				del Mar Bibiloni, Maria; Salas, Rogelio; Novelo, Hilda I.; Villarreal, Jesus Z.; Sureda, Antoni; Tur, Josep A.			Serum Lipid Levels and Dyslipidaemia Prevalence among 2-10 Year-Old Northern Mexican Children	PLOS ONE			English	Article							DENSITY-LIPOPROTEIN CHOLESTEROL; BODY-MASS INDEX; CARDIOVASCULAR RISK; ADOLESCENTS; TRACKING; OBESITY; CHILDHOOD; ASSOCIATION; POPULATION; OVERWEIGHT	Background and Aims The increase in overweight and obese children may be linked to increased rates of dyslipidaemia. The aim was to assess the prevalence of dyslipidaemia and associated risk factors among the Northern Mexican child population. Methods and Results Four hundred and fifty-one subjects aged between 2 and 10 (47.5% girls) took part in the Nuevo Leon State Survey of Nutrition and Health 2011-2012. According to the 2011 Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents, serum lipid levels (mg/dL) were categorized into three subgroups (acceptable, borderline-high/low or high/low) as follows: TChol: acceptable <170, borderline-high 170-199, high >= 200; LDL-chol: acceptable <110, borderline-high 110-129, high >= 130; non-HDL-chol: acceptable <120, borderline-high 120-144, high >= 145; HDL-chol: acceptable >45, borderline-low 40-45, low <40; and TG: acceptable <75, borderline-high 75-99, high >= 100 in <= 9 year-old children, and acceptable <90, borderline-high 90-129, and high >= 130 in 10 year-old children. The overall prevalence of borderline-high + high TG, non-HDL-chol, TChol, and LDL-chol was 63.0%, 44.1%, 43.5%, and 29.9%, respectively. The overall prevalence of borderline-low + low HDL-chol was 46.3%. The overall frequency of dyslipidaemia was 54.3%. Thirteen children (2.9%) had all five symptoms of dyslipidaemia. The most common dyslipidaemia was high TG in combination (26.2%) and in isolation (10.6%). Conclusions Half of the children had at least one abnormal lipid concentration. A high TG level was the most frequent dyslipidaemia. Obesity was associated with the occurrence of at least one abnormal lipid level. These findings emphasize the need to pay further attention to the prevention of cardiovascular disease and obesity from an early age.	[del Mar Bibiloni, Maria; Sureda, Antoni; Tur, Josep A.] Univ Balearic Isl, Res Grp Community Nutr & Oxidat Stress, Palma De Mallorca, Spain; [del Mar Bibiloni, Maria; Sureda, Antoni; Tur, Josep A.] CIBEROBN Physiopathol Obes & Nutr, Palma De Mallorca, Spain; [Salas, Rogelio; Novelo, Hilda I.] Autonomous Univ Nuevo Leon, Fac Publ Hlth Nutr, Monterrey, Mexico; [Villarreal, Jesus Z.] Dept Hlth State Nuevo Leon, Monterrey, Mexico	Universitat de les Illes Balears; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Universidad Autonoma de Nuevo Leon	Tur, JA (corresponding author), Univ Balearic Isl, Res Grp Community Nutr & Oxidat Stress, Palma De Mallorca, Spain.	pep.tur@uib.es	del Mar Bibiloni, Maria/M-3123-2014; Sureda, Antoni/N-9588-2019; Tur, Josep Antoni/F-5576-2014; Gomila, Antonio Sureda/L-7191-2014; Tur, Josep/AAE-5748-2020; Bibiloni, Maria del Mar/H-9734-2015; , Antoni/AAB-5250-2019	del Mar Bibiloni, Maria/0000-0001-8926-9206; Sureda, Antoni/0000-0001-8656-6838; Tur, Josep Antoni/0000-0002-6940-0761; Gomila, Antonio Sureda/0000-0003-2101-616X; Tur, Josep/0000-0002-6940-0761; , Antoni/0000-0001-8656-6838; /0000-0001-9835-1594	Department of Health, Government of the State of Nuevo Leon (Mexico); State Survey of Nutrition and Health-Nuevo Leon; Spanish Ministry of Health and Consumer Affairs [11/01791, RD06/0045/1004, CB12/03/30038]; Balearic Islands Gov. [35/2011]; Research Group on Community Nutrition and Oxidative Stress, University of the Balearic Islands under the Centre Catala de la Nutricio (IEC); Exernet Network; EU FEDER funds [35/2011]	Department of Health, Government of the State of Nuevo Leon (Mexico); State Survey of Nutrition and Health-Nuevo Leon; Spanish Ministry of Health and Consumer Affairs(Spanish Government); Balearic Islands Gov.; Research Group on Community Nutrition and Oxidative Stress, University of the Balearic Islands under the Centre Catala de la Nutricio (IEC); Exernet Network; EU FEDER funds(European Commission)	This study was financially supported by the Department of Health, Government of the State of Nuevo Leon (Mexico), State Survey of Nutrition and Health-Nuevo Leon 2011/2012 (EESN-NL 2011/2012); Spanish Ministry of Health and Consumer Affairs (Programme for Promotion of Biomedical Research and Health Sciences, Projects 11/01791, Red Predimed-RETIC RD06/0045/1004, and CIBEROBN CB12/03/30038); grant of support to research groups no. 35/2011 (Balearic Islands Gov. and EU FEDER funds); and the Research Group on Community Nutrition and Oxidative Stress, University of the Balearic Islands, coming under the Centre Catala de la Nutricio (IEC) and Exernet Network.	Agency for Healhcare Research and Quality, 2012, GUID CLIN PREV SERV; [Anonymous], 2011, Rev. salud pública, V13, P196, DOI 10.1590/S0124-00642011000200002; Azizi F, 2001, EUR J EPIDEMIOL, V17, P281, DOI 10.1023/A:1017932212350; Caamano MC, 2011, OJPM, V1, P171; Can M, 2013, PEDIATR CARDIOL, V34, P566, DOI 10.1007/s00246-012-0495-1; Cardoso-Saldaña Guillermo C., 2010, Arch. Cardiol. Méx., V80, P12; Cole TJ, 2007, BMJ-BRIT MED J, V335, P194, DOI 10.1136/bmj.39238.399444.55; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; Dai SF, 2014, J PEDIATR-US, V164, P247, DOI 10.1016/j.jpeds.2013.08.069; Alcântara Neto Osvaldo Dário de, 2012, Rev. bras. epidemiol., V15, P335, DOI 10.1590/S1415-790X2012000200011; Franca Everaldo de, 2006, Arq. Bras. Cardiol., V87, P722, DOI 10.1590/S0066-782X2006001900007; DELONG DM, 1986, JAMA-J AM MED ASSOC, V256, P2372, DOI 10.1001/jama.256.17.2372; Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents, 2011, Pediatrics, V128 Suppl 5, pS213, DOI 10.1542/peds.2009-2107C; Ford ES, 2009, CIRCULATION, V119, P1108, DOI 10.1161/CIRCULATIONAHA.108.816769; Ghergerehchi Robabeh, 2009, Ther Clin Risk Manag, V5, P739; Gidding SS, 1995, AM J MED SCI, V310, pS68, DOI 10.1097/00000441-199512000-00012; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Gutierrez JP, 2012, ENCUESTA NACL SALUD; Hernandez-Valero MA, 2012, J IMMIGR MINOR HEALT, V14, P517, DOI 10.1007/s10903-011-9535-9; Jellinger Paul S, 2012, Endocr Pract, V18 Suppl 1, P1; Kelder SH, 2002, PREV MED, V34, P324, DOI 10.1006/pmed.2001.0990; Kell KP, 2014, AM J CLIN NUTR, V100, P46, DOI 10.3945/ajcn.113.076505; Kosova EC, 2013, J ACAD NUTR DIET, V113, P219, DOI 10.1016/j.jand.2012.10.020; Li J, 2010, PHARMACOEPIDEM DR S, V19, P1031, DOI 10.1002/pds.1982; McCrindle BW, 2012, PEDIATRICS, V130, P353, DOI 10.1542/peds.2012-1137; Monge-Rojas R, 2001, ARCH LATINOAM NUTR, V51, P236; National Heart Lung and Blood Institute, 2012, NIH PUBLICATION, V12-7486; Nobre LN, 2013, J PEDIAT-BRAZIL, V89, P462, DOI 10.1016/j.jped.2013.02.020; oecd, OBESITY EC PREVENTIO; Okada M, 2001, PREV MED, V32, P224, DOI 10.1006/pmed.2000.0805; Pereira A, 2009, ARQ BRAS CARDIOL, V93, P253, DOI 10.1590/S0066-782X2009000900009; Peterson Amy L, 2012, WMJ, V111, P274; PORKKA KVK, 1994, AM J EPIDEMIOL, V140, P1096, DOI 10.1093/oxfordjournals.aje.a117210; PORKKA KVK, 1991, PREV MED, V20, P713, DOI 10.1016/0091-7435(91)90066-D; Posadas-Sanchez R, 2007, METABOLISM, V56, P1666, DOI 10.1016/j.metabol.2007.07.009; Reiner Z, 2011, EUR HEART J, V32, P1769, DOI [10.1093/eurheartj/ehr158, 10.1016/j.atherosclerosis.2011.06.012]; Roche Diagnostics Corporation, 2005, COB 6000 AN SER OP M; Martinez MDR, 2014, J PHYS ACT HEALTH, V11, pS74, DOI 10.1123/jpah.2014-0172; Srinivasan SR, 2006, PEDIATRICS, V118, P201, DOI 10.1542/peds.2005-1856; Stern D, 2014, J NUTR, V144, P949, DOI 10.3945/jn.114.190652; Sundvall J, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-63; United States Preventive Services Task Force, 2007, SCREEN LIP DIS CHILD; Vieira ACR, 2009, REV SAUDE PUBL, V43, P44, DOI 10.1590/S0034-89102008005000062; Lima SCVC, 2011, NUTR HOSP, V26, P304, DOI [10.3305/nh.2011.26.24961, 10.1590/S0212-16112011000200010]; WEBBER LS, 1991, AM J EPIDEMIOL, V133, P884, DOI 10.1093/oxfordjournals.aje.a115968; Welsh JA, 2011, CIRCULATION, V123, P249, DOI 10.1161/CIRCULATIONAHA.110.972166; Welsh JA, 2010, JAMA-J AM MED ASSOC, V303, P1490, DOI 10.1001/jama.2010.449; Yang S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049253	48	15	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0119877	10.1371/journal.pone.0119877	http://dx.doi.org/10.1371/journal.pone.0119877			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25793380	gold, Green Submitted, Green Published			2022-12-27	WOS:000352084200123
J	Engler, RJM; Nelson, MR; Collins, LC; Spooner, C; Hemann, BA; Gibbs, BT; Atwood, JE; Howard, RS; Chang, AS; Cruser, DL; Gates, DG; Vernalis, MN; Lengkeek, MS; McClenathan, BM; Jaffe, AS; Cooper, LT; Black, S; Carlson, C; Wilson, C; Davis, RL				Engler, Renata J. M.; Nelson, Michael R.; Collins, Limone C., Jr.; Spooner, Christina; Hemann, Brian A.; Gibbs, Barnett T.; Atwood, J. Edwin; Howard, Robin S.; Chang, Audrey S.; Cruser, Daniel L.; Gates, Daniel G.; Vernalis, Marina N.; Lengkeek, Marguerite S.; McClenathan, Bruce M.; Jaffe, Allan S.; Cooper, Leslie T.; Black, Steve; Carlson, Christopher; Wilson, Christopher; Davis, Robert L.			A Prospective Study of the Incidence of Myocarditis/Pericarditis and New Onset Cardiac Symptoms following Smallpox and Influenza Vaccination	PLOS ONE			English	Article							INDUCED MYOCARDIAL-ISCHEMIA; LONG-TERM MORTALITY; TROPONIN-T; ADVERSE EVENTS; UNITED-STATES; GENERAL-POPULATION; RISK; ELEVATION; EXERCISE; RECOMMENDATIONS	Background Although myocarditis/pericarditis (MP) has been identified as an adverse event following smallpox vaccine (SPX), the prospective incidence of this reaction and new onset cardiac symptoms, including possible subclinical injury, has not been prospectively defined. Purpose The study's primary objective was to determine the prospective incidence of new onset cardiac symptoms, clinical and possible subclinical MP in temporal association with immunization. Methods New onset cardiac symptoms, clinical MP and cardiac specific troponin T (cTnT) elevations following SPX (above individual baseline values) were measured in a multi-center prospective, active surveillance cohort study of healthy subjects receiving either smallpox vaccine or trivalent influenza vaccine (TIV). Results New onset chest pain, dyspnea, and/or palpitations occurred in 10.6% of SPX-vaccinees and 2.6% of TIV-vaccinees within 30 days of immunization (relative risk (RR) 4.0, 95% CI: 1.7-9.3). Among the 1081 SPX-vaccinees with complete follow-up, 4 Caucasian males were diagnosed with probable myocarditis and 1 female with suspected pericarditis. This indicates a post-SPX incidence rate more than 200-times higher than the pre-SPX background population surveillance rate of myocarditis/pericarditis (RR 214, 95% CI 65-558). Additionally, 31 SPX-vaccinees without specific cardiac symptoms were found to have over 2-fold increases in cTnT (>99th percentile) from baseline (pre-SPX) during the window of risk for clinical myocarditis/pericarditis and meeting a proposed case definition for possible subclinical myocarditis. This rate is 60-times higher than the incidence rate of overt clinical cases. No clinical or possible subclinical myocarditis cases were identified in the TIV-vaccinated group. Conclusions Passive surveillance significantly underestimates the true incidence of myocarditis/pericarditis after smallpox immunization. Evidence of subclinical transient cardiac muscle injury post-vaccinia immunization is a finding that requires further study to include long-term outcomes surveillance. Active safety surveillance is needed to identify adverse events that are not well understood or previously recognized.	[Engler, Renata J. M.; Collins, Limone C., Jr.; Spooner, Christina] Walter Reed Natl Mil Med Ctr, Immunizat Healthcare Branch, Def Hlth Agcy, Mil Vaccine Agcy Vaccine Healthcare Ctr Network, Bethesda, MD 20889 USA; [Engler, Renata J. M.; Nelson, Michael R.] Uniformed Serv Univ Hlth Sci, Dept Med & Pediat, Bethesda, MD 20814 USA; [Nelson, Michael R.] Walter Reed Natl Mil Med Ctr, Allergy Immunol Immunizat, Bethesda, MD USA; [Hemann, Brian A.; Gibbs, Barnett T.; Atwood, J. Edwin] Walter Reed Natl Mil Med Ctr, Dept Med, Serv Cardiol, Bethesda, MD USA; [Hemann, Brian A.; Gibbs, Barnett T.; Atwood, J. Edwin] Uniformed Serv Univ Hlth Sci, Dept Med, Bethesda, MD 20814 USA; [Howard, Robin S.; Chang, Audrey S.] Walter Reed Natl Mil Med Ctr, Dept Res Programs, Bethesda, MD USA; [Cruser, Daniel L.] Vassar Bros Med Ctr, Dept Pathol, Poughkeepsie, NY USA; [Gates, Daniel G.] Ft Belvoir Community Hosp, Serv Cardiol, Ft Belvoir, VA USA; [Vernalis, Marina N.] Walter Reed Natl Mil Med Ctr, Integrated Cardiac Hlth Project, Bethesda, MD USA; [Lengkeek, Marguerite S.] Allergy & Asthma Care Ctr, Chantilly, VA USA; [McClenathan, Bruce M.] Womack Army Med Ctr, Def Hlth Agcy, Immunizat Healthcare Branch, Mil Vaccine Agcy Vaccine Healthcare Ctr Network, Ft Bragg, NC USA; [Jaffe, Allan S.; Cooper, Leslie T.] Mayo Clin, Div Cardiovasc Dis, Rochester, MN USA; [Black, Steve] Cincinnati Childrens Hosp Ctr Global Hlth, Cincinnati, OH USA; [Carlson, Christopher] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98104 USA; [Wilson, Christopher] Univ Washington, Dept Immunol, Seattle, WA 98195 USA; [Davis, Robert L.] Univ Tennessee, Ctr Hlth Sci, Ctr Biomed Informat, Memphis, TN 38163 USA; [Davis, Robert L.] Oak Ridge Natl Lab, Oak Ridge, TN USA	Walter Reed National Military Medical Center; Uniformed Services University of the Health Sciences - USA; Walter Reed National Military Medical Center; Walter Reed National Military Medical Center; Uniformed Services University of the Health Sciences - USA; Walter Reed National Military Medical Center; Walter Reed National Military Medical Center; United States Department of Defense; United States Army; Mayo Clinic; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; University of Tennessee System; University of Tennessee Health Science Center; United States Department of Energy (DOE); Oak Ridge National Laboratory	Engler, RJM (corresponding author), Walter Reed Natl Mil Med Ctr, Immunizat Healthcare Branch, Def Hlth Agcy, Mil Vaccine Agcy Vaccine Healthcare Ctr Network, Bethesda, MD 20889 USA.	renata.engler@gmail.com	Nelson, Michael Shawn/GXF-4934-2022	Cooper, Leslie/0000-0003-1002-3313	Centers for Disease Control and Prevention [200-2002-00732]; National Institute of Allergy and Infectious Disease Population Genetics Program [N01 AI40069]; Federal funds from the National Institute of Allergies and Infectious Diseases, National Institutes of Health, Department of Health and Human Services [HHSN272201000024C]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [N01AI040069] Funding Source: NIH RePORTER	Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); National Institute of Allergy and Infectious Disease Population Genetics Program; Federal funds from the National Institute of Allergies and Infectious Diseases, National Institutes of Health, Department of Health and Human Services; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by the Vaccine Healthcare Centers Network and Allergy-Immunology, Walter Reed Army Medical Center (Bethesda, MD)/Military Vaccine Agency, Office of the Army Surgeon General, Clinical Immunization Safety Assessment Network (Atlanta, GA) (subcontract with America's Health Insurance Plans under contract 200-2002-00732 from the Centers for Disease Control and Prevention), National Institute of Allergy and Infectious Disease Population Genetics Program (N01 AI40069). This project has been funded in part with Federal funds from the National Institute of Allergies and Infectious Diseases, National Institutes of Health, Department of Health and Human Services, under Contract No. HHSN272201000024C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHLBORG BJORN, 1966, ACTA MED SCAND SUPPL, V464, P127; Apple FS, 2003, CLIN CHEM, V49, P1331, DOI 10.1373/49.8.1331; Arness MK, 2004, AM J EPIDEMIOL, V160, P642, DOI 10.1093/aje/kwh269; Babuin L, 2008, CRIT CARE MED, V36, P759, DOI 10.1097/CCM.0B013E318164E2E4; Baggs J, 2005, CLIN INFECT DIS, V40, P1133, DOI 10.1086/428731; Baker P, 2014, EMERG MED J, V31, P374, DOI 10.1136/emermed-2012-201465; Cohen JI, 2010, J INFECT DIS, V201, P1183, DOI 10.1086/651453; Cramer GE, 2013, HEART, V99, P528, DOI 10.1136/heartjnl-2012-302829; de Lemos JA, 2013, JAMA-J AM MED ASSOC, V309, P2262, DOI 10.1001/jama.2013.5809; de Lemos JA, 2010, JAMA-J AM MED ASSOC, V304, P2503, DOI 10.1001/jama.2010.1768; de Meester A, 2000, CHEST, V117, P1803, DOI 10.1378/chest.117.6.1803; deFilippi CR, 2012, J AM COLL CARDIOL, V60, P2539, DOI 10.1016/j.jacc.2012.08.1006; Eckart RE, 2004, J AM COLL CARDIOL, V44, P201, DOI 10.1016/j.jacc.2004.05.004; Eckart RE, 2007, VACCINE, V25, P8359, DOI 10.1016/j.vaccine.2007.09.064; Elizaga ML, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054407; Falkensammer J, 2012, CLIN CHIM ACTA, V413, P1678, DOI 10.1016/j.cca.2012.05.014; Friman G, 1999, EUR HEART J, V20, P1063, DOI 10.1053/euhj.1999.1640; Haim M, 2000, MIL MED, V165, P287, DOI 10.1093/milmed/165.4.287; Harper RW, 2010, J AM COLL CARDIOL, V56, P2145, DOI 10.1016/j.jacc.2010.08.618; Jacobson IG, 2008, VACCINE, V26, P4048, DOI 10.1016/j.vaccine.2008.05.044; Kao CD, 2004, CLIN NEUROL NEUROSUR, V106, P136, DOI 10.1016/j.clineuro.2003.11.002; KARJALAINEN J, 1983, ACTA MED SCAND, V213, P65; Lane JM, 2003, ANN INTERN MED, V138, P488, DOI 10.7326/0003-4819-138-6-200303180-00014; Lauer B, 1997, J AM COLL CARDIOL, V30, P1354, DOI 10.1016/S0735-1097(97)00317-3; Libby P, 2013, IMMUNITY, V38, P1092, DOI 10.1016/j.immuni.2013.06.009; Mascaro-Blanco A, 2008, AUTOIMMUNITY, V41, P442, DOI 10.1080/08916930802031579; McMahon AW, 2007, PHARMACOEPIDEM DR S, V16, P597, DOI 10.1002/pds.1349; Montgomery Jay R, 2012, MSMR, V19, P6; Morgan J, 2008, CLIN INFECT DIS, V46, pS242, DOI 10.1086/524747; Nalca A, 2010, DRUG DES DEV THER, V4, P71; Oluleye OW, 2013, ANN EPIDEMIOL, V23, P66, DOI 10.1016/j.annepidem.2012.11.004; Pervanidou P, 2013, METABOLISM, V62, P527, DOI 10.1016/j.metabol.2012.09.012; Rautaharju PM, 2009, J AM COLL CARDIOL, V53, P982, DOI 10.1016/j.jacc.2008.12.014; Regwan S, 2010, J INTERV CARDIOL, V23, P443, DOI 10.1111/j.1540-8183.2010.00575.x; Reif DM, 2009, GENES IMMUN, V10, P112, DOI 10.1038/gene.2008.80; Reif DM, 2008, J INFECT DIS, V198, P16, DOI 10.1086/588670; Rose NR, 2011, J INTERF CYTOK RES, V31, P705, DOI 10.1089/jir.2011.0057; Sabatine MS, 2009, EUR HEART J, V30, P162, DOI 10.1093/eurheartj/ehn504; Sagar S, 2012, LANCET, V379, P738, DOI 10.1016/S0140-6736(11)60648-X; Sano J, 2009, AM J MED, V122, P79, DOI 10.1016/j.amjmed.2008.07.025; Shave R, 2010, J AM COLL CARDIOL, V56, P169, DOI 10.1016/j.jacc.2010.03.037; Smallpox Vaccine Doses Data obtained from the Armed Forces Health Surveillance Center, 2012, SMALLPOX VACCINE DOS; Sniadack MM, 2008, CLIN INFECT DIS, V46, pS251, DOI 10.1086/524741; Soongswang J, 2005, PEDIATR CARDIOL, V26, P45, DOI 10.1007/s00246-004-0677-6; Thygesen K, 2012, CIRCULATION, V126, P2020, DOI 10.1161/CIR.0b013e31826e1058; Thygesen K, 2010, EUR HEART J, V31, P2197, DOI 10.1093/eurheartj/ehq251; Tian Y, 2012, J APPL PHYSIOL, V113, P418, DOI 10.1152/japplphysiol.00247.2012; Varricchio F, 2004, PEDIATR INFECT DIS J, V23, P287, DOI 10.1097/00006454-200404000-00002; Wallace TW, 2006, CIRCULATION, V113, P1958, DOI 10.1161/CIRCULATIONAHA.105.609974; Zarich SW, 2004, CLIN CHIM ACTA, V343, P223, DOI 10.1016/j.cccn.2004.01.020	50	89	90	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0118283	10.1371/journal.pone.0118283	http://dx.doi.org/10.1371/journal.pone.0118283			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25793705	Green Submitted, Green Published, gold			2022-12-27	WOS:000352084200018
J	Hasegawa, Y; Suyama, Y; Seiwa, K				Hasegawa, Yoichi; Suyama, Yoshihisa; Seiwa, Kenji			Variation in Pollen-Donor Composition among Pollinators in an Entomophilous Tree Species, Castanea crenata, Revealed by Single-Pollen Genotyping	PLOS ONE			English	Article							BIPARENTAL INBREEDING DEPRESSION; FLORAL DISPLAY SIZE; MULTIPLE PATERNITY; COMPUTER-PROGRAM; GENE FLOW; PLANT; CONSEQUENCES; DISPERSAL; CARRYOVER; DISTANCE	Background In plants, reproductive success is largely determined by the composition of pollen (i.e., self-pollen and outcross-pollen from near and distant pollen-donors) transported as a result of pollinator foraging behavior (e.g., pollen carryover). However, little evidence is available on how and to what extent the pollen carryover affects the pollen-donor composition and on which insect taxa are effective outcross-pollen transporters under field conditions. In this study, we explored roles of foraging behavior of insect pollinators on pollen-donor composition and subsequent reproductive success in a woody plant. Methods We performed paternity analyses based on microsatellite genotyping of individual pollen grains found on diurnal pollinators (i.e., bumblebee, small bee, fly, small beetle, and honeybee) visiting Castanea crenata trees. Results The outcross-pollen rate was highest in bumblebees (66%), followed by small bees (35%), flies (31%), and small beetles (18%). The effective number of pollen donors, representing pollen carryover, was greater in bumblebees (9.71) than in flies (3.40), small bees (3.32), and small beetles (3.06). The high percentages of pollen from outside the plot on bumblebees (65.4%) and flies (71.2%) compared to small bees (35.3%) and small beetles (13.5%) demonstrated their longer pollen dispersal distances. Conclusions All of the diurnal insects carried outcross-pollen grains for long distances via pollen carryover. This fact suggests that a wide range of insect taxa are potential outcross-pollen transporters for the self-incompatible C. crenata.	[Hasegawa, Yoichi; Suyama, Yoshihisa; Seiwa, Kenji] Tohoku Univ, Grad Sch Agr Sci, Osaki, Miyagi, Japan; [Hasegawa, Yoichi] Akita Prefectural Univ, Inst Wood Technol, Noshiro, Akita, Japan	Tohoku University; Akita Prefectural University	Hasegawa, Y (corresponding author), Tohoku Univ, Grad Sch Agr Sci, Osaki, Miyagi, Japan.	yohase@gmail.com	Suyama, Yoshihisa/H-6115-2017	Suyama, Yoshihisa/0000-0002-3136-5489	Japan Society for the Promotion of Science [17380095]; Sasakawa Scientific Research Grant from the Japan Science Society; Grants-in-Aid for Scientific Research [25850113] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Sasakawa Scientific Research Grant from the Japan Science Society; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was financially supported by the Japan Society for the Promotion of Science (No. 17380095) to YS and a Sasakawa Scientific Research Grant from the Japan Science Society to YH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe H, 2011, SINGLE-POLLEN GENOTYPING, P47, DOI 10.1007/978-4-431-53901-8_5; Aigner PA, 2001, OIKOS, V95, P177, DOI 10.1034/j.1600-0706.2001.950121.x; Barthelmess EL, 2006, NEW PHYTOL, V169, P689, DOI 10.1111/j.1469-8137.2005.01580.x; Bascompte J, 2003, P NATL ACAD SCI USA, V100, P9383, DOI 10.1073/pnas.1633576100; Brunet J, 2009, MOL ECOL, V18, P3745, DOI 10.1111/j.1365-294X.2009.04304.x; Buck EJ, 2003, MOL ECOL NOTES, V3, P239, DOI 10.1046/j.1471-8286.2003.00410.x; Chifflet R, 2011, J APPL ECOL, V48, P689, DOI 10.1111/j.1365-2664.2010.01904.x; Cozzolino S, 2005, P ROY SOC B-BIOL SCI, V272, P1271, DOI 10.1098/rspb.2005.3069; de Oliveira D, 2001, ACTA HORTIC, P269, DOI 10.17660/ActaHortic.2001.561.40; DUDASH MR, 1991, AM J BOT, V78, P1746, DOI 10.2307/2444854; Farrington L, 2009, AUST J BOT, V57, P276, DOI 10.1071/BT08138; GALEN C, 1988, J THEOR BIOL, V135, P419, DOI 10.1016/S0022-5193(88)80257-1; Harder LD, 1998, ECOLOGY, V79, P2789, DOI 10.1890/0012-9658(1998)079[2789:TCOHTC]2.0.CO;2; Hardy OJ, 2002, MOL ECOL NOTES, V2, P618, DOI 10.1046/j.1471-8286.2002.00305.x; Hasegawa Y, 2009, NEW PHYTOL, V182, P994, DOI 10.1111/j.1469-8137.2009.02806.x; Herlihy CR, 2004, EVOLUTION, V58, P2693, DOI 10.1111/j.0014-3820.2004.tb01622.x; Herrera Carlos M., 1996, P65; Herrera CM, 2000, ECOLOGY, V81, P15, DOI 10.1890/0012-9658(2000)081[0015:FTSCOD]2.0.CO;2; HERRERA CM, 1987, OIKOS, V50, P79, DOI 10.2307/3565403; Heywood John S., 1993, American Journal of Botany, V80, P545, DOI [10.1002/j.1537-2197.1993.tb13838.x, 10.2307/2445370]; Hirao AS, 2006, MOL ECOL, V15, P1165, DOI 10.1111/j.1365-294X.2006.02853.x; Hirota SK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0085601; Holmquist KG, 2012, PLANT SPEC BIOL, V27, P77, DOI 10.1111/j.1442-1984.2011.00329.x; Indsto JO, 2006, AUST J BOT, V54, P669, DOI 10.1071/BT05146; Jaynes R. A., 1975, Advances in fruit breeding. Temperate nuts., P490; Jha S, 2010, P NATL ACAD SCI USA, V107, P13760, DOI 10.1073/pnas.1002490107; Johnson SD, 2000, TRENDS ECOL EVOL, V15, P140, DOI 10.1016/S0169-5347(99)01811-X; Kalinowski ST, 2007, MOL ECOL, V16, P1099, DOI 10.1111/j.1365-294X.2007.03089.x; Kamm U, 2009, HEREDITY, V103, P476, DOI 10.1038/hdy.2009.70; Karron JD, 2004, HEREDITY, V92, P242, DOI 10.1038/sj.hdy.6800402; KLINAC DJ, 1995, NEW ZEAL J CROP HORT, V23, P331, DOI 10.1080/01140671.1995.9513906; Kondo T, 2011, SINGLE-POLLEN GENOTYPING, P63, DOI 10.1007/978-4-431-53901-8_6; Lertzman K.P., 1983, P474; LOISELLE BA, 1995, AM J BOT, V82, P1420, DOI 10.2307/2445869; Marinoni D, 2003, MOL BREEDING, V11, P127, DOI 10.1023/A:1022456013692; Marshall TC, 1998, MOL ECOL, V7, P639, DOI 10.1046/j.1365-294x.1998.00374.x; Matsuki Y, 2007, MOL ECOL NOTES, V7, P194, DOI 10.1111/j.1471-8286.2006.01588.x; Matsuki Y, 2008, AM J BOT, V95, P925, DOI 10.3732/ajb.0800036; Matsuki Y, 2011, SINGLE-POLLEN GENOTYPING, P17, DOI 10.1007/978-4-431-53901-8_3; MEAGHER TR, 1986, AM NAT, V128, P199, DOI 10.1086/284554; Mitchell RJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076312; Mitchell RJ, 2009, ANN BOT-LONDON, V103, P1355, DOI 10.1093/aob/mcp122; MURAWSKI DA, 1986, OECOLOGIA, V68, P161, DOI 10.1007/BF00384782; NASON JD, 1995, EVOLUTION, V49, P307, DOI [10.1111/j.1558-5646.1995.tb02243.x, 10.2307/2410341]; Ohashi K, 1998, AM J BOT, V85, P219, DOI 10.2307/2446309; Ohashi K, 2009, ANN BOT-LONDON, V103, P1365, DOI 10.1093/aob/mcp088; RAMSEY MW, 1988, OECOLOGIA, V76, P119, DOI 10.1007/BF00379609; RITLAND K, 1989, EVOLUTION, V43, P848, DOI [10.2307/2409312, 10.1111/j.1558-5646.1989.tb05182.x]; ROBERTSON AW, 1992, BIOL J LINN SOC, V46, P333, DOI 10.1111/j.1095-8312.1992.tb00868.x; Sampson JF, 1998, HEREDITY, V81, P349, DOI 10.1046/j.1365-2540.1998.00404.x; Sasaki M, 2010, BEES VIEW FLOWERING; SCHEMSKE DW, 1984, SCIENCE, V225, P519, DOI 10.1126/science.225.4661.519; SEAVEY SR, 1986, BOT REV, V52, P195, DOI 10.1007/BF02861001; STEBBINS G. L., 1970, Annual review of ecology and systematics., V1, P307, DOI 10.1146/annurev.es.01.110170.001515; Suyama Y, 1996, GENES GENET SYST, V71, P145, DOI 10.1266/ggs.71.145; Suyama Y, 2011, SINGLE-POLLEN GENOTYPING, P7, DOI 10.1007/978-4-431-53901-8_2; Teixeira S, 2007, MOL ECOL, V16, P4370, DOI 10.1111/j.1365-294X.2007.03493.x; Wadl PA, 2009, HORTSCIENCE, V44, P1527; Wagenius S, 2010, EVOLUTION, V64, P761, DOI 10.1111/j.1558-5646.2009.00860.x; Waser NM, 1996, ECOLOGY, V77, P1043, DOI 10.2307/2265575; WASER NM, 1984, OECOLOGIA, V62, P262, DOI 10.1007/BF00379024; Widmer A, 2000, MOL ECOL, V9, P1911, DOI 10.1046/j.1365-294x.2000.01103.x; Wilson EE, 2010, MOL ECOL, V19, P4823, DOI 10.1111/j.1365-294X.2010.04849.x; WILSON P, 1991, ECOLOGY, V72, P1503, DOI 10.2307/1941124; Yamamoto T, 2003, J HORTIC SCI BIOTECH, V78, P197, DOI 10.1080/14620316.2003.11511606; Young HJ, 2002, AM J BOT, V89, P433, DOI 10.3732/ajb.89.3.433; Zhang BC, 2016, J BASIC MICROB, V56, P670, DOI 10.1002/jobm.201500751	67	22	25	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0120393	10.1371/journal.pone.0120393	http://dx.doi.org/10.1371/journal.pone.0120393			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25793619	Green Submitted, Green Published, gold			2022-12-27	WOS:000352083900024
J	Higgins, MA; Asner, GP; Anderson, CB; Martin, RE; Knapp, DE; Tupayachi, R; Perez, E; Elespuru, N; Alonso, A				Higgins, Mark A.; Asner, Gregory P.; Anderson, Christopher B.; Martin, Roberta E.; Knapp, David E.; Tupayachi, Raul; Perez, Eneas; Elespuru, Nydia; Alonso, Alfonso			Regional-Scale Drivers of Forest Structure and Function in Northwestern Amazonia	PLOS ONE			English	Article							RAIN-FOREST; IMAGING SPECTROSCOPY; TROPICAL FORESTS; FOOTPRINT LIDAR; PATTERNS; TREE; BIOMASS; SOILS; PTERIDOPHYTES; TURNOVER	Field studies in Amazonia have found a relationship at continental scales between soil fertility and broad trends in forest structure and function. Little is known at regional scales, however, about how discrete patterns in forest structure or functional attributes map onto underlying edaphic or geological patterns. We collected airborne LiDAR (Light Detection and Ranging) data and VSWIR (Visible to Shortwave Infrared) imaging spectroscopy measurements over 600 km(2) of northwestern Amazonian lowland forests. We also established 83 inventories of plant species composition and soil properties, distributed between two widespread geological formations. Using these data, we mapped forest structure and canopy reflectance, and compared them to patterns in plant species composition, soils, and underlying geology. We found that variations in soils and species composition explained up to 70% of variation in canopy height, and corresponded to profound changes in forest vertical profiles. We further found that soils and plant species composition explained more than 90% of the variation in canopy reflectance as measured by imaging spectroscopy, indicating edaphic and compositional control of canopy chemical properties. We last found that soils explained between 30% and 70% of the variation in gap frequency in these forests, depending on the height threshold used to define gaps. Our findings indicate that a relatively small number of edaphic and compositional variables, corresponding to underlying geology, may be responsible for variations in canopy structure and chemistry over large expanses of Amazonian forest.	[Higgins, Mark A.; Asner, Gregory P.; Anderson, Christopher B.; Martin, Roberta E.; Knapp, David E.; Tupayachi, Raul] Carnegie Inst Sci, Dept Global Ecol, Stanford, CA 94305 USA; [Perez, Eneas; Elespuru, Nydia] Univ Nacl Amazonia Peruana, Fac Ciencias Biol, Iquitos, Peru; [Alonso, Alfonso] Smithsonian Conservat Biol Inst, Ctr Conservat Educ & Sustainabil, Washington, DC USA	Carnegie Institution for Science; Universidad Nacional de la Amazonia Peruana; Smithsonian Institution; Smithsonian National Zoological Park & Conservation Biology Institute	Asner, GP (corresponding author), Carnegie Inst Sci, Dept Global Ecol, Stanford, CA 94305 USA.	gpa@stanford.edu	Tupayachi, Raul/F-3986-2011; Asner, Gregory/G-9268-2013; Martin, Roberta/A-5073-2015	Tupayachi, Raul/0000-0002-4661-2075; Asner, Gregory/0000-0001-7893-6421; Martin, Roberta/0000-0003-3509-8530; Anderson, Christopher/0000-0001-7392-4368	Carnegie Institution for Science (USA); National Science Foundation (USA); American-Scandinavian Foundation (USA); Duke University (USA)	Carnegie Institution for Science (USA); National Science Foundation (USA)(National Science Foundation (NSF)); American-Scandinavian Foundation (USA); Duke University (USA)	This work was supported by the Carnegie Institution for Science (USA; www.carnegiescience.edu), Fellowship support to MAH. Grant number not available. This work was also supported by the National Science Foundation (USA; www.nsf.gov), Fellowship support to MAH. Grant number not available. This study was further supported by the American-Scandinavian Foundation (USA; www.amscan.org), Fellowship support to MAH. Grant number not available. Finally, the study was supported by Duke University (USA; www.duke.edu), Small travel grant to MAH. Grant numbers not available. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Sanchez-Azofeifa GA, 2009, REMOTE SENS ENVIRON, V113, P2076, DOI 10.1016/j.rse.2009.05.013; Asner GP, 2013, BIOGEOSCI DISCUSS, V10, P15415; Asner GP, 2007, J APPL REMOTE SENS, V1, DOI 10.1117/1.2794018; Asner GP, 2008, REMOTE SENS ENVIRON, V112, P3958, DOI 10.1016/j.rse.2008.07.003; Asner GP, 2015, REMOTE SENS ENVIRON, V158, P15, DOI 10.1016/j.rse.2014.11.011; Asner GP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060875; Asner GP, 2012, REMOTE SENS ENVIRON, V124, P454, DOI 10.1016/j.rse.2012.06.012; Asner GP, 2012, OECOLOGIA, V168, P1147, DOI 10.1007/s00442-011-2165-z; Asner GP, 2011, REMOTE SENS ENVIRON, V115, P3587, DOI 10.1016/j.rse.2011.08.020; Asner GP, 2011, NEW PHYTOL, V189, P999, DOI 10.1111/j.1469-8137.2010.03549.x; Asner GP, 2010, P NATL ACAD SCI USA, V107, P16738, DOI 10.1073/pnas.1004875107; Baker TR, 2004, GLOBAL CHANGE BIOL, V10, P545, DOI 10.1111/j.1365-2486.2004.00751.x; Baldeck CA, 2013, REMOTE SENS-BASEL, V5, P2057, DOI 10.3390/rs5052057; Botschek J, 1996, GEODERMA, V72, P119, DOI 10.1016/0016-7061(96)00026-2; Clark DB, 2000, FOREST ECOL MANAG, V137, P185, DOI 10.1016/S0378-1127(99)00327-8; Clark ML, 2012, REMOTE SENS-BASEL, V4, P1820, DOI 10.3390/rs4061820; Clark ML, 2011, REMOTE SENS ENVIRON, V115, P2931, DOI 10.1016/j.rse.2010.08.029; Colgan MS, 2012, REMOTE SENS-BASEL, V4, P3462, DOI 10.3390/rs4113462; Drake JB, 2002, REMOTE SENS ENVIRON, V81, P378, DOI 10.1016/S0034-4257(02)00013-5; Feret JB, 2012, REMOTE SENS-BASEL, V4, P2457, DOI 10.3390/rs4082457; Fine PVA, 2004, SCIENCE, V305, P663, DOI 10.1126/science.1098982; Higgins MA, 2004, CONSERV BIOL, V18, P799, DOI 10.1111/j.1523-1739.2004.00235.x; Higgins MA, 2014, REMOTE SENS ENVIRON, V154, P358, DOI 10.1016/j.rse.2013.09.032; Higgins MA, 2011, J BIOGEOGR, V38, P2136, DOI 10.1111/j.1365-2699.2011.02585.x; Higgins MA, 2012, REMOTE SENS-BASEL, V4, P2401, DOI 10.3390/rs4082401; INGEMMET, 2000, MAP GEOL PER; Jones MM, 2013, J ECOL, V101, P506, DOI 10.1111/1365-2745.12053; Kellner JR, 2011, ECOSYSTEMS, V14, P1156, DOI 10.1007/s10021-011-9472-4; Kellner JR, 2009, ECOL LETT, V12, P887, DOI 10.1111/j.1461-0248.2009.01345.x; Kellner JR, 2009, ECOL LETT, V12, P155, DOI 10.1111/j.1461-0248.2008.01274.x; Kokaly RF, 2009, REMOTE SENS ENVIRON, V113, pS78, DOI 10.1016/j.rse.2008.10.018; Malhi Y, 2004, GLOBAL CHANGE BIOL, V10, P563, DOI 10.1111/j.1529-8817.2003.00778.x; Malhi Y, 2006, GLOBAL CHANGE BIOL, V12, P1107, DOI 10.1111/j.1365-2486.2006.01120.x; Mascaro J, 2011, BIOGEOSCIENCES, V8, P1615, DOI 10.5194/bg-8-1615-2011; Myneni RB, 1997, IEEE T GEOSCI REMOTE, V35, P1380, DOI 10.1109/36.649788; Phillips OL, 2003, J ECOL, V91, P757, DOI 10.1046/j.1365-2745.2003.00815.x; Phillips OL, 2004, PHILOS T R SOC B, V359, P381, DOI 10.1098/rstb.2003.1438; Quesada CA, 2012, BIOGEOSCIENCES, V9, P2203, DOI 10.5194/bg-9-2203-2012; Quesada CA, 2011, BIOGEOSCIENCES, V8, P1415, DOI 10.5194/bg-8-1415-2011; Ruokolainen K, 1997, J TROP ECOL, V13, P243, DOI 10.1017/S0266467400010439; Ruokolainen K, 2007, J TROP ECOL, V23, P13, DOI 10.1017/S0266467406003889; SANCHEZ PA, 1974, SOIL SCI SOC AM J, V38, P117, DOI 10.2136/sssaj1974.03615995003800010036x; ter Steege H, 2006, NATURE, V443, P444, DOI 10.1038/nature05134; Thiers B., INDEX HERBARIORUM GL; Toomey M, 2009, REMOTE SENS ENVIRON, V113, P1787, DOI 10.1016/j.rse.2009.04.002; Tuomisto H, 2003, J ECOL, V91, P743, DOI 10.1046/j.1365-2745.2003.00802.x; TUOMISTO H, 1995, SCIENCE, V269, P63, DOI 10.1126/science.269.5220.63; Tuomisto H, 2003, SCIENCE, V299, P241, DOI 10.1126/science.1078037; Ustin SL, 2009, REMOTE SENS ENVIRON, V113, pS67, DOI 10.1016/j.rse.2008.10.019; Vitousek P, 2009, ECOLOGY, V90, P3074, DOI 10.1890/08-0813.1; WESSMAN CA, 1988, NATURE, V335, P154, DOI 10.1038/335154a0	51	15	17	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0119887	10.1371/journal.pone.0119887	http://dx.doi.org/10.1371/journal.pone.0119887			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25793602	Green Published, Green Submitted, gold			2022-12-27	WOS:000352084200125
J	Holloway, DM; Spirov, AV				Holloway, David M.; Spirov, Alexander V.			Mid-Embryo Patterning and Precision in Drosophila Segmentation: Kruppel Dual Regulation of hunchback	PLOS ONE			English	Article							GENE-EXPRESSION; GAP GENES; POSITIONAL INFORMATION; MORPHOGEN GRADIENT; REACTION-DIFFUSION; SHARP BORDERS; HOX PRO; TRANSCRIPTION; REPRESSION; ACTIVATION	In early development, genes are expressed in spatial patterns which later define cellular identities and tissue locations. The mechanisms of such pattern formation have been studied extensively in early Drosophila (fruit fly) embryos. The gap gene hunchback (hb) is one of the earliest genes to be expressed in anterior-posterior (AP) body segmentation. As a transcriptional regulator for a number of downstream genes, the spatial precision of hb expression can have significant effects in the development of the body plan. To investigate the factors contributing to hb precision, we used fine spatial and temporal resolution data to develop a quantitative model for the regulation of hb expression in the mid-embryo. In particular, modelling hb pattern refinement in mid nuclear cleavage cycle 14 (NC14) reveals some of the regulatory contributions of simultaneously-expressed gap genes. Matching the model to recent data from wild-type (WT) embryos and mutants of the gap gene Kruppel (Kr) indicates that a mid-embryo Hb concentration peak important in thoracic development (at parasegment 4, PS4) is regulated in a dual manner by Kr, with low Kr concentration activating hb and high Kr concentration repressing hb. The processes of gene expression (transcription, translation, transport) are intrinsically random. We used stochastic simulations to characterize the noise generated in hb expression. We find that Kr regulation can limit the positional variability of the Hb mid-embryo border. This has been recently corroborated in experimental comparisons of WT and Kr-mutant embryos. Further, Kr regulation can decrease uncertainty in mid-embryo hb expression (i.e. contribute to a smooth Hb boundary) and decrease between-copy transcriptional variability within nuclei. Since many tissue boundaries are first established by interactions between neighbouring gene expression domains, these properties of Hb-Kr dynamics to diminish the effects of intrinsic expression noise may represent a general mechanism contributing to robustness in early development.	[Holloway, David M.] British Columbia Inst Technol, Dept Math, Burnaby, BC V5G 3H2, Canada; [Spirov, Alexander V.] SUNY Stony Brook, Comp Sci, Stony Brook, NY 11794 USA; [Spirov, Alexander V.] SUNY Stony Brook, Ctr Excellence Wireless & Informat Technol, Stony Brook, NY 11794 USA; [Spirov, Alexander V.] IM Sechenov Evolutionary Physiol & Biochem Inst, St Petersburg 194223, Russia	British Columbia Institute of Technology; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; North-Western State Medical University named after I.I. Mechnikov; Russian Academy of Sciences; Sechenov Institute of Evolutionary Physiology & Biochemistry	Holloway, DM (corresponding author), British Columbia Inst Technol, Dept Math, Burnaby, BC V5G 3H2, Canada.	David_Holloway@bcit.ca	Spirov, Alexander V/G-4806-2010; Holloway, David/B-1075-2015	Spirov, Alexander V/0000-0002-0509-6203; Holloway, David/0000-0002-3865-0725	United States National Institutes of Health [R01-GM072022]; Russian Foundation for Basic Research [13-04-02137]; Dynasty Foundation [NG13-083]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072022, R56GM072022] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Dynasty Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the United States National Institutes of Health (www.nih.gov), grant R01-GM072022 (to DMH AVS); the Russian Foundation for Basic Research (www.rfbr.ru/rffi/eng), grant 13-04-02137 (to AVS); and The Dynasty Foundation (www.dynastyfdn.com/english/), grant NG13-083 (to AVS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Arish A, 2010, BIOPHYS J, V99, pL33, DOI 10.1016/j.bpj.2010.05.031; Alves F, 2006, J THEOR BIOL, V241, P342, DOI 10.1016/j.jtbi.2005.11.034; Ay A, 2011, CRIT REV BIOCHEM MOL, V46, P137, DOI 10.3109/10409238.2011.556597; Bauer DC, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-366; Bergmann S, 2007, PLOS BIOL, V5, P232, DOI 10.1371/journal.pbio.0050046; Bieler J, 2011, BIOPHYS J, V101, P287, DOI 10.1016/j.bpj.2011.05.060; Bolouri H, 2003, P NATL ACAD SCI USA, V100, P9371, DOI 10.1073/pnas.1533293100; Bonneton F, 1997, MECH DEVELOP, V66, P143, DOI 10.1016/S0925-4773(97)00100-7; Carey LB, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001528; Chen HT, 2012, CELL, V149, P618, DOI 10.1016/j.cell.2012.03.018; Clyde DE, 2003, NATURE, V426, P849, DOI 10.1038/nature02189; DRIEVER W, 1989, NATURE, V340, P363, DOI 10.1038/340363a0; DRIEVER W, 1989, NATURE, V337, P138, DOI 10.1038/337138a0; Dubuis JO, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2012.72; Elf J., 2004, Systems Biology, V1, P230, DOI 10.1049/sb:20045021; Elf J, 2003, P SOC PHOTO-OPT INS, V5110, P114, DOI 10.1117/12.497009; Ephrussi A, 2004, CELL, V116, P143, DOI 10.1016/S0092-8674(04)00037-6; Garcia HG, 2013, CURR BIOL, V23, P2140, DOI 10.1016/j.cub.2013.08.054; GIERER A, 1972, KYBERNETIK, V12, P30, DOI 10.1007/BF00289234; Gray S, 1996, GENE DEV, V10, P700, DOI 10.1101/gad.10.6.700; Gregor T, 2007, CELL, V130, P153, DOI 10.1016/j.cell.2007.05.025; Hardway H, 2008, J THEOR BIOL, V254, P390, DOI 10.1016/j.jtbi.2008.05.021; Hattne J, 2005, BIOINFORMATICS, V21, P2923, DOI 10.1093/bioinformatics/bti431; He F, 2008, DEV CELL, V15, P558, DOI 10.1016/j.devcel.2008.09.004; He F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060876; He F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019122; He X, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000935; HOCH M, 1991, EMBO J, V10, P2267, DOI 10.1002/j.1460-2075.1991.tb07763.x; Holloway DM, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001069; Holloway DM, 2002, TRENDS GENET, V18, P385, DOI 10.1016/S0168-9525(02)02724-5; Holloway DM, 1999, MATH BIOSCI, V156, P271, DOI 10.1016/S0025-5564(98)10070-6; Houchmandzadeh B, 2002, NATURE, V415, P798, DOI 10.1038/415798a; Howard M, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.208103; HULSKAMP M, 1990, NATURE, V346, P577, DOI 10.1038/346577a0; HULSKAMP M, 1991, BIOESSAYS, V13, P261, DOI 10.1002/bies.950130602; Ilsley GR, 2013, ELIFE, V2, DOI 10.7554/eLife.00522; JACKLE H, 1986, NATURE, V324, P668, DOI 10.1038/324668a0; Jaeger J, 2004, GENETICS, V167, P1721, DOI 10.1534/genetics.104.027334; Jaeger J, 2004, NATURE, V430, P368, DOI 10.1038/nature02678; Jaeger J, 2009, MOL BIOSYST, V5, P1549, DOI 10.1039/b904722k; Janssens H, 2006, NAT GENET, V38, P1159, DOI 10.1038/ng1886; Kozlov K, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002635; KRAUT R, 1991, DEVELOPMENT, V111, P601; KRAUT R, 1991, DEVELOPMENT, V111, P611; Lacalli T.C., 1991, Seminars in Developmental Biology, V2, P107; Little SC, 2013, CELL, V154, P789, DOI 10.1016/j.cell.2013.07.025; Liu JB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062641; Lopes FJP, 2012, DEV BIOL, V370, P165, DOI 10.1016/j.ydbio.2012.07.020; Lopes FJP, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000184; Lucas T, 2013, CURR BIOL, V23, P2135, DOI 10.1016/j.cub.2013.08.053; Manu, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000303; MANU, 2009, PLOS COMPUT BIOL, V5, P53908, DOI DOI 10.1371/JOURNAL.PBIO.1000049; MARGOLIS JS, 1995, DEVELOPMENT, V121, P3067; McGregor AP, 2001, EVOL DEV, V3, P397, DOI 10.1046/j.1525-142X.2001.01043.x; McGregor AP, 2001, DEV GENES EVOL, V211, P315, DOI 10.1007/s004270100148; Okabe-Oho Y, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000486; Papatsenko D, 2008, P NATL ACAD SCI USA, V105, P2901, DOI 10.1073/pnas.0711941105; Papatsenko D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021145; Pare A, 2009, CURR BIOL, V19, P2037, DOI 10.1016/j.cub.2009.10.028; Perkins TJ, 2006, PLOS COMPUT BIOL, V2, P417, DOI 10.1371/journal.pcbi.0020051; Perry MW, 2012, CURR BIOL, V22, P2247, DOI 10.1016/j.cub.2012.09.051; Perry MW, 2011, P NATL ACAD SCI USA, V108, P13570, DOI 10.1073/pnas.1109873108; Porcher A, 2010, DEVELOPMENT, V137, P2795, DOI 10.1242/dev.051300; RiveraPomar R, 1996, TRENDS GENET, V12, P478, DOI 10.1016/0168-9525(96)10044-5; Samee MA, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003467; Sanchez L, 2001, J THEOR BIOL, V211, P115, DOI 10.1006/jtbi.2001.2335; SAUER F, 1993, NATURE, V364, P454, DOI 10.1038/364454a0; SAUER F, 1991, NATURE, V353, P563, DOI 10.1038/353563a0; Sauer F, 1996, PHILOS T ROY SOC B, V351, P579, DOI 10.1098/rstb.1996.0057; SCHRODER C, 1988, EMBO J, V7, P2881, DOI 10.1002/j.1460-2075.1988.tb03145.x; SCHULZ C, 1994, DEVELOPMENT, V120, P3043; Sokolowski TR, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002654; Spirov AV, 2000, NUCLEIC ACIDS RES, V28, P337, DOI 10.1093/nar/28.1.337; Spirov AV, 2002, NUCLEIC ACIDS RES, V30, P351, DOI 10.1093/nar/30.1.351; Surkova S, 2013, DEV BIOL, V376, P99, DOI 10.1016/j.ydbio.2013.01.008; TREISMAN J, 1989, NATURE, V341, P335, DOI 10.1038/341335a0; Umulis D, 2008, CURR TOP DEV BIOL, V81, P65, DOI 10.1016/S0070-2153(07)81002-7; WOLPERT L, 1969, J THEOR BIOL, V25, P1, DOI 10.1016/S0022-5193(69)80016-0; Wu XL, 2001, DEV BIOL, V237, P79, DOI 10.1006/dbio.2001.0355; Yu D, 2008, CURR BIOL, V18, P868, DOI 10.1016/j.cub.2008.05.050; Zagrijchuk EA, 2014, J BIOINF COMPUT BIOL, V12, DOI 10.1142/S0219720014410091; Zamparo L, 2009, BIOINFORMATICS, V25, P2670, DOI 10.1093/bioinformatics/btp415; ZUO P, 1991, GENE DEV, V5, P254, DOI 10.1101/gad.5.2.254	83	14	15	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0118450	10.1371/journal.pone.0118450	http://dx.doi.org/10.1371/journal.pone.0118450			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25793381	Green Published, gold, Green Submitted			2022-12-27	WOS:000352084200024
J	Horiuchi, H; Parajuli, B; Wang, Y; Azuma, YT; Mizuno, T; Takeuchi, H; Suzumura, A				Horiuchi, Hiroshi; Parajuli, Bijay; Wang, Yue; Azuma, Yasu-Taka; Mizuno, Tetsuya; Takeuchi, Hideyuki; Suzumura, Akio			Interleukin-19 Acts as a Negative Autocrine Regulator of Activated Microglia	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; INTERFERON-GAMMA; CUTTING EDGE; IL-19; EXPRESSION; CYTOKINES; FAMILY; HEMICHANNELS; BRAIN; IL-20	Activated microglia can exert either neurotoxic or neuroprotective effects, and they play pivotal roles in the pathogenesis and progression of various neurological diseases. In this study, we used cDNA microarrays to show that interleukin-19 (IL-19), an IL-10 family cytokine, is markedly upregulated in activated microglia. Furthermore, we found that microglia are the only cells in the nervous system that express the IL-19 receptor, a heterodimer of the IL-20R alpha and IL-20R beta subunits. IL-19 deficiency increased the production of such pro-inflammatory cytokines as IL-6 and tumor necrosis factor-alpha in activated microglia, and IL-19 treatment suppressed this effect. Moreover, in a mouse model of Alzheimer's disease, we observed upregulation of IL-19 in affected areas in association with disease progression. Our findings demonstrate that IL-19 is an anti-inflammatory cytokine, produced by activated microglia, that acts negatively on microglia in an autocrine manner. Thus, microglia may self-limit their inflammatory response by producing the negative regulator IL-19.	[Horiuchi, Hiroshi; Parajuli, Bijay; Wang, Yue; Mizuno, Tetsuya; Takeuchi, Hideyuki; Suzumura, Akio] Nagoya Univ, Environm Med Res Inst, Dept Neuroimmunol, Chikusa Ku, Nagoya, Aichi 4648601, Japan; [Azuma, Yasu-Taka] Osaka Prefecture Univ, Grad Sch Life & Environm Sci, Lab Vet Pharmacol, Div Vet Sci, Osaka 5988531, Japan	Nagoya University; Osaka Metropolitan University	Takeuchi, H (corresponding author), Nagoya Univ, Environm Med Res Inst, Dept Neuroimmunol, Chikusa Ku, Furo Cho, Nagoya, Aichi 4648601, Japan.	htake@riem.nagoya-u.ac.jp	Parajuli, Bijay/G-2961-2015; Bijay, Parajuli/AAT-5590-2021	Parajuli, Bijay/0000-0003-3813-113X; Takeuchi, Hideyuki/0000-0001-5912-7581; Horiuchi, Hiroshi/0000-0001-9008-2027; Azuma, Yasu-Taka/0000-0002-3515-171X	Ministry of Health, Labour and Welfare of Japan; Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (NIBIO) of Japan	Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (NIBIO) of Japan(National Institute of Biomedical Innovation)	This work was supported by a grant-in-aid for Scientific Research on Innovative Areas; grants from the Ministry of Health, Labour and Welfare of Japan; and the Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (NIBIO) of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azuma YT, 2010, INFLAMM BOWEL DIS, V16, P1017, DOI 10.1002/ibd.21151; Block ML, 2007, NAT REV NEUROSCI, V8, P57, DOI 10.1038/nrn2038; Boche D, 2013, NEUROPATH APPL NEURO, V39, P3, DOI 10.1111/nan.12011; Borchelt DR, 1997, NEURON, V19, P939, DOI 10.1016/S0896-6273(00)80974-5; Bruijn LI, 2004, ANNU REV NEUROSCI, V27, P723, DOI 10.1146/annurev.neuro.27.070203.144244; Cagnin A, 2001, LANCET, V358, P461, DOI 10.1016/S0140-6736(01)05625-2; Cooley ID, 2014, GLIA, V62, P818, DOI 10.1002/glia.22644; Cuneo AA, 2010, J MOL CELL CARDIOL, V49, P647, DOI 10.1016/j.yjmcc.2010.04.016; Doi Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061988; Dumoutier L, 2001, J IMMUNOL, V167, P3545, DOI 10.4049/jimmunol.167.7.3545; Eikelenboom P, 2002, GLIA, V40, P232, DOI 10.1002/glia.10146; Ellison S, 2014, AM J PATHOL, V184, P2134, DOI 10.1016/j.ajpath.2014.04.001; Fickenscher H, 2002, TRENDS IMMUNOL, V23, P89, DOI 10.1016/S1471-4906(01)02149-4; Gallagher G, 2000, GENES IMMUN, V1, P442, DOI 10.1038/sj.gene.6363714; Hsing CH, 2008, SHOCK, V29, P7, DOI 10.1097/shk.0b013e318067de40; Hsing CH, 2006, ANN THORAC SURG, V81, P2196, DOI 10.1016/j.athoracsur.2006.01.092; Hsing CH, 2008, CYTOKINE, V44, P221, DOI 10.1016/j.cyto.2008.06.007; Jimenez S, 2008, J NEUROSCI, V28, P11650, DOI 10.1523/JNEUROSCI.3024-08.2008; Kawanokuchi J, 2006, MULT SCLER J, V12, P558, DOI 10.1177/1352458506070763; Kawanokuchi J, 2008, J NEUROIMMUNOL, V194, P54, DOI 10.1016/j.jneuroim.2007.11.006; Kempermann G, 2003, SCIENCE, V302, P1689, DOI 10.1126/science.1092864; Kreutzberg GW, 1996, TRENDS NEUROSCI, V19, P312, DOI 10.1016/0166-2236(96)10049-7; Liang JF, 2008, BRAIN RES, V1210, P11, DOI 10.1016/j.brainres.2008.03.012; Liao SC, 2004, J IMMUNOL, V173, P6712, DOI 10.4049/jimmunol.173.11.6712; Liao YC, 2002, J IMMUNOL, V169, P4288, DOI 10.4049/jimmunol.169.8.4288; McGeer PL, 2002, MUSCLE NERVE, V26, P459, DOI 10.1002/mus.10191; Menon R, 2006, J MATERN-FETAL NEO M, V19, P209, DOI 10.1080/14767050500440986; Nakanishi H, 2009, BEHAV BRAIN RES, V201, P1, DOI 10.1016/j.bbr.2009.02.001; Nelson PT, 2002, ANN MED, V34, P491, DOI 10.1080/078538902321117698; Novak JP, 2002, J BIOL CHEM, V277, P47517, DOI 10.1074/jbc.M205114200; Orellana JA, 2009, ANTIOXID REDOX SIGN, V11, P369, DOI 10.1089/ars.2008.2130; Orr CF, 2002, PROG NEUROBIOL, V68, P325, DOI 10.1016/S0301-0082(02)00127-2; Pavese N, 2006, NEUROLOGY, V66, P1638, DOI 10.1212/01.wnl.0000222734.56412.17; Preimel D, 2004, J MOL MODEL, V10, P290, DOI 10.1007/s00894-004-0195-8; Sabat R, 2007, EXPERT OPIN THER TAR, V11, P601, DOI 10.1517/14728222.11.5.601; Sakurai N, 2008, RHEUMATOLOGY, V47, P815, DOI 10.1093/rheumatology/ken061; Sawada M, 1999, J NEUROCHEM, V72, P1466, DOI 10.1046/j.1471-4159.1999.721466.x; Sawada M, 2009, PARKINSONISM RELAT D, V15, pS39, DOI 10.1016/S1353-8020(09)70011-2; Sonobe Y, 2005, BRAIN RES, V1040, P202, DOI 10.1016/j.brainres.2005.01.100; SUZUMURA A, 1987, J NEUROIMMUNOL, V15, P263, DOI 10.1016/0165-5728(87)90121-4; Takeuchi H, 2006, NEUROBIOL DIS, V22, P33, DOI 10.1016/j.nbd.2005.09.014; Takeuchi H, 2005, J BIOL CHEM, V280, P10444, DOI 10.1074/jbc.M413863200; Takeuchi H., 2010, CLIN EXP NEUROIMMUNO, V1, P12, DOI [10.1111/j.1759-1961.2009.00001.x, DOI 10.1111/J.1759-1961.2009.00001.X]; Takeuchi H, 2006, J BIOL CHEM, V281, P21362, DOI 10.1074/jbc.M600504200; Takeuchi H, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00189; Takeuchi H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021108; Wang XS, 2007, J INTERF CYTOK RES, V27, P599, DOI 10.1089/jir.2006.0157; Wolk K, 2002, J IMMUNOL, V168, P5397, DOI 10.4049/jimmunol.168.11.5397	48	23	25	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0118640	10.1371/journal.pone.0118640	http://dx.doi.org/10.1371/journal.pone.0118640			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25794104	Green Published, gold, Green Submitted			2022-12-27	WOS:000352084200031
J	Hwang, JC; Jiang, MY; Lu, YH; Wang, CT				Hwang, Jyh-Chang; Jiang, Ming-Yan; Lu, Yi-Hua; Wang, Charn-Ting			Precedent Fluctuation of Serum hs-CRP to Albumin Ratios and Mortality Risk of Clinically Stable Hemodialysis Patients	PLOS ONE			English	Article							C-REACTIVE PROTEIN; CHRONIC KIDNEY-DISEASE; PERITONEAL-DIALYSIS PATIENTS; INFLAMMATION; MALNUTRITION; NUTRITION	Background A high sensitivity C-reactive protein to albumin ratio (hs-CRP/Alb) predicts mortality risk in patients with acute kidney injury. However, it varies dynamically. This study was conducted to evaluate whether a variation of this marker was associated with long-term outcome in clinically stable hemodialysis (HD) patients. Methods hs-CRP/Alb was checked bimonthly in 284 clinically stable HD outpatients throughout all of 2008. Based on the "slope" of trend equation derived from 5-6 hs-CRP/alb ratios for each patient, the total number of patients was divided into quartiles-Group 1: beta <=-0.13, n = 71; group 2: beta>-0.13 <= 0.003; n = 71, group 3: beta>0.003 <= 0.20; and group 4: beta>0.20, n = 71. The observation period was from January 1, 2009 to August 31, 2012. Results Group 1+4 showed a worse long-term survival (p = 0.04) and a longer 5-year hospitalization stay than Group 2+3 (38.7 +/- 44.4 vs. 16.7 +/- 22.4 days, p<0.001). Group 1+4 were associated with older age (OR = 1.03, 95% CI = 1.01-1.05) and a high prevalence of congestive heart failure (OR = 2.02, 95% CI = 1.00-4.11). Standard deviation (SD) of hs-CRP/Alb was associated with male sex (beta = 0.17, p = 0.003), higher Davies co-morbidity score (beta = 0.16, p = 0.03), and baseline hs-CRP (beta = 0.39, p<0.001). Patients with lower baseline and stable trend of hs-CRP/Alb had a better prognosis. By multivariate Cox proportional methods, SD of hs-CRP/alb (HR: 1.05, 95% CI: 1.01-1.08) rather than baseline hs-CRP/Alb was an independent predictive factor for long-term mortality after adjusting for sex and HD vintage. Conclusion Clinically stable HD patients with a fluctuating variation of hs-CRP/Alb are characterized by old age, and more co-morbidity, and they tend to have longer subsequent hospitalization stay and higher mortality risk.	[Hwang, Jyh-Chang; Jiang, Ming-Yan; Lu, Yi-Hua; Wang, Charn-Ting] Chi Mei Med Ctr, Div Nephrol, Tainan, Taiwan; [Hwang, Jyh-Chang] Chia Nan Univ Pharm & Sci, Dept Hosp & Hlth Care Adm, Tainan, Taiwan	Chi Mei Hospital; Chia Nan University of Pharmacy & Science	Hwang, JC (corresponding author), Chi Mei Med Ctr, Div Nephrol, Tainan, Taiwan.	alfonjch@seed.net.tw						Barreto DV, 2010, KIDNEY INT, V77, P550, DOI 10.1038/ki.2009.503; Cooper BA, 2004, AM J KIDNEY DIS, V43, P61, DOI 10.1053/j.ajkd.2003.08.045; DAVIES SJ, 1995, AM J KIDNEY DIS, V26, P353, DOI 10.1016/0272-6386(95)90657-6; DEVILLOTA ED, 1980, INTENS CARE MED, V7, P19, DOI 10.1007/BF01692917; Don BR, 2004, SEMIN DIALYSIS, V17, P432, DOI 10.1111/j.0894-0959.2004.17603.x; Ikizler TA, 2013, KIDNEY INT, V84, P1096, DOI 10.1038/ki.2013.147; Jindal KK, 1988, SEMIN DIALYSIS, V1, P82, DOI DOI 10.1111/J.1525-139X.1988.TB00710.X; Kalantar-Zadeh K, 2003, AM J KIDNEY DIS, V42, P864, DOI 10.1016/j.ajkd.2003.07.016; Kaptoge S, 2010, LANCET, V375, P132, DOI 10.1016/S0140-6736(09)61717-7; Menon V, 2003, AM J KIDNEY DIS, V42, P44, DOI 10.1016/S0272-6386(03)00407-4; Panichi V, 2008, NEPHROL DIAL TRANSPL, V23, P2337, DOI 10.1093/ndt/gfm951; Ranzani OT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059321; Snaedal S, 2009, AM J KIDNEY DIS, V53, P1024, DOI 10.1053/j.ajkd.2009.02.008; Stenvinkel P, 2004, SEMIN DIALYSIS, V17, P505, DOI 10.1111/j.0894-0959.2004.17611.x; Su YJ, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-185; Tsirpanlis G, 2005, NEPHROL DIAL TRANSPL, V20, P658, DOI 10.1093/ndt/gfh663; Yeun JY, 2000, AM J KIDNEY DIS, V35, P469, DOI 10.1016/S0272-6386(00)70200-9	17	19	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0120266	10.1371/journal.pone.0120266	http://dx.doi.org/10.1371/journal.pone.0120266			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25793462	Green Published, gold, Green Submitted			2022-12-27	WOS:000352083900005
J	Ju, GQ; Cheng, J; Zhong, L; Wu, S; Zou, XY; Zhang, GY; Gu, D; Miao, S; Zhu, YJ; Sun, J; Du, T				Ju, Guan-qun; Cheng, Jun; Zhong, Liang; Wu, Shuai; Zou, Xiang-yu; Zhang, Guang-yuan; Gu, Di; Miao, Shuai; Zhu, Ying-jian; Sun, Jie; Du, Tao			Microvesicles Derived from Human Umbilical Cord Mesenchymal Stem Cells Facilitate Tubular Epithelial Cell Dedifferentiation and Growth via Hepatocyte Growth Factor Induction	PLOS ONE			English	Article							ACUTE KIDNEY INJURY; ISCHEMIA-REPERFUSION INJURY; POSTISCHEMIC KIDNEY; PROTECT; REPAIR; PATHOPHYSIOLOGY; PROGRESSION	During acute kidney injury (AKI), tubular cell dedifferentiation initiates cell regeneration; hepatocyte growth factor (HGF) is involved in modulating cell dedifferentiation. Mesenchymal stem cell (MSC)-derived microvesicles (MVs) deliver RNA into injured tubular cells and alter their gene expression, thus regenerating these cells. We boldly speculated that MVs might induce HGF synthesis via RNA transfer, thereby facilitating tubular cell dedifferentiation and regeneration. In a rat model of unilateral AKI, the administration of MVs promoted kidney recovery. One of the mechanisms of action is the acceleration of tubular cell dedifferentiation and growth. Both in vivo and in vitro, rat HGF expression in damaged rat tubular cells was greatly enhanced by MV treatment. In addition, human HGF mRNA present in MVs was delivered into rat tubular cells and translated into the HGF protein as another mechanism of HGF induction. RNase treatment abrogated all MV effects. In the in vitro experimental setting, the conditioned medium of MV-treated injured tubular cells, which contains a higher concentration of HGF, strongly stimulated cell dedifferentiation and growth, as well as Erk1/2 signaling activation. Intriguingly, these effects were completely abrogated by either c-Met inhibitor or MEK inhibitor, suggesting that HGF induction is a crucial contributor to the acceleration of cell dedifferentiation and growth. All these findings indicate that MV-induced HGF synthesis in damaged tubular cells via RNA transfer facilitates cell dedifferentiation and growth, which are important regenerative mechanisms.	[Ju, Guan-qun; Zhong, Liang; Sun, Jie] Shanghai Jiao Tong Univ, Sch Med, Shanghai Childrens Med Ctr, Dept Urol, Shanghai 200030, Peoples R China; [Zou, Xiang-yu; Zhang, Guang-yuan; Gu, Di; Miao, Shuai; Zhu, Ying-jian] Shanghai Jiao Tong Univ, Sch Med, Shanghai Peoples Hosp 1, Dept Urol, Shanghai 200030, Peoples R China; [Du, Tao] Henan Prov Peoples Hosp, Dept Urol, Zhengzhou, Peoples R China; [Cheng, Jun] Nantong Tongzhou Peoples Hosp, Dept Urol, Nantong, Peoples R China; [Wu, Shuai] Qingdao Municipal Hosp, Dept Urol, Qingdao, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Zhengzhou University; Qingdao Municipal Hospital	Sun, J (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Shanghai Childrens Med Ctr, Dept Urol, Shanghai 200030, Peoples R China.	ppdrsun@gmail.com; ddtcwxdzy@hotmail.com			National Natural Science Foundation of China [81170642, 81270689]; Research Program of Science and Technology Commission of Shanghai Municipality [12ZR1419200]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Program of Science and Technology Commission of Shanghai Municipality	Funding: This study is supported by grants from the National Natural Science Foundation of China (81170642, 81270689), and the Research Program of Science and Technology Commission of Shanghai Municipality (12ZR1419200). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bi B, 2007, J AM SOC NEPHROL, V18, P2486, DOI 10.1681/ASN.2007020140; Biancone L, 2012, NEPHROL DIAL TRANSPL, V27, P3037, DOI 10.1093/ndt/gfs168; Bonventre JV, 2011, J CLIN INVEST, V121, P4210, DOI 10.1172/JCI45161; Bonventre JV, 2010, CONTRIB NEPHROL, V165, P9, DOI 10.1159/000313738; Bonventre JV, 2003, J AM SOC NEPHROL, V14, pS55, DOI 10.1097/01.ASN.0000067652.51441.21; Boor P, 2010, NAT REV NEPHROL, V6, P643, DOI 10.1038/nrneph.2010.120; Bruno S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033115; Bruno S, 2009, J AM SOC NEPHROL, V20, P1053, DOI 10.1681/ASN.2008070798; Camussi G, 2013, BIOCHEM SOC T, V41, P283, DOI 10.1042/BST20120192; Camussi G, 2010, CURR OPIN NEPHROL HY, V19, P7, DOI 10.1097/MNH.0b013e328332fb6f; Chawla LS, 2011, CONTRIB NEPHROL, V174, P182, DOI 10.1159/000329396; Chawla LS, 2011, KIDNEY INT, V79, P1361, DOI 10.1038/ki.2011.42; Deregibus MC, 2007, BLOOD, V110, P2440, DOI 10.1182/blood-2007-03-078709; Du T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096836; Du T, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/261697; Du T, 2012, CYTOTHERAPY, V14, P1215, DOI 10.3109/14653249.2012.711471; Duffield JS, 2005, J CLIN INVEST, V115, P1743, DOI 10.1172/JCI22593; Gatti S, 2011, NEPHROL DIAL TRANSPL, V26, P1474, DOI 10.1093/ndt/gfr015; Gobe GC, 2007, INT J BIOCHEM CELL B, V39, P1551, DOI 10.1016/j.biocel.2007.04.025; Grgic I, 2012, PEDIATR NEPHROL, V27, P183, DOI 10.1007/s00467-011-1772-6; He J, 2012, NEPHROLOGY, V17, P493, DOI 10.1111/j.1440-1797.2012.01589.x; Humphreys BD, 2011, P NATL ACAD SCI USA, V108, P9226, DOI 10.1073/pnas.1100629108; Ishani A, 2009, J AM SOC NEPHROL, V20, P223, DOI 10.1681/ASN.2007080837; Ishibe S, 2008, CURR OPIN NEPHROL HY, V17, P379, DOI 10.1097/MNH.0b013e3283046507; Kilpinen L, 2013, J EXTRACELL VESICLES, V2, DOI 10.3402/jev.v2i0.21927; Kusaba T, 2013, P NATL ACAD SCI US; Lin FM, 2005, J CLIN INVEST, V115, P1756, DOI 10.1172/JCI23015; Macedo E, 2008, CURR OPIN CRIT CARE, V14, P660, DOI 10.1097/MCC.0b013e328317ee6e; Morigi M, 2010, STEM CELLS, V28, P513, DOI 10.1002/stem.293; Nakamura T, 2011, J GASTROEN HEPATOL, V26, P188, DOI 10.1111/j.1440-1746.2010.06549.x; Quesenberry PJ, 2010, ADV DRUG DELIVER REV, V62, P1141, DOI 10.1016/j.addr.2010.06.001; Quesenberry PJ, 2010, EXP HEMATOL, V38, P581, DOI 10.1016/j.exphem.2010.03.021; Ratajczak J, 2006, LEUKEMIA, V20, P1487, DOI 10.1038/sj.leu.2404296; Ratajczak MZ, 2012, LEUKEMIA, V26, P1166, DOI 10.1038/leu.2011.389; ROGERS SA, 1993, AM J PHYSIOL, V264, pF963, DOI 10.1152/ajprenal.1993.264.6.F963; Venkatachalam MA, 2010, AM J PHYSIOL-RENAL, V298, pF1078, DOI 10.1152/ajprenal.00017.2010; WITZGALL R, 1994, J CLIN INVEST, V93, P2175, DOI 10.1172/JCI117214; Wu S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061366; Zhuang SG, 2005, J BIOL CHEM, V280, P21036, DOI 10.1074/jbc.M413300200; Zou XY, 2014, STEM CELL RES THER, V5, DOI 10.1186/scrt428	40	97	102	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0121534	10.1371/journal.pone.0121534	http://dx.doi.org/10.1371/journal.pone.0121534			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25793303	gold, Green Published, Green Submitted			2022-12-27	WOS:000352083900138
J	Klein, HJ; Csordas, A; Falk, V; Slankamenac, K; Rudiger, A; Schonrath, F; Biefer, HRC; Starck, CT; Graf, R				Klein, Holger J.; Csordas, Adam; Falk, Volkmar; Slankamenac, Ksenija; Rudiger, Alain; Schoenrath, Felix; Biefer, Hector Rodriguez Cetina; Starck, Christoph T.; Graf, Rolf			Pancreatic Stone Protein Predicts Postoperative Infection in Cardiac Surgery Patients Irrespective of Cardiopulmonary Bypass or Surgical Technique	PLOS ONE			English	Article							INFLAMMATORY RESPONSE SYNDROME; SEPSIS BIOMARKERS; PROCALCITONIN; EXPRESSION; MORTALITY	Introduction We investigated the role of pancreatic stone protein (PSP) in predicting the occurrence of infection in the postoperative course of cardiac surgery patients. Several biomarkers indicating the presence of inflammation and infection are available in the clinical routine; yet, their utility in the postoperative course of patients following cardiac surgery remains uncertain. Moreover, cardiopulmonary bypass, also referred to as "on-pump surgery", increases the susceptibility to an exaggerated inflammatory state. However, the impact of such extracorporeal circulation on circulating PSP levels remains poorly understood. Methods In a prospective cohort of unselected patients undergoing cardiac surgery, we set out to elucidate the diagnostic accuracy of serum PSP levels as opposed to canonical biomarkers (CRP, WBC) of inflammation to discriminate between the presence of infection and surgical trauma,. In addition, we investigated whether the biomarkers were influenced by the surgical technique employed, i.e. on-pump vs. off-pump and minimally invasive surgery vs. sternotomy. Levels of circulating PSP and routine inflammatory biomarkers (CRP, WBC) were measured in samples taken from 120 patients at baseline as well as at postoperative day 1-3. Results Univariate analysis showed that among the biomarkers investigated, only PSP levels had discriminatory power to differentiate infection from surgical trauma in the postoperative course of the entire cohort of patients following cardiac surgery. With regard to cardiac surgical interventions, there was no significant association between the absence or presence of extracorporeal circulation and PSP levels. However, there was a significant difference in the slope of the rise of postoperative PSP between minimally invasive surgery as opposed to patients subjected to sternotomy. Conclusion In an unselected population of cardiac surgery patients, post-operative serum PSP levels were significantly associated with the presence of infection in both the on-pump and off-pump setting. Of note, the surgical technique employed (sternotomy vs. minimally invasive approach) had a significant impact on postoperative PSP levels.	[Klein, Holger J.; Falk, Volkmar; Schoenrath, Felix; Biefer, Hector Rodriguez Cetina; Starck, Christoph T.] Univ Zurich Hosp, Div Cardiovasc Surg, CH-8091 Zurich, Switzerland; [Csordas, Adam] Univ Heart Ctr Zurich, Dept Cardiol, Zurich, Switzerland; [Slankamenac, Ksenija; Graf, Rolf] Univ Zurich Hosp, Div Visceral & Transplant Surg, CH-8091 Zurich, Switzerland; [Rudiger, Alain] Univ Zurich Hosp, Div Anesthesiol, Cardiosurg Intens Care Unit, CH-8091 Zurich, Switzerland	University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital	Klein, HJ (corresponding author), Univ Zurich Hosp, Div Cardiovasc Surg, CH-8091 Zurich, Switzerland.	holger.klein@usz.ch	Starck, Christoph/AAC-7252-2022	Starck, Christoph/0000-0002-2753-1456; Graf, Rolf/0000-0001-7449-7302; Rudiger, Alain/0000-0001-7943-7624; Falk, Volkmar/0000-0002-7911-8620; Rodriguez Cetina Biefer, Hector/0000-0002-5855-8993; Slankamenac, Ksenija/0000-0002-3568-9253	Gebert-Ruef Foundation	Gebert-Ruef Foundation	This study was supported by a grant from the Gebert-Ruef Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angus DC, 2013, NEW ENGL J MED, V369, P840, DOI [10.1056/NEJMc1312359, 10.1056/NEJMra1208623]; Boeck L, 2011, CHEST, V140, P925, DOI 10.1378/chest.11-0018; Busani S, 2012, CRIT CARE, V16, DOI 10.1186/cc11433; CARRERE J, 1992, DIFFERENTIATION, V51, P55, DOI 10.1111/j.1432-0436.1992.tb00680.x; Chen GY, 2010, NAT REV IMMUNOL, V10, P826, DOI 10.1038/nri2873; Cremer J, 1996, ANN THORAC SURG, V61, P1714, DOI 10.1016/0003-4975(96)00055-0; DECARO A, 1979, BIOCHEM BIOPH RES CO, V87, P1176, DOI 10.1016/S0006-291X(79)80031-5; Erdfelder E., 2004, ALLGEMEINE PSYCHOL D, P148; Gukasjan R, 2013, CRIT CARE MED, V41, P1027, DOI 10.1097/CCM.0b013e3182771193; Holmes JH, 2002, INFLAMM RES, V51, P579, DOI 10.1007/PL00012432; Hotchkiss RS, 2003, NEW ENGL J MED, V348, P138, DOI 10.1056/NEJMra021333; IOVANNA J, 1993, PANCREAS, V8, P597, DOI 10.1097/00006676-199309000-00011; Keel M, 2009, CRIT CARE MED, V37, P1642, DOI 10.1097/CCM.0b013e31819da7d6; KEIM V, 1994, DIGESTION, V55, P65, DOI 10.1159/000201127; Kopterides P, 2010, CRIT CARE MED, V38, P2229, DOI 10.1097/CCM.0b013e3181f17bf9; Levy MM, 2001, INTENS CARE MED, V29, P530, DOI DOI 10.1007/S00134-003-1662-X; Litmathe J, 2011, HELL J CARDIOL, V52, P493; Llewelyn MJ, 2013, CRIT CARE, V17, DOI 10.1186/cc12588; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; Pierrakos C, 2010, CRIT CARE, V14, DOI 10.1186/cc8872; Prondzinsky R, 2005, J THORAC CARDIOV SUR, V129, P760, DOI 10.1016/j.jtcvs.2004.07.052; Que YA, 2012, CRIT CARE, V16, DOI 10.1186/cc11406; Sablotzki A, 2002, PERFUSION-UK, V17, P103, DOI 10.1191/0267659102pf543oa; Sinning JM, 2012, EUR HEART J, V33, P1459, DOI 10.1093/eurheartj/ehs002; Yang J, 2014, ENDOCRINE; Zhang Q, 2010, NATURE, V464, P104, DOI 10.1038/nature08780	26	12	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0120276	10.1371/journal.pone.0120276	http://dx.doi.org/10.1371/journal.pone.0120276			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25793700	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000352083900007
J	Knigge, A; Kloting, N; Schon, MR; Dietrich, A; Fasshauer, M; Gartner, D; Lohmann, T; Dressler, M; Stumvoll, M; Kovacs, P; Bluher, M				Knigge, Anja; Kloeting, Nora; Schoen, Michael R.; Dietrich, Arne; Fasshauer, Mathias; Gaertner, Daniel; Lohmann, Tobias; Dressler, Miriam; Stumvoll, Michael; Kovacs, Peter; Blueher, Matthias			ADCY5 Gene Expression in Adipose Tissue Is Related to Obesity in Men and Mice	PLOS ONE			English	Article							TYPE-2 DIABETES RISK; ADENYLYL-CYCLASE; BIRTH-WEIGHT; FAT; VARIANTS; LIFE	Genome wide association studies revealed an association of the single nucleotide polymorphism rs11708067 within the ADCY5 gene-encoding adenylate cyclase 5-with increased type 2 diabetes (T2D) risk and higher fasting glucose. However, it remains unclear whether the association between ADCY5 variants and glycemic traits may involve adipose tissue (AT) related mechanisms. We therefore tested the hypothesis that ADCY5 mRNA expression in human and mouse AT is related to obesity, fat distribution, T2D in humans and high fat diet (HFD) in mice. We measured ADCY5 mRNA expression in paired samples of visceral and subcutaneous adipose tissue from 244 individuals with a wide range of body weight and parameters of hyperglycemia, which have been genotyped for rs11708067. In addition, AT ADCY5 mRNA was assessed in C57BL/6NTac which underwent a 10 weeks standard chow (n = 6) or high fat diet (HFD, n = 6). In humans, visceral ADCY5 expression is significantly higher in obese compared to lean individuals. ADCY5 expression correlates with BMI, body fat mass, circulating leptin, fat distribution, waist and hip circumference, but not with fasting plasma glucose and HbA1c. Adcy5 expression in mouse AT is significantly higher after a HFD compared to chow (p< 0.05). Importantly, rs11708067 is not associated with ADCY5 mRNA expression levels in either fat depot in any of the genetic models tested. Our results suggest that changes in AT ADCY5 expression are related to obesity and fat distribution, but not with impaired glucose metabolism and T2D. However, altered ADCY5 expression in AT does not seem to be the mechanism underlying the association between rs11708067 and increased T2D risk.	[Knigge, Anja; Kloeting, Nora; Fasshauer, Mathias; Stumvoll, Michael; Blueher, Matthias] Univ Leipzig, Dept Endocrinol & Nephrol, Dept Med Dermatol & Neurol, D-04109 Leipzig, Germany; [Kloeting, Nora] Univ Leipzig, Integriertes Forsch & Behandlungszentrum IFB Adip, Jr Res Grp Anim Models Obes 2, D-04109 Leipzig, Germany; [Schoen, Michael R.; Gaertner, Daniel] Stadt Klinikum Karlsruhe, Clin Visceral Surg, Karlsruhe, Germany; [Dietrich, Arne] Univ Leipzig, Dept Surg, D-04109 Leipzig, Germany; [Lohmann, Tobias; Dressler, Miriam] Municipal Clin Dresden Neustadt, Dresden, Germany; [Kovacs, Peter] Univ Leipzig, Integriertes Forsch & Behandlungszentrum IFB Adip, D-04109 Leipzig, Germany	Leipzig University; Leipzig University; Municipal Hospital Karlsruhe; Leipzig University; Leipzig University	Bluher, M (corresponding author), Univ Leipzig, Dept Endocrinol & Nephrol, Dept Med Dermatol & Neurol, D-04109 Leipzig, Germany.	bluma@medizin.uni-leipzig.de	Stumvoll, Michael/ABE-1121-2021	Stumvoll, Michael/0000-0001-6225-8240; Kovacs, Peter/0000-0002-0290-5423	Deutsche Diabetes Gesellschaft, Germany; Kompetenznetz Adipositas (Competence network for Obesity) - Federal Ministry of Education and Research (German Obesity Biomaterial Bank) [FKZ 01GI1128]; Deutsche Forschungsgemeinschaft [Sonderforschungsbereich 1052]; Helmholtz Alliance ICEMED - Imaging and Curing Environmental Metabolic Diseases, through the Initiative and Networking Fund of the Helmholtz Association	Deutsche Diabetes Gesellschaft, Germany; Kompetenznetz Adipositas (Competence network for Obesity) - Federal Ministry of Education and Research (German Obesity Biomaterial Bank); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Helmholtz Alliance ICEMED - Imaging and Curing Environmental Metabolic Diseases, through the Initiative and Networking Fund of the Helmholtz Association	This work was supported by grants of Deutsche Diabetes Gesellschaft, Germany. This work was further supported by the Kompetenznetz Adipositas (Competence network for Obesity) funded by the Federal Ministry of Education and Research (German Obesity Biomaterial Bank; FKZ 01GI1128), a grant from Deutsche Forschungsgemeinschaft (Sonderforschungsbereich 1052, Obesity Mechanisms"; projects B01 and B03), and by the Helmholtz Alliance ICEMED - Imaging and Curing Environmental Metabolic Diseases, through the Initiative and Networking Fund of the Helmholtz Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson EA, 2010, DIABETOLOGIA, V53, P1908, DOI 10.1007/s00125-010-1790-0; Berndt J, 2005, DIABETES, V54, P2911, DOI 10.2337/diabetes.54.10.2911; Bluher M, 2013, BEST PRACT RES CL EN, V27, P163, DOI 10.1016/j.beem.2013.02.005; Bluher M, 2008, OBESITY FACTS, V1, P176, DOI 10.1159/000145930; Bluher M, 2002, DIABETOLOGIA, V45, P210, DOI 10.1007/s00125-001-0723-3; Cash TP, 2014, AGING CELL, V13, P1087, DOI 10.1111/acel.12261; de Gortari P, 2010, BRAIN RES, V1310, P37, DOI 10.1016/j.brainres.2009.11.009; Defer N, 2000, AM J PHYSIOL-RENAL, V279, pF400, DOI 10.1152/ajprenal.2000.279.3.F400; Du WW, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.305; Dupuis J, 2010, NAT GENET, V42, P105, DOI 10.1038/ng.520; Freathy RM, 2010, NAT GENET, V42, P430, DOI 10.1038/ng.567; Harman-Boehm I, 2007, J CLIN ENDOCR METAB, V92, P2240, DOI 10.1210/jc.2006-1811; Hodson DJ, 2014, DIABETES, V63, P3009, DOI 10.2337/db13-1607; Hu CL, 2009, AM J PHYSIOL-HEART C, V297, pH1776, DOI 10.1152/ajpheart.00050.2009; Huopio H, 2013, EUR J ENDOCRINOL, V169, P291, DOI 10.1530/EJE-13-0286; Jones RH, 2009, MOL CELL ENDOCRINOL, V297, P4, DOI 10.1016/j.mce.2008.06.020; Kloeting N, 2007, CELL METAB, V6, P79, DOI 10.1016/j.cmet.2007.06.002; Kloting N, 2010, AM J PHYSIOL-ENDOC M, V299, pE506, DOI 10.1152/ajpendo.00586.2009; Ortiz-Capisano MC, 2007, HYPERTENSION, V49, P618, DOI 10.1161/01.HYP.0000255172.84842.d2; Vasan SK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021331; Wagner R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023639; Windholz J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022101; Yaghootkar H, 2012, CURR OPIN CLIN NUTR, V15, P258, DOI 10.1097/MCO.0b013e328351f543	23	14	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0120742	10.1371/journal.pone.0120742	http://dx.doi.org/10.1371/journal.pone.0120742			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25793868	Green Published, Green Submitted, gold			2022-12-27	WOS:000352083900071
J	Lopez-Sanchez, P; Cersosimo, J; Wang, DJ; Flanagan, B; Stokes, JR; Gidley, MJ				Lopez-Sanchez, Patricia; Cersosimo, Julie; Wang, Dongjie; Flanagan, Bernadine; Stokes, Jason R.; Gidley, Michael J.			Poroelastic Mechanical Effects of Hemicelluloses on Cellulosic Hydrogels under Compression	PLOS ONE			English	Article							PLANT-CELL WALL; XYLOGLUCAN; ARCHITECTURE; COMPOSITES; DEFICIENT; GROWTH	Hemicelluloses exhibit a range of interactions with cellulose, the mechanical consequences of which in plant cell walls are incompletely understood. We report the mechanical properties of cell wall analogues based on cellulose hydrogels to elucidate the contribution of xyloglucan or arabinoxylan as examples of two hemicelluloses displaying different interactions with cellulose. We subjected the hydrogels to mechanical pressures to emulate the compressive stresses experienced by cell walls in planta. Our results revealed that the presence of either hemicellulose increased the resistance to compression at fast strain rates. However, at slow strain rates, only xyloglucan increased composite strength. This behaviour could be explained considering the microstructure and the flow of water through the composites confirming their poroelastic nature. In contrast, small deformation oscillatory rheology showed that only xyloglucan decreased the elastic moduli. These results provide evidence for contrasting roles of different hemicelluloses in plant cell wall mechanics and man-made cellulose-based composite materials.	[Lopez-Sanchez, Patricia; Cersosimo, Julie; Wang, Dongjie; Flanagan, Bernadine; Gidley, Michael J.] Univ Queensland, Australian Res Ctr, Ctr Excellence Plant Cell Walls, Ctr Nutr & Food Sci,Queensland Alliance Agr & Foo, Brisbane, Qld, Australia; [Stokes, Jason R.] Univ Queensland, Australian Res Ctr, Ctr Excellence Plant Cell Walls, Sch Chem Engn, Brisbane, Qld, Australia	University of Queensland; University of Queensland	Lopez-Sanchez, P (corresponding author), Univ Queensland, Australian Res Ctr, Ctr Excellence Plant Cell Walls, Ctr Nutr & Food Sci,Queensland Alliance Agr & Foo, Brisbane, Qld, Australia.	p.lopezsanchez@uq.edu.au	Stokes, Jason R/A-1608-2009; Flanagan, Bernadine/A-7130-2011; Flanagan, Bernadine/AAO-2273-2020; Gidley, Mike/AAT-9543-2021; Flanagan, Bernadine/U-7222-2019; Lopez-Sanchez, Patricia/AAA-8259-2021	Stokes, Jason R/0000-0001-7784-9297; Flanagan, Bernadine/0000-0002-5220-190X; Flanagan, Bernadine/0000-0002-5220-190X; Lopez-Sanchez, Patricia/0000-0002-2461-327X				Astley OM, 2003, INT J BIOL MACROMOL, V32, P28, DOI 10.1016/S0141-8130(03)00022-9; Burton RA, 2010, NAT CHEM BIOL, V6, P724, DOI [10.1038/NCHEMBIO.439, 10.1038/nchembio.439]; Busse-Wicher M, 2014, PLANT J, V79, P492, DOI 10.1111/tpj.12575; Buyanov AL, 2010, J MECH BEHAV BIOMED, V3, P102, DOI 10.1016/j.jmbbm.2009.06.001; CARPITA NC, 1993, PLANT J, V3, P1, DOI 10.1111/j.1365-313X.1993.tb00007.x; Carpita NC, 2001, PLANT PHYSIOL, V127, P551, DOI 10.1104/pp.010146; Cavalier DM, 2008, PLANT CELL, V20, P1519, DOI 10.1105/tpc.108.059873; Chanliaud E, 1999, PLANT J, V20, P25, DOI 10.1046/j.1365-313X.1999.00571.x; Chanliaud E, 2004, PLANT J, V38, P27, DOI 10.1111/j.1365-313X.2004.02018.x; Chanliaud E, 2002, PLANTA, V215, P989, DOI 10.1007/s00425-002-0783-8; CLARK AH, 1985, BRIT POLYM J, V17, P164, DOI 10.1002/pi.4980170214; Cosgrove DJ, 2005, NAT REV MOL CELL BIO, V6, P850, DOI 10.1038/nrm1746; Doblin MS, 2014, CURR OPIN BIOTECH, V26, P108, DOI 10.1016/j.copbio.2013.11.012; Ebringerova A, 2005, ADV POLYM SCI, V186, P1, DOI 10.1007/b136816; FRY SC, 1989, J EXP BOT, V40, P1, DOI 10.1093/jxb/40.1.1; GIDLEY MJ, 1991, CARBOHYD RES, V214, P299, DOI 10.1016/0008-6215(91)80037-N; Hamant O, 2010, CURR OPIN GENET DEV, V20, P454, DOI 10.1016/j.gde.2010.04.009; LOESCHER WH, 1973, PLANT PHYSIOL, V52, P248, DOI 10.1104/pp.52.3.248; Lopez-Sanchez P, 2014, BIOMACROMOLECULES, V15, P2274, DOI 10.1021/bm500405h; Macosko C.W., 1993, RHEOLOGY PRINCIPLES; MCCANN MC, 1990, J CELL SCI, V96, P323; McKenna BA, 2009, CELLULOSE, V16, P1047, DOI 10.1007/s10570-009-9340-y; Mikkelsen D, 2011, J AGR FOOD CHEM, V59, P4025, DOI 10.1021/jf104855e; Mikkelsen D, 2011, METHODS MOL BIOL, V715, P197, DOI 10.1007/978-1-61779-008-9_14; Moeendarbary E, 2013, NAT MATER, V12, P253, DOI [10.1038/NMAT3517, 10.1038/nmat3517]; Park YB, 2012, PLANT PHYSIOL, V158, P1933, DOI 10.1104/pp.111.192880; Park YB, 2012, PLANT PHYSIOL, V158, P465, DOI 10.1104/pp.111.189779; Pauly M, 1999, PLANT J, V20, P629, DOI 10.1046/j.1365-313X.1999.00630.x; Pettolino FA, 2012, NAT PROTOC, V7, P1590, DOI 10.1038/nprot.2012.081; ROSS P, 1991, MICROBIOL REV, V55, P35, DOI 10.1128/MMBR.55.1.35-58.1991; SHEDLETZKY E, 1992, PLANT PHYSIOL, V100, P120, DOI 10.1104/pp.100.1.120; Skotheim JM, 2005, SCIENCE, V308, P1308, DOI 10.1126/science.1107976; Somerville C, 2004, SCIENCE, V306, P2206, DOI 10.1126/science.1102765; Wang T, 2013, P NATL ACAD SCI USA, V110, P16444, DOI 10.1073/pnas.1316290110; Whitney SEC, 2006, AM J BOT, V93, P1402, DOI 10.3732/ajb.93.10.1402; WHITNEY SEC, 1995, PLANT J, V8, P491, DOI 10.1046/j.1365-313X.1995.8040491.x; Whitney SEC, 1999, PLANT PHYSIOL, V121, P657, DOI 10.1104/pp.121.2.657; Whitney SEC, 1998, CARBOHYD RES, V307, P299, DOI 10.1016/S0008-6215(98)00004-4; Zabotina OA, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00134	39	35	36	2	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0122132	10.1371/journal.pone.0122132	http://dx.doi.org/10.1371/journal.pone.0122132			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25794048	Green Published, Green Submitted, gold			2022-12-27	WOS:000352083900172
J	Oster, M; Scheel, M; Murani, E; Ponsuksili, S; Zebunke, M; Puppe, B; Wimmers, K				Oster, Michael; Scheel, Mathias; Murani, Eduard; Ponsuksili, Siriluck; Zebunke, Manuela; Puppe, Birger; Wimmers, Klaus			The Fight-Or-Flight Response Is Associated with PBMC Expression Profiles Related to Immune Defence and Recovery in Swine	PLOS ONE			English	Article							INDIVIDUAL BEHAVIORAL-CHARACTERISTICS; HOUSING CONDITION; HUMORAL IMMUNITY; PIGS; STRESS; ANIMALS; GENE; PERFORMANCE; PHYSIOLOGY; BACKTEST	Defining phenotypes according to molecular features would promote the knowledge of functional traits like behaviour in both human and animal research. Beside physiological states or environmental factors, an innate predisposition of individual coping strategies was discussed, including the proactive and reactive pattern. According to backtest reactivity, animals assigned as high-resisting (proactive) and low-resisting (reactive) were immune challenged with tetanus toxoid in a time course experiment. Using the Affymetrix platform and qPCR, individual coping characteristics were reflected as gene expression signatures in porcine peripheral blood mononuclear cells (PBMC) at naive state (day 0) and in response to the model antigen (day 14, day 28, and day 140). Further, the blood cell count was analysed at all stages. On the transcriptional level, processes acting on cell communication, vasculogenesis, and blood coagulation were highlighted in high-resisting animals at naive state (day 0), temporarily blurred due to immune challenge (day 14) but subsequently restored and intensified (day 28). Notably, similar amounts of white and red blood cells, platelets and haematocrit between high-resisting and low-resisting samples suggest coping-specific expression patterns rather than alterations in blood cell distribution. Taken together, the gene expression patterns indicate that proactive pigs might favour molecular pathways enabling an effective strategy for defence and recovery. This corroborates the previously suggested belief, that proactive animals are prone to an increased number of injuries as an evolutionary inherited mechanism. In contrast to previous assumptions, coping-specific immunity in pigs lacks inherited shifts between cellular and humoral immune responses.	[Oster, Michael; Scheel, Mathias; Murani, Eduard; Ponsuksili, Siriluck; Wimmers, Klaus] Leibniz Inst Farm Anim Biol FBN, Inst Genome Biol, Dummerstorf, Germany; [Zebunke, Manuela; Puppe, Birger] Leibniz Inst Farm Anim Biol FBN, Inst Behav Physiol, Dummerstorf, Germany	Forschungsinstitut fur Nutztierbiologie (FBN); Forschungsinstitut fur Nutztierbiologie (FBN)	Wimmers, K (corresponding author), Leibniz Inst Farm Anim Biol FBN, Inst Genome Biol, Wilhelm Stahl Allee 2, Dummerstorf, Germany.	wimmers@fbn-dummerstorf.de	Wimmers, Klaus/AAF-9434-2020	Puppe, Birger/0000-0002-5513-7907; Wimmers, Klaus/0000-0002-9523-6790; Zebunke, Manuela/0000-0002-5232-5873	Federal Ministry of Education and Research (BMBF) [0315536F]; Leibniz Institute for Farm Animal Biology (FBN)	Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Leibniz Institute for Farm Animal Biology (FBN)	This work was partly funded by the Federal Ministry of Education and Research (BMBF; www.bmbf.de) as part of the PHENOMICS project (support code: 0315536F; www.phaenomics.auf.uni-rostock.de). The Leibniz Institute for Farm Animal Biology (FBN) provided own matched funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler M, 2013, INT J BIOL SCI, V9, P907, DOI 10.7150/ijbs.6769; Adler M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058306; BLECHA F, 1983, J ANIM SCI, V56, P396, DOI 10.2527/jas1983.562396x; Bolhuis JE, 2003, PHYSIOL BEHAV, V79, P289, DOI 10.1016/S0031-9384(03)00090-8; Bourgon R, 2010, P NATL ACAD SCI USA, V107, P9546, DOI 10.1073/pnas.0914005107; Camm AJ, 1996, CIRCULATION, V93, P1043; Cannon W., 1915, BODILY CHANGES IN PA; Cerletti C, 2010, MEDITERR J HEMATOL I, V2, DOI 10.4084/MJHID.2010.023; Chmielowiec-Korzeniowska A, 2012, ARCH TIERZUCHT, V55, P469, DOI 10.5194/aab-55-469-2012; Dhabhar FS, 2003, ANN NY ACAD SCI, V992, P205, DOI 10.1111/j.1749-6632.2003.tb03151.x; ELGHAZALI GEB, 1993, EUR J IMMUNOL, V23, P2740, DOI 10.1002/eji.1830231103; Engel G L, 1972, Ciba Found Symp, V8, P57; Freeman TC, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-90; Geverink NA, 2004, J ANIM SCI, V82, P1227; Geverink NA, 2004, PHYSIOL BEHAV, V80, P541, DOI 10.1016/j.physbeh.2003.10.013; Geverink NA, 2003, APPL ANIM BEHAV SCI, V81, P29, DOI 10.1016/S0168-1591(02)00253-8; Geverink NA, 2002, APPL ANIM BEHAV SCI, V77, P43, DOI 10.1016/S0168-1591(02)00024-2; Graunke KL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074579; Grisart B, 2002, GENOME RES, V12, P222, DOI 10.1101/gr.224202; HESSING MJC, 1995, VET IMMUNOL IMMUNOP, V45, P97, DOI 10.1016/0165-2427(94)05338-S; HESSING MJC, 1993, APPL ANIM BEHAV SCI, V37, P285, DOI 10.1016/0168-1591(93)90118-9; HESSING MJC, 1994, PHYSIOL BEHAV, V55, P39, DOI 10.1016/0031-9384(94)90007-8; Kauffmann Audrey, 2009, Bioinformatics, V25, P415, DOI 10.1093/bioinformatics/btn647; Koolhaas JM, 2008, BRAIN BEHAV IMMUN, V22, P662, DOI 10.1016/j.bbi.2007.11.006; Koolhaas JM, 2010, FRONT NEUROENDOCRIN, V31, P307, DOI 10.1016/j.yfrne.2010.04.001; Koolhaas JM, 1999, NEUROSCI BIOBEHAV R, V23, P925, DOI 10.1016/S0149-7634(99)00026-3; LEDIVIDICH J, 1994, LIVEST PROD SCI, V38, P79, DOI 10.1016/0301-6226(94)90052-3; Li N, 2008, J LEUKOCYTE BIOL, V83, P1069, DOI 10.1189/jlb.0907615; Maier SF, 2003, BRAIN BEHAV IMMUN, V17, P69, DOI 10.1016/S0889-1591(03)00032-1; Marketon JIW, 2008, CELL IMMUNOL, V252, P16, DOI 10.1016/j.cellimm.2007.09.006; Mayer S, 2002, IMMUNOBIOLOGY, V205, P282, DOI 10.1078/0171-2985-00131; Olsson IAS, 1999, BEHAV PROCESS, V46, P201, DOI 10.1016/S0376-6357(99)00036-4; Petelle MB, 2013, ANIM BEHAV, V86, P1147, DOI 10.1016/j.anbehav.2013.09.016; Ponsuksili S, 2002, DEV BIOL BASEL, V132, P185; Rauw Wendy M., 2012, Frontiers in Genetics, V3, P267, DOI 10.3389/fgene.2012.00267; Ruis MAW, 2000, APPL ANIM BEHAV SCI, V66, P31, DOI 10.1016/S0168-1591(99)00070-2; Schrama JW, 1997, J ANIM SCI, V75, P2588; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Sutherland MA, 2005, J ANIM SCI, V83, P2087; Tierney TJ, 1997, VET IMMUNOL IMMUNOP, V57, P229, DOI 10.1016/S0165-2427(97)00011-1; Trillmich F, 2011, DEV PSYCHOBIOL, V53, P505, DOI 10.1002/dev.20573; Turner SP, 2008, BEHAV GENET, V38, P67, DOI 10.1007/s10519-007-9171-2; van Erp-van der Kooij E, 2000, APPL ANIM BEHAV SCI, V66, P171, DOI 10.1016/S0168-1591(99)00094-5; Van Reenen CG, 2005, PHYSIOL BEHAV, V85, P557, DOI 10.1016/j.physbeh.2005.06.015; Velie BD, 2009, J ANIM SCI, V87, P2767, DOI 10.2527/jas.2008-1328; Wilkie B, 1999, VET IMMUNOL IMMUNOP, V72, P231, DOI 10.1016/S0165-2427(99)00136-1; Winter A, 2002, P NATL ACAD SCI USA, V99, P9300, DOI 10.1073/pnas.142293799; Zebunke M., 2013, KTBL SCHRIFT, V503, P188; Zen M, 2011, AUTOIMMUN REV, V10, P305, DOI 10.1016/j.autrev.2010.11.009	49	14	14	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0120153	10.1371/journal.pone.0120153	http://dx.doi.org/10.1371/journal.pone.0120153			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25793368	Green Submitted, Green Published, gold			2022-12-27	WOS:000352084200150
J	Oudijk, L; van Nederveen, F; Badoual, C; Tissier, F; Tischler, AS; Smid, M; Gaal, J; Lepoutre-Lussey, C; Gimenez-Roqueplo, AP; Dinjens, WNM; Korpershoek, E; de Krijger, R; Favier, J				Oudijk, Lindsey; van Nederveen, Francien; Badoual, Cecile; Tissier, Frederique; Tischler, Arthur S.; Smid, Marcel; Gaal, Jose; Lepoutre-Lussey, Charlotte; Gimenez-Roqueplo, Anne-Paule; Dinjens, Winand N. M.; Korpershoek, Esther; de Krijger, Ronald; Favier, Judith			Vascular Pattern Analysis for the Prediction of Clinical Behaviour in Pheochromocytomas and Paragangliomas	PLOS ONE			English	Article							GLAND SCALED SCORE; TUMOR ANGIOGENESIS; EXPRESSION; GENETICS; BENIGN; KI-67	Pheochromocytomas (PCCs) are neuroendocrine tumors arising from chromaffin cells of the adrenal medulla. Related tumors that arise from the paraganglia outside the adrenal medulla are called paragangliomas (PGLs). PCC/PGLs are usually benign, but approximately 17% of these tumors are malignant, as defined by the development of metastases. Currently, there are no generally accepted markers for identifying a primary PCC or PGL as malignant. In 2002, Favier et al. described the use of vascular architecture for the distinction between benign and malignant primary PCC/PGLs. The aim of this study was to validate the use of vascular pattern analysis as a test for malignancy in a large series of primary PCC/PGLs. Six independent observers scored a series of 184 genetically well-characterized PCCs and PGLs for the CD34 immunolabeled vascular pattern and these findings were correlated to the clinical outcome. Tumors were scored as malignant if an irregular vascular pattern was observed, including vascular arcs, parallels and networks, while tumors with a regular pattern of short straight capillaries were scored as benign. Mean sensitivity and specificity of vascular architecture, as a predictor of malignancy was 59.7% and 72.9%, respectively. There was significant agreement between the 6 observers (mean kappa = 0.796). Mean sensitivity of vascular pattern analysis was higher in tumors > 5 cm (63.2%) and in genotype cluster 2 tumors (100%). In conclusion, vascular pattern analysis cannot be used in a stand-alone manner as a prognostic tool for the distinction between benign and malignant PCC, but could be used as an indicator of malignancy and might be a useful tool in combination with other morphological characteristics.	[Oudijk, Lindsey; Gaal, Jose; Dinjens, Winand N. M.; Korpershoek, Esther; de Krijger, Ronald] Erasmus MC, Univ Med Ctr, Erasmus MC Canc Inst, Dept Pathol, Rotterdam, Netherlands; [van Nederveen, Francien] PAL Dordrecht, Pathol Lab, Dordrecht, Netherlands; [Badoual, Cecile; Lepoutre-Lussey, Charlotte; Gimenez-Roqueplo, Anne-Paule; Favier, Judith] Univ Paris 05, Sorbonne Paris Cite, Fac Med, F-75006 Paris, France; [Badoual, Cecile] Hop Europeen Georges Pompidou, AP HP, Dept Anatomopathol, F-75015 Paris, France; [Tissier, Frederique] Univ Paris 06, Sorbonne Univ, Pitie Salpetriere Hosp, AP HP,Dept Pathol, Paris, France; [Tissier, Frederique] Univ Paris 05, Sorbonne Paris Cite, Inst Cochin, INSERM,CNRS,UMR8104,U1016, F-75006 Paris, France; [Tischler, Arthur S.] Tufts Univ, Sch Med, Dept Pathol, Boston, MA 02111 USA; [Tischler, Arthur S.] Tufts Med Ctr, Boston, MA USA; [Smid, Marcel] Canc Genom Netherlands, Erasmus MC Canc Inst, Dept Med Oncol, Rotterdam, Netherlands; [Lepoutre-Lussey, Charlotte; Gimenez-Roqueplo, Anne-Paule; Favier, Judith] INSERM, UMR970, Paris Cardiovasc Res Ctr, F-75015 Paris, France; [Gimenez-Roqueplo, Anne-Paule] Hop Europeen Georges Pompidou, AP HP, Serv Genet, F-75015 Paris, France; [de Krijger, Ronald] Reinier de Graaf Hosp, Dept Pathol, Delft, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus MC Cancer Institute; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Tufts University; Tufts Medical Center; Erasmus University Rotterdam; Erasmus MC; Erasmus MC Cancer Institute; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Reinier de Graaf Hospital	Favier, J (corresponding author), Univ Paris 05, Sorbonne Paris Cite, Fac Med, F-75006 Paris, France.	judith.favier@inserm.fr	Favier, Judith/M-7601-2017; Lussey-Lepoutre, Charlotte/AAO-7653-2020; de Krijger, Ronald/J-2564-2019; GIMENEZ-ROQUEPLO, Anne-Paule/T-6752-2018	Favier, Judith/0000-0001-8190-5853; Lussey-Lepoutre, Charlotte/0000-0003-2228-0106; GIMENEZ-ROQUEPLO, Anne-Paule/0000-0002-4816-670X; Tischler, Arthur/0000-0002-9726-5739; Smid, Marcel/0000-0003-0605-1901; Badoual, Cecile/0000-0002-1143-3085				August C, 2004, MODERN PATHOL, V17, P1119, DOI 10.1038/modpathol.3800160; Ayala-Ramirez M, 2011, J CLIN ENDOCR METAB, V96, P717, DOI 10.1210/jc.2010-1946; Crona J., 2013, J CLIN ENDOCRINOL ME; Dahia PLM, 2014, NAT REV CANCER, V14, P108, DOI 10.1038/nrc3648; Dahia PLM, 2005, PLOS GENET, V1, P72, DOI 10.1371/journal.pgen.0010008; Eisenhofer G, 2012, ENDOCR PATHOL, V23, P4, DOI 10.1007/s12022-011-9188-1; Elder EE, 2003, MODERN PATHOL, V16, P246, DOI 10.1097/01.MP.0000056982.07160.E3; Favier J, 2002, AM J PATHOL, V161, P1235, DOI 10.1016/S0002-9440(10)64400-8; Feng F, 2011, J UROLOGY, V185, P1583, DOI 10.1016/j.juro.2010.12.050; Gimenez-Roqueplo AP, 2012, HORM METAB RES, V44, P328, DOI 10.1055/s-0031-1301302; Kimura NTR, 2014, ENDOCR RELAT CANC; Lenders JWM, 2014, J CLIN ENDOCR METAB, V99, P1915, DOI 10.1210/jc.2014-1498; Lenders JWM, 2005, LANCET, V366, P665, DOI 10.1016/S0140-6736(05)67139-5; Letouze E, 2013, CANCER CELL, V23, P739, DOI 10.1016/j.ccr.2013.04.018; Liu Q, 1996, SURGERY, V120, P938, DOI 10.1016/S0039-6060(96)80037-7; Lloyd R, 2004, WHO CLASSIFICATION T; Lorenzo FR, 2012, J MOL MED BERL; Ohji H, 2001, BJU INT, V87, P381, DOI 10.1046/j.1464-410x.2001.00102.x; Ronald A, 2004, PATHOLOGY GENETICS T; Rooijens PPGM, 2004, ENDOCR PATHOL, V15, P39, DOI 10.1385/EP:15:1:39; Thompson LDR, 2002, AM J SURG PATHOL, V26, P551, DOI 10.1097/00000478-200205000-00002; Tischler AS, 2008, ARCH PATHOL LAB MED, V132, P1272, DOI 10.1043/1543-2165(2008)132[1272:PAEPU]2.0.CO;2; Welander J, 2011, ENDOCR-RELAT CANCER, V18, pR253, DOI 10.1530/ERC-11-0170; Wu D, 2009, AM J SURG PATHOL, V33, P599, DOI 10.1097/PAS.0b013e318190d12e; Zielke A, 2002, SURGERY, V132, P1056, DOI 10.1067/msy.2002.128613	25	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0121361	10.1371/journal.pone.0121361	http://dx.doi.org/10.1371/journal.pone.0121361			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25794004	Green Published, gold, Green Submitted			2022-12-27	WOS:000352083900127
J	Qin, WD; Mi, SH; Li, C; Wang, GX; Zhang, JN; Wang, H; Zhang, F; Ma, Y; Wu, DW; Zhang, MX				Qin, Wei-dong; Mi, Shao-hua; Li, Chen; Wang, Gui-xia; Zhang, Jian-ning; Wang, Hao; Zhang, Fan; Ma, Yang; Wu, Da-wei; Zhang, Mingxiang			Low Shear Stress Induced HMGB1 Translocation and Release via PECAM-1/PARP-1 Pathway to Induce Inflammation Response	PLOS ONE			English	Article							MOBILITY GROUP BOX-1; GLYCATION END-PRODUCTS; POLY(ADP-RIBOSE) POLYMERASE; WALL SHEAR; PROTEIN; ACTIVATION; EXPRESSION; CELLS; DNA; DYSFUNCTION	Low shear stress (LSS) plays a critical role in the site predilection of atherosclerosis through activation of cellular mechanosensors, such as platelet endothelial cell adhesion molecule 1 (PECAM-1). Poly(ADP-ribose) polymerase 1 (PARP-1) is a nuclear enzyme that regulates the expression of various inflammatory cytokines. The nuclear enzyme high mobility group box 1 (HMGB1) can induce inflammation response by binding to toll-like receptor 4 (TLR4). In the present study, we aimed to investigate the role and mechanism of HMGB1 in LSS induced inflammation in human umbilical vein endothelial cells (HUVECs). HUVECs were stimulated by undisturbed shear stress (USS, 1 Pa) and LSS (0.4 Pa) in our experiments. Gene expression was inhibited by small interfering RNA (siRNA). ICAM-1 expression was regulated by LSS in a time dependent manner. LSS can induce HMGB1 translocation from nucleus to cytoplasm and release. Compared with the USS, LSS could increase the protein expression of PECAM-1 and PARP-1 as well as the secretion of TNF-alpha and IL-1 beta. LSS induced the translocation of HMGB1 from nucleus to cytoplasm. Inhibition of HGMB1 reduced LSS-induced inflammatory response. Inhibition of PARP-1 suppressed inflammatory response through inhibiting TLR4 expression and HMGB1 translocation. PECAM-1 inhibition reduced LSS-induced ICAM-1 expression, TNF-alpha and IL-1 beta secretion, and monocytes adhesion. LSS can induce inflammatory response via PECAM-1/PARP-1/HMGB1 pathway. PARP-1 plays a fundamental role in HMGB1 translocation and TLR4 expression. Inhibition of PARP-1 may shed light on the treatment of HMGB1 involved inflammation during atherosclerosis.	[Qin, Wei-dong; Li, Chen; Zhang, Jian-ning; Wang, Hao; Zhang, Fan; Ma, Yang; Wu, Da-wei] Shandong Univ, Qilu Hosp, Dept Crit Care Unit, Jinan, Shandong, Peoples R China; [Mi, Shao-hua] Yu Huang Ding Hosp, Dept Cardiol, Yantai, Shandong, Peoples R China; [Wang, Gui-xia] Linyi Peoples Hosp, Dept Radiol, Linyi, Shandong, Peoples R China; [Zhang, Mingxiang] Shandong Univ, Qilu Hosp, Key Lab Cardiovasc Remodeling & Funct Res, Chinese Minist Educ, Jinan, Shandong, Peoples R China; [Zhang, Mingxiang] Shandong Univ, Qilu Hosp, Chinese Minist Publ Hlth, Jinan, Shandong, Peoples R China	Shandong University; Shandong University; Shandong University	Wu, DW (corresponding author), Shandong Univ, Qilu Hosp, Dept Crit Care Unit, Jinan, Shandong, Peoples R China.	wdw.55@163.com; season__202@163.com	, 秦伟栋/AAF-8151-2020; Qin, Weidong/GLU-1903-2022; Wang, Hao/AGS-5901-2022	Qin, Weidong/0000-0001-7238-6860; Wang, Hao/0000-0003-4493-3147	National 973 Basic Research Program of China [2009CB521904]; National Natural Science Foundation of China for Innovative Research Group [81021001]; State Key Program of National Natural Science of China [60831003]; National Natural Science Foundation of China [81170275, 30871037, 30873325, 81400340]	National 973 Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China for Innovative Research Group(National Natural Science Foundation of China (NSFC)); State Key Program of National Natural Science of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National 973 Basic Research Program of China (No. 2009CB521904), the State Program of National Natural Science Foundation of China for Innovative Research Group (No. 81021001), the State Key Program of National Natural Science of China (No. 60831003), and the National Natural Science Foundation of China (Nos. 81170275, 30871037, 30873325, and 81400340). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BIANCHI ME, 1989, SCIENCE, V243, P1056, DOI 10.1126/science.2922595; Burkle A, 2001, BIOESSAYS, V23, P795, DOI 10.1002/bies.1115; Bustin M, 1999, MOL CELL BIOL, V19, P5237; CARO CG, 1969, NATURE, V223, P1159, DOI 10.1038/2231159a0; Chappell DC, 1998, CIRC RES, V82, P532, DOI 10.1161/01.RES.82.5.532; Cohen-Armon M, 2007, TRENDS PHARM SCI; Dhawan SS, 2010, SHEAR STRESS PLAQUE; Dumitriu IE, 2005, J IMMUNOL, V174, P7506, DOI 10.4049/jimmunol.174.12.7506; Galkina E, 2007, ARTERIOSCL THROM VAS, V27, P2292, DOI 10.1161/ATVBAHA.107.149179; Han JY, 2008, DIABETES, V57, P2118, DOI 10.2337/db07-1499; Hassa PO, 2002, CELL MOL LIFE SCI, V59, P1534, DOI 10.1007/s00018-002-8527-2; Hill DA, 1999, NUCLEIC ACIDS RES, V27, P2135, DOI 10.1093/nar/27.10.2135; HORI O, 1995, J BIOL CHEM, V270, P25752, DOI 10.1074/jbc.270.43.25752; Jagtap P, 2005, NAT REV DRUG DISCOV, V4, P421, DOI 10.1038/nrd1718; Karlsson S, 2008, INTENS CARE MED, V34, P1046, DOI 10.1007/s00134-008-1032-9; Kim MY, 2005, GENE DEV, V19, P1951, DOI 10.1101/gad.1331805; Kokkola R, 2003, ARTHRITIS RHEUM, V48, P2052, DOI 10.1002/art.11161; Lotze MT, 2005, NAT REV IMMUNOL, V5, P331, DOI 10.1038/nri1594; McNally JS, 2003, AM J PHYSIOL-HEART C, V285, pH2290, DOI 10.1152/ajpheart.00515.2003; Mitola S, 2006, J IMMUNOL, V176, P12, DOI 10.4049/jimmunol.176.1.12; Pacher P, 2004, J PHARMACOL EXP THER, V311, P485, DOI 10.1124/jpet.104.069658; Pacher P, 2007, CARDIOVASC DRUG REV, V25, P235, DOI 10.1111/j.1527-3466.2007.00018.x; Park JS, 2003, AM J PHYSIOL-CELL PH, V284, pC870, DOI 10.1152/ajpcell.00322.2002; Paul A, 2003, ARTERIOSCLER THROMB; Poelmann RE, 2008, CIRCULATION, V117, P1124, DOI 10.1161/CIRCULATIONAHA.107.753889; Rao RM, 2007, CIRC RES, V101, P234, DOI 10.1161/CIRCRESAHA.107.151860b; Scaffidi P, 2002, NATURE, V418, P191, DOI 10.1038/nature00858; Schierbeck H, 2011, MOL MED, V17, P1039, DOI 10.2119/molmed.2010.00264; Sharp C, 2001, INFLAMMATION, V25, P157, DOI 10.1023/A:1011032313445; Soriano FG, 2001, CIRC RES, V89, P684, DOI 10.1161/hh2001.097797; Szabo C, 2002, CIRCULATION, V106, P2680, DOI 10.1161/01.CIR.0000038365.78031.9C; Szabo C, 1996, P NATL ACAD SCI USA, V93, P1753, DOI 10.1073/pnas.93.5.1753; Tzima E, 2005, NATURE, V437, P426, DOI 10.1038/nature03952; Urbonaviciute V, 2008, J EXP MED, V205, P3007, DOI 10.1084/jem.20081165; WALPOLA PL, 1995, ARTERIOSCL THROM VAS, V15, P2, DOI 10.1161/01.ATV.15.1.2; Wang J, 2011, MOL MED, V17, P990, DOI 10.2119/molmed.2011.00073; WEINBAUM S, 1993, J BIOMECH ENG-T ASME, V115, P602, DOI 10.1115/1.2895547; Yang HA, 2010, P NATL ACAD SCI USA, V107, P11942, DOI 10.1073/pnas.1003893107; ZARINS CK, 1983, CIRC RES, V53, P502, DOI 10.1161/01.RES.53.4.502; Zhou Z, 2005, EUR J PHARMACOL, V513, P1, DOI 10.1016/j.ejphar.2005.01.059	40	26	26	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0120586	10.1371/journal.pone.0120586	http://dx.doi.org/10.1371/journal.pone.0120586			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25793984	gold, Green Published, Green Submitted			2022-12-27	WOS:000352083900055
J	Thieme, K; Oliveira-Souza, M				Thieme, Karina; Oliveira-Souza, Maria			Renal Hemodynamic and Morphological Changes after 7 and 28 Days of Leptin Treatment: The Participation of Angiotensin II via the AT(1) Receptor	PLOS ONE			English	Article							NITRIC-OXIDE PRODUCTION; BLOOD-PRESSURE; INDUCED HYPERTENSION; ANTIOXIDANT TREATMENT; ENDOTHELIAL-CELLS; INFUSED RATS; OBESE RATS; KIDNEY; DISEASE; SYSTEM	The role of hyperleptinemia in cardiovascular diseases is well known; however, in the renal tissue, the exact site of leptin's action has not been established. This study was conducted to assess the effect of leptin treatment for 7 and 28 days on renal function and morphology and the participation of angiotensin II (Ang II), through its AT(1) receptor. Rats were divided into four groups: sham, losartan (10 mg/kg/day, s.c.), leptin (0.5 mg/kg/day for the 7 days group and 0.25 mg/kg/day for the 28 days group) and leptin plus losartan. Plasma leptin, Ang II and endothelin 1 (ET-1) levels were measured using an enzymatic immuno assay. The systolic blood pressure (SBP) was evaluated using the tail-cuff method. The renal plasma flow (RPF) and the glomerular filtration rate (GFR) were determined by p-aminohippuric acid and inulin clearance, respectively. Urinary Na+ and K+ levels were also analyzed. Renal morphological analyses, desmin and ED-1 immunostaining were performed. Proteinuria was analyzed by silver staining. mRNA expression of renin-angiotensin system (RAS) components, TNF-alpha and collagen type III was analyzed by quantitative PCR. Our results showed that leptin treatment increased Ang II plasma levels and progressively increased the SBP, achieving a pre-hypertension state. Rats treated with leptin 7 days showed a normal RPF and GFR, but increased filtration fraction (FF) and natriuresis. However, rats treated with leptin for 28 showed a decrease in the RPF, an increase in the FF and no changes in the GFR or tubular function. Leptin treatment-induced renal injury was demonstrated by: glomerular hypertrophy, increased desmin staining, macrophage infiltration in the renal tissue, TNF-a and collagen type III mRNA expression and proteinuria. In conclusion, our study demonstrated the progressive renal morphological changes in experimental hyperleptinemia and the interaction between leptin and the RAS on these effects.	[Thieme, Karina; Oliveira-Souza, Maria] Univ Sao Paulo, Inst Biomed Sci, Dept Physiol & Biophys, Sao Paulo, Brazil	Universidade de Sao Paulo	Thieme, K (corresponding author), Univ Sao Paulo, Inst Biomed Sci, Dept Physiol & Biophys, Sao Paulo, Brazil.	kathieme@icb.usp.br	Thieme, Karina/C-8560-2013; Oliveira-Souza, Maria/J-5800-2013	Thieme, Karina/0000-0003-2896-4445; Oliveira-Souza, Maria/0000-0003-0946-9377	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [08/58287-5, 10/51117-7, 10/19656-5, 13/19569-3, 13/23087-4]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [471946/2009-5, 1413112010-0]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) (Grants 08/58287-5, 10/51117-7, 10/19656-5, 13/19569-3, 13/23087-4) and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) (Grants 471946/2009-5 and 1413112010-0). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizawa-Abe M, 2000, J CLIN INVEST, V105, P1243, DOI 10.1172/JCI8341; Barton M, 2010, BBA-MOL BASIS DIS, V1802, P1203, DOI 10.1016/j.bbadis.2010.03.012; Beltowski J, 2002, OBES RES, V10, P939, DOI 10.1038/oby.2002.128; Beltowski J, 2006, ARCH MED RES, V37, P307, DOI 10.1016/j.arcmed.2005.06.008; Beltowski J, 2005, LIFE SCI, V77, P1855, DOI 10.1016/j.lfs.2005.02.013; Beltowski J, 2005, PHARMACOL RES, V51, P523, DOI 10.1016/j.phrs.2005.01.007; Beltowski J, 2005, ATHEROSCLEROSIS, V178, P403, DOI 10.1016/j.atherosclerosis.2004.10.002; Beltowski J, 2004, LIFE SCI, V74, P2987, DOI 10.1016/j.lfs.2003.10.029; Beltowski J, 2008, MOL CELL BIOCHEM, V319, P163, DOI 10.1007/s11010-008-9889-z; Beltowski J, 2008, J HYPERTENS, V26, P827, DOI 10.1097/HJH.0b013e3282f47688; Beltowski J, 2006, LIFE SCI, V79, P63, DOI 10.1016/j.lfs.2005.12.041; Beltowski J, 2007, REGUL PEPTIDES, V140, P168, DOI 10.1016/j.regpep.2006.12.007; Beltowski J, 2010, PEPTIDES, V31, P155, DOI 10.1016/j.peptides.2009.10.012; Beltowski J, 2009, LIFE SCI, V85, P557, DOI 10.1016/j.lfs.2009.08.002; Benigni A, 2001, AM J KIDNEY DIS, V37, pS21, DOI 10.1053/ajkd.2001.20734; Bettowski J, 2006, PEPTIDES, V27, P3234, DOI 10.1016/j.peptides.2006.08.010; Bornstein SR, 1998, HYPERTENSION, V32, P376, DOI 10.1161/01.HYP.32.2.376; Campos R, 2012, AM J PHYSIOL-LUNG C, V302, P1640, DOI 10.1152/ajplung.00097.2011; Castillo A, 2012, AM J PHYSIOL-RENAL, V302, pF1650, DOI 10.1152/ajprenal.00426.2011; Chen YC, 2011, EUR J PHARMACOL, V658, P213, DOI 10.1016/j.ejphar.2011.02.025; Coimbra TM, 2000, KIDNEY INT, V57, P167, DOI 10.1046/j.1523-1755.2000.00836.x; Crowley SD, 2009, J CLIN INVEST, V119, P943, DOI 10.1172/JCI34862; DiBona GF, 2004, HYPERTENSION, V43, P147, DOI 10.1161/01.HYP.0000113047.47711.fa; El-Gharbawy AH, 2002, AM J HYPERTENS, V15, P989, DOI 10.1016/S0895-7061(02)03089-3; Fortuno A, 2002, ENDOCRINOLOGY, V143, P3555, DOI 10.1210/en.2002-220075; FUHR J, 1955, KLIN WOCHENSCHR, V33, P729, DOI 10.1007/BF01473295; Gunduz Z, 2005, REGUL PEPTIDES, V132, P59, DOI 10.1016/j.regpep.2005.09.017; Hall JE, 2003, HYPERTENSION, V41, P625, DOI 10.1161/01.HYP.0000052314.95497.78; Hama H, 2004, ENDOCRINOLOGY, V145, P3935, DOI 10.1210/en.2004-0074; Han DC, 2001, KIDNEY INT, V59, P1315, DOI 10.1046/j.1523-1755.2001.0590041315.x; Hsu YH, 2012, EUR J PHARMACOL, V689, P65, DOI 10.1016/j.ejphar.2012.06.008; Ivy JR, 2014, J PHYSIOL-LONDON, V592, P3955, DOI 10.1113/jphysiol.2014.271676; Jackson EK, 1997, AM J PHYSIOL-RENAL, V272, pF333, DOI 10.1152/ajprenal.1997.272.3.F333; Kobori H, 2007, PHARMACOL REV, V59, P251, DOI 10.1124/pr.59.3.3; Kuo JJ, 2001, HYPERTENSION, V37, P670, DOI 10.1161/01.HYP.37.2.670; Loffreda S, 1998, FASEB J, V12, P57, DOI 10.1096/fasebj.12.1.57; Mark AL, 2002, J HYPERTENS, V20, P1245, DOI 10.1097/00004872-200207000-00001; Mark AL, 1999, J HYPERTENS, V17, P1949, DOI 10.1097/00004872-199917121-00026; Martinez-Anso E, 1999, KIDNEY INT, V55, P1129; Mehta PK, 2007, AM J PHYSIOL-CELL PH, V292, pC82, DOI 10.1152/ajpcell.00287.2006; Meyer C, 1997, AM J PHYSIOL-ENDOC M, V273, pE903, DOI 10.1152/ajpendo.1997.273.5.E903; Misra A, 1996, J INVEST MED, V44, P540; Morgan DA, 2008, AM J PHYSIOL-REG I, V295, pR1730, DOI 10.1152/ajpregu.90324.2008; Nasrallah MP, 2013, SEMIN NEPHROL, V33, P54, DOI 10.1016/j.semnephrol.2012.12.005; Navar LG, 2001, J RENIN-ANGIO-ALDO S, V2, pS176, DOI 10.1177/14703203010020013001; Nunes FC, 2011, J RENIN-ANGIO-ALDO S, V12, P440, DOI 10.1177/1470320310394891; Quehenberger P, 2002, CIRC RES, V90, P711, DOI 10.1161/01.RES.0000014226.74709.90; Marin ECS, 2011, NEPHRON EXP NEPHROL, V119, pE49, DOI 10.1159/000328337; Senador D, 2009, EXP PHYSIOL, V94, P648, DOI 10.1113/expphysiol.2008.046474; Shek EW, 1998, HYPERTENSION, V31, P409, DOI 10.1161/01.HYP.31.1.409; Shimizu MHM, 2013, EXP GERONTOL, V48, P298, DOI 10.1016/j.exger.2012.11.006; Skurk T, 2005, OBES RES, V13, P969, DOI 10.1038/oby.2005.113; SMITH HW, 1945, J CLIN INVEST, V24, P388, DOI 10.1172/JCI101618; Stenvinkel P, 1999, NEPHROL DIAL TRANSPL, V14, P1103, DOI 10.1093/ndt/14.5.1103; Villarreal D, 1998, AM J PHYSIOL-REG I, V275, pR2056, DOI 10.1152/ajpregu.1998.275.6.R2056; VONTHUN AM, 1994, AM J PHYSIOL, V266, pF120, DOI 10.1152/ajprenal.1994.266.1.F120; Wojcicka G, 2008, LIFE SCI, V82, P402, DOI 10.1016/j.lfs.2007.11.029; Wolf G, 2002, AM J KIDNEY DIS, V39, P1, DOI 10.1053/ajkd.2002.29865; Wolf G, 1999, KIDNEY INT, V56, P860, DOI 10.1046/j.1523-1755.1999.00626.x; Wollert KC, 1999, CARDIOVASC RES, V43, P838, DOI 10.1016/S0008-6363(99)00145-5; Zhang JD, 2014, HYPERTENSION, V64, P1275, DOI 10.1161/HYPERTENSIONAHA.114.03863; Zou LX, 1996, HYPERTENSION, V28, P669, DOI 10.1161/01.HYP.28.4.669; Zou LX, 1996, HYPERTENSION, V27, P658, DOI 10.1161/01.HYP.27.3.658	63	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0122265	10.1371/journal.pone.0122265	http://dx.doi.org/10.1371/journal.pone.0122265			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25793389	gold, Green Submitted, Green Published			2022-12-27	WOS:000352083900175
J	Zhao, MQ; Zheng, SG; Yang, JR; Wu, YJ; Ren, YN; Kong, X; Li, W; Xuan, JL				Zhao, Mengqiu; Zheng, Shuguo; Yang, Jieren; Wu, Yuanjie; Ren, Younan; Kong, Xiang; Li, Wei; Xuan, Jiali			Suppression of TGF-beta(1)/Smad Signaling Pathway by Sesamin Contributes to the Attenuation of Myocardial Fibrosis in Spontaneously Hypertensive Rats	PLOS ONE			English	Article							ANGIOTENSIN-II; CARDIAC FIBROBLASTS; INVOLVEMENT; EXPRESSION	This study investigated the effect of sesamin on myocardial fibrosis in spontaneously hypertensive rats (SHRs) and the possible mechanisms involved. Twenty-eight male SHRs were randomly allocated to SHR group, Ses160 group (sesamin 160 mg/kg), Ses80 group (sesamin 80 mg/kg) and Cap30 group (captopril 30 mg/kg). Seven male WKY rats were used as control. Sesamin and captopril were administered intragastrically for 12 weeks. Captopril significantly reduced systolic blood pressure and angiotensin II (Ang II) levels in SHRs, accompanied by a marked attenuation of left ventricular hypertrophy (LVH) and collagen deposition (P < 0.05 or P < 0.01). Though sesamin had no significant influence on Ang II levels, and the hypotensive effect was also significantly inferior to that of captopril (P < 0.05 or P < 0.01), however, the improvement of LVH and collagen deposition was similar to that in captopril group. Sesamin markedly reduced transforming growth factor-beta(1) (TGF-beta(1)) content in cardiac tissues, with Smad3 phosphorylation decreased and Smad7 protein expression increased notably (P < 0.05 or P < 0.01). Protein expression of type I collagen and type III collagen, target genes of Smad3, was down-regulated markedly by sesamin (P < 0.05 or P < 0.01). In addition, sesamin significantly increased total antioxidant capacity and superoxide dismutase protein in cardiac tissues (P < 0.05 or P < 0.01), while the expression of NADPH oxidase subunit p47phox and malondialdehyde content were reduced markedly (P < 0.05 or P < 0.01). In vitro studies also demonstrated that sesamin was able to suppress Ang II induced phosphorylation of Smad3 and secretion of TGF-beta 1 and type I and type III collagen in cultured rat cardiac fibroblasts. These data suggest that sesamin is capable of attenuating hypertensive myocardial fibrosis through, at least partly, suppression of TGF-beta(1)/Smad signaling pathway.	[Zhao, Mengqiu; Zheng, Shuguo; Yang, Jieren; Ren, Younan; Kong, Xiang; Li, Wei; Xuan, Jiali] Wannan Med Coll, Dept Pharmacol, Wuhu 241002, Peoples R China; [Wu, Yuanjie] Anhui Univ Chinese Med, Dept Basic Theory Chinese Med, Hefei 230038, Peoples R China	Wannan Medical College; Anhui University of Chinese Medicine	Zheng, SG (corresponding author), Wannan Med Coll, Dept Pharmacol, Wuhu 241002, Peoples R China.	zhengsg2000@163.com; anhuiwuyuanjie@126.com			Anhui Provincial Natural Science Foundation [1308085QH145]	Anhui Provincial Natural Science Foundation(Natural Science Foundation of Anhui Province)	Funding: This work was supported by Anhui Provincial Natural Science Foundation (No. 1308085QH145) (http://220.178.98.52/zrkxjj) to Xiang Kong. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berk BC, 2007, J CLIN INVEST, V117, P568, DOI 10.1172/JCI31044; Cat AND, 2013, ANTIOXID REDOX SIGN, V19, P1110, DOI 10.1089/ars.2012.4641; Chen K, 2004, CIRC RES, V95, P1167, DOI 10.1161/01.RES.0000150369.68826.2f; Donekal S, 2014, CIRC-CARDIOVASC IMAG, V7, P292, DOI 10.1161/CIRCIMAGING.113.001073; Golden HB, 2012, METHODS MOL BIOL, V843, P205, DOI 10.1007/978-1-61779-523-7_20; Gonzalez-Ramos M, 2013, INT J BIOCHEM CELL B, V45, P232, DOI 10.1016/j.biocel.2012.10.001; Graf K, 2010, HYPERTENSION, V55, P1088, DOI 10.1161/HYPERTENSIONAHA.110.150466; Itoh F, 2001, EMBO J, V20, P4132, DOI 10.1093/emboj/20.15.4132; Kannan A, 2014, CURR HYPERTENS REP, V16, DOI 10.1007/s11906-014-0447-7; Kong X, 2009, EUR J PHARMACOL, V620, P84, DOI 10.1016/j.ejphar.2009.08.023; Li WX, 2013, FOOD FUNCT, V4, P453, DOI 10.1039/c2fo30220a; Lijnen PJ, 2012, CARDIOVASC THER, V30, pe1, DOI 10.1111/j.1755-5922.2010.00205.x; Muxfeldt ES, 2014, CURR HYPERTENS REP, V16, DOI 10.1007/s11906-014-0471-7; Paravicini TM, 2008, DIABETES CARE, V31, pS170, DOI 10.2337/dc08-s247; Purnomo Y, 2013, OXID ANTIOXID MED SC, V2, P5; Purnomo Yudi, 2013, Cardiovascular & Hematological Disorders - Drug Targets, V13, P165; Qin YW, 2010, ACTA PHARMACOL SIN, V31, P1350, DOI 10.1038/aps.2010.109; Rehman A, 2012, HYPERTENSION, V59, P291, DOI 10.1161/HYPERTENSIONAHA.111.180158; Rizzi E, 2013, INT J CARDIOL, V165, P165, DOI 10.1016/j.ijcard.2011.08.060; Roghani M, 2011, INT J ENDOCRINOL MET, V9, P248, DOI 10.5812/Kowsar.1726913X.2142; Silva R. B. da, 2013, Health, V5, P78; Su SW, 2014, TOXICOL LETT, V224, P257, DOI 10.1016/j.toxlet.2013.10.034; Xu JA, 2010, AM J PHYSIOL-HEART C, V299, pH1328, DOI 10.1152/ajpheart.00538.2010; Yang L, 2009, EXP MOL MED, V41, P508, DOI 10.3858/emm.2009.41.7.056; Zhang YC, 2013, PROCEEDINGS OF THE EIGHTH INTERNATIONAL SYMPOSIUM ON VITICULTURE AND ENOLOGY (2013), P37	25	27	33	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0121312	10.1371/journal.pone.0121312	http://dx.doi.org/10.1371/journal.pone.0121312			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25793583	Green Submitted, Green Published, gold			2022-12-27	WOS:000352083900123
J	Zou, X; Wang, YK; Tu, GW; Zan, ZQ; Wu, XY				Zou, Xiang; Wang, Yongkang; Tu, Guangwei; Zan, Zhanquan; Wu, Xiaoyan			Adaptation and Transcriptome Analysis of Aureobasidium pullulans in Corncob Hydrolysate for Increased Inhibitor Tolerance to Malic Acid Production	PLOS ONE			English	Article							ESCHERICHIA-COLI; PROPIONIBACTERIUM-ACIDIPROPIONICI; SACCHAROMYCES-CEREVISIAE; FURFURAL TOLERANCE; POLYMALIC ACID; ORGANIC-ACIDS; FERMENTATION; PRETREATMENTS; ETHANOL	Malic acid is a dicarboxylic acid widely used in the food industry, and is also a potential C4 platform chemical. Corncob is a low-cost renewable feedstock from agricultural industry. However, side-reaction products (furfural, 5-hydroxymethylfurfural (HMF), formic acid, and acetic acid) that severely hinder fermentation are formed during corncob pretreatment. The process for producing malic acid from a hydrolysate of corncob was investigated with a polymalic acid (PMA)-producing Aureobasidium pullulans strain. Under the optimal hydrolysate sugar concentration 110 g/L, A. pullulans was further adapted in an aerobic fibrous bed bioreactor (AFBB) by gradually increasing the sugar concentration of hydrolysate. After nine batches of fermentation, the production and productivity of malic acid reached 38.6 g/L and 0.4 g/L h, respectively, which was higher than that in the first batch (27.6 g/L and 0.29 g/L h, respectively). The adapted strain could grow under the stress of 0.5 g/L furfural, 3 g/L HMF, 2g/L acetic acid, and 0.5 g/L formic acid, whereas the wild type did not. Transcriptome analysis revealed that the differentially expressed genes were related to carbohydrate transport and metabolism, lipid transport and metabolism, signal transduction mechanism, redox metabolism, and energy production and conversion under 0.5 g/L furfural and 3 g/L HMF stress conditions. In total, 42 genes in the adapted strain were upregulated by 15-fold or more, and qRT-PCR also confirmed that the expression levels of key genes (i.e. SIR, GSS, CYS, and GSR) involved in sulfur assimilation pathway were upregulated by over 10-fold in adapted strain for cellular protection against oxidative stress.	[Zou, Xiang; Wang, Yongkang; Tu, Guangwei; Zan, Zhanquan; Wu, Xiaoyan] Southwest Univ, Chongqing Engn Res Ctr Pharmaceut Proc & Qual Con, Coll Pharmaceut Sci, Chongqing 400715, Peoples R China; [Zou, Xiang] Chongqing Univ, Minist Educ, Key Lab Biorheol Sci & Technol, Chongqing 400044, Peoples R China	Southwest University - China; Chongqing University	Zou, X (corresponding author), Southwest Univ, Chongqing Engn Res Ctr Pharmaceut Proc & Qual Con, Coll Pharmaceut Sci, Chongqing 400715, Peoples R China.	zhx1030@swu.edu.cn		, xiang/0000-0002-5875-1224	National High Technology Research and Development Program of China (863 Program) [SS2015AA021005, 2014AA021205]; Fundamental Research Funds for the Central Universities [XDJK2013B039, 2362014XK07]; Visiting Scholar Foundation of Key Laboratory of Biorheological Science and Technology (Chongqing University), Ministry of Education [CQKLBST- 2014-006]	National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Visiting Scholar Foundation of Key Laboratory of Biorheological Science and Technology (Chongqing University), Ministry of Education	Funding: This work was supported by grants from the National High Technology Research and Development Program of China (863 Program) (SS2015AA021005 and 2014AA021205), Fundamental Research Funds for the Central Universities (XDJK2013B039 and 2362014XK07), and Visiting Scholar Foundation of Key Laboratory of Biorheological Science and Technology (Chongqing University), Ministry of Education (CQKLBST- 2014-006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen SA, 2010, BIOTECHNOL BIOFUELS, V3, DOI 10.1186/1754-6834-3-2; ASK M, 2013, BIOTECHNOL BIOFUELS, V6; BATTAT E, 1991, BIOTECHNOL BIOENG, V37, P1108, DOI 10.1002/bit.260371117; Brown SH, 2013, APPL MICROBIOL BIOT, V97, P8903, DOI 10.1007/s00253-013-5132-2; Cheng KK, 2010, APPL MICROBIOL BIOT, V87, P411, DOI 10.1007/s00253-010-2612-5; Chi ZM, 2009, APPL MICROBIOL BIOT, V82, P793, DOI 10.1007/s00253-009-1882-2; Davila JA, 2014, BIORESOURCE TECHNOL, V161, P84, DOI 10.1016/j.biortech.2014.02.131; Eken-Saracoglu N, 2000, BIOTECHNOL LETT, V22, P855, DOI 10.1023/A:1005663313597; Goldberg I, 2006, J CHEM TECHNOL BIOT, V81, P1601, DOI 10.1002/jctb.1590; Grant CM, 2001, MOL MICROBIOL, V39, P533, DOI 10.1046/j.1365-2958.2001.02283.x; Jiang L, 2011, BIOTECHNOL BIOENG, V108, P31, DOI 10.1002/bit.22927; Kawagoe M, 1997, J FERMENT BIOENG, V84, P333, DOI 10.1016/S0922-338X(97)89254-9; Kim D, 2013, APPL ENVIRON MICROB, V79, P5069, DOI 10.1128/AEM.00643-13; Liu HM, 2011, APPL BIOCHEM BIOTECH, V164, P1150, DOI 10.1007/s12010-011-9201-7; Liu XG, 2006, PROCESS BIOCHEM, V41, P801, DOI 10.1016/j.procbio.2005.10.009; Moon SY, 2008, BIOCHEM ENG J, V40, P312, DOI 10.1016/j.bej.2008.01.001; Robinson T, 2002, BIORESOURCE TECHNOL, V85, P119, DOI 10.1016/S0960-8524(02)00099-8; Sanchez C, 2012, CHEM ENG J, V181, P655, DOI 10.1016/j.cej.2011.12.033; Sauer M, 2008, TRENDS BIOTECHNOL, V26, P100, DOI 10.1016/j.tibtech.2007.11.006; Suwannakham S, 2005, BIOTECHNOL BIOENG, V91, P325, DOI 10.1002/bit.20473; Taing O, 2007, EUR FOOD RES TECHNOL, V224, P343, DOI 10.1007/s00217-006-0323-z; Thorsen M, 2006, MOL BIOL CELL, V17, P4400, DOI 10.1091/mbc.E06-04-0315; Wang X, 2011, APPL ENVIRON MICROB, V77, P5132, DOI 10.1128/AEM.05008-11; Wang X, 2013, P NATL ACAD SCI USA, V110, P4021, DOI 10.1073/pnas.1217958110; Werpy T., 2004, TOP VALUE ADDED CHEM, DOI DOI 10.2172/15008859; Yang J, 2012, OMICS, V16, P374, DOI 10.1089/omi.2011.0127; Yu J, 2010, J IND MICROBIOL BIOT, V37, P1033, DOI 10.1007/s10295-010-0750-5; Zalar P, 2008, STUD MYCOL, P21, DOI 10.3114/sim.2008.61.02; Zan ZQ, 2013, J CHEM TECHNOL BIOT, V88, P1822, DOI 10.1002/jctb.4033; Zelle RM, 2008, APPL ENVIRON MICROB, V74, P2766, DOI 10.1128/AEM.02591-07; Zhang A, 2009, BIOTECHNOL BIOENG, V104, P766, DOI 10.1002/bit.22437; Zhang X, 2011, APPL ENVIRON MICROB, V77, P427, DOI 10.1128/AEM.01971-10; Zou X, 2013, BIOTECHNOL BIOENG, V110, P2105, DOI 10.1002/bit.24876	33	23	26	1	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0121416	10.1371/journal.pone.0121416	http://dx.doi.org/10.1371/journal.pone.0121416			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25793624	gold, Green Published, Green Submitted			2022-12-27	WOS:000352083900132
J	bin Shawkataly, O; Goh, CP; Abu Tariq; Khan, IA; Fun, HK; Rosli, MM				bin Shawkataly, Omar; Goh, Chin-Ping; Abu Tariq; Khan, Imthyaz Ahmad; Fun, Hoong-Kun; Rosli, Mohd Mustaqim			Synthesis, Spectral Characterization and Crystals Structure of some Arsane Derivatives of Gold (I) Complexes: A Comparative Density Functional Theory Study	PLOS ONE			English	Article							AB-INITIO; CHEMISTRY; PLATINUM; POLYMERS; LIGANDS; HALIDES	A series of complexes of the type LAuCl where L = tris(p-tolylarsane), tris(m-tolylarsane), bis(diphenylarsano)ethane, and tris(naphthyl)arsane have been synthesized. All of the new complexes, 1-4, have been fully characterized by means of H-1 NMR and C-13 NMR spectroscopy and single crystal X-ray crystallography. The structures of complexes 1-4 have been determined from X-ray diffraction data. The linear molecules have an average bond distance between gold-arsenic and gold-chlorine of 2.3390 angstrom and 2.2846 angstrom, respectively. Aurophilic interaction was prominent in complex 1 and 3, whereas complex 2 and 4 do not show any such interaction. The intermolecular gold interaction bond length was affected by the electronegativity of the molecule. The computed values calculated at DFT level using B3LYP function are in good agreement with the experimental results.	[bin Shawkataly, Omar; Goh, Chin-Ping; Abu Tariq; Khan, Imthyaz Ahmad] Univ Sains Malaysia, Sch Distance Educ, Chem Sci Programme, George Town 11800, Malaysia; [Fun, Hoong-Kun; Rosli, Mohd Mustaqim] Univ Sains Malaysia, Sch Phys, Xray Crystallog Unit, George Town 11800, Malaysia; [Fun, Hoong-Kun] King Saud Univ, Dept Pharmaceut Chem, Coll Pharm, Riyadh 11451, Saudi Arabia	Universiti Sains Malaysia; Universiti Sains Malaysia; King Saud University	bin Shawkataly, O (corresponding author), Univ Sains Malaysia, Sch Distance Educ, Chem Sci Programme, George Town 11800, Malaysia.	omarsa@usm.my	Shawkataly, Omar/B-6034-2009; Fun, Hoong-Kun/A-3561-2009; Goh, Chin-Ping/K-6134-2013	Shawkataly, Omar/0000-0002-6248-6785; Rosli, Mohd Mustaqim/0000-0001-8402-1914	Malaysian Government; Universiti Sains Malaysia (USM) [1001/PJJAUH/811225]; Ministry of Education Malaysia; Universiti Sains Malaysia [1001/PFIZIK/811160]; Deanship of Scientific Research at King Saud University [RGP-VPP-207]	Malaysian Government; Universiti Sains Malaysia (USM)(Universiti Sains Malaysia); Ministry of Education Malaysia(Ministry of Education, Malaysia); Universiti Sains Malaysia(Universiti Sains Malaysia); Deanship of Scientific Research at King Saud University(King Saud University)	This study was supported by the Malaysian Government and Universiti Sains Malaysia (USM) (University Research Grant 1001/PJJAUH/811225 received by OBS); the Ministry of Education Malaysia, (MyPhD Scholarship Programme received by CPG) (https://biasiswa.moe.gov.my/MyBrain15/v2/index_myphd.php); the Universiti Sains Malaysia, (Post-Doctoral Fellowship received by AT); the Universiti Sains Malaysia, (Visiting Researcher Position received by IAK); Malaysian Government and Universiti Sains Malaysia (USM) (University Research Grant 1001/PFIZIK/811160 received by HKF and MMR); the Deanship of Scientific Research at King Saud University (project No. RGP-VPP-207 received by HKF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdou HE, 2009, COORDIN CHEM REV, V253, P1661, DOI 10.1016/j.ccr.2009.02.010; Anderson KM, 2007, INORG CHEM, V46, P6444, DOI 10.1021/ic700466y; [Anonymous], 2002, CRIT REV HEMATOL ONC; Balch AL, 1999, COORDIN CHEM REV, V185-6, P601, DOI 10.1016/S0010-8545(99)00013-2; BALCH AL, 1990, J AM CHEM SOC, V112, P5181, DOI 10.1021/ja00169a028; Barnard PJ, 2007, COORDIN CHEM REV, V251, P1889, DOI 10.1016/j.ccr.2007.04.006; Barnes NA, 2010, CRYSTENGCOMM, V12, P4240, DOI 10.1039/c0ce00024h; BECKE AD, 1993, J CHEM PHYS, V98, P5648, DOI 10.1063/1.464913; Bott RC, 2004, AUST J CHEM, V57, P213, DOI 10.1071/CH03172; BRUCE MI, 1989, INORG SYN, V26, P324, DOI 10.1002/9780470132579.ch59; Bruker, 2009, APEX2 SAINT SADABS; Bunge SD, 2000, ANGEW CHEM INT EDIT, V39, P3082, DOI 10.1002/1521-3773(20000901)39:17<3082::AID-ANIE3082>3.0.CO;2-2; Cabeza JA, 2008, ORGANOMETALLICS, V27, P4697, DOI 10.1021/om8006085; Cabrera GS, 2002, J ORGANOMET CHEM, V660, P153; Chiffey AF, 1996, POLYHEDRON, V15, P591, DOI 10.1016/0277-5387(95)00294-3; COOPER MK, 1984, INORG CHIM A-ART LET, V84, pL9, DOI 10.1016/S0020-1693(00)87658-6; DHUBHGHAILL OMN, 1990, J CHEM SOC DALTON, P2913; Feller D, 1996, J COMPUT CHEM, V17, P1571, DOI 10.1002/jcc.9; Frisch M.J., 2016, GAUSSIAN16 REV B01; HAY PJ, 1978, J CHEM PHYS, V69, P984, DOI 10.1063/1.436651; Hayashi A, 2002, J AM CHEM SOC, V124, P5791, DOI 10.1021/ja012416y; Irwin MJ, 1996, CHEM COMMUN, P1281, DOI 10.1039/cc9960001281; Irwin MJ, 1996, J AM CHEM SOC, V118, P13101, DOI 10.1021/ja963441k; Jensen F., 2007, INTRO COMPUTATIONAL, P30; JONES PG, 1980, ACTA CRYSTALLOGR B, V36, P2775, DOI 10.1107/S0567740880009983; Kitadai K, 2006, DALTON T, P2560, DOI 10.1039/b516538e; Laguna A, 2008, GOLD GOLD INTERACTIO, P65; LEE CT, 1988, PHYS REV B, V37, P785, DOI 10.1103/PhysRevB.37.785; Lim SH, 2012, INORG CHEM, V51, P1925, DOI 10.1021/ic2022165; Monkowius U, 2003, Z NATURFORSCH B, V58, P751, DOI 10.1515/znb-2003-0806; Monkowius U, 2009, Z NATURFORSCH B, V64, P1513, DOI 10.1515/znb-2009-11-1235; Nomiya K, 1998, J CHEM SOC DALTON, P4101, DOI 10.1039/a806283h; Odoh SO, 2010, J PHYS CHEM A, V114, P1957, DOI 10.1021/jp909576w; Ott I, 2009, COORDIN CHEM REV, V253, P1670, DOI 10.1016/j.ccr.2009.02.019; Pantazis DA, 2008, J CHEM THEORY COMPUT, V4, P908, DOI 10.1021/ct800047t; Paul M, 1996, CHEM BER, V129, P77, DOI 10.1002/cber.19961290116; Phillips FC, 1901, J AM CHEM SOC, V23, P250, DOI 10.1021/ja02030a008; PITZER KS, 1979, ACCOUNTS CHEM RES, V12, P272; Puddephatt RJ, 1998, CHEM COMMUN, P1055, DOI 10.1039/a800244d; PYYKKO P, 1979, ACCOUNTS CHEM RES, V12, P276, DOI 10.1021/ar50140a002; PYYKKO P, 1988, CHEM REV, V88, P563, DOI 10.1021/cr00085a006; Rackham O, 2007, BIOCHEM PHARMACOL, V74, P992, DOI 10.1016/j.bcp.2007.07.022; Schuchardt KL, 2007, J CHEM INF MODEL, V47, P1045, DOI 10.1021/ci600510j; SCHWERDTFEGER P, 1990, INORG CHEM, V29, P3593, DOI 10.1021/ic00343a057; SCHWERDTFEGER P, 1989, J CHEM PHYS, V91, P1762, DOI 10.1063/1.457082; Shawkataly OB, 2011, ACTA CRYSTALLOGR E, VE67, P427; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; STEPHENS PJ, 1994, J PHYS CHEM-US, V98, P11623, DOI 10.1021/j100096a001; Tiekink Edward R T, 2003, Bioinorg Chem Appl, P53, DOI 10.1155/S1565363303000050; Wang XY, 2008, DALTON T, P1521, DOI 10.1039/b715903j; WEISSBART B, 1995, INORG CHEM, V34, P393, DOI 10.1021/ic00105a060; ZIEGLER T, 1980, CHEM PHYS LETT, V75, P1, DOI 10.1016/0009-2614(80)80451-9	52	1	1	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0119620	10.1371/journal.pone.0119620	http://dx.doi.org/10.1371/journal.pone.0119620			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25798915	Green Published, gold, Green Submitted			2022-12-27	WOS:000351987300064
J	Wosgrau, ACC; Jeremias, TD; Leonardi, DF; Pereima, MJ; Di Giunta, G; Trentin, AG				Camara Wosgrau, Ana Carolina; Jeremias, Talita da Silva; Leonardi, Dilmar Francisco; Pereima, Mauricio Jose; Di Giunta, Gabriella; Trentin, Andrea Goncalves			Comparative Experimental Study of Wound Healing in Mice: Pelnac versus Integra	PLOS ONE			English	Article							ARTIFICIAL DERMIS; SUBSTITUTE; SKIN; REPAIR; BURNS; RECONSTRUCTION; SURGERY; LAYER	Strategies for skin regeneration have been developed to provide effective treatment for cutaneous wounds and disease. Dermal substitutes have been used to cover the lesion to facilitate cell colonization, thereby promoting dermal regeneration. However, very little is known about Pelnac matrix especially at histological level. Therefore, the present work carried out an experimental in vivo comparative analysis between Pelnac and Integra, the most used dermal templates, in a mouse model of full-thickness skin wounds. Histological sections performed at the 3rd, 6th and 9th days after surgery were analyzed with regard to inflammatory response and vascularization. Both templates were completely incorporated in all animals at the end of the analyzed period. Pelnac-treated animals displayed reduced granulation tissue during the first 6 days of treatment compared to the animals treated with Integra at the same time period. The number of inflammatory cells (neutrophils) was similar in both groups during the period, significantly reducing at the end of inflammatory phase (9th day of treatment) consistent with the progression of healing process. In addition, the density of blood vessels was also statistically similar in both matrices. Therefore, the two dermal templates displayed comparable biological behavior in tissue repair. It is noteworthy that this is the first experimental study comparing Pelnac and Integra dermal templates with focus on full-thickness skin wounds.	[Camara Wosgrau, Ana Carolina; Jeremias, Talita da Silva; Trentin, Andrea Goncalves] Univ Fed Santa Catarina, Ctr Ciencias Biol, Dept Biol Celular Embriol & Genet, Florianopolis, SC, Brazil; [Camara Wosgrau, Ana Carolina] Univ Fed Santa Catarina, Hosp Univ, Serv Pediat, Florianopolis, SC, Brazil; [Pereima, Mauricio Jose] Univ Fed Santa Catarina, Dept Pediat, Ctr Ciencias Saude, Florianopolis, SC, Brazil; [Di Giunta, Gabriella] Univ Fed Santa Catarina, Hosp Univ, Serv Anat Patol, Florianopolis, SC, Brazil; [Leonardi, Dilmar Francisco] Univ Sul Santa Catarina, Dept Cirurgia, Palhoca, SC, Brazil; [Pereima, Mauricio Jose] Hosp Infantil Joana de Gusmao, Florianopolis, SC, Brazil	Universidade Federal de Santa Catarina (UFSC); Universidade Federal de Santa Catarina (UFSC); Universidade Federal de Santa Catarina (UFSC); Universidade Federal de Santa Catarina (UFSC); Universidade do Sul de Santa Catarina	Trentin, AG (corresponding author), Univ Fed Santa Catarina, Ctr Ciencias Biol, Dept Biol Celular Embriol & Genet, Florianopolis, SC, Brazil.	andrea.trentin@ufsc.br	Trentin, Andrea/ABC-6215-2020	Trentin, Andrea/0000-0003-4961-5754	Ministerio da Saude (MS-SCTIE-DECIT); Ministerio da Ciencia, Tecnologia e Inovacao/Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (MCTI/CNPq/Brazil); CNPq/PIBIC/PIBIT (Brazil); Coordenacao de Aperfeicamento de Pessoal de Nivel Superior (CAPES, Brazil); Fundacao de Amparo a Pesquisa do Estado de Santa Catarina (FAPESC-PPSUS, Brazil)	Ministerio da Saude (MS-SCTIE-DECIT); Ministerio da Ciencia, Tecnologia e Inovacao/Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (MCTI/CNPq/Brazil); CNPq/PIBIC/PIBIT (Brazil); Coordenacao de Aperfeicamento de Pessoal de Nivel Superior (CAPES, Brazil); Fundacao de Amparo a Pesquisa do Estado de Santa Catarina (FAPESC-PPSUS, Brazil)	Funding: This work was supported by the Ministerio da Saude (MS-SCTIE-DECIT), Ministerio da Ciencia, Tecnologia e Inovacao/Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (MCTI/CNPq/Brazil), CNPq/PIBIC/PIBIT (Brazil), Coordenacao de Aperfeicamento de Pessoal de Nivel Superior (CAPES, Brazil), and Fundacao de Amparo a Pesquisa do Estado de Santa Catarina (FAPESC-PPSUS, Brazil). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bloemen MCT, 2010, PLAST RECONSTR SURG, V125, P1450, DOI 10.1097/PRS.0b013e3181d62b08; Bottcher-Haberzeth S, 2012, PEDIATR SURG INT, V28, P171, DOI 10.1007/s00383-011-2990-5; Brodbeck WG, 2009, CURR OPIN HEMATOL, V16, P53, DOI 10.1097/MOH.0b013e32831ac52e; BURKE JF, 1981, ANN SURG, V194, P413, DOI 10.1097/00000658-198110000-00005; Capito AE, 2012, ANN PLAS SURG, V68, P495, DOI 10.1097/SAP.0b013e31823b6b01; De Vries Henry J. C., 1993, Wound Repair and Regeneration, V1, P244, DOI 10.1046/j.1524-475X.1993.10410.x; Eming SA, 2007, J INVEST DERMATOL, V127, P514, DOI 10.1038/sj.jid.5700701; Eo S, 2011, INT WOUND J, V8, P261, DOI 10.1111/j.1742-481X.2011.00780.x; Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039; Harish V, 2014, J PLAST RECONSTR AES, V67, P1151, DOI 10.1016/j.bjps.2014.03.033; HEIMBACH D, 1988, ANN SURG, V208, P313, DOI 10.1097/00000658-198809000-00008; Heimbach DM, 2003, J BURN CARE REHABIL, V24, P42, DOI 10.1097/00004630-200301000-00009; Heitland A, 2004, BURNS, V30, P471, DOI 10.1016/j.burns.2004.01.010; Jeremias TD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089542; Kobus K, 2009, HISTOCHEM CELL BIOL, V132, P525, DOI 10.1007/s00418-009-0630-0; Leonardi D, 2012, BURNS, V38, P1143, DOI 10.1016/j.burns.2012.07.028; MacNeil S, 2007, NATURE, V445, P874, DOI 10.1038/nature05664; Mandarim-De-Lacerda CA, 2003, AN ACAD BRAS CIENC, V75, P469, DOI 10.1590/S0001-37652003000400006; Mizuno H, 1999, AESTHET PLAST SURG, V23, P316, DOI 10.1007/s002669900292; Nguyen DQA, 2010, BURNS, V36, P23, DOI 10.1016/j.burns.2009.07.011; Papa G, 2014, G CHIR, V35, P141, DOI 10.11138/gchir/2014.35.5.141; Papa G, 2011, DERMATOL SURG, V37, P1631, DOI 10.1111/j.1524-4725.2011.02156.x; Papini R, 2004, BRIT MED J, V329, P158, DOI 10.1136/bmj.329.7458.158; Parenteau-Bareil R, 2011, ACTA BIOMATER, V7, P3757, DOI 10.1016/j.actbio.2011.06.020; Shahrokhi S, 2014, WOUND REPAIR REGEN, V22, P14, DOI 10.1111/wrr.12119; Shevchenko RV, 2010, J R SOC INTERFACE, V7, P229, DOI 10.1098/rsif.2009.0403; Suzuki S, 2000, BRIT J PLAST SURG, V53, P659, DOI 10.1054/bjps.2000.3426; SUZUKI S, 1995, BRIT J PLAST SURG, V48, P222, DOI 10.1016/0007-1226(95)90006-3; Suzuki S, 2013, J PLAST RECONSTR AES, V66, pE229, DOI 10.1016/j.bjps.2013.03.018; Truong Anh-Tuan N, 2005, J Burns Wounds, V4, pe4; van der Veen VC, 2010, BURNS, V36, P305, DOI 10.1016/j.burns.2009.07.012	31	23	27	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0120322	10.1371/journal.pone.0120322	http://dx.doi.org/10.1371/journal.pone.0120322			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25798623	gold, Green Submitted, Green Published			2022-12-27	WOS:000351987300133
J	de Oliveira, PB; Puchnick, A; Szejnfeld, J; Goldman, SM				de Oliveira, Patricia Bedesco; Puchnick, Andrea; Szejnfeld, Jacob; Goldman, Suzan Menasce			Prevalence of Incidental Pancreatic Cysts on 3 Tesla Magnetic Resonance	PLOS ONE			English	Article							LESIONS; NEOPLASMS; DILATATION; DUCT	Objectives To ascertain the prevalence of pancreatic cysts detected incidentally on 3-Tesla magnetic resonance imaging (MRI) of the abdomen and correlate this prevalence with patient age and gender; assess the number, location, and size of these lesions, as well as features suspicious for malignancy; and determine the prevalence of incidentally detected dilatation of the main pancreatic duct (MPD). Methods Retrospective analysis of 2,678 reports of patients who underwent abdominal MRI between January 2012 and June 2013. Patients with a known history of pancreatic conditions or surgery were excluded, and the remaining 2,583 reports were examined for the presence of pancreatic cysts, which was then correlated with patient age and gender. We also assessed whether cysts were solitary or multiple, as well as their location within the pancreatic parenchyma, size, and features suspicious for malignancy. Finally, we calculated the prevalence of incidental MPD dilatation, defined as MPD diameter >= 2.5 mm. Results Pancreatic cysts were detected incidentally in 9.3% of patients (239/2,583). The prevalence of pancreatic cysts increased significantly with age (p<0.0001). There were no significant differences in prevalence between men and women (p=0.588). Most cysts were multiple (57.3%), distributed diffusely throughout the pancreas (41.8%), and 5 mm or larger (81.6%). In 12.1% of cases, cysts exhibited features suspicious for malignancy. Overall, 2.7% of subjects exhibited incidental MPD dilatation. Conclusions In this sample, the prevalence of pancreatic cysts detected incidentally on 3T MRI of the abdomen was 9.3%. Prevalence increased with age and was not associated with gender. The majority of cysts were multiple, diffusely distributed through the pancreatic parenchyma, and >= 5 mm in size; 12.1% were suspicious for malignancy. An estimated 2.7% of subjects had a dilated MPD.	[de Oliveira, Patricia Bedesco; Puchnick, Andrea; Szejnfeld, Jacob; Goldman, Suzan Menasce] Univ Fed Sao Paulo UNIFESP, Escola Paulista Med, Dept Imaging Diag, Sao Paulo, SP, Brazil	Universidade Federal de Sao Paulo (UNIFESP)	de Oliveira, PB (corresponding author), Univ Fed Sao Paulo UNIFESP, Escola Paulista Med, Dept Imaging Diag, Sao Paulo, SP, Brazil.	patricia_oliveira72@yahoo.com	Puchnick, Andrea/E-7826-2014	Puchnick, Andrea/0000-0002-7234-7121				Balcom IV J H, 2000, Curr Gastroenterol Rep, V2, P152; Canto MI, 2012, GASTROENTEROLOGY, V142, P796, DOI 10.1053/j.gastro.2012.01.005; Fernandez-del Castillo C, 2003, ARCH SURG-CHICAGO, V138, P427; Goh BKP, 2006, AM J SURG, V192, P148, DOI 10.1016/j.amjsurg.2006.02.020; Hruban RH, 2007, J HEPATO-BILIARY-PAN, V14, P255, DOI 10.1007/s00534-006-1170-9; IKEDA M, 1994, PANCREAS, V9, P508, DOI 10.1097/00006676-199407000-00014; Kiely JM, 2003, J GASTROINTEST SURG, V7, P890, DOI 10.1016/S1091-255X(03)00145-8; Kimura W, 1995, INT J PANCREATOL, V18, P197; Laffan TA, 2008, AM J ROENTGENOL, V191, P802, DOI 10.2214/AJR.07.3340; Lee KS, 2010, AM J GASTROENTEROL, V105, P2079, DOI 10.1038/ajg.2010.122; Matsubara S, 2012, PANCREAS, V41, P1241, DOI 10.1097/MPA.0b013e31824f5970; Megibow AJ, 2001, ABDOM IMAGING, V26, P640, DOI 10.1007/s00261-001-0024-9; MINAMI M, 1989, RADIOLOGY, V171, P53, DOI 10.1148/radiology.171.1.2928546; Spinelli KS, 2004, ANN SURG, V239, P651, DOI 10.1097/01.sla.0000124299.57430.ce; Tanaka S, 2010, RADIOLOGY, V254, P965, DOI 10.1148/radiol.09090992; Zaheer A, 2013, ABDOM IMAGING, V38, P331, DOI 10.1007/s00261-012-9898-y; Zhang XM, 2002, RADIOLOGY, V223, P547, DOI 10.1148/radiol.2232010815	17	28	28	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0121317	10.1371/journal.pone.0121317	http://dx.doi.org/10.1371/journal.pone.0121317			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25798910	Green Published, Green Submitted, gold			2022-12-27	WOS:000351987300234
J	He, L; Gao, L; Shi, Z; Li, YH; Zhu, LY; Li, SM; Zhang, P; Zheng, GY; Ren, Q; Li, Y; Hu, B; Feng, FM				He, Lei; Gao, Li; Shi, Zhe; Li, Yuhong; Zhu, Lingyan; Li, Shiming; Zhang, Peng; Zheng, Guoying; Ren, Qi; Li, Yun; Hu, Bo; Feng, Fumin			Involvement of Cytochrome P450 1A1 and Glutathione S-Transferase P1 Polymorphisms and Promoter Hypermethylation in the Progression of Anti-Tuberculosis Drug-Induced Liver Injury: A Case-Control Study	PLOS ONE			English	Article							DNA METHYLATION; CYP1A1 POLYMORPHISMS; LOW-DOSAGE; GSTM1; SUSCEPTIBILITY; CANCER; GENES; RISK; 2E1	Background Anti-tuberculosis (anti-TB) drug-induced liver injury (ADLI) is one of the most common adverse effects associated with TB treatment. Cytochrome P450 (CYP) 1A1 and glutathione S-transferase (GST) P1 are important phase I/II metabolizing enzymes involved in drug metabolism and detoxification. Genetic polymorphism and CpG island methylation have been reported as factors influencing the expression of CYP1A1 and GSTP1. Objective This study aimed to determine the potential relationships of CYP1A1 and GSTP1 polymorphisms and CpG island methylation with ADLI risk. Design This was a population-based one-to-one matched case-control study. Setting The subjects were patients with TB receiving treatment in China from December 2010 to June 2013. Patients In total, 127 patients with TB and ADLI (case group) and 127 patients with TB but without liver injury (control group) were included in this study. Subjects were matched in terms of sex, age, and therapeutic regimen. Methods The general condition of each patient was assessed using questionnaires. The CYP1A1 MspI and GSTP1 Ile105Val polymorphisms as well as methylation status were detected by polymerase chain reaction (PCR)-restriction fragment length polymorphism and the methylation-specific PCR method. Results We found no significant difference in GSTP1 and CYP1A1 genotypes between the two groups, probably because the sample size was not large enough; however, patients with ADLI had significantly higher GSTP1 and CYP1A1 promoter methylation rates than control subjects [odds ratio (OR) = 2.467 and 2.000, respectively]. After adjusting for drinking, which significantly differed between the groups as per univariate analysis, we found that hypermethylation of GSTP1 and CYP1A1 promoters was associated with ADLI (OR = 2.645 and 2.090, respectively). Conclusion Hypermethylation of CpG islands of GSTP1 and CYP1A1 promoters may thus play important roles in the development of ADLI and provide evidence of being used as novel markers for ADLI risk prediction.	[He, Lei; Gao, Li; Shi, Zhe; Li, Yuhong; Zhu, Lingyan; Zheng, Guoying; Ren, Qi; Li, Yun; Hu, Bo; Feng, Fumin] Hebei United Univ, Sch Publ Hlth, Key Lab Occupat Hlth & Safety, Tangshan 063000, Peoples R China; [Li, Shiming; Zhang, Peng] Tangshan TB Hosp, Dept Clin Labs, Tangshan 063000, Peoples R China	North China University of Science & Technology	Feng, FM (corresponding author), Hebei United Univ, Sch Publ Hlth, Key Lab Occupat Hlth & Safety, Tangshan 063000, Peoples R China.	fm_feng@sina.com		Feng, Fumin/0000-0001-6506-2235	National Natural Science Foundation of China [81041096]; Science Foundation of the Key Laboratory of Tangshan [08150201A-1-8]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science Foundation of the Key Laboratory of Tangshan	This study was supported by National Natural Science Foundation of China (No: 81041096) and Science Foundation of the Key Laboratory of Tangshan (No: 08150201A-1-8). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An HR, 2012, CLIN EXP PHARMACOL P, V39, P535, DOI 10.1111/j.1440-1681.2012.05713.x; Beedanagari SR, 2010, TOXICOL LETT, V194, P26, DOI 10.1016/j.toxlet.2010.01.019; BENICHOU C, 1990, J HEPATOL, V11, P272; Cai Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047769; Chen YL, 2010, BMC MED GENET, V11, DOI [10.1186/1471-2350-11-46, 10.1186/1471-2350-11-17]; Dufour DR, 2000, CLIN CHEM, V46, P2027; Esteller M, 2007, HUM MOL GENET, V16, pR50, DOI 10.1093/hmg/ddm018; Eurosurveillance editorial team, 2013, EUROSURVEILLANCE, V18, P20615; Fernandez-Villar A, 2004, INT J TUBERC LUNG D, V8, P1499; Gore Steven D, 2005, Nat Clin Pract Oncol, V2 Suppl 1, pS30, DOI 10.1038/ncponc0346; Han Derick, 2010, Handb Exp Pharmacol, P267, DOI 10.1007/978-3-642-00663-0_10; Issa JPJ, 2004, BLOOD, V103, P1635, DOI 10.1182/blood-2003-03-0687; Kovalenko VM, 2007, TOXICOL APPL PHARM, V225, P293, DOI 10.1016/j.taap.2007.08.011; Li T, 2011, J VIRAL HEPATITIS, V18, pE226, DOI 10.1111/j.1365-2893.2011.01438.x; Li ZQ, 2012, CELL BIOL INT, V36, P427, DOI 10.1042/CBI20100851; Lopez-Serra L, 2008, BRIT J CANCER, V98, P1881, DOI 10.1038/sj.bjc.6604374; Luo YJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049155; Mah WC, 2014, BIOMARK RES, V2, DOI 10.1186/2050-7771-2-5; Nishida N, 2012, HEPATOLOGY, V56, P994, DOI 10.1002/hep.25706; Padjen K, 2005, MOL CELL BIOL, V25, P4782, DOI 10.1128/MCB.25.11.4782-4791.2005; Park HJ, 2006, CANCER LETT, V233, P271, DOI 10.1016/j.canlet.2005.03.017; Peng ML, 2012, MOL VIS, V18, P1937; Rountree MR, 2001, ONCOGENE, V20, P3156, DOI 10.1038/sj.onc.1204339; Saeed HM, 2013, ASIAN PAC J CANCER P, V14, P3761, DOI 10.7314/APJCP.2013.14.6.3761; Schlesselman S., 1982, CASE CONTROL STUDIES; Schutz C, 2012, SAMJ S AFR MED J, V102, P506, DOI 10.7196/SAMJ.5650; Shen LH, 2013, ENVIRON TOXICOL PHAR, V36, P149, DOI 10.1016/j.etap.2013.03.016; Shukla D, 2013, BIOMED PAP, V157, P304, DOI 10.5507/bp.2013.028; Silverman Lewis R, 2005, Nat Clin Pract Oncol, V2 Suppl 1, pS12, DOI 10.1038/ncponc0347; Snykers S, 2009, J HEPATOL, V51, P187, DOI 10.1016/j.jhep.2009.03.009; Tang N, 2013, INT J TUBERC LUNG D, V17, P17, DOI 10.5588/ijtld.12.0447; Turesky RJ, 2011, CHEM RES TOXICOL, V24, P1169, DOI 10.1021/tx200135s; Varela-Lema L, 2008, GENET MED, V10, P369, DOI 10.1097/GIM.0b013e3181770196; Wang JH, 2006, CLIN BIOCHEM, V39, P344, DOI 10.1016/j.clinbiochem.2006.01.008; Wei BB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071640; Yimer G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027810; Yu L, 2012, MOL BIOL REP, V39, P6641, DOI 10.1007/s11033-012-1469-3; Zhang B, 2011, ENVIRON TOXICOL PHAR, V32, P486, DOI 10.1016/j.etap.2011.07.001	38	26	27	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0119481	10.1371/journal.pone.0119481	http://dx.doi.org/10.1371/journal.pone.0119481			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25798582	Green Submitted, Green Published, gold			2022-12-27	WOS:000351987300053
J	Kim, SW; Fishilevich, E; Arango-Argoty, G; Lin, YF; Liu, GD; Li, ZH; Monaghan, AP; Nichols, M; John, B				Kim, Sang Woo; Fishilevich, Elane; Arango-Argoty, Gustavo; Lin, Yuefeng; Liu, Guodong; Li, Zhihua; Monaghan, A. Paula; Nichols, Mark; John, Bino			Genome-Wide Transcript Profiling Reveals Novel Breast Cancer-Associated Intronic Sense RNAs	PLOS ONE			English	Article							NONCODING RNAS; HIRSCHSPRUNG-DISEASE; MENTAL-RETARDATION; MICRORNA; GENE; IDENTIFICATION; BIOMARKERS; SITES; MODEL	Non-coding RNAs (ncRNAs) play major roles in development and cancer progression. To identify novel ncRNAs that may identify key pathways in breast cancer development, we performed high-throughput transcript profiling of tumor and normal matched-pair tissue samples. Initial transcriptome profiling using high-density genome-wide tiling arrays revealed changes in over 200 novel candidate genomic regions that map to intronic regions. Sixteen genomic loci were identified that map to the long introns of five key protein-coding genes, CRIM1, EPAS1, ZEB2, RBMS1, and RFX2. Consistent with the known role of the tumor suppressor ZEB2 in the cancer-associated epithelial to mesenchymal transition (EMT), in situ hybridization reveals that the intronic regions deriving from ZEB2 as well as those from RFX2 and EPAS1 are down-regulated in cells of epithelial morphology, suggesting that these regions may be important for maintaining normal epithelial cell morphology. Paired-end deep sequencing analysis reveals a large number of distinct genomic clusters with no coding potential within the introns of these genes. These novel transcripts are only transcribed from the coding strand. A comprehensive search for breast cancer associated genes reveals enrichment for transcribed intronic regions from these loci, pointing to an underappreciated role of introns or mechanisms relating to their biology in EMT and breast cancer.	[Kim, Sang Woo; Fishilevich, Elane; Arango-Argoty, Gustavo; Lin, Yuefeng; Liu, Guodong; Li, Zhihua; John, Bino] Univ Pittsburgh, Sch Med, Pittsburgh, PA 15260 USA; [Monaghan, A. Paula] Univ Pittsburgh, Dept Neurobiol, Pittsburgh, PA 15260 USA; [Nichols, Mark] Univ Pittsburgh, Dept Pharmacol & Chem Biol, Sch Med, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Monaghan, AP (corresponding author), Univ Pittsburgh, Dept Neurobiol, 3501 Fifth Ave, Pittsburgh, PA 15260 USA.	monaghan@pitt.edu; mnichols@pitt.edu; bino@pitt.edu		Kim, Sang Woo/0000-0002-3144-4822	American Cancer Society [RSG-09-054-01]; Magee-Womens foundation [0027467]; National Institutes of Health [GM079756]; NATIONAL CANCER INSTITUTE [R21CA087414] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK059516] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079756] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); Magee-Womens foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding: The work was supported by American Cancer Society [RSG-09-054-01 to BJ] - www.cancer.org/, Magee-Womens foundation [0027467 to BJ] www.mwrif.org; and National Institutes of Health [GM079756 to BJ] - www.nih.gov. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acun T, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-223; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Brooks Mai, 2009, V472, P307, DOI 10.1007/978-1-60327-492-0_13; Cabili MN, 2011, GENE DEV, V25, P1915, DOI 10.1101/gad.17446611; Cawley S, 2004, CELL, V116, P499, DOI 10.1016/S0092-8674(04)00127-8; Clement JQ, 2001, J BIOL CHEM, V276, P16919, DOI 10.1074/jbc.M005104200; Comijn J, 2001, MOL CELL, V7, P1267, DOI 10.1016/S1097-2765(01)00260-X; Danin-Kreiselman M, 2003, MOL CELL, V11, P1279, DOI 10.1016/S1097-2765(03)00137-0; De Flora S, 2012, INT J CANCER, V131, P2763, DOI 10.1002/ijc.27814; Esteller M, 2011, NAT REV GENET, V12, P861, DOI 10.1038/nrg3074; Guay C, 2012, DIABETES OBES METAB, V14, P12, DOI 10.1111/j.1463-1326.2012.01654.x; Gupta RA, 2010, NATURE, V464, P1071, DOI 10.1038/nature08975; Hinton A, 2012, ADV GENET, V79, P1, DOI 10.1016/B978-0-12-394395-8.00001-3; Johnson WE, 2006, P NATL ACAD SCI USA, V103, P12457, DOI 10.1073/pnas.0601180103; Karreth FA, 2011, CELL, V147, P382, DOI 10.1016/j.cell.2011.09.032; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Leisegang MS, 2012, BIOL CHEM, V393, P599, DOI 10.1515/hsz-2012-0146; Lin SY, 2003, CELL, V113, P881, DOI 10.1016/S0092-8674(03)00430-6; Lin YF, 2012, NUCLEIC ACIDS RES, V40, P8460, DOI 10.1093/nar/gks637; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maher CA, 2009, NATURE, V458, P97, DOI 10.1038/nature07638; Mardis ER, 2012, NAT REV GASTRO HEPAT, V9, P477, DOI 10.1038/nrgastro.2012.126; McCarthy M, 2006, LANCET NEUROL, V5, P907, DOI 10.1016/S1474-4422(06)70594-4; Morlando M, 2008, NAT STRUCT MOL BIOL, V15, P902, DOI 10.1038/nsmb.1475; Mowat DR, 1998, J MED GENET, V35, P617, DOI 10.1136/jmg.35.8.617; Okamura K, 2007, CELL, V130, P89, DOI 10.1016/j.cell.2007.06.028; Prensner JR, 2011, NAT BIOTECHNOL, V29, P742, DOI 10.1038/nbt.1914; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; Ruby JG, 2007, NATURE, V448, P83, DOI 10.1038/nature05983; Sleutels F, 2002, NATURE, V415, P810, DOI 10.1038/415810a; St Laurent G, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-504; Tijsen AJ, 2012, AM J PHYSIOL-HEART C, V303, pH1085, DOI 10.1152/ajpheart.00191.2012; Ulitsky I, 2013, CELL, V154, P26, DOI 10.1016/j.cell.2013.06.020; Van de Putte T, 2003, AM J HUM GENET, V72, P465, DOI 10.1086/346092; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; Venables JP, 2004, CANCER RES, V64, P7647, DOI 10.1158/0008-5472.CAN-04-1910; Washietl S, 2012, WIRES RNA, V3, P759, DOI 10.1002/wrna.1134; Weigel MT, 2010, ENDOCR-RELAT CANCER, V17, pR245, DOI 10.1677/ERC-10-0136; Wurmbach E, 2007, HEPATOLOGY, V45, P938, DOI 10.1002/hep.21622	39	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0120296	10.1371/journal.pone.0120296	http://dx.doi.org/10.1371/journal.pone.0120296			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25798919	Green Published, gold, Green Accepted			2022-12-27	WOS:000351987300124
J	Li, TJ; Ren, BW; Wang, DH; Liu, GB				Li, Taijun; Ren, Bowen; Wang, Dahui; Liu, Guobin			Spatial Variation in the Storages and Age-Related Dynamics of Forest Carbon Sequestration in Different Climate Zones-Evidence from Black Locust Plantations on the Loess Plateau of China	PLOS ONE			English	Article							OLD-GROWTH FORESTS; PRECIPITATION GRADIENT; SOIL; BIOMASS; ACCUMULATION; CHRONOSEQUENCE; STOCKS; ALLOCATION; REDUCTION; FLUXES	Knowledge about the long-term influences of climate change on the amount of potential carbon (C) sequestration in forest ecosystems, including age-related dynamics, remains unclear. This study used two similar age-sequences of black locust forests (Robinia pseudoacacia L.) in the semi-arid and semi-humid zones of China's Loess Plateau to assess the variation in C stocks and age-related dynamics. Our results demonstrated that black locust forests of the semi-humid zone stored significantly more C than did forests in the semi-arid zone, across the chronosequence (P < 0.001). The C carrying capacity of the plantations was measured at 166.4 Mg C ha(-1) (1 Mg = 10(6) g) in the semi-humid zone, while the semi-arid zone had a capacity of only 79.4 Mg C ha(-1). Soil organic C (SOC) increased continuously with stand age in the semi-arid zone (R-2 = 0.84, P = 0.010). However, in the semi-humid zone, SOC declined sharply by 47.8% after the initial stage (5 to 10 y). The C stock in trees increased continuously with stand age in the semi-humid zone (R-2 = 0.83, P = 0.011), yet in the semi-arid zone, it decreased dramatically from 43.0 Mg C ha(-1) to 28.4 Mg C ha(-1) during the old forest stage (38 to 56 y). The shift from being a net C sink to a net C source occurred at the initial stage in the semi-humid zone versus at the old forest stage in the semi-arid zone after reforestation. Surprisingly, with the exception of the initial and later stages (55 y), the patterns of C allocation among trees, soils, understory and litter were not statistically different between the two climate zones. Our results suggest that climate factors can alter the potential amount and age-related dynamics of forest C sequestration.	[Li, Taijun; Ren, Bowen; Liu, Guobin] Northwest Agr & Forestry Univ, Coll Forestry, Yang Ling, Shaanxi, Peoples R China; [Wang, Dahui] Northwest Agr & Forestry Univ, Coll Vet Med, Yang Ling, Shaanxi, Peoples R China; [Liu, Guobin] Chinese Acad Sci, Inst Water & Soil Conservat, Yang Ling, Shaanxi, Peoples R China	Northwest A&F University - China; Northwest A&F University - China; Chinese Academy of Sciences	Liu, GB (corresponding author), Northwest Agr & Forestry Univ, Coll Forestry, Yang Ling, Shaanxi, Peoples R China.	gbliu@ms.iswc.ac.cn			foundation "Strategic Priority Research Program-Climate Change: Carbon Budget and Relevant Issues" of the Chinese Academy of Sciences [XDA05060300]	foundation "Strategic Priority Research Program-Climate Change: Carbon Budget and Relevant Issues" of the Chinese Academy of Sciences	This study was supported by the foundation "Strategic Priority Research Program-Climate Change: Carbon Budget and Relevant Issues" of the Chinese Academy of Sciences (Grant No. XDA05060300). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Austin AT, 2002, J VEG SCI, V13, P351, DOI 10.1111/j.1654-1103.2002.tb02059.x; Bellassen V, 2014, NATURE, V506, P153, DOI 10.1038/506153a; Berthrong ST, 2012, ECOL APPL, V22, P76, DOI 10.1890/10-2210.1; Cao JX, 2012, ECOL RES, V27, P883, DOI 10.1007/s11284-012-0965-1; Cao MK, 1998, NATURE, V393, P249, DOI 10.1038/30460; Fang JY, 2001, SCIENCE, V293, P1723, DOI 10.1126/science.293.5536.1723a; Fang S, 2007, J ENVIRON MANAGE, V85, P672, DOI 10.1016/j.jenvman.2006.09.014; Feng XM, 2013, SCI REP-UK, V3, DOI 10.1038/srep02846; Guo LB, 2002, GLOBAL CHANGE BIOL, V8, P345, DOI 10.1046/j.1354-1013.2002.00486.x; Guo ZD, 2010, FOREST ECOL MANAG, V259, P1225, DOI 10.1016/j.foreco.2009.09.047; Huxman TE, 2004, OECOLOGIA, V141, P254, DOI 10.1007/s00442-004-1682-4; Jackson RB, 2002, NATURE, V418, P623, DOI 10.1038/nature00910; Law BE, 2003, GLOBAL CHANGE BIOL, V9, P510, DOI 10.1046/j.1365-2486.2003.00624.x; Levasseur A, 2012, NAT CLIM CHANGE, V2, P6, DOI 10.1038/nclimate1335; Li TJ, 2014, CHINESE GEOGR SCI, V24, P414, DOI 10.1007/s11769-014-0704-3; Li X, 2011, J PLANT BIOL, V54, P33, DOI 10.1007/s12374-010-9140-9; Li X, 2010, J PLANT BIOL, V53, P381, DOI 10.1007/s12374-010-9134-7; Liao CZ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010867; Liu JG, 2008, P NATL ACAD SCI USA, V105, P9477, DOI 10.1073/pnas.0706436105; Lu N, 2013, BIOGEOSCIENCES DISCU, V10, P11181, DOI DOI 10.5194/BGD-10-11181-2013; Lu YH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031782; Luyssaert S, 2008, NATURE, V455, P213, DOI 10.1038/nature07276; Ma ZH, 2012, P NATL ACAD SCI USA, V109, P2423, DOI 10.1073/pnas.1111576109; Meier IC, 2010, GLOBAL CHANGE BIOL, V16, P1035, DOI 10.1111/j.1365-2486.2009.02074.x; Peri PL, 2006, FOREST ECOL MANAG, V233, P85, DOI 10.1016/j.foreco.2006.06.009; Poll C, 2013, AGR ECOSYST ENVIRON, V165, P88, DOI 10.1016/j.agee.2012.12.012; Powers MD, 2012, ECOL APPL, V22, P1297, DOI 10.1890/11-0411.1; Saiz G, 2012, GLOBAL CHANGE BIOL, V18, P1670, DOI 10.1111/j.1365-2486.2012.02657.x; Schrag DP, 2007, SCIENCE, V315, P812, DOI 10.1126/science.1137632; Schuur EAG, 2001, ECOLOGY, V82, P3182, DOI 10.1890/0012-9658(2001)082[3182:CCASCS]2.0.CO;2; Steffen W, 1998, SCIENCE, V280, P1393; Talmon Y, 2011, GLOBAL CHANGE BIOL, V17, P1108, DOI 10.1111/j.1365-2486.2010.02285.x; Varik M, 2013, FOREST ECOL MANAG, V302, P62, DOI 10.1016/j.foreco.2013.03.033; Vucetich JA, 2000, FOREST ECOL MANAG, V136, P135, DOI 10.1016/S0378-1127(99)00288-1; Wang B, 2012, ENVIRON EARTH SCI, V65, P597, DOI 10.1007/s12665-011-1107-8; Wei YW, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0072201, 10.1371/journal.pone.0060044]; Xia JY, 2014, NAT GEOSCI, V7, P173, DOI [10.1038/NGEO2093, 10.1038/ngeo2093]; Xu CY, 2012, J ECOL, V100, P428, DOI 10.1111/j.1365-2745.2011.01933.x; Zhang JF, 2010, INT J SUST DEV WORLD, V17, P475, DOI 10.1080/13504509.2010.520855; Zhou GY, 2006, SCIENCE, V314, P1417, DOI 10.1126/science.1130168; Zhou XH, 2009, ECOSYSTEMS, V12, P1369, DOI 10.1007/s10021-009-9296-7; Zhou ZC, 2005, J INTEGR PLANT BIOL, V47, P676, DOI 10.1111/j.1744-7909.2005.00067.x	42	13	14	1	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0121862	10.1371/journal.pone.0121862	http://dx.doi.org/10.1371/journal.pone.0121862			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25799100	Green Published, Green Submitted, gold			2022-12-27	WOS:000351987300296
J	Paul, D; Kazy, SK; Gupta, AK; Pal, T; Sar, P				Paul, Dhiraj; Kazy, Sufia K.; Gupta, Ashok K.; Pal, Taraknath; Sar, Pinaki			Diversity, Metabolic Properties and Arsenic Mobilization Potential of Indigenous Bacteria in Arsenic Contaminated Groundwater of West Bengal, India	PLOS ONE			English	Article							MICROBIAL COMMUNITIES; REDUCING BACTERIA; AQUIFER SEDIMENTS; ORGANIC-MATTER; DELTA PLAIN; SHALLOW; BANGLADESH; RELEASE; WATER; IRON	Arsenic (As) mobilization in alluvial aquifers is caused by a complex interplay of hydro-geo-microbiological activities. Nevertheless, diversity and biogeochemical significance of indigenous bacteria in Bengal Delta Plain are not well documented. We have deciphered bacterial community compositions and metabolic properties in As contaminated groundwater of West Bengal to define their role in As mobilization. Groundwater samples showed characteristic high As, low organic carbon and reducing property. Culture-independent and -dependent analyses revealed presence of diverse, yet near consistent community composition mostly represented by genera Pseudomonas, Flavobacterium, Brevundimonas, Polaromonas, Rhodococcus, Methyloversatilis and Methylotenera. Along with As-resistance and -reductase activities, abilities to metabolize a wide range carbon substrates including long chain and polyaromatic hydrocarbons and HCO3, As3+ as electron donor and As5+/Fe3+ as terminal electron acceptor during anaerobic growth were frequently observed within the cultivable bacteria. Genes encoding cytosolic As5+ reductase (arsC) and As3+ efflux/transporter [arsB and acr3(2)] were found to be more abundant than the dissimilatory As5+ reductase gene arrA. The observed metabolic characteristics showed a good agreement with the same derived from phylogenetic lineages of constituent populations. Selected bacterial strains incubated anaerobically over 300 days using natural orange sand of Pleistocene aquifer showed release of soluble As mostly as As3+ along with several other elements (Al, Fe, Mn, K, etc.). Together with the production of oxalic acid within the biotic microcosms, change in sediment composition and mineralogy indicated dissolution of orange sand coupled with As/Fe reduction. Presence of arsC gene, As5+ reductase activity and oxalic acid production by the bacteria were found to be closely related to their ability to mobilize sediment bound As. Overall observations suggest that indigenous bacteria in oligotrophic groundwater possess adequate catabolic ability to mobilize As by a cascade of reactions, mostly linked to bacterial necessity for essential nutrients and detoxification.	[Paul, Dhiraj; Sar, Pinaki] Indian Inst Technol, Dept Biotechnol, Kharagpur 721302, W Bengal, India; [Kazy, Sufia K.] Natl Inst Technol, Dept Biotechnol, Durgapur 713209, India; [Gupta, Ashok K.] Indian Inst Technol, Dept Civil Engn, Kharagpur 721302, W Bengal, India; [Pal, Taraknath] Geol Survey India, Cent Headquarters, Kolkata 700016, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Kharagpur; National Institute of Technology (NIT System); National Institute of Technology Durgapur; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Kharagpur; Geological Survey India	Sar, P (corresponding author), Indian Inst Technol, Dept Biotechnol, Kharagpur 721302, W Bengal, India.	psar@hijli.iitkgp.ernet.in			Department of Biotechnology, Govt. of India [BT/PR8933/GBD/27/41/2006]; Council of Scientific and Industrial Research [38/1314/11/EMR II]	Department of Biotechnology, Govt. of India(Department of Biotechnology (DBT) India); Council of Scientific and Industrial Research(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by the Department of Biotechnology, Govt. of India (RGYI scheme No. BT/PR8933/GBD/27/41/2006), Council of Scientific and Industrial Research (scheme No. 38/1314/11/EMR II). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achour AR, 2007, RES MICROBIOL, V158, P128, DOI 10.1016/j.resmic.2006.11.006; Akai J, 2004, APPL GEOCHEM, V19, P215, DOI 10.1016/j.apgeochem.2003.09.008; [Anonymous], 2001, WHO ENV HLTH CRIT 22; APHA-AWWA-WPCF, 1985, STANDARD METHODS EXA; Battaglia-Brunet F, 2006, ANTON LEEUW INT J G, V89, P99, DOI 10.1007/s10482-005-9013-2; Bondici VF, 2013, J APPL MICROBIOL, V114, P1671, DOI 10.1111/jam.12180; Corsini A, 2014, J HAZARD MATER, V269, P89, DOI 10.1016/j.jhazmat.2013.12.037; Costa PS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095655; Das R, 2014, ENVIRON SCI POLLUT R, V21, P7369, DOI 10.1007/s11356-014-2640-2; Delavat F, 2012, BIOL DIRECT, V7, DOI 10.1186/1745-6150-7-28; Dhar RK, 2011, ENVIRON SCI TECHNOL, V45, P2648, DOI 10.1021/es1022015; Donachie SP, 2007, ISME J, V1, P97, DOI 10.1038/ismej.2007.22; Drewniak L, 2008, ENVIRON POLLUT, V156, P1069, DOI 10.1016/j.envpol.2008.04.019; Duan MY, 2009, ENVIRON GEOL, V57, P997, DOI 10.1007/s00254-008-1384-z; Escudero LV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078890; Fendorf S, 2010, SCIENCE, V328, P1123, DOI 10.1126/science.1172974; Freikowski D, 2013, ECOTOX ENVIRON SAFE, V91, P139, DOI 10.1016/j.ecoenv.2013.01.021; Frey B, 2010, APPL ENVIRON MICROB, V76, P4788, DOI 10.1128/AEM.00657-10; Gault AG, 2005, MINERAL MAG, V69, P855, DOI 10.1180/0026461056950293; Ghosh S, 2013, WATER RES, V47, P6992, DOI 10.1016/j.watres.2013.08.044; GOOD IJ, 1953, BIOMETRIKA, V40, P237, DOI 10.2307/2333344; Gorra R, 2012, MICROB ECOL, V64, P171, DOI 10.1007/s00248-012-0014-1; Hasan MA, 2009, ENVIRON GEOL, V57, P499, DOI 10.1007/s00254-008-1319-8; Hery M, 2010, GEOBIOLOGY, V8, P155, DOI 10.1111/j.1472-4669.2010.00233.x; Inskeep WP, 2007, ENVIRON MICROBIOL, V9, P934, DOI 10.1111/j.1462-2920.2006.01215.x; Islam ABMR, 2013, J HAZARD MATER, V262, P989, DOI 10.1016/j.jhazmat.2012.07.022; Islam FS, 2004, NATURE, V430, P68, DOI 10.1038/nature02638; Jiang Z, 2014, ENVIRON EARTH SCI, V71, P311, DOI 10.1007/s12665-013-2435-7; Kalyuzhnaya MG, 2006, INT J SYST EVOL MICR, V56, P2819, DOI 10.1099/ijs.0.64191-0; Kar S, 2010, APPL GEOCHEM, V25, P1805, DOI 10.1016/j.apgeochem.2010.09.007; Kazy SK, 1999, WORLD J MICROB BIOT, V15, P599, DOI 10.1023/A:1008997718811; Lear G, 2007, APPL ENVIRON MICROB, V73, P1041, DOI 10.1128/AEM.01654-06; Lee JT, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-42; Li XK, 2007, J BACTERIOL, V189, P3705, DOI 10.1128/JB.01913-06; Liao VHC, 2011, J CONTAM HYDROL, V123, P20, DOI 10.1016/j.jconhyd.2010.12.003; LOVLEY DR, 1986, APPL ENVIRON MICROB, V52, P751, DOI 10.1128/AEM.52.4.751-757.1986; Mailloux BJ, 2009, APPL ENVIRON MICROB, V75, P2558, DOI 10.1128/AEM.02440-07; McArthur JM, 2004, APPL GEOCHEM, V19, P1255, DOI 10.1016/j.apgeochem.2004.02.001; Miles AA, 1938, J HYG-CAMBRIDGE, V38, P732, DOI 10.1017/S002217240001158X; Mukherjee A, 2008, J CONTAM HYDROL, V99, P31, DOI 10.1016/j.jconhyd.2007.10.005; Mukherjee A, 2008, APPL GEOCHEM, V23, P863, DOI 10.1016/j.apgeochem.2007.07.011; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; Nath B, 2011, APPL GEOCHEM, V26, P705, DOI 10.1016/j.apgeochem.2011.01.029; Neidhardt H, 2013, J HAZARD MATER, V262, P941, DOI 10.1016/j.jhazmat.2013.01.044; Neidhardt H, 2013, APPL GEOCHEM, V36, P70, DOI 10.1016/j.apgeochem.2013.06.017; Newman DK, 2001, SCIENCE, V292, P1312, DOI 10.1126/science.1060572; Nickson RT, 2000, APPL GEOCHEM, V15, P403, DOI 10.1016/S0883-2927(99)00086-4; Omoregie EO, 2013, APPL ENVIRON MICROB, V79, P4325, DOI 10.1128/AEM.00683-13; Oremland RS, 2005, TRENDS MICROBIOL, V13, P45, DOI 10.1016/j.tim.2004.12.002; Pal T, 2009, ENVIRON GEOL, V56, P1211, DOI 10.1007/s00254-008-1221-4; Patrauchan MA, 2012, APPL ENVIRON MICROB, V78, P6714, DOI 10.1128/AEM.01293-12; Ravenscroft P, 2001, ARSENIC EXPOSURE AND HEALTH EFFECTS IV, P53; Reardon CL, 2004, APPL ENVIRON MICROB, V70, P6037, DOI 10.1128/AEM.70.10.6037-6046.2004; Rowland HAL, 2006, ORG GEOCHEM, V37, P1101, DOI 10.1016/j.orggeochem.2006.04.011; Rowland HAL, 2009, J ENVIRON QUAL, V38, P1598, DOI 10.2134/jeq2008.0223; Sarkar A, 2014, ENVIRON SCI POLLUT R, V21, P8645, DOI 10.1007/s11356-014-2759-1; Sarkar A, 2013, ECOTOXICOLOGY, V22, P363, DOI 10.1007/s10646-012-1031-z; Saunders JA, 2005, GEOCHEM GEOPHY GEOSY, V6, DOI 10.1029/2004GC000803; SCHWYN B, 1987, ANAL BIOCHEM, V160, P47, DOI 10.1016/0003-2697(87)90612-9; Song B, 2009, FEMS MICROBIOL ECOL, V68, P108, DOI 10.1111/j.1574-6941.2009.00657.x; Sultana M, 2011, GEOMICROBIOL J, V28, P198, DOI 10.1080/01490451.2010.490078; Sun Z, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003701; Sutton NB, 2009, WATER RES, V43, P1720, DOI 10.1016/j.watres.2009.01.006; Swartz CH, 2004, GEOCHIM COSMOCHIM AC, V68, P4539, DOI 10.1016/j.gca.2004.04.020; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Uroz S, 2009, TRENDS MICROBIOL, V17, P378, DOI 10.1016/j.tim.2009.05.004; van Dongen BE, 2008, APPL GEOCHEM, V23, P3047, DOI 10.1016/j.apgeochem.2008.06.012; Van Geen A, 2004, GEOCHIM COSMOCHIM AC, V68, P3475, DOI 10.1016/j.gca.2004.02.014; Yan ZS, 2012, J HAZARD MATER, V199, P217, DOI 10.1016/j.jhazmat.2011.10.087; Zheng Y, 2005, GEOCHIM COSMOCHIM AC, V69, P5203, DOI 10.1016/j.gca.2005.06.001	70	43	44	2	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0118735	10.1371/journal.pone.0118735	http://dx.doi.org/10.1371/journal.pone.0118735			40	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25799109	Green Published, Green Submitted, gold			2022-12-27	WOS:000351987300016
J	Philomenadin, FS; Asokan, R; Viswanathan, N; George, R; Lingam, V; Sarangapani, S				Philomenadin, Ferdinamarie Sharmila; Asokan, Rashima; Viswanathan, N.; George, Ronnie; Lingam, Vijaya; Sarangapani, Sripriya			Genetic Association of SNPs near ATOH7, CARD10, CDKN2B, CDC7 and SIX1/SIX6 with the Endophenotypes of Primary Open Angle Glaucoma in Indian Population	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; TO-DISC RATIO; CENTRAL CORNEAL THICKNESS; INTRAOCULAR-PRESSURE; SUSCEPTIBILITY LOCI; RISK-FACTORS; VARIANTS; MUTATIONS; METAANALYSIS; PREVALENCE	Primary open angle glaucoma (POAG) belonging to a group of optic neuropathies, result from interaction between genetic and environmental factors. Study of associations with quantitative traits (QTs) is one of the successful strategies to understand the complex genetics of POAG. The current study attempts to explore the association of variations near/in genes like ATOH7, SIX1/SIX6 complex, CDKN2B, CARD10, and CDC7 with POAG and its QTs including vertical cup to disc ratio (VCDR), central corneal thickness (CCT), intra ocular pressure (IOP), and axial length (AL). Case-control study design was carried out in a sample size of 97 POAG cases and 371 controls from South India. Model-based (additive, recessive, dominant) association of the genotypes and their interaction was carried out between cases and controls using chi-square, linear and logistic regression methods. Nominal significance (P<0.05) was observed for QTs like i) VCDR with SNPs rs1900004 (ATOH7); rs1192415 (CDC7); rs10483727 (SIX1/SIX6), rs9607469 (CARD10); ii) CCT with rs1192415; iii) IOP with rs1900004 and iv) AL with rs1900004 and rs1063192 (CDKN2B). We were able to replicate previously known interactions between ATOH7-SIX6 and SIX6-CDKN2B along with few novel interactions between ATOH7-CDC7 and SIX6 with genes including CARD10 and CDC7. In summary, our results suggest that a probable interaction among the candidate genes for QTs, play a major role in determining the individual's susceptibility to POAG.	[Philomenadin, Ferdinamarie Sharmila; Sarangapani, Sripriya] Vis Res Fdn, SNONGC Dept Genet & Mol Biol, Chennai, Tamil Nadu, India; [Philomenadin, Ferdinamarie Sharmila] BITS, Pilani 333031, Rajasthan, India; [Asokan, Rashima; George, Ronnie; Lingam, Vijaya] Med & Vis Res Fdn, Chennai Glaucoma Study, Chennai, Tamil Nadu, India; [Viswanathan, N.] Med Res Fdn, Dept Prevent Ophthalmol, Chennai, Tamil Nadu, India	Birla Institute of Technology & Science Pilani (BITS Pilani)	Sarangapani, S (corresponding author), Vis Res Fdn, SNONGC Dept Genet & Mol Biol, Chennai, Tamil Nadu, India.	vatsanpriya@gmail.com		george, ronnie/0000-0001-7368-0252; , Ferdinamarie Sharmila/0000-0002-2058-2672	Chennai Glaucoma study [11-2003-P]	Chennai Glaucoma study	This research was supported by the Chennai Glaucoma study (Project no: 11-2003-P). Funding was received by RG LV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilo F, 2011, CANCER RES, V71, P5365, DOI 10.1158/0008-5472.CAN-10-4379; Allingham RR, 2009, EXP EYE RES, V88, P837, DOI 10.1016/j.exer.2008.11.003; Arvind H, 2003, OPHTHAL EPIDEMIOL, V10, P337, DOI 10.1076/opep.10.5.337.17320; Banerjee D, 2012, MOL VIS, V18, P1548; Blanco-Marchite C, 2011, INVEST OPHTH VIS SCI, V52, P8467, DOI 10.1167/iovs.11-7489; Burdon KP, 2011, NAT GENET, V43, P574, DOI 10.1038/ng.824; Cao D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039278; Charlesworth J, 2010, INVEST OPHTH VIS SCI, V51, P3509, DOI 10.1167/iovs.09-4786; Chen JH, 2012, INVEST OPHTH VIS SCI, V53, P779, DOI 10.1167/iovs.11-8277; Choi JH, 2010, MOL BRAIN, V3, DOI 10.1186/1756-6606-3-1; Cornes BK, 2012, HUM MOL GENET, V21, P437, DOI 10.1093/hmg/ddr463; Dandona L, 2000, OPHTHALMOLOGY, V107, P1702, DOI 10.1016/S0161-6420(00)00275-X; Fan BJ, 2011, INVEST OPHTH VIS SCI, V52, P1788, DOI 10.1167/iovs.10-6339; Fan BJ, 2004, CHINESE MED J-PEKING, V117, P706; Freeman EE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055573; George R, 2007, J CURR GLAUCOMA PRAC, V1, P7, DOI DOI 10.5005/jp-journals-10008-1049; Gong G, 2004, HUM MOL GENET, V13, pR91, DOI 10.1093/hmg/ddh074; Iglesias AI, 2014, HUM MOL GENET, V23, P1320, DOI 10.1093/hmg/ddt522; Khor CC, 2011, HUM MOL GENET, V20, P1864, DOI 10.1093/hmg/ddr060; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Kumar A, 2007, MOL VIS, V13, P667; Loomis SJ, 2014, OPHTHALMOLOGY, V121, P508, DOI 10.1016/j.ophtha.2013.09.012; Lu Y, 2013, NAT GENET, V45, P155, DOI 10.1038/ng.2506; Mabuchi F, 2012, OPHTHALMOLOGY, V119, P1819, DOI 10.1016/j.ophtha.2012.02.044; Macgregor S, 2010, HUM MOL GENET, V19, P2716, DOI 10.1093/hmg/ddq144; Meguro A, 2010, OPHTHALMOLOGY, V117, P1331, DOI 10.1016/j.ophtha.2009.12.001; Nirmalan PK, 2004, OPHTHALMOLOGY, V111, P1778, DOI 10.1016/j.ophtha.2004.02.012; Osman W, 2012, HUM MOL GENET, V21, P2836, DOI 10.1093/hmg/dds103; Ozel AB, 2014, HUM GENET, V133, P41, DOI 10.1007/s00439-013-1349-5; Prasov L, 2012, HUM MOL GENET, V21, P3681, DOI 10.1093/hmg/dds197; Ramdas WD, 2011, HUM MOL GENET, V20, P2464, DOI 10.1093/hmg/ddr120; Ramdas WD, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000978; Rao KN, 2010, INVEST OPHTH VIS SCI, V51, P4937, DOI 10.1167/iovs.10-5553; Raychaudhuri A, 2005, BRIT J OPHTHALMOL, V89, P1559, DOI 10.1136/bjo.2005.074948; Rezaie T, 2002, SCIENCE, V295, P1077, DOI 10.1126/science.1066901; Skarie JM, 2008, HUM MOL GENET, V17, P2474, DOI 10.1093/hmg/ddn147; Song WT, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt305; Springelkamp H, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5883; Sripriya S, 2006, MOL VIS, V12, P816; Sripriya S, 2004, CLIN GENET, V65, P333, DOI 10.1111/j.1399-0004.2004.00232.x; THYLEFORS B, 1994, B WORLD HEALTH ORGAN, V72, P323; TIELSCH JM, 1994, ARCH OPHTHALMOL-CHIC, V112, P69, DOI 10.1001/archopht.1994.01090130079022; van Koolwijk LME, 2007, INVEST OPHTH VIS SCI, V48, P3669, DOI 10.1167/iovs.06-1519; Vijaya L, 2005, INVEST OPHTH VIS SCI, V46, P4461, DOI 10.1167/iovs.04-1529; Vishal M, 2014, SCI REP-UK, V4, DOI 10.1038/srep05115; Vitart V, 2010, HUM MOL GENET, V19, P4304, DOI 10.1093/hmg/ddq349; Vithana EN, 2011, HUM MOL GENET, V20, P649, DOI 10.1093/hmg/ddq511; Wolfs RCW, 1998, ARCH OPHTHALMOL-CHIC, V116, P1640, DOI 10.1001/archopht.116.12.1640; Xin BZ, 2010, P NATL ACAD SCI USA, V107, P258, DOI 10.1073/pnas.0908457107; Yang ZY, 2003, DEV BIOL, V264, P240, DOI 10.1016/j.ydbio.2003.08.005; Yao J, 2007, MOL VIS, V13, P1066	51	25	25	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0119703	10.1371/journal.pone.0119703	http://dx.doi.org/10.1371/journal.pone.0119703			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25798827	Green Submitted, gold, Green Published			2022-12-27	WOS:000351987300074
J	Burmeister, WP; Buisson, M; Estrozi, LF; Schoehn, G; Billet, O; Hannas, Z; Sigoillot, C; Poulet, H				Burmeister, Wim P.; Buisson, Marlyse; Estrozi, Leandro F.; Schoehn, Guy; Billet, Olivier; Hannas, Zahia; Sigoillot, Cecile; Poulet, Herve			Structure Determination of Feline Calicivirus Virus-Like Particles in the Context of a Pseudo-Octahedral Arrangement	PLOS ONE			English	Article							MOLECULAR REPLACEMENT; ELECTRON-MICROSCOPY; RESOLUTION; RECONSTRUCTIONS; CRYSTALLOGRAPHY; REFINEMENT; GRAPHICS; SOFTWARE; RECEPTOR; PROGRAM	The vesivirus feline calicivirus (FCV) is a positive strand RNA virus encapsidated by an icosahedral T= 3 shell formed by the viral VP1 protein. Upon its expression in the insect cell baculovirus system in the context of vaccine development, two types of virus-like particles (VLPs) were formed, a majority built of 60 subunits (T= 1) and a minority probably built of 180 subunits (T= 3). The structure of the small particles was determined by x-ray crystallography at 0.8 nm resolution helped by cryo-electron microscopy in order to understand their formation. Cubic crystals belonged to space group P2(1)3. Their self-rotation function showed the presence of an octahedral pseudo-symmetry similar to the one described previously by Agerbandje and co-workers for human parvovirus VLPs. The crystal structure could be solved starting from the published VP1 structure in the context of the T= 3 viral capsid. In contrast to viral capsids, where the capsomers are interlocked by the exchange of the N-terminal arm (NTA) domain, this domain is disordered in the T= 1 capsid of the VLPs. Furthermore it is prone to proteolytic cleavage. The relative orientation of P (protrusion) and S (shell) domains is alerted so as to fit VP1 to the smaller T= 1 particle whereas the intermolecular contacts around 2-fold, 3-fold and 5-fold axes are conserved. By consequence the surface of the VLP is very similar compared to the viral capsid and suggests a similar antigenicity. The knowledge of the structure of the VLPs will help to improve their stability, in respect to a use for vaccination.	[Burmeister, Wim P.; Buisson, Marlyse] Univ Grenoble Alpes, Unit Virus Host Cell Interact, Grenoble, France; [Burmeister, Wim P.; Buisson, Marlyse] CNRS, Unite Mixte Int 3265, Unit Virus Host Cell Interact, Grenoble, France; [Buisson, Marlyse] CHU Grenoble, Virol Lab, F-38043 Grenoble, France; [Estrozi, Leandro F.; Schoehn, Guy] Commissariat Energie Atom, Inst Biol Struct Jean Pierre Ebel, Grenoble, France; [Estrozi, Leandro F.; Schoehn, Guy] CNRS, Inst Biol Struct Jean Pierre Ebel, Grenoble, France; [Estrozi, Leandro F.; Schoehn, Guy] Univ Grenoble Alpes, Inst Biol Struct Jean Pierre Ebel, Grenoble, France; [Billet, Olivier; Hannas, Zahia; Sigoillot, Cecile; Poulet, Herve] Merial R&D, Lyon Gerland Lab, Lyon, France	UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); Merial SASU	Burmeister, WP (corresponding author), Univ Grenoble Alpes, Unit Virus Host Cell Interact, Grenoble, France.	wpb@uvhci.fr	Estrozi, Leandro F/A-6578-2013	Estrozi, Leandro F/0000-0003-2548-2547; Burmeister, Wim/0000-0003-0876-6118; Schoehn, Guy/0000-0002-1459-3201	FRISBI [ANR-10-INSB-05-02]; GRAL within the PSB [ANR-10-LABX-49-01]	FRISBI; GRAL within the PSB	This work used the platforms of the Grenoble Instruct centre (ISBG; UMS 3518 CNRS-CEA-UJF-EMBL) with support from FRISBI (ANR-10-INSB-05-02) and GRAL (ANR-10-LABX-49-01) within the PSB. The electron microscope facility (Polara electron microscope) is supported by the Rhone-Alpes Region, FRM, CNRS, University of Grenoble and the GIS-IBISA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abente EJ, 2013, J VIROL, V87, P3003, DOI 10.1128/JVI.02480-12; AGBANDJE M, 1994, VIROLOGY, V203, P106, DOI 10.1006/viro.1994.1460; Barcena J, 2004, VIROLOGY, V322, P118, DOI 10.1016/j.virol.2004.01.021; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Bertolotti-Ciarlet A, 2002, J VIROL, V76, P4044, DOI 10.1128/JVI.76.8.4044-4055.2002; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chen R, 2006, P NATL ACAD SCI USA, V103, P8048, DOI 10.1073/pnas.0600421103; COWTAN KD, 1993, ACTA CRYSTALLOGR D, V49, P148, DOI 10.1107/S0907444992007698; Di Martino B, 2007, VET MICROBIOL, V120, P173, DOI 10.1016/j.vetmic.2006.10.021; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Estrozi LF, 2010, J STRUCT BIOL, V172, P253, DOI 10.1016/j.jsb.2010.06.023; Gan L, 2006, STRUCTURE, V14, P1655, DOI 10.1016/j.str.2006.09.006; Heymann JB, 2007, J STRUCT BIOL, V157, P3, DOI 10.1016/j.jsb.2006.06.006; Katpally U, 2010, J VIROL, V84, P5836, DOI 10.1128/JVI.00314-10; Kaufmann B, 2004, P NATL ACAD SCI USA, V101, P11628, DOI 10.1073/pnas.0402992101; Klug A, 1972, COLD SPRING HARB SYM, V36, P483; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Makino A, 2006, J VIROL, V80, P4482, DOI 10.1128/JVI.80.9.4482-4490.2006; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Natarajan P, 2005, NAT REV MICROBIOL, V3, P809, DOI 10.1038/nrmicro1283; Navaza J, 2003, J STRUCT BIOL, V144, P13, DOI 10.1016/j.jsb.2003.09.007; Navaza J, 2002, ACTA CRYSTALLOGR D, V58, P1820, DOI 10.1107/S0907444902013707; Navaza J, 1997, METHOD ENZYMOL, V276, P581, DOI 10.1016/S0076-6879(97)76079-8; Ossiboff RJ, 2007, J GEN VIROL, V88, P506, DOI 10.1099/vir.0.82488-0; Ossiboff RJ, 2010, J VIROL, V84, P5550, DOI 10.1128/JVI.02371-09; Pedersen NC, 2000, VET MICROBIOL, V73, P281, DOI 10.1016/S0378-1135(00)00183-8; Potterton L, 2004, ACTA CRYSTALLOGR D, V60, P2288, DOI 10.1107/S0907444904023716; Prasad BVV, 1999, SCIENCE, V286, P287, DOI 10.1126/science.286.5438.287; Schlesinger S, 1999, VIRUSES STRUCTURE BI; Tong L, 1997, METHOD ENZYMOL, V276, P594, DOI 10.1016/S0076-6879(97)76080-4; Vagin A, 2000, ACTA CRYSTALLOGR D, V56, P1622, DOI 10.1107/S0907444900013780; van Heel M, 2005, J STRUCT BIOL, V151, P250, DOI 10.1016/j.jsb.2005.05.009; Wang X, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003132; White LJ, 1997, J VIROL, V71, P8066, DOI 10.1128/JVI.71.10.8066-8072.1997; Winn MD, 2003, METHOD ENZYMOL, V374, P300, DOI 10.1016/S0076-6879(03)74014-2; Zwart P. H., 2005, CCP4 NEWSL, V43, P26	37	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0119289	10.1371/journal.pone.0119289	http://dx.doi.org/10.1371/journal.pone.0119289			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25794153	Green Submitted, Green Published, gold			2022-12-27	WOS:000352084200067
J	Castaneda-Ortiz, EJ; Ueti, MW; Camacho-Nuez, M; Mosqueda, JJ; Mousel, MR; Johnson, WC; Palmer, GH				Castaneda-Ortiz, Elizabeth J.; Ueti, Massaro W.; Camacho-Nuez, Minerva; Mosqueda, Juan J.; Mousel, Michelle R.; Johnson, Wendell C.; Palmer, Guy H.			Association of Anaplasma marginale Strain Superinfection with Infection Prevalence within Tropical Regions	PLOS ONE			English	Article							OUTER-MEMBRANE PROTEINS; BOOPHILUS-MICROPLUS; ANTIGENIC VARIATION; TRANSMISSION; CONSERVATION; DIVERSITY; TICK; EXPRESSION; PATHOGENS; IXODIDAE	Strain superinfection occurs when a second strain infects a host already infected with and having mounted an immune response to a primary strain. The incidence of superinfection with Anaplasma marginale, a tick-borne rickettsial pathogen of domestic and wild ruminants, has been shown to be higher in tropical versus temperate regions. This has been attributed to the higher prevalence of infection, with consequent immunity against primary strains and thus greater selective pressure for superinfection with antigenically distinct strains. However an alternative explanation would be the differences in the transmitting vector, Dermacentor andersoni in the studied temperate regions and Rhipicephalus microplus in the studied tropical regions. To address this question, we examined two tropical populations sharing the same vector, R. microplus, but with significantly different infection prevalence. Using two separate markers, msp1 alpha (one allele per genome) and msp2 (multiple alleles per genome), there were higher levels of multiple strain infections in the high infection prevalence as compared to the low prevalence population. The association of higher strain diversity with infection prevalence supports the hypothesis that high levels of infection prevalence and consequent population immunity is the predominant driver of strain superinfection.	[Castaneda-Ortiz, Elizabeth J.; Camacho-Nuez, Minerva] Univ Autonoma Ciudad Mexico, Posgrad Ciencias Genom, Mexico City, DF, Mexico; [Ueti, Massaro W.; Mousel, Michelle R.; Johnson, Wendell C.] Washington State Univ, USDA ARS, Anim Dis Res Unit, Pullman, WA 99164 USA; [Ueti, Massaro W.] Washington State Univ, Dept Vet Microbiol & Pathol, Pullman, WA 99164 USA; [Mosqueda, Juan J.] Univ Autonoma Queretaro, Juriquilla, Mexico; [Palmer, Guy H.] Washington State Univ, Paul G Allen Sch Global Anim Hlth, Pullman, WA 99164 USA	United States Department of Agriculture (USDA); Washington State University; Washington State University; Universidad Autonoma de Queretaro; Washington State University	Palmer, GH (corresponding author), Washington State Univ, Paul G Allen Sch Global Anim Hlth, Pullman, WA 99164 USA.	gpalmer@vetmed.wsu.edu	Camacho-Nuez, Minerva/AAG-4359-2020	Camacho-Nuez, Minerva/0000-0002-6354-3200	Universidad Autonoma de la Ciudad de Mexico; U.S. Department of Agriculture, Agricultural Research Service [5348-32000-033-00D]; National Institutes of Health [R37 AI44005]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI044005] Funding Source: NIH RePORTER	Universidad Autonoma de la Ciudad de Mexico(Universidad Nacional Autonoma de Mexico); U.S. Department of Agriculture, Agricultural Research Service(United States Department of Agriculture (USDA)USDA Agricultural Research Service); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Elizabeth J. Castaneda Ortiz was supported by Universidad Autonoma de la Ciudad de Mexico. This research was supported by the U.S. Department of Agriculture, Agricultural Research Service Grant 5348-32000-033-00D (MWU, MRM, WCJ) and the National Institutes of Health R37 AI44005 (GHP). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLRED DR, 1990, P NATL ACAD SCI USA, V87, P3220, DOI 10.1073/pnas.87.8.3220; Barbet AF, 2000, INFECT IMMUN, V68, P6133, DOI 10.1128/IAI.68.11.6133-6138.2000; Blackard JT, 2012, ANTIVIR THER, V17, P1443, DOI 10.3851/IMP2460; Brayton KA, 2005, P NATL ACAD SCI USA, V102, P844, DOI 10.1073/pnas.0406656102; Brayton KA, 2001, P NATL ACAD SCI USA, V98, P4130, DOI 10.1073/pnas.071056298; Chen DS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016629; Dark MJ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-16; de la Fuente J, 2007, VET MICROBIOL, V119, P375, DOI 10.1016/j.vetmic.2006.09.011; Esquerra EV, 2014, INFECT IMMUN, V82, P5286, DOI 10.1128/IAI.02537-14; Estrada-Pena A, 2006, EXP APPL ACAROL, V38, P307, DOI 10.1007/s10493-006-7251-2; Futse JE, 2008, P NATL ACAD SCI USA, V105, P2123, DOI 10.1073/pnas.0710333105; Futse JE, 2005, MOL MICROBIOL, V57, P212, DOI 10.1111/j.1365-2958.2005.04670.x; Futse JE, 2003, J CLIN MICROBIOL, V41, P3829, DOI 10.1128/JCM.41.8.3829-3834.2003; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Hutchinson OC, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-234; James AM, 2006, J MED ENTOMOL, V43, P17, DOI 10.1603/0022-2585(2006)043[0017:DSAHOT]2.0.CO;2; Noh SM, 2006, INFECT IMMUN, V74, P3471, DOI 10.1128/IAI.01843-05; Palmer GH, 2001, J CLIN MICROBIOL, V39, P631, DOI 10.1128/JCM.39.2.631-635.2001; Palmer GH, 2013, CELL MICROBIOL, V15, P1969, DOI 10.1111/cmi.12182; Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079; Rodriguez JL, 2005, GENE, V361, P127, DOI 10.1016/j.gene.2005.06.038; Rodriguez SD, 2009, INFECT GENET EVOL, V9, P1092, DOI 10.1016/j.meegid.2009.09.007; Rogovskyy AS, 2014, INFECT IMMUN, V82, P4542, DOI 10.1128/IAI.01817-14; Scoles GA, 2005, J MED ENTOMOL, V42, P153, DOI 10.1603/0022-2585(2005)042[0153:VAGSPO]2.0.CO;2; Smith DM, 2005, J INFECT DIS, V192, P438, DOI 10.1086/431682; Ueti MW, 2012, INFECT IMMUN, V80, P2354, DOI 10.1128/IAI.00341-12	26	21	21	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0120748	10.1371/journal.pone.0120748	http://dx.doi.org/10.1371/journal.pone.0120748			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25793966	Green Published, gold, Green Submitted			2022-12-27	WOS:000352083900072
J	Davis, ZW; Sun, C; Derieg, B; Chapman, B; Cheng, HJ				Davis, Zachary W.; Sun, Chao; Derieg, Brittany; Chapman, Barbara; Cheng, Hwai-Jong			Epibatidine Blocks Eye-Specific Segregation in Ferret Dorsal Lateral Geniculate Nucleus during Stage III Retinal Waves	PLOS ONE			English	Article							PATTERNED SPONTANEOUS ACTIVITY; GANGLION-CELL ACTIVITY; RETINOGENICULATE CONNECTIVITY; ACTION-POTENTIALS; BURSTING ACTIVITY; MAMMALIAN RETINA; INSTRUCTIVE ROLE; VISUAL-SYSTEM; ON-CENTER; REQUIREMENT	The segregation and maintenance of eye-specific inputs in the dorsal lateral geniculate nucleus (dLGN) during early postnatal development requires the patterned spontaneous activity of retinal waves. In contrast to the development of the mouse, ferret eye-specific segregation is not complete at the start of stage III glutamatergic retinal waves, and the remaining overlap is limited to the C/C1 lamina of the dLGN. To investigate the role of patterned spontaneous activity in this late segregation, we disrupted retinal waves pharmacologically for 5 day windows from postnatal day (P) 10 to P25. Multi-electrode array recordings of the retina in vitro reveal that the cholinergic agonist epibatidine disrupts correlated retinal activity during stage III waves. Epibatidine also prevents the segregation of eye-specific inputs in vivo during that period. Our results reveal a novel role for cholinergic influence on stage III retinal waves as an instructive signal for the continued segregation of eye-specific inputs in the ferret dLGN.	[Davis, Zachary W.; Derieg, Brittany; Chapman, Barbara; Cheng, Hwai-Jong] Univ Calif Davis, Ctr Neurosci, Davis, CA 95616 USA; [Sun, Chao; Chapman, Barbara; Cheng, Hwai-Jong] Univ Calif Davis, Dept Neurobiol Physiol & Behav, Davis, CA 95616 USA; [Cheng, Hwai-Jong] Univ Calif Davis, Dept Pathol & Lab Med, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Cheng, HJ (corresponding author), Univ Calif Davis, Ctr Neurosci, Davis, CA 95616 USA.	hjcheng@ucdavis.edu	Cheng, Hwai-Jong/AAY-5067-2021	Cheng, Hwai-Jong/0000-0003-0647-0567	National Eye Institute [EY11369, EY020743, EY015387]; NATIONAL EYE INSTITUTE [R01EY011369, R21EY020743, P30EY012576, T32EY015387] Funding Source: NIH RePORTER	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by National Eye Institute (http://www.nei.nih.gov/) grants to BC and HC, (EY11369 and EY020743) and a vision training grant to Jack Werner (EY015387). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackman JB, 2012, NATURE, V490, P219, DOI 10.1038/nature11529; Bansal A, 2000, J NEUROSCI, V20, P7672; Blankenship AG, 2009, NEURON, V62, P230, DOI 10.1016/j.neuron.2009.03.015; Butts DA, 2001, J NEUROSCI, V21, P961, DOI 10.1523/JNEUROSCI.21-03-00961.2001; Butts DA, 2007, PLOS BIOL, V5, P651, DOI 10.1371/journal.pbio.0050061; Cang JH, 2005, NEURON, V48, P797, DOI 10.1016/j.neuron.2005.09.015; Chapman B, 2000, J NEUROSCI, V20, P1922; Chapman B, 2000, SCIENCE, V287, P2479, DOI 10.1126/science.287.5462.2479; Cook PM, 1999, VISUAL NEUROSCI, V16, P491, DOI 10.1017/S0952523899163107; CUCCHIARO J, 1984, PROC R SOC SER B-BIO, V223, P141, DOI 10.1098/rspb.1984.0087; DANIELS JD, 1978, J NEUROPHYSIOL, V41, P1373, DOI 10.1152/jn.1978.41.6.1373; Feller MB, 1996, SCIENCE, V272, P1182, DOI 10.1126/science.272.5265.1182; Ford KJ, 2012, VISUAL NEUROSCI, V29, P61, DOI 10.1017/S0952523811000216; Ford KJ, 2012, J NEUROSCI, V32, P850, DOI 10.1523/JNEUROSCI.5309-12.2012; Gjorgjieva J, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000618; Huberman AD, 2002, J NEUROSCI, V22, P9419; Kerschensteiner D, 2008, NEURON, V58, P851, DOI 10.1016/j.neuron.2008.04.025; Lee CW, 2002, J NEUROPHYSIOL, V88, P2311, DOI 10.1152/jn.00372.2002; LINDEN DC, 1981, J COMP NEUROL, V203, P189, DOI 10.1002/cne.902030204; MEISTER M, 1991, SCIENCE, V252, P939, DOI 10.1126/science.2035024; Penn AA, 1998, SCIENCE, V279, P2108, DOI 10.1126/science.279.5359.2108; Pfeiffenberger C, 2005, NAT NEUROSCI, V8, P1022, DOI 10.1038/nn1508; ROE AW, 1989, J COMP NEUROL, V288, P208, DOI 10.1002/cne.902880203; Rossi FM, 2001, P NATL ACAD SCI USA, V98, P6453, DOI 10.1073/pnas.101120998; Shoham S, 2003, J NEUROSCI METH, V127, P111, DOI 10.1016/S0165-0270(03)00120-1; Speer CM, 2010, ANAT REC, V293, P1, DOI 10.1002/ar.21001; Stafford BK, 2009, NEURON, V64, P200, DOI 10.1016/j.neuron.2009.09.021; Stellwagen D, 2002, NEURON, V33, P357, DOI 10.1016/S0896-6273(02)00577-9; STRYKER MP, 1983, J NEUROSCI, V3, P1943; Sun C, 2008, J NEUROPHYSIOL, V100, P3253, DOI 10.1152/jn.90303.2008; Torborg CL, 2004, J NEUROSCI METH, V135, P17, DOI 10.1016/j.jneumeth.2003.11.019; VITEK DJ, 1985, J COMP NEUROL, V241, P1, DOI 10.1002/cne.902410102; Warland DK, 2006, J NEUROSCI, V26, P5190, DOI 10.1523/JNEUROSCI.0328-06.2006; Wong ROL, 1996, NEURON, V16, P1087, DOI 10.1016/S0896-6273(00)80135-X; WONG ROL, 1993, NEURON, V11, P923, DOI 10.1016/0896-6273(93)90122-8; Wong WT, 2000, J NEUROSCI, V20, P351, DOI 10.1523/JNEUROSCI.20-01-00351.2000; Xu HP, 2011, NEURON, V70, P1115, DOI 10.1016/j.neuron.2011.04.028	37	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0118783	10.1371/journal.pone.0118783	http://dx.doi.org/10.1371/journal.pone.0118783			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25794280	Green Published, gold			2022-12-27	WOS:000352084200040
J	Fang, Y; Qin, YF; Zhang, NQ; Wang, J; Wang, HY; Zheng, XQ				Fang, Yun; Qin, Yufang; Zhang, Naiqian; Wang, Jun; Wang, Haiyun; Zheng, Xiaoqi			DISIS: Prediction of Drug Response through an Iterative Sure Independence Screening	PLOS ONE			English	Article							VARIABLE SELECTION; GENE-EXPRESSION; CHEMOSENSITIVITY; METHYLATION; BIOMARKERS; RELEVANCE	Prediction of drug response based on genomic alterations is an important task in the research of personalized medicine. Current elastic net model utilized a sure independence screening to select relevant genomic features with drug response, but it may neglect the combination effect of some marginally weak features. In this work, we applied an iterative sure independence screening scheme to select drug response relevant features from the Cancer Cell Line Encyclopedia (CCLE) dataset. For each drug in CCLE, we selected up to 40 features including gene expressions, mutation and copy number alterations of cancer-related genes, and some of them are significantly strong features but showing weak marginal correlation with drug response vector. Lasso regression based on the selected features showed that our prediction accuracies are higher than those by elastic net regression for most drugs.	[Fang, Yun; Zhang, Naiqian; Wang, Jun; Zheng, Xiaoqi] Shanghai Normal Univ, Dept Math, Shanghai, Peoples R China; [Qin, Yufang] Shanghai Ocean Univ, Dept Math, Shanghai, Peoples R China; [Wang, Haiyun] Tongji Univ, Sch Life Sci & Technol, Dept Bioinformat, Shanghai 200092, Peoples R China	Shanghai Normal University; Shanghai Ocean University; Tongji University	Wang, HY (corresponding author), Tongji Univ, Sch Life Sci & Technol, Dept Bioinformat, Shanghai 200092, Peoples R China.	wanghaiyun@tongji.edu.cn; xqzheng@shnu.edu.cn			National Natural Science Foundation of China [31100953, 31100912, 11201306]; Innovation Program of Shanghai Municipal Education Commission [12YZ088, 13YZ065]; Program of Shanghai Normal University [DZL121, SK201207]; Supporting Program for Young College Teachers of Shanghai	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Innovation Program of Shanghai Municipal Education Commission(Innovation Program of Shanghai Municipal Education Commission); Program of Shanghai Normal University; Supporting Program for Young College Teachers of Shanghai	This work was supported by the National Natural Science Foundation of China (31100953, 31100912 and 11201306), the Innovation Program of Shanghai Municipal Education Commission (12YZ088 and 13YZ065), the Program of Shanghai Normal University (DZL121, SK201207) and the Supporting Program for Young College Teachers of Shanghai. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abudukadeer A, 2012, INT J MOL SCI, V13, P8353, DOI 10.3390/ijms13078353; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Chernova OB, 1998, ONCOGENE, V17, P2873, DOI 10.1038/sj.onc.1202481; DeRemer DL, 2008, CLIN THER, V30, P1956, DOI 10.1016/j.clinthera.2008.11.014; Ding Chris, 2005, Journal of Bioinformatics and Computational Biology, V3, P185, DOI 10.1142/S0219720005001004; Endoh M, 2005, BRIT J CANCER, V93, P1395, DOI 10.1038/sj.bjc.6602854; Fan JQ, 2008, J R STAT SOC B, V70, P849, DOI 10.1111/j.1467-9868.2008.00674.x; Fan JQ, 2009, J MACH LEARN RES, V10, P2013; Fan JQ, 2001, J AM STAT ASSOC, V96, P1348, DOI 10.1198/016214501753382273; Garnett MJ, 2012, NATURE, V483, P570, DOI 10.1038/nature11005; Hernandez-Caballero E, 2009, BMB REP, V42, P747, DOI 10.5483/BMBRep.2009.42.11.747; Holleman A, 2004, NEW ENGL J MED, V351, P533, DOI 10.1056/NEJMoa033513; Kaczmarek LK, 2006, NEURON, V49, P642, DOI 10.1016/j.neuron.2006.02.011; Kataoka T, 2001, J BIOL CHEM, V276, P19548, DOI 10.1074/jbc.M010520200; Lee JK, 2007, P NATL ACAD SCI USA, V104, P13086, DOI 10.1073/pnas.0610292104; Meinshausen N, 2006, ANN STAT, V34, P1436, DOI 10.1214/009053606000000281; Menden MP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061318; Niu Yue S, 2011, BMC Proc, V5 Suppl 9, pS108, DOI 10.1186/1753-6561-5-S9-S108; Peng HC, 2005, IEEE T PATTERN ANAL, V27, P1226, DOI 10.1109/TPAMI.2005.159; Ren XW, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks1288; Riddick G, 2011, BIOINFORMATICS, V27, P220, DOI 10.1093/bioinformatics/btq628; Shen LL, 2007, CANCER RES, V67, P11335, DOI 10.1158/0008-5472.CAN-07-1502; Staunton JE, 2001, P NATL ACAD SCI USA, V98, P10787, DOI 10.1073/pnas.191368598; Stratton MR, 2009, NATURE, V458, P719, DOI 10.1038/nature07943; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Ueki M, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-72; Vos MD, 2003, J BIOL CHEM, V278, P28045, DOI 10.1074/jbc.M300554200; Wang Y, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-S1-S15	28	11	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0120408	10.1371/journal.pone.0120408	http://dx.doi.org/10.1371/journal.pone.0120408			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25794193	gold, Green Published, Green Submitted			2022-12-27	WOS:000352083900029
J	Hsu, HK; Brown, TT; Li, XH; Young, S; Cranston, RD; D'Souza, G; Jacobson, LP; Martinez-Maza, O; Seaberg, EC; Margolick, JB; Jenkins, FJ; Moran, MG; Chua, K; Bolan, RK; Detels, R; Wiley, DJ				Hsu, Hilary K.; Brown, Todd T.; Li, Xiuhong; Young, Stephen; Cranston, Ross D.; D'Souza, Gypsyamber; Jacobson, Lisa P.; Martinez-Maza, Otoniel; Seaberg, Eric C.; Margolick, Joseph B.; Jenkins, Frank J.; Moran, Matthew G.; Chua, Kristofer; Bolan, Robert K.; Detels, Roger; Wiley, Dorothy J.			Association between Free Testosterone Levels and Anal Human Papillomavirus Types 16/18 Infections in a Cohort of Men Who Have Sex with Men	PLOS ONE			English	Article							REPLACEMENT THERAPY; CERVICAL-CANCER; RISK-FACTORS; DOUBLE-BLIND; HIV; WOMEN; AGE; HPV; PREVALENCE; ESTROGEN	Background Human papillomavirus (HPV) types 16 and 18 cause invasive cervical cancer and most invasive anal cancers (IACs). Overall, IAC rates are highest among men who have sex with men (MSM), especially MSM with HIV infection. Testosterone is prescribed for men showing hypogonadism and HIV-related wasting. While there are direct and indirect physiological effects of testosterone in males, its role in anal HPV16/18 infections in men is unknown. Methods Free testosterone (FT) was measured in serum from 340 Multicenter AIDS Cohort Study (MACS) participants who were tested for anal HPV16/18-DNA approximately 36 months later. The effect of log10-transformed current FT level on anal HPV16/18 prevalence was modeled using Poisson regression with robust error variance. Multivariate models controlled for other HPV types, cumulative years of exogenous testosterone use, race, age, lifetime number of receptive anal intercourse partnerships, body mass index, tobacco smoking, HIV-infection and CD4+ T-cell counts among HIV-infected, and blood draw timing. Results Participants were, on average, 60 (+5.4) years of age, White (86%), and HIV-uninfected (56%); Twenty-four percent tested positive for anal HPV16 and/or 18-DNA (HPV16 prevalence= 17.1%, HPV18=9.1%). In adjusted analysis, each half-log10 increase of FT was associated with a 1.9-fold (95% Confidence Interval: 1.11, 3.24) higher HPV16/18 prevalence. Additionally, other Group 1 high-risk HPVs were associated with a 1.56-fold (1.03, 2.37) higher HPV16/18 prevalence. Traditional risk factors for HPV16/18 infection (age, tobacco smoking; lifetime number of sexual partners, including the number of receptive anal intercourse partnerships within 24 months preceding HPV testing) were poorly correlated with one another and not statistically significantly associated with higher prevalence of HPV16/18 infection in unadjusted and adjusted analyses. Conclusions Higher free testosterone was associated with increased HPV16/18 prevalence measured approximately three years later, independent of sexual behavior and other potential confounders. The mechanisms underlying this association remain unclear and warrant further study.	[Hsu, Hilary K.; Moran, Matthew G.; Chua, Kristofer; Wiley, Dorothy J.] Univ Calif Los Angeles, Sch Nursing, Los Angeles, CA 90024 USA; [Brown, Todd T.] Johns Hopkins Univ, Sch Med, Baltimore, MD USA; [Li, Xiuhong; D'Souza, Gypsyamber; Jacobson, Lisa P.; Seaberg, Eric C.; Margolick, Joseph B.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Young, Stephen] Univ New Mexico, Tricore Reference Labs, Albuquerque, NM 87131 USA; [Cranston, Ross D.; Jenkins, Frank J.] Univ Pittsburgh, Dept Med, Pittsburgh, PA USA; [Martinez-Maza, Otoniel] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Martinez-Maza, Otoniel; Detels, Roger] Univ Calif Los Angeles, Jonathan & Karin Fielding Sch Publ Hlth, Los Angeles, CA USA; [Moran, Matthew G.] Desert AIDS Project, Palm Springs, CA USA; [Bolan, Robert K.] Jeffrey Goodman Clin, Los Angeles LGBT Ctr, Hollywood, CA USA	University of California System; University of California Los Angeles; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of New Mexico; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles	Wiley, DJ (corresponding author), Univ Calif Los Angeles, Sch Nursing, Los Angeles, CA 90024 USA.	dwiley@ucla.edu	Martinez-Maza, Otoniel/B-2667-2009; Bolan, Robert/AAD-4716-2020	Martinez-Maza, Otoniel/0000-0003-1364-0675; Hsu, Hilary/0000-0003-4608-4935; Cranston, Ross/0000-0002-2687-6217; Wiley, Dorothy/0000-0002-9416-473X; Jacobson, Lisa P./0000-0003-1722-6826	National Institute of Allergy and Infectious Diseases (NIAID); National Cancer Institute (NCI) [U01-AI-35042, U01-AI-35039, U01-AI-35040, U01-AI-35041, UM1-AI-35043]; National Heart, Lung, and Blood Institute (NHLBI); National Institute on Deafness and Communication Disorders (NIDCD); Johns Hopkins University Clinical and Translational Science Awards [UL1TR000424]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000424] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI035042, U01AI035039, U01AI035041, UM1AI035043, U01AI035040, U01AI035043] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH058107] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute on Deafness and Communication Disorders (NIDCD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Johns Hopkins University Clinical and Translational Science Awards; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The MACS is funded primarily by the National Institute of Allergy and Infectious Diseases (NIAID, http://www.niaid.nih.gov/Pages/default.aspx), with additional cofunding from the National Cancer Institute (NCI, www.cancer.gov). Grant numbers: Baltimore (U01-AI-35042), Chicago (U01-AI-35039), Los Angeles (U01-AI-35040), Pittsburgh (U01-AI-35041), and Data Coordinating Center (UM1-AI-35043). Targeted supplemental funding for specific projects was also provided by the National Heart, Lung, and Blood Institute (NHLBI, http://www.nhlbi.nih.gov), and the National Institute on Deafness and Communication Disorders (NIDCD, http://www.nidcd.nih.gov/Pages/default.aspx). MACS data collection is also supported by the Johns Hopkins University Clinical and Translational Science Awards: UL1TR000424(JHU CTSA, http://ictr.johnshopkins.edu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberg JA, 2014, CLIN INFECT DIS, V58, pE1, DOI [10.1093/cid/cit665, 10.1093/cid/cit757]; Abramowitz L, 2011, INT J CANCER, V129, P433, DOI 10.1002/ijc.25671; Alemany L, 2015, INT J CANCER, V136, P98, DOI 10.1002/ijc.28963; Anonymous, 2010, Morbidity and Mortality Weekly Report, V59, P626; [Anonymous], 2013, MMWR-MORBID MORTAL W, V18, P2; [Anonymous], 2011, COBAS HPV TEST; Appleby P, 2007, LANCET, V370, P1609, DOI 10.1016/S0140-6736(07)61684-5; Bertisch B, 2013, AM J EPIDEMIOL, V178, P877, DOI 10.1093/aje/kwt153; Bhasin S, 1998, J CLIN ENDOCR METAB, V83, P3155, DOI 10.1210/jc.83.9.3155; Bhasin S, 2010, J CLIN ENDOCR METAB, V95, P2536, DOI 10.1210/jc.2009-2354; Bhattacharya RK, 2012, CLIN INTERV AGING, V7, P321, DOI 10.2147/CIA.S32036; BOLELLI G, 1995, CANCER EPIDEM BIOMAR, V4, P509; Borst SE, 2007, CLIN INTERV AGING, V2, P561; BOUVARD V, 2009, LANCET ONCOL, V10, P321, DOI [DOI 10.1016/S1470-2045(09)70096-8, 10.1016/s1470-2045(09)70096-8]; Castle PE, 2008, J CLIN MICROBIOL, V46, P3437, DOI 10.1128/JCM.00620-08; Castle PE, 2008, J CLIN MICROBIOL, V46, P109, DOI 10.1128/JCM.01667-07; Chin-Hong PV, 2005, JNCI-J NATL CANCER I, V97, P896, DOI 10.1093/jnci/dji163; Chung SH, 2010, TRENDS ENDOCRIN MET, V21, P8; de Gonzalez AB, 2007, INT J CANCER, V120, P885, DOI 10.1002/ijc.22357; de Pokomandy A, 2009, J INFECT DIS, V199, P965, DOI 10.1086/597207; DOSEMECI M, 1990, AM J EPIDEMIOL, V132, P746, DOI 10.1093/oxfordjournals.aje.a115716; Dudgeon WD, 2006, HIV MED, V7, P299, DOI 10.1111/j.1468-1293.2006.00380.x; Elson DA, 2000, CANCER RES, V60, P1267; Glick SN, 2013, J INFECT DIS; Gravitt PE, 2000, J CLIN MICROBIOL, V38, P357; Handelsman DJ, 2013, MED J AUSTRALIA, V199, P548, DOI 10.5694/mja13.10111; Heiligenberg M, 2013, J INFECT DIS, V208, P1081, DOI 10.1093/infdis/jit295; Hoots BE, 2009, INT J CANCER, V124, P2375, DOI 10.1002/ijc.24215; *IARC, 2005, IARC MON EV CARC RIS; KASLOW RA, 1987, AM J EPIDEMIOL, V126, P310, DOI 10.1093/aje/126.2.310; Kaushic C, 2011, J REPROD IMMUNOL, V88, P6; Kim CJ, 2000, INT J GYNECOL CANCER, V10, P157, DOI 10.1046/j.1525-1438.2000.00016.x; KLEY HK, 1985, J CLIN CHEM CLIN BIO, V23, P875; Kwasniewska A, 2011, ONCOL REP, V26, P153, DOI 10.3892/or.2011.1256; Lakshman KM, 2010, J CLIN ENDOCR METAB, V95, P3955, DOI 10.1210/jc.2010-0102; Madeleine MM, 2001, CANCER EPIDEM BIOMAR, V10, P171; Markowitz LE, 2013, J INFECT DIS, V208, P385, DOI 10.1093/infdis/jit192; Monroe AK, 2014, AIDS RES THER, V11, DOI 10.1186/1742-6405-11-6; Monroe AK, 2011, JAIDS-J ACQ IMM DEF, V58, P173, DOI 10.1097/QAI.0b013e3182278c09; Mooij SH, 2013, CANCER EPIDEM BIOMAR, V22, P1698, DOI 10.1158/1055-9965.EPI-13-0460; Moreno V, 2002, LANCET, V359, P1085, DOI 10.1016/S0140-6736(02)08150-3; Nyitray AG, 2011, J INFECT DIS, V203, P49, DOI 10.1093/infdis/jiq021; Oettling G, 1998, EUR J OBSTET GYN R B, V77, P211, DOI 10.1016/S0301-2115(97)00212-1; Rabkin JG, 2000, ARCH GEN PSYCHIAT, V57, P141, DOI 10.1001/archpsyc.57.2.141; Rochira V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028512; Sartorius G, 2012, CLIN ENDOCRINOL, V77, P755, DOI 10.1111/j.1365-2265.2012.04432.x; Schabath M. B., 2014, International Journal of Cancer, V134, P2448, DOI 10.1002/ijc.28567; Schwartz LM, 2013, J INFECT DIS; Svartberg J, 2003, EUR J ENDOCRINOL, V149, P145, DOI 10.1530/eje.0.1490145; Valmary-Degano S, 2013, HUM PATHOL, V44, P11; Van Aar F, 2013, AIDS; Vermeulen A, 1999, J CLIN ENDOCR METAB, V84, P3666, DOI 10.1210/jc.84.10.3666; Villa LL, 2005, LANCET ONCOL, V6, P271, DOI 10.1016/S1470-2045(05)70101-7; Villa LL, 2006, INT J GYNECOL OBS S1, V94, P5; Wiley DJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079492; Yan X, 2010, CANCER BIOL THER, V9, P10, DOI DOI 10.1016/j.materresbull.2010.09.038; Yeap BB, 2012, CRIT REV CL LAB SCI, V49, P168, DOI 10.3109/10408363.2012.725461; Yoshikawa H, 2013, CANCER SCI, V104, P465, DOI 10.1111/cas.12106; Yuki A, 2013, SCI REP-UK, V3, DOI 10.1038/srep01818; Zirkin BR, 2012, J ANDROL, V33, P1111, DOI 10.2164/jandrol.112.017160; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	61	1	1	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0119447	10.1371/journal.pone.0119447	http://dx.doi.org/10.1371/journal.pone.0119447			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25794147	Green Published, gold, Green Accepted			2022-12-27	WOS:000352084200084
J	Marcus, U; Hickson, F; Weatherburn, P; Furegato, M; Breveglieri, M; Berg, RC; Schmidt, AJ				Marcus, Ulrich; Hickson, Ford; Weatherburn, Peter; Furegato, Martina; Breveglieri, Michele; Berg, Rigmor C.; Schmidt, Axel J.		EMIS Network	Antiretroviral Therapy and Reasons for Not Taking It among Men Having Sex with Men (MSM)-Results from the European MSM Internet Survey (EMIS)	PLOS ONE			English	Article							HIV	Background The preventive effects of antiretroviral treatment (ART) on onward transmission of HIV are a major reason for broadening eligibility for ART. In the WHO European Region, surveillance reveals substantial differences in access to ART across regions and sub-populations. We analysed self-reported data on ART and reasons for not taking ART from EMIS, a large Pan-European Internet survey among men-who-have-sex-with-men (MSM). Methods Respondents from 38 European countries reported their last HIV test result and, if diagnosed with HIV, their treatment status, and reasons for not taking or having stopped ART from a 7 item multiple choice list and/or answered an open-ended question to give other reasons. Responses were classified as fear of consequences, perceived lack of need, and ART inaccessibility based on factor analysis. Associations between not taking ART because of fear of consequences, and demographic, behavioural and contextual indicators were identified in a multivariable regression model. Results 13,353 (7.7%) of 174,209 respondents had been diagnosed with HIV. Among them 3,391 (25.4%) had never received ART, and 278 (2.1%) had stopped taking ART. Perceived lack of need was by far the most common reason for not taking or stopping ART (mentioned by 3259 (88.8%) respondents), followed by fear of consequences (428 (11.7%)), and ART inaccessibility (86 (2.3%)). For all reasons, an East- West gradient could be seen, with larger proportions of men living in Central and Eastern Europe reporting reasons other than medical advice for not taking ART. A minority of men were reluctant to start ART independent of medical advice and this was associated with experiences of discrimination in health care systems. Conclusions ART is widely available for MSM diagnosed with HIV across Europe. Not being on treatment is predominantly due to treatment not being recommended by their physician and/or not perceived to be needed by the respondent.	[Marcus, Ulrich; Schmidt, Axel J.] Robert Koch Inst, Dept Infect Dis Epidemiol, Berlin, Germany; [Hickson, Ford; Weatherburn, Peter] London Sch Hyg & Trop Med, Sigma Res, London WC1, England; [Furegato, Martina; Breveglieri, Michele] Reg Veneto, Dept Hlth, Verona, Italy; [Berg, Rigmor C.] Norwegian Knowledge Ctr Hlth Serv, Oslo, Norway	Robert Koch Institute; University of London; London School of Hygiene & Tropical Medicine; Norwegian Knowledge Centre for Health Services	Marcus, U (corresponding author), Robert Koch Inst, Dept Infect Dis Epidemiol, Berlin, Germany.	MarcusU@rki.de	Schmidt, Axel J/J-1855-2019; Weatherburn, Peter/AAC-2701-2019; Marcus, Ulrich/AAF-3085-2020	Schmidt, Axel J/0000-0002-6910-4399; Marcus, Ulrich/0000-0002-3143-2717; Weatherburn, Peter/0000-0002-4950-6163; , Martina/0000-0003-2168-8396	Executive Agency for Health and Consumers, EU Health Programme; CEEISCat-Centre d'Estudis Epidemiologics sobre les ITS/HIV/SIDA de Catalunya; Terrence Higgins Trust (CHAPS) for Department of Health for England; Maastricht University; Regione del Veneto; Robert Koch Institute; BZgA (Bundeszentrale fur gesundheitliche Aufklarung, Koln); German Ministry of Health; Finnish Ministry of Health; Norwegian Institute of Public Health; Swedish Board of Health and Welfare	Executive Agency for Health and Consumers, EU Health Programme; CEEISCat-Centre d'Estudis Epidemiologics sobre les ITS/HIV/SIDA de Catalunya; Terrence Higgins Trust (CHAPS) for Department of Health for England; Maastricht University; Regione del Veneto(Regione Veneto); Robert Koch Institute; BZgA (Bundeszentrale fur gesundheitliche Aufklarung, Koln); German Ministry of Health; Finnish Ministry of Health; Norwegian Institute of Public Health; Swedish Board of Health and Welfare	The EMIS project was funded by: Executive Agency for Health and Consumers, EU Health Programme 2008-2013 (funding period: 14.3.2009-13.9.2011); CEEISCat-Centre d'Estudis Epidemiologics sobre les ITS/HIV/SIDA de Catalunya (2009-2012); Terrence Higgins Trust (CHAPS) for Department of Health for England (2009-2012); Maastricht University (2009-2012); Regione del Veneto (2009-2012); Robert Koch Institute (2009-2012); BZgA (Bundeszentrale fur gesundheitliche Aufklarung, Koln: 2010-2011); German Ministry of Health (2010); Finnish Ministry of Health (2010); Norwegian Institute of Public Health (2010-2011); Swedish Board of Health and Welfare (2010-2011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson WJ, 2004, INT J STD AIDS, V15, P793, DOI 10.1258/0956462042563602; Berg RC, 2013, SOC SCI MED, V78, P61, DOI 10.1016/j.socscimed.2012.11.033; Cohen MS, 2008, J CLIN INVEST, V118, P1244, DOI 10.1172/JCI34706; European AIDS Clinical Society, EUR GUID TREATM HIV; European AIDS Clinical Society, 2013, EUR GUID TREATM HIV; Fehr J, 2013, 14 EUR AIDS C OCT 20; Hoen B, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.19034; Hsu LC, 2014, J INFECT DIS, V209, P1310, DOI 10.1093/infdis/jit599; IDF (International Diabetes Federation), 2021, CONSOLIDATED GUIDELI, V10th ed.; Lundgren JD, 2013, CLIN INFECT DIS, V57, P888, DOI 10.1093/cid/cit381; Panel of Antiretroviral Guidelines for Adults and Adolescents, GUIDELINES USE ANTIR; Ross MW, 2013, BMJ OPEN, V3, DOI [10.1136/bmjopen-2014-006175, 10.1136/bmjopen-2012-001928]; Russian Harm Reduction Network, CIV SOC REP 2008 RUS; Sabin CA, 2009, CURR OPIN INFECT DIS, V22, P191, DOI 10.1097/QCO.0b013e328326cd34; The EMIS Network, 2013, EMIS 2010 EUR MEN WH, P76; UNAIDS, UNAIDS REP GLOB AIDS; Weatherburn P, 2013, SEX RES SOC POLICY, V10, P243, DOI 10.1007/s13178-013-0119-4; Williams I, 2012, HIV MED, V13, P1, DOI [10.1111/j.1468-1293.2012.01029_1.x, 10.1111/j.1468-1293.2012.01029.x]	18	4	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0121047	10.1371/journal.pone.0121047	http://dx.doi.org/10.1371/journal.pone.0121047			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25793882	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000352083900099
J	Newsom, SA; Everett, AC; Park, S; van Pelt, DW; Hinko, A; Horowitz, JF				Newsom, Sean A.; Everett, Allison C.; Park, Sanghee; van Pelt, Douglas W.; Hinko, Alexander; Horowitz, Jeffrey F.			Lipid Mixtures Containing a Very High Proportion of Saturated Fatty Acids Only Modestly Impair Insulin Signaling in Cultured Muscle Cells	PLOS ONE			English	Article							SKELETAL-MUSCLE; MORPHOLOGICAL-CHANGES; BETA-CELLS; RESISTANCE; CERAMIDE; OBESITY; DIACYLGLYCEROL; ACCUMULATION; SENSITIVITY; PALMITATE	In vitro examinations of the effect of saturated fatty acids on skeletal muscle insulin action often use only one or two different fatty acid species, which does not resemble the human plasma fatty acid profile. We compared graded concentrations (0.1-0.8mM) of 3 different lipid mixtures: 1) a physiologic fatty acid mixture (NORM; 40% saturated fatty acids), 2) a physiologic mixture high in saturated fatty acids (HSFA; 60% saturated fatty acids), and 3) 100% palmitate (PALM) on insulin signaling and fatty acid partitioning into triacylglycerol (TAG) and diacylglycerol (DAG) in cultured muscle cells. As expected, PALM readily impaired insulin-stimulated pAkt(Thr308)/Akt and markedly increased intracellular DAG content. In contrast, the fatty acid mixtures only modestly impaired insulin-stimulated pAkt(Thr308M)/Akt, and we found no differences between NORM and HSFA. Importantly, NORM and HSFA did not increase DAG content, but instead dose-dependently increased TAG accumulation. Therefore, the robust impairment in insulin signaling found with palmitate exposure was attenuated with physiologic mixtures of fatty acids, even with a very high proportion of saturated fatty acids. This may be explained in part by selective partitioning of fatty acids into neutral lipid (i.e., TAG) when muscle cells were exposed to physiologic lipid mixtures.	[Newsom, Sean A.; Everett, Allison C.; Park, Sanghee; van Pelt, Douglas W.; Hinko, Alexander; Horowitz, Jeffrey F.] Univ Michigan, Sch Kinesiol, Substrate Metab Lab, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Horowitz, JF (corresponding author), Univ Michigan, Sch Kinesiol, Substrate Metab Lab, Ann Arbor, MI 48109 USA.	jeffhoro@umich.edu		Newsom, Sean/0000-0003-0585-3830	National Institutes of Health [DK077966]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK077966, P30DK020572] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grant DK077966, awarded to JFH (www.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JM, 2004, DIABETES, V53, P25, DOI 10.2337/diabetes.53.1.25; Bachmann OP, 2001, DIABETES, V50, P2579, DOI 10.2337/diabetes.50.11.2579; Bonen A, 2004, FASEB J, V18, P1144, DOI 10.1096/fj.03-1065fje; Chavez JA, 2003, ARCH BIOCHEM BIOPHYS, V419, P101, DOI 10.1016/j.abb.2003.08.020; Chavez JA, 2003, J BIOL CHEM, V278, P10297, DOI 10.1074/jbc.M212307200; Coll T, 2008, J BIOL CHEM, V283, P11107, DOI 10.1074/jbc.M708700200; Dimopoulos N, 2006, BIOCHEM J, V399, P473, DOI 10.1042/BJ20060244; Galgani JE, 2008, BRIT J NUTR, V100, P471, DOI 10.1017/S0007114508894408; Gao D, 2009, BRIT J NUTR, V102, P1557, DOI 10.1017/S0007114509990948; Holland WL, 2007, CELL METAB, V5, P167, DOI 10.1016/j.cmet.2007.01.002; Horowitz JF, 1999, AM J PHYSIOL-ENDOC M, V276, pE278, DOI 10.1152/ajpendo.1999.276.2.E278; Hu FB, 2001, DIABETOLOGIA, V44, P805, DOI 10.1007/s001250100547; Itani SI, 2002, DIABETES, V51, P2005, DOI 10.2337/diabetes.51.7.2005; JENSEN MD, 1989, J CLIN INVEST, V83, P1168, DOI 10.1172/JCI113997; Moffitt JH, 2005, DIABETOLOGIA, V48, P1819, DOI 10.1007/s00125-005-1861-9; Montell E, 2001, AM J PHYSIOL-ENDOC M, V280, pE229, DOI 10.1152/ajpendo.2001.280.2.E229; Newsom SA, 2013, DIABETES CARE; Newsom SA, 2011, METABOLISM, V60, P852, DOI 10.1016/j.metabol.2010.08.004; Pinnick K, 2010, J CELL BIOCHEM, V109, P683, DOI 10.1002/jcb.22445; ROUST LR, 1993, DIABETES, V42, P1567, DOI 10.2337/diabetes.42.11.1567; Sawada K, 2012, LIPIDS HEALTH DIS, V11, DOI 10.1186/1476-511X-11-36; Schenk S, 2005, AM J PHYSIOL-ENDOC M, V288, pE519, DOI 10.1152/ajpendo.00401.2004; Schenk S, 2007, J CLIN INVEST, V117, P1690, DOI 10.1172/JCI30566; Thompson DB, 1996, J CLIN INVEST, V98, P2346, DOI 10.1172/JCI119046; Turpin SM, 2006, AM J PHYSIOL-ENDOC M, V291, pE1341, DOI 10.1152/ajpendo.00095.2006; Watt MJ, 2012, AM J PHYSIOL-ENDOC M, V302, pE1, DOI 10.1152/ajpendo.00418.2011	26	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0120871	10.1371/journal.pone.0120871	http://dx.doi.org/10.1371/journal.pone.0120871			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25793412	gold, Green Published, Green Submitted			2022-12-27	WOS:000352083900085
J	Pei, JS; Hsu, CM; Tsai, CW; Chang, WS; Ji, HX; Hsiao, CL; Miao, CE; Hsu, YN; Bau, DT				Pei, Jen-Sheng; Hsu, Chin-Mu; Tsai, Chia-Wen; Chang, Wen-Shin; Ji, Hong-Xue; Hsiao, Chieh-Lun; Miao, Chia-En; Hsu, Yuan-Nian; Bau, Da-Tian			The Association of Methylenetetrahydrofolate Reductase Genotypes with the Risk of Childhood Leukemia in Taiwan	PLOS ONE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; SINGLE NUCLEOTIDE POLYMORPHISMS; MTHFR GENETIC POLYMORPHISMS; ACUTE LYMPHOCYTIC-LEUKEMIA; FOLATE METABOLIC PATHWAY; A1298C POLYMORPHISMS; C677T POLYMORPHISM; CANCER SUSCEPTIBILITY; CHINESE POPULATION; SMOKING HABIT	Background Acute lymphoblastic leukemia (ALL) is the most prevalent type of pediatric cancer, the causes of which are likely to involve an interaction between genetic and environmental factors. To evaluate the effects of the genotypic polymorphisms in methylenetetrahydrofolate reductase (MTHFR) on childhood ALL risk in Taiwan, two well-known polymorphic genotypes of MTHFR, C677T (rs1801133) and A1298C (rs1801131), were analyzed to examine the extent of their associations with childhood ALL susceptibility and to discuss the MTHFR genotypic contribution to childhood ALL risk among different populations. Methodology/Principal Findings In total, 266 patients with childhood ALL and an equal number of non-cancer controls recruited were genotyped utilizing PCR-RFLP methodology. The MTHFR C677T genotype, but not the A1298C, was differently distributed between childhood ALL and control groups. The CT and TT of MTHFR C677T genotypes were significantly more frequently found in controls than in childhood ALL patients (odds ratios=0.60 and 0.48, 95% confidence intervals=0.42-0.87 and 0.24-0.97, respectively). As for gender, the boys carrying the MTHFR C677T CT or TT genotype conferred a lower odds ratio of 0.51 (95% confidence interval=0.32-0.81, P=0.0113) for childhood ALL. As for age, those equal to or greater than 3.5 years of age at onset of disease carrying the MTHFR C677T CT or TT genotype were of lower risk (odds ratio=0.43 and 95% confidence interval=0.26-0.71, P=0.0016). Conclusions Our results indicated that the MTHFR C677T T allele was a protective biomarker for childhood ALL in Taiwan, and the association was more significant in male patients and in patients 3.5 years of age or older at onset of disease.	[Pei, Jen-Sheng] Minist Hlth & Welf, Taoyuan Gen Hosp, Dept Pediat, Taoyuan, Taiwan; [Hsu, Chin-Mu; Tsai, Chia-Wen; Chang, Wen-Shin; Ji, Hong-Xue; Hsiao, Chieh-Lun; Miao, Chia-En; Bau, Da-Tian] China Med Univ Hosp, Terry Fox Canc Res Lab, Taichung, Taiwan; [Tsai, Chia-Wen; Bau, Da-Tian] China Med Univ, Grad Inst Basic Med Sci, Taichung, Taiwan; [Chang, Wen-Shin; Ji, Hong-Xue; Bau, Da-Tian] China Med Univ, Grad Inst Clin Med Sci, Taichung, Taiwan; [Hsu, Yuan-Nian] Minist Hlth & Welf, Taoyuan Gen Hosp, Dept Family Med, Taoyuan, Taiwan	China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Taiwan	Bau, DT (corresponding author), China Med Univ Hosp, Terry Fox Canc Res Lab, Taichung, Taiwan.	artbau1@yahoo.com.tw			Terry Fox Cancer Research Foundation of China Medical University Hospital; Taoyuan General Hospital, Ministry of Health and Welfare, Taoyuan, Taiwan, ROC [PTH10332]; Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence [MOHW104-TDU-B-212-113002]	Terry Fox Cancer Research Foundation of China Medical University Hospital; Taoyuan General Hospital, Ministry of Health and Welfare, Taoyuan, Taiwan, ROC; Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence	This study was supported by research grants from the Terry Fox Cancer Research Foundation of China Medical University Hospital and Taoyuan General Hospital, Ministry of Health and Welfare, Taoyuan, Taiwan, ROC (grant number: PTH10332) and Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence (MOHW104-TDU-B-212-113002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcasabas P, 2008, PEDIATR BLOOD CANCER, V51, P178, DOI 10.1002/pbc.21511; Amigou A, 2012, CANCER CAUSE CONTROL, V23, P1265, DOI 10.1007/s10552-012-0004-0; Azhar MR, 2012, GENET TEST MOL BIOMA, V16, P198, DOI 10.1089/gtmb.2011.0041; Bailey LB, 1999, J NUTR, V129, P919, DOI 10.1093/jn/129.5.919; Balta G, 2003, AM J HEMATOL, V73, P154, DOI 10.1002/ajh.10339; Barry Elly V, 2008, Curr Hematol Malig Rep, V3, P161, DOI 10.1007/s11899-008-0023-9; Bau DT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016374; Belson M, 2007, ENVIRON HEALTH PERSP, V115, P138, DOI 10.1289/ehp.9023; Cartwright RA, 2002, BRIT J HAEMATOL, V118, P1071, DOI 10.1046/j.1365-2141.2002.03750.x; Chan JYS, 2011, HEMATOL ONCOL, V29, P116, DOI 10.1002/hon.965; Chatzidakis K, 2006, PEDIATR BLOOD CANCER, V47, P147, DOI 10.1002/pbc.20574; Damnjanovic T, 2010, J PEDIAT HEMATOL ONC, V32, pE148, DOI 10.1097/MPH.0b013e3181cbd252; de Jonge R, 2009, BLOOD, V113, P2284, DOI 10.1182/blood-2008-07-165928; Dierkes J, 2001, METABOLISM, V50, P640, DOI 10.1053/meta.2001.23286; Franco RF, 2001, BRIT J HAEMATOL, V115, P616, DOI 10.1046/j.1365-2141.2001.03140.x; Homberger A, 2000, EUR J HUM GENET, V8, P725, DOI 10.1038/sj.ejhg.5200522; Jia J, 2011, TUMOR BIOL, V35, P4943; Jiang Y, 2013, ASIAN PAC J CANCER P, V14, P6357, DOI 10.7314/APJCP.2013.14.11.6357; Kaatsch P, 2010, CANCER TREAT REV, V36, P277, DOI 10.1016/j.ctrv.2010.02.003; Kamel Azza M, 2007, J Egypt Natl Canc Inst, V19, P96; Kang S, 2005, GYNECOL ONCOL, V96, P173, DOI 10.1016/j.ygyno.2004.09.031; KANG SS, 1988, AM J HUM GENET, V43, P414; Kim NK, 2006, ANTICANCER RES, V26, P2879; Knock E, 2006, CANCER RES, V66, P10349, DOI 10.1158/0008-5472.CAN-06-2477; Krajinovic M, 2004, BLOOD, V103, P252, DOI 10.1182/blood-2003-06-1794; Li XL, 2014, EUR J MED RES, V19, DOI 10.1186/2047-783X-19-5; Lightfoot TJ, 2010, BLOOD, V115, P3923, DOI 10.1182/blood-2009-10-249722; Liu Chiu-Shong, 2009, Cancer Genomics & Proteomics, V6, P325; Liu ZB, 2013, GENE, V515, P214, DOI 10.1016/j.gene.2012.11.036; Mathew CG, 2006, ONCOGENE, V25, P5875, DOI 10.1038/sj.onc.1209878; Matsuo K, 2001, BLOOD, V97, P3205, DOI 10.1182/blood.V97.10.3205; Metayer C, 2011, CANCER CAUSE CONTROL, V22, P1243, DOI 10.1007/s10552-011-9795-7; Milne E, 2010, INT J CANCER, V126, P2690, DOI 10.1002/ijc.24969; Mossuz P, 1998, LEUKEMIA RES, V22, P1063, DOI 10.1016/S0145-2126(98)00101-5; Narayanan S, 2004, CANCER EPIDEM BIOMAR, V13, P1436; Nikbakht M., 2012, Experimental Oncology, V34, P43; Oliveira E, 2005, J PEDIAT HEMATOL ONC, V27, P425, DOI 10.1097/01.mph.0000177513.81465.94; Papoutsakis C, 2006, EUR J CLIN NUTR, V60, P155, DOI 10.1038/sj.ejcn.1602280; Pearce MS, 2001, INT J CANCER, V91, P402, DOI 10.1002/1097-0215(200002)9999:9999&lt;::AID-IJC1048&gt;3.0.CO;2-F; Pereira AC, 2004, CLIN CHIM ACTA, V340, P99, DOI 10.1016/j.cccn.2003.09.016; Petra BG, 2007, LEUKEMIA LYMPHOMA, V48, P786, DOI 10.1080/10428190601187711; Reddy H, 2006, LEUKEMIA LYMPHOMA, V47, P1333, DOI 10.1080/10428190600562773; Robien K, 2003, AM J EPIDEMIOL, V157, P571, DOI 10.1093/aje/kwg024; Sadananda AMN, 2010, INDIAN J CANCER, V47, P40, DOI 10.4103/0019-509X.58858; Schnakenberg E, 2005, BMC MED GENET, V6, DOI 10.1186/1471-2350-6-23; Silva RMS, 2013, GENET TEST MOL BIOMA, V17, P147, DOI 10.1089/gtmb.2012.0174; Skibola CF, 1999, P NATL ACAD SCI USA, V96, P12810, DOI 10.1073/pnas.96.22.12810; Sohn KJ, 2004, JNCI-J NATL CANCER I, V96, P134, DOI 10.1093/jnci/djh015; Sood S, 2010, LEUKEMIA LYMPHOMA, V51, P928, DOI 10.3109/10428191003719023; Szczepanski T, 2010, LANCET ONCOL, V11, P880, DOI 10.1016/S1470-2045(09)70369-9; Teng Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055332; Thirumaran RK, 2005, BLOOD, V106, P2590, DOI 10.1182/blood-2005-04-1719; Tong N, 2010, CANCER SCI, V101, P782, DOI 10.1111/j.1349-7006.2009.01429.x; Tsai CW, 2011, ANTICANCER RES, V31, P2395; van der Put NMJ, 1998, AM J HUM GENET, V62, P1044, DOI 10.1086/301825; Wiemels JL, 2001, P NATL ACAD SCI USA, V98, P4004, DOI 10.1073/pnas.061408298; Wu HC, 2010, ANTICANCER RES, V30, P3573; Wu KH, 2010, ANTICANCER RES, V30, P529; Yan JR, 2012, PEDIATR BLOOD CANCER, V58, P513, DOI 10.1002/pbc.23137; Yeoh AEJ, 2010, LEUKEMIA RES, V34, P276, DOI 10.1016/j.leukres.2009.07.003; Yu LW, 2012, DIAGN PATHOL, V7, DOI 10.1186/1746-1596-7-171; Zanrosso CW, 2006, LEUKEMIA RES, V30, P477, DOI 10.1016/j.leukres.2005.08.008; Zwaan CM, 2010, HEMATOL ONCOL CLIN N, V24, P19, DOI 10.1016/j.hoc.2009.11.009	63	17	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0119776	10.1371/journal.pone.0119776	http://dx.doi.org/10.1371/journal.pone.0119776			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25793509	Green Submitted, Green Published, gold			2022-12-27	WOS:000352084200115
J	Pfirrmann, T; Villavicencio-Lorini, P; Subudhi, AK; Menssen, R; Wolf, DH; Hollemann, T				Pfirrmann, Thorsten; Villavicencio-Lorini, Pablo; Subudhi, Abinash K.; Menssen, Ruth; Wolf, Dieter H.; Hollemann, Thomas			RMND5 from Xenopus laevis Is an E3 Ubiquitin-Ligase and Functions in Early Embryonic Forebrain Development	PLOS ONE			English	Article							GID COMPLEX; CATABOLITE DEGRADATION; PROTEASOME-SYSTEM; PROTEIN; MUSKELIN; RANBPM; DOMAIN; ARMC8-ALPHA; EXPRESSION; HOMOLOG	In Saccharomyces cerevisiae the Gid-complex functions as an ubiquitin-ligase complex that regulates the metabolic switch between glycolysis and gluconeogenesis. In higher organisms six conserved Gid proteins form the CTLH protein-complex with unknown function. Here we show that Rmnd5, the Gid2 orthologue from Xenopus laevis, is an ubiquitin-ligase embedded in a high molecular weight complex. Expression of rmnd5 is strongest in neuronal ectoderm, prospective brain, eyes and ciliated cells of the skin and its suppression results in malformations of the fore-and midbrain. We therefore suggest that Xenopus laevis Rmnd5, as a subunit of the CTLH complex, is a ubiquitin-ligase targeting an unknown factor for polyubiquitination and subsequent proteasomal degradation for proper fore-and midbrain development.	[Pfirrmann, Thorsten; Subudhi, Abinash K.; Hollemann, Thomas] Univ Halle Wittenberg, Inst Physiol Chem, D-06108 Halle, Germany; [Villavicencio-Lorini, Pablo] Univ Halle Wittenberg, Inst Human Genet, D-06108 Halle, Germany; [Menssen, Ruth; Wolf, Dieter H.] Univ Stuttgart, Inst Biochem, D-70569 Stuttgart, Germany	Martin Luther University Halle Wittenberg; Martin Luther University Halle Wittenberg; University of Stuttgart	Pfirrmann, T (corresponding author), Univ Halle Wittenberg, Inst Physiol Chem, D-06108 Halle, Germany.	thorsten.pfirrmann@medizin.uni-halle.de	Pfirrmann, Thorsten/AAC-5563-2019	Pfirrmann, Thorsten/0000-0002-9474-9535	Fonds der Chemischen Industrie, Frankfurt; Wilhelm Roux program, Halle (Saale) [FKZ 26/22]	Fonds der Chemischen Industrie, Frankfurt(Fonds der Chemischen Industrie); Wilhelm Roux program, Halle (Saale)	The project was supported by funding from the Fonds der Chemischen Industrie, Frankfurt and the Wilhelm Roux program (FKZ 26/22), Halle (Saale). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreasson C, 2008, J BIOL CHEM, V283, P8877, DOI 10.1074/jbc.M710063200; Braun B, 2011, FEBS LETT, V585, P3856, DOI 10.1016/j.febslet.2011.10.038; Cornesse Y, 2005, DEV BIOL, V277, P296, DOI 10.1016/j.ydbio.2004.09.016; Cox JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062857; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Emes RD, 2001, HUM MOL GENET, V10, P2813, DOI 10.1093/hmg/10.24.2813; Francis O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075217; Gerlitz G, 2005, CELL CYCLE, V4, P1632, DOI 10.4161/cc.4.11.2151; Heisler FF, 2011, NEURON, V70, P66, DOI 10.1016/j.neuron.2011.03.008; Hirsch N, 1997, J NEUROBIOL, V32, P45, DOI 10.1002/(SICI)1097-4695(199701)32:1<45::AID-NEU5>3.3.CO;2-V; Hollemann T, 1998, DEVELOPMENT, V125, P2425; Kelberman D, 2008, J CLIN ENDOCR METAB, V93, P1865, DOI 10.1210/jc.2007-2337; Kobayashi N, 2007, GENE, V396, P236, DOI 10.1016/j.gene.2007.02.032; Li J, 2014, NUCLEIC ACIDS RES, V42, P458, DOI 10.1093/nar/gkt839; Menssen R, 2012, J BIOL CHEM, V287, P25602, DOI 10.1074/jbc.M112.363762; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Panavas Tadas, 2009, V497, P303, DOI 10.1007/978-1-59745-566-4_20; Pfirrmann T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064870; Regelmann J, 2003, MOL BIOL CELL, V14, P1652, DOI 10.1091/mbc.E02-08-0456; Rizzino A, 2009, WIRES SYST BIOL MED, V1, P228, DOI 10.1002/wsbm.12; Santt O, 2008, MOL BIOL CELL, V19, P3323, DOI 10.1091/mbc.E08-03-0328; Sommer T, 2014, BBA-MOL CELL RES, V1843, P1, DOI 10.1016/j.bbamcr.2013.09.009; Suzuki T, 2008, BIOCHEM J, V411, P581, DOI 10.1042/BJ20071312; Tagnaouti N, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-28; Tomaru Koji, 2010, Open Biochem J, V4, P1, DOI 10.2174/1874091X01004010001; Tomastikova E, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-83; Umeda M, 2003, GENE, V303, P47, DOI 10.1016/S0378-1119(02)01153-8; van Wijk SJL, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.55; Vogel TW, 2012, J NEUROSURG-PEDIATR, V10, P25, DOI 10.3171/2012.3.PEDS11559	30	25	25	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0120342	10.1371/journal.pone.0120342	http://dx.doi.org/10.1371/journal.pone.0120342			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25793641	gold, Green Published, Green Submitted			2022-12-27	WOS:000352083900015
J	Reich, A; Dunn, C; Akasaka, K; Wessel, G				Reich, Adrian; Dunn, Casey; Akasaka, Koji; Wessel, Gary			Phylogenomic Analyses of Echinodermata Support the Sister Groups of Asterozoa and Echinozoa	PLOS ONE			English	Article							EVOLUTION; TRANSCRIPTOME; INSIGHTS; GENOME; CLASSIFICATION; RECONSTRUCTION; TOPOLOGIES; RESOLUTION; TREE	Echinoderms (sea urchins, sea stars, brittle stars, sea lilies and sea cucumbers) are a group of diverse organisms, second in number within deuterostome species to only the chordates. Echinoderms serve as excellent model systems for developmental biology due to their diverse developmental mechanisms, tractable laboratory use, and close phylogenetic distance to chordates. In addition, echinoderms are very well represented in the fossil record, including some larval features, making echinoderms a valuable system for studying evolutionary development. The internal relationships of Echinodermata have not been consistently supported across phylogenetic analyses, however, and this has hindered the study of other aspects of their biology. In order to test echinoderm phylogenetic relationships, we sequenced 23 de novo transcriptomes from all five clades of echinoderms. Using multiple phylogenetic methods at a variety of sampling depths we have constructed a well-supported phylogenetic tree of Echinodermata, including support for the sister groups of Asterozoa (sea stars and brittle stars) and Echinozoa (sea urchins and sea cucumbers). These results will help inform developmental and evolutionary studies specifically in echinoderms and deuterostomes in general.	[Reich, Adrian; Wessel, Gary] Brown Univ, Dept Mol Biol Cell Biol & Biochem, Providence, RI 02912 USA; [Dunn, Casey] Brown Univ, Dept Ecol & Evolutionary Biol, Providence, RI 02912 USA; [Akasaka, Koji] Univ Tokyo, Misaki Marine Biol Stn, Miura, Kanagawa, Japan	Brown University; Brown University; University of Tokyo	Wessel, G (corresponding author), Brown Univ, Dept Mol Biol Cell Biol & Biochem, Providence, RI 02912 USA.	gary_wessel@brown.edu		Dunn, Casey/0000-0003-0628-5150	National Science Foundation [IOS-1120972]; National Institutes Health [2R01HD028152, 5T32 GM007601]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD028152] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007601] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by the National Science Foundation IOS-1120972 (GW); National Institutes Health 2R01HD028152 (GW); National Institutes Health 5T32 GM007601 (AR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bather F, 1900, ECHINODERMATA TREA 3; Burns G, 2013, MAR GENOM, V9, P9, DOI 10.1016/j.margen.2012.05.003; Cannon JT, 2014, CURR BIOL, V24, P2827, DOI 10.1016/j.cub.2014.10.016; Carnevali MDC, 2001, MICROSC RES TECHNIQ, V55, P403; Church SH, 2014, AUTOMATION AND EVALU; DERBES AA, 1847, ANN SCI NAT ZOOL, V8, P80; Dunn CW, 2008, NATURE, V452, P745, DOI 10.1038/nature06614; Dunn CW, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-330; Enright AJ, 2002, NUCLEIC ACIDS RES, V30, P1575, DOI 10.1093/nar/30.7.1575; Ernst SG, 1997, AM ZOOL, V37, P250; Gahn Forest J, 2010, Integr Comp Biol, V50, p514a, DOI 10.1093/icb/icq155; GALE AS, 1987, ZOOL J LINN SOC-LOND, V89, P107, DOI 10.1111/j.1096-3642.1987.tb00652.x; Goldman N, 2000, SYST BIOL, V49, P652, DOI 10.1080/106351500750049752; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; Hart MW, 1997, EVOLUTION, V51, P1848, DOI 10.1111/j.1558-5646.1997.tb05108.x; Hejnol A, 2009, P ROY SOC B-BIOL SCI, V276, P4261, DOI 10.1098/rspb.2009.0896; Hinman VF, 2014, GENESIS, V52, P193, DOI 10.1002/dvg.22757; Howison M, 2012, P 4 USENIX WORKSH TH; Jangoux M., 1982, ECHINODERM NUTR, DOI DOI 10.1201/9781003078920; Janies D, 2001, CAN J ZOOL, V79, P1232, DOI 10.1139/cjz-79-7-1232; Janies DA, 2011, SYST BIOL, V60, P420, DOI 10.1093/sysbio/syr044; KANATANI H, 1969, NATURE, V221, P273, DOI 10.1038/221273a0; KISHINO H, 1989, J MOL EVOL, V29, P170, DOI 10.1007/BF02100115; Knott KE, 2000, AM ZOOL, V40, P382, DOI 10.1668/0003-1569(2000)040[0382:CACIAS]2.0.CO;2; Kouchinsky A, 2012, GEOL MAG, V149, P221, DOI 10.1017/S0016756811000720; Lartillot N, 2009, BIOINFORMATICS, V25, P2286, DOI 10.1093/bioinformatics/btp368; Le HS, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt215; Mac Bride EW, 1906, ECHINODERMATA; Mah CL, 2000, AM ZOOL, V40, P375, DOI 10.1668/0003-1569(2000)040[0375:PPOTFA]2.0.CO;2; Matsubara M, 2005, MOL PHYLOGENET EVOL, V36, P598, DOI 10.1016/j.ympev.2005.03.018; Perseke M, 2013, MOL PHYLOGENET EVOL, V66, P898, DOI 10.1016/j.ympev.2012.11.019; Perseke M, 2010, MOL PHYLOGENET EVOL, V56, P201, DOI 10.1016/j.ympev.2010.01.035; Pisani D, 2012, MOL PHYLOGENET EVOL, V62, P27, DOI 10.1016/j.ympev.2011.08.028; Raff RA, 2006, HEREDITY, V97, P244, DOI 10.1038/sj.hdy.6800866; Reich A, 2014, PHYLOGENETIC ANAL EC; Reich A, DATA PHYLOGENOMIC AN; Schlegel M, 2014, DEEP METAZOAN PHYLOGENY: THE BACKBONE OF THE TREE OF LIFE, P413; SMITH AB, 1984, PALAEONTOLOGY, V27, P431; Smith AB, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2391; Smith SA, 2011, NATURE, V480, P364, DOI 10.1038/nature10526; Sodergren E, 2006, SCIENCE, V314, P941, DOI 10.1126/science.1133609; Swanson WJ, 2002, NAT REV GENET, V3, P137, DOI 10.1038/nrg733; Swofford David L., 1996, P407; Telford MJ, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0479; Vaughn R, 2012, EVODEVO, V3, DOI 10.1186/2041-9139-3-19; Wada H, 1996, MOL PHYLOGENET EVOL, V6, P97, DOI 10.1006/mpev.1996.0062; Wessel GM, 2010, SYST BIOL REPROD MED, V56, P236, DOI 10.3109/19396361003674879	48	63	64	8	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0119627	10.1371/journal.pone.0119627	http://dx.doi.org/10.1371/journal.pone.0119627			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25794146	Green Published, Green Submitted, gold			2022-12-27	WOS:000352084200102
J	Su, ZM; Li, XM; Zhou, WQ; Ouyang, ZY				Su, Zhimin; Li, Xiaoma; Zhou, Weiqi; Ouyang, Zhiyun			Effect of Landscape Pattern on Insect Species Density within Urban Green Spaces in Beijing, China	PLOS ONE			English	Article							LEAST-SQUARES REGRESSION; LAND-USE; AGRICULTURAL LANDSCAPE; HABITAT FRAGMENTATION; TROPHIC LEVELS; URBANIZATION; COMMUNITIES; ASSEMBLAGES; DIVERSITY; GRADIENT	Urban green space is an important refuge of biodiversity in urban areas. Therefore, it is crucial to understand the relationship between the landscape pattern of green spaces and biodiversity to mitigate the negative effects of urbanization. In this study, we collected insects from 45 green patches in Beijing during July 2012 using suction sampling. The green patches were dominated by managed lawns, mixed with scattered trees and shrubs. We examined the effects of landscape pattern on insect species density using hierarchical partitioning analysis and partial least squares regression. The results of the hierarchical partitioning analysis indicated that five explanatory variables, i.e., patch area (with 19.9% independent effects), connectivity (13.9%), distance to nearest patch (13.8%), diversity for patch types (11.0%), and patch shape (8.3%), significantly contributed to insect species density. With the partial least squares regression model, we found species density was negatively related to patch area, shape, connectivity, diversity for patch types and proportion of impervious surface at the significance level of p < 0.05 and positively related to proportion of vegetated land. Regression tree analysis further showed that the highest species density was found in green patches with an area < 500 m(2). Our results indicated that improvement in habitat quality, such as patch area and connectivity that are typically thought to be important for conservation, did not actually increase species density. However, increasing compactness (low-edge) of patch shape and landscape composition did have the expected effect. Therefore, it is recommended that the composition of the surrounding landscape should be considered simultaneously with planned improvements in local habitat quality.	[Su, Zhimin; Li, Xiaoma; Zhou, Weiqi; Ouyang, Zhiyun] Chinese Acad Sci, State Key Lab Urban & Reg Ecol, Res Ctr Ecoenvironm Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Research Center for Eco-Environmental Sciences (RCEES)	Ouyang, ZY (corresponding author), Chinese Acad Sci, State Key Lab Urban & Reg Ecol, Res Ctr Ecoenvironm Sci, Beijing, Peoples R China.	zyouyang@rcees.ac.cn	Zhou, Weiqi/G-2427-2010		National Natural Science Foundation of China [41030744]; China Postdoctoral Science Foundation [2013M541053]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This work was supported by the National Natural Science Foundation of China (41030744) and China Postdoctoral Science Foundation (2013M541053). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beijing Municipal Bureau of Statistics, 2013, BEIJ STAT YB; Beyer HL, 2004, HAWTHS ANAL TOOLS AR; Blair RB, 1997, BIOL CONSERV, V80, P113, DOI 10.1016/S0006-3207(96)00056-0; Bowman J, 2002, CONSERV ECOL, V6; Cai W. Z., 2011, GEN ENTOMOLOGY; Chesson P, 2000, ANNU REV ECOL SYST, V31, P343, DOI 10.1146/annurev.ecolsys.31.1.343; Colwell R. K., 2009, ESTIMATES 8 2 USERS; De'ath G, 2000, ECOLOGY, V81, P3178, DOI 10.2307/177409; Denys C, 1998, OECOLOGIA, V113, P269, DOI 10.1007/s004420050378; DUNNING JB, 1992, OIKOS, V65, P169, DOI 10.2307/3544901; FAETH SH, 1978, OECOLOGIA, V32, P127, DOI 10.1007/BF00344697; Fahrig L, 1998, ECOSYSTEMS, V1, P197, DOI 10.1007/s100219900015; Gotelli NJ, 2001, ECOL LETT, V4, P379, DOI 10.1046/j.1461-0248.2001.00230.x; GUSTAFSON EJ, 1992, LANDSCAPE ECOL, V7, P101, DOI 10.1007/BF02418941; Heikkinen RK, 2005, P ROY SOC B-BIOL SCI, V272, P2203, DOI 10.1098/rspb.2005.3212; Herbst C, 2013, ENTOMOL EXP APPL, V147, P269, DOI 10.1111/eea.12072; Huang DC, 2010, LANDSCAPE URBAN PLAN, V96, P163, DOI 10.1016/j.landurbplan.2010.03.004; KAREIVA P, 1987, NATURE, V326, P388, DOI 10.1038/326388a0; Koh LP, 2004, ECOL APPL, V14, P1695, DOI 10.1890/03-5269; KRUESS A, 1994, SCIENCE, V264, P1581, DOI 10.1126/science.264.5165.1581; Li XM, 2013, APPL GEOGR, V38, P1, DOI 10.1016/j.apgeog.2012.11.004; Li XM, 2012, LANDSCAPE ECOL, V27, P887, DOI 10.1007/s10980-012-9731-6; Li Z, 2011, COMMON INSECTS OTHER; Lizee MH, 2012, LANDSCAPE ECOL, V27, P159, DOI 10.1007/s10980-011-9651-x; Luo Y., 1995, SOIL ENTOMOLOGY, P29; Martens H, 2000, FOOD QUAL PREFER, V11, P5, DOI 10.1016/S0950-3293(99)00039-7; Matteson KC, 2013, OIKOS, V122, P682, DOI 10.1111/j.1600-0706.2012.20229.x; McCabe DJ, 2000, OECOLOGIA, V124, P270, DOI 10.1007/s004420000369; McFrederick QS, 2006, BIOL CONSERV, V129, P372, DOI 10.1016/j.biocon.2005.11.004; McGarigal K, 2002, COMPUTER SOFTWARE PR; McKinney ML, 2006, BIOL CONSERV, V127, P247, DOI 10.1016/j.biocon.2005.09.005; McKinney ML, 2002, BIOSCIENCE, V52, P883, DOI 10.1641/0006-3568(2002)052[0883:UBAC]2.0.CO;2; Mevik BH, 2007, J STAT SOFTW, V18, P1, DOI 10.18637/jss.v018.i02; [牟凤云 MU Fengyun], 2007, [遥感学报, Journal of Remote Sensing], V11, P257; Niu W, 2012, CHINAS NEW URBANIZAT; R Development Core Team, 2012, R LANG ENV STAT COMP; Rosch V, 2013, J APPL ECOL, V50, P387, DOI 10.1111/1365-2664.12056; Rossi JP, 2010, ECOL INDIC, V10, P452, DOI 10.1016/j.ecolind.2009.07.016; Sadler JP, 2006, J BIOGEOGR, V33, P1126, DOI 10.1111/j.1365-2699.2006.01476.x; SIMPSON GG, 1964, SYST ZOOL, V13, P57, DOI 10.2307/2411825; Torma A, 2013, J INSECT CONSERV, V17, P35, DOI 10.1007/s10841-012-9484-1; WALSH C., 2013, HIER PART HIERARCHIC; Walz U, 2013, ECOL INDIC, V31, P1, DOI 10.1016/j.ecolind.2013.01.032; Wold S, 2001, CHEMOMETR INTELL LAB, V58, P109, DOI 10.1016/S0169-7439(01)00155-1; Wu J.G., 2007, LANDSCAPE ECOLOGY PA, V2nd	45	20	23	1	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0119276	10.1371/journal.pone.0119276	http://dx.doi.org/10.1371/journal.pone.0119276			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25793897	Green Published, gold, Green Submitted			2022-12-27	WOS:000352084200065
J	Vick, B; Rothenberg, M; Sandhofer, N; Carlet, M; Finkenzeller, C; Krupka, C; Grunert, M; Trumpp, A; Corbacioglu, S; Ebinger, M; Andre, MC; Hiddemann, W; Schneider, S; Subklewe, M; Metzeler, KH; Spiekermann, K; Jeremias, I				Vick, Binje; Rothenberg, Maja; Sandhoefer, Nadine; Carlet, Michela; Finkenzeller, Cornelia; Krupka, Christina; Grunert, Michaela; Trumpp, Andreas; Corbacioglu, Selim; Ebinger, Martin; Andre, Maya C.; Hiddemann, Wolfgang; Schneider, Stephanie; Subklewe, Marion; Metzeler, Klaus H.; Spiekermann, Karsten; Jeremias, Irmela			An Advanced Preclinical Mouse Model for Acute Myeloid Leukemia Using Patients' Cells of Various Genetic Subgroups and In Vivo Bioluminescence Imaging	PLOS ONE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; STEM-CELLS; IL2R-GAMMA(NULL) MICE; INITIATING CELLS; SCID MOUSE; AML CELLS; T-CELLS; ENGRAFTMENT; CANCER; HETEROGENEITY	Acute myeloid leukemia (AML) is a clinically and molecularly heterogeneous disease with poor outcome. Adequate model systems are required for preclinical studies to improve understanding of AML biology and to develop novel, rational treatment approaches. Xenografts in immunodeficient mice allow performing functional studies on patient-derived AML cells. We have established an improved model system that integrates serial retransplantation of patient-derived xenograft (PDX) cells in mice, genetic manipulation by lentiviral transduction, and essential quality controls by immunophenotyping and targeted resequencing of driver genes. 17/29 samples showed primary engraftment, 10/17 samples could be retransplanted and some of them allowed virtually indefinite serial transplantation. 5/6 samples were successfully transduced using lentiviruses. Neither serial transplantation nor genetic engineering markedly altered sample characteristics analyzed. Transgene expression was stable in PDX AML cells. Example given, recombinant luciferase enabled bioluminescence in vivo imaging and highly sensitive and reliable disease monitoring; imaging visualized minimal disease at 1 PDX cell in 10000 mouse bone marrow cells and facilitated quantifying leukemia initiating cells. We conclude that serial expansion, genetic engineering and imaging represent valuable tools to improve the individualized xenograft mouse model of AML. Prospectively, these advancements enable repetitive, clinically relevant studies on AML biology and preclinical treatment trials on genetically defined and heterogeneous subgroups.	[Vick, Binje; Carlet, Michela; Finkenzeller, Cornelia; Grunert, Michaela; Jeremias, Irmela] Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Dept Gene Vectors, Grp Apoptosis, Munich, Germany; [Vick, Binje; Sandhoefer, Nadine; Trumpp, Andreas; Ebinger, Martin; Hiddemann, Wolfgang; Subklewe, Marion; Spiekermann, Karsten; Jeremias, Irmela] German Canc Consortium DKTK, Heidelberg, Germany; [Vick, Binje; Sandhoefer, Nadine; Trumpp, Andreas; Ebinger, Martin; Hiddemann, Wolfgang; Subklewe, Marion; Spiekermann, Karsten; Jeremias, Irmela] German Canc Res Ctr, Heidelberg, Germany; [Rothenberg, Maja; Sandhoefer, Nadine; Krupka, Christina; Hiddemann, Wolfgang; Schneider, Stephanie; Subklewe, Marion; Metzeler, Klaus H.; Spiekermann, Karsten] Univ Munich, Univ Hosp Grosshadern, Dept Internal Med 3, Munich, Germany; [Sandhoefer, Nadine; Hiddemann, Wolfgang; Metzeler, Klaus H.; Spiekermann, Karsten] Helmholtz Zentrum Munchen, Clin Cooperat Grp Leukemia, German Res Ctr Environm Hlth, Munich, Germany; [Krupka, Christina; Subklewe, Marion] Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Clin Cooperat Grp Immunotherapy, Munich, Germany; [Trumpp, Andreas] German Canc Res Ctr, Div Stem Cells & Canc, Heidelberg, Germany; [Trumpp, Andreas] Heidelberg Inst Stem Cell Technol & Expt Med HI S, Heidelberg, Germany; [Corbacioglu, Selim] Univ Regensburg, Dept Pediat, D-93053 Regensburg, Germany; [Ebinger, Martin; Andre, Maya C.] Univ Tubingen, Univ Childrens Hosp, Dept Pediat Hematol Oncol, Tubingen, Germany; [Andre, Maya C.] Univ Childrens Hosp UKBB, Dept Pediat Intens Care Med, Basel, Switzerland; [Jeremias, Irmela] Univ Munich, Dr von Haunersches Kinderspital, Dept Oncol, Munich, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; German Cancer Research Center (DKFZ); University of Regensburg; Eberhard Karls University of Tubingen; TUBINGEN UNIVERSITY CHILDRENS HOSPITAL; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Munich	Jeremias, I (corresponding author), Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Dept Gene Vectors, Grp Apoptosis, Munich, Germany.	Irmela.Jeremias@helmholtz-muenchen.de	Metzeler, Klaus H./C-2118-2009; Ebinger, Martin/O-4936-2016; Trumpp, Andreas/Z-2141-2019; Subklewe, Marion/N-5873-2014; Corbacioglu, Selim/N-6152-2019; Jeremias, Irmela/Q-5934-2019; Spiekermann, Karsten/L-2065-2016	Metzeler, Klaus H./0000-0003-3920-7490; Ebinger, Martin/0000-0002-4229-8058; Trumpp, Andreas/0000-0002-6212-3466; Subklewe, Marion/0000-0001-9154-9469; Jeremias, Irmela/0000-0003-1773-7677; Vick, Binje/0000-0003-1956-2778	German Jose Carreras Leukemia Foundation [R 10/26]; Collaborative Research Center 684 "Molecular Mechanisms of Normal and Malignant Hematopoiesis" [A12, A22]; Bettina Brau-Foundation; Dr. Helmut Legerlotz Foundation; Alexander von Humboldt-Foundation	German Jose Carreras Leukemia Foundation; Collaborative Research Center 684 "Molecular Mechanisms of Normal and Malignant Hematopoiesis"; Bettina Brau-Foundation; Dr. Helmut Legerlotz Foundation; Alexander von Humboldt-Foundation(Alexander von Humboldt Foundation)	This work was supported by German Jose Carreras Leukemia Foundation (http://www.carreras-stiftung.de, R 10/26, KS and IJ); the Collaborative Research Center 684 "Molecular Mechanisms of Normal and Malignant Hematopoiesis" (http://www.sfb684.med.uni-muenchen.de/index.html, A12 (KS) and A22 (IJ)); Bettina Brau-Foundation (http://www.bettina-braeu-stiftung.de, IJ); Dr. Helmut Legerlotz Foundation(IJ); and Alexander von Humboldt-Foundation (http://www.humboldt-foundation.de/web/home.html, MC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agliano A, 2008, INT J CANCER, V123, P2222, DOI 10.1002/ijc.23772; Alves CC, 2012, BLOOD, V119, P4224, DOI 10.1182/blood-2011-08-370114; Barrett DM, 2011, BLOOD, V118, pE112, DOI 10.1182/blood-2011-04-346528; Bomken S, 2013, LEUKEMIA, V27, P718, DOI 10.1038/leu.2012.206; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; CESANO A, 1992, ONCOGENE, V7, P827; Christoph S, 2013, J HEMATOL ONCOL, V6, DOI 10.1186/1756-8722-6-10; Dick JE, 2005, INT J HEMATOL, V82, P389, DOI 10.1532/IJH97.05144; Dick JE, 2005, ANN NY ACAD SCI, V1044, P1, DOI 10.1196/annals.1349.001; Dick JE, 2008, BLOOD, V112, P4793, DOI 10.1182/blood-2008-08-077941; Ding L, 2012, NATURE, V481, P506, DOI 10.1038/nature10738; Distler E, 2008, EXP HEMATOL, V36, P451, DOI 10.1016/j.exphem.2007.12.011; Duy C, 2011, NATURE, V473, P384, DOI 10.1038/nature09883; Edinger Matthias, 1999, Neoplasia (New York), V1, P303, DOI 10.1038/sj.neo.7900048; Eppert K, 2011, NAT MED, V17, P1086, DOI 10.1038/nm.2415; Gerber JM, 2012, BLOOD, V119, P3571, DOI 10.1182/blood-2011-06-364182; Goardon N, 2011, CANCER CELL, V19, P138, DOI 10.1016/j.ccr.2010.12.012; Goyama S, 2013, J CLIN INVEST, V123, P3876, DOI 10.1172/JCI68557; Guzman ML, 2014, STEM CELLS, V32, P844, DOI 10.1002/stem.1597; Harismendy O, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-12-r124; Hope KJ, 2004, NAT IMMUNOL, V5, P738, DOI 10.1038/ni1080; Inoue Y, 2008, EXP HEMATOL, V36, P1634, DOI 10.1016/j.exphem.2008.08.004; Ishikawa F, 2005, BLOOD, V106, P1565, DOI 10.1182/blood-2005-02-0516; Ishikawa F, 2007, NAT BIOTECHNOL, V25, P1315, DOI 10.1038/nbt1350; Klco JM, 2014, CANCER CELL, V25, P379, DOI 10.1016/j.ccr.2014.01.031; Koboldt DC, 2012, GENOME RES, V22, P568, DOI 10.1101/gr.129684.111; Krupka C, 2014, BLOOD, V123, P356, DOI 10.1182/blood-2013-08-523548; LAPIDOT T, 1994, NATURE, V367, P645, DOI 10.1038/367645a0; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lumkul R, 2002, LEUKEMIA, V16, P1818, DOI 10.1038/sj.leu.2402632; Majeti R, 2009, CELL, V138, P286, DOI 10.1016/j.cell.2009.05.045; Malaise M, 2011, LEUKEMIA, V25, P1635, DOI 10.1038/leu.2011.121; McCormack E, 2013, BLOOD, V121, pE34, DOI 10.1182/blood-2012-05-429555; Modlich U, 2009, MOL THER, V17, P1919, DOI 10.1038/mt.2009.179; Nervi B, 2009, BLOOD, V113, P6206, DOI 10.1182/blood-2008-06-162123; Paietta E, 2012, HEMATOL-AM SOC HEMAT, P35, DOI 10.1182/asheducation-2012.1.35; Pan CP, 2009, MOL CELL PROTEOMICS, V8, P443, DOI 10.1074/mcp.M800258-MCP200; Patel JP, 2012, NEW ENGL J MED, V366, P1079, DOI 10.1056/NEJMoa1112304; Pearce DJ, 2006, BLOOD, V107, P1166, DOI 10.1182/blood-2005-06-2325; Rabinovich BA, 2008, P NATL ACAD SCI USA, V105, P14342, DOI 10.1073/pnas.0804105105; Rehemtulla A, 2000, NEOPLASIA, V2, P491, DOI 10.1038/sj.neo.7900121; Rombouts WJC, 2000, LEUKEMIA, V14, P889, DOI 10.1038/sj.leu.2401777; Saito Y, 2010, NAT BIOTECHNOL, V28, P275, DOI 10.1038/nbt.1607; Sanchez PV, 2009, LEUKEMIA, V23, P2109, DOI 10.1038/leu.2009.143; Sarry JE, 2011, J CLIN INVEST, V121, P384, DOI 10.1172/JCI41495; SAWYERS CL, 1992, BLOOD, V79, P2089, DOI 10.1182/blood.V79.8.2089.bloodjournal7982089; Shoemaker R H, 1988, Prog Clin Biol Res, V276, P265; Shultz LD, 2005, J IMMUNOL, V174, P6477, DOI 10.4049/jimmunol.174.10.6477; Sweeney TJ, 1999, P NATL ACAD SCI USA, V96, P12044, DOI 10.1073/pnas.96.21.12044; Taussig DC, 2008, BLOOD, V112, P568, DOI 10.1182/blood-2007-10-118331; Terziyska N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052798; Vascotto C, 2014, ONCOGENE, V33, P2876, DOI 10.1038/onc.2013.251; von Bonin M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060680; Wang XL, 2003, BLOOD, V102, P3478, DOI 10.1182/blood-2003-05-1432; Woiterski J, 2013, INT J CANCER, V133, P1547, DOI 10.1002/ijc.28170; Wunderlich M, 2010, LEUKEMIA, V24, P1785, DOI 10.1038/leu.2010.158; Wunderlich M, 2013, BLOOD, V121, pE90, DOI 10.1182/blood-2012-10-464677; Ye K, 2009, BIOINFORMATICS, V25, P2865, DOI 10.1093/bioinformatics/btp394; Ye P, 2014, CANCER LETT, V343, P98, DOI 10.1016/j.canlet.2013.09.022; Zimmerman EI, 2013, BLOOD, V122, P3607, DOI 10.1182/blood-2013-07-513044	60	63	65	3	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0120925	10.1371/journal.pone.0120925	http://dx.doi.org/10.1371/journal.pone.0120925			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25793878	Green Published, Green Submitted, gold			2022-12-27	WOS:000352083900089
J	Wienand, K; Shires, K				Wienand, Kirsty; Shires, Karen			The Use of MAGE C1 and Flow Cytometry to Determine the Malignant Cell Type in Multiple Myeloma	PLOS ONE			English	Article							CLONOTYPIC B-LYMPHOCYTES; HUMAN-BONE-MARROW; PERIPHERAL-BLOOD; PLASMA-CELLS; EXPRESSION; ANTIGENS; GENES; DIFFERENTIATION; SYSTEM; GROWTH	The malignant cell phenotype of Multiple Myeloma (MM) remains unclear with studies proposing it to be either clonotypic B or proliferating plasma cells. Cancer/testis antigen MAGE C1 is being extensively studied in MM and it has been suggested that it is involved in the pathogenesis of the cancer. Therefore, we report on the use of MAGE C1 to determine the malignant cell phenotype in MM using flow cytometry. Bone marrow aspirate (BM) and peripheral blood (PB) was collected from twelve MM patients at diagnosis, as well as three MM disease-free controls. Mononuclear cells were isolated using density-gradient centrifugation, and stabilized in 80% ethanol, before analysis via flow cytometry using relevant antibodies against B cell development cell-surface markers and nuclear MAGE C1. MAGE C1 expression was observed consistently in the early stem cells (CD34(+)) and early pro-B to pre-B cells (CD34(+/-)/CD19(+)), as well as the proliferating plasma cells in both the MM PB and BM, while no expression was observed in the corresponding control samples. Monoclonality indicated a common origin of these cell types suggesting that the CD34(+)/MAGE C1(+) are the primary malignant cell phenotype that sustains the downstream B cell maturation processes. Furthermore, this malignant cell phenotype was not restricted to the BM but also found in the circulating PB cells.	[Wienand, Kirsty; Shires, Karen] Univ Cape Town, Div Haematol, ZA-7925 Cape Town, South Africa; [Shires, Karen] Groote Schuur Hosp, Natl Hlth Lab Serv, Div Haematol, ZA-7925 Cape Town, South Africa	University of Cape Town; University of Cape Town	Shires, K (corresponding author), Univ Cape Town, Div Haematol, ZA-7925 Cape Town, South Africa.	karen.shires@uct.ac.za	Shires, karen/U-2196-2019	Shires, karen/0000-0001-8570-3714	Medical Research Council; Cancer Association of South Africa; National Health Laboratory Research Trust	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Association of South Africa; National Health Laboratory Research Trust	This work was supported by the Medical Research Council (WWW.MRC.ac.za) to KS, the Cancer Association of South Africa (WWW.CANSA.ORG.ZA) to KS and National Health Laboratory Research Trust (WWW.NHLS.AC.ZA) to KS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agematsu K, 2000, IMMUNOL TODAY, V21, P204, DOI 10.1016/S0167-5699(00)01605-4; Andrade Valeria C C, 2008, Cancer Immun, V8, P2; Atanackovic D, 2010, HAEMATOL-HEMATOL J, V95, P785, DOI 10.3324/haematol.2009.014464; Atanackovic D, 2009, CLIN CANCER RES, V15, P1343, DOI 10.1158/1078-0432.CCR-08-0989; Attal M, 1996, NEW ENGL J MED, V335, P91, DOI 10.1056/NEJM199607113350204; Bataille R, 2006, HAEMATOLOGICA, V91, P1234; BERGSAGEL PL, 1995, BLOOD, V85, P436, DOI 10.1182/blood.V85.2.436.bloodjournal852436; BILLADEAU D, 1993, J EXP MED, V178, P1023, DOI 10.1084/jem.178.3.1023; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Condomines M, 2007, J IMMUNOL, V178, P3307, DOI 10.4049/jimmunol.178.5.3307; Conway EJ, 2009, ARCH PATHOL LAB MED, V133, P1594, DOI 10.1043/1543-2165-133.10.1594; de Carvalho F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027707; Dhodapkar Madhav V, 2003, Cancer Immun, V3, P9; DREWINKO B, 1981, BLOOD, V57, P333; DURIE BGM, 1986, SEMIN ONCOL, V13, P300; Durie GMB, 1975, CANCER, V36, P842; Gonzalez M, 1999, HAEMATOLOGICA, V84, P779; Jeong Tae-Dong, 2012, Korean J Hematol, V47, P260, DOI 10.5045/kjh.2012.47.4.260; Jungbluth AA, 2005, BLOOD, V106, P167, DOI 10.1182/blood-2004-12-4931; Kyle RA, 2003, BRIT J HAEMATOL, V121, P749; LOKEN MR, 1987, BLOOD, V70, P1316; Luque R, 1998, CLIN EXP IMMUNOL, V112, P410; Matsui W, 2004, BLOOD, V103, P2332, DOI 10.1182/blood-2003-09-3064; Matsui W, 2008, CANCER RES, V68, P190, DOI 10.1158/0008-5472.CAN-07-3096; Ocqueteau M, 1996, BRIT J HAEMATOL, V95, P489, DOI 10.1111/j.1365-2141.1996.tb08993.x; OVERTON WR, 1988, CYTOMETRY, V9, P619, DOI 10.1002/cyto.990090617; Owen RG, 1996, J CLIN PATHOL, V49, P672, DOI 10.1136/jcp.49.8.672; Pellat-Deceunynck C, 2004, BLOOD CELL MOL DIS, V32, P293, DOI 10.1016/j.bcmd.2003.12.001; PILARSKI LM, 1994, BLOOD, V83, P724; PILARSKI LM, 1992, HEMATOL ONCOL CLIN N, V6, P297, DOI 10.1016/S0889-8588(18)30346-0; Rapoport AP, 2014, CLIN CANCER RES, V20, P1355, DOI 10.1158/1078-0432.CCR-13-2817; Rasmussen T, 2004, LEUKEMIA LYMPHOMA, V45, P1413, DOI 10.1080/10428190410001655157; Rawstron AC, 2008, HAEMATOLOGICA, V93, P431, DOI 10.3324/haematol.11080; SANMIGUEL JF, 1995, BLOOD, V85, P448; Simpson AJG, 2005, NAT REV CANCER, V5, P615, DOI 10.1038/nrc1669; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; STELZER GT, 1993, ANN NY ACAD SCI, V677, P265, DOI 10.1111/j.1749-6632.1993.tb38783.x; Stewart AK, 2001, J CLIN ONCOL, V19, P3771, DOI 10.1200/JCO.2001.19.17.3771; Szczepek AJ, 1998, BLOOD, V92, P2844, DOI 10.1182/blood.V92.8.2844.420k17_2844_2855; Szczepek AJ, 1997, BLOOD, V89, P1824, DOI 10.1182/blood.V89.5.1824.1824_1824_1833; TERSTAPPEN LWMM, 1990, BLOOD, V76, P1739; Tinguely M, 2008, CANCER SCI, V99, P720, DOI 10.1111/j.1349-7006.2008.00738.x; van Baren N, 1999, BLOOD, V94, P1156; Yaccoby S, 1999, BLOOD, V94, P3576, DOI 10.1182/blood.V94.10.3576.422k01_3576_3582; Yata K, 2004, LEUKEMIA, V18, P1891, DOI 10.1038/sj.leu.2403513	45	9	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0120734	10.1371/journal.pone.0120734	http://dx.doi.org/10.1371/journal.pone.0120734			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25793710	Green Published, gold, Green Submitted			2022-12-27	WOS:000352083900070
J	Yang, XT; Gui, N; Tu, JY; Jiang, SY				Yang, Xingtuan; Gui, Nan; Tu, Jiyuan; Jiang, Shengyao			Numerical Analysis of Granular Flows in a Silo Bed on Flow Regime Characterization	PLOS ONE			English	Article							DISCRETE; AVALANCHES; NETWORKS; POWDERS; REACTOR; MODEL	The flow characteristics of a gravity-driven dense granular flow in a granular bed with a contracted drainage orifice are studied by using discrete element method and quantitative analysis. Three values of discharging rates, ranging from fast to slow dense flows, are investigated. Time variations and derivatives of mean forces and velocities, as well as their respective correlations, are analyzed to quantitatively depict the characteristics of granular flow as well as flow regime categorization. The auto-correlation functions, as well as their Fourier spectrums, are utilized to characterize the differences between the mechanisms of slow and fast granular flows. Finally, it is suggested that the flow regimes of slow and fast flows can be characterized by the kinetic and kinematic flow properties of particles.	[Yang, Xingtuan; Gui, Nan; Tu, Jiyuan; Jiang, Shengyao] Tsinghua Univ, Inst Nucl & New Energy Technol, Beijing 100084, Peoples R China; [Yang, Xingtuan; Gui, Nan; Tu, Jiyuan; Jiang, Shengyao] Minist Educ, Key Lab Adv Reactor Engn & Safety, Beijing 100084, Peoples R China; [Gui, Nan] China Univ Petr, Coll Mech & Transportat Engn, Beijing, Peoples R China; [Tu, Jiyuan] RMIT Univ, Sch Aerosp Mech & Mfg Engn, Melbourne, Vic 3083, Australia	Tsinghua University; China University of Petroleum; Royal Melbourne Institute of Technology (RMIT)	Jiang, SY (corresponding author), Tsinghua Univ, Inst Nucl & New Energy Technol, Beijing 100084, Peoples R China.	shengyaojiang@sina.com	Gui, Nan/G-2394-2014; Gui, Nan/AAZ-6258-2021	Gui, Nan/0000-0003-4731-3082; Gui, Nan/0000-0003-4731-3082; Tu, Jiyuan/0000-0002-1264-4837	National Natural Science Foundations of China [51106180, 11072131]	National Natural Science Foundations of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundations of China (Grant Nos. 51106180 and 11072131) (http://www.nsfc.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander AW, 2006, POWDER TECHNOL, V164, P13, DOI 10.1016/j.powtec.2006.01.017; BENZA VG, 1993, PHYS REV E, V48, P4095, DOI 10.1103/PhysRevE.48.4095; Bratberg I, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.011301; CAMPBELL CS, 1990, ANNU REV FLUID MECH, V22, P57, DOI 10.1146/annurev.fl.22.010190.000421; CUNDALL PA, 1979, GEOTECHNIQUE, V29, P47, DOI 10.1680/geot.1979.29.1.47; Fischer R, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.128002; Gao ZK, 2015, EXP THERM FLUID SCI, V60, P157, DOI 10.1016/j.expthermflusci.2014.09.008; Gao ZK, 2013, EPL-EUROPHYS LETT, V103, DOI 10.1209/0295-5075/103/50004; Gao ZK, 2011, CHEM ENG SCI, V66, P2660, DOI 10.1016/j.ces.2011.03.008; Goldhirsch I, 1993, ANNU REV FLUID MECH, V35, P267; Gui N, 2014, POWDER TECHNOL, V254, P432, DOI 10.1016/j.powtec.2014.01.011; Gui N, 2013, AICHE J, V59, P1906, DOI 10.1002/aic.13999; Hajra SK, 2010, POWDER TECHNOL, V198, P175, DOI 10.1016/j.powtec.2009.10.020; Jaeger HM, 1996, REV MOD PHYS, V68, P1259, DOI 10.1103/RevModPhys.68.1259; Khalilitehrani M, 2013, POWDER TECHNOL, V249, P309, DOI 10.1016/j.powtec.2013.08.033; Muite BK, 2004, POWDER TECHNOL, V145, P190, DOI 10.1016/j.powtec.2004.07.003; RAJCHENBACH J, 1990, PHYS REV LETT, V65, P2221, DOI 10.1103/PhysRevLett.65.2221; Ryskamp J, 2003, INEELEXT0301163; Schall P, 2010, ANNU REV FLUID MECH, V42, P67, DOI 10.1146/annurev-fluid-121108-145544; Silbert LE, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.098002; Viduka S, 2013, ADV POWDER TECHNOL, V24, P473, DOI 10.1016/j.apt.2012.11.012; Wensrich CM, 2011, POWDER TECHNOL, V210, P288, DOI 10.1016/j.powtec.2011.03.031; Yang XT, 2012, NUCL ENG DES, V250, P247, DOI 10.1016/j.nucengdes.2012.06.011; Yang XT, 2014, NUCL ENG DES, V270, P404, DOI 10.1016/j.nucengdes.2014.02.010; Yu Peidong, 2005, Chaos, V15, P041102, DOI 10.1063/1.2130689	25	6	7	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0119155	10.1371/journal.pone.0119155	http://dx.doi.org/10.1371/journal.pone.0119155			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25793996	gold, Green Published, Green Submitted			2022-12-27	WOS:000352084200057
J	Cui, J; Frankham, GJ; Johnson, RN; Polkinghorne, A; Timms, P; O'Meally, D; Cheng, YY; Belov, K				Cui, Jian; Frankham, Greta J.; Johnson, Rebecca N.; Polkinghorne, Adam; Timms, Peter; O'Meally, Denis; Cheng, Yuanyuan; Belov, Katherine			SNP Marker Discovery in Koala TLR Genes	PLOS ONE			English	Article							TOLL-LIKE-RECEPTOR; LEUCINE-RICH REPEATS; PHASCOLARCTOS-CINEREUS; EXPRESSION ANALYSIS; CHLAMYDIA-TRACHOMATIS; TRACT DISEASE; IMMUNE GENES; STRANDED-RNA; RECOGNITION; DIVERSITY	Toll-like receptors (TLRs) play a crucial role in the early defence against invading pathogens, yet our understanding of TLRs in marsupial immunity is limited. Here, we describe the characterisation of nine TLRs from a koala immune tissue transcriptome and one TLR from a draft sequence of the koala genome and the subsequent development of an assay to study genetic diversity in these genes. We surveyed genetic diversity in 20 koalas from New South Wales, Australia and showed that one gene, TLR10 is monomorphic, while the other nine TLR genes have between two and 12 alleles. 40 SNPs (16 non-synonymous) were identified across the ten TLR genes. These markers provide a springboard to future studies on innate immunity in the koala, a species under threat from two major infectious diseases.	[Cui, Jian; O'Meally, Denis; Cheng, Yuanyuan; Belov, Katherine] Univ Sydney, Fac Vet Sci, Sydney, NSW 2006, Australia; [Frankham, Greta J.; Johnson, Rebecca N.] Australian Museum, Australian Museum Res Inst, Sydney, NSW 2000, Australia; [Polkinghorne, Adam; Timms, Peter] Univ Sunshine Coast, Fac Sci Hlth Educ & Engn, Sippy Downs, Qld 4556, Australia	University of Sydney; Australian Museum; University of the Sunshine Coast	Belov, K (corresponding author), Univ Sydney, Fac Vet Sci, Sydney, NSW 2006, Australia.	kathy.belov@sydney.edu.au	Cheng, Yuanyuan/M-6476-2017; O'Meally, Denis/A-3746-2012; Johnson, Rebecca N/U-6514-2017	Cheng, Yuanyuan/0000-0002-1747-9308; O'Meally, Denis/0000-0001-7749-9506; Belov, Katherine/0000-0002-9762-5554; Frankham, Greta/0000-0002-0585-6700; Timms, Peter/0000-0002-1682-0025; Polkinghorne, Adam/0000-0002-6803-9222; Polkinghorne, Adam/0000-0002-6567-2962; Johnson, Rebecca/0000-0003-3035-2827	ARC Future Fellowship [FT0992212]; ARC Linkage Grant [LP120200051]; University of Sydney; Bioplatforms Australia; NSW Foundation for National Parks and Wildlife	ARC Future Fellowship(Australian Research Council); ARC Linkage Grant(Australian Research Council); University of Sydney(University of Sydney); Bioplatforms Australia; NSW Foundation for National Parks and Wildlife	KB is supported by an ARC Future Fellowship (FT0992212). This work was partially supported by an ARC Linkage Grant (LP120200051) awarded to PT and AP and funding from the University of Sydney to KB. The authors thank Bioplatforms Australia for financial support. The Australian Museum mitochondrial work was supported by a grant from the NSW Foundation for National Parks and Wildlife. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2003, CURR OPIN IMMUNOL, V15, P5, DOI 10.1016/S0952-7915(02)00013-4; Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Bachmann NL, 2014, TRENDS MICROBIOL; Barreiro LB, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000562; Bell JK, 2006, P NATL ACAD SCI USA, V103, P8792, DOI 10.1073/pnas.0603245103; Bell JK, 2003, TRENDS IMMUNOL, V24, P528, DOI 10.1016/S1471-4906(03)00242-4; Bell JK, 2005, P NATL ACAD SCI USA, V102, P10976, DOI 10.1073/pnas.0505077102; Campos MA, 2001, J IMMUNOL, V167, P416, DOI 10.4049/jimmunol.167.1.416; Cui J, 2015, IMMUNOGENETICS, P1; Darville T, 2010, J INFECT DIS, V201, pS114, DOI 10.1086/652397; Denner J, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-108; Fowler EV, 2000, MOL ECOL, V9, P155, DOI 10.1046/j.1365-294x.2000.00844.x; Frankham GJ, 2014, CONSERV GENET, V15, P547, DOI 10.1007/s10592-013-0560-1; Grueber CE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045011; Guan Y, 2010, J IMMUNOL, V184, P5094, DOI 10.4049/jimmunol.0901888; Hajjar AM, 2002, NAT IMMUNOL, V3, P354, DOI 10.1038/ni777; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hawn TR, 2005, P NATL ACAD SCI USA, V102, P2487, DOI 10.1073/pnas.0409831102; Heil F, 2004, SCIENCE, V303, P1526, DOI 10.1126/science.1093620; Higuchi M, 2008, DEV COMP IMMUNOL, V32, P147, DOI 10.1016/j.dci.2007.05.003; Hobbs M, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-786; Houlden BA, 1996, MOL BIOL EVOL, V13, P1119, DOI 10.1093/oxfordjournals.molbev.a025674; Houlden BA, 1996, MOL ECOL, V5, P269, DOI 10.1111/j.1365-294X.1996.tb00314.x; Houlden BA, 1999, MOL ECOL, V8, P999, DOI 10.1046/j.1365-294x.1999.00656.x; Huang YH, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-149; Iqbal M, 2005, VET IMMUNOL IMMUNOP, V104, P117, DOI 10.1016/j.vetimm.2004.11.003; Ishii A, 2007, IMMUNOGENETICS, V59, P281, DOI 10.1007/s00251-007-0193-y; Jin MS, 2007, CELL, V130, P1071, DOI 10.1016/j.cell.2007.09.008; Jobbins SE, 2012, AUST J ZOOL, V60, P1, DOI 10.1071/ZO12013; Johnson Rebecca N., 2014, Technical Reports of the Australian Museum Online, V24, DOI 10.3853/j.1835-4211.24.2014.1624; Joyee AG, 2008, CURR PHARM DESIGN, V14, P593, DOI 10.2174/138161208783885344; Kaisho T, 2006, J ALLERGY CLIN IMMUN, V117, P979, DOI 10.1016/j.jaci.2006.02.023; Kang JY, 2009, IMMUNITY, V31, P873, DOI 10.1016/j.immuni.2009.09.018; Kollipara A, 2012, VACCINE, V30, P1875, DOI 10.1016/j.vaccine.2011.12.125; Kopp EB, 1999, CURR OPIN IMMUNOL, V11, P13, DOI 10.1016/S0952-7915(99)80003-X; Lau Q, 2013, IMMUNOGENETICS, V65, P37, DOI 10.1007/s00251-012-0658-5; Lee AK, 1988, KOALA NATURAL HIST; Lee KE, 2010, CONSERV GENET, V11, P2091, DOI 10.1007/s10592-009-9987-9; Maher IE, 2014, PEERJ, V2, DOI 10.7717/peerj.280; Mathew M, 2014, DEV COMP IMMUNOL, V46, P423, DOI 10.1016/j.dci.2014.05.015; Mathew M, 2013, GENE, V527, P570, DOI 10.1016/j.gene.2013.06.019; Mathew M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059958; Matsushima N, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-124; McCartney SA, 2009, IMMUNOL REV, V227, P87, DOI 10.1111/j.1600-065X.2008.00726.x; McGuire K, 2006, ANIM GENET, V37, P47, DOI 10.1111/j.1365-2052.2005.01364.x; Medzhitov R, 2000, TRENDS MICROBIOL, V8, P452, DOI 10.1016/S0966-842X(00)01845-X; Mehta SD, 2009, J INFECT DIS, V200, P370, DOI 10.1086/600074; Meijer AH, 2004, MOL IMMUNOL, V40, P773, DOI 10.1016/j.molimm.2003.10.003; Melzer A, 2000, CONSERV BIOL, V14, P619, DOI 10.1046/j.1523-1739.2000.99383.x; Miller SI, 2005, NAT REV MICROBIOL, V3, P36, DOI 10.1038/nrmicro1068; Mizel SB, 2003, J BIOL CHEM, V278, P23624, DOI 10.1074/jbc.M303481200; Morris K, 2014, AUST J ZOOL; Oldenburg M, 2012, SCIENCE, V337, P1111, DOI 10.1126/science.1220363; Palermo S, 2009, ANIM GENET, V40, P289, DOI 10.1111/j.1365-2052.2008.01833.x; Polkinghorne A, 2013, VET MICROBIOL, V165, P214, DOI 10.1016/j.vetmic.2013.02.026; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Purcell MK, 2006, COMP BIOCHEM PHYS D, V1, P77, DOI 10.1016/j.cbd.2005.07.003; Roach JC, 2005, P NATL ACAD SCI USA, V102, P9577, DOI 10.1073/pnas.0502272102; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Seabury CM, 2010, P NATL ACAD SCI USA, V107, P151, DOI 10.1073/pnas.0913006107; Simmons GS, 2012, AUST VET J, V90, P404, DOI 10.1111/j.1751-0813.2012.00964.x; Smirnova I, 2000, GENOME BIOL, V1; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tarlinton RE, 2006, NATURE, V442, P79, DOI 10.1038/nature04841; Taylor BD, 2012, J INFECT DIS, V205, P603, DOI 10.1093/infdis/jir822; Temperley ND, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-62; Wan C, 2011, AUST VET J, V89, P409, DOI 10.1111/j.1751-0813.2011.00827.x; Werling D, 2007, VET J, V174, P240, DOI 10.1016/j.tvjl.2006.10.010; Wochrle T, 2008, CYTOKINE, V41, P322, DOI 10.1016/j.cyto.2007.12.006; Yang ZH, 1998, MOL BIOL EVOL, V15, P568, DOI 10.1093/oxfordjournals.molbev.a025957; Zhang DX, 2003, MOL ECOL, V12, P563, DOI 10.1046/j.1365-294X.2003.01773.x; Zhang XY, 2004, BIOINFORMATIOCS, V4, P3	74	7	7	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0121068	10.1371/journal.pone.0121068	http://dx.doi.org/10.1371/journal.pone.0121068			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25799012	Green Published, Green Submitted, gold			2022-12-27	WOS:000351987300205
J	Harder, MN; Appel, EVR; Grarup, N; Gjesing, AP; Ahluwalia, TS; Jorgensen, T; Christensen, C; Brandslund, I; Linneberg, A; Sorensen, TIA; Pedersen, O; Hansen, T				Harder, Marie Neergaard; Appel, Emil Vincent Rosenbaum; Grarup, Niels; Gjesing, Anette Prior; Ahluwalia, Tarunveer S.; Jorgensen, Torben; Christensen, Cramer; Brandslund, Ivan; Linneberg, Allan; Sorensen, Thorkild I. A.; Pedersen, Oluf; Hansen, Torben			The Type 2 Diabetes Risk Allele of TMEM154-rs6813195 Associates with Decreased Beta Cell Function in a Study of 6,486 Danes	PLOS ONE			English	Article							INSULIN SENSITIVITY; GENETIC ARCHITECTURE; GLUCOSE-TOLERANCE	Objectives A trans-ethnicmeta-analysis of type 2 diabetes genome-wide association studies has identified seven novel susceptibility variants in or near TMEM154, SSR1/RREB1, FAF1, POU5F1/TCF19, LPP, ARL15 and ABCB9/MPHOSPH9. The aim of our study was to investigate associations between these novel risk variants and type 2 diabetes and pre-diabetic traits in a Danish population-based study with measurements of plasma glucose and serum insulin after an oral glucose tolerance test in order to elaborate on the physiological impact of the variants. Methods Case-control analyses were performed in up to 5,777 patients with type 2 diabetes and 7,956 individuals with normal fasting glucose levels. Quantitative trait analyses were performed in up to 5,744 Inter99 participants naive to glucose-lowering medication. Significant associations between TMEM154-rs6813195 and the beta cell measures insulinogenic index and disposition index and between FAF1-rs17106184 and 2-hour serum insulin levels were selected for further investigation in additional Danish studies and results were combined in meta-analyses including up to 6,486 Danes. Results We confirmed associations with type 2 diabetes for five of the seven SNPs (TMEM154-rs6813195, FAF1-rs17106184, POU5F1/TCF19-rs3130501, ARL15-rs702634 and ABCB9/MPHOSPH9-rs4275659). The type 2 diabetes risk C-allele of TMEM154-rs6813195 associated with decreased disposition index (n=5,181, beta=-0.042, p=0.012) and insulinogenic index (n=5,181, beta=-0.032, p=0.043) in Inter99 and these associations remained significant in meta-analyses including four additional Danish studies (disposition index n=6,486, beta=-0.042, p=0.0044; and insulinogenic index n=6,486, beta=-0.037, p=0.0094). The type 2 diabetes risk G-allele of FAF1-rs17106184 associated with increased levels of 2-hour serum insulin (n=5,547, beta=0.055, p=0.017) in Inter99 and also when combining effects with three additional Danish studies (n=6,260, beta=0.062, p=0.0040). Conclusion Studies of type 2 diabetes intermediary traits suggest the diabetogenic impact of the C-allele of TMEM154-rs6813195 is mediated through reduced beta cell function. The impact of the diabetes risk G-allele of FAF1-rs17106184 on increased 2-hour insulin levels is however unexplained.	[Harder, Marie Neergaard; Appel, Emil Vincent Rosenbaum; Grarup, Niels; Gjesing, Anette Prior; Ahluwalia, Tarunveer S.; Sorensen, Thorkild I. A.; Pedersen, Oluf; Hansen, Torben] Univ Copenhagen, Fac Hlth & Med Sci, Novo Nordisk Fdn Ctr Basic Metab Res, Copenhagen, Denmark; [Ahluwalia, Tarunveer S.] Univ Copenhagen, Fac Hlth & Med Sci, Copenhagen Prospect Studies Asthma Childhood, Copenhagen, Denmark; [Ahluwalia, Tarunveer S.] Gentofte Univ Hosp, Danish Pediat Asthma Ctr, Capital Reg, Copenhagen, Denmark; [Jorgensen, Torben; Linneberg, Allan] Glostrup Univ Hosp, Res Ctr Prevent & Hlth, Glostrup, Denmark; [Jorgensen, Torben] Univ Copenhagen, Fac Hlth & Med Sci, Dept Publ Hlth, Copenhagen, Denmark; [Christensen, Cramer] Vejle Hosp, Lillebaelt Hosp, Dept Med, Vejle, Denmark; [Brandslund, Ivan] Vejle Hosp, Lillebaelt Hosp, Dept Clin Immunol & Biochem, Vejle, Denmark; [Brandslund, Ivan] Univ Southern Denmark, Inst Reg Hlth Res, Odense, Denmark; [Linneberg, Allan] Glostrup Univ Hosp, Dept Clin Expt Res, Glostrup, Denmark; [Linneberg, Allan] Univ Copenhagen, Fac Hlth & Med Sci, Dept Clin Med, Copenhagen, Denmark; [Sorensen, Thorkild I. A.] Bispebjerg & Frederiksberg Hosp, Inst Prevent Med, Capital Reg, Copenhagen, Denmark; [Hansen, Torben] Univ Southern Denmark, Fac Hlth Sci, Odense, Denmark	Novo Nordisk Foundation; University of Copenhagen; University of Copenhagen; University of Copenhagen; Herlev & Gentofte Hospital; University of Copenhagen; University of Copenhagen; University of Southern Denmark; Lillebaelt Hospital; University of Southern Denmark; Lillebaelt Hospital; University of Southern Denmark; University of Copenhagen; University of Copenhagen; University of Copenhagen; Bispebjerg Hospital; University of Southern Denmark	Harder, MN (corresponding author), Univ Copenhagen, Fac Hlth & Med Sci, Novo Nordisk Fdn Ctr Basic Metab Res, Copenhagen, Denmark.	marie.harder@sund.ku.dk	Grarup, Niels/K-2807-2015; Jørgensen, Torben/Z-1335-2018; Pedersen, Oluf/Z-1731-2019; Gjesing, Anette/ACC-7521-2022; Dina, Christian R/D-3535-2015; Pedersen, Oluf/AAG-8015-2020; Ahluwalia, Tarunveer Singh/C-5549-2009	Grarup, Niels/0000-0001-5526-1070; Pedersen, Oluf/0000-0002-3321-3972; Gjesing, Anette/0000-0003-4580-1576; Dina, Christian R/0000-0002-7722-7348; Ahluwalia, Tarunveer Singh/0000-0002-7464-3354; Jorgensen, Torben/0000-0001-9453-2830; Hansen, Torben/0000-0001-8748-3831; Brandslund, Ivan/0000-0002-4203-5442; Linneberg, Allan/0000-0002-0994-0184	Novo Nordisk Foundation Center for Basic Metabolic Research, independent Research Center at the University of Copenhagen - Novo Nordisk Foundation; PhD School of Molecular Metabolism University of Southern Denmark; Copenhagen Graduate School of Health and Medical Sciences; Danish Council for Independent Research; Gene Diet Interactions in Obesity (GENDINOB) project; Lundbeck Foundation	Novo Nordisk Foundation Center for Basic Metabolic Research, independent Research Center at the University of Copenhagen - Novo Nordisk Foundation; PhD School of Molecular Metabolism University of Southern Denmark; Copenhagen Graduate School of Health and Medical Sciences; Danish Council for Independent Research(Det Frie Forskningsrad (DFF)); Gene Diet Interactions in Obesity (GENDINOB) project; Lundbeck Foundation(Lundbeckfonden)	This work was supported by research grants from The Novo Nordisk Foundation Center for Basic Metabolic Research, an independent Research Center at the University of Copenhagen partially funded by an unrestricted donation from the Novo Nordisk Foundation, the PhD School of Molecular Metabolism University of Southern Denmark, the Copenhagen Graduate School of Health and Medical Sciences, the Danish Council for Independent Research and the Gene Diet Interactions in Obesity (GENDINOB, www.gendinob.dk) project. The study is a part of the LuCamp initiative (www.lucamp.org) and is sponsored by the Lundbeck Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almasy L, 1998, AM J HUM GENET, V62, P1198, DOI 10.1086/301844; Black E, 2005, DIABETIC MED, V22, P1199, DOI 10.1111/j.1464-5491.2005.01615.x; Byberg S, 2012, DIABETIC MED, V29, pE354, DOI 10.1111/j.1464-5491.2012.03711.x; Gjesing AP, 2012, DIABETOLOGIA, V55, P1338, DOI 10.1007/s00125-012-2484-6; Grarup N, 2014, DIABETOLOGIA; Grarup N, 2010, CURR DIABETES REP, V10, P485, DOI 10.1007/s11892-010-0154-y; Hansen T, 2007, DIABETES CARE, V30, P257, DOI 10.2337/dc06-1240; Harder MN, 2013, J CLIN ENDOCR METAB, V98, pE801, DOI 10.1210/jc.2012-4169; Huyghe JR, 2013, NAT GENET, V45, P197, DOI 10.1038/ng.2507; Jorgensen T, 2003, OFFICIAL J EUROPEAN, V10, P377; KAHN SE, 1993, DIABETES, V42, P1663, DOI 10.2337/diabetes.42.11.1663; Lauritzen T, 2000, INT J OBESITY, V24, pS6, DOI 10.1038/sj.ijo.0801420; Lee EK, 2012, MOL CELL, V45, P826, DOI 10.1016/j.molcel.2012.01.016; Lyssenko V, 2013, DIABETES CARE, V36, pS120, DOI 10.2337/dcS13-2009; Mahajan A, 2014, NAT GENET, V46, P234, DOI 10.1038/ng.2897; Matsuda M, 1999, DIABETES CARE, V22, P1462, DOI 10.2337/diacare.22.9.1462; Morris AP, 2012, NAT GENET, V44, P981, DOI 10.1038/ng.2383; Paternoster L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024303; SELTZER HS, 1967, J CLIN INVEST, V46, P323, DOI 10.1172/JCI105534; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Thuesen BH, 2013, INT J EPIDEMIOL; Uhlen M, 2010, NAT BIOTECHNOL, V28, P1248, DOI 10.1038/nbt1210-1248; Voight BF, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002793	23	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0120890	10.1371/journal.pone.0120890	http://dx.doi.org/10.1371/journal.pone.0120890			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25799151	gold, Green Published, Green Submitted			2022-12-27	WOS:000351987300187
J	Joddar, B; Firstenberg, MS; Reen, RK; Varadharaj, S; Khan, M; Childers, RC; Zweier, JL; Gooch, KJ				Joddar, Binata; Firstenberg, Michael S.; Reen, Rashmeet K.; Varadharaj, Saradhadevi; Khan, Mahmood; Childers, Rachel C.; Zweier, Jay L.; Gooch, Keith J.			Arterial Levels of Oxygen Stimulate Intimal Hyperplasia in Human Saphenous Veins via a ROS-Dependent Mechanism	PLOS ONE			English	Article							AORTIC ENDOTHELIAL-CELLS; ACTIVATED PROTEIN-KINASE; ORGAN-CULTURE MODEL; NEOINTIMAL HYPERPLASIA; ANTIOXIDANT VITAMINS; OXIDATIVE STRESS; HYPOXIA; GROWTH; INJURY; ATHEROMATOSIS	Saphenous veins used as arterial grafts are exposed to arterial levels of oxygen partial pressure (pO(2)), which are much greater than what they experience in their native environment. The object of this study is to determine the impact of exposing human saphenous veins to arterial pO(2). Saphenous veins and left internal mammary arteries from consenting patients undergoing coronary artery bypass grafting were cultured ex vivo for 2 weeks in the presence of arterial or venous pO(2) using an established organ culture model. Saphenous veins cultured with arterial pO(2) developed intimal hyperplasia as evidenced by 2.8-fold greater intimal area and 5.8-fold increase in cell proliferation compared to those freshly isolated. Saphenous veins cultured at venous pO(2) or internal mammary arteries cultured at arterial pO(2) did not develop intimal hyperplasia. Intimal hyperplasia was accompanied by two markers of elevated reactive oxygen species (ROS): increased dihydroethidium associated fluorescence (4-fold, p< 0.05) and increased levels of the lipid peroxidation product, 4-hydroxynonenal (10-fold, p< 0.05). A functional role of the increased ROS saphenous veins exposed to arterial pO(2) is suggested by the observation that chronic exposure to tiron, a ROS scavenger, during the two-week culture period, blocked intimal hyperplasia. Electron paramagnetic resonance based oximetry revealed that the pO(2) in the wall of the vessel tracked that of the atmosphere with a similar to 30 mmHg offset, thus the cells in the vessel wall were directly exposed to variations in pO(2). Monolayer cultures of smooth muscle cells isolated from saphenous veins exhibited increased proliferation when exposed to arterial pO(2) relative to those cultured at venous pO(2). This increased proliferation was blocked by tiron. Taken together, these data suggest that exposure of human SV to arterial pO(2) stimulates IH via a ROS-dependent pathway.	[Joddar, Binata; Reen, Rashmeet K.; Childers, Rachel C.; Gooch, Keith J.] Ohio State Univ, Dept Biomed Engn, Columbus, OH 43210 USA; [Joddar, Binata; Reen, Rashmeet K.; Varadharaj, Saradhadevi; Khan, Mahmood; Childers, Rachel C.; Zweier, Jay L.; Gooch, Keith J.] Ohio State Univ, Davis Heart & Lung Res Inst, Columbus, OH 43210 USA; [Firstenberg, Michael S.] Ohio State Univ, Div Cardiothorac Surg, Columbus, OH 43210 USA; [Khan, Mahmood] Ohio State Univ, Dept Emergency Med, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Gooch, KJ (corresponding author), Ohio State Univ, Dept Biomed Engn, Columbus, OH 43210 USA.	gooch.20@osu.edu	Joddar, Binata/GYD-4661-2022; Gooch, Keith/E-3135-2011	Childers, Rachel/0000-0001-9430-4897	American Heart Association [0655323B]; National Institutes of Health [HL38324, HL63744, HL65608]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL065608, R29HL038324, R01HL038324, R01HL063744] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funding: American Heart Association (0655323B) to KJG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. National Institutes of Health (HL38324, HL63744, HL65608) to JLZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berard X, 2013, J VASC SURG, V57, P1371, DOI 10.1016/j.jvs.2012.09.041; Bindokas VP, 1996, J NEUROSCI, V16, P1324; Campbell GR, 1987, VASCULAR SMOOTH MUSC, V1, P39; Carr A, 1999, FASEB J, V13, P1007, DOI 10.1096/fasebj.13.9.1007; Castronuovo JJ, 2002, J VASC SURG, V35, P152, DOI 10.1067/mva.2002.119231; Das A, 2014, BRIT J PHARMACOL, V171, P2321, DOI 10.1111/bph.12572; De Pascali F, 2014, BIOCHEMISTRY-US, V53, P3679, DOI 10.1021/bi500076r; Deglise S, 2005, J VASC SURG, V41, P1043, DOI 10.1016/j.jvs.2005.02.036; Griendling KK, 2003, CIRCULATION, V108, P1912, DOI 10.1161/01.CIR.0000093660.86242.BB; Gusic RJ, 2005, J BIOMECH, V38, P1770, DOI 10.1016/j.jbiomech.2005.04.002; Gusic RJ, 2005, J BIOMECH, V38, P1760, DOI 10.1016/j.jbiomech.2004.10.030; Harrison D, 2003, AM J CARDIOL, V91, p7A; Jeremy JY, 2007, BIOMATERIALS, V28, P895, DOI 10.1016/j.biomaterials.2006.10.023; JHA P, 1995, ANN INTERN MED, V123, P860, DOI 10.7326/0003-4819-123-11-199512010-00009; Joddar B, 2011, BIOMECH MODEL MECHAN, V10, P161, DOI 10.1007/s10237-010-0224-8; Joddar B, 2011, FREE RADICAL BIO MED, V50, P700, DOI 10.1016/j.freeradbiomed.2010.12.008; Khan M, 2010, J PHARMACOL EXP THER, V333, P421, DOI 10.1124/jpet.109.165175; KJELDSEN K, 1968, J ATHEROSCLER RES, V8, P835, DOI 10.1016/S0368-1319(68)80046-8; KJELDSEN K, 1969, J ATHEROSCLER RES, V10, P173, DOI 10.1016/S0368-1319(69)80005-0; Lau AK, 2006, ATHEROSCLEROSIS, V185, P254, DOI 10.1016/j.atherosclerosis.2005.06.040; Medalion B, 1997, CIRCULATION, V95, P1853; Motwani JG, 1998, CIRCULATION, V97, P916, DOI 10.1161/01.CIR.97.9.916; Pandian RP, 2003, ARCH BIOCHEM BIOPHYS, V420, P169, DOI 10.1016/j.abb.2003.09.008; Paolini M, 2003, LANCET, V362, P920, DOI 10.1016/S0140-6736(03)14318-8; Porter KE, 1996, CARDIOVASC RES, V31, P607; Porter KE, 1998, J VASC SURG, V28, P695, DOI 10.1016/S0741-5214(98)70096-5; Porter KE, 2001, J VASC SURG, V34, P548, DOI 10.1067/mva.2001.115960; Rose BA, 2010, PHYSIOL REV, V90, P1507, DOI 10.1152/physrev.00054.2009; Ruef J, 1998, CIRCULATION, V97, P1071, DOI 10.1161/01.CIR.97.11.1071; Schachner T, 2006, J THORAC CARDIOV SUR, V131, P1065, DOI 10.1016/j.jtcvs.2005.11.043; Shi Y, 2001, CIRCULATION, V103, P2408; Ulrich-Merzenich G, 2002, IN VITRO CELL DEV-AN, V38, P265; Wilson YG, 1997, EUR J VASC ENDOVASC, V13, P557, DOI 10.1016/S1078-5884(97)80064-0; Wilson YG, 1996, J ENDOVASC SURG, V3, P436, DOI 10.1583/1074-6218(1996)003<0436:IOAVGP>2.0.CO;2; Zhao HT, 2005, P NATL ACAD SCI USA, V102, P5727, DOI 10.1073/pnas.0501719102	35	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0120301	10.1371/journal.pone.0120301	http://dx.doi.org/10.1371/journal.pone.0120301			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25799140	gold, Green Submitted, Green Published			2022-12-27	WOS:000351987300126
J	Besnard-Guerin, C; Jacquier, C; Pidoux, J; Deddouche, S; Antoniewsk, C				Besnard-Guerin, Corinne; Jacquier, Caroline; Pidoux, Josette; Deddouche, Safia; Antoniewsk, Christophe			The Cricket Paralysis Virus Suppressor Inhibits microRNA Silencing Mediated by the Drosophila Argonaute-2 Protein	PLOS ONE			English	Article							RNA INTERFERENCE; ANTIVIRAL IMMUNITY; VIRAL SUPPRESSORS; MAMMALIAN-CELLS; RECOGNITION; DEFENSE; MELANOGASTER; REPLICATION; PATHWAYS; B2	Small RNAs are potent regulators of gene expression. They also act in defense pathways against invading nucleic acids such as transposable elements or viruses. To counteract these defenses, viruses have evolved viral suppressors of RNA silencing (VSRs). Plant viruses encoded VSRs interfere with siRNAs or miRNAs by targeting common mediators of these two pathways. In contrast, VSRs identified in insect viruses to date only interfere with the siRNA pathway whose effector Argonaute protein is Argonaute-2 (Ago-2). Although a majority of Drosophila miRNAs exerts their silencing activity through their loading into the Argonaute-1 protein, recent studies highlighted that a fraction of miRNAs can be loaded into Ago-2, thus acting as siRNAs. In light of these recent findings, we re-examined the role of insect VSRs on Ago-2-mediated miRNA silencing in Drosophila melanogaster. Using specific reporter systems in cultured Schneider-2 cells and transgenic flies, we showed here that the Cricket Paralysis virus VSR CrPV1-A but not the Flock House virus B2 VSR abolishes silencing by miRNAs loaded into the Ago-2 protein. Thus, our results provide the first evidence that insect VSR have the potential to directly interfere with the miRNA silencing pathway.	[Antoniewsk, Christophe] CNRS, UMR7622, Inst Biol Paris Seine, Drosophila Genet & Epigenet, F-75005 Paris, France; Univ Paris 06, F-75005 Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite	Antoniewsk, C (corresponding author), CNRS, UMR7622, Inst Biol Paris Seine, Drosophila Genet & Epigenet, 9 Quai St Bernard, F-75005 Paris, France.	christophe.antoniewski@upmc.fr	Besnard-Guerin, Corinne/J-3985-2017; Antoniewski, Christophe/G-4519-2011	Antoniewski, Christophe/0000-0001-7709-2116	Centre National de la Recherche Scientifique University Pierre et Marie Curie Institut National de la Sante et de la Recherche Medicale Agence Nationale de la Recherche [ANR BLAN 1210 01]; Fondation pour la Recherche Medicale	Centre National de la Recherche Scientifique University Pierre et Marie Curie Institut National de la Sante et de la Recherche Medicale Agence Nationale de la Recherche(French National Research Agency (ANR)); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale)	Centre National de la Recherche Scientifique University Pierre et Marie Curie Institut National de la Sante et de la Recherche Medicale Agence Nationale de la Recherche [grant number ANR BLAN 1210 01 "nuclear endosiRNA"] to CA and Fondation pour la Recherche Medicale [post-doctoral fellowship] to SD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe M, 2014, GENE DEV, V28, P44, DOI 10.1101/gad.226654.113; Alvarado V, 2009, SEMIN CELL DEV BIOL, V20, P1032, DOI 10.1016/j.semcdb.2009.06.001; Ameres SL, 2013, NAT REV MOL CELL BIO, V14, P475, DOI 10.1038/nrm3611; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Berry B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005866; Bischof J, 2007, P NATL ACAD SCI USA, V104, P3312, DOI 10.1073/pnas.0611511104; Carre C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074296; Chao JA, 2005, NAT STRUCT MOL BIOL, V12, P952, DOI 10.1038/nsmb1005; Chou YT, 2007, FLY, V1, P311, DOI 10.4161/fly.5606; Czech B, 2009, MOL CELL, V36, P445, DOI 10.1016/j.molcel.2009.09.028; Ding SW, 2007, CELL, V130, P413, DOI 10.1016/j.cell.2007.07.039; Forstemann K, 2007, CELL, V130, P287, DOI 10.1016/j.cell.2007.05.056; Galiana-Arnoux D, 2006, NAT IMMUNOL, V7, P590, DOI 10.1038/ni1335; Ghildiyal M, 2010, RNA, V16, P43, DOI 10.1261/rna.1972910; Habayeb MS, 2006, J GEN VIROL, V87, P3045, DOI 10.1099/vir.0.81997-0; Haley B, 2008, DEV BIOL, V321, P482, DOI 10.1016/j.ydbio.2008.06.015; Haley B, 2010, P NATL ACAD SCI USA, V107, P11435, DOI 10.1073/pnas.1006689107; Iwasaki S, 2009, MOL CELL, V34, P58, DOI 10.1016/j.molcel.2009.02.010; Kakumani PK, 2013, J VIROL, V87, P8870, DOI 10.1128/JVI.02774-12; Lakatos L, 2006, EMBO J, V25, P2768, DOI 10.1038/sj.emboj.7601164; Leuschner PJF, 2005, CURR BIOL, V15, pR603, DOI 10.1016/j.cub.2005.07.044; Li Y, 2013, SCIENCE, V342, P231, DOI 10.1126/science.1241911; Lu R, 2005, NATURE, V436, P1040, DOI 10.1038/nature03870; Maillard PV, 2013, SCIENCE, V342, P235, DOI 10.1126/science.1241930; Miyoshi K, 2005, GENE DEV, V19, P2837, DOI 10.1101/gad.1370605; Morel JB, 2002, PLANT CELL, V14, P629, DOI 10.1105/tpc.010358; Nayak A, 2010, NAT STRUCT MOL BIOL, V17, P547, DOI 10.1038/nsmb.1810; Ni JQ, 2011, NAT METHODS, V8, P405, DOI [10.1038/NMETH.1592, 10.1038/nmeth.1592]; Okamura K, 2004, GENE DEV, V18, P1655, DOI 10.1101/gad.1210204; Okamura K, 2009, MOL CELL, V36, P431, DOI 10.1016/j.molcel.2009.09.027; Singh G, 2009, FASEB J, V23, P1845, DOI 10.1096/fj.08-125120; Sullivan CS, 2005, J VIROL, V79, P7371, DOI 10.1128/JVI.79.12.7371-7379.2005; Tili E, 2013, IMMUNOL REV, V253, P167, DOI 10.1111/imr.12050; Tomari Y, 2007, CELL, V130, P299, DOI 10.1016/j.cell.2007.05.057; van Mierlo JT, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002872; van Rij RP, 2006, GENE DEV, V20, P2985, DOI 10.1101/gad.1482006; Vargason JM, 2003, CELL, V115, P799, DOI 10.1016/S0092-8674(03)00984-X; Vijayendran D, 2013, J INVERTEBR PATHOL, V114, P186, DOI 10.1016/j.jip.2013.07.006; Voinnet O, 2009, CELL, V136, P669, DOI 10.1016/j.cell.2009.01.046; Ye KQ, 2003, NATURE, V426, P874, DOI 10.1038/nature02213; Zhang XR, 2006, GENE DEV, V20, P3255, DOI 10.1101/gad.1495506	41	6	6	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0120205	10.1371/journal.pone.0120205	http://dx.doi.org/10.1371/journal.pone.0120205			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25793377	Green Published, gold			2022-12-27	WOS:000352084200159
J	Boneparth, A; Huang, WQ; Bethunaickan, R; Woods, M; Sahu, R; Arora, S; Akerman, M; Lesser, M; Davidson, A				Boneparth, Alexis; Huang, Weiqing; Bethunaickan, Ramalingam; Woods, Megan; Sahu, Ranjit; Arora, Shitij; Akerman, Meredith; Lesser, Martin; Davidson, Anne			TLR7 Influences Germinal Center Selection in Murine SLE	PLOS ONE			English	Article							CELL-INTRINSIC TLR7; SYSTEMIC-LUPUS-ERYTHEMATOSUS; DNA B-CELLS; AUTOANTIBODY PRODUCTION; ANTIPHOSPHOLIPID SYNDROME; TOLERANCE; MECHANISM; RECEPTOR; CHAIN; ACCELERATION	TLR7 enhances germinal center maturation and migration of B cells to the dark zone where proliferation and somatic hypermutation occur. Our goal was to determine how Tlr7 dose influences selection of the autoreactive B cell repertoire in NZW/BXSB. Yaa mice bearing the site-directed heavy chain transgene 3H9 that encodes for the TLR7 regulated anti-CL response. To create a physiologic setting in which autoreactive B cells compete for survival with non-autoreactive B cells, we generated bone marrow chimeras in which disease onset occurred with similar kinetics and the transferred 3H9+ female non-Yaa, male Yaa or male TLR7-/Yaa cells could be easily identified by positivity for GFP. Deletion of 3H9 B cells occurred in the bone marrow and the remaining 3H9 follicular B cells manifested a decrease in surface IgM. Although there were differences in the naive repertoire between the chimeras it was not possible to distinguish a clear pattern of selection against lupus related autoreactivity in TLR7(-/Yaa) or female chimeras. By contrast, preferential expansion of 3H9+ B cells occurred in the germinal centers of male Yaa chimeras. In addition, although all chimeras preferentially selected 3H9/V kappa 5 encoded B cells into the germinal center and plasma cell compartments, 3H9 male Yaa chimeras had a more diverse repertoire and positively selected the 3H9/V kappa 5-48/J kappa 4 pair that confers high affinity anti-cardiolipin activity. We were unable to demonstrate a consistent effect of Tlr7 dose or Yaa on somatic mutations. Our data show that TLR7 excess influences the selection, expansion and diversification of B cells in the germinal center, independent of other genes in the Yaa locus.	[Boneparth, Alexis; Huang, Weiqing; Bethunaickan, Ramalingam; Woods, Megan; Sahu, Ranjit; Arora, Shitij; Davidson, Anne] Feinstein Inst Med Res, Ctr Autoimmun & Musculoskeletal Dis, Manhasset, NY 11030 USA; [Akerman, Meredith; Lesser, Martin] Feinstein Inst Med Res, Biostat Unit, Manhasset, NY 11030 USA	Northwell Health; Northwell Health	Davidson, A (corresponding author), Feinstein Inst Med Res, Ctr Autoimmun & Musculoskeletal Dis, Manhasset, NY 11030 USA.	adavidson1@nshs.edu	Bethunaickan, Ramalingam/AAZ-6429-2020; Bethunaickan, Ramalingam/N-6463-2015	Bethunaickan, Ramalingam/0000-0003-4595-5233; Davidson, Anne/0000-0002-4081-6464; Arora, Shitij/0000-0002-8927-6171	National Institutes of Health [R01 AI083901, R01 AR064811]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR064811] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by National Institutes of Health grants R01 AI083901 and R01 AR064811 to AD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akkerman A, 2004, AUTOIMMUNITY, V37, P445, DOI 10.1080/08916930400008524; Alabyev B, 2007, J IMMUNOL, V178, P5623, DOI 10.4049/jimmunol.178.9.5623; Arango D, 2004, BRIT J CANCER, V91, P1931, DOI 10.1038/sj.bjc.6602215; Chen C, 1995, IMMUNITY, V3, P747, DOI 10.1016/1074-7613(95)90064-0; Christensen SR, 2006, IMMUNITY, V25, P417, DOI 10.1016/j.immuni.2006.07.013; Clingan JM, 2013, J IMMUNOL, V191, P810, DOI 10.4049/jimmunol.1300244; Deane JA, 2007, IMMUNITY, V27, P801, DOI 10.1016/j.immuni.2007.09.009; Elkon KB, 2012, CURR OPIN RHEUMATOL, V24, P499, DOI 10.1097/BOR.0b013e3283562c3e; Fairhurst AM, 2008, EUR J IMMUNOL, V38, P1971, DOI 10.1002/eji.200838138; Fossati L, 1995, EUR J IMMUNOL, V25, P3412, DOI 10.1002/eji.1830251231; Gitlin AD, 2014, NATURE, V509, P637, DOI 10.1038/nature13300; Hua ZL, 2014, J IMMUNOL, V192, P875, DOI 10.4049/jimmunol.1300683; Huang WQ, 2011, J IMMUNOL, V187, P6571, DOI 10.4049/jimmunol.1101784; Huber W, 2005, STAT BIOL HEALTH, P161; Hwang IY, 2009, J EXP MED, V206, P2641, DOI 10.1084/jem.20091982; Hwang SH, 2012, J IMMUNOL, V189, P5786, DOI 10.4049/jimmunol.1202195; IBRAHIM SM, 1995, J IMMUNOL, V155, P3223; Jackson SW, 2014, J IMMUNOL, V192, P4525, DOI 10.4049/jimmunol.1400098; Kahn P, 2008, ARTHRITIS RHEUM, V58, P2824, DOI 10.1002/art.23764; Kawai T, 2008, ANN NY ACAD SCI, V1143, P1, DOI 10.1196/annals.1443.020; Kirchenbaum GA, 2014, EUR J IMMUNOL, V44, P970, DOI 10.1002/eji.201344276; Koh YT, 2013, J IMMUNOL, V190, P4982, DOI 10.4049/jimmunol.1202986; Lesser ML, 2014, J MOD APPL STAT METH, V13, P91; Li YJ, 2002, J EXP MED, V196, P1543, DOI 10.1084/jem.20021560; Liu Z, 2011, ARTHRITIS RHEUM-US, V63, P219, DOI 10.1002/art.30087; MandikNayak L, 1997, J EXP MED, V186, P1257, DOI 10.1084/jem.186.8.1257; Meyer-Bahlburg A, 2008, J EXP MED, V205, P155, DOI 10.1084/jem.20071088; Moisini I, 2012, J IMMUNOL, V189, P4305, DOI 10.4049/jimmunol.1200745; Paul E, 2004, INT IMMUNOL, V16, P377, DOI 10.1093/intimm/dxh035; Pisitkun P, 2006, SCIENCE, V312, P1669, DOI 10.1126/science.1124978; Pugh-Bernard AE, 2001, J CLIN INVEST, V108, P1061, DOI 10.1172/JCI12462; RADIC MZ, 1991, J IMMUNOL, V146, P176; RADIC MZ, 1993, J IMMUNOL, V150, P4966; RADIC MZ, 1994, ANNU REV IMMUNOL, V12, P487, DOI 10.1146/annurev.iy.12.040194.002415; RADIC MZ, 1993, J EXP MED, V177, P1165, DOI 10.1084/jem.177.4.1165; Ramanujam M, 2006, J CLIN INVEST, V116, P724, DOI 10.1172/JCI26385; Ramanujam M, 2004, J IMMUNOL, V173, P3524, DOI 10.4049/jimmunol.173.5.3524; Ramanujam M, 2009, ARTHRITIS RHEUM-US, V60, P1096, DOI 10.1002/art.24414; Rubtsov AV, 2013, IMMUNOL RES, V55, P210, DOI 10.1007/s12026-012-8365-8; Sabouri Z, 2014, P NATL ACAD SCI USA, V111, pE2567, DOI 10.1073/pnas.1406974111; Santiago-Raber ML, 2008, J IMMUNOL, V181, P1556, DOI 10.4049/jimmunol.181.2.1556; Schiffer L, 2008, J IMMUNOL, V180, P1938, DOI 10.4049/jimmunol.180.3.1938; Simon R. M, 2004, DESIGN ANAL DNA MICR, P121; Soni C, 2014, J IMMUNOL, V193, P4400, DOI 10.4049/jimmunol.1401720; Subramanian S, 2006, P NATL ACAD SCI USA, V103, P9970, DOI 10.1073/pnas.0603912103; Teichmann LL, 2013, IMMUNITY, V38, P528, DOI 10.1016/j.immuni.2012.11.017; Vuyyuru R, 2009, J IMMUNOL, V183, P5716, DOI 10.4049/jimmunol.0804215; Wang XB, 2002, J IMMUNOL, V168, P2046, DOI 10.4049/jimmunol.168.4.2046; Wardemann H, 2003, SCIENCE, V301, P1374, DOI 10.1126/science.1086907; Wardemann H, 2007, ADV IMMUNOL, V95, P83, DOI 10.1016/S0065-2776(07)95003-8	50	16	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0119925	10.1371/journal.pone.0119925	http://dx.doi.org/10.1371/journal.pone.0119925			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25794167	gold, Green Published, Green Submitted			2022-12-27	WOS:000352084200130
J	Bucchieri, F; Gammazza, AM; Pitruzzella, A; Fucarino, A; Farina, F; Howarth, P; Holgate, ST; Zummo, G; Davies, DE				Bucchieri, Fabio; Gammazza, Antonella Marino; Pitruzzella, Alessandro; Fucarino, Alberto; Farina, Felicia; Howarth, Peter; Holgate, Stephen T.; Zummo, Giovanni; Davies, Donna E.			Cigarette Smoke Causes Caspase-Independent Apoptosis of Bronchial Epithelial Cells from Asthmatic Donors	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; OXIDATIVE STRESS; AIRWAY HYPERRESPONSIVENESS; MOLECULAR-MECHANISMS; BARRIER FUNCTION; TOBACCO-SMOKE; LUNG; ANTIOXIDANT; DEATH; EXPRESSION	Background Epidemiologic studies have demonstrated important links between air pollution and asthma. Amongst these pollutants, environmental cigarette smoke is a risk factor both for asthma pathogenesis and exacerbation. As the barrier to the inhaled environment, the bronchial epithelium is a key structure that is exposed to cigarette smoke. Objectives Since primary bronchial epithelial cells (PBECs) from asthmatic donors are more susceptible to oxidant-induced apoptosis, we hypothesized that they would be susceptible to cigarette smoke-induced cell death. Methods PBECs from normal and asthmatic donors were exposed to cigarette smoke extract (CSE); cell survival and apoptosis were assessed by fluorescence-activated cell sorting, and protective effects of antioxidants evaluated. The mechanism of cell death was evaluated using caspase inhibitors and immunofluorescent staining for apoptosis-inducing factor (AIF). Results Exposure of PBEC cultures to CSE resulted in a dose-dependent increase in cell death. At 20% CSE, PBECs from asthmatic donors exhibited significantly more apoptosis than cells from non-asthmatic controls. Reduced glutathione (GSH), but not ascorbic acid (AA), protected against CSE-induced apoptosis. To investigate mechanisms of CSE-induced apoptosis, caspase-3 or -9 inhibitors were tested, but these failed to prevent apoptosis; in contrast, CSE promoted nuclear translocation of AIF from the mitochondria. GSH reduced the number of nuclear-AIF positive cells whereas AA was ineffective. Conclusion Our results show that PBECs from asthmatic donors are more susceptible to CSE-induced apoptosis. This response involves AIF, which has been implicated in DNA damage and ROS-mediated cell-death. Epithelial susceptibility to CSE may contribute to the impact of environmental tobacco smoke in asthma.	[Bucchieri, Fabio; Howarth, Peter; Holgate, Stephen T.; Davies, Donna E.] Univ Southampton, Fac Med, Acad Unit Clin & Expt Sci, Sir Henry Wellcome Labs,Univ Hosp Southampton, Southampton SO9 5NH, Hants, England; [Howarth, Peter; Holgate, Stephen T.; Davies, Donna E.] Univ Southampton, Fac Med, Southampton Natl Inst Hlth Res NIHR, Resp Biomed Res Unit,Sir Henry Wellcome Labs,Univ, Southampton SO9 5NH, Hants, England; [Bucchieri, Fabio; Gammazza, Antonella Marino; Pitruzzella, Alessandro; Fucarino, Alberto; Farina, Felicia; Zummo, Giovanni] Univ Palermo, Dipartimento Biomed Sperimentale & Neurosci Clin, Palermo, Italy; [Bucchieri, Fabio; Gammazza, Antonella Marino; Pitruzzella, Alessandro; Fucarino, Alberto] Ist Euromediterraneo Sci & Tecnol IEMEST, Palermo, Italy; [Bucchieri, Fabio] Italian Natl Res Council CNR, Inst Biomed & Mol Immunol IBIM, Palermo, Italy	University of Southampton; University of Southampton; University of Palermo; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biomedicina e di Immunologia Molecolare "Alberto Monroy" (IBIM-CNR); Istituto di Neuroscienze (IN-CNR)	Davies, DE (corresponding author), Univ Southampton, Fac Med, Acad Unit Clin & Expt Sci, Sir Henry Wellcome Labs,Univ Hosp Southampton, Southampton SO9 5NH, Hants, England.	donnad@soton.ac.uk	Bucchieri, Fabio/F-8877-2012; Davies, Donna E/H-2993-2012; Gammazza, Antonella Marino/AAV-3123-2020	PITRUZZELLA, Alessandro/0000-0002-4618-4963; Marino Gammazza, Antonella/0000-0002-1683-3803; fucarino, alberto/0000-0001-8958-525X; BUCCHIERI, Fabio/0000-0002-0209-8668; Howarth, Peter/0000-0003-0619-7927; Davies, Donna/0000-0002-5117-2991	Medical Research Council (United Kingdom) [G0900453]; Asthma Allergy and Inflammation Research (AAIR) Charity; Asthma United Kingdom; MRC [G0900453, G19/34] Funding Source: UKRI; Medical Research Council [G19/34, G0900453] Funding Source: researchfish	Medical Research Council (United Kingdom)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Asthma Allergy and Inflammation Research (AAIR) Charity; Asthma United Kingdom; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Funding provided by Medical Research Council (United Kingdom) Grant number G0900453 (STH, DED, PHH), http://www.mrc.ac.uk/, Asthma Allergy and Inflammation Research (AAIR) Charity (DED FB), http://www.aaircharity.org/, and Asthma United Kingdom (DED STH), http://www.asthma.org.uk/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aubier M, 2009, B ACAD NAT MED PARIS, V193, P1303, DOI 10.1016/S0001-4079(19)32469-0; Bazzini C, 2013, CELL PHYSIOL BIOCHEM, V32, P129, DOI 10.1159/000356633; Bergren Dale R., 2009, Inflammation & Allergy Drug Targets, V8, P340; Bucchieri F, 2002, AM J RESP CELL MOL, V27, P179, DOI 10.1165/ajrcmb.27.2.4699; CARP H, 1978, AM REV RESPIR DIS, V118, P617; Comhair SAA, 2010, ANTIOXID REDOX SIGN, V12, P93, DOI [10.1089/ars.2008.2425, 10.1089/ARS.2008.2425]; Contoli M, 2006, NAT MED, V12, P1023, DOI 10.1038/nm1462; CURVALL M, 1984, CELL BIOL TOXICOL, V1, P173, DOI 10.1007/BF00125573; Davies DE, 2003, J ALLERGY CLIN IMMUN, V111, P215, DOI 10.1067/mai.2003.128; Faux SP, 2009, BIOMARKERS, V14, P90, DOI 10.1080/13547500902965047; Fedorov IA, 2005, THORAX, V60, P389, DOI 10.1136/thx.2004.030262; Freishtat RJ, 2011, AM J RESP CELL MOL, V44, P863, DOI 10.1165/rcmb.2010-0029OC; Galluzzi L, 2014, SEMIN CELL DEV BIOL, V35, P24, DOI 10.1016/j.semcdb.2014.02.006; Gangl K, 2009, ALLERGY, V64, P398, DOI 10.1111/j.1398-9995.2008.01861.x; Gonzalez-Suarez I, 2014, CHEM RES TOXICOL, V27, P367, DOI 10.1021/tx400405s; Gumral N, 2009, CELL BIOCHEM FUNCT, V27, P276, DOI 10.1002/cbf.1569; Hackett TL, 2009, AM J RESP CRIT CARE, V180, P122, DOI 10.1164/rccm.200811-1730OC; HALLIWELL B, 1993, HAEMOSTASIS, V23, P118; Hellermann GR, 2002, RESP RES, V3, DOI 10.1186/rr172; Holgate ST, 2009, IMMUNITY, V31, P362, DOI 10.1016/j.immuni.2009.08.013; Iwanaga K, 2013, INHAL TOXICOL, V25, P653, DOI 10.3109/08958378.2013.827283; Kirkham P, 2006, PHARMACOL THERAPEUT, V111, P476, DOI 10.1016/j.pharmthera.2005.10.015; Kovacs K, 2012, FREE RADICAL BIO MED, V53, P1680, DOI 10.1016/j.freeradbiomed.2012.08.579; Liu XD, 2005, AM J RESP CELL MOL, V33, P121, DOI 10.1165/rcmb.2003-0341OC; Merendino AM, 2006, AM J RESP CELL MOL, V35, P155, DOI 10.1165/rcmb.2005-0433OC; Nadeem A, 2014, PULM PHARMACOL THER, V29, P31, DOI 10.1016/j.pupt.2014.06.001; Olatunji-Bello I I, 2008, West Afr J Med, V27, P78; Pierrou S, 2007, AM J RESP CRIT CARE, V175, P577, DOI 10.1164/rccm.200607-931OC; POSTMA DS, 1988, AM REV RESPIR DIS, V137, P57, DOI 10.1164/ajrccm/137.1.57; Puddicombe SM, 2003, AM J RESP CELL MOL, V28, P61, DOI 10.1165/rcmb.4715; Puddicombe SM, 2000, FASEB J, V14, P1362, DOI 10.1096/fj.14.10.1362; SEDGWICK JB, 1992, J IMMUNOL, V149, P3710; Siedlinski M, 2009, EUR RESPIR J, V33, P986, DOI 10.1183/09031936.00171507; Smith LJ, 1997, FREE RADICAL BIO MED, V22, P1301, DOI 10.1016/S0891-5849(96)00550-3; STONE KK, 1994, ENVIRON HEALTH PERSP, V102, P173, DOI 10.2307/3432235; Sugiura H, 2008, ANTIOXID REDOX SIGN, V10, P785, DOI 10.1089/ars.2007.1937; Swindle EJ, 2009, J ALLERGY CLIN IMMUN, V124, P23, DOI 10.1016/j.jaci.2009.05.037; To T, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-293; van der Toorn M, 2009, AM J PHYSIOL-LUNG C, V297, pL109, DOI 10.1152/ajplung.90461.2008; van Wijk SJL, 2005, FREE RADICAL BIO MED, V39, P81, DOI 10.1016/j.freeadbiomed.2005.03.021; Wark PAB, 2005, J EXP MED, V201, P937, DOI 10.1084/jem.20041901; Wood LG, 2010, ANTIOXID REDOX SIGN, V13, P1535, DOI 10.1089/ars.2009.3064; Wood LG, 2010, BRIT J NUTR, V103, P735, DOI 10.1017/S0007114509992376; Xiao C, 2011, J ALLERGY CLIN IMMUN, V128, P549, DOI 10.1016/j.jaci.2011.05.038; Yu SW, 2002, SCIENCE, V297, P259, DOI 10.1126/science.1072221	45	14	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0120510	10.1371/journal.pone.0120510	http://dx.doi.org/10.1371/journal.pone.0120510			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25793769	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000352083900044
J	Jia, YH; Zheng, Z; Wang, YC; Zhou, Q; Cai, WX; Jia, WB; Yang, LL; Dong, ML; Zhu, XX; Su, LL; Hu, DH				Jia, Yanhui; Zheng, Zhao; Wang, Yunchuan; Zhou, Qin; Cai, Weixia; Jia, Wenbin; Yang, Longlong; Dong, Maolong; Zhu, Xiongxiang; Su, Linlin; Hu, Dahai			SIRT1 Is a Regulator in High Glucose-Induced Inflammatory Response in RAW264.7 Cells	PLOS ONE			English	Article							NF-KAPPA-B; NITRIC-OXIDE SYNTHASE; TNF-ALPHA; INHIBITION; PATHWAY; DISEASE; PROTEIN; SEPSIS; LIPOPOLYSACCHARIDE; INACTIVATION	Sepsis is defined as a systemic inflammatory response syndrome that disorders the functions of host immune system, including the imbalance between pro-and anti-inflammatory responses mediated by immune macrophages. Sepsis could also induce acute hyperglycemia. Studies have shown that the silent mating type information regulation 2 homolog 1 (SIRT1), an NAD(+)-dependent deacetylase, mediates NF-kappa b deacetylation and inhibits its function. Therefore, SIRT1 is likely to play an important role in high glucose-mediated inflammatory signalings. Here we demonstrate that high glucose significantly downregulates both the mRNA and protein levels of SIRT1 and upregulates the mRNA level and the release of two pro-inflammatory cytokines, IL-1 beta and TNF-alpha, in RAW264.7 macrophages. Interestingly, the reduced level of SIRT1 by high glucose is remarkably upregulated by SIRT1 activator SRT1720, while the level and the release of IL-1 beta and TNF-alpha significantly decrease with the use of SRT1720. However, when the function of SIRT1 is inhibited by EX527 or its expression is suppressed by RNAi, the upregulated level and release of IL-1 beta and TNF-alpha by high glucose are further increased. Taken together, these findings collectively suggest that SIRT1 is an important regulator in many high glucose-related inflammatory diseases such as sepsis.	[Jia, Yanhui; Zheng, Zhao; Wang, Yunchuan; Zhou, Qin; Cai, Weixia; Jia, Wenbin; Yang, Longlong; Dong, Maolong; Zhu, Xiongxiang; Su, Linlin; Hu, Dahai] Fourth Mil Med Univ, Xijing Hosp, Dept Burns & Cutaneous Surg, Xian 710032, Shaanxi, Peoples R China	Air Force Military Medical University	Su, LL (corresponding author), Fourth Mil Med Univ, Xijing Hosp, Dept Burns & Cutaneous Surg, Xian 710032, Shaanxi, Peoples R China.	linlinsu@fmmu.edu.cn; hudhai@fmmu.edu.cn		Hu, Dahai/0000-0001-5543-092X; /0000-0002-3640-6729	National Natural Science Foundation of China (NSFC) [81372069, 81272084, 81372055]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (NSFC) to Dahai Hu (81372069), Xiongxiang Zhu (81272084) and Maolong Dong (81372055). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Centeno-Baez C, 2011, AM J PHYSIOL-ENDOC M, V301, pE922, DOI 10.1152/ajpendo.00530.2010; Chung EY, 2003, PLANTA MED, V69, P710, DOI 10.1055/s-2003-42787; Cohen J, 2002, NATURE, V420, P885, DOI 10.1038/nature01326; De Simone R, 2010, CHEM BIOL DRUG DES, V76, P17, DOI 10.1111/j.1747-0285.2010.00984.x; Dong J, 2010, GENE DEV, V24, P1709, DOI 10.1101/gad.1958410; Hotchkiss RS, 2010, NEW ENGL J MED, V363, P87, DOI 10.1056/NEJMcibr1004371; Ichikawa T, 2013, RESPIROLOGY, V18, P332, DOI 10.1111/j.1440-1843.2012.02284.x; Jungo F, 2001, CYTOKINE, V14, P272, DOI 10.1006/cyto.2001.0884; Kauppinen A, 2013, CELL SIGNAL, V25, P1939, DOI 10.1016/j.cellsig.2013.06.007; Liu TF, 2012, J BIOL CHEM, V287, P25758, DOI 10.1074/jbc.M112.362343; Liu TF, 2011, J BIOL CHEM, V286, P9856, DOI 10.1074/jbc.M110.196790; Luan RH, 2009, CARDIOVASC RES, V83, P294, DOI 10.1093/cvr/cvp085; Ma J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097985; Mortuza R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054514; Murakami A, 2003, CANCER LETT, V195, P17, DOI 10.1016/S0304-3835(03)00058-2; Peng CM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079739; Purushotham A, 2009, CELL METAB, V9, P327, DOI 10.1016/j.cmet.2009.02.006; Rai E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048621; Rajendrasozhan S, 2008, AM J RESP CRIT CARE, V177, P861, DOI 10.1164/rccm.200708-1269OC; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Shen Z, 2009, AM J PHYSIOL-GASTR L, V296, pG1047, DOI 10.1152/ajpgi.00016.2009; Takeda-Watanabe A, 2012, BIOCHEM BIOPH RES CO, V427, P191, DOI 10.1016/j.bbrc.2012.09.042; Vachharajani VT, 2014, J LEUKOCYTE BIOL, V96, P785, DOI 10.1189/jlb.3MA0114-034RR; Vachharajani VT, 2014, J LEUKOC BIOL; Wang Y, 2013, INVEST OPHTH VIS SCI, V54, P3806, DOI 10.1167/iovs.13-12091; Winnik S, 2012, CURR VASC PHARMACOL, V10, P693, DOI 10.2174/157016112803520756; Xu KP, 2009, DIABETES, V58, P1077, DOI 10.2337/db08-0997; Yang HY, 2013, J BIOL CHEM, V288, P37256, DOI 10.1074/jbc.M113.527531; Yang HH, 2012, SCI WORLD J, P1, DOI 10.1100/2012/149132; Yang ZG, 2010, J BIOL CHEM, V285, P19051, DOI 10.1074/jbc.M110.123620; Yeung F, 2004, EMBO J, V23, P2369, DOI 10.1038/sj.emboj.7600244; Yi CO, 2011, ANAT CELL BIOL, V44, P194, DOI 10.5115/acb.2011.44.3.194; Yoo CH, 2014, SCI REP-UK, V4, DOI 10.1038/srep04220; Yoshizaki T, 2010, AM J PHYSIOL-ENDOC M, V298, pE419, DOI 10.1152/ajpendo.00417.2009; Yoshizaki T, 2009, MOL CELL BIOL, V29, P1363, DOI 10.1128/MCB.00705-08; Zhang FX, 1999, J BIOL CHEM, V274, P7611, DOI 10.1074/jbc.274.12.7611	36	36	39	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0120849	10.1371/journal.pone.0120849	http://dx.doi.org/10.1371/journal.pone.0120849			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25793995	Green Published, Green Submitted, gold			2022-12-27	WOS:000352083900081
J	Ni, I; Ji, C; Vij, N				Ni, Inzer; Ji, Changhoon; Vij, Neeraj			Second-Hand Cigarette Smoke Impairs Bacterial Phagocytosis in Macrophages by Modulating CFTR Dependent Lipid-Rafts	PLOS ONE			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; OBSTRUCTIVE PULMONARY-DISEASE; AIRWAY EPITHELIAL-CELLS; PSEUDOMONAS-AERUGINOSA INFECTIONS; COMPLEMENT-MEDIATED PHAGOCYTOSIS; PROINFLAMMATORY CYTOKINE RELEASE; SMALL-MOLECULE MODULATOR; CYSTIC-FIBROSIS; ALVEOLAR MACROPHAGES; BIOFILM FORMATION	Introduction First/Second-hand cigarette-smoke (FHS/SHS) exposure weakens immune defenses inducing chronic obstructive pulmonary disease (COPD) but the underlying mechanisms are not fully understood. Hence, we evaluated if SHS induced changes in membrane/lipid-raft (m-/r)-CFTR (cystic fibrosis transmembrane conductance regulator) expression/activity is a potential mechanism for impaired bacterial phagocytosis in COPD. Methods RAW264.7 murine macrophages were exposed to freshly prepared CS-extract (CSE) containing culture media and/or Pseudomonas-aeruginosa-PA01-GFP for phagocytosis (fluorescence-microscopy), bacterial survival (colony-forming-units-CFU), and immunoblotting assays. The CFTR-expression/activity and lipid-rafts were modulated by transienttransfection or inhibitors/inducers. Next, mice were exposed to acute/sub-chronic-SHS or room-air (5-days/3-weeks) and infected with PA01-GFP, followed by quantification of bacterial survival by CFU-assay. Results We investigated the effect of CSE treatment on RAW264.7 cells infected by PA01-GFP and observed that CSE treatment significantly (p<0.01) inhibits PA01-GFP phagocytosis as compared to the controls. We also verified this in murine model, exposed to acute/subchronic-SHS and found significant (p<0.05, p<0.02) increase in bacterial survival in the SHS-exposed lungs as compared to the room-air controls. Next, we examined the effect of impaired CFTR ion-channel-activity on PA01-GFP infection of RAW264.7 cells using CFTR172-inhibitor and found no significant change in phagocytosis. We also similarly evaluated the effect of a CFTR corrector-potentiator compound, VRT-532, and observed no significant rescue of CSE impaired PA01-GFP phagocytosis although it significantly (p < 0.05) decreases CSE induced bacterial survival. Moreover, induction of CFTR expression in macrophages significantly (p<0.03) improves CSE impaired PA01-GFP phagocytosis as compared to the control. Next, we verified the link between m-/r-CFTR expression and phagocytosis using methyl-beta-cyclodextran (CD), as it is known to deplete CFTR from membrane lipid-rafts. We observed that CD treatment significantly (p<0.01) inhibits bacterial phagocytosis in RAW264.7 cells and adding CSE further impairs phagocytosis suggesting synergistic effect on CFTR dependent lipid-rafts. Conclusion Our data suggest that SHS impairs bacterial phagocytosis by modulating CFTR dependent lipid-rafts.	[Ni, Inzer; Ji, Changhoon; Vij, Neeraj] Johns Hopkins Univ, Sch Med, Dept Pediat Resp Sci, Baltimore, MD 21205 USA; [Ni, Inzer; Ji, Changhoon] Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Baltimore, MD 21205 USA; [Vij, Neeraj] Cent Michigan Univ, Coll Med, Dept Fdn Sci, Mt Pleasant, MI 48859 USA	Johns Hopkins University; Johns Hopkins University; Central Michigan University	Vij, N (corresponding author), Johns Hopkins Univ, Sch Med, Dept Pediat Resp Sci, Baltimore, MD 21205 USA.	neeraj.vij@cmich.edu			Flight Attendant Medical Research Institute's (FAMRI), Young Clinical Scientist Award (YCSA); other National Institute of Health (NIH) [U54CA141868, R01HL59410-04]; NATIONAL CANCER INSTITUTE [R43CA141868] Funding Source: NIH RePORTER	Flight Attendant Medical Research Institute's (FAMRI), Young Clinical Scientist Award (YCSA); other National Institute of Health (NIH); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by the Flight Attendant Medical Research Institute's (FAMRI), Young Clinical Scientist Award (YCSA) to NV. NV was also supported by other National Institute of Health (NIH, U54CA141868 and R01HL59410-04) grants during this period. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagaitkar Juhi, 2008, Tob Induc Dis, V4, P12, DOI 10.1186/1617-9625-4-12; Bajmoczi M, 2009, AM J PHYSIOL-CELL PH, V297, pC263, DOI 10.1152/ajpcell.00527.2008; Ballok AE, 2013, J BACTERIOL, V195, P4013, DOI 10.1128/JB.00339-13; Barnes PJ, 2007, PLOS MED, V4, P779, DOI 10.1371/journal.pmed.0040112; Barnes Peter J, 2004, COPD, V1, P59, DOI 10.1081/COPD-120028701; Barriere H, 2009, MOL BIOL CELL, V20, P3125, DOI 10.1091/mbc.E09-01-0061; Bodas M, 2011, AM J PHYSIOL-LUNG C, V300, pL811, DOI 10.1152/ajplung.00408.2010; Bodas M, 2011, J IMMUNOL, V186, P602, DOI 10.4049/jimmunol.1002850; Bomberger JM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001325; Caci E, 2008, BIOCHEM J, V413, P135, DOI 10.1042/BJ20080029; Cantin AM, 2006, AM J PHYSIOL-CELL PH, V290, pC262, DOI 10.1152/ajpcell.00070.2005; Cantin AM, 2006, AM J RESP CRIT CARE, V173, P1139, DOI 10.1164/rccm.200508-1330OC; Chiaw PK, 2010, MOL PHARMACOL, V78, P411, DOI 10.1124/mol.110.065862; Childers M, 2007, MED HYPOTHESES, V68, P101, DOI 10.1016/j.mehy.2006.06.020; Cholon DM, 2010, AM J PHYSIOL-LUNG C, V298, pL304, DOI 10.1152/ajplung.00016.2009; Clunes LA, 2012, FASEB J, V26, P533, DOI 10.1096/fj.11-192377; Del Porto P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019970; Deriy LV, 2009, J BIOL CHEM, V284, P35926, DOI 10.1074/jbc.M109.057372; Deziel E, 2001, J BACTERIOL, V183, P1195, DOI 10.1128/JB.183.4.1195-1204.2001; Di A, 2006, NAT CELL BIOL, V8, P933, DOI 10.1038/ncb1456; Dockrell DH, 2003, J IMMUNOL, V171, P5380, DOI 10.4049/jimmunol.171.10.5380; Donnelly LE, 2012, CHEST, V141, P1055, DOI 10.1378/chest.11-2348; Donova MV, 2007, MICROBIOL-SGM, V153, P1981, DOI 10.1099/mic.0.2006/001636-0; Drannik AG, 2004, AM J RESP CRIT CARE, V170, P1164, DOI 10.1164/rccm.200311-1521OC; Dransfield MT, 2013, CHEST, V144, P498, DOI 10.1378/chest.13-0274; Filosto S, 2011, AM J RESP CELL MOL, V44, P350, DOI 10.1165/rcmb.2009-0422OC; Goldberg JB, 2000, TRENDS MICROBIOL, V8, P514, DOI 10.1016/S0966-842X(00)01872-2; GREEN GM, 1967, NEW ENGL J MED, V276, P421, DOI 10.1056/NEJM196702232760801; Hodge S, 2003, IMMUNOL CELL BIOL, V81, P289, DOI 10.1046/j.1440-1711.2003.t01-1-01170.x; Hodge S, 2007, AM J RESP CELL MOL, V37, P748, DOI 10.1165/rcmb.2007-0025OC; Hunter MJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011598; Huvenne W, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-69; Johannesson B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044059; Kode A, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-132; Kowalski MP, 2004, J IMMUNOL, V172, P418, DOI 10.4049/jimmunol.172.1.418; Kreindler JL, 2005, AM J PHYSIOL-LUNG C, V288, pL894, DOI 10.1152/ajplung.00376.2004; LAURENZI GA, 1963, SCIENCE, V142, P1572, DOI 10.1126/science.142.3599.1572; Li CY, 2010, CANCER LETT, V292, P246, DOI 10.1016/j.canlet.2009.12.009; Lopez AD, 2006, EUR RESPIR J, V27, P397, DOI 10.1183/09031936.06.00025805; MacEachran DP, 2007, INFECT IMMUN, V75, P3902, DOI 10.1128/IAI.00338-07; Marin L, 2011, EXPERT OPIN DRUG DEL, V8, P1205, DOI 10.1517/17425247.2011.588697; Martinez-Solano L, 2008, CLIN INFECT DIS, V47, P1526, DOI 10.1086/593186; Min T, 2011, J MOL MED, V89, P577, DOI 10.1007/s00109-011-0732-8; Minematsu N, 2011, AM J RESP CELL MOL, V44, P474, DOI 10.1165/rcmb.2009-0463OC; Moodie FM, 2004, FASEB J, V18, P1897, DOI 10.1096/fj.04-1506fje; Moreau-Marquis S, 2008, PULM PHARMACOL THER, V21, P595, DOI 10.1016/j.pupt.2007.12.001; Murphy TF, 2008, AM J RESP CRIT CARE, V177, P853, DOI 10.1164/rccm.200709-1413OC; Pasyk S, 2009, BIOCHEM J, V418, P185, DOI 10.1042/BJ20081424; Phipps JC, 2010, INFECT IMMUN, V78, P1214, DOI 10.1128/IAI.00963-09; Pier GB, 1997, P NATL ACAD SCI USA, V94, P12088, DOI 10.1073/pnas.94.22.12088; Pier GB, 2000, P NATL ACAD SCI USA, V97, P8822, DOI 10.1073/pnas.97.16.8822; Pyle LC, 2010, AM J RESP CELL MOL, V43, P607, DOI 10.1165/rcmb.2009-0281OC; Radtke AL, 2005, P NATL ACAD SCI USA, V108, P1633; Rennolds J, 2010, TOXICOL SCI, V116, P349, DOI 10.1093/toxsci/kfq101; Schroeder TH, 2002, P NATL ACAD SCI USA, V99, P6907, DOI 10.1073/pnas.092160899; Sethi Sanjay, 2009, Proc Am Thorac Soc, V6, P532, DOI 10.1513/pats.200905-025DS; Singh PK, 2000, NATURE, V407, P762, DOI 10.1038/35037627; Sopori M, 2002, NAT REV IMMUNOL, V2, P372, DOI 10.1038/nri803; Su YC, 1998, AM J RESP CELL MOL, V19, P819, DOI 10.1165/ajrcmb.19.5.3091; Swiatecka-Urban A, 2006, AM J PHYSIOL-CELL PH, V290, pC862, DOI 10.1152/ajpcell.00108.2005; Taylor AE, 2010, EUR RESPIR J, V35, P1039, DOI 10.1183/09031936.00036709; THOMAS WR, 1978, INFECT IMMUN, V20, P468, DOI 10.1128/IAI.20.2.468-475.1978; Van de Weert-van Leeuwen PB, 2013, AM J RESP CELL MOL, V49, P463, DOI 10.1165/rcmb.2012-0502OC; Vij N, 2013, AM J RESP CRIT CARE, V187, P120, DOI 10.1164/rccm.201211-2011ED; Vij N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004664; Wang Y, 2007, J BIOL CHEM, V282, P33247, DOI 10.1074/jbc.C700175200; Wellhauser L, 2009, MOL PHARMACOL, V75, P1430, DOI 10.1124/mol.109.055608; Williams BJ, 2010, RESPIROLOGY, V15, P1037, DOI 10.1111/j.1440-1843.2010.01819.x; Xu YQ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011004; Zaidi T, 2008, INVEST OPHTH VIS SCI, V49, P1000, DOI 10.1167/iovs.07-0993; Zhang S, 2005, AM J RHINOL ALLERGY, V25, P307; Zhang Y, 2010, J IMMUNOL, V184, P5104, DOI 10.4049/jimmunol.0902851	72	38	38	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0121200	10.1371/journal.pone.0121200	http://dx.doi.org/10.1371/journal.pone.0121200			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25794013	Green Submitted, Green Published, gold			2022-12-27	WOS:000352083900109
J	Martinez, PRRD; Soares, MB				Romo de Vivar Martinez, Paula Rosario; Soares, Marina Bento			Dentary Morphological Variation in Clevosaurus brasiliensis (Rhynchocephalia, Clevosauridae) from the Upper Triassic of Rio Grande do Sul, Brazil	PLOS ONE			English	Article							SPHENODONTIAN DIAPSIDA LEPIDOSAURIA; FOSSIL RELATIVES; SKULL SHAPE; REPTILE; TOOTH; EUCYNODONTIA; PATAGONIA; PACKAGE; ORIGIN; RECORD	Clevosaurus was a cosmopolitan rhynchocephalian genus, known from the Late Triassic to the Early Jurassic. In South America this genus is represented by C. brasiliensis, an important component of the Linha Sao Luiz taphocoenosis, on the top of the Norian Santa Maria 2 Sequence of Southern Brazil. The best preserved and most abundant bone elements of C. brasiliensis are dentaries, in which variations of shape and size are observed. The aim of this study is to describe and evaluate the variation, using geometric morphometrics methods. Geometric morphometric analysis of 10 specimens highlights variations in relative size of the dentary. Most of the variation observed for PC1 (83.3%) is likely related to ontogeny, and PC2 (10.0%) is likely related to taphonomic signatures. The development patterns observed, such as the growth of the dentary, consists of differential growth in length between the posterior portion of the dentary, that grows at a higher rate, regarding the anterior portion of the element. This allometric growth is similar to what is observed in other rhynchocephalians and is accompanied by the allometric skull growth, similar to the trend exhibited by clevosaurs. The taphocoenosis is bimodal (juveniles and adults) with a bias towards adult preservation. Some diagenetic influence is reflected in deformed skulls and this is observed in the tangent-plot. Finally, a strong correlation was detected between the taphonomic signatures and the PC2, regarding specially disarticulation and degree of fragmentation.	[Romo de Vivar Martinez, Paula Rosario; Soares, Marina Bento] Univ Fed Rio Grande do Sul, Inst Geociencias, Dept Paleontol & Estratig, Lab Paleontol Vertebrados, Porto Alegre, RS, Brazil	Universidade Federal do Rio Grande do Sul	Martinez, PRRD (corresponding author), Univ Fed Rio Grande do Sul, Inst Geociencias, Dept Paleontol & Estratig, Lab Paleontol Vertebrados, Porto Alegre, RS, Brazil.	paulaoirasor@gmail.com	Soares, Marina Bento/M-9477-2017; Soares, Marina/AAN-8513-2020	Soares, Marina Bento/0000-0002-8393-2406; Soares, Marina/0000-0002-8393-2406; Romo de Vivar Martinez, Paulo R./0000-0002-4959-6349	CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior); CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico)	CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The authors thank CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior) for financial support (PRM) and CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico) for MBS financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams DC, 2013, HYSTRIX, V24, P7, DOI 10.4404/hystrix-24.1-6283; Adams DC, 2013, METHODS ECOL EVOL, V4, P393, DOI 10.1111/2041-210X.12035; Apesteguia S, 2003, NATURE, V425, P609, DOI 10.1038/nature01995; Apesteguia S, 2014, J VERTEBR PALEONTOL, V34, P303, DOI 10.1080/02724634.2013.803974; Apesteguia S, 2012, ZOOL J LINN SOC-LOND, V166, P342, DOI 10.1111/j.1096-3642.2012.00837.x; Arantes BD, 2009, REV BRAS PALEONTOLOG, V12, P43, DOI 10.4072/rbp.2009.1.04; Arbour J, 2013, LOST 1 0; Behrensmeyer Anna K., 1992, P15; Bonaparte J.F., 2007, Historical Biology, V19, P73, DOI 10.1080/08912960600866862; Bonaparte JF, 2001, PALAEONTOLOGY, V44, P623, DOI 10.1111/1475-4983.00194; Bonaparte Jose F., 2005, Revista Brasileira de Paleontologia, V8, P25; Bonaparte JF, 2006, PALAEONTOLOGY, V49, P917, DOI 10.1111/j.1475-4983.2006.00568.x; Bonaparte Jose F., 2003, Revista Brasileira de Paleontologia, V5, P5; Bonaparte JF, 2010, REV BRAS PALEONTOLOG, V13, P233, DOI 10.4072/rbp.2010.3.07; Bonaparte Jose F., 1999, National Science Museum Monographs, V15, P89; Brown CM, 2012, SYST BIOL, V61, P941, DOI 10.1093/sysbio/sys047; Campione NE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025186; Cisneros JC, 2003, NEUES JAHRB GEOL P-A, V227, P365; Costa da Silva R, 2012, J S AM EARTH SCI, V39, P16; Dendy A., 1899, Q J MICROSC SCI, Vs2-42, P1, DOI 10.1242/jcs.s2-42.165.1; Drake AG, 2008, P ROY SOC B-BIOL SCI, V275, P71, DOI 10.1098/rspb.2007.1169; Evans SE, 2010, NEW ASPECTS MESOZOIC, P27, DOI [DOI 10.1007/978-3-642-10311-7_2, DOI 10.1007/978-3-642-10311-7]; Farina RA, 2001, ACTA PALAEONTOL POL, V46, P219; Ferigolo J., 2000, PALEONTOLOGIA RIO GR, P236; Ferigolo J, 2009, VERTEBRADOS FOSSEIS, P89, DOI [10.1371/journal.pone.0116716, DOI 10.1371/JOURNAL.PONE.0116716]; Foth C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072007; FRASER NC, 1988, PHILOS T ROY SOC B, V321, P125, DOI 10.1098/rstb.1988.0092; FRASER NC, 1983, PALAEOGEOGR PALAEOCL, V42, P341, DOI 10.1016/0031-0182(83)90031-7; FRASER NC, 1986, PALAEONTOLOGY, V29, P165; Gradstein FM, 2012, GEOLOGIC TIME SCALE 2012, VOLS 1 & 2, P1; Harrison HS, 1901, ANAT ANZEIGER, V20, P145; Hedrick BP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069265; Herrel A, 2009, COPEIA, P727, DOI 10.1643/CG-08-136; Hoffstetter R, 1953, B MUSEUM, V25, P145; Holz M, 1998, LETHAIA, V31, P335; Howes G.B., 1901, T ZOOL SOC LONDON, V16, P1, DOI [10.1111/j.1096-3642.1901.tb00026.x, DOI 10.1111/J.1096-3642.1901.TB00026.X]; Humphries ED, 2010, J VERTEBR PALEONTOL, V2010, P108; Jones MEH, 2009, FRONT ORAL BIOL, V13, P9, DOI 10.1159/000242382; Jones Marc E.H., 2006, P55; Jones MEH, 2008, J MORPHOL, V269, P945, DOI 10.1002/jmor.10634; Jones MEH, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-208; Jones Marc E.H., 2006, Bulletin of the New Mexico Museum of Natural History and Science, V37, P548; Jones MEH, 2009, J ROY SOC NEW ZEAL, V39, P71, DOI 10.1080/03014220909510565; Kidwell SM, 2002, ANNU REV ECOL SYST, V33, P561, DOI 10.1146/annurev.ecolsys.33.030602.152151; Martinelli AG, 2005, AMEGHINIANA, V42, P191; Martinez RN, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.2057; Maxwell EE, 2013, PALEOBIOLOGY, V39, P123, DOI 10.1666/0094-8373-39.1.123; Meloro C, 2012, J EVOLUTION BIOL, V25, P2194, DOI 10.1111/j.1420-9101.2012.02595.x; Meloro C, 2012, BIOL J LINN SOC, V106, P70, DOI 10.1111/j.1095-8312.2011.01843.x; Mitteroecker P, 2004, J HUM EVOL, V46, P679, DOI 10.1016/j.jhevol.2004.03.006; Oba S, 2003, BIOINFORMATICS, V19, P2088, DOI 10.1093/bioinformatics/btg287; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Rauhut OWM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046839; Renesto S, 1955, MOD GEOL, V20, P149; Reynoso V.-H., 2014, DINOSAURS OTHER REPT, P4; Reynoso VH, 2003, CAN J EARTH SCI, V40, P609, DOI 10.1139/E02-097; Reynoso VH, 1997, J VERTEBR PALEONTOL, V17, P52, DOI 10.1080/02724634.1997.10010953; Reynoso VH, 1996, J VERTEBR PALEONTOL, V16, P210, DOI 10.1080/02724634.1996.10011309; Robinson P.L., 1976, Linnean Soc Symp Ser, V3, P43; Rohlf F. J., 2013, TPSDIG 2 17; Saila LK, 2005, PALAEONTOLOGY, V48, P817, DOI 10.1111/j.1475-4983.2005.00486.x; Soares M.B., 2013, INT S PTER RIO PTER, V50, P95; Soares MB, 2011, AN ACAD BRAS CIENC, V83, P329, DOI 10.1590/S0001-37652011000100021; Stacklies W, 2013, PCA METHODS; Stacklies W, 2007, BIOINFORMATICS, V23, P1164, DOI 10.1093/bioinformatics/btm069; SUES HD, 1995, J PALEONTOL, V69, P123, DOI 10.1017/S0022336000026974; Uetz P., REPTILE DATABASE; Vincent SE, 2007, INTEGR COMP BIOL, V47, P172, DOI 10.1093/icb/icm019; Wu XC, 1999, SHADOW DINOSAURS EAR, P38; Zeldicht ML, 2004, GEOMETRIC MORPHOMETR; Zerfass H, 2004, SEDIMENT GEOL, V166, P265, DOI 10.1016/j.sedgeo.2003.12.008; Zerfass H, 2003, SEDIMENT GEOL, V161, P85, DOI 10.1016/S0037-0738(02)00397-4	72	10	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0119307	10.1371/journal.pone.0119307	http://dx.doi.org/10.1371/journal.pone.0119307			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25793754	Green Published, gold			2022-12-27	WOS:000352084200072
J	Sakurai, G; Yonemura, S; Kishimoto-Mo, AW; Murayama, S; Ohtsuka, T; Yokozawa, M				Sakurai, Gen; Yonemura, Seiichiro; Kishimoto-Mo, Ayaka W.; Murayama, Shohei; Ohtsuka, Toshiyuki; Yokozawa, Masayuki			Inversely Estimating the Vertical Profile of the Soil CO2 Production Rate in a Deciduous Broadleaf Forest Using a Particle Filtering Method	PLOS ONE			English	Article							TEMPERATURE SENSITIVITY; CARBON DECOMPOSITION; RESPIRATION; MODEL; EFFLUX; TRANSPORT; ROOT	Carbon dioxide (CO2) efflux from the soil surface, which is a major source of CO2 from terrestrial ecosystems, represents the total CO2 production at all soil depths. Although many studies have estimated the vertical profile of the CO2 production rate, one of the difficulties in estimating the vertical profile is measuring diffusion coefficients of CO2 at all soil depths in a nondestructive manner. In this study, we estimated the temporal variation in the vertical profile of the CO2 production rate using a data assimilation method, the particle filtering method, in which the diffusion coefficients of CO2 were simultaneously estimated. The CO2 concentrations at several soil depths and CO2 efflux from the soil surface (only during the snow-free period) were measured at two points in a broadleaf forest in Japan, and the data were assimilated into a simple model including a diffusion equation. We found that there were large variations in the pattern of the vertical profile of the CO2 production rate between experiment sites: the peak CO2 production rate was at soil depths around 10 cm during the snow-free period at one site, but the peak was at the soil surface at the other site. Using this method to estimate the CO2 production rate during snow-cover periods allowed us to estimate CO2 efflux during that period as well. We estimated that the CO2 efflux during the snow-cover period (about half the year) accounted for around 13% of the annual CO2 efflux at this site. Although the method proposed in this study does not ensure the validity of the estimated diffusion coefficients and CO2 production rates, the method enables us to more closely approach the "actual" values by decreasing the variance of the posterior distribution of the values.	[Sakurai, Gen; Yonemura, Seiichiro; Kishimoto-Mo, Ayaka W.] Natl Inst Agroenvironm Sci, Tsukuba, Ibaraki 305, Japan; [Murayama, Shohei] Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki, Japan; [Ohtsuka, Toshiyuki] Gifu Univ, River Basin Res Ctr, Gifu, Gifu, Japan; [Yokozawa, Masayuki] Shizuoka Univ, Grad Sch Engn, Hamamatsu, Shizuoka 4328561, Japan	National Institute for Agro-Environmental Sciences (NIAES) Japan; National Institute of Advanced Industrial Science & Technology (AIST); Gifu University; Shizuoka University	Yokozawa, M (corresponding author), Shizuoka Univ, Grad Sch Engn, Hamamatsu, Shizuoka 4328561, Japan.	yokozawa@sys.eng.shizuoka.ac.jp	Murayama, Shohei/L-2973-2018; Yokozawa, Masayuki/O-2829-2014; , 大塚俊之/V-6687-2019	Murayama, Shohei/0000-0003-1923-6059; Yokozawa, Masayuki/0000-0001-7053-2465; , 大塚俊之/0000-0002-9032-7933	Ministry of Education, Culture, Sports, Science and Technology of Japan [23119520, 70452737]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported by Grants-in-Aid for Scientific Research in Innovative Areas from the Ministry of Education, Culture, Sports, Science and Technology of Japan (no. 23119520 to M.Y. and no. 70452737 to G.S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bauer J, 2012, BIOGEOCHEMISTRY, V108, P119, DOI 10.1007/s10533-011-9583-1; Breecker DO, 2012, ECOSYSTEMS, V15, P83, DOI 10.1007/s10021-011-9495-x; Candy J.V., 2009, ADAPTIVE LEARNING SY; Cook FJ, 1998, ECOL MODEL, V109, P155, DOI 10.1016/S0304-3800(98)00034-9; Davidson EA, 2006, NATURE, V440, P165, DOI 10.1038/nature04514; Davidson EA, 2006, GLOBAL CHANGE BIOL, V12, P944, DOI 10.1111/j.1365-2486.2005.01142.x; Hashimoto S, 2007, J FOREST RES-JPN, V12, P209, DOI 10.1007/s10310-007-0009-9; Hendry MJ, 1999, WATER RESOUR RES, V35, P2189, DOI 10.1029/1999WR900060; Hirano T, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2003JD003766; Jassal R, 2005, AGR FOREST METEOROL, V130, P176, DOI 10.1016/j.agrformet.2005.03.005; Jassal RS, 2004, AGR FOREST METEOROL, V124, P219, DOI 10.1016/j.agrformet.2004.01.013; Kitagawa G, 1998, J AM STAT ASSOC, V93, P1203, DOI 10.2307/2669862; Lee MS, 2005, AGR FOREST METEOROL, V134, P95, DOI 10.1016/j.agrformet.2005.08.011; Liptzin D, 2009, BIOGEOCHEMISTRY, V95, P151, DOI 10.1007/s10533-009-9303-2; Mariko S, 2000, ECOL RES, V15, P363, DOI 10.1046/j.1440-1703.2000.00357.x; MILLINGTON R, 1961, T FARADAY SOC, V57, P1200, DOI 10.1039/tf9615701200; Mo W, 2005, AGR FOREST METEOROL, V134, P81, DOI 10.1016/j.agrformet.2005.08.015; Murayama S, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2009JD013626; Powers LD, 2009, BOUNDARY VALUE PROBL; Pumpanen J, 2003, SOIL SCI SOC AM J, V67, P402, DOI 10.2136/sssaj2003.0402; R Core Team, 2021, R LANGUAGE ENV STAT; Saigusa N, 2002, AGR FOREST METEOROL, V112, P203, DOI 10.1016/S0168-1923(02)00082-5; Sakurai G, 2012, SOIL BIOL BIOCHEM, V46, P191, DOI 10.1016/j.soilbio.2011.11.005; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; SUAREZ DL, 1993, WATER RESOUR RES, V29, P499, DOI 10.1029/92WR02226; Subke JA, 2006, GLOBAL CHANGE BIOL, V12, P921, DOI 10.1111/j.1365-2486.2006.01117.x; Tang JW, 2005, AGR FOREST METEOROL, V132, P212, DOI 10.1016/j.agrformet.2005.07.011; Vargas R, 2008, VADOSE ZONE J, V7, P1055, DOI 10.2136/vzj2007.0138; Vargas R, 2010, GLOBAL CHANGE BIOL, V16, P1589, DOI 10.1111/j.1365-2486.2009.02111.x; von Lutzow M, 2009, BIOL FERT SOILS, V46, P1, DOI 10.1007/s00374-009-0413-8; Western AW, 2002, ANNU REV EARTH PL SC, V30, P149, DOI 10.1146/annurev.earth.30.091201.140434; Yasuda Y, 2012, J FOREST RES-JPN, V17, P253, DOI 10.1007/s10310-011-0298-x; Yonemura S, 2013, J FOREST RES-JPN, V18, P49, DOI 10.1007/s10310-012-0385-7; Yonemura Seiiehiro, 2009, Journal of Agricultural Meteorology, V65, P141	34	2	2	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0119001	10.1371/journal.pone.0119001	http://dx.doi.org/10.1371/journal.pone.0119001			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25793387	Green Submitted, Green Published, gold			2022-12-27	WOS:000352084200051
J	Santoro, FR; Ferreira, WS; Araujo, TAD; Ladio, AH; Albuquerque, UP				Santoro, Flavia Rosa; Ferreira Junior, Washington Soares; de Souza Araujo, Thiago Antonio; Haydee Ladio, Ana; Albuquerque, Ulysses Paulino			Does Plant Species Richness Guarantee the Resilience of Local Medical Systems? A Perspective from Utilitarian Redundancy	PLOS ONE			English	Article							MEDICINAL-PLANTS; KNOWLEDGE; MEMORY	Resilience is related to the ability of a system to adjust to disturbances. The Utilitarian Redundancy Model has emerged as a tool for investigating the resilience of local medical systems. The model determines the use of species richness for the same therapeutic function as a facilitator of the maintenance of these systems. However, predictions generated from this model have not yet been tested, and a lack of variables exists for deeper analyses of resilience. This study aims to address gaps in the Utilitarian Redundancy Model and to investigate the resilience of two medical systems in the Brazilian semi-arid zone. As a local illness is not always perceived in the same way that biomedicine recognizes, the term "therapeutic targets" is used for perceived illnesses. Semi-structured interviews with local experts were conducted using the free-listing technique to collect data on known medicinal plants, usage preferences, use of redundant species, characteristics of therapeutic targets, and the perceived severity for each target. Additionally, participatory workshops were conducted to determine the frequency of targets. The medical systems showed high species richness but low levels of species redundancy. However, if redundancy was present, it was the primary factor responsible for the maintenance of system functions. Species richness was positively associated with therapeutic target frequencies and negatively related to target severity. Moreover, information about redundant species seems to be largely idiosyncratic; this finding raises questions about the importance of redundancy for resilience. We stress the Utilitarian Redundancy Model as an interesting tool to be used in studies of resilience, but we emphasize that it must consider the distribution of redundancy in terms of the treatment of important illnesses and the sharing of information. This study has identified aspects of the higher and lower vulnerabilities of medical systems, adding variables that should be considered along with richness and redundancy.	[Santoro, Flavia Rosa; Ferreira Junior, Washington Soares; de Souza Araujo, Thiago Antonio; Albuquerque, Ulysses Paulino] Univ Fed Rural Pernambuco, Dept Biol, Lab Appl & Theoret Ethnobiol, Recife, PE, Brazil; [Haydee Ladio, Ana] Univ Nacl Comahue, CONICET, Ecotono Lab, San Carlos De Bariloche, Rio Negro, Argentina	Universidade Federal Rural de Pernambuco (UFRPE); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Universidad Nacional del Comahue	Santoro, FR (corresponding author), Univ Fed Rural Pernambuco, Dept Biol, Lab Appl & Theoret Ethnobiol, Recife, PE, Brazil.	flaviarsantoro@gmail.com; upa@db.ufrpe.br	Albuquerque, Ulysses P/I-5037-2012; Ladio, Ana Haydeé/W-2651-2019	Albuquerque, Ulysses P/0000-0002-8131-8429; Ladio, Ana/0000-0002-2844-6704	Improvement of Higher Education Personnel (CAPES); Pernambuco State Foundation for Science and Technology (FACEPE - APQ) [1264-2.05/10]; National Counsel of Technological and Scientific Development (CNPq) [Proc. 471989/2012-6]	Improvement of Higher Education Personnel (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Pernambuco State Foundation for Science and Technology (FACEPE - APQ); National Counsel of Technological and Scientific Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The authors would like to thank Coordination for the Improvement of Higher Education Personnel (CAPES), the Pernambuco State Foundation for Science and Technology (FACEPE - APQ - 1264-2.05/10), and the National Counsel of Technological and Scientific Development (CNPq - Proc. 471989/2012-6) for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albuquerque U.P., 2006, J ETHNOBIOL ETHNOMED, V2, P1, DOI DOI 10.1186/1746-4269-2-30; Albuquerque U. P., 2014, METHODS TECHNIQUES E, Vfirst, P1, DOI DOI 10.1007/978-1-4614-8636-7; Albuquerque UP, 2007, INTERCIENCIA, V27, P336; [Anonymous], 2007, WHO INT STAT CLASS D; AYRES M., 2007, BIOESTAT; BARRETT B, 1995, J COMMUN HEALTH, V20, P403, DOI 10.1007/BF02260437; Berkes F, 2002, CONSERV ECOL, V5; BOSTER JS, 1989, AM ANTHROPOL, V91, P866, DOI 10.1525/aa.1989.91.4.02a00040; BOYD R, 1995, ETHOL SOCIOBIOL, V16, P125, DOI 10.1016/0162-3095(94)00073-G; Brown KA, 2011, PLOS ONE, V6; Cavalli-Sforza LL., 1981, CULTURAL TRANSMISSIO; Albuquerque UP, 2007, J ETHNOPHARMACOL, V113, P156, DOI 10.1016/j.jep.2007.05.025; de Albuquerque UP, 2012, SCI WORLD J, DOI [10.1100/2012/205182, 10.1155/2012/202508]; de Medeiros PM, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/807452; Dunn F., 1976, ASIAN MEDICAL SYSTEM; Ferreira FS, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/126938; Ferreira WS, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/543207; Ferreira WS, 2013, ETHNOBIOL CONSERV, V2, DOI 10.15451/ec2013-8-2.1-1-10; Ferreira WS, 2011, J ETHNOPHARMACOL, V138, P238, DOI 10.1016/j.jep.2011.09.018; Ferreira Junior WS, 2013, ETNOBIOLOGIA BASES E, P63; FUNCEME IPECE, 2009, PERF BAS MUN CRAT FO; Greene S, 1998, AM ETHNOL, V25, P634, DOI 10.1525/ae.1998.25.4.634; Holling C.S., 1973, Annual Rev Ecol Syst, V4, P1, DOI 10.1146/annurev.es.04.110173.000245; Hopkins AL, 2012, ECON BOT, V66, P249, DOI 10.1007/s12231-012-9202-7; IUCN, 2013, IUCN RED LIST THREAT; Klein SB, 2002, PSYCHOL REV, V109, P306, DOI 10.1037//0033-295X.109.2.306; KLEINMAN A, 1978, SOC SCI MED-MED ANTH, V12, P85, DOI 10.1016/0160-7987(78)90014-5; Ladio AH, 2008, CURRENT TOPICS ETHNO, P39; Laland KN, 2004, LEARN BEHAV, V32, P4; Low B., 2003, NAVIGATING SOCIAL EC, P83; Medeiros PM, 2013, ETNOBIOLOGIA BASES E, P63; Mesoudi A., 2011, CULTURAL EVOLUTION D; Molares S, 2012, BIODIVERS CONSERV, V21, P1079, DOI 10.1007/s10531-012-0241-2; Nairne JS, 2008, J MEM LANG, V59, P377, DOI 10.1016/j.jml.2008.06.001; Salas-Zapata Walter A, 2012, Ecol. austral, V22, P74; Sieber S, 2014, METHODS TECHNIQUES E, P39, DOI [DOI 10.1007/978, 10.1007/978, DOI 10.1007/978-1-4614-8636-7]; Stewart K, 2009, FOREST ECOL MANAG, V258, P1121, DOI 10.1016/j.foreco.2009.05.039; Tanaka MM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005192; Tomasello Michael, 2003, CULTURAL ORIGINS HUM; Ungar M, 2012, SOCIAL ECOLOGY OF RESILIENCE: A HANDBOOK OF THEORY AND PRACTICE, P1, DOI 10.1007/978-1-4614-0586-3_1; Vandebroek I, 2010, ECON BOT, V64, P303, DOI 10.1007/s12231-010-9135-y; Walker B, 1999, ECOSYSTEMS, V2, P95, DOI 10.1007/s100219900062; WALKER BH, 1992, CONSERV BIOL, V6, P18, DOI 10.1046/j.1523-1739.1992.610018.x; Walker B, 2006, ECOL SOC, V11; Winter K, 2008, FUNC ECOSYST COMMUN, V2, P1	45	40	43	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0119826	10.1371/journal.pone.0119826	http://dx.doi.org/10.1371/journal.pone.0119826			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25793930	Green Published, Green Submitted, gold			2022-12-27	WOS:000352084200119
J	Yan, HD; Zhao, B; Kolkin, J; Li, ZJ; Chen, XL; Chu, TG; Gao, WY				Yan, Hede; Zhao, Bin; Kolkin, John; Li, Zhijie; Chen, Xinglong; Chu, Tinggang; Gao, Weiyang			The Management of Lower Extremity Multilevel Arterial Injuries: A 10-Year Experience	PLOS ONE			English	Article							COMPUTED TOMOGRAPHIC ANGIOGRAPHY; VASCULAR INJURY; RISK-FACTORS; LIMB LOSS; PHYSICAL-EXAMINATION; NATIONAL-TRAUMA; DIAGNOSIS; ARTERIOGRAPHY; ACCURACY; OUTCOMES	Background Limb amputation due to lower extremity arterial injury is not uncommon and multilevel arterial injury is even more limb-threatening and easily missed with potentially devastating consequences. There is limited information on multilevel arterial injuries. Purpose We undertook a review of our experience to gain insight on multilevel arterial injury patterns associated with lower extremity trauma and to analyze the results of management of such injuries with a special focus on the influence of initial diagnosis on limb salvage. Patients and Methods Between August 2002 and September 2012, 38 patients with lower extremity multilevel arterial injuries were reviewed, retrospectively. The injury patterns and amputation rates associated with initial diagnosis or misdiagnosis were analyzed. Results According to their injury levels, three multilevel arterial injury patterns were seen in this series: arterial injuries with the involvement of femoral artery and popliteal artery (pattern A), femoral artery and anterior or (and) posterior artery (pattern B), and popliteal artery and anterior or (and) posterior artery (pattern C). The general missed diagnosis rate was 31.6%. Pattern B had a much higher missed diagnosis rate than the other two patterns. The missed diagnosis rate was significantly correlated with the amputation rates (Odds Ratio = 10.7, 95% CI: 2.04-56.61). The definite diagnosis rate was only 14.8% using duplex ultrasonography examination. Conclusions Diagnosis of pattern B injury is more prone to be missed. DUS has low specificity in the detection of multilevel arterial injuries. Aggressive intraoperative exploration is considered to be valuable in the definitive diagnosis of highly suspected cases when other diagnostic tools are unavailable.	[Yan, Hede; Zhao, Bin; Li, Zhijie; Chen, Xinglong; Chu, Tinggang; Gao, Weiyang] Wenzhou Med Univ, Affiliated Hosp 2, Dept Orthopaed, Div Plast & Hand Surg, Wenzhou, Peoples R China; [Kolkin, John] Duke Raleigh Hosp, Dept Plast & Hand Surg, Raleigh, NC USA	Wenzhou Medical University	Gao, WY (corresponding author), Wenzhou Med Univ, Affiliated Hosp 2, Dept Orthopaed, Div Plast & Hand Surg, Wenzhou, Peoples R China.	wygao1@163.com			Natural Science Foundation of Zhejiang province [LY12H06003]; Health Department of Zhejiang province [201338025]	Natural Science Foundation of Zhejiang province(Natural Science Foundation of Zhejiang Province); Health Department of Zhejiang province	Funding: This study was supported by the Natural Science Foundation of Zhejiang province (Grant No. LY12H06003) and the funding of Health Department of Zhejiang province (201338025). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrikopoulos V, 1995, Cardiovasc Surg, V3, P15, DOI 10.1016/0967-2109(95)92895-O; Berne JD, 2006, J TRAUMA, V60, P1204, DOI 10.1097/01.ta.0000220435.55791.ce; Callcut RA, 2009, J TRAUMA, V67, P252, DOI 10.1097/TA.0b013e31819ea796; Davidovic LB, 2005, VASCULAR, V13, P141; Eastman AL, 2006, J TRAUMA, V60, P925, DOI 10.1097/01.ta.0000197479.28714.62; Franz RW, 2011, J VASC SURG, V53, P1604, DOI 10.1016/j.jvs.2011.01.052; Frykberg ER, 2002, SURG CLIN N AM, V82, P67, DOI 10.1016/S0039-6109(03)00141-5; FRYKBERG ER, 1991, J TRAUMA, V31, P502, DOI 10.1097/00005373-199104000-00009; Guerrero A, 2002, INJURY, V33, P765, DOI 10.1016/S0020-1383(01)00175-9; Hafez HM, 2001, J VASC SURG, V33, P1212, DOI 10.1067/mva.2001.113982; Halvorson JJ, 2011, J AM ACAD ORTHOP SUR, V19, P495, DOI 10.5435/00124635-201108000-00005; HUGHES CW, 1954, SURG GYNECOL OBSTET, V99, P91; Humphrey P W, 1994, Ann Vasc Surg, V8, P179, DOI 10.1007/BF02018867; Jens S, 2013, EUR J VASC ENDOVASC, V46, P329, DOI 10.1016/j.ejvs.2013.04.034; JOHANSEN KAJ, 1991, J TRAUMA, V31, P515, DOI 10.1097/00005373-199104000-00011; Kauvar DS, 2011, J VASC SURG, V53, P1598, DOI 10.1016/j.jvs.2011.01.056; Kohli Arvind, 2008, Asian Cardiovasc Thorac Ann, V16, P212; Kuzniec S, 1998, CARDIOVASC SURG, V6, P358, DOI 10.1016/S0967-2109(97)00166-X; Mullenix PS, 2006, J VASC SURG, V44, P94, DOI 10.1016/j.jvs.2006.02.052; Mutze S, 2005, RADIOLOGY, V237, P884, DOI 10.1148/radiol.2373042189; OGORMAN RB, 1984, ARCH SURG-CHICAGO, V119, P568; Patterson BO, 2012, BRIT J SURG, V99, P494, DOI 10.1002/bjs.7763; REYNOLDS RR, 1979, ANN SURG, V189, P700, DOI 10.1097/00000658-197906000-00005; Stannard JP, 2004, J BONE JOINT SURG AM, V86A, P910, DOI 10.2106/00004623-200405000-00004; Stewart DK, 2011, ANN VASC SURG, V25, DOI 10.1016/j.avsg.2010.03.035; Topal AE, 2010, VASC HEALTH RISK MAN, V6, P1103, DOI 10.2147/VHRM.S15316; Utter GH, 2006, J AM COLL SURGEONS, V203, P838, DOI 10.1016/j.jamcollsurg.2006.08.003; Wallin D, 2011, ANN VASC SURG, V25, P620, DOI 10.1016/j.avsg.2011.02.022; Zaraca F, 2011, MINERVA CHIR, V66, P397	29	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0121769	10.1371/journal.pone.0121769	http://dx.doi.org/10.1371/journal.pone.0121769			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25793506	Green Published, gold, Green Submitted			2022-12-27	WOS:000352083900149
J	Zwemer, CF; Davenport, RD; Gomez-Espina, J; Blanco-Gonzalez, E; Whitesall, SE; D'Alecy, LG				Zwemer, Charles F.; Davenport, Robertson D.; Gomez-Espina, Juan; Blanco-Gonzalez, Elisa; Whitesall, Steven E.; D'Alecy, Louis G.			Packed Red Blood Cells Are an Abundant and Proximate Potential Source of Nitric Oxide Synthase Inhibition	PLOS ONE			English	Article							ASYMMETRIC DIMETHYLARGININE ADMA; L-ARGININE; SYMMETRIC DIMETHYLARGININE; ENDOGENOUS METHYLARGININES; BANKED BLOOD; RAT-KIDNEY; DIMETHYLAMINOHYDROLASE; PLASMA; STORAGE; HEMOGLOBIN	Objective We determined, for packed red blood cells (PRBC) and fresh frozen plasma, the maximum content, and ability to release the endogenous nitric oxide synthase (NOS) inhibitors asymmetric dimethylarginine (ADMA) and monomethylarginine (LNMMA). Background ADMA and LNMMA are near equipotent NOS inhibitors forming blood's total NOS inhibitory content. The balance between removal from, and addition to plasma determines their free concentrations. Removal from plasma is by well-characterized specific hydrolases while formation is restricted to posttranslational protein methylation. When released into plasma they can readily enter endothelial cells and inhibit NOS. Fresh rat and human whole blood contain substantial protein incorporated ADMA however; the maximum content of ADMA and LNMMA in PRBC and fresh frozen plasma has not been determined. Methods We measured total (free and protein incorporated) ADMA and LNMMA content in PRBCs and fresh frozen plasma, as well as their incubation induced release, using HPLC with fluorescence detection. We tested the hypothesis that PRBC and fresh frozen plasma contain substantial inhibitory methylarginines that can be released chemically by complete in vitro acid hydrolysis or physiologically at 37 degrees C by enzymatic blood proteolysis. Results In vitro strong-acid-hydrolysis revealed a large PRBC reservoir of ADMA (54.5 +/- 9.7 mu M) and LNMMA (58.9 +/- 28.9 mu M) that persisted over 42-d at 6 degrees or -80 degrees C. In vitro 5h incubation at 37 degrees C nearly doubled free ADMA and LNMMNA concentration from PRBCs while no change was detected in fresh frozen plasma. Conclusion The compelling physiological ramifications are that regardless of storage age, 1) PRBCs can rapidly release pathologically relevant quantities of ADMA and LNMMA when incubated and 2) PRBCs have a protein-incorporated inhibitory methylarginines reservoir 100 times that of normal free inhibitory methylarginines in blood and thus could represent a clinically relevant and proximate risk for iatrogenic NOS inhibition upon transfusion.	[Zwemer, Charles F.] Dickinson Coll, Dept Biol, Carlisle, PA 17013 USA; [Davenport, Robertson D.] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI USA; [Gomez-Espina, Juan; Blanco-Gonzalez, Elisa] Univ Oviedo, Dept Phys & Analyt Chem, Oviedo, Spain; [Whitesall, Steven E.; D'Alecy, Louis G.] Univ Michigan, Sch Med, Dept Mol & Integrat Physiol, Ann Arbor, MI USA	Dickinson College; University of Michigan System; University of Michigan; University of Oviedo; University of Michigan System; University of Michigan	Zwemer, CF (corresponding author), Dickinson Coll, Dept Biol, Carlisle, PA 17013 USA.	zwemer@dickinson.edu		/0000-0002-2844-6739	Michigan Institute for Clinical and Health Research Pilot Grant [P/GU032484]	Michigan Institute for Clinical and Health Research Pilot Grant	Sources of support for this work are from the following organizations: 1) Michigan Institute for Clinical and Health Research Pilot Grant (P/GU032484) for LGD and RDD at http://www.michr.umich.edu/home; 2) donation of blood products (RDD) from The University of Michigan Health System Blood Bank at http://www.pathology.med.umich.edu/index.php?t=page & id=619; and 3) sabbatical leave for CFZ granted by The Provost and Dean of the College Office at Dickinson College at http://www.dickinson.edu/homepage/81/provost_and_dean_of_the_college. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achan V, 2003, ARTERIOSCL THROM VAS, V23, P1455, DOI 10.1161/01.ATV.0000081742.92006.59; Achan V, 2002, CIRC RES, V90, P764, DOI 10.1161/01.RES.0000014450.40853.2B; [Anonymous], 2000, NORMAL CIRCULATING A, P135; Bennett-Guerrero E, 2007, P NATL ACAD SCI USA, V104, P17063, DOI 10.1073/pnas.0708160104; Bernard A, 2007, J TRAUMA, V63, P1108, DOI 10.1097/TA.0b013e31814b2b17; Billecke SS, 2006, AM J PHYSIOL-HEART C, V291, pH1788, DOI 10.1152/ajpheart.00066.2006; Billecke SS, 2009, NEPHROL DIAL TRANSPL, V24, P489, DOI 10.1093/ndt/gfn500; Blackwell S, 2009, CLIN CHIM ACTA, V401, P14, DOI 10.1016/j.cca.2008.10.032; Bohmer A, 2012, NITRIC OXIDE-BIOL CH, V27, P72, DOI 10.1016/j.niox.2012.03.013; Boger RH, 1997, CIRCULATION, V95, P2068, DOI 10.1161/01.CIR.95.8.2068; BOGLE RG, 1995, AM J PHYSIOL-CELL PH, V269, pC750, DOI 10.1152/ajpcell.1995.269.3.C750; Bonaventura J, 2007, P NATL ACAD SCI USA, V104, P19165, DOI 10.1073/pnas.0708871105; Cardounel AJ, 2007, J BIOL CHEM, V282, P879, DOI 10.1074/jbc.M603606200; Carello KA, 2006, AM J PHYSIOL-HEART C, V290, pH209, DOI 10.1152/ajpheart.00208.2005; Chae JW, 2011, ARZNEIMITTELFORSCH, V61, P340, DOI 10.1055/s-0031-1296208; Damkjaer M, 2010, AM J PHYSIOL-REG I, V299, pR1449, DOI 10.1152/ajpregu.00440.2010; Davids M, 2012, AM J PHYSIOL-HEART C, V302, pH1762, DOI 10.1152/ajpheart.01205.2011; Davids M, 2012, METABOLISM, V61, P482, DOI 10.1016/j.metabol.2011.08.007; DAVIES MG, 1973, J SCI FOOD AGR, V24, P1525, DOI 10.1002/jsfa.2740241208; Frenchik MD, 2004, CLIN CHIM ACTA, V339, P199, DOI 10.1016/j.cccn.2003.09.017; Fullerton JN, 2013, J PATHOL, V231, P8, DOI 10.1002/path.4232; Gladwin MT, 2009, CURR OPIN HEMATOL, V16, P515, DOI 10.1097/MOH.0b013e32833157f4; Gladwin MT, 2004, CIRC RES, V94, P851, DOI 10.1161/01.RES.0000126697.64381.37; Hasegawa K, 2007, CIRC RES; HECKER M, 1991, FEBS LETT, V294, P221, DOI 10.1016/0014-5793(91)81434-A; Hov GG, 2007, SCAND J CLIN LAB INV, V67, P868, DOI 10.1080/00365510701429836; Hu XD, 2011, J COMB OPTIM, V21, P1, DOI 10.1007/s10878-010-9361-3; Hu XL, 2009, CIRCULATION, V120, P2222, DOI 10.1161/CIRCULATIONAHA.108.819912; IGNARRO LJ, 1988, J PHARMACOL EXP THER, V244, P181; Ito A, 1999, CIRCULATION, V99, P3092, DOI 10.1161/01.CIR.99.24.3092; Kang ES, 2001, FREE RADIC RES; Knipp M, 2001, J BIOL CHEM, V276, P40449, DOI 10.1074/jbc.M104056200; KUROSE I, 1995, AM J PHYSIOL-HEART C, V268, pH2224, DOI 10.1152/ajpheart.1995.268.6.H2224; Leiper J, 1999, CARDIOVASC RES, V43, P542, DOI 10.1016/S0008-6363(99)00162-5; Lu TM, 2003, CLIN CARDIOL, V26, P458, DOI 10.1002/clc.4960261006; MacAllister RJ, 1996, BRIT J PHARMACOL, V119, P1533, DOI 10.1111/j.1476-5381.1996.tb16069.x; Mihout F, 2010, J PATHOL; MOLINA CR, 1987, J CARDIOVASC PHARM, V10, P371, DOI 10.1097/00005344-198710000-00001; OGAWA T, 1989, J BIOL CHEM, V264, P10205; Procter LD, 2013, J SURG RES, V179, pE183, DOI 10.1016/j.jss.2012.01.054; Rael LT, 2009, OXID MED CELL LONGEV, V2, P166, DOI 10.4161/oxim.2.3.8608; Reynolds JD, 2007, P NATL ACAD SCI USA, V104, P17058, DOI 10.1073/pnas.0707958104; Richir MC, 2009, CRIT CARE MED, V37, P2010, DOI 10.1097/CCM.0b013e31819ffdaf; Salit ML, 2001, ANAL CHEM, V73, P4821, DOI 10.1021/ac0155097; SESSA WC, 1992, J BIOL CHEM, V267, P15274; Stuhlinger MC, 2007, CARDIOVASC RES, V75, P417, DOI 10.1016/j.cardiores.2007.04.030; Teerlink T, 2009, PHARMACOL RES, V60, P448, DOI 10.1016/j.phrs.2009.08.002; Tojo A, 1997, KIDNEY INT, V52, P1593, DOI 10.1038/ki.1997.490; Tsikas D, 2000, FEBS LETT, V478, P1, DOI 10.1016/S0014-5793(00)01686-0; Tsikas D, 2009, CLIN BIOCHEM, V42, P1739, DOI 10.1016/j.clinbiochem.2009.07.024; Vallance P, 2004, ARTERIOSCL THROM VAS, V24, P1023, DOI 10.1161/01.ATV.0000128897.54893.26; von Leitner EC, 2011, CIRCULATION, V124, P2735, DOI 10.1161/CIRCULATIONAHA.111.060541; Xiao WZ, 2011, J EXP MED, V208, P2581, DOI 10.1084/jem.20111354; Yokoro M, 2012, BIOSCI BIOTECH BIOCH, V76, P1334, DOI 10.1271/bbb.120086; Yoo JH, 2001, ATHEROSCLEROSIS, V158, P425, DOI 10.1016/S0021-9150(01)00444-0; Zani BG, 2005, AM J PHYSIOL-HEART C, V289, pH1381, DOI 10.1152/ajpheart.01231.2004	56	8	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0119991	10.1371/journal.pone.0119991	http://dx.doi.org/10.1371/journal.pone.0119991			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25793525	Green Published, Green Submitted, gold			2022-12-27	WOS:000352084200133
J	Droppa, M; Tschernow, D; Mueller, KAL; Tavlaki, E; Karathanos, A; Stimpfle, F; Schaeffeler, E; Schwab, M; Tolios, A; Siller-Matula, JM; Gawaz, M; Geisler, T				Droppa, Michal; Tschernow, Dimitri; Mueller, Karin A. L.; Tavlaki, Elli; Karathanos, Athanasios; Stimpfle, Fabian; Schaeffeler, Elke; Schwab, Matthias; Tolios, Alexander; Siller-Matula, Jolanta M.; Gawaz, Meinrad; Geisler, Tobias			Evaluation of Clinical Risk Factors to Predict High On-Treatment Platelet Reactivity and Outcome in Patients with Stable Coronary Artery Disease (PREDICT-STABLE)	PLOS ONE			English	Article							STENT THROMBOSIS; ANTIPLATELET THERAPY; CLOPIDOGREL; INTERVENTION; MORTALITY; REVASCULARIZATION; CYTOCHROME-P450; RESPONSIVENESS; INHIBITION; PRASUGREL	Objectives This study was designed to identify the multivariate effect of clinical risk factors on high on-treatment platelet reactivity (HPR) and 12 months major adverse events (MACE) under treatment with aspirin and clopidogrel in patients undergoing non-urgent percutaneous coronary intervention (PCI). Methods 739 consecutive patients with stable coronary artery disease (CAD) undergoing PCI were recruited. On-treatment platelet aggregation was tested by light transmittance aggregometry. Clinical risk factors and MACE during one-year follow-up were recorded. An independent population of 591 patients served as validation cohort. Results Degree of on-treatment platelet aggregation was influenced by different clinical risk factors. In multivariate regression analysis older age, diabetes mellitus, elevated BMI, renal function and left ventricular ejection fraction were independent predictors of HPR. After weighing these variables according to their estimates in multivariate regression model, we developed a score to predict HPR in stable CAD patients undergoing elective PCI (PREDICT-STABLE Score, ranging 0-9). Patients with a high score were significantly more likely to develop MACE within one year of follow-up, 3.4% (score 0-3), 6.3% (score 4-6) and 10.3% (score 7-9); odds ratio 3.23, P=0.02 for score 7-9 vs. 0-3. This association was confirmed in the validation cohort. Conclusions Variability of on-treatment platelet function and associated outcome is mainly influenced by clinical risk variables. Identification of high risk patients (e.g. with high PREDICT-STABLE score) might help to identify risk groups that benefit from more intensified antiplatelet regimen. Additional clinical risk factor assessment rather than isolated platelet function-guided approaches should be investigated in future to evaluate personalized antiplatelet therapy in stable CAD-patients.	[Droppa, Michal; Tschernow, Dimitri; Mueller, Karin A. L.; Tavlaki, Elli; Karathanos, Athanasios; Stimpfle, Fabian; Gawaz, Meinrad; Geisler, Tobias] Univ Tubingen Hosp, Dept Cardiol & Cardiovasc Med, Tubingen, Germany; [Schaeffeler, Elke; Schwab, Matthias] Dr Margarete Fischer Bosch Inst Clin Pharmacol, Stuttgart, Germany; [Schwab, Matthias] Univ Tubingen Hosp, Dept Clin Pharmacol, Tubingen, Germany; [Tolios, Alexander] Univ Munich, Med Ctr, Inst Lab Med, Munich, Germany; [Siller-Matula, Jolanta M.] Med Univ Vienna, Dept Cardiol, Vienna, Austria	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of Munich; Medical University of Vienna	Geisler, T (corresponding author), Univ Tubingen Hosp, Dept Cardiol & Cardiovasc Med, Tubingen, Germany.	tobias.geisler@med.uni-tuebingen.de	Schwab, Matthias/ABH-7449-2020; Geisler, Tobias/AAO-4472-2020; Jolanta Siller-Matula, PD/J-8992-2015	Jolanta Siller-Matula, PD/0000-0001-6041-1635; Droppa, Michal/0000-0001-5807-7615	Deutsche Forschungsgemeinschaft [SCHW 858/1-1]; Deutsche Forschungsgemeinschaft (Klinische Forschergruppe 274 Platelets - Molecular Mechanisms and Translational Implications); FP7 EU Initial Training Network program Fighting-DrugFailure [PITN-GA-2009-238132]; Robert Bosch Stiftung, Germany; Deutsche Forschungsgemeinschaft; Open Access Publishing Fund of Tuebingen University	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Deutsche Forschungsgemeinschaft (Klinische Forschergruppe 274 Platelets - Molecular Mechanisms and Translational Implications)(German Research Foundation (DFG)); FP7 EU Initial Training Network program Fighting-DrugFailure; Robert Bosch Stiftung, Germany; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Open Access Publishing Fund of Tuebingen University	This work was supported by the Deutsche Forschungsgemeinschaft, (www.dfg.de) (Grant SCHW 858/1-1 and Klinische Forschergruppe 274 Platelets - Molecular Mechanisms and Translational Implications), the FP7 EU Initial Training Network program Fighting-DrugFailure, (http://www.fightingdrugfailure.net) (Grant PITN-GA-2009-238132), and the Robert Bosch Stiftung, (www.bosch-stiftung.de), Germany. We acknowledge support by Deutsche Forschungsgemeinschaft and Open Access Publishing Fund of Tuebingen University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angiolillo Dominick J, 2004, J Invasive Cardiol, V16, P169; Bonello-Palot N, 2009, AM J CARDIOL, V104, P1511, DOI 10.1016/j.amjcard.2009.07.015; Bucher HC, 2000, BMJ-BRIT MED J, V321, P73, DOI 10.1136/bmj.321.7253.73; Chung I, 2006, EUR HEART J, V27, P2623, DOI 10.1093/eurheartj/ehl305; Collet JP, 2012, NEW ENGL J MED, V367, P2100, DOI 10.1056/NEJMoa1209979; Cuisset T, 2006, J THROMB HAEMOST, V4, P542, DOI 10.1111/j.1538-7836.2005.01751.x; Cuisset T, 2011, AM J CARDIOL, V108, P1411, DOI 10.1016/j.amjcard.2011.06.060; de Mulder M, 2011, EUR HEART J, V32, P1398, DOI 10.1093/eurheartj/ehr034; Gawaz M, 1997, CORONARY ARTERY DIS, V8, P121, DOI 10.1097/00019501-199703000-00001; Geisler T, 2008, J THROMB HAEMOST, V6, P54; Geisler T, 2007, DIABETES CARE, V30, P372, DOI 10.2337/dc06-1625; Geisler T, 2006, EUR HEART J, V27, P2420, DOI 10.1093/eurheartj/ehl275; Geisler T, 2010, CLIN RES CARDIOL, V99, P743, DOI 10.1007/s00392-010-0179-x; Gurbel PA, 2005, J AM COLL CARDIOL, V46, P1820, DOI 10.1016/j.jacc.2005.07.041; Gurbel PA, 2003, CIRCULATION, V107, P2908, DOI 10.1161/01.CIR.0000072771.11429.83; Gurbel PA, 2005, J AM COLL CARDIOL, V46, P1827, DOI 10.1016/j.jacc.2005.07.056; Gurbel PA, 2012, JAMA-J AM MED ASSOC, V308, P1785, DOI 10.1001/jama.2012.17312; Hochholzer W, 2005, CIRCULATION, V111, P2560, DOI 10.1161/01.CIR.0000160869.75810.98; Htun P, 2011, J AM SOC NEPHROL, V22, P627, DOI 10.1681/ASN.2010020220; Hulot JS, 2006, BLOOD, V108, P2244, DOI 10.1182/blood-2006-04-013052; James S, 2010, CIRCULATION, V122, P1056, DOI 10.1161/CIRCULATIONAHA.109.933796; Jeremias A, 2009, AM J MED, V122, P152, DOI 10.1016/j.amjmed.2008.07.027; Kotlyar M, 1999, INT J CLIN PHARM TH, V37, P8; Leblond F, 2001, J AM SOC NEPHROL, V12, P326, DOI 10.1681/ASN.V122326; Marcucci Rossella, 2007, Atherosclerosis, V195, pe217, DOI 10.1016/j.atherosclerosis.2007.04.048; Mega JL, 2012, NEW ENGL J MED, V366, P9, DOI 10.1056/NEJMoa1112277; Morel O, 2011, J AM COLL CARDIOL, V57, P399, DOI 10.1016/j.jacc.2010.09.032; Morrow DA, 2012, NEW ENGL J MED, V366, P1404, DOI 10.1056/NEJMoa1200933; Muller I, 2003, THROMB HAEMOSTASIS, V89, P783, DOI 10.1055/s-0037-1613462; Neumann FJ, 1996, J AM COLL CARDIOL, V27, P15, DOI 10.1016/0735-1097(95)00433-5; Peterson ED, 2010, J AM COLL CARDIOL, V55, P1923, DOI 10.1016/j.jacc.2010.02.005; Price MJ, 2011, JAMA-J AM MED ASSOC, V305, P1097, DOI 10.1001/jama.2011.290; Reny JL, 2012, CIRCULATION, V125, P3201, DOI 10.1161/CIRCULATIONAHA.111.085464; Serebruany VL, 2005, J AM COLL CARDIOL, V45, P246, DOI 10.1016/j.jacc.2004.09.067; Sibbing D, 2008, THROMB HAEMOSTASIS, V99, P121, DOI 10.1160/TH07-07-0478; Siller-Matula JM, 2012, J THROMB HAEMOST, V10, P529, DOI 10.1111/j.1538-7836.2012.04639.x; Silvain J, 2012, EUR HEART J, V33, P1241, DOI 10.1093/eurheartj/ehr407; Spiliopoulos S, 2013, J AM COLL CARDIOL, V61, P2428, DOI 10.1016/j.jacc.2013.03.036; Suh JW, 2006, CAN MED ASSOC J, V174, P1715, DOI 10.1503/cmaj.060664; Tantry US, 2013, J AM COLL CARDIOL, V62, P2261, DOI 10.1016/j.jacc.2013.07.101; Thygesen K, 2012, EUR HEART J, V33, P2551, DOI 10.1093/eurheartj/ehs184; TOUCHETTE MA, 1991, DICP ANN PHARMAC, V25, P1214, DOI 10.1177/106002809102501111; Trenk D, 2012, J AM COLL CARDIOL, V59, P2159, DOI 10.1016/j.jacc.2012.02.026; Wallentin L, 2009, NEW ENGL J MED, V361, P1045, DOI 10.1056/NEJMoa0904327; Wenaweser P, 2005, J AM COLL CARDIOL, V45, P1748, DOI 10.1016/j.jacc.2005.01.058; WIJNS W, 2010, EUR HEART J, V31, P2501, DOI DOI 10.1093/EURHEARTJ/EHQ277; Wiviott SD, 2007, NEW ENGL J MED, V357, P2001, DOI 10.1056/NEJMoa0706482	47	27	30	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0121620	10.1371/journal.pone.0121620	http://dx.doi.org/10.1371/journal.pone.0121620			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25799149	gold, Green Published, Green Submitted			2022-12-27	WOS:000351987300277
J	Haugen, T; Tonnessen, E; Oksenholt, O; Haugen, FL; Paulsen, G; Enoksen, E; Seiler, S				Haugen, Thomas; Tonnessen, Espen; Oksenholt, Oyvind; Haugen, Fredrik Lie; Paulsen, Goran; Enoksen, Eystein; Seiler, Stephen			Sprint Conditioning of Junior Soccer Players: Effects of Training Intensity and Technique Supervision	PLOS ONE			English	Article							PERFORMANCE; SPEED; STIFFNESS; STRENGTH; SPORTS; POWER; JUMP	The aims of the present study were to compare the effects of 1) training at 90 and 100% sprint velocity and 2) supervised versus unsupervised sprint training on soccer-specific physical performance in junior soccer players. Young, male soccer players (17 +/- 1 yr, 71 +/- 10 kg, 180 +/- 6 cm) were randomly assigned to four different treatment conditions over a 7-week intervention period. A control group (CON, n=9) completed regular soccer training according to their teams' original training plans. Three training groups performed a weekly repeated-sprint training session in addition to their regular soccer training sessions performed at A) 100% intensity without supervision (100UNSUP, n=13), B) 90% of maximal sprint velocity with supervision (90SUP, n=10) or C) 90% of maximal sprint velocity without supervision (90UNSUP, n=13). Repetitions x distance for the sprint-training sessions were 15x20 m for 100UNSUP and 30x20 m for 90SUP and 90UNSUP. Single-sprint performance (best time from 15x20 m sprints), repeated-sprint performance (mean time over 15x20 m sprints), countermovement jump and Yo-Yo Intermittent Recovery Level 1 (Yo-Yo IR1) were assessed during pre-training and post-training tests. No significant differences in performance outcomes were observed across groups. 90SUP improved Yo-Yo IR1 by a moderate margin compared to controls, while all other effect magnitudes were trivial or small. In conclusion, neither weekly sprint training at 90 or 100% velocity, nor supervised sprint training enhanced soccer-specific physical performance in junior soccer players.	[Haugen, Thomas; Tonnessen, Espen; Paulsen, Goran] Norwegian Olymp Sports Program Olympiatoppen, N-0840 Oslo, Norway; [Haugen, Thomas; Seiler, Stephen] Univ Agder, Fac Hlth & Sport Sci, N-4630 Kristiansand, Norway; [Oksenholt, Oyvind; Haugen, Fredrik Lie; Paulsen, Goran; Enoksen, Eystein] Norwegian Sch Sport Sci, N-0806 Oslo, Norway	University of Agder; Norwegian School of Sport Sciences	Haugen, T (corresponding author), Norwegian Olymp Sports Program Olympiatoppen, Sognsveien 228, N-0840 Oslo, Norway.	thomas.haugen@olympiatoppen.no	Haugen, Thomas/AAQ-5280-2021; Paulsen, Goran/ABG-6995-2020; Haugen, Thomas/I-9580-2015	Haugen, Thomas/0000-0001-5929-0389				Castellano J, 2014, SPORTS MED, V44, P701, DOI 10.1007/s40279-014-0144-3; Chelly SM, 2001, MED SCI SPORT EXER, V33, P326; Coutts AJ, 2004, J STRENGTH COND RES, V18, P316, DOI 10.1519/00124278-200405000-00021; Cummins C, 2013, SPORTS MED, V43, P1025, DOI 10.1007/s40279-013-0069-2; di Prampero PE, 2005, J EXP BIOL, V208, P2809, DOI 10.1242/jeb.01700; Di Salvo V, 2013, INT J SPORTS MED, V34, P526, DOI 10.1055/s-0032-1327660; Faude O, 2012, J SPORT SCI, V30, P625, DOI 10.1080/02640414.2012.665940; Foster C, 1998, MED SCI SPORT EXER, V30, P1164, DOI 10.1097/00005768-199807000-00023; Girard O, 2011, EUR J APPL PHYSIOL, V111, P125, DOI 10.1007/s00421-010-1638-9; Harland MJ, 1997, SPORTS MED, V23, P11, DOI 10.2165/00007256-199723010-00002; Haugen T, 2015, INT J SPORT PHYSIOL, V10, P269, DOI 10.1123/ijspp.2014-0350; Haugen T, 2014, J SPORT SCI, V32, P1979, DOI 10.1080/02640414.2014.976248; Haugen TA, 2014, INT J SPORT PHYSIOL, V9, P432, DOI [10.1123/IJSPP.2013-0121, 10.1123/ijspp.2013-0121]; Haugen TA, 2013, INT J SPORT PHYSIOL, V8, P148, DOI 10.1123/ijspp.8.2.148; Haugen TA, 2012, INT J SPORT PHYSIOL, V7, P340, DOI 10.1123/ijspp.7.4.340; Hopkins WG, 2009, MED SCI SPORT EXER, V41, P3, DOI 10.1249/MSS.0b013e31818cb278; Hunter JP, 2004, MED SCI SPORT EXER, V36, P261, DOI 10.1249/01.MSS.0000113664.15777.53; Kraemer WJ, 2002, MED SCI SPORT EXER, V34, P364, DOI 10.1097/00005768-200202000-00027; Krustrup P, 2003, MED SCI SPORT EXER, V35, P697, DOI 10.1249/01.MSS.0000058441.94520.32; Kuitunen S, 2002, MED SCI SPORT EXER, V34, P166, DOI 10.1097/00005768-200201000-00025; Mazzetti SA, 2000, MED SCI SPORT EXER, V32, P1175, DOI 10.1097/00005768-200006000-00023; Miller J, 1984, BURST OF SPEED; Salo AIT, 2011, MED SCI SPORT EXER, V43, P1055, DOI 10.1249/MSS.0b013e318201f6f8; Schmidt R. A., 2008, MOTOR LEARNING PERFO; Seiler S, 2013, SCAND J MED SCI SPOR, V23, P74, DOI 10.1111/j.1600-0838.2011.01351.x; Soares-Caldeira LF, 2014, J STRENGTH COND RES, V28, P2815, DOI 10.1519/JSC.0000000000000461; Tokmakidis SP, 1998, EUR J APPL PHYSIOL O, V77, P333, DOI 10.1007/s004210050342; Tonnessen E, 2011, J STRENGTH COND RES, V25, P2364, DOI 10.1519/JSC.0b013e3182023a65; Vittori C., 1996, NEW STUDIES ATHLETIC, V11, P85	29	23	23	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0121827	10.1371/journal.pone.0121827	http://dx.doi.org/10.1371/journal.pone.0121827			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25798601	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000351987300293
J	Ma, LL; Ma, J; Xu, KY				Ma, Lingling; Ma, Jun; Xu, Kanyan			Effect of Spaceflight on the Circadian Rhythm, Lifespan and Gene Expression of Drosophila melanogaster	PLOS ONE			English	Article							SLEEP; CLOCK; METABOLISM; DURATION; BIOLOGY; SYSTEM; RISK	Space travelers are reported to experience circadian rhythm disruption during spaceflight. However, how the space environment affects circadian rhythm is yet to be determined. The major focus of this study was to investigate the effect of spaceflight on the Drosophila circadian clock at both the behavioral and molecular level. We used China's Shenzhou-9 spaceship to carry Drosophila. After 13 days of spaceflight, behavior tests showed that the flies maintained normal locomotor activity rhythm and sleep pattern. The expression level and rhythm of major clock genes were also unaffected. However, expression profiling showed differentially regulated output genes of the circadian clock system between space flown and control flies, suggesting that spaceflight affected the circadian output pathway. We also investigated other physiological effects of spaceflight such as lipid metabolism and lifespan, and searched genes significantly affected by spaceflight using microarray analysis. These results provide new information on the effects of spaceflight on circadian rhythm, lipid metabolism and lifespan. Furthermore, we showed that studying the effect of spaceflight on gene expression using samples collected at different Zeitgeber time could obtain different results, suggesting the importance of appropriate sampling procedures in studies on the effects of spaceflight.	[Ma, Lingling; Ma, Jun; Xu, Kanyan] China Acad Space Technol, Lab Space Microbiol, Shenzhou Space Biotechnol Grp, Beijing, Peoples R China		Xu, KY (corresponding author), China Acad Space Technol, Lab Space Microbiol, Shenzhou Space Biotechnol Grp, Beijing, Peoples R China.	xukanyan@cast.cn						Agarwal R, 2010, CURR OPIN NEPHROL HY, V19, P51, DOI 10.1097/MNH.0b013e3283336ddb; ALPATOV AM, 1994, BIOL RHYTHM RES, V25, P168, DOI 10.1080/09291019409360284; Balsalobre A, 2002, CELL TISSUE RES, V309, P193, DOI 10.1007/s00441-002-0585-0; Basner M, 2013, P NATL ACAD SCI USA, V110, P2635, DOI 10.1073/pnas.1212646110; Broughton SJ, 2005, P NATL ACAD SCI USA, V102, P3105, DOI 10.1073/pnas.0405775102; Broughton S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003721; Campos Costa Ines, 2013, Am J Neurodegener Dis, V2, P228; Casey T, 2012, BIOL OPEN, V1, P570, DOI 10.1242/bio.2012687; Crocker A, 2010, GENE DEV, V24, P1220, DOI 10.1101/gad.1913110; Da Silva MS, 2002, NUTRITION, V18, P805, DOI 10.1016/S0899-9007(02)00915-2; Dayanandan P, 2011, J BIOSCIENCES, V36, P911, DOI 10.1007/s12038-011-9150-x; Dijk DJ, 2001, AM J PHYSIOL-REG I, V281, pR1647, DOI 10.1152/ajpregu.2001.281.5.R1647; Ernst J, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-191; Frigeri A, 2008, EXP BRAIN RES, V191, P289, DOI 10.1007/s00221-008-1523-5; Fuller C A, 1989, Adv Space Res, V9, P283, DOI 10.1016/0273-1177(89)90084-7; Fuller CA, 1996, J APPL PHYSIOL, V81, P188, DOI 10.1152/jappl.1996.81.1.188; Fuller CA, 1984, PHYSIOLOGIST S, V27, P93; Fuller CA, 1992, PHYSL S, V35, P63; Giebultowicz JM, 2000, ANNU REV ENTOMOL, V45, P769, DOI 10.1146/annurev.ento.45.1.769; Goel N, 2012, ACTA ASTRONAUT, V77, P207, DOI 10.1016/j.actaastro.2012.04.002; Gundel A, 1997, J SLEEP RES, V6, P1, DOI 10.1046/j.1365-2869.1997.00028.x; Hoban-Higgins TM, 2003, J INSECT PHYSIOL, V49, P671, DOI 10.1016/S0022-1910(03)00068-4; Hoban-Higgins TM, 1995, J GRAVI PHYSL, V2, P58; Holley DC, 2003, J APPL PHYSIOL, V95, P1266, DOI 10.1152/japplphysiol.00707.2002; Honda Y, 2012, SCI REP-UK, V2, DOI 10.1038/srep00487; Ikenaga M, 1997, Biol Sci Space, V11, P346, DOI 10.2187/bss.11.346; Inan OT, 2009, IEEE T BIO-MED ENG, V56, P522, DOI 10.1109/TBME.2008.2006018; Karemaker JM, 2009, RESP PHYSIOL NEUROBI, V169, pS55, DOI 10.1016/j.resp.2009.05.006; Le Bourg E, 1999, EXP GERONTOL, V34, P319, DOI 10.1016/S0531-5565(99)00004-2; Leandro LJ, 2007, ADV SPACE RES, V40, P506, DOI 10.1016/j.asr.2007.05.070; LeBlanc A, 2000, J APPL PHYSIOL, V89, P2158, DOI 10.1152/jappl.2000.89.6.2158; LEBLANC A, 1995, AVIAT SPACE ENVIR MD, V66, P1151; LeBlanc A. D., 2007, Journal of Musculoskeletal & Neuronal Interactions, V7, P33; LEONARD JI, 1983, AM J CLIN NUTR, V38, P667, DOI 10.1093/ajcn/38.5.667; Marcu O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015361; Matsumoto A, 2011, AVIAT SPACE ENVIR MD, V82, P615, DOI 10.3357/ASEM.2792.2011; Maury E, 2010, CIRC RES, V106, P447, DOI 10.1161/CIRCRESAHA.109.208355; Mavroudis PD, 2013, J INNATE IMMUN, V5, P153, DOI 10.1159/000342427; Miller MS, 1999, J GRAVIT PHYSL, V6, pP99; Min KJ, 2008, AGING CELL, V7, P199, DOI 10.1111/j.1474-9726.2008.00373.x; Monk TH, 1998, J BIOL RHYTHM, V13, P188, DOI 10.1177/074873098129000039; Monk TH, 2001, PSYCHOSOM MED, V63, P881, DOI 10.1097/00006842-200111000-00005; Morey-Holton E. R., 2007, Journal of Musculoskeletal & Neuronal Interactions, V7, P17; Murakami D M, 2000, J Gravit Physiol, V7, P79; Ohnishi Ken, 2004, Biol Sci Space, V18, P201, DOI 10.2187/bss.18.201; Paschos GK, 2010, CIRC RES, V106, P833, DOI 10.1161/CIRCRESAHA.109.211706; Rakshit K, 2012, CHRONOBIOL INT, V29, P5, DOI 10.3109/07420528.2011.635237; Schimmerling W, 2003, ADV SPACE RES, V31, P27, DOI 10.1016/S0273-1177(02)00653-1; STAMPI C, 1994, J CLIN PHARMACOL, V34, P518, DOI 10.1002/j.1552-4604.1994.tb04996.x; Stein TP, 1999, AM J PHYSIOL-REG I, V276, pR1739; SULZMAN FM, 1984, SCIENCE, V225, P232, DOI 10.1126/science.11540800; Vernikos J, 2010, GERONTOLOGY, V56, P157, DOI 10.1159/000252852; Williams JA, 2001, ANNU REV PHYSIOL, V63, P729, DOI 10.1146/annurev.physiol.63.1.729; Wu Q, 2006, ANNU REV ENTOMOL, V51, P1, DOI 10.1146/annurev.ento.51.110104.151011; Xu KY, 2008, CELL METAB, V8, P289, DOI 10.1016/j.cmet.2008.09.006; Xu KY, 2011, CELL METAB, V13, P639, DOI 10.1016/j.cmet.2011.05.001	56	31	33	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0121600	10.1371/journal.pone.0121600	http://dx.doi.org/10.1371/journal.pone.0121600			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25798821	Green Submitted, gold, Green Published			2022-12-27	WOS:000351987300274
J	Manen, O; Dussault, C; Sauvet, F; Montmerle-Borgdorff, S				Manen, Olivier; Dussault, Caroline; Sauvet, Fabien; Montmerle-Borgdorff, Stephanie			Limitations of Stroke Volume Estimation by Non-Invasive Blood Pressure Monitoring in Hypergravity	PLOS ONE			English	Article							WAVE-FORM ANALYSIS; FINGER ARTERIAL-PRESSURE; CARDIAC-OUTPUT; DOPPLER-ECHOCARDIOGRAPHY; AEROMEDICAL EVACUATION; RESISTANCE EXERCISE; FINAPRES; HUMANS; GRAVITY; TIME	Background Altitude and gravity changes during aeromedical evacuations induce exacerbated cardiovascular responses in unstable patients. Non-invasive cardiac output monitoring is difficult to perform in this environment with limited access to the patient. We evaluated the feasibility and accuracy of stroke volume estimation by finger photoplethysmography (SVp) in hypergravity. Methods Finger arterial blood pressure (ABP) waveforms were recorded continuously in ten healthy subjects before, during and after exposure to +Gz accelerations in a human centrifuge. The protocol consisted of a 2-min and 8-min exposure up to +4 Gz. SVp was computed from ABP using Liljestrand, systolic area, and Windkessel algorithms, and compared with reference values measured by echocardiography (SVe) before and after the centrifuge runs. Results The ABP signal could be used in 83.3% of cases. After calibration with echocardiography, SVp changes did not differ from SVe and values were linearly correlated (p<0.001). The three algorithms gave comparable SVp. Reproducibility between SVp and SVe was the best with the systolic area algorithm (limits of agreement -20.5 and +38.3 ml). Conclusions Non-invasive ABP photoplethysmographic monitoring is an interesting technique to estimate relative stroke volume changes in moderate and sustained hypergravity. This method may aid physicians for aeronautic patient monitoring.	[Manen, Olivier] Percy Mil Hosp, Aeromed Ctr, Clamart, France; [Dussault, Caroline; Sauvet, Fabien; Montmerle-Borgdorff, Stephanie] Armed Forces Biomed Res Inst IRBA, Bretigny Sur Orge, France; [Sauvet, Fabien] Paris Descartes Univ, Hotel Dieu, VIFASOM EA7330, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Hotel-Dieu - APHP; UDICE-French Research Universities; Universite Paris Cite	Manen, O (corresponding author), Percy Mil Hosp, Aeromed Ctr, Clamart, France.	manen.olivier@neuf.fr			Direction Generale de l'Armement (DGA, France) [10co706]	Direction Generale de l'Armement (DGA, France)	This study was financed by a grant from the Direction Generale de l'Armement (DGA, France, number 10co706). This institution had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arai T, 2013, AVIAT SPACE ENVIR MD, V84, P1178, DOI 10.3357/ASEM.3683.2013; Authority FA, 2013, AIRW STAND TRANSP CA; Bland JM, 1999, STAT METHODS MED RES, V8, P135, DOI 10.1191/096228099673819272; Bogert LWJ, 2010, ANAESTHESIA, V65, P1119, DOI 10.1111/j.1365-2044.2010.06511.x; Bogert LWJ, 2005, EXP PHYSIOL, V90, P437, DOI 10.1113/expphysiol.2005.030262; Cecconi M, 2009, CRIT CARE, V13, DOI 10.1186/cc7909; Convertino VA, 2001, AM J PHYSIOL-REG I, V280, pR947, DOI 10.1152/ajpregu.2001.280.4.R947; Convertino VA, 1998, J GRAVIT PHYSL, V5, P51; de Vet HW, 2011, MEASUREMENT MED PRAC; Dewitte K, 2002, CLIN CHEM, V48, P799; Dubost C, 2013, J TRAUMA ACUTE CARE, V74, P1146, DOI 10.1097/TA.0b013e31828271a8; Galderisi M, 2011, EUR J ECHOCARDIOGR, V12, P339, DOI 10.1093/ejechocard/jer051; Geerts BF, 2011, BRIT J CLIN PHARMACO, V71, P316, DOI 10.1111/j.1365-2125.2010.03798.x; GILLINGHAM KK, 1988, AVIAT SPACE ENVIR MD, V59, P12; Gomides RS, 2010, INT J SPORTS MED, V31, P590, DOI 10.1055/s-0030-1252054; Guelen I, 2008, J HYPERTENS, V26, P1321, DOI 10.1097/HJH.0b013e3282fe1d28; Hoffmann U, 2009, EUR J APPL PHYSIOL, V106, P589, DOI 10.1007/s00421-009-1052-3; Howard P, 1965, TXB AVIATION PHYSL, P593; Imholz BPM, 1998, CARDIOVASC RES, V38, P605, DOI 10.1016/S0008-6363(98)00067-4; LAURITZEN JB, 1987, AVIAT SPACE ENVIR MD, V58, P248; LINDBERG EVAN F., 1960, AEROSPACE MED, V31, P817; Lu ZW, 2006, J APPL PHYSIOL, V101, P598, DOI 10.1152/japplphysiol.01488.2005; MARTIN TE, 1992, J ROY SOC MED, V85, P32; Migeotte PF, 2002, ESA SP PUBL, V501, P181; Montmerle S, 2005, EUR J APPL PHYSIOL, V94, P235, DOI 10.1007/s00421-005-1331-6; Mukkamala R, 2010, AM J PHYSIOL-HEART C, V299, pH584, DOI 10.1152/ajpheart.00303.2010; Nitzan M, 2009, BIOMED ENG ONLINE, V8, DOI 10.1186/1475-925X-8-28; Pitt MS, 2004, CLIN SCI, V106, P407, DOI 10.1042/CS20030279; Polito MD, 2007, BLOOD PRESS MONIT, V12, P81, DOI 10.1097/MBP.0b013e32809ef9f1; Remmen JJ, 2002, CLIN SCI, V103, P143, DOI 10.1042/CS20010357; Ristuccia HL, 1997, HYPERTENSION, V29, P1039, DOI 10.1161/01.HYP.29.4.1039; Rohdin M, 2003, J APPL PHYSIOL, V95, P3, DOI 10.1152/japplphysiol.01154.2002; Rosenhamer G, 1967, Acta Physiol Scand Suppl, V276, P1; STOLL ALICE M., 1956, JOUR AVIATION MED, V27, P356; Sugawara J, 2003, ACTA PHYSIOL SCAND, V179, P361, DOI 10.1046/j.0001-6772.2003.01211.x; Sun JX, 2009, CRIT CARE MED, V37, P72, DOI 10.1097/CCM.0b013e3181930174; Sun JX, 2006, CARDIAC OUTPUT ESTIM; Teichman PG, 2007, NEW ENGL J MED, V356, P262, DOI 10.1056/NEJMra063651; Truijen J, 2012, J CLIN MONIT COMPUT, V26, P267, DOI 10.1007/s10877-012-9375-8; Van der Does Y, 2013, AM J EMERG MED, V31, P1012, DOI 10.1016/j.ajem.2013.03.004; van der Spoel AGE, 2012, J CLIN ANESTH, V24, P304, DOI 10.1016/j.jclinane.2011.09.008; van Lieshout JJ, 2003, EUR J APPL PHYSIOL, V90, P131, DOI 10.1007/s00421-003-0901-8; Warburton DER, 1999, SPORTS MED, V27, P23, DOI 10.2165/00007256-199927010-00003; WOOD EH, 1987, AVIAT SPACE ENVIR MD, V58, P699	44	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0121936	10.1371/journal.pone.0121936	http://dx.doi.org/10.1371/journal.pone.0121936			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25798613	Green Submitted, gold, Green Published			2022-12-27	WOS:000351987300303
J	Mo, M; Zhou, M; Wang, L; Qi, L; Zhou, KH; Liu, LF; Chen, Z; Zu, XB				Mo, Miao; Zhou, Mi; Wang, Lu; Qi, Lin; Zhou, Kehua; Liu, Long-Fei; Chen, Zhi; Zu, Xiong-Bing			CCL21/CCR7 Enhances the Proliferation, Migration, and Invasion of Human Bladder Cancer T24 Cells	PLOS ONE			English	Article							LYMPH-NODE METASTASIS; CHEMOKINE RECEPTOR CCR7; MESSENGER-RNA; GROWTH-FACTOR; EXPRESSION; OVEREXPRESSION; ASSOCIATION; INVOLVEMENT; APOPTOSIS; PROTEINS	Objective To investigate the effects of CCL21/CCR7 on the proliferation, migration, and invasion of T24 cells and the possible associated mechanisms: expression of MMP-2 and MMP-9, and regulation of BCL-2 and BAX proteins. Methods T24 cells received corresponding treatments including vehicle control, antibody (20ng/mL CCR7 antibody and 50 ng/ml CCL21), and 50, 100, and 200 ng/ml CCL21. Proliferation was evaluated by MTT assay; cell migration and invasion were assayed using a transwell chamber. Cell apoptosis was induced by Adriamycin (ADM). The rate of cell apoptosis was examined by flow cytometry using annexin V-FITC/PI staining. Western-blot was used to analyze MMP-2 and MMP-9 and BCL-2 and BAX proteins. Results CCL21 promoted T24 cell proliferation in concentration-dependent manner with that 200 ng/mL induced the largest amount of proliferation. Significant differences of cell migration were found between CCL21treatment groups and the control group in both the migration and invasion studies (P < 0.001 for all). The expressions of MMP-2 and MMP-9 proteins were significantly increased after CCL21 treatment (p < 0.05 for all). Protein expression of Bcl-21 follows an ascending trend while the expression of Bax follows a descending trend as the concentration of CCL21 increases. No difference was found between the control group and antibody group for all assessments. Conclusion CCL21/CCR7 promoted T24 cell proliferation and enhanced its migration and invasion via the increased expression of MMP-2 and MMP-9. CCL21/CCR7 had antiapoptotic activities on T24 cells via regulation of Bcl-2 and Bax proteins. CCL21/CCR7 may promote bladder cancer development and metastasis.	[Mo, Miao; Qi, Lin; Liu, Long-Fei; Chen, Zhi; Zu, Xiong-Bing] Cent South Univ, Xiangya Hosp, Dept Urol, Changsha 410008, Hunan, Peoples R China; [Zhou, Mi] Zhejiang Prov Peoples Hosp, Dept Urol, Hangzhou 310014, Zhejiang, Peoples R China; [Wang, Lu] Cent South Univ, Xiangya Hosp, Hlth Management Ctr, Changsha 410008, Hunan, Peoples R China; [Zhou, Kehua] Daemen Coll, Dept Hlth Care Studies, Amherst, NY 14226 USA	Central South University; Zhejiang Provincial People's Hospital; Central South University	Chen, Z (corresponding author), Cent South Univ, Xiangya Hosp, Dept Urol, Changsha 410008, Hunan, Peoples R China.	czhi1011@126.com; xymnwk@yeah.net						Banas B, 2002, J IMMUNOL, V168, P4301, DOI 10.4049/jimmunol.168.9.4301; Beavon IRG, 2000, EUR J CANCER, V36, P1607, DOI 10.1016/S0959-8049(00)00158-1; Bleul CC, 1996, J EXP MED, V184, P1101, DOI 10.1084/jem.184.3.1101; Bukholm IRK, 2002, APMIS, V110, P214, DOI 10.1034/j.1600-0463.2002.100303.x; Burger JA, 1999, BLOOD, V94, P3658, DOI 10.1182/blood.V94.11.3658.423k11_3658_3667; Cabioglu N, 2005, CLIN CANCER RES, V11, P5686, DOI 10.1158/1078-0432.CCR-05-0014; Carlsen HS, 2005, BLOOD, V106, P444, DOI 10.1182/blood-2004-11-4353; Chaffer CL, 2007, DIFFERENTIATION, V75, P831, DOI 10.1111/j.1432-0436.2007.00210.x; Ciborowski P, 2002, CLIN EXP METASTAS, V19, P339, DOI 10.1023/A:1015590515957; Ding YZ, 2003, CLIN CANCER RES, V9, P3406; Forster R, 2008, NAT REV IMMUNOL, V8, P362, DOI 10.1038/nri2297; Gao ZH, 2014, HISTOPATHOLOGY, V65, P527, DOI 10.1111/his.12435; Gunther K, 2005, INT J CANCER, V116, P726, DOI 10.1002/ijc.21123; Guruvayoorappan C, 2008, INTEGR CANCER THER, V7, P42, DOI 10.1177/1534735407313744; Han TT, 2014, CANCER BIOL THER, V15, P3, DOI 10.4161/cbt.26607; Heresi GA, 2005, UROL ONCOL-SEMIN ORI, V23, P261, DOI 10.1016/j.urolonc.2005.02.004; Ishida K, 2009, INT J ONCOL, V34, P915, DOI 10.3892/ijo_00000217; Itoh M, 2006, ONCOGENE, V25, P1195, DOI 10.1038/sj.onc.1209149; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kawakami S, 2001, ANTICANCER RES, V21, P213; Kim GC, 2003, INT ARCH ALLERGY IMM, V131, P101, DOI 10.1159/000070925; Li J, 2011, DIGEST LIVER DIS, V43, P40, DOI 10.1016/j.dld.2010.05.013; Maekawa S, 2008, ONCOL REP, V19, P1461; Mashino K, 2002, CANCER RES, V62, P2937; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Nakata B, 2008, ONCOLOGY-BASEL, V74, P69, DOI 10.1159/000139126; Nakopoulou L, 2001, APPL IMMUNOHISTO M M, V9, P130, DOI 10.1097/00022744-200106000-00005; Ohkouchi T, 2002, AM J OBSTET GYNECOL, V187, P353, DOI 10.1067/mob.2002.123203; Ploix C, 2001, J IMMUNOL, V167, P6724, DOI 10.4049/jimmunol.167.12.6724; Redondo-Munoz J, 2008, BLOOD, V111, P383, DOI 10.1182/blood-2007-08-107300; Salazar N, 2013, CRIT REV EUKAR GENE, V23, P77, DOI 10.1615/CritRevEukaryotGeneExpr.2013006905; Sancho M, 2006, J ENDOCRINOL, V191, P229, DOI 10.1677/joe.1.06688; Sehgal I, 2003, ANTICANCER RES, V23, P39; Takanami I, 2003, INT J CANCER, V105, P186, DOI 10.1002/ijc.11063; Vindrieux D, 2009, ENDOCR-RELAT CANCER, V16, P663, DOI 10.1677/ERC-09-0109; Wang J, 2005, ONCOGENE, V24, P5897, DOI 10.1038/sj.onc.1208740; Xu Y, 2012, J ENG FIBER FABR, V7, P7; Xu Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021119; Yang Zhi, 2009, Zhongguo Fei Ai Za Zhi, V12, P397, DOI 10.3779/j.issn.1009-3419.2009.05.004; Zhao B, 2011, J HEPATO-BIL-PAN SCI, V18, P821, DOI 10.1007/s00534-011-0395-4; Zyada MM, 2009, ANN DIAGN PATHOL, V13, P313, DOI 10.1016/j.anndiagpath.2009.06.003	41	41	44	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0119506	10.1371/journal.pone.0119506	http://dx.doi.org/10.1371/journal.pone.0119506			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25798926	Green Published, gold, Green Submitted			2022-12-27	WOS:000351987300055
J	Nadeau, VG; Gao, AQ; Deber, CM				Nadeau, Vincent G.; Gao, Anqi; Deber, Charles M.			Design and Characterization of a Membrane Protein Unfolding Platform in Lipid Bilayers	PLOS ONE			English	Article							FOLDING PROBLEM; STABILITY; LOOP; HAIRPIN; STATE; SITE; UREA	Accurate measurement of membrane protein stability-and particularly how it may vary as a result of disease-phenotypic mutations-ideally requires a denaturant that can unfold a membrane-embedded structure while leaving the solubilizing environment unaffected. The steric trap method fulfills this requirement by using monovalent streptavidin (mSA) molecules to unfold membrane proteins engineered with two spatially close biotin tags. Here we adapted this method to an 87-residue helix-loop-helix (hairpin) construct derived from helices 3 and 4 in the transmembrane domain of the human cystic fibrosis transmembrane conductance regulator (CFTR), wherein helix-helix tertiary interactions are anticipated to confer a portion of construct stability. The wild type CFTR TM3/4 hairpin construct was modified with two accessible biotin tags for mSA-induced unfolding, along with two helix-terminal pyrene labels to monitor loss of inter-helical contacts by pyrene excimer fluorescence. A series of eight constructs with biotin tags at varying distances from the helix-terminal pyrene labels were expressed, purified and labeled appropriately; all constructs exhibited largely helical circular dichroism spectra. We found that addition of mSA to an optimized construct in lipid vesicles led to a complete and reversible loss in pyrene excimer fluorescence and mSA binding, and hence hairpin unfolding-results further supported by SDS-PAGE visualization of mSA bound and unbound species. While some dimeric/oligomeric populations persist that may affect quantitation of the unfolding step, our characterization of the design yields a promising prototype of a future platform for the systematic study of membrane protein folding in a lipid bilayer environment.	[Nadeau, Vincent G.; Gao, Anqi; Deber, Charles M.] Hosp Sick Children, Res Inst, Div Mol Struct & Funct, Toronto, ON M5G 0A4, Canada; [Nadeau, Vincent G.; Gao, Anqi; Deber, Charles M.] Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto	Deber, CM (corresponding author), Hosp Sick Children, Res Inst, Div Mol Struct & Funct, Toronto, ON M5G 0A4, Canada.	deber@sickkids.ca			Cystic Fibrosis Canada; Canadian Institutes of Health Research (CIHR) [FRN-5810]; Fonds de la Recherche en Sante du Quebec (FRSQ); Banting and Best Canada Graduate Scholarship from CIHR	Cystic Fibrosis Canada; Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Fonds de la Recherche en Sante du Quebec (FRSQ)(Fonds de la Recherche en Sante du Quebec); Banting and Best Canada Graduate Scholarship from CIHR	Funding: This work was supported, in part, by grants to C. M. D. from Cystic Fibrosis Canada, and by the Canadian Institutes of Health Research (CIHR FRN-5810). V. G. N. is the recipient of a Doctoral Training Award from the Fonds de la Recherche en Sante du Quebec (FRSQ) and a Banting and Best Canada Graduate Scholarship from CIHR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beckett D, 1999, PROTEIN SCI, V8, P921, DOI 10.1110/ps.8.4.921; Blois TM, 2009, J AM CHEM SOC, V131, P13914, DOI 10.1021/ja905725n; Broecker J, 2013, LANGMUIR, V29, P8502, DOI 10.1021/la4013747; Chang YC, 2014, P NATL ACAD SCI USA, V111, P219, DOI 10.1073/pnas.1318576111; Chen I, 2005, NAT METHODS, V2, P99, DOI 10.1038/NMETH735; Choi MY, 2004, BIOCHEMISTRY-US, V43, P8077, DOI 10.1021/bi0494525; Curnow P, 2011, P NATL ACAD SCI USA, V108, P14133, DOI 10.1073/pnas.1012594108; Dill KA, 2008, ANNU REV BIOPHYS, V37, P289, DOI 10.1146/annurev.biophys.37.092707.153558; Dill KA, 2012, SCIENCE, V338, P1042, DOI 10.1126/science.1219021; Fiedler S, 2010, CELL MOL LIFE SCI, V67, P1779, DOI 10.1007/s00018-010-0259-0; Hong H, 2011, J AM CHEM SOC, V133, P11389, DOI 10.1021/ja204524c; Hong H, 2010, P NATL ACAD SCI USA, V107, P19802, DOI 10.1073/pnas.1010348107; Howarth M, 2006, NAT METHODS, V3, P267, DOI 10.1038/NMETH861; Jefferson RE, 2013, J AM CHEM SOC, V135, P15183, DOI 10.1021/ja407232b; Joh NH, 2008, NATURE, V453, P1266, DOI 10.1038/nature06977; Lau FW, 1997, BIOCHEMISTRY-US, V36, P5884, DOI 10.1021/bi963095j; Lehrer SS, 1997, METHOD ENZYMOL, V278, P286; McKibbin C, 2009, PHOTOCHEM PHOTOBIOL, V85, P494, DOI 10.1111/j.1751-1097.2008.00503.x; Mulvihill CM, 2012, BBA-BIOMEMBRANES, V1818, P49, DOI 10.1016/j.bbamem.2011.09.027; Nadeau VG, 2013, BIOCHEMISTRY-US, V52, P2419, DOI 10.1021/bi400187w; Nadeau VG, 2012, BIOCHEMISTRY-US, V51, P6228, DOI 10.1021/bi201853n; Otzen DE, 2002, BIOPHYS J, V83, P2219, DOI 10.1016/S0006-3495(02)73982-9; Rath A, 2012, ANNU REV BIOPHYS, V41, P135, DOI [10.1146/annurev-biophys-050511-102310, 10.1146/annurev-biophys-050591-102310]; Rath A, 2009, P NATL ACAD SCI USA, V106, P1760, DOI 10.1073/pnas.0813167106; Shortle D, 1996, FASEB J, V10, P27, DOI 10.1096/fasebj.10.1.8566543; Therien AG, 2002, J BIOL CHEM, V277, P6067, DOI 10.1074/jbc.M110264200; Wehbi H, 2007, BIOCHEMISTRY-US, V46, P7099, DOI 10.1021/bi602570u	27	2	2	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0120253	10.1371/journal.pone.0120253	http://dx.doi.org/10.1371/journal.pone.0120253			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25799099	Green Submitted, Green Published, gold			2022-12-27	WOS:000351987300116
J	Sie, M; den Dunnen, WFA; Lourens, HJ; Boer, TGJD; Scherpen, FJG; Zomerman, WW; Kampen, KR; Hoving, EW; de Bont, ESJM				Sie, Mariska; den Dunnen, Wilfred F. A.; Lourens, Harm Jan; Boer, Tiny G. J. Meeuwsen-de; Scherpen, Frank J. G.; Zomerman, Walderik W.; Kampen, Kim R.; Hoving, Eelco W.; de Bont, Eveline S. J. M.			Growth-Factor-Driven Rescue to Receptor Tyrosine Kinase (RTK) Inhibitors through Akt and Erk Phosphorylation in Pediatric Low Grade Astrocytoma and Ependymoma	PLOS ONE			English	Article							RESISTANCE PROTEIN ABCG2; P-GLYCOPROTEIN ABCB1; PHASE-I; BRAIN ACCUMULATION; PILOCYTIC ASTROCYTOMA; CELL-PROLIFERATION; DRUG-RESISTANCE; YOUNG-ADULTS; SORAFENIB; CHILDREN	Up to now, several clinical studies have been started investigating the relevance of receptor tyrosine kinase (RTK) inhibitors upon progression free survival in various pediatric brain tumors. However, single targeted kinase inhibition failed, possibly due to tumor resistance mechanisms. The present study will extend our previous observations that vascular endothelial growth factor receptor (VEGFR)-2, platelet derived growth factor receptor (PDGFR) beta, Src, the epidermal growth factor receptor (ErbB) family, and hepatocyte growth factor receptor (HGFR/cMet) are potentially drugable targets in pediatric low grade astrocytoma and ependymoma with investigations concerning growth-factor-driven rescue. This was investigated in pediatric low grade astrocytoma and ependymoma cell lines treated with receptor tyrosine kinase (RTK) inhibitors e.g. sorafenib, dasatinib, canertinib and crizotinib. Flow cytometry analyses showed high percentage of cells expressing VEGFR-1, fibroblast growth factor receptor (FGFR)-1, ErbB1/EGFR, HGFR and recepteur d'origine nantais (RON) (respectively 52-77%, 34-51%, 63-90%, 83-98%, 65-95%). Their respective inhibitors induced decrease of cell viability, measured with WST-1 cell viability assays. At least this was partially due to increased apoptotic levels measured by Annexin V/Propidium Iodide apoptosis assays. EGF, HGF and FGF, which are normally expressed in brain (tumor) tissue, showed to be effective rescue inducing growth factors resulting in increased cell survival especially during treatment with dasatinib (complete rescue) or sorafenib (partial rescue). Growth-factor-driven rescue was less prominent when canertinib or crizotinib were used. Rescue was underscored by significantly activating downstream Akt and/or Erk phosphorylation and increased tumor cell migration. Combination treatment showed to be able to overcome the growth-factor-driven rescue. In conclusion, our study highlights the extensive importance of environmentally present growth factors in developing tumor escape towards RTK inhibitors in pediatric low grade astrocytoma and ependymoma. It is of great interest to anticipate upon these results for the design of new therapeutic trials with RTK inhibitors in these pediatric brain tumors.	[Sie, Mariska; Lourens, Harm Jan; Boer, Tiny G. J. Meeuwsen-de; Scherpen, Frank J. G.; Zomerman, Walderik W.; Kampen, Kim R.; de Bont, Eveline S. J. M.] Univ Groningen, Univ Med Ctr Groningen, Dept Pediat, Beatrix Childrens Hosp,Pediat Oncol Hematol Div, Groningen, Netherlands; [den Dunnen, Wilfred F. A.] Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol, Div Pathol, Groningen, Netherlands; [Hoving, Eelco W.] Univ Groningen, Univ Med Ctr Groningen, Dept Neurosurg, Groningen, Netherlands	University of Groningen; University of Groningen; University of Groningen	de Bont, ESJM (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Pediat, Beatrix Childrens Hosp,Pediat Oncol Hematol Div, Groningen, Netherlands.	e.s.j.m.de.bont@umcg.nl	Kampen, Kim R/Q-8879-2018	Kampen, Kim R/0000-0001-5065-1272; den Dunnen, Wilfred/0000-0002-4168-1207	Jan Kornelis de Cock Stichting [2013-75]	Jan Kornelis de Cock Stichting	This work was supported by a grant from Jan Kornelis de Cock Stichting (project code 2013-75 to M. Sie). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achim CL, 1997, DEV BRAIN RES, V102, P299, DOI 10.1016/S0165-3806(97)00108-9; Akiyama K, 2012, AM J PATHOL, V180, P1283, DOI 10.1016/j.ajpath.2011.11.029; Batchelor TT, 2007, CANCER CELL, V11, P83, DOI 10.1016/j.ccr.2006.11.021; Bobola MS, 2005, CLIN CANCER RES, V11, P2747, DOI 10.1158/1078-0432.CCR-04-2045; Broniscer A, 2009, CLIN CANCER RES, V15, P701, DOI 10.1158/1078-0432.CCR-08-1923; Casanovas O, 2005, CANCER CELL, V8, P299, DOI 10.1016/j.ccr.2005.09.005; Chapuy B, 2011, BRIT J HAEMATOL, V152, P401, DOI 10.1111/j.1365-2141.2010.08526.x; di Tomaso E, 2011, CANCER RES, V71, P19, DOI 10.1158/0008-5472.CAN-10-2602; Due-Tonnessen BJ, 2002, PEDIATR NEUROSURG, V37, P71, DOI 10.1159/000065108; Duncan JS, 2012, CELL, V149, P307, DOI 10.1016/j.cell.2012.02.053; Fernandez C, 2003, NEUROSURGERY, V53, P544, DOI 10.1227/01.NEU.0000079330.01541.6E; Geoerger B, 2011, NEURO-ONCOLOGY, V13, P109, DOI 10.1093/neuonc/noq141; Geyer JR, 2010, EUR J CANCER, V46, P3287, DOI 10.1016/j.ejca.2010.07.005; Gilbertson RJ, 2002, CLIN CANCER RES, V8, P3054; Gremo F, 2000, INT J DEV NEUROSCI, V18, P271, DOI 10.1016/S0736-5748(99)00095-7; Gronych J, 2011, J CLIN INVEST, V121, P1344, DOI 10.1172/JCI44656; Hainsworth JD, 2010, CANCER-AM CANCER SOC, V116, P3663, DOI 10.1002/cncr.25275; Ho AL, 2012, CANCER RES, V72, P4515, DOI 10.1158/0008-5472.CAN-12-1319; Jain RK, 2007, NAT REV NEUROSCI, V8, P610, DOI 10.1038/nrn2175; Jakacki RI, 2008, J CLIN ONCOL, V26, P4921, DOI 10.1200/JCO.2007.15.2306; Jane EP, 2006, J PHARMACOL EXP THER, V319, P1070, DOI 10.1124/jpet.106.108621; Jun HJ, 2012, ONCOGENE, V31, P3039, DOI 10.1038/onc.2011.474; Lagas JS, 2009, CLIN CANCER RES, V15, P2344, DOI 10.1158/1078-0432.CCR-08-2253; Lee EQ, 2012, NEURO-ONCOLOGY, V14, P1511, DOI 10.1093/neuonc/nos264; Louis DN., 2007, CLASSIFICATION TUMOU, V4th; Maekawa T, 2007, INT J CLIN ONCOL, V12, P327, DOI 10.1007/s10147-007-0699-1; Minocha M, 2012, INT J PHARMACEUT, V436, P127, DOI 10.1016/j.ijpharm.2012.05.038; Mosse YP, 2013, LANCET ONCOL, V14, P472, DOI 10.1016/S1470-2045(13)70095-0; Namba H, 2009, NEUROSCIENCE, V158, P1731, DOI 10.1016/j.neuroscience.2008.10.057; Omerovic J, 2008, ONCOGENE, V27, P2754, DOI 10.1038/sj.onc.1210925; Pollack IF, 2011, NEURO-ONCOLOGY, V13, P290, DOI 10.1093/neuonc/noq199; Ramakrishnan V, 2012, AM J HEMATOL, V87, P277, DOI 10.1002/ajh.22263; Reardon DA, 2011, J NEURO-ONCOL, V101, P57, DOI 10.1007/s11060-010-0217-6; Rodriguez FJ, 2013, ANNU REV PATHOL-MECH, V8, P361, DOI 10.1146/annurev-pathol-020712-164009; Rosser AE, 2000, EUR J NEUROSCI, V12, P2405, DOI 10.1046/j.1460-9568.2000.00135.x; Severinsson EAD, 2011, BIOCHEM BIOPH RES CO, V414, P563, DOI 10.1016/j.bbrc.2011.09.118; Shao HW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080832; Shim KW, 2009, CHILD NERV SYST, V25, P1167, DOI 10.1007/s00381-009-0900-0; Sie M, 2014, CRIT REV ONCOL HEMAT, V89, P418, DOI 10.1016/j.critrevonc.2013.09.005; Sikkema AH, 2011, NEUROPATH APPL NEURO, V37, P538, DOI 10.1111/j.1365-2990.2011.01160.x; Sikkema AH, 2009, CANCER RES, V69, P5987, DOI 10.1158/0008-5472.CAN-08-3660; Slichenmyer WJ, 2001, SEMIN ONCOL, V28, P80, DOI 10.1016/S0093-7754(01)90285-4; Sugiyama H, 2011, J GASTROENTEROL, V46, P779, DOI 10.1007/s00535-011-0380-3; Tang SC, 2014, INT J CANCER, V134, P1484, DOI 10.1002/ijc.28475; Thewke DP, 1999, BRAIN RES, V821, P356, DOI 10.1016/S0006-8993(99)01115-4; Valenzuela CF, 1997, BRAIN RES REV, V24, P77; Lafuente JV, 2012, INT REV NEUROBIOL, V102, P317, DOI 10.1016/B978-0-12-386986-9.00012-0; Ware Kathryn E, 2010, PLoS One, V5, pe14117, DOI 10.1371/journal.pone.0014117; Wilson TR, 2012, NATURE, V487, P505, DOI 10.1038/nature11249; Yadav V, 2012, J BIOL CHEM, V287, P28087, DOI 10.1074/jbc.M112.377218; Young A, 2013, CANCER DISCOV, V3, P112, DOI 10.1158/2159-8290.CD-12-0231	51	16	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0122555	10.1371/journal.pone.0122555	http://dx.doi.org/10.1371/journal.pone.0122555			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25799134	Green Submitted, Green Published, gold			2022-12-27	WOS:000351987300336
J	Ammar, ED; Hentz, M; Hall, DG; Shatters, RG				Ammar, El-Desouky; Hentz, Matthew; Hall, David G.; Shatters, Robert G., Jr.			Ultrastructure of Wax-Producing Structures on the Integument of the Melaleuca Psyllid Boreioglycaspis melaleucae (Hemiptera: Psyllidae), with Honeydew Excretion Behavior in Males and Females	PLOS ONE			English	Article							BIOLOGICAL-CONTROL AGENT; DIAPHORINA-CITRI; FINE-STRUCTURE; SCALE INSECTS; HOST-RANGE; QUINQUENERVIA; HOMOPTERA; GLANDS; APHID; PSYLLOIDEA	The melaleuca psyllid, Boreioglycaspis melaleucae (Hemiptera: Psyllidae), was introduced to Florida as a biological control agent against Melaleuca quinquenervia, an invasive evergreen tree that has invaded large areas of Florida Everglades. Colonies of B. melaleucae nymphs are normally covered by white waxy secretions, and nymphs of various instars produce long bundles of white waxy filaments extending laterally and posteriorly from their abdomen. Scanning electron microscopy of 'naturally waxed' and 'dewaxed' nymphs (cleaned from wax) revealed two types of wax pore plates located dorsally and laterally on the integument of posterior abdominal segments starting with the 4th segment. Type-1 wax pore plates, with raised rim, peripheral groove, slits and pits, produce long ribbons and filaments of waxy secretions that are wound together forming long wax bundles, whereas type-2 wax pore plates, with slits only, produce shorter wax curls. Additionally, in both nymphs and adult females, the circumanal ring contained ornate rows of wax pores that produce wax filaments covering their honeydew excretions. Video recordings with stereomicroscopy showed that adult females produce whitish honeydew balls, powerfully propelled away from their body, probably to get these sticky excretions away from their eggs and newly hatched nymphs. Adult males, however, produce clear droplets of honeydew immediately behind them, simply by bending the posterior end of the abdomen downward. The possible role(s) of waxy secretions by nymphs and adults of B. melaleucae in reducing contamination of their colonies with honeydew, among other possibilities, are discussed.	[Ammar, El-Desouky; Hentz, Matthew; Hall, David G.; Shatters, Robert G., Jr.] USDA ARS, Hort Res Lab, Ft Pierce, FL 34945 USA	United States Department of Agriculture (USDA)	Ammar, ED (corresponding author), USDA ARS, Hort Res Lab, Ft Pierce, FL 34945 USA.	desoukyammar@gmail.com		Shatters, Robert/0000-0002-3903-772X	Agricultural Research Service, United States Department of Agriculture	Agricultural Research Service, United States Department of Agriculture(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	Funding: This work was supported by Agricultural Research Service, United States Department of Agriculture. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alene DC, 2011, AFR INVERTEBR, V52, P353, DOI 10.5733/afin.052.0210; Ammar E., 2013, J MICROSCOPY ULTRAST, V1, P43, DOI DOI 10.1016/J.JMAU.2013.05.001; Ammar ED, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064938; Balentine KM, 2009, ENVIRON ENTOMOL, V38, P1145, DOI 10.1603/022.038.0422; Brittain W. H., 1923, Proceedings Acadian Ent Soc Fredericton NB, V8, P23; CATLING HD, 1970, FAO PLANT PROTECT B, V18, P8; Center TD, 2007, ENVIRON ENTOMOL, V36, P569, DOI 10.1603/0046-225X(2007)36[569:IIAFVO]2.0.CO;2; Center TD, 2012, BIOCONTROL, V57, P151, DOI 10.1007/s10526-011-9390-6; Chiarelli RN, 2011, ANN ENTOMOL SOC AM, V104, P488, DOI 10.1603/AN10163; Douglas AE, 2006, J EXP BOT, V57, P747, DOI 10.1093/jxb/erj067; FOLDI I, 1991, ANN SOC ENTOMOL FR, V27, P163; FOLDI I, 1985, INT J INSECT MORPHOL, V14, P259, DOI 10.1016/0020-7322(85)90041-8; Franks SJ, 2006, ENVIRON ENTOMOL, V35, P366, DOI 10.1603/0046-225X-35.2.366; Franks SJ, 2011, CONSERV GENET, V12, P201, DOI 10.1007/s10592-010-0133-5; Gullan PJ, 1997, ANNU REV ENTOMOL, V42, P23, DOI 10.1146/annurev.ento.42.1.23; Hall DG, 2013, ENTOMOL EXP APPL, V146, P207, DOI 10.1111/eea.12025; Hodkinson I, 2009, J NAT HIST, V43, P65, DOI 10.1080/00222930802354167; Husain M. A., 1927, MEMOIRS DEP AGR INDI, V10, P1; Kumar V, 1997, ITAL J ZOOL, V64, P307, DOI 10.1080/11250009709356218; Lucchi A, 2004, ANN ENTOMOL SOC AM, V97, P1294, DOI 10.1603/0013-8746(2004)097[1294:WPIAOP]2.0.CO;2; Morath SU, 2006, ENVIRON ENTOMOL, V35, P1372, DOI 10.1603/0046-225X(2006)35[1372:HBBMHP]2.0.CO;2; Nelson DR, 2000, COMP BIOCHEM PHYS B, V125, P265, DOI 10.1016/S0305-0491(99)00177-7; Nelson DR, 1997, COMP BIOCHEM PHYS B, V117, P241, DOI 10.1016/S0305-0491(97)00047-3; POPE RD, 1983, J NAT HIST, V17, P489, DOI 10.1080/00222938300770431; Purcell MF, 1997, ENVIRON ENTOMOL, V26, P366, DOI 10.1093/ee/26.2.366; RETNAKARAN A, 1979, CAN ENTOMOL, V111, P67, DOI 10.4039/Ent11167-1; Smith RG, 1999, J NAT HIST, V33, P513, DOI 10.1080/002229399300227; WAKU Y, 1978, J MORPHOL, V158, P243, DOI 10.1002/jmor.1051580302	28	6	6	3	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0121354	10.1371/journal.pone.0121354	http://dx.doi.org/10.1371/journal.pone.0121354			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25793934	Green Submitted, gold, Green Published			2022-12-27	WOS:000352083900126
J	Fernandes, AMS; Andrade, AC; Barroso, ND; Borges, IC; Carvalho-Andrade, D; Rodrigues, ES; Guimaraes, LC; Duraes, AR; Borges, SM; Aras, R				Fernandes, Andre Mauricio S.; Andrade, Agnes Carvalho; Barroso, Natalia Duarte; Borges, Igor Carmo; Carvalho-Andrade, Dafne; Rodrigues Junior, Erenaldo S.; Guimaraes, Libia Castro; Duraes, Andre Rodrigues; Borges, Sirlene Mendes; Aras Junior, Roque			The Immediate Effect of Sildenafil on Right Ventricular Function in Patients with Heart Failure Measured by Cardiac Magnetic Resonance: A Randomized Control Trial	PLOS ONE			English	Article							PHOSPHODIESTERASE 5 INHIBITION; PULMONARY-HYPERTENSION; EJECTION FRACTION; PRESSURE-OVERLOAD; HYPERTROPHY; HEMODYNAMICS; THERAPY	Background Studies have demonstrated that phosphodiesterase 5 (PDE5) inhibition is associated with right ventricle (RV) functional improvement in patients with primary pulmonary hypertension. This study aims to demonstrate the immediate impact of Sildenafil, a PDE5 inhibitor, on RV function, measured by cardiovascular magnetic resonance (CMR), in patients with heart failure (HF). Methods We conducted a randomized double-blind controlled trial. Inclusion criteria: diagnosis of HF functional class I-III; left ventricle ejection fraction < 35%. Patients underwent CMR evaluation and were then equally randomly assigned to either 50 mg of Sildenafil or Placebo groups. One hour following drug administration, they were submitted to a second scan examination. Results 26 patients were recruited from a tertiary reference center in Brazil and 13 were allocated to each study group. The median age was 61.5 years (50-66.5 years). Except for the increase in RV fractional area change following the administration of sildenafil (Sildenafil [before vs. after]: 34.3 [25.2-43.6]% vs. 42.9 [28.5-46.7]%, p = 0.04; Placebo [before vs. after]: 28.1 [9.2-34.8]% vs. 29.2 [22.5-38.8]%, p = 0.86), there was no statistically significant change in parameters. There was no improvement in left ventricular parameters or in the fractional area change of the pulmonary artery. Conclusion This study demonstrated that a single dose of Sildenafil did not significantly improve RV function as measured by the CMR.	[Fernandes, Andre Mauricio S.; Andrade, Agnes Carvalho; Barroso, Natalia Duarte; Borges, Igor Carmo; Carvalho-Andrade, Dafne; Rodrigues Junior, Erenaldo S.; Duraes, Andre Rodrigues; Aras Junior, Roque] Univ Fed Bahia, Hosp Ana Neri, Dept Cardiol, BR-41170290 Salvador, BA, Brazil; [Guimaraes, Libia Castro; Borges, Sirlene Mendes] Univ Fed Bahia, Hosp Ana Neri, Dept Radiol, BR-41170290 Salvador, BA, Brazil	Universidade Federal da Bahia; Universidade Federal da Bahia	Fernandes, AMS (corresponding author), Univ Fed Bahia, Hosp Ana Neri, Dept Cardiol, BR-41170290 Salvador, BA, Brazil.	andremsf@hotmail.com	Borges, Igor Carmo/AAG-8531-2019; Duraes, Andre/X-8916-2019; Duraes, Andre R/N-2593-2017	Duraes, Andre/0000-0002-1506-0327; Duraes, Andre R/0000-0002-1506-0327; Carmo Borges, Igor/0000-0003-2749-0313				Andersen A, 2008, EUR J HEART FAIL, V10, P1158, DOI 10.1016/j.ejheart.2008.09.016; Borgdorff MAJ, 2012, EUR J HEART FAIL, V14, P1067, DOI 10.1093/eurjhf/hfs094; Dumitrescu D, 2012, INT J CARDIOL, V154, P205, DOI 10.1016/j.ijcard.2011.10.064; Galie N, 2005, NEW ENGL J MED, V353, P2148, DOI 10.1056/NEJMoa050010; Gopal AS, 2007, J AM SOC ECHOCARDIOG, V20, P445, DOI 10.1016/j.echo.2006.10.027; Haddad F, 2011, PROG CARDIOVASC DIS, V54, P154, DOI 10.1016/j.pcad.2011.06.003; Hassan Madiha A. H., 2005, BMC Pharmacology, V5, P10, DOI 10.1186/1471-2210-5-10; Hsu S, 2009, CARDIOVASC RES, V81, P301, DOI 10.1093/cvr/cvn324; Kind T, 2010, J CARDIOVASC MAGN R, V12, DOI 10.1186/1532-429X-12-35; Lewis GD, 2007, CIRCULATION, V116, P1555, DOI 10.1161/CIRCULATIONAHA.107.716373; Lewis GD, 2007, CIRCULATION, V115, P59, DOI 10.1161/CIRCULATIONAHA.106.626226; Lewis GD, 2008, CIRC-HEART FAIL, V1, P227, DOI 10.1161/CIRCHEARTFAILURE.108.785501; Meyer P, 2010, CIRCULATION, V121, P252, DOI 10.1161/CIRCULATIONAHA.109.887570; Nagayama T, 2009, J AM COLL CARDIOL, V53, P207, DOI 10.1016/j.jacc.2008.08.069; Nagendran J, 2007, CIRCULATION, V116, P238, DOI 10.1161/CIRCULATIONAHA.106.655266; Potter BJ, 2012, CAN J CARDIOL, V28, P69, DOI 10.1016/j.cjca.2011.09.018; Reichenbach A, 2013, INT J CARDIOL, V168, P60, DOI 10.1016/j.ijcard.2012.09.074; Salloum FN, 2008, AM J PHYSIOL-HEART C, V294, pH1398, DOI [10.1152/ajpheart.ajpheart.91438.2007, 10.1152/ajpheart.91438.2007]; Shan XY, 2012, CIRC-HEART FAIL, V5, P79, DOI 10.1161/CIRCHEARTFAILURE.111.961706; Takimoto E, 2005, NAT MED, V11, P214, DOI 10.1038/nm1175	20	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0119623	10.1371/journal.pone.0119623	http://dx.doi.org/10.1371/journal.pone.0119623			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25793988	Green Submitted, gold, Green Published			2022-12-27	WOS:000352084200101
J	Gisladottir, RS; Chwilla, DJ; Levinson, SC				Gisladottir, Rosa S.; Chwilla, Dorothee J.; Levinson, Stephen C.			Conversation Electrified: ERP Correlates of Speech Act Recognition in Underspecified Utterances	PLOS ONE			English	Article							RIGHT-HEMISPHERE; TIME-COURSE; LANGUAGE; WORD; SENTENCE; PERSPECTIVE; DISCOURSE; INFORMATION; ADDRESSEES; PREDICTION	The ability to recognize speech acts (verbal actions) in conversation is critical for everyday interaction. However, utterances are often underspecified for the speech act they perform, requiring listeners to rely on the context to recognize the action. The goal of this study was to investigate the time-course of auditory speech act recognition in action-underspecified utterances and explore how sequential context (the prior action) impacts this process. We hypothesized that speech acts are recognized early in the utterance to allow for quick transitions between turns in conversation. Event-related potentials (ERPs) were recorded while participants listened to spoken dialogues and performed an action categorization task. The dialogues contained target utterances that each of which could deliver three distinct speech acts depending on the prior turn. The targets were identical across conditions, but differed in the type of speech act performed and how it fit into the larger action sequence. The ERP results show an early effect of action type, reflected by frontal positivities as early as 200 ms after target utterance onset. This indicates that speech act recognition begins early in the turn when the utterance has only been partially processed. Providing further support for early speech act recognition, actions in highly constraining contexts did not elicit an ERP effect to the utterance-final word. We take this to show that listeners can recognize the action before the final word through predictions at the speech act level. However, additional processing based on the complete utterance is required in more complex actions, as reflected by a posterior negativity at the final word when the speech act is in a less constraining context and a new action sequence is initiated. These findings demonstrate that sentence comprehension in conversational contexts crucially involves recognition of verbal action which begins as soon as it can.	[Gisladottir, Rosa S.; Levinson, Stephen C.] Max Planck Inst Psycholinguist, Language & Cognit Dept, Nijmegen, Netherlands; [Chwilla, Dorothee J.] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, NL-6525 ED Nijmegen, Gelderland, Netherlands	Max Planck Society; Radboud University Nijmegen	Gisladottir, RS (corresponding author), Max Planck Inst Psycholinguist, Language & Cognit Dept, Nijmegen, Netherlands.	rosa.gisladottir@mpi.nl		Gisladottir, Rosa Signy/0000-0003-0941-1888	International Max Planck Research School for Language Sciences fellowship; European Research Council [269484]; Donders Centre of Cognition, Radboud University	International Max Planck Research School for Language Sciences fellowship; European Research Council(European Research Council (ERC)European Commission); Donders Centre of Cognition, Radboud University	This work was supported by an International Max Planck Research School for Language Sciences fellowship to RSG and Advance Grant INTERACT #269484 from the European Research Council to SCL. The research was also supported by Donders Centre of Cognition, Radboud University.lysis, decision to publish, or preparation of the manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altmann GTM, 1999, COGNITION, V73, P247, DOI 10.1016/S0010-0277(99)00059-1; Austin John, 1960, DO THINGS WORDS; Bar M, 2009, PHILOS T R SOC B, V364, P1235, DOI 10.1098/rstb.2008.0310; Baron-Cohen S, 2004, J AUTISM DEV DISORD, V34, P163, DOI 10.1023/B:JADD.0000022607.19833.00; Barr DJ, 2013, J MEM LANG, V68, P255, DOI 10.1016/j.jml.2012.11.001; Basnakova J, 2014, CEREB CORTEX, V24, P2572, DOI 10.1093/cercor/bht112; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Beeman MJ, 2000, BRAIN LANG, V71, P310, DOI 10.1006/brln.1999.2268; Blakemore D., 1992, UNDERSTANDING UTTERA; Brown CM, 2000, ARCHITECTURES MECH L, P213; Brown-Schmidt S, 2008, COGNITION, V107, P1122, DOI 10.1016/j.cognition.2007.11.005; Cole Peter, 1975, SYNTAX SEMANTICSVOL, P59, DOI DOI 10.1017/CBO9780511609213.004; Coulson S, 2005, J COGNITIVE NEUROSCI, V17, P494, DOI 10.1162/0898929053279568; Coulson S, 2004, PALG STUD PRAGM LANG, P187; Coulson S, 2010, ITAL J LINGUIST, V22, P107; De Ruiter JP, 2006, LANGUAGE, V82, P515, DOI 10.1353/lan.2006.0130; Dimitrova DV, 2012, J COGNITIVE NEUROSCI, V24, P2400, DOI 10.1162/jocn_a_00302; Dwivedi VD, 2006, BRAIN RES, V1117, P135, DOI 10.1016/j.brainres.2006.07.048; Dwivedi VD, 2010, NEUROREPORT, V21, P791, DOI 10.1097/WNR.0b013e32833cae0d; Egorova N, 2014, BRAIN TOPOGR, V27, P375, DOI 10.1007/s10548-013-0329-3; Egorova N, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00086; Federmeier KD, 2008, LANG LINGUIST COMPAS, V2, P1, DOI 10.1111/j.1749-818x.2007.00042.x; Federmeier KD, 2007, PSYCHOPHYSIOLOGY, V44, P491, DOI 10.1111/j.1469-8986.2007.00531.x; FOLDI NS, 1987, BRAIN LANG, V31, P88, DOI 10.1016/0093-934X(87)90062-9; Frith CD, 2006, NEURON, V50, P531, DOI 10.1016/j.neuron.2006.05.001; Gisladottir Rosa S., 2012, P 34 ANN M COGN SCI, P1596; Grainger J, 2012, PSYCHOPHYSIOLOGY, V49, P604, DOI 10.1111/j.1469-8986.2011.01337.x; Grice Herbert Paul, 1975, SPEECH ACTS, P41, DOI DOI 10.1163/9789004368811_003; Hagoort P., 1999, NEUROCOGNITION LANGU, P273, DOI DOI 10.1093/ACPROF:OSO/9780198507932.001.0001; Hagoort P, 2008, PHILOS T R SOC B, V363, P1055, DOI 10.1098/rstb.2007.2159; Hanna JE, 2004, COGNITIVE SCI, V28, P105, DOI 10.1016/j.cogsci.2003.10.002; Hanna JE, 2003, J MEM LANG, V49, P43, DOI 10.1016/S0749-596X(03)00022-6; Heldner M, 2010, J PHONETICS, V38, P555, DOI 10.1016/j.wocn.2010.08.002; Heller D, 2008, COGNITION, V108, P831, DOI 10.1016/j.cognition.2008.04.008; Heritage J, 2012, RES LANG SOC INTERAC, V45, P30, DOI 10.1080/08351813.2012.646685; Holtgraves T, 2012, BRAIN LANG, V121, P58, DOI 10.1016/j.bandl.2012.01.003; Indefrey P, 2004, COGNITION, V92, P101, DOI 10.1016/j.cognition.2002.06.001; Jaeger TF, 2008, J MEM LANG, V59, P434, DOI 10.1016/j.jml.2007.11.007; Karkkainen E, 2012, DISCOURSE STUD, V14, P587, DOI 10.1177/1461445612454069; KING JW, 1995, J COGNITIVE NEUROSCI, V7, P376, DOI 10.1162/jocn.1995.7.3.376; KLUENDER R, 1993, J COGNITIVE NEUROSCI, V5, P196, DOI 10.1162/jocn.1993.5.2.196; Kolk H, 2007, BRAIN LANG, V100, P257, DOI 10.1016/j.bandl.2006.07.006; Kutas M, 1997, PSYCHOPHYSIOLOGY, V34, P383, DOI 10.1111/j.1469-8986.1997.tb02382.x; KUTAS M, 1993, LANG COGNITIVE PROC, V8, P533, DOI 10.1080/01690969308407587; Kutas M., 2011, PREDICTIONBRAIN US, P190, DOI DOI 10.1093/ACPROF:OSO/9780195395518.003.0065; Kwon N, 2013, LANGUAGE, V89, P537, DOI 10.1353/lan.2013.0044; MacGregor LJ, 2010, NEUROPSYCHOLOGIA, V48, P3982, DOI 10.1016/j.neuropsychologia.2010.09.024; MAGLIANO JP, 1993, DISCOURSE PROCESS, V16, P35, DOI 10.1080/01638539309544828; Magne C, 2005, J COGNITIVE NEUROSCI, V17, P740, DOI 10.1162/0898929053747667; Meinhardt J, 2012, NEUROIMAGE, V63, P623, DOI 10.1016/j.neuroimage.2012.07.019; Menenti L, 2009, J COGNITIVE NEUROSCI, V21, P2358, DOI 10.1162/jocn.2008.21163; Munte TF, 1998, NATURE, V395, P71, DOI 10.1038/25731; Nieuwland MS, 2010, J MEM LANG, V63, P324, DOI 10.1016/j.jml.2010.06.005; Noveck IA, 2003, BRAIN LANG, V85, P203, DOI 10.1016/S0093-934X(03)00053-1; Nurmsoo E, 2008, PSYCHOL SCI, V19, P211, DOI 10.1111/j.1467-9280.2008.02069.x; OSTERHOUT L, 1992, J MEM LANG, V31, P785, DOI 10.1016/0749-596X(92)90039-Z; Pickering MJ, 2013, BEHAV BRAIN SCI, V36, P329, DOI 10.1017/S0140525X12001495; R Core Team, 2021, R LANGUAGE ENV STAT; Regel S, 2011, J COGNITIVE NEUROSCI, V23, P277, DOI 10.1162/jocn.2010.21411; Sabbagh MA, 2000, PSYCHOL SCI, V11, P46, DOI 10.1111/1467-9280.00213; Sadock Jerrold M., 1985, LANGUAGE TYPOLOGY SY, V1, P155; Schacter DL, 2007, NAT REV NEUROSCI, V8, P657, DOI 10.1038/nrn2213; Schank RC., 1977, SCRIPTS PLANS GOALS; Schegloff E.A., 1973, SEMIOTICA, V8, P289, DOI [10.1515/semi.1973.8.4.289, DOI 10.1515/SEMI.1973.8.4.289]; Schegloff EA, 2007, SEQUENCE ORGANIZATION IN INTERACTION: A PRIMER IN CONVERSATION ANALYSIS I, P1, DOI 10.2277/ 0521532795; SCHEGLOFF EA, 1988, J PRAGMATICS, V12, P55, DOI 10.1016/0378-2166(88)90019-7; Schnur TT, 2006, J PSYCHOLINGUIST RES, V35, P189, DOI 10.1007/s10936-005-9011-6; SCHOBER MF, 1989, COGNITIVE PSYCHOL, V21, P211, DOI 10.1016/0010-0285(89)90008-X; Searle John, 1969, SPEECH ACTS ESSAY PH; Sidnell J., 2013, HDB CONVERSATION ANA, P103, DOI DOI 10.1002/9781118325001.CH6; Spotorno N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066839; Stivers T, 2009, P NATL ACAD SCI USA, V106, P10587, DOI 10.1073/pnas.0903616106; ten Bosch L, 2005, SPEECH COMMUN, V47, P80, DOI 10.1016/j.specom.2005.05.009; Thornhill DE, 2012, INT J PSYCHOPHYSIOL, V83, P382, DOI 10.1016/j.ijpsycho.2011.12.007; van Ackeren MJ, 2012, J COGNITIVE NEUROSCI, V24, P2237, DOI 10.1162/jocn_a_00274; van Berkum JJA, 1999, J COGNITIVE NEUROSCI, V11, P657, DOI 10.1162/089892999563724; van Berkum JJA, 2003, COGNITIVE BRAIN RES, V17, P701, DOI 10.1016/S0926-6410(03)00196-4; van Berkum JJA, 2003, PSYCHOPHYSIOLOGY, V40, P235, DOI 10.1111/1469-8986.00025; Van Petten C, 2012, INT J PSYCHOPHYSIOL, V83, P176, DOI 10.1016/j.ijpsycho.2011.09.015; Wang L, 2011, NEUROPSYCHOLOGIA, V49, P813, DOI 10.1016/j.neuropsychologia.2010.12.035; WARD G, 1985, LANGUAGE, V61, P747, DOI 10.2307/414489; Wilson E.O., 1975, P1	82	43	44	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0120068	10.1371/journal.pone.0120068	http://dx.doi.org/10.1371/journal.pone.0120068			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CE8IA	25793289	Green Published, gold, Green Submitted			2022-12-27	WOS:000352084200140
J	Hou, XJ; Jin, ZD; Xu, C; Zhang, MM; Zhu, JW; Jiang, F; Li, ZS				Hou, Xiaojia; Jin, Zhendong; Xu, Can; Zhang, Minmin; Zhu, Jianwei; Jiang, Fei; Li, Zhaoshen			Contrast-Enhanced Harmonic Endoscopic Ultrasound-Guided Fine-Needle Aspiration in the Diagnosis of Solid Pancreatic Lesions: A Retrospective Study	PLOS ONE			English	Article							ON-SITE EVALUATION; DIFFERENTIAL-DIAGNOSIS; COMPUTED-TOMOGRAPHY; EUS; ACCURACY; BIOPSY; CANCER; IMPACT; TUMORS; FNA	Background The negative predictive value of endoscopic ultrasonography-guided fine needle aspiration for the diagnosis of solid pancreatic lesions remains low, and the biopsy specimens are sometimes inadequate for appropriate pathological diagnosis. Aims To evaluate the usefulness of a novel method of contrast-enhanced harmonic endoscopic ultrasonography-guided fine-needle aspiration for the differential diagnosis and adequate sampling of solid pancreatic lesions. Methods Patients with a diagnosis of solid pancreatic lesions who underwent fine-needle aspiration guided by contrast-enhanced harmonic endoscopic ultrasonography or by endoscopic ultrasonography from October 2010 to July 2013 were retrospectively identified and classified into the CH-EUS or EUS group, respectively. Surgical pathology and/or follow-up results were defined as the final diagnosis. Operating characteristics and adequacy of biopsy specimens by fine-needle aspiration were compared between the two groups. Results Operating characteristics for contrast-enhanced harmonic endoscopic ultrasonography-guided fine-needle aspiration in solid pancreatic lesions were as follows: area under the curve = 0.908, sensitivity = 81.6%, specificity = 100%, positive predictive value = 100%, negative predictive value = 74.1%, and accuracy = 87.9%. The percentage of adequate biopsy specimens in the CH-EUS group (96.6%) was greater than that in the EUS group (86.7%). Conclusion Simultaneous contrast-enhanced harmonic endoscopic ultrasonography during fine-needle aspiration is useful for improving the diagnostic yield and adequate sampling of solid pancreatic lesions.	[Hou, Xiaojia; Jin, Zhendong; Xu, Can; Zhang, Minmin; Zhu, Jianwei; Jiang, Fei; Li, Zhaoshen] Second Mil Med Univ, Changhai Hosp, Dept Gastroenterol, Shanghai 200433, Peoples R China	Naval Medical University	Jin, ZD (corresponding author), Second Mil Med Univ, Changhai Hosp, Dept Gastroenterol, Shanghai 200433, Peoples R China.	zhendjin@163.com; zhaoshenli11@163.com						Alsibai KD, 2006, CYTOPATHOLOGY, V17, P18, DOI 10.1111/j.1365-2303.2006.00312.x; Bhutani MS, 2004, ENDOSCOPY, V36, P385, DOI 10.1055/s-2004-814320; Brand B, 2000, SCAND J GASTROENTERO, V35, P1221; Chen G, 2013, PANCREATOLOGY, V13, P298, DOI 10.1016/j.pan.2013.01.013; DeWitt J, 2004, ANN INTERN MED, V141, P753, DOI 10.7326/0003-4819-141-10-200411160-00006; Dewitt J, 2006, CLIN GASTROENTEROL H, V4, P717, DOI 10.1016/j.cgh.2006.02.020; Eloubeidi MA, 2003, CANCER CYTOPATHOL, V99, P285, DOI 10.1002/cncr.11643; Erickson RA, 2000, GASTROINTEST ENDOSC, V51, P184, DOI 10.1016/S0016-5107(00)70416-0; Faigel DO, 1997, J CLIN ONCOL, V15, P1439, DOI 10.1200/JCO.1997.15.4.1439; Fisher L, 2009, J GASTROEN HEPATOL, V24, P90, DOI 10.1111/j.1440-1746.2008.05569.x; Fusaroli P, 2010, CLIN GASTROENTEROL H, V8, P629, DOI 10.1016/j.cgh.2010.04.012; Gincul R, 2014, ENDOSCOPY, V46, P373, DOI 10.1055/s-0034-1364969; Giovannini M, 2009, WORLD J GASTROENTERO, V15, P1587, DOI 10.3748/wjg.15.1587; Gong TT, 2012, GASTROINTEST ENDOSC, V76, P301, DOI 10.1016/j.gie.2012.02.051; Harewood GC, 2002, AM J GASTROENTEROL, V97, P1386, DOI 10.1016/S0002-9270(02)04133-3; Hebert-Magee S, 2013, CYTOPATHOLOGY, V24, P159, DOI 10.1111/cyt.12071; Hewitt MJ, 2012, GASTROINTEST ENDOSC, V75, P319, DOI 10.1016/j.gie.2011.08.049; Hocke M, 2011, ENDOSCOPY, V43, P163, DOI 10.1055/s-0030-1256022; Ibrahim Ashley A, 2014, J Am Soc Cytopathol, V3, P227, DOI 10.1016/j.jasc.2014.04.005; Iglesias-Garcia J, 2007, WORLD J GASTROENTERO, V13, P289, DOI 10.3748/wjg.v13.i2.289; Kedia P, 2013, CLIN ENDOSC, V46, P552, DOI 10.5946/ce.2013.46.5.552; Kitano M, 2008, GASTROINTEST ENDOSC, V67, P141, DOI 10.1016/j.gie.2007.07.045; Kitano M, 2014, DIGEST ENDOSC, V26, P79, DOI 10.1111/den.12179; Kitano M, 2012, AM J GASTROENTEROL, V107, P303, DOI 10.1038/ajg.2011.354; Klapman JB, 2003, AM J GASTROENTEROL, V98, P1289, DOI 10.1016/S0002-9270(03)00246-6; Legmann P, 1998, AM J ROENTGENOL, V170, P1315, DOI 10.2214/ajr.170.5.9574609; Maguchi H, 2006, ENDOSCOPY, V38, pS53, DOI 10.1055/s-2006-946653; Matynia AP, 2014, J GASTROEN HEPATOL, V29, P697, DOI 10.1111/jgh.12431; Park JS, 2014, WORLD J GASTROENTERO, V20, P518, DOI 10.3748/wjg.v20.i2.518; Reddy NK, 2011, WORLD J GASTROENTERO, V17, P42, DOI 10.3748/wjg.v17.i1.42; Romagnuolo J, 2011, GASTROINTEST ENDOSC, V73, P52, DOI 10.1016/j.gie.2010.09.014; ROSCH T, 1991, GASTROINTEST ENDOSC, V37, P347, DOI 10.1016/S0016-5107(91)70729-3; Rosch T, 1997, BRIT J SURG, V84, P1329, DOI 10.1002/bjs.1800841002; Sahai AV, 2010, ENDOSCOPY, V42, P900, DOI 10.1055/s-0030-1255676; Sakamoto H, 2008, ULTRASOUND MED BIOL, V34, P525, DOI 10.1016/j.ultrasmedbio.2007.09.018; Sakamoto H, 2010, WORLD J RADIOL, V2, P122, DOI 10.4329/wjr.v2.i4.122; Savides TJ, 2007, GASTROINTEST ENDOSC, V66, P277, DOI 10.1016/j.gie.2007.01.017; Schmidt RL, 2013, DIGEST DIS SCI, V58, P872, DOI 10.1007/s10620-012-2411-1; Takahashi K, 2005, GASTROINTEST ENDOSC, V61, P76, DOI 10.1016/S0016-5107(04)02224-2; Tamm E, 2001, CANCER J, V7, P298; Tarantino I, 2014, DIGEST LIVER DIS, V46, P523, DOI 10.1016/j.dld.2014.02.023; Volmar KE, 2005, GASTROINTEST ENDOSC, V61, P854, DOI 10.1016/S0016-5107(05)00364-0; Voss M, 2000, GUT, V46, P244, DOI 10.1136/gut.46.2.244; Wang Y, 2007, INT J CANCER, V121, P2716, DOI 10.1002/ijc.22997; Xu Can, 2012, Diagn Ther Endosc, V2012, P786239, DOI 10.1155/2012/786239	45	30	33	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0121236	10.1371/journal.pone.0121236	http://dx.doi.org/10.1371/journal.pone.0121236			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25793739	Green Submitted, gold, Green Published			2022-12-27	WOS:000352083900115
J	Kapetanovic, S; Aaron, L; Montepiedra, G; Anthony, P; Thuvamontolrat, K; Pahwa, S; Burchett, S; Weinberg, A; Kovacs, A				Kapetanovic, Suad; Aaron, Lisa; Montepiedra, Grace; Anthony, Patricia; Thuvamontolrat, Kasalyn; Pahwa, Savita; Burchett, Sandra; Weinberg, Adriana; Kovacs, Andrea		Pediatric AIDS Clinical Trials Grp	Effect of Cytomegalovirus Co-Infection on Normalization of Selected T-Cell Subsets in Children with Perinatally Acquired HIV Infection Treated with Combination Antiretroviral Therapy	PLOS ONE			English	Article							IMMUNE RECONSTITUTION; IN-VITRO; EXPRESSION; ACTIVATION; CD4(+); DIFFERENTIATION; LYMPHOCYTES; ANTIGENS; INDIVIDUALS; RESPONSES	Background We examined the effect of cytomegalovirus (CMV) co-infection and viremia on reconstitution of selected CD4+ and CD8+ T-cell subsets in perinatally HIV-infected (PHIV+) children >= 1-year old who participated in a partially randomized, open-label, 96-week combination antire-troviral therapy (cART)-algorithmstudy. Methods Participants were categorized as CMV-naive, CMV-positive (CMV+) viremic, and CMV+ aviremic, based on blood, urine, or throat culture, CMV IgG and DNA polymerase chain reaction measured at baseline. At weeks 0, 12, 20 and 40, T-cell subsets including naive (CD62L+CD45RA+; CD95-CD28+), activated (CD38+HLA-DR+) and terminally differentiated (CD62L-CD45RA+; CD95+CD28-) CD4+ and CD8+ T-cells were measured by flow cytometry. Results Of the 107 participants included in the analysis, 14% were CMV+ viremic; 49% CMV+ aviremic; 37% CMV-naive. In longitudinal adjusted models, compared with CMV+ status, baseline CMV-naive status was significantly associated with faster recovery of CD8+CD62L +CD45RA+% and CD8+CD95-CD28+% and faster decrease of CD8+CD95+CD28-%, independent of HIV VL response to treatment, cART regimen and baseline CD4%. Surprisingly, CMV status did not have a significant impact on longitudinal trends in CD8+CD38+HLA-DR+%. CMV status did not have a significant impact on any CD4+ T-cell subsets. Conclusions In this cohort of PHIV+ children, the normalization of naive and terminally differentiated CD8+ T-cell subsets in response to cART was detrimentally affected by the presence of CMV co-infection. These findings may have implications for adjunctive treatment strategies targeting CMV co-infection in PHIV+ children, especially those that are now adults or reaching young adulthood and may have accelerated immunologic aging, increased opportunistic infections and aging diseases of the immune system.	[Kapetanovic, Suad] NIMH, NIH, Bethesda, MD 20892 USA; [Aaron, Lisa; Montepiedra, Grace] Harvard Univ, Sch Publ Hlth, Ctr Biostat AIDS Res, Boston, MA 02115 USA; [Anthony, Patricia; Thuvamontolrat, Kasalyn; Kovacs, Andrea] Univ So Calif, Keck Sch Med, Maternal Child & Adolescent Ctr Infect Dis & Viro, Los Angeles, CA 90033 USA; [Pahwa, Savita] Univ Miami, Miller Sch Med, Miami, FL 33136 USA; [Burchett, Sandra] Childrens Hosp Boston, Boston, MA USA; [Burchett, Sandra] Harvard Univ, Sch Med, Boston, MA USA; [Weinberg, Adriana] Univ Colorado, Denver, CO 80202 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); Harvard University; Harvard T.H. Chan School of Public Health; University of Southern California; University of Miami; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; University of Colorado System; University of Colorado Denver	Kapetanovic, S (corresponding author), NIMH, NIH, Bethesda, MD 20892 USA.	suad.kapetanovic@nih.gov	Pahwa, Savita/AAA-4900-2019	Pahwa, Savita/0000-0002-4470-4216; Bonagura, Vincent/0000-0002-0681-2099	National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) [UM1AI068632, UM1AI068616, UM1AI106716]; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); National Institute of Mental Health (NIMH); Intramural Research Program of the NIMH; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001082] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025758] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI106716, UM1AI068616, UM1AI069477, UM1AI068632, UM1AI069415] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute of Mental Health (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Intramural Research Program of the NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Overall support for the International Maternal Pediatric Adolescent AIDS Clinical Trials Group (IMPAACT) was provided by the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) under Award Numbers UM1AI068632 (IMPAACT LOC), UM1AI068616 (IMPAACT SDMC) and UM1AI106716 (IMPAACT LC), with co-funding from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) and the National Institute of Mental Health (NIMH). This project was also supported in part by the Intramural Research Program of the NIMH. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appay V, 2008, J PATHOL, V214, P231, DOI 10.1002/path.2276; Appay V, 2002, NAT MED, V8, P379, DOI 10.1038/nm0402-379; Betensky RA, 2000, CLIN DIAGN LAB IMMUN, V7, P759, DOI 10.1128/CDLI.7.5.759-763.2000; CDC (Centers for Disease Control and Prevention), 1993, MMWR RECOMM REP, V41, P1; De Martino M, 1998, PEDIATR RES, V43, P752, DOI 10.1203/00006450-199806000-00007; Effros RB, 1997, DEV COMP IMMUNOL, V21, P471, DOI 10.1016/S0145-305X(97)00027-X; Gantt S, 2011, ANTIMICROB AGENTS CH, V55, P2696, DOI 10.1128/AAC.01295-10; Hengel RL, 2003, J IMMUNOL, V170, P28, DOI 10.4049/jimmunol.170.1.28; Henson SM, 2012, CURR OPIN IMMUNOL, V24, P476, DOI 10.1016/j.coi.2012.04.001; Hunt PW, 2011, J INFECT DIS, V203, P1474, DOI 10.1093/infdis/jir060; Jiang JD, 1997, J CLIN IMMUNOL, V17, P185, DOI 10.1023/A:1027386701052; Kapetanovic S, 2012, AIDS, V26, P959, DOI 10.1097/QAD.0b013e328352cee7; Kovacs A, 1999, NEW ENGL J MED, V341, P77, DOI 10.1056/NEJM199907083410203; Kovacs A, 2005, J INFECT DIS, V192, P296, DOI 10.1086/430922; Meditz AL, 2011, J VIROL, V85, P10189, DOI 10.1128/JVI.02529-10; Miles DJC, 2007, J VIROL, V81, P5766, DOI 10.1128/JVI.00052-07; Obar JJ, 2010, ANN NY ACAD SCI, V1183, P251, DOI 10.1111/j.1749-6632.2009.05126.x; ROEDERER M, 1995, J CLIN INVEST, V95, P2061, DOI 10.1172/JCI117892; Rosenblatt HM, 2005, J INFECT DIS, V192, P445, DOI 10.1086/431597; Roxby AC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087855; SCHLESINGER M, 1995, PEDIATR RES, V38, P390, DOI 10.1203/00006450-199509000-00020; Solana R, 2012, IMMUN AGEING, V9, DOI 10.1186/1742-4933-9-23; Weinberg A, 2008, CLIN VACCINE IMMUNOL, V15, P1398, DOI 10.1128/CVI.00479-07; Weinberg A, 2004, CLIN INFECT DIS, V39, P107, DOI 10.1086/420931	24	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0120474	10.1371/journal.pone.0120474	http://dx.doi.org/10.1371/journal.pone.0120474			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25794163	Green Published, gold, Green Submitted			2022-12-27	WOS:000352083900038
J	Kouba, M; Bartos, L; Korpimaki, E; Zarybnicka, M				Kouba, Marek; Bartos, Ludek; Korpimaki, Erkki; Zarybnicka, Marketa			Factors Affecting the Duration of Nestling Period and Fledging Order in Tengmalm's Owl (Aegolius funereus): Effect of Wing Length and Hatching Sequence	PLOS ONE			English	Article							DEVELOPMENTAL RATES; PARENTAL BEHAVIOR; FOOD ABUNDANCE; GROWTH-RATE; HOLE SHIFT; SEX-RATIO; AGE; PREDATION; EVOLUTION; SIZE	In altricial birds, the nestling period is an important part of the breeding phase because the juveniles may spend quite a long time in the nest, with associated high energy costs for the parents. The length of the nestling period can be variable and its duration may be influenced by both biotic and abiotic factors; however, studies of this have mostly been undertaken on passerine birds. We studied individual duration of nestling period of 98 Tengmalm's owl chicks (Aegolius funereus) at 27 nests during five breeding seasons using a camera and chip system and radio-telemetry. We found the nestlings stayed in the nest box for 27-38 days from hatching (mean +/- SD, 32.4 +/- 2.2 days). The individual duration of nestling period was negatively related to wing length, but no formally significant effect was found for body weight, sex, prey availability and/or weather conditions. The fledging sequence of individual nestlings was primarily related to hatching order; no relationship with wing length and/or other factors was found in this case. We suggest the length of wing is the most important measure of body condition and individual quality in Tengmalm's owl young determining the duration of the nestling period. Other differences from passerines (e.g., the lack of effect of weather or prey availability on nestling period) are considered likely to be due to different life-history traits, in particular different food habits and nesting sites and greater risk of nest predation among passerines.	[Kouba, Marek; Zarybnicka, Marketa] Czech Univ Life Sci Prague, Fac Environm Sci, Dept Ecol, Prague, Czech Republic; [Bartos, Ludek] Czech Univ Life Sci Prague, Fac Agrobiol Food & Nat Resources, Dept Anim Sci & Ethol, Prague, Czech Republic; [Bartos, Ludek] Inst Anim Sci, Dept Ethol, Prague, Czech Republic; [Korpimaki, Erkki] Univ Turku, Dept Biol, Sect Ecol, SF-20500 Turku, Finland	Czech University of Life Sciences Prague; Czech University of Life Sciences Prague; Czech Research Institute of Animal Science; University of Turku	Kouba, M (corresponding author), Czech Univ Life Sci Prague, Fac Environm Sci, Dept Ecol, Prague, Czech Republic.	marekkouba8@gmail.com	ZÃrybnickÃ, MarkÃ©ta/AAM-3181-2020; Kouba, Marek/A-1350-2019	Kouba, Marek/0000-0003-2262-5733; Zarybnicka, Marketa/0000-0001-5883-0988	Czech University of Life Sciences Prague (CIGA) [20104205, 20144203]; Ministry of Education, Youth and Sports of the Czech Republic (MSMT) [1321/213205]; Ministry of Agriculture of the Czech Republic (MZERO) [0714]	Czech University of Life Sciences Prague (CIGA); Ministry of Education, Youth and Sports of the Czech Republic (MSMT)(Ministry of Education, Youth & Sports - Czech Republic); Ministry of Agriculture of the Czech Republic (MZERO)	Funding: This study was supported by the Czech University of Life Sciences Prague (CIGA Grant No. 20104205 [MK] and 20144203 [MZ MK]), the Ministry of Education, Youth and Sports of the Czech Republic (MSMT Grant No. 1321/213205 [LB]), and Ministry of Agriculture of the Czech Republic (MZERO Grant No. 0714 [LB]). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEZOUSKA V, 2005, ITCE 2005 C, P173; Bize P, 2003, J ANIM ECOL, V72, P633, DOI 10.1046/j.1365-2656.2003.00734.x; Bize P, 2006, FUNCT ECOL, V20, P857, DOI 10.1111/j.1365-2435.2006.01157.x; BOSQUE C, 1995, AM NAT, V145, P234, DOI 10.1086/285738; Clutton-Brock T.H., 1991, EVOLUTION PARENTAL C; CRUZ JB, 1990, CONDOR, V92, P160, DOI 10.2307/1368394; Davis SK, 2009, J FIELD ORNITHOL, V80, P265, DOI 10.1111/j.1557-9263.2009.00229.x; Drdakova Marketa, 2003, Sylvia, V39, P35; Drdakova-Zarybnicka M., 2005, BUTEO, V14, P37; Durant JM, 2006, BIOL LETT-UK, V2, P628, DOI 10.1098/rsbl.2006.0520; Eldegard K, 2012, J ORNITHOL, V153, P385, DOI 10.1007/s10336-011-0753-7; Eldegard K, 2010, BEHAV ECOL SOCIOBIOL, V64, P815, DOI 10.1007/s00265-009-0898-z; Eldegard K, 2009, P ROY SOC B-BIOL SCI, V276, P1713, DOI 10.1098/rspb.2008.1775; EMLEN ST, 1991, CONDOR, V93, P591, DOI 10.2307/1368191; FREED LA, 1988, NATL GEOGR RES, V4, P395; Fridolfsson AK, 1999, J AVIAN BIOL, V30, P116, DOI 10.2307/3677252; Granadeiro JP, 2000, BEHAV ECOL, V11, P274, DOI 10.1093/beheco/11.3.274; Hipkiss T, 2004, POPUL ECOL, V46, P263, DOI 10.1007/s10144-004-0195-7; Johnson LS, 2013, J FIELD ORNITHOL, V84, P367, DOI 10.1111/jofo.12036; Johnson LS, 2004, ETHOLOGY, V110, P693, DOI 10.1111/j.1439-0310.2004.01001.x; Karell P, 2009, CAN J ZOOL, V87, P8, DOI 10.1139/Z08-133; Killpack TL, 2012, J EXP BIOL, V215, P1806, DOI 10.1242/jeb.066316; Konig C, 2008, OWLS WORLD; Korpimaki E, 2012, BOREAL OWL: ECOLOGY, BEHAVIOUR AND CONSERVATION OF A FOREST-DWELLING PREDATOR, P1, DOI 10.1017/CBO9780511844164; KORPIMAKI E, 1991, OECOLOGIA, V85, P543, DOI 10.1007/BF00323767; KORPIMAKI E, 1988, ORNIS FENNICA, V65, P21; KORPIMAKI E, 1987, J ANIM ECOL, V56, P185, DOI 10.2307/4808; KORPIMAKI E, 1992, J ANIM ECOL, V61, P103, DOI 10.2307/5513; KORPIMAKI E, 1986, ORNIS SCAND, V17, P326, DOI 10.2307/3676820; Korpimaki E., 1981, ACTA U OULUENSIS SER, V118, P1; Kouba M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097504; Kouba M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095594; Kouba M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067034; Kouba Marek, 2012, Sylvia, V48, P115; Kuhk R., 1969, BONNER ZOOL BEITR, V20, P141; Lack D., 1954, P343; LEMEL J, 1989, AUK, V106, P490; Lyons DE, 2011, J FIELD ORNITHOL, V82, P88, DOI 10.1111/j.1557-9263.2010.00311.x; MARTIN TE, 1995, ECOL MONOGR, V65, P101, DOI 10.2307/2937160; Michaud T, 2000, AUK, V117, P996, DOI 10.1642/0004-8038(2000)117[0996:TRODPB]2.0.CO;2; Mikkola H., 2020, OWLS, P97; Miller DA, 2010, P ROY SOC B-BIOL SCI, V277, P1659, DOI 10.1098/rspb.2010.0022; Nilsson J.-A., 1990, POPULATION BIOL PASS, P369; NILSSON JA, 1993, ANIM BEHAV, V46, P379, DOI 10.1006/anbe.1993.1200; Oyan HS, 1996, AUK, V113, P830; Pennycuick C.J., 1975, AVIAN BIOL, P1, DOI DOI 10.1016/B978-0-12-249405-5.50009-4; Radersma R, 2011, ANIM BEHAV, V81, P69, DOI 10.1016/j.anbehav.2010.09.007; Remes V, 2002, EVOLUTION, V56, P2505; Remes V, 2007, J EVOLUTION BIOL, V20, P320, DOI 10.1111/j.1420-9101.2006.01191.x; RICKLEFS RE, 1968, IBIS, V110, P419, DOI 10.1111/j.1474-919X.1968.tb00058.x; Risely A, 2013, BIRD STUDY, V60, P539, DOI 10.1080/00063657.2013.846293; Roff DA, 2005, J EVOLUTION BIOL, V18, P1425, DOI 10.1111/j.1420-9101.2005.00958.x; Searcy WA, 2004, J AVIAN BIOL, V35, P269, DOI 10.1111/j.0908-8857.2004.03247.x; SONERUD GA, 1985, J ANIM ECOL, V54, P179, DOI 10.2307/4629; Stodola KW, 2010, AUK, V127, P204, DOI 10.1525/auk.2009.09151; Takenaka M, 2005, CAN J ZOOL, V83, P1476, DOI 10.1139/Z05-145; Tao J, 2002, MIXED MODEL ANALYSES; TRENT B, 1977, WILSON BULL, V89, P609; Trivers R. L., 1985, SOCIAL EVOLUTION; TRIVERS RL, 1974, AM ZOOL, V14, P249; Vacik R, 1991, SYLVIA, V28, P95; Valkama J, 2002, OECOLOGIA, V133, P334, DOI 10.1007/s00442-002-1033-2; Wright J, 2006, P ROY SOC B-BIOL SCI, V273, P1895, DOI 10.1098/rspb.2006.3533; Zarybnicka M, 2013, ZOOL STUD, V52, DOI 10.1186/1810-522X-52-36; Zarybnicka M, 2013, POPUL ECOL, V55, P353, DOI 10.1007/s10144-013-0367-4; Zarybnicka M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036932; Zarybnicka M, 2011, ORNIS FENNICA, V88, P147; Zarybnicka M, 2009, ACTA ORNITHOL, V44, P81, DOI 10.3161/000164509X464911; Zarybnicka M, 2009, FOLIA ZOOL, V58, P104; Zarybnicka M, 2009, J ORNITHOL, V150, P231, DOI 10.1007/s10336-008-0342-6	70	7	7	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0121641	10.1371/journal.pone.0121641	http://dx.doi.org/10.1371/journal.pone.0121641			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25793880	gold, Green Published, Green Submitted			2022-12-27	WOS:000352083900143
J	Lerksuthirat, T; Lohnoo, T; Inkomlue, R; Rujirawat, T; Yingyong, W; Khositnithikul, R; Phaonakrop, N; Roytrakul, S; Sullivan, TD; Krajaejun, T				Lerksuthirat, Tassanee; Lohnoo, Tassanee; Inkomlue, Ruchuros; Rujirawat, Thidarat; Yingyong, Wanta; Khositnithikul, Rommanee; Phaonakrop, Narumon; Roytrakul, Sittiruk; Sullivan, Thomas D.; Krajaejun, Theerapong			The Elicitin-Like Glycoprotein, ELI025, Is Secreted by the Pathogenic Oomycete Pythium insidiosum and Evades Host Antibody Responses	PLOS ONE			English	Article							LINKED-IMMUNOSORBENT-ASSAY; GENOME SEQUENCE; HUMAN PYTHIOSIS; APHANOMYCES-EUTEICHES; EVOLUTIONARY HISTORY; RAPID SERODIAGNOSIS; HELICOBACTER-PYLORI; CANDIDA-ALBICANS; PHYTOPHTHORA; PROTEIN	Pythium insidiosum is a unique oomycete that can infect humans and animals. Patients with a P. insidiosum infection (pythiosis) have high rates of morbidity and mortality. The pathogen resists conventional antifungal drugs. Information on the biology and pathogenesis of P. insidiosum is limited. Many pathogens secrete proteins, known as effectors, which can affect the host response and promote the infection process. Elicitins are secretory proteins and are found only in the oomycetes, primarily in Phytophthora and Pythium species. In plant-pathogenic oomycetes, elicitins function as pathogen-associated molecular pattern molecules, sterol carriers, and plant defense stimulators. Recently, we reported a number of elicitin-encoding genes from the P. insidiosum transcriptome. The function of elicitins during human infections is unknown. One of the P. insidiosum elicitin-encoding genes, ELI025, is highly expressed and up-regulated at body temperature. This study aims to characterize the biochemical, immunological, and genetic properties of the elicitin protein, ELI025. A 12.4-kDa recombinant ELI025 protein (rELI025) was expressed in Escherichia coli. Rabbit anti-rELI025 antibodies reacted strongly with the native ELI025 in P. insidiosum's culture medium. The detected ELI025 had two isoforms: glycosylated and non-glycosylated. ELI025 was not immunoreactive with sera from pythiosis patients. The region near the transcriptional start site of ELI025 contained conserved oomycete core promoter elements. In conclusion, ELI025 is a small, abundant, secreted glycoprotein that evades host antibody responses. ELI025 is a promising candidate for development of diagnostic and therapeutic targets for pythiosis.	[Lerksuthirat, Tassanee; Inkomlue, Ruchuros; Khositnithikul, Rommanee; Krajaejun, Theerapong] Mahidol Univ, Ramathibodi Hosp, Fac Med, Dept Pathol, Bangkok 10400, Thailand; [Lohnoo, Tassanee; Rujirawat, Thidarat; Yingyong, Wanta] Mahidol Univ, Ramathibodi Hosp, Fac Med, Res Ctr, Bangkok 10400, Thailand; [Lerksuthirat, Tassanee; Rujirawat, Thidarat] Mahidol Univ, Fac Sci, Multidisciplinary Unit, Program Mol Med, Bangkok 10400, Thailand; [Phaonakrop, Narumon; Roytrakul, Sittiruk] Natl Sci & Technol Dev Agcy, Genome Inst, Prote Res Lab, Pathum Thani, Thailand; [Sullivan, Thomas D.] Univ Wisconsin, Dept Pediat, Sch Med & Publ Hlth, Madison, WI USA	Mahidol University; Mahidol University; Mahidol University; National Science & Technology Development Agency - Thailand; University of Wisconsin System; University of Wisconsin Madison	Krajaejun, T (corresponding author), Mahidol Univ, Ramathibodi Hosp, Fac Med, Dept Pathol, Bangkok 10400, Thailand.	mr_en@hotmail.com	Krajaejun, Theerapong/P-2550-2017; Lerksuthirat, Tassanee/A-1930-2016	Krajaejun, Theerapong/0000-0003-0545-3765; Lerksuthirat, Tassanee/0000-0001-9526-951X; Rujirawat, Thidarat/0000-0003-1256-7330	Thailand Research Fund [BRG5680011]; Mahidol University [E01/2557]; Royal Golden Jubilee Ph.D. Scholarship [PHD/0092/2553]	Thailand Research Fund(Thailand Research Fund (TRF)); Mahidol University; Royal Golden Jubilee Ph.D. Scholarship	This work is supported by the Thailand Research Fund (TK; grant number, BRG5680011; URL, http://www.trf.or.th), a Research Fund from Mahidol University (TK; grant number, E01/2557; URL, http://www.op.mahidol.ac.th/orra), and the Royal Golden Jubilee Ph.D. Scholarship (TLE; grant number, PHD/0092/2553; URL, http://rgj.trf.or.th, Lerksuthirat). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2006, TERRIFIC BROTH; Armbrust EV, 2004, SCIENCE, V306, P79, DOI 10.1126/science.1101156; Baxter L, 2010, SCIENCE, V330, P1549, DOI 10.1126/science.1195203; Bhavsar AP, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003518; Boissy G, 1996, STRUCTURE, V4, P1429, DOI 10.1016/S0969-2126(96)00150-5; Boissy G, 1999, PROTEIN SCI, V8, P1191, DOI 10.1110/ps.8.6.1191; Bosco SDG, 2005, EMERG INFECT DIS, V11, P715; Bowler C, 2008, NATURE, V456, P239, DOI 10.1038/nature07410; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cerqueira GC, 2014, NUCLEIC ACIDS RES, V42, pD705, DOI 10.1093/nar/gkt1029; CHAIPRASERT A, 1990, MYCOSES, V33, P317, DOI 10.1111/myc.1990.33.6.317; Chareonsirisuthigul T, 2013, DIAGN MICR INFEC DIS, V76, P42, DOI 10.1016/j.diagmicrobio.2013.02.025; Chevenet F, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-439; Cisse OH, 2013, MBIO, V4, DOI 10.1128/mBio.00428-12; Cock JM, 2010, NATURE, V465, P617, DOI 10.1038/nature09016; DECOCK AWAM, 1987, J CLIN MICROBIOL, V25, P344, DOI 10.1128/JCM.25.2.344-349.1987; Denoeud F, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-3-r29; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Eisenhaber B, 2004, J MOL BIOL, V337, P243, DOI 10.1016/j.jmb.2004.01.025; Gaastra W, 2010, VET MICROBIOL, V146, P1, DOI 10.1016/j.vetmic.2010.07.019; Gaulin E, 2010, PLANT SIGNAL BEHAV, V5, P258, DOI 10.4161/psb.5.3.10551; Gaulin E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001723; Gobler CJ, 2011, P NATL ACAD SCI USA, V108, P4352, DOI 10.1073/pnas.1016106108; HENDRIX JW, 1975, MYCOLOGIA, V67, P663, DOI 10.2307/3758403; Inglis DO, 2012, NUCLEIC ACIDS RES, V40, pD667, DOI 10.1093/nar/gkr945; Jiang RHY, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003272; Jiang RHY, 2006, MOL BIOL EVOL, V23, P338, DOI 10.1093/molbev/msj039; Jiang RHY, 2005, MOL GENET GENOMICS, V273, P20, DOI 10.1007/s00438-005-1114-0; Jindayok T, 2009, CLIN VACCINE IMMUNOL, V16, P1047, DOI 10.1128/CVI.00113-09; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; JUDELSON HS, 1991, MOL PLANT MICROBE IN, V4, P602, DOI 10.1094/MPMI-4-602; Judelson HS, 2009, OOMYCETE GENETICS GE, P435; Julenius K, 2005, GLYCOBIOLOGY, V15, P153, DOI 10.1093/glycob/cwh151; Kale SD, 2011, CELL MICROBIOL, V13, P1839, DOI 10.1111/j.1462-5822.2011.01659.x; Kamoun S, 1998, PLANT CELL, V10, P1413, DOI 10.1105/tpc.10.9.1413; Keeratijarut A, 2009, SE ASIAN J TROP MED, V40, P1298; Kemen E, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001094; Krajaejun T, 2002, CLIN DIAGN LAB IMMUN, V9, P378, DOI 10.1128/CDLI.9.2.378-382.2002; Krajaejun T, 2006, CLIN INFECT DIS, V43, P569, DOI 10.1086/506353; Krajaejun T, 2014, FUNGAL BIOL-UK, V118, P640, DOI 10.1016/j.funbio.2014.01.009; Krajaejun T, 2011, FUNGAL BIOL-UK, V115, P683, DOI 10.1016/j.funbio.2011.05.001; Krajaejun T, 2009, CLIN VACCINE IMMUNOL, V16, P506, DOI 10.1128/CVI.00276-08; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Lamour KH, 2012, MOL PLANT MICROBE IN, V25, P1350, DOI 10.1094/MPMI-02-12-0028-R; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lascombe MB, 2007, ACTA CRYSTALLOGR D, V63, P1102, DOI 10.1107/S0907444907043363; Lascombe MB, 2002, ACTA CRYSTALLOGR D, V58, P1442, DOI 10.1107/S0907444902011745; Levesque CA, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-7-r73; Loftus BJ, 2005, SCIENCE, V307, P1321, DOI 10.1126/science.1103773; Lohnoo Tassanee, 2014, Journal of the Medical Association of Thailand, V97, P342; Lopez-Estrano C, 2003, P NATL ACAD SCI USA, V100, P12402, DOI 10.1073/pnas.2133080100; Ma LJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000549; Madoui MA, 2009, NEW PHYTOL, V183, P291, DOI 10.1111/j.1469-8137.2009.02895.x; MENDOZA L, 1986, MYCOPATHOLOGIA, V94, P123, DOI 10.1007/BF00437377; Mendoza L, 2004, MYCOSES, V47, P14, DOI 10.1046/j.1439-0507.2003.00950.x; Mendoza L, 2013, CURR FUNGAL INFECT R, V7, P198, DOI 10.1007/s12281-013-0144-z; Mikes V, 1998, BIOCHEM BIOPH RES CO, V245, P133, DOI 10.1006/bbrc.1998.8341; Mikes V, 1997, FEBS LETT, V416, P190, DOI 10.1016/S0014-5793(97)01193-9; MortBontemps M, 1997, CURR GENET, V31, P272, DOI 10.1007/s002940050205; Mosbah E, 2012, J EQUINE VET SCI, V32, P164, DOI 10.1016/j.jevs.2011.08.014; Murata-Kamiya N, 2010, CELL HOST MICROBE, V7, P399, DOI 10.1016/j.chom.2010.04.005; Murdoch D, 1997, AUST NZ J OPHTHALMOL, V25, P177, DOI 10.1111/j.1442-9071.1997.tb01304.x; Nicholas K.B., 1997, EMBNEW NEWS, V4, P14; Nurnberger T, 2004, IMMUNOL REV, V198, P249, DOI 10.1111/j.0105-2896.2004.0119.x; Oldenhoff W, 2014, VET DERMATOL, V25, P52, DOI 10.1111/vde.12101; Osman H, 2001, MOL BIOL CELL, V12, P2825, DOI 10.1091/mbc.12.9.2825; Panabieres F, 1997, MYCOL RES, V101, P1459, DOI 10.1017/S0953756297004413; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Prasertwitayakij N, 2003, SEMIN ARTHRITIS RHEU, V33, P204, DOI 10.1016/j.semarthrit.2003.09.003; Qutob D, 2003, MOL PLANT PATHOL, V4, P119, DOI 10.1046/j.1364-3703.2003.00158.x; Radakovits R, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1688; Rivierre C, 2005, EMERG INFECT DIS, V11, P479; Rodrigues ML, 2006, BBA-PROTEINS PROTEOM, V1764, P110, DOI 10.1016/j.bbapap.2005.09.008; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schurko A, 2003, MYCOLOGIA, V95, P200, DOI 10.2307/3762031; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Supabandhu J, 2008, MED MYCOL, V46, P41, DOI 10.1080/13693780701513840; Tian MY, 2011, MOL PLANT MICROBE IN, V24, P543, DOI 10.1094/MPMI-08-10-0185; Torto-Alalibo T, 2010, MICROBIOL MOL BIOL R, V74, P479, DOI 10.1128/MMBR.00017-10; Torto-Alalibo T, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-S1-S3; Tyler BM, 2006, SCIENCE, V313, P1261, DOI 10.1126/science.1128796; Vanittanakom N, 2004, J CLIN MICROBIOL, V42, P3970, DOI 10.1128/JCM.42.9.3970-3974.2004; Wawra S, 2012, CURR OPIN MICROBIOL, V15, P685, DOI 10.1016/j.mib.2012.10.008; Weiland JJ, 2003, CURR GENET, V42, P344, DOI 10.1007/s00294-002-0359-y; Wilkins MR, 1999, METH MOL B, V112, P531; Wroblewski LE, 2010, CLIN MICROBIOL REV, V23, P713, DOI 10.1128/CMR.00011-10; YU LM, 1995, P NATL ACAD SCI USA, V92, P4088, DOI 10.1073/pnas.92.10.4088	88	17	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0118547	10.1371/journal.pone.0118547	http://dx.doi.org/10.1371/journal.pone.0118547			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25793767	gold, Green Published, Green Submitted			2022-12-27	WOS:000352084200028
J	Lockhart, SN; Luck, SJ; Geng, J; Beckett, L; Disbrow, EA; Carmichael, O; DeCarli, C				Lockhart, Samuel N.; Luck, Steven J.; Geng, Joy; Beckett, Laurel; Disbrow, Elizabeth A.; Carmichael, Owen; DeCarli, Charles			White Matter Hyperintensities among Older Adults Are Associated with Futile Increase in Frontal Activation and Functional Connectivity during Spatial Search	PLOS ONE			English	Article							PREFRONTAL CORTEX FUNCTION; VISUAL-ATTENTION; AGE-DIFFERENCES; COGNITIVE CONTROL; BRAIN; MRI; HYPOTHESIS; PERFORMANCE; MECHANISMS; DEFICITS	The mechanisms by which aging and other processes can affect the structure and function of brain networks are important to understanding normal age-related cognitive decline. Advancing age is known to be associated with various disease processes, including clinically asymptomatic vascular and inflammation processes that contribute to white matter structural alteration and potential injury. The effects of these processes on the function of distributed cognitive networks, however, are poorly understood. We hypothesized that the extent of magnetic resonance imaging white matter hyperintensities would be associated with visual attentional control in healthy aging, measured using a functional magnetic resonance imaging search task. We assessed cognitively healthy older adults with search tasks indexing processing speed and attentional control. Expanding upon previous research, older adults demonstrate activation across a frontal-parietal attentional control network. Further, greater white matter hyperintensity volume was associated with increased activation of a frontal network node independent of chronological age. Also consistent with previous research, greater white matter hyperintensity volume was associated with anatomically specific reductions in functional magnetic resonance imaging functional connectivity during search among attentional control regions. White matter hyperintensities may lead to subtle attentional network dysfunction, potentially through impaired frontal-parietal and frontal interhemispheric connectivity, suggesting that clinically silent white matter biomarkers of vascular and inflammatory injury can contribute to differences in search performance and brain function in aging, and likely contribute to advanced age-related impairments in cognitive control.	[Lockhart, Samuel N.; Carmichael, Owen; DeCarli, Charles] Univ Calif Davis, Imaging Dementia & Aging Lab, Davis, CA 95616 USA; [Lockhart, Samuel N.; Beckett, Laurel; Carmichael, Owen; DeCarli, Charles] Univ Calif Davis, Dept Neurol, Davis, CA 95616 USA; [Lockhart, Samuel N.; Luck, Steven J.; Geng, Joy; Disbrow, Elizabeth A.; DeCarli, Charles] Univ Calif Davis, Neurosci Grad Grp, Davis, CA 95616 USA; [Luck, Steven J.; Geng, Joy; DeCarli, Charles] Univ Calif Davis, Dept Psychol, Davis, CA 95616 USA; [Luck, Steven J.; Geng, Joy] Univ Calif Davis, Ctr Mind & Brain, Davis, CA 95616 USA; [Beckett, Laurel] Univ Calif Davis, Div Biostat, Davis, CA 95616 USA; [Disbrow, Elizabeth A.] Louisiana State Univ, Dept Neurol, Hlth Sci Ctr Shreveport, Shreveport, LA 71105 USA; [Carmichael, Owen] Louisiana State Univ, Pennington Biomed Res Ctr, Baton Rouge, LA 70808 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport; Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center	Lockhart, SN (corresponding author), Univ Calif Davis, Imaging Dementia & Aging Lab, Davis, CA 95616 USA.	snlockhart@ucdavis.edu	Carmichael, Owen/N-1955-2017; Geng, Joy/J-6225-2019; Lockhart, Samuel Neal/AET-0265-2022; DeCarli, Charles/B-5541-2009	Lockhart, Samuel Neal/0000-0002-0893-5420; Carmichael, Owen/0000-0002-0576-0047	National Institute on Aging [R01AG021028, P30AG010129, K01AG030514]; NATIONAL INSTITUTE ON AGING [K01AG030514, R01AG021028, P30AG010129] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the National Institute on Aging (nia.nih.gov) grants R01AG021028 (CD), P30AG010129 (CD), and K01AG030514 (OC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews-Hanna JR, 2007, NEURON, V56, P924, DOI 10.1016/j.neuron.2007.10.038; Baltes PB, 1997, PSYCHOL AGING, V12, P12, DOI 10.1037/0882-7974.12.1.12; Bergstrom ZM, 2013, NEUROIMAGE, V68, P141, DOI 10.1016/j.neuroimage.2012.11.030; Braver TS, 2002, NEUROSCI BIOBEHAV R, V26, P809, DOI 10.1016/S0149-7634(02)00067-2; Bronge L, 2002, ACTA RADIOL, V43, P7; Cabeza R, 2002, NEUROIMAGE, V17, P1394, DOI 10.1006/nimg.2002.1280; Cabeza R, 2002, PSYCHOL AGING, V17, P85, DOI 10.1037//0882-7974.17.1.85; Carmichael O, 2012, NEUROBIOL AGING, V33, P83, DOI 10.1016/j.neurobiolaging.2010.01.021; Carmichael O, 2010, ARCH NEUROL-CHICAGO, V67, P1370, DOI 10.1001/archneurol.2010.284; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Corbetta M, 1998, PHILOS T ROY SOC B, V353, P1353, DOI 10.1098/rstb.1998.0289; Cui X, 2003, STAT APPL GENET MOL, V2, P1009; Davis SW, 2008, CEREB CORTEX, V18, P1201, DOI 10.1093/cercor/bhm155; DeCarli C, 1996, JMRI-J MAGN RESON IM, V6, P519, DOI 10.1002/jmri.1880060316; DECARLI C, 1995, NEUROLOGY, V45, P2077, DOI 10.1212/WNL.45.11.2077; DeCarli C, 2005, NEUROBIOL AGING, V26, P491, DOI 10.1016/j.neurobiolaging.2004.05.004; DeCarli C, 2005, STROKE, V36, P50, DOI 10.1161/01.STR.0000150668.58689.f2; DECARLI C, 1992, J COMPUT ASSIST TOMO, V16, P274, DOI 10.1097/00004728-199203000-00018; Egeth HE, 1997, ANNU REV PSYCHOL, V48, P269, DOI 10.1146/annurev.psych.48.1.269; FORMAN SD, 1995, MAGNET RESON MED, V33, P636, DOI 10.1002/mrm.1910330508; Gazzaniga M. S, 2013, COGNITIVE NEUROSCIEN; Gold JM, 2007, SCHIZOPHR RES, V94, P148, DOI 10.1016/j.schres.2007.04.023; Grady CL, 2000, CURR OPIN NEUROBIOL, V10, P224, DOI 10.1016/S0959-4388(00)00073-8; Greenwood PM, 2000, J INT NEUROPSYCH SOC, V6, P705, DOI 10.1017/S1355617700666092; Gunning-Dixon FM, 2000, NEUROPSYCHOLOGY, V14, P224, DOI 10.1037//0894-4105.14.2.224; Hedden T, 2014, CEREBRAL CORTEX; Huang CM, 2010, J NEUROSCI METH, V189, P257, DOI 10.1016/j.jneumeth.2010.03.021; Huijbers W, 2014, J NEUROSCI, V34, P5200, DOI 10.1523/JNEUROSCI.3579-13.2014; Ihaka R., 1996, J COMPUT GRAPH STAT, V5, P299, DOI [DOI 10.1080/10618600.1996.10474713, 10.2307/1390807]; Kastner S, 2000, ANNU REV NEUROSCI, V23, P315, DOI 10.1146/annurev.neuro.23.1.315; Lieberman MD, 2009, SOC COGN AFFECT NEUR, V4, P423, DOI 10.1093/scan/nsp052; Lockhart SN, 2014, NEUROPSYCHOLOGIA, V52, P93, DOI 10.1016/j.neuropsychologia.2013.10.011; Lockhart SN, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00056; Madden DJ, 2007, CURR DIR PSYCHOL SCI, V16, P70, DOI 10.1111/j.1467-8721.2007.00478.x; Madden DJ, 2007, NEUROBIOL AGING, V28, P459, DOI 10.1016/j.neurobiolaging.2006.01.005; Madden DJ, 2004, NEUROIMAGE, V21, P1174, DOI 10.1016/j.neuroimage.2003.11.004; Mayda ABV, 2011, BRAIN, V134, P1673, DOI 10.1093/brain/awr065; Nordahl CW, 2006, J COGNITIVE NEUROSCI, V18, P418, DOI 10.1162/089892906775990552; Pantoni L, 2002, CEREBROVASC DIS, V13, P7, DOI 10.1159/000049143; Pinheiro J, 2001, MIXED EFFECTS MODELS; Rabbitt P, 2007, NEUROPSYCHOLOGY, V21, P363, DOI 10.1037/0894-4105.21.3.363; Rissman J, 2004, NEUROIMAGE, V23, P752, DOI 10.1016/j.neuroimage.2004.06.035; Rorden C, 2012, NEUROIMAGE, V61, P957, DOI 10.1016/j.neuroimage.2012.03.020; Rush BK, 2006, AGING NEUROPSYCHOL C, V13, P588, DOI 10.1080/13825580600680703; SALTHOUSE TA, 1985, J GERONTOL, V40, P443, DOI 10.1093/geronj/40.4.443; Salthouse TA, 1996, PSYCHOL REV, V103, P403, DOI 10.1037/0033-295X.103.3.403; Salthouse TA, 2009, NEUROBIOL AGING, V30, P507, DOI 10.1016/j.neurobiolaging.2008.09.023; Samanez-Larkin GR, 2008, SOC COGN AFFECT NEUR, V3, P290, DOI 10.1093/scan/nsn029; Smith EE, 2011, NEUROLOGY, V76, P1492, DOI 10.1212/WNL.0b013e318217e7c8; Sokal RR, 1995, BIOMETRY PRINCIPLES, V3, P1995; Stewart JC, 2014, NEUROIMAGE, V86, P326, DOI 10.1016/j.neuroimage.2013.10.016; Sullivan EV, 2006, NEUROSCI BIOBEHAV R, V30, P749, DOI 10.1016/j.neubiorev.2006.06.002; Todd RM, 2012, J NEUROSCI, V32, P11201, DOI 10.1523/JNEUROSCI.0155-12.2012; Tullberg M, 2004, NEUROLOGY, V63, P246, DOI 10.1212/01.WNL.0000130530.55104.B5; van den Berg RA, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-142; Vartanian O, 2013, P NATL ACAD SCI USA, V110, P10446, DOI 10.1073/pnas.1301227110; Voets NL, 2014, J NEUROSCI, V34, P4920, DOI 10.1523/JNEUROSCI.4281-13.2014; West R, 2000, J INT NEUROPSYCH SOC, V6, P727, DOI 10.1017/S1355617700666109; West RL, 1996, PSYCHOL BULL, V120, P272, DOI 10.1037/0033-2909.120.2.272; Xu HC, 2010, STROKE, V41, P2744, DOI 10.1161/STROKEAHA.110.591875	60	21	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0122445	10.1371/journal.pone.0122445	http://dx.doi.org/10.1371/journal.pone.0122445			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25793922	Green Published, gold, Green Submitted			2022-12-27	WOS:000352083900180
J	Mao, WH; Vu, HY; Xie, ZN; Chen, W; Tang, SL				Mao, Wenhui; Vu, Huyen; Xie, Zening; Chen, Wen; Tang, Shenglan			Systematic Review on Irrational Use of Medicines in China and Vietnam	PLOS ONE			English	Review							VILLAGE HEALTH CLINICS; ADVERSE DRUG-REACTIONS; PRIVATE PHARMACIES; 10 PROVINCES; ANTIBIOTICS; CHILDREN; INJECTIONS; MEDICATION; BEHAVIOR; ILLNESS	Background Irrational use of medicines has been an issue concerned all over the world and the outlooks in developing countries are more severe. This study aimed to assess the different patterns of irrational use of medicines and its influential factors in China and Vietnam. Methods A systematic review was performed on both published and grey literatures in English, Chinese and Vietnamese languages between 1993 and 2013 based on the WHO framework. Quality assessment was conducted on the basis of the Critical Appraisal Skills Programme. Key indicators were analyzed to compare the irrational use of medicines in two countries. Results A total of 67 published works about China and 29 about Vietnam were included, the majority of which were cross-sectional prescription studies in both China and Vietnam. Irrational use of medicines was found in both the countries but issues with polypharmacy as well as overuse of antibiotics were more severe in Vietnam while overuse of injections was unique to China. Various patterns of irrational use were also indicated between urban and rural areas, and among different levels of hospitals. Rarely does literature focus on the analysis of influential factors of irrational use of medicines. While lack of proper knowledge from both providers and patients were the most recognized influential factors in both countries, economic incentives from pharmaceutical companies in China, and weak control and regulation over prescriptions in Vietnam were the main factors attributed to this issue. Conclusion Severe irrational use of medicines has been abundantly evidenced in both China and Vietnam, highlighting the importance of policy interventions on the issue. However, limited evidence on the appropriateness or its compliance (conformity) to guidelines of prescription has been found. In addition, convincing evidence on the underlying explanation of this issue is lacking, although economic incentives, health insurance coverage, and knowledge of service providers and users have been implied to be factors influencing irrational drug use.	[Mao, Wenhui; Xie, Zening; Chen, Wen] Fudan Univ, Sch Publ Hlth, Shanghai 200032, Peoples R China; [Chen, Wen] Duke Univ, Collaborat Innovat Ctr Social Risks Governance Hl, Durham, NC 27708 USA; [Vu, Huyen; Tang, Shenglan] Duke Univ, Duke Global Hlth Inst, Durham, NC 27708 USA; [Tang, Shenglan] Duke Kunshan Univ, Kunshan 215316, Jiangsu, Peoples R China	Fudan University; Duke University; Duke University; Duke Kunshan University	Chen, W (corresponding author), Fudan Univ, Sch Publ Hlth, POB 187,138 Yi Xue Yuan Rd, Shanghai 200032, Peoples R China.	wenchen@fudan.edu.cn; shenglan.tang@duke.edu	MAO, Wenhui/L-1734-2019; Tang, Shenglan/AAO-7403-2020; Mao, Wenhui/T-3573-2019	Mao, Wenhui/0000-0001-9214-7787				Center for Health Statistics and Information Ministry of Health, 2013, CHIN HLTH FAM PLANN; Chen MS, 2014, PHARMACOECONOMICS, V32, P245, DOI 10.1007/s40273-013-0068-z; China National Health Economics Institute, 2012, CHIN NAT HLTH ACC RE; Chuc NTK, 1999, EUR J CLIN PHARMACOL, V55, P325, DOI 10.1007/s002280050636; Chuc NTK, 2001, ANN PHARMACOTHER, V35, P1283, DOI 10.1345/aph.10313; Critical Appraisal Skills Programme, 2013, MAK SENS EV; Dong HJ, 1999, INT J TECHNOL ASSESS, V15, P686, DOI 10.1017/S0266462399015482; Dong LF, 2008, J ANTIMICROB CHEMOTH, V62, P410, DOI 10.1093/jac/dkn153; GREENHALGH T, 1987, SOC SCI MED, V25, P307, DOI 10.1016/0277-9536(87)90233-4; Gumodoka B, 1996, TROP MED INT HEALTH, V1, P874; Han S, 2013, INT J HEALTH SERV, V43, P91, DOI 10.2190/HS.43.1.g; Hitchen L, 2006, BRIT MED J, V332, P1109, DOI 10.1136/bmj.332.7550.1109; Hoa NQ, 2007, HEALTH POLICY, V82, P320, DOI 10.1016/j.healthpol.2006.10.005; Hoan LT, 2009, PHARMACOEPIDEM DR S, V18, P448, DOI 10.1002/pds.1730; HOGERZEIL HV, 1995, BRIT J CLIN PHARMACO, V39, P1; Huong DB, 2007, INT J HEALTH SERV, V37, P555, DOI 10.2190/H0L2-8004-6182-6826; Kaljee LM, 2011, J BEHAV MED, V34, P254, DOI 10.1007/s10865-010-9305-5; Larsson M, 2000, TROP MED INT HEALTH, V5, P711, DOI 10.1046/j.1365-3156.2000.00630.x; Larsson M, 1999, THESIS KAROLINSKA I; Lazarou J, 1998, JAMA-J AM MED ASSOC, V279, P1200, DOI 10.1001/jama.279.15.1200; Li YB, 2012, HEALTH AFFAIR, V31, P1075, DOI 10.1377/hlthaff.2010.0965; Lieu DH, 2005, HLTH FINANCING HOUSE; Lonnroth K, 1998, HEALTH POLICY, V45, P81, DOI 10.1016/S0168-8510(98)00035-9; Luo J, 2009, THESIS CENTRAL S U; Mao WH, 2013, EXPERT REV PHARM OUT, V13, P693, DOI 10.1586/14737167.2013.856266; Michanek E, 1992, DOI MOI AND HLTH; Ministry of Health, 1996, STRAT OR PEOPL HLTH; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; National Health and Family Planning Commission of People's Republic of China, 2012, CHIN HLTH STAT YB 20; Nguyen QH, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-85; Nguyen TKC, 2002, THESIS KAROLINSKA I; Pirmohamed M, 2004, BMJ-BRIT MED J, V329, P15, DOI 10.1136/bmj.329.7456.15; Reeler AV, 1994, WHODAP948; Reynolds L, 2011, INT J HEALTH PLAN M, V26, P449, DOI 10.1002/hpm.1112; State Planning Commission, 1996, INT MEAS DRUG PRIC; State Planning Commission, 1998, STAT PLANN COMM NOT; Sun Q, 2008, HEALTH AFFAIR, V27, P1042, DOI 10.1377/hlthaff.27.4.1042; Tang S, 2007, PHARM POLICIES CHINA; van Staa A, 1996, WHODAP964; Vietnam's Ministry of Health, 2011, NAT STRAT H IN PRESS; Vietnam's Ministry of Health, 2004, NAT HLTH ACC PROC IM; Vietnam's Ministry of Health and WHO, 2010, NAT HLTH ACC IMPL VI; White TJ, 1999, PHARMACOECONOMICS, V15, P445, DOI 10.2165/00019053-199915050-00003; WHO, 2002, WHO POLICY PERSPECTI; World Health Organization, 1993, INV DRUG US HLTH FAC, V007; World Health Organization, 2004, EQ ACC ESS MED FRAM; World Health Organization, 2012, PURS RESP US MED SHA; World Health Organization, 2011, WORLD MED SIT 2011 R, DOI [10.1186/1475-2875-10-326, DOI 10.1186/1475-2875-10-326]; World Health Organization, 2009, MED US PRIM CAR DEV; World Health Organization, 2001, INV DRUG US HLTH FAC; Yip W, 2009, CHINA ECON REV, V20, P613, DOI 10.1016/j.chieco.2009.08.003	51	93	96	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0117710	10.1371/journal.pone.0117710	http://dx.doi.org/10.1371/journal.pone.0117710			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CE8IA	25793497	Green Published, Green Submitted, gold			2022-12-27	WOS:000352084200016
J	Takata, N; Yoshida, K; Komaki, Y; Xu, M; Sakai, Y; Hikishima, K; Mimura, M; Okano, H; Tanaka, KF				Takata, Norio; Yoshida, Keitaro; Komaki, Yuji; Xu, Ming; Sakai, Yuki; Hikishima, Keigo; Mimura, Masaru; Okano, Hideyuki; Tanaka, Kenji F.			Optogenetic Activation of CA1 Pyramidal Neurons at the Dorsal and Ventral Hippocampus Evokes Distinct Brain-Wide Responses Revealed by Mouse fMRI	PLOS ONE			English	Article							AXONAL PROJECTIONS; OPTICAL CONTROL; BOLD RESPONSE; LESIONS; MICE; CONNECTIVITY; ORGANIZATION; STIMULATION; EXPRESSION; NETWORKS	The dorsal and ventral hippocampal regions (dHP and vHP) are proposed to have distinct functions. Electrophysiological studies have revealed intra-hippocampal variances along the dorsoventral axis. Nevertheless, the extra-hippocampal influences of dHP and vHP activities remain unclear. In this study, we compared the spatial distribution of brain-wide responses upon dHP or vHP activation and further estimate connection strengths between the dHP and the vHP with corresponding extra-hippocampal areas. To achieve this, we first investigated responses of local field potential (LFP) and multi unit activities (MUA) upon light stimulation in the hippocampus of an anesthetized transgenic mouse, whose CA1 pyramidal neurons expressed a step-function opsin variant of channelrhodopsin-2 (ChR2). Optogenetic stimulation increased hippocampal LFP power at theta, gamma, and ultra-fast frequency bands, and augmented MUA, indicating light-induced activation of CA1 pyramidal neurons. Brain-wide responses examined using fMRI revealed that optogenetic activation at the dHP or vHP caused blood oxygenation level-dependent (BOLD) fMRI signals in situ. Although activation at the dHP induced BOLD responses at the vHP, the opposite was not observed. Outside the hippocampal formation, activation at the dHP, but not the vHP, evoked BOLD responses at the retrosplenial cortex (RSP), which is in line with anatomical evidence. In contrast, BOLD responses at the lateral septum (LS) were induced only upon vHP activation, even though both dHP and vHP send axonal fibers to the LS. Our findings suggest that the primary targets of dHP and vHP activation are distinct, which concurs with attributed functions of the dHP and RSP in spatial memory, as well as of the vHP and LS in emotional responses.	[Takata, Norio; Yoshida, Keitaro; Xu, Ming; Sakai, Yuki; Mimura, Masaru; Tanaka, Kenji F.] Keio Univ, Sch Med, Dept Neuropsychiat, Shinjuku Ku, Tokyo, Japan; [Komaki, Yuji; Hikishima, Keigo; Okano, Hideyuki] Keio Univ, Sch Med, Dept Physiol, Shinjuku Ku, Tokyo 160, Japan; [Takata, Norio; Komaki, Yuji; Sakai, Yuki; Hikishima, Keigo] Cent Inst Expt Anim, Kawasaki, Kanagawa, Japan; [Sakai, Yuki] Kyoto Prefectural Univ Med, Grad Sch Med, Dept Psychiat, Kyoto, Japan	Keio University; Keio University; Kyoto Prefectural University of Medicine	Takata, N (corresponding author), Keio Univ, Sch Med, Dept Neuropsychiat, Shinjuku Ku, Tokyo, Japan.	takata.norio@keio.jp; kftanaka@keio.jp	Hikishima, Keigo/L-1202-2013; Hikishima, Keigo/AAP-9586-2020; Okano, Hideyuki/X-9131-2019; Sakai, Yuki/AAV-6231-2021; Okano, Hideyuki/I-7584-2019	Hikishima, Keigo/0000-0003-1133-1297; Hikishima, Keigo/0000-0003-1133-1297; Okano, Hideyuki/0000-0001-7482-5935; Sakai, Yuki/0000-0003-2475-8548; Tanaka, Kenji/0000-0003-2511-0057; Komaki, Yuji/0000-0002-0250-0354; Yoshida, Keitaro/0000-0003-2196-7635; xu, ming/0000-0001-7974-0658	KAKENHI [25430011, 25115726, 24111551]; "Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program)" from Japan Society for the Promotion of Science; Ministry of Education, Culture, Sports, Science, and Technology of Japan; Grants-in-Aid for Scientific Research [15H03123, 25115726, 25116523, 23680042] Funding Source: KAKEN	KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); "Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program)" from Japan Society for the Promotion of Science; Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Funding: This work was supported by KAKENHI Grants (25430011 and 25115726 to N.T., 24111551 to K.F.T.) and "Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program)" to H.O. from Japan Society for the Promotion of Science and the Ministry of Education, Culture, Sports, Science, and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe Y, 2012, NEUROSCI RES, V74, P248, DOI 10.1016/j.neures.2012.08.007; Adamczak JM, 2010, NEUROIMAGE, V51, P704, DOI 10.1016/j.neuroimage.2010.02.083; Angenstein F, 2007, NEUROIMAGE, V38, P150, DOI 10.1016/j.neuroimage.2007.07.022; Baltes C, 2011, NMR BIOMED, V24, P439, DOI 10.1002/nbm.1613; Berndt A, 2009, NAT NEUROSCI, V12, P229, DOI 10.1038/nn.2247; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Buzsaki G, 2004, TRENDS NEUROSCI, V27, P186, DOI 10.1016/j.tins.2004.02.007; Buzsaki G, 2003, NEUROSCIENCE, V116, P201, DOI 10.1016/S0306-4522(02)00669-3; Canals S, 2008, MAGN RESON IMAGING, V26, P978, DOI 10.1016/j.mri.2008.02.018; Canals S, 2009, CURR BIOL, V19, P398, DOI 10.1016/j.cub.2009.01.037; Cenquizca LA, 2007, BRAIN RES REV, V56, P1, DOI 10.1016/j.brainresrev.2007.05.002; Cenquizca LA, 2006, J COMP NEUROL, V497, P101, DOI 10.1002/cne.20985; Chaudhury D, 2013, NATURE, V493, P532, DOI 10.1038/nature11713; Christie IN, 2013, NEUROIMAGE, V66, P634, DOI 10.1016/j.neuroimage.2012.10.074; Cowansage KK, 2014, NEURON, V84, P432, DOI 10.1016/j.neuron.2014.09.022; Desai M, 2011, J NEUROPHYSIOL, V105, P1393, DOI 10.1152/jn.00828.2010; Dougherty KA, 2012, J PHYSIOL-LONDON, V590, P5707, DOI 10.1113/jphysiol.2012.242693; Fanselow MS, 2010, NEURON, V65, P7, DOI 10.1016/j.neuron.2009.11.031; Ferbinteanu J, 2003, NEUROSCI LETT, V345, P131, DOI 10.1016/S0304-3940(03)00473-7; Franklin K.B.J., 2008, MOUSE BRAIN STEREOTA; Grandjean J, 2014, NEUROIMAGE, V102, P838, DOI 10.1016/j.neuroimage.2014.08.043; Hara K, 2002, ANESTH ANALG, V94, P313, DOI 10.1097/00000539-200202000-00015; HUGHES KR, 1965, CAN J PSYCHOLOGY, V19, P325, DOI 10.1037/h0082915; Huttunen JK, 2008, NEUROIMAGE, V39, P775, DOI 10.1016/j.neuroimage.2007.06.042; Jinno S, 2009, FRONT NEUROANAT, V3, DOI 10.3389/neuro.05.013.2009; Jonckers E, 2014, MAGN RESON MED, V72, P1103, DOI 10.1002/mrm.24990; JUNG MW, 1994, J NEUROSCI, V14, P7347; Kjelstrup KG, 2002, P NATL ACAD SCI USA, V99, P10825, DOI 10.1073/pnas.152112399; Lee JH, 2010, NATURE, V465, P788, DOI 10.1038/nature09108; MCLENNAN H, 1974, J PHYSIOL-LONDON, V237, P607, DOI 10.1113/jphysiol.1974.sp010500; MELLO LEAM, 1992, BRAIN RES, V587, P24, DOI 10.1016/0006-8993(92)91425-E; MORGAN JI, 1987, SCIENCE, V237, P192, DOI 10.1126/science.3037702; MOSER E, 1993, J NEUROSCI, V13, P3916; Nair G, 2004, MAGN RESON MED, V52, P430, DOI 10.1002/mrm.20158; Patel J, 2012, NEURON, V75, P410, DOI 10.1016/j.neuron.2012.07.015; Quiroga RQ, 2004, NEURAL COMPUT, V16, P1661, DOI 10.1162/089976604774201631; Ranganath C, 2012, NAT REV NEUROSCI, V13, P713, DOI 10.1038/nrn3338; Rudy JW, 2005, BEHAV NEUROSCI, V119, P154, DOI 10.1037/0735-7044.119.1.154; Seki F, 2013, FRONT NEUROANAT, V7, DOI 10.3389/fnana.2013.00045; Shmuel A, 2006, NAT NEUROSCI, V9, P569, DOI 10.1038/nn1675; Sinclair MD, 2003, CAN VET J, V44, P885; Singewald GM, 2011, NEUROPSYCHOPHARMACOL, V36, P793, DOI 10.1038/npp.2010.213; Song XW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025031; Stark E, 2014, NEURON, V83, P467, DOI 10.1016/j.neuron.2014.06.023; Stark E, 2012, J NEUROPHYSIOL, V108, P349, DOI 10.1152/jn.00153.2012; Takata N, 2014, NEUROMETHODS, V85, P191, DOI 10.1007/978-1-62703-785-3_12; Tanaka KF, 2012, CELL REP, V2, P397, DOI 10.1016/j.celrep.2012.06.011; van Zijl PCM, 2012, NEUROIMAGE, V62, P1092, DOI 10.1016/j.neuroimage.2012.01.029; Vann SD, 2009, NAT REV NEUROSCI, V10, P792, DOI 10.1038/nrn2733; Weber R, 2006, NEUROIMAGE, V29, P1303, DOI 10.1016/j.neuroimage.2005.08.028; Weitz AJ, 2015, NEUROIMAGE, V107, P229, DOI 10.1016/j.neuroimage.2014.10.039	51	38	38	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0121417	10.1371/journal.pone.0121417	http://dx.doi.org/10.1371/journal.pone.0121417			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25793741	gold, Green Published, Green Submitted			2022-12-27	WOS:000352083900133
J	Harris, DA; Patel, SH; Gucek, M; Hendrix, A; Westbroek, W; Taraska, JW				Harris, Dinari A.; Patel, Sajni H.; Gucek, Marjan; Hendrix, An; Westbroek, Wendy; Taraska, Justin W.			Exosomes Released from Breast Cancer Carcinomas Stimulate Cell Movement	PLOS ONE			English	Article							METASTASIS SUPPRESSOR GENE; MEMBRANE-VESICLES; PROSTATE-CANCER; MICROVESICLES; GROWTH; MIGRATION; MICROENVIRONMENT; BIOMARKERS; SECRETION; MICRORNAS	For metastasis to occur cells must communicate with to their local environment to initiate growth and invasion. Exosomes have emerged as an important mediator of cell-to-cell signalling through the transfer of molecules such as mRNAs, microRNAs, and proteins between cells. Exosomes have been proposed to act as regulators of cancer progression. Here, we study the effect of exosomes on cell migration, an important step in metastasis. We performed cell migration assays, endocytosis assays, and exosome proteomic profiling on exosomes released from three breast cancer cell lines that model progressive stages of metastasis. Results from these experiments suggest: (1) exosomes promote cell migration and (2) the signal is stronger from exosomes isolated from cells with higher metastatic potentials; (3) exosomes are endocytosed at the same rate regardless of the cell type; (4) exosomes released from cells show differential enrichment of proteins with unique protein signatures of both identity and abundance. We conclude that breast cancer cells of increasing metastatic potential secrete exosomes with distinct protein signatures that proportionally increase cell movement and suggest that released exosomes could play an active role in metastasis.	[Harris, Dinari A.; Taraska, Justin W.] NHLBI, Lab Mol Biophys, NIH, Bethesda, MD 20892 USA; [Patel, Sajni H.; Gucek, Marjan] NHLBI, Prote Core Facil, NIH, Bethesda, MD 20892 USA; [Hendrix, An] Ghent Univ Hosp, Lab Expt Canc Res, Dept Radiat Oncol & Expt Canc Res, Ghent, Belgium; [Westbroek, Wendy] NHGRI, Med Genet Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Ghent University; Ghent University Hospital; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Taraska, JW (corresponding author), NHLBI, Lab Mol Biophys, NIH, Bldg 10, Bethesda, MD 20892 USA.	justin.taraska@nih.gov	Hendrix, An/L-5918-2019; Taraska, Justin/H-8876-2016	Taraska, Justin/0000-0001-5355-9535	National Heart Lung and Blood Institute, National Institutes of Health [HL006098-02]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL006098, ZICHL006019, ZICHL005903] Funding Source: NIH RePORTER	National Heart Lung and Blood Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	All Authors were supported by the Intramural Research Program of the National Heart Lung and Blood Institute, National Institutes of Health, HL006098-02. (http://www.nhlbi.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelkarim M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023334; Berditchevski F, 2001, J CELL SCI, V114, P4143; Bobrie A, 2012, J EXTRACELL VESICLES, V1, DOI 10.3402/jev.v1i0.18397; Bobrie A, 2012, CANCER RES, V72, P4920, DOI 10.1158/0008-5472.CAN-12-0925; Boucheix C, 2001, Expert Rev Mol Med, V2001, P1, DOI 10.1017/S1462399401002381; Brabek J, 2010, CELL COMMUN SIGNAL, V8, DOI 10.1186/1478-811X-8-22; Camussi G, 2011, AM J CANCER RES, V1, P98; Castellana D, 2010, THROMB RES, V125, pS84, DOI 10.1016/S0049-3848(10)70021-9; Chaerkady R, 2008, J PROTEOME RES, V7, P4289, DOI 10.1021/pr800197z; Cocucci E, 2009, TRENDS CELL BIOL, V19, P43, DOI 10.1016/j.tcb.2008.11.003; Dimmer EC, 2012, NUCLEIC ACIDS RES, V40, pD565, DOI 10.1093/nar/gkr1048; DONG JT, 1995, SCIENCE, V268, P884, DOI 10.1126/science.7754374; Frost AR, 2012, INT J BREAST CANCER, V2012, DOI 10.1155/2012/756257; Ginestra A, 1998, ANTICANCER RES, V18, P3433; Ginestra A, 1999, ANTICANCER RES, V19, P3439; Guo XZ, 1998, HEPATOLOGY, V28, P1481, DOI 10.1002/hep.510280606; Hao S., 2006, Experimental Oncology, V28, P126; Hendrix A, 2010, JNCI-J NATL CANCER I, V102, P866, DOI 10.1093/jnci/djq153; Hessvik NP, 2012, BBA-GENE REGUL MECH, V1819, P1154, DOI 10.1016/j.bbagrm.2012.08.016; Higginbotham JN, 2011, CURR BIOL, V21, P779, DOI 10.1016/j.cub.2011.03.043; Hood JL, 2011, CANCER RES, V71, P3792, DOI 10.1158/0008-5472.CAN-10-4455; Iero M, 2008, CELL DEATH DIFFER, V15, P80, DOI 10.1038/sj.cdd.4402237; IKEYAMA S, 1993, J EXP MED, V177, P1231, DOI 10.1084/jem.177.5.1231; Kalra H, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001450; Koumangoye RB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024234; Lai TC, 2010, J PROTEOME RES, V9, P1302, DOI 10.1021/pr900825t; Liu L, 2007, J BIOL CHEM, V282, P31631, DOI 10.1074/jbc.M701165200; Lu Y, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001149; Mantegazza AR, 2004, BLOOD, V104, P1183, DOI 10.1182/blood-2004-01-0104; McCready J, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-294; Mineo M, 2012, ANGIOGENESIS, V15, P33, DOI 10.1007/s10456-011-9241-1; Muralidharan-Chari V, 2010, J CELL SCI, V123, P1603, DOI 10.1242/jcs.064386; Nagaraja GM, 2006, ONCOGENE, V25, P2328, DOI 10.1038/sj.onc.1209265; Nazarenko I, 2010, CANCER RES, V70, P1668, DOI 10.1158/0008-5472.CAN-09-2470; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; O'Brien K, 2013, EUR J CANCER, V49, P1845, DOI 10.1016/j.ejca.2013.01.017; Ochieng J, 2009, EXP CELL RES, V315, P1875, DOI 10.1016/j.yexcr.2009.03.010; Palazzolo G, 2012, ANTICANCER RES, V32, P847; Park JE, 2010, MOL CELL PROTEOMICS, V9, P1085, DOI 10.1074/mcp.M900381-MCP200; Peinado H, 2012, NAT MED, V18, P883, DOI 10.1038/nm.2753; Peinado H, 2011, SEMIN CANCER BIOL, V21, P139, DOI 10.1016/j.semcancer.2011.01.002; Pelchen-Matthews A, 2004, TRENDS MICROBIOL, V12, P310, DOI 10.1016/j.tim.2004.05.004; Pierre M, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-176; RADFORD KJ, 1995, INT J CANCER, V62, P631, DOI 10.1002/ijc.2910620523; Ramaswamy S, 2003, NAT GENET, V33, P49, DOI 10.1038/ng1060; Ratajczak J, 2006, LEUKEMIA, V20, P1487, DOI 10.1038/sj.leu.2404296; Ratajczak J, 2006, LEUKEMIA, V20, P847, DOI 10.1038/sj.leu.2404132; Roepman P, 2006, CANCER RES, V66, P11110, DOI 10.1158/0008-5472.CAN-06-3161; Sethi N, 2011, NAT REV CANCER, V11, P735, DOI 10.1038/nrc3125; Shen XY, 2012, P NATL ACAD SCI USA, V109, P14464, DOI 10.1073/pnas.1211877109; Simpson RJ, 2008, PROTEOMICS, V8, P4083, DOI 10.1002/pmic.200800109; Simpson RJ, 2009, EXPERT REV PROTEOMIC, V6, P267, DOI [10.1586/epr.09.17, 10.1586/EPR.09.17]; Skog J, 2008, NAT CELL BIOL, V10, P1470, DOI 10.1038/ncb1800; Thery C, 2002, NAT REV IMMUNOL, V2, P569, DOI 10.1038/nri855; Thery C, 2009, NAT REV IMMUNOL, V9, P581, DOI 10.1038/nri2567; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; Tian TA, 2010, J CELL BIOCHEM, V111, P488, DOI 10.1002/jcb.22733; Turner S, 2002, J THEOR BIOL, V216, P85, DOI 10.1006/jtbi.2001.2522; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Webber J, 2010, CANCER RES, V70, P9621, DOI 10.1158/0008-5472.CAN-10-1722; ZETTER BR, 1993, SEMIN CANCER BIOL, V4, P219	62	117	127	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0117495	10.1371/journal.pone.0117495	http://dx.doi.org/10.1371/journal.pone.0117495			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25798887	gold, Green Published, Green Submitted			2022-12-27	WOS:000351987300004
J	Paciello, G; Acquaviva, A; Pighi, C; Ferrarini, A; Macii, E; Zamo', A; Ficarra, E				Paciello, Giulia; Acquaviva, Andrea; Pighi, Chiara; Ferrarini, Alberto; Macii, Enrico; Zamo', Alberto; Ficarra, Elisa			VDJSeq-Solver: In Silico V(D)J Recombination Detection Tool	PLOS ONE			English	Article							CHRONIC LYMPHOCYTIC-LEUKEMIA; POLYMERASE-CHAIN-REACTION; CONCERTED ACTION BMH4-CT98-3936; ACUTE LYMPHOBLASTIC-LEUKEMIA; MANTLE CELL LYMPHOMA; V-H REGION; GENE REARRANGEMENTS; ANTIGEN RECEPTORS; B-CELLS; IMMUNOGLOBULIN	In this paper we present VDJSeq-Solver, a methodology and tool to identify clonal lymphocyte populations from paired-end RNA Sequencing reads derived from the sequencing of mRNA neoplastic cells. The tool detects the main clone that characterises the tissue of interest by recognizing the most abundant V(D)J rearrangement among the existing ones in the sample under study. The exact sequence of the clone identified is capable of accounting for the modifications introduced by the enzymatic processes. The proposed tool overcomes limitations of currently available lymphocyte rearrangements recognition methods, working on a single sequence at a time, that are not applicable to high-throughput sequencing data. In this work, VDJSeq-Solver has been applied to correctly detect the main clone and identify its sequence on five Mantle Cell Lymphoma samples; then the tool has been tested on twelve Diffuse Large B-Cell Lymphoma samples. In order to comply with the privacy, ethics and intellectual property policies of the University Hospital and the University of Verona, data is available upon request to supporto. utenti@ateneo.univr.it after signing a mandatory Materials Transfer Agreement. VDJSeq-Solver JAVA/Perl/Bash software implementation is free and available at http://eda.polito.it/VDJSeq-Solver/.	[Paciello, Giulia; Acquaviva, Andrea; Macii, Enrico; Ficarra, Elisa] Politecn Torino, Dept Control & Comp Engn, Turin, Italy; [Pighi, Chiara; Zamo', Alberto] Univ Verona, Dept Pathol & Diagnost, I-37100 Verona, Italy; [Pighi, Chiara] Harvard Univ, Sch Med, Dept Pathol, Children Hosp Boston, Boston, MA 02115 USA; [Ferrarini, Alberto] Univ Verona, Dept Biotechnol, I-37100 Verona, Italy	Polytechnic University of Turin; University of Verona; Harvard University; Boston Children's Hospital; Harvard Medical School; University of Verona	Paciello, G (corresponding author), Politecn Torino, Dept Control & Comp Engn, Turin, Italy.	giulia.paciello@studenti.polito.it	Zamò, Alberto/ABF-4436-2020	Zamo, Alberto/0000-0001-6203-7966; FICARRA, Elisa/0000-0002-8061-2124				ACHILLE A, 1995, DIAGN MOL PATHOL, V4, P14, DOI 10.1097/00019606-199503000-00005; Alamyar E., 2012, IMMUNOME RES, V8, P1, DOI [10.4172/1745-7580.1000056, DOI 10.4172/1745-7580.1000056]; Alamyar Eltaf, 2012, Methods Mol Biol, V882, P569, DOI 10.1007/978-1-61779-842-9_32; ALT FW, 1982, P NATL ACAD SCI-BIOL, V79, P4118, DOI 10.1073/pnas.79.13.4118; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bassing CH, 2002, CELL, V109, pS45, DOI 10.1016/S0092-8674(02)00675-X; BEISHUIZEN A, 1993, LEUKEMIA, V7, P2045; BERTIN PA, 1992, ANN NY ACAD SCI, V651, P464; Bossen C, 2012, ANNU REV IMMUNOL, V30, P337, DOI 10.1146/annurev-immunol-020711-075003; Boyd SD, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000540; BREIT TM, 1993, BLOOD, V82, P3063; Brochet X, 2007, ACT JOURN OUV BIOL I, V2007, P329; Burger JA, 2012, CURR HEMATOL MALIG R, V7, P26, DOI 10.1007/s11899-011-0104-z; Burger JA, 2011, SEMIN CANCER BIOL, V21, P308, DOI 10.1016/j.semcancer.2011.09.006; Chen LF, 2008, BLOOD, V111, P2230, DOI 10.1182/blood-2007-07-100115; Damle RN, 1999, BLOOD, V94, P1840, DOI 10.1182/blood.V94.6.1840; DEANE M, 1991, LEUKEMIA, V5, P726; Edgren H, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-1-r6; Efremov DG, 1996, BLOOD, V87, P3869, DOI 10.1182/blood.V87.9.3869.bloodjournal8793869; Fais F, 1998, J CLIN INVEST, V102, P1515, DOI 10.1172/JCI3009; Gaeta BA, 2007, BIOINFORMATICS, V23, P1580, DOI 10.1093/bioinformatics/btm147; Ghiotto F, 2004, J CLIN INVEST, V113, P1008, DOI 10.1172/JCI200419399; Ghiotto F, 2006, MOL MED, V12, P300, DOI 10.2119/2006-00080.Ghiotto; Giudicelli V, 2004, NUCLEIC ACIDS RES, V32, pW435, DOI 10.1093/nar/gkh412; Giudicelli Veronique, 2011, Cold Spring Harb Protoc, V2011, P695, DOI 10.1101/pdb.prot5633; Giudicelli Veronique, 2011, Cold Spring Harb Protoc, V2011, P716, DOI 10.1101/pdb.prot5634; Groenen Patricia J T A, 2008, J Hematop, V1, P97, DOI 10.1007/s12308-008-0013-9; Hadzidimitriou A, 2011, BLOOD, V118, P3088, DOI 10.1182/blood-2011-03-343434; Hamblin TJ, 1999, BLOOD, V94, P1848, DOI 10.1182/blood.V94.6.1848; Ippolito GC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035497; Jackson KJL, 2012, IMMUNOGENETICS, V64, P3, DOI 10.1007/s00251-011-0559-z; Johnson TA, 1997, J IMMUNOL, V158, P235; Jung D, 2004, CELL, V116, P299, DOI 10.1016/S0092-8674(04)00039-X; Jung D, 2006, ANNU REV IMMUNOL, V24, P541, DOI 10.1146/annurev.immunol.23.021704.115830; KIPPS TJ, 1989, P NATL ACAD SCI USA, V86, P5913, DOI 10.1073/pnas.86.15.5913; Kuppers R, 2005, NAT REV CANCER, V5, P251, DOI 10.1038/nrc1589; KUPPERS R, 1993, AM J PATHOL, V143, P230; Langerak AW, 2007, LEUKEMIA, V21, P222, DOI 10.1038/sj.leu.2404482; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lefranc M-P., 2001, IMMUNOGLOBULIN FACTS; Li HH, 2002, IMMUNOL REV, V190, P53, DOI 10.1034/j.1600-065X.2002.19005.x; LI S, 2013, NATURE COMM, V4, P1; McCarthy K P, 1992, Diagn Mol Pathol, V1, P173, DOI 10.1097/00019606-199203000-00025; Messmer BT, 2004, J EXP MED, V200, P519, DOI 10.1084/jem.20040544; Monod MY, 2004, BIOINFORMATICS, V20, P379, DOI 10.1093/bioinformatics/bth945; Mueller-Hermelink HK, 2008, WHO CLASSIFICATION T, P180; Ohm-Laursen L, 2006, IMMUNOLOGY, V119, P265, DOI 10.1111/j.1365-2567.2006.02431.x; Oscier DG, 1997, BLOOD, V89, P4153, DOI 10.1182/blood.V89.11.4153; Pighi C, 2011, CELL ONCOL, V34, P141, DOI 10.1007/s13402-011-0019-7; Prabakaran P, 2012, IMMUNOGENETICS, V64, P337, DOI 10.1007/s00251-011-0595-8; PRITSCH O, 1993, BLOOD, V82, P3103; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Rinaldi A, 2006, BRIT J HAEMATOL, V132, P303, DOI 10.1111/j.1365-2141.2005.05883.x; Rosenquist R, 1999, EUR J HAEMATOL, V63, P171; Rumble SM, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000386; Schweighofer CD, 2011, INT J CANCER, V128, P2759, DOI 10.1002/ijc.25605; Sebastian E, 2012, AM J PATHOL, V181, P1879, DOI 10.1016/j.ajpath.2012.07.028; Souto-Carneiro MM, 2004, J IMMUNOL, V172, P6790, DOI 10.4049/jimmunol.172.11.6790; Tobin G, 2004, BLOOD, V104, P2879, DOI 10.1182/blood-2004-01-0132; Tobin G, 2003, BLOOD, V101, P4952, DOI 10.1182/blood-2002-11-3485; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; van Dongen JJM, 2003, LEUKEMIA, V17, P2257, DOI 10.1038/sj.leu.2403202; van Krieken JHJM, 2007, LEUKEMIA, V21, P201, DOI 10.1038/sj.leu.2404467; Visco C, 2008, BLOOD, V111, P1110, DOI 10.1182/blood-2007-09-111492; Volpe JM, 2006, BIOINFORMATICS, V22, P438, DOI 10.1093/bioinformatics/btk004; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Widhopf GF, 2004, BLOOD, V104, P2499, DOI 10.1182/blood-2004-03-0818; Wu YC, 2010, BLOOD, V116, P1070, DOI 10.1182/blood-2010-03-275859; Zanotti R, 2010, AM J HEMATOL, V85, P494, DOI 10.1002/ajh.21737; Zhang J, 2011, J GENET GENOMICS, V38, P95, DOI 10.1016/j.jgg.2011.02.003	70	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0118192	10.1371/journal.pone.0118192	http://dx.doi.org/10.1371/journal.pone.0118192			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25799103	Green Published, Green Submitted, gold			2022-12-27	WOS:000351987300006
J	Wang, XW; Nie, S; Wang, BH				Wang, Xuwen; Nie, Sen; Wang, Binghong			Dependency Links Can Hinder the Evolution of Cooperation in the Prisoner's Dilemma Game on Lattices and Networks	PLOS ONE			English	Article							SMALL-WORLD NETWORKS; PROMOTE COOPERATION; SNOWDRIFT GAME; EMERGENCE	Networks with dependency links are more vulnerable when facing the attacks. Recent research also has demonstrated that the interdependent groups support the spreading of cooperation. We study the prisoner's dilemma games on spatial networks with dependency links, in which a fraction of individual pairs is selected to depend on each other. The dependency individuals can gain an extra payoff whose value is between the payoff of mutual cooperation and the value of temptation to defect. Thus, this mechanism reflects that the dependency relation is stronger than the relation of ordinary mutual cooperation, but it is not large enough to cause the defection of the dependency pair. We show that the dependence of individuals hinders, promotes and never affects the cooperation on regular ring networks, square lattice, random and scale-free networks, respectively. The results for the square lattice and regular ring networks are demonstrated by the pair approximation.	[Wang, Xuwen; Nie, Sen; Wang, Binghong] Univ Sci & Technol China, Dept Modern Phys, Hefei 230026, Anhui, Peoples R China; [Wang, Binghong] Wenzhou Univ, Coll Phys & Elect Informat Engn, Wenzhou 325035, Zhejiang, Peoples R China; [Wang, Binghong] Southwest Univ Sci & Technol, Sch Sci, Mianyang 621010, Sichuan, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Wenzhou University; Southwest University of Science & Technology - China	Wang, BH (corresponding author), Univ Sci & Technol China, Dept Modern Phys, Hefei 230026, Anhui, Peoples R China.	bhwang@ustc.edu.cn		Wang, Xu-Wen/0000-0001-7670-3544	National Natural Science Foundation of China [11275186, 91024026, FOM2014OF001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by The National Natural Science Foundation of China (Grant Nos. 11275186, 91024026, FOM2014OF001). The funders had important role in study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Axelrod RM, 2006, BASIC BOOKS; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Bashan A, 2011, J STAT PHYS, V145, P686, DOI 10.1007/s10955-011-0333-5; Boccaletti S, 2014, PHYS REP, V544, P1, DOI 10.1016/j.physrep.2014.07.001; Brandt H, 2003, P ROY SOC B-BIOL SCI, V270, P1099, DOI 10.1098/rspb.2003.2336; Chen XJ, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.017103; Du WB, 2009, EPL-EUROPHYS LETT, V87, DOI 10.1209/0295-5075/87/60004; Ebel H, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.056118; Fehr E, 2004, TRENDS COGN SCI, V8, P185, DOI 10.1016/j.tics.2004.02.007; Gao JX, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.195701; Gracia-Lazaro C, 2012, P NATL ACAD SCI USA, V109, P12922, DOI 10.1073/pnas.1206681109; Hauert C, 2005, AM J PHYS, V73, P405, DOI 10.1119/1.1848514; Hauert C, 2002, SCIENCE, V296, P1129, DOI 10.1126/science.1070582; Helbing D, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/8/083005; Hilbe C, 2013, P NATL ACAD SCI USA, V110, P6913, DOI 10.1073/pnas.1214834110; Jiang LL, 2013, SCI REP-UK, V3, DOI 10.1038/srep02483; Kim BJ, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.021907; Li W, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.228702; Meloni S, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.067101; NOWAK MA, 1992, NATURE, V359, P826, DOI 10.1038/359826a0; Parshani R, 2011, P NATL ACAD SCI USA, V108, P1007, DOI 10.1073/pnas.1008404108; Parshani R, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.048701; Pena J, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.016110; Perc M, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.011904; Perc M, 2012, NEW J PHYS, V14, DOI 10.1088/1367-2630/14/4/043013; Perc M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015117; Press WH, 2012, P NATL ACAD SCI USA, V109, P10409, DOI 10.1073/pnas.1206569109; Rand DG, 2011, P NATL ACAD SCI USA, V108, P19193, DOI 10.1073/pnas.1108243108; Rong ZH, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.027101; Rong ZH, 2013, EPL-EUROPHYS LETT, V102, DOI 10.1209/0295-5075/102/68005; Santos FC, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.098104; Santos FC, 2008, NATURE, V454, P213, DOI 10.1038/nature06940; Sigmund K, 2010, PRINC SER THEOR COMP, P1; Szabo G, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.047107; Szabo G, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.062903; Szabo G, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.118101; Szolnoki A, 2010, EPL-EUROPHYS LETT, V92, DOI 10.1209/0295-5075/92/38003; Szolnoki A, 2014, SCI REP-UK, V4, DOI 10.1038/srep05496; Szolnoki A, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.026104; Szolnoki A, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.056109; Vukov J, 2014, PHYS REV E, V90, DOI 10.1103/PhysRevE.90.032802; Wang SJ, 2014, SCI REPORTS, V4, P4095, DOI [10.1038/srep04095, DOI 10.1038/SREP04095]; Wang WX, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.056113; Wang Z, 2014, J THEOR BIOL, V349, P50, DOI 10.1016/j.jtbi.2014.01.037; Wang Z, 2013, PHYS REV E, V88, DOI 10.1103/PhysRevE.88.042145; Wang Z, 2013, SCI REP-UK, V3, DOI 10.1038/srep03055; Wang Z, 2013, SCI REP-UK, V3, DOI 10.1038/srep01183; Wang Z, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040218; Wang Z, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.037101; Wang Z, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.021115; Wu ZX, 2014, PHYS REV E, V89, DOI 10.1103/PhysRevE.89.012109; Wu ZX, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.037103; Yang HX, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.056107; Zimmermann MG, 2000, APPLICATIONS OF SIMULATION TO SOCIAL SCIENCES, P283, DOI 10.1142/S0219525900000212	54	3	3	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0121508	10.1371/journal.pone.0121508	http://dx.doi.org/10.1371/journal.pone.0121508			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25798579	gold, Green Published, Green Submitted			2022-12-27	WOS:000351987300263
J	Gionbelli, MP; Duarte, MS; Valadares, SC; Detmann, E; Chizzotti, ML; Rodrigues, FC; Zanetti, D; Gionbelli, TRS; Machado, MG				Gionbelli, Mateus P.; Duarte, Marcio S.; Valadares Filho, Sebastiao C.; Detmann, Edenio; Chizzotti, Mario L.; Rodrigues, Felipe C.; Zanetti, Diego; Gionbelli, Tathyane R. S.; Machado, Marcelo G.			Achieving Body Weight Adjustments for Feeding Status and Pregnant or Non-Pregnant Condition in Beef Cows	PLOS ONE			English	Article							VISCERAL ORGAN MASS; GESTATION LENGTH; GRAVID UTERUS; CATTLE; GROWTH; MODEL; IDENTIFICATION; RESTRICTION; VASCULARITY; PARAMETERS	Background Beef cows herd accounts for 70% of the total energy used in the beef production system. However, there are still limited studies regarding improvement of production efficiency in this category, mainly in developing countries and in tropical areas. One of the limiting factors is the difficulty to obtain reliable estimates of weight variation in mature cows. This occurs due to the interaction of weight of maternal tissues with specific physiological stages such as pregnancy. Moreover, variation in gastrointestinal contents due to feeding status in ruminant animals is a major source of error in body weight measurements. Objectives Develop approaches to estimate the individual proportion of weight from maternal tissues and from gestation in pregnant cows, adjusting for feeding status and stage of gestation. Methods and Findings Dataset of 49 multiparous non-lactating Nellore cows (32 pregnant and 17 non-pregnant) were used. To establish the relationships between the body weight, depending on the feeding status of pregnant and non-pregnant cows as a function of days of pregnancy, a set of general equations was tested, based on theoretical suppositions. We proposed the concept of pregnant compound (PREG), which represents the weight that is genuinely related to pregnancy. The PREG includes the gravid uterus minus the non-pregnant uterus plus the accretion in udder related to pregnancy. There was no accretion in udder weight up to 238 days of pregnancy. By subtracting the PREG from live weight of a pregnant cow, we obtained estimates of the weight of only maternal tissues in pregnant cows. Non-linear functions were adjusted to estimate the relationship between fasted, non-fasted and empty body weight, for pregnant and non-pregnant cows. Conclusions Our results allow for estimating the actual live weight of pregnant cows and their body constituents, and subsequent comparison as a function of days of gestation and feeding status.	[Gionbelli, Mateus P.] Univ Fed Lavras, Dept Anim Sci, Lavras, MG, Brazil; [Duarte, Marcio S.; Valadares Filho, Sebastiao C.; Detmann, Edenio; Chizzotti, Mario L.; Rodrigues, Felipe C.; Zanetti, Diego; Gionbelli, Tathyane R. S.; Machado, Marcelo G.] Univ Fed Vicosa, Dept Anim Sci, Vicosa, MG, Brazil	Universidade Federal de Lavras; Universidade Federal de Vicosa	Gionbelli, MP (corresponding author), Univ Fed Lavras, Dept Anim Sci, Lavras, MG, Brazil.	mateus.gionbelli@dzo.ufla.br	Duarte, Marcio/G-3815-2015; Gionbelli, Mateus P./W-5729-2019; Detmann, Edenio/O-9048-2019; Chizzotti, Mario/C-4854-2013; Gionbelli, Mateus P/W-4420-2018	Duarte, Marcio/0000-0002-5795-6420; Gionbelli, Mateus P./0000-0002-5168-4794; Chizzotti, Mario/0000-0001-9770-6891; Gionbelli, Mateus P/0000-0002-5168-4794; Gionbelli, Tathyane R. S./0000-0003-0087-2848	FAPEMIG (Fundacao de Amparo a Pesquisa de Minas Gerais) [APQ-01121-10]; INCT-CA (Instituto Nacional de Ciencia e Tecnologia-Ciencia Animal) [573592/2008-0]; Conselho Nacional de Ciencia e Tecnologia-CNPq [202062/2011-2]	FAPEMIG (Fundacao de Amparo a Pesquisa de Minas Gerais)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); INCT-CA (Instituto Nacional de Ciencia e Tecnologia-Ciencia Animal); Conselho Nacional de Ciencia e Tecnologia-CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by the FAPEMIG (Fundacao de Amparo a Pesquisa de Minas Gerais) (Grant: APQ-01121-10), the INCT-CA (Instituto Nacional de Ciencia e Tecnologia-Ciencia Animal) (Grant: 573592/2008-0) and the Conselho Nacional de Ciencia e Tecnologia-CNPq (Grant: 202062/2011-2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AFRC, 1993, ENERGY PROTEIN REQUI; Agricultural Research Council (ARC), 1980, NUTR REQ RUM LIV; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; American VeterinaryMedical Association (AVMA), 2013, ANIMALS-BASEL, DOI DOI 10.1016/B978-012088449-0.50009-1; ANDERSEN H, 1965, J DAIRY SCI, V48, P1224, DOI 10.3168/jds.S0022-0302(65)88431-4; AOAC, 2000, OFFICIAL METHODS ANA; BERESKIN B, 1967, J DAIRY SCI, V50, P220, DOI 10.3168/jds.S0022-0302(67)87391-0; Bibby J., 1977, PREDICTION IMPROVED; Caton JS, 2009, J ANIM SCI, V87, P222, DOI 10.2527/jas.2008-1043; Duarte MS, 2013, MEAT SCI, V94, P139, DOI 10.1016/j.meatsci.2013.01.008; Duchesne C, 2001, J PROCESS CONTR, V11, P553, DOI 10.1016/S0959-1524(00)00025-1; Fadel JG, 2004, J DAIRY SCI, V87, P169, DOI 10.3168/jds.S0022-0302(04)73154-9; FERRELL CL, 1976, J ANIM SCI, V42, P1477, DOI 10.2527/jas1976.4261477x; FOX DG, 1976, J ANIM SCI, V43, P566, DOI 10.2527/jas1976.433566x; Gionbelli MP, 2013, J ANIM SCI, V91, P320; INRA, 2007, AL BOV OV CAPR BES A; KOONG LJ, 1975, J ANIM SCI, V41, P1065, DOI 10.2527/jas1975.4141065x; LIN LI, 1989, BIOMETRICS, V45, P255, DOI 10.2307/2532051; LOFGREEN GP, 1962, J ANIM SCI, V21, P20, DOI 10.2527/jas1962.21120x; Martin O, 2007, ANIMAL, V1, P1143, DOI 10.1017/S1751731107000377; Martin O, 2003, P 10 RENC AUT RECH R, P167; MAYER DG, 1994, AGR SYST, V45, P93, DOI 10.1016/S0308-521X(94)90282-8; McNeill DM, 1997, J ANIM SCI, V75, P809; Meyer AM, 2010, J ANIM SCI, V88, P2410, DOI 10.2527/jas.2009-2220; Motulsky H, 2003, PRACTICAL GUIDE CURV; NASEM (National Academies of Science Engineering and Medicine), 2001, NUTR REQ DAIR CATTL, V7th, DOI 10.17226/9825; Nicholson M.J., 1986, GUIDE CONDITION SCOR; NRC (National Research Council), 2000, NUTR REQ BEEF CATTL, DOI DOI 10.17226/19014; Paulino P. V. R., 2010, Nutrient requirements of Zebu beef cattle - BR - Corte, P167; RICHARDS MW, 1986, J ANIM SCI, V62, P300, DOI 10.2527/jas1986.622300x; Ritchie RW, 1995, RES S ANN M KANS CIT, V27, P126; Rocha JCMC, 2005, ARQ BRAS MED VET ZOO, V57, P784, DOI 10.1590/S0102-09352005000600013; Scheaffer AN, 2004, J ANIM SCI, V82, P1826; Scheaffer AN, 2001, J ANIM SCI, V79, P2481; SILVEY MW, 1978, ANIM PROD, V27, P113, DOI 10.1017/S0003356100035881; Tedeschi LO, 2006, AGR SYST, V89, P225, DOI 10.1016/j.agsy.2005.11.004; Valadares Filho SC, 2010, NUTR REQUIREMENTS ZE; WILLIAMS WT, 1975, AUST J AGR RES, V26, P665, DOI 10.1071/AR9750665; Witteveen H. J., 1961, CONTRIBUTIONS EC ANA, P6	39	17	18	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0112111	10.1371/journal.pone.0112111	http://dx.doi.org/10.1371/journal.pone.0112111			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25793770	gold, Green Published, Green Submitted			2022-12-27	WOS:000352084200001
J	Hepp, D; Goncalves, GL; de Freitas, TRO				Hepp, Diego; Goncalves, Gislene Lopes; Ochotorena de Freitas, Thales Renato			Prediction of the Damage-Associated Non-Synonymous Single Nucleotide Polymorphisms in the Human MC1R Gene	PLOS ONE			English	Article							HUMAN MELANOCORTIN-1 RECEPTOR; GENOME-WIDE ASSOCIATION; AMINO-ACID SUBSTITUTIONS; IN-SILICO ANALYSIS; RED HAIR; HUMAN PIGMENTATION; MELANOMA RISK; MISSENSE MUTATIONS; PROTEIN MUTATIONS; VARIANT ALLELES	The melanocortin 1 receptor (MC1R) is involved in the control of melanogenesis. Polymorphisms in this gene have been associated with variation in skin and hair color and with elevated risk for the development of melanoma. Here we used 11 computational tools based on different approaches to predict the damage-associated non-synonymous single nucleotide polymorphisms (nsSNPs) in the coding region of the human MC1R gene. Among the 92 nsSNPs arranged according to the predictions 62% were classified as damaging in more than five tools. The classification was significantly correlated with the scores of two consensus programs. Alleles associated with the red hair color (RHC) phenotype and with the risk of melanoma were examined. The R variants D84E, R142H, R151C, I155T, R160W and D294H were classified as damaging by the majority of the tools while the r variants V60L, V92M and R163Q have been predicted as neutral in most of the programs The combination of the prediction tools results in 14 nsSNPs indicated as the most damaging mutations in MC1R (L48P, R67W, H70Y, P72L, S83P, R151H, S172I, L206P, T242I, G255R, P256S, C273Y, C289R and R306H); C273Y showed to be highly damaging in SIFT, Polyphen-2, MutPred, PANTHER and PROVEAN scores. The computational analysis proved capable of identifying the potentially damaging nsSNPs in MC1R, which are candidates for further laboratory studies of the functional and pharmacological significance of the alterations in the receptor and the phenotypic outcomes.	[Hepp, Diego; Goncalves, Gislene Lopes; Ochotorena de Freitas, Thales Renato] Univ Fed Rio Grande do Sul, Inst Biociencias, Dept Genet, BR-90049 Porto Alegre, RS, Brazil; [Goncalves, Gislene Lopes] Univ Tarapaca, Inst Alta Invest, Antofagasta 1520, Arica, Chile; [Hepp, Diego] Inst Fed Educ Ciencia & Tecnol Rio Grande Sul, BR-90049 Porto Alegre, RS, Brazil	Universidade Federal do Rio Grande do Sul; Universidad de Tarapaca; Instituto Federal do Rio Grande do Sul (IFRS)	Hepp, D (corresponding author), Univ Fed Rio Grande do Sul, Inst Biociencias, Dept Genet, BR-90049 Porto Alegre, RS, Brazil.	diego.hepp@gmail.com	Goncalves, Gislene Lopes/D-3567-2013; Freitas, Thales Renato Ochotorena de/G-1160-2012	Goncalves, Gislene Lopes/0000-0002-1459-4888; Freitas, Thales Renato Ochotorena de/0000-0002-1019-9303				Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Moreira LGA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081979; Balu K, 2013, GENE, V513, P184, DOI 10.1016/j.gene.2012.09.128; Barrett JH, 2011, NAT GENET, V43, P1108, DOI 10.1038/ng.959; Bastiaens MT, 2001, AM J HUM GENET, V68, P884, DOI 10.1086/319500; Beaumont KA, 2005, HUM MOL GENET, V14, P2145, DOI 10.1093/hmg/ddi219; Beaumont KA, 2007, HUM MOL GENET, V16, P2249, DOI 10.1093/hmg/ddm177; Beaumont KA, 2011, EUR J PHARMACOL, V660, P103, DOI 10.1016/j.ejphar.2010.11.040; Bendl J, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003440; Bishop DT, 2009, NAT GENET, V41, P920, DOI 10.1038/ng.411; Bromberg Y, 2007, NUCLEIC ACIDS RES, V35, P3823, DOI 10.1093/nar/gkm238; Brunham LR, 2005, PLOS GENET, V1, P739, DOI 10.1371/journal.pgen.0010083; Bush WS, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002822; Calabrese R, 2009, HUM MUTAT, V30, P1237, DOI 10.1002/humu.21047; Capriotti E, 2006, BIOINFORMATICS, V22, P2729, DOI 10.1093/bioinformatics/btl423; Capriotti E, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S2-S6; de Carvalho MDC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065558; Choi Y., 2012, P ACM C BIOINF COMP, P414, DOI 10.1145/2382936.2382989; Choi Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046688; Cone RD, 1996, RECENT PROG HORM RES, V51, P287; Doss CGP, 2008, J BIOMED INFORM, V41, P607, DOI 10.1016/j.jbi.2007.12.004; Duffy DL, 2004, HUM MOL GENET, V13, P447, DOI 10.1093/hmg/ddh043; Esaki S, 2012, EUR J HUM GENET, V20, P428, DOI 10.1038/ejhg.2011.198; Fernandez LP, 2007, CARCINOGENESIS, V28, P1659, DOI 10.1093/carcin/bgm084; Flanagan N, 2000, HUM MOL GENET, V9, P2531, DOI 10.1093/hmg/9.17.2531; Gorlatova N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027269; Gorski M, 2014, KIDNEY INT; Hichiya H, 2005, DRUG METAB DISPOS, V33, P630, DOI 10.1124/dmd.105.003830; Jimenez-Cervantes C, 2001, FEBS LETT, V508, P44, DOI 10.1016/S0014-5793(01)03025-3; Josephy PD, 2009, ARCH BIOCHEM BIOPHYS, V490, P24, DOI 10.1016/j.abb.2009.07.025; Kamaraj B, 2014, CELL BIOCHEM BIOPHYS, V68, P97, DOI 10.1007/s12013-013-9697-2; Kamaraj B, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/697051; Kanetsky PA, 2004, CANCER EPIDEM BIOMAR, V13, P808; Kennedy C, 2001, J INVEST DERMATOL, V117, P294, DOI 10.1046/j.0022-202x.2001.01421.x; Klein RJ, 2007, BMC GENET, V8, DOI 10.1186/1471-2156-8-58; Koppula SV, 1997, HUM MUTAT, V9, P30, DOI 10.1002/(SICI)1098-1004(1997)9:1<30::AID-HUMU5>3.3.CO;2-5; Kumar A, 2014, CELL BIOCHEM BIOPHYS, V68, P233, DOI 10.1007/s12013-013-9705-6; Kumar A, 2012, FEBS OPEN BIO, V2, P285, DOI 10.1016/j.fob.2012.09.003; Kumar A, 2012, MUTAT RES-FUND MOL M, V738, P28, DOI 10.1016/j.mrfmmm.2012.08.005; Li B, 2009, BIOINFORMATICS, V25, P2744, DOI 10.1093/bioinformatics/btp528; Liu CT, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002264; Mas JS, 2002, EUR J BIOCHEM, V269, P6133, DOI 10.1046/j.1432-1033.2002.03329.x; Mooney S, 2005, BRIEF BIOINFORM, V6, P44, DOI 10.1093/bib/6.1.44; Morisseau C, 2014, J LIPID RES, V55, P1131, DOI 10.1194/jlr.M049718; Nakayama K, 2006, HUM GENET, V119, P322, DOI 10.1007/s00439-006-0141-1; Ng PC, 2006, ANNU REV GENOM HUM G, V7, P61, DOI 10.1146/annurev.genom.7.080505.115630; NG PC, 2001, NUCLEIC ACIDS RES, V31, P3812; Ohashi J, 2001, J HUM GENET, V46, P478, DOI 10.1007/s100380170048; Olatubosun A, 2012, HUM MUTAT, V33, P1166, DOI 10.1002/humu.22102; Oliva ABP, 2009, HUM MUTAT, V30, P811, DOI 10.1002/humu.20971; Raimondi S, 2008, INT J CANCER, V122, P2753, DOI 10.1002/ijc.23396; Rajasekaran R, 2007, GENOMICS, V90, P447, DOI 10.1016/j.ygeno.2007.07.004; Rees JL, 2003, ANNU REV GENET, V37, P67, DOI 10.1146/annurev.genet.37.110801.143233; Reva B, 2011, NUCLEIC ACIDS RES, V39, pE118, DOI 10.1093/nar/gkr407; Ringholm A, 2004, J INVEST DERMATOL, V123, P917, DOI 10.1111/j.0022-202X.2004.23444.x; Scherer D, 2009, INT J CANCER, V125, P1868, DOI 10.1002/ijc.24548; Schioth HB, 1999, BIOCHEM BIOPH RES CO, V260, P488, DOI 10.1006/bbrc.1999.0935; Scott MC, 2002, J CELL SCI, V115, P2349; Spencer CCA, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000477; Sturm RA, 2003, ANN NY ACAD SCI, V994, P348, DOI 10.1111/j.1749-6632.2003.tb03199.x; Sturm RA, 2001, GENE, V277, P49, DOI 10.1016/S0378-1119(01)00694-1; Sulem P, 2007, NAT GENET, V39, P1443, DOI 10.1038/ng.2007.13; Thomas PD, 2004, P NATL ACAD SCI USA, V101, P15398, DOI 10.1073/pnas.0404380101; Thomas PD, 2003, GENOME RES, V13, P2129, DOI 10.1101/gr.772403; Thusberg J, 2009, HUM MUTAT, V30, P703, DOI 10.1002/humu.20938; Tully G, 2007, FORENSIC SCI INT-GEN, V1, P105, DOI 10.1016/j.fsigen.2007.01.005; Valastyan JS, 2014, DIS MODEL MECH, V7, P9, DOI 10.1242/dmm.013474; VALVERDE P, 1995, NAT GENET, V11, P328, DOI 10.1038/ng1195-328; Vanajothi R, 2012, Pak J Biol Sci, V15, P121; Vendruscolo M, 2003, PHILOS T R SOC A, V361, P1205, DOI 10.1098/rsta.2003.1194; Wong TH, 2005, PEPTIDES, V26, P1965, DOI 10.1016/j.peptides.2004.11.021; Yue P, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-166; Yue P, 2006, J MOL BIOL, V356, P1263, DOI 10.1016/j.jmb.2005.12.025; Zeron-Medina J, 2013, CELL, V155, P410, DOI 10.1016/j.cell.2013.09.017; Zhang CS, 2011, J ANIM VET ADV, V10, P928, DOI 10.3923/javaa.2011.928.931	75	28	29	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0121812	10.1371/journal.pone.0121812	http://dx.doi.org/10.1371/journal.pone.0121812			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25794181	Green Submitted, Green Published, gold			2022-12-27	WOS:000352083900155
J	Kim, MK; Cho, JH; Lee, JJ; Son, MH; Lee, KJ				Kim, Mi-Kyung; Cho, Jin-Hwan; Lee, Jae-Jin; Son, Moon-Ho; Lee, Kong-Joo			Proteomic Analysis of INS-1 Rat Insulinoma Cells: ER Stress Effects and the Protective Role of Exenatide, a GLP-1 Receptor Agonist	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; THIOREDOXIN-INTERACTING PROTEIN; MASS; PHOSPHORYLATION; IDENTIFICATION; APOPTOSIS; DEATH	Beta cell death caused by endoplasmic reticulum (ER) stress is a key factor aggravating type 2 diabetes. Exenatide, a glucagon-like peptide (GLP)-1 receptor agonist, prevents beta cell death induced by thapsigargin, a selective inhibitor of ER calcium storage. Here, we report on our proteomic studies designed to elucidate the underlying mechanisms. We conducted comparative proteomic analyses of cellular protein profiles during thapsigargin-induced cell death in the absence and presence of exenatide in INS-1 rat insulinoma cells. Thapsigargin altered cellular proteins involved in metabolic processes and protein folding, whose alterations were variably modified by exenatide treatment. We categorized the proteins with thapsigargin initiated alterations into three groups: those whose alterations were 1) reversed by exenatide, 2) exaggerated by exenatide, and 3) unchanged by exenatide. The most significant effect of thapsigargin on INS-1 cells relevant to their apoptosis was the appearance of newly modified spots of heat shock proteins, thimet oligopeptidase and 14-3-3 beta, epsilon, and theta, and the prevention of their appearance by exenatide, suggesting that these proteins play major roles. We also found that various modifications in 14-3-3 isoforms, which precede their appearance and promote INS-1 cell death. This study provides insights into the mechanisms in ER stress-caused INS-1 cell death and its prevention by exenatide.	[Kim, Mi-Kyung; Cho, Jin-Hwan; Lee, Jae-Jin; Lee, Kong-Joo] Ewha Womans Univ, Grad Sch Pharmaceut Sci, Seoul 120750, South Korea; [Kim, Mi-Kyung; Cho, Jin-Hwan; Lee, Jae-Jin; Lee, Kong-Joo] Ewha Womans Univ, Coll Pharm, Seoul 120750, South Korea; [Kim, Mi-Kyung; Son, Moon-Ho] Dong A ST Res Inst, Yongin 446905, Gyeonggi Do, South Korea	Ewha Womans University; Ewha Womans University	Lee, KJ (corresponding author), Ewha Womans Univ, Grad Sch Pharmaceut Sci, Seoul 120750, South Korea.	kjl@ewha.ac.kr		Lee, Kong-Joo/0000-0001-7972-6020	Global Research Lab Program [2012K1A1A2045441]; Proteogenomics Research Program [2012M3A9B90036680]	Global Research Lab Program; Proteogenomics Research Program	This work was supported by the Global Research Lab Program (No. 2012K1A1A2045441), the Proteogenomics Research Program (No. 2012M3A9B90036680). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen J, 2008, DIABETES, V57, P938, DOI 10.2337/db07-0715; Chen JQ, 2006, BIOCHEM BIOPH RES CO, V346, P1067, DOI 10.1016/j.bbrc.2006.06.027; Cho JM, 2011, DIABETES RES CLIN PR, V91, P72, DOI 10.1016/j.diabres.2010.10.012; Cnop M, 2010, DIABETES OBES METAB, V12, P76, DOI 10.1111/j.1463-1326.2010.01279.x; D'Hertog W, 2011, PROTEOMICS, V11, P1365, DOI 10.1002/pmic.201000006; Dalle S, 2013, CELL SIGNAL, V25, P570, DOI 10.1016/j.cellsig.2012.11.009; Dalle S, 2011, CELL SIGNAL, V23, P522, DOI 10.1016/j.cellsig.2010.09.014; Furman BL, 2012, TOXICON, V59, P464, DOI 10.1016/j.toxicon.2010.12.016; Jeong JH, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.000513; Kim MK, 2013, COMPUT MATH METHOD M, V2013, DOI 10.1155/2013/573734; Kim S, 2006, NUCLEIC ACIDS RES, V34, pW258, DOI 10.1093/nar/gkl245; Nomura M, 2003, J BIOL CHEM, V278, P2058, DOI 10.1074/jbc.M207880200; Obsilova V, 2008, PHYSIOL RES, V57, pS11, DOI 10.33549/physiolres.931598; Oslowski CM, 2012, CELL METAB, V16, P265, DOI 10.1016/j.cmet.2012.07.005; Seo J, 2008, J PROTEOME RES, V7, P587, DOI 10.1021/pr700657y; Sheikh-Ali M, 2010, NUTRITION, V26, P1146, DOI 10.1016/j.nut.2009.08.019; Shikano S, 2006, TRENDS CELL BIOL, V16, P370, DOI 10.1016/j.tcb.2006.05.006; Tian R, 2008, DIGEST DIS SCI, V53, P65, DOI 10.1007/s10620-007-9823-3; Tonnesen MF, 2009, ENDOCRINOLOGY, V150, P4094, DOI 10.1210/en.2009-0029; Tsuruta F, 2004, EMBO J, V23, P1889, DOI 10.1038/sj.emboj.7600194; Xu CY, 2005, J CLIN INVEST, V115, P2656, DOI 10.1172/JCI26373; Xue Y, 2008, MOL CELL PROTEOMICS, V7, P1598, DOI 10.1074/mcp.M700574-MCP200; Yusta B, 2006, CELL METAB, V4, P391, DOI 10.1016/j.cmet.2006.10.001	23	8	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0120536	10.1371/journal.pone.0120536	http://dx.doi.org/10.1371/journal.pone.0120536			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25793496	gold, Green Published, Green Submitted			2022-12-27	WOS:000352083900050
J	Molshatzki, N; Weinstein, G; Streifler, JY; Goldbourt, U; Tanne, D				Molshatzki, Noa; Weinstein, Galit; Streifler, Jonathan Y.; Goldbourt, Uri; Tanne, David			Serum Uric Acid and Subsequent Cognitive Performance in Patients with Pre-Existing Cardiovascular Disease	PLOS ONE			English	Article							PLASMA ANTIOXIDANTS; RISK; URATE; HYPERURICEMIA; HEART; ASSOCIATION; KIDNEY; COHORT; STROKE; DAMAGE	High serum uric acid (UA) levels are associated with numerous vascular risk factors, and vascular disease, that predispose patients to cognitive impairment, yet UA is also a major natural antioxidant and higher levels have been linked to slower progression of several neurodegenerative disease. In-order to test the association between UA and subsequent cognitive performance among patients that carry a high vascular burden, UA levels were determined by calorimetric enzymatic tests in a sub-cohort of patients with chronic cardiovascular disease who previously participating in a secondary prevention trial. After an average of 9.8 +/- 1.7 years, we assessed cognitive performance (Neurotrax Computerized Cognitive Battery) as well as cerebrovascular reactivity (CVR) and common carotid intima-media thickness (IMT). Among 446 men (mean age 62.3 +/- 6.4 yrs) mean UA levels were 5.8 +/- 1.1 mg/dL. Adjusted linear regressionmodels revealed that low UA levels (bottom quintile) were associated with poorer cognitive performance. Adjusted differences between the bottom quintile and grouped top UA quintiles were (B coefficient +/- SE) -4.23 +/- 1.28 for global cognitive scores (p = 0.001), -4.69 +/- 1.81 for memory scores (p = 0.010), -3.32 +/- 1.43 for executive scores (p = 0.020) and -3.43 +/- 1.97 for visual spatial scores (p = 0.082). Significant difference was also found for attention scores (p = 0.015). Additional adjustment for impaired CVR and high common carotid IMT slightly attenuated the relationship. Stronger UA effect on cognitive performance was found for older (age>65) patients with significant age interaction for global cognitive score (p = 0.016) and for executive (p = 0.018) and attention domains (p< 0.001). In conclusion, we demonstrate that low UA levels in patients with preexisting cardiovascular disease are associated with poorer cognitive function a decade later. These findings lend support to the hypothesis that oxidative stress may be involved in the pathogenesis of age-associated cognitive impairment.	[Molshatzki, Noa; Tanne, David] Chaim Sheba Med Ctr, Sagol Neurosci Ctr, IL-52621 Tel Hashomer, Israel; [Weinstein, Galit] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA; [Streifler, Jonathan Y.] Rabin Med Ctr, Neurol Unit, Petah Tiqwa, Israel; [Goldbourt, Uri; Tanne, David] Tel Aviv Univ, Sackler Fac Med, Sch Publ Hlth, Dept Epidemiol & Prevent Med, IL-69978 Tel Aviv, Israel	Chaim Sheba Medical Center; Boston University; Rabin Medical Center; Tel Aviv University; Sackler Faculty of Medicine	Tanne, D (corresponding author), Chaim Sheba Med Ctr, Sagol Neurosci Ctr, IL-52621 Tel Hashomer, Israel.	tanne@post.tau.ac.il	Tanne, David/F-2560-2010	Tanne, David/0000-0002-6699-2220	Chief Scientist Office, Israeli Ministry of Health; Leslie and Susan Gonda Foundation, Los Angeles, California	Chief Scientist Office, Israeli Ministry of Health; Leslie and Susan Gonda Foundation, Los Angeles, California	This study was supported by a grant from the Chief Scientist Office, Israeli Ministry of Health and by a grant from the Leslie and Susan Gonda Foundation, Los Angeles, California. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afsar B, 2011, AM J NEPHROL, V34, P49, DOI 10.1159/000329097; [Anonymous], 2010, R LANG ENV STAT COMP; Bos MJ, 2006, STROKE, V37, P1503, DOI 10.1161/01.STR.0000221716.55088.d4; Brosius FC, 2006, CIRCULATION, V114, P1083, DOI 10.1161/CIRCULATIONAHA.106.177321; Chen HL, 2009, AM J EPIDEMIOL, V169, P1064, DOI 10.1093/aje/kwp033; Chen XQ, 2013, P NATL ACAD SCI USA, V110, P300, DOI 10.1073/pnas.1217296110; Dahabreh IJ, 2011, JAMA-J AM MED ASSOC, V305, P822, DOI 10.1001/jama.2011.163; Davies KJ, 2002, BIOCHEM J, V235, P747; de la Torre JC, 2009, INT REV NEUROBIOL, V84, P35, DOI 10.1016/S0074-7742(09)00403-6; Dwolatzky Tzvi, 2003, BMC Geriatr, V3, P4, DOI 10.1186/1471-2318-3-4; Erkinjuntti Timo, 2009, V24, P79, DOI 10.1159/000197886; Euser SM, 2009, BRAIN, V132, P377, DOI 10.1093/brain/awn316; Feig DI, 2008, NEW ENGL J MED, V359, P1811, DOI 10.1056/NEJMra0800885; Grayson PC, 2011, ARTHRIT CARE RES, V63, P102, DOI 10.1002/acr.20344; Houlihan LM, 2010, HUM MOL GENET, V19, P2321, DOI 10.1093/hmg/ddq097; Irizarry MC, 2009, NEURODEGENER DIS, V6, P23, DOI 10.1159/000170883; Iseki K, 2001, HYPERTENS RES, V24, P691, DOI 10.1291/hypres.24.691; Jain S, 2011, NEUROEPIDEMIOLOGY, V36, P223, DOI 10.1159/000327748; Kim SY, 2009, ARTHRIT RHEUM-ARTHR, V61, P885, DOI 10.1002/art.24612; Kim TS, 2006, INT J GERIATR PSYCH, V21, P344, DOI 10.1002/gps.1469; Lee Ju-Mi, 2012, J Prev Med Public Health, V45, P181, DOI 10.3961/jpmph.2012.45.3.181; Li J, 2010, EXP GERONTOL, V45, P331, DOI 10.1016/j.exger.2010.01.005; Markesbery WR, 2007, ARCH NEUROL-CHICAGO, V64, P954, DOI 10.1001/archneur.64.7.954; MULLER M, 1995, STROKE, V26, P96, DOI 10.1161/01.STR.26.1.96; Neogi T, 2009, J RHEUMATOL, V36, P378, DOI 10.3899/jrheum.080646; Nunomura A, 2012, NEUROTOX RES, V22, P231, DOI 10.1007/s12640-012-9331-x; REHAK NN, 1977, CLIN CHEM, V23, P195; Rinaldi P, 2003, NEUROBIOL AGING, V24, P915, DOI 10.1016/S0197-4580(03)00031-9; Rubin DB, 1987, MULTIPLE IMPUTATION, DOI [10.1002/sim.6008, DOI 10.1002/SIM.6008]; Schlesinger Z, 2000, CIRCULATION, V102, P21, DOI 10.1161/01.CIR.102.1.21; Schretlen DJ, 2007, NEUROLOGY, V69, P1418, DOI 10.1212/01.wnl.0000277468.10236.f1; Schretlen DJ, 2007, NEUROPSYCHOLOGY, V21, P136, DOI 10.1037/0894-4105.21.1.136; Singh-Manoux A, 2008, EUR HEART J, V29, P2100, DOI 10.1093/eurheartj/ehn298; Verhaaren BFJ, 2013, NEUROEPIDEMIOLOGY, V41, P29, DOI 10.1159/000346606; Whiteman M, 2002, ANN NY ACAD SCI, V962, P242, DOI 10.1111/j.1749-6632.2002.tb04072.x	35	15	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0120862	10.1371/journal.pone.0120862	http://dx.doi.org/10.1371/journal.pone.0120862			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25794156	gold, Green Submitted, Green Published			2022-12-27	WOS:000352083900082
J	Zhang, Z; Wang, JY; Chai, RY; Qiu, HP; Jiang, H; Mao, XQ; Wang, YL; Liu, FQ; Sun, GC				Zhang, Zhen; Wang, Jiaoyu; Chai, Rongyao; Qiu, Haiping; Jiang, Hua; Mao, Xueqin; Wang, Yanli; Liu, Fengquan; Sun, Guochang			An S-(Hydroxymethyl) Glutathione Dehydrogenase Is Involved in Conidiation and Full Virulence in the Rice Blast Fungus Magnaporthe oryzae	PLOS ONE			English	Article							S-NITROSOGLUTATHIONE REDUCTASE; DEPENDENT FORMALDEHYDE DEHYDROGENASE; PLANT-PATHOGEN INTERACTIONS; III ALCOHOL-DEHYDROGENASE; GASEOUS NITRIC-OXIDE; NITROSATIVE STRESS; CELL-DEATH; CONIOTHYRIUM-MINITANS; ARABIDOPSIS-THALIANA; DISEASE RESISTANCE	Magnaporthe oryzae is a hemibiotrophic fungal pathogen that causes rice blast disease. A compatible interaction requires overcoming plant defense responses to initiate colonization during the early infection process. Nitric oxide (NO) plays important roles in defense responses during host-pathogen interactions. Microbes generally protect themselves against NO-induced damage by using enzymes. Here, we characterized an S-(hydroxymethyl)-glutathione dehydrogenase gene in M. oryzae, MoSFA1, the homologs of which are involved in NO metabolism by specifically catalyzing the reduction of S-nitrosoglutathione (GSNO) in yeasts and plants. As expected from the activities of S-(hydroxymethyl) glutathione dehydrogenase in formaldehyde detoxification and GSNO reduction, MoSFA1 deletion mutants were lethal in formaldehyde containing medium, sensitive to exogenous NO and exhibited a higher level of S-nitrosothiols (SNOs) than that of the wild type. Notably, the mutants showed severe reduction of conidiation and appressoria turgor pressure, as well as significantly attenuated the virulence on rice cultivar CO-39. However, the virulence of MoSFA1 deletion mutants on wounded rice leaf was not affected. An infection assay on barley leaf further revealed that MoSFA1 deletion mutants exhibited a lower infection rate, and growth of infectious hyphae of the mutants was retarded not only in primary infected cells but also in expansion from cell to cell. Furthermore, barley leaf cell infected by MoSFA1 deletion mutants exhibited a stronger accumulation of H2O2 at 24 and 36 hpi. MoSFA1 deletion mutants displayed hypersensitivity to different oxidants, reduced activities of superoxide dismutases and peroxidases, and lower glutathione content in cells, compared with the wild type. These results imply that MoSFA1-mediated NO metabolism is important in redox homeostasis in response to development and host infection of M. oryzae. Taken together, this work identifies that MoSFA1 is required for conidiation and contributes to virulence in the penetration and biotrophic phases in M. oryzae.	[Zhang, Zhen; Liu, Fengquan] Nanjing Agr Univ, Coll Plant Protect, Dept Plant Pathol, Nanjing, Jiangsu, Peoples R China; [Zhang, Zhen; Wang, Jiaoyu; Chai, Rongyao; Qiu, Haiping; Jiang, Hua; Mao, Xueqin; Wang, Yanli; Sun, Guochang] Zhejiang Acad Agr Sci, Inst Plant Protect & Microbiol, State Key Lab Breeding Base Zhejiang Sustainable, Hangzhou, Zhejiang, Peoples R China	Nanjing Agricultural University; Zhejiang Academy of Agricultural Sciences	Liu, FQ (corresponding author), Nanjing Agr Univ, Coll Plant Protect, Dept Plant Pathol, Nanjing, Jiangsu, Peoples R China.	fqliu20011@sina.com; sungc01@sina.com			Special Fund for Agro-Scientific Research in the Public Interest [201203014]; Zhejiang Academy of Agriculture Science; State Education Ministry; Key Subject Construction Program of Zhejiang for Modern Agricultural Biotechnology and Crop Disease control [2010DS700124-KF1101, 2010DS700124-KF1203]	Special Fund for Agro-Scientific Research in the Public Interest; Zhejiang Academy of Agriculture Science; State Education Ministry; Key Subject Construction Program of Zhejiang for Modern Agricultural Biotechnology and Crop Disease control	This project was supported by the Special Fund for Agro-Scientific Research in the Public Interest (201203014), Zhejiang Academy of Agriculture Science Innovate Found (2013), and State Education Ministry and Key Subject Construction Program of Zhejiang for Modern Agricultural Biotechnology and Crop Disease control (2010DS700124-KF1101; 2010DS700124-KF1203). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arasimowicz-Jelonek M, 2014, MOL PLANT PATHOL, V15, P406, DOI 10.1111/mpp.12095; ASAHI M, 1995, J BIOL CHEM, V270, P21035, DOI 10.1074/jbc.270.36.21035; Balhadere PV, 2001, PLANT CELL, V13, P1987, DOI 10.1105/tpc.13.9.1987; Belozerskaya TA, 2007, APPL BIOCHEM MICRO+, V43, P506, DOI 10.1134/S0003683807050031; Carreras Maria C., 2004, Molecular Aspects of Medicine, V25, P125, DOI 10.1016/j.mam.2004.02.014; Daudi A, 2012, PLANT CELL, V24, P275, DOI 10.1105/tpc.111.093039; Davis KL, 2001, ANNU REV PHARMACOL, V41, P203, DOI 10.1146/annurev.pharmtox.41.1.203; de Jesus-Berrios M, 2003, CURR BIOL, V13, P1963, DOI 10.1016/j.cub.2003.10.029; de Pinto MC, 2013, PLANT PHYSIOL, V163, P1766, DOI 10.1104/pp.113.222703; Dixon KP, 1999, PLANT CELL, V11, P2045, DOI 10.1105/tpc.11.10.2045; ENGELAND K, 1993, P NATL ACAD SCI USA, V90, P2491, DOI 10.1073/pnas.90.6.2491; Fang EGC, 2000, MOL PLANT MICROBE IN, V13, P1214, DOI 10.1094/MPMI.2000.13.11.1214; Feechan A, 2005, P NATL ACAD SCI USA, V102, P8054, DOI 10.1073/pnas.0501456102; Fernandez J, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0087300, 10.1371/journal.pone.0100872]; Foster MW, 2009, BIOCHEMISTRY-US, V48, P792, DOI 10.1021/bi801813n; Ghaffari A, 2006, NITRIC OXIDE-BIOL CH, V14, P21, DOI 10.1016/j.niox.2005.08.003; Gong XY, 2007, FUNGAL GENET BIOL, V44, P1368, DOI 10.1016/j.fgb.2007.07.007; Grant CM, 2001, MOL MICROBIOL, V39, P533, DOI 10.1046/j.1365-2958.2001.02283.x; Haque Mohammad Mahfuzul, 2005, Indian Journal of Experimental Biology, V43, P873; Hong JK, 2008, J EXP BOT, V59, P147, DOI 10.1093/jxb/erm244; Hu XY, 2003, CHINESE SCI BULL, V48, P358, DOI 10.1360/03tb9076; Kankanala P, 2007, PLANT CELL, V19, P706, DOI 10.1105/tpc.106.046300; Lai TF, 2011, CURR MICROBIOL, V62, P229, DOI 10.1007/s00284-010-9695-1; Lazar EE, 2008, LETT APPL MICROBIOL, V46, P688, DOI 10.1111/j.1472-765X.2008.02373.x; Lee U, 2008, PLANT CELL, V20, P786, DOI 10.1105/tpc.107.052647; Li B, 2010, APPL ENVIRON MICROB, V76, P2830, DOI 10.1128/AEM.02214-09; Li L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085252; Lin AH, 2012, PLANT PHYSIOL, V158, P451, DOI 10.1104/pp.111.184531; Lindermayr C, 2005, PLANT PHYSIOL, V137, P921, DOI 10.1104/pp.104.058719; Lindermayr C, 2010, PLANT CELL, V22, P2894, DOI 10.1105/tpc.109.066464; Liu LM, 2001, NATURE, V410, P490, DOI 10.1038/35068596; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Macherla C, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00193; Maldonado-Alconada AM, 2011, ACTA PHYSIOL PLANT, V33, P1493, DOI 10.1007/s11738-010-0688-2; Martinez LR, 2009, J INVEST DERMATOL, V129, P2463, DOI 10.1038/jid.2009.95; Missall TA, 2006, EUKARYOT CELL, V5, P518, DOI 10.1128/EC.5.3.518-529.2006; Mur LAJ, 2006, J EXP BOT, V57, P489, DOI 10.1093/jxb/erj052; Mur LAJ, 2013, AOB PLANTS, V5, DOI 10.1093/aobpla/pls052; Penninckx MJ, 2002, FEMS YEAST RES, V2, P295, DOI 10.1111/j.1567-1364.2002.tb00098.x; Prats E, 2008, RES MICROBIOL, V159, P476, DOI 10.1016/j.resmic.2008.04.001; Romero-Puertas MC, 2004, CELL MICROBIOL, V6, P795, DOI 10.1111/j.1462-5822.2004.00428.x; Rusterucci C, 2007, PLANT PHYSIOL, V143, P1282, DOI 10.1104/pp.106.091686; Sakamoto A, 2002, FEBS LETT, V515, P20, DOI 10.1016/S0014-5793(02)02414-6; Samalova M, 2013, NEW PHYTOL, V197, P207, DOI 10.1111/j.1469-8137.2012.04368.x; Sanghani PC, 2006, BIOCHEMISTRY-US, V45, P4819, DOI 10.1021/bi052554q; Sanghani PC, 2003, CHEM-BIOL INTERACT, V143, P195, DOI 10.1016/S0009-2797(02)00203-X; Sanghani PC, 2002, BIOCHEMISTRY-US, V41, P15189, DOI 10.1021/bi026705q; Schonhoff CM, 2011, CURRENT PROTOCOLS PR; Stroeher UH, 2007, J INFECT DIS, V196, P1820, DOI 10.1086/523107; Szabo C, 2003, TOXICOL LETT, V140, P105, DOI 10.1016/S0378-4274(02)00507-6; Tada Y, 2008, SCIENCE, V321, P952, DOI 10.1126/science.1156970; TALBOT NJ, 1993, PLANT CELL, V5, P1575, DOI 10.1105/tpc.5.11.1575; Thompson CM, 2010, TOXICOL LETT, V193, P1, DOI 10.1016/j.toxlet.2009.11.023; Wang J, 2005, FUNGAL GENET BIOL, V42, P284, DOI 10.1016/j.fgb.2004.12.006; Wang JR, 2013, NONLINEAR ANAL-HYBRI, V8, P1, DOI 10.1016/j.nahs.2012.08.003; Wang YQ, 2006, J EXP BOT, V57, P1777, DOI 10.1093/jxb/erj211; Yamakura F, 1998, J BIOL CHEM, V273, P14085, DOI 10.1074/jbc.273.23.14085; Yang ZN, 1997, J MOL BIOL, V265, P330, DOI 10.1006/jmbi.1996.0731; Yun BW, 2011, NATURE, V478, P264, DOI 10.1038/nature10427; Zaffagnini M, 2013, J BIOL CHEM, V288, P22777, DOI 10.1074/jbc.M113.475467	60	22	23	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0120627	10.1371/journal.pone.0120627	http://dx.doi.org/10.1371/journal.pone.0120627			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25793615	Green Published, gold, Green Submitted			2022-12-27	WOS:000352083900060
J	Zheng, YW; Adams, T; Zhi, HY; Yu, M; Wen, RR; Newman, PJ; Wang, DM; Newman, DK				Zheng, Yongwei; Adams, Tamara; Zhi, Huiying; Yu, Mei; Wen, Renren; Newman, Peter J.; Wang, Demin; Newman, Debra K.			Restoration of Responsiveness of Phospholipase C gamma 2-Deficient Platelets by Enforced Expression of Phospholipase C gamma 1	PLOS ONE			English	Article							B-CELL DEVELOPMENT; SIGNAL-TRANSDUCTION; THROMBUS FORMATION; C ISOZYMES; IN-VITRO; ACTIVATION; INTEGRIN; INVOLVEMENT; COLLAGEN; ROLES	Receptor-mediated platelet activation requires phospholipase C (PLC) activity to elevate intracellular calcium and induce actin cytoskeleton reorganization. PLCs are classified into structurally distinct beta, gamma, delta, epsilon, zeta and eta isoforms. There are two PLC gamma isoforms (PLC gamma 1, PLC gamma 2), which are critical for activation by tyrosine kinase-dependent receptors. Platelets express both PLC gamma 1 and PLC gamma 2. Although PLC gamma 2 has been shown to play a dominant role in platelet activation, the extent to which PLC gamma 1 contributes has not been evaluated. To ascertain the relative contributions of PLC gamma 1 and PLC gamma 2 to platelet activation, we generated conditionally PLC gamma 1-deficient, wild-type (WT), PLC gamma 2-deficient, and PLC gamma 1/PLC gamma 2 doubledeficient mice and measured the ability of platelets to respond to different agonists. We found that PLC gamma 2 deficiency abrogated alpha llb beta 3-dependent platelet spreading, GPVI-dependent platelet aggregation, and thrombus formation on collagen-coated surfaces under shear conditions, which is dependent on both GPVI and alpha llb beta 3. Addition of exogenous ADP overcame defective spreading of PLC gamma 2-deficient platelets on immobilized fibrinogen, suggesting that PLC gamma 2 is required for granule secretion in response to alpha llb beta 3 ligation. Consistently, alpha llb beta 3-mediated release of granule contents was impaired in the absence of PLC gamma 2. In contrast, PLC gamma 1-deficient platelets spread and released granule contents normally on fibrinogen, exhibited normal levels of GPVI-dependent aggregation, and formed thrombi normally on collagen-coated surfaces. Interestingly, enforced expression of PLC gamma 1 fully restored GPVI-dependent aggregation and alpha llb beta 3-dependent spreading of PLC gamma 2-deficient platelets. We conclude that platelet activation through GPVI and alpha llb beta 3 utilizes PLC gamma 2 because PLC gamma 1 levels are insufficient to support responsiveness, but that PLC gamma 1 can restore responsiveness if expressed at levels normally achieved by PLC gamma 2.	[Zheng, Yongwei; Adams, Tamara; Zhi, Huiying; Yu, Mei; Wen, Renren; Newman, Peter J.; Wang, Demin; Newman, Debra K.] BloodCtr Wisconsin, Blood Res Inst, Milwaukee, WI 53223 USA; [Zheng, Yongwei] Southeast Univ, Key Lab Dev Genes & Human Dis, Minist Educ, Inst Life Sci, Nanjing, Jiangsu, Peoples R China; [Newman, Peter J.; Newman, Debra K.] Med Coll Wisconsin, Dept Pharmacol & Toxicol, Milwaukee, WI 53226 USA; [Newman, Peter J.] Med Coll Wisconsin, Dept Cell Biol Neurobiol & Anat, Milwaukee, WI 53226 USA; [Wang, Demin; Newman, Debra K.] Med Coll Wisconsin, Dept Microbiol & Mol Genet, Milwaukee, WI 53226 USA	Versiti Blood Center of Wisconsin; Southeast University - China; Medical College of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin	Newman, DK (corresponding author), BloodCtr Wisconsin, Blood Res Inst, Milwaukee, WI 53223 USA.	Debra.Newman@bcw.edu	Yu, Mei/K-2206-2017; Wang, Demin/AAX-4449-2020	Wang, Demin/0000-0001-5549-3795	National Institutes of Health Grant [P01 HL44612, R01 AI079087]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL044612] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI079087] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health Grant #P01 HL44612 (to DW, PJN and DKN) and #R01 AI079087 (to DW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergmeier W, 2013, CURR OPIN HEMATOL, V20, P445, DOI 10.1097/MOH.0b013e3283642267; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; BRASS LF, 1984, J BIOL CHEM, V259, P2563; Bunney TD, 2011, TRENDS BIOCHEM SCI, V36, P88, DOI 10.1016/j.tibs.2010.08.003; Caraux A, 2006, BLOOD, V107, P994, DOI 10.1182/blood-2005-06-2428; Cho MJ, 2003, BLOOD, V101, P2646, DOI 10.1182/blood-2002-05-1363; Choi JH, 2007, ADV ENZYME REGUL, V47, P104, DOI 10.1016/j.advenzreg.2006.12.010; Fu GP, 2012, J IMMUNOL, V189, P2326, DOI 10.4049/jimmunol.1103458; Fu GP, 2010, J EXP MED, V207, P309, DOI 10.1084/jem.20090880; Goncalves I, 2003, J BIOL CHEM, V278, P34812, DOI 10.1074/jbc.M306504200; Gorjestani S, 2011, J BIOL CHEM, V286, P43651, DOI 10.1074/jbc.M111.307389; Graham DB, 2007, J CLIN INVEST, V117, P3445, DOI 10.1172/JCI32729; HARRISON P, 1993, BLOOD REV, V7, P52, DOI 10.1016/0268-960X(93)90024-X; Hashimoto A, 2000, J IMMUNOL, V165, P1738, DOI 10.4049/jimmunol.165.4.1738; Jakus Z, 2009, J EXP MED, V206, P577, DOI 10.1084/jem.20081859; Ji QS, 1997, P NATL ACAD SCI USA, V94, P2999, DOI 10.1073/pnas.94.7.2999; KAPLAN KL, 1979, BLOOD, V53, P604; Keenan C, 1998, CELL SIGNAL, V10, P225, DOI 10.1016/S0898-6568(97)00121-6; Li ZY, 2010, ARTERIOSCL THROM VAS, V30, P2341, DOI 10.1161/ATVBAHA.110.207522; Liu WS, 1998, CELL SIGNAL, V10, P529, DOI 10.1016/S0898-6568(98)00012-6; Mangin P, 2003, FEBS LETT, V542, P53, DOI 10.1016/S0014-5793(03)00337-5; Munnix ICA, 2005, ARTERIOSCL THROM VAS, V25, P2673, DOI 10.1161/01.ATV.0000193568.71980.4a; Nonne C, 2005, ARTERIOSCL THROM VAS, V25, P1293, DOI 10.1161/01.ATV.0000163184.02484.69; Rathore V, 2004, FEBS LETT, V573, P26, DOI 10.1016/j.febslet.2004.07.048; Regunathan J, 2006, J IMMUNOL, V177, P5365, DOI 10.4049/jimmunol.177.8.5365; Rhee SG, 2001, ANNU REV BIOCHEM, V70, P281, DOI 10.1146/annurev.biochem.70.1.281; Rhee SG, 1997, J BIOL CHEM, V272, P15045, DOI 10.1074/jbc.272.24.15045; Rowley JW, 2011, BLOOD, V118, pE101, DOI 10.1182/blood-2011-03-339705; Shattil SJ, 2004, BLOOD, V104, P1606, DOI 10.1182/blood-2004-04-1257; Suh PG, 2008, BMB REP, V41, P415, DOI 10.5483/BMBRep.2008.41.6.415; Suzuki-Inoue K, 2006, BLOOD, V107, P542, DOI 10.1182/blood-2005-05-1994; Suzuki-Inoue K, 2003, BLOOD, V102, P1367, DOI 10.1182/blood-2003-01-0029; Suzuki-Inoue K, 2007, THROMB RES, V120, P251, DOI 10.1016/j.thromres.2006.09.003; Tassi I, 2005, J IMMUNOL, V175, P749, DOI 10.4049/jimmunol.175.2.749; Wang DM, 2000, IMMUNITY, V13, P25, DOI 10.1016/S1074-7613(00)00005-4; Warren A, 2006, HEPATOLOGY, V44, P1182, DOI 10.1002/hep.21378; Wen RR, 2004, EMBO J, V23, P4007, DOI 10.1038/sj.emboj.7600405; Wilde JI, 2001, CELL SIGNAL, V13, P691, DOI 10.1016/S0898-6568(01)00191-7; Williams RL, 1996, STRUCTURE, V4, P1387, DOI 10.1016/S0969-2126(96)00146-3; Wonerow P, 2003, J BIOL CHEM, V278, P37520, DOI 10.1074/jbc.M305077200; Xu S, 2009, J BIOL CHEM, V284, P7038, DOI 10.1074/jbc.M806650200; Zhi HY, 2013, BLOOD, V121, P1858, DOI 10.1182/blood-2012-07-443325	42	8	8	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0119739	10.1371/journal.pone.0119739	http://dx.doi.org/10.1371/journal.pone.0119739			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25793864	Green Published, gold, Green Submitted			2022-12-27	WOS:000352084200109
J	Li, LL; Li, SS; Sun, GH; Peng, RZ; Zhao, LJ; Zhong, RG				Li, Lili; Li, Sisi; Sun, Guohui; Peng, Ruizeng; Zhao, Lijiao; Zhong, Rugang			Influence of the Expression Level of O-6-Alkylguanine-DNA Alkyltransferase on the Formation of DNA Interstrand Crosslinks Induced by Chloroethylnitrosoureas in Cells: A Quantitation Using High-Performance Liquid Chromatography-Mass Spectrometry	PLOS ONE			English	Article							DENSITY-FUNCTIONAL THEORY; BLOOD-BRAIN-BARRIER; ALKYLATION PRODUCTS; O-6-METHYLGUANINE-DNA METHYLTRANSFERASE; REACTION-MECHANISM; REPAIR; RESISTANCE; AGENTS; NITROSOUREAS; GLIOMA	Chloroethylnitrosoureas (CENUs), which are bifunctional alkylating agents widely used in the clinical treatment of cancer, exert anticancer activity by inducing crosslink within a guanine-cytosine DNA base pair. However, the formation of dG-dC crosslinks can be prevented by O-6-alkylguanine-DNA alkyltransferase (AGT), ultimately leading to drug resistance. Therefore, the level of AGT expression is related to the formation of dG-dC crosslinks and the sensitivity of cells to CENUs. In this work, we determined the CENU-induced dG-dC crosslink in mouse L1210 leukemia cells and in human glioblastoma cells (SF-763, SF-767 and SF-126) containing different levels of AGT using high-performance liquid chromatography coupled with electrospray ionization tandem mass spectrometry. The results indicate that nimustine (ACNU) induced more dG-dC crosslinks in L1210 leukemia cells than those induced by carmustine (BCNU), lomustine (CCNU) and fotemustine (FTMS). This result was consistent with a previously reported cohort study, which demonstrated that ACNU had a better survival gain than BCNU, CCNU and FTMS for patients with high-grade glioma. Moreover, we compared the crosslinking levels and the cytotoxicity in SF-763, SF-767 and SF-126 cells with different AGT expression levels after exposure to ACNU. The levels of dG-dC crosslink in SF-126 cells (low AGT expression) were significantly higher than those in SF-767 (medium AGT expression) and SF-763 (high AGT expression) cells at each time point. Correspondingly, the cytotoxicity of SF-126 was the highest followed by SF-767 and SF-763. The results obtained in this work provided unequivocal evidence for drug resistance to CENUs induced by AGT-mediated repair of DNA ICLs. We postulate that the level of dG-dC crosslink has the potential to be employed as a biomarker for estimating drug resistance and anticancer efficiencies of novel CENU chemotherapies.	[Li, Lili; Li, Sisi; Sun, Guohui; Peng, Ruizeng; Zhao, Lijiao; Zhong, Rugang] Beijing Univ Technol, Coll Life Sci & Bioengn, Beijing Key Lab Environm & Viral Oncol, Beijing, Peoples R China	Beijing University of Technology	Zhao, LJ (corresponding author), Beijing Univ Technol, Coll Life Sci & Bioengn, Beijing Key Lab Environm & Viral Oncol, Beijing, Peoples R China.	zhaolijiao@bjut.edu.cn		sun, guo hui/0000-0003-2259-5431	National Natural Science Foundation of China [21277001]; Beijing Municipal Education Commission Science and Technology Project [KZ201110005003]; Beijing Nova Program [2009B08]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Municipal Education Commission Science and Technology Project; Beijing Nova Program(Beijing Municipal Science & Technology Commission)	This work was supported by grants from the National Natural Science Foundation of China (No. 21277001, http://www.nsfc.gov.cn/), the Beijing Municipal Education Commission Science and Technology Project (No. KZ201110005003, http://www.bjedu.gov.cn/) and the Beijing Nova Program (No. 2009B08, http://www.bjkw.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIDA T, 1987, CANCER RES, V47, P1361; Bai BQ, 2011, RAPID COMMUN MASS SP, V25, P2027, DOI 10.1002/rcm.5064; Baumann RP, 2004, CANCER CHEMOTH PHARM, V53, P288, DOI 10.1007/s00280-003-0739-0; BOBOLA MS, 1995, MOL CARCINOGEN, V13, P70, DOI 10.1002/mc.2940130203; Bodell WJ, 2009, J NEURO-ONCOL, V91, P257, DOI 10.1007/s11060-008-9715-1; BODELL WJ, 1985, ENVIRON HEALTH PERSP, V62, P119, DOI 10.2307/3430103; BODELL WJ, 1988, CANCER RES, V48, P4489; Bodell WJ, 2003, MUTAT RES-FUND MOL M, V522, P85, DOI 10.1016/S0027-5107(02)00262-2; BODELL WJ, 1993, CHEM RES TOXICOL, V6, P434, DOI 10.1021/tx00034a008; Bodell WJ, 1999, CHEM RES TOXICOL, V12, P965, DOI 10.1021/tx980200c; BODELL WJ, 1985, CANCER RES, V45, P3460; Cao HC, 2008, ANAL CHEM, V80, P2932, DOI 10.1021/ac7023969; Chen FX, 1996, CHEM RES TOXICOL, V9, P208, DOI 10.1021/tx950097g; DEVITA VT, 1965, CANCER RES, V25, P1876; Drablos F, 2004, DNA REPAIR, V3, P1389, DOI 10.1016/j.dnarep.2004.05.004; Dronkert MLG, 2001, MUTAT RES-DNA REPAIR, V486, P217, DOI 10.1016/S0921-8777(01)00092-1; ERICKSON LC, 1980, NATURE, V288, P727, DOI 10.1038/288727a0; Georgieva P, 2008, CHEM PHYS LETT, V463, P214, DOI 10.1016/j.cplett.2008.08.043; GERSON SL, 1995, HEMATOL ONCOL CLIN N, V9, P431, DOI 10.1016/S0889-8588(18)30103-5; Gnewuch CT, 1997, CHEM REV, V97, P829, DOI 10.1021/cr941192h; Hou QQ, 2010, J PHYS CHEM B, V114, P15296, DOI 10.1021/jp106714m; Kemper EM, 2004, CANCER TREAT REV, V30, P415, DOI 10.1016/j.ctrv.2004.04.001; Kothandapani A, 2013, MUTAT RES-FUND MOL M, V743, P44, DOI 10.1016/j.mrfmmm.2012.11.007; Lawley PD, 1996, MUTAT RES-FUND MOL M, V355, P13, DOI 10.1016/0027-5107(96)00020-6; Li LL, 2014, RAPID COMMUN MASS SP, V28, P439, DOI 10.1002/rcm.6800; Liu HL, 2010, RADIOLOGY, V255, P415, DOI 10.1148/radiol.10090699; MAGANASCHWENCKE N, 1982, P NATL ACAD SCI-BIOL, V79, P1722, DOI 10.1073/pnas.79.6.1722; MATIJASEVIC Z, 1991, CANCER RES, V51, P1568; Michaelson-Richie ED, 2011, J PROTEOME RES, V10, P2785, DOI 10.1021/pr200042u; Mouawad R, 2010, CRIT REV ONCOL HEMAT, V74, P27, DOI 10.1016/j.critrevonc.2009.08.005; PEGG AE, 1990, CANCER RES, V50, P6119; Pegg AE, 2011, CHEM RES TOXICOL, V24, P618, DOI 10.1021/tx200031q; Penketh PG, 2000, BIOCHEM PHARMACOL, V59, P283, DOI 10.1016/S0006-2952(99)00328-7; Preuss I, 1996, INT J CANCER, V65, P506, DOI 10.1002/(SICI)1097-0215(19960208)65:4<506::AID-IJC19>3.0.CO;2-7; Rajski SR, 1998, CHEM REV, V98, P2723, DOI 10.1021/cr9800199; SCHABEL FM, 1963, CANCER RES, V23, P725; SCHOLD SC, 1989, J NEUROSURG, V70, P573, DOI 10.3171/jns.1989.70.4.0573; Sugiyama SI, 2007, J NEURO-ONCOL, V82, P41, DOI 10.1007/s11060-006-9247-5; Sun GH, 2014, CHEM RES TOXICOL, V27, P1253, DOI 10.1021/tx500143b; Ueda-Kawamitsu H, 2002, BIOCHEM PHARMACOL, V63, P1209, DOI 10.1016/S0006-2952(02)00878-X; Winum JY, 2003, EUR J MED CHEM, V38, P319, DOI 10.1016/S0223-5234(03)00014-X; Wolff JEA, 2008, J NEURO-ONCOL, V88, P57, DOI 10.1007/s11060-008-9533-5; Zhao LJ, 2013, INT J QUANTUM CHEM, V113, P1299, DOI 10.1002/qua.24283; Zhao LJ, 2013, CHEM RES TOXICOL, V26, P1526, DOI 10.1021/tx400235x; Zhao LJ, 2012, J PHYS ORG CHEM, V25, P1153, DOI 10.1002/poc.2970; Zhu R, 2013, BIOORG MED CHEM LETT, V23, P1853, DOI 10.1016/j.bmcl.2013.01.016; Zhu R, 2011, J MED CHEM, V54, P7720, DOI 10.1021/jm201115f	47	5	5	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0121225	10.1371/journal.pone.0121225	http://dx.doi.org/10.1371/journal.pone.0121225			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25799182	Green Submitted, gold, Green Published			2022-12-27	WOS:000351987300227
J	Toma, A; Takahashi, TS; Sato, Y; Yamagata, A; Goto-Ito, S; Nakada, S; Fukuto, A; Horikoshi, Y; Tashiro, S; Fukai, S				Toma, Aya; Takahashi, Tomio S.; Sato, Yusuke; Yamagata, Atsushi; Goto-Ito, Sakurako; Nakada, Shinichiro; Fukuto, Atsuhiko; Horikoshi, Yasunori; Tashiro, Satoshi; Fukai, Shuya			Structural Basis for Ubiquitin Recognition by Ubiquitin-Binding Zinc Finger of FAAP20	PLOS ONE			English	Article							63-LINKED POLYUBIQUITIN CHAINS; DNA-DAMAGE; UBZ DOMAINS; PROTEIN; KIAA1018/FAN1; NUCLEASE; COMPLEX; KAPPA; IDENTIFICATION; SPECIFICITY	Several ubiquitin-binding zinc fingers (UBZs) have been reported to preferentially bind K63-linked ubiquitin chains. In particular, the UBZ domain of FAAP20 (FAAP20-UBZ), a member of the Fanconi anemia core complex, seems to recognize K63-linked ubiquitin chains, in order to recruit the complex to DNA interstrand crosslinks and mediate DNA repair. By contrast, it is reported that the attachment of a single ubiquitin to Rev1, a translesion DNA polymerase, increases binding of Rev1 to FAAP20. To clarify the specificity of FAAP20-UBZ, we determined the crystal structure of FAAP20-UBZ in complex with K63-linked diubiquitin at 1.9 angstrom resolution. In this structure, FAAP20-UBZ interacts only with one of the two ubiquitin moieties. Consistently, binding assays using surface plasmon resonance spectrometry showed that FAAP20-UBZ binds ubiquitin and M1-, K48- and K63-linked diubiquitin chains with similar affinities. Residues in the vicinity of Ala168 within the a-helix and the C-terminal Trp180 interact with the canonical Ile44-centered hydrophobic patch of ubiquitin. Asp164 within the alpha-helix and the C-terminal loop mediate a hydrogen bond network, which reinforces ubiquitin-binding of FAAP20-UBZ. Mutations of the ubiquitin-interacting residues disrupted binding to ubiquitin in vitro and abolished the accumulation of FAAP20 to DNA damage sites in vivo. Finally, structural comparison among FAAP20-UBZ, WRNIP1-UBZ and RAD18-UBZ revealed distinct modes of ubiquitin binding. UBZ family proteins could be divided into at least three classes, according to their ubiquitin-binding modes.	[Toma, Aya; Takahashi, Tomio S.; Sato, Yusuke; Yamagata, Atsushi; Goto-Ito, Sakurako; Fukai, Shuya] Univ Tokyo, Struct Biol Lab, Div Life Sci, Synchrotron Radiat Res Org, Tokyo 1130032, Japan; [Toma, Aya; Takahashi, Tomio S.; Sato, Yusuke; Yamagata, Atsushi; Goto-Ito, Sakurako; Fukai, Shuya] Univ Tokyo, Inst Mol & Cellular Biosci, Tokyo 1130032, Japan; [Toma, Aya; Sato, Yusuke; Yamagata, Atsushi; Goto-Ito, Sakurako; Fukai, Shuya] Univ Tokyo, Grad Sch Frontier Sci, Dept Med Genome Sci, Chiba 2778501, Japan; [Nakada, Shinichiro] Osaka Univ, Grad Sch Med, Dept Bioregulat & Cellular Response, Osaka 5650871, Japan; [Fukuto, Atsuhiko; Horikoshi, Yasunori; Tashiro, Satoshi] Hiroshima Univ, Res Inst Radiat Biol & Med, Dept Cellular Biol, Hiroshima 7348553, Japan	University of Tokyo; University of Tokyo; University of Tokyo; Osaka University; Hiroshima University	Fukai, S (corresponding author), Univ Tokyo, Struct Biol Lab, Div Life Sci, Synchrotron Radiat Res Org, Tokyo 1130032, Japan.	fukai@iam.u-tokyo.ac.jp	Sato, Yusuke/GPW-9280-2022; takahashi, tomio/AAL-3599-2020; Fukai, Shuya/X-4838-2018; Horikoshi, Yasunori/G-8988-2019; Takahashi, Tomio S/H-5311-2017; OsakaU/AAY-3661-2020	Sato, Yusuke/0000-0001-8495-8950; takahashi, tomio/0000-0002-9381-3881; Fukai, Shuya/0000-0002-1241-1443; Nakada, Shinichiro/0000-0001-9297-1565	MEXT; JSPS; JST CREST; Grants-in-Aid for Scientific Research [22121003] Funding Source: KAKEN	MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); JST CREST(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants from MEXT and JSPS to S.F., A.Y., Y.S., K.K., S.G.-I. and S.N., and JST CREST to S.F. This work was partly carried out at the Joint Usage/Research Center (RIRBM), Hiroshima University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali AM, 2012, BLOOD, V119, P3285, DOI 10.1182/blood-2011-10-385963; Ceregido MA, 2014, J MOL BIOL, V426, P674, DOI 10.1016/j.jmb.2013.11.006; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bienko M, 2005, SCIENCE, V310, P1821, DOI 10.1126/science.1120615; Bish RA, 2007, J BIOL CHEM, V282, P23184, DOI 10.1074/jbc.M701042200; Bomar MG, 2007, EMBO REP, V8, P247, DOI 10.1038/sj.embor.7400901; Cordier F, 2008, J MOL BIOL, V377, P1419, DOI 10.1016/j.jmb.2008.01.048; Dikic I, 2009, NAT REV MOL CELL BIO, V10, P659, DOI 10.1038/nrm2767; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Guo C, 2008, J BIOL CHEM, V283, P4658, DOI 10.1074/jbc.M709275200; Huang J, 2009, NAT CELL BIOL, V11, P592, DOI 10.1038/ncb1865; Hurley JH, 2006, BIOCHEM J, V399, P361, DOI 10.1042/BJ20061138; Kim H, 2012, NAT STRUCT MOL BIOL, V19, P164, DOI 10.1038/nsmb.2222; Komander D, 2012, ANNU REV BIOCHEM, V81, P203, DOI 10.1146/annurev-biochem-060310-170328; Kratz K, 2010, CELL, V142, P77, DOI 10.1016/j.cell.2010.06.022; Kulathu Y, 2009, NAT STRUCT MOL BIOL, V16, P1328, DOI 10.1038/nsmb.1731; Lachaud C, 2014, J CELL SCI, V127, P2811, DOI 10.1242/jcs.146167; Lee S, 2006, NAT STRUCT MOL BIOL, V13, P264, DOI 10.1038/nsmb1064; Leung JWC, 2012, P NATL ACAD SCI USA, V109, P4491, DOI 10.1073/pnas.1118720109; MacKay C, 2010, CELL, V142, P65, DOI 10.1016/j.cell.2010.06.021; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Peisley A, 2014, NATURE, V509, P110, DOI 10.1038/nature13140; Penengo L, 2006, CELL, V124, P1183, DOI 10.1016/j.cell.2006.02.020; Plosky BS, 2006, EMBO J, V25, P2847, DOI 10.1038/sj.emboj.7601178; Rahighi S, 2009, CELL, V136, P1098, DOI 10.1016/j.cell.2009.03.007; Rizzo AA, 2014, BIOCHEMISTRY-US, V53, P5895, DOI 10.1021/bi500823h; Sato Y, 2008, NATURE, V455, P358, DOI 10.1038/nature07254; Sato Y, 2011, P NATL ACAD SCI USA, V108, P20520, DOI 10.1073/pnas.1109088108; Sato Y, 2009, EMBO J, V28, P3903, DOI 10.1038/emboj.2009.345; Sato Y, 2009, EMBO J, V28, P2461, DOI 10.1038/emboj.2009.160; Shereda RD, 2010, CELL CYCLE, V9, P3977, DOI 10.4161/cc.9.19.13207; Smogorzewska A, 2007, CELL, V129, P289, DOI 10.1016/j.cell.2007.03.009; Smogorzewska A, 2010, MOL CELL, V39, P36, DOI 10.1016/j.molcel.2010.06.023; Swanson KA, 2003, EMBO J, V22, P4597, DOI 10.1093/emboj/cdg471; Tashiro S, 2000, J CELL BIOL, V150, P283, DOI 10.1083/jcb.150.2.283; Tokunaga F, 2012, EMBO J, V31, P3856, DOI 10.1038/emboj.2012.241; Williams SA, 2011, BLOOD, V117, P5078, DOI 10.1182/blood-2010-10-311761; Yan ZJ, 2012, MOL CELL, V47, P61, DOI 10.1016/j.molcel.2012.05.026	39	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0120887	10.1371/journal.pone.0120887	http://dx.doi.org/10.1371/journal.pone.0120887			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25799058	Green Published, gold, Green Submitted			2022-12-27	WOS:000351987300186
J	Venardos, K; De Jong, KA; Elkamie, M; Connor, T; Mcgee, SL				Venardos, Kylie; De Jong, Kirstie A.; Elkamie, Mansour; Connor, Timothy; Mcgee, Sean L.			The PKD Inhibitor CID755673 Enhances Cardiac Function in Diabetic db/db Mice	PLOS ONE			English	Article							PROTEIN-KINASE-D; D ACTIVATION; TRANSCRIPTION; EXPRESSION; MOUSE; DEATH; HEART	The development of diabetic cardiomyopathy is a key contributor to heart failure and mortality in obesity and type 2 diabetes (T2D). Current therapeutic interventions for T2D have limited impact on the development of diabetic cardiomyopathy. Clearly, new therapies are urgently needed. A potential therapeutic target is protein kinase D (PKD), which is activated by metabolic insults and implicated in the regulation of cardiac metabolism, contractility and hypertrophy. We therefore hypothesised that PKD inhibition would enhance cardiac function in T2D mice. We first validated the obese and T2D db/db mouse as a model of early stage diabetic cardiomyopathy, which was characterised by both diastolic and systolic dysfunction, without overt alterations in left ventricular morphology. These functional characteristics were also associated with increased PKD2 phosphorylation in the fed state and a gene expression signature characteristic of PKD activation. Acute administration of the PKD inhibitor CID755673 to normal mice reduced both PKD1 and 2 phosphorylation in a time and dose-dependent manner. Chronic CID755673 administration to T2D db/db mice for two weeks reduced expression of the gene expression signature of PKD activation, enhanced indices of both diastolic and systolic left ventricular function and was associated with reduced heart weight. These alterations in cardiac function were independent of changes in glucose homeostasis, insulin action and body composition. These findings suggest that PKD inhibition could be an effective strategy to enhance heart function in obese and diabetic patients and provide an impetus for further mechanistic investigations into the role of PKD in diabetic cardiomyopathy.	[Venardos, Kylie; De Jong, Kirstie A.; Elkamie, Mansour; Connor, Timothy; Mcgee, Sean L.] Deakin Univ, Sch Med, Metab Res Unit, Metab Remodelling Lab, Waurn Ponds, Vic, Australia; [Mcgee, Sean L.] Baker IDI Heart & Diabet Inst, Program Metab & Inflammat, Melbourne, Vic, Australia	Deakin University; Baker Heart and Diabetes Institute	Mcgee, SL (corresponding author), Deakin Univ, Sch Med, Metab Res Unit, Metab Remodelling Lab, Waurn Ponds, Vic, Australia.	sean.mcgee@deakin.edu.au	Venardos, kylie/AAH-3234-2019	Venardos, kylie/0000-0002-1714-5594	Deakin University Molecular and Medical Research Strategic Research Centre; NHMRC Career Development Fellowship [APP1030474]	Deakin University Molecular and Medical Research Strategic Research Centre; NHMRC Career Development Fellowship(National Health and Medical Research Council (NHMRC) of Australia)	This study was supported by grants from the Deakin University Molecular and Medical Research Strategic Research Centre. SLM is supported by a NHMRC Career Development Fellowship (APP1030474). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belke Darrell D, 2012, Methods Mol Biol, V933, P47, DOI 10.1007/978-1-62703-068-7_4; Bossuyt J, 2011, J BIOL CHEM, V286, P33390, DOI 10.1074/jbc.M111.246447; Cuello F, 2007, CIRC RES, V100, P864, DOI 10.1161/01.RES.0000260809.15393.fa; Dirkx E, 2012, J BIOL CHEM, V287, P5871, DOI 10.1074/jbc.M111.281881; El Messaoudi S, 2011, CURR OPIN LIPIDOL, V22, P445, DOI 10.1097/MOL.0b013e32834ae1a7; Fillmore N, 2014, BRIT J PHARMACOL, V171, P2080, DOI 10.1111/bph.12475; Fillmore N, 2013, BR J PHARM; Forcheron F, 2009, CARDIOVASC DIABETOL, V8, DOI 10.1186/1475-2840-8-16; Geiss LS, 1995, DIABETES IN AMERICA, P233; Guo JF, 2011, J BIOL CHEM, V286, P6500, DOI 10.1074/jbc.M110.208058; Huang HY, 2013, J MOL CELL CARDIOL, V59, P151, DOI 10.1016/j.yjmcc.2013.03.007; Huck B, 2014, J BIOL CHEM, V289, P3138, DOI 10.1074/jbc.M113.502633; HUMMEL KP, 1972, BIOCHEM GENET, V7, P1, DOI 10.1007/BF00487005; Iglesias T, 1999, FEBS LETT, V454, P53, DOI 10.1016/S0014-5793(99)00772-3; Iglesias T, 1998, J BIOL CHEM, V273, P27662, DOI 10.1074/jbc.273.42.27662; Isfort M, 2014, HEART FAIL REV, V19, P35, DOI 10.1007/s10741-013-9377-8; Kim MS, 2008, CIRC RES, V103, P252, DOI 10.1161/CIRCRESAHA.108.178681; LaValle Courtney R., 2010, BMC Chemical Biology, V10, P5, DOI 10.1186/1472-6769-10-5; Matthews SA, 1999, J BIOL CHEM, V274, P26543, DOI 10.1074/jbc.274.37.26543; Mcgee SL, 2008, DIABETES, V57, P860, DOI 10.2337/db07-0843; McGee SL, 2014, FASEB J, V28, P3384, DOI 10.1096/fj.14-249359; Minamisawa S, 1999, CELL, V99, P313, DOI 10.1016/S0092-8674(00)81662-1; Nissen SE, 2007, NEW ENGL J MED, V356, P2457, DOI 10.1056/NEJMoa072761; Rozengurt E, 2011, PHYSIOLOGY, V26, P23, DOI 10.1152/physiol.00037.2010; Sharlow ER, 2008, J BIOL CHEM, V283, P33516, DOI 10.1074/jbc.M805358200; Steinbusch LKM, 2013, J MOL CELL CARDIOL, V55, P165, DOI 10.1016/j.yjmcc.2012.11.005; TROY BL, 1972, CIRCULATION, V45, P602, DOI 10.1161/01.CIR.45.3.602; Vega RB, 2004, MOL CELL BIOL, V24, P8374, DOI 10.1128/MCB.24.19.8374-8385.2004; Xiang SY, 2011, J CLIN INVEST, V121, P3269, DOI 10.1172/JCI44371; Xie ZL, 2011, DIABETES, V60, P1770, DOI 10.2337/db10-0351; Yuan JZ, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00060	31	23	24	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0120934	10.1371/journal.pone.0120934	http://dx.doi.org/10.1371/journal.pone.0120934			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25798941	Green Published, Green Submitted, gold			2022-12-27	WOS:000351987300195
J	Zobay, O; Palmer, AR; Hall, DA; Sereda, M; Adjamian, P				Zobay, Oliver; Palmer, Alan R.; Hall, Deborah A.; Sereda, Magdalena; Adjamian, Peyman			Source Space Estimation of Oscillatory Power and Brain Connectivity in Tinnitus	PLOS ONE			English	Article							RESIDUAL INHIBITION FUNCTIONS; FUNCTIONAL CONNECTIVITY; NEURAL ACTIVITY; WORKING-MEMORY; EEG-DATA; MEG; GENERATION; NETWORKS; PERCEPTION; MECHANISMS	Tinnitus is the perception of an internally generated sound that is postulated to emerge as a result of structural and functional changes in the brain. However, the precise pathophysiology of tinnitus remains unknown. Llinas' thalamocortical dysrhythmia model suggests that neural deafferentation due to hearing loss causes a dysregulation of coherent activity between thalamus and auditory cortex. This leads to a pathological coupling of theta and gamma oscillatory activity in the resting state, localised to the auditory cortex where normally alpha oscillations should occur. Numerous studies also suggest that tinnitus perception relies on the interplay between auditory and non-auditory brain areas. According to the Global Brain Model, a network of global fronto-parietal-cingulate areas is important in the generation and maintenance of the conscious perception of tinnitus. Thus, the distress experienced by many individuals with tinnitus is related to the top-down influence of this global network on auditory areas. In this magnetoencephalographic study, we compare resting-state oscillatory activity of tinnitus participants and normal-hearing controls to examine effects on spectral power as well as functional and effective connectivity. The analysis is based on beamformer source projection and an atlas-based region-of-interest approach. We find increased functional connectivity within the auditory cortices in the alpha band. A significant increase is also found for the effective connectivity from a global brain network to the auditory cortices in the alpha and beta bands. We do not find evidence of effects on spectral power. Overall, our results provide only limited support for the thalamocortical dysrhythmia and Global Brain models of tinnitus.	[Zobay, Oliver; Palmer, Alan R.; Adjamian, Peyman] MRC Inst Hearing Res, Nottingham, England; [Hall, Deborah A.; Sereda, Magdalena] Natl Inst Hlth Res NIHR Nottingham Hearing Biomed, Nottingham, England; [Hall, Deborah A.; Sereda, Magdalena] Univ Nottingham, Sch Med, Div Clin Neurosci, Otol & Hearing Grp, Nottingham, England	University of Nottingham	Adjamian, P (corresponding author), MRC Inst Hearing Res, Univ Pk, Nottingham, England.	peyman@ihr.mrc.ac.uk		Hall, Deborah/0000-0002-3804-1452; Zobay, Oliver/0000-0002-0229-0668; Palmer, Alan/0000-0001-5893-4525; Sereda, Magdalena/0000-0002-2792-8496; Adjamian, Peyman/0000-0002-3796-380X	Medical Research Council in the UK; MRC [MC_U135097129, MC_U135097126] Funding Source: UKRI; Medical Research Council [MC_U135097126, MC_U135097129] Funding Source: researchfish	Medical Research Council in the UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Funding: This study was entirely funded by the Medical Research Council in the UK.	Adamchic I, 2014, HUM BRAIN MAPP, V35, P2099, DOI 10.1002/hbm.22314; Adjamian P, 2004, CLIN NEUROPHYSIOL, V115, P691, DOI 10.1016/j.clinph.2003.10.023; Adjamian P, 2009, J NEUROSCI METH, V178, P120, DOI 10.1016/j.jneumeth.2008.12.006; Adjamian P, 2012, JARO-J ASSOC RES OTO, V13, P715, DOI 10.1007/s10162-012-0340-5; Adjamian P, 2009, HEARING RES, V253, P15, DOI 10.1016/j.heares.2009.04.001; Anderson MJ, 2001, AUST NZ J STAT, V43, P75, DOI 10.1111/1467-842X.00156; Ashton H, 2007, NEUROSCI LETT, V426, P23, DOI 10.1016/j.neulet.2007.08.034; Baccala LA, 2001, BIOL CYBERN, V84, P463, DOI 10.1007/PL00007990; Bressler SL, 2010, TRENDS COGN SCI, V14, P277, DOI 10.1016/j.tics.2010.04.004; Brookes MJ, 2008, NEUROIMAGE, V39, P1788, DOI 10.1016/j.neuroimage.2007.09.050; Burton H, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-3; Davis A., 2000, TINNITUS HDB, P1; De Ridder D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024273; De Ridder D, 2011, TEXTBOOK OF TINNITUS, P171, DOI 10.1007/978-1-60761-145-5_21; Dehaene S, 2006, TRENDS COGN SCI, V10, P204, DOI 10.1016/j.tics.2006.03.007; Eggermont JJ, 2004, TRENDS NEUROSCI, V27, P676, DOI 10.1016/j.tins.2004.08.010; Friston KJ, 2011, BRAIN CONNECT, V1, P13, DOI 10.1089/brain.2011.0008; Goebel G, 1998, TINNITUS FRAGEBOGEN; Hillebrand A, 2012, NEUROIMAGE, V59, P3909, DOI 10.1016/j.neuroimage.2011.11.005; Horwitz B, 2003, NEUROIMAGE, V19, P466, DOI 10.1016/S1053-8119(03)00112-5; Husain FT, 2014, HEARING RES, V307, P153, DOI 10.1016/j.heares.2013.07.010; Hyvarinen A, 2000, NEURAL NETWORKS, V13, P411, DOI 10.1016/S0893-6080(00)00026-5; JASTREBOFF PJ, 1990, NEUROSCI RES, V8, P221, DOI 10.1016/0168-0102(90)90031-9; Khalfa S, 2002, ORL-J OTO-RHIN-LARYN, V64, P436, DOI 10.1159/000067570; Lachaux JP, 1999, HUM BRAIN MAPP, V8, P194, DOI 10.1002/(SICI)1097-0193(1999)8:4<194::AID-HBM4>3.0.CO;2-C; Lehtela L, 1997, NEUROSCI LETT, V222, P111, DOI 10.1016/S0304-3940(97)13361-4; Llinas R, 2005, TRENDS NEUROSCI, V28, P325, DOI 10.1016/j.tins.2005.04.006; Llinas RR, 1999, P NATL ACAD SCI USA, V96, P15222, DOI 10.1073/pnas.96.26.15222; Lockwood AH, 2001, NEUROLOGY, V56, P472, DOI 10.1212/WNL.56.4.472; Lorenz I, 2009, NEUROSCI LETT, V453, P225, DOI 10.1016/j.neulet.2009.02.028; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; Maris E, 2007, J NEUROSCI METH, V164, P177, DOI 10.1016/j.jneumeth.2007.03.024; Maudoux A, 2012, BRAIN RES, V1485, P10, DOI 10.1016/j.brainres.2012.05.006; Mazaheri A, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00177; McCombe A, 2001, CLIN OTOLARYNGOL, V26, P388, DOI 10.1046/j.1365-2273.2001.00490.x; Moazami-Goudarzi M, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-40; Moller AR, 2011, TEXTBOOK OF TINNITUS, P29, DOI 10.1007/978-1-60761-145-5_5; Newman CW, 1996, ARCH OTOLARYNGOL, V122, P143; Nolte G, 2004, CLIN NEUROPHYSIOL, V115, P2292, DOI 10.1016/j.clinph.2004.04.029; Norena AJ, 2013, HEARING RES, V295, P161, DOI 10.1016/j.heares.2012.09.010; Norena AJ, 2011, NEUROSCI BIOBEHAV R, V35, P1089, DOI 10.1016/j.neubiorev.2010.11.003; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Oostenveld R, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/156869; Pierce KJ, 2012, J CLIN EXP NEUROPSYC, V34, P126, DOI 10.1080/13803395.2011.623120; Roberts LE, 2008, JARO-J ASSOC RES OTO, V9, P417, DOI 10.1007/s10162-008-0136-9; Roberts LE, 2006, ACTA OTO-LARYNGOL, V126, P27, DOI 10.1080/03655230600895358; Roberts LE, 2013, NEUROSCI BIOBEHAV R, V37, P1754, DOI 10.1016/j.neubiorev.2013.07.007; Rossiter S, 2006, J SPEECH LANG HEAR R, V49, P150, DOI 10.1044/1092-4388(2006/012); Schaette R, 2011, J NEUROSCI, V31, P13452, DOI 10.1523/JNEUROSCI.2156-11.2011; Schlee W, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-16; Schlee W, 2011, TEXTBOOK OF TINNITUS, P161, DOI 10.1007/978-1-60761-145-5_20; Schlee W, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-80; Schlee W, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-11; Schlee W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003720; Schoffelen JM, 2009, HUM BRAIN MAPP, V30, P1857, DOI 10.1002/hbm.20745; Sekihara K, 2008, SER BIOMED ENG, P1; Sereda M, 2011, INT J AUDIOL, V50, P303, DOI 10.3109/14992027.2010.551221; Shulman Abraham, 2002, Int Tinnitus J, V8, P77; Song JJ, 2013, NEUROBIOL AGING, V34, P1853, DOI 10.1016/j.neurobiolaging.2013.01.014; Spaak E, 2012, CURR BIOL, V22, P2313, DOI 10.1016/j.cub.2012.10.020; Ueyama T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067778; van der Loo E, 2011, AUTON NEUROSCI-BASIC, V165, P191, DOI 10.1016/j.autneu.2011.06.007; van Dijk H, 2010, EUR J NEUROSCI, V31, P1701, DOI 10.1111/j.1460-9568.2010.07227.x; Vanneste S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059728; VanVeen BD, 1997, IEEE T BIO-MED ENG, V44, P867, DOI 10.1109/10.623056; Vidaurre C, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/935364; Vrba J, 2001, METHODS, V25, P249, DOI 10.1006/meth.2001.1238; Weiler Elmar W J, 2004, Int Tinnitus J, V10, P127; Weisz N, 2005, PLOS MED, V2, P546, DOI 10.1371/journal.pmed.0020153; Weisz N, 2007, J NEUROSCI, V27, P1479, DOI 10.1523/JNEUROSCI.3711-06.2007	70	29	30	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0120123	10.1371/journal.pone.0120123	http://dx.doi.org/10.1371/journal.pone.0120123			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25799178	Green Published, Green Submitted, gold			2022-12-27	WOS:000351987300107
J	Corouge, M; Loridant, S; Fradin, C; Salleron, J; Damiens, S; Moragues, MD; Souplet, V; Jouault, T; Robert, R; Dubucquoi, S; Sendid, B; Colombel, JF; Poulain, D				Corouge, Marion; Loridant, Severine; Fradin, Chantal; Salleron, Julia; Damiens, Sebastien; Moragues, Maria Dolores; Souplet, Vianney; Jouault, Thierry; Robert, Raymond; Dubucquoi, Sylvain; Sendid, Boualem; Colombel, Jean Frederic; Poulain, Daniel			Humoral Immunity Links Candida albicans Infection and Celiac Disease	PLOS ONE			English	Article							INVASIVE CANDIDIASIS; GENE-EXPRESSION; DENDRITIC CELLS; TRANSGLUTAMINASE; ANTIBODIES; RESPONSES; COLONIZATION; COMMENSAL; PEPTIDES; EPITOPES	Objective The protein Hwp1, expressed on the pathogenic phase of Candida albicans, presents sequence analogy with the gluten protein gliadin and is also a substrate for transglutaminase. This had led to the suggestion that C. albicans infection (CI) may be a triggering factor for Celiac disease (CeD) onset. We investigated cross-immune reactivity between CeD and CI. Methods Serum IgG levels against recombinant Hwp1 and serological markers of CeD were measured in 87 CeD patients, 41 CI patients, and 98 healthy controls (HC). IgA and IgG were also measured in 20 individuals from each of these groups using microchips sensitized with 38 peptides designed from the N-terminal of Hwp1. Results CI and CeD patients had higher levels of anti-Hwp1 (p= 0.0005 and p= 0.004) and anti-gliadin (p= 0.002 and p= 0.0009) antibodies than HC but there was no significant difference between CeD and CI patients. CeD and CI patients had higher levels of anti-transglutaminase IgA than HC (p= 0.0001 and p= 0.0039). During CI, the increase in anti-Hwp1 paralleled the increase in anti-gliadin antibodies. Microchip analysis showed that CeD patients were more reactive against some Hwp1 peptides than CI patients, and that some deamidated peptides were more reactive than their native analogs. Binding of IgG from CeD patients to Hwp1 peptides was inhibited by gamma III gliadin peptides. Conclusions Humoral cross-reactivity between Hwp1 and gliadin was observed during CeD and CI. Increased reactivity to Hwp1 deamidated peptide suggests that transglutaminase is involved in this interplay. These results support the hypothesis that CI may trigger CeD onset in genetically-susceptible individuals.	[Corouge, Marion; Fradin, Chantal; Salleron, Julia; Souplet, Vianney; Jouault, Thierry; Sendid, Boualem; Poulain, Daniel] Univ Lille Nord France, Lille, France; [Corouge, Marion; Fradin, Chantal; Salleron, Julia; Souplet, Vianney; Jouault, Thierry; Sendid, Boualem; Poulain, Daniel] UDSL, Lille, France; [Fradin, Chantal; Damiens, Sebastien; Jouault, Thierry; Sendid, Boualem; Poulain, Daniel] INSERM, U995, F-59045 Lille, France; [Salleron, Julia] EA2694, Lille, France; [Salleron, Julia] InVS EPIMAD, INSERM, Pole Sante Publ Registre, Lille, France; [Corouge, Marion; Colombel, Jean Frederic] Serv Malad Appareil Digestif & Nutr, Lille, France; [Sendid, Boualem; Poulain, Daniel] Inst Microbiol, Serv Parasitol Mycol, Lille, France; [Loridant, Severine; Jouault, Thierry; Dubucquoi, Sylvain; Sendid, Boualem; Poulain, Daniel] CHRU, Lille, France; [Moragues, Maria Dolores] Univ Basque Country, Escuela Univ Enfermeria, Dept Enfermeria 1, Leioa 48940, Spain; [Dubucquoi, Sylvain] Inst Immunol, Pole Biol, Lille, France; [Robert, Raymond] Univ Angers, Grp Etude Interact Hote Pathogene, UPRES EA 3142, Angers, France; [Souplet, Vianney] Innobiochips, F-59000 Lille, France; [Colombel, Jean Frederic] Icahn Sch Med Mt Sinai, New York, NY 10029 USA	Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; Universite de Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; Universite de Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; CHU Lille; University of Basque Country; Universite d'Angers; Icahn School of Medicine at Mount Sinai	Poulain, D (corresponding author), Univ Lille Nord France, Lille, France.	dpoulain@univ-lille2.fr	Sendid, Boualem/ABE-9870-2020; Dubucquoi, Sylvain/I-5756-2018; Moragues, Maria D/F-5264-2010; SENDID, Boualem/B-7510-2014; Fradin, Chantal/N-2382-2018; Jouault, Thierry/I-1071-2018; Poulain, Daniel/I-6095-2018	Sendid, Boualem/0000-0003-1577-7325; Dubucquoi, Sylvain/0000-0002-8962-3719; Moragues, Maria D/0000-0002-7272-8610; Fradin, Chantal/0000-0002-3883-4401; Jouault, Thierry/0000-0003-1988-8647; LORIDANT, Severine/0000-0002-9440-7869; Poulain, Daniel/0000-0002-0729-5468	INSERM-Lille2 University [U995-2]; European Community [F2-2010-260338]; Digest Science Foundation; Innobiochips	INSERM-Lille2 University; European Community(European Commission); Digest Science Foundation; Innobiochips	Funding: This work received the following grant support: Unit U995-2 INSERM-Lille2 University; the European Community's 7th Framework program (FP7-2007-2013) grant agreement No Health F2-2010-260338 (ALLFUN); Digest Science Foundation. Co-author VS is affiliated to Innobiochips. Innobiochips provided support in the form of salary for author VS, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Innobiochips played an indirect role through the participation of the co-author VS. The specific role of this author is articulated in the 'author contributions' section.	Anderson RP, 2000, NAT MED, V6, P337, DOI 10.1038/73200; Ashorn S, 2009, J CLIN IMMUNOL, V29, P190, DOI 10.1007/s10875-008-9255-7; Bethune MT, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040034; Brinkert F, 2009, ACTA PAEDIATR, V98, P1685, DOI 10.1111/j.1651-2227.2009.01350.x; Casadevall A, 2003, NAT REV MICROBIOL, V1, P17, DOI 10.1038/nrmicro732; d'Ostiani CF, 2000, J EXP MED, V191, P1661, DOI 10.1084/jem.191.10.1661; Dahle C, 2010, ALIMENT PHARM THER, V32, P254, DOI 10.1111/j.1365-2036.2010.04337.x; Di Niro R, 2012, NAT MED, V18, P441, DOI 10.1038/nm.2656; Facchiano A, 2009, AMINO ACIDS, V36, P599, DOI 10.1007/s00726-008-0124-8; Fairweather D, 2001, J AUTOIMMUN, V16, P175, DOI 10.1006/jaut.2000.0492; Fradin C, 2008, INFECT IMMUN, V76, P4509, DOI 10.1128/IAI.00368-08; Garcia YH, 2002, PEDIATR DERMATOL, V19, P415, DOI 10.1046/j.1525-1470.2002.00117.x; Green PHR, 2007, NEW ENGL J MED, V357, P1731, DOI 10.1056/NEJMra071600; GURUPRASAD K, 1990, PROTEIN ENG, V4, P155, DOI 10.1093/protein/4.2.155; Hodrea J, 2010, IMMUNOL LETT, V130, P74, DOI 10.1016/j.imlet.2009.12.010; Hube B, 2004, CURR OPIN MICROBIOL, V7, P336, DOI 10.1016/j.mib.2004.06.003; Iliev ID, 2012, SCIENCE, V336, P1314, DOI 10.1126/science.1221789; Jawhara S, 2008, J INFECT DIS, V197, P972, DOI 10.1086/528990; Lain A, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-35; Ludvigsson JF, 2014, NEW ENGL J MED, V371, P1341, DOI 10.1056/NEJMe1408011; Maddur MS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001077; Marot-Leblond A, 2004, J CLIN MICROBIOL, V42, P4956, DOI 10.1128/JCM.42.11.4956-4960.2004; Matthias T, 2010, CLIN REV ALLERG IMMU, V38, P298, DOI 10.1007/s12016-009-8160-z; Molberg O, 2005, GASTROENTEROLOGY, V128, P393, DOI 10.1053/j.gastro.2004.11.003; Naglik JR, 2006, J MED MICROBIOL, V55, P1323, DOI 10.1099/jmm.0.46737-0; Nieuwenhuizen WF, 2003, LANCET, V361, P2152, DOI 10.1016/S0140-6736(03)13695-1; Odds, 1988, CAND CAND REV BIBL; Papp M, 2009, WORLD J GASTROENTERO, V15, P3891, DOI 10.3748/wjg.15.3891; Perez JC, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001510; Pfaller MA, 2007, CLIN MICROBIOL REV, V20, P133, DOI 10.1128/CMR.00029-06; Plantinga TS, 2012, MED MYCOL, V50, P785, DOI 10.3109/13693786.2012.690902; Ponniah G, 2007, J ORAL PATHOL MED, V36, P456, DOI 10.1111/j.1600-0714.2007.00565.x; Puel A, 2010, CURR OPIN IMMUNOL, V22, P467, DOI 10.1016/j.coi.2010.06.009; Qiao SW, 2009, CURR OPIN IMMUNOL, V21, P111, DOI 10.1016/j.coi.2009.03.004; Qiao SW, 2005, J IMMUNOL, V175, P254, DOI 10.4049/jimmunol.175.1.254; Ress K, 2007, DIGEST LIVER DIS, V39, P136, DOI 10.1016/j.dld.2006.07.012; Rubio-Tapia A, 2010, CURR OPIN GASTROEN, V26, P116, DOI 10.1097/MOG.0b013e3283365263; Schuppan D, 2003, CHEM BIOL, V10, P199, DOI 10.1016/S1074-5521(03)00055-3; Shan L, 2002, SCIENCE, V297, P2275, DOI 10.1126/science.1074129; Sobel JD, 2007, LANCET, V369, P1961, DOI 10.1016/S0140-6736(07)60917-9; Sollid LM, 2013, NAT REV IMMUNOL, V13, P294, DOI 10.1038/nri3407; Staab JF, 2004, J BIOL CHEM, V279, P40737, DOI 10.1074/jbc.M406005200; Staab JF, 1999, SCIENCE, V283, P1535, DOI 10.1126/science.283.5407.1535; Toumi D, 2007, SCAND J GASTROENTERO, V42, P821, DOI 10.1080/00365520601154996; Verdu EF, 2009, AM J GASTROENTEROL, V104, P1587, DOI 10.1038/ajg.2009.188; Viitasalo L, 2014, J CLIN GASTROENTEROL, V48, P620, DOI 10.1097/MCG.0000000000000089; Willing BP, 2011, NAT REV MICROBIOL, V9, P233, DOI 10.1038/nrmicro2536; Wolters VM, 2010, HUM IMMUNOL, V71, P392, DOI 10.1016/j.humimm.2010.01.016	48	19	21	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0121776	10.1371/journal.pone.0121776	http://dx.doi.org/10.1371/journal.pone.0121776			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25793717	Green Published, Green Submitted, gold			2022-12-27	WOS:000352083900151
J	Dachew, BA; Bisetegn, TA; Gebremariam, RB				Dachew, Berihun Assefa; Bisetegn, Telake Azale; Gebremariam, Resom Berhe			Prevalence of Mental Distress and Associated Factors among Undergraduate Students of University of Gondar, Northwest Ethiopia: A Cross-Sectional Institutional Based Study	PLOS ONE			English	Article							PSYCHOLOGICAL DISTRESS; MEDICAL-STUDENTS; HEALTH; STRESS; DEPRESSION; DISORDERS; SYMPTOMS; ANXIETY	Background Mental health problems affect society as a whole and no group is immune to mental disorders; however, students have significantly high level of mental distress than their community peers. Objectives The purpose of this study was to assess the prevalence and associated factors of mental distress among undergraduate students of University of Gondar, Northwest Ethiopia. Methods Institution based cross sectional study was conducted among 836 students from April 9-11/2014. Stratified multistage sampling technique was used to select the study participants. Data were collected using pretested and structured self-administered questionnaire. Bivariate and multivariate logistic regression model was fitted to identify factors associated with mental distress among students. An adjusted odds ratio with 95% confidence interval was computed to determine the level of significance. Results Prevalence of mental distress among students was found to be 40.9%. Female sex (AOR = 1.65; 95% CI 1.17-2.30), lack of interest towards their field of study (AOR = 2.28; 95% CI 1.49-3.50), not having close friends (AOR = 1.48; 95% CI 1.03-2.14), never attend religious programs (AOR = 1.58; 95% CI 1.02-2.46), conflict with friends (AOR = 1.93; 95% CI 1.41-2.65), having financial distress (AOR1.49 = 95% CI 1.05, 2.10), family history of mental illness (AOR = 2.12; 95% CI 1.31-3.45), Ever use of Khat (AOR = 1.71; 95% CI 1.12- 2.59), lower grade than anticipated(AOR = 2.07; 95% CI 1.51-2.83), lack of vacation or break (AOR = 1.46; 95% CI 1.06-2.02), and low social support(AOR = 2.58; 95% CI 1.58-4.22) were significantly associated with mental distress. Conclusion The overall prevalence of mental distress among students was found to be high. Therefore, it is recommended that mental distress needs due attention and remedial action from policy makers, college officials, non-governmental organizations, parents, students and other concerned bodies.	[Dachew, Berihun Assefa] Univ Gondar, Coll Med & Hlth Sci, Inst Publ Hlth, Dept Epidemiol & Biostat, Gondar, Ethiopia; [Bisetegn, Telake Azale] Univ Gondar, Coll Med & Hlth Sci, Inst Publ Hlth, Dept Reprod Hlth, Gondar, Ethiopia; [Gebremariam, Resom Berhe] Univ Gondar, Coll Med & Hlth Sci, Inst Publ Hlth, Dept Hlth Educ & Behav Sci, Gondar, Ethiopia	University of Gondar; University of Gondar; University of Gondar	Dachew, BA (corresponding author), Univ Gondar, Coll Med & Hlth Sci, Inst Publ Hlth, Dept Epidemiol & Biostat, Gondar, Ethiopia.	berihunassefa21@gmail.com	Dachew, Berihun Assefa/I-3111-2019	Dachew, Berihun Assefa/0000-0002-4041-6129; Berhe, Resom/0000-0001-9627-8717				Abdulahi H, 2001, ETHIOPIAN MED J, V39, P271; Abdulghani HM, 2011, J HEALTH POPUL NUTR, V29, P516; Adlaf E.M, 2007, J AM COLL HEALTH, V50, P67; Alem A, 2005, ETHIOPIAN MED J, V43, P159; Alzahem AM, 2011, EUR J DENT EDUC, V15, P8, DOI 10.1111/j.1600-0579.2010.00640.x; Bayram N, 2008, SOC PSYCH PSYCH EPID, V43, P667, DOI 10.1007/s00127-008-0345-x; Begg S., 2007, BURDEN DIS INJURY AU; Bernhardsdottir J, 2013, J PSYCHIATR MENT HLT, V20, P672, DOI 10.1111/jpm.12002; Beusenberg M., 1994, WHOMNHPSF948; Bray NJ, 1999, J COLL STUDENT DEV, V40, P645; Cvetkovski S, 2012, AUST NZ J PSYCHIAT, V46, P457, DOI 10.1177/0004867411435290; Dahlin M, 2008, MED EDUC, V39, P594; Damena T, 2011, ETHIOP J HEALTH SCI, V21, P37; Dessie Y, 2013, PAN AFR MED J, V15, DOI 10.11604/pamj.2013.15.95.2173; Eisenberg D, 2007, AM J ORTHOPSYCHIAT, V77, P534, DOI 10.1037/0002-9432.77.4.534; Galbraith ND, 2011, J ADV NURS, V67, P709, DOI 10.1111/j.1365-2648.2010.05549.x; Gallagher RP, 2010, MON INT ASS COUNS SE; Gelder Michael A N, SYMPTOMS MIND INTRO; Giang KB, 2010, GLOB HLTH ACTION, V15, P3; Goebert D, 2009, ACAD MED, V84, P236, DOI 10.1097/ACM.0b013e31819391bb; Havenaar JM, 2007, SOC PSYCH PSYCH EPID, V7, P294; Jenkins R, 2012, INT J ENV RES PUB HE, V9, P1810, DOI 10.3390/ijerph9051810; Leahy CM, 2010, AUST NZ J PSYCHIAT, V44, P608, DOI 10.3109/00048671003649052; Lund C, 2011, LANCET, V378, P1502, DOI 10.1016/S0140-6736(11)60754-X; MOSLEY TH, 1994, ACAD MED, V69, P765, DOI 10.1097/00001888-199409000-00024; Naheed Nabi, 2012, ASEAN J PSYCHIAT, V13, P1; Nerdrum P., 2006, J EDUC RES, V50, P95, DOI [10.1080/00313830500372075, DOI 10.1080/00313830500372075]; Ningombam S, 2011, NATL MED J INDIA, V24, P11; Omigbodun OO, 2006, SOC PSYCH PSYCH EPID, V41, P415, DOI 10.1007/s00127-006-0037-3; Ovuga E, 2006, WORLD PSYCHIATRY, V5, P51; Ozbay Fatih, 2007, Psychiatry (Edgmont), V4, P35; PAGEL MD, 1987, J PERS SOC PSYCHOL, V53, P793, DOI 10.1037/0022-3514.53.4.793; Lima MCP, 2006, REV SAUDE PUBL, V40, P1035, DOI 10.1590/S0034-89102006000700011; Rocha SV, 2010, REV BRAS EPIDEMIOL, V13, P1; Sherina Mohd Sidik, 2008, ASIA PACIFIC FAMILY, V2, P213; Sreeramareddy Chandrashekhar T, 2007, BMC Med Educ, V7, P26, DOI 10.1186/1472-6920-7-26; Stallman HM, 2008, AUST FAM PHYSICIAN, V37, P673; Stallman HM, 2010, AUST PSYCHOL, V45, P249, DOI 10.1080/00050067.2010.482109; Storrie K, 2010, INT J NURS PRACT, V16, P1, DOI 10.1111/j.1440-172X.2009.01813.x; Tesfaye Anteneh, 2009, East Afr J Public Health, V6, P85; Tyseen R, 2010, MED EDUC, V35, P110, DOI DOI 10.1046/j.1365-2923.2001.00770.x; Vaez Marjan, 2006, Work, V26, P167; Verger P, 2009, SOC PSYCH PSYCH EPID, V44, P643, DOI 10.1007/s00127-008-0486-y; Verger P, 2010, SOC PSYCH PSYCH EPID, V45, P189, DOI 10.1007/s00127-009-0055-z; World Health Organization, 2008, GLOBAL BURDEN DIS; Youngmann R, 2008, TRANSCULT PSYCHIATRY, V45, P566, DOI 10.1177/1363461508100783; ZIMET GD, 1990, J PERS ASSESS, V55, P610, DOI 10.1207/s15327752jpa5503&4_17	47	46	46	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0119464	10.1371/journal.pone.0119464	http://dx.doi.org/10.1371/journal.pone.0119464			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CE8IA	25794278	gold, Green Published, Green Submitted			2022-12-27	WOS:000352084200085
J	Wang, LZ; Goh, SH; Wong, ALA; Thuya, WL; Lau, JYA; Wan, SC; Lee, SC; Ho, PC; Goh, BC				Wang, Ling-Zhi; Goh, Sok-Hwei; Wong, Andrea Li-Ann; Thuya, Win-Lwin; Lau, Jie-Ying Amelia; Wan, Seow-Ching; Lee, Soo-Chin; Ho, Paul C.; Goh, Boon-Cher			Validation of a Rapid and Sensitive LC-MS/MS Method for Determination of Exemestane and Its Metabolites, 17 beta-Hydroxyexemestane and 17 beta-Hydroxyexemestane-17-O-beta-D-Glucuronide: Application to Human Pharmacokinetics Study	PLOS ONE			English	Article							POSITIVE BREAST-CANCER; AROMATASE INHIBITORS; LIQUID-CHROMATOGRAPHY; MASS-SPECTROMETRY; ADJUVANT THERAPY; WOMEN; 17-DIHYDROEXEMESTANE; PREVENTION; EFFICACY; PLASMA	A novel, rapid and sensitive liquid chromatography-tandem mass spectrometric (LC-MS/MS) method was developed and validated for the evaluation of exemestane pharmacokinetics and its metabolites, 17 beta-dihydroexemestane (active metabolite) and 17 beta-dihydroexemestane-17-O-beta-D-glucuronide (inactive metabolite) in human plasma. Their respective D3 isotopes were used as internal standards. Chromatographic separation of analytes was achieved using Thermo Fisher BDS Hypersil C18 analytic HPLC column (100 x 2.1 mm, 5 mu m). The mobile phase was delivered at a rate of 0.5 mL/min by gradient elution with 0.1 % aqueous formic acid and acetonitrile. The column effluents were detected by API 4000 triple quadrupole mass spectrometer using electrospray ionisation (ESI) and monitored by multiple reaction monitoring (MRM) in positive mode. Mass transitions 297 > 121 m/z, 300 > 121 m/z, 299 > 135 m/z, 302 > 135 m/z, 475 > 281 m/z, and 478 > 284 m/z were monitored for exemestane, exemestane-d3, 17 beta-dihydroexemestane, 17 beta-dihydroexemestane-d3, 17 beta-dihydroexemestane-17-O-beta-D-glucuronide, and 17 beta-dihydroexemestane-17-O-beta-D-glucuronide-d3 respectively. The assay demonstrated linear ranges of 0.4-40.0 ng/mL, for exemestane; and 0.2 - 15.0 ng/mL, for 17 beta-dihydroexemestane and 17 beta-dihydroexemestane-17-O-beta-D-glucuronide, with coefficient of determination (r(2)) of > 0.998. The precision (coefficient of variation) were <= 10.7%, 7.7% and 9.5% and the accuracies ranged from 88.8 to 103.1% for exemestane, 98.5 to 106.1% for 17 beta-dihydroexemestane and 92.0 to 103.2% for 17 beta-dihydroexemestane-17-O-beta-D-glucuronide. The method was successfully applied to a pharmacokinetics/dynamics study in breast cancer patients receiving exemestane 25mg daily orally. For a representative patient, 20.7% of exemestane in plasma was converted into 17 beta-dihydroexemestane and 29.0% of 17 beta-dihydroexemestane was inactivated as 17 beta-dihydroexemestane-17-O-beta-D-glucuronide 24 hours after ingestion of exemestane, suggesting that altered 17-dihydroexemestane glucuronidation may play an important role in determining effect of exemestane against breast cancer cells.	[Wang, Ling-Zhi; Wong, Andrea Li-Ann; Thuya, Win-Lwin; Lau, Jie-Ying Amelia; Wan, Seow-Ching; Lee, Soo-Chin; Goh, Boon-Cher] Natl Univ Singapore, Canc Sci Inst Singapore, Singapore 117599, Singapore; [Wang, Ling-Zhi; Goh, Boon-Cher] Natl Univ Hlth Syst, Yong Loo Lin Sch Med, Dept Pharmacol, Singapore 117599, Singapore; [Goh, Sok-Hwei; Ho, Paul C.] Natl Univ Singapore, Dept Pharm, Fac Sci, Singapore 117543, Singapore; [Wong, Andrea Li-Ann; Lee, Soo-Chin; Goh, Boon-Cher] Natl Univ Hlth Syst, Dept Haematol & Oncol, Singapore 119074, Singapore	National University of Singapore; National University of Singapore; National University of Singapore; National University of Singapore	Wang, LZ (corresponding author), Natl Univ Singapore, Canc Sci Inst Singapore, 14 Med Dr, Singapore 117599, Singapore.	csiwl@nus.edu.sg; phcgbc@nus.edu.sg	Lee, Soo Chin/S-9111-2016; Wang, Lingzhi/AAF-1851-2020	Lee, Soo Chin/0000-0002-5835-6419; Wang, Lingzhi/0000-0001-5585-5426	National Research Foundation of Singapore (Experimental Therapeutics Program); National Medical Research Council of Singapore [NMRC/CSA/021/2010, NMRC/NIG/MH95:03/1-36/2012]	National Research Foundation of Singapore (Experimental Therapeutics Program)(National Research Foundation, Singapore); National Medical Research Council of Singapore(National Medical Research Council, Singapore)	The study was sponsored by the National Research Foundation of Singapore (Experimental Therapeutics Program) and the National Medical Research Council of Singapore (NMRC/CSA/021/2010 and NMRC/NIG/MH95:03/1-36/2012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BREDA M, 1993, J CHROMATOGR-BIOMED, V620, P225, DOI 10.1016/0378-4347(93)80008-R; Cavalcanti GD, 2011, STEROIDS, V76, P1010, DOI 10.1016/j.steroids.2011.04.001; Corona G, 2009, J MASS SPECTROM, V44, P920, DOI 10.1002/jms.1566; Eisen A, 2008, CANCER TREAT REV, V34, P157, DOI 10.1016/j.ctrv.2007.11.001; Herold CI, 2008, CLIN BREAST CANCER, V8, P50, DOI 10.3816/CBC.2008.n.003; Kamdem LK, 2011, DRUG METAB DISPOS, V39, P98, DOI 10.1124/dmd.110.032276; Kim SH, 2012, ASIAN PAC J CANCER P, V13, P979, DOI 10.7314/APJCP.2012.13.3.979; Kittaneh M, 2011, BREAST CANCER-BASIC, V5, P209, DOI 10.4137/BCBCR.S6234; Litton JK, 2012, THER ADV MED ONCOL, V4, P107, DOI 10.1177/1758834012438214; Lonning PE, 2008, EXPERT OPIN DRUG MET, V4, P987, DOI [10.1517/17425255.4.7.987, 10.1517/17425255.4.7.987 ]; Sun D, 2010, PHARMACOGENET GENOM, V20, P575, DOI 10.1097/FPC.0b013e32833b04af; Takashima S, 2011, BREAST CANCER-TOKYO, V18, P189, DOI 10.1007/s12282-011-0258-5; Teo MCC, 2013, JPN J CLIN ONCOL, V43, P219, DOI 10.1093/jjco/hys230; Tomao F, 2011, EXPERT REV ANTICANC, V11, P1253, DOI [10.1586/ERA.11.96, 10.1586/era.11.96]; Van Asten K, 2014, ENDOCR-RELAT CANCER, V21, pR31, DOI 10.1530/ERC-13-0269; Winer EP, 2002, J CLIN ONCOL, V20, P3317, DOI 10.1200/JCO.2002.06.020; Winters Loren, 2007, Clin J Oncol Nurs, V11, P433, DOI 10.1188/07.CJON.433-439; Wong NS, 2011, PHARMACOGENET GENOM, V21, P760, DOI 10.1097/FPC.0b013e32834a8639; Zhang Y, 2012, AM J HEALTH-SYST PH, V69, P1384, DOI 10.2146/ajhp110585	19	148	154	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0118553	10.1371/journal.pone.0118553	http://dx.doi.org/10.1371/journal.pone.0118553			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25793887	gold, Green Submitted, Green Published			2022-12-27	WOS:000352084200029
J	Coubart, A; Streri, A; de Hevia, MD; Izard, V				Coubart, Aurelie; Streri, Arlette; de Hevia, Maria Dolores; Izard, Veronique			Crossmodal Discrimination of 2 vs. 4 Objects across Touch and Vision in 5-Month-Old Infants	PLOS ONE			English	Article							NUMBER DISCRIMINATION; REPRESENTATION; NUMEROSITIES; SYSTEMS	Infants are known to possess two different cognitive systems to encode numerical information. The first system encodes approximate numerosities, has no known upper limit and is functional from birth on. The second system relies on infants' ability to track up to 3 objects in parallel, and enables them to represent exact numerosity for such small sets. It is unclear, however, whether infants may be able to represent numerosities from all ranges in a common format. In various studies, infants failed to discriminate a small vs. a large numerosity (e.g., 2 vs. 4, 3 vs. 6), although more recent studies presented evidence that infants can succeed at these discriminations in some situations. Here, we used a transfer paradigm between the tactile and visual modalities in 5-month-olds, assuming that such cross-modal paradigm may promote access to abstract representations of numerosities, continuous across the small and large ranges. Infants were first familiarized with 2 to 4 objects in the tactile modality, and subsequently tested for their preference between 2 vs. 4, or 3 vs. 6 visual objects. Results were mixed, with only partial evidence that infants may have transferred numerical information across modalities. Implications on 5-month-old infants' ability to represent small and large numerosities in a single or in separate formats are discussed.	[Coubart, Aurelie; Streri, Arlette; de Hevia, Maria Dolores; Izard, Veronique] Univ Paris 05, Sorbonne Paris Cite, Paris, France; [Coubart, Aurelie; Streri, Arlette; de Hevia, Maria Dolores; Izard, Veronique] CNRS, Lab Psychol Percept, UMR 8242, Paris, France	UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite	Coubart, A (corresponding author), Univ Paris 05, Sorbonne Paris Cite, Paris, France.	aurelie.coubart@gmail.com			European Research Council [263179]	European Research Council(European Research Council (ERC)European Commission)	This work was supported by a Starting Grant from the European Research Council awarded to V.I. (Project MathConstruction 263179). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Burr DC, 2010, J VISION, V10, DOI 10.1167/10.6.20; Cordes S, 2009, DEV PSYCHOL, V45, P1583, DOI 10.1037/a0015666; Coubart A, 2014, DEVELOPMENTAL SCI, V17, P11, DOI 10.1111/desc.12108; Feigenson L, 2002, PSYCHOL SCI, V13, P150, DOI 10.1111/1467-9280.00427; Feigenson L, 2005, COGNITION, V97, P295, DOI 10.1016/j.cognition.2004.09.010; Feigenson L, 2004, TRENDS COGN SCI, V8, P307, DOI 10.1016/j.tics.2004.05.002; Feigenson L, 2011, J EXP CHILD PSYCHOL, V110, P347, DOI 10.1016/j.jecp.2011.04.004; Feron J, 2006, COGNITIVE DEV, V21, P81, DOI 10.1016/j.cogdev.2006.01.005; Hyde DC, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00150; Izard V, 2009, P NATL ACAD SCI USA, V106, P10382, DOI 10.1073/pnas.0812142106; Jones SM, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00550; Jordan KE, 2008, COGNITION, V108, P210, DOI 10.1016/j.cognition.2007.12.001; Lipton JS, 2004, INFANCY, V5, P271, DOI 10.1207/s15327078in0503_2; Nieder A, 2003, NEURON, V37, P149, DOI 10.1016/S0896-6273(02)01144-3; Nieder A, 2002, SCIENCE, V297, P1708, DOI 10.1126/science.1072493; PETRIE BF, 1980, INFANT BEHAV DEV, V3, P215, DOI 10.1016/S0163-6383(80)80027-0; SLATER A, 1991, J EXP CHILD PSYCHOL, V51, P395, DOI 10.1016/0022-0965(91)90084-6; Starr A, 2013, INFANCY, V18, P927, DOI 10.1111/infa.12008; Streri A, 2013, BEHAV SCI, V3, P154, DOI 10.3390/bs3010154; Vanmarle K, 2006, DEVELOPMENTAL SCI, V9, pF41, DOI 10.1111/j.1467-7687.2006.00508.x; Wood JN, 2005, COGNITION, V97, P23, DOI 10.1016/j.cognition.2004.06.007; Xu F, 2003, COGNITION, V89, pB15, DOI 10.1016/S0010-0277(03)00050-7; Xu F, 2000, COGNITION, V74, pB1, DOI 10.1016/S0010-0277(99)00066-9	23	6	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0120868	10.1371/journal.pone.0120868	http://dx.doi.org/10.1371/journal.pone.0120868			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CE6ZS	25798931	Green Published, gold, Green Submitted			2022-12-27	WOS:000351987300185
J	Galusca, B; Prevost, G; Germain, N; Dubuc, I; Ling, Y; Anouar, Y; Estour, B; Chartrel, N				Galusca, Bogdan; Prevost, Gaetan; Germain, Natacha; Dubuc, Isabelle; Ling, Yiin; Anouar, Youssef; Estour, Bruno; Chartrel, Nicolas			Neuropeptide Y and alpha-MSH Circadian Levels in Two Populations with Low Body Weight: Anorexia Nervosa and Constitutional Thinness	PLOS ONE			English	Article							BULIMIA-NERVOSA; PLASMA-LEVELS; LEPTIN; GHRELIN; APPETITE; WOMEN; METABOLISM; PERIPHERY; OBESTATIN; HORMONE	Context Anorexia nervosa (AN) presents an adaptive appetite regulating profile including high levels of ghrelin and 26RFa (orexigenic) and low levels of leptin and PYY (anorexigenic). However, this adaptive mechanism is not effective in promoting food intake. The NPY/proopiome-lanocortin (POMC) system plays a crucial role in the regulation of feeding behavior as NPY is the most potent orexigenic neuropeptide identified so far and as the POMC-derived peptide alpha-MSH drastically reduces food intake, and this peptidergic system has not been thoroughly studied in AN. Objective The aim of the present study was thus to investigate whether a dysfunction of the NPY/POMC occurs in two populations with low body weight, AN and constitutional thinness (CT). Design and Settings This was a cross-sectional study performed in an endocrinological unit and in an academic laboratory. Investigated Subjects Three groups of age-matched young women were studied: 23 with AN (AN), 22 CT and 14 normal weight controls. Main Outcome Measures Twelve-point circadian profiles of plasma NPY and alpha-MSH levels were measured in the three groups of investigated subjects. Results No significant circadian variation of NPY was detected between the three groups. Plasma alpha-MSH levels were significantly lower in AN (vs controls) all over the day. The CT group, compared to controls, presented lower levels of alpha-MSH in the morning and the evening, and an important rise during lunchtime. Conclusion In AN patients, the NPY system is not up-regulated under chronic undernutrition suggesting that this may play a role in the inability of anorectic women to adapt food intake to their energy demand. In contrast, low circadian alpha-MSH levels integrate the adaptive profile of appetite regulation of this disease. Finally, in CT women, the important alpha-MSH peak detected during lunchtime could explain why these patients are rapidly food satisfied.	[Galusca, Bogdan; Germain, Natacha; Ling, Yiin; Estour, Bruno] CHU St Etienne, Dept Endocrinol, St Etienne, France; [Prevost, Gaetan; Dubuc, Isabelle; Anouar, Youssef; Chartrel, Nicolas] Univ Rouen, IRIB, INSERM,Unite 982, Lab Neuronal & Neuroendocrine Differentiat & Comm, Mont St Aignan, France	CHU de St Etienne; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rouen Normandie	Chartrel, N (corresponding author), Univ Rouen, IRIB, INSERM,Unite 982, Lab Neuronal & Neuroendocrine Differentiat & Comm, Mont St Aignan, France.	nicolas.chartrel@univ-rouen.fr	chartrel, nicolas/E-5545-2016; PREVOST, Gaetan/AAD-4865-2019; Anouar, Youssef/F-9683-2017					American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Baranowska B, 1997, METABOLISM, V46, P1384, DOI 10.1016/S0026-0495(97)90136-0; Baranowska B, 2001, NEUROENDOCRINOL LETT, V22, P356; Beranova L, 2009, Vnitr Lek, V55, P925; Bossu C, 2007, AM J PHYSIOL-ENDOC M, V292, pE132, DOI 10.1152/ajpendo.00241.2006; Bronsky J, 2011, INT J EAT DISORDER, V44, P547, DOI 10.1002/eat.20857; Ehrlich S, 2010, J PSYCHIATR RES, V44, P827, DOI 10.1016/j.jpsychires.2010.01.011; Escobar L, 2002, Rev Esp Med Nucl, V21, P3; Estour B, 2010, J CLIN ENDOCR METAB, V95, P2203, DOI 10.1210/jc.2009-2608; Forbes S, 2001, P NATL ACAD SCI USA, V98, P4233, DOI 10.1073/pnas.071054298; Galusca B, 2008, J CLIN ENDOCR METAB, V93, P110, DOI 10.1210/jc.2007-1591; Galusca B, 2012, J CLIN ENDOCR METAB, V97, P2012, DOI 10.1210/jc.2011-3396; Germain N, 2014, NUTR DIABETES, V4, DOI 10.1038/nutd.2014.17; Germain N, 2009, PSYCHONEUROENDOCRINO, V34, P413, DOI 10.1016/j.psyneuen.2008.10.001; Germain N, 2007, AM J CLIN NUTR, V85, P967, DOI 10.1093/ajcn/85.4.967; Germain N, 2010, J CLIN ENDOCR METAB, V95, P3057, DOI 10.1210/jc.2009-2196; Iqbal R, 2006, NUTR J, V5, DOI 10.1186/1475-2891-5-18; Kuo LE, 2007, NAT MED, V13, P803, DOI 10.1038/nm1611; Niedzwiedzka B, 2013, GINEKOL POL, V84, P268; Ramos EJB, 2005, NUTRITION, V21, P269, DOI 10.1016/j.nut.2004.06.021; Sedlackova D, 2011, PHYSIOL RES, V60, P165, DOI 10.33549/physiolres.931952; Slominski A, 2000, PHYSIOL REV, V80, P979, DOI 10.1152/physrev.2000.80.3.979; Tennoune N, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2014.98; Tolle V, 2003, J CLIN ENDOCR METAB, V88, P109, DOI 10.1210/jc.2002-020645; VAUDRY H, 1978, NEUROENDOCRINOLOGY, V27, P9, DOI 10.1159/000122796; Xie F, 2012, CELL PHYSIOL BIOCHEM, V29, P111, DOI 10.1159/000337592; Zhang W, 2014, NUTR METAB, V11, DOI 10.1186/1743-7075-11-27	27	31	31	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0122040	10.1371/journal.pone.0122040	http://dx.doi.org/10.1371/journal.pone.0122040			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25798605	Green Published, Green Submitted, gold			2022-12-27	WOS:000351987300313
J	Riahi, Z; Bonnet, C; Zainine, R; Lahbib, S; Bouyacoub, Y; Bechraoui, R; Marrakchi, J; Hardelin, JP; Louha, M; Largueche, L; Ben Yahia, S; Kheirallah, M; Elmatri, L; Besbes, G; Abdelhak, S; Petit, C				Riahi, Zied; Bonnet, Crystel; Zainine, Rim; Lahbib, Saida; Bouyacoub, Yosra; Bechraoui, Rym; Marrakchi, Jihene; Hardelin, Jean-Pierre; Louha, Malek; Largueche, Leila; Ben Yahia, Salim; Kheirallah, Moncef; Elmatri, Leila; Besbes, Ghazi; Abdelhak, Sonia; Petit, Christine			Whole Exome Sequencing Identifies Mutations in Usher Syndrome Genes in Profoundly Deaf Tunisian Patients	PLOS ONE			English	Article							HEARING IMPAIRMENT; UPDATE; DNA	Usher syndrome (USH) is an autosomal recessive disorder characterized by combined deafness-blindness. It accounts for about 50% of all hereditary deafness blindness cases. Three clinical subtypes (USH1, USH2, and USH3) are described, of which USH1 is the most severe form, characterized by congenital profound deafness, constant vestibular dysfunction, and a prepubertal onset of retinitis pigmentosa. We performed whole exome sequencing in four unrelated Tunisian patients affected by apparently isolated, congenital profound deafness, with reportedly normal ocular fundus examination. Four biallelic mutations were identified in two USH1 genes: a splice acceptor site mutation, c.2283-1G>T, and a novel missense mutation, c.5434G>A (p.Glu1812Lys), in MYO7A, and two previously unreported mutations in USH1G, i.e. a frameshift mutation, c.1195_1196delAG (p.Leu399Alafs*24), and a nonsense mutation, c.52A>T (p.Lys18*). Another ophthalmological examination including optical coherence tomography actually showed the presence of retinitis pigmentosa in all the patients. Our findings provide evidence that USH is under-diagnosed in Tunisian deaf patients. Yet, early diagnosis of USH is of utmost importance because these patients should undergo cochlear implant surgery in early childhood, in anticipation of the visual loss.	[Riahi, Zied; Lahbib, Saida; Bouyacoub, Yosra; Abdelhak, Sonia] Inst Pasteur Tunis, LR11IPT05, Biomed Genom & Oncogenet Lab, Tunis 1002, Tunisia; [Riahi, Zied] Univ Tunis El Manar, Fac Sci Tunis, Tunis 2092, Tunisia; [Bonnet, Crystel; Petit, Christine] UPMC Paris 6, INSERM UMRS 1120, Inst Vis, Paris, France; [Zainine, Rim; Bechraoui, Rym; Marrakchi, Jihene; Besbes, Ghazi] La Rabta Hosp, Otorhinolaryngol Dis, Tunis, Tunisia; [Bouyacoub, Yosra] Univ Monastir, Inst Super Biotechnol, Monastir, Tunisia; [Hardelin, Jean-Pierre; Petit, Christine] Inst Pasteur, Unite Genet & Physiol Audit, Paris, France; [Louha, Malek] Hop Armand Trousseau, AP HP, Lab Biochim & Biol Mol, Paris, France; [Largueche, Leila; Elmatri, Leila] Hedi Rais Inst Ophthalmol, Dept Ophthalmol B, Tunis, Tunisia; [Ben Yahia, Salim; Kheirallah, Moncef] Univ Monastir, Fac Med, Fattouma Bourguiba Univ Hosp, Dept Ophthalmol, Monastir 5000, Tunisia; [Petit, Christine] Coll France, F-75231 Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Universite de Tunis-El-Manar; Institut Pasteur Tunis; Universite de Tunis-El-Manar; Faculte des Sciences de Tunis (FST); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite de Bordeaux; Universite de Tunis-El-Manar; Hopital La Rabta; Universite de Monastir; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Armand-Trousseau - APHP; UDICE-French Research Universities; Sorbonne Universite; Universite de Tunis-El-Manar; Institut Hedi Raies d'ophtalmologie de Tunis; Universite de Monastir; Hopital Fattouma Bourguiba; UDICE-French Research Universities; PSL Research University Paris; College de France	Abdelhak, S (corresponding author), Inst Pasteur Tunis, LR11IPT05, Biomed Genom & Oncogenet Lab, Tunis 1002, Tunisia.	sonia.abdelhak@pasteur.rns.tn	jihene, marrakchi/A-1415-2016; Bonnet, Crystel/AAN-5950-2021; Abdelhak, Sonia/L-2831-2013	jihene, marrakchi/0000-0001-8759-2894; Bonnet, Crystel/0000-0002-1916-9119; Petit, Christine/0000-0002-9069-002X; BOUYACOUB, Yosra/0000-0003-2423-199X; Abdelhak, Sonia/0000-0001-8466-5525	Tunisian Ministry of Public Health; Ministry of Higher Education and Scientific Research [LR11IPT05]; FP7 project GM-NCD-Inco [295097]; Mobidoc Fellowship under the Programme d'Appui au Systeme de recherche et d'Innovation (PASRI-Europe Aid); BNP Paribas foundation	Tunisian Ministry of Public Health; Ministry of Higher Education and Scientific Research(Ministry of Higher Education & Scientific Research (MHESR)); FP7 project GM-NCD-Inco; Mobidoc Fellowship under the Programme d'Appui au Systeme de recherche et d'Innovation (PASRI-Europe Aid); BNP Paribas foundation	This work was supported by the Tunisian Ministry of Public Health, the Ministry of Higher Education and Scientific Research (LR11IPT05), the E.C. Grant agreement No 295097 for FP7 project GM-NCD-Inco (www.genomedika.org), ZR is recipient of a Mobidoc Fellowship under the Programme d'Appui au Systeme de recherche et d'Innovation (PASRI-Europe Aid) and BNP Paribas foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonnet C, 2013, GENE, V527, P537, DOI 10.1016/j.gene.2013.06.044; Bonnet C, 2012, CURR OPIN NEUROL, V25, P42, DOI 10.1097/WCO.0b013e32834ef8b2; Bonnet C, 2011, ORPHANET J RARE DIS, V6, DOI 10.1186/1750-1172-6-21; Delmaghani S, 2012, HUM MOL GENET, V21, P3835, DOI 10.1093/hmg/dds212; Hilgert N, 2009, MUTAT RES-REV MUTAT, V681, P189, DOI 10.1016/j.mrrev.2008.08.002; Kimberling WJ, 2010, GENET MED, V12, P512, DOI 10.1097/GIM.0b013e3181e5afb8; Millan JM, 2011, J OPHTHALMOL, V2011, DOI 10.1155/2011/417217; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Morton CC, 2006, NEW ENGL J MED, V354, P2151, DOI 10.1056/NEJMra050700; Riahi Z, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099797; Riahi Z, 2013, GENE, V525, P1, DOI 10.1016/j.gene.2013.04.078; Riazuddin S, 2012, NAT GENET, V44, P1265, DOI 10.1038/ng.2426; Roux AF, 2011, INVEST OPHTH VIS SCI, V52, P4063, DOI 10.1167/iovs.10-6869; Saihan Z, 2009, CURR OPIN NEUROL, V22, P19, DOI 10.1097/WCO.0b013e3283218807; Smith RJ., 1993, GENEREVIEWS; Woo HM, 2013, BMC MED GENET, V14, DOI 10.1186/1471-2350-14-72	16	16	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0120584	10.1371/journal.pone.0120584	http://dx.doi.org/10.1371/journal.pone.0120584			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25798947	Green Published, gold, Green Submitted			2022-12-27	WOS:000351987300155
J	Liang, XY; Xing, WJ; He, JX; Fu, F; Zhang, W; Su, FF; Liu, F; Ji, LL; Gao, F; Su, H; Sun, X; Zhang, HF				Liang, Xiangyan; Xing, Wenjuan; He, Jinxiao; Fu, Feng; Zhang, Wei; Su, Feifei; Liu, Fange; Ji, Lele; Gao, Feng; Su, Hui; Sun, Xin; Zhang, Haifeng			Magnolol Administration in Normotensive Young Spontaneously Hypertensive Rats Postpones the Development of Hypertension: Role of Increased PPAR Gamma, Reduced TRB3 and Resultant Alleviative Vascular Insulin Resistance	PLOS ONE			English	Article							ACTIVATED-RECEPTOR-GAMMA; STIMULATE GLUCOSE-UPTAKE; MYOCARDIAL ISCHEMIA/REPERFUSION; TRIBBLES HOMOLOG; BLOOD-PRESSURE; PREHYPERTENSION; EXPRESSION; HONOKIOL; AKT; INFLAMMATION	Patients with prehypertension are more likely to progress to manifest hypertension than those with optimal or normal blood pressure. However, the mechanisms underlying the development from prehypertension to hypertension still remain largely elusive and the drugs for antihypertensive treatment in prehypertension are absent. Here we determined the effects of magnolol (MAG) on blood pressure and aortic vasodilatation to insulin, and investigated the underlying mechanisms. Four-week-old male spontaneous hypertensive rats (SHR) and age-matched normotensive Wistar-Kyoto (WKY) control rats were used. Our results shown that treatment of young SHRs with MAG (100 mg/kg/day, o.g.) for 3 weeks decreased blood pressure, improved insulin-induced aorta vasodilation, restored Akt and eNOS activation stimulated by insulin, and increased PPAR gamma and decreased TRB3 expressions. In cultured human umbilical vein endothelial cells (HUVECs), MAG incubation increased PPAR gamma, decreased TRB3 expressions, and restored insulin-induced phosphorylated Akt and eNOS levels and NO production, which was blocked by both PPAR gamma antagonist and siRNA targeting PPAR gamma. Improved insulin signaling in HUVECs by MAG was abolished by upregulating TRB3 expression. In conclusion, treatment of young SHRs with MAG beginning at the prehypertensive stage decreases blood pressure via improving vascular insulin resistance that is at least partly attributable to upregulated PPAR gamma, downregulated TRB3 and consequently increased Akt and eNOS activations in blood vessels in SHRs.	[Liang, Xiangyan; Liu, Fange; Ji, Lele; Zhang, Haifeng] Fourth Mil Med Univ, Expt Teaching Ctr, Xian 710032, Peoples R China; [Xing, Wenjuan; Fu, Feng; Gao, Feng] Fourth Mil Med Univ, Dept Physiol, Xian 710032, Peoples R China; [He, Jinxiao; Sun, Xin] Fourth Mil Med Univ, Xijing Hosp, Dept Pediat, Xian 710032, Peoples R China; [Zhang, Wei; Su, Feifei] Fourth Mil Med Univ, Tangdu Hosp, Dept Cardiol, Xian 710032, Peoples R China; [Su, Hui] Fourth Mil Med Univ, Xijing Hosp, Dept Geratol, Xian 710032, Peoples R China	Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University	Su, H (corresponding author), Fourth Mil Med Univ, Xijing Hosp, Dept Geratol, Xian 710032, Peoples R China.	huisu2011@gmail.com; sunxin6@fmmu.edu.cn; hfzhang@fmmu.edu.cn	Gao, Feng/X-4385-2019	Zhang, Haifeng/0000-0003-1938-3796	National Natural Science Foundation of China [81270330, 31371151, 81470537, 81300077, 81400197]; Shaanxi Province Science and Technology Research and Development Program [2013KJXX-89, 2013KW30-02]; Shaanxi Province Social Development Project in Science and Technology Research [2014K11-02-03-02]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shaanxi Province Science and Technology Research and Development Program; Shaanxi Province Social Development Project in Science and Technology Research	This work was supported by the National Natural Science Foundation of China (Nos. 81270330, 31371151, 81470537, 81300077, and 81400197), the Shaanxi Province Science and Technology Research and Development Program (Nos. 2013KJXX-89 and 2013KW30-02), and the Shaanxi Province Social Development Project in Science and Technology Research (No. 2014K11-02-03-02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen JH, 2003, N-S ARCH PHARMACOL, V368, P127, DOI 10.1007/s00210-003-0779-3; Chen YH, 2002, BRIT J PHARMACOL, V135, P37, DOI 10.1038/sj.bjp.0704458; Chen Yung-Hsiang, 2006, Cardiovascular & Hematological Disorders - Drug Targets, V6, P279; Chobanian AV., 2003, HYPERTENSION, V42, P1206, DOI [10.1161/01.HYP.0000107251, DOI 10.1161/01.HYP.9.2_PT_2.II36, DOI 10.1161/01.HYP.0000107251.49515.C2]; Choi SS, 2012, BIOFACTORS, V38, P372, DOI 10.1002/biof.1029; Du KY, 2003, SCIENCE, V300, P1574, DOI 10.1126/science.1079817; Fakhrudin N, 2010, MOL PHARMACOL, V77, P559, DOI 10.1124/mol.109.062141; Gupta AK, 2010, HYPERTENS RES, V33, P905, DOI 10.1038/hr.2010.91; Huang YL, 2014, AM HEART J, V167, P160, DOI 10.1016/j.ahj.2013.10.023; Ijuin T, 2003, MOL CELL BIOL, V23, P1209, DOI 10.1128/MCB.23.4.1209-1220.2003; Jin YC, 2008, EXP BIOL MED, V233, P1280, DOI 10.3181/0803-RM-79; Alonso-Castro AJ, 2011, PHYTOMEDICINE, V18, P926, DOI 10.1016/j.phymed.2011.02.015; Julius S, 2006, NEW ENGL J MED, V354, P1685, DOI 10.1056/NEJMoa060838; Julius S, 2014, J HYPERTENS, V32, P251, DOI 10.1097/HJH.0000000000000032; Karki R, 2013, EXP CELL RES, V319, P3238, DOI 10.1016/j.yexcr.2013.07.016; Karki R, 2013, BBA-GEN SUBJECTS, V1830, P2619, DOI 10.1016/j.bbagen.2012.12.015; Kim F, 2008, ARTERIOSCL THROM VAS, V28, P1982, DOI 10.1161/ATVBAHA.108.169722; Kim GD, 2013, INT J ONCOL, V43, P600, DOI 10.3892/ijo.2013.1959; Kim HM, 2007, INT IMMUNOPHARMACOL, V7, P1083, DOI 10.1016/j.intimp.2007.04.004; Kim YJ, 2013, MOL NUTR FOOD RES, V57, P1988, DOI 10.1002/mnfr.201300113; Kuo WW, 2005, CELL BIOCHEM FUNCT, V23, P325, DOI 10.1002/cbf.1244; Lee YM, 2001, EUR J PHARMACOL, V422, P159, DOI 10.1016/S0014-2999(01)01069-X; Li J, 2008, CRIT CARE MED, V36, P1551, DOI 10.1097/CCM.0b013e3181782335; Li R, 2007, AM J PHYSIOL-ENDOC M, V293, pE1703, DOI 10.1152/ajpendo.00462.2007; Li R, 2010, EUR J PHARMACOL, V628, P140, DOI 10.1016/j.ejphar.2009.11.038; Montagnani M, 2001, J BIOL CHEM, V276, P30392, DOI 10.1074/jbc.M103702200; Prudente S, 2005, DIABETES, V54, P2807, DOI 10.2337/diabetes.54.9.2807; Rieusset J, 2001, DIABETOLOGIA, V44, P544, DOI 10.1007/s001250051660; Taguchi K, 2012, DIABETES, V61, P1978, DOI 10.2337/db11-1729; Ungvari Z, 2001, AM J PHYSIOL-HEART C, V281, pH606, DOI 10.1152/ajpheart.2001.281.2.H606; Wu LY, 2004, AM J HYPERTENS, V17, P749, DOI 10.1016/j.amjhyper.2004.04.010; Xing WJ, 2013, AM J PHYSIOL-HEART C, V305, pH1111, DOI 10.1152/ajpheart.00290.2013; Xing WJ, 2013, HYPERTENSION, V61, P1028, DOI 10.1161/HYPERTENSIONAHA.111.00728; Yan WJ, 2013, BASIC RES CARDIOL, V108, DOI 10.1007/s00395-013-0329-1; Zhang HF, 2008, J HYPERTENS, V26, P560, DOI 10.1097/HJH.0b013e3282f343e1	35	19	21	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0120366	10.1371/journal.pone.0120366	http://dx.doi.org/10.1371/journal.pone.0120366			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25793876	Green Published, Green Submitted, gold			2022-12-27	WOS:000352083900017
J	Luo, ZF; Li, YA; Wang, HM; Fleming, J; Li, M; Kang, Y; Zhang, R; Li, DH				Luo, Zhaofan; Li, Yanan; Wang, Huamin; Fleming, Jason; Li, Min; Kang, Yaan; Zhang, Ran; Li, Donghui			Hepatocyte Nuclear Factor 1A (HNF1A) as a Possible Tumor Suppressor in Pancreatic Cancer	PLOS ONE			English	Article							DOMINANT-NEGATIVE SUPPRESSION; BETA-CELL FUNCTION; TRANSCRIPTION FACTORS; FACTOR 1-ALPHA; ACTIVATED AKT; GENE; HNF1-ALPHA; EXPRESSION; INACTIVATION; HNF-1-ALPHA	Background HNF1A (Hepatocyte nuclear factor 1 alpha) is a transcription factor that is known to regulate pancreatic differentiation and maintain homeostasis of endocrine pancreas. Recently, genome-wide association studies have implicated HNF1A as a susceptibility gene for pancreatic cancer. However, the functional significance and molecular mechanism of HNF1A in pancreatic carcinogenesis remains unclear. Methods Using RT-PCR, Western blot and immunohistochemistry methods, we examined HNF1A gene expression in eight pancreatic carcinoma cell lines and in paired tumor and normal tissue samples from patients with resected pancreatic ductal adenocarcinoma. We knocked down the HNF1A gene expression in two cancer cell lines using three siRNA sequences. The impacts on cell proliferation, apoptosis, and cell cycle as well as the phosphorylation of Akt signaling transduction proteins were examined using ATP assay, flow cytometry and Western blot. Results HNF1A was expressed in three out of eight pancreatic adenocarcinoma cell lines and the level of HNF1A mRNA and protein expression was significantly lower in tumors than in normal adjacent tissues by both RT-PCR and Western Blot analyses. Immunohistochemistry revealed that the level of HNF1A expression was significantly lower in tumor tissues than in non-tumor tissues. Selective blocking of HNF1A by specific siRNA conferred a 2-fold higher rate of cell proliferation, 20% increased S phase and G2 phase cells, and 30-40% reduced apoptosis in pancreatic cancer cell lines. We further demonstrated that HNF1A knockdown activated Akt and its downstream target, the mammalian target of rapamycin ( mTOR) in pancreatic cancer cells. Conclusion These observations provide experimental evidence supporting a possible tumor suppressor role of HNF1A in pancreatic cancer.	[Luo, Zhaofan; Li, Yanan; Li, Donghui] Univ Texas MD Anderson Canc Ctr, Dept Gastrointestinal Med Oncol, Houston, TX 77030 USA; [Wang, Huamin] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA; [Fleming, Jason; Kang, Yaan; Zhang, Ran] Univ Texas MD Anderson Canc Ctr, Dept Surg Oncol, Houston, TX 77030 USA; [Li, Min] Univ Texas Med Sch, Vivian L Smith Dept Neurosurg, Houston, TX USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas Health Science Center Houston	Li, DH (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Gastrointestinal Med Oncol, Houston, TX 77030 USA.	dli@mdanderson.org			G.S. Hogan Research Funds; Sheikh Ahmed Center for Pancreatic Cancer Research Funds; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER	G.S. Hogan Research Funds; Sheikh Ahmed Center for Pancreatic Cancer Research Funds; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	G.S. Hogan Research Funds and the Sheikh Ahmed Center for Pancreatic Cancer Research Funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asano T, 2004, ONCOGENE, V23, P8571, DOI 10.1038/sj.onc.1207902; Bellanne-Chantelot C, 2008, DIABETES, V57, P503, DOI 10.2337/db07-0859; Bluteau O, 2002, NAT GENET, V32, P312, DOI 10.1038/ng1001; Cerf ME, 2006, EUR J ENDOCRINOL, V155, P671, DOI 10.1530/eje.1.02277; D'Angelo A, 2010, DEVELOPMENT, V137, P1573, DOI 10.1242/dev.044420; Furukawa T, 1996, AM J PATHOL, V148, P1763; Furuta H, 2002, J CLIN ENDOCR METAB, V87, P3859, DOI 10.1210/jc.87.8.3859; Hay N, 2005, CANCER CELL, V8, P179, DOI 10.1016/j.ccr.2005.08.008; Hennessy BT, 2005, NAT REV DRUG DISCOV, V4, P988, DOI 10.1038/nrd1902; Hino K, 2008, RNA, V14, P1433, DOI 10.1261/rna.810208; Holmkvist J, 2006, DIABETOLOGIA, V49, P2882, DOI 10.1007/s00125-006-0450-x; Hoskins JW, 2014, CARCINOGENESIS, V35, P2670, DOI 10.1093/carcin/bgu193; Kleber ME, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-157; Lauc G, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001256; Lemm I, 1999, MOL CARCINOGEN, V24, P305, DOI 10.1002/(SICI)1098-2744(199904)24:4<305::AID-MC9>3.0.CO;2-8; Ley SH, 2010, CARDIOVASC DIABETOL, V9, DOI 10.1186/1475-2840-9-39; Li DH, 2012, CARCINOGENESIS, V33, P1384, DOI 10.1093/carcin/bgs151; Lussier CR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012378; Maestro MA, 2007, ENDOCR DEV, V12, P33, DOI 10.1159/000109603; Martin M, 2007, ENDOCR DEV, V12, P24, DOI 10.1159/000109602; Molero X, 2012, GUT, V61, P1187, DOI 10.1136/gutjnl-2011-300360; Pelletier L, 2010, HEPATOLOGY, V51, P557, DOI 10.1002/hep.23362; Pierce BL, 2011, CANCER RES, V71, P4352, DOI 10.1158/0008-5472.CAN-11-0124; Pontoglio M, 1996, CELL, V84, P575, DOI 10.1016/S0092-8674(00)81033-8; Pontoglio M, 1997, MOL CELL BIOL, V17, P4948, DOI 10.1128/MCB.17.9.4948; Pontoglio M, 1998, J CLIN INVEST, V101, P2215, DOI 10.1172/JCI2548; Rebouissou S, 2004, ONCOGENE, V23, P7588, DOI 10.1038/sj.onc.1207989; Schlieman MG, 2003, BRIT J CANCER, V89, P2110, DOI 10.1038/sj.bjc.6601396; Servitja JM, 2009, MOL CELL BIOL, V29, P2945, DOI 10.1128/MCB.01389-08; Shih DQ, 2001, NAT GENET, V27, P375, DOI 10.1038/86871; Song SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042699; Voight BF, 2010, NAT GENET, V42, P579, DOI 10.1038/ng.609; Wang H, 2000, ADV IND CON; Wei P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046887; Wobser H, 2006, DIABETOLOGIA, V49, P519, DOI 10.1007/s00125-005-0119-x; Wobser H, 2002, J BIOL CHEM, V277, P6413, DOI 10.1074/jbc.M108390200; Yamamoto S, 2004, CLIN CANCER RES, V10, P2846, DOI 10.1158/1078-0432.CCR-02-1441	37	32	34	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0121082	10.1371/journal.pone.0121082	http://dx.doi.org/10.1371/journal.pone.0121082			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25793983	Green Published, Green Submitted, gold			2022-12-27	WOS:000352083900100
J	McCrea, RL; Nazareth, I; Evans, SJW; Osborn, DPJ; Pinfold, V; Cowen, PJ; Petersen, I				McCrea, Rachel L.; Nazareth, Irwin; Evans, Stephen J. W.; Osborn, David P. J.; Pinfold, Vanessa; Cowen, Phil J.; Petersen, Irene			Lithium Prescribing during Pregnancy: A UK Primary Care Database Study	PLOS ONE			English	Article								Background Women taking lithium must decide whether to continue the medication if they conceive or plan to conceive. Little is known about the extent of prescribing of lithium during pregnancy. Aims To determine: 1) the prevalence of lithium prescribing during pregnancy and 2) to assess whether pregnancy is associated with discontinuation of lithium. Method First, we identified women receiving any lithium prescriptions before and during pregnancy using The Health Improvement Network (THIN) primary care database. Subsequently, we used a Kaplan-Meier plot to compare time to last prescription in women prescribed lithium continuously three months before pregnancy and a comparison group of non-pregnant women. Finally, we described the characteristics of the women prescribed lithium in pregnancy. Results Very few women were prescribed lithium during pregnancy; out of 458,761 pregnancies, we identified 47 (0.01%) in which lithium was prescribed after the 6th week of pregnancy (when the pregnancy was likely to be known). In our study of discontinuation, we found pregnant women were more likely to stop lithium than those who were not pregnant. Of the 52 women who were being continuously prescribed lithium three months before pregnancy, only 17 (33%) continued receiving prescriptions beyond the 6th week of pregnancy. However, most of these 17 women continued treatment throughout pregnancy. Conclusions Pregnancy was strongly associated with discontinuation of lithium. Further evidence on the risks of lithium is needed so that women can weight these against the risk of a deterioration in maternal mental health.	[McCrea, Rachel L.; Nazareth, Irwin; Petersen, Irene] UCL, Dept Primary Care & Populat Hlth, London, England; [Evans, Stephen J. W.] London Sch Hyg & Trop Med, London WC1, England; [Osborn, David P. J.] UCL, Div Psychiat, London, England; [Pinfold, Vanessa] McPin Fdn, London, England; [Cowen, Phil J.] Univ Oxford, Univ Dept Psychiat, Oxford, England	University of London; University College London; University of London; London School of Hygiene & Tropical Medicine; University of London; University College London; University of Oxford	Petersen, I (corresponding author), UCL, Dept Primary Care & Populat Hlth, London, England.	Irene.petersen@ucl.ac.uk	; Osborn PhD FRCPsych, David/B-8165-2009; Petersen, Irene/C-5702-2009	Cowen, Philip/0000-0001-5518-6138; Osborn PhD FRCPsych, David/0000-0003-2519-1539; Evans, Stephen/0000-0002-1474-2596; Petersen, Irene/0000-0002-0037-7524	National Institute of Health Research Health Technology Assessment (HTA) program [11/35/06]; National Institute for Health Research [11/35/06] Funding Source: researchfish	National Institute of Health Research Health Technology Assessment (HTA) program; National Institute for Health Research(National Institute for Health Research (NIHR))	This project was funded by the National Institute of Health Research Health Technology Assessment (HTA) program. Project 11/35/06 - Risks and benefits of psychotropic medication in pregnancy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blak Betina T, 2011, Inform Prim Care, V19, P251; KALLEN B, 1983, ACTA PSYCHIAT SCAND, V68, P134, DOI 10.1111/j.1600-0447.1983.tb06991.x; Man SL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052339; McKnight RF, 2012, LANCET, V379, P721, DOI 10.1016/S0140-6736(11)61516-X; NICE, 2014, ANT POSTN MENT HLTH; NORA JJ, 1974, LANCET, V2, P594; Petersen I, 2011, J CLIN PSYCHIAT, V72, P979, DOI 10.4088/JCP.10m06090blu; Viguera AC, 2007, AM J PSYCHIAT, V164, P1817, DOI 10.1176/appi.ajp.2007.06101639	8	19	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0121024	10.1371/journal.pone.0121024	http://dx.doi.org/10.1371/journal.pone.0121024			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25793580	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000352083900096
J	Montecchia, MS; Tosi, M; Soria, MA; Vogrig, JA; Sydorenko, O; Correa, OS				Montecchia, Marcela S.; Tosi, Micaela; Soria, Marcelo A.; Vogrig, Jimena A.; Sydorenko, Oksana; Correa, Olga S.			Pyrosequencing Reveals Changes in Soil Bacterial Communities after Conversion of Yungas Forests to Agriculture	PLOS ONE			English	Article							LAND-USE CHANGE; MICROBIAL COMMUNITY; DIVERSITY; MANAGEMENT; DEFORESTATION; BIOGEOGRAPHY; STABILITY; DYNAMICS; NITROGEN; ECOLOGY	The Southern Andean Yungas in Northwest Argentina constitute one of the main biodiversity hotspots in the world. Considerable changes in land use have taken place in this ecoregion, predominantly related to forest conversion to croplands, inducing losses in above-ground biodiversity and with potential impact on soil microbial communities. In this study, we used high-throughput pyrosequencing of the 16S ribosomal RNA gene to assess whether land-use change and time under agriculture affect the composition and diversity of soil bacterial communities. We selected two areas dedicated to sugarcane and soybean production, comprising both short-and long-term agricultural sites, and used the adjacent native forest soils as a reference. Land-use change altered the composition of bacterial communities, with differences between productive areas despite the similarities between both forests. At the phylum level, only Verrucomicrobia and Firmicutes changed in abundance after deforestation for sugarcane and soybean cropping, respectively. In cultivated soils, Verrucomicrobia decreased sharply (similar to 80%), while Firmicutes were more abundant. Despite the fact that local diversity was increased in sugarcane systems and was not altered by soybean cropping, phylogenetic beta diversity declined along both chronosequences, evidencing a homogenization of soil bacterial communities over time. In spite of the detected alteration in composition and diversity, we found a core microbiome resistant to the disturbances caused by the conversion of forests to cultivated lands and few or none exclusive OTUs for each land-use type. The overall changes in the relative abundance of copiotrophic and oligotrophic taxa may have an impact in soil ecosystem functionality. However, communities with many taxa in common may also share many functional attributes, allowing to maintain at least some soil ecosystem services after forest conversion to croplands.	[Montecchia, Marcela S.; Tosi, Micaela; Soria, Marcelo A.; Vogrig, Jimena A.; Sydorenko, Oksana; Correa, Olga S.] Univ Buenos Aires, Fac Agron, Catedra Microbiol Agr, Inst Invest Biociencias Agr & Ambientales INBA CO, Buenos Aires, DF, Argentina	University of Buenos Aires	Correa, OS (corresponding author), Univ Buenos Aires, Fac Agron, Catedra Microbiol Agr, Inst Invest Biociencias Agr & Ambientales INBA CO, Buenos Aires, DF, Argentina.	correa@agro.uba.ar		Montecchia, Marcela Susana/0000-0002-2718-7309; Tosi, Micaela/0000-0001-6552-951X	Universidad de Buenos Aires [UBACYT 20020100100767, 20020130100286BA]; Consejo Nacional de Investigaciones Cientificas y Tecnicas [PIP 114 201101 00247]	Universidad de Buenos Aires(University of Buenos Aires); Consejo Nacional de Investigaciones Cientificas y Tecnicas(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	This work was supported by grants from Universidad de Buenos Aires (UBACYT 20020100100767 and 20020130100286BA) and Consejo Nacional de Investigaciones Cientificas y Tecnicas (PIP 114 201101 00247). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MJ, 2003, ECOLOGY, V84, P511, DOI 10.1890/0012-9658(2003)084[0511:CAOPCA]2.0.CO;2; Bahr E, 2014, AGR ECOSYST ENVIRON, V188, P275, DOI 10.1016/j.agee.2014.03.005; Becerra AG, 2011, MYCOLOGIA, V103, P273, DOI 10.3852/10-193; Bergmann GT, 2011, SOIL BIOL BIOCHEM, V43, P1450, DOI 10.1016/j.soilbio.2011.03.012; Bissett A, 2011, APPL SOIL ECOL, V51, P66, DOI 10.1016/j.apsoil.2011.08.010; Brown A.D., 2001, BOSQUES NUBLADOS NEO, P623; Brown AD., 2009, SELVA PEDEMONTANA YU; Brussaard L, 2007, AGR ECOSYST ENVIRON, V121, P233, DOI 10.1016/j.agee.2006.12.013; Cabrera AL., 1976, REGIONES FITOGEOGRAF, DOI DOI 10.1038/ncomms2415; CHAO A, 1984, SCAND J STAT, V11, P265; CHAO A, 1992, J AM STAT ASSOC, V87, P210, DOI 10.2307/2290471; Daniele C, 1994, REGIONES NATURALES A; DeBruyn JM, 2011, APPL ENVIRON MICROB, V77, P6295, DOI 10.1128/AEM.05005-11; Deng H, 2012, J ENVIRON SCI, V24, P1027, DOI 10.1016/S1001-0742(11)60846-2; Don A, 2011, GLOBAL CHANGE BIOL, V17, P1658, DOI 10.1111/j.1365-2486.2010.02336.x; Dufrene M, 1997, ECOL MONOGR, V67, P345, DOI 10.1890/0012-9615(1997)067[0345:SAAIST]2.0.CO;2; Fierer N, 2006, P NATL ACAD SCI USA, V103, P626, DOI 10.1073/pnas.0507535103; Fierer N, 2003, SOIL BIOL BIOCHEM, V35, P167, DOI 10.1016/S0038-0717(02)00251-1; Fierer N, 2007, ECOLOGY, V88, P1354, DOI 10.1890/05-1839; Fierer N, 2012, P NATL ACAD SCI USA, V109, P21390, DOI 10.1073/pnas.1215210110; Fierer N, 2013, SCIENCE, V342, P621, DOI 10.1126/science.1243768; Figuerola ELM, 2015, ENVIRON MICROBIOL, V17, P678, DOI 10.1111/1462-2920.12497; Food and Agriculture Organization of the United Nations, 2012, STAT WORLDS FOR; Geml J, 2014, MOL ECOL, V23, P2452, DOI 10.1111/mec.12765; GOODFELLOW M, 1983, ANNU REV MICROBIOL, V37, P189, DOI 10.1146/annurev.mi.37.100183.001201; Grau HR, 2005, ENVIRON CONSERV, V32, P140, DOI 10.1017/S0376892905002092; Herlemann DPR, 2013, MBIO, V4, DOI 10.1128/mBio.00569-12; Gasparri NI, 2009, FOREST ECOL MANAG, V258, P913, DOI 10.1016/j.foreco.2009.02.024; Izquierdo AE, 2009, J ENVIRON MANAGE, V90, P858, DOI 10.1016/j.jenvman.2008.02.013; Jangid K, 2008, SOIL BIOL BIOCHEM, V40, P2843, DOI 10.1016/j.soilbio.2008.07.030; Jesus ED, 2009, ISME J, V3, P1004, DOI 10.1038/ismej.2009.47; Jones RT, 2009, ISME J, V3, P442, DOI 10.1038/ismej.2008.127; Kuo S., 1996, Methods of soil analysis. Part 3 - chemical methods., P869; Lauber CL, 2013, ISME J, V7, P1641, DOI 10.1038/ismej.2013.50; Lauber CL, 2009, APPL ENVIRON MICROB, V75, P5111, DOI 10.1128/AEM.00335-09; Lee-Cruz L, 2013, APPL ENVIRON MICROB, V79, P7290, DOI 10.1128/AEM.02541-13; Lupatini M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076465; Madsen EL, 2011, CURR OPIN BIOTECH, V22, P456, DOI 10.1016/j.copbio.2011.01.008; Malizia L., 2012, Ecosistemas, V21, P53; Montecchia MS, 2011, APPL SOIL ECOL, V47, P176, DOI 10.1016/j.apsoil.2010.12.008; Murty D, 2002, GLOBAL CHANGE BIOL, V8, P105, DOI 10.1046/j.1354-1013.2001.00459.x; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Navarrete AA, 2013, FEMS MICROBIOL ECOL, V83, P607, DOI 10.1111/1574-6941.12018; Nemergut DR, 2010, SOIL BIOL BIOCHEM, V42, P2153, DOI 10.1016/j.soilbio.2010.08.011; Olson DM, 2001, BIOSCIENCE, V51, P933, DOI 10.1641/0006-3568(2001)051[0933:TEOTWA]2.0.CO;2; Paula FS, 2014, MOL ECOL, V23, P2988, DOI 10.1111/mec.12786; Philippot L, 2013, ISME J, V7, P1609, DOI 10.1038/ismej.2013.34; R Core Team, 2021, R LANGUAGE ENV STAT; Reichenbach H, 1999, ENVIRON MICROBIOL, V1, P15, DOI 10.1046/j.1462-2920.1999.00016.x; Roberts DW, 2002, STEREOT FUNCT NEUROS, V78, P1, DOI 10.1159/000066929; Rodrigues JLM, 2013, P NATL ACAD SCI USA, V110, P988, DOI 10.1073/pnas.1220608110; Roesch LF, 2007, ISME J, V1, P283, DOI 10.1038/ismej.2007.53; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Shade A, 2012, ENVIRON MICROBIOL, V14, P4, DOI 10.1111/j.1462-2920.2011.02585.x; Shannon C.E, 1949, MATH THEORY COMMUNIC, V1st; SIMPSON EH, 1949, NATURE, V163, P688, DOI 10.1038/163688a0; Tardy V, 2014, ENV MICROBIOL REP, V6, P173, DOI 10.1111/1758-2229.12126; Tosi M, 2013, APORTES MICROBIOLOGI, P179; Tripathi BM, 2012, MICROB ECOL, V64, P474, DOI 10.1007/s00248-012-0028-8; Upchurch R, 2008, SOIL BIOL BIOCHEM, V40, P1294, DOI 10.1016/j.soilbio.2007.06.027; Volante JN, 2012, AGR ECOSYST ENVIRON, V154, P12, DOI 10.1016/j.agee.2011.08.012; Walker LR, 2010, J ECOL, V98, P725, DOI 10.1111/j.1365-2745.2010.01664.x	62	37	37	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0119426	10.1371/journal.pone.0119426	http://dx.doi.org/10.1371/journal.pone.0119426			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25793893	Green Published, gold, Green Submitted			2022-12-27	WOS:000352084200082
J	Niu, GF; Li, B; Sun, L; An, CG				Niu, Guangfeng; Li, Bin; Sun, Li; An, Chenggong			RETRACTED: MicroRNA-153 Inhibits Osteosarcoma Cells Proliferation and Invasion by Targeting TGF-beta 2 (Retracted article. See vol. 17, 2022)	PLOS ONE			English	Article; Retracted Publication							DOWN-REGULATION; TUMOR-SUPPRESSOR; GLIOBLASTOMA; METASTASIS; PROGRESSION; EXPRESSION; PTEN	Increasing evidence indicates that microRNAs (miRNAs), a class of small noncoding RNAs, participate in almost every step of cellular processes. MiRNAs are aberrantly expressed in human cancers and contribute to cancer development and progression. Study of miRNAs may provide a new clue for understanding the mechanism of carcinogenesis and a new tool for cancer treatment. In the present study, miR-153 was downregulated in human osteosarcoma tissues and cell lines. Introduction of miR-153 mimics into the MG-63 cells inhibited cell proliferation and invasion. Our results further revealed that transforming growth factor beta 2 (TGF-beta 2) was negatively regulated by miR-153. Furthermore, overexpression of miR-153 decreased p-SMAD2, p-SMAD3, epidermal growth factor receptor (EGFR) and insulin-like growth factor binding protein-3 (IGFBP-3) expressions, which were the downstream signaling molecules of TGF-beta. Furthermore, miRNA-153 suppressed TGF-beta-mediated MG-63 proliferation and migration. Therefore, our results suggest that miR-153 may act as a tumor suppressor in osteosarcoma through targeting TGF-beta 2.	[Niu, Guangfeng; Li, Bin; Sun, Li] Shandong Univ, Shandong Prov Hosp affiliated, Dept Orthopaed, Jinan 250100, Peoples R China; [An, Chenggong] Dingtao Cty Hosp, Dept Orthopaed, Dintao, Peoples R China	Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University	Li, B (corresponding author), Shandong Univ, Shandong Prov Hosp affiliated, Dept Orthopaed, Jinan 250100, Peoples R China.	lbr4de@163.com						Anaya-Ruiz M, 2013, ASIAN PAC J CANCER P, V14, P2983, DOI 10.7314/APJCP.2013.14.5.2983; Bier A, 2013, ONCOTARGET, V4, P665, DOI 10.18632/oncotarget.928; Bronnum H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056280; Chaussepied M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001197; Guo SB, 2014, TUMOR BIOL, V35, P7025, DOI 10.1007/s13277-014-1965-2; Hou CH, 2014, BIOCHEM PHARMACOL, V89, P453, DOI 10.1016/j.bcp.2014.03.010; Huang J, 2014, CELL PROLIFERAT, V47, P277, DOI 10.1111/cpr.12109; Huang JH, 2014, TUMOR BIOL, V35, P1095, DOI 10.1007/s13277-013-1146-8; Hui Wang, 2013, PLoS One, V8, pe54932, DOI 10.1371/journal.pone.0054932; Janda E, 2002, J CELL BIOL, V156, P299, DOI 10.1083/jcb.200109037; Kato M, 2009, NAT CELL BIOL, V11, P881, DOI 10.1038/ncb1897; Li HR, 2012, ONCOTARGET, V3, P1653; Li J, 2014, CELL PROLIFERAT, V47, P152, DOI 10.1111/cpr.12093; Li M, 2013, CELL PROLIFERAT, V46, P223, DOI 10.1111/cpr.12013; Li Z, 2015, GASTRIC CANCER, V18, P43, DOI 10.1007/s10120-014-0340-8; Liang WQ, 2013, FRONT BIOSCI-LANDMRK, V18, P788, DOI 10.2741/4142; Lyu XM, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-51; Matsuyama S, 2003, CANCER RES, V63, P7791; Miao J, 2013, TUMOUR BIOL; Nakashima T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014334; Namlos HM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048086; Ohdaira H, 2012, CELL PROLIFERAT, V45, P32, DOI 10.1111/j.1365-2184.2011.00798.x; Pang LJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112300; Perera M., 2010, Cancer Genomics & Proteomics, V7, P217; Schedlich LJ, 2013, MOL CELL ENDOCRINOL, V377, P56, DOI 10.1016/j.mce.2013.06.033; Schirmer U, 2014, ONCOTARGET, V5, P462, DOI 10.18632/oncotarget.1552; Shan N, 2014, BIOCH BIOPHYS RES CO; Sung JY, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.189; Taylor MA, 2013, J CLIN INVEST, V123, P150, DOI 10.1172/JCI64946; Wu ZQ, 2013, PROSTATE, V73, P596, DOI 10.1002/pros.22600; Xu HD, 2014, CELL PHYSIOL BIOCHEM, V33, P1547, DOI 10.1159/000358718; Xu Q, 2013, CARCINOGENESIS, V34, P539, DOI 10.1093/carcin/bgs374; Yang JL, 2013, CURR OPIN ONCOL, V25, P398, DOI 10.1097/CCO.0b013e3283622c1b; Yu X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083080; Yuan Y., 2014, INT J CANC; Zhang C, 2014, ONCOTARGET, V5, P9106, DOI 10.18632/oncotarget.2379; Zhang L, 2013, CANCER RES, V73, P6435, DOI 10.1158/0008-5472.CAN-12-3308; Zhao GY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053906; Zhao SG, 2013, MOL BIOL REP, V40, P2789, DOI 10.1007/s11033-012-2278-4	39	54	58	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0119225	10.1371/journal.pone.0119225	http://dx.doi.org/10.1371/journal.pone.0119225			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25793604	Green Published, Green Submitted, gold			2022-12-27	WOS:000352084200062
J	Notas, G; Bariotakis, M; Kalogrias, V; Andrianaki, M; Azariadis, K; Kampouri, E; Theodoropoulou, K; Lavrentaki, K; Kastrinakis, S; Kampa, M; Agouridakis, P; Pirintsos, S; Castanas, E				Notas, George; Bariotakis, Michail; Kalogrias, Vaios; Andrianaki, Maria; Azariadis, Kalliopi; Kampouri, Errika; Theodoropoulou, Katerina; Lavrentaki, Katerina; Kastrinakis, Stelios; Kampa, Marilena; Agouridakis, Panagiotis; Pirintsos, Stergios; Castanas, Elias			Accurate Prediction of Severe Allergic Reactions by a Small Set of Environmental Parameters (NDVI, Temperature)	PLOS ONE			English	Article							ATOPIC ECZEMA; ASTHMA; PREVALENCE; CHILDREN; SYMPTOMS; VEGETATION; CHILDHOOD; RHINITIS; CLIMATE; DISEASE	Severe allergic reactions of unknown etiology, necessitating a hospital visit, have an important impact in the life of affected individuals and impose a major economic burden to societies. The prediction of clinically severe allergic reactions would be of great importance, but current attempts have been limited by the lack of a well-founded applicable methodology and the wide spatiotemporal distribution of allergic reactions. The valid prediction of severe allergies (and especially those needing hospital treatment) in a region, could alert health authorities and implicated individuals to take appropriate preemptive measures. In the present report we have collecterd visits for serious allergic reactions of unknown etiology from two major hospitals in the island of Crete, for two distinct time periods (validation and test sets). We have used the Normalized Difference Vegetation Index (NDVI), a satellite-based, freely available measurement, which is an indicator of live green vegetation at a given geographic area, and a set of meteorological data to develop a model capable of describing and predicting severe allergic reaction frequency. Our analysis has retained NDVI and temperature as accurate identifiers and predictors of increased hospital severe allergic reactions visits. Our approach may contribute towards the development of satellite-based modules, for the prediction of severe allergic reactions in specific, well-defined geographical areas. It could also probably be used for the prediction of other environment related diseases and conditions.	[Notas, George; Andrianaki, Maria; Azariadis, Kalliopi; Kampouri, Errika; Theodoropoulou, Katerina; Lavrentaki, Katerina; Kampa, Marilena; Castanas, Elias] Univ Crete, Sch Med, Dept Expt Endocrinol, Iraklion, Greece; [Notas, George; Agouridakis, Panagiotis] Univ Crete, Sch Med, Dept Emergency Med, Iraklion, Greece; [Bariotakis, Michail; Kalogrias, Vaios; Pirintsos, Stergios] Univ Crete, Sch Sci & Technol, Dept Biol, Iraklion, Greece; [Kastrinakis, Stelios] Chania Gen Hosp, Hlth Ctr Gerani, Mournies Chania, Greece; [Pirintsos, Stergios] Univ Crete, Bot Garden, Rethimnon, Greece	University of Crete; University of Crete; University of Crete; University of Crete	Notas, G (corresponding author), Univ Crete, Sch Med, Dept Expt Endocrinol, Iraklion, Greece.	gnotas@med.uoc.gr; castanas@med.uoc.gr	Castanas, Elias/E-7007-2010; Notas, George/K-3709-2019	Castanas, Elias/0000-0002-8370-1835; Notas, George/0000-0002-2506-5252; Bariotakis, Michael/0000-0002-7624-5675; Kampouri, Eleftheria/0000-0001-8019-3073				AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Beasley R, 1998, LANCET, V351, P1225, DOI 10.1016/S0140-6736(97)07302-9; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Calcagno V, 2010, J STAT SOFTW, V34, P1; Fuertes E, 2014, ANN ALLERG ASTHMA IM, V113, P386, DOI 10.1016/j.anai.2014.06.021; Galan C, 2001, INT J BIOMETEOROL, V45, P8, DOI 10.1007/s004840000081; Geerken R, 2005, INT J REMOTE SENS, V26, P5535, DOI 10.1080/01431160500300297; Gupta R, 2004, CLIN EXP ALLERGY, V34, P520, DOI 10.1111/j.1365-2222.2004.1935.x; Holloway JW, 2010, J ALLERGY CLIN IMMUN, V125, pS81, DOI 10.1016/j.jaci.2009.10.071; Karlsen SR, 2009, AEROBIOLOGIA, V25, P15, DOI 10.1007/s10453-008-9105-3; Kiechl-Kohlendorfer U, 2007, ARCH DIS CHILD, V92, P339, DOI 10.1136/adc.2006.106278; Martiny N, 2010, THEOR APPL CLIMATOL, V100, P467, DOI 10.1007/s00704-009-0223-9; McCullagh P., 1989, GEN LINEAR MODELS, V(2nd), DOI [10.1007/978-1-4899-3242-6, https://doi.org/10.1007/978-1-4899-3242-6, DOI 10.1007/978-1-4899-3242-6]; Pettorelli N, 2005, TRENDS ECOL EVOL, V20, P503, DOI 10.1016/j.tree.2005.05.011; R Core Team, 2013, R LANG ENV STAT COMP; Spergel JM, 2010, ANN ALLERG ASTHMA IM, V105, P99, DOI 10.1016/j.anai.2009.10.002; Spiegelhalter D J, 2000, Health Technol Assess, V4, P1; Stewart AW, 2001, INT J EPIDEMIOL, V30, P173, DOI 10.1093/ije/30.1.173; Stingone JA, 2006, ANN ALLERG ASTHMA IM, V97, P244, DOI 10.1016/S1081-1206(10)60021-X; Stoms DM, 2000, INT J REMOTE SENS, V21, P401, DOI 10.1080/014311600210920; Weiland SK, 2004, OCCUP ENVIRON MED, V61, P609, DOI 10.1136/oem.2002.006809; Wong GWK, 2006, INT J TUBERC LUNG D, V10, P242; Worm M, 2010, ALLERGY, V65, P671, DOI 10.1111/j.1398-9995.2010.02332.x	23	3	3	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0121475	10.1371/journal.pone.0121475	http://dx.doi.org/10.1371/journal.pone.0121475			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25794106	Green Submitted, Green Published, gold			2022-12-27	WOS:000352083900136
J	Novak, M; Lah, L; Sala, M; Stojan, J; Bohlmann, J; Komel, R				Novak, Metka; Lah, Ljerka; Sala, Martin; Stojan, Jure; Bohlmann, Joerg; Komel, Radovan			Oleic Acid Metabolism via a Conserved Cytochrome P450 System-Mediated omega-Hydroxylation in the Bark Beetle-Associated Fungus Grosmannia clavigera	PLOS ONE			English	Article							FATTY-ACIDS; OPHIOSTOMA-PICEAE; SACCHAROMYCES-CEREVISIAE; ASPERGILLUS-NIDULANS; NEIGHBORING GENES; PINUS-CONTORTA; BETA-OXIDATION; EXPRESSION; PATHOGEN; REDUCTASE	The bark beetle-associated fungus Grosmannia clavigera participates in the large-scale destruction of pine forests. In the tree, it must tolerate saturating levels of toxic conifer defense chemicals (e.g. monoterpenes). The fungus can metabolize some of these compounds through the beta-oxidation pathway and use them as a source of carbon. It also uses carbon from pine triglycerides, where oleic acid is the most common fatty acid. High levels of free fatty acids, however, are toxic and can cause additional stress during host colonization. Fatty acids induce expression of neighboring genes encoding a cytochrome P450 (CYP630B18) and its redox partner, cytochrome P450 reductase (CPR2). The aim of this work was to study the function of this novel P450 system. Using LC/MS, we biochemically characterized CYP630 as a highly specific oleic acid.-hydroxylase. We explain oleic acid specificity using protein interaction modeling. Our results underscore the importance of omega-oxidation when the main beta-oxidation pathway may be overwhelmed by other substrates such as host terpenoid compounds. Because this CYP-CPR gene cluster is evolutionarily conserved, our work has implications for metabolism studies in other fungi.	[Novak, Metka; Lah, Ljerka; Sala, Martin; Komel, Radovan] Natl Inst Chem, SI-1000 Ljubljana, Slovenia; [Stojan, Jure] Univ Ljubljana, Fac Med, Inst Biochem, SI-1000 Ljubljana, Slovenia; [Novak, Metka; Bohlmann, Joerg] Univ British Columbia, Michael Smith Labs, Vancouver, BC V6T 1Z4, Canada	National Institute of Chemistry - Slovenia; University of Ljubljana; University of British Columbia	Lah, L (corresponding author), Univ Potsdam, Inst Biochem & Biol, Evolutionary Biol, D-14476 Potsdam, Germany.	ljerka.lah@ki.si; radovan.komel@ki.si	Novak, Metka/AAX-5743-2021; Sala, Martin/A-3250-2011	Novak, Metka/0000-0002-3041-1156; Sala, Martin/0000-0001-7845-860X	Slovenian Research Agency (ARRS) [P1-010]	Slovenian Research Agency (ARRS)(Slovenian Research Agency - Slovenia)	Project funded by the Slovenian Research Agency (ARRS) P1-010; Functional genomics and biotechnology for health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham L, 1998, CAN J MICROBIOL, V44, P698, DOI 10.1139/cjm-44-7-698; Alamouti SM, 2011, MOL ECOL, V20, P2581, DOI 10.1111/j.1365-294X.2011.05109.x; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Avis TJ, 2001, APPL ENVIRON MICROB, V67, P956, DOI 10.1128/AEM.67.2.956-960.2001; Benyagoub M, 1996, LIPIDS, V31, P1077, DOI 10.1007/BF02522465; Bohlmann J, 2012, TREE PHYSIOL, V32, P943, DOI 10.1093/treephys/tps065; Bojja RS, 2004, J AGR FOOD CHEM, V52, P2855, DOI 10.1021/jf035429z; Brase S, 2009, CHEM REV, V109, P3903, DOI 10.1021/cr050001f; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Chen WP, 2014, GENOME BIOL EVOL, V6, P1620, DOI 10.1093/gbe/evu132; Cresnar B, 2011, BBA-PROTEINS PROTEOM, V1814, P29, DOI 10.1016/j.bbapap.2010.06.020; DiGuistini S, 2011, P NATL ACAD SCI USA, V108, P2504, DOI 10.1073/pnas.1011289108; Doege H, 2006, PHYSIOLOGY, V21, P259, DOI 10.1152/physiol.00014.2006; Dorado J, 2000, J BIOTECHNOL, V80, P231, DOI 10.1016/S0168-1656(00)00264-9; Ebersberger I, 2012, MOL BIOL EVOL, V29, P1319, DOI 10.1093/molbev/msr285; Eschenfeldt WH, 2003, APPL ENVIRON MICROB, V69, P5992, DOI 10.1128/AEM.69.10.5992-5999.2003; Feng J, 2011, PLANT PATHOL, V60, P698, DOI 10.1111/j.1365-3059.2011.02434.x; Fleet C, 2001, HOLZFORSCHUNG, V55, P340, DOI 10.1515/HF.2001.057; Gabriel F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114531; GAO Y, 1995, WORLD J MICROB BIOT, V11, P638, DOI 10.1007/BF00361006; GAO Y, 1995, HOLZFORSCHUNG, V49, P20, DOI 10.1515/hfsg.1995.49.1.20; GARG AP, 1993, MYCOSES, V36, P51, DOI 10.1111/j.1439-0507.1993.tb00687.x; GRAHAMLORENCE S, 1995, PROTEIN SCI, V4, P1065, DOI 10.1002/pro.5560040605; Grauslund M, 1999, NUCLEIC ACIDS RES, V27, P4391, DOI 10.1093/nar/27.22.4391; GRAY SN, 1990, FEMS MICROBIOL LETT, V68, P131, DOI 10.1111/j.1574-6968.1990.tb04136.x; Gruber S, 2012, MICROBIOL-SGM, V158, P26, DOI 10.1099/mic.0.052613-0; Hamann T, 2007, PROTEIN EXPRES PURIF, V56, P121, DOI 10.1016/j.pep.2007.06.007; Haridas S, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-373; Hesse-Orce U, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-536; Hiltunen JK, 2003, FEMS MICROBIOL REV, V27, P35, DOI 10.1016/S0168-6445(03)00017-2; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Hynes MJ, 2011, EUKARYOT CELL, V10, P547, DOI 10.1128/EC.00295-10; Jacquier N, 2010, J CELL SCI, V123, P2218, DOI 10.1242/jcs.063073; Kelly DE, 2009, FUNGAL GENET BIOL, V46, pS53, DOI 10.1016/j.fgb.2008.08.010; Kim D, 2007, ARCH BIOCHEM BIOPHYS, V464, P213, DOI 10.1016/j.abb.2007.02.032; Kitazume T, 2002, EUR J BIOCHEM, V269, P2075, DOI 10.1046/j.1432-1033.2002.02855.x; Kitazume T, 2008, APPL MICROBIOL BIOT, V79, P981, DOI 10.1007/s00253-008-1513-3; Konc J, 2010, BIOINFORMATICS, V26, P1160, DOI 10.1093/bioinformatics/btq100; Kubicek CP, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-r40; Lah L, 2008, FUNGAL GENET BIOL, V45, P446, DOI 10.1016/j.fgb.2007.10.004; Lah L, 2013, FUNGAL GENET BIOL, V50, P72, DOI 10.1016/j.fgb.2012.10.002; Lah L, 2011, MOL MICROBIOL, V81, P1374, DOI 10.1111/j.1365-2958.2011.07772.x; LARM JA, 1994, J BIOL CHEM, V269, P30097; Lyskov S, 2008, NUCLEIC ACIDS RES, V36, pW233, DOI 10.1093/nar/gkn216; Maggio-Hall LA, 2004, MOL MICROBIOL, V54, P1173, DOI 10.1111/j.1365-2958.2004.04340.x; McGary KL, 2013, P NATL ACAD SCI USA, V110, P11481, DOI 10.1073/pnas.1304461110; Michalak P, 2008, GENOMICS, V91, P243, DOI 10.1016/j.ygeno.2007.11.002; Moktali V, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-525; Munro AW, 2002, TRENDS BIOCHEM SCI, V27, P250, DOI 10.1016/S0968-0004(02)02086-8; Nakayam J, 2001, SCIENCE, V292, P110, DOI 10.1126/science.1060118; Nakayama N, 1996, J BIOCHEM-TOKYO, V119, P435; Nelson D., 2005, LEHNINGER PRINCIPLES, P647; Nicol RW, 2012, APPL MICROBIOL BIOT, V93, P1865, DOI 10.1007/s00253-012-3921-7; Oh Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-5-r85; Park HG, 2010, BIOCHEM BIOPH RES CO, V396, P534, DOI 10.1016/j.bbrc.2010.04.138; Podobnik B, 2008, J MED CHEM, V51, P3480, DOI 10.1021/jm800030e; Pompon D, 1996, METHOD ENZYMOL, V272, P51, DOI 10.1016/S0076-6879(96)72008-6; Scheller U, 1998, J BIOL CHEM, V273, P32528, DOI 10.1074/jbc.273.49.32528; Scheller U, 1996, ARCH BIOCHEM BIOPHYS, V328; Smith CA, 2006, ANAL CHEM, V78, P779, DOI 10.1021/ac051437y; Syed K, 2013, APPL ENVIRON MICROB, V79, P2692, DOI 10.1128/AEM.03767-12; Syed K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028286; Tautenhahn R, 2012, ANAL CHEM, V84, P5035, DOI 10.1021/ac300698c; Thomas MC, 2012, ANAL CHEM, V84, P5976, DOI 10.1021/ac3006523; Wang GZ, 2011, GENOME BIOL EVOL, V3, P320, DOI [10.1093/gbe/evr049, 10.1093/gbe/evr025]; Wang Y, 2014, APPL ENVIRON MICROB; Wang Y, 2013, NEW PHYTOL, V197, P886, DOI 10.1111/nph.12063; Warrilow AGS, 2002, BIOCHEM BIOPH RES CO, V299, P189, DOI 10.1016/S0006-291X(02)02600-1; Watkins PA, 2008, J BIOL CHEM, V283, P1773, DOI 10.1074/jbc.R700037200; Yim SK, 2004, J BIOCHEM MOL BIOL, V37, P629; Zimmer T, 1998, EUR J BIOCHEM, V256, P398, DOI 10.1046/j.1432-1327.1998.2560398.x	71	11	12	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0120119	10.1371/journal.pone.0120119	http://dx.doi.org/10.1371/journal.pone.0120119			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25794012	Green Submitted, Green Published, gold			2022-12-27	WOS:000352084200147
J	Povinelli, BJ; Kokolus, KM; Eng, JWL; Dougher, CW; Curtin, L; Capitano, ML; Sailsbury-Ruf, CT; Repasky, EA; Nemeth, MJ				Povinelli, Benjamin J.; Kokolus, Kathleen M.; Eng, Jason W. -L.; Dougher, Christopher W.; Curtin, Leslie; Capitano, Maegan L.; Sailsbury-Ruf, Christi T.; Repasky, Elizabeth A.; Nemeth, Michael J.			Standard Sub-Thermoneutral Caging Temperature Influences Radiosensitivity of Hematopoietic Stem and Progenitor Cells	PLOS ONE			English	Article							BETA-ADRENERGIC STIMULATION; PANCREATIC-CANCER CELLS; WHOLE-BODY HYPERTHERMIA; MILD COLD-STRESS; LABORATORY MICE; BONE; THERMOGENESIS; INDUCTION; APOPTOSIS; RATS	The production of new blood cells relies on a hierarchical network of hematopoietic stem and progenitor cells (HSPCs). To maintain lifelong hematopoiesis, HSPCs must be protected from ionizing radiation or other cytotoxic agents. For many years, murine models have been a valuable source of information regarding factors that either enhance or reduce the survival of HSPCs after exposure of marrow to ionizing radiation. In a recent series of studies, however, it has become clear that housing-related factors such as the cool room temperature required for laboratory mice can exert a surprising influence on the outcome of experiments. Here we report that the mild, but chronic cold-stress endured by mice housed under these conditions exerts a protective effect on HSPCs after both non-lethal and lethal doses of total body irradiation (TBI). Alleviation of this cold-stress by housing mice at a thermoneutral temperature (30 degrees C) resulted in significantly greater baseline radiosensitivity to a lethal dose of TBI with more HSPCs from mice housed at thermoneutral temperature undergoing apoptosis following non-lethal TBI. Cold-stressed mice have elevated levels of norepinephrine, a key molecule of the sympathetic nervous system that binds to beta-adrenergic receptors. We show that blocking this signaling pathway in vivo through use of the beta-blocker propanolol completely mitigates the protective effect of cold-stress on HSPC apoptosis. Collectively this study demonstrates that chronic stress endured by the standard housing conditions of laboratory mice increases the resistance of HSPCs to TBI-induced apoptosis through a mechanism that depends upon beta-adrenergic signaling. Since beta-blockers are commonly prescribed to a wide variety of patients, this information could be important when predicting the clinical impact of HSPC sensitivity to TBI.	[Povinelli, Benjamin J.] Roswell Pk Canc Inst, Dept Mol & Cellular Biol, Buffalo, NY 14263 USA; [Kokolus, Kathleen M.; Eng, Jason W. -L.; Dougher, Christopher W.; Capitano, Maegan L.; Sailsbury-Ruf, Christi T.; Repasky, Elizabeth A.; Nemeth, Michael J.] Roswell Pk Canc Inst, Dept Immunol, Buffalo, NY 14263 USA; [Curtin, Leslie] Roswell Pk Canc Inst, Dept Lab Anim Resources, Buffalo, NY 14263 USA; [Nemeth, Michael J.] Roswell Pk Canc Inst, Dept Med, Buffalo, NY 14263 USA	Roswell Park Cancer Institute; Roswell Park Cancer Institute; Roswell Park Cancer Institute; Roswell Park Cancer Institute	Nemeth, MJ (corresponding author), Roswell Pk Canc Inst, Dept Immunol, Elm & Carlton St, Buffalo, NY 14263 USA.	Michael.Nemeth@RoswellPark.org	Kokolus, Kathleen M./I-8779-2019; Salisbury-Ruf, Christi/AAJ-9353-2020	Kokolus, Kathleen M./0000-0002-9088-5409; Salisbury-Ruf, Christi/0000-0003-2163-5876; Eng, Jason/0000-0002-8219-2290	National Institutes of Health [R01CA135368, R01 T32 CA085183]; Roswell Park Development Funds; NATIONAL CANCER INSTITUTE [P30CA016056, R01CA135368] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Roswell Park Development Funds; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Institutes of Health R01CA135368 to EAR, National Institutes of Health R01 T32 CA085183 to JW-LE and KMK, and Roswell Park Development Funds to BJP and MJN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartke A, 2013, ENDOKRYNOL POL, V64, P46; Bartke Andrzej, 2012, Frontiers in Genetics, V3, P288, DOI 10.3389/fgene.2012.00288; BENVENUTO R, 1960, Surg Forum, V10, P558; Blumberg MS, 2004, BODY HEAT TEMPERATUR; Boon MR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074083; BYRON JW, 1972, EXP CELL RES, V71, P228, DOI 10.1016/0014-4827(72)90283-2; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Cannon B, 2011, J EXP BIOL, V214, P242, DOI 10.1242/jeb.050989; Cannon B, 2009, P NUTR SOC, V68, P401, DOI 10.1017/S0029665109990255; Capitano ML, 2012, BLOOD, V120, P2600, DOI 10.1182/blood-2012-02-409805; Casarett AP, 1968, RAD BIOL; Cummings KJ, 2009, AM J PHYSIOL-REG I, V297, pR124, DOI 10.1152/ajpregu.91011.2008; Dacks PA, 2010, ENDOCRINOLOGY, V151, P1187, DOI 10.1210/en.2009-1112; Dainiak Nicholas, 2003, Hematology Am Soc Hematol Educ Program, P473; David JM, 2013, COMPARATIVE MED, V63, P386; DEPOCAS F, 1960, CAN J BIOCHEM PHYS, V38, P107, DOI 10.1139/o60-012; Eng JWL, 2014, INT J HYPERTHER, V30, P540, DOI 10.3109/02656736.2014.981300; Eng JW-L, 2014, NAT COMMUN IN PRESS; Feldmann HM, 2009, CELL METAB, V9, P203, DOI 10.1016/j.cmet.2008.12.014; Flowers MT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019734; Garami A, 2011, J NEUROSCI, V31, P1721, DOI 10.1523/JNEUROSCI.4671-10.2011; Gaskill BN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032799; Gordon CJ, 2012, J THERM BIOL, V37, P654, DOI 10.1016/j.jtherbio.2012.08.004; Gordon CJ, 2014, J THERM BIOL, V44, P41, DOI 10.1016/j.jtherbio.2014.06.006; Hassan S, 2013, J CLIN INVEST, V123, P874, DOI 10.1172/JCI63324; HORNSEY S, 1957, PROC R SOC SER B-BIO, V147, P547, DOI 10.1098/rspb.1957.0080; HSIEH ACL, 1957, AM J PHYSIOL, V190, P243, DOI 10.1152/ajplegacy.1957.190.2.243; JELKMANN W, 1980, EXP HEMATOL, V8, P742; Katayama Y, 2006, CELL, V124, P407, DOI 10.1016/j.cell.2005.10.041; Kokolus KM, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00023; Kokolus KM, 2013, P NATL ACAD SCI USA, V110, P20176, DOI 10.1073/pnas.1304291110; Kondo M, 2003, ANNU REV IMMUNOL, V21, P759, DOI 10.1146/annurev.immunol.21.120601.141007; LIPSKI S, 1976, INT J RADIAT BIOL, V29, P359, DOI 10.1080/09553007614550411; Lo Martire V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047032; Lutaif NA, 2008, NEPHROL DIAL TRANSPL, V23, P3798, DOI 10.1093/ndt/gfn368; Maestroni GJM, 1997, EXP HEMATOL, V25, P491; Mallick Hruda Nanda, 2012, Front Neurol, V3, P102, DOI 10.3389/fneur.2012.00102; Maloney SK, 2014, PHYSIOLOGY, V29, P413, DOI 10.1152/physiol.00029.2014; MAUCH P, 1995, INT J RADIAT ONCOL, V31, P1319, DOI 10.1016/0360-3016(94)00430-S; Mendez-Ferrer S, 2008, NATURE, V452, P442, DOI 10.1038/nature06685; Mendez-Ferrer S, 2010, ANN NY ACAD SCI, V1192, P139, DOI 10.1111/j.1749-6632.2010.05390.x; Messmer MN, 2014, BIOESSAYS, V36, P884, DOI 10.1002/bies.201400066; Mohrin M, 2010, CELL STEM CELL, V7, P174, DOI 10.1016/j.stem.2010.06.014; Muthu K, 2005, J NEUROIMMUNOL, V165, P129, DOI 10.1016/j.jneuroim.2005.04.015; National Research Council, 2011, GUIDE CARE USE LAB A; Nguyen KD, 2011, NATURE, V480, P104, DOI 10.1038/nature10653; Oguro H, 2013, CELL STEM CELL, V13, P102, DOI 10.1016/j.stem.2013.05.014; OKADA S, 1992, BLOOD, V80, P3044; Povinelli BJ, 2014, STEM CELLS, V32, P105, DOI 10.1002/stem.1513; Powell ND, 2013, P NATL ACAD SCI USA, V110, P16574, DOI 10.1073/pnas.1310655110; Ramanantsoa N, 2011, FRONT PHYSIOL, V2, DOI 10.3389/fphys.2011.00061; Ravussin Y, 2012, AM J PHYSIOL-REG I, V303, pR438, DOI 10.1152/ajpregu.00092.2012; Sastry KSR, 2007, J BIOL CHEM, V282, P14094, DOI 10.1074/jbc.M611370200; Serrat MA, 2014, COMPR PHYSIOL, V4, P621, DOI 10.1002/cphy.c130023; Serrat MA, 2008, P NATL ACAD SCI USA, V105, P19348, DOI 10.1073/pnas.0803319105; Shan T, 2011, EUR J PHARMACOL, V665, P1, DOI 10.1016/j.ejphar.2011.04.055; SHEN RN, 1991, INT J RADIAT ONCOL, V20, P525, DOI 10.1016/0360-3016(91)90065-C; Spiegel A, 2007, NAT IMMUNOL, V8, P1123, DOI 10.1038/ni1509; Swoap SJ, 2008, AM J PHYSIOL-HEART C, V294, pH1581, DOI 10.1152/ajpheart.01000.2007; Uchida K, 2010, PFLUG ARCH EUR J PHY, V459, P765, DOI 10.1007/s00424-010-0795-3; Virtue S, 2012, CELL METAB, V16, P665, DOI 10.1016/j.cmet.2012.10.008; Wang Y, 2006, BLOOD, V107, P358, DOI 10.1182/blood-2005-04-1418; Wang Y, 2010, FREE RADICAL BIO MED, V48, P348, DOI 10.1016/j.freeradbiomed.2009.11.005; Zaidi AK, 2002, J THERM BIOL, V27, P29, DOI 10.1016/S0306-4565(01)00012-2; Zhang D, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-146	65	13	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0120078	10.1371/journal.pone.0120078	http://dx.doi.org/10.1371/journal.pone.0120078			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25793392	Green Submitted, gold, Green Published			2022-12-27	WOS:000352084200141
J	Smith, D; Leary, P; Craggs, J; Bythell, J; Sweet, M				Smith, David; Leary, Peter; Craggs, Jamie; Bythell, John; Sweet, Michael			Microbial Communities Associated with Healthy and White Syndrome-Affected Echinopora lamellosa in Aquaria and Experimental Treatment with the Antibiotic Ampicillin	PLOS ONE			English	Article							BROWN BAND DISEASE; BACTERIAL COMMUNITIES; ANTIMICROBIAL PROPERTIES; CORAL DISEASE; REEF CORAL; CILIATE; PHAEOBACTER; DYNAMICS; IDENTIFICATION; DRIVERS	Prokaryotic and ciliate communities of healthy and aquarium White Syndrome (WS)-affected coral fragments were screened using denaturing gradient gel electrophoresis (DGGE). A significant difference (R = 0.907, p < 0.001) in 16S rRNA prokaryotic diversity was found between healthy (H), sloughed tissue (ST), WS-affected (WSU) and antibiotic treated (WST) samples. Although 3 Vibrio spp were found in WS-affected samples, two of these species were eliminated following ampicillin treatment, yet lesions continued to advance, suggesting they play a minor or secondary role in the pathogenesis. The third Vibrio sp increased slightly in relative abundance in diseased samples and was abundant in non-diseased samples. Interestingly, a Tenacibaculum sp showed the greatest increase in relative abundance between healthy and WS-affected samples, demonstrating consistently high abundance across all WS-affected and treated samples, suggesting Tenacibaculum sp could be a more likely candidate for pathogenesis in this instance. In contrast to previous studies bacterial abundance did not vary significantly (ANOVA, F2, 6 = 1.000, p = 0.422) between H, ST, WSU or WST. Antimicrobial activity (assessed on Vibrio harveyi cultures) was limited in both H and WSU samples (8.1% +/- 8.2 and 8.0% +/- 2.5, respectively) and did not differ significantly (Kruskal-Wallis, chi(2) (2) = 3.842, p = 0.146). A Philaster sp, a Cohnilembus sp and a Pseudokeronopsis sp. were present in all WS-affected samples, but not in healthy samples. The exact role of ciliates in WS is yet to be determined, but it is proposed that they are at least responsible for the neat lesion boundary observed in the disease.	[Smith, David; Leary, Peter; Bythell, John; Sweet, Michael] Newcastle Univ, Sch Biol, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Smith, David] Queens Univ Belfast, Ctr Med Biol, Sch Biol Sci, Belfast BT9 7BL, Antrim, North Ireland; [Craggs, Jamie] Horniman Museum & Gardens Aquarium, London SE23 3PQ, England; [Sweet, Michael] Univ Derby, Biol Sci Res Grp, Derby DE22 1GB, England	Newcastle University - UK; Queens University Belfast; University of Derby	Smith, D (corresponding author), Newcastle Univ, Sch Biol, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	dsmith37@qub.ac.uk	Bythell, John/ABE-6138-2021; Bythell, John C/E-7962-2010; Smith, David/AAH-4738-2020; Sweet, Michael/E-9661-2012	Bythell, John/0000-0003-2416-9786; Bythell, John C/0000-0003-2416-9786; Smith, David/0000-0002-5158-0522; Craggs, Jamie/0000-0002-3787-2203; Sweet, Michael/0000-0003-4983-8333	Natural Environment Research Council [NE/H020616/1]; NERC [NE/H020616/1] Funding Source: UKRI	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	Funding: This work was supported by the Natural Environment Research Council grant (NE/H020616/1) (www.nerc.ac.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abd El-Galil M., 2012, INT J ENV SCI ENG, V3, P25; Aeby GS, 2010, DIS AQUAT ORGAN, V91, P1, DOI 10.3354/dao02247; [Anonymous], 2011, PLOS PATHOG; Avendano-Herrera R, 2006, DIS AQUAT ORGAN, V71, P255, DOI 10.3354/dao071255; Bourne DG, 2008, APPL ENVIRON MICROB, V74, P883, DOI 10.1128/AEM.01124-07; BROCK TD, 1972, ARCH MIKROBIOL, V84, P54, DOI 10.1007/BF00408082; Bruno JF, 2007, PLOS BIOL, V5, P1220, DOI 10.1371/journal.pbio.0050124; Clarke KR, 2001, MAR ECOL PROG SER, V216, P265, DOI 10.3354/meps216265; Croquer A, 2013, ENV MICROBIOL REP, V5, P90, DOI 10.1111/j.1758-2229.2012.00397.x; D'Alvise PW, 2013, AQUACULTURE, V384, P82, DOI 10.1016/j.aquaculture.2012.12.013; D'Alvise PW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043996; Dalton SJ, 2010, MAR FRESHWATER RES, V61, P342, DOI 10.1071/MF09060; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Foden W, SPECIES SUSCEPTIBILI, P77; Gochfeld DJ, 2011, VARIABILITY ANTIBACT; GUNTHORPE L, 1990, TOXICON, V28, P1199, DOI 10.1016/0041-0101(90)90120-V; Harder T, 2008, FEMS MICROBIOLOGY EC, V43, P337; Harvell CD, 1999, SCIENCE, V285, P1505, DOI 10.1126/science.285.5433.1505; Harvell CD, 2002, SCIENCE, V296, P2158, DOI 10.1126/science.1063699; Harvell D, 2007, OCEANOGRAPHY, V20, P172, DOI 10.5670/oceanog.2007.91; Harvell D, 2009, ECOLOGY, V90, P912, DOI 10.1890/08-0616.1; Hayes RL, 1998, REV BIOL TROP, V46, P173; Janse I, 2004, J MICROBIOL METH, V57, P279, DOI 10.1016/j.mimet.2003.12.006; Jousset A, 2010, SCI TOTAL ENVIRON, V408, P1221, DOI 10.1016/j.scitotenv.2009.09.056; Kennedy J, 2009, MAR BIOTECHNOL, V11, P384, DOI 10.1007/s10126-008-9154-1; Kumar K.S., 2011, RES J MICROBIOL, V6, P385; Kvennefors ECE, 2012, MICROB ECOL, V63, P605, DOI 10.1007/s00248-011-9946-0; Luna GM, 2007, ENVIRON MICROBIOL, V9, P1851, DOI 10.1111/j.1462-2920.2007.01287.x; Luna GM, 2010, ENV MICROBIOL REP, V2, P120, DOI 10.1111/j.1758-2229.2009.00114.x; Manivasagan P, 2009, ADV BIOL RES, V3, P231; Marquis CP, 2005, CORAL REEFS, V24, P248, DOI 10.1007/s00338-005-0473-7; Messick GA, 1996, INVERTEBR BIOL, V115, P1, DOI 10.2307/3226937; Morado JF, 1999, DIS AQUAT ORGAN, V38, P143, DOI 10.3354/dao038143; MUSCATINE L, 1989, PROC R SOC SER B-BIO, V236, P311, DOI 10.1098/rspb.1989.0025; Muyzer G, 1998, ANTON LEEUW INT J G, V73, P127, DOI 10.1023/A:1000669317571; Nissimov J, 2009, FEMS MICROBIOL LETT, V292, P210, DOI 10.1111/j.1574-6968.2009.01490.x; Piskorska M, 2007, AFRICAN J ENV SCI TE, V1, P93; Porsby CH, 2008, APPL ENVIRON MICROB, V74, P7356, DOI 10.1128/AEM.01738-08; Prado S, 2009, INT MICROBIOL, V12, P107, DOI 10.2436/20.1501.01.87; Qin L, 2007, ACTA HYDROBIOL, V31, P622; Radjasa OK, 2008, MICROBIOLOGY INDONES, V2, P84; Raina JB, 2009, APPL ENVIRON MICROB, V75, P3492, DOI 10.1128/AEM.02567-08; Reshef L, 2006, ENVIRON MICROBIOL, V8, P2068, DOI 10.1111/j.1462-2920.2006.01148.x; Rosenberg E, 2002, ENVIRON MICROBIOL, V4, P318, DOI 10.1046/j.1462-2920.2002.00302.x; Rosenberg E, 2007, NAT REV MICROBIOL, V5, P355, DOI 10.1038/nrmicro1635; Sato Y, 2010, ISME J, V4, P203, DOI 10.1038/ismej.2009.103; Scanlan PD, 2008, ISME J, V2, P1183, DOI 10.1038/ismej.2008.76; Selinummi J, 2005, BIOTECHNIQUES, V39, P859, DOI 10.2144/000112018; Shimeta J, 2001, LIMNOL OCEANOGR, V46, P1709, DOI 10.4319/lo.2001.46.7.1709; Shnit-Orland M, 2009, FEMS MICROBIOL ECOL, V67, P371, DOI 10.1111/j.1574-6941.2008.00644.x; Small HJ, 2005, DIS AQUAT ORGAN, V67, P225, DOI 10.3354/dao067225; Smith D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097018; Sokolow S, 2009, DIS AQUAT ORGAN, V87, P5, DOI 10.3354/dao02099; Sunagawa S, 2009, ISME J, V3, P512, DOI 10.1038/ismej.2008.131; Sussman M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002393; Sussman M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004511; Sweet M, 2015, MOL ECOLOGY IN PRESS; Sweet MJ, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0094; Sweet MJ, 2011, CORAL REEFS, V30, P1121, DOI 10.1007/s00338-011-0800-0; Sweet M, 2012, ENVIRON MICROBIOL, V14, P2184, DOI 10.1111/j.1462-2920.2012.02746.x; Sweet M, 2012, J MAR BIOL ASSOC UK, V92, P791, DOI 10.1017/S0025315411001688; Sweet MJ, 2010, AQUAT MICROB ECOL, V61, P1, DOI 10.3354/ame01433; Sweet MJ, 2013, J EXPT ANAL BEHAV, V1, P1; Ushijima B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046717; WAGNER M, 1993, APPL ENVIRON MICROB, V59, P1520, DOI 10.1128/AEM.59.5.1520-1525.1993; Willis BL, 2004, CORAL HEALTH AND DISEASE, P69	66	6	6	3	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0121780	10.1371/journal.pone.0121780	http://dx.doi.org/10.1371/journal.pone.0121780			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25794037	Green Published, Green Submitted, gold			2022-12-27	WOS:000352083900154
J	Testa, R; Vanhooren, V; Bonfigli, AR; Boemi, M; Olivieri, F; Ceriello, A; Genovese, S; Spazzafumo, L; Borelli, V; Bacalini, MG; Salvioli, S; Garagnani, P; Dewaele, S; Libert, C; Franceschi, C				Testa, Roberto; Vanhooren, Valerie; Bonfigli, Anna Rita; Boemi, Massimo; Olivieri, Fabiola; Ceriello, Antonio; Genovese, Stefano; Spazzafumo, Liana; Borelli, Vincenzo; Bacalini, Maria Giulia; Salvioli, Stefano; Garagnani, Paolo; Dewaele, Sylviane; Libert, Claude; Franceschi, Claudio			N-Glycomic Changes in Serum Proteins in Type 2 Diabetes Mellitus Correlate with Complications and with Metabolic Syndrome Parameters	PLOS ONE			English	Article							O-GLCNAC MODIFICATION; INSULIN-RESISTANCE; GLYCOSYLATION; GLYCAN; GLYCOPROTEIN; OLIGOSACCHARIDES; MECHANISMS; PATHWAY; BLOOD; MICE	Background Glycosylation, i.e the enzymatic addition of oligosaccharides (or glycans) to proteins and lipids, known as glycosylation, is one of the most common co-/posttranslational modifications of proteins. Many important biological roles of glycoproteins are modulated by N-linked oligosaccharides. As glucose levels can affect the pathways leading to glycosylation of proteins, we investigated whether metabolic syndrome (MS) and type 2 diabetes mellitus (T2DM), pathological conditions characterized by altered glucose levels, are associated with specific modifications in serum N-glycome. Methods We enrolled in the study 562 patients with Type 2 Diabetes Mellitus (T2DM) (mean age 65.6 +/- 8.2 years) and 599 healthy control subjects (CTRs) (mean age, 58.5 +/- 12.4 years). N-glycome was evaluated in serum glycoproteins. Results We found significant changes in N-glycan composition in the sera of T2DM patients. In particular, alpha(1,6)-linked arm monogalactosylated, core-fucosylated diantennary N-glycans (NG1(6)A2F) were significantly reduced in T2DM compared with CTR subjects. Importantly, they were equally reduced in diabetic patients with and without complications (P<0.001) compared with CTRs. Macro vascular-complications were found to be related with decreased levels of NG1(6) A2F. In addition, NG1(6) A2F and NG1(3) A2F, identifying, respectively, monogalactosylated N-glycans with alpha(1,6)- and alpha(1,3)-antennary galactosylation, resulted strongly correlated with most MS parameters. The plasmatic levels of these two glycans were lower in T2DM as compared to healthy controls, and even lower in patients with complications and MS, that is the extreme "unhealthy" phenotype (T2DM+ with MS). Conclusions Imbalance of glycosyltransferases, glycosidases and sugar nucleotide donor levels is able to cause the structural changes evidenced by our findings. Serum N-glycan profiles are thus sensitive to the presence of diabetes and MS. Serum N-glycan levels could therefore provide a non-invasive alternative marker for T2DM and MS.	[Testa, Roberto] INRCA Ancona, Expt Models Clin Pathol, I-60127 Ancona, Italy; [Vanhooren, Valerie; Dewaele, Sylviane; Libert, Claude] VIB Inflammat Res Ctr, B-9052 Ghent, Belgium; [Vanhooren, Valerie; Dewaele, Sylviane; Libert, Claude] Univ Ghent, Dept Mol Biol, B-9052 Ghent, Belgium; [Bonfigli, Anna Rita] INRCA Ancona, Sci Direct, I-60124 Ancona, Italy; [Boemi, Massimo] INRCA Ancona, Metab Dis & Diabetol Unit, I-60127 Ancona, Italy; [Olivieri, Fabiola] Univ Politecn Marche, Dept Clin & Mol Sci, I-60020 Ancona, Italy; [Olivieri, Fabiola] INRCA Ancona, Ctr Clin Pathol & Innovat Therapy, I-60127 Ancona, Italy; [Ceriello, Antonio] Inst Invest Biomed August Pi & Sunyer IDIBAPS, Barcelona 08036, Spain; [Ceriello, Antonio] Ctr Invest Biomed Red Diabet & Enfermedades Metab, Barcelona 08017, Spain; [Genovese, Stefano] IRCCS Grp Multimed Sesto San Giovanni MI, Dept Cardiovasc & Metab Dis, I-20099 Sesto San Giovanni, Italy; [Spazzafumo, Liana] INRCA Ancona, Ctr Biostat, I-60124 Ancona, Italy; [Borelli, Vincenzo; Bacalini, Maria Giulia; Salvioli, Stefano; Garagnani, Paolo; Franceschi, Claudio] Univ Bologna, Dept Expt Diagnost & Specialty Med Expt Pathol, I-40126 Bologna, Italy; [Garagnani, Paolo; Franceschi, Claudio] St Orsola Malpighi Univ Hosp, Ctr Appl Biomed Res, I-40138 Bologna, Italy; [Garagnani, Paolo; Franceschi, Claudio] Univ Bologna, Interdept Ctr L Galvani CIG, I-40126 Bologna, Italy; [Franceschi, Claudio] Inst Neurol Sci Bologna, IRCCS, I-40124 Bologna, Italy	IRCCS INRCA; Flanders Institute for Biotechnology (VIB); Ghent University; IRCCS INRCA; IRCCS INRCA; Marche Polytechnic University; IRCCS INRCA; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM; IRCCS INRCA; University of Bologna; IRCCS Azienda Ospedaliero-Universitaria di Bologna; University of Bologna; IRCCS Istituto delle Scienze Neurologiche di Bologna (ISNB)	Testa, R (corresponding author), INRCA Ancona, Expt Models Clin Pathol, I-60127 Ancona, Italy.	r.testa@inrca.it	Bonfigli, Anna Rita R/J-7248-2016; Spazzafumo, Liana/E-5488-2015; Bacalini, Maria Giulia/K-4931-2016; Ceriello, Antonio/J-9575-2016; Testa, Roberto/ABH-7467-2020; Salvioli, Stefano/K-6663-2016; Olivieri, Fabiola/K-6465-2016; Franceschi, Claudio/L-4484-2017; Genovese, Stefano/F-9706-2017	Bonfigli, Anna Rita R/0000-0002-9619-0181; Bacalini, Maria Giulia/0000-0003-1618-2673; Testa, Roberto/0000-0001-8308-7663; Salvioli, Stefano/0000-0002-6191-1225; Olivieri, Fabiola/0000-0002-9606-1144; Franceschi, Claudio/0000-0001-9841-6386; Ceriello, Antonio/0000-0001-8122-3203; Garagnani, Paolo/0000-0002-4161-3626; Genovese, Stefano/0000-0002-6085-437X; Spazzafumo, Liana/0000-0002-9718-1658				Alberti KGMM, 2006, DIABETIC MED, V23, P469, DOI 10.1111/j.1464-5491.2006.01858.x; American Diabetes Association, 2007, Diabetes Care, V30 Suppl 1, pS42; Bunz SC, 2013, ANAL CHEM, V85, P10218, DOI 10.1021/ac401930j; Buse MG, 2006, AM J PHYSIOL-ENDOC M, V290, pE1, DOI 10.1152/ajpendo.00329.2005; Callewaert N, 2001, GLYCOBIOLOGY, V11, P275, DOI 10.1093/glycob/11.4.275; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Dall'Olio F, 2011, SPR CARB CH, V37, P21, DOI 10.1039/9781849732765-00021; Dall'Olio F, 2013, AGEING RES REV, V12, P685, DOI 10.1016/j.arr.2012.02.002; Dall'Olio F, 2012, FRONT BIOSCI-LANDMRK, V17, P670, DOI 10.2741/3951; Dias WB, 2007, MOL BIOSYST, V3, P766, DOI 10.1039/b704905f; Durand G, 2000, CLIN CHEM, V46, P795; Eckel RH, 2005, LANCET, V365, P1415, DOI 10.1016/S0140-6736(05)66378-7; Einarsdottir HK, 2013, GLYCOCONJUGATE J, V30, P147, DOI 10.1007/s10719-012-9381-6; Ellis TP, 2013, CURR DIABETES REV, V9, P146, DOI 10.2174/1573399811309020006; Gornik O, 2009, GLYCOBIOLOGY, V19, P1547, DOI 10.1093/glycob/cwp134; Haltiwanger RS, 1997, BIOCHEM BIOPH RES CO, V231, P237, DOI 10.1006/bbrc.1997.6110; Higai K, 2003, CLIN CHIM ACTA, V329, P117, DOI 10.1016/S0009-8981(02)00427-8; Hu G, 2004, ARCH INTERN MED, V164, P1066, DOI 10.1001/archinte.164.10.1066; Issad T, 2010, DIABETES METAB, V36, P423, DOI 10.1016/j.diabet.2010.09.001; Itoh N, 2007, AM J PHYSIOL-ENDOC M, V293, pE1069, DOI 10.1152/ajpendo.00182.2007; Jenkins N, 1996, NAT BIOTECHNOL, V14, P975, DOI 10.1038/nbt0896-975; Kobata A, 2003, BIOCHIMIE, V85, P13, DOI 10.1016/S0300-9084(03)00003-8; Laroy W, 2006, NAT PROTOC, V1, P397, DOI 10.1038/nprot.2006.60; LEE LPK, 1977, CLIN BIOCHEM, V10, P111, DOI 10.1016/S0009-9120(77)91508-9; Lefebvre T, 2010, BBA-GEN SUBJECTS, V1800, P67, DOI 10.1016/j.bbagen.2009.08.008; Leibowitz A, 2009, DIABETES CARE, V32, pS275, DOI 10.2337/dc09-S323; Liu XE, 2007, HEPATOLOGY, V46, P1426, DOI 10.1002/hep.21855; Lunde IG, 2012, PHYSIOL GENOMICS, V44, P162, DOI 10.1152/physiolgenomics.00016.2011; MARSHALL S, 1991, J BIOL CHEM, V266, P4706; MCMILLAN DE, 1972, DIABETES, V21, P863, DOI 10.2337/diab.21.8.863; Myslicki JP, 2014, DIABETOL METAB SYNDR, V6, DOI 10.1186/1758-5996-6-96; Ohtsubo K, 2006, CELL, V126, P855, DOI 10.1016/j.cell.2006.08.019; Ohtsubo K, 2011, NAT MED, V17, P1067, DOI 10.1038/nm.2414; Pickup JC, 1998, DIABETOLOGIA, V41, P1241, DOI 10.1007/s001250051058; REAVEN GM, 1988, DIABETES, V37, P1595, DOI 10.2337/diabetes.37.12.1595; SPIRO MJ, 1984, DIABETOLOGIA, V26, P70; Springhorn C, 2012, J CLIN ENDOCR METAB, V97, P4640, DOI 10.1210/jc.2012-2229; Strazzullo P, 2008, METABOLISM, V57, P355, DOI 10.1016/j.metabol.2007.10.010; Taniguchi N, 2011, BMB REP, V44, P772, DOI 10.5483/BMBRep.2011.44.12.772; Tozawa R, 2001, J BIOL CHEM, V276, P12624, DOI 10.1074/jbc.M011063200; Vanhooren V, 2008, BIOGERONTOLOGY, V9, P351, DOI 10.1007/s10522-008-9140-z; Vanhooren V, 2007, REJUV RES, V10, P521, DOI 10.1089/rej.2007.0556; WAJCHENBERG BL, 1994, DIABETES METAB REV, V10, P19, DOI 10.1002/dmr.5610100103; Wang Z, 2009, DIABETES, V58, P309, DOI 10.2337/db08-0994; Yarema KJ, 2001, GENOME BIOL, V2; YODAIKEN RE, 1975, DIABETES, V24, P286, DOI 10.2337/diabetes.24.3.286	46	73	75	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0119983	10.1371/journal.pone.0119983	http://dx.doi.org/10.1371/journal.pone.0119983			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25793407	Green Published, gold, Green Submitted			2022-12-27	WOS:000352084200132
J	Wuest, W; Lell, M; May, M; Scharf, M; Schlundt, C; Achenbach, S; Uder, M; Schmid, A				Wuest, Wolfgang; Lell, Michael; May, Matthias; Scharf, Michael; Schlundt, Christian; Achenbach, Stephan; Uder, Michael; Schmid, Axel			Determining Microvascular Obstruction and Infarct Size with Steady-State Free Precession Imaging Cardiac MRI	PLOS ONE			English	Article							ACUTE MYOCARDIAL-INFARCTION; NO-REFLOW PHENOMENON; LEFT-VENTRICULAR FUNCTION; PROGNOSTIC-SIGNIFICANCE; FUNCTIONAL RECOVERY; TIME-COURSE; CORONARY; ENHANCEMENT; PREDICTOR; PERFUSION	Purpose In cardiac MRI (cMRI) injection of contrast medium may be performed prior to the acquisition of cine steady-state free precession (SSFP) imaging to speed up the protocol and avoid delay before late Gadolinium enhancement (LGE) imaging. Aim of this study was to evaluate whether a condensed clinical protocol with contrast cine SSFP imaging is able to detect early microvascular obstruction (MO) and determine the infarct size compared to the findings of LGE inversion recovery sequences. Materials and Methods The study complies with the Declaration of Helsinki and was performed following approval by the ethic committee of the University of Erlangen-Nuremberg. Written informed consent was obtained from every patient. 68 consecutive patients (14 females/54 males) with acute ST-elevation myocardial infarction (STEMI) treated by percutaneous coronary revascularization were included in this study. CMRI was performed 6.6 +/- 2 days after symptom onset and MO and infarct size in early contrast SSFP cine imaging were compared to LGE imaging. Results MO was detected in 47/68 (69%) patients on cine SSFP and in 41/68 (60%) patients on LGE imaging. In 6 patients MO was found on cine SSFP imaging but was not detectable on LGE imaging. Infarct size on cine SSFP showed a strong agreement to LGE imaging (intraclass correlation coefficient [ICC] of 0.96 for enddiastolic, p<0.001 and 0.96 for endsystolic, p<0.001 respectively). Significant interobserver agreement was found measuring enddiastolic and endsystolic infarct size on cine SSFP imaging (p<0.01). Conclusions In patients after STEMI infarct size and presence of MO can be detected with contrast cine SSFP imaging. This could be an option in patients who are limited in their ability to comply with the demands of a cMRI protocol.	[Wuest, Wolfgang; Lell, Michael; May, Matthias; Scharf, Michael; Uder, Michael; Schmid, Axel] Univ Erlangen Nurnberg, Inst Radiol, D-91054 Erlangen, Germany; [Schlundt, Christian; Achenbach, Stephan] Univ Erlangen Nurnberg, Div Cardiol, Dept Internal Med 2, D-91054 Erlangen, Germany	University of Erlangen Nuremberg; University of Erlangen Nuremberg	Wuest, W (corresponding author), Univ Erlangen Nurnberg, Inst Radiol, D-91054 Erlangen, Germany.	wolfgang.wuest@uk-erlangen.de	May, Matthias/AAZ-4877-2021	May, Matthias/0000-0002-2540-850X				Bekkers SCAM, 2009, EUR RADIOL, V19, P2904, DOI 10.1007/s00330-009-1489-0; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Bogaert J, 2007, EUR RADIOL, V17, P2572, DOI 10.1007/s00330-007-0627-9; de Waha S, 2010, EUR HEART J, V31, P2660, DOI 10.1093/eurheartj/ehq247; Gerber BL, 2002, CIRCULATION, V106, P1083, DOI 10.1161/01.CIR.0000027818.15792.1E; Gibson CM, 2004, CIRCULATION, V109, P3096, DOI 10.1161/01.CIR.0000134278.50359.CB; Grines CL, 1999, N ENGL J MED; Hombach V, 2005, EUR HEART J, V26, P549, DOI 10.1093/eurheartj/ehi147; ITO H, 1992, CIRCULATION, V85, P1699, DOI 10.1161/01.CIR.85.5.1699; Ito H, 1996, CIRCULATION, V93, P223, DOI 10.1161/01.CIR.93.2.223; Judd RM, 2002, CIRCULATION, V106, P1083; Kim RJ, 1996, CIRCULATION, V94, P3318, DOI 10.1161/01.CIR.94.12.3318; KLONER RA, 1974, J CLIN INVEST, V54, P1496, DOI 10.1172/JCI107898; Krombach GA, 2011, EUR RADIOL, V21, P702, DOI 10.1007/s00330-010-1969-2; Lund GK, 2004, RADIOLOGY, V232, P49, DOI 10.1148/radiol.2321031127; Lund GK, 2007, RADIOLOGY, V245, P95, DOI 10.1148/radiol.2451061219; MANCIET LH, 1994, AM J PHYSIOL, V266, pH1541, DOI 10.1152/ajpheart.1994.266.4.H1541; Morishima I, 2000, J AM COLL CARDIOL, V36, P1202, DOI 10.1016/S0735-1097(00)00865-2; Nijveldt R, 2008, J AM COLL CARDIOL, V52, P181, DOI 10.1016/j.jacc.2008.04.006; PIANA RN, 1994, CIRCULATION, V89, P2514, DOI 10.1161/01.CIR.89.6.2514; Raff GL, 2006, RADIOLOGY, V240, P529, DOI 10.1148/radiol.2402050369; Rochitte CE, 1998, CIRCULATION, V98, P1006, DOI 10.1161/01.CIR.98.10.1006; Roe MT, 2001, J AM COLL CARDIOL, V37, P9, DOI 10.1016/S0735-1097(00)01101-3; Rogers WJ, 1999, CIRCULATION, V99, P744, DOI 10.1161/01.CIR.99.6.744; Schulz-Menger J, 2013, J CARDIOVASC MAGN R, V15, DOI 10.1186/1532-429X-15-35; SHEEHAN FH, 1988, J AM COLL CARDIOL, V12, P289, DOI 10.1016/0735-1097(88)90397-X; Topol EJ, 2000, CIRCULATION, V101, P570, DOI 10.1161/01.CIR.101.5.570; Wu KC, 1998, J AM COLL CARDIOL, V32, P1756, DOI 10.1016/S0735-1097(98)00429-X; Wu KC, 1998, CIRCULATION, V97, P765, DOI 10.1161/01.CIR.97.8.765; Yan AT, 2006, J CARDIOVASC MAGN R, V8, P831, DOI 10.1080/10976640600778049	30	1	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0119788	10.1371/journal.pone.0119788	http://dx.doi.org/10.1371/journal.pone.0119788			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25793609	gold, Green Published, Green Submitted			2022-12-27	WOS:000352084200116
J	Xu, JW; Lan, HX; Fang, HM; Huang, X; Zhang, HS; Huang, J				Xu, Jianwen; Lan, Hongxia; Fang, Huimin; Huang, Xi; Zhang, Hongsheng; Huang, Ji			Quantitative Proteomic Analysis of the Rice (Oryza sativa L.) Salt Response	PLOS ONE			English	Article							ARABIDOPSIS-THALIANA; PHOTOSYSTEM-I; SPIRULINA-PLATENSIS; DROUGHT STRESS; MODEL SYSTEM; PHOTOSYNTHESIS; PLANTS; GROWTH; SALINITY; PATHWAYS	Salt stress is one of most serious limiting factors for crop growth and production. An isobaric Tags for Relative and Absolute Quantitation (iTRAQ) approach was used to analyze proteomic changes in rice shoots under salt stress in this study. A total of 56 proteins were significantly altered and 16 of them were enriched in the pathways of photosynthesis, antioxidant and oxidative phosphorylation. Among these 16 proteins, peroxiredoxin Q and photosystem I subunit D were up-regulated, while thioredoxin M-like, thioredoxin x, thioredoxin peroxidase, glutathione S-transferase F3, PSI subunit H, light-harvesting antenna complex I subunits, chloroplast chaperonin, vacuolar ATP synthase subunit H, and ATP synthase delta chain were down-regulated. Moreover, physiological data including total antioxidant capacity, peroxiredoxin activity, chlorophyll a/b content, glutathione S-transferase activity, reduced glutathione content and ATPase activity were consistent with changes in the levels of these proteins. The levels of the mRNAs encoding these proteins were also analyzed by real-time quantitative reverse transcription PCR, and approximately 86% of the results were consistent with the iTRAQ data. Importantly, our data suggest the important role of PSI in balancing energy supply and ROS generation under salt stress. This study provides information for an improved understanding of the function of photosynthesis and PSI in the salt-stress response of rice.	[Xu, Jianwen; Lan, Hongxia; Fang, Huimin; Huang, Xi; Zhang, Hongsheng; Huang, Ji] Nanjing Agr Univ, State Key Lab Crop Genet & Germplasm Enhancement, Nanjing 210095, Jiangsu, Peoples R China; [Xu, Jianwen; Fang, Huimin; Huang, Xi; Zhang, Hongsheng; Huang, Ji] Jiangsu Collaborat Innovat Ctr Modern Crop Prod, Nanjing 210095, Jiangsu, Peoples R China; [Lan, Hongxia] Nanjing Agr Univ, Coll Life Sci, Nanjing 210095, Jiangsu, Peoples R China	Nanjing Agricultural University; Nanjing Agricultural University	Zhang, HS (corresponding author), Nanjing Agr Univ, State Key Lab Crop Genet & Germplasm Enhancement, Nanjing 210095, Jiangsu, Peoples R China.	hszhang@njau.edu.cn; huangji@njau.edu.cn	Huang, Ji/AAY-2852-2020; lan, hongxia/GWC-5420-2022	Huang, Ji/0000-0002-9057-4299; 	National Science Foundation of China [31071069]; Jiangsu Provincial Natural Science Foundation [BK20141362]; State Key Laboratory of Rice Biology [110101]; 111 Project; Fundamental Research Funds for the Central Universities [KYZ201137]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Provincial Natural Science Foundation(Natural Science Foundation of Jiangsu Province); State Key Laboratory of Rice Biology; 111 Project(Ministry of Education, China - 111 Project); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This research was funded by the National Science Foundation of China (31071069): JH. Jiangsu Provincial Natural Science Foundation (BK20141362): JH. State Key Laboratory of Rice Biology (110101): JH. The 111 Project, and the Fundamental Research Funds for the Central Universities (KYZ201137): JH	Abbasi FM, 2004, PROTEOMICS, V4, P2072, DOI 10.1002/pmic.200300741; Allakhverdiev SI, 2000, PLANT PHYSIOL, V123, P1047, DOI 10.1104/pp.123.3.1047; Carius AB, 2011, J BACTERIOL, V193, P1893, DOI 10.1128/JB.01353-10; Ceppi MG, 2012, PHYSIOL PLANTARUM, V144, P277, DOI 10.1111/j.1399-3054.2011.01549.x; Cheng YW, 2009, PROTEOMICS, V9, P3100, DOI 10.1002/pmic.200800340; Colmer TD, 2006, J EXP BOT, V57, P1059, DOI 10.1093/jxb/erj124; Courteille A, 2013, PLANT PHYSIOL, V161, P508, DOI 10.1104/pp.112.207019; Foreman J, 2003, NATURE, V422, P442, DOI 10.1038/nature01485; Foyer CH, 2005, PLANT CELL, V17, P1866, DOI 10.1105/tpc.105.033589; Foyer CH, 2011, PLANT PHYSIOL, V155, P93, DOI 10.1104/pp.110.166181; Gruber AV, 2013, TRENDS PLANT SCI, V18, P688, DOI 10.1016/j.tplants.2013.08.001; Hasegawa PM, 2000, ANNU REV PLANT PHYS, V51, P463, DOI 10.1146/annurev.arplant.51.1.463; Ihalainen JA, 2002, BIOPHYS J, V83, P2190, DOI 10.1016/S0006-3495(02)73979-9; Joliot P, 2006, BBA-BIOENERGETICS, V1757, P362, DOI 10.1016/j.bbabio.2006.02.018; Kao WY, 2001, J PLANT PHYSIOL, V158, P841, DOI 10.1078/0176-1617-00248; Khavari-Nejad RA, 1998, PHOTOSYNTHETICA, V35, P151, DOI 10.1023/A:1006846504261; Kim DW, 2005, ELECTROPHORESIS, V26, P4521, DOI 10.1002/elps.200500334; Kim SR, 2013, MOL CELLS, V35, P402, DOI 10.1007/s10059-013-2337-2; Kurban H, 1999, SOIL SCI PLANT NUTR, V45, P851, DOI 10.1080/00380768.1999.10414334; Lamkemeyer P, 2006, PLANT J, V45, P968, DOI 10.1111/j.1365-313X.2006.02665.x; Ledford HK, 2007, EUKARYOT CELL, V6, P919, DOI 10.1128/EC.00207-06; Liu DW, 2013, PROTEOMICS, V13, P2046, DOI 10.1002/pmic.201200425; Lu C, 2002, PHYSIOL PLANTARUM, V114, P405, DOI 10.1034/j.1399-3054.2002.1140310.x; Lu CM, 1999, NEW PHYTOL, V141, P231, DOI 10.1046/j.1469-8137.1999.00340.x; Mittler R, 2004, TRENDS PLANT SCI, V9, P490, DOI 10.1016/j.tplants.2004.08.009; Moradi F, 2007, ANN BOT-LONDON, V99, P1161, DOI 10.1093/aob/mcm052; Munekage YN, 2008, PLANT CELL PHYSIOL, V49, P1688, DOI 10.1093/pcp/pcn140; Naver H, 1999, J BIOL CHEM, V274, P10784, DOI 10.1074/jbc.274.16.10784; Parker R, 2006, J EXP BOT, V57, P1109, DOI 10.1093/jxb/erj134; Polisetty RV, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.013565; Pulido P, 2010, J EXP BOT, V61, P4043, DOI 10.1093/jxb/erq218; Thimm O, 2004, PLANT J, V37, P914, DOI 10.1111/j.1365-313X.2004.02016.x; Tiwari BS, 1997, PHOTOSYNTHETICA, V34, P303, DOI 10.1023/A:1006857027398; Unal D, 2013, PHOTOSYNTHESIS, DOI [10.5772/55350, DOI 10.5772/55350]; Wang XM, 2013, ACTA PHYSIOL PLANT, V35, P891, DOI 10.1007/s11738-012-1132-6; Yan SP, 2005, PROTEOMICS, V5, P235, DOI 10.1002/pmic.200400853; Yu QB, 2014, MOL PLANT, V7, P206, DOI 10.1093/mp/sst092; Zhang HY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069046; Zhang T, 2010, J PLANT PHYSIOL, V167, P951, DOI 10.1016/j.jplph.2009.12.020; Zhu JK, 2002, ANNU REV PLANT BIOL, V53, P247, DOI 10.1146/annurev.arplant.53.091401.143329; Zi J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074229	41	36	38	2	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0120978	10.1371/journal.pone.0120978	http://dx.doi.org/10.1371/journal.pone.0120978			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25793471	Green Submitted, Green Published, gold			2022-12-27	WOS:000352083900095
J	Ye, S; Yang, JX; Cao, DY; Bai, HM; Huang, HF; Wu, M; Chen, J; You, Y; Lang, JH; Shen, K				Ye, Shuang; Yang, Jiaxin; Cao, Dongyan; Bai, Huimin; Huang, Huifang; Wu, Ming; Chen, Jie; You, Yan; Lang, Jinghe; Shen, Keng			Characteristic and Prognostic Implication of Venous Thromboembolism in Ovarian Clear Cell Carcinoma: A 12-Year Retrospective Study	PLOS ONE			English	Article							CANCER; LYMPHADENECTOMY; PROPHYLAXIS; THROMBOSIS; SURVIVAL	Purpose To profile the characteristic and prognostic implications of venous thromboembolism (VTE) in Chinese ovarian clear cell carcinoma (CCC) patients. Methods We identified all of the cases between 2000 and 2012 by searching our institutional Ovarian CCC Database. A comprehensive review of the medical documentation was performed to collect relevant data. Kaplan-Meier models and Cox regression were employed for survival analysis. Results Of the 227 patients, 33 (14.5%) experienced VTE events. There was no significant difference between VTE and non-VTE group patients regarding age, serum cancer antigen 125 or tumor size. The optimal cytoreduction rate was higher in patients without VTE (70.1%) than in those with VTE (51.5%). VTE events were more likely to occur at presentation (36.4%) and recurrence (33.3%), followed by an adjuvant chemotherapy period (18.2%). VTE was more common in patients with advanced-stage disease than those with earlystage disease (P=0.003), whereas pulmonary embolism (PE) was 10-fold as common in advanced-stage disease as in early-stage disease (8.6% vs. 0.8%, P = 0.012). Patients with advanced disease tended to have thrombi in the proximal veins. Two patients died of PE, as confirmed by autopsy. Patients with VTE had reduced survival compared to those without VTE (median overall survival 54 vs. 140 months, P<0.001; median progression-free survival 17 vs. 43 months, P<0.001). Conclusions Overall, 14.5% of the patients with ovarian CCC experienced VTE, mainly before their cancer diagnosis or at a time of recurrence. VTE adversely impacted patient survival.	[Ye, Shuang; Yang, Jiaxin; Cao, Dongyan; Bai, Huimin; Huang, Huifang; Wu, Ming; Lang, Jinghe; Shen, Keng] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Obstet & Gynecol, Beijing 100730, Peoples R China; [Ye, Shuang; Yang, Jiaxin; Cao, Dongyan; Bai, Huimin; Huang, Huifang; Wu, Ming; Chen, Jie; You, Yan; Lang, Jinghe; Shen, Keng] Peking Union Med Coll, Beijing 100021, Peoples R China; [Chen, Jie; You, Yan] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Pathol, Beijing 100730, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital	Shen, K (corresponding author), Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Obstet & Gynecol, Beijing 100730, Peoples R China.	shenkeng@vip.sina.com		Ye, Shuang/0000-0001-5624-7908	National High Technology Research Development Program of China (863 program) [2012AA02A507]; National Natural Science Foundation of China [81172482, 81372780]	National High Technology Research Development Program of China (863 program)(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National High Technology Research Development Program of China (863 program): Grant No. 2012AA02A507; URLs: http://www.863.gov.cn/ and the National Natural Science Foundation of China: Grant No. 81172482 and No. 81372780; URLs: http://www.nsfc.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cohen AT, 2010, THROMB RES, V125, pS21, DOI 10.1016/S0049-3848(10)70008-6; Diaz ES, 2013, GYNECOL ONCOL, V131, P541, DOI 10.1016/j.ygyno.2013.09.005; DONATI MB, 1994, HAEMOSTASIS, V24, P128; du Bois A, 2010, J CLIN ONCOL, V28, P1733, DOI 10.1200/JCO.2009.25.3617; Duska LR, 2010, GYNECOL ONCOL, V116, P374, DOI 10.1016/j.ygyno.2009.10.069; Einstein MH, 2007, GYNECOL ONCOL, V105, P813, DOI 10.1016/j.ygyno.2007.03.004; Lee AYY, 2003, CIRCULATION, V107, pI17, DOI 10.1161/01.CIR.0000078466.72504.AC; Lim MC, 2010, ARCH GYNECOL OBSTET, V281, P329, DOI 10.1007/s00404-009-1120-2; Lyman GH, 2013, J CLIN ONCOL, V31, P2189, DOI 10.1200/JCO.2013.49.1118; Mandala M, 2006, CRIT REV ONCOL HEMAT, V59, P194, DOI 10.1016/j.critrevonc.2006.05.001; Matsuura Y, 2007, GYNECOL ONCOL, V104, P406, DOI 10.1016/j.ygyno.2006.08.026; Okamoto A, 2014, INT J GYNECOL CANCER, V24, pS20, DOI 10.1097/IGC.0000000000000289; Panici PB, 2005, JNCI-J NATL CANCER I, V97, P560, DOI 10.1093/jnci/dji102; Rodriguez AO, 2007, GYNECOL ONCOL, V105, P784, DOI 10.1016/j.ygyno.2007.02.024; Sandhu R, 2010, CANCER-AM CANCER SOC, V116, P2596, DOI 10.1002/cncr.25004; Satoh T, 2007, BRIT J CANCER, V97, P1053, DOI 10.1038/sj.bjc.6603989; Scarvelis D, 2006, CAN MED ASSOC J, V175, P1087, DOI 10.1503/cmaj.060366; Sorensen HT, 2000, NEW ENGL J MED, V343, P1846, DOI 10.1056/NEJM200012213432504; Sung PL, 2014, GYNECOL ONCOL, V133, P147, DOI 10.1016/j.ygyno.2014.02.016; Zhang Yu, 2003, Zhongguo Yi Xue Ke Xue Yuan Xue Bao, V25, P471	20	15	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0121818	10.1371/journal.pone.0121818	http://dx.doi.org/10.1371/journal.pone.0121818			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25793293	Green Published, Green Submitted, gold			2022-12-27	WOS:000352083900156
J	Arias, C; Fussero, G; Zacharonok, M; Macias, A				Arias, Carolina; Fussero, Gimena; Zacharonok, Marcelo; Macias, Ana			Dpp-Expressing and Non-Expressing Cells: Two Different Populations of Growing Cells in Drosophila	PLOS ONE			English	Article							JNK-DEPENDENT APOPTOSIS; PROLIFERATION; DEATH; GROWTH; GRADIENT; GENE; PHOSPHATASE; SURVIVAL; HOMOLOG; ENCODES	There are different models that explain growth during development. One model is based on insect and amphibian regeneration studies. This model proposes that growth is directed by pattern, and growth takes place by intercalation at a growth discontinuity; therefore, proliferation should surround the discontinuity. Currently, this model, apart from regenerative studies on mostly adult patterning, has not found supporting evidence in Drosophila that shows proliferation surrounding a discontinuity. Despite this lack of evidence, the importance of discontinuities has been shown in different experiments, even under wt conditions, more specifically in the formation of the leg joints because of the occurrence of cell death at their boundaries. Here, we show the existence of a sharp discontinuity in Decapentaplegic (Dpp) in the genital discs at the third larvae stage (L3), which determines the upregulation in the Jun-NH2-Terminal-Kinase (JNK) pathway, reaper (rpr), head involution defective (hid) and active caspases from its boundaries. The proliferation and cell death surrounding the discontinuity suggest that growth can proceed by intercalation and competitive death takes place in this area. Finally, we show that the Rpr, Grim and Hid (RGH) products are a few of the factors that define the growth discontinuity because they are negative regulators of growth, a new function that is unique from their known functions in apoptosis.	[Arias, Carolina; Fussero, Gimena; Zacharonok, Marcelo; Macias, Ana] Univ Nacl Cordoba, Fac Ciencias Exactas Fis & Nat, Dept Fisiol, Catedra Genet, RA-5000 Cordoba, Argentina	National University of Cordoba	Macias, A (corresponding author), Univ Nacl Cordoba, Fac Ciencias Exactas Fis & Nat, Dept Fisiol, Catedra Genet, RA-5000 Cordoba, Argentina.	amacias@com.uncor.edu		Fussero, Gimena Betina/0000-0003-0213-0637	Secretaria de Ciencia y Tecnica de la Universidad Nacional de Cordoba, Argentina (SECYT-UNC) [21610, 217-11, 162-12, 124-13]; Consejo Nacional de Ciencia y Tecnica (CONICET) [4541-12]; CONICET-UNC; UNC	Secretaria de Ciencia y Tecnica de la Universidad Nacional de Cordoba, Argentina (SECYT-UNC); Consejo Nacional de Ciencia y Tecnica (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); CONICET-UNC; UNC	Funding for the research was provided by Secretaria de Ciencia y Tecnica de la Universidad Nacional de Cordoba, Argentina (SECYT-UNC) 21610; 217-11; 162-12; 124-13) and Consejo Nacional de Ciencia y Tecnica (CONICET) (4541-12) to A. Macias. Ana Macias is supported by CONICET-UNC. Carolina Arias and Gimena Fussero were supported by UNC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi-Yamada T, 2002, DEV BIOL, V251, P74, DOI 10.1006/dbio.2002.0821; Adachi-Yamada T, 1999, NATURE, V400, P166, DOI 10.1038/22112; Benitez S, 2010, INT J DEV BIOL, V54, P643, DOI 10.1387/ijdb.082724sb; BRAND AH, 1993, DEVELOPMENT, V118, P401; Brennecke J, 2003, CELL, V113, P25, DOI 10.1016/S0092-8674(03)00231-9; Campbell G, 1999, CELL, V96, P553, DOI 10.1016/S0092-8674(00)80659-5; de Navas L, 2006, MECH DEVELOP, V123, P860, DOI 10.1016/j.mod.2006.07.010; Di Rienzo JA., 2012, INFOSTAT; Entchev EV, 2000, CELL, V103, P981, DOI 10.1016/S0092-8674(00)00200-2; Estrada B, 2003, DIFFERENTIATION, V71, P299, DOI 10.1046/j.1432-0436.2003.03017.x; FRENCH V, 1976, SCIENCE, V193, P969, DOI 10.1126/science.948762; Golic MM, 1997, NUCLEIC ACIDS RES, V25, P3665, DOI 10.1093/nar/25.18.3665; GRETHER ME, 1995, GENE DEV, V9, P1694, DOI 10.1101/gad.9.14.1694; Hay BA, 2006, ANNU REV CELL DEV BI, V22, P623, DOI 10.1146/annurev.cellbio.21.012804.093845; HAYNIE JL, 1976, NATURE, V259, P659, DOI 10.1038/259659b0; Holley CL, 2002, NAT CELL BIOL, V4, P439, DOI 10.1038/ncb798; Huh JR, 2004, CURR BIOL, V14, P1262, DOI 10.1016/j.cub.2004.06.015; Jiang CA, 2000, MOL CELL, V5, P445, DOI 10.1016/S1097-2765(00)80439-6; Kurada P, 1998, CELL, V95, P319, DOI 10.1016/S0092-8674(00)81764-X; Lawrence PA, 1996, CELL, V85, P951, DOI 10.1016/S0092-8674(00)81297-0; Li W, 2007, CELL, V129, P1215, DOI 10.1016/j.cell.2007.03.054; Manjon C, 2007, NAT CELL BIOL, V9, P57, DOI 10.1038/ncb1518; Martin FA, 2004, DEVELOPMENT, V131, P4921, DOI 10.1242/dev.01385; Martin-Blanco E, 1998, GENE DEV, V12, P557, DOI 10.1101/gad.12.4.557; Martin-Castellanos C, 2002, DEVELOPMENT, V129, P1003; McEwen DG, 2005, DEVELOPMENT, V132, P3935, DOI 10.1242/dev.01949; Moreno E, 2002, CURR BIOL, V12, P1263, DOI 10.1016/S0960-9822(02)00954-5; Moreno E, 2002, NATURE, V416, P755, DOI 10.1038/416755a; Muller B, 2003, CELL, V113, P221, DOI 10.1016/S0092-8674(03)00241-1; Neufeld TP, 1998, CELL, V93, P1183, DOI 10.1016/S0092-8674(00)81462-2; Perez-Garijo A, 2004, DEVELOPMENT, V131, P5591, DOI 10.1242/dev.01432; Ryoo HD, 2004, DEV CELL, V7, P491, DOI 10.1016/j.devcel.2004.08.019; STAEHLINGHAMPTON K, 1994, CELL GROWTH DIFFER, V5, P585; Wartlick O, 2011, SCIENCE, V331, P1154, DOI 10.1126/science.1200037; WHITE K, 1994, SCIENCE, V264, P677, DOI 10.1126/science.8171319	35	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0121457	10.1371/journal.pone.0121457	http://dx.doi.org/10.1371/journal.pone.0121457			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25798905	Green Published, gold, Green Submitted			2022-12-27	WOS:000351987300254
J	Chen, X; Liu, XJ; Lang, HB; Zhang, SQ; Luo, YL; Zhang, J				Chen, Xue; Liu, Xinjuan; Lang, Haibo; Zhang, Shiqi; Luo, Yanlin; Zhang, Jie			S100 Calcium-Binding Protein A6 Promotes Epithelial-Mesenchymal Transition through beta-Catenin in Pancreatic Cancer Cell Line	PLOS ONE			English	Article							INTERACTING PROTEIN; TUMOR-CELLS; EXPRESSION; CALCYCLIN; DEGRADATION; METASTASIS; SIAH-1; TARGET	The pathogenesis of pancreatic ductal adenocarcinoma (PDAC) remains poorly understood. S100 calcium-binding protein A6 (S100A6) has been associated with PDAC; however, the effect of S100A6 on PDAC migration and invasion has not yet been explored. In this study, Panc-1 cells were transfected with a plasmid to induce overexpression of S100A6, and beta-catenin was knocked down using a specific short hairpin RNA (shRNA). The wound-healing and Transwell assays demonstrated that S100A6 promoted PDAC cell migration and invasion. Furthermore, beta-catenin shRNA inhibited the migration and invasion of PDAC cells. We confirmed that S100A6 induces PDAC cell migration and invasion via activation of beta-catenin in vitro. Assessment of mRNA and protein levels revealed that S100A6 induces increased expression of beta-catenin, N-cadherin and vimentin, and decreased expression of E-cadherin in PDAC cells. beta-catenin shRNA also altered the expression of epithelial-mesenchymal transition (EMT)-related markers in PDAC cells. Specifically, expression of E-cadherin was increased, whereas expression of N-cadherin and vimentin was decreased. Finally, we demonstrated that S100A6 alters the expression of EMT-related markers via beta-catenin activation. In conclusion, S100A6 induces EMT and promotes cell migration and invasion in a beta-catenin-dependent manner. S100A6 may therefore represent a novel potential therapeutic target for the treatment of pancreatic cancer.	[Chen, Xue; Lang, Haibo; Zhang, Shiqi; Zhang, Jie] Capital Med Univ, Beijing An Zhen Hosp, Dept Gastroenterol, Beijing, Peoples R China; [Liu, Xinjuan] Capital Med Univ, Beijing Chao Yang Hosp, Dept Gastroenterol, Beijing, Peoples R China; [Luo, Yanlin] Capital Med Univ, Dept Neurobiol, Beijing, Peoples R China; [Luo, Yanlin] Capital Med Univ, Sch Basic Med Sci, Beijing Inst Brain Disorders, Beijing, Peoples R China	Capital Medical University; Capital Medical University; Capital Medical University; Capital Medical University	Zhang, J (corresponding author), Capital Med Univ, Beijing An Zhen Hosp, Dept Gastroenterol, Beijing, Peoples R China.	zhangjie4155@sina.com			Basic and Clinical Cooperation Foundation of Capital Medical University(China) [13JL77]	Basic and Clinical Cooperation Foundation of Capital Medical University(China)	This work was supported by the Basic and Clinical Cooperation Foundation of Capital Medical University No. 13JL77 (China). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bo HJ, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-496; Bonnomet A, 2010, J MAMMARY GLAND BIOL, V15, P261, DOI 10.1007/s10911-010-9174-0; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; De Craene B, 2013, NAT REV CANCER, V13, P97, DOI 10.1038/nrc3447; Filipek A, 2006, CHEMOTHERAPY, V52, P32, DOI 10.1159/000090240; Gao ZH, 2014, ONCOL LETT, V8, P2069, DOI 10.3892/ol.2014.2433; Guo ZH, 2013, J CLIN GASTROENTEROL, V47, P69, DOI 10.1097/MCG.0b013e3182601752; Cao H, 2013, ANTICANCER RES, V33, P1785; Ji YF, 2014, INT J MOL MED, V33, P769, DOI 10.3892/ijmm.2014.1633; Jurewicz E, 2013, NEUROCHEM RES, V38, P1941, DOI 10.1007/s11064-013-1100-6; Kahn M, 2014, NAT REV DRUG DISCOV, V13, P513, DOI 10.1038/nrd4233; Krantz SB, 2012, J SURG RES, V173, P105, DOI 10.1016/j.jss.2011.09.020; Lee YT, 2008, BIOCHEMISTRY-US, V47, P10921, DOI 10.1021/bi801233z; Lesniak W, 2009, BIOCHEM BIOPH RES CO, V390, P1087, DOI 10.1016/j.bbrc.2009.10.150; Li ZQ, 2014, J MOL MED, V92, P291, DOI 10.1007/s00109-013-1104-3; Logsdon CD, 2003, CANCER RES, V63, P2649; Long J, 2014, CANCER LETT, V346, P273, DOI 10.1016/j.canlet.2014.01.004; Matsuzawa S, 2001, MOL CELL, V7, P915, DOI 10.1016/S1097-2765(01)00242-8; Micalizzi DS, 2010, J MAMMARY GLAND BIOL, V15, P117, DOI 10.1007/s10911-010-9178-9; Nowotny M, 2000, J BIOL CHEM, V275, P31178, DOI 10.1074/jbc.M001622200; Ohuchida K, 2005, CLIN CANCER RES, V11, P7785, DOI 10.1158/1078-0432.CCR-05-0714; Ohuchida K, 2007, CANCER EPIDEM BIOMAR, V16, P649, DOI 10.1158/1055-9965.EPI-06-0157; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Rosenbluh J, 2014, TRENDS PHARMACOL SCI, V35, P103, DOI 10.1016/j.tips.2013.11.007; Saito-Diaz K, 2013, GROWTH FACTORS, V31, P1, DOI 10.3109/08977194.2012.752737; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Ueno K, 2013, INT J CANCER, V132, P1731, DOI 10.1002/ijc.27746; Vimalachandran D, 2005, CANCER RES, V65, P3218, DOI 10.1158/0008-5472.CAN-04-4311; Wang YH, 2014, NAT CELL BIOL, V16, P1092, DOI 10.1038/ncb3050; Xu W, 2015, CANCER LETT IN PRESS; Xu XF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096441; Yu M, 2012, NATURE, V487, P510, DOI 10.1038/nature11217; Zhai HH, 2008, J HISTOCHEM CYTOCHEM, V56, P765, DOI 10.1369/jhc.2008.950519; Zhang JL, 2014, DIGEST DIS SCI, V59, P2136, DOI 10.1007/s10620-014-3137-z	35	25	27	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0121319	10.1371/journal.pone.0121319	http://dx.doi.org/10.1371/journal.pone.0121319			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25799022	Green Submitted, Green Published, gold			2022-12-27	WOS:000351987300235
J	Chung, D; Young, J; Bomble, YJ; Vander Wall, TA; Groom, J; Himmel, ME; Westpheling, J				Chung, Daehwan; Young, Jenna; Bomble, Yannick J.; Vander Wall, Todd A.; Groom, Joseph; Himmel, Michael E.; Westpheling, Janet			Homologous Expression of the Caldicellulosiruptor bescii CelA Reveals that the Extracellular Protein Is Glycosylated	PLOS ONE			English	Article							STREPTOMYCES-LIVIDANS GLYCOSYLATES; CARBOHYDRATE-BINDING MODULE; ACCESSORY SEC SYSTEM; STREPTOCOCCUS-GORDONII; CELLULOMONAS-FIMI; PLANT BIOMASS; DELETION; ENZYME; THERMOSTABILITY; GLYCOPROTEINS	Members of the bacterial genus Caldicellulosiruptor are the most thermophilic cellulolytic microbes described with ability to digest lignocellulosic biomass without conventional pretreatment. The cellulolytic ability of different species varies dramatically and correlates with the presence of the multimodular cellulase CelA, which contains both a glycoside hydrolase family 9 endoglucanase and a glycoside hydrolase family 48 exoglucanase known to be synergistic in their activity, connected by three cellulose-binding domains via linker peptides. This architecture exploits the cellulose surface ablation driven by its general cellulase processivity as well as excavates cavities into the surface of the substrate, revealing a novel paradigm for cellulase activity. We recently reported that a deletion of celA in C. bescii had a significant effect on its ability to utilize complex biomass. To analyze the structure and function of CelA and its role in biomass deconstruction, we constructed a new expression vector for C. bescii and were able, for the first time, to express significant quantities of full-length protein in vivo in the native host. The protein, which contains a Histidine tag, was active and excreted from the cell. Expression of CelA protein with and without its signal sequence allowed comparison of protein retained intracellularly to protein transported extra-cellularly. Analysis of protein in culture supernatants revealed that the extracellular CelA protein is glycosylated whereas the intracellular CelA is not, suggesting that either protein transport is required for this post-translational modification or that glycosylation is required for protein export. The mechanism and role of protein glycosylation in bacteria is poorly understood and the ability to express CelA in vivo in C. bescii will allow the study of the mechanism of protein glycosylation in this thermophile. It will also allow the study of glycosylation of CelA itself and its role in the structure and function of this important enzyme in biomass deconstruction.	[Chung, Daehwan; Young, Jenna; Groom, Joseph; Westpheling, Janet] Univ Georgia, Dept Genet, Athens, GA 30602 USA; [Bomble, Yannick J.; Vander Wall, Todd A.; Himmel, Michael E.] Natl Renewable Energy Lab, Biosci Ctr, Golden, CO USA; [Chung, Daehwan; Young, Jenna; Bomble, Yannick J.; Vander Wall, Todd A.; Groom, Joseph; Himmel, Michael E.; Westpheling, Janet] Oak Ridge Natl Lab, BioEnergy Sci Ctr, Oak Ridge, TN USA	University System of Georgia; University of Georgia; United States Department of Energy (DOE); National Renewable Energy Laboratory - USA; United States Department of Energy (DOE); Oak Ridge National Laboratory; BioEnergy Science Center (BESC)	Westpheling, J (corresponding author), Univ Georgia, Dept Genet, Athens, GA 30602 USA.	janwest@uga.edu		Bomble, Yannick/0000-0001-7624-8000	Office of Biological and Environmental Research in the DOE Office of Science [10-21-RR093-367]	Office of Biological and Environmental Research in the DOE Office of Science(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The BioEnergy Science Center is a U.S. Department of Energy Bioenergy Research Center supported by the Office of Biological and Environmental Research in the DOE Office of Science, grant # 10-21-RR093-367. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adney WS, 2009, CELLULOSE, V16, P699, DOI 10.1007/s10570-009-9305-1; Beckham GT, 2012, CURR OPIN BIOTECH, V23, P338, DOI 10.1016/j.copbio.2011.11.030; Bensing BA, 2002, MOL MICROBIOL, V44, P1081, DOI 10.1046/j.1365-2958.2002.02949.x; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; Boraston AB, 2003, J MOL MICROB BIOTECH, V5, P29, DOI 10.1159/000068721; Boraston AB, 2001, BIOCHEM J, V358, P423, DOI 10.1042/0264-6021:3580423; Brunecky R, 2013, SCIENCE, V342, P1513, DOI 10.1126/science.1244273; Chauhan JS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040155; Chung DH, 2011, J IND MICROBIOL BIOT, V38, P1867, DOI 10.1007/s10295-011-0976-x; Chung D, 2014, P NATL ACAD SCI USA, V111, P8931, DOI 10.1073/pnas.1402210111; Chung D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062881; Chung DW, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-82; Chung D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043844; Farkas J, 2013, J IND MICROBIOL BIOT, V40, P41, DOI 10.1007/s10295-012-1202-1; Garvey M, 2013, TRENDS BIOTECHNOL, V31, P581, DOI 10.1016/j.tibtech.2013.06.006; Groom J, 2014, BIOTECHNOL BIOFUELS, V7, DOI 10.1186/s13068-014-0132-8; Jeoh T, 2008, BIOTECHNOL BIOFUELS, V1, DOI 10.1186/1754-6834-1-10; Kanafusa-Shinkai S, 2013, J BIOSCI BIOENG, V115, P64, DOI 10.1016/j.jbiosc.2012.07.019; LANGSFORD ML, 1987, FEBS LETT, V225, P163, DOI 10.1016/0014-5793(87)81150-X; MACLEOD AM, 1992, GENE, V121, P143, DOI 10.1016/0378-1119(92)90173-M; Messner P, 2004, J BACTERIOL, V186, P2517, DOI 10.1128/JB.186.9.2517-2519.2004; Messner P, 1997, GLYCOCONJUGATE J, V14, P3, DOI 10.1023/A:1018551228663; Moens S, 1997, ARCH MICROBIOL, V168, P169, DOI 10.1007/s002030050484; Nothaft H, 2010, NAT REV MICROBIOL, V8, P765, DOI 10.1038/nrmicro2383; OLSEN O, 1991, J GEN MICROBIOL, V137, P579, DOI 10.1099/00221287-137-3-579; ONG E, 1994, J BACTERIOL, V176, P999, DOI 10.1128/JB.176.4.999-1008.1994; Payne CM, 2013, P NATL ACAD SCI USA, V110, P14646, DOI 10.1073/pnas.1309106110; Sambrook J., 2001, MOL CLONING LAB MANU; Sammond DW, 2014, J BIOL CHEM, V289, P20960, DOI 10.1074/jbc.M114.573642; Schneewind O, 2012, PHILOS T R SOC B, V367, P1123, DOI 10.1098/rstb.2011.0210; SHEN H, 1991, J BIOL CHEM, V266, P11335; Sibbald MJJB, 2006, MICROBIOL MOL BIOL R, V70, P755, DOI 10.1128/MMBR.00008-06; Siboo IR, 2008, J BACTERIOL, V190, P6188, DOI 10.1128/JB.00300-08; Takamatsu D, 2005, J BACTERIOL, V187, P3878, DOI 10.1128/JB.187.11.3878-3883.2005; Voutilainen SP, 2010, PROTEIN ENG DES SEL, V23, P69, DOI 10.1093/protein/gzp072; Yi ZL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084172; Young J, 2014, BIOTECHNOL BIOFUELS, V7, DOI 10.1186/s13068-014-0142-6; Zverlov V, 1998, MICROBIOL-SGM, V144, P457, DOI 10.1099/00221287-144-2-457	38	35	37	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0119508	10.1371/journal.pone.0119508	http://dx.doi.org/10.1371/journal.pone.0119508			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25799047	Green Published, Green Submitted, gold			2022-12-27	WOS:000351987300056
J	Hammer, H; Ebert, B; Jensen, HS; Jensen, AA				Hammer, Harriet; Ebert, Bjarke; Jensen, Henrik Sindal; Jensen, Anders A.			Functional Characterization of the 1,5-Benzodiazepine Clobazam and Its Major Active Metabolite N-Desmethylclobazam at Human GABA(A) Receptors Expressed in Xenopus laevis Oocytes	PLOS ONE			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTORS; BENZODIAZEPINE BINDING-SITE; RECOMBINANT GABA(A); DELTA-SUBUNIT; 2 DISTINCT; SUBTYPES; SELECTIVITY; MODULATION; PHARMACOLOGY; CLONAZEPAM	The 1,5-benzodiazepine clobazam is indicated for the adjunctive treatment of seizures associated with Lennox-Gastaut syndrome in patients 2 years of age or older in the United States, and for treatment of anxiety and various forms of epilepsy elsewhere. Clobazam has been reported to exhibit different in vivo adverse effects and addiction liability profile than the classic 1,4-benzodiazepines. In this study, it was investigated whether the in vitro pharmacological properties of clobazam and its major active metabolite N-desmethylclobazam could explain some of these clinical differences. The functional properties of the two 1,5-benzodiazepines were characterized at the human.-aminobutyric acid type A receptor (GABA(A)R) subtypes alpha(1)beta(2)gamma(2S), alpha(2)beta(2)gamma(2S), alpha(3)beta(2)gamma(2S), alpha(5)beta(2)gamma(2S) and alpha(6)beta(2)delta expressed in Xenopus laevis oocytes by use of two-electrode voltage-clamp electrophysiology and compared to those exhibited by the 1,4-benzodiazepine clonazepam. All three compounds potentiated GABA EC20-evoked responses through the alpha(1,2,3,5)beta(2)gamma(2S) GABA(A)Rs in a reversible and concentration-dependent manner, with each displaying similar EC50 values at the four subtypes. Furthermore, the degrees of potentiation of the GABA EC20 currents through the four receptors mediated by saturating modulator concentrations did not differ substantially for any of the three benzodiazepines. The three compounds were substantially less potent (200-3900 fold) as positive allosteric modulators at the alpha(6)beta(2)(o) over bar GABA(A)R than at the alpha(1,2,3,5)beta(2)gamma(2S) receptors. Interestingly, however, clobazam and especially N-desmethylclobazam were highly efficacious potentiators of alpha(6)beta(2)delta receptor signaling. Although this activity component is unlikely to contribute to the in vivo effects of clobazam/N-desmethylclobazam, the 1,5-benzodiazepine could constitute an interesting lead for novel modulators targeting this low-affinity binding site in GABA(A)Rs. In conclusion, the non-selective modulation exerted by clobazam, N-desmethylclobazam and clonazepam at the alpha(1)beta(2)gamma(2S), alpha(2)beta(2)gamma(2S), alpha(3)beta(2)gamma(2S) and alpha(5)beta(2)gamma(2S) GABA(A)Rs indicate that the observed clinical differences between clobazam and 1,4-benzodiazepines are likely to arise from factors other than their respective pharmacological properties at the GABA(A)Rs as investigated here.	[Hammer, Harriet; Jensen, Anders A.] Univ Copenhagen, Dept Drug Design & Pharmacol, Fac Hlth & Med Sci, Copenhagen, Denmark; [Ebert, Bjarke; Jensen, Henrik Sindal] H Lundbeck & Co AS, Valby, Denmark	University of Copenhagen; Lundbeck Corporation	Jensen, AA (corresponding author), Univ Copenhagen, Dept Drug Design & Pharmacol, Fac Hlth & Med Sci, Copenhagen, Denmark.	aaj@sund.ku.dk	Jensen, Anders/AAJ-3335-2020	Jensen, Anders/0000-0002-7927-5052; Hammer, Harriet/0000-0002-5705-446X	Lundbeck (US); Novo Nordisk Foundation; Lundbeck (Denmark); Novo Nordisk Fonden [NNF11OC1014338] Funding Source: researchfish	Lundbeck (US); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Lundbeck (Denmark)(Lundbeck Corporation); Novo Nordisk Fonden(Novo Nordisk Foundation)	Funding: HH and AAJ received an unrestricted grant from Lundbeck (US) to conduct this work. AAJ thanks the Novo Nordisk Foundation for financial support. Lundbeck (Denmark) provided support in the form of salaries for authors HSJ and BE, but neither Lundbeck (US) or Lundbeck (Denmark) have had any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atack JR, 2011, CURR TOP MED CHEM, V11, P1176; Atack JR, 2011, CURR TOP MED CHEM, V11, P1203; Barnes NM, 2009, NEUROPHARMACOLOGY, V56, P273, DOI 10.1016/j.neuropharm.2008.08.003; Baumann SW, 2002, J BIOL CHEM, V277, P46020, DOI 10.1074/jbc.M207663200; Baur R, 2006, FEBS LETT, V580, P1616, DOI 10.1016/j.febslet.2006.02.002; Baur R, 2008, J NEUROCHEM, V106, P2353, DOI 10.1111/j.1471-4159.2008.05574.x; Belelli D, 2009, J NEUROSCI, V29, P12757, DOI 10.1523/JNEUROSCI.3340-09.2009; Bettler B, 2004, PHYSIOL REV, V84, P835, DOI 10.1152/physrev.00036.2003; Bowser DN, 2002, P NATL ACAD SCI USA, V99, P15170, DOI 10.1073/pnas.212320199; Brickley SG, 2012, NEURON, V73, P23, DOI 10.1016/j.neuron.2011.12.012; Buhr A, 1996, MOL PHARMACOL, V49, P1080; Cramer JA, 2013, ACTA NEUROL SCAND, V128, P91, DOI 10.1111/ane.12086; Ebert B, 2006, PHARMACOL THERAPEUT, V112, P612, DOI 10.1016/j.pharmthera.2005.04.014; Engin E, 2012, PHARMACOL THERAPEUT, V136, P142, DOI 10.1016/j.pharmthera.2012.08.006; Feng HJ, 2004, MOL PHARMACOL, V66, P988, DOI 10.1124/mol.104.002543; Feng HJ, 2004, MOL PHARMACOL, V66, P1517, DOI 10.1124/mol.104.003426; Feng HJ, 2010, J BIOL CHEM, V285, P23614, DOI 10.1074/jbc.M110.122564; Fisher JL, 2011, EUR J PHARMACOL, V654, P160, DOI 10.1016/j.ejphar.2010.12.037; Fradley RL, 2007, J PSYCHOPHARMACOL, V21, P384, DOI 10.1177/0269881106067255; HAIGH JRM, 1987, BRIT J CLIN PHARMACO, V23, P213, DOI 10.1111/j.1365-2125.1987.tb03032.x; Hevers W, 1998, MOL NEUROBIOL, V18, P35, DOI 10.1007/BF02741459; HillVenning C, 1997, BRIT J PHARMACOL, V120, P749, DOI 10.1038/sj.bjp.0700927; Hoestgaard-Jensen K, 2013, BRIT J PHARMACOL, V170, P919, DOI 10.1111/bph.12340; Hoestgaard-Jensen K, 2014, J NEUROSCI, V34, P16256, DOI 10.1523/JNEUROSCI.1495-14.2014; Hosie AM, 2003, NAT NEUROSCI, V6, P362, DOI 10.1038/nn1030; Jensen AA, 2005, J MED CHEM, V48, P4705, DOI 10.1021/jm040219e; Jensen AA, 2010, J BIOL CHEM, V285, P10141, DOI 10.1074/jbc.M109.079319; Jensen HS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088456; Karim N, 2013, AMINO ACIDS, V44, P1139, DOI 10.1007/s00726-012-1456-y; Karim N, 2012, BIOCHEM PHARMACOL, V84, P549, DOI 10.1016/j.bcp.2012.05.017; Khom S, 2006, MOL PHARMACOL, V69, P640, DOI 10.1124/mol.105.017236; Kinoshita M, 2007, J NEUROL SCI, V263, P44, DOI 10.1016/j.jns.2007.05.025; Krishek BJ, 1998, J PHYSIOL-LONDON, V507, P639, DOI 10.1111/j.1469-7793.1998.639bs.x; Leahy JT, 2011, NEUROPSYCH DIS TREAT, V7, P673, DOI [10.2147/NDT.520173, 10.2147/NDT.S20173]; Lynch JW, 2009, NEUROPHARMACOLOGY, V56, P303, DOI 10.1016/j.neuropharm.2008.07.034; McKernan RM, 2000, NAT NEUROSCI, V3, P587, DOI 10.1038/75761; Mirheydari P, 2014, NEUROCHEM RES, V39, P1057, DOI 10.1007/s11064-013-1156-3; Miura Y, 2002, EPILEPSY RES, V49, P189, DOI 10.1016/S0920-1211(02)00032-3; Morlock EV, 2011, MOL PHARMACOL, V80, P14, DOI 10.1124/mol.110.069542; Ng YT, 2007, NEUROTHERAPEUTICS, V4, P138, DOI 10.1016/j.nurt.2006.11.002; Olsen JA, 2013, J BIOL CHEM, V288, P35997, DOI 10.1074/jbc.M113.498618; Olsen RW, 2008, PHARMACOL REV, V60, P243, DOI 10.1124/pr.108.00505; Olsen RW, 2009, NEUROPHARMACOLOGY, V56, P141, DOI 10.1016/j.neuropharm.2008.07.045; Petroski RE, 2006, J PHARMACOL EXP THER, V317, P369, DOI 10.1124/jpet.105.096701; Pirker S, 2000, NEUROSCIENCE, V101, P815, DOI 10.1016/S0306-4522(00)00442-5; Pistis M, 1997, BRIT J PHARMACOL, V122, P1707, DOI 10.1038/sj.bjp.0701563; Rabe H, 2007, NEUROPHARMACOLOGY, V52, P796, DOI 10.1016/j.neuropharm.2006.09.013; Rahman M, 2006, EUR J PHARMACOL, V547, P37, DOI 10.1016/j.ejphar.2006.07.039; Ramerstorfer J, 2011, J NEUROSCI, V31, P870, DOI 10.1523/JNEUROSCI.5012-10.2011; Rowlett JK, 2005, P NATL ACAD SCI USA, V102, P915, DOI 10.1073/pnas.0405621102; Rudolph U, 1999, NATURE, V401, P796, DOI 10.1038/44579; Rudolph U, 2011, NAT REV DRUG DISCOV, V10, P685, DOI 10.1038/nrd3502; SANGER DJ, 1994, NEUROSCI BIOBEHAV R, V18, P355, DOI 10.1016/0149-7634(94)90049-3; Sankar R, 2012, CNS DRUGS, V26, P229, DOI 10.2165/11599020-000000000-00000; Sanna E, 2002, EUR J PHARMACOL, V451, P103, DOI 10.1016/S0014-2999(02)02191-X; SIEGHART W, 1995, PHARMACOL REV, V47, P181; Sieghart W, ADV PHARMACOL IN PRE; Sigel E, 2012, J BIOL CHEM, V287, P40224, DOI 10.1074/jbc.R112.386664; Sigel E, 2011, CURR TOP MED CHEM, V11, P241, DOI 10.2174/156802611794863562; SMART TG, 1991, BRIT J PHARMACOL, V103, P1837, DOI 10.1111/j.1476-5381.1991.tb12337.x; Steru L, 1986, EPILEPSIA, P27; Storustovu SI, 2006, J PHARMACOL EXP THER, V316, P1351, DOI 10.1124/jpet.105.092403; Strustovu SI, 2003, EUR J PHARMACOL, V467, P49, DOI 10.1016/S0014-2999(03)01603-0; Tolbert D, 2013, EPILEPSY CURRENTS S1, V13; VANDERMEYDEN CH, 1989, EUR J CLIN PHARMACOL, V37, P365, DOI 10.1007/BF00558501; Varagic Z, 2013, BRIT J PHARMACOL, V169, P384, DOI 10.1111/bph.12153; Wafford KA, 2009, NEUROPHARMACOLOGY, V56, P182, DOI 10.1016/j.neuropharm.2008.08.004; Wallner M, 2014, NEUROCHEM RES, V39, P1118, DOI 10.1007/s11064-014-1243-0; Walters RJ, 2000, NAT NEUROSCI, V3, P1274, DOI 10.1038/81800; Whiting PJ, 2003, DRUG DISCOV TODAY, V8, P445, DOI 10.1016/S1359-6446(03)02703-X; WILDIN JD, 1990, BRIT J CLIN PHARMACO, V29, P169, DOI 10.1111/j.1365-2125.1990.tb03616.x; WISDEN W, 1992, J NEUROSCI, V12, P1040; Wooltorton JRA, 1997, EUR J NEUROSCI, V9, P2225, DOI 10.1111/j.1460-9568.1997.tb01641.x; Wu TY, 2008, MOL PHARMACOL, V74, P466, DOI 10.1124/mol.107.044388; You H, 2007, J NEUROCHEM, V103, P1092, DOI 10.1111/j.1471-4159.2007.04817.x; Young GT, 2008, P NATL ACAD SCI USA, V105, P14686, DOI 10.1073/pnas.0804372105	77	16	16	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0120239	10.1371/journal.pone.0120239	http://dx.doi.org/10.1371/journal.pone.0120239			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25798598	gold, Green Published, Green Submitted			2022-12-27	WOS:000351987300113
J	Lester, PJ; Bosch, PJ; Gruber, MAM; Kapp, EA; Peng, LF; Brenton-Rule, EC; Buchanan, J; Stanislawek, WL; Archer, M; Corley, JC; Masciocchi, M; Van Oystaeyen, A; Wenseleers, T				Lester, Philip J.; Bosch, Peter J.; Gruber, Monica A. M.; Kapp, Eugene A.; Peng, Lifeng; Brenton-Rule, Evan C.; Buchanan, Joe; Stanislawek, Wlodek L.; Archer, Michael; Corley, Juan C.; Masciocchi, Maite; Van Oystaeyen, Annette; Wenseleers, Tom			No Evidence of Enemy Release in Pathogen and Microbial Communities of Common Wasps (Vespula vulgaris) in Their Native and Introduced Range	PLOS ONE			English	Article							DEFORMED WING VIRUS; HONEY-BEE; SOCIAL WASPS; BIOLOGICAL WEAPONS; STATISTICAL-MODEL; PARALYSIS VIRUS; HYMENOPTERA; TRANSMISSION; PROTEOMICS; VESPIDAE	When invasive species move to new environments they typically experience population bottlenecks that limit the probability that pathogens and parasites are also moved. The invasive species may thus be released from biotic interactions that can be a major source of density-dependent mortality, referred to as enemy release. We examined for evidence of enemy release in populations of the common wasp (Vespula vulgaris), which attains high densities and represents a major threat to biodiversity in its invaded range. Mass spectrometry proteomic methods were used to compare the microbial communities in wasp populations in the native (Belgium and England) and invaded range (Argentina and New Zealand). We found no evidence of enemy release, as the number of microbial taxa was similar in both the introduced and native range. However, some evidence of distinctiveness in the microbial communities was observed between countries. The pathogens observed were similar to a variety of taxa observed in honey bees. These taxa included Nosema, Paenibacillus, and Yersina spp. Genomic methods confirmed a diversity of Nosema spp., Actinobacteria, and the Deformed wing and Kashmir bee viruses. We also analysed published records of bacteria, viruses, nematodes and fungi from both V. vulgaris and the related invader V. germanica. Thirty-three different microorganism taxa have been associated with wasps including Kashmir bee virus and entomophagous fungi such as Aspergillus flavus. There was no evidence that the presence or absence of these microorganisms was dependent on region of wasp samples (i.e. their native or invaded range). Given the similarity of the wasp pathogen fauna to that from honey bees, the lack of enemy release in wasp populations is probably related to spill-over or spill-back from bees and other social insects. Social insects appear to form a reservoir of generalist parasites and pathogens, which makes the management of wasp and bee disease difficult.	[Lester, Philip J.; Gruber, Monica A. M.; Brenton-Rule, Evan C.; Buchanan, Joe] Victoria Univ Wellington, Ctr Biodivers & Restorat Ecol, Wellington, New Zealand; [Bosch, Peter J.; Peng, Lifeng] Victoria Univ Wellington, Ctr Biodiscovery, Wellington, New Zealand; [Bosch, Peter J.] Univ Iowa, Dept Biol, Iowa City, IA 52242 USA; [Kapp, Eugene A.] Walter & Eliza Hall Inst Med Res, Melbourne, Vic 3050, Australia; [Kapp, Eugene A.] Univ Melbourne, Melbourne, Vic, Australia; [Stanislawek, Wlodek L.] Minist Primary Ind, Invest & Diagnost Ctr Wallaceville, Upper Hutt, New Zealand; [Archer, Michael] York St John Univ, York, N Yorkshire, England; [Corley, Juan C.; Masciocchi, Maite] Consejo Nacl Invest Cient & Tecn, RA-1033 Buenos Aires, DF, Argentina; [Corley, Juan C.; Masciocchi, Maite] INTA EEA Bariloche, Grp Ecol Poblac Insectos, San Carlos De Bariloche, Rio Negro, Argentina; [Van Oystaeyen, Annette; Wenseleers, Tom] Univ Leuven, Lab Socioecol & Social Evolut, Leuven, Belgium	Victoria University Wellington; Victoria University Wellington; University of Iowa; Walter & Eliza Hall Institute; University of Melbourne; York Saint John University; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Instituto Nacional de Tecnologia Agropecuaria (INTA); KU Leuven	Lester, PJ (corresponding author), Victoria Univ Wellington, Ctr Biodivers & Restorat Ecol, Wellington, New Zealand.	Phil.Lester@vuw.ac.nz	Lester, Phil/A-1296-2008; Wenseleers, Tom/J-3960-2013; Masciocchi, Maite/K-3378-2019; Van Oystaeyen, Annette/AEG-9300-2022	Lester, Phil/0000-0002-1801-5687; Wenseleers, Tom/0000-0002-1434-861X; Bosch, Peter/0000-0002-0480-3439; Gruber, Monica/0000-0001-6780-8838; Peng, Lifeng/0000-0002-2043-5912; Masciocchi, Maite/0000-0002-0095-2170	Victoria University of Wellington; Department of Conservation; Royal Society of New Zealand Marsden Grant [13-VUW-037]; PIP CONICET [11220090100043]	Victoria University of Wellington; Department of Conservation; Royal Society of New Zealand Marsden Grant(Royal Society of New ZealandMarsden Fund (NZ)); PIP CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	PJL, MAMG, JB, PB, and ECBR received funding from Victoria University of Wellington, the Department of Conservation, and a Royal Society of New Zealand Marsden Grant (13-VUW-037). JCC and MM were funded by a PIP 2010 CONICET Grant #11220090100043. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aebersold R, 2003, NATURE, V422, P198, DOI 10.1038/nature01511; Aizenberg-Gershtein Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067556; Anderson KE, 2011, INSECT SOC, V58, P431, DOI 10.1007/s00040-011-0194-6; Anderson KE, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0058425, 10.1371/journal.pone.0083125]; Archer, 1989, RES MONOGRAPH COLL R, V31, P291; ARCHER ME, 1981, ECOL ENTOMOL, V6, P1, DOI 10.1111/j.1365-2311.1981.tb00966.x; ARCHER ME, 1985, J ANIM ECOL, V54, P473, DOI 10.2307/4492; BAKER MD, 1995, J EUKARYOT MICROBIOL, V42, P564, DOI 10.1111/j.1550-7408.1995.tb05906.x; Barlow ND, 2002, J ANIM ECOL, V71, P663, DOI 10.1046/j.1365-2656.2002.00630.x; Beggs JR, 2011, BIOCONTROL, V56, P505, DOI 10.1007/s10526-011-9389-z; Beggs JR, 1998, NEW ZEAL J ECOL, V22, P55; Blehert DS, 2009, SCIENCE, V323, P227, DOI 10.1126/science.1163874; Boerjan B, 2012, CAN J ZOOL, V90, P440, DOI 10.1139/Z2012-010; Bromenshenk JJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013181; Carpenter JM, 2010, AM MUS NOVIT, P1, DOI 10.1206/706.1; Colautti RI, 2004, ECOL LETT, V7, P721, DOI 10.1111/j.1461-0248.2004.00616.x; Dvorak Libor, 2007, Acta Musei Moraviae Scientiae Biologicae, V92, P181; Evans JD, 2011, TRENDS MICROBIOL, V19, P614, DOI 10.1016/j.tim.2011.09.003; Evison SEF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030641; Fantham H. B., 1914, Annals of Tropical Medicine and Parasitology, V8; Forsgren E, 2010, APIDOLOGIE, V41, P99, DOI 10.1051/apido/2009065; Foster LJ, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.006387; Francis RM, 2012, J APIC SCI, V56, P137, DOI 10.2478/v10289-012-0014-x; Fries I, 2001, APIDOLOGIE, V32, P199, DOI 10.1051/apido:2001122; Furst MA, 2014, NATURE, V506, P364, DOI 10.1038/nature12977; Gardner-Gee R, 2013, AUSTRAL ECOL, V38, P346, DOI 10.1111/j.1442-9993.2012.02412.x; Graystock P, 2013, J INVERTEBR PATHOL, V114, P114, DOI 10.1016/j.jip.2013.06.005; Gu X, 1996, P NATL ACAD SCI USA, V93, P4671, DOI 10.1073/pnas.93.10.4671; Heger T, 2014, OIKOS, V123, P741, DOI 10.1111/j.1600-0706.2013.01263.x; Jabbour RE, 2010, APPL ENVIRON MICROB, V76, P3637, DOI 10.1128/AEM.00055-10; Jacobs J, 2011, INDIVIDUAL BASED RAR; Jones CM, 2014, J ANIM ECOL, V83, P1428, DOI 10.1111/1365-2656.12235; Kanzaki N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099241; Keane RM, 2002, TRENDS ECOL EVOL, V17, P164, DOI 10.1016/S0169-5347(02)02499-0; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Knudsen GM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020873; Kristof LJ, 1879, MITTEILUNGEN NATURWI, V15, P38; Lanzi G, 2006, J VIROL, V80, P4998, DOI 10.1128/JVI.80.10.4998-5009.2006; Lester P., 2013, N SCI REV, V70, P56; Lester PJ, 2014, DIVERS DISTRIB, V20, P964, DOI 10.1111/ddi.12223; Lester PJ, 2014, NZ ENTOMOL, V37, P1; Levitt AL, 2013, VIRUS RES, V176, P232, DOI 10.1016/j.virusres.2013.06.013; Madden AA, 2013, ENVIRON ENTOMOL, V42, P703, DOI 10.1603/EN12159; MOLLER H, 1991, NEW ZEAL J ZOOL, V18, P171, DOI 10.1080/03014223.1991.10757964; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Oksanen J., 2020, VEGAN COMMUNITY ECOL; Peng LF, 2011, PROTEOMICS, V11, P4376, DOI 10.1002/pmic.201100169; R Core Team, 2021, R LANGUAGE ENV STAT; Reeson AF, 2003, INSECT MOL BIOL, V12, P85, DOI 10.1046/j.1365-2583.2003.00390.x; Rose EAF, 1999, NEW ZEAL J ZOOL, V26, P179, DOI 10.1080/03014223.1999.9518188; Scheipl F., 2020, LINEAR MIXED EFFECTS, DOI 10.18637/jss.v067.i01; Schroeder DC, 2012, VIRULENCE, V3, P589, DOI 10.4161/viru.22219; Singh R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014357; Stach JEM, 2003, ENVIRON MICROBIOL, V5, P828, DOI 10.1046/j.1462-2920.2003.00483.x; Strauss A, 2012, FUNCT ECOL, V26, P1249, DOI 10.1111/1365-2435.12011; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tavare S., 1986, LECT MATH LIFE SCI, V17, P57; Toft RJ, 1998, ECOL ENTOMOL, V23, P90, DOI 10.1046/j.1365-2311.1998.00100.x; Torchin ME, 2003, NATURE, V421, P628, DOI 10.1038/nature01346; URDANETA-MORALES S, 1983, Revista Brasileira de Biologia, V43, P409; Vilcinskas A, 2013, SCIENCE, V340, P862, DOI 10.1126/science.1234032; Vizcaino JA, 2014, NAT BIOTECHNOL, V32, P223, DOI 10.1038/nbt.2839; Yanez O, 2012, APIDOLOGIE, V43, P587, DOI 10.1007/s13592-012-0128-y; Yang CC, 2010, BIOL INVASIONS, V12, P3307, DOI 10.1007/s10530-010-9724-9	64	28	29	1	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0121358	10.1371/journal.pone.0121358	http://dx.doi.org/10.1371/journal.pone.0121358			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25798856	Green Published, gold, Green Submitted			2022-12-27	WOS:000351987300244
J	Teixeira, C; Silva, S; Severo, M; Barros, H				Teixeira, Cristina; Silva, Susana; Severo, Milton; Barros, Henrique			Socioeconomic Position Early in Adolescence and Mode of Delivery Later in Life: Findings from a Portuguese Birth Cohort	PLOS ONE			English	Article							BRITISH WOMENS HEART; CESAREAN-SECTION; HEALTH BEHAVIORS; ADULT HEALTH; RISK-FACTORS; FOLLOW-UP; CHILDBIRTH; PREFERENCE; OUTCOMES; TRENDS	Objective This study assessed the influence of socioeconomic position at 12 years of age (SEP-12) on the variability in cesarean rates later in life. Methods As part of the Portuguese Generation XXI birth cohort we evaluated 7358 women with a singleton pregnancy who delivered at five Portuguese public hospitals serving the region of Porto (April/2005-September/2006). Based on the twelve items that described socioeconomic circumstances at age 12, a latent class analysis was used to classify women's SEP-12 as high, intermediate and low. Multiple Poisson regression was used to estimate adjusted risk ratio (RR) and respective 95% confidence interval (95% CI). Results The cesarean rates in high, intermediate and low SEP-12 were, respectively, 40.9%, 37.5% and 40.5% (p = 0.100) among primiparous women; 14.2%, 11.6% and 15.5% (p = 0.04) among multiparous women with no previous cesarean and 78.6%, 72.2% and 70.0% (p = 0.08) among women with a previous cesarean. A low to moderate association between SEP-12 and cesarean rates was observed among multiparous women with a previous cesarean, illustrating that women from higher SEP-12 were more likely to have a surgical delivery (RR = 1.12;95% CI:1.01-1.24 comparing high with low SEP-12 and RR = 1.03:95% CI:0.94-1.14 comparing intermediate with low SEP-12) not explained by potential mediating factors. No such association was found either in primiparous or in multiparous women without a previous cesarean. Conclusions The association between SEP-12 and cesarean rates suggests the effect of past socioeconomic context on the decision concerning the mode of delivery, but only among women who experienced a previous cesarean. Accordingly, it appears that early-life socioeconomic circumstances drive cesarean rates but the effect can be modified by lived experiences concerning childbirth.	[Teixeira, Cristina; Silva, Susana; Severo, Milton; Barros, Henrique] Univ Porto, Inst Publ Hlth, P-4100 Oporto, Portugal; [Teixeira, Cristina; Silva, Susana; Severo, Milton; Barros, Henrique] Univ Porto, Sch Med, Dept Clin Epidemiol Predict Med & Publ Hlth, P-4100 Oporto, Portugal; [Teixeira, Cristina] Polytech Inst Braganca, Braganca, Portugal	Universidade do Porto; Universidade do Porto; Instituto Politecnico de Braganca	Teixeira, C (corresponding author), Univ Porto, Inst Publ Hlth, Rua Campo Alegre 823, P-4100 Oporto, Portugal.	cristina.teixeira@ipb.pt	Severo, Milton/I-3497-2012; Teixeira, Cristina/AAC-9697-2019; Silva, Susana/AAV-5517-2020; Barros, Henrique/A-5488-2008; Teixeira, Cristina/O-2296-2013; Barros, Henrique/Q-8609-2019	Severo, Milton/0000-0002-5787-4871; Silva, Susana/0000-0002-1335-8648; Teixeira, Cristina/0000-0001-5194-5141; Barros, Henrique/0000-0003-4699-6571	Health Ministry of Portugal (through Programa Operacional de Saude - SAUDE XXI); Calouste Gulbenkian Foundation; Portuguese Foundation for Science and Technology [PIC/IC/83038/2007, SFRH/PROTEC/67591/2010]; Health Ministry of Portugal (through Quadro Comunitario de Apoio III); Health Ministry of Portugal (through Administracao Regional de Saude do Norte)	Health Ministry of Portugal (through Programa Operacional de Saude - SAUDE XXI); Calouste Gulbenkian Foundation; Portuguese Foundation for Science and Technology(Portuguese Foundation for Science and Technology); Health Ministry of Portugal (through Quadro Comunitario de Apoio III); Health Ministry of Portugal (through Administracao Regional de Saude do Norte)	This study was supported by a grant from Health Ministry of Portugal (through Programa Operacional de Saude - SAUDE XXI, Quadro Comunitario de Apoio III and Administracao Regional de Saude do Norte), the Calouste Gulbenkian Foundation and the Portuguese Foundation for Science and Technology through institutional [PIC/IC/83038/2007] and individual grant (SFRH/PROTEC/67591/2010). The funders had no role in study design, data collection, analysis, decision to publish or preparation of the manuscript.	Abel T, 2008, J EPIDEMIOL COMMUN H, V62, DOI 10.1136/jech.2007.066159; Althabe F, 2004, LANCET, V363, P1934, DOI 10.1016/S0140-6736(04)16406-4; Alves B, 2005, BJOG-INT J OBSTET GY, V112, P994, DOI 10.1111/j.1471-0528.2005.00657.x; Amuzu A, 2009, EUR J CARDIOV PREV R, V16, P169, DOI 10.1097/HJR.0b013e328325d64d; Barros Aluisio J D, 2003, BMC Med Res Methodol, V3, P21, DOI 10.1186/1471-2288-3-21; Batty GD, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-302; Behague DP, 2002, BMJ-BRIT MED J, V324, P942, DOI 10.1136/bmj.324.7343.942; Borgonovi F, 2010, SOC SCI MED, V71, P1927, DOI 10.1016/j.socscimed.2010.09.018; Bryant AS, 2009, PAEDIATR PERINAT EP, V23, P454, DOI 10.1111/j.1365-3016.2009.01059.x; Cammu H, 2011, BIRTH-ISS PERINAT C, V38, P191, DOI 10.1111/j.1523-536X.2011.00476.x; Cesaroni G, 2008, BIRTH-ISS PERINAT C, V35, P241, DOI 10.1111/j.1523-536X.2008.00245.x; Clark EAS, 2011, AM J OBSTET GYNECOL, V205, pS2, DOI 10.1016/j.ajog.2011.09.028; Cohen S, 2010, ANN NY ACAD SCI, V1186, P37, DOI 10.1111/j.1749-6632.2009.05334.x; COHN J, 1985, LANCET, V2, P437; Declercq E, 2007, OBSTET GYNECOL, V109, P669, DOI 10.1097/01.AOG.0000255668.20639.40; Fairley L, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-330; Fenwick J, 2005, MIDWIFERY, V21, P23, DOI 10.1016/j.midw.2004.07.001; Flamm BL, 2001, BEST PRACT RES CL OB, V15, P81, DOI 10.1053/beog.2000.0150; Galobardes B, 2006, J EPIDEMIOL COMMUN H, V60, P95, DOI 10.1136/jech.2004.028092; Gamble JA, 2001, BIRTH-ISS PERINAT C, V28, P101, DOI 10.1046/j.1523-536X.2001.00101.x; Graham H, 2010, SOC SCI MED, V70, P582, DOI 10.1016/j.socscimed.2009.10.041; Graham WJ, 1999, BRIT J OBSTET GYNAEC, V106, P213, DOI 10.1111/j.1471-0528.1999.tb08233.x; Guihard P, 2001, BRIT J OBSTET GYNAEC, V108, P48, DOI 10.1016/S0306-5456(00)00009-7; Habiba M, 2006, BJOG-INT J OBSTET GY, V113, P647, DOI 10.1111/j.1471-0528.2006.00933.x; Hawe P, 2000, SOC SCI MED, V51, P871, DOI 10.1016/S0277-9536(00)00067-8; Henderson J, 2001, BRIT J OBSTET GYNAEC, V108, P149; Hildingsson I, 2002, BJOG-INT J OBSTET GY, V109, P618, DOI 10.1111/j.1471-0528.2002.01393.x; Hildingsson I, 2008, MIDWIFERY, V24, P46, DOI 10.1016/j.midw.2006.07.007; Hillsdon M, 2008, J EPIDEMIOL COMMUN H, V62, P344, DOI 10.1136/jech.2006.058610; Jefferis BJMH, 2004, AM J PUBLIC HEALTH, V94, P279, DOI 10.2105/AJPH.94.2.279; Johanson R, 2002, BRIT MED J, V324, P892, DOI 10.1136/bmj.324.7342.892; Kramer MS, 2001, PEDIATRICS, V108, DOI 10.1542/peds.108.2.e35; Krieger N, 2004, EPIDEMIOL REV, V26, P92, DOI 10.1093/epirev/mxh009; Kuh D, 2003, J EPIDEMIOL COMMUN H, V57, P778, DOI 10.1136/jech.57.10.778; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lawlor DA, 2005, AM J PUBLIC HEALTH, V95, P1245, DOI 10.2105/AJPH.2004.041129; Leone T, 2008, SOC SCI MED, V67, P1236, DOI 10.1016/j.socscimed.2008.06.032; Liu SL, 2007, CAN MED ASSOC J, V176, P455, DOI 10.1503/cmaj.060870; Lynch JW, 1997, SOC SCI MED, V44, P809, DOI 10.1016/S0277-9536(96)00191-8; Matijasevich A, 2012, J EPIDEMIOL COMMUN H, V66, P127, DOI 10.1136/jech.2010.108605; Mazzoni A, 2011, BJOG-INT J OBSTET GY, V118, P391, DOI 10.1111/j.1471-0528.2010.02793.x; Mercer BM, 2008, OBSTET GYNECOL, V111, P285, DOI 10.1097/AOG.0b013e31816102b9; Niino Y, 2011, BIOSCI TRENDS, V5, P139, DOI 10.5582/bst.2011.v5.4.139; Pang Man Wah, 2008, Birth, V35, P121, DOI 10.1111/j.1523-536X.2008.00225.x; PORDATA, 2012, BAS DAD PORT CONT; Scharoun-Lee M, 2011, DEMOGRAPHY, V48, P625, DOI 10.1007/s13524-011-0024-5; Severo M, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001510; Simpson KR, 2003, JOGNN-J OBST GYN NEO, V32, P767, DOI 10.1177/0884217503258528; Teixeira C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060168; Tollanes MC, 2007, ACTA OBSTET GYN SCAN, V86, P840, DOI 10.1080/00016340701417422; van de Mheen H, 1998, INT J EPIDEMIOL, V27, P431, DOI 10.1093/ije/27.3.431; Victora CG, 1997, INT J EPIDEMIOL, V26, P224, DOI 10.1093/ije/26.1.224; Walsh DJ, 2010, SOCIOL HEALTH ILL, V32, P486, DOI 10.1111/j.1467-9566.2009.01207.x; Witt WP, 2015, MATERN CHILD HLTH J, V19, P84, DOI 10.1007/s10995-014-1498-8; World Health Organization (WHO), 2020, EUR HLTH ALL DAT HFA; Wu JM, 2012, MATERN CHILD HLTH J, V16, P1447, DOI 10.1007/s10995-011-0910-x; Yuan KH, 2000, SOCIOL METHODOL, V30, P165, DOI 10.1111/0081-1750.00078; Zlot AI, 2005, MATERN CHILD HLTH J, V9, P11, DOI 10.1007/s10995-005-2447-3	58	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0119517	10.1371/journal.pone.0119517	http://dx.doi.org/10.1371/journal.pone.0119517			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CE6ZS	25799142	Green Published, gold, Green Submitted			2022-12-27	WOS:000351987300057
J	Chen, YK; Hou, HA; Tang, JL; Jhuang, JY; Lai, YJ; Lee, MC; Kuo, YY; Chou, WC; Liu, CY; Lin, CW; Chuang, SS; Chen, CY; Tseng, MH; Huang, CF; Chiang, YC; Lee, FY; Liu, MC; Liu, CW; Yao, M; Huang, SY; Ko, BS; Hsu, SC; Wu, SJ; Tsay, W; Chen, YC; Tien, HF				Chen, Yin-Kai; Hou, Hsin-An; Tang, Jih-Luh; Jhuang, Jie-Yang; Lai, Yan-Jun; Lee, Ming-Cheng; Kuo, Yuan-Yeh; Chou, Wen-Chien; Liu, Chieh-Yu; Lin, Chung-Wu; Chuang, Shih-Sung; Chen, Chien-Yuan; Tseng, Mei-Hsuan; Huang, Chi-Fei; Chiang, Ying-Chieh; Lee, Fen-Yu; Liu, Ming-Chih; Liu, Chia-Wen; Yao, Ming; Huang, Shang-Yi; Ko, Bor-Sheng; Hsu, Szu-Chun; Wu, Shang-Ju; Tsay, Woei; Chen, Yao-Chang; Tien, Hwei-Fang			Clinical and Prognostic Implications of Roundabout 4 (Robo4) in Adult Patients with Acute Myeloid Leukemia	PLOS ONE			English	Article							PRIMARY MYELODYSPLASTIC SYNDROME; BONE-MARROW ANGIOGENESIS; TUMOR ENDOTHELIAL MARKER; DISEASE PROGRESSION; MAGIC ROUNDABOUT; LUNG-CANCER; EXPRESSION; MUTATION; STABILITY; SURVIVAL	Background Robo4 is involved in hematopoietic stem/progenitor cell homeostasis and essential for tumor angiogenesis. Expression of Robo4 was recently found in solid tumors and leukemia stem cells. However, the clinical implications of Robo4 expression in patients with acute myeloid leukemia (AML) remain unclear. Methods We investigated the clinical and prognostic relevance of mRNA expression of Robo4 in bone marrow (BM) mononuclear cells from 218 adult patients with de novo AML. We also performed immunohistochemical staining to assess the Robo4 protein expression in the BM biopsy specimens from 30 selected AML patients in the cohort. Results Higher Robo4 expression was closely associated with lower white blood cell counts, expression of HLA-DR, CD13, CD34 and CD56 on leukemia cells, t(8; 21) and ASXL1 mutation, but negatively correlated with t(15; 17) and CEBPA mutation. Compared to patients with lower Robo4 expression, those with higher expression had significantly shorter disease- free survival (DFS) and overall survival (OS). This result was confirmed in an independent validation cohort. Furthermore, multivariate analyses showed that higher Robo4 expression was an independent poor prognostic factor for DFS and OS in total cohort and patients with intermediate-risk cytogenetics, irrespective of age, WBC count, karyotype, and mutation status of NPM1/FLT3-ITD, and CEBPA. Conclusions BM Robo4 expression can serve as a new biomarker to predict clinical outcomes in AML patients and Robo4 may serve as a potential therapeutic target in patients with higher Robo4 expression.	[Chen, Yin-Kai; Hou, Hsin-An; Tang, Jih-Luh; Lai, Yan-Jun; Lee, Ming-Cheng; Chou, Wen-Chien; Chen, Chien-Yuan; Tseng, Mei-Hsuan; Huang, Chi-Fei; Chiang, Ying-Chieh; Yao, Ming; Huang, Shang-Yi; Ko, Bor-Sheng; Wu, Shang-Ju; Tsay, Woei; Chen, Yao-Chang; Tien, Hwei-Fang] Natl Taiwan Univ Hosp, Dept Internal Med, Div Hematol, Taipei 100, Taiwan; [Chen, Yin-Kai] Natl Taiwan Univ Hosp, Dept Internal Med, Yun Lin Branch, Yun Lin, Brazil; [Hou, Hsin-An] Natl Taiwan Univ, Coll Med, Grad Inst Clin Med, Taipei 10764, Taiwan; [Jhuang, Jie-Yang] Far Eastern Mem Hosp, Dept Pathol, New Taipei City, Taiwan; [Kuo, Yuan-Yeh] Natl Taiwan Univ, Coll Med, Grad Inst Oncol, Taipei 10764, Taiwan; [Chou, Wen-Chien; Hsu, Szu-Chun; Chen, Yao-Chang] Natl Taiwan Univ Hosp, Dept Lab Med, Taipei, Taiwan; [Liu, Chieh-Yu] Natl Taipei Univ Nursing & Hlth Sci, Biostat Consulting Lab, Dept Nursing, Taipei, Taiwan; [Lin, Chung-Wu; Lee, Fen-Yu; Liu, Ming-Chih; Liu, Chia-Wen] Natl Taiwan Univ Hosp, Dept Pathol, Taipei 100, Taiwan; [Chuang, Shih-Sung] Chi Mei Med Ctr, Dept Pathol, Tainan, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; Far Eastern Memorial Hospital; National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taipei University of Nursing & Health Science (NTUNHS); National Taiwan University; National Taiwan University Hospital; Chi Mei Hospital	Tang, JL (corresponding author), Natl Taiwan Univ Hosp, Dept Internal Med, Div Hematol, Taipei 100, Taiwan.	hftien@ntu.edu.tw; hftien@ntu.edu.tw	Liu, Chieh-Yu/J-3789-2019; Liu, Chieh-Yu/AAR-9654-2021	Liu, Chieh-Yu/0000-0003-3283-028X; YAO, MING/0000-0003-2932-0019; Huang, Shang-Yi/0000-0001-5688-3410; HOU, HSIN-AN/0000-0003-2780-4845; KO, BOR-SHENG/0000-0002-7965-7579; KUO, YUAN-YEH/0000-0002-6090-9000; TIEN, HWEI-FANG/0000-0002-1384-5593; LIN, CHUNG-WU/0000-0001-5042-0503; CHOU, WEN-CHIEN/0000-0003-2967-698X; TANG, JIH-LUH/0000-0003-4021-3281	National Science Council (Taiwan) [NSC 100-2314-B002-057-MY3, NSC 100-314-B-002-112-MY3, NSC 100-2628-B-002-003-MY3]; Ministry of Health and Welfare (Taiwan) [MOHW103-TD-B-111-04]; Department of Medical Research, National Taiwan University Hospital [NTUH 102P06, UN 102-015]	National Science Council (Taiwan)(Ministry of Science and Technology, Taiwan); Ministry of Health and Welfare (Taiwan); Department of Medical Research, National Taiwan University Hospital	This work was partially sponsored by grants NSC 100-2314-B002-057-MY3, NSC 100-314-B-002-112-MY3 and NSC 100-2628-B-002-003-MY3 from the National Science Council (Taiwan), MOHW103-TD-B-111-04 from the Ministry of Health and Welfare (Taiwan) and NTUH 102P06 and UN 102-015 from the Department of Medical Research, National Taiwan University Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkin G, 2005, HUM PATHOL, V36, P1302, DOI 10.1016/j.humpath.2005.08.016; Bedell VM, 2005, P NATL ACAD SCI USA, V102, P6373, DOI 10.1073/pnas.0408318102; BENDALL LJ, 1994, EXP HEMATOL, V22, P1252; Braig M, 2014, LEUKEMIA, V28, P2028, DOI 10.1038/leu.2014.95; Chen CY, 2006, LEUKEMIA, V20, P1155, DOI 10.1038/sj.leu.2404190; Chen CY, 2007, BRIT J HAEMATOL, V139, P405, DOI 10.1111/j.1365-2141.2007.06811.x; Chen TC, 2014, BLOOD CANCER J, V4, DOI 10.1038/bcj.2013.74; Cheng CL, 2011, BRIT J CANCER, V105, P975, DOI 10.1038/bjc.2011.340; Cheng WC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017347; Chou WC, 2011, LEUKEMIA, V25, P246, DOI 10.1038/leu.2010.267; Chou WC, 2006, CANCER RES, V66, P3310, DOI 10.1158/0008-5472.CAN-05-4316; Chou WC, 2011, BLOOD; Edelman MJ, 2008, J CLIN ONCOL, V26, P848, DOI 10.1200/JCO.2007.13.8081; Falini B, 2005, NEW ENGL J MED, V352, P254, DOI 10.1056/NEJMoa041974; Forsberg EC, 2005, PLOS GENET, V1, P281, DOI 10.1371/journal.pgen.0010028; Giles FJ, 2003, BRIT J HAEMATOL, V121, P578, DOI 10.1046/j.1365-2141.2003.04306.x; Gorn M, 2005, LUNG CANCER-J IASLC, V49, P71, DOI 10.1016/j.lungcan.2004.12.005; Goto-Koshino Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050849; Grone J, 2006, ONCOL REP, V15, P1437; Hou HA, 2008, LEUKEMIA, V22, P1075, DOI 10.1038/sj.leu.2405005; Hou HA, 2014, LEUKEMIA, V28, P50, DOI 10.1038/leu.2013.236; Hou HA, 2009, BRIT J CANCER, V101, P738, DOI 10.1038/sj.bjc.6605207; Hou HA, 2008, LEUKEMIA RES, V32, P904, DOI 10.1016/j.leukres.2007.08.010; Hou HA, 2012, BLOOD, V119, P559, DOI 10.1182/blood-2011-07-369934; Hou HA, 2010, HAEMATOL-HEMATOL J, V95, P1420, DOI 10.3324/haematol.2009.019364; Hou HA, 2010, BLOOD, V115, P5222, DOI 10.1182/blood-2009-12-259390; Huminiecki L, 2002, GENOMICS, V79, P547, DOI 10.1006/geno.2002.6745; Huminiecki L, 2000, GENOME RES, V10, P1796, DOI 10.1101/gr.150700; Jones CA, 2008, NAT MED, V14, P448, DOI 10.1038/nm1742; Jones CA, 2009, NAT CELL BIOL, V11, P1325, DOI 10.1038/ncb1976; Kidd T, 1998, CELL, V92, P205, DOI 10.1016/S0092-8674(00)80915-0; Konopleva MY, 2011, J CLIN ONCOL, V29, P591, DOI 10.1200/JCO.2010.31.0904; Legg JA, 2008, ANGIOGENESIS, V11, P13, DOI 10.1007/s10456-008-9100-x; Lin CC, 2013, AM J HEMATOLOGY; Long H, 2004, NEURON, V42, P213, DOI 10.1016/S0896-6273(04)00179-5; Marcucci G, 2000, CANCER INVEST, V18, P768, DOI 10.3109/07357900009012209; Nervi B, 2009, BLOOD, V113, P6206, DOI 10.1182/blood-2008-06-162123; Park KW, 2003, DEV BIOL, V261, P251, DOI 10.1016/S0012-1606(03)00258-6; SCHOLZEL C, 1985, EXP HEMATOL, V13, P664; Seth P, 2005, BIOCHEM BIOPH RES CO, V332, P533, DOI 10.1016/j.bbrc.2005.03.250; Shiah HS, 2002, LEUKEMIA, V16, P196, DOI 10.1038/sj.leu.2402352; Shibata F, 2009, STEM CELLS, V27, P183, DOI 10.1634/stemcells.2008-0292; Shih TTF, 2009, BLOOD, V113, P3161, DOI 10.1182/blood-2008-08-173104; Smith-Berdan S, 2011, CELL STEM CELL, V8, P72, DOI 10.1016/j.stem.2010.11.030; Tang JL, 2009, BLOOD, V114, P5352, DOI 10.1182/blood-2009-05-223784; Tien HF, 1995, CANCER GENET CYTOGEN, V84, P60, DOI 10.1016/0165-4608(95)00084-4; Yoshikawa M, 2013, BLOOD, V121, P2804, DOI 10.1182/blood-2012-12-468363	47	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0119831	10.1371/journal.pone.0119831	http://dx.doi.org/10.1371/journal.pone.0119831			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25794001	gold, Green Submitted, Green Published			2022-12-27	WOS:000352084200120
J	Costa, VV; Amaral, FA; Coelho, FM; Queiroz, CM; Malagoli, BG; Gomes, JHS; Lopes, F; Silveira, KD; Sachs, D; Fagundes, CT; Tavares, LD; Pinho, V; Silva, TA; Teixeira, MM; Braga, FC; Souza, DG				Costa, Vivian V.; Amaral, Flavio A.; Coelho, Fernanda M.; Queiroz-Junior, Celso M.; Malagoli, Bruna G.; Gomes, Jose Hugo S.; Lopes, Fernando; Silveira, Katia D.; Sachs, Daniela; Fagundes, Caio T.; Tavares, Livia D.; Pinho, Vanessa; Silva, Tarcilia A.; Teixeira, Mauro M.; Braga, Fernao C.; Souza, Danielle G.			Lithothamnion muelleri Treatment Ameliorates Inflammatory and Hypernociceptive Responses in Antigen-Induced Arthritis in Mice	PLOS ONE			English	Article							SULFATED POLYSACCHARIDES; CHLORELLA-STIGMATOPHORA; NEUTROPHIL RECRUITMENT; SYNOVIAL-FLUID; MURINE MODEL; INVOLVEMENT; MICROALGAE; THERAPIES; ADHESION; DISEASE	Rheumatoid Arthritis (RA) is a chronic disease characterized by persistent inflammation and pain. Alternative therapies to reduce these symptoms are needed. Marine algae are valuable sources of diverse bioactive compounds. Lithothamnion muelleri (Hapalidiaceae) is a marine algae with anti-inflammatory, antitumor, and immunomodulatory properties. Here, we investigated the potential anti-inflammatory and analgesic activities of L. muelleri in a murine model of antigen-induced arthritis (AIA) in mice. Our results demonstrate that treatment with L. muelleri prevented inflammation and hypernociception in arthritic mice. Mechanistically, the crude extract and the polysaccharide-rich fractions of L. muelleri may act impairing the production of the chemokines CXCL1 and CXCL2, and consequently inhibit neutrophil influx to the knee joint by dampening the adhesion step of leukocyte recruitment in the knee microvessels. Altogether our results suggest that treatment with L. muelleri has a potential therapeutic application in arthritis treatment.	[Costa, Vivian V.; Queiroz-Junior, Celso M.; Fagundes, Caio T.; Tavares, Livia D.; Souza, Danielle G.] Univ Fed Minas Gerais, ICB, Dept Microbiol, Lab Interacao Microrganismo Hospedeiro, Belo Horizonte, MG, Brazil; [Costa, Vivian V.; Amaral, Flavio A.; Coelho, Fernanda M.; Lopes, Fernando; Silveira, Katia D.; Fagundes, Caio T.; Tavares, Livia D.; Pinho, Vanessa; Silva, Tarcilia A.; Teixeira, Mauro M.; Souza, Danielle G.] Univ Fed Minas Gerais, ICB, Dept Bioquim & Imunol, Imunofarmacol, Belo Horizonte, MG, Brazil; [Costa, Vivian V.] Singapore MIT Alliance Res & Technol, Interdisciplinary Res Grp Infect Dis, Singapore, Singapore; [Queiroz-Junior, Celso M.; Silva, Tarcilia A.] Univ Fed Minas Gerais, Dept Clin Patol & Cirurgia Odontol, Fac Odontol, Belo Horizonte, MG, Brazil; [Malagoli, Bruna G.; Gomes, Jose Hugo S.; Braga, Fernao C.] Univ Fed Minas Gerais, Fac Farm, Dept Prod Farmaceut, Belo Horizonte, MG, Brazil; [Lopes, Fernando; Pinho, Vanessa] Univ Fed Minas Gerais, ICB, Dept Morfol, Belo Horizonte, MG, Brazil; [Sachs, Daniela] Univ Fed Itajuba UNIFEI, Inst Ciencias Exatas, Dept Fis & Quim, Itajuba, MG, Brazil	Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Singapore-MIT Alliance for Research & Technology Centre (SMART); Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Universidade Federal de Itajuba	Souza, DG (corresponding author), Univ Fed Minas Gerais, ICB, Dept Microbiol, Lab Interacao Microrganismo Hospedeiro, Belo Horizonte, MG, Brazil.	souzadg@gmail.com	Pinho, Vanessa/AAR-1686-2021; da Silva, Tarcília Aparecida/O-7530-2015; SILVEIRA, KATIA D/N-3036-2013; pinho, vanessa/AAC-8437-2020; Sachs, Daniela DS/I-3741-2012; Fagundes, Caio/AAK-9336-2020; Silva, Tarcilia/AAP-3760-2021; Amaral, Flávio Almeida/C-3768-2018; Braga, Fernão/AAO-3888-2020; Costa, Vivian VVC/I-2499-2018; Teixeira, Mauro M/A-4587-2008; Queiroz-Junior, Celso/L-5438-2013; Braga, Fernão C/E-3236-2016; Pinho, Vanessa/GXM-8532-2022	da Silva, Tarcília Aparecida/0000-0001-9623-7835; SILVEIRA, KATIA D/0000-0003-4955-3709; pinho, vanessa/0000-0003-1038-2324; Fagundes, Caio/0000-0002-6747-5233; Silva, Tarcilia/0000-0001-9623-7835; Amaral, Flávio Almeida/0000-0002-1695-0612; Braga, Fernão/0000-0001-9468-376X; Costa, Vivian VVC/0000-0002-0175-642X; Teixeira, Mauro M/0000-0002-6944-3008; Queiroz-Junior, Celso/0000-0002-7884-7709; Braga, Fernão C/0000-0001-9468-376X; 	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, Brazil); Cordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES, Brazil); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais - FAPEMIG, Brazil; Instituto Nacional de Ciencia e Tecnologia em Dengue - INCTem Dengue; "Science without borders" program (CNPq, Brazil)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Cordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES, Brazil)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais - FAPEMIG, Brazil(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Instituto Nacional de Ciencia e Tecnologia em Dengue - INCTem Dengue; "Science without borders" program (CNPq, Brazil)	The authors study is supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, Brazil), Cordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES, Brazil), Fundacao de Amparo a Pesquisa do Estado de Minas Gerais - FAPEMIG, Brazil, and Instituto Nacional de Ciencia e Tecnologia em Dengue - INCTem Dengue. VVC was also supported by "Science without borders" program (CNPq, Brazil). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaral FA, 2012, ARTHRITIS RHEUM-US, V64, P474, DOI 10.1002/art.33355; Aslam MN, 2010, INTEGR CANCER THER, V9, P93, DOI 10.1177/1534735409360360; BENDER JG, 1986, INFLAMMATION, V10, P443, DOI 10.1007/BF00915828; BOISSET M, 1994, J RHEUMATOL, V21, P148; Chaves LD, 2013, IMMUNOPHARM IMMUNOT, V35, P93, DOI 10.3109/08923973.2012.707211; Coelho FM, 2008, ARTHRITIS RHEUM-US, V58, P2329, DOI 10.1002/art.23622; Courtois J, 2009, CURR OPIN MICROBIOL, V12, P261, DOI 10.1016/j.mib.2009.04.007; Cunha TM, 2008, J LEUKOCYTE BIOL, V83, P824, DOI 10.1189/jlb.0907654; Dias G. T. M, 2000, BRAZILIAN J GEOPHYS, V18, DOI [10.1590/S0102-261X2000000300008, DOI 10.1590/S0102-261X2000000300008]; EDWARDS SW, 1988, BIOCHEM J, V250, P81, DOI 10.1042/bj2500081; Faulkner DJ, 2000, NAT PROD REP, V17, P7, DOI 10.1039/a809395d; Figueiredo JG, 2010, PHARMACOL BIOCHEM BE, V96, P371, DOI 10.1016/j.pbb.2010.06.008; Frestedt JL, 2008, NUTR J, V7, DOI 10.1186/1475-2891-7-9; Frestedt JL, 2009, NUTR J, V8, DOI 10.1186/1475-2891-8-7; Grespan R, 2008, ARTHRITIS RHEUM, V58, P2030, DOI 10.1002/art.23597; Guzman S, 2003, PHYTOTHER RES, V17, P665, DOI 10.1002/ptr.1227; Guzman S, 2001, PHYTOTHER RES, V15, P224, DOI 10.1002/ptr.715; Jiao GL, 2011, MAR DRUGS, V9, P196, DOI 10.3390/md9020196; KITSIS E, 1991, CLIN ORTHOP RELAT R, P63; Klareskog L, 2009, LANCET, V373, P659, DOI 10.1016/S0140-6736(09)60008-8; Kolaczkowska E, 2013, NAT REV IMMUNOL, V13, P159, DOI 10.1038/nri3399; Kowanko IC, 1996, CLIN IMMUNOL IMMUNOP, V79, P36, DOI 10.1006/clin.1996.0048; LEVINE JD, 1984, SCIENCE, V225, P743, DOI 10.1126/science.6087456; Lipsky PE, 2000, NEW ENGL J MED, V343, P1594, DOI 10.1056/NEJM200011303432202; Malagoli BG, 2014, INT J BIOL MACROMOL, V66, P332, DOI 10.1016/j.ijbiomac.2014.02.053; Matsui MS, 2003, APPL BIOCHEM BIOTECH, V104, P13, DOI 10.1385/ABAB:104:1:13; McInnes IB, 2007, NAT REV IMMUNOL, V7, P429, DOI 10.1038/nri2094; McInnes IB, 2011, NEW ENGL J MED, V365, P2205, DOI 10.1056/NEJMra1004965; Queiroz CM, 2011, J IMMUNOL, V187, P3821, DOI 10.4049/jimmunol.1101195; Rao JK, 1999, ANN INTERN MED, V131, P409, DOI 10.7326/0003-4819-131-6-199909210-00003; Rezende BM, 2013, MAR DRUGS, V11, P2595, DOI 10.3390/md11072595; Rodrigues JAG, 2012, PHARMACOL REP, V64, P282, DOI 10.1016/S1734-1140(12)70766-1; Sachs D, 2011, BRIT J PHARMACOL, V162, P72, DOI 10.1111/j.1476-5381.2010.00895.x; Assreuy AMS, 2008, BIOL PHARM BULL, V31, P691, DOI 10.1248/bpb.31.691; Smolen JS, 2007, LANCET, V370, P1861, DOI 10.1016/S0140-6736(07)60784-3; Soares CM, 2012, Z NATURFORSCH C, V67, P391; Tanaka D, 2006, IMMUNOLOGY, V119, P195, DOI 10.1111/j.1365-2567.2006.02424.x; Weinblatt ME, 1999, NEW ENGL J MED, V340, P253, DOI 10.1056/NEJM199901283400401; Wipke BT, 2001, J IMMUNOL, V167, P1601, DOI 10.4049/jimmunol.167.3.1601; Wright HL, 2010, RHEUMATOLOGY, V49, P1618, DOI 10.1093/rheumatology/keq045; ZIMMERMANN M, 1983, PAIN, V16, P109, DOI 10.1016/0304-3959(83)90201-4	41	8	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0118356	10.1371/journal.pone.0118356	http://dx.doi.org/10.1371/journal.pone.0118356			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25793994	gold, Green Published, Green Submitted			2022-12-27	WOS:000352084200021
J	Cozzi, G; Borger, L; Hutter, P; Abegg, D; Beran, C; McNutt, JW; Ozgul, A				Cozzi, Gabriele; Borger, Luca; Hutter, Pascale; Abegg, Daniela; Beran, Celine; McNutt, J. Weldon; Ozgul, Arpat			Effects of Trophy Hunting Leftovers on the Ranging Behaviour of Large Carnivores: A Case Study on Spotted Hyenas	PLOS ONE			English	Article							HOME-RANGE; CROCUTA-CROCUTA; POPULATION-DYNAMICS; HABITAT USE; FOOD; LIVESTOCK; PATTERNS; PREY; PREFERENCES; YELLOWSTONE	Human-related food resources such as garbage dumps and feeding sites have been shown to significantly influence space use, breeding success and population dynamics in a variety of animal species. In contrast, relatively little is known on the effects of unpredictable sources of food, such as carcasses discarded by hunters, on carnivore species. We evaluated the effect of elephant carcasses, mainly deriving from trophy hunting, on the ranging and feeding behavior of spotted hyenas (Crocuta crocuta) in the Okavango Delta, Botswana. Using data from hyenas monitored before and during carcass availability via GPS radio-collars and camera traps, we investigated changes in ranging and feeding behavior over time. Carcass availability influenced hyenas' ranging behavior for an average of 10-12 days, after which their movements returned to patterns observed before carcass availability. In particular, we observed an increased spatial clustering of locations and reduced speeds (up to 15% less) between successive locations with carcass availability. Consistent feeding at carcasses during the first two weeks was typical, and some individuals fed from elephant carcasses for as long as 50 days. The impact and conservation value of hunting are often assessed based solely on the effects on the hunted species. Our results show that hunting remains can influence other species and suggest that such extra food could have important effects on critical life history processes and ultimately population dynamics. We recommend conservationists and wildlife managers evaluate management strategies and hunting practices regarding carcass disposal in order to incorporate the potential collateral impacts of hunting on non-hunted species in the same community.	[Cozzi, Gabriele; Hutter, Pascale; Abegg, Daniela; Beran, Celine; Ozgul, Arpat] Univ Zurich, Inst Evolutionary Biol & Environm Studies, Populat Ecol Res Grp, Zurich, Switzerland; [Cozzi, Gabriele; McNutt, J. Weldon] Botswana Predator Conservat Trust, Maun, Botswana; [Borger, Luca] Swansea Univ, Coll Sci, Dept Biosci, Swansea, W Glam, Wales	University of Zurich; Swansea University	Cozzi, G (corresponding author), Univ Zurich, Inst Evolutionary Biol & Environm Studies, Populat Ecol Res Grp, Zurich, Switzerland.	gabriele.cozzi@uzh.ch	Cozzi, Gabriele/ABI-8232-2020; Ozgul, Arpat/K-2032-2012; Börger, Luca/C-6003-2008	Ozgul, Arpat/0000-0001-7477-2642; Börger, Luca/0000-0001-8763-5997; Cozzi, Gabriele/0000-0002-1744-1940	Basel Zoo; Forschungskredit der Universitat Zurich; Vontobel Stiftung	Basel Zoo; Forschungskredit der Universitat Zurich; Vontobel Stiftung	Funding: This work was funded by the Basel Zoo (http://www.zoobasel.ch), the Forschungskredit der Universitat Zurich (http://www.researchers.uzh.ch/promotion/forschungskredit_en.html) and the Vontobel Stiftung (http://www.vontobel-stiftung.ch). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altmann J, 2005, BEHAV ECOL SOCIOBIOL, V57, P490, DOI 10.1007/s00265-004-0870-x; Bartlam-Brooks HLA, 2011, ORYX, V45, P210, DOI 10.1017/S0030605310000414; Bateman PW, 2012, J ZOOL, V287, P1, DOI 10.1111/j.1469-7998.2011.00887.x; Beckmann JP, 2003, J ZOOL, V261, P207, DOI 10.1017/S0952836903004126; Bennitt E., 2012, THESIS U BRISTOL; Binder WJ, 2000, J ZOOL, V252, P273, DOI 10.1111/j.1469-7998.2000.tb00622.x; Bischof R, 2012, J APPL ECOL, V49, P824, DOI 10.1111/j.1365-2664.2012.02167.x; Borger L, 2008, ECOL LETT, V11, P637, DOI 10.1111/j.1461-0248.2008.01182.x; BOUTIN S, 1990, CAN J ZOOL, V68, P203, DOI 10.1139/z90-031; Bowman AW, 1997, APPL SMOOTHING TECHN; Brashares JS, 2011, P NATL ACAD SCI USA, V108, P13931, DOI 10.1073/pnas.1011526108; Bronson FH, 1989, MAMMALIAN REPROD BIO; Burroughs R, 2012, CHEM PHYS RESTRAINT, P183; Chavez AS, 2006, J WILDLIFE MANAGE, V70, P1079, DOI 10.2193/0022-541X(2006)70[1079:LUAMOW]2.0.CO;2; Ciucci P, 1997, J ZOOL, V243, P803, DOI 10.1111/j.1469-7998.1997.tb01977.x; Cozzi G, 2013, BIODIVERS CONSERV, V22, P2937, DOI 10.1007/s10531-013-0564-7; Cozzi G., 2013, THESIS ZURICH U; Cozzi G, 2012, ECOLOGY, V93, P2590, DOI 10.1890/12-0017.1; Dassis M, 2012, MAMM BIOL, V77, P47, DOI 10.1016/j.mambio.2011.07.003; Department of Wildlife and National Parks, 2012, AER CENS AN BOTSW DR; Fedriani JM, 2001, ECOGRAPHY, V24, P325, DOI 10.1034/j.1600-0587.2001.240310.x; Fieberg J, 2007, ECOLOGY, V88, P1059, DOI 10.1890/06-0930; Fieberg J, 2012, J MAMMAL, V93, P890, DOI 10.1644/11-MAMM-S-172.1; Forsyth DM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097937; Gilchrist JS, 2002, CAN J ZOOL, V80, P1795, DOI 10.1139/Z02-113; Gittleman JL, 2001, CONSERV BIOL SER, V5, P1; Guerbois C, 2012, J APPL ECOL, V49, P1149, DOI 10.1111/j.1365-2664.2012.02192.x; Hayward MW, 2006, J ZOOL, V270, P606, DOI 10.1111/j.1469-7998.2006.00183.x; Hemson G, 2005, J ANIM ECOL, V74, P455, DOI 10.1111/j.1365-2656.2005.00944.x; HENSCHEL JR, 1990, AFR J ECOL, V28, P69, DOI 10.1111/j.1365-2028.1990.tb01138.x; HENSCHEL JR, 1988, AFR J ECOL, V26, P247, DOI 10.1111/j.1365-2028.1988.tb00977.x; HOFER H, 1993, ANIM BEHAV, V46, P559, DOI 10.1006/anbe.1993.1223; Holekamp KE, 1997, J ZOOL, V242, P1, DOI 10.1111/j.1469-7998.1997.tb02925.x; Honer OP, 2005, OIKOS, V108, P544, DOI 10.1111/j.0030-1299.2005.13533.x; Karlsson J, 2010, J APPL ECOL, V47, P166, DOI 10.1111/j.1365-2664.2009.01747.x; Kie J.G., 2013, ANIM BIOTELEM, V1, P13, DOI [10.1186/2050-3385-1-13, DOI 10.1186/2050-3385-1-13]; Kolowski JM, 2008, AFR J ECOL, V46, P341, DOI 10.1111/j.1365-2028.2007.00846.x; Kolowski JM, 2006, BIOL CONSERV, V128, P529, DOI 10.1016/j.biocon.2005.10.021; Kruuk H., 1972, P1; Lopez-Lopez P, 2014, ECOL APPL, V24, P938, DOI 10.1890/13-2000.1; Loveridge AJ, 2007, BIOL CONSERV, V134, P548, DOI 10.1016/j.biocon.2006.09.010; Lowry H, 2013, BIOL REV, V88, P537, DOI 10.1111/brv.12012; Macdonald D, 2001, NEW ENCY MAMMALS; MACDONALD DW, 1983, NATURE, V301, P379, DOI 10.1038/301379a0; Mendelsohn J.M., 2010, OKAVANGO DELTA FLOOD; Moreno-Opo R, 2010, WILDLIFE BIOL, V16, P25, DOI 10.2981/09-037; Ogada DL, 2012, CONSERV BIOL, V26, P453, DOI 10.1111/j.1523-1739.2012.01827.x; Olea PP, 2008, IBIS, V150, P98; OWENS D, 1979, J MAMMAL, V60, P405, DOI 10.2307/1379816; Palazy L, 2012, ANIM CONSERV, V15, P4, DOI 10.1111/j.1469-1795.2011.00476.x; Price SA, 2007, P R SOC B, V274, P1845, DOI 10.1098/rspb.2007.0505; Ruth TK, 2003, WILDLIFE SOC B, V31, P1150; Silverman B.W., 1986, DENSITY ESTIMATION S; Sorensen A, 2014, PREV VET MED, V113, P356, DOI 10.1016/j.prevetmed.2013.11.010; TILSON RL, 1984, ANIM BEHAV, V32, P715, DOI 10.1016/S0003-3472(84)80147-5; Tortosa FS, 2002, WATERBIRDS, V25, P39, DOI 10.1675/1524-4695(2002)025[0039:EORDOB]2.0.CO;2; Treves A, 2009, J APPL ECOL, V46, P1350, DOI 10.1111/j.1365-2664.2009.01729.x; WHITE TCR, 1978, OECOLOGIA, V33, P71, DOI 10.1007/BF00376997; Whyte Ian J., 2003, P332; Wilmers CC, 2003, ECOL LETT, V6, P996, DOI 10.1046/j.1461-0248.2003.00522.x; WORTON BJ, 1989, ECOLOGY, V70, P164, DOI 10.2307/1938423; Yamada A, 2010, PRIMATES, V51, P159, DOI 10.1007/s10329-009-0183-9; Yirga G, 2012, J ANIM ECOL, V81, P1052, DOI 10.1111/j.1365-2656.2012.01977.x; Zuur Alain F., 2009, P1	64	7	7	1	86	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0121471	10.1371/journal.pone.0121471	http://dx.doi.org/10.1371/journal.pone.0121471			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25793976	Green Submitted, Green Accepted, Green Published, gold			2022-12-27	WOS:000352083900135
J	de Hollander, G; Keuken, MC; Forstmann, BU				de Hollander, Gilles; Keuken, Max C.; Forstmann, Birte U.			The Subcortical Cocktail Problem; Mixed Signals from the Subthalamic Nucleus and Substantia Nigra	PLOS ONE			English	Article							BASAL GANGLIA; FUNCTIONAL CONNECTIVITY; DOPAMINERGIC MIDBRAIN; RESPONSE-INHIBITION; SELECTIVE ATTENTION; PARKINSONS-DISEASE; WORKING-MEMORY; FRONTAL-CORTEX; REWARD SYSTEM; NOVELTY	The subthalamic nucleus and the directly adjacent substantia nigra are small and important structures in the basal ganglia. Functional magnetic resonance imaging studies have shown that the subthalamic nucleus and substantia nigra are selectively involved in response inhibition, conflict processing, and adjusting global and selective response thresholds. However, imaging these nuclei is complex, because they are in such close proximity, they can vary in location, and are very small relative to the resolution of most fMRI sequences. Here, we investigated the consistency in localization of these nuclei in BOLD fMRI studies, comparing reported coordinates with probabilistic atlas maps of young human participants derived from ultra-high resolution 7T MRI scanning. We show that the fMRI signal reported in previous studies is likely not unequivocally arising from the subthalamic nucleus but represents a mixture of subthalamic nucleus, substantia nigra, and surrounding tissue. Using a simulation study, we also tested to what extent spatial smoothing, often used in fMRI preprocessing pipelines, influences the mixture of BOLD signals. We propose concrete steps how to analyze fMRI BOLD data to allow inferences about the functional role of small subcortical nuclei like the subthalamic nucleus and substantia nigra.	[de Hollander, Gilles; Keuken, Max C.; Forstmann, Birte U.] Univ Amsterdam, Amsterdam Brain & Cognit Ctr, Amsterdam, Netherlands; [Keuken, Max C.] Max Planck Inst Human Cognit & Brain Sci, Leipzig, Germany	University of Amsterdam; Max Planck Society	Forstmann, BU (corresponding author), Univ Amsterdam, Amsterdam Brain & Cognit Ctr, Amsterdam, Netherlands.	buforstmann@gmail.com	Forstmann, Birte/AAS-8515-2020	de Hollander, Gilles/0000-0003-1988-5091; Keuken, Max/0000-0002-9703-9125	Netherlands Organization for Scientific Research (NWO); ERC	Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); ERC(European Research Council (ERC)European Commission)	This work was supported by a VIDI (BUF) grant from the Netherlands Organization for Scientific Research (NWO) and an ERC starter grant (BUF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, CHINESE MEDICAL JOUR; Aron AR, 2007, NEUROSCIENTIST, V13, P214, DOI 10.1177/1073858407299288; Aron AR, 2007, J NEUROSCI, V27, P3743, DOI 10.1523/JNEUROSCI.0519-07.2007; Aron AR, 2004, J NEUROPHYSIOL, V92, P1144, DOI 10.1152/jn.01209.2003; Aron AR, 2006, J NEUROSCI, V26, P2424, DOI 10.1523/JNEUROSCI.4682-05.2006; Baudrexel S, 2011, NEUROIMAGE, V55, P1728, DOI 10.1016/j.neuroimage.2011.01.017; Beauregard M, 2006, APPL PSYCHOPHYS BIOF, V31, P3, DOI 10.1007/s10484-006-9001-y; Bishop C. M, 2006, PATTERN RECOGNITION; Boecker H, 2008, NEUROIMAGE, V39, P1356, DOI 10.1016/j.neuroimage.2007.09.069; Boehler CN, 2011, J NEUROSCI, V31, P4955, DOI 10.1523/JNEUROSCI.4845-10.2011; Boehler CN, 2011, J COGNITIVE NEUROSCI, V23, P362, DOI 10.1162/jocn.2010.21473; Bogacz R, 2007, NEURAL COMPUT, V19, P442, DOI 10.1162/neco.2007.19.2.442; Brunenberg EJL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039061; Bryclon L, 2008, BIOL PSYCHIAT, V63, P1022, DOI 10.1016/j.biopsych.2007.12.007; Bunzeck N, 2007, CEREB CORTEX, V17, P2940, DOI 10.1093/cercor/bhm020; Bunzeck N, 2006, NEURON, V51, P369, DOI 10.1016/j.neuron.2006.06.021; Cavanagh JF, 2011, NAT NEUROSCI, V14, P1462, DOI 10.1038/nn.2925; Chase HW, 2010, J NEUROSCI, V30, P6180, DOI 10.1523/JNEUROSCI.5758-09.2010; Colpan ME, 2010, PARKINSONISM RELAT D, V16, P398, DOI 10.1016/j.parkreldis.2010.03.008; Corlett PR, 2004, NEURON, V44, P877, DOI 10.1016/j.neuron.2004.11.022; Coxon JP, 2010, CEREB CORTEX, V20, P2368, DOI 10.1093/cercor/bhp306; D'Ardenne K, 2013, COGN AFFECT BEHAV NE, V13, P747, DOI 10.3758/s13415-013-0191-5; D'Ardenne K, 2012, P NATL ACAD SCI USA, V109, P19900, DOI 10.1073/pnas.1116727109; de Hollander G, 2014, HUM BRAIN MAPP, V35, P4440, DOI 10.1002/hbm.22485; den Dunnen WFA, 2005, MOVEMENT DISORD, V20, P893, DOI 10.1002/mds.20417; Duann JR, 2009, J NEUROSCI, V29, P10171, DOI 10.1523/JNEUROSCI.1300-09.2009; Erika-Florence M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5073; Fleming SM, 2010, J NEUROPHYSIOL, V103, P3238, DOI 10.1152/jn.01084.2009; Fleming SM, 2010, P NATL ACAD SCI USA, V107, P6005, DOI 10.1073/pnas.0910380107; Forstmann BU, 2012, NEUROIMAGE, V60, P370, DOI 10.1016/j.neuroimage.2011.12.044; Forstmann BU, 2010, P NATL ACAD SCI USA, V107, P15916, DOI 10.1073/pnas.1004932107; Forstmann BU, 2014, SCIENTIFIC DATA; Frank MJ, 2007, SCIENCE, V318, P1309, DOI 10.1126/science.1146157; Frank MJ, 2005, J COGNITIVE NEUROSCI, V17, P51, DOI 10.1162/0898929052880093; Fussenich M, 1967, VERGLEICHEND ANATOMI, P1; Guitart-Masip M, 2012, P NATL ACAD SCI USA, V109, P7511, DOI 10.1073/pnas.1202229109; Guitart-Masip M, 2011, J NEUROSCI, V31, P7867, DOI 10.1523/JNEUROSCI.6376-10.2011; HAASE A, 1986, J MAGN RESON, V67, P258, DOI 10.1016/0022-2364(86)90433-6; Hardman CD, 2002, J COMP NEUROL, V445, P238, DOI 10.1002/cne.10165; Hardman CD, 1997, J NEUROPATH EXP NEUR, V56, P132, DOI 10.1097/00005072-199702000-00003; Herz DM, 2014, J NEUROSCI, V34, P3210, DOI 10.1523/JNEUROSCI.4081-13.2014; Hu SE, 2014, HUM BRAIN MAPP, V35, P2531, DOI 10.1002/hbm.22347; Jahanshahi M, 2013, FRONTIERS IN SYSTEMS, V7, DOI [10.3389/fnsys.2013.00118/abstract, DOI 10.3389/FNSYS.2013.00118/ABSTRACT]; Jahfari S, 2011, J NEUROSCI, V31, P6891, DOI 10.1523/JNEUROSCI.5253-10.2011; Keuken MC, 2014, NEUROIMAGE, V94, P40, DOI 10.1016/j.neuroimage.2014.03.032; Keuken MC, 2013, J NEUROSCI, V33, P4896, DOI 10.1523/JNEUROSCI.3241-12.2013; Kirsch P, 2003, NEUROIMAGE, V20, P1086, DOI 10.1016/S1053-8119(03)00381-1; Kitajima M, 2008, NEURORADIOLOGY, V50, P675, DOI 10.1007/s00234-008-0388-4; Krebs RM, 2011, NEUROIMAGE, V58, P647, DOI 10.1016/j.neuroimage.2011.06.038; Krebs RM, 2012, CEREB CORTEX, V22, P607, DOI 10.1093/cercor/bhr134; Krebs RM, 2009, BIOL PSYCHIAT, V65, P103, DOI 10.1016/j.biopsych.2008.08.019; Lancaster JL, 2007, HUM BRAIN MAPP, V28, P1194, DOI 10.1002/hbm.20345; LANGE H, 1976, J NEUROL SCI, V28, P401, DOI 10.1016/0022-510X(76)90114-3; Lefranc M, 2014, NEUROSURGERY, V74, P615, DOI 10.1227/NEU.0000000000000319; Lehericy S, 2006, CEREB CORTEX, V16, P149, DOI 10.1093/cercor/bhi089; Lenglet C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029153; Leunissen I, 2013, HUM BRAIN MAPP, V34, P1254, DOI 10.1002/hbm.21508; Levesque J, 2006, NEUROSCI LETT, V394, P216, DOI 10.1016/j.neulet.2005.10.100; Levesque JC, 2005, MOVEMENT DISORD, V20, P574, DOI 10.1002/mds.20374; Li CSR, 2008, NEUROIMAGE, V41, P1352, DOI 10.1016/j.neuroimage.2008.04.023; Mansfield EL, 2011, J NEUROSCI, V31, P14688, DOI 10.1523/JNEUROSCI.2390-11.2011; Marani E, 2008, THE SUBTHALAMIC NUCL; Marchand WR, 2013, HUM BRAIN MAPP, V34, P1194, DOI 10.1002/hbm.21505; Menz MM, 2012, J NEUROSCI, V32, P6937, DOI 10.1523/JNEUROSCI.3553-11.2012; Monchi O, 2006, ANN NEUROL, V59, P257, DOI 10.1002/ana.20742; Murray GK, 2008, MOL PSYCHIATR, V13, P267, DOI 10.1038/sj.mp.4002058; O'Toole AJ, 2007, J COGNITIVE NEUROSCI, V19, P1735, DOI 10.1162/jocn.2007.19.11.1735; Poldrack RA, 2008, NEUROIMAGE, V40, P409, DOI 10.1016/j.neuroimage.2007.11.048; Poldrack RA, 2007, SOC COGN AFFECT NEUR, V2, P67, DOI 10.1093/scan/nsm006; Preuschoff K, 2006, NEURON, V51, P381, DOI 10.1016/j.neuron.2006.06.024; Prodoehl J, 2008, J NEUROPHYSIOL, V99, P3042, DOI 10.1152/jn.01108.2007; Robinson S, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-137; Sacchet MD, 2013, NEUROIMAGE, V66, P270, DOI 10.1016/j.neuroimage.2012.10.056; Schott BH, 2004, LEARN MEMORY, V11, P383, DOI 10.1101/lm.75004; Schott BH, 2008, J NEUROSCI, V28, P14311, DOI 10.1523/JNEUROSCI.2058-08.2008; Shohamy D, 2008, NEUROSCI BIOBEHAV R, V32, P219, DOI 10.1016/j.neubiorev.2007.07.008; Spraker MB, 2007, J NEUROPHYSIOL, V98, P821, DOI 10.1152/jn.00239.2007; Stelzer J, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00462; Tabelow K, 2009, J NEUROSCI METH, V178, P357, DOI 10.1016/j.jneumeth.2008.12.011; Turner R, 2013, MICROSTRUCTURAL PARC; Vaillancourt DE, 2007, NEUROIMAGE, V36, P793, DOI 10.1016/j.neuroimage.2007.03.002; Vaillancourt DE, 2004, NEUROIMAGE, V23, P175, DOI 10.1016/j.neuroimage.2004.04.040; van Maanen L, 2011, J NEUROSCI, V31, P17488, DOI 10.1523/JNEUROSCI.2924-11.2011; VONBONIN G, 1951, J COMP NEUROL, V94, P427, DOI 10.1002/cne.900940306; Weiss M, 2014, BRAIN STRUCT FUNCT; Wen X, 2012, THE SPATIAL PATTERN, P43; Wittmann BC, 2005, NEURON, V45, P459, DOI 10.1016/j.neuron.2005.01.010; Wittmann BC, 2007, NEUROIMAGE, V38, P194, DOI 10.1016/j.neuroimage.2007.06.038; Yelnik J, 2002, MOVEMENT DISORD, V17, pS15, DOI 10.1002/mds.10138; Yoon JH, 2013, BIOL PSYCHIAT, V74, P122, DOI 10.1016/j.biopsych.2012.11.018; Yu Y, 2013, J NEUROSCI, V33, P14040, DOI 10.1523/JNEUROSCI.1176-13.2013	91	30	30	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0120572	10.1371/journal.pone.0120572	http://dx.doi.org/10.1371/journal.pone.0120572			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25793883	gold, Green Published, Green Submitted			2022-12-27	WOS:000352083900054
J	Ferrario, M; Moissl, U; Garzotto, F; Cruz, DN; Tetta, C; Signorini, MG; Ronco, C; Grassmann, A; Cerutti, S; Guzzetti, S				Ferrario, Manuela; Moissl, Ulrich; Garzotto, Francesco; Cruz, Dinna N.; Tetta, Ciro; Signorini, Maria G.; Ronco, Claudio; Grassmann, Aileen; Cerutti, Sergio; Guzzetti, Stefano			The Forgotten Role of Central Volume in Low Frequency Oscillations of Heart Rate Variability	PLOS ONE			English	Article							SYMPATHETIC-NERVE ACTIVITY; POWER SPECTRAL-ANALYSIS; BODY NEGATIVE-PRESSURE; MAYER WAVES; RESPONSES; FAILURE; DISCHARGE; PATTERNS; HUMANS; SHOCK	The hypothesis that central volume plays a key role in the source of low frequency (LF) oscillations of heart rate variability (HRV) was tested in a population of end stage renal disease patients undergoing conventional hemodialysis (HD) treatment, and thus subject to large fluid shifts and sympathetic activation. Fluid overload (FO) in 58 chronic HD patients was assessed by whole body bioimpedance measurements before the midweek HD session. Heart Rate Variability (HRV) was measured using 24-hour Holter electrocardiogram recordings starting before the same HD treatment. Time domain and frequency domain analyses were performed on HRV signals. Patients were retrospectively classified in three groups according to tertiles of FO normalized to the extracellular water (FO/ECW%). These groups were also compared after stratification by diabetes mellitus. Patients with the low to medium hydration status before the treatment (i.e. 1st and 2nd FO/ECW% tertiles) showed a significant increase in LF power during last 30 min of HD compared to dialysis begin, while no significant change in LF power was seen in the third group (i.e. those with high pre-treatment hydration values). In conclusion, several mechanisms can generate LF oscillations in the cardiovascular system, including baroreflex feedback loops and central oscillators. However, the current results emphasize the role played by the central volume in determining the power of LF oscillations.	[Ferrario, Manuela; Signorini, Maria G.; Cerutti, Sergio] Politecn Milan, DEIB, Milan, Italy; [Moissl, Ulrich; Tetta, Ciro; Grassmann, Aileen] Fresenius Med Care R&D, Bad Homburg, Germany; [Garzotto, Francesco; Cruz, Dinna N.; Ronco, Claudio] San Bortolo Hosp, Vicenza, Italy; [Guzzetti, Stefano] Univ Milan, L Sacco Hosp, Milan, Italy	Polytechnic University of Milan; ULSS 8 Berica; Ospedale San Bortolo di Vicenza; University of Milan; Luigi Sacco Hospital	Ferrario, M (corresponding author), Politecn Milan, DEIB, Milan, Italy.	manuela.ferrario@polimi.it	garzotto, francesco/K-3552-2018; Cerutti, Sergio/A-3155-2009; signorini, maria g/A-4248-2014	garzotto, francesco/0000-0002-0233-3752; signorini, maria g/0000-0002-9391-9846; Ferrario, Manuela/0000-0001-7371-3624; Ronco, Claudio/0000-0002-6697-4065	Fresenius Medical Care Deutschland GmbH	Fresenius Medical Care Deutschland GmbH	Fresenius Medical Care Deutschland GmbH provided support in the form of salaries for authors UM, CT and AG, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	AKSELROD S, 1981, SCIENCE, V213, P220, DOI 10.1126/science.6166045; Cabezas-Cerrato J, 2009, DIABETES METAB, V35, P305, DOI 10.1016/j.diabet.2009.01.006; Convertino VA, 2004, AUTON NEUROSCI-BASIC, V111, P127, DOI 10.1016/j.autneu.2004.02.007; Cooke WH, 1999, J PHYSIOL-LONDON, V517, P617, DOI 10.1111/j.1469-7793.1999.0617t.x; Cooke WH, 2004, J APPL PHYSIOL, V96, P1249, DOI 10.1152/japplphysiol.01155.2003; Ferrario M, 2014, BMC NEPHROL, V15, DOI 10.1186/1471-2369-15-26; Furlan R, 2000, CIRCULATION, V101, P886, DOI 10.1161/01.CIR.101.8.886; Julien C, 2006, CARDIOVASC RES, V70, P12, DOI 10.1016/j.cardiores.2005.11.008; Kiviniemi AM, 2011, EXP PHYSIOL, V96, P718, DOI 10.1113/expphysiol.2011.058768; Manner J, 2010, DEV DYNAM, V239, P1035, DOI 10.1002/dvdy.22265; Mayer S, 1876, SITZUNGSBERICHT MATH, V74, P281; PAGANI M, 1986, CIRC RES, V59, P178, DOI 10.1161/01.RES.59.2.178; Perini R, 2003, EUR J APPL PHYSIOL, V90, P317, DOI 10.1007/s00421-003-0953-9; Petretta M, 1995, AM J HYPERTENS, V8, P1206, DOI 10.1016/0895-7061(95)00252-9; POLOSA C, 1984, P27; PREISS G, 1974, AM J PHYSIOL, V226, P724, DOI 10.1152/ajplegacy.1974.226.3.724; Ramchandra R, 2009, AM J PHYSIOL-REG I, V297, pR665, DOI 10.1152/ajpregu.00191.2009; Ramchandra R, 2008, AM J PHYSIOL-REG I, V295, pR719, DOI 10.1152/ajpregu.00824.2007; SELLER H, 1967, PFLUG ARCH GES PHYS, V296, P110, DOI 10.1007/BF00362724; Siegel G, 1984, VASCULAR SMOOTH MUSC, P319; Slama K, 2012, J INSECT PHYSIOL, V58, P1072, DOI 10.1016/j.jinsphys.2012.04.014; vandeBorne P, 1997, CIRCULATION, V95, P1449; Vinik AI, 2003, DIABETES CARE, V26, P1553, DOI 10.2337/diacare.26.5.1553; WASSERTHAL LT, 1976, EXPERIENTIA, V32, P577, DOI 10.1007/BF01990172	24	17	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0120167	10.1371/journal.pone.0120167	http://dx.doi.org/10.1371/journal.pone.0120167			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25793464	gold, Green Published, Green Submitted			2022-12-27	WOS:000352084200151
J	Hargreaves, JR; Davey, C; Fearon, E; Hensen, B; Krishnaratne, S				Hargreaves, James R.; Davey, Calum; Fearon, Elizabeth; Hensen, Bernadette; Krishnaratne, Shari			Trends in Socioeconomic Inequalities in HIV Prevalence among Young People in Seven Countries in Eastern and Southern Africa	PLOS ONE			English	Article							POPULATION-BASED SURVEYS; EDUCATIONAL-ATTAINMENT; INFECTION; RISK; ASSOCIATION; BIAS	Background In Eastern and Southern Africa, HIV prevalence was highest among higher socioeconomic groups during the 1990s. It has been suggested that this is changing, with HIV prevalence falling among higher-educated groups while stable among lower-educated groups. A multi-country analysis has not been undertaken. Methods We analysed data on socio-demographic factors and HIV infection from 14 nationally representative surveys of adults aged 15-24 (seven countries, two surveys each, 4-8 years apart). Sample sizes ranged from 2,408-12,082 (72,135 total). We used logistic regression to assess gender-stratified associations between highest educational level attended and HIV status in each survey, adjusting for age and urban/rural setting. We tested for interactions with urban/rural setting and age. Our primary hypothesis was that higher education became less of a risk factor for HIV over time. We tested for interaction between survey-year and the education-HIV association in each country and all countries pooled. Findings In Ethiopia and Malawi, HIV prevalence was higher in more educated women in both surveys. In Lesotho, Kenya and Zimbabwe, HIV prevalence was lower in higher educated women in both surveys. In Ethiopia, HIV prevalence fell among no and secondary educated women only (interaction p< 0.01). Only among young men in Tanzania there was some evidence that the association between education and HIV changed over time (p= 0.07). Pooled analysis found little evidence for an interaction between survey year and the education-HIV association among men (p= 0.60) or women (p= 0.37). Interpretation The pattern of prevalent HIV infection among young adults by level of education in different sub-Saharan African countries was heterogeneous. There was little statistical evidence that this pattern changed between 2003-5 and 2008-12. Explanations for the social epidemiology of HIV in Africa will need to account for time-trends and inter-country differences.	[Hargreaves, James R.] London Sch Hyg & Trop Med, Dept Social & Environm Hlth Res, London WC1, England; London Sch Hyg & Trop Med, Ctr Evaluat, London WC1, England	University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine	Hargreaves, JR (corresponding author), London Sch Hyg & Trop Med, Dept Social & Environm Hlth Res, London WC1, England.	james.hargreaves@lshtm.ac.uk		Fearon, Elizabeth/0000-0001-5574-251X; Hargreaves, James/0000-0002-3509-3572; Hensen, Bernadette/0000-0001-6719-6720	STRIVE consortium by UKaid from Department for International Development; Department for International Development (DFID) [201447] Funding Source: researchfish	STRIVE consortium by UKaid from Department for International Development; Department for International Development (DFID)	Funding: The study was supported through the STRIVE consortium by UKaid from the Department for International Development (http://strive.lshtm.ac.uk/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnighausen T, 2007, AIDS, V21, pS29, DOI 10.1097/01.aids.0000300533.59483.95; Brookmeyer R, 2010, EPIDEMIOL REV, V32, P26, DOI 10.1093/epirev/mxq002; Commission on the Social Determinants of Health, 2008, CLOS GAP GEN HLTH EQ; Corsi D, 2012, INT J EPIDEMIOL; de Lay Paul, 2007, BMJ, V334, P345, DOI 10.1136/bmj.39113.539595.94; de Walque D, 2005, TROP MED INT HEALTH, V10, P993, DOI 10.1111/j.1365-3156.2005.01475.x; England R, 2007, BMJ-BRIT MED J, V334, P344, DOI 10.1136/bmj.39113.402361.94; Fox AM, 2012, J BIOSOC SCI, V44, P459, DOI 10.1017/S0021932011000745; Gillespie S, 2007, AIDS, V21, pS5, DOI 10.1097/01.aids.0000300531.74730.72; Glick PJ, 2008, ECON DEV CULT CHANGE, V56, P397, DOI 10.1086/522893; Gregson S., 2001, Journal of International Development, V13, P467, DOI 10.1002/jid.798; Hargreaves J, 2011, J EPIDEMIOL COMMUN H, V65, pA363, DOI 10.1136/jech.2011.142976m.42; Hargreaves J, 2012, J EPIDEMIOL COMMUNIT; Hargreaves JR, 2008, AIDS, V22, P403, DOI 10.1097/QAD.0b013e3282f2aac3; Hargreaves JR, 2012, J INT AIDS SOC, V15, DOI 10.7448/IAS.15.3.17363; Hargreaves JR, 2010, AIDS, V24, P754, DOI 10.1097/QAD.0b013e328336672e; Hargreaves JR, 2002, TROP MED INT HEALTH, V7, P489, DOI 10.1046/j.1365-3156.2002.00889.x; Hogan DR, 2012, SEX TRANSM INFECT, V88, pI17, DOI 10.1136/sextrans-2012-050636; Johnson LF, 2009, AIDS, V23, P1583, DOI 10.1097/QAD.0b013e32832d407e; Kayeyi N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033652; Larose A, 2011, J PUBLIC HEALTH-UK, V33, P345, DOI 10.1093/pubmed/fdr001; Marston M, 2008, SEX TRANSM INFECT, V84, pI71, DOI 10.1136/sti.2008.030353; Measure DHS, 2010, DEM HLTH SURV ZIMB 2; Measure DHS, 2005, DEM HLTH SURV ZIMB 2; Measure DHS, DEM HLTH SURV ETH 20; Measure DHS, 2011, DEM HLTH SURV TANZ 2; Measure DHS [Internet], 2003, DEM HLTH SURV TANZ 2; Mishra V, 2008, SEX TRANSM INFECT, V84, pI63, DOI 10.1136/sti.2008.030411; Mishra V, 2006, B WORLD HEALTH ORGAN, V84, P537, DOI 10.2471/BLT.05.029520; Mmbaga EJ, 2007, SEX TRANSM DIS, V34, P947, DOI 10.1097/OLQ.0b013e31813e0c15; Parkhurst JO, 2010, UNDERSTANDING CORREL; Sandoy IF, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-60; UNAIDS, 2012, REP GLOB AIDS EP; UNAIDS, 1998, REP GLOB AIDS EP; UNAIDS, 2013, REP GLOB AIDS EP; Victora CG, 2000, LANCET, V356, P1093, DOI 10.1016/S0140-6736(00)02741-0	36	17	17	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0121775	10.1371/journal.pone.0121775	http://dx.doi.org/10.1371/journal.pone.0121775			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25793608	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000352083900150
J	King, PT; Sharma, R; O'Sullivan, K; Selemidis, S; Lim, S; Radhakrishna, N; Lo, C; Prasad, J; Callaghan, J; McLaughlin, P; Farmer, M; Steinfort, D; Jennings, B; Ngui, J; Broughton, BRS; Thomas, B; Essilfie, AT; Hickey, M; Holmes, PW; Hansbro, P; Bardin, PG; Holdsworth, SR				King, Paul T.; Sharma, Roleen; O'Sullivan, Kim; Selemidis, Stavros; Lim, Steven; Radhakrishna, Naghmeh; Lo, Camden; Prasad, Jyotika; Callaghan, Judy; McLaughlin, Peter; Farmer, Michael; Steinfort, Daniel; Jennings, Barton; Ngui, James; Broughton, Bradley R. S.; Thomas, Belinda; Essilfie, Ama-Tawiah; Hickey, Michael; Holmes, Peter W.; Hansbro, Philip; Bardin, Philip G.; Holdsworth, Stephen R.			Nontypeable Haemophilus influenzae Induces Sustained Lung Oxidative Stress and Protease Expression	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; INFLAMMATION; EXACERBATIONS; CIGARETTE	Nontypeable Haemophilus influenzae (NTHi) is a prevalent bacterium found in a variety of chronic respiratory diseases. The role of this bacterium in the pathogenesis of lung inflammation is not well defined. In this study we examined the effect of NTHi on two important lung inflammatory processes 1), oxidative stress and 2), protease expression. Bronchoalveolar macrophages were obtained from 121 human subjects, blood neutrophils from 15 subjects, and human-lung fibroblast and epithelial cell lines from 16 subjects. Cells were stimulated with NTHi to measure the effect on reactive oxygen species (ROS) production and extracellular trap formation. We also measured the production of the oxidant, 3-nitrotyrosine (3-NT) in the lungs of mice infected with this bacterium. NTHi induced widespread production of 3-NT in mouse lungs. This bacterium induced significantly increased ROS production in human fibroblasts, epithelial cells, macrophages and neutrophils; with the highest levels in the phagocytic cells. In human macrophages NTHi caused a sustained, extracellular production of ROS that increased over time. The production of ROS was associated with the formation of macrophage extracellular trap-like structures which co-expressed the protease metalloproteinase-12. The formation of the macrophage extracellular trap-like structures was markedly inhibited by the addition of DNase. In this study we have demonstrated that NTHi induces lung oxidative stress with macrophage extracellular trap formation and associated protease expression. DNase inhibited the formation of extracellular traps.	[King, Paul T.; Sharma, Roleen; O'Sullivan, Kim; Lim, Steven; Hickey, Michael; Holdsworth, Stephen R.] Monash Univ, Monash Med Ctr, Dept Med, Melbourne, Vic 3004, Australia; [King, Paul T.; Sharma, Roleen; Radhakrishna, Naghmeh; Prasad, Jyotika; McLaughlin, Peter; Farmer, Michael; Steinfort, Daniel; Jennings, Barton; Thomas, Belinda; Holmes, Peter W.; Bardin, Philip G.] Monash Med Ctr, Monash Lung & Sleep, Melbourne, Vic, Australia; [Selemidis, Stavros; Broughton, Bradley R. S.] Monash Univ, Dept Pharmacol, Melbourne, Vic 3004, Australia; [Lo, Camden; Callaghan, Judy] Monash Univ, Monash Micro Imaging, Melbourne, Vic 3004, Australia; [Ngui, James] Monash Med Ctr, Clin Immunol, Melbourne, Vic, Australia; [Thomas, Belinda; Bardin, Philip G.] Monash Inst Med Res, Melbourne, Vic, Australia; [Essilfie, Ama-Tawiah; Hansbro, Philip] Univ Newcastle, Sch Biomed Sci & Pharm, Newcastle, NSW 2300, Australia	Monash University; Monash University; Monash University; Monash University; Monash University; Monash University; University of Newcastle	King, PT (corresponding author), Monash Univ, Monash Med Ctr, Dept Med, Melbourne, Vic 3004, Australia.	paul.king@monash.edu	Hansbro, Phil/G-7486-2013; Steinfort, Daniel/AAO-6898-2020; Hickey, Michael/A-5429-2012	Hansbro, Phil/0000-0002-4741-3035; Steinfort, Daniel/0000-0002-8998-2949; O'Sullivan, Kim Maree/0000-0002-3098-7948; Essilfie, Ama-Tawiah/0000-0003-0443-9005; Hickey, Michael/0000-0003-2354-357X; Lo, Camden/0000-0002-6215-2363; /0000-0001-8844-974X; Selemidis, Stavros/0000-0002-3989-7615	Monash University Faculty of Medicine, Nursing and Health Sciences Strategic Grants; Australian Research Council Discovery Grant; Australian Research Council Future Fellowship	Monash University Faculty of Medicine, Nursing and Health Sciences Strategic Grants; Australian Research Council Discovery Grant(Australian Research Council); Australian Research Council Future Fellowship(Australian Research Council)	Supported by Monash University Faculty of Medicine, Nursing and Health Sciences Strategic Grants (to PK) and an Australian Research Council Discovery Grant and an Australian Research Council Future Fellowship Support (to SS).	Aaron SD, 2001, AM J RESP CRIT CARE, V163, P349, DOI 10.1164/ajrccm.163.2.2003122; Barcelo B, 2006, CLIN EXP IMMUNOL, V145, P474, DOI 10.1111/j.1365-2249.2006.03167.x; Barnes PJ, 2013, NAT REV DRUG DISCOV, V12, P543, DOI 10.1038/nrd4025; Bolduc GR, 2000, INFECT IMMUN, V68, P4505, DOI 10.1128/IAI.68.8.4505-4517.2000; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Chaudhuri R, 2012, J ALLERGY CLIN IMMUN, V129, P655, DOI 10.1016/j.jaci.2011.12.996; Cheng OZ, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00001; Cosio MG, 2009, NEW ENGL J MED, V360, P2445, DOI 10.1056/NEJMra0804752; Dromann D, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-67; Drummond GR, 2011, NAT REV DRUG DISCOV, V10, P453, DOI 10.1038/nrd3403; Eldika N, 2006, CURR OPIN PULM MED, V12, P118, DOI 10.1097/01.mcp.0000208451.50231.8f; Essilfie AT, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002244; Faner R, 2012, AM J RESP CRIT CARE, V186, P306, DOI 10.1164/rccm.201202-0282PP; Gaschler GJ, 2009, AM J RESP CRIT CARE, V179, P666, DOI 10.1164/rccm.200808-1306OC; Hakkim A, 2010, P NATL ACAD SCI USA, V107, P9813, DOI 10.1073/pnas.0909927107; Harrison A, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00040; Hector A, 2014, EUR RESPIR J, V44, P17, DOI 10.1183/09031936.00038114; Hodge S, 2011, AM J RESP CELL MOL, V44, P673, DOI 10.1165/rcmb.2009-0459OC; Hogg JC, 2004, LANCET, V364, P709, DOI 10.1016/S0140-6736(04)16900-6; Juneau RA, 2011, INFECT IMMUN, V79, P431, DOI 10.1128/IAI.00660-10; Keely S, 2012, MUCOSAL IMMUNOL, V5, P7, DOI 10.1038/mi.2011.55; King PT, 2013, J ALLERGY CLIN IMMUN, V131, P1314, DOI 10.1016/j.jaci.2012.09.030; Konstan MW, 2012, J CYST FIBROS, V11, P78, DOI 10.1016/j.jcf.2011.10.003; Moller LVM, 1998, AM J RESP CRIT CARE, V157, P950; Murphy TF, 2005, HARRISONS PRINCIPLES, P824; Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073; Naylor EJ, 2007, AM J RESP CELL MOL, V37, P135, DOI 10.1165/rcmb.2006-0375OC; O'Donnell AE, 1998, CHEST, V113, P1329, DOI 10.1378/chest.113.5.1329; Patel IS, 2002, THORAX, V57, P759, DOI 10.1136/thorax.57.9.759; Rahman I, 2012, CURR OPIN PHARMACOL, V12, P256, DOI 10.1016/j.coph.2012.01.015; Sethi S, 2007, AM J RESP CRIT CARE, V176, P356, DOI 10.1164/rccm.200703-417OC; Shapiro SD, 2001, AM J RESP CRIT CARE, V164, P339, DOI 10.1164/ajrccm.164.3.2105072c; Tuder RM, 2012, J CLIN INVEST, V122, P2749, DOI 10.1172/JCI60324; Vlahos R, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001271; Wong C, 2013, RESPIROLOGY, V18, P1037, DOI 10.1111/resp.12161; Wong KW, 2013, J INFECT DIS, V208, P109, DOI 10.1093/infdis/jit097	36	37	38	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0120371	10.1371/journal.pone.0120371	http://dx.doi.org/10.1371/journal.pone.0120371			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25793977	Green Published, gold			2022-12-27	WOS:000352083900018
J	Laut, J; Cappa, F; Nov, O; Porfiri, M				Laut, Jeffrey; Cappa, Francesco; Nov, Oded; Porfiri, Maurizio			Increasing Patient Engagement in Rehabilitation Exercises Using Computer-Based Citizen Science	PLOS ONE			English	Article							UPPER-LIMB; FUNCTIONAL RECOVERY; MOTOR IMPAIRMENT; STROKE; IMPROVES; THERAPY; CHILDREN; MOTIVATION; ADHERENCE; ENHANCE	Patient motivation is an important factor to consider when developing rehabilitation programs. Here, we explore the effectiveness of active participation in web-based citizen science activities as a means of increasing participant engagement in rehabilitation exercises, through the use of a low-cost haptic joystick interfaced with a laptop computer. Using the joystick, patients navigate a virtual environment representing the site of a citizen science project situated in a polluted canal. Participants are tasked with following a path on a laptop screen representing the canal. The experiment consists of two conditions: in one condition, a citizen science component where participants classify images from the canal is included; and in the other, the citizen science component is absent. Both conditions are tested on a group of young patients undergoing rehabilitation treatments and a group of healthy subjects. A survey administered at the end of both tasks reveals that participants prefer performing the scientific task, and are more likely to choose to repeat it, even at the cost of increasing the time of their rehabilitation exercise. Furthermore, performance indices based on data collected from the joystick indicate significant differences in the trajectories created by patients and healthy subjects, suggesting that the low-cost device can be used in a rehabilitation setting for gauging patient recovery.	[Laut, Jeffrey; Porfiri, Maurizio] NYU, Dept Mech & Aerosp Engn, Polytech Sch Engn, MetroTech Ctr 6, Brooklyn, NY 11201 USA; [Laut, Jeffrey; Porfiri, Maurizio] Univ Roma La Sapienza, Dept Mech & Aerosp Engn, I-00185 Rome, Italy; [Cappa, Francesco] LUISS Guido Carli Univ, Dept Business & Management, I-00198 Rome, Italy; [Nov, Oded] NYU, Dept Technol Management & Innovat, Polytech Sch Engn, MetroTech Ctr 5, Brooklyn, NY USA	New York University; New York University Tandon School of Engineering; Sapienza University Rome; Luiss Guido Carli University; New York University; New York University Tandon School of Engineering	Porfiri, M (corresponding author), NYU, Dept Mech & Aerosp Engn, Polytech Sch Engn, MetroTech Ctr 6, Brooklyn, NY 11201 USA.	mporfiri@nyu.edu	Cappa, Francesco/D-5055-2016	Cappa, Francesco/0000-0001-5628-731X; Porfiri, Maurizio/0000-0002-1480-3539	National Science Foundation [BCS-1124795]; COOPERLINK	National Science Foundation(National Science Foundation (NSF)); COOPERLINK	This research was supported by the National Science Foundation under Grant #BCS-1124795 and through a scholarship to J. Laut from COOPERLINK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, CONCISE ENCY STAT, P344; Betker AL, 2006, ARCH PHYS MED REHAB, V87, P1141, DOI 10.1016/j.apmr.2006.04.010; Burke JW, 2009, PROCEEDINGS OF THE IEEE VIRTUAL WORLDS FOR SERIOUS APPLICATIONS, P103, DOI 10.1109/VS-GAMES.2009.17; Burke JW, 2009, VISUAL COMPUT, V25, P1085, DOI 10.1007/s00371-009-0387-4; BUTEFISCH C, 1995, J NEUROL SCI, V130, P59, DOI 10.1016/0022-510X(95)00003-K; Campbell R, 2001, J EPIDEMIOL COMMUN H, V55, P132, DOI 10.1136/jech.55.2.132; Cappa P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083945; Carpinella I, 2009, J REHABIL MED, V41, P966, DOI 10.2340/16501977-0401; Casella G., 2021, STAT INFERENCE; Charles SK, 2005, INT C REHAB ROBOT, P13; Colombo R, 2005, IEEE T NEUR SYS REH, V13, P311, DOI 10.1109/TNSRE.2005.848352; Colombo R, 2007, J NEUROENG REHABIL, V4, DOI 10.1186/1743-0003-4-3; Cooper S, 2010, NATURE, V466, P756, DOI 10.1038/nature09304; Cordova DI, 1996, J EDUC PSYCHOL, V88, P715, DOI 10.1037/0022-0663.88.4.715; De Weyer Tom, 2012, Entertainment Computing, 11th International Conference (ICEC - 2012). Proceedings, P476, DOI 10.1007/978-3-642-33542-6_57; Deutsch JE, 2008, PHYS THER, V88, P1196, DOI 10.2522/ptj.20080062; DISHMAN R K, 1981, Journal of Behavioral Medicine, V4, P421, DOI 10.1007/BF00846151; DISHMAN RK, 1980, J APPL SOC PSYCHOL, V10, P115, DOI 10.1111/j.1559-1816.1980.tb00697.x; Duncan PW, 2002, STROKE, V33, P167, DOI 10.1161/hs0102.101014; Ellul C, 2011, ENGAGING LOCAL COMMU; Fasoli SE, 2003, ARCH PHYS MED REHAB, V84, P477, DOI 10.1053/apmr.2003.50110; Forster J, 2003, ORGAN BEHAV HUM DEC, V90, P148, DOI 10.1016/S0749-5978(02)00509-5; Frascarelli F, 2009, J REHABIL MED, V41, P988, DOI 10.2340/16501977-0412; Gentile D, 2009, PSYCHOL SCI, V20, P594, DOI 10.1111/j.1467-9280.2009.02340.x; GLOBERSON S, 1989, IIE TRANS, V21, P376, DOI 10.1080/07408178908966244; Greenberg BS, 2010, SIMULAT GAMING, V41, P238, DOI 10.1177/1046878108319930; GUNASEKERA WSL, 2005, SPR SP SURG SER, P407; Haklay M, 2013, CROWDSOURCING GEOGRA, P105, DOI [10.1007/978-94-007-4587-2_7, DOI 10.1007/978-94-007-4587-2_7]; Harris JE, 2009, STROKE, V40, P2123, DOI 10.1161/STROKEAHA.108.544585; Hidler Joseph, 2005, Top Stroke Rehabil, V12, P22, DOI 10.1310/RYT5-62N4-CTVX-8JTE; Hill AM, 2011, ARCH PHYS MED REHAB, V92, P1395, DOI 10.1016/j.apmr.2011.04.009; ICE R, 1985, PHYS THER, V65, P1832, DOI 10.1093/ptj/65.12.1832; Jaramillo P, 2012, PROCEEDINGS OF THE ASME 5TH ANNUAL DYNAMIC SYSTEMS AND CONTROL DIVISION CONFERENCE AND JSME 11TH MOTION AND VIBRATION CONFERENCE, DSCC 2012, VOL 2, P483; JAY S, 1984, J ADOLESCENT HEALTH, V5, P124, DOI 10.1016/S0197-0070(84)80012-1; Kafai YB, 1998, FROM BARBIE TO MORTAL KOMBAT, P90; Kwakkel G, 2004, STROKE, V35, P2529, DOI 10.1161/01.STR.0000143153.76460.7d; Lange B, 2009, PHYS THER REV, V14, P355, DOI 10.1179/108331909X12488667117258; Laut J, 2014, IEEE-ASME T MECH, V19, P1541, DOI 10.1109/TMECH.2013.2287705; Lee H, 2014, IEEE T NEUR SYS REH, V22, P44, DOI 10.1109/TNSRE.2013.2262689; Leversen JSR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038830; Liepert J, 2000, STROKE, V31, P1210, DOI 10.1161/01.STR.31.6.1210; Lintott CJ, 2008, MON NOT R ASTRON SOC, V389, P1179, DOI 10.1111/j.1365-2966.2008.13689.x; Luft AR, 2004, JAMA-J AM MED ASSOC, V292, P1853, DOI 10.1001/jama.292.15.1853; Lum PS, 2002, ARCH PHYS MED REHAB, V83, P952, DOI 10.1053/apmr.2001.33101; Masiero S, 2007, ARCH PHYS MED REHAB, V88, P142, DOI 10.1016/j.apmr.2006.10.032; Mazzoleni S, 2014, IEEE T HAPTICS, V7, P175, DOI 10.1109/TOH.2013.73; Nov O., 2010, PROC 19 INT C WORLD, P741, DOI [10.1145/1772690.1772766, DOI 10.1145/1772690.1772766]; Nov O, 2011, P 2011 ICONFERENCE, P68, DOI [DOI 10.1145/1940761.1940771, 10.1145/1940761.1940771]; Nov O, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090375; Patton JL, 2006, EXP BRAIN RES, V168, P368, DOI 10.1007/s00221-005-0097-8; Prestopnik N. R., 2011, Proceedings of the 2011 IEEE Seventh International Conference on e-Science Workshops (eScienceW 2011), P28, DOI 10.1109/eScienceW.2011.14; Raddick M. Jordan, 2010, Astronomy Education Review, V9, DOI 10.3847/AER2009036; Rand Debbie, 2008, J Neurol Phys Ther, V32, P155, DOI 10.1097/NPT.0b013e31818ee779; Ravichandran R, 2010, J R SOC INTERFACE, V7, pS559, DOI 10.1098/rsif.2010.0120.focus; Reinkensmeyer DJ, 2002, IEEE T NEUR SYS REH, V10, P102, DOI 10.1109/TNSRE.2002.1031978; Reker DM, 2002, ARCH PHYS MED REHAB, V83, P750, DOI 10.1053/apmr.2002.99736; Riener R, 2005, MED BIOL ENG COMPUT, V43, P2, DOI 10.1007/BF02345116; Rohrer B, 2002, J NEUROSCI, V22, P8297; Sandlund M, 2011, DEV NEUROREHABIL, V14, P15, DOI 10.3109/17518423.2010.533329; Sandlund M, 2009, DEV MED CHILD NEUROL, V51, P173, DOI 10.1111/j.1469-8749.2008.03184.x; Shelton FDAP, 2001, NEUROREHAB NEURAL RE, V15, P229, DOI 10.1177/154596830101500311; Silvertown J, 2009, TRENDS ECOL EVOL, V24, P467, DOI 10.1016/j.tree.2009.03.017; SLUIJS EM, 1993, PHYS THER, V73, P786, DOI 10.1093/ptj/73.11.786; THOMAS KW, 1990, ACAD MANAGE REV, V15, P666, DOI 10.2307/258687; Timmermans AAA, 2010, IEEE T NEUR SYS REH, V18, P284, DOI 10.1109/TNSRE.2010.2047608; Trewin S, 1999, INT J HUM-COMPUT ST, V50, P109, DOI 10.1006/ijhc.1998.0238; Vischer P, 1998, ROBOTICA, V16, P207, DOI 10.1017/S0263574798000538; Von Ahn Luis, 2004, P SIGCHI C HUM FACT, P319, DOI DOI 10.1145/985692.985733; Vong SK, 2011, ARCH PHYS MED REHAB, V92, P176, DOI 10.1016/j.apmr.2010.10.016; Whitall J, 2000, STROKE, V31, P2390, DOI 10.1161/01.STR.31.10.2390; Wong WY, 2007, PROSTHET ORTHOT INT, V31, P62, DOI 10.1080/03093640600983949; Zollo L, 2011, MED BIOL ENG COMPUT, V49, P1131, DOI 10.1007/s11517-011-0808-1; Zyda M, 2005, COMPUTER, V38, P25, DOI 10.1109/MC.2005.297	73	31	32	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0117013	10.1371/journal.pone.0117013	http://dx.doi.org/10.1371/journal.pone.0117013			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CE8IA	25793867	Green Published, gold, Green Submitted			2022-12-27	WOS:000352084200010
J	Schmitt, A; Rodel, P; Anamur, C; Seeliger, C; Imhoff, AB; Herbst, E; Vogt, S; van Griensven, M; Winter, G; Engert, J				Schmitt, Andreas; Roedel, Philipp; Anamur, Cihad; Seeliger, Claudine; Imhoff, Andreas B.; Herbst, Elmar; Vogt, Stephan; van Griensven, Martijn; Winter, Gerhard; Engert, Julia			Calcium Alginate Gels as Stem Cell Matrix - Making Paracrine Stem Cell Activity Available for Enhanced Healing after Surgery	PLOS ONE			English	Article							HYDROGELS	Regeneration after surgery can be improved by the administration of anabolic growth factors. However, to locally maintain these factors at the site of regeneration is problematic. The aim of this study was to develop a matrix system containing human mesenchymal stem cells (MSCs) which can be applied to the surgical site and allows the secretion of endogenous healing factors from the cells. Calcium alginate gels were prepared by a combination of internal and external gelation. The gelling behaviour, mechanical stability, surface adhesive properties and injectability of the gels were investigated. The permeability of the gels for growth factors was analysed using bovine serum albumin and lysozyme as model proteins. Human MSCs were isolated, cultivated and seeded into the alginate gels. Cell viability was determined by AlamarBlue assay and fluorescence microscopy. The release of human VEGF and bFGF from the cells was determined using an enzyme-linked immunoassay. Gels with sufficient mechanical properties were prepared which remained injectable through a syringe and solidified in a sufficient time frame after application. Surface adhesion was improved by the addition of polyethylene glycol 300,000 and hyaluronic acid. Humans MSCs remained viable for the duration of 6 weeks within the gels. Human VEGF and bFGF was found in quantifiable concentrations in cell culture supernatants of gels loaded with MSCs and incubated for a period of 6 weeks. This work shows that calcium alginate gels can function as immobilization matrices for human MSCs.	[Roedel, Philipp; Anamur, Cihad; Winter, Gerhard; Engert, Julia] Univ Munich, Dept Pharm Pharmaceut Technol & Biopharmaceut, D-81377 Munich, Germany; [Schmitt, Andreas; Imhoff, Andreas B.; Herbst, Elmar; Vogt, Stephan] Tech Univ Munich, Dept Sports Orthoped, D-81675 Munich, Germany; [Seeliger, Claudine; van Griensven, Martijn] Tech Univ Munich, Dept Trauma Surg, D-81675 Munich, Germany; [Herbst, Elmar] Med Univ Innsbruck, Dept Trauma Surg, A-6020 Innsbruck, Austria	University of Munich; Technical University of Munich; Technical University of Munich; Medical University of Innsbruck	Schmitt, A (corresponding author), Tech Univ Munich, Dept Sports Orthoped, Ismaninger Str 22, D-81675 Munich, Germany.	dr.schmitt@tum.de	van Griensven, Martijn/F-5808-2012; Vogt, Stephan/AAQ-7456-2021	van Griensven, Martijn/0000-0001-5104-9881; Seeliger, Claudine/0000-0002-7631-444X	German Research Foundation (DFG); Technische Universitat Munchen	German Research Foundation (DFG)(German Research Foundation (DFG)); Technische Universitat Munchen	This work was supported by the German Research Foundation (DFG) and the Technische Universitat Munchen within the funding programme Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allodi I, 2014, GLIA, V62, P1736, DOI 10.1002/glia.22712; ANDERSEN T, 2012, SPR CARB CH, V37, P227, DOI DOI 10.1039/9781849732765-00227; Asane GS, 2008, DRUG DEV IND PHARM, V34, P1246, DOI 10.1080/03639040802026012 ; Baksh D, 2004, J CELL MOL MED, V8, P301, DOI 10.1111/j.1582-4934.2004.tb00320.x; Buchmann S, 2013, J ORTHOP RES, V31, P300, DOI 10.1002/jor.22211; Caplan AI, 2011, CELL STEM CELL, V9, P11, DOI 10.1016/j.stem.2011.06.008; Carreau A, 2011, J CELL MOL MED, V15, P1239, DOI 10.1111/j.1582-4934.2011.01258.x; Chang CP, 2013, CLIN SCI, V124, P165, DOI 10.1042/CS20120226; de Groot M, 2004, J SURG RES, V121, P141, DOI 10.1016/j.jss.2004.02.018; DeVolder R, 2012, WIRES SYST BIOL MED, V4, P351, DOI 10.1002/wsbm.1174; DRAGET KI, 1990, CARBOHYD POLYM, V14, P159; Ehnert S, 2009, LANGENBECKS ARCH SUR; Ehnert S, 2009, LANGENBECK ARCH SURG, V394, P985, DOI 10.1007/s00423-009-0546-0; Elliott RB, 2005, TRANSPL P, V37, P3505, DOI 10.1016/j.transproceed.2005.09.038; Fannon M, 1996, J BIOL CHEM, V271, P17949, DOI 10.1074/jbc.271.30.17949; Hatef DA, 2008, ANN PLAS SURG, V61, P468, DOI 10.1097/SAP.0b013e3181641c17; Hou Y, 2009, MATRIX BIOL, V28, P324, DOI 10.1016/j.matbio.2009.04.007; Jeon O, 2014, ACTA BIOMATER, V10, P47, DOI 10.1016/j.actbio.2013.09.004; Kretlow JD, 2009, ADV MATER, V21, P3368, DOI 10.1002/adma.200802009; Kuo CK, 2001, BIOMATERIALS, V22, P511, DOI 10.1016/S0142-9612(00)00201-5; Lee KY, 2012, PROG POLYM SCI, V37, P106, DOI 10.1016/j.progpolymsci.2011.06.003; Liu C, 2014, BIOTECHNOL APPL BIOC; Lyras DN, 2010, ACTA ORTHOP BELG, V76, P380; Mandal K, 2011, ANGEW CHEM INT EDIT, V50, P8029, DOI 10.1002/anie.201103237; Oryan A, 2014, J TISSUE ENG REGEN M, V8, P421, DOI 10.1002/term.1534; Porada CD, 2010, ADV DRUG DELIVER REV, V62, P1156, DOI 10.1016/j.addr.2010.08.010; Rijcken E, 2014, J SURG RES, V187, P202, DOI 10.1016/j.jss.2013.10.013; Schmitt A, 2012, STEM CELLS INT, V2012, DOI 10.1155/2012/394962; Schnabel LV, 2009, J ORTHOP RES, V27, P1392, DOI 10.1002/jor.20887; Vaithilingam Vijayaganapathy, 2011, Rev Diabet Stud, V8, P51, DOI 10.1900/RDS.2011.8.51	30	34	37	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0118937	10.1371/journal.pone.0118937	http://dx.doi.org/10.1371/journal.pone.0118937			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25793885	gold, Green Published, Green Submitted			2022-12-27	WOS:000352084200047
J	Schurink, M; Kooi, EMW; Hulzebos, CV; Kox, RG; Groen, H; Heineman, E; Bos, AF; Hulscher, JBF				Schurink, Maarten; Kooi, Elisabeth M. W.; Hulzebos, Christian V.; Kox, Rozemarijn G.; Groen, Henk; Heineman, Erik; Bos, Arend F.; Hulscher, Jan B. F.			Intestinal Fatty Acid-Binding Protein as a Diagnostic Marker for Complicated and Uncomplicated Necrotizing Enterocolitis: A Prospective Cohort Study	PLOS ONE			English	Article							GUT-ASSOCIATED BIOMARKERS; LIVER-FABP; SEVERITY	Background Early NEC symptoms are non-specific and diagnostic tests lack discriminative power. Intestinal fatty acid-binding protein (I-FABP), mainly located in small bowel enterocytes, is released into the blood following NEC-associated enterocyte disruption. Aim of this prospective cohort trial was to determine the diagnostic value of I-FABP measured in plasma (I-FABPp) and urine (I-FABPu) for the presence of NEC, to evaluate I-FABP levels during NEC development, and to assess its prognostic value for the progression from suspected to complicated disease. Methods Between 2010 and 2012 we prospectively enrolled neonates with suspected NEC. We measured I-FABP levels eight-hourly from onset of suspected NEC for at least 48 hours, or until surgery. NEC diagnosis was confirmed radiologically or during operation. We defined NEC as complicated if it resulted in surgery and/or death. We determined disease course and diagnostic I-FABP cut-off points. Results The study comprised 37 neonates (24M, 13F), gestational age 28 (24-36) weeks, birth weight 1190 (570-2,400) grams. We found significantly higher I-FABPp and I-FABPu levels in NEC patients (n = 22) than in patients with other diagnoses (n = 15). Cut-off values for diagnosing NEC were 9 ng/mL I-FABPp and 218 ngmL I-FABPu, with corresponding likelihood ratios (LRs) of 5.6 (95% CI 0.89-35) and 5.1 (95% CI 0.73-36), respectively. I-FABP levels were highest in the first eight hours after symptom onset and gradually decreased over time. Cut-off values for complicated disease were 19 ng/mL I-FABPp and 232 ng/mL I-FABPu, with LRs of 10 (95% CI 1.6-70) and 11 (95% CI 1.6-81), respectively. Conclusions Both plasma and urinary I-FABP levels specifically identify NEC in preterm infants prior to appearance of diagnostic radiological signs suggestive for NEC. Moreover, serial I-FABP measurements accurately predict development of complicated disease.	[Schurink, Maarten; Heineman, Erik; Hulscher, Jan B. F.] Univ Groningen, Univ Med Ctr Groningen, Dept Paediat Surg, Groningen, Netherlands; [Kooi, Elisabeth M. W.; Hulzebos, Christian V.; Bos, Arend F.] Univ Groningen, Univ Med Ctr Groningen, Beatrix Childrens Hosp, Dept Neonatol, Groningen, Netherlands; [Kox, Rozemarijn G.] Univ Groningen, Univ Med Ctr Groningen, Surg Res Lab, Groningen, Netherlands; [Groen, Henk] Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, Groningen, Netherlands	University of Groningen; University of Groningen; University of Groningen; University of Groningen	Hulscher, JBF (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Paediat Surg, Groningen, Netherlands.	j.b.f.hulscher@umcg.nl	Heineman, Erik/ABG-9592-2021; Groen, Henk/B-2163-2013; Schurink, Maarten/P-7215-2015; Hulzebos, Christian Victor/AAY-6803-2021; Hulscher, Jan/AAD-3026-2021; Kooi, Elisabeth/AAD-3926-2022	Groen, Henk/0000-0002-6629-318X; Schurink, Maarten/0000-0003-4671-5565; Hulzebos, Christian Victor/0000-0002-8159-7501; Kooi, Elisabeth/0000-0001-9195-4018; Hulscher, Jan/0000-0003-4491-486X	NutsOhra Foundation; Doelmatigheidsfonds; University Medical Centre Groningen; Jan Kornelis de Cock Foundation	NutsOhra Foundation; Doelmatigheidsfonds; University Medical Centre Groningen; Jan Kornelis de Cock Foundation	Funding: This study was supported by grants from the following Dutch funding organizations: 1. NutsOhra Foundation, 2. Doelmatigheidsfonds [fitness for purpose fund], intramural funding by University Medical Centre Groningen, and 3. Jan Kornelis de Cock Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aydemir C, 2011, EARLY HUM DEV, V87, P659, DOI 10.1016/j.earlhumdev.2011.05.004; BELL MJ, 1978, ANN SURG, V187, P1, DOI 10.1097/00000658-197801000-00001; Benkoe TM, 2014, J PEDIATR SURG, V49, P1446, DOI 10.1016/j.jpedsurg.2014.03.012; Cronk Daniel R, 2006, Curr Surg, V63, P322, DOI 10.1016/j.cursur.2006.05.006; Derikx JPM, 2007, GUT, V56, P1473, DOI 10.1136/gut.2007.128934; Dutch Trial Register, 2004, ID NTR3239 NOV DIAGN; Edelson MB, 1999, J PEDIATR SURG, V34, P1453, DOI 10.1016/S0022-3468(99)90102-1; Evennett NJ, 2010, J PEDIATR SURG, V45, P735, DOI 10.1016/j.jpedsurg.2009.09.024; Guthmann F, 2002, MOL CELL BIOCHEM, V239, P227, DOI 10.1023/A:1020508420058; Hallstrom M, 2006, J PEDIATR SURG, V41, P792, DOI 10.1016/j.jpedsurg.2005.12.034; Lieberman JM, 1997, SURGERY, V121, P335, DOI 10.1016/S0039-6060(97)90363-9; Lin JC, 2000, PEDIATRICS, V106, part. no., DOI 10.1542/peds.106.2.e19; Ng EWY, 2013, ANN SURG, V258, P1111, DOI 10.1097/SLA.0b013e318288ea96; Pelsers MMAL, 2005, CLIN CHIM ACTA, V352, P15, DOI 10.1016/j.cccn.2004.09.001; Reisinger KW, 2012, J PEDIATR SURG, V47, P1640, DOI 10.1016/j.jpedsurg.2012.02.027; Relja B, 2010, ACAD EMERG MED, V17, P729, DOI 10.1111/j.1553-2712.2010.00792.x; Tam AL, 2002, J PEDIATR SURG, V37, P1688, DOI 10.1053/jpsu.2002.36696; Thuijls G, 2011, ANN SURG, V253, P303, DOI 10.1097/SLA.0b013e318207a767; Thuijls G, 2010, ANN SURG, V251, P1174, DOI 10.1097/SLA.0b013e3181d778c4; Valentine SL, 2012, PEDIATR CRIT CARE ME, V13, P22, DOI 10.1097/PCC.0b013e318219681d; WALSH MC, 1986, PEDIATR CLIN N AM, V33, P179, DOI 10.1016/s0031-3955(16)34975-6	21	62	66	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0121336	10.1371/journal.pone.0121336	http://dx.doi.org/10.1371/journal.pone.0121336			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25793701	gold, Green Published, Green Submitted			2022-12-27	WOS:000352083900124
J	Volis, S; Ormanbekova, D; Yermekbayev, K; Song, MS; Shulgina, I				Volis, Sergei; Ormanbekova, Danara; Yermekbayev, Kanat; Song, Minshu; Shulgina, Irina			Multi-Approaches Analysis Reveals Local Adaptation in the Emmer Wheat (Triticum dicoccoides) at Macro- but not Micro-Geographical Scale	PLOS ONE			English	Article							WILD TETRAPLOID WHEAT; NATURAL-SELECTION; GENETIC DIFFERENTIATION; ALLOZYME POLYMORPHISMS; EVOLUTIONARY SIGNIFICANCE; ADAPTIVE DIVERGENCE; TEMPORAL VARIATION; PLANT ADAPTATION; SPECIES RANGE; POPULATION	Detecting local adaptation and its spatial scale is one of the most important questions of evolutionary biology. However, recognition of the effect of local selection can be challenging when there is considerable environmental variation across the distance at the whole species range. We analyzed patterns of local adaptation in emmer wheat, Triticum dicoccoides, at two spatial scales, small (inter-population distance less than one km) and large (inter-population distance more than 50 km) using several approaches. Plants originating from four distinct habitats at two geographic scales (cold edge, arid edge and two topographically dissimilar core locations) were reciprocally transplanted and their success over time was measured as 1) lifetime fitness in a year of planting, and 2) population growth four years after planting. In addition, we analyzed molecular (SSR) and quantitative trait variation and calculated the Q(ST)/F-ST ratio. No home advantage was detected at the small spatial scale. At the large spatial scale, home advantage was detected for the core population and the cold edge population in the year of introduction via measuring life-time plant performance. However, superior performance of the arid edge population in its own environment was evident only after several generations via measuring experimental population growth rate through genotyping with SSRs allowing counting the number of plants and seeds per introduced genotype per site. These results highlight the importance of multi-generation surveys of population growth rate in local adaptation testing. Despite predominant self-fertilization of T. dicoccoides and the associated high degree of structuring of genetic variation, the results of the Q(ST) - F-ST comparison were in general agreement with the pattern of local adaptation at the two spatial scales detected by reciprocal transplanting.	[Volis, Sergei; Song, Minshu; Shulgina, Irina] Chinese Acad Sci, Kunming Inst Bot, Key Lab Plant Divers & Biogeog East Asia, Kunming 650204, Peoples R China; [Ormanbekova, Danara; Yermekbayev, Kanat] Inst Plant Biol & Biotechnol, Alma Ata 050040, Kazakhstan	Chinese Academy of Sciences; Kunming Institute of Botany, CAS; Institute of Plant Biology & Biotechnology in Kazakhstan	Volis, S (corresponding author), Chinese Acad Sci, Kunming Inst Bot, Key Lab Plant Divers & Biogeog East Asia, Kunming 650204, Peoples R China.	volis@mail.kib.ac.cn	Yermekbayev, Kanat/CAJ-5791-2022; Volis, Sergei/GLU-5848-2022	ORMANBEKOVA, DANARA/0000-0002-6564-3109	Israel Academy of Sciences [ISF 958/07]; CAS/SAFEA International Partnership Program for Creative Research Teams	Israel Academy of Sciences; CAS/SAFEA International Partnership Program for Creative Research Teams(Chinese Academy of Sciences)	The current study was supported by Israel Academy of Sciences (ISF 958/07) and the CAS/SAFEA International Partnership Program for Creative Research Teams. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angert AL, 2005, EVOLUTION, V59, P1671, DOI 10.1111/j.0014-3820.2005.tb01817.x; Angert AL, 2008, EVOLUTION, V62, P2660, DOI 10.1111/j.1558-5646.2008.00471.x; ANIKSTER Y, 1991, ISRAEL J BOT, V40, P351; ANIKSTER Y, 1991, ISRAEL J BOT, V40, P397; Becker U, 2006, OECOLOGIA, V150, P506, DOI 10.1007/s00442-006-0534-9; BENNINGTON CC, 1995, ECOL MONOGR, V65, P303, DOI 10.2307/2937062; Bischoff A, 2006, J ECOLOGY, V94; Blanquart F, 2013, ECOL LETT, V16, P1195, DOI 10.1111/ele.12150; Bradshaw AD, 1984, PERSPECTIVES PLANT P, P213; Brady KU, 2005, ANNU REV ECOL EVOL S, V36, P243, DOI 10.1146/annurev.ecolsys.35.021103.105730; Bridle JR, 2010, ECOL LETT, V13, P485, DOI 10.1111/j.1461-0248.2010.01442.x; Capaul M, 2003, EVOLUTION, V57, P249, DOI 10.1111/j.0014-3820.2003.tb00260.x; Charlesworth D, 2003, PHILOS T R SOC B, V358, P1051, DOI 10.1098/rstb.2003.1296; Clausen JC, 1940, CARNEGIE I WASHINGTO, V520; CONOVER DO, 1995, TRENDS ECOL EVOL, V10, P248, DOI 10.1016/S0169-5347(00)89081-3; CREEL S, 1990, P ROY SOC B-BIOL SCI, V241, P229, DOI 10.1098/rspb.1990.0090; Endler J.A., 1977, Monographs in Population Biology, pi; Feldman M., 1995, EVOLUTION CROP PLANT, V2nd, P184; Feldman M, 2007, ISR J PLANT SCI, V55, P207, DOI 10.1560/IJPS.55.3-4.207; FELSENBURG T, 1991, ISRAEL J BOT, V40, P451; Galloway LF, 2000, EVOLUTION, V54, P1173, DOI 10.1111/j.0014-3820.2000.tb00552.x; GarciaRamos G, 1997, EVOLUTION, V51, P21, DOI 10.2307/2410956; Geyer CJ, 2007, BIOMETRIKA, V94, P415, DOI 10.1093/biomet/asm030; GOLDING GB, 1980, GENETICS, V94, P777; GOMULKIEWICZ R, 1992, EVOLUTION, V46, P390, DOI [10.2307/2409860, 10.1111/j.1558-5646.1992.tb02047.x]; GRAFEN A, 1982, NATURE, V298, P425, DOI 10.1038/298425a0; Hangartner S, 2012, EVOLUTION, V66, P867, DOI 10.1111/j.1558-5646.2011.01472.x; HARLAN JR, 1966, SCIENCE, V153, P1074, DOI 10.1126/science.153.3740.1074; HASTINGS A, 1989, GENETICS, V121, P857; Hereford J, 2009, AM NAT, V173, P579, DOI 10.1086/597611; Holt RD, 2005, OIKOS, V108, P18, DOI 10.1111/j.0030-1299.2005.13147.x; Joshi J, 2001, ECOL LETT, V4, P536, DOI 10.1046/j.1461-0248.2001.00262.x; Jost L, 2008, MOL ECOL, V17, P4015, DOI 10.1111/j.1365-294X.2008.03887.x; Kawecki TJ, 2008, ANNU REV ECOL EVOL S, V39, P321, DOI 10.1146/annurev.ecolsys.38.091206.095622; Kawecki TJ, 2004, ECOL LETT, V7, P1225, DOI 10.1111/j.1461-0248.2004.00684.x; Kawecki TJ, 2002, AM NAT, V160, P333, DOI 10.1086/341519; Leimu R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004010; Levin D. A., 2000, OX ECOL EV; Lewis PO, 1999, GDA SOFTWARE ANAL DI; Li YC, 2000, MOL BIOL EVOL, V17, P851, DOI 10.1093/oxfordjournals.molbev.a026365; Li YC, 1999, THEOR APPL GENET, V98, P873, DOI 10.1007/s001220051146; Li YC, 2000, THEOR APPL GENET, V100, P985, DOI 10.1007/s001220051380; Li You-Chun, 2000, Conservation Genetics, V1, P191, DOI 10.1023/A:1011545403198; Linhart YB, 1996, ANNU REV ECOL SYST, V27, P237, DOI 10.1146/annurev.ecolsys.27.1.237; Macel M, 2007, ECOLOGY, V88, P424, DOI 10.1890/0012-9658(2007)88[424:CVSFIL]2.0.CO;2; McKay JK, 2002, TRENDS ECOL EVOL, V17, P285, DOI 10.1016/S0169-5347(02)02478-3; Merila J, 2001, J EVOLUTION BIOL, V14, P892, DOI 10.1046/j.1420-9101.2001.00348.x; NEVO E, 1988, THEOR APPL GENET, V76, P737, DOI 10.1007/BF00303521; NEVO E, 1988, THEOR APPL GENET, V75, P529, DOI 10.1007/BF00276761; NEVO E, 1991, ISRAEL J BOT, V40, P419; Norton LR, 2005, OECOLOGIA, V144, P407, DOI 10.1007/s00442-005-0102-8; NOYMEIR I, 1991, ISRAEL J BOT, V40, P363; Ozkan H, 2011, GENET RESOUR CROP EV, V58, P11, DOI 10.1007/s10722-010-9581-5; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Pregitzer CC, 2010, EVOL ECOL, V24, P1045, DOI 10.1007/s10682-010-9363-8; PRIMACK RB, 1989, ANNU REV ECOL SYST, V20, P367, DOI 10.1146/annurev.es.20.110189.002055; R Core Team, 2020, R LANG ENV STAT COMP; Rasanen K, 2008, ECOL LETT, V11, P624, DOI 10.1111/j.1461-0248.2008.01176.x; Ren J, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-169; Richardson JL, 2014, TRENDS ECOL EVOL, V29, P165, DOI 10.1016/j.tree.2014.01.002; RODER MS, 1995, MOL GEN GENET, V246, P327, DOI 10.1007/BF00288605; Roder MS, 1998, GENETICS, V149, P2007; Roff Derek A., 1992; ROGERS SO, 1985, PLANT MOL BIOL, V5, P69, DOI 10.1007/BF00020088; Sagarin RD, 2006, TRENDS ECOL EVOL, V21, P524, DOI 10.1016/j.tree.2006.06.008; Sagarin RD, 2002, ECOL LETT, V5, P137, DOI 10.1046/j.1461-0248.2002.00297.x; Sambatti JBM, 2006, EVOLUTION, V60, P696, DOI 10.1111/j.0014-3820.2006.tb01149.x; Santamaria L, 2003, ECOLOGY, V84, P2454, DOI 10.1890/02-0431; Schluter D, 2001, TRENDS ECOL EVOL, V16, P372, DOI 10.1016/S0169-5347(01)02198-X; Shaw RG, 2008, AM NAT, V172, pE35, DOI 10.1086/588063; SLATKIN M, 1985, ANNU REV ECOL SYST, V16, P393, DOI 10.1146/annurev.ecolsys.16.1.393; Smith DS, 2012, PLANT SOIL, V352, P243, DOI 10.1007/s11104-011-0992-7; Stanton-Geddes J, 2012, ECOLOGY, V93, P1604, DOI 10.1890/11-1701.1; Stanton-Geddes J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036015; Stearns S.C., 1992, pi; Thompson JN, 2005, LOCAL ADAPTATION; Turesson G, 1922, HEREDITAS, V3, P211, DOI 10.1111/j.1601-5223.1922.tb02734.x; Vander Mijnsbrugge K, 2010, BASIC APPL ECOL, V11, P300, DOI 10.1016/j.baae.2009.09.002; Venables WN., 2002, MODERN APPL STAT S 4; VIA S, 1991, EVOLUTION, V45, P827, DOI 10.1111/j.1558-5646.1991.tb04353.x; Volis S, 2005, HEREDITY, V95, P466, DOI 10.1038/sj.hdy.6800745; Volis S, 2014, HEREDITY, V113, P268, DOI 10.1038/hdy.2014.25; Volis S, 2004, AM NAT, V163, P312, DOI 10.1086/381406; Volis S, 2011, NEW PHYTOL, V192, P237, DOI 10.1111/j.1469-8137.2011.03799.x; Volis S, 2002, OECOLOGIA, V133, P131, DOI 10.1007/s00442-002-0999-0; Volis S, 2014, EVOL BIOL, V41, P166, DOI 10.1007/s11692-013-9256-1; Vucetich JA, 2003, CONSERV GENET, V4, P639, DOI 10.1023/A:1025671831349; Whitlock MC, 2012, MOL ECOL RESOUR, V12, P481, DOI 10.1111/j.1755-0998.2012.03122.x; Zohary M., 1973, Geobotanical foundations of the Middle East.	89	18	18	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0121153	10.1371/journal.pone.0121153	http://dx.doi.org/10.1371/journal.pone.0121153			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25793512	Green Submitted, Green Published, gold			2022-12-27	WOS:000352083900104
J	Weinheimer-Haus, EM; Mirza, RE; Koh, TJ				Weinheimer-Haus, Eileen M.; Mirza, Rita E.; Koh, Timothy J.			Nod-Like Receptor Protein-3 Inflammasome Plays an Important Role during Early Stages of Wound Healing	PLOS ONE			English	Article							INTERLEUKIN-1-BETA CONVERTING-ENZYME; NF-KAPPA-B; CELLULAR INFILTRATE; MICE DEFICIENT; DIABETIC MICE; ACTIVATION; SECRETION; REPAIR; MACROPHAGE; IL-1	The Nod-like receptor protein (NLRP)-3 inflammasome/IL-1 beta pathway is involved in the pathogenesis of various inflammatory skin diseases, but its biological role in wound healing remains to be elucidated. Since inflammation is typically thought to impede healing, we hypothesized that loss of NLRP-3 activity would result in a downregulated inflammatory response and accelerated wound healing. NLRP-3 null mice, caspase-1 null mice and C57Bl/6 wild type control mice (WT) received four 8 mm excisional cutaneous wounds; inflammation and healing were assessed during the early stage of wound healing. Consistent with our hypothesis, wounds from NLRP-3 null and caspase-1 null mice contained lower levels of the pro-inflammatory cytokines IL-1 beta and TNF-alpha compared to WT mice and had reduced neutrophil and macrophage accumulation. Contrary to our hypothesis, re-epithelialization, granulation tissue formation, and angiogenesis were delayed in NLRP-3 null mice and caspase-1 null mice compared to WT mice, indicating that NLRP-3 signaling is important for early events in wound healing. Topical treatment of excisional wounds with recombinant IL-1 beta partially restored granulation tissue formation in wounds of NLRP-3 null mice, confirming the importance of NLRP-3-dependent IL-1 beta production during early wound healing. Despite the improvement in healing, angiogenesis and levels of the pro-angiogenic growth factor VEGF were further reduced in IL-1 beta treated wounds, suggesting that IL-1 beta has a negative effect on angiogenesis and that NLRP-3 promotes angiogenesis in an IL-1 beta-independent manner. These findings indicate that the NLRP-3 inflammasome contributes to the early inflammatory phase following skin wounding and is important for efficient healing.	[Weinheimer-Haus, Eileen M.; Mirza, Rita E.; Koh, Timothy J.] Univ Illinois, Dept Kinesiol & Nutr, Chicago, IL 60607 USA; [Weinheimer-Haus, Eileen M.; Koh, Timothy J.] Univ Illinois, Ctr Wound Healing & Tissue Regenerat, Chicago, IL USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Koh, TJ (corresponding author), Univ Illinois, Dept Kinesiol & Nutr, Chicago, IL 60607 USA.	tjkoh@uic.edu		Koh, Timothy/0000-0001-6549-7060; Weinheimer-Haus, Eileen/0000-0001-5408-0024	National Institutes of Health [R01GM092850, T32DE018381]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [T32DE018381] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM092850] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by the National Institutes of Health (R01GM092850 to TJK and T32DE018381 to EMW; www.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barichello JM, 1999, INT J PHARM, V184, P189, DOI 10.1016/S0378-5173(99)00119-2; Bitto A, 2014, BRIT J PHARMACOL, V171, P2300, DOI 10.1111/bph.12557; Blakytny R, 2006, DIABETIC MED, V23, P594, DOI 10.1111/j.1464-5491.2006.01773.x; Broz P, 2012, NATURE, V490, P288, DOI 10.1038/nature11419; Carmi Y, 2009, J IMMUNOL, V183, P4705, DOI 10.4049/jimmunol.0901511; Choi YS, 2009, BLOOD, V114, P3117, DOI 10.1182/blood-2009-02-203372; Dinarello CA, 2002, CLIN EXP RHEUMATOL, V20, pS1; Dinarello CA, 1996, BLOOD, V87, P2095, DOI 10.1182/blood.V87.6.2095.bloodjournal8762095; Dinarello CA, 1998, ANN NY ACAD SCI, V856, P1, DOI 10.1111/j.1749-6632.1998.tb08307.x; Dinarello CA, 2009, ANNU REV IMMUNOL, V27, P519, DOI 10.1146/annurev.immunol.021908.132612; Doyle SL, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007616; Eming SA, 2007, J INVEST DERMATOL, V127, P514, DOI 10.1038/sj.jid.5700701; Feldmeyer L, 2007, CURR BIOL, V17, P1140, DOI 10.1016/j.cub.2007.05.074; Fix C, 2011, CYTOKINE, V53, P19, DOI 10.1016/j.cyto.2010.10.002; Goren I, 2003, DIABETES, V52, P2821, DOI 10.2337/diabetes.52.11.2821; Goren I, 2009, AM J PATHOL, V175, P132, DOI 10.2353/ajpath.2009.081002; Graves DT, 2001, J IMMUNOL, V167, P5316, DOI 10.4049/jimmunol.167.9.5316; Ishida Y, 2006, J IMMUNOL, V176, P5598, DOI 10.4049/jimmunol.176.9.5598; Kampfer H, 1999, J INVEST DERMATOL, V113, P369, DOI 10.1046/j.1523-1747.1999.00704.x; Kayagaki N, 2011, NATURE, V479, P117, DOI 10.1038/nature10558; Keller M, 2008, CELL, V132, P818, DOI 10.1016/j.cell.2007.12.040; KUIDA K, 1995, SCIENCE, V267, P2000, DOI 10.1126/science.7535475; Lee JG, 2012, INVEST OPHTH VIS SCI, V53, P1530, DOI 10.1167/iovs.11-9102; LEIBOVICH SJ, 1975, AM J PATHOL, V78, P71; Leslie KS, 2006, ARCH DERMATOL, V142, P1591, DOI 10.1001/archderm.142.12.1591; LI P, 1995, CELL, V80, P401, DOI 10.1016/0092-8674(95)90490-5; Liechty KW, 2000, J PEDIATR SURG, V35, P866, DOI 10.1053/jpsu.2000.6868; Loots MAM, 1998, J INVEST DERMATOL, V111, P850, DOI 10.1046/j.1523-1747.1998.00381.x; Lucas T, 2010, J IMMUNOL, V184, P3964, DOI 10.4049/jimmunol.0903356; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Mast Bruce A., 1996, Wound Repair and Regeneration, V4, P411, DOI 10.1046/j.1524-475X.1996.40404.x; Mirza RE, 2014, CYTOKINE; Mirza RE, 2013, DIABETES; Mirza R, 2011, CYTOKINE, V56, P256, DOI 10.1016/j.cyto.2011.06.016; Mirza R, 2009, AM J PATHOL, V175, P2454, DOI 10.2353/ajpath.2009.090248; Mirza RE, 2013, DIABETES, V62, P2579, DOI 10.2337/db12-1450; Ogura Y, 2006, CELL, V126, P659, DOI 10.1016/j.cell.2006.08.002; Pedra JHF, 2009, CURR OPIN IMMUNOL, V21, P10, DOI 10.1016/j.coi.2009.01.006; Qu Y, 2007, J IMMUNOL, V179, P1913, DOI 10.4049/jimmunol.179.3.1913; Redd MJ, 2004, PHILOS T R SOC B, V359, P777, DOI 10.1098/rstb.2004.1466; ROSNER K, 1995, APMIS, V103, P293, DOI 10.1111/j.1699-0463.1995.tb01109.x; Salven P, 2002, FASEB J, V16, P1471, DOI 10.1096/fj.02-0134fje; Strowig T, 2012, NATURE, V481, P278, DOI 10.1038/nature10759; Sutterwala FS, 2006, IMMUNITY, V24, P317, DOI 10.1016/j.immuni.2006.02.004; Thomay AA, 2009, AM J PATHOL, V174, P2129, DOI 10.2353/ajpath.2009.080765; Trengove NJ, 1999, WOUND REPAIR REGEN, V7, P442, DOI 10.1046/j.1524-475X.1999.00442.x; Voronov E, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00114; Watanabe H, 2007, J INVEST DERMATOL, V127, P1956, DOI 10.1038/sj.jid.5700819; Weinheimer-Haus EM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091355; Wietecha MS, 2011, AM J PHYSIOL-HEART C, V300, pH459, DOI 10.1152/ajpheart.00244.2010; Yazdi AS, 2010, J CLIN IMMUNOL, V30, P623, DOI 10.1007/s10875-010-9437-y; Yin H, 2013, MOL IMMUNOL, V56, P347, DOI 10.1016/j.molimm.2013.05.225; Zhao WH, 2010, CELL MOL IMMUNOL, V7, P260, DOI 10.1038/cmi.2010.3	53	61	61	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0119106	10.1371/journal.pone.0119106	http://dx.doi.org/10.1371/journal.pone.0119106			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25793779	Green Published, Green Submitted, gold			2022-12-27	WOS:000352084200055
J	Yamamoto, T; Shimojima, K; Sangu, N; Komoike, Y; Ishii, A; Abe, S; Yamashita, S; Imai, K; Kubota, T; Fukasawa, T; Okanishi, T; Enoki, H; Tanabe, T; Saito, A; Furukawa, T; Shimizu, T; Milligan, CJ; Petrou, S; Heron, SE; Dibbens, LM; Hirose, S; Okumura, A				Yamamoto, Toshiyuki; Shimojima, Keiko; Sangu, Noriko; Komoike, Yuta; Ishii, Atsushi; Abe, Shinpei; Yamashita, Shintaro; Imai, Katsumi; Kubota, Tetsuo; Fukasawa, Tatsuya; Okanishi, Tohru; Enoki, Hideo; Tanabe, Takuya; Saito, Akira; Furukawa, Toru; Shimizu, Toshiaki; Milligan, Carol J.; Petrou, Steven; Heron, Sarah E.; Dibbens, Leanne M.; Hirose, Shinichi; Okumura, Akihisa			Single Nucleotide Variations in CLCN6 Identified in Patients with Benign Partial Epilepsies in Infancy and/or Febrile Seizures	PLOS ONE			English	Article							CHLORIDE CHANNEL; MUTATIONS; VARIANTS; PRRT2; PROTEINS; CHILDREN; GENES; CLC-6	Nucleotide alterations in the gene encoding proline-rich transmembrane protein 2 (PRRT2) have been identified in most patients with benign partial epilepsies in infancy (BPEI)/benign familial infantile epilepsy (BFIE). However, not all patients harbor these PRRT2 mutations, indicating the involvement of genes other than PRRT2. In this study, we performed whole exome sequencing analysis for a large family affected with PRRT2-unrelated BPEI. We identified a non-synonymous single nucleotide variation (SNV) in the voltage-sensitive chloride channel 6 gene (CLCN6). A cohort study of 48 BPEI patients without PRRT2 mutations revealed a different CLCN6 SNV in a patient, his sibling and his father who had a history of febrile seizures (FS) but not BPEI. Another study of 48 patients with FS identified an additional SNV in CLCN6. Chloride channels (CLCs) are involved in a multitude of physiologic processes and some members of the CLC family have been linked to inherited diseases. However, a phenotypic correlation has not been confirmed for CLCN6. Although we could not detect significant biological effects linked to the identified CLCN6 SNVs, further studies should investigate potential CLCN6 variants that may underlie the genetic susceptibility to convulsive disorders.	[Yamamoto, Toshiyuki; Shimojima, Keiko; Sangu, Noriko; Furukawa, Toru] Tokyo Womens Med Univ, Inst Integrated Med Sci, Tokyo, Japan; [Komoike, Yuta] Tokyo Womens Med Univ, Dept Hyg & Publ Hlth 1, Tokyo, Japan; [Ishii, Atsushi; Hirose, Shinichi] Fukuoka Univ, Fac Med, Dept Pediat, Fukuoka 81401, Japan; [Abe, Shinpei; Shimizu, Toshiaki; Okumura, Akihisa] Juntendo Univ, Fac Med, Dept Pediat, Tokyo, Japan; [Yamashita, Shintaro] Juntendo Nerima Hosp, Dept Pediat, Tokyo, Japan; [Imai, Katsumi] Shizuoka Inst Epilepsy & Neurol Disorders, Natl Epilepsy Ctr, Shizuoka, Japan; [Kubota, Tetsuo; Fukasawa, Tatsuya] Anjo Kosei Hosp, Dept Pediat, Anjo, Japan; [Okanishi, Tohru; Enoki, Hideo] Seirei Hamamatsu Gen Hosp, Dept Child Neurol, Hamamatsu, Shizuoka, Japan; [Tanabe, Takuya] Tanabe Monbayashi Child Clin, Hirakata, Osaka, Japan; [Saito, Akira] StaGen Co Ltd, Tokyo, Japan; [Milligan, Carol J.; Petrou, Steven] Univ Melbourne, Florey Neurosci Inst, Melbourne Brain Ctr, Melbourne, Vic, Australia; [Heron, Sarah E.; Dibbens, Leanne M.] Univ S Australia, Sch Pharm & Med Sci, Epilepsy Res Program, Adelaide, SA 5001, Australia	Tokyo Women's Medical University; Tokyo Women's Medical University; Fukuoka University; Juntendo University; Juntendo University; Florey Institute of Neuroscience & Mental Health; University of Melbourne; University of South Australia	Yamamoto, T (corresponding author), Tokyo Womens Med Univ, Inst Integrated Med Sci, Tokyo, Japan.	yamamoto.toshiyuki@twmu.ac.jp	Furukawa, Toru/AAF-5596-2021; Heron, Sarah/F-4222-2013	Furukawa, Toru/0000-0002-1083-2324; Heron, Sarah/0000-0001-8759-6748; HIROSE, Shinichi/0000-0001-6796-3790; Petrou, Steven/0000-0002-4960-6375; Okanishi, Tohru/0000-0003-3295-2236; Dibbens, Leanne/0000-0002-5824-3342	Foundation of Synapse and Neurocircuit Pathology [23110534]; Ministry of Health, Labor and Welfare, Japan; Mother and Child Health Foundation in Japan; Kawano Masanori Memorial Public Interest Incorporated Foundation for Promotion of Pediatrics; Japan Society for the Promotion of Science (JSPS) [24791090]; Japan Epilepsy Research Foundation (JERF); Kanae Foundation for the promotion of Medical Science in Japan; Grants-in-Aid for Scientific Research [15H02548] Funding Source: KAKEN	Foundation of Synapse and Neurocircuit Pathology; Ministry of Health, Labor and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan); Mother and Child Health Foundation in Japan; Kawano Masanori Memorial Public Interest Incorporated Foundation for Promotion of Pediatrics; Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Epilepsy Research Foundation (JERF); Kanae Foundation for the promotion of Medical Science in Japan; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was partially supported by a Grant-in-Aid for Scientific Research on Innovated Areas "Foundation of Synapse and Neurocircuit Pathology" (23110534); a Grant-in-Aid for scientific research and a Grant-in-Aid of Health Labor Sciences Research Grants from the Ministry of Health, Labor and Welfare, Japan; a Grant from the Mother and Child Health Foundation in Japan; and a Grant from Kawano Masanori Memorial Public Interest Incorporated Foundation for Promotion of Pediatrics (T.Y.). This study was partially supported by a Grant-in-Aid for Young Scientists (B) (24791090), Japan Society for the Promotion of Science (JSPS), a Grant from the Japan Epilepsy Research Foundation (JERF), and a Grant from Kanae Foundation for the promotion of Medical Science in Japan (K.S.). The funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Berg AT, 2010, EPILEPSIA, V51, P676, DOI 10.1111/j.1528-1167.2010.02522.x; Brandt S, 1995, FEBS LETT, V377, P15, DOI 10.1016/0014-5793(95)01298-2; Buyse G, 1998, BIOCHEM J, V330, P1015, DOI 10.1042/bj3301015; Chen TT, 2013, NEUROLOGY, V80, P1078, DOI 10.1212/WNL.0b013e31828868e7; Chen WJ, 2011, NAT GENET, V43, P1252, DOI 10.1038/ng.1008; Del Greco FM, 2011, HUM MOL GENET, V20, P1660, DOI 10.1093/hmg/ddr035; Heron SE, 2012, AM J HUM GENET, V90, P152, DOI 10.1016/j.ajhg.2011.12.003; Jentsch TJ, 2008, CRIT REV BIOCHEM MOL, V43, P3, DOI [10.1080/10409230701829110, 10.1080/10409230701829110 ]; Kleefuss-Lie A, 2009, NAT GENET, V41, P954, DOI 10.1038/ng0909-954; KOCH MC, 1992, SCIENCE, V257, P797, DOI 10.1126/science.1379744; Kornak U, 2001, CELL, V104, P205, DOI 10.1016/S0092-8674(01)00206-9; Kugler SL, 1998, BRAIN DEV-JPN, V20, P265, DOI 10.1016/S0387-7604(98)00020-5; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Li N, 2010, INT J NEUROSCI, V120, P217, DOI 10.3109/00207450903477779; Lloyd SE, 1996, NATURE, V379, P445, DOI 10.1038/379445a0; Niemeyer MI, 2010, NAT GENET, V42, P3, DOI 10.1038/ng0110-3; Okumura A, 2006, NEUROPEDIATRICS, V37, P359, DOI 10.1055/s-2007-964905; Okumura A, 2006, EPILEPSIA, V47, P181, DOI 10.1111/j.1528-1167.2006.00385.x; Okumura A, 2006, EPILEPSY RES, V70, pS168, DOI 10.1016/j.eplepsyres.2005.11.019; Okumura A, 2013, NEUROPATHOLOGY, V33, P553, DOI 10.1111/neup.12007; Okumura A, 2013, BRAIN DEV-JPN, V35, P641, DOI 10.1016/j.braindev.2012.09.015; Poet M, 2006, P NATL ACAD SCI USA, V103, P13854, DOI 10.1073/pnas.0606137103; Pressey SNR, 2010, J NEUROPATH EXP NEUR, V69, P1228, DOI 10.1097/NEN.0b013e3181ffe742; Saghazadeh A, 2014, REV NEUROSCI, P1; Saint-Martin C, 2009, HUM MUTAT, V30, P397, DOI 10.1002/humu.20876; Sander T, 2000, HUM MOL GENET, V9, P1465, DOI 10.1093/hmg/9.10.1465; Shimojima K, 2009, GENOMICS, V94, P414, DOI 10.1016/j.ygeno.2009.08.015; Simon DB, 1997, NAT GENET, V17, P171, DOI 10.1038/ng1097-171; Suzuki T, 2006, J CELL PHYSIOL, V206, P792, DOI 10.1002/jcp.20516; Veeramah KR, 2013, EPILEPSIA, V54, P1270, DOI 10.1111/epi.12201; Waldegger S, 2000, J AM SOC NEPHROL, V11, P1331, DOI 10.1681/ASN.V1171331; Watanabe K, 2000, BRAIN DEV-JPN, V22, P296, DOI 10.1016/S0387-7604(00)00112-1	33	10	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0118946	10.1371/journal.pone.0118946	http://dx.doi.org/10.1371/journal.pone.0118946			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25794116	gold, Green Published, Green Submitted			2022-12-27	WOS:000352084200049
J	Garcia, LE; Sanchez-Puerta, MV				Evangelina Garcia, Laura; Virginia Sanchez-Puerta, M.			Comparative and Evolutionary Analyses of Meloidogyne spp. Based on Mitochondrial Genome Sequences	PLOS ONE			English	Article							ROOT-KNOT NEMATODES; PLANT-PARASITIC NEMATODES; PHYLOGENETIC-RELATIONSHIPS; GENE ORDER; RDNA; POPULATION; DIVERSITY; INCOGNITA; ARENARIA	Molecular taxonomy and evolution of nematodes have been recently the focus of several studies. Mitochondrial sequences were proposed as an alternative for precise identification of Meloidogyne species, to study intraspecific variability and to follow maternal lineages. We characterized the mitochondrial genomes (mtDNAs) of the root knot nematodesM. floridensis, M. hapla and M. incognita. These were AT rich (81-83%) and highly compact, encoding 12 proteins, 2 rRNAs, and 22 tRNAs. Comparisons with published mtDNAs of M. chitwoodi, M. incognita (another strain) andM. graminicola revealed that they share protein and rRNA gene order but differ in the order of tRNAs. The mtDNAs of M. floridensis andM. incognita were strikingly similar (97-100% identity for all coding regions). In contrast, M. floridensis, M. chitwoodi, M. hapla andM. graminicola showed 65-84% nucleotide identity for coding regions. Variable mitochondrial sequences are potentially useful for evolutionary and taxonomic studies. We developed a molecular taxonomic marker by sequencing a highly-variable similar to 2 kb mitochondrial region, nad5-cox1, from 36 populations of root-knot nematodes to elucidate relationships within the genus Meloidogyne. Isolates of five species formed monophyletic groups and showed little intraspecific variability. We also present a thorough analysis of the mitochondrial region cox2-rrnS. Phylogenies based on either mitochondrial region had good discrimination power but could not discriminate between M. arenaria, M. incognita and M. floridensis.	[Evangelina Garcia, Laura; Virginia Sanchez-Puerta, M.] Univ Nacl Cuyo, IBAM CONICET, RA-5500 Mendoza, Argentina; [Evangelina Garcia, Laura; Virginia Sanchez-Puerta, M.] Univ Nacl Cuyo, Fac Ciencias Agr, RA-5500 Mendoza, Argentina; [Virginia Sanchez-Puerta, M.] Univ Nacl Cuyo, Fac Ciencias Exactas & Nat, RA-5500 Mendoza, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University Nacional Cuyo Mendoza; University Nacional Cuyo Mendoza; University Nacional Cuyo Mendoza	Sanchez-Puerta, MV (corresponding author), Univ Nacl Cuyo, IBAM CONICET, RA-5500 Mendoza, Argentina.	mvsanchezpuerta@fca.uncu.edu.ar		Sanchez-Puerta, Maria Virginia/0000-0003-2511-5093; Garcia, Laura/0000-0002-9324-6872	Agencia Nacional de Promocion Cientifica y Tecnologica [PICT-2008-277]; Universidad Nacional de Cuyo [Sectyp 06/M053]	Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT); Universidad Nacional de Cuyo	This work was supported by Agencia Nacional de Promocion Cientifica y Tecnologica, www.agencia.mincyt.gob.ar, PICT-2008-277 to MVSP and by Universidad Nacional de Cuyo, www.uncu.edu.ar, Sectyp 06/M053 to MVSP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abad P, 2003, MOL PLANT PATHOL, V4, P217, DOI [10.1046/j.1364-3703.2003.00170.x, 10.1046/J.1364-3703.2003.00170.X]; Abad P, 2008, NAT BIOTECHNOL, V26, P909, DOI 10.1038/nbt.1482; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; AZEVEDO JLB, 1993, GENETICS, V133, P933; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Bernt M, 2013, MOL PHYLOGENET EVOL, V69, P352, DOI 10.1016/j.ympev.2013.05.002; Besnard G, 2014, CR BIOL, V337, P295, DOI 10.1016/j.crvi.2014.03.003; Blaxter ML, 1998, NATURE, V392, P71, DOI 10.1038/32160; Blok VC, 2002, NEMATOLOGY, V4, P773, DOI 10.1163/156854102760402559; Blok Vivian C., 2009, P98, DOI 10.1079/9781845934927.0098; Boore JL, 1999, NUCLEIC ACIDS RES, V27, P1767, DOI 10.1093/nar/27.8.1767; Cameron SL, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-394; Carneiro RMDG, 2014, NEMATOLOGY, V16, P289, DOI 10.1163/15685411-00002765; Castagnone-Sereno P, 2014, J EVOL BIOL IN PRESS; De Ley IT, 2002, J NEMATOL, V34, P319; De Ley P, 2004, NEMATOL MONOGR PERSP, V2, P633; Garcia LE, 2012, J NEMATOL, V44, P291; Fargette M, 2010, INFECT GENET EVOL, V10, P807, DOI 10.1016/j.meegid.2009.04.013; Frazer KA, 2004, NUCLEIC ACIDS RES, V32, pW273, DOI 10.1093/nar/gkh458; Gadberry MD, 2005, BIOINFORMATICS, V21, P1263, DOI 10.1093/bioinformatics/bti134; Gibson T, 2010, GENOME BIOL, V54, P565; Gissi C, 2008, HEREDITY, V101, P301, DOI 10.1038/hdy.2008.62; Hancock L, 2010, GENOME BIOL EVOL, V2, P897, DOI 10.1093/gbe/evq075; Hazkani-Covo E, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000834; HOFFMANN RJ, 1992, GENETICS, V131, P397; Holterman M, 2009, PHYTOPATHOLOGY, V99, P227, DOI 10.1094/PHYTO-99-3-0227; Holterman M, 2006, MOL BIOL EVOL, V23, P1792, DOI 10.1093/molbev/msl044; Hu M, 2006, TRENDS PARASITOL, V22, P78, DOI 10.1016/j.pt.2005.12.003; Hu M, 2003, INT J PARASITOL, V33, P1393, DOI 10.1016/S0020-7519(03)00130-9; HUGALL A, 1994, GENETICS, V136, P903; Humphreys-Pereira DA, 2014, MOL BIOCHEM PARASIT, V194, P20, DOI 10.1016/j.molbiopara.2014.04.003; Hunt David J., 2009, P55, DOI 10.1079/9781845934927.0055; Hyman BC, 2011, GENETICA, V139, P611, DOI 10.1007/s10709-010-9531-3; Jacob JE, 2009, BMC RES NOTES; Jones JT, 2013, MOL PLANT PATHOL, V14, P946, DOI 10.1111/mpp.12057; Karssen G., 2002, THE PLANT PARASITIC; Keddie EM, 1998, MOL BIOCHEM PARASIT, V95, P111, DOI 10.1016/S0166-6851(98)00102-9; Kim KH, 2006, INT J PARASITOL, V36, P319, DOI 10.1016/j.ijpara.2005.10.004; Koonin EV, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-5-209; Lavrov DV, 2014, MOL LIFE SCI, P1, DOI DOI 10.1007/978-1-4614-6436-5; Li MW, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-224; Liu GH, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-414; Lunt DH, 2014, PEERJ, V2, DOI 10.7717/peerj.356; Lunt DH, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-194; Lunt DH, 1998, MOL ECOL, V7, P1441, DOI 10.1046/j.1365-294x.1998.00495.x; Madison DR, 2000, MACCLADE 4 ANALYSIS; Maleita CM, 2012, PLANT DIS, V96, P865, DOI 10.1094/PDIS-09-11-0769-RE; McClure MA, 2012, PLANT DIS, V96, P635, DOI 10.1094/PDIS-09-11-0808; McNulty SN, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-145; OKIMOTO R, 1991, NUCLEIC ACIDS RES, V19, P1619, DOI 10.1093/nar/19.7.1619; Onkendi EM, 2013, EUR J PLANT PATHOL, V136, P1, DOI 10.1007/s10658-012-0142-y; Opperman CH, 2008, P NATL ACAD SCI USA, V105, P14802, DOI 10.1073/pnas.0805946105; Parr RL, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-185; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; POWERS TO, 1993, J NEMATOL, V25, P1; POWERS TO, 1993, J NEMATOL, V25, P564; SASSER JN, 1983, ANNU REV PHYTOPATHOL, V21, P271, DOI 10.1146/annurev.py.21.090183.001415; Schattner P, 2005, NUCLEIC ACIDS RES, V33, pW686, DOI 10.1093/nar/gki366; Skantar AM, 2008, J NEMATOL, V40, P179; Stothard P, 2000, BIOTECHNIQUES, V28, P1102, DOI 10.2144/00286ir01; Sultana T, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-12; Sun LH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098558; Swofford D.L, 1998, PAUP 4 0 PHYLOGENETI; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tigano MS, 2005, NEMATOLOGY, V7, P851, DOI 10.1163/156854105776186325; Watanabe K, 2010, P JPN ACAD B-PHYS, V86, P11, DOI 10.2183/pjab.86.11; Wende S, 2014, BIOCHIMIE, V100, P151, DOI 10.1016/j.biochi.2013.07.034; WOLSTENHOLME DR, 1992, INT REV CYTOL, V141, P173, DOI 10.1016/S0074-7696(08)62066-5; Zwickl D. J, 2006, GENETIC ALGORITHM AP	69	15	15	2	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0121142	10.1371/journal.pone.0121142	http://dx.doi.org/10.1371/journal.pone.0121142			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25799071	Green Published, gold, Green Submitted			2022-12-27	WOS:000351987300216
J	Zhang, H; Huang, JX; Williams, PH; Vaissiere, BE; Zhou, ZY; Gai, QB; Dong, J; An, JD				Zhang, Hong; Huang, Jiaxing; Williams, Paul H.; Vaissiere, Bernard E.; Zhou, Zhiyong; Gai, Qinbao; Dong, Jie; An, Jiandong			Managed Bumblebees Outperform Honeybees in Increasing Peach Fruit Set in China: Different Limiting Processes with Different Pollinators	PLOS ONE			English	Article							POLLEN-TUBE GROWTH; CLARKIA-UNGUICULATA ONAGRACEAE; APIS-MELLIFERA; SELF-POLLINATION; ALMOND; FERTILIZATION; PERFORMANCE; BEES; DEPOSITION; PLANTS	Peach Prunus persica (L.) Batsch is self-compatible and largely self-fertile, but under greenhouse conditions pollinators must be introduced to achieve good fruit set and quality. Because little work has been done to assess the effectiveness of different pollinators on peach trees under greenhouse conditions, we studied 'Okubo' peach in greenhouse tunnels near Beijing between 2012 and 2014. We measured pollen deposition, pollen-tube growth rates, ovary development, and initial fruit set after the flowers were visited by either of two managed pollinators: bumblebees, Bombus patagiatus Nylander, and honeybees, Apis mellifera L. The results show that B. patagiatus is more effective than A. mellifera as a pollinator of peach in greenhouses because of differences in two processes. First, B. patagiatus deposits more pollen grains on peach stigmas than A. mellifera, both during a single visit and during a whole day of open pollination. Second, there are differences in the fertilization performance of the pollen deposited. Half of the flowers visited by B. patagiatus are fertilized 9-11 days after bee visits, while for flowers visited by A. mellifera, half are fertilized 13-15 days after bee visits. Consequently, fruit development is also accelerated by bumblebees, showing that the different pollinators have not only different pollination efficiency, but also influence the subsequent time course of fertilization and fruit set. Flowers visited by B. patagiatus show faster ovary growth and ultimately these flowers produce more fruit. Our work shows that pollinators may influence fruit production beyond the amount of pollen delivered. We show that managed indigenous bumblebees significantly outperform introduced honeybees in increasing peach initial fruit set under greenhouse conditions.	[Zhang, Hong; Huang, Jiaxing; Williams, Paul H.; Zhou, Zhiyong; Gai, Qinbao; Dong, Jie; An, Jiandong] Chinese Acad Agr Sci, Inst Apicultural Res, Minist Agr, Key Lab Insect Pollinator Biol, Beijing 100193, Peoples R China; [Williams, Paul H.] Nat Hist Museum, Dept Life Sci, London SW7 5BD, England; [Vaissiere, Bernard E.] INRA, Lab Pollinisat & Ecol Abeilles, Abeilles & Environm UR406, Avignon, France	Chinese Academy of Agricultural Sciences; Institute of Apicultural Research, CAAS; Ministry of Agriculture & Rural Affairs; Natural History Museum London; INRAE	An, JD (corresponding author), Chinese Acad Agr Sci, Inst Apicultural Res, Minist Agr, Key Lab Insect Pollinator Biol, Beijing 100193, Peoples R China.	anjiandong@caas.cn			Special Fund for Agro-scientific Research in the Public Interest [201203080-4]; SAFEA High-end Foreign Experts Program [GDJ20140326002]; International Exchange and Cooperation Program in Agricultural Science [A6950]; CAAS Fundamental Research Funds [201422021]; Agricultural Science and Technology Innovation Program [CAAS-ASTIP-2015-IAR]; Natural Science Foundation of China [30901055]	Special Fund for Agro-scientific Research in the Public Interest; SAFEA High-end Foreign Experts Program; International Exchange and Cooperation Program in Agricultural Science; CAAS Fundamental Research Funds; Agricultural Science and Technology Innovation Program; Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported financially by the Special Fund for Agro-scientific Research in the Public Interest (201203080-4); the SAFEA High-end Foreign Experts Program (GDJ20140326002); the International Exchange and Cooperation Program in Agricultural Science (A6950); the CAAS Fundamental Research Funds (201422021); the Agricultural Science and Technology Innovation Program (CAAS-ASTIP-2015-IAR); and the Natural Science Foundation of China (30901055).	Abak K, 1995, ACTA HORTIC, P268, DOI 10.17660/ActaHortic.1995.412.30; Allen-Wardell G, 1998, CONSERV BIOL, V12, P8; An Jian-Dong, 2007, Yingyong Shengtai Xuebao, V18, P1071; ARBELOA A, 1987, ANN BOT-LONDON, V60, P681, DOI 10.1093/oxfordjournals.aob.a087500; Artz DR, 2011, J ECON ENTOMOL, V104, P1153, DOI 10.1603/EC10431; Benedek P., 1996, Acta Horticulturae, P169; Beyhan N, 2007, SCI HORTICULTURAE, V113, P347; Borgardt SJ, 2003, AM J BOT, V90, P1567, DOI 10.3732/ajb.90.11.1567; Cousin M, 1998, SCI HORTIC-AMSTERDAM, V72, P287, DOI 10.1016/S0304-4238(97)00138-6; Delaplane KS, 2013, J APICULT RES, V52, DOI [10.3896/IBRA.1.52.1.03, 10.3896/IBRA.1.52.4.12]; Dyer AG, 2004, J EXP BIOL, V207, P1683, DOI 10.1242/jeb.00941; FAOSTATS: Food and Agricultural Organization of the United Nations, 2014, 2014 STAT DIV; Freitas BM, 1998, J APPL ECOL, V35, P109, DOI 10.1046/j.1365-2664.1998.00278.x; Gallai N, 2009, ECOL ECON, V68, P810, DOI 10.1016/j.ecolecon.2008.06.014; Garibaldi LA, 2013, SCIENCE, V339, P1608, DOI 10.1126/science.1230200; Goulson Dave, 1999, Perspectives in Plant Ecology Evolution and Systematics, V2, P185, DOI 10.1078/1433-8319-00070; Gradziel TM, 1999, HORTSCIENCE, V34, P322, DOI 10.21273/HORTSCI.34.2.322; Herrero M, 1996, SEX PLANT REPROD, V9, P343, DOI 10.1007/BF02441953; HERRERO M, 1992, PLANT GROWTH REGUL, V11, P27, DOI 10.1007/BF00024429; JOHANSEN D.A., 1940, PLANT MICROTECHNIQUE; KHO YO, 1968, EUPHYTICA, V17, P298; King C, 2013, METHODS ECOL EVOL, V4, P811, DOI 10.1111/2041-210X.12074; Klein AM, 2007, P ROY SOC B-BIOL SCI, V274, P303, DOI 10.1098/rspb.2006.3721; Knox RB, 1984, CELLULAR INTERACTION, V17, P508; Kremen C, 2002, P NATL ACAD SCI USA, V99, P16812, DOI 10.1073/pnas.262413599; LANGRIDGE DF, 1979, AUST J EXP AGR, V19, P510, DOI 10.1071/EA9790510; LANGRIDGE DF, 1977, AUST J EXP AGR, V17, P697, DOI 10.1071/EA9770697; Layne D. R., 2008, PEACH BOT PRODUCTION; Liu JF, 2014, PLANT REPROD, V27, P145, DOI 10.1007/s00497-014-0248-9; Lord EM, 2002, ANNU REV CELL DEV BI, V18, P81, DOI 10.1146/annurev.cellbio.18.012502.083438; Ne'eman G, 2010, BIOL REV, V85, P435, DOI 10.1111/j.1469-185X.2009.00108.x; Nemeth M. Barbara, 2006, International Journal of Botany, V2, P83; Nemeth MB, 2003, INT J PLANT SCI, V164, P153, DOI 10.1086/344549; Nyeki J, 1998, ACTA HORTIC, P279, DOI 10.17660/ActaHortic.1998.465.35; Nyeki J., 2000, International Journal of Horticultural Science, V6, P123; PIMIENTA E, 1983, ANN BOT-LONDON, V51, P469, DOI 10.1093/oxfordjournals.aob.a086492; PRIMACK RB, 1975, NATURE, V255, P143, DOI 10.1038/255143a0; Sanzol J, 2001, SCI HORTIC-AMSTERDAM, V90, P1, DOI 10.1016/S0304-4238(00)00252-1; Shaheen MA, 1996, ENV ARID LAND AGR SC, V7, P99; SNOW AA, 1987, BIOTROPICA, V19, P57, DOI 10.2307/2388460; Socias I Company Rafel, 2013, Plants (Basel), V2, P50, DOI 10.3390/plants2010050; Sogo A, 2004, J PLANT RES, V117, P37, DOI 10.1007/s10265-003-0129-z; SOUTHWICK EE, 1992, J ECON ENTOMOL, V85, P621, DOI 10.1093/jee/85.3.621; Stanghellini MS, 1998, HORTSCIENCE, V33, P28, DOI 10.21273/HORTSCI.33.1.28; THOMSON JD, 1980, OECOLOGIA, V46, P68, DOI 10.1007/BF00346968; Thomson JD, 2001, J APPL ECOL, V38, P1032, DOI 10.1046/j.1365-2664.2001.00657.x; Vaissiere B.E, 2011, PROTOCOL DETECT ASSE; Velthuis HHW, 2006, APIDOLOGIE, V37, P421, DOI 10.1051/apido:2006019; WEINBAUM SA, 1986, EUPHYTICA, V35, P193, DOI 10.1007/BF00028557; WEINBAUM SA, 1983, FRUIT VARIETIES J, V37, P113; WESTERKAMP C, 1991, PLANT SYST EVOL, V177, P71, DOI 10.1007/BF00937827; Wilcock C, 2002, TRENDS PLANT SCI, V7, P270, DOI 10.1016/S1360-1385(02)02258-6; Williams PH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032992; Zhang Hong, 2013, Zhongguo Shengtai Nongye Xuebao / Chinese Journal of Eco-Agriculture, V21, P1249, DOI 10.3724/SP.J.1011.2013.01249; Zhang Y, 2010, AGR ENG TECHNOLOGY G, V8, P94	55	29	38	2	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0121143	10.1371/journal.pone.0121143	http://dx.doi.org/10.1371/journal.pone.0121143			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25799170	Green Published, Green Submitted, gold			2022-12-27	WOS:000351987300217
J	Kreiseder, B; Holper-Schichl, YM; Muellauer, B; Jacobi, N; Pretsch, A; Schmid, JA; de Martin, R; Hundsberger, H; Eger, A; Wiesner, C				Kreiseder, Birgit; Holper-Schichl, Yvonne M.; Muellauer, Barbara; Jacobi, Nico; Pretsch, Alexander; Schmid, Johannes A.; de Martin, Rainer; Hundsberger, Harald; Eger, Andreas; Wiesner, Christoph			Alpha-Catulin Contributes to Drug-Resistance of Melanoma by Activating NF-kappa B and AP-1	PLOS ONE			English	Article							CISPLATIN-INDUCED APOPTOSIS; CYTOCHROME-C RELEASE; DOUBLE-EDGED-SWORD; E-CADHERIN; MESENCHYMAL TRANSITION; SNAIL TRANSCRIPTION; CELL-PROLIFERATION; MALIGNANT-MELANOMA; EPITHELIAL-CELLS; ERK ACTIVATION	Melanoma is the most dangerous type of skin cancer accounting for 48,000 deaths worldwide each year and an average survival rate of about 6-10 months with conventional treatment. Tumor metastasis and chemoresistance of melanoma cells are reported as the main reasons for the insufficiency of currently available treatments for late stage melanoma. The cytoskeletal linker protein alpha-catulin (CTNNAL1) has been shown to be important in inflammation, apoptosis and cytoskeletal reorganization. Recently, we found an elevated expression of alpha-catulin in melanoma cells. Ectopic expression of alpha-catulin promoted melanoma progression and occurred concomitantly with the downregulation of E-cadherin and the upregulation of mesenchymal genes such as N-cadherin, Snail/Slug and the matrix metalloproteinases 2 and 9. In the current study we showed that alpha-catulin knockdown reduced NF-kappa B and AP-1 activity in malignant melanoma cells. Further, downregulation of alpha-catulin diminished ERK phosphorylation in malignant melanoma cells and sensitized them to treatment with chemotherapeutic drugs. In particular, cisplatin treatment led to decreased ERK-, JNK- and c-Jun phosphorylation in alpha-catulin knockdown melanoma cells, which was accompanied by enhanced apoptosis compared to control cells. Altogether, these results suggest that targeted inhibition of alpha-catulin may be used as a viable therapeutic strategy to chemosensitize melanoma cells to cisplatin by down-regulation of NF-kappa B and MAPK pathways.	[Kreiseder, Birgit; Muellauer, Barbara; Pretsch, Alexander; Wiesner, Christoph] SeaLife Pharma GmbH, Tulln, Austria; [Holper-Schichl, Yvonne M.; Schmid, Johannes A.; de Martin, Rainer] Med Univ Vienna, Dept Vasc Biol & Thrombosis Res, Ctr Physiol & Pharmacol, Vienna, Austria; [Jacobi, Nico; Hundsberger, Harald; Eger, Andreas; Wiesner, Christoph] Univ Appl Sci, Med & Pharmaceut Biotechnol, Krems, Austria	Medical University of Vienna	Wiesner, C (corresponding author), SeaLife Pharma GmbH, Tulln, Austria.	wiesner@sealifepharma.com	Schmid, Johannes A./C-7659-2009	Schmid, Johannes A./0000-0002-6586-3507; hundsberger, harald/0000-0002-8479-1633; Wiesner, Christoph/0000-0002-3281-0695	Austrian FFG (Forschungs Forderungs Gesellschaft); Project COIN, FFG-Project [821021]; Niederosterreichischen Forschungs-und Bildungsgesellschaft NFB Project [LS-11.013]	Austrian FFG (Forschungs Forderungs Gesellschaft); Project COIN, FFG-Project; Niederosterreichischen Forschungs-und Bildungsgesellschaft NFB Project	This work was supported by the Austrian FFG (Forschungs Forderungs Gesellschaft); Project COIN, FFG-Project Nr.: 821021 to CW and AE and by the Niederosterreichischen Forschungs-und Bildungsgesellschaft NFB Project Nr. LS-11.013 to AE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABATE C, 1990, SCIENCE, V249, P1157, DOI 10.1126/science.2118682; Amatschek S, 2011, BRIT J CANCER, V104, P469, DOI 10.1038/sj.bjc.6606056; Amiri KI, 2005, CANCER METAST REV, V24, P301, DOI 10.1007/s10555-005-1579-7; Bachelder RE, 2005, J CELL BIOL, V168, P29, DOI 10.1083/jcb.200409067; Balch CM, 2001, TUMORI, V87, pS64; Barbera MJ, 2004, ONCOGENE, V23, P7345, DOI 10.1038/sj.onc.1207990; BOURS V, 1994, BIOCHEM PHARMACOL, V47, P145, DOI 10.1016/0006-2952(94)90448-0; Cao C, 2012, MOL CANCER RES, V10, P892, DOI 10.1158/1541-7786.MCR-12-0169; Chang AE, 1998, CANCER, V83, P1664, DOI 10.1002/(SICI)1097-0142(19981015)83:8<1664::AID-CNCR23>3.0.CO;2-G; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Chin L, 2006, GENE DEV, V20, P2149, DOI 10.1101/gad.1437206; Chua HL, 2007, ONCOGENE, V26, P711, DOI 10.1038/sj.onc.1209808; Colpi GM, 2004, EUR J OBSTET GYN R B, V113, pS2, DOI 10.1016/j.ejogrb.2003.11.002; Costantini P, 2000, J NATL CANCER I, V92, P1042, DOI 10.1093/jnci/92.13.1042; Dent P, 2001, CLIN CANCER RES, V7, P775; Dhawan P, 2002, J BIOL CHEM, V277, P7920, DOI 10.1074/jbc.M112210200; Eferl R, 2003, NAT REV CANCER, V3, P859, DOI 10.1038/nrc1209; Elsum IA, 2013, J CELL SCI, V126, P3990, DOI 10.1242/jcs.129387; Fan LC, 2011, ONCOGENE, V30, P2610, DOI 10.1038/onc.2010.637; Grossman D, 2001, CANCER METAST REV, V20, P3, DOI 10.1023/A:1013123532723; Heiskanen KM, 1999, J BIOL CHEM, V274, P5654, DOI 10.1074/jbc.274.9.5654; Howell S J, 2005, J Natl Cancer Inst Monogr, P12; Hurst EA, 2003, ARCH DERMATOL, V139, P1067, DOI 10.1001/archderm.139.8.1067; Julien S, 2007, ONCOGENE, V26, P7445, DOI 10.1038/sj.onc.1210546; Karin M, 2001, BIOFACTORS, V15, P87, DOI 10.1002/biof.5520150207; Kim YK, 2005, J APPL TOXICOL, V25, P374, DOI 10.1002/jat.1081; Kojima H, 1998, J BIOL CHEM, V273, P16647, DOI 10.1074/jbc.273.27.16647; Kreiseder B, 2013, INT J CANCER, V132, P521, DOI 10.1002/ijc.27698; Kuphal S, 2004, ONCOGENE, V23, P8509, DOI 10.1038/sj.onc.1207831; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; Liang CH, 2013, CANCER RES, V73, P428, DOI 10.1158/0008-5472.CAN-12-2095; Liu J, 2005, CELL RES, V15, P36, DOI 10.1038/sj.cr.7290262; Mandic A, 2001, MELANOMA RES, V11, P11, DOI 10.1097/00008390-200102000-00002; Merdek KD, 2004, MOL CELL BIOL, V24, P2410, DOI 10.1128/MCB.24.6.2410-2422.2004; Mirmohammadsadegh A, 2007, J INVEST DERMATOL, V127, P2207, DOI 10.1038/sj.jid.5700870; Oeckinghaus A, 2011, NAT IMMUNOL, V12, P695, DOI 10.1038/ni.2065; Park B, 2002, J BIOL CHEM, V277, P45361, DOI 10.1074/jbc.M202447200; Paul I, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.186; Persons DL, 1999, CLIN CANCER RES, V5, P1007; Reed JC, 1997, CELL, V91, P559, DOI 10.1016/S0092-8674(00)80442-0; Roos WP, 2006, TRENDS MOL MED, V12, P440, DOI 10.1016/j.molmed.2006.07.007; Shaulian E, 2001, ONCOGENE, V20, P2390, DOI 10.1038/sj.onc.1204383; Siddik ZH, 2003, ONCOGENE, V22, P7265, DOI 10.1038/sj.onc.1206933; Spangler B, 2011, PIGM CELL MELANOMA R, V24, P148, DOI 10.1111/j.1755-148X.2010.00787.x; Sun W, 2001, CURR TREAT OPTION ON, V2, P139; Ueda Y, 2006, PIGM CELL RES, V19, P112, DOI 10.1111/j.1600-0749.2006.00304.x; Venkatraman M, 2005, MOL CARCINOGEN, V44, P51, DOI 10.1002/mc.20116; Wang CY, 1999, NAT MED, V5, P412, DOI 10.1038/7410; Wang D, 2005, NAT REV DRUG DISCOV, V4, P307, DOI 10.1038/nrd1691; Wang XT, 2000, J BIOL CHEM, V275, P39435, DOI 10.1074/jbc.M004583200; Wiesner C, 2008, ONCOGENE, V27, P2159, DOI 10.1038/sj.onc.1210863; Wu Y, 2009, CANCER CELL, V15, P416, DOI 10.1016/j.ccr.2009.03.016; Zhang W, 2002, CELL RES, V12, P9, DOI 10.1038/sj.cr.7290105	53	20	23	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0119402	10.1371/journal.pone.0119402	http://dx.doi.org/10.1371/journal.pone.0119402			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25793618	Green Published, gold, Green Submitted			2022-12-27	WOS:000352084200080
J	Liu, YC; Liu, ZB; Sun, GX; Wang, Y; Ling, JH; Gao, JY; Huang, JH				Liu, Yingchun; Liu, Zhongbo; Sun, Guoxiang; Wang, Yan; Ling, Junhong; Gao, Jiayue; Huang, Jiahao			Monitoring and Evaluating the Quality Consistency of Compound Bismuth Aluminate Tablets by a Simple Quantified Ratio Fingerprint Method Combined with Simultaneous Determination of Five Compounds and Correlated with Antioxidant Activities	PLOS ONE			English	Article							CHINESE HERBAL MEDICINE; CHROMATOGRAPHIC FINGERPRINT; PHARMACEUTICAL PRODUCTS; LICORICE	A combination method of multi-wavelength fingerprinting and multi-component quantification by high performance liquid chromatography (HPLC) coupled with diode array detector (DAD) was developed and validated to monitor and evaluate the quality consistency of herbal medicines (HM) in the classical preparation Compound Bismuth Aluminate tablets (CBAT). The validation results demonstrated that our method met the requirements of fingerprint analysis and quantification analysis with suitable linearity, precision, accuracy, limits of detection (LOD) and limits of quantification (LOQ). In the fingerprint assessments, rather than using conventional qualitative "Similarity" as a criterion, the simple quantified ratio fingerprint method (SQRFM) was recommended, which has an important quantified fingerprint advantage over the "Similarity" approach. SQRFM qualitatively and quantitatively offers the scientific criteria for traditional Chinese medicines (TCM)/HM quality pyramid and warning gate in terms of three parameters. In order to combine the comprehensive characterization of multi-wavelength fingerprints, an integrated fingerprint assessment strategy based on information entropy was set up involving a super-information characteristic digitized parameter of fingerprints, which reveals the total entropy value and absolute information amount about the fingerprints and, thus, offers an excellent method for fingerprint integration. The correlation results between quantified fingerprints and quantitative determination of 5 marker compounds, including glycyrrhizic acid (GLY), liquiritin (LQ), isoliquiritigenin (ILG), isoliquiritin (ILQ) and isoliquiritin apioside (ILA), indicated that multi-component quantification could be replaced by quantified fingerprints. The Fenton reaction was employed to determine the antioxidant activities of CBAT samples in vitro, and they were correlated with HPLC fingerprint components using the partial least squares regression (PLSR) method. In summary, the method of multi-wavelength fingerprints combined with antioxidant activities has been proved to be a feasible and scientific procedure for monitoring and evaluating the quality consistency of CBAT.	[Liu, Yingchun; Ling, Junhong] Shenyang Pharmaceut Univ, Sch Pharmaceut Engn, Key Lab Struct Based Drug Design & Discovery, Minist Educ, Shenyang, Peoples R China; [Liu, Yingchun; Liu, Zhongbo; Sun, Guoxiang; Wang, Yan; Gao, Jiayue; Huang, Jiahao] Shenyang Pharmaceut Univ, Sch Pharm, Pharmaceut Informat Lab, Shenyang, Peoples R China	Shenyang Pharmaceutical University; Shenyang Pharmaceutical University	Sun, GX (corresponding author), Shenyang Pharmaceut Univ, Sch Pharm, Pharmaceut Informat Lab, Shenyang, Peoples R China.	gxswmwys@126.com	LIU, YING/GZL-7252-2022; liu, ying/GXF-4294-2022					Asl MN, 2008, PHYTOTHER RES, V22, P709, DOI 10.1002/ptr.2362; Chen P, 2011, J AOAC INT, V94, P1411, DOI 10.5740/jaoacint.10-291; CHMP, 2005, GUID QUAL HERB MED P; Dan M, 2009, PHYTOCHEM ANALYSIS, V20, P68, DOI 10.1002/pca.1099; *DRUG ADM BUR CHIN, 2002, REQ STUD FING TRAD C; Feng HS, 2007, CHINA PHARM, V16, P32; Food and Drug Administration, 2004, GUID IND BOT DRUG PR; Garza-Juarez A, 2011, PLANTA MED, V77, P958, DOI 10.1055/s-0030-1250684; Gong F, 2005, ANAL LETT, V38, P2475, DOI 10.1080/00032710500318338; Gumus G, 2005, ANAL CHIM ACTA, V547, P138, DOI 10.1016/j.aca.2005.03.028; Jana S, 2010, APPL CLAY SCI, V50, P337, DOI 10.1016/j.clay.2010.08.023; Jeronimo PCA, 2004, ANAL CHIM ACTA, V504, P235, DOI 10.1016/j.aca.2003.10.049; Kondo K, 2013, PHYTOCHEM ANALYSIS, V24, P527, DOI [10.1002/pca.2427, DOI 10.1002/PCA.2427]; Kondo K, 2007, BIOL PHARM BULL, V30, P1271, DOI 10.1248/bpb.30.1271; National Pharmacopoeia Committee, 2010, PHARM PEOPL REP CHIN, V1, P587; Pan RJ, 2011, J PHARMACEUT BIOMED, V55, P391, DOI 10.1016/j.jpba.2011.01.016; Qiao X, 2012, J CHROMATOGR A, V1258, P84, DOI 10.1016/j.chroma.2012.08.041; Rodriguez JA, 2007, J PHARMACEUT BIOMED, V45, P47, DOI 10.1016/j.jpba.2007.05.025; SFDA. State Drug Administration of China, 2000, CHIN TRADIT PAT MED, V22, P671; Shen DADA, 2012, FOOD CHEM, V130, P1003, DOI 10.1016/j.foodchem.2011.07.121; Sun Guo-xiang, 2009, Yaoxue Xuebao, V44, P401; Sun GX, 2007, CENTRAL S PHARM, V6, P25; Sun GX, 2009, CENTRAL S PHARM, V2, P19; Syam Ari Fahrial, 2009, Acta Med Indones, V41, P95; Tzanavaras PD, 2004, ANAL CHIM ACTA, V505, P167, DOI 10.1016/S0003-2670(03)00017-5; Wang LB, 2012, BIOCHEM SYST ECOL, V40, P138, DOI 10.1016/j.bse.2011.10.014; Wichtl M, 1994, HERBAL DRUGS PHYTOPH; Wu YC, 2009, ACTA CHIN MED PHARM, V37, P56; Xie PS, 2006, J CHROMATOGR A, V1112, P171, DOI 10.1016/j.chroma.2005.12.091; Xu L, 2004, CHEMOMETRICS PRINCIP, P16; Xu LanJu, 2004, China Poultry, P14; Yun YR, 2012, LUMINESCENCE, V27, P352, DOI 10.1002/bio.1357; Zapata-Colindres JC, 2006, CAN J GASTROENTEROL, V20, P277, DOI 10.1155/2006/175217; Zhang QF, 2011, PHYTOCHEM ANALYSIS, V22, P18, DOI 10.1002/pca.1245; Zhang QY, 2009, J CHROMATOGR A, V1216, P1954, DOI 10.1016/j.chroma.2008.07.072	35	16	16	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0118223	10.1371/journal.pone.0118223	http://dx.doi.org/10.1371/journal.pone.0118223			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25793599	Green Submitted, gold, Green Published			2022-12-27	WOS:000352084200017
J	Ramasamy, S; Velmurugan, G; Rajan, KS; Ramprasath, T; Kalpana, K				Ramasamy, Subbiah; Velmurugan, Ganesan; Rajan, K. Shanmugha; Ramprasath, Tharmarajan; Kalpana, Krishnan			MiRNAs with Apoptosis Regulating Potential Are Differentially Expressed in Chronic Exercise-Induced Physiologically Hypertrophied Hearts	PLOS ONE			English	Article							CARDIAC-HYPERTROPHY; MICRORNAS; RATS; FAILURE; DISEASE; TOOL	Physiological cardiac hypertrophy is an adaptive mechanism, induced during chronic exercise. As it is reversible and not associated with cardiomyocyte death, it is considered as a natural tactic to prevent cardiac dysfunction and failure. Though, different studies revealed the importance of microRNAs (miRNAs) in pathological hypertrophy, their role during physiological hypertrophy is largely unexplored. Hence, this study is aimed at revealing the global expression profile of miRNAs during physiological cardiac hypertrophy. Chronic swimming protocol continuously for eight weeks resulted in induction of physiological hypertrophy in rats and histopathology revealed the absence of tissue damage, apoptosis or fibrosis. Subsequently, the total RNA was isolated and small RNA sequencing was executed. Analysis of small RNA reads revealed the differential expression of a large set of miRNAs during physiological hypertrophy. The expression profile of the significantly differentially expressed miRNAs was validated by qPCR. In silico prediction of target genes by miRanda, miRdB and TargetScan and subsequent qPCR analysis unraveled that miRNAs including miR-99b, miR-100, miR-19b, miR-10, miR-208a, miR-133, miR-191a, miR-22, miR-30e and miR-181a are targeting the genes that primarily regulate cell proliferation and cell death. Gene ontology and pathway mapping showed that the differentially expressed miRNAs and their target genes were mapped to apoptosis and cell death pathways principally via PI3K/Akt/mTOR and MAPK signaling. In summary, our data indicates that regulation of these miRNAs with apoptosis regulating potential can be one of the major key factors in determining pathological or physiological hypertrophy by controlling fibrosis, apoptosis and cell death mechanisms.	[Ramasamy, Subbiah; Velmurugan, Ganesan; Rajan, K. Shanmugha] Madurai Kamaraj Univ, Sch Biol Sci, Dept Mol Biol, Cardiac Hypertrophy Lab, Madurai 625021, Tamil Nadu, India; [Ramprasath, Tharmarajan] Univ Alberta, Dept Med, Edmonton, AB, Canada; [Kalpana, Krishnan] Tamilnadu Agr Univ, Reg Res Stn, Dept Plant Pathol, Krishangiri, Tamil Nadu, India	Madurai Kamaraj University; University of Alberta; Tamil Nadu Agricultural University	Ramasamy, S (corresponding author), Madurai Kamaraj Univ, Sch Biol Sci, Dept Mol Biol, Cardiac Hypertrophy Lab, Madurai 625021, Tamil Nadu, India.	subbiahr@nrcbsmku.org	Velmurugan, Ganesan/D-2360-2010; krishnan, kalpana/AAP-1297-2020; Ramprasath, Tharmarajan/V-5186-2017	Velmurugan, Ganesan/0000-0001-7536-4472; Ramprasath, Tharmarajan/0000-0002-2115-5875	Science & Engineering Research Board (SERB), Ministry of Science & Technology, Government of India [SR/FT/LS-37/2011]	Science & Engineering Research Board (SERB), Ministry of Science & Technology, Government of India	Funding: This work was funded by the Science & Engineering Research Board (SERB), Ministry of Science & Technology, Government of India (Project Ref. No. SR/FT/LS-37/2011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An JY, 2013, NUCLEIC ACIDS RES, V41, P727, DOI 10.1093/nar/gks1187; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Archer E, 2011, PROG CARDIOVASC DIS, V53, P387, DOI 10.1016/j.pcad.2011.02.006; Balakumar P, 2006, BASIC CLIN PHARMACOL, V99, P418, DOI 10.1111/j.1742-7843.2006.pto_569.x; Balcells I, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-70; Care A, 2007, NAT MED, V13, P613, DOI 10.1038/nm1582; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Coppola A, 2014, STEM CELL RES, V12, P323, DOI 10.1016/j.scr.2013.11.008; Da Silva ND, 2012, MED SCI SPORT EXER, V44, P1453, DOI 10.1249/MSS.0b013e31824e8a36; Dorn GW, 2007, HYPERTENSION, V49, P962, DOI 10.1161/HYPERTENSIONAHA.106.079426; Dweep H, 2011, J BIOMED INFORM, V44, P839, DOI 10.1016/j.jbi.2011.05.002; Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48; Fernandes T, 2011, BRAZ J MED BIOL RES, V44, P836, DOI 10.1590/S0100-879X2011000900003; Fernandes T, 2011, HYPERTENSION, V58, P182, DOI 10.1161/HYPERTENSIONAHA.110.168252; Frey N, 2003, ANNU REV PHYSIOL, V65, P45, DOI 10.1146/annurev.physiol.65.092101.142243; Friedlander MR, 2012, NUCLEIC ACIDS RES, V40, P37, DOI 10.1093/nar/gkr688; Huang ZP, 2013, CIRC RES, V112, P1234, DOI 10.1161/CIRCRESAHA.112.300682; Kemi OJ, 2008, J CELL PHYSIOL, V214, P316, DOI 10.1002/jcp.21197; Maillet M, 2013, NAT REV MOL CELL BIO, V14, P38, DOI 10.1038/nrm3495; Martinelli NC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093271; Martins PAD, 2012, CARDIOVASC RES, V93, P563, DOI 10.1093/cvr/cvs013; McMullen JR, 2007, CLIN EXP PHARMACOL P, V34, P255, DOI 10.1111/j.1440-1681.2007.04585.x; Montgomery RL, 2011, CIRCULATION, V124, P1537, DOI 10.1161/CIRCULATIONAHA.111.030932; Nagpal N, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00099; Pan W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053950; Pluim BM, 2000, CIRCULATION, V101, P336, DOI 10.1161/01.CIR.101.3.336; Soci UPR, 2011, PHYSIOL GENOMICS, V43, P665, DOI 10.1152/physiolgenomics.00145.2010; Song DW, 2014, BIOCHEM J, V457, P151, DOI 10.1042/BJ20130833; Sucharov C, 2008, J MOL CELL CARDIOL, V45, P185, DOI 10.1016/j.yjmcc.2008.04.014; Sun XH, 2012, J CLIN INVEST, V122, P1973, DOI 10.1172/JCI61495	30	30	33	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0121401	10.1371/journal.pone.0121401	http://dx.doi.org/10.1371/journal.pone.0121401			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25793527	Green Published, Green Submitted, gold			2022-12-27	WOS:000352083900131
J	Satherley, N; Milojev, P; Greaves, LM; Huang, YS; Osborne, D; Bulbulia, J; Sibley, CG				Satherley, Nicole; Milojev, Petar; Greaves, Lara M.; Huang, Yanshu; Osborne, Danny; Bulbulia, Joseph; Sibley, Chris G.			Demographic and Psychological Predictors of Panel Attrition: Evidence from the New Zealand Attitudes and Values Study	PLOS ONE			English	Article							BIG-6 FACTORS; PERSONALITY; HEALTH; DEPRIVATION; NONRESPONSE; SAMPLE; COHORT; TINY	This study examines attrition rates over the first four years of the New Zealand Attitudes and Values Study, a longitudinal national panel sample of New Zealand adults. We report the base rate and covariates for the following four distinct classes of respondents: explicit withdrawals, lost respondents, intermittent respondents and constant respondents. A multinomial logistic regression examined an extensive range of demographic and socio-psychological covariates (among them the Big-Six personality traits) associated with membership in these classes (N = 5,814). Results indicated that men, M ori and Asian peoples were less likely to be constant respondents. Conscientiousness and Honesty-Humility were also positively associated with membership in the constant respondent class. Notably, the effect sizes for the socio-psychological covariates of panel attrition tended to match or exceed those of standard demographic covariates. This investigation broadens the focus of research on panel attrition beyond demographics by including a comprehensive set of socio-psychological covariates. Our findings show that core psychological covariates convey important information about panel attrition, and are practically important to the management of longitudinal panel samples like the New Zealand Attitudes and Values Study.	[Satherley, Nicole; Milojev, Petar; Greaves, Lara M.; Huang, Yanshu; Osborne, Danny; Sibley, Chris G.] Univ Auckland, Auckland 1, New Zealand; [Bulbulia, Joseph] Victoria Univ Wellington, Wellington, New Zealand	University of Auckland; Victoria University Wellington	Sibley, CG (corresponding author), Univ Auckland, Auckland 1, New Zealand.	c.sibley@auckland.ac.nz	Sibley, Chris G/D-2974-2009	Sibley, Chris G/0000-0002-4064-8800; Satherley, Nicole/0000-0002-6929-759X; Huang, Yanshu/0000-0003-2120-6609; Bulbulia, Joseph/0000-0002-5861-2056; Osborne, Danny/0000-0002-8513-4125; Greaves, Lara/0000-0003-0537-7125	Templeton World Charity Foundation Grant [ID: 0077]	Templeton World Charity Foundation Grant(Templeton World Charity Foundation)	This research was supported by a Templeton World Charity Foundation Grant (ID: 0077). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], SOCIAL INEQUALITIES; Ashton MC, 2007, PERS SOC PSYCHOL REV, V11, P150, DOI 10.1177/1088868306294907; Behr A, 2005, EUR SOCIOL REV, V21, P489, DOI 10.1093/esr/jci037; Crampton P, 2000, HEALTH EDUC BEHAV, V27, P317, DOI 10.1177/109019810002700306; Cutrona C.E., 1987, ADV PERSONAL RELATIO, V1, P37; de Graaf R, 2000, AM J EPIDEMIOL, V152, P1039, DOI 10.1093/aje/152.11.1039; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; DOLLINGER SJ, 1993, J PSYCHOL, V127, P29, DOI 10.1080/00223980.1993.9915540; Donnellan MB, 2006, PSYCHOL ASSESSMENT, V18, P192, DOI 10.1037/1040-3590.18.2.192; Estrada M, 2014, EVALUATION REV, V38, P3, DOI 10.1177/0193841X14524956; Fitzgerald J, 1998, J HUM RESOUR, V33, P251, DOI 10.2307/146433; Frankel LL, 2014, POLIT ANAL, V22, P336, DOI 10.1093/pan/mpt020; Goldberg L.R., 1981, REV PERSONAL SOC PSY, V2, P141, DOI DOI 10.1037/0022-3514.59.6.1216; GOLDBERG LR, 1990, J PERS SOC PSYCHOL, V59, P1216, DOI 10.1037/0022-3514.59.6.1216; Hawkes D, 2006, J R STAT SOC A STAT, V169, P479, DOI 10.1111/j.1467-985X.2006.00401.x; Huang Y, 2014, NZAVS TECHNICAL DOCU; KOSTERMAN R, 1989, POLIT PSYCHOL, V10, P257, DOI 10.2307/3791647; Krynen A., 2013, NZ J PSYCHOL, V42, P69; Loosveldt G, 2002, INT J PUBLIC OPIN R, V14, P428, DOI 10.1093/ijpor/14.4.428; Loosveldt Geert, 2002, J OFFICIAL STAT STOC, V18, P545; Lugtig P, 2014, SOCIOL METHOD RES, V43, P699, DOI 10.1177/0049124113520305; Lynn P., 2009, METHODOLOGY LONGITUD, P1, DOI 10.1002/9780470743874.ch1; Milojev P, 2014, SOC PSYCHOL PERS SCI, V5, P760, DOI 10.1177/1948550614528545; Milojev P, 2014, J RES PERS, V51, P29, DOI 10.1016/j.jrp.2014.04.005; Milojev P, 2013, J RES PERS, V47, P936, DOI 10.1016/j.jrp.2013.09.004; Mitchell EA, 2000, SOC SCI MED, V51, P147, DOI 10.1016/S0277-9536(99)00415-3; Morton SMB, 2013, INT J EPIDEMIOL, V42, P65, DOI 10.1093/ije/dyr206; New Zealand Election Study, 2011, RESULTS FROM THE 201; Porter SR, 2005, RES HIGH EDUC, V46, P127, DOI 10.1007/s11162-004-1597-2; Radler BT, 2010, J AGING HEALTH, V22, P307, DOI 10.1177/0898264309358617; Richter D, 2014, J RES PERS, V53, P31, DOI 10.1016/j.jrp.2014.08.001; Sa&beta;enroth, 2013, IMPACT PERSONALITY P; Salmond C., 2007, NZDEP2006 INDEX DEPR; Salmond CE, 2012, CAN J PUBLIC HEALTH, V103, pS7; Schoeni RF, 2013, ANN AM ACAD POLIT SS, V645, P60, DOI 10.1177/0002716212456363; SCHWARTZ SH, 1992, ADV EXP SOC PSYCHOL, V25, P1, DOI 10.1016/s0065-2601(08)60281-6; Sibley C.G., 2014, NZAVS TECHNICAL DOCU; Sibley CG, 2012, NEW ZEAL J PSYCHOL, V41, P21; Sibley CG, 2013, NEW ZEAL J PSYCHOL, V42, P13; Sibley CG, 2011, NEW ZEAL J PSYCHOL, V40, P142; Statistics New Zealand, 2006, CENS POP DWELL; Ware RS, 2006, ANN EPIDEMIOL, V16, P820, DOI 10.1016/j.annepidem.2006.01.008; Watson N, 2009, METHODOLOGY LONGITUD, P157, DOI DOI 10.1002/9780470743874.CH10; White P, 2008, ATLAS SOCIOECONOMIC; Williams KD, 2000, J PERS SOC PSYCHOL, V79, P748, DOI 10.1037/0022-3514.79.5.748; Young AF, 2006, AUST NZ J PUBL HEAL, V30, P353, DOI 10.1111/j.1467-842X.2006.tb00849.x	46	62	62	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0121950	10.1371/journal.pone.0121950	http://dx.doi.org/10.1371/journal.pone.0121950			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CE8HY	25793746	Green Published, gold, Green Submitted			2022-12-27	WOS:000352083900160
J	Cheng, B; Annamalai, T; Sandhaus, S; Bansod, P; Tse-Dinh, YC				Cheng, Bokun; Annamalai, Thirunavukkarasu; Sandhaus, Shayna; Bansod, Priyanka; Tse-Dinh, Yuk-Ching			Inhibition of Zn(II) Binding Type IA Topoisomerases by Organomercury Compounds and Hg(II)	PLOS ONE			English	Article							ESCHERICHIA-COLI DNA; CLEAVAGE; DOMAINS; TOP3-BETA; PROTEIN	Type IA topoisomerase activities are essential for resolving DNA topological barriers via an enzyme-mediated transient single strand DNA break. Accumulation of topoisomerase DNA cleavage product can lead to cell death or genomic rearrangement. Many antibacterial and anticancer drugs act as topoisomerase poison inhibitors that form stabilized ternary complexes with the topoisomerase covalent intermediate, so it is desirable to identify such inhibitors for type IA topoisomerases. Here we report that organomercury compounds were identified during a fluorescence based screening of the NIH diversity set of small molecules for topoisomerase inhibitors that can increase the DNA cleavage product of Yersinia pestis topoisomerase I. Inhibition of relaxation activity and accumulation of DNA cleavage product were confirmed for these organomercury compounds in gel based assays of Escherichia coli topoisomerase I. Hg(II), but not As(III), could also target the cysteines that form the multiple Zn(II) binding tetra-cysteine motifs found in the C-terminal domains of these bacterial topoisomerase I for relaxation activity inhibition. Mycobacterium tuberculosis topoisomerase I activity is not sensitive to Hg(II) or the organomercury compounds due to the absence of the Zn(II) binding cysteines. It is significant that the type IA topoisomerases with Zn(II) binding domains can still cleave DNA when interfered by Hg(II) or organomercury compounds. The Zn(II) binding domains found in human Top3 alpha and Top3 beta may be potential targets of toxic metals and organometallic complexes, with potential consequence on genomic stability and development.	[Cheng, Bokun] New York Med Coll, Dept Biochem & Mol Biol, Valhalla, NY 10595 USA; [Annamalai, Thirunavukkarasu; Sandhaus, Shayna; Bansod, Priyanka; Tse-Dinh, Yuk-Ching] Florida Int Univ, Dept Chem & Biochem, Miami, FL 33199 USA; [Tse-Dinh, Yuk-Ching] Florida Int Univ, Biomol Sci Inst, Miami, FL 33199 USA	New York Medical College; State University System of Florida; Florida International University; State University System of Florida; Florida International University	Tse-Dinh, YC (corresponding author), Florida Int Univ, Dept Chem & Biochem, Miami, FL 33199 USA.	ytsedinh@fiu.edu			National Institute of Health [R21 NS067592, R01 AI069313, R01 GM054226]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI069313] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054226] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS067592] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Funding: This research was supported by National Institute of Health grants R21 NS067592 and R01 AI069313, R01 GM054226 to YT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aedo S, 2012, ANTIMICROB AGENTS CH, V56, P5458, DOI 10.1128/AAC.01182-12; Ahmed W, 2013, NUCLEIC ACIDS RES, V41, P7462, DOI 10.1093/nar/gkt506; Ahumada A, 2002, BMC BIOCHEM, V3, DOI 10.1186/1471-2091-3-13; Annamalai T, 2009, BMC BIOCHEM, V10, DOI 10.1186/1471-2091-10-18; Bhaduri T, 1998, J BIOL CHEM, V273, P13925, DOI 10.1074/jbc.273.22.13925; Chen SH, 2012, J BIOL CHEM, V287, P19346, DOI 10.1074/jbc.M112.363044; Cheng B, 2005, J BIOL CHEM, V280, P38489, DOI 10.1074/jbc.M509722200; Cheng BK, 2003, J BIOL CHEM, V278, P30705, DOI 10.1074/jbc.M303403200; Cheng B, 2008, NUCLEIC ACIDS RES, V36, P1017, DOI 10.1093/nar/gkm1126; Cheng BK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060770; Cheng BK, 2009, J MOL BIOL, V385, P558, DOI 10.1016/j.jmb.2008.10.073; Cowell IG, 2012, P NATL ACAD SCI USA, V109, P8989, DOI 10.1073/pnas.1204406109; Drolet M, 2006, MOL MICROBIOL, V59, P723, DOI 10.1111/j.1365-2958.2005.05006.x; Grishin NV, 2000, J MOL BIOL, V299, P1165, DOI 10.1006/jmbi.2000.3841; Jaxel C, 1999, EUR J BIOCHEM, V260, P103, DOI 10.1046/j.1432-1327.1999.00128.x; KARLOVSKY P, 1986, BIOCHEM BIOPH RES CO, V138, P778, DOI 10.1016/S0006-291X(86)80564-2; Kitchin KT, 2008, J INORG BIOCHEM, V102, P532, DOI 10.1016/j.jinorgbio.2007.10.021; Lu JX, 2011, BIOMETALS, V24, P729, DOI 10.1007/s10534-011-9425-6; Narula G, 2012, NUCLEIC ACIDS RES, V40, P9233, DOI 10.1093/nar/gks688; Pommier Y, 2013, ACS CHEM BIOL, V8, P82, DOI 10.1021/cb300648v; Sorokin EP, 2008, NUCLEIC ACIDS RES, V36, P4788, DOI 10.1093/nar/gkn460; Stoll G, 2013, NAT NEUROSCI, V16, P1228, DOI 10.1038/nn.3484; Tse-Dinh YC, 2009, NUCLEIC ACIDS RES, V37, P731, DOI 10.1093/nar/gkn936; TSEDINH YC, 1988, J BIOL CHEM, V263, P15857; TSEDINH YC, 1991, J BIOL CHEM, V266, P14317; Viard T, 2007, BIOCHIMIE, V89, P456, DOI 10.1016/j.biochi.2006.10.013; Vos SM, 2011, NAT REV MOL CELL BIO, V12, P827, DOI 10.1038/nrm3228; Wang JC, 2002, NAT REV MOL CELL BIO, V3, P430, DOI 10.1038/nrm831; Xu DY, 2013, NAT NEUROSCI, V16, P1238, DOI 10.1038/nn.3479; Yang J, 2010, J BIOL CHEM, V285, P21426, DOI 10.1074/jbc.M110.123216; Zhou XX, 2011, J BIOL CHEM, V286, P22855, DOI 10.1074/jbc.M111.232926; Zhu CX, 2000, J BIOL CHEM, V275, P5318, DOI 10.1074/jbc.275.8.5318; Zhu CX, 1995, J MOL BIOL, V50, P609; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	34	7	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0120022	10.1371/journal.pone.0120022	http://dx.doi.org/10.1371/journal.pone.0120022			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25798600	Green Published, gold, Green Submitted			2022-12-27	WOS:000351987300103
J	Gaillard, C; Strauss, F				Gaillard, Claire; Strauss, Francois			Construction of DNA Hemicatenanes from Two Small Circular DNA Molecules	PLOS ONE			English	Article							SINGLE-STRANDED-DNA; HOLLIDAY-JUNCTION; SV40 DNA; REPLICATION; COMPLEMENTARY; CATENANES; PROTEIN; GENOME; FORM; MINICHROMOSOMES	DNA hemicatenanes, one of the simplest possible junctions between two double stranded DNA molecules, have frequently been mentioned in the literature for their possible function in DNA replication, recombination, repair, and organization in chromosomes. They have been little studied experimentally, however, due to the lack of an appropriate method for their preparation. Here we have designed a method to build hemicatenanes from two small circular DNA molecules. The method involves, first, the assembly of two linear single strands and their circularization to form a catenane of two single stranded circles, and, second, the addition and base-pairing of the two single stranded circles complementary to the first ones, followed by their annealing using DNA topoisomerase I. The product was purified by gel electrophoresis and characterized. The arrangement of strands was as expected for a hemicatenane and clearly distinct from a full catenane. In addition, each circle was unwound by an average of half a double helical turn, also in excellent agreement with the structure of a hemicatenane. It was also observed that hemicatenanes are quickly destabilized by a single cut on either of the two strands passing inside the junction, strongly suggesting that DNA strands are able to slide easily inside the hemicatenane. This method should make it possible to study the biochemical properties of hemicatenanes and to test some of the hypotheses that have been proposed about their function, including a possible role for this structure in the organization of complex genomes in loops and chromosomal domains.	[Gaillard, Claire; Strauss, Francois] Museum Natl Hist Nat, F-75231 Paris, France	Museum National d'Histoire Naturelle (MNHN)	Strauss, F (corresponding author), Museum Natl Hist Nat, F-75231 Paris, France.	strauss@mnhn.fr		Strauss, Francois/0000-0003-4327-6827				Bocquet N, 2014, NAT STRUCT MOL BIOL, V21, P261, DOI 10.1038/nsmb.2775; BOREK D, 2008, NATURE PRECEDINGS; Bucka A, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.6.e24; Cejka P, 2012, MOL CELL, V47, P886, DOI 10.1016/j.molcel.2012.06.032; CHAMPOUX JJ, 1977, P NATL ACAD SCI USA, V74, P5328, DOI 10.1073/pnas.74.12.5328; Chen SH, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks1343; Cheok CF, 2005, BIOCHEM SOC T, V33, P1456, DOI 10.1042/BST0331456; COLS P, 1988, RADIAT ENVIRON BIOPH, V27, P261, DOI 10.1007/BF01209755; GAILLARD C, 1990, NUCLEIC ACIDS RES, V18, P378, DOI 10.1093/nar/18.2.378; Gaillard Claire, 2000, BMC Biochemistry, V1, P1; Gaillard C, 2006, J THEOR BIOL, V243, P604, DOI 10.1016/j.jtbi.2006.07.001; HAGERMAN PJ, 1988, ANNU REV BIOPHYS BIO, V17, P265; Hartung F, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000285; Jaouen S, 2005, J MOL BIOL, V353, P822, DOI 10.1016/j.jmb.2005.08.073; Khuu PA, 2006, J MOL RECOGNIT, V19, P234, DOI 10.1002/jmr.765; KIRKEGAARD K, 1978, NUCLEIC ACIDS RES, V5, P3811, DOI 10.1093/nar/5.10.3811; Laurie B, 1998, BIOPHYS J, V74, P2815, DOI 10.1016/S0006-3495(98)77988-3; Lee JY, 2007, PLOS BIOL, V5, P1334, DOI 10.1371/journal.pbio.0050160; Lee SH, 2013, P NATL ACAD SCI USA, V110, pE3587, DOI 10.1073/pnas.1304103110; LIU LF, 1976, J MOL BIOL, V106, P439, DOI 10.1016/0022-2836(76)90095-4; Lucas I, 2000, NUCLEIC ACIDS RES, V28, P2187, DOI 10.1093/nar/28.10.2187; Manthei KA, 2013, CELL MOL LIFE SCI, V70, P4067, DOI 10.1007/s00018-013-1325-1; PANYUTIN IG, 1994, P NATL ACAD SCI USA, V91, P2021, DOI 10.1073/pnas.91.6.2021; Plank JL, 2006, J BIOL CHEM, V281, P17510, DOI 10.1074/jbc.M602933200; POUWELS PH, 1968, J MOL BIOL, V32, P169, DOI 10.1016/0022-2836(68)90002-8; Prunell A, 1999, METH MOL B, V119, P79; Seeman NC, 2010, ANNU REV BIOCHEM, V79, P65, DOI 10.1146/annurev-biochem-060308-102244; SHURE M, 1976, CELL, V8, P215, DOI 10.1016/0092-8674(76)90005-2; SOGO JM, 1986, J MOL BIOL, V189, P189, DOI 10.1016/0022-2836(86)90390-6; STETTLER UH, 1979, J MOL BIOL, V131, P21, DOI 10.1016/0022-2836(79)90299-7; SUNDIN O, 1980, CELL, V21, P103, DOI 10.1016/0092-8674(80)90118-X; Wellinger RE, 2003, MOL CELL BIOL, V23, P6363, DOI 10.1128/MCB.23.18.6363-6372.2003; WHITE JH, 1984, P NATL ACAD SCI-BIOL, V81, P3322, DOI 10.1073/pnas.81.11.3322	33	6	6	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0119368	10.1371/journal.pone.0119368	http://dx.doi.org/10.1371/journal.pone.0119368			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25799010	Green Submitted, Green Published, gold			2022-12-27	WOS:000351987300045
J	Hegde, S; Rosengarten, R; Chopra-Dewasthaly, R				Hegde, Shivanand; Rosengarten, Renate; Chopra-Dewasthaly, Rohini			Disruption of the pdhB Pyruvate Dehyrogenase Gene Affects Colony Morphology, In Vitro Growth and Cell Invasiveness of Mycoplasma agalactiae	PLOS ONE			English	Article							HOST-PATHOGEN INTERACTIONS; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; HOMOLOGOUS RECOMBINATION; BINDING PROTEINS; ALPHA-ENOLASE; GALLISEPTICUM; MUTANTS; VIRULENCE; INVASION; PLASMID	The utilization of available substrates, the metabolic potential and the growth rates of bacteria can play significant roles in their pathogenicity. This study concentrates on Mycoplasma agalactiae, which causes significant economic losses through its contribution to contagious agalactia in small ruminants by as yet unknown mechanisms. This lack of knowledge is primarily due to its fastidious growth requirements and the scarcity of genetic tools available for its manipulation and analysis. Transposon mutagenesis of M. agalactiae type strain PG2 resulted in several disruptions throughout the genome. A mutant defective in growth in vitro was found to have a transposon insertion in the pdhB gene, which encodes a component of the pyruvate dehydrogenase complex. This growth difference was quite significant during the actively dividing logarithmic phase but a gradual recovery was observed as the cells approached stationary phase. The mutant also exhibited a different and smaller colony morphology compared to the wild type strain PG2. For complementation, pdhAB was cloned downstream of a strong vpma promoter and upstream of a lacZ reporter gene in a newly constructed complementation vector. When transformed with this vector the pdhBmutant recovered its normal growth and colony morphology. Interestingly, the pdhB mutant also had significantly reduced invasiveness in HeLa cells, as revealed by double immunofluorescence staining. This deficiency was recovered in the complemented strain, which had invasiveness comparable to that of PG2. Taken together, these data indicate that pyruvate dehydrogenase might be an important player in infection with and colonization by M. agalactiae.	[Hegde, Shivanand; Rosengarten, Renate; Chopra-Dewasthaly, Rohini] Univ Vet Med Vienna, Div Clin Microbiol & Infect Biol, Dept Pathobiol, Inst Bacteriol Mycol & Hyg, Vienna, Austria	University of Veterinary Medicine Vienna	Chopra-Dewasthaly, R (corresponding author), Univ Vet Med Vienna, Inst Microbiol, Dept Pathobiol, Vienna, Austria.	Rohini.Chopra-Dewasthaly@vetmeduni.ac.at	chopra-dewasthaly, rohini/GNH-3258-2022; Hegde, Shivanand/L-4999-2019	hegde, shivanand/0000-0001-7249-6795	Austrian Science Fund (FWF) [P21796-20]; Austrian Science Fund (FWF) [P 21796] Funding Source: researchfish	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by grant P21796-20 (to RCD, Joachim Spergser and RR) of the Austrian Science Fund (FWF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez RA, 2003, MOL MICROBIOL, V48, P1417, DOI 10.1046/j.1365-2958.2003.03518.x; Casadevall A, 1999, INFECT IMMUN, V67, P3703, DOI 10.1128/IAI.67.8.3703-3713.1999; Chambaud I, 1999, TRENDS MICROBIOL, V7, P493, DOI 10.1016/S0966-842X(99)01641-8; Chang J, 2008, FEMS IMMUNOL MED MIC, V53, P26, DOI 10.1111/j.1574-695X.2008.00394.x; Chen HJ, 2011, MICROB PATHOGENESIS, V51, P285, DOI 10.1016/j.micpath.2011.03.012; Chopra-Dewasthaly R, 2005, FEMS MICROBIOL LETT, V253, P89, DOI 10.1016/j.femsle.2005.09.021; Chopra-Dewasthaly R, 2005, INT J MED MICROBIOL, V294, P447, DOI 10.1016/j.ijmm.2004.09.010; Chopra-Dewasthaly R, 2008, MOL MICROBIOL, V67, P1196, DOI 10.1111/j.1365-2958.2007.06103.x; Chopra-Dewasthaly R, 2012, FEMS IMMUNOL MED MIC, V66, P307, DOI 10.1111/j.1574-695X.2012.01010.x; Cieri MV, 2002, INFECT IMMUN, V70, P1081, DOI 10.1128/IAI.70.3.1081-1086.2002; Corrales JC, 2007, SMALL RUMINANT RES, V68, P154, DOI 10.1016/j.smallrumres.2006.09.010; Czurda S, 2010, J BACTERIOL, V192, P4462, DOI 10.1128/JB.01537-09; Dallo SF, 2002, MOL MICROBIOL, V46, P1041, DOI 10.1046/j.1365-2958.2002.03207.x; DAMASSA AJ, 1992, J VET DIAGN INVEST, V4, P101, DOI 10.1177/104063879200400126; Dumke R, 2011, MICROBIOL-SGM, V157, P2328, DOI 10.1099/mic.0.048298-0; Dybvig K, 2007, J BACTERIOL, V189, P2197, DOI 10.1128/JB.01669-06; Fleury B, 2002, INFECT IMMUN, V70, P5612, DOI 10.1128/IAI.70.10.5612-5621.2002; Glew MD, 2000, INFECT IMMUN, V68, P4539, DOI 10.1128/IAI.68.8.4539-4548.2000; Halbedel S, 2007, INT J MED MICROBIOL, V297, P37, DOI 10.1016/j.ijmm.2006.11.001; Hasselbring BA, 2006, J BACTERIOL, V188, P6335, DOI 10.1128/JB.00698-06; Hegde S, 2011, INT J MED MICROBIOL, V301, P87; Hegde S, 2014, INT J MED MICROBIOL, V304, P1024, DOI 10.1016/j.ijmm.2014.07.011; KNUDTSON KL, 1993, GENE, V137, P217, DOI 10.1016/0378-1119(93)90009-R; Lee SW, 2008, MICROBIOL-SGM, V154, P2571, DOI 10.1099/mic.0.2008/019208-0; Li JH, 2015, J MICROBIOL METH, V108, P12, DOI 10.1016/j.mimet.2014.11.005; Maglennon GA, 2013, VET RES, V44, DOI 10.1186/1297-9716-44-63; McAuliffe L, 2006, MICROBIOL-SGM, V152, P913, DOI 10.1099/mic.0.28604-0; MELONI GA, 1980, J GEN MICROBIOL, V116, P435; MILES RJ, 1988, LETT APPL MICROBIOL, V7, P149, DOI 10.1111/j.1472-765X.1988.tb01266.x; Much P, 2002, FEMS IMMUNOL MED MIC, V34, P181, DOI 10.1111/j.1574-695X.2002.tb00622.x; Mudahi-Orenstein S, 2003, INFECT IMMUN, V71, P3812, DOI 10.1128/IAI.71.7.3812-3820.2003; Pang E, 2011, FEMS IMMUNOL MED MIC, V63, P108, DOI 10.1111/j.1574-695X.2011.00834.x; Peterson SN, 2001, GENOME BIOL, V2; Pilo P, 2005, J BACTERIOL, V187, P6824, DOI 10.1128/JB.187.19.6824-6831.2005; Pollack JD, 1997, CRIT REV MICROBIOL, V23, P269, DOI 10.3109/10408419709115140; Razin S, 1998, MICROBIOL MOL BIOL R, V62, P1094, DOI 10.1128/MMBR.62.4.1094-1156.1998; Rohmer L, 2011, TRENDS MICROBIOL, V19, P341, DOI 10.1016/j.tim.2011.04.003; Rosengarten R, 2000, INT J MED MICROBIOL, V290, P15; Sambrook J., 2001, MOL CLONING LAB MANU; Schreiner SA, 2012, VET MICROBIOL, V156, P88, DOI 10.1016/j.vetmic.2011.10.010; Sharma VM, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.17.e86; Sirand-Pugnet P, 2007, PLOS GENET, V3, P744, DOI 10.1371/journal.pgen.0030075; Skapski A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025291; Solsona M, 1996, VET MICROBIOL, V50, P45, DOI 10.1016/0378-1135(95)00200-6; Song ZQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038836; Sun ZH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088328; Thomas C, 2013, MICROBIOL-SGM, V159, P352, DOI 10.1099/mic.0.061184-0; WEISBURG WG, 1989, J BACTERIOL, V171, P6455, DOI 10.1128/jb.171.12.6455-6467.1989; Winner F, 2000, INFECT IMMUN, V68, P4238, DOI 10.1128/IAI.68.7.4238-4244.2000	49	10	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0119706	10.1371/journal.pone.0119706	http://dx.doi.org/10.1371/journal.pone.0119706			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25799063	gold, Green Published			2022-12-27	WOS:000351987300076
J	Liu, M; Li, DQ; Qin, PJ; Liu, CR; Wang, HJ; Wang, FL				Liu, Meng; Li, Daqing; Qin, Pengju; Liu, Chaoran; Wang, Huijuan; Wang, Feilong			Epidemics in Interconnected Small-World Networks	PLOS ONE			English	Article							WEIGHT RANDOMIZATION; PERCOLATION	Networks can be used to describe the interconnections among individuals, which play an important role in the spread of disease. Although the small-world effect has been found to have a significant impact on epidemics in single networks, the small-world effect on epidemics in interconnected networks has rarely been considered. Here, we study the susceptible-infected-susceptible (SIS) model of epidemic spreading in a system comprising two interconnected small-world networks. We find that the epidemic threshold in such networks decreases when the rewiring probability of the component small-world networks increases. When the infection rate is low, the rewiring probability affects the global steady-state infection density, whereas when the infection rate is high, the infection density is insensitive to the rewiring probability. Moreover, epidemics in interconnected small-world networks are found to spread at different velocities that depend on the rewiring probability.	[Liu, Meng; Li, Daqing; Qin, Pengju; Liu, Chaoran; Wang, Feilong] Beihang Univ, Sch Reliabil & Syst Engn, Beijing 100191, Peoples R China; [Liu, Meng; Li, Daqing; Qin, Pengju; Liu, Chaoran; Wang, Feilong] Sci & Technol Reliabil & Environm Engn Lab, Beijing, Peoples R China; [Wang, Huijuan] Delft Univ Technol, Fac Elect Engn Math & Comp Sci, Delft, Netherlands	Beihang University; Delft University of Technology	Li, DQ (corresponding author), Beihang Univ, Sch Reliabil & Syst Engn, Beijing 100191, Peoples R China.	daqingl@buaa.edu.cn	wang, hui/GRS-4730-2022; wang, huimin/HDM-8421-2022		National Natural Science Foundation of China [61104144]; European Commission [FP7-ICT-2011-8-317672]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); European Commission(European CommissionEuropean Commission Joint Research Centre)	This work is supported by National Natural Science Foundation of China (Grant No. 61104144). Huijuan Wang is partially supported by the European Commission within the framework of the CONGAS project FP7-ICT-2011-8-317672. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Zuzek LG, 2014, ARXIV14121430; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Boccaletti S, 2014, PHYS REP, V544, P1, DOI 10.1016/j.physrep.2014.07.001; Buono C, 2014, ARXIV14123139; Buono C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092200; Cohen R., 2010, COMPLEX NETWORKS STR; Dickison M, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.066109; ERDOS P, 1960, B INT STATIST INST, V38, P343; Gomez S, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.028701; Jin Q, 2014, SCI REP-UK, V4, DOI 10.1038/srep04095; Li D, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.168701; Li DQ, 2007, EUR PHYS J B, V57, P423, DOI 10.1140/epjb/e2007-00189-0; Li DQ, 2014, EPL-EUROPHYS LETT, V105, DOI 10.1209/0295-5075/105/68004; Li DQ, 2011, NAT PHYS, V7, P481, DOI [10.1038/NPHYS1932, 10.1038/nphys1932]; Li DQ, 2011, EPL-EUROPHYS LETT, V93, DOI 10.1209/0295-5075/93/68004; Li MH, 2007, PHYS LETT A, V364, P488, DOI 10.1016/j.physleta.2006.12.040; Li W, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.228702; Liu C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097822; Moore C, 2000, PHYS REV E, V61, P5678, DOI 10.1103/PhysRevE.61.5678; Newman MEJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071321; Newman M.E.J., 2010, NETWORKS INTRO; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Pastor-Satorras R, 2001, PHYS REV LETT, V86, P3200, DOI 10.1103/PhysRevLett.86.3200; Saumell-Mendiola A, 2012, PHYS REV E, V86, DOI 10.1103/PhysRevE.86.026106; Wang HJ, 2013, PHYS REV E, V88, DOI 10.1103/PhysRevE.88.022801; Wang Y, 2012, PHYS LETT A, V376, P2689, DOI 10.1016/j.physleta.2012.07.037; Wang YB, 2009, PHYSICA A, V388, P2535, DOI 10.1016/j.physa.2009.02.036; Wang Z, 2013, SCI REP-UK, V3, DOI 10.1038/srep01183; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Zhao S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108000	30	17	17	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0120701	10.1371/journal.pone.0120701	http://dx.doi.org/10.1371/journal.pone.0120701			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25799143	Green Published, Green Submitted, gold			2022-12-27	WOS:000351987300166
J	Arun, A; Baumle, V; Amelot, G; Nieberding, CM				Arun, Alok; Baumle, Veronique; Amelot, Gael; Nieberding, Caroline M.			Selection and Validation of Reference Genes for qRT-PCR Expression Analysis of Candidate Genes Involved in Olfactory Communication in the Butterfly Bicyclus anynana	PLOS ONE			English	Article							TIME RT-PCR; SEX-PHEROMONE; PHENOTYPIC PLASTICITY; NORMALIZATION; IDENTIFICATION; RESPONSES	Real-time quantitative reverse transcription PCR (qRT-PCR) is a technique widely used to quantify the transcriptional expression level of candidate genes. qRT-PCR requires the selection of one or several suitable reference genes, whose expression profiles remain stable across conditions, to normalize the qRT-PCR expression profiles of candidate genes. Although several butterfly species (Lepidoptera) have become important models in molecular evolutionary ecology, so far no study aimed at identifying reference genes for accurate data normalization for any butterfly is available. The African bush brown butterfly Bicyclus anynana has drawn considerable attention owing to its suitability as a model for evolutionary ecology, and we here provide a maiden extensive study to identify suitable reference gene in this species. We monitored the expression profile of twelve reference genes: eEF-1 alpha, FK506, UBQL40, RpS8, RpS18, HSP, GAPDH, VATPase, ACT3, TBP, eIF2 and G6PD. We tested the stability of their expression profiles in three different tissues (wings, brains, antennae), two developmental stages (pupal and adult) and two sexes (male and female), all of which were subjected to two food treatments (food stress and control feeding ad libitum). The expression stability and ranking of twelve reference genes was assessed using two algorithm-based methods, NormFinder and geNorm. Both methods identified RpS8 as the best suitable reference gene for expression data normalization. We also showed that the use of two reference genes is sufficient to effectively normalize the qRT-PCR data under varying tissues and experimental conditions that we used in B. anynana. Finally, we tested the effect of choosing reference genes with different stability on the normalization of the transcript abundance of a candidate gene involved in olfactory communication in B. anynana, the Fatty Acyl Reductase 2, and we confirmed that using an unstable reference gene can drastically alter the expression profile of the target candidate genes.	[Arun, Alok; Baumle, Veronique; Amelot, Gael; Nieberding, Caroline M.] Catholic Univ Louvain, Evolutionary Ecol & Genet Grp, Biodivers Res Ctr, Earth & Life Inst, Louvain La Neuve, Belgium	Universite Catholique Louvain	Arun, A (corresponding author), Catholic Univ Louvain, Evolutionary Ecol & Genet Grp, Biodivers Res Ctr, Earth & Life Inst, Croix Sud 4, Louvain La Neuve, Belgium.	alok.arun@uclouvain.be; caroline.nieberding@uclouvain.be	Arun, Alok/AAJ-7923-2020		Universite catholique de Louvain (ARC) [10/15-031]; Universite catholique de Louvain (FSR) [372 605031]; Belgian FRS-FNRS (FRFC) [2.4560.11, 2.4600.10, A8.31202.002]; FRS-FNRS	Universite catholique de Louvain (ARC); Universite catholique de Louvain (FSR); Belgian FRS-FNRS (FRFC)(Fonds de la Recherche Scientifique - FNRS); FRS-FNRS(Fonds de la Recherche Scientifique - FNRS)	This work was funded by the Universite catholique de Louvain (ARC grant 10/15-031 and FSR grant 372 605031 to C.N.), and by the Belgian FRS-FNRS (FRFC grants 2.4560.11, 2.4600.10, A8.31202.002 to C.N.). Additional funding bodies were the FRS-FNRS for mobility support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahola V, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5737; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Bacquet PMB, 2015, P R SOC B IN PRESS; Beldade P, 2008, HEREDITY, V100, P150, DOI 10.1038/sj.hdy.6800934; Beldade P, 2002, NAT REV GENET, V3, P442, DOI 10.1038/nrg818; BOPPRE M, 1984, BIOL BUTTERFLIES; Brakefield P. M., 2009, COLD SPRING HARB PRO; BRAKEFIELD PM, 1991, ECOL ENTOMOL, V16, P291, DOI 10.1111/j.1365-2311.1991.tb00220.x; Brakefield PM, 1998, AM NAT, V152, P853, DOI 10.1086/286213; Brunetti CR, 2001, CURR BIOL, V11, P1578, DOI 10.1016/S0960-9822(01)00502-4; Cheng DF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057718; Condamin M., 1973, MONOGRAPHIE GENRE BI; Czechowski T, 2005, PLANT PHYSIOL, V139, P5, DOI 10.1104/pp.105.063743; Dasmahapatra KK, 2012, NATURE, V487, P94, DOI 10.1038/nature11041; Dong MT, 2012, CURR GENET, V58, P13, DOI 10.1007/s00294-011-0361-3; Fu W, 2013, INT J BIOL SCI, V9, P792, DOI 10.7150/ijbs.5862; Groot AT, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.3054; Gu SH, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-636; Gutierrez L, 2008, PLANT BIOTECHNOL J, V6, P609, DOI 10.1111/j.1467-7652.2008.00346.x; Haskins WE, 2009, INSECT MOL BIOL, V18, P395, DOI [10.1111/j.1365-2583.2009.00883.x, DOI 10.1111/J.1365-2583.2009.00883.X]; Heuskin S, 2014, FRONT ECOL EVOL, V37, P1; Huggett J, 2005, GENES IMMUN, V6, P279, DOI 10.1038/sj.gene.6364190; Kong QS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087197; Kuijk EW, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-58; Lienard MA, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4957; Lord JC, 2010, J MICROBIOL METH, V80, P219, DOI 10.1016/j.mimet.2009.12.007; Lourenco AP, 2008, APIDOLOGIE, V39, P372, DOI 10.1051/apido:2008015; Lu YH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068059; Martin Gilles San, 2011, Proceedings of the Netherlands Entomological Society Meeting, V22, P9; Nieberding CM, 2012, ECOL LETT, V15, P415, DOI 10.1111/j.1461-0248.2012.01748.x; Nieberding CM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002751; Ometto L, 2011, MOL BIOL EVOL, V28, P1381, DOI 10.1093/molbev/msq322; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pijpe J, 2011, EXP GERONTOL, V46, P426, DOI 10.1016/j.exger.2010.11.033; Ponton F, 2011, J INSECT PHYSIOL, V57, P840, DOI 10.1016/j.jinsphys.2011.03.014; Radonic A, 2004, BIOCHEM BIOPH RES CO, V313, P856, DOI 10.1016/j.bbrc.2003.11.177; Robertson KA, 2005, P ROY SOC B-BIOL SCI, V272, P1541, DOI 10.1098/rspb.2005.3142; Saastamoinen M, 2013, ECOL EVOL, V3, P3576, DOI 10.1002/ece3.718; Schuler GD, 1997, GENOME RES, V7, P541, DOI 10.1101/gr.7.5.541; SCOBLE M. J., 1992, LEPIDOPTERA FORM FUN; Teng XL, 2012, J INSECT SCI, V12, DOI 10.1673/031.012.6001; Teste MA, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-99; van Bergen E, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0102; Van Hiel MB, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-56; Van't Hof AE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003882; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wahlberg N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080875; Wang GH, 2008, INSECT SCI, V15, P405, DOI 10.1111/j.1744-7917.2008.00227.x; Zhan S, 2011, CELL, V147, P1171, DOI 10.1016/j.cell.2011.09.052; Zhang SD, 2015, GENE, V555, P393, DOI 10.1016/j.gene.2014.11.038; Zhu HS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001345; Zhu XY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044405; Zhu X, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084730	53	8	10	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0120401	10.1371/journal.pone.0120401	http://dx.doi.org/10.1371/journal.pone.0120401			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25793735	Green Submitted, Green Published, gold			2022-12-27	WOS:000352083900025
J	Bunlon, F; Marshall, PJ; Quandt, LC; Bouquet, CA				Bunlon, Frederique; Marshall, Peter J.; Quandt, Lorna C.; Bouquet, Cedric A.			Influence of Action-Effect Associations Acquired by Ideomotor Learning on Imitation	PLOS ONE			English	Article							GOAL-DIRECTED ACTIONS; EFFECT ANTICIPATION; AUTOMATIC IMITATION; MOTOR RESONANCE; MIRROR NEURONS; BASE-LINE; EXPERIENCE; PERCEPTION; COMPATIBILITY; MOVEMENTS	According to the ideomotor theory, actions are represented in terms of their perceptual effects, offering a solution for the correspondence problem of imitation (how to translate the observed action into a corresponding motor output). This effect-based coding of action is assumed to be acquired through action-effect learning. Accordingly, performing an action leads to the integration of the perceptual codes of the action effects with the motor commands that brought them about. While ideomotor theory is invoked to account for imitation, the influence of action-effect learning on imitative behavior remains unexplored. In two experiments, imitative performance was measured in a reaction time task following a phase of action-effect acquisition. During action-effect acquisition, participants freely executed a finger movement (index or little finger lifting), and then observed a similar (compatible learning) or a different (incompatible learning) movement. In Experiment 1, finger movements of left and right hands were presented as action-effects during acquisition. In Experiment 2, only right-hand finger movements were presented during action-effect acquisition and in the imitation task the observed hands were oriented orthogonally to participants' hands in order to avoid spatial congruency effects. Experiments 1 and 2 showed that imitative performance was improved after compatible learning, compared to incompatible learning. In Experiment 2, although action-effect learning involved perception of finger movements of right hand only, imitative capabilities of right-and left-hand finger movements were equally affected. These results indicate that an observed movement stimulus processed as the effect of an action can later prime execution of that action, confirming the ideomotor approach to imitation. We further discuss these findings in relation to previous studies of action-effect learning and in the framework of current ideomotor approaches to imitation.	[Bunlon, Frederique; Bouquet, Cedric A.] Univ Poitiers, CNRS, Poitiers, France; [Marshall, Peter J.] Temple Univ, Philadelphia, PA 19122 USA; [Quandt, Lorna C.] Univ Penn, Philadelphia, PA 19104 USA	Centre National de la Recherche Scientifique (CNRS); Universite de Poitiers; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; University of Pennsylvania	Bunlon, F (corresponding author), Univ Poitiers, CNRS, Poitiers, France.	frederique.bunlon@univ-poitiers.fr	Bouquet, Cedric/AAT-9527-2020; Quandt, Lorna/I-3493-2019; Bouquet, Cedric/C-8518-2009	Bouquet, Cedric/0000-0003-4228-3291; Quandt, Lorna/0000-0002-0032-1918; Bouquet, Cedric/0000-0003-4228-3291	MENESR (Ministere de l'Education Nationale, de l'Enseignement Superieur et de la Recherche); Centre National de la Recherche Scientifique (PICS, DRI CNRS); Ecole Doctorale "Cognition, Comportements, Langage(s)"	MENESR (Ministere de l'Education Nationale, de l'Enseignement Superieur et de la Recherche); Centre National de la Recherche Scientifique (PICS, DRI CNRS); Ecole Doctorale "Cognition, Comportements, Langage(s)"	Funding: This research was supported by the MENESR (Ministere de l'Education Nationale, de l'Enseignement Superieur et de la Recherche) and a grant from the Centre National de la Recherche Scientifique (PICS, DRI CNRS). FB was supported by The Ecole Doctorale "Cognition, Comportements, Langage(s)." The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2002, IMITATION ANIMALS AR; Bien N, 2009, CEREB CORTEX, V19, P2338, DOI 10.1093/cercor/bhn251; Borroni P, 2008, EUR J NEUROSCI, V28, P1427, DOI 10.1111/j.1460-9568.2008.06458.x; Bouquet CA, 2011, EXP PSYCHOL, V58, P71, DOI 10.1027/1618-3169/a000069; Brass M, 2000, BRAIN COGNITION, V44, P124, DOI 10.1006/brcg.2000.1225; Capa RL, 2011, PSYCHOL RES-PSYCH FO, V75, P152, DOI 10.1007/s00426-010-0303-6; Catmur C, 2011, J EXP PSYCHOL HUMAN, V37, P409, DOI 10.1037/a0019325; Catmur C, 2009, PHILOS T R SOC B, V364, P2369, DOI 10.1098/rstb.2009.0048; Cross KA, 2013, NEUROIMAGE, V83, P493, DOI 10.1016/j.neuroimage.2013.06.060; Decety J, 1999, TRENDS COGN SCI, V3, P172, DOI 10.1016/S1364-6613(99)01312-1; Del Giudice M, 2009, DEVELOPMENTAL SCI, V12, P350, DOI 10.1111/j.1467-7687.2008.00783.x; DIPELLEGRINO G, 1992, EXP BRAIN RES, V91, P176, DOI 10.1007/BF00230027; Elsner B, 2004, PSYCHOL RES-PSYCH FO, V68, P138, DOI 10.1007/s00426-003-0151-8; Elsner B, 2001, J EXP PSYCHOL HUMAN, V27, P229, DOI 10.1037/0096-1523.27.1.229; Elsner B, 2007, ACTA PSYCHOL, V124, P44, DOI 10.1016/j.actpsy.2006.09.006; Ferrari PF, 2009, PHILOS T R SOC B, V364, P2311, DOI 10.1098/rstb.2009.0062; Flach R, 2010, BRIT J PSYCHOL, V101, P739, DOI 10.1348/000712609X484595; Gergely G, 2002, NATURE, V415, P755, DOI 10.1038/415755a; Gillmeister H, 2008, BRAIN RES, V1217, P157, DOI 10.1016/j.brainres.2007.12.076; Hauf P, 2004, PSYCHOL RES-PSYCH FO, V68, P115, DOI 10.1007/s00426-003-0149-2; Heiser M, 2003, EUR J NEUROSCI, V17, P1123, DOI 10.1046/j.1460-9568.2003.02530.x; Herwig A, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00444; Herwig A, 2009, Q J EXP PSYCHOL, V62, P219, DOI 10.1080/17470210802373290; Heyes C, 2013, CORTEX, V49, P2946, DOI 10.1016/j.cortex.2013.07.002; Heyes C, 2011, PSYCHOL BULL, V137, P463, DOI 10.1037/a0022288; Hommel B, 2001, BEHAV BRAIN SCI, V24, P849, DOI 10.1017/S0140525X01000103; Hommel B, 2003, VIS COGN, V10, P965, DOI 10.1080/13506280344000176; Hommel B, 1996, PSYCHOL RES-PSYCH FO, V59, P176, DOI 10.1007/BF00425832; Hommel B, 1997, PSYCHOL RES-PSYCH FO, V59, P248, DOI 10.1007/BF00439302; Hommel B., 2001, COGNITIVE PSYCHOL CO, P11195; Hurley S, 2008, BEHAV BRAIN SCI, V31, P1, DOI 10.1017/S0140525X07003123; Iacoboni M, 2009, ANNU REV PSYCHOL, V60, P653, DOI 10.1146/annurev.psych.60.110707.163604; Jimenez L, 2012, ACTA PSYCHOL, V141, P96, DOI 10.1016/j.actpsy.2012.07.007; Keller P. E., 2006, ADV COGN PSYCHOL, V2, P269, DOI [10.2478/v10053-008-0061-9, DOI 10.2478/V10053-008-0061-9]; Kiesel A, 2004, PSYCHOL RES-PSYCH FO, V68, P155, DOI 10.1007/s00426-003-0152-7; Kunde W, 2004, PSYCHOL RES-PSYCH FO, V68, P199, DOI 10.1007/s00426-003-0156-3; Kunde W, 2001, J EXP PSYCHOL HUMAN, V27, P387, DOI 10.1037//0096-1523.27.2.387; Leighton J, 2010, J EXP PSYCHOL HUMAN, V36, P1174, DOI 10.1037/a0019953; Leighton Jane, 2010, Cognition, V114, P423, DOI 10.1016/j.cognition.2009.11.001; Marshall PJ, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0620; Marshall PJ, 2009, NEUROPSYCHOLOGIA, V47, P2100, DOI 10.1016/j.neuropsychologia.2009.03.022; Meltzoff A.N., 2005, PERSPECTIVES IMITATI, V2, P55; Meltzoff AN, 1997, EARLY DEV PARENTING, V6, P179, DOI 10.1002/(SICI)1099-0917(199709/12)6:3/4<179::AID-EDP157>3.0.CO;2-R; Memelink J, 2013, PSYCHOL RES-PSYCH FO, V77, P249, DOI 10.1007/s00426-012-0435-y; Muhle-Karbe PS, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00450; Nattkemper D, 2010, NEUROSCI BIOBEHAV R, V34, P1092, DOI 10.1016/j.neubiorev.2009.12.013; Newman-Norlund RD, 2007, NAT NEUROSCI, V10, P817, DOI 10.1038/nn1911; Paulus M, 2014, EUR J DEV PSYCHOL, V11, P662, DOI 10.1080/17405629.2014.914432; Paulus M, 2011, DEVELOPMENTAL SCI, V14, P901, DOI 10.1111/j.1467-7687.2011.01040.x; Pfister R, 2014, NEUROSCIENCE, V259, P164, DOI 10.1016/j.neuroscience.2013.11.061; Prinz W., 2005, PERSPECT IMITATION N, V1, P141; Quandt LC, 2014, NEUROPSYCHOLOGIA, V56, P401, DOI 10.1016/j.neuropsychologia.2014.02.015; Quandt LC, 2011, NEUROSCI LETT, V499, P37, DOI 10.1016/j.neulet.2011.05.028; RATCLIFF R, 1979, PSYCHOL BULL, V86, P446, DOI 10.1037/0033-2909.86.3.446; Rizzolatti G, ANN REV NEUROSCI, V27, P169; Sartori L., 2013, FRONT HUM NEUROSCI, V13, P7; Senn S, 2006, STAT MED, V25, P4334, DOI 10.1002/sim.2682; Shin YK, 2012, ACTA PSYCHOL, V141, P360, DOI 10.1016/j.actpsy.2012.09.008; Shin YK, 2010, PSYCHOL BULL, V136, P943, DOI 10.1037/a0020541; Sturmer B, 2000, J EXP PSYCHOL HUMAN, V26, P1746, DOI 10.1037//0096-1523.26.6.1746; Subiaul F, 2010, BEHAV PROCESS, V83, P222, DOI 10.1016/j.beproc.2009.12.002; Van Breukelen GJP, 2006, J CLIN EPIDEMIOL, V59, P920, DOI 10.1016/j.jclinepi.2006.02.007; Waszak F, 2007, BRAIN RES, V1183, P74, DOI 10.1016/j.brainres.2007.08.082; Wiggett AJ, 2011, BRAIN COGNITION, V76, P87, DOI 10.1016/j.bandc.2011.02.014; Wohlschlager A, 2003, PHILOS T R SOC B, V358, P501, DOI 10.1098/rstb.2002.1257; Ziessler M, 2002, ATTENTION PERFORM, V19, P645; Ziessler M, 2001, J EXP PSYCHOL LEARN, V27, P595, DOI 10.1037/0278-7393.27.3.595	67	6	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0121617	10.1371/journal.pone.0121617	http://dx.doi.org/10.1371/journal.pone.0121617			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CE8HY	25793755	Green Published, Green Submitted, gold			2022-12-27	WOS:000352083900142
J	Cesqui, B; Mezzetti, M; Lacquaniti, F; d'Avella, A				Cesqui, Benedetta; Mezzetti, Maura; Lacquaniti, Francesco; d'Avella, Andrea			Gaze Behavior in One-Handed Catching and Its Relation with Interceptive Performance: What the Eyes Can't Tell	PLOS ONE			English	Article							VISUAL-SEARCH; TEMPORAL CONSTRAINTS; TARGET MOTION; REACTION-TIME; MOVEMENTS; BALL; PURSUIT; COORDINATION; INFORMATION; SMOOTH	In ball sports, it is usually acknowledged that expert athletes track the ball more accurately than novices. However, there is also evidence that keeping the eyes on the ball is not always necessary for interception. Here we aimed at gaining new insights on the extent to which ocular pursuit performance is related to catching performance. To this end, we analyzed eye and head movements of nine subjects catching a ball projected by an actuated launching apparatus. Four different ball flight durations and two different ball arrival heights were tested and the quality of ocular pursuit was characterized by means of several timing and accuracy parameters. Catching performance differed across subjects and depended on ball flight characteristics. All subjects showed a similar sequence of eye movement events and a similar modulation of the timing of these events in relation to the characteristics of the ball trajectory. On a trial-by-trial basis there was a significant relationship only between pursuit duration and catching performance, confirming that keeping the eyes on the ball longer increases catching success probability. Ocular pursuit parameters values and their dependence on flight conditions as well as the eye and head contributions to gaze shift differed across subjects. However, the observed average individual ocular behavior and the eye-head coordination patterns were not directly related to the individual catching performance. These results suggest that several oculomotor strategies may be used to gather information on ball motion, and that factors unrelated to eye movements may underlie the observed differences in interceptive performance.	[Cesqui, Benedetta; Lacquaniti, Francesco; d'Avella, Andrea] IRCCS Santa Lucia Fdn, Lab Neuromotor Physiol, Rome, Italy; [Cesqui, Benedetta; Lacquaniti, Francesco] Univ Roma Tor Vergata, Ctr Space Biomed, Rome, Italy; [Mezzetti, Maura] Univ Roma Tor Vergata, Dept Econ & Finance, Rome, Italy; [Lacquaniti, Francesco] Univ Rome, Neurosci Sect, Dept Syst Med, Rome, Italy; [d'Avella, Andrea] Univ Messina, Dept Biomed Sci & Morphol & Funct Images, Messina, Italy	IRCCS Santa Lucia; University of Rome Tor Vergata; University of Rome Tor Vergata; Sapienza University Rome; University of Messina	Cesqui, B (corresponding author), IRCCS Santa Lucia Fdn, Lab Neuromotor Physiol, Rome, Italy.	b.cesqui@hsantalucia.it	d'Avella, Andrea/K-6856-2018; Lacquaniti, Francesco/J-9842-2016	d'Avella, Andrea/0000-0002-3393-4956; Lacquaniti, Francesco/0000-0003-0896-7315; MEZZETTI, MAURA/0000-0002-8214-7000	European Union [248311]; Italian University Ministry (PRIN project) [2010MEFNF7 002]; Italian Space Agency (CRUSOE grant); Italian Space Agency (COREA grant)	European Union(European Commission); Italian University Ministry (PRIN project); Italian Space Agency (CRUSOE grant)(Agenzia Spaziale Italiana (ASI)); Italian Space Agency (COREA grant)(Agenzia Spaziale Italiana (ASI))	Research was supported by grants from the European Union FP7-ICT program (Adaptive Modular Architectures for Rich Motor skills, AMARSI, Grant 248311), the Italian University Ministry (PRIN project grant 2010MEFNF7 002), and Italian Space Agency (CRUSOE and COREA grants). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABERNETHY B, 1987, HUM MOVEMENT SCI, V6, P283, DOI 10.1016/0167-9457(87)90001-7; ABERNETHY B, 1990, PERCEPTION, V19, P63, DOI 10.1068/p190063; Abernethy B, 1990, J SPORT SCI, V8, P17, DOI 10.1080/02640419008732128; ABRAMS RA, 1990, J EXP PSYCHOL HUMAN, V16, P248, DOI 10.1037/0096-1523.16.2.248; Amazeen EL, 2001, ECOL PSYCHOL, V13, P71, DOI 10.1207/S15326969ECO1302_1; Baayen RH, 2008, J MEM LANG, V59, P390, DOI 10.1016/j.jml.2007.12.005; BAHILL AT, 1983, IEEE T BIO-MED ENG, V30, P781, DOI 10.1109/TBME.1983.325078; BAHILL AT, 1984, AM SCI, V72, P249; Barnes GR, 2008, BRAIN COGNITION, V68, P309, DOI 10.1016/j.bandc.2008.08.020; Barr DJ, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00328; Bates DM, 2010, LMER4 MIXED EFFECTS; Bennett SJ, 2003, J NEUROPHYSIOL, V90, P2504, DOI 10.1152/jn.01145.2002; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Bosco G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049381; Brenner E, 2011, HUM MOVEMENT SCI, V30, P475, DOI 10.1016/j.humov.2010.12.007; Brouwer AM, 2003, EXP BRAIN RES, V152, P368, DOI 10.1007/s00221-003-1556-8; Cesqui B, 2013, J VIS, V13, DOI [10.1167/13.14.13, DOI 10.1167/13.14.13]; Cesqui B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031770; Croft JL, 2010, HUM MOVEMENT SCI, V29, P751, DOI 10.1016/j.humov.2009.10.004; D'Andola M, 2013, FRONT COMPUT NEUROSC, V7, DOI 10.3389/fncom.2013.00107; d'Avella A, 2011, J NEUROSCI METH, V196, P264, DOI 10.1016/j.jneumeth.2011.01.013; Daye PM, 2014, J VIS, V14, DOI [10.1167/14.14.14, DOI 10.1167/14.14.14]; de Brouwer S, 2002, J NEUROPHYSIOL, V87, P1646, DOI 10.1152/jn.00432.2001; de Brouwer S, 2001, J NEUROPHYSIOL, V86, P550, DOI 10.1152/jn.2001.86.2.550; de Xivry JJO, 2007, J PHYSIOL-LONDON, V584, P11, DOI 10.1113/jphysiol.2007.139881; Delle Monache S, 2015, EXP BRAIN RES, V233, P359, DOI 10.1007/s00221-014-4120-9; deSperati C, 1997, J NEUROSCI, V17, P3932; Dessing JC, 2012, EXP BRAIN RES, V216, P635, DOI 10.1007/s00221-011-2967-6; Dessing JC, 2009, EXP BRAIN RES, V192, P669, DOI 10.1007/s00221-008-1588-1; Diaz G, 2013, J VIS, P13; Diaz G, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2013.0064; Ganesh G, 2010, J NEUROPHYSIOL, V104, P382, DOI 10.1152/jn.01058.2009; Hayhoe MM, 2012, EXP BRAIN RES, V217, P125, DOI 10.1007/s00221-011-2979-2; Hoffman L, 2007, BEHAV RES METHODS, V39, P101, DOI 10.3758/BF03192848; Huys R, 2002, J SPORT SCI, V20, P171, DOI 10.1080/026404102317284745; Katsumata H, 2012, EXP BRAIN RES, V216, P499, DOI 10.1007/s00221-011-2954-y; Krauzlis RJ, 2004, J NEUROPHYSIOL, V91, P591, DOI 10.1152/jn.00801.2003; LACQUANITI F, 1989, J NEUROSCI, V9, P134, DOI 10.1523/JNEUROSCI.09-01-00134.1989; Land MF, 2000, NAT NEUROSCI, V3, P1340, DOI 10.1038/81887; Land MF, 2000, PHILOS T ROY SOC B, V355, P1147, DOI 10.1098/rstb.2000.0656; LAURENT M, 1994, EXP BRAIN RES, V101, P314, DOI 10.1007/BF00228752; Locker L, 2007, BEHAV RES METHODS, V39, P723, DOI 10.3758/BF03192962; Lopez-Moliner J, 2010, EXP BRAIN RES, V206, P409, DOI 10.1007/s00221-010-2421-1; Mann DL, 2007, HUM MOVEMENT SCI, V26, P343, DOI 10.1016/j.humov.2006.12.003; Mann DL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058289; Marinovic W, 2009, EXP PSYCHOL, V56, P265, DOI 10.1027/1618-3169.56.4.265; Mazyn LIN, 2007, ACTA PSYCHOL, V126, P59, DOI 10.1016/j.actpsy.2006.10.001; Mazyn LIN, 2006, MOTOR CONTROL, V10, P143, DOI 10.1123/mcj.10.2.143; MCLEOD P, 1987, PERCEPTION, V16, P49, DOI 10.1068/p160049; Moscatelli A, 2012, J VIS, P12; Mrotek LA, 2007, J NEUROSCI, V27, P7297, DOI 10.1523/JNEUROSCI.2046-07.2007; Mrotek LA, 2006, EXP BRAIN RES, V172, P175, DOI 10.1007/s00221-005-0326-1; Mrotek LA, 2013, EXP BRAIN RES, V227, P161, DOI 10.1007/s00221-013-3496-2; Oudejans RRD, 1999, J EXP PSYCHOL HUMAN, V25, P531, DOI 10.1037/0096-1523.25.2.531; Panchuk D, 2013, ACTA PSYCHOL, V142, P394, DOI 10.1016/j.actpsy.2013.01.014; PEPER L, 1994, J EXP PSYCHOL HUMAN, V20, P591, DOI 10.1037/0096-1523.20.3.591; Regan D, 2012, OPHTHAL PHYSL OPT, V32, P257, DOI 10.1111/j.1475-1313.2012.00909.x; RIPOLL H, 1988, ERGONOMICS, V31, P1647, DOI 10.1080/00140138808966814; Rodrigues ST, 2002, J SPORT SCI, V20, P187, DOI 10.1080/026404102317284754; Savelsbergh GJP, 2002, J SPORT SCI, V20, P279, DOI 10.1080/026404102317284826; SCHALEN L, 1980, ACTA OTO-LARYNGOL, V90, P404, DOI 10.3109/00016488009131742; Schenk T, 2004, EXP BRAIN RES, V154, P85, DOI 10.1007/s00221-003-1642-y; Shapiro A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013296; Sharp R., 1975, J HUMAN MOVEMENT STU, V1, P124; Singer RN, 1998, RES Q EXERCISE SPORT, V69, P290, DOI 10.1080/02701367.1998.10607696; Spering M, 2011, J NEUROPHYSIOL, V105, P1756, DOI 10.1152/jn.00344.2010; Spering M, 2011, VISION RES, V51, P836, DOI 10.1016/j.visres.2010.10.017; Tijtgat P, 2010, EXP BRAIN RES, V201, P875, DOI 10.1007/s00221-009-2102-0; Tresilian JR, 2005, PERCEPT PSYCHOPHYS, V67, P129, DOI 10.3758/BF03195017; TYNAN PD, 1982, VISION RES, V22, P61, DOI 10.1016/0042-6989(82)90167-5; Vickers JN., 1997, INT J SPORTS VIS, V4, P18; WILLETT W, 1986, AM J EPIDEMIOL, V124, P17, DOI 10.1093/oxfordjournals.aje.a114366; Wilmut K, 2006, EXP BRAIN RES, V175, P654, DOI 10.1007/s00221-006-0580-x; Yarrow K, 2009, NAT REV NEUROSCI, V10, P585, DOI 10.1038/nrn2672; Zago M, 2004, J NEUROPHYSIOL, V91, P1620, DOI 10.1152/jn.00862.2003; Zago M, 2009, EXP BRAIN RES, V192, P571, DOI 10.1007/s00221-008-1691-3	76	33	34	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0119445	10.1371/journal.pone.0119445	http://dx.doi.org/10.1371/journal.pone.0119445			39	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CE8IA	25793989	Green Published, gold, Green Submitted			2022-12-27	WOS:000352084200083
J	Danaviah, S; de Oliveira, T; Bland, R; Viljoen, J; Pillay, S; Tuaillon, E; Van de Perre, P; Newell, ML				Danaviah, Sivapragashini; de Oliveira, Tulio; Bland, Ruth; Viljoen, Johannes; Pillay, Sureshnee; Tuaillon, Edouard; Van de Perre, Philippe; Newell, Marie-Louise			Evidence of Long-Lived Founder Virus in Mother-to-Child HIV Transmission	PLOS ONE			English	Article							BREAST-MILK; CELL-FREE; SEQUENCES; PERFORMANCE; INFECTION; AFRICA; WOMEN; RNA; DNA	Exposure of the infant's gut to cell-associated and cell-free HIV-1 trafficking in breast milk (BM) remains a primary cause of mother-to-child transmission (MTCT). The mammary gland represents a unique environment for HIV-1 replication and host-virus interplay. We aimed to explore the origin of the virus transmitted during breastfeeding, and the link with quasi-species found in acellular and cellular fractions of breast-milk (BM) and in maternal plasma. The C2-V5 region of the env gene was amplified, cloned and sequenced from the RNA and DNA of BM, the RNA from the mother's plasma (PLA) and the DNA from infant's dried blood spot (DBS) in 11 post-natal mother-infant pairs. Sequences were assembled in Geneious, aligned in ClustalX, manually edited in SeAL and phylogenetic reconstruction was undertaken in PhyML and MrBayes. We estimated the timing of transmission (ETT) and reconstructed the time for the most recent common ancestor (TMRCA) of the infant in BEAST. Transmission of single quasi-species was observed in 9 of 11 cases. Phylogenetic analysis illustrated a BM transmission event by cell-free virus in 4 cases, and by cell-associated virus in 2 cases but could not be identified in the remaining 5 cases. Molecular clock estimates, of the infant ETT and TMRCA, corresponded well with the timing of transmission estimated by sequential infant DNA PCR in 10 of 11 children. The TMRCA of BM variants were estimated to emerge during gestation in 8 cases. We hypothesize that in the remaining cases, the breast was seeded with a long-lived lineage latently infecting resting T-cells. Our analysis illustrated the role of DNA and RNA virus in MTCT. We postulate that DNA archived viruses stem from latently infected quiescent T-cells within breast tissue and MTCT can be expected to continue, albeit at low levels, should interventions not effectively target these cells.	[Danaviah, Sivapragashini; de Oliveira, Tulio; Bland, Ruth; Viljoen, Johannes; Pillay, Sureshnee; Newell, Marie-Louise] Univ KwaZulu Natal, Africa Ctr Hlth & Populat Studies, Durban, South Africa; [Viljoen, Johannes; Tuaillon, Edouard; Van de Perre, Philippe] Univ Montpellier I, F-34090 Montpellier, France; [Bland, Ruth] Royal Hosp Sick Children, Glasgow G3 8SJ, Lanark, Scotland; [Tuaillon, Edouard; Van de Perre, Philippe] CHU Montpellier, Dept Bacteriol Virol, Inst Rech Biotherapie, F-34295 Montpellier, France; [Tuaillon, Edouard; Van de Perre, Philippe] CHU Montpellier, Dept Med Informat, F-34295 Montpellier, France; [Newell, Marie-Louise] Univ Southampton, Fac Med, Southampton SO9 5NH, Hants, England	University of Kwazulu Natal; Universite de Montpellier; University of Glasgow; Universite de Montpellier; CHU de Montpellier; Universite de Montpellier; CHU de Montpellier; University of Southampton	Danaviah, S (corresponding author), Univ KwaZulu Natal, Africa Ctr Hlth & Populat Studies, Durban, South Africa.	sdanaviah@africacentre.ac.za	Van de Perre, Philippe/B-9692-2008; Newell, Marie-Louise/AAE-8222-2019	Van de Perre, Philippe/0000-0002-3912-0427; Newell, Marie-Louise/0000-0002-1074-7699; Bland, Ruth/0000-0003-1675-9268; Tuaillon, Edouard/0000-0001-5866-9530	Wellcome Trust; Africa Centre; Africa Centre Laboratory; French Agence Nationale de Recherches sur le Sida et les hepatitis virales (ANRS) [1271]	Wellcome Trust(Wellcome TrustEuropean Commission); Africa Centre; Africa Centre Laboratory; French Agence Nationale de Recherches sur le Sida et les hepatitis virales (ANRS)(ANRS)	The Wellcome Trust funds the Africa Centre and Africa Centre Laboratory and provided funding for the VTS Study. Additional funding for this investigation was provided by the French Agence Nationale de Recherches sur le Sida et les hepatitis virales (ANRS Grant#1271). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahams MR, 2009, J VIROL, V83, P3556, DOI 10.1128/JVI.02132-08; Becquart P, 2007, VIROLOGY, V363, P256, DOI 10.1016/j.virol.2007.02.003; Bland RM, 2007, CLIN INFECT DIS, V45, P1502, DOI 10.1086/523320; Bland RM, 2010, INT J EPIDEMIOL, V39, P351, DOI 10.1093/ije/dyp165; Brandtzaeg P, 2010, J PEDIATR-US, V156, pS8, DOI 10.1016/j.jpeds.2009.11.014; Chaillon A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090421; Chevenet F, 2013, BIOINFORMATICS, V29, P561, DOI 10.1093/bioinformatics/btt010; Coovadia HM, 2007, LANCET, V369, P1107, DOI 10.1016/S0140-6736(07)60283-9; Drummond A., 2011, GENEIOUS V5 5; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Duri K, 2012, AIDS RES HUM RETROV, V28, P885, DOI [10.1089/AID.2011.0217, 10.1089/aid.2011.0217]; Engstrom JL, 2007, BREASTFEED MED, V2, P83, DOI 10.1089/bfm.2006.0019; Gantt S, 2010, J VIROL, V84, P10812, DOI 10.1128/JVI.00543-10; Gordon M, 2003, J VIROL, V77, P2587, DOI 10.1128/JVI.77.4.2587-2599.2003; Gray RR, 2011, AIDS, V25, P143, DOI 10.1097/QAD.0b013e328340fdaf; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Jordan MR, 2010, J VIROL METHODS, V168, P114, DOI 10.1016/j.jviromet.2010.04.030; Keele BF, 2008, P NATL ACAD SCI USA, V105, P7552, DOI 10.1073/pnas.0802203105; Koulinska IN, 2006, JAIDS-J ACQ IMM DEF, V41, P93, DOI 10.1097/01.qai.0000179424.19413.24; Manasa J, 2014, JOVE-J VIS EXP, DOI 10.3791/51242; Masharsky AE, 2010, J INFECT DIS, V201, P1697, DOI 10.1086/652702; National Department of Health, 2004, NAT ANT TREATM GUID; Ndirangu J, 2012, PLOS ONE IN PRESS; Ndirangu J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051493; Neveu D, 2011, CLIN INFECT DIS, V52, P819, DOI 10.1093/cid/ciq203; Pillay S, 2014, AIDS RES THER, V11, DOI 10.1186/1742-6405-11-3; Pineda-Pena AC, 2013, INFECT GENET EVOL, V19, P337, DOI 10.1016/j.meegid.2013.04.032; Posada D, 2004, SYST BIOL, V53, P793, DOI 10.1080/10635150490522304; Rademeyer C, 2004, AIDS, V18, P2096, DOI 10.1097/00002030-200410210-00019; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Rousseau CM, 2004, J INFECT DIS, V190, P1880, DOI 10.1086/425076; Salazar-Gonzalez JF, 2011, J VIROL, V85, P2751, DOI 10.1128/JVI.02316-10; Shapiro RL, 2005, J INFECT DIS, V192, P713, DOI 10.1086/432489; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; UNAIDS, 2012, GLOBAL REPORT UNAIDS; Valea D, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-34; Van de Perre P, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003327	37	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0120389	10.1371/journal.pone.0120389	http://dx.doi.org/10.1371/journal.pone.0120389			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25793402	Green Published, gold, Green Submitted			2022-12-27	WOS:000352083900022
J	El Hachmane, MF; Komai, AM; Olofsson, CS				El Hachmane, Mickael F.; Komai, Ali M.; Olofsson, Charlotta S.			Cooling Reduces cAMP-Stimulated Exocytosis and Adiponectin Secretion at a Ca2+-Dependent Step in 3T3-L1 Adipocytes	PLOS ONE			English	Article							ADIPOSE-TISSUE; INSULIN; CELLS; CA2+; EXPRESSION; FUSION; ACRP30	We investigated the effects of temperature on white adipocyte exocytosis (measured as increase in membrane capacitance) and short-term adiponectin secretion with the aim to elucidate mechanisms important in regulation of white adipocyte stimulus-secretion coupling. Exocytosis stimulated by cAMP (included in the pipette solution together with 3 mM ATP) in the absence of Ca2+ (10 mM intracellular EGTA) was equal at all investigated temperatures (23 degrees C, 27 degrees C, 32 degrees C and 37 degrees C). However, the augmentation of exocytosis induced by an elevation of the free cytosolic [Ca2+] to similar to 1.5 mu M (9mMCa(2+) + 10 mM EGTA) was potent at 32 degrees C or 37 degrees C but less distinct at 27 degrees C and abolished at 23 degrees C. Adiponectin secretion stimulated by 30 min incubations with the membrane permeable cAMP analogue 8-Br-cAMP (1 mM) or a combination of 10 mu M forskolin and 200 mu M IBMX was unaffected by a reduction of temperature from 32 degrees C to 23 degrees C. At 32 degrees C, cAMP-stimulated secretion was 2-fold amplified by inclusion of the Ca2+ ionophore ionomycin (1 mu M), an effect that was not observed at 23 degrees C. We suggest that cooling affects adipocyte exocytosis/adiponectin secretion at a Ca2+-dependent step, likely involving ATP-dependent processes, important for augmentation of cAMP-stimulated adiponectin release.	[El Hachmane, Mickael F.; Komai, Ali M.; Olofsson, Charlotta S.] Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Dept Physiol Metab Physiol, Gothenburg, Sweden	University of Gothenburg	Olofsson, CS (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Dept Physiol Metab Physiol, Gothenburg, Sweden.	charlotta.olofsson@physiol.gu.se		Olofsson, Charlotta/0000-0001-8824-3151	Jeanssons Stiftelse; Ake Wibergs Stiftelse; Magnus Bergvalls Stiftelse; Diabetesfonden [DIA-2011-073, DIA2012-050, DIA2013-070]; Novonordiskfonden; Knut och Alice Wallenbergs Stiftelse [KAW2012.0263]; IngaBritt och Arne Lundbergs Stiftelse [401]; Swedish Medical Research Council [521-2012-2994, 522-2010-2656]	Jeanssons Stiftelse; Ake Wibergs Stiftelse; Magnus Bergvalls Stiftelse; Diabetesfonden; Novonordiskfonden(Novo Nordisk Foundation); Knut och Alice Wallenbergs Stiftelse(Knut & Alice Wallenberg Foundation); IngaBritt och Arne Lundbergs Stiftelse; Swedish Medical Research Council(Swedish Medical Research Council (SMRC))	Funding provided by Jeanssons Stiftelse, http://www.jeanssonsstiftelser.se/, Ake Wibergs Stiftelse, http://ake-wiberg.se/, Magnus Bergvalls Stiftelse, http://www.magnbergvallsstiftelse.nu/, Diabetesfonden (DIA-2011-073, DIA2012-050 and DIA2013-070), http://diabetesfonden.se/, Novonordiskfonden, http://www.novonordiskfonden.dk/en, Knut och Alice Wallenbergs Stiftelse (Dnr KAW2012.0263), https://www.wallenberg.com/kaw/, IngaBritt och Arne Lundbergs Stiftelse (Grant ID: 401), http://www.lundbergsstiftelsen.se/ and Swedish Medical Research Council (Grant IDs: 521-2012-2994 and 522-2010-2656), http://vr.se/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aspenstrom P, 2004, BBA-MOL CELL RES, V1742, P51, DOI 10.1016/j.bbamcr.2004.09.029; Astrom-Olsson K, 2012, BIOCHEM BIOPH RES CO, V422, P732, DOI 10.1016/j.bbrc.2012.05.071; BITTNER MA, 1992, J BIOL CHEM, V267, P16226; Blumer RME, 2008, METABOLISM, V57, P1655, DOI 10.1016/j.metabol.2008.07.020; Bogan JS, 1999, J CELL BIOL, V146, P609, DOI 10.1083/jcb.146.3.609; Bose A, 2005, J BIOL CHEM, V280, P36946, DOI 10.1074/jbc.M508317200; Burgoyne RD, 2003, PHYSIOL REV, V83, P581, DOI 10.1152/physrev.00031.2002; Elias M, 2014, TRENDS BIOCHEM SCI, V39, P1, DOI 10.1016/j.tibs.2013.11.001; Elmendorf JS, 1999, J BIOL CHEM, V274, P37357, DOI 10.1074/jbc.274.52.37357; Galic S, 2010, MOL CELL ENDOCRINOL, V316, P129, DOI 10.1016/j.mce.2009.08.018; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Kohn AD, 1996, J BIOL CHEM, V271, P31372, DOI 10.1074/jbc.271.49.31372; Komai AM, 2014, J PHYSIOL-LONDON, V592, P5169, DOI 10.1113/jphysiol.2014.280388; Lihn AS, 2004, MOL CELL ENDOCRINOL, V219, P9, DOI 10.1016/j.mce.2004.03.002; LINDAU M, 1988, PFLUG ARCH EUR J PHY, V411, P137, DOI 10.1007/BF00582306; Meyer LK, 2013, ADIPOCYTE, V2, P217, DOI 10.4161/adip.24953; NEHER E, 1988, J PHYSIOL-LONDON, V395, P193, DOI 10.1113/jphysiol.1988.sp016914; OKANO K, 1993, NEURON, V11, P165, DOI 10.1016/0896-6273(93)90280-5; Proks P, 1996, J PHYSIOL-LONDON, V496, P255, DOI 10.1113/jphysiol.1996.sp021682; Renstrom E, 1996, J PHYSIOL-LONDON, V494, P41, DOI 10.1113/jphysiol.1996.sp021474; Spranger J, 2003, LANCET, V361, P226, DOI 10.1016/S0140-6736(03)12255-6; THOMAS P, 1993, NEURON, V11, P93, DOI 10.1016/0896-6273(93)90274-U; Tse A, 2000, J PHYSIOL-LONDON, V528, P79, DOI 10.1111/j.1469-7793.2000.00079.x; Zhang Z, 2008, J GEN PHYSIOL, V131, P117, DOI 10.1085/jgp.200709891	24	19	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0119530	10.1371/journal.pone.0119530	http://dx.doi.org/10.1371/journal.pone.0119530			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25793888	Green Published, Green Submitted, gold			2022-12-27	WOS:000352084200092
J	Garg, KM; Chattopadhyay, B; Doss, DPS; Kumar, AKV; Kandula, S; Ramakrishnan, U				Garg, Kritika M.; Chattopadhyay, Balaji; Doss, D. P. Swami; Kumar, A. K. Vinoth; Kandula, Sripathi; Ramakrishnan, Uma			Males and Females Gain Differentially from Sociality in a Promiscuous Fruit Bat Cynopterus sphinx	PLOS ONE			English	Article							KIN SELECTION; CONSEQUENCES; POPULATIONS; COOPERATION; EVOLUTION; PATERNITY; PROGRAM; ECOLOGY; RELATEDNESS; CHIMPANZEES	Sociality emerges when the benefits of group living outweigh its costs. While both males and females are capable of strong social ties, the evolutionary drivers for sociality and the benefits accrued maybe different for each sex. In this study, we investigate the differential reproductive success benefits of group membership that males and females might obtain in the promiscuous fruit bat Cynopterus sphinx. Individuals of this species live in flexible social groups called colonies. These colonies are labile and there is high turnover of individuals. However, colony males sire more offspring within the colony suggesting that being part of a colony may result in reproductive benefits for males. This also raises the possibility that long-term loyalty towards the colony may confer additional advantage in terms of higher reproductive success. We used ten seasons of genetic parentage data to estimate reproductive success and relatedness of individuals in the colony. We used recapture data to identify long and short-term residents in the colony as well as to obtain rates of recapture for males and females. Our results reveal that males have a significantly higher chance of becoming long-term residents (than females), and these long-term resident males gain twice the reproductive success compared to short-term resident males. We also observed that long-term resident females are related to each other and also achieve higher reproductive success than short-term resident females. In contrast, long-term resident males do not differ from short-term resident males in their levels of relatedness. Our results re-iterate the benefits of sociality even in species that are promiscuous and socially labile and possible benefits of maintaining a colony.	[Garg, Kritika M.; Chattopadhyay, Balaji; Ramakrishnan, Uma] TIFR, Natl Ctr Biol Sci, Ecol & Evolut, Bangalore 560065, Karnataka, India; [Chattopadhyay, Balaji; Doss, D. P. Swami; Kumar, A. K. Vinoth; Kandula, Sripathi] Madurai Kamaraj Univ, Sch Biol Sci, Madurai 625021, Tamil Nadu, India	Tata Institute of Fundamental Research (TIFR); National Centre for Biological Sciences (NCBS); Madurai Kamaraj University	Garg, KM (corresponding author), TIFR, Natl Ctr Biol Sci, Ecol & Evolut, Bellary Rd, Bangalore 560065, Karnataka, India.	kritika.m.garg@gmail.com		Devaraj, Paramanantha Swami Doss/0000-0001-8602-6612; Chattopadhyay, Balaji/0000-0002-4423-3127; Garg, Kritika M./0000-0003-3510-3408; Ramakrishnan, Uma/0000-0002-5370-5966	Department of Science and Technology; National Centre for Biological Science-Tata Institute of Fundamental Research; Department of Science and Technology Young Scientist grant; Ramanujan fellowship (Department of Science and Technology, Government of India)	Department of Science and Technology(Department of Science & Technology (India)); National Centre for Biological Science-Tata Institute of Fundamental Research; Department of Science and Technology Young Scientist grant; Ramanujan fellowship (Department of Science and Technology, Government of India)	This work was supported by Department of Science and Technology grant to UR, National Centre for Biological Science-Tata Institute of Fundamental Research funding to KMG and UR, and Department of Science and Technology Young Scientist grant to DPS. UR was supported by the Ramanujan fellowship (Department of Science and Technology, Government of India). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnard C.J., 2004, ANIMAL BEHAV MECH DE; Black JM, 2001, BEHAV ECOL, V12, P640, DOI 10.1093/beheco/12.5.640; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Cameron EZ, 2009, P NATL ACAD SCI USA, V106, P13850, DOI 10.1073/pnas.0900639106; Campbell P, 2008, J MAMMAL, V89, P1351, DOI 10.1644/08-MAMM-S-059.1; Chattopadhyay B, 2011, MAMM BIOL, V76, P290, DOI 10.1016/j.mambio.2010.08.003; Clutton-Brock T, 2002, SCIENCE, V296, P69, DOI 10.1126/science.296.5565.69; Clutton-Brock T, 2009, NATURE, V462, P51, DOI 10.1038/nature08366; Dunbar RIM, 2010, BEHAVIOUR, V147, P775, DOI 10.1163/000579510X501151; EMLEN ST, 1977, SCIENCE, V197, P215, DOI 10.1126/science.327542; Garg KM, 2012, MOL ECOL, V21, P4093, DOI 10.1111/j.1365-294X.2012.05665.x; Hatchwell BJ, 2010, ETHOLOGY, V116, P203, DOI 10.1111/j.1439-0310.2009.01732.x; Hua PY, 2011, MOL ECOL, V20, P3669, DOI 10.1111/j.1365-294X.2011.05192.x; Kalinowski ST, 2007, MOL ECOL, V16, P1099, DOI 10.1111/j.1365-294X.2007.03089.x; Kappeler PM, 2002, INT J PRIMATOL, V23, P707, DOI 10.1023/A:1015520830318; Kerth G, 2012, MOL ECOL, V21, P633, DOI 10.1111/j.1365-294X.2011.05233.x; Kerth G, 2008, BIOSCIENCE, V58, P737, DOI 10.1641/B580810; Krause J, 2002, LIVING GROUPS; Krause J, 2009, BEHAV ECOL SOCIOBIOL, V63, P967, DOI 10.1007/s00265-009-0747-0; Krebs JR, 1993, INTRO BEHAV ECOLOGY; Langergraber KE, 2007, P NATL ACAD SCI USA, V104, P7786, DOI 10.1073/pnas.0611449104; Marshall TC, 1998, MOL ECOL, V7, P639, DOI 10.1046/j.1365-294x.1998.00374.x; Matschiner M, 2009, BIOINFORMATICS, V25, P1982, DOI 10.1093/bioinformatics/btp303; MORIN PA, 1994, SCIENCE, V265, P1193, DOI 10.1126/science.7915048; Ortega J, 2003, MOL ECOL, V12, P2409, DOI 10.1046/j.1365-294X.2003.01924.x; PACKER C, 1982, NATURE, V296, P740, DOI 10.1038/296740a0; R Core Team, 2013, R LANG ENV STAT COMP, DOI [10.3758/s13428-013-0330-5, DOI 10.3758/S13428-013-0330-5]; SANDHU S, 1984, Journal of the Bombay Natural History Society, V81, P600; Schulke O, 2010, CURR BIOL, V20, P2207, DOI 10.1016/j.cub.2010.10.058; Schwarz CJ, 1996, BIOMETRICS, V52, P860, DOI 10.2307/2533048; Silk JB, 2007, SCIENCE, V317, P1347, DOI 10.1126/science.1140734; Storz Jay F., 1999, Mammalian Species, V613, P1; Storz JF, 2001, EVOLUTION, V55, P1215; Storz JF, 2000, J ZOOL, V251, P151; Voigt CC, 2003, ANIM BEHAV, V65, P149, DOI 10.1006/anbe.2002.2031; Wang JL, 2011, MOL ECOL RESOUR, V11, P141, DOI 10.1111/j.1755-0998.2010.02885.x; White GC, 1999, BIRD STUDY, V46, P120, DOI 10.1080/00063659909477239; Whitehead H, 2008, ANAL ANIMAL SOC QUAN, DOI 10.7208/chicago/9780226895246.001.0001; Wiszniewski J, 2010, ANIM BEHAV, V80, P895, DOI 10.1016/j.anbehav.2010.08.013	39	6	6	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0122180	10.1371/journal.pone.0122180	http://dx.doi.org/10.1371/journal.pone.0122180			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25794185	Green Submitted, gold, Green Published			2022-12-27	WOS:000352083900173
J	Kritchevsky, SB; Beavers, KM; Miller, ME; Shea, MK; Houston, DK; Kitzman, DW; Nicklas, BJ				Kritchevsky, Stephen B.; Beavers, Kristen M.; Miller, Michael E.; Shea, M. Kyla; Houston, Denise K.; Kitzman, Dalane W.; Nicklas, Barbara J.			Intentional Weight Loss and All-Cause Mortality: A Meta-Analysis of Randomized Clinical Trials	PLOS ONE			English	Article							LIFE-STYLE INTERVENTION; BODY-MASS INDEX; PHYSICAL-ACTIVITY; OBESE ADULTS; OLDER-ADULTS; KNEE OSTEOARTHRITIS; DIABETES-MELLITUS; BLOOD-PRESSURE; OVERWEIGHT; REDUCTION	Background Obesity is associated with increased mortality, and weight loss trials show rapid improvement in many mortality risk factors. Yet, observational studies typically associate weight loss with higher mortality risk. The purpose of this meta-analysis of randomized controlled trials (RCTs) of weight loss was to clarify the effects of intentional weight loss on mortality. Methods 2,484 abstracts were identified and reviewed in PUBMED, yielding15 RCTs reporting (1) randomization to weight loss or non-weight loss arms, (2) duration of >= 18 months, and (3) deaths by intervention arm. Weight loss interventions were all lifestyle-based. Relative risks (RR) and 95% confidence intervals (95% CI) were estimated for each trial. For trials reporting at least one death (n = 12), a summary estimate was calculated using the Mantel-Haenszel method. Sensitivity analysis using sparse data methods included remaining trials. Results Trials enrolled 17,186 participants (53% female, mean age at randomization = 52 years). Mean body mass indices ranged from 30-46 kg/m(2), follow-up times ranged from 18 months to 12.6 years (mean: 27 months), and average weight loss in reported trials was 5.5 +/- 4.0 kg. A total of 264 deaths were reported in weight loss groups and 310 in non-weight loss groups. The weight loss groups experienced a 15% lower all-cause mortality risk (RR = 0.85; 95% CI: 0.73-1.00). There was no evidence for heterogeneity of effect (Cochran's Q = 5.59 (11 d.f.; p = 0.90); I-2 = 0). Results were similar in trials with a mean age at randomization >= 55 years (RR = 0.84; 95% CI 0.71-0.99) and a follow-up time of >= 4 years (RR = 0.85; 95% CI 0.72-1.00). Conclusions In obese adults, intentional weight loss may be associated with approximately a 15% reduction in all-cause mortality.	[Kritchevsky, Stephen B.; Beavers, Kristen M.; Miller, Michael E.; Houston, Denise K.; Kitzman, Dalane W.; Nicklas, Barbara J.] Wake Forest Univ, Bowman Gray Sch Med, Dept Internal Med, Winston Salem, NC 27103 USA; [Beavers, Kristen M.] Wake Forest Univ, Dept Hlth & Exercise Sci, Winston Salem, NC 27103 USA; [Miller, Michael E.] Wake Forest Sch Med, Dept Biostat Sci, Winston Salem, NC USA; [Shea, M. Kyla] Tufts Univ, Human Nutr Res Ctr Aging, Boston, MA 02111 USA	Wake Forest University; Wake Forest Baptist Medical Center; Wake Forest University; Wake Forest University; Tufts University; United States Department of Agriculture (USDA)	Kritchevsky, SB (corresponding author), Wake Forest Univ, Bowman Gray Sch Med, Dept Internal Med, Winston Salem, NC 27103 USA.	skritche@wakehealth.edu	Nicklas, Barbara/AAA-2781-2020	Shea, Kyla/0000-0002-3202-5582; Houston, Denise/0000-0002-3355-4304	Wake Forest Older Americans Independence Center [P30 AG021332];  [R01 AG033087]; NATIONAL INSTITUTE ON AGING [R01AG033087, P30AG021332] Funding Source: NIH RePORTER	Wake Forest Older Americans Independence Center; ; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the Wake Forest Older Americans Independence Center (P30 AG021332) and by R01 AG033087. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bales CW, 2008, J AM MED DIR ASSOC, V9, P302, DOI 10.1016/j.jamda.2008.01.006; Bano G, 2013, BEST PRACT RES CL OB, V27, P715, DOI 10.1016/j.bpobgyn.2013.02.007; Beavers KM, 2013, J AM GERIATR SOC, V61, P1089, DOI 10.1111/jgs.12321; Billington CJ, 2000, ARCH INTERN MED, V160, P898, DOI 10.1001/archinte.160.7.898; Bradburn MJ, 2007, STAT MED, V26, P53, DOI 10.1002/sim.2528; Chaston TB, 2007, INT J OBESITY, V31, P743, DOI 10.1038/sj.ijo.0803483; Daumit GL, 2013, NEW ENGL J MED, V368, P1594, DOI 10.1056/NEJMoa1214530; DAVIS BR, 1993, ARCH INTERN MED, V153, P1773, DOI 10.1001/archinte.153.15.1773; Espeland MA, 2013, J AM GERIATR SOC, V61, P912, DOI 10.1111/jgs.12271; Fitzgibbon ML, 2010, OBESITY, V18, P2317, DOI 10.1038/oby.2010.47; Gabriel KKP, 2011, MENOPAUSE, V18, P759, DOI 10.1097/gme.0b013e31820acdcc; Gould AL, 2007, CLIN THER, V29, P778, DOI 10.1016/j.clinthera.2007.05.012; Harrington M, 2009, NUTR RES REV, V22, P93, DOI 10.1017/S0954422409990035; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Jensen MD, 2014, OBESITY, V22, pS5, DOI 10.1002/oby.20821; Johnson SS, 2008, PREV MED, V46, P238, DOI 10.1016/j.ypmed.2007.09.010; Klenk J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084817; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Knudtson MD, 2005, ANN EPIDEMIOL, V15, P483, DOI 10.1016/j.annepidem.2004.12.003; Lee DC, 2010, J PSYCHOPHARMACOL, V24, P27, DOI 10.1177/1359786810382057; Messier SP, 2004, ARTHRITIS RHEUM-US, V50, P1501, DOI 10.1002/art.20256; Messier SP, 2013, JAMA-J AM MED ASSOC, V310, P1263, DOI 10.1001/jama.2013.277669; Poobalan AS, 2007, OBES REV, V8, P503, DOI 10.1111/j.1467-789X.2007.00393.x; Rejeski WJ, 2010, OBES REV, V11, P671, DOI 10.1111/j.1467-789X.2009.00679.x; Rejeski WJ, 2011, ARCH INTERN MED, V171, P880, DOI 10.1001/archinternmed.2010.522; ROBINS J, 1986, BIOMETRICS, V42, P311, DOI 10.2307/2531052; Ryan DH, 2010, ARCH INTERN MED, V170, P146, DOI 10.1001/archinternmed.2009.508; Shea MK, 2011, AM J CLIN NUTR, V94, P839, DOI 10.3945/ajcn.110.006379; Shea MK, 2010, J GERONTOL A-BIOL, V65, P519, DOI 10.1093/gerona/glp217; Sjostrom L, 2007, NEW ENGL J MED, V357, P741, DOI 10.1056/NEJMoa066254; Somes GW, 2002, AM J EPIDEMIOL, V156, P132, DOI 10.1093/aje/kwf019; Sorensen T I A, 2003, Obes Rev, V4, P3, DOI 10.1046/j.1467-789X.2003.00090.x; Sorensen TIA, 2005, PLOS MED, V2, P510, DOI 10.1371/journal.pmed.0020171; STAMLER R, 1987, JAMA-J AM MED ASSOC, V257, P1484, DOI 10.1001/jama.257.11.1484; Studenski S, 2011, JAMA-J AM MED ASSOC, V305, P50, DOI 10.1001/jama.2010.1923; Sweeting MJ, 2004, STAT MED, V23, P1351, DOI 10.1002/sim.1761; Turnbull F, 2005, ARCH INTERN MED, V165, P1410; van Wier MF, 2011, J OCCUP ENVIRON MED, V53, P680, DOI 10.1097/JOM.0b013e31821f2bbb; Villareal DT, 2011, NEW ENGL J MED, V364, P1218, DOI 10.1056/NEJMoa1008234; Volpato S, 2001, CIRCULATION, V103, P947; WHELTON PK, 1993, ARCH INTERN MED, V153, P186, DOI 10.1001/archinte.153.2.186; WHELTON PK, 1992, JAMA-J AM MED ASSOC, V267, P1213, DOI 10.1001/jama.1992.03480090061028; Whelton PK, 1998, JAMA-J AM MED ASSOC, V279, P839, DOI 10.1001/jama.279.11.839; Whelton PK, 1997, ARCH INTERN MED, V157, P657, DOI 10.1001/archinte.157.6.657; Wing R, 2013, NEW ENGL J MED, V369, P145, DOI 10.1056/NEJMoa1212914; Zheng H, 2013, AM J EPIDEMIOL, V178, P1591, DOI 10.1093/aje/kwt179	46	111	115	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0121993	10.1371/journal.pone.0121993	http://dx.doi.org/10.1371/journal.pone.0121993			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25794148	gold, Green Submitted, Green Published			2022-12-27	WOS:000352083900163
J	Lee, JS; Chun, JW; Lee, SH; Kim, E; Lee, SK; Kim, JJ				Lee, Jung Suk; Chun, Ji Won; Lee, Sang-Hoon; Kim, Eosu; Lee, Seung-Koo; Kim, Jae-Jin			Altered Neural Basis of the Reality Processing and Its Relation to Cognitive Insight in Schizophrenia	PLOS ONE			English	Article							EPISODIC MEMORY RETRIEVAL; RECOGNITION MEMORY; WORD RECOGNITION; SPATIAL CONTEXT; HIPPOCAMPUS; SYMPTOMS; CONNECTIVITY; ASSOCIATION; PSYCHOSIS; NETWORK	It has been reported that reality evaluation and recognition are impaired in patients with schizophrenia and these impairments are related to the severity of psychotic symptoms. The current study aimed to investigate the neural basis of impairments in reality evaluation and recognition and their relationships with cognitive insight in schizophrenia. During functional magnetic resonance imaging, 20 patients with schizophrenia and 20 healthy controls performed a set of reality evaluation and recognition tasks, in which subjects judged whether scenes in a series of drawings were real or unreal and whether they were familiar or novel. During reality evaluation, patients showed decreased activity in various regions including the inferior parietal lobule, retrosplenial cortex and parahippocampal gyrus, compared with controls. Particularly, parahippocampal gyrus activity was correlated with the severity of positive symptoms in patients. During recognition, patients also exhibited decreased activity in various regions, including the dorsolateral prefrontal cortex, inferior parietal lobule and posterior cingulate cortex. Particularly, inferior parietal lobule activity and posterior cingulate cortex activity were correlated with cognitive insight in patients. These findings provide evidence that neural impairments in reality evaluation and recognition are related to psychotic symptoms. Anomalous appraisal of context by dysfunctions in the context network may contribute to impairments in the reality processing in schizophrenia, and abnormal declarative memory processes may be involved in cognitive insight in patients with schizophrenia.	[Lee, Jung Suk; Chun, Ji Won; Lee, Sang-Hoon; Kim, Eosu; Kim, Jae-Jin] Yonsei Univ, Coll Med, Inst Behav Sci Med, Seoul, South Korea; [Lee, Jung Suk] Bundang Jesaeng Hosp, Dept Psychiat, Songnam, South Korea; [Kim, Eosu; Kim, Jae-Jin] Yonsei Univ, Coll Med, Dept Psychiat, Seoul, South Korea; [Lee, Seung-Koo; Kim, Jae-Jin] Yonsei Univ, Coll Med, Dept Radiol, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Kim, JJ (corresponding author), Yonsei Univ, Coll Med, Inst Behav Sci Med, Seoul, South Korea.	jaejkim@yonsei.ac.kr		Lee, Seung-Koo/0000-0001-5646-4072; Chun, Ji-Won/0000-0002-0629-0358; Kim, Jae-Jin/0000-0002-1395-4562; Kim, Eosu/0000-0001-9472-9465	National Research Foundation of Korea (NRF) - Korea government (MEST) [NRF-2013R1A2A2A03068342]	National Research Foundation of Korea (NRF) - Korea government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaNational Research Foundation of KoreaKorean Government)	This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MEST) (No. NRF-2013R1A2A2A03068342). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggleton JP, 2012, NEUROSCI BIOBEHAV R, V36, P1579, DOI 10.1016/j.neubiorev.2011.09.005; Bar M, 2003, NEURON, V38, P347, DOI 10.1016/S0896-6273(03)00167-3; Beck AT, 2004, SCHIZOPHR RES, V68, P319, DOI 10.1016/s0920-9964(03)00189-0; Bora E, 2007, PSYCHIAT CLIN NEUROS, V61, P634, DOI 10.1111/j.1440-1819.2007.01731.x; Brebion G, 2005, NEUROPSYCHOLOGY, V19, P612, DOI 10.1037/0894-4105.19.5.612; Brebion G, 1998, J NERV MENT DIS, V186, P604, DOI 10.1097/00005053-199810000-00003; Burgess N, 2001, NEUROIMAGE, V14, P439, DOI 10.1006/nimg.2001.0806; Cabeza R, 2008, NEUROPSYCHOLOGIA, V46, P1813, DOI 10.1016/j.neuropsychologia.2008.03.019; Crone EA, 2009, DEVELOPMENTAL SCI, V12, P55, DOI 10.1111/j.1467-7687.2008.00743.x; Donaldson DI, 2010, J COGNITIVE NEUROSCI, V22, P377, DOI 10.1162/jocn.2009.21242; First M.B., 2014, STRUCTURED CLIN INTE; Gradin VB, 2011, BRAIN, V134, P1751, DOI 10.1093/brain/awr059; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261, DOI 10.1093/schbul/13.2.261; Keene CS, 2008, BEHAV NEUROSCI, V122, P89, DOI 10.1037/0735-7044.122.1.89; Kim H, 2010, NEUROIMAGE, V49, P1045, DOI 10.1016/j.neuroimage.2009.07.058; Krawczyk DC, 2012, BRAIN RES, V1428, P13, DOI 10.1016/j.brainres.2010.11.080; Ledoux AA, 2013, PSYCHIAT RES-NEUROIM, V211, P47, DOI 10.1016/j.pscychresns.2012.10.005; Lee JS, 2013, PSYCHIAT RES, V210, P721, DOI 10.1016/j.psychres.2013.07.035; Lepage M, 2008, EUR PSYCHIAT, V23, P368, DOI 10.1016/j.eurpsy.2008.02.003; Mackey AP, 2013, J NEUROSCI, V33, P4796, DOI 10.1523/JNEUROSCI.4141-12.2013; Meyers J. E., 1995, REY COMPLEX FIGURE T; O'Connor AR, 2010, J NEUROSCI, V30, P2924, DOI 10.1523/JNEUROSCI.4225-09.2010; Prasad KMR, 2004, PROG NEURO-PSYCHOPH, V28, P651, DOI 10.1016/j.pnpbp.2004.01.017; Ragland JD, 2003, BIOL PSYCHIAT, V54, P1154, DOI 10.1016/S0006-3223(03)00235-X; Ramsey NF, 2002, BRAIN, V125, P1793, DOI 10.1093/brain/awf188; Raven JC, 1988, MANUAL RAVENS PROGR; Rey A., 1964, EXAMEN CLIN PSYCOL; Rudy JW, 2009, LEARN MEMORY, V16, P573, DOI 10.1101/lm.1494409; SNODGRASS JG, 1988, J EXP PSYCHOL GEN, V117, P34, DOI 10.1037/0096-3445.117.1.34; Surguladze S, 2006, BIOL PSYCHIAT, V60, P423, DOI 10.1016/j.biopsych.2005.11.021; Suzuki M, 2005, NEUROIMAGE, V25, P993, DOI 10.1016/j.neuroimage.2004.12.021; Talamini LM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010356; Wagner AD, 2005, TRENDS COGN SCI, V9, P445, DOI 10.1016/j.tics.2005.07.001; Wang L, 2010, NEUROIMAGE, V51, P910, DOI 10.1016/j.neuroimage.2010.02.046; Watson CE, 2012, NEUROIMAGE, V59, P2831, DOI 10.1016/j.neuroimage.2011.09.030; Xiao F, 2014, BIOL PSYCHOL, V101, P61, DOI 10.1016/j.biopsycho.2014.06.005; Zierhut K, 2010, PSYCHIAT RES-NEUROIM, V183, P187, DOI 10.1016/j.pscychresns.2010.03.007	37	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0120478	10.1371/journal.pone.0120478	http://dx.doi.org/10.1371/journal.pone.0120478			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25793291	Green Published, Green Submitted, gold			2022-12-27	WOS:000352083900039
J	Mazaheri, S; Poorolajal, J; Hosseinzadeh, A; Fazlian, MM				Mazaheri, Shahir; Poorolajal, Jalal; Hosseinzadeh, Akram; Fazlian, Mohammad Mahdi			Effect of Intravenous Sodium Valproate vs Dexamethasone on Acute Migraine Headache: A Double Blind Randomized Clinical Trial	PLOS ONE			English	Article							EMERGENCY-DEPARTMENT; METOCLOPRAMIDE; PATHOPHYSIOLOGY; PLACEBO; ACID; AURA	Background Despite the impact of sodium valproate and dexamethasone on migraine headache, the efficacy of the two drugs has not been properly investigated and compared. This trial compared the effect of the two drugs on acute migraine headache. Methods This double blind randomized clinical trial was conducted on patients aged 18 to 65 years with acute migraine headache who referred to the emergency departments of Beasat and Farshchian Hospitals in Hamadan, Iran, from April 2012 to June 2014. Patients were randomly assigned to receive a single-dose of either 400 mg sodium valproate or 16 mg dexamethasone plus 50 ml saline normal solution within 15 min intravenously. The severity of headache in the two groups was evaluated at baseline, 0.5 and 2 hours later using the Visual Analog Scale (VAS) on a scale of 0 to 10. Results Of 104 patients enrolled, 72 patients remained for analysis. The effect of both sodium valproate and dexamethasone on acute migraine headache was statistically significant at 0.5 and 2 hours post-treatment compared to pre-treatment (P=0.001). The severity of headache based on VAS reduced form 8.20 (7.72, 8.68) before treatment to 5.31 (4.74, 5.89) and 3.66 (2.99, 4.33) at 0.5 and 2 hours after treatment, respectively, in patients receiving sodium valproate and from 8.46 (8.05, 8.86) before treatment to 5.46 (4.81, 6.11) and 3.59 (2.84, 4.35) at 0.5 and 2 hours after treatment, respectively, in patients receiving dexamethasone. Both drugs were highly effective in improvement of acute headache in patients without aura. However, sodium valproate significantly improved the acute headache in patients with aura but dexamethasone did not. The severity of headache based on VAS reduced form 8.50 (7.40, 9.60) before treatment to 4.67 (2.40, 6.93) and 3.50 (1.78, 5.22) at 0.5 and 2 hours after treatment, respectively, in patients with aura receiving sodium valproate and from 8.80 (7.76, 9.84) before treatment to 7.20 (4.98, 9.42) and 6.20 (2.43, 9.97) at 0.5 and 2 hours after treatment, respectively, in patients with aura receiving dexamethasone. Conclusions This trial indicated that, in overall, intravenous sodium valproate is not superior to intravenous dexamethasone in treatment of acute migraine attacks. However, in patients with aura, only sodium valproate but not dexamethasone is effective in headache relief. This issue needs further investigations.	[Mazaheri, Shahir] Hamadan Univ Med Sci, Sch Med, Dept Neurol, Hamadan, Iran; [Poorolajal, Jalal] Hamadan Univ Med Sci, Sch Publ Hlth, Modeling Noncommunicable Dis Res Ctr, Hamadan, Iran; [Poorolajal, Jalal] Hamadan Univ Med Sci, Sch Publ Hlth, Dept Epidemiol & Biostat, Hamadan, Iran; [Hosseinzadeh, Akram] Hamadan Univ Med Sci, Hamadan Dist Hlth Ctr, Hamadan, Iran; [Fazlian, Mohammad Mahdi] Hamadan Univ Med Sci, Beasat Hosp, Hamadan, Iran		Poorolajal, J (corresponding author), Hamadan Univ Med Sci, Sch Publ Hlth, Modeling Noncommunicable Dis Res Ctr, Hamadan, Iran.	poorolajal@umsha.ac.ir	Poorolajal, Jalal/D-3506-2013; mazaheri, shahir/V-8606-2017	mazaheri, shahir/0000-0001-6812-8922	Hamadan University of Medical Sciences	Hamadan University of Medical Sciences	This study was funded by the Vice-Chancellor of Research and Technology, Hamadan University of Medical Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakhshayesh B, 2013, AM J EMERG MED, V31, P540, DOI 10.1016/j.ajem.2012.10.014; Bigal M, 2008, HEADACHE, V48, P1286, DOI 10.1111/j.1526-4610.2008.01092.x; Dalkara T, 2010, LANCET NEUROL, V9, P309, DOI 10.1016/S1474-4422(09)70358-8; Donaldson D, 2008, AM J EMERG MED, V26, P124, DOI 10.1016/j.ajem.2007.03.029; Edwards KR, 2001, HEADACHE, V41, P976, DOI 10.1046/j.1526-4610.2001.01191.x; Fiesseler FW, 2011, J EMERG MED, V40, P463, DOI 10.1016/j.jemermed.2009.08.022; Foroughipour M, 2013, IRAN J MED SCI, V38, P150; Frazee LA, 2008, ANN PHARMACOTHER, V42, P403, DOI 10.1345/aph.1K531; Friedman BW, 2007, NEUROLOGY, V69, P2038, DOI 10.1212/01.WNL.0000281105.78936.1d; Friedman BW, 2007, ANN EMERG MED, V49, P409, DOI 10.1016/j.annemergmed.2006.11.004; Friedman BW, 2014, NEUROLOGY, V82, P976, DOI 10.1212/WNL.0000000000000223; Friedman BW, 2014, 4 VALPROATE ACUTE MI; Kozubski W, 1995, Neurol Neurochir Pol, V29, P929; Leniger T, 2005, HEADACHE, V45, P42, DOI 10.1111/j.1526-4610.2005.05009.x; Mathew NT, 2000, HEADACHE, V40, P720, DOI 10.1046/j.1526-4610.2000.00125.x; Norton J, 2000, HEADACHE, V40, P755, DOI 10.1046/j.1526-4610.2000.00133.x; Olesen J., 2004, INT CLASSIFICATION H; Palermo A, 2009, NEUROSCI LETT, V467, P26, DOI 10.1016/j.neulet.2009.09.054; Rowe BH, 2008, HEADACHE, V48, P333, DOI 10.1111/j.1526-4610.2007.00959.x; Sarrouilhe D, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00078; Vinson DR, 2002, ANN EMERG MED, V39, P215, DOI 10.1067/mem.2002.121400; Waberzinek G, 2007, NEUROENDOCRINOL LETT, V28, P59	22	11	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0120229	10.1371/journal.pone.0120229	http://dx.doi.org/10.1371/journal.pone.0120229			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25793707	Green Submitted, Green Published, gold			2022-12-27	WOS:000352084200162
J	McCleery, RA; Holdorf, AR; Hubbard, LL; Peer, BD				McCleery, Robert A.; Holdorf, Allison R.; Hubbard, Laura L.; Peer, Brian D.			Maximizing the Wildlife Conservation Value of Road Right-of-Ways in an Agriculturally Dominated Landscape	PLOS ONE			English	Article							LAND-USE CHANGE; SMALL MAMMALS; SPECIES RICHNESS; COMMUNITY STRUCTURE; BIRD COMMUNITIES; GRASSLAND BIRDS; HABITAT; MANAGEMENT; POPULATIONS; VERGES	There has been a growing recognition that the narrow linear strips of uncultivated vegetation that lie between roads and agricultural crops, referred to as roadside right-of-ways or verges, can serve as areas for the conservation of wildlife. The features of right-of-ways that should influence the composition of wildlife communities vary considerably. Our goal was to determine what features of right-of-ways increased the conservation potential of right-of-ways for wildlife in a grassland system dominated by agricultural production. We sampled 100 right-of-ways for birds and 92 right-of-ways for small mammals in McDonough and Warren Counties in west-central Illinois. We found that the sizes of right-of-ways and the amount of traffic on the adjacent roads synergistically worked to influence wildlife communities. On roads with low traffic, avian species richness increased rapidly with increased right-of-way width, while on roads with high traffic, avian richness increased only slightly with increasing right-of-way widths. We found that wider roadside right-of-ways (preferably across the road from equally wide right-of-ways) with thicker and taller vegetation had the greatest conservation value for birds and small mammals. The features that enhanced the conservation value of right-of-ways in our study area were uncommon. Efforts to create or enhance these features for the benefit of wildlife would likely face numerous obstacles. Nonetheless, from a grassland conservation perspective, working with stakeholders to implement specific strategies to enhance these often neglected areas may be an effective complement to purchasing and restoring conservation lands away from roads.	[McCleery, Robert A.] Univ Florida, Dept Wildlife Ecol & Conservat, Gainesville, FL 32611 USA; [Holdorf, Allison R.; Hubbard, Laura L.; Peer, Brian D.] Western Illinois Univ, Dept Biol Sci, Macomb, IL 61455 USA	State University System of Florida; University of Florida; Western Illinois University	McCleery, RA (corresponding author), Univ Florida, Dept Wildlife Ecol & Conservat, Gainesville, FL 32611 USA.	ramccleery@ufl.edu		McCleery, Robert/0000-0001-7018-005X; Holdorf, Allison/0000-0001-9629-6106	Illinois Institute for Rural Affairs at Western Illinois University	Illinois Institute for Rural Affairs at Western Illinois University	This project was funding through non-grant funding from the Illinois Institute for Rural Affairs at Western Illinois University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS LW, 1983, J APPL ECOL, V20, P403, DOI 10.2307/2403516; Anderson RP, 2003, ECOL MODEL, V162, P211, DOI 10.1016/S0304-3800(02)00349-6; Andrews Kimberly M., 2008, P121; ARNOLD GW, 1990, BIOL CONSERV, V53, P295, DOI 10.1016/0006-3207(90)90098-A; Avenant N, 2011, WILDLIFE RES, V38, P626, DOI 10.1071/WR10223; Avenant NL, 2007, INTEGR ZOOL, V2, P212, DOI 10.1111/j.1749-4877.2007.00064.x; Bellamy PE, 2000, MAMMAL REV, V30, P131, DOI 10.1046/j.1365-2907.2000.00061.x; BENNETT AF, 1990, LANDSCAPE ECOL, V4, P109, DOI 10.1007/BF00132855; Berger RL., 2005, NCHRP SYNTHESIS HIGH; Bergin TM, 1997, WILSON BULL, V109, P437; Bissonette JA, 2009, ECOL SOC, V14; BOLLINGER EK, 1990, WILDLIFE SOC B, V18, P142; Brennan LA, 2005, J WILDLIFE MANAGE, V69, P1, DOI 10.2193/0022-541X(2005)069&lt;0001:NAGBAU&gt;2.0.CO;2; Brown DG, 2005, ECOL APPL, V15, P1851, DOI 10.1890/03-5220; Buckingham DL, 2006, AGR ECOSYST ENVIRON, V112, P21, DOI 10.1016/j.agee.2005.06.019; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Butcher GS, 2007, COMBINING DATA CHRIS; Campbell HW, 1082, HERPETOLOGICAL COMMU, V13, P193; Canterbury GE, 2000, CONSERV BIOL, V14, P544, DOI 10.1046/j.1523-1739.2000.98235.x; Ceballos G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008562; DAUBENMIRE R., 1959, NORTHWEST SCI, V33, P43; de Molenaar Johannes G., 2006, P114; DeVault TL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087944; Fleishman E, 2002, OECOLOGIA, V133, P78, DOI 10.1007/s00442-002-1003-8; Fleishman E, 2005, CONSERV BIOL, V19, P1125, DOI 10.1111/j.1523-1739.2005.00168.x; Forman RTT, 1998, ANNU REV ECOL SYST, V29, P207, DOI 10.1146/annurev.ecolsys.29.1.207; Forman RTT, 2002, ENVIRON MANAGE, V29, P782, DOI 10.1007/s00267-001-0065-4; Gannon W, 2009, J MAMMAL, V88, P809; Garden JG, 2007, AUSTRAL ECOL, V32, P669, DOI 10.1111/j.1442-9993.2007.01750.x; Goldewijk KK, 2011, GLOBAL ECOL BIOGEOGR, V20, P73, DOI 10.1111/j.1466-8238.2010.00587.x; Goldewijk KK, 2001, GLOBAL BIOGEOCHEM CY, V15, P417, DOI 10.1029/1999GB001232; Govindan BN, 2012, OIKOS, V121, P623, DOI 10.1111/j.1600-0706.2011.19747.x; Hinsley SA, 2000, J ENVIRON MANAGE, V60, P33, DOI 10.1006/jema.2000.0360; Hofmann JE., 2008, FIELD MANUAL ILLINOI; Hopwood JL, 2008, BIOL CONSERV, V141, P2632, DOI 10.1016/j.biocon.2008.07.026; HOWE HF, 1994, CONSERV BIOL, V8, P691, DOI 10.1046/j.1523-1739.1994.08030691.x; Hurst ZM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074520; Iverson LR, 1988, LANDSCAPE ECOL, V2, P45, DOI 10.1007/BF00138907; Jaster L.A., 2012, BIRDS N AM ONLINE; Kamp J, 2011, BIOL CONSERV, V144, P2607, DOI 10.1016/j.biocon.2011.07.010; Keesing F, 2000, BIOSCIENCE, V50, P205, DOI 10.1641/0006-3568(2000)050[0205:CCATEO]2.3.CO;2; Kery M, 2012, BAYESIAN POPULATION ANALYSIS USING WINBUGS: A HIERARCHICAL PERSPECTIVE, P1; Kery M., 2010, INTRO WINBUGS ECOLOG; Kociolek AV, 2011, CONSERV BIOL, V25, P241, DOI 10.1111/j.1523-1739.2010.01635.x; Koford RR, 1999, STUD AVIAN BIOL-SER, P187; Lambin EF, 2011, P NATL ACAD SCI USA, V108, P3465, DOI 10.1073/pnas.1100480108; Laurance WF, 2008, BIOL CONSERV, V141, P1731, DOI 10.1016/j.biocon.2008.05.011; Legagneux P, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2013.0417; LEIGHTON MM, 1948, J GEOL, V56, P16, DOI 10.1086/625474; Lucey A, 2011, TRANSPORT RES REC, P164, DOI 10.3141/2262-16; Lunn DJ, 2000, STAT COMPUT, V10, P325, DOI 10.1023/A:1008929526011; MAC ARTHUR ROBERT H., 1967; MacKenzie D. I., 2017, OCCUPANCY ESTIMATION; Manson RH, 2001, ECOLOGY, V82, P3320, DOI 10.2307/2680155; McClure CJW, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.2290; McGregor RL, 2008, J APPL ECOL, V45, P117, DOI 10.1111/j.1365-2664.2007.01403.x; McKinney ML, 2006, BIOL CONSERV, V127, P247, DOI 10.1016/j.biocon.2005.09.005; Meunier FD, 1999, CAN J ZOOL, V77, P108, DOI 10.1139/cjz-77-1-108; Meunier FD, 2000, BIOL CONSERV, V92, P291, DOI 10.1016/S0006-3207(99)00094-4; Millar RB, 2009, BIOMETRICS, V65, P962, DOI 10.1111/j.1541-0420.2008.01162.x; Mineau P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057457; Monadjem A, 2003, AFR ZOOL, V38, P127; Nakarmi B, 2009, ILLINOIS ROADSIDE RI; Newton I, 2004, IBIS, V146, P579, DOI 10.1111/j.1474-919X.2004.00375.x; NOSS RF, 1990, CONSERV BIOL, V4, P355, DOI 10.1111/j.1523-1739.1990.tb00309.x; OXLEY DJ, 1974, J APPL ECOL, V11, P51, DOI 10.2307/2402004; PARISH T, 1994, J APPL ECOL, V31, P764, DOI 10.2307/2404166; Plummer M, 2008, BIOSTATISTICS, V9, P523, DOI 10.1093/biostatistics/kxm049; POWELL GVN, 1986, BIOL CONSERV, V36, P101, DOI 10.1016/0006-3207(86)90001-7; REIJNEN R, 1995, J APPL ECOL, V32, P187, DOI 10.2307/2404428; Reijnen R, 2006, ENVIRONM POLLUT SER, V10, P255, DOI 10.1007/1-4020-4504-2_12; Benayas JMR, 2012, ECOSYSTEMS, V15, P883, DOI 10.1007/s10021-012-9552-0; Rich SM, 1996, J MAMMAL, V77, P985, DOI 10.2307/1382779; Ries L, 2004, ANNU REV ECOL EVOL S, V35, P491, DOI 10.1146/annurev.ecolsys.35.112202.130148; Ries L, 2001, CONSERV BIOL, V15, P401, DOI 10.1046/j.1523-1739.2001.015002401.x; Roach GL, 1985, TRANSPORT RES REC, V1016, P11; ROBEL RI, 1970, J RANGE MANAGE, V23, P295, DOI 10.2307/3896225; Saarinen K, 2005, BIOL CONSERV, V123, P403, DOI 10.1016/j.biocon.2004.12.012; Salek M, 2009, AGR ECOSYST ENVIRON, V134, P8, DOI 10.1016/j.agee.2009.06.018; SAMSON F, 1994, BIOSCIENCE, V44, P418, DOI 10.2307/1312365; Samson FB, 2004, WILDLIFE SOC B, V32, P6, DOI 10.2193/0091-7648(2004)32[6:GPEPPA]2.0.CO;2; SAUNDERS DA, 1991, CONSERV BIOL, V5, P18, DOI 10.1111/j.1523-1739.1991.tb00384.x; Schlaepfer MA, 2002, TRENDS ECOL EVOL, V17, P474, DOI 10.1016/S0169-5347(02)02580-6; Sekercioglu CH, 2006, TRENDS ECOL EVOL, V21, P464, DOI 10.1016/j.tree.2006.05.007; Spiegelhalter DJ, 2002, J R STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353; Sturtz S, 2005, J STAT SOFTW, V12, P1, DOI 10.18637/jss.v012.i03; Temple Stanley A., 2002, Birds of North America, V703, P1; Trombulak SC, 2000, CONSERV BIOL, V14, P18, DOI 10.1046/j.1523-1739.2000.99084.x; Underhill J. E., 2000, Environmental Reviews, V8, P21, DOI 10.1139/er-8-1-21; United States Census Bureau, 2014, AM FACTF PROF GEN PO; United States Department of Agriculture, LAND VAL 2013 SUMM; VANHORNE B, 1983, J WILDLIFE MANAGE, V47, P893; Walther BA, 2001, IBIS, V143, P413, DOI 10.1111/j.1474-919X.2001.tb04942.x; WARNER RE, 1992, WILDLIFE SOC B, V20, P279; WAY J M, 1977, Biological Conservation, V12, P65, DOI 10.1016/0006-3207(77)90058-1; Weaver JE, 1932, BOT GAZ, V93, P0113, DOI 10.1086/334244; Webster W.D., 1982, Mammalian Species, P1; With KA, 2008, BIOL CONSERV, V141, P3152, DOI 10.1016/j.biocon.2008.09.025	98	7	7	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0120375	10.1371/journal.pone.0120375	http://dx.doi.org/10.1371/journal.pone.0120375			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25794180	Green Published, gold, Green Submitted			2022-12-27	WOS:000352083900020
J	Meng, QB; Kang, WM; Yu, JC; Liu, YQ; Ma, ZQ; Zhou, L; Cui, QC; Zhou, WX				Meng, Qing-Bin; Kang, Wei-Ming; Yu, Jian-Chun; Liu, Yu-Qin; Ma, Zhi-Qiang; Zhou, Li; Cui, Quan-Cai; Zhou, Wei-Xun			Overexpression of Eukaryotic Translation Initiation Factor 5A2 (EIF5A2) Correlates with Cell Aggressiveness and Poor Survival in Gastric Cancer	PLOS ONE			English	Article							CARCINOMAS CORRELATION; INDEPENDENT PREDICTOR; C-MYC; PROMOTES; METASTASIS; MTA1; PROGRESSION; EXPRESSION; INVASION; EIF-5A2	Eukaryotic translation initiation factor 5A2 (EIF5A2) plays an important role in tumor progression and prognosis evaluation. However, little information is available about its potential role in gastric cancer. This study aimed to investigate the function of EIF5A2 in tumor progression and its potential mechanisms. EIF5A2 expression was measured in human gastric cancer cell lines, the immortalized gastric mucosal epithelial cell line (GES-1) and human gastric cancer tissues and knocked down by RNA interference or upregulated by EIF5A2 plasmid transfection. Cell proliferation, migration and invasion were assessed in vitro. The downstream targets of EIF5A2 were examined by western blotting. EIF5A2 and its potential target metastasis-associated protein 1 (MTA1) expression were examined in 160 pairs of human gastric cancer and adjacent non-tumor specimens using immunohistochemistry (IHC) staining, and its correlation with clinicopathological features and survival was investigated. Knockdown of EIF5A2 or MTA1 caused an apparent suppression of HGC27 cell proliferation, migration and invasion. After knockdown of EIF5A2 in HGC27 cells, E-cadherin levels were upregulated and vimentin, cyclin D1, cyclin D3, C-MYC and MTA1 levels were downregulated. Upregulation of EIF5A2 in MKN45 cells resulted in the converse. IHC results showed a positive correlation between EIF5A2 and MTA1 expression in gastric cancers (P< 0.001). Both EIF5A2 and MTA1 overexpression were correlated with pT stage (P= 0.018 and P= 0.042), pN stage (P= 0.037 and P= 0.020) and lymphovascular invasion (P= 0.016 and P= 0.044). EIF5A2 or MTA1 overexpression was significantly associated with poor overall survival and disease-free survival (All P< 0.05). Multivariate analyses identified EIF5A2 as an independent predictor for both overall survival (P= 0.012) and disease-free survival (P= 0.008) in gastric cancer patients. Our findings indicate that EIF5A2 upregulation plays an important oncogenic role in gastric cancer. EIF5A2 may represent a new predictor for poor survival and is a potential therapeutic target for gastric cancer.	[Meng, Qing-Bin; Kang, Wei-Ming; Yu, Jian-Chun; Ma, Zhi-Qiang; Zhou, Li] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Gen Surg, Beijing 100730, Peoples R China; [Meng, Qing-Bin; Kang, Wei-Ming; Yu, Jian-Chun; Ma, Zhi-Qiang; Zhou, Li; Cui, Quan-Cai; Zhou, Wei-Xun] Peking Union Med Coll, Beijing 100021, Peoples R China; [Meng, Qing-Bin] First Hosp, Dept Gastrointestinal Surg, Wuhan, Hubei Provence, Peoples R China; [Liu, Yu-Qin] Chinese Acad Med Sci, Inst Basic Med Sci, Cell Ctr, Wuhan, Hubei Provence, Peoples R China; [Cui, Quan-Cai; Zhou, Wei-Xun] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Pathol, Beijing 100730, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital	Yu, JC (corresponding author), Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Gen Surg, Beijing 100730, Peoples R China.	yujch001@163.com	Zhou, Li/GSE-4531-2022	Kang, Weiming/0000-0002-6736-4728	Beijing Municipal Natural Science Foundation [7132209]; Hubei Province health and family planning scientific research project [WJ2015MB137]; Major science and technology projects in Beijing City [D141100000414004]	Beijing Municipal Natural Science Foundation(Beijing Natural Science Foundation); Hubei Province health and family planning scientific research project; Major science and technology projects in Beijing City	This work was supported by grants from the Beijing Municipal Natural Science Foundation (No. 7132209), Hubei Province health and family planning scientific research project (No. WJ2015MB137) and Major science and technology projects in Beijing City (No. D141100000414004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bang YJ, 2012, LANCET, V379, P315, DOI 10.1016/S0140-6736(11)61873-4; Cao DF, 2004, CANCER BIOL THER, V3, P1081, DOI 10.4161/cbt.3.11.1175; CHEN W, 2009, CHIN J CANCER RES, V25, P10, DOI DOI 10.3978/J.ISSN.1000-9604.2012.12.04; Chen W, 2009, CANCER EPIDEM BIOMAR, V18, P400, DOI 10.1158/1055-9965.EPI-08-0754; Deng XM, 2013, WORLD J SURG, V37, P792, DOI 10.1007/s00268-012-1898-0; Guan XY, 2000, CANCER GENET CYTOGEN, V123, P27, DOI 10.1016/S0165-4608(00)00306-X; He LR, 2011, INT J CANCER, V129, P143, DOI 10.1002/ijc.25669; He QJ, 2003, CANCER GENET CYTOGEN, V144, P112, DOI 10.1016/S0165-4608(02)00959-7; Hu N, 2009, CANCER RES, V69, P5908, DOI 10.1158/0008-5472.CAN-08-4622; Hyung WJ, 2002, ANN SURG ONCOL, V9, P562; Japanese Gastric Canc Assoc, 2011, GASTRIC CANCER, V14, P101, DOI 10.1007/s10120-011-0041-5; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jenkins ZA, 2001, GENOMICS, V71, P101, DOI 10.1006/geno.2000.6418; Kawasaki G, 2008, INT J ORAL MAX SURG, V37, P1039, DOI 10.1016/j.ijom.2008.05.020; Khosravi S, 2014, BRIT J CANCER, V110, P399, DOI 10.1038/bjc.2013.688; LAUREN P, 1965, ACTA PATHOL MIC SC, V64, P31, DOI 10.1111/apm.1965.64.1.31; Marchet A, 2007, ANN SURG ONCOL, V14, P1058, DOI 10.1245/s10434-006-9090-0; Schaefer IM, 2011, MED ONCOL, V28, P1023, DOI 10.1007/s12032-010-9604-2; Song YA, 2012, PATHOL INT, V62, P127, DOI 10.1111/j.1440-1827.2011.02765.x; Tang DJ, 2010, HEPATOLOGY, V51, P1255, DOI 10.1002/hep.23451; Toh Y, 1997, INT J CANCER, V74, P459, DOI 10.1002/(SICI)1097-0215(19970822)74:4<459::AID-IJC18>3.3.CO;2-H; Wang FW, 2013, INT J BIOL SCI, V9, P1013, DOI 10.7150/ijbs.7191; Washington K, 2010, ANN SURG ONCOL, V17, P3077, DOI 10.1245/s10434-010-1362-z; Wei Ying-xin, 2013, Zhongguo Yi Xue Ke Xue Yuan Xue Bao, V35, P634, DOI 10.3881/j.issn.1000-503X.2013.06.009; Yang F, 2013, J CANCER RES CLIN, V139, P437, DOI 10.1007/s00432-012-1324-x; Yang GF, 2009, GYNECOL ONCOL, V112, P314, DOI 10.1016/j.ygyno.2008.10.024; Yoo YA, 2011, CANCER RES, V71, P7061, DOI 10.1158/0008-5472.CAN-11-1338; Zender L, 2008, CELL, V135, P852, DOI 10.1016/j.cell.2008.09.061; Zheng LD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055719; Zhu W, 2012, GUT, V61, P562, DOI 10.1136/gutjnl-2011-300207	30	44	47	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0119229	10.1371/journal.pone.0119229	http://dx.doi.org/10.1371/journal.pone.0119229			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25793713	Green Published, Green Submitted, gold			2022-12-27	WOS:000352084200063
J	Miller, DL; Thomas, L				Miller, David L.; Thomas, Len			Mixture Models for Distance Sampling Detection Functions	PLOS ONE			English	Article							CLOSED POPULATION; SPATIAL MODELS; SIZE	We present a new class of models for the detection function in distance sampling surveys of wildlife populations, based on finite mixtures of simple parametric key functions such as the half-normal. The models share many of the features of the widely-used "key function plus series adjustment" (K+A) formulation: they are flexible, produce plausible shapes with a small number of parameters, allow incorporation of covariates in addition to distance and can be fitted using maximum likelihood. One important advantage over the K+A approach is that the mixtures are automatically monotonic non-increasing and non-negative, so constrained optimization is not required to ensure distance sampling assumptions are honoured. We compare the mixture formulation to the K+A approach using simulations to evaluate its applicability in a wide set of challenging situations. We also re-analyze four previously problematic real-world case studies. We find mixtures outperform K+A methods in many cases, particularly spiked line transect data (i.e., where detectability drops rapidly at small distances) and larger sample sizes. We recommend that current standard model selection methods for distance sampling detection functions are extended to include mixture models in the candidate set.	[Miller, David L.] Univ St Andrews, Ctr Res Ecol & Environm Modelling, St Andrews, Fife, Scotland; Univ St Andrews, Sch Math & Stat, St Andrews, Fife, Scotland	University of St Andrews; University of St Andrews	Miller, DL (corresponding author), Univ St Andrews, Ctr Res Ecol & Environm Modelling, St Andrews, Fife, Scotland.	dave@ninepointeightone.net		Thomas, Len/0000-0002-7436-067X; Miller, David/0000-0002-9640-6755	UK Engineering and Physical Sciences Research Council	UK Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	DLM acknowledges the UK Engineering and Physical Sciences Research Council for financial support during his PhD, and Simon Wood for useful discussions. Both authors thank David Borchers, who suggested the parametrisation for the mixture proportions (S1 Appendix) and Tiago Marques for helpful comments on an earlier draft. The authors also wish to thank Rain-coast Conservation Foundation and Rob Williams for allowing the use of perpendicular sightings distance data previously reported in [20]; Daniel Pike, Gisli Vikingsson and Bjarni Mikkelsen at the Marine Research Institute, Iceland for the long-finned pilot whales data; Kerry Borkin for the wood ant data and Steven Fancy for the use of the Amakihi data.	Borchers D, 2010, J AGR BIOL ENVIR ST, V15, P346, DOI 10.1007/s13253-010-0021-y; Borkin KM, 2012, EUR J ENTOMOL, V109, P47, DOI 10.14411/eje.2012.007; Buckland S., 2004, ADV DISTANCE SAMPLIN; Buckland S.T., 2001, pi; BUCKLAND ST, 1992, J R STAT SOC C-APPL, V41, P63, DOI 10.2307/2347618; Dorazio RM, 2003, BIOMETRICS, V59, P351, DOI 10.1111/1541-0420.00042; Eidous O, 2011, COMMUN STAT-THEOR M, V40, P4353, DOI 10.1080/03610926.2010.510253; Giammarino M, 2014, ENVIRONMENTAL AND EC; Hedley SL, 2004, J AGR BIOL ENVIR ST, V9, P181, DOI 10.1198/1085711043578; LAAKE J., 2014, MRDS MARK RECAPTURE; Laake JL, 2011, J AGR BIOL ENVIR ST, V16, P389, DOI 10.1007/s13253-011-0059-5; Laake JL, 2004, ADV DISTANCE SAMPLIN, P48; Link WA, 2003, BIOMETRICS, V59, P1123, DOI 10.1111/j.0006-341X.2003.00129.x; Marques FFC, 2003, BIOMETRICS, V59, P924, DOI 10.1111/j.0006-341X.2003.00107.x; Marques TA, 2007, AUK, V124, P1229, DOI 10.1642/0004-8038(2007)124[1229:IEOBDU]2.0.CO;2; Miller D. A., 2014, DISTANCE SIMPLE WAY; Miller DL, 2013, METHODS ECOL EVOL, V4, P1001, DOI 10.1111/2041-210X.12105; Miller DL, 2011, MMDS MIXTURE MODEL D; Morgan BJT, 2008, J R STAT SOC C-APPL, V57, P433, DOI 10.1111/j.1467-9876.2008.00620.x; OTTO MC, 1990, BIOMETRICS, V46, P239, DOI 10.2307/2531648; Pike DG, 2003, SC11AE10; Pledger S, 2005, BIOMETRICS, V61, P868, DOI 10.1111/j.1541-020X.2005.00411_1.x; R Core Team, 2021, R LANGUAGE ENV STAT; Schittkowski K., 1986, Annals of Operations Research, V5, P485, DOI 10.1007/BF02739235; Thomas L, 2010, J APPL ECOL, V47, P5, DOI 10.1111/j.1365-2664.2009.01737.x; Williams Rob, 2007, Journal of Cetacean Research and Management, V9, P15; Ye Y., 1987, THESIS USA STANFORD	28	4	5	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0118726	10.1371/journal.pone.0118726	http://dx.doi.org/10.1371/journal.pone.0118726			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25793744	Green Published, Green Submitted, gold			2022-12-27	WOS:000352084200036
J	Nazar, FN; Barrios, BE; Kaiser, P; Marin, RH; Correa, SG				Nicolas Nazar, F.; Barrios, Bibiana E.; Kaiser, Pete; Marin, Raul H.; Correa, Silvia G.			Immune Neuroendocrine Phenotypes in Coturnix coturnix: Do Avian Species Show LEWIS/FISCHER-Like Profiles?	PLOS ONE			English	Article							SOCIAL REINSTATEMENT BEHAVIOR; PITUITARY-ADRENAL AXIS; REAL-TIME PCR; JAPANESE-QUAIL; MESSENGER-RNA; ADRENOCORTICAL RESPONSIVENESS; CORTICOSTERONE RESPONSE; TONIC IMMOBILITY; CHRONIC STRESS; LEWIS RATS	Immunoneuroendocrinology studies have identified conserved communicational paths in birds and mammals, e. g. the Hypothalamus-Pituitary-Adrenal axis with anti-inflammatory activity mediated by glucocorticoids. Immune neuroendocrine phenotypes (INPs) have been proposed for mammals implying the categorization of a population in subgroups underlying divergent immune-neuroendocrine interactions. These phenotypes were studied in the context of the LEWIS/FISCHER paradigm (rats expressing high or low pro-inflammatory profiles, respectively). Although avian species have some common immunological mechanisms with mammals, they have also evolved some distinct strategies and, until now, it has not been studied whether birds may also share with mammals similar INPs. Based on corticosterone levels we determined the existence of two divergent groups in Coturnix coturnix that also differed in other immune-neuroendocrine responses. Quail with lowest corticosterone showed higher lymphoproliferative and antibody responses, interferon-gamma and interleukin-1 beta mRNA expression levels and lower frequencies of leukocyte subpopulations distribution and interleukin-13 levels, than their higher corticosterone counterparts. Results suggest the existence of INPs in birds, comparable to mammalian LEWIS/FISCHER profiles, where basal corticosterone also underlies responses of comparable variables associated to the phenotypes. Concluding, INP may not be a mammalian distinct feature, leading to discuss whether these profiles represent a parallel phenomenon evolved in birds and mammals, or a common feature inherited from a reptilian ancestor millions of years ago.	[Nicolas Nazar, F.; Marin, Raul H.] Natl Sci & Tech Res Council CONICET, Biol & Technol Invest Inst IIByT, Cordoba, Argentina; [Nicolas Nazar, F.; Barrios, Bibiana E.; Marin, Raul H.; Correa, Silvia G.] Natl Univ Cordoba, Cordoba, Argentina; [Kaiser, Pete] Univ Edinburgh, Roslin Inst, Easter Bush, Midlothian, Scotland; [Barrios, Bibiana E.; Correa, Silvia G.] Natl Sci & Tech Res Council CONICET, Clin Biochem & Immunol Res Ctr CIBICI, Cordoba, Argentina	Centro Nacional Patagonico (CENPAT); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Cordoba; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; Centro Nacional Patagonico (CENPAT); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Correa, SG (corresponding author), Natl Sci & Tech Res Council CONICET, Clin Biochem & Immunol Res Ctr CIBICI, Cordoba, Argentina.	scorrea@fcq.unc.edu.ar	Nazar, Franco Nicolas/I-5464-2019	Nazar, Franco Nicolas/0000-0002-5282-5931; Marin, Raul/0000-0001-8161-4044	Secretaria de Ciencia y Tecnologia (SECyT) de la Universidad Nacional de Cordoba (UNC); CONICET-FONCyT-PICT ANPCyT [1216 2012]	Secretaria de Ciencia y Tecnologia (SECyT) de la Universidad Nacional de Cordoba (UNC); CONICET-FONCyT-PICT ANPCyT	This work was supported by Secretaria de Ciencia y Tecnologia (SECyT) de la Universidad Nacional de Cordoba (UNC); and Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET-Fondo para la Investigacion Cientifica y Tecnologica (FONCyT)-Proyecto de Investigacion Cientifica y Tecnologica (PICT) 1216 2012 de la Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alheim K, 1997, P NATL ACAD SCI USA, V94, P2681, DOI 10.1073/pnas.94.6.2681; BAUMGARTNER J, 1994, WORLD POULTRY SCI J, V50, P227; Bilcik B, 1999, BRIT POULTRY SCI, V40, P444, DOI 10.1080/00071669987188; Butts CL, 2008, CELL IMMUNOL, V252, P7, DOI 10.1016/j.cellimm.2007.09.009; Carmichael NL, 1998, APPL ANIM BEHAV SCI, V58, P353, DOI 10.1016/S0168-1591(97)00151-2; Cockrem JF, 2005, HORM BEHAV, V48, P492, DOI 10.1016/j.yhbeh.2005.03.008; Correa SG, 2007, CYTOKINE GROWTH F R, V18, P125, DOI 10.1016/j.cytogfr.2007.01.011; Davison F, 2011, AVIAN IMMUNOLOGY; Dhabhar Firdaus S, 2008, Allergy Asthma Clin Immunol, V4, P2, DOI 10.1186/1710-1492-4-1-2; Dhabhar FS, 2009, NEUROIMMUNOMODULAT, V16, P300, DOI 10.1159/000216188; Dhabhar FS, 1996, J IMMUNOL, V157, P1638; Dhabhar FS, 1997, BRAIN BEHAV IMMUN, V11, P286, DOI 10.1006/brbi.1997.0508; Di Rienzo J., 2013, INFOSTAT VERSION 201; Downing JEG, 2000, IMMUNOL TODAY, V21, P281, DOI 10.1016/S0167-5699(00)01635-2; Elenkov IJ, 2000, PHARMACOL REV, V52, P595; Elenkov IJ, 2008, J IMMUNOL, V181, P1737, DOI 10.4049/jimmunol.181.3.1737; Francois N, 2000, BEHAV PROCESS, V48, P171, DOI 10.1016/S0376-6357(99)00081-9; Hazard D, 2008, GEN COMP ENDOCR, V155, P288, DOI 10.1016/j.ygcen.2007.05.009; Heijnen CJ, 2007, BRAIN BEHAV IMMUN, V21, P1, DOI 10.1016/j.bbi.2006.08.008; Huss D, 2008, LAB ANIMAL, V37, P513, DOI 10.1038/laban1108-513; Jafarian-Tehrani M, 2000, ANN NY ACAD SCI, V917, P819; Jones RB, 1996, WORLD POULTRY SCI J, V52, P131, DOI 10.1079/WPS19960013; Kaiser P, 2009, GEN COMP ENDOCR, V163, P83, DOI 10.1016/j.ygcen.2008.09.013; Kuenzel WJ, 2010, POULTRY SCI, V89, P832, DOI 10.3382/ps.2009-00376; Labaque MC, 2008, BRIT POULTRY SCI, V49, P409, DOI 10.1080/00071660802262050; Laurence A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047475; Lay DC, 2011, POULTRY SCI, V90, P278, DOI 10.3382/ps.2010-00962; Marin RH, 2002, POULTRY SCI, V81, P261, DOI 10.1093/ps/81.2.261; Martin LB, 2005, GEN COMP ENDOCR, V140, P126, DOI 10.1016/j.ygcen.2004.10.010; MILLS AD, 1991, J COMP PSYCHOL, V105, P25, DOI 10.1037/0735-7036.105.1.25; Monfort SL, 2002, REPROD SCI INTEGRATE, DOI [10.1017/CBO9780511615016, DOI 10.1017/CBO9780511615016]; Nazar FN, 2011, STRESS, V14, P166, DOI 10.3109/10253890.2010.523093; Nilsson PB, 2008, COMP BIOCHEM PHYS A, V149, P275, DOI 10.1016/j.cbpa.2008.01.002; Puvadolpirod S, 2000, POULTRY SCI, V79, P363, DOI 10.1093/ps/79.3.363; Raisman G, 1997, ANNU REV NEUROSCI, V20, P533, DOI 10.1146/annurev.neuro.20.1.533; REESE EP, 1962, J EXP ANAL BEHAV, V5, P265, DOI 10.1901/jeab.1962.5-265; Roberts ML, 2009, J EXP BIOL, V212, P3125, DOI 10.1242/jeb.030726; Romero LM, 2005, COMP BIOCHEM PHYS A, V140, P73, DOI 10.1016/j.cbpb.2004.11.004; Rubolini D, 2005, HORM BEHAV, V47, P592, DOI 10.1016/j.yhbeh.2005.01.006; Satterlee DG, 2004, POULTRY SCI, V83, P1003, DOI 10.1093/ps/83.6.1003; Satterlee DG, 2002, POULTRY SCI, V81, P1071, DOI 10.1093/ps/81.7.1071; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Sever J, 1962, J IMMUNOL; Shini S, 2009, Stress, V12, P388, DOI 10.1080/10253890802526894; Shini S, 2010, POULTRY SCI, V89, P841, DOI 10.3382/ps.2009-00483; Shini S, 2010, STRESS, V13, P185, DOI 10.3109/10253890903144639; Smits JEG, 2005, DEV COMP IMMUNOL, V29, P161, DOI 10.1016/j.dci.2004.06.007; STADECKER MJ, 1977, J IMMUNOL, V118, P1564; Sternberg EM, 2001, J ENDOCRINOL, V169, P429, DOI 10.1677/joe.0.1690429; STERNBERG EM, 1989, P NATL ACAD SCI USA, V86, P2374, DOI 10.1073/pnas.86.7.2374; STERNBERG EM, 1989, P NATL ACAD SCI USA, V86, P4771, DOI 10.1073/pnas.86.12.4771; Tella JL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003295; Thomas DG, 2004, NEW ZEAL VET J, V52, P76, DOI 10.1080/00480169.2004.36408; Turnbull AV, 1999, PHYSIOL REV, V79, P1, DOI 10.1152/physrev.1999.79.1.1; Uchiyama R, 2005, J VET MED SCI, V67, P441, DOI 10.1292/jvms.67.441; Uno Y, 2012, POULTRY SCI, V91, P2496, DOI 10.3382/ps.2012-02283; Washburn BE, 2002, CONDOR, V104, P558, DOI 10.1650/0010-5422(2002)104[0558:UACART]2.0.CO;2; Wei RT, 2003, J NEUROIMMUNOL, V135, P10, DOI 10.1016/S0165-5728(02)00429-0; Zalcman SS, 2006, BRAIN BEHAV IMMUN, V20, P507, DOI 10.1016/j.bbi.2006.05.002	59	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0120712	10.1371/journal.pone.0120712	http://dx.doi.org/10.1371/journal.pone.0120712			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25793369	Green Published, gold, Green Submitted			2022-12-27	WOS:000352083900067
J	Smejkal, M; Ricard, D; Prchalova, M; Riha, M; Muska, M; Blabolil, P; Cech, M; Vasek, M; Juza, T; Herreras, AM; Encina, L; Peterka, J; Kubecka, J				Smejkal, Marek; Ricard, Daniel; Prchalova, Marie; Riha, Milan; Muska, Milan; Blabolil, Petr; Cech, Martin; Vasek, Mojmir; Juza, Tomas; Herreras, Agustin Monteoliva; Encina, Lourdes; Peterka, Jiri; Kubecka, Jan			Biomass and Abundance Biases in European Standard Gillnet Sampling	PLOS ONE			English	Article							LAKE FISH ASSEMBLAGES; SIZE-SELECTIVITY; WATER; CATCHABILITY; TRAWL; COMMUNITIES; POPULATIONS; GRADIENTS; DENSITY; CATCHES	The European Standard EN 14757 recommends gillnet mesh sizes that range from 5 to 55mm (knot-to-knot) for the standard monitoring of fish assemblages and suggests adding gillnets with larger mesh sizes if necessary. Our research showed that the recommended range of mesh sizes did not provide a representative picture of fish sizes for larger species that commonly occur in continental Europe. We developed a novel, large mesh gillnet which consists of mesh sizes 70, 90, 110 and 135mm (knot to knot, 10m panels) and assessed its added value for monitoring purposes. From selectivity curves obtained by sampling with single mesh size gillnets (11 mesh sizes 6 - 55mm) and large mesh gillnets, we identified the threshold length of bream (Abramis brama) above which this widespread large species was underestimated by European standard gillnet catches. We tested the European Standard gillnet by comparing its size composition with that obtained during concurrent pelagic trawling and purse seining in a cyprinid-dominated reservoir and found that the European Standard underestimated fish larger than 292mm by 26 times. The inclusion of large mesh gillnets in the sampling design removed this underestimation. We analysed the length-age relationship of bream in the Rimov Reservoir, and concluded that catches of bream larger than 292mm and older than five years were seriously underrepresented in European Standard gillnet catches. The Rimov Reservoir is a typical cyprinid-dominated water body where the biomass of bream > 292mm formed 70% of the pelagic trawl and purse seine catch. The species-specific relationships between the large mesh gillnet catch and European Standard catch suggested that the presence of carp (Cyprinus carpio), European catfish (Silurus glanis), tench (Tinca tinca) or bream warrants the use of both gillnet types. We suggest extending the gillnet series in the European Standard to avoid misinterpretation of fish community biomass estimates.	[Smejkal, Marek; Ricard, Daniel; Prchalova, Marie; Riha, Milan; Muska, Milan; Blabolil, Petr; Cech, Martin; Vasek, Mojmir; Juza, Tomas; Peterka, Jiri; Kubecka, Jan] Acad Sci Czech Republ, Inst Hydrobiol, Ctr Biol, Vvi, Ceske Budejovice, Czech Republic; [Smejkal, Marek; Blabolil, Petr] Univ South Bohemia, Fac Sci, Ceske Budejovice, Czech Republic; [Herreras, Agustin Monteoliva] Ecohydros SL, Poligono Ind Cros, Maliano, Cantabria, Spain; [Encina, Lourdes] Univ Seville, Fac Biol, Dept Plant Biol & Ecol, Seville, Spain	Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences; University of South Bohemia Ceske Budejovice; University of Sevilla	Kubecka, J (corresponding author), Acad Sci Czech Republ, Inst Hydrobiol, Ctr Biol, Vvi, Ceske Budejovice, Czech Republic.	kubecka@hbu.cas.cz	Peterka, Jiří/C-7218-2014; Ricard, Daniel/G-1814-2014; Vasek, Mojmir/C-5839-2014; Čech, Martin/C-5797-2014; Prchalová, Marie/F-8664-2014; Blabolil, Petr/K-9548-2015; Riha, Milan/AAF-9819-2019; Blabolil, Petr/N-8719-2019; Riha, Milan/G-1065-2014; Juza, Tomas/G-3159-2014; Šmejkal, Marek/E-1269-2017; Muska, Milan/AAC-8744-2019; Muska, Milan/A-7978-2014; Kubecka, Jan/A-8230-2011	Vasek, Mojmir/0000-0001-6386-4015; Čech, Martin/0000-0003-1350-4286; Prchalová, Marie/0000-0001-5000-2918; Blabolil, Petr/0000-0003-1344-9627; Riha, Milan/0000-0002-3930-420X; Šmejkal, Marek/0000-0002-7887-6411; Muska, Milan/0000-0001-6659-986X; Kubecka, Jan/0000-0001-9203-4854	Ecohydros S.L.	Ecohydros S.L.	Ecohydros S.L. provided support in the form of salaries for authors [AMH], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Achleitner D, 2012, FISHERIES MANAG ECOL, V19, P352, DOI 10.1111/j.1365-2400.2012.00851.x; [Anonymous], 2014, R LANG ENV STAT COMP; Appelberg M, 1995, WATER AIR SOIL POLL, V85, P401, DOI 10.1007/BF00476862; Argillier C, 2013, HYDROBIOLOGIA, V704, P193, DOI 10.1007/s10750-012-1282-y; Baum JK, 2009, J ANIM ECOL, V78, P699, DOI 10.1111/j.1365-2656.2009.01531.x; Begon M, 2009, ECOLOGY INDIVIDUALS, P89; Bonar SA, 2009, STANDARD METHODS FOR SAMPLING NORTH AMERICAN FRESHWATER FISHES, P1; Brucet S, 2013, FRESHWATER BIOL, V58, P1779, DOI 10.1111/fwb.12167; Bunn SE, 2002, ENVIRON MANAGE, V30, P492, DOI 10.1007/s00267-002-2737-0; Carol J, 2007, J APPL ICHTHYOL, V23, P654, DOI 10.1111/j.1439-0426.2007.00871.x; CEN, 2005, 147572013 CEN PREN; D & L Software Pty Ltd Australia, 2011, DES NEWM OZIEXPLORER; Emmrich M, 2014, J BIOGEOGR, V41, P2221, DOI 10.1111/jbi.12366; Emmrich M, 2011, FRESHWATER BIOL, V56, P2316, DOI 10.1111/j.1365-2427.2011.02658.x; EU, 2000, OFFICIAL J L, V327, P1; Finstad AG, 2000, CAN J FISH AQUAT SCI, V57, P1718, DOI 10.1139/cjfas-57-8-1718; Garcia XF, 2006, J FISH BIOL, V68, P1144, DOI 10.1111/j.0022-1112.2006.01009.x; Gassner H, 2005, INT REV HYDROBIOL, V90, P422, DOI 10.1002/iroh.200510798; GODO OR, 1990, FISH RES, V9, P165, DOI 10.1016/0165-7836(90)90062-Z; HAMLEY JM, 1975, J FISH RES BOARD CAN, V32, P1943, DOI 10.1139/f75-233; Hansen Michael J., 1998, North American Journal of Fisheries Management, V18, P847, DOI 10.1577/1548-8675(1998)018<0847:GNSBLT>2.0.CO;2; HANSSON S, 1995, CAN J FISH AQUAT SCI, V52, P75, DOI 10.1139/f95-007; Hjellvik V, 2002, CAN J FISH AQUAT SCI, V59, P33, DOI 10.1139/F01-193; Holmgren K, 2000, J FISH BIOL, V57, P1312, DOI 10.1006/jfbi.2000.1395; Garcia-Asorey MI, 2011, CAN J FISH AQUAT SCI, V68, P1892, DOI 10.1139/F2011-108; JENSEN JW, 1986, J FISH BIOL, V28, P637, DOI 10.1111/j.1095-8649.1986.tb05198.x; Jurvelius J, 2011, HYDROBIOLOGIA, V660, P29, DOI 10.1007/s10750-010-0385-6; Kottelat M., 2007, HDB EUROPEAN FRESHWA, P646; Kurkilahti M, 2002, FISH RES, V54, P153, DOI 10.1016/S0165-7836(00)00301-5; Kurkilahti M, 1996, FISH RES, V27, P243, DOI 10.1016/0165-7836(95)00463-7; LAMMENS EHRR, 1992, ENVIRON BIOL FISH, V33, P195, DOI 10.1007/BF00002564; Maury O, 2013, J THEOR BIOL, V324, P52, DOI 10.1016/j.jtbi.2013.01.018; Mehner T, 2007, FRESHWATER BIOL, V52, P2285, DOI 10.1111/j.1365-2427.2007.01836.x; Mehner T, 2010, LIMNOL OCEANOGR, V55, P203, DOI 10.4319/lo.2010.55.1.0203; Muska M, 2013, HYDROBIOLOGIA, V707, P17, DOI 10.1007/s10750-012-1401-9; Olin M, 2003, HYDROBIOLOGIA, V506, P443, DOI 10.1023/B:HYDR.0000008545.33035.c4; Olin M, 2004, FISH RES, V68, P135, DOI 10.1016/j.fishres.2004.01.005; Olin M, 2009, FISH RES, V96, P88, DOI 10.1016/j.fishres.2008.09.007; Pope KL, 2005, FISH RES, V76, P117, DOI 10.1016/j.fishres.2005.05.013; Prchalova M, 2011, FISH RES, V107, P201, DOI 10.1016/j.fishres.2010.10.021; Prchalova M, 2010, FISH RES, V102, P291, DOI 10.1016/j.fishres.2009.12.011; Prchalova M, 2009, FISH RES, V96, P51, DOI 10.1016/j.fishres.2008.09.017; Psuty I, 1997, FISH RES, V32, P249, DOI 10.1016/S0165-7836(97)00056-8; Reis EG, 1999, FISH RES, V39, P263, DOI 10.1016/S0165-7836(98)00199-4; Riha M, 2009, FISHERIES MANAG ECOL, V16, P121, DOI 10.1111/j.1365-2400.2008.00650.x; Riha M, 2012, FISH RES, V127, P56, DOI 10.1016/j.fishres.2012.04.012; RUDSTAM LG, 1984, CAN J FISH AQUAT SCI, V41, P1252, DOI 10.1139/f84-151; Sondergaard M, 2005, J APPL ECOL, V42, P616, DOI 10.1111/j.1365-2664.2005.01040.x; Turunen T, 1998, ERGEB LIMNOL, V50, P429; Vasek M, 2004, INT REV HYDROBIOL, V89, P352, DOI 10.1002/iroh.200410734; Vasek M, 2013, ECOL ENG, V52, P104, DOI 10.1016/j.ecoleng.2012.12.100	51	33	35	2	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0122437	10.1371/journal.pone.0122437	http://dx.doi.org/10.1371/journal.pone.0122437			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25793776	Green Published, Green Submitted, gold			2022-12-27	WOS:000352083900179
J	Wang, F; Yang, T; Burlyaeva, M; Li, L; Jiang, JY; Fang, L; Redden, R; Zong, XX				Wang, Fang; Yang, Tao; Burlyaeva, Marina; Li, Ling; Jiang, Junye; Fang, Li; Redden, Robert; Zong, Xuxiao			Genetic Diversity of Grasspea and Its Relative Species Revealed by SSR Markers	PLOS ONE			English	Article							LATHYRUS-SATIVUS L.; INFERENCE; NUMBER; WILD; EST	The study of genetic diversity between Lathyrus sativus L. and its relative species may yield fundamental insights into evolutionary history and provide options to meet the challenge of climate changes. 30 SSR loci were employed to assess the genetic diversity and population structure of 283 individuals from wild and domesticated populations from Africa, Europe, Asia and ICARDA. The allele number per loci ranged from 3 to 14. The average gene diversity index and average polymorphism information content (PIC) was 0.5340 and 0.4817, respectively. A model based population structure analysis divided the germplasm resources into three subgroups: the relative species, the grasspea from Asia, and the grasspea from Europe and Africa. The UPGMA dendrogram and PCA cluster also demonstrated that Asian group was convincingly separated from the other group. The AMOVA result showed that the cultivated species was quite distinct from its relative species, however a low level of differentiation was revealed among their geographic origins. In all, these results provided a molecular basis for understanding genetic diversity of L. sativus and its relatives.	[Wang, Fang; Yang, Tao; Jiang, Junye; Fang, Li; Zong, Xuxiao] Chinese Acad Agr Sci, Natl Key Facil Crop Gene Resources & Genet Improv, Inst Crop Sci, Beijing 100081, Peoples R China; [Burlyaeva, Marina] NI Vavilov Res Inst Plant Ind, Dept Leguminous Crops Genet Resources, St Petersburg 190000, Russia; [Li, Ling] Liaoning Acad Agr Sci, Inst Cash Crops, Liaoyang 111000, Peoples R China; [Redden, Robert] Australian Temperate Field Crops Collect, Dept Primary Ind, Horsham, Vic 3401, Australia	Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS; Vavilov All-Russian Institute of Plant Genetic Resources	Redden, R (corresponding author), Australian Temperate Field Crops Collect, Dept Primary Ind, Horsham, Vic 3401, Australia.	bob.redden@depi.vic.gov.au; zongxuxiao@caas.cn	Burlyaeva, Marina Olegovna/I-1283-2017	Burlyaeva, Marina Olegovna/0000-0002-3708-2594	Agricultural Science and Technology Innovation Program (ASTIP) in CAAS; Ministry of Agriculture of China [2014NWB030-09, CARS-09]; National Infrastructure for Crop Germplasm Resources project from the Ministry of Science and Technology of China [2005DKA21001-006]; National Key Technology R&D Program of China from the Ministry of Science and Technology of China [2013BAD01B05-2]	Agricultural Science and Technology Innovation Program (ASTIP) in CAAS; Ministry of Agriculture of China(Ministry of Agriculture & Rural Affairs); National Infrastructure for Crop Germplasm Resources project from the Ministry of Science and Technology of China; National Key Technology R&D Program of China from the Ministry of Science and Technology of China	This study was funded by the Agricultural Science and Technology Innovation Program (ASTIP) in CAAS, grants from the Ministry of Agriculture of China (2014NWB030-09, CARS-09), National Infrastructure for Crop Germplasm Resources project from the Ministry of Science and Technology of China (2005DKA21001-006), supported by the National Key Technology R&D Program of China from the Ministry of Science and Technology of China (2013BAD01B05-2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allkin R, 1986, NAMES SYNONYMS SPECI, V7, P1; [Anonymous], 2001, LATHYRUS LATHYRISM N; Asmussen CB, 1998, AM J BOT, V85, P387, DOI 10.2307/2446332; Barik DP, 2007, Z NATURFORSCH C, V62, P869; Belaid Y, 2006, GENET RESOUR CROP EV, V53, P1413, DOI 10.1007/s10722-005-5680-0; Blair MW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049488; Ceccarelli M, 2010, CYTOGENET GENOME RES, V128, P237, DOI 10.1159/000298852; Chabane K, 2005, GENET RESOUR CROP EV, V52, P903, DOI 10.1007/s10722-003-6112-7; Croft AM, 1999, EUPHYTICA, V107, P167, DOI 10.1023/A:1003520721375; Dellaporta SL, 1983, PLANT MOL BIOL REP, V1, P19, DOI DOI 10.1007/BF02712670; Doyle JJ, 1987, PHYTOCHEM B, V19, P11, DOI 10.1016/j.bse.2009.07.003; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Falush D, 2003, GENETICS, V164, P1567; Gupta PK, 2003, MOL GENET GENOMICS, V270, P315, DOI 10.1007/s00438-003-0921-4; Hijmans RJ, 2001, PLANT GENETIC RESOUR, P15, DOI DOI 10.1007/s10344-011-0563-5; Hopf M., 1986, ARCHAEOLOGICAL EVIDE, P35; JACKSON MT, 1984, EUPHYTICA, V33, P549, DOI 10.1007/BF00021156; Kumar S, 2011, FOOD CHEM TOXICOL, V49, P589, DOI 10.1016/j.fct.2010.06.051; KUPICHA F K, 1983, Notes from the Royal Botanic Garden Edinburgh, V41, P209; Lioi L, 2011, GENET RESOUR CROP EV, V58, P425, DOI 10.1007/s10722-010-9589-x; Liu KJ, 2005, BIOINFORMATICS, V21, P2128, DOI 10.1093/bioinformatics/bti282; NEI M, 1978, GENETICS, V89, P583; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Pritchard JK, 2000, GENETICS, V155, P945; Rohlf F, 2006, NTSYSPC NUMERICAL TA; Shehadeh A, 2013, GENET RESOUR CROP EV, V60, P2101, DOI 10.1007/s10722-013-9977-0; Shiferaw E, 2012, MOL BREEDING, V30, P789, DOI 10.1007/s11032-011-9662-y; Singh M., 2013, GRASS PEA, P269; Sthapit B., 2010, INDIAN J PLANT GENET, V23, P145; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tavoletti S, 2007, PLANT BREEDING, V126, P607, DOI 10.1111/j.1439-0523.2007.01407.x; Vavilov, 1951, CHRON BOT, V13, P13; Weir BS, 1996, SINAUER ASS SUNDERL; Yang T, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-65; Yeh Francis C., 1997, Belgian Journal of Botany, V129, P157; Zalkind FL., 1937, GRASS PEA, P171; Zhang XY, 2008, THEOR APPL GENET, V117, P629, DOI 10.1007/s00122-008-0807-2	37	23	27	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0118542	10.1371/journal.pone.0118542	http://dx.doi.org/10.1371/journal.pone.0118542			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25793712	Green Published, gold, Green Submitted			2022-12-27	WOS:000352084200027
J	Wu, Z; Wang, L; Guo, ZG; Wang, K; Zhang, Y; Tian, KB; Zhang, JT; Sun, W; Yu, CJ				Wu, Zhen; Wang, Liang; Guo, Zhengguang; Wang, Ke; Zhang, Yang; Tian, Kaibing; Zhang, Junting; Sun, Wei; Yu, Chunjiang			Experimental Study on Differences in Clivus Chordoma Bone Invasion: An iTRAQ-Based Quantitative Proteomic Analysis	PLOS ONE			English	Article							SKULL BASE; EXPRESSION; PTEN	Although a bone tumor, significant differences in the extent of bone invasion exist in skull base chordoma, which directly affect the extent of surgical resection, and have an impact on its prognosis. However, the underlying mechanism of the phenomenon is not clearly understood. Therefore, we used an iTRAQ-based quantitative proteomics strategy to identify potential molecular signatures, and to find predictive markers of discrepancy in bone invasion of clivus chordoma. According to bone invasive classification criteria, 35 specimens of clivus chordoma were calssified to be either endophytic type (Type I) or exophytic type (Type II). An initial screening of six specimens of endophytic type and six of exophytic was performed, and 250 differentially expressed proteins were identified. Through the GO and IPA analysis, we found evidence that the expression of inflammatory activity-associated proteins up-regulated in endophytic type, whereas the expression of cell motility-associated proteins up-regulated in exophytic ones. Moreover, TGF beta 1 and mTOR signal pathway seemed to be related with bone invasion. Thus, TGF beta 1, PI3K, Akt, mTOR, and PTEN were validated in the following 23 samples by immune histochemistry and Western blot. The expression levels of TGF beta 1 and PTEN were significantly lower in the endophytic type than in the exophytic ones. It was found that TGF beta 1 may play an important role in its bone invasion. The mechanisms may be related with conducting an increased inflammatory cell response and a decline in cytoskeletal protein expression. PTEN is confirmed to be associated with the degree of bone invasion. The PI3K/AKT/mTOR signaling pathway might be associated with the bone invasion, but still needs a larger sample size to be verified These results, for the first time, not only demonstrate the biological changes that occur in different growth patterns from the perspective of proteomics, but also provide novel markers that may help to reveal the mechanisms behind clivus chordomas.	[Wu, Zhen; Wang, Liang; Wang, Ke; Zhang, Yang; Tian, Kaibing; Zhang, Junting] Capital Med Univ, Beijing Tiantan Hosp, Dept Neurosurg, China Natl Clin Res Ctr Neurol Dis, Beijing, Peoples R China; [Guo, Zhengguang; Sun, Wei] Chinese Acad Med Sci, Sch Basic Med, Core Facil Instruments, Inst Basic Med Sci,Peking Union Med Coll, Beijing 100730, Peoples R China; [Yu, Chunjiang] Capital Med Univ, Beijing Sanbo Brain Hosp, Dept Neurosurg, Beijing, Peoples R China	Capital Medical University; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Capital Medical University	Yu, CJ (corresponding author), Capital Med Univ, Beijing Sanbo Brain Hosp, Dept Neurosurg, Beijing, Peoples R China.	sunwei1018@hotmail.com; ttyyliguilin@126.com			National Nature Science Foundation of China [81101910]; Natural Science Foundation of Beijing [7122062]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Beijing(Beijing Natural Science Foundation)	This study was supported by the National Nature Science Foundation of China (No. 81101910) and the Natural Science Foundation of Beijing (No. 7122062). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bydon M, 2012, EXPERT OPIN THER TAR, V16, P1139, DOI 10.1517/14728222.2012.714772; Chen KW, 2014, MED ONCOL, V31, DOI 10.1007/s12032-014-0886-7; Hopkins BD, 2014, TRENDS BIOCHEM SCI, V39, P183, DOI 10.1016/j.tibs.2014.02.006; Kim S, 2008, CELLULAR SIGNALING, V20, P1212; Kitamura Y, 2013, J NEUROPATH EXP NEUR, V72, P816, DOI 10.1097/NEN.0b013e3182a065d0; Letterio JJ, 1998, ANNU REV IMMUNOL, V16, P137, DOI 10.1146/annurev.immunol.16.1.137; McMaster ML, 2001, CANCER CAUSE CONTROL, V12, P1, DOI 10.1023/A:1008947301735; Naka T, 2008, HUM PATHOL, V39, P217, DOI 10.1016/j.humpath.2007.06.005; Presneau N, 2009, BRIT J CANCER, V100, P1406, DOI 10.1038/sj.bjc.6605019; Samii A, 2007, J NEUROSURG, V107, P319, DOI 10.3171/JNS-07/08/0319; Song K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061896; Sun W, 2006, MOL CELL PROTEOMICS, V5, P769, DOI 10.1074/mcp.T500022-MCP200; Thodou E, 2000, J NEUROSURG, V92, P976, DOI 10.3171/jns.2000.92.6.0976; Triana A, 2005, AM J SURG PATHOL, V29, P1422, DOI 10.1097/01.pas.0000180447.25141.a4; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/NMETH.1322, 10.1038/nmeth.1322]; Wu Z, 2010, NEUROSURG REV, V33, P451, DOI 10.1007/s10143-010-0273-6; Zhao P, 2012, J BIOL CHEM, V287, P25230, DOI 10.1074/jbc.M112.339465; Zhou H, 2010, J SURG ONCOL, V102, P720, DOI 10.1002/jso.21674	18	15	16	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0119523	10.1371/journal.pone.0119523	http://dx.doi.org/10.1371/journal.pone.0119523			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25793716	Green Published, gold, Green Submitted			2022-12-27	WOS:000352084200090
J	Zhang, L; Narayanan, K; Chugh, H; Shiota, T; Zheng, ZJ; Chugh, SS				Zhang, Lin; Narayanan, Kumar; Chugh, Harpriya; Shiota, Takahiro; Zheng, Zhi-Jie; Chugh, Sumeet S.			Factors Influencing Utilization of the Primary Prevention Implantable Defibrillator	PLOS ONE			English	Article							SUDDEN CARDIAC DEATH; CARDIOVERTER-DEFIBRILLATORS; HEART-FAILURE; PROPHYLACTIC IMPLANTATION; EJECTION FRACTION; NATIONAL-SURVEY; UNITED-STATES; GUIDELINES; THERAPY; SEX	Background A growing literature suggests underutilization of the primary prevention implantable cardioverter-defibrillator (ICD); thus, factors influencing utilization need to be understood. We performed a comprehensive assessment of patient characteristics and health insurance status among subjects eligible for primary prevention ICD in a tertiary care center. Methods From among a group of patients who met criteria for primary prevention ICD based on left ventricular dysfunction (LVEF <= 35%), ICD recipients (n = 110) were compared to ICD non-recipients (n = 110) to identify determinants of ICD implantation. We evaluated demographics, clinical profile including Charlson Comorbidity Index [CCI, categorized as low (<= 3) or high (> 3)] and health insurance status. Results ICD recipients were younger (62.1+/-15.0 vs. 68.0+/-18.2; P = 0.01), with more males (80% vs. 65.5%; P = 0.01), higher NYHA class (II/III: 75.5% vs. 40.2%; P< 0.001) and more likely to have supplemental private health insurance (61.8% vs. 46.4%; P = 0.02). CCI was not significantly different between the two groups (low CCI 61.8% vs. 62.7%; P = 0.89). In multivariable analysis, factors independently associated with ICD implantation were male sex (OR, 2.77, [1.31-5.85]; P = 0.01), age< 75 (OR, 2.68, [1.30-5.50]; P = 0.01), private insurance (OR, 2.17, [1.08-4.36], P = 0.03) and NYHA Class II/III (OR, 5.91, [2.91-12.01]; P< 0.001). Documentation of discussion about primary prevention ICD was absent in the majority (57.2%) of non-recipients. Conclusion In a contemporary urban tertiary care setting, age, sex and heart failure symptom class were associated with ICD utilization, with socioeconomic/insurance status also potentially playing a role. These findings have implications for optimizing appropriate utilization of the prophylactic ICD and warrant follow-up in larger, more diverse populations.	[Zhang, Lin; Zheng, Zhi-Jie] Shanghai Jiao Tong Univ, Sch Publ Hlth, Shanghai 200030, Peoples R China; [Narayanan, Kumar; Chugh, Harpriya; Shiota, Takahiro; Chugh, Sumeet S.] Cedars Sinai Med Ctr, Inst Heart, Los Angeles, CA 90048 USA	Shanghai Jiao Tong University; Cedars Sinai Medical Center	Chugh, SS (corresponding author), Cedars Sinai Med Ctr, Inst Heart, Los Angeles, CA 90048 USA.	sumeet.chugh@cshs.org						Al-Khatib SM, 2012, CIRCULATION, V125, P1094, DOI 10.1161/CIRCULATIONAHA.111.066605; Al-Khatib SM, 2011, JAMA-J AM MED ASSOC, V305, P43, DOI 10.1001/jama.2010.1915; Bardy GH, 2005, NEW ENGL J MED, V352, P225, DOI 10.1056/NEJMoa043399; Bradfield J, 2009, PACE, V32, pS194, DOI 10.1111/j.1540-8159.2008.02281.x; Castellanos JM, 2012, HEART RHYTHM, V9, P874, DOI 10.1016/j.hrthm.2012.01.029; Chae Sanders H, 2010, Congest Heart Fail, V16, P141, DOI 10.1111/j.1751-7133.2009.00139.x; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Curtis LH, 2007, JAMA-J AM MED ASSOC, V298, P1517, DOI 10.1001/jama.298.13.1517; Daugherty SL, 2009, AM HEART J, V158, P224, DOI 10.1016/j.ahj.2009.05.018; Epstein Andrew E, 2008, J Am Coll Cardiol, V51, pe1, DOI 10.1016/j.hrthm.2008.04.014; Gupta A, 2014, CIRC-HEART FAIL, V7, P140, DOI 10.1161/CIRCHEARTFAILURE.113.000753; Hammill SC, 2010, HEART RHYTHM, V7, P1340, DOI 10.1016/j.hrthm.2010.07.015; Hernandez AF, 2007, JAMA-J AM MED ASSOC, V298, P1525, DOI 10.1001/jama.298.13.1525; Hoang A, 2014, HEART RHYTHM, V11, P849, DOI 10.1016/j.hrthm.2014.02.019; Hubinette C, 2014, EUROPACE, V16, P1580, DOI 10.1093/europace/eut416; Kim J, 2012, HEALTH SOC CARE COMM, V20, P42, DOI 10.1111/j.1365-2524.2011.01012.x; LaPointe NMA, 2011, CIRC-CARDIOVASC QUAL, V4, P146, DOI [10.1161/CIRCOUTCOMES.111.958603, 10.1161/CIRCOUTCOMES.110.958603]; McHale B, 2009, EUROPACE, V11, P1313, DOI 10.1093/europace/eup236; Mezu U, 2012, EUROPACE, V14, P341, DOI 10.1093/europace/eur360; Moss AJ, 2004, CIRCULATION, V110, P3760, DOI 10.1161/01.CIR.0000150390.04704.B7; Moss AJ, 2002, NEW ENGL J MED, V346, P877, DOI 10.1056/NEJMoa013474; Myerburg RJ, 2012, CIRCULATION, V125, P1043, DOI 10.1161/CIRCULATIONAHA.111.023846; Narayanan K, 2013, CIRCULATION, V128, P1733, DOI 10.1161/CIRCULATIONAHA.113.002539; Nichol G, 2008, JAMA-J AM MED ASSOC, V300, P1423, DOI 10.1001/jama.300.12.1423; Saba S, 2009, PACE, V32, P1444, DOI 10.1111/j.1540-8159.2009.02509.x; Shah B, 2009, J AM COLL CARDIOL, V53, P416, DOI 10.1016/j.jacc.2008.09.045; Tracy CM, 2012, J AM COLL CARDIOL, V60, P1297, DOI 10.1016/j.jacc.2012.07.009; Udell JA, 2007, INT J TECHNOL ASSESS, V23, P354, DOI 10.1017/S0266462307070389	28	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0121515	10.1371/journal.pone.0121515	http://dx.doi.org/10.1371/journal.pone.0121515			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25794248	Green Submitted, Green Published, gold			2022-12-27	WOS:000352083900137
J	Amaral, FE; Parker, D; Randis, TM; Kulkarni, R; Prince, AS; Shirasu-Hiza, MM; Ratner, AJ				Amaral, Fabio E.; Parker, Dane; Randis, Tara M.; Kulkarni, Ritwij; Prince, Alice S.; Shirasu-Hiza, Mimi M.; Ratner, Adam J.			Rational Manipulation of mRNA Folding Free Energy Allows Rheostat Control of Pneumolysin Production by Streptococcus pneumoniae	PLOS ONE			English	Article							SYNONYMOUS CODON USAGE; TRANSLATION EFFICIENCY; BIAS; EXPRESSION; SELECTION; ASSOCIATION; VAGINOLYSIN; ADAPTATION; VIRULENCE	The contribution of specific factors to bacterial virulence is generally investigated through creation of genetic "knockouts" that are then compared to wild-type strains or complemented mutants. This paradigm is useful to understand the effect of presence vs. absence of a specific gene product but cannot account for concentration-dependent effects, such as may occur with some bacterial toxins. In order to assess threshold and dose-response effects of virulence factors, robust systems for tunable expression are required. Recent evidence suggests that the folding free energy (Delta G) of the 5' end of mRNA transcripts can have a significant effect on translation efficiency and overall protein abundance. Here we demonstrate that rational alteration of 5' mRNA folding free energy by introduction of synonymous mutations allows for predictable changes in pneumolysin (PLY) expression by Streptococcus pneumoniae without the need for chemical inducers or heterologous promoters. We created a panel of isogenic S. pneumoniae strains, differing only in synonymous (silent) mutations at the 5' end of the PLY mRNA that are predicted to alter Delta G. Such manipulation allows rheostat-like control of PLY production and alters the cytotoxicity of whole S. pneumoniae on primary and immortalized human cells. These studies provide proof-of-principle for further investigation of mRNA Delta G manipulation as a tool in studies of bacterial pathogenesis.	[Amaral, Fabio E.; Parker, Dane; Randis, Tara M.; Kulkarni, Ritwij; Prince, Alice S.; Ratner, Adam J.] Columbia Univ, Dept Pediat, New York, NY 10027 USA; [Prince, Alice S.] Columbia Univ, Dept Pharmacol, New York, NY USA; [Shirasu-Hiza, Mimi M.] Columbia Univ, Dept Genet & Dev, New York, NY USA; [Amaral, Fabio E.] Univ Minho, Sch Hlth Sci, Life & Hlth Sci Res Inst ICVS, Braga, Portugal; [Amaral, Fabio E.] ICVS 3Bs, PT Govt Associate Lab, Braga, Portugal	Columbia University; Columbia University; Columbia University; Universidade do Minho	Ratner, AJ (corresponding author), Columbia Univ, Dept Pediat, New York, NY 10027 USA.	ar127@columbia.edu	Parker, Dane/AAX-7001-2021	Parker, Dane/0000-0001-7304-3392; Randis, Tara/0000-0003-0348-6766; Amaral, Fabio/0000-0002-1547-8213; Ratner, Adam/0000-0003-1761-794X	National Institutes of Health [R01 AI092743, R21 AI111020]; Portuguese Foundation for Science and Technology [SFRH/BD/33901/2009]; Luso-American Development Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI111020, R01AI092743] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Portuguese Foundation for Science and Technology(Portuguese Foundation for Science and Technology); Luso-American Development Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	`This work was supported by the National Institutes of Health (www.nih.gov) (R01 AI092743 and R21 AI111020 to A.J.R.). F.E.A. was supported by the Portuguese Foundation for Science and Technology (www.fct.pt) SFRH/BD/33901/2009 and the Luso-American Development Foundation (www.flad.pt). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar JL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008076; BERRY AM, 1989, INFECT IMMUN, V57, P2037, DOI 10.1128/IAI.57.7.2037-2042.1989; Coleman JR, 2008, SCIENCE, V320, P1784, DOI 10.1126/science.1155761; Coleman JR, 2011, J INFECT DIS, V203, P1264, DOI 10.1093/infdis/jir010; Crook J, 1998, CLIN DIAGN LAB IMMUN, V5, P205, DOI 10.1128/CDLI.5.2.205-210.1998; Gelber SE, 2008, J BACTERIOL, V190, P3896, DOI 10.1128/JB.01965-07; Goodman DB, 2013, SCIENCE, V342, P475, DOI 10.1126/science.1241934; Hershberg R, 2008, ANNU REV GENET, V42, P287, DOI 10.1146/annurev.genet.42.110807.091442; IKEMURA T, 1985, MOL BIOL EVOL, V2, P13; Johansson N, 2008, DIAGN MICR INFEC DIS, V60, P255, DOI 10.1016/j.diagmicrobio.2007.10.011; Kudla G, 2009, SCIENCE, V324, P255, DOI 10.1126/science.1170160; LACKS S, 1960, BIOCHIM BIOPHYS ACTA, V39, P508, DOI 10.1016/0006-3002(60)90205-5; Lee SF, 2009, MICROBIOL-SGM, V155, P3581, DOI 10.1099/mic.0.030064-0; Los FCO, 2013, MICROBIOL MOL BIOL R, V77, P173, DOI 10.1128/MMBR.00052-12; Markham NR, 2005, NUCLEIC ACIDS RES, V33, pW577, DOI 10.1093/nar/gki591; Puigbo P, 2008, BIOL DIRECT, V3, DOI 10.1186/1745-6150-3-38; Rampersaud R, 2011, J BACTERIOL, V193, P1034, DOI 10.1128/JB.00694-10; Randis TM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005207; Roller M, 2013, NUCLEIC ACIDS RES, V41, P8842, DOI 10.1093/nar/gkt673; Shah P, 2013, CELL, V153, P1589, DOI 10.1016/j.cell.2013.05.049; SHARP PM, 1987, NUCLEIC ACIDS RES, V15, P1281, DOI 10.1093/nar/15.3.1281; Shockett PE, 1996, P NATL ACAD SCI USA, V93, P5173, DOI 10.1073/pnas.93.11.5173; Stoletzki N, 2007, MOL BIOL EVOL, V24, P374, DOI 10.1093/molbev/msl166; Sung CK, 2001, APPL ENVIRON MICROB, V67, P5190, DOI 10.1128/AEM.67.11.5190-5196.2001; Supek F, 2010, GENETICS, V185, P1129, DOI 10.1534/genetics.110.115477; Tuller T, 2011, NUCLEIC ACIDS RES, V39, P4743, DOI 10.1093/nar/gkr054; Tuller T, 2010, P NATL ACAD SCI USA, V107, P3645, DOI 10.1073/pnas.0909910107; Zur H, 2012, EMBO REP, V13, P272, DOI 10.1038/embor.2011.262	28	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0119823	10.1371/journal.pone.0119823	http://dx.doi.org/10.1371/journal.pone.0119823			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25798590	Green Published, Green Submitted, gold			2022-12-27	WOS:000351987300083
J	Inoue-Mochita, M; Inoue, T; Fujimoto, T; Kameda, T; Awai-Kasaoka, N; Ohtsu, N; Kimoto, K; Tanihara, H				Inoue-Mochita, Miyuki; Inoue, Toshihiro; Fujimoto, Tomokazu; Kameda, Takanori; Awai-Kasaoka, Nanako; Ohtsu, Naoki; Kimoto, Kenichi; Tanihara, Hidenobu			p38 MAP Kinase Inhibitor Suppresses Transforming Growth Factor-beta 2-Induced Type 1 Collagen Production in Trabecular Meshwork Cells	PLOS ONE			English	Article							OPEN-ANGLE GLAUCOMA; INTRAOCULAR-PRESSURE; AQUEOUS-HUMOR; EXTRACELLULAR-MATRIX; MESENCHYMAL TRANSITION; FLUID-DYNAMICS; ROCK INHIBITOR; DEXAMETHASONE; TGF-BETA-2; CORTICOSTEROIDS	Glaucoma is an age-related neurodegenerative disease of retinal ganglion cells, and appropriate turnover of the extracellular matrix in the trabecular meshwork is important in its pathology. Here, we report the effects of Rho-associated kinase (ROCK) and p38 MAP kinase on transforming growth factor (TGF)-beta 2-induced type I collagen production in human trabecular meshwork cells. TGF-beta 2 increased RhoA activity, actin polymerization, and myosin light chain 2 phosphorylation. These effects were significantly inhibited by Y-27632, but not SB203580. TGF-beta 2 also increased promoter activity, mRNA synthesis, and protein expression of COL1A2. These effects were significantly inhibited by SB203580, but not Y-27632. Additionally, Y-27632 did not significantly inhibit TGF-beta 2-induced promoter activation, or phosphorylation or nuclear translocation of Smad2/3, whereas SB203580 partially suppressed these processes. Collectively, TGF-beta 2-induced production of type 1 collagen is suppressed by p38 inhibition and accompanied by partial inactivation of Smad2/3, in human trabecular meshwork cells.	[Inoue-Mochita, Miyuki; Inoue, Toshihiro; Fujimoto, Tomokazu; Kameda, Takanori; Awai-Kasaoka, Nanako; Ohtsu, Naoki; Tanihara, Hidenobu] Kumamoto Univ, Fac Life Sci, Dept Ophthalmol, Kumamoto, Japan; [Kameda, Takanori] Kyoto Univ, Grad Sch Med, Dept Ophthalmol & Visual Sci, Kyoto, Japan; [Kimoto, Kenichi] Oita Univ, Dept Ophthalmol, Yufu, Japan	Kumamoto University; Kyoto University; Oita University	Inoue, T (corresponding author), Kumamoto Univ, Fac Life Sci, Dept Ophthalmol, Kumamoto, Japan.	noel@da2.so-net.ne.jp		Fujimoto, Tomokazu/0000-0002-4867-1925; Inoue, Toshihiro/0000-0003-3769-7609	JSPS KAKENHI [23390403, 25861640, 23791994]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI Grant Numbers 23390403, 25861640 and 23791994. The sponsor or funding organization had no role in the design or conduct of this research.	Acott TS, 2008, EXP EYE RES, V86, P543, DOI 10.1016/j.exer.2008.01.013; [Anonymous], 2004, J HUAZHONG U SCI TEC; ARMALY MF, 1963, ARCH OPHTHALMOL-CHIC, V70, P492, DOI 10.1001/archopht.1963.00960050494011; ARMALY MF, 1963, ARCH OPHTHALMOL-CHIC, V70, P482, DOI 10.1001/archopht.1963.00960050484010; Cao Y, 2004, J HUAZHONG U SCI TEC, V24, P496; Chen SY, 2006, J BIOL CHEM, V281, P1765, DOI 10.1074/jbc.M507771200; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Fujimoto T, 2012, INVEST OPHTH VIS SCI, V53, P7097, DOI 10.1167/iovs.12-9989; Fukushima M, 2005, LIVER INT, V25, P829, DOI 10.1111/j.1478-3231.2005.01142.x; Gottanka J, 2004, INVEST OPHTH VIS SCI, V45, P153, DOI 10.1167/iovs.03-0796; Han H, 2011, INVEST OPHTH VIS SCI, V52, P2889, DOI 10.1167/iovs.10-6640; Honjo M, 2001, INVEST OPHTH VIS SCI, V42, P137; Inatani M, 2001, GRAEF ARCH CLIN EXP, V239, P109, DOI 10.1007/s004170000241; Itoh Y, 2007, EXP EYE RES, V84, P464, DOI 10.1016/j.exer.2006.10.017; Junglas B, 2009, EXP EYE RES, V88, P1065, DOI 10.1016/j.exer.2009.01.008; Kang MH, 2013, INVEST OPHTH VIS SCI, V54, P2523, DOI 10.1167/iovs.12-11474; Kimoto K, 2004, INVEST OPHTH VIS SCI, V45, P2431, DOI 10.1167/iovs.03-1276; Kopczynski C, 2013, BRIT J OPHTHALMOL, V97, P567, DOI 10.1136/bjophthalmol-2012-302466; Lee J, 2010, J BIOL CHEM, V285, P26618, DOI 10.1074/jbc.M109.073155; Mihira H, 2012, J BIOCHEM, V151, P145, DOI 10.1093/jb/mvr121; Nakamura Y, 2002, INVEST OPHTH VIS SCI, V43, P3465; Pattabiraman PP, 2014, J CELL PHYSIOL, V229, P927, DOI 10.1002/jcp.24524; Pattabiraman PP, 2010, AM J PHYSIOL-CELL PH, V298, pC749, DOI 10.1152/ajpcell.00317.2009; Quigley HA, 2006, BRIT J OPHTHALMOL, V90, P262, DOI 10.1136/bjo.2005.081224; Rao PV, 2001, INVEST OPHTH VIS SCI, V42, P1029; Sethi A, 2013, EXP EYE RES, V113, P117, DOI 10.1016/j.exer.2013.05.011; Takai Y, 2012, INVEST OPHTH VIS SCI, V53, P241, DOI 10.1167/iovs.11-8434; Tan JCH, 2006, CURR OPIN OPHTHALMOL, V17, P168; Tanihara H, 2008, ARCH OPHTHALMOL-CHIC, V126, P309, DOI 10.1001/archophthalmol.2007.76; Tanihara H, 2013, JAMA OPHTHALMOL, V131, P1288, DOI 10.1001/jamaophthalmol.2013.323; Tanihara H, 2013, AM J OPHTHALMOL, V156, P731, DOI 10.1016/j.ajo.2013.05.016; TRIPATHI RC, 1994, EXP EYE RES, V59, P723, DOI 10.1006/exer.1994.1158; Williams RD, 2011, AM J OPHTHALMOL, V152, P834, DOI 10.1016/j.ajo.2011.04.012; Xu T, 2012, INT J MOL MED, V30, P1119, DOI 10.3892/ijmm.2012.1107; Yue BYJT, 1996, SURV OPHTHALMOL, V40, P379	35	18	18	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0120774	10.1371/journal.pone.0120774	http://dx.doi.org/10.1371/journal.pone.0120774			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25799097	gold, Green Published, Green Submitted			2022-12-27	WOS:000351987300175
J	Mitchell, M; Mali, S; King, CC; Bark, SJ				Mitchell, Morgan; Mali, Sujina; King, Charles C.; Bark, Steven J.			Enhancing MALDI Time-Of-Flight Mass Spectrometer Performance through Spectrum Averaging	PLOS ONE			English	Article							BREAST-CANCER; PROTEINS; TOF; IDENTIFICATION; MICROBIOLOGY; IONIZATION	Matrix-assisted laser desorption ionization time-of-flight (MALDI-TOF) mass spectrometers are simple and robust mass spectrometers used for analysis of biologically relevant molecules in diverse fields including pathogen identification, imaging mass spectrometry, and natural products chemistry. Despite high nominal resolution and accuracy, we have observed significant variability where 30-50% of individual replicate measurements have errors in excess of 5 parts-per-million, even when using 5-point internal calibration. Increasing the number of laser shots for each spectrum did not resolve this observed variability. What is responsible for our observed variation? Using a modern MALDI-TOF/TOF instrument, we evaluated contributions to variability. Our data suggest a major component of variability is binning of the raw flight time data by the electronics and clock speed of the analog-to-digital (AD) detection system, which requires interpolation by automated peak fitting algorithms and impacts both calibration and the observed mass spectrum. Importantly, the variation observed is predominantly normal in distribution, which implies multiple components contribute to the observed variation and suggests a method to mitigate this variability through spectrum averaging. Restarting the acquisition impacts each spectrum within the electronic error of the AD detector system and defines a new calibration function. Therefore, averaging multiple independent spectra and not a larger number of laser shots leverages this inherent binning error to mitigate variability in accurate MALDI-TOF mass measurements.	[Mitchell, Morgan; Mali, Sujina; Bark, Steven J.] Univ Houston, Dept Biol & Biochem, Houston, TX 77004 USA; [King, Charles C.] Univ Calif San Diego, Pediat Diabet Res Ctr, Dept Pediat, San Diego, CA 92103 USA	University of Houston System; University of Houston; University of California System; University of California San Diego	Bark, SJ (corresponding author), Univ Houston, Dept Biol & Biochem, Houston, TX 77004 USA.	sbark@uh.edu		Bark, Steven/0000-0001-6608-6132	University of Houston Division of Research; Department of Biology and Biochemistry	University of Houston Division of Research; Department of Biology and Biochemistry	The authors thank the University of Houston Division of Research and Department of Biology and Biochemistry for initial funds supporting this research (S.J.B.). The funders had no role in design, data collection, data analysis, preparation or publication of the manuscript.	Bakry R, 2011, ANAL CHIM ACTA, V690, P26, DOI 10.1016/j.aca.2011.01.044; Caprioli RM, 2014, PROTEOMICS; Chaurand P, 2002, ELECTROPHORESIS, V23, P3125, DOI 10.1002/1522-2683(200209)23:18<3125::AID-ELPS3125>3.0.CO;2-#; Cobo Fernando, 2013, Open Virol J, V7, P84, DOI 10.2174/1874357920130927003; Craig R, 2004, BIOINFORMATICS, V20, P1466, DOI 10.1093/bioinformatics/bth092; Croxatto A, 2012, FEMS MICROBIOL REV, V36, P380, DOI 10.1111/j.1574-6976.2011.00298.x; FENN JB, 1989, SCIENCE, V246, P64, DOI 10.1126/science.2675315; Gast MCW, 2009, BREAST CANCER RES TR, V116, P17, DOI 10.1007/s10549-008-0263-3; Hudelist G, 2006, PROTEOMICS, V6, P1989, DOI 10.1002/pmic.200500129; KARAS M, 1988, ANAL CHEM, V60, P2299, DOI 10.1021/ac00171a028; Mamyrin B. A., 1973, Soviet Physics - JETP, V37, P45; Moree WJ, 2012, P NATL ACAD SCI USA, V109, P13811, DOI 10.1073/pnas.1206855109; Schappi JM, 2014, BBA-BIOMEMBRANES, V1838, P674, DOI 10.1016/j.bbamem.2013.08.026; Takach EJ, 1997, J PROTEIN CHEM, V16, P363, DOI 10.1023/A:1026376403468; Van de Water J, 2000, METH MOL B, V146, P453; Vestal ML, 2009, J MASS SPECTROM, V44, P303, DOI 10.1002/jms.1537; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; WILEY WC, 1955, REV SCI INSTRUM, V26, P1150, DOI 10.1063/1.1715212; Wojewoda C, 2013, AM J CLIN PATHOL, V140, P143, DOI 10.1309/AJCPU0AYZ5SYQIUK; Yang YL, 2009, NAT CHEM BIOL, V5, P885, DOI 10.1038/nchembio.252; Zhang WZ, 2000, ANAL CHEM, V72, P2482, DOI 10.1021/ac991363o	21	7	7	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0120932	10.1371/journal.pone.0120932	http://dx.doi.org/10.1371/journal.pone.0120932			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25798583	Green Published, gold, Green Submitted			2022-12-27	WOS:000351987300193
J	Okimoto, S; Yamashita, K; Shibata, T; Kiuchi, Y				Okimoto, Satoshi; Yamashita, Keiko; Shibata, Tetsuo; Kiuchi, Yoshiaki			Morphological Features and Important Parameters of Large Optic Discs for Diagnosing Glaucoma	PLOS ONE			English	Article							HEIDELBERG RETINA TOMOGRAPH; NERVE-FIBER LAYER; PRIMARY OPEN-ANGLE; FIELD LOSS; STRUCTURAL DAMAGE; TENSION GLAUCOMA; SIZE; REPRODUCIBILITY; DEFINITION; PREVALENCE	Purpose To compare the optic disc parameters of glaucomatous eyes to those of non-glaucomatous eyes with large discs. Methods We studied 225 consecutive eyes with large optic discs (>2.82 mm2): 91 eyes with glaucoma and 134 eyes without glaucoma. An eye was diagnosed with glaucoma when visual field defects were detected by the Humphrey Field Analyzer. All of the Heidelberg Retina Tomograph II (HRT II) parameters were compared between the non-glaucomatous and glaucomatous eyes. A logistic regression analysis of the HRT II parameters was used to establish a new formula for diagnosing glaucoma, and the sensitivity and specificity of the Moorfields Regression Analysis (MRA) was compared to the findings made by our analyses. Results The mean disc area was 3.44 +/- 0.50 mm2 in the non-glaucomatous group and 3.40 +/- 0.52 mm2 in the glaucoma group. The cup area, cup volume, cup-to-disc area ratio, linear cup/disc ratio, mean cup depth, and the maximum cup depth were significantly larger in glaucomatous eyes than in the non-glaucomatous eyes. The rim area, rim volume, cup shape measurement, mean retinal nerve fiber layer (RNFL) thickness, and RFNL cross-sectional area were significantly smaller in glaucomatous eyes than in non-glaucomatous eyes. The cup-to-disc area ratio, the height variation contour (HVC), and the RNFL cross-sectional area were important parameters for diagnosing the early stage glaucoma, and the cup-to-disc area ratio and cup volume were useful for diagnosing advanced stage glaucoma in eyes with a large optic disc. The new formula had higher sensitivity and specificity for diagnosing glaucoma than MRA. Conclusions The cup-to-disc area ratio, HVC, RNFL cross-sectional area, and cup volume were important parameters for diagnosing glaucoma in eyes with a large optic disc. The important disc parameters to diagnose glaucoma depend on the stage of glaucoma in patients with large discs.	[Okimoto, Satoshi; Kiuchi, Yoshiaki] Hiroshima Univ, Grad Sch Biomed Sci, Dept Ophthalmol & Visual Sci, Hiroshima, Japan; [Yamashita, Keiko; Shibata, Tetsuo] Shibata Eye Clin, Amagasaki, Hyogo, Japan	Hiroshima University	Okimoto, S (corresponding author), Hiroshima Univ, Grad Sch Biomed Sci, Dept Ophthalmol & Visual Sci, Hiroshima, Japan.	okimoto@hiroshima-u.ac.jp			Shibata Eye Clinic; Grants-in-Aid for Scientific Research [26462688] Funding Source: KAKEN	Shibata Eye Clinic; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Shibata Eye Clinic provided support in the form of salaries for authors KY and TS, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions" section.	Abe H, 2009, OPHTHALMOLOGY, V116, P223, DOI 10.1016/j.ophtha.2008.09.013; Anderson DR., 1999, AUTOMATED STATIC PER; Bathija R, 1998, J GLAUCOMA, V7, P121; BURK ROW, 1992, GRAEF ARCH CLIN EXP, V230, P552, DOI 10.1007/BF00181778; Costa AMC, 2014, J GLAUCOMA, V23, P368, DOI 10.1097/IJG.0b013e318279b3af; Ford BA, 2003, OPHTHALMOLOGY, V110, P1145, DOI 10.1016/S0161-6420(03)00230-6; Foster PJ, 2002, BRIT J OPHTHALMOL, V86, P238, DOI 10.1136/bjo.86.2.238; Hoffmann EM, 2007, SURV OPHTHALMOL, V52, P32, DOI 10.1016/j.survophthal.2006.10.002; Hood DC, 2009, INVEST OPHTH VIS SCI, V50, P4254, DOI 10.1167/iovs.08-2697; Iwase A, 2004, OPHTHALMOLOGY, V111, P1641, DOI 10.1016/j.ophtha.2004.03.029; Jonas JB, 2000, INVEST OPHTH VIS SCI, V41, P1764; Kim CS, 2011, OPHTHALMOLOGY, V118, P1024, DOI 10.1016/j.ophtha.2010.10.016; Lester M, 1997, OPHTHALMOLOGY, V104, P545; Medeiros FA, 2008, OPHTHALMOLOGY, V115, P1340, DOI 10.1016/j.ophtha.2007.11.008; Miglior S, 2003, AM J OPHTHALMOL, V136, P26, DOI 10.1016/S0002-9394(03)00084-9; Miglior S, 2002, OPHTHALMOLOGY, V109, P1072, DOI 10.1016/S0161-6420(02)01032-1; Mikelberg F S, 1995, J Glaucoma, V4, P242; Oddone F, 2011, OPHTHALMOLOGY, V118, P1340, DOI 10.1016/j.ophtha.2010.12.017; Onmez FE, 2014, J GLAUCOMA, V23, pE152, DOI 10.1097/IJG.0000000000000021; PEDERSON JE, 1980, ARCH OPHTHALMOL-CHIC, V98, P490; QUIGLEY HA, 1979, OPHTHALMOLOGY, V86, P1803; QUIGLEY HA, 1980, ARCH OPHTHALMOL-CHIC, V98, P1564; QUIGLEY HA, 1992, OPHTHALMOLOGY, V99, P19; Saito H, 2009, OPHTHALMOLOGY, V116, P1854, DOI 10.1016/j.ophtha.2009.03.048; SOMMER A, 1979, ARCH OPHTHALMOL-CHIC, V97, P1449, DOI 10.1001/archopht.1979.01020020111003; SOMMER A, 1991, ARCH OPHTHALMOL-CHIC, V109, P77, DOI 10.1001/archopht.1991.01080010079037; Tan JCH, 2003, INVEST OPHTH VIS SCI, V44, P1132, DOI 10.1167/iovs.02-0039; Teesalu P, 1997, INVEST OPHTH VIS SCI, V38, P2452; TOMITA G, 1994, GRAEF ARCH CLIN EXP, V232, P290, DOI 10.1007/BF00194478; TUULONEN A, 1992, ARCH OPHTHALMOL-CHIC, V110, P211, DOI 10.1001/archopht.1992.01080140067029; Uchida H, 1996, INVEST OPHTH VIS SCI, V37, P2393; Vihanninjoki K, 2002, ACTA OPHTHALMOL SCAN, V80, P47, DOI 10.1034/j.1600-0420.2002.800110.x; Wollstein G, 1998, OPHTHALMOLOGY, V105, P1557, DOI 10.1016/S0161-6420(98)98047-2	33	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0118920	10.1371/journal.pone.0118920	http://dx.doi.org/10.1371/journal.pone.0118920			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25798580	Green Published, gold, Green Submitted			2022-12-27	WOS:000351987300023
J	Sun, B; Liu, R; Ye, N; Xiao, ZD				Sun, Bo; Liu, Rui; Ye, Nan; Xiao, Zhong-Dang			Comprehensive Evaluation of microRNA Expression Profiling Reveals the Neural Signaling Specific Cytotoxicity of Superparamagnetic Iron Oxide Nanoparticles (SPIONs) through N-Methyl-D-Aspartate Receptor	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; CELL-DEATH; GENOTOXICITY EVALUATION; SILICA NANOPARTICLES; DISACCHARIDE MOIETY; GOLD NANOPARTICLES; TITANIUM-DIOXIDE; OXIDATIVE STRESS; AMORPHOUS SILICA; NMDA RECEPTORS	Though nanomaterials are considered as drug carriers or imaging reagents targeting the central nervous system their cytotoxicity effect on neuronal cells has not been well studied. In this study, we treated PC12 cells, a model neuronal cell line, with a nanomaterial that is widely accepted for medical use, superparamagnetic iron oxide nanoparticles (SPIONs). Our results suggest that, after treated with SPIONs, the expression pattern of the cellular miRNAs changed widely in PC12 cells. As potential miRNA targets, NMDAR, one of the candidate mRNAs that were selected using GO and KEGG pathway enrichment, was significantly down regulated by SPIONs treatment. We further illustrated that SPIONs may induce cell death through NMDAR suppression. This study revealed a NMDAR neurotoxic effect of SPIONs and provides a reliable approach for assessing the neurocytotoxic effects of nanomaterials based on the comprehensive annotation of miRNA profiling.	[Sun, Bo; Ye, Nan; Xiao, Zhong-Dang] Southeast Univ, State Key Lab Bioelect, Sch Biol Sci & Med Engn, Nanjing 210096, Jiangsu, Peoples R China; [Sun, Bo] Seoul Natl Univ, Inst Microbiol, Sch Biol Sci, Seoul, South Korea; [Liu, Rui] Seoul Natl Univ, Biophys Lab, Sch Biol Sci, Seoul, South Korea	Southeast University - China; Seoul National University (SNU); Seoul National University (SNU)	Sun, B (corresponding author), Southeast Univ, State Key Lab Bioelect, Sch Biol Sci & Med Engn, Nanjing 210096, Jiangsu, Peoples R China.	sunbo@seu.edu.cn; zdxiao@seu.edu.cn			Natural Science Foundation of Jiangsu Province [BK2012122]; National Natural Science Foundation of China (NSFC) [61071047]; Major State Basic Research Development Program of China (973 Program) [2013CB932902]	Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Major State Basic Research Development Program of China (973 Program)(National Basic Research Program of China)	This work was supported by grants from the Natural Science Foundation of Jiangsu Province (No. BK2012122), the National Natural Science Foundation of China (NSFC) (No. 61071047), and the Major State Basic Research Development Program of China (973 Program) (No. 2013CB932902). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams SM, 2004, J NEUROSCI, V24, P9441, DOI 10.1523/JNEUROSCI.3290-04.2004; Bannunah AM, 2014, MOL PHARMACEUT, V11, P4363, DOI 10.1021/mp500439c; Bigini P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032326; Borisova T, INT J BIOCH CELL BIO; Cai HAX, 2014, COLLOID SURFACE B, V123, P900, DOI 10.1016/j.colsurfb.2014.10.042; Carp SA, 2008, VALIDATION OPTICAL M, pBMD2; Chou LYT, 2012, NAT NANOTECHNOL, V7, P416, DOI 10.1038/nnano.2012.110; Creighton CJ, 2009, BRIEF BIOINFORM, V10, P490, DOI 10.1093/bib/bbp019; Drechsel DA, 2012, NEUROTOX RES, V22, P251, DOI 10.1007/s12640-012-9322-y; Du J, 2009, NEUROSCI LETT, V464, P140, DOI 10.1016/j.neulet.2009.07.032; Efimova T, 2010, CELL CYCLE, V9, P498, DOI 10.4161/cc.9.3.10541; Fang Q, 2015, J HAZARD MATER, V283, P897, DOI 10.1016/j.jhazmat.2014.10.039; Ferrari R, 2014, COLLOID SURFACE B, V123, P639, DOI 10.1016/j.colsurfb.2014.10.003; Fu J, 2012, ADV SCI LETT, V5, P294, DOI DOI 10.1166/ASL.2012.1946; Gomes T, 2014, AQUAT TOXICOL, V155, P327, DOI 10.1016/j.aquatox.2014.07.015; Grau Cristina Malagelada, 2012, Methods Mol Biol, V846, P201, DOI 10.1007/978-1-61779-536-7_18; Gu JL, 2011, SCI CHINA LIFE SCI, V54, P793, DOI 10.1007/s11427-011-4215-5; He SY, 2011, ENVIRON POLLUT, V159, P3468, DOI 10.1016/j.envpol.2011.08.024; Hu MCT, 1999, J BIOL CHEM, V274, P7095, DOI 10.1074/jbc.274.11.7095; Hu YL, 2010, INT J PHARMACEUT, V394, P115, DOI 10.1016/j.ijpharm.2010.04.026; Huang Y, 2015, BIOMATERIALS, V37, P13, DOI 10.1016/j.biomaterials.2014.10.042; Ishima T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037989; Izarra A, 2014, J TISSUE ENG REGENER; Jiang WL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037376; Johnson EM, 1996, BRAIN PATHOL, V6, P397, DOI 10.1111/j.1750-3639.1996.tb00872.x; Kawakami Z, 2011, J ETHNOPHARMACOL, V134, P74, DOI 10.1016/j.jep.2010.11.063; Khamwannah J, 2012, NANO ENERGY, V1, P411, DOI 10.1016/j.nanoen.2012.03.010; Kingwell K, 2012, NAT REV NEUROL, V8, P589, DOI [10.1038/nrneurol.2012.229, 10.1038/nrneurol.2012.128, 10.1038/nrneurol.2012.218, 10.1038/nrneurol.2012.55, 10.1038/nrneurol.2012.84]; Kircher MF, 2003, CANCER RES, V63, P8122; Kircher MF, 2012, NAT MED, V18, P829, DOI 10.1038/nm.2721; Li SC, 2011, BIOMATERIALS, V32, P9021, DOI 10.1016/j.biomaterials.2011.08.033; Liu Y, 2014, NANO LIFE, V4; Liu YR, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0110611, 10.1371/journal.pone.0087094]; Liu YR, 2014, MOL PHARMACEUT, V11, P1651, DOI 10.1021/mp5000373; Mahmood M, 2011, J CELL MOL MED, V15, P2297, DOI 10.1111/j.1582-4934.2010.01234.x; Manke A, 2014, INT J MOL SCI, V15, P7444, DOI 10.3390/ijms15057444; Mellado-Gil J, 2011, DIABETES, V60, P525, DOI 10.2337/db09-1305; Michaelis EK, 1998, PROG NEUROBIOL, V54, P369, DOI 10.1016/S0301-0082(97)00055-5; Park MVDZ, 2011, NANOTOXICOLOGY, V5, P168, DOI 10.3109/17435390.2010.506016; Park S, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/18/185101; Patel D, 2010, BIOMATERIALS, V31, P2866, DOI 10.1016/j.biomaterials.2009.12.025; Patil G, 2012, ENVIRON TOXICOL PHAR, V34, P436, DOI 10.1016/j.etap.2012.05.014; Perruisseau-Carrier C, 2011, MOL NEUROBIOL, V43, P215, DOI 10.1007/s12035-011-8179-z; Pisanic TR, 2007, BIOMATERIALS, V28, P2572, DOI 10.1016/j.biomaterials.2007.01.043; Raynal I, 2004, INVEST RADIOL, V39, P56, DOI 10.1097/01.rli.0000101027.57021.28; Rivet CJ, 2012, CHEM RES TOXICOL, V25, P153, DOI 10.1021/tx200369s; Roberson MS, 1999, ENDOCRINOLOGY, V140, P1310, DOI 10.1210/en.140.3.1310; Ruan J, 2015, NEUROREPORT, V26, P66, DOI 10.1097/WNR.0000000000000302; Saito Y, 2003, MOL BRAIN RES, V110, P159, DOI 10.1016/S0169-328X(02)00548-X; Sayed D, 2011, PHYSIOL REV, V91, P827, DOI 10.1152/physrev.00006.2010; Schroeder BR, 2014, J AM CHEM SOC, V136, P13641, DOI 10.1021/ja507255g; Siegrist KJ, 2014, PART FIBRE TOXICOL, V11, DOI 10.1186/1743-8977-11-6; Suh WH, 2009, PROG NEUROBIOL, V87, P133, DOI 10.1016/j.pneurobio.2008.09.009; Sun B, 2013, BMC GENET, V14, DOI 10.1186/1471-2156-14-120; Sun J, 2014, SCI REP, V4; Sun K-T, BONE; Takadera T, 1999, J NEUROCHEM, V73, P548, DOI 10.1046/j.1471-4159.1999.0730548.x; Takadera T, 2007, NEUROCHEM RES, V32, P1336, DOI 10.1007/s11064-007-9310-4; Tavares AM, 2014, TOXICOL IN VITRO, V28, P60, DOI 10.1016/j.tiv.2013.06.009; Veiseh O, 2010, ADV DRUG DELIVER REV, V62, P284, DOI 10.1016/j.addr.2009.11.002; Wang G, 2005, FEBS LETT, V579, P4005, DOI 10.1016/j.febslet.2005.06.013; Yang H, 2010, PHARM RES-DORDR, V27, P1759, DOI 10.1007/s11095-010-0141-7; Yu MK, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/41/415102; Yu T, 2011, ACS NANO, V5, P5717, DOI 10.1021/nn2013904; Yu ZQ, 2013, J AM CHEM SOC, V135, P2883, DOI 10.1021/ja311090e; Zhang S, 2009, NANOSCALE RES LETT, V4, P70, DOI 10.1007/s11671-008-9204-7; Zhu K, 2012, INT J PHARMACEUT, V423, P378, DOI 10.1016/j.ijpharm.2011.12.030	67	15	15	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0121671	10.1371/journal.pone.0121671	http://dx.doi.org/10.1371/journal.pone.0121671			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25798908	Green Published, gold, Green Submitted			2022-12-27	WOS:000351987300284
J	van den Boomen, C; Jonkman, LM; Jaspers-Vlamings, PHJM; Cousijn, J; Kemner, C				van den Boomen, Carlijn; Jonkman, Lisa M.; Jaspers-Vlamings, Petra H. J. M.; Cousijn, Janna; Kemner, Chantal			Developmental Changes in ERP Responses to Spatial Frequencies	PLOS ONE			English	Article							CATEGORIZING FACIAL IDENTITIES; CONTRAST SENSITIVITY; CHILDREN; FACES; SELECTIVITY; ATTENTION; EMOTIONS	Social interaction starts with perception of other persons. One of the first steps in perception is processing of basic information such as spatial frequencies (SF), which represent details and global information. However, although behavioural perception of SF is well investigated, the developmental trajectory of the temporal characteristics of SF processing is not yet well understood. The speed of processing of this basic visual information is crucial, as it determines the speed and possibly accuracy of subsequent visual and social processes. The current study investigated developmental changes in the temporal characteristics of selective processing of high SF (HSF; details) versus low SF (LSF; global). To this end, brain activity was measured using EEG in 108 children aged 3-15 years, while HSF or LSF grating stimuli were presented. Interest was in the temporal characteristics of brain activity related to LSF and HSF processing, specifically at early (N80) or later (P1 or N2) peaks in brain activity. Analyses revealed that from 7-8 years onwards HSF but not LSF stimuli evoked an N80 peak. In younger children, aged 3-8 years, the visual manipulation mainly affected the visual N2 peak. Selective processing of HSF versus LSF thus occurs at a rather late time-point (N2 peak) in young children. Although behavioural research previously showed that 3-6 year-olds can perceive detailed information, the current results point out that selective processing of HSF versus LSF is still delayed in these children. The delayed processing in younger children could impede the use of LSF and HSF for emotional face processing. Thus, the current study is a starting point for understanding changes in basic visual processing which underlie social development.	[van den Boomen, Carlijn; Cousijn, Janna; Kemner, Chantal] Helmholtz Inst, Dept Expt Psychol, NL-3584 CS Utrecht, Netherlands; [van den Boomen, Carlijn; Kemner, Chantal] Univ Utrecht, Dept Dev Psychol, NL-3584 CS Utrecht, Netherlands; [Jonkman, Lisa M.; Jaspers-Vlamings, Petra H. J. M.] Maastricht Univ, Dept Cognit Neurosci, Sect Dev Cognit Neurosci, Fac Psychol & Neurosci, NL-6200 MD Maastricht, Netherlands; [Kemner, Chantal] Univ Med Ctr, Dept Child & Adolescent Psychiat, Brain Ctr Rudolf Magnus, NL-3584 CX Utrecht, Netherlands	Utrecht University; Maastricht University; Utrecht University; Utrecht University Medical Center	van den Boomen, C (corresponding author), Helmholtz Inst, Dept Expt Psychol, Heidelberglaan 2,Unnik Bldg Room 16-17, NL-3584 CS Utrecht, Netherlands.	C.vandenboomen@uu.nl		Cousijn, Janna/0000-0002-7699-2582	Netherlands Organisation for Scientific Research (NWO) [45307004]	Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	This work was funded by The Netherlands Organisation for Scientific Research (NWO), Grant number 45307004 awarded to CK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achenbach TM, 1991, MANUAL CHILD BEHAV C; Adams RJ, 2002, VISION RES, V42, P1205, DOI 10.1016/S0042-6989(02)00038-X; BEAZLEY LD, 1980, BRIT J OPHTHALMOL, V64, P863, DOI 10.1136/bjo.64.11.863; Boeschoten MA, 2007, CLIN NEUROPHYSIOL, V118, P2076, DOI 10.1016/j.clinph.2007.05.004; Boeschoten MA, 2005, CLIN NEUROPHYSIOL, V116, P1956, DOI 10.1016/j.clinph.2005.03.021; Braddick O, 2011, VISION RES, V51, P1588, DOI 10.1016/j.visres.2011.02.018; Dakin S, 2005, NEURON, V48, P497, DOI 10.1016/j.neuron.2005.10.018; Deruelle C, 2005, J EXP CHILD PSYCHOL, V90, P172, DOI 10.1016/j.jecp.2004.09.001; Deruelle C, 2008, BRAIN COGNITION, V66, P115, DOI 10.1016/j.bandc.2007.06.001; Dobkins KR, 2014, J VISION, V14, DOI 10.1167/14.1.1; Ellemberg D, 2001, SPATIAL VISION, V15, P99, DOI 10.1163/15685680152692042; FOSTER KH, 1985, J PHYSIOL-LONDON, V365, P331, DOI 10.1113/jphysiol.1985.sp015776; Gao XQ, 2010, J EXP CHILD PSYCHOL, V107, P67, DOI 10.1016/j.jecp.2010.05.003; GRATTON G, 1983, ELECTROEN CLIN NEURO, V55, P468, DOI 10.1016/0013-4694(83)90135-9; Gwiazda J, 1997, OPTOMETRY VISION SCI, V74, P785, DOI 10.1097/00006324-199710000-00017; Hawken MJ, 1997, EXP BRAIN RES, V114, P86, DOI 10.1007/PL00005626; Kenemans JL, 2000, CLIN NEUROPHYSIOL, V111, P1113, DOI 10.1016/S1388-2457(00)00270-4; Leat SJ., 2009, J OPTOM, V2(1), P19, DOI DOI 10.3921/JOPTOM.2009.19; Leonard HC, 2010, J EXP CHILD PSYCHOL, V106, P193, DOI 10.1016/j.jecp.2010.03.005; NORCIA AM, 1985, VISION RES, V25, P1399, DOI 10.1016/0042-6989(85)90217-2; Pourtois G, 2005, HUM BRAIN MAPP, V26, P65, DOI 10.1002/hbm.20130; Simmons DR, 2009, VISION RES, V49, P2705, DOI 10.1016/j.visres.2009.08.005; Spreen O, 1998, COMPENDIUM NEUROPSYC; Taylor MJ, 2004, J COGNITIVE NEUROSCI, V16, P1426, DOI 10.1162/0898929042304732; Tellegen PJ, 1998, MANUAL JUSTIFICATION; van den Boomen C, 2012, Front Psychiatry, V3, P16, DOI 10.3389/fpsyt.2012.00016; Vlamings PHJM, 2010, CHILD DEV, V81, P1304, DOI 10.1111/j.1467-8624.2010.01470.x; Vlamings PHJM, 2009, J VISION, V9, DOI 10.1167/9.5.12; Vlamings PHJM, 2010, BIOL PSYCHIAT, V68, P1107, DOI 10.1016/j.biopsych.2010.06.024; Vuilleumier P, 2003, NAT NEUROSCI, V6, P624, DOI 10.1038/nn1057; Wechsler D., 1991, WISC 3 WECHSLER INTE	31	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0122507	10.1371/journal.pone.0122507	http://dx.doi.org/10.1371/journal.pone.0122507			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CE6ZS	25799038	Green Published, Green Submitted, gold			2022-12-27	WOS:000351987300335
J	Zheng, W; Wu, CX				Zheng, Wei; Wu, Chunxian			A Bio-Inspired Memory Model Embedded with a Causality Reasoning Function for Structural Fault Location	PLOS ONE			English	Article							DAMAGE DETECTION; DIAGNOSIS; SYSTEMS; IDENTIFICATION; ALGORITHMS; EXTRACTION; NETWORKS	Structural health monitoring (SHM) is challenged by massive data storage pressure and structural fault location. In response to these issues, a bio-inspired memory model that is embedded with a causality reasoning function is proposed for fault location. First, the SHM data for processing are divided into three temporal memory areas to control data volume reasonably. Second, the inherent potential of the causal relationships in structural state monitoring is mined. Causality and dependence indices are also proposed to establish the mechanism of quantitative description of the reason and result events. Third, a mechanism of causality reasoning is developed for the reason and result events to locate faults in a SHM system. Finally, a deformation experiment conducted on a steel spring plate demonstrates that the proposed model can be applied to real-time acquisition, compact data storage, and system fault location in a SHM system. Moreover, the model is compared with some typical methods based on an experimental benchmark dataset.	[Zheng, Wei; Wu, Chunxian] Chongqing Univ, Key Lab Optoelect Technol & Syst, Educ Minist China, Coll Optoelect Engn, Chongqing 630044, Peoples R China	Chongqing University	Zheng, W (corresponding author), Chongqing Univ, Key Lab Optoelect Technol & Syst, Educ Minist China, Coll Optoelect Engn, Chongqing 630044, Peoples R China.	zw3475@163.com			National Natural Science Foundation of China [61174006]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Funding: The project is supported by the National Natural Science Foundation of China (Grant No. 61174006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold A, 2007, KDD-2007 PROCEEDINGS OF THE THIRTEENTH ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P66; Atkinson R. C., 1968, PSYCHOL LEARN MOTIVA, V2, P89, DOI 10.1016/S0079-7421(08)60422-3; Bacca B, 2013, ROBOT AUTON SYST, V61, P1539, DOI 10.1016/j.robot.2013.07.003; Baldwin JF, 2003, IEEE INT CONF FUZZY, P630; Bastesen E, 2012, J GEOL SOC LONDON, V169, P477, DOI 10.1144/0016-76492011-100; Borges CCH, 2007, INT J NUMER METH ENG, V69, P2663, DOI 10.1002/nme.1857; Bryer EJ, 2013, J INT NEUROPSYCH SOC, V19, P751, DOI 10.1017/S1355617713000490; Chandrashekhar M, 2009, MECH SYST SIGNAL PR, V23, P384, DOI 10.1016/j.ymssp.2008.03.013; Cowan N, 2000, AM J PSYCHOL, V113, P639, DOI 10.2307/1423476; da Silva S, 2007, J BRAZ SOC MECH SCI, V29, P174, DOI 10.1590/S1678-58782007000200007; Figueiredo E., 2009, STRUCTURAL HLTH MONI; Holroyd TJ, 2003, INSIGHT, V45, P127, DOI 10.1784/insi.45.2.127.52622; Hou ZK, 2006, COMPUT-AIDED CIV INF, V21, P268, DOI 10.1111/j.1467-8667.2006.00434.x; Huang YX, 2009, MECH SYST SIGNAL PR, V23, P2470, DOI 10.1016/j.ymssp.2009.06.003; Ijmker J, 2012, J ASIAN EARTH SCI, V44, P176, DOI 10.1016/j.jseaes.2011.04.021; Bejarano FJ, 2012, INT J CONTROL, V85, P648, DOI 10.1080/00207179.2012.661463; Johnson S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0050276; Karimi K, 2002, PROC INT C TOOLS ART, P375, DOI 10.1109/TAI.2002.1180827; Kullaa J, 2011, MECH SYST SIGNAL PR, V25, P2976, DOI 10.1016/j.ymssp.2011.05.017; Lynch JP, 2003, STRUCT ENG MECH, V15, P285, DOI 10.12989/sem.2003.15.3.285; Mazack LJ, 2003, IEEE INT CONF FUZZY, P684; Mosterman PJ, 1999, IEEE T SYST MAN CY A, V29, P554, DOI 10.1109/3468.798059; Mujica LE, 2008, STRUCT HEALTH MONIT, V7, P215, DOI 10.1177/1475921708090560; Nee DE, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00796; Nikovski D, 2000, IEEE T KNOWL DATA EN, V12, P509, DOI 10.1109/69.868904; Pastukhov A, 2014, ATTEN PERCEPT PSYCHO, V76, P123, DOI 10.3758/s13414-013-0557-3; Ruff CC, 2013, ANN NY ACAD SCI, V1296, P88, DOI 10.1111/nyas.12204; Sharda B, 2013, J MANUF SYST, V32, P315, DOI 10.1016/j.jmsy.2013.01.001; Song YD, 2010, J BIONIC ENG, V7, P127, DOI 10.1016/S1672-6529(09)60201-8; Sterritt R, 2000, IEEE SYS MAN CYBERN, P3646, DOI 10.1109/ICSMC.2000.886576; Sultan M, 2008, J HYDROL, V349, P475, DOI 10.1016/j.jhydrol.2007.11.029; Sumner JA, 2014, MEMORY, V22, P163, DOI 10.1080/09658211.2013.774021; Wang YJ, 2013, APPL INTELL, V39, P614, DOI 10.1007/s10489-013-0437-5; Wen FH, 2006, WCICA 2006: SIXTH WORLD CONGRESS ON INTELLIGENT CONTROL AND AUTOMATION, VOLS 1-12, CONFERENCE PROCEEDINGS, P5938; Widrow B, 2013, NEURAL NETWORKS, V41, P3, DOI 10.1016/j.neunet.2013.01.016; Wood J, 2005, SIAM J CONTROL OPTIM, V43, P1493, DOI 10.1137/S0363012903429979; Worden K, 2000, J SOUND VIB, V229, P647, DOI 10.1006/jsvi.1999.2514; Yuen KV, 2006, COMPUT-AIDED CIV INF, V21, P280, DOI 10.1111/j.1467-8667.2006.00435.x; Zagrai A, 2010, J INTEL MAT SYST STR, V21, P921, DOI 10.1177/1045389X10369850; Zhang XG, 2014, IEEE T IMAGE PROCESS, V23, P769, DOI 10.1109/TIP.2013.2294549	40	5	6	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0120080	10.1371/journal.pone.0120080	http://dx.doi.org/10.1371/journal.pone.0120080			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25798991	Green Published, gold, Green Submitted			2022-12-27	WOS:000351987300105
J	Alao, JP; Weber, AM; Shabro, A; Sunnerhagen, P				Alao, John P.; Weber, Andrea M.; Shabro, Aidin; Sunnerhagen, Per			Suppression of Sensitivity to Drugs and Antibiotics by High External Cation Concentrations in Fission Yeast	PLOS ONE			English	Article							LACTIC-ACID BACTERIA; CELL-WALL INTEGRITY; SACCHAROMYCES-CEREVISIAE; SCHIZOSACCHAROMYCES-POMBE; ANTIFUNGAL RESISTANCE; POTASSIUM-TRANSPORT; PROTEIN-PHOSPHATASE; PH HOMEOSTASIS; SALT TOLERANCE; KILLER TOXINS	Background Potassium ion homeostasis plays an important role in regulating membrane potential and therefore resistance to cations, antibiotics and chemotherapeutic agents in Schizosaccharomyces pombe and other yeasts. However, the precise relationship between drug resistance in S. pombe and external potassium concentrations (particularly in its natural habitats) remains unclear. S. pombe can tolerate a wide range of external potassium concentrations which in turn affect plasma membrane polarization. We thus hypothesized that high external potassium concentrations suppress the sensitivity of this yeast to various drugs. Methods We have investigated the effect of external KCl concentrations on the sensitivity of S. pombe cells to a wide range of antibiotics, antimicrobial agents and chemotherapeutic drugs. We employed survival assays, immunoblotting and microscopy for these studies. Results We demonstrate that KCl, and to a lesser extent NaCl and RbCl can suppress the sensitivity of S. pombe to a wide range of antibiotics. Ammonium chloride and potassium hydrogen sulphate also suppressed drug sensitivity. This effect appears to depend in part on changes to membrane polarization and membrane transport proteins. Interestingly, we have found little relationship between the suppressive effect of KCl on sensitivity and the structure, polarity or solubility of the various compounds investigated. Conclusions High concentrations of external potassium and other cations suppress sensitivity to a wide range of drugs in S. pombe. Potassium-rich environments may thus provide S. pombe a competitive advantage in nature. Modulating potassium ion homeostasis may sensitize pathogenic fungi to antifungal agents.	[Alao, John P.; Weber, Andrea M.; Shabro, Aidin; Sunnerhagen, Per] Univ Gothenburg, Dept Chem & Mol Biol, SE-40530 Gothenburg, Sweden	University of Gothenburg	Alao, JP (corresponding author), Univ Gothenburg, Dept Chem & Mol Biol, Box 462, SE-40530 Gothenburg, Sweden.	john.p.alao@cmb.gu.se	Sunnerhagen, Per/G-1696-2012; Alao, John-Patrick/AAY-8645-2021	Sunnerhagen, Per/0000-0002-0967-8729; 	Swedish Research Council [2010 4645]; Chemical Biology Platform at the University of Gothenburg	Swedish Research Council(Swedish Research CouncilEuropean Commission); Chemical Biology Platform at the University of Gothenburg	This work was financially supported by the Swedish Research Council (2010 4645) and the Chemical Biology Platform at the University of Gothenburg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam C, 2012, MICROBIOL-SGM, V158, P1258, DOI 10.1099/mic.0.057075-0; AHMED S, 1983, BIOCHEM J, V212, P105, DOI 10.1042/bj2120105; Alao JP, 2008, MOL MICROBIOL, V68, P246, DOI 10.1111/j.1365-2958.2008.06147.x; Alao JP, 2010, MOL MICROBIOL, V77, P143, DOI 10.1111/j.1365-2958.2010.07193.x; Alcazar-Fuoli L, 2014, BRIT J HAEMATOL, V166, P471, DOI 10.1111/bjh.12896; Aouida M, 2004, BIOCHEM J, V384, P47, DOI 10.1042/BJ20040392; Aouida M, 2004, CANCER RES, V64, P1102, DOI 10.1158/0008-5472.CAN-03-2729; Aouida M, 2004, CURR GENET, V45, P265, DOI 10.1007/s00294-004-0492-x; Arino J, 2010, MICROBIOL MOL BIOL R, V74, P95, DOI 10.1128/MMBR.00042-09; Asher V, 2010, WORLD J SURG ONCOL, V8, DOI 10.1186/1477-7819-8-113; Balcells L, 1997, EUR J BIOCHEM, V250, P476, DOI 10.1111/j.1432-1033.1997.0476a.x; Bianchi L, 1998, CANCER RES, V58, P815; Brown WRA, 2011, G3-GENES GENOM GENET, V1, P615, DOI 10.1534/g3.111.001123; Calero F, 2003, FEMS YEAST RES, V4, P1, DOI 10.1016/S1567-1356(03)00111-9; Calero F, 2000, J BACTERIOL, V182, P394, DOI 10.1128/JB.182.2.394-399.2000; Canovas D, 2007, FEMS MICROBIOL ECOL, V61, P258, DOI 10.1111/j.1574-6941.2007.00344.x; Castaneda-Garcia A, 2011, J ANTIMICROB CHEMOTH, V66, P1489, DOI 10.1093/jac/dkr165; Cowen LE, 2008, EUKARYOT CELL, V7, P747, DOI 10.1128/EC.00041-08; Deresinski SC, 2003, CLIN INFECT DIS, V36, P1445, DOI 10.1086/375080; FAPARUSI SI, 1972, APPL MICROBIOL, V24, P853, DOI 10.1128/AEM.24.6.853-856.1972; Forsburg SL, 2003, GROWTH MANIPULATION, pChapter 13; Georgopapadakou NH, 1996, ANTIMICROB AGENTS CH, V40, P279, DOI 10.1128/AAC.40.2.279; GRAVEN SN, 1966, P NATL ACAD SCI USA, V56, P654, DOI 10.1073/pnas.56.2.654; GUFFANTI AA, 1979, J GEN MICROBIOL, V114, P201, DOI 10.1099/00221287-114-1-201; Gullberg E, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002158; Hohmann S, 2002, MICROBIOL MOL BIOL R, V66, P300, DOI 10.1128/MMBR.66.2.300-372.2002; KAGAN BL, 1983, NATURE, V302, P709, DOI 10.1038/302709a0; Konings WN, 2000, CURR OPIN MICROBIOL, V3, P276, DOI 10.1016/S1369-5274(00)00089-8; LAFONLAFOURCADE S, 1983, A VAN LEEUW J MICROB, V49, P349, DOI 10.1007/BF00399509; Lupetti A, 2002, TRENDS MOL MED, V8, P76, DOI 10.1016/S1471-4914(02)02280-3; Madrid R, 1998, J BIOL CHEM, V273, P14838, DOI 10.1074/jbc.273.24.14838; Miceli MH, 2011, MYCOSES, V54, pE666, DOI 10.1111/j.1439-0507.2011.02032.x; Navarro L, 2000, J APPL MICROBIOL, V88, P44, DOI 10.1046/j.1365-2672.2000.00865.x; NKANGA EJ, 1978, ANTIMICROB AGENTS CH, V14, P51, DOI 10.1128/AAC.14.1.51; PERLIN DS, 1988, J BIOL CHEM, V263, P18118; Schmitt MJ, 2006, NAT REV MICROBIOL, V4, P212, DOI 10.1038/nrmicro1347; Shapiro RS, 2011, MICROBIOL MOL BIOL R, V75, P213, DOI 10.1128/MMBR.00045-10; Sheehan DJ, 1999, CLIN MICROBIOL REV, V12, P40, DOI 10.1128/CMR.12.1.40; Stella CA, 2001, ANTIMICROB AGENTS CH, V45, P1589, DOI 10.1128/AAC.45.5.1589-1590.2001; Teixeira MC, 2011, MICROBIOL-SGM, V157, P945, DOI 10.1099/mic.0.043661-0; Tenreiro S, 2005, BIOCHEM BIOPH RES CO, V327, P952, DOI 10.1016/j.bbrc.2004.12.097; Thornton G, 2005, GENES CELLS, V10, P941, DOI 10.1111/j.1365-2443.2005.00891.x; Vanden B.H., 1989, FOCUS AZOLE ANTIF S1, V32, P35, DOI DOI 10.1111/j.1439-0507.1989.tb02293.x; Vargas RC, 2007, EUKARYOT CELL, V6, P134, DOI 10.1128/EC.00290-06; VERTUTDOI A, 1988, BIOCHEM BIOPH RES CO, V157, P692, DOI 10.1016/S0006-291X(88)80305-X; VILLALOBO A, 1982, J BIOL CHEM, V257, P1824; Walworth NC, 1996, SCIENCE, V271, P353, DOI 10.1126/science.271.5247.353; Wang LY, 2005, MOL CELL BIOL, V25, P3945, DOI 10.1128/MCB.25.10.3945-3955.2005; Wright MB, 1997, J BIOL CHEM, V272, P13647, DOI 10.1074/jbc.272.21.13647; Yang XX, 2006, FEMS YEAST RES, V6, P195, DOI 10.1111/j.1567-1364.2006.00026.x; Yenush L, 2002, EMBO J, V21, P920, DOI 10.1093/emboj/21.5.920; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a; Zhang YQ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000939	53	4	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0119297	10.1371/journal.pone.0119297	http://dx.doi.org/10.1371/journal.pone.0119297			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25793410	Green Published, gold, Green Submitted			2022-12-27	WOS:000352084200069
J	Bukontaite, R; Ranarilalatiana, T; Randriamihaja, JH; Bergsten, J				Bukontaite, Rasa; Ranarilalatiana, Tolotra; Randriamihaja, Jacquelin Herisahala; Bergsten, Johannes			In or Out-of-Madagascar?-Colonization Patterns for Large-Bodied Diving Beetles (Coleoptera: Dytiscidae)	PLOS ONE			English	Article							DISPERSAL-VICARIANCE ANALYSIS; EXONEURINE ALLODAPINE BEES; MOLECULAR PHYLOGENY; SINGLE-ORIGIN; EVOLUTIONARY HISTORY; ENDEMIC CLADES; DIVERSIFICATION; BIOGEOGRAPHY; RADIATION; INFERENCE	High species diversity and endemism within Madagascar is mainly the result of species radiations following colonization from nearby continents or islands. Most of the endemic taxa are thought to be descendants of a single or small number of colonizers that arrived from Africa sometime during the Cenozoic and gave rise to highly diverse groups. This pattern is largely based on vertebrates and a small number of invertebrate groups. Knowledge of the evolutionary history of aquatic beetles on Madagascar is lacking, even though this species-rich group is often a dominant part of invertebrate freshwater communities in both standing and running water. Here we focus on large bodied diving beetles of the tribes Hydaticini and Cybistrini. Our aims with this study were to answer the following questions 1) How many colonization events does the present Malagasy fauna originate from? 2) Did any colonization event lead to a species radiation? 3) Where did the colonizers come from-Africa or Asia- and has there been any out-of-Madagascar event? 4) When did these events occur and were they concentrated to any particular time interval? Our results suggest that neither in Hydaticini nor in Cybistrini was there a single case of two or more endemic species forming a monophyletic group. The biogeographical analysis indicated different colonization histories for the two tribes. Cybistrini required at least eight separate colonization events, including the non-endemic species, all comparatively recent except the only lotic (running water) living Cybister operosus with an inferred colonization at 29 Ma. In Hydaticini the Madagascan endemics were spread out across the tree, often occupying basal positions in different species groups. The biogeographical analyses therefore postulated the very bold hypothesis of a Madagascan origin at a very deep basal node within Hydaticus and multiple out-of-Madagascar dispersal events. This hypothesis needs to be tested with equally intense taxon sampling of mainland Africa as for Madagascar.	[Bukontaite, Rasa; Bergsten, Johannes] Swedish Museum Nat Hist, Dept Zool, Box 50007, S-10405 Stockholm, Sweden; [Bukontaite, Rasa] Stockholm Univ, Dept Zool, S-10691 Stockholm, Sweden; [Ranarilalatiana, Tolotra; Randriamihaja, Jacquelin Herisahala] Univ Antananarivo, Fac Sci, Dept Entomol, Antananarivo, Madagascar; [Ranarilalatiana, Tolotra; Randriamihaja, Jacquelin Herisahala] Programme Natl Lutte Paludisme Madagascar, Antananarivo 101, Madagascar	Swedish Museum of Natural History; Stockholm University; University Antananarivo	Bukontaite, R (corresponding author), Swedish Museum Nat Hist, Dept Zool, Box 50007, S-10405 Stockholm, Sweden.	rasa.bukontaite@nrm.se			Swedish Research Council [2009-3744]; Royal Swedish Academy of Sciences [FOA09H-024]; Riksmusei Vanner (Rene och Ebba Malaises stiftelse); Entomological Society in Stockholm	Swedish Research Council(Swedish Research CouncilEuropean Commission); Royal Swedish Academy of Sciences; Riksmusei Vanner (Rene och Ebba Malaises stiftelse); Entomological Society in Stockholm	This work was supported by the Swedish Research Council (Grant No: 2009-3744) to JB, the Royal Swedish Academy of Sciences (Grant No: FOA09H-024) to JB, Riksmusei Vanner (Rene och Ebba Malaises stiftelse) to JB and from the Entomological Society in Stockholm to RB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnarsson I, 2012, CURRENT TOPICS IN PHYLOGENETICS AND PHYLOGEOGRAPHY OF TERRESTRIAL AND AQUATIC SYSTEMS, P33; Ali JR, 2010, NATURE, V463, P653, DOI 10.1038/nature08706; Almeida EAB, 2012, J BIOGEOGR, V39, P526, DOI 10.1111/j.1365-2699.2011.02624.x; [Anonymous], 2015, PHYTOPATHOLOGY, DOI DOI 10.1094/PHYTO-04-15-0101-RVW; [Anonymous], 2003, P BIOL SCI; Balke M., 1993, Koleopterologische Rundschau, V63, P39; Balke M, 2010, DYTISCIDAE GENUS RHA, P129; Balke M, 2007, ZOOL SCR, V36, P173, DOI 10.1111/j.1463-6409.2006.00265.x; Balke M, 2009, P ROY SOC B-BIOL SCI, V276, P2359, DOI 10.1098/rspb.2009.0015; Benstead JP, 2003, BIOSCIENCE, V53, P1101, DOI 10.1641/0006-3568(2003)053[1101:CMFB]2.0.CO;2; Brown JM, 2010, SYST BIOL, V59, P145, DOI 10.1093/sysbio/syp081; Buerki S, 2013, BOT J LINN SOC, V171, P304, DOI 10.1111/boj.12008; Buerki S, 2011, J BIOGEOGR, V38, P531, DOI 10.1111/j.1365-2699.2010.02432.x; Bukontaite R, 2014, BMC EVOL BIOL, V14, DOI 10.1186/1471-2148-14-5; Chapman JW, 2010, SCIENCE, V327, P682, DOI 10.1126/science.1182990; Chenoweth LB, 2011, J BIOGEOGR, V38, P1471, DOI 10.1111/j.1365-2699.2011.02488.x; Crandall KA, 2008, HYDROBIOLOGIA, V595, P295, DOI 10.1007/s10750-007-9120-3; Crottini A, 2012, P NATL ACAD SCI USA, V109, P5358, DOI 10.1073/pnas.1112487109; Daniels SR, 2006, MOL PHYLOGENET EVOL, V40, P227, DOI 10.1016/j.ympev.2006.02.022; Dijkstra KDB, 2014, ANNU REV ENTOMOL, V59, P143, DOI 10.1146/annurev-ento-011613-161958; Douady CJ, 2002, MOL PHYLOGENET EVOL, V22, P357, DOI 10.1006/mpev.2001.1055; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Duncan R.A., 1990, P ODP SCI RESULTS, V115, P43, DOI DOI 10.2973/ODP.PROC.SR.115.141.1990; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Filardi CE, 2005, NATURE, V438, P216, DOI 10.1038/nature04057; Gioria Margherita, 2014, P307; Goodman SM, 2005, UPDATED ESTIMATES BI, P39; Goswami A, 2010, ZOOL SCR, V39, P406, DOI 10.1111/j.1463-6409.2010.00433.x; Griffith MB, 1998, ANN ENTOMOL SOC AM, V91, P195, DOI 10.1093/aesa/91.2.195; Hanski I, 2007, BIOLOGY LETT, V3, P344, DOI 10.1098/rsbl.2007.0043; Harmon LJ, 2008, SYST BIOL, V57, P562, DOI 10.1080/10635150802304779; Harris AJ, 2009, J SYST EVOL, V47, P349, DOI 10.1111/j.1759-6831.2009.00044.x; Heads M, 2005, CLADISTICS, V21, P62, DOI 10.1111/j.1096-0031.2005.00052.x; Heads M, 2011, SYST BIOL, V60, P204, DOI 10.1093/sysbio/syq075; Hjalmarsson AE, 2014, ECOGRAPHY; Hjalmarsson AE, 2013, ZOOKEYS, P21, DOI 10.3897/zookeys.350.6127; Hug LA, 2007, MOL BIOL EVOL, V24, P1889, DOI 10.1093/molbev/msm115; Hunt T, 2007, SCIENCE, V318, P1913, DOI 10.1126/science.1146954; Isambert B, 2011, BIOL CONSERV, V144, P1902, DOI 10.1016/j.biocon.2011.04.016; Jackson D. J., 1956, Journal of the Linnean Society London, V43, P18; Jansa SA, 1999, CLADISTICS, V15, P253, DOI 10.1111/j.1096-0031.1999.tb00267.x; Kodandaramaiah U, 2010, J BIOGEOGR, V37, P3, DOI 10.1111/j.1365-2699.2009.02221.x; Kruger A, 2012, TAXON, V61, P629, DOI 10.1002/tax.613011; Kuntner M, 2011, MOL PHYLOGENET EVOL, V59, P477, DOI 10.1016/j.ympev.2011.02.002; Lewis PO, 2001, SYST BIOL, V50, P913, DOI 10.1080/106351501753462876; LOBL I., 2003, ARCHOSTEMATA MYXOPHA, V1, P1, DOI DOI 10.1673/031.013.12601; Losos JB, 2009, NATURE, V457, P830, DOI 10.1038/nature07893; Marshall DC, 2010, SYST BIOL, V59, P108, DOI 10.1093/sysbio/syp080; Matzke N, 2013, PROBABILISTIC HIST B, P1; McPeek MA, 2007, AM NAT, V169, pE97, DOI 10.1086/512135; Miller KB, 2003, BIOL J LINN SOC, V79, P359, DOI 10.1046/j.1095-8312.2003.00195.x; Miller KB, ECOLOGY SYSTEM UNPUB; Miller KB, 2007, ZOOL SCR, V36, P41, DOI 10.1111/j.1463-6409.2006.00254.x; Miller KB, 2009, ZOOL SCR, V38, P591, DOI 10.1111/j.1463-6409.2009.00393.x; Miraldo Andreia, 2011, Insects, V2, P112, DOI 10.3390/insects2020112; Monaghan MT, 2005, P ROY SOC B-BIOL SCI, V272, P1829, DOI 10.1098/rspb.2005.3139; Moriniere J, 2014, CLADISTICS, P1; Nazari V, 2011, J ZOOL SYST EVOL RES, V49, P204, DOI 10.1111/j.1439-0469.2011.00620.x; Nilsson AN, 2001, DYTISCIDAE COLEOPTER, P1; Nobre T, 2010, P ROY SOC B-BIOL SCI, V277, P359, DOI 10.1098/rspb.2009.1373; Nylander JAA, 2008, SYSTEMATIC BIOL, V57, P257, DOI 10.1080/10635150802044003; O'Grady P, 2008, BIOL LETTERS, V4, P195, DOI 10.1098/rsbl.2007.0575; Orsini L, 2007, CLADISTICS, V23, P145, DOI 10.1111/j.1096-0031.2006.00139.x; Parent CE, 2008, PHILOS T R SOC B, V363, P3347, DOI 10.1098/rstb.2008.0118; Pearson RG, 2009, EVOLUTION, V63, P959, DOI 10.1111/j.1558-5646.2008.00596.x; PECK SB, 1993, CAN ENTOMOL, V125, P259, DOI 10.4039/Ent125259-2; Pena C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039071; Poux C, 2005, SYST BIOL, V54, P719, DOI 10.1080/10635150500234534; Rabosky DL, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001381; Raxworthy CJ, 2008, J ZOOL, V275, P423, DOI 10.1111/j.1469-7998.2008.00460.x; Raxworthy CJ, 2002, NATURE, V415, P784, DOI 10.1038/415784a; Ree RH, 2005, EVOLUTION, V59, P2299; Ree RH, 2008, SYSTEMATIC BIOL, V57, P4, DOI 10.1080/10635150701883881; Rehan SM, 2010, MOL PHYLOGENET EVOL, V55, P1042, DOI 10.1016/j.ympev.2010.01.011; Ribera I, 2008, CLADISTICS, V24, P563, DOI 10.1111/j.1096-0031.2007.00192.x; Rocchi S., 1991, Frustula Entomologica, V14, P71; Rocha S, 2007, MOL PHYLOGENET EVOL, V43, P685, DOI 10.1016/j.ympev.2006.07.010; Ronquist F, 1997, SYST BIOL, V46, P195, DOI 10.2307/2413643; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Ronquist F, 2011, ANNU REV ECOL EVOL S, V42, P441, DOI 10.1146/annurev-ecolsys-102209-144710; Samonds KE, 2012, P NATL ACAD SCI USA, V109, P5352, DOI 10.1073/pnas.1113993109; Sandwell DT, 2014, SCIENCE, V346, P65, DOI 10.1126/science.1258213; Sanmartin I, 2004, SYST BIOL, V53, P216, DOI 10.1080/10635150490423430; Sauquet H, 2012, SYST BIOL, V61, P289, DOI 10.1093/sysbio/syr116; Schwarz MP, 2006, SYST BIOL, V55, P31, DOI 10.1080/10635150500431148; Sole CL, 2011, INSECT SYST EVOL, V42, P29, DOI 10.1163/187631211X552800; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Toon A, 2010, J BIOGEOGR, V37, P2275, DOI 10.1111/j.1365-2699.2010.02374.x; Upchurch P, 2008, TRENDS ECOL EVOL, V23, P229, DOI 10.1016/j.tree.2007.11.006; van den Bogaard P, 2013, SCI REP-UK, V3, DOI 10.1038/srep02107; Vences M, 2009, TRENDS ECOL EVOL, V24, P456, DOI 10.1016/j.tree.2009.03.011; Vuataz L, 2013, MOL PHYLOGENET EVOL, V66, P979, DOI 10.1016/j.ympev.2012.12.003; Warren BH, 2003, MOL PHYLOGENET EVOL, V29, P67, DOI 10.1016/S1055-7903(03)00063-0; Weir JT, 2008, MOL ECOL, V17, P2321, DOI 10.1111/j.1365-294X.2008.03742.x; Welch JJ, 2005, TRENDS ECOL EVOL, V20, P320, DOI 10.1016/j.tree.2005.02.007; Wells NA, 2003, SOME HYPOTHESES MESO; Wikstrom N, 2010, J BIOGEOGR, V37, P1094, DOI 10.1111/j.1365-2699.2009.02258.x; Wilme L, 2006, SCIENCE, V312, P1063, DOI 10.1126/science.1122806; Wirta H, 2010, MOL PHYLOGENET EVOL, V57, P710, DOI 10.1016/j.ympev.2010.08.013; Yoder AD, 2003, NATURE, V421, P734, DOI 10.1038/nature01303; Yoder AD, 2006, ANNU REV ECOL EVOL S, V37, P405, DOI 10.1146/annurev.ecolsys.37.091305.110239; Yu Y, 2010, MOL PHYLOGENET EVOL, V56, P848, DOI 10.1016/j.ympev.2010.04.011; Zakharov EV, 2004, EVOLUTION, V58, P2763	106	16	16	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0120777	10.1371/journal.pone.0120777	http://dx.doi.org/10.1371/journal.pone.0120777			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25794184	Green Submitted, Green Published, gold			2022-12-27	WOS:000352083900074
J	Dicay, MS; Hirota, CL; Ronaghan, NJ; Peplowski, MA; Zaheer, RS; Carati, CA; MacNaughton, WK				Dicay, Michael S.; Hirota, Christina L.; Ronaghan, Natalie J.; Peplowski, Michael A.; Zaheer, Raza S.; Carati, Colin A.; MacNaughton, Wallace K.			Interferon-gamma Suppresses Intestinal Epithelial Aquaporin-1 Expression via Janus Kinase and STAT3 Activation	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; ULCERATIVE-COLITIS; RECEPTOR; IRF-1; TRANSLOCATION; MACROPHAGES; MODEL	Inflammatory bowel diseases are associated with dysregulated electrolyte and water transport and resultant diarrhea. Aquaporins are transmembrane proteins that function as water channels in intestinal epithelial cells. We investigated the effect of the inflammatory cytokine, interferon-gamma, which is a major player in inflammatory bowel diseases, on aquaporin-1 expression in a mouse colonic epithelial cell line, CMT93. CMT93 monolayers were exposed to 10 ng/mL interferon-gamma and aquaporin-1 mRNA and protein expressions were measured by real-time PCR and western blot, respectively. In other experiments, CMT93 cells were pretreated with inhibitors or were transfected with siRNA to block the effects of Janus kinases, STATs 1 and 3, or interferon regulatory factor 2, prior to treatment with interferon-gamma. Interferon-gamma decreased aquaporin-1 expression in mouse intestinal epithelial cells in a manner that did not depend on the classical STAT1/JAK2/IRF-1 pathway, but rather, on an alternate Janus kinase (likely JAK1) as well as on STAT3. The pro-inflammatory cytokine, interferon-gamma may contribute to diarrhea associated with intestinal inflammation in part through regulation of the epithelial aquaporin-1 water channel via a non-classical JAK/STAT receptor signalling pathway.	[Dicay, Michael S.; Hirota, Christina L.; Ronaghan, Natalie J.; Peplowski, Michael A.; Zaheer, Raza S.; MacNaughton, Wallace K.] Univ Calgary, Inflammat Res Network, Calgary, AB, Canada; [Dicay, Michael S.; Hirota, Christina L.; Ronaghan, Natalie J.; Peplowski, Michael A.; Zaheer, Raza S.; MacNaughton, Wallace K.] Univ Calgary, Dept Physiol & Pharmacol, Calgary, AB, Canada; [Carati, Colin A.] Flinders Univ S Australia, Dept Anat & Histol, Bedford Pk, SA 5042, Australia	University of Calgary; University of Calgary; Flinders University South Australia	MacNaughton, WK (corresponding author), Univ Calgary, Inflammat Res Network, Calgary, AB, Canada.	wmacnaug@ucalgary.ca	Hirota, Christina/AAS-8585-2020	Hirota, Christina/0000-0003-0799-2041	Crohn's and Colitis Foundation of Canada	Crohn's and Colitis Foundation of Canada	Funding was provided by Crohn's and Colitis Foundation of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Ani B, 1999, BRIT J PHARMACOL, V128, P1105, DOI 10.1038/sj.bjp.0702834; Asfaha S, 2001, AM J PHYSIOL-GASTR L, V281, pG635, DOI 10.1152/ajpgi.2001.281.3.G635; Blanco JCG, 2000, J EXP MED, V191, P2131, DOI 10.1084/jem.191.12.2131; Caldenhoven E, 1999, J LEUKOCYTE BIOL, V65, P391, DOI 10.1002/jlb.65.3.391; Duan ZF, 2006, CLIN CANCER RES, V12, P6844, DOI 10.1158/1078-0432.CCR-06-1330; Finley MJ, 2011, J LEUKOCYTE BIOL, V90, P111, DOI 10.1189/jlb.1010546; FRANKS LM, 1978, J PATHOL, V124, P35, DOI 10.1002/path.1711240108; Glover LE, 2011, J IMMUNOL, V186, P1790, DOI 10.4049/jimmunol.1001442; HARADA H, 1994, MOL CELL BIOL, V14, P1500, DOI 10.1128/MCB.14.2.1500; Hardin JA, 2004, CELL TISSUE RES, V318, P313, DOI 10.1007/s00441-004-0932-4; Hering NA, 2012, J PHYSIOL-LONDON, V590, P1035, DOI 10.1113/jphysiol.2011.224568; KAMIJO R, 1994, SCIENCE, V263, P1612, DOI 10.1126/science.7510419; Kaser A, 2010, ANNU REV IMMUNOL, V28, P573, DOI 10.1146/annurev-immunol-030409-101225; Laforenza U, 2012, MOL ASPECTS MED, V33, P642, DOI 10.1016/j.mam.2012.03.001; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; McKay DM, 1996, AM J PHYSIOL-CELL PH, V270, pC418, DOI 10.1152/ajpcell.1996.270.2.C418; Ng IHW, 2012, BIOCHEM J, V447, P125, DOI 10.1042/BJ20120941; Paul G, 2012, J BIOL CHEM, V287, P2144, DOI 10.1074/jbc.M111.318139; Ramana CV, 2002, TRENDS IMMUNOL, V23, P96, DOI 10.1016/S1471-4906(01)02118-4; Sakai H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054788; Salkowski CA, 1999, J IMMUNOL, V163, P1529; Scharl M, 2009, J BIOL CHEM, V284, P27952, DOI 10.1074/jbc.M109.046292; Thiagarajah JR, 2007, GUT, V56, P1529, DOI 10.1136/gut.2006.104620; Zahn A, 2007, WORLD J GASTROENTERO, V13, P1687, DOI 10.3748/wjg.v13.i11.1687	24	12	12	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0118713	10.1371/journal.pone.0118713	http://dx.doi.org/10.1371/journal.pone.0118713			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25793528	gold, Green Published, Green Submitted			2022-12-27	WOS:000352084200034
J	Kang, SH; Jung, DJ; Cho, KH; Park, JW; Yoon, KW; Do, JY				Kang, Seok Hui; Jung, Da Jung; Cho, Kyu Hyang; Park, Jong Won; Yoon, Kyung Woo; Do, Jun Young			The Association between Metabolic Syndrome or Chronic Kidney Disease and Hearing Thresholds in Koreans: The Korean National Health and Nutrition Examination Survey 2009-2012	PLOS ONE			English	Article							RISK-FACTORS; US ADULTS; RENAL-FAILURE; UNITED-STATES; INNER-EAR; POPULATION; IMPAIRMENT; PREVALENCE; HYPERFILTRATION; WOMEN	Background The aim of this study was to determine whether metabolic syndrome (MetS) or chronic kidney disease (CKD) is associated with hearing thresholds in the general Korean population. Patients and Methods A total of 16,554 participants were included in this study. MetS was defined using the National Cholesterol Education Program Adult Treatment Panel III guidelines, and CKD was defined as an estimated glomerular filtration rate <60 mL/min/1.73 m(2) or a dipstick protein-uria result of >= 1+. The hearing thresholds were measured at 0.5, 1, 2, 3, 4, and 6 kHz. Low-frequency (Freq) was defined as pure-tone averages at 0.5 and 1 kHz, while Mid-Freq and High-Freq were defined as the average thresholds at mid-frequency (2 and 3 kHz) and high frequency (4 and 6 kHz), respectively. Results In men, the hearing thresholds were 15.1 +/- 14.5 dB, 22.2 +/- 21.3 dB, and 37.3 +/- 26.5 dB for Low-, Mid-, and High-Freq, respectively. In women, the hearing thresholds were 14.9 +/- 15.3 dB, 16.6 +/- 18.0 dB, and 26.1 +/- 21.5 dB for Low-, Mid-, and High-Freq, respectively. The hearing thresholds for men were significantly higher than the hearing thresholds for women in all 3 threshold categories. Male and female subjects with MetS or CKD had higher hearing thresholds than the subjects that did not have these disorders. In the multivariate analysis, MetS was associated with increased hearing thresholds in women, and CKD was associated with increased hearing thresholds in men and women. Conclusion MetS is associated with hearing thresholds in women, and CKD is associated with hearing thresholds in men and women. Therefore, patients with MetS or CKD should be closely monitored for hearing impairment.	[Kang, Seok Hui; Cho, Kyu Hyang; Park, Jong Won; Yoon, Kyung Woo; Do, Jun Young] Yeungnam Univ Hosp, Dept Internal Med, Div Nephrol, Daegu, South Korea; [Jung, Da Jung] Kyungpook Natl Univ Hosp, Dept Otorhinolaryngol Head & Neck Surg, Sch Med, Daegu, South Korea	Yeungnam University; Yeungnam University Hospital; Kyungpook National University; Kyungpook National University Hospital	Do, JY (corresponding author), Yeungnam Univ Hosp, Dept Internal Med, Div Nephrol, Daegu, South Korea.	jydo@med.yu.ac.kr						ADLER D, 1980, ACTA OTO-LARYNGOL, V90, P55, DOI 10.3109/00016488009131697; Agrawal Y, 2008, ARCH INTERN MED, V168, P1522, DOI 10.1001/archinte.168.14.1522; Agrawal Y, 2009, OTOL NEUROTOL, V30, P139, DOI 10.1097/MAO.0b013e318192483c; Akiyama K, 2010, J HISTOCHEM CYTOCHEM, V58, P759, DOI 10.1369/jhc.2010.956045; [Anonymous], 2010, AUDIOL MED; Antonelli A R, 1990, Acta Otolaryngol Suppl, V476, P54; ARNOLD W, 1984, ANN OTO RHINOL LARYN, V93, P119, DOI 10.1177/00034894840930S420; Bainbridge KE, 2008, ANN INTERN MED, V149, P1, DOI 10.7326/0003-4819-149-1-200807010-00231; Bainbridge KE, 2011, DIABETES CARE, V34, P1540, DOI 10.2337/dc10-2161; Bainbridge KE, 2010, DIABETES CARE, V33, P811, DOI 10.2337/dc09-1193; BAZZI C, 1995, NEPHROL DIAL TRANSPL, V10, P1865; Brouns R, 2004, CLIN NEUROL NEUROSUR, V107, P1, DOI 10.1016/j.clineuro.2004.07.012; Cao X, 2014, INT UROL NEPHROL, V46, P2183, DOI 10.1007/s11255-014-0805-z; DEFRONZO RA, 1981, J CLIN INVEST, V67, P563, DOI 10.1172/JCI110067; Fetoni AR, 2011, EXP GERONTOL, V46, P413, DOI 10.1016/j.exger.2010.12.003; Flamme GA, 2011, INT J AUDIOL, V50, pS11, DOI 10.3109/14992027.2010.540582; Ford ES, 2002, JAMA-J AM MED ASSOC, V287, P356, DOI 10.1001/jama.287.3.356; Fransen E, 2008, JARO-J ASSOC RES OTO, V9, P264, DOI 10.1007/s10162-008-0123-1; Frisina ST, 2006, HEARING RES, V211, P103, DOI 10.1016/j.heares.2005.09.002; GATLAND D, 1991, J ROY SOC MED, V84, P587; Gohh R., 2013, R I MED J, V104, P14; Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404; Haroun MK, 2003, J AM SOC NEPHROL, V14, P2934, DOI 10.1097/01.ASN.0000095249.99803.85; Hederstierna C, 2007, ACTA OTO-LARYNGOL, V127, P149, DOI 10.1080/00016480600794446; Hwang JH, 2011, CLIN ENDOCRINOL, V75, P614, DOI 10.1111/j.1365-2265.2011.04090.x; Kang HT, 2013, NEPHROL DIAL TRANSPL, V28, P927, DOI 10.1093/ndt/gfs535; Kang JW, 2014, AM J CLIN NUTR, V99, P1407, DOI 10.3945/ajcn.113.072793; Kang YU, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093795; Kidney Disease: Improving Global Outcomes (KDIGO) Blood Pressure Work Group, 2012, KIDNEY INT SUPPL, V2, P337; Lakka HM, 2002, JAMA-J AM MED ASSOC, V288, P2709, DOI 10.1001/jama.288.21.2709; Levey AS, 2007, KIDNEY INT, V72, P247, DOI 10.1038/sj.ki.5002343; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Levin A, 2013, KIDNEY INT SUPPL, V3, P5, DOI 10.1038/kisup.2012.77; Magee GM, 2009, DIABETOLOGIA, V52, P691, DOI 10.1007/s00125-009-1268-0; Melsom T, 2011, DIABETES CARE, V34, P1546, DOI 10.2337/dc11-0235; Miller RK, 2010, DEV DYNAM, V239, P77, DOI 10.1002/dvdy.22059; MORTON LP, 1992, ADV PERIT D, V8, P150; Odagiri K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088873; Oh SW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094120; Ohashi T, 1999, ANN OTO RHINOL LARYN, V108, P955, DOI 10.1177/000348949910801006; Park HS, 2004, INT J EPIDEMIOL, V33, P328, DOI 10.1093/ije/dyh032; Schaeffner ES, 2008, NEPHROL DIAL TRANSPL, V23, P1246, DOI 10.1093/ndt/gfm757; Shargorodsky J, 2010, LARYNGOSCOPE, V120, P1887, DOI 10.1002/lary.21039; Thodi C, 2006, NEPHROL DIAL TRANSPL, V21, P3023, DOI 10.1093/ndt/gfl472; Tsuruya K, 2014, ATHEROSCLEROSIS, V233, P260, DOI 10.1016/j.atherosclerosis.2013.12.037; Vilayur E, 2010, AM J KIDNEY DIS, V56, P661, DOI 10.1053/j.ajkd.2010.05.015; Woodcock K, 2008, INT J REHABIL RES, V31, P297, DOI 10.1097/MRR.0b013e3282fb7d4d; Yamasoba T, 2013, HEARING RES, V303, P30, DOI 10.1016/j.heares.2013.01.021	48	19	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0120372	10.1371/journal.pone.0120372	http://dx.doi.org/10.1371/journal.pone.0120372			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25794036	gold, Green Published, Green Submitted			2022-12-27	WOS:000352083900019
J	Liu, X; Hinney, A; Scholz, M; Scherag, A; Tonjes, A; Stumvoll, M; Stadler, PF; Hebebrand, J; Bottcher, Y				Liu, Xuanshi; Hinney, Anke; Scholz, Markus; Scherag, Andre; Toenjes, Anke; Stumvoll, Michael; Stadler, Peter F.; Hebebrand, Johannes; Boettcher, Yvonne			Indications for Potential Parent-of-Origin Effects within the FTO Gene	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; BODY-MASS INDEX; COMMON VARIANTS; FAT MASS; MISSING HERITABILITY; SEQUENCE VARIANTS; EARLY-ONSET; LOCI; OBESITY; POPULATION	Genome-Wide Association Studies (GWAS) were successfully applied to discover associations with obesity. However, the GWAS design is usually based on unrelated individuals and inheritance information on the parental origin of the alleles is missing. Taking into account parent-of-origin may provide further insights into the genetic mechanisms contributing to obesity. We hypothesized that there may be variants within the robustly replicated fat mass and obesity associated (FTO) gene that may confer different risk for obesity depending on transmission from mother or father. Genome-wide genotypes and pedigree information from the Sorbs population were used. Phased genotypes among 525 individuals were generated by AlphaImpute. Subsequently, 22 SNPs within FTO introns 1 to 3 were selected and parent-of-origin specific association analyses were performed using PLINK. Interestingly, we identified several SNPs conferring different genetic effects (P <= 0.05) depending on parental origin-among them, rs1861868, rs1121980 and rs9939973 (all in intron 1). To confirm our findings, we investigated the selected variants in 705 German trios comprising an (extremely) obese child or adolescent and both parents. Again, we observed evidence for POE effects in intron 2 and 3 (P <= 0.05) as indicated by the parental asymmetry test. Our results suggest that the obesity risk transmitted by several FTO variants may depend on the parental origin of the allele. Larger family-based studies are warranted to replicate our findings.	[Liu, Xuanshi; Stumvoll, Michael; Boettcher, Yvonne] Univ Leipzig, IFB Adipos Dis, D-04109 Leipzig, Germany; [Liu, Xuanshi] Univ Leipzig, Dept Comp Sci, Bioinformat Grp, D-04109 Leipzig, Germany; [Hinney, Anke; Hebebrand, Johannes] Univ Duisburg Essen, Psychosomat & Psychotherapy Uni Klinkum Essen, Dept Child & Adolescent Psychiat, Essen, Germany; [Scholz, Markus] Univ Leipzig, Inst Med Informat Stat & Epidemiol, D-04109 Leipzig, Germany; [Scherag, Andre] Jena Univ Hosp, CSCC, Integrated Res & Treatment Ctr IFB, Clin Epidemiol, Jena, Germany; [Toenjes, Anke; Stumvoll, Michael] Univ Leipzig, Dept Med, D-04109 Leipzig, Germany; [Stadler, Peter F.] AG RNom, Fraunhofer Inst Cell Therapy & Immunol, Leipzig, Germany; [Stadler, Peter F.] Univ Leipzig, Interdisciplinary Ctr Bioinformat, D-04109 Leipzig, Germany; [Stadler, Peter F.] Univ Vienna, Inst Theoret Chem, Vienna, Austria; [Stadler, Peter F.] Sante Fe Inst, Santa Fe, NM USA	Leipzig University; Leipzig University; University of Duisburg Essen; Leipzig University; Friedrich Schiller University of Jena; Leipzig University; Fraunhofer Gesellschaft; Leipzig University; University of Vienna; The Santa Fe Institute	Bottcher, Y (corresponding author), Univ Leipzig, IFB Adipos Dis, D-04109 Leipzig, Germany.	yvonne.boettcher@medizin.uni-leipzig.de	Hinney, Anke/D-6953-2011; Stumvoll, Michael/ABE-1121-2021; Stadler, Peter F. F/L-7857-2015	Hinney, Anke/0000-0001-5659-0706; Stumvoll, Michael/0000-0001-6225-8240; Stadler, Peter F. F/0000-0002-5016-5191	German Research Foundation [BO 3147/4-1, DFG - SFB 1052 C01, SPP 1629 TO 718/2-1]; German Diabetes Association; DDS Foundation; IFB AdiposityDiseases [ADI-K50D, K7-45, ADI-K7-39, ADI-K-7-38]; Federal Ministry of Education and Research (BMBF), Germany [FKZ: 01EO1001, FKZ: 01EO1002, 01GI1120A, 01GI1120B]; Kompetenznetz Adipositas (Competence network for Obesity) - Federal Ministry of Education and Research (German Obesity Biomaterial Bank) [FKZ 01GI1128]; Deutsche Forschungsgemeinschaft [SFB 1052/1, HI1865/2-1]; LIFE - Leipzig Research Center for Civilization Diseases, University of Leipzig; European Union; European Regional Development Fund (ERDF); Free State of Saxony; European Union [262055 ESGI]; BMBF (NGFN-Plus) [01GS0820]	German Research Foundation(German Research Foundation (DFG)); German Diabetes Association; DDS Foundation; IFB AdiposityDiseases; Federal Ministry of Education and Research (BMBF), Germany(Federal Ministry of Education & Research (BMBF)); Kompetenznetz Adipositas (Competence network for Obesity) - Federal Ministry of Education and Research (German Obesity Biomaterial Bank); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); LIFE - Leipzig Research Center for Civilization Diseases, University of Leipzig; European Union(European Commission); European Regional Development Fund (ERDF)(European Commission); Free State of Saxony; European Union(European Commission); BMBF (NGFN-Plus)(Federal Ministry of Education & Research (BMBF))	This work was supported by the German Research Foundation (BO 3147/4-1 to Y.B and DFG - SFB 1052 C01, SPP 1629 TO 718/2-1 to A.T.). This work was further supported by grants from the German Diabetes Association (to Y.B.) and from the DDS Foundation to Y.B. Y.B was further supported by a research grant from the IFB AdiposityDiseases ADI-K50D; K7-45; and ADI-K7-39, ADI-K-7-38. IFB AdiposityDiseases is supported by the Federal Ministry of Education and Research (BMBF), Germany, FKZ: 01EO1001. This work was further supported by the Kompetenznetz Adipositas (Competence network for Obesity) funded by the Federal Ministry of Education and Research (German Obesity Biomaterial Bank; FKZ 01GI1128), a grant from Deutsche Forschungsgemeinschaft the SFB 1052/1: "Obesity mechanisms" (project A01) (to M. S.). This work is supported by LIFE - Leipzig Research Center for Civilization Diseases, University of Leipzig. LIFE is funded by means of the European Union, by the European Regional Development Fund (ERDF) and by means of the Free State of Saxony within the framework of the excellence initiative. The work of A.H. was supported by grants from the European Union (FP7 no262055 ESGI), the BMBF (NGFN-Plus; 01GS0820) and the Deutsche Forschungsgemeinschaft (HI1865/2-1). A. S. who performed the PAT analyses is supported by the Federal Ministry of Education and Research (BMBF), Germany, FKZ: 01EO1002, 01GI1120A, and 01GI1120B. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett Jeffrey C, 2009, Cold Spring Harb Protoc, V2009, DOI 10.1101/pdb.ip71; Berndt SI, 2013, NAT GENET, V45, P501, DOI 10.1038/ng.2606; Cichon S, 2001, HUM MOL GENET, V10, P2933, DOI 10.1093/hmg/10.25.2933; Daniels SE, 1996, NATURE, V383, P247, DOI 10.1038/383247a0; Dina C, 2007, NAT GENET, V39, P724, DOI 10.1038/ng2048; Eichler EE, 2010, NAT REV GENET, V11, P446, DOI 10.1038/nrg2809; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Gong J, 2013, AM J HUM GENET, V93, P661, DOI 10.1016/j.ajhg.2013.08.012; Gorkin DU, 2014, NATURE, V507, P309, DOI 10.1038/nature13212; Gross A, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-67; Guo YR, 2013, HUM MOL GENET, V22, P184, DOI 10.1093/hmg/dds396; Hebebrand J, 1994, AKTUELLE ERNAHRUNGSM; Hickey JM, 2012, GENET SEL EVOL, V44, DOI 10.1186/1297-9686-44-9; Hinney A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001361; Hoggart CJ, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004508; Karason A, 2003, AM J HUM GENET, V72, P125, DOI 10.1086/345646; Keating BJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003583; Knoll N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055884; Kong A, 2008, NAT GENET, V40, P1068, DOI 10.1038/ng.216; Kong A, 2009, NATURE, V462, P868, DOI 10.1038/nature08625; Loos RJF, 2008, NAT GENET, V40, P768, DOI 10.1038/ng.140; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Meyre D, 2009, NAT GENET, V41, P157, DOI 10.1038/ng.301; Okada Y, 2012, NAT GENET, V44, P302, DOI 10.1038/ng.1086; Paterson AD, 1999, HUM HERED, V49, P197, DOI 10.1159/000022875; Peters U, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003171; Pruim RJ, 2010, BIOINFORMATICS, V26, P2336, DOI 10.1093/bioinformatics/btq419; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Scherag A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000916; Scuteri A, 2007, PLOS GENET, V3, P1200, DOI 10.1371/journal.pgen.0030115; Smemo S, 2014, NATURE, V507, P371, DOI 10.1038/nature13138; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Thorleifsson G, 2009, NAT GENET, V41, P18, DOI 10.1038/ng.274; Tonjes A, 2010, EUR J HUM GENET, V18, P104, DOI 10.1038/ejhg.2009.107; Veeramah KR, 2011, EUR J HUM GENET, V19, P995, DOI 10.1038/ejhg.2011.65; Villalobos-Comparan M, 2008, OBESITY, V16, P2296, DOI 10.1038/oby.2008.367; Weinberg CR, 1999, AM J HUM GENET, V65, P229, DOI 10.1086/302466; Welter D, 2014, NUCLEIC ACIDS RES, V42, pD1001, DOI 10.1093/nar/gkt1229; Wen WQ, 2012, NAT GENET, V44, P307, DOI 10.1038/ng.1087; Willer CJ, 2009, NAT GENET, V41, P25, DOI 10.1038/ng.287	40	20	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0119206	10.1371/journal.pone.0119206	http://dx.doi.org/10.1371/journal.pone.0119206			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25793382	Green Submitted, Green Published, gold			2022-12-27	WOS:000352084200060
J	McCarty, G; Loeb, DM				McCarty, Gregory; Loeb, David M.			Hypoxia-Sensitive Epigenetic Regulation of an Antisense-Oriented lncRNA Controls WT1 Expression in Myeloid Leukemia Cells	PLOS ONE			English	Article							TUMOR SUPPRESSOR WT1; MINIMAL RESIDUAL DISEASE; DNA METHYLATION; MESSENGER-RNA; PEDIATRIC AML; GENE WT1; DIFFERENTIATION; DIAGNOSIS; SURVIVAL; ROLES	WT1 is a transcription factor expressed in hematopoietic stem cells and in most cases of myeloid leukemia. We investigated the roles of hypoxia and epigenetics in the regulation of WT1 expression in myeloid leukemia cells. WT1 expression correlates with hypomethylation of the CpG island in Intron 1, and pharmacologic demethylation of this CpG island induces WT1 mRNA expression. Hypoxia causes decreases in DNMT expression and activity and increased expression and activity of TET2 and TET3, resulting in demethylation of this CpG island and expression of WT1 mRNA. Demethylation of the CpG island, either from pharmacologic treatment or induction of hypoxia, results in transcription of an antisense-oriented lncRNA, and inhibiting lncRNA expression with shRNA blocks WT1 mRNA expression. These results reveal a novel model of hypoxia-mediated epigenetic gene regulation. In addition, this is the first report that TET2 and TET3, increasingly recognized as important epigenetic regulators of gene expression in stem cells and in cancer cells, can be regulated by hypoxia, providing a solid mechanistic link between hypoxia and epigenetic regulation of gene expression with important implications for the role of hypoxia in stem cell function.	[McCarty, Gregory; Loeb, David M.] Johns Hopkins Univ, Dept Oncol, Div Pediat Oncol, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21231 USA	Johns Hopkins University; Johns Hopkins Medicine	Loeb, DM (corresponding author), Johns Hopkins Univ, Dept Oncol, Div Pediat Oncol, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21231 USA.	loebda@jhmi.edu			Children's Cancer Foundation; Heather Brooke Foundation; Giant Food Children's Cancer Research Fund	Children's Cancer Foundation; Heather Brooke Foundation; Giant Food Children's Cancer Research Fund	This work was funded by the Children's Cancer Foundation, The Heather Brooke Foundation, Giant Food Children's Cancer Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beerman I, 2013, CELL STEM CELL, V12, P413, DOI 10.1016/j.stem.2013.01.017; CALL KM, 1990, CELL, V60, P509, DOI 10.1016/0092-8674(90)90601-A; Challen GA, 2012, NAT GENET, V44, P23, DOI 10.1038/ng.1009; Chapuis AG, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004916; Chawla RK, 1996, J CELL BIOCHEM, V61, P72; Cheever MA, 2009, CLIN CANCER RES, V15, P5323, DOI 10.1158/1078-0432.CCR-09-0737; Cilloni D, 2009, J CLIN ONCOL, V27, P5195, DOI 10.1200/JCO.2009.22.4865; Dallosso AR, 2007, RNA, V13, P2287, DOI 10.1261/rna.562907; Dallosso AR, 2004, HUM MOL GENET, V13, P405, DOI 10.1093/hmg/ddh038; Dao T, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005661; Eliasson P, 2010, J CELL PHYSIOL, V222, P17, DOI 10.1002/jcp.21908; Ellisen LW, 2001, EMBO J, V20, P1897, DOI 10.1093/emboj/20.8.1897; Fatemi M, 2014, CANCER-AM CANCER SOC, V120, P172, DOI 10.1002/cncr.28316; Gal-Yam EN, 2008, ANNU REV MED, V59, P267, DOI 10.1146/annurev.med.59.061606.095816; GESSLER M, 1990, NATURE, V343, P774, DOI 10.1038/343774a0; Ho PA, 2014, PEDIATR BLOOD CANCER, V61, P81, DOI 10.1002/pbc.24700; INOUE K, 1994, BLOOD, V84, P3071, DOI 10.1182/blood.V84.9.3071.3071; JINNO Y, 1994, NAT GENET, V6, P305, DOI 10.1038/ng0394-305; Loeb DM, 2001, CANCER RES, V61, P921; Malik K, 2000, CANCER RES, V60, P2356; Maurer U, 1997, EXP HEMATOL, V25, P945; McCarty G, 2011, J BIOL CHEM, V286, P43634, DOI 10.1074/jbc.M111.310128; Melvin A, 2012, CELL SIGNAL, V24, P35, DOI 10.1016/j.cellsig.2011.08.019; Miglino M, 2011, LEUKEMIA LYMPHOMA, V52, P1961, DOI 10.3109/10428194.2011.585673; MIWA H, 1992, LEUKEMIA, V6, P405; Moorwood K, 1998, J PATHOL, V185, P352, DOI 10.1002/(SICI)1096-9896(199808)185:4<352::AID-PATH119>3.0.CO;2-#; Noronha SA, 2009, PEDIATR BLOOD CANCER, V53, P1136, DOI 10.1002/pbc.22142; Piccolo FM, 2013, MOL CELL, V49, P1023, DOI 10.1016/j.molcel.2013.01.032; Shahrzad S, 2007, EPIGENETICS-US, V2, P119, DOI 10.4161/epi.2.2.4613; Shide K, 2012, LEUKEMIA, V26, P2216, DOI 10.1038/leu.2012.94; Skowronski K, 2010, EPIGENETICS-US, V5, DOI 10.4161/epi.5.6.12400; Smith ZD, 2013, NAT REV GENET, V14, P204, DOI 10.1038/nrg3354; Wagner KD, 2003, FASEB J, V17, P1364, DOI 10.1096/fj.02-1065fje; Wagner KD, 2002, FASEB J, V16, P1117, DOI 10.1096/fj.01-0986fje; Ward A, 1998, J PATHOL, V185, P342, DOI 10.1002/(SICI)1096-9896(199808)185:4<342::AID-PATH136>3.0.CO;2-9; Willasch AM, 2009, LEUKEMIA, V23, P1472, DOI 10.1038/leu.2009.51; Yang WT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088827	37	47	48	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0119837	10.1371/journal.pone.0119837	http://dx.doi.org/10.1371/journal.pone.0119837			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25794157	Green Published, gold, Green Submitted			2022-12-27	WOS:000352084200121
J	Moser, CB; Gupta, M; Archer, BN; White, LF				Moser, Carlee B.; Gupta, Mayetri; Archer, Brett N.; White, Laura F.			The Impact of Prior Information on Estimates of Disease Transmissibility Using Bayesian Tools	PLOS ONE			English	Article							INFLUENZA-A H1N1; SERIAL INTERVAL; REPRODUCTION NUMBER; GENERATION INTERVAL; PARAMETERS	The basic reproductive number (R-0) and the distribution of the serial interval (SI) are often used to quantify transmission during an infectious disease outbreak. In this paper, we present estimates of R-0 and SI from the 2003 SARS outbreak in Hong Kong and Singapore, and the 2009 pandemic influenza A(H1N1) outbreak in South Africa using methods that expand upon an existing Bayesian framework. This expanded framework allows for the incorporation of additional information, such as contact tracing or household data, through prior distributions. The results for the R-0 and the SI from the influenza outbreak in South Africa were similar regardless of the prior information ((R-0) over cap = 1.36-1.46, (mu) over cap = 2.0-2.7, (mu) over cap = mean of the SI). The estimates of R-0 and mu for the SARS outbreak ranged from 2.0-4.4 and 7.4-11.3, respectively, and were shown to vary depending on the use of contact tracing data. The impact of the contact tracing data was likely due to the small number of SARS cases relative to the size of the contact tracing sample.	[Moser, Carlee B.; Gupta, Mayetri; White, Laura F.] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02215 USA; [Archer, Brett N.] Natl Inst Communicable Dis, Natl Hlth Lab Serv, Johannesburg, South Africa	Boston University; National Health Laboratory Service; National Institute for Communicable Diseases (NICD)	Moser, CB (corresponding author), Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02215 USA.	cmoser@sdac.harvard.edu	Archer, Brett Nicholas/A-5610-2012	Archer, Brett Nicholas/0000-0002-4144-1094; White, Laura F/0000-0002-0588-8235	National Institute of General Medical Sciences [U54GM088558]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM088558] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	LFW was supported by the National Institute of General Medical Sciences (Grant U54GM088558). CBM, MG, and BNA received no specific funding for this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, R LANG ENV STAT COMP; [Anonymous], INFECT DIS HUMANS DY; Archer BN, 2009, EUROSURVEILLANCE, V14, P11; Archer BN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049482; Archer BN, 2012, J INFECT DIS, V206, pS148, DOI 10.1093/infdis/jis583; Becker NG, 2010, EURO SURVEILL, V14; Benavoli A., 2011, IJCAI 2011 P INT JOI, P2107; Bernardo JM, 1998, J ROY STAT SOC D-STA, V47, P101; Black AJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073420; Cauchemez S, 2004, STAT MED, V23, P3469, DOI 10.1002/sim.1912; Chowell G, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-214; Cowling BJ, 2009, EPIDEMIOLOGY, V20, P344, DOI 10.1097/EDE.0b013e31819d1092; Donnelly CA, 2011, CLIN INFECT DIS, V52, pS123, DOI 10.1093/cid/ciq028; Fraser C, 2004, P NATL ACAD SCI USA, V101, P6146, DOI 10.1073/pnas.0307506101; Gelman A., 2003, BAYESIAN DATA ANAL; Gelman A, 2006, BAYESIAN ANAL, V1, P515, DOI 10.1214/06-BA117A; Griffin JT, 2011, BIOSTATISTICS, V12, P303, DOI 10.1093/biostatistics/kxq058; Hens N, 2012, AM J EPIDEMIOL, V176, P196, DOI 10.1093/aje/kws006; Kelly D, 2011, RELIAB ENG SYST SAFE, V96, P398, DOI 10.1016/j.ress.2010.11.008; Kenah E, 2008, MATH BIOSCI, V213, P71, DOI 10.1016/j.mbs.2008.02.007; Lipsitch M, 2003, SCIENCE, V300, P1966, DOI 10.1126/science.1086616; Lunn D, 2009, STAT MED, V28, P3049, DOI 10.1002/sim.3680; McBryde E, 2009, EURO SURVEILL, V14; McDonald SA, 2014, INFLUENZA OTHER RESP, V8, P33, DOI 10.1111/irv.12201; Opatowski L, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002225; Shubin M, 2014, EPIDEMIOL INFECT, V142, P964, DOI 10.1017/S0950268813002537; Spiegelhalter DJ, 2002, J R STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353; Svensson A, 2007, MATH BIOSCI, V208, P300, DOI 10.1016/j.mbs.2006.10.010; te Beest DE, 2013, EPIDEMIOLOGY, V24, P244, DOI 10.1097/EDE.0b013e31827f50e8; Thomas A., 2006, R NEWS, V6, P12, DOI DOI 10.1159/000323281; Wallinga J, 2004, AM J EPIDEMIOL, V160, P509, DOI 10.1093/aje/kwh255; White LF, 2008, STAT MED, V27, P2999, DOI 10.1002/sim.3136; White LF, 2009, INFLUENZA OTHER RESP, V3, P267, DOI 10.1111/j.1750-2659.2009.00106.x; Yang F, 2013, ANN EPIDEMIOL, V23, P301, DOI 10.1016/j.annepidem.2013.04.005; Zhu M, 2004, J STAT ED, V12, P1	35	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0118762	10.1371/journal.pone.0118762	http://dx.doi.org/10.1371/journal.pone.0118762			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25793993	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000352084200038
J	Shi, M; Liu, L; Wang, ZY; Wang, L				Shi, Meng; Liu, Li; Wang, Zi Yue; Wang, Lie			The Mediating Role of Resilience in the Relationship between Big Five Personality and Anxiety among Chinese Medical Students: A Cross-Sectional Study	PLOS ONE			English	Article							DEPRESSION; TRAITS; DISORDERS; SYMPTOMS; BURDEN; HEALTH; CONSCIENTIOUSNESS; POPULATION; STABILITY; DISTRESS	Backgrounds The psychological distress of medical students is a major concern of public health world-wide. However, few studies have been conducted to evaluate anxiety symptoms of medical students in China. The purpose of this study was to investigate the anxiety symptoms among Chinese medical students, to examine the relationships between big five personality traits and anxiety symptoms among medical students, and to explore the mediating role of resilience in these relationships. Methods This multicenter cross-sectional study was conducted in June 2014. Self-reported questionnaires consisting of the Zung Self-Rating Anxiety Scale (SAS), Big Five Inventory (BFI), Wagnild and Young Resilience Scale (RS-14) and demographic section were distributed to the subjects. A stratified random cluster sampling method was used to select 2925 medical students (effective response rate: 83.57%) at four medical colleges and universities in Liaoning province, China. Asymptotic and resampling strategies were used to explore the mediating role of resilience. Results The prevalence of anxiety symptoms was 47.3%(SAS index score >= 50) among Chinese medical students. After adjusting for the demographic factors, the traits of agreeableness, conscientiousness and openness were all negatively associated with anxiety whereas neuroticism was positively associated with it. Resilience functioned as a mediator in the relationships between agreeableness/conscientiousness/openness and anxiety symptoms. Conclusions Among Chinese medical students, the prevalence of anxiety symptoms was high and resilience mediated the relationships between big five personality traits and anxiety symptoms. Identifying at-risk individuals and undertaking appropriate intervention strategies that focus on both personality traits and resilience might be more effective to prevent and reduce anxiety symptoms.	[Shi, Meng] China Med Univ, Dept English, Sch Basic Med, Shenyang 110001, Peoples R China; [Liu, Li; Wang, Zi Yue; Wang, Lie] China Med Univ, Sch Publ Hlth, Dept Social Med, Shenyang 110001, Peoples R China	China Medical University; China Medical University	Wang, L (corresponding author), China Med Univ, Sch Publ Hlth, Dept Social Med, Shenyang 110001, Peoples R China.	liewang@mail.cmu.edu.cn		Shi, Meng/0000-0002-1732-4293				Bogg T, 2004, PSYCHOL BULL, V130, P887, DOI 10.1037/0033-2909.130.6.887; Bogg T, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00370; Bowler JO, 2012, J CONSULT CLIN PSYCH, V80, P1021, DOI 10.1037/a0029932; Brandes Mina, 2006, Curr Psychiatry Rep, V8, P263, DOI 10.1007/s11920-006-0061-8; Brook Christina A, 2008, Neuropsychiatr Dis Treat, V4, P123; Bunevicius A, 2008, INT J SOC PSYCHIATR, V54, P494, DOI 10.1177/0020764008090843; Campbell-Sills L, 2006, BEHAV RES THER, V44, P585, DOI 10.1016/j.brat.2005.05.001; Cohen J., 2013, APPL MULTIPLE CORREL, DOI DOI 10.4324/9780203774441; Cooke GPE, 2013, BMC MED EDUC, V13, DOI 10.1186/1472-6920-13-2; Ding YW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107130; Dyrbye LN, 2006, ACAD MED, V81, P354, DOI 10.1097/00001888-200604000-00009; Eley DS, 2013, PEERJ, V1, DOI 10.7717/peerj.216; Fahrenkopf AM, 2008, BRIT MED J, V336, P488, DOI 10.1136/bmj.39469.763218.BE; Ferguson E, 2013, HEALTH PSYCHOL REV, V7, pS32, DOI 10.1080/17437199.2010.547985; Fraley RC, 2005, PSYCHOL REV, V112, P60, DOI 10.1037/0033-295X.112.1.60; Gaertner L, 2008, J CROSS CULT PSYCHOL, V39, P463, DOI 10.1177/0022022108318431; Gao YQ, 2012, BMC PSYCHIATRY, V12, DOI 10.1186/1471-244X-12-141; Gong YF, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0103242, 10.1371/journal.pone.0095597]; Gramstad TO, 2013, BMC MED EDUC, V13, DOI 10.1186/1472-6920-13-150; Graziano WG, 2002, J PERS, V70, P695; Hope V, 2014, MED EDUC, V48, P963, DOI 10.1111/medu.12512; Javaras KN, 2012, EMOTION, V12, P875, DOI 10.1037/a0028105; John O.P., 1999, HDB PERSONALITY THEO, VVolume 2, P102; Khanlou N, 2014, INT J MENT HEALTH AD, V12, P64, DOI 10.1007/s11469-013-9470-1; Kotter T, 2014, BMC MED EDUC, V14, DOI 10.1186/1472-6920-14-134; Kotov R, 2010, PSYCHOL BULL, V136, P768, DOI 10.1037/a0020327; Liu XC, 1997, SOC PSYCH PSYCH EPID, V32, P63, DOI 10.1007/BF00788922; Lockenhoff CE, 2008, J RES PERS, V42, P577, DOI 10.1016/j.jrp.2007.09.004; Lockenhoff CE, 2011, PSYCHOL AGING, V26, P592, DOI 10.1037/a0022209; Lupo MK, 2011, ISR MED ASSOC J, V13, P613; Luthar SS, 2007, DEV PSYCHOPATHOL, V19, P931, DOI 10.1017/S0954579407000454; Markon KE, 2005, J PERS SOC PSYCHOL, V88, P139, DOI 10.1037/0022-3514.88.1.139; Masten AS, 2007, DEV PSYCHOPATHOL, V19, P921, DOI 10.1017/S0954579407000442; Nishi D, 2013, PSYCHIAT CLIN NEUROS, V67, P174, DOI 10.1111/pcn.12028; O'Reilly E, 2014, TEACH LEARN MED, V26, P56, DOI 10.1080/10401334.2013.857330; Preacher KJ, 2008, BEHAV RES METHODS, V40, P879, DOI 10.3758/BRM.40.3.879; Rab F., 2008, Eastern Mediterranean Health Journal, V14, P126; Salazar-Pousada D, 2010, OBSTET GYNECOL INT, V2010, DOI 10.1155/2010/952493; Saravanan Coumaravelou, 2014, ScientificWorldJournal, V2014, P737382, DOI 10.1155/2014/737382; Sareen J, 2005, ARCH GEN PSYCHIAT, V62, P1249, DOI 10.1001/archpsyc.62.11.1249; Senaratne R, 2010, J NERV MENT DIS, V198, P876, DOI 10.1097/NMD.0b013e3181fe7450; Singh I., 2013, J ED DEV PSYCHOL, V3, P222, DOI [10.5539/jedp.v3n1p222, DOI 10.5539/JEDP.V3N1P222]; Soubelet A, 2010, PERS INDIV DIFFER, V49, P896, DOI 10.1016/j.paid.2010.07.026; Tian J, 2013, SUPPORT CARE CANCER, V21, P1497, DOI 10.1007/s00520-012-1699-x; Uliaszek AA, 2010, ANXIETY STRESS COPIN, V23, P363, DOI 10.1080/10615800903377264; Vos T, 2012, LANCET, V380, P2163, DOI 10.1016/S0140-6736(12)61729-2; Wagnild G M, 1993, J Nurs Meas, V1, P165; Wagnild G, 2009, J NURS MEAS, V17, P105, DOI 10.1891/1061-3749.17.2.105; Wang Y, 2014, BMC PSYCHIATRY, V14, DOI 10.1186/1471-244X-14-61; Wang Z.Y., 1984, J SHANGHAI PSYCHIAT, V2, P73; Wen DL, 2013, BMC MED EDUC, V13, DOI 10.1186/1472-6920-13-130; Windle G, 2011, HEALTH QUAL LIFE OUT, V9, DOI 10.1186/1477-7525-9-8; Wittchen HU, 2002, DEPRESS ANXIETY, V16, P162, DOI 10.1002/da.10065; Wu G, 2013, FRONT BEHAV NEUROSCI, V7, DOI 10.3389/fnbeh.2013.00010; Yusoff MSB, 2013, ASIAN J PSYCHIATR, V6, P128, DOI 10.1016/j.ajp.2012.09.012; Zhang X., 2005, PSYCHOL DEV ED, V21, P98; ZUNG WWK, 1971, PSYCHOSOMATICS, V12, P371	57	64	66	2	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0119916	10.1371/journal.pone.0119916	http://dx.doi.org/10.1371/journal.pone.0119916			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CE8IA	25794003	Green Published, gold, Green Submitted			2022-12-27	WOS:000352084200129
J	Talley, DM; Talley, TS; Blanco, A				Talley, Drew M.; Talley, Theresa Sinicrope; Blanco, Alexander			Insights into the Establishment of the Manila Clam on a Tidal Flat at the Southern End of an Introduced Range in Southern California, USA	PLOS ONE			English	Article							SALT-MARSH; RUDITAPES-PHILIPPINARUM; ENVIRONMENTAL-STRESS; BRITISH-COLUMBIA; INVASION; RECRUITMENT; SETTLEMENT; ORGANISMS; DIVERSITY; ESTUARIES	Coastal ecosystem modifications have contributed to the spread of introduced species through alterations of historic disturbance regimes and resource availability, and increased propagule pressure. Frequency of occurrence of the Manila clam (Venerupis phillipinarum, Veneridae) in Southern California estuaries has increased from absent or sparse to common since the mid-1990s. Potential invasion vectors include seafood sales and aquaculture, and spread from established northern populations over decades. The clam's post-settlement habitat preferences are, however, uncertain in this region. Our project aimed to identify factors associated with established patches of the clam within a bay toward the southern end of this introduced range. During summer 2013, we sampled 10 tidal flat sites in Mission Bay, San Diego; each containing an area with and without hard structure (e. g., riprap, boulders). We measured likely environmental influences (e. g., sediment variables, distance to ocean). Manila clam densities across the bay were most strongly associated with site, where highest densities were located in the northern and/or back halves of the bay; and weakly correlated with lower porewater salinities. Within sites, Manila clam density was enhanced in the presence of hard structure in most sites. Prevailing currents and salinity regimes likely contribute to bay wide distributions, while hard structures may provide suitable microhabitats (refuge from predators and physical stress) and larval entrapment within sites. Results provide insights into decisions about future shoreline management efforts. Finally, we identify directions for future study to better understand and therefore predict patterns of establishment of the Manila clam in the southern portion of its introduced range.	[Talley, Drew M.; Blanco, Alexander] Univ San Diego, Dept Marine Sci & Environm Studies, San Diego, CA 92110 USA; [Talley, Theresa Sinicrope] Univ Calif San Diego, Scripps Inst Oceanog, Calif Sea Grant Extens Program, La Jolla, CA 92093 USA	University of San Diego; University of California System; University of California San Diego; Scripps Institution of Oceanography	Talley, DM (corresponding author), Univ San Diego, Dept Marine Sci & Environm Studies, San Diego, CA 92110 USA.	dtalley@sandiego.edu	Talley, Drew/M-7872-2019		University of San Diego TRiO McNair Scholars Post274 baccalaureate Achievement Program	University of San Diego TRiO McNair Scholars Post274 baccalaureate Achievement Program	This project was funded in part by the University of San Diego TRiO McNair Scholars Post274 baccalaureate Achievement Program in which AB participated during summer 2013. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Abelson A, 1997, ANNU REV ECOL SYST, V28, P317, DOI 10.1146/annurev.ecolsys.28.1.317; Barros F, 2001, ESTUAR COAST SHELF S, V52, P191, DOI 10.1006/ecss.2000.0734; BAYNE BL, 1979, PHILOS T ROY SOC B, V286, P563, DOI 10.1098/rstb.1979.0046; Bendell LI, 2014, ESTUAR COAST, V37, P369, DOI 10.1007/s12237-013-9677-1; Bonsall MB, 2004, J ANIM ECOL, V73, P1043, DOI 10.1111/j.0021-8790.2004.00874.x; BOURNE N, 1982, Journal of Shellfish Research, V2, P47; Burnaford JL, 2011, MAR BIOL, V158, P1915, DOI 10.1007/s00227-011-1703-x; Caldow RWG, 2007, P ROY SOC B-BIOL SCI, V274, P1449, DOI 10.1098/rspb.2007.0072; Carlton James T., 1992, Journal of Shellfish Research, V11, P489; Chew K, 1989, DEV AQUACULTURE FISH, P243; Cohen A.N, 2011, EXOTICS GUIDE NONNAT; Cooper M, 2013, SAN DIEGO BAY NATIVE; Crooks Jeffrey A., 2001, Biological Invasions, V3, P23, DOI 10.1023/A:1011404914338; Davis JLD, 2002, MAR BIOL, V140, P1249, DOI 10.1007/s00227-002-0779-8; DAVIS N, 1982, MAR BIOL, V70, P295, DOI 10.1007/BF00396848; Dudas SE, 2005, J EXP MAR BIOL ECOL, V325, P8, DOI 10.1016/j.jembe.2005.04.015; Dugan JE, 2008, MAR ECOL-EVOL PERSP, V29, P160, DOI 10.1111/j.1439-0485.2008.00231.x; Ermgassen PSEZ, 2012, P ROY SOC B-BIOL SCI, V279, P3393, DOI 10.1098/rspb.2012.0313; Fimrite P, 2013, SFGATE          1115; Fimrite P, 2012, SFGATE          0706; Fisheries and Aquaculture Department, 2011, DAT INTR AQ SPEC DIA; Gedan KB, 2009, ANNU REV MAR SCI, V1, P117, DOI 10.1146/annurev.marine.010908.163930; GREEN BF, 1960, PSYCHOMETRIKA, V25, P127, DOI 10.1007/BF02288577; Grosholz ED, 2012, AQUATIC INVASIVE SPE; Herbert RJH, 2012, J BIOGEOGR, V39, P585, DOI 10.1111/j.1365-2699.2011.02626.x; Johnson K, 2008, STATUS FISHERIES REP; Jones G.G., 1993, MANILA CLAMS HATCHER; Largier JL, 1997, ESTUAR COAST SHELF S, V45, P789, DOI 10.1006/ecss.1997.0279; Levin LA, 2000, CONCEPTS AND CONTROVERSIES IN TIDAL MARSH ECOLOGY, P661; LEVIN LA, 1983, ESTUARIES, V6, P364, DOI 10.2307/1351395; LINDBERG SE, 1973, LIMNOL OCEANOGR, V18, P788, DOI 10.4319/lo.1973.18.5.0788; Lockwood JL, 2007, INVASION ECOLOGY; MACDONALD KB, 1969, ECOL MONOGR, V39, P33, DOI 10.2307/1948564; MENGE BA, 1987, AM NAT, V130, P730, DOI 10.1086/284741; NORDBY CS, 1991, ESTUARIES, V14, P80, DOI 10.2307/1351985; Novoa A, 2013, P 2013 SACNAS NAT C; Paul-Pont I, 2010, ENVIRON SCI POLLUT R, V17, P987, DOI 10.1007/s11356-009-0283-5; Pellizzato M, 2011, AQUACULT INT, V19, P541, DOI 10.1007/s10499-010-9370-3; Peterson CH, 2004, MAR ECOL PROG SER, V268, P81, DOI 10.3354/meps268081; Ponurovsky S. K., 1992, Journal of Shellfish Research, V11, P265; Pranovi F, 2006, BIOL INVASIONS, V8, P595, DOI 10.1007/s10530-005-1602-5; Queiros AD, 2011, BIOL INVASIONS, V13, P1059, DOI 10.1007/s10530-011-9948-3; Reilly PN, 2001, CALIFORNIAS LIVING M; Siegel DA, 2008, P NATL ACAD SCI USA, V105, P8974, DOI 10.1073/pnas.0802544105; Silliman BR, 2004, CONSERV BIOL, V18, P1424, DOI 10.1111/j.1523-1739.2004.00112.x; Souza W, 1979, ECOLOGY, V60, P1225; Steel R., 1997, PRINCIPLES PROCEDURE; Tezuka N, 2013, J EXP MAR BIOL ECOL, V439, P108, DOI 10.1016/j.jembe.2012.10.020; THOMPSON DS, 1995, ESTUARIES, V18, P91, DOI 10.2307/1352285; Thrush SF, 1996, MAR ECOL PROG SER, V132, P83, DOI 10.3354/meps132083; Tuskes Paul M., 2012, Festivus, V44, P13; Tyrrell MC, 2007, J EXP MAR BIOL ECOL, V342, P54, DOI 10.1016/j.jembe.2006.10.014; Wetzel MA, 2014, MAR ENVIRON RES, V99, P125, DOI 10.1016/j.marenvres.2014.04.008	53	11	11	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0118891	10.1371/journal.pone.0118891	http://dx.doi.org/10.1371/journal.pone.0118891			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25793603	Green Published, Green Submitted, gold			2022-12-27	WOS:000352084200044
J	Wang, T; Huang, KK; Wang, Z; Zheng, XP				Wang, Tao; Huang, Keke; Wang, Zhen; Zheng, Xiaoping			Impact of Small Groups with Heterogeneous Preference on Behavioral Evolution in Population Evacuation	PLOS ONE			English	Article							TIT-FOR-TAT; PRISONERS-DILEMMA; COOPERATION; RECIPROCITY; GAMES; NEIGHBORHOOD	Up to now, there have been a great number of mechanisms to explain the individual behavior and population traits, which seem of particular significance in evolutionary biology and social behavior analysis. Among them, small groups and heterogeneity are two useful frameworks to the above issue. However, vast majority of existing works separately consider both scenarios, which is inconsistent with realistic cases in our life. Here we propose the evolutionary games of heterogeneous small groups (namely, different small groups possess different preferences to dilemma) to study the collective behavior in population evacuation. Importantly, players usually face completely different dilemmas inside and outside the small groups. By means of numerous computation simulations, it is unveiled that the ratio of players in one certain small group directly decides the final behavior of the whole population. Moreover, it can also be concluded that heterogeneous degree of preference for different small groups plays a key role in the behavior traits of the system, which may validate some realistic social observations. The proposed framework is thus universally applicable and may shed new light into the solution of social dilemmas.	[Wang, Tao; Huang, Keke; Wang, Zhen; Zheng, Xiaoping] Tsinghua Univ, Dept Automat, Beijing 100084, Peoples R China; [Wang, Zhen] Kyushu Univ, Interdisciplinary Grad Sch Engn Sci, Kasuga, Fukuoka 8168580, Japan	Tsinghua University; Kyushu University	Zheng, XP (corresponding author), Tsinghua Univ, Dept Automat, Beijing 100084, Peoples R China.	asean@mail.tsinghua.edu.cn			973 Program [2011CB706900]; National Natural Science Foundation of China [71225007]	973 Program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was financially supported in part by the 973 Program under Grant 2011CB706900, and by the National Natural Science Foundation of China under Grants 71225007. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramson G, 2001, PHYS REV E, V63, DOI 10.1103/PhysRevE.63.030901; AVENI AF, 1977, SOCIOMETRY, V40, P96, DOI 10.2307/3033551; AXELROD R, 1981, SCIENCE, V211, P1390, DOI 10.1126/science.7466396; Boccaletti S, 2014, PHYS REP, V544, P1, DOI 10.1016/j.physrep.2014.07.001; Bonabeau E, 2002, P NATL ACAD SCI USA, V99, P7280, DOI 10.1073/pnas.082080899; Chadefaux T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013471; Chazelle B, 2015, J STAT PHYS, V158, P514, DOI 10.1007/s10955-014-1140-6; Doebeli M, 2005, ECOL LETT, V8, P748, DOI 10.1111/j.1461-0248.2005.00773.x; Fu F, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.016104; Ge WN, 2012, IEEE T PATTERN ANAL, V34, P1003, DOI 10.1109/TPAMI.2011.176; Helbing D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012530; Helbing D, 2008, ADV COMPLEX SYST, V11, P641, DOI 10.1142/S0219525908001866; Hofbauer J, 1998, EVOLUTIONARY GAMES P; Jin Q, 2014, SCIENTIFIC REPORTS, V4; JOHNSON NR, 1987, SOC PROBL, V34, P362, DOI 10.1525/sp.1987.34.4.03a00040; Ma ZQ, 2011, INT J MOD PHYS C, V22, P1257, DOI 10.1142/S0129183111016877; Macal CM, 2005, PROCEEDINGS OF THE 2005 WINTER SIMULATION CONFERENCE, VOLS 1-4, P2, DOI 10.1109/WSC.2005.1574234; Maynard Smith J., 1982, pi; Meloni S, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.067101; NOWAK M, 1993, NATURE, V364, P56, DOI 10.1038/364056a0; NOWAK MA, 1992, NATURE, V355, P250, DOI 10.1038/355250a0; NOWAK MA, 1992, NATURE, V359, P826, DOI 10.1038/359826a0; Nowak MA, 2006, EVOLUTIONARY DYNAMIC; Nowak MA, 2006, SCIENCE, V314, P1560, DOI 10.1126/science.1133755; Ohtsuki H, 2009, NATURE, V457, P79, DOI 10.1038/nature07601; Paternotte C, 2012, BRIT J PHILOS SCI; Pennisi E, 2005, SCIENCE, V309, P93, DOI 10.1126/science.309.5731.93; Perc M, 2013, CHAOS SOLITON FRACT, V56, P1, DOI 10.1016/j.chaos.2013.06.002; Perc M, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0997; Perc M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015117; Perc M, 2010, BIOSYSTEMS, V99, P109, DOI 10.1016/j.biosystems.2009.10.003; Poncela J, 2010, INT J BIFURCAT CHAOS, V20, P849, DOI 10.1142/S0218127410026137; Poundstone W., 1992, PRISONERS DILEMMA J; Rand DG, 2013, P NATL ACAD SCI USA, V110, P2581, DOI 10.1073/pnas.1214167110; Roca CP, 2009, PHYS LIFE REV, V6, P208, DOI 10.1016/j.plrev.2009.08.001; Roca CP, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.046106; Santos FC, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.098104; Smelser N.J., 2011, THEORY COLLECTIVE BE; Sysi-Aho M, 2005, EUR PHYS J B, V44, P129, DOI 10.1140/epjb/e2005-00108-5; Szabo G, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.118101; Szabo G, 2007, PHYS REP, V446, P97, DOI 10.1016/j.physrep.2007.04.004; Szolnoki A, 2010, EPL-EUROPHYS LETT, V92, DOI 10.1209/0295-5075/92/38003; Uguz S, 2013, INT J BIFURCAT CHAOS, V23, DOI 10.1142/S0218127413501010; Wang J, 2012, CHINESE SCI BULL, V57, P724, DOI 10.1007/s11434-011-4890-4; Wang Z, 2013, SCI REPORTS, V3; Wang Z, 2013, PHYS REV E, V88, DOI 10.1103/PhysRevE.88.042145; Weibull J W, 1997, EVOLUTIONARY GAME TH; Xia CY, 2013, CHAOS SOLITON FRACT, V51, P22, DOI 10.1016/j.chaos.2013.03.002; Yuan WJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091012; Zhang GQ, 2013, CHAOS SOLITON FRACT, V51, P31, DOI 10.1016/j.chaos.2013.03.003; Zheng XP, 2011, COMPUT MATH APPL, V62, P4627, DOI 10.1016/j.camwa.2011.10.048	52	19	19	5	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0121949	10.1371/journal.pone.0121949	http://dx.doi.org/10.1371/journal.pone.0121949			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25793637	gold, Green Published, Green Submitted			2022-12-27	WOS:000352083900159
J	Wolfson, LJ; Walker, A; Hettle, R; Lu, XY; Kambili, C; Murungi, A; Knerer, G				Wolfson, Lara J.; Walker, Anna; Hettle, Robert; Lu, Xiaoyan; Kambili, Chrispin; Murungi, Andrew; Knerer, Gerhart			Cost-Effectiveness of Adding Bedaquiline to Drug Regimens for the Treatment of Multidrug-Resistant Tuberculosis in the UK	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; HOUSEHOLD CONTACTS; TRANSMISSION; FITNESS; RISK; LIFE	Objective To evaluate the cost-effectiveness of adding bedaquiline to a background regimen (BR) of drugs for multidrug-resistant tuberculosis (MDR-TB) in the United Kingdom (UK). Methods A cohort-based Markov model was developed to estimate the incremental cost-effectiveness ratio of bedaquiline plus BR (BBR) versus BR alone (BR) in the treatment of MDR-TB, over a 10-year time horizon. A National Health Service (NHS) and personal social services perspective was considered. Cost-effectiveness was evaluated in terms of Quality-Adjusted Life Years (QALYs) and Disability-Adjusted Life Years (DALYs). Data were sourced from a phase II, placebo-controlled trial, NHS reference costs, and the literature; the US list price of bedaquiline was used and converted to pounds ( pound 18,800). Costs and effectiveness were discounted at a rate of 3.5% per annum. Probabilistic and deterministic sensitivity analysis was conducted. Results The total discounted cost per patient (pp) on BBR was pound 106,487, compared with pound 117,922 for BR. The total discounted QALYs pp were 5.16 for BBR and 4.01 for BR. The addition of bedaquiline to a BR resulted in a cost-saving of pound 11,434 and an additional 1.14 QALYs pp over a 10-year period, and is therefore considered to be the dominant (less costly and more effective) strategy over BR. BBR remained dominant in the majority of sensitivity analyses, with a 81% probability of being dominant versus BR in the probabilistic analysis. Conclusions In the UK, bedaquiline is likely to be cost-effective and cost-saving, compared with the current MDR-TB standard of care under a range of scenarios. Cost-savings over a 10-year period were realized from reductions in length of hospitalization, which offset the bedaquiline drug costs. The cost-benefit conclusions held after several sensitivity analyses, thus validating assumptions made, and suggesting that the results would hold even if the actual price of bedaquiline in the UK were higher than in the US.	[Wolfson, Lara J.; Lu, Xiaoyan] Janssen Pharmaceut NV, Beerse, Belgium; [Walker, Anna; Hettle, Robert] HERON Commercializat, London, England; [Kambili, Chrispin] Janssen Global Serv LLC, Raritan, NJ USA; [Murungi, Andrew; Knerer, Gerhart] Janssen Janssen Cilag, High Wycombe, Bucks, England	Johnson & Johnson; Janssen Pharmaceuticals; Johnson & Johnson; Janssen Pharmaceuticals	Wolfson, LJ (corresponding author), Janssen Pharmaceut NV, Beerse, Belgium.	LWolfson@its.jnj.com	Wolfson, Lara/AAC-1400-2019	Wolfson, Lara/0000-0002-6454-3368	Janssen Pharmaceutical Companies of Johnson and Johnson; Janssen Pharmaceutica N.V.; Janssen Global Services LLC; Janssen-Cilag; HERON(TM) Commercialization	Janssen Pharmaceutical Companies of Johnson and Johnson; Janssen Pharmaceutica N.V.(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Janssen Global Services LLC; Janssen-Cilag(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); HERON(TM) Commercialization	The study was commissioned and funded by Janssen Pharmaceutical Companies of Johnson and Johnson. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. LJW and XL were employed by Janssen Pharmaceutica N.V. at the time of writing this manuscript; CK was employed by Janssen Global Services LLC; and GK and AM were employed by Janssen-Cilag. Janssen Pharmaceutica N.V., Janssen Global Services LLC, Janssen-Cilag and AW and RH are employed by HERON (TM) Commercialization. Janssen Pharmaceutica N.V., Janssen Global Services LLC, Janssen-Cilag and HERON (TM) Commercialization provided support in the form of salaries for authors LJW, XL, CK, GK, AM, AW and RH, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the author contributions section.	[Anonymous], 2008, GUID PROGR MAN DRUG; Blower SM, 2004, NAT MED, V10, P1111, DOI 10.1038/nm1102; Brigden G, 2014, B WORLD HEALTH ORGAN, V92, P68, DOI 10.2471/BLT.13.122028; Cohen T, 2004, NAT MED, V10, P1117, DOI 10.1038/nm1110; Curry International TB Center, 2008, CITC CURR INT TUB CT; Day M, 2012, EURO SURVEILL, V17; Denholm JT, 2012, INT J TUBERC LUNG D, V16, P1320, DOI 10.5588/ijtld.12.0092; Department of Health, 2013, BRIT NATL FORMULARY; Department of Health, 2012, NHS REF COSTS 2011 2; Diacon AH, 2014, NEW ENGL J MED, V371, P723, DOI 10.1056/NEJMoa1313865; Diel R., 2013, EUR RESP J; Drummond MF, 2007, INT J TECHNOL ASSESS, V23, P36, DOI 10.1017/S0266462307051550; ECDC, 2013, TUB SURV MON EUR; EMA, 2014, ORPH DES; European Commission, 2015, COMM REG MED PROD HU; European Medicines Agency, 2013, EMACHMP7713242013; FDA, 2012, ANT DRUGS ADV COMM M; Franke MF, 2008, CLIN INFECT DIS, V46, P1844, DOI 10.1086/588292; Grandjean L, 2011, INT J TUBERC LUNG D, V15, P1164, DOI 10.5588/ijtld.11.0030; Guglielmetti L, 2015, CLIN INFECT DIS, V60, P188, DOI 10.1093/cid/ciu786; Guo N, 2009, HEALTH QUAL LIFE OUT, V7, DOI 10.1186/1477-7525-7-14; Health Protection Agency, 2013, TUB UK ANN REP TUB S; HPA, 2014, TUB UK 2013 REP; Janssen, 2013, SIRTURO HIGHLIGHTS U; Jit M, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5376; Kind P., 1999, 172 U YORK YORK HLTH; Kurbatova E, 2013, EVALUATION SPUTUM CU; Liao CM, 2012, RISK ANAL, V32, P1420, DOI 10.1111/j.1539-6924.2011.01750.x; Liu CH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019399; Luciani F, 2009, P NATL ACAD SCI USA, V106, P14711, DOI 10.1073/pnas.0902437106; Lunn DJ, 2000, STAT COMPUT, V10, P325, DOI 10.1023/A:1008929526011; Murphy BM, 2002, MATH BIOSCI, V180, P161, DOI 10.1016/S0025-5564(02)00133-5; MURRAY CJL, 1994, B WORLD HEALTH ORGAN, V72, P429; National Institute for Health & Care Excellence (NICE), 2010, MEAS EFF COST EFF QA; Ndjeka N, 2014, S AFR MED J, V104, P164; Neely F, 2010, J PUBLIC HEALTH-UK, V32, P44, DOI 10.1093/pubmed/fdp056; NICE, 2011, CG117 NICE; NICE, 2009, METH DEV NICE PUBL H; ONS, 2013, OFF NAT STAT LIF TAB; Ormerod P, 1998, THORAX, V53, P536; Rawlins MD, 2004, BRIT MED J, V329, P224, DOI 10.1136/bmj.329.7459.224; Resch SC, 2006, PLOS MED, V3, P1048, DOI 10.1371/journal.pmed.0030241; Salomon JA, 2012, LANCET, V380, P2129, DOI 10.1016/S0140-6736(12)61680-8; Siebert U, 2012, VALUE HEALTH, V15, P812, DOI 10.1016/j.jval.2012.06.014; Single N, 2011, INT J TUBERC LUNG D, V15, P1326, DOI 10.5588/ijtld.10.0564; Tiemersma EW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017601; US CDC, 2007, MULT RES TUB MDR TB; Van Deun A, 2010, AM J RESP CRIT CARE, V182, P684, DOI 10.1164/rccm.201001-0077OC; Vassell A, 2013, COST EFFECTIVENESS I; White VLC, 2000, THORAX, V55, P962, DOI 10.1136/thorax.55.11.962; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; *WHO, 2011, GLOB PLAN STOP TB 20; World Health Organization, 2013, USE BEDAQUILINE TREA; World Health Organization, DEF REP FRAM TUB 201	54	31	34	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0120763	10.1371/journal.pone.0120763	http://dx.doi.org/10.1371/journal.pone.0120763			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25794045	Green Published, Green Submitted, gold			2022-12-27	WOS:000352083900073
J	Xia, H; Hu, C; Zhang, DK; Tang, S; Zhang, Z; Kou, Z; Fan, ZJ; Bente, D; Zeng, CQ; Li, TX				Xia, Han; Hu, Cheng; Zhang, Dake; Tang, Shuang; Zhang, Zhong; Kou, Zheng; Fan, Zhaojun; Bente, Dennis; Zeng, Changqing; Li, Tianxian			Metagenomic Profile of the Viral Communities in Rhipicephalus spp. Ticks from Yunnan, China	PLOS ONE			English	Article							DISEASE VIRUS; BORNE; DIVERSITY; FEVER; PHLEBOVIRUS; REVEALS; BATS	Besides mosquitoes, ticks are regarded as the primary source of vector-borne infectious diseases. Indeed, a wide variety of severe infectious human diseases, including those involving viruses, are transmitted by ticks in many parts of the world. To date, there are no published reports on the use of next-generation sequencing for studying viral diversity in ticks or discovering new viruses in these arthropods from China. Here, Ion-torrent sequencing was used to investigate the presence of viruses in three Rhipicephalus spp. tick pools (NY-11, NY-13, and MM-13) collected from the Menglian district of Yunnan, China. The sequencing run resulted in 3,641,088, 3,106,733, and 3,871,851 reads in each tick pool after trimming. Reads and assembled contiguous sequences (contigs) were subject to basic local alignment search tool analysis against the GenBank database. Large numbers of reads and contigs related to known viral sequences corresponding to a broad range of viral families were identified. Some of the sequences originated from viruses that have not been described previously in ticks. Our findings will facilitate better understanding of the tick virome, and add to our current knowledge of disease-causing viruses in ticks living under natural conditions.	[Xia, Han; Tang, Shuang; Zhang, Zhong; Kou, Zheng; Fan, Zhaojun; Li, Tianxian] Chinese Acad Sci, Wuhan Inst Virol, State Key Lab Virol, Wuhan, Hubei, Peoples R China; [Xia, Han; Bente, Dennis] Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA; [Hu, Cheng] Wuhan Univ, Int Sch Software, Wuhan, Hubei, Peoples R China; [Zhang, Dake; Zeng, Changqing] Chinese Acad Sci, Lab Genome Variat & Precis Biomed, Beijing Inst Genom, Beijing, Peoples R China	Chinese Academy of Sciences; Wuhan Institute of Virology, CAS; University of Texas System; University of Texas Medical Branch Galveston; Wuhan University; Chinese Academy of Sciences; Beijing Institute of Genomics, CAS	Zeng, CQ (corresponding author), Chinese Acad Sci, Lab Genome Variat & Precis Biomed, Beijing Inst Genom, 1 Beichen West Rd, Beijing, Peoples R China.	czeng@big.ac.cn; litx@wh.iov.cn	XIA, HAN/AAT-7458-2020; Zhang, Dake/H-3210-2019; goletti, delia/AAM-6577-2020	XIA, HAN/0000-0001-9932-6040; Zhang, Dake/0000-0001-9508-8209; Goletti, Delia/0000-0001-8360-4376; KOU, Zheng/0000-0003-4758-2872	Ministry of Science and Technology of China [2013FY113500]; Chinese Academy of Sciences [INFOXXH12504-1-06]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); Chinese Academy of Sciences(Chinese Academy of Sciences)	This research was supported by the Ministry of Science and Technology of China (grant No. 2013FY113500), Chinese Academy of Sciences (grant Nos. INFOXXH12504-1-06). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreotti R, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-6; Bente DA, 2013, ANTIVIR RES, V100, P159, DOI 10.1016/j.antiviral.2013.07.006; Biagini P, 2006, J MED VIROL, V78, P298, DOI 10.1002/jmv.20539; Bzhalava D, 2013, J DATA MIN GENOM PRO, V4, P134; Chen Z, 2008, SICHUAN J ZOOL, V27, P4; Chitimia L, 2009, PARASITOL RES, V105, P907, DOI 10.1007/s00436-009-1474-1; Dacheux L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087194; Dantas-Torres F, 2012, TRENDS PARASITOL, V28, P437, DOI 10.1016/j.pt.2012.07.003; de la Fuente J, 2008, FRONT BIOSCI, V1, P9; de Villiers EM, 2011, J VIROL, V85, P7284, DOI 10.1128/JVI.02472-10; Gao XY, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000624; Ge XY, 2012, J VIROL, V86, P4620, DOI 10.1128/JVI.06671-11; Ghedin E, 2013, J GEN VIROL, V94, P2609, DOI 10.1099/vir.0.055939-0; Gibbs A, 1986, THE PLANT VIRUSES, P167; Gong ZD, 2001, CHINA J PEST CO, V2, P3; Havlikova S, 2013, ACTA VIROL, V57, P123, DOI 10.4149/av_2013_02_123; Holbrook MR, 2012, ANTIVIR RES, V96, P353, DOI 10.1016/j.antiviral.2012.10.005; Honig JE, 2004, VIROLOGY, V318, P10, DOI 10.1016/j.virol.2003.09.021; Jiang DH, 2013, ADV VIRUS RES, V86, P215, DOI 10.1016/B978-0-12-394315-6.00008-8; Karabatsos N., 1985, INTERNATIONAL CATALO; Kaufman WR, 2003, EXP PARASITOL, V104, P20, DOI 10.1016/S0014-4894(03)00113-9; Labuda M, 2004, PARASITOLOGY, V129, pS221, DOI 10.1017/S0031182004005220; Lasecka L, 2014, ARCH VIROL, V159, P1249, DOI 10.1007/s00705-013-1940-z; Liu L, 2012, J BIOMED BIOTECHNOL, V50, P2881; Lwande OW, 2013, VECTOR-BORNE ZOONOT, V13, P637, DOI 10.1089/vbz.2012.1190; Marczinke BI, 2002, VIROLOGY, V303, P146, DOI 10.1006/viro.2002.1514; McMullan LK, 2012, NEW ENGL J MED, V367, P834, DOI 10.1056/NEJMoa1203378; Nersesov V. A., 2003, Meditsinskaya Parazitologiya i Parazitarnye Bolezni, P30; Ng TFF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020579; Radford AD, 2012, J GEN VIROL, V93, P1853, DOI 10.1099/vir.0.043182-0; Savage HM, 2013, AM J TROP MED HYG, V89, P445, DOI 10.4269/ajtmh.13-0209; Steffen MM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044002; Tokarz R, 2014, J VIROL, V88, P11480, DOI 10.1128/JVI.01858-14; Tokarz R, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-26; Wang JL, 2009, EMERG INFECT DIS, V15, P326, DOI 10.3201/eid1502.080979; Whon TW, 2012, J VIROL, V86, P8221, DOI 10.1128/JVI.00293-12; Wu XB, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-119; Xia H, 2011, INT J INFECT DIS, V15, pE459, DOI 10.1016/j.ijid.2011.03.013; Yu XJ, 2011, NEW ENGL J MED, V364, P1523, DOI 10.1056/NEJMoa1010095	39	82	87	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2015	10	3							e0121609	10.1371/journal.pone.0121609	http://dx.doi.org/10.1371/journal.pone.0121609			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE6ZS	25867946	Green Published, Green Submitted, gold			2022-12-27	WOS:000351987300276
J	Xia, H; Wang, XM; Li, FB; Longuet, C; Vernet, G; Goletti, D; Zhao, YL; Lagrange, PH				Xia, Hui; Wang, Xiaomen; Li, Fabin; Longuet, Christophe; Vernet, Guy; Goletti, Delia; Zhao, Yanlin; Lagrange, Philippe H.			Diagnostic Values of the QuantiFERON-TB Gold In-Tube Assay Carried out in China for Diagnosing Pulmonary Tuberculosis	PLOS ONE			English	Article							GAMMA RELEASE ASSAYS; BLOOD INTERFERON-GAMMA; ACTIVE TUBERCULOSIS; MYCOBACTERIUM-TUBERCULOSIS; SKIN-TEST; CLINICAL UTILITY; INFECTION; LATENT; BCG; IMMUNODIAGNOSIS	Background Interferon-release assays (IGRAs) for diagnosing active pulmonary tuberculosis (PTB) are not yet fully validated, particularly in high TB-endemic areas as the People's Republic of China (PRC). The aim of this report was to assess the performance of the QuantiFERON-TB Gold In-tube (QFT-GIT) and tuberculin skin test (TST), in addition to microbiological results, as contributors for diagnosing active PTB in the PRC. Methods/Principal Findings A total of 300 PTB patients, 41 disease controls (DC) and 59 healthy community controls (HCC) were included prospectively between May 2010 and April 2011 from two provinces of the PRC (Heilongjiang and Zhejiang). The QFT-GIT and TST yielded an overall sensitivity for active TB of 80.9% and 86.2%, and a specificity of 36.6% and 26.8%, respectively. The province of origin and smear microscopy status did not significantly impact the diagnostic values for PTB. However, using the TST with a 10 mm cut-off point, a significantly higher proportion of LTBI was observed in the DC than the HCC (p=0.01). Discordant results between the QFT-GIT and TST were found among 1/3 of the PTB, HCC and DC. Two-thirds of the individuals presented TST-positive/QFT-GIT-negative discordant results. The TST-negative/QFT-GIT-positive result was not associated with age or bacillary load. Cumulative QFT-GIT and TST positive results increased the overall sensitivity (95.9%), but it was associated with a dramatic decrease of the overall specificity (24.8%) leading to a suboptimal PPV (80.1%) and a low NPV (61.1%). Conclusions/Significance The usefulness of the QFT-GIT to diagnose active TB in high TB-endemic countries remains doubtful because like the TST, the QFT-GIT cannot distinguish between LTBI and active TB. Used as single stand-alone tests, both the QFT-GIT and TST have very limited roles in the diagnosis of active PTB. However, the combined use of SM, the TST and QFT-GIT may allow for the exclusion of ATB.	[Xia, Hui; Zhao, Yanlin] Chinese Ctr Dis Control & Prevent, Natl TB Reference Lab, Beijing, Peoples R China; [Wang, Xiaomen] TB Control Ctr Heilongjiang Prov, Harbin, Heilongjiang, Peoples R China; [Li, Fabin] Zhejiang Prov Ctr Dis Control & Prevent, Hangzhou, Zhejiang, Peoples R China; [Longuet, Christophe; Vernet, Guy] Fdn Merieux, Lyon, France; [Goletti, Delia] L Spallanzani Natl Inst Infect Dis INMI, Dept Epidemiol & Preclin Res, Rome, Italy; [Lagrange, Philippe H.] Paris VII Denis Diderot Univ, Hop St Louis, AP HP, Microbiol Serv, Paris, France	Chinese Center for Disease Control & Prevention; Zhejiang Provincial Center for Disease Control & Prevention; IRCCS Lazzaro Spallanzani; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite	Zhao, YL (corresponding author), Chinese Ctr Dis Control & Prevent, Natl TB Reference Lab, Beijing, Peoples R China.	zhaoyanlin@chinatb.org; plagrange@sfr.fr	XIA, HAN/AAT-7458-2020; Zhang, Dake/H-3210-2019; goletti, delia/AAM-6577-2020	XIA, HAN/0000-0001-9932-6040; Zhang, Dake/0000-0001-9508-8209; Goletti, Delia/0000-0001-8360-4376; KOU, Zheng/0000-0003-4758-2872	Fondation Merieux	Fondation Merieux	Fondation Merieux funded the study. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen P, 2000, LANCET, V356, P1099, DOI 10.1016/S0140-6736(00)02742-2; Arend SM, 2007, AM J RESP CRIT CARE, V175, P618, DOI 10.1164/rccm.200608-1099OC; Bass Jr JB, 1993, TUBERCULOSIS A COMPR; Chen XC, 2009, CLIN VACCINE IMMUNOL, V16, P879, DOI 10.1128/CVI.00044-09; CHEN ZR, 1982, CHINESE MED J-PEKING, V95, P437; Chiacchio T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027539; Chinese Ministry of Health Disease Control and Prevention Bureau Center for Disease Control and Prevention, 2008, GUIDELINES FOR IMPLE; Chinese Ministry of Health Disease Control and Prevention Bureau Center for Disease Control and Prevention China TB control program, 2009, SPUTUM SMEAR MICROSC; Dai Y, 2012, EUR J CLIN MICROBIOL, V31, P3127, DOI 10.1007/s10096-012-1674-y; Delogu G, 2014, J RHEUMATOL, V41, P11, DOI 10.3899/jrheum.140097; Dheda K, 2009, CURR OPIN PULM MED, V15, P188, DOI 10.1097/MCP.0b013e32832a0adc; Diel R, 2010, CHEST, V137, P952, DOI 10.1378/chest.09-2350; Dosanjh DPS, 2008, ANN INTERN MED, V148, P325, DOI 10.7326/0003-4819-148-5-200803040-00003; Ewer K, 2006, AM J RESP CRIT CARE, V174, P831, DOI 10.1164/rccm.200511-1783OC; Farhat M, 2006, INT J TUBERC LUNG D, V10, P1192; Feng Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032652; Goletti D, 2014, J RHEUMATOL, V41, P24, DOI 10.3899/jrheum.140099; Goletti D, 2010, J INFECTION, V61, P133, DOI 10.1016/j.jinf.2010.05.002; Harada N, 2006, INFECT CONT HOSP EP, V27, P442, DOI 10.1086/504358; Hill PC, 2005, CLIN INFECT DIS, V40, P273, DOI 10.1086/427030; Hu PL, 2014, CHINESE MED J-PEKING, V127, P3744, DOI 10.3760/cma.j.issn.0366-6999.20141004; Jafari C, 2009, AM J RESP CRIT CARE, V180, P666, DOI 10.1164/rccm.200904-0557OC; Jiang WM, 2009, BMC IMMUNOL, V10, DOI 10.1186/1471-2172-10-31; Kabeer BSA, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-135; Kabeer BSA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009051; Lagrange PH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073579; Li WM, 2007, SCAND J INFECT DIS, V39, P138, DOI 10.1080/00365540600951234; Ling DI, 2011, EUR RESPIR J, V38, P649, DOI 10.1183/09031936.00181610; Lui G, 2011, J INFECTION, V62, P440, DOI 10.1016/j.jinf.2011.04.011; Mazurek GH, 2007, CLIN INFECT DIS, V45, P826, DOI 10.1086/521106; Menzies D, 2007, ANN INTERN MED, V146, P340, DOI 10.7326/0003-4819-146-5-200703060-00006; Metcalfe JZ, 2011, J INFECT DIS, V204, pS1120, DOI 10.1093/infdis/jir410; Ministry of Health People's Republic of China Joint United Nations Program on HIV/AIDS World Health Organization, 2011, 2011 ESTIMATES FOR T; Mori T, 2007, INT J TUBERC LUNG D, V11, P1021; Nahid Payam, 2006, Proc Am Thorac Soc, V3, P103, DOI 10.1513/pats.200511-119JH; Nienhaus A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002665; Ou XC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094544; Pai M, 2004, LANCET INFECT DIS, V4, P761, DOI 10.1016/S1473-3099(04)01206-X; Pai M, 2006, AM J RESP CRIT CARE, V174, P349, DOI 10.1164/rccm.200604-472OC; Pai M, 2006, EXPERT REV MOL DIAGN, V6, P413, DOI 10.1586/14737159.6.3.413; Park SY, 2009, SCAND J INFECT DIS, V41, P818, DOI 10.3109/00365540903214298; Sester M, 2011, EUR RESPIR J, V37, P100, DOI 10.1183/09031936.00114810; Small PM, 2010, NEW ENGL J MED, V363, P1070, DOI 10.1056/NEJMe1008496; Sodhi A, 1997, CLIN INFECT DIS, V25, P617, DOI 10.1086/513769; Theron G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037436; Thompson ML, 2003, BIOSTATISTICS, V4, P341, DOI 10.1093/biostatistics/4.3.341; Tsiouris SJ, 2006, J CLIN MICROBIOL, V44, P2844, DOI 10.1128/JCM.02411-05; World Health Organization [WHO], 2014, WHO REPORT 2013; Zhang M, 2010, INT J TUBERC LUNG D, V14, P1556; Zhang S, 2010, CLIN VACCINE IMMUNOL, V17, P1985, DOI 10.1128/CVI.00294-10	50	82	87	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0121021	10.1371/journal.pone.0121021	http://dx.doi.org/10.1371/journal.pone.0121021			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25867946	Green Published, gold, Green Submitted			2022-12-27	WOS:000352845100031
